whitefish antibody.immunoglobulin g.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||allergen specific antibody interpretation, semi-quantitative||component_of
alc withdraw failure times ssaga ii||how many times were you unable to stop or cut down on drinking||component_of
escherichia coli enterotoxigenic stb gene:prthr:pt:isolate:ord:probe.amp.tar||gene (substance)||component_of
borrelia burgdorferi 37kd antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal:immune blot||borrelia burgdorferi||component_of
c pneum igg csf ia-acnc||chlamydia pneumoniae grayston et al. 1989 (approved lists 1980)||component_of
r- + s-baib + d- + l-serine panel ur||s-beta aminoisobutyrate (substance)||component_of
gastrin [mass/volume] in serum or plasma --5th specimen post xxx challenge||gastrin^5th specimen post xxx challenge||component_of
cs site-specific factor 24 cancer||collaborative staging site-specific factor 24||component_of
malonate/creatinine:mrto:pt:urine:qn||malonate/creatinine||component_of
service comment 02:impression/interpretation of study:point in time:to be specified in another part of the message:nominal||service comment 02||component_of
epineph sp2 p chal plas-mcnc||challenge||component_of
nod2 gene mutation analysis:presence or identity:point in time:whole blood/tissue, unspecified:narrative:molecular genetics||gene (substance)||component_of
immunoglobulin m.monoclonal:presence or threshold:to identify measures at a point in time:serum:ordinal:immunofixation||igm - immunoglobulin m||component_of
reticulocytes.immature:number concentration (count/vol):to identify measures at a point in time:whole blood:quantitative||immature reticulocyte||component_of
mestanolone metabolite:presence or threshold:to identify measures at a point in time:urine:ordinal||mestanolone metabolite||component_of
knowledge deficit of dietary regimen:find:pt:^patient:ord:observed.ccc||rndx knowledge deficit of dietary regimen (diagnosis)||component_of
oral fluid benzodiazepine level||benzodiazepine||component_of
histoplasma capsulatum mycelial phase ab [titer] in serum by complement fixation||histoplasma capsulatum mycelial phase||component_of
my dislikes and fears:finding:to identify measures at a point in time:^patient:narrative:reported||my dislikes and fears||component_of
views screening for implant:finding:to identify measures at a point in time:breast:document:xr||views||component_of
albumin glycated serpl-mcnc||albumin.glycated||component_of
multisection^wo contrast:finding:to identify measures at a point in time:abdomen+pelvis:document:magnetic resonance||multisection^ wo contrast||component_of
hla-b71(70) in blood or tissue of donor (lab test)||human leucocyte ag b71(70)||component_of
arginine/total aa (dbs) [molar fraction]||arg||component_of
candida albicans reaction wheal^2 days post dose candida albicans intradermal:diameter:to identify measures at a point in time:skin:quantitative||reaction (qualifier value)||component_of
candida albicans igg4 ab [mass/volume] in serum||procandida albicans (c.p. robin) e.k. novak & zsolt, 1961||component_of
diagnostic imaging report - recommended c-cda r1.1 sections:-:to identify measures at a point in time:{setting}:-||c||component_of
11-ketoandrosterone [mass/volume] in 24 hour urine --pre high dose dexamethasone||before values (qualifier value)||component_of
feline infectious peritonitis virus ab:prthr:pt:ser:ord:ia||feline infectious peritonitis virus ab||component_of
btv10 ab titr ser||bluetongue virus 10 antibody||component_of
social worker initial evaluation note||initial evaluation note||component_of
m stage of distant metastasis:find:pt:skin melanoma:ord:cap cancer protocols||stages||component_of
bcat short form total score [bcat]||bcat short form total score||component_of
cd8+cd38+ cells nfr bld||cell type||component_of
isopropanol:presence or threshold:to identify measures at a point in time:whole blood:ordinal||isopropanol||component_of
(cucumis sativus+daucus carota+solanum tuberosum+spinacia oleracea) ab.ige:prthr:pt:ser:ord:multidisk||carrot (daucus carota)||component_of
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine/creatinine:mrto:pt:urine:qn||2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine/creatinine||component_of
gastrin pre chal serpl-scnc||gastrin^pre xxx challenge||component_of
coxiella burnetii ab.igm^2nd specimen:acnc:pt:ser:qn:if||immunoglobulin igm (substance)||component_of
bacteria # 6 identified in bronchial specimen by aerobe culture||superkingdom bacteria (organism)||component_of
frequency of pain interfering with activity or movement [cms assessment]||activities||component_of
serum fructosamine||fructosamine||component_of
(dactylis glomerata+festuca elatior+lolium perenne+phleum pratense+poa pratensis) antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal:multidisk||allergen specific antibody interpretation, semi-quantitative (observable entity)||component_of
eggplant ige rast ql||immunoglobulin e antibody||component_of
ara-c/cbdca/ida||arabinosylcytosine||component_of
hcov oc43 rna spec ql naa+probe||non polyadenylated rna||component_of
views static^w radionuclide intravenous:finding:to identify measures at a point in time:head>salivary gland:document:nm||views static^w radionuclide iv||component_of
ganglioside gd1b igg ib ql (s)||gd1b immunoglobulin g ganglioside antibody||component_of
qrs i-amp l-v1||qrs initial amplitude.lead v1||component_of
i had a headache in past 7d:find:7d:^patient:ord:promis.peds||i nos ag||component_of
lymphocyte proliferation stimulated by 2.5 ug phytohemagglutin actual/normal (bld) [relative ratio]||lymphocyte proliferation||component_of
blood flow velocity.systole.max/blood flow velocity.diastole.max:velocity ratio:to identify measures at a point in time:pulmonary vein.left upper:quantitative:ultrasound.doppler||diastole maximum||component_of
quinine induced platelet antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:flow cytometry||quinine-containing product||component_of
goosefoot igg qn (s)||ab.igg||component_of
hemoglobin test status cphs||haemoglobin, nos||component_of
oasis c2 - patient history and diagnoses - start of care or resumption of care:-:pt:^patient:-:cms assessment||patient history||component_of
2-methylpropyl methylphosphonate (u) [mass/vol]||2-methylpropyl methylphosphonate||component_of
porcine gelatin ige ab [units/volume] in serum||porcine gelatin||component_of
oxygen saturation:mass fraction:to identify measures at a point in time:heart.ventricle.right:quantitative||product containing oxygen (product)||component_of
risk assessment and screening note:find:pt:{setting}:doc:ophthalmology||risk assessment and screening note||component_of
special treatments &or programs - none of above:-:to identify measures at a point in time:^patient:set:mdsv3||therapy (treatment)||component_of
ctx/dox/5-fu/szc||szc||component_of
coagulation factor xi activity actual/normal coag (ppp) [relative time]||coagulation profile||component_of
axin2 gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method||dkfzp781b0869||component_of
hpv igg ser ql||virus, human papilloma||component_of
pupil assessment panel:-:pt:pupil:-||assessed||component_of
number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 2:num:pt:^patient:qn:cms assessment||number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 2||component_of
medication risk:finding:to identify measures at a point in time:^patient:ordinal:observed.ccc||medication risk||component_of
cyclophosphamide/didanosine/doxorubicin/etoposide/vincristine||hydrochloride, doxorubicin||component_of
neutrophils.band form:number concentration (count/vol):to identify measures at a point in time:cerebral spinal fluid:quantitative||polymorphonuclear cell||component_of
coagulation reptilase induced.factor substitution^immediately after addition of normal plasma:time:to identify measures at a point in time:platelet poor plasma:quantitative:coagulation assay||coagulation reptilase induced.factor substitution^immediately after addition of normal plasma||component_of
calcitonin 4th specimen post unsp challenge [mass/vol]||calcitonin^4th specimen||component_of
tyrosine aminotransferase measurement (procedure)||tyrosine transaminase||component_of
rbc morphology - polychromatophilia (lab test)||blood reticulocyte||component_of
pa serotonin prp||5-ht - 5-hydroxytryptamine||component_of
platelets:ncnc:pt:bldc:qn:manual count||hayem's elementary corpuscle||component_of
can pronounce acquiescence:finding:to identify measures at a point in time:^patient:ordinal:nih toolbox||can pronounce acquiescence||component_of
t(15;17)(q24.1;q21.1)(pml,rara) bcr1 fusion transcript molgen ql (bld/tiss)||pml nuclear body scaffold||component_of
deprecated fraxe gene cgg repeats [presence] in blood or tissue by molecular genetics method||gene, nos||component_of
cortisone [moles/volume] in saliva (oral fluid) --pm trough specimen||cortisone^pm trough specimen||component_of
lactobacillus sp dna [log #/volume] in vaginal fluid by naa with probe detection||deoxyribonucleic acid, nos||component_of
phosphate [mass/volume] in specimen||phosphate (substance)||component_of
hepatitis b virus surface ag [presence] in cerebral spinal fluid||hbv||component_of
squamous #/area urns auto||epithelial cell||component_of
cd3+8+45ro+45ra+ cells nfr bld||cells.cd3+cd8+cd45ro+cd45ra+||component_of
japanese cedar ige rast ql||loinc class types||component_of
bone marrow ablation with stem cell support||transplantation, umbilical cord blood||component_of
xr chest r-obl+l-obl||views r-oblique + l-oblique||component_of
have you ever seen a doctor about this pain:finding:to identify measures at a point in time:^patient:ordinal:phenx||have you ever seen a doctor about this pain||component_of
ox-eye daisy ige rast class (s)||chrysanthemum leucanthemum ab.ige.rast class||component_of
strontium/creatinine:srto:24h:urine:qn||product containing strontium (product)||component_of
jc virus deoxyribonucleic acid:number concentration (count/vol):to identify measures at a point in time:tissue, unspecified:quantitative:probe.amp.tar||deoxyribonucleic acid of john cunningham virus||component_of
quantitative microbial culture, pour plate||organism||component_of
metabotropic glutamate receptor 1 igg ab [presence] in cerebral spinal fluid by immunofluorescence||metabotropic glutamate receptor 1 ab||component_of
(acer negundo+betula verrucosa+corylus avellana+quercus alba+platanus acerifolia) antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal:multidisk||hazelnut (corylus avellana)||component_of
neisseria meningitidis serogroup y antigen:presence or threshold:to identify measures at a point in time:not specified:ordinal:latex agglutination||antigen of neisseria meningitidis serogroup y (substance)||component_of
nsdv ab ser ql||sheep antigen||component_of
watch team report:finding:to identify measures at a point in time:^event:document||watch team report||component_of
hepatitis b core and surface antibody, surface antigen panel in serum||antibody to hepatitis b surface antigen||component_of
your child finds it easy to work out what someone is thinking or feeling just by looking at their face:finding:to identify measures at a point in time:^patient:ordinal:aq adolescent||feeling, nos||component_of
s pneum da 5 igg 2:1 ser-rto||streptococcus pneumoniae danish serotype 5 ab.igg^2nd specimen/1st specimen||component_of
aldosterone^3 hours post 25 mg captopril oral:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||captopril (substance)||component_of
guidance for transjugular biopsy+venography:find:pt:abdomen>kidney:doc:{imaging modality}||guidance for transjugular biopsy||component_of
leukocyte count corrected for nucleated erythrocytes (procedure)||white blood cell, nos||component_of
over the past week, are you able to get in and out of bed [haq]||are you able to get in and out of bed||component_of
wheat dust ige rast ql||allergen specific antibody interpretation, semi-quantitative (observable entity)||component_of
warfarin response genotype panel molgen (bld/tiss)||warfarin response genotype panel||component_of
percent sten of r-plb||constriction, pathological||component_of
cancer ag 19-9 [units/volume] in serum or plasma by immunoassay||malignant neoplasm||component_of
urine urate / creatinine ratio measurement||4h-imidazol-4-one, 2-amino-1,5-dihydro-1-methyl-||component_of
human immunodeficiency virus 1+hepatitis c virus ribonucleic acid:presence or threshold:to identify measures at a point in time:serum/plasma^bpu:ordinal:probe.amp.tar||hepatitis c virus ribonucleic acid||component_of
mds v3.0 - rai v1.17.2 - activities of daily living (activities of daily living) assistance - support provided - osa:-:reporting period:^patient:-:cms assessment||household composition (observable entity)||component_of
i worry about getting a job to support myself because of my illness history in the past 4w:find:4w:^patient:ord:facit||abo1 (isbt symbol)||component_of
leucine-enkephalin measurement||enkephalin leu||component_of
vr-36 role physical score - orthogonal method:score:to identify measures at a point in time:^patient:quantitative:vr||role||component_of
p-r interval l-v6||p-r interval, function (observable entity)||component_of
cancer ag 549 [presence] in serum or plasma||antigen, cancer 549||component_of
vigabatrin level||vigabatrine||component_of
intermittent pulse oximetry (procedure)||oxyhemoglobins||component_of
inspiratory capacity measured/predicted||capacityquantity||component_of
heart valve e velocity/annulus e wave by us||haema||component_of
condom use count 12mo nrate phenx||on how many of these occasions did you or your partner use a condom in the past 12mo||component_of
9oh-risperidone serpl-mcnc||paliperidone product||component_of
traumatic brain injury [minimum data set]||tbi||component_of
lymphocytes.immunoglobulin m/100 lymphocytes:number fraction:to identify measures at a point in time:not specified:quantitative||antibody, igm||component_of
prolactin^15 minutes post dose thyrotropin-releasing hormone intravenous:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||protirelin preparation (product)||component_of
hospital stay description||in hospital||component_of
fsh sp1 p chal serpl-acnc||challenge||component_of
ganglioside gm2 igm ia qn (s)||ganglioside gm2 antibody.immunoglobulin m||component_of
hepatitis a virus rna [presence] in stool by naa with probe detection||hav||component_of
hydroxytriazolam (mec) [mass/mass]||hydroxytriazolam||component_of
cortisol free [moles/time] in 24 hour urine by radioimmunoassay (ria)||free cortisol (substance)||component_of
how helpful was your child's coping strategy during the covid-19 outbreak||mns3 (isbt symbol)||component_of
l-pam/pred/wobe-mugos||wobe-mugos e||component_of
soluble liver ab ib ql (s)||soluble liver ab||component_of
resp rate p exc||respiratory air||component_of
spont vt on vent corrected airway||vt - tidal volume||component_of
marv rna spec ql naa+probe||marburg virus ribonucleic acid||component_of
human leukocyte antigen antibody positive cells:number:to identify measures at a point in time:serum:quantitative||cellula||component_of
multisection^w contrast iv:find:pt:abdomen>adrenal gland:doc:mr||multisection||component_of
mycoplasma pneumoniae deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:respiratory.lower:ordinal:probe.amp.tar||mycoplasmoides pneumoniae||component_of
cells.igg/100 cells:nfr:pt:xxx:qn||ab.igg||component_of
h. capsulatum mycelial phase ab band pattern immune diff nom (specimen)||histoplasma capsulatum mycelial phase antibody band pattern||component_of
neuronal nuclear type 2 ab if ql (s)||property type (attribute)||component_of
cells.cd3-cd56+/100 cells:nfr:pt:csf:qn||cells.cd3-cd56+/100 cells||component_of
olanzapine induced neutrophil igm fc ql||immunoglobulin m (substance)||component_of
can pronounce valetudinarian:finding:to identify measures at a point in time:^patient:ordinal:nih toolbox||can pronounce valetudinarian||component_of
cd3 blasts/100 blasts (bm)||cd3+ blast cell||component_of
pm+r plan of care note||plan: (treatment)||component_of
standard thickness parameter:len:pt:cornea.right:qn:tonometry||thick (qualifier value)||component_of
mycoplasma pneumoniae igm ab [presence] in serum by immunofluorescence||mycoplasma pneumoniae antibody (substance)||component_of
hepatitis c virus genotype [identifier] in tissue by naa with probe detection||virus-hepatitis c||component_of
chromium intake 24 hour estimated||cr||component_of
dexamethasone/doxorubicin/prednisone/quinine/vincristine||vincristine sulphate||component_of
lymphocytic choriomeningitis virus ab.igm:prthr:pt:ser:ord:ia||lymphocytic choriomeningitis antibody||component_of
hsv2 dna anogenital ql naa+probe||herpes simplex virus 2 dna||component_of
things paralysis weakness occur phenx||paralysis (finding)||component_of
toxoplasma gondii dna:acnc:pt:body fld:qn:probe.amp||dna molecules||component_of
guidance for biopsy of transplanted liver:finding:to identify measures at a point in time:abdomen:document:ultrasound||guidance for biopsy of transplanted liver||component_of
cockroach ige qn (s)||blatella germanica ab.ige||component_of
multisection for blood flow^w tc-99m glucoheptonate iv:find:pt:abdomen>renal vessels:doc:nm.spect||flows||component_of
glucose [mass/volume] in serum or plasma --post cfst||after values||component_of
human papilloma virus immunization status:history:to identify measures at a point in time:^patient:nominal||status||component_of
ibuprofen induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc)||ibuprofen induced platelet ab||component_of
views for shunt patency^w radionuclide iv:find:pt:abdomen+pelvis:doc:nm||views for shunt||component_of
muv rna and n gene panel (specimen)||mumps (disorder)||component_of
number of days vacuum has been used since changing bag or emptying the collection chamber [phenx]||d||component_of
mental health nurse triage note||triage note||component_of
molybdenum intake:mass rate:24 hours:^patient:quantitative:estimated||molybdenum (mo)||component_of
feline leukemia provirus:prthr:pt:xxx:ord||felv||component_of
naglu gene full mutation analysis:find:pt:bld/tiss:doc:sequencing||naglu gene full mutation analysis||component_of
poa pratensis antibody.igg4:mass concentration:to identify measures at a point in time:serum:quantitative||kentucky blue grass (poa pratensis) ab||component_of
malignant cells:number concentration (count/vol):to identify measures at a point in time:synovial fluid (joint fluid):quantitative:manual count||cellular structures||component_of
cheese cheddar type antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||cheese cheddar type ab.ige.rast class||component_of
efa serpl-mcnc||fatty acid, nos||component_of
respiratory syncytial virus igm antibody in serum||respiratory syncytial virus antibody.immunoglobulin m||component_of
parainfluenza virus 1+2+3 ab (s) [titer]||parainfluenza virus (organism)||component_of
chlamydia trachomatis g+f+k ab.igm:acnc:pt:ser:qn||chlamydia trachomatis (organism)||component_of
solanum tuberosum ab.ige:acnc:pt:ser:qn||solanum tuberosum ab||component_of
hla-a19 ql (bld/tiss donor)||human leukocyte antigen||component_of
streptococcus pneumoniae 9 antibody.immunoglobulin g:mass concentration:to identify measures at a point in time:serum:quantitative:immunoassay||streptococcus pneumoniae 9 ab||component_of
ct retroperitoneum wo+w contr iv||(multisection||component_of
monosodium glutamate ab.ige:acnc:pt:ser:qn||sodium hydrogen l-glutamate||component_of
b. burgdorferi igg and igm panel ia (csf)||borrelia burgdorferi johnson et al. 1984||component_of
acceptable creat ur ql||specimen creatinine acceptable||component_of
t gondii iga ser ql||toxoplasma gondii antibody||component_of
abnormal head size of spermatozoa/100 spermatozoa in semen||population of all spermatozoa with abnormal head size in portion of fluid (body structure)||component_of
xr wrist ap+lat+obl||views and ap||component_of
communication with community resources.knowledge:finding:to identify measures at a point in time:^patient:ordinal:observed.omaha||communication (attribute)||component_of
l intracell rna ct spec qn naa+probe||lawsonia intracellularis||component_of
bluetongue virus 13 ab (s) [titer]||bluetongue virus 13 (organism)||component_of
nm liver and spleen views w tc-99m maa iv||view||component_of
creatine kinase.mm/creatine kinase.total:catalytic fraction:to identify measures at a point in time:serum/plasma:quantitative||creatine kinase.total||component_of
cholesterol.in vldl 1+2:mcnc:pt:ser/plas:qn||cholesterol, pre-beta-lipoprotein||component_of
idec-2b8/moab idec-c2b8||rituximab cd20 antibody||component_of
turnip antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||turnip ige||component_of
e wave/a wave:velrto:pt:mitral valve^fetus:qn:us.doppler||e wave||component_of
indirect immunobead assay (procedure)||factors, immunologic||component_of
acetylcholine receptor modulation ab/acetylcholine ab.total:sfr:pt:ser:qn||ethanaminium, 2-(acetyloxy)-n,n,n-trimethyl-||component_of
trimellitic anhydride (tma) ige ab/ige total in serum||ige total||component_of
eye problem:finding:to identify measures at a point in time:^patient:nominal:phenx||eye||component_of
p aeruginosa dna bal naa+non-prb-ncncrng||deoxyribonucleic acid of pseudomonas aeruginosa (substance)||component_of
borrelia burgdorferi 58kd ab.igg:acnc:pt:ser:ord||borrelia burgdorferi sensu stricto||component_of
total cells counted amn||cells counted total||component_of
gelatin ige/total ige (s) [%]||gelatin ige||component_of
cortisol [mass/volume] in serum or plasma --15 minutes post dose corticotropin im||dose level||component_of
intercellular bridge ana pattern if ql (s)||antibody nuclear||component_of
leptospira interrogans serovar pomona ab:prthr:pt:ser:ord:aggl||leptospira interrogans serovar pomona ab||component_of
cerebroside sulfatase:ccnc:pt:ser/plas:qn||sulfitide-sulfatase||component_of
views ap + lateral + oblique:find:pt:upper extremity.left>finger:doc:xr||views ap + lateral + oblique||component_of
deprecated erythroblasts late fr mar||oxyphilic normoblast||component_of
vzv dna csf ql naa+non-probe||deoxyribonucleic acids||component_of
quinidine+quinine [presence] in urine||quin||component_of
mds v3.0 - rai v1.17.2 - other health conditions - np, nq, sp:-:pt:^patient:-:cms assessment||health conditions||component_of
aa/epa bld||arachidonate/eicosapentaenoate||component_of
breath rate device inventory #||institution inventory number||component_of
prealbumin/protein.total [pure mass fraction] in cerebral spinal fluid by electrophoresis||prealbumin/protein.total||component_of
(actinidia deliciosa+carica papaya+mangifera indica+musa spp+persea americana) ab.ige:acnc:pt:ser:qn:multidisk||(actinidia deliciosa+carica papaya+mangifera indica+musa spp+persea americana) antibody.immunoglobulin e||component_of
methylenedioxymethamphetamine:mcnc:pt:ser/plas/bld:qn||ecstasy drug||component_of
maximum expiratory gas flow respiratory system airway predicted||flow||component_of
texture.yeast colony:type:pt:isolate:nom:culture||textured||component_of
flubv igm spec 1 ia qn (s)||influenza virus b ab.igm^1st specimen||component_of
codfish igg rast ql||gadus morhua antibody.immunoglobulin g.rast class||component_of
hhv6 dna # bal naa+probe||double-stranded dna||component_of
genomic dna change:find:pt:^patient:nom||dna - deoxyribonucleic acid||component_of
fragaria vesca antibody.immunoglobulin e/immunoglobulin e.total:arbitrary fraction:to identify measures at a point in time:serum:quantitative||strawberry (fragaria vesca) ab||component_of
ps iga ser ia-acnc||phosphatidylserine||component_of
xr wrist scaphoid 1 view||(views||component_of
on average, during the last year, how many day were there in a typical menstrual cycle, that is, from the beginning of bleeding of one menstrual period to the beginning of bleeding of the next period [phenx]||d||component_of
gm-csf/klh||keyhole limpet hemocyanin||component_of
multisection for postoperative:finding:to identify measures at a point in time:head>brain:document:magnetic resonance||(multisection||component_of
blood in gastric contents measurement||blood, nos||component_of
s pneum da 5 igg sp2 ser ia-mcnc||igg antibody||component_of
minor axis.end systole:len:pt:heart.atrium.right:qn:us.2d.a4c||axis||component_of
formate+formaldehyde (bld) [mass/vol]||formaldehyde (substance)||component_of
s. pneumoniae danish type 18c igg (s) [mass/vol]||streptococcus pneumoniae danish serotype||component_of
carboplatin/cyclophosphamide/cytarabine/etoposide phosphate/rituximab/sodium thiosulfate||cis-diammine(cyclobutane-1,1-dicarboxylato)platinum||component_of
anxiety frightened no reason scared-r||i-antigen||component_of
porcine parvovirus org specific cx ql (specimen)||genus parvovirus||component_of
body weight discordance in multiple fetuses us+calculated||body weight discordance||component_of
stn meth spec||stain||component_of
infused volume.segment procedure||volume (property) (qualifier value)||component_of
specimen source subject:type:to identify measures at a point in time:*:nominal||specimen source subject||component_of
glyburide:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||glybenzcyclamide||component_of
date of last plan of treatment certification:date:to identify measures at a point in time:psychiatric rehabilitation treatment plan:quantitative||plan:||component_of
deprecated p nos ag [presence] on red blood cells from blood product unit||antigen in p blood group system||component_of
cytomegalovirus igm level (procedure)||cytomegalovirus antibody (substance)||component_of
ih ab ql||ih antibody||component_of
dna antibody double stranded high avidity||anti deoxyribonucleic acid antibody||component_of
norpropoxyphene cutoff:mcnc:pt:urine:qn:confirm||norpropoxyphene cutoff||component_of
blood count; manual differential wbc count, buffy coat||leukocyte||component_of
fine gran casts #/area urns hpf||granular casts.fine (substance)||component_of
did your main daytime activities during a typical work w have you on water for a total of three or more h a d, for example working on a boat:finding:to identify measures at a point in time:^patient:ordinal:phenx||working, function (observable entity)||component_of
promis parent proxy item bank - pain behavior - version 1.0:-:point in time:^patient:-:promis.parentproxy||behaviors pain||component_of
gait+turn+tandem gait||gait type||component_of
chlamydia trachomatis d+e+f+g+h+i+j+k ab.igm:titr:pt:ser:qn||blood group antigen rh g||component_of
colony forming unit-granulocyte-monocyte-erythroid-megakaryocyte assay||immunologic substance (substance)||component_of
guidance for percutaneous biopsy:find:pt:abdomen>biliary ducts:doc:{imaging modality}||biopsy procedure||component_of
promyelocytes manual cnt (body fld) [#/vol]||promyelocyte, nos||component_of
date of ulcer measurement [care]||date of ulcer measurement||component_of
ovulation tests, by visual color comparison methods for human luteinizing hormone||pituitary interstitial cell stimulating hormone (substance)||component_of
acylcarnitine/acylcarnitine+carnitine free (c0):substance ratio:to identify measures at a point in time:dried blood spot:quantitative||carnitine acyl||component_of
urine panels centers for environmental health trace metals||201 minerals||component_of
us guided salivary gland bx||guidance for percutaneous biopsy||component_of
cd13+hla-dr+ cells nfr csf||100 cells||component_of
patient-centered disability questionnaire||patient-centered disability questionnaire||component_of
cobalamins.unsaturated binding capacity:mcnc:pt:ser/plas:qn||cyanocobalamin.unsaturated binding capacity||component_of
complement c3d+g:acnc:pt:plas:qn||blood group antigen rh g||component_of
n. meningitidis w135 ag la ql (specimen)||neisseria intracellularis||component_of
rosemary ige ab [units/volume] in serum||immunoglobulin ige||component_of
plan of care note:finding:to identify measures at a point in time:{setting}:document:kinesiotherapy||notes||component_of
blasts.cytoplasmic cd3:arbitrary concentration:to identify measures at a point in time:whole blood:quantitative||t3 antigen||component_of
streptococcus pneumoniae nana gene:number content = count/mass:to identify measures at a point in time:not specified.tissue:quantitative:probe.amp.tar||genes||component_of
fluav and flubv and rsv pnl naa+probe (upper resp)||influenza virus a and b and respiratory syncytial virus rna panel||component_of
staff with unknown influenza vaccination status:num:rptperiod:{setting}^population:qn||staff with unknown influenza vaccination status||component_of
interferon-gamma producing hla-a2 cmv specific cd8 cells [#/volume] in blood by flow cytometry (fc)||normal cell||component_of
escherichia coli verotoxin 2 antibody:dilution factor (titer):to identify measures at a point in time:stool:quantitative:virus neutralization||escherichia coli verotoxin||component_of
kras gene:vcf:pt:cancer specimen:doc:sequencing||kirsten ras1||component_of
guidance for percutaneous biopsy:find:pt:neck>thyroid gland:doc:rf||guidance for percutaneous biopsy||component_of
interferon.omega:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||interferon.omega||component_of
c peptide 2.5h p chal serpl-mcnc||proinsulin c-peptide||component_of
intravascular mean:pres:pt:pulmonary artery:qn||intravascular mean||component_of
al beta42/abeta 40 csf||substance, amyloid||component_of
formate [moles/volume] in urine||formate||component_of
taenia solium larva antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immunoassay||larva of taenia solium (organism)||component_of
hbv e ag titr ser||little e||component_of
babesia duncani ab.igg:titr:pt:ser:qn:if||antibody to babesia duncani (substance)||component_of
heart rate^post exercise:nrat:pt:xxx:qn:oximetry||hr - heart rate||component_of
mr hip-bl wo contr||multisection||component_of
initial evaluation note:finding:to identify measures at a point in time:telephone encounter:document:{role}||initial assessment note||component_of
urinary incontinence and indwelling catherter trigger:finding:to identify measures at a point in time:^patient:narrative:mds||urinary incontinence and indwelling catherter trigger||component_of
s antigen:presence or threshold:to identify measures at a point in time:erythrocytes:ordinal||s antigen||component_of
jamestown canyon virus ab.igm:acnc:pt:csf:qn:if||jamestown canyon virus||component_of
specify, in general, what you have you ever experienced, witnessed, or otherwise been involved in any events that could have brought serious harm or even death to you or someone else:find:pt:^patient:nom:phenx||event (event)||component_of
carbamazepine dbs-mcnc||product containing carbamazepine||component_of
carboplatin/cisplatin/paclitaxel||product containing carboplatin (medicinal product)||component_of
vsiv ab titr ser nt||antibody to vesicular stomatitis indiana virus (substance)||component_of
procyclidine measurement (procedure)||1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride||component_of
bartonella sp identified:presence or identity:to identify measures at a point in time:not specified:nominal:organism specific culture||bartonella species (organism)||component_of
canrenone (u) [mass/vol]||canrenone (substance)||component_of
levetiracetam induced platelet antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:flow cytometry||levetiracetam induced platelet ab||component_of
silicone ab.iga:acnc:pt:ser:qn||silicone ab||component_of
my teachers believe that i can do well in my school work [phenx]||my teachers believe that i can do well in my school work||component_of
t. canis ab qn (specimen)||toxocara canis ab||component_of
glucose pre lac po serpl-mcnc||lactose.po||component_of
herpes simplex virus 1+2 dna [#/volume] (viral load) in cerebral spinal fluid by naa with probe detection||herpes simplex virus 1 & 2||component_of
trypanosoma cruzi igg ab [presence] in serum by immunoassay||trypanosoma cruzus||component_of
wheal 3d p 50ug trichophyt diam||trichophyton||component_of
chicken meat ab.ige/ige.total:afr:pt:ser:qn||immunoglobulin e (ige)||component_of
xr shoulder-bl ap+transthoracic||views and ap||component_of
ct neck wo contr||multisection^wo contrast||component_of
cucumber ige/ige total %||cucumis sativus ab||component_of
cranberry ige qn (s)||immunoglobulin e antibody||component_of
diagonal artery 1a:prthr:pt:coronary arteries:ord:angiogram||additional first diagonal artery||component_of
tmem216 gene.c.218g>t:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||tmem216||component_of
hmpv b rna spec ql naa+probe||human metapneumovirus||component_of
asp transferase||l-aspartate:2-oxoglutarate aminotransferase||component_of
participation in assessment:-:to identify measures at a point in time:^patient:-||assess||component_of
calprotectin snv-mcnc||antigen, 27e10||component_of
standard bicarbonate measurement||carbonates, hydrogen||component_of
how much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools:finding:to identify measures at a point in time:^patient:ordinal:phenx||working (qualifier value)||component_of
long-term care hospital (ltch) continuity assessment record and evaluation (care) data set (lcds) - unplanned discharge - version 5.00:-:pt:^patient:-:cms assessment||assessment||component_of
i have trouble running like other people in the past 7d:find:7d:^patient:ord:facit||other or miscellaneous||component_of
codfish (rgad c) 1 ige qn||codfish (gadus morhua) recombinant (rgad c) 1||component_of
sp gr ur strip||sg - specific gravity||component_of
functional assessment of cancer therapy for patients with prostate cancer questionnaire - version 4:-:to identify measures at a point in time:^patient:-:facit||malignancy||component_of
did the infection require hospitalization:finding:to identify measures at a point in time:^patient:ordinal:esrd||did the infection require hospitalization||component_of
mr temporomandibular joint - left wo and w contrast iv||multisection^wo & w contrast||component_of
pumpkin ige rast class (s)||pumpkin (cucurbita pepo)||component_of
cyclic citrullinated peptide ab.igg:acnc:pt:ser/plas:qn||cyclic citrullinated peptide igg||component_of
galop igm [titer]||galop ab.igm||component_of
promis short form - emotional support 8a - version 2.0 raw score:score:to identify measures at a point in time:^patient:quantitative:promis||scored||component_of
norfloxacin:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal||norfloxacin (product)||component_of
sexual attempt other ltvh||was there any other time when anyone, male or female, tried to force or bully you into doing something sexual that you didn't want to do, but it didn't end up happening||component_of
pathology biopsy report:find:pt:pleura:nar||pathology studies||component_of
2-hydroxyestrone and 16-alpha hydroxyestrone panel - serum or plasma||16.alpha.-hydroxyestrone||component_of
multisection^w i-131 iv:find:pt:neck>thyroid gland:doc:nm.spect||i not otherwise specified antigen||component_of
chromosome region xp22.33 &or yp11.32 deletion+duplication:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:mlpa||chromosomes||component_of
corticotropin [moles/volume] in plasma --pre xxx challenge||challenge||component_of
cd45ro cells/100 cd3+cd8+ cells in blood||uchl-1 - university college hospital lymphocyte-1||component_of
cyclic citrullinated peptide antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal||anti-keratin antibody||component_of
cheese cheddar type ige ab rast class [presence] in serum||cheeses||component_of
rationale for wait time:cmplx:pt:ambulance transport:set||rationale for wait time||component_of
hopping - confidence - score change:score difference:to identify measures at a point in time:^patient:quantitative:optimal||hopping - confidence - score change||component_of
mental health op plan of care note||plans treatment||component_of
ct abd wo contr||multisection^ wo contrast||component_of
mo of pregnancy when rubella-like symptoms appeared:date:to identify measures at a point in time:^mother:quantitative||symptom (finding)||component_of
t gondii igg+igm pnl ser||toxoplasma gondii ab||component_of
insulin [moles/volume] in serum or plasma --2.5 hours post dose glucose iv||dosage (attribute)||component_of
spect unspecified body region for infection or inflammation||multisection for infection||component_of
blood flow velocity.systolic.max:velocity:to identify measures at a point in time:aorta descending^fetus:quantitative:ultrasound.doppler||flowing||component_of
platelet aggregation adp induced 10 umol/l (bld) [rel units/vol]||adenosine diphosphate||component_of
yellow fever virus ribonucleic acid:presence or threshold:to identify measures at a point in time:whole blood:ordinal:probe.amp.tar||yellow fever virus ribonucleic acid||component_of
cells.cd3/100 cells:nfr:pt:bronchial:qn||100 cells||component_of
myelin igm qn (s)||myelin (substance)||component_of
cd16 blasts/100 blasts in specimen||blasts.cd16/100 blasts||component_of
views for shunt patency^w radionuclide intravenous:finding:to identify measures at a point in time:abdomen+pelvis:document:nm||views for shunt patency||component_of
ceftazidime induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry||caz||component_of
legionella pneumophila 8 ab [units/volume] in serum||legionella pneumophila brenner et al. 1979||component_of
streptococcus pneumoniae danish serotype 19a deoxyribonucleic acid:threshold number:to identify measures at a point in time:not specified:quantitative:probe.amp.tar||dna - deoxyribonucleic acid||component_of
waxy casts lm ql (urine sed)||cast||component_of
(daucus carota+lycopersicon lycopersicum+mustard+solanum tuberosum+allium sativum) antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative:multidisk||garlic (allium sativum) ige||component_of
hepatitis b virus surface antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:immune stain||surface||component_of
amitriptyline peak [mass/vol]||5-(3-dimethylaminopropylidene)-10,11-dihydro-5h-dibenzo(a,d)cycloheptene||component_of
helminthosporium sp ab.ige:acnc:pt:ser:qn||helminthosporium sp||component_of
xr ankle - left lateral views w manual stress||views lateral||component_of
c peptide [mass/volume] in serum or plasma --20 minutes post xxx challenge||rh2 (isbt symbol)||component_of
ana speckled titr ser||nuclear||component_of
alpha1 glob serpl elph-mcnc||alpha1 globulin (substance)||component_of
note:find:pt:{setting}:doc:obstetrics and gynecology||note||component_of
erythrocytes.plasmodium sp infected/1000 erythrocytes:number fraction:to identify measures at a point in time:whole blood:quantitative||erythrocyte||component_of
blood flow velocity.systole.max:velocity:to identify measures at a point in time:heart.ventricle.right.outflow tract:quantitative:ultrasound.doppler||blood flow, nos||component_of
gestational age estimated from tibia length on us||age, fetal||component_of
instrumental support survey - fixed length form - ages 18+:-:1mo:^patient:-:nih toolbox||support - dental||component_of
low resolution human leukocyte antigen (hla) class i and ii typing of hla-a, hla-b, hla-c, hla-drb1/3/4/5, and hla-dqb1||gene, nos||component_of
computerized dynamic posturography sensory organization test (cdp-sot), 6 conditions (ie, eyes open, eyes closed, visual sway, platform sway, eyes closed platform sway, platform and visual sway), including interpretation and report; with motor control test (mct) and adaptation test (adt)||equilibrium (function)||component_of
cyclophosphamide/epirubicin/fluorouracil/methotrexate||methotrexate (medication)||component_of
c pn+psitt dna tiss ql naa+probe||chlamydophila pneumoniae+chlamydophila psittaci dna||component_of
methotrexate^1-2w post dose:mcnc:pt:ser/plas:qn||4-amino-4-deoxy-10-methylpteroyl-l-glutamic acid||component_of
flucv rna islt ql naa+probe||virus, nos||component_of
phenx measure - percent energy from fat:-:to identify measures at a point in time:^patient:-:phenx||phenx measure - percent energy from fat||component_of
lisinopril induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc)||product containing lisinopril (medicinal product)||component_of
piromidate islt grad strip||piromidate||component_of
xylose^baseline:mass concentration:to identify measures at a point in time:urine:quantitative||product containing xylose||component_of
lacv igm ser-acnc||anti-la crosse virus igm||component_of
bacteria identified:presence or identity:to identify measures at a point in time:ocular fld:nominal:anaerobic culture||bacteria <bacteria>||component_of
weight of dust collected:mass:to identify measures at a point in time:^patient:quantitative:phenx||bw||component_of
calcium.ionized [mass/volume] in blood||ca - calcium||component_of
multisection^wo contrast:find:pt:chest>chest vessels:doc:ct.angio||multisection^wo contrast||component_of
pronormoblasts # bld||rubriblast||component_of
cyp1a2 gene.c.2473g>a:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||cytochrome p450, subfamily i, polypeptide 2||component_of
myc gene targeted mutation analysis:prid:pt:bld/tiss:nom:molgen||myc gene targeted mutation analysis||component_of
volume expired during 1.0 s of forced expiration^post 0.25 mg/ml methacholine:volume:to identify measures at a point in time:respiratory system:quantitative||after values||component_of
e3 specific ige antibody measurement||horse dander specific immunoglobulin e (substance)||component_of
mass spectrometry, plasma desorption type||substance||component_of
human immunodeficiency virus 1+o+2 antibody:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal||hiv 1+o+2||component_of
cd10+fmc7+ cells nfr fld||lymphocyte antigen fmc7||component_of
cause of death entity axis code:finding:to identify measures at a point in time:^patient:nominal:automated||death cause||component_of
docetaxel/doxorubicin/tamoxifen||tamoxifen citrate||component_of
fluid output subarachnoid drain 1h||fluid output subarachnoid drain||component_of
nasopharyngeal culture for moraxella catarrhalis (lab test)||branhamella catarrhalis||component_of
cmv early ag ql (specimen)||salivary gland viruses||component_of
serum or plasma trans-3-hydroxycotinine||3'-hydroxycotinine||component_of
hbv surface ab qn (s)||300 virus||component_of
coxiella burnetii phase 1 ab.iga:titr:pt:ser:qn||rickettsia burneti||component_of
escherichia coli k99:arbitrary concentration:point in time:tsmi:ordinal:agglutination||bacterium coli commune||component_of
xr ankle-bl ap+lat w stand||views (ap||component_of
cd138 cells (bld) [#/vol]||cells set||component_of
ctx/dox/meprdl/mtx/pred/vcr||chloridrato de doxorrubicina||component_of
bone age assessment - tanner-whitehouse (tw2) associated observations panel||bone age assessment - tanner-whitehouse (tw2) associated observations panel||component_of
cd45rb ag:prthr:pt:tiss:ord:immune stain||antigens, cd45rb||component_of
guidance for percutaneous biopsy of bone||guidance||component_of
multisection^w contrast iv:find:pt:abdomen:doc:ct||(multisection||component_of
bartonella elizabethae ab.igm:titr:pt:body fld:qn||immunoglobulin igm||component_of
tyrosine sfr spec||tyrosine/amino acids.total||component_of
service comment 31:impression/interpretation of study:to identify measures at a point in time:not specified:nominal||comment||component_of
crab igg ab rast class [presence] in serum||crab (cancer pagurus)||component_of
r eye color vision||colour||component_of
sars-cov-2 (covid-19) rna [cycle threshold #] in specimen by naa with probe detection||rna, non polyadenylated||component_of
custodial care facility transfer summary note||transfer summary note||component_of
carboplatin/cyclophosphamide/doxorubicin||cytophosphane||component_of
mag igm ser ia-acnc||myelin associated glycoprotein antibody||component_of
cells.cd3+cd4+/100 cells:number fraction:to identify measures at a point in time:cerebral spinal fluid:quantitative||antigens cd 003||component_of
fluav + flubv spec bioassay||influenza virus a & b identified||component_of
naa with probe detection for bk virus dna in urine||deoxyribonucleic acid of human polyomavirus 1||component_of
myasthenia gravis panel measurement, nos||not otherwise specified antibody||component_of
beta hydroxybutyrate 1 hr post unsp challenge [mass/vol]||challenge||component_of
fluav ab (s) [titer]||influenza virus type a||component_of
drvvt in platelet poor plasma by coagulation assay --post heparin neutralization||test, blood coagulation||component_of
c peptide 10th specimen post unsp challenge [mass/vol]||challenges||component_of
analysis of emergency department visits:find:pt:^event:nar||analysis of emergency department visits||component_of
bordetella pertussis dna:prthr:pt:respiratory.upper:ord:probe.amp.tar||bordetella pertussis dna||component_of
bfv rna bld ql naa+probe||barmah forest virus rna||component_of
ct ta + aa wo contr||(multisection||component_of
proc urgency||interventional procedures||component_of
adenovirus+rotavirus nom (stl)||rotaviruses||component_of
are you able to move wet clothes from the washer to the dryer [promis]||are you able to move wet clothes from the washer to the dryer||component_of
while you were having your loss of vision, did any of these things occur:finding:to identify measures at a point in time:^patient:ordinal:phenx||while you were having your loss of vision, did any of these things occur||component_of
promis parent proxy item bank - mobility - version 2.0:-:to identify measures at a point in time:^patient:-:promis.parentproxy||versions||component_of
employer address:address:to identify measures at a point in time:^patient:nominal||employer address||component_of
cystinyl aminopeptidase:catalytic concentration:to identify measures at a point in time:serum:quantitative||cystinyl aminopeptidase||component_of
methotrexate/prednisone/procarbazine/vincristine||pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-||component_of
phosphoserine/creatinine:ratio:24h:urine:qn||dl-2-amino-3-hydroxypropanoic acid 3-phosphate||component_of
cells.cd3+cd4+cd27-cd45ro+cd62l-:number concentration (count/vol):to identify measures at a point in time:whole blood:quantitative||cd27 antigen||component_of
n not otherwise specified antibody:presence or threshold:to identify measures at a point in time:serum/plasma^bpu:ordinal||unidentified antibody||component_of
influenza virus a rna tissue culture infective dose 50:ncnc:pt:xxx:qn||viruses, general||component_of
us guided brst-bl bx||guidance for percutaneous biopsy||component_of
chloride (24h stl) [moles/vol]||cl- element||component_of
tramadol [mass/volume] in urine by confirmatory method||tramadol (product)||component_of
power spectrum.mean dominant frequency:frequency:to identify measures at a point in time:cerebral cortex:quantitative:electroencephalogram||with frequency||component_of
pantothenate/creatinine (u) [molar ratio]||concept ob||component_of
influenza virus a hemagglutinin type rna [identifier] in isolate by sequencing||a||component_of
pressure.airway^on ventilator.volume targeted assist & control:pressure:to identify measures at a point in time:respiratory system.airway:quantitative:airway pressure monitor||volumes||component_of
hydroxydecanedioate/creatinine:mrto:pt:urine:qn||hydroxydecanedioate||component_of
aortic valve mean flow velocity during systole by us.doppler||flows||component_of
c peptide^4th specimen post xxx challenge:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||post||component_of
deprecated hindfoot - right and midfoot - right x-ray harris||view harris||component_of
adenovirus 16 deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:not specified:ordinal:probe.amp.tar||adenoviral||component_of
bacteria identified:presence or identity:to identify measures at a point in time:vagina:nominal:aerobic culture||unidentified bacterium||component_of
dental prosthesis:type:point in time:*:nominal||dental||component_of
how much of the d did these feelings usually last:find:pt:^patient:ord:cidi-sf||d||component_of
influenza virus a subtype [identifier] in lower respiratory specimen by naa with probe detection||influenzavirus||component_of
toileting deficit:finding:to identify measures at a point in time:^patient:ordinal:observed.ccc||rndx toileting deficit||component_of
lv max long strain rate dias 2d us||diastole||component_of
streptococcus pneumoniae danish serotype 3 ab.igg:mcnc:pt:ser:qn||streptococcus pneumoniae danish serotype 3 igg||component_of
androstanolone^pre dose corticotropin:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||dosage (attribute)||component_of
buckwheat igg4-mcnc||buckwheat (fagopyrum esculentum)||component_of
clostridioides difficile toxin a+b [units/volume] in stool by immunoassay||blood group antigen a, nos||component_of
physical findings:find:pt:heart:nar:observed||physical findings||component_of
multisection:finding:to identify measures at a point in time:pelvis>ovary:document:ultrasound||(multisection||component_of
cells.t(2;13)(q36.1;q14.4)(pax3,foxo1)/cells.total:nfr:pt:bld/tiss:qn:molgen||cells.t(2;13)(q36.1;q14.4)(pax3,foxo1)||component_of
cd126 cells/100 cells (bld)||cells.cd126||component_of
strongyloides stercoralis antibody assay||strongyloides stercoralis ab||component_of
podiatry flowsheet||flowsheet||component_of
17-hydroxyprogesterone 1st specimen post dose gonadotropin releasing hormone [mass/vol]||dosage (attribute)||component_of
plateau achieved [phenx]||plateau||component_of
basophils/100 leukocytes:nfr:pt:plr fld:qn||100 leukocytes||component_of
dehydroepiandrosterone sulfate^45m post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||dehydroisoandrosterone-3-sulfate||component_of
western juniper ige rast class (s)||western juniper (juniperus occidentalis)||component_of
ascorbate^post dose:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||ascorbate^post dose||component_of
i am satisfied with the amount of time i spend performing my daily routines:find:pt:^patient:ord:promis||*time (e.g. seconds)||component_of
thought insertion di-pad||thought insertion (finding)||component_of
peripheral oxygen saturation (observable entity)||oxyhemoglobins||component_of
quinapril induced platelet igg fc ql||quinapril (medication)||component_of
bermuda grass triggered histamine release qn (bld)||cynodon dactylon basophil bound antibody||component_of
long-term care hospital (ltch) continuity assessment record and evaluation (care) data set (lcds) - planned discharge - version 5.00:-:to identify measures at a point in time:^patient:-:cms assessment||long-term care hospital (ltch) continuity assessment record and evaluation (care) data set (lcds) - planned discharge - version 5.00||component_of
johnson grass smut ige rast class (s)||loinc class types||component_of
liver fibr score serpl calc hepascore||fibrosis score||component_of
aorta mean blood pressure||intravascular mean||component_of
healthcare agent authority to inspect and disclose mental and physical health information:finding:to identify measures at a point in time:^patient:narrative:reported||healthcare agent||component_of
trichophyton reaction wheal^1 day post dose trichophyton intradermal:diameter:to identify measures at a point in time:skin:quantitative||status post||component_of
barley igg ab rast class [presence] in serum||barley (hordeum vulgare) ab||component_of
atg/etn||thymoglobulin||component_of
reason for no radiation rx cancer||ray (radiation)||component_of
fus gene mutations found [identifier] in blood or tissue by molecular genetics method nominal||gene, nos||component_of
c peptide 11th specimen post unsp challenge [moles/vol]||c peptide^11th specimen post xxx challenge||component_of
coxsackievirus a7 ab^1st specimen:titr:pt:ser:qn:comp fix||coxsackievirus a7 ab^1st specimen||component_of
chironomus thummi ab.ige:acnc:pt:ser:qn||bloodworm (chironomus thummi) ige||component_of
caltrol/tax||1 alpha,25-dihydroxycholecalciferol||component_of
these symptoms affect my relationships with friends or family:finding:to identify measures at a point in time:^patient:ordinal:m3||symptoms nos||component_of
asp/dm/dox/mp/mtx/vcr||dexamethasone preparation (product)||component_of
diabetes type ii action plan:find:pt:{setting}:doc:{role}||diabetes type ii action plan||component_of
date last screened cancer||date property||component_of
flubv igg (csf) [mass/vol]||b ab.igg||component_of
serum thyroglobulin antibody test||antithyroglobulin||component_of
setaria italica antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||setaria italica antibody.immunoglobulin e||component_of
estazolam (specimen) [mass/vol]||4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-||component_of
r wave duration.lead v3:time:pt:heart:qn:ekg||lead metal||component_of
prolactin^6th specimen:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||prolactin^6th specimen||component_of
total vaccine doses distributed per 100,000 population||vaccine doses distributed||component_of
ramipril induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc)||7s gamma globulin||component_of
microscopic exam:impression/interpretation of study:to identify measures at a point in time:sputum:nominal:cytology||microscopic exam||component_of
herpes simplex virus 1 deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:aspirate:ordinal:probe.amp.tar||deoxyribonucleic acid (dna)||component_of
pregnancy function status [omaha]||pregnancy nos||component_of
hydrogen/expired gas 5 hr post unsp challenge (exhl gas) [volume fraction]||hydrogen/expired gas||component_of
b-globulin 24h ur elph-mrate||beta-globulin||component_of
miscellaneous allergen igg ab [identifier] in serum||ab.igg||component_of
cortisol^5m pre 1 ug/kg crh iv:mcnc:pt:ser/plas:qn||cortisol^5m pre 1 ug/kg crh iv||component_of
glucose [mass/volume] in serum or plasma --6th specimen post dose lactose||after||component_of
pleural fluid mycobacterium detection by neutralization test (lab test)||mycobacterium lehmann and neumann 1896 (approved lists 1980) emend. gupta et al. 2018||component_of
sshv igm ser ql if||section 3 viruses||component_of
cyclophosphamide/etoposide/sargramostim||cyclophosphamidum||component_of
b burgdor igg+igm ser ia-imp||immunoglobulin igg||component_of
rv es area a4c||area.end systole||component_of
microscopic observation:prid:pt:dial fld prt:nom:gram stain||microscopic observation||component_of
sagbrsh igg qn||artemisia tridentata ab.igg||component_of
follitropin^15m post dose triple bolus:acnc:pt:ser/plas:qn||pluset||component_of
chlamydia trachomatis l1 antibody.immunoglobulin g+immunoglobulin a+immunoglobulin m interpretation:impression/interpretation of study:to identify measures at a point in time:serum:nominal:immunoassay||chlamydia trachomatis l1 antibody.immunoglobulin g+immunoglobulin a+immunoglobulin m interpretation||component_of
autologous dendritic cells/gp100 antigen||glycoprotein 100||component_of
arginine^post therapeutic diet:scnc:pt:bld.dot:qn||l-(+)-arginine||component_of
can recall staff names &or faces:find:pt:^patient:ord:mds||recalling||component_of
glomerular basement membrane antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal:immune fluorescence||basement glomerular membranes||component_of
pa aa prp ql||platelets blood||component_of
simvastatin induced neutrophil ab.igg:prthr:pt:ser/plas:ord:flow cytometry||neutrophil antibody.immunoglobulin g||component_of
yellow jacket ige rast ql||vespula spp ab||component_of
polymorphonuclear cells/100 leukocytes in pericardial fluid by automated count||cells (biology)||component_of
naloxone cutoff confirm (u) [mass/vol]||product containing naloxone||component_of
deprecated views ap & lateral:finding:point in time:abdomen:narrative:xr||(view ap||component_of
i (int) subtype:acnc:pt:rbc^donor:ord:aggl rbc||i ag||component_of
naa with probe detection for human papilloma virus dna 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 (lab test)||human papillomavirus 68 dna||component_of
promis pediatric item bank - strength impact - version 1.0||strength||component_of
microscopic observation:prid:pt:liver.fna:nom:cyto stain||microscopic observation (procedure)||component_of
neisseria meningitidis serogroup z' ag [presence] in isolate by agglutination||neisseria meningitidis serogroup||component_of
views^w contrast iv:find:pt:abdomen>kidney.bilateral:doc:xr||views^w contrast||component_of
mattress dust ige rast class (s)||mattress dust ab.ige.rast class||component_of
thrombin time.factor substitution immediately after addition of protamine sulfate coag (ppp) [time]||coagulation assay||component_of
phenx measure - neck circumference:-:point in time:^patient:-:phenx||measure||component_of
views 1 or 2:finding:to identify measures at a point in time:pelvis>sacroiliac joint:document:xr||views 1 or 2||component_of
prescription for diagnostic or specialist care:finding:to identify measures at a point in time:{setting}:document:{role}||prescription for diagnostic or specialist care||component_of
speech-language pathology services - group minutes^week 2:time:rptperiod:^patient:qn:cms assessment||speech-language pathology services - group minutes^week 2||component_of
alzheimer's or dementia special care unit:finding:to identify measures at a point in time:^patient:ordinal:mds||blood group antigen s||component_of
rf gt plac ck w contr via gi tb||view (attribute)||component_of
epcam gene exons 8 and 9 del and dup mutation analysis mlpa doc (bld/tiss)||trophoblast cell surface antigen 1||component_of
ceftizoxime induced platelet ab.igg:prthr:pt:ser/plas:ord:flow cytometry||platelet ab||component_of
guidance for drainage+placement of drainage catheter^w contrast iv:find:pt:pelvis:doc:ct||guidance for drainage||component_of
us colon fetus study||study observation||component_of
coagulation tissue factor induced.factor substitution^immediately after addition of factor v depleted plasma:time:to identify measures at a point in time:platelet poor plasma:quantitative:coagulation assay||prothrombin time (pt) factor substitution||component_of
eastern white pine ige ab rast class [presence] in serum||pinus strobus ab.ige||component_of
t wave amplitude in lead v6||pb - lead||component_of
pancreatic polypeptide^5 minutes post sham feeding:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||post||component_of
lacv ab sp2 titr ser if||lac virus||component_of
toxoplasma gondii igm ab [titer] in serum||immunoglobulin m (substance)||component_of
t gondii igm serpl ql ia||toxoplasma gondius||component_of
bacterial beta-lactam resistance esbl blaper gene:presence or threshold:to identify measures at a point in time:isolate/specimen:ordinal:molecular genetics||bacterial beta-lactam resistance esbl blaper gene||component_of
contraindication for thrombolytic use nemsis||contraindication for thrombolytic use||component_of
monocytes/leukocytes:decimal number fraction:to identify measures at a point in time:body fluid, unsp:quantitative:manual count||monocytes/leukocytes||component_of
long-term care hospital (ltch) continuity assessment record and evaluation (care) data set (lcds) - unplanned discharge - version 5.00:-:to identify measures at a point in time:^patient:-:cms assessment||discharged||component_of
list sorting working memory test nih||list||component_of
midazolam in urine by confirmatory method||midazolamum||component_of
hemoglobin d/hemoglobin.total:mfr:pt:bld.dot:qn||hemoglobin d (substance)||component_of
views^w tc-99m pertechnetate intravenous:finding:to identify measures at a point in time:neck>parotid gland:document:nm||(views||component_of
r wave duration in lead avf||has duration||component_of
multisection^wo & w contrast intravenous:finding:to identify measures at a point in time:abdomen>retroperitoneum:document:computed tomography||(multisection||component_of
pregnancy function knowledge community [omaha]||pregnancy (qualifier value)||component_of
suberylglycine measurement||suberylglycine (substance)||component_of
enterovirus rna [presence] in amniotic fluid by naa with probe detection||enterovirus rna||component_of
hazelnut native (ncor a) 9 ige ab rast class [presence] in serum||corylus avellana native (ncor a) 9 antibody.immunoglobulin e||component_of
hip fracture 10-year probability [likelihood] fracture risk assessment||fractured hips||component_of
london plane ige rast ql||platanus acerifolia||component_of
hepatitis c virus ab:prthr:pt:body fld:ord||hepacivirus c||component_of
emotional stability behavior^post {event}:find:pt:^patient:nom||event||component_of
sodium intake estimated||sodium intake||component_of
plasma cholinesterase measurement (lab test)||choline esterase ii||component_of
xr elbow-r lat||views lateral||component_of
measurement of borrelia burgdorferi 66 kilodalton antibody (procedure)||borrelia burgdorferi 66-kd antibody (substance)||component_of
promis short form - pain interference 8a - version 1.0 raw score:score:pt:^patient:qn:promis||types of pain||component_of
end-systolic volume:vol:pt:heart.ventricle.left:qn:us.teichholz.calculated||end-systolic volume||component_of
duck meat igg ab [mass/volume] in serum||duck meat ab.igg||component_of
fluid intake enema measured||fluids intake (treatment)||component_of
glycosaminoglycans/creatinine:ratio:24 hours:urine:quantitative||glycosaminoglycans/creatinine||component_of
adenosine deaminase binding protein measurement||adenosine deaminase complexing protein 2||component_of
hered prst8 ca rltd do trgt mrna seq alys 11 gen||genes||component_of
amoxicillin antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||rast class||component_of
physical therapy plan of care panel:-:point in time:^patient:-||treatment plan||component_of
head circumference/abdominal circumference:length ratio:to identify measures at a point in time:^fetus:quantitative:ultrasound.derived||circumference head||component_of
deprecated||physician certification statement||component_of
acvrl1+eng gene del+dup bld/t mlpa||acvrl1 gene+eng gene deletion+duplication||component_of
hpiv2 spec ql cult||viruses||component_of
promis short form - alcohol - alcohol use 7a - version 1.0 raw score:score:pt:^patient:qn:promis||score (attribute)||component_of
continuous pulse oximetry (procedure)||hbo2||component_of
surgical operation note specimens taken||surgical operation note||component_of
indomethacin/interleukin-1-alpha||1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-h-indole-3-acetic acid||component_of
effective orifice area.diastole:area:to identify measures at a point in time:mitral valve:quantitative:ultrasound.doppler.pressure half time||effective orifice area.diastole||component_of
urobilinogen concentration, test strip measurement||urobilinogen (substance)||component_of
osteoblasts nfr mar manual||cells osteoblast||component_of
act glass bead ind hepntr bld micrvisc||after||component_of
abachi wood dust ige qn (s)||triplochiton scleroxylon antibody.immunoglobulin e||component_of
thyrotropin^30m post xxx challenge:acnc:pt:ser/plas:qn||thyrotrophin (substance)||component_of
cbdca/gm-csf/il-6/vp-16||carboplat||component_of
fluid output chest tube 24h||fluid||component_of
i have trouble doing all of the work that i feel i should do (include work at home):find:pt:^patient:ord:promis||i not otherwise specified antigen||component_of
valproate.free and valproate panel - serum or plasma||valproate free||component_of
qualitative analysis of lactose in urine||lactose, unspecified form||component_of
prednisone induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry||immunoglobulin m||component_of
dccs nih||dimensional change card sort test||component_of
tin/creatinine (24h u) [molar ratio]||creatinine (substance)||component_of
pigeon droppings ab.ige:acnc:pt:ser:qn||pigeon droppings ab||component_of
campylobacter coli ribosomal ribonucleic acid:arbitrary concentration:to identify measures at a point in time:serum:quantitative:probe||ribosomal ribonucleic acid of campylobacter coli (substance)||component_of
ulcers, wounds and skin problems:find:pt:^patient:nom:cms assessment||ulcerates||component_of
ganglioside gm1 ab.igm:titr:pt:ser:qn||gamma globulin, 19s||component_of
h. influenzae b dna naa+probe ql (bld)||haemophilus influenzae b||component_of
carbon dioxide [partial pressure] in capillary blood by transcutaneous co2 monitor --pre chest physiotherapy||carbogen||component_of
h capsulatum h+m ab panel csf||m not otherwise specified antigen||component_of
c peptide^1st specimen post xxx challenge:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||c peptide^1st specimen post xxx challenge||component_of
n2o set during insp vfr/ppres gas ds||in breathing||component_of
polymorphonuclear cells/100 wbc manual cnt (pleur fld fetus)||polymorphonuclear cells/100 leukocytes||component_of
diflunisal:mcnc:pt:ser/plas:qn||diflunisal (medication)||component_of
med admin.brief||medication administration||component_of
honeysuckle ige rast class (s)||ab.ige||component_of
feel useless at times rosenberg||certainly feel useless at times||component_of
how often did you have difficulty with lack of interest in sex:find:pt:^patient:ord:phenx||how often did you have difficulty with lack of interest in sex||component_of
burkholderia pseudomallei antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative:hemagglutination||pseudomonas pseudomallei||component_of
cefpodoxime+clavulanate [susceptibility] by gradient strip||betacillin||component_of
covid-19+intubation advance directives:finding:to identify measures at a point in time:{setting}:document:{role}||intubation (note)||component_of
doxorubicin/fluoxymesterone/methotrexate/mitolactol/tamoxifen/vincristine||méthotrexate||component_of
insulin [moles/volume] in serum or plasma --1 hour post xxx challenge||challenge||component_of
long-term care hospital (ltch) continuity assessment record and evaluation (care) data set (lcds) - expired - version 4.00 [cms assessment]||hospital, nos||component_of
codeine||codeine-containing product||component_of
bacteria identified:presence or identity:to identify measures at a point in time:ulcer:nominal:aerobic culture||bacteria identified||component_of
detection of poison||toxic substances||component_of
elder ige ab [units/volume] in serum||elderberry (sambucus nigra) ab||component_of
4th deg burn area/bsa est||fourth degree burn area||component_of
lcds v5.00 - mobility - discharge performance:-:reporting period:^patient:-:cms assessment||mobility - discharge performance||component_of
microscopic observation [identifier] in duodenal fluid by wet preparation||micro||component_of
midazolam confirm [mass/vol]||midazolam-containing product||component_of
cd13+hla-dr+ cells/100 cells (bm)||cells.cd13||component_of
boron intake 24h est||boron-11||component_of
plasminogen activator inhibitor type 1 assay, nos||plasminogen activator inhib 1||component_of
horn beam specific ige antibody measurement||carpinus betulus specific immunoglobulin e||component_of
guidance for percutaneous biopsy:find:pt:xxx>spine:doc:ct||bx||component_of
ross river virus ab.iga:prthr:pt:xxx:ord:ia||ross river virus ab.iga||component_of
prolactin [mass/volume] in serum or plasma --8th specimen post xxx challenge||prolactin^8th specimen||component_of
discharge summary note:finding:to identify measures at a point in time:{setting}:document:burn management||summary note||component_of
mitogen stimulated gamma interferon^^corrected for background:arbitrary concentration:to identify measures at a point in time:whole blood:quantitative||mitogen stimulated gamma interferon^^corrected for background||component_of
during the past 3mo, how often have you failed to do what was normally expected of you because of your use of prescribed amphetamine type stimulants:find:3mo:^patient:ord:nida||rac-amphetamine||component_of
varicella zoster virus strain deoxyribonucleic acid:type:to identify measures at a point in time:not specified:nominal:probe.amp.tar||dna molecules||component_of
oxygen content:scnc:pt:pulmonary artery.main:qn||chemical oxygen||component_of
serum enzyme immunoassay borrelia burgdorferi igg + igm, interpretation||borrelia burgdorferi antibody.immunoglobulin g||component_of
deprecated||drug preparation, nos||component_of
color:type:point in time:nail bed:nominal||color (property) (qualifier value)||component_of
methotrexate/piritrexim||mtx - methotrexate||component_of
volume expired during 1.0 s of forced expiration/forced vital capacity^post bronchodilation:volume ratio:to identify measures at a point in time:respiratory system:quantitative||capacities, vital||component_of
erythropoietin given:arbitrary content:to identify measures at a point in time:dose:quantitative||epo||component_of
end-systolic volume:volume:to identify measures at a point in time:heart.ventricle.left:quantitative:ultrasound||vol||component_of
number hospital admissions in last 90d:number:90 days:^patient:quantitative:mds||hosp||component_of
synthetic glucocorticoid in serum or plasma||glucocorticoid-containing product||component_of
protein electrophoresis panel - 24 hour urine||protein preparations||component_of
macrocheira kaempferi ab.ige:acnc:pt:ser:qn||giant japanese spider crab (macrocheira kaempferi)||component_of
c peptide 12m p chal serpl-mcnc||rh2 (isbt symbol)||component_of
papova virus sv40 dna:ncnc:pt:csf:qn:probe.amp.tar||papova virus sv40||component_of
neisseria meningitidis serogroup b ag [presence] in specimen||blood group antigen b||component_of
streptococcus pneumoniae danish serotype 6b antibody.immunoglobulin g:mass concentration:to identify measures at a point in time:serum:quantitative:immunoassay||immunoglobulin g (igg)||component_of
filling period.diastole:time:to identify measures at a point in time:heart.atrium.right:quantitative:ultrasound.measured||diastolic filling period||component_of
glucose [presence] in urine by test strip --3 hours post 75 g glucose po||glucose (oral)||component_of
g blood group antibody identification (procedure)||blood group antibody rh<sup>g</sup>||component_of
relationships:-:pt:^patient:-:facit||relations||component_of
serum clomipramine level (procedure)||product containing clomipramine||component_of
enterococ dna bld pos ql naa+non-probe||enterococcus sp.||component_of
vbamdex||9alpha-fluoro-16alpha- methylprednisolone||component_of
xr finger.4th-l lat||single view||component_of
haemophilus influenzae b ag [presence] in specimen by latex agglutination||bacterium influenzae||component_of
microscopic observation [identifier] in tissue by periodic acid-schiff stain with diatase digestion||microscopic observation||component_of
diphenoxylate+atropine induced platelet antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:flow cytometry||diphenoxylate+atropine induced platelet ab||component_of
child easy to read face aq adol||working, function||component_of
murine typhus igg antibody test||anti-rickettsia typhi igg||component_of
basophils+mast cells/100 leukocytes in cerebral spinal fluid||cells||component_of
afipia felis ab.igg:titr:pt:ser:qn||immune globulin,gamma (igg) human||component_of
tyr gene targeted mutation analysis:presence or identity:to identify measures at a point in time:whole blood/tissue, unspecified:nominal:molecular genetics||tyrosinase gene||component_of
cd4 cells/cd8 cells (bld) [# ratio]||class 1 hum leucocyte ag recep||component_of
recommendation patient doc-imp||recommendations||component_of
vr-12 physical component summary score - oblique method:t score:to identify measures at a point in time:^patient:quantitative:vr||scores (qualifier value)||component_of
insulin level 6 hours post challenge||insulin regular||component_of
views 3:finding:to identify measures at a point in time:upper extremity.bilateral>wrist:document:xr||3 views||component_of
hepatitis c virus rna [#/volume] (viral load) in bone marrow by naa with probe detection||virus||component_of
clozapine trough serpl-mcnc||clozapine product||component_of
lysine/amino acids.total in specimen||lysine/amino acids.total||component_of
lymphocytes/100 leukocytes:nfr:pt:dial fld:qn||lymphocytes/100 leukocytes||component_of
multisection endovaginal:find:pt:xxx:doc:mr||multisection||component_of
platelet aggregation collagen induced atp secretion [presence] in blood --1 ug/ml||platelet aggregation.collagen induced||component_of
dentistry outpatient progress note||progress note||component_of
left eye cylinder autorefractor.sciascopy||cylinder||component_of
berry juniper+oneseed juniper+rocky mountain juniper ige rast class multidisk (s)||(citharexylum caudatum+juniperus monosperma+juniperus scopulorum) antibody.immunoglobulin e||component_of
thyroid stimulating antibody level (procedure)||thyrotropin receptor ab||component_of
urinary catheter tip culture pseudallescheria boydii (lab test)||pseudallescheria boydii||component_of
no menstrual period 3 or more mos phenx||since the age of 18, have you ever experienced a time interval of 3 or months when you did not have a menstrual period||component_of
child describe restless legs bed phenx||child restless legs bed||component_of
internal medicine intensive care unit note||note (document)||component_of
asp/dox/mp/pred/vcr||prednisone-containing product||component_of
dnr/pred/tg/vcr/vm-26/vp-16||l-lyxo-hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-,hydrochloride||component_of
creat 4h p pd prt-mcnc||creatinine^4h post peritoneal dialysis||component_of
glycine csf/glycine plas:relative substance concentration:to identify measures at a point in time:plasma+cerebral spinal fluid:quantitative||glycine product||component_of
views pa + lateral + waters:finding:to identify measures at a point in time:head>sinuses:document:xr||views pa and lateral||component_of
burkholderia pseudomallei ab.igg:titr:pt:ser:qn:if||burkholderia pseudomallei ab||component_of
promis short form - physical function 6b - version 1.2 raw score:score:pt:^patient:qn:promis||promis short form - physical function 6b - version 1.2 raw score||component_of
prolactin [mass/volume] in serum or plasma --50 minutes post 200 ug trh iv||thyrotropin releasing factor agent||component_of
(beef+chicken meat+pork+turkey meat) ab.ige.rast class:prthr:pt:ser:ord:multidisk||chickens||component_of
choriogonadotropin.alpha subunit:mcnc:pt:ser/plas:qn||choriogonadotropin.alpha subunit||component_of
deoxyribonucleic acid double strand antibody:arbitrary concentration:to identify measures at a point in time:body fluid, unsp:quantitative:farr||dna double strand||component_of
how short of breath did you get lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) over past 7d:find:7d:^patient:ord:promis||lifting||component_of
oj ab:prthr:pt:ser:ord||oj||component_of
garenoxacin:susc:pt:isolate:ordqn:mic||geninax||component_of
forced vital capacity^post bronchodilation:volume:to identify measures at a point in time:respiratory system:quantitative:spirometry||forced vital capacity^post bronchodilation||component_of
pm-1 ab if ql (s)||pm-1||component_of
redfish ige ab [units/volume] in serum||redfish (substance)||component_of
serum rheumatoid antibody level||autoantibody (substance)||component_of
senecavirus a rna [cycle threshold #] in specimen by naa with probe detection||gene products, rna||component_of
can pronounce plethora [nih toolbox]||can pronounce plethora||component_of
prolintane ur-mcnc||prolintane (product)||component_of
acinetobacter sp identified org specific cx nom (specimen)||acinetobacter species (organism)||component_of
mexican tea ige rast class (s)||immunoglobulin ige||component_of
adenosine monophosphate.cyclic/creatinine [ratio] in urine --baseline||ade-rib||component_of
erythrocyte mean corpuscular diameter:len:pt:rbc:qn||erythrocyte mean corpuscular diameter||component_of
blm gene targeted mutation analysis molgen doc (bld/tiss)||blm gene targeted mutation analysis||component_of
salmonella typhi o ab:titr:pt:ser:qn||salmonella typhi o||component_of
how much bodily pain have you had during the past 4w:find:4w:^patient:ord:vr||how much bodily pain have you had during the past 4w||component_of
(ceratonia siliqua+lens esculenta+phaseolus vulgaris+pisum sativum) ab.ige:acnc:pt:ser:qn:multidisk||ceratonia siliqua antigen||component_of
dimethylxanthenone acetic acid/docetaxel||docetaxol||component_of
measurement of influenzavirus a/victoria/3/75 (h1n1) antibody||influenzavirus a/victoria/3/75 (h1n1) antibody (substance)||component_of
intellectual disability and developmental disability with no organic condition:find:pt:^patient:ord:mdsv3||conditions||component_of
r cornea refractive power.mean by km||refractive power||component_of
mra chest veins wo and w contrast iv||multisection||component_of
mr posterior fossa w contrast iv||multisection^w contrast iv||component_of
lysine/creatinine:srto:pt:urine:qn||lysine (medication)||component_of
giardia lamblia ab.igm:prthr:pt:ser:ord:ia||giardia lamblia antibody.immunoglobulin m||component_of
pork ige rast ql||pork antigen||component_of
erysipelothrix rhusiopathiae dna [cycle threshold #] in specimen by naa with probe detection||erysipelothrix insidiosa||component_of
metamyelocytes.neut/leuk nfr mar manual||100 leukocytes||component_of
cd4+cd45ro+ cells [#/volume] in blood||antigens, cd45r0||component_of
5-alpha tetrahydrocortisol^2d post high dose dexamethasone:mcnc:24h:urine:qn||tetrahydrocortisol||component_of
sleep during night qids||sleep during the night in past 7d||component_of
influenza virus a antibody:arbitrary concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||antibody a||component_of
status of regional dialysis centers:finding:point in time:^event:narrative||status of regional dialysis centers||component_of
carbon dioxide^post dialysis:scnc:pt:ser/plas:qn||dialyses||component_of
mg breast - bilateral displacement views for implant||eklund views||component_of
benzoylecgonine:mcnc:pt:bld:qn:confirm||o-benzoylecgonine||component_of
serum arginine level||arginine (substance)||component_of
lymphocytes.immunoglobulin d/100 lymphocytes:number fraction:to identify measures at a point in time:leukocytes:quantitative||lymph cell||component_of
p. multocida toxin ia ql (specimen)||pasteurella multocida antigen||component_of
psilocybin cutoff [mass/volume] in urine for screen method||psilocybin cutoff||component_of
views ap + pa^w standing:find:pt:lower extremity.left>knee:doc:xr||views ap and pa||component_of
vc p bd vol respiratory||vital capacity^post bronchodilation||component_of
plasma oxalate||oxalate (substance)||component_of
pattern comparison processing speed test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment:score:to identify measures at a point in time:^patient:quantitative:nih toolbox||pattern comparison processing speed test||component_of
blood flow velocity.systolic.max:vel:pt:tricuspid valve:qn:us.doppler||blood flow.velocity||component_of
htlv i+ii p24 ab:prthr:pt:ser/plas:ord:ib||htlv i+ii p24||component_of
bovine respiratory syncytial virus ag:prthr:pt:tiss:ord:immune stain||section 3 viruses||component_of
blood group antibody screen:presence or threshold:to identify measures at a point in time:blood - cord:ordinal||blood||component_of
measles virus igm ab [presence] in cerebral spinal fluid by immunoassay||immunoglobulin m antibody||component_of
3-hydroxybenzoate:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||3-hydroxybenzoate||component_of
human papilloma virus 6 dna:ncnc:pt:xxx:qn:probe.amp.tar||human papillomavirus virus||component_of
are you able to hike a couple of miles on uneven surfaces, including hills:finding:to identify measures at a point in time:^patient:ordinal:promis||are you able to hike a couple of miles on uneven surfaces, including hills||component_of
corticotropin^pre dose glucose:scnc:pt:plas:qn||pre||component_of
3oh-bze mec cfm-mcnt||m-hydroxybenzoylecgonine||component_of
service comment 18||comments||component_of
(arachis hypogaea+cow milk+egg white+glycine max+triticum aestivum+oryza sativa) antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative:multidisk||oryza sativa ab||component_of
capecitabine/celecoxib||celecoxib product||component_of
diazinon spec-mcnt||phosphorothioic acid, o,o-diethyl o-(6-methyl-2-(1-methylethyl)-4-pyrimidinyl) ester||component_of
hla-a igg ab [identifier] in serum or plasma by flow cytometry (fc)||antigens, hla a||component_of
coccidioides sp rrna [presence] in specimen by naa with probe detection||coccidioides sp rrna||component_of
streptococcus pneumoniae ab.igg^1st specimen:acnc:pt:ser:qn||streptococcus pneumoniae antibody (substance)||component_of
mycobacterium tuberculosis ribosomal ribonucleic acid assay||bacterial nucleic acid (substance)||component_of
powassan virus igm ab [units/volume] in specimen||pow||component_of
view jones:finding:to identify measures at a point in time:upper extremity>elbow:document:xr||jones||component_of
platelet genotype [identifier] in amniotic fluid||platelet genotype||component_of
11-ketoandrosterone [mass/volume] in 24 hour urine --pre dose dexamethasone||11-ketoandrosterone^pre dose dexamethasone||component_of
axr and flr ugi w h2o soluble contr po||product containing water||component_of
lime tree (citrus aurantifolia tree) ige ab [units/volume] in serum||citrus aurantifolia tree antibody.immunoglobulin e||component_of
o tsut kato igg titr fld if||gamma globulin 07s||component_of
resistivity index:velocity ratio:to identify measures at a point in time:uterine artery.right:quantitative:ultrasound.doppler||resistivity index||component_of
mr guided brain str loc--wo contr||spatial guidance for medical procedure||component_of
naa with probe detection for hiv-2 rna viral load in serum or plasma||human immunodeficiency virus 2 rna||component_of
aldost 30m p chal serpl-mcnc||after values||component_of
allyl chloride (air) [mass/vol]||chlorallylene||component_of
alloisoleucine [moles/volume] in serum or plasma --post therapeutic diet||threo 2-amino 3-methylpentanoic acid||component_of
va c&p exam cushings syndrome||va c&p exam.cushings syndrome note||component_of
beta hydroxybutyrate+acetoacetate^pre-meal:substance concentration:to identify measures at a point in time:whole blood:quantitative||acetoacetate^pre-meal||component_of
(avena sativa+fagopyrum esculentum+sesamum indicum+triticum aestivum+zea mays) ab.ige.rast class:prthr:pt:ser:ord:multidisk||zea mays ab||component_of
cytoplasmic cd3 blasts/100 blasts in specimen||cytoplasmic cd3||component_of
inner ear 68kd ab [presence] in body fluid||inner ear 68kd||component_of
cells.cd235a/100 cells:nfr:pt:bone mar:qn||100 cells||component_of
blood relative eye problem phenx||blood, nos||component_of
valdecoxib induced platelet igg fc ql||thrombocytes||component_of
follitropin [units/volume] in serum or plasma --1.5 hours post dose gonadotropin releasing hormone||follicle-stimulating hormone||component_of
chicken feather+duck feather+goose feather+turkey feather igg multidisk (s) [mass/vol]||goose||component_of
creatinine^9h post xxx challenge:scnc:pt:ser/plas:qn||creatinine^9h post xxx challenge||component_of
matrix metalloproteinases-9 ab ia qn||gelatinase b||component_of
uun 24h ur-mcnc||carbonyldiamide||component_of
propoxyphene+acetaminophen induced platelet antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:flow cytometry||platelet antibody||component_of
90 minute plasma tsh measurement||thyrotrophin product||component_of
t. rubrum ige qn (s)||epidermophyton rubrum castell., 1910||component_of
plasma free protein s level (procedure)||protein s.free||component_of
vascular surgery initial eval note||note (document)||component_of
deprecated allergy and immunology treatment plan note||note||component_of
deprecated lung nm v w rnc aero ih||ih blood group||component_of
hgb g-coush mfr bld||hemoglobin g-coushatta/hemoglobin.total||component_of
bluetongue virus 13 antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:virus neutralization||bluetongue virus||component_of
multisection^wo & w contrast iv:find:pt:upper extremity.bilateral>upper extremity vessels:doc:ct.angio||multisection^wo & w contrast||component_of
deprecated toxoplasma igm titr ser if||toxoplasma species||component_of
(acer negundo+betula verrucosa+quercus alba+ulmus americana+juglans californica) ab.ige:prthr:pt:ser:ord:multidisk||ulmus americana antigen||component_of
jo-1 antibody||anti jo-1 antibody (substance)||component_of
goat epithelium specific immunoglobulin e antibody measurement||goat epithelium specific immunoglobulin e||component_of
trout igg (s) [mass/vol]||oncorhynchus mykiss||component_of
multisection:find:pt:upper extremity>wrist+hand:doc:mr||(multisection||component_of
gliadin ab [units/volume] in serum||gliadin antibodies||component_of
p wave duration:time:pt:heart:qn:ekg||durations||component_of
xylulose measurement||xylulose (substance)||component_of
angiostrongylus cantonensis deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:not specified:ordinal:probe.amp.tar||angiostrongylus cantonensis deoxyribonucleic acid||component_of
asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/leucovorin calcium/mercaptopurine/methotrexate/thioguanine/vincristine||n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-l-glutamic acid||component_of
current level of confidence i can use public transportation:finding:to identify measures at a point in time:^patient:ordinal:promis||i1 (isbt symbol)||component_of
6-alpha hydroxytetrahydro-11-deoxycortisol 2 days post dose dexamethasone (24h u) [mass/time]||after values (qualifier value)||component_of
views ulnar deviation + radial deviation:finding:to identify measures at a point in time:upper extremity>wrist:document:xr||view (attribute)||component_of
cortis f am peak serpl-mcnc||cortisol.free^am peak specimen||component_of
gamma aminobutyrate b receptor antibody.immunoglobulin g:dilution factor (titer):to identify measures at a point in time:cerebral spinal fluid:quantitative:immune fluorescence||b ag||component_of
streptococcus agalactiae dna:prthr:pt:xxx:ord:probe.amp.tar||lancefield group b streptococcus||component_of
adenovirus ab spec 2 cf (s) [titer]||adenovirus ab^2nd specimen||component_of
5-alpha tetrahydrocortisol^2d post dose dexamethasone:mcnc:24h:urine:qn||pregnan-20-one, 3,11,17,21-tetrahydroxy-, (3alpha,5beta,11beta)-||component_of
how many times in the last y have you used a harder drug, such as heroin, cocaine or lsd:nrat:1y:^patient:qn:denver youth survey||how many times in the last y have you used a harder drug, such as heroin, cocaine or lsd||component_of
deprecated pulmonary therapy treatment plan, diagnosis addressed by plan identifier||diagnosis.addressed by plan||component_of
cocaine metabolites.other:mcnc:pt:urine:qn||cocaine substance||component_of
promis short form - emotional support 8a - version 2.0:-:to identify measures at a point in time:^patient:-:promis||support||component_of
other cells/100 leukocytes in pleural fluid by manual count||the cell||component_of
how often did you eat cold cereal in the past 30d:find:30d:^patient:ord:phenx||how often did you eat cold cereal in the past 30d||component_of
dicarboxyoleylcarnitine (c18:1-dc) [moles/volume] in dbs||dicarboxyoleylcarnitine (c18:1-dc)||component_of
blood flow velocity.systole.max/blood flow velocity.diastole.max^inspiration:velrto:pt:hepatic vein:qn:us.doppler.derived||blood||component_of
glipizide:mass concentration:to identify measures at a point in time:not specified:quantitative||glidiazinamide||component_of
fetal interventricular septum narrative study observation us||study observation||component_of
campylobacter fetus ab [titer] in serum by complement fixation||antibody to campylobacter fetus (substance)||component_of
beta-lactam resistance ampc blafox gene [presence] by molecular method||beta-lactam (substance)||component_of
human papilloma virus 18 dna [presence] in tissue by naa with probe detection||virus, nos||component_of
pt 8h p chal ppp||after||component_of
microscopic observation [identifier] in tissue by neutral red stain||microscopic observation||component_of
rift valley fever virus igm ia ql (specimen)||rift valley fever virus igm||component_of
long axis.mean:len:pt:humerus.diaphysis^fetus:qn:estimated from gestational age.merz 1987||axis||component_of
st. john's wort ige qn||immunoglobulin ige (substance)||component_of
xr tomography elbow - bilateral||multisection||component_of
17-n-allylamino-17-demethoxygeldanamycin/paclitaxel||paclitaxel||component_of
service comment 51:impression/interpretation of study:to identify measures at a point in time:not specified:nominal||comment||component_of
mra shoulder vessels - right||multisection||component_of
multisection^wo & w contrast iv:find:pt:chest>spine.thoracic vessels:doc:mr.angio||multisection||component_of
date fundal height reaches umbilicus:date:pt:^patient:qn||date fundal height reaches umbilicus||component_of
i am bothered by having a blocked nose in the past 7d:finding:7 days:^patient:ordinal:facit||blood group antigen a, nos||component_of
how many of his or her brothers have, had, or were suspected of having this eye problem:num:pt:^patient:qn:phenx||how many of his or her brothers have, had, or were suspected of having this eye problem||component_of
progress note:find:pt:hospital:doc:cardiovascular disease.attending||progress||component_of
cells.cd4+cd7-/100 cells:number fraction:to identify measures at a point in time:marrow (bone):quantitative||cells.cd4+cd7+/100 cells||component_of
radish ige rast class (s)||ab.ige||component_of
allelic frequency:number fraction:to identify measures at a point in time:^population:quantitative||frequency (attribute)||component_of
cytomegalovirus:prthr:pt:bone mar:ord:organism specific culture||cytomegalovirus (living organism) (organism)||component_of
specific effective resistance.airway^pre bronchodilation:fldresist:stdy^mean:respiratory system.airway:qn:calculated||airway resistance (observable)||component_of
cddp/ctx/dm/vp-16||cis platinum||component_of
htlv i+ii igg ab [presence] in serum by immunoblot||human t lymphotropic virus||component_of
avian metapneumovirus antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immunoassay||antibody to avian metapneumovirus (substance)||component_of
hbv e ag + ab pnl ser||little e||component_of
clostridium perfringens igg ab [units/volume] in serum||immunoglobulin g||component_of
night sweats:finding:24 hours:immune system:ordinal:reported.hiv-ssc||sweat; night sweats||component_of
avian infectious laryngotracheitis virus ab if (s) [titer]||section 3 viruses||component_of
neuronal nuclear ab:acnc:pt:ser:qn:ib||neuronal||component_of
prolactin^45m post dose insulin intravenous:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||prolactin^45m post dose insulin iv||component_of
hordeum vulgare antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||hordeum vulgare antigen||component_of
bamboo shoot ige ab rast class [presence] in serum||immunoglobulin e||component_of
aspen ige rast class (s)||aspen (populus tremula) ab||component_of
pressure injury risk - none of the above [mdsv3]||pressure injury||component_of
patient lives alone [cms assessment]||patient lives alone||component_of
11doc sp7 p chal serpl-mcnc||trailing||component_of
deprecated cardiac rehabilitation treatment plan, plan of treatment (narrative)||plan treatment||component_of
participation in assessment significant other [minimum data set]||assessment||component_of
bacteria identified sterile body fluid culture nom (specimen)||bacteria identified||component_of
ephemeral fv ab ser ql nt||ephemeral fever virus||component_of
o. tsutsugamushi ab (s) [titer]||rickettsia tsutsugamushi (organism)||component_of
clostridium tetani toxoid antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||clostridium tetani toxoid antibody.immunoglobulin e||component_of
platelet glycoprotein pnl bld fc||platelet (cell structure)||component_of
ara-c/bi213 moab m195/g-csf||bismuth bi213 monoclonal antibody m195||component_of
s. pneumoniae igg (s) [mass/vol]||immunoglobulin igg, nos||component_of
i was too tired to go out with my family in past 7d:finding:7 days:^patient:ordinal:promis||i was too tired to go out with my family in past 7 days||component_of
site/lat/seq # o/r cancer case||lat||component_of
how often are you distracted by activity or noise around you:find:pt:^patient:ord:asrs||signal noise||component_of
s' wave amplitude.lead v5:electrical potential (voltage):to identify measures at a point in time:heart:quantitative:ekg||lead metal||component_of
human coronavirus 229e+hku1+nl63+oc43 & parainfluenza virus 1+2+3+4 rna panel:-:pt:respiratory.upper:-:probe.amp.tar||parainfluenza virus, nos||component_of
sars-cov-2 orf1ab spec ql naa+probe||urbani sars-associated coronavirus||component_of
fluid output.gastrointestinal drain:volume:to identify measures at a point in time:gastrointestinal system:quantitative:measured||fluids output||component_of
in the past year, have you been treated with antibiotics for a chest illness [phenx]||522-523 miscellaneous antibiotics||component_of
hla-dw13 ql||human leukocyte antigen (hla) antigen||component_of
abo group p hsct bld||abo group^post hematopoietic stem cell transplant||component_of
v. cholerae dna naa+non-probe ql (stl)||deoxyribonucleic acid of vibrio cholerae||component_of
views ap + lateral crosstable:find:pt:pelvis & lower extremity.right>hip:doc:xr||views||component_of
pt pivka sensitive act/nor bldc||coagulation tissue factor induced.pivka sensitive||component_of
chloride 2 hr post dose vasopressin [moles/vol]||vasopressin, unspecified||component_of
phenobarbital cutoff [mass/volume] in urine for confirmatory method||phenobarbital cutoff||component_of
i am irritable in the past 7 days [facit]||i not otherwise specified antigen||component_of
bermuda grass ige/ige total %||allergen pack bermuda grass||component_of
nuclear mitotic apparatus ab if ql (s)||nuclear||component_of
asparagine+ornithine [moles/volume] in dbs||asparagine+ornithine||component_of
sars coronavirus 2 antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:immunoassay||coronavirus, wuhan||component_of
dm/g3139/thal||oblimersen sodium||component_of
cardiac arrest within 24h prior to procedure:history:24 hours:^patient:ordinal||cardiac standstill||component_of
calcitonin [mass/volume] in serum or plasma --1 minute post xxx challenge||calcitonin agent||component_of
ct head+neck wo contr||multisection||component_of
s. pneumoniae danish type 11a igg ia (s) [mass/vol]||streptococcus pneumoniae danish serotype 11a (organism)||component_of
eeev igm ser-acnc||eastern equine encephalomyelitis virus||component_of
chlorpromazine measurement||chlorpromazine product||component_of
methotrexate/sirolimus/tacrolimus||slm||component_of
campylobacter sp identified:prid:pt:body fld:nom:organism specific culture||campylobacter sp identified||component_of
multisection:find:pt:head>mandible:doc:ct||(multisection||component_of
r. rickettsii igm if (body fld) [titer]||igm - immunoglobulin m||component_of
docetaxel/monoclonal antibody anti-alpha v beta 3 integrin/prednisone/zoledronate||prednisone||component_of
insulin level 2 hours post challenge||insulin products||component_of
l. pneumophila igg spec 1 if ql (s)||legionella pneumophila (organism)||component_of
ct guidance for aspiration of cyst of lung - right||guidance for percutaneous aspiration of cyst||component_of
engraulis encrasicolus antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||engraulis encrasicolus antigen||component_of
axis:impression/interpretation of study:point in time:heart:narrative:ekg||axis||component_of
stroke volume/body surface area:volume/area:to identify measures at a point in time:heart.ventricle.left:quantitative:ultrasound.2d+calculated by single-plane ellipse method||area (qualifier value)||component_of
hsv1 dna serpl ql naa+probe||homini, herpesvirus||component_of
spermatozoa antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:semen:quantitative||immunoglobulin igg (substance)||component_of
hantavirus rna [presence] in serum by naa with probe detection||hantanvirus||component_of
chromosome band involved start:find:pt:bld/tiss:nom:molgen||chromosomal||component_of
propionylgly/creat 24h ur-srto||propionylglycine (substance)||component_of
acinetobacter baumannii dna:prthr:pt:bld.pos growth:ord:probe.amp.tar||herellea vaginicola||component_of
obesity med consult note||note (document)||component_of
i have numbness in my legs in the past 7 days [facit]||i1 (isbt symbol)||component_of
srp ab serpl-acnc||signal recognition particle antibody||component_of
discharge summary||note (document)||component_of
glycine/creatinine:ratio:24 hours:urine:quantitative||creatinine||component_of
dihydrocodeine free+hydrocodol free confirm ql (umb cord tissue)||dihydrocodeine.free+hydrocodol.free||component_of
us.doppler heart for blood flow||multisection for blood flow||component_of
murray valley encephalitis virus antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||vira||component_of
cd4+cd7- cells/100 cells in body fluid||cells.cd4+cd7-||component_of
dextromethorphan:mass concentration:to identify measures at a point in time:urine:quantitative||delta-methorphan||component_of
campylobacter fetus ss venerealis ab [presence] in genital mucus||campylobacter fetus (organism)||component_of
p16ink4a ag:prthr:pt:tiss:ord:immune stain||p16ink4a||component_of
rickettsia (proteus oxk) ab:prthr:pt:ser:ord:la||rickettsia (proteus oxk)||component_of
noroxycodone cutoff:mass concentration:to identify measures at a point in time:urine:quantitative:confirm||noroxycodone cutoff||component_of
views ap + danelius miller:find:pt:lower extremity.right>hip:doc:xr||views & ap||component_of
ribonucleic acid polymerase iii rp11 antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:immunoassay||non-polyadenylated rna||component_of
lithium:scnc:24h:urine:qn||lithium 7||component_of
prunus persica var nucipersica ab.igg4:mcnc:pt:ser:qn||nectarine (prunus persica var nucipersica)||component_of
lactyl lactate/creatinine [molar ratio] in urine||lactyl lactate||component_of
promis short form - alcohol - positive expectancies 7a - version 1.0 raw score:score:to identify measures at a point in time:^patient:quantitative:promis||form||component_of
view ap^w r-bending:finding:to identify measures at a point in time:abdomen>spine.lumbar:document:xr||(view ap||component_of
digestion-hydration.status:finding:to identify measures at a point in time:^patient:ordinal:observed.omaha||status (attribute)||component_of
phleum pratense recombinant (rphl p) 1+5b ab.igg4:mcnc:pt:ser:qn||phleum pratense recombinant (rphl p) 1||component_of
xylose p 5 g xyl po 5h ur-mrate||d-xylose preparation (product)||component_of
uea1 ag tiss ql imstn||ulex europaeus agglutinin-1||component_of
foxl2 gene targeted mutation analysis in tissue by molecular genetics method||gene (substance)||component_of
education note:finding:to identify measures at a point in time:{setting}:document:urology||education note||component_of
watson-schwartz test||pbg||component_of
sulphonamide ige qn (s)||ige||component_of
deprecated cardiolipin igm ab [units/volume] in serum by immunoassay||cardiolipin antibody||component_of
overall summary score:score:to identify measures at a point in time:^patient:quantitative:kccq-12||scores (qualifier value)||component_of
htlv i+ii p24 ab:prthr:pt:ser:ord||i-antigen||component_of
multisection^wo & w contrast iv:find:pt:upper extremity.bilateral>upper extremity vessels:doc:ct.angio||(multisection||component_of
views 2^w manual stress:finding:to identify measures at a point in time:lower extremity.left>ankle:document:xr||views 2||component_of
cystine crystals:number aeric (number per area):to identify measures at a point in time:urine sediment:quantitative:microscopy.light.hpf||l-alanine, 3,3'-dithiobis-||component_of
tidal volume.spontaneous+mechanical/body weight [volume/mass] corrected for compressible gas volume --on ventilator||volume (property) (qualifier value)||component_of
ketoconazole/paclitaxel||ketoconazole [skin]||component_of
cells.cd27-cd45ro+cd62l-ccr7-/100 cells.cd3+cd8+:number fraction:to identify measures at a point in time:whole blood:quantitative||lymphocyte antigen cd3||component_of
current level of confidence i can get to the bathroom in time [promis]||i1 (isbt symbol)||component_of
epid allerg mix71 ige rast ql||class||component_of
bbs1 gene targeted mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||genes||component_of
(views 2) + (view tunnel^w standing):find:pt:lower extremity.left>knee:doc:xr||view (attribute)||component_of
hla-dqa1*01:02 ql (bld/tiss)||hla-dqa1*01:02||component_of
syzygium aromaticum ab.igg.rast class:prthr:pt:ser:ord||clove (syzygium aromaticum) igg||component_of
home patients restarting dialysis population #||home patients restarting dialysis||component_of
promis cancer emotional distress - depression - version 1.0 t-score:t score:to identify measures at a point in time:^patient:quantitative:promis||cancer (nos)||component_of
erythritol/creatinine (u) [molar ratio]||erythritol (substance)||component_of
rf bladder+urethra views w contr ru||views^w contrast retrograde via urethra||component_of
mecy||product containing methotrexate||component_of
hydrogen measurement (procedure)||protium||component_of
itpa gene.g.9330c>a:type:pt:ser/plas:nom:molgen||itpa gene.g.9330c>a||component_of
mg breast - left diagnostic limited views||single view||component_of
epidermal antibody level (procedure)||autoimmune antibody||component_of
alpha cortolone/creatinine [mass ratio] in urine||creatinine (substance)||component_of
hiv 1 ab ia ql (bldc)||human immunodeficiency virus 1 antibody||component_of
corynebacterium diphtheriae ab^2nd specimen/1st specimen:ratio:pt:ser:qn||corynebacterium diphtheriae antibody (substance)||component_of
pik3ca gene trgt seq alys||gene (substance)||component_of
renin renal clearance in 24 hour urine and serum or plasma||angiotensinogenase||component_of
chick pea ige ab/ige total in serum||immunoglobulins, e||component_of
squid ige/ige total %||loligo sp ab||component_of
echinococcus granulosus ab.ige.rast class:prthr:pt:ser:ord||loinc class types||component_of
lidocaine [moles/vol]||lidocaine (substance)||component_of
cisplatin, mitomycin and vindesine chemotherapy protocol||chemotherapeutics mitomycin||component_of
salmonella sp dna [cycle threshold #] in specimen by naa with probe detection||desoxyribonucleic acid||component_of
infection nipple||disorder of nipple infection||classified_as
crush injury, face nos||crush injury, face||classified_as
virilism fetal||fetal virilism (disorder)||classified_as
pathogen resistance||cross resistance||classified_as
increased vitamin a (biological function) (finding)||increased vitamin a (biological function) (finding)||classified_as
oral paraesthesia||paresthesia mouth||classified_as
hyperplasia, melanocytic||atypical melanocytic hyperplasia||classified_as
mania (disorder)||manic disorder, recurrent episode, severe degree, specified as with psychotic behaviour||classified_as
congestion; pulmonary||pulmonary configuration increased||classified_as
renal insufficiency, acute||renal failure nos||classified_as
general physical condition abnormal||general body appearance abnormal||classified_as
rash candida||moniliasis axillary||classified_as
stage iii rectal carcinoma ajcc v6||stage iii rectal carcinoma ajcc v6||classified_as
respiratory system procedures, nec||medical and surgical @ respiratory system @ occlusion @ main bronchus, left @ open @ no device @ no qualifier||classified_as
angina pectoris, variant||prinzmetal's angina||classified_as
total complement activity decreased||total complement activity decreased||classified_as
other and unspecified complications of birth; puerperium affecting management of mother||oth ob compl-deliv w p/p||classified_as
venous and arterial catheter placement||insertion of infusion device into left hand vein, open approach||classified_as
glaucoma capsulare||secondary open-angle glaucoma with pseudoexfoliation||classified_as
endocrine procedures, nec||destruction of glomus jugulare, open approach||classified_as
neurosarcomas||neurofibrosarcoma non-metastatic||classified_as
scoliosis and other postural dorsopathic deformities||other kyphosis, cervicothoracic region||classified_as
hepatocellular cancers||hepatic cancers||classified_as
sandpapering of skin||abrasion trunk||classified_as
mineral metabolism disorder||disorder of mineral metabolism, unspecified||classified_as
device data issue||device data issue||classified_as
megacolons||megacolon -not hirschsprung||classified_as
musculoskeletal device procedures, nec||medical and surgical @ bursae and ligaments @ removal @ lower bursa and ligament @ open @ nonautologous tissue substitute @ no qualifier||classified_as
biopsy palate||biopsy palate||classified_as
external cause codes: sequela||passenger in heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident, sequela||classified_as
tightness in throat||feeling of tightness in throat||classified_as
ocular absence||absence of eyeballs||classified_as
gastrointestinal carcinoma||intestinal neoplasms, malignant||classified_as
comb hepatocell ca+cholangioca||malignant neoplasm of liver and intrahepatic bile ducts||classified_as
syndrome; right heart, hypoplastic||syndrome; heart, hypoplastic right||classified_as
abscesses tooth||paradontal abscess||classified_as
psoriasis, unspecified||psoriasis aggravated||classified_as
uterine cervical cancer, stage iii||cervix neoplasm stage iii||classified_as
undifferentiated high-grade pleomorphic sarcoma||malignant fibrous histiocytoma of bone localized||classified_as
subcutaneous tissue, fascia, and muscle biopsy||drainage of left lower leg, open approach, diagnostic||classified_as
creatinine clearance normal||creatinine renal clearance normal||classified_as
abnormal basophil count||plasma basophils abnormal||classified_as
systemic lupus erythematosus rash||lupoid dermatitis||classified_as
gardnerella test negative||gardnerella test negative||classified_as
[d]abnormal heart sounds nos (context-dependent category)||second cardiac sound abnormality||classified_as
coronavirus test positive (finding)||sars virus test positive||classified_as
peripheral nerve denervation||medical and surgical @ peripheral nervous system @ division @ head and neck sympathetic nerve @ percutaneous @ no device @ no qualifier||classified_as
traumatic hemorrhage||traumatic hemorrhage (disorder)||classified_as
hepatectomy||hemihepatectomy||classified_as
blood gonadotropin abnormal (lab test)||blood gonadotrophin abnormal||classified_as
cmv viremia||cytomegalovirus viremia||classified_as
dis calcium metablsm nos||calcium disorder||classified_as
brachyolmia||bcym1a||classified_as
amputation of a limb, subsequent encounter||complete traumatic transphalangeal amputation of unspecified finger, subsequent encounter||classified_as
toxic effect of chemical (disorder)||pesticide toxicity, nos||classified_as
fracture of the lower limb (except hip), initial encounter||nondisplaced fracture of unspecified tibial spine, initial encounter for closed fracture||classified_as
periprosthetic capsulotomy of breast (procedure)||capsulotomy of breast||classified_as
hiv-associated neurocognitive disorder||acquired immune deficiency syndrome dementia complex (disorder)||classified_as
labial hypertrophy was observed||hypertrophy of the labia||classified_as
mitral valve sclerosis||mitral valve sclerosis (disorder)||classified_as
drug effective for unapproved indication||drug effective for unapproved indication||classified_as
adenosquamous cell lung cancer recurrent||recurrent adenosquamous cell carcinoma of lung||classified_as
otitis media acute nos||acute non-supp otit med,serous||classified_as
mast cell; sarcoma||mal mastocytosis inguin||classified_as
sprains and strains, subsequent encounter||strain of muscle(s) and tendon(s) of anterior muscle group at lower leg level, right leg, subsequent encounter||classified_as
[d] upper abdominal pain (situation)||upper right quadrant pain||classified_as
hepatitis c rna decreased||hepatitis c rna decreased||classified_as
toxic effects, subsequent encounter||toxic effect of paints and dyes, nec, assault, subs||classified_as
syndrome; malabsorption||sprue||classified_as
stupor||torpor||classified_as
stage 0 esophageal adenocarcinoma||esophageal adenocarcinoma lower third stage 0||classified_as
acute rapidly progressive glomerulonephritis||pauci-immune glomerulonephritis||classified_as
carotid revascularisation||carotid revascularization||classified_as
disease, lutz-lewandowsky||disease, lewandowsky-lutz||classified_as
stage iii bladder squamous cell cancer||stage iii bladder squamous cell carcinoma ajcc v6||classified_as
pseudoparalysis (physical finding)||pseudoparalysis||classified_as
limb crushing injury||crush injury of shoulder||classified_as
renal insufficiency (diagnosis)||renal insufficiency, chronic||classified_as
ototoxicity (disorder)||vestibular toxicity||classified_as
precursor b-lymphoblastic lymphoma stage iii||lymphoblastic lymphoma (precursor b-lymphoblastic lymphoma/leukemia) stage iii||classified_as
liveborn||[v]singleton, born outside hospital and not hospitalized (context-dependent category)||classified_as
hypoplastic bone marrow||bone marrow aplasia (diagnosis)||classified_as
adrenal gland hypofunction||insufficiency adrenal||classified_as
ovarian germ cell embryonal carcinoma stage iii||ovarian germ cell embryonal carcinoma stage iii||classified_as
injury facial||open wound of jaw, uncomplicated||classified_as
disorder of tendon, nos||disorder of tendon||classified_as
sprains and strains, subsequent encounter||sprain of unspecified parts of left shoulder girdle, subsequent encounter||classified_as
anterior segment ischaemia||anterior segment ischemia (diagnosis)||classified_as
lacrimoauriculodentodigital syndrome||lacrimo-auriculo-dento-digital syndrome||classified_as
biliary catheter insertion||insertion of bile duct t-tube||classified_as
suppressed lactation nos (disorder)||suppressed lactation-delivered||classified_as
internal fixation bone (& for fracture) (procedure)||internal fixation of fracture (procedure)||classified_as
lung metastases||metastatic tumor to the lung||classified_as
leukemic cardiac infiltration||leukemic cardiac infiltration||classified_as
application site scar||application site scar||classified_as
vascular narrowing||stenosis vascular||classified_as
anti-prothrombin antibody positive||anti-prothrombin antibody positive||classified_as
fracture of the upper limb, subsequent encounter||displ transverse fx shaft of l ulna, 7thh||classified_as
neonatal bradycardia (diagnosis)||neonatal bradycardia spells||classified_as
anazoturia||anazoturia||classified_as
skin graft scar||skin graft scar||classified_as
carcinoma in situ of nasopharynx||malignant neoplasm of anterior wall of nasopharynx stage 0||classified_as
musculoskeletal procedures, nec||medical and surgical @ anatomical regions, upper extremities @ reattachment @ index finger, left @ open @ no device @ no qualifier||classified_as
cataract operation||cataract operation||classified_as
injury to blood vessels, subsequent encounter||other specified injury of other blood vessels of thorax, unspecified side, subsequent encounter||classified_as
screening; antenatal||encounter for antenatal screening for fetal growth retardation||classified_as
hyperammonaemic encephalopathy||hyperammonaemic encephalopathy||classified_as
ligation and embolization of vessels||occlusion of middle colic artery, open approach||classified_as
vertebral compression||collapse; vertebra||classified_as
klebsiella test positive||klebsiella granulomatis test positive||classified_as
ameba test||amebic serology||classified_as
haemolytic anaemia neonatal (from blood incompatibility)||blood incompatibility hemolytic anemia of newborn||classified_as
computerized transverse axial tomography normal||computer-assisted transaxial tomography normal||classified_as
aortopulmonary septal anomaly (disorder)||absence; pulmonary artery - aorta, septum||classified_as
serum transferrin saturation||iron saturation||classified_as
immunosuppressant drug level decreased||immunosuppressant drug level decreased||classified_as
feeling of body temperature change nos||temperature changed sensation||classified_as
myelosuppression||hemopoiesis suppressed||classified_as
asperg bronchopulm||aspergillus fumigatus bronchopulmonary infection||classified_as
bilateral bundle branch block (disorder)||bilat bb block nec||classified_as
introduction of catheter into vein||totally implanted venous catheterization||classified_as
sinus tachy||tachycardia sinus||classified_as
malignant tumor of nasopharynx stage i||malignant neoplasm of other specified sites of nasopharynx stage i||classified_as
alveolitis, extrinsic allergic||other allergic pneumonitis||classified_as
fracture of lower limb (except hip), subsequent encounter||nondisp transverse fx shaft of l femr, 7thk||classified_as
packing of nose (procedure)||nasal balloon placement||classified_as
skin testing||epicutaneous test||classified_as
noninfective oophoritis||inflammation of ovary||classified_as
giant hives||vascular edema||classified_as
carcinoma of esophagus (disorder)||gastrooesophageal junction cancer||classified_as
stage 0 bladder urothelial carcinoma||stage 0 transitional cell carcinoma of urinary bladder||classified_as
raoultella ornithinolytica infection||klebsiella ornithinolytica infection||classified_as
open wounds of trunk, initial encounter||laceration with foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter||classified_as
prostate and seminal vesicle procedures (excluding prostatectomy)||revision of drainage device in prostate and seminal vesicles, percutaneous endoscopic approach||classified_as
artery, vein, and great vessel procedures, nec||drainage of left brachial artery, percutaneous approach, diagnostic||classified_as
peripheral t-cell lymphoma unspecified stage iv||t-immunoblastic lymphoma (peripheral t-cell lymphoma unspecified) (kiel classification) stage iv||classified_as
laryngeal cancer recurrent||recurrent laryngeal cancer||classified_as
cystitis chemical||chemical cystitis (diagnosis)||classified_as
injection site mass||injection site redness mass||classified_as
oriental liver fluke disease||infection, clonorchis||classified_as
head discomfort||fullness head||classified_as
psychosis polyneuritica||amnestic syndromes, alcohol-induced||classified_as
stool sodium increased||stool sodium increased||classified_as
fredrickson type v lipidemia||hyperchylomicronemia late onsets||classified_as
decreased therapeutic response||subtherapeutic response||classified_as
tonsil; hypertrophy||tonsillar swelling||classified_as
retroperitoneal hematoma||hematoma; retroperitoneal||classified_as
spinal cord syndrome central||t(1)-t(6) level with central cord syndrome||classified_as
muscle, tendon, bursa, and ligament excision||medical and surgical @ bursae and ligaments @ excision @ lower extremity bursa and ligament, left @ open @ no device @ no qualifier||classified_as
disease, kahler||multiple myeloma (clinical)||classified_as
amino acid level||urine leucine present||classified_as
peripheral nerve lesion||lesion of medial popliteal nerve, nos||classified_as
cryoglobulin urine present||cryoglobulin urine present||classified_as
ligation and embolization of vessels||medical and surgical @ upper veins @ occlusion @ axillary vein, right @ percutaneous @ extraluminal device @ no qualifier||classified_as
esophagitis candida||oesophageal candida||classified_as
device extension damage||device extension damage||classified_as
osteoarthritis nos, of unspecified site||osteoarthrosis, generalized, involving hand||classified_as
glutamate dehydrogenase increased||glutamate dehydrogenase increased||classified_as
nasal disorders||nasal disorder nos||classified_as
osteophyte fracture||osteophyte fracture||classified_as
diverticular disorder of intestine (disorder)||diverticulosis of small intestine (without mention of haemorrhage)||classified_as
sympathetic nerve injury nos (disorder)||injury of sympathetic nerve (diagnosis)||classified_as
acute megakaryoblastic leukemia in remission (diagnosis)||acute megakaryoblastic leukaemia, in remission||classified_as
sycosis barbae (diagnosis)||barbers rash||classified_as
fixation of upper extremity bones||revision of external fixation device in left humeral head, external approach||classified_as
synovitis||villonodular synovitis involving upper arm||classified_as
diffuse esophageal spasm (diagnosis)||jackhammer esophagus||classified_as
throw up||nausea and vomiting symptoms||classified_as
estrogen receptor assay negative||estrogen receptor assay negative||classified_as
[x]schizoaffective disorder, unspecified||subchronic schizoaffective disorder with acute exacerbation (diagnosis)||classified_as
tendon and synovial disorders||spontaneous rupture of other tendons, right upper arm||classified_as
chest wall procedures, nec||medical and surgical @ anatomical regions, general @ excision @ chest wall @ percutaneous @ no device @ no qualifier||classified_as
chronic disease, nos||chronic disease (disorder)||classified_as
seip-bernardinelli syndrome||generalised lipodystrophy||classified_as
infantile apnoea||neonatal apnea spells||classified_as
hamartomas||other congenital hamartoses, not elsewhere classified||classified_as
other specified joint disorders, site unspecified||loose body in unspecified wrist||classified_as
fibrin breakdown products assay||degradation fibrin products||classified_as
azotaemia||hypernitraemia due to urea||classified_as
lipids abnormal (finding)||serum lipid abnormal nos||classified_as
furuncle of skin and/or subcutaneous tissue (disorder)||boil of foot nos||classified_as
porphyria non-acute||hematoporphyrinemia||classified_as
musculo-skeletal system disorders||muscle/ligament dis nec||classified_as
euphorias||hyperthymic state||classified_as
ligation and embolization of vessels||medical and surgical @ lower veins @ occlusion @ femoral vein, left @ percutaneous @ no device @ no qualifier||classified_as
injury, sequela||partial traumatic amputation of one left lesser toe, sequela||classified_as
closed reduction of bones and joints||medical and surgical @ lower bones @ reposition @ femoral shaft, left @ external @ no device @ no qualifier||classified_as
carcinoma in situ (morphologic abnormality)||carcinoma in situ of other specified site||classified_as
biliary colic symptom||gallbladder; colic||classified_as
salivary gland mass||sublingual mass (finding)||classified_as
endometrium carcinomas||endometrial ca||classified_as
pyruvate levels raised (blood)||increased blood pyruvic acid||classified_as
blood isopropanol||isopropanol test||classified_as
muscle, tendon, bursa, and ligament excision||medical and surgical @ bursae and ligaments @ destruction @ shoulder bursa and ligament, right @ open @ no device @ no qualifier||classified_as
overgrowth of filiform papillae (disorder)||hairy tongue||classified_as
wet cough||phlegm||classified_as
necrotizing vasculitis||necrotizing vasculopathy, unspecified||classified_as
free catecholamines||urine catecholamine level||classified_as
internal organ injury, initial encounter||laceration of unsp part of small intestine, init encntr||classified_as
factor viii deficiency||congenital factor viii deficiency||classified_as
eardrum hyperaemia||eardrum hyperemia||classified_as
stage i testicular mixed germ cell tumor ajcc v7||stage i testicular mixed germ cell tumor ajcc v6||classified_as
porphyria; acute intermittent||cpro deficiency||classified_as
impaired renal creatinine clearance||decreased glomerular filtration rate||classified_as
blood iron increased||increased serum iron||classified_as
epidural abscess||abscesses epidural||classified_as
upper gastrointestinal tract endoscopy normal||endoscopy upper gastrointestinal tract normal||classified_as
ventilation perfusion mismatch||intrapulmonary shunting||classified_as
prenatal growth failure||slow foetal growth and foetal malnutrition, nos||classified_as
influenza a virus test||h1n1 influenza pcr||classified_as
nasal and sinus excision||medical and surgical @ ear, nose, sinus @ extraction @ sphenoid sinus, left @ open @ no device @ no qualifier||classified_as
lentigo maligna recurrent||recurrent lentigo maligna melanoma||classified_as
hra||absent kidney||classified_as
arteriovenous graft aneurysm||arteriovenous graft aneurysm (disorder)||classified_as
intestinal metastasis||secondary malignant neoplasm of large intestine or rectum nos (disorder)||classified_as
intervertebral disc disorder||cervical disc disease spine||classified_as
musculoskeletal device procedures, nec||revision of nonaut sub in l toe phalanx, extern approach||classified_as
device computer issue||device date-time programming issue||classified_as
therapy, interleukin||interleukin-7 therapy||classified_as
peripheral arterial bypass (procedure)||medical and surgical @ lower arteries @ bypass @ femoral artery, right @ open @ autologous arterial tissue @ femoral artery, left||classified_as
percutaneous coronary interventions||release coronary artery, three arteries, percutaneous approach||classified_as
oscillopsia||movement of visual image||classified_as
stage i breast cancer ajcc v6||breast cancer stage i ajcc v6||classified_as
unspecified anemia||other anemias (disorder)||classified_as
inulin clearance normal||inulin clearance normal||classified_as
fracture of thigh||open #femur-shaft/unspecified||classified_as
hemangioendothelioma malignant||haemangiosarcoma nos||classified_as
rotator cuff syndrome||strain of infraspinatus tendon (disorder)||classified_as
combined immunity deficiency||x-linked sev comb immunodefic||classified_as
obstructed labor nos unspec.||other causes of obstructed labor, delivered, with or without mention of antepartum condition||classified_as
lymphovenous anastomosis||lymphovenous bypass||classified_as
poisoning/toxic effect/adverse effects/underdosing, sequela||underdosing of unspecified antidepressants, sequela||classified_as
aleukemic leukemia [obs]||leukemid||classified_as
phaeochromocytoma (disorder)||pheochromocytoma (diagnosis)||classified_as
ovarian germ cell polyembryoma stage iii||ovarian germ cell polyembryoma stage iii||classified_as
dermabrasion||superficial abrasion||classified_as
acid phosphatase prostatic low||acid phosphatase prostatic low||classified_as
serum color abnormal||serum colour abnormal||classified_as
operation on brain (procedure)||1-91 operative procedures on the brain||classified_as
prekallikrein increased||prekallikrein increased||classified_as
vaginal oedema||vaginal oedema||classified_as
musculoskeletal procedures, nec||repair right upper extremity, percutaneous endoscopic approach||classified_as
dislocation of joint (diagnosis)||other open anterior dislocation of hip||classified_as
jaw fractures||broken jaw||classified_as
school refusal (finding)||phobias, school||classified_as
hepatobiliary and pancreatic procedures, nec||medical and surgical @ hepatobiliary system and pancreas @ release @ cystic duct @ via natural or artificial opening endoscopic @ no device @ no qualifier||classified_as
fracture of lower limb (except hip), subsequent encounter||nondisp commnt fx shaft of l tibia, 7thr||classified_as
toxicity to various agents||antifungal antibiotic poisoning||classified_as
pancreatic pseudocyst hemorrhage||pancreatic pseudocyst hemorrhage||classified_as
fracture of rib (diagnosis)||ninth rib fracture||classified_as
nasal mucosal discoloration||nasal mucosal discoloration||classified_as
urticaria-angio-edema||urticarias, giant||classified_as
trembles||tremor, fine||classified_as
hepatitis b virus test||hepatitis b screening test||classified_as
adult t-cell lymphoma/leukemia (htlv-1-assoc), in relapse||pleomorphic medium sized and large t-cell htlv1 lymphoma (kiel classification) recurrent||classified_as
pain jaw||gnathodynia||classified_as
septal repair and other therapeutic heart procedures||dilation of l ventricle with drug-elut intra, perc approach||classified_as
av fistula maturation failure||arteriovenous fistula maturation failure||classified_as
blood follicle stimulating hormone increased||blood follicle stimulating hormone increased||classified_as
poikilocytosis (procedure)||abnormally shaped red blood cells present in blood||classified_as
not feeling great||unwell||classified_as
tumor invasion||tumor cell invasion||classified_as
sequela of injury||laceration of duodenum, sequela||classified_as
oral aphthae (disorder) [ambiguous]||aphthous stoma||classified_as
cutaneous t-cell lymphoma, recurrent||sezary's syndrome recurrent||classified_as
sudden infant death syndr.||sudden infant death; syndrome||classified_as
abdominal hernia nos gangrenous||abdominal hernia gangrenous||classified_as
other or procedures on vessels other than head and neck||resection of other thoracic vessels with replacement||classified_as
lcad - long chain acyl-coa dehydrogenase deficiency||long chain acyl-coa dehydrogenase deficiency||classified_as
joint dislocation postoperative||joint dislocation postoperative||classified_as
oesophageal prosthesis insertion||insertion of esophageal stent||classified_as
t3 reverse measurement (procedure)||t3 reverse||classified_as
aneurysm intracranial||cerebellar arterial aneurysm||classified_as
human rhinovirus test positive||human rhinovirus test positive||classified_as
control of bleeding (non-endoscopic)||medical and surgical @ anatomical regions, upper extremities @ control @ axilla, right @ open @ no device @ no qualifier||classified_as
hemoglobin e absent||hemoglobin e absent||classified_as
injury of mouth||open wound of buccal mucosa without complication||classified_as
chronic pigmented purpura||schamberg||classified_as
chromosome banding abnormal||chromosome banding abnormal||classified_as
jaundice;newborn||perinatal jaundice due to hereditary haemolytic anaemia||classified_as
male reproductive system procedures, nec||medical and surgical @ male reproductive system @ supplement @ vas deferens, bilateral @ via natural or artificial opening endoscopic @ synthetic substitute @ no qualifier||classified_as
histiocytosis x, nos||hand-schüller-christian disease (disorder)||classified_as
other and unspecified mental conditions||unspecified emotional disturbance of childhood or adolescence||classified_as
fetus affected by placental transfer of anticonvulsant (disorder)||syndrome; hydantoin, fetal||classified_as
clotting time increased||clotting time lengthened||classified_as
cervical spinal cord injury||c1-c4 level with complete lesion of spinal cord||classified_as
profundoplasty||repair of profunda femoris artery (procedure)||classified_as
tachycardia||[d]rapid heart beat||classified_as
ischemic stroke||malignant ischaemic stroke||classified_as
friction blister with infection||blister, infected of face, neck and scalp excl eye||classified_as
wnv||west nile viral infection||classified_as
cardiac and circulatory congenital anomalies||other specified congenital malformations of peripheral vascular system||classified_as
mucopolysaccharidosis (mps) iii (a, b, c, d)||syndrome, sanfilippo||classified_as
blood methaemoglobin||methaemoglobin||classified_as
larynx||carcinoma in situ of larynx nos||classified_as
ovarian germ cell embryonal carcinoma stage ii||ovarian germ cell embryonal carcinoma stage ii b||classified_as
drainage of abscess (procedure)||abdominal wall abscess drainage||classified_as
oesophageal adenocarcinoma site unspecified stage 0||oesophageal adenocarcinoma lower third in situ||classified_as
conjunctivitis (diagnosis)||conjunctivitis, unspecified||classified_as
(sexual precocity nos) or (puberty - precocious) (disorder)||premature; puberty||classified_as
transsphenoidal surgery||transsphenoidal surgery||classified_as
middle ear; inflammation||otitis media, nonsuppurative||classified_as
increased vitamin b12 (biological function) (finding)||serum b12 elevated||classified_as
alphafetoprotein amniotic fluid normal||amniotic fluid alpha-fetoprotein normal (finding)||classified_as
acute nonlymphocytic leukemia (anll)||acute myeloblastic leukemia||classified_as
penile curvature||penile buckling||classified_as
tibial fractures||fx tibia nos-open||classified_as
hematoma of kidney||kidney haematoma without rupture of capsule, with open wound into cavity||classified_as
external cause codes: natural/environment; initial encounter||other contact with nonvenomous snake, initial encounter||classified_as
personality disorder; hysterical||histrionic personality disorders||classified_as
superficial injury; contusion, subsequent encounter||insect bite (nonvenomous), right hip, subsequent encounter||classified_as
enlarged colon||megarectum||classified_as
histiocytoses, familial hemophagocytic||familial hemophagocytic lymphocytosis||classified_as
dysplasia, ectodermal||hay-wells syndrome of ectodermal dysplasia (disorder)||classified_as
follicle centre lymphoma, follicular grade i, ii, iii refractory||follicular predominantly small cleaved cell lymphoma (working formulation) refractory||classified_as
beta interferon therapy||fibroblast interferon therapy||classified_as
cushingoid||cushing-like build||classified_as
estrone increased||blood oestrone increased||classified_as
acquired hypogammaglobulinemia||hypogammaglobulinemia late onset||classified_as
tendon rupture nos (disorder)||tendon rupture||classified_as
candida tests||candida igg test||classified_as
thermometry normal||rectal thermometry normal||classified_as
follicle centre lymphoma diffuse small cell lymphoma stage iv||follicle centre lymphoma diffuse small cell lymphoma stage iv||classified_as
feeling of body temperature change||temperature changed sensation||classified_as
hyperlipoproteinemia, type iv||hypertriglyceridemia; essential||classified_as
herpes simplex reactivation||herpes simplex type i reactivation||classified_as
[x]hyperkinetic disorder, unsp||adhd, combined type (diagnosis)||classified_as
ischemias||ischemia (disorder)||classified_as
pof||poi||classified_as
central nervous system tuberculosis||tuberculosis of meninges and central nervous system (disorder)||classified_as
gastric catarrh||unspecified gastritis and gastroduodenitis||classified_as
fit; newborn||fit; newborn||classified_as
external cause codes: intent of injury, accidental/unintentional||crush betw canoe/kayk and oth wtrcrft/obj due to clsn, init||classified_as
tuberculous nephropathy||tuberculosis of kidney, confirmed by bacterial culture||classified_as
packing and dressing procedures||change bandage on left lower arm||classified_as
glaucoma syndrome||glaucoma w systemic synd||classified_as
supernumerary liver lobe||supernumerary liver lobe (disorder)||classified_as
bladder cancer recurrent||malignant neoplasm of bladder recurrent||classified_as
lung inflammation||bronchopulmonary infection||classified_as
cerebellar ischemia||cerebellar ischemia||classified_as
entropion||unspecified entropion (disorder)||classified_as
ophthalmopathy nos||section a-7 diseases of the eye||classified_as
ultrasound antenatal screening nos||ultrasound antenatal screen||classified_as
lymphatic sinus catarrh||lymphatic sinus catarrh||classified_as
angioplasty and related vessel procedures (endovascular; excluding carotid)||dilation of left subclavian artery with intraluminal device, using drug-coated balloon, percutaneous approach||classified_as
device information output issue||device image display issue||classified_as
malignant liver tumour||resectable hepatic malignant neoplasm||classified_as
toxicity to various agents||ganglion-blocking agent toxicity||classified_as
ectopic pregnancy nos||ectopic pregn||classified_as
central nervous system dermoid tumour||epidermoid neoplasm of central nervous system||classified_as
low density lipoprotein cholesterol normal||low density lipoprotein normal||classified_as
pivd - prolapsed intervertebral disc||schmorl's hernia||classified_as
instillation site haemorrhage||instillation site haemorrhage||classified_as
ostectomy, nos||excision of right ethmoid bone, open approach||classified_as
gastric hypertonia||gastric hypertonia||classified_as
tri-iodothyronine||assay of triiodothyronine t3 total tt3||classified_as
spontaneous abortion and complications of spontaneous abortion||sepsis following complete or unsp spontaneous abortion||classified_as
tendon inflamed||achilles tendonitis||classified_as
malignant neoplasm of pineal parenchyma||malignant pineal region tumor||classified_as
urinary system procedures, nec||medical and surgical @ urinary system @ removal @ urethra @ via natural or artificial opening @ extraluminal device @ no qualifier||classified_as
macular disorder||macular degeneration, due to cyst, hole, or pseudohole||classified_as
swelling of lymph nodes||[d]lymph node enlargement||classified_as
cardiovascular strokes||age indeterminate lateral myocardial infarction||classified_as
chronic unspecified sinusitis||other chronic sinusitis nos||classified_as
product dose omission in error||product dose omission in error||classified_as
heart sounds, abnormal [d] (finding)||midsystolic click||classified_as
angiogenesis biomarker||angiogenesis biomarker||classified_as
carrier of viral hepatitis||hepatitis b surface antigen (hbsag) carrier||classified_as
thermal burn (morphologic abnormality)||burn nos chin||classified_as
ent repair||replacement of nasal turbinate with nonautologous tissue substitute, open approach||classified_as
perfusion brain scan abnormal||perfusion brain scan abnormal||classified_as
calcification of tricuspid valve||tricuspid valve calcification||classified_as
thrombosis of retinal vein||thrombosis retinal vein||classified_as
postprocedural or postoperative eye complication||postproc hematoma of unsp and adnexa fol an opth procedure||classified_as
ache in joint||diffuse arthralgia||classified_as
bile duct stones||gall stones, common bile duct||classified_as
chest discomfort (finding)||chest wall discomfort||classified_as
autoimmune dermatitis||autoimmune dermatitis||classified_as
other therapeutic endocrine procedures||part adrenalectomy nec||classified_as
external cause codes: fire/burn; initial encounter||exposure to flames in uncontrolled fire in building or structure, initial encounter||classified_as
lip and/or oral cavity cancer nos||malignant neoplasm of other and unspecified parts of mouth (disorder)||classified_as
musculoskeletal procedures, nec||release right radius, open approach||classified_as
external cause codes: subsequent encounter||bus occupant (driver) (passenger) injured in other specified transport accidents, subsequent encounter||classified_as
itching of skin||pruritis (excluding d05 x16)||classified_as
le cells absent||le cells absent||classified_as
device information output issue||device test results high||classified_as
virus; bronchitis||acute viral bronchitis||classified_as
chlamydial infection (diagnosis)||infection, chlamydia pneumoniae||classified_as
cervicitis/other cervical disease||abn cervix nec-antepart||classified_as
non-pressure ulcer of skin||chronic cutaneous ulcer non-pressure buttock with fat layer exposed||classified_as
paresis anal sphincter||paresis anal sphincter||classified_as
bartonella test positive||bartonella quintana test positive||classified_as
stomach cancer stage i||malignant neoplasm of cardia stage i||classified_as
lower gi therapeutic procedures, nec (excluding open and laparoscopic)||bypass large intestine to large intestine with autologous tissue substitute, via natural or artificial opening endoscopic||classified_as
arteriosclerosis of renal artery||arteriosclerosis of renal artery (disorder)||classified_as
rubella antibodies positive||rubella antibody positive||classified_as
product label issue||product leaflet text wrong||classified_as
red blood cell rouleaux formation present||red blood cell rouleaux formation present||classified_as
esophageal adenocarcinoma stage 0||adenocarcinoma in situ of esophagus||classified_as
cerebrospinal fluid measles antibody positive||csf measles nos antibody positive||classified_as
vascular wall hypertrophy||intimal proliferation||classified_as
blood glucose elevated||increased blood glucose||classified_as
biliary ischemia||biliary ischemia||classified_as
haemorrhoid (disorder)||internal hemorrhoids reduce spontaneously (grade ii)||classified_as
acroosteolyses, neurogenic||sensory neuropathy, congenital||classified_as
abdominal wall anomaly nos (disorder)||congenital anomaly of abdominal wall, nos||classified_as
large bowel anastomosis||refashioning of anastomosis||classified_as
emphysematous cystitis (disorder)||emphysematous cystitis (diagnosis)||classified_as
biopsy cartilage normal||nasal septal biopsy normal||classified_as
pathological fracture, subsequent encounter||path fracture in oth disease, l foot, subs for fx w malunion||classified_as
penetrating aortic ulcer||penetrating abdominal aortic ulcer||classified_as
type iv lipidaemia||familial chylomicronemia syndrome||classified_as
infections, plasmodium||malaria-postpartum||classified_as
stage i transitional cell carcinoma of urinary bladder||stage i transitional cell carcinoma of the bladder||classified_as
abnormal visual field test||visual field perimetric tests abnormal||classified_as
renal concentrating power decreased||renal concentrating power decreased||classified_as
pneumonia; chlamydial||chlamydia trachomatis pneumonia||classified_as
ast elevated||sgot, elevated||classified_as
physical, occupational, and respiratory therapy treatment||range of motion and joint mobility treatment of neurological system - head and neck using prosthesis||classified_as
fascitides, necrotizing||fascitis necrotizing||classified_as
ru - rodent ulcer||sclerosing basal cell carcinoma||classified_as
instillation site burn||instillation site burn||classified_as
inflammatory bowel disease ulcerative colitis||proctocolitis, idiopathic||classified_as
delivery delayed||artific rupt membr-unsp||classified_as
gaisbock's syndrome||polycythemia stress||classified_as
pericarditis meningococcal||meningococc pericarditis||classified_as
brachytherapy to ear, nose, or throat||interstitial ear, nose, or throat brachytherapy||classified_as
gonococcal joint infection||gonococcal synovitis||classified_as
body discomfort||baresthesia (function)||classified_as
illusions||disturbance of perception (function)||classified_as
anorectal disorder||anus abnormal||classified_as
delayed sexual development||delayed; puberty||classified_as
myocardial infarction (acute) nos||myocardial infarction scai definition||classified_as
retina exudates||retinal exudates (disorder)||classified_as
pain chest||[d]retrosternal chest pain (situation)||classified_as
transitional cell cancer of the renal pelvis and ureter recurrent||relapsed transitional cell cancer of the renal pelvis and ureter||classified_as
peripheral t-cell lymphoma unspecified stage iv||t-immunoblastic lymphoma (peripheral t-cell lymphoma unspecified) (kiel classification) stage iv||classified_as
anti-insulin receptor antibody positive||anti-insulin receptor antibody positive||classified_as
reflux gastritis||gastritis, biliary||classified_as
pharyngitis, mycoplasmal||mycoplasma pneumoniae pharyngitis||classified_as
rickettsial diseases||[x]other specified rickettsioses||classified_as
administration site thrombosis||administration site thrombosis||classified_as
disease of teeth (disorder)||dental disease||classified_as
hip arthroplasty nos||removal of synthetic substitute from left hip joint, acetabular surface, open approach||classified_as
granulomatous lesion||granulomatous lesion (morphologic abnormality)||classified_as
aml - acute myeloblastic leukemia||aml (acute myelogenous leukemia)||classified_as
diabetes with renal manifestations (diagnosis)||diabetic nephropathy||classified_as
contracture of joint nos (disorder)||joint contracture of the lower leg||classified_as
pingueculum||pinguecula (disorder)||classified_as
family death||fh: father dead||classified_as
colostomy procedure||(loop colostomy) or (operation)||classified_as
mean cell hemoglobin decreased||mean cell haemoglobin low||classified_as
bone tuberculosis||tuberculosis of other specified bone, confirmed histologically||classified_as
complication, sequela||mech compl of internal fixation device of vertebrae, sequela||classified_as
carotid artery dissection (disorder)||dissecting carotid artery aneurysm||classified_as
malignant neoplasm of brain, nos||brain neopl malignant||classified_as
retained fetal membrane||placenta, retained||classified_as
fetal disorder, nos||other specified fetal and placental problems, affecting management of mother, antepartum||classified_as
pruritic rash, nos||pruritus - itch - nos||classified_as
jaw disorder nos||other specified anomalies of jaw size||classified_as
metastatic stomach cancer||gastric cancer, metastatic||classified_as
portal and other venous bypass procedures||bypass left common iliac vein to lower vein with autologous tissue substitute, open approach||classified_as
alpha-1 anti-trypsin increased||alpha-1 anti-trypsin increased||classified_as
victim of burglary (finding)||victim of burglary (finding)||classified_as
familial hyperprebetalipoproteinemia||hyperlipoproteinemia type iv||classified_as
disease scleroderma||scleroderma nos||classified_as
git congenital anomalies nos||gastrointestinal tract congenital anomaly (disorder)||classified_as
repair of ovary (procedure)||oophoroplasty||classified_as
heart and great vessel bypass procedures||medical and surgical @ heart and great vessels @ bypass @ ventricle, left @ percutaneous endoscopic @ autologous venous tissue @ pulmonary artery, right||classified_as
burns and corrosion, subsequent encounter||burn of second degree of right shoulder, subs encntr||classified_as
esophageal anastomosis procedure||oesophageal anastomosis||classified_as
scan nos myocardial perfusion abnormal||scan nos myocardial perfusion abnormal||classified_as
diaphragmatic pacemaker insertion||diaphragmatic pacemaker insertion||classified_as
hysterical psychosis||excitative type psychosis (diagnosis)||classified_as
iris cyst (finding)||idiopathic cysts||classified_as
transplant abscess||renal transplant abscess||classified_as
unspecified anomaly of cartilage (disorder)||achondroplasia||classified_as
lip exfoliation||lips peeling||classified_as
osmolar gap abnormal||osmolar gap abnormal||classified_as
repair of pericardium (procedure)||pericardioplasty||classified_as
iga - linear immunoglobulin a bullous dermatosis||lad - linear iga disease||classified_as
benign bone tumor||benign bone tumors||classified_as
light chain analysis increased||kappa light chain analysis increased||classified_as
d>1< trisomy syndrome||trisomy; syndrome, 13||classified_as
herpes zoster meningomyelitis||herpes zoster meningomyelitis||classified_as
fracture of the upper limb, subsequent encounter||disp fx of base of metacarpal bone, subs for fx w routn heal||classified_as
enthesopathy||other peripheral enthesopathies (disorder)||classified_as
borrelia test||borrelia test||classified_as
catheterisation arterial nos normal||catheterisation arterial nos normal||classified_as
pemphigus nos||pemphigus vulgaris||classified_as
spinal cord biopsy abnormal||biopsy spinal cord abnormal||classified_as
syndrome corticosteroid withdrawal||syndrome corticosteroid withdrawal||classified_as
ventricular fibrillations||ventricular fibrillation||classified_as
acquired deformities (excluding foot)||mallet finger of left finger(s)||classified_as
energy loss||depressive weariness||classified_as
respiratory syncytial virus test negative||rsv serology negative||classified_as
disorders testicles||disorders testes||classified_as
ns - nephrotic syndrome||nephrotic syndrome with lesion of membranous glomerulonephritis||classified_as
dislocation (morphologic abnormality)||recurrent dislocation of elbow (disorder)||classified_as
radiation alveolitis||radiation alveolitis||classified_as
endometriosis ablation||endometriosis ablation||classified_as
biliary duct obstruction||bile duct obstruction due to calculus||classified_as
necrotising fasciitis (disorder)||melenay's syndrome||classified_as
invasive ductal carcinoma of the breast||infiltrating; ductal carcinoma, unspecified site||classified_as
cosmetic procedure||medical and surgical @ subcutaneous tissue and fascia @ alteration @ subcutaneous tissue and fascia, buttock @ percutaneous @ no device @ no qualifier||classified_as
contact radiation therapy procedure, nos||insertion of radioactive element into bilateral breast, percutaneous approach||classified_as
disorder of vertebral column (disorder)||spinal disease||classified_as
external cause codes: intent of injury, legal intervention/war||milt op w dest arcrft d/t acc deton onbrd munit, civ, init||classified_as
thyroid atrophy (disorder)||atrophy thyroid||classified_as
radiosurgery, stereotactic||stereotactic particulate radiosurgery of cervix||classified_as
nocardia test positive||nocardia brasiliensis test positive||classified_as
traum subcutan emphysema||traumatic subcutaneous emphysema (disorder)||classified_as
major depressive illness||psychosis; depressive||classified_as
follicle center lymphoma, follicular grade i, ii, iii stage iii||follicular predominantly large cell lymphoma (working formulation) stage iii||classified_as
saphenous vein harvest and other therapeutic vessel removal||excision of right axillary vein, percutaneous endoscopic approach||classified_as
gastrointestinal sounds abnormal||bowel sounds increased||classified_as
male reproductive tract disorder||diseases of the male genital organs||classified_as
fungal lower respiratory tract infections||lower respiratory tract infection fungal||classified_as
hip arthroplasty nos (procedure)||medical and surgical @ lower joints @ replacement @ hip joint, right @ open @ synthetic substitute, ceramic @ cemented||classified_as
pollution nos||a30 pollution, nos||classified_as
labyrinthine vertigo||labyrinthine vertigo||classified_as
blood catecholamines increased||plasma catecholamines increased||classified_as
disorder;back||back disorders nos||classified_as
dysmenorrhea (finding) [ambiguous]||dysmenorrhea, primary||classified_as
aspartate aminotransferase||plasma glutamic-oxaloacetic transferase||classified_as
delusional perception (finding)||delusional perception||classified_as
chilaiditi's syndrome||chilaiditi's syndrome||classified_as
bronchitis bacterial||acute bacterial exacerbation of chronic bronchitis||classified_as
fracture of the upper limb, subsequent encounter||displaced fracture of lateral condyle of left humerus, subsequent encounter for fracture with routine healing||classified_as
precipitate labor unspecified (disorder)||rapid progress of labor||classified_as
endoscopic retrograde cannulation of pancreas (ercp)||end retrograde cholangiography||classified_as
rcud||ra - refractory anaemia||classified_as
herpes zoster with ophthalmic complication||ophthalmic herpes zoster infection||classified_as
abnormal cord insertion||abnormal cord insertion||classified_as
agranulocytosis nos||schultz||classified_as
cervix ca in situ||stage 0 cervix cancer||classified_as
histoplasmosis, unspecified, pericarditis||histoplasma duboisii with pericarditis (disorder)||classified_as
anti-vgkc antibody positive||anti-voltage-gated potassium channel antibody positive||classified_as
tri-iodothyronine abnormal nos||serum t3 level abnormal||classified_as
seminal vesiculitis gonococcal||chronic gonococcal seminal vesiculitis (disorder)||classified_as
stoma site discharge||stoma site discharge||classified_as
stage i angiocentric lymphoma||angiocentric immunoproliferative lesion grade 2 stage i||classified_as
dissem histoplasmosis capsulat||disseminated histoplasma capsulatum infection||classified_as
blood zinc decreased||zn++ low||classified_as
decreased circulating ige||decreased ige||classified_as
wound (morphologic abnormality)||multiple open wounds with complication, of unspecified site (disorder)||classified_as
blood testosterone increased||serum testosterone increased||classified_as
wagenmann-froboese syndrome||mea iib||classified_as
other or procedures on vessels other than head and neck||other revision of vascular procedure||classified_as
lymph node ulcer||lymph node ulcer||classified_as
drug induced or toxic related condition||osteonecrosis due to drugs, unspecified fibula||classified_as
craniolacunia||lacunar skull||classified_as
beta 2 microglobulin increased||serum beta 2 microglobulin increased||classified_as
skatoma||stercoroma||classified_as
oesophageal diverticulum (disorder)||oesophagocele||classified_as
bacillus test positive||bacillus cereus test positive||classified_as
compl diabetes mellitus||type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral||classified_as
urinary system procedures, nec||release right kidney pelvis, via opening||classified_as
cardiac failure (nos)||heart failure (nos)||classified_as
optic nerve infarction (disorder)||optic disc infarction||classified_as
cystic angiomatosis||cystic angiomatosis||classified_as
ocular stem cell transplant||conjunctival limbal autograft||classified_as
abnormality of body mass index||body mass index abnormal||classified_as
internal organ injury, subsequent encounter||laceration of lung, bilateral, subsequent encounter||classified_as
radiotherapy to mediastinum||radiotherapy to mediastinum||classified_as
gastric biopsy abnormal||biopsy gastric abnormal||classified_as
fixation of upper extremity bones||reposition left humeral shaft, percutaneous approach||classified_as
poisoning/toxic effect/adverse effects/underdosing, sequela||toxic effect of tetrachloroethylene, self-harm, sequela||classified_as
tumor, burkitt||burkitt's lymphoma (disorder)||classified_as
ann arbor stage i b lymphoblastic lymphoma||lymphoblastic lymphoma (precursor b-lymphoblastic lymphoma/leukemia) stage i||classified_as
muscle; atrophy, duchenne-aran||pure progressive muscular atrophy||classified_as
users, drug||intravenous drug abuser||classified_as
neonatal deaths||late neonatal death (event)||classified_as
third degree burns||burn involving 40-49 percent of body surface with third degree burn of 20-29%||classified_as
carcinoma of anus||malignant tumor of anal canal||classified_as
hiatal hernia (diagnosis)||sliding hiatal hernias||classified_as
total systemic resistance within normal range||vascular resistance nos normal||classified_as
amoebiasis, intestinal||amebiasis||classified_as
fracture of the spine and back, subsequent encounter||other traumatic nondisplaced spondylolisthesis of fifth cervical vertebra, subsequent encounter for fracture with delayed healing||classified_as
application site hypersensitivity||application site allergy||classified_as
skin vasculitis||leucocytoclastic vasculitis (finding)||classified_as
adult t-cell leukemia/lymphoma, stage ii||diffuse small cleaved cell lymphoma (adult t-cell lymphoma/leukemia) (working formulation) stage ii||classified_as
colon cancer stage ii||scirrhous carcinoma of the colon stage ii||classified_as
palatal biopsy normal||biopsy palate normal||classified_as
congenital narrowed pulmonary artery||a.pulmonalis; stricture, congenital||classified_as
visual impairment (diagnosis)||can't see properly||classified_as
poisoning by drugs, subsequent encounter||poisoning by smallpox vaccines, assault, subsequent encounter||classified_as
asthma disorders||airway hyperreactivity||classified_as
angiotensin ii abnormal||angiotensin ii abnormal||classified_as
disorder of tongue (disorder)||disorders tongue||classified_as
hemorrhages, subarachnoid||op subarach hem-prol com||classified_as
other specified bone disease and musculoskeletal deformities||oth disord of continuity of bone, left pelv region and thigh||classified_as
general physical condition abnormal||general body appearance abnormal||classified_as
fracture of lower limb (except hip), subsequent encounter||nondisp longitud fx r patella, subs for clos fx w delay heal||classified_as
kidney transplant rupture||kidney transplant rupture||classified_as
abscess subcutaneous||pubic abscess||classified_as
behavior-related disorder||behavior disorder||classified_as
artery, vein, and great vessel procedures, nec||drainage of right brachial vein, perc endo approach||classified_as
malignant tumour head and neck||lateral floor of mouth||classified_as
urine ketone body absent||urine ketone body absent||classified_as
tuberculosis, urogenital||tuberculosis of other urinary organs, tubercle bacilli found in sputum by microscopy||classified_as
suture insertion||secondary suture of wound||classified_as
operation on intervertebral disc nos (procedure)||reconstruction of intervertebral disc||classified_as
alphavirus test||ross river virus serology test||classified_as
bnp decreased||brain natriuretic peptide decreased||classified_as
hepatic comas||comas, hepatic||classified_as
amniotic membrane rupture test||pooling test||classified_as
infusion site calcification||infusion site calcification||classified_as
abdominal; pain||duodenal ulcer-type symptoms||classified_as
syndromes, neurotoxicity||syndrome, neurotoxicity||classified_as
cap contraception||cervical cap||classified_as
thyroid function tests normal||thyroid function tests nos normal||classified_as
cranial nerve injury nos||injury to other cranial nerves (disorder)||classified_as
open wounds to limbs, subsequent encounter||laceration with foreign body of right little finger with damage to nail, subsequent encounter||classified_as
orthopedic examination abnormal||orthopedic examination abnormal||classified_as
hepatic neoplasms||hepatic neoplasm||classified_as
carbohydrate deficient transferrin increased||carbohydrate deficient transferrin increased||classified_as
vascular disorder prophylaxis||vascular disorder prophylaxis||classified_as
diverticulum intestinal hemorrhagic||diverticulum intestinal haemorrhagic||classified_as
genital hemorrhage||genital bleeding||classified_as
abnormal hair texture||dull hair||classified_as
recurrent esophageal adenocarcinoma||oesophageal adenocarcinoma cervical recurrent||classified_as
dysphemia||stammering (finding)||classified_as
post-partum stress disorder||post-partum stress disorder||classified_as
iridocyclitis||unspecified chronic iridocyclitis (disorder)||classified_as
implant subsidence||implant subsidence||classified_as
rickets; renal||rickets, renal||classified_as
pituitary gonadotropin hyperfunction||pituitary gonadotropin hyperfunction||classified_as
homosexual behaviour||men who have sex with men||classified_as
magnetic resonance imaging [mri]||magnetic resonance imaging (mri) of multiple coronary arteries using other contrast, unenhanced and enhanced||classified_as
bipolar i disorder (diagnosis)||manic-depressive psychosis, circular type but currently manic||classified_as
providing one or more vitamins based on suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. (source: idnt reference manual, edition 4; isbn #978-0-88091-467-3).||vitamin therapy||classified_as
skin ulcers||sore(s);skin||classified_as
oxalosis (disorder)||oxalosis (disorder)||classified_as
genitourinary tract gonococcal infection nos||chronic gonococcal infections of upper genitourinary tract||classified_as
sputum discoloured||phlegm discolored||classified_as
metabolic acidosis||acidosis metabolic||classified_as
bacterial test positive||bacteria ascites identified||classified_as
hepatic cyst ruptured||hepatic cyst ruptured||classified_as
haemodilution||hemodilution||classified_as
anti-muscle specific kinase antibody positive||anti-muscle specific kinase antibody positive||classified_as
haemorrhage;subarachnoid||subarach hem-concussion||classified_as
other acquired deformity||acquired deformity of neck (diagnosis)||classified_as
anesthetic complication cardiac nos||anaesthetic complication cardiac in labour or delivery||classified_as
cardiac iron overload||cardiac iron overload||classified_as
ligation and embolization of vessels||occlusion of abdominal aorta, percutaneous approach||classified_as
unspecified mood affective disorder||recur depr psych-severe||classified_as
drug metabolite level high||drug metabolite level high||classified_as
drug detoxification therapy procedures||drug detoxification (regime/therapy)||classified_as
dilation of vagina procedure||dilation of vagina (procedure) [ambiguous]||classified_as
pathological fracture due to osteoporosis (disorder)||fractures osteoporosis||classified_as
[x]injury of other pelvic organs||injury of unspecified pelvic organ||classified_as
sequelae of; injury||other tear of lateral meniscus, current injury, left knee, sequela||classified_as
haemostasis||haemostasis - action||classified_as
dehydroepiandrosterone test||blood dehydroepiandrosterone sulfate||classified_as
gi system repair (excluding anorectal)||supplement anus with nonautologous tissue substitute, via natural or artificial opening||classified_as
cns stimulation nos||excitation cerebral||classified_as
febrile convulsions nos||atypical febrile seizure||classified_as
vascular graft complication||arteriovenous graft site inflammation||classified_as
removal of inert matter from skin or subcutaneous tissue||removal of metal from skin (procedure)||classified_as
abscess of vulva [ambiguous]||genital labial abscess||classified_as
fractures multiple||open fos or face with oth bones, with oth and unspec intcran hem, with brief loc||classified_as
procedure on eyelid (procedure)||excision of right lacrimal duct, via natural or artificial opening endoscopic, diagnostic||classified_as
cortisol free urine low||cortisol free urine decreased||classified_as
bartholin's gland duct cyst||bartholin; cyst||classified_as
infrapatellar fat pad inflammation||hoffa's disease or liposynovitis prepatellaris||classified_as
disabilities||disability (finding)||classified_as
other obstetric trauma unspec.||invers uterus-del w p/p||classified_as
adrenal diseases gland||disorder of adrenal gland||classified_as
x-ray dental abnormal||opt abnormal||classified_as
"change of life"||pre-menopause||classified_as
cerebral; inflammation||other mosquito-borne viral encephalitis||classified_as
embolectomy, endarterectomy, and related vessel procedures (non-endovascular; excluding carotid)||dilation of right basilic vein, perc endo approach||classified_as
biopsy liver abnormal||kuppfer cell decrease||classified_as
other specified eye disorders||pupillary abnormality, right eye||classified_as
proconvertin; deficiency||stable factor; deficiency||classified_as
fracture of the neck of the femur (hip), subsequent encounter||nondisplaced subtrochanteric fracture of right femur, subsequent encounter for open fracture type iiia, iiib, or iiic with routine healing||classified_as
circumcisions, male||postectomy||classified_as
liver tenderness of||hepatomegaly tender||classified_as
mitral valve sclerosis||mitral valve sclerosis||classified_as
atypical fracture, subsequent encounter||complete oblique atypical femoral fracture, unsp leg, 7thd||classified_as
external cause codes: poisoning by non-drug||toxic effect of nitroglycerin and other nitric acids and esters, undetermined, initial encounter||classified_as
[d]failure of peripheral circulation (context-dependent category)||fainting (syncope)||classified_as
blood zinc abnormal||blood zinc abnormal||classified_as
chronic obstructive pulmonary disease and bronchiectasis||chronic bronchitis (disorder)||classified_as
desire for fluids||effects of thirst nos (disorder)||classified_as
punctate basophilia||rbc morphology - basophilic stippling (lab test)||classified_as
premature beats nos||bigeminies ventricular||classified_as
excessive tears||dacryorrhoea||classified_as
arthritis (finding)||arthritis nos aggravated||classified_as
testicular mixed germ cell neoplasm||mixed germ cell tumor of the testis||classified_as
sulphemoglobin normal||sulphemoglobin normal||classified_as
neoplasms, urogenital||urogenital neoplasms||classified_as
vascular wall hypertrophy||intimal thickening||classified_as
fractures, skull||op skl vlt fx-concus nos||classified_as
external cause codes: other specified, classifiable and nec; initial encounter||legal intervention involving injury by dynamite, unspecified person injured, initial encounter||classified_as
unspecified filariasis||loiasis (diagnosis)||classified_as
anemia hemolytic (nos)||primaquine sensitivity anaemia||classified_as
tuberculosis of genitourinary system (disorder)||tuberculosis of other urinary organs, confirmed by animal inoculation||classified_as
infection surgical wound||post procedural site wound infection||classified_as
refusal to speak (symptom)||elective mutism specific to childhood and adolescence||classified_as
infiltration anaesthesia||infiltration anaesthesia||classified_as
scan myocardial perfusion normal||scan nos myocardial perfusion normal||classified_as
vertebra osteophyte||lumbar spine osteophyte||classified_as
other specified connective tissue disease||lateral epicondylitis, unspecified elbow||classified_as
hypersensitivities, delayed||type iv reaction||classified_as
maceration was seen||maceration was seen||classified_as
mood altered||bad mood||classified_as
brainstem auditory evoked potential (baep)||auditory evoked potential, function||classified_as
sequelae of; injury||partial traumatic amputation of scrotum and testis, sequela||classified_as
craniotomy nos||incision of bone of skull||classified_as
hypocitraturia (lab test)||decreased urine citrate concentration||classified_as
osteomyelitis nos||osteomyelitis hip||classified_as
blisters with epidermal loss due to second degree burn, unspecified site||blisters with epidermal loss due to burn (second degree) of upper limb, except wrist and hand||classified_as
trembles (physical finding)||essential and other specified forms of tremor (finding)||classified_as
autoimmune haemolytic anaemia (disorder)||haemolytic anaemia due to antibody, nos||classified_as
genito-pelvic pain penetration disorder||vaginal spasm||classified_as
gynecol neopl||female genital neoplasms||classified_as
neuropsychiatric symptoms||behavioral and psychological symptoms of dementia||classified_as
infrapatellar fat pad inflammation||infrapatellar fat pad inflammation||classified_as
cutaneous melanoma||malignant melanoma of skin of other and unspecified parts of face||classified_as
attack - heart||age indeterminate anterior myocardial infarction||classified_as
haemorrhagic cerebrum||late effects of intracerebral hemorrhage||classified_as
stereotactic electroencephalography||stereotactic electroencephalography||classified_as
pharynx dry||pharynx dry||classified_as
artery, vein, and great vessel procedures, nec||drainage of left subclavian artery, open approach, diagnostic||classified_as
loop electrosurgical excision procedure (procedure)||loop electrosurgical excision||classified_as
proteus infection (disorder)||proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site||classified_as
anosmia, isolated congenital||congenital anosmia (disorder)||classified_as
carpectomy||proximal row carpectomy||classified_as
hiving||weals||classified_as
dreams abnormal||lucid dreaming||classified_as
blood caffeine increased||caffeine increased||classified_as
complications labor||unspecified indication for care or intervention related to labor and delivery||classified_as
attention disturbances||disturbed mental concentration||classified_as
[d]convulsion nos||seizure cerebral||classified_as
abnormal constituents urine||abn urine findings nec||classified_as
nasopharynx cancer, stage 0||carcinoma in situ of epipharynx||classified_as
prolapse of urinary bladder||bladder prolapse aggravated||classified_as
fixation of upper extremity bones||removal of internal fixation device from left humeral shaft, external approach||classified_as
relapsed cancer of small intestine||malignant neoplasm of small intestine, incl duodenum recurrent||classified_as
blindness and vision defects||sector and/or arcuate visual field defect||classified_as
alpha tumour necrosis factor increased||alpha tnf increased||classified_as
body fluid analysis (procedure)||body fluid analysis||classified_as
infection, shigella||shigella sonnei gastroenteritis||classified_as
disturbance; vision||before eyes spots||classified_as
subcutaneous tissue and fascia procedures, nec||supplement of left neck subcutaneous tissue and fascia with synthetic substitute, percutaneous approach||classified_as
hypercreatininemia||hypercreatininaemia||classified_as
sepsis (disorder)||septic; intoxication, general||classified_as
prolonged labour, unspecified||prolonged first stage of labor, delivered||classified_as
gastrointestinal melanoma||digestive system melanoma||classified_as
thymoma||epithelial malignant thymoma noninvasive||classified_as
dysfunction;sexual||decreased genital sensation||classified_as
immunizations and screening for infectious disease||sleeping sickness screening||classified_as
bleeding in mouth||bleeding of mouth||classified_as
laryngitis (diagnosis)||laryngitis; chronic||classified_as
cardiovascular evaluation||cardiovascular evaluations||classified_as
bite (morphologic abnormality)||biting||classified_as
multiple agent systemic chemotherapy||multiple agent systemic chemotherapy||classified_as
chiropractice||chiropractice||classified_as
erotophonophilia||erotophonophilia||classified_as
nerve stimulation tests nos normal||sensory nerve stimulation tests normal||classified_as
biliary anastomosis complication||biliary anastomotic stenosis||classified_as
ddd||galli-galli disease||classified_as
erythematous disorder (disorder)||redness facial||classified_as
external cause codes: intent of injury, assault||toxic effect of unspecified gases, fumes and vapors, assault, initial encounter||classified_as
stage iii b-lymphoblastic lymphoma||precursor b-lymphoblastic lymphoma/leukemia stage iii||classified_as
degenerative diseases, neurologic||other cerebral degenerations||classified_as
other lower respiratory disease||chest pain on breathing (finding)||classified_as
acute polio||acute poliomyelitis, unspecified, poliovirus type iii||classified_as
blood glucose normal (finding)||normal glucose||classified_as
total lung capacity increased||total lung capacity increased||classified_as
traumatic arthrosis||traumatic arthrosis||classified_as
anomalous pulmonary venous connection||papvd - part anom pul vn drain||classified_as
vibrio test positive||vibrio parahaemolyticus test positive||classified_as
vascular-biliary fistula (disorder)||biliary-vascular fistula||classified_as
infection in an immunocompromized host||infection in an immunocompromized host||classified_as
pseudomembranous colitis||clostridium difficile colitis (diagnosis)||classified_as
abdominal wall edema (disorder)||abdominal wall edema||classified_as
implant site dermatitis||implant site dermatitis||classified_as
thyroid hemorrhage||struma nodosa haemorrhage||classified_as
spinal cord traumas||multiple sites of spinal cord lesion without spinal bone injury||classified_as
external cause codes: other specified, classifiable and nec; initial encounter||exposure to other electric current, initial encounter||classified_as
digestive disease||upper gastrointestinal disorder||classified_as
artery; injury||injury of anterior tibial artery||classified_as
thyroid enlargement||heterogenous nodular goitre||classified_as
malignant tumor of stomach (disorder)||malignant tumor of pyloric antrum of stomach||classified_as
anemia; hemorrhagic||ac posthemorrhag anemia||classified_as
repair of rotator cuff||repair rotator cuff shoulder||classified_as
neurodermatitis atopic||atopic dermatitis flare||classified_as
basophil count abnormal nos||plasma basophils abnormal||classified_as
nikolsky sign (finding)||nikolsky sign||classified_as
injury to blood vessels, subsequent encounter||laceration of other specified blood vessels at shoulder and upper arm level, left arm, subsequent encounter||classified_as
promotion of wound healing (physical finding)||promotion of wound healing (physical finding)||classified_as
schizoaffective; disorder, bipolar type||schizoaffective disorder bipolar type||classified_as
device environmental compatibility issue||device environmental compatibility issue||classified_as
arthroplasty of other joint (excluding knee and hip)||revision of synthetic substitute in thoracolumbar vertebral disc, open approach||classified_as
central cord injury syndrome||c5-c7 level with central cord syndrome||classified_as
vessel repair and replacement||supplement r peroneal art with synth sub, open approach||classified_as
trembling||tremor, muscle||classified_as
musculoskeletal device procedures, nec||revision of synthetic substitute in right toe phalanx, percutaneous endoscopic approach||classified_as
strep toxic shock syndrome||streptococcal toxic shock syndrome||classified_as
acute myeloblastic leukemias||[m]acute myeloid leukemia||classified_as
ann arbor stage iii nasal type nk/t-cell lymphoma||angiocentric lymphoma stage iii||classified_as
scrotal dermatitis||scrotal dermatitis||classified_as
removal of foreign body from respiratory tract||removal of foreign body from respiratory tract||classified_as
other operation on fallopian tube nos||partial bilateral salpingectomy (treatment)||classified_as
maternal condition affecting foetus||fetus or newborn affected by maternal condition, nos||classified_as
fracture of the upper limb, subsequent encounter||unspecified fracture of shaft of right ulna, subsequent encounter for open fracture type iiia, iiib, or iiic with delayed healing||classified_as
abdominal scan nos normal||scan nos abdomen normal||classified_as
radiation therapy radioactive source (treatment)||low dose rate (ldr) brachytherapy of eye using palladium 103 (pd-103), unidirectional source||classified_as
hip arthroplasty nos||supplement left hip joint with nonautologous tissue substitute, percutaneous endoscopic approach||classified_as
c-telopeptide assay||c-telopeptide serum||classified_as
fracture of rib||rib fractures||classified_as
burns full thickness||deep necrosis of underlying tissues due to deep third degree burn of lower leg, without mention of loss of lower leg||classified_as
amyloid polyneuropathies, familial||hereditary neuropathic amyloidosis, indiana type||classified_as
artery, vein, and great vessel procedures, nec||medical and surgical @ upper veins @ drainage @ vertebral vein, right @ percutaneous @ drainage device @ no qualifier||classified_as
amygdalotomy (procedure)||incision of brain amygdalotomy||classified_as
genital tract inflammation||unspecified inflammatory disease of cervix, vagina and vulva||classified_as
raoultella test positive||raoultella test positive||classified_as
external cause codes: intent of injury, accidental/unintentional||other exposure to forces of nature, initial encounter||classified_as
fracture;face bone(s)||orbital floor (blow-out) closed fracture||classified_as
[x]inj bl vess unsp body reg||iliac blood vessel injury||classified_as
swelling mouth||swelling & soreness of mouth||classified_as
extrapyramidal disorder||unspecified extrapyramidal disease||classified_as
cephalalgias||hemicephalalgia||classified_as
femoral vein perforation||femoral vein perforation||classified_as
streptococcal cellulitis||cellulitis streptococcal||classified_as
sclerosing mediastinitis||fibrous mediastinitis [ambiguous]||classified_as
pancreatic ductal adenocarcinoma||malignant neoplasm of pancreatic duct non-resectable||classified_as
atrophy of kidney (disorder)||kidney atrophy||classified_as
external cause codes: sequela||driver of three-wheeled motor vehicle injured in collision with pedestrian or animal in traffic accident, sequela||classified_as
cognitive deficit||cognition disorder||classified_as
liver ablation||liver ablation||classified_as
htlv-associated leukemia-lymphoma||pleomorphic small t-cell htlv1 lymphoma (kiel classification)||classified_as
peripheral artery bypass||popliteal plantar artery bypass||classified_as
resection trachea||resection trachea||classified_as
paralysis of bowel||bowel peristalsis absent||classified_as
poisoning/toxic effect/adverse effects/underdosing, sequela||poisoning by antifungal antibiotics, systemically used, assault, sequela||classified_as
external cause codes: intent of injury, accidental/unintentional||driver of snowmobile injured in nontraffic accident, init||classified_as
other perinatal conditions nos (disorder)||other transitory neonatal electrolyte disturbance (disorder)||classified_as
bulbar paralysis||bulbar paralysis||classified_as
varicose veins of abdominal wall||varicose veins of abdominal wall||classified_as
nevus nos||mucosal pigmented naevus||classified_as
bacteremia, nos||gram positive bacteremia||classified_as
occupational exposure to air contaminants||occupational exposure to air contaminants (history)||classified_as
[d]painful respiration||[d]painful respiration nos||classified_as
constrictive pericarditis (disorder)||chronic pericardial constriction||classified_as
hepatitis infectious mononucleosis||infectious mononucleosis hepatitis||classified_as
aleukemic leukemia -retired-||aleukemic leukemia (morphologic abnormality)||classified_as
other gi system device procedures||medical and surgical @ gastrointestinal system @ insertion @ anal sphincter @ open @ stimulator lead @ no qualifier||classified_as
tb - urogenital tuberculosis||tuberculosis of other urinary organs, confirmed by animal inoculation||classified_as
blood testosterone decreased||testosterone low||classified_as
giant cell tumor of tenosynovium||pvns - pigmented villonodular synovitis||classified_as
plegias||palsy||classified_as
parrot fever||ornithosis with other specified complications (disorder)||classified_as
sequelae of; injury||corrosion of first degree of left axilla, sequela||classified_as
angioplasty and related vessel procedures (endovascular; excluding carotid)||medical and surgical @ lower arteries @ dilation @ peroneal artery, left @ percutaneous @ intraluminal device, drug-eluting @ drug-coated balloon||classified_as
external cause codes: drowning/submersion; initial encounter||drown after fall into swimming pool, undet intent, init||classified_as
pulmonary function challenge test normal||pulmonary methacholine challenge test normal||classified_as
injury of oesophagus [ambiguous]||injury of oesophagus [ambiguous]||classified_as
congenital melanosis||congenital melanosis||classified_as
thalassemia; anemia||thalassemia; hemoglobinopathy (with thalassemia)||classified_as
lung carcinoma cell type unspecified stage iii||carcinoma of lung stage iii||classified_as
disorder; oppositional defiance||oppositional disorder of childhood or adolescence||classified_as
superficial injury; contusion, subsequent encounter||insect bite (nonvenomous) of right ear, subsequent encounter||classified_as
cerebral parenchym hemorrhage||intracerebral haemorrhage, unspecified||classified_as
dislocated spine nos||open dislocation, coccyx||classified_as
complicated appendicitis (disorder)||necrotizing appendicitis||classified_as
colonoscopy and proctoscopy with biopsy||drainage of ileocecal valve, via natural or artificial opening endoscopic, diagnostic||classified_as
papilledema (disorder)||edema, optic disc||classified_as
paralysis sleep||postdormital paralysis||classified_as
autoimmune retinopathy||autoimmune retinitis||classified_as
17-hydroxyprogesterone increased||17-hydroxyprogesterone, increased||classified_as
myocardial necrosis marker increased||cardiac enzymes increased||classified_as
cardiac arrest-ventric fibrill||ventricular fibrillation and flutter||classified_as
antibiotic level nos below therapeutic||antibiotic level nos decreased||classified_as
amblyopia (disorder)||suppression amblyopias||classified_as
conjunctiva inflamed||blepharoconjunctivitis nos||classified_as
acne; cystic||acne cystic||classified_as
medium-chain acyl-coa dehydrogenase deficiency (diagnosis)||medium-chain acyl-coenzyme a dehydrogenase deficiency (disorder)||classified_as
oa - osteoarthrosis||loc 2nd osteoarth-up/arm||classified_as
recurrent cancer||reactivation of carcinoma||classified_as
hematocrit drop||packed cell volume decreased||classified_as
lip and/or oral cavity cancer stage iii||malignant neoplasm of ill-defined sites within the lip and oral cavity stage iii||classified_as
haematoma of ovary||ovarian haematoma||classified_as
lower gi therapeutic procedures, nec (excluding open and laparoscopic)||reposition ileum, external approach||classified_as
blood calcitonin normal||blood calcitonin normal||classified_as
ovarian dysgerminoma stage ii||ovarian dysgerminoma stage ii||classified_as
superficial injury; contusion, subsequent encounter||contusion of unspecified index finger without damage to nail, subsequent encounter||classified_as
blood bilirubin normal||plasma bilirubin normal||classified_as
muscle, tendon, bursa, and ligament excision||resection of lw spine bursa/lig, perc endo approach||classified_as
3-28 endocarditides||endocarditis;bacterial||classified_as
blood cholesterols||measurement of total cholesterol||classified_as
skull base fracture||open frac of bos with cerebral lacer and contu, with no loc||classified_as
anterior chamber hypopyon||hypopyon; ulcer||classified_as
abscess; spinal cord||intramedullary spinal abscess||classified_as
frequent stools||loose/mushy stools||classified_as
leiomyoma of the corpus uteri||uterine fibromatosis||classified_as
outcome of delivery (v codes)||postpartum care and examination immediately after delivery||classified_as
skin and breast procedures, nec||division of left hand skin, external approach||classified_as
exposure to extreme temperature (event)||exposure to extreme temperature, non-occupational||classified_as
excision of cyst of kidney (procedure) [ambiguous]||renal cystectomy||classified_as
vascular access site thrombosis||vascular access site thrombosis||classified_as
injection site joint pain||injection site joint pain||classified_as
peritoneal effluent leucocyte count increased||peritoneal effluent neutrophil count increased||classified_as
ultrasound of liver (procedure)||doppler ultrasound liver||classified_as
external cause codes: intent of injury, self-harm||self-harm by drown after jump into swimming pool, init||classified_as
acne fulminans (disorder)||acne fulminans (disorder)||classified_as
abortion induced complicated||legally induced abortion complicated by genital tract and pelvic infection||classified_as
intrathecal infusion pump user||intrathecal infusion pump user||classified_as
fungal meningitides||meningitis fungal nos||classified_as
strabismus nos (disorder)||alternating intermittent esotropia (disorder)||classified_as
erythromelalgia (diagnosis)||weir-mitchell disease||classified_as
abnormally early onset of puberty||gonadotropin dependent precocious puberty||classified_as
apolipoprotein a-i decreased||apolipoprotein a-i low||classified_as
acromicric dysplasia (disorder)||acmicd||classified_as
musculoskeletal procedures, nec||extirpation of matter from left wrist bursa and ligament, percutaneous approach||classified_as
peroneal nerve palsy postoperative||peroneal nerve palsy postoperative||classified_as
lymphatic procedures, nec||supplement right upper extremity lymphatic with nonautologous tissue substitute, percutaneous endoscopic approach||classified_as
relapsed t-cell lymphoma||recurrent t-cell and nk-cell non-hodgkin's lymphoma||classified_as
hemiasomatognosia||hemiasomatognosia||classified_as
adrenal rest tumour of the testis||adrenal rest tumor of the testis||classified_as
external cause codes: intent of injury, assault||poisoning by enzymes, assault, initial encounter||classified_as
fits||unknown onset behavioral arrest seizure with impairment of awareness||classified_as
pyelocaliectasis||pelvicaliectasis||classified_as
intrauterine growth failure||poor fetal growth affecting management of mother||classified_as
pyelonephritides||unspecified pyelonephritis nos||classified_as
anca increased||perinuclear antineutrophil cytoplasmic antibody increased||classified_as
sigmoidectomy (treatment)||open and other cecectomy||classified_as
administration of therapeutic substances, nec||administration @ physiological systems and anatomical regions @ introduction @ peripheral artery @ percutaneous @ other therapeutic substance @ other substance||classified_as
total excision of pituitary gland, unspecified approach||excision pituitary gland nos||classified_as
infarct, liver||hepatic infarction (diagnosis)||classified_as
computerised tomogram breast normal||computerized tomogram breast normal||classified_as
whooping cough immunization||pertussis immunisation||classified_as
other joint dis.-site unspec.||hemarthrosis right foot||classified_as
metastasis of malignant neoplasm to peritoneum (diagnosis)||peritoneal dissemination||classified_as
pseudohermaphroditism||pseudohermaphroditism||classified_as
escherichia coli vaginitis||escherichia coli vaginitis||classified_as
toxicity to various agents||haematological agent poisoning||classified_as
underdose||vaccine underdose||classified_as
amyloidosis, hepatic||hepatic amyloidosis||classified_as
incision and exploration of testis (procedure)||surgical reduction of torsion of testis||classified_as
carcinoma in situ of lung (diagnosis)||cancer of bronchus in situ||classified_as
ent repair||supplement l maxillary sinus w synth sub, perc endo||classified_as
penis swelling edema||edematous penis||classified_as
glomerulonephritis||nephritis-glomerular||classified_as
inflammatory disorder due to increased blood urate level||gout aggravated||classified_as
xanthomatous deposition (morphologic abnormality)||tendon xanthoma||classified_as
left-sided heart failure syndrome||lvf - left ventricular failure||classified_as
osmotic fragility, rbc||sucrose haemolysis test (procedure)||classified_as
abnormal breath sounds (finding) [ambiguous]||abnormal chest sounds||classified_as
subretinal haematoma||subretinal hematoma||classified_as
toe brachial index abnormal||toe brachial index abnormal||classified_as
drug tolerance decreased||decreased drug tolerance (disorder)||classified_as
ifs||congenital; fibrosarcoma||classified_as
rectal cancer stage ii ajcc v6||astler-coller b2 rectal cancer||classified_as
open wounds of head and neck, initial encounter||puncture wound with foreign body of trachea, initial encounter||classified_as
blood aluminium level||serum aluminium||classified_as
unspecified visual field defect (finding)||peripheral scotoma (finding)||classified_as
synovitis (disorder)||synovitis of hip (disorder)||classified_as
external cause codes: intent of injury, accidental/unintentional||prsn brd/alit pk-up/van inj pick-up truck, pk-up/van, init||classified_as
lipidoses: [familial xanthomatosis] or [nos]||lipidosis (disorder)||classified_as
tongue carcinoma stage iv||tongue carcinoma stage iv||classified_as
diseases iris||unspecified disorder of iris and ciliary body||classified_as
other intracranial injury||closed fos or face with oth bones, with cerebral lacer and contu, with state of cons unspec||classified_as
diplegia, nos||diplegia of upper limbs||classified_as
x-ray of pelvis and hip normal||pelvic x-ray normal||classified_as
product administration interrupted||product administration interrupted||classified_as
aortogram normal||aortogram translumbar normal||classified_as
limb traumatic amputation||traumatic amputation of arm and hand (complete) (partial), unilateral, at or above elbow, complicated||classified_as
fanconi syndrome, nos||de toni-debre-fanconi syndrome||classified_as
bannayan-zonana syndrome||cowden disease||classified_as
eye procedure (procedure)||medical and surgical @ eye @ revision @ eye, right @ via natural or artificial opening endoscopic @ intraluminal device @ no qualifier||classified_as
urinary diversion with anastomosis or ostomy||bypass right ureter to right ureter, perc endo approach||classified_as
digestive tract x-ray normal||x-ray of upper gi tract normal||classified_as
refractory t lymphoblastic leukemia/lymphoma||precursor t lymphoblastic lymphoma/leukemia refractory||classified_as
occlusion of retinal vein (diagnosis)||occlusion; retina, vein||classified_as
ectopic beats (disorder)||pulsus trigeminus||classified_as
intracranial bleed||haemorrhage intracranial||classified_as
liver function tests abnormal (finding)||abnormal lft's||classified_as
liver injury, drug induced||disease drug induced liver||classified_as
contact dermatitides||contact dermatitis and other eczema||classified_as
fracture of lower limb (except hip), subsequent encounter||nondisp fx of med malleolus of r tibia, 7thd||classified_as
drug abuser||drugs misuse||classified_as
dermal; sinus||congenital dermal sinus (disorder)||classified_as
therapeutic response changed||effects good||classified_as
atrial fibrillation||fibrillation atrial aggravated||classified_as
failure to lose weight||failure to lose weight||classified_as
electrolyte substitution therapy||electrolytes replacement||classified_as
limb injury||other shoulder and upper arm injury nos (disorder)||classified_as
anastomosis of oesophagus to small bowel||anast esophagus to jejunum||classified_as
post-surgical ovarian failure||post-surgical ovarian failure||classified_as
endoscopic control of bleeding||control bleeding in genitourinary tract, via opening||classified_as
other peritoneal cavity procedures||medical and surgical @ anatomical regions, general @ removal @ pelvic cavity @ open @ drainage device @ no qualifier||classified_as
hernia nos||herniation, nos||classified_as
thyroid bleeding||struma nodosa hemorrhage||classified_as
sexually transmitted infections (not hiv or hepatitis)||gonococcal synovitis or tenosynovitis (disorder)||classified_as
oedema laryngotracheal||laryngotracheal edema||classified_as
malignant neoplasm of larynx nos||cancer of larynx extrinsic (excl vocal cord)||classified_as
nodules on lateral aspect of left little finger (physical finding)||little finger, lateral surface||finding_site_of
retroverted incarcerated gravid uterus with antenatal prob||entire gravid uterus||finding_site_of
avascular retinal pigment epithelial detachment (disorder)||pigmented layer of retina||finding_site_of
closed wound of left temporomandibular joint (physical finding)||preauricular region structure (body structure)||finding_site_of
subacute non-puerperal mastitis (disorder)||mammary part of chest||finding_site_of
excoriation on medial surface of left thumb (physical finding)||skin of medial surface, thumb||finding_site_of
mesial caries of right lower first molar (physical finding)||lr6 - permanent lower right 6 tooth||finding_site_of
laceration of anterior aspect of right lower leg (physical finding)||structure of anterior part of lower leg||finding_site_of
homologous chimaera||chromosomal component||finding_site_of
stenosis of bilateral external auditory canals due to and following infection (disorder)||right external auditory meatus||finding_site_of
autosomal dominant charcot-marie-tooth disease type 2i (disorder)||nerves||finding_site_of
intracranial; hypotension||structures of the central nervous system||finding_site_of
x-ray clavicle mixed soft tissue mass suspected||clavicle bone||finding_site_of
open division foot ligament||structure of ligament of foot||finding_site_of
normal active range of thumb adduction||structure of thumb joint region||finding_site_of
perlèche (disorder)||mouth angle||finding_site_of
spontaneous abortion with laceration of uterus||pelvic region||finding_site_of
compartment syndrome of forearm extensor||structure of extensor compartment of forearm (body structure)||finding_site_of
temporomandibular joint stable (finding)||temporomandibular joint structure (body structure)||finding_site_of
beta cell tumor, malignant||pancreo-||finding_site_of
anomalous origin of single coronary artery from right coronary artery aortic sinus||coronary artery||finding_site_of
stress fracture of left foot (diagnosis)||bone structure of left foot (body structure)||finding_site_of
purpura on lateral surface of both thighs (physical finding)||structure of lateral surface of thigh||finding_site_of
hard palate neoplasm malignant carcinoma||palatum durum||finding_site_of
hair, white||hair-bearing skin (body structure)||finding_site_of
anomaly of chromosome pair 17 (diagnosis)||chromosomes, human, pair 17||finding_site_of
parachute deformity of mitral valve||left atrioventricular valve||finding_site_of
lesion of uterus (finding)||uterine structure (body structure)||finding_site_of
skin papule on left ulnar wrist||skin of ulnar border of wrist||finding_site_of
closed fracture thumb proximal phalanx, shaft||shaft of proximal phalanx of thumb (body structure)||finding_site_of
bronchoscopy (diagnostic) left lower superior segment bronchial mass (___ mm) erythematous||left superior segmental bronchus||finding_site_of
chronic pulmonary heart disease nos||ventriculus dexter||finding_site_of
laryngeal obstruction associated with vocal cord collapse (disorder)||head+neck>larynx||finding_site_of
iron pigmentation of oral mucosa (disorder)||oral mucous membrane structure (body structure)||finding_site_of
tingling of left second and third toes (symptom)||skin of third toe||finding_site_of
congenital rectovesical fistula (disorder)||bladder, nos||finding_site_of
deep third degree burn of thigh (disorder)||skin and/or subcutaneous tissue structure of thigh||finding_site_of
traumatic amputation of thumb (complete)(partial), complicated||thumbs||finding_site_of
detrusor hyperreflexia of bladder||muscularis of urinary bladder||finding_site_of
inferior lateral to superior medial incision of right lower paraspinal region (physical finding)||skin structure of lumbosacral region (body structure)||finding_site_of
congenital cubitus varus||joint, elbow||finding_site_of
far peripheral retinal edema of right eye||far periphery of retina (body structure)||finding_site_of
pain of lateral peroneus brevis of left ankle elicited by motion (physical finding)||tendon of peroneus brevis||finding_site_of
magnetic resonance imaging of shoulder: calcific tendonitis of left teres minor tendon||structure of tendon of teres minor (body structure)||finding_site_of
neoplasm of uncertain behaviour of urinary organ nos||urologic/renal body system||finding_site_of
right posterior open bite||dentition||finding_site_of
burn of larynx and trachea (disorder)||larynx and/or tracheal structures||finding_site_of
anomaly of dental arch (disorder)||dent arches||finding_site_of
complex laceration of chin (disorder)||chin structure||finding_site_of
sebaceous cyst of skin of bilateral breasts (disorder)||structure of skin of right breast||finding_site_of
benign neoplasm of alveolar ridge mucosa (disorder)||gingival mucous membrane||finding_site_of
contact dematitis||cutaneous tissue||finding_site_of
neoplasm of uncertain behavior of parathyroid gland||parathyroids||finding_site_of
partial corpus callosum agenesis, cerebellar vermis hypoplasia with posterior fossa cysts syndrome (disorder)||infratentorial brain structure||finding_site_of
swelling of anterior talofibular ligament of left ankle||structure of talofibular ligament||finding_site_of
t-spine mri osseous mass si ratio hyperintense signal t6 peritendinous||sixth thoracic vertebra||finding_site_of
open multiple fractures of upper limb with sternum and ribs||113-114 ribs||finding_site_of
atelosteogenesis, type 2||joint structure of multiple body sites (body structure)||finding_site_of
macular and peripheral retinoschisis||peripheral retina (body structure)||finding_site_of
foreign body of skin of breast (disorder)||skin of breast||finding_site_of
testicular prosthesis extrusion (disorder)||94 testes||finding_site_of
insect bite to cornea - nonvenomous (disorder)||corneal structure (body structure)||finding_site_of
thrombosis of the popliteal vein||structure of popliteal vein (body structure)||finding_site_of
oral lesions in reiter's syndrome (disorder)||conjunctival structure (body structure)||finding_site_of
nonunion of fracture of right eleventh rib posteriorly||eleventh rib||finding_site_of
nodule of subcutaneous tissue of chest wall||subcutaneous tissue structure of chest||finding_site_of
vma - vitreomacular adhesions||bodies, vitreous||finding_site_of
hsan2a||system, peripheral nervous||finding_site_of
brachydactyly of toes of right foot||entire toe of right foot||finding_site_of
capillary filling||peripheral vascular system structure||finding_site_of
acute pulmonary histoplasmosis (diagnosis)||structure of lungs, unspecified||finding_site_of
perichondritis of larynx (diagnosis)||structure of laryngeal perichondrium (body structure)||finding_site_of
incision of left temporomandibular joint extending to fascia (physical finding)||skin structure of preauricular region (body structure)||finding_site_of
x-ray of left hip: superior anterior displacement with fracture of femoral head and neck (epstein ib) (procedure)||femur head||finding_site_of
brain mri t2-weighted se hyperintense signal subdural left||space, subdural||finding_site_of
mixed type rhabdomyosarcoma of epididymis (diagnosis)||epididymi||finding_site_of
surgically induced astigmatism (disorder)||structure of visual system||finding_site_of
chronic gout of shoulder due to renal impairment||shoulder region structure (body structure)||finding_site_of
bathrocephaly (disorder)||occipital bone, nos||finding_site_of
mesenteric embolus||mesenteric arteries||finding_site_of
epigastric hernia with gangrene and obstruction (disorder)||organ within abdominopelvic cavity||finding_site_of
cerebral vein occlusion (disorder)||cerebral vein, nos||finding_site_of
pain in forearm (finding)||structure of forearm, unspecified||finding_site_of
valsalva retinopathy (disorder)||retinal||finding_site_of
puncture wound of wrist (diagnosis)||wrist region||finding_site_of
chancre between third and fourth toes on left foot (physical finding)||structure of skin between third and fourth toes||finding_site_of
direction of incision of left lateral chest (physical finding)||skin lateral surface thorax||finding_site_of
neoplasm of maxilla||maxillae||finding_site_of
ulcer of palmar surface of right hand (physical finding)||hand palms skin||finding_site_of
spina bifida; dorsal||tubes, neural||finding_site_of
spondyloperipheral dysplasia with short ulna syndrome (disorder)||bone structure||finding_site_of
microcystic corneal dystrophy syndrome||structure of bowman layer||finding_site_of
syphilis; primary, fingers||skin of finger (body structure)||finding_site_of
deafness, bilateral sensorineural, and hydrocephalus due to foramen of monro obstruction||corpus cerebellus||finding_site_of
animal bite of elbow (disorder)||elbow (anatomy)||finding_site_of
closed fracture of epiphyseal plate of metatarsal bone||structure of epiphyseal plate of metatarsal bone (body structure)||finding_site_of
simple craniosynostosis (disorder)||sutures, cranial||finding_site_of
rumination - mouth||face structure||finding_site_of
flat; chest||wall, thoracic||finding_site_of
ectopia lentis with ectopia of pupil||lens||finding_site_of
incus abnormal||anvil (ear)||finding_site_of
joint pain in little finger of left hand (symptom)||finger interphalangeal joints||finding_site_of
relative probing depth at distal right lower second molar (physical finding)||right lower second molar tooth||finding_site_of
ecchymosis of right maxillary region (physical finding)||maxillary antrum||finding_site_of
malignant tumor involving bladder by separate metastasis from prostate (disorder)||bladder, nos||finding_site_of
heart-lung transplant recipient (finding)||structure of transplanted lung (body structure)||finding_site_of
nonvenomous insect bite of hand without infection||skin hand||finding_site_of
papule on upper arms left dorsal||skin structure of posterior surface of upper arm||finding_site_of
mosaic trisomy chromosome 1||chromosome 1||finding_site_of
chondropathia tuberosa||sternal cartilage||finding_site_of
adenoma of small intestine (diagnosis)||small intestinal structure (body structure)||finding_site_of
incomplete ossification of vomer (disorder)||vomer bone structure||finding_site_of
talipes||foot structure||finding_site_of
gangliocytoma of central nervous system (disorder)||cerebrospinal axis||finding_site_of
pulmonary hypertension due to interstitial lung disease||pulmonary vascular structure||finding_site_of
liver in central position (disorder)||structure of liver||finding_site_of
proliferative retinopathy due to sickle cell disease (disorder)||tunica interna bulbi||finding_site_of
computed tomography of brain: mass of left cerebellum||cerebellum, nos||finding_site_of
idiopathic pure sudomotor failure (disorder)||sweat gland structure (body structure)||finding_site_of
partial tetrasomy of chromosome 9 (disorder)||chromosome pair 9 (body structure)||finding_site_of
laceration of glans penis with ragged edges||penis glans||finding_site_of
macule on both ear canals (physical finding)||skin of external auditory meatus||finding_site_of
t-spine mri osseous mass si ratio isointense t9||ninth thoracic vertebra||finding_site_of
cysts on right auricle helix||skin structure of helix||finding_site_of
exfoliation of proximal end of left thumb||skin structure of thumb||finding_site_of
gangrene of finger of right hand (disorder)||structure of finger of right hand (body structure)||finding_site_of
wound of left lateral chest with poorly approximated postsuture edges||side of chest||finding_site_of
acute renal failure due to angiotensin converting enzyme inhibitor||abdomen>kidney||finding_site_of
exfoliation was seen on the right thumb on the palmar aspect||skin structure of palmar surface of thumb (body structure)||finding_site_of
multiple mitral valve orifice (finding)||mitral valve structure||finding_site_of
extra; kidney||ren(o)-||finding_site_of
argentous deposits right eye||cornea of right eye||finding_site_of
c-spine mri t1-weighted osseous mass isointense signal at c3 vertebra anterior||bone structure of c3 (body structure)||finding_site_of
x-ray erosions right second toe dip joint||distal interphalangeal joint of second digit of foot||finding_site_of
numbness of upper arms||skin of upper arm||finding_site_of
hemorrhage of gingiva on right maxillary third molar (physical finding)||right maxillary third secondary molar tooth||finding_site_of
pododermatitis circumscripta (disorder)||sole of hoof (body structure)||finding_site_of
intraepithelial neoplasia of vagina grade 3 ajcc v6||genital system, female, vagina||finding_site_of
chemical burn of the forehead left||forehead structure (body structure)||finding_site_of
superior lateral to inferior medial incision of left forearm (physical finding)||skin of forearm||finding_site_of
ortolani sign positive||coxa||finding_site_of
tenderness on palpation of dorsal aspect of first metatarsal of right foot (physical finding)||structure of first metatarsal bone of right foot (body structure)||finding_site_of
acute tear of medial meniscus of right knee||medial meniscus of knee joint||finding_site_of
injury of transverse colon with open wound into abdominal cavity||transverse colon||finding_site_of
soft tissue swelling of left hand between ring and little finger||structure of subcutaneous tissue between fourth and fifth fingers (body structure)||finding_site_of
t-spine mri t1-weighted osseous destructive lesion hyperintense signal t6||bone structure of t6 (body structure)||finding_site_of
chronic peptic ulcer with hemorrhage and perforation||gi tract upper||finding_site_of
abnormality of walk toe walking (symptom)||lower extremity structure||finding_site_of
septic synovitis of extensor muscle of left ankle (diagnosis)||ankle joint synovium (body structure)||finding_site_of
late diastolic murmur||cardiac internal structure (body structure)||finding_site_of
spinocerebellar ataxia dysmorphism syndrome||spinali, medulla||finding_site_of
secluded pupil||anterior lens capsule||finding_site_of
three column fracture of cervical vertebra||cervical vertebrae (ci-cvii)||finding_site_of
ulcer of left elbow||skin of olecranal region||finding_site_of
neoplasm of autonomic nerves of flank||peripheral nerve structure of trunk||finding_site_of
non-infective non-allergic rhinitis||tunica mucosa nasi||finding_site_of
collagenous gastritis||section 5 digestive tract||finding_site_of
elbow joint colour - finding||joint, elbow||finding_site_of
gingivitis due to candida||gingival structure (body structure)||finding_site_of
incision of left foot with tissue bleeding (physical finding)||foot skin||finding_site_of
cardiac failure with reduced ejection fraction due to heart valve disease||cardiac structure (body structure)||finding_site_of
purulent enteritis (disorder)||intestinal tract, nos||finding_site_of
adult-onset cpeo (chronic progressive external ophthalmoplegia) with mitochondrial myopathy||nervous system nos (body structure)||finding_site_of
foreign body of anus and rectum||pelvis>anus||finding_site_of
poorly differentiated sertoli-leydig tumor of testis with heterologous elements (diagnosis)||male gonad, nos||finding_site_of
abrasion of teeth, occupational||dentes||finding_site_of
disorder of vein (diagnosis)||veins set||finding_site_of
atypical mycobacterial lymphadenitis (disorder)||lymphonodus||finding_site_of
finger hyperphalangy, toe anomalies, severe pectus excavatum syndrome (disorder)||bone structure of sternum||finding_site_of
papule on the face cheeks right inner (medial)||cheek skin||finding_site_of
open-angle glaucoma with optic disc cupping of right eye||structure of right optic disc||finding_site_of
hepatic vein to left atrium and right atrium (disorder)||atrium right||finding_site_of
closed traumatic dislocation of seventh cervical vertebra||joint structure of seventh cervical vertebra||finding_site_of
multiple anterior segment anomalies||segmentum anterius (bulbus oculi)||finding_site_of
cerebellar ataxia associated with another disorder||corpus cerebelli||finding_site_of
petechial hemorrhage of lateral aspect of little toe of left foot (physical finding)||skin structure of lateral surface of fifth toe||finding_site_of
loose, yellow, and tan appearance of wound bed of right hand (physical finding)||hand structure||finding_site_of
tenderness on palpation of sternocleidomastoid muscle bilaterally||scm - sternocleidomastoid||finding_site_of
fracture of symphysis of mandible||symphysis mandibulae||finding_site_of
localized pallor of right hand||skin of hand, nos||finding_site_of
charcot-marie-tooth disease type 2b5 (disorder)||nerve structure (body structure)||finding_site_of
carcinoma in situ of skin of forearm (disorder)||skin structure of forearm||finding_site_of
laceration of right thumb (disorder)||upper extremity.right>thumb||finding_site_of
stress radionuclide ventriculography: post-peak left ventricle wall motion hypokinetic lateral (procedure)||left lateral ventricle structure||finding_site_of
serosanguineous drainage from laceration of left wrist||carpus||finding_site_of
absence of clavicle||clavicle bone||finding_site_of
infected external fixator pin (disorder)||ossa||finding_site_of
laceration of stomach with massive damage (disorder)||structure of stomach||finding_site_of
fetal endocrine disorder||endocrine||finding_site_of
cortex laceration + open i/c||cerebral grey matter||finding_site_of
hyperextension injury of finger||set of digits of hand||finding_site_of
abdominal wall haematoma||abdomen>abdominal wall||finding_site_of
skin cyst of palmar aspect of left thumb (symptom)||skin of palmar surface of thumb||finding_site_of
hemorrhage of gingiva on distal surface of left mandibular first molar||distal marginal gingivae||finding_site_of
bilateral exposure keratoconjunctivitis of eyes||wall of right conjunctival sac||finding_site_of
hypoplasia of uterus and cervix||cervix uteri, nos||finding_site_of
ulcerative dermatitis||skin structure (body structure)||finding_site_of
uncomp tooth crown/root frac||crown of tooth, nos||finding_site_of
primary malignant neoplasm of soft tissue of right upper extremity (disorder)||structure of soft tissues of right upper extremity||finding_site_of
lyme carditis (disorder)||hearts||finding_site_of
partial colon obstruction||structure of lumen of colon (body structure)||finding_site_of
skin neoplasm malignant melanoma of lower lip||lower lip skin||finding_site_of
laceration of right mid back extending to bone||structure of back of lower thoracic region||finding_site_of
minimally compromised occlusal scheme||tooth structure||finding_site_of
ischaemia co-occurrent and due to increased oxygen demand||section 4 blood vessels||finding_site_of
corneal hypesthesia with retinal abnormalities, sensorineural deafness, unusual facies, persistent ductus arteriosus, and mental retardation||structure of auditory system (body structure)||finding_site_of
split-hand deformity||structure of hand||finding_site_of
blister of external auditory canal||external acoustic meatus skin||finding_site_of
cervical hydromyelocele (disorder)||medulla spinalis||finding_site_of
male infertility due to cystic fibrosis||male genital||finding_site_of
disproportion between fetus and pelvis due to fetal sacral teratoma (disorder)||structure of innominate bone and/or sacrum and/or coccyx (body structure)||finding_site_of
hirschsprung disease, ganglioneuroblastoma syndrome||peripheral autonomic nerve||finding_site_of
low assimilation pelvis (disorder)||sacra||finding_site_of
relative probing depth at labial left upper lateral incisor (physical finding)||ul2 - permanent upper left 2 tooth||finding_site_of
crusts on right external auditory canal||external acoustic meatus skin||finding_site_of
neoplasm of skin of groin (disorder)||skin of groin||finding_site_of
ovariectomized female||structure of female genital system subdivision||finding_site_of
epidural supratentorial pyogenic abscess (disorder)||cranial epidural space (body structure)||finding_site_of
candidas nail||nail unit structure (body structure)||finding_site_of
toes effusion right third toe pip joint (physical finding)||proximal interphalangeal joint of third digit of foot||finding_site_of
right direct inguinal hernia (disorder)||structure of hesselbach triangle||finding_site_of
contusion of ruq of abdomen||abdomen>right upper quadrant||finding_site_of
secondary malignant neoplasm of third cuneiform bone of foot (diagnosis)||lateral cuneiform bone, nos||finding_site_of
malunion of fracture of distal end of ulna (diagnosis)||bone structure of distal ulna||finding_site_of
cyst of left parotid gland||parotid gland left||finding_site_of
paradoxical chest movement||musculoskeletal struct thorax||finding_site_of
mass of distal interphalangeal joint of second toe of right foot||distal interphalangeal joint structure of second toe||finding_site_of
wound of right ear with adequately approximated postsuture edges||auris||finding_site_of
skin rash of right shin||skin structure of shin||finding_site_of
magnetic resonance imaging of thoracic spine: perineural mass of t11 vertebra with hyperintense t2 signal||eleventh thoracic vertebra||finding_site_of
right achilles tendon tear||structure of right achilles tendon||finding_site_of
left ear tissue incision surrounding tissue indurated||skin ear||finding_site_of
atherosclerotic retinopathy||retina, nos||finding_site_of
fibrinous epicarditis||pericardial sac structure (body structure)||finding_site_of
papule on entire upper lip (physical finding)||entire skin of upper lip (body structure)||finding_site_of
juvenile elastoma (disorder)||skin (anatomy)||finding_site_of
beaded ridging of nails (finding)||nail unit structure||finding_site_of
ulcer of ulnar surface of both wrists (physical finding)||skin of medial border of wrist (body structure)||finding_site_of
diffuse induration of middle finger of right hand (physical finding)||skin of third finger, nos||finding_site_of
dysplasia; dentin||dentin structure||finding_site_of
tmj left tissue injury laceration shape angulated y-shaped||temporomandibular joint structure (body structure)||finding_site_of
malunion of fracture left 4th metacarpal epiphyseal with growth arrest||fourth metacarpal bone structure||finding_site_of
abdominal puncture wound consistent with entry of multiple bullets||abdominal wall structure (body structure)||finding_site_of
flexion strength of right elbow (physical finding)||flexor of elbow joint||finding_site_of
klinefelter syndrome karyotype 47, xxy||female sex chromosome||finding_site_of
atresia of nasolacrimal duct||duct, nasolacrimal||finding_site_of
intussusception of small intestine (diagnosis)||small bowel||finding_site_of
hereditary spherocytosis due to combined deficiency of spectrin and ankyrin||erythrocyte (cell)||finding_site_of
midbrain corectopia||pupillary||finding_site_of
cyst;follicular;ovary||antral follicle||finding_site_of
primary cerebell degeneration||cerebellar||finding_site_of
nodular; goiter||entire thyroid gland (body structure)||finding_site_of
papule on lateral surface of right little toe (physical finding)||skin of lateral surface of fifth toe||finding_site_of
mri ankle interosseous ligament||structure of interosseous ligaments of ankle (body structure)||finding_site_of
chronic non-constrictive carditis||pericardial structure (body structure)||finding_site_of
scar; trachea||tracheal||finding_site_of
disorder: acute myeloid leukemia, minimal differentiation, fab m0 [ambiguous]||bone marrow (body structure)||finding_site_of
wheal on entire lower back (physical finding)||skin of lower back||finding_site_of
barrel-shaped chest||wall, chest||finding_site_of
delayed healing of skin donor site||wound biopsy||finding_site_of
bilateral neonatal conjunctivitis of eyes||left conjunctiva||finding_site_of
magnetic resonance imaging of thoracic spine: cystic mass of mid t9 vertebra (procedure)||bone structure of t9 (body structure)||finding_site_of
acquired deformity upper arm (diagnosis)||upper arms||finding_site_of
bullae between toes on right foot (physical finding)||skin of interdigital space of foot||finding_site_of
leuconychia striata||nail unit structure (body structure)||finding_site_of
delay in meconium passage||gut||finding_site_of
congenital anomaly of sternocleidomastoid muscle -retired-||sternomastoid muscle||finding_site_of
entropion of both lower eyelids (physical finding)||structure of left lower eyelid (body structure)||finding_site_of
refraction measurement - finding||visual structure||finding_site_of
closed fracture of base of fourth metacarpal of right hand||fourth metacarpal bone base||finding_site_of
chronic osteomyelitis of left hand||structure of bone marrow of left hand (body structure)||finding_site_of
t-spine mri osseous mass with surrounding edema t10 peritendinous||tenth thoracic vertebra||finding_site_of
cellulitis of submental space||submental space||finding_site_of
hypotonia neonatal||muscle, voluntary||finding_site_of
hypogonadism-cataract syndrome||lens (eye)||finding_site_of
mucogingival deformity on edentulous ridge||alveolar ridge mucous membrane structure (body structure)||finding_site_of
cellulitis between first and second toes on right foot||skin between great toe and second toe||finding_site_of
lordosis deformity of spine||musculoskeletal structure of spine (body structure)||finding_site_of
macrodactylia of fifth toe of left foot (diagnosis)||fifth toe structure||finding_site_of
open fracture of head of second metatarsal of left foot with dislocation (diagnosis)||second metatarsal bone epiphysis||finding_site_of
left upper arm pain (symptom)||arms left||finding_site_of
krukenberg spindle (disorder)||corneal endothelium||finding_site_of
chemical burn of the left upper lip||lip upper||finding_site_of
superficial incision of right lower leg (physical finding)||leg skin||finding_site_of
pneumonitis caused by fumes||28 lungs||finding_site_of
lip neoplasm malignant vermilion border secondary||vermilion border of lip||finding_site_of
cong abs/atres/sten small int||intestines, small||finding_site_of
laceration of right lateral chest wall with aligned margins||skin of side of thorax||finding_site_of
navicular suspensory ligament desmitis||extremity -retired-||finding_site_of
eumycotic; mycetoma||skin and subcutaneous tissue structure||finding_site_of
cholera - non-agglutin vibrio||gut||finding_site_of
open dislocation of index finger of right hand||r hand||finding_site_of
malignant solitary fibrous tumor of jaw||bones face||finding_site_of
rudimentary vas deferens||96 vasa deferentia||finding_site_of
warmth of dorsal aspect of left wrist (physical finding)||skin structure of dorsal area of wrist (body structure)||finding_site_of
compound naevus of skin||skin||finding_site_of
closed fracture of twelfth rib (diagnosis)||bone structure of twelvth rib||finding_site_of
spindle cell transitional cell carcinoma of male genitalia||male genital system||finding_site_of
malignant neoplasm of oral cavity||structure of internal part of mouth||finding_site_of
classical histoplasmosis mediastinal granuloma (disorder)||mediastinum||finding_site_of
excoriation on lateral surface of both thighs (physical finding)||skin of lateral aspect of thigh||finding_site_of
hemorrhage of gingiva on right maxillary second bicuspid||gum of maxilla||finding_site_of
carbuncle of thumb||skin of first finger||finding_site_of
acquired deformity of abdominal wall||anterior abdominal wall structure (body structure)||finding_site_of
acquired penile torsion (disorder)||structure of the penis||finding_site_of
aldosteronism due to neoplasm of the adrenal cortex (disorder)||cortex glandulae suprarenalis||finding_site_of
episodic ataxia, type 4||cerebellum||finding_site_of
drug-induced osteoporosis with pathological fracture of upper arm||bone of arm||finding_site_of
skin pimple of both wrists||skin of wrist||finding_site_of
madura foot due to streptomyces somaliensis||skin and subcutaneous tissue structure of foot (body structure)||finding_site_of
drug induced dystonia||extrapyramidal system structure||finding_site_of
opc dwarfism||brain structure (body structure)||finding_site_of
melanoma carcinomatosis (diagnosis)||multiple topographic sites||finding_site_of
closed fracture of epiphyseal plate of distal end of left radius||epiphysis of radial styloid||finding_site_of
pathological fracture of right radius due to osteoporosis (disorder)||bone structure of right radius (body structure)||finding_site_of
somatic dysfunction of sacrococcygeal region (finding)||structure of musculoskeletal system (body structure)||finding_site_of
skin necrosis of proximal phalanx of middle finger of right hand (physical finding)||skin structure of middle finger (body structure)||finding_site_of
malignant melanoma of accessory sinus||paranasal sinuses||finding_site_of
pulmonary artery embolism of right upper lobe branch (diagnosis)||apical segmental artery of right lung||finding_site_of
skin tag between third and fourth toes of right foot||skin between third and fourth toes||finding_site_of
posterior cerebral artery syn||cerebral vessel||finding_site_of
right radial blood vessel rupture||radial vessel (body structure)||finding_site_of
fissure of skin of medial aspect of index finger of left hand (physical finding)||skin structure of medial surface of index finger (body structure)||finding_site_of
x-ray of teeth: bone loss of distal surface of right maxillary cuspid (procedure)||tooth 6||finding_site_of
mesial caries of left lower first molar||left lower first deciduous molar tooth||finding_site_of
non-traumatic rupture of tendon of right foot||structure of tendon of right foot||finding_site_of
swelling of posterior tibialis tendon sheath of right ankle (physical finding)||structure of posterior tibial muscle tendon sheath (body structure)||finding_site_of
lesions toes left fourth toe distal||foot digit 4||finding_site_of
primary malignant neoplasm of breast upper inner quadrant||uiq - upper inner quadrant of breast||finding_site_of
avulsion of toe (physical finding)||set of toes||finding_site_of
chronic disease of lymphatic vessels (disorder)||structure of lymphatic vessel (body structure)||finding_site_of
dec active range wrist exten||wrist, nos||finding_site_of
abdominal skin reflexes were absent||structure of abdominopelvic cavity and/or content of abdominopelvic cavity and/or anterior abdominal wall (body structure)||finding_site_of
chronic cold agglutinin disease||corpuscles, red blood||finding_site_of
infectious encephalitis epilepsy||structure of cerebrum||finding_site_of
cleft limb heart malformation syndrome||bone of extremity||finding_site_of
closed fracture of anterior column of left acetabulum (disorder)||anterior column of left acetabulum (body structure)||finding_site_of
extratemporal epilepsy (disorder)||structure of cerebrum||finding_site_of
exostosis, anetoderma, brachydactyly type e syndrome (disorder)||bones structure||finding_site_of
traumatic rupture of patellar tendon (disorder)||patellar tendons||finding_site_of
open fracture of head of fifth metatarsal of left foot with dislocation||distal end of fifth metatarsal bone||finding_site_of
pleural effusion due to congestive heart failure (diagnosis)||cavitas pleuralis||finding_site_of
mri thoracic osseous mass t1 isointense signal t10 medial||tenth dorsal vertebra||finding_site_of
lobular carcinoma in situ of both breasts||left breast structure (body structure)||finding_site_of
incision of genitalia with uniform healing ridge||skin of external genitalia||finding_site_of
exfoliation was seen on the front of both shoulders||skin of part of shoulder (body structure)||finding_site_of
murine hepatitis (disorder)||livers||finding_site_of
ulcer of nipple||teats||finding_site_of
spontaneous reduction in size of ventricular septal defect due to accessory tissue of atrioventricular valve (finding)||ventricular septum||finding_site_of
ganglion of hip (disorder)||structure of soft tissues of hip||finding_site_of
palatal impaction||palates||finding_site_of
thyrotoxic chorea (disorder)||systema nervosum||finding_site_of
thoraco-abdominal enteric duplication||intestine, small||finding_site_of
iliac bruit right (physical finding)||iliac artery, nos||finding_site_of
pregnancy ectopic tubal left with intrauterine pregnancy||fallopian tube - left||finding_site_of
thyroid dyshormonogenesis 4||entire thyroid gland||finding_site_of
chronic silicosis (diagnosis)||pulmonary||finding_site_of
acrpv||bone structure of spine||finding_site_of
skin rash of palmar aspect of little finger of right hand||skin structure of palmar surface of little finger (body structure)||finding_site_of
edentulous mandible bone height 11mm to 15mm||sets teeth||finding_site_of
cardiomyopathy co-occurrent with human immunodeficiency virus infection (disorder)||cardiac muscle (tissue)||finding_site_of
erythrocytosis due to defective oxygen transport||bloods cells red||finding_site_of
ocular nerve palsy caused by herpes zoster (disorder)||nervus oculomotorius||finding_site_of
tendinosis of right knee (disorder)||structure of tendon of right knee||finding_site_of
primary malignant neoplasm of right upper extremity||structure of right upper limb (body structure)||finding_site_of
congenital pseudostrabismus||regio orbitalis||finding_site_of
frydman cohen karmon syndrome||fissures palpebral||finding_site_of
hereditary sensory autonomic neuropathy type iib||nervus||finding_site_of
paralytic ileus of large intestine (disorder)||structure of lumen of large intestine (body structure)||finding_site_of
thrombosis of superior cerebellar artery (disorder)||structure of cerebral artery||finding_site_of
anterior cord syndrome of spinal cord at third lumbar level (disorder)||third lumbar spinal cord segment||finding_site_of
relative probing depth at distal right lower second molar (physical finding)||deciduous mandibular right second molar tooth||finding_site_of
bronchopleural subphrenic fistula||bronchial structure||finding_site_of
diffuse burn of mcp joint of ring finger of right hand||metacarpophal jt ring finger||finding_site_of
superficial foreign body, right lesser toe(s)||structure of lesser toe of right foot (body structure)||finding_site_of
lateral epicondylitis of bilateral humerus (disorder)||structure of lateral epicondyle of right humerus (body structure)||finding_site_of
erb-duchenne palsy on left||superior trunk of brachial plexus||finding_site_of
gout secondary chronic lead-induced knee||knee||finding_site_of
colovaginal fistula (disorder)||colon (anatomy)||finding_site_of
malignant carcinoid tumor of the main bronchus (diagnosis)||principal bronchus||finding_site_of
purulent discharge of gums on labial surface of left mandibular cuspid||mandibular left primary canine tooth||finding_site_of
petechial hemorrhage of posterior aspect of left heel||skin structure of posterior part of heel||finding_site_of
bronchoscopy yellow secretions of right medial basal segmental bronchus (procedure)||right cardiac segmental bronchus||finding_site_of
intussusception of cecum||cecal||finding_site_of
distal renal tubular acidosis with sensorineural deafness (diagnosis)||kidney, nos||finding_site_of
hydrocephalus, cardiac malformation, dense bones, etc.||structure of heart, unspecified||finding_site_of
child hc = 75th-89th centile (finding)||head, nos||finding_site_of
skin plaque of lateral aspect of right thumb||skin structure of lateral surface of thumb||finding_site_of
scales of pubic area (physical finding)||skin structure of hypogastric region||finding_site_of
cerebro-oculo-facio-skeletal syndrome (disorder)||structure of nervous system||finding_site_of
breakdown of transplant urological anastomosis (disorder)||structure of urinary tract proper (body structure)||finding_site_of
urethral overactivity (finding)||urethra, nos||finding_site_of
follicular cyst of bilateral ovaries (disorder)||structure of left ovarian follicle (body structure)||finding_site_of
ultrasound right breast superior lateral quadrant mass #2 (___cm)||upper outer quadrant of right breast (body structure)||finding_site_of
polyarthropathy of foot||joint of foot||finding_site_of
bionbaum's syndrome||cerebellar structure (body structure)||finding_site_of
x-ray of finger: periarticular soft tissue swelling of proximal interphalangeal joint of ring finger of left hand (procedure)||proximal interphalangeal joint structure of fourth finger (body structure)||finding_site_of
skin scab of anterior aspect of right ankle||skin of front of ankle||finding_site_of
autoimmune chronic active hepatitis||organ system, hepatic||finding_site_of
benign hemangioma of joint||anatomy joint||finding_site_of
skin wound of both sides of chin (symptom)||skin of side of chin (body structure)||finding_site_of
leukaem.reticuloend.-mult.site||lymph nodes of multiple sites (body structure)||finding_site_of
neonatal autoimmune hemolytic anemia (disorder)||rbc||finding_site_of
retinal defects+ no detachment||retinal||finding_site_of
refractive accommodative esotropia||visual system structure||finding_site_of
clear drainage of stump wound of left ankle amputation (physical finding)||ankle region||finding_site_of
no passive range of wrist flexion||wrists||finding_site_of
benign neoplasm of mesothelial tissue of pericardium||pericardial mesothelium||finding_site_of
post-infarction mitral papillary muscle rupture (diagnosis)||structure of papillary muscles of left ventricle (body structure)||finding_site_of
anorectal agenesis||entire anus and rectum (body structure)||finding_site_of
sequestrum of middle phalanx of equine limb||ossa||finding_site_of
hand spiderlike||digits||finding_site_of
benign tumor of tympanic antrum (disorder)||mastoid antrum||finding_site_of
wheezing was heard on the left at the base||structure of base of left lung||finding_site_of
primary malignant neoplasm of skin of axilla||skin structure of axillary fossa (body structure)||finding_site_of
idiopathic granulomatous hepatitis (disorder)||livers||finding_site_of
human bite of palm of hand||palm (region) structure (body structure)||finding_site_of
chancre on superior medial quadrant of right breast||breasts skin||finding_site_of
cellulitis of second toe of right foot (diagnosis)||skin of second digit of foot||finding_site_of
mri thoracic osseous mass t1 isointense signal t10 cephalad||tenth dorsal vertebra||finding_site_of
amputation tuft of toe||bone tissue of distal phalanx of foot (body structure)||finding_site_of
hypersensitivities, contact||structure of skin and/or mucous membrane||finding_site_of
contact dermatitis caused by insecticide||skin (anatomy)||finding_site_of
malignant epithelial neoplasm of hypopharynx (disorder)||hypopharynges||finding_site_of
closed traumatic dislocation of interphalangeal joint of toe, single (diagnosis)||set of interphalangeal joints of foot||finding_site_of
double outlet right ventricle with doubly committed ventricular septal defect||interventricular septum, nos||finding_site_of
open fracture of right half of mandible||bone structure of right half of mandible||finding_site_of
conjunctivitis, follicular||conjunctival structure (body structure)||finding_site_of
acute cholestatic jaundice syndrome (disorder)||bile duct structure (body structure)||finding_site_of
deep third degree burns of middle finger of right hand||skin of third finger, nos||finding_site_of
tenosynovitis of ring finger of left hand (diagnosis)||tendon of fourth digit of hand||finding_site_of
infection causing subacute endocarditis (disorder)||endocardium, nos||finding_site_of
albright hereditary osteodystrophy-like syndrome||chromosome 02||finding_site_of
bilateral madelung deformity||structure of joint of left wrist (body structure)||finding_site_of
open smith's type ii fracture of left radius (diagnosis)||wrist-left||finding_site_of
at-hook dna binding motif containing 1-related intellectual disability, obstructive sleep apnoea, mild dysmorphism syndrome||faces||finding_site_of
carcinoma in situ of bronchus of right upper lobe||structure of bronchus of right upper lobe (body structure)||finding_site_of
melena of newborn due to swallowed maternal blood||alimentary system||finding_site_of
marginal corneal infiltrate associated with blepharoconjunctivitis (disorder)||cornea||finding_site_of
pain was elicited by motion of both middle fingers dip joints||dipj - distal interphalangeal joint of middle finger||finding_site_of
tactile hyperesthesia knee and medial legs (l4) - bilateral||dliv - dermatom 4th lumbar nrv||finding_site_of
skin rash of shoulder||shoulder skin||finding_site_of
purulent discharge of gums on mesial surface of right maxillary second bicuspid (physical finding)||mesial marginal gingivae (body structure)||finding_site_of
fordyce spots of penis (disorder)||gland sebaceous||finding_site_of
nailfold/finger-pulp infarcts in rheumatoid disease (diagnosis)||periungual skin structure (body structure)||finding_site_of
malignant medulloepithelioma of digestive tract (diagnosis)||digestive organ structure (body structure)||finding_site_of
open fracture of phalanx of thumb||bone thumb||finding_site_of
open dislocation of wrist||wrist joints||finding_site_of
neoplasm of uncertain behaviour of extrahepatic bile ducts, nos||biliary systems, extrahepatic||finding_site_of
skin nodule of plantar aspect of both feet (symptom)||skin of plantar part of foot||finding_site_of
macular edema not clinically significant due to diabetes mellitus (disorder)||retinal macula||finding_site_of
instability of pelvic floor (disorder)||diaphragm, pelvic||finding_site_of
high degree second degree atrioventricular block (disorder)||nodes, a-v||finding_site_of
diarrhoea co-occurrent and due to diabetes mellitus||intestino-||finding_site_of
erythema of stump of left thigh amputation (physical finding)||thigh structure||finding_site_of
arthritis of finger of left hand due to trauma (disorder)||structure of joint of finger of left hand (body structure)||finding_site_of
cor/3rd deg/hip+l lmb,ex ak+ft||lower extremity region||finding_site_of
bronchoscopy purulent secretions of right apical segmental bronchus||structure of right apical segmental bronchus||finding_site_of
cyst of palmar aspect of little finger of right hand (physical finding)||skin structure of palmar surface of little finger (body structure)||finding_site_of
nasopharynx rosenmueller's fossa swelling||structure of pharyngeal recess||finding_site_of
t-spine mri osseous mass si ratio hyperintense t11 mid||bone structure of t11 (body structure)||finding_site_of
paraplegias, spastic||cerebrospinal axis||finding_site_of
complications of heart-lung transplant (diagnosis)||transplanted lung||finding_site_of
gartner duct, cyst||ducts, gartner's||finding_site_of
injection site pigmentation change||injections sites||finding_site_of
biopsy of liver lymphangioma||liver||finding_site_of
aberrant premature complexes (diagnosis)||systema conducente cordis||finding_site_of
injury of left musculocutaneous nerve||structure of left musculocutaneous nerve||finding_site_of
straddling right atrioventricular valve (disorder)||right (non-tricuspid) atrioventricular valve structure (body structure)||finding_site_of
non-hodgkin's lymphoma of intestine||bowel, nos||finding_site_of
subhyaloid hemorrhage of inferonasal aspect of midperipheral retina of left eye||middle periphery of retina||finding_site_of
marks skin||skin nos (body structure)||finding_site_of
spine magnetic resonance imaging thoracic osseous destructive lesion si ratio hyperintense signal t11||bone structure of t11||finding_site_of
abdominal early pain pregnancy||abdominopelvic regions||finding_site_of
inherited cutis laxa (disorder)||portion of connective tissue||finding_site_of
disease of midbrain, nos||mesencephalon, nos||finding_site_of
wheal on posterior surface of right thigh||skin of posterior aspect of thigh||finding_site_of
pustules on left infraclavicular region||skin of infraclavicular region||finding_site_of
cystocele with unspecified uterine prolapse (disorder)||anterior wall of vagina||finding_site_of
acute necrotising encephalopathy of childhood||brain tissue structure (body structure)||finding_site_of
open fracture of proximal shaft of fifth metatarsal of right foot (diagnosis)||shaft of fifth metatarsal bone||finding_site_of
polydactyly of bilateral index fingers||structure of left index finger||finding_site_of
bile duct injury contusion||duct, bile||finding_site_of
secondary osteonecrosis of left ankle||ankle bones||finding_site_of
burns periorbital third degree||structure of skin and/or subcutaneous tissue of eye region||finding_site_of
nonunion of fracture of proximal end of right radius||bone structure of proximal radius (body structure)||finding_site_of
fusiform type small cell carcinoma of nasopharynx (diagnosis)||rhinopharyngeal||finding_site_of
cervicothoracic spina bifida cystica with hydrocephalus||cervical spinal cord, nos||finding_site_of
dissection of intracranial artery||structure of intracranial artery (body structure)||finding_site_of
ileum; stricture||ileo||finding_site_of
cervical, vaginal and external female genital anomalies (disorder)||cervix||finding_site_of
x-ray of cervical spine: disc space narrowing at c1-c2 (procedure)||intervertebral disk of cervical vertebra||finding_site_of
chemical hair colour change||structure of hair||finding_site_of
patch on the fingers right little finger proximal||skin of fifth finger, nos||finding_site_of
ulcer of left forearm with deep abscess (physical finding)||skin structure of forearm||finding_site_of
opacity of right corneal limbus (physical finding)||junction, corneoscleral||finding_site_of
irritant contact cheilitis||skin of the lip||finding_site_of
ichthyosis, short stature, brachydactyly, microspherophakia syndrome (disorder)||digit structure (body structure)||finding_site_of
x-ray of foot: mixed lytic and sclerotic lesion of epiphysis||epiphyses||finding_site_of
malignant neoplasm of conjunctiva (diagnosis)||conjunctival structure||finding_site_of
cataract; glass-blower's||lens structure||finding_site_of
stenosis of left frontal sinus||frontal sinus||finding_site_of
thumb joint-synovial thicken||thumb joint structure||finding_site_of
mri right infraspinatus tendon complete tear chronic||infraspinatus tendon||finding_site_of
crocodile tears syndrome||cranial nerve viis||finding_site_of
squamous metaplasia of lung (disorder)||pulmonary||finding_site_of
shape of incision of right upper back (physical finding)||skin of upper back||finding_site_of
skin crust on palmar surface of ring finger of right hand (symptom)||skin of palmar surface of ring finger||finding_site_of
mesial caries of left upper first bicuspid||12||finding_site_of
nystagmus, voluntary||regio orbitalis||finding_site_of
benign neoplasm of connective tissue of head, face, or neck (diagnosis)||head neck||finding_site_of
lesion of periaxillary region on left (physical finding)||skin of part of upper limb||finding_site_of
neck posterior tissue injury incision shape curvilinear||skin structure of nuchal region||finding_site_of
cormack and lehane grade 3 (finding)||upper respiratory tract, nos||finding_site_of
retinal vessel venous engorge left branch superior nasal||superior nasal retinal vein||finding_site_of
uveitis; sympathetic||structure of uveal tract of right eye (body structure)||finding_site_of
pustules on the shins both inferior||skin shin||finding_site_of
magnetic resonance imaging of shoulder: superior band of right glenohumeral ligament intact (procedure)||glenohumeral ligament||finding_site_of
hereditary persistence of fetal haemoglobin thalassaemia||erythrocyte, nos||finding_site_of
preductal aortic stenosis||preligamental region of aortic arch||finding_site_of
ebs with pyloric atresia||pyloro-||finding_site_of
thrombosis of splenic artery (disorder)||splenic artery||finding_site_of
epithelial opacity of cornea||cornea, external epithelium||finding_site_of
heritable pulmonary arterial hypertension due to bone morphogenetic protein receptor type ii mutation||structure of trunk of pulmonary artery (body structure)||finding_site_of
gastric malignant carcinoma lesser curve||lesser curvature of stomach||finding_site_of
shoulder joint color - finding||joint, shoulder||finding_site_of
familial dilated cardiomyopathy with conduction defect due to lamin a/c mutation||systems, heart conduction||finding_site_of
spontaneous hemorrhage of gingiva on distal surface of left maxillary second bicuspid (physical finding)||distal marginal gingivae (body structure)||finding_site_of
truncal valve regurgitation (diagnosis)||truncal valve structure (body structure)||finding_site_of
benign tumour of abdomen||intra-abdominopelvic structure and/or anterior abdominal wall||finding_site_of
induced female hypogonadism syndrome||ovarian endocrine structure||finding_site_of
malunion of fracture of proximal interphalangeal joint of ring finger of left hand||interphalangeal articular surface of phalanx of ring finger||finding_site_of
benign neoplasm of retropharyngeal lymph nodes||nodi lymphoidei retropharyngei||finding_site_of
patch on both ankles (physical finding)||skin of ankle, nos||finding_site_of
air conduction deafness (finding)||ear structure||finding_site_of
third degree burns of ring finger of right hand||skin structure of ring finger||finding_site_of
partial corpus callosum agenesis, cerebellar vermis hypoplasia with posterior fossa cysts syndrome||infratentorial brain||finding_site_of
decreased vibratory sensation of all four limbs||peripheral nerve of upper limb||finding_site_of
liver carcinoma in situ intraductal micropapillary carcinoma||body system, hepatic||finding_site_of
gc bartholin's gland abscess||bartholin's gland structure (body structure)||finding_site_of
labial filling in right upper cuspid||haderup designation 3+||finding_site_of
absolute probing depth at labial right lower lateral incisor||lr2 - permanent lower right 2 tooth||finding_site_of
maceration on the breasts||skin of breast||finding_site_of
x-ray of foot: extra-articular fracture of medial process of right calcaneus||structure of medial process of calcaneal tubercle||finding_site_of
burn involving 50-59 percent of body surface, with 10-19 percent of body surface with full thickness burn (disorder)||10 to 19 percent of body surface||finding_site_of
retraction of left upper eyelid (physical finding)||upper left eyelid||finding_site_of
ulcer of forehead (physical finding)||skin of frontal region||finding_site_of
esophagitis grade ii (disorder)||esophagus||finding_site_of
periarthritis; wrist||wrist joint (body structure)||finding_site_of
skin lump on the posterior right knee||skin structure of popliteal fossa||finding_site_of
purpura on entire forehead (physical finding)||entire skin of forehead||finding_site_of
tender lymph nodes (physical finding)||lymph nodes||finding_site_of
cyanosis of left arm||extremity-upper||finding_site_of
cellular immunologic aplastic anemia||bone mar||finding_site_of
distortion of orbit||bony orbit structure||finding_site_of
thin basement membrane nephrop||renal tuft||finding_site_of
absolute probing depth at distal left upper second bicuspid||left permanent second upper premolar tooth||finding_site_of
progeroid syndrome, congenital, petty type||skin structure||finding_site_of
open fracture of surgical neck of left humerus (disorder)||structure of surgical neck of left humerus||finding_site_of
encephalopathy caused by h1n1 influenza||encephalon||finding_site_of
stricture; urethra, infective||urethral structure||finding_site_of
double orifice of common atrioventricular valve (disorder)||common atrioventricular orifice (body structure)||finding_site_of
stress image 2 lv wall motion akinetic posterior||left ventricle posterior segment||finding_site_of
post-radiological embolism of lower limb artery (disorder)||peripheral artery||finding_site_of
liver disorder in pregnancy - not delivered (disorder)||hepatic body system||finding_site_of
target skin lesion||piel||finding_site_of
pain due to fracture||structure of bone (organ)||finding_site_of
cancer pharyngeal||structure of pharynx||finding_site_of
swan-neck deformity of left finger(s)||proximal interphalangeal joint of finger||finding_site_of
nasal syphilis (disorder)||nasal cavity structure (body structure)||finding_site_of
flexion strength of ring finger of left hand (physical finding)||muscle acting on joint of finger (body structure)||finding_site_of
glossopalatine ankylosis||structure of internal part of mouth||finding_site_of
skin cyst of medial aspect of both feet (symptom)||skin of medial side of foot||finding_site_of
medullary cystic kidney disease on right (diagnosis)||kidney right||finding_site_of
petechial hemorrhage of lip skin||hair bearing lip||finding_site_of
bladder exstrophy (physical finding)||bladder||finding_site_of
ruptured popliteal artery aneurysm||arteria poplitea||finding_site_of
normal male sexual function||male sex||finding_site_of
petechial hemorrhage of proximal end of little finger of left hand (physical finding)||skin structure of little finger||finding_site_of
infected wound of right elbow due to non venomous insect bite (disorder)||skin structure of right elbow||finding_site_of
internal hemorrhoids grade ii (disorder)||internal haemorrhoidal plexus||finding_site_of
partial seizure with multiple symptoms||nervous system, brain||finding_site_of
intestinal roundworm infection by toxascaris leonina||intestines, nos||finding_site_of
ankle blister||skin ankle||finding_site_of
nephrotic syndrome w diffuse membranous glomerulonephritis||glomerulus kidney||finding_site_of
larva migrans; cutaneous||skin||finding_site_of
tetraplegic infantile cerebral palsy||cerebral structure||finding_site_of
dermoid cyst of brain (disorder)||suprasegmental structures||finding_site_of
pelvic fracture acetabulum anterior wall nondisplaced||anterior column of acetabulum (body structure)||finding_site_of
wound of right hand with aligned margins (physical finding)||hand structure||finding_site_of
bursting injury of jejunum||jejunums||finding_site_of
straight wound of posterior neck (physical finding)||structure of nuchal region of neck||finding_site_of
mild nonproliferative retinopathy co-occurrent and due to type 2 diabetes mellitus (disorder)||retinas||finding_site_of
primary progressive freezing gait syndrome (disorder)||systems, nervous||finding_site_of
spasm of levator scapulae muscle of both shoulders||levator scapulae||finding_site_of
elfin facies was observed||facies||finding_site_of
x-ray of toe: joint space narrowing of proximal surface of fourth interphalangeal joint (procedure)||joint of fourth toe||finding_site_of
ulcer of right ankle with sinus tract||skin of tarsal region||finding_site_of
alopecia, syphilitic||set of head hairs||finding_site_of
unstable artificial eye||eyeballs||finding_site_of
lesions on the chest areola(e)||skin of areola||finding_site_of
brachial neuritis of right upper limb||structure of brachial plexus of right upper limb||finding_site_of
induration of lateral aspect of left distal lower leg||skin of lateral surface of leg||finding_site_of
congenital anomaly of muscle or tendon||skeletal muscle and/or tendon structure (body structure)||finding_site_of
demyelination of central nervous system co-occurrent and due to neurosarcoidosis (disorder)||axis, cerebrospinal||finding_site_of
mammogram decreased number of previous masses of superior medial quadrant of left breast (procedure)||upper inner quadrant of left breast||finding_site_of
macule on left buttock (physical finding)||buttocks skin||finding_site_of
gradenigos syndrome||nervus faciali||finding_site_of
enlarged labial frenum||labial frenum||finding_site_of
nonunion of fracture of right ninth rib anteriorly||ninth rib||finding_site_of
magnetic resonance imaging of knee: old osteochondral injury of anterior aspect of medial tibial plateau (procedure)||tibial plateau structure (body structure)||finding_site_of
baboon syndrome (disorder)||buttock skin crease||finding_site_of
clear drainage of right sphenoid sinus||right sphenoid sinus structure||finding_site_of
idiopathic ventricular fibrillation not brugada type||ventricular conducting pathway||finding_site_of
x-ray of foot: lytic lesion with soft tissue mass superiorly (procedure)||bones feet||finding_site_of
varicose veins of lower limb co-occurrent with edema||limb, lower||finding_site_of
unrefreshed by sleep||brain tissue||finding_site_of
obst.labour-fetal malpr.nos||canal birth||finding_site_of
supraorbital facial cleft - tessier cleft 8||bone structure of head||finding_site_of
degenerative disorder of extremity (disorder)||limb structure (body structure)||finding_site_of
perceptual disturbances and seizures co-occurrent and due to sedative withdrawal||vertebrate brain||finding_site_of
indocyanine green videoangiography: hyperfluorescent plaque of superior temporal aspect of midperipheral retina||middle periphery of retina||finding_site_of
hypophysis; cyst||pituitary, nos||finding_site_of
porphyria, erythrohepatic||liver structure (body structure)||finding_site_of
posterior tonsillar pillar||entire pharyngopalatine arch (body structure)||finding_site_of
nonvenomous insect bite of right shoulder||skin structure of right shoulder||finding_site_of
accelerated rejection of pancreas transplant||structure of transplanted pancreas (body structure)||finding_site_of
pneumonia, non-infect cause||pulmo||finding_site_of
petechial hemorrhage of medial aspect of second toe of right foot||skin structure of medial surface of second toe (body structure)||finding_site_of
traumatic acute pancreatitis (disorder)||exocrine and endocrine pancreas, nos||finding_site_of
ecchymosis of oral cavity (finding)||structure of internal part of mouth||finding_site_of
hamartoma of apocrine sweat gland apparatus||apocrine sweat gland structure (body structure)||finding_site_of
arterial-enteric fistula (disorder)||xxx>artery||finding_site_of
effects; altitude, on sinuses||paranasal sinus cavity||finding_site_of
lentigo - freckle (disorder)||skin, nos||finding_site_of
nodule of skin of bilateral hands (finding)||skin structure of left hand (body structure)||finding_site_of
fracture of humerus greater tuberosity||tubercles, greater||finding_site_of
pustules on dorsal surface of right third toe (physical finding)||skin of dorsal surface, third toe||finding_site_of
wheal on scrotum (physical finding)||skin of scrotum (body structure)||finding_site_of
clavicle sternoclavicular joint motion||sternoclavicular joint structure||finding_site_of
lesion of joint capsule of wrist and hand||capsule, radiocarpal joint||finding_site_of
tinea corporis caused by trichophyton schoenleinii (disorder)||the integument||finding_site_of
tophus of left ankle (physical finding)||ankle subdivision||finding_site_of
chronic respiratory distress with surfactant metabolism deficiency||interstitial tissue of lung||finding_site_of
injury of the radial nerve at upper arm level||radial nerve in upper arm (body structure)||finding_site_of
buccal tooth inclinat - buccal||dentition||finding_site_of
stab wound of head and neck (disorder)||neck||finding_site_of
progressive sensorineural hearing loss and hypertrophic cardiomyopathy syndrome (disorder)||auditory structure (body structure)||finding_site_of
melanoma in situ of vermilion border of lip (disorder)||vermilion border region||finding_site_of
lichen planus co-occurrent with onycholysis||skin, nos||finding_site_of
artificial skin on lateral aspect of right thigh (physical finding)||skin lateral surface thigh||finding_site_of
localized adhesions and/or strands of conjunctiva (disorder)||conjunctival||finding_site_of
hematuria due to radiation cystitis||systema urinaria||finding_site_of
erythema at site of femoral artery insertion for balloon pump||line insertion site (morphologic abnormality)||finding_site_of
obstetric trauma causing pelvic haematoma nos||structure of pelvic region of trunk of female||finding_site_of
skin wound of left upper back||skin structure of upper back||finding_site_of
brain injury with open intracranial wound (disorder)||cranial cavity structure (body structure)||finding_site_of
neurogenic bladder due to spina bifida (disorder)||neurologic body system||finding_site_of
attic perforation of right tympanic membrane||structure of pars flaccida of right tympanic membrane (body structure)||finding_site_of
congenital hypoganglionosis of large intestine||submucous plexus||finding_site_of
perio-endo defect of gingiva of left lower second bicuspid||gum of mandible||finding_site_of
pain of all toes of both feet elicited by motion (physical finding)||all toes (body structure)||finding_site_of
skin rash of medial aspect of right elbow (symptom)||elbows skin||finding_site_of
closed posterior dislocation of left hip with fracture of femoral head (thompson-epstein v)||structure of head of femur (body structure)||finding_site_of
striae; cutis distensae||skin system||finding_site_of
malignant mastocytosis of appendix (diagnosis)||vermiform appendix||finding_site_of
indurated incision of back of head (physical finding)||skin of occipital region (body structure)||finding_site_of
odonto-onychial dysplas + alop||ectoderm structure||finding_site_of
thoracic lymphadenopathy||thoracic lymph node, nos||finding_site_of
arthritis of joint of toe (disorder)||interphalangeal toe joint structure (body structure)||finding_site_of
open wound of nasal cavity with complication||cavity, nasal||finding_site_of
mass left foot between 3rd and 4th toes||structure of third web space of foot (body structure)||finding_site_of
contracture of second toe of right foot on extension||joint of second toe (body structure)||finding_site_of
skin texture of proximal aspect of right thumb (physical finding)||skin of part of thumb (body structure)||finding_site_of
neural tuberculoid leprosy||integument||finding_site_of
localized secondary osteoarthritis of toes||interphalang toe joint struct||finding_site_of
x-ray of toe: osteonecrosis of proximal interphalangeal joint of fifth toe||structure of articular surface, interphalangeal, of phalanx of fifth toe||finding_site_of
recurrent ventral hernia with gangrene||abdomen+||finding_site_of
atrioventricular septal defect with additional muscular ventricular septal defect||atrioventricular septum||finding_site_of
lesion of left canthus||structure of canthus of left eye (body structure)||finding_site_of
bilateral benign neoplasm of choroid||structure of choroid of left eye||finding_site_of
carcinoma of midline of tongue||tongue structure||finding_site_of
gastrostomy present (physical finding)||gastrostomy site||finding_site_of
polyneurop+mononeurop||nerve, peripheral||finding_site_of
granulomatous retinitis (disorder)||retinal structure (body structure)||finding_site_of
atrophy of thyroid||thyroids||finding_site_of
creutzfeldt-jakob disease caused by human growth hormone||brain tissue structure||finding_site_of
anal sac impaction||sac, anal||finding_site_of
closed fracture of cervical region with spinal cord injury||cervical spinal cord||finding_site_of
glaucoma associated with vascular disorder (disorder)||eye (anatomy)||finding_site_of
oculodento-oss dysplas - mild||facial bones, nos||finding_site_of
insulin shock||system, endocrine||finding_site_of
lesion of right upper motor neuron||systems, central nervous||finding_site_of
atherosclerosis of bypass graft of left lower limb||peripheral artery graft (body structure)||finding_site_of
mass of volar aspect of forearm (physical finding)||structure of flexor compartment of forearm||finding_site_of
skin lesion of back of right thigh||skin of posterior aspect of thigh||finding_site_of
passive extension of dip joint of ring finger of left hand hyperextensible||structure of distal interphalangeal joint of ring finger (body structure)||finding_site_of
osteogenesis imperfecta (diagnosis)||skeletal bone||finding_site_of
benign tum soft tissue pelvis||pelvis soft tissue||finding_site_of
inflammatory conditions of jaw periostitis chronic||periosteum (body structure)||finding_site_of
left metatarsus primus varus||structure of first metatarsal bone of left foot||finding_site_of
large cell carcinoma of renal pelvis (diagnosis)||kidney pelvis||finding_site_of
acute ulcerative gastroenteritis complicating pneumonia (disorder)||stomach structure (body structure)||finding_site_of
benign frontal sinus tumor||sinus frontalis||finding_site_of
blue pulsatile discoloration of lower buccal vestibule on right||structure of mandibular buccal sulcus||finding_site_of
delayed union of fracture of multiple thoracic vertebral bodies (diagnosis)||thoracic vertebral body||finding_site_of
herpesviral encephalitis||brain tissue structure (body structure)||finding_site_of
grommet obscured by wax||ear structures||finding_site_of
loosening of external fixator pin||bones set||finding_site_of
incision of right wrist with specified total tube drainage (physical finding)||skin structure of wrist (body structure)||finding_site_of
malignant nerve sheath neoplasm of peripheral nerve of lower limb (disorder)||lower extremity nerve (body structure)||finding_site_of
traumatic injury of lumbar plexus (disorder)||plexus lumbalis||finding_site_of
outlet ventricular septal defect with posteriorly malaligned outlet septum||outlet muscular septum||finding_site_of
ureterocele (diagnosis)||ureter, nos||finding_site_of
cochlear otosclerosis involving round window (diagnosis)||rw - round window||finding_site_of
bronchoscopy telangiectasia of posterior aspect of right middle lobe medial segmental bronchus (procedure)||right middle lobe medial segmental bronchus||finding_site_of
ecchymosis of fourth toe of left foot (physical finding)||foot digit 4||finding_site_of
polioencephalopathy (diagnosis)||brain structure (body structure)||finding_site_of
thrombosis of brachiocephalic vein (diagnosis)||innominate veins||finding_site_of
skin plaque of medial aspect of ring finger of right hand (symptom)||skin structure of medial surface of ring finger (body structure)||finding_site_of
macule on eyebrow||skin of eyebrow||finding_site_of
exfoliation of distal end of right thigh||skin of the thigh||finding_site_of
theater sign||knee region||finding_site_of
chronic osteomyelitis of upper arm with draining sinus||upper arm structure (body structure)||finding_site_of
circumference of left elbow (physical finding)||cubitus||finding_site_of
hip; melanoma in situ||skin of hip||finding_site_of
burns of radial aspect of interphalangeal joint of thumb of right hand (physical finding)||interphalangeal joint of thumb||finding_site_of
one placental membrane present (finding)||uterine membrane structure (body structure)||finding_site_of
pneumoconiosis; diatomite||lung structure (body structure)||finding_site_of
atrioventricular septal defect with separate atrioventricular orifices (disorder)||structure of atrioventricular septum||finding_site_of
pustules on the chest nipple(s) left||nipple (& skin of nipple) (& skin of nipple) (body structure)||finding_site_of
guttate morphea (disorder)||skin of body||finding_site_of
gum neoplasm malignant upper gum secondary||upper jaw gingiva||finding_site_of
francois dyscephalic syndrome||hair||finding_site_of
soft tissue pain in the right great toe||skin and subcutaneous tissue structure of toe (body structure)||finding_site_of
spondylometaphyseal dysplasia czarny ratajczak type||bone, skeletal||finding_site_of
pancreatic steatorrhea (diagnosis)||58 small intestine||finding_site_of
dog bite of neck||neck||finding_site_of
pain of metatarsophalangeal joint of second toe of left foot elicited by motion||metatarsophalangeal joint structure of second toe||finding_site_of
pain of left peroneus brevis elicited by motion against resistance||tendon of fibularis brevis||finding_site_of
tetanus complicating ectopic and/or molar pregnancy (disorder)||ns - nervous system||finding_site_of
ct angiography: left common carotid artery arises from common trunk||carotid artery.left||finding_site_of
cornea infection||corneas||finding_site_of
ischaemic skin ulcer||skin structure (body structure)||finding_site_of
contracture with ectodermal dysplasia and orofacial cleft syndrome||cranial and facial bones (body structure)||finding_site_of
macule on multiple fingers of left hand||skin of finger (body structure)||finding_site_of
intermittent soft tissue swelling of right upper arm||structure of soft tissue of upper arm||finding_site_of
urethra; injury||75 urethra||finding_site_of
multiple foetal parts palpable||fetal parts, nos||finding_site_of
bilateral congenital cortical cataract of eyes||structure of left cortex of lens (body structure)||finding_site_of
nodule of lateral aspect of great toe of left foot||skin of lateral surface of great toe||finding_site_of
dislocation of metacarpophalangeal joint||metacarpophalangeal joint, nos||finding_site_of
ventricular trigeminy||ventricular conducting pathway (body structure)||finding_site_of
stroke due to embolism of bilateral middle cerebral arteries||human brain||finding_site_of
right fifth mtp pain||fifth metatarsophalangeal joint||finding_site_of
strain of rectus femoris muscle||rectus femoris muscle||finding_site_of
syndrome, devic's||spinal cord structure||finding_site_of
right atrial non-cavotricuspid isthmus dependent macro re-entrant atrial tachycardia||systema conducente cordis||finding_site_of
incision of left foot with tube drainage (physical finding)||foot skin||finding_site_of
acute viral idiopathic pericarditis||serous sac of pericardium||finding_site_of
nodule of subcutaneous tissue of left lower limb (finding)||subcutaneous tissue structure of left lower extremity (body structure)||finding_site_of
double outlet left atrium||interatrial septum||finding_site_of
double-chambered right ventricle||right ventricle of heart||finding_site_of
the wound bed on the left upper back had soft black eschar||skin structure of upper back||finding_site_of
congenital lymphangiectasia with chylous reflux (disorder)||structure of lymphatic vessel||finding_site_of
varicose leg veins in pregnancy or puerperium with baby delivered||venous system of lower extremity, nos||finding_site_of
ductal eccrine adenocarcinoma||eccrine gland structure (body structure)||finding_site_of
injury of nerve at lower leg level||nerve lower extremity||finding_site_of
ulcer of right lower back||skin lower back||finding_site_of
anomalous insertion of ductus arteriosus into pulmonary trunk (disorder)||arteriosus, ductus||finding_site_of
freckles||skins||finding_site_of
oronasal fistula||cavitas nasi||finding_site_of
blood in schlemm's canal of right eye (physical finding)||sclera, sinus venosus||finding_site_of
severe left ventricular hypertrophy (disorder)||entire left cardiac ventricle||finding_site_of
bloody laceration of abdominal wall (physical finding)||abdominal wall structure (body structure)||finding_site_of
dislocation of joint of digit closed traumatic of hand||structure of joint of digit of hand||finding_site_of
skin graft on the left superior chest||skin structure of upper chest wall||finding_site_of
neoplasm of ischium||ischium||finding_site_of
painful legs and moving toes||lower limbs||finding_site_of
shape of wound of left lower back (physical finding)||lower back structure (body structure)||finding_site_of
weeping wound of left side of neck||structure of left half of neck (body structure)||finding_site_of
benign tumour of head of pancreas||right extremity of pancreas||finding_site_of
fracture of cricoid cartilage||cartilages, cricoid||finding_site_of
obstructed internal hernia||wall of peritoneal sac||finding_site_of
scratch of cheek||cheeks skin||finding_site_of
neonatal intestinal perforation with congenital intestinal stenosis||intestinal||finding_site_of
papillary adenocarcinoma of anus||anal||finding_site_of
laceration of right lower paraspinal region with venous bleeding||paravertebral area||finding_site_of
melanoma-astrocytoma syndrome||structure of nervous system (body structure)||finding_site_of
iliohypogastric nerve neuritis (disorder)||iliohypogastric nerve||finding_site_of
rupture of synovium, ankle and foot||synovial structure of ankle and/or foot||finding_site_of
varix of vocal cord (disorder)||vein, nos||finding_site_of
joint pain in right little toe precipitated by cold weather (symptom)||joint of fifth toe (body structure)||finding_site_of
blepharitis in seb eczema||skin of palpebral margin||finding_site_of
heart murmur pitch, pure frequency||cardiac internal structure (body structure)||finding_site_of
subluxation of extensor indicis proprius tendon of right hand (diagnosis)||structure of tendon of extensor indicis (body structure)||finding_site_of
puncture wound of breast (disorder)||breast, nos||finding_site_of
tenderness on palpation of left transverse process of c4 (physical finding)||structure of transverse process of fourth cervical vertebra||finding_site_of
vesicle of palmar aspect of ring finger of right hand||skin structure of palmar surface of ring finger (body structure)||finding_site_of
spastic diplegia of upper extremities||nervous structure of upper limb (body structure)||finding_site_of
ulcer of left external auditory canal||skin of external auditory meatus||finding_site_of
malignant frozen pelvis (disorder)||pelvic peritoneal structure (body structure)||finding_site_of
fracture of pelvic ring with incomplete disruption of posterior arch (disorder)||structure of posterior arch of pelvic ring||finding_site_of
grain fever||pulmonary alveolar structure (body structure)||finding_site_of
hypopyon corneal ulcer (diagnosis)||outer coat of the eyeball||finding_site_of
nonkeratinizing small cell squamous cell carcinoma of fallopian tube||fallopian tubes||finding_site_of
infected insect bite of genitalia||skin structure of external genitalia||finding_site_of
adductor canal syndrome (disorder)||femoral artery, nos||finding_site_of
osteoarthritis of both wrists (diagnosis)||structure of joint of right wrist region||finding_site_of
subtalar joint stiff (finding)||structure of subtalar joint region||finding_site_of
lesions on right upper back||skin of upper back||finding_site_of
vitreous amyloid||vitreous body structure (body structure)||finding_site_of
granulation tissue of stump wound of right ankle amputation (physical finding)||regio tarsalis||finding_site_of
skin patch of right lower back (symptom)||of lower back skin||finding_site_of
thoracic nerve root injury-t10||spinal nerve root t10 (body structure)||finding_site_of
deletion of part of long arm of chromosome 2 (disorder)||long arm of chromosome||finding_site_of
aneurysm of left common iliac artery (diagnosis)||trunk of left common iliac arterial tree||finding_site_of
tenderness on palpation of dorsal aspect of fifth metatarsal of left foot||structure of fifth metatarsal bone of left foot (body structure)||finding_site_of
straight wound of right elbow (physical finding)||elbow region structure (body structure)||finding_site_of
acute lymphadenitis of face, head and neck (disorder)||lymph node struct head & neck||finding_site_of
acute sickle cell splenic sequestration crisis (disorder)||red blood cell||finding_site_of
biopsy of thoracic spinal cord ependymoma (procedure)||thoracic spinal cord structure (body structure)||finding_site_of
stress ulcer, nos||uppr gastrointest tract struct||finding_site_of
cellulitis of middle finger of left hand (physical finding)||middle finger||finding_site_of
scales on distal end of left third toe (physical finding)||skin of third digit of foot||finding_site_of
lacrimal sac fistula||lacrimal sac structure (body structure)||finding_site_of
primary malignant neoplasm of lunate bone||bone, lunate||finding_site_of
hereditary inclusion body myopathy type 3||structure of joint region (body structure)||finding_site_of
wheal of left anterior axillary fold (physical finding)||skin structure of anterior axillary fold (body structure)||finding_site_of
atherosclerosis of posterior tibial artery without gangrene (diagnosis)||structure of posterior tibial artery||finding_site_of
synaechia posterior||capsule of anterior lens||finding_site_of
access tissue lt av valv leaf||ventricular septum||finding_site_of
otolaryngologic surgical result: edema of incision of right side of neck (treatment)||necks||finding_site_of
aberrant muscle of lower limb||muscle of lower extremity||finding_site_of
localized joint pain in both shoulders||structure of left glenohumeral joint||finding_site_of
inc active range wrist exten||wrist region structure||finding_site_of
pyogenic granuloma of the oral mucosa||oral mucous membrane structure||finding_site_of
obs of pericard friction rub||cardiac structure||finding_site_of
right inferior pulmonary vein stenosis||right inferior pulmonary vein||finding_site_of
schistosomal hepatomegaly||entire liver (body structure)||finding_site_of
t-spine mri t1-weighted osseous mass isointense signal t9 cephalad||t9 vertebra||finding_site_of
infestation by sarcoptes scabiei var suis||integument||finding_site_of
furuncles on right lower abdomen||skin structure of lower abdomen (body structure)||finding_site_of
skin patch of right buttocks||buttock skin||finding_site_of
connective tissue and disc stenosis of intervertebral foramina of thoracic region||thoracic intervertebrl foramen||finding_site_of
magnetic resonance imaging of knee: contusion of anterior aspect of patella (procedure)||patella, nos||finding_site_of
rupture post cruciate ligament||cruciate ligament posterior||finding_site_of
puncture wound of male external genital organs without foreign body (diagnosis)||male external genitalia structure (body structure)||finding_site_of
myositis; interstitial||skeletal musculature||finding_site_of
os cuboideum (ankle); fracture||centroquartal tarsal bone||finding_site_of
ep wth grnd-ml seizs on awakng||structure of cerebrum (body structure)||finding_site_of
laceration of left foot||structure of left foot (body structure)||finding_site_of
coronary angiography: right coronary third right posterolateral branch aneurysm diffuse (procedure)||third right posterolateral branch of the posterior descending branch of right coronary artery||finding_site_of
pallor of nail beds||subungual skin||finding_site_of
endothelial cell morphometry||eye structure||finding_site_of
umbilical cord entanglement with compression with baby delivered||cords, umbilical||finding_site_of
primary malignant neoplasm of blood vessel of thorax (disorder)||area thoracic||finding_site_of
spinal hydromeningocele-thorac||spinal cord, thoracic||finding_site_of
cutaneous synovial metaplasia||skin, nos||finding_site_of
bone pain in foot||bone of foot, nos||finding_site_of
magnetic resonance imaging of thoracic spine: solid mass of posterior aspect of t8 vertebra (procedure)||eighth dorsal vertebra||finding_site_of
furuncles on proximal end of left second toe||skin structure of second toe||finding_site_of
tuberculous necrosis of bone (disorder)||ossa||finding_site_of
x-ray of teeth: cavity of left maxillary third molar (procedure)||structure of permanent maxillary left third molar tooth||finding_site_of
open fracture of fourth metacarpal bone||mc4 - fourth metacarpal||finding_site_of
bilateral trilobed lungs due to isomerism of right lung (disorder)||left lung, nos||finding_site_of
hiv infection with visual impairment||visual system structure (body structure)||finding_site_of
chronic otitis externa of both external auditory canals||left external auditory canal structure (body structure)||finding_site_of
incision of right wrist with sterile strips in place||skin of wrist, nos||finding_site_of
aneurysm of popliteal artery on exam||artery, popliteal||finding_site_of
dermo odontodysplasia||pili||finding_site_of
superficial injury of female external genital organs||external female genital structure||finding_site_of
lad-leucocyte adhes defic typ2||immune system structure||finding_site_of
acantholytic squamous cell carcinoma of skin (disorder)||skin||finding_site_of
adhesions of biliary tree (disorder)||bile tract||finding_site_of
mmpsi - malignant migrating partial seizures of infancy||brain, nos||finding_site_of
stress radionuclide ventriculography: post-peak left ventricle wall motion hypokinetic anterior||lv - left ventricle ant segmt||finding_site_of
bullae on right lateral canthus (physical finding)||skin of lateral palpebral commissure||finding_site_of
bilateral paving stone retinal degeneration||structure of peripheral retina of right eye||finding_site_of
inhalation smoke||pulmones||finding_site_of
grommet not present||ear||finding_site_of
right upper arm muscles decreasing in size||skeletal muscle structure of upper arm (body structure)||finding_site_of
myocarditis due to echovirus||myocardia||finding_site_of
diastasis of symphysis pubis||symphysis pubis||finding_site_of
congenital blepharoptosis||upper eye lid||finding_site_of
bitemporal wasting (physical finding)||temple region structure (body structure)||finding_site_of
mr angiography: right internal carotid artery arises as additional accessory branch artery||right internal carotid artery||finding_site_of
telangiectasia unilateral||microscopic skin vascular structure (body structure)||finding_site_of
lesion with dermatomal configuration on right||dermatome||finding_site_of
open fracture of shaft of second metacarpal bone||diaphysis of second metacarpal bone||finding_site_of
pneumonia idiopathic eosinophilic||pulmones||finding_site_of
atrioventricular septal defect - ventricular component||common (non-mitral, non-tricuspid) atrioventricular valve structure (body structure)||finding_site_of
pneumonia left lower zone||structure of left lower lobe of lung (body structure)||finding_site_of
respiratory function finding||respiratory system structure||finding_site_of
laceration of left lower back with arterial bleeding||lower back structure||finding_site_of
soft tissue swelling of medial aspect of proximal left foot (symptom)||subcutaneous tissue structure of medial border of sole of foot (body structure)||finding_site_of
cutaneous photosensitivity and lethal colitis syndrome||cutis||finding_site_of
benign submandibular gland neoplasm||submandibular salivary structure (body structure)||finding_site_of
choroid finding||choroids||finding_site_of
lacrimal drainage - not patent (finding)||lacrimal drainage system||finding_site_of
perforation of femoral artery (disorder)||structure of femoral artery (body structure)||finding_site_of
edentulous muscle attachment with no attached mucosal base in mandibular anterior region||structure of internal part of mouth (body structure)||finding_site_of
skin reaction weak (finding)||skin (anatomy)||finding_site_of
right double pterygium of eye||right cornea (physical finding)||finding_site_of
acute mi lateral - of high lateral wall||lateral myocardium||finding_site_of
amphoric breath sounds||lower respiratory tract, nos||finding_site_of
perinatal jaundice from maternal transmission drug or toxin||structure of skin and/or skin-associated mucous membrane||finding_site_of
parapsoriasis varigata||skinned||finding_site_of
skin crack of fingers||hand digit skin||finding_site_of
lichenification of front of left shoulder||skin of part of shoulder||finding_site_of
complete epiphyseal arrest of right distal radius (disorder)||structure of distal epiphysis of right radius (body structure)||finding_site_of
purulent discharge of gums on palatal surface of right maxillary first molar||structure of permanent maxillary right first molar tooth (body structure)||finding_site_of
central serous retinopathy with pit of optic disc||layer of rods and cones||finding_site_of
acute laryngitis and tracheitis nos (disorder)||larynx and/or tracheal structures (body structure)||finding_site_of
lupus erythematosus overlap syndrome (disorder)||tissue, connective||finding_site_of
serosal tear of cecum (diagnosis)||large intestine, cecum||finding_site_of
distal 7q11.23 microduplication syndrome||chromosomes, human, pair 7||finding_site_of
reported burn of finger by explosion of butane||set of digits of hand||finding_site_of
chronic pharyngolaryngitis (disorder)||laryngeal structure (body structure)||finding_site_of
obstetric anesthesia with pulmonary complications - delivered with postnatal problem||respiratory||finding_site_of
neoplasm of left eighth costal cartilage (diagnosis)||structure of eighth costal cartilage (body structure)||finding_site_of
animal bite of lower limb||structure of lower extremity, unspecified||finding_site_of
giant cell tumor of sacrum||sacrum||finding_site_of
skin tags of superior aspect of both calves (physical finding)||skin of calf of leg||finding_site_of
efe - endocard fibroelastosis||endocardium structure (body structure)||finding_site_of
injection site thrombosis (disorder)||injections sites||finding_site_of
contact dermatitis of right upper and lower eyelids||skin structure of right upper eyelid||finding_site_of
congenital obstruction of small intestine||small intestinal lumen, nos||finding_site_of
trigeminal neuralgia left||trigeminal nerve structure||finding_site_of
exophytic mass of buccal mucosa (physical finding)||structure of buccal mucosa||finding_site_of
closed fracture of distal phalanx of ring finger of left hand (disorder)||bone structure of distal phalanx of ring finger of left hand (body structure)||finding_site_of
contact dermatitis of hand (disorder)||skin of hand, nos||finding_site_of
termination of pregnancy complicated by blood-clot embolism||vessel||finding_site_of
mri thoracic osseous mass t2 image signal hyperintense t7||t7 vertebra||finding_site_of
malignant neoplasm of cartilage of ear (diagnosis)||auricular cartilage structure (body structure)||finding_site_of
amputation left lower leg||left legs||finding_site_of
lacrimal canaliculitis caused by actinomyces israelii (disorder)||canaliculus lacrimalis||finding_site_of
suppurative osteomyelitis of jaw (disorder)||structure of bone marrow of jaw||finding_site_of
abscess at site of ductus arteriosus||arterial duct||finding_site_of
idiopathic anterior chamber cyst||anterior chamber eye||finding_site_of
patch on upper left eyelid (physical finding)||skin of upper eyelid (body structure)||finding_site_of
skin texture of eyelid||eyelids skin||finding_site_of
lichenification of lateral surface of both knees||skin of lateral surface of knee||finding_site_of
polyp colon||colon, nos||finding_site_of
tenderness on palpation of serratus muscles of both shoulders (physical finding)||chest wall muscle||finding_site_of
spine magnetic resonance imaging thoracic osseous mass si ratio isointense t5 periosseus||bone structure of t5 (body structure)||finding_site_of
sense; prickling||cutaneous tissue||finding_site_of
plaque of left antecubital fossa||skin structure of antecubital fossa||finding_site_of
fanconis syndrome||tubulus renalis||finding_site_of
circumscribed alopecia areata of trunk||hairs set||finding_site_of
torsion; uterus||entire womb||finding_site_of
malabsorption - iron (disorder)||small intestine||finding_site_of
yellow discoloration of left thumbnail||structure of nail unit of thumb||finding_site_of
ataxic hemiparesis||axi, cerebrospinal||finding_site_of
infective esophagitis (disorder)||oesophageal structure||finding_site_of
benign neoplasm of skin of left upper eyelid (disorder)||structure of skin of left upper eyelid||finding_site_of
childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia (disorder)||cerebellum, nos||finding_site_of
syphilitic myelitis||spinal cord tissue structure (body structure)||finding_site_of
dermatofibroma of right lower limb||skin structure of right lower limb||finding_site_of
lump on anterior lingual surface of right upper gum (symptom)||gum of maxilla||finding_site_of
decreased active range of motion of metatarsophalangeal joint of great toe of left foot on adduction||metatarsophalan joint great toe||finding_site_of
presystolic mitral murmur (diagnosis)||valve, mitral||finding_site_of
x-ray finger(s) mixed lesion cortex||cortical bone||finding_site_of
infected abrasion of right ear||skin structure of right ear||finding_site_of
lumbar strain||lower back muscle||finding_site_of
leakage of bile from gallbladder bed||fossa for gallbladder||finding_site_of
prereticulotic poikiloderma||skin structure||finding_site_of
sensation vibration perception threshold left foot (physical finding)||skin of foot||finding_site_of
bartter's syndrome type 4||structure of medullary thick ascending limb of loop of henle||finding_site_of
myalgia of shoulder region||shoulder muscle||finding_site_of
nonfamilial asexual dwarfism (disorder)||anterior pituitary gland||finding_site_of
decreased range of motion of thoracolumbar spine on passive rotation to left||thoracolumbar region of spine structure (body structure)||finding_site_of
congenital hydrocele of canal of nuck (disorder)||structure of canal of nuck||finding_site_of
burn involving 30-39 percent of body surface, with 20-29 percent of body surface with full thickness burn||30 to 39 percent of body surface (body structure)||finding_site_of
wound of face with approximation of postsuture edges (physical finding)||face (volume)||finding_site_of
ear/nose/throat symptom nos||upper respiratory structure||finding_site_of
punctate epithelial keratopathy||structure of corneal epithelium||finding_site_of
rupture of flexor digitorum sublimis tendon to middle finger of right hand||superficial flexor tendon of middle finger||finding_site_of
skin necrosis of middle phalanx of third toe of left foot||third toe skin||finding_site_of
hypertrophies, bone||bone, skeletal||finding_site_of
irregularly shaped wound of posterior neck (physical finding)||structure of nuchal region of neck (body structure)||finding_site_of
left fifth mtp stiffness||5th metatarsophalangeal joint||finding_site_of
lump under skin of nose||subcutaneous tissue structure of nose||finding_site_of
sarcoma of sternum||bone, sternum||finding_site_of
third degree burn of wrist (disorder)||skin and/or subcutaneous tissue structure of wrist||finding_site_of
single lobe lung infiltrate||lungs||finding_site_of
peripheral nerve injury digital nerve hand right||digital nerve of hand (body structure)||finding_site_of
purpura of lower extremity (physical finding)||skin structure of lower extremity||finding_site_of
acute effusive pericarditis (diagnosis)||pericardial sac structure||finding_site_of
ulcer of proximal end of right thigh (physical finding)||skin of part of thigh||finding_site_of
carcinomatous meningitis||central nervous system meninges||finding_site_of
observation of colour of lips||lips of mouth||finding_site_of
nail damage from external cause (disorder)||nail unit structure (body structure)||finding_site_of
tinea corporis caused by microsporum audouinii||integumentary system structure (body structure)||finding_site_of
modified ashworth scale - adduction right hip||right hip joint||finding_site_of
seeing spots in front of eyes (finding)||eye (anatomy)||finding_site_of
benign teratoma of testis (diagnosis)||testicles||finding_site_of
prinzmetals angina||heart muscles||finding_site_of
double orifice rt av valve||av (non-mit/tricus) val struct||finding_site_of
malunion of fracture of left fourth rib anteriorly||bone structure of fourth rib||finding_site_of
idiopathic condylar resorption||idiopathic condylar resorption||translation_of
schistosomiases||infection caused by schistosoma||translation_of
retained suture material||retained suture material||translation_of
at-hook 1c protein, high mobility group||hmga q 001c protein||translation_of
laugier-hunziker syndrome (diagnosis)||laugier-hunziker syndrome (diagnosis)||translation_of
lung diffusion test abnormal||lung diffusion test abnormal||translation_of
congenital herpes simplex (disorder)||congenital herpes simplex infection||translation_of
stage iii paranasal sinus and nasal cavity cancer||paranasal sinus and nasal cavity cancer, stage iii||translation_of
hch||hypochondroplasia||translation_of
pyruvate low||pyruvate low||translation_of
magnus' syndrome||protoporphyria, erythropoietic||translation_of
skin neoplasm malignant melanoma lower limb, including hip||malignant melanoma of skin of lower limb, including hip||translation_of
euglycemic diabetic ketoacidosis||euglycemic diabetic ketoacidosis||translation_of
nitrogen mustards||derivative nitrogen mustard||translation_of
smooth muscle cell neoplasm||smooth muscle cell neoplasm||translation_of
penis; deformity, acquired||penis; deformity, acquired||translation_of
computerized tomogram abnormal||computerised transverse axial tomography abnormal||translation_of
duodenitis with bleeding (diagnosis)||erosive duodenitis||translation_of
angular blepharitis||angular blepharitis (disorder)||translation_of
other specified aplastic anaemias||[x]oth spcfd aplastic anaemias||translation_of
sinus tarsi syndrome||sinus tarsi syndrome (disorder)||translation_of
complete legal abortion with no mention of complication||legally induced abortion, without mention of complication, complete||translation_of
pigmentation; conjunctiva||conjunctiva; pigmentation||translation_of
toxic conjunctivitis||toxic conjunctivitis||translation_of
ankylosing spondylitis relapse||ankylosing spondylitis relapse||translation_of
dental pain and sensation disorder||dental pain and sensation disorder||translation_of
nephropathy due to ischaemia||ischaemic nephropathy||translation_of
syndrome, tourette||syndrome tourettes||translation_of
contracture scar of skin||contracture scar of skin||translation_of
chronic lymphocytic leukaemia variants||chronic lymphocytic leukemia variants||translation_of
skin ulcer removal||skin ulcer excision||translation_of
erythema of palate (physical finding)||erythema of palate (physical finding)||translation_of
pediatric hepatoblastoma||hbl||translation_of
neonatal and infancy disorders||neonatal and infancy disorders||translation_of
non-hodgkin's lymphoma unspecified histology indolent stage iv||non-hodgkin's lymphoma unspecified histology indolent stage iv||translation_of
vaccination site ischaemia||vaccination site ischaemia||translation_of
antabuse effect||antabus effect||translation_of
light coag||photocoagulation - action||translation_of
fluoroscopic urinary tract loopogram||urinary tract loopogram||translation_of
syndromes, hospital-addiction||munchausen syndrome||translation_of
citrullinemia ll||citrullinemia ll||translation_of
korsakov's psychosis (non-alcoholic)||nonalcoholic polyneuritic psychosis||translation_of
coprolith||faecolith||translation_of
hypoglycaemia unspecified (disorder)||hypoglycemic disorder||translation_of
epstein-barr viremia||epstein-barr viremia||translation_of
necrotizing fasciitis nos||necrotizing fasciitides||translation_of
resting tremors||resting tremor (finding)||translation_of
atony of bladder (disorder)||atony; bladder||translation_of
embryoma; kidney||wilms tumor (nephroblastoma)||translation_of
gravitropisms||gravitropism||translation_of
continuous muscle fiber activ||neuromyotonia [ambiguous]||translation_of
mucosa hemorrhage nos||mucosal hemorrhage||translation_of
policeman's heels||fasciitis, plantar||translation_of
crushing injury of forearm, part unspecified||crushing injury; forearm||translation_of
atrophy; muscle, pseudohypertrophic||atrophy; muscle, pseudohypertrophic||translation_of
rheumatoid nodule removal||rheumatoid nodule removal||translation_of
management, disease||disease management||translation_of
adenoma; prostate||prostatic adenomas||translation_of
anemia, neonatal||neonatal anemia, nos||translation_of
liver ultrasound abnormal||ultrasound liver abnormal||translation_of
skin tingling||[d]tingling of skin (context-dependent category)||translation_of
visual discomfort (diagnosis)||visual discomfort, unspecified||translation_of
bladder adenocarcinoma stage unspecified||bladder adenocarcinoma stage unspecified||translation_of
atrophic iris (disorder)||atrophy of iris||translation_of
dilatation - action||dilate||translation_of
comoros islands (geographic location)||km||translation_of
other typhus||other typhus nos||translation_of
11 beta hsd||dehydrogenase, 11 beta-hydroxysteroid||translation_of
staphylococcal; infection||staphylococcal infection, unspecified||translation_of
blood alkaline phosphatase decreased||blood alkaline phosphatase decreased||translation_of
echinoidea||urchin, sea||translation_of
drug prescription issue||drug prescription issue||translation_of
reversals, vasectomy||vasovasostomies||translation_of
excision of gingiva||gingivectomy (treatment)||translation_of
4-he||helium (substance)||translation_of
carcinoma signet ring cell||adenocarcinoma cells ring signet||translation_of
heterosexuals||heterosexual||translation_of
dutch cap||dutch cap||translation_of
spec lacrimal gland anom||specified congenital anomalies of lacrimal gland||translation_of
lupus encephalitis||sle encephalopathy||translation_of
salivary gland cancer, stage iii||stage iii salivary gland cancer||translation_of
nocturnal urinary frequency||nocturnal urinary frequency||translation_of
amyotrophy||wasting;muscle(s)||translation_of
shallot||shallot||translation_of
infections testicular||infections testicular||translation_of
binder syndrome||maxillonasal dysplasia syndrome||translation_of
paraplegia; hereditary||hereditary; paraplegia||translation_of
sperm concentration normal||sperm concentration normal||translation_of
regeneration, guided tissue||tissue regeneration, guided||translation_of
skin and subcutaneous tissue fungal infections||skin and subcutaneous tissue fungal infections||translation_of
patellar resurfacing||patellar resurfacing||translation_of
hysterical neurosis, dissociative type||hysterical; fugue||translation_of
central nervous system complications of anesthesia or other sedation in labor and delivery, unspecified as to episode of care||cns compl labor/del-unsp||translation_of
cyst pancreas||pancreas cyst||translation_of
trigeminal neuralgia nos (disorder)||trigeminal neuralgia [no drugs here]||translation_of
acquired haemophilia with anti fviii, xi, or xiii||acquired hemophilia with anti fviii, xi, or xiii||translation_of
throat cancer nos||throat carcinoma||translation_of
cardiomyopathy; in chagas' disease, acute (etiology)||cardiomyopathy; in chagas' disease, acute (etiology)||translation_of
other complications of anesthesia or other sedation in labor and delivery, delivered||other complications of anesthesia or other sedation in labor and delivery, postpartum||translation_of
endothelial cell loss, corneal||corneal endothelial cell damage||translation_of
other nonspecific findings on examination of urine||other nonspecific findings on examination of urine||translation_of
45x0 - turner's syndrome||bonnevie-ullrich syndrome||translation_of
skin pressure mark||skin pressure mark||translation_of
aortic intramural hematoma||aortic intramural hematoma||translation_of
infestation by sarcoptes scabiei||infestation; scabies||translation_of
pubiotomy to assist delivery||pubiotomy to assist del||translation_of
urethral carcinoma||cancer, urethral||translation_of
high grade dysplasia in barrett's esophagus||barrett's oesophagus high grade dysplasia||translation_of
immune-mediated arthritis||immune-mediated arthritis (disorder)||translation_of
renal structural abnormalities and trauma||renal structural abnormalities and trauma||translation_of
vesicocutaneous fistula (diagnosis)||vesicocutaneous fistula (diagnosis)||translation_of
fibroid; pneumonia||fibroid; pneumonia||translation_of
sokolow-lyon index positive||sokolow-lyon index positive||translation_of
exons, vdj||v(d)j exons||translation_of
congenital anomaly nos (disorder)||congenital; deformity||translation_of
adenovirus serology test positive||adenovirus serology test positive||translation_of
benign pinealoma||pineocytomas||translation_of
vestibular nerve damage||vestibular nerve damage||translation_of
prothrombin level abnormal nos||coagulation factor ii level abnormal nos||translation_of
wine (substance)||wine||translation_of
arm paresis||weakness arm||translation_of
rochon-duvigneaud syndrome||orbital apex-sphenoid syndrome||translation_of
adrenocortical overactivity||disorder of corticoadrenal overactivity (disorder)||translation_of
gray goose||gooses||translation_of
hiv vpr gene product||vpr gene products, human immunodeficiency virus||translation_of
breath odor nec||breath odour nec||translation_of
stage 0 carcinoma of extrahepatic bile duct||extrahepatic bile duct cancer stage 0||translation_of
flatus increased||flatus excessive||translation_of
human antichimeric antibody positive||human antichimeric antibody positive||translation_of
kyphosis nec||other kyphosis (acquired)||translation_of
open fracture of metacarpal bone(s)||open fracture of metacarpal bone, nos||translation_of
increased diastolic arterial pulse pressure||high diastolic arterial||translation_of
sensory; loss||lack of sensation||translation_of
traumatic lumbar puncture||traumatic lumbar puncture||translation_of
sterilisation reversal||reversal of sterilization||translation_of
edema of thigh (finding)||thigh edema||translation_of
elevated cpk||increased creatine kinase||translation_of
uvula, cleft||cleft uvula||translation_of
uterine adnexitis||adnexitis||translation_of
hereditary sensory neuropathy (diagnosis)||neuropathy, hereditary sensory||translation_of
abnormal hemoglobin||abnormal haemoglobin||translation_of
optic disc disorders||optic disk disorder||translation_of
cleft lip, cleft palate||cleft lip palate||translation_of
test;liver function||liver function tests (procedure)||translation_of
electrocardiogram pr segment depression||electrocardiogram pr segment depression||translation_of
stereotactic needle biopsy of breast||stereotactic needle biopsy of breast||translation_of
ketotifen||ketotifen [eye]||translation_of
human leucocyte antigen||hla factors||translation_of
furuncle of skin and subcutaneous tissue, nos||boil||translation_of
colobus monkey||colobus monkeys||translation_of
iron black||c.i. 77499||translation_of
abnormal eosinophil count||abnormal eosinophil count||translation_of
overgrowth filiform papillae||overgrowth of filiform papillae||translation_of
mucosal induration||mucosal induration||translation_of
hypergammaglobulinaemia||hypergammaglobulinemia (finding)||translation_of
neurotic depressions||depression neurotic||translation_of
acute rheumatic endocarditis||acute rheumatic endocard||translation_of
product colour leaching||product color leaching||translation_of
endosseous implant into jaw||endodontic endosseous implant therapy||translation_of
multiple joint disorder||polyarticular; arthrosis||translation_of
acute distention of stomach||acute gastric dilation||translation_of
right ventricular failures||right sided heart failure||translation_of
choroidal effusion (disorder)||choroidal effusions||translation_of
lcp||osteochondrosis of the femoral head||translation_of
migrainosus; status||status migranosus||translation_of
anorexia post chemotherapy||anorexia post chemotherapy||translation_of
postcolectomy panenteritis||postcolectomy panenteritis||translation_of
tuberculosis of other specified organs, confirmed histologically||tuberculosis of other specified organs, confirmed histologically||translation_of
shortened p-r interval||electrocardiographic short pr interval||translation_of
nucleic acid amplification tests||nucleic acid amplification, nos||translation_of
joint; paralytic contracture||joint; paralytic contracture||translation_of
placental cyst||placental cyst||translation_of
hand, foot, and mouth disease||(hand, foot & mouth disease) or (vesicular stomatitis with xanthem) (disorder)||translation_of
muscle induration||muscle induration||translation_of
existentialism||existentialism||translation_of
eyelid; eczema||eyelid eczema||translation_of
prostatitis; trichomonas (manifestation)||trichomonas; prostatitis (etiology)||translation_of
serum hepatitis b e antigen test (lab test)||hbeag measurement||translation_of
fibrinogen; deficiency, acquired||acquired fibrinogen deficiency||translation_of
endometrial hypoplasia||hypoplasia of endometrium (disorder)||translation_of
anancastic personality disord||obsessional personality (& disorder)||translation_of
syphilis; cerebrovascular (etiology)||syphilis; cerebrovascular (manifestation)||translation_of
light chain analysis increased||light chain analysis increased||translation_of
ttp (thrombotic thrombocytopenic purpura)||ttp - thrombotic thrombocytopenic purpura||translation_of
accidental drug intake by child||accidental drug intake by child||translation_of
polyalthia blume, 1830||polyalthia||translation_of
conjunctiva biopsy||biopsy conjunctiva||translation_of
ancient lands||ancient lands||translation_of
t-zone lymphoma (kiel classification) stage iii||t-zone lymphoma (kiel classification) stage iii||translation_of
family; isolation||isolation; social||translation_of
ventricular fibrillation paroxysm||ventricular fibrillation||translation_of
circulating anticoagulants test||circulating anticoagulant assay, nos||translation_of
enterovirus serology test negative||enterovirus serology test negative||translation_of
hg element||quicksilver||translation_of
kidney cancer stage i||kidney carcinoma stage i||translation_of
fatal attempts||fatal attempts||translation_of
blood glucagon abnormal nos||blood glucagon abnormal||translation_of
mature b-cell type acute leukemia||mature b-cell type acute leukemia||translation_of
hodgkin's paragranuloma of intrathoracic lymph nodes||hodgkins paragran thorax||translation_of
reticulocyte counts||count reticulocyte||translation_of
burn nos genitalia||burn of unspecified degree of genitalia||translation_of
tppase||phosphohydrolase, thiamine pyrophosphate||translation_of
bladder disorders nec||bladder disorders nec||translation_of
oth closed skull frac with oth and unspec intcran hem, with loc of unspec duration||other closed skull fracture with other and unspecified intracranial hemorrhage, with loss of consciousness of unspecified duration||translation_of
degenerative disorder of globe||degenerative globe disorder nos||translation_of
hyperthymic state||hyperthymic state||translation_of
stage i large cell carcinoma of lung||stage i large cell carcinoma of the lung||translation_of
cd201 antigen||receptor, protein c||translation_of
b-immunoblastic lymphoma (kiel classification) refractory||b-immunoblastic lymphoma (kiel classification) refractory||translation_of
legal abort w embol-unsp||legal abortion complicated by embolism||translation_of
pneumothorax disorder||pneumothorax (diagnosis)||translation_of
neurotripsy (procedure)||nerve crushed (situation)||translation_of
other, multiple, and ill-defined dislocations||other, multiple, and ill-defined dislocations||translation_of
cyclic-nucleotide gated ion channels||gated channel, cyclic-nucleotide||translation_of
depression rating scale score increased||depression rating scale score increased||translation_of
bronchial secretion retention||bronchial secretion retention||translation_of
en - erythema nodosum||erythema nodosum (disorder)||translation_of
pulsus intercidens||pulsus intercidens||translation_of
tibc - total iron binding capacity low (finding)||tibc decreased||translation_of
increased diastolic arterial pressure (finding)||dbp increased||translation_of
galectin-3 increased||galectin-3 increased||translation_of
tuberculosis; eustachian tube (manifestation)||tuberculosis; eustachian tube (etiology)||translation_of
administration site erosion||administration site erosion||translation_of
deformity; foot||foot deformity nos||translation_of
urine barbiturates||urine barbiturate measurement (procedure)||translation_of
iridoplasty||iridoplasty||translation_of
arsenic in serum||arsenic in serum||translation_of
selective provider restrictions||restriction, selective provider||translation_of
leukemia, acute erythroblastic||m6b||translation_of
paediatric early warning score increased||pediatric early warning score increased||translation_of
trim bone||trim bone||translation_of
bile reflux gastritis||gastritis bile-induced||translation_of
cyst tonsil||tonsillar cyst||translation_of
post-traumatic brain stem hemorrhage||post-traumatic brainstem hemorrhage||translation_of
eyelash injury||eyelash injury||translation_of
tooth pulp bleeding||tooth pulp bleeding||translation_of
spirillum minor rat-bite fever||rat-bite spirillary fever||translation_of
cartilage biopsy||biopsy of cartilage||translation_of
erythropenia (finding)||oligocytosis of red blood cells||translation_of
pseudohypoglycemia||pseudohypoglycemia||translation_of
anti factor x activity normal||anti factor x activity normal||translation_of
atresia of vagina (physical finding)||congenital absence of the vagina||translation_of
pyogenic infection||infection pyogenic||translation_of
ear, nose, or throat photon radiation therapy||ear, nose, or throat photon radiation therapy||translation_of
paradoxical diarrhoea||paradoxical diarrhoea||translation_of
collagen, type x||type x collagen||translation_of
nail growth abnormal||nail growth abnormal||translation_of
delinquency||delinquency||translation_of
cervix uteri cancer stage iv||carcinoma uterine cerix stage iv||translation_of
bacillus amylovorus||bacterium amylovorus||translation_of
viral titer increased||viral titer increased||translation_of
bact arthritis-mult||arthropathy associated with other bacterial diseases, multiple sites||translation_of
strumectomy||strumectomy||translation_of
gastric ulcer reactivation||ulcer stomach reactivated||translation_of
ribeta, camp protein kinase||ri beta, camp protein kinase||translation_of
transmission of an infectious agent via a medicinal product||transmission of an infectious agent via a medicinal product||translation_of
surgical removal of the breast||mastectomy (treatment)||translation_of
stage i laryngeal cancer||larynx neoplasm malignant stage i||translation_of
amppnp||adenosine 5'-(beta,gamma-imino)triphosphate||translation_of
drainage of abscess of pinna (procedure)||drainage of abscess in external ear (treatment)||translation_of
nutcracker syndrome||nutcracker syndrome||translation_of
animal; phobia||phobia animal||translation_of
gastrointestinal motility disorder nos||gastrointestinal motility disorder||translation_of
primate lentivirus serogroup||immunodeficiency viruses, primate||translation_of
plasma zinc increased||plasma zinc increased||translation_of
subcapsular hepatic haematoma||hepatic subcapsular hematoma||translation_of
paralogism||paralogism||translation_of
total protein low||protein total decreased||translation_of
chondronecrosis||chondronecrosis||translation_of
bacteroides infections||bacteroides; infection||translation_of
device leakage||device leakage||translation_of
diarrhoea symptom||d - diarrhoea||translation_of
systolic dysfunction||systolic dysfunction||translation_of
total blood loss||total blood loss||translation_of
episiotomy, nos||episiotomy, nos||translation_of
psychosexual dysfunc nec||psychosexual dysfunction with other specified psychosexual dysfunctions||translation_of
blood folate increased||blood folate increased||translation_of
blood ph decreased||blood ph decreased||translation_of
bladder hyperemia||hyperemia of bladder||translation_of
t-b cell activating molecule||tnf-related activation protein||translation_of
pulmonary venous hypertension||pulmonary venous hypertension||translation_of
excessive dietary intake of fiber (finding)||excessive dietary intake of fibre||translation_of
labral tear, glenoid||glenoid labral tear||translation_of
spinal cord; abscess, tuberculous (manifestation)||spinal cord; abscess, tuberculous (etiology)||translation_of
tubulovillous adenoma of the colon||colonic tubulovillous adenoma||translation_of
anomaly; narrowing eyelid||narrowing eyelid; anomaly||translation_of
uric acid measurement, urine (procedure)||urine uric acid measurement||translation_of
closed dislocation of radioulnar joint, distal||closed dislocation of distal radioulnar joint (diagnosis)||translation_of
urine albumin/creatinine ratio normal||urine albumin/creatinine ratio normal||translation_of
bacterial otitis media (disorder)||otitis media bacterial||translation_of
behaviour therapy||conditioning ther||translation_of
wound drainage||drainage wound||translation_of
administration site cyst||administration site cyst||translation_of
parvovirus b19 serology||parvovirus b19 serology||translation_of
primary biliary cholangitis (disorder)||biliary cirrhosis pbc primary||translation_of
product formulation issue||product formulation issue||translation_of
abortifacient agents, nonsteroidal||abortifacient agents, non-steroidal||translation_of
angioma capillare et venosum calcificans||parkes weber syndrome (disorder)||translation_of
descemet's detachment||detachment of descemet membrane||translation_of
injury to lumbar nerve root||injury of lumbar nerve root (disorder)||translation_of
rectosigmoid cancer stage iv||rectosigmoid cancer stage iv||translation_of
hodgkin's disease, nos of lymph nodes of multiple sites||hodgkin's disease, unspecified type, involving lymph nodes of multiple sites||translation_of
neuroscience nursing||neurological nursing||translation_of
idiopathic hypertension||eht||translation_of
acute polyradiculoneuritis||acute polyradiculoneuritis||translation_of
hygienists dent||hygienist, dental||translation_of
non-mechanical ileus||ileus of intestine||translation_of
poliosis||poliosis||translation_of
labeled drug-disease interaction issue||labelled drug-disease interaction issue||translation_of
virus antibody test nos||virus antibody test nos||translation_of
hemorrhagic stomatitis||hemorrhagic stomatitis (disorder)||translation_of
foetal tobacco exposure||fetal tobacco exposure||translation_of
subclavian artery dissection||subclavian artery dissection||translation_of
neoplasm prophylaxis||neoplasm prophylaxis||translation_of
struma; ovarii||struma ovarii||translation_of
proximal focal femoral deficiency||proximal focal femoral deficiency||translation_of
brugada-type electrocardiogram||brugada-type ecg||translation_of
spermatic cord stenosis||spermatic cord stenosis||translation_of
moderate bleeding - gusto classification||moderate bleeding - gusto classification||translation_of
muscle disorder||skeletal muscle disorder||translation_of
anti-voltage-gated potassium channel antibody positive||anti-vgkc antibody positive||translation_of
gum erosion||erosion of gingiva||translation_of
hypertrophy of the pulmonary artery wall||hypertrophy of the pulmonary artery wall||translation_of
h hepatitis||h hepatitis||translation_of
normal lipase||normal lipase||translation_of
pulm embol nos-postpart||obstetrical blood-clot embolism, postpartum condition or complication||translation_of
instillation site atrophy||instillation site atrophy||translation_of
blood loss anemia (disorder)||anemia; hemorrhage||translation_of
fungal retinitis||fungal retinitis||translation_of
maternal; disease, affecting fetus||maternal disorder nos affecting foetus||translation_of
ecostigmine iodide||echothiophate iodide (substance)||translation_of
decreased gag reflex||retching reflex decreased||translation_of
blood heavy metal nos normal||blood heavy metal nos normal||translation_of
non-24-hour sleep-wake disorder||non 24 hour sleep wake disorder||translation_of
red neck syndrome||red neck syndrome||translation_of
sickle cell anemia crisis||sickle-cell crisis nos||translation_of
dislocation; sternum||dislocated sternum||translation_of
depression;psychotic||depression psychotic||translation_of
renal graft infection||renal graft infection||translation_of
congenital anomaly of eye||congenital anolmaly of eye||translation_of
cauterization - action||cauterisation - action (qualifier value)||translation_of
lower airway obstruction||lower airway obstruction||translation_of
dermatitis; hiemalis||dermatitis; hiemalis||translation_of
glucose urine false positive test||glucosuria false positive||translation_of
radioactive air pollution||pollution, radioactive air||translation_of
antinuclear factor abnormal||antinuclear factor abnormal||translation_of
carotid artery diseases||disorder of carotid artery (disorder)||translation_of
cerebral softening||encephalomalacia||translation_of
quadrantanopsia (physical finding)||quandrantanopia||translation_of
shallow anterior chamber of eye||shallow anterior chamber eye||translation_of
larynx operations||operative procedures on the larynx||translation_of
bicarbonate blood||bicarbonate in blood||translation_of
hospital military||military hosp||translation_of
unattended death, nos||[d]unattended death nos (situation)||translation_of
decreased hemoglobin||haemoglobin low||translation_of
acquired c1 inhibitor deficiency||acquired c1 inhibitor deficiency||translation_of
induced cardioplegia||induced cardioplegia (procedure)||translation_of
anal biopsy normal||biopsy anus normal||translation_of
trifunctional enzyme deficienc||trifunctional enzyme deficienc||translation_of
operation on pleural cavity, nos||operation on pleural cavity, nos||translation_of
radiation injury nos affecting foetus||radiation injury nos affecting foetus||translation_of
anti-ganglioside antibody negative||anti-ganglioside antibody negative||translation_of
urobilin urine||urobilin urine||translation_of
colon, irritable||mucous colitides||translation_of
audiogram normal (finding)||audiogram normal||translation_of
injury of uterine vein||injury; uterine vein||translation_of
collagen cross-linked n-telopeptide urine normal||n-telopeptide urine normal||translation_of
chemotherapy cytokine prophylaxsis||chemotherapy cytokine prophylaxis||translation_of
mc2 receptor||melanocortin-2 receptor||translation_of
social role||roles social||translation_of
neurotic disorder||neurotic; disorder||translation_of
product impurity||product impurity||translation_of
glycopeptide antibiotic resistant staphylococcus aureus infection||glycopeptide antibiotic resistant staphylococcus aureus infection||translation_of
disease, bone marrow||disease, bone marrow||translation_of
obstruction; bladder-neck||bladder outlet obstruction (disorder)||translation_of
hyperinsulinaemia||hyperinsulinism (diagnosis)||translation_of
spleen abscess||splenic abscess (diagnosis)||translation_of
decreased heart rate variability||reduced heart rate variability||translation_of
dementia nos aggravated||dementia aggravated||translation_of
sputum; abnormal||abnormality; sputum||translation_of
diarrhoea;spurious||diarrhoea;spurious||translation_of
rupture of the diaphragm||rupture of diaphragm (disorder)||translation_of
other specified mononeuritis of lower limb||other specified mononeuritis of lower limb||translation_of
hair aluminum normal||hair aluminium normal||translation_of
vulgare lectin, triticum||wheat germ agglutinin||translation_of
benign bone tumours||benign bone tumors||translation_of
avascular necrosis secondary to diving||osteonecrosis in caisson disease (diagnosis)||translation_of
teleworking||remote working||translation_of
unspecified mastoiditis, unspecified ear||mastoiditis, unspecified||translation_of
operation on pleural cavity||pleural procedure||translation_of
eyeball atrophic||eyeball; phthisis||translation_of
epley procedure||canalith repositioning procedure||translation_of
transfusion-related alloimmune neutropenia||transfusion-related alloimmune neutropenia||translation_of
autoimmune lung disease||autoimmune lung disease||translation_of
adrenal gland calcification||adrenal gland calcification||translation_of
ganglioneuroblastoma, malignant||ganglioneuroblastoma (morphologic abnormality)||translation_of
therapeutic procedures on the esophagus||therapeutic procedures on the esophagus||translation_of
neutralizing antibodies positive||neutralising antibodies positive||translation_of
liver sequestration||hepatic sequestration||translation_of
fear of falling (finding)||falls fear||translation_of
colostomy infection (diagnosis)||colostomy infection (diagnosis)||translation_of
paran schizo-chr/exacerb||paran schizo-chr/exacerb||translation_of
plasma copper abnormal||plasma copper abnormal||translation_of
fibroadenosis of breast (disorder)||fibroadenosis; breast||translation_of
blood urine present||blood urine present||translation_of
carnitine normal||carnitine normal||translation_of
root canal, not otherwise specified||root canal ther||translation_of
affective psychosis nos||unspecif.affective psych.nos||translation_of
pial synangiosis (procedure)||pial synangiosis||translation_of
abrasion of hard tooth tissue||abrasion of hard tooth tissue||translation_of
microtechnology||microfabrication||translation_of
cockroachs, german||blattellidae||translation_of
intes infec astrovirus||astrovirus enteritis||translation_of
myocardial dysfunction||dysfunction; heart||translation_of
electricity static||static electricity (physical force)||translation_of
endoribonuclease (substance)||endoribonuclease||translation_of
posterior tibial tendon dysfunction||tibial tendon dysfunction, posterior||translation_of
deformity; choroid, plexus, congenital||deformity; choroid, plexus, congenital||translation_of
mauriac's syndrome||diabetes-dwarfism-obesity syndrome||translation_of
stage iii bladder adenocarcinoma||stage iii bladder adenocarcinoma ajcc v7||translation_of
pancreatitis fungal||pancreatitis fungal||translation_of
anestrus (finding)||anoestrus||translation_of
genetic replication (finding)||genetic replication||translation_of
erythrocyte sedimentation rate (esr) low||red blood cell sedimentation rate decreased||translation_of
stomach ulcer/hemorrhage + perforation||unspec. gu + h'ge + perforat.||translation_of
bisphosphonate-associated osteonecrosis of the jaw||bisphosphonate-induced osteonecrosis of the jaw||translation_of
inappropriate device therapy for atrial arrhythmia||inappropriate device therapy for atrial arrhythmia||translation_of
nerve disease, sciatic||n.ischiadicus; neuropathic||translation_of
eyes irritation||irritation of eyes||translation_of
cerebrovascular spasm||cerebral angiospasms||translation_of
mucinous endometrial carcinoma||mucinous endometrial carcinoma||translation_of
blood arsenic increased||blood arsenic increased||translation_of
squamous intraepithelial lesions of the cervix||squamous intraepithelial lesions of the cervix||translation_of
diffuse panbronchiolitis||diffuse panbronchiolitis (diagnosis)||translation_of
mucosal pigmentation||mucosal pigmentation||translation_of
intradermal test negative||skin test nos negative||translation_of
gonorrhea of pharynx||gonorrhea of pharynx||translation_of
appetite decrease||decrease appetite||translation_of
shoulder dislocation reduction||reduction of dislocated shoulder||translation_of
segregation, chromosome||segregation, chromosome||translation_of
sham seizures||pseudoseizures||translation_of
blood immunoglobulin a decreased||blood immunoglobulin a decreased||translation_of
change in sustained attention||change in sustained attention||translation_of
ocular infections, bacterial||bacterial eye infection (disorder)||translation_of
gastroesophageal junction ulcer||gastrooesophageal junction ulcer||translation_of
schirmer tear test||schirmer tear test||translation_of
nasal septum haematoma||nasal septum haematoma||translation_of
total serum bilirubin level||serum total bilirubin measurement (lab test)||translation_of
intracardiac pressure increased||intracardiac pressure increased||translation_of
venous thrombosis (disorder)||venous thrombosis, nos||translation_of
adenocarcinoma of the vagina||adenocarcinoma of vagina||translation_of
non-metastatic alveolar soft part sarcoma||non-metastatic alveolar soft part sarcoma||translation_of
photon radiation therapy to uterus||uterus photon radiation therapy||translation_of
poisoning by hypnotic||poisoning by hypnotic||translation_of
dyserythropoietic anemia, and neutrophilic dermatosis||majeed's syndrome||translation_of
ear anomalies with hearing impaired, unspecified (disorder)||congenital deformity of ear causing impairment of hearing||translation_of
other and unspecified arthropathies||other and unspecified disorders of joint||translation_of
late effect of other and unspecified injuries||late effect of other and unspecified injuries (disorder)||translation_of
interleukin-4 therapy||interleukin-4 therapy||translation_of
intermediate density lipoprotein increased||intermediate density lipoprotein increased||translation_of
malignant renal hypertension||malignant renal hypertension||translation_of
mental status changes postoperative||mental status changes postoperative||translation_of
salivary gland biopsy normal||biopsy salivary gland normal||translation_of
logorrhoea||logorrhea||translation_of
delusion associated with abnormal perception||delusion associated with abnormal perception (disorder)||translation_of
opioid dependence-remiss||opioid type dependence, in remission||translation_of
medullary carcinoma of breast stage ii||medullary carcinoma of breast stage ii||translation_of
acute radiation disease (disorder)||radiation syndromes, acute||translation_of
gynecological examination normal (finding)||gynecological examination normal||translation_of
splenic artery embolisation||splenic artery embolisation||translation_of
unspecified type delusional disorder||delusional disorder, unspecified type||translation_of
myocardial necrosis marker decreased||myocardial necrosis marker decreased||translation_of
swollen gum||swollen gums (finding)||translation_of
sickle-cell thalassemia nos||thalassemia sickle cell||translation_of
contact lens wearer||contact lens wearer||translation_of
epididymo-orchitis||epididymo-orchitis nos (disorder)||translation_of
corneal macula not interfering with central vision||peripheral opacity of cornea||translation_of
perihepatic fluid collection||perihepatic fluid collection||translation_of
fibrin d dimer high||fibrin d dimer high||translation_of
infection, bacteroides||infection caused by bacteroides||translation_of
prostanoic acids||prostanoic acid||translation_of
neurotensinoma||neurotensinoma||translation_of
cystoprostatectomy (procedure)||cystoprostatectomy (procedure)||translation_of
peptic ulcer (disorder)||peptic ulcer - (pu) site unsp.||translation_of
simons' disease||progressive lipodystrophy||translation_of
cyst;breast;f||breast cyst||translation_of
aspergillosis oral||aspergillosis oral||translation_of
delayed; delivery, following spontaneous rupture of membranes, affecting fetus||delayed; delivery, following spontaneous rupture of membranes, affecting fetus||translation_of
infected corn||infected corn||translation_of
staphylococcus epidermidis septicaemia||staphylococcus epidermidis septicemia||translation_of
zuclomiphene||zuclomiphene||translation_of
limb reconstructive surgery||limb reconstructive surgery||translation_of
enuresis aggravated||enuresis aggravated||translation_of
throat irritation (finding)||itching throat||translation_of
aldolase abnormal||aldolase abnormal||translation_of
hyper hdl cholesterolaemia||hyper hdl cholesterolaemia||translation_of
occupational bursitis||specific bursitis often of occupational origin (disorder)||translation_of
finger nail removal||finger nail removal||translation_of
multiple lipomas, familial||familial multiple lipomata (disorder)||translation_of
stenotrophomonas maltophilia test positive||stenotrophomonas maltophilia test positive||translation_of
queensland fever||[x]leptospirosis, unspecified||translation_of
socioeconomic factor||factor, socioeconomic||translation_of
nodule; rheumatoid||subcutaneous rheumatoid nodules||translation_of
residual function low||residual function decreased||translation_of
libman-sacks; endocarditis (manifestation)||atypical verrucous endocarditis||translation_of
csf lymphocyte count increased||lymphocyte count csf increased||translation_of
crocodile tear syndrome||paroxysmal lacrimation||translation_of
foraminifera||forams||translation_of
missed withdrawal bleeding (finding)||withdrawal bleeding missed||translation_of
anticardiolipin antibody level test||anticardiolipin antibody measurement (procedure)||translation_of
incorrect product formulation administered||incorrect product formulation administered||translation_of
expiratory reserve volume normal||expiratory reserve volume normal||translation_of
herniated tissue||unspecified hernia (disorder)||translation_of
blood elevate pressure||pressure arterial increased||translation_of
ulorrhagia||ulorrhagia||translation_of
penile hyperaesthesia||penile hyperaesthesia||translation_of
acute pulmonary histoplasmosis||ac pulm classic histoplasmosis||translation_of
pericardial mass||pericardial mass||translation_of
interdisciplinary placements||placements, interdisciplinary||translation_of
musculoskeletal and connective tissue pain and discomfort||musculoskeletal and connective tissue pain and discomfort||translation_of
mineral supplement therapy (treatment)||mineral supplementation||translation_of
perinatal stroke||perinatal stroke||translation_of
spider veins of mucous membrane of nose||angioectasia of mucosa of nose||translation_of
virologic failure||virologic failure||translation_of
immunisation anxiety related reaction||immunization anxiety related reaction||translation_of
unilateral femoral hernia nos||unilateral femoral hernia||translation_of
aids-related anal cancer stage i||aids-related anal cancer stage i||translation_of
illiteracy (finding)||illiteracy||translation_of
dissatisfactions, body image||body dissatisfaction||translation_of
diverticuloma||diverticuloma||translation_of
spermatogenesis arrest (finding)||spermatogenesis; arrest||translation_of
breakthrough haemolysis||breakthrough hemolysis||translation_of
syndesmophytes||syndesmophytes||translation_of
choroidal haematoma||choroidal hematoma||translation_of
tuberculosis; balanitis (etiology)||tuberculosis; balanitis (manifestation)||translation_of
infection; knee, tuberculous (joint) (manifestation)||infection; knee, tuberculous (joint) (etiology)||translation_of
specialization||specialization||translation_of
immunocytoma (extranodal marginal zone low grade b-cell lymphoma of malt type) stage iv||immunocytoma (extranodal marginal zone low grade b-cell lymphoma of malt type) stage iv||translation_of
sarcoma of pancreas (diagnosis)||pancreatic sarcoma||translation_of
leukaemic reticuloendotheliosis of lymph nodes of axilla and upper limb||leukemic reticuloendotheliosis of lymph nodes of axilla and upper limb||translation_of
inflammation of inner ear (disorder)||inner ear inflammation||translation_of
coagulation factor assay, nos||coag pathway factor assay||translation_of
malignant neoplasm of larynx, nos||larynx--cancer||translation_of
ulcer of tongue, nos||tongue ulcers||translation_of
qsart||qsart||translation_of
immunoenzyme technic||technic, immunoenzyme||translation_of
heavy frequent periods||excessive or frequent menstruation||translation_of
ceramidase, glucosyl||beta-glucosidase, acid||translation_of
fat redistribution||fat redistribution||translation_of
fallopian tube; stricture, gonococcal (manifestation)||stricture; fallopian tube, gonococcal (etiology)||translation_of
gonadal dysgenesis, xx type||ovarian failure, hypergonadotropic||translation_of
haemorrhagic fever due to junin virus||north-east buenos aires hemorrhagic viremia||translation_of
increased venous pressure||increased; venous pressure||translation_of
pigmentation of colon mucosa||pigmentation of colon mucosa||translation_of
biopsy pancreas normal||biopsy pancreas normal||translation_of
nevus (disorder)||mole, skin||translation_of
pressure sensation||baresthesia, function (observable entity)||translation_of
slipped capital femoral epiphyses||slipped femoral capital epiphysis||translation_of
blood calcitonin normal||blood calcitonin normal||translation_of
oxidoreductase process||redox||translation_of
allergy peanuts||allergy, peanut||translation_of
biopsy of tonsil (procedure)||biopsy of tonsil||translation_of
prevention of endometrial hyperplasia||prevention of endometrial hyperplasia||translation_of
liquid product consistency issue||liquid product consistency issue||translation_of
ethanol gelation test positive||ethanol gelation test positive||translation_of
oral thermometry||oral thermometry||translation_of
transient-type calcium channels||calcium channels, transient-type||translation_of
antiplatyhelmintic agent||agents, antiplatyhelmintic||translation_of
anorectal manometry (procedure)||anorectal manometry||translation_of
normal pregnancy+deliv.||delivery: [normal in a completely normal case] or [spontaneous vaginal]||translation_of
pericardial excision||pericardectomies||translation_of
hypophosphataemic osteomalacia||hypophosphataemic osteomalacia||translation_of
neonatal hemorrhage, nos||neonatal bleeding||translation_of
diffuse small cleaved cell lymphoma (intestinal t-cell lymphoma) (working formulation) recurrent||diffuse small cleaved cell lymphoma (intestinal t-cell lymphoma) (working formulation) recurrent||translation_of
ligament pain||ligament pain||translation_of
encephalitis toxic acute||encephalitis toxic acute||translation_of
idh differentiation syndrome||idh differentiation syndrome||translation_of
skin replaced by transplant||encounter due to skin transplant status||translation_of
gm2 gangliosidosis||gm2 gangliosidosis (disorder)||translation_of
keratectomy (procedure)||excision procedures on the cornea||translation_of
diverticulitis of colon with haemorrhage||dvrtcli colon w hmrhg||translation_of
negative schumm test||negative schumm's test||translation_of
caspase blockers||caspase blockers||translation_of
deoxyribonucleosides||deoxyribonucleosides||translation_of
immunodeficiency secondary to chemotherapy (diagnosis)||immunodeficiency secondary to chemotherapy (diagnosis)||translation_of
oesophagus ulcer||ulcer of esophagus, nos||translation_of
diabetes; unstable||diabetes; unstable||translation_of
coagulation factor xiii level||coagulation factor xiii level||translation_of
cornea globular||congenital megalocornea||translation_of
urticaria vesiculosa||bullous urticaria||translation_of
theas||camellia (organism)||translation_of
hypoglossal nerve paralysis||hypoglossal nerve paralysis||translation_of
kaliuresis||kaluresis||translation_of
throat infection - tonsillitis||tonsillar inflammation||translation_of
arthritis sle||arthritis sle||translation_of
dd||dd - diastrophic dysplasia||translation_of
tourettism||tourettism||translation_of
bannworth's syndrome||nervous system lyme borreliosis||translation_of
anus disorder||anus diseases||translation_of
clinical trials data monitoring committees||safety monitoring boards||translation_of
tourette's syndrome aggravated||tourette's syndrome aggravated||translation_of
other deficiency anemias nos (disorder)||other deficiency anemias nos (disorder)||translation_of
ann arbor stage iv follicular lymphoma||follicle center lymphoma, follicular grade i, ii, iii stage iv||translation_of
toxic pulmonary arterial hypertension||toxic pulmonary arterial hypertension||translation_of
device false alarm issue||device false alarm issue||translation_of
hydremia||overhydration||translation_of
atrial myxoma right||myxoma of the right atrium||translation_of
toxic leucocyte granulations||toxic neutrophilic granulations||translation_of
2,3-bisphosphate, glycerate||2, 3 diphosphoglycerate (substance)||translation_of
cancer of penis||malig neo penis nos||translation_of
chemical actions and uses||chemical actions and uses||translation_of
misleading laboratory test result||misleading laboratory test result||translation_of
computerised tomogram head abnormal||computerised tomogram head abnormal||translation_of
myringitis; acute||tympanitis; acute||translation_of
kidneys; triple||kidneys; triple||translation_of
fecal calprotectin abnormal||faecal calprotectin abnormal||translation_of
pulmonary complications of anasthesia or other sedation in labor and delivery||pulmonary complications of anasthesia or other sedation in labor and delivery||translation_of
sanitation||sanitation||translation_of
agent anxiolytic||anti-agents||translation_of
contact lens discolouration||contact lens discoloration||translation_of
other spcfd disorders/penis||other spcfd disorders/penis||translation_of
dcc gene||igdcc1||translation_of
female haematocele||female hematocele||translation_of
device position test||device position test||translation_of
metabolic bone disorders||bone metabolism disorder||translation_of
csf wbc positive||csf white blood cell count positive||translation_of
application site discomfort||application site discomfort||translation_of
research, biomedical||research biomed||translation_of
irreducible hernia||hernia incarcerated||translation_of
other spec infect and parasit diseases of mother, with delivery, with ment of postpart comp||other spec infect and parasit diseases of mother, with delivery, with ment of postpart comp||translation_of
icsh||lh - luteinising hormone||translation_of
open wound of buttock without complication (disorder)||open wound of buttock, uncomplicated||translation_of
urometry||urometry||translation_of
renal cyst haemorrhage||renal cyst bleeding||translation_of
atrophy; macular, syphilitic, skin, striated (manifestation)||atrophy; macular, syphilitic, skin, striated (manifestation)||translation_of
cytoplasmic streaming||cytoplasmic streamings||translation_of
lid retraction &/or lag (disorder)||lid retraction or lag||translation_of
tympanosclerosis involving tympanic membrane only||tympanoscl-tympanic memb||translation_of
perimenopausal symptoms||perimenopausal symptoms||translation_of
plasminogen activator inhibitor increased||plasminogen activator inhibitor increased||translation_of
injury; nerve, multiple regions, hand||injury; nerve, multiple regions, hand||translation_of
hgh, increased||growth hormone increased||translation_of
tension pneumocephalus||tension pneumocephalus||translation_of
[x]person injured in collision between car and heavy transport vehicle (traffic) (event)||person injured in collision between car and heavy transport vehicle, traffic||translation_of
aminoacidurias, renal||aminoacidurias, renal||translation_of
inflam spondylopathy nos||spondylitis, nos||translation_of
neoplasm of the hair follicle||hair matrix neoplasm||translation_of
cmv esophagitis recurrent||cmv oesophagitis recurrent||translation_of
actaea l., 1753||bugbanes||translation_of
serum potassium normal||serum potassium normal||translation_of
nk cell lectin-like receptor subfamily d||nk cell lectin like receptor subfamily d||translation_of
fourth cranial nerve palsy||palsy;iv nerve||translation_of
cong skin pigment anomal||congenital pigmentary skin anomaly nos||translation_of
congenital ptosis, nos||congenital ptosis (diagnosis)||translation_of
serum magnesium decreased||decreased serum magnesium||translation_of
neuroendocrine carcinoma of the bladder||neuroendocrine carcinoma of the bladder||translation_of
segmental tracheal resection||segmental tracheal resection||translation_of
staphylococcal toxemia||staphylococcal toxemia||translation_of
septicaemia due to pseudomonas||pseudomonas septicemia (diagnosis)||translation_of
aorto-bronchial fistula||aorto-bronchial fistula||translation_of
sequestrum of bone||bone sequestration||translation_of
unstable diabetes||unstable diabetes (disorder)||translation_of
myoglobin blood absent||myoglobin blood absent||translation_of
sperm concentration zero||sperm concentration zero||translation_of
ischemic heart disease nos||ischemia, myocardial||translation_of
persistence of hemoglobin f||increased hemoglobin f||translation_of
cytokeratin 19 increased||cytokeratin 19 increased||translation_of
tietze||costal; chondritis, tietze||translation_of
renal hypoplasia, unspecified||kidney, hypoplasia||translation_of
mitral stenosis (diagnosis)||ms||translation_of
suture of wound, primary||suture of wound, primary||translation_of
keratomalacia (diagnosis)||keratomalacia (diagnosis)||translation_of
running (physical activity)||running (physical activity)||translation_of
inj||injury nos (disorder)||translation_of
oculopneumoplethysmogram abnormal||oculopneumoplethysmogram abnormal||translation_of
retinal pigment epithelial tear||retinal pigment epithelial tear||translation_of
purpura; senile||senile purpura (diagnosis)||translation_of
trimalleolar fractures||fractures, trimalleolar||translation_of
malignant tumor of vulva stage iii||malignant neoplasm of vulva stage iii (diagnosis)||translation_of
other basal ganglia degenerative diseases (disorder)||other basal ganglia degenerative diseases (disorder)||translation_of
urinary system hemorrhage||hemorrhage urinary tract||translation_of
embolic stroke of undetermined source||embolic stroke of undetermined source||translation_of
hld - hyperlipidaemia||lipidaemia||translation_of
delftia acidovorans infection||delftia acidovorans infection||translation_of
antinuclear antibody (ana) positive||ana present||translation_of
serotonin deficiency||serotonin deficiency||translation_of
bone hyperpigmentation||bone hyperpigmentation||translation_of
extragonadal primary seminoma (pure) stage i||extragonadal primary seminoma (pure) stage i||translation_of
x-ray therapy to bone||x-ray therapy to bone||translation_of
intrahepatic bile duct||intrahepatic bile duct, nos||translation_of
anal blister||anal blister||translation_of
retinal biopsy||biopsy of retina (procedure)||translation_of
pyruvate kinase increased||pyruvate kinase increased||translation_of
denosumab product||denosumab product||translation_of
cyclin g2||cyclin g2||translation_of
administration site wound||administration site wound||translation_of
progeria syndromes, hutchinson-gilford||progeria syndromes, hutchinson-gilford||translation_of
tms||transcranial magnetic stimulat||translation_of
skin-grafting||dermatoplasties||translation_of
erythroblast transforming gene a||erba gene||translation_of
enterovaginal; fistula||enterovaginal fistulas||translation_of
synchysis scintillans||cholesterolosis vitreous||translation_of
marinesco-radovici reflex||marinesco-radovici reflex||translation_of
atelectasis of newborn||pulmon collapse perin period||translation_of
arthropathy associated with other infectious and parasitic diseases, multiple sites||arthropathy associated with other infectious and parasitic diseases, multiple sites||translation_of
acid haemolysin test negative||acid hemolysin test negative||translation_of
breast capsulectomy||breast capsulectomy||translation_of
deep necrosis of underlying tissues due to deep third degree burn of elbow, with loss of elbow||deep necrosis of underlying tissues due to burn (deep third degree) of elbow, with loss of elbow||translation_of
myoma of prostate||prostatic myoma||translation_of
bacteroides nodosus (beveridge 1941) mraz 1963 (approved lists 1980)||organism k||translation_of
ocular structural change, deposit and degeneration nec||structural change, deposit and degeneration of eye nec||translation_of
cortex visual||visual area of cortex||translation_of
alpha-2 macroglobulin normal||alpha-2 macroglobulin normal||translation_of
diminazene||diminazene||translation_of
pseudospondylolisthesis||pseudospondylolisthesis||translation_of
tooth decay||dent decay||translation_of
anti-nmda antibody negative||anti-nmda antibody negative||translation_of
homozygous 2p21 deletion syndrome||homozygous 2p16 deletion syndrome, formerly||translation_of
corneal toxicity||corneal toxicity||translation_of
blood caffeine increased||blood caffeine increased||translation_of
right hemiplegia||right-sided hemiplegia||translation_of
transitional cell carcinoma of the bladder stage i with cancer in situ||transitional cell carcinoma of the bladder stage i with cancer in situ||translation_of
paradoxical urinary retention||paradoxical urinary retention||translation_of
infusion site discharge||infusion site discharge||translation_of
dilated veins||dilate veins||translation_of
disaccharidase deficiency||disaccharide; malabsorption||translation_of
personality unstable||personality unstable||translation_of
propionibacterium test positive||propionibacterium test positive||translation_of
anti-ss-a antibody positive||anti-ss-a antibody positive||translation_of
aorta; deformity||aorta; anomaly||translation_of
autoinflammatory diseases||autoinflammatory disease (diagnosis)||translation_of
carcinogenicity||carcinogenicity||translation_of
pyloric carcinoma stage iii||pyloric carcinoma stage iii||translation_of
salpingitis; tuberculous (etiology)||salpingitis; tuberculous (manifestation)||translation_of
yersinia sepsis||yersinia sepsis||translation_of
eye haemangioma||eye haemangioma||translation_of
shift work disorder||shift work disorder||translation_of
pyrodictiaceae burggraf et al. 1997||family pyrodictiaceae||translation_of
phosphorus isotopes||phosphorus--isotopes||translation_of
malignant tracheal tumor||malignant neoplasm of trachea nos||translation_of
cyst of periodontal tissue||cyst, dental root||translation_of
abdominal fat apron||abdominal fat apron||translation_of
unspecified chest pain||[d]chest pain, unspecified (situation)||translation_of
drug eruption erythroderma-like||drug eruption erythroderma-like||translation_of
tumors of body of uterus, unspecified as to episode of care or not applicable||uter tumor in preg-unsp||translation_of
carcinoma of eyelid||carcinoma of the eyelid||translation_of
canthoplasty (procedure)||repair of canthus||translation_of
hyperamylasemia||hyperamylasaemia||translation_of
coatomer protein||coatomer protein||translation_of
other specified leptospiral infection (disorder)||leptospiral infect nec||translation_of
full sleep study||sleep testing (procedure)||translation_of
blood citric acid increased||blood citric acid increased||translation_of
low cardiac output syndrome (disorder)||low cardiac output syndrome||translation_of
urine beryllium increased||urine beryllium increased||translation_of
induced labor||onset of labour induced||translation_of
renal haemangioma||renal haemangioma||translation_of
spleen ischemia||spleen ischemia||translation_of
nasal decongestion therapy||nasal decongestion therapy||translation_of
1-piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester||remifentanilo||translation_of
administration site plaque||administration site plaque||translation_of
extensive mastoid surgery||mastoidectomy; radical||translation_of
nucleic acids, immobilized||acids, immobilized nucleic||translation_of
[d]abnormal heart sounds nos (situation)||[d]abnormal heart sounds nos||translation_of
injections, intraventricular||intraventricular injections||translation_of
other lymphedema||other lymphedema (disorder)||translation_of
gastric variceal ligation (treatment)||gastric variceal ligation||translation_of
sylvestri, pinus||scotch pine||translation_of
benign neop. bronchus/lung nos||benign neoplasm bronchus/lung||translation_of
vortex keratopathy||cornea verticillata (disorder)||translation_of
arteriovenous graft site infection||arteriovenous graft site infection||translation_of
cancer of the testis||cancers, testicular||translation_of
medical device site paraesthesia||medical device site paraesthesia||translation_of
planings, root||root planing of tooth||translation_of
lipectomy||panniculectomy||translation_of
epiploic appendage removal||epiploic appendage removal||translation_of
device fracture||device fracture||translation_of
coagulation factor xiii level||coagulation factor xiii level||translation_of
emodin, rheum||1,3,8-trihydroxy-6-methyl-9,10-anthraquinone||translation_of
hernia strangulate||strangulated; hernia||translation_of
absolute reticulocyte count increased||absolute reticulocyte count increased||translation_of
psychosine||sphingosine galactoside||translation_of
methanosarcinaceae balch and wolfe 1981 emend. sowers et al. 1984||family methanosarcinaceae (organism)||translation_of
unspecified infection or infestation of mother, unspecified as to episode of care or not applicable||infect in preg nos-unsp||translation_of
poland anomaly (disorder)||poland's syndrome||translation_of
drug eruption, fixed||drug eruption fixed||translation_of
lupoid hepatic cirrhosis||lupoid hepatic cirrhosis||translation_of
pseudohermaphroditism, male||male pseudohermaphroditisms||translation_of
liver calcifications||liver calcifications||translation_of
zinc sulfate turbidity abnormal nos||zinc sulphate turbidity abnormal||translation_of
apnea test abnormal||apnoea test abnormal||translation_of
application site joint discomfort||application site joint discomfort||translation_of
varicocele embolization||embolization of varicocele (procedure)||translation_of
gastrointestinal disorder congenital nos||gastrointestinal disorder congenital nos||translation_of
biopsy heart normal||biopsy heart normal||translation_of
sexual function and fertility disorders||sexual function and fertility disorders||translation_of
metastatic laryngeal cancer||laryngeal cancer, stage iv||translation_of
idiopathic angioedema-urticaria||idiopath angio-oedema-urticar||translation_of
thymus-independent antigens||thymus-independent antigen||translation_of
perforated nasal septum||nasal septum perforated||translation_of
other specified hemorrhage in early pregnancy, delivered||other specified hemorrhage in early pregnancy, delivered, with or without mention of antepartum condition||translation_of
menstrual cycle shortened||epimenorrhea||translation_of
tongue scallop||crenated tongue (disorder)||translation_of
biopsy parathyroid gland abnormal||biopsy parathyroid gland abnormal||translation_of
hypotestosteronemia||hypotestosteronism||translation_of
mycoplasmal pelvic inflammatory disease||mycoplasmal pelvic inflammatory disease (disorder)||translation_of
mental retardation-deafnes, skeletal abnormalities, coarse face with full lips||deafness with skeletal dysplasia and lip granuloma syndrome (disorder)||translation_of
cramps in legs||lower extremity cramp||translation_of
bewilderment||bewilderment||translation_of
other specifed complication, antepartum||other specifed complication, antepartum||translation_of
nail biting||biting nails||translation_of
pneumonia; cytomegaloviral disease (etiology)||cytomegaloviral pneumonitis||translation_of
hemoglobin c (substance)||hb 6 (a3), glu-lys, beta chain||translation_of
unspecified complete abortion nos (disorder)||abortion complete nos||translation_of
vocal cord polyp (diagnosis)||polyp(s);vocal cord||translation_of
syndromes, burger-grutz||hyperlipoproteinemia; fredrickson type i||translation_of
dysphagia aggravated||dysphagia aggravated||translation_of
hepatic hematoma (diagnosis)||hepatic hematoma (diagnosis)||translation_of
anal papillitis||anal papillitis||translation_of
occupational problem environmental||occupational environmental problems||translation_of
a40 vitamins: miscellaneous preparations||vitamin preparation||translation_of
cyp2c19 polymorphism||cyp2c19 polymorphism||translation_of
pneumonia in mycoses (diagnosis)||fungal pneumonia||translation_of
barbiturate and similarly acting sedative or hypnotic||barbiturate and similarly acting sedative or hypnotic||translation_of
surgical construction of arteriovenous shunt (procedure)||arteriovenous anastomoses||translation_of
urine estrone decreased||urine estrone decreased||translation_of
tuberous sclerosis complex 2 protein||tuberous sclerosis 2 protein||translation_of
rectoprostatic fistula (disorder)||rectoprostatic fistula||translation_of
pharyngo-oral irritation||pharyngo-oral irritation||translation_of
gallbladder cancer recurrence||gallbladder cancer, recurrent||translation_of
lymph gland biopsy abnormal||lymph gland biopsy abnormal||translation_of
disease (or disorder); caisson||aerobullosis||translation_of
tuberculosis; pericardium (manifestation)||tuberculosis of pericardium (diagnosis)||translation_of
misshapened teeth||teeth; deformity||translation_of
phoria||phorias||translation_of
breath odor, almond||breath odor, almond||translation_of
malignant skin neoplasm nos||skin cancer, including melanoma||translation_of
ambulance diversions||diversions, ambulance||translation_of
bursitis nos (disorder)||inflammation of bursa||translation_of
dural fistula||dural fistula||translation_of
unsp disorder of middle ear and mastoid, unspecified ear||unspecified disorder of middle ear and mastoid, unspecified ear||translation_of
maternal death during childbirth||maternal death during childbirth||translation_of
research, transdisciplinary||transdisciplinary research||translation_of
muscle mitochondria||sarcosomes||translation_of
palindrom rheum-shlder||palindrom rheum-shlder||translation_of
hyponatraemic seizure||hyponatremic seizure||translation_of
viral; infection, herpesvirus, disseminated||disseminated herpesviral disease||translation_of
evasions, tumor immune||immune evasions, tumor||translation_of
pulmonary arterial hypertension who functional class iv||pulmonary arterial hypertension who functional class iv||translation_of
babuvirus||babuvirus||translation_of
trans cereb ischemia nec||other specified transient cerebral ischemias||translation_of
viral genome (substance)||genome, viral||translation_of
transplantation complications||transplantation complication||translation_of
slow vital capacity decreased||slow vital capacity decreased||translation_of
vesicular breathing abnormal||vesicular breathing abnormal||translation_of
neonatal subarachnoid hemorrhage (diagnosis)||subarachnoid haemorrhage neonatal||translation_of
flatulence, bloating and distension||flatulence, bloating and distension||translation_of
electrocardiogram u-wave biphasic||electrocardiogram u-wave biphasic||translation_of
right fascicular block (diagnosis)||right bundle branch block (diagnosis)||translation_of
acute urticaria (disorder)||acute urticaria||translation_of
sleepwalking disorder nonorganic||sleep walking dis||translation_of
fulminant type 1 diabetes mellitus||fulminant type i diabetes mellitus||translation_of
vitamin depletion||vitamin depletion||translation_of
illegal termination of pregnancy complicated by damage to pelvic organs and/or tissues||illegal termination of pregnancy complicated by damage to pelvic organs and/or tissues||translation_of
letterer-siwe disease of spleen (disorder)||letterer-siwe disease of spleen (diagnosis)||translation_of
lymphadenitis bacterial||lymphadenitis bacterial||translation_of
lyme disease spirochete||borrelia burgdorferi johnson et al. 1984||translation_of
left renal vein (lrv) entrapment syndrome||left renal vein entrapment syndrome (disorder)||translation_of
birch pollen allergy||birch pollen allergy||translation_of
facial neuropathy, idiopathic acute||paralyses, idiopathic facial||translation_of
floppy iris syndrome||floppy iris syndrome||translation_of
moschkowitz dis||thrombotic thrombocytopenic purpura (disorder)||translation_of
retinopathy hyperviscosity||hyperviscosity retinopathy (disorder)||translation_of
prophylaxis against chemotherapy induced vomiting||chemotherapy inducted emesis prophylaxis||translation_of
necrotizing enterocolitis, nos||enterocolitis, necrotizing||translation_of
insect chromosome||chromosomes, insect||translation_of
syphilis; atrophy of skin, macular (etiology)||syphilis; atrophy of skin, macular (etiology)||translation_of
vocal disorders||defect; voice||translation_of
open fracture of base of skull with intracranial injury of other and unspecified nature, with brief [less than one hour] loss of consciousness||opn skl base fx-brf coma||translation_of
adenosquamous carcinoma of the gallbladder||adenosquamous carcinoma of gallbladder (diagnosis)||translation_of
bladder tumor antigen (procedure)||bladder tumor antigen (procedure)||translation_of
disorders reproductive system||disorder of reproductive system||translation_of
car t cell therapy||car t cell therapy||translation_of
reversible ischemic neurologic deficit syndrome||rind syndrome||translation_of
uterus; tuberculous (manifestation)||tuberculosis; uterus (etiology)||translation_of
increased serum zinc||increased serum zinc||translation_of
vascular stent thrombosis||vascular stent thrombosis||translation_of
aspiration pleural cavity normal||aspiration pleural cavity normal||translation_of
oedema at application site||edema application site||translation_of
stationary night blindness, oguchi type||hereditary night blindness nos (disorder)||translation_of
acute pityriasis lichenoides||pleva - pityriasis lichenoides et varioliformis acuta||translation_of
parosmias||parosmias||translation_of
x-ray of the spine||x-ray;back||translation_of
bone in pharynx||bones throat||translation_of
food contamination||contamination food||translation_of
chromosomes philadelphia positive||philadelphia chromosome positive||translation_of
inflammation of joint of hand (disorder)||arthritis hands||translation_of
dependence; barbiturate(s)||barbiturate dependence (disorder)||translation_of
osteoblastic osteosarcoma localized||osteoblastic osteosarcoma localised||translation_of
stomatitis, aphthous||canker sores||translation_of
ketoacidosis||ketoacidoses||translation_of
leprosy; tuberculoid||leprosy; tuberculoid||translation_of
isomerism, left atrial||left atrial isomerisms||translation_of
[x]other congenital malformations of tricuspid valve||[x]other congenital malformations of tricuspid valve||translation_of
2,6,8-trioxopurine||2,6,8-trioxopurine||translation_of
polyvinyls||polyvinyls||translation_of
secondary malignant neoplasm of respiratory or digestive system nos||secondary malignant neoplasm of respiratory and digestive systems (disorder)||translation_of
focal contusion of parietal lobe||contusion; parietal lobe||translation_of
cyst of the cerebral hemispheres||cyst of cerebrum||translation_of
pseudophakic glaucoma||pseudophakic glaucoma||translation_of
primary ulcer of intestine (disorder)||intestine ulceration||translation_of
microcytic hypochromic anaemia||hypochromic / microcytic anemia||translation_of
bacillus nephritidis equi||bacterium pyosepticum||translation_of
neurological examination normal||neurological examination normal||translation_of
cystadenocarcinoma (diagnosis)||cystadenocarcinoma (diagnosis)||translation_of
transport, ion||ion transport||translation_of
47,xyy syndrome (diagnosis)||47,xyy syndrome (diagnosis)||translation_of
glottis; hypoplasia||glottis; hypoplasia||translation_of
thyroid neoplasm, benign||benign thyroid gland neoplasm||translation_of
rhabdovirus infection, nos||rhabdoviridae infection||translation_of
cogan's epithelial dystrophy of cornea (physical finding)||microscopic cystic corneal dystrophy (disorder)||translation_of
uterine tumor-delivered||tumors of body of uterus, delivered, with or without mention of antepartum condition||translation_of
cancers, colonic||colon nos cancer||translation_of
intravenous pyelogram abnormal||intravenous pyelogram abnormal||translation_of
pustules on lip||lip pustule||translation_of
chronotropic incompetence||chronotropic incompetence||translation_of
product use in unapproved indication||product use in unapproved indication||translation_of
1-71d kidney: transplantations and transpositions||transplant of kidney||translation_of
hypertonicity of bladder||bladder hypertonicity||translation_of
traumatic fat embolism||fat embolism as early complication of trauma (disorder)||translation_of
pityriases||pityriasis nos||translation_of
decreased immune responsiveness||decreased immune responsiveness||translation_of
ecthyma||ecthyma (diagnosis)||translation_of
anaerobic septicemia (diagnosis)||septicaemia due to anaerobes||translation_of
catatonia, malignant||lethal catatonias||translation_of
aggravated ringing in ears||tinnitus aggravated||translation_of
hepatic enzyme decreased||hepatic enzyme decreased||translation_of
ssss||disease, ritter||translation_of
uterus electron beam therapy||uterus electron beam therapy||translation_of
amniocentesis, nos||amniocentesis diagnosic||translation_of
large intestine therapeutic procedures||large intestine therapeutic procedures||translation_of
sterile phlebitis||sterile phlebitis||translation_of
magnetic resonance imaging of head abnormal (finding)||magnetic resonance imaging of head abnormal (finding)||translation_of
urethritis, not sexually transmitted, and urethral syndrome||urethritis, not sexually transmitted, and urethral syndrome||translation_of
fdp defic||fructosediphosphatase deficiencies||translation_of
hemorrhage;subconjunctival||subconjunctival hemorrhage (disorder)||translation_of
[d]projectile vomiting (context-dependent category)||vomiting projectile||translation_of
discriminant anal||discriminant anal||translation_of
hypertension uncomplicated||uncomplicated hypertension||translation_of
disorder of transplanted kidney||transplanted kidney complication||translation_of
neoplasm of uncertain behavior of meninges, unspecified||neoplasm of uncertain behavior of meninges nos (disorder)||translation_of
sialolithiasis||calculus, salivary gland||translation_of
cdr - clin dement rating scale||clinical dementia rating scale (assessment scale)||translation_of
disseminated mycobacterium avium complex infection||disseminated mycobacterium avium complex infection||translation_of
ultrasound;prostate||diagnostic ultrasound prostate||translation_of
maxillary sinus neoplasm||neoplasm of maxillary sinus||translation_of
product colour leaching||product color leaching||translation_of
alpha 2 globulin decreased||alpha 2 globulin low||translation_of
ubiquinone increased||ubiquinone increased||translation_of
serum alkaline phosphatase nos||sap||translation_of
syndrome; renal, in hemorrhagic fever (etiology)||hemorrhagic fever; renal syndrome (etiology)||translation_of
abnormality of forces of labor (disorder)||abnormality of labor (diagnosis)||translation_of
intracranial injury of other and unspecified nature with open intracranial wound, with brief [less than one hour] loss of consciousness||intracranial injury of other and unspecified nature with open intracranial wound, with brief [less than one hour] loss of consciousness||translation_of
1,2-dimethyl-3-hydroxy-4-pyridinone||deferiprone product||translation_of
bile duct cancer stage iii||bile duct cancer stage iii||translation_of
intrapulmonary shunts||shunt intrapulmonary||translation_of
[d]hallucinations, auditory (situation)||hallucinations auditory||translation_of
borderline hypercholesterolemia||borderline hypercholesterolaemia||translation_of
trophedema||trophedema||translation_of
unspecified alveolar and parietoalveolar pneumopathy||alveol pneumonopathy nos||translation_of
w element||tungsten, nos||translation_of
cortex (cerebral) laceration with open intracranial wound||cortex laceration with open intracranial wound (finding)||translation_of
diabulimia||eating disorder diabetes mellitus type 1||translation_of
parasite dna test||parasite dna test||translation_of
pnet - primitive neuroectodermal tumor||neuroepithelial neopl primitive||translation_of
hemorrhage of parathyroid (disorder)||hemorrhage; parathyroid||translation_of
hypothyroidism resulting from resorcinol||resorcinol hypothyroidism||translation_of
snomed (systematized nomenclature of medicine)||snomed||translation_of
computerised tomogram spinal myelogram abnormal||computerised tomogram spinal myelogram abnormal||translation_of
imprinting, psychology||psychologic imprinting||translation_of
trichotillomanias||plucking hair||translation_of
neoplasm of diaphragm||neoplasm of soft tissue of diaphragm (diagnosis)||translation_of
product containing isosorbide||isotrate er||translation_of
cardiac procedure complication||cardiac procedure complication||translation_of
uri||uri - upper respiratory infection||translation_of
mater dura||dura mater structure||translation_of
burkholderia cepacia complex sepsis||burkholderia cepacia complex sepsis||translation_of
retinal toxicity||retinal toxicity||translation_of
biopsy of esophagus||oesophageal biopsy||translation_of
nail bed injury||nail bed injury||translation_of
lipoatrophic diabetes mellitus||congenital total lipodystrophy (disorder)||translation_of
prerenal insufficiency||prerenal insufficiency||translation_of
prostatectomy, suprapubic||transvesical prostatectomy (procedure)||translation_of
et-nanbh||epidemic non a, non b hepatitis||translation_of
acidemia||acidemia nos||translation_of
iron def anaemia syndrome||unspecified iron deficiency anaemia||translation_of
symmetrical drug-related intertriginous and flexural exanthema (disorder)||symmetrical drug-related intertriginous and flexural exanthema (disorder)||translation_of
neoplasm of endocrine system||neoplasm of endocrine gland||translation_of
infusion site joint erythema||infusion site joint erythema||translation_of
dynamics, nonlinear||non linear dynamics||translation_of
late effects of central nervous system tuberculosis (disorder)||late effects of cns tb||translation_of
clinical finding absent||wound exudate odor absent||isa
nose finding [dup] (finding)||nasal regurgitation||isa
breathing mouth||mouth breathing with nasal obstruction||isa
regulation of chanoclavine-i aldehyde formation||inhibition of chanoclavine-i aldehyde synthesis||isa
arizona ash pollen extract injectable product||fraxinus velutina pollen 40000 [pnu] in 1 ml intradermal solution [arizona velvet ash pollen]||isa
penicillin phenoxymethyl||phenoxymethylpenicillin-containing product in oral dose form||isa
benign neoplasm of choroid (disorder)||choroidal naevus||isa
architects and town planners||architect||isa
myeloid neoplasm (morphologic abnormality)||myeloproliferative myelodisplastic diseases||isa
malignant tumor of middle ear (disorder)||carcinoma of middle ear with osteoclast-like cells (diagnosis)||isa
skin and subcutaneous tissue structure of lower limb||skin and subcutaneous tissue structure of foot (body structure)||isa
lesion of degenerative abnormality||ferruginous body||isa
calamine / pramoxine topical lotion||leader calamine plus topical lotion||isa
papillomavirus infect||human papilloma virus infection type 24||isa
acute thrombosis of superficial vein of right lower extremity (disorder)||acute thrombosis of superficial veins of both lower extremities||isa
structure of crest of head of fifth rib||crest of head of left fifth rib||isa
gonorrhea; specified site not listed||gonococcal tysonitis||isa
tannic acid topical||tannic acid topical lotion||isa
fiberoptic sigmoidoscopy (procedure)||fiberoptic sigmoidoscopy with balloon dilation of one or more strictures (treatment)||isa
wheal on third toe of left foot (physical finding)||wheal on plantar surface of third toe of left foot||isa
body temperature (function)||temperature of forehead (observable entity)||isa
malignant orbital tumour||malignant orbital neoplasm primary||isa
redtop grass pollen extract injectable product||agrostis gigantea pollen 100000 [bau] in 1 ml percutaneous injection, solution [standardized redtop grass pollen]||isa
surface of distal metaphysis of metatarsal bone||surface of distal metaphysis of right metatarsal bone||isa
duodenal muscularis propria structure (body structure)||longitudinal muscle layer of duodenum||isa
constitutional; dwarfism||ichthyosis-oligophrenia-epilepsy syndrome||isa
operative procedure on hypophysis, nos||chiasmopexy (procedure)||isa
microbial stain||giemsa stains||isa
ruptured aneurysm of artery (disorder)||pregnancy complications: ruptured aneurysm (diagnosis)||isa
neoplasia of the breast||carcinoma in situ; lobular, breast||isa
furuncle of finger (disorder)||furuncle of medial aspect of ring finger of right hand (physical finding)||isa
doppler ultrasonography of aorta and femoral artery||doppler ultrasonography of aorta and left femoral artery||isa
esophagogastrostomy||intrathoracic oesophagogastric anastomosis||isa
fracture dislocation of knee joint closed||closed fracture subluxation of knee joint||isa
neuroprotective drugs||nitroso gsh s||isa
drug therapy status (situation)||phosphodiesterase 5 inhibitor declined||isa
medial accessory saphenous vein||left medial accessory saphenous vein||isa
minor calyx wall||wall of left minor calyx||isa
medical supply||oval amber 16 oz||isa
prolymphocytic leukemia (clinical)||b-cell type prolymphocytic leukemia||isa
benign neoplasm of the peritoneum (disorder)||benign peritoneal mesothelioma||isa
posterior external vertebral venous plexus of sacral vertebra||s2 part of posterior external vertebral venous plexus||isa
mri ankle posterior tibial tendon right||magnetic resonance imaging of ankle: partial tear of right posterior tibial tendon (procedure)||isa
drainage of mediastinum||mediastinotomy with drainage by transthoracic approach (procedure)||isa
cervical vertebral segment of anterior longitudinal ligament||c3 symphysis segment of anterior longitudinal ligament||isa
coats, cell||lysosomal glycocalyx||isa
dorsal portion of pons||medial lemniscus of the pons||isa
home exercises for strengthening||home exercises for strengthening lower back||isa
disturbance of tooth eruption or exfoliation||precocious exfoliation of primary tooth||isa
poisoning caused by warfarin sodium (disorder)||intentional warfarin poisoning||isa
cellulitis; scalp||cellulitis of top of scalp (physical finding)||isa
oral habits - finding||habitual finger biting||isa
congenital conditions||anisocoria, congenital||isa
infection of skin of finger||carbuncle of finger (disorder)||isa
microbial identification tests||sputum acridine orange stain||isa
miscellaneous mental disorders and culture-bound syndromes||qi-gong psychotic reaction||isa
butterfly macular dystrophy||butterfly-shaped pattern dystrophy||isa
competitive games psychotherapy (regime/therapy)||team games for therapy (regime/therapy)||isa
reddish-blue discoloration of fingernail||reddish-blue discoloration of little fingernail of left hand (symptom)||isa
subdivision of surface of proximal epiphysis of tibia||facies articularis superior tibiae||isa
alergen specific immunoglobulin g||mold specific igg||isa
device finding||pseudophakic corneal edema||isa
norethindrone and ethinyl estradiol tablets||ethinylestradiol 30micrograms/norethisterone acetate 1mg tablet||isa
entire extrahepatic bile duct (body structure)||entire lateral branch of left hepatic duct (body structure)||isa
class thermoplasmata (organism)||thermoplasmatales reysenbach 2002||isa
pemolert pill||pemoline 10 mg oral tablet||isa
erosion; bone||computed tomography of cervical spine: erosion of vertebral lamina (procedure)||isa
regulation of antibacterial peptide biosynthetic process||up regulation of antibacterial peptide biosynthetic process||isa
anesthesia for radical or modified radical mastectomy (medication)||anesthesia for radical/modified radical mastectomy with node dissection||isa
blasts 10-19 percent of bone marrow nucleated cells||myeloblasts between 10 and 19% of bone marrow nucleated cells||isa
coniochaetales||coniochaetaceae||isa
macerated skin (physical finding)||maceration on the face eyebrows right||isa
product containing only ursodeoxycholic acid (medicinal product)||ursodeoxycholic acid only product in oral dose form||isa
woodcock-munoz language survey, revised (wmls-r)||wmls-r composite scores||isa
left ventricular thrombosis (diagnosis)||echocardiogram l ventricle thrombus formation (___cm)||isa
disability;intellectual||intellectual disability buenos aires type (disorder)||isa
posterior surface of lamina of thoracic vertebra||posterior surface of lamina of eleventh thoracic vertebra||isa
inflammation of specific body organs||external ear inflammation (physical finding)||isa
supraglottis tnm finding||pt2: tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx (finding)||isa
needles, suture, surgical||needles, suture, surgical, cutting edge||isa
food preservatives||benzoate, sodium||isa
disorder of amputation stump||granulation tissue of stump wound of left ankle amputation||isa
nodular heterotopia (diagnosis)||subcortical nodular heterotopia (disorder)||isa
nursing care: intravenous therapy administration (treatment)||nursing care: iv therapy check iv contents for accuracy||isa
musculoskeletal system: endoscopy||arthroscopy of shoulder with excision of distal clavicle (procedure)||isa
prelaminar branch of lumbar spinal artery||prelaminar branch of spinal branch of fourth lumbar artery||isa
cellulitis of middle toe of left foot (diagnosis)||cellulitis of lateral surface of left third toe (physical finding)||isa
amphetamine / dextroamphetamine extended release oral capsule||amphet/d-amphet 25mg triphasic sa cap||isa
gingivae finding (finding)||relative probing depth at mesial left lower second bicuspid (physical finding)||isa
macrolide antibiotics||product containing carbomycin (medicinal product)||isa
genus paradisaea||paradisaea minor||isa
cogwheel rigidity was noted||cogwheel rigidity was noted only on the left||isa
bones flat||wormian bones||isa
rheumatoid arthritis of joint of spine||other rheumatoid arthritis of vertebrae||isa
superficial fatty layer of thigh||fatty layer of superficial fascia of left thigh||isa
cyclin family gene||cyclin et||isa
injection of upper limb using ultrasonographic guidance||ultrasonic guidance for injection of bilateral carpal tunnels||isa
erythema at injection site||allergy testing red pepper erythema (lab test)||isa
anti ulcer drug||plaunotol||isa
manic; disorder||manic bipolar disorder in remission||isa
structure of segment of left lung (body structure)||bronchiole of left lung||isa
voice finding||finding of shouting||isa
skin cyst (symptom)||skin cyst of anterior aspect of right shoulder (symptom)||isa
measurement of barmah forest virus antibody (procedure)||serum barmah forest encephalitis virus antibody test by elisa (lab test)||isa
arthropathy of joint of both hands||osteoarthritis both hands||isa
jerboas||zapodinae||isa
closed fracture of skull vault (diagnosis)||closed skull fracture with loss of consciousness >24 hours without return to prior level of consciousness||isa
fulmarus glacialis (linnaeus, 1761)||pacific fulmar||isa
lensometry eyeglasses left lens||lensometry eyeglasses left lens diopters of cylinder||isa
biopsy of oropharynx showed hodgkin's lymphoma with nodular sclerosis||biopsy of oropharynx showed hodgkin's lymphoma with grade 1 nodular sclerosis (procedure)||isa
organ component of pelvic fascia||parametrium of cervix||isa
insertion of denture||complete denture, including adjustments, nos||isa
microscopic examination of specimen from skin||microbiology test of skin lesion of area around both sides of mouth||isa
induration of skin||induration of medial collateral ligament of left ankle (physical finding)||isa
obstetrical/gynaecological device||endoscopic cyst-aspiration set||isa
computed tomography without contrast (procedure)||ct scan of airway without contrast||isa
removal, nos||removal of corneal epithelium, nos||isa
mass lesion of floor of posterior cranial fossa||mass lesion of floor of posterior cranial fossa on right||isa
schistosomiasis - bilharziasis||schistosoma mansoni||isa
heterocycle metabolism||vibriobactin metabolic process||isa
mucosal melanoma of the head and neck pathologic regional lymph nodes tnm finding v8||mucosal melanoma of the head and neck pnx tnm finding v8||isa
vesicle on right thumb||vesicle on lateral surface of right thumb||isa
magnetic resonance imaging of cervical spine: proliferative lesion of cervical vertebra with t2 signal (procedure)||magnetic resonance imaging of cervical spine: proliferative lesion of cervical vertebra with hyperintense t2 signal||isa
microtubule inhibitor product||2-ethyl-3-o-sulphamoyl-estra-1,3,5(10) 16-tetraene||isa
gastrooesophageal reflux status||bile reflux status||isa
communicating branch of auricular branch of vagus nerve with posterior auricular nerve||communicating branch of auricular branch of right vagus nerve with right posterior auricular nerve||isa
scar tissue mobilization of foot (treatment)||scar tissue mobilization of left foot (treatment)||isa
supplies,other||laryngeal prosthesis,blom-singer in2025-sl||isa
tubal pregnancy nos||combined tubal and intrauterine pregnancy||isa
hemorrhage of gingiva on distal surface of left maxillary lateral incisor (physical finding)||spontaneous hemorrhage of gingiva on distal surface of left maxillary lateral incisor||isa
inflammation of specific body organs||inflammation of large intestine (disorder)||isa
cholinergic muscarinic agonist||oxytremorine||isa
diffuse joint pains||pain in temporomandibular joint (symptom)||isa
redox activity||violaxanthin:ascorbate oxidoreductase activity||isa
assisting with procedure||examination assistance (procedure)||isa
onychomycosis of toenail of right foot (diagnosis)||onychomycosis of second toenail of right foot (diagnosis)||isa
haring||subgenus macrotolagus||isa
paenibacillus sp.||paenibacillus residui vaz-moreira et al. 2010||isa
down-regulation of secretion by cell||down regulation of hormone secretion||isa
structure of half of neck lateral to midsagittal plane (body structure)||structure of corniculate cartilage (body structure)||isa
respiratory failure, neonatal||insufficiency; lung, newborn||isa
arteriovenous fistula thrombosis||arteriovenous fistul thrombos||isa
specialised cell structure||photoreceptor membrane lamellae (cell structure)||isa
product containing nitrogen and nitrogen compound (product)||xamoterol [sympathomimetic] (substance)||isa
bite of reptile (finding)||[x]bitten or struck by crocodile or alligator (event)||isa
neoplasm of exocervix (disorder)||malignant exocervix neoplasm||isa
allografts||tissue cult allogen derm subst feet wound surface area 100 sq cm or greater||isa
vitamin b12 and vitamin b12 derivative (substance)||product containing methylcobalamin||isa
unilateral mixed conductive and sensorineural hearing loss||mixed conductive and sensorineural hearing loss of right ear||isa
sporosarcina kluyver and van niel 1936 emend. yoon et al. 2001||sporosarcina aquimarina||isa
surface of arch of thoracic vertebra||surface of arch of fourth thoracic vertebra||isa
sensory manifestations||dysesthesias||isa
fetal head||structure of foetal cephalic prominence||isa
olive-backed woodcreeper||xiphorhynchus triangularis triangularis||isa
893 glass and ceramics kilnmen||glass temperer||isa
genus archaeoglobus (organism)||archaeoglobus lithotrophicus||isa
applicators||applicator, absorbent tipped, sterile||isa
coronary artery abnormality [ambiguous]||dual coronary orifice (disorder)||isa
depth of wound of posterior neck||neck posterior tissue injury wound superficial||isa
salmonella cholerae-suis subsp. salamae||salmonella ii, group o:60||isa
recreation equipment||golf club, device (physical object)||isa
chronic musculoskeletal disorder||renal osteodystrophy with low bone turnover||isa
endocrine disorder monitoring status (finding)||endocrine symptom change (procedure)||isa
entire cervical vertebral pedicle||c4 vertebral pedicle||isa
magnetic resonance imaging without iv contrast followed by contrast and more sections (procedure)||magnetic resonance angiography of abdomen without, then with contrast material||isa
hypocalcemia (diagnosis)||hypocalcemic rickets (disorder)||isa
chemical burn of fingers||chemical burn thumb (diagnosis)||isa
cleft palate with cleft lip (diagnosis)||ectodermal dysplasia type 4||isa
stereotactic ablation of brain tissue nos (procedure)||stereotactic ablation of brainstem tissue (procedure)||isa
obs relat to compl & soc behav||attachment behaviour||isa
dacryocystitis chronic||chronic dacryocystitis of both eyes (diagnosis)||isa
observation of sensation||stinging of skin (finding)||isa
mobilizing||mobilization of duodenum||isa
subluxation wrist||subluxation of radiocarpal joint of right wrist (diagnosis)||isa
drugs, anti-arrhythmia||oxprenolol-containing product||isa
fifth superficial transverse metatarsophalangeal ligament||right fifth superficial transverse metatarsophalangeal ligament||isa
bone infection nos, of unspecified site||infection of multiple bones (disorder)||isa
general morphologic terms||cellular pleomorphism||isa
oral albuterol preparation||albuterol 4.8 mg/ml oral solution||isa
product containing doxorubicin in parenteral dose form (medicinal product form)||doxorubicin hydrochloride liposome 2 mg/1 ml intravenous solution [doxil]_#1||isa
feeling - sensation||finding of sensation of touch||isa
fluoxetine oral product||prozac 60 mg oral capsule||isa
hypothyroidism, congenital||congenital hypothyroidism due to absence of thyroid gland (disorder)||isa
atypical lymphocyte (morphologic abnormality)||b-cell abnormalities||isa
malignant tumor of the small intestine||malignant neoplasm of small intestine, including duodenum metastatic||isa
unilateral repair of femoral hernia (situation)||unil femor hrn rep-grft||isa
proximal epiphysis of distal phalanx of little finger||basal epiphysis of distal phalanx of right little finger||isa
scale assessment||qrisk2 cardiovascular disease 10 year risk calculator (assessment scale)||isa
severe protein-calorie malnutrition (gomez: less than 60% of standard weight) (disorder)||severe insufficient nutrition (diagnosis)||isa
malignant tumor of the supraglottis||malignant neoplasm of supraglottis secondary||isa
localised periodontitis||american academy of periodontology and european federation of periodontology 2017 classification of periodontal and peri-implant diseases and conditions localised periodontitis stage 3 grade a||isa
rrna processing||rrna 5' end processing||isa
neoplasm of intrathoracic lymph node||neoplasm of intrathoracic lymph nodes (disorder)||isa
therapeutic autologous lymphocytes||mage-a3/12-specific t-cell receptor gene-transduced autologous peripheral blood lymphocytes||isa
skin eschar (disorder)||eschar of periungual region of ring finger of left hand||isa
wall of subdivision of epididymis||wall of body of epididymis||isa
androsterone assay||urine androsterone 24 hr||isa
anti-bacterial agents||cyclic lipopeptide antibiotic (substance)||isa
scans, spect ct||single photon emission computed tomography with computed tomography of bone (procedure)||isa
ecce & insert intraocular lens||extracapsular cataract extraction with prosthesis insertion complex||isa
stomach acupuncture points (body structure)||st28 (body structure)||isa
lactic dehydrogenase isoenzyme (substance)||lactic dehydrogenase isoenzyme, m>3<h fraction (substance)||isa
abrasion of elbow, infected||abrasion and/or friction burn of elbow with infection (disorder)||isa
costal fracture||delayed union of fracture of left third rib||isa
acc caught-architect feature||accidentally caught in sash window||isa
cardiovascular palpation (physical finding)||examination of apical impulse (physical finding)||isa
crust of little finger of left hand (physical finding)||crust of palmar aspect of little finger of left hand (physical finding)||isa
magnetic resonance imaging of cervical spine: proliferative lesion of cervical vertebra with hyperintense signal intensity (s/i) ratio||magnetic resonance imaging of cervical spine: proliferative lesion of c4 vertebra with hyperintense signal intensity (s/i) ratio||isa
biocatalysts||asparagine synthase||isa
class iii antiarrhythmic drug (product)||methanone, (2-butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)-||isa
fibrous membrane of articular capsule of metatarsophalangeal joint of first toe||fibrous membrane of articular capsule of metatarsophalangeal joint of right big toe||isa
glucose / potassium chloride / sodium chloride injection||potassium chloride in dextrose 5 %-0.45 % sodium chloride@20 meq/l@intraven@intravenous solution||isa
betaine / pepsin a pill||betaine 520 mg / pepsin a 104 mg oral capsule||isa
median motor nerve conduction study on right side motor function||median motor nerve conduction study on right side f-wave latency||isa
covid-19 consultation note (treatment)||covid-19 intubation consultation note||isa
i d||incision and drainage of musculoskeletal system (procedure)||isa
ear parts||ductus semicirculares||isa
purulent discharge of gums on left mandibular first bicuspid||purulent discharge of gums on mesial surface of left mandibular first bicuspid||isa
sequential hemibody irradiations||irradiation of left side of body (treatment)||isa
rare non-neoplastic disorder||hellp - syndrome of haemolysis/elev liver enz/low platelet||isa
third-nerve palsies, partial||cyclical oculomotor palsy||isa
stomach neoplasms||stomach, unspecified||isa
lymphocyte studies (lab test)||mitogen-induced blastogenesis (lab test)||isa
layer of occipital lobe (body structure)||entire layer of occipital lobe||isa
closure by suturing - action (qualifier value)||resuture wound (procedure)||isa
negative regulation of reproductive process||negative regulation of border follicle cell delamination||isa
reproductive system hereditary disorder||frontonasal dysplasia with alopecia and genital abnomality||isa
reason for stopping medication (history)||stopped medication because of nausea||isa
codeine||chlorpheniramine/codeine/pe/k iodide||isa
bloc-1 related complex location||bloc-2 complex||isa
carbuncles on left auricle (physical finding)||carbuncles on left helix||isa
ids-c clinical classification question||ids-c - involvement||isa
cellular response to ether||cellular response to ionomycin||isa
segment of inferior vena cava||extrapericardial part of inferior vena cava||isa
skin texture of arm||skin texture of right arm (physical finding)||isa
digital therapeutics endocrine, nutritional, metabolic diseases||digital therapeutics for metabolic syndrome (treatment)||isa
fibroadipose stroma of parathyroid gland||stroma of inferior parathyroid gland||isa
skin of part of second toe||skin structure of dorsal surface of second toe||isa
ceftriaxone poisoning||intentional ceftriaxone poisoning (disorder)||isa
procedure on joint of lower extremity (procedure)||examination of joint of foot||isa
procedure on male genital system||operative procedures on the male genital system||isa
product containing fosamprenavir in oral dosage form||fosamprenavir only product in oral dose form||isa
cytotoxic antibiotic overdose||plicamycin overdose||isa
bckd - branched chain alpha-ketoacid dehydrogenase deficiency||maple syrup urine disease, multiple dehydrogenase form||isa
open fracture of left acetabulum with letournel qualifier||open fracture of left acetabulum with impaction of femoral head (delta 2) (diagnosis)||isa
repair, complex, scalp, arms, and/or legs||cmplx rpr s/a/l 2.6-7.5 cm||isa
occupational allergen specific immunoglobulin e||methyltetrahydrophtalic anhydrid specific immunoglobulin e||isa
puncture of left lower paraspinal region consistent with shrapnel exit wound||puncture of left lower paraspinal region consistent with exit wound of specified shrapnel fragment (#___)||isa
excision of sacral pressure ulcer||excision of sacral pressure ulcer with myocutaneous flap closure||isa
viral nucleic acid assay||human t cell lymphotropic virus 1 (htlv 1) nucleic acid assay (procedure)||isa
procedure by intent||preventative||isa
pentosan polysulfate topical product||pentosan polysulfate 0.015 mg/mg topical gel||isa
colchicine in oral dosage form||colchicine oral solution [gloperba]||isa
dna-dependent atpase activity||dna topoisomerase (atp-hydrolyzing) activity||isa
graft versus host disease final skin score||graft versus host disease final skin score 2||isa
anxiousness||fear (of);dying||isa
set of lymphatic vessels of face||set of lymphatic vessels of mouth||isa
therapeutic drug assay - serum or plasma topiramate||therapeutic drug assay - serum or plasma topiramate free||isa
cellulose oral powder product||unifiber 3 gm oral powder||isa
mammogram of left breast (procedure)||mammography of left breast implant (procedure)||isa
body substance||nervous system hormone-like substance, nos||isa
antimuscarinic/antipasmodic combinations||belladonna 10.8/phenobarbital 16mg tab||isa
genus: coronavirus||coronavirus group 3||isa
childhood seizure (finding)||autism epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency (disorder)||isa
difficulty cutting own nails||difficulty cutting own fingernails (finding)||isa
otolaryngologic surgical result of left ear (treatment)||otolaryngologic surgical result of left ear: hearing (treatment)||isa
mmadhc gene panel reagents||ivd panels, human genetics, metabolic disorder, methylmalonic aciduria/homocystinuria, del/dup||isa
laxatives overdose||bulk-forming laxative overdose (disorder)||isa
bone of proximal epiphysis of distal phalanx of ring finger||compact bone of proximal epiphysis of distal phalanx of ring finger||isa
drug overdose of undetermined intent (disorder)||progestogen od undeterm int||isa
eel (organism)||family xenocongridae - false moray||isa
iron carbonyl pill||iron pentacarbonyl 50 mg oral tablet [iron carbonyl]||isa
product containing only mesalazine (medicinal product)||mesalazine only product in rectal dose form||isa
epinephrine / prilocaine cartridge||prilocaine hcl/epinephrine bit 40 mg/ml (4 %)-1:200,000 injection cartridge (ml)||isa
codeine oral product||codeine 2.22 mg/ml oral suspension||isa
puncture wound of chest (disorder)||pnctr w fb of back wall of thorax w penet thoracic cavity||isa
organic nitrogen compounds||product containing sibutramine hydrochloride monohydrate (medicinal product)||isa
abdominal x-ray and fluoroscopy of upper gi tract with po contrast (procedure)||abdominal x-ray and fluoroscopy of upper gi tract with po water soluble contrast||isa
unqualified appendicitis||grumbling appendix||isa
right foot congenital deformity||bilateral congenital deformity of feet||isa
neurocranium structure (body structure)||fontanel||isa
magnesium compound||mag tab sr||isa
calcium lactate / niacin oral product||calcium lactate 324 mg / niacin 25 mg oral tablet||isa
ring finger mcp joint flexion||passive flexion of left ring finger metacarpophalangeal joint (___ degrees)||isa
single photon emission computed tomography using gallium (procedure)||spect for abscess with iv ga-67 (procedure)||isa
carcinoma urinary bladder||refractory bladder cancer||isa
x-ray wrist sclerotic lesion periosteal reaction||x-ray of wrist: sclerotic lesion with thick periosteal reaction||isa
malignant neoplasm of retroperitoneum nos (disorder)||small b-cell lymphocytic lymphoma of retroperitoneum||isa
actin-binding proteins||vinculin||isa
restoration, inlay, porcelain/ceramic||restoration, inlay, porcelain/ceramic, per tooth, in addition to inlay||isa
pain of left knee joint (finding)||chronic pain following left total knee arthroplasty (finding)||isa
neuronal component of white matter of sacral subsegment of spinal cord||neuronal component of white matter of s3 segment||isa
zone of distal epiphysis of femur||condylus lateralis (femur)||isa
excision of preauricular sinus (treatment)||excision of preauricular sinus of ear, radical||isa
chlorhexidine / ketoconazole medicated pad||chlorhexidine gluconate 2 g in 100 g / ketoconazole 1 g in 100 g topical cloth [davis ketohexidine]||isa
radiographic imaging procedure requested||barium meal requested (context-dependent category)||isa
adverse effect of topical agents (diagnosis)||adv effect top agents affect skin & mucous memb & ophthal, otorhino & dental||isa
molar pregnancy with choriocarcinoma (disorder)||gestational ovarian choriocarcinoma||isa
set of all joints of hip||set of all joints of right hip||isa
orphenadrine-containing product in oral dose form||aspirin / caffeine / orphenadrine oral product||isa
muscle energy treatment method||muscle energy therapy for right vastus medialis||isa
fluocinolone topical||fluocinolone / hydroquinone / tretinoin topical product||isa
neuraxis fibers||rubroolivary tract (body structure)||isa
pulmonary imaging sign||tree-in-bud pattern||isa
needle stick injury of upper limb (disorder)||needle stick injury upper arm||isa
olfactory receptor, family 51, subfamily e, member 2||or51e2 wt allele||isa
fracture of intermediate cuneiform||closed fracture of intermediate cuneiform bone of foot (disorder)||isa
context-dependent procedure||imaging finding reviewed (situation)||isa
hydrolase gene||esterase gene||isa
ivd test reagent/kits, immunoassay, tumor marker, enzyme||ivd test reagent/kits, immunoassay, tumor marker, enzyme, alkaline phosphatase||isa
submission domain||dv||isa
hereditary disorder of nervous system (diagnosis)||spastic paraplegia, intellectual disability, palmoplantar hyperkeratosis syndrome (disorder)||isa
tooth observable||feature of tooth plaque (observable entity)||isa
cloroquina||chloroquine phosphate + primaquine phosphate (medication)||isa
retracted tympanic membrane of right ear||retraction of pars flaccida of right ear||isa
sulfate ferrous||product containing ascorbic acid and ferrous sulfate (medicinal product)||isa
allergy testing animals (lab test)||allergy testing sheep (crude wool)||isa
sensation, hyperesthetic||tactile hyperesthesia sensory level at xiphisternum (t6, t7, t8)||isa
chromosome analysis, nos||hras pathogenic variant (lab test)||isa
self destructive behavior||swallowing objects||isa
whole blood saturation oxyhemoglobin test||capillary blood saturated oxyhemoglobin test||isa
thalurania colombica fannyae||thalurania fannyi subtropicalis (organism)||isa
treatment, radiation||radiosensitizing measure||isa
mab||immunoglobulin g1, anti-(human interleukin 22) (human monoclonal heavy chain), disulfide with human monoclonal lambda-chain, dimer||isa
thallium poisoning (disorder)||poisoning by thallium due to self-inflicted overdose (diagnosis)||isa
open wound of thigh (diagnosis)||open injury femoral nerve (disorder)||isa
doxylamine-containing product||doxylamine + dextromethorphan + acetaminophen||isa
positive regulation of cysteine-type endopeptidase activity||up-regulation of caspase activity||isa
pain level (observable entity)||disruptive effects of pain||isa
anatomical line of ulna||posterior border of shaft of ulna||isa
nonsegmental pneumatic appliance used with compressor (treatment)||nonsegmental pneumatic appliance used with compressor, leg||isa
dextromethorphan oral solution [simply cough]||dextromethorphan hydrobromide 15 mg in 15 ml oral solution [daytime cough]||isa
deep lymph node||deep lateral cervical node||isa
derman topical product||undecylenate topical lotion||isa
limit or limitation question||frequency that fatigue limits work||isa
antibiotic measurement||cyclacillin measurement (procedure)||isa
carybdeidae||genus chironex (organism)||isa
injury colon||injury of multiple sites in colon and/or rectum with open wound into abdominal cavity||isa
cartilage of acromion||cartilage of clavicular facet of left scapula||isa
traumatic open division of ligament||open division lumbosacral ligament (disorder)||isa
hyalomma (organism)||hyalomma truncatum (organism)||isa
biological regulation||regulation of pro-t lymphocyte differentiation||isa
musculocutaneous neural branch||branch of musculocutaneous nerve to humerus||isa
bulk compounding chemicals||bismuth nitrate pentahydrate||isa
finding of patterns of eye movement||non-rhythmic abnormal eye movement||isa
patient referral for consultation||request consultation by hematology (treatment)||isa
edema trunk||intestinal angioedema caused by angiotensin-converting enzyme inhibitor||isa
malignant neoplasm of female genital organ, nos||angioimmunoblastic t-cell lymphoma of female genitalia (diagnosis)||isa
a. buccalis||left buccal artery||isa
rn care: feeding tube care||nursing care: j-tube care (treatment)||isa
who grade iv glioma||small cell glioblastoma (morphologic abnormality)||isa
extravasation of urine from ureter||escape of urine from tx ureter||isa
bag,closed without adhesive colostomy/ileostomy||pouch,closed,guardian h#4503||isa
superficial ulcer of skin||skin erosion on left lower paranasal fold (physical finding)||isa
agent combination not indexed in open clinical trials||ara-c/ctx/vm-26||isa
ascorbic acid effervescent oral tablet||ascorbic acid@1,000 mg@oral@tablet, effervescent||isa
disorder of soft tissue of lower limb||deep tissue pressure injury of right heel (disorder)||isa
rnax administer medication treatment||injection of anti-infective agent, nos||isa
leptotrichia trevisan 1879||sneathia vaginalis eisenberg et al. 2021||isa
increased active range of thumb flexion (finding)||active flexion of left thumb metacarpophalangeal joint improved by (___ degrees)||isa
diagnostic tests||seralyzer ar phenobarbital||isa
adenosinetriphosphatase activity||atpase-coupled transmembrane transporter activity||isa
bones disease||mechanical complication of internal nails||isa
trunk of temporo-occipital branch of middle cerebral artery||trunk of temporo-occipital branch of left middle cerebral artery||isa
ulcer on scalp stage (physical finding)||ulcer on scalp stage 2||isa
structure of neck of metacarpal bone of left hand (body structure)||structure of neck of fifth metacarpal bone of left hand||isa
urinary elimination alteration||urgency, urinary||isa
biological death||death sudden (nos)||isa
cis-diammine(1,1-cyclobutanedicarboxylato)platinum(ii)||carboplatin-containing product in parenteral dose form||isa
fractures leg lower||potts fracture||isa
metolazone pill||metolazone 10 mg oral tablet [metolazone]||isa
companies||county municipal hospital authority||isa
snare, device (physical object)||wire loop aural snares||isa
system||corneal bur system, line-powered (physical object)||isa
genital or reproductive signs and symptoms||leukorrhagia||isa
airway procedure||maintaining clear airway (procedure)||isa
arthropathy of joint of left hand (disorder)||heberden node of the distal interphalangeal joints of the left hand||isa
alpha tocopherol / ascorbic acid / biotin / dexpanthenol / ergocalciferol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin a / vitamin b12 / vitamin k1 injectable product||alpha-tocopherol acetate 1.4 mg/ml / vit-c 16 mg/ml / biotin 0.004 mg/ml / dexpanthenol 1 mg/ml / vit-d 0.002 mg/ml / folate 0.028 mg/ml / niacinamide 3.4 mg/ml / vit-b6 hydrochloride 0.2 mg/ml / riboflavin 0.28 mg/ml / vit-b1 hydrochloride 0.24 mg/ml / vitamin a 0.14 mg/ml / vitamin b12 0.0002 mg/ml / vitamin k1 0.04 mg/ml injectable solution [mvi pediatric]||isa
mass of soft tissue (finding)||abscess of uvula of palate||isa
enzyme inhibitor-containing product||product containing alcohol dehydrogenase inhibitor||isa
raw plant part||pith, stem||isa
hepatitis c antibody||antibody to hepatitis c virus ns5 (substance)||isa
infusion pump administration set||mechanical infusion pump administration set (physical object)||isa
tissue lysis||cytolytic process||isa
scabs skin||eschar of dorsal aspect of middle finger of left hand (physical finding)||isa
morvans fibrillary chorea||generalized myokymias||isa
laceration of neck (diagnosis)||laceration of right side of neck with well approximated postsuture edges||isa
superficial lymphatic plexus of testis||superficial lymphatic plexus of left testis||isa
relaxants, central muscle||5-chloro-2-hydroxybenzoxazole||isa
finding of quality of voice (finding)||normal vocal quality (finding)||isa
acetaminophen pill||acetaminophen oral tablet [tactinal]||isa
calcification - muscle||ossification of upper arm muscle||isa
drug, neuroprotective||methylprednisolone hemisuccinate||isa
disease of teeth and/or supporting structures||irregular alveolar process||isa
skin findings||cyst of diaper area||isa
peeling of skin||exfoliation was seen on the right thumb periungual region||isa
bone structure of proximal femur||region of proximal femur||isa
intentional opioid receptor agonist poisoning||intentional poisoning by morphine (diagnosis)||isa
genus trichuris larva||trichuris trichiura larval form||isa
drug use behavior||current use of mood-altering drugs denied but suspected||isa
burns of nose (diagnosis)||burns of left side of nose (diagnosis)||isa
benign neoplasm of head, nos||benign tumor of the ear||isa
stage of retinopathy of prematurity of zone 2 of right eye||stage 4 retinopathy of prematurity of zone 2 of right eye (diagnosis)||isa
lamina of brodmann area 44||external granular layer of brodmann area 44||isa
location||mbloc||isa
malignant neoplasm of vulva, unspecified||vulva; melanoma||isa
myzomela albigula (organism)||myzomela albigula albigula||isa
nerves peripheral||nervus ulnaris||isa
receptor blockader, beta-adrenergic||2-propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (s)-||isa
rhinitides||atrophic rhinitis (disorder)||isa
st adl goals upper garments techniques / assistive device||short-term: put on / take off upper garments using a long-handled reaching device||isa
plantar arch||arcuate artery, deep plantar branch||isa
cell function assay||lymphocyte transformation with mitogen culture (procedure)||isa
subdivision of costal pleura||anterior part of costal pleura||isa
acute tracheitis nos (disorder)||acute tracheobronchitis (diagnosis)||isa
enzymes levels||superoxide dismutase measurement||isa
ulcer in right paranasal fold||ulcer of right lower paranasal fold||isa
warfare agent, chemical||tnm||isa
{number}||days to platelet count greater than 100,000 per microliter||isa
condition of fetal growth and/or malnutrition||slow fetal growth or malnutrition||isa
coronary angioplasty (procedure)||coronary art dilation 4 or more arteries bifurcation w/ 4 or more intralum dev||isa
personal care services (treatment)||care provider services personal care services per day||isa
cubomedusae||family chirodropidae (organism)||isa
receptor gene||cd274 gene||isa
patient prepared shopping list||home management shopping preparing list minimum assistance||isa
open wound of shoulder||open bite of shoulder||isa
decreased specific antibody response to protein vaccine||partial absence of specific antibody response to tetanus vaccine||isa
finding of protein level||serology: false positive||isa
shavings||shaving scalp||isa
procedure on bone of upper extremity||oth dx proc-metacar/car||isa
enzyme inhibitor (product)||2,7-diamino-10-ethyl-9-phenylphenanthridinium||isa
adverse reaction to hallucinogen (finding)||adverse reaction to mescaline (finding)||isa
fourth daughter of brother #2 deceased (history)||age at death of fourth daughter of brother #2 (history)||isa
oxidoreductase activity, acting on the ch-nh2 group of donors||2-aminobenzoyl-coa reductase activity||isa
joint fluid specimen (specimen)||foot joint synovial fluid (specimen)||isa
proximal tendon of auricularis posterior||proximal tendon of right auricularis posterior||isa
spec.hndling/conveyance ea.s||handling of oriented specimen (procedure)||isa
cholagogue or choleretic agent||exiproben||isa
allograft for temporary wound closure of thigh (treatment)||allograft for temporary wound closure of thigh, each additional 100 sq cm or less||isa
order dioctophymatida||573 superfamily dioctophymatoidea||isa
articular cartilage disorder of ulna/radius/wrist||chondromalacia of joint of right wrist||isa
zonae hypothalamicae||retrochiasmatic area||isa
unlisted special service or report (treatment)||clinical consultation report||isa
connective tissue neopl||askin's tumor of connective tissue (diagnosis)||isa
cardioverter-defibrillator final programmed parameters zone 2||icd final programmed parameters zone 2 defibrillation (___ joules)||isa
ethane, 1,1'-oxybis-||ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-,(+-)-||isa
x-ray of foot (procedure)||x-ray of right foot, lateral view||isa
subsegmental part of posterior basal segmental artery||accessory subsuperior part of posterior basal segmental artery||isa
carbetapentane / chlorpheniramine oral liquid product||carbetapentane / chlorpheniramine oral suspension||isa
magnet extraction of foreign body from sclera (procedure)||magnetic removal of scleral foreign body from left eye (treatment)||isa
evaluation for hearing aid and testing||electroacoustic evaluation for binaural hearing aids||isa
selenomonas von prowazek 1913||ancyromonas ruminantium||isa
product containing only fenoterol and ipratropium in pulmonary dose form (medicinal product form)||fenoterol 500 microgram and ipratropium 1.25 mg/actuation solution for inhalation||isa
hydatid mole||chm - compl hydatidiform mole||isa
cut(s) on forearm||reported cut of forearm by jagged-edged object (history)||isa
anti-inflammatory preparations||triamcinolone acetonide||isa
bookkeeper, cashier/related worker||wages clerk (occupation)||isa
dilated cardiomyopathy gene tnni3(dcm)||tnni3 variant of uncertain significance (lab test)||isa
diphenhydramine / pramoxine topical lotion||diphenhydramine hydrochloride/pramoxine hydrochloride 2%-1% topical application lotion [dermatox]||isa
question about doctor||i feel that my physician cares about me as a person||isa
wet gangrene of little finger||wet gangrene of little finger of both hands (physical finding)||isa
war injury from firearm ammunition (diagnosis)||war injury from bullets||isa
vitamin b6 oral tablet [vitelle nestrex]||product containing only pyridoxine hydrochloride 20 mg/1 each oral tablet (clinical drug)||isa
trace metal injectable product||trace metals, 2 mcg-0.2 mg-0.16 mg-0.8 mg/ml intravenous solution||isa
nitrous oxide toxicity||nitrous oxide poisoning of undetermined intent||isa
at risk of disease (finding)||at risk of graft-versus-host disease associated with transfusion (finding)||isa
alpha streptococcus||alpha-hemolytic streptococcus species not streptococcus pneumoniae||isa
aluminum chloride topical cream [hyperdrol]||aluminum chloride 190 mg/ml topical cream [hyperdrol]||isa
structure of thenar muscle (body structure)||adductor pollicis muscle structure (body structure)||isa
fusion protein expression||col1a1/pdgfb fusion protein expression||isa
hereditary disorder of nervous system||inherited autonomic nervous system disorder (disorder)||isa
surgical repair procedure by device||guide wire recanalization of central venous catheter using fluoroscopic guidance (procedure)||isa
segment of skin of free upper limb||skin of lateral part of elbow||isa
biological property||copy_number||isa
transplantation of tissue of hand||release of thumb-in-palm deformity||isa
transfusion reaction due to isoantibody (disorder)||abo incompat reaction due to transfuse of bld/bld prod, unsp||isa
post-traumatic hypopituitarism||post-infarction hypopituitarism (disorder)||isa
product containing acetylcysteine in oral dosage form||acys-5 500 mg oral tablet||isa
blood cell count ratio measurement||immature reticulocyte fraction||isa
endoscopy of nose||diagnostic endoscopy of nose and sinuses||isa
test results documented and reviewed (treatment)||performance of chlamydia and gonorrhea screenings documented (treatment)||isa
biopsy small intestine benign neoplasm carcinoid||biopsy small intestine benign neoplasm carcinoid jejunum (procedure)||isa
disorder characterized by edema (disorder)||venous stasis ulcer co-occurrent with oedema of lower leg||isa
isavuconazonium injection [cresemba]||isavuconazonium sulfate 372 mg injection [cresemba]||isa
fascia of flexor digiti minimi brevis of hand||epimysium of flexor digiti minimi brevis of hand||isa
skin observation||area of artificial skin of ankle||isa
tight retinacular ligament test of finger of right hand (physical finding)||tight retinacular ligament test of index finger of right hand||isa
analgesics, opioid||buprenorphine hydrochloride 8mg, naloxone hydrochloride 2mg sublingual tablet||isa
topical anti-infective||halazone||isa
mouse noncancerous conditions||inflammatory conditions of the mouse mammary gland||isa
adaptive behavior assessment procedures||behavior id assessment by phys/qhp ea 15 min||isa
peridental branch of anterior superior alveolar artery||peridental branch of right anterior superior alveolar artery||isa
aortic valve; regurgitation||moderate aortic valve regurgitation||isa
vein of cochlear window||vein of left cochlear window||isa
structure of bilaminar embryo (body structure)||bilaminar embryo||isa
dorsal ramus of sixth thoracic spinal nerve||posterior right sixth thoracic ramus||isa
bronchoscopy secretions of right upper lobe anterior segmental bronchus (procedure)||bronchoscopy (diagnostic) right upper anterior segment bronchial secretions amount||isa
open procedure on cecum or ascending colon in detail (treatment)||ascending colon procedure peritoneal cavity irrigated||isa
surface of superior articular process proper of twelfth thoracic vertebra||surface of right superior articular process proper of twelfth thoracic vertebra||isa
retention, nos||sebum retention (morphologic abnormality)||isa
administration of pain reliever||analgesic administration: intraspinal||isa
contracture of quadriceps||contracture of rectus femoris (disorder)||isa
oxybutynin oral product||oxybutynin cl 5mg tab||isa
2,4-imidazolidinedione, 3-ethyl-5-phenyl-||product containing ethotoin in oral dose form (medicinal product form)||isa
antileprotic drug adverse reaction (disorder)||ar - clofazimine||isa
ciliary body||structure of ciliary body of right eye (body structure)||isa
joint problems||sprain of shoulder (disorder)||isa
ultraviolet light a (uva) treatment of toe of left foot (treatment)||modalities uva treatment of left fourth toe||isa
partial thromboplastin time||activated ptt 1:1 incubated mix with normal plasma||isa
alkene substituted compound anabolism||cortisol biosynthesis||isa
microbiology test of skin lesion of right wrist||microbiology test of skin lesion of dorsal aspect of right wrist (lab test)||isa
subcutaneous tissue of plantar surface, third toe||entire subcutaneous tissue of plantar surface of third toe (body structure)||isa
central nervous system stimulants (medication)||benzphetamine product||isa
implantable cardioverter-defibrillator post-adjustment summary (procedure)||implantable cardioverter-defibrillator post-adjustment summary device functioning correctly (procedure)||isa
medical record review||chart review, verification of charges (procedure)||isa
disease or syndrome of uterine cervix||infertility of cervical origin||isa
skin findings||skin erosion on left middle back (physical finding)||isa
drug therapy status||thrombolysis therapy not indicated||isa
structure of dorsal foramina of sacrum||right dorsal sacral foramen||isa
insecticide||fenthion||isa
pancreatin delayed release oral tablet||pancreatin 500 mg delayed release oral tablet||isa
plasmacytoma (morphologic abnormality)||multiple solitary plasmacytomas (diagnosis)||isa
emverm pill||mebendazole 100 mg oral capsule||isa
nutritional supplement (substance)||nubasics with fiber vanilla swirl||isa
non-steroidal anti-inflammatory overdose||nabumetone overdose||isa
stomatorrhaphy||suture of floor of mouth (procedure)||isa
surface of articular process of thoracic vertebra||surface of articular process of seventh thoracic vertebra||isa
assessment of anxiety||beck anxiety inventory for youth (bai-y) (procedure)||isa
mouse skeletal system neoplasms||osteosarcoma of the mouse skeletal system||isa
external knee prosthesis||motorized external knee prosthesis||isa
duplex scan left carotid bulb||duplex scan left carotid bulb edv||isa
health status of female cousin #3 by mother's sister #4 (history)||year of birth of female cousin #3 by mother's sister #4 (history)||isa
perineal (qualifier value)||perineum (male)||isa
structure of lateral femoral cutaneous nerve||right lateral femoral cutaneous nerve||isa
organic molecular entity metabolic process||flavonoid metabolism||isa
radiation sensitizing agents||tirapazamine||isa
measurement of output from drain (procedure)||drainage catheter output from mediastinum||isa
cosmopsarus||lamprotornis ornatus||isa
lateral part of dorsal digital artery of foot||lateral part of dorsal digital artery of third toe||isa
tophus (morphologic abnormality)||ankle tophus||isa
medical supply||dr scholl's callous cushion||isa
syphilis infectious titre test||total and rpr immunoassay||isa
betrixaban capsules||betrixaban 40 mg (as betrixiban maleate) oral capsule||isa
catheters foley||catheter,foley 20fr 30cc bard#0166l-20||isa
guaifenesin- and pseudoephedrine-containing product in oral dose form||guaifenesin/pseudoephedrine hcl@580 mg-60 mg@oral@tablet, extended release 12 hr||isa
procedure categorized by device involved||arthroplasty patella w/prosthesis||isa
lufenuron / milbemycin oxime / praziquantel chewable tablet [sentinel spectrum]||lufenuron 230 mg / milbemycin oxime 11.5 mg / praziquantel 114 mg chewable tablet||isa
diphenhydramine only product in oral dose form||goodsense diphedryl 25mg capsule||isa
structure of upper chest wall (body structure)||skin structure of upper chest wall (body structure)||isa
amphetamine and derivatives (substance)||clobenzorex||isa
circulatory system part||heart part (body structure)||isa
scleral conjunctiva||structure of left bulbar conjunctiva (body structure)||isa
glaucoma, secondary||glaucoma caused by silicone oil||isa
amidoline oral product||amidoline 3 mg/ml oral solution||isa
non-infectious skin disorders||prurigo of pregnancy (disorder)||isa
variant coronary artery||absent right coronary artery||isa
peripheral neuropathy, sensory||deafness, nerve type, with mesenteric diverticula of small bowel and progressive sensory neuropathy||isa
direct repair of blood vessel (treatment)||repair blood vessel direct neck||isa
specimen from female genital tract (specimen)||specimen from fallopian tube (specimen)||isa
wound finding (finding)||open fracture of proximal end of ulna (disorder)||isa
refractory malignant skin neoplasm||refractory primary cutaneous lymphoma||isa
developmental hereditary disorder||aniridia, renal agenesis, psychomotor retardation syndrome||isa
supraventricular arrhythmia adverse event nos||grade 5 supraventricular arrhythmia nos||isa
functionally dependent||dependent for sitting (finding)||isa
bronchoscopy secretions of mid trachea||bronchoscopy amount of secretions of mid trachea (procedure)||isa
substance with cytochrome p450 inhibitor mechanism of action (substance)||cobicistat-containing product||isa
product containing cefamandole in parenteral dose form (medicinal product form)||cefamandole in dextrose 5 % 2 gram/100 ml intraven intravenous solution, piggyback (ml)||isa
diagnostic procedure on upper respiratory tract (procedure)||diagnostic endoscopic examination of larynx nos (procedure)||isa
mri ankle articular cart left thinning focal subtalar||mri ankle articular cart left thin focal subtalar anterior||isa
cpd6||cyp2d6*8||isa
family history: sister dead||sixth sister deceased||isa
moles per unit time (qualifier value)||mole/day (qualifier value)||isa
bacillus coagulans chewable product||lactobacillus sporogenes 250,000,000 unt chewable tablet||isa
procedure on small intestine||reduction of volvulus of small bowel||isa
apadaz pill||apadaz 8.16mg-325mg tablet||isa
insufficiency, mitral||macrothrombocytopenia with mitral valve insufficiency||isa
cutaneous nocardiosis||disseminated nocardiosis infection affecting skin||isa
tuberositas tibiae||left tibial tuberosity||isa
product containing only cisatracurium (medicinal product)||product containing only cisatracurium in parenteral dose form (medicinal product form)||isa
at risk of venous thromboembolus||at low risk of venous thromboembolism (finding)||isa
non opioid analgesic||interleukin 002||isa
aluminum hydroxide / magnesium hydroxide / simethicone oral product||alumina, magnesia, and simethicone oral suspension||isa
parenteral dosage form product||product containing docetaxel in parenteral dosage form||isa
uterine mass (___ cm)||lump of cervix (finding)||isa
grossly pathogenic childcare (history)||grossly pathogenic childcare by repeatedly new primary caregivers precluding stable attachments||isa
infective epididymitis (disorder)||epididymis; tuberculous (manifestation)||isa
head neoplasms||intracranial neoplasms||isa
beta-galactosidase-1 deficiency disease||gangliosidosis gm1, juvenile type||isa
rosuvastatin oral capsule||ezallor sprinkle 10mg capsule||isa
sacrum ala||right ala of sacrum||isa
contracture of fingers of right hand||contracture of ring finger of right hand||isa
breast absent||acquired absence of breast (disorder)||isa
perforation, nos||lateral cervical puncture with injection||isa
podofilox topical gel [condylox]||podofilox 0.5% top gel||isa
injury of left internal carotid artery, intracranial portion (diagnosis)||injury of left internal carotid, intracranial portion, w/ loc > 24 hr w/o return to pre-existing conscious level w/ patient surviving (diagnosis)||isa
periosteum of inferior articular process of seventh cervical vertebra||periosteum of right inferior articular process of seventh cervical vertebra||isa
mutagen||7-hydroperoxycholesterol||isa
opioid analgesics||diphenoxylate [dup] (substance)||isa
distal epiphysis of phalanx of third toe||head of phalanx of third toe||isa
acetaminophen / chlormezanone rectal product||acetaminophen / chlormezanone rectal suppository||isa
family sphyraenidae - barracuda (organism)||sphyraena barracuda||isa
patient history||symp&sign distal symm polyneuropathy revwd&docd||isa
x-ray of pelvis and hip||x-ray pelvis and hips ap and lateral frog views||isa
mass of subcutaneous tissue (finding)||lump under skin of dorsal aspect of left elbow (symptom)||isa
toxic metabolic encephalopathy (diagnosis)||urate encephalopathy||isa
anticholinesterase agent (substance)||bis(18)-huperzine b||isa
active range of wrist flexion - finding||active flexion of left wrist (physical finding)||isa
mammography||mammogram magnification and spot views||isa
metatarsal bone structure (body structure)||left metatarsal bone||isa
muscle wasting||atrophy of rhomboid muscle of left shoulder (physical finding)||isa
kemerovo virus subgroup, nos||tindholmur virus (organism)||isa
azelate / cupric oxide / folic acid / niacinamide / pyridoxine / zinc oxide pill||azelate / cupric oxide / folic acid / niacinamide / pyridoxine / zinc oxide oral tablet [tri-zel]||isa
reference||reference point||isa
support group procedure||postnatal support group||isa
left arm hemodialysis catheter site fistula||left arm hemodialysis catheter fistula bruit (physical finding)||isa
retinal round hole||retinal hole of superior aspect of far peripheral retina of left eye||isa
diagnostic ultrasound procedures of the pelvis obstetrical||retired procedure [54291002]||isa
advancement of tendon||retired procedure [26815004]||isa
strep suis||streptococcus suis serotype 17 (organism)||isa
chromosomal translocations||t(1;21)(p36;q22)||isa
genus daphoenositta (organism)||daphoenositta chrysoptera||isa
musculoskeletal implant||carbonic bone filling/substitute implant||isa
langerhans cell histiocytosis, unifocal (morphologic abnormality)||langerhans cell histiocytosis, unifocal, gastrointestinal tract||isa
magnetic resonance imaging of brain (procedure)||magnetic resonance imaging of brain and brain stem, nos||isa
oreothlypis ruficapilla (wilson, 1811)||vermivora ruficapilla ruficapilla||isa
tafinlar oral product||tafinlar 50 mg (as dabrafenib mesylate 59.25 mg) oral capsule||isa
no evidence of mental illness||no history of psychiatric disorder (situation)||isa
fluorouracil injectable solution [adrucil]||fluorouracil 250mg/5ml inj||isa
chlorhexidine -retired-||product containing chlorhexidine in oromucosal dose form (medicinal product form)||isa
caspofungin injectable product||caspofungin acetate 50mg powder for infusion solution vial (product)||isa
catheter,external urinary||cath,external 2" tube lg urocare512235||isa
1-35 operative procedures on the arteries of the head and neck||release of right common carotid artery (treatment)||isa
citric acid topical product||citric acid 5 mg/ml topical solution||isa
closed capitellar fracture of humerus||closed capitellar fracture of left humerus||isa
lasers||laser beam delivery unit, fiberoptic||isa
antibiotic drugs||alamecin||isa
cell part||langerhans' granule (cell structure)||isa
female_repro problem||vaginal wall lesion||isa
genus: tityus||tityus bahiensis (organism)||isa
knee x-ray anteroposterior and lateral views||ap and lateral view x-rays of both knees||isa
forebrains||mature diencephalon||isa
carcinoma of head and neck||head and neck accessory tissue-associated carcinoma||isa
ct arthrography of upper extremity||computed tomography arthrography of metacarpophalangeal joint (procedure)||isa
aromatic amino acid family metabolic process||aromatic amino acid family biosynthetic process||isa
cd14 molecule positive||cd14-positive neoplastic cells present||isa
large bowel fistula (disorder)||extrasphincteric fistula||isa
bacteria and virus antigens-containing vaccine product||mink enteritis vaccine - clostridium botulinum type c bacterin - toxoid (product)||isa
hepatico-duodenostomy||hepaticocystoduodenostomy||isa
erythema multiforme, ctcae||grade 4 erythema multiforme, ctcae||isa
bag,drainable without adhesive,colostomy/ileostomy||pouch,ostomy,active life c#0227-59||isa
training for scooting up in bed (treatment)||training for scooting up in bed with contact guard (treatment)||isa
anomaly of the gallbladder||supernumerary gallbladder||isa
cardiac conduction pathway||areas of slow cardiac conduction (observable entity)||isa
fact-taxane version 4 questionnaire question||fac06335||isa
bacterial cystitis (diagnosis)||gonococcal cystitis||isa
analgesic, non-opioid||apap 226.8mg/cafn 32.4mg/salicylamide 97.2mg tab||isa
closing wound||cls inj common peroneal nerve||isa
melanocytic nevus of face (disorder)||melanocytic naevi of eyelid, including canthus||isa
acetylneuraminic acid n||acido aceneuramico||isa
chemical categorized by structure (substance)||silicon and silicon compound (substance)||isa
joint movement decreased||anterior movement of distal interphalangeal joint of fourth toe of left foot decreased (physical finding)||isa
cerebellar ataxia (disorder)||episodic ataxia type 5||isa
periosteum of diaphysis proper of second metacarpal bone||periosteum of diaphysis proper of left second metacarpal bone||isa
x-ray of toe: erosion (procedure)||x-ray of toe: erosion of second proximal interphalangeal joint||isa
intertrans ligamt thorac regn||t10/t11 intertransverse ligament||isa
structure of jugular lymph node||upper jugular lymph nodes||isa
furuncles on infraclavicular region (physical finding)||furuncles on both infraclavicular regions||isa
free radical scavenger||pentoxifylline (substance)||isa
cholesterol-lowering drug (substance)||olestra (substance)||isa
anterior neck puncture wound||puncture of anterior neck by nail||isa
hydrolase (substance)||oxoprolyl peptidase 05||isa
lypressin nasal product||lypressin nasal spray||isa
periosteum of proximal epiphysis of fifth metacarpal bone||periosteum of proximal epiphysis of left fifth metacarpal bone||isa
product containing oxprenolol in oral dose form (medicinal product form)||oxprenolol extended release oral tablet||isa
category iii codes||place interstitial device(s) in bone for rsa||isa
opening of anterior semicircular canal (body structure)||entire opening of anterior semicircular canal (body structure)||isa
econochlor ophthalmic product||product containing precisely chloramphenicol 10 milligram/1 gram conventional release eye ointment||isa
x-ray of forearm: sclerotic lesion (procedure)||x-ray of forearm: appearance of cortex with sclerotic lesion (procedure)||isa
d86 family loranthaceae||phoradendron nutt., 1848||isa
malignant neopl duodenum||duodenoscopy mass malignant neoplasm (procedure)||isa
cartilage of central part of body of lumbar vertebra||cartilage of central part of body of third lumbar vertebra||isa
drug||aspirin use chronic||isa
maternal hypotension syndrome (diagnosis)||maternal hypotension syndrome as antepartum condition||isa
poorly mineralized cranium||lack of ossification of supraoccipital bone (disorder)||isa
herding breed||belgian tervuren dog||isa
abnormalities nails||abnormality of nail color||isa
clinical assessment tool||confidence scale||isa
structure of suprascapular region||structure of left suprascapular region of back (body structure)||isa
closed wounds||closed injury, brachial plexus, all roots (complete) (disorder)||isa
abnormal auditory perception (diagnosis)||diplacusis||isa
postpartum hemorrhage level of diagnostic certainty||level 3 postpartum haemorrhage||isa
caretaking/parenting skills teaching, guidance, and counseling (regime/therapy)||parent counseling||isa
t4 stage finding||t4 (iva): tumor of uterine cervix/vagina invades mucosa of bladder or rectum and/or extends beyond true pelvis||isa
eyebrows absent||lack of eyebrow||isa
short cord unspecified||short cord+a/n problem||isa
organic sulfur compounds||product containing folpet||isa
secondary disorder of glomerulus||diffuse glomerulosclerosis (morphologic abnormality)||isa
restrictions on physical activity (treatment)||physical activity restrictions - weight-bearing||isa
workstations, digital radiography||workstations, digital radiography, dental||isa
vulva; fusion||labia fusion||isa
x-linked genetic disease||primary ciliary dyskinesia and retinitis pigmentosa syndrome (disorder)||isa
pustules on the scalp||pustules on posterior scalp (physical finding)||isa
flura-drops oral product||sodium fluoride oral solution [flura-drops]||isa
procedure on small intestine||small intestine injection||isa
anaphylactoid reaction to dialysis (disorder)||non-allergic hypersensitivity reaction caused by dialysis membrane||isa
product containing only trandolapril in oral dose form (medicinal product form)||mavik 1 mg oral tablet||isa
cptac questions||was tumor reoccurrence present after initial treatment||isa
flumadine oral product||rimantadine only product in oral dose form||isa
amputated hand||amputation of finger (physical finding)||isa
chlorpheniramine / phenylephrine extended release suspension||chlortan d 8mg-10mg/5ml suspension||isa
namespace concept||extension namespace 1000189||isa
boston naming test (bnt)||bnt phonemic cues given||isa
nutrition (function)||physiology, child nutritional||isa
giant ragweed pollen extract injectable product||ambrosia trifida pollen 1000 [pnu] in 1 ml intradermal injection, solution [ambrosia trifida pollen]||isa
renal artery, anterior division||entire anterior division of renal artery (body structure)||isa
compact bone of inferior articular process of thoracic vertebra||compact bone of right inferior articular process of thoracic vertebra||isa
carbamide peroxide otic solution [e-r-o]||carbamide peroxide 65 mg in 1 ml auricular (otic) solution/ drops [tech care earwax removal drops]||isa
docosahexaenoate / eicosapentaenoate pill||docosahexaenoic acid 200 mg / eicosapentaenoic acid 320 mg oral capsule||isa
superficial flexor muscle of forearm||pronator muscle||isa
typing||serotyping||isa
listening skills promotion therapy (procedure)||auditory monitoring therapy||isa
creation of intrathoracic vascular shunt or bypass, nos||central aortopulmonary shunt operation (procedure)||isa
influenza virus vaccine intranasal||intranasal influenza live virus vaccine (product)||isa
hughes virus||zirqa virus||isa
[m]adenocarcinomas||adenocarcinoma of liver||isa
passive extension of distal interphalangeal joint of second toe of left foot (physical finding)||hypermobile distal interphalangeal joint of second toe of left foot on passive extension||isa
crypturellus erythropus (organism)||crypturellus erythropus margaritae||isa
magnetic removal of intraocular foreign body from anterior segment (treatment)||magnetic removal of intraocular foreign body from anterior segment of left eye||isa
miconazole oral||miconazole buccal tablet||isa
peptidyl-phenylalanine bromination||peptidyl-phenylalanine bromination to l-2'-bromophenylalanine||isa
recurrent aggressive non-hodgkin lymphoma||diffuse mixed cell lymphoma, recurrent, adult||isa
entire intercostal space||entire eighth intercostal space (body structure)||isa
phensuximide oral tablet [milontin]||milontin, 0.5 g oral tablet||isa
thrombectomy of pulmonary artery (procedure)||percutaneous mechanical thrombectomy of pulmonary artery using fluoroscopic guidance with contrast||isa
spl - spondylolisthesis||cervical spondylolisthesis c7 traumatic nondisplaced||isa
finding related to ability to take care of clothes (finding)||able to take care of clothes||isa
hydrolase inhibitor, peptide||tiorphan||isa
procainamide pill||procainamide hcl 750 mg extended release oral tablet||isa
articular cartilage of lunate||articular cartilage of scaphoid facet of lunate||isa
patch on left elbow||patch on outside of left elbow||isa
hla typings||hla class ii typing, high resolution (ie, alleles or allele groups)||isa
african sign language||tanzanian sign language (qualifier value)||isa
aspirin overdoses||toxicity from aspirin due to a self-inflicted overdose||isa
adverse reaction caused by saluretic agent (disorder)||ethacrynic acid adverse reaction||isa
norepinephrine, challenge tests (procedure)||noradrenaline measurement, supine||isa
inflammatory dermatosis (disorder)||seborrhea-like dermatitis with psoriasiform elements (disorder)||isa
muscle strength reduced||weakness of fingers of both hands||isa
structure of perichondrium of ear||entire perichondrium of ear||isa
mycobacterial infection (excluding tuberculosis and leprosy) (disorder)||infection due to mycobacterium goodii (disorder)||isa
finding related to ability to grip||unable to grip||isa
amlodipine / hydrochlorothiazide / valsartan pill||amlodipine 5mg + hydrochlorothiazide 12.5mg + valsartan 160mg tablet (product)||isa
response to lipid||response to estradiol||isa
malignant neoplasm of small intestine tnm staging distant metastasis (m)||malignant small intestine neoplasm m1||isa
ulcer on face along the jaw line||ulcer along jaw line stage||isa
mass of fifth toe of right foot (physical finding)||mass of proximal interphalangeal joint of fifth toe of right foot||isa
rupture of blood vessels||rupture of gastric artery (diagnosis)||isa
have trouble or difficulty question||difficulty understanding me in noisy room||isa
injury;skin||erythrocyanosis (diagnosis)||isa
skin biopsy of right cheek||skin biopsy of right outer cheek||isa
gene (substance)||code, genetic||isa
papaveretum / scopolamine injectable product||papaveretum and scopolamine only product in parenteral dose form||isa
origin||transplantation (procedure)||isa
diagnostic reagent||iprofenin||isa
hormones peptides||ppy gene product||isa
uncoupling agents||alamethicin||isa
cramp in lower limb (finding)||cramp of muscle of right lower limb (finding)||isa
antiestrogen therapy agent||tamoxifen (substance)||isa
antiviral||interferons||isa
biliary stents||polymer biliary stent||isa
treron pompadora (gmelin, jf, 1789)||treron pompadora aromaticus||isa
ccl||cephaclor||isa
bronchial disease||exercise-induced bronchospasms||isa
menthol oral liquid product||menthol 0.2 % mouthwash||isa
measurement of substance (procedure)||pemoline measurement (procedure)||isa
leukodystrophy (disorder)||vanishing white matter leukodystrophy||isa
congenital fusion of ossicles of ear||fusion of ossicles of left ear||isa
bowel rupture||perforation appendicitis||isa
structure of venous network||entire haemorrhoidal plexus||isa
traumatic injury (disorder)||major head injury||isa
forearm||ultrasound scan of forearm (procedure)||isa
horse skin extract injectable solution||equus caballus skin 0.05 g in 1 ml subcutaneous solution [horse epithelia]||isa
carer (person)||child care officer (occupation)||isa
urea cycle; metabolic disorder||high blood ammonia levels||isa
potassium cpds||potassium phosphate||isa
conchal sphenoidal sinus||right conchal sphenoidal sinus||isa
cholagogues or choleretic agents||chenodiol (medication)||isa
active resistive exercises for right shoulder||repetitions of active resistive exercises for right shoulder||isa
compact bone of body of third cervical vertebra||compact bone of central part of body of third cervical vertebra||isa
design of house (history)||house: laundry location||isa
structure of superficial temporal artery||left superficial temporal artery||isa
betamimetics||isoetharine hydrochloride (substance)||isa
embolism of superficial veins of upper extremities (diagnosis)||chronic embolism of superficial veins of upper extremities (diagnosis)||isa
nail bed proper of toe||nail bed proper of second toe||isa
biological control||positive regulation of protein-pyridoxal-5-phosphate linkage||isa
scleritis of left eye (diagnosis)||episcleritis of left eye (diagnosis)||isa
nutritional supplementation||glucerna shake hunger smart vanilla||isa
numerical||520 (qualifier value)||isa
tissue injury of right upper paraspinal region||incision of right upper paraspinal region (physical finding)||isa
periosteum of posterolateral part of body of thoracic vertebra||periosteum of posterolateral part of body of first thoracic vertebra||isa
fluoroscopic arthrography of ankle (procedure)||fluoroscopic arthrography of right ankle (procedure)||isa
gold radioisotope||gold 198||isa
deformity; oviduct||malposition; congenital, fallopian tube||isa
t1 posterior nerve rootlet complex of medial pectoral nerve||t1 posterior nerve rootlet complex of left medial pectoral nerve||isa
oropharynx structures visualized (mallampati classification)||mallampati class 3 oropharynx||isa
immunosuppressant (product)||basiliximab (medication)||isa
physical therapy precautions for range of motion of finger of right hand||physical therapy precautions for range of motion of ring finger of right hand (treatment)||isa
infected nonvenomous insect bite of left eyelid||bilateral infected wound of eyelids due to nonvenomous insect bite||isa
oral haloperidol (product)||product containing only haloperidol 5 mg/1 each oral tablet||isa
boils legs||furuncle of knee||isa
device substance (physical object)||eye dye (physical object)||isa
negative regulation of cell development||negative regulation of establishment of blood-brain barrier||isa
head finding||absence of skull bone (finding)||isa
reason for no specific anti-cancer treatment||no anti-cancer treatment - poor performance status (finding)||isa
delayed second delivery in multiple pregnancy (diagnosis)||delayed delivery of triplet (disorder)||isa
auditory system hereditary disorder||albinism, ocular, with late-onset sensorineural deafness (disorder)||isa
inferior surface of palatine process of maxilla||inferior surface of palatine process of right maxilla||isa
procedure on anterior chamber of eye (procedure)||ant chamber fb remov by magnet||isa
acute nervous system disorder||acute stroke due to occlusion of right posterior cerebral artery||isa
dot blot hemorrhage||deep retinal hemorrhage of right eye (diagnosis)||isa
product containing ketoprofen in cutaneous dose form (medicinal product form)||powergel 2.5% gel 100g||isa
malignant tumor of esophagus tnm staging||malignant esophageal neoplasm tnm staging of distant metastasis (m)||isa
cephalic versions, external||external cephalic version with tocolysis (treatment)||isa
calcium carbonate chewable tablet [d-cal]||calcium carbonate 850 mg chewable tablet [alka-mints]||isa
spleen acupuncture points (body structure)||sp5 (body structure)||isa
bone marrow culture (procedure)||bone marrow culture erythroid colonies (lab test)||isa
pericarditis chronic||pericarditis due to myxoedema||isa
bowel imaging (procedure)||imaging guided colorectal therapeutic operation (procedure)||isa
bile acid and bile acid derivative (substance)||conjugated bile acids (substance)||isa
needles, syringes and injection supplies||aimsco ultra-thin ii insulin syringes 1cc, 30||isa
dihydric alcohol metabolic process||sphing-4-enine metabolic process||isa
abnormality of the spine||atlantoaxial abnormality||isa
aorta||embolisation of aorta||isa
other coagulation adverse event||ctcae grade 2 coagulation - other||isa
human leukocyte antigen dpw (substance)||human leukocyte antigen dpw1||isa
procedure on organ (procedure)||drainage of cerebral subdural space by aspiration (procedure)||isa
vertebral artery injury||vertebral artery laceration||isa
bandage||sunmark bandage adhesive foam||isa
device evaluation method||device from reserve sample evaluated evaluation method||isa
trunk of systemic vein||vena nutriens||isa
accessory nasal cartilage||accessory nasal cartilages||isa
lentisphaerae||class lentisphaeria||isa
history of viral illness||history of human papillomavirus infection (situation)||isa
purpura on right fourth toe (physical finding)||purpura on the right fourth toe plantar||isa
disease caused by genus rickettsia (disorder)||rickettsial pneumonia (disorder)||isa
animal vocalization (observable entity)||whimpering||isa
ovarian monodermal teratoma||ovarian monodermal and highly specialized teratoma||isa
disease of penis (disorder)||fibrosis of penis (disorder)||isa
haematology test||unlisted hematology study (lab test)||isa
family verbenaceae (organism)||lantana||isa
superficial ulcer of skin (disorder)||skin erosion on dorsal surface of right fourth toe (physical finding)||isa
posterior traumatic dislocation of hip (disorder)||opn trmtc dslctn hip jt, post||isa
poisoning caused by chemical substance||enzyme poisoning nos (disorder)||isa
balanitis circinata (disorder)||circinate balanitis of reiter's disease (disorder)||isa
cartrol tablets||cartrol 5mg tablet||isa
tailor's bunion (disorder)||type ii tailor's bunion of foot (diagnosis)||isa
rotigotine only product||rotigotine only product in transdermal dose form||isa
genus tepidibacter||tepidibacter thalassicus (organism)||isa
purchased services, information technology||document imaging services||isa
neoplasm of shoulder||neoplasm of soft tissue of shoulder||isa
food specific immunoglobulin e||malus sylvestris specific immunoglobulin e||isa
tumor of paratesticular structures||neoplasm of seminal vesicle (diagnosis)||isa
aspirin delayed-release tablets||rite aid aspirin low strength 81mg enteric coated tablet||isa
type - attribute||type of denture (attribute)||isa
laboratory instruments and equipment (physical object)||blood cell freeze/thaw system (physical object)||isa
internal capsule, posterior thalamic radiation||entire posterior thalamic radiation of internal capsule||isa
unit of dose calculation||pg/mmol||isa
insecticide, nos||azinphos-methyl||isa
connective tissues||externa, theca||isa
lymphatic tissue||dispersed lymphoid system||isa
reparative closure using a device (procedure)||operation on ileocecal valve restriction with intraluminal device||isa
fracture of lower epiphysis of femur (diagnosis)||displaced fracture of lower epiphysis of femur (diagnosis)||isa
soft tissues of pelvis, nos||subserosa of oviduct||isa
dermatological agent||trans-butenedioic acid dimethyl ester||isa
chromosome analyses||vcp pathogenic variant||isa
product containing only valaciclovir in oral dose form (medicinal product form)||valaciclovir (as valaciclovir hydrochloride) 250 mg oral tablet||isa
anaesthetic agent concentration||age adjusted minimum alveolar concentration of inhaled anesthetic (observable entity)||isa
basal branch of left pulmonary artery||left pulmonary artery, lateral basal branch||isa
ulcer of right auricle tissue base||ulcer of right auricle tissue base fibrosis||isa
multidrug-resistant bacteria (organism)||multidrug-resistant salmonella||isa
station of fetus||fetal station +1||isa
surgeon||vascular surgeon (occupation)||isa
isotope, nos||iridium isotope (substance)||isa
poisoning caused by aluminum hydroxide||aluminum hydroxide overdose (disorder)||isa
clomipramine pill||clomipramine hydrochloride 5 mg oral tablet [caniquell]||isa
buphenyl oral product||sodium phenylbutyrate 250 mg/ml oral solution||isa
streptomyces, nos||streptomyces globisporus subspecies globisporus||isa
accident-sharp pointed object||accident-dressmaking pin||isa
drugs vasodilators||yohimbine hydrochloride||isa
niacin extended release oral tablet||vitamin b3 250 mg extended release oral tablet||isa
psychotherapy (regime/therapy)||transcendental meditation therapy (procedure)||isa
septum primum structure||entire septum primum||isa
region of surface of vertebra||articular facet of atlas||isa
facial nerve disorders nos||fdfm||isa
chlorpheniramine / hydrocodone / phenylephrine oral solution [baltussin hc]||chlorpheniramine maleate 0.4 mg/ml / hydrocodone bitartrate 1.2 mg/ml / phenylephrine hcl 2.4 mg/ml oral solution||isa
unspecified disorder of bone||x-ray of foot: mixed lytic and sclerotic lesion of inferior cortex (procedure)||isa
dislocation patella||lateral patellofemoral disloc||isa
phenylephrine / shark liver oil rectal product||formulation r, 0.25%-3% rectal cream||isa
biological process involved in symbiotic interaction||arbuscular mycorrhizal association||isa
intolerant ambient temperature||intolerant of heat||isa
posterior pituitary hormone (product)||oxytocin preparation (substance)||isa
radical resection of soft tissue tumor of head (treatment)||radical resection of soft tissue tumor of head 2cm or greater||isa
rutuss with hydrocodone oral product||hydrocodone bitartrate/pheniramine maleate/phenylephrine hydrochloride/phenylpropanolamine hydrochloride/pyrilamine maleate 1.7 mg/5 ml-3.3 mg/5 ml-5 mg/5 ml-3.3 mg/5 ml-3.3 mg/5 ml oral liquid||isa
physostigmine injection||physostigmine salicylate 1 mg/ml injection||isa
diagnostic image digitization systems||image digitization systems, portal||isa
peripheral retinal oedema||midperipheral retinal edema in both eyes||isa
aplasia/hypoplasia of the phalanges of the 3rd toe||absent/small middle 3rd toe bone||isa
meningococcus immunisation||administration of vaccine product containing only neisseria meningitidis serogroup a, c, w135 and y antigens||isa
arroyo willow pollen extract injectable product||arroyo willow pollen extract injectable solution||isa
spurge, nettle||jatropha gossypifolia||isa
product containing betahistine in oral dose form (medicinal product form)||serc-8 tablet||isa
introduction of substance by body site||injection of spinal epidural space (procedure)||isa
erythema of helix (physical finding)||erythema of helix of both ears (physical finding)||isa
acquired pyloric constriction||acquired gastric outlet stenosis||isa
malignant tumor of cervix (disorder)||biopsy of cervix showed large cell nonkeratinizing squamous cell carcinoma||isa
biopsy salivary gland||biopsy salivary gland incisional||isa
deformity; joint||overriding fingers (disorder)||isa
occurrences (qualifier value)||reinfected||isa
gastrectomy subtotal proximal||proximal subtotal gastrectomy, thoracic approach (treatment)||isa
trunk of branch of femoral artery||superficial circumflex iliac arterial trunk||isa
introduction of substance by body site (procedure)||repair of secondary flexor tendon of foot with free graft||isa
iron workers||83 blacksmiths, toolmakers and machine-tool operators||isa
mri ankle left||mri of left ankle with contrast (procedure)||isa
autotrophic co2 fixation||c4 photosynthesis||isa
maalox total stomach relief oral liquid product||bismuth subsalicylate oral suspension||isa
narcotics||17-(cyclobutylmethyl)morphinan-3,14-diol||isa
admission statuses (finding)||listed for obstetric admission (treatment)||isa
hyperfunction; parathyroid||primary; hyperparathyroidism||isa
patient refusal of treatment||medium-chain acyl-coenzyme a dehydrogenase deficiency screening test declined||isa
capillary leak syndrome, ctcae||grade 1 capillary leak syndrome, ctcae||isa
shoulder girdle exercises (regime/therapy)||exercises shoulder||isa
obstetrics and gynecology department||obstetrics department||isa
product containing only coagulation factor xi (medicinal product)||coagulation factor xi only product in parenteral dose form||isa
paliperidone prefilled syringe [invega]||1.75 ml invega 312 mg/ml prefilled syringe||isa
fexofenadine oral liquid product||fexofenadine hydrochloride 30 mg in 5 ml oral suspension [childrens fexofenadine hydrochloride allergy]||isa
mea - multip endocr adenomatos||men (multiple endocrine neoplasia) 4 syndrome||isa
promethazine only product in oral dose form||promethazine hydrochloride 10 mg oral tablet||isa
adult pineal parenchymal cell neoplasm||pineoblastoma||isa
carbuncle of index finger of right hand||carbuncle of periungual region of index finger of right hand (physical finding)||isa
bulk compounding chemicals||multiwax 180-w||isa
cutaneous plaque||skin patch of palmar aspect of middle finger of right hand||isa
total hip replacement prosthesis (physical object)||ceramic-on-metal total hip prosthesis (physical object)||isa
closure sutures||suture of wound of forelimb (procedure)||isa
paralyses||paralysis spastic||isa
catheterized||insertion of tunnelled indwelling catheter with cuff into pleura||isa
rattlesnake (organism)||eastern diamondback||isa
dextran product||dextran 75 in saline||isa
injection of therapeutic substance nos (procedure)||therapeutic injection of hyaluronic acid||isa
hormone drug, nos||secretin product||isa
ninth innermost intercostal muscle||left ninth innermost intercostal muscle||isa
regulation of embryonic development||regulation of basement membrane disassembly involved in semicircular canal fusion by cell communication||isa
eating abilities||ability to bottle feed||isa
malignant neoplasm of the bladder||medullary carcinoma of bladder||isa
superficial injury of lower extremity without infection (disorder)||superficial injury of thigh without infection||isa
disorder of lipoprotein storage and metabolism (disorder)||low density lipoprotein receptor mutation (disorder)||isa
carcinoma of urinary bladder, invasive||biopsy of bladder showed carcinoma invasive||isa
mass of thoracic vertebrae (finding)||t-spine mri osseous mass si ratio hypointense t8||isa
lymph metastases nodes||lymph node neoplasm malignant secondary neck infraclavicular||isa
rhomboideus thoracis muscle||entire rhomboideus thoracis muscle (body structure)||isa
mass of hand (physical finding)||exostosis of right hand||isa
neuroplasty, major peripheral nerve, arm or leg, open||neuroplasty, major peripheral nerve, arm or leg, open; brachial plexus||isa
intracellular protein transmembrane transport||peroxisome matrix protein import, translocation||isa
trunk of branch of anterior ethmoidal artery||trunk of anterior meningeal branch of anterior ethmoidal artery||isa
appliance procedures||release of suprapubic sling||isa
[x]phobic anxiety disorders||androphobia||isa
procedure carried out on subject||facial bone foreign body removed (procedure)||isa
x-ray of finger: mixed lytic and sclerotic lesion (procedure)||x-ray finger(s) mixed lesion septated||isa
haemorrhagic ovary||hematoma of right ovary||isa
insufflation - action||pneumoperitoneum - abdomen (procedure)||isa
aspirin pill||aspirin extended release oral tablet [zero-order release]||isa
genus pterocles||pterocles senegallus (organism)||isa
bothrops (organism)||palm viper||isa
radionuclide venous thrombosis study||radioisotope scan of extremity veins for thrombosis||isa
albumin human, usp injection [albuminex]||flexbumin 50 mg/ml injection||isa
induced termination of pregnancy complicated by shock||legal abortion complicated by shock (disorder)||isa
ethotoin only product in oral dose form||peganone 250 mg oral tablet||isa
muscular branch of lateral branch of dorsal branch of first lumbar artery||muscular branch of lateral branch of dorsal branch of left first lumbar artery||isa
external hemorrhoids, nos||external hemorrhoids without mention of complication||isa
measure of uterine contractions (observable entity)||duration of uterine contraction (observable entity)||isa
clinical chemistry test||triiodothyronine t3 (chemistry procedures)||isa
surface of ampulla of oviduct||external surface of ampulla of uterine tube||isa
bone skull||frontal; fracture||isa
dura mater of anterior root of fifth sacral nerve||dura mater of anterior root of right fifth sacral nerve||isa
localized loss of skin surface (symptom)||localized skins (symptom)||isa
skin erosion on right little toe (physical finding)||skin erosion on the right little toe medial||isa
product manufactured as oral dosage form||lactulose-containing product in oral dose form||isa
lifting hips off bed assistance required (physical finding)||lifting hips off bed required contact guard (physical finding)||isa
compact bone of third cervical vertebral arch||compact bone of lamina of third cervical vertebra||isa
skin finding||skin graft of left side of neck||isa
degeneration; retina||clumped pigmentary retinal degeneration of inner macula of right eye||isa
exposure to chemical liquids||exposure to hydrocarbon solvents (history)||isa
hand excision (procedure)||tenectomy of hand||isa
oxidoreductase gene||c1-thf-synthase||isa
placidyl pill||placidyl 750mg capsule||isa
biological regulation||negative regulation of regulation of translation initiation by eif2alpha phosphorylation in response to endoplasmic reticulum stress||isa
shaft of phalanx of ring finger||shaft of middle phalanx of fourth digit of hand||isa
purpura was seen||infraclavicular purpura was seen||isa
polymorphonuclear leukocytes||immature granulocyte||isa
organ part cavity||lumen of cochlear duct of membranous labyrinth||isa
hydroxytryptamine antagonists 05||gran||isa
assessment of fingerstick site of middle finger of right hand||lipohypertrophy of middle finger of right hand at fingerstick site (physical finding)||isa
lipstick (substance)||cdisc terminology||subset_includes_concept
immunoglobulin g subclass 2 measurement||send||subset_includes_concept
inflammatory pseudotumor||gdc value terminology||subset_includes_concept
curie per milliliter||ich unit of measure terminology||subset_includes_concept
pegfilgrastim||national cancer institute drug dictionary||subset_includes_concept
pentobarbital measurement (procedure)||cdisc||subset_includes_concept
azipramine hydrochloride||fda unii code terminology||subset_includes_concept
belt||component code||subset_includes_concept
numeric test result||germ cell tumor variable terminology||subset_includes_concept
4-pyrimidinamine, 5-bromo-2,6-di-1h-pyrazol-1-yl-||clinical trials reporting program agent terminology||subset_includes_concept
mavrilimumab||ncit covid-19 terminology||subset_includes_concept
unknown||gdc site of resection or biopsy terminology||subset_includes_concept
obstructions, ureteral||pediatric adverse events terminology||subset_includes_concept
refractory anemia with excess of blasts||mapped icd-o-3.2 terminology||subset_includes_concept
diphosphoric acid, tetrasodium salt||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
dobhoff tube||pediatric medical device terminology||subset_includes_concept
dad0144||cdisc questionnaire terminology||subset_includes_concept
histone-lysine n-methyltransferase ezh2||clinical trials reporting program biomarker terminology||subset_includes_concept
match arm eay131-z1m||clinical trial data commons value terminology||subset_includes_concept
streptococcus pneumoniae serotype 19f igg antibody||sdtm-mbtestcd||subset_includes_concept
feline sarcoma oncogene gene||genomics data commons terminology||subset_includes_concept
frontal sinus structure (body structure)||too||subset_includes_concept
product containing zanolimumab||national cancer institute drug dictionary||subset_includes_concept
study stop rules||tsparmcd||subset_includes_concept
braf c.1790t>g||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
guanine nucleotide-binding protein g(y) subunit alpha||clinical trials reporting program biomarker terminology||subset_includes_concept
haq0232||sdtm||subset_includes_concept
low density lipoprotein receptor wt allele||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
sum of viable diameter||cdisc sdtm terminology||subset_includes_concept
uhdr1-finances||cdisc qrs terminology||subset_includes_concept
sapropterin-containing product||clinical trials reporting program biomarker terminology||subset_includes_concept
sf36409c||sf364tn||subset_includes_concept
radix angelicae sinensis/radix astragali herbal supplement||genomics data commons terminology||subset_includes_concept
maximum concentration normalized by surface area||cdisc sdtm pharmacokinetic parameter long name terminology||subset_includes_concept
thyroid stimulating immunoglobulins||lbtest||subset_includes_concept
gastroparesis, ctcae||gdc value terminology||subset_includes_concept
omasum (body structure)||spec||subset_includes_concept
recurrent gastric adenocarcinoma||ctrp terminology||subset_includes_concept
farletuzumab||ctrp terminology||subset_includes_concept
trichlormethiazide (medication)||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
reverse transcriptase pcr||molecular_analysis_method||subset_includes_concept
nm_005228.3:c.2239_2247delttaagagaa||clinical trials reporting program biomarker terminology||subset_includes_concept
ms||clinical trials reporting program biomarker terminology||subset_includes_concept
becquerel(s)/litre||cdisc sdtm unit of measure terminology||subset_includes_concept
obi-888||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
taxol analogue sid 530||genomics data commons terminology||subset_includes_concept
eye disorders - other||gdc value terminology||subset_includes_concept
adenomas parathyroid||ncit neoplasm core terminology||subset_includes_concept
papilloma of the breast||mapped icdo3.1 morphology terminology||subset_includes_concept
fact-taxane version 4 - i feel ill||qs-fact-taxane version 4 test||subset_includes_concept
stage iiia small intestinal cancer ajcc v7||ctrp disease terminology||subset_includes_concept
disconnected precordial electrode v6 by ecg finding||send||subset_includes_concept
per 200hpf||cdisc send terminology||subset_includes_concept
indecainida||fda unii code terminology||subset_includes_concept
elbow joint structure||sdtm-loc||subset_includes_concept
large cell calcifying sertoli cell tumor (morphologic abnormality)||mapped icdo3.2 morphology terminology||subset_includes_concept
gaf gene amplification||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
tp55||cdisc send terminology||subset_includes_concept
uhdr104||cdisc terminology||subset_includes_concept
fac061-illness is hardship for my family||cdisc questionnaire terminology||subset_includes_concept
nras1 c.181_183caa>aag||ctrp terminology||subset_includes_concept
stage i nasal cavity and paranasal sinus squamous cell carcinoma ajcc v7||clinical trials reporting program disease terminology||subset_includes_concept
murphy prostate cancer 1980 oncology response criteria||category of oncology response assessment||subset_includes_concept
sxa||cdisc sdtm terminology||subset_includes_concept
fac10060||cdisc questionnaire terminology||subset_includes_concept
micrococcus lylae||clinical data interchange standards consortium terminology||subset_includes_concept
refractory severe aplastic anemia||clinical trials reporting program disease terminology||subset_includes_concept
asp||clinical trials reporting program terminology||subset_includes_concept
clpb||sdtm||subset_includes_concept
bovine lactoferrin supplement||ncit covid-19 agent terminology||subset_includes_concept
malignancy, unspecified site||neoplasm type||subset_includes_concept
sodium/calcium exchanger 1||ctrp terminology||subset_includes_concept
puquitinib||genomics data commons terminology||subset_includes_concept
organization staff role code||biomedical research integrated domain group model terminology||subset_includes_concept
pdef||ctrp biomarker terminology||subset_includes_concept
elk4||clinical trials reporting program terminology||subset_includes_concept
naproxen etemesil||fda unii code terminology||subset_includes_concept
postpartum complication||cptac codelists terminology||subset_includes_concept
ethanol measurement (procedure)||cdisc sdtm laboratory test name terminology||subset_includes_concept
nicotine transdermal patch (medication)||clinical trials reporting program terminology||subset_includes_concept
idsr109||cdisc terminology||subset_includes_concept
callithrix||genus and species response||subset_includes_concept
constructional praxis||cdisc||subset_includes_concept
solute carrier family 36 member 1||ctrp molecular genetic biomarker terminology||subset_includes_concept
4-[2-[4-[(11r)-3,10-dibromo-8-chloro-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide||clinical trials reporting program terminology||subset_includes_concept
carcinoma of the bronchus||cptac neoplasms codelist||subset_includes_concept
rh1 benzoquinone||agent||subset_includes_concept
saint johnswort||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
u2af1 gene||genomics data commons terminology||subset_includes_concept
pentanucleotide marker name||mercaptopurine/methotrexate/tretinoin||subset_includes_concept
maximum observed excretion rate normalized by dose||cdisc send terminology||subset_includes_concept
gemcitabine-doxil regimen||multi-agent therapeutic regimens||subset_includes_concept
intraductal route of administration||fda structured product labeling terminology||subset_includes_concept
distal femur r1||cdisc send terminology||subset_includes_concept
bone structure of clavicle (body structure)||ews biopsy/surgical procedures table||subset_includes_concept
have you had a problem with passing wind / gas / flatulence||quality of life questionnaire - gastrointestinal neuroendocrine tumors 21||subset_includes_concept
large (qualifier value)||size||subset_includes_concept
acquired ovarian failure||pediatric endocrinology terminology||subset_includes_concept
tbr-ii||second_gene_symbol||subset_includes_concept
glutathione peroxidase 3||clinical trials reporting program biomarker terminology||subset_includes_concept
eccrine poromas||mapped icd-o-3.1 terminology||subset_includes_concept
not reported||gdc ajcc staging system edition terminology||subset_includes_concept
generic name||fda electronic common technical documents terminology||subset_includes_concept
ds-1001||gdc therapeutic agent terminology||subset_includes_concept
stage i oropharyngeal (p16-negative) throat cancer||clinical trials reporting program terminology||subset_includes_concept
toxoplasmoses||pediatric infectious disease terminology||subset_includes_concept
css0416b||cdisc||subset_includes_concept
cancer surgery||cptac treatments codelist||subset_includes_concept
fgfr3 p.g370c||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
vitamin a (acetate)||fda unii code terminology||subset_includes_concept
fac029-i have a lack of energy||clinical data interchange standards consortium terminology||subset_includes_concept
arprinocid||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
zn-15l||clinical trials reporting program terminology||subset_includes_concept
css0414b||cdisc qrs terminology||subset_includes_concept
pco2adjt||cdisc sdtm laboratory test code terminology||subset_includes_concept
fac08407||cdisc qrs terminology||subset_includes_concept
deltex (drosophila) homolog 2||clinical trials reporting program reference gene terminology||subset_includes_concept
stage r0||cptac lihc baseline form||subset_includes_concept
recombinant insulin||gdc value terminology||subset_includes_concept
average||clinical data interchange standards consortium terminology||subset_includes_concept
embryo tissue||gdc biospecimen type terminology||subset_includes_concept
adenocarcinoma of the anal gland||gdc terminology||subset_includes_concept
chronic lymphocytic leukemia, in remission||clinical trials reporting program disease terminology||subset_includes_concept
tonsil||genomics data commons terminology||subset_includes_concept
fac061-i worry transplant will not work||cdisc questionnaire terminology||subset_includes_concept
cael101||national cancer institute drug dictionary||subset_includes_concept
gad-7 - feel afraid as if something awful might happen||cdisc questionnaire gad-7 test name terminology||subset_includes_concept
uhdrs 1999 version - permanently institutionalized||sdtm||subset_includes_concept
magnesium glycinate-containing product||fda unii code terminology||subset_includes_concept
lbreasex||cdisc send variable terminology||subset_includes_concept
sppb1-did not attempt balance specify||cdisc functional test terminology||subset_includes_concept
exocrine pancreatic carcinoma pt0 tnm finding v8||cptac baseline medical forms terminology||subset_includes_concept
common iliac lymph node||gdc lymph node involved site terminology||subset_includes_concept
delta(4)-desaturase, sphingolipid 1||clinical trials reporting program biomarker terminology||subset_includes_concept
stage iv nodular lymphocyte predominant hodgkin's disease||ctrp terminology||subset_includes_concept
acetazolamide sodium (medication)||ctrp agent terminology||subset_includes_concept
tsval||cdisc-variable||subset_includes_concept
legionella pneumophila serogroup 5||microorganism||subset_includes_concept
hairy cells to total cells ratio measurement||send||subset_includes_concept
ciliary body||cdisc sdtm anatomical location terminology||subset_includes_concept
empjob||clinical data interchange standards consortium terminology||subset_includes_concept
brca 1 gene||clinical trials reporting program biomarker terminology||subset_includes_concept
cas-br-m (murine) ecotropic retroviral transforming sequence gene||ctrp biomarker terminology||subset_includes_concept
karnofksy performance status not evaluated||cptac cervical squamous cell carcinoma and endocervical adenocarcinoma baseline form||subset_includes_concept
bebq concurrent version - baby would take too much milk||cdisc||subset_includes_concept
cd140a gene mutation||ctrp molecular genetic biomarker terminology||subset_includes_concept
tscyc164||qs-tscyc test||subset_includes_concept
cervical cancer pt2a tnm finding v8||cptac cervical squamous cell carcinoma and endocervical adenocarcinoma baseline form||subset_includes_concept
methobarbitone||fda unii code terminology||subset_includes_concept
facit-f version 4 - limit social activity, i am tired||fac071tn||subset_includes_concept
extracranial neuroblastoma||ctrp disease terminology||subset_includes_concept
acute anterolateral myocardial infarction by ecg finding||clinical data interchange standards consortium terminology||subset_includes_concept
skin chemical peel||cptac treatments codelist||subset_includes_concept
feneritrol||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
cdisc questionnaire c-ssrs pediatric/cognitively impaired lifetime/recent test name terminology||clinical data interchange standards consortium terminology||subset_includes_concept
pancreatic preparations pancrelipase||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
powder for injection solution||ncpdp strengthform terminology||subset_includes_concept
cd288||ctrp terminology||subset_includes_concept
g/dl||cdisc||subset_includes_concept
tetralogy of fallot, unspecified (disorder)||nrnt||subset_includes_concept
fact-cog version 3 - work harder than usual to express||cdisc questionnaire terminology||subset_includes_concept
r3601-phys health: limit kind of work||r3601tn||subset_includes_concept
css0405a||cdisc||subset_includes_concept
hamd321||sdtm||subset_includes_concept
ntrk3 fusion||ctrp biomarker terminology||subset_includes_concept
glomerular sclerosis||nichd terminology||subset_includes_concept
grade 1 infant sedation||inc-meddra neonatal adverse events terminology||subset_includes_concept
plvap||clinical trials reporting program biomarker terminology||subset_includes_concept
trial phase 2a||cdisc||subset_includes_concept
pql1808||clinical data interchange standards consortium terminology||subset_includes_concept
i am able to get around by myself||functional assessment of cancer therapy bone marrow transplant questionnaire||subset_includes_concept
vesencumab||ncit antineoplastic agent terminology||subset_includes_concept
(l/d)/(mg/kg/d)||send||subset_includes_concept
date of last contact||cptac melanoma follow-up form||subset_includes_concept
socs-2||clinical trials reporting program terminology||subset_includes_concept
chsf1-strangers spoke with last month||cdisc sdtm terminology||subset_includes_concept
distress over emotional problem with fear||nccn guidelines version 1.2011 distress management problem list screening tool||subset_includes_concept
pcr, reverse transcriptase||sdtm-method||subset_includes_concept
phq03-anxiety attack||cdisc questionnaire phq screener version test name terminology||subset_includes_concept
solid carcinoma||genomics data commons terminology||subset_includes_concept
carbetimer||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
clinical stage iib esophageal adenocarcinoma ajcc v8||clinical trials reporting program terminology||subset_includes_concept
bixalomer||fda unii code terminology||subset_includes_concept
octyl salicylate||fda unii code terminology||subset_includes_concept
ip3 of the foot||loc||subset_includes_concept
st elevation myocardial infarction by ecg finding||cdisc terminology||subset_includes_concept
pike county, al||us counties terminology||subset_includes_concept
podci adolescent parent-reported version - how he or she looks||sdtm||subset_includes_concept
soapr103||qs-soapp-r test||subset_includes_concept
biologicentityidentifier.effectivedaterange||bridg terminology||subset_includes_concept
mycolicibacterium chimaera||cdisc sdtm terminology||subset_includes_concept
observed steady state volume of distribution normalized by body mass index||send||subset_includes_concept
cigarette||cdisc terminology||subset_includes_concept
stage i papillary thyroid gland carcinoma||ctrp terminology||subset_includes_concept
lipoderm||ncit antineoplastic agent terminology||subset_includes_concept
cyp8a1||clinical trials reporting program reference gene terminology||subset_includes_concept
pirotinib||ncit antineoplastic agent terminology||subset_includes_concept
26s proteasome regulatory subunit s5a||clinical trials reporting program biomarker terminology||subset_includes_concept
powder for topical solution dosage form||pharmaceutical dosage form||subset_includes_concept
carcinoma, basal cell||nci ctep sdc terminology||subset_includes_concept
snx-5422 mesylate||national cancer institute drug dictionary||subset_includes_concept
pelvic pain, ctcae 5.0||gdc value terminology||subset_includes_concept
differentiated and anaplastic thyroid carcinoma pt1a tnm finding v8||cptac baseline medical forms terminology||subset_includes_concept
angiogenin, ribonuclease, rnase a family, 5 gene||clinical trials reporting program biomarker terminology||subset_includes_concept
cinoxopazide||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
ring finger, nos||gdc value terminology||subset_includes_concept
boolean value||bridg terminology||subset_includes_concept
snuff dipper's cancer||ctrp disease terminology||subset_includes_concept
viral conjunctivitides||pediatric infectious disease terminology||subset_includes_concept
s. pneumoniae sero 2 igg ab||sdtm||subset_includes_concept
tumors, thymus||cellosaurus disease terminology||subset_includes_concept
rpq0114||clinical data interchange standards consortium terminology||subset_includes_concept
delayed word recall: word [7]||cdisc questionnaire terminology||subset_includes_concept
tsqm version 1.4 - interfere with physical health||cdisc qrs terminology||subset_includes_concept
pul0209||cdisc functional test pul 2.0 test name terminology||subset_includes_concept
ewing's sarcoma (morphologic abnormality)||clinical proteomic tumor analysis consortium terminology||subset_includes_concept
clostridium difficile regulatory protein dna measurement||sdtm-mbtestcd||subset_includes_concept
johnson county, ne||us counties terminology||subset_includes_concept
sideropenic anaemia||pediatric hematology-oncology terminology||subset_includes_concept
corpus callosum genu||cdisc terminology||subset_includes_concept
cognitive electrophysiology assessment||ctrp terminology||subset_includes_concept
progesterone receptor||gdc gene symbol terminology||subset_includes_concept
congenital melanocytic nevus (disorder)||cellosaurus disease terminology||subset_includes_concept
interleukin 27||cdisc send terminology||subset_includes_concept
chp-brentuximab vedotin||pharmacotherapy regimens||subset_includes_concept
glands, submandibular||cdisc terminology||subset_includes_concept
diazepam product||ctrp terminology||subset_includes_concept
hypertrophy/hyperplasia||send-nonneo||subset_includes_concept
rcamifps||cdisc send terminology||subset_includes_concept
selz||clinical trials reporting program biomarker terminology||subset_includes_concept
sfnp - small fiber neuropathy||cellosaurus disease terminology||subset_includes_concept
pancreatic medullary carcinoma||cptac pancreatic baseline form||subset_includes_concept
classical mantle cell lymphoma||clinical trials reporting program disease terminology||subset_includes_concept
carcinoma; follicular, pure||mapped icdo3.2 terminology||subset_includes_concept
cd1 nu||send||subset_includes_concept
egfr c.2322_2322g>ccacgtg||ctrp biomarker terminology||subset_includes_concept
paget disease and intraductal carcinoma of breast||mapped icdo3.1 terminology||subset_includes_concept
mms1-what is the day of week||cdisc||subset_includes_concept
pr01||cdisc questionnaire terminology||subset_includes_concept
ass||clinical trials reporting program disease terminology||subset_includes_concept
hla-a*02:01/tp53aa264-272 complex||clinical trials reporting program biomarker terminology||subset_includes_concept
tissue donor, nos||cdisc terminology||subset_includes_concept
microencapsulated rapamycin||nci drug dictionary terminology||subset_includes_concept
npi1lfs||cdisc questionnaire terminology||subset_includes_concept
plug device||component code||subset_includes_concept
greatest dimension tumor||cptac baseline medical forms terminology||subset_includes_concept
ihh wt allele||clinical trials reporting program terminology||subset_includes_concept
stage ii ovarian cancer ajcc v8||ctrp disease terminology||subset_includes_concept
puff dosing unit||ucum terminology||subset_includes_concept
stil centriolar assembly protein||ctrp biomarker terminology||subset_includes_concept
gose1-other problems related to injury||cdisc sdtm terminology||subset_includes_concept
iu/ml/(ug/day)||pk units of measure||subset_includes_concept
rpq01-sleep disturbance||cdisc questionnaire terminology||subset_includes_concept
hsa-mir-210||ctrp terminology||subset_includes_concept
stricture of: [colon] or [ileum] or [intestine nos]||nichd terminology||subset_includes_concept
brown fat tumour||gdc value terminology||subset_includes_concept
stage iva oropharyngeal (p16-negative) carcinoma ajcc v8||ctrp terminology||subset_includes_concept
fac050-i feel ill||cdisc qrs terminology||subset_includes_concept
rigui||ctrp biomarker terminology||subset_includes_concept
anesthesias, general||nichd terminology||subset_includes_concept
coding system||bridg attribute terminology||subset_includes_concept
vfq25-self administered format - difficulty shaving or styling hair or putting on makeup||cdisc questionnaire vfq25-self administered format test code terminology||subset_includes_concept
khk2823||agent||subset_includes_concept
ductal lavage||ctrp intervention terminology||subset_includes_concept
adl01-usual eating performance||alzheimer's disease cooperative study-activities of daily living inventory questionnaire test code||subset_includes_concept
4-stair descend functional test test code||clinical data interchange standards consortium terminology||subset_includes_concept
flotetuzumab||genomics data commons terminology||subset_includes_concept
pancreatic polypeptide||sdtm||subset_includes_concept
inh||fda structured product labeling terminology||subset_includes_concept
nc051||us counties terminology||subset_includes_concept
ccnd3||gdc value terminology||subset_includes_concept
u-13c-gln||clinical trials reporting program agent terminology||subset_includes_concept
neurotensin wt allele||ctrp molecular genetic biomarker terminology||subset_includes_concept
autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine||ncit antineoplastic agent terminology||subset_includes_concept
1h-imidazolium, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-3-(2-(4-fluorophenyl)-2-oxoethyl)-, chloride||fda unii code terminology||subset_includes_concept
anaplastic lymphoma receptor tyrosine kinase||ctrp molecular genetic biomarker terminology||subset_includes_concept
isis-2503||ncit antineoplastic agent terminology||subset_includes_concept
pericarditis, ctcae||gdc value terminology||subset_includes_concept
lymphangioendothelial; sarcoma||mapped icd-o-3.2 morphology terminology||subset_includes_concept
d-phenylalanyl-cysteinyl-tyrosyl-d-tryptophyl-lysyl-valyl-cysteinyl-tryptophanamide||ncit antineoplastic agent terminology||subset_includes_concept
schisto||cdisc||subset_includes_concept
hemicrania continua||nichd terminology||subset_includes_concept
css11-number of actual attempts-life||cdisc questionnaire terminology||subset_includes_concept
argininosuccinate synthase 1 gene||ctrp molecular genetic biomarker terminology||subset_includes_concept
pik3r1 gene||genomics data commons terminology||subset_includes_concept
h3 histone family, member j gene||ctrp molecular genetic biomarker terminology||subset_includes_concept
odi01-walking||cdisc questionnaire odi v2.1a test code terminology||subset_includes_concept
podci168||clinical data interchange standards consortium terminology||subset_includes_concept
medicated animal feed manufacture||structured product labeling business operation terminology||subset_includes_concept
acetate, phenylmercuric||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
sf36 v1.0 standard - physical component score||cdisc terminology||subset_includes_concept
css0803a||css08tn||subset_includes_concept
1-hexylcarbamoyl-5-fluorouracil||ncit antineoplastic agent terminology||subset_includes_concept
eating disorder bulimia nervosa||nichd terminology||subset_includes_concept
nadh dehydrogenase (ubiquinone) deficiency||neonatal research network terminology||subset_includes_concept
npi1-other signs of not caring||cdisc questionnaire npi test name terminology||subset_includes_concept
inulin clearance test||cdisc sdtm laboratory test code terminology||subset_includes_concept
cutaneous surgery||clinical proteomic tumor analysis consortium terminology||subset_includes_concept
honey mouthwash||nci drug dictionary terminology||subset_includes_concept
uterine infection||gdc terminology||subset_includes_concept
terbucromil||fda unii code terminology||subset_includes_concept
max 40279||gdc therapeutic agent terminology||subset_includes_concept
gsk2302024a||gdc terminology||subset_includes_concept
dickey county||us counties terminology||subset_includes_concept
fact-g version 4 - my family has accepted my illness||the functional assessment of cancer therapy-general version 4 questionnaire test code||subset_includes_concept
hla-ha1||ctrp molecular genetic biomarker terminology||subset_includes_concept
undifferentiated sarcoma, not otherwise specified||mapped icdo3.1 morphology pt terminology||subset_includes_concept
tesamorelin acetate (substance)||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
docetaxol||clinical trials reporting program terminology||subset_includes_concept
rita||clinical trials reporting program terminology||subset_includes_concept
1-[n-(2-chloroethyl)-n-nitrosoureido]ethylphosphonic acid diethyl ester||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
orifice of the ureter||sdtm||subset_includes_concept
bottle plastic||fda pharmaceutical quality/cmc terminology||subset_includes_concept
i am interested in sex||functional assessment of cancer therapy bone marrow transplant questionnaire||subset_includes_concept
qsgrpid||cdisc variable terminology||subset_includes_concept
loss of fine movements||extremity manual dexterity||subset_includes_concept
syncytioma||cts-api disease main type terminology||subset_includes_concept
ptap114||cdisc functional test terminology||subset_includes_concept
bsf2 gene||ctrp terminology||subset_includes_concept
v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog wt allele||ctrp biomarker terminology||subset_includes_concept
subject's ability to walk||health utilities index (hui)||subset_includes_concept
podci379||cdisc terminology||subset_includes_concept
not applicable||european directorate for the quality of medicines and healthcare routes and methods of administration||subset_includes_concept
mbp||cdisc sdtm terminology||subset_includes_concept
carcinomatosis nos||mapped icdo3.2 terminology||subset_includes_concept
t3 vertebra||cdisc terminology||subset_includes_concept
gliosarcoma; unspecified site||ncit neoplasm core terminology||subset_includes_concept
tcf12||gene2||subset_includes_concept
hydrochloride, arginine||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
transendocardial route of administration||fda structured product labeling terminology||subset_includes_concept
brivoligide sodium||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
stage iv small intestinal adenocarcinoma||clinical trials reporting program disease terminology||subset_includes_concept
stage iva intrahepatic cholangiocarcinoma||ctrp disease terminology||subset_includes_concept
severity of adverse event||cdisc variable terminology||subset_includes_concept
monohydrate creatine||clinical trials reporting program agent terminology||subset_includes_concept
requested by regulatory agency||cdisc||subset_includes_concept
jnj 65195208||gdc therapeutic agent terminology||subset_includes_concept
allodepleted t-cell immunotherapeutics||ncit antineoplastic agent terminology||subset_includes_concept
esophagus and esophagogastric junction cancer (squamous cell carcinoma and adenocarcinoma) pn2 tnm finding v8||cptac terminology||subset_includes_concept
epds - unhappy had difficulty sleeping||cdisc sdtm terminology||subset_includes_concept
bwtestcd||cdisc send variable terminology||subset_includes_concept
akt inhibitor sr13668||clinical trials reporting program agent terminology||subset_includes_concept
dental paste||ncpdp terminology||subset_includes_concept
infant reflex||nichd terminology||subset_includes_concept
pedsql neuromuscular module acute version 3.0 teen report - hard ask doctors and nurses questions||clinical data interchange standards consortium terminology||subset_includes_concept
rhodotorula <melanotaeniaceae>||microorg||subset_includes_concept
aeout||biomedical research integrated domain group model terminology||subset_includes_concept
dach-platin micelle nc-4016||therapeutic_agents||subset_includes_concept
ca middle third esophagus (disorder)||cptac neoplasms codelist||subset_includes_concept
diabetes mellitus (e08-e13)||cptac chol baseline form||subset_includes_concept
rochalimaea, nos||microorganism||subset_includes_concept
overthecounterproductindicator||bridg attribute terminology||subset_includes_concept
lec01-serious injury caused: job||sdtm||subset_includes_concept
succinylsulfathiazole (substance)||fda unii code terminology||subset_includes_concept
gelonin||genomics data commons terminology||subset_includes_concept
uretero-||ps||subset_includes_concept
erlstb||send||subset_includes_concept
tauroursodeoxycholate||sdtm||subset_includes_concept
indium (111-in) pentetreotide (substance)||clinical trials reporting program terminology||subset_includes_concept
abo a1 subtype determination||send||subset_includes_concept
basc-3 f index (procedure)||behavior assessment system for children, third edition||subset_includes_concept
plasma membrane calcium pump||ctrp molecular genetic biomarker terminology||subset_includes_concept
exporting||fda structured product labeling terminology||subset_includes_concept
qids-sr - total score||cdisc||subset_includes_concept
advanced lung small cell carcinoma||ctrp disease terminology||subset_includes_concept
pacritinib||therapeutic_agents||subset_includes_concept
clover||structured product labeling shape terminology||subset_includes_concept
source documents||cdisc||subset_includes_concept
weight loss exceeding three kilograms||geriatric screening tool||subset_includes_concept
infection pyogenic||health effect - clinical code||subset_includes_concept
biscuits||clinical data interchange standards consortium terminology||subset_includes_concept
sgrq0228||st. george's respiratory questionnaire past 4 weeks version questionnaire test name||subset_includes_concept
fac07522||clinical data interchange standards consortium terminology||subset_includes_concept
can taste most foods normally||university of washington quality of life scale, version 4||subset_includes_concept
percist||cdisc sdtm category of oncology response assessment terminology||subset_includes_concept
peptide transporter involved in antigen processing 2||ctrp terminology||subset_includes_concept
pql1703||cdisc questionnaire terminology||subset_includes_concept
rdq01-only walk short distances||qs-rdq testcd||subset_includes_concept
non-synonymous pdgfr family gene mutation||ctrp terminology||subset_includes_concept
cancer history unknown||cptac baseline medical forms terminology||subset_includes_concept
rc48-acd||gdc therapeutic agent terminology||subset_includes_concept
tympanic bulla||send||subset_includes_concept
kdr protein, human||clinical trials reporting program biomarker terminology||subset_includes_concept
apache ii - hematocrit||cdisc clinical classification terminology||subset_includes_concept
css0517a||sdtm||subset_includes_concept
podci1-climb three flights of stairs||cdisc questionnaire terminology||subset_includes_concept
sr-ai||clinical trials reporting program reference gene terminology||subset_includes_concept
southern pig-tailed macaque||genusspc||subset_includes_concept
psa level less than 100||clinical trials reporting program disease terminology||subset_includes_concept
cdisc questionnaire adcs-cgic test code terminology||cdisc terminology||subset_includes_concept
nortopixantrone||agent||subset_includes_concept
ibandronate sodium (substance)||clinical trials reporting program agent terminology||subset_includes_concept
dcn wt allele||ctrp molecular genetic biomarker terminology||subset_includes_concept
podci189||cdisc terminology||subset_includes_concept
age_at_hist_assessment||germ cell tumor table terminology||subset_includes_concept
homeobox 1h||clinical trials reporting program terminology||subset_includes_concept
record mood||cdisc-obscls||subset_includes_concept
thrap3||ctrp terminology||subset_includes_concept
collagen type v antibody||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
selective estrogen receptor degrader srn-927||gdc therapeutic agent terminology||subset_includes_concept
2-(3,4-dihydroxyphenyl)ethanol||gdc therapeutic agent terminology||subset_includes_concept
powder and solvent for prolonged-release suspension for injection dosage form||european directorate for the quality of medicines and healthcare combined pharmaceutical dose form||subset_includes_concept
lipocortin ii||clinical trials reporting program terminology||subset_includes_concept
english foxhound (organism)||icdc breeds terminology||subset_includes_concept
css0302c||cdisc||subset_includes_concept
octapinol||fda unii code terminology||subset_includes_concept
1h-1,2,3-triazole-5-methanol, alpha-(6,7-bis(difluoromethoxy)-2-naphthalenyl)-alpha-(1-methylethyl)-, (alphas)-||fda unii code terminology||subset_includes_concept
ubidecarenone nanodispersion bpm31510||national cancer institute drug dictionary||subset_includes_concept
indc||clinical data interchange standards consortium||subset_includes_concept
sfmp2-stabbing pain||cdisc qrs terminology||subset_includes_concept
cushingoid, ctcae||gdc adverse event terminology||subset_includes_concept
oncogene sis||clinical trials reporting program reference gene terminology||subset_includes_concept
glutamate carboxypeptidase ii, human||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
stage ii head and neck squamous cell cancer||cptac head and neck squamous cell carcinoma baseline form||subset_includes_concept
ct - chemotherapy||cptac codelists terminology||subset_includes_concept
npi1-change in appetite or weight||neuropsychiatric inventory questionnaire test name||subset_includes_concept
suppqs||sdtm||subset_includes_concept
acoustic nerve disorder nos, ctcae||gdc adverse event terminology||subset_includes_concept
wd6d5_8||qs-whodas 2.0 36-item version proxy-administered test||subset_includes_concept
untreated childhood oligodendroglioma||ctrp disease terminology||subset_includes_concept
gp-100 antigen||nci drug dictionary terminology||subset_includes_concept
bronchiolo-alveolar adenocarcinoma of lung (diagnosis)||neoplasm type||subset_includes_concept
refractory meningioma||ctrp terminology||subset_includes_concept
safe-biopharma standard||cdisc-glossary||subset_includes_concept
piraxostat||fda unii code terminology||subset_includes_concept
genus cedecea (organism)||cdisc sdtm terminology||subset_includes_concept
triptorelin pamoate (medication)||gdc therapeutic agent terminology||subset_includes_concept
trisodium citrate dihydrate||fda unii code terminology||subset_includes_concept
ugt1i||ctrp biomarker terminology||subset_includes_concept
haq01-open a new milk carton||cdisc terminology||subset_includes_concept
naptumomab estafenatox||national cancer institute drug dictionary||subset_includes_concept
disorders of lipid metabolism||nichd terminology||subset_includes_concept
c. difficile toxin b positive||clinical trials reporting program biomarker terminology||subset_includes_concept
mediastinal||tas||subset_includes_concept
guaifenesin (substance)||fda unii code terminology||subset_includes_concept
adl0210a||cdisc sdtm terminology||subset_includes_concept
lec-5 standard version - assault with a weapon: witnessed||sdtm||subset_includes_concept
ict - intracavitary treatment||sdtm||subset_includes_concept
inositol preparation (product)||ncit antineoplastic agent terminology||subset_includes_concept
acid-fast bacilli||cdisc terminology||subset_includes_concept
somatization scale||self-report of personality||subset_includes_concept
drri1c09||deployment risk and resilience inventory-2 questionnaire test name||subset_includes_concept
trial compliance||nci_cdisc-gloss||subset_includes_concept
hla-b wt allele||ctrp molecular genetic biomarker terminology||subset_includes_concept
vascular invasion||clinical data interchange standards consortium terminology||subset_includes_concept
fa-d2||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
gds0209||cdisc terminology||subset_includes_concept
pituitary blastoma||mapped icd-o-3.2 morphology terminology||subset_includes_concept
cisplatin/docetaxel regimen||gdc regimen terminology||subset_includes_concept
pit thyroid hormone resistance||pediatric endocrinology terminology||subset_includes_concept
normal||american college of cardiology/american heart association pediatric and congenital cardiology terminology||subset_includes_concept
apg-2575||ctrp terminology||subset_includes_concept
list a short delay free recall||california verbal learning test, children's version||subset_includes_concept
clogestone||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
lcp1-bcl6 fusion gene||clinical trials reporting program terminology||subset_includes_concept
cyck gene deletion||clinical trials reporting program terminology||subset_includes_concept
udp glycosyltransferase 1 family, polypeptide a7||clinical trials reporting program terminology||subset_includes_concept
mri patient||ctrp terminology||subset_includes_concept
tdg||clinical trials reporting program terminology||subset_includes_concept
nefl protein measurement||sdtm||subset_includes_concept
saimiri boliviensis boliviensis||cdisc terminology||subset_includes_concept
n-ras c.35g>t||cptac melanoma baseline form||subset_includes_concept
pressure, partial||koq||subset_includes_concept
px 478||clinical trials reporting program agent terminology||subset_includes_concept
acrp30||ctrp molecular genetic biomarker terminology||subset_includes_concept
(ml/d)/(ug/kg/d)||pk units of measure - dose mg||subset_includes_concept
ncoa3||clinical trials reporting program terminology||subset_includes_concept
anaplastic lymphoma kinase receptor gene amplification||ctrp disease terminology||subset_includes_concept
alacizumab pegol||fda unii code terminology||subset_includes_concept
prot-att study monitoring||cdisc protocol terminology||subset_includes_concept
osteopontin||cdisc||subset_includes_concept
camiverine||fda unii code terminology||subset_includes_concept
lmdda-llo-chher2 fusion protein-secreting live-attenuated listeria cancer vaccine adxs31-164||national cancer institute drug dictionary||subset_includes_concept
1 pad per day||the expanded prostate cancer index composite short form questionnaire||subset_includes_concept
metastatic squamous cell carcinoma (disorder)||mapped icdo3.2 morphology pt terminology||subset_includes_concept
ft-paced tapping test||cdisc terminology||subset_includes_concept
casp9 protein||ctrp biomarker terminology||subset_includes_concept
islet amyloid polypeptide measurement||cdisc send terminology||subset_includes_concept
sema3f||ctrp reference gene terminology||subset_includes_concept
anti-pd-l1 monoclonal antibody gr1405||ncit antineoplastic agent terminology||subset_includes_concept
ptap114h||cdisc||subset_includes_concept
childhood non-hodgkin lymphoma||nichd terminology||subset_includes_concept
myopathies in metabolic diseases (diagnosis)||nrnt||subset_includes_concept
finding romance||brief appraisal inventory||subset_includes_concept
atrx negative||ctrp molecular genetic biomarker terminology||subset_includes_concept
mpai-4 - adjustment: impaired self-awareness||mpai1tn||subset_includes_concept
hairy and enhancer of split 6 (drosophila) wt allele||clinical trials reporting program biomarker terminology||subset_includes_concept
antiviral elbasvir + grazoprevir||agent||subset_includes_concept
senaparib||ncit antineoplastic agent terminology||subset_includes_concept
neoviderm||national cancer institute drug dictionary||subset_includes_concept
head injury||fda center for devices and radiological health terminology||subset_includes_concept
spray (qualifier value)||ucum terminology||subset_includes_concept
epstein-barr virus associated gastric carcinoma||ctrp terminology||subset_includes_concept
dom||clinical trials reporting program biomarker terminology||subset_includes_concept
css1109b||sdtm||subset_includes_concept
unspecified hepatic or biliary problem||annex e||subset_includes_concept
orange crush||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
intra-cerebrospinal fluid thiotepa regimen||pharmacotherapy regimens||subset_includes_concept
plsmce||cdisc||subset_includes_concept
helicobacter mustelae (organism)||cdisc terminology||subset_includes_concept
uveitis||gdc terminology||subset_includes_concept
mgst2||ctrp reference gene terminology||subset_includes_concept
wd7d4_5||qs-whodas 2.0 36-item version self-administered testcd||subset_includes_concept
4-hydroxy-3-(3-oxo-1-phenylbutyl)coumarin||clinical trials reporting program terminology||subset_includes_concept
pedsql neuromuscular module acute version 3.0 child report - hard explain illness to people||cdisc||subset_includes_concept
lysine-specific demethylase 5c||clinical trials reporting program biomarker terminology||subset_includes_concept
karnofsky performance status 90||cptac lung squamous cell carcinoma and lung adenocarcinoma baseline form||subset_includes_concept
blood antidiuretic hormone abnormal, ctcae||gdc adverse event terminology||subset_includes_concept
cdisc send irradiation field orientation/sequence response terminology||cdisc send terminology||subset_includes_concept
spermatogenesis associated, serine-rich 2-like wt allele||clinical trials reporting program biomarker terminology||subset_includes_concept
pmol/l/(ug/m2/day)||cdisc sdtm pharmacokinetic parameter unit of measure terminology||subset_includes_concept
fit's||annex e||subset_includes_concept
brain, forebrain||cdisc send biospecimens terminology||subset_includes_concept
11q23||clinical trials reporting program terminology||subset_includes_concept
body weight gain reason for exclusion from statistics||cdisc send variable terminology||subset_includes_concept
zinc finger protein 198 gene||clinical trials reporting program terminology||subset_includes_concept
cows - sweating||cdisc qrs terminology||subset_includes_concept
one to four activity minutes||nhs ii-paq||subset_includes_concept
carcinoma simplex of rectum||ncit neoplasm core terminology||subset_includes_concept
epic106c||cdisc questionnaire terminology||subset_includes_concept
fk506 binding protein, 12-kd gene||ctrp biomarker terminology||subset_includes_concept
intestinal vascular disorder||cptac codelists terminology||subset_includes_concept
lap band surgery||cptac treatments codelist||subset_includes_concept
renal disease bone||pediatric adverse events terminology||subset_includes_concept
approach anatomic site code||biomedical research integrated domain group model terminology||subset_includes_concept
piperazine edetate calcium||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
lascufloxacin||fda unii code terminology||subset_includes_concept
intra-arterial brachytherapy||cptac codelists terminology||subset_includes_concept
fact-c version 4 - i have pain||cdisc qrs terminology||subset_includes_concept
definitive therapy date of completion||clinical proteomic tumor analysis consortium terminology||subset_includes_concept
borderline phyllodes tumor (morphologic abnormality)||gdc terminology||subset_includes_concept
electrically controlled extended release patch||spl terminology||subset_includes_concept
lysophospholipase i wt allele||ctrp terminology||subset_includes_concept
rask positive||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
study treatment||cdisc sdtm subcategory for disposition event terminology||subset_includes_concept
semuloparin||ncit antineoplastic agent terminology||subset_includes_concept
anemias, refractory||mapped icdo3.1 morphology pt terminology||subset_includes_concept
(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-α-l-lyxo-hexopyranoside||aml table terminology||subset_includes_concept
adl01-highest level of food preparation||adl01tc||subset_includes_concept
mitis group||microorg||subset_includes_concept
clopamide [ingredient see bdek.]||fda unii code terminology||subset_includes_concept
phase-contrast mri||clinical data interchange standards consortium terminology||subset_includes_concept
varicella zoster immunoglobulin (human)||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
bpi - gnawing||sdtm||subset_includes_concept
pharmacotherapy||gdc value terminology||subset_includes_concept
karnofsky performance status 10||cptac baseline medical forms terminology||subset_includes_concept
gene signature||ctrp terminology||subset_includes_concept
prostate carcinoma pnx tnm finding v8||clinical proteomic tumor analysis consortium terminology||subset_includes_concept
cytochrome p450 family 3 subfamily a member 4||clinical trials reporting program reference gene terminology||subset_includes_concept
allergies||gdc terminology||subset_includes_concept
glutathione s-transferase theta 1 wt allele||clinical trials reporting program terminology||subset_includes_concept
choroidal and ciliary body melanoma pathologic primary tumor tnm finding v8||cptac uveal melanoma baseline form||subset_includes_concept
laboratory test method||cdisc variable terminology||subset_includes_concept
pharmacogenomic study||cdisc sdtm terminology||subset_includes_concept
fac01838||cdisc questionnaire terminology||subset_includes_concept
azurin (50-77)||gdc terminology||subset_includes_concept
emotional symptoms index||srp||subset_includes_concept
ad-rhendo||ctrp agent terminology||subset_includes_concept
rna polymerase iii igg antibody measurement||send||subset_includes_concept
suppre||cdisc terminology||subset_includes_concept
tlr7 agonist lhc165||national cancer institute drug dictionary||subset_includes_concept
vl-2397||nci drug dictionary terminology||subset_includes_concept
pricon||cdisc sdtm subject characteristic test code terminology||subset_includes_concept
amt rec infinity pred norm by wt||sdtm||subset_includes_concept
rituximab-cyclophosphamide-vincristine-prednisone regimen||pharmacotherapy regimens||subset_includes_concept
facit-dyspnea scale 33 item bank version - severity: singing or humming||cdisc qrs terminology||subset_includes_concept
hydrogen peroxide||clinical trials reporting program biomarker terminology||subset_includes_concept
cmv ul38||ctrp biomarker terminology||subset_includes_concept
osmolality||cdisc||subset_includes_concept
rab27a, member ras oncogene family wt allele||ctrp terminology||subset_includes_concept
hilum nodi lymphoidei||cdisc terminology||subset_includes_concept
cancer/testis antigen family 1, member 11 gene||ctrp biomarker terminology||subset_includes_concept
levinea malonatica young et al. 1971 (approved lists 1980)||cdisc terminology||subset_includes_concept
qles1-enjoy the leisure activities||cdisc terminology||subset_includes_concept
elpamotide||national cancer institute drug dictionary||subset_includes_concept
cyclophosphamide/vincristine/methotrexate/prednisone||multi-agent therapeutic regimens||subset_includes_concept
cd29||clinical trials reporting program biomarker terminology||subset_includes_concept
parathyrin, intact||laboratory test code||subset_includes_concept
rg-7212||ncit antineoplastic agent terminology||subset_includes_concept
deleterious muts, e. coli, homolog of, 6 gene mutation||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
avl02-list a word 12||cdisc functional test terminology||subset_includes_concept
no problems with self-care||european quality of life five dimension three level scale questionnaire||subset_includes_concept
activating hepatocyte growth factor receptor mutation||clinical trials reporting program terminology||subset_includes_concept
orange, agent||cptac codelists terminology||subset_includes_concept
phosphatidylcholine-bound silybin||national cancer institute drug dictionary||subset_includes_concept
sgrq0221||cdisc questionnaire sgrq past 4 weeks version test code terminology||subset_includes_concept
fac05014||national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire test name||subset_includes_concept
date of sample collection||nichd terminology||subset_includes_concept
carcinoma, undifferentiated type, nos||mapped icdo3.1 terminology||subset_includes_concept
bone response||sdtm-rstestcd||subset_includes_concept
advanced colon adenocarcinoma||clinical trials reporting program terminology||subset_includes_concept
central african republic||country_of_residence_at_enrollment||subset_includes_concept
charcot-marie-tooth disease type 4j (diagnosis)||cellosaurus disease terminology||subset_includes_concept
4-(5-(5-(4-methylpiperazin-1-yl)benzimidazol-2- yl)benzimidazol-2-yl)phenol||ncit antineoplastic agent terminology||subset_includes_concept
fai50/dose||ich unit of measure terminology||subset_includes_concept
degree unit of plane angle||hl7 unit of measure terminology||subset_includes_concept
baculoviral iap repeat-containing 3||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
immunoglobulin g4, anti-(hepatitis a virus cellular receptor 2 (havcr2)) (humanized clone abt2 gamma4-chain), disulfide with humanized clone abt2 kappa-chain, dimer||ctrp terminology||subset_includes_concept
parturition||sdtm-modtrn||subset_includes_concept
nm_005228.3:c.2156g>a||clinical trials reporting program biomarker terminology||subset_includes_concept
doing your work as well as you would like||quickdash outcome measure||subset_includes_concept
academic research council acute stent thrombosis||cdisc terminology||subset_includes_concept
stage i bladder cancer||cptac terminology||subset_includes_concept
wright staining (procedure)||sdtm||subset_includes_concept
pql1817||cdisc questionnaire pedsql neuromuscular module acute version 3.0 parent of toddler test code terminology||subset_includes_concept
soap, liquid||ncpdp strengthform terminology||subset_includes_concept
hek4||ctrp molecular genetic biomarker terminology||subset_includes_concept
heinz bodies/erythrocytes||send||subset_includes_concept
adenosquamous carcinoma (disorder)||genomics data commons terminology||subset_includes_concept
diffuse; lymphoma, small cell, cleaved||cptac codelists terminology||subset_includes_concept
stage ii large cell carcinoma of the lung||ctrp disease terminology||subset_includes_concept
human papilloma virus associated oropharyngeal squamous cell carcinoma||ctrp disease terminology||subset_includes_concept
css01-most lethal attempt damage||cdisc qrs terminology||subset_includes_concept
malignant tumor of ethmoidal sinus||cptac terminology||subset_includes_concept
arv-471||ctrp agent terminology||subset_includes_concept
refractory myelodysplastic syndrome||clinical trials reporting program disease terminology||subset_includes_concept
phq-15 - shortness of breath||sdtm||subset_includes_concept
haq-di without vas - aid: wheelchair||cdisc qrs terminology||subset_includes_concept
fact-g version 4 - i have pain||cdisc terminology||subset_includes_concept
eye drops suspension (qualifier value)||dosage form||subset_includes_concept
trichinella spiralis (owen 1835)||sdtm||subset_includes_concept
rnclint||cdisc||subset_includes_concept
phq03-feeling bad about yourself||qs-phq screener version testcd||subset_includes_concept
socket||fda center for devices and radiological health terminology||subset_includes_concept
ecog 0||cptac melanoma baseline form||subset_includes_concept
aids-related hpv infection||aids-related human papillomavirus||subset_includes_concept
gab1 wt allele||clinical trials reporting program biomarker terminology||subset_includes_concept
anisochromia||cdisc send terminology||subset_includes_concept
bcl2/adenovirus e1b 19-kd protein-interacting protein 3a gene||ctrp biomarker terminology||subset_includes_concept
dds0303||cdisc questionnaire terminology||subset_includes_concept
nsa-16 - restricted speech quantity||clinical data interchange standards consortium terminology||subset_includes_concept
s-adenosylhomocysteine measurement||clinical data interchange standards consortium terminology||subset_includes_concept
middlebrook 7h12 growth medium||cdisc sdtm terminology||subset_includes_concept
dcarbt||sdtm||subset_includes_concept
ability to wash your back||quickdash||subset_includes_concept
stage ia liver cell carcinoma ajcc v8||cptac lihc baseline form||subset_includes_concept
rucaina||clinical proteomic tumor analysis consortium terminology||subset_includes_concept
approval||clinical data interchange standards consortium||subset_includes_concept
bacterial dermatological disorders||cptac terminology||subset_includes_concept
south africa||send||subset_includes_concept
cohorts||node||subset_includes_concept
organization.effectivedaterange||bridg class and attribute terminology||subset_includes_concept
[x]assault by unspecified means (finding)||clinical proteomic tumor analysis consortium terminology||subset_includes_concept
macao||gdc value terminology||subset_includes_concept
mineral county, montana||us counties terminology||subset_includes_concept
free haemoglobin||clinical trials reporting program terminology||subset_includes_concept
rovalpituzumab tesirine||fda unii code terminology||subset_includes_concept
was additional surgery for new metastatic tumor event performed||cptac glioblastoma multiforme follow-up form||subset_includes_concept
length of umbilical cord||perinatal terminology||subset_includes_concept
metacarpophalangeal joint 4||cdisc send terminology||subset_includes_concept
nps0102||cdisc qrs terminology||subset_includes_concept
paclitaxel preparation||ctrp agent terminology||subset_includes_concept
morphine sulfate sustained-release tablet||national cancer institute drug dictionary||subset_includes_concept
psa level fifty or less||clinical trials reporting program terminology||subset_includes_concept
g6pd-deficient erythrocytes to erythrocytes ratio measurement||sdtm||subset_includes_concept
ec 6.3.2.-, formerly||clinical trials reporting program biomarker terminology||subset_includes_concept
lasp-1||clinical trials reporting program terminology||subset_includes_concept
imc/psca-zeta car bpx-601||ncit antineoplastic agent terminology||subset_includes_concept
t-allo10||nci drug dictionary terminology||subset_includes_concept
vardenafil dihydrochloride||fda unii code terminology||subset_includes_concept
anal ulcer||genomics data commons terminology||subset_includes_concept
g-quadruplex stabilizer bmvc||gdc therapeutic agent terminology||subset_includes_concept
sample size consideration text||bridg class and attribute terminology||subset_includes_concept
gds01-feel worthless||qs-gds testcd||subset_includes_concept
picibanil||genomics data commons terminology||subset_includes_concept
activeingredientdose||bridg terminology||subset_includes_concept
fluprednidene product||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
other histologic type||cptac lihc baseline form||subset_includes_concept
stage ib hepatocellular cancer||clinical trials reporting program terminology||subset_includes_concept
pediatric renal cell carcinoma||nichd terminology||subset_includes_concept
polymorphous adenocarcinoma, classic||mapped icdo3.1 morphology pt terminology||subset_includes_concept
propenzolate||fda unii code terminology||subset_includes_concept
ntrkr3 l239r||ctrp terminology||subset_includes_concept
menstrual irregularities||health effect - clinical code||subset_includes_concept
feline histiocytic sarcoma||cellosaurus disease terminology||subset_includes_concept
tscc01-wanting to yell and break things||cdisc qrs terminology||subset_includes_concept
occcasional (qualifier value)||frequency||subset_includes_concept
day*mmol/l/(mg/g/day)||cdisc sdtm pharmacokinetic parameter unit of measure terminology||subset_includes_concept
pedsql neuromuscular module acute version 3.0 parent of toddler - hard to breathe||cdisc questionnaire terminology||subset_includes_concept
tumor laterality right||cptac head and neck squamous cell carcinoma baseline form||subset_includes_concept
adverse event meddra low level term code||cdisc variable terminology||subset_includes_concept
borderline ovarian endometrioid adenofibroma||mapped icd-o-3.1 morphology terminology||subset_includes_concept
sowsa105||subjective opiate withdrawal scale questionnaire test code||subset_includes_concept
ed102_4||cdisc questionnaire terminology||subset_includes_concept
balantioides coli||cdisc terminology||subset_includes_concept
upd142a||unified parkinson's disease rating scale questionnaire test code||subset_includes_concept
tdi01-change in magnitude of effort||cdisc qrs terminology||subset_includes_concept
propan-1,2-diol||ctrp biomarker terminology||subset_includes_concept
adenoma mucinous||mapped icdo3.2 terminology||subset_includes_concept
nitrogen mustard prodrug pr-104||clinical trials reporting program agent terminology||subset_includes_concept
cariprazine hydrochloride||fda unii code terminology||subset_includes_concept
retained specimens do not contain dna||cdisc sdtm terminology||subset_includes_concept
2-hydroxyflutamide controlled-release formulation||nci drug dictionary terminology||subset_includes_concept
vincristine/prednisone/procarbazine regimen||seer rx interactive antineoplastic drugs database-regimen||subset_includes_concept
sirolimus regimen||single-agent therapeutic regimens||subset_includes_concept
membranoproliferative glomerulonephritis type 3 (aq)||nichd terminology||subset_includes_concept
anesthetized exsanguination and perfusion||cdisc send method of termination terminology||subset_includes_concept
primary mediastinal clear cell lymphoma of b-cell type||ncit neoplasm core terminology||subset_includes_concept
hamd114||qs-hamd 17 testcd||subset_includes_concept
cadmium sulfate||fda unii code terminology||subset_includes_concept
spray dosing unit||spl terminology||subset_includes_concept
levamfetamine||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
lipid granulomatosis||mapped icdo3.2 morphology pt terminology||subset_includes_concept
glioma, retinal||clinical trials reporting program terminology||subset_includes_concept
have trouble finding way to familiar place||functional assessment of cancer therapy-cognitive function version 3||subset_includes_concept
pain score 4||dart||subset_includes_concept
fac071-satisfied with how i am coping||functional assessment of chronic illness therapy-fatigue version 4 questionnaire test code||subset_includes_concept
telo1||clinical trials reporting program disease terminology||subset_includes_concept
proton magnetic resonance spectroscopic imaging||clinical trials reporting program intervention terminology||subset_includes_concept
oabq02||cdisc questionnaire terminology||subset_includes_concept
unknown age when started using smokeless tobacco after regular use||cptac head and neck squamous cell carcinoma follow-up form||subset_includes_concept
childhood tumor||ctrp terminology||subset_includes_concept
rzr-gamma||clinical trials reporting program terminology||subset_includes_concept
pediatric quality of life neuromuscular module acute version 3.0 child report questionnaire||cdisc terminology||subset_includes_concept
x-ray repair cross complementing 5||clinical trials reporting program biomarker terminology||subset_includes_concept
conicine hydrochloride||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
gbp1||send||subset_includes_concept
stage i renal pelvis cancer||ctrp terminology||subset_includes_concept
adenovirus-mediated human interleukin-12 inxn-2001 plus veledimex||clinical trials reporting program terminology||subset_includes_concept
yiqi-yangyin-jiedu herbal decoction||ncit antineoplastic agent terminology||subset_includes_concept
skeletal examination||cdisc terminology||subset_includes_concept
kras g12c inhibitor mrtx849||therapeutic_agents||subset_includes_concept
structure of lunate-triquetrum joint||cdisc send terminology||subset_includes_concept
fact-bmt version 4 - cost of treatment is burden on me||fac061tc||subset_includes_concept
iddm20||clinical trials reporting program biomarker terminology||subset_includes_concept
adcs-adl mci - description of usual performance of physically getting dressed||clinical data interchange standards consortium terminology||subset_includes_concept
disease progression||ta||subset_includes_concept
testicular malignant germ cell tumor nos||ncit neoplasm core terminology||subset_includes_concept
fbr||sdtm-loc||subset_includes_concept
pql02-hard to swallow food||sdtm||subset_includes_concept
sonermin||ncit antineoplastic agent terminology||subset_includes_concept
qles2-leisure time activities||qles2tc||subset_includes_concept
lbornrlo||cdisc-variable||subset_includes_concept
magnesium-based bvf||clinical trials reporting program terminology||subset_includes_concept
css11-preparatory acts/behavior, descr||cdisc sdtm terminology||subset_includes_concept
bone structures||gdc progression or recurrence anatomic site terminology||subset_includes_concept
melanotic schwannoma (disorder)||mapped icd-o-3.2 terminology||subset_includes_concept
liter per minute per microgram per meter squared||sdtm||subset_includes_concept
relative, household||cdisc sdtm terminology||subset_includes_concept
r3601-did you feel worn out||r3601tn||subset_includes_concept
fac05716||sdtm||subset_includes_concept
ventricular arrhythmia associated with brugada syndrome||cdisc||subset_includes_concept
haematocrit (observable entity)||lbtestcd||subset_includes_concept
eccrine syringofibroadenoma of skin (disorder)||mapped icdo3.2 morphology terminology||subset_includes_concept
undetermined (qualifier value)||cdisc send tumor findings histopathology result category terminology||subset_includes_concept
gi-4000 vaccine||ctrp agent terminology||subset_includes_concept
derivedethnicityorigincode||biomedical research integrated domain group model terminology||subset_includes_concept
aurixim||agent||subset_includes_concept
tag-72||lbtest||subset_includes_concept
ug (qualifier value)||unit||subset_includes_concept
isa-hpv-01||ctrp terminology||subset_includes_concept
valve area||cdisc sdtm terminology||subset_includes_concept
gad0203||cdisc questionnaire gad-7 version 2 test name terminology||subset_includes_concept
stage iii soft tissue sarcoma of the trunk and extremities ajcc v8||ctrp terminology||subset_includes_concept
aieoplam92||aml table terminology||subset_includes_concept
tenth cranial nerve, nos||spec||subset_includes_concept
avb6||ctrp biomarker terminology||subset_includes_concept
r-spondin 3 wt allele||ctrp molecular genetic biomarker terminology||subset_includes_concept
top2a wt allele||ctrp biomarker terminology||subset_includes_concept
estramustine phosphate sodium (substance)||national cancer institute drug dictionary||subset_includes_concept
not stated||cogrrg||subset_includes_concept
e1a lipid complex||ncit antineoplastic agent terminology||subset_includes_concept
monosomy 7||acute myeloid leukemia table terminology||subset_includes_concept
disorder, neurologic||nrnt||subset_includes_concept
st. clair county||us counties terminology||subset_includes_concept
chorioamnionitis [ambiguous]||health effect - clinical code||subset_includes_concept
nsaa101||cdisc sdtm terminology||subset_includes_concept
pkce||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
fludase||clinical trials reporting program agent terminology||subset_includes_concept
lyn gene mutation||clinical trials reporting program biomarker terminology||subset_includes_concept
chemokine, cxc motif, receptor 7 gene||clinical trials reporting program terminology||subset_includes_concept
healthcare facility identifier||bridg class and attribute terminology||subset_includes_concept
r3601-i expect my health to get worse||cdisc questionnaire rand 36-item health survey 1.0 test name terminology||subset_includes_concept
housing humidity units||send trial summary parameter test code||subset_includes_concept
superficial (qualifier value)||send||subset_includes_concept
peruvian inca orchid||misc||subset_includes_concept
unknown ecog performance status||cptac pancreatic ductal adenocarcinoma follow-up form||subset_includes_concept
renalcld||pkparmcd||subset_includes_concept
measurement of leucine aminopeptidase (lap)||sdtm-lbtest||subset_includes_concept
avl01-list a recall 4 word 2||sdtm||subset_includes_concept
intravenous bolus route of administration||cdisc sdtm route of administration terminology||subset_includes_concept
sf36319||cdisc questionnaire sf36 v2.0 standard test name terminology||subset_includes_concept
fac06317||cdisc qrs terminology||subset_includes_concept
auc %back extrapolation pred||pk parameters code||subset_includes_concept
erv - expiratory reserve volume||sdtm-retest||subset_includes_concept
ground strap/wire||component code||subset_includes_concept
autologous car-19/car-20-t cells hu1928-hu20bb||ctrp terminology||subset_includes_concept
homeobox protein cdx-2||ctrp molecular genetic biomarker terminology||subset_includes_concept
hsan5||cellosaurus disease terminology||subset_includes_concept
inpp5d gene product||clinical trials reporting program terminology||subset_includes_concept
ribosomal protein s6 gene||ctrp molecular genetic biomarker terminology||subset_includes_concept
inguinal hernia incarcerated||pediatric adverse events terminology||subset_includes_concept
idiopathic focal segmental glomerulosclerosis||nichd terminology||subset_includes_concept
dorsal nasal turbinate||send||subset_includes_concept
milligram||units for planned exposure||subset_includes_concept
locoregional||tuidrs||subset_includes_concept
stage iii breast cancer||ctrp terminology||subset_includes_concept
deleted in azoospermia-like 1||ctrp molecular genetic biomarker terminology||subset_includes_concept
chymotrypsin-like elastase family, member 1 wt allele||ctrp terminology||subset_includes_concept
haircolr||cdisc||subset_includes_concept
global alignment of immunization safety assessment in pregnancy level 2a assessment of gestational age||global alignment of immunization safety assessment in pregnancy preterm birth level of diagnostic certainty terminology||subset_includes_concept
cd4||clinical data interchange standards consortium terminology||subset_includes_concept
mucor ramosissimus (organism)||cdisc sdtm terminology||subset_includes_concept
upd23a||cdisc||subset_includes_concept
humanitarian device exemption||spl terminology||subset_includes_concept
deviated septum nasal||non-neoplastic finding type||subset_includes_concept
sgrq0242||cdisc questionnaire terminology||subset_includes_concept
performedmaterialprocessstep.standardtimeindicator||bridg terminology||subset_includes_concept
cancer/testis antigen family 47 gene||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
bloating||gdc terminology||subset_includes_concept
examination of skin||ctrp intervention terminology||subset_includes_concept
intraoperative hemorrhage, ctcae||gdc value terminology||subset_includes_concept
international unit/liter||germ celll tumor permissible value terminology||subset_includes_concept
palb2||ctrp biomarker terminology||subset_includes_concept
65 kda phosphoprotein antibody||ctrp terminology||subset_includes_concept
gds02-satisfied with life||cdisc terminology||subset_includes_concept
blackberries (substance)||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
esrs-a - cgi-s akathisia||cdisc qrs terminology||subset_includes_concept
brain, medulla oblongata||cdisc sdtm terminology||subset_includes_concept
idh gene family mutation||cptac chol baseline form||subset_includes_concept
stage iic prostate cancer ajcc v8||ctrp disease terminology||subset_includes_concept
2nd lpl||clinical data interchange standards consortium terminology||subset_includes_concept
siq02-wished i had never been born||cdisc terminology||subset_includes_concept
msqol-54 - ability to satisfy sexual partner||qs-msqol-54 test||subset_includes_concept
obesity||gdc terminology||subset_includes_concept
caudal type homeo box transcription factor 2||ctrp molecular genetic biomarker terminology||subset_includes_concept
emulsion stabilizing excipient||fda pharmaceutical quality/cmc terminology||subset_includes_concept
malignant thecoma of the ovary||mapped icdo3.2 terminology||subset_includes_concept
sf12 v2.0 acute||cdisc questionnaire terminology||subset_includes_concept
conbercept||nci drug dictionary terminology||subset_includes_concept
balls (testicles)||srb||subset_includes_concept
fk506 binding protein, 12-kd gene||ctrp terminology||subset_includes_concept
neck||genomics data commons terminology||subset_includes_concept
soft vaginal capsule dosage form||edqm healthcare controlled vocabularies||subset_includes_concept
sodium cation||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
sodium/creatinine||cdisc terminology||subset_includes_concept
breast feeding (function)||sdtm-modtrn||subset_includes_concept
h*ngeq/ml||pkunit||subset_includes_concept
bisfentidine||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
seizure at its worst||mdasi-bt||subset_includes_concept
qles160||cdisc qrs terminology||subset_includes_concept
panulisib||gdc terminology||subset_includes_concept
fact-lym version 4 - i am able to enjoy life||cdisc qrs terminology||subset_includes_concept
wd4-maintaining a fiendship||cdisc qrs terminology||subset_includes_concept
minimal to no clearance||mbsimp||subset_includes_concept
cancer/testis antigen family 5, member 2a||ctrp reference gene terminology||subset_includes_concept
msql1-rate your own quality-of-life||msql1tn||subset_includes_concept
hospital blood bank||spl blood form establishment type terminology||subset_includes_concept
broad bean - dietary||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
accomack county, va||us counties terminology||subset_includes_concept
ferriclate calcium sodium||fda unii code terminology||subset_includes_concept
sgrqc1-walking up a flight of stairs||qs-sgrq-c testcd||subset_includes_concept
crypt abscess assessment||sdtm||subset_includes_concept
npi - show any other signs of irritability||clinical data interchange standards consortium terminology||subset_includes_concept
product.lotnumbertext||bridg terminology||subset_includes_concept
biologic entity group type code||biomedical research integrated domain group model terminology||subset_includes_concept
css0913||cdisc questionnaire terminology||subset_includes_concept
fac018-i feel close to my friends||clinical data interchange standards consortium terminology||subset_includes_concept
fenoxazoline hydrochloride (medication)||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
unable to walk alone, even with walking equipment. able to walk short distances with the help of another person, and required a wheelchair to get around the neighborhood||hui||subset_includes_concept
erbb1 c.2125_2129delgaaac||clinical trials reporting program terminology||subset_includes_concept
polymorphonuclear leukocytes||clinical trials reporting program biomarker terminology||subset_includes_concept
(r)-modafinil||ctrp terminology||subset_includes_concept
chronic leukemia eosinophilic||gdc value terminology||subset_includes_concept
control analyte||sample_type_id||subset_includes_concept
c-ssrs lifetime/recent version - description of interrupted suicide attempt||cdisc sdtm terminology||subset_includes_concept
braf np_004324.2:p.gly469arg||clinical trials reporting program biomarker terminology||subset_includes_concept
sdmt01-total score||cdisc functional test terminology||subset_includes_concept
streptococcus pneumoniae serotype 10a igg antibody measurement||sdtm||subset_includes_concept
{patch}||ucum terminology||subset_includes_concept
poultice dose form||send||subset_includes_concept
avn 944||gdc therapeutic agent terminology||subset_includes_concept
l-jak gene mutation||clinical trials reporting program biomarker terminology||subset_includes_concept
embryonal ca - polyembryonal||ncit neoplasm core terminology||subset_includes_concept
outmssec||cdisc protocol terminology||subset_includes_concept
malignant giant cell tumor||clinical proteomic tumor analysis consortium terminology||subset_includes_concept
hai01tc||cdisc||subset_includes_concept
family history of syncope (situation)||acc-aha pediatric and congenital cardiology ehr terminology||subset_includes_concept
doxorubicin-prednisone-vincristine||pharmacotherapy regimens||subset_includes_concept
paste||cdisc sdtm terminology||subset_includes_concept
emactuzumab||national cancer institute drug dictionary||subset_includes_concept
antepartum obstetric thromboembolism||nichd terminology||subset_includes_concept
ro 16-9100||genomics data commons terminology||subset_includes_concept
refractory lymphoblastic lymphoma||ctrp disease terminology||subset_includes_concept
guidewire device||cdrh component code terminology||subset_includes_concept
1-acyl-sn-glycerol-3-phosphate o-acyltransferase 9||clinical trials reporting program biomarker terminology||subset_includes_concept
hamd 24 - suicidal thoughts||cdisc clinical classification terminology||subset_includes_concept
g2||cptac pancreatic baseline form||subset_includes_concept
marketed as bulk ingredient||marketing category||subset_includes_concept
catechol-o-methyltransferase||ctrp terminology||subset_includes_concept
deleterious g protein subunit alpha q gene mutation||clinical trials reporting program terminology||subset_includes_concept
ishak score 5||gdc terminology||subset_includes_concept
ic - inspiratory capacity||sdtm||subset_includes_concept
pigmentations||cdisc||subset_includes_concept
childhood rhabdoid tumor of the central nervous system||ctrp terminology||subset_includes_concept
size reduction particle sizing||fda emanufacturing terminology||subset_includes_concept
fusin||ctrp molecular genetic biomarker terminology||subset_includes_concept
flj38703||ctrp terminology||subset_includes_concept
anop3||ctrp biomarker terminology||subset_includes_concept
pegylated recombinant il-2 variant thor-707||clinical trials reporting program terminology||subset_includes_concept
karnofksy performance status not evaluated||cptac acute myeloid leukemia follow-up form||subset_includes_concept
every six hours (qualifier value)||cdisc sdtm terminology||subset_includes_concept
cd334||genomics data commons terminology||subset_includes_concept
sdtm-ebfats||sdtm||subset_includes_concept
was targeted molecular therapy administered as an additional treatment for a new tumor event||cptac uterine corpus endometrial carcinoma follow-up form||subset_includes_concept
germ cell depletion||cdisc terminology||subset_includes_concept
bcr/abl thr315ile mutation||clinical trials reporting program biomarker terminology||subset_includes_concept
cam-kinase ii beta chain||clinical trials reporting program reference gene terminology||subset_includes_concept
chromosome inversions||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
homoeopathy||clinical trials reporting program intervention terminology||subset_includes_concept
cholic acid measurement||cdisc sdtm terminology||subset_includes_concept
duloxetine hydrochloride||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
adl03-clean room performance||cdisc questionnaire terminology||subset_includes_concept
li||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
synthetic peptides e-pra and e-psm vaccine||clinical trials reporting program terminology||subset_includes_concept
human herpesvirus 8 open reading frame 73 gene||clinical trials reporting program terminology||subset_includes_concept
heart failure therapy intensification type||sdtm-cvfats||subset_includes_concept
braf1 fusion positive||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
hamd 21||cccat||subset_includes_concept
tscyc1-seeing bad happened in the past||cdisc sdtm terminology||subset_includes_concept
av septal defect||send||subset_includes_concept
proteasome (prosome, macropain) 26s subunit, non-atpase, 4 protein, human||clinical trials reporting program terminology||subset_includes_concept
challenge agent type mixed field indicator||challenge agent parameter long name||subset_includes_concept
world health organization disability assessment schedule 2.0 - 12 + 24-item interviewer questionnaire test name||cdisc qrs terminology||subset_includes_concept
rose geranium in sesame oil nasal spray||nci drug dictionary terminology||subset_includes_concept
procedures cardiac surg||cptac terminology||subset_includes_concept
dermis||specimen type||subset_includes_concept
mhc class i antigen hla-a0301 heavy chain||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
intimal sarcoma of the pulmonary artery||cellosaurus disease terminology||subset_includes_concept
platelet factor 4 assay (procedure)||cdisc terminology||subset_includes_concept
{linear ft*lb}||clinical data interchange standards consortium terminology||subset_includes_concept
qs-pedsql neuromuscular module acute version 3.0 parent report for young child test||cdisc terminology||subset_includes_concept
number of new bone lesions||cdisc sdtm tumor or lesion properties test name terminology||subset_includes_concept
ff10850||ctrp agent terminology||subset_includes_concept
streptococcus massiliensis (organism)||sdtm-microorg||subset_includes_concept
1,3-bis(3-butoxy-2-hydroxypropyl)-5-ethyl-5-phenylbarbituric acid dicarbamate||fda unii code terminology||subset_includes_concept
ff-21101(90y)||genomics data commons terminology||subset_includes_concept
carcinoma, basal cell, skin||gdc terminology||subset_includes_concept
infantile renal fibrosarcoma||ncit neoplasm core terminology||subset_includes_concept
haq01-cut your meat||clinical data interchange standards consortium terminology||subset_includes_concept
madurella grisea||sdtm||subset_includes_concept
gastric carcinoma pn3a tnm finding v8||cptac baseline medical forms terminology||subset_includes_concept
cb 10-277||gdc terminology||subset_includes_concept
zimberelimab||national cancer institute drug dictionary||subset_includes_concept
ticlopidine (medication)||fda unii code terminology||subset_includes_concept
carntexr||laboratory test name||subset_includes_concept
pemlimogene merolisbac||fda unii code terminology||subset_includes_concept
fear score 4||concerns about recurrence scale||subset_includes_concept
sgrq past 3 months version - wheeze worse when get up in the morning||cdisc qrs terminology||subset_includes_concept
kloeckera corticis var. pulquensis||microorganism||subset_includes_concept
childhood testicular mature teratoma||nichd terminology||subset_includes_concept
non-clinical premating trial phase||cdisc||subset_includes_concept
fbrsi - i am able to enjoy life||cdisc questionnaire fbrsi test name terminology||subset_includes_concept
fanconi anemia group p protein||ctrp biomarker terminology||subset_includes_concept
milliliter per microgram per kilogram||cdisc send terminology||subset_includes_concept
ewsr1-erg||clinical trials reporting program biomarker terminology||subset_includes_concept
fas-nacc uds version 3.0 - preparing a balanced meal||clinical data interchange standards consortium terminology||subset_includes_concept
wnt-activated||ncit neoplasm core terminology||subset_includes_concept
fibro-odontoma||cdisc terminology||subset_includes_concept
17-hydroxysteroid dehydrogenase deficiency||pediatric endocrine terminology||subset_includes_concept
smdds106||cdisc questionnaire terminology||subset_includes_concept
colon, descending||cdisc send terminology||subset_includes_concept
iodine i-123 adam||ctrp terminology||subset_includes_concept
severe||genomics data commons terminology||subset_includes_concept
powder for implantation suspension dosage form||pharmaceutical dosage form||subset_includes_concept
lens||send||subset_includes_concept
nephroblastoma, malignant||neonatal research network terminology||subset_includes_concept
mds-updrs - medication for parkinson's disease||cdisc questionnaire mds-updrs test code terminology||subset_includes_concept
connective and soft tissue neoplasm, benign||cptac terminology||subset_includes_concept
fus/fev fusion gene||ews molecular analysis table||subset_includes_concept
ampkalpha||ctrp terminology||subset_includes_concept
product containing troglitazone (medicinal product)||fda established names and unique ingredient identifier codes terminology||subset_includes_concept
decitabine + cedazuridine||ncit antineoplastic agent terminology||subset_includes_concept
intrauterine emulsion||edqm-hc administrable dose form terminology||subset_includes_concept
excessive heating (medical device)||annex a||subset_includes_concept
lymphoblastic lymphosarcoma, diffuse||cellosaurus disease terminology||subset_includes_concept
suicide attempt (disorder)||pediatric adverse events terminology||subset_includes_concept
polyovular follicle||send||subset_includes_concept
endotracheopulmonary instillation, powder for suspension dosage form||european directorate for the quality of medicines and healthcare controlled vocabularies||subset_includes_concept
mrimagingacquisitionprotocolelement.magneticfieldstrength||bridg terminology||subset_includes_concept
bnt 411||ctrp agent terminology||subset_includes_concept
[m]lymphoblastic lymphoma nos||gdc disease type terminology||subset_includes_concept
conventional release emulsion for eye drops||pharmaceutical dosage form||subset_includes_concept
css11-most severe idea, frequency-p1m||sdtm||subset_includes_concept
digestive system well differentiated neuroendocrine tumor||mapped icd-o-3.2 terminology||subset_includes_concept
sf361-emotional: cut down time on work||sf361tn||subset_includes_concept
astx295||ctrp terminology||subset_includes_concept
asalex||ncit antineoplastic agent terminology||subset_includes_concept
xe||genc terminology||subset_includes_concept
first variant gene symbol||aml table terminology||subset_includes_concept
platelets extended dating||structured product labeling blood and tissue form terminology||subset_includes_concept
gray zone lymphoma||cptac neoplasms codelist||subset_includes_concept
thrombocythemias||pediatric adverse events terminology||subset_includes_concept
avl01-list a recall 1 word 8||avl01tn||subset_includes_concept
gds02tc||cdisc terminology||subset_includes_concept
cd58 antigen||clinical trials reporting program molecular genetic biomarker terminology||subset_includes_concept
inactivating retinoblastoma gene mutation||ctrp biomarker terminology||subset_includes_concept
syntaxin 11 protein, human||ctrp biomarker terminology||subset_includes_concept
aids-related non-hodgkin lymphoma||cellosaurus disease terminology||subset_includes_concept
fgfr1/fgfr1op2 fusion gene||ctrp molecular genetic biomarker terminology||subset_includes_concept
follicle centre-cell b-cell lymphoma (nodal/systemic with skin involvement)||mass lymphoreticular structure||inverse_isa
chlamydial infection of the central nervous system||chlamydia bacteria infection||inverse_isa
fear of ear disease||fear of contracting disease||inverse_isa
transfusion reaction caused by allergen in blood||reaction, allergic||inverse_isa
amylase 59000 unt / lipase 18000 unt / protease 59000 unt extended release oral capsule [pangestyme]||amylase / lipase / protease extended release oral capsule||inverse_isa
aspiration of urinary bladder using trocar||procedure on bladder (procedure)||inverse_isa
soleus branch of right tibial nerve||soleus branch of tibial nerve||inverse_isa
going from||general site descriptor (qualifier value)||inverse_isa
medication administration: intramuscular (procedure)||procedure on skeletal muscle (procedure)||inverse_isa
graves' disease in remission||graves' disease with exophthalmos||inverse_isa
submandibular lymphatic vessel||lymphatics of head (body structure)||inverse_isa
entire apical part of peripheral zone of left half prostate (body structure)||left apical peripheral zone of prostate||inverse_isa
catheter,external inter roch#36303/36103||catheter,external urinary||inverse_isa
peripheral neuritis in pregnancy nos||symptomatic disorders in pregnancy (diagnosis)||inverse_isa
carbaryl medicated shampoo||carbaryl shampoo product||inverse_isa
umbilical cord calcification||calcification, pathologic||inverse_isa
radionuclide lung permeability study (procedure)||radionuclide study of lung (procedure)||inverse_isa
dental veneer too wide||tooth finding (finding)||inverse_isa
percutaneous insertion of stent into cerebral venous sinus using fluoroscopic guidance (procedure)||percutaneous insertion of stent into vein using fluoroscopic guidance||inverse_isa
fifth||general adjectival modifiers||inverse_isa
free omental flap w/microvascular anast||surgical procedures on the omental flap||inverse_isa
brevoxyl-4 acne wash kit||benzoyl peroxide medicated liquid soap||inverse_isa
structure of anterior cardiac vein (body structure)||venae cordis||inverse_isa
prism - profile in semantics||assessment scales||inverse_isa
internal fixation of radius without fracture reduction||internal fixation of bone without fracture reduction||inverse_isa
flufyllin||phosphodiesterase inhibitor (product)||inverse_isa
dorsal surface of body of penis||subdivision of surface of penis||inverse_isa
productive cough -green sputum||cough; bronchial||inverse_isa
monocular esotropia, right eye||observation of body region||inverse_isa
closure of ileal fistula (procedure)||repair of ileum (treatment)||inverse_isa
contracture of biceps||disorder of soft tissue of upper limb||inverse_isa
insulin, protamine zinc, beef injectable suspension||hypurin bovine protamine zinc injectable product||inverse_isa
brompheniramine / chlophedianol / phenylephrine oral solution||brompheniramine / chlophedianol / phenylephrine oral product||inverse_isa
demerol, 100 mg/ml injectable solution_#1||product containing pethidine in parenteral dose form (medicinal product form)||inverse_isa
skin scab of back of both shoulders||skin scab of both shoulders (symptom)||inverse_isa
fluconazole 50mg/25ml i-v inf||antifungal agents||inverse_isa
soft tissue swell l third toe w/ black & blue discoloration||soft tissue swelling of left third toe with discoloration||inverse_isa
trunk of segmental lymphatic tree||pulmonary lymphatic trunk||inverse_isa
pressure ulcer of right heel (diagnosis)||pressure sore on heel (disorder)||inverse_isa
dmot4039a||conjugate, antibody-toxin||inverse_isa
cataract; drug-induced||drug-induced lesion (disorder)||inverse_isa
metaproterenol only product in oral dose form||product containing only orciprenaline (medicinal product)||inverse_isa
liquefied petroleum gas (substance)||oils, crude||inverse_isa
hla-cw7 in blood or tissue||human leukocyte antigen class i serotyping (procedure)||inverse_isa
deflux 50mg/ml 1ml syr||genito-urinary agents,other||inverse_isa
aromatoleum toluclasticum (song et al. 1999) rabus et al. 2019||azoarcus||inverse_isa
c2 symphysis segment of posterior longitudinal ligament||posterior longitudinal ligament of craniovertebral joint||inverse_isa
simple craniosynostosis||early closure of cranial sutures||inverse_isa
fine needle aspiration biopsy of kidney with fluoroscopic guidance (procedure)||closed renal biopsy fine needle aspiration||inverse_isa
wearing sunglasses||sun protection (history)||inverse_isa
precentral branch of lumbar artery||lumbar arterial branch||inverse_isa
ercp: pancreas findings (procedure)||finding of pancreas||inverse_isa
mri thoracic osseous mass size t9 anterior (___ mm)||mri thoracic osseous structures mass size t9 (___ mm)||inverse_isa
infrared treatment of distal volar region of left forearm||infrared treatment of left forearm (treatment)||inverse_isa
annuloplasty of truncal valve||reconstruction of annulus of cardiac valve||inverse_isa
lateral border of nail of finger||border of nail of finger||inverse_isa
reddened epithelium of right external auditory meatus (physical finding)||external auditory meatus reddened epithelium||inverse_isa
laparoscopy: cyst of large intestine (procedure)||laparoscopy: appearance of large intestine||inverse_isa
dextromethorphan/pheniramine/phenylephrine||product containing pheniramine and phenylephrine||inverse_isa
intravenous infusion of ringer's solution||parenteral fluids||inverse_isa
leuprolide acetate@7.5 mg (1 month)@intramusc@syringe kit (ea)||leuprolide injectable product||inverse_isa
mentum presentation of fetus with baby delivered||mentum presentation of fetus||inverse_isa
lipid metabolic process||primary metabolic process||inverse_isa
apply long leg cast brace||application long leg cast thigh-toe||inverse_isa
antimony thioglycolate (substance)||antimony compounds||inverse_isa
swelling, erythema, and warmth of lateral aspect of nail border of left thumb (physical finding)||swelling, erythema, and warmth of nail border of left thumb (physical finding)||inverse_isa
ribostamycin a||antibacterials||inverse_isa
isotopic scans spleen mass lesion multiple||isotopic scans spleen mass lesion (procedure)||inverse_isa
1st stg bilateral orchidopexy||first stage of two stage orchidopexy||inverse_isa
erosion of skin of lateral aspect of middle finger of right hand||erosion of skin of middle finger of right hand (physical finding)||inverse_isa
benzoyl peroxide 7 % topical cleanser (gram)||benzoyl peroxide medicated liquid soap [acnefree bp]||inverse_isa
intentional enflurane overdose||non-accidental overdose||inverse_isa
bony part of distal part of scaphoid||bony part of zone of carpal bone||inverse_isa
stenosis; coronary||heart disease structural disorder||inverse_isa
fenofibrate capsules||lipidil supra oral product||inverse_isa
marsupialization of abscess of pharynx||surgical procedure for clinical finding and/or disorder (procedure)||inverse_isa
herpes simplex with unspecified complications (disorder)||herpes||inverse_isa
ultrasonography of cardiac ventricle for resynchronization||cardiac ventriculography (procedure)||inverse_isa
prevertebral ganglion||sympathetic ganglion, nos||inverse_isa
adjustments to partial upper dentures||ease denture||inverse_isa
operative procedure on upper extremity (procedure)||upper_ext problem||inverse_isa
injection of upper limb (procedure)||injection of substance||inverse_isa
primary malignant neoplasm of rectouterine pouch||primary malignant neoplasm of pelvic peritoneum (disorder)||inverse_isa
metastatic malignant neoplasm in the lacrimal drainage system||malignant lacrimal drainage system neoplasm||inverse_isa
wetting||test results [use for free text]||inverse_isa
current use of overhead sling setup||functional exam current use of technical aids (physical finding)||inverse_isa
systolic murmur holosystolic||heart troubled||inverse_isa
obstetric ultrasound: narrative observation of fetal head (procedure)||ultrasound obstetric narrative fetal study observation (procedure)||inverse_isa
fetal or neonatal effect of narcotic transmitted via placenta (disorder)||fetus or newborn affected by narcotic transmitted via placenta or breast milk||inverse_isa
hypersensitivity pneumonitis due to air conditioning (diagnosis)||hypersensitivity pneumonia, nos||inverse_isa
t(13;22)(q22;q13.3)||translocation, chromosomal||inverse_isa
removal of existing dental restoration||removal of device from digestive system, nos||inverse_isa
lumbar facet joint effusion||arthropathy of lumbar facet joint||inverse_isa
lysine hcl 500 mg oral capsule||l-formula pill||inverse_isa
occipital part of aponeurosis of epicranius||subdivision of aponeurosis of epicranius||inverse_isa
bartter's syndrome with hypercalciuria and nephrocalcinosis||inherited renal disease||inverse_isa
puncture of left hand by single needle||puncture wound of hand (disorder)||inverse_isa
shoulder pain exertional||joint||inverse_isa
laceration of buttock||tissue injury of buttock||inverse_isa
russian thistles||d34 family chenopodiaceae - goosefoot||inverse_isa
admission to hospital - emergency severity index||assessment scale||inverse_isa
intravenous pyelography: solitary ureter calculus (procedure)||intravenous pyelogram||inverse_isa
aimophila rufescens mcleodii||rusty sparrow||inverse_isa
sulfurated lime 60 mg/ml topical solution||sulfurated lime topical product||inverse_isa
functional disease of the cns with neuroendocrine disturbance (disorder)||nervous system; disorder, central||inverse_isa
interlobular stroma of liver||organ component of liver||inverse_isa
mammogram increased diffuse fibrosis of superior medial quadrant of right breast compared with previous result (procedure)||mammogram diffuse fibrosis of superior medial quadrant of right breast compared with previous result||inverse_isa
t4: thyroid tumour of any size extending beyond the thyroid capsule||t4 cancer stage finding||inverse_isa
thumb stiffness, brachydactyly, intellectual disability syndrome (disorder)||finding of joint of thumb (finding)||inverse_isa
skin structure of lateral part of heel||heel skin||inverse_isa
closure of skin wound by tape (procedure)||application of adhesive skin closure (procedure)||inverse_isa
stair patient transfer chairs||assistive chair||inverse_isa
progestrogens gestonorone caproate||progestagens, synthetic||inverse_isa
arteriectomy of upper limb, nos||excision of vessel of upper limb||inverse_isa
proctectasis||lower gastrointestinal procedr||inverse_isa
sitrex pd, 75 mg-7.5 mg/5 ml oral liquid||guaifenesin / phenylephrine oral liquid product||inverse_isa
diagnostic mediastinoscopy and thoracoscopy with ventilation of lung||diagnostic procedure by site||inverse_isa
courgette with egg||egg product (substance)||inverse_isa
destruction of lesion of penis (procedure)||penis operation||inverse_isa
demethylkotanin metabolic process||aromatic compound metabolism||inverse_isa
structure of right upper lid margin||structure of free margin of right eyelid (body structure)||inverse_isa
mucosa ventral surf of tongue||mucosa of surface of tongue||inverse_isa
rnax teach fracture care (treatment)||care regimes education (procedure)||inverse_isa
silicon dioxide 10 mg oral capsule||silicon dioxide oral product||inverse_isa
roscovitine||antiviral||inverse_isa
dicarboxylate:inorganic phosphate antiporter activity||solute:anion antiporter activity||inverse_isa
ecg q waves||ecg: qrs complex nos||inverse_isa
opn dvsn,thyroid cartilge lgmt||posttraumatic arthropathy||inverse_isa
t-spine mri t2-weighted osseous mass hyperintense signal t2 lateral||mass of thoracic vertebrae||inverse_isa
appearance of wound bed of right thigh (physical finding)||wound of right thigh||inverse_isa
giant cell type neoplasm of male genitalia (diagnosis)||neoplasm malig;genital sys;m||inverse_isa
n. ampullaris posterior||vestibular neural branch||inverse_isa
interosseous border of right ulna||margo interosseus ulnae||inverse_isa
cryptosporidium canis||cryptosporidium species||inverse_isa
interferon alfa-2b injectable solution||interferon alfa-2b-containing product in parenteral dose form||inverse_isa
ultrasound of pelvis: catheterized post-void residual volume of bladder (procedure)||bladder volume (pvr)||inverse_isa
product containing only theophylline, anhydrous 400 mg/1 each oral capsule||uniphyl oral product||inverse_isa
anterior capsule contraction (finding)||crystalline lens observation||inverse_isa
incision of ear||incision, nos (-otomy)||inverse_isa
first left aortic arch||structure of first left aortic arch (body structure)||inverse_isa
iliococcygeus epimysium||fascia of iliococcygeus||inverse_isa
ct scan of ribs without contrast (procedure)||computerised axial tomography without contrast||inverse_isa
primary fatty amide catabolic process||fatty acid primary amide metabolic process||inverse_isa
prosopis juliflora pollen extract 1000 unt/ml injectable solution||mesquite pollen extract injectable solution||inverse_isa
product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet||ranitidine oral tablet [zantac]||inverse_isa
allergy testing pork erythema (lab test)||erythema at injection site||inverse_isa
entire right wrist (body structure)||entire wrist region||inverse_isa
dextran 70 / glycerin / hypromellose ophthalmic solution||dextran 70 / glycerin / hypromellose ophthalmic product||inverse_isa
mrcm reference set||reference set (foundation metadata concept)||inverse_isa
musculi intercostales interni||muscle, intercostal||inverse_isa
tendon of psoas major (body structure)||tendon of psoas muscle||inverse_isa
perineogram||section 5-4 radiologic procedures for obstetrics and gynecology||inverse_isa
tibilone||androgens, synthetic||inverse_isa
influenza with encephalopathy||influenza with manifestations (diagnosis)||inverse_isa
open fracture of shaft of left femur||fx femur shaft-open||inverse_isa
corticosteroid injection into sacral joint by transforaminal approach with ct guidance, each additional level (medication)||corticosteroid injection into sacral joint by transforaminal approach, each additional level (medication)||inverse_isa
entire posterior mediastinal cavity||structure of posterior mediastinal cavity||inverse_isa
cellulitis of lateral surface of left knee||cellulitis of knee (physical finding)||inverse_isa
width of ulcer of right side of nose and mouth||ulcer of skin of face||inverse_isa
benzoyl peroxide 5.2% topical application foam [benzepro]||benzoyl peroxide in topical dosage form||inverse_isa
cartilage of body of fifth thoracic vertebra||cartilage of body of thoracic vertebra||inverse_isa
contour of breast||form of breast||inverse_isa
iliotibial band syndrome||connective tissue disorder by body site (disorder)||inverse_isa
transplanted liver (physical finding)||liver finding||inverse_isa
fibrae nervi facialis||cranial nerve root||inverse_isa
direct repair of artery of lower extremity||surgical repair of lower extremity||inverse_isa
inferior articular facet of head of left rib||inferior articular facet of head of rib||inverse_isa
vitamin b1 0.05 mg/ml oral solution||thiamine oral liquid product||inverse_isa
benzeneacetic acid, alpha-methyl-3-phenoxy-, (+-)-||non-steroidal anti-inflammatory agent, nos||inverse_isa
osteoarthritis localized knee left||localized osteoarthritis of knee||inverse_isa
viral diseases with exanthemata nos (disorder)||viral infection of skin||inverse_isa
salmo olidus||family osmeridae - smelts||inverse_isa
venous; hemangioma||neoplasm cardiovascular||inverse_isa
troglostrongylus subcrenatus||bronchostrongylus, nos||inverse_isa
intraepithelial neoplasia (dysplasia) of stomach||5-32-33 diseases of the stomach||inverse_isa
malignant neoplasm extraskeletal osteosarcoma||malignant mesenchymal tumour||inverse_isa
muscle body of palmaris longus||muscle body of muscle of forearm||inverse_isa
open fracture of lateral cuneiform bone of right foot (disorder)||open fracture of tarsal bone of right foot||inverse_isa
thoracic disc prolapse with root compression||prolapse thorac intervert disc||inverse_isa
gram per meter squared||non-si unit of pressure (qualifier value)||inverse_isa
2-(2,3-dihydro-9h-imidazo(1,2-a)benzimidazol-9-yl)-n,n-diethylethanamine||drugs, antiplatelet||inverse_isa
a. thyroidea superior||branch of external carotid artery (body structure)||inverse_isa
black-and-yellow broadbill||genus eurylaimus||inverse_isa
juglone 3-monooxygenase||661-675 oxidoreductases||inverse_isa
idiopathic aseptic necrosis of left fibula||aseptic necrosis idiopathic fibula (diagnosis)||inverse_isa
fit orthodontic headgear (procedure)||{orthodontic treatment}||inverse_isa
injection of upper limb using ultrasonographic guidance (procedure)||injection of upper limb||inverse_isa
flair magnetic resonance imaging of lumbar spine: solid intramedullary mass of cord||flair magnetic resonance imaging of lumbar spine: intramedullary mass of cord||inverse_isa
simeticone-containing product||agents, antifoaming||inverse_isa
amniotic sac visualized - membranes ruptured||spontaneous rupture of membranes (finding)||inverse_isa
follicular carcinoma, clear cell (morphologic abnormality)||thyroid malignant carcinoma follicualr||inverse_isa
oregano oil||herbs/alternative therapies||inverse_isa
high frequency sensorineural hearing loss of bilateral ears (disorder)||sensorineural hearing loss high frequency right||inverse_isa
x-ray of thoracic spine: mixed lytic and sclerotic lesion with soft tissue mass seen (procedure)||disorder of bone, unspecified||inverse_isa
nifedipine 40mg m/r tablet (product)||fortipine la40 pill||inverse_isa
north american hoary bat||lasiurus gray, 1831||inverse_isa
12q14||chromosomal band||inverse_isa
musculus iliacus||pelvic girdle musculature||inverse_isa
cenesthopathic schizophrenia||schizophrenia (diagnosis)||inverse_isa
ability to join in conversation||ability to make conversation (observable entity)||inverse_isa
glucosamine sulfate dipot chlr 1,000 mg oral capsule||glucosamine oral capsule [synovacin]||inverse_isa
popliteal cyst fluid||specimen from cyst||inverse_isa
infected arthroplasty||infection associated with implant||inverse_isa
up regulation of transcription from rna polymerase ii promoter by glucose||up regulation of transcription by glucose||inverse_isa
dilatation catheter (physical object)||sterile urethral catheters (physical object)||inverse_isa
theophylline + noscapine||theophylline combinations||inverse_isa
structure of left posterior division of left branch of atrioventricular bundle||conducting system of subdivision of heart||inverse_isa
flavor,cherry||structured product labeling flavor||inverse_isa
stretch||manipulation, nos||inverse_isa
subdivision of vestibular gland||organ subdivision||inverse_isa
need for vaccination against smallpox||vaccine needed against viral diseases (treatment)||inverse_isa
periosteum of right transverse process of fifth lumbar vertebra||periosteum of transverse process of fifth lumbar vertebra||inverse_isa
granuloma of brainstem (disorder)||encephalitis brain stem||inverse_isa
noonan syndrome-like disorder with loose anagen hair (disorder)||face congenital deformities||inverse_isa
second degree atrioventricular heart block||incomplete atrioventricular block||inverse_isa
ecg: no ectopic beats||electrocardiogram finding absent||inverse_isa
medial root trunk proper segment of c8 root of left median nerve||medial root trunk proper segment of c8 root of median nerve||inverse_isa
protein initiator methionine removal involved in protein maturation||removal of initiator methionine from protein||inverse_isa
pain of cervical spine elicited by bilateral rotation throughout range of motion||cervical spine painful on movement (finding)||inverse_isa
blood profile anemia b||blood profile anemia (lab test)||inverse_isa
pseudoephedrine oral tablet [pseudoval]||product containing pseudoephedrine in oral dosage form (medicinal product form)||inverse_isa
cellular response to stimulus||stimulus/response||inverse_isa
crus i of bolk||cerebellar hemisphere structure||inverse_isa
surface of left superior articular process of fifth cervical vertebra||surface of superior articular process of fifth cervical vertebra||inverse_isa
cefsulodin||agent, anti-bacterial||inverse_isa
austrobilharzia penneri (organism)||austrobilharzia||inverse_isa
6-methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol||anti arrhythmia agent||inverse_isa
stromal sarcoma (diagnosis)||[m]complex mixed or stromal neoplasm nos||inverse_isa
shaving of lesion of nose over 2cm||shaving of lesion of nose (treatment)||inverse_isa
doxepin oral tablet [silenor]||doxepin-containing product in oral dose form||inverse_isa
superior capsular augmentation of shoulder joint using graft (procedure)||soft tissue operations nos (procedure)||inverse_isa
entire filiform papillae of tongue||structure of filiform papillae of tongue||inverse_isa
ranibizumab 6 mg in 1 ml intravitreal injection, solution [lucentis]_#1||ranibizumab prefilled syringe [lucentis]||inverse_isa
isosorbide (product)||osmotic diuretic product||inverse_isa
muscle body of region of deltoid||skeletal muscle body||inverse_isa
tributary of inferior petrosal sinus||tributary of dural venous sinus||inverse_isa
low grade pedunculated tubulovillous dysplasia of the mouse intestinal tract||pedunculated tubulovillous adenoma of the mouse intestinal tract||inverse_isa
puncture of posterior neck consistent with bullet exit wound||puncture wound of neck||inverse_isa
tenderness of distal medial aspect of right thigh with erythema and warmth (physical finding)||tenderness of distal aspect of right thigh with erythema and warmth (physical finding)||inverse_isa
entire tendon and tendon sheath of shoulder||entire tendon and tendon sheath of shoulder and upper extremity||inverse_isa
incision with aligned margins on right upper arm||incision on right upper arm||inverse_isa
gadoteric acid only product in parenteral dose form||product containing only gadoteric acid (medicinal product)||inverse_isa
retired procedure (procedure) [2323008]||closed treatment of distal radial fracture (eg, colles or smith type) or epiphyseal separation, includes closed treatment of fracture of ulnar styloid, when performed||inverse_isa
metachromatic leukodystrophy without arylsulfatase deficiency||metachromatic leukoencephalopathies||inverse_isa
partial obstruction of ileum unspecified as to cause||ileal obstruction||inverse_isa
bypass esophagus to jejunum with nonautologous tissue substitute (treatment)||bypass esophagus to jejunum||inverse_isa
purine nucleoside monophosphate metabolic process||nucleoside monophosphate metabolic process||inverse_isa
product containing precisely lamotrigine 50 milligram/1 each conventional release oral tablet||lamictal pill||inverse_isa
sunmark lancet thin 26 g||blood glucose monitoring supplies||inverse_isa
phospho-5-dehydro-2-deoxygluconate aldolase||lyase, nos||inverse_isa
injection of nerve root of lumbar spine using fluoroscopic guidance (procedure)||fluoroscopy of systems||inverse_isa
cubital lymph nodes||lymph node of upper extremity||inverse_isa
ivd test reagent/kits, microbiology, bacteria, susceptibility, automated test, break-point||ivd test reagent/kits, microbiology, bacteria, susceptibility, automated test||inverse_isa
tushin horse breed||stallion||inverse_isa
lipoprotein-containing product||62 proteins||inverse_isa
polytene chromosome ectopic fiber||cellular anatomical entity||inverse_isa
foot ulcer draining||foot problem||inverse_isa
vesicles on both eyelids||vesicle (___mm)||inverse_isa
mri wrist tendons||mri of wrist||inverse_isa
product containing only lurasidone (medicinal product)||lurasidone||inverse_isa
percutaneous embolization of neoplasm of cervical vertebra using fluoroscopic guidance (procedure)||fluoroscopy neck||inverse_isa
thoracodorsal nerve component of left c7 nerve||c7 nerve component of thoracodorsal nerve||inverse_isa
closed fracture of joint of finger on left hand||closed fracture of joint of finger (diagnosis)||inverse_isa
pellucid marginal degeneration of cornea of bilateral eyes (disorder)||pellucid marginal degeneration of cornea of left eye (disorder)||inverse_isa
plastic operation on tendon, nos||reconstructive orthopedic procedure (procedure)||inverse_isa
left radial head pain||elbow joint pain (finding)||inverse_isa
cacna1c gene (procedure)||chromosome 12p13 (lab test)||inverse_isa
guanfacine hydrochloride 4mg extended release tablet (product)||sympathomimetics (adrenergics)||inverse_isa
recurrent childhood pleomorphic xanthoastrocytoma||recurrent astrocytic tumor||inverse_isa
flucytosine-containing product||antifungal agents (medication)||inverse_isa
biopsy of pancreas showed microinvasive squamous cell carcinoma (procedure)||malignant neoplasm of pancreas (diagnosis)||inverse_isa
methadone hydrochloride 20 mg/ml oral solution||methadone oral solution [methex]||inverse_isa
trainee laboratory technician (occupation)||laboratory technician nos (occupation)||inverse_isa
intra-operative finding of corneal clarity: edema _____grade (1-4) (treatment)||unspecified corneal edema (disorder)||inverse_isa
radial deviation of dip joint of ring finger of left hand||radial deviation of hands||inverse_isa
injury of left vertebral artery||injury; vertebral artery||inverse_isa
distal tendon of alar part of nasalis||distal tendon of nasalis||inverse_isa
adenocarcinoid tumor of ovary (diagnosis)||ovarian carcinoma||inverse_isa
crushing of cranial nerve||destruction of cranial nerve (procedure)||inverse_isa
digitoxin only product in oral dose form||digitoxin only product||inverse_isa
cervical masses||female_repro||inverse_isa
personal hygiene managed menstrual needs minimum assistance||patient managed menstrual needs (physical finding)||inverse_isa
sprouting of injured axon||developmental growth of a unicellular organism||inverse_isa
pomarea mendozae (organism)||genus pomarea (organism)||inverse_isa
assessment using chessington occupational therapy neurological assessment battery||assessment using assessment scale||inverse_isa
n-(alpha-methylbenzyl)linoleamide||enzyme inhibitor drugs||inverse_isa
flavone apiosyltransferase activity||transferase activity, transferring pentosyl groups||inverse_isa
foetal methylmercury syndrome||disorder of fetal structure||inverse_isa
cvs saline 0.65% nasal spray||sodium chloride nasal||inverse_isa
sumatriptan succinate, 6 mg/0.5 ml subcutaneous solution_#1||parenteral form sumatriptan (product)||inverse_isa
thrombosis of thoracic aorta (disorder)||thrombosis; aortic||inverse_isa
genitourinary tract normal (finding)||urogenital observation||inverse_isa
using decision-making strategies||finding related to ability to use decision-making strategies (finding)||inverse_isa
normal passive range of thumb abduction||finding of passive range of thumb abduction||inverse_isa
fumigaclavine c metabolic process||acetyl ester metabolism||inverse_isa
work restrictions no exposure to animals (treatment)||work restrictions no dust exposure (treatment)||inverse_isa
dnaja1 wt allele||dnaja1 gene||inverse_isa
2,4'-dihydroxyacetophenone dioxygenase||dehydrogenase||inverse_isa
papules on glans penis (physical finding)||penile papule||inverse_isa
surface of limbic lobe||surface of cerebral lobe||inverse_isa
retroperitoneoscopic repair of ureter||laparoscopic repair of ureter (procedure)||inverse_isa
active knee movements (regime/therapy)||procedure on knee joint||inverse_isa
unable to move soft palate||unable to perform oral motor functions (finding)||inverse_isa
theanine hydrolase (substance)||substance with hydrolase mechanism of action||inverse_isa
inhalant-induced persistent dementia (diagnosis)||inhalant-related disorders (diagnosis)||inverse_isa
myalgia pelvic region and thigh||generalized muscle aches||inverse_isa
mdi||symptom assessment tool||inverse_isa
wheal on both eyebrows||wheal on eyebrow (physical finding)||inverse_isa
n-ethyl-n-nitroso-ethanamine||product containing alkylating agent (product)||inverse_isa
glass engraver/etcher (occupation)||glass former, potter/related worker||inverse_isa
peroneus longus tenosynovitis||synovial membrane abnormal||inverse_isa
pupil peaked bilaterally (physical finding)||teardrop pupil||inverse_isa
percutaneous embolisation of external carotid artery using fluoroscopic guidance||external carotid angiogram||inverse_isa
congenital anomaly of left lung trilobed||anomaly; lungs, congenital||inverse_isa
current diet deficient in vitamin a||current diet vitamin deficient||inverse_isa
rectum; anomaly||anorectal anomaly, nos||inverse_isa
congenital torsion of ovary (disorder)||ovary, torsion||inverse_isa
negative regulation of dna damage checkpoint||down-regulation of cell cycle checkpoint||inverse_isa
nitrosoacetoxymethylmethylamine||29 carcinogens||inverse_isa
serum herpes simplex virus type ii detection by polymerase chain reaction||herpes simplex polymerase chain reaction (procedure)||inverse_isa
peptidyl-glycine cholesteryl ester formation from peptidyl-glycine||cellular modified amino acid biosynthesis||inverse_isa
implantable vibrator bone-conduction hearing implant system (physical object)||device system||inverse_isa
compact bone of central part of body of fifth thoracic vertebra||compact bone of central part of body of thoracic vertebra||inverse_isa
entire skin and mucous membrane||structure of skin and/or mucous membrane (body structure)||inverse_isa
pleural tissue swab (lab test)||microbiology test of pleural tissue||inverse_isa
bullae on tops of both feet||bullae on top of foot (physical finding)||inverse_isa
infrared treatment of anterior region of right elbow (treatment)||infrared therapy nos (procedure)||inverse_isa
radical lymphadenectomy (radical resection of lymph nodes)||lymphatic system surgical procedure||inverse_isa
sore mouth||pain;mouth||inverse_isa
ncs l ulnar nerve motor below elbow to wrist distance (cm)||motor nerve conduction studies (procedure)||inverse_isa
placental insufficiency fetal effect||foetus or newborn affected by placental insufficiency||inverse_isa
x-ray ankle three or more views right||x-ray of right ankle (procedure)||inverse_isa
reconstruction of right breast||breast plastic surgery||inverse_isa
diffuse pain of fingers of both hands elicited by flexion||diffuse pain of fingers of both hands elicited by motion (physical finding)||inverse_isa
spinal cord myelodysplasias||neural tube defects||inverse_isa
structure of left popliteal fossa (body structure)||popliteal fossa structure (body structure)||inverse_isa
leg bag c/strap||incontinence supplies||inverse_isa
hypoplastic/small middle phalanx of the 3rd toe||short phalanx of the third toe||inverse_isa
neural hearing loss, bilateral||neural hearing loss of right ear (diagnosis)||inverse_isa
open fracture of head of first metatarsal of left foot||open fracture of first metatarsal bone of left foot (diagnosis)||inverse_isa
homograft implantation with recipient pancreatectomy (treatment)||pancreatic transplant homograft implantation||inverse_isa
avoid high altitudes||advice to avoid behaviour||inverse_isa
chryseomonas luteola||liquidomonas||inverse_isa
apply thomas splint traction (procedure)||procedure on bone of extremity (procedure)||inverse_isa
physio mobilstn-intphalang jnt||physiological mobilization of the hand (regime/therapy)||inverse_isa
breakdown (mechanical) of implanted testicular prosthesis||mechanical complication of implanted testicular prosthesis (diagnosis)||inverse_isa
fibrosarcoma of jaw (diagnosis)||primary malignant neoplasm of jaw (diagnosis)||inverse_isa
primary malignant soft tissue neoplasm of shoulder (diagnosis)||primary malignant neoplasm of shoulder||inverse_isa
diagnostic bronchoscopy: mid trachea lumen has atresia (procedure)||atresia of trachea (disorder)||inverse_isa
malic acid (substance)||industrial aid||inverse_isa
surgical delay of flap at cheek||surgical delay of flap at face||inverse_isa
kimono microthin aqua lube||condom (physical object)||inverse_isa
bladder carcinosarcoma||infiltrating transitional cell carcinoma of the urinary bladder||inverse_isa
guanadrelum||guanidine (substance)||inverse_isa
peritoneal foreign body removal tissue of abdomen deep periumbilical region||removal of foreign body from deep tissue of abdomen (treatment)||inverse_isa
savv-psaap||inhibitor, cysteine proteinase||inverse_isa
bite of left side of neck||left neck tissue injury||inverse_isa
se 10-5 ss topical cream||sulfacetamide / sulfur topical cream||inverse_isa
locally advanced pleural malignant mesothelioma||metastatic pleural malignant mesothelioma||inverse_isa
elagolix-containing product in oral dose form||elagolix-containing product||inverse_isa
excision of malignant shoulder lesion 1.1 to 2cm||excision of malignant lesion of skin of extremities, nos||inverse_isa
naphazoline ophthalmic solution||naphazoline ophthalmic||inverse_isa
epithelial cell of external acoustic meatus||general ecto-epithelial cell||inverse_isa
isoproterenol 30 mg oral tablet||isoproterenol pill||inverse_isa
dipyridamole||phosphodiesterase antagonists||inverse_isa
us scan of salivary glands||diagnostic ultrasound of digestive system||inverse_isa
diphenhydramine 25mg oral disintegra tab||diphenhydramine disintegrating oral tablet||inverse_isa
flecainide acetate 150 mg oral tablet [tambocor]||flecainide oral tablet [tambocor]||inverse_isa
plasma taurine level||plasma amino acid measurement||inverse_isa
bulging of intervertebral disc at l5-s1 on left||disk herniated lumbar||inverse_isa
structure of medial margin of forearm (body structure)||structure of forearm||inverse_isa
gastric folds||subdivision of stomach wall||inverse_isa
crystallichthys cyclospilus (organism)||family cyclopteridae - snailfish||inverse_isa
computed tomography arteriography of bronchial artery with contrast (procedure)||bronchial artery angiography||inverse_isa
fracture;malleolus;lateral||extremities lower problems||inverse_isa
hla-dr2 in blood or tissue (lab test)||hla dr antigens||inverse_isa
anterior nerve rootlet complex of right first cervical nerve||c1 anterior nerve rootlet complex||inverse_isa
nitroprusside-containing product||vasodilating agent||inverse_isa
fenproporex measurement||measurement of substance||inverse_isa
inferior subscapular nerve component of posterior root of fifth cervical nerve||segment of c5 root of inferior subscapular nerve||inverse_isa
peripheral pulse taking||taking pulse||inverse_isa
surgical section of flap at toe (treatment)||surgical section of flap at lower extremity (treatment)||inverse_isa
excision of malignant lesion of lip .6 to 1cm||excision of lesion of lip||inverse_isa
vagus nerve parasympathetic fibers||neurofibrum||inverse_isa
orlistat product||drug, anti-obesity||inverse_isa
actinobacillus pleuropneumoniae serotype 5||actinobacillus pleuropneumoniae (shope 1964) pohl et al. 1983||inverse_isa
adrenaline acetate||bronchial-dilating agents||inverse_isa
flavonoid biosynthesis||flavonoid metabolic process||inverse_isa
magnetic resonance imaging of thoracic spine: size of periosseus mass of t6 vertebra (procedure)||mass of thoracic vertebrae (finding)||inverse_isa
ct of left hip with contrast||ct scan of hip with contrast (procedure)||inverse_isa
overdose of analgesic drug (disorder)||poisoning by analgesic drug (disorder)||inverse_isa
supplemental qualifiers for demographics||supplemental qualifiers tabulation dataset||inverse_isa
ultrasound foot right 1st intermetatarsal space||ultrasound of intermetatarsal space of right foot (procedure)||inverse_isa
peritoneal dialysis catheter adaptor/dialysate line holder (physical object)||peritoneal dialysis catheter adaptor (physical object)||inverse_isa
simple endometrial glandular hyperplasia with atypia (disorder)||endometrial hyperplasia with atypia (diagnosis)||inverse_isa
x-ray of pelvis: lytic lesion with septation (procedure)||x-ray of pelvis: lytic lesion (procedure)||inverse_isa
acidosis metabolic non anion gap||endo/metab||inverse_isa
trophozoite of blastocystis hominis (organism)||trophozoite form of protozoa (organism)||inverse_isa
stemphylium sarciniforme extract 0.05 gm/ml injectable solution||stemphylium sarciniforme allergenic extract injectable product||inverse_isa
sep.||month of the year||inverse_isa
oxazolone||immune adjuvant||inverse_isa
unclean incision of right lower paraspinal region||skin incision||inverse_isa
pasteurella coagulans||capsulary||inverse_isa
abrasion and/or friction burn of vulva without infection (disorder)||injury; superficial, vulva||inverse_isa
blood glucose status||general clinical states (observable entity)||inverse_isa
lower limb stretching||therapeutic stretching (procedure)||inverse_isa
historical clinical risk management-20 violence risk assessment scheme version 3 (assessment scale)||assessment scaling||inverse_isa
aesculapian snake||rear-fanged snake||inverse_isa
interphalangeal joint structure (body structure)||joint by site||inverse_isa
grasping plantar reflex||primitive reflex||inverse_isa
allograft for temporary wound closure of genitalia||allograft for temporary wound closure (treatment)||inverse_isa
se||polysomnogram||inverse_isa
ethanol 0.665 ml/ml medicated pad||ethyl alcohol-containing product in cutaneous dose form||inverse_isa
saccharin (medication)||sweeteners, non-nutritive||inverse_isa
cadinene catabolic process||organic cyclic compound degradation||inverse_isa
superficial head of left flexor pollicis brevis||superficial head of flexor pollicis brevis||inverse_isa
carotid artery surgery bypass internal right to right extracranial artery||bypass right internal carotid artery (treatment)||inverse_isa
deaminase, asparagine||chemotherapy drug, cancer||inverse_isa
neoplasm of buccal sulcus||tumor of oral cavity (disorder)||inverse_isa
purine and pyrimidine disorder marker enzyme (substance)||purine and pyrimidine metabolism disorder marker (substance)||inverse_isa
delavirdina||product containing azole||inverse_isa
histone h3-k36 trimethylation||peptidyl-lysine trimethylation||inverse_isa
c-ssrs baseline/screening version - most recent suicide attempt potential lethality||c-ssrs baseline/screening version questionnaire question||inverse_isa
petrolatum 300 mg/ml topical spray [moistureworx]||dermacerin topical product||inverse_isa
bone-marrow transplant rejection||transplanted organ rejection (disorder)||inverse_isa
entire anterior surface of lens||structure of anterior surface of lens||inverse_isa
skin plaque of top of scalp (symptom)||skin plaque of scalp||inverse_isa
injury of coccyx||pelvis disease||inverse_isa
accidental lomustine poisoning||lomustine poisoning||inverse_isa
short-term physical therapy goals increase tone in muscles of mcp joints of left hand||short-term physical therapy goals movement of metacarpophalangeal joints of left hand (treatment)||inverse_isa
calcium carbonate 750 mg in 24 / dimethicone 250 mg in 24 oral tablet, chewable [phazyme]||phazyme gas & acid pill||inverse_isa
lumen of ampulla of left uterine tube||lumen of ampulla of oviduct||inverse_isa
non-tube ileostomy||ileostomy nos||inverse_isa
case management conference for 30 minutes or more with nonphysician||case management conference for 30 minutes or more to coordinate care||inverse_isa
head region of muscle body of right deltoid||head region of muscle body of deltoid muscle||inverse_isa
assessment using wiig criterion referenced inventory of language||assessment using assessment scale (procedure)||inverse_isa
upper arm burn caused by gunpowder explosion||chemical explosion burn of upper arms||inverse_isa
primary malignant neoplasm of meckel diverticulum||neoplasm - soft tissue abdomen malignant primary||inverse_isa
fluoroscopic angiography of femorofemoral crossover bypass (procedure)||femoral angiogram||inverse_isa
education about infant stimulation at 5-8 months (procedure)||teach infant care||inverse_isa
neurocentral junction of sacral segment||neurocentral junction of vertebra||inverse_isa
open wound of chest, complicated||open wound of trunk with complication||inverse_isa
3,7,12,16-tetramethyl-1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-octadeca-1,3,5,7,9,11,13,15,17-nonaene||vitamin (substance)||inverse_isa
scopulariopsis melanospora udagawa, 1959||microascus, nos||inverse_isa
bony part of body of thoracic vertebra||bony part of thoracic vertebra||inverse_isa
pigmented basal cell carcinoma (diagnosis)||basal cell carcinoma of skin (disorder)||inverse_isa
subcutaneous tissue structure of tragus (body structure)||tragal part of pinna||inverse_isa
bcr/abl1 fusion protein with abl1 np_005148.2:p.e255v||bcr/abl||inverse_isa
open wound tongue||tongue lesions||inverse_isa
eno2 positive||expressed||inverse_isa
bone tissue sample (specimen)||specimen from bone (specimen)||inverse_isa
ad5-ncov vaccine||recombinant virus vaccine||inverse_isa
naa with probe detection, respiratory panel, 22 targets including sars-cov-2, nasopharynx swab, using biofire||naa with probe detection for respiratory virus panel (lab test)||inverse_isa
minocycline hydrochloride 105 mg oral tablet, extended release [solodyn]||minocycline pill||inverse_isa
banocide||filaricides (product)||inverse_isa
melanerpes chrysogenys flavinuchus (organism)||melanerpes chrysogenys||inverse_isa
assessment using canadian cardiovascular society grading of angina pectoris||assessment using assessment scale (procedure)||inverse_isa
dorsal rootlet of coccygeal spinal nerve||posterior rootlet of spinal nerve||inverse_isa
laceration on the face extending to fascia||laceration face||inverse_isa
removal of foreign body from anterior aspect of forearm by incision (treatment)||removal of foreign body from upper limb, except hand||inverse_isa
dopamine-containing product||total catecholamines||inverse_isa
activation of cysteine-type endopeptidase activity||zymogen activation||inverse_isa
time (attribute)||measurement property||inverse_isa
fibrin dusard||congenital dysfibrinogens||inverse_isa
tissue cultured skin autograft, trunk, arms, legs; first 25 sq cm or less||tissue cultured skin autograft, trunk, arms, legs||inverse_isa
gonadotropin producing pituitary gland adenoma||noncancerous tumour in pituitary gland||inverse_isa
short-chain fatty acid-coa ligase activity||coa-ligase activity||inverse_isa
down-regulation of emericellamide biosynthesis||negative regulation of cellular amide metabolic process||inverse_isa
sarilumab 175 mg/ml auto-injector||sarilumab auto-injector [kevzara]||inverse_isa
radiate ligament of head of left eleventh rib||radiate ligament of head of eleventh rib||inverse_isa
acute hepatitis c nos||viral hepatitis type c||inverse_isa
lymphocyte positive for cd11 antigen||lymphocyte||inverse_isa
acquired cholesteatoma of middle ear||epidermosis of ear||inverse_isa
born in greece||country of birth - european||inverse_isa
bacampicillin only product||bacampicilline||inverse_isa
ascorbic acid / zinc gluconate chewable tablet||ascorbic acid / zinc gluconate oral product||inverse_isa
maxilla residual ridge morphology with absent anterior labial vestibule (finding)||maxilla residual ridge morphology||inverse_isa
positive regulation of hydrogen sulphide biosynthesis||biological control||inverse_isa
urinary concentration, function||function kidney||inverse_isa
root of nail of little toe||structure of nail root of toe||inverse_isa
rotation flap (substance)||general flap||inverse_isa
infugem regimen||regimen used to treat malignant fallopian tube neoplasm||inverse_isa
anterior neck fluid cells rbc (lab test)||red cell count||inverse_isa
echography, scan b-mode for foetal age determination||echography, b-scan, nos||inverse_isa
structure of wall of artery (body structure)||arterial part (body structure)||inverse_isa
losartan 50 mg oral tablet||losartan oral tablet [cozaar]||inverse_isa
place cath carotd art||diagnostic studies of cervicocerebral arteries||inverse_isa
abnormal placental secretion of chorionic gonadotrophin||disorder of placenta and placental transfusion||inverse_isa
tendon of left iliocostalis thoracis||tendon of iliocostalis thoracis||inverse_isa
crushing of nerve, nos||crushing - action||inverse_isa
cuboidal||cell morphology||inverse_isa
diffuse burns of metatarsophalangeal joint of middle toe of right foot||toe burn||inverse_isa
mesuximidum||succinimides||inverse_isa
open genital incision||skin incision (finding)||inverse_isa
b-cell acute lymphocytic leukemia not having achieved remission (diagnosis)||b-cell precursor type acute leukemia||inverse_isa
nystatin 300000 unt oral capsule||nystatin oral capsule||inverse_isa
college of american pathologists cancer checklist; ureter: resection (qualifier value)||pathologist report||inverse_isa
mannitol transmembrane transporter activity||polyol transmembrane transporter activity||inverse_isa
compact bone of base of middle phalanx of right ring finger||compact bone of proximal epiphysis of middle phalanx of ring finger||inverse_isa
gongylonema verrucosum||gongylonema||inverse_isa
perf divertic - small int nos||perforation small intestine||inverse_isa
structure of larynx||larynx and/or tracheal structures||inverse_isa
burns of dorsal aspect of middle phalanx of fourth toe of left foot||burn of toe (disorder)||inverse_isa
trabecular bone of left lamina of fifth thoracic vertebra||trabecular bone of lamina of fifth thoracic vertebra||inverse_isa
inj unspec blood vess neck||injury of blood vessels of head and neck, nos||inverse_isa
neoplasm of seminal vesicle primary||primary malignant neoplasm of pelvis||inverse_isa
oxymetazoline nasal spray||oxymetazoline nasal product||inverse_isa
10h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-,(e)-2-butenedioate(1:1)||antihistaminic h1||inverse_isa
structure of metaphysis of fifth metatarsal bone of left foot (body structure)||structure of fifth metatarsal bone of left foot (body structure)||inverse_isa
fibrosis pulmonary||interstitial lung disease||inverse_isa
nelaton 18ch antimicrobial-coated female length urethral catheter (physical object)||nelaton antimicrobial-coated female length urethral catheter||inverse_isa
metaphysis of fourth metatarsal bone||metaphysis of metatarsal bone||inverse_isa
idrocodone||agents, antitussive||inverse_isa
skin of upper eyelid||[so]skin of eyelid||inverse_isa
hepatitis c virus genotype analysis by nucleic acid||infectious agent genotype analysis by nucleic acid||inverse_isa
leaden sensation quality||sensations (qualifier value)||inverse_isa
fluocinolone medicated shampoo [fs shampoo]||capex shampoo product||inverse_isa
primary malignant neoplasm of skin of elbow (diagnosis)||primary malignant neoplasm of skin of upper limb (disorder)||inverse_isa
sperm identification from tissue specimen from testis (procedure)||laboratory procedure related to reproduction (procedure)||inverse_isa
cellulitis of plantar aspect of right little toe (physical finding)||cellulitis of little toe of right foot||inverse_isa
blood, injection, injury type phobia - fear of blood||fear associated with illness and body function||inverse_isa
glaucidium brasilianum tucumanum (organism)||ferruginous pygmy owl||inverse_isa
scalloped lung borders||abnormal findings on diagnostic imaging of lung (finding)||inverse_isa
superficial popliteal lymph nodes set||set of lymph nodes||inverse_isa
c6-c7 ligamentum flavum||cervical ligamentum flavum (body structure)||inverse_isa
x-ray of ankle: mixed lytic and sclerotic lesion with thin periosteal reaction (procedure)||x-ray of ankle: mixed lytic and sclerotic lesion with periosteal reaction (procedure)||inverse_isa
laryngeal granulomas||laryngeal inflammation||inverse_isa
test duration (observable entity)||tim||inverse_isa
five chamber view||cardiac imaging views||inverse_isa
lansoprazole allergy||proton pump inhibitor allergy (disorder)||inverse_isa
recurrent uveal melanoma||melanoma of uvea||inverse_isa
subcutaneous haemangioma||hemangioma unspecified site||inverse_isa
open wound of labium minus||labia - open wound||inverse_isa
cinclodes patagonicus (organism)||genus cinclodes||inverse_isa
neurology options include speech therapy||neurology options (treatment)||inverse_isa
dihydroergotoxine oral tablet||dihydroergotoxine oral product||inverse_isa
macular cutaneous amyloidosis (disorder)||skin lesions||inverse_isa
saltator orenocensis orenocensis||saltator orenocensis (organism)||inverse_isa
interferon beta-1b||interferon beta (product)||inverse_isa
subfamily tomopeatinae||family vespertilionidae||inverse_isa
lidocaine / menthol topical cream [lexifen]||lexifen topical product||inverse_isa
peginterferon alfa-2b 50 mcg per 0.5 ml pen injector||pegintron injectable product||inverse_isa
surface of pedicle of third cervical vertebra||surface of pedicle of cervical vertebra||inverse_isa
increased compound s level||hormone level - finding||inverse_isa
japanese encephalitis virus antibody assay||immunology tests||inverse_isa
trapymin||phosphodiesterase inhibitor (product)||inverse_isa
aneurysm of inf.mesenteric art||arterial aneurysms||inverse_isa
structure of nail bed of middle finger of left hand (body structure)||structure of nail bed of middle finger||inverse_isa
product containing only prednisone 5 mg/1 each oral tablet (clinical drug)||prednisone oral product||inverse_isa
arcanobacterial mastitis||infective mastitis (diagnosis)||inverse_isa
patch of periungual region of index finger of left hand||skin plaque||inverse_isa
bluespotted cornetfish||family fistulariidae - cornetfishes||inverse_isa
reduction of corneal clarity||corneal degeneration (disorder)||inverse_isa
bursae trochantericae musculi glutei medii||synovial bursa||inverse_isa
adverse reaction caused by lovastatin (disorder)||adverse effect of hmg-coa reductase inhibitors (diagnosis)||inverse_isa
cmp tr fngr pipj uln coll lgmt||cmplt tr lgmt finger nos||inverse_isa
uterine disease, nos||gynecological disease||inverse_isa
sulfacetamide sodium/sulfur@10 %-5 % (w/w)@topical@lotion (gram)||sulfacetamide / sulfur topical product||inverse_isa
hulc complex location||ubiquitin ligase complex location||inverse_isa
alds||auditory system hereditary disorder (disorder)||inverse_isa
closed fracture of head of talus of right ankle||fracture of talus head closed||inverse_isa
relabelling||remedial activity||inverse_isa
malignant melanoma of skin tnm staging primary tumor (t) t2b||melanoma of skin||inverse_isa
decompr median nerve at wrist||operative procedure on upper extremity||inverse_isa
right perirenal fat capsule||perirenal fat capsule||inverse_isa
lipoprotein electroph. - ldl (procedure)||lipoprotein electrophoresis (procedure)||inverse_isa
implantation of cardioverter defibrillator with three electrode leads (procedure)||implantation of automatic cardiac defibrillator (procedure)||inverse_isa
subtalar joint x-ray||foot radiography||inverse_isa
obstruction of tracheobronchial tree caused by aspergillus infection||inflammation of specific body organs||inverse_isa
surface of subdivision of jejunum||surface of subdivision of small intestine||inverse_isa
snout reflex absent (finding)||snout reflex finding (finding)||inverse_isa
surface of scapular part of pectoral girdle||surface of free upper limb||inverse_isa
distance acuity left with current correction pinhole (20/___) (physical finding)||corrected visual acuity - left eye||inverse_isa
congenital eventration of left crus of diaphragm||back deformity congenital||inverse_isa
negative regulation of mrna modification||downregulation of mrna metabolism||inverse_isa
b tubule||axonemal microtubule||inverse_isa
product containing vitamin b1 (medicinal product)||a44 vitamin b complex preparations||inverse_isa
antibody hypervariable region (substance)||immunoglobulin region||inverse_isa
injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic||injection, drainage, or aspiration procedures on the spine and spinal cord||inverse_isa
open wound lowr arm+tendon inj||injury of tendon at forearm level (disorder)||inverse_isa
broxil 250 mg oral capsule||broxil pill||inverse_isa
need help with daily activities||supportive care question||inverse_isa
hematoporphyrins||photosensitizing agents||inverse_isa
30th interval infusion rate||stress test 30th interval measurements||inverse_isa
diff performing lip spreading||difficulty moving lips (finding)||inverse_isa
leptasthenura striata striata||leptasthenura striata||inverse_isa
monoplegia of unknown etiology of left lower limb affecting dominant side||monoplegia of lower limb affecting dominant side||inverse_isa
pancreatic insulin secreting beta cell tumor||ben neopl endocrine pancreas||inverse_isa
fluconazole 100mg tablet (product)||antifungal product||inverse_isa
blue pulsatile discoloration of upper buccal vestibule on both sides (physical finding)||blue discoloration of upper buccal vestibule on both sides||inverse_isa
rhabdomyosarcoma of retina (diagnosis)||myosarcoma of retina||inverse_isa
hyperextension of both knees during stance phase of gait||hyperextension of knee during stance phase of gait||inverse_isa
anterior bronchopulmonary part of left bronchial vein||anterior segmental bronchial vein||inverse_isa
cocklebur pollen extract injectable solution||cocklebur pollen extract injectable product||inverse_isa
astrocyte||glia cells||inverse_isa
papaverine overdose||vasodilator overdose||inverse_isa
carcinoma of endocervix||cervical neoplasm malignant endocervix primary||inverse_isa
cavity of right seventh costotransverse joint||seventh costotransverse joint cavity||inverse_isa
finding of oxygen saturation (finding)||protein level - finding||inverse_isa
at moderate risk of venous thromboembolism (finding)||at risk of venous thromboembolus (finding)||inverse_isa
family behavior||psychiatric exam (physical finding)||inverse_isa
adjuvant post-operative pharmaceutical therapy was administered||cptac responses||inverse_isa
manipulation of tissue of vulva||perineum manipulation||inverse_isa
cytophaga latercula lewin 1969 (approved lists 1980)||genus aquimarina||inverse_isa
stomach acupuncture points (body structure)||points acupuncture||inverse_isa
curity gauze sponge 3x3"||bandage, device||inverse_isa
(10s)-10-hydroxy-10,11-dihydro-5h-dibenzo(b,f)azepin-5-carboxamide||enzyme inhibitor (product)||inverse_isa
lumbosacral plexopathy due to and following procedure caused by ionising radiation||lumbosacral plexus neuropathy (disorder)||inverse_isa
shoulder instability inferior multidirectional (physical finding)||joint instability of shoulder region (diagnosis)||inverse_isa
nervous system of left upper limb||nerves of the hand, forearm, upper arm and shoulder||inverse_isa
acute gangrenous cholecystitis||lesion of gallbladder||inverse_isa
warmth second toe right dip joint (physical finding)||toe joint - warm (finding)||inverse_isa
buccal caries of left lower third molar (physical finding)||caries of left lower third molar||inverse_isa
no passive range lumbar r rot||no lumbar spine movement||inverse_isa
cardiac catheterization complications false aneurysm requiring exploration||false aneurysm of artery, nos||inverse_isa
pulmonary valve systolic peak acceleration rate at end of expiration||pulmonary valve systolic peak acceleration rate||inverse_isa
area of skin graft of toe||skin graft on the toes||inverse_isa
grade 4 ejection fraction decreased, ctcae||ejection fraction decreased||inverse_isa
contracture of long toe flexor(s) (disorder)||soft tissue lesion of foot||inverse_isa
mannan breakdown||mannan metabolism||inverse_isa
stephenson county, il||us county||inverse_isa
primary laminoplasty of cervical spine||vertebral column reconstruction||inverse_isa
gd1a igg level (procedure)||measurement of ganglioside gd1a antibody||inverse_isa
postpartum cardiomyopathy (disorder)||idiopathic disease||inverse_isa
amlodipine 5 mg (as amlodipine besylate 6.9 mg) / olmesartan medoxomil 40 mg oral tablet||product containing amlodipine and olmesartan in oral dosage form (medicinal product form)||inverse_isa
west african; trypanosomiasis||african sleeping sickness||inverse_isa
eschar on lateral surface of left thigh (physical finding)||eschar on left thigh||inverse_isa
heterozygous methylenetetrahydrofolate reductase mutation||chapter 4 congenital diseases||inverse_isa
duodenum, ulcer||disease of duodenum||inverse_isa
product containing only zolmitriptan in oral dose form (medicinal product form)||product containing only zolmitriptan (medicinal product)||inverse_isa
l-glutamic acid-ethylamine ligase||enzymes (medication)||inverse_isa
abnormal glucose level (finding)||measurement finding outside reference range||inverse_isa
blood group antibody singleton||blood group antibody lutheran||inverse_isa
klln normal variant||klln gene (lab test)||inverse_isa
product containing only indometacin 50 mg/1 each oral capsule (clinical drug)||oral form indomethacin||inverse_isa
ocular surgery||ophthalmologies||inverse_isa
allergy testing melaleuca erythema (lab test)||erythema at injection site (disorder)||inverse_isa
duration of military service in air force (symptom)||air force personnel (symptom)||inverse_isa
sputum culture for coccidioides immitis||culture sputum||inverse_isa
skin fissure on right fourth toe (physical finding)||skin finding||inverse_isa
laceration without foreign body of thyroid gland||laceration of thyroid gland (diagnosis)||inverse_isa
cover, surgical shoe||shoe cover (physical object)||inverse_isa
l-shaped laceration of right upper back (physical finding)||shape of laceration of right upper back (physical finding)||inverse_isa
tenderness on palpation right little finger mcp volar||finger joint - tender||inverse_isa
collj & interpj data ea 30 d||digitally stored data and remote physiologic monitoring services||inverse_isa
referral to tobacco use quit line (treatment)||referral to tobacco use cessation services||inverse_isa
meningeal branch of right seventh cervical nerve||meningeal branch of seventh cervical nerve||inverse_isa
excision of accessory breast (procedure) [ambiguous]||excision of breast tissue||inverse_isa
interleukin-3 in serum or plasma (lab test)||il-3 assay||inverse_isa
unable to use escalator||finding related to ability to use escalator||inverse_isa
(+/-)-pirbuterol||pyridine and pyridine derivative (substance)||inverse_isa
multiple abdominal and pelvic blood vessel injury (disorder)||multiple injuries of abdomen||inverse_isa
difficulty turning body||finding related to ability to turn body (finding)||inverse_isa
furuncles on anal region||furuncle of perineum (disorder)||inverse_isa
hexachlorophene 0.25 % topical liquid (ml)||soaps/shampoos/soap-free cleansers||inverse_isa
x-ray of knee: chondrocalcinosis||chondrocalcinosis of knee joint (disorder)||inverse_isa
rupture of ligaments at ankle and foot level (diagnosis)||rupture of ankle ligament||inverse_isa
cimetidine hcl in 0.9 % sodium chloride@300 mg/50 ml@intraven@intravenous solution, piggyback (ml)||cimetidine only product in parenteral dose form||inverse_isa
structure of membrane of stapes||membrane (organ)||inverse_isa
zone of corpus spongiosum of penis||subdivision of cavernous organ||inverse_isa
referral to community diabetes antenatal clinic (procedure)||referral to diabetes program/service (treatment)||inverse_isa
midface reconstruction, lefort i with bone graft, one piece (treatment)||midface reconstruction, lefort i with bone graft (treatment)||inverse_isa
upper lobe part of posterior pulmonary nerve plexus||subdivision of posterior pulmonary nerve plexus||inverse_isa
oesophagitis bacterial||gastroenteritis - bact.||inverse_isa
microbacterium testaceum (komagata and iizuka 1964) takeuchi and hatano 1998||microbacterium||inverse_isa
chlorhexidine gluconate 4 g in 100 ml topical liquid [cardinal health]||chlorhexidine soap product||inverse_isa
dilation of coronary artery, three arteries, bifurcation, with radioactive intraluminal device (treatment)||coronary artery repair||inverse_isa
anterior root of third lumbar spinal nerve||ventral root of lumbar spinal nerve||inverse_isa
oxyquinoline 1% topical application solution||oxyquinoline topical solution||inverse_isa
sulfur hydride||gaseous messenger molecule||inverse_isa
ascorbic acid / calcium phosphate oral tablet||ascorbic acid / calcium phosphate pill||inverse_isa
papule on left outside elbow||rash papular||inverse_isa
proteobact beta||purple non-sulfur bacteria||inverse_isa
abscess of urethral gland due to neisseria gonorrhoeae (disorder)||abscess of urethral gland (disorder)||inverse_isa
belly of second palmar interosseous of right hand||belly of second palmar interosseous of hand||inverse_isa
magnesium salicylate oral tablet||magnesium salicylate pill||inverse_isa
t6 branch to spinalis thoracis||muscular branch of medial branch of posterior ramus of sixth thoracic nerve||inverse_isa
basal lamina of secondary lactiferous duct||basal lamina of lactiferous duct||inverse_isa
short-term physical therapy goals improve motor control of left wrist (treatment)||short-term physical therapy goals movement of left wrist||inverse_isa
counter strain therapy for left tongue (treatment)||jones method||inverse_isa
neoplasm unspecified behavior bone, soft tissue, and skin||neoplasm of unspecified behavior (diagnosis)||inverse_isa
tositumomab||anti-cd20 monoclonal antibody||inverse_isa
left facial canal space||space of facial canal||inverse_isa
mn1/tel fusion protein||fusion protein-containing product||inverse_isa
war injury due to crushing by falling aeroplane||war injury from the destruction of an aircraft||inverse_isa
superficial partial thickness burn of buttock||second degree burns of buttocks (physical finding)||inverse_isa
regulation of tongue muscle cell differentiation||regulation of skeletal muscle fiber differentiation||inverse_isa
induced termination of pregnancy complicated by amniotic fluid embolism||amniotic embolism fluid||inverse_isa
injury of ciliary ganglion||injuries orbit||inverse_isa
escherichia coli o15:k52:h1 (organism)||escherichia coli o:k:h group||inverse_isa
c alphanumeric strain||microbiological strains||inverse_isa
angiotensin ii, 1-sarcosine-8-isoleucine||antihypertensive medicines||inverse_isa
hepatitis lupus||autoimmune hepatitis (disorder)||inverse_isa
macular yaws||early skin lesions of yaws||inverse_isa
cancer of liver||cancer of intraabdominal organ||inverse_isa
coonhound||canis familiaris (organism)||inverse_isa
history of neoplasm of pituitary gland||history of - endocrine disorder nos (context-dependent category)||inverse_isa
breast surgery mammoplasty reduction with scar tissue multiple||breasts problems||inverse_isa
procardia||calcium channel blocker (product)||inverse_isa
lighted stylette (physical object)||airway devices||inverse_isa
feature of trachea||tracheobronchial features (observable entity)||inverse_isa
tendonitis (diagnosis)||non-neoplastic soft tissue disorder||inverse_isa
reported puncture wound of ankle by single needle (history)||reported puncture wound of ankle by needle||inverse_isa
x-ray of finger: erosion of proximal interphalangeal joint of middle finger of right hand||x-ray of finger: erosions of right hand||inverse_isa
ramus atrialis intermedius (ramus circumflexus) (arteria coronaria sinistra)||branches of left coronary artery||inverse_isa
structure of spinal cord dorsal median sulcus (body structure)||dorsal median sulcus (body structure)||inverse_isa
structure of layer of sclera (body structure)||scleral structure (body structure)||inverse_isa
eeg with central focal spikes||eeg with focal spikes||inverse_isa
cervical dilation premature||problem pregnancy||inverse_isa
product containing palbociclib||aromatic ketone||inverse_isa
lip||benign cavity oral tumors||inverse_isa
born in haiti (finding)||country of birth - atlantic (finding)||inverse_isa
telbivudine oral tablet||telbivudine pill||inverse_isa
creation of conduit between right ventricle of heart and vena cava (procedure)||construction of a cardiac conduit||inverse_isa
vecamyl oral product||product manufactured as oral dose form||inverse_isa
total hysterectomy via vaginal approach using intrafascial technique||vaginal total hysterectomy||inverse_isa
periosteum of diaphysis of left humerus||periosteum of diaphysis of humerus||inverse_isa
non-bullous impetigo||impetigos||inverse_isa
product containing only omeprazole (medicinal product)||product containing omeprazole||inverse_isa
coombs-positive hemolytic anemia||anemia hemolytic||inverse_isa
sphenoid and ethmoid bones (combined site) (body structure)||combined site||inverse_isa
external granular layer of brodmann area 13||lamina of brodmann area 13||inverse_isa
dextromethorphan hbr 20 mg / pseudoephedrine hcl 30 mg per 5 ml oral solution||dextromethorphan / pseudoephedrine oral liquid product||inverse_isa
repair of urethroscrotal fistula||closure urethral fistula -male||inverse_isa
intensity change||ear finding (finding)||inverse_isa
stapling of lung laceration||repair of lung laceration (procedure)||inverse_isa
benzalkonium 130 mg/ml topical solution||benzalkonium-containing product in cutaneous dose form||inverse_isa
pta of left posterior tibial artery, additional vessel, with atherectomy (treatment)||percutaneous transluminal angioplasty of lower limb||inverse_isa
endosc extirp lesion duodenum||duodenum operation||inverse_isa
350 ml soybean oil 200 mg/ml injection [nutrilipid]||nutrilipid injectable product||inverse_isa
product containing imidazole||azole-containing product||inverse_isa
digital tomosynthesis of left breast duct views with intra duct contrast (procedure)||digital tomosynthesis of left breast (procedure)||inverse_isa
part_of relationship value||structural relationship value||inverse_isa
toes maceration right foot 2nd interdigital space||macerated skin (finding)||inverse_isa
product containing protirelin in parenteral dose form (medicinal product form)||trh-thyrotrophin rel horm||inverse_isa
cervical somatic dysfunction||somatic dysfunction of back (finding)||inverse_isa
schisis of left retina (disorder)||rs - retinoschisis||inverse_isa
accidental poisoning by dihydrocodeine (event)||accidental poisoning by opiate agonist||inverse_isa
salbutamol 250mcg/5ml inj||albuterol injectable solution [ventolin]||inverse_isa
breastfeeding maintenance (observable entity)||breastfeeding performance||inverse_isa
iron dextran complex||antianemia drug (substance)||inverse_isa
phrynoderma||skin hyperkeratosis||inverse_isa
respiratory function interpretation||specific test feature (observable entity)||inverse_isa
cmplx||general adjectival modifiers||inverse_isa
structure of permanent mandibular right third molar tooth (body structure)||structure of permanent lower third molar tooth||inverse_isa
tender tissue surrounding wound of left breast (physical finding)||wound finding (finding)||inverse_isa
short fifth metacarpal insulin resistance syndrome (disorder)||multiple malformation syndrome with limb defect as major feature (diagnosis)||inverse_isa
cutaneous branch of lateral branch of dorsal branch of right third posterior intercostal artery||cutaneous branch of lateral branch of dorsal branch of third posterior intercostal artery||inverse_isa
docusate potassium 240 mg oral capsule, liquid filled||docusate oral capsule||inverse_isa
dyphylline and guaifenesin oral solution||lufyllin-gg oral product||inverse_isa
papillary adenocarcinoma of salivary gland (diagnosis)||glands malignant salivary tumors||inverse_isa
petechial hemorrhage of periungual region of little finger of right hand (physical finding)||petechial hemorrhage of little finger of right hand||inverse_isa
appendage of neuron||cell appendage||inverse_isa
ptca svg-1 probable success <60% / high risk (treatment)||percutaneous transluminal angioplasty of vascular graft (procedure)||inverse_isa
metformin hydrochloride 1000 mg / sitagliptin 50 mg (as sitagliptin phosphate monohydrate 64.25 mg) oral tablet||metformin / sitagliptin oral tablet||inverse_isa
bypass duodenum to ileum with nonautologous tissue substitute||duodenal-ileal bypass||inverse_isa
hematopoietic maturation arrest (finding)||abnormality of bone marrow cell morphology||inverse_isa
product containing only niclosamide 500 mg/1 each oral tablet||niclosamide oral tablet||inverse_isa
compact bone of right posterolateral part of body of third thoracic vertebra||compact bone of posterolateral part of body of third thoracic vertebra||inverse_isa
lidocaine rectal cream [lidocream]||lidocream rectal product||inverse_isa
skin spot of left side of groin||symptoms affecting skin [d]: [& etc] (finding)||inverse_isa
regulation of action potential||regulatory process||inverse_isa
low-pitched continuous apical murmur||heart murmur pitch, low (finding)||inverse_isa
indomethacin product (substance)||cardioactive drugs||inverse_isa
laceration of lacrimal passage (disorder)||open wound of ocular adnexa, nos||inverse_isa
microbiology test of postauricular fistula (lab test)||microbiology test of ear specimen||inverse_isa
med-hist expectorant, 200 mg-5 mg-60 mg/5 ml oral liquid||med-hist expectorant oral product||inverse_isa
constriction ring syndrome of lower limb with lymphedema (diagnosis)||constriction ring of lower limb (disorder)||inverse_isa
24 hr empagliflozin 25 mg / linagliptin 5 mg / metformin hydrochloride 1000 mg extended release oral tablet [trijardy]||empagliflozin / linagliptin / metformin extended release oral tablet [trijardy]||inverse_isa
congenital epiblepharon (diagnosis)||congenital eyelid deformity nos (disorder)||inverse_isa
medication set-up treatments and procedures||drug administration||inverse_isa
methanococcus halophilus zhilina 1984||methanohalophilus paterek and smith 1988 emend. katayama et al. 2014||inverse_isa
penicillin v 1000000 unt oral tablet||penicillin v oral tablet||inverse_isa
phytobacter diazotrophicus||phytobacter||inverse_isa
subdivision of pronator teres||subdivision of muscle (organ)||inverse_isa
pheromone degradation||cellular catabolic process||inverse_isa
urine sarcosine measurement (lab test)||urine glycine measurement||inverse_isa
ferlini ragno calzolari syndrome||hereditary disorder of nervous system (diagnosis)||inverse_isa
bilateral ear tragus posterior||ear tragus bilateral (physical finding)||inverse_isa
t3 branch to right longissimus capitis||t3 branch to longissimus capitis||inverse_isa
znso4 1.35 mg/ml oral solution||verazinc oral product||inverse_isa
nsc-crad-survivin-pk7||anti-cancer biological agent||inverse_isa
negative regulation of axon regeneration||negative regulation of neuron projection regeneration||inverse_isa
non-articular surface of right capitate bone||non-articular surface of capitate||inverse_isa
x-ray of toe: erosion of distal surface of fourth distal interphalangeal joint (procedure)||erosion; bone||inverse_isa
pd-l1 peptide vaccine||vaccines, peptide||inverse_isa
audiological implant in situ (finding)||ear and auditory finding (finding)||inverse_isa
passive range of joint movement increased||range of joint movement increased (finding)||inverse_isa
amifostinum||immunomod||inverse_isa
obstructive biliary cirrhosis||d.choledochus; obstruction||inverse_isa
malignant glaucoma||ac shallow||inverse_isa
adverse effect of topical or infiltrative cocaine||[x] adverse react to cocaine||inverse_isa
age at death of male cousin #2 by father's brother #2 (history)||male cousin #2 by father's brother #2 deceased||inverse_isa
sodium (4-(carbamoylmethylamino)phenyl)methyl-oxido-arsinic acid||product containing amino acid derivative (product)||inverse_isa
right superior segmental bronchial artery||superior bronchopulmonary part of bronchial artery||inverse_isa
technetium 99m compounds, skeletal system diagnostic radiopharmaceuticals||skeleton diagnostic radiopharmaceuticals||inverse_isa
upadacitinib 15 mg oral tablet, extended release [rinvoq]||other antirheumatics||inverse_isa
fracture of lacrimal bone (disorder)||orbit; wound||inverse_isa
exfoliation on left eyebrow||exfoliation on eyebrow||inverse_isa
entire intervertebral disc of sixth cervical vertebra||intervertebral disc, c6-c7||inverse_isa
lisdexamfetamine 60 mg oral tablet, chewable||lisdexamfetamine in oral dosage form||inverse_isa
paramethadione 300 mg oral capsule||paradione pill||inverse_isa
aconitum vulparia (organism)||aconitum finet & gagnep., 1904||inverse_isa
tenderness on palpation of left lower lateral incisor (physical finding)||tenderness on palpation of tooth||inverse_isa
space of right carotid canal||space of carotid canal||inverse_isa
common duct lymph node||entire hepatic lymph node||inverse_isa
risk for infection||infect_nos problem||inverse_isa
displaced transverse fracture of left patella (diagnosis)||fracture knee cap||inverse_isa
cyclizine / dipipanone oral tablet||cyclizine / dipipanone pill||inverse_isa
personnel trainee||personnel/industrial relations nos (occupation)||inverse_isa
procedure on abducens nerve||procedure on cranial nerve (procedure)||inverse_isa
unable to do polishing (finding)||finding related to ability to do polishing (finding)||inverse_isa
dlgh1||maguk family gene||inverse_isa
doppler ultrasound velocimetry of umbilical artery of fetus||doppler ultrasonography of artery||inverse_isa
angiography of neck||imaging of neck (procedure)||inverse_isa
jeotgalicoccus psychrophilus (organism)||genus jeotgalicoccus||inverse_isa
x-ray of both temporomandibular joints, five views (procedure)||x-ray;temporomandibular joint||inverse_isa
vocal cord present (finding)||vocal cord observation||inverse_isa
entire mid inferolateral segment of left cardiac ventricle (body structure)||left ventricle mid inferolateral segment (body structure)||inverse_isa
able to undo clothes fastenings||finding related to ability to undo clothes fastenings||inverse_isa
plant organ senescence||aging||inverse_isa
human papillomavirus 66 dna||human papilloma virus dna||inverse_isa
cartilage of superior surface of posterolateral part of body of fourth cervical vertebra||cartilage of posterolateral part of body of fourth cervical vertebra||inverse_isa
papillary carcinoma in situ of oropharynx (diagnosis)||carcinoma in situ of oropharynx, nos||inverse_isa
product containing only fentanyl in transdermal dose form (medicinal product form)||fentanyl topical||inverse_isa
burning (in);esophagus||burns of alimentary tract||inverse_isa
vacuole-isolation membrane contact site||mcs||inverse_isa
feeding tube surrounding skin itching (symptom)||feeding tube surrounding skin||inverse_isa
percutaneous embolization of cephalic vein using fluoroscopic guidance with contrast||fluoroscopic venography of upper limb with contrast (procedure)||inverse_isa
trunk of brachialis branch of right radial recurrent artery||trunk of brachialis branch of radial recurrent artery||inverse_isa
pouch,closed,esteem synergy c#4054-03||bag,closed without adhesive colostomy/ileostomy||inverse_isa
crush injury of lesser toe(s) of right foot (diagnosis)||injury of toe of right foot||inverse_isa
positive regulation of dna topoisomerase type ii activity||positive regulation of isomerase activity||inverse_isa
ulcer of infraclavicular region tissue base necrosis (physical finding)||ulcer skin||inverse_isa
granulocytic leukaemoid reaction||nnutrophilia||inverse_isa
renal filtration fraction, function||kidney function||inverse_isa
shaft of left second metatarsal bone||diaphysis of second metatarsal bone||inverse_isa
oesophageal polyp||polyp(s)||inverse_isa
liptruzet, 10 mg-10 mg oral tablet||hypolipidemic drug||inverse_isa
magnetic resonance imaging of abdomen: absent left kidney only (procedure)||magnetic resonance imaging of abdomen: absent kidney||inverse_isa
myiophobus roraimae rufipennis (organism)||myiophobus roraimae||inverse_isa
arthrodesis of distal tibiofibular joint (procedure)||arthrodeses||inverse_isa
arbovirus culture (procedure)||viral culture (procedure)||inverse_isa
aminoglycosides poisoning||antibiotic toxicity||inverse_isa
envenomation resulting in positive regulation of blood coagulation in other organism||envenomation resulting in impairment of hemostasis in other organism||inverse_isa
para-aortic staging lymphadenectomy, node was indeterminate (procedure)||para-aortic staging lymphadenectomy node number (#___)||inverse_isa
infra-orbital part of right cheek||infraorbital region of face||inverse_isa
menthol||product containing plant agent (product)||inverse_isa
t2: ampulla tumor invades duodenal wall||tumor stage t2||inverse_isa
child in custody of biological remarried mother (history)||child in custody of biological mother (history)||inverse_isa
central protective suture of eyelid (procedure)||protective suture of eyelid nos (procedure)||inverse_isa
barrier,sensura coloplast #10512||discs,ostomy||inverse_isa
increased motion of midtarsal joints on adduction of right foot (physical finding)||foot joint hypermobility (finding)||inverse_isa
sex determination by dna||sex determination||inverse_isa
intractable menstrual migraine (disorder)||menstrual migraine nos||inverse_isa
burn caused by paint stripper||burn-caustic organic chemical||inverse_isa
lump in lower outer quadrant of right breast (symptom)||lump in right breast||inverse_isa
chancre on right alar groove||chancre on alar groove (physical finding)||inverse_isa
congenital superior sulcus anomaly of orbit (disorder)||congenital anomaly of orbit proper||inverse_isa
infrared treatment of posterior region of right upper arm (treatment)||infrared treatment of right upper arm (treatment)||inverse_isa
left tenth rib body||structure of shaft of tenth rib (body structure)||inverse_isa
microscopic examination of bacterial smear of specimen from peritoneum (procedure)||microscopic examination of specimen from peritoneum (procedure)||inverse_isa
barium enema solitary polyp of ascending colon (procedure)||barium enema appearance of ascending colon (procedure)||inverse_isa
erythromycin propionate lauryl sulphate||enzymes inhibitors||inverse_isa
tendon of posterior crural muscle||tendon lower leg||inverse_isa
pseudoephedrine tannate 9 mg/ml / triprolidine tannate 0.5 mg/ml oral suspension||pseudoephedrine / triprolidine oral suspension||inverse_isa
moistness of wound||wound observable (observable entity)||inverse_isa
the thoracic spine exhibited an elevated rib on the right at the t9 vertebra||thoracic spine rib motion elevated right (physical finding)||inverse_isa
preventing pain||prophylaxis, nos||inverse_isa
trichomycteridae||fish, nos||inverse_isa
percutan placement soft tissue localiz device initial lesion||percutaneous placement of soft tissue localization device (treatment)||inverse_isa
salmonella 6,7,14:c:1,2||salmonella i, group o:7 (organism)||inverse_isa
wide 2nd toe||abnormality of the 2nd toe||inverse_isa
sunburn of second degree (disorder)||acute effect of ultraviolet radiation on normal skin||inverse_isa
age of third sister (history)||health status of sister #3||inverse_isa
unable to rise from squatting without using hands (finding)||unable to rise from squatting||inverse_isa
musculus splenius colli||extensor of cervical intervertebral joint (body structure)||inverse_isa
short-term physical therapy goals increase dorsiflexion of right ankle (treatment)||short-term goals ankle right increase rom by (___ degrees)||inverse_isa
transpalatine choanal atresia repair (treatment)||repair choanal atresia||inverse_isa
fitting of prosthesis or prosthetic device of leg below knee (procedure)||fitting of prosthesis of lower leg (procedure)||inverse_isa
regulation of t-cell anergy||regulation of t cell tolerance induction||inverse_isa
structure of free surface of gingiva (body structure)||gingival part (body structure)||inverse_isa
late effect of injury of testicle (disorder)||late effect of unspecified injury||inverse_isa
structure of middle clinoid process (body structure)||zone of sphenoid||inverse_isa
streptomyces olivaceiviridis||streptomyces||inverse_isa
skin biopsy of posterior aspect of right side of scrotum (procedure)||skin biopsy of right side of scrotum||inverse_isa
consultation for colposcopy related procedure (procedure)||consultation with healthcare provider||inverse_isa
anomalous origin of single coronary artery from right coronary artery aortic sinus (disorder)||anomalous origin of coronary artery from aorta||inverse_isa
8-9 month exam not attended||general examination not done (finding)||inverse_isa
congenital thickening of ulna||congenital anomaly of ulna||inverse_isa
trunk of dorsal tributary of right second posterior intercostal vein||trunk of dorsal tributary of second posterior intercostal vein||inverse_isa
x-ray of shoulder, two views (procedure)||diagnostic radiography, shoulder||inverse_isa
nafcillin 20 mg/ml injectable solution||product containing nafcillin in parenteral dosage form (medicinal product form)||inverse_isa
reconstruction of supraorbital margin using autograft (procedure)||reconstruction of cranial and facial bones using autograft (procedure)||inverse_isa
regulation of il-35 production||biological regulation||inverse_isa
trabecular bone of diaphysis||trabecular bone of subdivision of long bone||inverse_isa
metabolic measurement trolley (physical object)||stretcher, wheeled||inverse_isa
cuneocuboidal ligament (body structure)||ligament of intertarsal joint (body structure)||inverse_isa
luride 1.1 mg (fluoride ion 0.5 mg) chewable tablet||luride oral product||inverse_isa
palonosetron 0.5 mg oral capsule [aloxi]||palonosetron oral capsule||inverse_isa
dna replication initiation involved in mitotic cell cycle dna replication||mitotic cell cycle process||inverse_isa
camphor 0.0122 mg/mg / menthol 0.0244 mg/mg / methyl salicylate 0.0244 mg/mg medicated patch||dragon topical product||inverse_isa
deficiency of acetyl-coa synthetase||specific enzyme deficiency (disorder)||inverse_isa
transient decreased circulating igd||decreased igd in blood||inverse_isa
recent decrease in alcohol consumption (history)||finding of alcohol intake||inverse_isa
radial lymphatic tree of right free upper limb segment||radial lymphatic tree of free upper limb segment||inverse_isa
lower back pain radiating to right buttock||lower back pain radiating to buttocks||inverse_isa
cphs neurologic screen follow-up status||cphs attachment set neurologic screen assessment||inverse_isa
premarin, 0.45 mg oral tablet||premarin tablets||inverse_isa
superficial lymphatic vessel of free lower limb||superficial lymphatic vessel of subdivision of lower limb||inverse_isa
warm tissue surrounding incision on right upper arm||tissue surrounding incision on right upper arm (physical finding)||inverse_isa
infective endocarditis at site of interatrial communication||endocarditides, infective||inverse_isa
lens scale pollen extract||grain, pollen||inverse_isa
surface of articular process of fifth cervical vertebra||surface of articular process of cervical vertebra||inverse_isa
carcinoma in situ of fraenum of upper lip||carcinoma in situ of fraenum of lip||inverse_isa
tumor necrosis factor alpha (tnf-alpha) inhibitors||immunosuppressive agents||inverse_isa
pregnanetriolone (substance)||prenol lipid||inverse_isa
articaine hydrochloride 40 mg/ml / epinephrine 0.01 mg/ml cartridge||product containing articaine and epinephrine in parenteral dose form (medicinal product form)||inverse_isa
negative regulation of hindgut contraction||regulation of hindgut contraction||inverse_isa
left cracked nipple during lactation||cracked nipple associated with lactation (diagnosis)||inverse_isa
anterior surface of right knee||anterior surface of knee||inverse_isa
dietilcarbamazina||filaricides (substance)||inverse_isa
tiprostanide||analogue, prostaglandin||inverse_isa
desquamation was seen on the right breast superior medial quadrant||skin scales||inverse_isa
progressive encephalopathy with edema, hypsarrhythmia and optic atrophy syndrome (disorder)||chronic brain syndrome||inverse_isa
xeljanz 1 mg/ml oral solution||product containing tofacitinib in oral dosage form (medicinal product form)||inverse_isa
cetirizine oral solution [alleroff]||cetirizine-containing product in oral dose form||inverse_isa
anadrol-50 50 mg oral tablet||anadrol-50 pill||inverse_isa
neuroma of hand||benign neoplasm of hand, nos||inverse_isa
disposable bed sheets||bed sheets||inverse_isa
benefit||conceptual entity||inverse_isa
bony part of third lumbar vertebra||bony part of lumbar vertebra||inverse_isa
trna(ile)-2-lysyl-cytidine synthase activity||ligase activity, forming carbon-nitrogen bonds||inverse_isa
vena anterior septi pellucidi||tributary of superior thalamostriate vein||inverse_isa
vena portae hepatis||portal vein structure (body structure)||inverse_isa
regulation of two-component signal transduction system (phosphorelay)||biological regulation||inverse_isa
cause of gunshot wound||gunshot wound (disorder)||inverse_isa
hcos16||regulatory proteins||inverse_isa
removal of anal seton||biomedical equipment procedure||inverse_isa
pneumonia; viral, congenital||pneumonia, abacterial||inverse_isa
burning caused by conflagration in tenement||burning caused by conflagration in private dwelling nos (event)||inverse_isa
human adenovirus 38||human adenovirus species d||inverse_isa
corticosteroid injection into cervical joint by interlaminar approach (medication)||injections joint steroid||inverse_isa
intravenous pyelogram||medical image||inverse_isa
congenital infection nos||chapter 4 congenital diseases||inverse_isa
open fracture finger metacarpal (disorder)||open fracture of metacarpal bones, site unspecified||inverse_isa
cholinergic dermographism (disorder)||heat; urticaria||inverse_isa
serinus canicollis sassii||serinus canicollis||inverse_isa
acquired heart murmur||finding of heart murmur||inverse_isa
spasm anal||gastrointestinal symptoms (finding)||inverse_isa
iodide, dimethylphenylpiperazinium||nicotinic acetylcholine receptor agonist||inverse_isa
ehec, serotype o45:h2||escherichia coli serotype o45:h2||inverse_isa
posterior labial branch of internal pudendal artery||female anogenital region||inverse_isa
benign granular cell tumor of esophagus (diagnosis)||benign esophagus tumors||inverse_isa
anterior left coccygeal ramus||ventral ramus of coccygeal nerve||inverse_isa
autopsy planned||planned procedure (situation)||inverse_isa
skin structure of right lower eyelid (body structure)||structure of right lower eyelid (body structure)||inverse_isa
vulval varices||vulva--diseases||inverse_isa
septa - device||plate device||inverse_isa
regulation of protein adp-ribosylation||biological regulation||inverse_isa
nci ctep sdc ovarian cancer (excluding ovarian germ cell cancer) sub-category terminology||nci ctep simple disease classification reproductive system neoplasm, female category terminology||inverse_isa
proper palmar digital branch of median nerve to ring finger||proper palmar digital branch of median nerve||inverse_isa
diatrizoate product||contrast materials||inverse_isa
radioisotope scan of left vein||radioisotope scan of vein (procedure)||inverse_isa
solanum pseudo-capsicum (organism)||horse nettles||inverse_isa
prepj& antigen prv allergen immunotherapy 1 do||allergen immunotherapy services and procedures||inverse_isa
creation of arteriovenous fistula by other than direct arteriovenous anastomosis (separate procedure); autogenous graft||creation of arteriovenous fistula by other than direct arteriovenous anastomosis (separate procedure)||inverse_isa
echocardiography: appearance of tricuspid valve annulus (procedure)||echocardiography: tricuspid valve (procedure)||inverse_isa
immunodeficiency with multicarboxylase deficiency (disorder)||immunologic deficiency syndromes||inverse_isa
aorta clamping||vascular clamps||inverse_isa
extent of surgical margin involvement by malignant neoplasm cannot be assessed||surgical margin finding (finding)||inverse_isa
sprain of first cuneiform metatarsal joint of right foot (diagnosis)||joint; injury||inverse_isa
keratitis of both corneas||keratitis;measles||inverse_isa
chlorpheniramine polistirex/hydrocodone polistirex 8 mg-10 mg oral capsule, extended release [tussicaps]||tussicaps pill||inverse_isa
sequela of injury to nerve||late effect-nervous syst.inj.||inverse_isa
irish sign language (qualifier value)||european sign language||inverse_isa
decreased pancreatic secretion (finding)||decline in functional status (finding)||inverse_isa
entire sacroiliac ligament (body structure)||sacroiliac ligament (body structure)||inverse_isa
optic papillitis of left eye (diagnosis)||retinitis of left eye (disorder)||inverse_isa
diabetes mellitus associated with hormonal etiology (disorder)||secondary diabetes mellitus, nos||inverse_isa
fear of men||simple phobia (disorder)||inverse_isa
discharge by clinical hematologist (procedure)||discharge by doctor (procedure)||inverse_isa
recently bought new shoes of different type (history)||recently bought new shoes (history)||inverse_isa
allergy to zinc and zinc compound (finding)||allergy to metal and metal compound (finding)||inverse_isa
calcium citrate 300 mg / cholecalciferol 100 unt oral tablet||calcium citrate / cholecalciferol oral product||inverse_isa
did not attend dtap, polio and mmr booster||did not attend||inverse_isa
corticoadrenal insufficiency, nos||insufficiency adrenal||inverse_isa
deleted from recall-not coming||patient recall status (finding)||inverse_isa
dasabuvir / ombitasvir / paritaprevir / ritonavir oral product||ombitasvir + paritaprevir + ritonavir + dasabuvir (medication)||inverse_isa
plication of kidney||tuck||inverse_isa
flsi - i have been coughing||flsi questionnaire question||inverse_isa
triphalangeal thumb (disorder)||abnormality of thumb phalanx||inverse_isa
nodular lymphoma involving lymph nodes of multiple sites||[m]brill - symmers' disease||inverse_isa
regulation of activation of jak protein||biological control||inverse_isa
juvenile idiopathic thoracic scoliosis (diagnosis)||juvenile idiopathic scoliosis||inverse_isa
epiphyseal arrest femur left distal partial (diagnosis)||partial epiphyseal arrest (disorder)||inverse_isa
posture lower extremities flexed left (physical finding)||posture lower extremities flexed (physical finding)||inverse_isa
heavy metal screen, nos||heavy metal level||inverse_isa
pregnancy complicated by cytomegaloviral infection as antepartum condition (diagnosis)||pregnancy complicated by cytomegalovirus (diagnosis)||inverse_isa
certhiaxis cinnamomeus cearensis (organism)||certhiaxis cinnamomeus (organism)||inverse_isa
ostomy barriers||barrier,sensura coloplast #10022||has_ingredient
pouch,ostomy||pouch,drainable,sur-fit c#1253-07||has_ingredient
antihemophilic factor b||rixubis (coagulation factor ix (recombinant human)) 1 unt injection||has_ingredient
iva annua var. annua pollen||rough marshelder pollen extract 50 mg/ml||has_ingredient
tricalcium citrate||prenate 90 tab||has_ingredient
codeine phosphate [git]||product containing precisely codeine phosphate 60 milligram/1 each conventional release oral tablet (clinical drug)||has_ingredient
1-nitropentane||amyl nitrite 0.18 ml||has_ingredient
prednisolone acetate||poly-pred ophthalmic suspension||has_ingredient
urea (product)||urea topical cream||has_ingredient
glucose control||one touch select (glucose) control soln||has_ingredient
product containing quetiapine (medicinal product)||product containing only quetiapine 300 mg/1 each oral tablet (clinical drug)||has_ingredient
corticosteroids prednisolone acetate||neomycin so4 0.5%/prednisolone acetate 0.5% oint,top||has_ingredient
asparagus||asparagus allergenic extract 100 mg/ml||has_ingredient
antibacterial azithromycin||azithromycin dihydrate 100 mg in 1 ml intravenous injection, powder, lyophilized, for solution||has_ingredient
idrocodone||guaifenesin/hydrocodone 100 mg-5 mg/5 ml oral syrup||has_ingredient
ala hcl||aminolevulinic acid hydrochloride 0.1 mg/mg [ameluz]||has_ingredient
aquatab d (obsolete1)||aquatab d 1200mg-60mg extended-release tablet||has_ingredient
methaqualone hydrochloride||diphenhydramine hcl 50 mg oral capsule||has_ingredient
chondroitin (substance)||glucosamine hcl 500 mg / chondroitin sulfates 400 mg oral tablet||has_ingredient
coal-tar||coal tar 5 % topical lotion (ml)||has_ingredient
carbonic acid calcium salt (1:1)||alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / cupric oxide / ferrous bisglycinate / folic acid / iron protein succinylate / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin b12 / zinc oxide pill||has_ingredient
chlorhexidinum||chlorhexidine topical spray [douxo chlorhexidine]||has_ingredient
product containing benzoyl peroxide (medicinal product)||benzoyl peroxide 50 mg/ml [terminator]||has_ingredient
carprofen (medication)||carprofen 75 mg chewable tablet [rimadyl]||has_ingredient
pouch ostomy||pouch,mini,closed,new image h#18383||has_ingredient
metoprolol succinate||product containing metoprolol tartrate 100 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug)||has_ingredient
nephramine||amino acids 5 %/dextrose 15 %/electrolytes@5 %@intraven@intravenous solution||has_ingredient
emollients||aveeno baby calming comfort bath plus set kit||has_ingredient
asendis||amoxapine 50 mg oral tablet [amoxapine]||has_ingredient
alpha-methyl-4-(2-methylpropyl)benzeneacetic acid||ibuprofen 100 mg oral tablet, chewable [health mart ibuprofen]||has_ingredient
(s)-2-amino-4-methylpentanoic acid||leucine 3.65 mg/ml||has_ingredient
cephalexin product||biocef pill||has_ingredient
epinephrine (substance) [ambiguous]||epinephrine 0.5 mg/ml||has_ingredient
guaianesin||dextromethorphan hbr 20 mg / guaifenesin 400 mg / phenylephrine hcl 10 mg oral tablet||has_ingredient
calcium carbonated||product containing calcium carbonate in oral dosage form||has_ingredient
product containing carmustine||product containing carmustine in parenteral dose form (medicinal product form)||has_ingredient
delavirdine mesylate (substance)||product containing delavirdine in oral dose form (medicinal product form)||has_ingredient
b polymyxin||hydrocortisone / neomycin / polymyxin b ophthalmic solution||has_ingredient
albright's solution||regiocit injectable product||has_ingredient
dextromethorphan hydrobromide product||chlorpheniramine/dextromethorp/phenylephrine 8 mg-30 mg-20 mg oral tablet, extended release||has_ingredient
zenieva cream and cleanser||zenieva cream and cleanser, topical kit||has_ingredient
pseudoephedrine (substance)||apap 500 mg / codeine phosphate 20 mg / guaifenesin 400 mg / pseudoephedrine hydrochloride 60 mg oral tablet||has_ingredient
glove, device (physical object)||glove nitrile medium w/aloe nsterl tx||has_ingredient
pazopanib||pazopanib tablets||has_ingredient
amoxicillin [generic additions]||amoxicillin / carbocysteine oral suspension||has_ingredient
product containing acetylcysteine (medicinal product)||acetylcysteine oral liquid product||has_ingredient
potassium (nos)||glucerna 1.2 cal liquid 1500ml||has_ingredient
vanalice||r & c lice treatment kit, 3%-0.3% topical kit||has_ingredient
tazarotène||tazarotene 1 mg/ml [fabior]||has_ingredient
tydemy||drospir/eth estra/levomefol ca 3 mg-0.03 mg-0.451 mg (21)/0.451 mg (7) oral tablet||has_ingredient
prelief||criticare hn liquid||has_ingredient
product containing human insulin||insulin isophane / insulin, regular, human injectable suspension||has_ingredient
vanatab dm||dextromethorphan / phenylephrine pill||has_ingredient
product containing fluocinolone||fluocinolone acetonide 0.00025 mg/mg [flurosyn]||has_ingredient
q10||coenzyme q10 60 mg oral capsule [leader coq-10]||has_ingredient
thiabendazole product||tiabendazole-containing product in oral dose form||has_ingredient
canadian oil||nutrition supl fibersource hn liquid||has_ingredient
pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (e)-||pyrantel 228 mg||has_ingredient
paracetamol-containing product||acetaminophen 400mg/hydrocodone 7.5mg tablet||has_ingredient
acetaminofén||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [multi-symptom cold relief non-drowsy daytime]||has_ingredient
buthiazide||buthiazide / reserpine oral product||has_ingredient
tositumomab/iodine (<o>131</o>i) tositumomab||{2 (20 ml) (iodine-131-tositumomab 1.1 mg/ml injectable solution) / 2 (16.1 ml) (tositumomab 14 mg/ml injectable solution) } pack||has_ingredient
viscum album preparation||viscum album preparation 0.5 mg/ml||has_ingredient
prochlorperazine dimaleate||product containing prochlorperazine 10 mg/1 each oral capsule (clinical drug)||has_ingredient
niva-fol||renaphro softgel||has_ingredient
tetracaine product||tetracaine 20 mg/ml [numfast]||has_ingredient
(-)-β-2',3'-dideoxy-5-fluoro-3'-thiacytidine||emtriva oral liquid product||has_ingredient
cleanser||eucerin, topical soap||has_ingredient
nyquil severe cold & flu||tylenol cold + flu + cough 325mg-10mg-6.25mg-5mg/15ml night solution (wild berry burst)||has_ingredient
product containing docusate||docusate sodium 100 mg oral capsule, liquid filled [duosol]||has_ingredient
laxadan||docusate sodium/phenolphthalein 100 mg-65 mg oral tablet [laxative]||has_ingredient
hexachlorophene (obsolete)||hexachlorophene topical compounding powder||has_ingredient
ethyl chloride (substance)||ethyl chloride 100% topical application spray [gebauer's ethyl chloride]||has_ingredient
ondansetron-containing product||ondansetron 0.8 mg/ml||has_ingredient
6 alpha-fluorodihydroxy-16 alpha,17 alpha-isopropylidenedioxy-1,4-pregnadiene-3,20- dione||flunisolide 29 mcg (0.025 %) nasal aerosol, spray (ml)||has_ingredient
avinza||morphine sulphate 500mg/20 ml solution||has_ingredient
iva axillaris pollen||poverty weed pollen extract injectable solution||has_ingredient
vitamin bc||multiret folic 500, vitamin b complex with c, folic acid and iron oral tablet, extended release||has_ingredient
n-(2-(diphenylmethoxy)ethyl)-n,n-dimethylamine||acetaminophen / diphenhydramine / phenylephrine granule product||has_ingredient
product containing guaifenesin||codeine phosphate/guaifenesin 10 mg-200 mg/5 ml oral liquid (ml)||has_ingredient
omnopon||papaveretum 20 mg/ml||has_ingredient
product containing ferrous fumarate (medicinal product)||tandem ob oral product||has_ingredient
genapap c||acetaminophen/dextromethorphan hydrobromide/pseudoephedrine hydrochloride 325 mg-15 mg-30 mg oral tablet [cold multi-symptom max strength]||has_ingredient
mentol||menthol topical product||has_ingredient
ketamine hydrochloride (medication)||ketamine 50 mg/ml injectable solution [ketalar]||has_ingredient
eprinomectin (substance)||centragard topical product||has_ingredient
incontinence pads||underpad,bed 23in x 36in fqp #up-080||has_ingredient
colloidal oatmeal (medication)||colloidal oatmeal 0.51 mg/mg||has_ingredient
α-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester||cyclopentolate ophthalmic solution||has_ingredient
carbinoxamine maleate (substance)||carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5ml/15mg/5ml/60mg/5ml syrup||has_ingredient
canakinumab (medication)||ilaris injectable product||has_ingredient
2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate||carbetapentane / carbinoxamine / phenylephrine oral product||has_ingredient
hydrochlorothiazide (product)||moduretic pill||has_ingredient
sodium chloride [skin]||sodium chloride 14.6 % in 20 ml injection||has_ingredient
lanolin (medication)||lip balm,petrolatum||has_ingredient
papaveretum [cns narcotic]||omnopon oral product||has_ingredient
one-a-day essentials||one-a-day essentials, multiple vitamins oral tablet||has_ingredient
amino acid||travasol 8.5% with electrolytes solution for injection||has_ingredient
2'3' dideoxycytidine||product containing zalcitabine in oral dosage form (medicinal product form)||has_ingredient
docetaxel hydrate||docetaxel anhydrous 10 mg in 1 ml intravenous injection, solution [docetaxel]_#1||has_ingredient
pvp-i||ethanol / isopropyl alcohol / povidone-iodine topical solution||has_ingredient
product containing dehydroepiandrosterone||dehydroepiandrosterone (prasterone) 6.5 mg vaginal insert||has_ingredient
product containing pipecuronium (medicinal product)||pipecuronium injectable product||has_ingredient
d-norgestrel||ethinyl estradiol-levonorgestrel, extended cycle 30 mcg-0.15 mg oral tablet||has_ingredient
lowila||cleansing soap bar||has_ingredient
benzoyl peroxide wash||benzoyl peroxide acne treatment pack, 4% topical kit||has_ingredient
dextrose preparation (product)||dextrose monohydrate 5 g in 100 ml intravenous injection, solution [dextrose]||has_ingredient
acetazolamides||acetazolamide 125 mg oral tablet||has_ingredient
diclofenac and misoprostol product||diclofenac sodium 50 mg / misoprostol 0.2 mg oral tablet, delayed release [diclofenac sodium and misoprostol delayed-release]||has_ingredient
hepatitis b virus recombinant vaccine (product)||hepatitis b virus subtype adw2 hbsag surface protein antigen 20 ug in 1 ml intramuscular injection, suspension [engerix-b]||has_ingredient
1,4-pregnadiene-11β,17α,21-triol-3,20-dione||cotolone pill||has_ingredient
adalimumab-atto||adalimumab atto 40 mg/0.8 ml subcutaneous solution||has_ingredient
product containing relugolix (medicinal product)||relugolix oral tablet [orgovyx]||has_ingredient
product containing hydrocodone||hydrocodone polistirex 2 mg/ml||has_ingredient
bag,leg||bag,leg large 32 oz rusch #452932||has_ingredient
tretinoin microsphere||tretinoin 0.04 % topical gel||has_ingredient
sodium hyaluronate-urea topical||urea nail kit, 0.2%-40% topical kit||has_ingredient
astedin||amphetamine sulfate, 5 mg oral tablet||has_ingredient
glyceryl guaiacolate||ephedrine / guaifenesin pill||has_ingredient
product containing vasopressin (medicinal product)||vasopressin 20 u/1 ml intravenous solution||has_ingredient
aminosyn-hbc||aminosyn-hbc sulfite-free, amino acids 7% (aminosyn-hbc sulfite-free) intravenous solution||has_ingredient
calcium carbonate-containing product||product containing calcium carbonate in oral dose form (medicinal product form)||has_ingredient
vitamin b complex with c and zinc||viogen-c capsule||has_ingredient
dr scholl's essentials cracked skin repair||dimethicone 1.5 g in 100 ml topical cream [boa vida recovery creme]||has_ingredient
kaolin (medication)||kaolin pwdr||has_ingredient
nonacog alfa (product)||recombinant coagulation factor ix 1000iu powder and solvent for injection solution vial||has_ingredient
menadiol sodium phosphate||menadiol 10 mg/ml injectable solution||has_ingredient
chickpea||chickpea allergenic extract injectable solution||has_ingredient
oil, canadian||isosource 1.5 cal liquid,1000ml (closed system)||has_ingredient
product containing ibuprofen (medicinal product)||ibuprofen 100 mg oral tablet, chewable [equate ibuprofen junior strength]||has_ingredient
kalziumkarbonat||os-cal extra d3 500 mg / 600 unt oral tablet, as calcium carbonate||has_ingredient
oxaceprol (substance)||oxaceprol topical product||has_ingredient
decitabine product||decitabine 50mg powder for injection solution vial||has_ingredient
salicylamide product||aspirin / caffeine / salicylamide oral solution||has_ingredient
mifépristone||korlym 300 mg oral tablet||has_ingredient
ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1) (salt)||product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet||has_ingredient
androst-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)-||methyltestosterone tablets||has_ingredient
product containing calcium carbonate||oysco d, 250 mg-3.125 mcg oral tablet||has_ingredient
a42 vitamin a preparations||vitamin a 5000unt/0.1ml drops,oral||has_ingredient
peroxide, dibenzoyl||benzoyl peroxide 55 mg/ml [effaclar duo]||has_ingredient
glycopyrronium||glycopyrrolate 0.2 mg/1 ml injection solution [glyrx-pf]_#4||has_ingredient
catheter device||catheter,external small lhb #451-7656||has_ingredient
panthenol/vitamin e/zinc oxide||panthenol/vitamin e/zinc oxide top cream||has_ingredient
pteroyl-l-monoglutamic acid||nicomide sa tab||has_ingredient
zinc omadine||zinc pyrithione shampoo product||has_ingredient
rev-eyes||dapiprazole hcl 0.5 % ophthalmic solution||has_ingredient
moexipril hydrochloride + hydrochlorothiazide||moexipril hydrochloride 15mg, hydrochlorothiazide 25mg oral tablet||has_ingredient
pouch,ostomy||pouch,drainable,firstchoice h#3617||has_ingredient
catheter||catheter,external std uri-drain sherwood #sd-732500||has_ingredient
kate farms||kate farms 1.4 liquid plain||has_ingredient
oxyde de zinc||petrolatum / zinc oxide topical ointment||has_ingredient
pseudoephedrine hydrochloride||acetaminophen/pseudoephedrine hydrochloride 500 mg-30 mg oral tablet [sine-aid maximum strength]||has_ingredient
chloroxylenol (product)||derma cidol soap product||has_ingredient
saccharomyces cerevisiae||saccharomyces cerevisiae allergenic extract injectable solution||has_ingredient
aluminum acetate - chemical (substance)||aluminum acetate 3 mg/ml||has_ingredient
vitamin c preparations||ascorbic acid 1000 mg oral tablet, extended release [vitamin c w/rose hips natural]||has_ingredient
collagen [hemostatic] (product)||collagen 400 mg||has_ingredient
almasilate||aluminum magnesium silicate 400 mg||has_ingredient
salicylic acid||salicylic acid 0.17 mg/mg||has_ingredient
product containing salicylic acid||salicylic acid 20 mg/ml [lerosett]||has_ingredient
barley grain||barley grain 450 mg||has_ingredient
dihydrohydroxycodeinone||oxycodone 27 mg 12 hr extended release oral capsule, abuse-deterrent||has_ingredient
nizatidine (medication)||nizatidine 100mg/4ml injection (substance)||has_ingredient
humira||adalimumab prefilled syringe [humira]||has_ingredient
super high vitamins and minerals||super high vitamins and minerals tablet||has_ingredient
caffeine product||caffeine / riboflavin / thiamine / vitamin b12 / vitamin b6 pill||has_ingredient
monosodium carbonate||magnesium chloride 0.00279 meq/ml / sodium bicarbonate 0.104 meq/ml / sodium chloride 0.479 meq/ml [normocarb hf 25]||has_ingredient
magnesio hidróxido||health mart antacid/antigas suspension||has_ingredient
bur oak pollen extract||bur oak pollen extract injectable solution||has_ingredient
insulin,regular,human/semisynthetic||insulin isophane biphasic human 20/80 100units/ml injection 1.5ml cartridge||has_ingredient
product containing clindamycin (medicinal product)||clindamycin 0.01 mg/mg||has_ingredient
co q-10||ubidecarenone@300 mg@oral@capsule||has_ingredient
potassium chloride (substance)||calcium carbonate / potassium chloride / sodium chloride pill||has_ingredient
product containing pramocaine||lactate / pramoxine topical cream [amlactin ap]||has_ingredient
1,3-dimethylxanthine||guaifenesin / theophylline oral liquid product||has_ingredient
tretinoin [skin] (substance)||tretinoin 0.0001 mg/mg topical gel [tretin x]||has_ingredient
dl norgestrel||ethinyl estradiol 0.03mg/fe fumarate 75mg/norgestrel 0.3mg tab||has_ingredient
1,3,7-trimethylxanthine||acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg oral capsule||has_ingredient
cefaclor (product)||cefaclor 750 mg||has_ingredient
barrier,ostomy||barrier,sensura coloplast #16974||has_ingredient
ropivacaine hydrochloride (substance)||product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug)||has_ingredient
cefoperazone sodium (substance)||cefoperazone sodium 2g injection (pdr for recon)||has_ingredient
aspirin-containing product||aspirin 325 mg [uni-tren]||has_ingredient
urological antibacterial nitrofurantoin||nitrofurantoin oral suspension||has_ingredient
fucithalmic||fusidate oral solution||has_ingredient
product containing human isophane insulin||product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)||has_ingredient
sa - salicylic acid||salicylic acid topical solution [salactic film]||has_ingredient
liquid paraffin||milk of magnesia 300 mg / mineral oil 1.25 ml per 5 ml oral suspension||has_ingredient
bandages (physical object)||elastoplast 6in||has_ingredient
estrone preparation (substance)||estradiol / estrone injectable solution||has_ingredient
klotrimazole||betamethasone / clotrimazole topical cream [lotrisone]||has_ingredient
egg||influenza subviron 0.5ml syringe||has_ingredient
sodium caseinate||osmolite 1.5 cal liquid 1000ml||has_ingredient
vitamin b<sub>12</sub> (substance) [ambiguous]||vitamin b12 chewable tablet||has_ingredient
cefiximum||cefixime oral suspension||has_ingredient
lignocaine hydrochloride [eye] (substance)||lidocaine hydrochloride 10 mg in 1 ml perineural injection, solution [lidocaine hydrochloride]||has_ingredient
omega 3 fatty acids (w3)||omega-3 polyunsaturated fatty acids with vitamin d oral liquid||has_ingredient
multi-symptom cold relief||multi-symptom cold relief, varying strength oral tablet||has_ingredient
topical form tolnaftate||tolnaftate 1% topical application powder||has_ingredient
histionex||quadra-hist-d ped reformulated mar 2009 pill||has_ingredient
caldesene||peptamen vanilla liquid 250ml||has_ingredient
alpha galactosidase a||alpha-d-galactosidase enzyme 30 unt/ml||has_ingredient
caféine||aspirin / caffeine oral product||has_ingredient
isolated soy protein||calcium carbonate / ergocalciferol / soy protein isolate oral tablet||has_ingredient
(4s,4as,5as,6s,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride||tetracycline 125mg/5ml susp||has_ingredient
prob||product containing probenecid 500 mg/1 each oral tablet (clinical drug)||has_ingredient
sulfogaiacol hemihydrate||guaiacolsulfonate 300 mg / guaifenesin 600 mg extended release oral tablet [uni-guaifen 600/300]||has_ingredient
zinc (substance)||caltrate 600+d plus minerals, vitamin d with minerals oral tablet, chewable||has_ingredient
clascoterone (substance)||clascoterone topical cream||has_ingredient
celecoxib product||amlodipine / celecoxib oral tablet [consensi]||has_ingredient
folic acid (medication)||ascorbic acid 100 mg / thiamine mononitrate 1.5 mg / riboflavin 1.7 mg / niacinamide 20 mg / pyridoxine hydrochloride 10 mg / folic acid 1 mg / cobalamin 6 ug / biotin 300 ug / calcium pantothenate 10 mg oral tablet, coated [dialyvite]||has_ingredient
pouch ostomy||pouch,mini,drainable h#8644||has_ingredient
product containing vitamin d<sub>3</sub>||cholecalciferol 13,000 unt oral capsule||has_ingredient
product containing azatadine (medicinal product)||azatadine maleate 1 mg||has_ingredient
(+)-dextromethorphan||acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine oral product||has_ingredient
taraxacum officinale pollen extract||dandelion pollen extract 50 mg/ml||has_ingredient
salicylic acid [callosity]||salicylic acid topical product||has_ingredient
phenylephrine-containing product||chlorcyclizine hydrochloride 12.5 mg / phenylephrine hydrochloride 5 mg chewable tablet [dallergy reformulated nov 2011]||has_ingredient
bovine kunitz pancreatic trypsin inhib||fibrin sealant (thrombin 6.5 unt/ml, human) topical solution||has_ingredient
g penicillin||penicillin g benzathine 900000 unt/ml||has_ingredient
n''-cyano-n-methyl-n'-(2-{[(5-methyl-1h-imidazol-4-yl)methyl]thio}ethyl)guanidine||cimetidine 800 mg oral tablet, film coated||has_ingredient
n-(2-(diphenylmethoxy)ethyl)-n,n-dimethylamine||diphenhydramine hydrochlorid 25mg||has_ingredient
promethazine product||dextromethorphan / promethazine oral solution||has_ingredient
aliskiren + hydrochlorothiazide||aliskiren-hydrochlorothiazide 300 mg-25 mg oral tablet||has_ingredient
sodium orthophosphate monobasic||osmoprep 1.102g-0.398g tablet||has_ingredient
hes||hetastarch 6% infusion solution bottle||has_ingredient
product containing verapamil||verapamil 80 mg||has_ingredient
lidocaine (product)||lidocaine hydrochloride 10 mg/ml||has_ingredient
pouch ostomy||pouch,ostomy,active life c#1757-66||has_ingredient
medicago sativa pollen extract||alfalfa pollen extract injectable product||has_ingredient
abacavir sulfate (product)||abacavir sulfate 300 mg oral tablet [ziagen]||has_ingredient
1,2-propanediol, 3-(2-methoxyphenoxy)-||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 100 mg / phenylephrine hydrochloride 5 mg oral tablet, coated [pressure plus pain pe plus cold]||has_ingredient
product containing fluocinolone (medicinal product)||fluocinolone otic||has_ingredient
clonazepam [epilepsy control] (substance)||product containing only clonazepam 1 mg/1 each oral tablet||has_ingredient
charcoal, activated||activated charcoal 20000 mg||has_ingredient
cleansers (medication)||bodi bath & shampoo, topical soap||has_ingredient
product containing adalimumab (medicinal product)||adalimumab@40 mg/0.4 ml@subcut@syringe kit (ea)||has_ingredient
oxacillin sodium add-vantage||oxacillin sodium 2 gram intraven vial (ea)||has_ingredient
ogen®||product containing precisely estropipate 2.5 milligram/1 each conventional release oral tablet (clinical drug)||has_ingredient
recombinant somatropin||somatropin injectable suspension [nutropin depot]||has_ingredient
tobramycin sulfate (substance)||tobramycin sulfate, 10 mg/ml injectable solution||has_ingredient
cis-estradiol||oestradiol 100micrograms patch||has_ingredient
product containing risdiplam (medicinal product)||risdiplam 0.75 mg/ml oral solution, reconstituted, oral||has_ingredient
phenylephrine (medication)||apap 261/caff 32/gg 100/phenyleph 5mg tb||has_ingredient
phenylephrine (product)||phenylephrine/hydrocodone/cpm 5 mg-5 mg-2 mg/5 ml oral syrup||has_ingredient
atropine sulphate - chemical||belladonna alkaloids 0.1296mg/simethicone 40mg liquid,oral||has_ingredient
cerenia (product)||maropitant 10 mg/ml injectable solution||has_ingredient
product containing itraconazole (medicinal product)||itraconazole compounding powder||has_ingredient
zno||macuvite with lutein pill||has_ingredient
cholesterol management||oat bran 800 mg||has_ingredient
trijardy xr||24 hr empagliflozin 5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended release oral tablet||has_ingredient
aluminium magnesium silicate hydrate||aluminum magnesium silicate / calcium carbonate / sodium bicarbonate chewable tablet||has_ingredient
magnésium||lvp solution dextrose 1.5% with electrolytes (dialyte) intraperitoneal solution||has_ingredient
wing scale allergenic extract||wing scale pollen extract 40000 unt/ml||has_ingredient
benzocaine as anorexic (medication)||benzocaine 200 mg/ml [anbesol]||has_ingredient
benzocainum||alpha-caine oral product||has_ingredient
pregnenedione||progesterone 15 mg||has_ingredient
manganese sulphate||manganese sulfate 0.1 mg in 1 ml intravenous injection, solution||has_ingredient
streptococcus pneumoniae serotype 14 capsular antigen diphtheria crm197 protein conjugate vaccine||streptococcus pneumoniae serotype 1 capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 14 capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 18c capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 19a capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 19f capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 22f capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 23f capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 3 capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 33f capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 4 capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 5 capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 6a capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 6b capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 7f capsular antigen diphtheria crm197 protein conjugate vaccine / streptococcus pneumoniae serotype 9v capsular antigen diphtheria crm197 protein conjugate vaccine prefilled syringe [vaxneuvance]||has_ingredient
product containing thyroglobulin||thyroglobulin 65 mg oral tablet||has_ingredient
menthol product||capsaicin / menthol / methyl salicylate topical gel||has_ingredient
amantadine hydrochloride - chemical (substance)||amantadine hcl 100mg cap||has_ingredient
mus musculus skin||house mouse skin extract 20000 unt/ml||has_ingredient
dyclonine hydrochloride (substance)||benzocaine mucosal spray [cepacol]||has_ingredient
furosemidum||co-amilofruse 10mg/80mg tablet (product)||has_ingredient
olanzapinum||fluoxetine 25 mg / olanzapine 3 mg [symbyax]||has_ingredient
5-allyl-5-isobutyl-pyrimidine-2,4,6-trione||acetaminophen/butalbital/caffeine 325 mg-50 mg-40 mg oral tablet [anoquan]||has_ingredient
product containing nalmefene||nalmefene hcl 1mg/ml inj,amp,2ml||has_ingredient
product containing paracetamol (medicinal product)||lortab 2.5 mg / 500 mg (hydrocodone bitartrate / acetaminophen) oral tablet||has_ingredient
theragran||theragran, therapeutic multiple vitamins oral tablet||has_ingredient
metolazone-containing product||metolazone oral tablet||has_ingredient
phenylephrine (medication)||phenylephrine hydrochloride 0.1 mg/ml||has_ingredient
amyl nitrite (product)||amyl nitrite 0.18 ml nasal inhalant||has_ingredient
menthol||menthol 90 mg/ml [myogesic-cs]||has_ingredient
2-(acetyloxy)benzoic acid||81 mg aspirin||has_ingredient
paraffinum flavum||moisturizing cream||has_ingredient
1,1-dioxide-1,2-benzisothiazol-3(2h)-one, sodium salt||cepastat extra strength, 29 mg mucous membrane lozenge||has_ingredient
phenylephrine hydrochloride [cvs sympathomimetic]||phenylephrine hcl in 0.9 % sodium chloride/pf@0.4 mg/10 ml (40 mcg/ml)@intraven@syringe (ml)||has_ingredient
beta 1,4 glucan 4 glucanohydrolase||amylase + lipase + protease 3000unt/2400unt/3000unt capsule (product)||has_ingredient
promethazine (product)||phenylephrine hydrochloride 1 mg/ml / promethazine hydrochloride 1.25 mg/ml [phenergan vc]||has_ingredient
benzoyl peroxide -retired-||benzoyl peroxide 52.5 mg/ml [benziq]||has_ingredient
methyl salicylate (substance)||menthol/methyl salicylate 10%-15% topical application cream [arthritis hot pain relief]||has_ingredient
clindamycin (product)||benzoyl peroxide 0.05 mg/mg||has_ingredient
tavist allergy/sinus/headache||acetaminophen 325 mg / clemastine fumarate 0.335 mg / pseudoephedrine hydrochloride 30 mg oral tablet||has_ingredient
mucinex||tl-dex dm 15mg-32mg-200mg/5ml liquid||has_ingredient
product containing pentobarbital (medicinal product)||caffeine / ergotamine / levorotatory alkaloids of belladonna / pentobarbital oral tablet||has_ingredient
6alpha,9alpha-difluoro-16alpha-hydroxyprednisolone 16,17-acetonide||fluocinolone 0.18mg oph implant||has_ingredient
desvenlafaxine product||24 hr desvenlafaxine 50 mg extended release oral tablet [khedezla]||has_ingredient
dimethyl tubocurarine iodide||metocurine iodide 2 mg/1 ml intravenous solution||has_ingredient
product containing glucose (medicinal product)||glucose chewable tablet [glutose]||has_ingredient
bromfenac (product)||bromfenac 0.07 % ophthalmic solution||has_ingredient
thymomodulin||thymomodulin oral liquid product||has_ingredient
oxacillin, monosodium salt, anhydrous||oxacillin sodium 10 gm intravenous powder for solution [premierpro rx oxacillin]||has_ingredient
alpha-glyceryl guaiacol ether||product containing guaifenesin in oral dosage form (medicinal product form)||has_ingredient
catherization set||foley catheterization tray w/o catheter||has_ingredient
pafuramidine (substance)||pafuramidine 100 mg||has_ingredient
carraklenz wound cleanser||carraklenz wound cleanser, topical spray||has_ingredient
p-hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)benzyl alcohol||yutopar 15 mg/ml injectable solution||has_ingredient
tmz||temozolomide 20 mg [temodar]||has_ingredient
bupheninum||nylidrin 4 mg||has_ingredient
folic acid preparation (substance)||multivitamin joint health cap/tab||has_ingredient
brompheniramine tannate||brompheniramine tannate 12 mg chewable tablet [brovex ct]||has_ingredient
product containing vitamin b6||multivitamin/minerals therapeut cap/tab||has_ingredient
dihydrazinophthalazin||dihydralazine / propranolol oral tablet||has_ingredient
vanamide||sulfacetamide sodium/sulfur@10 %-5 %@topical@cleanser (gram)||has_ingredient
choline (medication)||choline pill||has_ingredient
1-phenethyl-4-(n-phenylpropionamido)piperidine||fentanyl 10mcg/bupivacaine 0.2%/ml/ns inj,syr,10ml||has_ingredient
dressings (treatment)||dressing,comfeel ulcer coloplast #3110||has_ingredient
carbono||activated charcoal 520 mg||has_ingredient
docusate sodium (substance)||docusate sodium 100 mg oral capsule, liquid filled||has_ingredient
diperodon hydrochloride||b-tracin 400unt/diperodon 1%/n-mycin 5mg/polymyx 5000unt/gm oint||has_ingredient
product containing erythromycin lactobionate (medicinal product)||erythromycin lactobionate 1 gm intravenous powder for solution||has_ingredient
norethisterone product||norinyl 1+50 28 day pack||has_ingredient
paracétamol||apap 300/dm 15/gg 100/phenyleph 10mg tab||has_ingredient
fentyl||fentanyl citrate in 0.9 % sodium chloride/pf 1,200 mcg/30 ml injection patient controlled analgesia vial||has_ingredient
amlodipine and hydrochlorothiazide and valsartan||amlodipine besylate/hydrochlorothiazide/valsartan 5 mg-25 mg-160 mg oral tablet||has_ingredient
salicylamide product||acetaminophen 115 mg / aspirin 210 mg / caffeine 16 mg / salicylamide 65 mg [saleto]||has_ingredient
mi-c-t||mi-c-t, therapeutic multiple vitamins with minerals oral tablet||has_ingredient
etiracetam, s isomer||levetiracetam extended release oral tablet [keppra]||has_ingredient
anti-inhibitor coagulant complex-containing product||feiba 1 unt injection||has_ingredient
cream e vitamin||vitamin e topical topical cream||has_ingredient
phospholipid with choline||carrington incontinence skin kit||has_ingredient
diclofenac sodium [eye] (product)||diclostream, 1.5%-10% topical liquid||has_ingredient
product containing codeine and paracetamol||acetaminophen with codeine phosphate@120 mg-12 mg/5 ml@oral@suspension, oral (final dose form)||has_ingredient
selenium product (product)||glutofac tab||has_ingredient
multi-vite||multi-vite liquid||has_ingredient
bilirubin/blood,occult/glucose/ketone/ph/protein/urobilinogen te||multistix (for clini-tek) test strip||has_ingredient
(4r,5s,6s)-3-{[(3s,5s)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid||meropenem 1 gram intraven infusion bottle (ea)||has_ingredient
(s)-(-)-hyoscyamine||oral hyoscyamine (product)||has_ingredient
polythiazide (medication)||product containing only polythiazide 4 mg/1 each oral tablet (clinical drug)||has_ingredient
histrelin acetate preparation||supprelin injectable product||has_ingredient
sulfate, copper||copper sulfate 0.2 mg/ml||has_ingredient
charcoal||activated charcoal/simethicone 250 mg-80 mg oral tablet [charcoal plus]||has_ingredient
amerigel||dressing,amerigel hydrogel 2x2in #5002||has_ingredient
diltiazem (product)||diltiazem hydrochloride 180 mg extended release oral capsule||has_ingredient
cyanocobalamin||vitamin b12 injectable product||has_ingredient
streptococcus pneumoniae type 8 capsular polysaccharide antigen||streptococcus pneumoniae type 1 capsular polysaccharide antigen / streptococcus pneumoniae type 10a capsular polysaccharide antigen / streptococcus pneumoniae type 11a capsular polysaccharide antigen / streptococcus pneumoniae type 12f capsular polysaccharide antigen / streptococcus pneumoniae type 14 capsular polysaccharide antigen / streptococcus pneumoniae type 15b capsular polysaccharide antigen / streptococcus pneumoniae type 17f capsular polysaccharide antigen / streptococcus pneumoniae type 18c capsular polysaccharide antigen / streptococcus pneumoniae type 19a capsular polysaccharide antigen / streptococcus pneumoniae type 19f capsular polysaccharide antigen / streptococcus pneumoniae type 2 capsular polysaccharide antigen / streptococcus pneumoniae type 20 capsular polysaccharide antigen / streptococcus pneumoniae type 22f capsular polysaccharide antigen / streptococcus pneumoniae type 23f capsular polysaccharide antigen / streptococcus pneumoniae type 3 capsular polysaccharide antigen / streptococcus pneumoniae type 33f capsular polysaccharide antigen / streptococcus pneumoniae type 4 capsular polysaccharide antigen / streptococcus pneumoniae type 5 capsular polysaccharide antigen / streptococcus pneumoniae type 6b capsular polysaccharide antigen / streptococcus pneumoniae type 7f capsular polysaccharide antigen / streptococcus pneumoniae type 8 capsular polysaccharide antigen / streptococcus pneumoniae type 9n capsular polysaccharide antigen / streptococcus pneumoniae type 9v capsular polysaccharide antigen prefilled syringe||has_ingredient
aprobarbital-containing product||aprobarbital / butabarbital / phenobarbital oral tablet||has_ingredient
carvedilol-containing product||eucardic 3.125 tablet||has_ingredient
pseudoephedrine hydrochloride (product)||acetaminophen/diphenhydramine hydrochloride/pseudoephedrine hydrochloride 500 mg-25 mg-30 mg oral tablet [sine-off night time formula]||has_ingredient
dihydrocodeinone||guaifenesin / hydrocodone / pheniramine / phenylephrine / phenylpropanolamine oral solution||has_ingredient
(±)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea||zileuton oral capsule||has_ingredient
phenylpropanolamine (product)||westrim, 37.5 mg oral tablet||has_ingredient
live attenuated influenza a virus subtype h1n1 ag||influenza, injectable, madin darby canine kidney, preservative free, quadrivalent 0.5 ml syringe 2017-2018 [flucelvax]||has_ingredient
phenyl acetate||sodium benzoate 100 mg/ml / sodium phenylacetate 100 mg/ml injection [ammonul]||has_ingredient
hydrochloride, ciprofloxacin||ciprofloxacin hydrochloride 750 mg oral tablet||has_ingredient
l-tryptophan (substance)||alanine / arginine / calcium chloride / dibasic potassium phosphate / glucose / glycine / histidine / isoleucine / leucine / magnesium chloride / methionine / phenylalanine / proline / serine / sodium acetate / sodium chloride / threonine / tryptophan / tyrosine / valine injectable solution [clinimix e 5/35]||has_ingredient
catheter device||catheter,intermittent personal 12fr rochester #63912||has_ingredient
carbamazepine - chemical||carbamazepine (prasco) 100mg cap,sa||has_ingredient
hydrocodone bitartrate||canges-xp, 150 mg-5 mg/5 ml oral liquid||has_ingredient
methanaminium, 1-carboxy-n,n,n-trimethyl-, inner salt||betaine / folic acid / mecobalamin / pyridoxine oral product||has_ingredient
thyroideum siccatum||thyroid (usp) 30 mg oral tablet||has_ingredient
biotin (substance)||biotin / zinc pyrithione medicated bar soap||has_ingredient
secbutabarbital sodium (substance)||butabarbital 25 mg / epinephrine 24 mg / theophylline 130 mg oral tablet||has_ingredient
belt, device (physical object)||belt,support x-small better life||has_ingredient
dibasic sodium phosphate (medication)||sodium phosphate, dibasic 268 mg/ml||has_ingredient
mylanta maximum strength cherry||aluminum hydroxide 800 mg in 10 ml / magnesium hydroxide 800 mg in 10 ml / dimethicone 80 mg in 10 ml oral suspension [topcare antacid plus anti gas]||has_ingredient
ephedrine (medication)||ephedrine hydrochloride 24 mg||has_ingredient
methyl salicylate (product)||methyl salicylate 1000 mg/ml||has_ingredient
dressing,restore||dressing,restore taper 17in h#519959||has_ingredient
silenor||silenor 3 mg oral tablet||has_ingredient
2,6-dichloro-n-2-imidazolidinylidenebenzenamine||clonidine injection||has_ingredient
nepafenaco||nepafenac 3 mg/ml [ilevro]||has_ingredient
benzoyl superoxide||benzoyl peroxide 100 mg in 1 g topical soap [equate beauty acne cleansing bar]||has_ingredient
1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide||tribavirin 6g inhalation (pdr for recon) (substance)||has_ingredient
thiopental sodium (substance)||thiopental 50 mg/ml injectable solution||has_ingredient
product containing doxepin (medicinal product)||doxepin 12.5 mg/ml||has_ingredient
timolol maleate [b-blocker] (product)||timolol ophthalmic maleate long-acting, 0.5% ophthalmic solution||has_ingredient
petroleum jelly||dermaphor topical product||has_ingredient
product containing digoxin||digoxin-containing product in oral dose form||has_ingredient
2-((p-chlorobenzyl)(2-dimethylaminoethyl)amino)pyridine||chloropyramine 10 mg/ml||has_ingredient
17-ethinyl-3,17-oestradiol||{21 (ethinyl estradiol 0.035 mg / norethindrone 1 mg oral tablet) / 7 (inert ingredients 1 mg oral tablet) } pack||has_ingredient
product containing calcium phosphate||calcium phosphate 250 mg||has_ingredient
povidone-iodine [mouth] (product)||povidone-iodine 100 mg in 1 ml topical solution [prep solution topical antiseptic microbicide]||has_ingredient
preservision 2||eicosapentaenoic acid 760 mg||has_ingredient
9-alpha-fluoro-11-beta,21-dihydroxy-16-alpha-isopropylidenedioxy-1,4-pregnadiene,3,20-dione||triamcinolone ophthalmic 8 mg/0.1 ml intraocular suspension||has_ingredient
catheter, device||catheter,intermittent 10fr coloplast #28410||has_ingredient
avedana cool hot ice||menthol 2 g in 100 g topical gel [avedana cool hot ice]||has_ingredient
product containing theophylline||theophylline 300 mg oral tablet, extended release, 12 hr [theophylline tr]||has_ingredient
vitamin b-11||prenatal vits with calcium no.96/ferrous fumarate/folic acid 27 mg iron-800 mcg oral tablet||has_ingredient
luteine||progesterone, micronized;cream base na multiple routes kit [first-progesterone mc 5]||has_ingredient
canagliflozin anhydrous||canagliflozin/metformin hydrochloride 150 mg-1000 mg oral tablet||has_ingredient
acide flufénamique||flufenamic acid topical ointment||has_ingredient
glibornuride (product)||glibornuride oral tablet||has_ingredient
sodium citrate + citric acid (medication)||citric acid 334/na citrate 500/5ml soln||has_ingredient
phenylephrine (as hydrochloride)||chlorpheniramine maleate 0.4 mg/ml / hydrocodone bitartrate 0.5 mg/ml / phenylephrine hydrochloride 1 mg/ml oral solution [baltussin hc]||has_ingredient
platelet cofactor i||antihemophilic factor (recombinant) pegylated 1 unt||has_ingredient
salicylic acid product||salicylic acid delayed release oral tablet||has_ingredient
magnesium trisilicate (medication)||magnesium trisilicate/aluminum hydroxide/sodium bicarbonate@@oral@tablet,chewable||has_ingredient
tasimelteon (product)||hetlioz lq, 4 mg/ml oral suspension||has_ingredient
pergolide mesylate (medication)||pergolide mesylate powder||has_ingredient
acid, sorbic||solumol cream,top||has_ingredient
aminophylline-containing product||aminophylline 130 mg / guaifenesin 100 mg oral tablet||has_ingredient
epinephrine acid tartrate (substance)||p4e1, 1%-4% ophthalmic solution||has_ingredient
fluoxetine (as hydrochloride)||prozac 10 mg oral tablet||has_ingredient
bacillus coagulans / inulin||bacillus coagulans-inulin oral tablet, chewable||has_ingredient
debriding agents carbamide preparations||chlorophyllin copper complex, sodium/papain/urea 0.5%-521700 u/1 gm-10% topical application spray [panafil se]||has_ingredient
dibromomannitol (product)||mitobronitol 125 mg [myelobromol]||has_ingredient
trimethoprim (substance)||trimethoprim 200 mg||has_ingredient
amiodarona||amiodarone injectable product||has_ingredient
felis catus skin extract||cat skin extract 20000 unt/ml injectable solution||has_ingredient
oil, silicone||maxilube, topical gel||has_ingredient
guaiacolate, glycerol||product containing guaifenesin in oral dose form (medicinal product form)||has_ingredient
product containing risedronate sodium (medicinal product)||risedronate sodium 35 mg oral tablet, delayed release||has_ingredient
fusidate||fusidate topical cream [fucidin]||has_ingredient
product containing phenylephrine (medicinal product)||guaifenesin/hydrocodone bitartrate/phenylephrine hydrochloride 50 mg/5 ml-2.5 mg/5 ml-7.5 mg/5 ml oral syrup [donatussin dc]||has_ingredient
diabetic supplies lancet||lancet,acti-lance special 17g||has_ingredient
diacrid||acriflavine 0.0015 mg/ml||has_ingredient
atenolol - chemical (substance)||tenormin 0.5 mg/ml injectable solution||has_ingredient
iodoform product||iodoform topical product||has_ingredient
hydrobromide, dextromethorphan||dextromethorphan hbr 10 mg / guaifenesin 187 mg / pseudoephedrine hcl 30 mg in 5 ml oral solution||has_ingredient
tetanus-diphtheria toxoids, adult (td)||tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 lf of tetanus toxoid and 2 lf of diphtheria toxoid) vial||has_ingredient
vinorelbine ditartrate||vinorelbine (as vinorelbine tartrate) 50 mg/5 ml solution for infusion vial||has_ingredient
k-phos||monobasic potassium phosphate 0.0408 meq/ml [k-phos]||has_ingredient
codeine phosphate [gastro-intestinal use] (product)||codeine 10mg/gg 100mg/p-propanol 18.75mg/5ml liquid||has_ingredient
n,n-dimethyl-2-(2-(phenylmethyl)phenoxy)ethanamine||chlorpheniramine / phenylpropanolamine / phenyltoloxamine / pseudoephedrine oral product||has_ingredient
razoxane-containing product||product containing razoxane in oral dosage form||has_ingredient
dextromethorphan hbr||apap 500mg/dm 20mg/pseudefed 60mg/pkt pwdr,oral||has_ingredient
phenyl salicylate||urinary antisept w/methenamin 120mg tab||has_ingredient
triamcinolone||triamcinolone / urea topical product||has_ingredient
ulmus americana pollen||american elm pollen extract 10 mg/ml||has_ingredient
guaifenesin + codeine phosphate (medication)||codeine phosphate 10 mg / guaifenesin 200 mg per 5 ml oral solution||has_ingredient
naproxen sodium (medication)||diphenhydramine hydrochloride-naproxen sodium, 25 mg-220 mg oral tablet||has_ingredient
hydroquinone (medication)||hydroquinone 3%/sunscreens cream,top||has_ingredient
product containing famotidine (medicinal product)||famotidine disintegrating oral tablet||has_ingredient
hydrocodone / pseudoephedrine||liqui-tuss hd, 5 mg-60 mg/5 ml oral liquid||has_ingredient
benzocaine-containing product||orabase paste plain||has_ingredient
isophane insulin nph (substance)||insulin isophane injectable suspension [eli lilly brand of insulin isophane, beef-pork]||has_ingredient
thiamine nitrate||ascorbic acid/calcium pantothenate/cyanocobalamin/ferrous sulfate/folic acid/niacin/pyridoxine/riboflavin/thiamine 500 mg-10 mg-25 mcg-105 mg-0.8 mg-30 mg-5 mg-6 mg-6 mg oral tablet, extended release [vita-ret-folic 500]||has_ingredient
dihydrotachysterol>2< preparation||dihydrotachysterol oral capsule||has_ingredient
na||travasol 3.5% with electrolytes solution for injection||has_ingredient
citric acid, trisodium salt||citrolith pill||has_ingredient
g-tusicof||dextromethorphan hydrobromide 20 mg / guaifenesin 400 mg / phenylephrine hydrochloride 10 mg per 5 ml oral solution||has_ingredient
efexor||venlafaxine 25 mg [effexor]||has_ingredient
zinc sulfate [eye] (product)||zinc sulfate 0.36 mg/mg||has_ingredient
framycétine||soframycin eye ointment||has_ingredient
prempro||medroxyprogesterone acetate 5 mg||has_ingredient
potassium iodide (ki)||elixophyllin ki oral liquid product||has_ingredient
ethinylestradiol [malignancy] (substance)||drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium kit||has_ingredient
fibrinogen||fibrinogen / thrombin topical product||has_ingredient
ca++ element||boost hi-protein liquid, chocolate||has_ingredient
benzyl alcohol/sodium chloride||sodium chloride 0.9% injection solution 3ml vial||has_ingredient
3,4-dimethyl-5-sulphanilamidoisoxazole||sulfimycin, 200 mg-600 mg/5 ml oral granule for reconstitution||has_ingredient
cellulose hydroxyethylate||hydroxyethyl cellulose 4 mg/ml||has_ingredient
hematinics ferrous gluconate||ferrous gluconate tablets||has_ingredient
donepezil- and memantine-containing product||memantine hcl/donepezil hcl 21 mg-10 mg oral capsule sprinkle, extended release 24 hr||has_ingredient
cns stimulants armodafinil||armodafinil 150 mg oral tablet||has_ingredient
desogestrel and ethinylestradiol||desogestrel 0.15mg/ee biphasic tab 28||has_ingredient
valine (substance)||alanine / arginine / glucose / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine injectable solution||has_ingredient
2-(3-benzoylphenyl)propionic acid||ketoprofen 50 mg oral capsule [orudis]||has_ingredient
trihexyphenidyl hydrochloride (medication)||trihexyphenidyl hydrochloride 5 mg oral tablet||has_ingredient
darvon n||propoxyphene napsylate 100 mg / acetaminophen 650 mg oral tablet, film coated [propoxyphene and acetaminophen]||has_ingredient
niferex (iron polysaccharide)||nata par tab||has_ingredient
mvi pediatric||ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin a / vitamin b12 / vitamin b6 / vitamin e chewable tablet||has_ingredient
dimeticona||dimethicone 13 mg in 1 g topical lotion [daily moisturizing]||has_ingredient
slow fe||ferrous sulfate extended release oral tablet||has_ingredient
ibuprofen [musc-skel use 2]||motrin junior strength, 100 mg oral tablet||has_ingredient
pramoxine product||proctozone-p, 1% topical cream||has_ingredient
tramadol hydrochloride (substance)||tramadol hcl 100mg tab||has_ingredient
product containing simeticone||bismuth carbonate / simethicone pill||has_ingredient
acid, l-ascorbic||compleat regular liquid (closed system)||has_ingredient
2-(methoxycarbonyl)phenol||menthol- and methyl salicylate-containing product in cutaneous dose form||has_ingredient
apraclonidina||apraclonidine 5 mg/ml [iopidine]||has_ingredient
mineral supplements calcium carbonate||calcium carbonate 1,000 mg oral tablet||has_ingredient
product containing simethicone||simethicone 30 mg/ml||has_ingredient
sodium ascorbate preparation (substance)||copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin b12 / zinc sulfate pill||has_ingredient
desloratadine (product)||desloratadine 2.5 mg / pseudoephedrine sulfate 120 mg 12hr extended release oral tablet||has_ingredient
eslicarbazepine-containing product||eslicarbazepine acetate 800 mg [aptiom]||has_ingredient
product containing nifedipine (medicinal product)||nifedipine 30 mg oral tablet, extended release_#1||has_ingredient
lidocaine (substance)||lidocaine 2% preservative-free intravenous solution||has_ingredient
alpha-6-deoxyoxytetracycline||doxycycline hyclate 200 mg||has_ingredient
product containing fluconazole||fluconazole@40 mg/ml@oral@suspension, reconstituted, oral (ml)||has_ingredient
phenylephrine tannate (substance)||phenylephrine tannate/chlorpheniramine tannate 25 mg-9 mg oral tablet||has_ingredient
rvpaque||rvpaque, with cinoxate topical cream||has_ingredient
thermobacterium intestinale||lactobacillus acidophilus 70000000 unt||has_ingredient
pentoxyverine-containing product||tussi-12 oral product||has_ingredient
pseudoephedrine hydrochloride (substance)||guaifenesin/pseudoephedrine hydrochloride 100 mg/5 ml-30 mg/5 ml oral liquid [biotuss pe]||has_ingredient
chlorcyclizine hydrochloride (medication)||chlorcyclizine hydrochloride/codeine phosphate 9.375 mg/5 ml-10 mg/5 ml oral solution [poly-tussin]||has_ingredient
miltex||miltefosine 50mg cap||has_ingredient
bretylium (product)||bretylium 2mg/ml d5w inj bag 250ml||has_ingredient
i- element||nutr supl promote liq van 1000ml||has_ingredient
liquid paraffin [laxative]||camphor/menthol topical application ointment [ice mint]||has_ingredient
electrodes, (e.g., apnea monitor), per pair||electrode,pals platinum 2in #879200||has_ingredient
m-benzoylhydratropic acid||ketocid 200 m/r capsule||has_ingredient
cellulase preparation (substance)||amylase/cellulase/hyoscyamine/lipase/p-toloxamine/protease cap||has_ingredient
menthol (medication)||benzocaine 200 mg/ml / menthol 10 mg/ml medicated pad||has_ingredient
sevelamer product||sevelamer hcl@800 mg@oral@tablet||has_ingredient
2-(diethylamino)-2',6'-acetoxylidide||lidocaine 50 mg/ml [lidum]||has_ingredient
isd||isosorbide dinitrate tablets||has_ingredient
co gesic||hydrocodone bitartrate 5 mg||has_ingredient
product containing fenofibrate||fenofibrate 54mg tablet||has_ingredient
calcium carbonates||calcium carbonate 350 mg||has_ingredient
rapdone||phendimetrazine tartrate 35mg tablet (product)||has_ingredient
salicyl alcohol glucoside||salicin pill||has_ingredient
2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide||hydrochlorothiazide 100 mg oral tablet [hydrodiuril]||has_ingredient
esterified estrogens (medication)||estrogens, esterified (usp) / methyltestosterone oral tablet||has_ingredient
catheters||catheter,foley silicone 16fr 30cc||has_ingredient
urea, n,n'-bis(2-chloroethyl)-n-nitroso-||carmustine 100 mg intravenous powder for solution [bicnu]||has_ingredient
vitamins ascorbic acid||ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin a / vitamin b12 / vitamin b6 / vitamin e oral product||has_ingredient
antigen of inactivated influenza a virus subtype h1n1 (substance)||fluarix quadrivalent 2020-2021 injectable product||has_ingredient
4-acetamidophenol||acetaminophen / phenylpropanolamine oral tablet||has_ingredient
product containing iodine||ensure clear liquid (mixed berry)||has_ingredient
lispro insulin (product)||insulin lispro 100 [iu] in 1 ml intravenous injection, solution [insulin lispro]||has_ingredient
fluoride/phosphoric acid||fluoride 1.23% gel,dent||has_ingredient
phenyltoloxamine citrate (substance)||acetaminophen/phenyltoloxamine citrate 600 mg-66 mg oral tablet, extended release||has_ingredient
mumps skin test antigen||msta mumps skin test antigen, intradermal solution||has_ingredient
trichlormethiazide product||product containing trichlormethiazide in oral dose form (medicinal product form)||has_ingredient
lhrh-luteinizing horm rel horm||gonadorelin 100mcg inj pdr||has_ingredient
938 emollients||chap stick total hydration hello bordeaux, topical stick||has_ingredient
product containing naproxen sodium (medicinal product)||naproxen sodium 220 mg oral tablet, coated [naproxen sodium]||has_ingredient
lecithin soya||isocal liquid,can,960ml||has_ingredient
pseudoephedrine hcl||codeine phosphate 20 mg / pseudoephedrine hcl 60 mg oral capsule||has_ingredient
potassium gluconate||potassium gluconate 75 mg||has_ingredient
hydrochloride pseudoephedrine||guaifenesin-pseudoephedrine 500 mg-60 mg oral tablet, extended release||has_ingredient
lidocaine product||lidocaine hydrochloride 0.05 mg/mg||has_ingredient
iron-containing product||niferex 20 mg/ml oral solution||has_ingredient
repaglinide||novonorm 1 mg oral tablet||has_ingredient
product containing dexpanthenol||multivitamin,w/vit-k inj||has_ingredient
almotriptan malate (substance)||axert, 12.5 mg oral tablet||has_ingredient
potassium chloride (product)||furosemide / potassium chloride oral product||has_ingredient
caffeine products||stanback headache powder oral powder product||has_ingredient
carvedilol product||carvedilol 6.25mg tablet (product)||has_ingredient
d amphetamines||product containing dexamfetamine in oral dose form (medicinal product form)||has_ingredient
rifampin (medication)||rifampin 150 mg oral capsule [rimactane]||has_ingredient
substance with piperazine structure||piperazine oral suspension||has_ingredient
antigen of live attenuated influenza a virus subtype h1n1 (substance)||fluzone 2019-2020 injectable product||has_ingredient
selexipag-containing product||selexipag injection||has_ingredient
nikotinsäure||renal multivite (renal tab-i) oral tab||has_ingredient
liotrix (medication)||product containing only levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each oral tablet (clinical drug)||has_ingredient
product containing histamine||histamine dihydrochloride 0.75 mg/ml||has_ingredient
catheter, device (physical object)||catheter,intermittent 16fr rusch #220600-16||has_ingredient
catheters||catheter,intermittent coude 14fr coloplast #28494||has_ingredient
4-hydroxyacetanilide||hydrocodone 7.5mg/acetaminophen 325mg/15ml soln,oral,15ml||has_ingredient
soolantra topical product||ivermectin 1% topical application cream [soolantra]||has_ingredient
jelly, petroleum||camphor / petrolatum topical ointment||has_ingredient
fluocinolone||fluocinolone acetonide 0.1 mg/ml||has_ingredient
h-c tussive d||hydrocodone bitartrate/pseudoephedrine hydrochloride 5 mg/5 ml-60 mg/5 ml oral liquid [liqui-tuss hd]||has_ingredient
phenol||edrophonium chloride/atropine sulfate@10 mg-0.14 mg/ml@intraven@vial (ml)||has_ingredient
silver preparation||dress,polymem ag finger/toe,ferris #1404||has_ingredient
analgesic balm||cooling gel, topical gel||has_ingredient
ascorbic acid [urine ph - no drugs here]||ferro-sequels, (as elemental iron) 25 mg-65 mg oral tablet, extended release||has_ingredient
2',3'-dideoxy-3'-thiacytidine||lamivudine 150mg oral tablet||has_ingredient
product containing potassium bromide||k+ bromide 500 mg chewable tablet||has_ingredient
pix carbonis||coal tar 0.075 mg/mg [psorigel]||has_ingredient
codeine phosphate (medication)||codeine 10mg/gg 100mg/p-propanol 12.5mg/5ml liquid||has_ingredient
ethylenediaminetetraacetic acid (edta)||edetic acid topical lotion||has_ingredient
as zinc oxide||hemorid, 0.25%-11% rectal suppository||has_ingredient
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester||nifediac oral product||has_ingredient
gatiflo||gatifloxacin 10 mg/ml intraven vial (ml)||has_ingredient
product containing calcium gluconate (medicinal product)||calcium gluconate 23.1 mg/ml||has_ingredient
nystatin [gynecological use]||neomycin / nystatin / thiostrepton / triamcinolone topical ointment||has_ingredient
menthol (substance)||biofreeze, 10% topical cream||has_ingredient
pentaetrazol||vitamin b3 200 mg / pentylenetetrazole 75 mg extended release oral tablet||has_ingredient
ketones test||n-multistix clini-tek test strip||has_ingredient
phenterminum||phentermine hydrochloride 8 mg [teramine]||has_ingredient
acide cromoglicique||cromolyn pill||has_ingredient
n-heptylic acid||heptanoic acid / iodine topical product||has_ingredient
pseudoéphédrine||chlorpheniramine maleate 0.4 mg/ml / codeine phosphate 2 mg/ml / pseudoephedrine hydrochloride 6 mg/ml oral solution [co-histine dh]||has_ingredient
beta seron||betaseron kit||has_ingredient
dextromethorphan hydrobromide (substance)||dextromethorphan hbr 30 mg / guaifenesin 200 mg / phenylephrine hcl 10 mg in 5 ml oral solution||has_ingredient
3,5-dibromo-n(alpha)-cyclohexyl-n(alpha)-methyltoluene-alpha-2-diamine||benzydamine / bromhexine oral product||has_ingredient
hydrochloride, ethambutol||product containing ethambutol hydrochloride 400 mg/1 each oral tablet (clinical drug)||has_ingredient
benzenemethanaminium, n,n-dimethyl-n-(2-(2-(4-(1,1,3,3-tetramethylbutyl)phenoxy)ethoxy)ethyl)||benzethonium / benzocaine rectal ointment||has_ingredient
ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(n,n,n-trimethyl-)||succinylcholine 20 mg/ml injectable solution||has_ingredient
vitamin c (ascorbic acid)||ocuvite tab||has_ingredient
d-leu^6^, desgly-nh>2<^10^, proethylamide^9^-gnrh monoacetate||lupron depot 6-month 45mg powder for injection||has_ingredient
depamine||cuprimine oral product||has_ingredient
gh - growth hormone||somatropin 10 mg in 2 ml subcutaneous injection, solution [nutropin aq nuspin 10]||has_ingredient
sulfur (obsolete)||salicylic acid / sulfur medicated shampoo [nova pearls]||has_ingredient
chlorhexidine bigluconate||lubricating jelly,top (k-y)||has_ingredient
dermasorb af||clioquinol 30 mg/ml / hydrocortisone 10 mg/ml topical cream [vio-tex-hc]||has_ingredient
product containing mycophenolate mofetil (medicinal product)||mycophenolate mofetil 200 mg/ml [cellcept]||has_ingredient
sodium chloride [mouth]||lvp solution with potassium dextrose 10% with 0.2% nacl and kcl 20 meq/l intravenous solution||has_ingredient
periostat||doxycycline oral capsule [periostat]||has_ingredient
metoclopramide-containing product||cinametic acid / metoclopramide / simethicone oral product||has_ingredient
zinacef add-vantage||cefuroxime sodium 750 mg injection powder for solution||has_ingredient
linoleate (c18:2w6)||linoleate / sunflower oil pill||has_ingredient
vitamin-d||o-cal fa tab||has_ingredient
ephedrine product||ephedrine sulfate 5 mg/ml injection [emerphed]||has_ingredient
phenylethylbarbitursäure||belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg tablet||has_ingredient
alcohol,dehydrated||triamcinol acetonid 55mcg spry||has_ingredient
acetic acid, sodium salt (1:1)||sodium acetate 4meq/ml (pf) inj||has_ingredient
product containing esterified estrogen||estrogens, esterified (usp) / methyltestosterone pill||has_ingredient
ispaghula husk-containing product||psyllium 0.4 gm oral capsule||has_ingredient
chloride (as potassium)||potassium chloride, 2 meq/5 ml-nacl 0.9% intravenous solution||has_ingredient
glucose preparations||glucose 5556 mg/ml||has_ingredient
trifluoperazine [antipsychotic]||trifluoperazine compounding powder||has_ingredient
chlorpromazine hydrochloride (product)||chlorpromazine hcl@100 mg/ml@oral@concentrate, oral||has_ingredient
2',2'-difluoro-2'-deoxycytidine||gemcitabine hydrochloride 100mg/1ml solution for injection||has_ingredient
pentoxyverine (substance)||tusso-zr oral liquid product||has_ingredient
menthol (substance)||menthol / pectin oral liquid product||has_ingredient
nicotinamide||nutrition supl pivot 1.5 cal liq||has_ingredient
chlorpheniramine (as maleate)||chlorpheniramine/hydrocodone/pse 2.5 mg-1.67 mg-17.5 mg/5 ml oral liquid||has_ingredient
fluocinolona||fluocinolone acetonide 0.18 mg intraoculr implant (ea)||has_ingredient
cefuroxime sodium||kefurox 1.5g powder for injection||has_ingredient
ursodiol||product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral capsule||has_ingredient
paracetamol product||product containing only paracetamol 650 mg and butalbital 50 mg/1 each oral tablet||has_ingredient
maxitrol||dexamethasone 1 mg/ml / neomycin 3.5 mg/ml / polymyxin b 10000 unt/ml [maxitrol]||has_ingredient
cromolyn sodium (product)||cromolyn na 5.2mg 200d nasal inhl||has_ingredient
product containing pregabalin||lyrica, 25 mg oral capsule||has_ingredient
alogliptin-containing product||oseni 12.5/45 oral tablet||has_ingredient
guaiacolsulfonate||hydro-pro 5mg-300mg/5ml solution||has_ingredient
methionine||methionine 8.3 mg/ml||has_ingredient
spironolactone (substance)||spironolactone 5 mg/ml||has_ingredient
ampicillin-containing product||ampicillin capsules||has_ingredient
xanthan gum||simplythick gel,oral pkt,96gm||has_ingredient
flagyl i.v. rtu||metronidazole-containing product in vaginal dose form||has_ingredient
biofreeze professional||menthol 6 g in 120 g topical gel [kanjo pain relief gel]||has_ingredient
allergenic extract, velvet grass pollen||holcus lanatus pollen extract 1000 unt/ml injectable solution||has_ingredient
product containing vitamin b1||acetaminophen / thiamine oral tablet||has_ingredient
aspirin [central nervous system use] (substance)||aspirin 1000 mg / caffeine 65 mg [bc arthritis]||has_ingredient
l-histidin||alanine / arginine / aspartate / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / taurine / threonine / tryptophan / tyrosine / valine injectable solution [aminosyn-pf 7%]||has_ingredient
isradipine (product)||isradipine oral capsule [dynacirc]||has_ingredient
topical form fluorouracil (product)||fluorouracil 0.5% topical cream||has_ingredient
iotussin hc||iotussin hc 2mg-2.5mg-5mg/5ml solution||has_ingredient
artificial larynx||laryngeal prosthesis,provox #7111||has_ingredient
selenium sulfide-containing product||selenium sulfide 10 mg in 1 ml topical shampoo [meijer medicated selenium sulfide anti-dandruff]||has_ingredient
phenol product||phenol injection, 6% intramuscular solution||has_ingredient
daktarin dual action||remedy antifungal with olivamine, 2% topical cream||has_ingredient
tropicamide (substance)||product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye solution (clinical drug)||has_ingredient
guaiacol||guaiacol 0.041 mg/mg||has_ingredient
bronchial brand of guaifenesin-theophylline||theophylline 150 mg||has_ingredient
nettle pollen extract||nettle pollen extract 50 mg/ml||has_ingredient
acid, ortho-hydroxybenzoic||salicylic acid topical lotion [acneclir]||has_ingredient
activated dimethicone||valumag plus oral liquid product||has_ingredient
propanoic acid, 2-oxo-, ion(1-)||glycolate / pyruvate topical cream||has_ingredient
{12 (dexamethasone 0.75 mg oral tablet) } pack||{12 (dexamethasone 0.75 mg oral tablet [decadron]) } pack [decadron 5-12]||has_ingredient
cyclopentolate hydrochloride [dup] (substance)||cyclopentolate hcl 1% s-d e/d||has_ingredient
diltiazem hydrochloride (substance)||diltiazem hydrochloride 420 mg extended release oral tablet||has_ingredient
trifluoperazine hcl||product containing only trifluoperazine 5 mg/1 each oral tablet||has_ingredient
prasugrel (substance)||prasugrel oral tablet||has_ingredient
exenatide (medication)||exenatide 2 mg subcutaneous powder for injection, extended release||has_ingredient
sodium chloride [eye] (product)||sodium chloride 250mg tab,oph||has_ingredient
probalance||probalance liquid vanilla 250ml||has_ingredient
aduhelm||aduhelm, 100 mg/ml intravenous solution_#1||has_ingredient
sodium chloride||glucose 50 mg/ml / monobasic potassium phosphate 0.00735 meq/ml / potassium chloride 0.0275 meq/ml / sodium chloride 0.021 meq/ml / sodium lactate 0.002 meq/ml [dextrose and electrolyte no. 75]||has_ingredient
phenylpropanolamine||hypamine oral liquid product||has_ingredient
retinoic acid a cis 013||isotretinoin 30 mg||has_ingredient
triprolidine product||product containing pseudoephedrine and triprolidine in oral dose form (medicinal product form)||has_ingredient
catheter, nos||catheter,self-cath 12fr coloplast #412||has_ingredient
trovafloxacin mesilate||product containing trovafloxacin mesylate 100 mg/1 each oral tablet||has_ingredient
immunoglobulin, intravenous||human immunoglobulin g 165 mg in 1 ml subcutaneous solution [cutaquig]_#2||has_ingredient
phenobarbital sodium (substance)||phenobarbital sodium, 130 mg/ml injectable solution||has_ingredient
4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide||brodspec pill||has_ingredient
dextromethorphan hydrobromide (substance)||tylenol cough, 250 mg-5 mg/5 ml oral liquid||has_ingredient
heparin product||heparin sodium, porcine 4000 unt/ml||has_ingredient
codeine phosphate||ammonium chloride 6.66 mg/ml / chlorpheniramine maleate 0.4 mg/ml / codeine phosphate 1.97 mg/ml / phenylephrine hydrochloride 1 mg/ml oral solution||has_ingredient
n-(4-hydroxyphenyl)acetanilide||acetaminophen 100 mg/ml||has_ingredient
phenemal||belladonna alkaloids 0.25mg/phenobarbital 50mg tab,sa||has_ingredient
peroxide, benzoyl||benzoyl peroxide 0.08 mg/mg||has_ingredient
vit c||ascorbic acid / thiamine pill||has_ingredient
modopar||benserazide 0.5 mg/ml||has_ingredient
hydrocortisone sod succinate||a-hydrocort, 100 mg injectable powder for injection||has_ingredient
na element||clinimix e 8/10 sulfite-free 8% with electrolytes in dextrose 10% with calcium solution for injection||has_ingredient
p-hydroxy-acetanilid||gnp headache relief tablet||has_ingredient
(s)-brompheniramine||dexbrompheniramine / dextromethorphan / phenylephrine / pyrilamine oral liquid product||has_ingredient
3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-||ciprofloxacin pill||has_ingredient
molecular iodine||iodine topical solution [io-blend]||has_ingredient
carrington oral wound rinse||carrington oral wound rinse, mucous membrane powder for reconstitution||has_ingredient
product containing relugolix (medicinal product)||relugolix oral product||has_ingredient
methohexital sodium (medication)||methohexital in water/pf 100 mg/10 ml (10 mg/ml) intraven syringe (ml)||has_ingredient
quso f-22||silicon dioxide pill||has_ingredient
propyphenazone (substance)||ergotamine / propyphenazone rectal product||has_ingredient
fat||soybean oil refined 200 mg/ml emulsion for injection||has_ingredient
3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione||guaifenesin 90 mg / theophylline 150 mg extended release oral capsule||has_ingredient
phenyltoloxamine dihydrogen citrate (medication)||chlorpheniramine maleate/phenylephrine hydrochloride/phenyltoloxamine citrate 4 mg-20 mg-50 mg oral capsule, extended release [linhist-l.a.]||has_ingredient
hydrocodeinonebitartrate||acetaminophen/hydrocodone bitartrate 500 mg-5 mg oral capsule [ugesic]||has_ingredient
dxm||acetaminophen / dextromethorphan / doxylamine / phenylephrine oral tablet||has_ingredient
specific gravity test||n-multistix sg (multiple) test strip||has_ingredient
salicylic acid [psoriasis] (substance)||salicylic acid medicated liquid soap||has_ingredient
leucine (substance)||alanine 10.4 mg/ml / arginine 5.75 mg/ml / calcium chloride 0.004 meq/ml / dibasic k+ phosphate 2.61 mg/ml / glucose 200 mg/ml / glycine 5.15 mg/ml / histidine 2.4 mg/ml / isoleucine 3 mg/ml / leucine 3.65 mg/ml / lysine 2.9 mg/ml / magnesium chloride 0.01 meq/ml / methionine 2 mg/ml / phenylalanine 2.8 mg/ml / proline 3.4 mg/ml / serine 2.5 mg/ml / sodium acetate trihydrate 3.4 mg/ml / nacl 0.01 meq/ml / threonine 2.1 mg/ml / tryptophan 0.9 mg/ml / tyrosine 0.2 mg/ml / valine 2.9 mg/ml injectable solution||has_ingredient
hexetidine (product)||hexetidine 10 mg||has_ingredient
amylase/cellulase/homatropine/phenobarbital/protease||amylase/cellulase/homatropine methylbromide/phenobarbital/protease 30 mg-2 mg-2.5 mg-7.5 mg-6 mg oral tablet [gustase plus]||has_ingredient
rabies immune globulin, human (medication)||rabies immune globulin, human 150 unt/ml [hyperrab]||has_ingredient
product containing amiodarone||amiodarone hcl 200mg tab,ud||has_ingredient
white petroleum jelly||petrolatum 0.843 mg/mg||has_ingredient
chlorphthalidolone||chlorthalidone 25 mg oral tablet||has_ingredient
technetium (99m-tc) bicisate||kit prep of technetium tc-99 bicisate||has_ingredient
product containing thiamine||nutr supl nepro carb stdy liq b-pecan||has_ingredient
cr element||cider vinegar pill||has_ingredient
valsartan (product)||sacubitril 49mg/valsartan 51mg tab ud||has_ingredient
magnesium hydroxide (product)||calcium carbonate 5 mg / magnesium hydroxide 5 mg / phenobarbital 8 mg oral tablet||has_ingredient
theophylline product||ephedrine sulfate 18.75 mg / hydroxyzine hydrochloride 7.5 mg / theophylline 97.5 mg per 15 ml oral solution||has_ingredient
humibid gc||guaifenesin/pseudoephedrine hydrochloride 400 mg-60 mg oral tablet [zephrex]||has_ingredient
epoprostenol (as sodium)||epoprostenol 1.5 mg (as epoprostenol sodium) injection||has_ingredient
proxibarbal||proxibarbal pill||has_ingredient
pseudoephedrine-containing product||codeine / pseudoephedrine / triprolidine oral product||has_ingredient
phenyl propanolamine hydrochloride||guaifenesin-phenylpropanolamine 600 mg-75 mg oral tablet, extended release||has_ingredient
epinephrinum||epi (auvi-q 0.15) 0.15mg/0.15ml injector||has_ingredient
product containing phenyl salicylate (medicinal product)||atropine sulfate 0.03 mg / benzoic acid 4.5 mg / hyoscyamine sulfate 0.03 mg / methenamine 40.8 mg / methylene blue 5.4 mg / phenyl salicylate 18.1 mg [usept]||has_ingredient
tiaprofenate||tiaprofenate oral capsule||has_ingredient
lvp solution with potassium||lvp solution with potassium dextrose 5% with electrolytes (isolyte p) intravenous solution||has_ingredient
benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (3(s)-endo)-||atropine sulfate/benzoic acid/hyoscyamine sulfate/methenamine/methylene blue/phenyl salicylate 0.03 mg-4.5 mg-0.03 mg-40.8 mg-5.4 mg-18.1 mg oral tablet [urinary antiseptic #2]||has_ingredient
acidol||betaine / glutamate / pepsin a oral product||has_ingredient
methadone hcl||methadone hcl 0.58mg/ml soln,oral||has_ingredient
suction canister||suction canister kit 800ml #zrsucc48k||has_ingredient
acetominophen||acetaminophen 575 mg||has_ingredient
product containing ispaghula husk||maalox daily fiber therapy, 3.4 g/11 g oral powder for reconstitution||has_ingredient
glyceryl monostearate||cream, multi ingredient topical application cream [dml forte]||has_ingredient
pouch,ostomy||pouch,drainable,sensura coloplast #11517||has_ingredient
hydrochlorothiazide (medication)||telmisartan 80 mg / hydrochlorothiazide 25 mg oral tablet [telmisartan and hydrochlorothiazide 80 mg/25 mg]||has_ingredient
product containing velpatasvir (medicinal product)||product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)||has_ingredient
loperamid||loperamide pill||has_ingredient
phenylephrine hydrochloride [cvs sympathomimetic] (substance)||phenylephrine hcl/codeine phosphate 10 mg-10 mg/5 ml oral liquid (ml)||has_ingredient
phenylpropanolamine hcl||phenylpropanolamine hydrochloride 50 mg oral tablet||has_ingredient
wart therapeutic agents lactic acid (duofilm)||lactic acid 50 mg/ml topical cream [penederm]||has_ingredient
healthcare supplies (physical object)||liner,securely yours,ahdesive,paper pak #gh-2||has_ingredient
lactase||lactase@@oral@tablet||has_ingredient
manganese chloride (product)||manganese chloride injection||has_ingredient
product containing xylometazoline (medicinal product)||xylometazoline nose drops (product)||has_ingredient
doxycycline hemiethanolate||doxycycline hyclate 200mg/vial injection||has_ingredient
tetracycline||tetracycline hydrochloride 500 mg||has_ingredient
follistim||recombinant human follicle stimulating hormone beta 600iu/0.72ml cartridge (product)||has_ingredient
magnolia bark||estroven extra strength cap/tab||has_ingredient
chlorhexidine gluconate/ispropyl alcohol||isopropyl alcohol 70 g in 100 g / chlorhexidine gluconate 2 g in 100 g topical solution||has_ingredient
dressing,maxorb||dressing,maxorb extra ag 12in rope #msc9412||has_ingredient
stannous fluoride (medication)||stannous fluoride oral gel [prodenrx]||has_ingredient
2-chloro-5-hydroxy-1,3-dimethylbenzene||chloroxylenol shampoo product||has_ingredient
a1pi||alpha-1-proteinase inhibitor@1 gram/50 ml (2 %)@intraven@vial (ea)||has_ingredient
mucus er||12 hr guaifenesin 600 mg extended release oral tablet||has_ingredient
dioval xx||estradiol valerate 20 mg/1 ml intramuscular oil [dioval xx]||has_ingredient
hyoscyamine (dl-)||atropine sulfate 0.5% ophthalmic solution [atropisol]||has_ingredient
bendrofluazide||bendroflumethiazide / potassium chloride oral product||has_ingredient
calcipotriene + betamethasone dipropionate||calcipotriene 50 ug in 1 g / betamethasone dipropionate 0.643 mg in 1 g topical suspension [taclonex scalp]||has_ingredient
carbidopum||aspirin / carbidopa oral product||has_ingredient
oxycodone hydrochloride (substance)||oxycodone hcl 20mg tab,sa_#1||has_ingredient
minoxidil [androgen alopecia] (substance)||minoxidil topical solution||has_ingredient
camphor, (+/-)-||benzalkonium / benzocaine / camphor topical solution||has_ingredient
alcohol + dextrose (product)||dextrose/ethanol 5%-5% intravenous solution||has_ingredient
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2h-1,4-benzodiazepine-2-thione||doral 7.5 mg oral tablet||has_ingredient
thyroid, unspecified||thyroid (usp) pill||has_ingredient
product containing povidone iodine||povidone-iodine oral solution||has_ingredient
pants (physical object)||net pants,medium coloplast #5603||has_ingredient
dexmedetomidine-containing product||dexdomitor injectable product||has_ingredient
product containing diazepam (medicinal product)||diazepam;lubricant 5 mg; na multiple routes gel/jelly||has_ingredient
sulfate, sodium dodecyl||sodium lauryl sulfate/sorbic acid/standapol shampoo||has_ingredient
chlortrianisen||chlorotrianisene 12 mg oral capsule [tace]||has_ingredient
(+/-)-emtricitabine||bictegravir / emtricitabine / tenofovir alafenamide oral tablet||has_ingredient
carbomer-980 product||carrington skin balm gel,top||has_ingredient
magnesium product||nutr supl osmolite 1.2 cal liquid||has_ingredient
product containing triprolidine (medicinal product)||actamine oral liquid product||has_ingredient
carbonyldiamide||urea 45 % topical gel with prefilled applicator (ml)||has_ingredient
adalimumab (medication)||adalimumab 40 mg/0.4 ml subcutaneous kit||has_ingredient
2b alfa interferon||interferon alfa-2b 5 million iu/0.2 ml injection solution||has_ingredient
kallikrein trypsin inactivator||tisseel duploject kit, 2 ml topical kit||has_ingredient
diphenhydramine.hcl||acetaminophen/diphenhydramine hydrochloride 500 mg-25 mg oral tablet [pain reliever & nighttime sleep aid pm]||has_ingredient
benzoyl peroxide products||benzoyl peroxide@2.5 %@topical@cream (gram)||has_ingredient
vital e- a + d3||vitamin a, d, vitamin a and d oral capsule||has_ingredient
guaifenesin||guaifenesin 6.67 mg/ml||has_ingredient
phentermine product||phentermine extended release oral tablet||has_ingredient
chlorzoxozone||lorzone 375 mg oral tablet||has_ingredient
hydrocodone (substance)||chlorpheniramine / hydrocodone / phenylephrine oral solution [baltussin hc]||has_ingredient
phenylephrine (product)||h c tussive-nr oral liquid product||has_ingredient
hcl, duloxetine||duloxetine hcl 60mg cap,oral,ud||has_ingredient
novaferrum 50||iron polysaccharide complex@50 mg iron@oral@capsule||has_ingredient
product containing paracetamol||acetaminophen-hydrocodone 500 mg-7.5 mg oral tablet||has_ingredient
choriogonadotrophin||chorionic gonadotropin 10000 unt/ml [chorex]||has_ingredient
benzocaine (otic) (medication)||benzocaine oral gel||has_ingredient
antidiabetics albiglutide||albiglutide pen injector [tanzeum]||has_ingredient
human insulin, nos||insulin, regular, human 15 unt/ml||has_ingredient
disalicylsäure||salsalate-containing product in oral dose form||has_ingredient
ethinyloestradiol [malignancy]||ethinyl estradiol-norgestrel, 30 mcg-0.3 mg oral tablet||has_ingredient
pad dosage form||incont liner tranquility #2382||has_ingredient
carya tomentosa pollen||white hickory pollen extract injectable product||has_ingredient
phendimetrazine product||phendimetrazine tartrate 105 mg [bontril]||has_ingredient
acetamide, n-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-||acetazolamide 500mg injection||has_ingredient
clozapine (clozaril)||clozapine 25 mg oral tablet||has_ingredient
product containing nitrogen (product)||nitrogen 90 %||has_ingredient
sodium fluoride product (substance)||sodium fluoride oral powder product||has_ingredient
dihydrotachysterol preparation (product)||dihydrotachysterol 0.25 mg/ml oral solution||has_ingredient
codeine product||brompheniramine maleate 4 mg||has_ingredient
calcium carbonate/magnesium hydroxide/phenobarbital||calcium carbonate 5 mg / magnesium hydroxide 5 mg / phenobarbital 8 mg oral tablet||has_ingredient
product containing oxybutynin (medicinal product)||oxybutynin oral suspension||has_ingredient
naratriptan (substance)||naratriptan / sumatriptan oral tablet||has_ingredient
4h-pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6 ,7,8,9-tetrahydro-2-methyl-||risperidone 0.5 mg [risperdal]||has_ingredient
cyclohexanol, 5-methyl-2-(1-methylethyl)-||menthol topical gel||has_ingredient
phosphosoda||sodium phosphate, monobasic, monohydrate 276 mg in 1 ml / sodium phosphate, dibasic, anhydrous 142 mg in 1 ml intravenous injection, solution [sodium phosphates]_#2||has_ingredient
cat hair standardized allergenic extract||cat hair extract 400 bau/ml||has_ingredient
tiagabine-containing product||tiagabine hydrochloride 2mg film tablet (product)||has_ingredient
phenylbarbital||phenerbel-s, 0.2 mg-0.6 mg-40 mg oral tablet, extended release||has_ingredient
(6r-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1h-tetrazol-1-yl)acetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt||cefazolin sodium 500 mg/50 ml intravenous solution [ancef]||has_ingredient
quinapril hydrochloride (product)||hctz 12.5 mg / quinapril 20 mg oral tablet||has_ingredient
vitamin b1 preparation||thiamine / vitamin b12 oral tablet||has_ingredient
product containing ferrous fumarate||ascorbic acid-ferrous fumarate 150 mg-67 mg oral tablet, extended release||has_ingredient
bupivacaine hydrochloride [dup] (substance)||bupivacaine hcl in 0.9 % sodium chloride/pf 0.1 % 400 ml injection elastomeric pump, hi variable rate||has_ingredient
benzoyl peroxide [generic additions] (substance)||benzoyl peroxide-clindamycin topical 5%-1.2% with emollients topical kit||has_ingredient
phenol topical||top care sore throat 1.4% spray (menthol)||has_ingredient
nimodipine (medication)||nimodipine 0.2 mg/ml||has_ingredient
docusate||ferraplus pill||has_ingredient
ketone test||chemstrip 10 with sg (multiple) test strip||has_ingredient
magnesium salicylate (substance)||phenyltoloxamine citrate 25 mg||has_ingredient
amfebutamon||bupropion hcl@150 mg@oral@tablet, extended release 12 hr||has_ingredient
benzatropine||product containing only benztropine mesylate 1 mg/1 each oral tablet||has_ingredient
guaifenesin (substance)||tussafin liquid, 200 mg-5 mg-60 mg/5 ml oral liquid||has_ingredient
cholan||dehydrocholic acid 125 mg||has_ingredient
hepatitis b virus surface protein antigen, b||haemophilus influenzae b (ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis b surface antigen vaccine injectable product||has_ingredient
methylprednisolone [endocrine use]||methylprednisolone 8mg tab||has_ingredient
verticillium albo-atrum allergenic extract||verticillium albo-atrum allergenic extract injectable solution||has_ingredient
product containing thimerosal (medicinal product)||antivenin (micrurus fulvius), intravenous kit||has_ingredient
sodium, dalteparin||dalteparin na 10000 unt/ml inj||has_ingredient
7-methyltheophylline||aspirin / butalbital / caffeine oral tablet||has_ingredient
sodium||peritoneal dialysis solution no.6 with 1.5 % dextrose low calcium (2.5 meq/l)-low magnesium (0.5 meq/l) intraperit intraperitoneal solution (ml)||has_ingredient
catheter, nos||catheter,intermittent,closed system 12fr cure #cs12||has_ingredient
.omega.-diethylamino-2,6-dimethylacetanilide||lidocaine/neomycin sulfate/polymyxin b sulfate topical application cream [antibiotic]||has_ingredient
immunomodulators dimethyl fumarate||dimethyl fumarate, 240 mg oral delayed release capsule||has_ingredient
lixisenatide (substance)||lixisenatide 0.05 mg/ml||has_ingredient
belt, device (physical object)||belt,support 4in med nu-hope #2661-p-sp||has_ingredient
acidum ascorbicum||ascorbic acid / zinc gluconate oral tablet||has_ingredient
delta(1)-dehydrohydrocortisone||prednisolone acetate 10 mg/ml ophthalmic suspension [ocu-pred-a]||has_ingredient
acetamide, n-((4-aminophenyl)sulfonyl)-||sulfacetamide sodium 0.06 mg/mg [albucid]||has_ingredient
dressing,primapore||dressing,primapore 8in x 4in||has_ingredient
mefloquine hydrochloride (medication)||lariam tablets||has_ingredient
product containing zinc acetate (medicinal product)||chloroxylenol/glycerin/pramoxine hydrochloride/zinc acetate 0.1%-1%-1%-1% otic solution [zinotic es]||has_ingredient
methorphan d||dextromethorphan hydrobromide 30 mg / guaifenesin 600 mg / phenylpropanolamine hydrochloride 37.5 mg extended release oral tablet||has_ingredient
catherization set||catherization set,foley 18fr bard #899618||has_ingredient
axicabtagene ciloleucel product||axicabtagene ciloleucel@@intraven@plastic bag, injection (ea)||has_ingredient
phenazopyridine hydrochloride (substance)||phenazo 200 mg oral tablet||has_ingredient
(5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol||morphine sulfate 50 mg extended release oral capsule||has_ingredient
catheter device||catheter,foley 30fr 30cc bard#0166l-30||has_ingredient
beta-alanine, n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (r)-||myadec tab||has_ingredient
levonorgestrel [progestogen contraceptive] (substance)||ethinyl estradiol 30 ug / levonorgestrel 0.15 mg oral tablet [levonorgestrel and ethinyl estradiol]||has_ingredient
albumin/stannous chloride||pulmolite inj,susp||has_ingredient
benzonitrile, 2-(1',6'-dihydro-6'-oxo-1'-phenyl(2,3'-bipyridin)-5'-yl)-||perampanel 0.5 mg/ml||has_ingredient
lidocaine||bacitracin / lidocaine / polymyxin b topical product||has_ingredient
k-y silk-e vaginal moisturizer||k-y silk-e vaginal moisturizer, vaginal spray||has_ingredient
r-(+)-ethyl 1-(1-phenylethyl)-1h-imidazole-5-carboxylate||etomidate injectable product||has_ingredient
sulfasoxazole||erythromycin ethylsuccinate/sulfisoxazole acetyl 200 mg-600 mg/5 ml oral suspension, reconstituted, oral (ml)||has_ingredient
benztropine mesylate (medication)||benztropine mesylate bulk powder||has_ingredient
pure oxygen||oxygen 30 %||has_ingredient
oxymetazoline hcl||oxymetazoline hydrochloride 0.0005 g in 1 g nasal liquid [xlear nasal decongestant]||has_ingredient
avanafil product||stendra 100mg tablet||has_ingredient
trichophyton rubrum extract (product)||trichophyton rubrum allergenic extract 5 mg/ml||has_ingredient
clostridium botulinum toxin a||incobotulinumtoxina 50 unt||has_ingredient
beclomethasone dipropionate preparation (product)||beclomethasone dipropionate 0.04 mg/actuat metered dose inhaler, 120 actuats||has_ingredient
product containing benzoyl peroxide (medicinal product)||loroxide 5.5 % topical lotion||has_ingredient
hydrochlorothiazide (medication)||hydrochlorothiazide 25mg tablet (product)||has_ingredient
dicyclomine hydrochloride||product containing dicycloverine in parenteral dosage form||has_ingredient
anthralin-containing product||anthralin topical 0.1% topical cream||has_ingredient
3-hydroxy-4,5-dimethylol-α-picoline||ascorbic acid / calcium sulfate / cupric oxide / niacinamide / pyridoxine / vitamin b12 oral tablet||has_ingredient
meprobamate (product)||meprobamate 200 mg [mb-tab]||has_ingredient
dihydrocodeinone bitartrate||phenylephrine hcl/hydrocodone bitartrate/diphenhydramine@7.5 mg-2 mg-12.5 mg/5 ml@oral@syrup||has_ingredient
product containing docusate (medicinal product)||docusate oral capsule [doculase]||has_ingredient
robitussin pediatric cough & cold nighttime||chlorpheniramine maleate 0.2 mg/ml / dextromethorphan hydrobromide 1 mg/ml / phenylephrine hydrochloride 0.5 mg/ml oral solution||has_ingredient
product containing manganese||nutren 2.0 liquid vanilla 1000ml||has_ingredient
mineral supplements magnesium gluconate||magnesium gluconate 205 mg||has_ingredient
pseudoephedrine hcl||guaifenesin/pseudoephedrine hcl@400 mg-20 mg@oral@tablet||has_ingredient
ascorbic acid||vitamin c 250 mg/ml injectable solution [ortho cs]||has_ingredient
otic preparations antipyrine||antipyrine 5%/hc 0.1%/n-mycin 5mg/polymyx 2000unt/ml soln,otic||has_ingredient
paddrugform||poise pad extra absorbent||has_ingredient
guaiphenesin||guaifenesin 388 mg||has_ingredient
miconazol||miconazole powder spray [cruex prescription strength]||has_ingredient
tylenol cold multi-symptom nighttime rapid release||acetaminophen/chlorpheniramine maleate/dextromethorphan hydrobromide/phenylephrine hydrochloride 325 mg-2 mg-10 mg-5 mg oral tablet [good sense cold nighttime multi-symptom]||has_ingredient
prochlorperazine maleate (medication)||product containing prochlorperazine maleate 5 mg/1 each oral tablet||has_ingredient
carbinoxamine (substance)||carbinoxamine maleate@1.5 mg/5 ml@oral@liquid (ml)||has_ingredient
monopotassium lactate||ammonium lactate topical topical cream||has_ingredient
alpha-(2,4-difluorophenyl)-alpha- (1,2,4-triazol-1-ylmethyl)-1,2, 4- triazole-1-ethanol||fluconazole 10mg/ml suspension||has_ingredient
product containing prilocaine hydrochloride (medicinal product)||prilocaine cartridge||has_ingredient
cocaine hydrochloride (medication)||cocaine topical compounding powder||has_ingredient
triprolidine preparations||triprolidine hydrochloride 0.625 mg/ml [pediaclear childrens]||has_ingredient
lanadelumab-containing product||lanadelumab injection||has_ingredient
2-imino-4-keto-5-phenyltetrahydrooxazole||pemolert 18.8 mg oral tablet||has_ingredient
multiple vitamins with iron and minerals, prenatal||multivitamin, prenatal prenatal multivitamins with folic acid 1.24 mg and docusate oral capsule||has_ingredient
bag, nos||bag,leg medium consolidated #0936||has_ingredient
albumin human (substance)||albumin human, usp 250 mg/ml [alburx]||has_ingredient
product containing clotrimazole||betamethasone / clotrimazole topical lotion||has_ingredient
iron (iii) maltol||ferric maltol oral capsule [accrufer]||has_ingredient
guaifenesin (product)||muco-fen 800 dm, 60 mg-800 mg oral tablet, extended release||has_ingredient
(s)-serine||alanine / arginine / aspartate / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine injectable solution||has_ingredient
product containing isotretinoin in topical dosage form (medicinal product form)||product containing only isotretinoin 10 mg/1 each oral capsule||has_ingredient
pseudoephedrine.hcl||pseudoephedrine/dextromethorphan/guaifenesin/acetaminophen@30 mg-10 mg-100 mg-250 mg@oral@capsule||has_ingredient
product containing ascorbic acid (medicinal product)||ascorbic acid 180 mg/ml||has_ingredient
1b beta interferon||interferon beta-1b 8million iu inj (pdr for recon)+diluent||has_ingredient
cat hair standardized allergenic extract||cat hair extract injectable product||has_ingredient
empagliflozin (substance)||product containing empagliflozin 10 mg/1 each oral tablet (clinical drug)||has_ingredient
l-alpha,epsilon-diaminocaproic acid||lysine 7.35 mg/ml||has_ingredient
dehydrocholate||dehydrocholic acid 250 mg oral tablet||has_ingredient
ergoloid mesylates||ergoloid mesylates, usp 2 mg||has_ingredient
acetic acid [ear]||acetic acid / glycerin / oxyquinoline / ricinoleate vaginal gel||has_ingredient
nifedipine (medication)||nifedipine 10 mg||has_ingredient
sulphate of iron||ferrous sulfate 500 mg||has_ingredient
citalopram hydrobromide (medication)||citalopram 10 mg [celexa]||has_ingredient
hydrocodonum||hydrocodone bitartrate 0.7 mg/ml||has_ingredient
dextromethorphan (substance)||dextromethorphan oral solution||has_ingredient
influenza a virus (h1n1) antigen||influenza a virus a/california/7/2009 (h1n1) antigen 0.03 mg/ml / influenza a virus a/hong kong/4801/2014 (h3n2) antigen 0.03 mg/ml / influenza b virus b/brisbane/60/2008 antigen 0.03 mg/ml / influenza b virus b/phuket/3073/2013 antigen 0.03 mg/ml injection [fluzone quadrivalent 2016-2017]||has_ingredient
cis-4-amino-5-chloro-n-(1-(3- (p-fluorophenoxy)propyl)-3-methoxy-4- piperidyl)-o-anisamide||cisapride pill||has_ingredient
travatan z||travoprost-containing product in ocular dose form||has_ingredient
adapter||adapter,luer pleural drainage bard #1505||has_ingredient
baking soda||calcium carbonate / potassium bicarbonate / sodium bicarbonate oral suspension||has_ingredient
chloride sodium||menthol / sodium chloride topical product||has_ingredient
product containing dienogest (medicinal product)||dienogest / estradiol oral tablet||has_ingredient
urostomy bag (physical object)||pouch,urinary nu-flex nu-hope #8854-sp||has_ingredient
strap, device||catheter holder,marpac #400||has_ingredient
sodium sulfacetamide||fml-s liquifilm, 0.1%-10% ophthalmic suspension||has_ingredient
juniperus ashei pollen||mountain cedar pollen extract 20 mg/ml||has_ingredient
calcium carbonate (product)||calcium carbonate / magnesium hydroxide / phenobarbital oral tablet||has_ingredient
tripelennamine (product)||tripelennamine 25 mg||has_ingredient
clavulanate potassium (substance)||ticarcillin-clavulanate 30 g-1 g intravenous powder for injection||has_ingredient
zafirlukast product||product containing zafirlukast 20 mg/1 each oral tablet||has_ingredient
2-propen-1-one, 1-((3r)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-||ibrutinib 70 mg oral capsule [imbruvica]||has_ingredient
1,2-dehydrohydrocortisone||neomycin / polymyxin b / prednisolone ophthalmic suspension [poly pred]||has_ingredient
carbetapentane tannate (medication)||carbetapentane tannate/phenylephrine tannate/pyrilamine 30 mg-5 mg-30 mg/5 ml oral suspension, oral (final dose form)||has_ingredient
p-acetamidophenol||acetaminophen/pamabrom/pyrilamine maleate 500 mg-25 mg-15 mg oral tablet||has_ingredient
2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole||pramipexole dihydrochloride 0.125 mg [mirapex]||has_ingredient
fentanylum||fentanyl, 4 mcg/ml-d5% injectable solution||has_ingredient
homatropine||dipyrone / homatropine oral solution||has_ingredient
tafenoquine||tafenoquine pill||has_ingredient
pteroylglutamic acid preparation||multivitamin vitamin b complex with c intravenous solution||has_ingredient
quetiapine (medication)||quetiapine fumarate 300 mg oral tablet, film coated, extended release [quetiapine fumarate]||has_ingredient
codeine phosphate product (substance)||codeine phosphate/guaifenesin/phenylpropanolamine hydrochloride 10 mg/5 ml-100 mg/5 ml-12.5 mg/5 ml oral liquid||has_ingredient
kcz||keto-c 2 % / 1 % medicated pad||has_ingredient
amitriptyline hydrochloride||endep, 150 mg oral tablet||has_ingredient
pseudoephedrine hydrochloride||guaifenesin/pseudoephedrine hydrochloride 250 mg-120 mg oral capsule, extended release [g-phed]||has_ingredient
hose||hose anti-embolism full leg x-sm-reg||has_ingredient
2-(diphenylmethoxy)-n,n-dimethylethylamine||aid to sleep, 25 mg oral tablet||has_ingredient
leuprorelin acetate (substance)||leuprolide acetate (lupron) 3.75mg (1 month) inj,susp,sa||has_ingredient
product containing naproxen||vimovo pill||has_ingredient
t<sub>4</sub> thyroxine sodium preparation||levothyroxine sodium anhydrous 100 microgram oral tablet||has_ingredient
dimenhydrinate-containing product||dimenhydrinate 50 mg oral capsule [t-circ]||has_ingredient
chlorpheniramine maleate (medication)||chlorpheniramine-pseudoephedrine 4 mg-60 mg oral tablet||has_ingredient
product containing calcium chloride (medicinal product)||plasma-lyte/dextrose 5% inj||has_ingredient
doxapram (substance)||doxapram hydrochloride 20 mg/ml [respiram]||has_ingredient
glycerin (obsolete)||neutracett 0.5 % / 5 % topical gel||has_ingredient
candesartan (substance)||candesartan / hydrochlorothiazide pill||has_ingredient
aspirin antiplatelet||product containing precisely aspirin 81 milligram/1 each gastro-resistant oral tablet (clinical drug)||has_ingredient
3,4-pyridinedimethanol, 5-hydroxy-6-methyl-||ascorbic acid / biotin / folic acid / mecobalamin / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / zinc citrate oral product||has_ingredient
zcort 7-day||dexamethasone 1.5 mg (25 tabs) oral tablet, dose pack||has_ingredient
product containing phenolphthalein (medicinal product)||mineral oil / phenolphthalein oral solution||has_ingredient
antithymoglobulin||lymphocyte immune globulin,antithymocyte (equine)@50 mg/ml@intraven@ampul (ml)||has_ingredient
magnesium salicylate||acetaminophen / magnesium salicylate oral tablet||has_ingredient
benzoic acid/methenamine/sodium salicylate||methenamine 162 mg / sodium salicylate 162.5 mg oral tablet [good neighbor antibacterial plus urinary pain relief]||has_ingredient
nortryptyline||aventyl pill||has_ingredient
calcium caseinate (substance)||isosource liquid (vanilla)||has_ingredient
morphine-3-methyl ether||tylenol with codeine pill||has_ingredient
dimeticone-containing product||allantoin / benzocaine / camphor / dimethicone / petrolatum oral gel product||has_ingredient
ethinyloestradiol product||drospirenone/ethinyl estradiol/levomefolate 3 mg-0.03 mg-0.451 mg oral tablet||has_ingredient
pancrelipase-containing product||zenpep (lipase 40,000unit) delayed-release capsule||has_ingredient
product containing vitamin b12||calcium/cyanocobalamin/folic acid/pyridoxine 200 mg-0.012 mg-1 mg-75 mg oral tablet [premesis rx]||has_ingredient
cholecalciferol||cholecalciferol-lactobacillus reuteri oral liquid||has_ingredient
chlorphenamine||chlorpheniramine maleate 0.01 mg/ml||has_ingredient
product containing sucrose||ensure plus hn liquid vanilla||has_ingredient
phenylephrine hcl [eye]||dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride 18 mg/15 ml-200 mg/15 ml-10 mg/15 ml oral solution||has_ingredient
caffeine as diuretic (medication)||excedrin quicktabs orally disintegrating tablet (peppermint)||has_ingredient
carbamide peroxide (substance)||carbamide peroxide otic solution||has_ingredient
atorvastatin calcium (medication)||atorvastatin calcium 80mg tab||has_ingredient
dextromethorphan hydrobromide (medication)||dextromethorphan-guaifenesin 10 mg-187 mg/5 ml oral liquid||has_ingredient
pouch ostomy||pouch,drainble,contour i ctf h#1620||has_ingredient
hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3h-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4h,23h)-tetrone||tacrolimus 5 mg/1 each oral capsule||has_ingredient
kallikrein trypsin inactivator||fibrin sealant topical 4 ml topical kit||has_ingredient
promethazine-containing product||phenylephrine / promethazine oral solution||has_ingredient
racemic bupivacaine||bupivacaine-nacl in on q pump p100x2, 0.375%-nacl 0.9% injectable solution||has_ingredient
methylphenobarbital product||mephobarbital / phenobarbital / phenytoin oral product||has_ingredient
l-threonine (substance)||alanine / arginine / aspartate / glucose / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine injectable solution [aminosyn ii 3.5 % in 25 % dextrose]||has_ingredient
sodium cromoglycate||cromolyn nasal product||has_ingredient
vitamin e (d-alpha tocopherol)||cvs vitamin e 400units softgel||has_ingredient
cefazolin||cefazolin sodium, 2 g/10 ml-nacl 0.9% intravenous solution||has_ingredient
fe heme polypeptide||fe heme polypeptide / polysaccharide iron complex oral product||has_ingredient
3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-n,n-dimethyl-1-propanamine||amitriptyline hydrochloride 50mg oral tablet||has_ingredient
product containing choline||lipogen, lipotropic with multivitamins oral tablet||has_ingredient
pseudoephedrine hydrochloride||tusnel dm pediatric drops, 2.5 mg-50 mg-7.5 mg/ml oral liquid||has_ingredient
chinidinum||quinidine gluconate 324 mg||has_ingredient
lidocaine (medication)||lidocaine hydrochloride anhydrous 10 mg in 1 ml / epinephrine bitartrate 0.005 mg in 1 ml epidural injection, solution [xylocaine mpf]_#1||has_ingredient
mucinex||guaifenesin/pseudoephedrine hydrochloride 600 mg-120 mg oral tablet, extended release [enomine pse]||has_ingredient
adrenaline hydrochloride||epinephrine 0.3 mg in 0.3 ml intramuscular injection, solution||has_ingredient
amaranthus retroflexus pollen||redroot pigweed pollen extract 10000 unt/ml||has_ingredient
methoxylpectin||bismuth / pectin oral suspension||has_ingredient
7-bromo-5-methylquinolin-8-ol||5-methyl-8-hydroxyquinoline / tilbroquinol pill||has_ingredient
clorazepate dipotassium (medication)||product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug)||has_ingredient
corn starch,hydrolyzed||nutrition supl citrotein/punch pwd||has_ingredient
vericiguat (substance)||vericiguat 10 mg oral tablet, film coated [verquvo]||has_ingredient
dexametasona||dexamethasone / neomycin / polymyxin b ophthalmic ointment||has_ingredient
o-2-naphthyl m,n-dimethylthiocarbanilate||mycozyl al 1% topical solution||has_ingredient
pyranisamine||viravan-t pill||has_ingredient
propranolol hydrochloride (substance)||propranolol hcl 4.28mg/ml soln,oral||has_ingredient
xarelto starter pack||xarelto tablet starter pack||has_ingredient
benzoyl peroxide product (substance)||benzoyl peroxide 0.0525 mg/mg||has_ingredient
fat||fat emulsion, intravenous with fish, medium chain, olive, and soy oil 20% intravenous emulsion||has_ingredient
oxytetracyclin||oxytetracycline injectable solution||has_ingredient
leucomycin v, 9-o-(5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)-, (9(5s,6r))-||spiramycin 250 mg||has_ingredient
ser||alanine / arginine / cysteine / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / phosphoric acid / proline / serine / sodium bisulfite / threonine / tryptophan / valine injectable solution [freamine iii 10]||has_ingredient
meningococcal serogroups a, c, y, w-135 polysaccharide diphtheria toxoid conjugate vaccine (medication)||neisseria meningitidis serogroup a capsular polysaccharide diphtheria toxoid protein conjugate vaccine / neisseria meningitidis serogroup c capsular polysaccharide diphtheria toxoid protein conjugate vaccine / neisseria meningitidis serogroup w-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / neisseria meningitidis serogroup y capsular polysaccharide diphtheria toxoid protein conjugate vaccine prefilled syringe [menactra]||has_ingredient
belladonna alkaloids - chemical (substance)||belladonna alkaloids oral solution||has_ingredient
topical form lignocaine||lidocaine hydrochloride 0.005 mg/mg topical gel||has_ingredient
na sodium||nutrition supl perative 1500ml liq||has_ingredient
paracetamol - chemical||oral form paracetamol (product)||has_ingredient
phenoxymethyl penicillin potassium||phenoxymethylpenicillin 125mg/5ml s/f oral solution||has_ingredient
chloroethane (medication)||ethyl chloride 100% topical application spray||has_ingredient
p-ethoxycarboxylic aniline||benzocaine / menthol mucous membrane topical solution||has_ingredient
propane-1,2,3-triyl trinitrate||nitroglycerin oral spray product||has_ingredient
hydrochloride phentermine||phentermine hydrochloride 8 mg oral tablet [pro-fast sa]||has_ingredient
vitamin b>12< preparation||ferric ammonium citrate / folic acid / vitamin b12 oral product||has_ingredient
metaproterenol sulfate (medication)||orciprenaline sulfate 50 mg/ml solution for inhalation||has_ingredient
milk,nonfat||ensure pudding chocolate||has_ingredient
kcz||ketoconazole 200 mg [nizoral]||has_ingredient
product containing buprenorphine||buprenorphine 200 mg/ml||has_ingredient
metronidazolum||metronidazole 0.75% vaginal gel||has_ingredient
product containing pramoxine||ivderm 10mg-10mg-1mg/ml topical lotion||has_ingredient
5h-dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10-oxo-||oxcarbazepine 600mg tablet (product)||has_ingredient
narcotics morphine||morphine sulfate 5 mg/ml [mst continus]||has_ingredient
5-(((2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3h-1,2,4-triazol-3-one||aprepitant 80 mg oral capsule [aprepitant]||has_ingredient
beta-bromo-beta-nitrotrimethyleneglycol||bronopol 2000 mg in 1 l topical liquid [gil sani-guard]||has_ingredient
nih chronic gvhd consensus project response criteria||mouth progression gvhd||concept_in_subset
bridg data type terminology||positive integer data type||concept_in_subset
ft-pul 2.0 test||pul0204||concept_in_subset
mapped icd-o-3.2 morphology terminology||papillary microcarcinoma of the thyroid||concept_in_subset
cptac terminology||cutaneous squamous cell carcinoma of the head and neck pt4b tnm finding v8||concept_in_subset
routes and methods of administration||intralymphatic use||concept_in_subset
adapt||sweeping (5 minutes nonstop)||concept_in_subset
fda established names and unique ingredient identifier codes terminology||cyclopamine||concept_in_subset
fda established names and unique ingredient identifier codes terminology||3-(2-(4-(p-fluorobenzoyl)piperidino)ethyl)-2-thio-2,4(1h,3h)-quinazolinedione||concept_in_subset
cdisc||emo1-happiness responded as happiness||concept_in_subset
ctrp intervention terminology||barium enemas||concept_in_subset
ctrp biomarker terminology||ssx4/syt fusion gene||concept_in_subset
genomics data commons terminology||anti-prolactin receptor antibody lfa102||concept_in_subset
pediatric heme-onc terminology||childhood yolk sac neoplasm||concept_in_subset
cdisc qrs terminology||haq02tn||concept_in_subset
cdisc sdtm terminology||trochlear nerve tree||concept_in_subset
cptac terminology||unknown site of new tumor event||concept_in_subset
cdisc sdtm terminology||ccq02tc||concept_in_subset
sdtm||picomole per liter per milligram per meter squared||concept_in_subset
cdisc terminology||pulmonary arterial tree organ part||concept_in_subset
cdisc sdtm terminology||bq||concept_in_subset
spl flavor terminology||flavor,coconut||concept_in_subset
gdc therapeutic agent terminology||medi0457||concept_in_subset
sdtm||cdisc functional test pul 1.2 test name terminology||concept_in_subset
clinical trials reporting program terminology||ph' chromosome positive chronic myelocytic leukemia||concept_in_subset
operator of medical device individual case safety report terminology||patient family member or friend||concept_in_subset
qs-oab-q test||oabq0110||concept_in_subset
gdc terminology||tqb 3455||concept_in_subset
cdisc sdtm laboratory test code terminology||hydroxyalprazolam||concept_in_subset
pediatric endocrinology terminology||reyes syndromes||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||maturation factor 1||concept_in_subset
structured product labeling route of administration terminology||per vaginam||concept_in_subset
sdtm||intsfbro||concept_in_subset
ctrp reference gene terminology||pleomorphic adenoma gene 1||concept_in_subset
send||austria (geographic location)||concept_in_subset
cdisc||drri-2 - p: family tell me when problem||concept_in_subset
send-stsprmcd||study title||concept_in_subset
edqm health care terminology||poultice dosage form||concept_in_subset
gdc terminology||current reformed smoker, years unknown||concept_in_subset
fda established names and unique ingredient identifier codes terminology||oxamisole||concept_in_subset
fda cdrh terminology||concussion; brain||concept_in_subset
fda established names and unique ingredient identifier codes terminology||6,7-dihydro-9-fluoro-5-methyl-1-oxo- 1h,5h-quinolizine-2-carboxylic acid||concept_in_subset
cdisc sdtm terminology||css0318||concept_in_subset
mapped icd-o-3.2 morphology pt terminology||sarcomatosis of meninges||concept_in_subset
cdisc sdtm microbiology test code terminology||a. tenuis alternata ige ab rast score||concept_in_subset
sdtm||rvpp||concept_in_subset
ncpdp terminology||vial dosing unit||concept_in_subset
cellosaurus disease terminology||pleomorphic; rhabdomyosarcoma||concept_in_subset
cdisc terminology||uhdr1-total behavior score||concept_in_subset
cdisc qrs terminology||drri1-h: prepared to deal with climate||concept_in_subset
fac062tc||fac06202||concept_in_subset
sdtm||chsf114||concept_in_subset
ctrp terminology||cyp2a6||concept_in_subset
send||pct||concept_in_subset
us counties terminology||jackson county, alabama||concept_in_subset
clinical trials reporting program terminology||bst2||concept_in_subset
cptac esophageal carcinoma baseline form||specify number of lymph nodes positive for tumor by h&e||concept_in_subset
ctrp biomarker terminology||meis1-related gene 1||concept_in_subset
cdisc||structure of hepatic vein (body structure)||concept_in_subset
fda established names and unique ingredient identifier codes terminology||nanafrocin||concept_in_subset
gdc terminology||5-prime-nucleotidase, cytosolic ii||concept_in_subset
cdisc qrs terminology||eq-5d-5l||concept_in_subset
fda established names and unique ingredient identifier codes terminology||caricotamide||concept_in_subset
fda cdrh terminology||syndrome; hyponatremic||concept_in_subset
cptac baseline medical forms terminology||liposarcoma, no icd-o subtype (morphologic abnormality)||concept_in_subset
ctrp biomarker terminology||proto-oncogene c-erbb-1 d770_n771inssvp||concept_in_subset
send||cartilage not fused||concept_in_subset
cdisc sdtm terminology||cdisc questionnaire hads test name terminology||concept_in_subset
mapped icd-o-3.2 terminology||ft-ump||concept_in_subset
ctdc property terminology||uid||concept_in_subset
ncpdp strength form terminology||oral flakes||concept_in_subset
germ cell tumor table terminology||46xx female genotype||concept_in_subset
clinical data interchange standards consortium terminology||endoscopy of urinary bladder (procedure)||concept_in_subset
hospital anxiety and depression scale questionnaire (hads)||a little||concept_in_subset
clinical trials reporting program agent terminology||bgb-3245||concept_in_subset
cdrh terminology||design change validation inadequate||concept_in_subset
cdisc sdtm laboratory test terminology by name||shellfish mix ige ab rast score||concept_in_subset
alzheimer's disease cooperative study-activities of daily living inventory questionnaire test name||adcs-adl - description of usual performance of clearing dishes||concept_in_subset
clinical trials reporting program terminology||deleterious shfm1 mutation||concept_in_subset
ctrp biomarker terminology||ctrc wt allele||concept_in_subset
ctrp terminology||fibroblast growth factor 19||concept_in_subset
ctrp terminology||ptop||concept_in_subset
ae||hemolysis (e.g., immune hemolytic anemia, drug-related hemolysis)||concept_in_subset
cdisc send terminology||decibels||concept_in_subset
clinical trials reporting program terminology||domino, drosophila, homolog of gene||concept_in_subset
cdisc||rad/nuc||concept_in_subset
cptac baseline medical forms terminology||prostate carcinoma pt4 tnm finding v8||concept_in_subset
clinical trials reporting program biomarker terminology||ccr-5 gene||concept_in_subset
cptac terminology||stage ia1 cervical carcinoma ajcc v8||concept_in_subset
cre||er||concept_in_subset
fda established names and unique ingredient identifier codes terminology||pirepolol||concept_in_subset
cdisc terminology||chronic total occlusion vessel||concept_in_subset
cdisc questionnaire terminology||eortc qlq-c30 version 3 - limited hobbies or leisure activities||concept_in_subset
ae||unknown (qualifier value)||concept_in_subset
ncit covid-19 terminology||tacrolimus||concept_in_subset
clinical trials reporting program terminology||dhpln||concept_in_subset
fda established names and unique ingredient identifier codes terminology||eupatorium perfoliatum whole||concept_in_subset
cdisc||dose frequency||concept_in_subset
fact-g||i am content with the quality of my life right now||concept_in_subset
fda unii code terminology||benzenepropanoic acid, alpha-((4,6-dimethoxy-2-pyrimidinyl)oxy)-beta-methoxy-beta-phenyl-, (s)-||concept_in_subset
cdisc sdtm terminology||copeptin measurement||concept_in_subset
national cancer institute drug dictionary||dipyridamine||concept_in_subset
ctrp biomarker terminology||dadb-159g18.7||concept_in_subset
clinical trials reporting program terminology||sti1, yeast, homolog of||concept_in_subset
clinical trials reporting program terminology||trb-2||concept_in_subset
ipaq02tn||ipa02-days bicycle place to place||concept_in_subset
perinatal terminology||near term infant||concept_in_subset
acute myeloid leukemia table terminology||others||concept_in_subset
cdisc questionnaire terminology||c-ssrs since last visit - description of interrupted suicide attempt||concept_in_subset
cdisc||blastocystis hominis||concept_in_subset
clinical data interchange standards consortium terminology||distal circumflex artery||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||est||concept_in_subset
rf||fatty degeneration (morphologic abnormality)||concept_in_subset
fda unii code terminology||elvitegravir||concept_in_subset
ctrp terminology||lap||concept_in_subset
mapped icdo3.1 morphology pt terminology||schwannomatosis (diagnosis)||concept_in_subset
ctrp disease terminology||stage 0a renal pelvis cancer||concept_in_subset
mapped icd-o-3.1 terminology||papillary meningioma||concept_in_subset
clinical trials reporting program terminology||nk-kappa b-activating kinase nak||concept_in_subset
ctrp biomarker terminology||silver, mouse, homolog of gene||concept_in_subset
ctrp molecular genetic biomarker terminology||ppp1r15a gene||concept_in_subset
cptac baseline medical forms terminology||no 30 day prior medications||concept_in_subset
genomics data commons terminology||twins||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||mcm2, formerly||concept_in_subset
sctest||inl1yind||concept_in_subset
gdc terminology||tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide gene||concept_in_subset
cdisc questionnaire terminology||mpai119||concept_in_subset
ctrp reference gene terminology||splicing factor, serine/arginine-rich, 2||concept_in_subset
cdisc||metacarpophalangeal joint 4||concept_in_subset
cdisc qrs terminology||revised fibromyalgia impact questionnaire||concept_in_subset
clinical data interchange standards consortium terminology||tscyc1-avoiding bad happened in past||concept_in_subset
progression_or_recurrence||not known||concept_in_subset
clinical trials reporting program disease terminology||stage iia large cell lung cancer||concept_in_subset
gdc therapeutic agent terminology||ipdr||concept_in_subset
cdisc||soluble kidney injury molecule-1 measurement||concept_in_subset
cdisc questionnaire tscc test code terminology||tscc01-having sex feelings in my body||concept_in_subset
ctrp terminology||infection, viral||concept_in_subset
loc||metacarpal bone 5||concept_in_subset
cptac chol baseline form||distal bile duct carcinoma clinical distant metastasis tnm finding v8||concept_in_subset
cdisc||drri-2 - g: health might suffer nbc agents||concept_in_subset
cdisc send chemical challenge agent name response terminology||bont/e10||concept_in_subset
clinical proteomic tumor analysis consortium terminology||m0 adult acute minimally differentiated myeloid leukemia||concept_in_subset
dev||mouthpiece||concept_in_subset
clinical trials reporting program disease terminology||stage iii thyroid gland papillary cancer||concept_in_subset
ncit antineoplastic agent terminology||sc-002||concept_in_subset
ctrp terminology||kb35 gene mutation||concept_in_subset
ncit neoplasm core terminology||primary squamous cell carcinoma of endometrium (disorder)||concept_in_subset
cdisc send biospecimens terminology||set of intercarpal joints||concept_in_subset
cdisc sdtm respiratory test name terminology||forced expiratory flow at 50 percent forced vital capacity||concept_in_subset
cdisc send terminology||degrees f (qualifier value)||concept_in_subset
nci drug dictionary terminology||thiazolidine carboxylic acid||concept_in_subset
clinical trials reporting program disease terminology||anal cancer, epidermoid carcinoma||concept_in_subset
ncit neoplasm core terminology||cystosarcoma phyllodes nos||concept_in_subset
fda structured product labeling terminology||fresh frozen plasma, human (product)||concept_in_subset
fahi||thinking is clear||concept_in_subset
university of washington quality of life scale, version 4||i am somewhat depressed about my cancer||concept_in_subset
clinical trials reporting program biomarker terminology||mb1||concept_in_subset
cdisc questionnaire terminology||iief0102||concept_in_subset
cptac terminology||tendon therapeutic procedures||concept_in_subset
sdtm-microorg||acanthamoeba polyphaga||concept_in_subset
memorial symptom assessment scale - msas||frequency of nervous feelings||concept_in_subset
health effect - clinical code||kidney insufficiency||concept_in_subset
confederated icdc terminology||study_site||concept_in_subset
cptac baseline medical forms terminology||gastric cancer pathologic primary tumor tnm finding v8||concept_in_subset
cdisc qrs terminology||css11-wish to be dead-p1m||concept_in_subset
gdc terminology||bca101||concept_in_subset
ctrp biomarker terminology||high sensitivity crp measurement||concept_in_subset
ncit neoplasm core terminology||mixed astrocytoma-ependymoma||concept_in_subset
cdisc sdtm terminology||campylobacter fetus ss. fetus (1)||concept_in_subset
clinical data interchange standards consortium terminology||analysis using pyrosequencing technique (procedure)||concept_in_subset
second_gene_symbol||ptc4-ret fusion gene||concept_in_subset
clinical data interchange standards consortium terminology||h.g/ml/(mg/g)||concept_in_subset
sdtm||fac006-losing hope against illness||concept_in_subset
cptac cesc baseline form||cervical carcinoma pt1b1 tnm finding v8||concept_in_subset
cdisc questionnaire pedsql neuromuscular module acute version 3.0 young adult report test name terminology||pql1015||concept_in_subset
cdisc variable terminology||vsorresu||concept_in_subset
gdc terminology||spinal meninges||concept_in_subset
cdisc||haq0120||concept_in_subset
ncit covid-19 agent terminology||vadadustat||concept_in_subset
cdisc||cartilage, nos||concept_in_subset
clinical trials reporting program terminology||her-2/neu c.2606t>g||concept_in_subset
ctrp terminology||unresectable digestive system mixed adenoneuroendocrine carcinoma||concept_in_subset
bridg terminology||performed activity ordered number of repeats||concept_in_subset
spl drug route of administration terminology||enteralroute||concept_in_subset
nci drug dictionary terminology||wheat germ juice||concept_in_subset
ncit antineoplastic agent terminology||dovitinib||concept_in_subset
clinical trials reporting program terminology||mr-guided sbrt||concept_in_subset
cdisc questionnaire rdq test code terminology||rdq0115||concept_in_subset
european quality of life five dimension three level scale questionnaire test name||eq5d0102||concept_in_subset
gene2||myd88 innate immune signal transduction adaptor||concept_in_subset
cellosaurus disease terminology||peritoneum; mesothelioma||concept_in_subset
ncit covid-19 agent terminology||ledipasvir, sofosbuvir drug combination||concept_in_subset
ctrp biomarker terminology||il21r||concept_in_subset
send||auc infinity obs||concept_in_subset
qs-c-ssrs baseline/screening version testcd||css0420b||concept_in_subset
ctrp terminology||hire1p||concept_in_subset
ctrp biomarker terminology||glycogen synthase kinase 3 beta||concept_in_subset
cdisc-variable||tutestcd||concept_in_subset
clinical trials reporting program disease terminology||gestational trophoblastic tumor, metastatic, poor prognosis||concept_in_subset
fda unii code terminology||tbg-mino||concept_in_subset
nichd terminology||placenta, multilobate||concept_in_subset
fda unii code terminology||sodium tripolyphosphate anhydrous||concept_in_subset
cdisc send terminology||gbq||concept_in_subset
sdtm||pul 1.2 - push on the light||concept_in_subset
cdisc sdtm terminology||(l/d)/(ug/m2)||concept_in_subset
hospital anxiety and depression scale questionnaire test code||hads - i feel restless as if i have to be on the move||concept_in_subset
gdc terminology||tsa||concept_in_subset
fda established names and unique ingredient identifier codes terminology||(1r,4s,5s,6s)-4-(l-methionylamino)-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic acid 2,2-dioxide monohydrate||concept_in_subset
sgrq02tn||sgrq past 4 weeks version - cannot move far from bed or chair||concept_in_subset
laboratory test code||catninb||concept_in_subset
ccq02tn||ccq0205||concept_in_subset
cdisc terminology||blcs0104||concept_in_subset
fda unii code terminology||sodium stearate||concept_in_subset
pediatric adverse events terminology||collapse - lung||concept_in_subset
clinical data interchange standards consortium terminology||datamonitoringcommitteeindicator||concept_in_subset
gdc therapeutic agent terminology||danusertib||concept_in_subset
clinical trials reporting program disease terminology||somatostatin producing carcinoma||concept_in_subset
laboratory test name||adpnctn||concept_in_subset
ctrp disease terminology||stage ii adult contiguous non-hodgkin's lymphoma||concept_in_subset
cdisc sdtm laboratory test terminology by name||c165880||concept_in_subset
cellosaurus disease terminology||edmd2 - autosomal dominant emery-dreifuss muscular dystrophy||concept_in_subset
clinical trials reporting program biomarker terminology||ask1 protein, human||concept_in_subset
clinical trials reporting program biomarker terminology||angiopoietin-3||concept_in_subset
ctrp molecular genetic biomarker terminology||abraxas||concept_in_subset
fda unii code terminology||tiropramida||concept_in_subset
clinical data interchange standards consortium glossary||ethics committee||concept_in_subset
ctrp disease terminology||stage iia skin melanoma ajcc v7||concept_in_subset
ctrp terminology||steroid 5 alpha-reductase 1||concept_in_subset
cptac blca baseline form||skip to next section if no||concept_in_subset
cdisc sdtm ecg test terminology by code||qrs duration, single beat||concept_in_subset
sdtm||annum||concept_in_subset
sdtm||genus pestalotiopsis||concept_in_subset
cdisc terminology||fac01822||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||pkr2||concept_in_subset
cdisc send terminology||target cells||concept_in_subset
sdtm-method||chemiluminescent magnetic microparticle immunoassay||concept_in_subset
cdisc terminology||ivcpp||concept_in_subset
qscat||oab-q short form||concept_in_subset
cptac neoplasms codelist||lymphoma, true histiocytic||concept_in_subset
ctrp terminology||cd87 antigen, human||concept_in_subset
cdisc send terminology||sézary cell to lymphocyte ratio measurement||concept_in_subset
cts-api disease main type terminology||[m]lymphoid leukaemias||concept_in_subset
cdisc qrs terminology||fac100-sev: talking while walk why not||concept_in_subset
cellosaurus disease terminology||iron-56 ion irradiation||concept_in_subset
cptac lung squamous cell carcinoma and lung adenocarcinoma baseline form||egfr mutation analysis testing method||concept_in_subset
cptac neoplasms codelist||recurrence||concept_in_subset
cdisc questionnaire pedsql neuromuscular module version 3.0 young adult report test code terminology||pql01-legs hurt||concept_in_subset
aml table terminology||whole body irradiation||concept_in_subset
gdc treatment type terminology||hormonal therapies||concept_in_subset
gdc terminology||lymphoma mature t-cell subcutaneous panniculitis-like||concept_in_subset
cdisc||vfq25-interviewer administered format - limited in how long you can work because of vision||concept_in_subset
clinical trials reporting program terminology||lymphoplasmacytoid lymphoma/immunocytoma stage iv||concept_in_subset
us counties terminology||milam county, texas||concept_in_subset
clinical trials reporting program disease terminology||stage iii esophageal squamous cell cancer||concept_in_subset
fda established names and unique ingredient identifier codes terminology||crescendo||concept_in_subset
sdtm||nonrenal cl norm by wt||concept_in_subset
clinical data interchange standards consortium terminology||avmetsuv||concept_in_subset
gdc value terminology||hmgic||concept_in_subset
ctrp terminology||rp3500||concept_in_subset
clinical trials reporting program biomarker terminology||ldp1||concept_in_subset
cdisc sdtm country terminology||st. helena||concept_in_subset
cdisc sdtm terminology||swls01-my life conditions are excellent||concept_in_subset
clinical trials reporting program reference gene terminology||ikaros||concept_in_subset
cdisc questionnaire terminology||drri1a03||concept_in_subset
cdisc||phialophoras||concept_in_subset
gdc value terminology||oral pain, ctcae 5.0||concept_in_subset
acute myeloid leukemia variable terminology||disease response||concept_in_subset
icdc fss breeds||appenzeller sennenhunde||concept_in_subset
sdtm-microorg||bifidobacterium angulatum scardovi and crociani 1974||concept_in_subset
gdc therapeutic agent terminology||tespa||concept_in_subset
fda unii code terminology||product containing dichlorisone (medicinal product)||concept_in_subset
clinical trials reporting program terminology||rbl2 wt allele||concept_in_subset
cptac codelists terminology||bone sarcoma||concept_in_subset
cptac codelists terminology||tns - transcut nerve stimulatn||concept_in_subset
sdtm-pkuwkg||day*ng/ml/ug||concept_in_subset
ctrp molecular genetic biomarker terminology||a170||concept_in_subset
clinical trials reporting program agent terminology||fidaxomicin (product)||concept_in_subset
mapped icdo3.2 terminology||germ cell tumor, nonseminomatous (morphologic abnormality)||concept_in_subset
cdisc sdtm terminology||c-ssrs baseline - preparatory acts or behaviors toward suicide attempt||concept_in_subset
cdisc||sgrq0113||concept_in_subset
ctrp terminology||syndecan 2 wt allele||concept_in_subset
cptac baseline medical forms terminology||did the individual have multiple known primary tumors at initial melanoma diagnosis||concept_in_subset
inc-meddra neonatal adverse events terminology||grade 1 neonatal convulsion||concept_in_subset
gdc terminology||a167||concept_in_subset
cdisc||ect||concept_in_subset
sdtm||quasi-static compliance||concept_in_subset
sdtm||bee mix antigen igg4 antibody||concept_in_subset
cdisc terminology||collinsella intestinalis (organism)||concept_in_subset
gdc value terminology||cyclin c gene||concept_in_subset
send||juvenile studies||concept_in_subset
ctrp molecular genetic biomarker terminology||cach3||concept_in_subset
cdisc questionnaire terminology||fac06133||concept_in_subset
fda unii code terminology||3-(4-(2-chlorophenyl)-9-methyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-2-yl)-1-(4-morpholinyl)-1-propanone||concept_in_subset
ps||brain coverings||concept_in_subset
clinical trials reporting program agent terminology||propanimidamide, 3-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-n-(aminosulfonyl)-||concept_in_subset
cdisc terminology||lead site v3||concept_in_subset
second_gene_symbol||homeo box hb9||concept_in_subset
fda established names and unique ingredient identifier codes terminology||beta-naphthol (substance)||concept_in_subset
clinical trials reporting program biomarker terminology||pth1||concept_in_subset
cptac glioblastoma multiforme follow-up form||was adjuvant post-operative targeted molecular therapy administered||concept_in_subset
agent||tqb 3602||concept_in_subset
dataf||portable document format||concept_in_subset
clinical trials reporting program biomarker terminology||cellular retinoic acid binding protein 1 wt allele||concept_in_subset
genomics data commons terminology||mixed cell adenoma||concept_in_subset
therapeutic_agents||kn 044||concept_in_subset
annex f||serious public health threat||concept_in_subset
sdtm-microorg||achorion schoenleinii||concept_in_subset
cptac codelists terminology||occlusion of colon or intestine nos||concept_in_subset
nichd terminology||idiopathic hydrops foetalis||concept_in_subset
clinical trials reporting program terminology||nfib||concept_in_subset
cptac pancreatic baseline form||syndrome, peutz-jegher's||concept_in_subset
fda unii code terminology||pirbuterol (substance)||concept_in_subset
acute myeloid leukemia variable terminology||transient abnormal myelopoiesis||concept_in_subset
cdisc questionnaire terminology||sf361-limit walking more than a mile||concept_in_subset
ncit covid-19 agent terminology||bcg vaccine||concept_in_subset
seq12||more or less sure||concept_in_subset
fda established names and unique ingredient identifier codes terminology||n-(3-tetrahydrofuranyl)-6-aminopurine riboside||concept_in_subset
gdc value terminology||exposure to wood dust||concept_in_subset
sdtm domain abbreviation||ho||concept_in_subset
fda established names and unique ingredient identifier codes terminology||tert-amyloxycarbonyltetragastrin||concept_in_subset
fda unii code terminology||vestronidase alfa-containing product||concept_in_subset
cptac baseline medical forms terminology||nm_002524.4:c.181c>a||concept_in_subset
fda established names and unique ingredient identifier codes terminology||radium 223 dichloride||concept_in_subset
ewing sarcoma demographics table||black or african-american||concept_in_subset
cptac prostate adenocarcinoma baseline form||specify number of lymph nodes positive for tumor by ihc staining only||concept_in_subset
qs-nps testcd||nps - tell us how intense your pain is||concept_in_subset
wpai02tc||wpai-gh version 2 - problems affect productivity||concept_in_subset
bsp||met_non_lung_mgmt||concept_in_subset
gdc terminology||glembatumumab vedotin||concept_in_subset
cdisc qrs terminology||adcdrl01||concept_in_subset
ncit antineoplastic agent terminology||mk-8353||concept_in_subset
bridg class and attribute terminology||id.effectivedaterange||concept_in_subset
cdisc sdtm terminology||junctional premature depolarization||concept_in_subset
clinical trials reporting program terminology||breast densities||concept_in_subset
cdisc||bpi1-pain interfered walking ability||concept_in_subset
fda established names and unique ingredient identifier codes terminology||taldefgrobep alfa||concept_in_subset
rps terminology||notification of charging under treatment ind||concept_in_subset
cdisc sdtm terminology||gds0119||concept_in_subset
clinical trials reporting program biomarker terminology||rp11-264j4.7||concept_in_subset
edqm-hc pharmaceutical dosage form terminology||concentrate for dip suspension||concept_in_subset
send||astck||concept_in_subset
ctrp disease terminology||stage iib appendix carcinoma||concept_in_subset
fda established names and unique ingredient identifier codes terminology||cilobamine||concept_in_subset
cdisc questionnaire terminology||fact-l version 4 - i have a lack of energy||concept_in_subset
cdisc qrs terminology||epic206c||concept_in_subset
fda unii code terminology||tretamine||concept_in_subset
clinical trials reporting program terminology||blf supplement||concept_in_subset
mapped icdo3.2 morphology terminology||tubulovillous adenoma, nos||concept_in_subset
clinical trials reporting program agent terminology||sodabic||concept_in_subset
ncit neoplasm core terminology||breast adenoid cystic carcinoma||concept_in_subset
fda unii code terminology||sweet sedge||concept_in_subset
cdisc questionnaire fact-bmt version 4 test name terminology||fact-bmt version 4 - i am interested in sex||concept_in_subset
cptac terminology||fundus structure of stomach||concept_in_subset
clinical trials reporting program biomarker terminology||hei10/hmgic fusion gene||concept_in_subset
clinical trials reporting program disease terminology||activating c-ros-1 gene mutation negative||concept_in_subset
cdisc qrs terminology||tscyc130||concept_in_subset
ctrp molecular genetic biomarker terminology||major histocompatibility complex, class i, b wt allele||concept_in_subset
aml concomitant medication table||disease phases||concept_in_subset
us counties terminology||mccormick county, sc||concept_in_subset
fda unii code terminology||cefoperazono||concept_in_subset
gdc terminology||glaucarubolone||concept_in_subset
fda unii code terminology||dexamisole||concept_in_subset
clinical trials reporting program terminology||mcph1||concept_in_subset
ctrp disease terminology||stage i colorectal carcinoma ajcc v8||concept_in_subset
ctrp agent terminology||product containing canakinumab||concept_in_subset
cdisc sdtm terminology||vaccines technical specification guidance v1.0||concept_in_subset
pharmacotherapy regimens||zejula regimen||concept_in_subset
mapped icd-o-3.1 morphology terminology||verrucous carcinoma (diagnosis)||concept_in_subset
send trial summary parameter test code||test facility location||concept_in_subset
10 promis global health||in the past 7 days, how would you rate your fatigue on average||concept_in_subset
fda center for devices and radiological health terminology||bushing||concept_in_subset
ctrp terminology||atpase, na+/k+ transporting, alpha 1 polypeptide||concept_in_subset
cdisc variable terminology||sudostot||concept_in_subset
qs-adni avlt test||avl01-list a intrusions 1||concept_in_subset
national cancer institute drug dictionary||mr1-1||concept_in_subset
nci drug dictionary terminology||allogeneic mov19 car-cd3zeta-4-1bb-expressing t-lymphocytes||concept_in_subset
clinical proteomic tumor analysis consortium terminology||robotic-assisted surgery||concept_in_subset
columbia-suicide severity rating scale since last visit questionnaire test code||c-ssrs since last visit - reasons for most severe ideation||concept_in_subset
us counties terminology||sedgwick county, colorado||concept_in_subset
fda center for devices and radiological health terminology||safety interlock||concept_in_subset
cdisc terminology||avl01065||concept_in_subset
fda unii code terminology||altabax||concept_in_subset
cdisc sdtm terminology||drri-2 - k: made crude sexual remarks at me||concept_in_subset
cdisc clinical classification panss test code terminology||panss109||concept_in_subset
qs-pedsql neuromuscular module acute version 3.0 parent report for child test||pql1521||concept_in_subset
ectd application type||new drug application||concept_in_subset
clinical proteomic tumor analysis consortium terminology||targeted molecular therapy was administered as an additional treatment for a new tumor event||concept_in_subset
clinical trials reporting program terminology||ddit4 wt allele||concept_in_subset
the health care climate questionnaire (hccq)||i feel understood by my physician||concept_in_subset
fda unii code terminology||dietary aluminum||concept_in_subset
clinical trials reporting program terminology||gnai2b protein, human||concept_in_subset
cdisc sdtm pharmacokinetic parameter short name terminology||c0||concept_in_subset
genomics data commons terminology||vofatamab||concept_in_subset
ctrp terminology||stage ivb colon cancer ajcc v8||concept_in_subset
qs-c-ssrs lifetime/recent version testcd||c-ssrs lifetime/recent version - duration of most severe ideation (past 1 month)||concept_in_subset
clinical data interchange standards consortium terminology||virologic failure||concept_in_subset
gdc terminology||visceral arterial ischemia, ctcae||concept_in_subset
sdtm||vfq1-worry i'll do embarrassing things||concept_in_subset
laboratory test code||helmetce||concept_in_subset
cdisc qrs terminology||sgrq01-how long worst resp attack last||concept_in_subset
clinical proteomic tumor analysis consortium terminology||abnormal finding||concept_in_subset
cdisc||blunt-tipped||concept_in_subset
fda unii code terminology||timigutuzumab||concept_in_subset
fda established names and unique ingredient identifier codes terminology||pbi-shrna stmn1 lp||concept_in_subset
ctrp terminology||homeobox protein six4||concept_in_subset
clinical proteomic tumor analysis consortium terminology||mixed adenocarcinoma of the stomach||concept_in_subset
sdtm-cvfatscd||symptom onset date||concept_in_subset
agent||pz01||concept_in_subset
cdisc send terminology||mucosal route of administration||concept_in_subset
fda established names and unique ingredient identifier codes terminology||product containing magnesium sulfate (medicinal product)||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||human herpesvirus-8 replication transactivation activator gene||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||serine/arginine-rich splicing factor 2 protein variant||concept_in_subset
ctrp biomarker terminology||ebf1-pdgfrb fusion protein||concept_in_subset
cdisc sdtm terminology||r360104||concept_in_subset
sdtm||kfss1-weakness interferes with testing||concept_in_subset
sdtm||percent change from nadir in sum of diameter||concept_in_subset
cptac terminology||anemia; deficiency, iron||concept_in_subset
cdisc terminology||globicatella sulfidifaciens (organism)||concept_in_subset
genomics data commons terminology||gingival pain, ctcae||concept_in_subset
qs-expanded drs-pi caregiver version test||expanded drs-pi caregiver version - need 24-hour care||concept_in_subset
cptac neoplasms codelist||malignant neoplasm of oral cavity||concept_in_subset
clinical data interchange standards consortium terminology||hypertext||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||ywhaz||concept_in_subset
genomics data commons terminology||phenylbutyric acid nitrogen mustard||concept_in_subset
cdisc questionnaire terminology||adcs-adl severe dementia||concept_in_subset
clinical trials reporting program terminology||v-crk avian sarcoma virus ct10 oncogene homolog-like||concept_in_subset
suicidal ideation questionnaire test name||siq01-my life was too rotten to continue||concept_in_subset
qs-ids-sr testcd||idsr1-energy level||concept_in_subset
national cancer institute drug dictionary||exemestano||concept_in_subset
ctrp molecular genetic biomarker terminology||alpha-l-iduronidase, human||concept_in_subset
nichd terminology||sertoli cell adenomas||concept_in_subset
oncrsr||increases||concept_in_subset
ctrp agent terminology||florbetaben (18-f) (substance)||concept_in_subset
ncit antineoplastic agent terminology||so c101||concept_in_subset
pharmacotherapy regimens||cvd regimen||concept_in_subset
gdc value terminology||mhl||concept_in_subset
cdisc qrs terminology||lec-5 standard version - life-threatening illness: learned||concept_in_subset
nichd terminology||hypothyroid goiter||concept_in_subset
cptac follow-up forms terminology||unknown use of menopausal hormone therapy||concept_in_subset
aml total dose table||medication_course_number||concept_in_subset
send||liter/second/kilopascal (qualifier value)||concept_in_subset
mapped icdo3.1 morphology pt terminology||adenoca+spindle cell metaplas||concept_in_subset
send||muscle tremor artifact||concept_in_subset
cdisc terminology||mixed agonist-antagonist||concept_in_subset
sdtm||iscdind||concept_in_subset
ncit antineoplastic agent terminology||recombinant human interferon-alfa-2a||concept_in_subset
biomedical research integrated domain group model terminology||performed genetic observation result genetic region of interest||concept_in_subset
clinical trials reporting program biomarker terminology||gf1 gene mutation||concept_in_subset
pcc||fullterm births||concept_in_subset
ctrp biomarker terminology||hoxc11||concept_in_subset
ctrp intervention terminology||antisense therapy||concept_in_subset
cts-api disease category terminology||fallopian tube, carcinoma||concept_in_subset
ctrp biomarker terminology||t(2;13)||concept_in_subset
cdisc qrs terminology||css0406b||concept_in_subset
cdisc questionnaire terminology||sf36411d||concept_in_subset
mapped icd-o-3.2 morphology terminology||glucagon-producing tumor of the islet cells||concept_in_subset
fda established names and unique ingredient identifier codes terminology||protizinic acid||concept_in_subset
clinical trials reporting program intervention terminology||delphi technic||concept_in_subset
method||slit-lamp tests||concept_in_subset
wechsler preschool and primary scale of intelligence - fourth edition||wisc-v vocabulary||concept_in_subset
clinical data interchange standards consortium terminology||epic206c||concept_in_subset
cdisc qrs terminology||css1016a||concept_in_subset
ncit antineoplastic agent terminology||vx803||concept_in_subset
gdc therapeutic agent terminology||dual-affinity retargeting protein mgd019||concept_in_subset
columbia-suicide severity rating scale lifetime/recent version questionnaire test name||css1106b||concept_in_subset
mapped icdo3.1 morphology pt terminology||non-infiltrating ductal carcinoma and infiltrating lobular carcinoma||concept_in_subset
ctrp intervention terminology||photopheresis extracorporeal||concept_in_subset
cellosaurus disease terminology||osteogenesis imperfecta type iv (diagnosis)||concept_in_subset
haq01tc||haq-di with vas - aids or devices - long-handled appliances for reach||concept_in_subset
fda established names and unique ingredient identifier codes terminology||hcl, rilpivirine||concept_in_subset
ctrp intervention terminology||immune function testing||concept_in_subset
cdisc sdtm terminology||adl03-talk about tv content within a day||concept_in_subset
sdtm-lbtest||chloride clearance measurement||concept_in_subset
cdash||by inhalation (route)||concept_in_subset
spl ucum terminology||homeopathic potency of millesimal series||concept_in_subset
send-chagnamr||bont/b8||concept_in_subset
ncit antineoplastic agent terminology||pen-866||concept_in_subset
nichd terminology||doppler velocimetry, fetal||concept_in_subset
sdtm-lbtestcd||oxyhemoglobin measurement||concept_in_subset
gdc vital status terminology||not_reported||concept_in_subset
ctrp disease terminology||recurrent gliomatosis cerebri||concept_in_subset
prognosis treatment and perceptions questionnaire (ptpq)||how helpful has knowing about your prognosis been for making decisions about treatment||concept_in_subset
send-nonneo||hypospermatogenesis||concept_in_subset
cdisc||total clearance predicted normalized by body mass index||concept_in_subset
national cancer institute drug dictionary||lenograstim||concept_in_subset
cptac baseline medical forms terminology||how old were you when you first smoked a cigarette (even one or two puffs)||concept_in_subset
cptac head and neck squamous cell carcinoma baseline form||karnofsky performance status 60||concept_in_subset
clinical trials reporting program terminology||refractory endometrial dedifferentiated carcinoma||concept_in_subset
ctrp agent terminology||gsk-2241658a||concept_in_subset
cdisc qrs terminology||dad01-decide to wash||concept_in_subset
ctrp agent terminology||anti-cd70 moab sgn70-mmaf conjugate||concept_in_subset
cdisc sdtm terminology||title||concept_in_subset
cdisc qrs terminology||hamd-21 - diurnal variation||concept_in_subset
pharmaceutical dosage form||suspension for suspension for injection||concept_in_subset
cdisc sdtm terminology||nccn-fact fosi-18 version 2||concept_in_subset
ctrp biomarker terminology||chromosome 3 distal arm||concept_in_subset
clinical trials reporting program biomarker terminology||v-rel avian reticuloendotheliosis viral oncogene homolog b (nuclear factor of kappa light polypeptide gene enhancer in b-cells 3)||concept_in_subset
stability study data file reason terminology||generic investigational new animal drug file||concept_in_subset
cdisc send terminology||arbitrary unit of immunoglobulin g isotype for phospholipid antigen (qualifier value)||concept_in_subset
fda unii code terminology||cyclazodone||concept_in_subset
sf363tn||sf-36 v2.0 standard - felt down nothing cheer you up||concept_in_subset
cdisc cdash variable terminology||sudur||concept_in_subset
cptac thyroid carcinoma baseline form||differentiated and anaplastic thyroid carcinoma pn1b tnm finding v8||concept_in_subset
cdisc sdtm terminology||nash fibrosure formula||concept_in_subset
qs-pedsql neuromuscular module version 3.0 young child report test||pedsql neuromuscular module version 3.0 young child report - feel tired||concept_in_subset
clinical proteomic tumor analysis consortium terminology||[m]acute lymphoid leukemia||concept_in_subset
ctrp disease terminology||stage i colon neuroendocrine tumor||concept_in_subset
clinical trials reporting program terminology||health promotion education (regime/therapy)||concept_in_subset
clinical data interchange standards consortium terminology||proximal phalanx 2 of the hand||concept_in_subset
ctrp molecular genetic biomarker terminology||ip protein, human||concept_in_subset
qs-rand-36 v1.0 test||rand-36 - health limit vigorous activities||concept_in_subset
cdisc qrs terminology||coronary thrombus timi grade clinical classification||concept_in_subset
laboratory test code||immunoglobulin g to albumin ratio measurement||concept_in_subset
us counties terminology||trimble county, ky||concept_in_subset
ncit covid-19 terminology||lyophilized rad26/rad5-expressing sars-cov-2 sp vaccine gam-covid-vac lyo||concept_in_subset
ncpdp strength unit of measure terminology||mg (qualifier value)||concept_in_subset
cdisc||hepatitis e virus antibody measurement||concept_in_subset
ctrp disease terminology||recurrent malignant extragonadal non-seminomatous germ cell tumor||concept_in_subset
clinical trials reporting program biomarker terminology||zglp1||concept_in_subset
cdisc send terminology||basic oestrogen: 17-b-oestriol (& level)||concept_in_subset
clinical data interchange standards consortium terminology||cervicovaginal secretion||concept_in_subset
cptac renal cell carcinoma follow-up form||type of new tumor event (check all that apply)||concept_in_subset
send||c130094||concept_in_subset
cdisc||avl01132||concept_in_subset
ctrp terminology||teclistamab||concept_in_subset
cdisc-variable||pporresu||concept_in_subset
cdisc terminology||send-bodsys||concept_in_subset
fda established names and unique ingredient identifier codes terminology||tizolemide||concept_in_subset
cdisc questionnaire terminology||css0409b||concept_in_subset
ctrp terminology||egfr np_005219.2:p.d770_n771insgd||concept_in_subset
ctrp terminology||mage-a3 tcr-transduced autologous t cells||concept_in_subset
cdisc terminology||diagnostic doppler ultrasonography (procedure)||concept_in_subset
us counties terminology||maverick county||concept_in_subset
ewing sarcoma permissible value terminology||trm||concept_in_subset
gdc terminology||etrumadenant||concept_in_subset
cellosaurus disease terminology||rabbit cutaneous lymphoma||concept_in_subset
cptac baseline medical forms terminology||schistosomiasis||concept_in_subset
cdisc-obscls||flrt||concept_in_subset
adverse_event||lymphocyte count increased, ctcae||concept_in_subset
bridg class and attribute terminology||submissionunit.receiptdate||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||cytochrome p450, subfamily xxiv (vitamin d 24-hydroxylase)||concept_in_subset
send||basophilic leukocytosis||concept_in_subset
spl terminology||intralesional route (qualifier value)||concept_in_subset
ctrp terminology||chemokine, cc motif, ligand 1 gene||concept_in_subset
ctrp terminology||2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-beta-d-ribofuranosyl)-||concept_in_subset
cdisc sdtm holter ecg results terminology||polymorphic ventricular tachycardia by ekg finding||concept_in_subset
cptac cholangiocarcinoma baseline form||ishak fibrosis score||concept_in_subset
nichd terminology||adenoma, prolactin secreting||concept_in_subset
fda center for devices and radiological health terminology||pyelonephritis, nos||concept_in_subset
pediatric adverse events terminology||ulcer of skin, nos||concept_in_subset
cdisc||site, injury||concept_in_subset
agent||fianlimab||concept_in_subset
sdtm microscopic findings test name||proto-oncogene tyrosine-protein kinase ros measurement||concept_in_subset
cptac uterine corpus endometrial carcinoma baseline form||month-day-year||concept_in_subset
biomedical research integrated domain group model terminology||revisionreasoncode||concept_in_subset
clinical trials reporting program agent terminology||suba-itraconazole (medication)||concept_in_subset
fda unii code terminology||antiarrhythmics lorcainide hydrochloride||concept_in_subset
sdtm||egrepltr||concept_in_subset
cdisc||parakeratotic papilloma||concept_in_subset
ncit neoplasm core terminology||colorectal small cell carcinoma||concept_in_subset
cdisc qrs terminology||odi v2.1a - standing||concept_in_subset
clinical trials reporting program biomarker terminology||nuclear receptor subfamily 1 group i member 3||concept_in_subset
cdisc questionnaire podci pediatric parent-reported version test name terminology||podci1-able to do activities at home||concept_in_subset
clinical data interchange standards consortium terminology||npi - awaken too early in morning||concept_in_subset
nichd terminology||pulmonary valve atresia with ventricular septal defect||concept_in_subset
cdisc protocol terminology||tphase||concept_in_subset
american college of cardiology/american heart association pediatric and congenital cardiology terminology||left upper sternal border||concept_in_subset
gdc terminology||2-hydroxyflutamide controlled-release formulation||concept_in_subset
clinical trials reporting program terminology||p53 loss of function gene mutation||concept_in_subset
cdisc questionnaire terminology||ibdq - felt frustrated||concept_in_subset
genomics data commons terminology||1h-pyrrole-2-carboxamide, n-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1h-pyrrol-3-yl)-4-(((4-((4-(bis(2-chloroethyl)amino)benzoyl)amino)-1-methyl-1h-pyrrol-2-yl)carbonyl)amino)-1-methyl-||concept_in_subset
mapped icdo3.1 terminology||waldenström; macroglobulinemia||concept_in_subset
mapped icdo3.2 morphology pt terminology||ismcn||concept_in_subset
sdtm||css0511a||concept_in_subset
cptac melanoma baseline form||pathologic stage ia cutaneous melanoma ajcc v8||concept_in_subset
icdc fss breeds||australian kelpie||concept_in_subset
clinical trials reporting program terminology||alcohol-related hepatocellular carcinoma||concept_in_subset
pediatric adverse events terminology||drug eruptions fixed||concept_in_subset
agent||90y-imp288||concept_in_subset
gdc value terminology||ffpe recurrent||concept_in_subset
neoplasm type||adenoma, amphophilic vacuolar||concept_in_subset
cptac cholangiocarcinoma baseline form||stage iiia extrahepatic (distal) bile duct cancer||concept_in_subset
mapped icd-o-3.2 terminology||teratoma; malignant, trophoblastic, unspecified site||concept_in_subset
clinical trials reporting program biomarker terminology||osteoprotegerin ligand, human||concept_in_subset
ctrp biomarker terminology||hin-1||concept_in_subset
sdtm-microorg||clostridioides difficile (organism)||concept_in_subset
ctrp molecular genetic biomarker terminology||cell division cycle-associated protein 8||concept_in_subset
therapeutic_agents||adebrelimab||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||mip-3-beta||concept_in_subset
cdisc clinical classification hamd 21 test name terminology||hamd2-anxiety psychological||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||rb gene mutation||concept_in_subset
genomics data commons terminology||mandible, nos||concept_in_subset
ctrp reference gene terminology||zinc finger and ring finger protein 3||concept_in_subset
sdtm||han chinese||concept_in_subset
clinical trials reporting program biomarker terminology||mage-12 antigen positive||concept_in_subset
the short form 36 health survey standard, us version 2.0 questionnaire test name||sf363-emotional: accomplished less||concept_in_subset
ctrp molecular genetic biomarker terminology||retinoic acid-binding protein, cellular, type ii||concept_in_subset
fda established names and unique ingredient identifier codes terminology||amantadine sulfate||concept_in_subset
cptac follow-up forms terminology||unknown outcome||concept_in_subset
us counties terminology||marquette county, mi||concept_in_subset
gdc terminology||aleukemic lymphoid leukemia||concept_in_subset
cdisc||modified release tablet dosage form||concept_in_subset
microorganism||campylobacter fetus ss. fetus (1)||concept_in_subset
cdisc sdtm microorganism terminology||megamonas hypermegale corrig. (harrison and hansen 1963) shah and collins 1983||concept_in_subset
pediatric adverse events terminology||toxic erythema of chemotherapy||concept_in_subset
cdisc sdtm unit of measure terminology||milliliter per minute per 1.73 m2 of body surface area||concept_in_subset
cptac treatments codelist||hypnotx ndvdl ea.15min||concept_in_subset
cptac sarcoma follow-up form||adjuvant post-operative radiation therapy was not administered||concept_in_subset
pediatric endocrinology terminology||pseudo-turner syndrome||concept_in_subset
ncit antineoplastic agent terminology||allodepleted t cell immunotherapeutic atir101||concept_in_subset
nichd terminology||third degree perineal laceration (physical finding)||concept_in_subset
fda unii code terminology||uredo maydis||concept_in_subset
cdisc questionnaire terminology||gose1-assistance at home before injury||concept_in_subset
acute myeloid leukemia table terminology||(+)-daunomycin||concept_in_subset
procedure||left atrial appendage occlusion||concept_in_subset
ctrp disease terminology||glial tumor||concept_in_subset
cdisc sdtm terminology||tscyc1-being bothered by memories||concept_in_subset
european directorate for the quality of medicines and healthcare controlled vocabularies||oral powder in sachet||concept_in_subset
send||wall of right ventricle||concept_in_subset
clinical trials reporting program biomarker terminology||v-ki-ras2 kirsten rat sarcoma viral oncogene homolog c.34_36ggt>tgc||concept_in_subset
cdisc qrs terminology||hcs0108||concept_in_subset
ctrp terminology||adenosquamous cell lung cancer stage ii||concept_in_subset
fda unii code terminology||diethadione||concept_in_subset
alzheimer's disease cooperative study-activities of daily living inventory severe dementia version questionnaire test code||adcs-adl severe dementia - dispose of garbage in appropriate place at home||concept_in_subset
ctrp reference gene terminology||ct111||concept_in_subset
clinical trials reporting program biomarker terminology||microtubule affinity regulating kinase 2||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||her1 c.2303g>t||concept_in_subset
clinical trials reporting program disease terminology||recurrent carcinoma of unknown primary||concept_in_subset
cdisc send terminology||non-esterified fatty acid, saturated||concept_in_subset
clinical trials reporting program biomarker terminology||bcor-l1||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||dj400n23||concept_in_subset
sdtm-method||hplc-fl||concept_in_subset
cdisc questionnaire whodas 2.0 12+24-item version interviewer-administered test code terminology||wd4d2_4||concept_in_subset
cdrh medical device problem code terminology||image display error/artifact||concept_in_subset
world health organization disability assessment schedule 2.0 - 36-item interviewer questionnaire test name||wd5d4_5||concept_in_subset
cdisc questionnaire terminology||wpai02-hours actually work||concept_in_subset
genomics data commons terminology||horn cyst||concept_in_subset
cdisc qrs terminology||siqr0112||concept_in_subset
cdisc terminology||aeromonas schubertii||concept_in_subset
clinical trials reporting program terminology||poly(adp-ribose) polymerase 2 gene||concept_in_subset
clinical proteomic tumor analysis consortium terminology||substantia alba||concept_in_subset
ncit antineoplastic agent terminology||autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes||concept_in_subset
gdc terminology||dcis grade 3||concept_in_subset
fda unii code terminology||proquinolate||concept_in_subset
ctrp terminology||locally advanced gastric carcinoma||concept_in_subset
pediatric infectious disease terminology||chikungunya; fever||concept_in_subset
clinical trials reporting program terminology||8-aminoisoindolo(1,2-b)quinazolin-12(10h)-one||concept_in_subset
cdisc questionnaire terminology||mnsi1-are your legs and/or feet numb||concept_in_subset
gdc terminology||musculoskeletal deformity, ctcae||concept_in_subset
cdisc||category of questionnaire||concept_in_subset
european directorate for the quality of medicines and healthcare units of presentation||{jar}||concept_in_subset
genomics data commons terminology||white carrot||concept_in_subset
clinical trials reporting program agent terminology||n-(4-{[(5r)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1h-1-benzazepin-1-yl]carbonyl}-3-methylphenyl)-2-methylbenzamide||concept_in_subset
clinical trials reporting program biomarker terminology||kiaa1549 wt allele||concept_in_subset
ctrp biomarker terminology||acsl6/etv6 fusion protein||concept_in_subset
clinical trials reporting program disease terminology||neoplastic plasma cells under 5 percent of bone marrow nucleated cells||concept_in_subset
cdisc questionnaire fact-brm version 4 test name terminology||fac06221||concept_in_subset
neuro-qol||my thinking was slow||concept_in_subset
ctrp disease terminology||l2 acute lymphoblastic leukemia, adult||concept_in_subset
geopolitical entities, names, and codes terminology||gtm||concept_in_subset
fda emanufacturing terminology||production/fractionation, intermediate paste/animal blood, blood products||concept_in_subset
cptac clear cell renal cell carcinoma baseline form||unifocal lesion||concept_in_subset
ctrp terminology||vitamin b>3<||concept_in_subset
gdc value terminology||ileal obstruction, ctcae||concept_in_subset
cdisc questionnaire terminology||number cancellation: errors||concept_in_subset
cdisc terminology||galactose-specific lectin 3||concept_in_subset
cptac melanoma baseline form||2||concept_in_subset
cdisc sdtm anatomical location terminology||atrial||concept_in_subset
position||reverse trendelenburg||concept_in_subset
acute myeloid leukemia permissible value terminology||acute myeloid leukemia with mutated npm1 (morphologic abnormality)||concept_in_subset
cptac pancreatic ductal adenocarcinoma follow-up form||patient lost to follow-up||concept_in_subset
nrnt||pneumopericardium||concept_in_subset
ctrp molecular genetic biomarker terminology||eml4-alk variant 5 splicing isoform a fusion gene||concept_in_subset
sdtm||bdi0104||concept_in_subset
clinical data interchange standards consortium terminology||onset unifocal or multifocal||concept_in_subset
clinical trials reporting program terminology||blm||concept_in_subset
genomics data commons terminology||mepact||concept_in_subset
columbia-suicide severity rating scale already enrolled subjects questionnaire test name||c-ssrs already enrolled subjects - description of wish to be dead||concept_in_subset
fda pharmaceutical quality/cmc terminology||gram(s)||concept_in_subset
cptac esca baseline form||greatest measured dimension||concept_in_subset
clinical trials reporting program biomarker terminology||cd33 wt allele||concept_in_subset
ctrp molecular genetic biomarker terminology||ctag||concept_in_subset
clinical trials reporting program reference gene terminology||h3 histone family, member h||concept_in_subset
genomics data commons terminology||d-0316||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||tia1 gene||concept_in_subset
nci ctep sdc terminology||megakaryocytic myelosclerosis||concept_in_subset
basic dose form||cachet dosage form category||concept_in_subset
national eye institute visual functioning questionnaire - 25 version 2000 self-administered format questionnaire test name||vfq2a01||concept_in_subset
health effect - clinical code||rectovaginal fistula (physical finding)||concept_in_subset
adni auditory verbal learning functional test test code||avl01020||concept_in_subset
ctrp terminology||sf3b1 p.v701x||concept_in_subset
sdtm-unit||10^3 per milliliter||concept_in_subset
clinical trials reporting program biomarker terminology||hel-s-101||concept_in_subset
pediatric outcomes data collection instrument, adolescent self-reported version questionnaire test name||podci adolescent self-reported version - competitive sports limited by: pain||concept_in_subset
ctrp molecular genetic biomarker terminology||np_000133.1:p.y373c||concept_in_subset
cdisc send terminology||cancer of placenta||concept_in_subset
cardiovascular findings about results||jvp elevated (estimated)||concept_in_subset
ctrp biomarker terminology||cd135 gene mutation negative||concept_in_subset
mdasi-core||symptom interference with life score 1||concept_in_subset
ae||movements involuntary||concept_in_subset
cdisc qrs terminology||ipa03-days travel in a motor vehicle||concept_in_subset
neonatal research network terminology||electrocardiogram: supraventricular arrythmia nos||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||ntrkr3 c.716t>g||concept_in_subset
sdtm||adcs-adl mci - subscore for items 13 to 14||concept_in_subset
genomics data commons terminology||atrial fibrillation (diagnosis)||concept_in_subset
perinatal terminology||congenital disruption||concept_in_subset
fda established names and unique ingredient identifier codes terminology||eldelumab||concept_in_subset
clinical proteomic tumor analysis consortium terminology||nras mutation analysis||concept_in_subset
cdisc terminology||cervical spinal cord||concept_in_subset
cdisc sdtm type 1 diabetes findings about test code terminology||servnum||concept_in_subset
clinical trials reporting program disease terminology||rectosigmoid adenocarcinoma||concept_in_subset
fac036tn||nccn-fact fhnsi-22 version 2 - i have mouth sores||concept_in_subset
acute myeloid leukemia permissible value terminology||cain acridine||concept_in_subset
send||tanzania||concept_in_subset
ctrp reference gene terminology||cd162||concept_in_subset
fda unii code terminology||sipt||concept_in_subset
qs-bpi short form testcd||bpi2-pain interfered with sleep||concept_in_subset
agent||lentinan||concept_in_subset
ctrp biomarker terminology||immunoglobulin heavy chain variable, diversity, and joining region gene rearrangement||concept_in_subset
clinical trials reporting program biomarker terminology||adenosylhomocysteinase, human||concept_in_subset
mapped icdo3.2 terminology||meningiomas, hemangioblastic||concept_in_subset
cdisc terminology||study product storage||concept_in_subset
ncit neoplasm core terminology||leukemia in infancy||concept_in_subset
cdisc send terminology||g-series nerve agent gd||concept_in_subset
bridg terminology||diseasestatusmissingreasoncode||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||hrad54 gene mutation||concept_in_subset
clinical trials reporting program terminology||recurrent anaplastic large cell lymphoma||concept_in_subset
spl terminology||unknown route of drug administration||concept_in_subset
fda unii code terminology||2-((5-cyano-2-thienyl)methylene)hydrazinecarbothioamide||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||ngf||concept_in_subset
cdisc questionnaire c-ssrs baseline/screening version test code terminology||css04-idea, intent, no plan, describe||concept_in_subset
cptac baseline medical forms terminology||pancreatic intraepithelial neoplasia-1b||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||rorc||concept_in_subset
clinical data interchange standards consortium terminology||pcl01-avoid memories/thoughts/feelings||concept_in_subset
aml table terminology||age in days at start of cellular immunotherapy||concept_in_subset
sdtm||c5b9||concept_in_subset
fda unii code terminology||iotrizoic acid||concept_in_subset
clinical trials reporting program disease terminology||stage i borderline ovarian surface epithelial-stromal tumor||concept_in_subset
clinical trials reporting program disease terminology||folr1 positive||concept_in_subset
pkunit||nanomole/gram (qualifier value)||concept_in_subset
fda established names and unique ingredient identifier codes terminology||caramiphen hcl||concept_in_subset
cptac normal endometrial baseline form||former oral contraceptive user||concept_in_subset
cdisc terminology||mol/l/(ug/d)||concept_in_subset
fda established names and unique ingredient identifier codes terminology||n1-(3-(dimethylamino)propyl)-n8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide||concept_in_subset
mapped icd-o-3.2 terminology||ovarian mixed epithelial carcinoma||concept_in_subset
us counties terminology||marshall county, mississippi||concept_in_subset
cdisc-variable||immunogenicity specimen assessments test code||concept_in_subset
ncit antineoplastic agent terminology||phosphatidylcholine-bound silybin||concept_in_subset
single-agent therapeutic regimens||goserelin regimen||concept_in_subset
qs-gmss version type 1 diabetes test||gmss01-feel less restricted by diabetes||concept_in_subset
fda established names and unique ingredient identifier codes terminology||3,3-bis(4-hydroxyphenyl)-7-methyl-2-indolinone, disodium salt of sulfuric acid diester||concept_in_subset
seer rx interactive antineoplastic drugs database||cisplatin/methotrexate||concept_in_subset
health utilities index||moderate to severe pain or discomfort that prevented some activities||concept_in_subset
genomics data commons terminology||bcr-abl kinase inhibitor pf-114||concept_in_subset
gct table terminology||mrecist byrne mesothelioma 2004||concept_in_subset
mapped icd-o-3.2 morphology terminology||fibromyxoma (morphologic abnormality)||concept_in_subset
fda established names and unique ingredient identifier codes terminology||(thiodiethylene)bis(ethyldimethylammonium)||concept_in_subset
ctrp biomarker terminology||cell, myeloid||concept_in_subset
cdisc sdtm terminology||updrs - complications of therapy: clinical fluctuations - average off periods per day||concept_in_subset
cdisc sdtm terminology||hiv-1/2 antibody and hiv-1 p24 antigen measurement||concept_in_subset
clinical data interchange standards consortium terminology||science, translational||concept_in_subset
clinical trials reporting program biomarker terminology||renal cell carcinoma antigen, human||concept_in_subset
clinical trials reporting program terminology||tuberous sclerosis 2 gene mutation||concept_in_subset
cdisc sdtm terminology||ukat/10^12{rbc}||concept_in_subset
cdisc sdtm terminology||old or age indeterminate inferior wall myocardial infarction||concept_in_subset
clinical data interchange standards consortium terminology||lyme igm antibody||concept_in_subset
ncpdp doseunitofmeasure terminology||capsule - unit of product usage||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||hmate-1||concept_in_subset
cdisc terminology||css0307a||concept_in_subset
cdisc sdtm respiratory test name terminology||gaw - airway conductance||concept_in_subset
pdf||conventional release buccal tablet (dose form)||concept_in_subset
clinical trials reporting program biomarker terminology||ec 2.7.7.49||concept_in_subset
cdisc questionnaire terminology||c-ssrs since last visit - control over most severe ideation||concept_in_subset
ctrp disease terminology||prognostic stage iiic breast cancer ajcc v8||concept_in_subset
modified 18-item memorial anxiety scale for prostate cancer||just hearing the words "prostate cancer" scared me||concept_in_subset
aml table terminology||age in days at time of lab test||concept_in_subset
fda unii code terminology||lefitolimod||concept_in_subset
cptac baseline medical forms terminology||ret gene rearrangement negative||concept_in_subset
cdisc qrs terminology||qles119||concept_in_subset
gdc therapeutic agent terminology||obrindatamab||concept_in_subset
cdisc sdtm terminology||assay of theophylline||concept_in_subset
mapped icd-o-3.1 morphology terminology||nb - neuroblastoma||concept_in_subset
agent||pak4/nampt inhibitor atg-019||concept_in_subset
idsc1tc||idsc122||concept_in_subset
clinical trials reporting program biomarker terminology||her2/neu status||concept_in_subset
clinical trials reporting program terminology||myeloblasts greater than or equal to 5 percent of peripheral blood white cells||concept_in_subset
cellosaurus disease terminology||glioma, sarcomatous||concept_in_subset
mapped icd-o-3.2 terminology||carcinoma of apocrine gland (disorder)||concept_in_subset
mapped icd-o-3.2 morphology terminology||hydatidiform mole, no icd-o subtype (morphologic abnormality)||concept_in_subset
genomics data commons terminology||mr1-1kdel||concept_in_subset
cdisc sdtm terminology||cdisc questionnaire pr v1 test name terminology||concept_in_subset
cdisc questionnaire terminology||siqr01-walk continuously for 20 minutes||concept_in_subset
clinical trials reporting program terminology||wilms' tumor, stage ii||concept_in_subset
fda unii code terminology||cornu aspersum||concept_in_subset
clinical trials reporting program terminology||stage ii paranasal sinus cancer ajcc v6||concept_in_subset
ctrp biomarker terminology||monocytopenia with susceptibility to infections (disorder)||concept_in_subset
icdc property terminology||file size||concept_in_subset
clinical trials reporting program biomarker terminology||chemokine orphan receptor 1 gene||concept_in_subset
genomics data commons terminology||aggressive osteoblastoma (morphologic abnormality)||concept_in_subset
send||ducts||concept_in_subset
clinical data interchange standards consortium terminology||von willebrand factor multimers||concept_in_subset
ncit antineoplastic agent terminology||tqb 3303||concept_in_subset
cdisc qrs terminology||ed1-how they communicate primarily||concept_in_subset
seer rx interactive antineoplastic drugs database||dibromodulcitol/adriamycin/vincristine/halotestin||concept_in_subset
nci drug dictionary terminology||kordicepin||concept_in_subset
cdisc sdtm microorganism terminology||nocardia nova (organism)||concept_in_subset
clinical trials reporting program terminology||arhgap41||concept_in_subset
tumor or lesion properties test code||pchgbl||concept_in_subset
gdc terminology||polyadenylate-binding protein 1||concept_in_subset
cdisc questionnaire terminology||cdisc questionnaire borg cr10 test code terminology||concept_in_subset
fda established names and unique ingredient identifier codes terminology||dimethyl[2-(n-methyldodecanamido)ethyl][(phenylcarbamoyl)methyl]ammonium||concept_in_subset
fda established names and unique ingredient identifier codes terminology||idaverine||concept_in_subset
ctrp disease terminology||stage ii aids-related anal carcinoma ajcc v6 and v7||concept_in_subset
cdisc functional test terminology||pul02-push on light||concept_in_subset
bridg class and attribute terminology||study protocol version primary purpose code||concept_in_subset
structured product labeling flavor terminology||fish||concept_in_subset
fda established names and unique ingredient identifier codes terminology||oxetorone fumarate (substance)||concept_in_subset
gdc value terminology||hereditary papillary renal cancer||concept_in_subset
mapped icdo3.2 morphology terminology||rela fusion-positive ependymoma (morphologic abnormality)||concept_in_subset
ewing sarcoma variable terminology||age in days at disease phase||concept_in_subset
clinical proteomic tumor analysis consortium terminology||was tumor progression present after initial treatment||concept_in_subset
device-in-use test code||voxdimy||concept_in_subset
clinical trials reporting program biomarker terminology||trka fusion positive||concept_in_subset
cdisc sdtm terminology||fac01514||concept_in_subset
nichd terminology||kerasin thesaurismosis (disorder)||concept_in_subset
agent||inavolisib||concept_in_subset
clinical trials reporting program terminology||gr||concept_in_subset
ctrp biomarker terminology||osteoblast (cell)||concept_in_subset
gdc gene symbol terminology||hucep-6||concept_in_subset
seer rx interactive antineoplastic drugs database||tic protocol||concept_in_subset
breed group||tibetan spaniel (organism)||concept_in_subset
send||butocarboxim||concept_in_subset
ctrp terminology||imalumab||concept_in_subset
fda unii code terminology||talotrexin||concept_in_subset
cdisc sdtm terminology||tachycardia||concept_in_subset
cdisc qrs terminology||fac07010||concept_in_subset
ctrp terminology||t(2;8)||concept_in_subset
cdisc qrs terminology||c-ssrs children's baseline/screening - active suicidal ideation with specific plan and intent (past 6 months)||concept_in_subset
fda unii code terminology||2-propenamide, n-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-||concept_in_subset
fda established names and unique ingredient identifier codes terminology||bromellete||concept_in_subset
cdisc send terminology||every 36 hours||concept_in_subset
ma||17p deletion||concept_in_subset
send-fxfindrs||distended||concept_in_subset
cdisc||salve dose form||concept_in_subset
mapped icdo3.2 terminology||sertoli-leydig cell tumour, moderately differentiated, with heterologous elements||concept_in_subset
qs-gad-7 test||gad0104||concept_in_subset
sdtm||superficial||concept_in_subset
non-neoplastic finding type||alpha 2mu-globulin neuropathy||concept_in_subset
bridg attribute terminology||text||concept_in_subset
inc-meddra neonatal adverse events terminology||grade 3 neonatal spontaneous intestinal perforation||concept_in_subset
ctrp terminology||n-myc gene amplification||concept_in_subset
genomics data commons terminology||not allowed to collect||concept_in_subset
gdc value terminology||fascial fibroma (morphologic abnormality)||concept_in_subset
clinical trials reporting program reference gene terminology||bda1||concept_in_subset
fda unii code terminology||levamlodipine malate||concept_in_subset
cdisc questionnaire terminology||mds-updrs - rigidity neck||concept_in_subset
structured product labeling unit of presentation terminology||package dosing unit||concept_in_subset
fda established names and unique ingredient identifier codes terminology||pseudothiourea||concept_in_subset
exdosu||gram(s)||concept_in_subset
cdisc send terminology||pathogen exclusion verification method||concept_in_subset
cellosaurus disease terminology||cesium-137 gamma radiation||concept_in_subset
genomics data commons terminology||raltitrexed product||concept_in_subset
fda established names and unique ingredient identifier codes terminology||desidustat||concept_in_subset
cdisc||splenium of corpus callosum||concept_in_subset
cellosaurus disease terminology||pulmonary surfactant metabolism dysfunction-3||concept_in_subset
cdisc||vent tach polymorp+q-t prolong||concept_in_subset
quality of life questionnaire-head & neck 35 (qlq-h&n35)||extent of problems with teeth||concept_in_subset
cdisc terminology||susceptible-dose dependent||concept_in_subset
ctrp biomarker terminology||bcl2-like 1 wt allele||concept_in_subset
cdisc sdtm terminology||photobacterium (organism)||concept_in_subset
clinical trials reporting program agent terminology||tilsotolimod sodium||concept_in_subset
cdisc questionnaire terminology||fac00612||concept_in_subset
cdisc sdtm terminology||new lesion progression||concept_in_subset
cdisc variable terminology||disease response sequence number||concept_in_subset
clinical trials reporting program agent terminology||gm-csf-secreting breast tumor vaccine||concept_in_subset
cdisc sdtm terminology||facit-dyspnea scale 33 item bank version - limit: lifting less than 5 lbs||concept_in_subset
expanded prostate cancer index composite||gained less than 10 pounds||concept_in_subset
ncit neoplasm core terminology||neurofibroma||concept_in_subset
biomedical research integrated domain group model terminology||signaturetext||concept_in_subset
ctrp terminology||mucosal melanoma||concept_in_subset
cdisc terminology||rhizopus arrhizus||concept_in_subset
cdisc||fac071-enjoy things i usually do for fun||concept_in_subset
tumor assessment table||primary tumor||concept_in_subset
sdtm-method||targeted rna-seq||concept_in_subset
admdf||oromucosal patch||concept_in_subset
sdtm-lbtestcd||volume, mean platelet||concept_in_subset
sdtm||cdisc questionnaire eortc qlq-lc13 test name terminology||concept_in_subset
ctrp terminology||dcaf7 wt allele||concept_in_subset
gdc terminology||thiazolidinedione antidiabetic agent||concept_in_subset
sdtm||common terminology criteria for adverse events grade 5||concept_in_subset
laboratory test name||drvvt screen to confirm pct difference||concept_in_subset
spl terminology||intrabronchialroute||concept_in_subset
genomics data commons terminology||colon, ascending||concept_in_subset
clinical trials reporting program agent terminology||13-ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one||concept_in_subset
cdisc||gummy||concept_in_subset
pediatric adverse events terminology||cardiac perforation||concept_in_subset
cdisc-gloss||clinical study anchor||concept_in_subset
specimen type||fluids pleural||concept_in_subset
cdisc qrs terminology||pql02-hard tell doctors/nurses how feel||concept_in_subset
clinical data interchange standards consortium terminology||7-benzofuranol, 2,3-dihydro-2,2-dimethyl-, methylcarbamate||concept_in_subset
clinical trials reporting program terminology||refractory malignant solid neoplasm||concept_in_subset
ncit antineoplastic agent terminology||bromovinyl-deoxyuridine||concept_in_subset
nci drug dictionary terminology||oncolytic mg1 virus-encoding e6e7||concept_in_subset
fda unii code terminology||uk-2371||concept_in_subset
gdc terminology||basal cell carcinoma - adenoid||concept_in_subset
ncit antineoplastic agent terminology||rebimastat||concept_in_subset
ncit antineoplastic agent terminology||estradiol 3-bis(2-chloroethyl)carbamate||concept_in_subset
cdisc qrs terminology||rdq01-stay in bed||concept_in_subset
adni auditory verbal learning functional test test code||avl01029||concept_in_subset
nichd terminology||inflammation vagina||concept_in_subset
clinical trials reporting program biomarker terminology||3-isoleucine-8-leucine vasopressin||concept_in_subset
gdc value terminology||ls 454 sequencing||concept_in_subset
pkparmcd||aumc to last nonzero conc norm by bmi||concept_in_subset
global alignment of immunization safety assessment in pregnancy pathways to preterm birth level of diagnostic certainty terminology||gaia level 3 assessment of provider initiated preterm delivery||concept_in_subset
ctrp terminology||t lymphotropic virus type iii infections, human||concept_in_subset
mapped icd-o-3.2 morphology terminology||osteoid osteoma (disorder)||concept_in_subset
mapped icd-o-3.1 morphology pt terminology||pseudomyxoma peritonei||concept_in_subset
pediatric rheumatology terminology||peripheral nerve disorder||concept_in_subset
clinical data interchange standards consortium terminology||american house dust mite ige antibody rast score||concept_in_subset
fda ectd terminology||promotional 2253 material||concept_in_subset
fda center for devices and radiological health terminology||increased sensitivity||concept_in_subset
us counties terminology||wilkes county, north carolina||concept_in_subset
us counties terminology||suwannee county, fl||concept_in_subset
cellosaurus disease terminology||small intestinal cancer||concept_in_subset
gdc value terminology||glycogen-rich carcinoma||concept_in_subset
cptac melanoma follow-up form||click or tap here to enter text||concept_in_subset
cptac glioblastoma multiforme follow-up form||post-operative therapy rounds section||concept_in_subset
ctrp molecular genetic biomarker terminology||long-chain acyl-coa synthetase 2 gene||concept_in_subset
gdc value terminology||infantile; fibrosarcoma||concept_in_subset
functional assessment of chronic illness therapy-fatigue 13-item scale version 4 questionnaire test code||fac070-i feel weak all over||concept_in_subset
ncit covid-19 terminology||fibrinogen to albumin ratio measurement||concept_in_subset
clinical proteomic tumor analysis consortium terminology||radiographic length||concept_in_subset
clinical trials reporting program disease terminology||stage 0 bladder cancer ajcc v6||concept_in_subset
cdisc||functional assessment of cancer therapy-kidney symptom index-15 questionnaire test code||concept_in_subset
fda unii code terminology||2-octyl cyanoacrylate-containing product||concept_in_subset
gdc value terminology||urostomy leak, ctcae||concept_in_subset
gdc value terminology||pineal pnet||concept_in_subset
cdisc sdtm anatomical location terminology||of radius bone||concept_in_subset
fda unii code terminology||cinodine ii||concept_in_subset
genomics data commons terminology||dubermatinib||concept_in_subset
gdc terminology||q702||concept_in_subset
pharmacotherapy regimens||lapatinib regimen||concept_in_subset
microorganism||streptococcus lancefield group b||concept_in_subset
agent||rebimastat||concept_in_subset
european directorate for the quality of medicines and healthcare controlled vocabularies||suspension for injection in multidose container||concept_in_subset
bridg data type terminology||history data type||concept_in_subset
gdc value terminology||calcifying nested epithelial stromal tumor (morphologic abnormality)||concept_in_subset
cellosaurus disease terminology||secondary myelofibrosis||concept_in_subset
clinical trials reporting program molecular genetic biomarker terminology||insulin like growth factor 2 receptor protein, human||concept_in_subset
microorganism||genus arthrographis (organism)||concept_in_subset
cdisc questionnaire terminology||npi - difficulty falling asleep||concept_in_subset
cdisc qrs terminology||fac016-i am satisfied with my sex life||concept_in_subset
clinical trials reporting program terminology||procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 gene||concept_in_subset
sdtm||isg15 measurement||concept_in_subset
ctrp disease terminology||urachal carcinoma||concept_in_subset
nichd terminology||sex chromosome differences of sex development||concept_in_subset
nichd terminology||hypoparathyroidism, autosomal recessive||concept_in_subset
cdisc sdtm terminology||sacral tuberosity||concept_in_subset
fda established names and unique ingredient identifier codes terminology||credelio||concept_in_subset
fda established names and unique ingredient identifier codes terminology||triplatin tetranitrate||concept_in_subset
single-agent therapeutic regimens||niraparib regimen||concept_in_subset
clinical trials reporting program biomarker terminology||choline metabolite||concept_in_subset
fda unii code terminology||balovaptan||concept_in_subset
clinical trials reporting program terminology||gestational choriocarcinoma of fallopian tube||concept_in_subset
npi1tn||npi1dist||concept_in_subset
genomics data commons terminology||hpv-59||concept_in_subset
fda unii code terminology||(2s-(1(r*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid||concept_in_subset
nichd terminology||acute therapy related myeloid leukemia and myelodysplastic syndrome||concept_in_subset
mapped icdo3.1 morphology pt terminology||malignant gastrinoma (diagnosis)||concept_in_subset
genomics data commons terminology||lontucirev (replicating adenovirus)||concept_in_subset
cdisc clinical classification terminology||cdai0104||concept_in_subset
sdtm||pul01-remove lid from container||concept_in_subset
national cancer institute drug dictionary||ppe-expressing replication-defective hsv-1 vector np2||concept_in_subset
agent||cord blood-derived expanded natural killer cells pnk-007||concept_in_subset
nccn guidelines version 1.2011 distress management problem list screening tool||distress over emotional problem with nervousness||concept_in_subset
cdisc qrs terminology||bpi122b||concept_in_subset
cdisc||partial pressure of carbon dioxide adjusted for body temperature measurement||concept_in_subset
ctrp biomarker terminology||transient receptor potential cation channel, subfamily c, member 2, pseudogene||concept_in_subset
pediatric endocrine terminology||hyperinsulinism-hyperammonemia syndrome||concept_in_subset
ncpdp terminology||dci||concept_in_subset
ctrp molecular genetic biomarker terminology||mitotic checkpoint serine/threonine-protein kinase bub1||concept_in_subset
cdisc send terminology||auc infinity predicted normalized by surface area||concept_in_subset
ctrp reference gene terminology||tap binding protein (tapasin)||concept_in_subset
qs-fact-b version 4 testcd||fac00505||concept_in_subset
cdisc qrs terminology||hamd323||concept_in_subset
send||mmmt||concept_in_subset
gdc terminology||uncle, biological paternal||concept_in_subset
fda unii code terminology||4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol||concept_in_subset
cdisc questionnaire chart-sf paper version test code terminology||chart-sf paper version - paid personal care per day||concept_in_subset
genomics data commons terminology||cell granulosa theca tumor||concept_in_subset
ncit covid-19 terminology||ptx||concept_in_subset
clinical trials reporting program terminology||atr-x gene||concept_in_subset
ctrp terminology||circulating myeloid cell||concept_in_subset
pq/cmc terminology||micrometer (qualifier value)||concept_in_subset
multi-agent therapeutic regimens||cim||concept_in_subset
anatomical location||postremal chamber||concept_in_subset
fda established names and unique ingredient identifier codes terminology||diclonixin||concept_in_subset
sdtm-ntfats||frequencies||concept_in_subset
genomics data commons terminology||2-amino-6-(benzyloxy)purine||concept_in_subset
clinical trials reporting program biomarker terminology||rab27||concept_in_subset
acremolide b||depsipeptide||mapped_from
graf1 protein, mouse||gap||mapped_from
bulgaria celebica||ascomycotas||mapped_from
epidemic; hemorrhagic fever (manifestation)||other viral diseases||mapped_from
pleurotopsis longinqua||agaricales anamorphs||mapped_from
limtongozyma cylindracea||budding yeast||mapped_from
raphanusamic acid||thiazole||mapped_from
delayed expulsion of placenta||[x]other specified complications of labor and delivery||mapped_from
mucin marker ovx1||glycoprotein, nos||mapped_from
polyprenyl-pyrophosphoryl-n-acetylglucosamine||polyisoprenyl phosphates||mapped_from
strain of flexor pollicis longus tendon (disorder)||injury of long flexor muscle and tendon of thumb at wrist and hand level||mapped_from
dmahp cpd||ammonium compounds, quaternary||mapped_from
nondep amph. type abuse-in rem||other stimulant abuse, uncomplicated||mapped_from
mas063dp||glycerrhetinic acid||mapped_from
liver; necrosis, complicating pregnancy||liver disorders in pregnancy, childbirth and the puerperium||mapped_from
itp regimen||combinations, antineoplastic drug||mapped_from
calculus;ureter||kidney, calculus||mapped_from
acute laryngopharyngitis (disorder)||acute laryngopharyngitis (diagnosis)||mapped_from
inefficient uterine activity||other uterine inertia unspecified (disorder)||mapped_from
carbon-polylactic acid polymer||α-hydroxypropionic acid||mapped_from
facial palsy, congenital, unilateral or bilateral||palsy, facial||mapped_from
juxtapapillary; chorioretinitis||oth inf/inflam of eye (excl herpes)||mapped_from
heterocornol g||polyketides||mapped_from
paraproteinemias||hypergammaglobulinemia, unspecified||mapped_from
anemarsaponin c||saponins||mapped_from
odontogenic infection of jaw||inflammatory conditions of jaw||mapped_from
pilonidal disease (disorder)||pilonidal cyst w/o absc||mapped_from
glda chelating agent||glutamate||mapped_from
osmoses||osmosis, nos||mapped_from
nitrogen||nitrogen (n)||mapped_from
abdominal pregnancy with viable fetus - delivered (diagnosis)||abdominal pregnancy with viable fetus - delivered||mapped_from
c 205||acridine||mapped_from
closure; incomplete, palate||digestive system abnormality||mapped_from
pqd-be cpd||quinazoline (substance)||mapped_from
2-(2-(2-(5-(dimethylamino)thiophen-2-yl)vinyl)-6-methyl-4h-pyran-4-ylidene)malononitrile||nitriles||mapped_from
dysautonomia-like disorder||dysautonomia, primary||mapped_from
telomere repeat-binding bouquet formation protein 2, mouse||telomere-binding protein||mapped_from
pde5 protein, s cerevisiae||saccharomyces cerevisiae proteins||mapped_from
sty1 protein, s pombe||kinase, mitogen-activated protein||mapped_from
failure; fetal head entering pelvic brim, affecting fetus or newborn||perinatal morbidity other||mapped_from
blindness; uremic||unspecified renal failure||mapped_from
dermatosis; papulosa nigra||skin disease other||mapped_from
geodermatophilus obscurus subsp. utahensis||actinobacteria stackebrandt et al. 1997 emend. nouioui et al. 2018||mapped_from
annulatascus velatisporus k.d. hyde, 1992||ascomycete||mapped_from
seen by psychogeriatric service (finding)||[x]persons encountering health services in other specified circumstances (situation)||mapped_from
steroid-containing product||hormones, adrenal cortex||mapped_from
gelsenine||alkaloid product||mapped_from
note:finding:to identify measures at a point in time:{setting}:document:ophthalmology+optometry||note:finding:to identify measures at a point in time:{setting}:document:ophthalmology||mapped_from
forebrain defects||abnormalities craniofacial||mapped_from
protein-calorie malnutrit. nos||calorie malnutrition protein||mapped_from
creka-tris-gd(dota)3||complexes, coordination||mapped_from
drug catalog||drug catalogs as topic||mapped_from
cataract, congenital nuclear, autosomal recessive 3||cataract (morphologic abnormality)||mapped_from
rash; pustular||skin; lesion, suppurative||mapped_from
progr post haem ventric dilat||hydrocephalus communicating||mapped_from
leukocytosis nos||other specified disease of white blood cells||mapped_from
congenital absence upper arm and forearm with hand present||complete phocomelia upper limb||mapped_from
klinefelter's syndrome nos||klinefelter's syndrome (disorder)||mapped_from
scn 4-autosomal recessive||neutropenia, unspecified||mapped_from
clce protein, arabidopsis||arabidopsis proteins||mapped_from
bdi-2h||imine||mapped_from
ggtga-specific type ii deoxyribonucleases||type ii site-specific deoxyribonuclease||mapped_from
pneumonia due to methicillin-susceptible staphylococcus aureus||staphylococcal pneumonias||mapped_from
9,10-seco-9,19-cyclolanostane xyloside||triterpenes||mapped_from
bays||bay (geographic)||mapped_from
1-phenylcyclopropene||cyclopropanes||mapped_from
tuberculosis; rhinitis, with bacteriological and histological confirmation||[x]oth resp tb,cnfrm bact+hist||mapped_from
fetal anencephaly (disorder)||cns -congenital anomaly||mapped_from
helicobacter callitrichis||helicobacter||mapped_from
ns10743||oxadiazoles||mapped_from
brachial artery embolus||embolism and thrombosis of arteries of the upper extremities||mapped_from
stachybotrin a||indole compound||mapped_from
colon; colostomy||colostomy status (diagnosis)||mapped_from
streptomyces polygonati||streptomyces species||mapped_from
history of neoplasm of carotid body||personal history of neoplasm of uncertain behavior||mapped_from
exposure to unspecified radiation||exposure to radiation||mapped_from
spe-beta-cd||beta-cyclodextrins||mapped_from
lichen ruber acuminatus||rubra pilaris; pityriasis||mapped_from
dermatology domiciliary visit done (finding)||[x]persons encount health serv in other specif circumstance||mapped_from
polyneuropathies, diabetic asymmetric||type 2 diabetes mellitus with diabetic polyneuropathy||mapped_from
absence of tongue||[x]other congenital malformations of tongue (disorder)||mapped_from
choleperitonitis||[x]other peritonitis||mapped_from
balanoposthitis nos (disorder)||balanitis in diseases ce||mapped_from
tooth sensitivity to brush or floss||dis hard tiss teeth nec||mapped_from
anesthestic drugs||anaesthetic agent||mapped_from
n-(2-te)-dcp-apa cpd||acetamides||mapped_from
acvr1b protein, mouse||activin receptor like kinases, type i||mapped_from
ipad protein, shigella flexneri||antigens bact||mapped_from
[v]plastic surgery used in aftercare||[v]follow-up care involving plastic surgery||mapped_from
furanodiene||2-ring heterocyclic compounds||mapped_from
allergic colitis (disorder)||allergic and dietetic gastroenteritis and colitis||mapped_from
1,4-cyclohexanedione||cyclohexanones||mapped_from
fever; desert (etiology)||coccidioidomycosis primary pulmonary acute||mapped_from
n(2)-(1-carboxyethyl)-glutamine||l-glutamic acid γ-amide||mapped_from
3-chloro-mofbs||sulphonamide||mapped_from
tricuspid truncal valve (disorder)||endocarditis and heart valve disorders in diseases classified elsewhere||mapped_from
fs 3798||acrylic resin||mapped_from
limb; dislocation, upper||dislocation, sprain and strain of unspecified joint and ligament of upper limb, level unspecified||mapped_from
primary malignant neoplasm of cervical vertebral column (disorder)||malignant neoplasm of spine, nos||mapped_from
bacitracin - cysteine - glycine - neomycin - threonine drug combination||glycine - amino acid||mapped_from
oligohydramnios, delivered, with or without mention of antepartum condition||low levels of amniotic fluid||mapped_from
n.medianus; hand, injury||peripheral nerve injury median nerve wrist and hand||mapped_from
l-ala-ala-n||dipeptides||mapped_from
retamatrioside||glycosides||mapped_from
hyperscabrin a||phloroglucinol||mapped_from
fpld4 - familial partial lipodystrophy type 4||lipodystrophy, not elsewhere classified||mapped_from
heterosporium variabile||cladosporium||mapped_from
sarcocele; syphilitic (manifestation)||[x]disorders of testis and epididymis in diseases classified elsewhere (disorder)||mapped_from
echinusitheca citrispora||phylum ascomycota||mapped_from
piceatannol-3'-o-glucopyranoside||stilbene||mapped_from
5,5-dimethoxy-2-hydroxy-1,3,2-dioxaphosphorinan-2-one||dihydroxyacetone monophosphate||mapped_from
familial diabetes insipidus (disorder)||diabetes insipidus (disorder)||mapped_from
beta-(3,4-dihydroxyphenyl)ethyl-rhamnopyranosyl-(1''''-3''')-rhamnopyranosyl-(1''''-3')-glucopyranosyl(1''-6')-4-o-(3,4-dihydroxycinnamoyl)glucopyranoside||caffeic acids||mapped_from
fezf2 protein, xenopus||xenopus proteins||mapped_from
band; peritoneum, with intestinal obstruction||other diseases of digestive system||mapped_from
crushing injury; trunk, with limb(s)||multiple trauma/internal injury||mapped_from
xanthiside||thiazines||mapped_from
reticuloendotheliosis, x-linked||reticuloendothelial system stimulated||mapped_from
ribosomal protein l35, e coli||ribosomal protein||mapped_from
4.5 year examination normal (finding)||encounter for routine child health examination without abnormal findings||mapped_from
3-methoxycyclohexanol||cyclohexanols||mapped_from
pulmonary hemorrhage [d]||other symptom/complaint respiratory system||mapped_from
4-chlorocatechol||o-dihydroxybenzenes||mapped_from
sas-5 protein, c elegans||caenorhabditis elegans proteins||mapped_from
ybr132c protein, s cerevisiae||baker's yeast proteins||mapped_from
phage infection protein, lactococcus lactis||bact gene proteins||mapped_from
strevertene a||polyene||mapped_from
inj unsp bl ves,forearm lev||injury of multiple blood vessels at forearm level||mapped_from
phoma dactylidis||ascomycete||mapped_from
methylobact||233 methylobacterium||mapped_from
ovary; cystadenoma, papillary, borderline malignancy||malignant neoplasm genital female other||mapped_from
glucagon(1-21)||hyperglycaemic-glycogenolytic factor preparation||mapped_from
anomaly; optic, nerve||[x]oth spec cong malf nerv sys||mapped_from
arginine amidinotransferase||amidinotransferase||mapped_from
increased urobilinogen level (finding)||oth ab fnd,spc ot org/sy/ts||mapped_from
spontaneous reduction in size of ventricular septal defect due to prolapse of cusp of aortic valve||septal defects, ventricular||mapped_from
calydaphninone||heterocyclic compounds a 4 or more rings||mapped_from
infection; leishmania, braziliensis||espundia||mapped_from
yhr071w protein, s cerevisiae||saccharomyces cerevisiae proteins||mapped_from
arachidic; bronchitis||bronchial foreign body||mapped_from
lu 97175||quinoxalines||mapped_from
tunica vaginalis; ulcer||[x]other specified disorders of male genital organs (disorder)||mapped_from
aneurysm of iliac artery||aneurysm of iliac artery nos||mapped_from
n-hydroxy-chhob||hydroxamic acid||mapped_from
pina protein, enterobacteria phage t4||gene products, viral||mapped_from
abscess; vaginorectal, puerperal||[x]other infection of genital tract following delivery||mapped_from
jaundice haematogenous||other anaemias||mapped_from
n-cpmnm||exalgo||mapped_from
edema of right lower limb (finding)||[d]edema, localized (context-dependent category)||mapped_from
bilateral vertebral artery occlusion (diagnosis)||brain; lesion, vascular||mapped_from
cervical endometriosis||endometriosis of myometrium (diagnosis)||mapped_from
glaucoma; spot||cat. - cataract||mapped_from
o44, octane||octanes||mapped_from
dansyl-8-aminoquinoline||aminoquinolines||mapped_from
thumb agenesis, short stature, and immunodeficiency||primary immune deficiency disorder (disorder)||mapped_from
acute gu unspecified||acute gastric ulcer without haemorrhage or perforation||mapped_from
rubropunctatin||benzopyrans||mapped_from
bcas3-bcas4 protein, human||proteins, oncogene fusion||mapped_from
antofine||phenanthroline||mapped_from
mpnst (malignant peripheral nerve sheath tumour) with perineurial differentiation||mal neoplasm/periph nerves+autonomic nervous system,unspc||mapped_from
3-methyl-n,n-diethyl-p-phenylenediamine||phenylenediamine||mapped_from
neurosyphilis; ataxia||syphilis male||mapped_from
tlshalo compound||boron compound||mapped_from
paranoid; state, simple||delusional disorder (diagnosis)||mapped_from
orf u83 protein, hhv6||protein virus||mapped_from
sr 80356a||oligosaccharide (substance)||mapped_from
gallium alloy gf||metallic alloy||mapped_from
costal; chondritis, tietze||other musculoskeletal disorder nos (disorder)||mapped_from
diaphragm injury-closed||[x]injury of other specified intrathoracic organs (disorder)||mapped_from
syreiteate a||sesquiterpene||mapped_from
reversin 121||oligopeptide||mapped_from
paris saponin i||spirost-5-en-3-ol, (3beta,25r)-||mapped_from
gpr19 protein, rat||nerve proteins||mapped_from
vsag-7 protein, mouse mammary tumor virus||viral antigen (substance)||mapped_from
menin protein, rat||factors transcription||mapped_from
megalodactylia; toes||other congenital malformations of lower limb(s), including pelvic girdle||mapped_from
cortinarius raphanoides||cortinarius (organism)||mapped_from
backward reading||specific learning problems||mapped_from
pulmonary trunk dilatation||other specified diseases of pulmonary vessels||mapped_from
botryozyma mucatilis||budding yeast (organism)||mapped_from
winogradskyella litorisediminis kang et al. 2013||flavobacteriaceae reichenbach et al. 1992 emend. bernardet et al. 2002||mapped_from
pimafucort||combination, drug||mapped_from
history of revision of left total knee arthroplasty||personal history of major surgery, nec in icd10am_2000||mapped_from
nat14 protein, xenopus||xenopus proteins||mapped_from
cycloinulohexaose cf6||oligosaccharides||mapped_from
hepatoglobine||globins||mapped_from
marathon one composite resin||composites resins||mapped_from
atwhy1 protein, arabidopsis||dna binding protein||mapped_from
lcl-464||dodecanoic acids||mapped_from
scopulariopsis danica||scopulariopsis bainier, 1907||mapped_from
n-pyrimidinobenzamide-2-carboxylic acid||pyrimidines||mapped_from
marseilla massiliensis||bacteroidaeota oren et al. 2015||mapped_from
1,3-dideazaadenosine||4-amino-7-.beta.-d-ribofuranosyl-7h-pyrrolo[2, 3-d]pyrimidine||mapped_from
acquired spondylolysis (disorder)||spondylolisthesis acquired||mapped_from
shapiro syndrome||hyperhidrosis||mapped_from
abp protein, pseudomonas||gene product bact||mapped_from
p(pegma)-(ppfs)||product containing macrogol (medicinal product)||mapped_from
structure of supinator muscle||malignant neoplasm of connective and soft tissue of upper limb and shoulder nos||mapped_from
juvenile linear scleroderma||localised scleroderma [morphea]||mapped_from
rpp 201||phenothiazines (medication)||mapped_from
cpr5 protein, arabidopsis||membrane-associated protein||mapped_from
hypothalamic granuloma||intracranial abscess and granuloma (diagnosis)||mapped_from
agenesis of clitoris||congenital anomaly of female genital system (disorder)||mapped_from
ophthalmia; egyptian (manifestation)||[x]conjunctivitis in infectious and parasitic diseases ce||mapped_from
formyl-methionyl-leucyl-2-aminoindane-2-carboxylic acid methyl ester||formylmethionylleucylphenylalanine n||mapped_from
mycena laevigata||order agaricales - mushroom (organism)||mapped_from
otitis; media, nonsuppurative, subacute||otitis media serous||mapped_from
gg-52 compound||pregnene||mapped_from
neurovascular corn||callus corn||mapped_from
asat||genetic diseases, x linked||mapped_from
urethritis; gonococcal, with abscess||gonorrhea male||mapped_from
headache which is generalized||[d]headache (situation)||mapped_from
labor; volatile||delivery;complicated;liveborn||mapped_from
secondary malignant neoplasm of paravaginal lymph nodes (disorder)||secondary and unspec malig neop intrapelvic ln nos||mapped_from
3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-(3-(4-octylphenoxy)-2-oxopropyl)indole-5-carboxylic acid||oxadiazoles||mapped_from
lobaria kurokawae||phylum ascomycota (organism)||mapped_from
deletion 2q syndrome||chromosome pair 2||mapped_from
lepraria larrainiana||sac fungi||mapped_from
cystic pseudoporencephalic cavitation||congenital cerebral cyst nos (disorder)||mapped_from
amyloid beta-protein (34-39)||amyloid beta proteins||mapped_from
ikwitang||plant extract product||mapped_from
anoxybacillus geothermalis||anoxybacillus||mapped_from
benzodiazepine overdose (disorder)||poisoning caused by benzodiazepine-based tranquilliser||mapped_from
chiangraiomyces bauhiniae||phylum ascomycota||mapped_from
rp-170||nucleoside (substance)||mapped_from
poly(4-vinylpyridine) osmium(bipyridine)chloride-co-ethylamine||polyvinyl||mapped_from
acinetobacter idrijaensis||acinetobacter brisou and prevot 1954||mapped_from
tagalsin s||diterpene||mapped_from
finding partially removed since previous mammogram (finding)||oth abn and inconclusive findings on dx imaging of breast||mapped_from
prepuce; infection||penis inflammation||mapped_from
dextran metronidazole monosuccinate ester||product containing metronidazole (medicinal product)||mapped_from
wandering spleens||[x]other diseases of spleen||mapped_from
p95 protein, tetrahymena||rna binding protein||mapped_from
lymphoguanylin||peptide product||mapped_from
sn-28 compound||product containing morphinan (product)||mapped_from
ppm1e protein, human||ppm1 magnesium dependent protein phosphatases||mapped_from
meningococcal myocarditis (disorder)||meningococcal myocarditis (diagnosis)||mapped_from
alcr protein, bordetella||transcription factors||mapped_from
hemorrhage of cesarean section and perineal wound (diagnosis)||other obst.wound complic.nos||mapped_from
isoborneol||bornanes||mapped_from
slc35c1 protein, human||proteins, monosaccharide transport||mapped_from
endocarditis; parietalis fibroplastica||constrictive endocarditis||mapped_from
malignant; embryoma, testis, descended (scrotal)||other malignant neoplasm||mapped_from
infection caused by endolimax||acute amebic rectocolitis||mapped_from
ydal protein, e coli||endonucleases||mapped_from
(tyr(3))octreotate||cyclopeptides||mapped_from
enoxolone, hyaluronic acid, levomenol, telmesteine, vitis vinifera drug combination||combination drug||mapped_from
ependymoma; papillary||neoplasm of uncertain or unknown behavior of brain||mapped_from
9,10-epoxy-7,8-dihydroxy-7,8,9,10-tetrahydro-5-methylchrysene||chrysenes||mapped_from
epo mimetic peptide 1||erythropoetin||mapped_from
ifp1 protein, human||transport proteins||mapped_from
2,5-dimethoxybenzylamine||benzylamine||mapped_from
atrophy; muscle, neuropathic (peroneal) (progressive)||hereditary motor sensory neuropathies||mapped_from
bilateral femoral hernias (diagnosis)||other abdominal hernia||mapped_from
benign membrane mucous pemphigoid||skin disease other||mapped_from
1-phenyl-1-benzazepine||benzazepines||mapped_from
malignant tumor of lower labial sulcus||malignant tumor of vestibule of mouth||mapped_from
degeneration; osseous labyrinth||other diseases of ear/mastoid||mapped_from
electrocardiogram: premature ventricular contractions (finding)||abnormal electrocardiogram [ecg] [ekg]||mapped_from
herpesvir inf perianal skn/rec||herpesviral infection of perianal skin and rectum||mapped_from
tyrosyl-norleucyl-glycyl-tryptophyl-norleucyl-aspartyl-phenylalaninamide||oligopeptide||mapped_from
gonorrhea of pharynx||gonorrhoea female||mapped_from
2-(6-chloro-2-(4-(2-fluoroethoxy)phenyl)imidazo(1,2-a)pyridin-3-yl)-n,n-diethylacetamide||pyridines||mapped_from
superficial foreign body of penis without major open wound but with infection||foreign body trunk-infec||mapped_from
rhinocladiella tropicalis c.m.p.s. azevedo, r.r. gomes, v.a. vicente & de hoog, 2016||ascomycotas||mapped_from
yaw||yaws, nos||mapped_from
gsk8470||anilines||mapped_from
n-(5-(1-(3-(2,2-bis(4-fluorophenyl)acetylamino)propyl)piperidin-4-yl)-2,4-difluorophenyl)isobutyramide||anilide||mapped_from
cyphobasidium hypogymniicola||phylum basidiomycota (organism)||mapped_from
small form histoplasmosis (diagnosis)||diseases infectious other||mapped_from
4-amino-1-((aminoacetyl)methylamino)-1,4-dideoxy-3-o-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-l-lyxo-heptopyranosyl)-6-o-methyl-l-chiro-inositol||aminoglycoside (substance)||mapped_from
c.pregnancy; transverse and oblique lie||pregnancy; high-risk||mapped_from
alpha-l-threofuranosyl nucleoside triphosphate||nucleoside, nos||mapped_from
2h-pyran-2-one, 4-hydroxy-6-undecyl-||pyrone (substance)||mapped_from
egl-20 protein, c elegans||caenorhabditis elegans proteins||mapped_from
syrosingopine (substance)||3,4,5-trimethoxybenzoyl methyl reserpate||mapped_from
cecum; fistula||fistulas intestinal||mapped_from
obstruction; nasopharynx||other pharyngeal disease nos (disorder)||mapped_from
xeroderma of right eyelid (diagnosis)||noninfectious dermatoses of eyelid||mapped_from
gyromitra infula (organism)||ascomycetes||mapped_from
1-cddpo||ketone, nos||mapped_from
cellulitis; neck||0-016 other infections of the skin||mapped_from
il-22 receptor||interleukin receptors||mapped_from
vitamin b12; deficiency, dementia (etiology)||[x]dement,oth sp dis cl elsewh||mapped_from
tetrahydrodithieno(2,3-b-2',3'-d)thieno(2'',3''c-2'',3''c')diquinolin-6,14-dione||thiophenes||mapped_from
structure of sciatic nerve||peripheral nerves of lower limb, including hip||mapped_from
cetyldimethylbenzylammonium chloride||product containing quaternary ammonium compound||mapped_from
(4,5)setrp||compounds, organoselenium||mapped_from
gaming disorder predominantly online||[x]other habit and impulse dis||mapped_from
linderane||sesquiterpene||mapped_from
isorhamnetin 3,7-di-o-glucopyranoside||3 hydroxy 4 keto flavonoids||mapped_from
hymen; closure||other diseases female genital system||mapped_from
kora protein, bacteria||gene product, bacterial||mapped_from
iv orf protein, camv||dna binding proteins||mapped_from
alzheimer disease type 1||dementia alzheimer||mapped_from
histop. duboisii +endocarditis||histoplasmosis due to histoplasma duboisii||mapped_from
4-dmpbd||butane||mapped_from
syphilis; early, latent||syphilis; early, latent||mapped_from
injury of sacral nerve root||injury of nerve root of lumbar and sacral spine||mapped_from
hemoglobin; fetal, hereditary persistent||hereditary persistence of fetal haemoglobin [hpfh]||mapped_from
chime||oth congenital malformation syndromes, nec||mapped_from
l-708,365||erythromycin||mapped_from
march hemoglobinuria||haemoglobinuria due to haemolysis from other external causes||mapped_from
talaromyces emodensis||talaromyce||mapped_from
under breathing||[x]other and unspecified abnormalities of breathing (finding)||mapped_from
fall in home (event)||fall down||mapped_from
finger agnosia||[x]other and unspecified symbolic dysfunctions (finding)||mapped_from
irhmrg cpd||glycosides||mapped_from
gum; tuberculous (manifestation)||[x]diso/oth spc dig org/dis ce||mapped_from
qua-quine starch protein, arabidopsis||arabidopsis proteins||mapped_from
cam kinase-like vesicle-associated protein, rat||nerve protein||mapped_from
exclamation mark hair||other hair colour and hair shaft abnormalities||mapped_from
neoplasm of uncertain behavior of talus (disorder)||neoplasm of uncertain behavior of bone and articular cartilage||mapped_from
dances||dancing||mapped_from
ggti-2133||imidazole||mapped_from
dna modification methylase ccrm||dna modification methylases (adenine-specific)||mapped_from
conjunctival lymphangiectasis||[x]other specified disorders of conjunctiva||mapped_from
tubaria keralensis||hymenogastrales||mapped_from
acute chorioamnionitis (disorder)||infct of amniotic sac and membrns, unsp, unsp tri, unsp||mapped_from
allergy to triclosan (finding)||allergy status to other anti-infective agents||mapped_from
torsion dystonia||dystonia; idiopathic, familial||mapped_from
sepsis; dialysis catheter||infect/inflm reaction due to oth cardi/vasc dev/implnt/grft||mapped_from
fluorecite||chemical, organic||mapped_from
bifidobacterium aesculapii||bifidobacterium (organism)||mapped_from
external ear; malposition, congenital, causing impairment of hearing||congenital anomaly;ear||mapped_from
cladonia merochlorophaea var. novochlorophaea sipman 1973||ascomycetes||mapped_from
myiasis; orbit (etiology)||ocular myiasis (disorder)||mapped_from
perfluoroadamantane||adamantane||mapped_from
myomontanone||sesquiterpene||mapped_from
interleukin 17 receptor e-like protein, human||il 17 receptors||mapped_from
cytoplasmic fmr1 interacting protein 1, mouse||signal transducing adaptor protein||mapped_from
spiro(imidazolidine-4,6'-morphinan)-2,5-dione, 4',5'-epoxy-3',14'-dihydroxy-17'-(2-propenyl)-, (5'alpha)-||imidazolidine 2,4 diones||mapped_from
lu-176 radioisotope||radionuclides||mapped_from
exposure to iodine||contact with and (suspected) exposure to other hazardous substances||mapped_from
klf2a protein, zebrafish||brachydanio rerio proteins||mapped_from
acidovorax soli choi et al. 2010||comamonadaceae||mapped_from
deafness, autosomal recessive 35||snd - sensorineural deafness||mapped_from
2-(6'-methoxy-3',4'-dihydro-1'-naphthyl)-4h-3,1-benzoxazin-4-one||benzoxazines||mapped_from
c 410||9 aminoacridine||mapped_from
4-chloro-n-(5-(((2-chloroquinolin-3-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)benzamide||quinolines||mapped_from
contusion; breast||contusion, breast (disorder)||mapped_from
nonomuraea purpurea suksaard et al. 2016||actinobacteria||mapped_from
unable to understand concept of danger||other symptoms and signs involving cognitive functions and awareness||mapped_from
pyromania (disorder)||firesetting (finding)||mapped_from
l-cysteine, mixt. with retinol, retinol acetate, sulfur and yeast||sulfur-containing product||mapped_from
4-(6,7-dihydro-5h-indeno(5,6-d)thiazol-2-yl)benzene-1,3-diol||resorcinols||mapped_from
bone; fracture, in neoplastic disease (manifestation)||pathologic fracture of bone at site of neoplasm||mapped_from
nfkbil1 protein, mouse||adaptor proteins, signal transducing||mapped_from
tetrahydrophthalamic acid||acids, phthalic||mapped_from
bilateral lower extremity edema||localised oedema||mapped_from
uterus; anomaly, in pregnancy or childbirth, causing obstructed labor, affecting fetus or newborn||perinatal morbidity other||mapped_from
marichromatium chrysaorae||thiocapsaceae bavendamm 1924||mapped_from
hemoglobin disease, nos||other hemoglobinopathies||mapped_from
4-(2-methylthiazol-4-yl)-n-(3,3,3-trifluoropropyl)benzamide||benzamides||mapped_from
3-o-acetylspectaline||piperidines||mapped_from
trimazosin||piperazines||mapped_from
child maltreatment; syndrome||child; abuse||mapped_from
cellulitis; periurethral||abscess (of) urethral (gland)||mapped_from
harknessia australiensis||ascomycota (fungus)||mapped_from
xenopus atonal homolog-3 protein, xenopus||basic helix-loop-helix transcription factor||mapped_from
matrix metalloproteinase 25||gpi-anchored proteins||mapped_from
duplication of clitoris||congenital malformation of clitoris (disorder)||mapped_from
1-fp-fp-obd-pib cpd||butanones||mapped_from
3-o-(alpha-l-rhamnopyranosyl(1-->2)-beta-d-xylopyranosyl(1-->3))-beta-d-+ ++glucopyranoide (25r,26r)-spirost-5-en-3beta,26-diol||saponins||mapped_from
child/parent violence||oth sp prob rel prim sup gp||mapped_from
infection; kidney, following abortion (subsequent episode)||disorder of pregnancy/delivery other||mapped_from
congenital coloboma of right eyelid||[x]other congenital malformations of eyelid (disorder)||mapped_from
ribosomal protein l17, mouse||proteins, ribosomal||mapped_from
cellulitis of left wrist||[x]cellulitis of other parts limb (disorder)||mapped_from
transmural; myocardial infarction, inferior wall||myocardial infarction (acute) nos||mapped_from
factor viii deficiency with vascular defect||other haemorrhagic conditions||mapped_from
(8s, 10s)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-l-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8²-valerate||product containing doxorubicin (medicinal product)||mapped_from
conjunctival cysts||other conjunctival vascular disorders and cysts||mapped_from
fyua protein, e coli||cell receptors||mapped_from
alveolitis due to cryptostroma corticale||maple bark strippers' lung||mapped_from
abdominal rigidity of epigastrium||abdominal rigidity epigastric||mapped_from
leptographium multifidum||ophiostomatales||mapped_from
tulasnella bifrons bourdot & galzin, 1924||basidiomycotas||mapped_from
arthrographis cuboidea (sacc. & ellis) sigler||fungus sac||mapped_from
haemophilia b without inhibitors||hemophilia bs (m)||mapped_from
congenital cardiac defects multiple||congenital heart disease||mapped_from
progressive; chorea, hereditary||oth dis of neurol system||mapped_from
programmed cell death 10b protein, zebrafish||proto-oncogene products, cellular||mapped_from
primary syphilis of nipple||[x]primary syphilis of other sites||mapped_from
fetal malnutrition, without mention of light or small for gestational age (disorder)||infant not underweight for age showing signs of foetal malnutrition as dry peeling skin and loss of subcutaneous tissue||mapped_from
non-malignant female frozen pelvis||[x]other specified conditions associated with female genital organs and menstrual cycle||mapped_from
parishin f||glucosides||mapped_from
trichococcus alkaliphilus dai et al. 2018||carnobacteriaceae||mapped_from
2-(3-cyano-6-methoxyquinolin-2-ylthio)-n-(2-methoxy-5-methylphenyl)acetamide||1 benzazine||mapped_from
kl10 protein, cricetulus griseus||protein product||mapped_from
nonorganic origin; sleep rhythm inversion||sleep dysfunction||mapped_from
tracheobronchial collapse||other diseases of respiratory system||mapped_from
zinc finger with krab and scan domains 5 protein, human||factors transcription||mapped_from
9-hydroxypiperitone glucopyranoside||cyclohexanones||mapped_from
fgf-1 (112-147)||heparin binding fibroblast growth factor class i||mapped_from
eye malignant lymphoma conjunctiva||non-hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck||mapped_from
injury; orbit, orbital, penetrating (with foreign body)||penetrating wound of orbit with or without foreign body||mapped_from
succinimidyl n-(n'-(3-azido-5-nitrobenzoyl)-tyr)7beta-ala||dipeptide (substance)||mapped_from
upper thoracic spina bifida aperta||thoracic spina bifida without hydrocephalus||mapped_from
caesalpinetate||diterpenoid||mapped_from
2-amino-5-hydroxyacetophenone||acetophenones||mapped_from
abuse, cannabis||mental and behavioural disorders due to use of cannabinoids, harmful use||mapped_from
ethylene glycol methacrylate phosphate||methacrylates||mapped_from
clitopilus brunnescens||toadstool||mapped_from
n-methylacrylamide||acrylamides||mapped_from
product containing iodine-125||iodine radioesotope, nos||mapped_from
history of abnormally low blood pressure||personal history of other diseases of the circulatory system||mapped_from
1-octyl-3-(1-naphthoyl)indole||naphthalenes||mapped_from
esteya vermicola||ophiostomatale||mapped_from
cyst; pilar||follicular isthmus cyst||mapped_from
epinectin||proteins, neoplasm||mapped_from
bank, eye||banks, eye||mapped_from
slc7a9 protein, human||cationic amino acid transport proteins||mapped_from
glutarimidoxioxime||oxime||mapped_from
iridocyclitis; gonococcal infection (manifestation)||oth inf/inflam of eye (excl herpes)||mapped_from
galpha14 protein, mouse||gtp binding protein alpha subunits, gq g11||mapped_from
patient given advice about management of depression (situation)||other specfd counseling||mapped_from
abscess; peritoneal, tuberculous (etiology)||tuberculosis (diagnosis)||mapped_from
3',4'-dihydroxy-5,6,7,8-tetramethoxyflavone||flavones||mapped_from
placental dysfunction||[x]other placental disorders (disorder)||mapped_from
1-cyano-3-butene||alkene (substance)||mapped_from
sore mouth - symptom||[x]oth+unspc lesns/oral mucosa||mapped_from
brain; tubercle (etiology)||other infect neurol system||mapped_from
rtbp1 protein, oryza sativa||telomere binding protein||mapped_from
1h-imidazole-1-ethanol, 2-methyl-5-nitro-, mixture with 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-1h-imidazole||2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole||mapped_from
an6426||boron compound, nos||mapped_from
(3s)-1-(5-tert-butyl-3-((1-cyclopropyltetrazol-5-yl)methyl)triazolo(4,5-d)pyrimidin-7-yl)pyrrolidin-3-ol||tetrahydropyridine||mapped_from
difficulty removing waste plug (finding)||[v]other problems related to life-management difficulty||mapped_from
mphbm protein, staphylococcus aureus||bact protein||mapped_from
fugax; proctalgia||anal spasm||mapped_from
myocardial diseases, primary||[x]other forms of heart disease||mapped_from
mental retardation; family history||[v]family history of mental retardation (situation)||mapped_from
ramariopsis cremicolor||mushroom (organism)||mapped_from
hilus cell tumor of ovary (disorder)||benign neoplasm ovary||mapped_from
hypocalcaemia syndrome||calcium blood decreased||mapped_from
bone neoplasm uncertain behavior lower limb first cuneiform of foot||unc behav neo bone||mapped_from
glandulae laryngeales||malig neop larynx nos||mapped_from
dlam-1p compound||lactam (substance)||mapped_from
atsp-7041||circular peptide||mapped_from
sting or bite; poisoning, marine animal||[x]toxic effect of contact with other marine animals (disorder)||mapped_from
phyllanthacidoid b||sesquiterpene derivatives||mapped_from
ndufs4 protein, mouse||electron transport complex i||mapped_from
prv protein, e coli||dna repair enzymes||mapped_from
sam4 protein, s cerevisiae||homocysteine methyltransferase, s-methylmethionine||mapped_from
macula multifoc placoid lesion||[x]oth specfd retinal disordrs||mapped_from
hemoglobinopathy; osteonecrosis (etiology)||osteonecrosis due to hemoglobinopathy (disorder)||mapped_from
pelobium manganitolerans||bacteroides-cytophaga-flexibacter group||mapped_from
osteoclast-associated receptor, mouse||recept cell surface||mapped_from
laceration of vagina following induced termination of pregnancy||damage to pelvic organs fol (induced) term of pregnancy||mapped_from
stuttering, familial persistent 2||non-fluent speech||mapped_from
farnesyl anthranilate||2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-||mapped_from
dihydrotestosterone propionate||stanolone||mapped_from
(3r,3's,6'r)-lutein||(3r,3'r,6'r)-beta,epsilon-carotene-3,3'-diol||mapped_from
spastic paraplegia with precocious puberty||paraplegia, spasmodic infantile||mapped_from
dothiora cannabinae froidevaux, 1972||ascomycota||mapped_from
spotting periods||spotting periods||mapped_from
cicuta||cicuta||mapped_from
prolactin-rf||placental hormone (substance)||mapped_from
suicide; observation following alleged attempt||[x]observation for other suspected diseases and conditions (context-dependent category)||mapped_from
[x]other haemoglobinopathies||other specified hereditary hemolytic anemias (disorder)||mapped_from
k24 antigen, e coli-k24-h||bacterial antigens||mapped_from
p-(chlorodimethylsilyl)styrene||styrenes||mapped_from
2,2,2,-trichloro-1-(3,4-dichlorophenyl)-ethylacetate||chlorinated hydrocarbon, nos||mapped_from
mineral deficiency, nec in icd9cm_2014||magnesium defic||mapped_from
hypomyces albidus||hypocreale||mapped_from
2-amino-4-(4-chlorophenyl)-5-methylthiazole||thiazole (substance)||mapped_from
cone dystrophy with supernormal rod response (disorder)||hereditary retinal dystrophy (disorder)||mapped_from
biperiden allergy||allergy status to other drug/meds/biol subst||mapped_from
4-(4-(3,4-difluorophenyl)pyrimidin-2-yl)-n-(pyridazin-3-yl)piperazine-1-carboxamide||pyridazines||mapped_from
n-hydroxy-n'-methylurea||product containing urea (medicinal product)||mapped_from
carbuncles on upper arm (physical finding)||carbuncle of limb||mapped_from
adenosquamous cell carcinoma of larynx||ca larynx - nos||mapped_from
leukoencephalopathy, metachromatic||endocrine/metabolic/nutritional disease other||mapped_from
fistula; nasolacrimal duct||other eye disorders (disorder)||mapped_from
progressive palmoplantar keratoderma of greither (disorder)||other specified congenital anomalies of skin||mapped_from
saprochaete quercus||endomycetales||mapped_from
cyclohexylcarbamic acid biphenyl-3-yl ester||biphenyl cpds||mapped_from
history of intestinal by-pass (situation)||intestinal bypass and anastomosis status||mapped_from
inocybe metrodii||mushroom||mapped_from
pfp 6||propiophenones||mapped_from
6-addopoa||sugars, amino||mapped_from
foodborne botulism, type b (disorder)||botulism food poisoning||mapped_from
fetus or newborn affected by hypotonic uterine dysfunction (disorder)||[x]f+n af/o spc complc/lab+del||mapped_from
questinomycine a||oxazines||mapped_from
psychosis; organic, endocrine, acute or subacute||[x]other delirium||mapped_from
dyspepsia/indigestion||indigestions||mapped_from
arm; anomaly||congenital musculoskeletal abnormality, nos||mapped_from
gymnopus polygramma||nidulariales||mapped_from
1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine||carbocyanines||mapped_from
benign hard palate tumor||benign neo/o+unsp prt/mouth||mapped_from
optic nerve haemorrhage||disorders of optic nerve, not elsewhere classified||mapped_from
hypogonadism, male, with mental retardation and skeletal anomalies||intellectual functioning disability||mapped_from
disorder; mental, due to use of, cocaine||abuse; drugs||mapped_from
rhodotorula armeniaca||phylum: dikaryomycota||mapped_from
coat protein, brome mosaic virus||capsid proteins||mapped_from
2(5h)-furanone, 5-(2,4,6-tetradecatriene-8,10-diynylidene)-, (z,e,e,e)-||lactone (substance)||mapped_from
dental periosteum; suppuration||disease of teeth/gums||mapped_from
varicose veins of vulva in puerperium (disorder)||venous compl nec-postpar||mapped_from
membrana tympanica||ear drum, nos||mapped_from
glass in lower leg||oth superfic inj lower leg||mapped_from
liver; deformity||[x]oth cong malforms of liver||mapped_from
sensitised platelet||platelets; defect||mapped_from
disease caused by leporipoxvirus (disorder)||other specified viral infections characterized by skin and mucous membrane lesions||mapped_from
gpr22 protein, mouse||recept g protein coupled||mapped_from
inflammation; catheter, infusion catheter, spinal||infec & inflam react due oth int prosth device/imp/graft||mapped_from
other specified candidiasis||candidal meningitis (disorder)||mapped_from
exaggeration of ankle reflex (finding)||[d]abnormal reflex, unspecified (context-dependent category)||mapped_from
enterocolitis hemorrhagic||oth diseases digest system||mapped_from
severe protein calorie malnutrition||[x]unspec sev prot-energy maln||mapped_from
cicutol||fatty alcohols||mapped_from
institutional care||institutionalizations||mapped_from
nbzg-peg||glycol, polyethylene||mapped_from
vesiculin peptide||somatomedin a||mapped_from
zinc finger, imprinted 2 protein, human||kruppel-like factors||mapped_from
threatened abortion in first trimester||threatened abortion (antepartum) (disorder)||mapped_from
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine||whole cell bordetella pertussis and clostridium tetani toxoid adsorbed and corynebacterium diphtheriae toxoid antigens-containing vaccine product||mapped_from
hyperbilirubinemia; familial conjugated||[x]other bilirubin metabolism disorders||mapped_from
vascular ring with left aortic arch and right arterial duct arising from aberrant retroesophageal right subclavian artery (disorder)||other anomalies of aorta nos (disorder)||mapped_from
ha15 compound||product containing sulfonamide||mapped_from
brachmann-de lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay||de lange syndrome (disorder)||mapped_from
splint; adjustment||[x]oth spec orthop f'-up care||mapped_from
addnc||fluoroquinolones||mapped_from
3-phtb-quinoxalinone||hydrazone||mapped_from
first degree burns of ear||erythema due to burn [first degree] of ear [any part]||mapped_from
mdl 20646||pyridine||mapped_from
tn552 beta-lactamase, s haemolyticus||beta lactamase||mapped_from
jaw; ameloblastoma, upper jaw||neoplasm musculoskeletal benign/unspecified||mapped_from
gasteriacenone a||anthracenes||mapped_from
levels, high cholesterol||hyperlipidemia, group a (disorder)||mapped_from
grifola gargal||grifola||mapped_from
sox1 protein, mouse||soxb1 transcription factors||mapped_from
calculus; bladder diverticulum||stone, bladder||mapped_from
sspb specificity factor, e coli||escherichia coli proteins||mapped_from
chaetomium incomptum||chaetomium, nos||mapped_from
gla-af adjuvant||1,2 dipalmitoylphosphatidylcholine||mapped_from
sargafuran||furans||mapped_from
bikaverin||xanthone derivatives||mapped_from
adjustment; change of job problem||problems at work (finding)||mapped_from
francisella adeliensis||francisella||mapped_from
anomalous intramural course of proximal portion of coronary artery within aortic sinus of valsalva||malformations of coronary vessels (diagnosis)||mapped_from
pradimicin h||anthracyclines||mapped_from
silica; granuloma||skin disease other||mapped_from
simmonds; cachexia||pituitary hypofunction||mapped_from
salmonella; meningitis (manifestation)||meningitis in bacterial diseases classified elsewhere (diagnosis)||mapped_from
atrophoderma; senile||skin disease other||mapped_from
chlorexolone||sulfonamide-containing product||mapped_from
verruga peruana||cutaneous/mucocut bartonellos||mapped_from
7-hydroxy-6-(3-(pyrrolidin-1-yl)propoxy)-2h-chromen-2-one||coumarins||mapped_from
citrex s-5||carboxylic acid||mapped_from
n-(3-(aminomethyl)benzyl)acetamidine||benzylamines||mapped_from
disease (or disorder); tubulo-interstitial, systemic lupus erythematosus (etiology)||systemic lupus erythematosus with organ or system involvement||mapped_from
n-acetylcysteinylcobalamin||(2r)-2-amino-3-mercaptopropanoic acid||mapped_from
defined green tea catechin extract||(+)-catechin||mapped_from
anomaly; thyroid cartilage||other anomaly of larynx, trachea or bronchus nos||mapped_from
deficiency of creatine kinase (disorder)||other specified metabolic disorders||mapped_from
poly(phthalic anhydride-co-trimellitic anhydride-co-glycols)||phthalic anhydrides||mapped_from
hernia, crural pectineal||unilateral femoral hernia, without obstruction or gangrene, not specified as recurrent||mapped_from
cytokine inducible sh2-containing protein||socs family protein||mapped_from
kericembrenolide d||lactones||mapped_from
central nervous system; syphilitic, with taboparesis||syphilis female||mapped_from
1,5-anhydroxylitol||xylimelts||mapped_from
sleepiness||coma (nos)||mapped_from
eosinophilic polymyositis||neuromyositis||mapped_from
2-(6-(1-hydroxy-cyclohexyl)-pyridin-2-yl)-1h-indole-5-carboxamidine||pyridines||mapped_from
sinaconitine b||diterpenoids||mapped_from
cardiotin||actinin||mapped_from
cervix; canal, stricture, in pregnancy or childbirth||[x]maternal care for other abnormalities of cervix (procedure)||mapped_from
tuberculous interstitial keratitis||tuberculous keratitis (diagnosis)||mapped_from
te80a||ostamer||mapped_from
co(a-b-) phenotype||encounter due to unspecified blood type, rh positive||mapped_from
balaxiflorin b||glycoside||mapped_from
pdcd10 protein, mouse||regulatory protein, apoptosis||mapped_from
microgemma tincae||microsporidian||mapped_from
2-(4-(aminosulfonyl)phenyl)-3-(4-methoxyphenyl)-1h-indole||indole compound||mapped_from
bhsa||other disorders of tyrosine metabolism||mapped_from
thrombocytopenia, neonatal||neonatal; thrombocytopenia, transitory||mapped_from
mucus gp sulfotransferase||sulfotransferase (substance)||mapped_from
n,n,n',n'-tetrakis(6-pivalamido-2-pyridylmethyl)-1,3-diaminopropan-2-ol||pyridines||mapped_from
unilateral maldescent of testis (situation)||undescended testicle (disorder)||mapped_from
non-muscle myosin heavy chain-b||myosin b||mapped_from
lcta-949||teicoplaninum||mapped_from
alpha-fluoro-n-(3-(amimomethyl)phenyl)acetamidine||amidine||mapped_from
sphingomonas crusticola zhang et al. 2017||sphingomonas yabuuchi et al. 1990 emend. busse et al. 2003||mapped_from
neurosensory nonsyndromic recessive deafness 9||sensoryneural deafness||mapped_from
nosomania||neurosis; hypochondriacal||mapped_from
full thickness burn of multiple sites of arm||burn of third degree of shoulder and upper limb, except wrist and hand||mapped_from
procyanidin b1||biflavonoid||mapped_from
2-hghmdm cpd||lignan||mapped_from
n-methoxyindole-3-carbinol||indole||mapped_from
laryngospasms||other respiratory system diseases||mapped_from
teratosphaeria encephalarti||ascomycotas||mapped_from
aristoquinoline c||ethyl ether||mapped_from
mg7ag antigen, human||antigens, neoplasm||mapped_from
lichenoides pityriasis||parapsoriasis varioliformis chronica||mapped_from
aromatic-aminoadipate aminotransferase 1 protein, s cerevisiae||s cerevisiae proteins||mapped_from
esa36 protein, streptomyces thermoviolaceus||gene products, bacterial||mapped_from
8-hydroxyisoscoparin||flavonoids||mapped_from
vaccines malaria||vaccine malaria||mapped_from
citrobacter europaeus||citrobacter (organism)||mapped_from
human spumaretrovirus infection||retrovirus infection (diagnosis)||mapped_from
carbarsone||p-aminophenylarsonic acid||mapped_from
fulvophyton cerei (schiman-czeika) tehler, 2017||sac fungi||mapped_from
3-amptm-acrylonitrile||2-propenenitrile||mapped_from
acute leukaemia nos||leukemia acute||mapped_from
ramopenidiella cycadicola||ascomycotas||mapped_from
middle ear not seen (finding)||[x]o spc disor/mid ear+mastoid||mapped_from
amyotrophic lateral sclerosis als9||sclerosis; spinal, lateral (amyotrophic)||mapped_from
phytoene desaturase||oxidoreductase, nos||mapped_from
memory: present month not knwn||other amnesia||mapped_from
halomonas stevensii kim et al. 2010||genus halomonas (organism)||mapped_from
buopy cpd||propanoates||mapped_from
paracoccus sulfuroxidans||paracoccus davis 1969 (approved lists 1980) emend. liu et al. 2008||mapped_from
chronic plaque-like oral candidosis (disorder)||oral muguet||mapped_from
aikupikoxide c||terpene compound||mapped_from
2-bmdb||coumarone||mapped_from
history of corneal erosion||[v]personal history of nervous system disease||mapped_from
dictyonamide b||oligopeptides||mapped_from
n(epsilon)-cyclosuccinyllysine||l-lysin||mapped_from
rarasaponin v||saponins||mapped_from
hepatic venoocclusive disease with immunodeficiency||disease (or disorder); liver, veno-occlusive [vod]||mapped_from
male with 46,xx karyotype||deformity; multiple||mapped_from
female infertility of tubal origin - primary||female infert-tubal origin nos||mapped_from
congenital pulmonary stenosis||congenital cvs anomaly nos (disorder)||mapped_from
phlebitis of central nervous system venous sinus nos||intracranial and intraspinal phlebitis and thrombophlebitis||mapped_from
beta-catenin-like protein 1, mouse||nuclear proteins||mapped_from
poly(4,4'-diphenylenevinylene)||polyvinyl||mapped_from
nonomuraea indica quadri et al. 2016||class actinobacteria (organism)||mapped_from
immunate solvent detergent, human||antihaemophilic factor a||mapped_from
carp protein, card-containing||gene product||mapped_from
plpp3 protein, human||phosphatase, phosphatidic acid||mapped_from
cep protocol||lomustina||mapped_from
4'-(1-(((6,7-dichloro-3- oxo-2,3-dihydro-4h-1,4-benzoxazin-4-yl)acetyl)(methyl)amino)-2-(4-morpholinyl)ethyl)-4-biphenylcarboxylic acid||benzoates||mapped_from
p(hpg-prazosin carbamate)||peptide||mapped_from
secondary malignant neoplasm of diaphragm||secondary malig neo nec||mapped_from
n(alpha)-tosyl-glycyl-3-amidinophenylalanine||dipeptides||mapped_from
erf2 protein, gossypium||plant proteins||mapped_from
barbamide||thiazole||mapped_from
conjunctiva; calcification||conjunctival degenerations and deposits (disorder)||mapped_from
atp1a1 protein, rat||sodium potassium atpase||mapped_from
dupuytren's disease of palm of left hand||dupuytren's disease of palm, with contracture||mapped_from
serum bilirubin borderline low||[x]oth sp abn find blood chem||mapped_from
h/o: polymenorrhea||personal history of diseases of genitourinary system||mapped_from
pelvic organ; malposition||high-risk pregnancy||mapped_from
kcnk6 protein, rat||k channel baseline||mapped_from
endemic goiter||[x]iodine-deficiency-related (endemic) goiter, unspecified (disorder)||mapped_from
triggering receptor expressed on myeloid cells 2||immune receptor||mapped_from
transient neonatal hyperglycaemia||[x]other transitory disorders of carbohydrate metabolism of fetus and newborn||mapped_from
tuberculosis; respiratory, with bacteriological and histological confirmation||respiratory tuberculosis, bacteriologically and histologically confirmed||mapped_from
zfpn1a2 protein, mouse||binding protein, dna||mapped_from
rheumatic; aortitis||rheumatic fever with heart involvement (disorder)||mapped_from
malignant cranial nerve neopl||malignant tumor cranial nerve||mapped_from
nose; underdevelopment||atresia; nose||mapped_from
neodevriesia stirlingiae (crous) crous, 2015||phylum ascomycota||mapped_from
ftz-f2 protein, drosophila||proteins, drosophila||mapped_from
vm - vascular malformation||aneurysm - lesion (qualifier value)||mapped_from
paget's disease-lumbar spine (disorder)||osteitis deformans of vertebrae||mapped_from
abnormality of the bone of the forehead||other musculoskeletal disorder nos (disorder)||mapped_from
cnto3157||mab||mapped_from
adverse effect; anesthesia, spinal and epidural, headache||complications of medical and surgical care||mapped_from
benzoic acid, malic acid, propylene glycol, salicylic acid drug combination||salicylate (product)||mapped_from
8-methylnonanoic acid 3-hydroxy-4-methoxy benzyl ester||capsaicin (product)||mapped_from
(4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone||triazoles||mapped_from
6,7-dimethoxy-2,3-dimethylquinoxaline||quinoxaline||mapped_from
mycoril||pentaerithrityl tetranitrate (substance)||mapped_from
nisc-6||nitriles||mapped_from
septum; incomplete||vsd||mapped_from
n-methyl-3-(methoxycarbonyl)-4-hydroxy-2-pyridone||pyridinone||mapped_from
mitochondrial rna editing factor 10, arabidopsis||arabidopsis proteins||mapped_from
dm-aob-b cpd||lactone (substance)||mapped_from
nunduva britannica hauer 2018||algae, blue-green||mapped_from
golovinomyces circumfusus (schltdl.) u. braun, 2012||division ascomycota (organism)||mapped_from
venereal; salpingitis (etiology)||female gonococcal pelvic inflammatory disease||mapped_from
phthiodiolone ketoreductase||carbonyl reductase||mapped_from
birth premature||complicated delivery deadborn||mapped_from
unable to take turns in conversation (finding)||cognitive communication deficit||mapped_from
chaetomium jabalpurense||chaetomium||mapped_from
3-((benzyloxy)methyl)morpholine||tetrahydrooxazines 01 04||mapped_from
piperlactam s||lactams||mapped_from
sulfurmycin a||anthracycline||mapped_from
polyarteritis nodosa; dementia (etiology)||[x]o+unsp diso/circulatry syst||mapped_from
gtp-binding protein rheb homolog, drosophila||rheb gtpase||mapped_from
first degree burn of left forearm||erythema of shoulder and upper limb, except wrist and hand||mapped_from
oxyhemoglobin oxidase||dehydrogenase (substance)||mapped_from
occupational; cramp(s), organic||[x]other specified extrapyramidal and movement disorders||mapped_from
late effect of injury to blood vessel head/neck/extremities||sequelae of other specified injury of head||mapped_from
cobalt carbide||co - cobalt||mapped_from
aldh protein, staphylococcus aureus||aldehyde oxidoreductase||mapped_from
fps||cong malform syndr-facial app||mapped_from
familial spastic paraplegia with kallmann's syndrome||paraplegia, hereditary spastic||mapped_from
prominent leg veins - symptom||[x]other specified symptoms and signs involving circulatory and respiratory systems (finding)||mapped_from
uterus; suppuration||uterus; inflammation||mapped_from
deinococcus aquivivus||deinococcus||mapped_from
dependent; on machine||[x]dependence on other enabling machines and devices (finding)||mapped_from
robo2 protein, xenopus||xenopus proteins||mapped_from
as - aortic stenosis||aortic defects valve||mapped_from
disease (or disorder); respiratory tract, chronic, fetus or newborn||perinatal chronic respiratory disease nos||mapped_from
1-((9-deazahypoxanthin-9-yl)methyl)-3-hydroxy-4-hydroxymethylpyrrolidine||hypoxanthines||mapped_from
propofol allergy||[v]personal history of anesthetic agent allergy (situation)||mapped_from
pseudocamarosporium pinicola wijayaw., camporesi & k.d. hyde, 2015||ascomycotas||mapped_from
nosd protein, pseudomonas stutzeri||proteins, bacterial||mapped_from
tc007||product containing aminoglycoside||mapped_from
2-amino-7-isopropyl-5-oxo-5h-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid||aminopyridines||mapped_from
glucosyl hesperidin||glucosides||mapped_from
enanthematous infectious disease (disorder)||infectious and parasitic diseases nos||mapped_from
acquired fixed flexion deformity of elbow (disorder)||flexion deformity, unspecified elbow||mapped_from
erythema over frontal sinus (finding)||[x]other specified disorders of nose and nasal sinuses||mapped_from
multiple superficial injuries of abdominal wall (disorder)||mult sup inj abd/low back/pelv||mapped_from
p1188||pyridine||mapped_from
adhesions of iris (disorder)||unspecified adhesions of iris and ciliary body, unspecified eye||mapped_from
vacuolating virus||simian vacuolating virus||mapped_from
mulberrofuran c||benzofurans||mapped_from
persistent depressive disorder||other depressive episodes||mapped_from
laccocephalum mylittae (cooke & massee) nunez & ryvarden||family polyporaceae||mapped_from
collinsella tanakaei (organism)||actinobacteria class||mapped_from
na(+)-translocating nqr subunit f, vibrio alginolyticus||flavoprotein||mapped_from
ccfdn||craniofacial abnormalities||mapped_from
abnormal fear||abnormal fear||mapped_from
myocardium; insufficiency, rheumatic||rheumatic fever with heart involvement (disorder)||mapped_from
4-(hydroxymethyl)-2-pentadecyl-1,3-dioxolane||dioxolanes||mapped_from
agaricus coniferarum||agaricus l., 1753||mapped_from
speract||oligopeptides||mapped_from
tropical steatorrhea||tropical steatorrhoea||mapped_from
tulostoma calongei||tulostomatales||mapped_from
21,21,21-trifluoroapovincaminic acid ethyl ester||vinca alkaloid||mapped_from
methyl 2-((3,5-dimethylpyrazole-4-yl)hydrazono)4-methoxy-3-oxobutyrate||hydrazone||mapped_from
2-(1-phenyl-1h-benzo(d)imidazol-2-yl)phenol||phenol compound||mapped_from
brain vascular anomalies||other malformations of cerebral vessels||mapped_from
liquorilactobacillus capillatus||lactobacillus (organism)||mapped_from
mvap53||cancer vaccines||mapped_from
cell division cycle 20 homolog (s. cerevisiae), mouse||cdc20 proteins||mapped_from
pandoraea faecigallinarum sahin et al. 2011||family burkholderiaceae (organism)||mapped_from
nr3a nmda receptor||methyl aspartate receptors nd||mapped_from
1-pentanoyl-n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pyrrolidine-2-carboxamide||2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole||mapped_from
t-lgl leukemias||other lymphoid leukemia not having achieved remission||mapped_from
malate homopolymer||malates||mapped_from
infection caused by rodentibacter pneumotropicus||pasteurellosis nos (disorder)||mapped_from
parturient haemorrhage associated with afibrinogenaemia||premature separation of placenta, unspecified as to episode of care||mapped_from
hppp-enone||1,3 diphenyl propenones||mapped_from
irpex consors berk.||aphyllophorales||mapped_from
hb tianshui||hemoglobins abnorm||mapped_from
discoloration of kidney||[x]other specified disorders of kidney and ureter (disorder)||mapped_from
vasculitis; syndrome||leukocytoclastic angiitides, cutaneous||mapped_from
neoplasm of uncertain behaviour of inguinal region, nos||uncert. neopl. other specif.||mapped_from
education; health||other general/unspecified diseases||mapped_from
5-chloro-3-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)benzo(d)thiazol-2(3h)-one||benzothiazoles||mapped_from
taraxinic acid glucopyranosyl ester||glucosides||mapped_from
pca-principal compon analysis||analysis, principal component||mapped_from
ir76b protein, drosophila||ionotropic glutamate receptors||mapped_from
retina; disorder, batten(-mayou) (etiology)||endocr/metab/nutrit disease other||mapped_from
injury to other specified nerves of pelvic girdle and lower limb||tibial nerve injury at lower leg level (diagnosis)||mapped_from
d1 protein, mealworm beetle||insect protein (substance)||mapped_from
cerebellar; hemorrhage, traumatic||other head injury without skull fracture||mapped_from
w84 compound||ammonium compounds, quaternary||mapped_from
mirn362 microrna, human||mirna||mapped_from
methemoglobinemia; acquired||increased methemoglobin (biological function)||mapped_from
myocarditis; septic||infectious disease circulatory system||mapped_from
carbohydrate agent (substance)||dietary carbohydrate||mapped_from
hb turriff||abnormal haemoglobin, nos||mapped_from
lymphadenitis submandibular||tongue/mouth/lip disease||mapped_from
myelin basic protein (87-99), ala(91,96)-||myelin basic protein (substance)||mapped_from
secondary malignant soft tissue neoplasm of trunk (diagnosis)||[x]2ndry mal neo/oth spec site||mapped_from
cuc1 protein, c elegans||caenorhabditis elegans proteins||mapped_from
abscess of left breast with lactation||abscess of breast associated with childbirth||mapped_from
open protocol||antineoplastic agent, combined||mapped_from
upper eyelid entropion (disorder)||unspecified entropion of unspecified eye, unspecified eyelid||mapped_from
propanamide, n-((1,5,6,7,9,10,13,14,14a,15-decahydro-7-hydroxy-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4h-isoquino(3,2-b)(3)benzazocin-9-yl)methyl)-2-oxo-||isoquinolines||mapped_from
phimosis of lens capsule||other specif disorders/lens||mapped_from
cti protein, pseudomonas putida||cis trans isomerase||mapped_from
ureterovesical orifice; contracture||kinking and stricture of ureter without hydronephrosis||mapped_from
pregnancy; disorder, blood||pregnancy/outcome at risk: (high risk)||mapped_from
di-trapex||propane (substance)||mapped_from
lipase binding protein, rat||cell surface receptor||mapped_from
hypomyces polyporinus peck, 1873||hypocreale||mapped_from
persistent mood disorder||mood disorder of depressed type||mapped_from
disease fibrocystic||other endocr/nutr/metab disord||mapped_from
fusarium hainanense m.m. wang, qian chen & l. cai, 2019||albonectria rossman & samuels, 1999||mapped_from
linaroside||glucosides||mapped_from
tuberculosis; suprarenal gland (manifestation)||infection caused by mycobacterium tuberculosis (disorder)||mapped_from
brevibacillus gelatini||bacillus brevis group||mapped_from
lysinibacillus telephonicus||bacillaceae (organism)||mapped_from
dentu hold||carboxymethylcellulose sodium, unspecified form||mapped_from
glandular function, exocrine, increased||[x]other specified diseases of the digestive system||mapped_from
perfluoro-fmiq||fluorocarbons||mapped_from
pt(asb)(2)cl(2)||organoplatinum compounds||mapped_from
ergotism; ergot used as drug (migraine therapy), overdose or wrong substance||poisoning by oxytocic agents||mapped_from
cladophialophora humicola||ascomycetes||mapped_from
radioactive substances; eczema||solar keratosis/sunburn||mapped_from
secondary malignant neoplasm of vocal cord||secondary malignant neoplasm of other respiratory organs||mapped_from
ypl179w protein, s cerevisiae||saccharomyces cerevisiae proteins||mapped_from
2-((phenylselanyl)methyl)pyrrolidine||compounds, organoselenium||mapped_from
rega protein, rhodobacter sphaeroides||bact protein||mapped_from
belumosudil||acetamides||mapped_from
gamma-aminobutyric acid (gaba) receptor, rho 1, human||gaba benzodiazepine receptors||mapped_from
hernia; paraesophageal, congenital||hiatal; hernia, congenital||mapped_from
5-chloro-n-cyclopropylmethyl-n-(2,6-dichloro-4-iodophenyl)-2-methyl-n-propylpyrimidine-4,6-diamine||cyclopropanes||mapped_from
vn 87-1||triazole (substance)||mapped_from
anterior dysphasia (disorder)||dysphasias||mapped_from
3-acetoxy-2,2'-bi-1h-indole||indole compound||mapped_from
squamanita pearsonii||mushroom (organism)||mapped_from
bcchs7 protein, botrytis cinerea||chitin-udp acetylglucosaminyltransferase||mapped_from
diethylamine hydrogen sulfite||diethylamines||mapped_from
oophoritis; complicating pregnancy||infections of the genital tract in pregnancy (disorder)||mapped_from
congenital lymphangiectasia with chylous reflux (disorder)||oth spcfd noninfectv disordrs/lymphatc vessls+lymph nodes||mapped_from
cdr factor||furans||mapped_from
web of larynx, subglottic||congenital laryngeal web||mapped_from
acute infective polyneuritis||guillain-barré||mapped_from
4-bdbdt||benzodiazepines||mapped_from
meconium stained liquor - grade ii||lab+del compl/mec in amnio fld||mapped_from
xpv||epitheliomatosis; pigmented||mapped_from
evans' syndrome (diagnosis)||thrombocytopenia, nos||mapped_from
4-nitrobenzofurazan||oxadiazoles||mapped_from
(4s)-n-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline||isoquinolines, 1,2,3,4-tetrahydro-||mapped_from
antenatal care: gynecological risk (situation)||supervision of high risk pregnancy, unsp, unsp trimester||mapped_from
mycena chlorophos||champignon||mapped_from
peripheral neuralgia (finding)||neuralgia/neuritis - nos||mapped_from
des(ala-lys)-calmodulin||activator, phosphodiesterase protein||mapped_from
sclerostagonospora rosae wanas., e.b.g. jones & k.d. hyde, 2018||division ascomycota (organism)||mapped_from
tetra-mu3-bromotetrakis((triphenylphosphite-p)copper(i))||organic phosphorus compound (substance)||mapped_from
explosion in watercraft, occupant small powered boat injured||acc unsp craft caus oth inj||mapped_from
dalteparin allergy (disorder)||allergy status to other drugs, medicaments and biological substances||mapped_from
pcau protein, acinetobacter||bacterial gene protein||mapped_from
cervical malignant germ cell tumour||malignant neoplasm of cervix uteri||mapped_from
nails dirty||[x] other symptoms and signs involving appearance and behavior||mapped_from
ent-kaurane-6beta,16alpha-diol-3-one||diterpenoid||mapped_from
vertebrogenic pain syndrome||backache symptom nos (finding)||mapped_from
n-(6-ethoxybenzo(d)thiazol-2-yl)cyclohexanecarbothiamide||benzothiazoles||mapped_from
at3g05530 protein, arabidopsis||arabidopsis proteins||mapped_from
slt70 protein, e coli||glycohydrolases||mapped_from
spousal abuser||assault/harmful event problem||mapped_from
syphilis; endocarditis, mitral valve (manifestation)||syphilis female||mapped_from
syntaxin binding protein 5 (tomosyn) protein, human||r-snare proteins||mapped_from
11,15-eicosadienoic acid||acid, unsaturated fatty||mapped_from
family history of leukaemia||risk factor for malignancy||mapped_from
4-hydroxycyclophosphamide||2-[bis(2-chloroethylamino)]-tetrahydro-2h-1,3,2-oxazaphosphorine-2-oxide||mapped_from
retina; syphilitic (manifestation)||syphilis female||mapped_from
pseudoaustroboletus valens||basidiomycota||mapped_from
dhact protocol||cytosine-beta-arabinoside||mapped_from
infection masked nos||[x]oth+unspecf infectious dis||mapped_from
pneumonitis; lymphatic||hiv disease resulting in lymphoid interstitial pneumonitis (disorder)||mapped_from
frostbite; abdominal wall, superficial||superficial frostbite of abd wall, lower back and pelvis||mapped_from
adverse reaction to folic acid and/or iron||medicinal substance; adverse effect||mapped_from
amyloidosis organ-limited||endocr/metab/nutrit disease other||mapped_from
retropharyngeal abscess drained (situation)||other specified postprocedural states||mapped_from
band 3 protein memphis variant ii||erythrocyte membrane band protein 03||mapped_from
curcuminol g||sesquiterpene derivatives||mapped_from
late effects of burn of eye, head, face and neck (diagnosis)||sequelae of other specified burn, corrosion and frostbite||mapped_from
involutional paraphrenia (diagnosis)||[x]delusional disorder||mapped_from
inappropriate lactation||inappropriate production of milk||mapped_from
supracardiac location of anomalous pulmonary venous connection to left sided vertical vein||anomalous pulmonary venous drainage, nos||mapped_from
examination; following accident, transport||examination and observation following transport accident||mapped_from
(6r,7r)-3-((5-amino-4-(((2-aminoethyl)carbamoyl)amino)-1-methyl-1h-pyrazol-2-ium-2- yl)methyl)-7-(((2z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-((1-carboxy-1- methylethoxy)imino)acetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylate||cephalosporin -class of antibiotic- (product)||mapped_from
anxiety||disorders, anxiety||mapped_from
kloeckeraspora osmophila niehaus, 1932||genus hanseniaspora (organism)||mapped_from
congenital anomaly of large intestine, nos||congenital anomaly nos of digestive system nos||mapped_from
5-trifluoroacetamidopentyl beta-n-acetyllactosaminide||amino sugar, nos||mapped_from
rhinitis; tuberculous||[x]o resp tb,w't m/bact hist c||mapped_from
salvianic borneol ester||bornanes||mapped_from
hla-drb1*11:43 antigen||hla-dr antigen (substance)||mapped_from
listeria, nos||genus listeria||mapped_from
abnormal; diagnostic imaging, breast||abnormal results investig nos||mapped_from
procion brilliant orange m-2rs||triazines||mapped_from
parmelia rubescens||division ascomycota||mapped_from
hypogin protein, arachis hypogaea||protein, plant||mapped_from
chromosomal disease||sex chromosome disorder||mapped_from
porina internigrans||ascomycota||mapped_from
ncx 4215||aspirina||mapped_from
transcription repression factor et, xenopus||xenopus proteins||mapped_from
secondary malignant neoplasm of sigmoid colon||2-malig neop colon/rectum||mapped_from
lhpp protein, human||pyrophosphatase, proton-pumping inorganic||mapped_from
ems1 protein, arabidopsis||kinase protein||mapped_from
glomerulonephritis; bilharziasis (etiology)||worms/other parasites||mapped_from
fever; mexican||typhus, endemic||mapped_from
hsa-mir-429||micro rna||mapped_from
disorder of sclera of both eyes||disorder of sclera, unspecified||mapped_from
glu p-3||imidazoles||mapped_from
charcot-marie-tooth disease, autosomal dominant, type 2k||hmsn-hered motor & sens neurop||mapped_from
obp28a protein, drosophila||intercellular signaling peptides proteins||mapped_from
glottis; edema, allergic||reaction hypersensitivity (nos)||mapped_from
hmpv g protein, human metapneumovirus||glycoproteins||mapped_from
ureterocele (disorder)||other urinary tract disorders nos||mapped_from
3,9-di-9-oxotetradocosanecarboxy-11-oxohexacosane||natural waxes||mapped_from
lysine amidase||amidases||mapped_from
1,4-bis(5-hexyl-2-thienyl)butane-1,4-dione||thioketones||mapped_from
v.lienalis; rupture||hemorrhage, not elsewhere classified||mapped_from
mucopurulent conjunctivitis of both eyes||other mucopurulent conjunctivitis, bilateral||mapped_from
injury; birth, spinal cord||birth injury to spine and spinal cord||mapped_from
alpha, alpha'-bis(di(2-chloroethyl)amino)-4,4'-(2-biacetophenone)||biphenyl cpds||mapped_from
hfr||nephrosis; epidemic hemorrhagic fever (manifestation)||mapped_from
temporo-aural dysostosis||dysostosis; craniofacial||mapped_from
c.pregnancy; phlebitis, lower limb, superficial||other disease of pregnancy/delivery/puerperium||mapped_from
deformity; shoulder blade||[x]oth spcf acqd deform/limbs||mapped_from
transverse and oblique lie; causing obstructed labor||complicated delivery deadborn||mapped_from
peg-pe||poly(oxyethylene)||mapped_from
pois-antihyperten agent||centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified||mapped_from
asialo-gal-beta(1-3)-galnac||desialylated glycoproteins||mapped_from
injury to blood vessels of thorax||injury of unspecified blood vessel of thorax||mapped_from
5-hydroxyflorasulam||sulfonilamide||mapped_from
acute deep vein thrombosis of lower limb (disorder)||phlebitis and thrombophlebitis of deep vessels of low extrm||mapped_from
hypophosphatasias||disorders of phosphorus metabolism (disorder)||mapped_from
achaete-scute complex-like 1a protein, zebrafish||zebra fish proteins||mapped_from
accessory sinus neoplasm malignant secondary||secondary malignant neoplasm of other and unspecified respiratory organs||mapped_from
2-dodecenoic acid||fatty acids, monounsaturated||mapped_from
hemosiderosis; dietary||other nutritional; endocrine; and metabolic disorders||mapped_from
benzenepropanoic acid, alpha-((4,6-dimethoxy-2-pyrimidinyl)oxy)-beta-methoxy-beta-phenyl-, (s)-||pyrimidines||mapped_from
occlusion and stenosis of vertebral artery||infarction; cerebral due to thrombosis, precerebral arteries||mapped_from
tsh protein, e coli||e coli adhesin||mapped_from
5-dcpmh||hydantoins||mapped_from
congenital neurogenic urinary bladder (finding)||[x]neuromuscular dysfunction of bladder, unspecified||mapped_from
doxa certex||calcium compounds, inorganic||mapped_from
cornea; ulcer, tuberculous (phlyctenular) (manifestation)||corneal ulcer, unspecified||mapped_from
congenital atresia of aortic valve||deformity; aortic valve, stenosis||mapped_from
neonatal monilia infection||infection; candida, neonatal||mapped_from
swollen pinna||[x]oth spcf disord/externl ear||mapped_from
2-((tert-butylamino)methyl)-7-methyl-2,7-benzofurandimethanol||ethanolamines||mapped_from
estradiol abnormal nos||other specified endocrine disorders||mapped_from
invagination of intestines||intussusception||mapped_from
saccharopolyspora tripterygii||saccharopolyspora species||mapped_from
nata1 protein, arabidopsis||arabidopsis proteins||mapped_from
magnesium nitrate||nitrate salt||mapped_from
fluoroglycofen ethyl||nitrobenzoates||mapped_from
abnormal limbs||acquired limb deformity||mapped_from
6-fudca cpd||3alpha,12alpha-dihydroxy-5beta-cholanic acid||mapped_from
reduction deformity of unspecified limb nos (disorder)||oth reductn def uns limb(s)||mapped_from
reactive confusion (diagnosis)||somatization disorder [ambiguous]||mapped_from
1-ethoxyethyl-2-dimethylaminoethylthiobenzimidazole||benzimidazoles||mapped_from
intraocular non-hodgkin's lymphoma (diagnosis)||non-hodgkin's lymphoma - disorder||mapped_from
4-o-beta-glucopyranosyloxy-(z)-7-hydroxycinnamic acid||sugars, simple||mapped_from
trauma; history||risk factor (observable entity)||mapped_from
primary cytopenia (finding)||other specified disease of blood or blood-forming organ nos (disorder)||mapped_from
kelch-like 15 (drosophila) protein, human||microfilament protein||mapped_from
pyrrocidine b||pyrrolidinone||mapped_from
chest wall veins distended||[x]varicose veins of other specified sites (disorder)||mapped_from
benign neoplasm of apex of urinary bladder||bladder tumor benign||mapped_from
parasola glabra||champignon||mapped_from
excessive amniotic fluid||oth disrd of amniotic fluid and membrns, unsp tri, unsp||mapped_from
n-(hexyl)-5-azido-2-nitrobenzoic acid amide||nitrobenzoates||mapped_from
epitrochlear lymph node||secondary and unspec malig neop axilla and upper limb ln nos||mapped_from
12beta,16beta-diacetoxyscalarolbutenolide||sesterterpenes||mapped_from
elastic skin; acquired||cutis; laxa, senile||mapped_from
wig1 protein, xenopus||factors, transcription||mapped_from
chlamydia; infection, sexually transmitted||other disease male genital including breast||mapped_from
euphoheliosnoid e||diterpenes||mapped_from
bpg3 protein, arabidopsis||chloroplast proteins||mapped_from
hedge nettles||stachys||mapped_from
helminthiasis;intestinal||parasitic gastrointestinal disorder||mapped_from
injection site cyst (disorder)||injection site cyst (disorder)||mapped_from
mediastinal; aneurysm, syphilitic (manifestation)||syphilis female||mapped_from
daryamide a||polyunsaturated alkylamides||mapped_from
d.hepaticus; calculus||calculus of bile duct without cholangitis or cholecystitis||mapped_from
neochrome||xanthophyll carotenoids||mapped_from
aquafresh all tartar control||potassium compounds||mapped_from
unable to control trunk posture||abnormal; posture||mapped_from
sun protein, s cerevisiae||membrane-associated protein||mapped_from
tonometry abnormal||abnormal results of other function studies of eye||mapped_from
psoriasis diffusa||[x]other psoriasis (disorder)||mapped_from
amniotic sac; infection, complicating pregnancy||infct of amniotic sac and membrns, unsp, unsp tri, unsp||mapped_from
blood pressure; labile||other disease circulatory system||mapped_from
sfericase||serine protease||mapped_from
pentamethonium||bis trimethyl ammonium compounds||mapped_from
longsightedness||far-sightedness||mapped_from
primary apnea in the newborn||[x]other apnoea of newborn||mapped_from
vaxstrate||fsh-releasing hormone||mapped_from
mesenteric pseudocyst||[x]other specified disorders of peritoneum (disorder)||mapped_from
penicillium vanderhammenii houbraken, c. lpez, frisvad & samson, 2011||penicillium (organism)||mapped_from
thiabenzonium iodide||benzodiazepine compounds||mapped_from
primary generalized absence epilepsy||syndrome; epileptic, generalized, idiopathic||mapped_from
incest (finding)||incest (event)||mapped_from
plain x-ray shoulder joint abnormal||abn find diag imag oth muscul||mapped_from
deformity; spermatic cord, acquired||genital disease male other||mapped_from
thyrotoxic; exophthalmos (manifestation)||hyperthyroidism/thyrotoxicosis||mapped_from
suffocation; drowning||drowning or non-fatal submersion nos||mapped_from
lyme disease, unspecified||lyme disease||mapped_from
cyst; brain, congenital||congenital cerebral cysts (diagnosis)||mapped_from
3-(4-(2-methylimidazo(4,5-c)pyridin-1-yl)benzyl)-3h-benzothiazol-2-one||imidazoles||mapped_from
hla - human leucocyte ag cw1||human leukocyte antigen-c||mapped_from
postdys reac arthrop mult site||postdysenteric arthropathy, multiple sites||mapped_from
l985p protein, human||lymphocyte antigen cd23 (substance)||mapped_from
vls protein, drosophila||proteins, drosophila||mapped_from
tmm protocol||anticancer drug combinations||mapped_from
rhexocercosporidium panacis reeleder 2007||fungus sac||mapped_from
zp1 protein, mouse||zp proteins||mapped_from
benign neopl.sphincter of oddi||benign extrahepatic bile duct tumor||mapped_from
hypertension; renal disease, arterial (i.e. secundary hypertension due to arterial renal disorders)||hypertension due to renovascular disease||mapped_from
placental insuffic.||maternl care-poor fetal growth||mapped_from
energy modified diet||[x]persons encount health serv in other specif circumstance||mapped_from
acetonemia (diagnosis)||ketoacidosis||mapped_from
cits protein, e coli||escherichia coli proteins||mapped_from
congenital tracheocele||[x]oth cong malform trachea||mapped_from
2,6-di-o-benzylmyoinositol||1,2,3,5/4,6-cyclohexanehexol||mapped_from
cholera toxoid||toxoid product||mapped_from
thc 5||anti-gout agents colchicinum||mapped_from
c.pregnancy; ablatio placentae||complicated delivery liveborn||mapped_from
bronchiolectasia||chronic dilatation of bronchus and bronchiole||mapped_from
desoxybilianic acid||deoxycholic acid||mapped_from
thelephora vitellina||phylum dikaryomycota (organism)||mapped_from
temporomandibular; arthritis||arthritis of left temporomandibular joint||mapped_from
adaptive response to alkylation damage protein, e coli||e coli proteins||mapped_from
pregnancy; viable fetus in abdominal pregnancy||pregnancy, high risk||mapped_from
suppression of secretion of milk||suppressed lactation, unspecified as to episode of care or not applicable||mapped_from
pancreatic thread protein, human||pancreatic thread protein||mapped_from
paralysis of intestine or colon||gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (smq)||has_member
posterior optic neuritis||immune-mediated/autoimmune disorders (smq)||has_member
myelinoclases, extrapontine||hyponatraemia/siadh (smq)||has_member
disease graves'||hyperthyroidism (smq)||has_member
stage iii esophageal squamous cell carcinoma||non-hematological malignant tumors (smq)||has_member
malar mound||periorbital and eyelid disorders (smq)||has_member
virus stool test positive||opportunistic infections (smq)||has_member
generalised epileptic seizure||noninfectious encephalopathy/delirium (smq)||has_member
myeloid sarcoma in remission||hematological malignant tumors (smq)||has_member
mal neo breast low-outer||breast malignant tumors (smq)||has_member
hairy skin itching||hypersensitivity (smq)||has_member
recurrent burkitt lymphoma||haematological malignant tumours (smq)||has_member
serum t4 level abnormal||hypothyroidism (smq)||has_member
adenosquamous carcinoma of cervix (disorder)||uterine and fallopian tube malignant tumours (smq)||has_member
hypertrichosis universalis||congenital, familial and genetic disorders (smq)||has_member
infection caused by aspergillus flavus||opportunistic infections (smq)||has_member
recurrent mesothelial sarcoma||non-hematological malignant tumors (smq)||has_member
after taste||taste and smell disorders (smq)||has_member
acute renal insufficiency (disorder)||hypovolemic shock conditions (smq)||has_member
hepatic hydrothorax||liver related investigations, signs and symptoms (smq)||has_member
haematoma of kidney||haemorrhage terms (excl laboratory terms) (smq)||has_member
ovarian dysgerminoma stage iii c||non-hematological malignant tumors (smq)||has_member
pulmonary; blastomycotic, acute (etiology)||opportunistic infections (smq)||has_member
tumor optic nerve||non-haematological tumours of unspecified malignancy (smq)||has_member
somatoform disorder pregnancy||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
cornea diseases||corneal disorders (smq)||has_member
adenocarcinoma of the colon stage 0||non-hematological malignant tumors (smq)||has_member
liver biopsy abnormal||liver related investigations, signs and symptoms (smq)||has_member
administration site discomfort||extravasation events (injections, infusions and implants) (smq)||has_member
metastasis to the skin||non-hematological malignant tumors (smq)||has_member
[d]tachycardia, unspecified (context-dependent category)||neuroleptic malignant syndrome (smq)||has_member
pain in esophagus (finding)||gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||has_member
collaborative staging site-specific factor 14:prid:pt:cancer.xxx:nom||stage &or prognostic factors section:-:pt:^patient:set:naaccr v.12||has_member
abdomen feels bloated||gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||has_member
identification and background information section||mds full assessment form - version 2.0:-:point in time:^patient:-||has_member
dependent drug abuse (diagnosis)||depression (excl suicide and self injury) (smq)||has_member
post-term labour||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
laceration of cervix, postpartum condition or complication||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
generalized nonconvulsive seizure dis||systemic lupus erythematosus (smq)||has_member
b-lymphocytic, cll (kiel classification) stage i||hematological malignant tumors (smq)||has_member
tongue red swollen pain||oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||has_member
blackout spell||noninfectious meningitis (smq)||has_member
mucocoele of salivary gland||oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||has_member
carotid atheroscleroses||ischemic central nervous system vascular conditions (smq)||has_member
polyhydramnios, with delivery||foetal disorders (smq)||has_member
gastrointestinal ischaemia||ischemic colitis (smq)||has_member
cerebrovascular accident of basal ganglia (disorder)||haemorrhagic central nervous system vascular conditions (smq)||has_member
anaesthesia lip||guillain-barre syndrome (smq)||has_member
symptom checklist scl||symptomatology (psycinfo subcluster term)||has_member
concentric; sclerosis||immune-mediated/autoimmune disorders (smq)||has_member
protein urine positive||chronic kidney disease (smq)||has_member
convulsions aggravated||noninfectious meningitis (smq)||has_member
hyperactive delirium||anticholinergic syndrome (smq)||has_member
hemialgia||conditions associated with central nervous system hemorrhages and cerebrovascular accidents (smq)||has_member
idiopathic acute peripheral facial nerve palsy||hearing impairment (smq)||has_member
supra-aortic trunk stenosis||pulmonary hypertension (smq)||has_member
abnormal creatinine||rhabdomyolysis/myopathy (smq)||has_member
urohepatic syndrome||hypovolaemic shock conditions (smq)||has_member
analgesic &/or antipyretic and antirheumatic drug poisoning||drug abuse and dependence (smq)||has_member
impairment level: better eye: moderate impairment; lesser eye: blind, not further specified||optic nerve disorders (smq)||has_member
esophoria (diagnosis)||ocular motility disorders (smq)||has_member
metamyelocyte count decreased||haematopoietic leukopenia (smq)||has_member
hypertension complicating pregnancy, childbirth, and the puerperium||neuroleptic malignant syndrome (smq)||has_member
hodgkin's disease of lymph nodes of axilla and/or upper limb (disorder)||hematological malignant tumors (smq)||has_member
vascular injury||accidents and injuries (smq)||has_member
chronic synovitis||arthritis (smq)||has_member
inherited copper toxicosis||congenital, familial, neonatal and genetic disorders of the liver (smq)||has_member
gb calc.+ac.cholecyst-obst.nos||gallstone related disorders (smq)||has_member
nontoxic nodular goitre nos||hypothyroidism (smq)||has_member
diffuse mixed small and large cell lymphoma (peripheral t-cell lymphoma unspecified) recurrent||skin malignant tumors (smq)||has_member
paranasal sinus bleeding||haemorrhage terms (excl laboratory terms) (smq)||has_member
papilloedema due to low ocular pressure||optic nerve disorders (smq)||has_member
anast common bile duct/duoden||biliary tract disorders (smq)||has_member
glucose^2h post 75 g glucose po:mcnc:pt:ser/plas:qn||hedis 2019-2020 value set - glucose tests:-:to identify measures at a point in time:^patient:-||has_member
hsv ophthalmia neonatorum||opportunistic infections (smq)||has_member
acute anaphylaxis||hypersensitivity (smq)||has_member
arthritis aggravated||arthritis (smq)||has_member
parkinsonian rest tremor||parkinson-like events (smq)||has_member
rupture; cecum||gastrointestinal perforation (smq)||has_member
infusion site recall reaction||hypersensitivity (smq)||has_member
vesicles||hypersensitivity (smq)||has_member
restlessness (finding)||anticholinergic syndrome (smq)||has_member
dysmetabolic syndrome||dyslipidaemia (smq)||has_member
labyrinth; hyperemia||vestibular disorders (smq)||has_member
salivary hyposecretion||dehydration (smq)||has_member
sarcosine dehydrogenase complex deficiency||congenital, familial and genetic disorders (smq)||has_member
burkitt's tumor or lymphoma stage iv||hematological malignant tumors (smq)||has_member
rupture; cerebral aneurysm, syphilitic (etiology)||hemorrhage terms (excluding laboratory terms) (smq)||has_member
lymphoplasmacytoid immunocytoma recurrent||malignant lymphomas (smq)||has_member
chronic myelomonocytic leukemia, in remission||myelodysplastic syndrome (smq)||has_member
vitreous prolapse||accidents and injuries (smq)||has_member
bundle branch block, other and unspecified||conduction defects (smq)||has_member
paresis ulnar nerve||conditions associated with central nervous system haemorrhages and cerebrovascular accidents (smq)||has_member
neonatal gastrointestinal hemorrhage (diagnosis)||gastrointestinal haemorrhage (smq)||has_member
methionine [moles/volume] in serum or plasma||amino acids panel:scnc:pt:ser/plas:qn||has_member
congenital hypoplastic anaemia blackfan-diamond type||congenital, familial and genetic disorders (smq)||has_member
recurrent thrush||opportunistic infections (smq)||has_member
open dislocation of hip, unspecified site||accidents and injuries (smq)||has_member
acute transmural myocardial infarction||myocardial infarction (smq)||has_member
left talus||set of tarsal bones of left foot||has_member
cardiac resynchronisation therapy / implantable cardioverter defibrillator replacement||cardiac failure (smq)||has_member
respiratory arrest (excl neonatal)||respiratory failure (smq)||has_member
cardiac ventricular scarring||cardiomyopathy (smq)||has_member
hypermethioninaemia||congenital, familial and genetic disorders (smq)||has_member
calcinosis cutis, raynaud's, sclerodactyly and telangiectasia||immune-mediated/autoimmune disorders (smq)||has_member
unspecified umbilical cord complication complicating labor and delivery, delivered, with or without mention of antepartum condition||foetal disorders (smq)||has_member
retinochoroiditis; focal||retinal disorders (smq)||has_member
fibrosis myocardial||cardiomyopathy (smq)||has_member
abscess amebic liver||liver infections (smq)||has_member
blood triglycerides abnormal||dyslipidaemia (smq)||has_member
hallpike caloric tests abnormal||vestibular disorders (smq)||has_member
edema or excessive weight gain in pregnancy, with delivery, with mention of postpartum complication.||hemodynamic edema, effusions and fluid overload (smq)||has_member
propionic; acidemia||congenital, familial and genetic disorders (smq)||has_member
breast cancer visceral crisis||non-haematological malignant tumours (smq)||has_member
focal seizure with secondary generalisation||convulsions (smq)||has_member
high blood cholesterol/triglycerides||lipodystrophy (smq)||has_member
tonsillitis bacterial||agranulocytosis (smq)||has_member
crushing injury ankle||accidents and injuries (smq)||has_member
product containing calcipotriol||other antipsoriatics for topical use||has_member
chronic cholecystitis (disorder)||gallbladder related disorders (smq)||has_member
follicular predominantly small cleaved cell lymphoma (working formulation) nos||malignant lymphomas (smq)||has_member
fam iii hyperlipoproteinemia||dyslipidaemia (smq)||has_member
perinatal infections nos||neonatal disorders (smq)||has_member
device failure, meter||lack of efficacy/effect (smq)||has_member
urine albumin/creatinine ratio increased||chronic kidney disease (smq)||has_member
agents affecting blood constituents toxicity||drug abuse and dependence (smq)||has_member
neoplasm uncert behavior of histiocytic & mast cells systemic mastocytosis||hematological tumors of unspecified malignancy (smq)||has_member
hemoglobin nos abnormal||haematopoietic erythropenia (smq)||has_member
diversity in the workplace||organizations & organizational behavior (psycinfo subcluster term)||has_member
tonsillitis chronic nos||oropharyngeal infections (smq)||has_member
open fracture acetabulum nos||osteoporosis/osteopenia (smq)||has_member
dizzying||vestibular disorders (smq)||has_member
fetus or neonate affected by maternal injury||fetal disorders (smq)||has_member
optic neuropathy (disorder)||immune-mediated/autoimmune disorders (smq)||has_member
potassium abnormal nos||chronic kidney disease (smq)||has_member
septicaemia serratia||opportunistic infections (smq)||has_member
protein urine 24 hour increased||systemic lupus erythematosus (smq)||has_member
edema of pharynx (diagnosis)||oropharyngeal allergic conditions (smq)||has_member
[d]anuria (situation)||anaphylactic/anaphylactoid shock conditions (smq)||has_member
myeloblastic leukemias, acute||haematological malignant tumours (smq)||has_member
diphtheria vaccine poisoning||drug abuse and dependence (smq)||has_member
neurocirculatory dystonia||guillain-barre syndrome (smq)||has_member
placental lake||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
malignant histiocytosis of the intestine with ulcerative jejunitis stage iv||haematological malignant tumours (smq)||has_member
energy decreased||guillain-barre syndrome (smq)||has_member
hemorrhage from placenta previa, delivered, with or without mention of antepartum condition||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
other umbilical cord complications during labor and delivery, delivered||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
15 trisomy||congenital, familial and genetic disorders (smq)||has_member
allergic rhinitis due to allergen||hypersensitivity (smq)||has_member
cytomegalovirus retinitis aggravated||opportunistic infections (smq)||has_member
c1 esterase deficiency acquired||oropharyngeal allergic conditions (smq)||has_member
itraconaz islt mic||bacterial susceptibility panel:-:pt:isolate:ordqn:mic||has_member
allergy to sulfa drugs||hypersensitivity (smq)||has_member
feel swollen||dementia (smq)||has_member
toxic symptom||drug abuse and dependence (smq)||has_member
combative reaction||hostility/aggression (smq)||has_member
x linked hypophosphatemia in rickets||congenital, familial and genetic disorders (smq)||has_member
corneal reflex decreased absent||corneal disorders (smq)||has_member
ladd||congenital, familial and genetic disorders (smq)||has_member
sensitisation rash||hypersensitivity (smq)||has_member
catheter disconnection issue||medication errors (smq)||has_member
(bone internal fixator) & (operation)||osteoporosis/osteopenia (smq)||has_member
lymphangioendothelioma, malignant||hematological malignant tumors (smq)||has_member
burn of unspecified degree of lips||accidents and injuries (smq)||has_member
esophagogastric devascularization||hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (smq)||has_member
subacute kidney injury||rhabdomyolysis/myopathy (smq)||has_member
thrombosis and thrombophlebitis of unspecified site||embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||has_member
chb - complete heart block||hypokalaemia (smq)||has_member
ca major salivary gland||non-haematological malignant tumours (smq)||has_member
congenital anomaly;cardiovas||congenital, familial and genetic disorders (smq)||has_member
gingival and periodontal diseases||gingival disorders (smq)||has_member
extended oligoarthritis||immune-mediated/autoimmune disorders (smq)||has_member
involuntary movement oral (circumoral)||neuroleptic malignant syndrome (smq)||has_member
ankles swelling||tendinopathies and ligament disorders (smq)||has_member
panophthalmitis (disorder)||ocular infections (smq)||has_member
shock refractory||hypoglycemic and neurogenic shock conditions (smq)||has_member
phenx - personal history of type 1 - type 2 diabetes protocol:-:point in time:^patient:-:phenx||phenx domain - diabetes:-:to identify measures at a point in time:^patient:-:phenx||has_member
other and unspec cord entanglement, w/o mention of compression, comp labor and delivery||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
lack of colour||hypotonic-hyporesponsive episode (smq)||has_member
chest dull pains||anaphylactic reaction (smq)||has_member
erythema due to burn (first degree) of wrist(s) and hand(s)||accidents and injuries (smq)||has_member
extraischaemic cerebral haematoma||haemorrhagic central nervous system vascular conditions (smq)||has_member
discolor urine||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
fetal deaths||termination of pregnancy and risk of abortion (smq)||has_member
malposition &/or malpresentation of fetus||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
aregenerative anemia||agranulocytosis (smq)||has_member
buphthalmos (disorder)||glaucoma (smq)||has_member
abnormal faeces||gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||has_member
hormone receptor positive breast cancer||breast malignant tumours (smq)||has_member
osmed, homozygous||congenital, familial and genetic disorders (smq)||has_member
odor of breath acetone or fruity||hyperglycaemia/new onset diabetes mellitus (smq)||has_member
cecal cancer stage 0||non-haematological malignant tumours (smq)||has_member
thyrotoxicosis [ambiguous]||immune-mediated/autoimmune disorders (smq)||has_member
epiglottitis obstructive||oropharyngeal infections (smq)||has_member
hepatitis delta without mention of active hepatitis b disease with hepatic coma||opportunistic infections (smq)||has_member
thinking about my life, i have a clear purpose in life:finding:to identify measures at a point in time:^patient:ordinal:promis.peds||promis pediatric item bank - meaning and purpose - version 1.0:-:point in time:^patient:-:promis.peds||has_member
unspecified allergic alveolitis||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
clo fos or face with oth bones, with intcran inj of oth and unspec nature, with state of cons unspec||accidents and injuries (smq)||has_member
diffuse large cell lymphoma (adult t-cell lymphoma/leukaemia) (working formulation) stage ii||malignant lymphomas (smq)||has_member
fetal virilism (disorder)||congenital, familial and genetic disorders (smq)||has_member
white blood cell count high||neuroleptic malignant syndrome (smq)||has_member
glands neoplasms salivary||oropharyngeal neoplasms (smq)||has_member
neuromuscular weakness||rhabdomyolysis/myopathy (smq)||has_member
atrophy;muscular||noninfectious encephalopathy/delirium (smq)||has_member
de ritis ratio abnormal||liver related investigations, signs and symptoms (smq)||has_member
[x]candidiasis, unspecified||opportunistic infections (smq)||has_member
bipolar i disorder, most recent episode (or current) manic, in partial or unspecified remission||psychosis and psychotic disorders (smq)||has_member
pringle nodule||convulsions (smq)||has_member
puerperal venous thrombosis (deep)||embolic and thrombotic events, venous (smq)||has_member
closed fracture of dorsal vertebra with spinal cord injury||osteoporosis/osteopenia (smq)||has_member
low muscle tone||hypotonic-hyporesponsive episode (smq)||has_member
paraneopl limbic enceph||immune-mediated/autoimmune disorders (smq)||has_member
paralysis bulbar||guillain-barre syndrome (smq)||has_member
yeast infections||opportunistic infections (smq)||has_member
scrotal laceration (physical finding)||accidents and injuries (smq)||has_member
asthma late-onset||eosinophilic pneumonia (smq)||has_member
kidney tumours recurrent||non-haematological malignant tumours (smq)||has_member
back stiffness||arthritis (smq)||has_member
leukemia, granulocytic, chronic||hematological malignant tumors (smq)||has_member
closed fractures involving skull or face with other bones with subarachnoid, subdural, and extradural hemorrhage, with concussion, unspecified||osteoporosis/osteopenia (smq)||has_member
sprain subscapularis||accidents and injuries (smq)||has_member
dub (dysfunctional uterine bleeding)||hemorrhage terms (excluding laboratory terms) (smq)||has_member
hodgkin's disease lymphocyte predominance type stage iii||haematological malignant tumours (smq)||has_member
localized ewing's tumor||non-haematological malignant tumours (smq)||has_member
desquamation gum||hypersensitivity (smq)||has_member
gastric pacemaker removal||gastrointestinal obstruction (smq)||has_member
gastrointestinal anastomotic leak (diagnosis)||gastrointestinal haemorrhage (smq)||has_member
macula; cornea||corneal disorders (smq)||has_member
hepatic sinusoidal obstruction syndrome||embolic and thrombotic events, venous (smq)||has_member
toilet transfer - usual functional ability:finding:reporting period:^patient:ordinal:cms assessment||oasid d - mobility - follow-up perfomance:-:reporting period:^patient:-:cms assessment||has_member
open wound of finger with tendon involvement||accidents and injuries (smq)||has_member
peptostreptococcus test positive||opportunistic infections (smq)||has_member
increased thyroid stimulating hormone level (biological function) (finding)||hyperthyroidism (smq)||has_member
abnormal electrolytes||hyponatremia/siadh (smq)||has_member
infusion site hemorrhage||haemorrhage terms (excl laboratory terms) (smq)||has_member
involuntary movement symptom nos (finding)||neuroleptic malignant syndrome (smq)||has_member
dermatitis;perioral||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
fractured ribs||osteoporosis/osteopenia (smq)||has_member
accommodation disorder nos||anticholinergic syndrome (smq)||has_member
disorder dark accommodation||optic nerve disorders (smq)||has_member
mg breast - right xccl||hedis my 2020 value set - mammography||has_member
febrile infection related epilepsy syndrome||noninfectious encephalitis (smq)||has_member
blood beta-d-glucan increased||opportunistic infections (smq)||has_member
perforation gastrointestinal||ischaemic colitis (smq)||has_member
lumbosacral strain||accidents and injuries (smq)||has_member
poisoning by opium (alkaloids), unspecified||drug abuse and dependence (smq)||has_member
myocarditis hypersensitivity||cardiomyopathy (smq)||has_member
congenital urogenital anomaly (disorder)||congenital, familial and genetic disorders (smq)||has_member
stage iii endometrial cancer||non-haematological malignant tumours (smq)||has_member
legally induced abortion, complicated by shock, complete||termination of pregnancy and risk of abortion (smq)||has_member
coupled pulse||tachyarrhythmia terms, nonspecific (smq)||has_member
repair of ligament (procedure)||tendinopathies and ligament disorders (smq)||has_member
congestion lungs||cardiac failure (smq)||has_member
duplicate drug prescription error||medication errors (smq)||has_member
cancer with high tmb||non-hematological malignant tumors (smq)||has_member
renal failure aggravated||hypoglycaemic and neurogenic shock conditions (smq)||has_member
impatience||hostility/aggression (smq)||has_member
meniscus injury||accidents and injuries (smq)||has_member
mucopolysaccharidosis type v (diagnosis)||congenital, familial and genetic disorders (smq)||has_member
hodgkin's sarcoma, spleen||haematological malignant tumours (smq)||has_member
fatty livers, nonalcoholic||hepatitis, non-infectious (smq)||has_member
s pneum da 23f igg ser-mcnc||s. pneumoniae 7 types igg panel b (s) [mass/vol]||has_member
periodic paralysis hyperkalemic||congenital, familial and genetic disorders (smq)||has_member
proctocolitis, nos||pseudomembranous colitis (smq)||has_member
pharyngeal contusion||oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||has_member
chronic brain syndrome (disorder)||noninfectious encephalopathy/delirium (smq)||has_member
excessive fetal growth, affecting management of mother, unspecified as to episode of care or not applicable||neonatal disorders (smq)||has_member
pain in thoracic spine (finding)||osteonecrosis (smq)||has_member
free-living amoeba infection||opportunistic infections (smq)||has_member
arthritis, degenerative||arthritis (smq)||has_member
diabetic hyperosmolar nonketotic state with coma||hyperglycaemia/new onset diabetes mellitus (smq)||has_member
sterculia [appetite suppressants]||bulk-forming laxative (substance)||has_member
hepatic perfusion disorder||hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (smq)||has_member
tubular breast cancer stage iii||non-hematological malignant tumors (smq)||has_member
pulmonary phthises||infective pneumonia (smq)||has_member
systemic lupus erythematos.nos||immune-mediated/autoimmune disorders (smq)||has_member
bromism||drug abuse and dependence (smq)||has_member
sometimes feel unsteady when walking:find:pt:^patient:ord||stay independent panel:-:to identify measures at a point in time:^patient:-:stay independent||has_member
linitis plastica stage ii||non-hematological malignant tumors (smq)||has_member
hypothyroxinemia of prematurity||neonatal disorders (smq)||has_member
anti-la antibody positive||systemic lupus erythematosus (smq)||has_member
lumbar cord injury without spinal bone injury (disorder)||accidents and injuries (smq)||has_member
generic substitution altered therapeutic response||lack of efficacy/effect (smq)||has_member
liver function tests multiple abnorm||liver related investigations, signs and symptoms (smq)||has_member
decreased consciousness||noninfectious encephalitis (smq)||has_member
[x]miliary tb,unspecified||opportunistic infections (smq)||has_member
manic disorder, recurrent episode, unspecified degree||psychosis and psychotic disorders (smq)||has_member
infantile acne||neonatal disorders (smq)||has_member
sars-cov-2 test positive||infective pneumonia (smq)||has_member
recur manic dis-severe||hostility/aggression (smq)||has_member
crushing injury of face||accidents and injuries (smq)||has_member
axial osteosclerosis with bamboo hair||congenital, familial and genetic disorders (smq)||has_member
congenital spinal deformity (diagnosis)||congenital, familial and genetic disorders (smq)||has_member
intestinal bacteria flora disturbance||gastrointestinal nonspecific dysfunction (smq)||has_member
trifluoperazine screen ql (bld/u)||antipsychotics drug panel:-:to identify measures at a point in time:whole blood/urine:-:screen||has_member
left ventricular diastolic dysfunction (disorder)||cardiac failure (smq)||has_member
sensory deprivation delirium||anticholinergic syndrome (smq)||has_member
pneumovirus test positive||infective pneumonia (smq)||has_member
soemmering's ring||lens disorders (smq)||has_member
pharyngeal cancer stage iv||oropharyngeal neoplasms (smq)||has_member
ultrasound thyroid abnormal||hypothyroidism (smq)||has_member
other and unspecified malignant neoplasms of lymphoid and histiocytic tissue inv axillary lymph ns||malignant lymphomas (smq)||has_member
spasm carpopedal||hypokalaemia (smq)||has_member
are you able to walk up and down two steps [promis]||promis item bank - physical function - version 2.0:-:pt:^patient:-:promis||has_member
hepatic sarcoidosis||hepatitis, non-infectious (smq)||has_member
sleepy (finding)||noninfectious encephalopathy/delirium (smq)||has_member
circulatory failure acute||shock-associated circulatory or cardiac conditions (excluding torsade de pointes) (smq)||has_member
epicondylitis medial||tendinopathies and ligament disorders (smq)||has_member
malignant tumor of the salivary gland||oropharyngeal neoplasms (smq)||has_member
intoxication by breast feeding||neonatal disorders (smq)||has_member
globulin gamma serum plasma increased||hypersensitivity (smq)||has_member
exacerbation of multiple sclerosis (disorder)||optic nerve disorders (smq)||has_member
drug-induced polyneuropathy||guillain-barre syndrome (smq)||has_member
cerebral artery occlusion, unspecified||ischaemic central nervous system vascular conditions (smq)||has_member
posthemorrhagic ventricular dilatation||neonatal disorders (smq)||has_member
hughes syndrome||immune-mediated/autoimmune disorders (smq)||has_member
estimated glomerular filtration rate abnormal||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
dermatitides, contact||hypersensitivity (smq)||has_member
bronchial carcinoma stage iv||non-haematological malignant tumours (smq)||has_member
hyporesponsive to verbal stimuli||anticholinergic syndrome (smq)||has_member
rbc enzymes abnormal||congenital, familial and genetic disorders (smq)||has_member
lipoprotein abnormal||dyslipidaemia (smq)||has_member
toxic respiratory epitheliolysis||immune-mediated/autoimmune disorders (smq)||has_member
post-partum haemorrhage||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
mechanical ptosis||ocular motility disorders (smq)||has_member
paresis of one side of body||conditions associated with central nervous system hemorrhages and cerebrovascular accidents (smq)||has_member
tearing||lacrimal disorders (smq)||has_member
chronic or unspecified duodenal ulcer with perforation, with obstruction||gastrointestinal perforation (smq)||has_member
bei decreased||hypothyroidism (smq)||has_member
kupffer cell decrease||liver related investigations, signs and symptoms (smq)||has_member
4s,6s-dorzolamide||carbonic anhydrase inhibitors||has_member
condition; medical as cause of delirium||dehydration (smq)||has_member
apnea; newborn||respiratory failure (smq)||has_member
t-immunoblastic sarcoma (anaplastic large cell lymphoma t- and null-cell types) stage i||malignant lymphomas (smq)||has_member
infantile seborrhoeic dermatitis (disorder)||congenital, familial and genetic disorders (smq)||has_member
visual deficit||glaucoma (smq)||has_member
oth closed skull frac with subarac, sub/extradural hem, with moderate loc||accidents and injuries (smq)||has_member
recurrent iridocyclitis (diagnosis)||ocular infections (smq)||has_member
endometrial neoplasm malignant stage ii||non-haematological malignant tumours (smq)||has_member
depression agitated||depression (excl suicide and self injury) (smq)||has_member
arthropathy involving other specified sites associated with reiter's disease and nonspecific urethri||ocular infections (smq)||has_member
electrocution and nonfatal effects of electric current||accidents and injuries (smq)||has_member
non-granulomatous ulcerative jejunoileitis||pseudomembranous colitis (smq)||has_member
malignant tumor of salivary gland stage iv||non-hematological malignant tumors (smq)||has_member
conjunctival ecchymosis||haemorrhage terms (excl laboratory terms) (smq)||has_member
a-21 extrapyramidal diseases||neuroleptic malignant syndrome (smq)||has_member
portal triaditis, nos||hepatitis, non-infectious (smq)||has_member
ca-in-situ respiratory system||non-haematological malignant tumours (smq)||has_member
maxillofacial edema||anaphylactic reaction (smq)||has_member
juvenile absence seizure (diagnosis)||convulsions (smq)||has_member
sigmatism||dementia (smq)||has_member
raised prostate specific antigen (finding)||prostate tumors of unspecified malignancy (smq)||has_member
gastrointestinal stromal cancer||non-haematological tumours of unspecified malignancy (smq)||has_member
catheter site thrombosis||embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||has_member
fetal exposure during pregnancy||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
corneal relaxing incision||corneal disorders (smq)||has_member
eyes infection||ocular infections (smq)||has_member
oral hyperaesthesia||oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||has_member
reagin ab [presence] in serum||hedis 2012 codes to identify sexually active women (chl-b)||has_member
toes web||congenital, familial and genetic disorders (smq)||has_member
microalbumin/creat ur dl<=3.0 mg/l-rto||hedis 2020 value set - urine protein tests:-:pt:^patient:-||has_member
incomplete spontaneous abortion with no mention of complication (disorder)||termination of pregnancy and risk of abortion (smq)||has_member
drug reaction with eosinophilia and systemic symptoms||eosinophilic pneumonia (smq)||has_member
cardiac biomarkers||laboratory studies (set)||has_member
hpt dlt wo b w hpt coma||liver infections (smq)||has_member
chronic or unspecified gastrojejunal ulcer with perforation, with obstruction||gastrointestinal perforation (smq)||has_member
weakness in lower extremities||peripheral neuropathy (smq)||has_member
thyroid infection (disorder)||opportunistic infections (smq)||has_member
bilateral cataract||lens disorders (smq)||has_member
other allergic pneumonitis||asthma/bronchospasm (smq)||has_member
stage i intestinal t-cell lymphoma||hematological malignant tumors (smq)||has_member
centrocytic (mantle cell) lymphoma (kiel classification) stage ii||haematological malignant tumours (smq)||has_member
acute lymphocytic leukaemia refractory||hematological malignant tumors (smq)||has_member
autonomic imbalance||neuroleptic malignant syndrome (smq)||has_member
destructive thyroiditis||hypothyroidism (smq)||has_member
ophthalmic fluid drainage||glaucoma (smq)||has_member
touraine renault syndrome||lipodystrophy (smq)||has_member
limb weakness||rhabdomyolysis/myopathy (smq)||has_member
pauciart juv rheum arthr||immune-mediated/autoimmune disorders (smq)||has_member
tooth damage||accidents and injuries (smq)||has_member
tremor of limbs||noninfectious encephalopathy/delirium (smq)||has_member
blood loss surg||haemorrhage terms (excl laboratory terms) (smq)||has_member
absent septum between aorta and pulmonary artery||congenital, familial and genetic disorders (smq)||has_member
type i lipidemia||dyslipidaemia (smq)||has_member
presentation of prolapsed arm of fetus||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
conjunctival melanocytic intraepithelial neoplasia||conjunctival disorders (smq)||has_member
orbital haematoma||hemorrhage terms (excluding laboratory terms) (smq)||has_member
stomach cancer stage iv without metastases||non-haematological malignant tumours (smq)||has_member
bacterial infection due to clostridium perfringens||pseudomembranous colitis (smq)||has_member
treatment-related aml||hematological malignant tumors (smq)||has_member
hemorrhage from placenta previa, antepartum||hemorrhage terms (excluding laboratory terms) (smq)||has_member
automations||automation (psycinfo subcluster term)||has_member
infusion site inflammation||extravasation events (injections, infusions and implants) (smq)||has_member
evan's syndrome||hemolytic disorders (smq)||has_member
cerebellar or brain stem contusion without mention of open intracranial wound, with concussion, unspecified||accidents and injuries (smq)||has_member
colic infant||neonatal disorders (smq)||has_member
other upper resp.tract disease||acute central respiratory depression (smq)||has_member
neonatal early-onset sepses||opportunistic infections (smq)||has_member
senile; wart||skin premalignant disorders (smq)||has_member
pressure-difference vertigo||vestibular disorders (smq)||has_member
aki - acute kidney injury||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
wrong drug stocked||medication errors (smq)||has_member
polychondritides, relapsing||immune-mediated/autoimmune disorders (smq)||has_member
simple chronic conjunctivitis (disorder)||severe cutaneous adverse reactions (smq)||has_member
central retinal vein occlusion - ischaemic||embolic and thrombotic events, venous (smq)||has_member
infusion site joint warmth||arthritis (smq)||has_member
chronic haemophilus influenzae infection||infective pneumonia (smq)||has_member
eosinophilic infiltrate||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
eye dis||retinal disorders (smq)||has_member
prostate carcinoma metastatic||non-hematological malignant tumors (smq)||has_member
visual acuity reduced transiently||glaucoma (smq)||has_member
closed eyeball trauma||accidents and injuries (smq)||has_member
arthropathy of knee||arthritis (smq)||has_member
laceration of eyelid skin and periocular area (diagnosis)||accidents and injuries (smq)||has_member
tumour haemorrhage||haemorrhage terms (excl laboratory terms) (smq)||has_member
malignant pineal area neoplasm||non-hematological malignant tumors (smq)||has_member
pulmonary infarction (disorder)||embolic and thrombotic events, venous (smq)||has_member
chemotherapy fatigue||malignancy related conditions (smq)||has_member
edema of cervix||haemodynamic oedema, effusions and fluid overload (smq)||has_member
chills fever||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
supracondylar fracture of femur, open||osteoporosis/osteopenia (smq)||has_member
distress abdominal||gastrointestinal perforation, ulcer, hemorrhage, obstruction non-specific findings/procedures (smq)||has_member
carcinoma in situ of skin of lower limb||skin malignant tumours (smq)||has_member
anthrax septicaemia||opportunistic infections (smq)||has_member
confusion, reactive||noninfectious meningitis (smq)||has_member
cervical gland tuberculosis||opportunistic infections (smq)||has_member
b-immunoblastic lymphoma (kiel classification) stage ii||haematological malignant tumours (smq)||has_member
behavioral and psychiatric symptoms of dementia||dementia (smq)||has_member
polyposis, familial multiple||congenital, familial and genetic disorders (smq)||has_member
positive pressure breathing||acute central respiratory depression (smq)||has_member
contusion of eye and ocular adnexa (disorder)||corneal disorders (smq)||has_member
effusion, wrist||arthritis (smq)||has_member
disorientation (symptom)||noninfectious encephalopathy/delirium (smq)||has_member
fat intake panel||macronutrient intake panel||has_member
malignant tumor of mesopharynx||oropharyngeal neoplasms (smq)||has_member
combinations of drug dependence excluding morphine type drug||depression (excl suicide and self injury) (smq)||has_member
burn any degree involving 50-59 percent of body surface||accidents and injuries (smq)||has_member
small intestine angiodysplasia hemorrhagic||hemorrhage terms (excluding laboratory terms) (smq)||has_member
myopathies nec||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
detachment of retinal pigment epithelium||retinal disorders (smq)||has_member
loss of consciousness; attack||noninfectious encephalitis (smq)||has_member
renal stent-graft thrombosis||embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||has_member
cicatricial mucous mem. pemphig.||severe cutaneous adverse reactions (smq)||has_member
migratory polyarthritis||arthritis (smq)||has_member
subchondral insufficiency fracture||osteoporosis/osteopenia (smq)||has_member
anaplastic lymphoma kinase gene and nucleophosmin gene fusion overexpression||congenital, familial and genetic disorders (smq)||has_member
unspecified monoarthritis of the forearm (disorder)||immune-mediated/autoimmune disorders (smq)||has_member
contusion of multiple sites of trunk||haemorrhage terms (excl laboratory terms) (smq)||has_member
aplastic anemia, unspecified||agranulocytosis (smq)||has_member
acute bilineal leukemia||hematological malignant tumors (smq)||has_member
asphyxia (disorder)||acute central respiratory depression (smq)||has_member
i enjoy a good physical fight:finding:to identify measures at a point in time:^patient:ordinal:phenx||psychopathy proto||has_member
disturbance of attention, nos||depression (excluding suicide and self injury) (smq)||has_member
hypoaesthesia of genital male||peripheral neuropathy (smq)||has_member
foreign body in penis (disorder)||accidents and injuries (smq)||has_member
dysfunctional aod use||depression (excluding suicide and self injury) (smq)||has_member
oligospermia (diagnosis)||fertility disorders (smq)||has_member
addison's disease due to autoimmunity (disorder)||immune-mediated/autoimmune disorders (smq)||has_member
hemoglobin h disease, deletional||congenital, familial and genetic disorders (smq)||has_member
acute prerenal failure||hypovolemic shock conditions (smq)||has_member
stimulation of labor||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
[d]tingling of skin (context-dependent category)||guillain-barre syndrome (smq)||has_member
gastrointestinal sounds abnormal||gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||has_member
obstructive cholangitis||retroperitoneal fibrosis (smq)||has_member
current level of confidence i can manage my frustration [promis]||promis item bank - self-efficacy for managing emotions - version 1.0:-:point in time:^patient:-:promis||has_member
parainfluenza virus 4 rna:prthr:pt:nph:ord:non-probe.amp.tar||respiratory pathogens dna and rna panel - nasopharynx by naa with non-probe detection||has_member
ectopic beats||hypokalemia (smq)||has_member
monoplegic||conditions associated with central nervous system haemorrhages and cerebrovascular accidents (smq)||has_member
low; function, kidney||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
staphylococcus saprophyticus test positive||infective pneumonia (smq)||has_member
venous cannula insertion (procedure)||embolic and thrombotic events, venous (smq)||has_member
proteinuria aggravated||tubulointerstitial diseases (smq)||has_member
pericardial effusion malignant||malignancy related conditions (smq)||has_member
exposure via eye contact||medication errors (smq)||has_member
cellulitis of lacrimal sac||ocular infections (smq)||has_member
transient hypertension of pregnancy, delivered , with or without mention of antepartum condition||hypertension (smq)||has_member
vernal keratoconjunctivitis seasonal||corneal disorders (smq)||has_member
[d]fit (context-dependent category)||noninfectious encephalopathy/delirium (smq)||has_member
systemic hypotension||dehydration (smq)||has_member
burn confined to eye and adnexa (diagnosis)||corneal disorders (smq)||has_member
sloughing of mouth||severe cutaneous adverse reactions (smq)||has_member
leukoplakia of vocal cords||premalignant disorders, general conditions and other site specific disorders (smq)||has_member
centripetal obesity (truncal)||hyperglycemia/new onset diabetes mellitus (smq)||has_member
diffuse large cell lymphoma (intestinal t-cell lymphoma) (working formulation) recurrent||malignant lymphomas (smq)||has_member
congenital ulnar bowing||congenital, familial and genetic disorders (smq)||has_member
meningisms||noninfectious meningitis (smq)||has_member
adhf||cardiomyopathy (smq)||has_member
brain venous angioma||congenital, familial and genetic disorders (smq)||has_member
dacryocystocele acquired||lacrimal disorders (smq)||has_member
closure of perforated duodenal ulcer (procedure)||gastrointestinal perforation (smq)||has_member
vesicoamniotic shunt||fetal disorders (smq)||has_member
lichen sclerosus||immune-mediated/autoimmune disorders (smq)||has_member
jaw joint rigid state of||arthritis (smq)||has_member
ventricular triplet||ventricular tachyarrhythmias (smq)||has_member
neurological eyelid disorder nos||periorbital and eyelid disorders (smq)||has_member
post-encephalitic syndrome||noninfectious encephalopathy/delirium (smq)||has_member
unspecified pulmonary tuberculosis, confirmed histologically||infective pneumonia (smq)||has_member
difficulty in walking involving joint of pelvic region and thigh||anticholinergic syndrome (smq)||has_member
goiter, adenomatous||hypothyroidism (smq)||has_member
infertility (symptom)||fertility disorders (smq)||has_member
extrinsic alveolitis, allergic||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
medullary carcinoma of breast stage iii||non-hematological malignant tumors (smq)||has_member
creatinine blood increased||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
mouth ulceration aggravated||systemic lupus erythematosus (smq)||has_member
disorder ecg/ekg (nos)||cardiomyopathy (smq)||has_member
fungal paronychia||opportunistic infections (smq)||has_member
occult hematuria||tubulointerstitial diseases (smq)||has_member
relapsed esophagus carcinoma||non-hematological malignant tumors (smq)||has_member
oth and unspec cerebral lacer and contu, with open intcran wound, with concussion, unspec||accidents and injuries (smq)||has_member
sleepiness||hypoglycemia (smq)||has_member
hydralazine le type reaction||immune-mediated/autoimmune disorders (smq)||has_member
sclerosus; lichen||immune-mediated/autoimmune disorders (smq)||has_member
iatrogenic hypotension||dehydration (smq)||has_member
closure of ileorectal fistula (procedure)||gastrointestinal perforation (smq)||has_member
allergic edema nos||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
face neck swelling||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
anemia during pregnancy||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
papule||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
syndrome, tachycardia-bradycardia||disorders of sinus node function (smq)||has_member
floppy iris syndrome||lens disorders (smq)||has_member
blanch||hypotonic-hyporesponsive episode (smq)||has_member
purpura of newborn||neonatal disorders (smq)||has_member
rectal ulcer hemorrhage||gastrointestinal ulceration (smq)||has_member
respiratory failure, unspecified||torsade de pointes, shock-associated conditions (smq)||has_member
bicarbonate reserve decreased||chronic kidney disease (smq)||has_member
generalised urticarial rash||anaphylactic reaction (smq)||has_member
amniotic cavity infectn.unspec||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
arthritis nos aggravated||systemic lupus erythematosus (smq)||has_member
lung injuries, acute||eosinophilic pneumonia (smq)||has_member
transient partial visual loss||hypoglycemia (smq)||has_member
menstruation;excessive||haemorrhage terms (excl laboratory terms) (smq)||has_member
arthritis hips||immune-mediated/autoimmune disorders (smq)||has_member
diabetic ketosis without acidosis||hyperglycemia/new onset diabetes mellitus (smq)||has_member
progesterone receptor gene overexpression||congenital, familial and genetic disorders (smq)||has_member
hypoglycemic and neurogenic shock conditions (smq)||shock (smq)||has_member
salivary secretion disturbance: ptyalism||oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||has_member
blood osmolarity abnormal nos||hyponatraemia/siadh (smq)||has_member
mouth sores (symptom)||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
disseminated toxin effect||drug abuse and dependence (smq)||has_member
multilobar pneumonia (diagnosis)||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
retinal vessel avulsion||retinal disorders (smq)||has_member
bamberger's disease||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
other jaw asymmetry||congenital, familial and genetic disorders (smq)||has_member
sodium low||hyponatremia/siadh (smq)||has_member
suicidal depression||suicide/self-injury (smq)||has_member
retinal detachments and defects||accidents and injuries (smq)||has_member
brachialgia statica paresthetica||peripheral neuropathy (smq)||has_member
small cleaved follicular center cell lymphoma refractory||hematological malignant tumors (smq)||has_member
liver fibrosis score:score:to identify measures at a point in time:serum/plasma:quantitative:calculated.fibrometer||liver fibrosis score panel - serum or plasma calculated by fibrometer||has_member
pfr abnormal||asthma/bronchospasm (smq)||has_member
voice disturbance, unspecified||parkinson-like events (smq)||has_member
writers' spasm||neuroleptic malignant syndrome (smq)||has_member
itching - generalized||hypersensitivity (smq)||has_member
biliary cholangitides, primary||biliary tract disorders (smq)||has_member
mucosal erosion||hypersensitivity (smq)||has_member
excision of lesion of rectum (procedure)||gastrointestinal premalignant disorders (smq)||has_member
anal eczema||gastrointestinal nonspecific inflammation (smq)||has_member
peptic ulcer perforation, obstructive||gastrointestinal obstruction (smq)||has_member
unspecified, known or suspected fetal abnormality affecting management of mother||foetal disorders (smq)||has_member
left levator palpebrae superioris muscle||musculature of left side of face||has_member
closed fracture of vault of skull with intracranial injury of other and unspecified nature, with moderate [1-24 hours] loss of consciousness||accidents and injuries (smq)||has_member
opn skul vlt fx-coma nos||accidents and injuries (smq)||has_member
coordination; lack of||noninfectious meningitis (smq)||has_member
necrotizing dermatitis||oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||has_member
anemia hemolytic indirect coombs negative||hemolytic disorders (smq)||has_member
metastatic malignant neoplasm to the mediastinum||non-hematological malignant tumors (smq)||has_member
transverse arrest of the leg||congenital, familial and genetic disorders (smq)||has_member
neoplasm of uncertain behavior of paraganglion (disorder)||non-haematological tumours of unspecified malignancy (smq)||has_member
transient systolic hypotension||neuroleptic malignant syndrome (smq)||has_member
physically restless||anticholinergic syndrome (smq)||has_member
subarac hem following inj, with open intcran wound, with concussion, unspec||haemorrhagic central nervous system vascular conditions (smq)||has_member
postpartum anxiety||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
herpesviral pharyngitis||opportunistic infections (smq)||has_member
basocytopenia||hematopoietic leukopenia (smq)||has_member
cornea edema||angioedema (smq)||has_member
fetal cerebral bleeding||fetal disorders (smq)||has_member
clostridium difficile sepsis||opportunistic infections (smq)||has_member
neoplasm of the nipple||non-haematological tumours of unspecified malignancy (smq)||has_member
hepatitis a virus igg antibody present||liver infections (smq)||has_member
implant site haematoma||hemorrhage terms (excluding laboratory terms) (smq)||has_member
amyloid related imaging abnormality-microhaemorrhages||central nervous system vascular disorders, not specified as hemorrhagic or ischemic (smq)||has_member
arrythmias sinus||disorders of sinus node function (smq)||has_member
polyp colon||gastrointestinal premalignant disorders (smq)||has_member
shuddering attacks||dystonia (smq)||has_member
helicobacter pylori identification test positive||opportunistic infections (smq)||has_member
serum triglycerides abnormal||lipodystrophy (smq)||has_member
expired vaccine used||medication errors (smq)||has_member
androgen receptor gene overexpression||congenital, familial and genetic disorders (smq)||has_member
other diseases of conjunctiva due to viruses and chlamydiae||hypersensitivity (smq)||has_member
bowel; hypomotility||gastrointestinal obstruction (smq)||has_member
venous thromboses, deep||thrombophlebitis (smq)||has_member
ophthalmoplegia syndrome||guillain-barre syndrome (smq)||has_member
convulsive syncope (disorder)||arrhythmia related investigations, signs and symptoms (smq)||has_member
decreased fluid output||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
erythema nodosum with hypersensitivity reaction in tuberculosis, bact or hist exam not done||immune-mediated/autoimmune disorders (smq)||has_member
groin node||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
transient tachypnoea of the newborn||respiratory failure (smq)||has_member
extreme generalized edema||haemodynamic oedema, effusions and fluid overload (smq)||has_member
aggravated asthma||hypersensitivity (smq)||has_member
angiotensin converting enzyme inhibitor fetopathy||congenital, familial and genetic disorders (smq)||has_member
plasma phosphate abnormal||tumor lysis syndrome (smq)||has_member
acute myopia||lens disorders (smq)||has_member
lymphomatous||hematological malignant tumors (smq)||has_member
herpes simplex viremia||opportunistic infections (smq)||has_member
collapse of vertebra (disorder)||accidents and injuries (smq)||has_member
marginal corneal ulcer||corneal disorders (smq)||has_member
atrophic gastritis (& chronic) (disorder)||gastrointestinal premalignant disorders (smq)||has_member
port-wine naevus||congenital, familial and genetic disorders (smq)||has_member
haemopoiesis suppressed||agranulocytosis (smq)||has_member
bloating feelings||acute pancreatitis (smq)||has_member
secondary aldosteronism, nos||hypertension (smq)||has_member
ambition loss of||psychosis and psychotic disorders (smq)||has_member
congenital anomaly of urinary tract proper (diagnosis)||congenital, familial and genetic disorders (smq)||has_member
summer-type hypersen pneu-itis||asthma/bronchospasm (smq)||has_member
lipothymia||anticholinergic syndrome (smq)||has_member
acute dacryocystitis||lacrimal disorders (smq)||has_member
physical findings:finding:to identify measures at a point in time:chest:narrative:observed||ed h&p exam data deeds||has_member
drug enanthema||hypersensitivity (smq)||has_member
ring scotoma||retinal disorders (smq)||has_member
fine corneal edema (disorder)||hypersensitivity (smq)||has_member
metastatic tumor to the nervous system||non-hematological malignant tumors (smq)||has_member
cholangiolitis||infectious biliary disorders (smq)||has_member
bhr - bronchial hyperreactivity||eosinophilic pneumonia (smq)||has_member
anaemia haemolytic occult||haemolytic disorders (smq)||has_member
intracranial hemorrhage nos||hemorrhagic central nervous system vascular conditions (smq)||has_member
nonreassuring fetal status||fetal disorders (smq)||has_member
dimethyl sulfoxide (medication)||other topical products for joint and muscular pain in atc||has_member
pulmonary fibrosis (diagnosis)||immune-mediated/autoimmune disorders (smq)||has_member
proteinuria nos||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
stage iii anal cancer||non-hematological malignant tumors (smq)||has_member
liver enlargement||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
blood creatinine abnormal||tumour lysis syndrome (smq)||has_member
combinations of drug dependence excluding morphine type drug||drug abuse and dependence (smq)||has_member
seronegative arthritis||arthritis (smq)||has_member
paranoid delusion||psychosis and psychotic disorders (smq)||has_member
pharyngoesophageal dysphagia||noninfectious meningitis (smq)||has_member
renal tumor excision||malignancy related therapeutic and diagnostic procedures (smq)||has_member
external nose lesion biopsy abnormal||malignancy related therapeutic and diagnostic procedures (smq)||has_member
psoriasis aggravated||immune-mediated/autoimmune disorders (smq)||has_member
hypomagnesic tetany of infancy||neonatal disorders (smq)||has_member
emotional; instability||psychosis and psychotic disorders (smq)||has_member
cefprozil islt grad strip||bacterial susc pnl islt grad strip||has_member
malignant neoplasm of pelvis||non-hematological malignant tumors (smq)||has_member
arm paralysis||embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||has_member
malignant hypertensive heart and renal disease with congestive heart failure and renal failure||hypertension (smq)||has_member
apparent mineralocorticoid excess (disorder)||congenital, familial and genetic disorders (smq)||has_member
neuropathies, facial||guillain-barre syndrome (smq)||has_member
myelosclerosis with myeloid metaplasia (morphologic abnormality)||blood premalignant disorders (smq)||has_member
enterococcal urinary tract infection||opportunistic infections (smq)||has_member
boop||interstitial lung disease (smq)||has_member
obstructive pneumonia||hypersensitivity (smq)||has_member
mesothelioma malignant advanced||non-hematological malignant tumors (smq)||has_member
quadricep tendon rupture||tendinopathies and ligament disorders (smq)||has_member
optic neuritis nec||immune-mediated/autoimmune disorders (smq)||has_member
blepharoptosis; congenital||ocular motility disorders (smq)||has_member
acute osteomyelitis, shoulder region||osteonecrosis (smq)||has_member
damaged eyebrows||accidents and injuries (smq)||has_member
supine hypotension syndrome||ovarian tumors of unspecified malignancy (smq)||has_member
psychiatric commitment||legal processes (psycinfo subcluster term)||has_member
acute haemorrhagic oedema of infancy||vasculitis (smq)||has_member
coma, hypoglycemic||hypoglycaemia (smq)||has_member
congenital cardiovascular disorder||congenital, familial and genetic disorders (smq)||has_member
oral mucosa red||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
human papilloma virus 5 antigen:presence or threshold:to identify measures at a point in time:not specified:ordinal||hedis 2013 codes to identify sexually active women (chl-b):-:point in time:^patient:-||has_member
respiratory distress syndrome in the newborn||neonatal disorders (smq)||has_member
septicaemia meningococcal||sepsis (smq)||has_member
hepatic angioma (disorder)||liver neoplasms, benign (including cysts and polyps) (smq)||has_member
burns of eye (diagnosis)||accidents and injuries (smq)||has_member
end-tidal co2 decreased||acute central respiratory depression (smq)||has_member
biliary cholangitis, primary||hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (smq)||has_member
abortion spontaneous incomplete complicated||termination of pregnancy and risk of abortion (smq)||has_member
thrombosis prophylaxis in hemodialysis||embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||has_member
respiratory failure (diagnosis)||anaphylactic/anaphylactoid shock conditions (smq)||has_member
regurgitation of medication||gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||has_member
mycs fng unsp xtrndl org||skin malignant tumors (smq)||has_member
syndrome hemolytic uremic||haemolytic disorders (smq)||has_member
centroblastic lymphoma stage ii||hematological malignant tumors (smq)||has_member
anti-thyroid antibody positive||hypothyroidism (smq)||has_member
low luminance best-corrected visual acuity decreased||optic nerve disorders (smq)||has_member
dysfunction; labyrinthine||vestibular disorders (smq)||has_member
cerebrospinal fluid oligoclonal band abnormal||immune-mediated/autoimmune disorders (smq)||has_member
ocular deviation||ocular motility disorders (smq)||has_member
i feel sad in the past 7d:finding:7 days:^patient:ordinal:facit||emotional well being - fact-gp:-:pt:^patient:-:facit||has_member
mucolipidosis type iv (disorder)||congenital, familial and genetic disorders (smq)||has_member
hyprtrophc obst cardiomy||cardiomyopathy (smq)||has_member
deficiency;colour vision||congenital, familial and genetic disorders (smq)||has_member
ap - acute pancreatitis||acute pancreatitis (smq)||has_member
carotid artery dolichoectasia||central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (smq)||has_member
skin test nos positive||hypersensitivity (smq)||has_member
venous thrombosis deep (limbs)||embolic and thrombotic events, venous (smq)||has_member
crohn's ileocolitis||ischemic colitis (smq)||has_member
surgical vascular shunt||embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||has_member
n. gonorrhoeae dna naa+probe ql (u)||hedis 2010 codes to identify sexually active women (chl-b):-:to identify measures at a point in time:^patient:-||has_member
chronic leukaemia in remission||haematological malignant tumours (smq)||has_member
nausea, postoperative||gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||has_member
irritability after vaccination||noninfectious meningitis (smq)||has_member
inflammation corneal||corneal disorders (smq)||has_member
rigidity, extrapyramidal||parkinson-like events (smq)||has_member
other infections involving bone in diseases classified elsewhere, ankle and foot||osteonecrosis (smq)||has_member
b-lymphocytic, prolymphocytic leukaemia (kiel classification) recurrent||malignant lymphomas (smq)||has_member
infantile cerebral palsy, unspecified||congenital, familial and genetic disorders (smq)||has_member
malignant neoplasm of liver (diagnosis)||liver malignant tumours (smq)||has_member
increased urea||tumour lysis syndrome (smq)||has_member
transient arthropathy of the pelvic region and thigh (disorder)||arthritis (smq)||has_member
convulsions in newborn (diagnosis)||noninfectious encephalitis (smq)||has_member
hepatitis c virus genotype 1a positive||opportunistic infections (smq)||has_member
macular neovascularisation||retinal disorders (smq)||has_member
total score [skindex-29]||skindex-29:-:4w:^patient:-:skindex-29||has_member
seizures, generalized tonic-clonic (gtcs)||systemic lupus erythematosus (smq)||has_member
malignant neoplasm of other parts of bronchus or lung, stage 0||non-hematological malignant tumors (smq)||has_member
burn of upper limb, excluding wrist and hand, unspecified degree||accidents and injuries (smq)||has_member
bleeding hemorrhoids nos||gastrointestinal hemorrhage (smq)||has_member
organic brain syndrome||noninfectious encephalitis (smq)||has_member
acute gastritis (diagnosis)||gastrointestinal nonspecific inflammation (smq)||has_member
attention disturbances||depression (excl suicide and self injury) (smq)||has_member
nonprotein nitrogen blood elevated||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
epilepsy with myoclonic-atonic seizures||convulsions (smq)||has_member
essential cryoglobulinaemic vasculitis||immune-mediated/autoimmune disorders (smq)||has_member
insufficient dosage||medication errors (smq)||has_member
stage 2 acute kidney injury||hypoglycaemic and neurogenic shock conditions (smq)||has_member
abasic||guillain-barre syndrome (smq)||has_member
congenital scleral disorder||congenital, familial and genetic disorders (smq)||has_member
painful feet||tendinopathies and ligament disorders (smq)||has_member
malt workers' lung||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
mouth; injury||accidents and injuries (smq)||has_member
muscle hypertonias||neuroleptic malignant syndrome (smq)||has_member
chemotherapy side effect prophylaxis||malignancy related therapeutic and diagnostic procedures (smq)||has_member
cin3||uterine and fallopian tube malignant tumours (smq)||has_member
hydrocele male||congenital, familial and genetic disorders (smq)||has_member
active; trachoma||ocular infections (smq)||has_member
eyelash thickening||periorbital and eyelid disorders (smq)||has_member
cerebral; thrombophlebitis||embolic and thrombotic events, venous (smq)||has_member
excision of ileum nos (procedure)||gastrointestinal perforation, ulcer, hemorrhage, obstruction non-specific findings/procedures (smq)||has_member
hypoxic ischaemic encephalopathy||ischaemic central nervous system vascular conditions (smq)||has_member
lupus vasculitis cns||immune-mediated/autoimmune disorders (smq)||has_member
blepharospasm was seen||periorbital and eyelid disorders (smq)||has_member
ovarian germ cell polyembryoma stage i b||non-hematological malignant tumors (smq)||has_member
open # reduction||osteoporosis/osteopenia (smq)||has_member
destructive spondyloarthropathy||chronic kidney disease (smq)||has_member
burn of arm excl wrist/hand||accidents and injuries (smq)||has_member
abnormalities platelets||haematopoietic thrombocytopenia (smq)||has_member
[d]stupor||noninfectious encephalitis (smq)||has_member
closed fracture of vault of skull with intracranial injury of other and unspecified nature, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level||accidents and injuries (smq)||has_member
recurrent stomach carcinoma||non-hematological malignant tumors (smq)||has_member
atrioventricular nodal tachycardia||supraventricular tachyarrhythmias (smq)||has_member
invasion||malignancy related conditions (smq)||has_member
accidental device ingestion by a child||medication errors (smq)||has_member
di^a antigen inferred phenotype:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||blood group ag & hemoglobin s predicted phenotype panel molgen (bld/tiss)||has_member
malignant neoplasm of dome of urinary bladder recurrent||non-haematological malignant tumours (smq)||has_member
cerebral cortex laceration with open intracranial wound||hemorrhage terms (excluding laboratory terms) (smq)||has_member
reaven syndrome x||hypertension (smq)||has_member
peeling tongue||hypersensitivity (smq)||has_member
mcv infection||opportunistic infections (smq)||has_member
squamous carcinomas||non-hematological malignant tumors (smq)||has_member
low fibrinogen||liver-related coagulation and bleeding disturbances (smq)||has_member
encephalitis cytomegalovirus||opportunistic infections (smq)||has_member
open globe injury||accidents and injuries (smq)||has_member
cramps abdominal||gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||has_member
high density lipoprotein (plasma) raised||dyslipidaemia (smq)||has_member
nephrotic syndrome nos||chronic kidney disease (smq)||has_member
secondary hypertension, benign||chronic kidney disease (smq)||has_member
arthritis;acute||systemic lupus erythematosus (smq)||has_member
upper limb fracture||accidents and injuries (smq)||has_member
autonomic central nervous system diseases||guillain-barre syndrome (smq)||has_member
day care, child||career areas (psycinfo subcluster term)||has_member
lymphocyte depletion hodgkin's disease of intrapelvic lymph nodes||haematological malignant tumours (smq)||has_member
acute renal failure after childbirth||torsade de pointes, shock-associated conditions (smq)||has_member
structural epilepsy||generalized convulsive seizures following immunization (smq)||has_member
digestive enzyme abnormal||gastrointestinal nonspecific inflammation (smq)||has_member
hemicolectomy (treatment)||malignancy related therapeutic and diagnostic procedures (smq)||has_member
impaired judgement (finding)||dementia (smq)||has_member
location of neoplasm of breast||non-hematological tumors of unspecified malignancy (smq)||has_member
parity two||normal pregnancy conditions and outcomes (smq)||has_member
sleepiness||noninfectious encephalopathy/delirium (smq)||has_member
cervix cancer, stage iii||uterine and fallopian tube malignant tumors (smq)||has_member
subdural hematoma (disorder)||accidents and injuries (smq)||has_member
40-49% bdy brn/40-49% 3d||accidents and injuries (smq)||has_member
histone antibody positive||immune-mediated/autoimmune disorders (smq)||has_member
pharyngo-oesophageal dysphagia||oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||has_member
helicobacter pylori urea breath test positive||gastrointestinal premalignant disorders (smq)||has_member
warty (condylomatous) carcinoma of penis||non-hematological malignant tumors (smq)||has_member
excision of external ear, complete amputation (procedure)||hearing impairment (smq)||has_member
dios||gastrointestinal obstruction (smq)||has_member
vulvar cancer stage i||non-haematological malignant tumours (smq)||has_member
argininosuccinate [moles/volume] in dbs||aa nb scn pnl dbs-scnc||has_member
acquired aplastic anemia nos||haematopoietic erythropenia (smq)||has_member
urinary occult blood||haemorrhage terms (excl laboratory terms) (smq)||has_member
dyspnea^resting||respiratory failure (smq)||has_member
disorders grand mal seizures||noninfectious encephalopathy/delirium (smq)||has_member
toxicity from emollients, demulcents, and protectants||anticholinergic syndrome (smq)||has_member
nonallopathic lesions of thoracic region, not elsewhere classified||rhabdomyolysis/myopathy (smq)||has_member
lobster claw deformity||congenital, familial and genetic disorders (smq)||has_member
1 eye-sev/oth-blind nos||optic nerve disorders (smq)||has_member
epigenetic transmission to third generation||congenital, familial and genetic disorders (smq)||has_member
malig tumor verm bord upp lip||non-hematological malignant tumors (smq)||has_member
multiple sclerosis aggravated||immune-mediated/autoimmune disorders (smq)||has_member
adrenal gland biopsy abnormal||malignancy related therapeutic and diagnostic procedures (smq)||has_member
fetal damage||foetal disorders (smq)||has_member
pulmonary granulomatosis||eosinophilic pneumonia (smq)||has_member
malignant neoplasm of pyloric antrum of stomach||non-hematological malignant tumors (smq)||has_member
other specified tongue conditions nos||oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||has_member
closed fracture sternum||accidents and injuries (smq)||has_member
edema or excessive weight gain, postpartum||hemodynamic edema, effusions and fluid overload (smq)||has_member
passive-aggressive personality||hostility/aggression (smq)||has_member
cervix carcinoma stage ii||uterine and fallopian tube malignant tumours (smq)||has_member
gravida ii||normal pregnancy conditions and outcomes (smq)||has_member
somatotropin^30m post dose glucose:mcnc:pt:ser/plas:qn||somatotropin post glucose stimulation panel:-:pt:ser/plas:-||has_member
pigment calculus||gallbladder related disorders (smq)||has_member
large cell immunoblastic lymphoma (diffuse large b-cell lymphoma) (working formulation) recurrent||malignant lymphomas (smq)||has_member
anti-lrp2 nephropathy||tubulointerstitial diseases (smq)||has_member
femur; anteversion||congenital, familial and genetic disorders (smq)||has_member
neoplasm of connective tissues (disorder)||non-hematological tumors of unspecified malignancy (smq)||has_member
bilateral retinoblastoma||non-haematological malignant tumours (smq)||has_member
embolism||embolic and thrombotic events, arterial (smq)||has_member
malignant neoplasm of thyroid||non-haematological malignant tumours (smq)||has_member
radiotherapy to nose||malignancy related therapeutic and diagnostic procedures (smq)||has_member
intentional product use in unapproved population||depression (excl suicide and self injury) (smq)||has_member
disease (or disorder); sickle-cell, double heterozygous||congenital, familial and genetic disorders (smq)||has_member
major depressive affective disorder, single episode, severe, specified as with psychotic behavior||depression (excluding suicide and self injury) (smq)||has_member
carya tomentosa ab.ige:acnc:pt:ser:qn||respiratory allergen panel, us - central midwest b:-:pt:ser:-||has_member
back arched backwards||dystonia (smq)||has_member
comb drug dep nec-remiss||depression (excl suicide and self injury) (smq)||has_member
oral mucosa sore||gastrointestinal ulceration (smq)||has_member
acute confusion (finding)||hypoglycemia (smq)||has_member
biliary tract internal pressure increased||biliary system related investigations, signs and symptoms (smq)||has_member
duodenitis, nonspecific||gastrointestinal nonspecific inflammation (smq)||has_member
mantle cell lymphoma stage iii||haematological malignant tumours (smq)||has_member
white blood cell count increased||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
malignant neoplasm of main bronchus recurrent||non-haematological malignant tumours (smq)||has_member
popliteal arterial obstruction||embolic and thrombotic events, arterial (smq)||has_member
hyponatremia||hyponatremia/siadh (smq)||has_member
chest, funnel||congenital, familial and genetic disorders (smq)||has_member
small intestinal ulcer nos haemorrhage||gastrointestinal haemorrhage (smq)||has_member
nonverbal learning||academic learning & achievement (psycinfo subcluster term)||has_member
blood human chorionic gonadotrophin positive||normal pregnancy conditions and outcomes (smq)||has_member
pleural_effusion||infective pneumonia (smq)||has_member
serum alkaline phosphatase elevated (lab test)||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
laryngeal neopl||non-haematological tumours of unspecified malignancy (smq)||has_member
arrhenoblastoma of ovary||ovarian tumours of unspecified malignancy (smq)||has_member
climacteric arthritis of the hand||arthritis (smq)||has_member
focal onset impaired awareness seizure||noninfectious encephalitis (smq)||has_member
b2 transferrin csf ql||beta-2 transferrin panel:-:to identify measures at a point in time:serum/plasma+cerebral spinal fluid:-||has_member
acute onset of confusion||noninfectious encephalitis (smq)||has_member
hemorrhagic shock (diagnosis)||hemorrhage terms (excluding laboratory terms) (smq)||has_member
twelfth thoracic vertebra||thoracic vertebra, unspecified||has_member
confusion; reactive psychosis||neuroleptic malignant syndrome (smq)||has_member
h simplex iridocyclitis||opportunistic infections (smq)||has_member
simple partial seizures||systemic lupus erythematosus (smq)||has_member
malignant neoplasm of posterior hypopharyngeal wall stage ii||non-haematological malignant tumours (smq)||has_member
neoplasm of uncertain behavior of brain and/or spinal cord (diagnosis)||non-haematological tumours of unspecified malignancy (smq)||has_member
abnormal uterine bleeding||haemorrhage terms (excl laboratory terms) (smq)||has_member
bile duct cancer stage ivb||non-haematological malignant tumours (smq)||has_member
lacrimal canaliculitis chronic||ocular infections (smq)||has_member
carcinoma bronchiogenic recurrent||non-hematological malignant tumors (smq)||has_member
depression worsened||depression (excluding suicide and self injury) (smq)||has_member
polyangiitides, granulomatosis with||immune-mediated/autoimmune disorders (smq)||has_member
cong subaortic stenosis||cardiomyopathy (smq)||has_member
nerve root lesion||guillain-barre syndrome (smq)||has_member
acute nephritis (disorder)||acute renal failure (smq)||has_member
discomposure marked||dementia (smq)||has_member
puerperal venous thrombosis (deep)||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
flat affect (finding)||dementia (smq)||has_member
narrow mouth||congenital, familial and genetic disorders (smq)||has_member
articulation problem||noninfectious encephalitis (smq)||has_member
nystagmus end-position||noninfectious meningitis (smq)||has_member
larynx verrucous carcinoma, stage iv||non-hematological malignant tumors (smq)||has_member
sarcoma of breast||breast malignant tumors (smq)||has_member
central scotoma (physical finding)||retinal disorders (smq)||has_member
fixed beliefs contradicted by reality||dementia (smq)||has_member
kidney; absence, congenital||congenital, familial and genetic disorders (smq)||has_member
giant condyloma of buschke and lowenstein||opportunistic infections (smq)||has_member
chronic schizoaffective disorder (diagnosis)||psychosis and psychotic disorders (smq)||has_member
gas stomach||acute pancreatitis (smq)||has_member
anal cancer recurrent||non-haematological malignant tumours (smq)||has_member
breathless - at rest||respiratory failure (smq)||has_member
joint cartilage softening||arthritis (smq)||has_member
neoplasm of uncertain behavior of adrenal||non-haematological tumours of unspecified malignancy (smq)||has_member
pelvic hematoma (disorder)||haemorrhage terms (excl laboratory terms) (smq)||has_member
functional disorder of gastrointestinal tract (disorder)||gastrointestinal nonspecific inflammation (smq)||has_member
dermatoses bullous||immune-mediated/autoimmune disorders (smq)||has_member
hemophilus influenzae acute exacerbations of chronic bronchitis||opportunistic infections (smq)||has_member
muscular weaknesses||peripheral neuropathy (smq)||has_member
wakes early||depression (excl suicide and self injury) (smq)||has_member
race or ethnicity:type:to identify measures at a point in time:^patient:nominal:omb.1997||mds v3.0 - rai v1.17.2 - identification information - ipa [cms assessment]||has_member
social irresponsibility||hostility/aggression (smq)||has_member
hemorrhage colon||ischemic colitis (smq)||has_member
hazy vision (disorder)||retinal disorders (smq)||has_member
neck edema of||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
monomorphous round cell rhabdomyosarcoma||non-hematological malignant tumors (smq)||has_member
renal interstitium disorder||acute renal failure (smq)||has_member
illusion||noninfectious encephalopathy/delirium (smq)||has_member
capsuloplasty||osteonecrosis (smq)||has_member
allergic reaction to analgesics||angioedema (smq)||has_member
activity motor exaggerated||depression (excluding suicide and self injury) (smq)||has_member
dna mismatch repair protein gene mutation||congenital, familial and genetic disorders (smq)||has_member
br. asthma||hypersensitivity (smq)||has_member
senile ectropion (diagnosis)||periorbital and eyelid disorders (smq)||has_member
injury of finger||accidents and injuries (smq)||has_member
direct hyperbilirubinemia||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
congenital; goiter||congenital, familial and genetic disorders (smq)||has_member
anemia in mother complicating pregnancy, childbirth or puerperium||hematopoietic erythropenia (smq)||has_member
urography abnormal||retroperitoneal fibrosis (smq)||has_member
hepatic encephalopathy stage 3||hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (smq)||has_member
structure of permanent maxillary right central incisor tooth||right maxillary dentition||has_member
infusion administration interrupted||medication errors (smq)||has_member
pleomorphic small t-cell lymphoma (kiel classification) recurrent||malignant lymphomas (smq)||has_member
hinton positive||opportunistic infections (smq)||has_member
radiation underdose||medication errors (smq)||has_member
orbit biopsy abnormal||malignancy related therapeutic and diagnostic procedures (smq)||has_member
streptomycin, combinations||antibiotics||has_member
blurring of eyes||hypoglycemia (smq)||has_member
streptococcus agalactiae septicaemia||agranulocytosis (smq)||has_member
hyaline membrane disease||respiratory failure (smq)||has_member
renal shutdown||torsade de pointes, shock-associated conditions (smq)||has_member
optic disc disease||optic nerve disorders (smq)||has_member
spinal cord; hematoma||haemorrhage terms (excl laboratory terms) (smq)||has_member
tb bronchiect-no exam||infective pneumonia (smq)||has_member
acute angio oedema||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
paraneoplastic inappropriate antidiuretic hormone secretion||hyponatremia/siadh (smq)||has_member
on the pill bleeding||hemorrhage terms (excluding laboratory terms) (smq)||has_member
how often did you eat cheese in the past 30d:find:30d:^patient:ord:phenx||phenx - calcium intake - pediatric protocol 050201:-:pt:^patient:-:phenx||has_member
inappropriate exhilaration||dementia (smq)||has_member
second degree chemical burn of skin||accidents and injuries (smq)||has_member
discolouration tongue||oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||has_member
faints, neurally mediated||hypoglycemia (smq)||has_member
plasma calcium decreased||tumour lysis syndrome (smq)||has_member
trembling||parkinson-like events (smq)||has_member
regional enteritis||immune-mediated/autoimmune disorders (smq)||has_member
mlf syndrome||ocular motility disorders (smq)||has_member
other specified acute and subacute form of ischemic heart disease||other ischaemic heart disease (smq)||has_member
swelling;salivary gland||oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||has_member
malignant neoplasm of salivary gland stage 0||oropharyngeal neoplasms (smq)||has_member
infection caused by trypanosoma gambiense||opportunistic infections (smq)||has_member
conjunctival irritation||conjunctival disorders (smq)||has_member
haemolytic anaemia indirect coombs pos||hemolytic disorders (smq)||has_member
vasovagal symptoms||hypoglycaemia (smq)||has_member
malignant neoplasm of cervix uteri recurrent||non-haematological malignant tumours (smq)||has_member
repair of middle ear, nos||hearing impairment (smq)||has_member
eyelid bleeding||hemorrhage terms (excluding laboratory terms) (smq)||has_member
acute on chronic heart failure||cardiomyopathy (smq)||has_member
family member diseases hx||ctnn - recommended ihe set||has_member
low white blood cell count||systemic lupus erythematosus (smq)||has_member
exploration of peritoneum||gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (smq)||has_member
acute myocardial infarction, of anterolateral wall, initial episode of care||myocardial infarction (smq)||has_member
candidiasis of other specified sites (disorder)||opportunistic infections (smq)||has_member
biopsy lung abnormal||interstitial lung disease (smq)||has_member
malignant fibrous histiocytomas||non-hematological malignant tumors (smq)||has_member
stroke, cardioembolic||ischemic central nervous system vascular conditions (smq)||has_member
brain hem nec-proln coma||haemorrhagic central nervous system vascular conditions (smq)||has_member
precursor b-lymphoblastic lymphoma/leukaemia stage i||malignant lymphomas (smq)||has_member
payment diagnosis - primary icd code:prid:pt:^patient:nom:oasis||principal diagnosis:-:point in time:^patient:-||has_member
non-hodgkin's lymphoma unspecified histology intermediate grade recurrent||malignant lymphomas (smq)||has_member
injury of lung with open wound into thorax (disorder)||accidents and injuries (smq)||has_member
testicular malignant germ cell tumor nos||non-hematological malignant tumors (smq)||has_member
unspecified senile cataract||lens disorders (smq)||has_member
large bowel endoscopy nos abnormal||ischaemic colitis (smq)||has_member
acquired kyphosis (disorder)||osteoporosis/osteopenia (smq)||has_member
ac myocardit in oth dis||immune-mediated/autoimmune disorders (smq)||has_member
acute miliary tuberculosis, bacteriological or histological examination not done||sepsis (smq)||has_member
polymyalgia worsened||eosinophilic pneumonia (smq)||has_member
gastroesophageal junction cancer||non-hematological malignant tumors (smq)||has_member
blood drops pressure||hypokalaemia (smq)||has_member
peeling gum||drug reaction with eosinophilia and systemic symptoms syndrome (smq)||has_member
cong malf of genital organ||congenital, familial and genetic disorders (smq)||has_member
stevens-johnson syndrome (disorder)||severe cutaneous adverse reactions (smq)||has_member
adenovirus encephalomyeloradiculitis||opportunistic infections (smq)||has_member
prolonged 1st stage of labour||pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||has_member
cholesterol blood increased||lipodystrophy (smq)||has_member
cyp2b6 polymorphism||congenital, familial and genetic disorders (smq)||has_member
metastatic neoplasm swelling||malignancy related conditions (smq)||has_member
drug exposure via breast milk||neonatal exposures via breast milk (smq)||has_member
effort syncope||arrhythmia related investigations, signs and symptoms (smq)||has_member
black eye, not otherwise specified||accidents and injuries (smq)||has_member
acute delirium||dehydration (smq)||has_member
idiopathic pneumonia syndrome (disorder)||interstitial lung disease (smq)||has_member
abnormal thyroxine||hyperthyroidism (smq)||has_member
decidual endometritis (disorder)||pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||has_member
bile duct cancer stage ivb||non-hematological malignant tumors (smq)||has_member
sensorimotor disorder nos||guillain-barre syndrome (smq)||has_member
neck oedema of||angioedema (smq)||has_member
maternal death affecting fetus (diagnosis)||fetal disorders (smq)||has_member
exophthalmic hyperthyroidism (diagnosis)||hyperthyroidism (smq)||has_member
pulmonary tb nos-no exam||opportunistic infections (smq)||has_member
foreign body; eyeball, old (nonmagnetic)||corneal disorders (smq)||has_member
nictitating spasm||ocular motility disorders (smq)||has_member
affect disorders||psychosis and psychotic disorders (smq)||has_member
influenzas||infective pneumonia (smq)||has_member
reduced co2 tension||eosinophilic pneumonia (smq)||has_member
multiple contusion arm||accidents and injuries (smq)||has_member
carcinoid tumor nos, of appendix||non-hematological malignant tumors (smq)||has_member
fractured transverse process||accidents and injuries (smq)||has_member
atrioventricular block unspec.||conduction defects (smq)||has_member
dystonia; torsion, symptomatic||dystonia (smq)||has_member
hereditary angioedema breakthrough attack||congenital, familial and genetic disorders (smq)||has_member
traumatic blister of trunk, without mention of infection||hypersensitivity (smq)||has_member
herpes simplex necrotizing retinopathy||opportunistic infections (smq)||has_member
dyscinesia||dyskinesia (smq)||has_member
erythema due to burn (first degree) of eye (with other parts face, head, and neck)||accidents and injuries (smq)||has_member
immune-mediated pneumonitis||immune-mediated/autoimmune disorders (smq)||has_member
heat retention||anticholinergic syndrome (smq)||has_member
angioedema (smq)||secondary corneal edema [dup] (disorder)||member_of
myelodysplastic syndrome (smq)||primary idiopathic aplastic anemia||member_of
other ischemic heart disease (smq)||atherosclerotic heart disease, of native coronary artery||member_of
immune-mediated/autoimmune disorders (smq)||chr bull dermatosis of child||member_of
severe cutaneous adverse reactions (smq)||nasal mucosal blistering||member_of
psychosis and psychotic disorders (smq)||single manic episode in full remission||member_of
hematological malignant tumors (smq)||b-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma stage ii||member_of
osteoporosis/osteopenia (smq)||bone mineral content decreased||member_of
non-haematological tumours of unspecified malignancy (smq)||tumor of the epidermis nos||member_of
infective pneumonia (smq)||primary tuberculous infection, unspecified type, bact or hist exam unknown||member_of
malignant lymphomas (smq)||large cell immunoblastic lymphoma (intestinal t-cell lymphoma) (working formulation) stage i||member_of
haematological malignant tumours (smq)||acute leukemias||member_of
coccidioides immitis antibody.immunoglobulin g & immunoglobulin m panel:-:to identify measures at a point in time:serum/plasma:-||coccidioides immitis igm ab [presence] in serum||member_of
uterine and fallopian tube malignant tumors (smq)||bilateral salpingo-oophorectomy (procedure)||member_of
noninfectious encephalitis (smq)||breakthrough seizure||member_of
hostility/aggression (smq)||adaptability diminished||member_of
extravasation events (injections, infusions and implants) (smq)||infusion site irritation||member_of
optic nerve disorders (smq)||disease, graves||member_of
noninfectious meningitis (smq)||loss of initiative (finding)||member_of
congenital, familial and genetic disorders (smq)||olfactogenital syndrome||member_of
drug abuse and dependence (smq)||addiction, nos||member_of
psychosis and psychotic disorders (smq)||catatonic state||member_of
non-haematological malignant tumours (smq)||colon carcinoma stage ii||member_of
covid-19 (smq)||sars-cov-2 rapid antibody test||member_of
gastrointestinal nonspecific symptoms and therapeutic procedures (smq)||pain abdo||member_of
non-hematological malignant tumors (smq)||breast angiosarcoma metastatic||member_of
torsade de pointes/qt prolongation (smq)||[d]micturition syncope||member_of
uterine and fallopian tube tumors of unspecified malignancy (smq)||cervix tumour excision||member_of
ischemic colitis (smq)||mesenteric artery stenosis (diagnosis)||member_of
lacrimal disorders (smq)||dacryoadenitis acquired||member_of
patient activity scale ii [pasii]||over the past w, are you able to lift heavy objects:find:1w:^patient:ord:haqii||member_of
congenital, familial and genetic disorders (smq)||baller-gerold syndrome (bgs)||member_of
hypokalemia (smq)||heart block third degree||member_of
hypokalaemia (smq)||ecg t-u wave fusion||member_of
acute pancreatitis (smq)||cytosteatonecrosis||member_of
dementia (smq)||dementia due to parkinson's disease||member_of
opportunistic infections (smq)||tuberculosis of eye, bacteriological or histological examination unknown at present||member_of
non-haematological malignant tumours (smq)||renal cell cancer, stage ii||member_of
congenital, familial and genetic disorders (smq)||primary coenzyme q10 deficiency||member_of
dementia (smq)||character change in||member_of
angioedema (smq)||edema of mouth||member_of
dyskinesia (smq)||extrapyramidal disorder aggravated||member_of
asthma/bronchospasm (smq)||prolonged expiration||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||unspecified chronic liver disease without mention of alcohol||member_of
oropharyngeal neoplasms (smq)||malignant neoplasm of pharynx (diagnosis)||member_of
specific immunoglobulins (substance)||anthrax immune globulin||member_of
glaucoma (smq)||better eye: profound vi, lesser eye: profound vi||member_of
severe cutaneous adverse reactions (smq)||sloughing of buccal mucosa||member_of
central nervous system vascular disorders, not specified as hemorrhagic or ischemic (smq)||arteriovenous fistulas, dural||member_of
rhabdomyolysis/myopathy (smq)||kidney function issue||member_of
haematological malignant tumours (smq)||monocytic leukaemia, unspecified, in remission||member_of
hematopoietic leukopenia (smq)||serum monocytes abnormal||member_of
drug abuse and dependence (smq)||other specified drug dependence, episodic (disorder)||member_of
periorbital and eyelid disorders (smq)||eyelid; edema||member_of
haematological malignant tumours (smq)||malignant lymphoma, hodgkin's||member_of
respiratory failure (smq)||mechanical ventilation pressure high||member_of
infective pneumonia (smq)||tuberculosis nos (disorder)||member_of
immune-mediated/autoimmune disorders (smq)||systemic vasculitis||member_of
non-hematological malignant tumors (smq)||testicular malignant teratoma stage i||member_of
medication errors (smq)||device failure to align||member_of
hypersensitivity (smq)||cornea; edema||member_of
antiinflammatory preparations, non-steroids for topical use||benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-||member_of
hedis 2020 value sets:-:to identify measures at a point in time:^patient:-||hedis 2019-2020 value set - hpv tests||member_of
haemodynamic oedema, effusions and fluid overload (smq)||pulm edema||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||disease (or disorder); tubulo-interstitial (in)||member_of
cyp2c9 + vkorc1 pnl bld/t||cyp2c9 & vkorc1 bld/t-imp||member_of
non-hematological malignant tumors (smq)||bladder squamous cell carcinoma stage 0||member_of
malignancy related therapeutic and diagnostic procedures (smq)||hysterectomies, vaginal||member_of
noninvasive prenatal fetal aneuploidy and microdeletion panel based on plasma cell-free+wbc dna by dosage of chromosome-specific circulating cell free (ccf) dna||fetal trisomy 21 risk [likelihood] based on plasma cell-free+wbc dna by dosage of chromosome-specific cfdna||member_of
anticholinergic syndrome (smq)||excitable||member_of
hedis 2014-2016 value set - group a strep tests:-:pt:^patient:-||s. pyogenes dna naa+probe ql (throat)||member_of
gastrointestinal obstruction (smq)||malignant gastrointestinal obstruction||member_of
hypersensitivity (smq)||corneal edema, nos||member_of
pulmonary hypertension (smq)||liver; cirrhosis||member_of
oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||open wound of pharynx||member_of
lactic acidosis (smq)||acidemia nos||member_of
opportunistic infections (smq)||cytomegalovirus interstitial pneumonitis||member_of
anaphylactic reaction (smq)||flushing (disorder)||member_of
congenital, familial and genetic disorders (smq)||congenital nuclear cataract (diagnosis)||member_of
parkinson-like events (smq)||laryngeal tremor||member_of
dementia (smq)||paranoid psychoses||member_of
hypersensitivity (smq)||oedema around eye||member_of
congenital, familial and genetic disorders (smq)||congenital monoplegia||member_of
neuroleptic malignant syndrome (smq)||plantar hyperhidrosis||member_of
conduction defects (smq)||rbbb-with left post fasc block||member_of
accidents and injuries (smq)||injury of retina (disorder)||member_of
hypertension (smq)||increased catecholamines||member_of
cardiac failure (smq)||acro-edema||member_of
opportunistic infections (smq)||tuberculosis cerebral||member_of
angioedema (smq)||edema, idiopathic||member_of
pseudomembranous colitis (smq)||diarrhea, secretory||member_of
non-haematological tumours of unspecified malignancy (smq)||oesophageal neoplasm nos||member_of
dementia (smq)||respiratory malfunction arising from mental factor||member_of
noninfectious meningitis (smq)||gen nonconv ep w intr ep||member_of
noninfectious encephalitis (smq)||reaction; psychotic||member_of
accidents and injuries (smq)||tympanic membrane - total perforation||member_of
liver infections (smq)||hepatitis e antibody abnormal||member_of
fetal disorders (smq)||percutaneous fetal blood sampling||member_of
malignancy related therapeutic and diagnostic procedures (smq)||skin cancer excision||member_of
dystonia (smq)||muscle spasms in calf (symptom)||member_of
opportunistic infections (smq)||brucella sepsis||member_of
accidents and injuries (smq)||crush injury of upper extremities (diagnosis)||member_of
liver-related coagulation and bleeding disturbances (smq)||coagulation factor ii level decreased||member_of
systemic lupus erythematosus (smq)||systemic lupus erythematosus syndrome aggravated||member_of
skin malignant tumours (smq)||dermatofibrosarcoma metastatic||member_of
hypoglycaemia (smq)||oth spcf hypoglycemia||member_of
torsade de pointes/qt prolongation (smq)||paroxysmal ventricular tachycardia (disorder)||member_of
accidents and injuries (smq)||assault||member_of
non-hematological malignant tumors (smq)||malignant neoplasm of head of pancreas recurrent||member_of
hypersensitivity (smq)||necrolysis epidermal||member_of
pulmonary hypertension (smq)||respiration labored||member_of
haematological malignant tumours (smq)||lymphoblastic lymphoma (precursor t-lymphoblastic lymphoma/leukaemia) refractory||member_of
systemic lupus erythematosus (smq)||abscence||member_of
hypothyroidism (smq)||operation on thyroid gland||member_of
hypoglycaemia (smq)||ambulation difficulty||member_of
osteoporosis/osteopenia (smq)||cervical spine fracture||member_of
rehabilitation (psycinfo subcluster term)||twelve step programs||member_of
malignant lymphomas (smq)||b-lymphoblastic lymphoma (kiel classification) stage iv||member_of
synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders||spasmolevel||member_of
hypoglycemia (smq)||syncope, neurogenic||member_of
peripheral neuropathy (smq)||decreased arm strength||member_of
malignancy related therapeutic and diagnostic procedures (smq)||scan nos lymph nodes abnormal||member_of
systemic lupus erythematosus (smq)||afebrile seizure||member_of
congenital, familial and genetic disorders (smq)||acyanotic congenital heart disease nos||member_of
corneal disorders (smq)||eyes inflammation||member_of
embolic and thrombotic events, arterial (smq)||clinically-driven target lesion coronary revascularisation||member_of
congenital, familial and genetic disorders (smq)||sterile multifocal osteomyelitis with periostitis and pustulosis||member_of
hematopoietic cytopenias affecting more than one type of blood cell (smq)||aplastic anaemia (disorder)||member_of
gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (smq)||ulcerative; colitis||member_of
non-haematological malignant tumours (smq)||testicular malignant teratoma stage iii||member_of
hemorrhage terms (excluding laboratory terms) (smq)||haemorrhagic conversion stroke||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||syncytial giant cell hepatitis||member_of
malignancy related therapeutic and diagnostic procedures (smq)||lymph nodes removal||member_of
infective pneumonia (smq)||primary atypical pneumonia caused by mycoplasma pneumoniae||member_of
hypoglycemia (smq)||narcosis, nos||member_of
hemorrhage terms (excluding laboratory terms) (smq)||ureteric hemorrhage||member_of
noninfectious meningitis (smq)||classic fit||member_of
skin tumors of unspecified malignancy (smq)||x-ray therapy to skin||member_of
optic nerve disorders (smq)||naion||member_of
guillain-barre syndrome (smq)||unstable gait||member_of
rhabdomyolysis/myopathy (smq)||renal; failure||member_of
hemorrhage terms (excluding laboratory terms) (smq)||bleeding ulcer of oesophagus||member_of
haemorrhage terms (excl laboratory terms) (smq)||rupture of the heart||member_of
gastrointestinal obstruction (smq)||gastroesophageal obstruction||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||metastatic trophoblastic disease||member_of
accidents and injuries (smq)||open wound thyroid gland||member_of
accidents and injuries (smq)||traumatic shock (disorder)||member_of
congenital, familial and genetic disorders (smq)||thalassemia traits||member_of
tendinopathies and ligament disorders (smq)||villonod synovit-up/arm||member_of
opportunistic infections (smq)||orthopoxvirus test positive||member_of
malignant lymphomas (smq)||non-hodgkin's lymphoma progression||member_of
optic nerve disorders (smq)||neuronal demyelination||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||pruritus allergic||member_of
drug induced platelet antibody panel:-:to identify measures at a point in time:serum/plasma:-||irbesartan+hydrochlorothiazide induced platelet ab.igg:prthr:pt:ser/plas:ord:flow cytometry||member_of
demyelination (smq)||other specified central nervous system demyelination nos (disorder)||member_of
hypersensitivity (smq)||palpebral edema was seen||member_of
retinal disorders (smq)||vision; loss||member_of
torsade de pointes/qt prolongation (smq)||fibrillation cardiac||member_of
hedis 2009 codes to identify physiologic monitoring tests - serum creatinine (scr) (mpm-a):-:to identify measures at a point in time:^patient:-||basic metabolic 2000 panel:-:pt:ser/plas:qn||member_of
cardiomyopathy (smq)||cardiac rhythm disturbances||member_of
interstitial lung disease (smq)||interstitial pneumonia aggravated||member_of
promis item bank - physical function - version 1.0||are you able to trim your fingernails:finding:to identify measures at a point in time:^patient:ordinal:promis||member_of
accidents and injuries (smq)||scratched||member_of
non-hematological malignant tumors (smq)||relapsed pharyngeal carcinoma||member_of
hypersensitivity (smq)||hydroblepharon||member_of
arthritis (smq)||traumatic; arthritis||member_of
noninfectious meningitis (smq)||nystagmus, pathologic||member_of
sepsis (smq)||puerperal fever||member_of
torsade de pointes, shock-associated conditions (smq)||acute kidney failure following labor and delivery, unspecified as to episode of care or not applicable||member_of
arthritis (smq)||joint contracture-lower leg||member_of
neonatal disorders (smq)||gmh - germinal matrix haemorrh||member_of
noninfectious encephalopathy/delirium (smq)||convulsions in newborn||member_of
ischemic central nervous system vascular conditions (smq)||cerebrovascular disorder foetal||member_of
foetal disorders (smq)||antenatal; screening mother, ultrasonic abnormal||member_of
opportunistic infections (smq)||mis-c||member_of
dyslipidaemia (smq)||atherogenic dyslipidemia||member_of
haemorrhage terms (excl laboratory terms) (smq)||chronic or unsp gastric ulcer w both hemorrhage and perf||member_of
agranulocytosis (smq)||autoimmune aplastic anaemia||member_of
hypertension (smq)||malignant hypertensive heart and renal disease with renal failure (diagnosis)||member_of
oropharyngeal neoplasms (smq)||lip and/or oral cavity cancer stage iii||member_of
cardiac failure (smq)||heart failure; sudden||member_of
non-hematological malignant tumors (smq)||renal pelvis and ureteral cancer transitional cell nos||member_of
biliary tumors of unspecified malignancy (smq)||biliary neoplasia||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||glomerular hematuria||member_of
tendinopathies and ligament disorders (smq)||sprain of internal collateral ligament of ankle||member_of
hypoglycemic and neurogenic shock conditions (smq)||neurogenic shock||member_of
malignancy related therapeutic and diagnostic procedures (smq)||brain electron beam therapy||member_of
non-haematological malignant tumours (smq)||squamous cell carcinoma of oesophagus||member_of
irf-pai - therapy provided - week 2 [cms assessment]||irf-pai - occupational therapy - week 2:-:rptperiod:^patient:-:cms assessment||member_of
hypersensitivity (smq)||skin eruption||member_of
non-hematological malignant tumors (smq)||bronchiolo-alveolar adenocarcinoma of lung||member_of
phenx - respiratory - sleep apnea - adult protocol 091501:-:pt:^patient:-:phenx||body weight:mass:point in time:^patient:quantitative||member_of
accidents and injuries (smq)||chronic subdural hemorrhage||member_of
congenital, familial and genetic disorders (smq)||congenital hiatus hernia (diagnosis)||member_of
infective pneumonia (smq)||pneumonia, atypical||member_of
hostility/aggression (smq)||superficial injuries of other, multiple, and unspecified sites||member_of
oropharyngeal neoplasms (smq)||oropharynx squamous cell carcinoma||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||ulcer mouth||member_of
peripheral neuropathy (smq)||zonesthesia||member_of
tumor markers (smq)||tumor marker abnormal||member_of
hypersensitivity (smq)||complement fixation test positive||member_of
oropharyngeal neoplasms (smq)||oral cavity; mucocele||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||oth ob compl-deliv w p/p||member_of
accidents and injuries (smq)||closed fracture of vault of skull without mention of intracranial injury, with prolonged [more than 24 hours] loss of consciousness and return to pre-existing conscious level||member_of
accidents and injuries (smq)||closed frac of bos with oth and unspec intcran hem, with brief loc||member_of
psychosis and psychotic disorders (smq)||irresponsibility||member_of
immune-mediated/autoimmune disorders (smq)||ten - toxic epidermal necrolys||member_of
gastrointestinal ulceration (smq)||backwash ileitis||member_of
angioedema (smq)||respiratory obstruction unspecified||member_of
thrombophlebitis (smq)||venous thrombosis deep (limbs)||member_of
retinal disorders (smq)||congenital anomaly of the eye||member_of
ischemic central nervous system vascular conditions (smq)||artery stenosis, vertebral||member_of
congenital and neonatal arrhythmias (smq)||right ventricular dysplasia||member_of
anticholinergic syndrome (smq)||pyrexia of unknown origin (excluding puerperal)||member_of
congenital, familial and genetic disorders (smq)||herrick's anemia||member_of
proteinuria (smq)||protein defic||member_of
rhabdomyolysis/myopathy (smq)||acute kidney tubular necrosis||member_of
accidents and injuries (smq)||open dislocation of first cervical vertebra (diagnosis)||member_of
gp bld culture pnl bld pos probe||vancomycin resistance vana gene [presence] by probe in positive blood culture||member_of
acute central respiratory depression (smq)||apnoeic attack||member_of
opportunistic infections (smq)||cryptococcosis (disorder)||member_of
oropharyngeal neoplasms (smq)||pharyngeal dysplasia||member_of
immune-mediated/autoimmune disorders (smq)||bullous rash upper chest||member_of
dystonia (smq)||tetanus with trismus||member_of
haematological malignant tumours (smq)||leukaemic infiltration extramedullary||member_of
hemorrhage terms (excluding laboratory terms) (smq)||subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness||member_of
non-haematological tumours of unspecified malignancy (smq)||gby||member_of
ischaemic central nervous system vascular conditions (smq)||vascular cerebral accident||member_of
oropharyngeal neoplasms (smq)||malignant neoplasm of pharynx stage iv (diagnosis)||member_of
left prevertebral muscles set||left psoas minor muscle||member_of
noninfectious meningitis (smq)||generalised epileptic seizure||member_of
oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||hypertrophy; pharynx||member_of
guillain-barre syndrome (smq)||ophthalmoplegia, nos||member_of
gallbladder related disorders (smq)||cholesterol cholelithiasis||member_of
sepsis (smq)||cytomegalovirus viremia||member_of
immune-mediated/autoimmune disorders (smq)||lupus encephalitis||member_of
eosinophilic pneumonia (smq)||reduced co2 tension||member_of
guillain-barre syndrome (smq)||pandy's test increased||member_of
embolic and thrombotic events, venous (smq)||portomesenteric vein thrombosis||member_of
congenital, familial and genetic disorders (smq)||disease von willebrand||member_of
accidents and injuries (smq)||multiple fractures of hand bones, open||member_of
systemic lupus erythematosus (smq)||decreasing wbc||member_of
liver related investigations, signs and symptoms (smq)||alanine aminotransferase increase||member_of
myelodysplastic syndrome (smq)||maturation arrest platelet||member_of
haemorrhage terms (excl laboratory terms) (smq)||purpuras, henoch schonlein||member_of
guillain-barre syndrome (smq)||facial numbness||member_of
musculature of hand||adductor pollicis muscle structure||member_of
normal pregnancy conditions and outcomes (smq)||cesarean delivery on maternal request||member_of
noninfectious encephalitis (smq)||demonstrated behavior psychomotor agitation||member_of
drug abuse and dependence (smq)||emollient cathartic toxicity (diagnosis)||member_of
hypersensitivity (smq)||other specified urticaria nos (disorder)||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||blood creatinine abnormal||member_of
osteoporosis/osteopenia (smq)||path fx oth specif site||member_of
neonatal disorders (smq)||stroke in utero||member_of
arthritis (smq)||chondrocalcinosis due to pyrophosphate crystals, of the upper arm||member_of
congenital, familial and genetic disorders (smq)||aorta-pulmonary art transposition||member_of
haemorrhage terms (excl laboratory terms) (smq)||spleen contusion of||member_of
opportunistic infections (smq)||herpes zoster meningitis||member_of
oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||tongue mucositis||member_of
congenital, familial and genetic disorders (smq)||congenital malformation due to vitamin a||member_of
rhabdomyolysis/myopathy (smq)||renal function abnormal||member_of
accidents and injuries (smq)||achiles tendon rupture||member_of
arthritis (smq)||arthrodesis of wrist||member_of
hypoglycemic and neurogenic shock conditions (smq)||prerenal failure||member_of
tendinopathies and ligament disorders (smq)||fibrosis tendinous||member_of
immune-mediated/autoimmune disorders (smq)||immune-mediated oesophagitis||member_of
ocular motility disorders (smq)||blepharospasms||member_of
myocardial infarction (smq)||age indeterminate inferolateral myocardial infarction||member_of
depression (excluding suicide and self injury) (smq)||cannabis depend-remiss||member_of
congenital, familial and genetic disorders (smq)||cyst of rathke's pouch||member_of
immune-mediated/autoimmune disorders (smq)||pemphigoid, benign mucous membrane||member_of
breast malignant tumours (smq)||her2-negative breast cancer||member_of
pseudomembranous colitis (smq)||colitis, lymphocytic||member_of
glaucoma (smq)||degeneration; pupillary margin||member_of
neuro-qol pediatric item bank - anger - version 1.0:-:to identify measures at a point in time:^patient:-:neuroqol.peds||i was so mad that i felt like throwing something in the past 7d:finding:7 days:^patient:ordinal:neuroqol.peds||member_of
haemorrhagic central nervous system vascular conditions (smq)||hemorrhage; intracerebral||member_of
cardiomyopathy (smq)||dyspnea (finding)||member_of
premalignant disorders, general conditions and other site specific disorders (smq)||polyp removal||member_of
arrhythmia related investigations, signs and symptoms (smq)||electrocardiogram u-wave biphasic||member_of
haemolytic disorders (smq)||abo incompatibilities||member_of
anticholinergic syndrome (smq)||muscular hyperactivity||member_of
accidents and injuries (smq)||blisters with epidermal loss due to burn (second degree) of unspecified site of lower limb (leg)||member_of
cardiomyopathy (smq)||blood increased pressure systolic||member_of
other antineoplastic agents||product containing estramustine (medicinal product)||member_of
hematological malignant tumors (smq)||immunocytoma (lymphoplasmacytoid lymphoma/immunocytoma) (kiel classification)||member_of
tumor lysis syndrome (smq)||nonprotein nitrogen blood incr||member_of
corneal disorders (smq)||burn with resulting rupture and/or destruction of eyeball (disorder)||member_of
depression (excl suicide and self injury) (smq)||cocaine dependence, episodic||member_of
immune-mediated/autoimmune disorders (smq)||arthropathy in behcet's syndrome of the shoulder region||member_of
congenital, familial and genetic disorders (smq)||diencephalic syndrome||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||primary immune thrombocytopenic purpura||member_of
immune-mediated/autoimmune disorders (smq)||immune-mediated neurological disorder||member_of
anticholinergic syndrome (smq)||increased purposeless goalless activity||member_of
rhabdomyolysis/myopathy (smq)||upper extremity paresis||member_of
neuroleptic malignant syndrome (smq)||sweaty||member_of
gastrointestinal premalignant disorders (smq)||biopsy lip abnormal||member_of
oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||exposed bone in jaw||member_of
congenital, familial, neonatal and genetic disorders of the liver (smq)||glycogenosis, type vi||member_of
hematological malignant tumors (smq)||acute megakaryoblastic leukemia (disorder)||member_of
gastrointestinal ulceration (smq)||ulcer; duodeni, acute, with hemorrhage||member_of
hypersensitivity (smq)||kounis syndrome type ii||member_of
hypertension (smq)||hypertensive heart and renal disease, benign, with heart failure and renal failure||member_of
hematological malignant tumors (smq)||pleomorphic small t-cell htlv1 lymphoma (kiel classification) recurrent||member_of
sepsis (smq)||unspecified miliary tuberculosis, confirmed histologically||member_of
congenital, familial and genetic disorders (smq)||chediak anomaly||member_of
noninfectious encephalitis (smq)||myasthenia of facial muscles||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||amniotic infection syndrome||member_of
noninvasive prenatal fetal aneuploidy panel:-:pt:wbc.dna+plas.cfdna:-:dosage of chromosome specific cf dna||fetal trisomy 21 risk:imp:pt:wbc.dna+plas.cfdna:ord:dosage of chromosome specific cf dna||member_of
rhabdomyolysis/myopathy (smq)||tubular necrosis nos||member_of
hostility/aggression (smq)||antisocial or sociopathic personality disorder||member_of
peripheral neuropathy (smq)||paraesthesia aggravated||member_of
sepsis (smq)||salmonella septicaemia||member_of
hostility/aggression (smq)||ear laceration||member_of
fertility disorders (smq)||urine human chorionic gonadotropin decreased||member_of
dyslipidaemia (smq)||very low density lipoprotein cholesterol abnormal nos||member_of
malignancy related therapeutic and diagnostic procedures (smq)||laryngeal biopsy abnormal||member_of
drug abuse and dependence (smq)||poisoning by typhus vaccine (disorder)||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||ulcerative stomatitis (disorder)||member_of
osteoporosis/osteopenia (smq)||kyphoses||member_of
osteonecrosis (smq)||arthroplasty, nos||member_of
immune-mediated/autoimmune disorders (smq)||glomerulonephritis (disorder)||member_of
foetal disorders (smq)||fetus disorder||member_of
medication errors (smq)||multiple use of single-use product||member_of
infective pneumonia (smq)||pulmonary mucormycosis (diagnosis)||member_of
malignancy related conditions (smq)||skin neoplasm bleeding||member_of
oropharyngeal allergic conditions (smq)||urticarias, giant||member_of
non-hematological malignant tumors (smq)||malignant neoplasm of other and unspecified parts of mouth recurrent||member_of
hyperthyroidism (smq)||iodine 131 uptake increased||member_of
accidents and injuries (smq)||cortex (cerebral) contu w/o ment of open intcran wound, with no loc||member_of
glaucoma (smq)||acute glaucoma||member_of
non-hematological malignant tumors (smq)||malignant neoplasm of cardia in situ||member_of
cholestasis and jaundice of hepatic origin (smq)||deficiency of bile secretion||member_of
haematological malignant tumours (smq)||mixed lymphosarc mult||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||foetal thrombotic vasculopathy||member_of
systemic lupus erythematosus (smq)||pneumorenal syndrome||member_of
immune-mediated/autoimmune disorders (smq)||dysthyroid orbitopathy||member_of
anaphylactic reaction (smq)||redness generalized||member_of
malignant lymphomas (smq)||waldenstrom's macroglobulinaemia stage iii||member_of
noninfectious encephalopathy/delirium (smq)||smon||member_of
liver related investigations, signs and symptoms (smq)||bilirubin total increased||member_of
infective pneumonia (smq)||infection; koch||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||[d]hyperpyrexia nos (situation)||member_of
hematopoietic leukopenia (smq)||absolute lymphocyte count abnormal||member_of
congenital, familial, neonatal and genetic disorders of the liver (smq)||hereditary perinatal jaundice (diagnosis)||member_of
opportunistic infections (smq)||delftia acidovorans infection||member_of
antiretroviral therapy status section:-:to identify measures at a point in time:^patient:set:hiv-art||human immunodeficiency virus rx prior to enrollment:type:point in time:^patient:nominal:reported||member_of
malignant lymphomas (smq)||hodgkin disease, nodular sclerosis of lymph nodes of multiple sites||member_of
infective pneumonia (smq)||streptococcus viridans group test positive||member_of
ischaemic colitis (smq)||fistulizing crohn's disease||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||unspecified abnormality of labor, antepartum||member_of
congenital, familial and genetic disorders (smq)||congenital lymphatic dysplasia||member_of
retinal disorders (smq)||chorioretinal scar nos||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||breech extraction, without mention of indication, delivered, with or without mention of antepartum condition||member_of
haemorrhage terms (excl laboratory terms) (smq)||ulcer; gastric, with perforation, and hemorrhage||member_of
lacrimal disorders (smq)||chronic dacryoadenitis (diagnosis)||member_of
non-haematological malignant tumours (smq)||nervous system neoplasm malignant metastasis||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||rhesus isoimmunisation unspec.||member_of
immune-mediated/autoimmune disorders (smq)||bickerstaff brainstem encephalitis||member_of
oropharyngeal neoplasms (smq)||malignant tumor of retromolar area stage i||member_of
blood premalignant disorders (smq)||5q minus mds||member_of
haemorrhage terms (excl laboratory terms) (smq)||gastrointestinal bleeding, nos||member_of
hypersensitivity (smq)||immediate post-injection reaction||member_of
oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||black hairy tongue||member_of
accidents and injuries (smq)||injuries intentional||member_of
accidents and injuries (smq)||dislocation;jaw||member_of
osteoporosis/osteopenia (smq)||closed fractures involving skull or face with other bones, with other and unspecified intracranial hemorrhage, with loss of consciousness of unspecified duration||member_of
congenital, familial and genetic disorders (smq)||congenital kyphoscoliosis (disorder)||member_of
malignancy related conditions (smq)||malignant hepatopathy||member_of
eosinophilic pneumonia (smq)||pco2 decreased||member_of
accidents and injuries (smq)||closed fracture of cervical vertebral body at c5-c7 level with central cord syndrome (diagnosis)||member_of
ocular infections (smq)||viral uveitis||member_of
ocular infections (smq)||trachoma inc. conjunctivitis||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||intrapartum; hemorrhage||member_of
conduction defects (smq)||left ventricular asynchrony||member_of
acute central respiratory depression (smq)||cardiorespiratory arrest of newborn||member_of
severe cutaneous adverse reactions (smq)||oral mucosa redness||member_of
oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||mouth puckered||member_of
guillain-barre syndrome (smq)||vith nerve paresis||member_of
liver malignant tumors (smq)||hepatoblastoma recurrent||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||cerclage, cervical||member_of
infectious biliary disorders (smq)||cholecystitis acute nos||member_of
suicide/self-injury (smq)||thoughts of self harm||member_of
pseudomembranous colitis (smq)||enterocolitis necrotising||member_of
optic nerve disorders (smq)||aion||member_of
ischemic central nervous system vascular conditions (smq)||cerebral arterial occlusion (disorder)||member_of
non-hematological malignant tumors (smq)||gliomatosis cerebri||member_of
retinal disorders (smq)||decreased visual acuity||member_of
malignancy related therapeutic and diagnostic procedures (smq)||gastric biopsy abnormal||member_of
haemodynamic oedema, effusions and fluid overload (smq)||implant site edema||member_of
non-hematological malignant tumors (smq)||carcinoma of skin||member_of
congenital, familial and genetic disorders (smq)||c-kit gene overexpression||member_of
malignant lymphomas (smq)||angiocentric immunoproliferative lesion grade 2 stage iv||member_of
conjunctival disorders (smq)||conjunctival hemorrhages||member_of
hemorrhage terms (excluding laboratory terms) (smq)||oral hemorrhages||member_of
neonatal disorders (smq)||agitation neonatal||member_of
rhabdomyolysis/myopathy (smq)||myotendinal junction pain||member_of
hematological malignant tumors (smq)||centroblastic follicular (kiel classification) refractory||member_of
infective pneumonia (smq)||viral; pneumonia, parainfluenza||member_of
liver infections (smq)||hepatitis c recurrent||member_of
haematological malignant tumours (smq)||leukemia;acute lymphocytic||member_of
hypoglycemia (smq)||excitable||member_of
non-hematological tumors of unspecified malignancy (smq)||tumor of duodenum||member_of
arthritis (smq)||septic arthritis streptobacillus||member_of
neonatal disorders (smq)||neonatal deformities||member_of
accidents and injuries (smq)||deep necrosis of underlying tissues due to burn (deep third degree) of wrist(s) and hand(s)||member_of
student characteristics & academic environment (psycinfo subcluster term)||writing skills||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||other kidney and ureter disorders (disorder)||member_of
retinal disorders (smq)||crvo - central ret vein occln||member_of
dehydration (smq)||hypoosmolar state||member_of
congenital, familial and genetic disorders (smq)||congenital cardiovascular disease||member_of
anaphylactic reaction (smq)||generalized urticarial rash||member_of
non-haematological malignant tumours (smq)||intraductal papillary-colloidal carcinoma of the pancreas||member_of
hypotonic-hyporesponsive episode (smq)||shock, surgical||member_of
medication errors (smq)||product label font size complaint||member_of
premalignant disorders, general conditions and other site specific disorders (smq)||c-cell hyperplasia of thyroid (disorder)||member_of
malignant lymphomas (smq)||angiocentric immunoproliferative lesion grade 2 stage i||member_of
corneal disorders (smq)||shield ulcer||member_of
hypersensitivity (smq)||purpura, anaphylactoid||member_of
cardiomyopathy (smq)||heart pounding||member_of
angioedema (smq)||edema of the tongue||member_of
anticholinergic syndrome (smq)||disorders equilibrium||member_of
haematopoietic cytopenias affecting more than one type of blood cell (smq)||myelosis; nonleukemic||member_of
haemorrhage terms (excl laboratory terms) (smq)||cerebellar or brain stem contu w/o ment of open intcran wound, with prolonged loc, w/o rtrn to pecl||member_of
neuroleptic malignant syndrome (smq)||drug-induced extrapyramidal side effects||member_of
congenital, familial and genetic disorders (smq)||cong mitral insufficienc||member_of
oropharyngeal infections (smq)||epiglottitis (diagnosis)||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||encephalopathy allergic||member_of
skin malignant tumors (smq)||penile squamous cell carcinoma stage ii||member_of
cytokines pnl serpl||interleukin 13 [mass/volume] in serum or plasma||member_of
hyperthyroidism (smq)||thyroid microsome antibody positive||member_of
immune-mediated/autoimmune disorders (smq)||anti-saccharomyces cerevisiae antibody test positive||member_of
bacterial susceptibility panel:-:pt:isolate:ordqn:agar diffusion||erythromycin islt kb||member_of
embolic and thrombotic events, venous (smq)||pulm embol nos-delivered||member_of
accidents and injuries (smq)||recurrent dislocation of the patellofemoral joint (disorder)||member_of
haemolytic disorders (smq)||hemolytic anemia indirect coombs positive||member_of
severe cutaneous adverse reactions (smq)||ulceration of vulva and vagina (disorder)||member_of
accidents and injuries (smq)||uns thickn burn unsp prt trnk||member_of
gastrointestinal ulceration (smq)||ileocecal ulcer||member_of
noninfectious encephalopathy/delirium (smq)||rhythmic small waves decreased||member_of
oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||dryness mouth||member_of
non-hematological malignant tumors (smq)||ocular haemangiopericytoma||member_of
neuroleptic malignant syndrome (smq)||parkinson's disease, lewy body||member_of
opportunistic infections (smq)||mycobacterium tuberculosis salpingitis||member_of
labor and delivery summary - recommended ihe set:-:point in time:{setting}:-||chief complaint:finding:point in time:^patient:narrative:reported||member_of
uterine and fallopian tube neoplasms, malignant and unspecified (smq)||uterine and fallopian tube tumours of unspecified malignancy (smq)||member_of
accidents and injuries (smq)||fracture of lateral condyle of tibia (diagnosis)||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||ast elevated||member_of
accidents and injuries (smq)||intracranial injury of other and unspecified nature without mention of open intracranial wound||member_of
breast tumours of unspecified malignancy (smq)||insertion of prosthetic device into breast (procedure)||member_of
malignancy related therapeutic and diagnostic procedures (smq)||mastoidectomy, nos||member_of
lens disorders (smq)||ocular lens excision (procedure)||member_of
non-hematological malignant tumors (smq)||mesothelioma of the pleura||member_of
congenital, familial and genetic disorders (smq)||ataxia; telangiectasia||member_of
non-hematological malignant tumors (smq)||eyelid malignant melanoma skin including canthus||member_of
hemodynamic edema, effusions and fluid overload (smq)||fluid retention||member_of
noninfectious encephalopathy/delirium (smq)||decreased arm strength||member_of
oropharyngeal neoplasms (smq)||neoplasm of uncertain behavior of major salivary glands (diagnosis)||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||conditions of the amniotic cavity and membranes||member_of
acute pancreatitis (smq)||pancreatitis, recurrent||member_of
hyperthyroidism (smq)||thyrotoxic myopathy||member_of
neuroleptic malignant syndrome (smq)||tachycardia (excluding paroxysmal)||member_of
scleral disorders (smq)||incision of sclera (procedure)||member_of
ocular infections (smq)||infection, ocular||member_of
skin malignant tumors (smq)||malignant melanoma of skin of upper limb, including shoulder||member_of
hematological malignant tumors (smq)||leukemid||member_of
nmmds job satisfaction panel:-:pt:{nursing unit}:-||i rarely think of quitting this job [nmmds]||member_of
malignancy related therapeutic and diagnostic procedures (smq)||wedge excision of lung||member_of
premalignant disorders, general conditions and other site specific disorders (smq)||pulmonary necrotising granuloma||member_of
non-haematological malignant tumours (smq)||malignant neoplasm of floor of mouth stage iii (diagnosis)||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||prolonged active phase of labor||member_of
noninfectious encephalitis (smq)||disorder brain (acute)||member_of
torsade de pointes/qt prolongation (smq)||vasovagal symptoms||member_of
ischemic colitis (smq)||gastrointestinal gangrene||member_of
chronic kidney disease (smq)||nephrotic syndrome with lesion of membranous glomerulonephritis||member_of
ocular infections (smq)||other keratoconjunctivitis nos||member_of
acute renal failure (smq)||uremia (disorder)||member_of
hypersensitivity (smq)||asthma attack (& nos) (disorder)||member_of
opportunistic infections (smq)||infection due to mycobacterium tuberculosis (disorder)||member_of
termination of pregnancy and risk of abortion (smq)||ab nos w metab dis-comp||member_of
noninfectious diarrhea (smq)||bloody diarrhea (symptom)||member_of
embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||diplegia of lower limbs||member_of
cardiomyopathy (smq)||non-ischaemic dilated cardiomyopathy||member_of
congenital, familial and genetic disorders (smq)||multiple endocrine neoplasia type ii||member_of
ocular motility disorders (smq)||monofixation syndrome unspecif||member_of
immune-mediated/autoimmune disorders (smq)||antineutrophil cytoplasmic antibody increased||member_of
dehydration (smq)||renal failure acute uratic||member_of
gastrointestinal ulceration (smq)||gastrointestinal pain nos||member_of
arthritis (smq)||nodal osteoarthritis||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||hypocytosis||member_of
haemorrhage terms (excl laboratory terms) (smq)||acute necrotising haemorrhagic leukoencephalitis||member_of
infective pneumonia (smq)||pneumonia caused by chlamydiaceae||member_of
dyskinesia (smq)||pharyngeal dyskinesia||member_of
non-hematological malignant tumors (smq)||vaginal adenocarcinoma stage iva||member_of
haemorrhagic central nervous system vascular conditions (smq)||hematoma, subdural, chronic||member_of
chronic kidney disease management personal goals panel:-:pt:^patient:-||important functional area||member_of
phenx - preg high blood pressure protocol 040401:-:to identify measures at a point in time:^patient:-:phenx||toxemia including high blood pressure, albumin in urine and swelling of ankles during this pregnancy:finding:to identify measures at a point in time:^patient:ordinal||member_of
opportunistic infections (smq)||capnocytophaga test positive||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||subicteric||member_of
hepatitis c virus resistance panel by genotype method||telaprevir:susceptibility:to identify measures at a point in time:isolate:ordinal:genotyping||member_of
opportunistic infections (smq)||infection; viral, herpesvirus, anogenital||member_of
opportunistic infections (smq)||streptococcus agalactiae infection||member_of
congenital, familial, neonatal and genetic disorders of the liver (smq)||other del.conj.neonatal jaund.||member_of
non-haematological tumours of unspecified malignancy (smq)||skin neoplasm hemorrhage||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||kidney disease||member_of
oropharyngeal conditions (excluding neoplasms, infections and allergies) (smq)||pharyngitis; atrophic||member_of
immune-mediated/autoimmune disorders (smq)||uc aggravated||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||rash herpetiform||member_of
cognitive status, mood, pain - acute [care]||observational assessment of cognitive status at 2d assessment period:-:2 days:^patient:-||member_of
hypothyroidism (smq)||other postablative hypothyroid||member_of
hemorrhage terms (excluding laboratory terms) (smq)||prostatic congestion or hemorrhage nos||member_of
gingival disorders (smq)||gum; hypertrophy||member_of
glaucoma (smq)||iridencleisis||member_of
hypoglycemia (smq)||exacerbation of anxiety||member_of
functional lactation disorders (smq)||chronic mastitis (disorder)||member_of
joints of t11-t12 vertebrae||eleventh thoracic intervertebral symphysis||member_of
hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (smq)||prophylaxis of gastroesophageal variceal bleeding||member_of
liver infections (smq)||viral hepatitis b with hepatic coma||member_of
tendinopathies and ligament disorders (smq)||pain neck/shoulder||member_of
neuroleptic malignant syndrome (smq)||writer; cramp(s), organic||member_of
accidents and injuries (smq)||open fracture of base of skull with subarachnoid, subdural, or extradural hemorrhage with no loss of consciousness||member_of
presence of pressure ulcers:-:pt:^patient:-||number of unhealed pressure ulcers at each stage - at assessment and onset during this service:-:point in time:^patient:-||member_of
extrinsic muscle group of left hand||left extensor pollicis longus muscle||member_of
comparative nutrition assessment standards panel||calorie need 24h est||member_of
gastrointestinal perforation (smq)||excision of fistula in ano||member_of
gastrointestinal haemorrhage (smq)||intestinal haematoma||member_of
immune-mediated/autoimmune disorders (smq)||neuromyelitis optica pseudo relapse||member_of
ocular infections (smq)||acute inflammation of orbit nos (disorder)||member_of
non-hematological malignant tumors (smq)||carcinoma thyroid gland||member_of
toxic-septic shock conditions (smq)||subacute kidney injury||member_of
lipodystrophy (smq)||fat deposit around shoulder||member_of
liver infections (smq)||hepatitis b virus surface antigen antibody positive||member_of
haemorrhage laboratory terms (smq)||deficiency; fibrinogen, acquired||member_of
congenital, familial and genetic disorders (smq)||chromosomal imbalance syndrome||member_of
accidents and injuries (smq)||injury to spleen without mention of open wound into cavity, laceration extending into parenchyma||member_of
accidents and injuries (smq)||fractures limb||member_of
malignancy related therapeutic and diagnostic procedures (smq)||plasmid or naked dna in vivo gene therapy||member_of
acute pancreatitis (smq)||abdomen periumbilical pain||member_of
infective pneumonia (smq)||haemoph influ infect in cond class elsewhere and of unspec site||member_of
immune-mediated/autoimmune disorders (smq)||age-related amyloidosis||member_of
malignancy related therapeutic and diagnostic procedures (smq)||chemotherapy side effect prophylaxis||member_of
generalized convulsive seizures following immunization (smq)||hypotonus||member_of
congenital, familial and genetic disorders (smq)||sacralization||member_of
hypothyroidism (smq)||atrophy of thyroid||member_of
acute renal failure (smq)||npn increased||member_of
retroperitoneal fibrosis (smq)||inferior vena cava syndrome (diagnosis)||member_of
haemorrhagic central nervous system vascular conditions (smq)||cerebral hyperaemia||member_of
congenital, familial and genetic disorders (smq)||fredrickson type i lipidaemia||member_of
ischaemic central nervous system vascular conditions (smq)||a.cerebri anterior; occlusion||member_of
malignant lymphomas (smq)||ibl-like t-cell lymphoma (lukes-collins classification) refractory||member_of
hemorrhage terms (excluding laboratory terms) (smq)||bleeding into fallopian tube||member_of
gastrointestinal nonspecific inflammation (smq)||already mapped above aaha id #: 832||member_of
epilepsy autoimmune ab pnl serpl||pca-2 igg ab [titer] in serum by immunofluorescence||member_of
opportunistic infections (smq)||tb laryngitis-micro dx||member_of
hypothyroidism (smq)||thyroiditides, post-partum||member_of
hypothyroidism (smq)||thyroid caesium therapy||member_of
acute renal failure (smq)||acute kidney failure following labor and delivery, delivered, with mention of postpartum complication||member_of
malignant lymphomas (smq)||refractory non-hodgkin lymphoma||member_of
gastrointestinal premalignant disorders (smq)||acquired colon polyposis||member_of
gastrointestinal ulceration (smq)||acute haemorrhagic ulcerative colitis||member_of
congenital, familial and genetic disorders (smq)||congenital bilateral facial weakness||member_of
congenital, familial and genetic disorders (smq)||xxy syndromes||member_of
infective pneumonia (smq)||primary atypical pneumonia (pap) due to mycoplasma||member_of
embolic and thrombotic events, arterial (smq)||axillary-femoral arterial bypass||member_of
immune-mediated/autoimmune disorders (smq)||cidp-chr inflammatory demyelinating polyradiculoneuropathy||member_of
hypothyroidism (smq)||enlarged thyroid gland in neck||member_of
cardiomyopathy (smq)||ejection fraction low||member_of
other ischemic heart disease (smq)||acute myocardial ischemia (disorder)||member_of
non-hematological malignant tumors (smq)||sarcoma of peritoneum (diagnosis)||member_of
ovarian malignant tumours (smq)||malignant gynecologic tumor||member_of
breast malignant tumours (smq)||metastatic breast cancer||member_of
largest ulcer measurements:-:pt:^patient:-||diameter.any.max:len:pt:pressure injury.largest stage 3 or 4:qn:cms assessment||member_of
drug abuse and dependence (smq)||substance user||member_of
accidents and injuries (smq)||dislocation nec-open||member_of
gastrointestinal perforation, ulcer, hemorrhage, obstruction non-specific findings/procedures (smq)||mechanical ileus||member_of
glaucoma (smq)||optic disc pathological cupping (finding)||member_of
gastrointestinal nonspecific inflammation (smq)||duodenum; scar||member_of
embolic and thrombotic events, arterial (smq)||acute aortic syndrome||member_of
hemorrhage terms (excluding laboratory terms) (smq)||wound haematoma||member_of
gastrointestinal premalignant disorders (smq)||leukoplakia labialis||member_of
ocular motility disorders (smq)||lid lag (finding)||member_of
accidents and injuries (smq)||evacuation of subdural haematoma||member_of
ace inhibitors, other combinations||perindopril, amlodipine and indapamide||member_of
noninfectious encephalitis (smq)||apathetic behavior||member_of
gangl ab pnl ser||asialoganglioside gm2 ab ql (s)||member_of
accidents and injuries (smq)||injury abducens nerve||member_of
depression (excl suicide and self injury) (smq)||poor short-term memory||member_of
haematopoietic erythropenia (smq)||macrocytic anaemia of unspecified cause (disorder)||member_of
congenital, familial and genetic disorders (smq)||optic atrophies, hereditary||member_of
neonatal disorders (smq)||newborns seizures||member_of
congenital, familial and genetic disorders (smq)||aplasia; eye||member_of
skin malignant tumours (smq)||large cell immunoblastic lymphoma (peripheral t-cell lymphoma unspecified) (working formulation)||member_of
osteoporosis/osteopenia (smq)||fracture of upper end or unspecified part of radius and ulna, open||member_of
hostility/aggression (smq)||sentenced to jail||member_of
non-hematological malignant tumors (smq)||hypernephroma stage ii||member_of
conduction defects (smq)||blocks, right bundle-branch||member_of
retroperitoneal fibrosis (smq)||pain;abdominal||member_of
noninfectious diarrhea (smq)||antidiarrheal supportive care||member_of
myelodysplastic syndrome (smq)||hematopoiesis suppressed||member_of
neuroleptic malignant syndrome (smq)||drug-induced delirium (disorder)||member_of
hypokalemia (smq)||premature depolarization atrial||member_of
guillain-barre syndrome (smq)||electric shock sensation in head||member_of
respiratory failure (smq)||respiratory rate decreased||member_of
non-hematological malignant tumors (smq)||kidney carcinoma stage i||member_of
hearing impairment (smq)||conductive hearing loss (finding)||member_of
vasculitis (smq)||viral vasculitis||member_of
fertility disorders (smq)||anovular menstruation (finding)||member_of
congenital, familial and genetic disorders (smq)||spondylolisthesis, nos||member_of
patient safety event report - hospital - device or medical &or surgical supply, including health information technology - version 1.2:-:to identify measures at a point in time:^patient:-:ahrq||best characterization of health information technology device:find:pt:{device}:nom:ahrq||member_of
optic nerve disorders (smq)||cannot see||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||extrarenal uremia syndrome||member_of
embolic and thrombotic events, venous (smq)||venous thrombosis complicating pregnancy||member_of
accidents and injuries (smq)||closed traumatic dislocation of joint of finger||member_of
hpv high and low risk dna panel (cvx)||hpv low risk dna cvx ql probe||member_of
malignancy related conditions (smq)||tumour inflammation||member_of
glaucoma (smq)||moderate impairment of better eye with near-total impairment of lesser eye||member_of
lacrimal disorders (smq)||artificial tear duct insertion||member_of
chronic kidney disease (smq)||bone cyst||member_of
hearing impairment (smq)||facial muscle weakness||member_of
noninfectious encephalopathy/delirium (smq)||electroencephalogram (eeg) abnormal||member_of
extravasation events (injections, infusions and implants) (smq)||injection site joint redness||member_of
gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (smq)||enterostomy (treatment)||member_of
accidents and injuries (smq)||injury, finger||member_of
haemorrhage terms (excl laboratory terms) (smq)||post procedural hematoma||member_of
medication errors (smq)||lack of application site rotation||member_of
angioedema (smq)||nasal turbinate edema||member_of
glaucoma (smq)||xfg||member_of
systemic lupus erythematosus (smq)||lupus cns||member_of
arthritis (smq)||contracture of hip joint (disorder)||member_of
noninfectious encephalitis (smq)||clonus||member_of
malignancy related therapeutic and diagnostic procedures (smq)||abdominal wall biopsy abnormal||member_of
burkholderia pseudomallei igg and igm panel - serum by immunofluorescence||burkholderia pseudomallei antibody.immunoglobulin m:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||member_of
non-hematological malignant tumors (smq)||carcinoma bile duct recurrent||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||pregnancy with young maternal age||member_of
congenital, familial and genetic disorders (smq)||platelet-derived growth factor receptor gene mutation||member_of
hematopoietic leukopenia (smq)||marrow maturation arrest||member_of
opportunistic infections (smq)||complicated malaria||member_of
opportunistic infections (smq)||tuberculosis of oesophagus, confirmed by animal inoculation||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||sjs-ten overlap||member_of
neuroleptic malignant syndrome (smq)||transient loss of consciousness||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||urticaria, unspecified||member_of
liver malignant tumours (smq)||hepatocellular carcinoma stage ii||member_of
skin malignant tumors (smq)||pleomorphic medium and large t-cell lymphoma (kiel classification) stage iii||member_of
embolic and thrombotic events, arterial (smq)||superficial femoral artery occlusion (disorder)||member_of
hypothyroidism (smq)||thyroid function test abn.||member_of
non-haematological tumours of unspecified malignancy (smq)||optic nerve tumor||member_of
tumour markers (smq)||gastrin-releasing peptide precursor increased||member_of
congenital, familial and genetic disorders (smq)||stenoses, pulmonary subvalvular||member_of
non-hematological malignant tumors (smq)||tonsil cancer metastatic||member_of
osteoporosis/osteopenia (smq)||closed fracture of seven ribs (disorder)||member_of
opportunistic infections (smq)||virus urine test positive||member_of
biliary tract disorders (smq)||pancreatitis biliary||member_of
hemodynamic edema, effusions and fluid overload (smq)||mouth swelling||member_of
hypokalaemia (smq)||atrial premature complexes||member_of
haematological malignant tumours (smq)||malignant lymphoma, nodular nos||member_of
malignant lymphomas (smq)||diffuse small cleaved cell lymphoma (adult t-cell lymphoma/leukaemia) (working formulation)||member_of
non-hematological malignant tumors (smq)||oesophageal adenocarcinoma thoracic stage unspecified||member_of
breast malignant tumours (smq)||recurrent breast cancer||member_of
noninfectious encephalitis (smq)||disorder; organic, emotionally labile||member_of
delayed hypersensitivity anergy intradermal panel||wheal 1d p trichophyt diam||member_of
cholestasis and jaundice of hepatic origin (smq)||conjugated hyperbilirubinaemia||member_of
conjunctival disorders (smq)||conjunctival discharge (physical finding)||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||idiopathic myocarditis (diagnosis)||member_of
generalized convulsive seizures following immunization (smq)||flaccidity (finding)||member_of
embolic and thrombotic events, arterial (smq)||other sequelae of myocardial infarction, not elsewhere classified||member_of
oropharyngeal neoplasms (smq)||malignant neoplasm of salivary gland (diagnosis)||member_of
cardiomyopathy (smq)||cardiovascular syncope||member_of
set of muscles of medial compartment of thigh||musculus pectineus||member_of
non-haematological malignant tumours (smq)||breast ductal carcinoma in situ, not otherwise specified||member_of
tendinopathies and ligament disorders (smq)||villonod synovit-mult jt||member_of
gastrointestinal obstruction (smq)||large intestinal obstruction nos||member_of
haemodynamic oedema, effusions and fluid overload (smq)||edema of finger||member_of
malignancy related conditions (smq)||acquired chromosomal abnormality||member_of
accidents and injuries (smq)||ear foreign body||member_of
neuroleptic malignant syndrome (smq)||unresponsive to pain stimuli||member_of
hypoglycaemia (smq)||seizure, nos||member_of
haematological malignant tumours (smq)||hodgkin granuloma of lymph nodes of inguinal region and/or lower limb||member_of
hypersensitivity (smq)||pulmonary eosinophilic infiltrate||member_of
opportunistic infections (smq)||cytomegalovirus gastrointestinal infection||member_of
haematological malignant tumours (smq)||5q- syndrome||member_of
opportunistic infections (smq)||herpes zoster||member_of
tendinopathies and ligament disorders (smq)||other and ill-defined sprains and strains (disorder)||member_of
accidents and injuries (smq)||parasympathetic nerve injury||member_of
noninfectious encephalopathy/delirium (smq)||arteriosclerotic dementia with delusional features||member_of
accidents and injuries (smq)||foreign body hand||member_of
non-haematological malignant tumours (smq)||oesophageal carcinoma thoracic recurrent||member_of
non-haematological malignant tumours (smq)||sinonasal anaplastic carcinoma||member_of
optic nerve disorders (smq)||loss of vision of right eye||member_of
hypersensitivity (smq)||eosinophilic granulocytosis||member_of
accidents and injuries (smq)||open wound in mouth with complication (disorder)||member_of
neonatal disorders (smq)||weight loss neonatal||member_of
congenital, familial and genetic disorders (smq)||cong.pulmonary stenosis nos||member_of
noninfectious encephalopathy/delirium (smq)||disruptions of 24 hour sleep-wake cycle (disorder)||member_of
malignancy related conditions (smq)||tumour haemorrhage||member_of
noninfectious encephalitis (smq)||bewilderment||member_of
ovarian malignant tumours (smq)||atypical proliferating ovarian tumour||member_of
nmmds environmental condition panel:-:pt:{nursing unit}:-||to what extent do you agree or disagree with psychosocial factors contributing to the phenomenon of complexity:find:pt:{nursing unit}:ord:nmmds||member_of
accidents and injuries (smq)||collapse of vertebra, nos||member_of
fertility disorders (smq)||fertilization (function)||member_of
immune-mediated/autoimmune disorders (smq)||toxic epidermal necrolysis||member_of
accidents and injuries (smq)||gum bruising||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||lochia malodourous||member_of
noninfectious diarrhea (smq)||colitis erosive||member_of
rhabdomyolysis/myopathy (smq)||lower extremity dysfunction||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||immune-mediated nephritis||member_of
pest + insect pnl serpl-mcnc||1naphthol serpl-mcnc||member_of
functional lactation disorders (smq)||acute mastitis (disorder)||member_of
peripheral neuropathy (smq)||paresthesia ear||member_of
eosinophilic pneumonia (smq)||psychogenic hyperventilation (finding)||member_of
hyperglycaemia/new onset diabetes mellitus (smq)||borderline hypercholesterolaemia||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||amniotic fluid; leak||member_of
haematological malignant tumours (smq)||megakaryocytic leukaemia without mention of remission||member_of
gastrointestinal premalignant disorders (smq)||chronic universal ulcerative colitis||member_of
noninfectious encephalopathy/delirium (smq)||hallucination, synaesthetic||member_of
noninfectious encephalopathy/delirium (smq)||dementia aggravated||member_of
cardiomyopathy (smq)||ventricular dysrhythmia (finding)||member_of
hypothyroidism (smq)||thyrotropin receptor antibody positive||member_of
opportunistic infections (smq)||malaria; plasmodium malariae||member_of
torsade de pointes/qt prolongation (smq)||ventricular tachycardia pulseless||member_of
vasculitis (smq)||disease, bazin||member_of
non-haematological malignant tumours (smq)||cloacogenic carcinoma stage unspecified||member_of
hypoglycaemia (smq)||insulin c-peptide high||member_of
hypersensitivity (smq)||conjunctivitis aggravated||member_of
gastrointestinal perforation (smq)||anorectal fistula (disorder)||member_of
haemolytic disorders (smq)||hemolytic anemia due to antibody, nos||member_of
non-haematological malignant tumours (smq)||carcinoma of the cervix, stage i||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||pelvic haematoma, postpartum||member_of
opportunistic infections (smq)||tubrcloma brain-no exam||member_of
congenital, familial and genetic disorders (smq)||cholesterol ester storage dis||member_of
chronic kidney disease (smq)||hemodialysis complication||member_of
opportunistic infections (smq)||cytomegalovirus infection reactivation||member_of
medication errors (smq)||accidental device ingestion by a child||member_of
corneal disorders (smq)||other posterior corneal dystrophies||member_of
severe cutaneous adverse reactions (smq)||hla-b*1502 assay positive||member_of
noninfectious encephalitis (smq)||influenza encephalopathy||member_of
fetal disorders (smq)||fetal heart rate disorder nos||member_of
anaphylactic reaction (smq)||coughing ineffective (finding)||member_of
haemorrhage terms (excl laboratory terms) (smq)||antepartum haemorrhage||member_of
noninfectious encephalitis (smq)||neurological findings abnormal||member_of
congenital, familial and genetic disorders (smq)||metatarsus varus (disorder)||member_of
oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||dysesthesia pharynx||member_of
malignancy related therapeutic and diagnostic procedures (smq)||malignant and unspecified skin neoplasm excision||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||uterine diverticulum||member_of
embolic and thrombotic events, venous (smq)||obstruction; portal||member_of
noninfectious encephalopathy/delirium (smq)||psychotic disorder due to a general medical condition||member_of
rhabdomyolysis/myopathy (smq)||[d]myoglobinuria (situation)||member_of
non-hematological malignant tumors (smq)||malignant neoplasm of small intestine, unspecified recurrent||member_of
lipodystrophy (smq)||cholesterol deposit||member_of
accidents and injuries (smq)||acute reaction to foreign substance accidentally left during a procedure, not elsewhere classified||member_of
hypersensitivity (smq)||neurodermatitis aggravated||member_of
haemorrhage terms (excl laboratory terms) (smq)||purpura, rheumatoid||member_of
noninfectious diarrhea (smq)||fecal incontinence nos||member_of
gastrointestinal perforation (smq)||perforation of cecum||member_of
embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (smq)||arteriovenous fistula thrombosis (disorder)||member_of
optic nerve disorders (smq)||multiple sclerosis-like syndrome||member_of
non-haematological malignant tumours (smq)||basosquamous tumor, malignant||member_of
malignant lymphomas (smq)||follicular predominantly small cleaved cell lymphoma (working formulation) stage i||member_of
non-hematological malignant tumors (smq)||larynx cancer stage iv||member_of
tumor lysis syndrome (smq)||serum phosphate abnormal||member_of
congenital, familial and genetic disorders (smq)||tuberculosis; congenital||member_of
immune-mediated/autoimmune disorders (smq)||unspecified monoarthritis involving upper arm||member_of
congenital, familial and genetic disorders (smq)||toledo type brachyolmia||member_of
rhabdomyolysis/myopathy (smq)||stage 1 acute kidney injury||member_of
sepsis (smq)||septic phlebitis (diagnosis)||member_of
noninfectious encephalopathy/delirium (smq)||convulsions, febrile||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||oth placent cond-deliver||member_of
non-hematological malignant tumors (smq)||primary cancer of liver resectable||member_of
ieee rosetta laboratory panel:-:pt:bld:-||potassium:mass concentration:to identify measures at a point in time:whole blood:quantitative||member_of
hypokalaemia (smq)||alkalosis, hypokalemic||member_of
hemorrhage terms (excluding laboratory terms) (smq)||umbilical hemorrhage congenital||member_of
ischemic central nervous system vascular conditions (smq)||occlusion and stenosis of unspecified precerebral artery||member_of
opportunistic infections (smq)||leukoplakia, hairy||member_of
arrhythmia related investigations, signs and symptoms (smq)||electrocardiogram abnormal non-specific||member_of
conjunctival disorders (smq)||infectious uroarthritis||member_of
hypertension (smq)||hypertension retinopathy grade 1||member_of
noninfectious encephalopathy/delirium (smq)||obtundation mental||member_of
anaphylactic reaction (smq)||facial edema||member_of
psychosis and psychotic disorders (smq)||flexibilities, waxy||member_of
embolic and thrombotic events (smq)||embolic and thrombotic events, venous (smq)||member_of
haemorrhage terms (excl laboratory terms) (smq)||chronic or unspecified gastric ulcer with hemorrhage and perforation||member_of
sepsis (smq)||enterococcal septicaemia||member_of
vasculitis (smq)||viral vasculitis||member_of
oropharyngeal neoplasms (smq)||oral neoplasm malignant stage iii||member_of
depression (excl suicide and self injury) (smq)||intentional product use in unapproved population||member_of
rhabdomyolysis/myopathy (smq)||truncal muscle weakness||member_of
non-hematological malignant tumors (smq)||malignant neoplasm of parotid gland stage iii||member_of
lipodystrophy (smq)||lipoma, unspecified site||member_of
accidents and injuries (smq)||injury; axillary nerve||member_of
oropharyngeal infections (smq)||necrotizing ulcerative periodontitis||member_of
anticholinergic syndrome (smq)||mercurial diuretic poisoning nos||member_of
hypersensitivity (smq)||anti-insulin antibody positive||member_of
non-haematological malignant tumours (smq)||hormone sensitive malignant neoplasm||member_of
haematopoietic cytopenias affecting more than one type of blood cell (smq)||anaemia aplastic aregenerative||member_of
glaucoma (smq)||better eye: near total visual impairment, lesser eye: near total visual impairment||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||purpura symptomatica||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||prurigo (diagnosis)||member_of
antiretroviral therapy status section:-:point in time:^patient:set:hiv-art||body weight:mass:enctr^frst:^patient:qn:measured||member_of
noninfectious encephalitis (smq)||hallucinations, sensory||member_of
dyslipidaemia (smq)||raised triglycerides||member_of
ocular infections (smq)||dacryoadenitis acquired||member_of
oropharyngeal neoplasms (smq)||malignant neoplasm of parotid gland stage iv||member_of
noninfectious encephalopathy/delirium (smq)||pseudohallucination||member_of
drug abuse and dependence (smq)||drug dependence of morphine type||member_of
anticholinergic syndrome (smq)||poisoning by anti-common-cold drugs||member_of
hemorrhage terms (excluding laboratory terms) (smq)||hematoma of rectus sheath||member_of
hemorrhage terms (excluding laboratory terms) (smq)||liver haematoma and contusion with open wound into cavity||member_of
accidents and injuries (smq)||cerebel contus w opn wnd||member_of
respiratory failure (smq)||infantile mixed apnoea||member_of
non-haematological malignant tumours (smq)||esophageal adenocarcinoma middle third stage unspecified||member_of
non-hematological malignant tumors (smq)||breast adenocarcinoma stage iv||member_of
corneal disorders (smq)||cornea; degeneration||member_of
conduction defects (smq)||third degree a-v block||member_of
arthritis (smq)||hysterical coxalgia||member_of
psychosis and psychotic disorders (smq)||ambition loss of||member_of
hematopoietic thrombocytopenia (smq)||thrombocytopenia aggravated||member_of
hostility/aggression (smq)||sexual deviation &/or disorder||member_of
liver related investigations, signs and symptoms (smq)||increased liver function tests||member_of
hematological malignant tumors (smq)||leukemia, myeloid||member_of
oropharyngeal neoplasms (smq)||buccal polyp||member_of
ovarian malignant tumours (smq)||carcinoma in situ other and unspecified female genital organ||member_of
testing methods (psycinfo subcluster term)||computer assisted testing||member_of
haematopoietic leukopenia (smq)||leukocyte count abnormal||member_of
arthritis (smq)||localized primary osteoarthritis of shoulder (diagnosis)||member_of
systemic lupus erythematosus (smq)||actinodermatitis||member_of
accidents and injuries (smq)||open frac of bos with oth and unspec intcran hem, with prolonged loc, w/o return to pecl||member_of
guillain-barre syndrome (smq)||cns mass||member_of
congenital, familial and genetic disorders (smq)||fredrickson type iia hyperlipidaemia||member_of
congenital, familial and genetic disorders (smq)||congenital anomaly of cornea||member_of
hemorrhage terms (excluding laboratory terms) (smq)||atonic postpartum haemorrhage, nos||member_of
congenital, familial and genetic disorders (smq)||gastrointestinal anomalies||member_of
hypothyroidism (smq)||parenchymatous goiter||member_of
haemorrhage terms (excl laboratory terms) (smq)||bronchopulmonary hemorrhage||member_of
chronic kidney disease (smq)||renal tubulitis||member_of
neuro-qol item bank - lower extremity - version 1.0||how much difficulty do you currently have walking around one floor of your home [neuroqol]||member_of
demyelination (smq)||neuromyelitis optica spectrum disorder progression||member_of
cardiomyopathy (smq)||myocarditis mycotic||member_of
pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (smq)||dystocia, shoulder||member_of
set of muscles of larynx||right vocalis||member_of
non-hematological malignant tumors (smq)||malignant nasopharyngeal neoplasm stage iii||member_of
hypersensitivity (smq)||reaction to medical agent preservatives||member_of
hypoglycaemia (smq)||anxious behavior||member_of
acute central respiratory depression (smq)||irregular respiration||member_of
rhabdomyolysis/myopathy (smq)||necrosis kidney tubular||member_of
opportunistic infections (smq)||pheohyphomycosis||member_of
liver infections (smq)||viral hepatitis (b15-b19)||member_of
l3 ems pt care rpt cda r1+r2 set||ems situation:-:pt:^patient:nar:nemsis||member_of
myelodysplastic syndrome (smq)||granulocytes maturation arrest||member_of
non-haematological malignant tumours (smq)||extragonadal primary germ cell tumour mixed||member_of
hypersensitivity (smq)||jaw swelling||member_of
noninfectious meningitis (smq)||nystagms w vestibulr dis||member_of
non-hematological malignant tumors (smq)||malignant neoplasm of other specified parts of mouth stage 0||member_of
retinal disorders (smq)||disseminated chorioretinitis and retinochoroiditis nos (disorder)||member_of
uterine and fallopian tube tumors of unspecified malignancy (smq)||tumors of body of uterus, antepartum condition or complication||member_of
uterine and fallopian tube malignant tumours (smq)||malignant neoplasm of cervix uteri stage ii||member_of
oropharyngeal conditions (excl neoplasms, infections and allergies) (smq)||salivary secretion, nos||member_of
ischaemic colitis (smq)||rectal hemorrhage (disorder)||member_of
haemorrhage terms (excl laboratory terms) (smq)||chronic subdural haemotoma||member_of
other ischemic heart disease (smq)||vascular stent-graft restenosis||member_of
glaucoma (smq)||blindness impairment level not further specified||member_of
malignant lymphomas (smq)||precursor b-lymphoblastic lymphoma/leukemia refractory||member_of
accidents and injuries (smq)||contusion of wrist and hand(s), except finger(s) alone||member_of
gastrointestinal premalignant disorders (smq)||granulomatous ileocolitis||member_of
immune-mediated/autoimmune disorders (smq)||laryngoparalysis||member_of
chronic kidney disease (smq)||drug-induced renal disease (disorder)||member_of
haematological malignant tumours (smq)||diffuse large cell lymphoma (adult t-cell lymphoma/leukaemia) (working formulation) stage iv||member_of
non-hematological malignant tumors (smq)||anus carcinoma cell squamous||member_of
congenital, familial and genetic disorders (smq)||circulation; defect, newborn||member_of
central nervous system vascular disorders, not specified as hemorrhagic or ischemic (smq)||small vessel cerebrovascular disease (disorder)||member_of
generalized convulsive seizures following immunization (smq)||stupor (physical finding)||member_of
respiratory failure (smq)||respiration biot-type||member_of
retinal disorders (smq)||disorders of vitreous body||member_of
accidents and injuries (smq)||open wound of wrist, without mention of complication||member_of
haemodynamic oedema, effusions and fluid overload (smq)||oedema of bone marrow||member_of
gastrointestinal perforation (smq)||intestinal perforation large||member_of
accidents and injuries (smq)||open fracture of five ribs (disorder)||member_of
tumor markers (smq)||abnormality of alphafetoprotein (lab test)||member_of
career areas (psycinfo subcluster term)||behavioral sciences||member_of
physical therapy initial visit panel:-:pt::-||identifier:identifier:to identify measures at a point in time:^patient:nominal||member_of
gastrointestinal perforation, ulcer, hemorrhage, obstruction non-specific findings/procedures (smq)||nontraumatic hemoperitoneum||member_of
congenital, familial and genetic disorders (smq)||spastic quadriplegia-congenital ichthyosiform erythroderma-oligophrenia syndrome||member_of
hypoglycemia (smq)||unable to focus||member_of
embolic and thrombotic events, arterial (smq)||myocardial infarction 4th universal definition||member_of
non-haematological malignant tumours (smq)||malignant neoplasm of upper lip, vermilion border||member_of
anaphylactic reaction (smq)||angioedema aggravated||member_of
systemic lupus erythematosus (smq)||other dermatitis due to solar radiation||member_of
glaucoma (smq)||blindness,one eye, unspecified||member_of
opportunistic infections (smq)||oesophageal candida||member_of
sepsis (smq)||systemic inflammatory response syndrome||member_of
congenital, familial and genetic disorders (smq)||paucity of interlobular bile ducts (pilbd)||member_of
arthritis (smq)||partial knee replacement||member_of
immune-mediated/autoimmune disorders (smq)||autoimmune hyperlipidaemia||member_of
prot elph pnl ur elph||albumin ur elph-mcnc||member_of
opportunistic infections (smq)||tuberculous empyema||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||unspecified pruritic disorder||member_of
hypothyroidism (smq)||immune-mediated hypothyroidism||member_of
opportunistic infections (smq)||pseudomonas test positive||member_of
noninfectious encephalitis (smq)||nystagmus, pathologic||member_of
tendinopathies and ligament disorders (smq)||sprains and strains of wrist and hand||member_of
retinal disorders (smq)||chorioretinitis disseminated peripheral and choroiditis||member_of
hepatitis, non-infectious (smq)||portal triaditis (disorder)||member_of
non-haematological malignant tumours (smq)||adenocarcinoma sigmoid colon||member_of
fertility disorders (smq)||androgen decreased||member_of
opportunistic infections (smq)||typhus rickettsia test positive||member_of
angioedema (smq)||chronic wheezing||member_of
accidents and injuries (smq)||traumatic pneumothorax without mention of open wound into thorax||member_of
opportunistic infections (smq)||candida test positive||member_of
osteonecrosis (smq)||unspecified osteomyelitis, other specified sites||member_of
hearing impairment (smq)||tympanoplasty type 1||member_of
malignant lymphomas (smq)||diffuse large cell lymphoma (high grade b-cell burkitt-like lymphoma) stage iii||member_of
opportunistic infections (smq)||staphylococcal infectious disease (disorder)||member_of
corneal disorders (smq)||corneal ulcer nos (disorder)||member_of
retinal disorders (smq)||dr - diabetic retinopathy||member_of
hypersensitivity (smq)||eczema; nummular||member_of
anaphylactic reaction (smq)||weeping edema||member_of
anaphylactic reaction (smq)||warm skin (finding)||member_of
malignant lymphomas (smq)||small noncleaved cell non-burkitt's lymphoma (working formulation)||member_of
normal pregnancy conditions and outcomes (smq)||para 2 (finding)||member_of
haemorrhagic central nervous system vascular conditions (smq)||neonatal cerebral hemorrhage||member_of
arthritis (smq)||stiffness of joint, nec, involving lower leg in mdr24_0||member_of
bordetella sp filamentous hemagglutinin & pertussis toxin ab.iga & igg panel:-:pt:ser:-:line blot||b pert+para.fha iga ser ql line blot||member_of
ocular infections (smq)||epithelial filamentary keratitis was observed||member_of
gastrointestinal nonspecific inflammation (smq)||feline oesophagus||member_of
opportunistic infections (smq)||haemophilus parainfluenzae pneumonia||member_of
neonatal disorders (smq)||large fontanelle bulging||member_of
infective pneumonia (smq)||infections, histoplasma||member_of
vestibular disorders (smq)||felt giddy||member_of
optic nerve disorders (smq)||neuritides, optic||member_of
taste and smell disorders (smq)||[d]parosmia (context-dependent category)||member_of
noninfectious encephalopathy/delirium (smq)||senile dementia with delirium (disorder)||member_of
systemic lupus erythematosus (smq)||oral mucosa; ulcer||member_of
accidents and injuries (smq)||burn lesion||member_of
optic nerve disorders (smq)||delayed dark adaptation||member_of
gastrointestinal perforation, ulcer, hemorrhage, obstruction non-specific findings/procedures (smq)||mesenteric hematoma||member_of
corneal disorders (smq)||arcus lipoides||member_of
reproductive premalignant disorders (smq)||leukoplakia of cervix||member_of
number of falls since admission or prior assessment:-:reporting period:^patient:-:cms assessment||number of falls since admission or prior assessment - no injury:num:rptperiod:^patient:ord:cms assessment||member_of
rhabdomyolysis/myopathy (smq)||acute renal failures||member_of
malignancy related therapeutic and diagnostic procedures (smq)||tumourectomy||member_of
tendinopathies and ligament disorders (smq)||palmar fasciitis||member_of
non-hematological malignant tumors (smq)||serous cystadenocarcinoma of pancreas (disorder)||member_of
noninfectious encephalitis (smq)||groggy and sluggish||member_of
oropharyngeal neoplasms (smq)||carcinoma mouth||member_of
hemorrhage terms (excluding laboratory terms) (smq)||hemorrhage of liver||member_of
noninfectious encephalitis (smq)||unconscious partial||member_of
haemorrhage terms (excl laboratory terms) (smq)||lip haematoma||member_of
psychosis and psychotic disorders (smq)||schizo nec-subchr/exacer||member_of
accidents and injuries (smq)||subluxation patellofemoral joint||member_of
accidents and injuries (smq)||other cranial and peripheral nerve injuries due to birth trauma||member_of
conjunctival disorders (smq)||conjunctival injection (finding)||member_of
liver related investigations, signs and symptoms (smq)||pain hepatic||member_of
hypersensitivity (smq)||erythema auricular||member_of
opportunistic infections (smq)||african trypanosomiasis (disorder)||member_of
depression (excl suicide and self injury) (smq)||opioid dependences||member_of
additional concerns - fact-an [facit]||i feel tired in the past 7d:finding:7 days:^patient:ordinal:facit||member_of
congenital, familial and genetic disorders (smq)||acrocephalopolysyndactyly (disorder)||member_of
noninfectious encephalitis (smq)||sensory ataxias||member_of
cardiac failure (smq)||rvf - r ventricular failure||member_of
ieee rosetta laboratory panel:-:pt:bld:-||base excess in extracellular fluid by calculation||member_of
malignancy related therapeutic and diagnostic procedures (smq)||sarcoma excision||member_of
haemorrhage terms (excl laboratory terms) (smq)||brain stem hematoma||member_of
congenital, familial and genetic disorders (smq)||sitosterolemia (disorder)||member_of
tendinopathies and ligament disorders (smq)||pelvic sprain||member_of
non-haematological malignant tumours (smq)||nasal adenocarcinoma||member_of
drug induced platelet ab panel - serum or plasma||valproate induced platelet igg fc ql||member_of
cholestasis and jaundice of hepatic origin (smq)||liver cholestasis||member_of
cardiomyopathy (smq)||intraventricular dyssynchrony||member_of
accidents and injuries (smq)||torn muscle||member_of
functional lactation disorders (smq)||nonpurulent mastitis associated with childbirth, unspecified as to episode of care||member_of
drug reaction with eosinophilia and systemic symptoms syndrome (smq)||[d]abnormal liver function test (situation)||member_of
hyperglycemia/new onset diabetes mellitus (smq)||sugar fasting bloodlevel inc||member_of
ovarian malignant tumors (smq)||ovarian germ cell endodermal sinus tumour stage iii c||member_of
asthma/bronchospasm (smq)||fev1/fvc ratio decreased||member_of
systemic lupus erythematosus (smq)||immune-mediated nephritis||member_of
fluoroquinolones||1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid||member_of
accidents and injuries (smq)||elbow broken||member_of
congenital, familial and genetic disorders (smq)||congenital aortic valve stenosis (diagnosis)||member_of
cardiac failure (smq)||[d]peripheral oedema (situation)||member_of
noninfectious encephalitis (smq)||swallowing apraxia||member_of
oropharyngeal neoplasms (smq)||malignant neoplasm of waldeyer's ring stage 0||member_of
corneal disorders (smq)||corneal infiltration||member_of
pulmonary hypertension (smq)||cirrhosis (of);liver||member_of
fluid and weight panel [esrd]||sodium profiling-modeling prescribed for any dialysis sessions in the reporting mo:finding:to identify measures at a point in time:^patient:ordinal:esrd||member_of
liver infections (smq)||hepatitis due to epstein-barr virus (diagnosis)||member_of
pregnancy, labor and delivery complications and risk factors (excluding abortions and stillbirth) (smq)||gestational trophoblastic detachment||member_of
non-hematological malignant tumors (smq)||cancer of lung stage ii||member_of
haematological malignant tumours (smq)||hodgkin's sarcoma, intrathoracic lymph nodes||member_of
malignancy related therapeutic and diagnostic procedures (smq)||bladder transurethral resection||member_of
blood premalignant disorders (smq)||ppp - primary proliferative polycythemia||member_of
noninfectious encephalitis (smq)||other symbolic dysfunctions||member_of
neuroleptic malignant syndrome (smq)||fine tremor||member_of
retinal disorders (smq)||vitreal cells||member_of
accidents and injuries (smq)||burns second degree||member_of
conjunctival disorders (smq)||conjunctival fold||member_of
anticholinergic syndrome (smq)||poisoning caused by skeletal muscle relaxant (disorder)||member_of
congenital, familial and genetic disorders (smq)||fahr's syndrome||member_of
hypoglycemia (smq)||anxiety nec||member_of
hyperglycaemia/new onset diabetes mellitus (smq)||hyperlipemias||member_of
noninfectious meningitis (smq)||convulsions nos aggravated||member_of
psychosis and psychotic disorders (smq)||oppression to conduct act||member_of
accidents and injuries (smq)||contusion axillary reg||member_of
accidents and injuries (smq)||open fracture of base of skull with intracranial injury of other and unspecified nature, with prolonged [more than 24 hours] loss of consciousness and return to pre-existing conscious level||member_of
stiffness of joint, not elsewhere classified, involving shoulder region||stiffness of joint, not elsewhere classified, involving shoulder region||has_translation
hair sulfur normal||hair sulfur normal||has_translation
pemphigoid nos (disorder)||pemphigoid nos (disorder)||has_translation
bleeding;postpartum||bleeding;postpartum||has_translation
closure of colostomy (procedure)||colostomy take-down||has_translation
pits, cell-membrane coated||bristle-coated pit||has_translation
postoperative wound necrosis||postoperative wound necrosis||has_translation
oropharyngeal discoloration||oropharyngeal discolouration||has_translation
unspecified inflammatory disease of uterus||uterus; inflammation||has_translation
decreased circulating ige||decreased circulating ige||has_translation
viral infectious disorders||viral infectious disorders||has_translation
pcf - posterior capsular fibrosis||pcf - posterior capsular fibrosis||has_translation
[v]procedure not carried out for unspecified reason (situation)||procedure not carried out, unspecified reason||has_translation
pms - premenstrual syndrome||premenstrual syndrome (pms)||has_translation
unspecified complication of anesthesia or other sedation in labor and delivery, delivered, with mention of postpartum complication||anesth compl nos-del p/p||has_translation
autologous grafting||autograft (substance)||has_translation
kinetic ataxia||motor ataxias||has_translation
hypotension aggravated||hypotension aggravated||has_translation
sugar cane worker pneumonitis||bagassosis||has_translation
exaggerated startle response||exaggerated startle response||has_translation
dilated left atrium||dilated left atrium||has_translation
ca 27 29||carbohydrate antigen 27.29||has_translation
genital dysaesthesia||genital dysesthesia||has_translation
veno-venous ecmo||veno-venous ecmo||has_translation
infection caused by rubulavirus (disorder)||disease due to rubulavirus (disorder)||has_translation
lipoid pneumonia||pneumonias, lipid||has_translation
synovial fluid glucose||synovial fluid glucose||has_translation
mammary dysplasia (benign)||benign mamm dysplas nos||has_translation
peripartum cardiomyopathy||cardiomyopathy peripartum||has_translation
haemophilus influenza acute exacerbations of chronic bronchitis||haemophilus influenzae acute exacerbations of chronic bronchitis||has_translation
[d]wheezing (situation)||wheezing (finding)||has_translation
drug chemical incompatibility||drug chemical incompatibility||has_translation
satellite dnas||dna, satellite||has_translation
1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester||etazolate||has_translation
psychology regression||regression (defense mechanism)||has_translation
implant site discolouration||implant site discoloration||has_translation
schirmer's test normal||schirmer's test normal||has_translation
comfort scale score increased||comfort scale score increased||has_translation
magnetic resonance imaging of liver||magnetic resonance imaging (mri) of liver||has_translation
transfusion-related circulatory overload||transfusion-related circulatory overload||has_translation
incision site inflammation||incision site inflammation||has_translation
high-pitched crying||high-pitched cry||has_translation
form muscle||observ form skeletal muscle||has_translation
hematocrit elevated||increase in hematocrit||has_translation
cortactin||cortactin||has_translation
closure premature epiphysis||closure epiphysis premature||has_translation
renal cell carcinoma, stage ii ajcc v6||renal cell carcinoma, stage ii ajcc v6||has_translation
b-type lamin||b-type lamins||has_translation
allergy, unspecified, not elsewhere classified||allergy, unspecified, nec in mdr||has_translation
tetanus like||tetanus like||has_translation
hyperpallaesthesia||hyperpallesthesia||has_translation
rubella without mention of complication||german measles||has_translation
hepatitis, nos||hepatitis (diagnosis)||has_translation
familial rectal pain syndrome||familial rectal pain syndrome||has_translation
tumor urethra||neoplasia of the urethra||has_translation
tissue donor, nos||donor, tissue||has_translation
marfan syndrome (diagnosis)||marfan||has_translation
eye lubrication therapy||eye lubrication therapy||has_translation
cranial operation||cranial operation||has_translation
mouth breath||mouth breathings||has_translation
food chain||chains, food||has_translation
narenga bor, 1940||erianthus michx., 1803||has_translation
lymphatic tissue operation||lymphatic tissue operations||has_translation
injury leg vessel nos||injury to blood vessels of lower limb||has_translation
femoral pulse decreased||femoral pulse decrease||has_translation
liver; prolapse||liver prolapse||has_translation
vascular resistance pulmonary||vascular resistance pulmonary||has_translation
penile size reduced||penile size reduced||has_translation
muscle denervation||denervation muscle||has_translation
placental diseases||placental disorder, unspecified||has_translation
central nervous system angiitis||angiitis cns||has_translation
intra-ocular pressure test||intraocular pressure||has_translation
neuranatomies||neuroanat||has_translation
eye; complications||complications; eye||has_translation
malum perforans pedis||malum perforans pedis||has_translation
1-5b0 liver: general and miscellaneous operative procedures||1-5b0 liver: general and miscellaneous operative procedures||has_translation
bilirubin conjugated increased||increased conjugated bilirubin||has_translation
crocodile shagreen||crocodile shagreen||has_translation
bleeding oesophageal ulcer||bleeding esophageal ulcer||has_translation
enthesophyte||enthesophyte (morphologic abnormality)||has_translation
liver injury without open wound into cavity, unspecified||liver injuries without mention of open wound into cavity, nos (disorder)||has_translation
haemoperfusion||hemoperfusion (procedure)||has_translation
viral hepatitis b||viral serum hepatitis b||has_translation
traveling||travel (event)||has_translation
stenosis; bladder-neck||bladder neck contracture||has_translation
nasal turbinate oedema||nasal turbinate edema||has_translation
dysphylaxia||dysphylaxia||has_translation
meckel diverticulum||meckel; diverticulum||has_translation
implantable defibrillator insertion||implantable defibrillator insertion||has_translation
pecoma||tumor with perivascular epithelioid cell differentiation||has_translation
newborn head molding||newborn head moulding||has_translation
apolipoprotein a-i measurement||apolipoprotein a-i||has_translation
endocrine procedural complications||endocrine procedural complications||has_translation
distortions, perceptual||perceptual distortion||has_translation
mitogen activated protein kinase 02||p42(mapk)||has_translation
biopsy small intestine abnormal||biopsy small intestine abnormal||has_translation
out of body experience (finding)||out of body experiences||has_translation
csf immunoglobulin increased||csf immunoglobulin increased||has_translation
associated encephalopathies, sepsis||associated encephalopathy, sepsis||has_translation
perineal necrosis||perineal necrosis||has_translation
reduction of intussusception of large intestine||reduction of intussusception of large intestine||has_translation
tumor of the tongue||neoplasm tongue||has_translation
a.cerebri anterior; occlusion||a.cerebri anterior; occlusion||has_translation
advanced gastric carcinoma||advanced gastric carcinoma||has_translation
vasoepididymostomy||vasoepididymostomy||has_translation
other hodgkin's disease||[x]other hodgkin's disease (disorder)||has_translation
adenocarcinoma of lung stage unspecified||adenocarcinoma of lung stage unspecified||has_translation
cardiovascular autonomic function test abnormal||cardiovascular autonomic function test abnormal||has_translation
obsessional; rumination||obsession||has_translation
ophthalmologist (occupation)||ophthalmologist||has_translation
serum alkaline phosphatase measurement||serum alkal phosphatase level||has_translation
respiratory syncytial virus test positive||respiratory syncytial virus test positive||has_translation
cerebrospinal fluid neutrophil count increased||csf neutrophil count increased||has_translation
renal concentrating power decr||hyposthenuria||has_translation
hemolytic; icterus, congenital||hemolytic; jaundice, congenital||has_translation
anal sinus repair||anal sinus repair||has_translation
abnormal tooth eruption||tooth eruption disturbances||has_translation
congestion of nose||nasal congestion (finding)||has_translation
coxsackie virus infection in conditions classified elsewhere and of unspecified site||coxsackie virus inf nos||has_translation
normochromic normocytic anemia||normochromic normocytic anemia||has_translation
fertility testing||fertility study||has_translation
rubella virus vaccine live||rubella virus live vaccine||has_translation
acute urinary retention||acute retention of urine||has_translation
subclinical hyperthyroidism||subclinical hyperthyroidism (diagnosis)||has_translation
papillary transitional cell carcinoma of bladder (diagnosis)||papillary transitional cell carcinoma of bladder||has_translation
personnels, medical laboratory||personnels, clinical laboratory||has_translation
homonymous diplopia||homonymous diplopia||has_translation
pouched mammal, nos||pouched mammal (organism)||has_translation
eyelid; hyperemia||hyperemia of eyelid (physical finding)||has_translation
viral; pneumonia, adenovirus||pneumonia due to adenovirus||has_translation
derang ant med meniscus||derangement of anterior horn of medial meniscus (disorder)||has_translation
testosterone, increased||increased testosterone||has_translation
arf1 protein||arf1 protein||has_translation
penile biopsy abnormal||biopsy penis abnormal||has_translation
pneumonolysis||pneumonolysis||has_translation
schizophrenic; psychosis, paranoid||psychosis; paranoid, schizophrenic||has_translation
pneumonia in mycoses||pneumonia in mycoses (diagnosis)||has_translation
veterinary pharmaceuticals||veterinary drug||has_translation
elastofibromas||elastofibromas||has_translation
abortion with complications (diagnosis)||abortion with complications (diagnosis)||has_translation
abnormal oxytocin (biological function) (finding)||oxytocin abnormal nos||has_translation
sputum normal||sputum normal||has_translation
partial splenic embolization||partial splenic embolisation||has_translation
congenital genitourinary abnormality||congenital urogenital anomaly, nos||has_translation
thyrotoxicosis nos||toxic; thyroid||has_translation
orbit biopsy abnormal||orbit biopsy abnormal||has_translation
light reflex tests pupillary abnormal||pupillary light reflex tests abnormal||has_translation
[d]elevated sedimentation rate (situation)||[d]elevated sedimentation rate (context-dependent category)||has_translation
keratosis foll spinulos decalv||keratosis pilaris decalvans||has_translation
implant complications (disorder)||complications implants||has_translation
striatopallidal system; disorder||striatopallidal system; disorder||has_translation
acneform eruption||acneform eruptions (disorder)||has_translation
injection site subcutaneous fat decreased||lipoatrophy injection site||has_translation
congenital septal defects||congenital malformation of cardiac septum, unspecified||has_translation
tendon necrosis||tendon necrosis||has_translation
excision;mole||excision;mole||has_translation
fog in front of eyes||fog in front of eyes||has_translation
sgs||shprintzen goldberg craniosynostosis syndrome (diagnosis)||has_translation
rna, trp transfer||trp transfer rna||has_translation
conjunctivitis due to adenovirus (disorder)||conjunctivitis due to adenovirus||has_translation
malignant neoplasm of respiratory tract, nos||malignant neoplasm of respiratory system (disorder)||has_translation
cardiovascular event prophylaxis||cardiovascular event prophylaxis||has_translation
stroke, ischemic||ischemic stroke nos||has_translation
duodenal polyps||duodenal polyp (diagnosis)||has_translation
paraesthesia of genital female||paresthesia of genital female||has_translation
abnormal progesterone -retired-||progesterone abnormal||has_translation
thyroid goiter hyperthyroid||hyperthyroid goiter||has_translation
rigor(s)||rigors (symptom)||has_translation
sialoadenitis infection||sialoadenitis infection||has_translation
oedema dependent||dependent edema (morphologic abnormality)||has_translation
incomplete development, nos||congenital hypoplasia, nos||has_translation
cerebrospinal fluid test||csf test||has_translation
testicular inflammation||non-specific orchitis, nos||has_translation
excessive foetal growth, affecting management of mother, antepartum||excess fet grth-antepart||has_translation
other dysfunctions of sleep stages or arousal from sleep||sleep stage dysfunc nec||has_translation
calcitonin secretion disorder||disord thyrocalcitonin secretn||has_translation
family cryptosporiidae (organism)||family cryptosporiidae||has_translation
metabolic disorder; amino-acid||acid amino disorders||has_translation
syndrome; chromosome||chromosome; syndrome||has_translation
transfusion; complications||transfusion; complications||has_translation
bronchial artery aneurysm||bronchial artery aneurysm||has_translation
hydroxymethyl and formyl transferase||hydroxymethyl and formyl transferases||has_translation
septicaemia due to escherichia coli (e. coli)||septicaemia due to e. coli||has_translation
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections||pandas - paediatric autoimmune neuropsychiatric disorder associated with streptococcal infection||has_translation
diaphragmatic pleurisy (disorder)||diaphragmatic pleurisy (diagnosis)||has_translation
open posterior dislocation of humerus (diagnosis)||open posterior dislocation of humerus (disorder)||has_translation
hammond's diseases||athetosis, nos||has_translation
hydroxycorticosteroids urine low||hydroxycorticosteroids urine low||has_translation
intrapleural fluid retention of||intrapleural fluid retention of||has_translation
cpk mb elevated||cpk-mb increased||has_translation
agvhd||acute graft-versus-host disease (disorder)||has_translation
edema due to hepatic disease||edema due to hepatic disease||has_translation
moniliasis genital||candidas genital||has_translation
immunodeficiency 2s||wiskott syndromes||has_translation
meat (substance)||meat (substance)||has_translation
tumor embolisms||tumour embolism||has_translation
food poisoning, nos||food poisoning nos (disorder)||has_translation
immunity||response, immune||has_translation
blindness traumatic||blindness traumatic||has_translation
cns muscle-tone depressant toxicity||central nervous system muscle-tone depressant toxicity (diagnosis)||has_translation
salmonella septicaemia||septicaemia salmonella||has_translation
rheumatoid vasculitides||rheumatoid vasculitis||has_translation
conjunctival scars||conjunctiva; cicatrix||has_translation
hypercholesterolemia aggravated||hypercholesterolaemia aggravated||has_translation
time perception altered||time perception altered||has_translation
aids nephropathy||aids-related nephropathy||has_translation
myasthenia gravis, anti-musk||musk myasthenia gravis||has_translation
neurofibrils||neurofibrils||has_translation
pots - postural orthostatic tachycardia syndrome||syndrome, postural tachycardia||has_translation
metallic alloy (substance)||metallic alloy, nos||has_translation
blood heavy metal increased||blood heavy metal nos increased||has_translation
elevated bun||bun elevated||has_translation
blood gonadotrophin normal||blood gonadotrophin normal||has_translation
complement fixation abnormal||abnormal complement fixation||has_translation
metastatic epithelioid cell sarcoma||epithelioid sarcoma metastatic||has_translation
postlaminectomy; kyphosis||postlaminectomy kyphosis (disorder)||has_translation
threshold, sensory||sensory thresholds||has_translation
trauma, fifth-nerve||trigeminal nerve traumas||has_translation
aurora kinase b||aurora kinases b||has_translation
secondary hyperprolactinaemia due to prolactin-secreting tumour||forbes-albright syndrome||has_translation
nucleocapsid protein||nucleocapsid proteins||has_translation
uterine fibroid cyst||uterine fibroid cyst||has_translation
diagnostic aspiration of bone marrow||bone marrow aspiration procedure (procedure)||has_translation
thyroid calcification||thyroid calcification||has_translation
cholangiolitis, nos||cholangiolitis, nos||has_translation
elbow deformity||elbow; deformity||has_translation
tuberculosis; spermatic cord (manifestation)||spermatic cord; tuberculous (etiology)||has_translation
blood salivary amylase||blood salivary amylase||has_translation
gastrointestinal mucosal necrosis||disorder of gastrointestinal tract mucosal necrosis||has_translation
histamine level increased||histamine level increased||has_translation
intracranial germ cell tumor||intracranial germ cell tumor||has_translation
[so]salivary apparatus||major salivary gland, nos||has_translation
displacement (lateral) of globe||displacement (lateral) of globe||has_translation
postrenal failure||postrenal failure||has_translation
syndrome; malabsorption||malabsorption syndrome nos||has_translation
molineoidae||molineoidae||has_translation
herpes simplex keratitides||herpes simplex ophthalmicus||has_translation
larynx inflamed||larynx inflamed||has_translation
nizatidine (medication)||nizatidine (substance)||has_translation
prolymphocytic leukemia -retired-||prolymphocytic leukemia -retired-||has_translation
primary cancer of liver recurrent||liver, cancer of, primary recurrent||has_translation
colonic strictures||colon stenosis||has_translation
myoclonic epilepsy, severe infantile||severe myoclonic epilepsy in infancy (disorder)||has_translation
vascular graft restenosis||occlusion, vascular graft||has_translation
hyperexplexia||hyperekplexia||has_translation
sars-cov-2 rna fluctuation||sars-cov-2 rna fluctuation||has_translation
heart; congestive||disease congestive heart||has_translation
accessory navicular syndrome||accessory navicular syndrome||has_translation
immunoreactive trypsinogen abnormal||immunoreactive trypsinogen abnormal||has_translation
tinea capitis profunda||tinea capitis (diagnosis)||has_translation
skin infection pyogenic||skin infection pyogenic||has_translation
drug specific antibody absent||drug specific antibody absent||has_translation
joint pain-jt nec||pain in joint, other specified sites||has_translation
coagulation factor viii level high||coagulation factor viii level increased||has_translation
hypertension; renal||renal hypertension||has_translation
aortic restenosis||aortic restenosis||has_translation
stage i extrahepatic bile duct cancer||stage i extrahepatic bile duct carcinoma||has_translation
parkinsonian rest tremor||parkinsonian rest tremor||has_translation
defic syndromes immunol||deficiency syndrome, immunologic||has_translation
iliolumbar syndrome||iliolumbar syndrome||has_translation
gb calc.+ot.cholecyst-obst.nos||gallbladder calculus with other cholecystitis - obstruct nos||has_translation
spermatozoa progressive motility normal||spermatozoa progressive motility normal||has_translation
c4a - complement component 4a||c4a complement||has_translation
anterior q wave||anterior q wave||has_translation
cell marker decreased||cell marker decreased||has_translation
malignant neoplasm of bladder stage iv||malignant tumor of bladder stage iv||has_translation
carbamic acid,(5-(propylthio)-1h-benzimidazol-2-yl)-, methyl ester||(5-(propylthio)-1h-benzimidazol-2-yl)carbamic acid methyl ester||has_translation
pantoea agglomerans infection||pantoea agglomerans infection||has_translation
genus mitragyna||genus mitragyna (organism)||has_translation
protein induced by vitamin k absence or antagonist ii increased||pivka ii increased||has_translation
seroma||seroma (disorder)||has_translation
hiccuping||hiccoughing||has_translation
retinal nonperfusion||retinal nonperfusion||has_translation
eyelid stinging||eyelid stinging||has_translation
carotid pulse abnormal||carotid pulse abnormal||has_translation
auricular haematoma||hematoma; pinna||has_translation
hemorrhage; bladder||urinary bladder hemorrhage||has_translation
drug up-titration||drug up-titration||has_translation
absence of tooth||tooth absent||has_translation
spinal cord paralysis||spinal cord paralysis||has_translation
strongylocentrotus||strongylocentrotus||has_translation
fraser syndrome (diagnosis)||cyclopism||has_translation
glucagon secretion abnormality nos (disorder)||glucagon secretion abnormality nos (disorder)||has_translation
mycoplasma hominis pyelonephritis||mycoplasma hominis pyelonephritis||has_translation
duane's syndrome (diagnosis)||duane||has_translation
calcium/oxalate||calcium oxalate (substance)||has_translation
systemic vasculitis||systemic vasculitis syndrome||has_translation
models, logistic||logistic models||has_translation
disruption of perineal laceration repair in the puerperium||disruption of perineal laceration repair in puerperium||has_translation
reiter arthritis-unspec||arthropathy associated with reiter's disease and nonspecific urethritis, site unspecified||has_translation
nephritis haemorrhagic||hemorrhagic nephritis||has_translation
antimicrobial susceptibility test (procedure)||antimicrobial susceptibility tests||has_translation
product dosage form issue||product dosage form issue||has_translation
paresthesia upper limb||extremity paresthesia, upper||has_translation
other primary progressive tuberculosis, confirmed by animal inoculation||other primary progressive tuberculosis, confirmed by animal inoculation||has_translation
pulmonary artery endarterectomy (treatment)||pulmonary artery endarterectomy||has_translation
hyperemia of eye||hyperemia of eye||has_translation
blood phosphorus decreased||blood phosphorus decreased||has_translation
per vaginal discharge||per vaginal discharge||has_translation
worker, community health||health aide, community||has_translation
muscle diaphragm weakness||weak diaphragm||has_translation
johnson stevens syndrome||johnson stevens syndrome||has_translation
chest distressed feeling of||chest distressed feeling||has_translation
pulmonary arterial pressure decreased||pulmonary arterial pressure decreased||has_translation
cystic fibrosis related diabetes||cystic fibrosis related diabetes||has_translation
genotype drug resistance test negative||genotype drug resistance test negative||has_translation
plasminogen inactivator, nos||activator inhibitor, plasminogen||has_translation
leukoderma (disorder)||leukoderma nos (disorder)||has_translation
primary tuberculous complex, tubercle bacilli found (in sputum) by microscopy||primary tuberculous complex, tubercle bacilli found (in sputum) by microscopy||has_translation
blood homocysteine normal||blood homocysteine normal||has_translation
diffuse mixed small and large cell lymphoma (intestinal t-cell lymphoma) refractory||diffuse mixed small and large cell lymphoma (intestinal t-cell lymphoma) refractory||has_translation
chronic recurrent multifocal osteomyelitis||crmo -chr multifoc osteomyelit||has_translation
igg4-related sclerosing diseases||igg4-related disease||has_translation
bodies foreign swallowed||bodies foreign swallowed||has_translation
huntington; family history||huntington; family history||has_translation
blood chromium decreased||blood chromium decreased||has_translation
ct hypotension complex||ct hypoperfusion complex||has_translation
presumed infectious diarrhoea||diarrhea & vomiting -? infect||has_translation
metastatic pain||metastatic pain||has_translation
ben lipomatous neoplm of skin, subcu of head, face and neck||benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck||has_translation
laparoscopy normal||laparoscopy normal||has_translation
other autosomal anomaly condit||other condition due to autosomal anomaly (disorder)||has_translation
biopsy breast normal||breast biopsy normal||has_translation
bacterial polysaccharide||polysaccharides bact||has_translation
chronic synovitis (disorder)||synovitis chronic||has_translation
femur fracture; femur neck||fracture; femur, neck||has_translation
membrane, vitelline||membranes, vitelline||has_translation
other pulmonary fibroses nos||other pulmonary fibroses nos||has_translation
diphyllobothrium infections||diphyllobothriasis, intestinal||has_translation
increased plasma ldl levels||increased circulating low-density lipoprotein cholesterol||has_translation
pain in area of anesthesia (finding)||anaesthesia dolorosa||has_translation
plasma viscosity nos (procedure)||plasma viscosity||has_translation
arteriogram coronary abnormal||arteriogram coronary abnormal||has_translation
perforation of femoral artery (disorder)||perforation of femoral artery (disorder)||has_translation
ewing's tumour metastatic||metastatic tumors of the ewing's family||has_translation
increased mean platelet volume||mean platelet volume increased||has_translation
bromosulphthalein retention||bromsulphthalein retention||has_translation
already mapped above aaha id #: 832||gastric inflammation||has_translation
trifluperidol (product)||product containing trifluperidol||has_translation
endocrine procedural complication||endocrine procedural complications||has_translation
herpes zoster infection neurological||herpes zoster infection neurological||has_translation
submandibular salivary gland swelling||submandibular salivary gland swelling (finding)||has_translation
block facet joint||blocks facet joint||has_translation
prostatic calcification||prostatic calcification||has_translation
ultrasound, doppler||ultrasound, doppler||has_translation
applanation tonometry (procedure)||applanation tonometry (procedure)||has_translation
[x]diphtheria, unspecified (disorder)||diphtheria (diagnosis)||has_translation
mammitis||breast inflammation nos (disorder)||has_translation
viral gastritis (disorder)||gastritis viral nos||has_translation
inhibitor, sglt-2||sglt-2 inhibitor||has_translation
autoimmune anaemia||autoimmune anaemia||has_translation
burn involving greater than 90% of body surface nos||burns involving 90% or more of body surface (diagnosis)||has_translation
small intestine computerised tomography||small intestine computerised tomography||has_translation
operation on adrenal gland||operative procedure on adrenal gland||has_translation
lipopeptides||lipopeptide||has_translation
hiv-2 test negative||hiv-2 test negative||has_translation
total glossectomy (procedure)||total excision of tongue||has_translation
diseases glycogen storage||liver; disease, glycogen storage (etiology)||has_translation
anticoagulation drug level decreased||anticoagulation drug level decreased||has_translation
cerebral injuries nec||cerebral injuries nec||has_translation
aspiration sperm||aspiration sperm||has_translation
anti-islet antigen 2 antibody||anti-ia2 antibody||has_translation
persistent depressive disorder (dysthymia) (diagnosis)||dysthymic disorders||has_translation
dental discomfort||tooth discomfort||has_translation
buttock, nos||buttock (surface region) (body structure)||has_translation
atypical platelet||abnormalities platelet||has_translation
abscess of mediastinum||mediastinal abscess||has_translation
steroid nephropathy||steroid nephropathy||has_translation
inflammation of the esophagus||oesophagitis nos||has_translation
dental implant removal||removal of dental implant||has_translation
product color issue||product colour issue||has_translation
optic nerve infections and inflammations||optic nerve infections and inflammations||has_translation
walking distance test||walking distance test||has_translation
scleritis allergic||scleritis allergic||has_translation
esophageal squamous cell carcinoma lower third stage i||oesophageal squamous cell carcinoma lower third stage i||has_translation
ps2, protein||ps2, protein||has_translation
oropharyngeal lymphepithelioma stage i||stage i oropharyngeal undifferentiated carcinoma ajcc v6||has_translation
mushy diarrhea||mushy diarrhoea||has_translation
macular focal oedema||macular focal oedema||has_translation
candida test positive||candida test positive||has_translation
left ventricular end-diastolic dimension||left ventricular end-diastolic dimension||has_translation
brachial plexus repair||brachial plexus repair||has_translation
traumatic amputation of arm and hand, unilateral, level not specified, without mention of complication||traumatic ampu of arm and hand (complete) (partial), unilat, level not spec, w/o ment of comp||has_translation
imaging lung||lungs scan||has_translation
hsv infection||herpes simplex viral infection||has_translation
thoracic aortic aneurysm enlargement||thoracic aortic aneurysm enlargement||has_translation
sex, anal||sex, anal||has_translation
sprains and strains of sacrum||sprains and strains of sacrum||has_translation
closed fracture of vault of skull with subarachnoid, subdural, and extradural hemorrhage, with brief [less than one hour] loss of consciousness||closed frac of vos with subarac, sub/extradural hem, with brief loc||has_translation
posterior fossa tumor||neopl infratentorial||has_translation
nia||nia (us)||has_translation
burns of thigh (diagnosis)||burns of thighs||has_translation
eyelid margin crusting||eyelid margin crusting||has_translation
histoplasmosis; histoplasma capsulatum, pulmonary, chronic (etiology)||chronic pulmonary histoplasmosis||has_translation
injury of nose nos||nasal injury||has_translation
intravenous leiomyomatosis (diagnosis)||intravascular leiomyomatosis of uterus||has_translation
htlv test||htlv test||has_translation
chromosome; abnormal||anomaly of chromosome||has_translation
panic-stricken||panic||has_translation
thyroid autoantibody test||anti-thyroid antibodies||has_translation
congen abn uter-postpart||congen abn uter-postpart||has_translation
insufficiency; aorta (valve), congenital||deformity; aortic valve, insufficiency||has_translation
psychotic disorder caused by substance||substance induced psychotic disorder||has_translation
hepatitis c virus genotype 3c positive||hepatitis c virus genotype 3c positive||has_translation
stage iva cancer of the vagina||vaginal cancer, stage iva||has_translation
haemoglobin distribution width decreased||haemoglobin distribution width decreased||has_translation
radiation neuropathy||radiation neuropathy||has_translation
coprophrasia||corprolalia||has_translation
abn result liver funct studies||abnorm.liver function test||has_translation
uterine vessel ligation||uterine vessel ligation||has_translation
salivary gland biopsy abnormal||salivary gland biopsy abnormal||has_translation
disorders pancreatic||diseases of the pancreas||has_translation
reticulocyte count abnormal nos||reticulocyte count abnormal nos||has_translation
thymic cancer metastatic||thymic cancer metastatic||has_translation
respiratory infect||infections, respiratory||has_translation
oedema of extremity||edema limbs||has_translation
spinal cord injury nec||spinal cord injuries nec||has_translation
blood normal tests||blood normal tests||has_translation
open traumatic dislocation elbow joint, anterior||open anterior dislocation of elbow (disorder)||has_translation
cancer of the vagina, stage iva||stage iva vagina cancer||has_translation
disassociation/association||disassociation/association||has_translation
memories, immediate||memory short term||has_translation
spasm; occupational||occupational; spasm||has_translation
vasodilation procedure||vasodilation procedure||has_translation
intracranial increased pressure||hypertensions intracranial||has_translation
cryoglobulins||cryoglobulin measurement, nos||has_translation
count high reticulocyte||reticulocyte count increased||has_translation
placental polyp-postpart||placental polyp-postpart||has_translation
therapy, situational||environmental intervention||has_translation
ureterolithotomy (treatment)||ureterolithotomy (procedure)||has_translation
myopathic condition||disorder muscle||has_translation
ultrasonic prenatal diagnoses||diagnoses, ultrasonic prenatal||has_translation
increased hemoglobin (biological function) (finding)||hemoglobin elevated||has_translation
biopsy artery normal||biopsy artery normal||has_translation
product colour issue||product color issue||has_translation
peripheral blast cells present||peripheral blast cells present||has_translation
igm decreased||immunoglobulin m low||has_translation
open dislocation of phalanx of hand, nos||open dislocation of finger (diagnosis)||has_translation
thioredoxin reductase activity||thioredoxin reductase activity||has_translation
enterochromaffin cell||5-ht-containing enterochromaffin cell||has_translation
slipped extraocular muscle||slipped extraocular muscle||has_translation
autonomic nervous system diseases||autonomic dysfunction||has_translation
bipol i currnt dep remis||bipol i currnt dep remis||has_translation
southern tick-associated rash illness (disorder)||stari||has_translation
muscle relaxant drug level below therapeutic||muscle relaxant drug level below therapeutic||has_translation
cheilitis granulomatosa||miescher's cheilitis||has_translation
ehrlichia chafeenis||ehrlichia chafeenis||has_translation
hepatitis b dna detectable||hbv dna detectable||has_translation
laparoscopy abnormal||laparoscopy abnormal||has_translation
urod deficiency||urod deficiency||has_translation
electrocardiogram: qrs complex nos (observable entity)||ecg qrs||has_translation
tachycardia paroxysmal nos||pt - paroxysmal tachycardia||has_translation
national eye institute (u.s.)||national eye institute (u.s.)||has_translation
incisional hernia perforation||incisional hernia perforation||has_translation
fnhtr||febrile nonhemolytic transfusion reaction||has_translation
scan with contrast nos abnormal||scan with contrast abnormal||has_translation
terminal state||terminal state||has_translation
diseases uterine||uterine disorder nos||has_translation
brief psychotic disorder with marked stressors||brief psychotic disorder with marked stressors (diagnosis)||has_translation
closed fracture of patella (diagnosis)||closed fracture of patella||has_translation
ct of pelvis abnormal||ct of pelvis abnormal||has_translation
polyarthropathy (excluding rheumatoid arthritis)||polyarthropathy (excl rheumatoid arthritis)||has_translation
anesthesia, infiltration||infiltration anesthesia||has_translation
halobacteriaceae gibbons 1974 (approved lists 1980) emend. gupta et al. 2016||haloarchaeaceae||has_translation
[d]left lower quadrant pain (context-dependent category)||abdominal pain in the left lower belly (llq)||has_translation
sacral radiculopathy (diagnosis)||sacral radiculopathy (disorder)||has_translation
cxcl4||plf4||has_translation
ventricular failure||failure;ventricular||has_translation
asphyxiating thoracic dysplasia (disorder)||asphyxiating thoracic dystrophy (diagnosis)||has_translation
effects of; fluoroscopy||fluoroscopy; adverse effect||has_translation
bed||bed (physical object)||has_translation
hyporesponsive to stimuli||hyporesponsive to stimuli||has_translation
helicobacter heilmannii smet et al. 2012||gastrospirillum hominis||has_translation
fracture two ribs-open||open fracture of two ribs||has_translation
cyclin d3||cyclin d3||has_translation
langerhan cell||epidermal dendritic cells||has_translation
open dislocation of temporomandibular joint||compound dislocation of jaw||has_translation
large cell lymphoma, diffuse||dlbcl - diffuse large b cell lymphoma||has_translation
head discomfort||head discomfort||has_translation
therapy, estrogen replacement||estrogen replacement therapy (ert)||has_translation
systemic viral infection||systemic viral infection||has_translation
[m]transitional cell carcinoma nos||carcinoma transitional cell||has_translation
bladder thrombotic tamponade||bladder tamponade||has_translation
chronic peptic ulcer of unspecified site w/o mention of hemorrhage or perforation, with obstruction||chronic peptic ulcer of unspecified site w/o mention of haemorrhage or perforation, with obstruction||has_translation
hemorrhage; hemorrhoids||hemorrhoids with bleeding (diagnosis)||has_translation
orexin receptor||receptors, orexin||has_translation
burns - multiple (disorder)||multiple burns nos||has_translation
nuclear respiratory factors||respiratory factor, nuclear||has_translation
muscle/ligament dis nos||muscle, ligament or fascia disorder nos (disorder)||has_translation
si qiii tiii pattern||si qiii tiii pattern||has_translation
malignant neoplasm of gallbladder stage iva (diagnosis)||malignant tumor of gallbladder stage iva||has_translation
congenital cyst of fallopian tube (disorder)||congenital cyst of oviduct||has_translation
drug effect variable||drug effect variable||has_translation
iva||isovaleryl-coenzyme a dehydrogenase deficiency||has_translation
hydrocephalus in infectious and parasitic diseases classified elsewhere (diagnosis)||hydrocephalus/infectious+parasitic diseases ce||has_translation
complications; prosthesis, male genital||complications; prosthesis, male genital||has_translation
alphafoetoprotein amniotic fluid abnormal nos||alphafoetoprotein amniotic fluid abnormal nos||has_translation
bulbus cordis anomalies and anomalies of cardiac septal closure||bulbus cordis anomalies and anomalies of cardiac septal closure||has_translation
oedema infusion site||infusion site edema||has_translation
leukoplakia of anus||leukoplakia of anus||has_translation
eye pigment epithelium||eye pigment epithelium||has_translation
preauricular dimple (disorder)||preauricular pit||has_translation
oesophageal variceal injection||esophageal variceal injection||has_translation
urinary anastomotic leak||urinary anastomotic leak||has_translation
necrosis of liver; maternal, affecting fetus||maternal; necrosis of liver, affecting fetus||has_translation
o,o-dimethyldithiophosphate diethylmercaptosuccinate||succinic acid, mercapto-, diethyl ester, s-ester with o,o-dimethylphosphorodithioate||has_translation
pollinosis (& allergic rhinitis due to pollens)||allergic rhinitis due to pollen (diagnosis)||has_translation
keratopathy||keratopathy||has_translation
[x]foreign object accidentally left in body during surgical and medical care (disorder)||[x]foreign object accidentally left in body during unspecified surgical and medical care (disorder)||has_translation
corneal lesion (disorder)||corneal lesion, nos||has_translation
enterocolitis, nos||enterocolitis||has_translation
electrolyte replacement||electrolytes replacement||has_translation
soft tissue haemorrhage||soft tissue haemorrhage||has_translation
[x]mental and behav dis due to use alcohol: dependence syndr||alcohol dependences||has_translation
extinction, biological||biological extinction||has_translation
pulmonary hypertension nos||hypertension pulm||has_translation
fibrin d dimer normal||fibrin d dimer normal||has_translation
hemolysis (diagnosis)||haemolysis nos||has_translation
psychogenic inhibited male orgasm (finding)||inhibited male orgasm||has_translation
lung smokers||lung smokers||has_translation
bone scintigraphy||bone scintigraphy||has_translation
anti-exosome complex antibody negative||anti-exosome complex antibody negative||has_translation
blood 1,25-dihydroxy vitamin d increased||blood 1,25-dihydroxy vitamin d increased||has_translation
angioplasty;artery;coronary||angioplasty of coronary artery [ambiguous]||has_translation
superficial femoral arterial restenosis||superficial femoral arterial restenosis||has_translation
cyp2d6 slow metaboliser status||cyp2d6 slow metabolizer status||has_translation
block; bundle-branch, wilson's type||block; bundle-branch, wilson's type||has_translation
age-related ischemic white matter lesion||age-related ischemic white matter lesion||has_translation
vulval wart||vulval warts (disorder)||has_translation
anal paraesthesia||anal paraesthesia||has_translation
poisoning caused by coronary vasodilator (disorder)||coronary vasodilator poisoning nos||has_translation
fear, focus nec||fear, focus nec||has_translation
embolism; cerebral artery, with infarction||artery; cerebellar, embolism, with infarction||has_translation
biopsy ovary normal||ovarian biopsy normal||has_translation
tinea imbricata||ringworm; tokelau||has_translation
post stroke depression||post stroke depression||has_translation
color blindness (disorder)||color blindness (disorder)||has_translation
failure to suspend medication||failure to suspend medication||has_translation
abnormal glomerular filtration rate||glomerular filtration rate abnormal nos||has_translation
p+||p+||has_translation
instrument; puncture||instrument; puncture||has_translation
visual receptor||photoreceptor cell||has_translation
chorioadenoma destruens||molar pregnancy with invasive mole||has_translation
post procedural pruritus||post procedural pruritus||has_translation
keratectomies||keratectomy||has_translation
postgastrectomy syndrome||postgastric surgery syndrome nos (disorder)||has_translation
deep necrosis of underlying tissues due to deep third degree burn of scapular region, without mention of loss of scapula||deep necrosis of underlying tissues due to burn [deep third degree] of scapular region, without mention of loss of scapula||has_translation
infarct, hemorrhagic||hemorrhagic infarction||has_translation
mechanical acne||mechanical acne||has_translation
hemangiosarcoma of the liver||angiosarcoma of liver (diagnosis)||has_translation
acute monocytic leukemia, fab m5||leukemia, monocytic, acute||has_translation
atrophy of tongue (diagnosis)||tongue; atrophy||has_translation
unspecified otalgia||earaches||has_translation
intensive care||intensive care||has_translation
undifferentiated lymphoma burkitt's variety refractory||undifferentiated lymphoma burkitt's variety refractory||has_translation
blood parathyroid hormone normal||blood parathyroid hormone normal||has_translation
excision esophagus + stomach||excision esophagus & stom nos||has_translation
obstruction co-occurrent and due to bilateral recurrent femoral hernia (disorder)||obstruction co-occurrent and due to bilateral recurrent femoral hernia||has_translation
facial drooping||weakness of the facial muscles||has_translation
vesicular stomatitis indiana virus (organism)||vesicular stomatitis-indiana virus||has_translation
complication of device removal||complication of device removal||has_translation
vla-2 - very late activation-2 alpha chain||vla 2 alpha chain||has_translation
de novo purine synthesis inhibitors associated acute inflammatory syndrome||de novo purine synthesis inhibitors associated acute inflammatory syndrome||has_translation
sezarys lymphoma||sezary's disease-unspec. site||has_translation
syndromes, cardio-renal||cardiorenal syndrome||has_translation
anapc3||apc3 subunit, anaphase-promoting complex||has_translation
anti-lrp2 nephropathy||anti-lrp2 nephropathy||has_translation
product preparation error||product preparation error||has_translation
closed fracture of distal end of radius with ulna||closed fracture of radius and ulna, lower end||has_translation
adhesion; nasal||nasal adhesions||has_translation
disorder aggravation||disorder aggravation||has_translation
catheter site effusion||catheter site effusion||has_translation
oxidoreductase, thiol-protein disulfide||protein-disulfide reductase (glutathione) (substance)||has_translation
coagulation factor xiii level normal||coagulation factor xiii level normal||has_translation
noninfectious meningitis (smq)||noninfectious meningitis (smq)||has_translation
antenatal bleeding||bleeding;antepartum||has_translation
fatal attempts||fatal suicide||has_translation
mating factor receptors||receptors, mating factor||has_translation
other closed skull fracture with cerebral laceration and contusion||other closed skull fracture with cerebral laceration and contusion||has_translation
nondependent abuse of barbiturates and tranquillizers||nondependent abuse of barbiturates and tranquilizers||has_translation
cells, neural stem||neural stem cells||has_translation
meningeal-derived tumours||meningeal tumor||has_translation
ovarian germ cell teratoma stage iii a||ovarian germ cell teratoma stage iii a||has_translation
adder venom||viper venom||has_translation
psychogenic rumination||psychogenic rumination (disorder)||has_translation
annular elastolytic giant cell granuloma||annular elastolytic giant cell granuloma||has_translation
elderly primigravida, antepartum condition or complication||elder primigravid-antepa||has_translation
mutagenic effect male||mutagenic effect male||has_translation
penile cancer, stage ii||stage ii penile cancer||has_translation
dissociative; amnesia||amnesia neurosis||has_translation
catheter site scab||catheter site scab||has_translation
cricopharyngeal myotomy||esophageal surgery cricopharyngeal myotomy||has_translation
gynecological infections||gynaecological infection||has_translation
misuses drugs||abuser drug||has_translation
genotype drug resistance test||genotype drug resistance test||has_translation
dementia due to multiple aetiologies||dementia due to multiple aetiologies||has_translation
schools health occup||schools, health occupations||has_translation
engaged in sports activity, function (observable entity)||engaged in sports activity, function (observable entity)||has_translation
fracture; femur, head||bone head of femur||has_translation
transplantation associated food allergy||transplantation associated food allergy||has_translation
tooth discoloration congenital||tooth discolouration congenital||has_translation
hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (smq)||hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (smq)||has_translation
[d]paresthesia (situation)||paresthesias||has_translation
generalised vaccinia (finding)||vaccinia, generalized||has_translation
coronary (artery) occlusion||occlusions, coronary||has_translation
ulcer of bronchus (disorder)||bronchial ulcer||has_translation
characters||personality character||has_translation
skin lesion||skin lesions (physical finding)||has_translation
hypergammaglobulinaemia||hypergammaglobulinemia [dup] (finding)||has_translation
non-site specific bone disorders congenital||non-site specific bone disorders congenital||has_translation
head-down tilt||head-down tilt||has_translation
benign neoplasm of eyeball, excl conjunctiva, cornea, retina, and choroid||benign neoplasm of eyeball, except conjunctiva, cornea, retina and choroid||has_translation
post-infective arthritis (disorder)||arthritides, postinfectious||has_translation
angiolymphoid hyperplasia with eosinophilia (disorder)||epithelioid hemangioma||has_translation
tsh measurement||thyroid stimulating hormone measurement (procedure)||has_translation
phalangeridae||835 family phalangeridae||has_translation
febrile seizures||fever convulsion||has_translation
inferior vena cava stenosis (disorder)||inferior vena cava stenosis (disorder)||has_translation
stage ii gastric cancer ajcc v7||gastric cancer, stage ii||has_translation
phase checkpoint, m||m phase checkpoints||has_translation
atrial contractions, premature||extrasystoles supraventricular||has_translation
blood corticosterone decreased||blood corticosterone decreased||has_translation
tall for age||tall stature for age||has_translation
bone metabolism disorder||metabolic bone disease (diagnosis)||has_translation
laminoplasty (treatment)||laminoplasty||has_translation
accidental device ingestion by a child||accidental device ingestion by a child||has_translation
pericarditis, tuberculous||pericardium; tuberculous (manifestation)||has_translation
dementia; creutzfeldt-jakob (etiology)||creutzfeldt-jakob disease with dementia (diagnosis)||has_translation
stomach; atonic||stomach; atonic||has_translation
mri-pdff||magnetic resonance proton density fat fraction measurement||has_translation
other shoulder/upper arm inj.||other and unspecified injury to shoulder and upper arm||has_translation
cd135 antigen increased||cd135 antigen increased||has_translation
other spinal muscular atrophy||other spinal muscular atrophy||has_translation
dementia due to huntington chorea (disorder)||dementia due to huntington chorea (disorder)||has_translation
blood beta human chorionic gonadotropin abnormal||blood beta human chorionic gonadotropin abnormal||has_translation
memory immunol||anamnestic reaction||has_translation
protein||test;protein||has_translation
anosmias||anosmias||has_translation
vascular bypass dysfunction||vascular bypass dysfunction||has_translation
disruptions of 24-hour sleep-wake cycle||disruptions of 24 hour sleep-wake cycle (disorder)||has_translation
varicose veins of abdominal wall||varicose veins of abdominal wall||has_translation
malignant tumor of commissure of lip (disorder)||malig neop commissure of lip||has_translation
radial nerve transposition||radial nerve transposition||has_translation
general symptoms (finding)||[d]general symptoms (context-dependent category)||has_translation
complement factor c2 increased||complement factor c2 increased||has_translation
yellow skin||jaundice of skin only||has_translation
hepatic artery occlusion||hepatic artery occlusion||has_translation
biopsy vulva normal||vulval biopsy normal||has_translation
coagulation test normal||coagulation test normal||has_translation
syndromes, orofaciodigital||orodigitofacial syndrome||has_translation
excision of lesion of trachea||tracheal lesion excision||has_translation
excision of lesion of muscle, nos||excision of lesion of muscle (procedure)||has_translation
biosimilar product substitution issue||biosimilar product substitution issue||has_translation
imbalance problems||equilibrium disorder of (nos)||has_translation
delusional disorder, jealous type||jealous type delusional disorder||has_translation
vaccines, alzheimer||alzheimer vaccine||has_translation
degeneration; dental pulp||degeneration; dental pulp||has_translation
iris hyperpigmentation||iris hyperpigmentation||has_translation
asymmetric di-methylarginine increased||adma increased||has_translation
cocaine depend-unspec||[x]mental and behavioral disorders due to use of cocaine: dependence syndrome (disorder)||has_translation
salicylate increased||salicylate high||has_translation
lactate pyruvate ratio normal||normal lactate to pyruvate ratio||has_translation
smell, absent||smell; loss||has_translation
other psychalgia||other psychalgia||has_translation
non-neutralising antibodies negative||non-neutralizing antibodies negative||has_translation
infection; alternaria||alternaria; infection||has_translation
skene's duct cyst||skene's duct cyst||has_translation
blisters, epidermal loss [second degree] of other and multiple sites of trunk||2nd deg burn trunk nec||has_translation
clear cell carcinoma of endometrium||carcinoma, clearcell, endometrial||has_translation
kelly's syndrome||syndrome, plummer vinson||has_translation
carbohydrate sequence||carbohydrate sequence||has_translation
empty nose syndrome||empty nose syndrome||has_translation
ureteric anastomosis complication||ureteric anastomosis complication||has_translation
174 argon||argon||has_translation
muscle relaxant drug level above therapeutic||muscle relaxant drug level above therapeutic||has_translation
acute gastric ulcer with hemorrhage, without mention of obstruction||acute gastric ulcer with hemorrhage, without mention of obstruction||has_translation
incision site edema||incision site oedema||has_translation
blood urine absent||blood urine absent||has_translation
leukaemic infiltration hepatic||leukaemic infiltration hepatic||has_translation
strabismus congenital||congenital strabismus (disorder)||has_translation
hymenolepiasis (disorder)||infection, hymenolepis||has_translation
breast discharge||nipple discharge (diagnosis)||has_translation
precipitate labor, antepartum condition or complication||precipitate labour, antepartum||has_translation
compact disks, interactive||interactive cd||has_translation
infantile hypertrophic pyloric stenosis||congenital or infantile stenosis of pylorus||has_translation
subdural cerebrospinal fluid leakage||csf leakage subdural||has_translation
poikiloderma, congenital||poikiloderma congen||has_translation
biopsy of ear (procedure)||biopsy of ear||has_translation
impaired driving ability||difficulty driving a car||has_translation
peak nasal inspiratory flow decreased||peak nasal inspiratory flow decreased||has_translation
care; colostomy||[v]attention to colostomy (situation)||has_translation
renal failure acute hypotensive||renal failure acute hypotensive||has_translation
basaloid carcinoma of the anus stage unspecified||basaloid carcinoma of the anus stage unspecified||has_translation
medical; counseling, boarding school resident||medical; counseling, boarding school resident||has_translation
tongue pruritus||itching of tongue||has_translation
high thyroxine||thyroxine high||has_translation
bruunstrom approach||bruunstrom approach||has_translation
congenital lumbar syndrome||congenital lumbar syndrome||has_translation
lassa virus infection||infection caused by lassa virus||has_translation
decreased intraocular pressure (physical finding)||hypotony ocular||has_translation
foreign body of nose||nasal foreign body (disorder)||has_translation
complicated open wound of penis||complicated open wound of penis||has_translation
diuresis, function||diuresis, function||has_translation
helicobacter gastroduodenitis||helicobacter gastroduodenitis||has_translation
plasma cholesterol total normal||plasma cholesterol total normal||has_translation
retinal detachments and defects||unspecified retinal detachments and defects||has_translation
oxygen saturation immeasurable||oxygen saturation immeasurable||has_translation
trendelenburg's symptom||trendelenburg's symptom||has_translation
abnormal erythrocyte maturation||abnormal erythrocyte production (finding)||has_translation
foreign body of alimentary tract||foreign body in gi tract||has_translation
savanna||prairie||has_translation
anti-exosome complex antibody negative||anti-exosome complex antibody negative||has_translation
injury of unspecified pulmonary vessel||injury to pulmonary blood vessels||has_translation
lymphocyte subset||subsets, lymphocyte||has_translation
haemoglobin s increased||haemoglobin s increased||has_translation
other and unspecified intracranial haemorrhage||other and unspecified intracranial haemorrhage||has_translation
enzyme multiplied immunoassay technique (emit)||enzyme-multiplied immunoassay technique (procedure)||has_translation
normocytic anaemia||normocytic anemia (disorder)||has_translation
epiderma spongiosis||epiderma spongiosis||has_translation
requiring medical attention bleeding - timi classification||requiring medical attention bleeding - timi classification||has_translation
eustachian catarrh||eustachian catarrh||has_translation
discoidin domain receptor 1||discoidin domain receptor 1||has_translation
gastrectomies partial||gastrectomies partial||has_translation
sierra leone (geographic location)||sierra leone||has_translation
stenosis; esophagus||esophageal stenoses||has_translation
parasomnia (diagnosis)||parasomnia (sleep disorder)||has_translation
somatic symptom disorder of pregnancy||somatic symptom disorder of pregnancy||has_translation
alternative-complement-pathway c3/c5 convertase||alternative pathway c3 c5 convertases||has_translation
stage d prostate cancer||cancer of the prostate, stage d||has_translation
eighth nerve; syphilitic (etiology)||eighth nerve; syphilitic (manifestation)||has_translation
adipose most abundant gene transcript 1||apm 1 protein||has_translation
ulceration tongue||ulceration tongue||has_translation
breast painful||pain of breast (finding)||has_translation
menstrual irregularities||irregular menses||has_translation
mechanical complication of implant (disorder)||mechanical complication of implant (disorder)||has_translation
parasympathetic nerve injury (disorder)||parasympathetic nerve injury||has_translation
focal laser photocoagulation||focal laser coagulation||has_translation
flood (event)||flood||has_translation
internal fixation; complications, mechanical||complications; internal fixation, mechanical||has_translation
pulmonary artery therapeutic procedure||pulmonary artery therapeutic procedure||has_translation
blood growth hormone normal||blood growth hormone normal||has_translation
thrombus in catheter||thrombus on the catheter||has_translation
tuberculosis intestinal||tuberculosis intestinal||has_translation
[x]somatoform disorder, unspecified (disorder)||somatoform disorder (diagnosis)||has_translation
vanishing bile duct syndrome (disorder)||bile duct syndrome vanishing||has_translation
perianal warts (disorder)||perianal wart||has_translation
normoglycaemic||normoglycemic||has_translation
precerebral artery embolism||embolism of precerebral artery||has_translation
narcotic abuse||abuse, narcotic||has_translation
malignant neoplasm of small intestine, unspecified resectable||malignant neoplasm of small intestine, unspecified resectable||has_translation
breast adenocarcinoma stage ii||breast adenocarcinoma stage ii||has_translation
discogram normal||discogram normal||has_translation
injury of pharynx (disorder)||injury of pharynx||has_translation
anencephalus nos (disorder)||anencephaly||has_translation
xanthelasma||xanthoma of the eyelid||has_translation
puffy lids||eyelid; edema||has_translation
aneurysm; congenital, coronary||coronary; aneurysm, congenital||has_translation
family callitrichidae (organism)||marmoset||has_translation
malig neop oth endocrine gland||malignant neoplasm of endocrine gland or related structure nos (disorder)||has_translation
cholecystitis suppurative||suppurative; cholecystitis||has_translation
lysophospholipid||lysophosphatidic acids||has_translation
infantile back arching||infantile back arching||has_translation
zonaesthesia||zonaesthesia||has_translation
medical-surgical nursing||medical surgical nursing||has_translation
cinchonism||cinchonism||has_translation
hepatic angioma||hemangiomas liver||has_translation
immunotactoid glomerulonephritis (diagnosis)||immunotactoid glomerulonephritis (disorder)||has_translation
hepatic porphyria, nos||porphyria, hepatic||has_translation
lens, multifocal intraocular||multifocal iols||has_translation
[v]dependnt rel need care/home||[v]dependent relative needing care at home (context-dependent category)||has_translation
heaviness in arm||heaviness in arm||has_translation
failure heart congestive||heart congestive failure||has_translation
serum catecholamines||serum catecholamines||has_translation
hypnotic; withdrawal state||withdrawal state; hypnotics||has_translation
abnormal visual evoked potentials||abnormal vision evoked potentials||has_translation
teratoma, testicular||testis cancer, teratoma||has_translation
arthrop+behcet's synd-hand||behcet arthritis-hand||has_translation
erythrocytes decreased||blood cells count low red||has_translation
closed dislocation, fourth cervical vertebra||disloc 4th cerv vert-cl||has_translation
spinal cord injury of cauda equina||spinal cord injury of cauda equina||has_translation
lorazepam-containing product||lorazepam||has_translation
subfalcine herniation||herniation under falx cerebri (disorder)||has_translation
facial pruritis||itching of skin on face (finding)||has_translation
error in performing labelled medication monitoring||error in performing labelled medication monitoring||has_translation
immune related side effect||immune-related adverse event||has_translation
abortion illegal complicated by shock||illegal abortion with circulatory collapse||has_translation
agrypnia||agrypnia||has_translation
beta vulgaris (organism)||beet sugar||has_translation
[d]agnosia||agnosia (diagnosis)||has_translation
keeled chest||carinatum pectus||has_translation
central line management||central line management||has_translation
erosion of gum||superficial gingival ulcer (disorder)||has_translation
low blood sugar after a meal||reactive hypoglycaemia||has_translation
ectodermal dysplasia 3, anhidrotic||ectodermal dysplasia anhidrotic 03||has_translation
chronic iron deficiency anemia secondary to blood loss||iron deficiency anemia due to chronic blood loss||has_translation
cuboid syndrome (disorder)||cuboid syndrome||has_translation
ureter injury-open||injury to ureter with open wound into cavity||has_translation
fistulography abnormal||fistulography abnormal||has_translation
indeterminate glucose tolerance||indeterminate glucose tolerance||has_translation
administration of steroid (procedure) [ambiguous]||corticosteroid therapy||has_translation
carotid artery distension test||carotid artery distension test||has_translation
painful ejaculation -retired-||ejaculations pain||has_translation
echo reaction||echologia||has_translation
lung transplant (procedure)||transplantation of lung||has_translation
coronary atherosclerosis of non-autologous biological bypass graft||coronary atherosclerosis of non-autologous biological bypass graft||has_translation
accident-explosive material||accident caused by explosive material (finding)||has_translation
autoimmune neutropenia (diagnosis)||autoimmune neutropenia (disorder)||has_translation
polyvesicular; tumor, unspecified site, female||tumor; polyvesicular, unspecified site, female||has_translation
sputum discoloured||sputum discoloured||has_translation
financing, construction||financings, construction||has_translation
x-ray with contrast upper gastrointestinal tract normal||x-ray with contrast upper gastrointestinal tract normal||has_translation
neuroendocrine tumor of the lung metastatic||neuroendocrine tumor of the lung metastatic||has_translation
enterotoxin||enterotoxin||has_translation
therapy, reflex||therapy, reflex||has_translation
tear;muscle||muscle tearing||has_translation
touraine renault syndrome||touraine renault syndrome||has_translation
hemorrhage, splinter||splinter bleeding||has_translation
application of dressing for burn (procedure)||burns dressings||has_translation
unspecified abortion, complete, complicated by damage to pelvic organs or tissues||unspecified abortion, complicated by damage to pelvic organs or tissues, complete||has_translation
arteriogram carotid abnormal||carotid angiogram abnormal||has_translation
vaginal cancer, metastatic||stage ivb vaginal carcinoma ajcc v6||has_translation
polyomavirus jc infection||polyomavirus jc infection||has_translation
le-like drug eruption||le-like drug eruption||has_translation
transient av block complete||transient av block complete||has_translation
hemolytic jaundice (disorder)||hemolytic jaundice (disorder)||has_translation
skull or face bone anomaly nos (disorder)||congenital abnormality of skull and face bones (disorder)||has_translation
gout, hprt-related||hprt1 deficiency, partial||has_translation
wart||wart(s)||has_translation
leishmaniasis, mucocutaneous, american||mucocutaneous leishmaniasis, (american)||has_translation
peer rev research||peer reviews, research||has_translation
bacterial otitis externa||bacterial otitis externa||has_translation
laterocollis||laterocollis||has_translation
hgpin||high-grade prostatic intraepithelial neoplasia||has_translation
bare metal stent thrombosis||bare metal stent thrombosis||has_translation
tata binding protein related factors||tbp-related factor||has_translation
roth||bernhardt's paraesthesia||has_translation
pancreastatin decreased||pancreastatin decreased||has_translation
breast intraductal papillary neoplasm||breast intraductal papillary neoplasm||has_translation
methicillin-resistant staphylococcus aureus cellulitis||methicillin-resistant staphylococcus aureus cellulitis||has_translation
peeling gingival||peeling gum||has_translation
blood culture positive viral||blood culture positive viral||has_translation
product containing emetine||emetan, 6',7',10,11-tetramethoxy-||has_translation
haemoglobin a absent||hemoglobin a absent||has_translation
obstruction of bladder outlet||urinary outlet obstruction||has_translation
primary tuberculous infection, unspecified type||primary tuberculous infection, unspecified type||has_translation
agent, coloring||coloring agent||has_translation
operation on iris, nos||operation on iris, nos||has_translation
mitosis inhibitors||mitosis inhibitor agents||has_translation
ec 5||isomerase||has_translation
muscle, tendon and ligament injuries||muscle, tendon and ligament injuries||has_translation
pseudofractures||pseudofracture||has_translation
murine; typhus||endemic typhus||has_translation
spep||serum protein electrophoresis||has_translation
relaxation; bladder||bladder; relaxation||has_translation
infections, community acquired||community-acquired infection||has_translation
malignant neoplasm of anterior wall of nasopharynx stage iv||malignant neoplasm of anterior wall of nasopharynx stage iv||has_translation
transplantations, heart-lung||grafting, heart lung||has_translation
plant embryo||embryos, plant||has_translation
microadenomas pituitary||pituitary microadenoma (disorder)||has_translation
erysipelothrix||erysipelothrix (disease)||has_translation
oral neoplasm malignant stage iii||oral neoplasm malignant stage iii||has_translation
malignant renal tumor||malignant neoplasm of kidney||has_translation
ulnar neuritides||ulnar neuritis (disorder)||has_translation
increased basal metabolic rate||hypercatabolism||has_translation
microcytosis, red cells||microcytosis, red cells (finding)||has_translation
ahts - adductvar ham toe synd||adductovarus deformity of toe||has_translation
arteriovenous graft site oedema||arteriovenous graft site oedema||has_translation
crush injury,knee+lw leg||crushing injury of knee and lower leg||has_translation
biliary tract hemorrhages||hemobilia||has_translation
malignant neoplasm of penis, unspecified||cancer of the penis||has_translation
facility administrators, health||facility administrators, health||has_translation
malposition; congenital, auditory canal||auditory canal; malposition, congenital||has_translation
degeneration; retina, with pigmentary (primary)||degeneration; retina, with pigmentary (primary)||has_translation
enterobiasis threadworm||enterobiasis||has_translation
burning hip||burning hip||has_translation
abdominal tenderness, upper||abdominal tenderness, upper||has_translation
pre-eclamptic; albuminuria, severe, affecting fetus or newborn||pre-eclamptic; albuminuria, severe, affecting fetus or newborn||has_translation
abdominal distention, gaseous||abdominal distention, gaseous||has_translation
ovarian germ cell cancer nos stage iii a||ovarian germ cell cancer nos stage iii a||has_translation
orthostatic hypotension was observed||hypotension;postural||has_translation
sequelae of; poisoning due to drug||sequelae of; poisoning due to drug||has_translation
loss (of);equilibrium||loss of equilibrium (finding)||has_translation
brachial artery entrapment syndrome||brachial artery entrapment syndrome||has_translation
ketonaemia absent||ketonemia absent||has_translation
c/ebpalpha mutation||cebpa gene mutation||has_translation
life expectancy shortened||life expectancy shortened||has_translation
medium chain acyl-coa dehydrogenase deficiency||acadmd||has_translation
nijmegen breakage syndrome (nbs)||variant 1s, ataxia-telangiectasia||has_translation
prophylaxis against radiation induced nausea and vomiting||prophylaxis against radiation induced nausea and vomiting||has_translation
bone tumor (morphologic abnormality)||neoplasms, bone||has_translation
progenitor cells, megakaryocyte||progenitor cell, megakaryocyte||has_translation
headache caused by drug (finding)||drug induced headache||has_translation
hyperlactatemias||hyperlactatemias||has_translation
lafora disease||lafora body disorder||has_translation
larynx carcinoma stage ii||stage ii larynx carcinoma||has_translation
large intestinal hemorrhage||large intestinal haemorrhage||has_translation
ileostomy (procedure) [ambiguous]||ileostomy (procedure) [ambiguous]||has_translation
cataract; senile, brunescens||cataract; senile, brunescens||has_translation
malignant neoplasm of trachea, bronchus, and lung, stage iv||malignant neoplasm of trachea, bronchus, and lung, cell type unspecified stage iv||has_translation
herpes simplex virus conjunctivitis neonatal||hsv ophthalmia neonatorum||has_translation
rnrx blood pressure (treatment)||taking blood pressure||has_translation
[x]other ill-defined heart diseases (disorder)||oth ill-defnd heart disease||has_translation
ovarian germ cell yolk sac tumour stage ii||ovarian germ cell yolk sac tumor stage ii||has_translation
sciatic hernia||sciatic hernia (diagnosis)||has_translation
antistreptolysin abnormal||antistreptolysin abnormal||has_translation
invasive duct carcinoma of breast||invasive ductal carcinoma, nst||has_translation
proximal radioulnar dislocation||dislocation; radioulnar proximal||has_translation
injury to iliac blood vessels||injury of iliac blood vessel||has_translation
pyogranulomatous dermatitis (disorder)||cutaneous nocardiosis (disorder)||has_translation
food-induced anaphylactoid reaction (disorder)||anaphylactic; shock, food||has_translation
nucleotide, cyclic||cyclic nucleotides||has_translation
placenta; multilobed||placenta; multilobed||has_translation
myeloperoxidase||peroxidase||has_translation
capillary resistance||capillary resistance, function||has_translation
biopsy ear abnormal||biopsy ear abnormal||has_translation
other symptoms referable to joint, other specified sites||other symptoms referable to joint of other specified sites||has_translation
weak urinary stream||poor stream of urine||has_translation
hemidysaesthesia||hemidysaesthesia||has_translation
swelling of the ear||swelling ear||has_translation
recurrent mycobacterium avium complex infections||recurrent mycobacterium avium complex infections||has_translation
gymnastic||activities involving gymnastics||has_translation
hyphaemia||blood in anterior chamber||has_translation
burns of breast (diagnosis)||burn of breast||has_translation
angiogenesis biomarker decreased||angiogenesis biomarker decreased||has_translation
apolipoprotein a-i||apoprotein a1||has_translation
seasonings||seasonings||has_translation
proteus genomosp. 1||proteus vulgaris indole neg||has_translation
bones infections joints||bone and joint infections||has_translation
mosaic trisomy 8 syndrome (disorder)||warkany syndrome||has_translation
hcv viral load fluctuation||hcv viral load fluctuation||has_translation
drug dependence, postpartum||drug dependence-postpart||has_translation
hepatitis b dna assay positive||hepatitis b dna assay positive||has_translation
flat retinoschisis (diagnosis)||flat retinoschisis||has_translation
tobacco use disorder, unspecified use||tobacco use disorder, unspecified use||has_translation
ultrasound prostate abnormal||ultrasound prostate abnormal||has_translation
blood cell count, nos||cell blood count||has_translation
product contamination fungal||product contamination fungal||has_translation
overmedication||overmedication||has_translation
cryptosporidiosis||cryptosporidiosis||has_translation
radiation somnolence syndrome||radiation somnolence syndrome||has_translation
injection site vesicles||injection site vesicles||has_translation
stage iii esophageal adenocarcinoma||esophageal adenocarcinoma site unspecified stage iii||has_translation
laryngocele||laryngoceles||has_translation
stabilization of joint||stabilization of joint||has_translation
myoclonic jerking||myoclonus (diagnosis)||has_translation
respiratory disorder prophylaxis||respiratory disorder prophylaxis||has_translation
hyperprolinemia, nos||hyperprolinemia||has_translation
diffuse enamel opacities||mottled tooth||has_translation
lower extremity ischemia||ischemic leg||has_translation
cervical computerized tomogram myelography abnormal||cervical computerised tomogram myelography abnormal||has_translation
hoarseness symptom nos (finding)||hoarseness (symptom)||has_translation
lactate dehydrogenase normal||lactate dehydrogenase normal||has_translation
palate; high||high palate||has_translation
acute delusional psychoses||psychotic; disorder, delusional, acute||has_translation
central corneal neovascularization||central corneal neovascularization||has_translation
normal finding of forced expiratory volume (finding)||forced expiratory volume (fev) normal||has_translation
breakpoints, chromosome||chromosome breakpoint||has_translation
hemorrhage; intraventricular, fetus or newborn||neonatal intraventricular hemorrhage||has_translation
peripheral edema neonatal||peripheral oedema neonatal||has_translation
congenital male reproductive tract disorders||male reproductive tract disorders congenital||has_translation
surgery plastic||plastic surgical procedures||has_translation
mood swing||labile mood (physical finding)||has_translation
intestine bleed||intestinal hemorrhages||has_translation
deformity; ear, inner ear||inner ear anomaly||has_translation
cardiac failure high output||high output heart failure||has_translation
systoles;ventricular (extra)||ventricular complex, premature||has_translation
loss (of);speech||loss (of);speech||has_translation
improper use of device||improper use of device||has_translation
gallbladder carcinoma localized||gallbladder carcinoma localised||has_translation
ultrasound pancreas abnormal||ultrasound pancreas abnormal||has_translation
viral hepatitis||virus; hepatitis||has_translation
free t4 abnormal||thyroxine free abnormal||has_translation
other threatened labor, unspecified as to episode of care or not applicable||threat labor nec-unspec||has_translation
controlled ovarian stimulation (procedure)||controlled ovarian stimulation (procedure)||has_translation
pharyngeal paresthesia||pharyngeal paraesthesia||has_translation
esophageal squamous cell carcinoma middle third stage 0||oesophageal squamous cell carcinoma middle third in situ||has_translation
antithyroid agent poison.nos||poisoning caused by antithyroid agent (disorder)||has_translation
diffuse mixed small and large cell lymphoma (angioimmunoblastic t-cell lymphoma)||diffuse mixed small and large cell lymphoma (angioimmunoblastic t-cell lymphoma)||has_translation
intra-atrial pressure||pressure, atrial||has_translation
infective iritis||infective iritis||has_translation
intracranial hemangiopericytoma||intracranial haemangiopericytoma||has_translation
apolipoprotein b decreased||apolipoprotein b low||has_translation
decreased immune responsiveness||decreased immune responsiveness||has_translation
b-lymphocyte count||lymphocyte b cells (lab test)||has_translation
hyperechogenic pancreas||hyperechogenic pancreas||has_translation
retinoic acid syndrome (disorder)||retinoic acid syndrome (diagnosis)||has_translation
pathologic fracture of femur (diagnosis)||pathological fracture of femur (disorder)||has_translation
edema blister (morphologic abnormality)||oedema blister||has_translation
intestines small transplant||transplantation of small intestine (procedure)||has_translation
immunoblot assay (procedure)||immunoblot assay, nos||has_translation
nodular goitre||nodular goiter nos||has_translation
geniculate body structure||metathalamus, nos||has_translation
necrotized pneumonia||pneumonia; necrotic||has_translation
gamma radiation therapy to bone||gamma radiation therapy to bone||has_translation
cyclopropanes||cyclopropanes||has_translation
pseudoverrucous papules and nodules||pseudoverrucous papules and nodules||has_translation
rhytides||wrinkled||has_translation
neopl cranial nerve benign||neopl cranial nerve benign||has_translation
spasm; esophagus||os - oesophageal spasm||has_translation
third-stage postpartum haemorrhage nos||third-stage postpartum hemorrhage nos (disorder)||has_translation
cd13+hla-dr+ cells/100 cells (body fld)||cd13+hla-dr+ cells/100 cells (body fld)||expanded_form_of
lymphocyte proliferation.anti-cd28.maximum/cd3:nfr:pt:bld:qn:flow cytometry||lymphocyte proliferation.anti-cd28.maximum/cd3:nfr:pt:bld:qn:flow cytometry||expanded_form_of
drainage of r com iliac vein, perc endo approach, diagn||medical and surgical @ lower veins @ drainage @ common iliac vein, right @ percutaneous endoscopic @ no device @ diagnostic||expanded_form_of
cervical & ocular vemp testing w/i&r||vemp tst i&r cervical&ocular||expanded_form_of
inj flexor musc/fasc/tend left thumb at forearm level||other injury of flexor muscle, fascia and tendon of left thumb at forearm level||expanded_form_of
3-part fracture of surgical neck of right humerus, initial encounter for open fracture||3-part fracture of surgical neck of right humerus, initial encounter for open fracture||expanded_form_of
skeletal muscle relaxants||poisoning by, adverse effect of and underdosing of skeletal muscle relaxants [neuromuscular blocking agents]||expanded_form_of
histone h2a+h2b ab [units/volume] in serum||histone h2a+h2b ab [units/volume] in serum||expanded_form_of
medical and surgical @ muscles @ drainage @ hand muscle, right @ open @ no device @ no qualifier||drainage of right hand muscle, open approach||expanded_form_of
removal of synth sub from r toe phalanx, open approach||removal of synthetic substitute from right toe phalanx, open approach||expanded_form_of
unspecified sprain of unspecified toe(s), initial encounter||unspecified sprain of unspecified toe(s), initial encounter||expanded_form_of
penicillium expansum antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||penicillium expansum ige ab [units/volume] in serum||expanded_form_of
fluoroscopy of left femur||fluoroscopy of left femur||expanded_form_of
anesthesia for procedures on posterior wall of upper abdomen (medication)||anesthesia for procedure on upper rear abdominal wall||expanded_form_of
imaging @ axial skeleton, except skull and facial bones @ plain radiography @ cervical disc(s) @ high osmolar @ none @ none||plain radiography of cervical disc(s) using high osmolar contrast||expanded_form_of
intraductal carcinoma in situ of left breast (disorder)||breast neoplasm carcinoma in situ intraductal left||expanded_form_of
excision of prostate, percutaneous endoscopic approach||excision of prostate, percutaneous endoscopic approach||expanded_form_of
myxoid cyst||synovial cyst, unspecified||expanded_form_of
cytomegalovirus ul97 gene mutations detected:prid:pt:isolate:nom||cmv ul97 gene mutations detected nom (isol)||expanded_form_of
pain in thigh (diagnosis)||pain in unspecified thigh||expanded_form_of
blood injection||blood injections||expanded_form_of
displaced fracture of lesser trochanter of left femur, subsequent encounter for open fracture type iiia, iiib, or iiic with malunion||disp fx of less trochanter of l femr, 7thr||expanded_form_of
krt8p21 gene||krt8p21||expanded_form_of
fragmentation of right innominate vein, perc approach||fragmentation of right innominate vein, perc approach||expanded_form_of
nfkb inhibitor, epsilon||nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, epsilon||expanded_form_of
caveolin 1||cav||expanded_form_of
drip-1||drip-1||expanded_form_of
depth of myometrial invasion/myometrial thickness:length fraction:to identify measures at a point in time:endometrial cancer specimen:quantitative||depth of myometrial invasion/myometrial thickness:length fraction:to identify measures at a point in time:endometrial cancer specimen:quantitative||expanded_form_of
restless legs syndrome, susceptibility to, 6 (finding)||restless legs syndrome, susceptibility to, 6 (finding)||expanded_form_of
knee synovectomy||synovectomy of knee||expanded_form_of
blasts.cytoplasmic cd117/100 cells:nfr:pt:bone mar:qn||cycd117 blasts nfr mar||expanded_form_of
inj adductor muscle, fascia and tendon of right thigh||inj adductor muscle, fascia and tendon of right thigh||expanded_form_of
pregnancy:hx:pt:^patient:ord||pregnancy:history:to identify measures at a point in time:^patient:ordinal||expanded_form_of
excision of transverse colon, via natural or artificial opening endoscopic, diagnostic||medical and surgical @ gastrointestinal system @ excision @ transverse colon @ via natural or artificial opening endoscopic @ no device @ diagnostic||expanded_form_of
location of meeting||location of meeting:loc:pt:^event:nom||expanded_form_of
open treatment interphalangeal joint dislocation||repair of toe dislocation||expanded_form_of
hyp||hyp||expanded_form_of
rna, u6 small nuclear 932, pseudogene||rnu6-932p||expanded_form_of
mech compl of gastrointestinal prosth dev/grft, sequela||other mechanical complication of other gastrointestinal prosthetic devices, implants and grafts, sequela||expanded_form_of
administrative note:finding:to identify measures at a point in time:{setting}:document:nurse||administrative note:finding:to identify measures at a point in time:{setting}:document:nurse||expanded_form_of
fibroblast growth factor 23.intact [mass/volume] in plasma by immunoassay --6th specimen post xxx challenge||fibroblast growth factor 23.intact^6th specimen post xxx challenge:mass concentration:to identify measures at a point in time:plasma:quantitative:immunoassay||expanded_form_of
wash harvest stem cells||trnsp prep hmatop prog thaw prev hrv wsh per dnr||expanded_form_of
destruction of l metatarsophal jt, perc endo approach||destruction of left metatarsal-phalangeal joint, percutaneous endoscopic approach||expanded_form_of
gastrin [mass/volume] in serum or plasma --7 minutes post 0.2 u/kg secretin||gastrin 7 min post 0.2 u/kg secretin [mass/vol]||expanded_form_of
pt pivka insensitive actual/normal coag (bldc) [relative time]||pt pivka insensitive act/nor bldc||expanded_form_of
gordonia plants||plants, gordonia||expanded_form_of
gpr85 gene||g protein-coupled receptor 85||expanded_form_of
klraq motif-containing protein 1||protein phosphatase 1, regulatory subunit 21||expanded_form_of
restriction of right ulnar artery with intraluminal device, open approach||restriction of r ulnar art with intralum dev, open approach||expanded_form_of
other monocytic leukemia, in relapse||other monocytic leukemia, in relapse||expanded_form_of
dengue virus antigen:presence or threshold:to identify measures at a point in time:serum:ordinal:immune fluorescence||dengue virus ag [presence] in serum by immunofluorescence||expanded_form_of
supplement papillary muscle with zooplastic tissue, percutaneous approach||medical and surgical @ heart and great vessels @ supplement @ papillary muscle @ percutaneous @ zooplastic tissue @ no qualifier||expanded_form_of
unsp injury of axillary or brachial vein, left side, sequela||unsp injury of axillary or brachial vein, left side, sequela||expanded_form_of
replacement of right tarsometatarsal joint with autologous tissue substitute, open approach||medical and surgical @ lower joints @ replacement @ tarsometatarsal joint, right @ open @ autologous tissue substitute @ no qualifier||expanded_form_of
radiation therapy @ central and peripheral nervous system @ stereotactic radiosurgery @ brain @ stereotactic particulate radiosurgery @ none @ none||radiation therapy @ central and peripheral nervous system @ stereotactic radiosurgery @ brain @ stereotactic particulate radiosurgery @ none @ none||expanded_form_of
superficial foreign body of right lesser toe||superficial foreign body, right lesser toe(s)||expanded_form_of
medical and surgical @ mouth and throat @ extirpation @ upper tooth @ open @ no device @ all||extirpation of matter from upper tooth, all, open approach||expanded_form_of
bypass inferior vena cava to lower vein with synthetic substitute, open approach||bypass inferior vena cava to lower vein with synthetic substitute, open approach||expanded_form_of
insertion of infusion device into left foot vein, percutaneous approach||insertion of infusion device into left foot vein, percutaneous approach||expanded_form_of
rbc # snv||erythrocytes:number concentration (count/vol):to identify measures at a point in time:synovial fluid (joint fluid):quantitative||expanded_form_of
prq trluml coronry tot occlus revasc mi one vsl||percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel||expanded_form_of
amyloid beta precursor protein binding family a member 1||lin10 lin10, c. elegans, homolog of, a||expanded_form_of
ct bone||multisection:find:pt:bone:doc:ct||expanded_form_of
diphenhydramine [presence] in specimen||diphenhydramine:presence or threshold:to identify measures at a point in time:not specified:ordinal||expanded_form_of
imaging @ non-axial lower bones @ fluoroscopy @ foot/toe joint, right @ other contrast @ none @ none||fluoroscopy of right foot/toe joint using other contrast||expanded_form_of
intersex-like||intersex, drosophila, homolog of||expanded_form_of
medical and surgical @ heart and great vessels @ dilation @ coronary artery, one artery @ percutaneous @ intraluminal device, four or more @ no qualifier||medical and surgical @ heart and great vessels @ dilation @ coronary artery, one artery @ percutaneous @ intraluminal device, four or more @ no qualifier||expanded_form_of
dislocation of metatarsophalangeal joint of unspecified great toe, sequela||dislocation of metatarsophalangeal joint of unspecified great toe, sequela||expanded_form_of
accidental poisoning by acids not elsewhere classified||acc poison-acids||expanded_form_of
undet circ-suf plast bag||suffocation by plastic bag, undetermined whether accidentally or purposely inflicted||expanded_form_of
r. prowazekii ab (s) [titer]||r. prowazekii ab (s) [titer]||expanded_form_of
release left renal vein, open approach||medical and surgical @ lower veins @ release @ renal vein, left @ open @ no device @ no qualifier||expanded_form_of
revision of autologous tissue substitute in uterus and cervix, external approach||revision of autol sub in uterus & cervix, extern approach||expanded_form_of
motorcycle passenger injured in collision with railway train or railway vehicle in nontraffic accident||motorcycle passenger injured in collision with railway train or railway vehicle in nontraffic accident||expanded_form_of
replacement, aortic valve; by translocation of autologous pulmonary valve with allograft replacement of pulmonary valve (ross procedure)||replacement of aortic valve||expanded_form_of
rnu6-971p||rna, u6 small nuclear 971, pseudogene||expanded_form_of
restrict inf mesent art w intralum dev, perc endo||restrict inf mesent art w intralum dev, perc endo||expanded_form_of
anabolic steroids ql (u)||anabolic steroids:prthr:pt:urine:ord||expanded_form_of
percutaneous endoscopic jejunostomy||percutaneous (endoscopic) jejunostomy [pej]||expanded_form_of
heat exposure on board unspecified watercraft||heat exposure on board unspecified watercraft||expanded_form_of
ifitm5 gene full mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:sequencing||ifitm5 gene full mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:sequencing||expanded_form_of
trypanosoma cruzi antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum^donor:ordinal:immunoassay||trypanosoma cruzi ab.igg:prthr:pt:ser^donor:ord:ia||expanded_form_of
o-desmethylvenlafaxine:mass concentration:to identify measures at a point in time:urine:quantitative:confirm||o-desmethylvenlafaxine:mcnc:pt:urine:qn:confirm||expanded_form_of
noninvasive colorectal cancer deoxyribonucleic acid+occult blood screening:impression/interpretation of study:to identify measures at a point in time:stool:narrative||noninv colon ca dna+occ bld scrn stl-imp||expanded_form_of
medical and surgical @ heart and great vessels @ repair @ tricuspid valve @ percutaneous endoscopic @ no device @ atrioventricular valve, right||medical and surgical @ heart and great vessels @ repair @ tricuspid valve @ percutaneous endoscopic @ no device @ atrioventricular valve, right||expanded_form_of
medical and surgical @ hepatobiliary system and pancreas @ bypass @ common bile duct @ open @ intraluminal device @ small intestine||bypass common bile duct to small intestine with intraluminal device, open approach||expanded_form_of
atpase type 13a3||afurs1||expanded_form_of
drainage of left vitreous, percutaneous approach, diagnostic||drainage of left vitreous, percutaneous approach, diagnostic||expanded_form_of
arsenic fractions panel:-:to identify measures at a point in time:urine:quantitative||arsenic fractions panel - urine||expanded_form_of
igkv1or9-1||immunoglobulin kappa variable 1/or9-1 (pseudogene)||expanded_form_of
cucumber igg ab rast class [presence] in serum||cucumber igg rast ql||expanded_form_of
fluav h14 ab hai (s) [titer]||fluav h14 ab hai (s) [titer]||expanded_form_of
medical and surgical @ mouth and throat @ drainage @ adenoids @ percutaneous @ no device @ diagnostic||drainage of adenoids, percutaneous approach, diagnostic||expanded_form_of
glomerular filtration rate/1.73 sq m.predicted [volume rate/area] in serum, plasma or blood by creatinine and cystatin c-based formula (ckd-epi)||gfr/1.73 sq m.predicted creatinine and cystatin c-based formula (ckd-epi) (s/p/bld) [vol rate/area]||expanded_form_of
alteration of neck with autol sub, open approach||alteration of neck with autol sub, open approach||expanded_form_of
myositis ossificans traumatica, forearm||myositis ossificans traumatica, forearm||expanded_form_of
ptcd2 gene||ptcd2 gene||expanded_form_of
nondisp fx (avulsion) of lateral epicondyle of unsp humerus||nondisp fx (avulsion) of lateral epicondyle of unsp humerus||expanded_form_of
insulin-like growth factor [moles/volume] in serum or plasma --8th specimen post xxx challenge||insulin-like growth factor^8th specimen post xxx challenge:scnc:pt:ser/plas:qn||expanded_form_of
cmd1w||cardiomyopathy, dilated, 1w||expanded_form_of
unspecified fracture of right foot, subsequent encounter for fracture with routine healing||unspecified fracture of right foot, subsequent encounter for fracture with routine healing||expanded_form_of
temazepam:mcnc:pt:body fld:qn||temazepam:mcnc:pt:body fld:qn||expanded_form_of
removal of monitoring device from trachea, percutaneous approach||removal of monitoring device from trachea, perc approach||expanded_form_of
bypass r subclav art to r low arm art w autol art, open||bypass right subclavian artery to right lower arm artery with autologous arterial tissue, open approach||expanded_form_of
restriction of left subclavian artery, perc endo approach||restriction of left subclavian artery, perc endo approach||expanded_form_of
burn of third degree of right shoulder, initial encounter||burn of third degree of right shoulder, initial encounter||expanded_form_of
impotence;psychogenic||psychogenic impotence (disorder)||expanded_form_of
high dose rate (hdr) brachytherapy of cervix using palladium 103 (pd-103)||radiation therapy @ female reproductive system @ brachytherapy @ cervix @ high dose rate (hdr) @ palladium 103 (pd-103) @ none||expanded_form_of
age when first fed something other than breast milk or formula||age 1st fed other than brst milk or form||expanded_form_of
toxic effect of taipan venom, accidental (unintentional)||toxic effect of taipan venom, accidental (unintentional)||expanded_form_of
bilirubin.conjugated [moles/volume] in serum or plasma||bilirub conj serpl-scnc||expanded_form_of
release left abdomen tendon, external approach||release left abdomen tendon, external approach||expanded_form_of
needle biopsy of lung or chest tissue, accessed through the skin||needle biopsy of lung or chest tissue, accessed through the skin||expanded_form_of
retinal dystrophy with leukodystrophy||rdlkd||expanded_form_of
mirror image polydactyly||mirror hands and feet with nasal defects||expanded_form_of
unspecified physeal fracture of lower end of unspecified femur||unsp physeal fracture of lower end of unspecified femur||expanded_form_of
drainage of right toe phalangeal joint, perc approach||drainage of right toe phalangeal joint, perc approach||expanded_form_of
pedl cyc passenger injured in clsn w ped/anml in traf, init||pedl cyc passenger injured in clsn w ped/anml in traf, init||expanded_form_of
rheumatoid factor [titer] in serum||rheumatoid factor [titer] in serum||expanded_form_of
drug-induced akathisia (diagnosis)||acathisia drug ind||expanded_form_of
bypass small intestine to anus with synth sub, endo||bypass small intestine to anus with synthetic substitute, via natural or artificial opening endoscopic||expanded_form_of
sarcobatus vermiculatus ab.ige:acnc:pt:ser:qn||greasewood ige qn (s)||expanded_form_of
polymerase, dna, theta||dna polymerase theta gene||expanded_form_of
nuclear medicine @ hepatobiliary system and pancreas @ tomographic (tomo) nuclear medicine imaging||nuclear medicine, hepatobiliary system and pancreas, tomographic (tomo) nuclear medicine imaging||expanded_form_of
medical and surgical @ ear, nose, sinus @ extirpation @ nasal mucosa and soft tissue @ external @ no device @ no qualifier||extirpation of matter from nose sft tiss, extern approach||expanded_form_of
revision of synthetic substitute in neck, external approach||revision of synthetic substitute in neck, external approach||expanded_form_of
toxic effect of taipan venom, assault, subsequent encounter||toxic effect of taipan venom, assault, subsequent encounter||expanded_form_of
replace of l innom vein with nonaut sub, perc endo approach||replacement of left innominate vein with nonautologous tissue substitute, percutaneous endoscopic approach||expanded_form_of
medical and surgical @ upper bones @ reposition @ clavicle, right @ external @ no device @ no qualifier||reposition right clavicle, external approach||expanded_form_of
psoriatic arthropathy (diagnosis)||arthritis psoriatica||expanded_form_of
unsp injury of muscle, fascia and tendon of pelvis, subs||unsp injury of muscle, fascia and tendon of pelvis, subs||expanded_form_of
cmv igm if [titer]||cytomegalovirus igm ab [titer] in serum or plasma by immunofluorescence||expanded_form_of
medical and surgical @ peripheral nervous system @ transfer @ femoral nerve @ percutaneous endoscopic @ no device @ peroneal nerve||transfer femoral nerve to peroneal nerve, perc endo approach||expanded_form_of
gxylt1 pseudogene 5||gxylt1p5||expanded_form_of
vag hyst 250 gm/< w/rmvl tube&/ovary||vag hyst including t/o||expanded_form_of
transfer optic nerve to acoustic nerve, perc endo approach||transfer optic nerve to acoustic nerve, percutaneous endoscopic approach||expanded_form_of
anaplastic large cell lymphoma, alk-negative, intrapelvic lymph nodes||lymphoma anaplastic large cell intrapelvic alk-negative||expanded_form_of
note:find:pt:{setting}:doc:breastfeeding||breastfeeding note||expanded_form_of
solute carrier family 35 member d2||slc35d2||expanded_form_of
supplement of face subcutaneous tissue and fascia with nonautologous tissue substitute, open approach||supplement face subcu/fascia w nonaut sub, open||expanded_form_of
rheu arthritis w rheu factor of l elbow w/o org/sys involv||rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement||expanded_form_of
unspecified injury of muscle, fascia and tendon of lower back, subsequent encounter||unsp injury of muscle, fascia and tendon of lower back, subs||expanded_form_of
cftr+fmr1+smn1 mut anl bld/t||cftr+fmr1+smn1 mut anl bld/t||expanded_form_of
extirpation of matter from right retinal vessel, external approach||medical and surgical @ eye @ extirpation @ retinal vessel, right @ external @ no device @ no qualifier||expanded_form_of
disp fx of coracoid process, right shoulder, sequela||displaced fracture of coracoid process, right shoulder, sequela||expanded_form_of
medical and surgical @ mouth and throat @ repair @ buccal mucosa @ open @ no device @ no qualifier||repair buccal mucosa, open approach||expanded_form_of
supplement left epididymis with autologous tissue substitute, open approach||supplement left epididymis with autologous tissue substitute, open approach||expanded_form_of
contact with sharp glass, undetermined intent||contact with sharp glass, undetermined intent||expanded_form_of
cortisol 30 min post 1 ug/kg crh iv [moles/vol]||cortisol^30 minutes post 1 ug/kg crh intravenous:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||expanded_form_of
triplet preg w two or more monochorionic fetuses, unsp tri||triplet preg w two or more monochorionic fetuses, unsp tri||expanded_form_of
medical and surgical @ upper joints @ reposition @ carpal joint, right @ external @ no device @ no qualifier||medical and surgical @ upper joints @ reposition @ carpal joint, right @ external @ no device @ no qualifier||expanded_form_of
excision of left fallopian tube, via natural or artificial opening, diagnostic||excision of left fallopian tube, via natural or artificial opening, diagnostic||expanded_form_of
testost free serpl dl<= 3.47 pmol/l-scnc||testosterone free dl <= 3.47 pmol/l [moles/vol]||expanded_form_of
insertion of feeding device into small intestine, percutaneous approach||insertion of feeding device into small intest, perc approach||expanded_form_of
arsacs||arsacs - autosomal recessive spastic ataxia of charlevoix-saguenay||expanded_form_of
revise eye socket implant||orbital implant (implant outside muscle cone); removal or revision||expanded_form_of
ac004542.c22.1||zcwcc1||expanded_form_of
reposition left ulna with monopln ext fix, open approach||medical and surgical @ upper bones @ reposition @ ulna, left @ open @ external fixation device, monoplanar @ no qualifier||expanded_form_of
cl skl w oth fx-brf coma||closed fractures involving skull or face with other bones, with cerebral laceration and contusion, with brief [less than one hour] loss of consciousness||expanded_form_of
bypass l cephalic vein to up vein w synth sub, open||medical and surgical @ upper veins @ bypass @ cephalic vein, left @ open @ synthetic substitute @ upper vein||expanded_form_of
medical and surgical @ lower joints @ drainage @ tarsometatarsal joint, left @ percutaneous endoscopic @ drainage device @ no qualifier||drain l tarsometatars jt w drain dev, perc endo||expanded_form_of
refractory migraine with aura||intractable migraine with aura||expanded_form_of
mecp2 gene analysis known familial variant||mecp2 gene known variant||expanded_form_of
displ commnt fx shaft of humerus, right arm, init for opn fx||displ commnt fx shaft of humerus, right arm, init for opn fx||expanded_form_of
cnsa-p2||sh3gl1p2 gene||expanded_form_of
keratinocyte-associated protein 3||keratinocyte associated protein 3||expanded_form_of
medical and surgical @ heart and great vessels @ dilation @ aortic valve @ percutaneous @ no device @ no qualifier||medical and surgical @ heart and great vessels @ dilation @ aortic valve @ percutaneous @ no device @ no qualifier||expanded_form_of
gustatory sweating syndrome||gustatory sweating syndrome||expanded_form_of
ribosomal protein s27 pseudogene 9||rps27p9||expanded_form_of
ct hand||multisection:finding:to identify measures at a point in time:upper extremity>hand:document:computed tomography||expanded_form_of
acute drug-induced dystonia||acute dystonia due to drugs||expanded_form_of
indiv psychotherapy for substance abuse, psychoanalysis||indiv psychotherapy for substance abuse, psychoanalysis||expanded_form_of
irrigation of cran cav/brain using irrigat, perc approach||administration @ physiological systems and anatomical regions @ irrigation @ cranial cavity and brain @ percutaneous @ irrigating substance @ no qualifier||expanded_form_of
extirpation of matter from thoracic sympathetic nerve, open approach||extirpation of matter from thor symp nrv, open approach||expanded_form_of
kng1||hk||expanded_form_of
organic sleep apnea, unspecified||organic sleep apnea (diagnosis)||expanded_form_of
radiologic examination of optic foramina||x-ray skull optic foramen||expanded_form_of
hallucinogen use, unspecified with hallucinogen-induced anxiety disorder||hallucinogen use, unsp w anxiety disorder||expanded_form_of
trio- and filamentous-actin-binding protein||trio and f-actin binding protein||expanded_form_of
opiates cutoff:mass concentration:to identify measures at a point in time:urine:quantitative:screen||opiates cutoff:mcnc:pt:urine:qn:screen||expanded_form_of
drug test def simple all cl||drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes||expanded_form_of
nose allergy test||direct nasal mucous membrane test||expanded_form_of
tubbp7||tubbp7||expanded_form_of
activating transcription factor 4 gene||atf4||expanded_form_of
bypass right atrium to right pulmonary artery with autologous venous tissue, open approach||medical and surgical @ heart and great vessels @ bypass @ atrium, right @ open @ autologous venous tissue @ pulmonary artery, right||expanded_form_of
medical and surgical @ bursae and ligaments @ release @ elbow bursa and ligament, left @ percutaneous @ no device @ no qualifier||release left elbow bursa and ligament, percutaneous approach||expanded_form_of
replacement of soft palate with nonautologous tissue substitute, open approach||replacement of soft palate with nonautologous tissue substitute, open approach||expanded_form_of
methylenedioxyamphetamine:prthr:pt:urine:ord||methylenedioxyamphetamine ql (u)||expanded_form_of
unspecified tuberculosis of central nervous system, tubercle bacilli not found by microscopy, but found by bacterial culture||unspecified tuberculosis of central nervous system, tubercle bacilli not found (in sputum) by microscopy, but found by bacterial culture||expanded_form_of
rib, fracture||fracture of rib||expanded_form_of
methanol||toxic effect of methyl alcohol (disorder) [ambiguous]||expanded_form_of
infectious agent antigen detection by immunoassay with direct optical observation; influenza||influenza assay w/optic||expanded_form_of
insertion of infusion device into azygos vein, perc approach||insertion of infusion device into azygos vein, perc approach||expanded_form_of
corros 1st deg of unsp site right low limb, ex ank/ft, sqla||corrosion of first degree of unspecified site of right lower limb, except ankle and foot, sequela||expanded_form_of
time elapsed since stroke:find:pt:^patient:ord||time elapsed since stroke||expanded_form_of
flounder basophil bound antibody:arbitrary concentration:to identify measures at a point in time:whole blood:quantitative:leukocyte histamine release||flounder triggered histamine release [units/volume] in blood||expanded_form_of
release lingula bronchus, via natural or artificial opening endoscopic||release lingula bronchus, endo||expanded_form_of
salmonella sp serotype [identifier] in isolate by agglutination||salmonella sertyp islt aggl||expanded_form_of
lipoprotein metabolism panel||lipoprotein metabolism panel:-:to identify measures at a point in time:serum/plasma:-||expanded_form_of
resection of abdominal artery with replacement||resection of abdominal artery with replacement (procedure)||expanded_form_of
repair left lacrimal duct, open approach||repair left lacrimal duct, open approach||expanded_form_of
occlusion intracran vein w extralum dev, perc endo||medical and surgical @ upper veins @ occlusion @ intracranial vein @ percutaneous endoscopic @ extraluminal device @ no qualifier||expanded_form_of
dilation of left basilic vein using drug-coated balloon, percutaneous approach||dilation of left basilic vein using drug blln, perc approach||expanded_form_of
revision of other device in left ear, percutaneous approach||medical and surgical @ ear, nose, sinus @ revision @ ear, left @ percutaneous @ other device @ no qualifier||expanded_form_of
displaced avulsion fracture of tuberosity of unspecified calcaneus, subsequent encounter for fracture with malunion||displ avuls fx tuberosity of unsp calcaneus, 7thp||expanded_form_of
opn skl vlt fx-proln com||open frac of vos with intcran inj of oth and unspec nature, with prolonged loc and rtrn to pecl||expanded_form_of
human leukocyte antigen-drb1 unresolved alleles:type:to identify measures at a point in time:whole blood/tissue, unspecified:nominal:high resolution||hla-drb1 unresolved alleles [type] by high resolution||expanded_form_of
removal of other device from heart, percutaneous endoscopic approach||removal of other device from heart, perc endo approach||expanded_form_of
revision of synth sub in r knee jt, femoral, extern approach||revision of synth sub in r knee jt, femoral, extern approach||expanded_form_of
bent bone of left rad, subs for opn fx type i/2 w malunion||bent bone of left radius, subsequent encounter for open fracture type i or ii with malunion||expanded_form_of
physical rehabilitation and diagnostic audiology @ rehabilitation @ caregiver training @ none @ grooming/personal hygiene @ prosthesis @ none||caregiver training in grooming/hygiene using prosthesis||expanded_form_of
cbdca/txt||carboplatin/docetaxel||expanded_form_of
diameter.long:length:to identify measures at a point in time:kidney.right:quantitative:ultrasound.measured||kidney - right longitudinal diameter us||expanded_form_of
t(9;22)(abl1,bcr)/control bld/t-lnrto||t(9;22)(q34.1;q11)(abl1,bcr) fusion transcript/control transcript [log number ratio] in blood or tissue by molecular genetics method||expanded_form_of
poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, sequela||poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, sequela||expanded_form_of
dilation of right hypogastric vein, percutaneous approach||dilation of right hypogastric vein, percutaneous approach||expanded_form_of
nondisplaced transverse fracture of shaft of left fibula, subsequent encounter for open fracture type iiia, iiib, or iiic with routine healing||nondisp transverse fx shaft of l fibula, 7thf||expanded_form_of
toxic effect of herbicides and fungicides, accidental||toxic effect of herbicides and fungicides, accidental (unintentional)||expanded_form_of
voice sympt/complt||voice symptom/complaint||expanded_form_of
medical and surgical @ anatomical regions, general @ removal @ peritoneal cavity @ percutaneous endoscopic @ infusion device @ no qualifier||removal of infusion device from peritoneal cavity, percutaneous endoscopic approach||expanded_form_of
occlusion of r temporal art with intralum dev, perc approach||medical and surgical @ upper arteries @ occlusion @ temporal artery, right @ percutaneous @ intraluminal device @ no qualifier||expanded_form_of
disp fx of greater trochanter of unsp femr, 7thr||disp fx of greater trochanter of unsp femr, 7thr||expanded_form_of
drainage of right nipple, open approach||medical and surgical @ skin and breast @ drainage @ nipple, right @ open @ no device @ no qualifier||expanded_form_of
medical and surgical @ head and facial bones @ excision @ ethmoid bone, right @ percutaneous @ no device @ no qualifier||medical and surgical @ head and facial bones @ excision @ ethmoid bone, right @ percutaneous @ no device @ no qualifier||expanded_form_of
afo tib fx cast plaster mold||afo tib fx cast plaster mold||expanded_form_of
dilation of right posterior tibial artery with drug-eluting intraluminal device, using drug-coated balloon, percutaneous endoscopic approach||medical and surgical @ lower arteries @ dilation @ posterior tibial artery, right @ percutaneous endoscopic @ intraluminal device, drug-eluting @ drug-coated balloon||expanded_form_of
deprecated ck mb serpl eia-ccnc||deprecated creatine kinase.mb||expanded_form_of
nondisplaced pilon fracture of right tibia, subsequent encounter for closed fracture with routine healing||nondisplaced pilon fracture of right tibia, subsequent encounter for closed fracture with routine healing||expanded_form_of
oth injury of femoral artery, unspecified leg, init encntr||oth injury of femoral artery, unspecified leg, init encntr||expanded_form_of
medical and surgical @ heart and great vessels @ excision @ conduction mechanism @ open @ no device @ diagnostic||excision of conduction mechanism, open approach, diagnostic||expanded_form_of
cddp/mito/vcr||cddp/mito/vcr||expanded_form_of
i cannot go out of the house to do the shopping:finding:to identify measures at a point in time:^patient:ordinal:phenx||i cannot go out of the house to do the shopping:find:pt:^patient:ord:phenx||expanded_form_of
medical and surgical @ gastrointestinal system @ bypass @ jejunum @ via natural or artificial opening endoscopic @ nonautologous tissue substitute @ anus||bypass jejunum to anus with nonautologous tissue substitute, via natural or artificial opening endoscopic||expanded_form_of
insertion of int fix into r sternoclav jt, open approach||insertion of internal fixation device into right sternoclavicular joint, open approach||expanded_form_of
hut2||solute carrier family 14 (urea transporter), member 2||expanded_form_of
electrographic monitoring||electrographic monitoring||expanded_form_of
pgrmc2||dg6||expanded_form_of
medical and surgical @ lower bones @ insertion @ tibia, left @ percutaneous endoscopic @ external fixation device, hybrid @ no qualifier||insertion of hybrid ext fix into l tibia, perc endo approach||expanded_form_of
bypass superior vena cava to right pulmonary artery with autologous venous tissue, percutaneous endoscopic approach||bypass sup vena cava to r pulm art w autol vn, perc endo||expanded_form_of
medical and surgical @ female reproductive system @ extirpation @ fallopian tubes, bilateral @ via natural or artificial opening @ no device @ no qualifier||medical and surgical @ female reproductive system @ extirpation @ fallopian tubes, bilateral @ via natural or artificial opening @ no device @ no qualifier||expanded_form_of
protein interacting with app tail 1||hs.84084||expanded_form_of
magnetoencephalograpy evoked fields 1 modality||meg evoked single||expanded_form_of
excision of left upper arm muscle, open approach||excision of left upper arm muscle, open approach||expanded_form_of
foxtail millet ige qn (s)||foxtail millet ige qn (s)||expanded_form_of
unspecified open-angle glaucoma, stage unspecified||unspecified open-angle glaucoma, stage unspecified||expanded_form_of
protein disulfide isomerase family a, member 16||anterior gradient 1, xenopus, homolog of||expanded_form_of
medical and surgical @ bursae and ligaments @ extraction @ abdomen bursa and ligament, right @ percutaneous @ no device @ no qualifier||extraction of right abdomen bursa and ligament, percutaneous approach||expanded_form_of
release liver, percutaneous endoscopic approach||medical and surgical @ hepatobiliary system and pancreas @ release @ liver @ percutaneous endoscopic @ no device @ no qualifier||expanded_form_of
unsp focal tbi w loc w death d/t brain injury bf consc, init||unsp focal tbi w loc w death d/t brain injury bf consc, init||expanded_form_of
vendor model number:prid:pt:cardiac measurement device:nom||vendor model number:presence or identity:to identify measures at a point in time:cardiac measurement device:nominal||expanded_form_of
nondisplaced fracture of navicular [scaphoid] of unspecified foot, subsequent encounter for fracture with malunion||nondisplaced fracture of navicular [scaphoid] of unspecified foot, subsequent encounter for fracture with malunion||expanded_form_of
c2orf43||c2orf43||expanded_form_of
external constriction, right ankle, initial encounter||external constriction, right ankle, initial encounter||expanded_form_of
replacement of left hand artery with nonautologous tissue substitute, percutaneous endoscopic approach||medical and surgical @ upper arteries @ replacement @ hand artery, left @ percutaneous endoscopic @ nonautologous tissue substitute @ no qualifier||expanded_form_of
microrna 9986||mir9986||expanded_form_of
camf||ctx/dox/fa/mtx||expanded_form_of
how many of your father's sisters have had, or were suspected of having this eye problem [#] [phenx]||how many of your father's sisters have had, or were suspected of having this eye problem:number:to identify measures at a point in time:^patient:quantitative:phenx||expanded_form_of
insulin type serpl lc/ms/ms||insulin type lc/ms/ms nom||expanded_form_of
benzoylecgonine screen method >300 ng/ml ql (u)||benzoylecgonine [presence] in urine by screen method >300 ng/ml||expanded_form_of
reflex irritability^10m post birth:fcn:pt:^patient:ord:apgar||reflex irritability^10 minutes post birth:function:to identify measures at a point in time:^patient:ordinal:apgar||expanded_form_of
occlusion of left anterior tibial artery, perc endo approach||occlusion of left anterior tibial artery, perc endo approach||expanded_form_of
crisis intervention mental h||crisis intervention mental h||expanded_form_of
other heart failure||other heart failure||expanded_form_of
bypass abdominal aorta to celiac artery with autologous venous tissue, open approach||medical and surgical @ lower arteries @ bypass @ abdominal aorta @ open @ autologous venous tissue @ celiac artery||expanded_form_of
adss||adss2||expanded_form_of
cutting ramus open w/graft||osteotomy - mandibular rami with bone graft; includes obtaining the graft||expanded_form_of
other specified disorders of cartilage, upper arm||other specified disorders of cartilage, upper arm||expanded_form_of
glucose [moles/volume] in serum or plasma --5 minutes post dose glucose||glucose 5m p glc serpl-scnc||expanded_form_of
remove synth sub from l knee jt, femoral, perc endo||removal of synthetic substitute from left knee joint, femoral surface, percutaneous endoscopic approach||expanded_form_of
excision of left kidney, via opening, diagn||excision of left kidney, via opening, diagn||expanded_form_of
incision and drainage below fascia, with or without tendon sheath involvement, foot; multiple areas||retired procedure [11765002]||expanded_form_of
revision of autologous tissue substitute in right tarsal, external approach||revision of autologous tissue substitute in right tarsal, external approach||expanded_form_of
communicable disease [ambiguous]||infectious disease nos||expanded_form_of
other specific infections by free-living amebae||other specific infections by free-living amebae||expanded_form_of
nickel [mass/volume] in 24 hour urine||nickel (24h u) [mass/vol]||expanded_form_of
anterior subluxation of right humerus, initial encounter||anterior subluxation of right humerus, initial encounter||expanded_form_of
linc02478||long intergenic non-protein coding rna 2478||expanded_form_of
cmbl gene||carboxymethylenebutenolidase homolog (pseudomonas)||expanded_form_of
repair paravag defect open||repair paravag defect open||expanded_form_of
gcc1p||golgi coiled-coil protein 1||expanded_form_of
fluid output chest tube [appearance]||fluid output chest tube [appearance]||expanded_form_of
medical and surgical @ heart and great vessels @ supplement @ ventricle, left @ percutaneous @ zooplastic tissue @ no qualifier||medical and surgical @ heart and great vessels @ supplement @ ventricle, left @ percutaneous @ zooplastic tissue @ no qualifier||expanded_form_of
injection, mitoxantrone hydrochloride, per 5 mg||mitoxantrone hydrochl / 5 mg||expanded_form_of
stroke volume/body surface area:volume/area:to identify measures at a point in time:heart.ventricle.right:quantitative:ultrasound.doppler||stroke volume/body surface area:arvol:pt:heart.ventricle.right:qn:us.doppler||expanded_form_of
medical and surgical @ eye @ supplement @ upper eyelid, right @ external @ nonautologous tissue substitute @ no qualifier||supplement right upper eyelid with nonautologous tissue substitute, external approach||expanded_form_of
[x]other lactose intolerance (disorder)||other lactose intolerance||expanded_form_of
delta-5 desaturase||d5d||expanded_form_of
malig neop great curv stom uns||malignant tumor of greater curve of stomach (disorder)||expanded_form_of
revision of internal fixation device in right metacarpal, open approach||medical and surgical @ upper bones @ revision @ metacarpal, right @ open @ internal fixation device @ no qualifier||expanded_form_of
bypass small intestine to small intestine with synthetic substitute, percutaneous endoscopic approach||bypass small intestine to small intestine with synthetic substitute, percutaneous endoscopic approach||expanded_form_of
major lacerat great saph at hip and thi lev, right leg, subs||major laceration of greater saphenous vein at hip and thigh level, right leg, subsequent encounter||expanded_form_of
fragmentation in carina, via natural or artificial opening||fragmentation in carina, via natural or artificial opening||expanded_form_of
passenger in pick-up truck or van injured in collision with other motor vehicles in nontraffic accident, initial encounter||passenger in pick-up truck or van injured in collision with other motor vehicles in nontraffic accident, initial encounter||expanded_form_of
alkaline phosphatase:catalytic concentration:to identify measures at a point in time:whole blood:quantitative||alkaline phosphatase:ccnc:pt:bld:qn||expanded_form_of
linc00930||long intergenic non-protein coding rna 930||expanded_form_of
paralytic calcification and ossification of muscle, unspecified site||muscle; ossification, paralytic||expanded_form_of
arthropathy associated with respiratory disorders||arthropathy associated with respiratory disorder||expanded_form_of
rnu6-866p||rnu6-866p gene||expanded_form_of
displaced fracture of lunate, unspecified wrist, sequela||displaced fracture of lunate [semilunar], unspecified wrist, sequela||expanded_form_of
nuclear pore associated protein 1 pseudogene 8||npap1p8||expanded_form_of
medical and surgical @ central nervous system and cranial nerves @ excision @ thoracic spinal cord @ open @ no device @ diagnostic||excision of thoracic spinal cord, open approach, diagnostic||expanded_form_of
gout due to renal impairment, unspecified knee||gout due to renal impairment, unspecified knee||expanded_form_of
tshz1 gene||teashirt zinc finger 1||expanded_form_of
bypass left axillary artery to right lower arm artery with autologous arterial tissue, open approach||bypass left axillary artery to right lower arm artery with autologous arterial tissue, open approach||expanded_form_of
division of left femoral shaft, open approach||division of left femoral shaft, open approach||expanded_form_of
direct antiglobulin test.polyspecific reagent^post transfusion reaction:presence or threshold:to identify measures at a point in time:erythrocytes:ordinal||direct antiglobulin test.polyspecific reagent^post transfusion reaction:presence or threshold:to identify measures at a point in time:erythrocytes:ordinal||expanded_form_of
removal of infusion device from pancreatic duct, open approach||removal of infusion device from pancreat duct, open approach||expanded_form_of
medical and surgical @ lower bones @ revision @ acetabulum, left @ open @ autologous tissue substitute @ no qualifier||medical and surgical @ lower bones @ revision @ acetabulum, left @ open @ autologous tissue substitute @ no qualifier||expanded_form_of
continuing pregnancy after spontaneous abortion of one fetus or more, third trimester, other fetus||continuing pregnancy after spontaneous abortion of one fetus or more, third trimester, other fetus||expanded_form_of
medical and surgical @ lower bones @ revision @ femoral shaft, right @ open @ external fixation device @ no qualifier||revision of ext fix in r femur shaft, open approach||expanded_form_of
medical and surgical @ upper veins @ supplement @ azygos vein @ percutaneous @ synthetic substitute @ no qualifier||supplement azygos vein with synth sub, perc approach||expanded_form_of
revision of synth sub in l sternoclav jt, open approach||medical and surgical @ upper joints @ revision @ sternoclavicular joint, left @ open @ synthetic substitute @ no qualifier||expanded_form_of
bypass r ureter to colon with nonaut sub, perc endo approach||medical and surgical @ urinary system @ bypass @ ureter, right @ percutaneous endoscopic @ nonautologous tissue substitute @ colon||expanded_form_of
measurement and monitoring @ physiological systems @ measurement @ central nervous @ percutaneous @ pressure @ intracranial||measurement and monitoring @ physiological systems @ measurement @ central nervous @ percutaneous @ pressure @ intracranial||expanded_form_of
urb2||urb2 gene||expanded_form_of
ags5||aicardi-goutieres syndrome 5||expanded_form_of
medical and surgical @ upper bones @ drainage @ glenoid cavity, right @ percutaneous endoscopic @ no device @ no qualifier||drainage of right glenoid cavity, perc endo approach||expanded_form_of
wheezing whistling chest past phenx||have you ever had wheezing or whistling in the chest at any time in the past:find:pt:^patient:ord:phenx||expanded_form_of
hereditary leiomyomatosis & rcc-associated renal cell carcinoma||hlrcc||expanded_form_of
unsp acc to commrcl fix-wing arcrft injuring occupant, subs||unspecified accident to commercial fixed-wing aircraft injuring occupant, subsequent encounter||expanded_form_of
medical and surgical @ central nervous system and cranial nerves @ fragmentation @ spinal canal @ percutaneous @ no device @ no qualifier||fragmentation in spinal canal, percutaneous approach||expanded_form_of
burn of first degree of single left finger (nail) except thumb, subsequent encounter||burn of first degree of single left finger (nail) except thumb, subsequent encounter||expanded_form_of
cf/moab idec-c2b8/mtx/tmz||leucovorin calcium/methotrexate/rituximab/temozolomide||expanded_form_of
supplement nasal turbinate with synthetic substitute, via natural or artificial opening||medical and surgical @ ear, nose, sinus @ supplement @ nasal turbinate @ via natural or artificial opening @ synthetic substitute @ no qualifier||expanded_form_of
occlusion of left radial artery with intraluminal device, open approach||occlusion of l radial art with intralum dev, open approach||expanded_form_of
nox2||cytochrome b(558), beta subunit||expanded_form_of
fibrinoligase assay||clot factor xiii fibrin stab||expanded_form_of
fluorescence guided procedure of trunk region, open approach||fluorescence guided procedure of trunk region, open approach||expanded_form_of
replacement of right glenoid cavity with synthetic substitute, open approach||replacement of r glenoid cav with synth sub, open approach||expanded_form_of
medical and surgical @ gastrointestinal system @ excision @ esophagus @ percutaneous endoscopic @ no device @ diagnostic||medical and surgical @ gastrointestinal system @ excision @ esophagus @ percutaneous endoscopic @ no device @ diagnostic||expanded_form_of
bus occupant (driver) (passenger) injured in unspecified nontraffic accident, subsequent encounter||bus occupant (driver) (passenger) injured in unspecified nontraffic accident, subsequent encounter||expanded_form_of
minocycline [susceptibility]||minocycline:susc:pt:isolate:ordqn||expanded_form_of
linc00163||narcolepsy candidate-region 1 gene a||expanded_form_of
introduction of platelet inhibitor into heart, open approach||administration @ physiological systems and anatomical regions @ introduction @ heart @ open @ platelet inhibitor @ no qualifier||expanded_form_of
release left ankle joint, percutaneous endoscopic approach||medical and surgical @ lower joints @ release @ ankle joint, left @ percutaneous endoscopic @ no device @ no qualifier||expanded_form_of
senile; verruca||wart(s);senile||expanded_form_of
nuclear medicine @ anatomical regions @ planar nuclear medicine imaging @ chest @ fluorine 18 (f-18) @ none @ none||planar nuclear medicine imaging of chest using fluorine 18 (f-18)||expanded_form_of
wish||nck interacting protein with sh3 domain||expanded_form_of
medical and surgical @ upper bones @ reposition @ humeral shaft, left @ open @ external fixation device, ring @ no qualifier||reposition left humeral shaft with ring external fixation device, open approach||expanded_form_of
la crosse virus ab.igm:prthr:pt:ser:ord||la crosse virus igm ql (s)||expanded_form_of
other antepartum hemorrhage, first trimester||other antepartum hemorrhage, first trimester||expanded_form_of
medical and surgical @ upper arteries @ dilation @ common carotid artery, left @ percutaneous endoscopic @ intraluminal device, drug-eluting @ no qualifier||medical and surgical @ upper arteries @ dilation @ common carotid artery, left @ percutaneous endoscopic @ intraluminal device, drug-eluting @ no qualifier||expanded_form_of
revision of autologous tissue substitute in upper artery, open approach||medical and surgical @ upper arteries @ revision @ upper artery @ open @ autologous tissue substitute @ no qualifier||expanded_form_of
congenital anomaly;nerv sys||nervous system anomalies nos||expanded_form_of
removal of nonautologous tissue substitute from right upper extremity, percutaneous approach||removal of nonaut sub from r up extrem, perc approach||expanded_form_of
ht013||c20orf19||expanded_form_of
xylose^3 hours post dose xylose oral:substance concentration:to identify measures at a point in time:whole blood:quantitative||xylose^3 hours post dose xylose oral:substance concentration:to identify measures at a point in time:whole blood:quantitative||expanded_form_of
alanine aminotransferase:catalytic concentration:to identify measures at a point in time:serum/plasma:quantitative:no addition of p-5'-p||alanine aminotransferase:catalytic concentration:to identify measures at a point in time:serum/plasma:quantitative:no addition of p-5'-p||expanded_form_of
medical and surgical @ lower joints @ fusion @ toe phalangeal joint, left @ percutaneous @ internal fixation device, sustained compression @ no qualifier||medical and surgical @ lower joints @ fusion @ toe phalangeal joint, left @ percutaneous @ internal fixation device, sustained compression @ no qualifier||expanded_form_of
csnb, complete, autosomal recessive||night blindness, congenital stationary, type 1e||expanded_form_of
fenoprofen [mass/volume] in serum or plasma||fenoprofen [mass/volume] in serum or plasma||expanded_form_of
fibrosis due to genitourinary prosth dev/grft, subs||fibrosis due to genitourinary prosth dev/grft, subs||expanded_form_of
mt-trx||thioredoxin 2||expanded_form_of
ctc.prostate # bld||ctc.prostate # bld||expanded_form_of
medical and surgical @ muscles @ division @ lower leg muscle, right @ percutaneous @ no device @ no qualifier||division of right lower leg muscle, percutaneous approach||expanded_form_of
occlusion of left external carotid artery with bioactive intraluminal device, percutaneous endoscopic approach||medical and surgical @ upper arteries @ occlusion @ external carotid artery, left @ percutaneous endoscopic @ intraluminal device, bioactive @ no qualifier||expanded_form_of
medical and surgical @ peripheral nervous system @ transfer @ sciatic nerve @ percutaneous endoscopic @ no device @ tibial nerve||medical and surgical @ peripheral nervous system @ transfer @ sciatic nerve @ percutaneous endoscopic @ no device @ tibial nerve||expanded_form_of
medical and surgical @ anatomical regions, upper extremities @ control @ upper arm, right @ percutaneous @ no device @ no qualifier||medical and surgical @ anatomical regions, upper extremities @ control @ upper arm, right @ percutaneous @ no device @ no qualifier||expanded_form_of
mult.intrathorac.inj.-closed||multiple intrathoracic organ injury without mention of open wound into cavity (disorder)||expanded_form_of
retinal detachment with single break, unspecified eye||rhegmatogenous retinal detachment with single break (disorder)||expanded_form_of
physical abuse complicating pregnancy, childbirth and the puerperium||physical abuse complicating pregnancy, childbirth, and puerperium||expanded_form_of
analysis of 5 substances in maternal blood to assess risk of abnormal chromosomes in fetus and preeclampsia||ftl cgen abnor prnt comp 5||expanded_form_of
intelectin 2||intelectin 2||expanded_form_of
note:finding:to identify measures at a point in time:outpatient:document:adolescent medicine||note:finding:to identify measures at a point in time:outpatient:document:adolescent medicine||expanded_form_of
aspergillus fumigatus+aspergillus niger ige qn (s)||(aspergillus fumigatus+aspergillus niger) ab.ige:acnc:pt:ser:qn||expanded_form_of
excision of coronary vein, open approach||medical and surgical @ heart and great vessels @ excision @ coronary vein @ open @ no device @ no qualifier||expanded_form_of
spinocerebellar ataxia 21||c1orf70||expanded_form_of
unspecified open wound of right upper arm, sequela||unspecified open wound of right upper arm, sequela||expanded_form_of
stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion||stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion||expanded_form_of
anagallis arvensis/scarlet p||anagallis arvensis homeopathic preparation||expanded_form_of
psychotherapy for crisis; first 60 minutes||psytx crisis initial 60 min||expanded_form_of
emerg response plan prob analysis||emergency response plan problem analysis:finding:to identify measures at a point in time:^event:narrative||expanded_form_of
barbus foerschi <systomus foerschi>||puntius foerschi||expanded_form_of
stereotactic gamma beam radiosurgery of ear||stereotactic gamma beam radiosurgery of ear||expanded_form_of
displ commnt fx shaft of rad, l arm, 7thj||displaced comminuted fracture of shaft of radius, left arm, subsequent encounter for open fracture type iiia, iiib, or iiic with delayed healing||expanded_form_of
hosp transfer sum note||hospital transfer summary note||expanded_form_of
replacement of thor aorta asc with autol sub, open approach||medical and surgical @ heart and great vessels @ replacement @ thoracic aorta, ascending/arch @ open @ autologous tissue substitute @ no qualifier||expanded_form_of
repair of inflatable urethral/bladder neck sphincter, including pump, reservoir, and cuff||surgical correction of hydraulic abnormality of inflatable sphincter device||expanded_form_of
physical rehabilitation and diagnostic audiology @ diagnostic audiology @ hearing assessment @ none @ electrocochleography @ none @ none||physical rehabilitation and diagnostic audiology @ diagnostic audiology @ hearing assessment @ none @ electrocochleography @ none @ none||expanded_form_of
creatinine^4.5 hours post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||creat 4.5h p chal serpl-mcnc||expanded_form_of
fatty alcohol:nad+ oxidoreductase deficiency||ichthyosis-spastic neurologic disorder-oligophrenia syndrome||expanded_form_of
medical and surgical @ upper arteries @ destruction @ internal mammary artery, left @ percutaneous endoscopic @ no device @ no qualifier||destruction of left internal mammary artery, percutaneous endoscopic approach||expanded_form_of
medical and surgical @ ear, nose, sinus @ drainage @ nasopharynx @ percutaneous endoscopic @ drainage device @ no qualifier||drainage of nasopharynx with drain dev, perc endo approach||expanded_form_of
malig tumor sublingual glnd||malignant tumor of the sublingual gland||expanded_form_of
restriction of l int carotid with flow divert, open approach||medical and surgical @ upper arteries @ restriction @ internal carotid artery, left @ open @ intraluminal device, flow diverter @ no qualifier||expanded_form_of
medical and surgical @ lower arteries @ replacement @ anterior tibial artery, left @ open @ nonautologous tissue substitute @ no qualifier||replacement of left anterior tibial artery with nonautologous tissue substitute, open approach||expanded_form_of
tra-tgc4-1||tra-tgc4-1||expanded_form_of
phospholipase c, beta-2||flj38135||expanded_form_of
nogob receptor||c6orf68||expanded_form_of
almond igg4-mcnc||almond igg4 ab [mass/volume] in serum||expanded_form_of
mlh1 gene||mlh1 gene analysis promoter methylation analysis||expanded_form_of
troponin i.cardiac [presence] in serum, plasma or blood by rapid immunoassay||troponin i.cardiac [presence] in serum, plasma or blood by rapid immunoassay||expanded_form_of
medical and surgical @ heart and great vessels @ supplement @ papillary muscle @ percutaneous @ synthetic substitute @ no qualifier||medical and surgical @ heart and great vessels @ supplement @ papillary muscle @ percutaneous @ synthetic substitute @ no qualifier||expanded_form_of
medical and surgical @ upper arteries @ dilation @ hand artery, left @ percutaneous endoscopic @ intraluminal device, two @ no qualifier||dilation of left hand artery with two intraluminal devices, percutaneous endoscopic approach||expanded_form_of
other injury of intrinsic muscle, fascia and tendon of left middle finger at wrist and hand level, subsequent encounter||other injury of intrinsic muscle, fascia and tendon of left middle finger at wrist and hand level, subsequent encounter||expanded_form_of
transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes||transesoph doppl cardiac mon||expanded_form_of
neurodevelopmental disorder with visual defects and brain anomalies||nedviba||expanded_form_of
medical and surgical @ lymphatic and hemic systems @ drainage @ lymphatic, right axillary @ via natural or artificial opening endoscopic @ no device @ no qualifier||medical and surgical @ lymphatic and hemic systems @ drainage @ lymphatic, right axillary @ via natural or artificial opening endoscopic @ no device @ no qualifier||expanded_form_of
unspecified injury of axillary artery, left side, subsequent encounter||unsp injury of axillary artery, left side, subs encntr||expanded_form_of
[d]anorexia nos||[d]anorexia (context-dependent category)||expanded_form_of
hexacarboxylporphyrin [mass/time] in 24 hour urine||hexacarboxylporphyrin [mass/time] in 24 hour urine||expanded_form_of
sry-box transcription factor 10||sry (sex determining region y)-box 10||expanded_form_of
germ cell-specific gene 2||germ cell-specific gene 2||expanded_form_of
acetylcholine receptor binding antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||acetylcholine receptor binding antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||expanded_form_of
haemophilus influenzae a ag:prthr:pt:xxx:ord:if||haemophilus influenzae a ag:prthr:pt:xxx:ord:if||expanded_form_of
sltr-haris type iv physl fx lower end ulna, right arm, init||salter-harris type iv physeal fracture of lower end of ulna, right arm, initial encounter for closed fracture||expanded_form_of
corrosion of second degree of right lower leg, init encntr||corrosion of second degree of right lower leg, initial encounter||expanded_form_of
insertion of infusion device into left elbow region, percutaneous approach||medical and surgical @ anatomical regions, upper extremities @ insertion @ elbow region, left @ percutaneous @ infusion device @ no qualifier||expanded_form_of
physical rehabilitation and diagnostic audiology @ rehabilitation @ speech assessment @ none @ voice prosthetic @ other equipment @ none||physical rehabilitation and diagnostic audiology @ rehabilitation @ speech assessment @ none @ voice prosthetic @ other equipment @ none||expanded_form_of
male reproductive system, dilation||male reproductive system, dilation||expanded_form_of
primary coccygectomy (procedure)||primary coccygectomy (treatment)||expanded_form_of
partial traumatic metacarpophalangeal amputation of right ring finger, initial encounter||partial traumatic mcp amputation of right ring finger, init||expanded_form_of
fetal heart r-r duration us||fet hrt r-r dur us.meas||expanded_form_of
chromium/creatinine:srto:pt:urine:qn||chromium/creatinine [molar ratio] in urine||expanded_form_of
insert infusion dev in l peroneal art, perc endo||medical and surgical @ lower arteries @ insertion @ peroneal artery, left @ percutaneous endoscopic @ infusion device @ no qualifier||expanded_form_of
medical and surgical @ respiratory system @ drainage @ lung, right @ percutaneous @ no device @ no qualifier||drainage of right lung, percutaneous approach||expanded_form_of
extirpation of matter from r peroneal art, open approach||medical and surgical @ lower arteries @ extirpation @ peroneal artery, right @ open @ no device @ no qualifier||expanded_form_of
dilation of abdominal aorta with three drug-eluting intraluminal devices, percutaneous endoscopic approach||dilation of abdominal aorta with three drug-eluting intraluminal devices, percutaneous endoscopic approach||expanded_form_of
tlk1ps||tlk1p||expanded_form_of
glutathione s-transferase mu 3||brain gst||expanded_form_of
drainage of left lower extremity with drainage device, open approach||drainage of left lower extremity with drainage device, open approach||expanded_form_of
medical and surgical @ upper arteries @ bypass @ radial artery, right @ open @ autologous venous tissue @ lower arm artery, right||bypass right radial artery to right lower arm artery with autologous venous tissue, open approach||expanded_form_of
release left neck muscle, percutaneous endoscopic approach||release left neck muscle, percutaneous endoscopic approach||expanded_form_of
supplement right toe phalangeal joint with autologous tissue substitute, open approach||medical and surgical @ lower joints @ supplement @ toe phalangeal joint, right @ open @ autologous tissue substitute @ no qualifier||expanded_form_of
medical and surgical @ ear, nose, sinus @ excision @ sphenoid sinus, right @ via natural or artificial opening endoscopic @ no device @ diagnostic||medical and surgical @ ear, nose, sinus @ excision @ sphenoid sinus, right @ via natural or artificial opening endoscopic @ no device @ diagnostic||expanded_form_of
ranbp2||ran binding protein 2||expanded_form_of
were the glasses or contact lenses prescribed for astigmatism:finding:to identify measures at a point in time:^patient:ordinal:phenx||were the glasses or contact lenses prescribed for astigmatism:find:pt:^patient:ord:phenx||expanded_form_of
medical and surgical @ upper veins @ drainage @ subclavian vein, right @ percutaneous @ drainage device @ no qualifier||drainage of right subclavian vein with drainage device, percutaneous approach||expanded_form_of
medical and surgical @ upper joints @ drainage @ metacarpophalangeal joint, left @ percutaneous @ no device @ diagnostic||drainage of l metacarpophal jt, perc approach, diagn||expanded_form_of
ng31||c6orf25||expanded_form_of
cytochrome c oxidase subunit 6b1 pseudogene 7||cytochrome c oxidase subunit vib polypeptide 1 (ubiquitous) pseudogene 7||expanded_form_of
trna-val (cac) 10-1||transfer rna valine 38 (anticodon cac)||expanded_form_of
medical and surgical @ anatomical regions, upper extremities @ inspection @ upper arm, left @ external @ no device @ no qualifier||medical and surgical @ anatomical regions, upper extremities @ inspection @ upper arm, left @ external @ no device @ no qualifier||expanded_form_of
laceration of axillary artery, unspecified side, subs encntr||laceration of axillary artery, unspecified side, subsequent encounter||expanded_form_of
excision of bilateral spermatic cords, percutaneous endoscopic approach, diagnostic||excision of bi sperm cord, perc endo approach, diagn||expanded_form_of
specimen volume:volume:18 hours:urine:quantitative||specimen volume (18h u)||expanded_form_of
other bursal cyst, left hand||other bursal cyst, left hand||expanded_form_of
destruction of left knee joint, open approach||medical and surgical @ lower joints @ destruction @ knee joint, left @ open @ no device @ no qualifier||expanded_form_of
hydrogel dsg<=16 sq in||gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing||expanded_form_of
stick/puncture w bld contam object||stick or puncture with a needle or other object contaminated with blood:finding:to identify measures at a point in time:^patient:nominal||expanded_form_of
cyclophosphamide/doxorubicin/prednisone/teniposide||cics||expanded_form_of
hla-dw16 ql (bld/tiss)||hla-dw16 [presence]||expanded_form_of
gata2 gene full mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:sequencing||gata2 gene full mutation analysis:find:pt:bld/tiss:doc:sequencing||expanded_form_of
medical and surgical @ lower joints @ removal @ ankle joint, left @ open @ autologous tissue substitute @ no qualifier||medical and surgical @ lower joints @ removal @ ankle joint, left @ open @ autologous tissue substitute @ no qualifier||expanded_form_of
destruction of right lower leg muscle, percutaneous endoscopic approach||destruction of right lower leg muscle, perc endo approach||expanded_form_of
excision of nasal mucosa and soft tissue, open approach, diagnostic||excision of nose sft tiss, open approach, diagn||expanded_form_of
bypass left popliteal artery to foot artery with autologous arterial tissue, percutaneous endoscopic approach||bypass l popl art to foot art w autol art, perc endo||expanded_form_of
family with sequence similarity 170, member a||fam170a gene||expanded_form_of
cyclophosphamide/daunorubicin/dexamethasone/vincristine||ctx/dm/dnr/vcr||expanded_form_of
drainage of right lower lobe bronchus, open approach, diagn||drainage of right lower lobe bronchus, open approach, diagn||expanded_form_of
cltx thigh fx w/mnpj||closed tx femoral fracture prox head w/manj||expanded_form_of
bypass l com iliac art to abd aorta, perc endo approach||bypass left common iliac artery to abdominal aorta, percutaneous endoscopic approach||expanded_form_of
plexin a2||plexin a2||expanded_form_of
excision of sacrum, percutaneous endoscopic approach, diagn||medical and surgical @ lower bones @ excision @ sacrum @ percutaneous endoscopic @ no device @ diagnostic||expanded_form_of
walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat||walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat||expanded_form_of
xg sup(a) ab serpl ql||xg^a antibody:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal||expanded_form_of
eno1p2||eno1p2||expanded_form_of
supplement ventricular septum with nonautologous tissue substitute, percutaneous endoscopic approach||medical and surgical @ heart and great vessels @ supplement @ ventricular septum @ percutaneous endoscopic @ nonautologous tissue substitute @ no qualifier||expanded_form_of
view && views^w barium contrast oral:finding:to identify measures at a point in time:abdomen>gastrointestinal tract.upper:document:xr && radiofluoroscopy||xr abdomen and rf gastrointestinal tract upper w barium contrast po||expanded_form_of
fet/plac prob nec-unspec||other spec fetal and placental problems, affecting manag of mother, unspec as to eoc||expanded_form_of
jwh-073 butanoate ur ql cfm||jwh-073 butanoate:prthr:pt:urine:ord:confirm||expanded_form_of
nzf1||myelin transcription factor 1-like||expanded_form_of
patched domain-containing protein 2||dispatched, drosophila, homolog of, 3||expanded_form_of
ma adp bld||maximum clot strength amplitude.adenosine diphosphate induced:length:to identify measures at a point in time:whole blood:quantitative||expanded_form_of
hoxd8 gene||hoxd8||expanded_form_of
heaviness head||head heaviness||expanded_form_of
infant formula intake 24 hour measured||inf formula int 24h measured||expanded_form_of
revision of drain dev in r extraoc muscle, open approach||revision of drainage device in right extraocular muscle, open approach||expanded_form_of
patient has respiratory insufficiency||pt has resp insufficiency||expanded_form_of
linc01173||linc01173 gene||expanded_form_of
excision of left neck muscle, open approach, diagnostic||medical and surgical @ muscles @ excision @ neck muscle, left @ open @ no device @ diagnostic||expanded_form_of
nondisp fx of dist phalanx of r mid fngr, 7thk||nondisp fx of dist phalanx of r mid fngr, 7thk||expanded_form_of
person on outside of heavy transport vehicle injured in collision with pedestrian or animal in traffic accident, sequela||person on outside of heavy transport vehicle injured in collision with pedestrian or animal in traffic accident, sequela||expanded_form_of
tom1l1 gene||tom1l1||expanded_form_of
laps rpr incisional hernia ncrc8/strangulated||lap inc hern repair comp||expanded_form_of
retained (old) magnetic foreign body in iris or ciliary body, unspecified eye||retained (old) magnetic fb in iris or ciliary body, unsp eye||expanded_form_of
nondisplaced fracture of pisiform, unspecified wrist, subsequent encounter for fracture with malunion||nondisp fx of pisiform, unsp wrist, subs for fx w malunion||expanded_form_of
frostbite w tissue necros right knee and lower leg, sequela||frostbite w tissue necros right knee and lower leg, sequela||expanded_form_of
destruction of left seminal vesicle, percutaneous approach||medical and surgical @ male reproductive system @ destruction @ seminal vesicle, left @ percutaneous @ no device @ no qualifier||expanded_form_of
excision tracheal stenosis&anastomosis cervica||reconstruct windpipe||expanded_form_of
protein phosphatase 1, regulatory subunit 137||ryanodine receptor 1 (skeletal)||expanded_form_of
nondisp fx of proximal phalanx of unsp finger, init||nondisp fx of proximal phalanx of unsp finger, init||expanded_form_of
introduction of anesthetic agent into male reproductive, via natural or artificial opening endoscopic||introduction of anesthetic agent into male reprod, endo||expanded_form_of
sir2l||sirtuin (silent mating type information regulation 2 homolog) 2 (s. cerevisiae)||expanded_form_of
blister (nonthermal) of breast, right breast||blister (nonthermal) of breast, right breast||expanded_form_of
medical and surgical @ endocrine system @ repair @ adrenal gland, left @ percutaneous @ no device @ no qualifier||repair left adrenal gland, percutaneous approach||expanded_form_of
guidance for placement of clip^preoperative:finding:to identify measures at a point in time:not specified:document:{imaging modality}||guidance for placement of clip^preoperative:find:pt:xxx:doc:{imaging modality}||expanded_form_of
fracture of unspecified metatarsal bone(s), unspecified foot||fracture of unspecified metatarsal bone(s), unspecified foot||expanded_form_of
alteration of l elbow with autol sub, open approach||alteration of left elbow region with autologous tissue substitute, open approach||expanded_form_of
f5 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal||f5 gene targeted mutation analysis molgen nom (bld/tiss)||expanded_form_of
adenoid hypertrophy||adenoid; enlargement||expanded_form_of
yam-bean <pachyrhizus erosus>||pachyrhizus erosus||expanded_form_of
onc mrna 5 gen rsk urthl ca||onc mrna 5 genes ur alg risk urothelial cancer||expanded_form_of
replace of aort valve with nonaut sub, perc endo approach||replacement of aortic valve with nonautologous tissue substitute, percutaneous endoscopic approach||expanded_form_of
t vaginalis dna spec ql naa+probe||trichomonas vaginalis deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:not specified:ordinal:probe.amp.tar||expanded_form_of
aryl hydrocarbon hydroxylase||p1-450||expanded_form_of
tp53tg5||tp53 target gene 5||expanded_form_of
unsp comp fol infusion and theraputc injection, sequela||unspecified complication following infusion and therapeutic injection, sequela||expanded_form_of
lamot prtl ffd exc disc reexpl 1 ntrspc cervical||laminotomy single cervical||expanded_form_of
exp xs artif heat unsp plce||[x]exposure to excessive heat of man-made origin (event)||expanded_form_of
streptococcus pneumoniae 6a+6b antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||streptococcus pneumoniae 6a+6b antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||expanded_form_of
supplement right parietal bone with nonautologous tissue substitute, percutaneous approach||supplement r parietal bone with nonaut sub, perc approach||expanded_form_of
restriction of l face vein with extralum dev, open approach||restriction of left face vein with extraluminal device, open approach||expanded_form_of
linc01225||ldc1p||expanded_form_of
kanamycin [susceptibility] by method for slow-growing mycobacteria||kanamycin [susceptibility] by method for slow-growing mycobacteria||expanded_form_of
other nondisplaced fracture of first cervical vertebra, initial encounter for open fracture||other nondisplaced fracture of first cervical vertebra, initial encounter for open fracture||expanded_form_of
[d] raised prostatic specific antigen||[d]raised psa||expanded_form_of
dyx8||dyslexia, susceptibility to, 8||expanded_form_of
pgsf2||immunoglobulin-like domain-containing 1||expanded_form_of
dmi neuro uncntrld||diabetes mellitus juvenile type, uncontrolled, with neurological manifestations||expanded_form_of
adverse effect of antitussives, sequela||adverse effect of antitussives, sequela||expanded_form_of
inspection of left sternoclavicular joint, external approach||medical and surgical @ upper joints @ inspection @ sternoclavicular joint, left @ external @ no device @ no qualifier||expanded_form_of
pedl cyc passenger injured in clsn w oth mv nontraf, init||pedal cycle passenger injured in collision with other motor vehicles in nontraffic accident, initial encounter||expanded_form_of
mra ta||mra thoracic aorta||expanded_form_of
pde4dip gene||phosphodiesterase 4d-interacting protein||expanded_form_of
linc01160||long intergenic non-protein coding rna 1160||expanded_form_of
repair left tarsometatarsal joint, external approach||medical and surgical @ lower joints @ repair @ tarsometatarsal joint, left @ external @ no device @ no qualifier||expanded_form_of
stupor||mental status, stupor||expanded_form_of
release head lymphatic, percutaneous approach||medical and surgical @ lymphatic and hemic systems @ release @ lymphatic, head @ percutaneous @ no device @ no qualifier||expanded_form_of
chdr||aldo-keto reductase family 1, member c4||expanded_form_of
foot; mycetoma, actinomycotic||mycetoma; foot, actinomycotic||expanded_form_of
mat care/o abnr/gravd uteru||maternal care for other abnormalities of gravid uterus||expanded_form_of
other spondylosis with myelopathy, cervicothoracic region||other spondylosis with myelopathy, cervicothoracic region||expanded_form_of
dna analysis discrete sequence variation basic associated observations panel - blood or tissue by molecular genetics method||dna analysis discrete sequence variation basic associated observations panel - blood or tissue by molecular genetics method||expanded_form_of
contact with mouse||contact with mouse||expanded_form_of
toxic effect of noxious substnc eaten as food, assault, subs||toxic effect of noxious substnc eaten as food, assault, subs||expanded_form_of
prenatal counselling||prenatal counselling||expanded_form_of
radiation therapy @ central and peripheral nervous system @ other radiation @ spinal cord @ plaque radiation @ none @ none||radiation therapy @ central and peripheral nervous system @ other radiation @ spinal cord @ plaque radiation @ none @ none||expanded_form_of
specialty:type:pt:personnel:nom||specialty:type:to identify measures at a point in time:personnel:nominal||expanded_form_of
displaced oblique fracture of shaft of left ulna, subsequent encounter for open fracture type i or ii with delayed healing||displaced oblique fracture of shaft of left ulna, subsequent encounter for open fracture type i or ii with delayed healing||expanded_form_of
removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure||removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure||expanded_form_of
ophthalmol teleimaging consult note||ophthalmol teleimaging consult note||expanded_form_of
pipecolate/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||pipecolate/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||expanded_form_of
medical and surgical @ lower joints @ replacement @ hip joint, left @ open @ synthetic substitute, metal @ uncemented||medical and surgical @ lower joints @ replacement @ hip joint, left @ open @ synthetic substitute, metal @ uncemented||expanded_form_of
medical and surgical @ upper bones @ division @ humeral shaft, left @ open @ no device @ no qualifier||division of left humeral shaft, open approach||expanded_form_of
other fracture of upper end of left ulna, initial encounter for closed fracture||other fracture of upper end of left ulna, initial encounter for closed fracture||expanded_form_of
i intend to report the dementia measures group||dementia measures group||expanded_form_of
alteration of right lower leg with nonautologous tissue substitute, open approach||medical and surgical @ anatomical regions, lower extremities @ alteration @ lower leg, right @ open @ nonautologous tissue substitute @ no qualifier||expanded_form_of
traumatic compartment syndrome of abdomen (diagnosis)||trauma compart synd abd||expanded_form_of
medical and surgical @ respiratory system @ occlusion @ main bronchus, left @ open @ intraluminal device @ no qualifier||medical and surgical @ respiratory system @ occlusion @ main bronchus, left @ open @ intraluminal device @ no qualifier||expanded_form_of
mucin clot^15m post incubation:aper:pt:synv fld:ord||mucin clot [appearance] in synovial fluid qualitative --15 minutes post incubation||expanded_form_of
interval note:find:pt:{setting}:doc:{author type}||interval note||expanded_form_of
encntr for removal and reinsertion of uterin contracep dev||encntr for removal and reinsertion of uterin contracep dev||expanded_form_of
anterior displaced fracture of sternal end of right clavicle, initial encounter for open fracture||anterior displaced fracture of sternal end of right clavicle, initial encounter for open fracture||expanded_form_of
revision of drainage device in right tarsal joint, percutaneous endoscopic approach||revision of drainage device in right tarsal joint, percutaneous endoscopic approach||expanded_form_of
bypass graft, with other than vein; aortosubclavian or carotid||bypass not vein aortosubcla/carotid/innominate||expanded_form_of
acute and subacute bacterial endocarditis (disorder)||bacterial endocarditis (acute) (subacute)||expanded_form_of
poisoning by oral contraceptives, intentional self-harm, sequela||poisoning by oral contraceptives, intentional self-harm, sequela||expanded_form_of
drainage of scalp subcutaneous tissue and fascia, open approach||drainage of scalp subcu/fascia, open approach||expanded_form_of
patient survey results not available||pt surv results not avail||expanded_form_of
linc01399 gene||linc01399||expanded_form_of
removal of internal fixation device from left patella, external approach||removal of int fix from l patella, extern approach||expanded_form_of
cutaneous appendico-vesicostomy (treatment)||appendico-vesicostomy||expanded_form_of
medical and surgical @ hepatobiliary system and pancreas @ removal @ gallbladder @ open @ drainage device @ no qualifier||medical and surgical @ hepatobiliary system and pancreas @ removal @ gallbladder @ open @ drainage device @ no qualifier||expanded_form_of
cd91:arbitrary concentration:to identify measures at a point in time:leukocytes:quantitative||cd91:arbitrary concentration:to identify measures at a point in time:leukocytes:quantitative||expanded_form_of
leprecan-like 2||p3h3||expanded_form_of
exposure to sofa fire due to burning cigarette, sequela||exposure to sofa fire due to burning cigarette, sequela||expanded_form_of
nondisp suprcndl fx w intrcndl extn low end l femr, 7thn||nondisplaced supracondylar fracture with intracondylar extension of lower end of left femur, subsequent encounter for open fracture type iiia, iiib, or iiic with nonunion||expanded_form_of
capreomycin genotyping [susc]||capreomycin:susceptibility:to identify measures at a point in time:isolate:ordinal:genotyping||expanded_form_of
unsp foreign body in trachea causing other injury, sequela||unspecified foreign body in trachea causing other injury, sequela||expanded_form_of
can pronounce c:find:pt:^patient:ord:nih toolbox||can pronounce c:finding:to identify measures at a point in time:^patient:ordinal:nih toolbox||expanded_form_of
medical and surgical @ female reproductive system @ transplantation @ uterus @ open @ no device @ syngeneic||medical and surgical @ female reproductive system @ transplantation @ uterus @ open @ no device @ syngeneic||expanded_form_of
congenital complete absence of teeth||teeth; absent||expanded_form_of
stromelysin 1 pdgf-responsive element-binding protein||spre-binding protein||expanded_form_of
zmat1 gene||kiaa1789||expanded_form_of
intraoperative hemorrhage and hematoma of a genitourinary system organ or structure complicating a genitourinary system procedure||intraoperative hemorrhage and hematoma of a genitourinary system organ or structure complicating a genitourinary system procedure||expanded_form_of
cutaneous abscess of left lower limb||cutaneous abscess of left lower limb||expanded_form_of
laceration of unspecified blood vessel at forearm level, unspecified arm, sequela||lacerat unsp blood vessel at forarm lv, unsp arm, sequela||expanded_form_of
unsp injury at t2-t6 level of thoracic spinal cord, subs||unsp injury at t2-t6 level of thoracic spinal cord, subs||expanded_form_of
excision of left ovary, percutaneous endoscopic approach, diagnostic||excision of left ovary, perc endo approach, diagn||expanded_form_of
osteochondritis dissecans other site||osteochondritis dissecans of other site||expanded_form_of
medical and surgical @ female reproductive system @ dilation @ fallopian tube, right @ open @ intraluminal device @ no qualifier||medical and surgical @ female reproductive system @ dilation @ fallopian tube, right @ open @ intraluminal device @ no qualifier||expanded_form_of
urea/creatinine:srto:pt:ser/plas:qn||urea/creat serpl-srto||expanded_form_of
sys nucl med therapy of chest using phosphorus 32||systemic nuclear medicine therapy of chest using phosphorus 32 (p-32)||expanded_form_of
displacement of indwelling ureteral stent, subsequent encounter||displacement of indwelling ureteral stent, subs||expanded_form_of
release upper gingiva, percutaneous approach||medical and surgical @ mouth and throat @ release @ upper gingiva @ percutaneous @ no device @ no qualifier||expanded_form_of
lithium.plasma/lithium.rbc:mrto:pt:bld:qn||lithium.plasma/lithium.rbc [mass ratio] in blood||expanded_form_of
other specified fracture of right ischium, initial encounter for open fracture||oth fracture of right ischium, init encntr for open fracture||expanded_form_of
poisoning by unsp general anesthetics, intentional self-harm||poisoning by unspecified general anesthetics, intentional self-harm||expanded_form_of
displaced spiral fracture of shaft of humerus, left arm, subsequent encounter for fracture with nonunion||displ spiral fx shaft of humer, l arm, 7thk||expanded_form_of
medical and surgical @ lower bones @ reposition @ lower femur, right @ percutaneous endoscopic @ external fixation device @ no qualifier||medical and surgical @ lower bones @ reposition @ lower femur, right @ percutaneous endoscopic @ external fixation device @ no qualifier||expanded_form_of
can pronounce art [nih toolbox]||pronounce art nih||expanded_form_of
restriction of right internal mammary lymphatic with extraluminal device, open approach||medical and surgical @ lymphatic and hemic systems @ restriction @ lymphatic, internal mammary, right @ open @ extraluminal device @ no qualifier||expanded_form_of
other specified injury of left internal jugular vein||other specified injury of left internal jugular vein||expanded_form_of
sp100 antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal:line blot||sp100 antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal:line blot||expanded_form_of
views^w weight:finding:to identify measures at a point in time:upper extremity.bilateral>acromioclavicular joint:document:xr||views^w weight:finding:to identify measures at a point in time:upper extremity.bilateral>acromioclavicular joint:document:xr||expanded_form_of
brix1||brx1, biogenesis of ribosomes, homolog (s. cerevisiae)||expanded_form_of
bengn carcinoid oth site||benign carcinoid tumor of other sites||expanded_form_of
xr wrist-l views||views:finding:to identify measures at a point in time:upper extremity.left>wrist:document:xr||expanded_form_of
inj r int carotid, intcr w loc >24 hr w ret consc lev, subs||inj r int carotid, intcr w loc >24 hr w ret consc lev, subs||expanded_form_of
aspiration curettage following delivery or abortion||aspiration curettage following delivery or abortion||expanded_form_of
medical and surgical @ lymphatic and hemic systems @ extraction @ lymphatic, right lower extremity @ percutaneous @ no device @ diagnostic||extraction of right lower extremity lymphatic, percutaneous approach, diagnostic||expanded_form_of
spinal enthesopathy of lumbar region (diagnosis)||spinal enthesopathy of lumbar region||expanded_form_of
organic anion transporter 1b1||slc21a6, formerly||expanded_form_of
tmem123||porimin||expanded_form_of
pentobarbital [mass/mass] in stool||pentobarbital:mcnt:pt:stool:qn||expanded_form_of
pressure ulcer of right heel (diagnosis)||pressure ulcer of right heel||expanded_form_of
crushing injury of left ring finger, subsequent encounter||crushing injury of left ring finger, subsequent encounter||expanded_form_of
atazanavir confirm (csf) [mass/vol]||atazanavir csf cfm-mcnc||expanded_form_of
medical and surgical @ gastrointestinal system @ drainage @ small intestine @ via natural or artificial opening @ drainage device @ no qualifier||drainage of small intestine with drain dev, via opening||expanded_form_of
tricyclic antidepressants [presence] in blood by screen method||tricyclic antidepressants:presence or threshold:to identify measures at a point in time:whole blood:ordinal:screen||expanded_form_of
uterine art emb w coils||uterine art emb w coils||expanded_form_of
low dose rate (ldr) brachytherapy of prostate using cesium 137 (cs-137)||radiation therapy @ male reproductive system @ brachytherapy @ prostate @ low dose rate (ldr) @ cesium 137 (cs-137) @ none||expanded_form_of
period, drosophila, homolog of||per||expanded_form_of
how quickly after this loss of sleep, do you return to your usual self if you are allowed to sleep as much as you like [phenx]||how quickly after this loss of sleep, do you return to your usual self if you are allowed to sleep as much as you like:time:pt:^patient:qn:phenx||expanded_form_of
defic dis dihydropteridine reductase||deficiency disease, dihydropteridine reductase||expanded_form_of
internal fixation of bone without fracture reduction, humerus||internal fixation of bone without fracture reduction, humerus||expanded_form_of
bypass right common carotid artery to left extracranial artery with autologous venous tissue, open approach||bypass r com carotid to l extracran art w autol vn, open||expanded_form_of
other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema||other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema||expanded_form_of
cortisol^11th specimen post xxx challenge:scnc:pt:ser/plas:qn||cortisol^11th specimen post xxx challenge:scnc:pt:ser/plas:qn||expanded_form_of
excision of inferior vena cava, open approach, diagnostic||excision of inferior vena cava, open approach, diagnostic||expanded_form_of
monoplegia of lower limb affecting dominant side||monplga lwr lmb dmnt sde||expanded_form_of
medical and surgical @ female reproductive system @ release @ vestibular gland @ open @ no device @ no qualifier||medical and surgical @ female reproductive system @ release @ vestibular gland @ open @ no device @ no qualifier||expanded_form_of
coordinated care fee, maintenance rate||mccd,maintenance rate||expanded_form_of
revision of drainage device in parathyroid gland, percutaneous endoscopic approach||medical and surgical @ endocrine system @ revision @ parathyroid gland @ percutaneous endoscopic @ drainage device @ no qualifier||expanded_form_of
medical and surgical @ upper arteries @ drainage @ thyroid artery, left @ percutaneous endoscopic @ no device @ diagnostic||drainage of left thyroid artery, perc endo approach, diagn||expanded_form_of
medical and surgical @ mouth and throat @ reposition @ lower tooth @ external @ external fixation device @ single||reposition lower tooth, single, with external fixation device, external approach||expanded_form_of
retain plastic fragments||retain plastic fragments||expanded_form_of
medical and surgical @ female reproductive system @ dilation @ uterus @ percutaneous @ intraluminal device @ no qualifier||medical and surgical @ female reproductive system @ dilation @ uterus @ percutaneous @ intraluminal device @ no qualifier||expanded_form_of
inflation phase duration:time:pt:ventilator:qn||inflation phase duration:time:to identify measures at a point in time:ventilator:quantitative||expanded_form_of
imaging @ axial skeleton, except skull and facial bones @ plain radiography @ cervical disc(s) @ none @ none @ none||plain radiography of cervical disc(s)||expanded_form_of
anti human globulin test, direct||anti human globulin test technique, direct (qualifier value)||expanded_form_of
repair bilateral spermatic cords, percutaneous approach||repair bilateral spermatic cords, percutaneous approach||expanded_form_of
other mechanical complication of infusion catheter||other mechanical complication of infusion catheter||expanded_form_of
computerized tomography (ct scan) of left calcaneus using high osmolar contrast||ct scan of l calcaneus using h osm contrast||expanded_form_of
insertion of interspinous process spinal stabilization device into thoracolumbar vertebral joint, percutaneous endoscopic approach||insert intspin prcs stabl dev in t-lum jt, perc endo||expanded_form_of
medical and surgical @ urinary system @ excision @ kidney, left @ percutaneous endoscopic @ no device @ diagnostic||excision of left kidney, perc endo approach, diagn||expanded_form_of
bypass thoracic aorta, descending to subclavian with autologous venous tissue, percutaneous endoscopic approach||medical and surgical @ heart and great vessels @ bypass @ thoracic aorta, descending @ percutaneous endoscopic @ autologous venous tissue @ subclavian||expanded_form_of
bypass r axilla vein to up vein w nonaut sub, perc endo||bypass right axillary vein to upper vein with nonautologous tissue substitute, percutaneous endoscopic approach||expanded_form_of
bypass duodenum to ileum with nonaut sub, perc endo approach||bypass duodenum to ileum with nonautologous tissue substitute, percutaneous endoscopic approach||expanded_form_of
medical and surgical @ ear, nose, sinus @ resection @ nasopharynx @ via natural or artificial opening @ no device @ no qualifier||resection of nasopharynx, via natural or artificial opening||expanded_form_of
clostridium perfringens [c. perfringens] as the cause of diseases classified elsewhere||clostridium perfringens causing diseases classd elswhr||expanded_form_of
four-and-a-half lim domains 3||four and a half lim domains 3||expanded_form_of
insertion of internal fixation device into right toe phalangeal joint, percutaneous endoscopic approach||insertion of internal fixation device into right toe phalangeal joint, percutaneous endoscopic approach||expanded_form_of
personal history of other malignant neoplasm of bronchus and lung||hx-bronchogenic malignan||expanded_form_of
bradykinin (protein) level||bradykinin||expanded_form_of
ct wrist-l wo contr||multisection^wo contrast:find:pt:upper extremity.left>wrist:doc:ct||expanded_form_of
burn of unspecified degree of chest wall, initial encounter||burn of unspecified degree of chest wall, initial encounter||expanded_form_of
dilation of left subclavian artery with three drug-eluting intraluminal devices, percutaneous endoscopic approach||dilate of l subclav art with 3 drug-elut, perc endo approach||expanded_form_of
encounter for examination of eyes and vision following failed vision screening without abnormal findings||enctr for ex of eyes and vis fol fail vis scrn w/o abn find||expanded_form_of
osteopathic treatment of lumbar region using indirect forces||osteopathic @ anatomical regions @ treatment @ lumbar @ external @ indirect @ none||expanded_form_of
subtalar arthro w/fb rmvl||arthrs subtalar joint remove loose/foreign body||expanded_form_of
revision of other device in left breast, open approach||revision of other device in left breast, open approach||expanded_form_of
schistosoma sp ab.igg:acnc:pt:ser:qn:ia||schistosoma sp antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immunoassay||expanded_form_of
nondisp fx of dist phalanx of unsp less toe(s), 7thg||nondisplaced fracture of distal phalanx of unspecified lesser toe(s), subsequent encounter for fracture with delayed healing||expanded_form_of
recurrence distant site 3 cancer||recurrence distant site 3:prid:pt:cancer.xxx:nom||expanded_form_of
drainage of common hepatic duct, perc endo approach, diagn||drainage of common hepatic duct, percutaneous endoscopic approach, diagnostic||expanded_form_of
other disorders of external ear in diseases classified elsewhere, bilateral||other disorders of external ear in diseases classified elsewhere, bilateral||expanded_form_of
cmh2||familial hypertrophic cardiomyopathy type 2||expanded_form_of
pear poln ige qn||pyrus communis pollen antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||expanded_form_of
kanamycin 6 ug/ml [susceptibility] by method for slow-growing mycobacteria||kanamycin 6 ug/ml [susceptibility] by method for slow-growing mycobacteria||expanded_form_of
medical and surgical @ tendons @ supplement @ hip tendon, right @ open @ autologous tissue substitute @ no qualifier||supplement right hip tendon with autol sub, open approach||expanded_form_of
plain radiography of right single mammary duct using high osmolar contrast||plain radiography of right single mammary duct using high osmolar contrast||expanded_form_of
other complications specific to multiple gestation, unspecified trimester, other fetus||other complications specific to multiple gestation, unspecified trimester, other fetus||expanded_form_of
amiloride [mass/volume] in serum or plasma||amiloride:mcnc:pt:ser/plas:qn||expanded_form_of
bypass abd aorta to b int ilia w autol vn, perc endo||bypass abd aorta to b int ilia w autol vn, perc endo||expanded_form_of
other sprain of right index finger, initial encounter||other sprain of right index finger, initial encounter||expanded_form_of
unstable burst fracture of unspecified lumbar vertebra, sequela||unstable burst fracture of unsp lumbar vertebra, sequela||expanded_form_of
streptococcus pneumoniae 4 antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||streptococcus pneumoniae 4 antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||expanded_form_of
fee covid-19 vac 8 booster||fee covid-19 vac 8 booster||expanded_form_of
bypass r kidney pelvis to ileocutan w nonaut sub, perc endo||medical and surgical @ urinary system @ bypass @ kidney pelvis, right @ percutaneous endoscopic @ nonautologous tissue substitute @ ileocutaneous||expanded_form_of
insertion of infusion device into left hand artery, open approach||medical and surgical @ upper arteries @ insertion @ hand artery, left @ open @ infusion device @ no qualifier||expanded_form_of
fluoroscopy of r pelvic vein using l osm contrast, guidance||fluoroscopy of right pelvic (iliac) veins using low osmolar contrast, guidance||expanded_form_of
erythrocytes:ncnc:pt:pericard fld:qn||rbc # pcar||expanded_form_of
medical and surgical @ upper arteries @ dilation @ ulnar artery, left @ percutaneous @ intraluminal device, two @ no qualifier||medical and surgical @ upper arteries @ dilation @ ulnar artery, left @ percutaneous @ intraluminal device, two @ no qualifier||expanded_form_of
for unfair reasons, have you ever not been hired for a job:find:pt:^patient:ord:phenx||for unfair reasons, have you ever not been hired for a job:find:pt:^patient:ord:phenx||expanded_form_of
fla17||jbts11||expanded_form_of
znf663p gene||znf663||expanded_form_of
introduction of anti-inflammatory into lymph, perc approach||administration @ physiological systems and anatomical regions @ introduction @ lymphatics @ percutaneous @ anti-inflammatory @ no qualifier||expanded_form_of
tp53tg3 gene||p53tg3||expanded_form_of
infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], immunochemiluminometric assay [imca]), qualitative or semiquantitative; multiple-step method, not otherwise specified, each organism||infectious agent antigen detection by enzyme immunoassay , multiple steps||expanded_form_of
displaced avulsion fracture of unspecified ilium, subsequent encounter for fracture with routine healing||displaced avulsion fracture of unspecified ilium, subsequent encounter for fracture with routine healing||expanded_form_of
c. trachomatis+n. gonorrhoeae dna naa+probe ql (cvx)||chlamydia trachomatis+neisseria gonorrhoeae deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:cervix:ordinal:probe.amp.tar||expanded_form_of
cmtm8 gene||cklf like marvel transmembrane domain containing 8||expanded_form_of
oth ultralt/microlt/pwr-glider accident injuring occupant||other ultralight, microlight or powered-glider accident injuring occupant||expanded_form_of
calculus of gb and bile duct w acute cholecyst w obstruction||calculus of gallbladder and bile duct with acute cholecystitis with obstruction||expanded_form_of
other subluxation of right knee (diagnosis)||subluxation knee joint other right||expanded_form_of
diverticulosis of small intestine without perforation or abscess with bleeding||dvrtclos of sm int w/o perforation or abscess w bleeding||expanded_form_of
golga2 pseudogene 9||golga2p9 gene||expanded_form_of
vocal cord and pharyngeal dysfunction with distal myopathy, formerly||myopathy, distal, 2, formerly||expanded_form_of
drainage of left axillary artery, percutaneous approach, diagnostic||medical and surgical @ upper arteries @ drainage @ axillary artery, left @ percutaneous @ no device @ diagnostic||expanded_form_of
asthma symptoms evaluate||asthma symptoms evaluated||expanded_form_of
removal of drainage device from right eye, external approach||removal of drainage device from right eye, external approach||expanded_form_of
pimelate/creat ur-srto||pimelate/creatinine [molar ratio] in urine||expanded_form_of
probable rna polymerase ii nuclear localization protein slc7a6os||solute carrier family 7 member 6 opposite strand||expanded_form_of
transfer median nerve to ulnar nerve, percutaneous endoscopic approach||medical and surgical @ peripheral nervous system @ transfer @ median nerve @ percutaneous endoscopic @ no device @ ulnar nerve||expanded_form_of
open biopsy of thyroid gland||open biopsy of thyroid gland||expanded_form_of
methadone cutoff [mass/volume] in urine for confirmatory method||methadone cutoff [mass/volume] in urine for confirmatory method||expanded_form_of
annual evaluation note:finding:to identify measures at a point in time:outpatient:document:spinal cord injury medicine||spinal cord injury medicine outpatient annual evaluation note||expanded_form_of
medical and surgical @ central nervous system and cranial nerves @ release @ accessory nerve @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ central nervous system and cranial nerves @ release @ accessory nerve @ percutaneous endoscopic @ no device @ no qualifier||expanded_form_of
mtnd5p40 gene||mtnd5p40 gene||expanded_form_of
supplement left trunk tendon with nonaut sub, open approach||supplement left trunk tendon with nonautologous tissue substitute, open approach||expanded_form_of
bypass stomach to ileum with synthetic substitute, endo||bypass stomach to ileum with synthetic substitute, endo||expanded_form_of
skin test; unlisted antigen, each||skin test; unlisted antigen, each||expanded_form_of
leg inflamed due to varicose veins||varicose veins;inflamed;leg||expanded_form_of
destruction of right vertebral vein, perc endo approach||destruction of right vertebral vein, perc endo approach||expanded_form_of
cd13+hla-dr+ cells/100 cells in specimen||cd13+hla-dr+ cells/100 cells (specimen)||expanded_form_of
revision of nonautologous tissue substitute in mediastinum, external approach||revision of nonaut sub in mediastinum, extern approach||expanded_form_of
release head and neck bursa and ligament, open approach||medical and surgical @ bursae and ligaments @ release @ head and neck bursa and ligament @ open @ no device @ no qualifier||expanded_form_of
unspecified open wound of unspecified part of thorax||unspecified open wound of unspecified part of thorax||expanded_form_of
insertion of spacer into left metacarpophalangeal joint, open approach||insertion of spacer into left metacarpophalangeal joint, open approach||expanded_form_of
trimipramine:mass concentration:to identify measures at a point in time:gastric fluid/contents:quantitative||trimipramine:mass concentration:to identify measures at a point in time:gastric fluid/contents:quantitative||expanded_form_of
stroke volume:volume:to identify measures at a point in time:heart.ventricle.left:quantitative:computed tomography spiral||lv sv spiral ct||expanded_form_of
dilation of left subclavian artery with four or more drug-eluting intraluminal devices, percutaneous approach||dilation of left subclavian artery with four or more drug-eluting intraluminal devices, percutaneous approach||expanded_form_of
nondisplaced fracture of capitate bone of right wrist (diagnosis)||nondisplaced fracture of capitate bone of right wrist (diagnosis)||expanded_form_of
resection of thoracic vertebral disc, open approach||medical and surgical @ upper joints @ resection @ thoracic vertebral disc @ open @ no device @ no qualifier||expanded_form_of
medical and surgical @ central nervous system and cranial nerves @ extraction @ cerebral hemisphere @ open @ no device @ no qualifier||medical and surgical @ central nervous system and cranial nerves @ extraction @ cerebral hemisphere @ open @ no device @ no qualifier||expanded_form_of
unsp fb in oth prt resp tract causing oth injury, subs||unsp fb in oth prt resp tract causing oth injury, subs||expanded_form_of
formimidoyltransferase cyclodeaminase||ftcd gene||expanded_form_of
medical and surgical @ male reproductive system @ excision @ testis, right @ open @ no device @ diagnostic||excision of right testis, open approach, diagnostic||expanded_form_of
nek6||nek6 gene||expanded_form_of
coxsackievirus b5 ab:acnc:pt:body fld:qn||cv b5 ab fld-acnc||expanded_form_of
tid17||insulin-dependent diabetes mellitus 17||expanded_form_of
injection, belatacept, 1 mg administered||belatacept injection||expanded_form_of
release right lower arm and wrist muscle, perc approach||release right lower arm and wrist muscle, perc approach||expanded_form_of
b igm [titer]||b igm [titer]||expanded_form_of
qt interval:time:pt:lead avf:qn:ekg||qt interval:time:pt:lead avf:qn:ekg||expanded_form_of
rnu6atac21p||rnu6atac21p gene||expanded_form_of
person on outside of special agricult veh inj in trff acc||[x]person on outside of special agricult veh inj in trff acc||expanded_form_of
toxic effect of other corrosive organic compounds, undetermined, initial encounter||toxic effect of corrosive organic compounds, undet, init||expanded_form_of
replacement of left lower leg subcutaneous tissue and fascia with nonautologous tissue substitute, percutaneous approach||replace l low leg subcu/fascia w nonaut sub, perc||expanded_form_of
breaths^pre cardioversion:number=count/time:to identify measures at a point in time:respiratory system:quantitative||respiratory rate --pre cardioversion||expanded_form_of
prolapse; female||female genital prolapse||expanded_form_of
igd [units/volume] in serum||immunoglobulin d:arbitrary concentration:to identify measures at a point in time:serum:quantitative||expanded_form_of
ifn-alphad||ifn||expanded_form_of
chronic irreversible airway obstruction||chronic obstructive lung dis||expanded_form_of
johanson-blizzard syndrome (jbs)||johanson-blizzard syndrome (jbs)||expanded_form_of
ggt4p gene||gamma-glutamyltransferase 4 pseudogene||expanded_form_of
supplement right neck muscle with nonautologous tissue substitute, open approach||supplement right neck muscle with nonautologous tissue substitute, open approach||expanded_form_of
gprc5d-as1||gprc5d-as1 gene||expanded_form_of
poisoning by cannabis, assault, subsequent encounter||poisoning by cannabis, assault, subsequent encounter||expanded_form_of
xr knee - bilateral oblique views||views oblique:find:pt:lower extremity.bilateral>knee:doc:xr||expanded_form_of
rbc osmotic fragility||osmotic fragility rbc incubated||expanded_form_of
micronychia||micronychia||expanded_form_of
nadh dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kda||nadh-ubiquinone oxidoreductase 1 alpha subcomplex 2||expanded_form_of
removal of cast on left thumb||placement @ anatomical regions @ removal @ thumb, left @ external @ cast @ no qualifier||expanded_form_of
atriplex lentiformis ab.igg4:mcnc:pt:ser:qn||atriplex lentiformis ab.igg4:mcnc:pt:ser:qn||expanded_form_of
dibenzepin (bld) [mass/vol]||dibenzepin:mass concentration:to identify measures at a point in time:whole blood:quantitative||expanded_form_of
unspecified open wound, left thigh||unspecified open wound, left thigh||expanded_form_of
person outside special industr vehicle inj nontraf, sequela||person outside special industr vehicle inj nontraf, sequela||expanded_form_of
plain radiography of right lower extremity arteries using other contrast||imaging @ lower arteries @ plain radiography @ lower extremity arteries, right @ other contrast @ none @ none||expanded_form_of
transfer facial muscle with skin, open approach||transfer facial muscle with skin, open approach||expanded_form_of
pnctr of abd wall w/o fb, right lower q w/o penet perit cav||pnctr of abd wall w/o fb, right lower q w/o penet perit cav||expanded_form_of
oth place in children's home and orphanage as place||other place in children's home and orphanage as the place of occurrence of the external cause||expanded_form_of
nondisplaced fracture of trapezoid [smaller multangular], right wrist, subsequent encounter for fracture with malunion||nondisplaced fracture of trapezoid [smaller multangular], right wrist, subsequent encounter for fracture with malunion||expanded_form_of
partial traumatic metacarpophalangeal amputation of right thumb, subsequent encounter||partial traumatic mcp amputation of right thumb, subs||expanded_form_of
medical and surgical @ respiratory system @ excision @ lung, right @ open @ no device @ no qualifier||medical and surgical @ respiratory system @ excision @ lung, right @ open @ no device @ no qualifier||expanded_form_of
medical and surgical @ lower veins @ dilation @ external iliac vein, right @ percutaneous @ no device @ no qualifier||dilation of right external iliac vein, percutaneous approach||expanded_form_of
fca fract 3h p 300 ug cln po plas-mcnc||catecholamines free fractionated [mass/volume] in plasma --3 hours post 300 ug clonidine po||expanded_form_of
destruction;cardiovascular||destruction (cardiovascular)||expanded_form_of
other disorders of synovium and tendon||other disorders of synovium and tendon||expanded_form_of
other appendix diseases nos||other diseases of appendix nos||expanded_form_of
dcf/gm-csf||dcf/gm-csf||expanded_form_of
radiation therapy @ gastrointestinal system @ beam radiation @ rectum @ electrons @ none @ intraoperative||beam radiation of rectum using electrons, intraoperative||expanded_form_of
immunoglobulin light chains.lambda (u) [mass/vol]||lambda lc ur-mcnc||expanded_form_of
airway temperature||body temperature:temp:pt:respiratory system.airway:qn||expanded_form_of
phc2 antisense rna 1||phc2-as1 gene||expanded_form_of
medical and surgical @ upper bones @ revision @ thumb phalanx, left @ external @ external fixation device @ no qualifier||medical and surgical @ upper bones @ revision @ thumb phalanx, left @ external @ external fixation device @ no qualifier||expanded_form_of
lymphoma panel - specimen by flow cytometry (fc)||lymphoma pnl spec fc||expanded_form_of
stenosis degree:find:pt:pulmonic valve:ord:us||pv sten deg us||expanded_form_of
chronic or unspecified gastrojejunal ulcer with hemorrhage and perforation, without mention of obstruction||chr margin ulc hem/perf||expanded_form_of
jc virus dna:prthr:pt:csf:ord:probe.amp.tar||jc virus dna:prthr:pt:csf:ord:probe.amp.tar||expanded_form_of
adp ribosylation factor like gtpase 4a pseudogene 5||adp ribosylation factor like gtpase 4a pseudogene 5||expanded_form_of
supplement right tympanic membrane with autol sub, endo||supplement right tympanic membrane with autol sub, endo||expanded_form_of
kaiso||zbtb33||expanded_form_of
cyclin-dependent kinase 5, regulatory subunit 2||cyclin-dependent kinase 5, regulatory subunit 2 (p39)||expanded_form_of
rheumatoid myopathy with rheumatoid arthritis of unspecified hip||rheumatoid myopathy with rheumatoid arthritis of unsp hip||expanded_form_of
other spec.gallbladder disord.||other specified disorders of gallbladder||expanded_form_of
derangement of anterior horn of medial meniscus due to old tear or injury, unspecified knee||derang of ant horn of med mensc d/t old tear/inj, unsp knee||expanded_form_of
reposition right thorax tendon, open approach||medical and surgical @ tendons @ reposition @ thorax tendon, right @ open @ no device @ no qualifier||expanded_form_of
other chronic hematogenous osteomyelitis, femur||other chronic hematogenous osteomyelitis, femur||expanded_form_of
excision of thalamus, percutaneous approach, diagnostic||excision of thalamus, percutaneous approach, diagnostic||expanded_form_of
medical and surgical @ gastrointestinal system @ supplement @ transverse colon @ via natural or artificial opening @ nonautologous tissue substitute @ no qualifier||medical and surgical @ gastrointestinal system @ supplement @ transverse colon @ via natural or artificial opening @ nonautologous tissue substitute @ no qualifier||expanded_form_of
medical and surgical @ gastrointestinal system @ excision @ jejunum @ via natural or artificial opening @ no device @ no qualifier||excision of jejunum, via natural or artificial opening||expanded_form_of
psmd10 gene||gankyrin||expanded_form_of
drip36||mediator complex subunit 4||expanded_form_of
acute gastroenteropathy due to norwalk agent||acute gastroenteropathy due to norwalk agent (diagnosis)||expanded_form_of
oth fracture of l low leg, subs for clos fx w delay heal||other fracture of left lower leg, subsequent encounter for closed fracture with delayed healing||expanded_form_of
oth transport vehicle as place||other transport vehicle as the place of occurrence of the external cause||expanded_form_of
flrt2 gene||flrt2 gene||expanded_form_of
burn of wrist (physical finding)||burn of wrist||expanded_form_of
radiation therapy @ lymphatic and hematologic system @ stereotactic radiosurgery @ spleen @ stereotactic other photon radiosurgery @ none @ none||stereotactic other photon radiosurgery of spleen||expanded_form_of
basal ganglia calcification, idiopathic, 3, formerly||basal ganglia calcification, idiopathic, 1||expanded_form_of
male reproductive system, resection||medical and surgical @ male reproductive system @ resection||expanded_form_of
multisection^w contrast ia:find:pt:chest>pulmonary arteries.bilateral:doc:mr.angio||multisection^w contrast ia:find:pt:chest>pulmonary arteries.bilateral:doc:mr.angio||expanded_form_of
medical and surgical @ upper bones @ removal @ carpal, left @ percutaneous endoscopic @ nonautologous tissue substitute @ no qualifier||removal of nonautologous tissue substitute from left carpal, percutaneous endoscopic approach||expanded_form_of
rondeletia bicolor||rondeletia bicolor goode & bean, 1895||expanded_form_of
decubitus ulcer (specify)||sore; pressure||expanded_form_of
microdissection prep identified target laser||microdissection laser||expanded_form_of
st13p12 gene||st13p12||expanded_form_of
echovirus 30 antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative:virus neutralization||echovirus 30 ab [units/volume] in serum by neutralization test||expanded_form_of
barriers to self management:finding:point in time:^patient:ordinal||barriers to self management:finding:point in time:^patient:ordinal||expanded_form_of
rfa ic+neck ves views w contr||views^w contrast:find:pt:head>intracranial vessel & neck>neck vessel:doc:rf.angio||expanded_form_of
tbc1d23||tbc1 domain family, member 23||expanded_form_of
revision of short-term external heart assist system in heart, percutaneous approach||medical and surgical @ heart and great vessels @ revision @ heart @ percutaneous @ short-term external heart assist system @ no qualifier||expanded_form_of
introduce low dose il-2 in epidural space, perc||introduce low dose il-2 in epidural space, perc||expanded_form_of
stent placemt retro carotid||stent placemt retro carotid||expanded_form_of
hdr brachytherapy of cervix using iridium 192||hdr brachytherapy of cervix using iridium 192||expanded_form_of
revision of infusion device in cereb vent, extern approach||revision of infusion device in cereb vent, extern approach||expanded_form_of
extirpation of matter from left hepatic duct, percutaneous endoscopic approach||extirpation of matter from left hepatic duct, percutaneous endoscopic approach||expanded_form_of
medical and surgical @ urinary system @ repair @ bladder @ open @ no device @ no qualifier||repair bladder, open approach||expanded_form_of
ascc1 gene||ascc1 gene||expanded_form_of
monoplg upr lmb fol ntrm subarach hemor aff left dom side||monoplg upr lmb fol ntrm subarach hemor aff left dom side||expanded_form_of
srcin1 gene||snap25-interacting protein||expanded_form_of
small nucleolar rna, h/aca box 89||small nucleolar rna, h/aca box 89||expanded_form_of
revision of nonautologous tissue substitute in spinal cord, percutaneous approach||revision of nonautologous tissue substitute in spinal cord, percutaneous approach||expanded_form_of
phbp13 gene||phbp13||expanded_form_of
displaced spiral fracture of shaft of humerus, right arm, subsequent encounter for fracture with malunion||displaced spiral fracture of shaft of humerus, right arm, subsequent encounter for fracture with malunion||expanded_form_of
medical and surgical @ upper arteries @ extirpation @ internal carotid artery, right @ percutaneous @ no device @ stent retriever||extirpation of matter from right internal carotid artery using stent retriever, percutaneous approach||expanded_form_of
unspecified open wound of right elbow||unspecified open wound of right elbow||expanded_form_of
special teletherapy port plan, particles, hemibody, total body||special teletx port plan||expanded_form_of
collapsed vertebra, not elsewhere classified, site unspecified, subsequent encounter for fracture with routine healing||collapsed vertebra, not elsewhere classified, site unspecified, subsequent encounter for fracture with routine healing||expanded_form_of
ajcc cln cncr stage 1 docd||ajcc cln cncr stage 1 docd||expanded_form_of
catecholamines free (24h u) [mass/time]||catecholamines free [mass/time] in 24 hour urine||expanded_form_of
orotate/creatinine:ratio:pt:urine:qn||orotate/creatinine (u) [ratio]||expanded_form_of
nondisp fx of prox phalanx of thmb, subs for fx w malunion||nondisplaced fracture of proximal phalanx of unspecified thumb, subsequent encounter for fracture with malunion||expanded_form_of
medical and surgical @ heart and great vessels @ release @ thoracic aorta, ascending/arch @ open @ no device @ no qualifier||medical and surgical @ heart and great vessels @ release @ thoracic aorta, ascending/arch @ open @ no device @ no qualifier||expanded_form_of
seven in absentia, drosophila, homolog of, 3||seven in absentia homolog 3 (drosophila)||expanded_form_of
contact with prime movers, initial encounter||contact with prime movers, initial encounter||expanded_form_of
flj14502||c15orf23||expanded_form_of
adenovirus b(14) dna [presence] in specimen by naa with probe detection||adenovirus b(14) dna [presence] in specimen by naa with probe detection||expanded_form_of
umodl1-as1||umodl1-as1||expanded_form_of
amyl ether bld ql||amyl ether ql (bld)||expanded_form_of
flash conjunctivitis||flash conjunctivitis||expanded_form_of
vps34, yeast, homolog of||phosphatidylinositol 3-kinase, catalytic subunit type 3||expanded_form_of
epilepsy, pyridoxine-dependent||epd||expanded_form_of
introduction of nutritional substance into genitourinary tract, via natural or artificial opening||introduction of nutritional into gu tract, via opening||expanded_form_of
functional outcome score:score:pt:^patient:ord:gose||functional outcome score:score:to identify measures at a point in time:^patient:ordinal:gose||expanded_form_of
fasciola hepatica ab [titer] in serum by hemagglutination||fasciola hepatica ab [titer] in serum by hemagglutination||expanded_form_of
medical and surgical @ lower arteries @ insertion @ foot artery, left @ percutaneous endoscopic @ intraluminal device @ no qualifier||insertion of intraluminal device into left foot artery, percutaneous endoscopic approach||expanded_form_of
ocular laceration without prolapse or loss of intraocular tissue, unspecified eye||ocular laceration without prolapse or loss of intraocular tissue, unspecified eye||expanded_form_of
developmental and epileptic encephalopathy 23||dee23||expanded_form_of
phosphatase.leukocyte:acnc:pt:wbc:qn||leukocyte phosphatase qn (wbc)||expanded_form_of
myo9b gene||myosin ixb||expanded_form_of
drainage of lower gingiva with drainage device, percutaneous approach||drainage of lower gingiva with drainage device, percutaneous approach||expanded_form_of
dilation of abdominal aorta with two intraluminal devices, percutaneous approach||dilation of abd aorta with 2 intralum dev, perc approach||expanded_form_of
removal of skull tongs or halo traction device||removal of skull tongs or halo traction device||expanded_form_of
excision of common bile duct, via natural or artificial opening endoscopic||excision of common bile duct, via natural or artificial opening endoscopic||expanded_form_of
medical and surgical @ lower bones @ insertion @ femoral shaft, right @ percutaneous endoscopic @ external fixation device, ring @ no qualifier||insert ring ext fix in r femur shaft, perc endo||expanded_form_of
medical and surgical @ central nervous system and cranial nerves @ drainage @ accessory nerve @ open @ no device @ no qualifier||drainage of accessory nerve, open approach||expanded_form_of
excision of breast lesion identified by preoperative placement of radiological marker, open; single lesion||excision of breast lesion identified by preoperative placement of radiological marker, open; single lesion||expanded_form_of
intrapartum doula services each 60 minutes||intrapartum doula services each 60 minutes||expanded_form_of
meh||epoxide hydrolase 1, microsomal (xenobiotic)||expanded_form_of
removal of torus palatinus||removal of torus palatinus||expanded_form_of
additives preservatives hypersensitivity 16 to 30 items||additives preservatives hypersensitivity 16 to 30 items||expanded_form_of
rpl39 gene||ribosomal protein l39 pseudogene 42||expanded_form_of
medical and surgical @ gastrointestinal system @ dilation @ large intestine @ open @ intraluminal device @ no qualifier||dilation of large intestine with intralum dev, open approach||expanded_form_of
proteasome (prosome, macropain) 26s subunit, non-atpase, 7 like||psmd7l||expanded_form_of
placement @ anatomical regions @ compression @ upper leg, left @ external @ intermittent pressure device @ no qualifier||compression of left upper leg using intermittent pressure device||expanded_form_of
fusion of right ankle joint with external fixation device, percutaneous endoscopic approach||medical and surgical @ lower joints @ fusion @ ankle joint, right @ percutaneous endoscopic @ external fixation device @ no qualifier||expanded_form_of
aluminium oxide (substance)||alumina||expanded_form_of
clarithro serpl-mcnc||clarithromycin [mass/volume] in serum or plasma||expanded_form_of
medical and surgical @ gastrointestinal system @ repair @ large intestine @ open @ no device @ no qualifier||repair large intestine, open approach||expanded_form_of
corrosions of right ear drum||corrosions of right ear drum||expanded_form_of
c4st3||carbohydrate (chondroitin 4) sulfotransferase 13||expanded_form_of
medical and surgical @ peripheral nervous system @ revision @ peripheral nerve @ external @ monitoring device @ no qualifier||medical and surgical @ peripheral nervous system @ revision @ peripheral nerve @ external @ monitoring device @ no qualifier||expanded_form_of
reposition right glenoid cavity with internal fixation device, percutaneous approach||reposition right glenoid cavity with internal fixation device, percutaneous approach||expanded_form_of
lacerat blood vessels at hip and thigh level, unsp leg, init||laceration of other blood vessels at hip and thigh level, unspecified leg, initial encounter||expanded_form_of
removal of intraluminal device from kidney, percutaneous endoscopic approach||medical and surgical @ urinary system @ removal @ kidney @ percutaneous endoscopic @ intraluminal device @ no qualifier||expanded_form_of
excision of right knee region, perc endo approach||excision of right knee region, perc endo approach||expanded_form_of
injury of innominate or subclavian artery||injury to innominate and subclavian arteries||expanded_form_of
disord iron metablsm nec||other disorders of iron metabolism||expanded_form_of
pmgys||polymicrogyria with seizures||expanded_form_of
radiation therapy @ anatomical regions @ brachytherapy @ cranial cavity @ low dose rate (ldr) @ palladium 103 (pd-103) @ none||low dose rate (ldr) brachytherapy of cranial cavity using palladium 103 (pd-103)||expanded_form_of
extirpation of matter from left nipple, perc approach||extirpation of matter from left nipple, percutaneous approach||expanded_form_of
note:finding:to identify measures at a point in time:{setting}:document:licensed practical nurse||licensed practical nurse note||expanded_form_of
microorganism resistance mutation nucleic acid change:type:to identify measures at a point in time:isolate/specimen:nominal:molecular genetics||microorganism resistance mutation nucleic acid change:type:to identify measures at a point in time:isolate/specimen:nominal:molecular genetics||expanded_form_of
other foreign object in bronchus causing asphyxiation||other foreign object in bronchus causing asphyxiation||expanded_form_of
rad51 (s. cerevisiae)-like 1||rad51 (s. cerevisiae)-like 1||expanded_form_of
remove impl dev-humerus||removal of implanted device from humerus||expanded_form_of
operative ablation of ventricular arrhythmogenic focus with cardiopulmonary bypass||oprative abltj ventr arrhythmogenic foc w/bypass||expanded_form_of
restrict of l inqnl lymph with intralum dev, open approach||restriction of left inguinal lymphatic with intraluminal device, open approach||expanded_form_of
medical and surgical @ anatomical regions, upper extremities @ reattachment @ upper extremity, left @ open @ no device @ no qualifier||medical and surgical @ anatomical regions, upper extremities @ reattachment @ upper extremity, left @ open @ no device @ no qualifier||expanded_form_of
prepj& antigen allergen immunotherapy whl inse||prepj& antigen allergen immunotherapy whl inse||expanded_form_of
trna-gln (anticodon ttg) 6-1||trna-gln (anticodon ttg) 6-1||expanded_form_of
car passenger injured in collision w 2/3-whl mv in traf||car passenger injured in collision w 2/3-whl mv in traf||expanded_form_of
chromosome 5 open reading frame 7||lysine demethylase 3b gene||expanded_form_of
revision of penis||corpora cavernosa-saphenous vein shunt (priapism operation), unilateral or bilateral||expanded_form_of
how often do you feel close to people:finding:to identify measures at a point in time:^patient:ordinal:ucla loneliness scale v3||how often do you feel close to people [ucla loneliness v3]||expanded_form_of
medical and surgical @ tendons @ supplement @ lower leg tendon, right @ open @ nonautologous tissue substitute @ no qualifier||supplement r low leg tendon with nonaut sub, open approach||expanded_form_of
auditory hallucinations (finding)||auditory; hallucination||expanded_form_of
ct scan of r toe using h osm contrast||computerized tomography (ct scan) of right toe(s) using high osmolar contrast||expanded_form_of
disp fx of second metatarsal bone, unspecified foot||disp fx of second metatarsal bone, unspecified foot||expanded_form_of
anxiety disorder generalized||generalized anxiety disorder (diagnosis)||expanded_form_of
vectocardiogram||vectocardiogram||expanded_form_of
drainage of l abd muscle with drain dev, perc approach||medical and surgical @ muscles @ drainage @ abdomen muscle, left @ percutaneous @ drainage device @ no qualifier||expanded_form_of
medical and surgical @ muscles @ resection @ foot muscle, left @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ muscles @ resection @ foot muscle, left @ percutaneous endoscopic @ no device @ no qualifier||expanded_form_of
displ maisonneuve's fx l leg, 7thn||displaced maisonneuve's fracture of left leg, subsequent encounter for open fracture type iiia, iiib, or iiic with nonunion||expanded_form_of
immunoglobulin heavy chain locus (igh@) gene rearrangement analysis for detection of abnormal clonal population using direct probe method||immunoglobulin heavy chain locus (igh@) gene rearrangement analysis for detection of abnormal clonal population using direct probe method||expanded_form_of
anesth pelvic tumor surgery||anesth pelvic tumor surgery||expanded_form_of
medical and surgical @ upper joints @ replacement @ shoulder joint, left @ open @ autologous tissue substitute @ no qualifier||replacement of l shoulder jt with autol sub, open approach||expanded_form_of
insertion of int fix into l wrist jt, perc approach||insertion of internal fixation device into left wrist joint, percutaneous approach||expanded_form_of
non-specified hcpcs ii biofeedback device reference code no charge||nnspcfd hcpcs biofeedback rf||expanded_form_of
drug addict counselling||drug addiction counseling||expanded_form_of
removal of other device from stomach, perc endo approach||removal of other device from stomach, percutaneous endoscopic approach||expanded_form_of
oxacillin:susc:pt:isolate:ordqn:gradient strip||oxacillin:susc:pt:isolate:ordqn:gradient strip||expanded_form_of
memory poor||memory impairment (finding)||expanded_form_of
ct unspecified body region limited wo contrast||multisection limited^wo contrast:finding:to identify measures at a point in time:not specified:document:computed tomography||expanded_form_of
medical and surgical @ lymphatic and hemic systems @ destruction @ lymphatic, right inguinal @ percutaneous endoscopic @ no device @ no qualifier||destruction of right inguinal lymphatic, percutaneous endoscopic approach||expanded_form_of
superficial frostbite of left hip and thigh||superficial frostbite of left hip and thigh||expanded_form_of
infiltrate;genital;m||infiltrate;genital;m||expanded_form_of
blood flow velocity.diastolic.min:vel:pt:umbilical artery.at fetus^fetus:qn:us.doppler||fet umb a at fetus vmin dias dop||expanded_form_of
disease;pelvic;complicat preg||pelvic disease during pregnancy||expanded_form_of
medical and surgical @ gastrointestinal system @ release @ esophagus, lower @ via natural or artificial opening endoscopic @ no device @ no qualifier||release lower esophagus, via natural or artificial opening endoscopic||expanded_form_of
arsenic/creatinine [molar ratio] in urine||arsenic/creatinine [molar ratio] in urine||expanded_form_of
medical and surgical @ upper bones @ removal||upper bones, removal||expanded_form_of
coxpd51||combined oxidative phosphorylation deficiency 51||expanded_form_of
medical and surgical @ upper joints @ revision @ cervical vertebral joint @ percutaneous endoscopic @ synthetic substitute @ no qualifier||revision of synth sub in cerv jt, perc endo approach||expanded_form_of
snx18p1y||snx18p1y gene||expanded_form_of
unilat adrenal explorat||unilat adrenal explorat||expanded_form_of
burn of third degree of unspecified lower leg||burn of third degree of unspecified lower leg||expanded_form_of
other injury of unspecified muscle, fascia and tendon at shoulder and upper arm level, right arm, initial encounter||inj unsp musc/fasc/tend at shldr/up arm, right arm, init||expanded_form_of
initial insertion of rate-responsive single-chamber device||initial insertion of rate-responsive single-chamber device||expanded_form_of
ocumo||yautia||expanded_form_of
removal of spacer from r sternoclav jt, perc approach||removal of spacer from r sternoclav jt, perc approach||expanded_form_of
retained (old) foreign body following penetrating wound of left orbit||retained (old) foreign body following penetrating wound of left orbit||expanded_form_of
[x]toxic effect of unspecified seafood||toxic effect unspec seafood||expanded_form_of
portable home suction pump||portable home suction pump||expanded_form_of
medical and surgical @ lower joints @ drainage @ toe phalangeal joint, right @ percutaneous endoscopic @ drainage device @ no qualifier||medical and surgical @ lower joints @ drainage @ toe phalangeal joint, right @ percutaneous endoscopic @ drainage device @ no qualifier||expanded_form_of
lac w/o fb of unsp front wall of thrx w penet thor cav, subs||lac w/o fb of unsp front wall of thrx w penet thor cav, subs||expanded_form_of
displ transverse fx shaft of unsp fibula, 7thm||displ transverse fx shaft of unsp fibula, 7thm||expanded_form_of
cleft palate with coloboma of eye and deafness syndrome (disorder)||charge-like syndrome||expanded_form_of
removal of synth sub from up vein, perc endo approach||medical and surgical @ upper veins @ removal @ upper vein @ percutaneous endoscopic @ synthetic substitute @ no qualifier||expanded_form_of
polyhydramnios, second trimester, fetus 4||polyhydramnios, second trimester, fetus 4||expanded_form_of
drainage of left parietal bone with drainage device, open approach||drainage of left parietal bone with drain dev, open approach||expanded_form_of
ocular surface reconstruction limbal allograft||ocular surface reconstruction; limbal stem cell allograft (eg, cadaveric or living donor)||expanded_form_of
drainage of left frontal sinus, perc endo approach||medical and surgical @ ear, nose, sinus @ drainage @ frontal sinus, left @ percutaneous endoscopic @ no device @ no qualifier||expanded_form_of
organic psychosis nos||organic psychoses nos (disorder)||expanded_form_of
medical and surgical @ upper joints @ repair @ carpal joint, right @ percutaneous endoscopic @ no device @ no qualifier||repair right carpal joint, percutaneous endoscopic approach||expanded_form_of
mir194-1||mirna194-1||expanded_form_of
medical and surgical @ upper joints @ removal @ finger phalangeal joint, left @ percutaneous @ synthetic substitute @ no qualifier||removal of synth sub from l finger phalanx jt, perc approach||expanded_form_of
card inhibitor of nfkb-activating ligands||card inhibitor of nfkb-activating ligands||expanded_form_of
fam227a gene||fam227a||expanded_form_of
medical and surgical @ lower veins @ occlusion @ femoral vein, left @ open @ intraluminal device @ no qualifier||occlusion of l femor vein with intralum dev, open approach||expanded_form_of
tomographic (tomo) nuclear medicine imaging of myocardium using thallium 201 (tl-201)||nuclear medicine @ heart @ tomographic (tomo) nuclear medicine imaging @ myocardium @ thallium 201 (tl-201) @ none @ none||expanded_form_of
a-kinase anchor protein 4||akap82||expanded_form_of
nordoxepin dose||nordoxepin (dose) [mass]||expanded_form_of
malignant neoplasm other/unspec||malignant neoplasm other/unspec||expanded_form_of
bypass left axillary artery to left lower leg artery with nonautologous tissue substitute, open approach||bypass left axillary artery to left lower leg artery with nonautologous tissue substitute, open approach||expanded_form_of
dilate of l axilla art with intralum dev, perc endo approach||medical and surgical @ upper arteries @ dilation @ axillary artery, left @ percutaneous endoscopic @ intraluminal device @ no qualifier||expanded_form_of
occup of bus injured in nonclsn trnsp accident in traf, init||unspecified occupant of bus injured in noncollision transport accident in traffic accident, initial encounter||expanded_form_of
oatpf||organic anion transporter f||expanded_form_of
osteopathic manipulative treatment using low- velocity, high-amplitude forces||omt with lo-vel,hi-ampli||expanded_form_of
endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; subsequent vein(s) treated in a single extremity, each through separate access sites (list separately in addition to code for primary procedure)||endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; subsequent vein(s) treated in a single extremity, each through separate access sites (list separately in addition to code for primary procedure)||expanded_form_of
inflammatory disorder of joint||arthritis||expanded_form_of
blunted affect:finding:to identify measures at a point in time:^patient:ordinal:di-pad cgp v 1.4||blunted affect [di-pad]||expanded_form_of
perinatal hematological disorder, unspecified||perinatal haematological disorder, unspecified||expanded_form_of
corrosion of second degree of unspecified ankle, subsequent encounter||corrosion of second degree of unspecified ankle, subsequent encounter||expanded_form_of
pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident||pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident||expanded_form_of
albumin mfr.df serpl elph||albumin elph [pure mass fraction]||expanded_form_of
burn of third degree of ankle and foot||full thickness burn of ankle and foot||expanded_form_of
high-mobility group box 3-like 2||high-mobility group box 3 pseudogene 2||expanded_form_of
insertion of spacer into cerv jt, perc approach||insertion of spacer into cervical vertebral joint, percutaneous approach||expanded_form_of
medical and surgical @ anatomical regions, lower extremities @ revision @ lower extremity, right @ external @ nonautologous tissue substitute @ no qualifier||revision of nonaut sub in r low extrem, extern approach||expanded_form_of
beta endorphin [mass/vol]||beta endorphin:mcnc:pt:ser/plas:qn||expanded_form_of
dilate r com iliac art w intralum dev, drug blln, perc endo||dilate r com iliac art w intralum dev, drug blln, perc endo||expanded_form_of
selenium (24h u) [mass/vol]||selenium:mcnc:24h:urine:qn||expanded_form_of
rnu6-162p gene||rnu6-162p gene||expanded_form_of
open monteggia's fracture (disorder)||open proximal fracture of ulna (monteggia's fracture)||expanded_form_of
malignant neoplasm of unspecified ovary||malignant neoplasm of unspecified ovary||expanded_form_of
oth fx right patella, subs for opn fx type i/2 w routn heal||other fracture of right patella, subsequent encounter for open fracture type i or ii with routine healing||expanded_form_of
olfactory receptor family 5 subfamily p member 3||jcg1||expanded_form_of
pnctr w foreign body of right great toe w damage to nail||pnctr w foreign body of right great toe w damage to nail||expanded_form_of
legionella sp igm ql (s)||legionella sp igm ab [presence] in serum||expanded_form_of
hht1||hht1||expanded_form_of
superficial frostbite of right wrist, subsequent encounter||superficial frostbite of right wrist, subsequent encounter||expanded_form_of
pitt-hopkins-like syndrome 2||pitt-hopkins-like syndrome 2||expanded_form_of
itm2b gene||itm2b gene||expanded_form_of
s chartarum ige-mcnc||stachybotrys chartarum ige ab [mass/volume] in serum||expanded_form_of
retired procedure [60673005]||neurectomy, intrinsic musculature of foot||expanded_form_of
ruizia travassos & kloss, 1959||ruizia travassos & kloss, 1959||expanded_form_of
other fracture of right femur, subsequent encounter for open fracture type i or ii with routine healing||other fracture of right femur, subsequent encounter for open fracture type i or ii with routine healing||expanded_form_of
bypass r ventricle to pulm trunk w autol art, perc endo||bypass right ventricle to pulmonary trunk with autologous arterial tissue, percutaneous endoscopic approach||expanded_form_of
reposition right tarsal joint with internal fixation device, external approach||reposition right tarsal joint with int fix, extern approach||expanded_form_of
medical and surgical @ ear, nose, sinus @ revision @ ear, left @ percutaneous endoscopic @ intraluminal device @ no qualifier||revision of intraluminal device in l ear, perc endo approach||expanded_form_of
service comment 07||service comment 07 [interp]||expanded_form_of
11-hydroxyandrosterone [mass/volume] in 24 hour urine --pre dose dexamethasone||11oh-androst pre dex 24h ur-mcnc||expanded_form_of
beam radiation of oropharynx using photons <1 mev||radiation therapy @ ear, nose, mouth and throat @ beam radiation @ oropharynx @ photons <1 mev @ none @ none||expanded_form_of
chromodomain protein, y chromosome, 2||cdy2a||expanded_form_of
reposition left lower eyelid, percutaneous approach||medical and surgical @ eye @ reposition @ lower eyelid, left @ percutaneous @ no device @ no qualifier||expanded_form_of
bypass sigmoid colon to sigmoid colon, percutaneous endoscopic approach||bypass sigmoid colon to sigmoid colon, percutaneous endoscopic approach||expanded_form_of
porphobilinogen:prthr:pt:urine:ord||porphobilinogen ql (u)||expanded_form_of
transfer facial muscle, percutaneous endoscopic approach||transfer facial muscle, percutaneous endoscopic approach||expanded_form_of
koehlers grass ige rast ql||koehlers grass ige rast class (s)||expanded_form_of
erythema due to first degree burn of thumbnail||erythema [first degree] of thumb (nail)||expanded_form_of
restriction of right innominate vein with intraluminal device, open approach||restriction of right innominate vein with intraluminal device, open approach||expanded_form_of
drainage of left sphenoid sinus, percutaneous endoscopic approach||drainage of left sphenoid sinus, perc endo approach||expanded_form_of
medical and surgical @ heart and great vessels @ bypass @ thoracic aorta, ascending/arch @ open @ zooplastic tissue @ innominate artery||medical and surgical @ heart and great vessels @ bypass @ thoracic aorta, ascending/arch @ open @ zooplastic tissue @ innominate artery||expanded_form_of
administration @ physiological systems and anatomical regions @ introduction @ central vein @ open @ other therapeutic substance @ other substance||administration @ physiological systems and anatomical regions @ introduction @ central vein @ open @ other therapeutic substance @ other substance||expanded_form_of
osteopathic @ anatomical regions @ treatment @ upper extremities @ external @ lymphatic pump @ none||osteopathic treatment of upper extremities using lymph pump||expanded_form_of
bypass bladder to cutaneous, open approach||medical and surgical @ urinary system @ bypass @ bladder @ open @ no device @ cutaneous||expanded_form_of
hemoglobin yoshizuka:presence or threshold:to identify measures at a point in time:whole blood:ordinal||hemoglobin yoshizuka ql (bld)||expanded_form_of
lead-induced gout, site unspecified||lead-induced gout, unspecified site||expanded_form_of
disp fx of post column of r acetab, subs for fx w nonunion||displaced fracture of posterior column [ilioischial] of right acetabulum, subsequent encounter for fracture with nonunion||expanded_form_of
medical and surgical @ heart and great vessels @ occlusion @ pulmonary vein, left @ percutaneous @ no device @ no qualifier||occlusion of left pulmonary vein, percutaneous approach||expanded_form_of
s100 calcium-binding protein a5||s100 calcium binding protein a5||expanded_form_of
medical and surgical @ eye @ release||medical and surgical @ eye @ release||expanded_form_of
test;physical function;respira||physical function test, respiratory||expanded_form_of
medical and surgical @ gastrointestinal system @ drainage @ large intestine @ via natural or artificial opening @ drainage device @ no qualifier||medical and surgical @ gastrointestinal system @ drainage @ large intestine @ via natural or artificial opening @ drainage device @ no qualifier||expanded_form_of
medical and surgical @ lower veins @ restriction @ hypogastric vein, left @ percutaneous endoscopic @ intraluminal device @ no qualifier||restriction of left hypogastric vein with intraluminal device, percutaneous endoscopic approach||expanded_form_of
heterocyclic compound (substance)||4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid||mapped_to
[x]other congenital malformations of upper limb(s), including shoulder girdle (disorder)||accessory; carpal bones||mapped_to
middle ear||malignant neoplasm of auditory tube, middle ear and mastoid air cells nos (disorder)||mapped_to
n-oxides, heterocyclic||l-tyrosinamide, s-(2-oxo-2-((2,2,5,5-tetramethyl-1-oxy-3-pyrrolidinyl)amino)ethyl)-l-cysteinyl-||mapped_to
mat care/o abnr/gravd uteru||pregnancy; uterus, abnormal position||mapped_to
worms/other parasites||eye; onchocerciasis (manifestation)||mapped_to
basidiomycotas||phallus aureolatus||mapped_to
7-beta-d-ribofuranosyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine||mtc-9-ado||mapped_to
anziaceae||relicina filsonii||mapped_to
sordariale||cercophora arenicola r. hilber, 1979||mapped_to
sac fungi||pertusaria diluta||mapped_to
pregnancy high risk||pregnancy; elderly primigravida||mapped_to
triterpene (substance)||astrasieversianin xv||mapped_to
[x]superficial mycosis, unspecified||otomycosis (manifestation)||mapped_to
oligopeptide||bq 485||mapped_to
dissociative [conversion] disorders||acute; psychotic disorder, hysterical||mapped_to
heterocyclic compounds, 3 ring||3-(4-(9-methoxy-1,2,3,3a,4,9b-hexahydro(1)benzopyran(3,4-c)pyrrol-2-yl)butyl)-8-phenylpyrazino(2',3'-4,5)thieno(3,2-d)pyrimidine-2,4(1h,3h)-dione||mapped_to
bisdeaefluorenone||vufb 13371||mapped_to
cytochromes type c||cytochrome c 558, rhodopseudomonas viridis||mapped_to
sprains & strains of other joint||phalanx; sprain (strain), toes||mapped_to
[x]inj oth mus/ten,ank/foot lv||partial division, extensor tendon of foot (disorder)||mapped_to
acridine||7-methylbenz(c)acridine-5,6-oxide||mapped_to
triterpene (substance)||acankoreoside k||mapped_to
imidazoles||fenoxazoline||mapped_to
heterocyclic cpds 3 ring||bip-5 compound||mapped_to
other specified leptospiral infection nos (disorder)||pretibial; fever||mapped_to
phylum ascomycota (organism)||catillaria jemtlandica||mapped_to
nerve proteins||ma2 onconeural antigen||mapped_to
glucoside||4-o-beta-glucopyranosyl caffeic acid||mapped_to
octreotida||sdz-204-090||mapped_to
thiophenes||2,4-dimethyltetrahydrothiophene-1,1- dioxide||mapped_to
danio rerio proteins||igf2a protein, zebrafish||mapped_to
hexosyltransferase (substance)||l-ara4n transferase||mapped_to
disorder of visual pathways (disorder)||disorders of optic nerve &/or visual pathways||mapped_to
biphenyl compound||oicr-9429||mapped_to
local infection skin/subcut tissue nos||pathologic fistula||mapped_to
other specified helminthiasis||polymorphosis||mapped_to
abnormal reflexes||triceps reflexes unequal||mapped_to
fluorine compounds||bromine trifluoride (substance)||mapped_to
factors, transcription||bromodomain containing 2 protein, human||mapped_to
chronic sinusitis, sphenoidal||sphenoidal; empyema||mapped_to
eighth cranial nerve diseases||disorder of eighth cranial nerve||mapped_to
ruptured aortic aneurysm nos (disorder)||aorta; sacculation, ruptured||mapped_to
mannitol, d-||2,5-ah-1-tsm||mapped_to
factors transcription||cogc-2 protein, c elegans||mapped_to
mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state||sedative withdrawal||mapped_to
recept g protein coupled||cg4322 protein, drosophila||mapped_to
adrenals cancer||anterior surface adrenal gland||mapped_to
champignons||aroramyces gelatinosporus||mapped_to
mitochondrial proteins||urf a protein, s pombe||mapped_to
unspecified nephritic syndrome, diffuse mesangiocapillary glomerulonephritis||mpgnii||mapped_to
haemobartonella||mycoplasma felifaucium||mapped_to
neurosyphilis, symptomatic||neurorecidive; syphilitic, of retina (etiology)||mapped_to
[x]other cong malform aorta||ascending aorta abnormality||mapped_to
other specified disorder of metabolism||deficiency of diphosphoric monoester hydrolase (disorder)||mapped_to
[x]oth cong malf great veins||anomaly, scimitar||mapped_to
problem with working conditions||job; adjustment, problem, change||mapped_to
phenelzinum||n-acetylphenelzine||mapped_to
other/unspecified neoplasms||adrenal; glomerulosa cell adenoma||mapped_to
vertical heterophoria||hyperphoria||mapped_to
benzeneacetamides||benzeneacetamide, n-(4-(aminocarbonyl)phenyl)-4-(bis(2-chloroethyl)amino)-||mapped_to
paper wasp ige qn||polistes spp antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||mapped_to
piperazines||idf-11774||mapped_to
problems of adjustment to life-cycle transitions||crisis life mid||mapped_to
cervical dystonia||dyt23||mapped_to
motion picture||motion pictures as topic||mapped_to
order hypocreales||hypomyces luteovirens||mapped_to
cupriavidus||ralstonia campinensis||mapped_to
diterpene||(12e,2s,3s,4r,5r,6s,9s,11s,15r)-3-propionyloxy-5,15-diacetoxy-6,17-epoxylathyra-12-en-14-one||mapped_to
sinusitis acute/chron||abscess; antrum||mapped_to
i (intermediate) subtype ql (rbc bpu)||i (int) subtype:arbitrary concentration:to identify measures at a point in time:serum/plasma^bpu:ordinal:agglutination rbc||mapped_to
lim domain proteins||mlp60a protein, drosophila||mapped_to
ren tub-int disord transpl rej||tubulo-interstitial; disease, transplant rejection (manifestation)||mapped_to
[d]exanthem (context-dependent category)||rash vesicular||mapped_to
postprocedural hypothyroidism||irradiation hypothyroidism (disorder)||mapped_to
other forms of heart disease||block; bundle-branch, wilson's type||mapped_to
[x]other specified disorders of carbohydrate metabolism||deficiency of maltose phosphorylase||mapped_to
oligopeptides||tyr-pro-trp-(2-furyl)map-nh2||mapped_to
rna binding proteins||drb1 protein, rat||mapped_to
gallbladder calculus without mention of cholecystitis (disorder)||calculus of cystic duct||mapped_to
mammalian gestation||pregnancy and drug use||mapped_to
oligopeptide||n-methylpiperazine-urea-arginyl-homophenylalanyl-vinylsulfonebenzene||mapped_to
cements, glass ionomer||fuji ii lc cement||mapped_to
ulcer; gastrojejunal, acute, with hemorrhage, and perforation||acute gastrojejunal ulcer with hemorrhage and perforation (disorder)||mapped_to
coil insertion||fitting of diaphragm||mapped_to
complications of genitourinary prosth dev/grft||complications; penile prosthesis||mapped_to
skeletal anomaly-congen||hollow foot||mapped_to
galactoside||o-hydrazinocarbonylpentyl galactoside||mapped_to
met-enkephalin (substance)||met-enkephalinamide, ala(2)-||mapped_to
preg state, incidental||summary of previous pregnancies gravida - 9||mapped_to
antigens, ly||ly6c antigen, mouse||mapped_to
complexes, coordination||bis(mu-methyl-n-(dithiocarboxy-ks,ks')-n-methylglycinato)(bis(methyl-n-(dithiocarboxy-ks,ks')-n-methylglycinato)zinc(ii))||mapped_to
dipeptide (substance)||trp-trp||mapped_to
other causes of obstructed labour nos||other cause of obstructed labor, nec||mapped_to
laryngitis acute nos||pseudocroup||mapped_to
[x]other haemoglobinopathies||low affinity haemoglobin||mapped_to
1,25-dihydroxyvitamin d3||gs 1500||mapped_to
bcr/abl1 fusion protein||bcr-abl1 fusion protein, human||mapped_to
oligopeptide||ep 51389||mapped_to
other diseases of urinary system||renal; infarction||mapped_to
femoral hernia with gangrene nos||femoral hernia with gangrene and obstruction (disorder)||mapped_to
[x]cellulitis finger and toe||pseudomonas aeruginosa infection of nail||mapped_to
pulmonary fibrosis, unspecified||pf-ild-progressive fibrosing interstitial lung disease||mapped_to
chronic periodontitis apical||granuloma; pyogenic, pyogenic, alveolar, upper jaw||mapped_to
other infect neurol system||cerebrospinal; tuberculous (etiology)||mapped_to
malaria; nephropathy, complication plasmodium malariae||plasm malariae mal + nephropth||mapped_to
iontophoresis each 20 minutes||physical medicine iontophoresis||mapped_to
catalases||polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase||mapped_to
ascomycota||coniolariella macrothecia||mapped_to
product containing cinnarizine||touristil||mapped_to
benzopyran (substance)||7-(isopropoxymethyl)-5-phenyl-7,8-dihydro-5h-(1,3)dioxolo(4,5-g)isochromene||mapped_to
glycosides||lycoperoside g||mapped_to
cardiac failure right heart due to pulmonary hypertension||pulmonary; rupture pulmonary artery||mapped_to
2-chloroadenosine||8-cl-ado||mapped_to
panteoa (organism)||pantoea eucrina||mapped_to
allergy status to analgesic agent||allergy to phenylbutazone (finding)||mapped_to
membrane protein, lysosomal||lgp107||mapped_to
glomerulonephritis/nephrosis||disease (or disorder); glomerular, in subacute bacterial endocarditis (manifestation)||mapped_to
other penile inflammatory dis.||inflammatory disorder of penis||mapped_to
repressor proteins||transcriptional repressor p66-beta, human||mapped_to
wound myiasis (disorder)||calliphoridosis||mapped_to
bleeding - ovulation||intermenstrual bleeding-regul.||mapped_to
other specified acute viral hepatitis||virus; hepatitis, type, non-a, non-b||mapped_to
encounter for blood typing||jk(a-b-) phenotype||mapped_to
oleanol||esculentoside n||mapped_to
persons encountering health services in other specified circumstances||patient on maximum tolerated dose (finding)||mapped_to
other viral meningitis (disorder)||meningitis; arboviral (etiology)||mapped_to
[x]mat care/o abnr/gravd uteru||cesarean section for; prolapse, uterus||mapped_to
chloroplast proteins||porphobilinogen deaminase, chloroplastic, arabidopsis||mapped_to
2(1h)-pyrimidinone, 4-amino-1.beta.-d-arabinofuranosyl-||bavc protocol||mapped_to
ischaemic heart dis without angina||embolism; cardiac, not resulting in infarction||mapped_to
gestational proteinuria (disorder)||albuminuria in pregnancy without hypertension (disorder)||mapped_to
acute peritonitis, nos||intraperitoneal abscess, nos||mapped_to
fluorene||l-cysteine, n-((1,1-dimethylethoxy)carbonyl)-s-(9h-fluoren-9-ylmethyl)-, 4-nitrophenyl ester||mapped_to
12 lipoxygenase||12(r)-lipoxygenase, human||mapped_to
cyclobutanes||1,2-dianilinosquairane||mapped_to
transport proteins||rrbp1 protein, human||mapped_to
aphyllophorales (organism)||wolfiporia dilatohypha||mapped_to
removal of iud||iud removal (& [awaited]) (finding)||mapped_to
recept urogastrone||egfr protein, rat||mapped_to
effect(s);prosthetic device||infusion catheter, spinal; thrombosis||mapped_to
potassium channels, kv||potassium channel, subfamily v, member 1 protein, mouse||mapped_to
diterpenoids||vilmorrianine e||mapped_to
[d]fit||hypotonia, seizures, and precocious puberty||mapped_to
mastitides, bovine||bovine prototheca mastitis||mapped_to
piperazines||1-(4-fluorobenzyl)piperazine||mapped_to
eye tuberculosis||tuberculous interstitial keratitis||mapped_to
cyclohexanols||tcdl cpd||mapped_to
other fractures||fracture of patella (disorder)||mapped_to
yaws hyperkeratosis||palmar yaws hyperkeratosis||mapped_to
croton tiglium/croton oil||croton oil (substance)||mapped_to
benzhydryl cpds||o-972||mapped_to
carrier protein, nos||bbp protein, staphylococcus aureus||mapped_to
oth personal risk factors, not elsewhere classified||at risk of child abuse||mapped_to
ascomycetes||roccella babingtonii||mapped_to
other infectious diseases (b99)||weil dis||mapped_to
lectin, nos||sialic acid binding ig-like lectin 11, human||mapped_to
sixth [abducent] nerve palsy, unspecified eye||sixth cranial nerve disease, nos||mapped_to
other malignant neoplasms||alpha chain dis||mapped_to
butyrates||2-htrimeb||mapped_to
secondary malignant neoplasm bone||secondary malignant neoplasm of tibia||mapped_to
peripheral myelin protein 2||myelin p2 peptide sp26||mapped_to
inonotus||inonotus ulmicola||mapped_to
other symptomatic late syphilis||uveitis; syphilitic, late (etiology)||mapped_to
product containing mephobarbital||phenytoin + phenobarbital + mephobarbital (medication)||mapped_to
dihydropyridines||bay w 9798||mapped_to
n-oxides, heterocyclic||2-hexyl-2,3,5,5-tetramethyl-4-(3-iodo-2-oxopropylidene)imidazolidine-1-oxyl||mapped_to
unspecified congenital anomaly of digestive system||torsion; meckel's diverticulum||mapped_to
cyp11b2||corticosterone methyl oxidase i||mapped_to
s cerevisiae proteins||avl9 protein, s cerevisiae||mapped_to
arabidopsis proteins||arf19 protein, arabidopsis||mapped_to
endodeoxyribonuclease||atrad1 protein, arabidopsis||mapped_to
anthracycline||n05wa963c||mapped_to
dinucleoside phosphates||ap(s)pchclpp(s)a||mapped_to
bladder; atonic||high bladder compliance (diagnosis)||mapped_to
protein, apoptosis regulatory||tigar protein, mouse||mapped_to
cellulitis and abscess mouth||cellulitis of canine space of mouth (disorder)||mapped_to
oligopeptide||n-myr-hdapigyd||mapped_to
organophosphates||tris(chloroethyl)phosphate||mapped_to
teeth/gum disease||nonhereditaria; amelogenesis imperfecta||mapped_to
abnormal findings on diagnostic imaging of skull and head, not elsewhere classified||imaging of head abnormal||mapped_to
neurosecretion (function)||neurosecretion, function (observable entity)||mapped_to
olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-||methyl cnddo||mapped_to
solar hyperkeratosis||actinic; keratosis||mapped_to
other lesions of oral mucosa||salivary gland haematoma||mapped_to
thiophenes||2-ddmt-carboxamide||mapped_to
[x]other specified disorders of brain||corpus callosum syndrome||mapped_to
[x]persons encountering health services in other specified circumstances (situation)||seen by surgeon||mapped_to
phenol||spinonin||mapped_to
erythromycin product||erythronolide b||mapped_to
tyrosine, l-isomer||n-(4-azido-2,3,5,6-tetrafluorobenzoyl)tyrosine||mapped_to
tetralins||a 75200||mapped_to
utp||s(4)-ddutp||mapped_to
cerebrovascular disorder (nos)||artery; pontine, narrowing||mapped_to
taurine (medication)||tauropyrone||mapped_to
zebrafish proteins||adrb2 protein, zebrafish||mapped_to
phenyl ethers||asterric acid||mapped_to
arabidopsis proteins||kin10 protein, arabidopsis||mapped_to
transport protein||ypr115w protein, s cerevisiae||mapped_to
quinolones||megistonine ii||mapped_to
cellulitis of right lower limb||cellulitis of right ankle (disorder)||mapped_to
envelope protein, viral||gp45 teg protein, retrovirus||mapped_to
palpitations/aware of heartbeat||heart beat; slow||mapped_to
non-medicinal agent causing toxic effects||skevas-zerfus||mapped_to
naphthalenediones||1-(5,8-dihydro-1,4-dihydroxy-5,8-dioxo-2-naphthyl)-4-methylpent-3-en-1-yl cinnamate||mapped_to
saponins||drevogenin d-3-o-beta-d-glucopyranosyl-(1-4-)-6-deoxy-3-o-methyl-beta-d-allopyranosyl-1-4-beta-d-cymaropyranosyl-1-4-beta-d-digitoxopyranoside||mapped_to
dikvertin||difaprost||mapped_to
[x]other reduction defects of lower limb(s)||brachydactyly of toes of left foot (disorder)||mapped_to
other infectious diseases (b99)||old world cutaneous leishmaniasis (disorder)||mapped_to
neuropathy; hereditary ataxia||ataxia; hereditary, with neuropathy||mapped_to
oligopeptides||internalizing-rgd peptide||mapped_to
other spondylosis with radiculopathy, thoracic region||single-level thoracic spondylosis with radiculopathy||mapped_to
ocadaic acid||corozalic acid||mapped_to
genus talaromyces||talaromyces sublevisporus||mapped_to
vincristine||cmopp protocol||mapped_to
follistatin relat proteins||follistatin-related protein 1, mouse||mapped_to
division ascomycota||alfoldia vorosii||mapped_to
extracts plant||lacrinat||mapped_to
cerebrovascular accident||infarction; cerebral due to stenosis, cerebral arteries||mapped_to
superficial injury of ear||hematoma of left auricular region||mapped_to
env proteins, human immunodeficiency virus||hiv-env (583-599) peptide||mapped_to
function oxidase, mixed||arylamine n-hydroxylase||mapped_to
phylum basidiomycota (organism)||endoraecium falciforme||mapped_to
peptide fragment||pur4 peptide||mapped_to
cyclic peptide-containing product||cyclocpppcacpamide||mapped_to
other specified anomalies||congenital flat back deformity (disorder)||mapped_to
benign lipomatous neoplasm of spermatic cord||connective tissue; spermatic cord, lipoma||mapped_to
toxic effect of other specified substances||non-medicinal agent causing toxic effect nos||mapped_to
lncrna||ak124742 long non-coding rna, human||mapped_to
purine nucleoside-containing product||amdoxovir||mapped_to
hemoglobin f (substance)||hemoglobin f joanopolis||mapped_to
hippurates||glycine, n-benzoyl, compound with 1,3,5,7-tetraazatricyclo(3.3.1.1(sup 3,7))decane(1:1)||mapped_to
phylum ascomycota||fissurina bullata mangold, luecking & lumbsch, 2014||mapped_to
sulphonamide||polymyxin b sulfate - neomycin sulfate - sulfonamide - hydrocortisone||mapped_to
senility (finding)||tremor; senile||mapped_to
occlusion and stenosis of carotid artery||asymptomatic occlusion of extracranial carotid artery||mapped_to
phenanthroline||phenanthroquinolizidine||mapped_to
monooxygenase (biological function) (substance)||porphobilinogen oxygenase||mapped_to
other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus||clonic seizure, non-refractory (finding)||mapped_to
acetophenones||2,4,6-trihydroxy-3-geranylacetophenone||mapped_to
antibodies, monoclonal, humanized||anti-c-met monoclonal antibody sait301||mapped_to
rod myopathies||nemaline myopathy caused by mutation in the tropomyosin 2 gene||mapped_to
nuclear proteins||target of jun 3 protein, coturnix coturnix||mapped_to
villonodular synovitis (pigmented), unspecified hip||pigmented villonodular synovitis of hip joint (disorder)||mapped_to
inadequate family support nos||family support; inadequate||mapped_to
bacteroidetes krieg et al. 2012||mucilaginibacter phyllosphaerae||mapped_to
phylum dikaryomycota||derxomyces bambusicola||mapped_to
limb deformities nos (acquired)||abnormality of the hand||mapped_to
protein, stress||sesn3 protein, mouse||mapped_to
malignant neoplasm of lower lobe, bronchus or lung nos||right lower lobe of lung||mapped_to
benzamides||smp-534||mapped_to
[x]secondary malignant neoplasm of other specified sites||secondary malignant neoplasm of hypopharyngeal aspect of interarytenoid fold||mapped_to
superficial injury of trunk, level unspecified||abrasion or friction burn of trunk with infection||mapped_to
drug combination||atoltivimab, maftivimab, and odesivimab-ebgn drug combination||mapped_to
increased heart size||moderate left ventricular hypertrophy (disorder)||mapped_to
venous insufficiency (chronic)(peripheral)||circulatory system disorder (nos)||mapped_to
diterpene||trigochinin a||mapped_to
diterpenoid||ingenol derivative leo 43204 gel||mapped_to
other specified congenital malformations of heart||atrioventricular valve chordae in common atrioventricular junction too short||mapped_to
other anomalies of intestine||enterogenous; cyst||mapped_to
product containing protein (product)||nepenthin||mapped_to
rheum fev w/o hrt involv||rheumatic; pneumonia (etiology)||mapped_to
cyclic-3',5'-monophosphate, guanosine||8-(p-chlorophenylthio)cyclic gmp||mapped_to
indole alkaloids||lolitrem b||mapped_to
other fractures||fracture; shoulder (girdle), blade||mapped_to
[x]other chronic thyroiditis||thyroiditis; chronic, fibrous||mapped_to
[x]inhalation and ingestion of food causing obstruction of respiratory tract||asphyxia by sweet in air passages (finding)||mapped_to
exchange factors, gdp||als2 protein, drosophila||mapped_to
three ring heterocyclic compounds||7-methyl-1-phenyl-1,8-dihydropyrazolo(3,4d)(1,2,4)-triazolo(1,5a)pyrimidin-4-one||mapped_to
diphtheria toxin (substance)||e7777 fusion protein||mapped_to
ascomycota||neomicrosphaeropsis elaeagni wanas., bulgakov., e.b.g. jones & k.d. hyde, 2018||mapped_to
sesquiterpenoids||hobs1 compound||mapped_to
complexes, metal||poly(((mu2-benzene-1,4-dicarboxylato)(mu2-n(4),n(4')-bis(pyridin-3-yl)-(1,1'-biphenyl)-4,4'-dicarboxamide)dicadmium(ii))dihydrate||mapped_to
glycerophospholipid||phosphatidylglucose||mapped_to
talaromyces infections||infection due to penicillium palitans (disorder)||mapped_to
cerebroside (substance)||pycnangloside||mapped_to
diverticular disease of both small and large intestine without perforation or abscess (diagnosis)||diverticulum; large intestine, with small intestine||mapped_to
other specified congenital musculoskeletal anomalies||other congenital anomaly of upper limb, including shoulder girdle||mapped_to
bones and bone||de hauwere syndrome||mapped_to
non-ins-dep diabetes mellitus||niddm with deafness||mapped_to
informofer||hrp23 protein, chironomus tentans||mapped_to
other musculoskeletal dis. nos||hypermobility; scapula||mapped_to
melanocytic nevi of unspecified eyelid, including canthus||compound naevus of eyelid||mapped_to
phylum dikaryomycota||ustilago avenae (oat smut)||mapped_to
lactone (substance)||acremonol||mapped_to
compounds, trialkyltin||(1,1'-biphenyl)-2-ol, mixt. with kerosine and tributylstannane||mapped_to
benign/unspecified neoplasm male genital||tumor; leydig cell, unspecified site, male||mapped_to
ascomycete||glyphis batuana||mapped_to
gonorrhoea male||gonorrhea; cowper, without abscess||mapped_to
semustine (substance)||fmt protocol||mapped_to
failed attempted termination of pregnancy complicated by metabolic disorder||failed attempted abortion with electrolyte imbalance (disorder)||mapped_to
[x]other diseases of the digestive system||lymph node; tuberculous, mesenteric (manifestation)||mapped_to
azo cpds||2-(8-quinolylazo)-4,5-diphenylimidazole||mapped_to
resin cements||sondhi indirect bonding resin||mapped_to
table sugar||1'-deoxy-1'-fluorosucrose||mapped_to
azasteroids||3-hydroxy-17-aza-d-homoandrostan-4-n,n-bis(2-chloroethyl)aminophenylacetate||mapped_to
skull or face bone anomaly nos||skull congenital deformities (disorder)||mapped_to
morphines||10-oxomorphine||mapped_to
carbon-carbon lyase (biological function)||s-adenosyl-l-methionine tryptophan lyase, streptomyces actuosus||mapped_to
dental veneer||white coat tooth coating material||mapped_to
poliglusam||poly(ethylene glycol)-poly(alanine-co-phenyl alanine) grafted chitosan||mapped_to
[x]aneurysm of aorta in diseases classified elsewhere (disorder)||rupture; aortic, syphilitic (etiology)||mapped_to
[x]varicose vns/oth spcf sites||acute aneurysm of right popliteal vein||mapped_to
triazine||n,n-diallylmelamine||mapped_to
varicella infection (disorder)||viral disease||mapped_to
carbazoles||7-methyldibenzo(c,g)carbazole||mapped_to
escherichia coli proteins||yjgk protein, e coli||mapped_to
triterpene||pulsatilloside f||mapped_to
proteins, bacterial||imidazolone-5-propionate hydrolase, bacillus subtilis||mapped_to
chinese drugs, plant||tianhuang||mapped_to
brevibacillus species||brevibacillus brevis||mapped_to
spectrin||betaiv spectrin, mouse||mapped_to
[x]persons encountering health services in other specified circumstances (context-dependent category)||b12 injections started (situation)||mapped_to
sprain (strain); wrist||cmplt tr radial collat lgmt||mapped_to
metalloporphyrins||cd-texaphyrin||mapped_to
oth diseases resp system||stricture; bronchus||mapped_to
rhodococcus species||rhodococcus tukisamuensis||mapped_to
accessory ear auricle nos (disorder)||accessory auricle of left ear||mapped_to
ester hydrolase||pe11 protein, mycobacterium tuberculosis||mapped_to
chalcone||gemichalone c||mapped_to
ascomycota||ramularia acris lindroth, 1902||mapped_to
[x]calculus of urinary tract in other diseases ce||calculus; xanthine (manifestation)||mapped_to
intracellular signaling peptides and proteins||mag2l protein, arabidopsis||mapped_to
polychlorinated biphenyl (substance)||3,5-dichlorobiphenyl||mapped_to
esdl||polyestradiol (substance)||mapped_to
cardiac arrest with successful resuscitation (disorder)||cardiac arrest, unspecified (disorder)||mapped_to
arthrosis, unspecified||hemarthrosis, site unspecified||mapped_to
other specified disorders of tympanic membrane||retraction pocket of right tympanic membrane of ear||mapped_to
oth comp gu pros dev/imp/gf||complications; prosthesis, urinary tract or organ, thrombosis||mapped_to
xenopus proteins||sulf2 protein, xenopus||mapped_to
stones, kidney||calculus; ureter||mapped_to
etoposide (substance)||2'-chloroetoposide||mapped_to
poliglusam||(2-hydroxy-3-butoxy)propylcarboxymethylchitosan||mapped_to
underimmunization status||requires vaccination against measles||mapped_to
[x]victim of flood||accident caused by flood resulting directly from storm (event)||mapped_to
ascomycete||batcheloromyces proteae||mapped_to
barbiturate-containing product||gsk1278863||mapped_to
trans acting factors||pcau protein, acinetobacter||mapped_to
polyacetylene||c3decaynol||mapped_to
mtb - mycobacterium tuberculosis infection||abscess; tuberculous, joint, sternoclavicular (etiology)||mapped_to
valine product||azdu-val||mapped_to
benign meningeal neoplasm (morphologic abnormality)||meningiomas, meningotheliomatous||mapped_to
child behaviour symptom/complaint||delayed developmental milestones gross motor late walker (physical finding)||mapped_to
moldy hay disease||diseases farmer's lung||mapped_to
other infect neurol system||sspe - sbacut sclros panenceph||mapped_to
[x]other specified congen malformation of digestive system||congenital anomaly of digestive system absence of alimentary tract||mapped_to
strongyloides infection||infection by strongyloides ransomi (disorder)||mapped_to
diflucortolone product||6-fluoro-dopmpd||mapped_to
infection by acanthamoeba||disease caused by acanthamoebidae||mapped_to
violence, physical||battered baby||mapped_to
anemia, dyserythropoietic, congenital||chronic recurrent multifocal osteomyelitis, congenital dyserythropoietic anaemia and neutrophilic dermatosis||mapped_to
glucuronide||deoxynivalenol-15-glucuronide||mapped_to
ichthyosis congenita||dominant congenital ichthyosiform erythroderma (disorder)||mapped_to
product containing salicylate||3-hexylsalicylic acid||mapped_to
acute bronchitis/bronchiolitis||inflammation of the bronchioles||mapped_to
dihydroxybenzenes p||quinhydrone||mapped_to
sinusitis acute/chronic||acute maxillary sinusitis||mapped_to
muscle weakness generalized||weakness of distal muscles||mapped_to
confidentiality||confidential communications||mapped_to
hypovolaemia||extracellular fluid volume depletion (finding)||mapped_to
arthritis in other bacterial diseases classified elsewhere||arthritis due to salmonella infection (diagnosis)||mapped_to
compounds, polycyclic||3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid||mapped_to
arabidopsis proteins||otc protein, arabidopsis||mapped_to
collagen (medication)||matriderm||mapped_to
disorder of phosphorus metabolism (diagnosis)||hops||mapped_to
benign hypertensive heart and renal disease (disorder)||benign hypertensive heart and renal disease||mapped_to
phylum dikaryomycota||poria nothofagi g. cunn., 1965||mapped_to
wernicke encephalopathy||wernicke-korsakoff syndromes||mapped_to
peppts||phosphoenolpyruvate-protein phosphotransferase (substance)||mapped_to
acetylcysteine [paracetamol poisoning treatment]||trihydroxybutyl mercapturic acid||mapped_to
benzofuran (substance)||1-(benzofuran-2-yl(phenyl)methyl)-3-(2-(4-methoxyphenyl)-2-oxoethyl)-1h-benzo(d)imidazol-3-ium||mapped_to
peptide fragment||tnfrf (159-178)||mapped_to
hypocreale||trichoderma olivascens jaklitsch, samuels & voglmayr, 2013||mapped_to
rapamycin||homotemsirolimuse c||mapped_to
thoracic aorta injury||intramural hematoma of aorta||mapped_to
[v]other problems related to care-provider dependency||dominated by carer||mapped_to
2(3h)-furanone, dihydro-||cardiobutanolide||mapped_to
toxin, bacterial||cbm17.1 protein, clostridium bifermentans||mapped_to
other forms of aspergillosis||infection due to aspergillus conicus (disorder)||mapped_to
malignant prostatic tumour||adenocarcinoma; endometrioid, unspecified site, male||mapped_to
pyrrolidinone||3-(n,n-bis(2-chloroethyl)amino)-1-(2'-methoxyphenyl)pyrrolidine-2,5-dione||mapped_to
immune globulin, unspecified formulation||crlm2 protein, mouse||mapped_to
gloperba||3,8,9,10-tetramethoxyallocolchicine||mapped_to
splenomegaly, not elsewhere classified||enlarg spleen||mapped_to
physical exercise; lack of||exercise physically impossible||mapped_to
naphthalene||naphthyl-naphthalinesulphonylpropyl sulfoxide||mapped_to
insect protein||bs-dprit1 protein, mesobuthus tamulus sindicus||mapped_to
valine (medication)||n-(3-indolylacetyl)valine||mapped_to
other specified disorder of kidney and ureter||idiopathic dilation of ureter (disorder)||mapped_to
fusarium (organism)||fusarium poae||mapped_to
arabidopsis proteins||atpgp2 protein, arabidopsis||mapped_to
structure of eyelash (body structure)||lymphedema-distichiasis syndrome with renal disease and diabetes mellitus||mapped_to
erysiphe||erysiphe rosae||mapped_to
piperazines||golmaenone||mapped_to
sulfohydrolase, arylsulfate||l-ascorbate-2-sulfate sulfohydrolase||mapped_to
coumarins||7-o-beta-d-glucopyranosyl-nutanocoumarin||mapped_to
effects of a prosthetic device||[v]presence of aortocoronary bypass graft (situation)||mapped_to
ischemic heart disease chronic||increased myocardial ischaemia compared to prior study||mapped_to
deuteroporphyrins||deuxemether||mapped_to
triazole||2-(benzotriazol-1-yl)oxy-1,3-dimethylimidazolidinium||mapped_to
depsipeptide||cyclo-((3-oxy-4-(1,2-dihydroxyethyl)-1-methylcarbonylazetidin-2-one)-arginyl-glycyl-aspartyl)||mapped_to
phenylamines||azopyram||mapped_to
chest pain, nos||parasternal chest pain||mapped_to
leishmaniasis, cutaneous||indian zoonotic cutaneous leishmaniasis||mapped_to
encounter for routine child health examination with abnormal findings||8 week examination abnormal - for observation (finding)||mapped_to
[x]other congenital malformations of aortic and mitral valves (disorder)||commisural fusion-aortic cusp||mapped_to
persons encountering health services in oth circumstances||sodium diet, nos||mapped_to
other neurological disorders||descending paralysis||mapped_to
(11beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione||bmpd protocol||mapped_to
malig neop lip, unsp, external||external lip, unspecified||mapped_to
female pseudohermaphroditism, not elsewhere classified||46,xx disorder of sex development due to maternal adrenal neoplasm||mapped_to
acids, indolylacetic||4-cl-iaa||mapped_to
pyrazoles||1-pmc-hmt cpd||mapped_to
open dislocation of acromioclavicular joint (disorder)||open dislocation of clavicle (disorder)||mapped_to
endometrium carcinomas||uterine neoplasm, malignant - of corpus uteri carcinoma||mapped_to
[x]other specified disorders of metabolism (disorder)||deficiency of mitochondrial aspartyl transfer ribonucleic acid synthetase (disorder)||mapped_to
antineoplastic agent, combined||vinblastine/doxorubicin/thiotepa/fluoxymesterone||mapped_to
current effect electric||death by electrocution (finding)||mapped_to
pantoea species (organism)||pantoea wallisii brady et al. 2012||mapped_to
scoliosis in oth dis||acquired scoliosis (disorder)||mapped_to
ascomycota||pseudopithyella minuscula||mapped_to
phenx - ethnicity protocol 010502||phenx - ethnicity protocol||mapped_to
schilder's disease||centrolobar progressive; encephalopathy||mapped_to
propane (substance)||rs 39604||mapped_to
perenniporiaceae||megasporia cystidiolophora (b.k. cui & y.c. dai) b.k. cui & hai j. li 2013||mapped_to
minichromosome maintenance proteins||mcm10 protein, s cerevisiae||mapped_to
hydroxyalkyl-protein kinase||regb protein, rhodobacter||mapped_to
medical abortion, incomplete, complicated by genital tract and pelvic infection||legally induced abortion, complicated by genital tract and pelvic infection, unspecified||mapped_to
escherichia coli proteins||qsef protein, e coli||mapped_to
benign neoplasm of breast nos||intracanalicular; fibroadenoma, unspecified site||mapped_to
benzaldehydes||4-(4'-methylphenyl)benzaldehyde||mapped_to
piperidines||piperidinium, 3-(hydroxymethyl)-1,1-dimethyl-, (8s-cis)-||mapped_to
membrane associated proteins||rmr2 protein, arabidopsis||mapped_to
monoterpenes, cyclopentane||oleuropein aglycone||mapped_to
acid, pyrogallic||4,4'-dihydroxy-3,3',5,5'-tetramethoxy-2,7'-cyclolignin-9,9'-acetonide||mapped_to
presence of artificial hip joint, bilateral||history of bilateral hip replacement||mapped_to
[v]family history of other mental and behavioural disorders||parasuicide; history, family||mapped_to
methane (substance)||tetraphenylmethane||mapped_to
marasmic kwashiorkor||other severe protein-calorie malnutrition||mapped_to
oth diseases digest system||toxic colitis (disorder)||mapped_to
other disease of eye||stenosis; lacrimal passages or duct||mapped_to
unspecified mononeuropathy of upper limb||entrapment of peripheral nerve of left upper limb (disorder)||mapped_to
cholesteatoma nos||cholesterin granuloma of middle ear and mastoid||mapped_to
vertebral column (body structure)||oculoauriculofrontonasal dysplasia||mapped_to
psychomotor deficit (history)||cognitive deficit in psychomotor function (finding)||mapped_to
loss of teeth due to accident, extraction, or local periodontal disease||comp edentulism,class ii||mapped_to
child behavior symptom/complaint||development; delayed, physiological, specified stage||mapped_to
biopterin analyte||tepidopterin||mapped_to
nucleotidyltransferase (substance)||reovirus protein lambda2||mapped_to
sleepiness||relaxing||mapped_to
transporter, abc||ecsa protein, bacillus subtilis||mapped_to
renal agenesis or dysgenesis nos (disorder)||agenesis; kidney, bilateral||mapped_to
lim kinase||lim-domain containing, protein kinase, mouse||mapped_to
benzoate||n-succinimidyl-2,4-dimethoxy-3-(tributylstannyl)benzoate||mapped_to
discordant ventriculoarterial connection with concordant atrioventricular connection||great transposition vessel||mapped_to
osteochondrodysplasia syndrome||situs inversus totalis with cystic dysplasia of kidneys and pancreas||mapped_to
oth comp int ort pr dev/imp||joint prosthesis; hemorrhage||mapped_to
high risk pregnancy||pregnancy; death of fetus (near term)||mapped_to
malaria, unspecified||anemia; paludal (manifestation)||mapped_to
bacterial toxin, nos||pro-aerolysin||mapped_to
caenorhabditis elegans proteins||myc and mondo-like 1 protein, c elegans||mapped_to
isozyme||alpp||mapped_to
2,3-dihydro-3-oxobenzisosulfonazole||win 65936||mapped_to
endocr/metab/nutrit disease other||nelson's syndrome||mapped_to
cesarean section; with hysterectomy||delivery by cesarean hysterectomy (diagnosis)||mapped_to
[x]other symptoms and signs concerning food and fluid intake||defective thirst mechanism||mapped_to
triazole||bis(5-(2,3-dihydro-1,4-benzodioxin-2-yl)-4h-1,2,4-triazol-3-yl)disulfide||mapped_to
worms/other parasites||meningitis; eosinophilic (etiology)||mapped_to
malignant spinal cord neoplasm||well differentiated spinal cord oligodendroglioma||mapped_to
trans activators||transforming growth factor-beta-inducible early gene 2 product, rat||mapped_to
inborn metal metabolism disorder||ict||mapped_to
group ii chaperonins||bbs6 protein, human||mapped_to
hemorr choroid detachmnt||haemorrhagic choroidal detachm||mapped_to
[x]intracranial and intraspinal abscess and granuloma in diseases classified elsewhere||cladosporium; bantianum (brain abscess) (etiology)||mapped_to
vinblastinum||m-cavi protocol||mapped_to
current tear of semilunar cartilage||tear; cartilage, knee, meniscus||mapped_to
piperidines||n-(4-chlorophenyl)-4-(3-(1-(2-(4-(2,4-dimethoxybenzoyl)phenoxy)acetyl)piperidin-4-yl)propyl)piperidine-1-carboxamide||mapped_to
pyridinone||rk 1009||mapped_to
microrna||mmu-mir-300||mapped_to
skin disease other||appenheim's disease||mapped_to
sinusitis acute/chronic||frontal sinusitis (disorder)||mapped_to
gene products, bacterial||peptide 145, streptococcus||mapped_to
syphilis male||hemianesthesia; syphilitic||mapped_to
organophosphorus compounds||(hydroxyphosphinyl)pyruvic acid||mapped_to
intellectual disabilities||deafness, cochlear, with myopia and intellectual impairment||mapped_to
viral coat proteins||vp3 protein, simian virus 40||mapped_to
bauxite fibrosis of lung (disorder)||shavers disease||mapped_to
venoms, snake||helicopsin, helicops angulatus||mapped_to
knee; loose body||knee; mice||mapped_to
endocrine/metabolic/nutritional disease other||disease, wolff periodic||mapped_to
effect(s);prosthetic device||complications; implant or graft, vascular, pain||mapped_to
amidohydrolases||aculeacin a acylase||mapped_to
arabidopsis proteins||at1g25560 protein, arabidopsis||mapped_to
arabinonucleosides||1-arabinofuranosyl-2-thiocytosine||mapped_to
syphilis female||atrophy; macular, syphilitic, skin (manifestation)||mapped_to
abnormal electrocardiogram [ecg] [ekg]||electrocardiographic st interval abnormal (finding)||mapped_to
[x]o+unsp dis/plp+periapical t||nonvital tooth (finding)||mapped_to
malignant neoplasm of skin of lower limb and hip||malignant neoplasm of skin of knee||mapped_to
organophosphonates||diethyl benzylpiperazinomethylbenzylphosphonate||mapped_to
unifiber||cellulose tris-3,5-dimethylphenyl-carbamate||mapped_to
cortinarius, nos||cortinarius austrovaginatus gasparini, 2007||mapped_to
n-acetylglucosamine transferases||beta3gn-t3||mapped_to
isoxazole||5-(3-(hexahydroazepin-1-yl)propyl)(benzodioxol-5-yl)amino-3-(3,5-difluorophenyl)isoxazole||mapped_to
genus chryseomonas||pseudomonas costantinii munsch et al. 2002||mapped_to
ascomycota||pseudocercospora perae||mapped_to
phylum chytridiomycota (organism)||rhizophydium elyense sparrow, 1957||mapped_to
dideoxynucleosides||3'-fluoro-2',3'-dideoxythymidine||mapped_to
pseudoalteromonas gauthier et al. 1995 emend. ivanova et al. 2002||pseudoalteromonas xiamenensis zhao et al. 2014||mapped_to
factor, transcription||pikd protein, streptomyces venezuelae||mapped_to
maternal care for disproportion of other origin||delivery or maternal condition affecting care major abnormality of bony pelvis||mapped_to
arabidopsis proteins||cpn1 protein, arabidopsis||mapped_to
heterocyclic compounds, 3-ring||iotrochotazine a||mapped_to
quercetin product||5,7,3'-trimethoxy-quercetin-3-o-beta-d-glucopyranoside||mapped_to
propionates||3-(5-((5-(4-chlorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoic acid||mapped_to
vascular disorder of intestine acute||infarction; bowel||mapped_to
third-nerve palsy||third cranial nerve disease||mapped_to
oth spcfd disorders/urethra||rupture of posterior urethra (disorder)||mapped_to
protein disulfide isomerase family||pdia3 protein, mouse||mapped_to
female pelvic inflammatory diseases nos (disorder)||endometritis; tuberculous (manifestation)||mapped_to
pyrimidines||g-749 compound||mapped_to
rna, micro||mirn305 microrna, drosophila||mapped_to
chromosome, ring||ring chromosome 7 syndrome (diagnosis)||mapped_to
phenylamines||3,5,n,n-tetramethylaniline||mapped_to
protein, virus envelope||32kda protein, vaccinia virus||mapped_to
pediculosis/other skin infest||body lice (physical finding)||mapped_to
micro-rna||mirn-1181 microrna, human||mapped_to
phyllachorales||phyllachora phyllostachydis||mapped_to
phylum basidiomycota||rhizopogon butyraceus a.h. sm., 1966||mapped_to
disorders of pyruvate metabolism and gluconeogenesis (disorder)||defic dis pyruvate carboxylase||mapped_to
fungus sac||ellisembia calyptrata||mapped_to
myosin type i||nm1 protein, human||mapped_to
serine threonine kinase||il-1 receptor-associated kinase 4, rat||mapped_to
aniline cpds||n,n-dimethylaminobenzyl alcohol||mapped_to
hypo-osmolality and hyponatremia||inadequate sodium intake (finding)||mapped_to
indazole||n1-(4-(3-isopropyl-2-methylindazol-5-yl)pyrimidin-2-yl)-n4-tetrahydropyran-4-yl-cyclohexane-1,4-diamine||mapped_to
sulfonamide product||incb 13739||mapped_to
oth+unspc lesns/oral mucosa||disease of uvula of palate (disorder)||mapped_to
inadequate social skills, not elsewhere classified in icd10cm||inadequate social skills (finding)||mapped_to
c. glabrata||torulopsis||mapped_to
basidiomycota||lactarius pasohensis||mapped_to
electric conductivity||conductivity, electrical||mapped_to
unspec sev prot-energy maln||nutritional; hydrops||mapped_to
protein, membrane||itn1 protein, arabidopsis||mapped_to
injury of conjunctiva and corneal abrasion without menti||conjunctiva; wound||mapped_to
oligosaccharides||methyl o-(3-o-hexylglucopyranosyl)-1-6-(o-(glucopyranosyl)-1-6-o-(3-o-hexylglucopyranosyl)-1-6)3-glucopyranoside||mapped_to
division ascomycota (organism)||pseudophloeospora jollyi crous, 2019||mapped_to
jatenzo||delta(6)-testosterone||mapped_to
syphilis male||syphilis; late, latent, positive serology||mapped_to
gdp exchange factors||rabx-5 protein, c elegans||mapped_to
intercellular signaling peptides proteins||ovcnp-39 peptide||mapped_to
triterpenes||3beta,6beta,19alpha,24-tetrahydroxy-urs-12-en-28-oic acid||mapped_to
fungus sac||peziza domiciliana cooke, 1877||mapped_to
oth disordrs/kidney+ureter/infects+parasitic diseases ce||pyonephrosis; tuberculous (etiology)||mapped_to
thiophenes||gpi688||mapped_to
fluorocarbon||fs069||mapped_to
phylum ascomycota||fulvoflamma eucalypti||mapped_to
1,3 diphenyl 2 propen 1 one||phlebodril||mapped_to
idiopathic non-familial dystonia||idiopathic nonfamilial dystonia (diagnosis)||mapped_to
suspiciousness and marked evasiveness (finding)||marked evasiveness; behavior||mapped_to
shigella infection||enteritis; bacillary||mapped_to
allergy status to other drug/meds/biol subst||ethamivan allergy||mapped_to
adenin||octadecyloxyethyl 9-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine||mapped_to
lichen sclerosis||adult lichen sclerosus||mapped_to
disaccharides||n-acetylneuraminyl-(2-3)-galactose||mapped_to
[x]any cyclist inj in unsp ta||pedal cycle accident nos||mapped_to
abnormal levels of other serum enzymes (finding)||enzyme level in serum specimen above reference range||mapped_to
abnormal;reflex||finger jerk present only with reinforcement||mapped_to
pyridines||2,6-dichloro-3-trifluoromethylpyridine||mapped_to
thiazoles||sar inducer bit||mapped_to
complication of medical treatment||rejection of transplanted pancreas (treatment)||mapped_to
specific learning problems||primary dyscalculias||mapped_to
[x]other cardiomyopathies (disorder)||arrhythmogenic left ventricular cardiomyopathy (disorder)||mapped_to
other specified disorders of adrenal glands||adrenal calcification (diagnosis)||mapped_to
pyridines||urmc-099||mapped_to
acids, anilinesulfonic||4'-dimethylphenylsilyl-1'-hexen-6'-yl 4-(acetylamino)benzenesulfonate||mapped_to
other complic of puerperium||puerperium; acute renal failure||mapped_to
effect prosthetic device||complications; internal fixation, pain||mapped_to
resin, composite||grandioso flow||mapped_to
dna binding proteins||hslr protein, e coli||mapped_to
[d]icterus (context-dependent category)||yellow sclera||mapped_to
carbocyanine||1,1'-diethyl-4,4'-carbocyanine||mapped_to
congenital abnormality of the circulatory system||heart valve; supernumerary, aortic||mapped_to
poison-ent preparation||poisoning caused by ear anti-infective||mapped_to
peptide||pr(20) peptide||mapped_to
stress, mechanical||strains and stresses||mapped_to
malignant tumour of undescended testis||malignant tumour of retained testis||mapped_to
neuritis||neuropathy vitamin b6 deficiency||mapped_to
tb bone||tuberculosis; shoulder, shoulder blade (manifestation)||mapped_to
[x]other miliary tuberculosis||chronic miliary tuberculosis (diagnosis)||mapped_to
hericium||hericium yumthangense k. das, stalpers & stielow, 2013||mapped_to
other respiratory system diseases (disorder)||air-conditner+humidifier lung||mapped_to
oth disor/autonomc nerv sys||parasympathetic cardiovascular function disorder (finding)||mapped_to
guanine nucleotide exchange factor||sec12 guanine nucleotide exchange factor, rat||mapped_to
vitamin/nutritional deficiency||deficiency; edema||mapped_to
ethylenediamine||tc-99m-mpbm-deeaotc||mapped_to
acquired arteriovenous fistula (morphologic abnormality)||surgically constructed brachiobasilic arteriovenous fistula (finding)||mapped_to
patient education about nutrition (treatment)||teaching about nutrition||mapped_to
metallo-organic compound||(eta(6)-cycloheptatriene)tricarbonylchromium||mapped_to
inborn error of metabolism nos||warfarin resistance||mapped_to
drug combinations||benzenepropanaminium, gamma-(aminocarbonyl)-n-methyl-n,n-bis(1-methylethyl)-gamma-phenyl-, iodide, mixt. with (r*,s*)-(+-)-alpha-(1-aminoethyl)benzenemethanol hydrochloride and 4-(diphenylmethoxy)-1-methylpiperidine hydrochloride||mapped_to
glycoside||madhucoside a||mapped_to
neoplasm malig;cervix||malignant tumor involving left fallopian tube by direct extension from uterine cervix (disorder)||mapped_to
surface protein||spe-19 protein, c elegans||mapped_to
penicillamine [musculoskeletal use]||bis(copper(ii)-d-penicillamine disulfide)nonahydrate||mapped_to
oth symptoms and signs involving the musculoskeletal system||difficulty pushing and pulling while running (finding)||mapped_to
alginates||alg-pdea||mapped_to
benzopyran 2 ones||coumaryl gamma-amino-butyric acid diazopyruvate||mapped_to
aza cpds||gamma-(gamma-azaglutamyl)cysteinylglycine||mapped_to
birth trauma intraventricular hemorrhage||intraventricular hemorrhage due to birth injury||mapped_to
indoles||bms-594726||mapped_to
cortinarius (pers.) gray, 1821||cortinarius palatinus harrower, 2015||mapped_to
neonicotinoids||thiacloprid||mapped_to
mushroom||bovista minor||mapped_to
acetylcysteine (medication)||aama sulfoxide||mapped_to
retracted nipple associated with childbirth||other+unspcf disorders/breast associated with childbirth||mapped_to
extracellular matrix proteins||2610001e17rik protein, mouse||mapped_to
1-aza-2,4-cyclopentadiene||nuclear import inhibitor ini-43||mapped_to
low-grade vaginal squamous intraepithelial lesion||vain grade 1||mapped_to
plant proteins||cbp4 protein, nicotiana tabacum||mapped_to
propiophenones||propiophenones||mapped_to
ot comp card pros dv/imp/gf||fibrosis; arterial graft||mapped_to
heterocyclic cpds 3 ring||8-geranyloxypsolaren||mapped_to
[x]myelopathy in diseases ce||a.spinalis anterior; syndrome, compression (manifestation)||mapped_to
catalytic rna||hairpin ribozyme||mapped_to
polyacetylenes||2s-tetrahydro-2 alpha(e)-(1-nonene-3,5,7-triynyl)- 2h-pyran-3 beta-ol||mapped_to
fourth degree perineal tear||c.delivery; laceration sphincter ani, with mucosa||mapped_to
fungal gene proteins||candida albicans adhesin||mapped_to
ascomycetes||eriopeziza caesia||mapped_to
other infectious diseases||candidiasis cheilitis||mapped_to
malignant neoplasm of unspecified ovary||primary mucinous adenocarcinoma of ovary (disorder)||mapped_to
exotropia (diagnosis)||exotropia, nos||mapped_to
dysplasia, odontogenic||odontoonychodermal dysplasia||mapped_to
breast cancer female||non-invasive papillary breast carcinoma||mapped_to
allergy status to other drugs, medicaments and biological substances||allergy to levocarnitine (finding)||mapped_to
cdc proteins||pek1 protein, s pombe||mapped_to
chaperone, molecular||csaa protein, bacillus subtilis||mapped_to
tributyrinase||lipl-4 protein, c elegans||mapped_to
toe web||toe webbed||mapped_to
chlorobenzoates||2-(3-hydroxypiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate||mapped_to
escherichia coli proteins||zapd protein, e coli||mapped_to
contusion of eyelids and/or periocular area (disorder)||ecchymosis of eyelid (disorder)||mapped_to
fluoresceins||acetamidofluorescein-kinesin||mapped_to
(1alpha,3beta,5z,7e)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol||24-keto-1,23,25-trihydroxyvitamin d3||mapped_to
orientation disturbed||delirium caused by substance or medication (disorder)||mapped_to
downs syndrome||facies mongoloid||mapped_to
benzodiones||2-methoxy-3-methyl-1,4-benzoquinone||mapped_to
reptile proteins||laticauda semifasciata iii||mapped_to
false labour (disorder)||c.pregnancy; false labor||mapped_to
other eye disorders (disorder)||degenerative progressive high myopia||mapped_to
regulatory proteins, apoptosis||air synthetic protein||mapped_to
pyrazoles||4-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1h-pyrazol-1-yl)-4-oxobutanoic acid||mapped_to
oligopeptides||cryptomaldamide||mapped_to
deformity congen foot||foot; malposition, congenital||mapped_to
body oxygen consumption (observable entity)||oxygen consumption (physiology)||mapped_to
dislocations, sprains, and strains involving other combinations of body regions (diagnosis)||dislocation; multiple, body regions||mapped_to
imidazolidine-2,4-diones||5-(3,5-diiodo-4-(3-isopropyl-4-hydroxyphenoxy)benzyl)imidazolidine-2,4-dione||mapped_to
secondary malig neo nec||secondary malignant neoplasm of foot, nos||mapped_to
diterpenoid||6beta-hydroxy-labda-8,13-dien-15-ol||mapped_to
aminoquinolines||cdn1163||mapped_to
complexes, metal||bis(n-(4-pyridyl)-p-toluene sulfonamide)palladium dichloride||mapped_to
neuropeptides||mas-mip iii protein, manduca sexta||mapped_to
pyrimidines||alpha-(2-chlorophenyl)-alpha-(4-chlorophenyl)-5-pyrimidinemethanol||mapped_to
p-dihydroxybenzenes||ethylhydroquinone||mapped_to
ascomycota (fungus)||geoglossum geesterani s. arauzo & a. lebre, 2014||mapped_to
presence of cerebrospinal fluid drainage device||postsurgical presence of cerebrospinal fluid drainage device||mapped_to
acetogenins||muricadienin||mapped_to
histop. duboisii infection nos||chronic pulmonary african histoplasmosis (disorder)||mapped_to
sulfonamides||ethyl cfscc||mapped_to
compound dental caries||primary non-active dental caries extending into middle third of dentin (disorder)||mapped_to
bronchopneumonia, hiberno-vernal||coxiella burnetii; rickettsiosis||mapped_to
photosystem i protein complex||psi-c protein, oryza sativa||mapped_to
mortierella coem., 1863||mortierella basiparvispora||mapped_to
other arterial obstructive/peripheral vascular disease||embolic; endarteritis||mapped_to
diaphorase (nadh dehydrogenase)||nd5 protein, mouse||mapped_to
seroconversions, hiv||seroconversion, hiv||mapped_to
connective and other soft tissue of thorax axilla||benign neoplasm soft tissue of thoracic spine||mapped_to
imidazole||2'-methylsulfonyl-5'-methoxy-2-(anilinomethyl)imidazoline||mapped_to
synthetase, anthranilate||anthranilate aggregate||mapped_to
pain/tenderness of skin||sensation disorder||mapped_to
[x]other multiple gestation (disorder)||quintuplet pregnancies||mapped_to
chronic; thyroiditis, fibrous||riedels thyroiditis||mapped_to
traumatic pneumohemothorax (diagnosis)||pneumohemothorax; traumatic||mapped_to
non-venereal endemic syphilis (disorder)||bejel||mapped_to
other specified congenital malformation syndromes, not elsewhere classified||pili torti with developmental delay and neurological abnormality syndrome||mapped_to
ear/mastoid disease other||external ear canal; collapse||mapped_to
transport protein||wap follistatin-kazal immunoglobulin kunitz and netrin domain containing 1 protein, human||mapped_to
oth cong malf lacrim appar||congenital ectopia of lacrimal punctum (disorder)||mapped_to
mastitis, associated with childbirth (disorder)||breast abscess pregnancy||mapped_to
peripheral neuritis/neuropathy||guillaine-barre syndrome||mapped_to
burn of third degree of hip and lower limb, except ankle and foot||third degree burn of multiple sites of lower leg||mapped_to
22-oxovincaleukoblastin||vip regimen 2||mapped_to
pias proteins||piasy protein, human||mapped_to
[d]difficulty in swallowing (situation)||difficulty swallowing saliva||mapped_to
diynes||1-chloro-9,10-epoxy-4,6-heptadecadiyne-2,3-diol||mapped_to
panniculitis nos||localized lipoatrophy of winkelmann||mapped_to
acute lymphoblastic leukemia protein 1||mll-af4 fusion protein, human||mapped_to
congenital deformity of digestive system, nos||congenital hiatus hernia (diagnosis)||mapped_to
phylum ascomycota||xylaria microceras||mapped_to
phosphates, deoxyadenosine||ddatp||mapped_to
dna binding protein||betl-4 protein, zea mays||mapped_to
sigma subunit||sigmax factor, bacillus subtilis||mapped_to
other urinary tract disorders||fistula; intestinovesical||mapped_to
protein, membrane||tenm3 protein, human||mapped_to
electron transport chain complex proteins||cox11 protein, human||mapped_to
tetrahydro 1,4 oxazines||n-(3-chloro-4-morpholin-4-yl) phenyl-n'-hydroxyimido formamide||mapped_to
other malignant neoplasms||endometrioid adenofibroma, malignant (morphologic abnormality)||mapped_to
a lipid||3-o-desacyl-4'-monophosphoryl lipid a||mapped_to
propionates||ethyl 3-(2-chlorophenyl)propenoate||mapped_to
disorders of plasma-protein metabolism, nec||deficiency of acetylserotonin methyltransferase||mapped_to
drug-induced osteoporosis with pathological fracture, site unspecified||fracture, pathological||mapped_to
disorder of iron metabolism nos (disorder)||iron; storage disorder||mapped_to
degenerative neurologic disease||acquired cerebral atrophy||mapped_to
familial multilocular cystic disease of the jaws||cherubism-gingival fibromatosis-epilepsy-mental deficiency syndrome||mapped_to
syphilis female||syphilis; thrombosis, coronary artery (etiology)||mapped_to
other urinary system diseases (disorder)||renal function alteration||mapped_to
[x]other mitral valve diseases (disorder)||mitral annular calcification||mapped_to
[v]pres/coron angiopl impl+gft||bare metal stent in anterior descending branch of left coronary artery||mapped_to
factor, transcription||dmrt6 protein, mouse||mapped_to
chronic instability of knee (finding)||old complete tear lateral collateral ligament||mapped_to
molybdenum||phosphoantimonylmolybdenum blue||mapped_to
disease fibrocystic||cf (cystic fibrosis)||mapped_to
derivatives, sesquiterpene||alpha-agarofuran||mapped_to
meningitis encephalitis||choriomeningitis (manifestation)||mapped_to
slc4a1 protein||anion exchange protein 1||mapped_to
digestive organ; anomaly||cecum; diverticulum, congenital||mapped_to
phylum ascomycota||umbilicaria squamosa j.c. wei & y.m. jiang 1992||mapped_to
contracture, unspecified wrist||ulnar deviation contracture of the wrist (disorder)||mapped_to
abnormal findings in specimens from other organs, systems and tissues||amniotic fluid; abnormality||mapped_to
zebra danio proteins||tnfsf18 protein, zebrafish||mapped_to
phenylalanine (substance)||cj-1737||mapped_to
champignon||gymnopus subsupinus||mapped_to
endopeptidases||proinsulin endopeptidase i||mapped_to
rndx drug abuse (diagnosis)||ethylbromide; dependence||mapped_to
streptococcus pneumoniae danish serotype 3 antibody^1st specimen:arbitrary concentration:to identify measures at a point in time:serum:quantitative||deprecated streptococcus pneumoniae 3 ab [units/volume] in serum --1st specimen||mapped_to
disulfide-isomerase, protein||protein disulfide isomerase-3, c elegans||mapped_to
other congen malf of ovary||duct of epoophoron (disorder)||mapped_to
female pregnancy||chromosome; abnormality, screening, by amniocentesis||mapped_to
other female genital disorder nos||abscess;bartholin||mapped_to
other neurological disorders||nervous system; degeneration, amyloid (manifestation)||mapped_to
homeodomain family protein||lbx1 protein, human||mapped_to
poisoning-opiates nec||codeine toxicity||mapped_to
product containing cytarabine (medicinal product)||2(1h)-pyrimidinone, 4-amino-1-(5-o-(hydroxy((hydroxy(2-(trimethylammonio)ethoxy)phosphinyl)oxy)phosphinyl)-beta-d-arabinofuranosyl)-||mapped_to
perinatal morbidity other||pelvic organ; deformity, in pregnancy or childbirth, causing obstructed labor, affecting fetus or newborn||mapped_to
bowel sounds abnormal||bowel sound||mapped_to
scabies infestation||crusted scabies||mapped_to
2-phenyl-2-ene-benzopyran-4-one compounds||triticumoside||mapped_to
ingrowing nail (disorder)||ingrowing nail nos||mapped_to
complication of surgical / medical care||rejection; transplant, liver||mapped_to
2 phenyl chromenes||2'-chloroflavone||mapped_to
monooxygenase (substance)||senecionine n-oxygenase||mapped_to
bromhidrosis (diagnosis)||bromhidrosis (disorder)||mapped_to
pyrroles||su11652||mapped_to
order mucorales (organism)||circinella angarensis||mapped_to
pregnancy related conditions, unsp, unspecified trimester||auscultatory sign (finding)||mapped_to
anemias, hereditary hemolytic||hemolytic; anemia, hereditary||mapped_to
marfan's syndrome, unspecified||marfanoid habitus-microcephaly-glomerulonephritis syndrome||mapped_to
tuberculosis of intestines, peritoneum, and mesenteric glands||tuberculosis orificialis of anus (diagnosis)||mapped_to
congenital anomalies of lens shape||spherophakia (disorder)||mapped_to
cyclohexanones||salvionoside c||mapped_to
encephalitis, saint louis||st. louis encephalitis||mapped_to
fragments, peptide||vasoactive intestinal polypeptide (6-23)||mapped_to
isophane insulin preparation (substance)||insulin isophane porcine||mapped_to
guanidine||nsggmpp||mapped_to
oligopeptides||z-evd-ch2-dcb||mapped_to
escherichia coli proteins||tssj protein, e coli||mapped_to
connective and soft tissue, unspecified||rhabdomyosarcoma||mapped_to
local edema||breast oedema||mapped_to
butanes||1,4-diethoxybutane||mapped_to
oligonucleotides||gti-2501||mapped_to
proteins, drosophila||vimar protein, drosophila||mapped_to
anziaceae||parmotrema perlatum||mapped_to
other peripheral neuritis||neuritis; gouty (manifestation)||mapped_to
triazene||triacsin d||mapped_to
myelin proteolipid protein||plp1a protein, zebrafish||mapped_to
ascomycotas||placodium lobulatum||mapped_to
organoselenium compounds||etnbse||mapped_to
disorders of magnesium metabolism||hypomagnesemia (disorder)||mapped_to
nucleotide aptamers||cxcl12-targeted agent nox-a12||mapped_to
monoterpenes||linalyl phenylacetate||mapped_to
hiv envelope protein gp 160||gp160 protein, hiv-i||mapped_to
spiro compounds||poly(2-hydroxyethyl methacrylate-co-3,9-divinyl-2,4,8,10-tetraoxaspiro(5.5)undecane)||mapped_to
other sleep disturbances||exploding head syndrome||mapped_to
cortinarius, nos||cortinarius permagnificus||mapped_to
retinal (bacteriorhodopsin)||5,6-epoxyretinal||mapped_to
idiopathic corneal edema||idiopathic corneal edema (diagnosis)||mapped_to
sac fungi||clarireedia jacksonii c. salgado, l.a. beirn, b.b. clarke, & j.a. crouch, 2018||mapped_to
neurologic degenerative condition||brain wasting||mapped_to
phylum ascomycota||lecanora leptacina sommerf., 1826||mapped_to
chainia||streptomyces platensis tresner and backus 1956||mapped_to
pyridines||dihydropyridine-bodipy||mapped_to
eosine||acetamide, 2-iodo-n-(2',4',5',7'-tetrabromo-3',6'-dihydroxy-3-oxospiro(isobenzofuran-1(3h),9'-(9h)xanthen)-5-yl)-||mapped_to
personal history of other diseases of the musculoskeletal system and connective tissue||history of polymyalgia rheumatica||mapped_to
lymphocytic meningitis||lymphocytic choriomeningitis||mapped_to
(-)-propafenone||2-(2-(diethylamino)ethoxy)-3-phenylpropiophenone||mapped_to
pe - pre-eclampsia||proteinuria; with hypertension, complicating pregnancy||mapped_to
cis-diamminedichloroplatinum(ii)||mpepie protocol||mapped_to
infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts||complications; device, infection or inflammation||mapped_to
malignant neoplasm female breast||adenocarcinoma in situ of breast (diagnosis)||mapped_to
repressor proteins||rbak protein, human||mapped_to
phylum dikaryomycota||xylodon spathulatus||mapped_to
neuropeptides||dansyl-pro-gln-arg amide||mapped_to
nervous system congenital abnormalities||diplomyelia||mapped_to
lactone||n-octanoyl-hsl||mapped_to
fall on same level from slipping, tripping and stumbling causing accidental injury||fall due unev surf indoor||mapped_to
other complications of internal prosthetic devices, implants and grafts, not elsewhere classified||complications; implant or graft, eye, thrombosis, intraocular lens||mapped_to
deficiency of glucan 1,4-alpha-glucosidase||acid maltase deficiency||mapped_to
phylum ascomycota||pisorosporium cymbiforme reblova & j. fourn., 2014||mapped_to
vinblastina||4-o-(hypsschgnssp)desacv||mapped_to
oximes||retinal, oxime, (11-cis,15z)-||mapped_to
cytophaga-flavobacteria-bacteroides group bacteria||lunatimonas lonarensis||mapped_to
protein, thrombospondin-5||thrombospondin 5, human||mapped_to
pale color||livedo (finding)||mapped_to
rna-binding protein||mos2 protein, arabidopsis||mapped_to
ankyrin (substance)||protein 2.1, human||mapped_to
peptide, nos||kistamicin b||mapped_to
malignant tumor of lymphoid, hemopoietic and/or related tissue||primary malignant neoplasm of bone marrow (disorder)||mapped_to
psoriasis unspecified||x-linked mental retardation associated with psoriasis||mapped_to
xenopus proteins||cenp-t protein, xenopus||mapped_to
pyrexia during labor, not elsewhere classified in icd10cm||pyrexia; during labor||mapped_to
benzene-1,3,5-triol||saroaspidin a||mapped_to
imipramine (product)||2-(n,n-dimethylaminomethyl)-2,3,7,8-tetrahydro-1h-quino(1,8-ab)(1)benzazepine||mapped_to
fluorenes||benzo[j]fluoranthene||mapped_to
nephropathy caused by heavy metals||nephropathy induced by heavy metals||mapped_to
triplicin||dexamethasone / neomycin / polymyxin b||mapped_to
other abnormal findings in urine||urine: orange (finding)||mapped_to
sulphonamides||grl-0519||mapped_to
maleates||calcium-sodium maleate methyl vinyl ether copolymer||mapped_to
anziaceae||bryoria tenuis||mapped_to
lyase, s-hydroxyalkyl glutathione||cvgst1 protein, culicoides variipennis sonorensis||mapped_to
congenital anomaly of respiratory system, nos||tracheal agenesis||mapped_to
hemorrhagic condition||diathesis, hemorrhagic||mapped_to
other inj of eye & orbit||superficial injury of eye and/or adnexa (disorder)||mapped_to
family planococcaceae||chryseomicrobium amylolyticum (organism)||mapped_to
bile duct neoplasms||bile ducts cancer||mapped_to
other general/unspecified diseases||not done; procedure, patient's decision, social pressure||mapped_to
congenital anomaly of cardiovascular system||myocardium; anomaly||mapped_to
gpi-linked proteins||oligodendrocyte myelin glycoprotein, rat||mapped_to
saccharomyces cerevisiae proteins||rrt2 protein, s cerevisiae||mapped_to
1 benzazine||isaindigotidione||mapped_to
pyridines||n-(2-pyridyl)glycine||mapped_to
fusarium link, 1809||fusarium nepalense t. aoki, carter, nicholson, kistler & o'donnell, 2014||mapped_to
polymeric||reigning resin||mapped_to
tuberculosis of other specified organs nos (disorder)||pericardium; adhesion, tuberculous (etiology)||mapped_to
pseudo hypoparathyroidism||pseudohypoparathyroidism and pseudopseudohypoparathyroidism (disorder)||mapped_to
malignant neoplasm of upper limb, nos||malignant neoplasm of arm, nos||mapped_to
trifluoroacetic acid||tfa-acr-rsa||mapped_to
benzyl compounds||dibenzyl diselenide||mapped_to
62 proteins||zinc finger, an1-type domain 5 protein, human||mapped_to
205-207 hydrocarbons||gilsonite||mapped_to
[x]exposure to man-made visible and ultraviolet light, occurrence at unspecified place (event)||exposure to man-made vis light||mapped_to
onygenale||gymnascella afilamentosa||mapped_to
abietane diterpenes||sugikurojin d||mapped_to
chronic antritis||maxilla; infection, sinus (chronic)||mapped_to
[x]unspecified b-cell non-hodgkin's lymphoma||b-cell lymphoma of lymph nodes of multiple sites (disorder)||mapped_to
zebra danio proteins||hadp1 protein, zebrafish||mapped_to
congenital hip deformity||congenital deformity of right hip joint||mapped_to
ascomycota||phyllosticta iridigena||mapped_to
bacterial protein (substance)||ompl protein, bacteria||mapped_to
separation of muscle (nontraumatic), other site||diastatsis recti||mapped_to
dimethylamines||2-(2-dimethylaminoethoxy)ethanol||mapped_to
sulfonamide-containing product||ynt-707||mapped_to
cat-scratch; disease||lymphadenitis; regional||mapped_to
cationic antimicrobial peptide||k4-s4(1-13)a||mapped_to
naphthalenesulfonates||5-amino-1- naphthalenesulfonic acid||mapped_to
abnormal level enzymes in cerebrospinal fluid||abnormal; fluid, cerebrospinal||mapped_to
pentyl alcohols||prenol||mapped_to
penicillium, nos||penicillium sclerotigenum||mapped_to
erysiphe (organism)||microsphaera coriariae||mapped_to
organic metallic compound (substance)||gadopentetate dimeglumine polylysine||mapped_to
sprain and strain involving (anterior)(posterior) cruciate ligament of knee||chronic rupture of posterior cruciate ligament of left knee||mapped_to
[x]oth spec symptom+signs involving circulat+respiratory sys (finding)||ectopic pulse||mapped_to
gene proteins, bacterial||nifl protein, bacteria||mapped_to
nontraumatic hematoma of soft tissue||colonic haematoma||mapped_to
hypo-osmolality and hyponatraemia||hyponatraemia with decreased serum osmolality||mapped_to
cathelicidins||art-175||mapped_to
order agaricales - mushrooms||amyloflagellula verrucosa agerer & boidin, 1981||mapped_to
phylum dikaryomycota||russula fragilis fr., 1838||mapped_to
bile alcohol||6,6-difluorocholestanol||mapped_to
cervical cancer||pt2 (ii): cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (tnm category and figo stage) (uterine cervix)||mapped_to
retromolar area||malignant retromolar area neoplasm||mapped_to
l cysteine n acetyl||2-((2-(acetylamino-2-carboxyethyl)sulfanyl)butanedioic acid||mapped_to
muses||pge0||mapped_to
drug combination||chlorpromazine, dexamethasone, metoclopramide, orphenadrine drug combination||mapped_to
thiazine (substance)||ym58875||mapped_to
phenylalanine product||2-(n'-acetylphenylalanylamino)ethyl-2'-pyridyl disulfide||mapped_to
compounds, benzyl||4,4'-bismaleimidodiphenylmethane||mapped_to
clostridium group firmicutes||ezakiella peruensis||mapped_to
9-β-d-ribofuranosyl-9h-purin-6-amine||2-azido-adenosine||mapped_to
acridine||n-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide||mapped_to
other fecal abnormalities||dry faeces||mapped_to
thiolester hydrolase||carnitine acetyl-coa hydrolase||mapped_to
pterins||ec140 compound||mapped_to
doxorubicin product||4-demethoxy-7-o-(2,6-dideoxy-2-fluorotalopyranosyl)adriamycinone||mapped_to
adverse effect of physical factor, nos||effects of; exertion||mapped_to
[d]nausea and vomiting||nausea and vomiting (disorder)||mapped_to
carbohydrate metabolism, inborn error||phgdhd||mapped_to
rndx fluid volume deficit||dehydrated||mapped_to
pneumonia caused by mycoplasma pneumoniae (disorder)||bronchopneumonia; mycoplasma (pneumoniae)||mapped_to
plant protein||hydroxyproline-rich glycoprotein, plant||mapped_to
maternal care for disproportion due to outlet contraction (pelvis)||pregnancy; contracted pelvis, outlet||mapped_to
adp ribosylation factor||arf2 protein, rat||mapped_to
arabinonucleosides||arabinofuranosylthymine||mapped_to
surface markers, immunological||tra-1-60 protein, human||mapped_to
inflammatory diseases of the female genital organs and tissues||myometritis (disorder)||mapped_to
[x]crushing injury of other and unspecified parts of wrist and hand (disorder)||closed crush injury wrist, dorsum||mapped_to
fission yeast proteins||psy1 protein, s pombe||mapped_to
fracture hand/foot bones||fracture of cuboid (disorder)||mapped_to
lung secondaries||secondary adenocarcinoma of right lung (disorder)||mapped_to
mal neo head/face/neck||preauricular region||mapped_to
rhizobium frank 1889 (approved lists 1980) emend. young et al. 2001||rhizobium lentis rashid et al. 2015||mapped_to
indole compound||indolin-2-one||mapped_to
bipolar affective disorder, depressed, severe degree, without mention of psychotic behavior||severe depressed bipolar disorder without psychotic features||mapped_to
genus rhodococcus||rhodococcus yunnanensis zhang et al. 2005||mapped_to
[x]oth prob rel life-manag dif||unable to use pedestrian crossing (finding)||mapped_to
[x]other diseases/capillaries||thrombosis; capillary||mapped_to
cytophaga-flavobacteria-bacteroides group bacteria||mucilaginibacter aquaedulcis joung et al. 2015||mapped_to
other ovarian failure nos||other ovarian failure, nec||mapped_to
1,2-benzopyrones||d719 compound||mapped_to
injury of multiple blood vessels at abdomen, lower back and pelvis level||injury; blood vessel, back, lower, multiple||mapped_to
endocrine anomaly nec||pituitary; accessory||mapped_to
hla-dr beta||hla-drb6 antigen||mapped_to
basidiomycota||arcangeliella camphorata (singer & a.h. sm.) pegler & t.w.k. young, 1979||mapped_to
breast cancer stage unspecified||lipid-rich carcinoma (morphologic abnormality)||mapped_to
crushing injury of shoulder and upper arm -retired-||crushing injury of scapular region||mapped_to
guanine||(z)-9-((2,2-bis-(hydroxymethyl)cyclopropylidene)methyl)guanine||mapped_to
open wound of head, part unspecified||open wnd head nec-compl||mapped_to
osteochondrosis, capital femoral epiphysis||legg-calvâe-perthes disease||mapped_to
congenital myopathies other||myopathy with abnormality of histochemical fiber type||mapped_to
peptide fragments||pacap-related peptide||mapped_to
[x]oth spcf diso/kidney+ureter||kidney; degeneration, fatty||mapped_to
2-phenyl-3-hydroxy-benzopyran-4-ones||4h-1-benzopyran-4-one, 3-(beta-d-glucopyranosyloxy)-2-(4-(beta-d-glucopyranosyloxy)phenyl)-5-hydroxy-7-methoxy-||mapped_to
dna binding proteins||arf8 protein, arabidopsis||mapped_to
taurine (product)||(2-sulfoethyl)carbamodithioic acid, monosodium salt||mapped_to
other eye disorders (disorder)||ocular melanocytosis||mapped_to
cerebrovascular disease, nos||disease (or disorder); brain, arteriosclerotic||mapped_to
azulenes||2-methylbut-2-enoic acid 4-butyryloxy-6-ethoxy-3,3a-dihydroxy-3,6,9-trimethyl-2-oxododecahydroazuleno(4,5-b)furan-8-yl ester||mapped_to
succinate||hmeps compound||mapped_to
infertility/subfertility male||advice; procreative||mapped_to
acids, cholalic||3alpha-hydroxy-12-oxo-5beta-cholanoic acid||mapped_to
behavior problem parent/family||[v]aged parents or in-law problems||mapped_to
genus marinomonas (organism)||marinomonas pontii||mapped_to
tetrahydro isoquinoline||n,n'-bis-(2-carbamoyl-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinyl)piperazine||mapped_to
basidiomycotas||leccinum roseotinctum||mapped_to
phyllachorale||phyllachora furnasensis santos, r.b. medeiros & dianese, 2016||mapped_to
effect prosthetic device||artificial; opening gastrointestinal tract, care||mapped_to
bordetella species||bordetella muralis||mapped_to
hepatomegaly, not elsewhere classified||liver mass||mapped_to
loss; hair||hereditary mucoepithelial dysplasia||mapped_to
congenital unstable hip (diagnosis)||unilateral congenital subluxation of hip (disorder)||mapped_to
congen.cystic lung dis.unsp.||congenital cystic lung disease, unspecified (disorder)||mapped_to
atypical mycobacterial infection pulmonary||battey; mycobacterium infection||mapped_to
1 aminonaphthalene||1-(6-fluoro-3-(trifluoromethyl)phenyl)-1-methyl-3-(naphthalen-1-yl)guanidine||mapped_to
zebra danio proteins||orf1 protein, zebrafish||mapped_to
neoplasm of uncertain behavior of other specified female genital organs||neoplasm of uncertain behavior of round ligament of uterus (disorder)||mapped_to
malignant tumor of brain||gemistocytic astrocytoma of brain (diagnosis)||mapped_to
long ncrnas||yellow-achaete intergenic rna, drosophila||mapped_to
endotracheal tube wrongly placed during anaesthetic procedure (event)||endobronchial tube wrongly placed during anesthetic procedure (finding)||mapped_to
atypical anorexia nervosa (diagnosis)||atypical anorexia nervosa (diagnosis)||mapped_to
peripheral arteriovenous malformation||arteriovenous malformation of duodenum (diagnosis)||mapped_to
dioxole (substance)||6-(naphthalen-1-yl)(1,3)dioxolo(4,5-g)quinolin-8(5h)-one||mapped_to
saponins||lotoidoside d||mapped_to
ribosomal protein||ribosomal protein s1||mapped_to
perinatal morbidity other||fetal or neonatal effect of placentitis (disorder)||mapped_to
membrane proteins||systemin-binding protein, lycopersicon esculentum||mapped_to
proteins, drosophila||nmdar1 protein, drosophila||mapped_to
sulfone - chemical (substance)||n-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine||mapped_to
nitrile (substance)||diaminomaleonitrile||mapped_to
other cong malformat syndr due to known exogenous causes||foetal acitretin syndrome||mapped_to
piperidines||troxyl||mapped_to
acquired short achilles tendon (diagnosis)||other synovial, tendon and bursa disorders||mapped_to
224 organic metallic compounds||copper(ii)-doxorubicin complex||mapped_to
compounds, biphenyl||biphenyl 2,3',4,5',6-pentakisphosphate||mapped_to
complexes, coordination||(eta6-p-cymene)ruthenium(2-anthracen-9-ylmethylene-n-ethylhydrazinecarbothioamide)||mapped_to
unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent (diagnosis)||inguinal herniae||mapped_to
organophosphorus compound||cyclobutylene ap5||mapped_to
proteins, nuclear||pcid2 protein, human||mapped_to
product containing quinazoline (product)||smo antagonist bms 833923||mapped_to
cinnamate||4-o-glucopyranosyloxy-8-hydroxycinnamic acid||mapped_to
premat.cranial suture closure||opitz trigonocephaly-like syndrome||mapped_to
arabidopsis proteins||rpotmp protein, arabidopsis||mapped_to
renal function abnormal glomer||dysfunctions kidney||mapped_to
delay puberty||sexual; development delayed||mapped_to
neurosyphilis, symptomatic||meningeal; neurosyphilis (etiology)||mapped_to
other congen malform lower limb(s), includ pelvic girdle||thigh; anomaly||mapped_to
pneumonia, abacterial||viral pneumonia nos||mapped_to
saponins||18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-o-beta-d-glucopyranurosyl-alpha-d-glucopyranosiduronate magnesium tetrahydrate||mapped_to
[x]other superficial injuries of abdomen, lower back and pelvis (disorder)||blister of groin without infection (disorder)||mapped_to
knee; sprain (strain), cruciate ligament||knee; sprain (strain), cruciate ligament||mapped_to
tissue injury of conjunctiva||tissue injury of conjunctiva||mapped_to
oligopeptide||win 67694||mapped_to
cellulitis of arm||acute lymphangitis of forearm (diagnosis)||mapped_to
imidoesters||4-azidobenzimidate||mapped_to
triazole (substance)||7-((4-(4-chlorophenyl)-4h-1,2,4-triazol-3-yl)methoxy)-4-phenyl-2h-chromen-2-one||mapped_to
auto driver exam||automobile drivers' tests||mapped_to
cycloheptanes||10-hydroxykarahanaenone||mapped_to
infection by candida species||infection caused by candida albicans||mapped_to
amino acids, diamino||spermic acid||mapped_to
triterpenoids||alangidiol||mapped_to
disorders neuropathy||nervous system dis||mapped_to
bmpr-i receptors||bone morphogenetic protein receptor ia, xenopus||mapped_to
zea mays (corn) starch||ondansetron hydrochloride, 8 mg oral tablet||has_inactive_ingredient
titanium dioxide||sodium fluoride 1.5 mg in 1 g dental paste, dentifrice [hello hemp seed oil plus coconut oil extra freshening fluoride]||has_inactive_ingredient
magnesium stearate (substance)||sertraline hydrochloride 25mg tablet (product)||has_inactive_ingredient
peg-9 diglycidyl ether/sodium hyaluronate crosspolymer||body prescriptions antibacterial hand sanitizer winter mint cranberry kit||has_inactive_ingredient
red ferric oxide||oxycodone 20 mg oral tablet, extended release||has_inactive_ingredient
brilliant blue||lansoprazole 15mg cap,sa,ud||has_inactive_ingredient
sodium phosphate,dibasic,anhydrous||aranesp 100mcg/ml solution for injection||has_inactive_ingredient
h2o - water||alcohol 80 ml in 100 ml topical solution [center for applied innovation llc hand sanitizer]||has_inactive_ingredient
sodium chloride [mouth] (substance)||lolium perenne pollen 100000 [bau] in 1 ml percutaneous injection, solution||has_inactive_ingredient
1,2-octanediol||octinoxate 1.28 g in 32 g / titanium dioxide .96 g in 32 g topical cream [ceramide lift and firm makeup broad spectrum sunscreen spf 15 bisque]||has_inactive_ingredient
corn starch product||heb allergy relief 24 hour 180mg tablet||has_inactive_ingredient
5-(1,3-bis(hydroxymethyl)ureido)-1,3-bis(hydroxymethyl)imidazol-2,5(3h,5h)dione||benzoyl peroxide 2.5 g in 100 g topical lotion [spot acne treatment]||has_inactive_ingredient
ethyl citrate||aspirin 81 mg oral tablet, coated [coraspirina 81 mg tabletas con cubierta enterica]||has_inactive_ingredient
ethylhexylglycerin||salicylic acid 20 mg in 1 ml topical lotion [breakout clearing overnight treatment]||has_inactive_ingredient
glyceryl isostearate||octinoxate 0.068 g in 1 g topical lipstick [esika hd color high definition color spf 20 hd naranja provocacion - orange]||has_inactive_ingredient
polysorbate 60||salicylic acid 10 mg in 1 ml topical cream [yourgoodskin blackhead clearing scrub]||has_inactive_ingredient
aluminum hydroxide (product)||octinoxate 2 mg in 40 ml / zinc oxide 1.96 mg in 40 ml / titanium dioxide 1.66 mg in 40 ml topical cream [color correcting primer purple]||has_inactive_ingredient
lauroyl/myristoyl amidopropyl amine oxide||benzalkonium chloride 1.3 mg in 1 ml topical soap [walgreens fresh antibacterial foaming hand]||has_inactive_ingredient
oleyl alcohol (substance)||octinoxate 0.068 g in 1 g topical lipstick [esika hd color high definition color spf 20 (hd ciruela glam) - red]||has_inactive_ingredient
cornflour (substance)||silicon dioxide 16 g in 100 g / aminocaproic acid 0.1 g in 100 g dental paste, dentifrice [mastikis mastic gumcare]||has_inactive_ingredient
carbomer homopolymer, unspecified type||ensulizole 1.19 g in 70 g / octinoxate 5.25 g in 70 g topical cream [harmon face values revitalizing day cream]||has_inactive_ingredient
(3beta)-cholest-5-en-3-ol||titanium dioxide 9.0 g in 100 ml / zinc oxide 6.3 g in 100 ml topical cream [your skin but better cc color correcting full coverage spf 50 rich]||has_inactive_ingredient
vanilla bean allergenic extract||dimethicone 1 % topical lotion||has_inactive_ingredient
microcrystalline celullose||loperamide hydrochloride 1 mg/7.5 ml oral suspension [sunmark anti-diarrheal]||has_inactive_ingredient
kiwi fruit oil||avobenzone 30 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 70 mg in 1 g topical cream [lancome paris renergie lift multi action broad spectrum spf 15 sunscreen lifting and firming for dry skin]||has_inactive_ingredient
magnesium searate||subvenite 25mg tablet||has_inactive_ingredient
cetostearyl alcohol (substance)||hydrocortisone butyrate 1 mg/g cutaneous cream||has_inactive_ingredient
hydrolyzed wheat protein (enzymatic; 3000 mw)||octinoxate 0.05 g in 1 g / zinc oxide 0.042 g in 1 g topical cream [esika pro natural matte mattifying foundation adaptable to your skin tone spf 20 medio2/beige]||has_inactive_ingredient
edta, disodium||avobenzone 3 g in 100 ml / homosalate 5 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 4 g in 100 ml topical cream [h-e-b dead sea organics protect and perfect day broad spectrum spf15]||has_inactive_ingredient
menthyl lactate||salicylic acid 2 g in 100 g topical soap||has_inactive_ingredient
silicon dioxide||sure result o3d3 system kit||has_inactive_ingredient
methyl aspartylphenylalanine||acetaminophen 80 mg oral tablet, chewable [non-aspirin pain relief children's]||has_inactive_ingredient
methylparaben||benzalkonium chloride 2 mg/ml / benzocaine 2 mg/ml medicated pad||has_inactive_ingredient
polyoxyethylene 40 stearate||diphenhydramine hydrochloride 10 mg in 1 g / zinc acetate 1 mg in 1 g topical cream [winco original strength anti-itch]||has_inactive_ingredient
lauryl sulfate, sodium||calcium carbonate 400 mg oral tablet, chewable [children's maalox]||has_inactive_ingredient
syrup, maize||dextromethorphan hbr 20 mg / guaifenesin 200 mg in 10 ml oral suspension||has_inactive_ingredient
citric acid, trisodium salt||loratadine/pseudoephedrine sulfate 10 mg-240 mg oral tablet, extended release, 24 hr [health mart allergy relief & nasal decongestant]||has_inactive_ingredient
5-stigmasten-3beta-ol||salicylic acid 2 g in 100 ml topical gel [stop spot]||has_inactive_ingredient
iron oxide,yellow||rozerem 8 mg oral tablet||has_inactive_ingredient
sodium benzoate-containing product||caffeine 125 mg in 1 ml intramuscular injection, solution||has_inactive_ingredient
glycerol - chemical||octinoxate 5424 mg in 110.7 g / octocrylene 3321 mg in 110.7 g / zinc oxide 13.84 g in 110.7 g topical lotion [shiseido extra smooth sun protection n]||has_inactive_ingredient
brilliant blue fcf (substance)||phenylephrine hydrochloride 5 mg / acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [alka-seltzer plus maximum strength night cold and flu powermax gels]||has_inactive_ingredient
water||potassium nitrate 50 mg in 1 g oral paste, dentifrice [dr. sheffield sensitive care]||has_inactive_ingredient
microcrystalline celullose||guaifenesin 1200 mg / dextromethorphan hydrobromide 60 mg oral tablet, extended release [leader mucus dm]||has_inactive_ingredient
tranexamic acid product||niacinamide 0.025 in 25 ml / adenosine 0.0004 in 25 ml / panthenol 0.006 in 25 ml topical patch [p1p chitosan v-mask]||has_inactive_ingredient
agania spinosa (argan) oil||titanium dioxide 2.72118 g in 35 ml topical emulsion [cle de peau beaute radiant fluid foundation b60]||has_inactive_ingredient
baking soda||phalaris arundinacea pollen 0.05 g in 1 ml intradermal injection [canary grass pollen]||has_inactive_ingredient
talcum powder||mylanta gas maximum strength, 125 mg oral tablet, chewable||has_inactive_ingredient
lemon allergenic extract||avobenzone 2 g in 100 ml / homosalate 5 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 1.86 g in 100 ml topical cream [perfect truth cc broad spectrum spf 30 ole henriksen]||has_inactive_ingredient
sulisobenzone||alcohol 62 ml in 100 ml topical gel [hand sanitizer w/carabiner]||has_inactive_ingredient
oxide, polyethylene||lorlatinib 25 mg oral tablet||has_inactive_ingredient
cellulose microcrystalline||acetaminophen 500 mg oral tablet [certi-cet plus extra strength]||has_inactive_ingredient
pvp k-30||acetaminophen/aspirin/caffeine oral tablet [headache formula]||has_inactive_ingredient
lactose, anhydrous||diazepam 5mg tab ud||has_inactive_ingredient
citric acid monohydrate||acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 30 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml oral liquid [family care cold and flu nighttime]||has_inactive_ingredient
polyacrylamide (10000 mw)||histamine dihydrochloride .025 g in 100 g topical cream [cvs arthritis pain relief]||has_inactive_ingredient
methylpropanediol||octinoxate 0.05 g in 1 g / zinc oxide 0.042 g in 1 g topical cream [esika pro natural mattifying foundation adaptable to your skin tone spf 20 claro 1/beige]||has_inactive_ingredient
maltodextrin||silver nitrate 6 [hp_c] in 180 / veratrum album root 30 [hp_c] in 180 / arsenic triiodide 30 [hp_c] in 180 / hyoscyamus niger leaf 30 [hp_c] in 180 oral tablet [brightspark]||has_inactive_ingredient
3-(2-ethylhexyloxy)propane-1,2-diol||benzalkonium chloride 1.287 mg in 1 ml topical soap [defense zone antibacterial]||has_inactive_ingredient
indigotindisulfonate sodium product (product)||levothyroxine sodium 0.075 mg oral tablet [levothyroxine sodium]||has_inactive_ingredient
polyquaternium-7 (70-30 acrylamide-dadmac 1600000 mw)||triclosan 0.3 ml in 100 ml topical liquid [jasmine tea and basil antibacterial hand sp]||has_inactive_ingredient
lacca||walgreens aspirin 325mg enteric coated tablet||has_inactive_ingredient
methylethylene glycol||clobazam 2.5 mg/ml oral suspension, oral (final dose form)||has_inactive_ingredient
d&c red no. 40||sertraline hydrochloride 25 mg oral tablet [sertraline hydrochloride]||has_inactive_ingredient
talco||aluminum zirconium tetrachlorohydrex gly 18.2 g in 100 g topical stick [degree motionsense grapefruit and verbena scent antiperspirant]||has_inactive_ingredient
citric acid monohydrate||pyrithione zinc 1 mg in 1 ml topical shampoo [simply clean dandruff]||has_inactive_ingredient
product containing water (medicinal product)||acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [multi-symptom nitetime]||has_inactive_ingredient
dihydrogen oxide||alcohol 150 ml in 200 ml topical spray [disinfectantspray]||has_inactive_ingredient
polyethylene glycol product (product)||ibuprofen 200 mg oral tablet [dragon tabs]||has_inactive_ingredient
white pine oil||titanium dioxide 9.0 g in 100 ml / zinc oxide 6.3 g in 100 ml topical cream [your skin but better cc color correcting full coverage spf 50 light]||has_inactive_ingredient
alpha-isobutylphenethyl alcohol||(spl review) benzalkonium chloride .13 mg in 1 ml topical lotion [safe and silky natural hand sanitizer]||has_inactive_ingredient
cyclomethicone 5||octinoxate 2.1 mg in 30 ml / octisalate 0.9 mg in 30 ml / titanium dioxide 2.508 mg in 30 ml topical cream [cle ccc deep]||has_inactive_ingredient
cross-linked carboxymethylcellulose sodium||product containing citalopram 10 mg/1 each oral tablet||has_inactive_ingredient
glycol polyethylene||night time cold/flu, 325 mg-15 mg-6.25 mg oral capsule||has_inactive_ingredient
gelborange s||acetaminophen 500 mg oral tablet [reliable drugs]||has_inactive_ingredient
h2o - water||quercus agrifolia pollen 10000 [pnu] in 1 ml subcutaneous injection, solution||has_inactive_ingredient
silicon dioxide (substance)||acetaminophen 650 mg and butalbital 50 mg oral tablet||has_inactive_ingredient
polymethylsilsesquioxane (4.5 microns)||titanium dioxide 415 mg in 10 g topical stick [bareminerals complexion rescue hydrating foundation broad spectrum spf 25 cashew 2.5cn]||has_inactive_ingredient
pvp k30||carvedilol 25mg tab||has_inactive_ingredient
pepermint oil||magnesium sulfate, unspecified 11.2 g in 112 g / arnica montana 1.12 g in 112 g / witch hazel 1.12 g in 112 g topical cream [magsoothium pure formula]||has_inactive_ingredient
methylpropanediol||octinoxate 0.065 g in 1 g / zinc oxide 0.036 g in 1 g topical lotion [esika pro instant perfection 3 en 1 face refining foundation spf 25 medio 1 - beige]||has_inactive_ingredient
white sugar||calcium carbonate 1000 mg oral tablet, chewable [heartburn fix]||has_inactive_ingredient
corn syrup||mentha piperita 3 [hp_x] in 188 ml oral liquid [zicam naturals cough suppressant]||has_inactive_ingredient
potassium hydrolyzed jojoba esters||benzalkonium chloride 0.13 g in 100 ml topical lotion [body prescriptions infused with vitamin e sugar cookie antibacterial hand]||has_inactive_ingredient
2-thiol-l-histidine-betaine||octinoxate 6.5 g in 100 ml / octisalate 2.5 g in 100 ml / zinc oxide 8.5 g in 100 ml topical emulsion [neova dna damage control - everyday broad spectrum spf 44]||has_inactive_ingredient
hemorrodil||avobenzone 0.13 g in 4.25 g / homosalate 0.32 g in 4.25 g / octisalate 0.21 g in 4.25 g / octocrylene 0.11 g in 4.25 g / oxybenzone 0.26 g in 4.25 g topical stick||has_inactive_ingredient
water product||onosmodium virginianum 30 [hp_c] in 1 ml oral liquid [onosmodium virginianum]||has_inactive_ingredient
polysorbate 60||foot cream, 1% topical cream||has_inactive_ingredient
crimson 4r||chloroxylenol 0.003 mg in 1 ml topical liquid [don luxury foam antibacterial handwash]||has_inactive_ingredient
product containing gelatin||ziprasidone (as ziprasidone hydrochloride monohydrate) 40 mg oral capsule||has_inactive_ingredient
1-vinylpyrrolidin-2-one homopolymer||quetiapine 25mg tablet||has_inactive_ingredient
monoctanoin component d||benzalkonium chloride 4.5 mg topical solution [body prescriptions antibacterial hand wipes winter berry]||has_inactive_ingredient
kaliumhydroxid||salicylic acid 0.03 mg/mg topical gel||has_inactive_ingredient
bis-diglyceryl polyacyladipate-2||dimethicone 2 g in 100 g / avobenzone 3 g in 100 g / homosalate 10 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g topical stick [blistex five star lip protection broad spectrum]||has_inactive_ingredient
sentry aq mardel clout||hydralazine hydrochloride 25 mg oral tablet, film coated [hydralazine hydrochloride]||has_inactive_ingredient
ferric oxide black (iron oxide)||deutetrabenazine 6mg tab||has_inactive_ingredient
vinylpyrrolidone/eicosene copolymer||octinoxate 75 mg in 1 g / zinc oxide 48 mg in 1 g topical cream [dynamic broad spectrum sunscreen spf 55]||has_inactive_ingredient
fd and c blue no.1 aluminum lake||sunmark pain relief extra strength 500mg rapid release gelcap||has_inactive_ingredient
corn starch, pregelatinized||product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug)||has_inactive_ingredient
hydroxypropyl cellulose (1600000 wamw)||cyclobenzaprine hydrochloride 10 mg oral tablet [cycoflex]||has_inactive_ingredient
avocado oil@@miscell@oil (ml)||titanium dioxide 9.0 g in 100 ml / zinc oxide 6.3 g in 100 ml topical cream [bye bye foundation full coverage moisturizer spf 50 fair light]||has_inactive_ingredient
propanol 02||celecoxib 100mg capsule||has_inactive_ingredient
triethoxycaprylylsilane||octinoxate 55 mg in 1 ml / titanium dioxide 27 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [just enough spf 15 tinted moisturizer golden brown is beautiful]||has_inactive_ingredient
(2r,3r,4r,5r)-hexane-1,2,3,4,5,6-hexaol||ciprofloxacin hydrochloride 3 mg in 1 ml ophthalmic solution/ drops||has_inactive_ingredient
arlex||enalapril maleate 1 mg/ml oral solution||has_inactive_ingredient
quaternium-52||benzalkonium chloride 0.13 g topical swab [skin-aid-medics antibacterial wipes kit citrus scent]||has_inactive_ingredient
hydroxypropyl methylcellulose e5 [ii]||product containing precisely zolpidem tartrate 10 milligram/1 each conventional release oral tablet (clinical drug)||has_inactive_ingredient
hydrogen oxide||octinoxate 588 mg in 12 g / titanium dioxide 996 mg in 12 g topical powder [nars all day luminous foundation mont blanc]||has_inactive_ingredient
sodium chloride||fagus grandifolia pollen 0.05 g in 1 ml percutaneous injection, solution [pollens - trees, beech, american fagus grandifolia]||has_inactive_ingredient
camellia sinesis leaf extract||alcohol 70 ml in 100 ml topical spray [biomedik premium hand sanitizer mist]||has_inactive_ingredient
sodium chloride nasal||streptomyces griseus 0.05 g in 1 ml intradermal injection, solution||has_inactive_ingredient
glycerol product||alcohol 62 ml in 100 ml topical liquid [body raves antibacterial hand sanitizer - wild strawberry]||has_inactive_ingredient
trometamol (substance)||atorvastatin calcium 80 mg oral tablet||has_inactive_ingredient
h2o2 - hydrogen peroxide||isopropyl alcohol 75 ml in 100 ml topical liquid [carepure 01]||has_inactive_ingredient
baking soda||mercurialis perennis 3 [hp_x] in 1 ml oral liquid||has_inactive_ingredient
c12-15 alkyl benzoate||octinoxate 4 g in 40 g / titanium dioxide 1.84 g in 40 g topical cream [seacret cc cream color corrector broad spectrum spf 15 light]||has_inactive_ingredient
calcium sulfate dihydrate||levothyroxine sodium 100mcg oral tablet||has_inactive_ingredient
indigotindisulfonate sodium||product containing only cyclobenzaprine hydrochloride 10 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
triethylene amine||alcohol 70 ml in 100 ml topical gel [livesafe orange hand sanitizer]||has_inactive_ingredient
sulfuric acid monododecyl ester sodium salt||sodium fluoride 0.2592 g in 108 g topical paste, dentifrice [koala pals berrylicious]||has_inactive_ingredient
xanthan gum||atorvastatin calcium trihydrate 80 mg oral tablet, film coated [lipitor]||has_inactive_ingredient
product containing titanium dioxide||fluoxetine 20mg capsule (substance)||has_inactive_ingredient
saccharin (substance)||dimethicone 1 g in 100 g / octinoxate 7.5 g in 100 g / oxybenzone 2.5 g in 100 g topical stick [fruit smoothies peaches and cream]||has_inactive_ingredient
sodium starch glycolate type a potato||rite aid pain relief acetaminophen 500mg extra strength caplet||has_inactive_ingredient
product containing lactose||artemisia vulgaris root 6 [hp_c] / copper 200 [hp_c] oral pellet [alartem 40 (number 524)]||has_inactive_ingredient
sodium chloride (medication)||chloroxylenol 3 mg in 1 ml topical soap [healthy hands aloe antiseptic hand and body wash]||has_inactive_ingredient
sodio hidróxido||(spl review) terbinafine hydrochloride 1 g in 100 g topical gel [silka gel]||has_inactive_ingredient
product containing water||tretinoin 1 mg/ml topical cream [tretin x]||has_inactive_ingredient
microcrystalline celluose||diphenhydramine hcl 25 mg / phenylephrine hcl 10 mg oral tablet||has_inactive_ingredient
melaleuca oil (obsolete)||benzalkonium chloride 0.13 % topical cream||has_inactive_ingredient
drug and cosmetic yellow dye number 10||doxepin 10 mg oral capsule||has_inactive_ingredient
sodium indigo-disulfonate||vanatrip, 50 mg oral tablet||has_inactive_ingredient
iron black||product containing precisely mirtazapine 30 milligram/1 each conventional release oral tablet (clinical drug)||has_inactive_ingredient
glyceryl behenate||paroxetine hydrochloride hemihydrate 20 mg oral tablet, film coated||has_inactive_ingredient
cocamidopropylbetaine (in water)||chloroxylenol 3 mg in 1 ml topical liquid [health smart antibacterial hand lavender chamomile]||has_inactive_ingredient
aloe vera leaf||benzalkonium chloride 0.13 g in 100 ml topical solution [moisturizer hand sanitizer]||has_inactive_ingredient
hydrochloric acid preparations||naloxone hydrochloride 0.4 mg in 1 ml subcutaneous injection, solution||has_inactive_ingredient
polyhydroxystearic acid (2300 mw)||titanium dioxide 43 mg in 1 ml / zinc oxide 30 mg in 1 ml topical lotion [aveeno ultra-calming daily moisturizer sunscreen broad spectrum spf 30]||has_inactive_ingredient
cottonseed oil oil||miconazole nitrate 200 mg vaginal suppository [harris teeter miconazole 3]||has_inactive_ingredient
aloe barbadensis leaf extract||alcohol 357 ml in 510 ml topical gel [essentials by urban secrets advanced hand sanitizer]||has_inactive_ingredient
2-hydroxy-1,2,3-propanetricarboxylic acid, anhydrous||stannous fluoride 0.969 mg in 1 g oral gel [home care fluoride]||has_inactive_ingredient
kaolin product (product)||tolnaftate 10 mg in 1 g topical spray [walgreens medicated antifungal athletes foot]||has_inactive_ingredient
starch corn||prednisone 1 mg oral tablet||has_inactive_ingredient
anhydrous dibasic calcium phosphate||fluconazole 150 mg oral tablet [diflucan]||has_inactive_ingredient
ethylhexyl stearate||titanium dioxide 89.6 mg in 1 ml / zinc oxide 112 mg in 1 ml topical lotion [blue lizard sensitive spf 50 sunscreen]||has_inactive_ingredient
medium chain triglyceride product||homosalate 70 mg in 1 ml / octinoxate 50 mg in 1 ml / octocrylene 50 mg in 1 ml / avobenzone 20 mg in 1 ml topical cream [dr. c. tuna resurface essential day cream]||has_inactive_ingredient
matricaria recutita preparation||menthol 0.035 mg/mg topical gel [fast freeze naturally cool]||has_inactive_ingredient
fd & c red #40||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [topcare mucus relief]||has_inactive_ingredient
hydroxide potassium||avobenzone 20.16 mg in 1 ml / octocrylene 30.24 mg in 1 ml / homosalate 50.4 mg in 1 ml / octisalate 45.36 mg in 1 ml topical lotion [coppertone sport spf 15]||has_inactive_ingredient
ceteth-10-phosphate||ensulizole 2 ml in 100 ml / octinoxate 7.5 ml in 100 ml / octocrylene 7.5 ml in 100 ml / zinc oxide 1.9 ml in 100 ml topical lotion [rite aid renewal sunscreen]||has_inactive_ingredient
microcrystaline cellulose||product containing precisely amitriptyline hydrochloride 10 milligram/1 each conventional release oral tablet||has_inactive_ingredient
iron oxide black||venlafaxine hcl 75mg sa cap||has_inactive_ingredient
serina||octisalate 0.05 g in 100 g / avobenzone 0.03 g in 100 g / octinoxate 0.029 g in 100 g / octocrylene 0.022 g in 100 g topical lotion [tbs seaweed spf15]||has_inactive_ingredient
product containing talc (medicinal product)||simvastatin 10 mg oral tablet||has_inactive_ingredient
butyloctyl salicylate||octocrylene 2.8 g in 100 g / octisalate 4.75 g in 100 g / avobenzone 2.75 g in 100 g / oxybenzone 4.25 g in 100 g topical cream [spf rx - anti-aging sunscreen spf 30]||has_inactive_ingredient
poly(methyl methacrylate; 450000 mw)||octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (rosa encanto femme) - pink]||has_inactive_ingredient
glycol stearate||miconazole nitrate/zinc ox/pet 0.25 %-15 %-81.35 % topical ointment (gram)||has_inactive_ingredient
behenyl behenate||octocrylene 10 g in 100 ml / avobenzone 3 g in 100 ml / homosalate 15 g in 100 ml / octisalate 5 g in 100 ml topical spray [drive sunscreen spf 50]||has_inactive_ingredient
coco monoethanolamide||(spl review) benzalkonium chloride .999 mg in 1 ml topical liquid [hand wash]||has_inactive_ingredient
phenyl alcohol||pinus echinata pollen 6666.6666 [pnu] in 1 ml / pinus taeda pollen 6666.6666 [pnu] in 1 ml / pinus strobus pollen 6666.6666 [pnu] in 1 ml percutaneous solution [pine pollen mix]||has_inactive_ingredient
ceresin||octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (rojo deseo) - red]||has_inactive_ingredient
hydroxyethyl cellulose (4000 mpa.s at 1%)||glucotrol xl 10 mg 24hr extended release oral tablet||has_inactive_ingredient
fd & c blue no. 1||alcohol 620 mg in 1 ml topical gel [justice letter l blueberry scent anti-bacterial hand sanitizer]||has_inactive_ingredient
bicarbonate, sodium||rumex obtusifolius pollen 0.01 g in 1 ml / rumex acetosella pollen 0.01 g in 1 ml / rumex altissimus pollen 0.01 g in 1 ml / rumex salicifolius var. mexicanus pollen 0.01 g in 1 ml / rumex crispus pollen 0.01 g in 1 ml subcutaneous injection, solution||has_inactive_ingredient
sodium hydroxide||ocufen 0.03% ophthalmic solution||has_inactive_ingredient
sodium bicarbonate (vaginal) (medication)||house fly extract 10,000 unt/ml injectable solution||has_inactive_ingredient
honey (product)||dextromethorphan hydrobromide/guaifenesin 5 mg/5 ml-50 mg/5 ml oral syrup [cough formula children's]||has_inactive_ingredient
magnesium distearate||labetalol 200mg tablets||has_inactive_ingredient
magnesium oxide||thuja occidentalis leaf 3 [hp_x] in 100 g / comfrey 1 [hp_x] in 100 g topical ointment [mom of 11 kids no time for eczema maximum strength]||has_inactive_ingredient
sorbate potassium||metronidazole topical, 0.75% topical lotion||has_inactive_ingredient
lactose product||chrysopogon zizanioides root 30 [hp_c] in 30 [hp_c] oral pellet [anatherum muriaticum]||has_inactive_ingredient
yellow iron oxide||titanium dioxide 0.0698 g in 1 ml / zinc oxide 0.0268 g in 1 ml topical cream [redness solutions daily protective base broad spectrum spf 15]||has_inactive_ingredient
dimeticone-containing product||octinoxate 0.07 g in 1 ml / titanium dioxide 0.0244 g in 1 ml topical lotion [lbel effet parfait signs of age appearance minimizer foundation spf 20 fm obscure 8 - brown]||has_inactive_ingredient
h2o - water||benzalkonium chloride 1.3 g in 1 l topical liquid [deb instantfoam non-alcohol hand sanitizer]||has_inactive_ingredient
acide stéarique||petrolatum 30 g in 100 g topical jelly [pharmacys prescription 4.5 oz cocoa butter petroleum jelly]||has_inactive_ingredient
paraffinum flavum||lanolin 300 mg in 1 g topical ointment [primaguard daily care skin protectant]||has_inactive_ingredient
nitrilotriethanol||sulfur 0.2 ml in 100 ml / dipyrithione 0.5 ml in 100 ml topical liquid [feix facial]||has_inactive_ingredient
2-oh-4-methbenzph-5-sulph acid||alcohol 650 mg in 1 ml topical liquid [care one peppermint swirl]||has_inactive_ingredient
xanthan gum||avobenzone 30 mg in 1 ml / homosalate 70 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 27 mg in 1 ml topical cream [dead sea essentials algae smoothing and protecting day broad spectrum spf 20]||has_inactive_ingredient
cholest-5-en-3beta-ol||octinoxate 0.07 g in 1 g / oxybenzone 0.03 g in 1 g / titanium dioxide 0.008 g in 1 g topical lipstick [lbel effet parfait lip moisturizer spf 18 fm hidratante para labios fps 18 fm]||has_inactive_ingredient
glycerol||guaifenesin/hydrocodone 200 mg-2.5 mg/5 ml oral solution, oral||has_inactive_ingredient
lactose (product)||aloe ferox leaf 5 [hp_c] in 5 [hp_c] oral pellet [aloe]||has_inactive_ingredient
water-containing product||alcohol 1.05 ml in 1.5 ml topical gel [be flat. frecent hand sanitizer]||has_inactive_ingredient
sodium starch glycolate type a corn||phenazopyridine hydrochloride 100mg oral tablet||has_inactive_ingredient
rubigo||memantine hydrochloride 21mg extended release capsule||has_inactive_ingredient
d & c green #5||benzocaine 20% oromucosal gel/jelly [leader oral analgesic gel]||has_inactive_ingredient
peg-100 stearate||salicylic acid 2 g in 100 ml topical cream [azelaic acid bha spot treatment]||has_inactive_ingredient
cycloheptaamylose||aluminum zirconium tetrachlorohydrex gly 15 g in 100 g topical stick [secret pomegranate invisible solid]||has_inactive_ingredient
vaginal preparations sodium bicarbonate vaginal||cynodon dactylon pollen 16 [bau] in 1 ml / festuca pratensis pollen 800 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.0004 g in 1 ml / felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / alternaria alternata 0.0004 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml subcutaneous injection, solution||has_inactive_ingredient
d and c blue no.1||sertraline hydrochloride, 25 mg oral tablet||has_inactive_ingredient
linolic acid||octinoxate 0.065 g in 1 ml / titanium dioxide 0.016 g in 1 ml topical liquid [lbel natural finish moisturizing foundation spf 25 (medium 6b) - brown]||has_inactive_ingredient
trisodium ethylenediamine disuccinate||avobenzone 3 mg in 100 ml / homosalate 10 mg in 100 ml / octocrylene 6 mg in 100 ml / octisalate 5 mg in 100 ml topical liquid [senegence senesun hydrating facial sunscreen spf 20]||has_inactive_ingredient
fast green fcf (substance)||sodium fluoride 2 % dental gel||has_inactive_ingredient
magnesium sterate||product containing precisely atorvastatin 80 milligram/1 each conventional release oral tablet (clinical drug)||has_inactive_ingredient
salt||carya alba pollen 0.1 g in 1 ml subcutaneous injection, solution||has_inactive_ingredient
hydrastis canadensis root||baptisia tinctoria 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / apis mellifera 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml oral spray [throat formula]||has_inactive_ingredient
high-density polyethylene||octinoxate 0.07 g in 1 g topical lipstick [esika pro advance lasting long-lasting and comfort spf 20 (fucsia sublime) - pink]||has_inactive_ingredient
butylated hydroxytoluene product||octinoxate 2.27 g in 30.66 g / octocrylene 0.92 g in 30.66 g / zinc oxide 2.64 g in 30.66 g topical emulsion [shiseido urban environment oil-free uv protector]||has_inactive_ingredient
alpha tocopherol acetate||titanium dioxide 0.062393 g in 1 g / zinc oxide 0.049 g in 1 g / octinoxate 0.03 g in 1 g topical powder [lbel divine polvos compactos doble uso fps 15 edicion de lujo plateado/double use compact spf 15 silver deluxe edition claire 4]||has_inactive_ingredient
propylene glycol (product)||alcohol 700 ml in 1000 ml topical liquid [lavender]||has_inactive_ingredient
polyethylene glycol 1000||betamethasone 1 mg/ml topical cream [betamethacot]||has_inactive_ingredient
mannitol (substance)||omeprazole 40 mg delayed release oral capsule||has_inactive_ingredient
glycerol analyte||alcohol 70 ml in 100 ml topical gel [new life moisturizing hand sanitizer]||has_inactive_ingredient
1,2,3-propanetriol||alcohol 70 ml in 100 ml topical gel [orange blossom scented hand sanitizer 01]||has_inactive_ingredient
natriumbisulfit||prednisolone acetate 10 mg/ml eye suspension||has_inactive_ingredient
water product||therapeutic 0.5% shampoo||has_inactive_ingredient
silicon dioxide||hydrocodone bitartrate@20 mg@oral@capsule, extended release 12 hr||has_inactive_ingredient
trihydroxypropane||octisalate 0.05 g in 1 ml / avobenzone 0.03 g in 1 ml / octinoxate 0.029 g in 1 ml / octocrylene 0.022 g in 1 ml topical lotion [aloe soothing moisture spf 15]||has_inactive_ingredient
2-hydroxypropanol||product containing only pantoprazole sodium 40 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
watering||menthol, unspecified form 12.5 mg in 1 g topical cream [efac pain relieving]||has_inactive_ingredient
monoctanoin component d||imidacloprid 37.5 mg chewable tablet [advantus]||has_inactive_ingredient
titanium dioxide (substance)||bexarotene 75 mg oral capsule, liquid filled||has_inactive_ingredient
caustic soda||camphor 5 mg/ml / menthol 5 mg/ml topical lotion [dermasarra]||has_inactive_ingredient
tartrazine stain||benzalkonium chloride 0.13 g in 100 ml topical soap [shieldplex antibacterial hand wash]||has_inactive_ingredient
silica (sio2)||12 hr bupropion hydrochloride 150 mg extended release oral tablet [budeprion]||has_inactive_ingredient
hydrated silica (substance)||octinoxate 408 mg in 12 g / titanium dioxide 624 mg in 12 g topical cream [cle de peau beaute radiant cream to powder foundation o60]||has_inactive_ingredient
carbomer interpolymer type a (allyl sucrose crosslinked)||alcohol 70 ml in 100 ml topical gel [clenova gel hand sanitizer]||has_inactive_ingredient
octadecanoic acid, magnesium salt||methocarbamol 750 mg oral tablet [methocarbamol]||has_inactive_ingredient
cetearyl glucoside||octinoxate 0.075 g in 1 g / oxybenzone 0.02 g in 1 g / zinc oxide 0.0196 g in 1 g topical suspension [lbel clarite clarifying effect foundation spf 30 medium 7- beige]||has_inactive_ingredient
sorbitol||cetirizine hydrochloride 1 mg/1 ml oral solution [children's all day allergy]||has_inactive_ingredient
oils, olive||avobenzone 0.12 g in 4.25 g / homosalate 0.32 g in 4.25 g / octisalate 0.21 g in 4.25 g / octocrylene 0.10 g in 4.25 g / oxybenzone 0.25 g in 4.25 g topical stick [vanilla mint lip spf 30 balm]||has_inactive_ingredient
talcum||product containing methotrexate 2.5 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
hydrogen oxide||chlorhexidine gluconate 1.3 mg in 1 ml oral rinse [dental]||has_inactive_ingredient
paraffin white soft bp (substance)||arnica montana 1.73 g in 29.7 g / hamamelis virginiana leaf 0.0178 g in 29.7 g topical cream [arnica montana nartex]||has_inactive_ingredient
glycerin product||alcohol 16.41 mg in 30 ml topical gel [hand and nature sanitizer aloe]||has_inactive_ingredient
watering||dextromethorphan hbr/phenylephrine hcl/dexbrompheniramine@20 mg-10 mg-2 mg/5 ml@oral@syrup||has_inactive_ingredient
glycerol product (product)||allantoin 1 g in 100 ml topical cream [dr deep aqua wrinkle]||has_inactive_ingredient
starch, corn||lansoprazole 30 mg oral capsule, delayed release||has_inactive_ingredient
lactose||budesonide 180mcg/inhl 120d oral inhl||has_inactive_ingredient
microcrystalline cellulose||dextromethorphan 30 mg oral tablet [robotablets]||has_inactive_ingredient
product containing titanium dioxide||product containing precisely labetalol hydrochloride 300 milligram/1 each conventional release oral tablet (clinical drug)||has_inactive_ingredient
polyethylene glycol 100 stearate||methyl salicylate 18 mg in 60 mg / menthol 6 mg in 60 mg / capsaicin 0.015 mg in 60 mg topical lotion [dendracin neurodendraxcin]||has_inactive_ingredient
cellulose microcrystalline||amlodipine besilate 5 mg and atorvastatin 40 mg oral tablet||has_inactive_ingredient
goat milk||alcohol 0.7 ml in 1 ml topical liquid [nature drops hand sanitizer]||has_inactive_ingredient
ammonia, nos||product containing only clomipramine hydrochloride 50 mg/1 each oral capsule (clinical drug)||has_inactive_ingredient
acide phénique||xanthium strumarium pollen 20000 [pnu] in 1 ml / chenopodium album pollen 20000 [pnu] in 1 ml / amaranthus retroflexus pollen 20000 [pnu] in 1 ml / rumex crispus pollen 20000 [pnu] in 1 ml / rumex acetosella pollen 20000 [pnu] in 1 ml subcutaneous injection, solution [pollens - weeds, weed mix 2630]||has_inactive_ingredient
f d & c red #33||alcohol 70 ml in 100 ml topical gel [cindelight gel]||has_inactive_ingredient
octadecanoic acid, magnesium salt||escitalopram 10 mg oral tablet||has_inactive_ingredient
crospovidone||d&c yellow no. 10 10 mg oral tablet, film coated||has_inactive_ingredient
siliziumdioxid||lorcet, 325 mg-5 mg oral tablet||has_inactive_ingredient
d & c red #28||benzocaine 200 mg periodontal gel||has_inactive_ingredient
hydrochloric acid preparations||english plantain pollen extract 10000 unt/ml injectable suspension||has_inactive_ingredient
dodecyl sulfate, sodium||rifampicin 150mg capsule (substance)||has_inactive_ingredient
sodium dehydroacetate||avobenzone 1000 mg in 50 ml / octinoxate 3750 mg in 50 ml topical cream [laura mercier tinted moisturizer broad spectrum spf 20 sunscreen 2w1 bisque]||has_inactive_ingredient
acetylated monoglycerides||aspirin 81 mg oral tablet, coated [aspirin low strength, enteric]||has_inactive_ingredient
d mannitol||lisinopril 20mg tab ud||has_inactive_ingredient
benzalkonium chloride (medication)||olopatadine hydrochloride 2 mg in 1 ml ophthalmic solution [eye allergy itch relief]||has_inactive_ingredient
cetostearyl alcohol (substance)||halobetasol propionate 0.05 % topical foam||has_inactive_ingredient
fd&c red#40||brompheniramine maleate/dextromethorphan hydrobromide/pseudoephedrine hydrochloride 2 mg/5 ml-10 mg/5 ml-30 mg/5 ml oral syrup [gen-tane dx]||has_inactive_ingredient
1,2,3-propanetriol, triacetate||rosuvastatin calcium, 20 mg oral tablet||has_inactive_ingredient
titanium oxide||amoxicillin 500 mg oral capsule [a-cillin]||has_inactive_ingredient
glycol, ethylene||sulisobenzone 2 g in 100 g topical swab||has_inactive_ingredient
α-propyleneglycol||product containing nortriptyline hydrochloride 25 mg/1 each oral capsule||has_inactive_ingredient
alcohol etílico||echinacea angustifolia 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / fenugreek seed 3 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa spleen 8 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / bufo bufo cutaneous gland 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / canis lupus familiaris milk 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / bos taurus mammary gland 36 [hp_c] in 1 ml oral liquid [mammaryplex]||has_inactive_ingredient
hydroxypropyl methylcellulose (product)||exemestane 25 mg oral tablet, film coated||has_inactive_ingredient
sclerosing agents talc||aluminum zirconium trichlorohydrex gly 200 mg in 1 g topical stick [cvs pharmacy clinical strength]||has_inactive_ingredient
tartrazine food and drug dye||alcohol 62 g in 100 ml topical gel [plu premium hand sanitizer]||has_inactive_ingredient
indigo carmine stain (substance)||diphenhydramine hydrochloride 25 mg oral tablet, film coated [betr sleep aid]||has_inactive_ingredient
2-amino-2-methylpropanol||alcohol 69 ml in 100 ml topical gel [qur eucalyptus essential oil hand sanitizer]||has_inactive_ingredient
microcrystalline celluose||product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet||has_inactive_ingredient
macrogol-containing product||cyclobenzaprine hydrochloride 5 mg oral tablet||has_inactive_ingredient
kieselsäureanhydrid||hydrogen peroxide 2.14 g in 100 g oral gel, dentifrice [100 toothpast e afternoon]||has_inactive_ingredient
alpha-bisabolol||titanium dioxide 12.35 g in 100 ml / zinc oxide 3.5 g in 100 ml topical cream [safe harbor - natural sunscreen face and neck cream broad spectrum spf40 sunscreen]||has_inactive_ingredient
sodium lauryl sulfate (substance)||sodium fluoride 6 mg in 1 g dental gel, dentifrice [orajel]||has_inactive_ingredient
hydrastis canadensis whole preparation||homosalate 15 g in 100 ml / octinoxate 7.5 g in 100 ml / oxybenzone 6 g in 100 ml / octocrylene 5.5 g in 100 ml / octisalate 5 g in 100 ml / avobenzone 3 g in 100 ml topical spray [sun therape pro sport spf-35]||has_inactive_ingredient
product containing titanium dioxide (medicinal product)||product containing ondansetron 4 mg/1 each oral tablet||has_inactive_ingredient
diethylmalonylbenzylidene oxypropene dimethicone||avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 50 mg in 1 ml topical cream [chuda]||has_inactive_ingredient
magnesium distearate||terazosin hydrochloride 5 mg oral capsule [terazosin hydrochloride]||has_inactive_ingredient
povidone product||dextromethorphan hydrobromide 30 mg in 5 ml oral suspension [leader childrens cough dm]||has_inactive_ingredient
dibasic magnesium stearate||desmopressin acetate 0.2 mg oral tablet||has_inactive_ingredient
potassium cetyl phosphate||avobenzone 30.66 mg in 1 ml / homosalate 102.2 mg in 1 ml / octisalate 51.1 mg in 1 ml / octocrylene 28.11 mg in 1 ml topical spray [miami beach spf 50 kids c/s sunscreen]||has_inactive_ingredient
cellulose hydroxypropyl methyl ether||ropinirole hydrochloride 1mg tablet (product)||has_inactive_ingredient
crospovidone (120 .mu.m)||duloxetine 20mg m/r capsule (product)||has_inactive_ingredient
peg/ppg-19/19 dimethicone||octinoxate 0.07 g in 1 ml / titanium dioxide 0.0244 g in 1 ml topical lotion [lbel effet parfait signs of age appearance minimizer foundation spf 20 fm medium 6 - beige]||has_inactive_ingredient
hydroxide, sodium||bupivacaine hydrochloride 2.5 mg in 1 ml perineural injection, solution||has_inactive_ingredient
panthenol||octisalate 5 g in 100 g / octocrylene 10 g in 100 g / oxybenzone 6 g in 100 g / avobenzone 3 g in 100 g / homosalate 10 g in 100 g topical spray [banana boat]||has_inactive_ingredient
trizinc dicitrate||stannous fluoride 1.6 mg in 1 g dental paste, dentifrice [crest pro-health advanced sensitive and enamel shield]||has_inactive_ingredient
boo-boo magic||aluminum zirconium tetrachlorohydrex gly 19 g in 100 g topical stick [secret outlast xtend invisible active fresh]||has_inactive_ingredient
water (substance)||sodium monofluorophosphate 0.82 g in 100 g oral paste [blanx white shock]||has_inactive_ingredient
barley||titanium dioxide 66.46 mg in 1 ml / zinc oxide 42.2 mg in 1 ml topical lotion [perfectionist pro multi-defense uv fluid broad sprectrum spf 45]||has_inactive_ingredient
tridymite||quality choice ibuprofen ib 200mg tablet||has_inactive_ingredient
hydroxypropylmethylcellulose||anastrozole 1mg tab||has_inactive_ingredient
polysorbate 80s||psoriasin 0.0125 mg/mg topical gel||has_inactive_ingredient
floril redness relief||avobenzone 1.5 g in 50 g / octocrylene 3.75 g in 50 g / octisalate 2.5 g in 50 g topical cream [no7 protect and perfect intense advanced day cream spf 30]||has_inactive_ingredient
polacrilin||product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug)||has_inactive_ingredient
magnesium octadecanoate||anastrozole 1mg tablet||has_inactive_ingredient
bicarbonates sodium||avena sativa pollen extract 50 mg/ml injectable solution||has_inactive_ingredient
pelargonium graveolens flower oil||camphor (natural) 3 g in 100 ml topical spray [pure nerium dermal pain relief therapy]||has_inactive_ingredient
iron oxide yellow||niacin (niaspan-kos) 500mg sa tab||has_inactive_ingredient
h2o - water||sodium fluoride 0.2094 mg in 1 ml oral rinse [anticavity]||has_inactive_ingredient
h2o2 - hydrogen peroxide||alcohol 80 ml in 100 ml topical liquid [pulverize hand sanitizer]||has_inactive_ingredient
benzalkonium chloride (substance)||triamcinolone acetonide@55 mcg@nasal@aerosol, spray (gram)||has_inactive_ingredient
carmellose sodium [eye] (substance)||sodium fluoride 2.4 mg in 100 g dental paste [shopkins brush buddies]||has_inactive_ingredient
product containing ethyl alcohol (medicinal product)||dicyclomine hydrochloride 10 mg oral capsule [bentyl]||has_inactive_ingredient
1,2 propanediol||24 hr ms 30 mg extended release oral capsule [avinza]||has_inactive_ingredient
menthol-containing product||luster premium white pro sonic dental whitening system kit||has_inactive_ingredient
hypromellose 2910 (5 cps)||metformin hydrochloride 500 mg oral tablet, coated||has_inactive_ingredient
sodium bicarbonate [antacid] (substance)||goodsense nicotine fruit, 2 mg oral transmucosal gum||has_inactive_ingredient
carminic acid||product containing azithromycin 500 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
silica (sio2)||octinoxate 1.95 g in 30 g / titanium dioxide 1.275 g in 30 g / octisalate 1.5 g in 30 g topical cream [no7 perfect and perfect intense advanced all in one foundation spf 50 deeply bronze]||has_inactive_ingredient
carbolic acid||plantago lanceolata pollen 0.05 g in 1 ml intradermal solution [english plantain]||has_inactive_ingredient
sodium bicarbonate (product)||pascopyrum smithii pollen 0.05 g in 1 ml subcutaneous injection [western wheatgrass pollen]||has_inactive_ingredient
acide octadécanoïque||geri-kot, 8.6 mg oral tablet||has_inactive_ingredient
octadecanoic acid, magnesium salt||ropinirole hydrochloride 6 mg oral tablet, extended release||has_inactive_ingredient
xanthan||homosalate 150 mg in 1 ml / octocrylene 70 mg in 1 ml / octisalate 50 mg in 1 ml / avobenzone 30 mg in 1 ml / drometrizole trisiloxane 5 mg in 1 ml topical lotion [garnier ombrelle face anti-shine spf 60 mexoryl technology]||has_inactive_ingredient
sodium starch glycolate type a potato||health mart laxative 5mg enteric coated tablet||has_inactive_ingredient
polydextrose (substance)||.beta.-carotene 600 [iu] / vitamin a acetate 1100 [iu] / ascorbic acid 60 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, dl- 30 [iu] / thiamine mononitrate 1.6 mg / riboflavin 1.8 mg / niacinamide 15 mg / pyridoxine hydrochloride 2.5 mg / folic acid 0.4 mg / levomefolate calcium 0.6 mg / cobalamin 5 ug / iron 29 mg / magnesium oxide 25 mg / zinc oxide 15 mg oral tablet, chewable [select ob]||has_inactive_ingredient
linalool, (+/-)-||octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (fucsia cautivante) - pink]||has_inactive_ingredient
oxide, polyethylene||citalopram hydrobromide 10 milligram in 1 tablet oral tablet||has_inactive_ingredient
glyceryl stearate citrate||allantoin 0.425 g in 85 g topical aerosol, spray [allantoin]||has_inactive_ingredient
dihydrogen oxide||alcohol 70 ml in 100 ml topical gel [ejk hand sanitizer]||has_inactive_ingredient
product containing macrogol 3350||cvs oral anesthetic 20% maximum strength topical gel||has_inactive_ingredient
sodium starch glycolate type a potato||dexmethylphenidate hydrochloride 2.5mg tablet||has_inactive_ingredient
soda, baking||sarcobatus vermiculatus pollen 0.05 g in 1 ml intradermal injection, solution||has_inactive_ingredient
hypromellose e15||product containing precisely clarithromycin 250 milligram/1 each conventional release oral tablet||has_inactive_ingredient
ginseng, asian||zinc oxide 5 g in 100 g / titanium dioxide 5 g in 100 g topical cream||has_inactive_ingredient
himanthalia elongata extract||avobenzone 3 ml in 100 ml / homosalate 8 ml in 100 ml / octisalate 4 ml in 100 ml / oxybenzone 5 ml in 100 ml topical cream [sea results line resolution sea results line resolution spf30]||has_inactive_ingredient
hexyl laurate||octinoxate 0.075 g in 1 g / zinc oxide 0.0784 g in 1 g topical liquid [lbel clarite clarifying effect foundation spf 30 claire 7/beige]||has_inactive_ingredient
carbomer homopolymer, unspecified type||avobenzone 90 mg in 1 ml / octisalate 250 mg in 1 ml / octocrylene 250 in 1 ml topical lotion [oil-free moisturizer]||has_inactive_ingredient
boron nitride||titanium dioxide 50 mg in 1 ml / zinc oxide 50 mg in 1 ml topical cream [amazonian clay bb tinted moisturizer broad spectrum spf 20 sunscreen medium]||has_inactive_ingredient
glycerinum||oxycodone hydrochloride 5 mg per 5 ml oral solution||has_inactive_ingredient
glycereth-2 cocoate||titanium dioxide 5 g in 100 g / zinc oxide 7 g in 100 g topical lotion [project sunscreen spfu mineral sunscreen roll-on spf-50]||has_inactive_ingredient
pyrocellulose||valsartan 160mg tab||has_inactive_ingredient
almond oil@@oral@oil (ml)||octinoxate 7.3 ml in 100 ml / avobenzone 2.9 ml in 100 ml topical lipstick [baume prodigieux levres 04 red charismatic nutri-protecting lip care spf 15]||has_inactive_ingredient
sentry aq mardel clout||equaline senna laxative 8.6mg tablet||has_inactive_ingredient
simmondsia chinensis seed oil||lidocaine hydrochloride 2.24 g in 56 g topical cream [restoriden lidocaine cream]||has_inactive_ingredient
indigo carmine (substance)||product containing lamotrigine 200 mg/1 each oral tablet||has_inactive_ingredient
trideceth-6||menthol 9.62 mg in 1 ml / lidocaine hydrochloride 38.48 mg in 1 ml topical gel [cbdaf topical gel]||has_inactive_ingredient
magnesium octadecanoate||product containing only carvedilol 12.5 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
jojoba seed oil||benzalkonium chloride 0.13 g in 100 ml topical lotion [body prescriptions grapefruit infused with vitamin e antibacterial hand]||has_inactive_ingredient
povidones||naproxen 200mg capsule (product)||has_inactive_ingredient
pomegranate seed oil||titanium dioxide 9.0 g in 100 ml / zinc oxide 6.3 g in 100 ml topical cream [your skin but better cc color correcting full coverage spf 50 rich]||has_inactive_ingredient
polyvinyl alcohol-containing product||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [head congestion cold relief]||has_inactive_ingredient
pigment white 6||product containing only nitrofurantoin 50 mg/1 each oral capsule||has_inactive_ingredient
glycérol||octinoxate 225 mg in 3 g topical lipstick [healthy makeup]||has_inactive_ingredient
glycerin-containing product||docusate sodium 250 mg oral capsule, liquid filled||has_inactive_ingredient
benzyl alcohol||avobenzone 30 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [loreal paris revitalift anti wrinkle firming moisturizer spf 25]||has_inactive_ingredient
citric acid anhydrous||activated charcoal 1 [hp_x] in 1 ml / caraway seed 3 [hp_x] in 1 ml / chamomile 3 [hp_x] in 1 ml / fennel seed 3 [hp_x] in 1 ml / melissa officinalis 3 [hp_x] in 1 ml / mentha piperita 3 [hp_x] in 1 ml / prunus spinosa flower bud 3 [hp_x] in 1 ml / ginger 3 [hp_x] in 1 ml oral liquid [colic calm]||has_inactive_ingredient
propylene carbonate||octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel hydratess long-lasting intense moisturizing spf 20 - amour]||has_inactive_ingredient
fd and c yellow 5||octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - violet pourpre]||has_inactive_ingredient
product containing coumarin||avobenzone 30 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 70 mg in 1 g topical cream [lancome paris renergie lift multi action all]||has_inactive_ingredient
chamaecyparis obtusa leaf extract||niacinamide 2.4 g in 120 ml / panthenol 0.12 g in 120 ml / adenosine 0.04 g in 120 ml topical liquid [vita volu 101 essence]||has_inactive_ingredient
product containing talc (medicinal product)||quetiapine fumarate 400mg tab ud||has_inactive_ingredient
glycerol (substance)||lobster extract 50 mg/ml injectable solution||has_inactive_ingredient
sentry aq mardel clout||cefprozil 250mg tablet (product)||has_inactive_ingredient
polyhydroxystearic acid (2300 mw)||zinc oxide 3.2 mg in 100 ml / titanium dioxide 2.9 mg in 100 ml topical lotion [yes to carrots daily facial moisturizer spf 15]||has_inactive_ingredient
siliceous earth, purified||titanium dioxide 1470 mg in 10 g / zinc oxide 100 mg in 10 g topical powder [bareminerals ready touch up veil broad spectrum spf 15 medium]||has_inactive_ingredient
4-isothiazolin-3-one, 5-chloro-2-methyl-||triclosan 4.6 mg/ml medicated liquid soap||has_inactive_ingredient
d & c yellow #10||uloric 40 mg oral tablet||has_inactive_ingredient
fortrans||product containing precisely metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug)||has_inactive_ingredient
d glucitol||ibuprofen 200 mg oral capsule, liquid filled [good neighbor ibuprofen]||has_inactive_ingredient
hydroxyisohexyl 3-cyclohexene carboxaldehyde||octinoxate 0.075 g in 1 g / zinc oxide 0.0784 g in 1 g topical liquid [lbel clarite clarifying effect foundation spf 30 claire 9/brown]||has_inactive_ingredient
aminomethyl propanol||alcohol 62 ml in 100 ml topical solution [best accessory group sweet strawberry scented hand sanitizer]||has_inactive_ingredient
raw corn starch||gabapentin 100 mg oral capsule [neurontin]||has_inactive_ingredient
methylcarbinol||avobenzone 2.7 g in 100 g / homosalate 9 g in 100 g / octisalate 4.5 g in 100 g / octocrylene 6 g in 100 g topical spray [hawaiian tropic]||has_inactive_ingredient
glycols, polyethylene||acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [nighttime cold flu relief]||has_inactive_ingredient
oils, chamomile||zinc oxide 0.07 g in 1 g / titanium dioxide 0.0419 g in 1 g / octinoxate 0.075 g in 1 g topical cream [missha m perfect cover bb no 31]||has_inactive_ingredient
cellulose,microcrystalline||all day relief, sodium 220 mg oral tablet||has_inactive_ingredient
xylitol -retired-||sodium fluoride 1.1 mg in 1 g / potassium nitrate 50 mg in 1 g dental paste, dentifrice [colgate advanced sensitive plus whitening]||has_inactive_ingredient
magnesium sterate||famotidine 20 mg oral tablet, film coated [members mark acid pep]||has_inactive_ingredient
caco3||desipramine hydrochloride 150mg tablet||has_inactive_ingredient
muriatic acid||methylphenidate hcl 5mg/5ml soln,oral||has_inactive_ingredient
carboxymethylcellulose sodium, unspecified||titanium dioxide 62 mg in 1 ml topical liquid [bareminerals complexion rescue broad spectrum spf 30 natural 05]||has_inactive_ingredient
silica, colloidal||premier value cetirizine hydrochloride 10mg tablet||has_inactive_ingredient
d glucitol||sodium monofluorophosphate 0.0088 mg/mg toothpaste||has_inactive_ingredient
aloe vera leaf extract||triclosan 0.3 % topical soap, liquid||has_inactive_ingredient
liquid paraffin [laxative] (substance)||hydrocortisone 1% oint 100g||has_inactive_ingredient
food blue 2||alcohol 70 ml in 100 ml topical liquid [rbx for men antibacterial hand sanitizer unscented]||has_inactive_ingredient
xanthan gum (product)||dimethicone topical application lotion [proshield glove skin protectant]||has_inactive_ingredient
baking soda||quercus nigra pollen 40000 [pnu] in 1 ml percutaneous solution [water oak pollen]||has_inactive_ingredient
citrus aurantium fruit||octinoxate 7.5 mg in 1 ml / octisalate 6 mg in 1 ml / zinc oxide 3 mg in 1 ml / avobenzone 3 mg in 1 ml topical spray [soleil broad spectrum spf-50]||has_inactive_ingredient
hydroxypropyl methylcellulose 2910 (6 cps)||sertraline hydrochloride 25mg tablet||has_inactive_ingredient
monostearin||sulfacetamide sodium 10% topical application soap [seb-prev wash]||has_inactive_ingredient
polyglycol||quetiapine 100 mg oral tablet||has_inactive_ingredient
sodium indigo-disulphonate||lisinopril 10 mg / hydrochlorothiazide 12.5 mg oral tablet [lisinopril and hydrochlorothiazide]||has_inactive_ingredient
citric acid monohydrate (substance)||triclosan 0.4600 ml in 100.0000 ml topical soap [foaming antibacterial pear]||has_inactive_ingredient
dehydroacetic acid||benzalkonium chloride 1.3 mg in 1 ml topical cloth [jnk yrd antibacterial wipes lemon scent]||has_inactive_ingredient
methyl para-hydroxybenzoate||product containing only diltiazem hydrochloride 60 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
tocopherols||avobenzone 25.95 mg in 1 g / homosalate 86.5 mg in 1 g / octisalate 43.25 mg in 1 g / octocrylene 17.3 mg in 1 g / oxybenzone 34.6 mg in 1 g topical spray [sunscreen]||has_inactive_ingredient
alpha tocopheryl product (product)||benzalkonium chloride 1 mg cutaneous cloth [sani-com pre-moistened, multi-purpose cleaning towel]||has_inactive_ingredient
polacrilin potassium||product containing only lorazepam 1 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
silicon oxide||octinoxate 70 mg in 1 g / titanium dioxide 41.5 mg in 1 g / zinc oxide 98 mg in 1 g topical emulsion [capture dreamskin fresh and perfect cushion with sunscreen broad spectrum spf 50 030]||has_inactive_ingredient
peg 1500||calendula officinalis flowering top 12 [hp_x] in 1 ml / croton tiglium seed 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / plantago major 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / smilax regelii root 30 [hp_x] in 1 ml topical spray [muscle/tendon pain stress relief]||has_inactive_ingredient
methylparaben||octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe rouge amplifier xp amplifying spf 15 (rose femme) - pink]||has_inactive_ingredient
sorbate potassium||mineral oil 6.19 / petrolatum 18.63 oral paste [hairball relief]||has_inactive_ingredient
copernicia prunifera wax||aspirin 81 mg oral tablet [aspirin low dose]||has_inactive_ingredient
disulfurous acid, disodium salt||epinephrine hydrochloride 0.1 mg in 1 ml / lidocaine hydrochloride 50 mg in 1 ml topical spray [numquick analgesic]||has_inactive_ingredient
fd&c yellow no. 5||triclosan 0.3 ml in 100 ml topical liquid [jasmine tea and basil antibacterial hand sp]||has_inactive_ingredient
polyoxyethylene||estrogens, conjugated, synthetic b 0.3 mg oral tablet||has_inactive_ingredient
disteareth-75 isophorone diisocyanate||benzalkonium chloride 1.3 mg in 1 ml topical liquid [gentle touch antibacterial hand]||has_inactive_ingredient
monobasic sodium phosphate monohydrate (substance)||methylprednisolone sodium succinate 1 g intravenous injection, powder, for solution||has_inactive_ingredient
2,6-ditertiary-butyl-4-cresol||lidocaine 560 mg topical patch [equaline lidocaine]||has_inactive_ingredient
chlorhexidine product||titanium dioxide 9.0 g in 100 ml / zinc oxide 6.3 g in 100 ml topical cream [bye bye foundation full coverage moisturizer spf 50 neutral tan]||has_inactive_ingredient
tricalcium orthophosphate||ctx4 gel 5000 1.1 % oral gel||has_inactive_ingredient
cellulose powders||walgreens infants' pain & fever 160mg/5ml suspension (grape)||has_inactive_ingredient
product containing gelatin||24 hr diltiazem hydrochloride 240 mg extended release oral capsule [tiadylt]||has_inactive_ingredient
sodium benzoate (product)||sodium fluoride 0.2 mg in 10 ml oral rinse [crest pro-health restore enamel]||has_inactive_ingredient
carbomer homopolymer, unspecified type||alcohol 70 ml in 100 ml topical gel [vencer hand sanitizer]||has_inactive_ingredient
lactose, unspecified form||plantago major 200 [kp_c] in 200 [kp_c] oral pellet [plantago major]||has_inactive_ingredient
sucrose preparation (substance)||methylcellulose@@oral@powder (gram)||has_inactive_ingredient
eucalyptus globulus oil rwanda||camphor 3.4 g in 85 g / menthol 8.5 g in 85 g topical gel||has_inactive_ingredient
ferric oxide yellow||hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet||has_inactive_ingredient
xanthan||walgreens nicotine polacrilex 2mg sugar free mini lozenge (cherry ice)||has_inactive_ingredient
sodium saccharin||cvs children's cold & cough dm liquid (red grape)||has_inactive_ingredient
sodium lauryl sulfate (substance)||cefadroxil monohydrate@500 mg@oral@capsule||has_inactive_ingredient
polyoxyethylene 40 stearate||diphenhydramine hydrochloride 50 mg in 30 ml oral liquid [premier value nighttime sleep-aid liquid sleep-aid]||has_inactive_ingredient
watering||titanium dioxide 60 mg in 1 ml / zinc oxide 30 mg in 1 ml topical liquid [amazonian clay 12-hour full coverage foundation broad spectrum spf 15 sunscreen 46s tan-deep sand]||has_inactive_ingredient
sulfate, sodium dodecyl||ascorbic acid 100 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, dl- 30 [iu] / thiamine hydrochloride 1.6 mg / riboflavin 1.6 mg / niacinamide 20 mg / pyridoxine hydrochloride 3.1 mg / folic acid 1 mg / cyanocobalamin 12 ug / calcium carbonate 200 mg / ferrous fumarate 27 mg / zinc oxide 10 mg / cupric sulfate 2 mg oral tablet, coated [tricare prenatal]||has_inactive_ingredient
dimethicone-containing product||titanium dioxide 3.86 g in 50 g / octinoxate 1.5 g in 50 g cutaneous cream [aloe sun bb spf20 pa plus number1 natural skin]||has_inactive_ingredient
ethylhexyl stearate||avobenzone 30 g in 1 ml / homosalate 150 g in 1 ml / octisalate 50 g in 1 ml / octocrylene 100 g in 1 ml topical aerosol, spray [zo skin health oclipse sun spf 50 broad spectrum sunscreen spf 50 for face plus body water/perspiration resistant (80 minutes)]||has_inactive_ingredient
hydrochloric acid preparations||sodium cl 5% pres free e/d||has_inactive_ingredient
cetearyl glucoside||zinc oxide 5 g in 100 ml / titanium dioxide 3 g in 100 ml topical lotion [let it block spf-30]||has_inactive_ingredient
liquid paraffin [laxative] (substance)||gentak, 0.3% ophthalmic ointment||has_inactive_ingredient
calcium phosphate, dihydrate (1:1)||lisinopril 40 mg oral tablet [lisinoril]||has_inactive_ingredient
methyl sulfonmethane||menthol 3.85 g in 100 ml / camphor (synthetic) 3.85 g in 100 ml / capsaicin 0.0355 g in 100 ml topical lotion [pain relieving]||has_inactive_ingredient
boswellia||arnica montana 1 [hp_x] in 88.721 ml / capsicum 2 [hp_x] in 88.721 ml / crotalus horridus horridus venom 6 [hp_x] in 88.721 ml / lachesis muta venom 8 [hp_x] in 88.721 ml / naja naja venom 5 [hp_x] in 88.721 ml topical gel [cobrazol]||has_inactive_ingredient
ppg-14 butyl ether||aluminum chlorohydrate 23.3 g in 100 g topical aerosol, spray [degree men motionsense overtime 48h antiperspirant]||has_inactive_ingredient
glycerin-containing product||avobenzone 0.75 g in 25 g / octocrylene 1.875 g in 25 g / octisalate 1.25 g in 25 g topical cream [no7 protect and perfect intense advanced day cream spf 30]||has_inactive_ingredient
3-iodo-2-propynylbutylcarbamate||avobenzone 3 g in 100 ml / homosalate 15 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 2.6 g in 100 ml / oxybenzone 6 g in 100 ml topical lotion [olay luminous brightening and protecting with sunscreen broad spectrum spf 30]||has_inactive_ingredient
c20-40 pareth-10||hydrocortisone 1 g in 100 g topical cream [makesense maximum strength]||has_inactive_ingredient
1,2,3-trihydroxypropane||pyrantel pamoate 144 mg/ml oral suspension||has_inactive_ingredient
jasmine||triclosan 0.3% topical application lotion [aplicare antibacterial]||has_inactive_ingredient
bee propolis extract||menthol 0.2 % topical ointment||has_inactive_ingredient
407s, poloxamer||product containing only gabapentin 800 mg/1 each oral tablet||has_inactive_ingredient
product containing kaolin||octinoxate 1.1988 ml in 30 ml topical lotion [flawless finish bare perfection makeup spf 8 warm cappuccino]||has_inactive_ingredient
fd & c red no. 40||acetaminophen 500 mg oral tablet, coated [extra strength pain reliever]||has_inactive_ingredient
acetyl tetrapeptide-15||zinc oxide 82 mg in 1 ml / titanium dioxide 65 mg in 1 ml topical cream [breathable camouflagelight sand]||has_inactive_ingredient
cellulose microcrystalline||levonorgestrel 0.15 mg / ethinyl estradiol 0.03 mg oral tablet, film coated [fayosim]||has_inactive_ingredient
poly(vinyl pyrrolidone-co-vinyl acetate)||pyridostigmine 180 mg oral tablet, extended release||has_inactive_ingredient
1,2-octanediol||octinoxate 75 mg in 1 g / zinc oxide 48 mg in 1 g topical cream [sharx - sunbreaker moisturizing sunscreen spf55 broad spectrum]||has_inactive_ingredient
magnesium ascorbyl phosphate||avobenzone 1255 mg in 50.2 g / octinoxate 3715 mg in 50.2 g / octocrylene 1004 mg in 50.2 g topical cream [shiseido future solution lx total protective]||has_inactive_ingredient
titanium dioxide product||hydrochlorothiazide + valsartan 12.5mg/320mg tablet (product)||has_inactive_ingredient
starch 1500||heb rx act all day pain relief 220mg tablet||has_inactive_ingredient
sentry aq mardel clout||zinc oxide 7 g in 100.0 ml / titanium dioxide 3 g in 100.0 ml topical cream [dermadoctor dd eye spf30]||has_inactive_ingredient
hydroxypropyl cellulose (1600000 wamw)||floxin, 300 mg oral tablet||has_inactive_ingredient
sodium starch glycolate type a potato||topiramate 25 mg oral tablet [topiragen]||has_inactive_ingredient
calcium sulfate (1:1), dihydrate||product containing liothyronine sodium 5 microgram/1 each oral tablet||has_inactive_ingredient
product containing water||losartan k+ 100 mg oral tablet||has_inactive_ingredient
corn flour (product)||percocet 5/325 oral tablet||has_inactive_ingredient
sodium acrylate||dimethicone 1 mg in 100 mg topical gel [s.o.s. instant rescue]||has_inactive_ingredient
dihydrogen oxide||sodium fluoride 0.0272 g in 1 g dental aerosol, foam [darby topical sodium fluoride mint]||has_inactive_ingredient
product containing isopropyl alcohol||alcohol 0.26 g in 26 g topical gel [brompton and langley green apple hand sanitizer green apple]||has_inactive_ingredient
zzip||octinoxate 3.75 ml in 50 ml topical cream [calcium repair]||has_inactive_ingredient
monobasic sodium phosphate anhydrous (substance)||polyvinyl alcohol 5 mg in 1 ml / povidone 6 mg in 1 ml ophthalmic solution [goodsense artificial tears]||has_inactive_ingredient
titanium dioxide||simethicone 125 mg oral capsule, liquid filled [mylanta gas maximum strength]||has_inactive_ingredient
vitamin a palmitate (substance)||titanium dioxide 0.04 g in 1 g topical stick [esika perfect skin coverage concealer spf 17]||has_inactive_ingredient
cetyl palmitate||aluminum zirconium trichlorohydrex gly 200 mg in 1 ml topical stick [duradry antiperspirant deoderant]||has_inactive_ingredient
fd and c red 40 (substance)||amoxicillin 250mg cap ud||has_inactive_ingredient
agua||glycopyrrolate 0.2 mg/1 ml injection solution [glycopyrrolate novaplus]_#3||has_inactive_ingredient
peg-30-dipolyhydroxystearate||zinc oxide 200 mg in 1 g topical cream [cotz flawless complexion]||has_inactive_ingredient
agua||diphenhydramine hydrochloride 6.25 mg/5 ml oral solution [polydryl dye-free medication]||has_inactive_ingredient
alcohol (grain)||chlorhexidine gluconate 1.2 mg in 1 ml dental liquid [denti-care denti-rinse chlorhexidine gluconate oral rinse]||has_inactive_ingredient
4-hydroxybenzoic acid, 1-methylethyl ester||octinoxate 3 ml in 40 ml / avobenzone 0.8 ml in 40 ml topical cream [tinted moisturizer spf-20 caramel]||has_inactive_ingredient
d&c red 33||benzalkonium chloride 1.3 g in 1 ml topical soap [benzalkonium chloride]||has_inactive_ingredient
gelatin product||product containing only fluoxetine 20 mg/1 each oral capsule||has_inactive_ingredient
salix alba (willow) bark extract||arnica montana 6 [hp_x] in 1 g / hamamelis virginiana bark 6 [hp_x] in 1 g / toxicodendron pubescens leaf 6 [hp_x] in 1 g / whey 6 [hp_x] in 1 g topical gel [arnica plus]||has_inactive_ingredient
1,3-butanediol||titanium dioxide 38.5 mg in 1 ml / zinc oxide 31.2 mg in 1 ml topical lotion [paulas choice calm redness relief spf 30 mineral (normal to oily)]||has_inactive_ingredient
hydrogen oxide||zinc oxide 12% topical application cream||has_inactive_ingredient
yellow ferric oxide||benazepril hydrochloride 20 mg oral tablet, coated||has_inactive_ingredient
calcium product||avobenzone 300 g in 1 g / homosalate 1500 g in 1 g / octisalate 500 g in 1 g / octocrylene 275 g in 1 g topical aerosol, foam [california tan spf 45 face sunscreen]||has_inactive_ingredient
zinc stearate (substance)||menthol 16 % topical spray||has_inactive_ingredient
sodium saccharin||potassium nitrate 50 mg in 1 g / sodium fluoride 1.15 mg in 1 g oral paste [sensodyne pronamel intensive enamel repair extra fresh]||has_inactive_ingredient
hydrogen oxide||povidone-iodine 10% paint (product)||has_inactive_ingredient
glycerin (substance)||sesame seed 0.1 mg in 1 ml percutaneous injection, solution||has_inactive_ingredient
methacrylic acid and ethyl acrylate copolymer||bupropion hydrochloride 150 mg oral tablet, extended release [bupropion hydrochloride (xl)]||has_inactive_ingredient
eudragit l 100||focalin xr, 10 mg oral capsule, extended release||has_inactive_ingredient
butane-1,3-diol||titanium dioxide 74.7 mg in 1 ml / zinc oxide 47.5 mg in 1 ml topical liquid [foundcealer multi-tasking foundation broad spectrum spf 20 sunscreen 34n medium neutral]||has_inactive_ingredient
product containing water||alcohol 62 ml in 100 ml topical gel [pharmacys prescription 2pk 2oz hand sanitizer]||has_inactive_ingredient
ethylhexyl palmitate||octinoxate 7.5 g in 100 g / oxybenzone 2 g in 100 g topical emulsion [lbel effet parfait spots reducing effect foundation spf 18 - obscure 10]||has_inactive_ingredient
peg-ppg-36-41 dimethyl ether||octinoxate 948 mg in 32.7 g / titanium dioxide 1700 mg in 32.7 g topical emulsion [shiseido sheer and perfect foundation i40]||has_inactive_ingredient
sodium starch glycolate type a potato||letrozole 2.5mg tablet (product)||has_inactive_ingredient
water-containing product||triclosan 0.375 ml in 100 ml topical liquid [dermacen foaming antimicrobial-t hand]||has_inactive_ingredient
alpha tocopheryl acetate (substance)||menthol 400 mg topical patch [qc cold and hot pain relief]||has_inactive_ingredient
ferric oxide black (iron oxide)||sumox 500mg capsule||has_inactive_ingredient
microcrystalline celullose||losartan potassium 50mg tablet (product)||has_inactive_ingredient
xanthan gum (product)||salicylic acid 20 mg in 1 ml topical gel [neutrogena rapid clear acne eliminating spot]||has_inactive_ingredient
starch 1500 pregelatinized||esomeprazole 40 mg (as esomeprazole magnesium) delayed release oral capsule||has_inactive_ingredient
lactose monhydrate||meloxicam 15 mg oral tablet [meloxicam]||has_inactive_ingredient
water-containing product||avobenzone 1030 mg in 50 ml / octinoxate 2524 mg in 50 ml / octocrylene 2575 mg in 50 ml / oxybenzone 1030 mg in 50 ml topical cream [cle de peau beaute protective fortifying n]||has_inactive_ingredient
cornflour (substance)||dexbromphenir 2mg/p-ephrin 7.5mg tab||has_inactive_ingredient
sodium chloride||zinc oxide 132 mg in 1 ml topical lotion [ilia super serum skin tint (st16.5 jardin)]||has_inactive_ingredient
aloe vera leaf||alcohol 75 ml in 100 ml topical gel [plyfah hand sanitizer]||has_inactive_ingredient
nitrogen (substance)||product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection vial||has_inactive_ingredient
glycerol 1-caprylate||salicylic acid 20 mg in 1 g topical cream [dermaclear mask]||has_inactive_ingredient
isopropylene glycol||benzalkonium chloride 0.115 g topical cloth [best choice fresh scent]||has_inactive_ingredient
bd persist||octinoxate 50 mg in 1 ml / titanium dioxide 20.6 mg in 1 ml topical lotion [benefit hello happy soft blur foundation spf 15 shade 9]||has_inactive_ingredient
polyglycols||product containing precisely fluphenazine hydrochloride 2.5 milligram/1 each conventional release oral tablet||has_inactive_ingredient
sodium chloride [nose] (substance)||ensulizole 10 mg in 1 ml / octinoxate 75 mg in 1 ml / zinc oxide 30 mg in 1 ml topical cream [oil control mattifier spf 15]||has_inactive_ingredient
phenoxyethanol||titanium dioxide 9.0 g in 100 ml / zinc oxide 6.3 g in 100 ml topical cream [your skin but better cc color correcting full coverage spf 50 rich]||has_inactive_ingredient
ethylidene difluoride||aluminum chlorohydrate 23.3 g in 100 g topical aerosol, spray [degree shower clean antiperspirant]||has_inactive_ingredient
isostearyl alcohol||octinoxate 0.072 g in 1 g topical lipstick [effet parfait rouge amplifier amplifying spf 15 (fucsia passion) - purple]||has_inactive_ingredient
linoleic acid||octinoxate 0.02775 g in 1 ml / titanium dioxide 0.010767 g in 1 ml topical liquid [virtual matte oil control makeup broad spectrum spf 15]||has_inactive_ingredient
colcothar||titanium dioxide 170 mg in 1 ml topical cream [bareminerals 5-in-1 bb advanced performance eyeshadow broad spectrum spf 15 soft shell]||has_inactive_ingredient
sodium laureth-3 sulfate||pyrithione zinc 5 g in 500 g topical shampoo [vegetability natural]||has_inactive_ingredient
lactose monhydrate||product containing amitriptyline hydrochloride 100 mg/1 each oral tablet||has_inactive_ingredient
3-(2-ethylhexyloxy)propane-1,2-diol||avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 100 mg in 1 ml topical lotion [neutrogena ultra sheer dry touch sunscreen broad spectrum spf45]||has_inactive_ingredient
titanium dioxide (product)||omeprazole 20 mg oral capsule, delayed release (obs 06-25-01)||has_inactive_ingredient
mapico red||octinoxate 3 g in 100 ml topical cream [the healthy foundation]||has_inactive_ingredient
sodium benzoate product||goodsense children's ibuprofen 100mg/5ml suspension (bubblegum)||has_inactive_ingredient
silicon dioxide||select brand ibuprofen 200mg tablet||has_inactive_ingredient
sodio acetato||octreotide acetate 1000 mcg/1 ml injection solution [sandostatin]||has_inactive_ingredient
polysorbate 80||topiramate@100 mg@oral@tablet||has_inactive_ingredient
octyldodecyl neopentanoate||zinc oxide 1.5 g in 30 ml / titanium dioxide 1.5 g in 30 ml topical lotion [sei bella tinted bb moisturizing creme medium 440 n]||has_inactive_ingredient
glycerin preparation (substance)||avobenzone 2.25 g in 75 g / octinoxate 0.375 g in 75 g / octisalate 3.75 g in 75 g / octocrylene 5.625 g in 75 g topical cream [yourgoodskin spf 30 anti-oxidant day sunscreen broad spectrum spf 30]||has_inactive_ingredient
f d & c blue #1||amantadine hydrochloride 100 mg oral capsule [symadine]||has_inactive_ingredient
water (substance)||alcohol 0.7 ml in 1 ml topical gel [peeps vanilla marshmallow screme hand sanitizer]||has_inactive_ingredient
magnesium stearate (substance)||crestor 20mg tablet||has_inactive_ingredient
2-(2-quinolyl)-1,3-indandione disulfonic acid disodium salt||hctz 25 mg / triamterene 37.5 mg oral tablet||has_inactive_ingredient
povidone k90||24 hr desvenlafaxine succinate 25 mg extended release oral tablet||has_inactive_ingredient
talc (mg3h2(sio3)4)||rite aid aspirin low strength 81mg enteric coated tablet||has_inactive_ingredient
siliceous earth, purified||diovan hct 80/12.5 oral tablet||has_inactive_ingredient
1-tetradecene||octinoxate 382 mg in 9.8 g / titanium dioxide 588 mg in 9.8 g topical powder [shiseido sheer matifying compact (refill) b60]||has_inactive_ingredient
chloride sodium||timothy grass pollen extract 10000 bau/ml injectable solution||has_inactive_ingredient
polyethylene, high-density||octisalate 5.0 ml in 100 ml / avobenzone 3.0 ml in 100 ml topical cream [time zone line and wrinkle reducing creme spf 15 for dry skin]||has_inactive_ingredient
carbomer homopolymer, unspecified type||avobenzone 15 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 30 mg in 1 g / oxybenzone 40 mg in 1 g topical cream [neutrogena men age fighter face broad spectrum spf15]||has_inactive_ingredient
sodium polyacrylate (2500000 mw)||niacinamide 1.1 g in 55 ml topical cream [the hayan cherry blossom brightening essence]||has_inactive_ingredient
aloe barbadensis leaf extract||(spl review) menthol 0.05 g in 1 g cutaneous tape [csi cooling patch]||has_inactive_ingredient
hydrochloric acid preparations||midazolam hcl@125 mg/25 ml(5 mg/ml)@intraven@syringe (ml)||has_inactive_ingredient
p-hydroxybenzoic propyl ester||aluminum hydroxide/magnesium hydroxide/simethicone 200 mg/5 ml-200 mg/5 ml-20 mg/5 ml oral suspension [health care america antacid]||has_inactive_ingredient
cyclomethicone||octinoxate 948 mg in 32.7 g / titanium dioxide 1700 mg in 32.7 g topical emulsion [shiseido sheer and perfect foundation b40]||has_inactive_ingredient
nitrotan||alcohol 165.2 ml in 236 ml topical liquid||has_inactive_ingredient
annickia chlorantha bark extract||salicylic acid 2 in 100 topical disc [first aid beauty fab pharma white clay acne treatment]||has_inactive_ingredient
fd&c red #40||cholestyramine 4gm/5gm (light) oral pwd||has_inactive_ingredient
product containing cod liver oil||zinc oxide 532 mg in 1 g topical paste [diaper rash]||has_inactive_ingredient
hydroxide sodium||populus fremontii pollen 0.05 g in 1 ml subcutaneous injection, solution [populus fremontii pollen]||has_inactive_ingredient
d and c red no.7||octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel couleur luxe rouge irresistible maximum hydration spf 17 (fuchsia intense) - purple]||has_inactive_ingredient
microcrystalline cellulose||guaifenesin 200 mg oral tablet [mucus relief chest congestion]||has_inactive_ingredient
cornstarch||acetaminophen 325 mg / phenylephrine hydrochloride 5 mg oral tablet, coated [pressure plus pain pe]||has_inactive_ingredient
propyleneglycol||levaquin 250 mg oral tablet||has_inactive_ingredient
hydrogen oxide||menthol 5 g in 100 g / capsaicin .0375 g in 100 g / methyl salicylate 5 g in 100 g topical patch [medrox]||has_inactive_ingredient
dimeticone product||avobenzone 25 mg in 1 ml / homosalate 80 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 80 mg in 1 ml topical lotion [neutrogena clear body breakout free oil free sunscreen broad spectrum spf 30]||has_inactive_ingredient
sorbitol||acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [cold and flu nighttime, multi-symptom]||has_inactive_ingredient
ferrosoferric oxide||supramine 37.5 mg oral capsule||has_inactive_ingredient
magnesium silicate (substance)||octisalate 0.04 g in 1 ml / homosalate 0.08 g in 1 ml / avobenzone 0.03 g in 1 ml / octocrylene 0.07 g in 1 ml / octinoxate 0.02 g in 1 ml topical lotion [vitamin e moisture-protect spf 30 pa plus plus plus]||has_inactive_ingredient
calcarea carbonica||product containing atorvastatin 20 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
polyethylene glycol 3350 (medication)||bupropion hcl 150 mg 12hr extended release oral tablet||has_inactive_ingredient
sls||minocycline hydrochloride 100mg capsule||has_inactive_ingredient
alpha-propylene glycol||product containing only tetracycline 500 mg/1 each oral capsule (clinical drug)||has_inactive_ingredient
citrus maxima seed extract||sodium monofluorophosphate 0.1 g in 100 g dental paste, dentifrice [fluoridetoothpaste]||has_inactive_ingredient
hydroxypropyl methylcellulose (product)||acetaminophen 325 mg oral tablet, coated [medique at home apap]||has_inactive_ingredient
triethoxy(octyl)silane||octinoxate 7.5 mg in 100 ml / zinc oxide 3.4 mg in 100 ml topical lotion [urban decay naked skin dark beauty balm spf20]||has_inactive_ingredient
product containing macrogol (medicinal product)||acetaminophen 650 mg oral tablet, extended release [the medicine shoppe arthritis pain reliever]||has_inactive_ingredient
2-methylpentane-2,4-diol||benzoyl peroxide 50 mg in 1 ml topical lotion [l-topical benzoyl peroxide 5%]||has_inactive_ingredient
fd & c blue #2||budeprion sr 150 mg 12 hr extended release oral tablet||has_inactive_ingredient
paeonia suffruticosa root extract||avobenzone 2 g in 100 ml / homosalate 4 g in 100 ml / octisalate 4 g in 100 ml / octocrylene 2 g in 100 ml topical cream [murad - age reform - invisiblur perfecting shield spf 30]||has_inactive_ingredient
caprylyl glycol||avobenzone 1 g in 100 g / octocrylene 7.4 g in 100 g / oxybenzone 3 g in 100 g topical aerosol, spray [banana boat]||has_inactive_ingredient
aloe vera leaf||benzalkonium chloride 1.3 mg in 1 g / camphor (synthetic) 30 mg in 1 g topical cream [careone cold sore treatment]||has_inactive_ingredient
dipropylene glycol||titanium dioxide 62.2 mg in 1 ml / zinc oxide 38.3 mg in 1 ml topical liquid [rainforest of the sea water foundation broad spectrum spf 15 sunscreen 12n fair neutral]||has_inactive_ingredient
dimeticone (product)||aluminum zirconium tetrachlorohydrex gly 20 g in 100 g topical stick [secret clinical strength fast acting invisible fresh burst]||has_inactive_ingredient
cotton fiber allergenic extract||epinephrine hydrochloride 0.197 mg in 10 mm dental solution [gingi-pak max z-twist no 00]||has_inactive_ingredient
manitol||hydrochlorothiazide 12.5mg/lisinopril 10mg tab||has_inactive_ingredient
cyclomethicone 5||aluminum zirconium trichlorohydrex gly 17 g in 100 g topical stick [old spice original high endurance]||has_inactive_ingredient
dipropylene glycol||avobenzone 0.75 g in 25 g / octocrylene 1.875 g in 25 g / octisalate 1.25 g in 25 g topical cream [no7 lift and luminate triple action day cream spf 30]||has_inactive_ingredient
dha-s||octinoxate 50 mg in 1 ml topical cream [flormar bb bb03 light]||has_inactive_ingredient
tridymite||amoxicillin (as amoxicillin trihydrate) 875 mg / clavulanic acid (as clavulanate potassium) 125 mg oral tablet||has_inactive_ingredient
product containing water (medicinal product)||benzalkonium chloride@0.1 %-1" x 3"@topical@adhesive patch, medicated||has_inactive_ingredient
2-hydroxypropanoic acid sodium salt||octinoxate 3.9 g in 50 ml / zinc oxide 3.8 g in 50 ml topical lotion [decorte sheer brilliance 30]||has_inactive_ingredient
407s, poloxamer||aciclovir 50 mg/g cutaneous cream||has_inactive_ingredient
methyl 4-hydroxybenzoate (product)||salicylic acid 20 mg in 1 ml topical gel [the inkey list c 50 serum]||has_inactive_ingredient
oil, soya||octisalate 0.21 g in 4.25 g / avobenzone 0.09 g in 4.25 g / octocrylene 0.06 g in 4.25 g / octinoxate 0.28 g in 4.25 g topical stick||has_inactive_ingredient
lactose monhydrate||buspirone hydrochloride 5mg tablet (product)||has_inactive_ingredient
methyl glycol||cvs anti-itch maximum strength 1% topical cream||has_inactive_ingredient
hypromelloses||aspirin 325 mg oral tablet, coated [bayer aspirin regimen enteric coated]||has_inactive_ingredient
iron (ii, iii) oxide||prazosin hcl@1 mg@oral@capsule||has_inactive_ingredient
lauryl sulfate, sodium||sofosbuvir 150 mg oral pellet [sovaldi]||has_inactive_ingredient
d-(-)-sorbitol||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [daytime severe cold and flu relief softgels]||has_inactive_ingredient
1-ethenyl-2-pyrrolidinone, homopolymer||product containing only acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg/1 each oral tablet||has_inactive_ingredient
tartrazine stain (substance)||octinoxate 0.075 g in 1 g / zinc oxide 0.0392 g in 1 g topical lipstick [lbel concentre total labios global perfection spf 20 burdeos/red]||has_inactive_ingredient
matmate||keppra, 750 mg oral tablet||has_inactive_ingredient
nacl||platanus occidentalis pollen 10000 [pnu] in 1 ml intradermal injection, solution||has_inactive_ingredient
iron oxide black||product containing precisely omeprazole 20 milligram/1 each conventional release oral capsule||has_inactive_ingredient
glucidex||acetaminophen 325 / guaifenesin 200 / phenylephrine hydrochloride 5 oral tablet, coated [head congestion plus mucus pe]||has_inactive_ingredient
water product (substance)||sodium fluoride 12.3 mg in 1 g dental gel [60-second fluoride bubble gum]||has_inactive_ingredient
lactose monohydrte||product containing precisely lamotrigine 100 milligram/1 each conventional release oral tablet (clinical drug)||has_inactive_ingredient
2,6-di-tert-butyl-4-cresol||minoxidil 5 g in 100 g topical aerosol, foam [kirkland signature minoxidil]||has_inactive_ingredient
4xla base||succinylcholine chloride 20 mg/ml injection syringe (ml)||has_inactive_ingredient
chamomile extract (substance)||octinoxate 75 mg in 1 ml / zinc oxide 100 mg in 1 ml topical lotion [solar defender spf 30]||has_inactive_ingredient
pseudopterogorgia elisabethae||benzoyl peroxide 10% topical application lotion||has_inactive_ingredient
water product||thuja occidentalis leafy twig 6 [hp_c] in 1 ml / daphne mezereum bark 8 [hp_c] in 1 ml / silicon dioxide 8 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / measles virus 30 [hp_c] in 1 ml / mumps virus 30 [hp_c] in 1 ml / bordetella pertussis 30 [hp_c] in 1 ml / poliovirus 30 [hp_c] in 1 ml / rubella virus 30 [hp_c] in 1 ml / clostridium tetani 30 [hp_c] in 1 ml / human breast tumor cell 15 [hp_c] in 1 ml / antimony trisulfide 30 [hp_c] in 1 ml / ledum palustre twig 30 [hp_c] in 1 ml / thimerosal 30 [hp_c] in 1 ml oral liquid [vax reaction]||has_inactive_ingredient
edetate sodium||menthol topical 7.5% topical film||has_inactive_ingredient
brilliant blue fcf (substance)||verapamil hydrochloride 180 mg extended release oral tablet [covera]||has_inactive_ingredient
fatty acid 18:0||ibuprofen to go, 200 mg oral tablet||has_inactive_ingredient
isododecane||octocrylene 3 g in 100 g / oxybenzone 4 g in 100 g / homosalate 10 g in 100 g / octisalate 5 g in 100 g / avobenzone 3 g in 100 g topical spray [hawaiian tropic silk hydration clear sunscreen broad spectrum spf 50]||has_inactive_ingredient
tonka bean camphor||octinoxate 74.9 mg in 1 ml topical lotion [diorskin nude air nude healthy glow ultra-fluid serum foundation with sunscreen broad spectrum spf25 040 honey beige]||has_inactive_ingredient
ferrosoferric oxide||octinoxate 7.5 g in 100 g / zinc oxide 7.84 g in 100 g topical paste [clarite makeup foundation for a clearer appearance spf 30 220-c]||has_inactive_ingredient
carboxymethylcellulose sodium product||acetaminophen 160 mg/5 ml oral suspension [infants' fever reducer & pain reliever]||has_inactive_ingredient
caprylyl trisiloxane||zinc oxide 12 g in 100 ml topical cream [ultra uv protective mineral defense spf 50]||has_inactive_ingredient
cellulose powder||product containing only conjugated estrogens 1.25 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
d&c red # 33||benzalkonium chloride 0.005 mg in 1 ml topical liquid [reliable luxury foam antimicrobial handwash citrus floral scent]||has_inactive_ingredient
sorbate potassium||salicylic acid 2 g in 100 g topical liquid [slmd salicylic acid body wash]||has_inactive_ingredient
sorbitol (product)||sodium monofluorophosphate 1 mg in 1 g oral paste [morning fresh]||has_inactive_ingredient
onion||dextromethorphan hydrobromide 20 mg / guaifenesin 200 mg per 30 ml oral solution||has_inactive_ingredient
blue no. 1||alcohol 620 mg in 1 ml topical gel [justice flamingo berry scented anti bacterial hand sanitizer]||has_inactive_ingredient
phenol (substance)||juglans regia pollen extract 0.001 gm/ml injectable solution||has_inactive_ingredient
lecithin soya||olumiant, 2 mg oral tablet||has_inactive_ingredient
cordycepic acid||hyoscyamine sulfate 0.125 mg oral tablet, orally disintegrating||has_inactive_ingredient
recticare advanced wipes||acetaminophen 160 mg in 5 ml oral liquid [little remedies infant fever/pain reliever]||has_inactive_ingredient
stearic acid||wellbutrin 100 mg oral tablet||has_inactive_ingredient
ethyl alcohol (product)||salicylic acid 5 g topical patch [m skin care blemish patches]||has_inactive_ingredient
sorbate potassium||titanium dioxide 3 g in 50 g / octinoxate 3.75 g in 50 g topical lotion [umbrella sunscreen]||has_inactive_ingredient
propanediol||alcohol 70 ml in 100 ml topical gel [amouage]||has_inactive_ingredient
titanium dioxide-containing product||bisacodyl 5 mg oral tablet, coated [laxative for women]||has_inactive_ingredient
macrogol (substance)||ibuprofen 200 mg oral capsule, liquid filled [ibuprofen liqui-gels]||has_inactive_ingredient
poloxamer 407s||sodium fluoride 0.2 mg/ml mouthwash||has_inactive_ingredient
water product (substance)||kochia scoparia pollen 40000 [pnu] in 1 ml intradermal injection, solution||has_inactive_ingredient
firstflush||alcohol 80 ml in 100 ml topical cloth [molecure skincare alcohol wipes]||has_inactive_ingredient
sorbitan||docusate sodium 100 mg oral capsule, liquid filled [quality choice stool softener]||has_inactive_ingredient
sorbitan sesquioleate||zinc oxide 200 mg in 1 ml topical lotion [argan stem cell bb benefit balm un-tinted sfp 30]||has_inactive_ingredient
corn starch, pregelatinized||hydrochlorothiazide 25 milligram in 1 tablet oral tablet [hydrochlorothiazide]||has_inactive_ingredient
chloride sodium||rocuronium bromide 10mg/ml injection||has_inactive_ingredient
ethyl alcohol product||avobenzone 3 g in 100 ml / homosalate 15 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 10 g in 100 ml topical gel [bull frog spf 50]||has_inactive_ingredient
gelatins||acetaminophen/dextromethorphan hydrobromide/phenylephrine hydrochloride 325 mg-10 mg-5 mg oral capsule, liquid filled [topcare daytime]||has_inactive_ingredient
product containing water||hydromorphone hcl in 0.9 % sodium chloride/pf@0.5 mg/ml@intraven@plastic bag, injection (ml)||has_inactive_ingredient
sodium polystyrene sulfonate||dextromethorphan hydrobromide 30 mg/5 ml oral suspension, extended release||has_inactive_ingredient
aloe vera leaf||octisalate 49 mg in 1 ml / avobenzone 29.4 mg in 1 ml / octocrylene 49 mg in 1 ml / homosalate 73.5 mg in 1 ml topical spray [australian gold spf 30]||has_inactive_ingredient
fd & c red #40||hydralazine hcl@50 mg@oral@tablet||has_inactive_ingredient
raw sugar||lansoprazole 15 mg oral capsule, delayed release [equate lansoprazole]||has_inactive_ingredient
e421 - mannitol||amantadine hydrochloride 100 mg oral capsule, gelatin coated||has_inactive_ingredient
sunset yellow fcf stain||vitamin a acetate 2000 [iu] / .beta.-carotene 2000 [iu] / ascorbic acid 120 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, dl- 22 mg / thiamine mononitrate 1.84 mg / riboflavin 3 mg / niacinamide 20 mg / pyridoxine hydrochloride 10 mg / folic acid 1 mg / cyanocobalamin 12 ug / calcium carbonate 200 mg / ferrous fumarate 27 mg / zinc oxide 25 mg / cupric oxide 2 mg oral tablet [pnv prenatal plus multivitamin]||has_inactive_ingredient
product containing talc (medicinal product)||gabapentin 100mg oral capsule||has_inactive_ingredient
octadecanoic acid-containing product||lorcet plus 7.5mg-325mg tablet||has_inactive_ingredient
2,2',2''-nitrilotriethanol||alcohol 70 ml in 100 ml topical gel [beautytreats hand sanitizer]||has_inactive_ingredient
tridecyl trimellitate||octinoxate 0.075 g in 1 g / zinc oxide 0.0392 g in 1 g topical lipstick [esika pro hidracolor 3 in 1 moisturizing, color and perfecting effect spf 25 (fresa hot) - pink]||has_inactive_ingredient
methyl 4-hydroxybenzoate (substance)||gnp cough dm er 12 hour 30mg/5ml extended-release suspension (grape)||has_inactive_ingredient
(+)-alfa-tocopherol acetate||avobenzone 30 mg in 1 g / homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 23.5 mg in 1 g topical aerosol, spray [face values ultra sport active spf 50 sunscreen]||has_inactive_ingredient
magnesium stearate (substance)||ascorbic acid/cyanocobalamin/docusate sodium/folic acid/iron/succinic acid/zinc;placebo 175 mg-12 mcg-50 mg-1 mg-75 mg-150 mg-10 mg; na oral tablet [feriva 21/7]||has_inactive_ingredient
crospovidone (15 mpa.s at 5%)||amlodipine 5 mg / hydrochlorothiazide 12.5 mg / valsartan 160 mg oral tablet||has_inactive_ingredient
viva-drops lubricating eye drops||miconazole nitrate 40 mg in 1 g vaginal cream [lagicam antifungal]||has_inactive_ingredient
glyceryl triacetate||ondansetron 8mg tablet (product)||has_inactive_ingredient
poly(v-co-v-ac)||neurontin, 600 mg oral tablet||has_inactive_ingredient
ferric oxide,yellow||venlafaxine hcl 150 mg oral capsule, ext release 24 hr||has_inactive_ingredient
glycerol (product)||ulmus americana pollen 0.05 g in 1 ml percutaneous injection, solution [ulmus americana pollen]||has_inactive_ingredient
iron oxide, red||montelukast 5mg chewable tablet (substance)||has_inactive_ingredient
sunflower lecithin||zinc oxide 140 mg in 1 ml topical cream||has_inactive_ingredient
1,2-propanediol, 3-(4-chlorophenoxy)-||octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 spf 25 (fucsia cautivante exotic) - pink]||has_inactive_ingredient
mhpc polymer||ondansetron 8 mg oral tablet||has_inactive_ingredient
lexidronam pentasodium||salicylic acid 20 mg in 1 ml topical solution [clear skin acne treatment cleanser]||has_inactive_ingredient
orange||witch hazel 0.1 mg in 100 ml topical cream [dr. dream cold plazma whitening]||has_inactive_ingredient
linalool, (+/-)-||zinc oxide 114 mg in 1 ml topical cream [pacifica ultra cc radiant foundation broad spectrum spf 17 neutral fair]||has_inactive_ingredient
octadecanoic acid, magnesium salt||ibuprofen 100 mg oral tablet, chewable [equaline childrens ibuprofen]||has_inactive_ingredient
d&c red no. 27||bismuth subsalicylate 262 mg oral tablet, film coated [walgreen]||has_inactive_ingredient
propanol 02||alcohol 700 mg in 1 ml topical liquid [sierra soft alcohol hand sanitizer]||has_inactive_ingredient
magnesium distearate||minocycline 100mg tablet (product)||has_inactive_ingredient
edathamil||octinoxate 75 mg in 50 ml / oxybenzone 60 mg in 50 ml / octisalate 50 mg in 50 ml / octocrylene 40 mg in 50 ml / avobenzone 30 mg in 50 ml topical lotion [prevage anti agining triple defense shield broad spectrum sunscreen spf 50]||has_inactive_ingredient
glycérine||alcohol 0.72 ml in 1 ml topical gel [club donatello hand sanitizer]||has_inactive_ingredient
edta, disodium||oatmeal 50 mg in 1 g topical cream [dr. sayman wonder cream]||has_inactive_ingredient
cetyl peg/ppg-10/1 dimethicone (hlb 1.5)||octinoxate 0.3 g in 6 ml / titanium dioxide 0.2328 g in 6 ml topical cream [age20s jericho rose tone essential uv primer pale lavender]||has_inactive_ingredient
dodecyl sulfate, ammonium salt||selenium sulfide 10 mg in 1 ml topical liquid [cvs pharmacy maximum strength dandruff]||has_inactive_ingredient
hypromellose product (substance)||venlafaxine hydrochloride 225 mg oral tablet, coated||has_inactive_ingredient
stingeze max||camponotus pennsylvanicus 0.001 g in 1 ml subcutaneous solution [black carpenter ant]||has_inactive_ingredient
carmellose sodium||pot nitrate 0.05 mg/mg / sodium fluoride 0.0015 mg/mg toothpaste||has_inactive_ingredient
gelatine||pregabalin 225mg capsule||has_inactive_ingredient
dibasic magnesium stearate||product containing methazolamide 25 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
tocopheryl||titanium dioxide 3.36 g in 96 g / zinc oxide 3.36 g in 96 g topical cream [moisturizer spf 15]||has_inactive_ingredient
ocimum basilicum flowering top||tribasic calcium phosphate 12 [hp_x] in 29.6 ml / helianthemum nummularium flower 5 [hp_x] in 29.6 ml / potassium carbonate 6 [hp_c] in 29.6 ml / potassium phosphate, dibasic 6 [hp_x] in 29.6 ml / sodium carbonate 9 [hp_c] in 29.6 ml / phosphorus 6 [hp_c] in 29.6 ml / populus tremula flowering top 5 [hp_x] in 29.6 ml / prunus cerasifera flower 5 [hp_x] in 29.6 ml topical spray [calm down]||has_inactive_ingredient
methyltrimethylene glycol||niacinamide 2 g in 100 ml / adenosine 0.04 g in 100 ml topical liquid [wellage fresh water essence mist]||has_inactive_ingredient
high density polyethylene||octinoxate 5.0 g in 100 g / octisalate 2.5 g in 100 g topical lipstick [rich lip color spf 12]||has_inactive_ingredient
peg-10 dimethicone (600 cst)||octinoxate 0.065 g in 1 ml / zinc oxide 0.33 g in 1 ml topical cream [esika pro hydra smart hydro-nutritive foundation spf 15]||has_inactive_ingredient
polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 mpa.s)||zinc oxide 82 mg in 1 ml / titanium dioxide 65 mg in 1 ml topical cream [breathable camouflage light tawny]||has_inactive_ingredient
titanium dioxide (substance)||oxybutynin chloride 10 mg prolonged-release oral tablet||has_inactive_ingredient
f d & c yellow #5||benzethonium chloride 0.1 g in 100 ml topical liquid [family dollar antibacterial]||has_inactive_ingredient
polysorbate 80s||product containing only valacyclovir 1000 milligram/1 each oral tablet||has_inactive_ingredient
propyl para-hydroxybenzoate||avobenzone 3 ml in 100 ml / homosalate 10 ml in 100 ml / octisalate 2.5 ml in 100 ml / octocrylene 2.4 ml in 100 ml / oxybenzone 5 ml in 100 ml topical cream [sun protection emulsion face la prairie]||has_inactive_ingredient
sucrose preparation (substance)||nickel 30 [hp_c] oral pellet [niccolum metallicum]||has_inactive_ingredient
lavandula angustifolia flower extract||menthol 30 mg in 1 ml / lidocaine 20 mg in 1 ml topical gel [joint and muscle relief 450 mg]||has_inactive_ingredient
water-containing product||isopropyl alcohol 75 ml in 100 ml topical liquid [hand sanitizer]||has_inactive_ingredient
agua||alcohol 80 ml in 100 ml topical gel [sci 70 hand sanitizer gel]||has_inactive_ingredient
phyllanthus emblica fruit extract||titanium dioxide 50 mg in 1 ml / zinc oxide 30 mg in 1 ml topical lotion [bareminerals advanced protection spf 20 moisturizer sheer tint combination skin]||has_inactive_ingredient
peg-10 dimethicone (600 cst)||octinoxate 60 mg in 1 ml / titanium dioxide 56 mg in 1 ml topical emulsion [vitalumiere aqua ultra-light skin perfecting sunscreen makeup broad spectrum spf 15, 52 beige rose]||has_inactive_ingredient
citric acid,anhydrous||ascorbic acid 80 mg in 4 ml / vitamin a palmitate 2300 [iu] in 4 ml / cholecalciferol 400 [iu] in 4 ml / thiamine hydrochloride 1.2 mg in 4 ml / riboflavin 5'-phosphate sodium 1.4 mg in 4 ml / pyridoxine hydrochloride 1 mg in 4 ml / niacinamide 17 mg in 4 ml / dexpanthenol 5 mg in 4 ml / .alpha.-tocopherol acetate 7 [iu] in 4 ml / phytonadione 0.2 mg in 4 ml intravenous injection, solution [pediatric infuvite multiple vitamins]||has_inactive_ingredient
tea seed oil||menthol 15 g in 100 ml topical oil [po sum on medicated]||has_inactive_ingredient
cellulose,microcrystalline||pseudoephedrine hydrochloride 30 mg oral tablet [sudophed]||has_inactive_ingredient
d and c yellow 10||sodium fluoride 1.5 mg in 1 g / triclosan 3 mg in 1 g dental paste, dentifrice [colgate total advance whitening]||has_inactive_ingredient
sodium, croscarmellose||product containing precisely citalopram (as citalopram hydrobromide) 20 milligram/1 each conventional release oral tablet||has_inactive_ingredient
vitamin a (palmitate)||octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - rouge rubi]||has_inactive_ingredient
d-sorbit||calcium carbonate/magnesium hydroxide/simethicone@1,200 mg-270 mg-80 mg/10 ml@oral@suspension, oral (final dose form)||has_inactive_ingredient
cellulose, microcrystalline||buspirone hydrochloride 10mg oral tablet||has_inactive_ingredient
2-methyl-4-isothiazolin-3-one||benzalkonium chloride 0.26 g in 100 ml topical gel [sanitaxe antibacterial]||has_inactive_ingredient
magnesium octadecanoate||stool softener with laxative 50mg-8.6mg tablet||has_inactive_ingredient
aluminum hydroxide (substance)||titanium dioxide 28 mg in 1 ml topical emulsion [clarins everlasting youth fluid broad spectrum spf 15 titanium dioxide sunscreen illuminating and firming foundation 115]||has_inactive_ingredient
food blue 2||iron 65 mg oral tablet [leader iron tablets]||has_inactive_ingredient
cornstarch||al oh 75mg/asa 325mg/ca carb 75mg/mg oh 75mg tab||has_inactive_ingredient
saccharin (substance)||octinoxate 75 mg in 1 g / oxybenzone 20 mg in 1 g topical gel [neutrogena moistureshine lip soother sunscreen spf20 - shine 30]||has_inactive_ingredient
wax, carnauba||rite aid aspirin low dose 81mg enteric coated tablet||has_inactive_ingredient
pregelatinized starch (corn)||acetaminophen 250 mg / caffeine 50 mg / magnesium salicylate 290 mg oral tablet [backprin]||has_inactive_ingredient
cellulose, microcrystalline||lovastatin 40mg tab ud||has_inactive_ingredient
blackberry allergenic extract||lamotrigine@5 mg@oral@tablet, chewable dispersible||has_inactive_ingredient
medium chain triglyceride product||zinc oxide 10 g in 100 ml topical emulsion [perfecting liquid foundation golden beige spf 15]||has_inactive_ingredient
peg||atorvastatin calcium 80mg tab||has_inactive_ingredient
cellulose, microcrystalline||hydrochlorothiazide-losartan, 12.5 mg-100 mg oral tablet||has_inactive_ingredient
disodium sulfate||chloroxylenol 0.003 mg in 1 ml topical liquid [qsc assist antimicrobial hand cleanser]||has_inactive_ingredient
natriumhydrogenkarbonat||phalaris arundinacea pollen 0.001 g in 1 ml subcutaneous solution [reed canarygrass]||has_inactive_ingredient
propan-1,2-diol||minoxidil 5 g in 100 ml topical solution [members mark hair regrowth treatment]||has_inactive_ingredient
cyclomethicone 5||zinc oxide 85 mg in 1 g / titanium dioxide 137 mg in 1 g topical cream [i conceal flawless foundation broad spectrum spf 30 sunscreen porcelain]||has_inactive_ingredient
sucrose preparation||duloxetine hydrochloride 30 mg oral capsule, delayed release pellets||has_inactive_ingredient
ethyl alcohol product||sodium bromide 30 [hp_c] in 1 ml oral liquid [natrum bromatum]||has_inactive_ingredient
dioxide titanium||avobenzone 0.6 g in 30.0 ml / octinoxate 2.25 g in 30.0 ml topical cream [mally perfect prep poreless primer]||has_inactive_ingredient
hydrogen peroxide||alcohol 80 ml in 100 ml topical liquid [hatchet sanitizer]||has_inactive_ingredient
hydrogenated coco-glycerides||octinoxate 0.065 g in 1 g / titanium dioxide 0.0244 g in 1 g / zinc oxide 0.0157 g in 1 g topical paste [lbel mousse matiffiant matte finish mousse foundation spf 15 obscure 9/ beige]||has_inactive_ingredient
polyethylene glycol 12 cetostearyl ether||avobenzone 20 mg in 1 ml / octisalate 50 mg in 1 ml / homosalate 100 mg in 1 ml / octocrylene 55 mg in 1 ml topical liquid [coola refreshing water mist sunscreen spf 30]||has_inactive_ingredient
saccharin sodium dihydrate||sodium fluoride 0.243 g in 100 g dental paste, dentifrice [heb hebuddy]||has_inactive_ingredient
d & c red #27||acetaminophen 160 mg oral tablet,chewable||has_inactive_ingredient
product containing propylene glycol||wal-itin children's allergy 5mg/5ml solution (bubblegum)||has_inactive_ingredient
croscarmellose sodium||trifexis for dogs 1620 mg / 27 mg chewable tablet||has_inactive_ingredient
cyanosin||benzocaine 20 g in 100 g topical gel [makesense pain relief]||has_inactive_ingredient
dimeticonum||octinoxate 0.07 g in 1 ml topical liquid [lbel filling effect foundation spf 10 (medium 6) - brown]||has_inactive_ingredient
hydroxpropyl cellulose||product containing perphenazine 8 mg/1 each oral tablet||has_inactive_ingredient
product containing water||alcohol 63 in 100 g topical gel [ritz spritz mulled cranberry]||has_inactive_ingredient
dihydrogen oxide||alcohol 80 ml in 100 ml topical liquid [renew apothecary hand sanitizer]||has_inactive_ingredient
p-hydroxybenzoic acid propyl ester||betamethasone 0.05% cream (product)||has_inactive_ingredient
iron oxide,yellow||uptravi 200 mcg oral tablet||has_inactive_ingredient
isopropyl titanium triisostearate||titanium dioxide 146.3 mg in 1 g / octinoxate 67 mg in 1 g / octisalate 40 mg in 1 g topical cream [jungsaemmool masterclass radiant cushion n1 ivory]||has_inactive_ingredient
polyvinyl alcohol product (substance)||acetaminophen/diphenhydramine hydrochloride/phenylephrine hydrochloride 325 mg-12.5 mg-5 mg oral tablet [theraflu expressmax severe cold & cough nighttime]||has_inactive_ingredient
gardenia jasminoides fruit||glycerin 5 mg in 100 ml topical cream [queen79 noble goldcream]||has_inactive_ingredient
water||sodium chloride 0.9% intravenous solution_#9||has_inactive_ingredient
carbomer 934||alcohol 65 ml in 100 ml topical solution [body prescriptions 65 percent alcohol antibacterial hand sanitizer sugar cookie]||has_inactive_ingredient
product containing edetate disodium (medicinal product)||cvs headache relief extra strength geltab||has_inactive_ingredient
ethanol||aloe 20 [hp_x] in 1 ml / silver nitrate 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / atropa belladonna 20 [hp_x] in 1 ml / benzoic acid 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / causticum 20 [hp_x] in 1 ml / equisetum hyemale 20 [hp_x] in 1 ml / iron 20 [hp_x] in 1 ml / gelsemium sempervirens root 20 [hp_x] in 1 ml / strychnos ignatii seed 20 [hp_x] in 1 ml / potassium phosphate, dibasic 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / sodium chloride 20 [hp_x] in 1 ml / nitric acid 20 [hp_x] in 1 ml / plantago major 20 [hp_x] in 1 ml / pulsatilla vulgaris 20 [hp_x] in 1 ml / rhus aromatica root bark 20 [hp_x] in 1 ml / saw palmetto 20 [hp_x] in 1 ml / claviceps purpurea sclerotium 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / delphinium staphisagria seed 20 [hp_x] in 1 ml / datura stramonium 20 [hp_x] in 1 ml / thyroid, unspecified 20 [hp_x] in 1 ml / verbascum thapsus 20 [hp_x] in 1 ml / echinacea, unspecified 8 [hp_x] in 1 ml / goldenseal 8 [hp_x] in 1 ml oral liquid [incontinence]||has_inactive_ingredient
dioxide titanium||octinoxate 7.5 g in 30 g topical cream [no7 stay perfect foundation sunscreen broad spectrum spf 15 latte]||has_inactive_ingredient
fd&c blue #1||potassium chloride 10 meq extended release oral capsule [klor-con]||has_inactive_ingredient
dodecyl sulfate, sodium||carbamide peroxide 65 mg in 1 ml topical solution/ drops [ear wax removal drops]||has_inactive_ingredient
glycerin||benzalkonium chloride 0.05 g in 100 ml topical liquid [dr.toc perfect clean hand wash]||has_inactive_ingredient
cross-linked carboxymethylcellulose sodium||ezetimibe 10mg/rosuvastatin 10mg tab||has_inactive_ingredient
d&c red no. 33||alcohol 310 ml in 500 ml topical gel [wonder hand fresh gel lemon flavor (ethanol)]||has_inactive_ingredient
poly(hexamethylene biguanide)||benzalkonium chloride 1.3 mg in 1 ml topical liquid [hoboco and co french lavender]||has_inactive_ingredient
glycol, propylene||oxymetazoline hydrochloride 0.05 g in 100 ml nasal spray [dg health nasal original]||has_inactive_ingredient
hydroxypropyl methylcellulose||tramadol hydrochloride 37.5 mg / acetaminophen 325 mg oral tablet||has_inactive_ingredient
salt, nos||juniperus occidentalis pollen extract 100 mg/ml injectable solution||has_inactive_ingredient
polyvinyl pyrrolidone||hctz 25 mg / triamterene 37.5 mg oral tablet||has_inactive_ingredient
pva||fenofibrate,micronized 145 mg oral tablet||has_inactive_ingredient
phenol compound||black walnut pollen extract 50 mg/ml injectable solution||has_inactive_ingredient
product containing cornflour (medicinal product)||trazodone hydrochloride 50 mg oral tablet [trazodone hydrochloride]||has_inactive_ingredient
hypromellose 2910 (3 mpa.s)||sertraline 25mg tablet||has_inactive_ingredient
strawberry||cephalexin 250mg/5ml oral susp||has_inactive_ingredient
sodium bicarbonate (medication)||aspergillus niger var. niger 8000 [pnu] in 1 ml / aspergillus fumigatus 8000 [pnu] in 1 ml / eurotium amstelodami 8000 [pnu] in 1 ml / aspergillus flavus 8000 [pnu] in 1 ml / aspergillus nidulans 8000 [pnu] in 1 ml subcutaneous solution [aspergillus mix]||has_inactive_ingredient
starch 1551||levonorgestrel, 0.75 mg oral tablet||has_inactive_ingredient
fragrance floral orc0902236||ethanol 224 g in 400 g topical aerosol, spray [zytec germ buster hand sanitizer]||has_inactive_ingredient
water (substance)||chloroxylenol 0.003 mg in 1 ml topical liquid [grand touch antimicrobial ltion so ap]||has_inactive_ingredient
titanium dioxide (product)||gabapentin 400 mg oral capsule [gabapentin]||has_inactive_ingredient
magnesium octadecanoate||norgestimate 0.25 mg / ethinyl estradiol 0.035 mg oral tablet [sprintec]||has_inactive_ingredient
propanetriol||diphenhydramine hydrochloride 50 mg in 50 mg oral capsule||has_inactive_ingredient
microcrystalline celullose||tylenol sinus congestion and pain daytime non-drowsy gelcap||has_inactive_ingredient
fd & c red #40||perfect choice 2% neutral topical gel (wild berry)||has_inactive_ingredient
cyclomethicone||ethanol 85 % topical foam||has_inactive_ingredient
lactose monohydrte||indomethacin 50mg capsule||has_inactive_ingredient
pullulan||octinoxate 35 mg in 1 ml / avobenzone 30 mg in 1 ml / octocrylene 90 mg in 1 ml / octisalate 50 mg in 1 ml topical lotion [villa floriani aloe ultra-hydrating day spf 20]||has_inactive_ingredient
polyglyceryl 3 diisostearate||octinoxate 0.072 g in 1 g topical lipstick [effet parfait rouge amplifier amplifying spf 15 (rose tentation) - pink]||has_inactive_ingredient
talc-containing product||24 hr avinza 120 mg extended release oral capsule||has_inactive_ingredient
water (substance)||zinc oxide 13.13 g in 1 g / titanium dioxide 4.42 g in 1 g topical lotion [alex md phd antidotal skincare daily defense tinted mineral anti-aging sunscreen]||has_inactive_ingredient
d mannitol||nicotine 4 mg oral gum, chewing [nicotine coated fruit flavor]||has_inactive_ingredient
glycerol product||alcohol 42 ml in 60 ml topical gel [rinse-free disinfectant gel]||has_inactive_ingredient
cnidium seed||menthol 20 mg/ml / methyl salicylate 5 mg/ml topical cream||has_inactive_ingredient
fungasol||aluminum chlorohydrate 100 mg in 1 ml topical cream [lactovit deodorant antiperspirant lactourea]||has_inactive_ingredient
persea americana leaf extract||oatmeal 10 g in 17 g topical lotion||has_inactive_ingredient
water product||avobenzone 3 g in 100 g / homosalate 13 g in 100 g / octisalate 5 g in 100 g / octocrylene 7 g in 100 g / oxybenzone 4 g in 100 g topical lotion [walgreens sunscreen spf 50]||has_inactive_ingredient
magnesium sulfate-containing product||octinoxate 0.027375 g in 100 ml / titanium dioxide 0.01095 g in 100 ml topical liquid [studio fix fluid spf 15 broad spectrum]||has_inactive_ingredient
water||alcohol 75 ml in 100 topical cloth [75% alcohol wipes]||has_inactive_ingredient
oxide, ferrosoferric||(spl review) alcohol 62 g in 112 ml topical gel [hand sanitizer]||has_inactive_ingredient
gums xanthan||avobenzone 0.02 g in 1 ml / homosalate 0.068 g in 1 ml / octocrylene 0.044 g in 1 ml / octisalate 0.034 g in 1 ml topical lotion [redefine triple defense]||has_inactive_ingredient
gotu kola whole||zinc oxide 5.5 mg in 100 ml / titanium dioxide 5.5 mg in 100 ml topical cream [cc cream deep230]||has_inactive_ingredient
titanium dioxide product||cyclosporine 50 mg oral capsule, liquid filled [cyclosporine modified]||has_inactive_ingredient
chlorphenesin (product)||octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel hydratess long-lasting intense moisturizing spf 20 - rose clasique]||has_inactive_ingredient
sodium hydroxide (substance)||phenol 156 g in 1 l / phenolate sodium 0.06 g in 1 l topical solution [regency post milking teat dip]||has_inactive_ingredient
lapsana communis flowering top||titanium dioxide 84 mg in 1 ml topical cream [clarins mission perfection yeux broadspectrum spf 15 sunscreen]||has_inactive_ingredient
microcrystaline cellulose||eszopiclone 3mg oral tablet||has_inactive_ingredient
tartrazine dye||benzocaine 220 mg in 1 g dental gel [smartpractice topical anesthetic gel bubble gum]||has_inactive_ingredient
sacharose||tartaric acid 1 [hp_x] oral pellet||has_inactive_ingredient
polyethylene, high-density||titanium dioxide 2 ml in 100 ml topical lotion [equalizer smart makeup spf 10]||has_inactive_ingredient
butyl acrylate/methyl methacrylate/methacrylic acid copolymer (18000 mw)||alcohol 80 ml in 100 ml topical gel [froggys simply sanitizer gel]||has_inactive_ingredient
sodium chloride [nose]||medetomidine hydrochloride 1 mg/ml injectable solution||has_inactive_ingredient
yellow iron oxide||venlafaxine hcl 37.5mg tab,ud||has_inactive_ingredient
1,3-butylene glycol||octinoxate 75 mg in 1 ml / octisalate 20 mg in 1 ml / octocrylene 40 mg in 1 ml topical lotion [nu skin nu colour advanced finish broad spectrum spf 15 - mocha]||has_inactive_ingredient
cyclomethicone 6||octinoxate 50 mg in 1 ml / octisalate 20 mg in 1 ml topical lotion [nu skin nu colour tinted moisturizer broad spectrum spf 15 sand]||has_inactive_ingredient
trisiloxane||octocrylene 45 mg in 1 ml / octisalate 50 mg in 1 ml / homosalate 100 mg in 1 ml / avobenzone 30 mg in 1 ml / oxybenzone 40 mg in 1 ml topical lotion [cvs health spf 70 beach guard sun]||has_inactive_ingredient
salting||rocuronium bromide 10 mg/ml injectable solution||has_inactive_ingredient
peg-7 glyceryl cocoate||alcohol 70 ml in 100 ml topical cloth [magic xtreme xtra soft alcohol wipes 80]||has_inactive_ingredient
2-hydroxy-1,2,3-propanetricarboxylic acid, anhydrous||iodine 52 g in 1 l / glycerin 85 g in 1 l topical concentrate [instamix iodine concentrate ic]||has_inactive_ingredient
1,2,3-propanetriol||vanacof ac 12.5mg-25mg/30ml solution||has_inactive_ingredient
propyl 4-hydroxybenzoate-containing product||hydralazine hydrochloride 20 mg in 1 ml intravenous injection [hydralazine hydrochloride]||has_inactive_ingredient
sodium laureth-3 sulfate||benzalkonium chloride 1.3 mg in 1 ml topical liquid [my-shield sanitizing]||has_inactive_ingredient
polysorbate 80||goodsense children's ibuprofen 100mg/5ml suspension (grape)||has_inactive_ingredient
product containing sorbitol (medicinal product)||diphenhydramine hydrochloride 50 mg oral capsule, liquid filled [basic care nighttime sleep aid]||has_inactive_ingredient
cellulose microcrystalline||ivacaftor 150 mg / tezacaftor 100 mg oral tablet||has_inactive_ingredient
fd&c blue no. 1.||alcohol 62 ml in 100 ml topical gel [earth baby hand sanitizer gel]||has_inactive_ingredient
iron oxide,yellow||nabumetone 750 mg oral tablet||has_inactive_ingredient
talcum||product containing only phenazopyridine hydrochloride 200 mg/1 each oral tablet (clinical drug)||has_inactive_ingredient
vite - tocopherol||titanium dioxide 8.3 g in 100 g topical cream [too faced bb creme complete coverage make-up spf-20 cream glow]||has_inactive_ingredient
citric acid monohydrate||aloe 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 [hp_x] in 59 ml / croton tiglium seed 10 [hp_x] in 59 ml / cupric arsenite 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / podophyllum 10 [hp_x] in 59 ml / veratrum album root 10 [hp_x] in 59 ml oral liquid [control remedy no. 17]||has_inactive_ingredient
octadecanoic acid-containing product||octinoxate 1.69 g in 30 ml / titanium dioxide 0.345 g in 30 ml topical emulsion [shiseido synchro skin self-refreshing foundation 560 obsidian]||has_inactive_ingredient
product containing colophony (medicinal product)||cornstick 40 % topical ointment||has_inactive_ingredient
product containing isopropyl alcohol (medicinal product)||omeprazole 40 mg oral capsule, delayed release (obs 06-25-01)||has_inactive_ingredient
rosemary oil miscell oil (ml)||alcohol 75 ml in 100 ml topical gel [al kogel hand sanitizer]||has_inactive_ingredient
glyceryl monostearate||esomeprazole 20 mg oral capsule, delayed release [up and up esomeprazole magnesium]||has_inactive_ingredient
tris(β-hydroxyethyl)amine||alcohol 65 ml in 100 ml topical solution [health smart instant hand sanitizer with aloe vera and vitamin e sweet pea]||has_inactive_ingredient
polyvinyl pyrrolidone (substance)||cetirizine hydrochloride 10 mg oral tablet, film coated [sunmark all day allergy]||has_inactive_ingredient
benzoate, sodium||product containing precisely oxycodone hydrochloride 20 milligram/1 milliliter conventional release oral solution (clinical drug)||has_inactive_ingredient
isopropyl palmitate||aluminum chlorohydrate 8.8 g in 100 g topical aerosol, spray [suave fresh aerosol antiperspirant and deodorant]||has_inactive_ingredient
glucosamine sulfate potassium chloride (substance)||menthol, unspecified form 4534 mg in 226.7 g topical lotion [flexible pain relief]||has_inactive_ingredient
mcts||zinc oxide 194 mg in 1 ml topical lotion [celesty antioxidant series rejuvenating sunscreen spf 30]||has_inactive_ingredient
dihydrogen oxide||product containing precisely hydrocortisone valerate 2 microgram/1 milligram conventional release cutaneous ointment (clinical drug)||has_inactive_ingredient
alpha-propylene glycol||alcohol 0.69 ml in 1 ml topical spray [mad beauty hand sanitizer coconut]||has_inactive_ingredient
tridecyl stearate||octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [effet parfait hydratess long-lasting intense moisturizing spf 20 (terre) - brown]||has_inactive_ingredient
product containing titanium dioxide||nabumetone 500 mg oral tablet [relafen]||has_inactive_ingredient
titanium dioxide (substance)||product containing mesna 400 mg/1 each oral tablet||has_inactive_ingredient
phenol (substance)||chenopodium album pollen 20000 [pnu] in 1 ml subcutaneous injection, solution [pollens - weeds and garden plants, lambs quarters chenopodium album]||has_inactive_ingredient
peg-150 pentaerythrityl tetrastearate||miconazole nitrate 20 mg in 1 ml / salicylic acid 20 mg in 1 ml / chloroxylenol 10 mg in 1 ml topical shampoo [sebozole deep cleaning, antimicrobial]||has_inactive_ingredient
product containing lactose||picric acid 30 [hp_c] oral pellet [picricum acidum]||has_inactive_ingredient
phenyl trimethicone||titanium dioxide 0.1462 g in 1 g / octinoxate 0.067 g in 1 g / octisalate 0.04 g in 1 g topical cream [lagom cf cushion 30]||has_inactive_ingredient
propylene glycol (product)||avobenzone 0.03 g in 1 ml / homosalate 0.1 g in 1 ml / octocrylene 0.08 g in 1 ml topical lotion [lbel defense total broad spectrum spf 50 plus sunscreen for face and body]||has_inactive_ingredient
water||oatmeal 1 g in 100 g topical cream [honest eczema cream]||has_inactive_ingredient
product containing mineral oil (medicinal product)||miconazole nitrate 1200 mg vaginal insert [miconazole nitrate]||has_inactive_ingredient
water (substance)||echinacea angustifolia 30 [hp_c] in 1 ml oral liquid [echinacea angustifolia]||has_inactive_ingredient
kieselsäureanhydrid||zinc oxide 6 g in 100 g / titanium dioxide 14 g in 100 g topical stick [clear foundation sunscreen broad spectrum spf 45]||has_inactive_ingredient
methyl para-hydroxybenzoate||octinoxate 55 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [laura mercier tinted moisturizer spf 20 blush]||has_inactive_ingredient
cellulose powders||gnp cold max severe cool taste caplet||has_inactive_ingredient
sorbitan monostearate||clotrimazole 1% topical application cream [good sense clotrimazole]||has_inactive_ingredient
beeswax@100 %@miscell@wax (gram)||zinc oxide 150 mg in 1 ml topical cream [saie slip cover broad spectrum spf 35 sunscreen tinted moisturizer four]||has_inactive_ingredient
glycerin preparation (product)||dimethicone 1 g in 100 ml topical lotion [lucky daily moisturizing]||has_inactive_ingredient
fd&c #1 blue||doxepin hydrochloride 150 mg oral capsule [sinequan]||has_inactive_ingredient
(e)-3,7-dimethylocta-2,6-dien-1-ol||octinoxate 11.25 ml in 150 ml topical cream [perfect bust body]||has_inactive_ingredient
starch, pregelatinized corn||leader headache formula added strength tablet||has_inactive_ingredient
hydroxypropyl cellulose (1200000 wamw)||fentanyl 25 mcg/1 hr transdermal patch, extended release [fentanyl transdermal system]||has_inactive_ingredient
cetostearyl alcohol (substance)||avobenzone 0.03 g in 100 g / octinoxate 0.02 g in 100 g / homosalate 0.08 g in 100 g / octisalate 0.04 g in 100 g / octocrylene 0.07 g in 100 g topical lotion [tbs vitamin e spf]||has_inactive_ingredient
aloe vera leaf||alcohol 375 ml in 500 ml topical gel [instant hand sanitizer]||has_inactive_ingredient
magnesium stearate||actoplus met 15 mg / 500 mg oral tablet||has_inactive_ingredient
1,2-hexanediol||zinc oxide 0.8 g in 12 g / titanium dioxide 1.4 g in 12 g topical cream [aekyungluna long lasting conceal fixing cushion medium beige 23m]||has_inactive_ingredient
maldrin||avobenzone 26.8 mg in 1 ml / homosalate 96 mg in 1 ml / octisalate 28.8 mg in 1 ml / octocrylene 53.8 mg in 1 ml / oxybenzone 34.6 mg in 1 ml topical lotion [la roche posay laboratoire dermatologique anthelios aox daily antioxidant serum broad spectrum spf 50 sunscreen]||has_inactive_ingredient
dimethyl sulfone product||methyl salicylate, topical cream||has_inactive_ingredient
sodium, croscarmellose||dimethyl fumarate 120 mg oral delayed release capsule||has_inactive_ingredient
shellac (substance)||bisacodyl 5 mg oral tablet, enteric coated [colax]||has_inactive_ingredient
citric acid,anhydrous||povidone-iodine 100 mg in 1 ml topical solution [povidone-iodinetopical antiseptic]||has_inactive_ingredient
echinacea preparation (product)||octocrylene 5 g in 100 ml / octisalate 3 g in 100 ml / avobenzone 2.5 g in 100 ml topical lotion [reef safe spf 30 oxybenzone free]||has_inactive_ingredient
peg-150 distearate||chloroxylenol 0.3 g in 100 ml topical soap [klenlii hand antibacterial]||has_inactive_ingredient
tanacetum parthenium whole extract||titanium dioxide 18.8 mg in 1 g topical cream [neutrogena healthy skin brightening eye perfector sunscreen broad spectrum spf25 - buff 09]||has_inactive_ingredient
glycerin (medication)||alcohol 26.36 g in 44 ml topical liquid [fresh breeze]||has_inactive_ingredient
microcrystalline celullose||remeron soltab, 45 mg oral tablet, disintegrating||has_inactive_ingredient
2-pyrrolidinone, 1-ethenyl-, homopolymer||chlorpromazine hcl@50 mg@oral@tablet||has_inactive_ingredient
citrus aurantium fruit extract||octisalate 5 ml in 100 ml / avobenzone 3 ml in 100 ml / octocrylene 2.7 ml in 100 ml topical lotion [a perfect world spf 25 age defense moisturizer with white tea]||has_inactive_ingredient
sodium bicarbonate-containing product||mesocricetus auratus skin 0.05 g in 1 ml intradermal solution [hamster epithelia]||has_inactive_ingredient
hydrochloric acid (substance)||epinephrine-lidocaine hydrochloride, 1:200000-0.5% injectable solution||has_inactive_ingredient
product containing water (medicinal product)||juniperus osteosperma pollen 20000 [pnu] in 1 ml subcutaneous injection, solution||has_inactive_ingredient
carbomer interpolymer type a (55000 mpa.s)||avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octinoxate 75 mg in 1 ml / octocrylene 20 mg in 1 ml topical lotion [protective day]||has_inactive_ingredient
peg-8000||diovan 40mg tablet||has_inactive_ingredient
wool oil||sulfur 10 % topical ointment||has_inactive_ingredient
fd&c blue no. 1||dyazide, 25 mg-37.5 mg oral capsule||has_inactive_ingredient
aloe vera leaf extract||calendula officinalis flower 1 [hp_q] in 0.1 g / echinacea angustifolia 1 [hp_q] in 0.1 g / lytta vesicatoria 3 [hp_x] in 0.1 g topical gel [sunburnt advanced after-sun]||has_inactive_ingredient
mineral oil, light oil||petrolatum 41 mg in 1 g topical stick [leader medicated lip balm]||has_inactive_ingredient
dióxido de titanio||sodium monofluorophosphate 0.13 g in 100 g oral paste, dentifrice [go smile luxury am]||has_inactive_ingredient
sodium bicarbonate [antacid] (substance)||house dust 0.1 g in 1 ml intradermal injection, solution [a. dust]||has_inactive_ingredient
castor wax||aluminum zirconium trichlorohydrex gly 18 g in 100 g topical stick [old spice wild collection wolfthorn invisible]||has_inactive_ingredient
alpha tocopheryl acetate (product)||alcohol 177 ml in 236 ml extracorporeal gel||has_inactive_ingredient
talc product||octinoxate 0.071 g in 1 g / oxybenzone 0.16 g in 1 g topical lipstick [lbel effet parfait hydratess long-lasting intense moisturizing spf 20 (moka) - brown]||has_inactive_ingredient
ölsüß||benzalkonium chloride 1.3 mg in 1 ml topical cloth [maxsani hand sanitizing and cleaning wipes]||has_inactive_ingredient
glycerin product||acetaminophen 650 mg in 20 ml / diphenhydramine hydrochloride 25 mg in 20 ml / phenylephrine hydrochloride 10 mg in 20 ml oral solution [mucinex fast-max night time cold and flu clear and cool]||has_inactive_ingredient
polyglyceryl - 2 dipolyhydroxystearate||zinc oxide 126 mg in 1 ml topical lotion [sunnydays broad spectrum spf 30 tinted sunscreen 40 runyon]||has_inactive_ingredient
product containing macrogol||loperamide hydrochloride 2 mg oral tablet [sunmark anti-diarrheal]||has_inactive_ingredient
glycerin||dog skin extract 10000 unt/ml injectable solution||has_inactive_ingredient
glycerine||benzocaine 5.07 g in 67.5 g topical gel [shunga sensation balm]||has_inactive_ingredient
sodium indigotin disulfonate||ibuprofen 200 mg oral tablet, film coated [365 everday value ibuprofen]||has_inactive_ingredient
disodium oleamido monoethanolamine sulfosuccinate||benzoyl peroxide 6% topical gel||has_inactive_ingredient
product containing gelatin||kadian 100mg extended-release capsule||has_inactive_ingredient
ethenol, homopolymer||niacin 750 mg oral tablet, extended release 24 hr||has_inactive_ingredient
octyldodecyl xyloside||titanium dioxide 40 mg in 1 ml / homosalate 100 mg in 1 ml / octocrylene 40 mg in 1 ml / octisalate 50 mg in 1 ml topical cream [laura geller better than bare tinted moisturizer broad spectrum sunscreen spf 50 plus sand 400]||has_inactive_ingredient
watering||adenosine 1 mg in 150 ml topical lotion [tosowoong mens booster repair]||has_inactive_ingredient
gelatins||day time multi-symptom cold/flu relief softgel||has_inactive_ingredient
sodium pyrrolidone carboxylate||avobenzone 25 mg in 1 ml / homosalate 30 mg in 1 ml / octocrylene 40 mg in 1 ml topical emulsion [benefit weightless moisture face moisturizer broad spectrum spf 15 sunscreen]||has_inactive_ingredient
alpha-tocopheryl acid succinate||octinoxate 5.1 g in 100 g / titanium dioxide 6 g in 100 g topical powder [la mer the soft moisture foundation broad spectrum spf 30]||has_inactive_ingredient
citric acid monohydrate (substance)||witch hazel 0.5 mg in 1 ml topical cloth [signature care medicated wipes hemorrhoidal wipes with witch hazel]||has_inactive_ingredient
dibasic magnesium stearate||nicotine 2 mg oral lozenge [up and up mini nicotine]||has_inactive_ingredient
sodium starch glycolate type a corn||potassium chloride 6 [hp_x] oral tablet [kali muriaticum]||has_inactive_ingredient
polysorbate 80||product containing phentermine hydrochloride 30 mg/1 each oral capsule (clinical drug)||has_inactive_ingredient
polysorbate 65||product containing atorvastatin 20 mg/1 each oral tablet||has_inactive_ingredient
coconut oil fatty acids||sulfur 1 [hp_x] in 1 g / thuja occidentalis leafy twig 6 [hp_x] in 1 g topical soap [naturasil tinea versicolor]||has_inactive_ingredient
titanium dioxide (substance)||alectinib hcl@150 mg@oral@capsule||has_inactive_ingredient
polyethylene glycol 8000||fluvoxamine 50 mg oral tablet||has_inactive_ingredient
alpha-isomethyl ionone||titanium dioxide 0.057 g in 1 g / zinc oxide 0.049 g in 1 g topical powder [lbel effet parfait polvos compactos de larga duracion para rostro fps 15 long lasting compact spf 15 (claire 1) - beige]||has_inactive_ingredient
hypromellose 2910 (6 cps)||retrovir, 300 mg oral tablet||has_inactive_ingredient
macrogol 400||acetaminophen/dextromethorphan hydrobromide/doxylamine succinate 650 mg/30 ml-30 mg/30 ml-12.5 mg/30 ml oral solution||has_inactive_ingredient
d-glucose, 4-o-beta-d-galactopyranosyl-||psyllium husk 3.4 g in 5.8 g oral powder, for solution [reguloid]||has_inactive_ingredient
microcrystalline wax||diaperene 130 mg/ml topical cream||has_inactive_ingredient
stearic acid, magnesium salt||aminocaproic acid 500mg (product)||has_inactive_ingredient
xanthan gum||zinc oxide 73 mg in 1 ml / octinoxate 75 mg in 1 ml topical cream [micro day riche]||has_inactive_ingredient
chamomile||zinc oxide 0.8 g in 12 g / titanium dioxide 1.4 g in 12 g topical cream [aekyungluna long lasting conceal fixing cushion warm beige 21w]||has_inactive_ingredient
starch, pregelatinized corn||adefovir dipivoxil 10mg oral tablet||has_inactive_ingredient
sodium indigo-disulphonate||azithromycin anhydrous 500 mg oral tablet, film coated||has_inactive_ingredient
aloe vera leaf||benzocaine 5 g in 100 g topical liquid [bite and sting medicated relief pads cvs]||has_inactive_ingredient
ethanol, 2,2'-(oxybis(2,1-ethanediyloxy)bis-||cvs ibuprofen ib 200mg tablet||has_inactive_ingredient
talc (mg3h2(sio3)4)||gabapentin 300mg capsule (product)||has_inactive_ingredient
kieselsäureanhydrid||octinoxate 0.068 g in 1 g topical lipstick [esika pro hd color high definition color spf 20 (hd fucsia vibrante) - pink]||has_inactive_ingredient
caprylyl glycol||octisalate 5 ml in 100 ml / avobenzone 3 ml in 100 ml / octocrylene 2.7 ml in 100 ml topical lotion [a perfect world spf 25 age defense moisturizer with white tea]||has_inactive_ingredient
h2o - water||alcohol 62 ml in 100 ml topical liquid [benchmark shield]||has_inactive_ingredient
fd&c blue #1||esomeprazole magnesium/glycerin 20 mg oral kit, capsule, delayed release and spray||has_inactive_ingredient
titanium white||phenylephrine hydrochloride 5 mg / acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [vicks formula 44 cough and congestion severe nighttime]||has_inactive_ingredient
cellulose, 2-hydroxypropyl methyl ether||prochlorperazine maleate 10mg tab||has_inactive_ingredient
sodium chloride [skin] (product)||artemisia ludoviciana pollen 0.05 g in 1 ml intradermal solution [prairie mugwort darkleaved sagebrush]||has_inactive_ingredient
recticare advanced wipes||ambrosia artemisiifolia pollen 0.05 g in 1 ml percutaneous injection, solution [short ragweed]||has_inactive_ingredient
fats, lanolin||camphor 3.1 % / menthol 2.6 % medicated patch||has_inactive_ingredient
lactose monohydrate||pravastatin sodium, 40 mg oral tablet||has_inactive_ingredient
sunset yellow fcf (substance)||acetaminophen 360 mg in 15 ml / codeine phosphate 36 mg in 15 ml oral solution||has_inactive_ingredient
sodium citrate (product)||stannous fluoride 1.1 mg in 1 g dental paste, dentifrice [colgate total sf advanced whitening]||has_inactive_ingredient
peg 200||nabumetone 750 mg oral tablet||has_inactive_ingredient
thioneine||zinc oxide 20.2 g in 100 g topical lotion [elta skincare broad-spectrum sunscreen tinted spf36]||has_inactive_ingredient
2-amino-1-ethanol||chloroxylenol 0.003 mg in 1 ml topical liquid [highmark professional gold and clean antimicrobial ltn sp]||has_inactive_ingredient
dscada cpd||benzalkonium chloride 0.13 g in 100 g topical patch [first aid only bzk antiseptic towelette]||has_inactive_ingredient
h2o - water||walgreens children's dye-free pain & fever 160mg/5ml suspension (cherry)||has_inactive_ingredient
alcohol, denatured||toxicodendron pubescens leaf 1 [hp_x] in 0.25 l oral tincture [rhus toxicodendron mt]||has_inactive_ingredient
glycerin (obsolete)||benzalkonium chloride 0.13 ml in 1 ml topical tincture [cold sore treatment]||has_inactive_ingredient
sentry aq mardel clout||zorvolex 35mg capsule||has_inactive_ingredient
1,3-butanediol||titanium dioxide 79.2 mg in 1 ml / octinoxate 29.9 mg in 1 ml / zinc oxide 19 mg in 1 ml topical cream [everglam bb natural beige]||has_inactive_ingredient
vibracolor blue abl9||calcium glycerophosphate 0.13 % / sodium monofluorophosphate 0.76 % toothpaste||has_inactive_ingredient
copovidone k26-29||metronidazole 500mg tablet||has_inactive_ingredient
80s, polysorbate||sodium fluoride 2.43 mg in 1 g dental paste, dentifrice [up and up anticavity toothpaste whitening plus mouthwash]||has_inactive_ingredient
disteardimonium hectorite||octinoxate 74.9 mg in 1 ml topical lotion [diorskin nude air nude healthy glow ultra-fluid serum foundation with sunscreen broad spectrum spf25 021 linen]||has_inactive_ingredient
2-hydroxy-1,2,3-propanetricarboxylic acid, delta triethyl ester||24 hr metoprolol succinate 25 mg extended release oral capsule [kapspargo]||has_inactive_ingredient
phenoxyethanol product||niacinamide 1 mg in 50 ml / adenosine 0.02 mg in 50 ml topical cream [uniwell natural]||has_inactive_ingredient
gelatin||clindamycin hcl 150mg cap||has_inactive_ingredient
water-containing product||alcohol 620 mg in 1 ml topical gel [justice strawberry stardust scented anti-bacterial hand sanitizer]||has_inactive_ingredient
croscarmellose sodium||ponvory 10 mg oral tablet||has_inactive_ingredient
1,2-octanediol||titanium dioxide 0.302 g in 30 ml / octinoxate 0.606 g in 30 ml topical liquid [ck one 3-in-1 face makeup with spf 8 sunscreen 850 toffee]||has_inactive_ingredient
1-alpha-d-glucopyranosyl-2-beta-d-fructofuranoside||kalmia latifolia leaf 30 [hp_c] in 30 [hp_c] oral pellet [kalmia latifolia]||has_inactive_ingredient
c.i. 77499||product containing precisely mercaptamine (as mercaptamine bitartrate) 50 milligram/1 each conventional release oral capsule (clinical drug)||has_inactive_ingredient
potasio hidróxido||terazosin 10 mg oral capsule [hytrin]||has_inactive_ingredient
methyl glycol||sulfur 5 g in 85 g topical soap [dermaklear akne treatment with sulfur]||has_inactive_ingredient
c 13-14 isoparaffin||octinoxate 7.5 ml in 100 ml / homosalate 5.0 ml in 100 ml / oxybenzone 3.0 ml in 100 ml / avobenzone 2.0 ml in 100 ml topical cream [extra repair moisturing balm spf 25]||has_inactive_ingredient
gelatin||zinc chloride 0.15 g in 100 g / menthol 0.5 g in 100 g / benzocaine 20 g in 100 g topical gel [cvs severe toothache and gum relief triple medicated]||has_inactive_ingredient
magnesium octadecanoate||amphetamine aspartate/amphetamine sulfate/dextroamphetamine saccharate/dextroamphetamine sulfate 30 mg oral tablet [amphetamine/dextroamphetamine]||has_inactive_ingredient
h2o - water||isopropyl alcohol 75 ml in 100 ml topical spray [defense ag disinfectant]||has_inactive_ingredient
sclerosing agents talc||aluminum zirconium trichlorohydrex gly 18 g in 100 g topical stick [secret invisible sheer clean]||has_inactive_ingredient
sodium chloride [eye]||2 ml butorphanol tartrate 2 mg/ml injection||has_inactive_ingredient
propanediol||zinc oxide 132 mg in 1 ml topical lotion [wl-aad-z-w-1054]||has_inactive_ingredient
gelatin-containing product||select brand docusate sodium 100mg capsule||has_inactive_ingredient
alpha tocopheryl acetate||alcohol 70 ml in 100 ml topical solution [ecolab hand sanitizer]||has_inactive_ingredient
phenol (medication)||aspergillus niger var. niger 0.001 g in 1 ml percutaneous solution||has_inactive_ingredient
carbomer copolymer type a (allyl pentaerythritol crosslinked)||alcohol 70 ml in 100 ml topical gel [germs are stupid]||has_inactive_ingredient
fd & c yellow no. 5||guaifenesin 83.3 mg in 30 ml / caffeine 30 mg in 30 ml / chlorpheniramine 2.5 mg in 30 ml / methylephedrine hydrochloride, dl- 17.5 mg in 30 ml / acetaminophen 300 mg in 30 ml oral liquid [pancold s]||has_inactive_ingredient
crospovidone (120 .mu.m)||rosuvastatin ca 20mg tab ud||has_inactive_ingredient
beet sugar||canis lupus familiaris milk 30 [hp_c] oral pellet [lac caninum kit refill]||has_inactive_ingredient
triethoxy(octyl)silane||octinoxate 0.065 g in 1 g / titanium dioxide 0.024 g in 1 g / zinc oxide 0.015 g in 1 g topical paste [lbel effet parfait mineral natural skin effect mousse foundation spf 16 (claire 3) - beige]||has_inactive_ingredient
gelatin, unspecified||fenofibrate micronised 67 mg oral capsule||has_inactive_ingredient
sodium phosphate,dibasic dihydrate||desmopressin acetate 0.1 mg in 1 ml nasal solution||has_inactive_ingredient
sweet cherry seed oil||zinc oxide 177 mg in 1 ml topical cream [everyday sheer coverage medium tint spf 20]||has_inactive_ingredient
2-phenoxyethyl alcohol||octinoxate 75 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 50 mg in 1 ml / avobenzone 30 mg in 1 ml topical cream [protetor solar grip action fps 40]||has_inactive_ingredient
1,3-dimethylol-5,5-dimethylhydantoin||selenium sulfide@1 %@topical@shampoo||has_inactive_ingredient
marijuana seed oil||menthol, unspecified form 85 mg in 1 ml topical gel [painpatrol cbd professional pain relief]||has_inactive_ingredient
batilol||homosalate 80 mg in 1 ml / octisalate 40 mg in 1 ml / avobenzone 30 mg in 1 ml / octocrylene 30 mg in 1 ml topical cream [nutricentials day dream protective]||has_inactive_ingredient
phenol, nos||periplaneta americana allergenic extract 0.1 gm/ml injectable solution||has_inactive_ingredient
glycerin preparation (substance)||titanium dioxide 60 mg in 1 ml / zinc oxide 60 mg in 1 ml topical lotion [jungle screen spf 30]||has_inactive_ingredient
1,3-butandiol||octinoxate 7.5 g in 100 g / titanium dioxide 5.02 g in 100 g topical liquid [sheer defense tinted moisturizer spf15 l20 merle norman]||has_inactive_ingredient
microcrystalline celluose||hydralazine hydrochloride 50mg oral tablet||has_inactive_ingredient
polysorbate 80||fluticasone propionate 50mcg/spray soln,nasal,15.8gm||has_inactive_ingredient
mannitol-containing product||product containing precisely naproxen 200 milligram/1 each conventional release oral capsule (clinical drug)||has_inactive_ingredient
lecithin, soybean||octinoxate 1.5 ml in 30 ml / titanium dioxide 0.48 ml in 30 ml topical emulsion [no7 radiant glow foundation sunscreen spf 15 buff 15]||has_inactive_ingredient
white sugar||phenytoin sodium 100 mg extended release oral capsule||has_inactive_ingredient
candelilla wax||quinapril (as quinapril hydrochloride) 20 mg oral tablet||has_inactive_ingredient
quso f-22||razadyne 8mg tablet||has_inactive_ingredient
aloe barbadensis leaf extract||benzalkonium chloride 0.1 g in 100 ml topical cloth [flashwipes lime aloe]||has_inactive_ingredient
polyethylene glycol 1000||comfort pac with ibuprofen tablet||has_inactive_ingredient
octyltriethoxysilane||avobenzone 2 g in 100 ml / octinoxate 5 g in 100 ml / octisalate 4 g in 100 ml / octocrylene 1.8 g in 100 ml topical cream [cc cream complexion corrector medium broad spectrum spf 15 jafra]||has_inactive_ingredient
hydrochloric acid (product)||naloxone 0.4 mg/ml injectable solution||has_inactive_ingredient
magnesium sterate||phentermine hydrochloride 30 mg oral capsule [phentermine hydrochloride]||has_inactive_ingredient
kohlensaurer kalk||product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug)||has_inactive_ingredient
coconut oil oil||titanium dioxide 62.2 mg in 1 ml / zinc oxide 38.3 mg in 1 ml topical liquid [rainforest of the sea water foundation broad spectrum spf 15 sunscreen 48g tan-deep golden]||has_inactive_ingredient
benzyl benzoate (medication)||titanium dioxide 212 mg in 1 g / zinc oxide 120 mg in 1 g topical powder [natural finish pressed foundation spf 20 sunscreen]||has_inactive_ingredient
gums xanthan||octinoxate 60 mg in 1 ml topical lotion [skin caviar foundation sunscreen spf 15 - porcelaine blush]||has_inactive_ingredient
phenyl trimethicone||octinoxate 0.068 g in 1 g topical lipstick [esika hd color high definition color spf 20 hd coral ensueno - red]||has_inactive_ingredient
2-hydroxy-1,2,3-propanetricarboxylic acid, anhydrous||aspirin 325 mg oral tablet, film coated [health mart aspirin]||has_inactive_ingredient
glutamic acid preparation (product)||salicylic acid 2 g in 100 g topical gel [acne defense spot treatment merle norman]||has_inactive_ingredient
aloe barbadensis leaf extract||benzalkonium chloride 1 mg in 1 ml topical soap [antibacterial hand unicorn sprinkles]||has_inactive_ingredient
talcum||premier value calcium antacid regular strength 500mg chewable tablet (peppermint)||has_inactive_ingredient
povidone [mouth]||premier value pain relief extra strength 500mg tablet||has_inactive_ingredient
ferric oxide,red||homosalate 4 g in 100 ml / octisalate 2 g in 100 ml / octocrylene 3 g in 100 ml topical cream [black radiance true complexion bb cream spf 15]||has_inactive_ingredient
stearic acid, magnesium salt||dexamethasone@4 mg@oral@tablet||has_inactive_ingredient
iron oxide (red)||octinoxate 1.5 g in 30 g / titanium dioxide 0.5 g in 30 g topical cream [no7 lift and luminate triple action serum foundation sunscreen broad spectrum spf 15 deep beige]||has_inactive_ingredient
1h-pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-((4-sulfophenyl)azo)-, trisodium salt||octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 spf 25 (fucsia cautivante) - pink]||has_inactive_ingredient
dioxide, silicon||trazodone hydrochloride 100mg oral tablet||has_inactive_ingredient
siliziumdioxid||ibuprofen, 400 mg oral tablet||has_inactive_ingredient
n-tetradecyl alcohol||coal tar 2 % medicated liquid soap||has_inactive_ingredient
yeast, unspecified||octinoxate 0.06962 g in 1 ml / titanium dioxide 0.0412 g in 1 ml / zinc oxide 0.033 g in 1 ml topical liquid [even better makeup broad spectrum spf 15]||has_inactive_ingredient
hydroxypropyl cellulose (1200000 mw)||zocor 40mg tablet||has_inactive_ingredient
octadecanoic acid, magnesium salt||carvedilol 80 mg oral capsule, extended release||has_inactive_ingredient
vitamin e (alpha tocopherol acetate)||titanium dioxide 0.057 g in 1 g / zinc oxide 0.049 g in 1 g topical powder [lbel effet parfait polvos compactos de larga duracion para rostro fps 15 long lasting compact spf 15 (claire 2) - beige]||has_inactive_ingredient
povidone [mouth] (substance)||chlorpromazine hcl 10mg tab,ud||has_inactive_ingredient
silicon dioxide, fumed||prinivil, 20 mg oral tablet||has_inactive_ingredient
yellow ferric oxide||lofibra 54mg tablet||has_inactive_ingredient
triglycerides, medium-chain||diphenhydramine hydrochloride 25 mg oral capsule||has_inactive_ingredient
citric acid monohydrate (substance)||histamine dihydrochloride 0.03 % topical cream||has_inactive_ingredient
fd & c blue no. 1||sennosides 17.2 mg in 17.2 oral capsule, liquid filled||has_inactive_ingredient
watering||diphenhydramine hydrochloride 20 mg in 1 g topical gel [after bite outdoor]||has_inactive_ingredient
(1,1-dimethylethyl)-4-methoxyphenol||mineral oil 14 g in 100 g / petrolatum 74.9 g in 100 g / phenylephrine hydrochloride 0.25 g in 100 g topical ointment [lucky supersoft hemorrhoidal]||has_inactive_ingredient
titanium dioxide-containing product||voriconazole 200mg tab||has_inactive_ingredient
natriumhydrogenkarbonat||tamarix gallica pollen 20000 [pnu] in 1 ml subcutaneous injection, solution||has_inactive_ingredient
alpha-propyleneglycol||tamsulosin hydrochloride 400micrograms m/r capsule (substance)||has_inactive_ingredient
vitamin e (alpha tocopherol acetate)||hydroquinone .02 g in 1 g topical cream||has_inactive_ingredient
lauramide dea||chloroxylenol 1 % / miconazole nitrate 2 % / salicylic acid 2 % medicated shampoo||has_inactive_ingredient
chondroitin sulfate (porcine)||titanium dioxide 0.7 g in 10 g topical powder [spf 15 fair]||has_inactive_ingredient
polyoxyl 40 hydrogenated castor oil||alcohol 70 l in 100 l topical gel [emhs1 hand sanitizer]||has_inactive_ingredient
acid, hydrochloric||fosaprepitant 150 mg injection||has_inactive_ingredient
shellac (substance)||product containing only thiothixene hydrochloride 2 mg/1 each oral capsule||has_inactive_ingredient
butyloctyl salicylate||oxybenzone 4 mg in 1 g / octinoxate 7.5 mg in 1 g / octisalate 5 mg in 1 g / octocrylene 3 mg in 1 g / avobenzone 2 mg in 1 g topical emulsion [ceramide premiere broad spectrum spf 30]||has_inactive_ingredient
leuconostoc/radish root ferment filtrate||sulfur 3 % topical ointment||has_inactive_ingredient
epoetin beta 60000 unt/ml||epob||ingredient_of
dexbrompheniramine / dextromethorphan / phenylephrine / pyrilamine oral liquid product||product containing pyrilamine||ingredient_of
dressing,mepilex border lite 2in x 5in #281100||dressing,mepilex||ingredient_of
lanoplex forte cap||3-pyridinecarboxamide||ingredient_of
alfentanil injectable solution [alfenta]||alfentanilo||ingredient_of
darbepoetin alfa 0.2 mg/1 ml injection solution [aranesp]||darbepoetin alfa (medication)||ingredient_of
ubidecarenone / vitamin e oral capsule [neoq10]||vitamin e preparation (product)||ingredient_of
carprofen 75 mg oral tablet, chewable [carprofen]||product containing carprofen||ingredient_of
arginine topical cream [equineaid]||l-(+)-arginine||ingredient_of
capsaicin-containing product in cutaneous dose form||n-(4-hydroxy-3-methoxyphenylmethyl) -8-methyl-6-nonenamide||ingredient_of
ms 5 mg rectal suppository||morphine sulphate||ingredient_of
nutrition supl isosource hn/closed liq||citric acid, trisodium salt||ingredient_of
triamcinolone acetonide 1.5 mg oral tablet||triamcinolone [endocrine use] (substance)||ingredient_of
activated charcoal 25 gm/29.4 gm oral powder for suspension [ez-char]||char-flo aqueous base||ingredient_of
tru-micin 100 mg/ml topical lotion||paraben mix (substance)||ingredient_of
meperidine hydrochloride 50 mg/ml||pethidine hydrochloride [anesthesia]||ingredient_of
mycostatin 500000 unt delayed release oral tablet||nystatin [gynecological use] (substance)||ingredient_of
cyclothiazide / triamterene oral product||6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide||ingredient_of
polyvinyl alcohol / povidone / tetrahydrozoline ophthalmic solution [murine tears]||ocusan reformulated dec 2019||ingredient_of
kaolectrolyte, oral powder for reconstitution||chloride ions||ingredient_of
aluminum hydroxide pill||aluminum hydroxide (in vaccine)||ingredient_of
l1 protein, human papillomavirus type 11 vaccine / l1 protein, human papillomavirus type 16 vaccine / l1 protein, human papillomavirus type 18 vaccine / l1 protein, human papillomavirus type 31 vaccine / l1 protein, human papillomavirus type 33 vaccine / l1 protein, human papillomavirus type 45 vaccine / l1 protein, human papillomavirus type 52 vaccine / l1 protein, human papillomavirus type 58 vaccine / l1 protein, human papillomavirus type 6 vaccine injection [gardasil 9]||recombinant human papillomavirus type 16 l1 protein||ingredient_of
delsym adult night time multi-symptom, 325 mg-10 mg-6.25 mg-5 mg/15 ml oral liquid||dextromethmorphan hydrobromide||ingredient_of
fexofenadine hcl 30 mg oral tablet,disintegrating||fexofenadine product||ingredient_of
nucofed oral product||d-isoephedrine||ingredient_of
allergenic extract, mixed antigens||allergenic extract,mixed antigens||ingredient_of
product containing only hyoscyamine sulfate 0.375 milligram/1 each oral tablet||hyoscyaminum||ingredient_of
bacitracin 0.4 unt/mg / neomycin 0.0035 mg/mg / polymyxin b 10 unt/mg / pramoxine hydrochloride 0.01 mg/mg topical ointment [spectrocin plus]||neomycin sulphate [ear]||ingredient_of
calcium chloride 16.55 mg/ml / magnesium chloride 25.5 mg/ml / potassium acetate 98 mg/ml / sodium acetate 64.6 mg/ml / sodium chloride 74.5 mg/ml injectable solution [nutrilyte ii]||magnesium-containing product||ingredient_of
delhistine d sr, 16 mg-50 mg-16 mg-16 mg oral capsule, extended release||pheniramine maleate [dup] (substance)||ingredient_of
calcium 500mg/vitamin d 500unit chew tab||vitamin d preparation, nos||ingredient_of
pancreatin 250 mg||product containing pancreatin||ingredient_of
equaline infants' pain relief 80mg/0.8ml drops||4'-hydroxyacetanilide||ingredient_of
aspirin 160 mg||aspirin product||ingredient_of
dextrothyroxine 2 mg||d-thyroxine preparation||ingredient_of
alanine 8.8 mg/ml / arginine 4.4 mg/ml / dibasic potassium phosphate 2.61 mg/ml / glucose 100 mg/ml / glycine 8.8 mg/ml / histidine 1.86 mg/ml / isoleucine 2.03 mg/ml / leucine 2.63 mg/ml / lysine 2.46 mg/ml / magnesium chloride 0.01 meq/ml / methionine 2.46 mg/ml / phenylalanine 2.63 mg/ml / proline 1.78 mg/ml / sodium acetate 0.036 meq/ml / sodium chloride 0.013 meq/ml / threonine 1.78 mg/ml / tryptophan 0.76 mg/ml / tyrosine 0.17 mg/ml / valine 1.95 mg/ml injectable solution [travasol 4.25/10]||ethanoate||ingredient_of
lanolin 150 mg/ml / petrolatum 300 mg/ml [supraderm]||petrolatum yellow||ingredient_of
ascorbic acid/calcium/copper/docusate sodium/folic acid/iodine/iron/niacinamide/pyridoxine/riboflavin/thiamine/vitamin a/vitamin d/vitamin e/zinc 120 mg-125 mg-2 mg-50 mg-1 mg-0.15 mg-27 mg-20 mg-20 mg-3.4 mg-3 mg-2700 iu-400 iu-30 iu-25 mg oral tablet [vinate calcium]||vinate calcium||ingredient_of
diclofenac sodium 50 mg oral tablet, delayed release (enteric coated)||diclofenac sodium 2 (substance)||ingredient_of
surfaxin, 30 mg/ml intratracheal suspension||lucinactant (medication)||ingredient_of
atropine sulfate/benzoic acid/hyoscyamine sulfate/methenamine/methylene blue/phenyl salicylate 0.03 mg-4.5 mg-0.03 mg-40.8 mg-5.4 mg-18.1 mg oral tablet [urinary antiseptic]||hyoscyamin||ingredient_of
guaiacolsulfonate 60 mg/ml / hydrocodone bitartrate 1 mg/ml oral solution [protuss]||sulfogaiacol hemihydrate||ingredient_of
oral testosterone||testosterone preparation (substance)||ingredient_of
contact lens rinse oxysept-2 soln 15ml||sodium acid phosphate (product)||ingredient_of
nutrition supl pulmocare/tube feeding||n-(2,4-dihydroxy-3,3-dimethylbutyryl)-beta-alanine||ingredient_of
lenvima 14 mg daily dose 30 day supply pack||e7080 mesylate||ingredient_of
inotuzumab ozogamicin injection||besponsa||ingredient_of
cocaine / epinephrine ophthalmic solution||(-)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol||ingredient_of
tofacitinib 10mg tab,oral||tofacitinib citrate (substance)||ingredient_of
tracheostomy care kit medline #dynd40582||tracheostomy care kit||ingredient_of
esomeprazole 5 mg||esomeprazol||ingredient_of
vanatol 50 mg / 325 mg / 40 mg in 15 ml oral solution||paracetamol - chemical (substance)||ingredient_of
formoterol-mometasone 5 mcg-100 mcg/inh inhalation aerosol||mometasone-containing product||ingredient_of
pegfilgrastim-apgf 6 mg/0.6 ml subcut syringe (ml)||pegfilgrastim (medication)||ingredient_of
daytrana, 30 mg/9 hr transdermal film, extended release||2-piperidineacetic acid, alpha-phenyl-, methyl ester||ingredient_of
product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug)||dyclonine hydrochloride (substance)||ingredient_of
product containing only hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 0.1 mg/1 each oral tablet||hydralazine hydrochloride (medication)||ingredient_of
hydrochlorothiazide 10 mg/ml||dihydrochlorothiazide||ingredient_of
loteprednol etabonate 10 mg in 1 ml topical suspension [inveltys]||loteprednol etabonate||ingredient_of
fluosol 20% emulsion,intravascular||egg phospholipid (substance)||ingredient_of
product containing only acetaminophen 500 mg and oxycodone hydrochloride 7.5 mg/1 each oral tablet||oxycodone hydrochloride (product)||ingredient_of
pouch,drainable,sensura coloplast #11127||pouch,ostomy||ingredient_of
salicylic acid 15% transdermal patch, extended release||acid, ortho-hydroxybenzoic||ingredient_of
lamotrigine orange oral tablet||lamictal||ingredient_of
carbamazepine 300 mg extended release oral capsule [carbatrol]||cbz||ingredient_of
neoral 100 mg oral capsule||cyclosporin-a (medication)||ingredient_of
oxycodone hydrochloride 10 mg [oxycontin]||oxycodone hydrochloride (medication)||ingredient_of
chlorpheniramine maleate/phenylpropanolamine hcl 4 mg-25 mg oral tablet||sunset yellow fcf stain (substance)||ingredient_of
brompheniramine / dextromethorphan / pseudoephedrine oral solution [myphetane dx]||dextromethorphan product||ingredient_of
calcipotriene hydrate 50 ug in 1 g / betamethasone dipropionate 0.5 mg in 1 g topical ointment [taclonex]||calcipotriol-containing product||ingredient_of
pancreatin 1500 mg||product containing pancreatin (medicinal product)||ingredient_of
gemfibrozil 300 mg [lopid]||2,2-dimethyl-5-(2,5-xylyloxy)valeriansäure||ingredient_of
chlophedianol hydrochloride 25 mg / chlorcyclizine hydrochloride 25 mg / pseudoephedrine hydrochloride 60 mg oral tablet||isoephedrine hydrochloride||ingredient_of
saccharomyces boulardii 50 mg||product containing saccharomyces boulardii||ingredient_of
humibid dm(obsolete), 30 mg-600 mg oral tablet, extended release||humibid dm(obsolete)||ingredient_of
carbinoxamine maleate 4mg/5ml, pseudoephedrine hydrochloride 60mg/5ml oral syrup||pseudoephedrine hcl||ingredient_of
delflex/dextrose 4.25% soln||calcium chloride-containing product||ingredient_of
antipyrine/benzocaine 54 mg/1 ml-14 mg/1 ml otic solution||octacosanol||ingredient_of
pholedrine 25 mg||p-hydroxymethamphetamine||ingredient_of
product containing precisely rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)||antiviral rilpivirine||ingredient_of
primsol 10 mg/ml oral solution||trimetoprima||ingredient_of
allergenic extract, 10 tree mix 10000 pnu/ml inj||allergenic extract, 10 tree mix||ingredient_of
red mulberry pollen extract / white mulberry pollen extract injectable product||tree pollen-mulberry, red||ingredient_of
dressing,alginate/cmc ag 18in rope||silver||ingredient_of
protease 6200 unt||protease preparation (product)||ingredient_of
rimantadine oral tablet [flumadine]||product containing rimantadine||ingredient_of
nutrition supl isosource hn 1000ml||high chromium yeast||ingredient_of
lidocaine hcl/pf 20 mg/ml (2 %) injection ampul (ml)_#2||xylocaine||ingredient_of
orabase paste plain||paraffinum liquidum||ingredient_of
guaifenesin/pseudoephedrine hydrochloride 600 mg-60 mg oral tablet, extended release [iosal ii]||guaiacol glyceryl ether||ingredient_of
vitamin b comp w/c,folic acid,zinc tab||zn element||ingredient_of
hydrocodone bitartrate 80 mg 24hr extended release oral tablet, abuse-deterrent||product containing hydrocodone bitartrate (medicinal product)||ingredient_of
alanine / arginine / dibasic potassium phosphate / glucose / glycine / histidine / isoleucine / leucine / lysine / magnesium chloride / methionine / phenylalanine / proline / sodium acetate / sodium chloride / threonine / tryptophan / tyrosine / valine injectable product||acetato de sodio||ingredient_of
urea 500 mg/gm topical ointment||urea (medication)||ingredient_of
chlormadinone / mestranol oral tablet||pregna-4,6-diene-3,20-dione, 17-(hydroxy)-6-chloro-||ingredient_of
liver derivative complex 25.5 mg/1 ml injection solution [nexavir]||immunomodulators liver derivative complex||ingredient_of
kaolin / pectin oral product||pectin - chemical (substance)||ingredient_of
multivitamins w/minerals,high potency tab||manganese (as manganese sulfate)||ingredient_of
botrytis cinerea allergenic extract injectable solution||botrytis cinerea||ingredient_of
coal tar topical solution||product containing coal tar||ingredient_of
alprostadil 20.2mcg/ml solution||erectile dysfunction alprostadil||ingredient_of
phenazopyridine-sulfamethoxazole 100 mg-500 mg oral tablet||product containing sulfamethoxazole (medicinal product)||ingredient_of
dextromethorphan / guaifenesin / phenylephrine extended release oral tablet||guaifenesin (substance)||ingredient_of
levodopa 100mg/carbidopa 25mg/entacapone 200mg tablet||product containing entacapone (medicinal product)||ingredient_of
alumina, magnesia, and simethicone chewable tablets||simethicone (substance)||ingredient_of
salicylic acid 0.02 mg/mg||salicylic acid (medication)||ingredient_of
bromfenac 0.09% ophthalmic solution (product)||bromfenac sodium (substance)||ingredient_of
catheter,external med freedom #5210||external catheter||ingredient_of
phenylephrine/chlor-tan 5 mg-4.5 mg oral tablet,chewable||rynatan or rynatan pediatric chewable||ingredient_of
topiramate 50mg tablet (product)||tpm||ingredient_of
monofluorophosphate 0.0076 mg/mg||monofluorophosphate||ingredient_of
cromolyn oral liquid product||cromoglicic acid product||ingredient_of
buprenorphine hcl 0.3 mg in 1 ml injection||buprenex||ingredient_of
hydrochlorothiazide 10 mg||hydrochlorothiazide (medication)||ingredient_of
acetaminophen 1000 mg / dextromethorphan hydrobromide 30 mg / pseudoephedrine hydrochloride 60 mg powder for oral solution||dextromethorphan hydrobromide product||ingredient_of
acetaminophen / caffeine oral capsule||n-(4-hydroxyphenyl)acetamide||ingredient_of
methocarbamol 500 mg oral tablet [methocarbamol]||methocarbamol (product)||ingredient_of
chlorhexidine gluconate 2 % topical solution||chlorhexidine||ingredient_of
chlorhexidine oral gel [corsodyl]||chlorhexidine-containing product||ingredient_of
diazepam rectal suppository||diazepam (valium) injection||ingredient_of
desipramine hydrochloride 10 mg oral tablet [norpramin]||desipramine hydrochloride||ingredient_of
visken pill||pindolol||ingredient_of
catheter,suction,12fr kit m#dynd41471||suction set||ingredient_of
guaifenesin 75 mg in 5 ml / phenylephrine hydrochloride 2.5 mg in 5 ml / dextromethorphan hydrobromide 5 mg in 5 ml oral syrup [tussi pres pediatric]||guaifenesin-containing product||ingredient_of
foscarnet sodium 6000 mg in 250 ml injection||foscarnet sodium (substance)||ingredient_of
alcohol 70%/camphor 3.6%/capsicum/me salicylate 15% aerosol||methyl salicylates||ingredient_of
biotuss pe, 100 mg-30 mg/5 ml oral syrup||pseudoephedrine + guaifenesin (product)||ingredient_of
dextromethorphan polistirex/guaifenesin 30 mg/5 ml-200 mg/5 ml oral suspension, extended release [atuss-12 dx]||dextromethorphan polistirex||ingredient_of
belladonna extract, usp topical product||deadly nightshade||ingredient_of
emtricitabine / rilpivirine / tenofovir disoproxil oral product||4-{[4-({4-[(e)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile||ingredient_of
lidocaine hydrochloride 30 mg/ml [zionodil]||α-diethylamino-2,6-dimethylacetanilide||ingredient_of
nandrolone 200 mg/ml [deca-durabolin]||nandrolone [blood]||ingredient_of
etravirine@25 mg@oral@tablet||product containing etravirine (medicinal product)||ingredient_of
visbiome extra strength high potency probiotic powder for solution||product containing lactobacillus (medicinal product)||ingredient_of
alpha 1-proteinase inhibitor, human 1 mg injection [prolastin]||alpha>1< anti-trypsin||ingredient_of
chlorpheniramine/hydrocodone/pse 2 mg-2.5 mg-30 mg/5 ml oral liquid||product containing pseudoephedrine||ingredient_of
dobutamine 0.25mg/ml/d5% inj bag 500ml||dextrose product||ingredient_of
droxidopa, 200 mg oral capsule||droxidopa (substance)||ingredient_of
multivitamins/fluoride 0.25mg tab,chewable||fluoride, sodium||ingredient_of
lorazepam 1mg tab,ud||lorazepam (substance)||ingredient_of
eugenol oral solution||phenol, 2-methoxy-4-(2-propenyl)-||ingredient_of
tresiba flextouch pen prefilled syringe 100unit/ml solution for injection||product containing insulin degludec||ingredient_of
catheter,foley silicone 22fr 5cc||catheter, device (physical object)||ingredient_of
metylperon injectable product||melperone product||ingredient_of
dextrose monohydrate 50 mg in 1 ml intravenous injection, solution||dextrose 5% and water add-vantage||ingredient_of
calcium chloride / glucose / lactate / magnesium chloride / sodium chloride intraperitoneal solution [dianeal low calcium 3.5]||lactate (substance)||ingredient_of
milrinone injection||inotropes milrinone||ingredient_of
amlodipine 10 mg / olmesartan medoxomil 20 mg oral tablet||besylate amlodipine||ingredient_of
loratadine/pseudoephedrine sulfate 10 mg-240 mg oral tablet, extended release, 24 hr [kirkland signature allerclear-d]||decongestants pseudoephedrine sulfate||ingredient_of
fexofenadine hydrochloride 60 mg oral capsule [allegra]||fexofenadine hydrochloride (substance)||ingredient_of
belladonna alkaloids/opium alkaloids 15 mg-60 mg rectal suppository||opium,powdered||ingredient_of
nitrofurantoin / sulfadiazine oral capsule||5-nitrofurantoin||ingredient_of
polysorbate 80 10 mg/ml||80s, polysorbate||ingredient_of
dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg / acetaminophen 325 mg oral capsule, liquid filled [alka-seltzer plus maximum strength day cold and flu]||product containing dextromethorphan hydrobromide (medicinal product)||ingredient_of
vit b/fe gluconate 50mg/liver w/procaine inj||allocaine||ingredient_of
product containing calciferol 1.25 mg/1 each oral tablet||9,10-secoergosta-5,7,10(19),22-tetraen-3-beta-ol||ingredient_of
queen palm pollen extract 1000 unt/ml||queen palm pollen extract||ingredient_of
influenza a virus (h1n1) antigen / influenza a virus (h3n2) antigen / influenza b virus antigen injectable suspension [fluvirin 2017-2018]||influenza a virus h1n1 antigen||ingredient_of
triprolidine oral liquid product||triprolidine (medication)||ingredient_of
benzalkonium chloride 1.3 mg in 1 ml topical liquid [cvs pharmacy juicy pear]||softsoap antibacterial||ingredient_of
product containing aspirin and caffeine and paracetamol in oral dosage form||coffein||ingredient_of
hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate, monobasic 40.8 mg oral tablet [utrona-c]||colour index no. 52015||ingredient_of
flunixin meglumine 1500 mg in 30 g oral paste [prevail]||flunixin||ingredient_of
erythromycin lactobionate 500mg/vial||product containing erythromycin lactobionate||ingredient_of
mannitol / mecobalamin injectable product||mannitol (product)||ingredient_of
carbinoxamine/pseudoephed/dm 4 mg-60 mg-12.5/5 ml oral syrup||pseudoephedrine + carbinoxamine + dextromethorphan (medication)||ingredient_of
clenbuterol oral tablet||clenbuterolum||ingredient_of
product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet||carbinoxamine maleate||ingredient_of
travert 5%/electrolyte no.2 inj||sodium lactate (substance)||ingredient_of
lucentis 0.5 mg per 0.05 ml injection||ranibizumab (product)||ingredient_of
lancet,surgilance safety||lancet (physical object)||ingredient_of
draxace, 2%-8% topical suspension||sulfacetamide sodium (medication)||ingredient_of
nafronyl 200 mg||nafronyl (substance)||ingredient_of
empagliflozin@25 mg@oral@tablet||empagliflozin (product)||ingredient_of
hydrochlorothiazide 30 mg / methyldopa 500 mg oral tablet [aldoril]||2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide||ingredient_of
propranolol hydrochloride 10 mg||propranolol (product)||ingredient_of
bandage,elastic,adhesive 4in x 5yd||bandage, device (physical object)||ingredient_of
heparin sodium, porcine 100 unt/ml [hep-pak]||unfractionated heparin||ingredient_of
glycopyrronium inhalation powder [seebri]||seebri||ingredient_of
nystex oral liquid product||nystatin (vaginal)||ingredient_of
codeine / pseudoephedrine oral solution||psi-ephedrine||ingredient_of
dronabinol 5 mg||synthetic delta-9-tetrahydrocannabinol||ingredient_of
triclocarban 0.015 mg/mg medicated bar soap [next-1 antibacterial]||next-1 antibacterial||ingredient_of
potassium gluconate and potassium citrate oral solution||potassium citrate||ingredient_of
amlodipine 10 mg||valsartan (substance)||ingredient_of
xylometazoline nasal||2-(4-tert-butyl-2,6-dimethylbenzyl)-2-imidazoline||ingredient_of
ctm 4mg/dm 10mg/gg 100mg/p-ephrine 10mg/5ml elixir||product containing guaifenesin||ingredient_of
rytary 61.25 mg / 245 mg 8hr extended release oral capsule||levodopa||ingredient_of
codeine phosphate/guaifenesin/phenylpropanolamine hydrochloride 10 mg/5 ml-100 mg/5 ml-12.5 mg/5 ml oral liquid||alpha-glyceryl guaiacol ether||ingredient_of
sulfacetamide ophthalmic solution||sulphacetamidum||ingredient_of
tobi 300 mg per 5 ml inhalation solution||tobrex||ingredient_of
calcium gluconate 650 mg||calgluc||ingredient_of
aspirin low strength, 81 mg oral delayed release tablet||aspirin product||ingredient_of
menopause support, oral tablet||actaea racemosa root||ingredient_of
glucose irrigation product||glucose preparation (substance)||ingredient_of
urea 40 gm intravenous powder for solution [ureaphil]||debriding agents carbamide preparations||ingredient_of
calcium gluconate 20 mg/ml-nacl 0.67% intravenous solution||calcium di-gluconate||ingredient_of
hepatitis b surface antigen vaccine 0.01 mg/ml||hepatitis b surface antigen vaccine||ingredient_of
aluminum hydroxide 26 mg/ml||aluminum hydroxide product||ingredient_of
lactobacillus acidophilus chew tab||bacillus acidophilus whole||ingredient_of
phenylephrine 0.25% solution nasal (product)||phenylephrine hydrochloride [cvs sympathomimetic]||ingredient_of
nutren glytrol liquid vanilla||lecithin, soybean||ingredient_of
mannitol hexanitrate 30mg/phenobarbital 15mg tab||hexanitromannitol||ingredient_of
pyrantel pamoate 144 mg/ml [ascarel]||product containing pyrantel (medicinal product)||ingredient_of
pseudoephedrine hcl/hydrocodone bitartrate 60 mg-5 mg/5 ml oral solution, oral||tussafin||ingredient_of
colchicine 0.6 mg oral capsule||acetamide, n-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (s)-||ingredient_of
aminophylline 105mg/5ml oral liquid (product)||ammophyllin||ingredient_of
halofantrine oral tablet||smithkline beecham||ingredient_of
tylenol sinus congestion and pain daytime non-drowsy gelcap||phenylephrine hcl||ingredient_of
influenza virus vaccine trivalent 2014-15 (6 mos and older)@45 mcg (15 mcg x 3)/0.5 ml@intramusc@vial (ml)||fluzone quadrivalent 2014-2015||ingredient_of
tape,microfoam 3in||tape (treatment)||ingredient_of
azatadine maleate 1mg tab||optimine||ingredient_of
hydrocodone bitartrate 10mg, acetaminophen 750mg oral tablet||acetaminophen and hydrocodone product||ingredient_of
product containing theophylline, anhydrous 400 mg/1 each oral tablet (clinical drug)||theophylline (medication)||ingredient_of
trilostane 10 mg||4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile||ingredient_of
multivitamin lipotropic with multivitamins oral tablet||product containing zinc (product)||ingredient_of
capsaicin/lidocaine/menthol/methyl salic top 0.0325%-4%-10%-27.5% topical ointment||capsaicin/lidocaine/menthol/methyl salic top||ingredient_of
calcium 250mg/vitamin d 125 unt tab||os-cal with d||ingredient_of
hydrochlorothiazide-irbesartan, 12.5 mg-300 mg oral tablet||irbesartan (substance)||ingredient_of
ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride oral powder product||ascorbic acid [urine ph - no drugs here] (product)||ingredient_of
clorazepate dipotassium@11.25 mg@oral@tablet, extended release||tranxene sd||ingredient_of
risperidone 3 mg oral tablet, disintegrating [risperidone m-tab]||risperidonum||ingredient_of
asa 10 mg/ml / brompheniramine maleate 0.04 mg/ml / dextromethorphan hydrobromide 0.2 mg/ml / phenylpropanolamine hydrochloride 0.4 mg/ml oral solution||dextromethorphan hydrobromide||ingredient_of
product containing hydrocortisone in cutaneous dosage form (medicinal product form)||compound f preparation||ingredient_of
oral form thiethylperazine||thiethylperazin||ingredient_of
guaifenesin / pseudoephedrine chewable product||product containing pseudoephedrine (medicinal product)||ingredient_of
renamin 6.5 injectable product||plenamine||ingredient_of
thyroid (usp) 16.25 mg [nature-throid]||thyroid, unspecified||ingredient_of
capsaicin 2 mg/ml / menthol 120 mg/ml [soothanol x2]||mentol||ingredient_of
pouch,urostomy,firstchoice h#1467||pouch urostomy||ingredient_of
24 hr cardizem 420 mg extended release oral tablet||latiazem hydrochloride||ingredient_of
restoril capsules||methyloxazepam||ingredient_of
methylphenidate hydrochloride 10 mg oral tablet [methylphenidate hydrochloride extended release]||quillivant xr||ingredient_of
quinapril 10 mg [accupro]||2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid||ingredient_of
theophylline 80 mg/15 ml oral elixir [lanophyllin]||theophyllines||ingredient_of
product containing levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each oral tablet||product containing levothyroxine sodium and liothyronine sodium (medicinal product)||ingredient_of
mefenamate disintegrating oral tablet||ponstan dispersible||ingredient_of
simethicone 80 mg oral tablet, chewable [gas relief]||simethicone (substance)||ingredient_of
tri-phen-chlor pediatric, 0.5 mg-1.25 mg-5 mg-2 mg/ml oral liquid||phenyltoloxamine citrate (substance)||ingredient_of
jevity 1 cal liquid||potasio||ingredient_of
ephedrine sulfate 25 mg||guaiphenesin||ingredient_of
calcium pyruvate / dihydroxyacetone oral capsule||calcium pyruvate||ingredient_of
guaifenesin oral granules||guaiacolate, glycerol||ingredient_of
domeboro otic, 2%-0.79% otic solution||acetic acid [ear] (substance)||ingredient_of
cimetidine 200 mg oral tablet, film coated [acid reducer]||guanidine, n-cyano-n'-methyl-n''-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)-||ingredient_of
catheter,red rubber 16fr bard #056116||catheter, nos||ingredient_of
coal tar / salicylic acid shampoo product||salicylic acid (substance)||ingredient_of
fenofibrate 160 mg oral tablet, film coated||fenofibrate (tricor)||ingredient_of
meadow fescue grass pollen extract 10000 bau/ml||meadow fescue grass pollen extract||ingredient_of
ergotamine tartrate 2 mg [ergostat]||ergotaminum||ingredient_of
pancrelipase 20,000 units-44,000 units-56,000 units oral delayed release capsule||protease (substance)||ingredient_of
abilify 7.5 mg/ml injection||7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1h)-quinolinone||ingredient_of
gadobenate dimeglumine 529mg/ml soln||product containing meglumine gadobenate||ingredient_of
barium sulfate 40% oral suspension||sulfate, barium||ingredient_of
lettuce whole allergenic extract injectable product||lactuca sativa l.||ingredient_of
lisinopril 2.5mg tab ud||lisinopril-containing product||ingredient_of
fosphenytoin sodium 75 mg/ml||fosfenitoina||ingredient_of
actos pill||pioglitazone||ingredient_of
antacid with simethicone, 200 mg-200 mg-20 mg oral tablet, chewable||aluminium hydroxide (in vac)||ingredient_of
propafenone oral tablet [rythmol]||hydrochloride, propafenone||ingredient_of
abacavir oral liquid product||product containing abacavir (medicinal product)||ingredient_of
nata 29 ob, prenatal multivitamins with folic acid 1 mg oral tablet||multiple vitamins with iron and minerals, prenatal||ingredient_of
acetaminophen / chlorpheniramine / codeine pill||acmp||ingredient_of
p6e1 ophthalmic product||adrenaline - chemical||ingredient_of
ondansetron hydrochloride 32 mg/50 ml intravenous solution [zofran]||ondansetron||ingredient_of
ibuprofen oral liquid product||non-prescription ibuprofen||ingredient_of
cerasport rtd, oral solution||dextrose||ingredient_of
bifidobacterium animalis / lactobacillus acidophilus oral capsule||bifidobacterium animalis subsp animalis||ingredient_of
magnesium salicylate@@oral@tablet||magnesium salicylate||ingredient_of
barium so4 420gm/bag pwdr,rtl||barium sulfate (product)||ingredient_of
xylocaine 1.5% injection 25ml||xylocaine hcl||ingredient_of
pouch,urostomy,assura coloplast #1752||urostomy bag (physical object)||ingredient_of
pouch,drainable,assura coloplast #12569||pouch,ostomy||ingredient_of
capsaicin 0.25 g in 1 g topical patch [2-count heat patches]||satogesic hot||ingredient_of
tretinoin 0.1 mg in 1 g topical gel [retin-a]||all-trans-vitamin a acid||ingredient_of
calcium carbonate / cholecalciferol / vitamin k chewable tablet [viactiv calcium plus d]||vitamin k preparation||ingredient_of
metformin hydrochloride 500 mg / rosiglitazone 4 mg oral tablet [avandamet]||product containing metformin hydrochloride (medicinal product)||ingredient_of
erythromycin ethylsuccinate 400mg/5ml oral suspension (product)||erythromycin ethyl succinate (product)||ingredient_of
dressing,cutimed sorbact wcl #7266203||dressings (treatment)||ingredient_of
butalbital 50 mg / acetaminophen 300 mg / caffeine 40 mg oral capsule||butalbarbital||ingredient_of
peginterferon alfa-2b 50mcg/0.5ml inj,kit||peginterferon alfa-2b||ingredient_of
myadec tab||calcium, nos||ingredient_of
ascorbic acid 226 mg / cuprous oxide 0.8 mg / dl-alpha tocopheryl acetate 200 unt / lutein 5 mg / zinc oxide 34.8 mg [preservision with lutein]||copper(i) oxide||ingredient_of
pyrogallol topical product||pyrogallal||ingredient_of
miconazole nitrate 2 g in 100 g vaginal cream [sunmark miconazole 7]||miconazole (product)||ingredient_of
product containing acetylcysteine in respiratory dosage form (medicinal product form)||acetylcysteine [eyes] (product)||ingredient_of
prop-a-tane, 10 mg/ml injectable solution||2-pyridinepropanamine, gamma-(4-bromophenyl)-n,n-dimethyl-,(z)-butenedioate(1:1)||ingredient_of
equagesic oral product||meprobamate (substance)||ingredient_of
product containing flucytosine in parenteral dosage form||5-fluorocytosine||ingredient_of
copper sulfate topical solution [sentry aq mardel aquari-sol]||copper monosulphate||ingredient_of
product containing prednisolone and sulfacetamide in ocular dose form (medicinal product form)||n-acetyl-4-aminobenzenesulfonamide||ingredient_of
requip xl, 2 mg oral tablet, extended release||requip||ingredient_of
benzocaine / menthol topical spray||product containing menthol||ingredient_of
trolamine salicylate 10 g in 100 g topical cream [myoflex]||product containing trolamine salicylate||ingredient_of
diphenhydramine hydrochloride 50 mg oral capsule [sleep aid nighttime]||methaqualone hydrochloride (substance)||ingredient_of
methohexital sodium 10 mg/1 ml injection solution||sodium methohexital||ingredient_of
lufenuron 90 mg [program]||lufenuron (substance)||ingredient_of
valacyclovir hydrochloride 1 g oral tablet||valtrex||ingredient_of
hydrocortisone 1 mg oral granules||11beta,17alpha,21-trihydroxy-4-pregnene-3,20-dione||ingredient_of
asa 650 mg / butalbital 50 mg oral tablet||vazalore||ingredient_of
ferocyl, 40 mg-150 mg (50 mg iron) oral tablet, extended release||ferocyl||ingredient_of
insulin isophane injectable suspension [iletin nph]||isophane insulin, regular||ingredient_of
carbetapentane tannate/chlorpheniramine tannate/ephedrine tannate/phenylephrine tannate 60 mg-5 mg-10 mg-10 mg oral tablet [ry-tuss]||phenylephrine tannate||ingredient_of
pouch,urostomy,firstchoice h#1488||urostomy bag||ingredient_of
probucol 500mg tab||product containing probucol (medicinal product)||ingredient_of
nutr supl replete liquid||corn syrup solids||ingredient_of
ramses crystal clear, 5% vaginal gel||nonoxinol 9 (substance)||ingredient_of
urea nail, 45% topical gel||urea-containing product||ingredient_of
lidocaine hydrochloride 2% viscous topical solution||lignocaine hcl [anaesthesia]||ingredient_of
fenoprofen 600 mg [fenopron]||(+/-)-fenoprofen||ingredient_of
ampicillin / sulbactam injectable solution||ampicillin sodium/ sulbactam sodium||ingredient_of
benzoyl peroxide 75 mg/ml||benzoyl peroxide product (product)||ingredient_of
product containing precisely armodafinil 250 milligram/1 each conventional release oral tablet (clinical drug)||product containing armodafinil||ingredient_of
product containing hydralazine hydrochloride 100 mg/1 each oral tablet||hydralazine hydrochloride (substance)||ingredient_of
vaporub (obsolete), 4.8%-2.6% topical ointment||menthol||ingredient_of
guaifenesin / hydromorphone oral solution [dilaudid cough]||4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one||ingredient_of
penicillin g potassium 5 million u intravenous powder for solution [pfizerpen]||tabilin||ingredient_of
eletriptan 20mg tablet (product)||3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1h-indole hydrobromide||ingredient_of
flurandrenolide 0.25 mg/ml topical cream||flurandrenolide preparation (substance)||ingredient_of
estrogenic substances 2 mg/ml||estrogenic substances||ingredient_of
clarithromycin 500 mg oral tablet, film coated, extended release [biaxin]||clarithromycin product||ingredient_of
phenobarbital sodium compounding powder||phenylethylbarbiturate||ingredient_of
chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule (product)||phenylephrine hydrochloride [nose] (substance)||ingredient_of
droperidol 2.5 mg/ml injection ampul (ml)||droperidol [cns]||ingredient_of
dianeal pd-1/dextrose 4.25% soln||sodium chloride eye||ingredient_of
sodium hypochlorite 0.057 % irrigation solution, irrigation||anasept||ingredient_of
ascorbic acid / iron carbonyl chewable product||acide ascorbique||ingredient_of
catheter,external small lhb #451-7659||catheter, nos||ingredient_of
materna prenatal tab||iodine (vaginal)||ingredient_of
metformin pill||metformin hydrochloride||ingredient_of
dxevo 11-day dose pack 1.5mg tablet||dexabliss 11-day dose pack||ingredient_of
azedra 15 mci/ml per 22.5 ml injection||cold contaminant-free iobenguane i 131||ingredient_of
fosinopril 10mg/hydrochlorothiazide 12.5mg tablet||monopril hct||ingredient_of
atnaa, 2.1 mg/0.7 ml-600 mg/2 ml intramuscular solution||atropine and pralidoxime product||ingredient_of
fenofibric acid 135mg gastro-resistant oral capsule (product)||2-(4-(4'-chlorophenoxy)phenoxy)propionic acid||ingredient_of
polyoxyethylene ether 0.02 mg/mg||polyoxyethylene ether||ingredient_of
epinephrine 10 mg/ml / pilocarpine hydrochloride 10 mg/ml ophthalmic solution||epinephrine bitartrate||ingredient_of
cholic acid 50 mg [cholbam]||cholic acid||ingredient_of
amylases 24,600 unt / endopeptidases 14,200 unt / lipase 4200 unt delayed release oral capsule||pancrelipase-containing product||ingredient_of
potassium chloride 1.33 meq/ml [klorvess]||muriate of potash||ingredient_of
m-trace 5 inj,conc||manganese sulfate||ingredient_of
chlorpheniramine tannate/carbetapentane tannate@4 mg-30 mg/5 ml@oral@suspension, oral (final dose form)||carbetapentane (medication)||ingredient_of
phexxi vaginal product||citric acid preparation (substance)||ingredient_of
benzalkonium chloride 1 mg in 1 ml topical soap [gentle hand antibacterial eucalyptus mint]||benzalkonium-containing product||ingredient_of
oral form diphenhydramine (product)||ethanamine, 2-(diphenylmethoxy)-n,n-dimethyl-||ingredient_of
butorphanol tartrate 1 mg/ml||(-)-butorphanol||ingredient_of
brompheniramine/phenylpropanol 4 mg-25 mg oral tablet||phenylpropanolamine hydrochloride (product)||ingredient_of
ginseng cap/tab||extract ginseng||ingredient_of
levothyroxine sodium bulk powder||levothyroxine sodium preparation||ingredient_of
orazinc lozenge oral product||zinc (as gluconate)||ingredient_of
caps chromagen ob||magnesio||ingredient_of
urethral meatal dilator adult||supplies (treatment)||ingredient_of
acetaminophen, 500 mg/15 ml oral liquid||product containing paracetamol||ingredient_of
quinidine pill||α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol||ingredient_of
pyridoxine 10 mg||d-(+)-biotin||ingredient_of
sertraline 50 mg||hydrochloride, sertraline||ingredient_of
multiple trace element inj,conc||zinc sulphate [skin]||ingredient_of
verteporfin 15 mg||verteporfina||ingredient_of
ellura, oral capsule||ellura||ingredient_of
apap 200 mg / asa 230 mg / phenylpropanolamine hydrochloride 15 mg oral capsule||phenylpropanolamine + aspirin + apap||ingredient_of
amino acids 7% intravenous solution [aminosyn ii]||histidine (substance)||ingredient_of
guaifenesin 20 mg/ml / phenylpropanolamine 1.8 mg/ml oral solution||guaiphenesin||ingredient_of
hydrochlorothiazide 25 mg / spironolactone 25 mg oral tablet [spironolactone plus]||17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid, gamma lactone, acetate||ingredient_of
ivermectin 0.165 mg [heartgard]||ivermectin (medication)||ingredient_of
memantine hydrochloride 10 mg oral tablet, film coated [memantine hydrochloride]||memantine hydrochloride||ingredient_of
prednisolone delayed release oral tablet||delta(1)-hydrocortisone||ingredient_of
cilastatin 250 mg/ml / imipenem 250 mg/ml [primaxin]||cilastatine||ingredient_of
diatrizoate meglumine 52%/diatrizoate sodium 8% solution||product containing diatrizoate||ingredient_of
terbinafine hydrochloride 10 mg/ml topical cream [lamisil]||lamisil at jock itch||ingredient_of
servira (atropine sulfate 0.058 mg / hyoscyamine sulfate 0.31 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.02 mg) 12 hr extended release oral tablet||atropine sulfate [antispasmodic] (substance)||ingredient_of
stannous fluoride 6.3 mg/ml mouthwash||fluoride stannous||ingredient_of
vancomycin hydrochloride 6 mg in 1 ml intravenous injection, solution||vancomycin (as hydrochloride)||ingredient_of
salicylic acid 0.005 mg/mg topical gel||salicylic acid [acne] (substance)||ingredient_of
colistin sulphate 1.5million units tablet||colistin-containing product||ingredient_of
product containing bisoprolol in oral dose form (medicinal product form)||bisoprolol-containing product||ingredient_of
pentobarbital sodium 3.64 mg/ml [nembutal]||sodium pentobarbital||ingredient_of
rotigotine 3 mg in 24 h transdermal patch, extended release [neupro]||product containing rotigotine (medicinal product)||ingredient_of
nutritional supplement oral tablet [pharmassure premium women's biomultiple]||product containing cranberries (medicinal product)||ingredient_of
benzalkonium chloride 0.13 kg in 100 kg topical liquid [hand sanitizer solution 101]||benzalkonium chloride topical||ingredient_of
product containing amiodarone in oral dosage form||2-n-butyl-3',5'-diiodo-4'-n-diethylaminoethoxy-3-benzoylbenzofuran||ingredient_of
dobesilic acid 400 mg||dobesilic acid||ingredient_of
z-cof 8 dm 15mg-30mg-175mg/5ml suspension||guaifenesin-containing product||ingredient_of
let, 0.05%-4%-0.5% topical gel||tetracaine hydrochloride (amethocaine)||ingredient_of
brompheniramine / phenylephrine oral tablet||l-(3-hydroxyphenyl)-n-methylethanolamine||ingredient_of
phentermine hydrochloride 18.8 mg||lomaira||ingredient_of
brazil nut whole allergenic extract 50 mg/ml||bertholletia nobilis whole||ingredient_of
calcium carbonate / prasterone pill||carbonate de calcium||ingredient_of
doxycycline hyclate 75mg ec cap||doxycycline hyclate||ingredient_of
dyphylline 125 mg/ml||product containing dyphylline||ingredient_of
benzocaine + trimethobenzamide hydrochlor 2%ww/200mg (product)||trimethobenzamide||ingredient_of
goodsense nighttime sleep aid 25mg mini-caplet||histaprin||ingredient_of
rite aid dual action acid reducer plus antacid chewable tablet (mint)||magnesium hydroxide||ingredient_of
opium 24mg/b-donna 0.1296mg/kaolin/pectin/30ml susp||atropine sulphate [premedication]||ingredient_of
phenobarbital / sodium nitrite oral tablet||phenylbarbital||ingredient_of
mometasone furoate 0.22 mg/actuat||mometasone||ingredient_of
benzyl alcohol / isopropyl alcohol / picrate / tannic acid topical spray [nitrotan]||picrate||ingredient_of
levsin oral product||hyoscyamine sulfate||ingredient_of
acetaminophen 325 mg oral tablet [careall non-aspirin]||paracetamol-containing product||ingredient_of
ascorbic acid/vitamin a/vitamin d 35 mg/1 ml-1500 iu/1 ml-400 iu/1 ml oral liquid||ascorbic acid [nutrition] (substance)||ingredient_of
sotorasib 120mg tab||lumakras||ingredient_of
reserpine 0.1 mg / hydralazine hcl 25 mg / hydrochlorothiazide 15 mg oral tablet||reserpin||ingredient_of
berotralstat-containing product in oral dose form||product containing berotralstat (medicinal product)||ingredient_of
pedialyte freezer pops, oral solution||cl- element||ingredient_of
glycolate 0.7 mg/mg [fluoro/gly]||glycolate||ingredient_of
dextromethorphan/pseudoephedrine/acetaminophen/chlorpheniram@15 mg-30 mg-325 mg-2 mg@oral@tablet||chlorphenamine and dextromethorphan and paracetamol and pseudoephedrine product||ingredient_of
lactase extra strength 4500 unt oral tablet||lactase||ingredient_of
amino acids/multivitamins/minerals liquid||levocarnitin||ingredient_of
ictasol 120 mg||ictasol||ingredient_of
ca 100mg/ergocalciferol 50unt/salicylamide 400mg tab||calciferol preparation||ingredient_of
albumin human 0.03% / allergenic extract, pollen mix inj||allergenic extract,pollen||ingredient_of
ethinyl estradiol 2 mg||ethinylestradiolum||ingredient_of
nutrition supl magnacal renal can 240ml||selenium (medication)||ingredient_of
insulin biphasic isophane human 30/70 100units/ml injection 10ml vial (product)||semisynthetic human insulin preparation||ingredient_of
vital hp liquid||d-alpha tocoferil acetate||ingredient_of
tirbanibulin 1% oint,top,pkt||product containing tirbanibulin (medicinal product)||ingredient_of
warfarin sodium 2.5 mg [jantoven]||jantoven||ingredient_of
esterified estrogens tablets||estrogens esterified||ingredient_of
ring,sure seal small round #alrs0110||ring, device (physical object)||ingredient_of
levothyroxine sodium 12.5 mcg oral tablet||sodium thyroxine||ingredient_of
barrier,brava strips c#120740||barrier device||ingredient_of
psyllium husk 3.4 g in 7 g oral powder [ultra organic fiber sugar free]||ispaghula husk agent (product)||ingredient_of
trach tube,sz 6 w/cuff shly#6-perc||tracheostomy device||ingredient_of
hematoporphyrin / procaine oral capsule||hematoporphyrin||ingredient_of
quinine sulfate 260 mg||product containing quinine||ingredient_of
menthol 3 mg oromucosal lozenge/troche||cyclohexanol, 5-methyl-2-(1-methylethyl)-||ingredient_of
guaiacol/menthol/methyl salicylate cream,top||menthol product||ingredient_of
acetaminophen 650 mg in 20 ml / dextromethorphan hydrobromide 20 mg in 20 ml / guaifenesin 400 mg in 20 ml / phenylephrine hydrochloride 10 mg in 20 ml oral solution [childrens mucinex cold, cough and sore throat]||phenylephrine + dextromethorphan + guaifenesin + acetaminophen (medication)||ingredient_of
naproxen 500mg tab,ud||naproxeno||ingredient_of
zinc oxide 113 mg/ml topical cream||zinc white||ingredient_of
3 ml aduhelm 100 mg/ml injection||aducanumab||ingredient_of
acetic acid 2% solution (product)||acetic acid product (substance)||ingredient_of
metaxalone tablets||product containing metaxalone (medicinal product)||ingredient_of
niva-hist dm, 4 mg-15 mg-7.5 mg/5 ml oral liquid||brompheniramine + dextromethorphan + phenylephrine (medication)||ingredient_of
bufexamac 50 mg/ml [jomax]||bufexamacum||ingredient_of
complete blink-n-clean||tyloxapol (substance)||ingredient_of
mineral oil/petrolatum,white ophthalmic lubricant||lubricant (product)||ingredient_of
kanamycin ophthalmic ointment||kanamycin (substance)||ingredient_of
miconazole nitrate 40 mg/ml [lagicam]||miconazole [oropharyngeal]||ingredient_of
nuvigil 200mg tablet||r-modafinil||ingredient_of
chlorhexidine / phenylephrine topical cream||r(-)-phenylephrine||ingredient_of
insulin novolin 70/30 inj innolet 3ml||relion novolin 70/30 innolet||ingredient_of
amoxicillin 775mg sa tab||amoxicillin trihydrate (substance)||ingredient_of
vitamin e, 100 intl units oral tablet||product containing vitamin e (product)||ingredient_of
ditropan, 5 mg oral tablet||4-(diethylamino)-2-butynyl ()-,alpha-phenylcyclohexaneglycolate hydrochloride||ingredient_of
guaifenesin/dextromethorphan hbr/pseudoephedrine hcl 1,000 mg-30 mg-60 mg oral tablet, extended release 12 hr||dextromethorphan hydrobromide (substance)||ingredient_of
influenza a virus a/guangdong-maonan/swl1536/2019 (h1n1) antigen 0.03 mg/ml / influenza a virus a/hong kong/2671/2019 (h3n2) antigen 0.03 mg/ml / influenza b virus b/phuket/3073/2013 antigen 0.03 mg/ml / influenza b virus b/washington/02/2019 antigen 0.03 mg/ml injectable suspension [fluzone quadrivalent 2020-2021]||influenza virus vaccines||ingredient_of
lamotrigine 100 mg oral tablet [lamotrigine]||lamotrigine (medication)||ingredient_of
calcium chloride / glucose / lactate / magnesium chloride / sodium chloride intraperitoneal solution [dianeal low calcium 3.5]||glucose preparation (product)||ingredient_of
pad,nasal large||pad,foam||ingredient_of
clonidine hcl 0.17 mg oral tablet, extended release 24 hr||clonidine hcl||ingredient_of
iodine topical product||iodine (medication)||ingredient_of
naloxone hydrochloride 1 mg/ml [evzio]||(-)-naloxone||ingredient_of
levetiracetam 1500 mg extended release oral tablet [elepsia]||levetiracetam (medication)||ingredient_of
valproic acid 250 mg [depakene]||propylisopropylacetic acid||ingredient_of
alanine 11 mg/ml / arginine 8.5 mg/ml / glycine 11 mg/ml / histidine 2.6 mg/ml / isoleucine 6.2 mg/ml / leucine 8.1 mg/ml / lysine 6.24 mg/ml / magnesium chloride 0.00502 meq/ml / methionine 3.4 mg/ml / phenylalanine 3.8 mg/ml / k+ chloride 0.0654 meq/ml / proline 7.5 mg/ml / serine 3.7 mg/ml / nacl 0.00479 meq/ml / sodium phosphate 0.0299 meq/ml / threonine 4.6 mg/ml / tryptophan 1.5 mg/ml / tyrosine 0.44 mg/ml / valine 6.8 mg/ml injectable solution||ethanoate||ingredient_of
product containing cobimetinib in oral dosage form||cobimetinib (product)||ingredient_of
dextromethorphan/guafenesin/ppa 5 mg-50 mg-6.25 mg/ml oral liquid||naldecon-dx pediatric||ingredient_of
feso4 195 mg oral tablet||iron sulfate (1:1)||ingredient_of
brompheniramine oral tablet||brompheniramine maleate (substance)||ingredient_of
triple antibiotic plus topical ointment||polymyxin b sulf [systemic] (product)||ingredient_of
product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug)||sutent||ingredient_of
morphine sulfate 80 mg oral capsule, extended release [morphine sulfate]||sulfate, morphine||ingredient_of
ropivacaine hcl in on q pump cb6007, 0.5% injectable solution||ropivacaine hcl in on q pump p400x4||ingredient_of
fluticasone propionate 50 ug nasal spray, metered [topcare childrens allergy relief nasal 24 hour]||fluticasone propionate[skin] (product)||ingredient_of
cordron-dm nr, 3 mg-15 mg-12.5 mg/5 ml oral liquid||carbinoxamine maleate||ingredient_of
sulfacetamide sodium 100 mg/ml||sulfur, nos||ingredient_of
indomethacin, submicronized 40 mg oral capsule||indometacin-containing product||ingredient_of
vitamin liquid, multiple vitamins oral liquid||liquid vitamins||ingredient_of
dysport, 300 units intramuscular powder for injection||abobotulinumtoxina (substance)||ingredient_of
promogran prisma 4.75in x 4.75in jj#4434||oxidized cellulose product||ingredient_of
bromfenac 25 mg||bromfenaco||ingredient_of
ziprasidone 80 mg [geodon]||ziprazidone||ingredient_of
polyethylene glycol 400 / propylene glycol ophthalmic solution||ocusan dry eyes||ingredient_of
hydrochlorothiazide/olmesartan medoxomil 12.5 mg-20 mg oral tablet [benicar hct]||hydrochlorothiazide-containing product||ingredient_of
dextrose monohydrate 4.25 g in 100 ml / sodium chloride 538 mg in 100 ml / sodium lactate 448 mg in 100 ml / calcium chloride 25.7 mg in 100 ml / magnesium chloride 5.08 mg in 100 ml intraperitoneal injection, solution [dianeal pd-2 with dextrose]||magnesium-containing product||ingredient_of
phenylephrine hydrochloride 2.5 mg/ml||pramoxine||ingredient_of
dm 7.4mg/ipecac 0.17min/k guaiacolsulf 44mg/prometh 5mg syr||n-(2-dimethylaminopropyl-1)phenothiazine hydrochloride||ingredient_of
theophylline 200mg m/r tablet (product)||theophyllin||ingredient_of
cysteine hcl@50 mg/ml@intraven@vial (ml)||half-cystine||ingredient_of
diperodon 0.5/hc 0.5%/zn oxide oint||domolene||ingredient_of
lamotrigine 25mg chewable tablet||lamictal||ingredient_of
wellbutrin 100 mg oral tablet||antidepressants bupropion hydrochloride||ingredient_of
product containing zileuton in oral dose form (medicinal product form)||zileuton product||ingredient_of
diltiazem hydrochloride, 5 mg/ml intravenous solution_#1||diltiazem hydrochloride 2 (substance)||ingredient_of
meperidine hydrochloride 25 mg in 1 ml subcutaneous injection, solution [demerol]||pethidine hydrochlor [analg]||ingredient_of
cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet||cetirizine product||ingredient_of
belladonna extract, usp / opium rectal product||belladonna (substance)||ingredient_of
calcium carbonate-psyllium 60 mg-550 mg oral capsule||semen plantaginis||ingredient_of
clozapine (clozaril) 100mg tab ud||clozapine (sandoz)||ingredient_of
insulin analog, glulisine 100 unt/ml injectable solution||insulin glulisine (recombinant dna origin)||ingredient_of
carbarson 250 mg||4-ureidobenzenearsonic acid||ingredient_of
penicillin g benzathine 300000 unt/ml||product containing benzylpenicillin||ingredient_of
dexamphetamine 12.5mg cap||dextro amphetamine||ingredient_of
fremanezumab prefilled syringe [ajovy]||product containing fremanezumab (medicinal product)||ingredient_of
sitosterols chewable product||sitosterols (medication)||ingredient_of
clotrimazole 1% spray (substance)||clotrimazole||ingredient_of
becaplermin 0.01 % topical gel||becaplermin-containing product in cutaneous dose form||ingredient_of
nutrition supl ensure plus hn/choc liq||potassium iodide (ki)||ingredient_of
potassium chloride in dextrose 5 %-0.2 % sodium chloride 20 meq/l intraven intravenous solution||salt, nos||ingredient_of
hypaque sodium, 10 g injectable powder for injection||product containing sodium amidotrizoate (medicinal product)||ingredient_of
poractant alfa 80 mg/ml [curosurf]||product containing poractant alfa||ingredient_of
ketorolac / phenylephrine ophthalmic irrigation solution||phenylephrine (substance)||ingredient_of
fluocortolone oral product||fluocortolone (product)||ingredient_of
ergoloid mesylates, usp / nifedipine oral product||hydrogenated ergot alkaloids||ingredient_of
qual-tussin dc, 50 mg-2.5 mg-7.5 mg/5 ml oral syrup||fenilefrina||ingredient_of
cedazuridine / decitabine oral tablet||decitabine (substance)||ingredient_of
lisinopril 2.5mg tablet||lysinopril||ingredient_of
fiberall tablets, 1000 mg oral tablet, chewable||sodium (substance)||ingredient_of
hydrocortisone acetate 30 mg rectal suppository, rectal||hc||ingredient_of
suction set,suction pro 72 14fr closed catheter #z115n-14||suction set||ingredient_of
oxytocin 15 [usp'u] in 250 ml intravenous injection, solution||product containing oxytocin||ingredient_of
spiramycin 250 mg||provamycin||ingredient_of
dressing,curafoam 4in x 4in drain sponge k#9392||dressing,curafoam||ingredient_of
product containing only hydralazine hydrochloride 10 mg/1 each oral tablet||hydralazine hydrochloride (medication)||ingredient_of
eicosapentaenoic acid 216 mg||eicosapentaenoate (c20:5w3)||ingredient_of
sulfamethoxazole + trimethoprim 200mg/40mg suspension (product)||smx tmp||ingredient_of
cestex oral product||cestex (product)||ingredient_of
pramoxine hydrochloride 1 % topical gel||pramoxine hcl||ingredient_of
tyrosine 0.22 mg/ml||l-tyrosine||ingredient_of
octoxynol 0.03 mg/mg||octoxinol (substance)||ingredient_of
promethazine 6.25mg/dextromethorphan 15mg 5ml oral syrup (product)||promethazine hydrochloride [hypnotic] see section c8i.. (substance)||ingredient_of
night time cold medicine, 325 mg-38.33 mg-15 mg oral tablet, effervescent||2-(diphenylmethoxy)-n,n-dimethylethylamine citrate (1:1)||ingredient_of
risperidone 50mg powder for suspension for injection||risperidonum||ingredient_of
folic acid 5 mg in 1 ml intramuscular injection, solution||folic acid||ingredient_of
empagliflozin 10 mg / linagliptin 5 mg oral tablet [glyxambi]||linagliptin (substance)||ingredient_of
festex oint,top||camphor lump||ingredient_of
procainamide hcl 500mg 6hr sa tab||novocamid hydrochloride||ingredient_of
trimetrexate injectable solution [neutrexin]||2,4-quinazolinediamine, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-||ingredient_of
acyclovir 400mg dispersible tablet||product containing acyclovir in ophthalmic dosage form||ingredient_of
flavocoxid/zinc, chelated 500 mg-50 mg oral capsule [limbrel 500]||(t-4)-bis(glycinato-n,o)zinc||ingredient_of
nutrition supl sustacal/van liquid||caseinate, sodium||ingredient_of
atropine / morphine injectable solution||phenohytro||ingredient_of
antacid with simethicone ii, 200 mg-200 mg-20 mg/5 ml oral suspension||activated dimeticone||ingredient_of
ascorbic acid / biotin / calcium carbonate / cupric oxide / ferrous fumarate / folic acid / magnesium oxide / niacinamide / pantothenic acid / riboflavin / thiamine / vitamin a / vitamin b12 / vitamin b6 / vitamin e / zinc oxide oral tablet||vitamins pantothenic acid||ingredient_of
influenza a virus a/tasmania/503/2020 (h3n2) antigen 0.09 mg/ml / influenza a virus a/wisconsin/588/2019 (h1n1) antigen 0.09 mg/ml / influenza b virus b/phuket/3073/2013 antigen 0.09 mg/ml / influenza b virus b/washington/02/2019 antigen 0.09 mg/ml [flublok quadrivalent 2021-2022]||antigen of inactivated influenza a virus subtype h1n1 (substance)||ingredient_of
pseudoephedrine hcl 15 mg in 5 ml oral solution||sudafed children's nasal decongestant||ingredient_of
acyclovir 0.04 mg/mg / lidocaine hydrochloride 0.04 mg/mg topical ointment||acyclovir/lidocaine||ingredient_of
siberian ginseng root 250 mg||siberian ginseng root||ingredient_of
nutrition supl ensure/butrscth pudding||cuprum||ingredient_of
paxil 12.5 mg extended release oral tablet||paroxetine hcl||ingredient_of
capsaicin / menthol topical product||product containing menthol||ingredient_of
aspirin 5.5 mg/ml / chlorpheniramine maleate 0.0338 mg/ml / phenylpropanolamine hcl 0.407 mg/ml oral solution||aspirin [musculoskeletal use] (substance)||ingredient_of
product containing only fenofibrate micronized 160 mg/1 each oral tablet||2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester||ingredient_of
flupenthixol 100 mg/ml||flupentixol (medication)||ingredient_of
dextromethorphan 30 mg oral capsule||dextromethorphan hydrobromide (substance)||ingredient_of
rosanil soap product||sulfur (substance)||ingredient_of
dimethic 5%crm/lidocaine 5% patch kit 15||dimethicone/lidocaine||ingredient_of
typhoid polysaccharide vaccine 25mcg prefilled syringe||sodium chloride [skin] (product)||ingredient_of
lotilaner oral product||lotilaner||ingredient_of
serzone 250mg tablet||nefazodone hydrochloride (product)||ingredient_of
chlorpheniramine / dextromethorphan / phenylephrine / phenylpropanolamine oral product||phenylephrine||ingredient_of
multivitamin/minerals herbal cap/tab||product containing zinc and/or zinc compound||ingredient_of
salicylic acid 0.06 g in 1 ml topical shampoo [narasoo healing]||salicylic acid (product)||ingredient_of
vitamin b12 0.005 mg/mg||vitamin b12 (medication)||ingredient_of
catheter,external freedom mentor #5490||catheter, device||ingredient_of
biogaia protectis, oral liquid||lactobacillus fermentum biotype ii||ingredient_of
gnp pink bismuth 262mg chewable tablet||soothe chewable||ingredient_of
cresol 35%/formaldehyde 1% liquid||methanal||ingredient_of
calcium chloride 0.48 mg/ml||calcium chloride (product)||ingredient_of
pramipexole dihydrochloride 2.25 mg [mirapex]||pramipexole product||ingredient_of
insulin isophane pork 100units/ml injection 10ml vial||porcine isophane insulin (substance)||ingredient_of
arformoterol tartrate 15 mcg in 2 ml inhalation solution||brovana||ingredient_of
b-scorbic tablet||multivitamin with minerals||ingredient_of
atropine / hyoscyamine / phenobarbital / scopolamine oral liquid product||elixiral||ingredient_of
hydrocortisone / neomycin ophthalmic solution||hidrocortisona||ingredient_of
trach tube,sz 5 cuffed shly #50xltcp||tracheostomy device||ingredient_of
ascorbic acid / ferrous sulfate / folic acid oral product||acidum ascorbinicum||ingredient_of
keri facial cleanser liquid,top||4-hydroxybenzoic acid, propyl ester||ingredient_of
sodium salicylate bulk powder||sodium salicylate (medication)||ingredient_of
salicylic acid 20 mg in 1 ml topical cream [md acne customized hydrating cleanser]||salicylic acid, nos||ingredient_of
lamivudine / tenofovir disoproxil oral tablet [temixys]||4-amino-1-((2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1h)-pyrimidinone||ingredient_of
doxycycline 20mg tablet||doxycycline hyclate (substance)||ingredient_of
fluoxetine 50 mg / olanzapine 6 mg oral capsule [symbyax]||olanzapine product||ingredient_of
braftovi 50 mg oral capsule||product containing encorafenib (medicinal product)||ingredient_of
phenylephrine / shark liver oil rectal ointment||shark liver oil preparation||ingredient_of
alpha-tocopherol acetate 30 unt / ascorbic acid 25 mg / cholecalciferol 170 unt / docosahexaenoic acid 265 mg / docusate sodium 55 mg / ferrous fumarate 30 mg / folic acid 1.24 mg / pyridoxine hydrochloride 25 mg / tricalcium phosphate 160 mg [prenexa]||n-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-l-glutamic acid||ingredient_of
rivastigine tartrate 6mg capsule||rivastigmine (as rivastigmine tartrate)||ingredient_of
vesagex topical product||product containing cetrimide||ingredient_of
prednisolone-containing product in rectal dose form||pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-||ingredient_of
vancomycin hcl 1gm/btl soln,oral||vancomycin (as hydrochloride)||ingredient_of
ammonium lactate, 12% topical lotion||amlactin xl||ingredient_of
vitamin e 400 iu oral capsule, liquid filled [vitamin e blend]||novipet joint support||ingredient_of
depend adjustable underwear,maximum absorb small/medium||diaper, device (physical object)||ingredient_of
calcium carbonate 800 mg / famotidine 10 mg / magnesium hydroxide 165 mg [tums dual action]||magnesium hydroxide-containing product||ingredient_of
dextromethorphan tannate 5 mg/ml / phenylephrine tannate 2.5 mg/ml / pyrilamine tannate 6 mg/ml oral suspension||dextromethorphan / phenylephrine / pyrilamine||ingredient_of
benzoyl peroxide 5 g in 100 g topical gel [perrigo benzoyl peroxide hydroalcoholic base]||superoxide, diphenylglyoxal||ingredient_of
belladonna extract, usp 5 mg / methenamine 250 mg / salicylamide 120 mg delayed release oral tablet||salicilamida||ingredient_of
perfect coat 1 % (coal tar solution 5 % ) medicated shampoo||liquor picis carbonis||ingredient_of
afatinib 20 mg||2-butenamide, n-[4-[(3-chloro-4-fluorophenyl)amino]7-[[(3s)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2e)-, (2z)-2-butenedioate (1:2)||ingredient_of
diaoxia, 6%-4% topical gel||niacin (as niacinamide)||ingredient_of
product containing benzalkonium in cutaneous dose form (medicinal product form)||benzalkonium||ingredient_of
product containing azathioprine 75 mg/1 each oral tablet||azathioprine [gastrointestinal] (substance)||ingredient_of
castor oil / peruvian balsam / trypsin topical ointment||ricinus compactus oil||ingredient_of
isosource 1.5 cal liquid,1000ml (closed system)||potassium iodide (medication)||ingredient_of
blinatumomab injectable product||blincyto||ingredient_of
hydrocortisone topical lotion [locoid]||hydrocortisone||ingredient_of
atropine sulfate/chlorpheniramine maleate/hyoscyamine sulfate/phenylephrine hydrochloride/phenylpropanolamine hydrochloride/scopolamine hydrobromide 0.04 mg-8 mg-0.19 mg-25 mg-50 mg-0.01 mg oral tablet, extended release [tuss delay]||chlor trimeton||ingredient_of
omega-3 polyunsaturated fatty acids 200 mg oral capsule||oil, n-3||ingredient_of
chlorcyclizine hydrochloride 25 mg oral tablet, chewable [bonine kids]||ciclizina||ingredient_of
melatonin 3 mg oral tablet, extended release [meladox natural sleep aid]||mlt||ingredient_of
bald-faced hornet venom protein / common wasp venom protein / eastern yellow jacket venom protein / german wasp venom protein / southern yellow jacket venom protein / western yellow jacket venom protein / yellow hornet venom protein injectable product||german wasp venom protein||ingredient_of
ropivacaine hcl in 0.9 % sodium chloride/pf 0.25 % injection prefilled pump reservoir||ropivacaine hcl||ingredient_of
rilpivirine 25 mg||edurant||ingredient_of
benzocaine mucous membrane topical solution [finafta baby]||benzocaine [dup] (substance)||ingredient_of
cetirizine hydrochloride 10 mg oral tablet [cetirizine]||cetirizine hydrochloride [dup] (substance)||ingredient_of
60 actuat fluticasone propionate 0.22 mg/actuat metered dose inhaler [flovent]||fluticasone propionate[skin]||ingredient_of
robitussin pediatric cough & cold nighttime, 1 mg-5 mg-2.5 mg/5 ml oral liquid||dextromethorphan hydrobromide product||ingredient_of
inon ace tablet pill||dulcolax soft chews||ingredient_of
drixoral, 6 mg-120 mg oral tablet, extended release||pseudoephedrine sulfate (medication)||ingredient_of
iopamidol 755mg + iodine 370mg/ml (76%) injection solution 100ml bottle||product containing iopamidol||ingredient_of
dexbrompheniramine / guaifenesin / pseudoephedrine oral solution||pseudoephedrine (product)||ingredient_of
palivizumab 100 mg intramuscular powder for solution [synagis]||palivizumab-containing product||ingredient_of
s-m-a lo-iron,infant formula pwdr||vitamin a preparation (product)||ingredient_of
atovaquone 62.5 mg and proguanil hydrochloride 25 mg oral tablet||atovaquone, proguanil drug combination||ingredient_of
aspirin 500 mg / phenyltoloxamine citrate 15 mg [momentum tradename]||ácido acetilsalicílico||ingredient_of
gemcitabine, 200 mg intravenous powder for injection||gemcitabine (product)||ingredient_of
sitosterols pill||sitosterols||ingredient_of
glucose 700 mg/ml injectable solution includes 500 ml & 1000 ml injection||glucose (dextrose) (medication)||ingredient_of
theophylline 250 mg [elixophyllin]||theophylline product||ingredient_of
pilocarpine hydrochloride 20 mg/ml||product containing pilocarpine||ingredient_of
aceprometazine 10 mg||1-(10-(2-(dimethylamino)propyl)-10h-phenothiazin- 2-yl)ethanone||ingredient_of
phenazopyridine / sulfamethizole oral product||phenazopyridine||ingredient_of
risperidone 3mg tab,ud||risperidone (substance)||ingredient_of
parenteral nutrition solution w/electrolytes amino acids 3.5% with electrolytes (travasol) intravenous solution||parenteral nutrition solution w/electrolytes||ingredient_of
hpr plus hydrogel kit||938 emollients||ingredient_of
pseudoeph/dm/guaifen/acetamin 60 mg-20 mg-200 mg-325 mg oral tablet||dextromethorphan hydrobromide (medication)||ingredient_of
solodyn (minocycline hydrochloride) 115 mg 24 hr extended release oral tablet||2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4s-(4alpha,4aalpha,5aalpha,12aalpha))-||ingredient_of
al oh 75mg/asa 325mg/ca carb 75mg/mg oh 75mg tab||aspirin (product)||ingredient_of
irrigation set h#7726||irrigation kit||ingredient_of
morphine tablets (product)||morphine product||ingredient_of
clocream, with cod liver oil topical cream||product containing colecalciferol||ingredient_of
vi-daylin plus iron drops,oral||tocopherol (substance)||ingredient_of
aspirin 500 mg / diphenhydramine citrate 38.3 mg oral tablet||diphenhydramine citrate (1:1)||ingredient_of
nifedipine 10 mg||nifedipine (medication)||ingredient_of
lo loestrin fe, with iron biphasic 10 mcg-1 mg oral tablet||19-nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one||ingredient_of
coal tar 25 mg/ml||product containing coal tar||ingredient_of
pedituss, 0.75 mg-5 mg-2.5 mg-75 mg/5 ml oral syrup||chlorpheniramine maleate (product)||ingredient_of
kanamycin 500 mg oral capsule [kantrex]||kanamycin||ingredient_of
calcium carbonate-magnesium hydroxide 350 mg-150 mg oral tablet, chewable||magnesium hydroxide||ingredient_of
gemcitabine hcl in 0.9 % sodium chloride@2,000 mg/200 ml (10 mg/ml)@intraven@intravenous solution, piggyback (ml)||gemcitabine (product)||ingredient_of
allopurinol 300 mg / lesinurad 200 mg oral tablet [duzallo]||4-hydroxypyrazolopyrimidine||ingredient_of
celery allergenic extract 25 mg/ml||celery||ingredient_of
dm 15mg/gg 400mg/pseudoephedrine 60mg tab||pseudoephedrine product||ingredient_of
sensorcaine mpf 0.25% solution for injection||bupivacaine hydrochloride (medication)||ingredient_of
potassium chloride 20meq/50ml inj,bag||potassium chloride||ingredient_of
chlorophyllin copper complex oral tablet||chloresium||ingredient_of
b-donna oral product||tropine-l-tropate||ingredient_of
chlorpheniramine maleate/phenylephrine hcl/codeine phosphate 2 mg-5 mg-7.5 mg/5 ml oral liquid (ml)||r(-)-phenylephrine||ingredient_of
di-bromm, 1 mg-15 mg/5 ml oral liquid||2-pyridinepropanamine, gamma-(4-bromophenyl)-n,n-dimethyl-,(z)-butenedioate(1:1)||ingredient_of
aluminum hydroxide / bismuth subnitrate / milk of magnesia oral tablet||aluminum hydroxide product||ingredient_of
chlorpheniramine maleate 2 mg / dihydrocodeine bitartrate 6.5 mg / phenylephrine hcl 4 mg in 5 ml oral solution||chlorpheniramine maleate (medication)||ingredient_of
trimethobenzamide rectal product||product containing trimethobenzamide||ingredient_of
marcaine 5 mg/ml injection||bupivacaine hydrochloride (medication)||ingredient_of
calcium carbonate / kaolin oral liquid product||native hydrated aluminum silicate (substance)||ingredient_of
zinc oxide 0.07 mg/mg||zinc oxide (product)||ingredient_of
super plenamins, therapeutic multiple vitamins oral tablet||multivitamin,therapeutic||ingredient_of
bifidobacterium infantis pill||bifidobacterium infantis||ingredient_of
epoetin alfa 2000 units/ml injectable solution||epoetin alfa,recombinant||ingredient_of
norethindrone tablets||nor-qd||ingredient_of
cefixime 200 mg [suprax]||product containing cefixime (medicinal product)||ingredient_of
candida albicans allergenic extract 40000 unt/ml||candida albicans extract||ingredient_of
ritonavir oral powder||product containing ritonavir (medicinal product)||ingredient_of
acetaminophen / chlorpheniramine / phenylephrine / pyrilamine pill||phenylephrine||ingredient_of
toceranib phosphate 10 mg||product containing toceranib (medicinal product)||ingredient_of
nutrition supl magnacal liquid 120ml||vit a||ingredient_of
ntg 0.3 mg sublingual tablet [ethex brand of nitroglycerin]||nitroglycerol||ingredient_of
hydrocortisone 1.02 g in 100 g topical lotion [intensive healing eczema]||(11beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione||ingredient_of
carbetapentane citrate/guaifenesin/phenylephrine hydrochloride 15 mg/5 ml-100 mg/5 ml-5 mg/5 ml oral solution||extendryl gcp||ingredient_of
timothy grass pollen extract 100 ir||allergenic extract, timothy grass||ingredient_of
propoxyphene hcl 32 mg / aspirin 389 mg / caffeine 32.4 mg / oral capsule||caffeine, nos||ingredient_of
chlophedianol / dexbrompheniramine / pseudoephedrine oral solution||clofedianolo||ingredient_of
azasan 25mg tablet||aztp||ingredient_of
multivitamins/fluoride 0.5mg/ml liquid||thiamine hydrochloride (medication)||ingredient_of
ascorbic acid 100 mg / calcium carbonate 200 mg / cholecalciferol 0.01 mg / copper sulfate 2 mg / dl-alpha tocopheryl acetate 30 unt / ferrous fumarate 65 mg / folic acid 1 mg / magnesium oxide 10 mg / niacinamide 20 mg / potassium iodide 0.15 mg / pyridoxine hydrochloride 5 mg / retinol acetate 4000 unt / riboflavin 3.4 mg / thiamine mononitrate 3 mg / vitamin b12 0.012 mg / zinc sulfate 15 mg oral tablet||dermatologicals drying agents zinc sulfate (medication)||ingredient_of
lvp solution dextrose 5% in lactated ringers injection intravenous solution||potassium preparations (medication)||ingredient_of
calcium carbonate / famotidine / magnesium hydroxide chewable tablet [duo fusion]||3-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-n-(aminosulfonyl)propanimidamide||ingredient_of
lodrane xr, 8 mg/5 ml oral suspension, extended release||brompheniramine tannate||ingredient_of
pazopanib tablets||pazopanibum||ingredient_of
acetaminophen 20 mg/ml||product containing paracetamol (medicinal product)||ingredient_of
tetrabenazine oral suspension||tetrabenazina||ingredient_of
dexpanthenol 250 mg/ml||product containing dexpanthenol (medicinal product)||ingredient_of
enalapril 5 mg||l-proline, 1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, (s)-||ingredient_of
acetaminophen 325 mg / guaifenesin 200 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [maximum strength severe congestion relief]||phenylephrine hcl [eye]||ingredient_of
pheniramine maleate/phenylpropanolamine hydrochloride/phenyltoloxamine citrate/pyrilamine maleate 4 mg/5 ml-12.5 mg/5 ml-4 mg/5 ml-4 mg/5 ml oral elixir [multihist d]||pyrilamine maleate||ingredient_of
alcohol 28/salicylic acid 0.5% lotion||sodium dodecylbenzenesulfonate||ingredient_of
androlone-d injectable product||nandrolone preparation||ingredient_of
goose feather extract 1 mg/ml||goose feathers extract (product)||ingredient_of
darbepoetin alfa in polysorbate 80@300 mcg/ml@injection@vial (ml)||aranesp albumin free||ingredient_of
alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / cupric oxide / ferrous bisglycinate / folic acid / iron protein succinylate / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin b12 / zinc oxide pill||beta carotene||ingredient_of
sirolimus 2 mg||sirolimus (product)||ingredient_of
catheter,foley silicone 2-way 22fr 5cc kendall #5221||catheter||ingredient_of
pediamist nasal product||sodium chloride [mouth] (substance)||ingredient_of
lente insulin, pork injectable suspension||lente insulin, pork||ingredient_of
cephalexin 250 mg in 5 ml oral for suspension [cephalexin]||panixine||ingredient_of
alpha tocopherol / ascorbic acid / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin b12 / zinc oxide oral product||vitamin g preparation||ingredient_of
chlorpheniramine/dextromethorp/phenylephrine 1 mg-3 mg-2 mg/ml oral drops||phenylephrine (as hydrochloride)||ingredient_of
antipyrine / meprobamate / papaverine oral tablet||neuramate||ingredient_of
dehydrocholic acid 20 mg||dehydrocholate||ingredient_of
leucovorin calcium 200 mg in 20 ml intravenous injection, powder, lyophilized, for solution [leucovorin calcium]||calcium folinate||ingredient_of
guaifenesin / hydrocodone / phenylephrine oral liquid product||hydrocodon||ingredient_of
chlorpheniramine/codeine/pseudoephedrine 2 mg-8 mg-30 mg/5 ml oral liquid||product containing chlorphenamine and codeine and pseudoephedrine||ingredient_of
ropivacaine hydrochloride monohydrate 0.2% solution for injection_#4||ropivacaine||ingredient_of
menthol, unspecified form 0.04574 g in 1 g / histamine dihydrochloride 0.00028 g in 1 g topical stick [activon ultra strength arthritis]||menthol (product)||ingredient_of
sodium stibogluconate 10g/100ml injection (substance)||stibogluconate, sodium||ingredient_of
acetaminophen rectal product||4-acetamidophenol||ingredient_of
aspirin/calcium carbonate 81 mg oral tablet [bayer aspirin regimen w/calcium]||bayer aspirin regimen||ingredient_of
baclofen 500 mcg/ml intrathec kit||4-amino-3-(4-chlorophenyl)butyric acid||ingredient_of
ciprofloxacin injectable product||ciprofloxacin (medication)||ingredient_of
hydrochlorothiazide 25 mg / moexipril hydrochloride 15 mg [uniretic]||moexipril||ingredient_of
moxidectin topical solution [cydectin]||product containing moxidectin (medicinal product)||ingredient_of
desoxycorticosterone pivalate 25 mg/ml [zycortal]||desoxycortone||ingredient_of
hydrophilic ointment topical application ointment [hydrophilic grx ointment]||emollient agent||ingredient_of
minocycline 135 mg extended release oral tablet||minocyclinum||ingredient_of
sodium fluoride 0.5 mg/ml||sodium fluoride preparations (medication)||ingredient_of
theophylline in dextrose 5 % 800 mg/l intraven intravenous solution||dextrose preparation||ingredient_of
eltrombopag olamine 25 mg oral tablet, film coated [promacta]||eltrombopag (substance)||ingredient_of
carbetapentane/guaifenesin/phenylephrine, 20 mg-100 mg-15 mg/5 ml oral liquid||phenylephrine hcl [eye] (substance)||ingredient_of
diclofenac sodium topical, 1% topical gel||dst plus pak||ingredient_of
infant formula sma lo-iron liquid||2-hydroxyethyl-trimethyl-ammonium||ingredient_of
guaifenesin 600 mg oral tablet, extended release [topcare mucus er]||guaibid la||ingredient_of
somatropin 5.83 mg/ml [saizen]||recombinant gh||ingredient_of
ephedrine sulfate 0.25% nasal spray [pretz-d]||antiasthmatics ephedrine||ingredient_of
folic acid / vitamin b12 / vitamin b6 oral tablet [nufol]||vitamin b6||ingredient_of
carbachol@0.01 %@intraoculr@vial (ml)||carbacol||ingredient_of
caffeine / dimenhydrinate / ergotamine oral capsule||1,3,7-trimethyl-2,6-dioxopurine||ingredient_of
betamethasone 0.001 mg/mg||betamethasone||ingredient_of
product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)||[n2-[(s)-1-carboxy-3-phenylpropyl]-l-lysyl-l-proline||ingredient_of
diclofenac epolamine 0.013 g topical system [licart]||dicrofenac||ingredient_of
levobunolol hydrochloride 0.5% single-use eye drops (product)||levobunolol hydrochloride (medication)||ingredient_of
acid mantle creme||acidmantle||ingredient_of
zolgensma kit (10.6 - 11.0kg)||zolgensma (10.6-11.0 kg)||ingredient_of
atropine so4 1.2mg/neostigmine methylsulfate 2.5mg/vil inj||neostigmine methylsulfate [anesthesia] (substance)||ingredient_of
jentadueto 2.5/1000 oral tablet||linagliptin and metformin product||ingredient_of
sonafine, topical emulsion||sonafine||ingredient_of
ensure w/fiber liquid vanilla||niacin (substance) [ambiguous]||ingredient_of
benzocaine 6.3 % / phenol 0.5 % mouthwash||äthylalkohol||ingredient_of
alpha tocopherol / ascorbic acid / docosahexaenoate / eicosapentaenoate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate oral product||vitamin b6||ingredient_of
triamterene 50 mg [dyrenium]||6-phenyl-2,4,7-pteridinetriamine||ingredient_of
hexachlorophene 3% emulsion||product containing hexachlorophene in cutaneous dose form (medicinal product form)||ingredient_of
ethyl hexyl salicylate / titanium dioxide topical product||ethyl hexyl salicylate||ingredient_of
apazone oral tablet [rheumox]||rheumox||ingredient_of
albumin human 7mg/stannous tartrate 0.08mg inj||albumin/stannous tartrate||ingredient_of
optiflex-g 750mg tablet||glucosamine products||ingredient_of
hyoscyamine sulfate 0.125 mg in 5 ml oral elixir [hyosyne]||hyoscyamine sulfate||ingredient_of
somatropin 8.8 mg/ml injectable solution [serostim]||product containing somatropin (medicinal product)||ingredient_of
calcium carbonate / cholecalciferol pill||product containing vitamin d<sub>3</sub>||ingredient_of
dermacerin topical product||paraffin-white soft (product)||ingredient_of
benzalkonium chloride 1.25 mg/ml [mane 'n tail pro-tect]||benzalkonium||ingredient_of
ducodyl, 5 mg oral delayed release tablet||bisacodyl-containing product||ingredient_of
influenza a virus a/brisbane/02/2018 (h1n1) antigen 0.03 mg/ml||antigen of inactivated influenza a virus subtype h1n1||ingredient_of
potassium chloride 20meq/15ml liquid||chloride of potash||ingredient_of
product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet||citrate, orphenadrine||ingredient_of
c1 esterase inhibitor, human 2000 iu subcutaneous powder for solution||complement c1s inhibitor, human||ingredient_of
miconazole nitrate 2% suppository (product)||product containing miconazole in topical dosage form||ingredient_of
hydrochlorothiazide 25 mg [esidrix]||hidroclorotiazida||ingredient_of
ampicillin sodium 500 mg injection powder for solution [ampicillin novaplus]||ampicillin sodium (medication)||ingredient_of
nephrocaps qt disintegrating oral product||vitamin b a 05||ingredient_of
endosol extra ( sodium bicarbonate 0.025 meq/ml / sodium chloride 0.122 meq/ml / sodium phosphate, dibasic 0.42 mg/ml) ophthalmic solution||phosphoric acid, disodium salt||ingredient_of
acetaminophen 80 mg/ml oral solution||product containing acetaminophen||ingredient_of
dextromethorphan / guaiacolsulfonate / phenylephrine oral liquid product||morphinan, 3-methoxy-17-methyl-, (9alpha,13alpha,14alpha)-||ingredient_of
acebutolol oral tablet||n-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide||ingredient_of
amobarbital compounding powder||amylobarbitone sodium - chemical||ingredient_of
alteplase, recombinant 100 mg intravenous powder for solution [activase]||alteplase (product)||ingredient_of
opticaine, 0.5% ophthalmic solution||amethocaine hcl||ingredient_of
penicillin g injectable product||bencilpenicilina||ingredient_of
vitamin b/fe gluconate 50mg inj||thiamine hydrochloride||ingredient_of
phenylephrine hydrochloride/shark liver oil 0.25%-3% topical application ointment [prep-hem]||shark liver oil preparation (product)||ingredient_of
theophylline 150 mg||theophylline-containing product||ingredient_of
cholecalciferol / glucose oral gel||cholecalciferolum||ingredient_of
clonazepam 0.25 mg oral tablet,disintegrating||clonazepam-containing product||ingredient_of
nutren junior 1.0 liquid||milk (medication)||ingredient_of
d.a. 2mg-1.25mg-10mg chewable tablet||phenylephrine (as hydrochloride)||ingredient_of
policresulen 0.018 mg/mg||policresulen||ingredient_of
easy step (glucose) low control soln||glucose control||ingredient_of
guaiacolsulfonate / guaifenesin extended release oral tablet||guaiacolsulfonate||ingredient_of
multivitamins/fluoride 1mg/fa 0.3mg tab,chewable||thiamin nitrate||ingredient_of
hexatussin oral product||psi-ephedrin||ingredient_of
caffeine / chlorphenoxamine pill||contristamine||ingredient_of
doxorubicin 10 mg intravenous powder for injection||14-hydroxydaunorubicin hydrochloride||ingredient_of
product containing prochlorperazine maleate 10 mg/1 each oral tablet (clinical drug)||prochlorperazine maleate (medication)||ingredient_of
ferrous fumarate 20 mg/ml [feostat]||ferrous fumarate||ingredient_of
florfenicol / mometasone / terbinafine otic solution [claro]||florfenicol||ingredient_of
erythromycin ethylsuccinate 400 mg in 5 ml oral suspension||ethyl succinate, eyrthromycin||ingredient_of
lithium citrate 8 meq/5 ml oral solution||lithium-containing product||ingredient_of
penicillin g potassium 313 mg||benzyl penicillin||ingredient_of
insulin detemir 100 unt/ml||insulin detemir-containing product||ingredient_of
vandetanib oral tablet [caprelsa]||product containing vandetanib (medicinal product)||ingredient_of
clozapine oral suspension [versacloz]||clozapin||ingredient_of
dialyte/dextrose 1.5% soln||dextrose/peritoneal dialysis solution||ingredient_of
250 ml albumin human, usp 50 mg/ml injection||serum albumin, human||ingredient_of
nutrition supl glucerna/vanilla liquid||mn - manganese||ingredient_of
lomaira, 8 mg oral tablet||phentermine hydrochloride (substance)||ingredient_of
gambels oak pollen extract 1 mg/ml||gambels oak pollen extract||ingredient_of
bacillus calmette-guerin vaccine vial [bcg vaccine]||bcg tice||ingredient_of
butalbital 50 mg / aspirin 325 mg / caffeine 40 mg / codeine phosphate 30 mg oral capsule||butalbital (medication)||ingredient_of
ascorbic acid / cholecalciferol / ferrous sulfate / niacin / riboflavin / thiamine / vitamin a / vitamin b6 / vitamin e oral solution [poly-vi-sol with iron]||calciol||ingredient_of
dm 7.4mg/ipecac 0.17min/k guaiacolsulf 44mg/prometh 5mg syr||alcohol ethyl||ingredient_of
suvorexant 15 mg oral tablet, film coated [belsomra]||suvorexant product||ingredient_of
garlic oil cap||oil of garlic (substance)||ingredient_of
salicylic acid;urea 6%; 40% topical application foam [salvax duo]||carbamide||ingredient_of
dextromethorphan hydrobromide/guaifenesin/pseudoephedrine hydrochloride 15 mg/5 ml-100 mg/5 ml-30 mg/5 ml oral liquid||dextromethmorphan||ingredient_of
spherusol 1.27 mcg per 0.1 ml injectable solution||coccidioides immitis antigen||ingredient_of
pyrantel pamoate 144 mg in 1 ml oral suspension [walgreens pinworm medicine]||pin-away||ingredient_of
adrenaline- and prilocaine-containing product in parenteral dose form||o-methyl-2-propylaminopropionanilide||ingredient_of
product containing midazolam in parenteral dose form (medicinal product form)||product containing midazolam||ingredient_of
iopromide 240 mg i/ml injection solution 100ml bottle||iopromide (substance)||ingredient_of
phenazopyridine hydrochloride 100 mg oral tablet [phenazo hcl]||product containing phenazopyridine hydrochloride||ingredient_of
octreotide 10 mg [sandostatin]||bynfezia||ingredient_of
cefazolin na 40mg/ml/nacl 0.9% inj,bag,50ml||cephazolin, sodium||ingredient_of
syringe tuberculin 1cc 27g 1/2"||needles syringes||ingredient_of
allergenic extract, house dust 40000 pnu/ml inj||allergenic extract,house dust||ingredient_of
isoetharine hydrochloride, 0.1% inhalation solution||isoetarine hydrochloride||ingredient_of
collar,tan,sur-fit flex c#0225-20||ostomy collar||ingredient_of
camphor / capsicum extract / menthol topical lotion [inflammation otc deep pain care hot]||capsicum extract||ingredient_of
acetaminophen/diphenhydramine hydrochloride/pseudoephedrine hydrochloride 500 mg-25 mg-30 mg oral tablet [allergy sinus nighttime]||diphenhydramine hydrochloride||ingredient_of
aureomycin oral product||product containing chlortetracycline (medicinal product)||ingredient_of
norpace 100mg capsule||2-(1-(ammoniocarbonyl)-3-(diisopropylammonio)-1-phenylpropyl)pyridinium phosphate||ingredient_of
ivermectin/metronidazole/niacinamide top 1%-1%-4% topical gel||ivermectina||ingredient_of
urokinase 50000 unt/ml [kinlytic]||upa||ingredient_of
ethinyl estradiol and levonorgestrel in oral dosage form||product containing levonorgestrel||ingredient_of
bupivacaine+adrenaline 0.5%/1:200000 sterile wrapped injection||marcaine||ingredient_of
pouch,urostomy,lo-profile h#1419||bags urostomy||ingredient_of
premier value vitamin c 500mg chewable tablet (orange)||malpighia punicifolia extract||ingredient_of
allantoin / hexachlorophene / squalene topical product||allantoin (product)||ingredient_of
botulinum neurotoxin c immune fab2, equine 3000 unt||botulinum neurotoxin c immune fab2||ingredient_of
acetic/antipyrine/benzocaine/polycos otic||policosanol||ingredient_of
liqh, 100 mg/ml oral liquid||active q||ingredient_of
prezcobix 800 mg (as darunavir ethanolate ) / 150 mg oral tablet||cobicistat + darunavir||ingredient_of
benzocaine / cetylpyridinium / menthol / tannic acid mucous membrane topical solution [orasep]||benzocaina||ingredient_of
capsicum oleoresin topical gel||oleoresins of capsicum||ingredient_of
phosphorus/potassium/sodium 250 mg/1 packet-280 mg/1 packet-160 mg/1 packet oral powder for suspension [phosphorus-potassium-sodium]||phosphorus/potassium/sodium||ingredient_of
antipyrine 50 mg/ml / benzocaine 50 mg/ml / phenylephrine 2.5 mg/ml [tympagesic]||product containing phenylephrine||ingredient_of
pravachol, 20 mg oral tablet||pravasin||ingredient_of
aminosyn tpn 7%/electrolytes inj||valine (product)||ingredient_of
ascorbic acid / folic acid oral capsule||vitamina c||ingredient_of
cloxapen pill||cloxacilline||ingredient_of
magnesium oxide 420 mg||magnesia||ingredient_of
chlorpheniramine maleate 0.4 mg/ml / hydrocodone bitartrate 0.5 mg/ml / phenylephrine hydrochloride 1 mg/ml oral solution||r(-)-phenylephrine||ingredient_of
amylase 90,750unit/lipase 24,000unit/protease 86,250unit cap,ec||protease-containing product||ingredient_of
catherization set,foley w/o cath m#dynd10160||catherization set||ingredient_of
cough & cold, 4 mg-30 mg oral tablet||cough & cold||ingredient_of
dynamin brand of isosorbide mononitrate 10 mg oral tablet||dynamin brand of isosorbide mononitrate||ingredient_of
kit prep of technetum tc-99 mebrofenin inj||mebrofenine||ingredient_of
fluzone preservative-free 2011-2012, preservative-free trivalent intramuscular suspension||influenza, unspecified formulation||ingredient_of
salicylic acid in topical dosage form||salicylic acid [antifungal]||ingredient_of
asa 454/caff 33/cinnamedrine 15mg tab||aspirin + cinnamedrine + caffeine (medication)||ingredient_of
digoxin 0.05mg capsule (product)||cardiogoxin||ingredient_of
grapiprant 60 mg oral tablet [galliprant]||galliprant||ingredient_of
clidinium 2.5 mg oral capsule||clinidium bromide||ingredient_of
travoprost 0.03 mg/ml [izba]||product containing travoprost||ingredient_of
liraglutide pen injector [saxenda]||liraglutide (product)||ingredient_of
product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug)||dolutegravir sodium (substance)||ingredient_of
product containing precisely alvimopan 12 milligram/1 each conventional release oral capsule||trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine||ingredient_of
allantoin / sulfadiazine oral product||allantoin-containing product||ingredient_of
norethynodrel 5 mg||19-norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-, (17alpha)-||ingredient_of
dexchlorpheniramine / dextromethorphan / pseudoephedrine oral liquid product||gamma-(4-chlorophenyl)-n,n-dimethyl-2-pyridinepropanamine||ingredient_of
acetaminophen 32 mg/ml oral suspension [nanomol suspension]||paracetamolum||ingredient_of
chlordiazepoxide hcl 10mg cap,ud||libritaps||ingredient_of
suprax 150 mg chewable tablet||cefixima||ingredient_of
carbidopa / entacapone / levodopa oral tablet||entacapone (substance)||ingredient_of
levothyroxine sodium 250 microgram/1 each oral tablet||t>4< thyroxine sodium preparation||ingredient_of
isosource 1.5 cal liquid,250ml||thiamine(1+) ion||ingredient_of
phenylephrine/hydrocodone/cpm 10 mg-3.5 mg-2.5 mg/5 ml oral syrup||dihydrocodeinone bitartrate||ingredient_of
miconazole topical spray||miconazole nitrate (vaginal)||ingredient_of
roxicet, 325 mg-5 mg/5 ml oral solution||p-hydroxyacetanilide||ingredient_of
nepro carb steady liquid vanilla||soy lecithin (substance)||ingredient_of
calcium chloride / sodium fluoride / sodium phosphate, monobasic oral liquid product||mineral supplements sodium phosphate, monobasic||ingredient_of
product containing tranylcypromine in oral dosage form||(+-)-trans-2-phenylcyclopropylamine sulfate (2:1)||ingredient_of
pouch,drainable,sensura coloplast #11591||pouch,ostomy||ingredient_of
thyroglobulin 100 mg||thyroglobulin||ingredient_of
premier value pressure & pain & cold caplet||dextromethorphan hydrobromide (substance)||ingredient_of
suclear bowel prep kit||suclear||ingredient_of
clorazepate oral capsule [tranxene]||gen-xene||ingredient_of
sulfacetamide sodium 100 mg/ml / sulfur 50 mg/ml topical foam||clarifoam ef||ingredient_of
hydroxychloroquine sulfate 200 mg||hydroxychloroquine sulphate [anti malarial]||ingredient_of
goodsense nicotine, 2 mg oral transmucosal gum||nicorette white ice mint||ingredient_of
miconazole topical lotion [zeasorb]||product containing miconazole (medicinal product)||ingredient_of
electrolyte-r ph 7.4 solution||product containing magnesium chloride||ingredient_of
dressing,oasis meshed matrix 7x20cm||dressing,oasis||ingredient_of
guaifenesin/phenylephrine hydrochloride/phenylpropanolamine hydrochloride 100 mg/5 ml-5 mg/5 ml-20 mg/5 ml oral liquid [phenylfenesin]||crantex(obsolete)||ingredient_of
pectin 150 mg/ml||pectin (medication)||ingredient_of
phenobarbital 0.5 mg/ml||phenylethylmalonylurea||ingredient_of
magnesium citrate / magnesium oxide / potassium citrate / pyridoxine pill||potassium citrate (medication)||ingredient_of
penicillin v potassium 250 mg [v-cil-k]||penicillin v (medication)||ingredient_of
pouch,gentle touch system c#0209-29||urostomy bags||ingredient_of
meclizine oral tablet [verticalm]||meclizine||ingredient_of
catheter,external std uri-drain #732300||catheter, device (physical object)||ingredient_of
vitamin b/fe gluconate 20mg inj||vitamin b1 hydrochloride||ingredient_of
amlodipine besylate 10 mg / atorvastatin calcium 10 mg oral tablet, film coated [caduet]||atorvastatin calcium (medication)||ingredient_of
coal tar 10% topical application shampoo [x-seb t pearl]||sulfate, sodium dodecyl||ingredient_of
product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug)||palbociclib (substance)||ingredient_of
pantothenic acid / simethicone oral product||simeticone product||ingredient_of
ensure w/fiber liquid vanilla||na sodium||ingredient_of
dehydrocholic ac 125mg/homatropine 2.5mg/phenobarb 8mg tab||méthylbromure d'homatropine||ingredient_of
hytussin expectorant oral product||pseudoephedrinum||ingredient_of
bandage,viscopaste pb7 3in x 6.5yd sn#4948||zinc white||ingredient_of
cetalkonium chloride medicated shampoo||cetalkonium chloride (substance)||ingredient_of
product containing protriptyline hydrochloride 10 mg/1 each oral tablet (clinical drug)||protriptyline hydrochloride (substance)||ingredient_of
ethanol 0.738 ml/ml||grain alcohol||ingredient_of
alanine / arginine / aspartate / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / taurine / threonine / tryptophan / tyrosine / valine injectable product||product containing valine (medicinal product)||ingredient_of
hepatitis a vaccine, inactivated 360 el u/0.5 ml intramuscular suspension||hepatitis a vaccine (inactivated)||ingredient_of
acetaminophen/aloh/aspirin/caffeine/mgoh oral tablet||vtol||ingredient_of
guaifenesin/phenylpropanolamine hydrochloride 400 mg-75 mg oral tablet, extended release [guaipax]||guaiphenesin||ingredient_of
chlorpheniramine 2mg/phenylephrine 3mg elixir||chlorpheniramine phenylephrine||ingredient_of
brompheniramine maleate/hydrocodone bitartrate/pseudoephedrine hydrochloride 3 mg/5 ml-2.5 mg/5 ml-15 mg/5 ml oral solution [j-tan d hc]||hycodan||ingredient_of
pediasure liquid chocolate||product containing vitamin k<sub>1</sub> (medicinal product)||ingredient_of
dolorex forte 500mg-5mg capsule||dihydrocodeinone bitartrate||ingredient_of
cholecalciferol / folic acid oral product||cholecalciferol (vitamin d3)||ingredient_of
tapentadol pill||tapentadol hcl||ingredient_of
triphrocaps, vitamin b complex with c and folic acid oral capsule||vitamin b complex c||ingredient_of
brompheniramine maleate 2 mg in 10 ml / dextromethorphan hydrobromide 10 mg in 10 ml / phenylephrine hydrochloride 5 mg in 10 ml oral solution [cold and cough dm]||brompheniramine maleate (medication)||ingredient_of
apap 325 mg disintegrating oral tablet||paracetamol - chemical||ingredient_of
morphine sulph 100mg/5ml soln||narcotics morphine sulfate||ingredient_of
calcium citrate / calcium phosphate pill||calcium citrate (substance)||ingredient_of
hepatitis a vaccine (inactivated) strain hm175 1440 unt per 1 ml prefilled syringe||hepatitis a virus vaccine (product)||ingredient_of
amylase / lipase oral product||product containing amylase (medicinal product)||ingredient_of
alanine 8.8 mg/ml / arginine 4.89 mg/ml / calcium chloride 0.004 meq/ml / dibasic potassium phosphate 2.61 mg/ml / glucose 100 mg/ml / glycine 4.38 mg/ml / histidine 2.04 mg/ml / isoleucine 2.55 mg/ml / leucine 3.11 mg/ml / lysine 2.47 mg/ml / magnesium chloride 0.01 meq/ml / methionine 1.7 mg/ml / phenylalanine 2.38 mg/ml / proline 2.89 mg/ml / serine 2.13 mg/ml / sodium acetate trihydrate 2.97 mg/ml / sodium chloride 0.013 meq/ml / threonine 1.79 mg/ml / tryptophan 0.77 mg/ml / tyrosine 0.17 mg/ml / valine 2.47 mg/ml [clinimix e 4.25/10]||(s)-2-amino-3-hydroxy-propanoic acid||ingredient_of
isosorbide dinitrate 2.5mg sublingual tablet||product containing isosorbide dinitrate||ingredient_of
cerovite senior, therapeutic multiple vitamins with minerals oral tablet||multivitamin w/minerals||ingredient_of
alpha tocopherol 30 unt / vit-c 28 mg / cholecalciferol 400 unt / docosahexaenoic acid 300 mg / doss sodium 55 mg / ferrous fumarate 27 mg / folate 1.25 mg / vitamin b6 hydrochloride 25 mg / tricalcium phosphate 160 mg oral capsule||docusate (substance)||ingredient_of
cedar elm pollen extract 25 mg/ml||tree pollen-elm, cedar||ingredient_of
dph 25 mg/ml oral suspension [dilantin]||sodium phenytoin||ingredient_of
resource 2.0 liquid (orange creme)||vitamin b12 (substance)||ingredient_of
polythiazide-prazosin 0.5 mg-5 mg oral capsule||prazosin hydrochloride product (product)||ingredient_of
pseudoephedrine hcl 30 mg in 5 ml oral solution||isoephedrine hydrochloride||ingredient_of
tussigon pill||homatropina||ingredient_of
psyllium 3400 mg||metamucil||ingredient_of
aluminum acetate 0.005 mg/mg [domeboro cooling]||hydroxyaluminum di(acetate)||ingredient_of
gonadorelin injectable solution||fertagyl||ingredient_of
ethinyl estradiol-levonorgestrel, biphasic extended cycle oral tablet||oral contraceptives ethinyl estradiol||ingredient_of
aspirin 856 mg||2-acetoxybenzoic acid||ingredient_of
cyclogyl ophthalmic product||2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate||ingredient_of
sulfacetamide sodium 100 mg in 1 g / sulfur 50 mg in 1 g topical cream [sodium sulfacetamide and sulfur]||sulphur||ingredient_of
theophylline 450 mg||theophylline-containing product||ingredient_of
ginkgo 60 mg oral capsule||biloba ginkgo||ingredient_of
guaifenesin 600 mg||glycerol guaiacolate||ingredient_of
bupivacaine hcl@7.5 mg/ml@injection@ampul (ml)||bupivacaine hcl||ingredient_of
ketoconazole, compounding powder||kcz||ingredient_of
phenylephrine tannate/pyrilamine tannate/chlorpheniramine 25 mg-25 mg-8 mg oral tablet||tannate, phenylephrine||ingredient_of
amylases 25,000 unt / endopeptidases 25,000 unt / lipase 2000 unt / pancreatin 1000 mg delayed release oral tablet||triacylglycerol acylhydrolase||ingredient_of
heptanoic acid / iodine topical product||iodine-127||ingredient_of
benzoate / phenylacetate injection||acetic acid phenyl ester||ingredient_of
diphenhydramine hydrochloride 10 mg/ml||diphenhydramine hydrochloride [antihistamine] (substance)||ingredient_of
griseofulvin, ultramicrosize 250mg tablet (product)||griseofulvin, ultramicrocrystalline||ingredient_of
levomilnacipran 20 mg extended release oral capsule||levomilnacipran||ingredient_of
carboxymethylcellulose sodium 0.5% ophthalmic drops, solution||sodium carboxymethyl cellulose||ingredient_of
fesoterodine fumarate 8 mg oral tablet, extended release [toviaz]||fesoterodine fumarate (medication)||ingredient_of
product containing salbutamol in pulmonary dosage form||salbutamol [obstetric]||ingredient_of
benzocaine 20% oromucosal solution||benzocaine (otic) (medication)||ingredient_of
leader nite-time cold and flu softgel||acetaminophen / dextromethorphan / doxylamine / pseudoephedrine||ingredient_of
magnesium carbonate 27.5 mg/ml||magnesio carbonato||ingredient_of
chlorcyclizine / codeine / phenylephrine oral product||decongestants phenylephrine||ingredient_of
vital 1.0 cal liquid||activated 7-dehydrocholesterol (substance)||ingredient_of
codeine 10/apap 300/gg 100/ppa 25mg tab||codeine phosphate [analgesic] (substance)||ingredient_of
lipase / simethicone delayed release oral tablet||simethicone (substance)||ingredient_of
product containing only fluphenazine hydrochloride 5 mg/1 each oral tablet||fluphenazine hydrochloride (substance)||ingredient_of
magnesium carbonate / sodium bicarbonate oral capsule||magnesium carbonate (substance)||ingredient_of
meningococcal polysaccharide vaccine groups a & c comb. inj||neisseria meningitidis group y capsular polysaccharide antigen||ingredient_of
product containing certolizumab pegol in parenteral dose form (medicinal product form)||product containing certolizumab pegol (medicinal product)||ingredient_of
influenza a virus vaccine, a-victoria-361-2011 (h3n2)-like virus 0.03 mg/ml / influenza a-california-7-2009-(h1n1)v-like virus vaccine 0.03 mg/ml / influenza b virus vaccine, b-wisconsin-1-2010-like virus 0.03 mg/ml prefilled syringe||influenza a virus vaccine, a-victoria-361-2011 (h3n2)-like virus||ingredient_of
pennyroyal oil||pennyroyal oil||ingredient_of
sodium bicarbonate 325 mg||baking soda||ingredient_of
amnesteem, 40 mg oral capsule||cis-ra||ingredient_of
perampanel 8 mg||benzonitrile, 2-(1',6'-dihydro-6'-oxo-1'-phenyl(2,3'-bipyridin)-5'-yl)-||ingredient_of
docosaenoic acid 200 mg||docosaenoic acid||ingredient_of
hydrocortisone acetate 5 mg/ml / neomycin 3.5 mg/ml / polymyxin b 10000 unt/ml topical cream [cortisporin]||polymyxine b||ingredient_of
multivitamins/fluoride 0.125mg chew tab||vitamin b3||ingredient_of
quetiapine fumarate 50mg sa tab||ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-,(e)-2-butenedioate(2:1)(salt)||ingredient_of
maxifed-g (obsolete), 500 mg-60 mg oral tablet, extended release||ether, guaiacol glyceryl||ingredient_of
chlorpheniramine / guaifenesin / pseudoephedrine oral product||guaiacol glyceryl ether||ingredient_of
tafluprost 0.0045 mg in 0.3 ml ophthalmic solution/ drops [zioptan]||1-methylethyl (5z)-7-((1r,2r, 3r,5s)-2-((1e)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate||ingredient_of
ammonia nasal product||product containing ammonia||ingredient_of
diphenhydramine / pseudoephedrine oral capsule||product containing diphenhydramine (medicinal product)||ingredient_of
midol menstrual complete 500mg-60mg-15mg tablet||caffeine (medication)||ingredient_of
aspirin / butalbital / caffeine pill||5-isobutyl-5-allylbarbituric acid||ingredient_of
product containing precisely clonazepam 2 milligram/1 each conventional release orodispersible tablet (clinical drug)||product containing clonazepam||ingredient_of
hyoscyamine sulfate/phenobarbital 0.125 mg-15 mg oral tablet||hyoscyamine-phenobarbital||ingredient_of
attapulgite 50 mg/ml||palygorskite||ingredient_of
cyanocobalamin 0.1 mg oral tablet||b12 - cyanocobalamin||ingredient_of
salicylic acid / sulfur soap product||sulphur product||ingredient_of
duvelisib 15 mg [copiktra]||duvelisib (substance)||ingredient_of
dextromethorphan hydrobromide 7.5 mg||dextromethorfan||ingredient_of
vasopressin 20unt/ml injection (product)||vasopressin-containing product||ingredient_of
oxymetazoline hydrochloride 0.5 mg/ml||oxymetazoline (product)||ingredient_of
resource beneprotein pwdr||soy lecithin||ingredient_of
cath set,intermit 10fr h#96104||catherization set||ingredient_of
codeine phosphate 2 mg/ml||guaifenesin - chemical||ingredient_of
sargramostim 250 mcg intravenous powder for solution [prokine]||sagramostim||ingredient_of
multivitamins/iron 10mg/ml (sf) drops,oral||multivitamin with iron||ingredient_of
psyllium oral powder product||psyllium-containing product||ingredient_of
papain 830000 unt / urea 0.1 unt/mg topical ointment [gladase]||harnstoff||ingredient_of
apomorphine compounding powder||(-)-10,11-dihydroxyaporphine||ingredient_of
product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral tablet||omeprazolum||ingredient_of
beclomethasone dipropionate 0.08 mg/1 actuation inhalation aerosol liquid [qvar]_#2||beclomethasone dipropionate preparation (substance)||ingredient_of
fentora 800 mcg buccal tablet||fentanyl citrate||ingredient_of
glucose- and potassium chloride- and sodium chloride-containing product in parenteral dose form||sodium chloride eye||ingredient_of
sodium picosulfate/magnesium oxide/citric acid 10 mg-3.5 gram-12 gram/160 ml oral solution, oral||citric acid- and magnesium oxide- and sodium picosulfate-containing product||ingredient_of
orbivan pill||orbivan||ingredient_of
colistin / furazolidone pill||colimycin||ingredient_of
promethazine hydrochloride 10 mg||prometazina||ingredient_of
dextromethorphan hydrobromide 10mg/5ml, guaifenesin 100mg/5ml oral solution||menthol (product)||inactive_ingredient_of
titanium dioxide 9.0 g in 100 ml / zinc oxide 6.3 g in 100 ml topical cream [your skin but better cc color correcting full coverage spf 50 medium-tan]||citric acid monohydrate (substance)||inactive_ingredient_of
anodynz medicated biofrequency chip 5%-0.0375% patch||aloe vera leaf||inactive_ingredient_of
avobenzone 30 mg in 1 ml / octocrylene 42 mg in 1 ml / octinoxate 75 mg in 1 ml topical cream [recapture 360 day plus ir defense]||polyethylene glycol 2000 sorbitan laurate||inactive_ingredient_of
product containing precisely cyclobenzaprine hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug)||hydroxypropyl cellulose (1200000 mw)||inactive_ingredient_of
menthol 70 mg in 1 ml topical liquid [brazilian heat brazilian heat]||coconut oil bp||inactive_ingredient_of
benzalkonium chloride 1 g in 59 g topical gel [blueberry scented hand sanitizer emoji smile tongue]||ölsüß||inactive_ingredient_of
lansoprazole 30mg cap,sa||peg-400||inactive_ingredient_of
product containing precisely somatropin(rbe) 800 microgram/1 syringe powder for conventional release solution for injection (clinical drug)||monobasic sodium phosphate anhydrous||inactive_ingredient_of
levaquin 500 mg oral tablet||iron oxide red||inactive_ingredient_of
benzoyl peroxide 1.25 g in 25 g topical cream||product containing allantoin (medicinal product)||inactive_ingredient_of
benzoyl peroxide 1.5 g in 60 g topical lotion [equate repairing]||pantothenol||inactive_ingredient_of
aluminum zirconium tetrachlorohydrex gly 15.2 g in 100 g topical stick [dove go sleeveless original clean antiperspirant and deodorant]||calendula flower||inactive_ingredient_of
alcohol 70 ml in 100 ml topical liquid [evaxo 70% ethyl rubbing alcohol]||fd&c red#40||inactive_ingredient_of
calcium carbonate 750 mg oral tablet, chewable [extra strength antacid]||acid phosphoric||inactive_ingredient_of
alcohol 62 ml in 100 ml topical liquid [holiday wonders frosted marshmallow antibacterial hand sanitizer]||product containing isopropyl myristate||inactive_ingredient_of
avobenzone 30 g in 1000 g / octinoxate 75 g in 1000 g / petrolatum 402 g in 1000 g topical ointment [intense therapy lip balm winter melon]||theobroma cacao (cocoa) seed butter||inactive_ingredient_of
mucomyst-10 100 mg/ml inhalation solution||sodium hydrate||inactive_ingredient_of
octinoxate 3.25 g in 50 ml / titanium dioxide 1.765 g in 50 ml topical lotion [botanic twenty daily sunblock spf50]||lonicera japonica flower extract||inactive_ingredient_of
zinc oxide 127 mg in 1 g topical powder [mineral sunscreen lip gloss - tropical punch]||mica||inactive_ingredient_of
metformin hydrochloride 500 mg oral tablet||dibasic magnesium stearate||inactive_ingredient_of
sage 3 [hp_x] in 1 ml / angelica archangelica root 5 [hp_x] in 1 ml / hyoscyamus niger leaf 7 [hp_x] in 1 ml / ferrous disulfide 7 [hp_x] in 1 ml / silver 15 [hp_x] in 1 ml / hyacinthus orientalis whole 17 [hp_x] in 1 ml oral liquid||lactose (product)||inactive_ingredient_of
sertraline hydrochloride 100 mg oral tablet [sertraline hydrochloride]||polyoxyethylenes||inactive_ingredient_of
alfuzosin hydrochloride, 10 mg oral tablet, extended release||cellulose powders||inactive_ingredient_of
avobenzone 3 g in 100 g / homosalate 8 g in 100 g / octisalate 4 g in 100 g / octocrylene 5 g in 100 g topical cream [olay regenerist whip active moisturizer broad spectrum spf 25 sunscreen]||alcohol cetyl||inactive_ingredient_of
avobenzone 30 mg in 1 g / homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 100 mg in 1 g topical spray [neutrogena beach defense water plus sun protection sunscreen broad spectrum spf 60 plus]||acrylate/isobutyl methacrylate/n-tert-octylacrylamide copolymer (75000 mw)||inactive_ingredient_of
quineprox 200 mg oral tablet||polyethylene glycol 4000-containing product||inactive_ingredient_of
avobenzone 0.0003 g in 1 g / octisalate 0.0003 g in 1 g / zinc oxide 0.01 g in 1 g / octinoxate 0.071 g in 1 g / oxybenzone 0.02 g in 1 g topical lipstick [cy better lips balm humectante para labios con color fps 18 (choco therapy) - brown]||fd & c red no. 40||inactive_ingredient_of
octinoxate 0.075 g in 1 g topical lipstick [esika pro perfect match volumen spf 20 plus lip liner for maximum fullness - (fresa energy) - red]||dipentaerythrityl hexacaprylate||inactive_ingredient_of
triclosan 1.15 mg in 1 ml topical liquid [antibacterial]||sodium laureth-3 sulfate||inactive_ingredient_of
pregabalin 300mg oral capsule||ferric oxide||inactive_ingredient_of
avobenzone 3 g in 100 ml / homosalate 3 g in 100 ml / octinoxate 5 g in 100 ml / octocrylene 2.6 g in 100 ml topical lotion [careone daily moisturizer broad spectrum spf15 sunscreen]||glycerin product||inactive_ingredient_of
ramipril 2.5mg capsule (substance)||titanium dioxide-containing product||inactive_ingredient_of
24 hr quetiapine 400 mg extended release oral tablet||sodium chloride-containing product||inactive_ingredient_of
methocarbamol@500 mg@oral@tablet||sodium starch glycolate type a potato||inactive_ingredient_of
aripiprazole 5 mg oral tablet [aripiprazole]||magnesium octadecanoate||inactive_ingredient_of
pregabalin 75 mg oral capsule [lyrica]||ferriferrous oxide||inactive_ingredient_of
calendula officinalis flowering top 12 [hp_x] in 1 ml / croton tiglium seed 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / plantago major 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / sarsaparilla 30 [hp_x] in 1 ml topical spray [headache pain and sinus pressure relief]||achillea millefolium extract (substance)||inactive_ingredient_of
ditropan xl, 5 mg/24 hours oral tablet, extended release||ethyl acrylate (substance)||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [aerium hand sanitizer 70% 250ml]||terpineol (substance)||inactive_ingredient_of
renvela, carbonate 800 mg oral tablet||talc (product)||inactive_ingredient_of
cvs infants' ibuprofen 50mg/1.25ml concentrated drops (berry)||citric acid,anhydrous||inactive_ingredient_of
octisalate 5 g in 100 ml / zinc oxide 9.1 g in 100 ml / octocrylene 10 g in 100 ml topical lotion [daily defense spf 50]||1,3-butylene glycol||inactive_ingredient_of
periplaneta americana 0.1 g in 1 ml / blattella germanica 0.1 g in 1 ml percutaneous injection, solution||sinucleanse||inactive_ingredient_of
lotrel, 5 mg-20 mg oral capsule||sls||inactive_ingredient_of
potassium chloride 750 mg oral capsule, extended release [potassium chloride]||dibutylsebacate||inactive_ingredient_of
acetaminophen 650 mg in 20 ml / dextromethorphan hydrobromide 20 mg in 20 ml / guaifenesin 400 mg in 20 ml / phenylephrine hydrochloride 10 mg in 20 ml oral liquid [mucus relief cold, flu and sore throat]||water product (product)||inactive_ingredient_of
product containing only disopyramide 100 mg/1 each oral capsule (clinical drug)||azo fuchsine||inactive_ingredient_of
alcohol 0.62 ml in 1 ml topical gel [1902 hand sanitizer]||d&c red 33||inactive_ingredient_of
alcohol 0.8 ml in 1 ml topical solution [sd kleen rx antiseptic hand rub]||recticare advanced wipes||inactive_ingredient_of
octinoxate 7 g in 100 g / titanium dioxide 3.5 g in 100 g / zinc oxide 1.95 g in 100 g topical cream [take cover anti-aging foundation light]||cetyl peg-ppg-10-1 dimethicone (hlb 2)||inactive_ingredient_of
titanium dioxide 1.8 g in 100 g / zinc oxide 2 g in 100 g topical lipstick [california naturel lip balm spf 8]||2-methyl-heptadecanoic acid||inactive_ingredient_of
clotrimazole 1 g in 100 g topical cream [meijer clotrimazole antifungal]||1,2,3-trihydroxypropane||inactive_ingredient_of
sumatriptan 50mg tablet||microcrystaline cellulose||inactive_ingredient_of
avobenzone 2 g in 100 ml / homosalate 5.5 g in 100 ml / octisalate 4.5 g in 100 ml / octocrylene 4 g in 100 ml topical lotion [sunscreen spf 30 meijer]||mica||inactive_ingredient_of
quercus virginiana pollen 10000 [pnu] in 1 ml subcutaneous injection, solution||water (substance)||inactive_ingredient_of
omeprazole 20 mg oral capsule, delayed release (obs 06-25-01)||sodium dodecyl sulfate||inactive_ingredient_of
acetaminophen 500 mg / diphenhydramine hydrochloride 25 mg oral tablet, coated [non aspirin pm extra strength]||microcrystalline celluose||inactive_ingredient_of
water 98.6 ml per 100 ml ophthalmic irrigation solution||polyhexamethylenbiguanide||inactive_ingredient_of
cyclobenzaprine hydrochloride 5 mg oral tablet [cyclobenzaprine hydrochloride]||wax, carnauba||inactive_ingredient_of
acetaminophen 160 mg in 5 ml oral suspension [topcare childrens pain and fever]||propanetriol||inactive_ingredient_of
cimetidine 800mg tab,ud||polysorbate 80s||inactive_ingredient_of
premier value naproxen sodium 220mg tablet||c18:0||inactive_ingredient_of
triamcinolone acetonide 0.5 mg in 1 g topical ointment||lanolin simple alcohols||inactive_ingredient_of
menthol 2.2 g in 100 g topical cream [jack black performance remedy dragon ice]||honeysuckle flower extract||inactive_ingredient_of
product containing only allopurinol 100 mg/1 each oral tablet||starch 1500||inactive_ingredient_of
amlodipine (as amlodipine besilate) 5 mg and atorvastatin (as atorvastatin calcium) 80 mg oral tablet||calcarea carbonica||inactive_ingredient_of
product containing diltiazem hydrochloride 90 mg/1 each oral tablet||fd&c blue no. 1.||inactive_ingredient_of
octinoxate 0.075 g in 1 g / zinc oxide 0.0392 g in 1 g topical lipstick [esika pro hidracolor 3 in 1 moisturizing, color and perfecting effect spf 25 (nude savanna) - orange]||titanium dioxide (product)||inactive_ingredient_of
mineral ice 100 mg/ml topical foam||sodium chloride (nacl)||inactive_ingredient_of
xanthium strumarium pollen 0.05 g in 1 ml percutaneous injection, solution [pollens - weeds and garden plants, cocklebur xanthium strumarium]||glycerol (product)||inactive_ingredient_of
minocycline 100 mg oral tablet [dynacin]||povidone [mouth] (substance)||inactive_ingredient_of
granisetron hydrochloride 1mg/1ml solution for injection_#1||nasal sodium chloride||inactive_ingredient_of
octinoxate 75 mg in 1 g / oxybenzone 40 mg in 1 g topical salve [carmex daily care moisturizing lip balm wintergreen spf 15]||cetyl esters wax||inactive_ingredient_of
lacosamide 100mg tablet (product)||alcohol polyvinyl||inactive_ingredient_of
loratadine 10 mg / pseudoephedrine sulfate 240 mg oral tablet, film coated [allergy and congestion relief non drowsy]||poly(mannuronic acid), sodium salt||inactive_ingredient_of
zinc oxide 10 g in 17.5 ml / octinoxate 7.5 g in 17.5 ml topical cream [sunscreen broad spectrum spf 50 vitality institute]||pummelo extract||inactive_ingredient_of
octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - rose damour]||palmitic acid,2-ethylhexyl ester||inactive_ingredient_of
cephalexin anhydrous 500 mg oral capsule||potassium hydroxide (substance)||inactive_ingredient_of
bupropion hydrochloride 300 mg oral tablet, film coated, extended release [bupropion hydrochloride (xl)]||product containing propylene glycol||inactive_ingredient_of
.gamma.-aminobutyric acid 100 mg oral capsule [theramine 60]||gelatin substance||inactive_ingredient_of
asa 845 mg / caffeine 65 mg oral powder [bc original formula]||d-(-)-mannitol||inactive_ingredient_of
causticum 3 [hp_x] oral granule [causticum]||sucrose preparation (substance)||inactive_ingredient_of
hydrocortisone 0.005 mg/mg topical ointment||fd&c blue no. 1.||inactive_ingredient_of
duloxetine hydrochloride 60 mg oral capsule, delayed release [duloxetine]||lacca||inactive_ingredient_of
chelidonium majus 3 [hp_x] in 1 g / dryopteris filix-mas root 3 [hp_x] in 1 g / pteridium aquilinum whole 3 [hp_x] in 1 g / salix purpurea bark 3 [hp_x] in 1 g / willow bark 3 [hp_x] in 1 g / asplenium scolopendrium top 3 [hp_x] in 1 g / solidago canadensis flowering top 3 [hp_x] in 1 g / taraxacum palustre root 3 [hp_x] in 1 g topical cream||lavender oil bulgaria||inactive_ingredient_of
panthenol 1.5 g in 100 ml / glycerin 0.1159 g in 100 ml / dimethicone 1 g in 100 ml topical cream [banacos centellamide cica peptidecream]||lacolin||inactive_ingredient_of
acetaminophen+oxycodone hydrochloride 325mg/5mg solution||water product (product)||inactive_ingredient_of
mycophenolate mofetil 500 mg oral tablet [cellcept]||peg-400||inactive_ingredient_of
eucalyptol 0.92 mg in 1 ml / menthol 0.42 mg in 1 ml / methyl salicylate 0.6 mg in 1 ml / thymol 0.64 mg in 1 ml oral liquid [marcs original]||ethanol (substance)||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [trumed hand sanitizer]||p-oxybenzoesauremethylester||inactive_ingredient_of
zinc oxide 13 g in 100 g topical cream [s-cream zinc oxide 13%]||sulfate, magnesium||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [cvs hand sanitizer]||carbomer 980||inactive_ingredient_of
amaranthus tuberculatus pollen 40000 [pnu] in 1 ml subcutaneous injection, solution [amaranthus tuberculatus pollen]||phoh||inactive_ingredient_of
octinoxate 1.07 g in 21 ml / titanium dioxide 0.3 g in 21 ml topical emulsion [cle de peau beaute radiant foundation n o100]||p-oxybenzoesauremethylester||inactive_ingredient_of
product containing chlorpromazine hydrochloride 50 mg/1 each oral tablet (clinical drug)||product containing calcium sulfate||inactive_ingredient_of
octinoxate 70 mg in 1 g / titanium dioxide 41.5 mg in 1 g / zinc oxide 98 mg in 1 g topical emulsion [capture dreamskin fresh and perfect cushion with sunscreen broad spectrum spf 50 025]||trihydroxypropane||inactive_ingredient_of
product containing metformin hydrochloride 1000 milligram/1 each oral tablet||lactose product||inactive_ingredient_of
venlafaxine hcl 150mg 24hr cap,sa,ud||polyethylene glycol-400||inactive_ingredient_of
salicylic acid 20 mg in 1 ml topical shampoo [equate anti dandruff]||coconut oil - herbal supplement||inactive_ingredient_of
simethicone 125mg chewable tablet||trichlorogalactosucrose||inactive_ingredient_of
diltiazem (inwood) 180mg sa cap||triethyl 2-hydroxy-1,2,3-propanetricarboxylate||inactive_ingredient_of
product containing terazosin hydrochloride 5 mg/1 each oral capsule (clinical drug)||d&c red # 28||inactive_ingredient_of
zinc oxide 20 g in 100 g topical stick [premium natural sunscreen broad spectrum spf 30 baby bum]||ricinus communis oil||inactive_ingredient_of
methylphenidate hydrochlorid 10mg tablet (product)||magnesium sterate||inactive_ingredient_of
nystatin 100,000 units/ml oral suspension sugar free (product)||sodium citrate monobasic||inactive_ingredient_of
duloxetine (as duloxetine hydrochloride) 30 mg gastro-resistant oral capsule||steritalc||inactive_ingredient_of
cocoa butter 2211 mg / phenylephrine hydrochloride 6.5 mg rectal suppository [equaline hemorrhoidal]||modified corn starch (1-octenyl succinic anhydride)||inactive_ingredient_of
aluminum sesquichlorohydrate 0.136 g in 1 ml topical liquid [pulso antiperspirant roll-on deodorant]||steareth-21||inactive_ingredient_of
bromocriptine mesylate 2.5 milligram in 1 tablet oral tablet||povidone-containing product||inactive_ingredient_of
glipizide 5 mg oral tablet, extended release [glipizide er]||dioxide, silicon||inactive_ingredient_of
menthol 1.4 g in 100 g topical cream [topical analgesic]||(2r,4'r,8'r)-alpha-tocopheryl acetate||inactive_ingredient_of
gnp ibuprofen 200mg caplet||indian red||inactive_ingredient_of
benzalkonium chloride 0.115 g in 100 g topical liquid [assured antiseptic wet wipes vitamin e and aloe]||methylchloroisothiazolinone||inactive_ingredient_of
flibanserin 100mg tab,oral||magnesium stearate||inactive_ingredient_of
losartan pot 25 mg oral tablet||hydroxypropyl cellulose (1600000 wamw)||inactive_ingredient_of
lidocaine hydrochloride 40 mg in 1000 mg topical cream [extra strength naturally hl foot care]||aloe barbadensis leaf extract||inactive_ingredient_of
octinoxate 4 g in 100 g / zinc oxide 2.4 g in 100 g topical cream [studio look base de alta cobertura para el rostro con fps 20 toffee 240-c]||yellow iron oxide||inactive_ingredient_of
emend, 125 mg oral capsule||product containing gelatin||inactive_ingredient_of
fexofenadine hydrochloride/pseudoephedrine hydrochloride 60 mg-120 mg oral tablet, extended release||lactose monohydrte||inactive_ingredient_of
product containing precisely loxapine 50 milligram/1 each conventional release oral capsule (clinical drug)||glycol, propylene||inactive_ingredient_of
guaifenesin 400 mg / dextromethorphan hydrobromide 20 mg oral capsule, liquid filled [mucus relief dm]||methylethyl glycol||inactive_ingredient_of
calcium carbonate 750 mg oral tablet, chewable [topcare antacid calcium extra strength]||product containing cornflour (medicinal product)||inactive_ingredient_of
terazosin hcl 1mg cap ud||ferriferrous oxide||inactive_ingredient_of
product containing ursodeoxycholic acid 300 mg/1 each oral capsule||pigment white 6||inactive_ingredient_of
phentermine hydrochloride 37.5mg tablet (product)||calcium phosphate, dibasic, hydrous||inactive_ingredient_of
factor ix human recombinant, threonine 148 1,000 unit intraven vial (ea)||d-(-)-mannitol||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [avant ex]||carbomer homopolymer, unspecified type||inactive_ingredient_of
doxorubicin hydrochloride 10mg/vial injection (product)||muriaticum acidum / hydrochloric acid||inactive_ingredient_of
octinoxate 0.066 g in 1 g / oxybenzone 0.015 g in 1 g topical lipstick [esika extreme moisturizing spf 16 (coral chic) - pink]||glycerin-containing product||inactive_ingredient_of
avobenzone 2.2 g in 100 ml / octinoxate 7.5 g in 100 ml topical lotion [jack black the supreme shave]||dulse extract||inactive_ingredient_of
fexofenadine hcl 60mg tab,ud||iron oxide yellow||inactive_ingredient_of
benzalkonium chloride 0.005 mg in 1 ml topical liquid [pro-link antibacterial plum perfection foam so ap]||1,2 propanediol||inactive_ingredient_of
sodium fluoride 0.559 mg in 1 ml oral mouthwash [xerostom]||chlorophylls||inactive_ingredient_of
alcohol 65.76 ml in 100 ml topical gel [rhino pure]||glycerin (obsolete)||inactive_ingredient_of
cyproheptadine hcl 2mg/5ml syrup||tootsweet||inactive_ingredient_of
sennosides 8.6 mg oral tablet, film coated [senna standardized senna concentrate 8.6 mg sennosides each]||magnesium searate||inactive_ingredient_of
gleevec 100mg tablet||titanium dioxide||inactive_ingredient_of
ethinyl estradiol 0.035mg/norgestimate 0.18mg tablet||polyvinylalcohol||inactive_ingredient_of
fenofibrate 48 mg oral tablet, coated||polyvinyl alcohol, unspecified||inactive_ingredient_of
lidocaine 9 g in 100 g topical patch [medium pain relief patches]||polyacrylic acid (300000 mw)||inactive_ingredient_of
fluoxetine hydrochloride/olanzapine 50 mg-12 mg oral capsule||gelatina||inactive_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 50 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [vichy laboratories liftactiv peptide-c spf 30 phyto peptides vitamin c]||dicaprylyl carbonate||inactive_ingredient_of
octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - orange delirant]||isostearyl neopentanoate||inactive_ingredient_of
diabetic tuss dm, 10 mg-100 mg/5 ml oral liquid||methyl 4-hydroxybenzoate||inactive_ingredient_of
aspirin-methocarbamol, 325 mg-400 mg oral tablet||croscarmellose sodium||inactive_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [cold, flu and sore throat maximum strength]||propyl hydroxybenzoate||inactive_ingredient_of
acetaminophen 250 mg / chlorpheniramine maleate 2 mg / dextromethorphan hbr 10 mg / phenylephrine hcl 5 mg oral capsule||product containing gelatin (medicinal product)||inactive_ingredient_of
ethinyl estradiol 10 microgram oral tablet||peg 8o00||inactive_ingredient_of
sus scrofa skin 8 g in 100 g topical liquid [pige ll real skin mask pack]||(2s)-alpha-leucine||inactive_ingredient_of
benzalkonium chloride 1.3 mg in 1 g topical cloth [visibly clean antibacterial wet wipes fresh lemonade]||glyzerin||inactive_ingredient_of
benzalkonium chloride 0.006 g topical solution [purelogic antibacterial wipes refreshing aloe 2 travel packs]||2 phenoxyethanol||inactive_ingredient_of
gabapentin@400 mg@oral@capsule||2-hydroxypropanol||inactive_ingredient_of
octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - saumon essentiel]||candelilla wax||inactive_ingredient_of
homosalate 15 ml in 100 ml / octisalate 5 ml in 100 ml / oxybenzone 6 ml in 100 ml / avobenzone 2 ml in 100 ml topical lotion [no-ad 60 sunscreen]||tocopherol acetate||inactive_ingredient_of
menthol 50 mg in 1 g / camphor (synthetic) 30 mg in 1 g topical cream [china-gel topical pain reliever]||hamamelis virginiana leaf||inactive_ingredient_of
titanium dioxide 28 mg in 1 ml topical emulsion [clarins everlasting youth fluid broad spectrum spf 15 titanium dioxide sunscreen illuminating and firming foundation 110]||methyl trimethicone||inactive_ingredient_of
alcohol 75 ml in 100 ml topical solution [body prescriptions antibacterial hand sanitizer strawberry scented]||tris(β-hydroxyethyl)amine||inactive_ingredient_of
avobenzone 2.7 g in 100 g / octisalate 4 g in 100 g / homosalate 9 g in 100 g / octocrylene 5 g in 100 g topical lotion [hawaiian tropic antioxidant sunscreen spf 50 broad spectrum]||sodium ascorbyl monophosphate||inactive_ingredient_of
product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug)||silicon dioxide (substance)||inactive_ingredient_of
flex24 performance (camphor 3 % / menthol 2.52 % ) medicated patch||boo-boo magic||inactive_ingredient_of
titanium dioxide 18.8 mg in 1 g topical cream [neutrogena healthy skin brightening eye perfector sunscreen broad spectrum spf25 - medium 15]||cyclomethicone 5||inactive_ingredient_of
salicylic acid 2 mg in 100 ml topical shampoo [fyenacel calming shooter cellandir hair loss-shampoo]||2-amino-3-hydroxypropionic acid||inactive_ingredient_of
benzalkonium chloride 1 mg in 1 ml topical soap [new wave cleaning solutions foaming hand sanitizer]||citric acid monohydrate (substance)||inactive_ingredient_of
product containing ezetimibe 10 mg/1 each oral tablet||product containing hypromellose (medicinal product)||inactive_ingredient_of
tamsulosin hydrochloride 400micrograms m/r capsule (substance)||triacetin||inactive_ingredient_of
octinoxate 0.05 g in 1 g / titanium dioxide 0.042 g in 1 g topical cream [tinted moisturizer spf20 medium]||c12-15 alkyl benzoate||inactive_ingredient_of
benzoic acid 0.1 g in 100 g topical cloth [eyelids wipes]||citric acid monohydrate (substance)||inactive_ingredient_of
caffeine 200 mg oral tablet, film coated [stay awake maximum strength]||maltodextrin||inactive_ingredient_of
dimethicone 20 mg in 1 g / octinoxate 75 mg in 1 g / oxybenzone 40 mg in 1 g topical stick [softlips oasis pineapple coconut, peach mango, strawberry kiwi]||porphyra umbilicalis||inactive_ingredient_of
octinoxate 1617 mg in 30 ml / titanium dioxide 825 mg in 30 ml topical cream [cle de peau beaute radiant fluid foundation b20]||xylitol||inactive_ingredient_of
amitriptyline hydrochloride 10 mg oral tablet, film coated||cellulose, microcrystalline||inactive_ingredient_of
benzalkonium chloride 1.3 mg in 1 ml topical solution [7 select cold sore symptom treatment]||dimethylol-5,5-dimethylhydantoin||inactive_ingredient_of
alcohol 0.7 ml in 1 ml topical gel [mamtec hand sanitizer]||2,2',2''-nitrilotriethanol||inactive_ingredient_of
glycerin 10.0028 g in 100 ml / dimethicone 2 g in 100 ml topical lotion [banacocica-aid centella peptide emulsion]||n5-(aminocarbonyl)-l-ornithine||inactive_ingredient_of
titanium dioxide 3.95 g in 100 g topical cream [organic wear 100% natural origin tinted moisturizer spf 15]||soy lecithin (substance)||inactive_ingredient_of
sodium monofluorophosphate 1 mg in 1 g dental gel, dentifrice [colgate sparkling white mint zing]||titanium white||inactive_ingredient_of
hydroquinone 2 g in 100 g topical cream [clear-n-smooth]||omc cinnamate||inactive_ingredient_of
osimertinib 40 oral tablet, film coated [tagrisso]||talcum powder||inactive_ingredient_of
guaifenesin 200 mg oral tablet [organ-i nr]||octadecanoic acid, magnesium salt||inactive_ingredient_of
nicotine 2 mg oral lozenge [nicotine polacrilex lozenge mint]||acesulfame potassium||inactive_ingredient_of
octinoxate 75 mg in 1 g / octisalate 50 mg in 1 g / titanium dioxide 20 mg in 1 g topical stick [napoleon perdis foundation broad spectrum spf 15 look 4]||aloe barbadensis leaf extract||inactive_ingredient_of
alcohol 0.62 ml in 1 ml topical gel [antiseptic hand sanitizer gel]||floril redness relief||inactive_ingredient_of
xylocaine 2 % mucous membrane topical solution||product containing methyl 4-hydroxybenzoate (medicinal product)||inactive_ingredient_of
nifediac cc 30 mg 24hr extended release oral tablet||hydroxyethyl cellulose (140 cps at 5%)||inactive_ingredient_of
benzalkonium chloride 1.3 mg in 1 ml topical liquid [covex antibacterial liquid hand wash cool protection]||polyquaternium-10 (30000 mpa.s at 2%)||inactive_ingredient_of
hydroxyzine hcl 25 mg oral tablet||sodium starch glycolate type a potato||inactive_ingredient_of
altace, 10 mg oral capsule||óxido de titanio(4)||inactive_ingredient_of
ondansetron hydrochloride, 8 mg oral tablet||cross linked sodium carboxymethylcellulose||inactive_ingredient_of
alcohol 75 ml in 100 ml topical gel [jmc hunt instant hand sanitizer]||perhydrosqualene||inactive_ingredient_of
doxycycline hyclate 100mg capsule (product)||titanium white||inactive_ingredient_of
aspirin 325 mg / omeprazole 40 mg oral tablet, film coated [aspirin and omeprazole delayed-release tab]||fatty acid 18:0||inactive_ingredient_of
codeine 12mg/acetaminophen 120mg/5ml elixir||anhydrous citric acid||inactive_ingredient_of
octinoxate 7.5 g in 100 ml / oxybenzone 2 g in 100 ml topical cream [timeless illuminating makeup spf 30 ivory merle norman]||medium chain trigylcerides||inactive_ingredient_of
salt cedar pollen extract 1 mg/ml injectable solution||phenylic acid||inactive_ingredient_of
alcohol 77.5 ml in 125 ml topical swab [hand sanitizer]||(+)-alpha-tocopherol acetate||inactive_ingredient_of
cefaclor 500 mg oral capsule [cefaclor]||monopropylene glycol||inactive_ingredient_of
octinoxate 0.07 g in 1 ml / titanium dioxide 0.0244 g in 1 ml topical lotion [lbel effet parfait signs of age appearance minimizer foundation spf 20 fm obscure 9 - brown]||acetate, tocopherol||inactive_ingredient_of
pyrithione zinc 10 mg in 1 ml topical liquid [daylogic 2in1 dandruff dry scalp care]||salting||inactive_ingredient_of
pyrithione zinc 1 ml in 100 ml topical liquid [safeway dandruff classic clean]||product containing water||inactive_ingredient_of
triclosan 0.1500 ml in 100.0000 ml topical soap [antibacterial hand]||edetate disodium (product)||inactive_ingredient_of
nicotine 4 mg oral gum, chewing [health mart nicotine polacrilex]||sodio bicarbonato||inactive_ingredient_of
levothyroxine sodium 0.088mg tablet||cornflour||inactive_ingredient_of
product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug)||octadecanoic acid, magnesium salt||inactive_ingredient_of
sodium fluoride 0.05 g in 100 ml oral rinse [family wellness kids anticavity]||polysorbate 80s||inactive_ingredient_of
avobenzone 2.7 g in 100 ml / octinoxate 6.99 g in 100 ml / octocrylene 2 g in 100 ml topical cream [ultimate miracle worker multi-rejuvenating spf 30]||α-hydroxyacetic acid||inactive_ingredient_of
zinc oxide 10.5 g in 100 g topical stick [lip balm]||d-alpha-tocopherol||inactive_ingredient_of
nitrofurantoin 50mg capsule (product)||titanium dioxide product||inactive_ingredient_of
octocrylene 5 g in 100 g / homosalate 9 g in 100 g / octisalate 4 g in 100 g / avobenzone 2.7 g in 100 g topical lotion [hawaiian tropic sheer touch sunscreen ultra radiance broad spectrum spf 50]||titanium white||inactive_ingredient_of
zinc oxide 132 mg in 1 ml topical lotion [ilia super serum skin tint (st16 pavones)]||shea butter||inactive_ingredient_of
alcohol 0.75 ml in 1 ml topical gel [activex antibacterial hand sanitizer active]||denatonium benzoate||inactive_ingredient_of
aluminum zirconium tetrachlorohydrex gly 15.2 g in 100 g topical stick [dove go sleeveless nourished beauty antiperspirant and deodorant]||bht - butyl hydroxytoluene||inactive_ingredient_of
avobenzone 1.25 g in 50 ml / octinoxate 3.745 g in 50 ml / oxybenzone 0.5 g in 50 ml / octocrylene 1 g in 50 ml topical cream [laura mercier tinted moisturizer broad spectrum spf 30 sunscreen - 1c1 cameo]||dimethicone/vinyl dimethicone crosspolymer (soft particle)||inactive_ingredient_of
dimethicone 1.25 g in 50 g topical cream [queens rose elysee essence eye]||rosa x damascena flower oil||inactive_ingredient_of
sodium fluoride 1.5 mg in 1 g dental gel, dentifrice [crest complete plus 3 in 1]||óxido de titanio(4)||inactive_ingredient_of
sodium monofluorophosphate 0.0075 mg/mg toothpaste||oils, chamomile||inactive_ingredient_of
octinoxate 0.065 g in 1 g / titanium dioxide 0.024 g in 1 g / zinc oxide 0.015 g in 1 g topical paste [lbel effet parfait mineral natural skin effect mousse foundation spf 16 claire 1 - beige]||disteardimonium hectorite||inactive_ingredient_of
selenium sulfide topical 2.25% topical shampoo||hydroxypropyl methylcellulose, ophthalmic||inactive_ingredient_of
product containing only propranolol hydrochloride 20 mg/1 each oral tablet||d and c blue no.1||inactive_ingredient_of
simethicone 125 mg oral capsule, liquid filled [gas aid maximum strength]||l-gulitol||inactive_ingredient_of
semecarpus anacardium juice 30 [hp_c] in 30 ml / arnica montana 1.5 [hp_c] in 30 ml / calcium fluoride 30 [hp_c] in 30 ml / silybum marianum seed oil 1.5 [hp_c] in 30 ml / cinchona officinalis bark 3 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / ginkgo 3 [hp_c] in 30 ml / egg phospholipids 6 [hp_c] in 30 ml / achillea millefolium 1.5 [hp_c] in 30 ml / phosphoric acid 30 [hp_c] in 30 ml / saccharomyces cerevisiae rna 6 [hp_c] in 30 ml / silicon dioxide 6 [hp_c] in 30 ml / zinc sulfate heptahydrate 6 [hp_c] in 30 ml oral spray [brain power]||trihydroxypropane||inactive_ingredient_of
dimethicone 2 g in 100 g / octinoxate 7.5 g in 100 g / oxybenzone 2.5 g in 100 g topical stick [blistex silk and shine]||1,3-butylene glycol||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [luiantt hand sanitizer gel]||water (substance)||inactive_ingredient_of
dextromethorphan hydrobromide 1 mg/ml oral solution [dayquil cough]||propylene glycol (substance)||inactive_ingredient_of
saccharomyces cerevisiae 20000 [pnu] in 1 ml intradermal solution||sodium chloride nacl||inactive_ingredient_of
acetaminophen 650 mg / diphenhydramine hcl 25 mg / phenylephrine hcl 10 mg granules for oral solution||quso f-22||inactive_ingredient_of
octinoxate 60 mg in 1 ml / titanium dioxide 56 mg in 1 ml topical liquid [boy de chanel le teint foundation broad spectrum spf 25 sunscreen no50 medium plus]||dimeticone-containing product||inactive_ingredient_of
meloxicam 7.5 mg tablet||lactose monohydrate||inactive_ingredient_of
alcohol 62 ml in 100 ml topical liquid [1904 hand sanitizer]||methyl ethyl glycol||inactive_ingredient_of
avobenzone 2 g in 100 ml / homosalate 10 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 4 g in 100 ml / oxybenzone 5 g in 100 ml topical lotion [sport sunscreen spf 30 exchange select]||oleth-3||inactive_ingredient_of
body prescriptions antibacterial hand sanitizer duo peppermint scented aloe scented kit||carboxypolymethylene||inactive_ingredient_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (rojo esika) - red]||d&c red no. 7||inactive_ingredient_of
nupro 0.02 mg/mg dental gel||20s, polysorbate||inactive_ingredient_of
biofreeze 10 % topical cream||glyceryl monostearate||inactive_ingredient_of
paroxetine hydrochloride hemihydrate 30 mg oral tablet, film coated||calcium phosphate dibasic anhydrous (substance)||inactive_ingredient_of
allantoin 0.5 g in 100 g topical stick [run guard sensitive]||white paraffin product||inactive_ingredient_of
octinoxate 1.5 ml in 30 ml topical cream [intervene makeup spf 15 soft shell]||isododecane||inactive_ingredient_of
blackberry 0.1 g in 1 ml intradermal injection, solution||natriumchlorid||inactive_ingredient_of
gemfibrozil 600mg tab ud||peg-400||inactive_ingredient_of
hydroquinone 2 g in 100 ml topical solution [differin dark spot correcting serum]||edta disodium||inactive_ingredient_of
cefuroxime 250mg tablet||dye fdc blue #1||inactive_ingredient_of
health mart pain relief extra strength 500mg caplet||hypromellose product (product)||inactive_ingredient_of
acetaminophen 325 mg in 15 ml / dextromethorphan hydrobromide 10 mg in 15 ml / phenylephrine hydrochloride 5 mg in 15 ml oral solution [equate daytime cold and flu]||gums xanthan||inactive_ingredient_of
aluminum zirconium trichlorohydrex gly 13.49 g in 71 g topical stick [power up drive]||phenyl trimethicone||inactive_ingredient_of
rumex acetosella pollen 20000 [pnu] in 1 ml / plantago lanceolata pollen 20000 [pnu] in 1 ml subcutaneous solution [plantain sorrel mix]||sodium chloride-containing product in solution for irrigation||inactive_ingredient_of
octinoxate 0.065 g in 1 ml / zinc oxide 0.33 g in 1 ml topical cream [esika pro hydra smart hydro-nutritive foundation spf 15 brown 4]||dimethicone 100||inactive_ingredient_of
octinoxate 37.4 mg in 1 ml / oxybenzone 10 mg in 1 ml / titanium dioxide 35.5 mg in 1 ml topical emulsion [lingerie de peau bb invisible skin-fusion multi-perfecting makeup with sunscreen broad spectrum spf 30 bb 4 medium]||disteardimonium hectorite||inactive_ingredient_of
nicotine cinnamon, 4 mg oral transmucosal gum||talcum||inactive_ingredient_of
octinoxate 63.4 mg in 1 g / titanium dioxide 30 mg in 1 g topical cream [extralasting cream-to-powder foundation]||wax,microcrystalline||inactive_ingredient_of
salicylic acid 50 mg in 1 ml topical liquid [neutrogena skinclearing oil free makeup - soft beige 50]||cetyl lactate||inactive_ingredient_of
quinapril hydrochloride 5 mg oral tablet, film coated||ferric oxide,yellow||inactive_ingredient_of
oxycodone hydrochloride 10mg, acetaminophen 325mg oral tablet||cross linked sodium carboxymethylcellulose||inactive_ingredient_of
pantoprazole sodium 20 mg oral tablet, delayed release [protonix]||viva-drops lubricating eye drops||inactive_ingredient_of
jadenu 180mg tablet||talcum powder||inactive_ingredient_of
neosporin eczema daily moisturizing topical cream||benzalkonium chloride||inactive_ingredient_of
salicylic acid 2 g in 100 ml topical liquid [skinlycious glow exfoliant]||α-propyleneglycol||inactive_ingredient_of
sodium fluoride 0.15 g in 100 g oral paste, dentifrice [handy solutions crest complete multi-benefit whitening plus scope]||stevia rebaudiana whole||inactive_ingredient_of
alcohol 70 ml in 100 ml topical liquid [shield dr.]||carmoisine||inactive_ingredient_of
mucinex fast-max nighttime cold & flu solution||sodium calciumedetate||inactive_ingredient_of
cefuroxime axetil 500 milligram in 1 tablet oral tablet [cefuroxime axetil]||colloidal silica||inactive_ingredient_of
avobenzone 3163 mg in 126.5 g / octinoxate 9361 mg in 126.5 g / octocrylene 2530 mg in 126.5 g / oxybenzone 1265 mg in 126.5 g topical emulsion [cle de peau beaute gentle protective i]||2-phenoxyethanol||inactive_ingredient_of
alcohol 75 ml in 100 ml topical gel [papilion hygienic antibacterial hand sanitizer]||methyl glycol||inactive_ingredient_of
octinoxate 588 mg in 12 g / titanium dioxide 996 mg in 12 g topical powder [nars all day luminous foundation siberia]||ascorbyl glucoside||inactive_ingredient_of
famotidine 40mg tablet (substance)||starch (corn)||inactive_ingredient_of
octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - natural persistant]||ceramide 3||inactive_ingredient_of
pregabalin 75mg oral capsule||sodium lauryl sulphate||inactive_ingredient_of
octinoxate 0.975 g in 15 g topical lotion [amorepacific age correcting foundation cushion 106]||product containing titanium dioxide||inactive_ingredient_of
titanium dioxide 2.72118 g in 35 ml topical emulsion [cle de peau beaute radiant fluid foundation o70]||moroccan oil||inactive_ingredient_of
divalproex sodium@125 mg@oral@tablet, delayed release (enteric coated)||talcum powder||inactive_ingredient_of
topiramate, 25 mg oral tablet||pigment white 6||inactive_ingredient_of
acetaminophen 160 mg/5 ml oral elixir [acetaminophen children's]||polyethylene glycol (substance)||inactive_ingredient_of
health mart senna-s tablet||dicalcium phosphate anhydrous||inactive_ingredient_of
product containing valsartan 80 mg/1 each oral tablet||hydroxypropyl methylcellulose 606||inactive_ingredient_of
ethambutol hydrochloride 400 mg oral tablet, film coated [ethambutol]||hypromellose 2910 (3 cps)||inactive_ingredient_of
acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 30 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml oral solution [welby nighttime cold and flu]||macrogol (substance)||inactive_ingredient_of
alcohol 62 ml in 100 ml topical gel [you are a magical unicorn antibacterial hand sanitizer berry scented]||pigment blue 1||inactive_ingredient_of
warfarin sodium 5 mg oral tablet [jantoven]||lactose,anhydrous||inactive_ingredient_of
nifedipine 60 mg oral tablet, extended release_#2||sodium chloride (product)||inactive_ingredient_of
celecoxib 200mg cap ud||gelatine||inactive_ingredient_of
lotrimin, 1% topical cream||n-1-octadecanol||inactive_ingredient_of
24 hr venlafaxine 150 mg extended release oral tablet||cordycepic acid||inactive_ingredient_of
dimethicone 2 g in 100 g / octinoxate 6.6 g in 100 g / octisalate 4.4 g in 100 g topical stick [blistex complete moisture]||citric acid monohydrate (substance)||inactive_ingredient_of
octinoxate 50 mg in 1 ml topical cream [flormar reborn foundation sunscreen broad spectrum spf 20 sf13 nude ivory]||1,2-octanediol||inactive_ingredient_of
product containing sucralfate 1 g/1 each oral tablet||baby butz||inactive_ingredient_of
perampanel@8 mg@oral@tablet||product containing titanium dioxide||inactive_ingredient_of
warfarin na 5mg tab||sunset yellow fcf stain||inactive_ingredient_of
octinoxate 7 g in 100 ml / zinc oxide 6 g in 100 ml topical lotion [roman broad spectrum spf 28 sunscreen face moisturizer]||glucono-delta-lactone||inactive_ingredient_of
lyleq 28 day pack||talcum powder (medication)||inactive_ingredient_of
dextromethorphan hydrobromide 30 mg in 5 ml oral suspension, extended release [health mart cough dm]||pvp - polyvinylpyrrolidone||inactive_ingredient_of
benzalkonium chloride 0.13 g in 100 ml topical spray [arridus hand and skin sanitizer]||fd & c red no. 40||inactive_ingredient_of
cladosporium sphaerospermum 0.10 g in 1 ml percutaneous injection, solution [cladosporium sphaerospermum]||glycérine||inactive_ingredient_of
alcohol 75 ml in 100 ml topical gel [goodearth]||acetate, tocopherol||inactive_ingredient_of
octinoxate 50 mg in 1 ml topical aerosol [flormar smooth touch foundation 09 golden beige]||disteardimonium hectorite||inactive_ingredient_of
amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula populifolia pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.005 g in 1 ml / populus alba pollen 0.005 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.0004 g in 1 ml / morus rubra pollen 0.002 g in 1 ml subcutaneous injection, solution||sodium chloride (product)||inactive_ingredient_of
octinoxate 1.31 g in 30 ml / titanium dioxide 1.09 g in 30 ml topical emulsion [shiseido synchro skin lasting liquid foundation golden 5]||thymus serpyllum (substance)||inactive_ingredient_of
ciprofloxacin 250 mg oral tablet||sodium starch glycolate type a potato||inactive_ingredient_of
product containing ropinirole 1 mg/1 each oral tablet (clinical drug)||sodium, croscarmellose||inactive_ingredient_of
neomycin sulfate 3.5 mg in 1 g / pramoxine hydrochloride 10 mg in 1 g / polymyxin b sulfate 10000 [usp'u] in 1 g topical cream [signature care first aid antibiotic]||methyl 4-hydroxybenzoate||inactive_ingredient_of
pyrithione zinc 1 kg in 100 l topical shampoo [everyday clean dandruff]||cocamidopropylbetaine (in water) (product)||inactive_ingredient_of
robitussin lingering cold long-acting coughgels||povidona||inactive_ingredient_of
octinoxate 0.075 g in 1 g / oxybenzone 0.02 g in 1 g / zinc oxide 0.0196 g in 1 g topical suspension [lbel clarite clarifying effect foundation spf 30 claire 1- beige]||phenoxyethanol product||inactive_ingredient_of
meclizine hydrochloride 25 mg oral tablet [meclizine hcl 25 mg]||acid stearic||inactive_ingredient_of
calendula officinalis flowering top 12 [hp_x] in 1 ml / croton tiglium seed 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / plantago major 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / smilax regelii root 30 [hp_x] in 1 ml topical spray [shingles pain ulceration relief]||carbowax 1500||inactive_ingredient_of
pramipexole dihydrochloride 3 mg oral tablet, extended release||hypromellose 2208 (15000 mpa.s)||inactive_ingredient_of
octinoxate 2.25 g in 30 ml topical lotion [sei bella age-defying liquid foundation porcelain]||pentane-1,5-diol||inactive_ingredient_of
dexone, 4 mg/ml injectable solution||sodium citrate,anhydrous||inactive_ingredient_of
octisalate 0.09 g in 17 g / avobenzone 0.51 g in 17 g / octocrylene 0.43 g in 17 g / oxybenzone 1.02 g in 17 g / homosalate 1.28 g in 17 g topical stick||ceresin||inactive_ingredient_of
asparagus 30 [hp_c] oral pellet||sucrose product||inactive_ingredient_of
prednisone 10 mg oral tablet [prednisone]||siliziumdioxid||inactive_ingredient_of
product containing celecoxib 200 mg/1 each oral capsule (clinical drug)||dióxido de titanio||inactive_ingredient_of
neomycin sulfate 0.35 % / polymyxin b sulfate 10,000 unt/ml / hydrocortisone 1 % otic solution||h2o - water||inactive_ingredient_of
cinacalcet (as cinacalcet hydrochloride) 60 mg oral tablet||polyethylene glycol 400||inactive_ingredient_of
esomeprazole magnesium 40mg oral capsule, gastro-resistant pellets||sodium dodecyl sulfate||inactive_ingredient_of
aluminum sesquichlorohydrate 13.6 g in 100 ml topical emulsion [esika winner sport antiperspirant roll-on deodorant]||benzylic alcohol||inactive_ingredient_of
niacinamide 0.02 in 30 ml / adenosine 0.0004 in 30 ml topical cream [primerose double effect eye]||alpha-d-glucopyranosyl-alpha-d-glucopyranoside||inactive_ingredient_of
potassium chloride 20 meq oral tablet, extended release||vanillin product||inactive_ingredient_of
klor-con m10 10 meq extended release oral tablet||diethyl phthalate product||inactive_ingredient_of
bencocaine 20 % oral gel||sunset yellow fcf (substance)||inactive_ingredient_of
bacitracin zinc 400 mg in 1 ml / neomycin sulfate 5 mg in 1 ml / polymyxin b sulfate 5000 u in 1 ml topical ointment [triastem topical antibiotic]||gluconic lactone||inactive_ingredient_of
clindamycin 150 mg oral capsule||magnesium searate||inactive_ingredient_of
walgreens nicotine polacrilex 4mg chewing gum (fruit)||gelatin||inactive_ingredient_of
aspirin/dextromethorphan hydrobromide/doxylamine succinate/phenylephrine tartrate 500 mg-10 mg-6.25 mg-7.8 mg oral tablet, effervescent||d-mannitol||inactive_ingredient_of
octinoxate/oxybenzone topical application cream [blistex dct]||synthetic camphor||inactive_ingredient_of
titanium dioxide 19.2 mg in 1 g / zinc oxide 150 mg in 1 g topical powder [arbonne setting pretty translucent broad spectrum spf 15 sunscreen]||potassium sorbate||inactive_ingredient_of
halobetasol propionate 0.05% top foam||ethyl alcohol (product)||inactive_ingredient_of
lidocaine 50 mg/ml topical cream||product containing glycerol (medicinal product)||inactive_ingredient_of
promethazine hcl 25mg tab||hydroxypropyl cellulose, unspecified||inactive_ingredient_of
hydrocortisone 10 mg in 1 g topical cream [hydrocortisone plus]||5-cholesten-3b-ol||inactive_ingredient_of
glycerin 3.25 g in 50 ml topical cream [dr deep enrich nourishingcream]||citrus paradisi fruit oil||inactive_ingredient_of
hydroquinone 5 mg in 100 ml topical cream [gold cosmetics bleach cream silver]||1-octadecanol||inactive_ingredient_of
alcohol 72 ml in 100 ml topical gel [earth to skin coconut aloe hand sanitizer 2.0 oz]||hyaluronate sodium (avian)||inactive_ingredient_of
product containing only naloxone hydrochloride 0.5 mg and pentazocine hydrochloride 50 mg/1 each oral tablet (clinical drug)||dibasic calcium phosphate anhydrous||inactive_ingredient_of
dog skin extract 20000 unt/ml injectable solution||sodium bicarbonate||inactive_ingredient_of
aluminum chlorohydrate 23.3 g in 100 g topical aerosol, spray [degree]||sodium benzoate-containing product||inactive_ingredient_of
vitamin d 50000unt cap||gelatin-containing product||inactive_ingredient_of
witch hazel 50 g in 100 g topical swab [shopko medicated cooling]||aloe vera leaf||inactive_ingredient_of
zinc oxide 21 g in 100 ml topical lotion [mychelle dermaceuticals replenishing solar defense body spf 50 broad spectrum]||water||inactive_ingredient_of
octinoxate 0.065 g in 1 ml / titanium dioxide 0.016 g in 1 ml topical liquid [lbel natural finish moisturizing foundation spf 25 (obscure 9) - brown]||caprylyltriethoxysilane||inactive_ingredient_of
octinoxate 1655 mg in 30 ml / titanium dioxide 676 mg in 30 ml topical liquid [shiseido synchro skin glow luminizing fluid foundation golden 3]||1,3-butylenglykol||inactive_ingredient_of
dicycloverine hydrochloride 10 mg/1 each oral capsule||magnesium distearate||inactive_ingredient_of
dr.s cream, 0.025% topical cream||cetostearyl alcohol (substance)||inactive_ingredient_of
string bean 0.1 mg in 1 ml percutaneous injection, solution||phenyl alcohol||inactive_ingredient_of
quetiapine 100 mg oral tablet [seroquel]||polyethylene glycol 400||inactive_ingredient_of
triclosan 2 g in 1 l topical soap [theochem tea tree hand and body wash]||cocamidopropylbetaine (in water) (substance)||inactive_ingredient_of
product containing only aripiprazole 15 mg/1 each oral tablet||cellulose, 2-hydroxypropyl ether||inactive_ingredient_of
alcohol 70 ml in 100 ml topical spray [ms. germsafe antibacterial hand sanitizer - unscented]||agua||inactive_ingredient_of
antifungal, 2% topical cream||product containing quaternium 15 (medicinal product)||inactive_ingredient_of
octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - violet pourpre]||eosine acid||inactive_ingredient_of
octinoxate 0.525 g in 7 ml / oxybenzone 0.21 g in 7 ml topical cream [marcelle cc cream complete correction sunscreen broad spectrum spf 35]||biosaccharide gum-1||inactive_ingredient_of
azithromycin 250 mg oral tablet 6 count pack||sulfuric acid monododecyl ester sodium salt||inactive_ingredient_of
octinoxate 2 g in 40 ml / titanium dioxide 1.896 g in 40 ml topical cream [age20s signature essence cover tone-up base 03 purple]||aluminum oxide (al2o3)||inactive_ingredient_of
asa 81 mg oral film||acesulfame potassium||inactive_ingredient_of
fluoxetine 10 mg (as fluoxetine hcl 11.2 mg) oral capsule||gum lac||inactive_ingredient_of
azithromycin dihydrate 500 mg oral tablet, film coated [zithromax]_#1||silicon dioxide, fumed||inactive_ingredient_of
atenolol 50mg tab||polyvidons||inactive_ingredient_of
zinc oxide .9 ml in 30 ml topical cream [roccos old school healing balm]||bees wax||inactive_ingredient_of
diltiazem (eqv-tiazac) 300mg 24hr cap||ammonio methacrylate copolymer type a||inactive_ingredient_of
octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [effet parfait hydratess long-lasting intense moisturizing spf 20 (marron glace) - brown]||c.i. 16035||inactive_ingredient_of
salicylic acid 20 mg in 1 ml topical gel [artistry studio done with zit acne treatment clearing gel]||citronella oil||inactive_ingredient_of
product containing only conjugated estrogens 0.3 mg/1 each oral tablet (clinical drug)||d&c yellow no.10||inactive_ingredient_of
octinoxate 4.5 ml in 100 ml / octisalate 5 ml in 100 ml topical spray [parrot head dedicated to sunshine oil 4]||wild carrot seed oil||inactive_ingredient_of
diltiazem (inwood) 360mg cap,sa||povidone [mouth]||inactive_ingredient_of
benazepril hcl 10mg tab ud||crospovidone (15 mpa.s at 5%)||inactive_ingredient_of
octinoxate 0.05635 g in 100 ml / titanium dioxide 0.03335 g in 100 ml topical liquid [halo hd foundation broad spectrum spf 15 oil free]||hyaluronate sodium (product)||inactive_ingredient_of
clonazepam 2 mg orodispersible tablet||product containing mannitol||inactive_ingredient_of
octisalate 20 mg in 1 ml / octocrylene 50 mg in 1 ml / homosalate 50 mg in 1 ml / avobenzone 17.5 mg in 1 ml topical lotion [coola classic face sunscreen white tea spf 50]||t butanol||inactive_ingredient_of
sodium fluoride 2.43 mg in 1 g dental paste, dentifrice [auraglow daily]||1,1-dioxide-1,2-benzisothiazol-3(2h)-one, sodium salt||inactive_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [nitetime cold flu relief]||α-propyleneglycol||inactive_ingredient_of
avobenzone 30 mg in 1 ml / octinoxate 75 mg in 1 ml / octocrylene 100 mg in 1 ml topical cream [pearlixime illuminating perfecting sunscreen broad spectrum spf 15]||citric acid monohydrate (substance)||inactive_ingredient_of
trolamine salicylate 10% topical application cream [flexpower]||hydrocarbon oils||inactive_ingredient_of
benzoyl peroxide 5% gel (product)||propyl 4-hydroxybenzoate (product)||inactive_ingredient_of
tolnaftate 10 mg in 1 g topical cream [winco foods tolnaftate]||ceteth 20||inactive_ingredient_of
aluminum zirconium tetrachlorohydrex gly 19.0 g in 100 g topical stick [degree ironman antiperspirant and deodorant]||2,6 di t butyl 4 methylphenol||inactive_ingredient_of
salicylic acid 28.8 mg in 1 ml topical liquid [clear acne spot treatment]||sarcosine (substance)||inactive_ingredient_of
zinc gluconate 2 [hp_x] oral lozenge [cvs cherry zinc cold relief 25ct]||product containing water (medicinal product)||inactive_ingredient_of
temazepam 30 mg oral capsule [temazepam]||ferrosoferric oxide||inactive_ingredient_of
sodium fluoride 0.15 g in 100 g dental paste [dr.fresh kids pediatric]||sodium cocoyl glycinate||inactive_ingredient_of
ulmus pumila pollen 1 g in 20 ml percutaneous injection, solution [chinese siberian elm pollen]||product containing phenol||inactive_ingredient_of
zinc oxide 210 mg in 1 g topical cream [daily spf facial sunscreenlotion broad spectrum spf 32]||medium-chain triglycerides||inactive_ingredient_of
avobenzone 90 g in 1 g / homosalate 2250 g in 1 g / octisalate 250 g in 1 g / octocrylene 640 g in 1 g topical spray [sunscreen]||triethanolamine||inactive_ingredient_of
alprazolam 500micrograms tablet||fd & c yellow no. 6||inactive_ingredient_of
sodium fluoride 1.1 mg in 1 g dental gel, dentifrice [colgate you red fresh mint]||product containing sorbitol||inactive_ingredient_of
product containing only amoxicillin 875 mg and clavulanate potassium 125 mg/1 each oral tablet (clinical drug)||hydroxypropyl methylcellulose e5 [ii]||inactive_ingredient_of
nonoxynol 9 28% vaginal film [vcf contraceptive]||polydesis||inactive_ingredient_of
echinacea angustifolia 3 [hp_x] in 1 ml / handroanthus impetiginosus bark 3 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / colchicum autumnale bulb 12 [hp_x] in 1 ml / ledum palustre twig 12 [hp_x] in 1 ml / mercuric cyanide 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / aflatoxin b1 30 [hp_x] in 1 ml oral liquid [asp]||alcohol,ethyl||inactive_ingredient_of
acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 30 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml oral solution [nighttime hbp]||1,2-dihydroxypropane||inactive_ingredient_of
diphenhydramine hydrochloride/zinc acetate 2%-0.1% topical application spray [itch relief]||product containing tromethamine||inactive_ingredient_of
octinoxate 5 g in 100 ml / octocrylene 7.5 g in 100 ml / avobenzone 3 g in 100 ml topical cream [the healthy foundation]||1,3-butylenglykol||inactive_ingredient_of
levofloxacin 500mg tablet (product)||polysorbate 80s||inactive_ingredient_of
crestor 40mg tablet||d-(-)-n-methylglucamine||inactive_ingredient_of
octinoxate 67 mg in 1 ml topical cream [2-power fabric spf 25]||cyclomethicone 6||inactive_ingredient_of
clocortolone pivalate 0.1% topical cream||caustic alkali of sodium||inactive_ingredient_of
trazodone hydrochloride 100 mg oral tablet [desyrel]||tridymite||inactive_ingredient_of
menthol 3.7 % topical cream||2-(2-(2-(2-phenoxyethoxy)ethoxy)ethoxy)ethanol||inactive_ingredient_of
aluminum chlorohydrate 23.3 g in 100 g topical aerosol, spray [degree fresh energy antiperspirant]||propylene carbonate||inactive_ingredient_of
product containing ramipril 5 mg/1 each oral capsule||fd and c red 40||inactive_ingredient_of
octinoxate 50 mg in 1 ml topical liquid [purminerals 4-in-1 14-hour wear foundation broad spectrum spf 15 (golden medium)]||product containing sodium citrate (medicinal product)||inactive_ingredient_of
duloxetine hcl 60mg oral cap||gum lac||inactive_ingredient_of
chloroxylenol 0.3 g in 100 ml topical soap [antibacterial hand]||sodium laureth sulfate||inactive_ingredient_of
pyrithione zinc 1 g in 100 ml topical lotion/shampoo [head and shoulders 2in1 classic clean]||water product (substance)||inactive_ingredient_of
starch, tapioca 0.05 g in 1 ml intradermal injection, solution||glycerin||inactive_ingredient_of
menthol 0.1 % topical spray||linalool, (-)-||inactive_ingredient_of
clotrimazole 1% topical application cream [jock itch cream]||agua||inactive_ingredient_of
benzocaine 50 mg in 1 ml topical lotion [chigg away]||product containing cetyl alcohol||inactive_ingredient_of
robinia pseudoacacia pollen 0.05 g in 1 ml intradermal solution [black locust blossom]||acide carbolique||inactive_ingredient_of
benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww gel||benzalkonium chloride (medication)||inactive_ingredient_of
product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous cream||macrogol stearate 400||inactive_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / oxybenzone 60 mg in 1 ml / octocrylene 100 mg in 1 ml / octisalate 50 mg in 1 ml topical lotion [walmart equate beauty ultra light sunscreen spf 100]||silicon dioxide (amorphous)||inactive_ingredient_of
benzocaine 200 mg in 1 g dental gel [ipana 20% benzocaine topical]||1,1-dioxide-1,2-benzisothiazol-3(2h)-one, sodium salt||inactive_ingredient_of
octinoxate 290 mg in 10 g / octocrylene 200 mg in 10 g / titanium dioxide 620 mg in 10 g topical powder [shiseido sheer and perfect compact (refill) i100]||methicone (20 cst)||inactive_ingredient_of
alcohol 0.7 ml in 1 ml topical gel [medyskin hand sanitizer]||peg-60 hydrogenated castor oil||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [bextera health hand sanitizer]||vitamin e (alpha tocopherol acetate)||inactive_ingredient_of
product containing atenolol 50 mg/1 each oral tablet (clinical drug)||microcrystalline cellulose||inactive_ingredient_of
sodium fluoride 1.1 mg in 1 g / potassium nitrate 50 mg in 1 g dental paste, dentifrice [colgate sensitive maximum strength whitening]||glycerin preparation||inactive_ingredient_of
oregon ash pollen extract 1 mg/ml injectable solution||salted||inactive_ingredient_of
diphenhydramine hydrochloride 50 mg in 30 ml oral liquid [cvs health nighttime sleep aid]||dye fdc blue #1||inactive_ingredient_of
titanium dioxide 62 mg in 1 ml topical emulsion [clarins everlasting cushion long-wearing and hydrating foundation broad spectrum spf 50 tint 103 tester refill with sponge]||mica||inactive_ingredient_of
benzalkonium chloride 0.1 g in 100 ml topical spray [hand sanitizer]||water (substance)||inactive_ingredient_of
product containing only escitalopram 20 mg/1 each oral tablet (clinical drug)||polyethylene oxides||inactive_ingredient_of
flexeril 10 mg oral tablet||macrogol (medication)||inactive_ingredient_of
dexacorten, 4 mg/ml injectable solution||anhydrous trisodium citrate||inactive_ingredient_of
octinoxate 1.2 ml in 30 ml / titanium dioxide 1.5 ml in 30 ml topical liquid [match perfection spf 18 true ivory 130]||xanthan gum||inactive_ingredient_of
alcohol 18.335 ml in 29.574 ml topical gel [anti-bacterial hand]||product containing lactose (medicinal product)||inactive_ingredient_of
iron polysaccharide 150 mg oral capsule [iferex 150]||fd&c #1 blue||inactive_ingredient_of
onion 6 [hp_x] in 1 ml / apis mellifera 3 [hp_x] in 1 ml / aralia racemosa root 6 [hp_x] in 1 ml / arundo pliniana root 30 [hp_c] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia whole 4 [hp_x] in 1 ml / euphrasia stricta 6 [hp_x] in 1 ml / gelsemium sempervirens root 200 [hp_c] in 1 ml / histamine dihydrochloride 12 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / toxicodendron pubescens leaf 200 [hp_c] in 1 ml / schoenocaulon officinale seed 6 [hp_x] in 1 ml / sanguinaria canadensis root 200 [hp_c] in 1 ml / urtica urens whole 3 [hp_x] in 1 ml oral spray [pollen distress]||drinking alcohol||inactive_ingredient_of
octinoxate 0.068 g in 1 g topical lipstick [esika pro hd longwear long-lasting high-definition color spf 20 pimienta caliente - red]||dioxide, silicon||inactive_ingredient_of
chlorhexidine gluconate 0.12% oral liquid||glycerol product (product)||inactive_ingredient_of
glyburide/metformin hcl 5 mg-500 mg oral tablet||sunset yellow fcf stain (substance)||inactive_ingredient_of
niacinamide 2 g in 100 ml / adenosine 0.04 g in 100 ml topical liquid [rgo tension up serum]||pine needle oil (pinus sylvestris)||inactive_ingredient_of
dimethicone 2 g in 100 g / octinoxate 6.6 g in 100 g / octisalate 4.4 g in 100 g topical stick [blistex superfruit soother]||gnp eucalyptus oil||inactive_ingredient_of
azithromycin 200 mg in 5 ml oral powder, for suspension [azithromycin]||banana allergenic extract||inactive_ingredient_of
bupropion hcl 150 mg oral tablet, extended release 12 hr||1h-indole-5-sulfonic acid, 2-(1,3-dihydro-3-oxo-5-sulfo-2h-indol-2-ylidene)-2,3-dihydro-3-oxo-, disodium salt||inactive_ingredient_of
aluminum chlorohydrate 20.2 g in 100 g topical aerosol, spray [dove caring coconut dry antiperspirant]||.beta.-citronellol, (r)-||inactive_ingredient_of
tamsulosin hydrochloride 0.4mg capsule (product)||gelatina||inactive_ingredient_of
sodium valproate 500 mg gastro-resistant oral tablet||fortrans||inactive_ingredient_of
octinoxate 50 mg in 1 ml / titanium dioxide 63 mg in 1 ml topical lotion [yves saint laurent top secrets cc primer color correcting primer broad spectrum spf 35 sunscreen]||diisostearyl malate||inactive_ingredient_of
reyataz 200 mg oral capsule||fd & c red no. 40||inactive_ingredient_of
duloxetine 30mg capsule||propanediol 01 02||inactive_ingredient_of
avobenzone 16 mg in 1 ml / octisalate 40.3 mg in 1 ml / octocrylene 22.2 mg in 1 ml topical spray [california tan broad spectrum spf 15]||water (substance)||inactive_ingredient_of
alprazolam 2 mg oral tablet||lactose-containing product||inactive_ingredient_of
alcohol 62 ml in 100 ml topical liquid [lucky instant hand sanitizer with vitamin e and moisturizers]||tocopherol acetate||inactive_ingredient_of
octinoxate 70 mg in 1 ml / titanium dioxide 25 mg in 1 ml topical lotion [urban skin rx dermshield all day sun protection mattifying moisturizer spf 30]||aliphatic carboxylic acid, c18:0||inactive_ingredient_of
product containing precisely imatinib 100 milligram/1 each conventional release oral tablet (clinical drug)||povidone||inactive_ingredient_of
lisinopril 5 mg oral tablet, film coated||dibasic calcium phosphate, anhydrous||inactive_ingredient_of
colloidal oatmeal@1 %@topical@lotion (gram)||benzalkonium chloride [dup] (substance)||inactive_ingredient_of
thorazine 200 mg oral tablet||peph||inactive_ingredient_of
pyrithione zinc 1 ml in 100 ml topical shampoo [classic clean 2 in 1 for normal hair]||ethylene glycol distearate||inactive_ingredient_of
populus fremontii pollen 0.05 g in 1 ml percutaneous injection, solution [populus fremontii pollen]||1,2,3-propanetriol||inactive_ingredient_of
benzalkonium chloride 4.5 mg topical solution [body prescriptions antibacterial wipes aloe scented]||propan-1,2-diol||inactive_ingredient_of
product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral tablet (clinical drug)||titanium dioxide product||inactive_ingredient_of
naloxone hydrochloride 2 mg/0.4 ml injection solution||salted||inactive_ingredient_of
sulfur 2 % medicated liquid soap||2,2',2''-nitrilotriethanol||inactive_ingredient_of
product containing nebivolol 10 mg/1 each oral tablet (clinical drug)||hydroxypropyl methylcellulose product (product)||inactive_ingredient_of
aluminum zirconium tetrachlorohydrex gly 14.8 g in 100 g topical stick [handy solutions dove cool essential cucumber and green tea scent anti-perspirant]||dibutylhydroxytoluene||inactive_ingredient_of
ondansetron hydrochloride 2 mg in 1 ml intramuscular injection_#2||sodium citrate dehydrate||inactive_ingredient_of
ramipril 5mg oral capsule||product containing gelatin (medicinal product)||inactive_ingredient_of
cyclobenzaprine hydrochloride;gel, multi ingredient 10 mg; na multiple routes kit||octadecanoic acid, magnesium salt||inactive_ingredient_of
publix anti-diarrheal 2mg caplet||croscarmellose sodium||inactive_ingredient_of
walgreens infants' pain & fever 160mg/5ml suspension (cherry)||meg||inactive_ingredient_of
docusate sodium 50 mg / sennosides 8.6 mg oral tablet [stool softener plus stimulant]||talc (medication)||inactive_ingredient_of
benzalkonium chloride 0.13 g in 100 g topical swab [creamol antibacterial wet wipes 40 pcs]||product containing phenoxyethanol (medicinal product)||inactive_ingredient_of
cefadroxil 250mg/5ml suspension (substance)||orange||inactive_ingredient_of
bacitracin zinc 500 unit/gram topical ointment in packet (ea)||wsp - white soft paraffin||inactive_ingredient_of
irbesartan@75 mg@oral@tablet||dibasic magnesium stearate||inactive_ingredient_of
octinoxate 0.068 g in 1 g topical lipstick [esika pro hd color high definition color spf 20 (hd rosa obsession) - pink]||titanium dioxide (product)||inactive_ingredient_of
rattus norvegicus skin 0.1 g in 1 ml intradermal injection, solution||dihydrogen oxide||inactive_ingredient_of
ziprasidone hcl@40 mg@oral@capsule||gelatin-containing product||inactive_ingredient_of
glycopyrrolate 4 mg in 20 ml intravenous injection||alcohol benzyl||inactive_ingredient_of
product containing precisely baclofen 20 milligram/1 each conventional release oral tablet||starch 1500, pregelatinized||inactive_ingredient_of
cyclobenzaprine hydrochloride 30mg oral capsule, extended release||hydroxypropyl cellulose (1200000 wamw)||inactive_ingredient_of
octinoxate 30 mg in 1 ml / zinc oxide 68 mg in 1 ml topical emulsion [jafra royal jelly radiance broad spectrum spf 20 honey m6]||ferric oxide,yellow||inactive_ingredient_of
acetaminophen/tramadol hydrochloride 325 mg-37.5 mg oral tablet||starch 1500 pregelatinized||inactive_ingredient_of
octinoxate 1655 mg in 30 ml / titanium dioxide 676 mg in 30 ml topical liquid [shiseido synchro skin glow luminizing fluid foundation rose 5]||polyquaternium-51 (2-methacryloyloxyethyl phosphorylcholine/n-butyl methacrylate; 3:7)||inactive_ingredient_of
walgreens children's pain & fever 160mg chewable tablet (grape)||d and c red no.30||inactive_ingredient_of
camphor (synthetic) 3.1 g in 100 g / menthol 6.0 g in 100 g / methyl salicylate 10 g in 100 g topical patch [large pain relieving]||liquid petroleum||inactive_ingredient_of
cefdinir 50 mg/ml oral suspension||light anhydrous silicic acid||inactive_ingredient_of
product containing only levofloxacin 250 mg/1 each oral tablet||polysorbate 80s||inactive_ingredient_of
benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % topical solution||aloe vera leaf||inactive_ingredient_of
indomethacin, 25 mg oral capsule||lactose monohydrte||inactive_ingredient_of
titanium dioxide 62.2 mg in 1 ml / zinc oxide 38.3 mg in 1 ml topical liquid [rainforest of the sea water foundation broad spectrum spf 15 sunscreen 27b light-medium beige]||ferric oxide,yellow||inactive_ingredient_of
alcohol 62 g in 100 g topical liquid [healing water amber flower anti-bacterial hand sanitizer]||pg||inactive_ingredient_of
alcohol 62 g in 100 g topical liquid [hand sanitizer]||carboxypolymethylene||inactive_ingredient_of
camphor 40 mg/ml / menthol 100 mg/ml / methyl salicylate 300 mg/ml topical cream||product containing octadecanoic acid||inactive_ingredient_of
etodolac 500 mg oral tablet [etodalac]||product containing povidone||inactive_ingredient_of
phenylephrine hcl 10 mg / triprolidine hcl 2.5 mg oral tablet||octadecanoic acid, magnesium salt||inactive_ingredient_of
avobenzone 75 mg in 1 ml / octinoxate 50 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [cellular radiance emulsion spf 30 la prairie]||cholesteryl nonanoate||inactive_ingredient_of
octinoxate 408 mg in 12 g / titanium dioxide 516 mg in 12 g topical cream [cle de peau beaute radiant cream to powder foundation o20]||ferric oxide,yellow||inactive_ingredient_of
benzalkonium chloride 1 mg in 1 ml topical soap [whiskcare 357]||f d & c red #33||inactive_ingredient_of
octinoxate 0.066 g in 1 g / oxybenzone 0.015 g in 1 g topical lipstick [esika extreme moisturizing spf 16 (rosa encanto) - pink]||polyethylene||inactive_ingredient_of
ranitidine 300 mg (as ranitidine hcl 336 mg) oral tablet||dibasic magnesium stearate||inactive_ingredient_of
norgestimate 0.18 mg / ethinyl estradiol 0.025 mg oral tablet, film coated||microcrystalline cellulose||inactive_ingredient_of
mahonia aquifolium root bark 1 [hp_x] in 28 g topical cream [psoriaflora]||benzalalcohol||inactive_ingredient_of
titanium dioxide 28 mg in 1 ml topical emulsion [clarins everlasting youth fluid broad spectrum spf 15 titanium dioxide sunscreen illuminating and firming foundation 116.5]||edetate disodium anhydrous||inactive_ingredient_of
ensulizole 656 mg in 32.79 g / octinoxate 2426 mg in 32.79 g / titanium dioxide 2361 mg in 32.79 g topical cream [shiseido perfect hydrating bb dark]||product containing octadecanoic acid||inactive_ingredient_of
alcohol 0.75 u in 1 u topical patch [75% alcohol wipes]||water||inactive_ingredient_of
octinoxate 290 mg in 10 g / octocrylene 200 mg in 10 g / titanium dioxide 620 mg in 10 g topical powder [shiseido sheer and perfect compact (refill) b100]||cetyl ethylhexanoate||inactive_ingredient_of
24 hr morphine sulfate 60 mg extended release oral capsule [avinza]||sucrose product||inactive_ingredient_of
grafco silver nitrate applicator 30cm||product containing sodium chloride||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [bye bye germs hand sanitizer sugar cookie]||glyceryl caprylate-caprate||inactive_ingredient_of
amitriptyline hydrochloride 150mg tablet||silica||inactive_ingredient_of
titanium dioxide 0.0698 g in 1 ml / zinc oxide 0.0268 g in 1 ml topical cream [redness solutions daily protective base broad spectrum spf 15]||butane-1,3-diol||inactive_ingredient_of
docusate sodium 50 mg / sennosides 8.6 mg oral tablet [stool softener plus laxative]||benzoate, sodium||inactive_ingredient_of
tadalafil 5mg tablet||sulfate, sodium lauryl||inactive_ingredient_of
fluoxetine hydrochloride 20mg capsule (product)||ätzkali||inactive_ingredient_of
diltiazem (actavis) 180mg sa cap||product containing titanium dioxide||inactive_ingredient_of
titanium dioxide 1.19 g in 17 g / octinoxate 0.59 g in 17 g topical powder [flawless finish dual perfection makeup spf 8 beige]||ethyl 4-hydroxybenzoate-containing product||inactive_ingredient_of
ensulizole 0.03 mg in 1 ml topical liquid [covergirl outlast stay fabulous 3in1 foundation broad spectrum spf 20 - 860 classic tan]||cyclomethicone 5||inactive_ingredient_of
octinoxate 40 mg in 1 g / titanium dioxide 23.6 mg in 1 g topical stick [benefit hello happy air foundation shade 6]||c12-15 alkyl ethylhexanoate||inactive_ingredient_of
pantoprazole 20mg gastro-resistant tablet||yellow iron oxide||inactive_ingredient_of
acetaminophen 160 mg in 5 ml oral elixir [childrens acetaminophen]||acid red 33||inactive_ingredient_of
ethinyl estradiol 0.01 mg oral tablet||siliziumdioxid||inactive_ingredient_of
isoproterenol hydrochloride 0.2 mg in 1 ml intracardiac injection, solution||sodium citrate( as dihydrate)||inactive_ingredient_of
estriol 2 mg in 85 g / estradiol 0.5 mg in 85 g transdermal cream [biest 2.5 estrogen cream]||glycerin (substance)||inactive_ingredient_of
naproxen (as naproxen sodium) 500 mg gastro-resistant oral tablet||sodium indigotindisulfonate stain||inactive_ingredient_of
octinoxate 75 mg in 1 ml / titanium dioxide 20 mg in 1 ml / zinc oxide 171 mg in 1 ml topical cream [algenist]||aluminium hydroxide product||inactive_ingredient_of
octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel hydratess long-lasting intense moisturizing spf 20 - vin]||fd and c no.5 (tartrazine)||inactive_ingredient_of
sertraline hydrochloride 50 milligram in 1 tablet oral tablet, film coated||magnesium stearate||inactive_ingredient_of
sodium chloride 9 g in 1000 ml intravenous injection, solution [sodium chloride]_#1||water product (product)||inactive_ingredient_of
salicylic acid 5 mg/ml topical solution||2-hydroxypropanol||inactive_ingredient_of
arava 10 mg oral tablet||octadecanoic acid, magnesium salt||inactive_ingredient_of
juglans californica pollen 0.0005 g in 1 ml / juglans regia pollen 0.0005 g in 1 ml percutaneous solution [western walnut pollen mix]||sodium chloride product||inactive_ingredient_of
benzalkonium chloride 130 mg in 100 ml topical liquid [puroma hand sanitizer wipe alcohol free with fragrance]||1,2-dihydroxyoctane||inactive_ingredient_of
salicylic acid 2 % facial scrub||white caustic||inactive_ingredient_of
dextromethorphan hydrobromide/guaifenesin 10 mg/5 ml-100 mg/5 ml oral liquid [guaicon dm]||propanediol 01 02||inactive_ingredient_of
chicken 1 g in 20 ml percutaneous injection, solution [chicken food]||sodium hydrogencarbonate||inactive_ingredient_of
neurontin 100 mg oral capsule||corn starch||inactive_ingredient_of
alcohol 700 g in 1000 ml topical gel [aomi hand sanitizer cleansing plus]||d and c violet no. 2||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [sealuxe hand sanitizer]||aloe barbadensis leaf extract||inactive_ingredient_of
.beta.-carotene 2700 [iu] / ascorbic acid 120 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, d- 20 [iu] / thiamine mononitrate 2 mg / riboflavin 3 mg / pyridoxine hydrochloride 10 mg / folic acid 1 mg / cyanocobalamin 12 ug / iron 28 mg / niacinamide 20 mg oral tablet, chewable [natachew]||peo-400||inactive_ingredient_of
erythromycin 500 mg oral tablet, enteric coated||titanium white||inactive_ingredient_of
betamethasone 1 mg/ml topical cream||firstflush||inactive_ingredient_of
octinoxate 7.5 g in 30 g topical cream [no7 lift and luminate foundation sunscreen broad spectrum spf 15 honey]||mica (substance)||inactive_ingredient_of
octinoxate 0.068 g in 1 g topical paste [esika pro hd longwear long-lasting high-definition color spf 20 vino deseo - purple]||jeweler's rouge||inactive_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 90 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 90 mg in 1 ml topical cream [loccitane en provence light comforting spf 15]||product containing benzyl salicylate (medicinal product)||inactive_ingredient_of
aciclovir 200 mg oral capsule||sodium starch glycolate type a potato||inactive_ingredient_of
alcohol 63 ml in 100 ml topical gel [waterless aloe scented hand sanitizer]||lycium barbarum fruit||inactive_ingredient_of
alcohol 70 ml in 100 ml topical solution [crossco antiseptic hand sanitizer]||aloe barbadensis leaf extract||inactive_ingredient_of
octinoxate 50 mg in 1 g / octisalate 25 mg in 1 g / titanium dioxide 11 mg in 1 g topical lipstick [neutrogena moistureshine spf20 tickled pink 120]||sorbitan isostearate||inactive_ingredient_of
pepcid ac 40 mg oral tablet||starch (corn)||inactive_ingredient_of
avobenzone 1.8 g in 100 g / homosalate 7 g in 100 g / octocrylene 5 g in 100 g topical lotion [cvs sport spf 30]||trisodium ascorbate-2-phosphate||inactive_ingredient_of
avobenzone 0.03 ml in 1 ml / octocrylene 0.10 ml in 1 ml / oxybenzone 0.05 ml in 1 ml topical spray [banana boat ultra defense sheer protect spf 50]||caprylyl glycol||inactive_ingredient_of
diazepam 5mg tablet (product)||microcrystalline celullose||inactive_ingredient_of
quetiapine fumarate 50mg tab ud||sodium starch glycolate type a potato||inactive_ingredient_of
aciphex, 20 mg oral delayed release tablet||crospovidone (120 .mu.m)||inactive_ingredient_of
avobenzone 0.028 g in 1 ml / homosalate 0.093 g in 1 ml / octocrylene 0.061 g in 1 ml / octisalate 0.0467 g in 1 ml topical lotion [reverse brightening defense fluid]||citral (substance)||inactive_ingredient_of
gentamicin sulfate, topical, 0.1% topical cream||methylethylene glycol||inactive_ingredient_of
avobenzone 0.0309 g in 100 ml / homosalate 0.0515 g in 100 ml / octisalate 0.0515 g in 100 ml / octocrylene 0.0278 g in 100 ml / oxybenzone 0.0309 g in 100 ml topical lotion [mac prep and prime face protect broad spectrum spf 50]||dipentaerythrityl tri-polyhydroxystearate||inactive_ingredient_of
salicylic acid 2 g in 100 ml topical gel [triderma psoriasis control body wash]||polysorbate 20||inactive_ingredient_of
azithromycin 250mg tab_#2||product containing talc||inactive_ingredient_of
camphor (synthetic) 11 g in 100 g / menthol 16 g in 100 g / methyl salicylate 30 g in 100 g topical ointment [neck and lumbar pain relieving balm]||taxillus chinensis top extract||inactive_ingredient_of
avobenzone 3 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml / oxybenzone 6 g in 100 ml topical lotion [photo dynamic therapy spf 30]||2,2',2''-nitrilotris(ethanol)||inactive_ingredient_of
sepia officinalis juice 9 [hp_c] in 9 [hp_c] oral pellet [sepia]||alpha-d-glucopyranoside, beta-d-fructofuranosyl||inactive_ingredient_of
octinoxate 7.5 g in 100 g / zinc oxide 3.4 g in 100 g topical cream [naked skin one and done, medium]||disteardimonium hectorite||inactive_ingredient_of
product containing only atenolol 25 mg/1 each oral tablet||microcrystalline celullose||inactive_ingredient_of
buspar 5mg tablets x126||microcrystalline cellulose 102||inactive_ingredient_of
cialis 10 mg oral tablet||povidone k-30||inactive_ingredient_of
furosemide 20mg oral tablet||sodium starch glycolate type a potato||inactive_ingredient_of
tretinoin 0.025% cream,top||c18:0||inactive_ingredient_of
chloroxylenol 0.005 mg in 1 ml topical liquid [propower originals antimicrobial foaming so ap]||poloxamer 124||inactive_ingredient_of
octinoxate 75 mg in 1 ml / octisalate 50 mg in 1 ml / oxybenzone 60 mg in 1 ml / titanium dioxide 26 mg in 1 ml topical lotion [spf 50 stay put sunscreen]||methyl paraben||inactive_ingredient_of
pain reliever plus 250mg-250mg-65mg tablet||microcrystalline cellulose||inactive_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [nighttime maximum strength cold and flu]||macrogol 400||inactive_ingredient_of
alcohol 80 ml in 100 ml topical solution [kvs chemical 80 percent alcohol hand sanitizer]||preop (substance)||inactive_ingredient_of
product containing only losartan potassium 50 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet||macrogol 3350 product||inactive_ingredient_of
sunmark gas relief 125mg extra strength chewable tablet||siliceous earth, purified||inactive_ingredient_of
hydroxyurea 500 mg oral capsule [hydrea]||sodium indigo-disulphonate stain||inactive_ingredient_of
phenohytro, 0.0194 mg-0.1037 mg-16.2 mg-0.0065 mg/5 ml oral elixir||d and c blue no.1||inactive_ingredient_of
benzoyl peroxide 9.8 g in 100 g topical aerosol [benzefoam ultra]||cetostearyl alcohol (substance)||inactive_ingredient_of
octinoxate 4 mg in 1 g / avobenzone 3 mg in 1 g topical emulsion [eight hour nourishing lip spf 20]||yellow wax||inactive_ingredient_of
oxymetazoline hydrochloride 0.05 g in 100 ml nasal spray [meijer original]||carboxymethyl cellulose sodium||inactive_ingredient_of
avobenzone 30 mg in 1 g / octinoxate 75 mg in 1 g topical gel [be sweet spf 15 tinted blush crush]||propylene glycol ricinoleate||inactive_ingredient_of
prednisone, 5 mg oral tablet_#1||cellulose, microcrystalline||inactive_ingredient_of
octinoxate 50 mg in 1 ml topical cream [flormar foundation sunscreen broad spectrum spf 20 lf16 natural beige]||dimeticone (product)||inactive_ingredient_of
toprol-xl, 50 mg oral tablet, extended release||agua||inactive_ingredient_of
magnesium carbonate/asafetida@250 mg/5 ml@oral@suspension, oral (final dose form)||asafetida extract||inactive_ingredient_of
amitriptyline hcl 50mg tab,ud||viva-drops lubricating eye drops||inactive_ingredient_of
alcohol 65 ml in 100 ml topical liquid [hand sanitizer]||4-hydroxy-1-(5-isocamphyl)cyclohexane||inactive_ingredient_of
alcohol 350 ml in 500 ml topical gel [tion hand sanitizer gel]||glycerol-containing product||inactive_ingredient_of
octocrylene 70 mg in 1 ml / avobenzone 35 mg in 1 ml / octisalate 50 mg in 1 ml / titanium dioxide 40 mg in 1 ml / ecamsule 15 mg in 1 ml topical lotion [kiehls activated sun protector ultra light sunscreen spf 50 for body sweat and water resistant]||alkyl (c12-15) benzoate||inactive_ingredient_of
potassium nitrate 50 mg in 1 g / sodium fluoride 2.43 mg in 1 g dental paste, dentifrice [sensitive whitening tooth-paste]||1,1-dioxide-1,2-benzisothiazol-3(2h)-one, sodium salt||inactive_ingredient_of
avobenzone 10 mg in 1 g / octinoxate 75 mg in 1 g / octisalate 50 mg in 1 g / oxybenzone 50 mg in 1 g topical lotion [obagi hydrafactor broad spectrum spf 30]||propanetriol||inactive_ingredient_of
lidocaine hcl 4 % topical gel (ml)||hydrogen oxide||inactive_ingredient_of
divalproex sodium 125 mg oral tablet, delayed release [depakote]||cellulose,microcrystalline||inactive_ingredient_of
product containing precisely aciclovir 200 milligram/1 each conventional release oral capsule||product containing gelatin||inactive_ingredient_of
product containing precisely loxapine 25 milligram/1 each conventional release oral capsule||blue no. 1||inactive_ingredient_of
simbrinza (brimonidine tartrate 0.2 % / brinzolamide 1 % ) ophthalmic suspension||chloride, hydrogen||inactive_ingredient_of
product containing only lamivudine 150 mg/1 each oral tablet||peg - polyethylene glycol||inactive_ingredient_of
rivastigmine 6mg capsule (product)||ferric oxide,yellow||inactive_ingredient_of
sennosides a and b 25 mg oral tablet [laxative maximum strength]||stearic acid, magnesium salt||inactive_ingredient_of
lidocaine 2.36 g in 118 ml topical gel [liquid sex]||propanediol||inactive_ingredient_of
aloe 10 [hp_x] in 1 g / arsenic trioxide 10 [hp_x] in 1 g / calcium fluoride 10 [hp_x] in 1 g / collinsonia canadensis root 10 [hp_x] in 1 g / crotalus horridus horridus venom 10 [hp_x] in 1 g / hydrofluoric acid 10 [hp_x] in 1 g / lachesis muta venom 10 [hp_x] in 1 g / lycopodium clavatum spore 10 [hp_x] in 1 g / strychnos nux-vomica seed 10 [hp_x] in 1 g / krameria lappacea root 10 [hp_x] in 1 g / vipera berus venom 10 [hp_x] in 1 g / horse chestnut 3 [hp_x] in 1 g / calendula officinalis flowering top 3 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 g / hypericum perforatum 3 [hp_x] in 1 g / solidago virgaurea flowering top 3 [hp_x] in 1 g / urtica urens 3 [hp_x] in 1 g topical cream [hemorrhoid cream]||product containing ethanol||inactive_ingredient_of
homosalate 10 g in 100 g / octisalate 5 g in 100 g / octocrylene 4 g in 100 g / titanium dioxide 4 g in 100 g topical cream [spf 50 plus]||dimethicone-vinyl dimethicone crosspolymer||inactive_ingredient_of
ibuprofen 800mg tablet (substance)||hydroxycellulose||inactive_ingredient_of
salicylic acid 20 mg in 1 ml topical cream [clear and cover acne treatment concealer clear and cover acne treatment concealer 4 sand]||decyl oleate||inactive_ingredient_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (fresa coqueta) - red]||d & c red #30||inactive_ingredient_of
octinoxate 30 mg in 1 ml / titanium dioxide 17.5 mg in 1 ml topical cream [teint couture everwear 24h wear satin finish full coverage and comfort broad spectrum spf 20 p95]||dipotassium glycyrrhizinate||inactive_ingredient_of
mexiletine hydrochloride 250 mg oral capsule [mexitil]||isopropyl alcohol (substance) [ambiguous]||inactive_ingredient_of
acetaminophen 325 mg / chlorpheniramine maleate 2 mg / phenylephrine hydrochloride 5 mg oral tablet [smart sense sinus plus headache]||ferric oxide,yellow||inactive_ingredient_of
acetaminophen 160 mg/5 ml oral suspension [leader infants' pain & fever]||sentry aq mardel clout||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [smart care advanced hand sanitizer]||product containing carmellose||inactive_ingredient_of
methylprednisolone 4 mg tablet 6 day 21 count pack||lactose monohydrte||inactive_ingredient_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (rosa dulzura) - pink]||2-(3,6-dihydroxy-2,4,5,7-tetrabromoxanthen-9-yl)-benzoic acid||inactive_ingredient_of
isopropyl alcohol 0.7 ml in 1 ml topical swab [first aid only alcohol antiseptic pad]||mouthwashes cetylpyridinium chloride||inactive_ingredient_of
benzalkonium chloride 0.001 topical cloth [germ-away]||sodium benzoate||inactive_ingredient_of
ulmus crassifolia pollen 20000 [pnu] in 1 ml subcutaneous solution [cedar elm pollen]||bicarbonate of soda||inactive_ingredient_of
product containing precisely ibuprofen 800 milligram/1 each conventional release oral tablet||hydroxycellulose||inactive_ingredient_of
octinoxate 2.25 g in 30 ml / oxybenzone 0.9 g in 30 ml topical cream [marcelle cc cream complete correction sunscreen broad spectrum spf 35]||matmate||inactive_ingredient_of
levalbuterol, 0.63 mg/3 ml inhalation solution||water product (product)||inactive_ingredient_of
octinoxate 50 mg in 1 ml topical emulsion [vitalumiere moisture-rich radiance sunscreen fluid makeup, broad spectrum spf 15, 35 soft bisque]||citric acid monohydrate||inactive_ingredient_of
tylenol sinus congestion and pain daytime non-drowsy rapid release gelcap||cellulose, microcrystalline||inactive_ingredient_of
benzonatate 200 mg oral capsule, gelatin coated||glycerinum||inactive_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [health mart daytime]||d&c yellow 10 aluminum lake||inactive_ingredient_of
blue crab 0.05 g in 1 ml intradermal solution [crab]||nasal sodium chloride||inactive_ingredient_of
alcohol 70 ml in 100 ml topical spray [the creme shop bt21 moisturizing sanitizerspray peach scented]||citric acid monohydrate||inactive_ingredient_of
levetiracetam, 750 mg oral tablet||magnesium sterate||inactive_ingredient_of
amlodipine 5/benazepril 20mg cap||kaliumhydroxid||inactive_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 100 mg in 1 ml topical lotion [sun bum spf 70 premium moisturizing sunscreen]||tetrasodium glutamate diacetate||inactive_ingredient_of
octinoxate 0.075 g in 1 g topical lipstick [esika pro perfect match volumen spf 20 plus lip liner for maximum fullness - (burgundy vital) - red]||fd & c red no. 40||inactive_ingredient_of
alcohol 67 ml in 100 ml topical liquid [pacific blue basic gel hand sanitizer with moisturizers]||product containing sucrose (medicinal product)||inactive_ingredient_of
cymbalta 20 mg (as duloxetine hydrochloride 22.4 mg) delayed release oral capsule||ethyl alcohol product||inactive_ingredient_of
homosalate 7 g in 100 g / octinoxate 2.5 g in 100 g / oxybenzone 2.0 g in 100 g / titanium dioxide 4.1 g in 100 g topical cream [cc cream broad spectrum spf 30 merle norman]||propylene glycol dicaprylate/dicaprate||inactive_ingredient_of
octinoxate 0.06 g in 1 g topical powder [esika hydrated face makeup foundation spf 15]||water||inactive_ingredient_of
titanium dioxide 6 mg in 100 ml topical cream [putto secret sun screen]||glycerin||inactive_ingredient_of
artemisia tridentata pollen 0.05 g in 1 ml percutaneous injection, solution [artemisia tridentata pollen]||sodium chloride [mouth]||inactive_ingredient_of
sennalax-s, 50 mg-8.6 mg oral tablet||titanium dioxide-containing product||inactive_ingredient_of
24 hr ditropan xl 15 mg extended release oral tablet||microcrystalline celluose||inactive_ingredient_of
budesonide 3 mg oral delayed release capsule||d & c yellow #10||inactive_ingredient_of
alcohol 75 ml in 100 ml topical gel [soleil hand sanitizer]||fiber choice weight management||inactive_ingredient_of
metformin hydrochloride, 500 mg oral tablet||corn starch top pwd||inactive_ingredient_of
zinc oxide 87 mg in 1 g topical stick [100% pure sweet mint lip balm spf 15]||ricinus obermannii oil||inactive_ingredient_of
octinoxate 40 mg in 1 g / titanium dioxide 23.6 mg in 1 g topical stick [benefit hello happy air foundation shade 6]||c12-15 alkyl ethylhexanoate||inactive_ingredient_of
product containing only sulindac 200 mg/1 each oral tablet||corn flour (product)||inactive_ingredient_of
avobenzone 2 g in 100 kg / octinoxate 7.5 g in 100 kg / octisalate 3 g in 100 kg topical cream [anti-aging eye broad spectrum spf 15 la prairie switzerland]||product containing titanium dioxide||inactive_ingredient_of
sulfur 10 % topical lotion (ml)||product containing phenoxyethanol (medicinal product)||inactive_ingredient_of
buprenorphine 8 mg / naloxone 2 mg sublingual film [suboxone]||acesulfame potassium-containing product||inactive_ingredient_of
chloroxylenol 3 mg in 1 ml topical soap [suds high foaming antiseptic hand and body wash]||n-methylisothiazolone||inactive_ingredient_of
zinc oxide 216 mg in 1 ml topical lotion [open nature children spf 50 mineral sunscreen]||hydrogen oxide||inactive_ingredient_of
titanium dioxide 15 g in 100 g / zinc oxide 5 g in 100 g topical powder [pure transformation sheer light]||mica||inactive_ingredient_of
benzalkonium chloride 0.0013 ml in 1 ml topical solution [bzk plus swabsticks]||2-phenoxyethanol||inactive_ingredient_of
ammonium chloride 30 [hp_c] in 1 ml oral pellet [colds coughs]||lactose (substance)||inactive_ingredient_of
maxzide 75mg-50mg tablet||lactose monohydrate||inactive_ingredient_of
avobenzone 20 mg in 1 ml / homosalate 70 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 50 mg in 1 ml / oxybenzone 30 mg in 1 ml topical lotion [harmon face values ultra light dry to the touch spf 30 sunscreen]||2,6-di-tert-butyl-p-cresol||inactive_ingredient_of
ibuprofen 800 mg oral tablet, film coated [ibuprofen]||lactose monohydrate||inactive_ingredient_of
octinoxate 75 mg in 1 g / octisalate 50 mg in 1 g / titanium dioxide 20 mg in 1 g topical stick [napoleon perdis foundation broad spectrum spf 15 look 1]||black ferric oxide||inactive_ingredient_of
product containing precisely levothyroxine sodium 250 microgram/1 each conventional release oral tablet (clinical drug)||2,6-ditert-butyl-4-cresol (bht)||inactive_ingredient_of
sodium fluoride 0.243% dental paste [rembrandt gentle white]||sorbitol (medication)||inactive_ingredient_of
dextran 70 1 mg/ml / hypromellose 3 mg/ml ophthalmic solution [tears renewed]||h2o - water||inactive_ingredient_of
docetaxel 10mg/ml injection solution 160mg vial (product)||viva-drops lubricating eye drops||inactive_ingredient_of
buprenorphine-naloxone 6.3 mg-1 mg buccal film||yellow ferric oxide||inactive_ingredient_of
acycycloguanosine 200 mg oral capsule||triiron tetraoxide||inactive_ingredient_of
product containing only mirtazapine 45 mg/1 each oral tablet||dibasic magnesium stearate||inactive_ingredient_of
homosalate 10 g in 100 ml / octisalate 5 g in 100 ml / avobenzone 3 g in 100 ml / octocrylene 7 g in 100 ml topical lotion [play it safe sunscreen spf 30]||dipropylene glycol||inactive_ingredient_of
naproxen sodium 220 mg oral tablet, film coated [rugby all day relief]||dibasic magnesium stearate||inactive_ingredient_of
tetrahydrozoline ophthalmic 0.05% ophthalmic solution||product containing sodium chloride (medicinal product)||inactive_ingredient_of
ketotifen fumarate 0.035% ophthalmic solution [refresh eye itch relief]||trihydroxypropane||inactive_ingredient_of
octinoxate 30 mg in 1 ml / titanium dioxide 17.5 mg in 1 ml topical emulsion [forever skin glow 24h wear radiant perfection skin caring foundation with sunscreen broad spectrum spf 35 lasting hydration 7n]||isododecane||inactive_ingredient_of
tobramycin 0.3% ophthalmic solution (product)||ácido bórico||inactive_ingredient_of
giant wild rye pollen extract 10000 unt/ml injectable solution||phenol product (product)||inactive_ingredient_of
octinoxate 83 mg in 1 ml / zinc oxide 66 mg in 1 ml topical cream [sekkisei treatment bb 01]||2-ethylhexyl palmitate||inactive_ingredient_of
allantoin 0.5 in 25 g topical patch [cellapy mgf hydro gel intense mask]||zhigancao (glycyrrhiza glabra)||inactive_ingredient_of
warfarin na 4mg tab,ud||d and c blue no.2||inactive_ingredient_of
product containing only metoprolol tartrate 100 mg/1 each oral tablet||silicon dioxide, fumed||inactive_ingredient_of
duloxetine hydrochloride 60 mg oral capsule, delayed release pellets [duloxetine delayed-release]||ethyl citrate||inactive_ingredient_of
capsaicin 0.025 % / histamine dihydrochloride 0.075 % topical cream||alcohol stearyl||inactive_ingredient_of
pramoxine hydrochloride 10 mg in 1 ml topical shampoo [dermal-soothe]||ceramide eos||inactive_ingredient_of
product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)||polyvinyl pyrrolidone (substance)||inactive_ingredient_of
octinoxate 4 g in 100 g / zinc oxide 2.4 g in 100 g topical cream [studio look base de alta cobertura para el rostro con fps 20 almendra 230-n]||.alpha.-hexylcinnamaldehyde||inactive_ingredient_of
leader loratadine 10mg tablet||magnesium stearate||inactive_ingredient_of
alcohol 70 ml in 100 ml / triclosan 0.35 mg in 100 ml topical gel [wash-free disinfectant gel]||glycerin product||inactive_ingredient_of
product containing only tetracycline 500 mg/1 each oral capsule||magnesium palmitostearate||inactive_ingredient_of
quetiapine 100mg tablet (product)||fortran||inactive_ingredient_of
product containing fexofenadine hydrochloride 180 mg/1 each oral tablet (clinical drug)||cellulose powders||inactive_ingredient_of
eucalyptus oil 0.05 in 10 ml / allantoin 0.1 in 10 ml topical liquid [phs hair science adv revitalizing scalp ampoule]||lavender oil product||inactive_ingredient_of
dicyclomine hcl@20 mg@oral@tablet||cellulose hydroxypropyl methyl ether||inactive_ingredient_of
amphetamine 3.1 mg oral tablet, disintegrating, extended release||mannitol (medication)||inactive_ingredient_of
naproxen 375 mg oral tablet [naproxen]||polyvidons||inactive_ingredient_of
octinoxate 0.072 g in 1 g topical lipstick [effet parfait rouge amplifier amplifying spf 15 (coral maximum) - orange]||titanium dioxide product||inactive_ingredient_of
atorvastatin calcium trihydrate 10 mg oral tablet [atorvastatin calcium]||sodium bicarbonate product||inactive_ingredient_of
pyrithione zinc 10 mg in 1 ml topical shampoo [topcare everyday clean dandruff]||fd & c blue no. 1||inactive_ingredient_of
amitriptyline hcl 100mg tab||hypromellose 2910 (6 mpa.s)||inactive_ingredient_of
belbuca, 150 mcg buccal film||saccharin sodium||inactive_ingredient_of
product containing emtricitabine 200 mg and tenofovir 136 mg/1 each oral tablet||microcrystalline celluose||inactive_ingredient_of
acetaminophen/diphenhydramine hydrochloride/phenylephrine hydrochloride 325 mg-12.5 mg-5 mg oral tablet [severe cold & sinus relief pe]||talc (substance)||inactive_ingredient_of
sultan/topex neutral ph 2% gel (pina colada)||magnesium aluminium silicate||inactive_ingredient_of
product containing rosuvastatin 10 mg/1 each oral tablet||lactose monhydrate||inactive_ingredient_of
ondansetron hydrochloride 4mg oral tablet||pregelatinized corn starch 1551||inactive_ingredient_of
avobenzone 30 mg in 1 ml / octinoxate 50 mg in 1 ml / octisalate 50 mg in 1 ml / oxybenzone 40 mg in 1 ml topical cream [super creme solaire corps body sun care spf 15]||product containing lavender oil (medicinal product)||inactive_ingredient_of
chloroxylenol .5 ml in 100 ml topical aerosol, foam [secure]||water product (product)||inactive_ingredient_of
octinoxate 3.9 g in 50 ml / zinc oxide 3.8 g in 50 ml topical lotion [decorte sheer brilliance 40]||palmitoyl pentapeptide-3||inactive_ingredient_of
product containing only sertraline 50 mg/1 each oral tablet||calcium phosphate dibasic dihydrate||inactive_ingredient_of
camphor 4.6 mg/ml / capsicum extract 0.25 mg/ml / menthol 17 mg/ml topical lotion||soybean oil emulsion||inactive_ingredient_of
octinoxate 39.9 mg in 1 ml / titanium dioxide 30.4 mg in 1 ml topical emulsion [lingerie de peau aqua nude water-infused perfecting fluid intense hydration long-wear foundation with sunscreen broad spectrum spf 20 05w deep warm]||beta-hydroxyethyl phenyl ether||inactive_ingredient_of
product containing only cinacalcet 30 mg/1 each oral tablet (clinical drug)||sclerosing agents talc||inactive_ingredient_of
alcohol 0.75 ml in 1 ml topical gel [dimyoor hand sanitizer]||calendula eriocarpa flower||inactive_ingredient_of
loperamide hydrochloride 2 mg oral capsule, liquid filled [good neighbor pharmacy anti-diarrheal]||product containing gelatin (medicinal product)||inactive_ingredient_of
calcium carbonate, 1250 mg oral tablet||titanium(iv) oxide||inactive_ingredient_of
octinoxate 682 mg in 35.88 g / titanium dioxide 1471 mg in 35.88 g topical cream [shiseido radiant lifting foundation wb60]||lavender oil greece||inactive_ingredient_of
titanium dioxide 1.648359 g in 30 ml / octinoxate 0.999 g in 30 ml topical lotion [ck one all day perfection face makeup spf 20 sunscreen 100 porcelain]||poly(methyl methacrylate; 450000 mw)||inactive_ingredient_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (borgona sexy) - purple]||oils, soy bean||inactive_ingredient_of
salicylic acid 2 g in 100 ml topical gel [pink grapefruit foaming acne scrub daylogic]||aloe vera leaf extract||inactive_ingredient_of
octinoxate 75 mg in 1 ml / octisalate 20 mg in 1 ml / oxybenzone 40 mg in 1 ml / titanium dioxide 25 mg in 1 ml topical lotion [spf30 sunscreen]||myristyl propionate||inactive_ingredient_of
benzethonium chloride 0.2 mg in 10 ml / dyclonine hydrochloride 0.75 mg in 10 ml topical liquid [benzethonium chloride plus dyclonine hydrochloride]||ricinus lividus oil||inactive_ingredient_of
losartan potassium 50 mg oral tablet||corn flour (substance)||inactive_ingredient_of
frusemide 10mg/ml injection||product containing sodium chloride||inactive_ingredient_of
ezetimibe/simvastatin 10 mg-10 mg oral tablet [vytorin]||hydroxy propyl methyl cellulose||inactive_ingredient_of
octinoxate 4 g in 100 g / zinc oxide 2.4 g in 100 g topical cream [studio look base de alta cobertura para el rostro con fps 20 cacao 350-n]||ferric oxide red||inactive_ingredient_of
hydroquinone 5 mg in 100 ml topical cream [gold cosmetics bleach cream]||jojoba seed oil||inactive_ingredient_of
methylphenidate hcl@30 mg@oral@capsule,extended release biphasic 50-50||shellac||inactive_ingredient_of
camphor (synthetic) 50 mg in 1 ml topical cream [goldies pain off]||methyltocols||inactive_ingredient_of
octinoxate 55 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [laura mercier tinted moisturizer oil free broad spectrum spf 20 sunscreen 5w1 tan]||edta disodium salt (anhydrous)||inactive_ingredient_of
amoxicillin 775mg extended release tablet (product)||magnesium octadecanoate||inactive_ingredient_of
avobenzone 29 mg in 1 ml / homosalate 90 mg in 1 ml / octinoxate 68 mg in 1 ml / octisalate 45 mg in 1 ml / octocrylene 50 mg in 1 ml topical lotion [aegis daily facial spf 25]||dehydrated ethanol||inactive_ingredient_of
dextroamphetamine sulfate 10 mg extended release oral capsule||product containing gelatin (medicinal product)||inactive_ingredient_of
product containing only metformin hydrochloride 500 mg/1 each oral tablet (clinical drug)||hydroxypropyl methylcellulose (ophthalmic) (medication)||inactive_ingredient_of
johnson grass pollen extract 20000 unt/ml injectable solution||h2o - water||inactive_ingredient_of
lotensin 20 mg oral tablet||polydextrose (substance)||inactive_ingredient_of
hydrocortisone 1 g in 100 ml topical cream [truelipids anti-itch barrier]||sodium citrate, anhydrous||inactive_ingredient_of
avobenzone 3 g in 100 ml / homosalate 6 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 6.5 g in 100 ml topical oil [lipidol]||safflower seed||inactive_ingredient_of
octinoxate 3.5 ml in 50 ml / avobenzone 1.5 ml in 50 ml / titanium dioxide 12.5 ml in 50 ml topical cream [whitening glycobest]||trioctanoin (substance)||inactive_ingredient_of
octinoxate 40 mg in 1 g / titanium dioxide 23.6 mg in 1 g topical stick [benefit hello happy air foundation shade 2]||chamomile extract||inactive_ingredient_of
titanium dioxide 85.4 mg in 1 ml / zinc oxide 40.7 mg in 1 ml topical cream [facecotz (sunscreen)]||dimethicone product||inactive_ingredient_of
alcohol 69.4 ml in 100 ml topical gel [virus gone]||product containing glycerol (medicinal product)||inactive_ingredient_of
lolium perenne pollen 10000 [bau] in 1 ml percutaneous solution||bicarb||inactive_ingredient_of
calcium carbonate 420 oral tablet, chewable [mint antacid]||corn starch||inactive_ingredient_of
wormwood 10 [hp_x] in 1 ml / semecarpus anacardium juice 10 [hp_x] in 1 ml / silver nitrate 10 [hp_x] in 1 ml / arsenic trioxide 10 [hp_x] in 1 ml / atropa belladonna 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 1 ml / camphor (natural) 10 [hp_x] in 1 ml / matricaria recutita 10 [hp_x] in 1 ml / black cohosh 10 [hp_x] in 1 ml / cinchona officinalis bark 10 [hp_x] in 1 ml / arabica coffee bean 10 [hp_x] in 1 ml / cypripedium parvifolum root 10 [hp_x] in 1 ml / gelsemium sempervirens root 10 [hp_x] in 1 ml / hops 10 [hp_x] in 1 ml / hyoscyamus niger 10 [hp_x] in 1 ml / strychnos ignatii seed 10 [hp_x] in 1 ml / potassium bromide 10 [hp_x] in 1 ml / strychnos nux-vomica seed 10 [hp_x] in 1 ml / passiflora incarnata flowering top 10 [hp_x] in 1 ml / pulsatilla vulgaris 10 [hp_x] in 1 ml / scutellaria lateriflora 10 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml / thuja occidentalis leafy twig 10 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml oral liquid [insomnia]||alcohol ethyl||inactive_ingredient_of
octinoxate 40 mg in 1 g topical lipstick [yanbal hydra-lip labial color intenso intense color sunscreen spf 15 lady malbec]||candelilla wax||inactive_ingredient_of
enalapril 1mg/ml (rtu) oral soln||cordycepic acid||inactive_ingredient_of
chaste tree 10 [hp_x] in 59 ml / arnica montana 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / dieffenbachia seguine 10 [hp_x] in 59 ml / potassium bromide 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / nuphar luteum root 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / onosmodium virginianum whole 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / picric acid 10 [hp_x] in 59 ml / selenium 10 [hp_x] in 59 ml oral liquid [male strengthener]||potassium sorbate||inactive_ingredient_of
benzalkonium chloride 0.1 g in 100 ml topical liquid [nano pure]||lauryltrimethylammonium chloride||inactive_ingredient_of
diphenhydramine hydrochloride 25 mg oral tablet [good neighbor pharmacy allergy]||calcium hydrogen phosphate anhydrous||inactive_ingredient_of
alcohol 40 g in 100 g / chlorhexidine gluconate 1 g in 100 g topical liquid [freeman packing alcohol wipe]||benzalkonium chloride||inactive_ingredient_of
phenylephrine hcl@10 mg@oral@tablet||siliceous earth, purified||inactive_ingredient_of
titanium dioxide 0.65 g in 1 g topical emulsion [oi lin natural emulsion spf 30]||water product||inactive_ingredient_of
octinoxate 0.068 g in 1 g topical lipstick [esika pro hd color high definition color spf 20 (hd cafe habano) - brown]||shea butter||inactive_ingredient_of
lorazepam .5 mg oral tablet [lorazepam]||cellulose powders||inactive_ingredient_of
titanium dioxide 80 mg in 5 g topical stick [cle de peau beaute concealer ivory]||ferriferrous oxide||inactive_ingredient_of
homosalate 99.2 mg in 1 ml / octisalate 49.6 mg in 1 ml / octocrylene 49.6 mg in 1 ml / avobenzone 29.76 mg in 1 ml topical lotion [tropic sun spf 50]||aloe vera leaf||inactive_ingredient_of
chlorpromazine hydrochloride 50 mg oral tablet, sugar coated [chlorpromazine hydrochloride]||lactose, anhydrous||inactive_ingredient_of
octinoxate 60 mg in 1 ml / octocrylene 70 mg in 1 ml / oxybenzone 40 mg in 1 ml / titanium dioxide 40 mg in 1 ml / zinc oxide 50 mg in 1 ml topical lotion [solar protection formula spf 65 sunscreen]||6-o-palmitoylascorbic acid||inactive_ingredient_of
product containing only methazolamide 50 mg/1 each oral tablet||corn flour||inactive_ingredient_of
octinoxate 60 mg in 1 ml topical lotion [skin caviar foundation sunscreen spf 15 - mocha]||product containing lysine (medicinal product)||inactive_ingredient_of
mirtazapine, 15 mg oral tablet||hydroxypropylmethylcellulose (substance)||inactive_ingredient_of
isopropyl alcohol 70 ml in 100 ml topical gel [hand sanitizer tobacco leather]||glycerin||inactive_ingredient_of
valacyclovir hydrochloride 500 mg oral tablet [valacyclovir]||hypromellose 2910 (3 mpa.s)||inactive_ingredient_of
topiragen, 25 mg oral tablet||hypromellose product||inactive_ingredient_of
cupressus arizonica pollen extract 0.1 gm/ml injectable solution||water||inactive_ingredient_of
witch hazel 0.5 g in 1 g topical swab [medicated wipes maximum srenght formula]||glyzerin||inactive_ingredient_of
octinoxate 1.5 ml in 30 ml / titanium dioxide 0.48 ml in 30 ml topical emulsion [no7 lifting and firming foundation sunscreen spf 15 truffle 50]||product containing aluminium oxide||inactive_ingredient_of
product containing only simvastatin 5 mg/1 each oral tablet||magnesium distearate||inactive_ingredient_of
pyrithione zinc 0.2 mg in 1 ml topical cream [blue cap cream]||galactosyl-alpha(1-4)-galactosyl-beta(1-4)- glucosyl-beta(1-1)-ceramide||inactive_ingredient_of
product containing precisely naproxen sodium 550 milligram/1 each conventional release oral tablet (clinical drug)||magnesium stearate (substance)||inactive_ingredient_of
carbidopa@25 mg@oral@tablet||cellulose, powdered||inactive_ingredient_of
pyrithione zinc@0.25 %@topical@cream (ml)||product containing propyl 4-hydroxybenzoate||inactive_ingredient_of
lignoc+adren 2% ster wrap inj||citric acid monohydrate||inactive_ingredient_of
benzocaine/menthol/zinc chlor 20 %-0.26 %-0.15 % mucous mem gel (gram)||acid, propenylacrylic||inactive_ingredient_of
yosprala, 325 mg-40 mg oral delayed release tablet||quso f-22||inactive_ingredient_of
titanium dioxide 3.71 mg in 40 ml topical cream [3 concept eyes honey face chiffon fluid 001]||product containing water||inactive_ingredient_of
ginger 0.5 g in 100 g / arnica montana flower 0.5 g in 100 g / magnesium chloride 2 g in 100 g / curcumin 1 g in 100 g / thiamine 1 g in 100 g / piperine 0.2 g in 100 g / pyridoxine 1 g in 100 g topical patch||p-chlorophenyl-α-glyceryl ether||inactive_ingredient_of
product containing precisely oxymorphone 10 milligram/1 each conventional release oral tablet (clinical drug)||cellulose, microcrystalline||inactive_ingredient_of
octinoxate 30 mg in 1 ml topical liquid [yanbal base liquida hidratante moisturizing foundation sunscreen broad spectrum spf 15 tono 2]||phenoxyethanol (substance)||inactive_ingredient_of
nickel sulfate hexahydrate 3 [hp_x] in 237 ml / sodium bromide 2 [hp_x] in 237 ml / zinc bromide 4 [hp_x] in 237 ml / potassium bromide 1 [hp_x] in 237 ml / potassium sulfate 4 [hp_x] in 237 ml oral liquid [psoriasis]||4-hydroxybenzoic acid methyl ester||inactive_ingredient_of
dextroamphetamine so4 10mg tab||polyvidone||inactive_ingredient_of
product containing naproxen 500 mg/1 each oral tablet||polividone||inactive_ingredient_of
octinoxate 7.49 g in 100 ml / avobenzone 2 g in 100 ml topical oil [mele men plus care hydrate face]||tonka bean camphor||inactive_ingredient_of
children's allergy (loratadine), 5 mg/5 ml oral syrup||α-propyleneglycol||inactive_ingredient_of
benzalkonium chloride 0.13 g topical cloth [personal care wet wipes citrus]||sorbate potassium||inactive_ingredient_of
simvastatin 5mg tab,ud||pyrocellulose||inactive_ingredient_of
dicyclomine hcl@10 mg/5 ml (5 ml)@oral@solution, oral||fd & c blue no. 1||inactive_ingredient_of
oatmeal 10 mg in 1 ml topical oil [cerave developed with dermatologists eczema relief creamy]||1,2,3-propanetriol||inactive_ingredient_of
today's health day time multi-symptom cold/flu relief solution||1,1-dioxide-1,2-benzisothiazol-3(2h)-one, sodium salt||inactive_ingredient_of
octinoxate 7.14 mg in 1 g / oxybenzone 4 mg in 1 g / octisalate 4.75 mg in 1 g / avobenzone 3 mg in 1 g topical emulsion [flawless future spf 30]||product containing benzyl salicylate||inactive_ingredient_of
titanium dioxide 70 mg in 1 ml / zinc oxide 100 mg in 1 ml topical lotion [spit and polish sun smart sunscreen]||medium-chain trigylcerides||inactive_ingredient_of
ethinyl estradiol 10 microgram oral tablet||product containing titanium dioxide||inactive_ingredient_of
octinoxate 75 mg in 1 ml / oxybenzone 50 mg in 1 ml / zinc oxide 186 mg in 1 ml / titanium dioxide 19 mg in 1 ml topical cream [cellular swiss protection veil broad spectrum spf 50]||hydroxycitronellal||inactive_ingredient_of
product containing only ramipril 5 mg/1 each oral capsule (clinical drug)||f d & c red #40||inactive_ingredient_of
duloxetine 30 mg oral delayed release capsule||nh3 - ammonia||inactive_ingredient_of
flecainide acetate 100 mg oral tablet||silica (sio2)||inactive_ingredient_of
dextromethorphan hydrobromide 30 mg in 5 ml oral suspension [up and up 12 hour cough relief]||gum tragacanth||inactive_ingredient_of
venlafaxine hydrochloride er, 75 mg oral tablet, extended release||glycol, propylene||inactive_ingredient_of
benzalkonium chloride 1.3 mg in 1 g topical cloth [safe and soft antibacterial hand wipes]||laureth 4||inactive_ingredient_of
octinoxate 0.072 g in 1 g topical lipstick [effet parfait rouge amplifier amplifying spf 15 (carmine) - red]||siliceous earth, purified||inactive_ingredient_of
sulfur 30 mg in 1 ml topical lotion [acne lotionsulfur sulfur]||l-glutamic acid, monosodium salt||inactive_ingredient_of
benzocaine 200 mg in 1 g topical gel [quality choice maximum strength oral pain relieving]||macrogol 3350 product||inactive_ingredient_of
naproxen sodium 220 mg oral capsule, liquid filled [topcare naproxen sodium]||glycerol-containing product||inactive_ingredient_of
alcohol 75 ml in 100 ml topical gel [suave hand sanitizer]||carbomer homopolymer (allyl sucrose crosslinked)||inactive_ingredient_of
product containing precisely cinacalcet (as cinacalcet hydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug)||silicon oxide||inactive_ingredient_of
publix acid reducer maximum strength 20mg tablet||magnesium distearate||inactive_ingredient_of
mercurius solubilis 15 [hp_c] in 15 [hp_c] oral pellet [mercurius solubilis]||sucrose preparation (substance)||inactive_ingredient_of
octinoxate 1832 mg in 30 ml topical cream [shiseido future lx total radiance foundation e neutral 4]||.alpha.-tocopherol acetate, dl-||inactive_ingredient_of
octinoxate 0.065 g in 1 ml / zinc oxide 0.33 g in 1 ml topical cream [esika pro hydra smart hydro-nutritive foundation spf 15 beige 2]||2-amino-2-(hydroxymethyl)-1,3-propanediol||inactive_ingredient_of
lidocaine 4 % topical gel (gram)||menthol||inactive_ingredient_of
octinoxate 50 mg in 1 ml topical cream [pretty by flormar weigthless foundation 011 honey]||cyclomethicone 5||inactive_ingredient_of
ursodeoxycholic acid 500mg tablet||matmate||inactive_ingredient_of
amitriptyline hcl 75mg tab,ud||sodium starch glycolate type a potato||inactive_ingredient_of
avobenzone 1 g in 100 ml / octinoxate 7.5 g in 100 ml topical cream [auolive day glower facial moisturiser with sunscreen]||óxido de titanio(4)||inactive_ingredient_of
sodium fluoride 0.5 mg / vitamin a palmitate 2500 [iu] / ascorbic acid 60 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate 15 [iu] / thiamine mononitrate 1.05 mg / riboflavin 1.2 mg / niacinamide 13.5 mg / pyridoxine hydrochloride 1.05 mg / folic acid 0.3 mg / cyanocobalamin 4.5 ug oral tablet, chewable [mvc]||sentry aq mardel clout||inactive_ingredient_of
zinc oxide 0.113 g in 1 g topical cream [balmex adult care rash]||wax,microcrystalline||inactive_ingredient_of
acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 20 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml / phenylephrine hydrochloride 10 mg in 30 ml oral solution [signature care nighttime severe cold and flu relief]||propan-1,2-diol||inactive_ingredient_of
octinoxate 55 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [laura mercier tinted moisturizer oil free broad spectrum spf 20 sunscreen 5w1 tan]||dha's||inactive_ingredient_of
product containing propranolol hydrochloride 20 mg/1 each oral tablet (clinical drug)||blue no. 1||inactive_ingredient_of
octinoxate 0.071 g in 1 g / oxybenzone 0.16 g in 1 g topical lipstick [lbel effet parfait hydratess long-lasting intense moisturizing spf 20 (tulip) - pink]||ceramide np||inactive_ingredient_of
phenylephrine hydrochloride 10 mg oral tablet [dg health nasal decongestant pe maximum strength]||titanium oxide||inactive_ingredient_of
lidocaine 140 mg cutaneous patch [lidocaine]||propylene glycol||inactive_ingredient_of
salicylic acid 30 mg in 6 g topical powder [bareminerals blemish rescue skin-clearing loose foundation medium beige 2.5n]||licorice root||inactive_ingredient_of
acer saccharinum pollen 20000 [pnu] in 1 ml subcutaneous solution [silver soft maple pollen]||1,2,3-propanetriol||inactive_ingredient_of
anas platyrhynchos feather extract 10,000 unt/ml injectable solution||sodium chloride (product)||inactive_ingredient_of
benzene 30 [hp_c] in 30 [hp_c] oral pellet [benzinum]||sucrose preparation||inactive_ingredient_of
finasteride 1 mg oral tablet [propecia]||titanium dioxide product||inactive_ingredient_of
hydrocortisone butyrate 1 mg/ml topical lotion||water||inactive_ingredient_of
camphor (synthetic) 5.56 g in 459.93 g / levomenthol 25.48 g in 459.93 g / methyl salicylate 28.1 g in 459.93 g topical patch [sinsinpas pain relieving patch]||paste, lassar's||inactive_ingredient_of
menthol 5 mg oral lozenge [equate organic honey strawberry cough drop]||sucrose preparation||inactive_ingredient_of
octinoxate 2 mg in 1 ml topical cream [camouflage concealer cream]||dipentaerythrityl tri-polyhydroxystearate||inactive_ingredient_of
succinylcholine chloride 20 mg in 1 ml intravenous injection, solution||white caustic||inactive_ingredient_of
venlafaxine hcl 150 mg 24hr extended release oral tablet||lactose product||inactive_ingredient_of
gelusil antacid & anti-gas (aluminum hydroxide 200 mg / milk of magnesia 200 mg / simethicone 25 mg) chewable tablet||product containing mannitol (medicinal product)||inactive_ingredient_of
sodium monofluorophosphate 0.76 g in 100 g oral gel [jason nutrismile anticavity orange cinnamon mint]||sorbitan monooleate||inactive_ingredient_of
zinc oxide 11.6 g in 100 ml / titanium dioxide 0.67 g in 100 ml topical lotion [mychelle dermaceuticals sun shield spf 28 coconut protect]||leuconostoc/radish root ferment filtrate||inactive_ingredient_of
isopropyl alcohol 75 ml in 100 ml topical gel [naturia]||carboxypolymethylene||inactive_ingredient_of
avobenzone 2 g in 100 g / octocrylene 5 g in 100 g / oxybenzone 3 g in 100 g topical lotion [meijer oil free faces spf 30]||boo-boo magic||inactive_ingredient_of
titanium dioxide 28 mg in 1 ml topical liquid [clarins - skin illusion - broad spectrum spf 15 - titanium dioxide - sunscreen - natural hydrating foundation 103]||potassium sorbate||inactive_ingredient_of
product containing only nizatidine 150 mg/1 each oral capsule (clinical drug)||iron black||inactive_ingredient_of
product containing precisely promethazine hydrochloride 25 milligram/1 each conventional release oral tablet||microcrystaline cellulose||inactive_ingredient_of
pseudoephedrine hydrochloride 30 mg oral tablet [leader nasal decongestant]||allura red ac dye||inactive_ingredient_of
octinoxate 0.068 g in 1 g topical lipstick [esika pro hd color high definition color spf 20 (hd coral ensueno) - red]||mica (substance)||inactive_ingredient_of
fenofibrate, 160 mg oral tablet||dimethicone as antiflatulent||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [higeen antiseptic hand sanitizer gel with vitamin beads wild berry]||maldrin||inactive_ingredient_of
rifampin 300mg cap||fd & c red #40||inactive_ingredient_of
peg-400/propylene glycol 0.4%-0.3% ophthalmic solution [ultra lubricant eye drops]||sodium hydroxide||inactive_ingredient_of
titanium dioxide 0.96 g in 12 g / zinc oxide 0.792 g in 12 g topical lipstick [mdsolarsciences natural mineral sunscreen]||glyceryl isostearate||inactive_ingredient_of
safety 1st oh sh t kit kit||ultramarine blue||inactive_ingredient_of
metoclopramide hcl 5mg/5ml oral soln||glycerol-containing product||inactive_ingredient_of
sildenafil citrate 25 mg oral tablet [viagra]||octadecanoic acid, magnesium salt||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [sanitizing hand]||lemon myrtle leaf oil||inactive_ingredient_of
naproxen sodium 550 mg oral tablet, film coated [naproxen sodium]||dióxido de titanio||inactive_ingredient_of
levothyroxine sodium 88mcg tablet||d&c blue no. 2||inactive_ingredient_of
castanea sativa leaf 1 [hp_x] in 1 ml sublingual solution [g-9]||water-containing product||inactive_ingredient_of
diclofenac na 50mg ec tab||alumina hydrate||inactive_ingredient_of
cloderm 0.1 % topical cream||benzalcohol||inactive_ingredient_of
synalar, 0.025% topical cream||edathamil disodium||inactive_ingredient_of
titanium dioxide 2.44 g in 100 g / octinoxate 6.5 g in 100 g / zinc oxide 1.57 g in 100 g topical paste [lbel mousse matiffiant matte finish mousse foundation spf 15 medium 6]||cyclomethicone 6||inactive_ingredient_of
menthol 50.25 mg topical patch [icy hot medicated micro]||titanium oxide||inactive_ingredient_of
acepromazine maleate 10 mg/ml injectable solution [promace]||sodium citrate dehydrate||inactive_ingredient_of
pregabalin, 225 mg oral capsule||shellac (substance)||inactive_ingredient_of
octinoxate 75 mg in 1 ml / oxybenzone 50 mg in 1 ml / zinc oxide 186 mg in 1 ml / titanium dioxide 19 mg in 1 ml topical cream [cellular swiss protection veil broad spectrum spf 50]||equisetum arvense extract||inactive_ingredient_of
oxymetazoline hydrochloride 0.05% nasal spray [nasal extra moisturising 12 hour]||petarmor anti-itch||inactive_ingredient_of
paxil 12.5 mg 24 hr extended release oral tablet||magnesium sterate||inactive_ingredient_of
avobenzone 1 ml in 50 ml / octinoxate 3 ml in 50 ml topical cream [glytone essentials rejuvenate daily]||glyceryl monostearate||inactive_ingredient_of
octinoxate 68 mg in 1 ml / octisalate 45 mg in 1 ml / zinc oxide 126.6 mg in 1 ml / titanium dioxide 24.9 mg in 1 ml topical cream [artistry ideal radiance uv protect spf 50 plus broad spectrum sunscreen]||mgso4||inactive_ingredient_of
calcium polycarbophil 625 mg (as polycarbophil 500 mg) oral tablet||crospovidone (15 mpa.s at 5%)||inactive_ingredient_of
menthol 5 mg in 1000 ml topical lotion [carvanum]||2-methylpentane-2,4-diol||inactive_ingredient_of
docusate sodium 100 mg oral capsule, liquid filled [leader stool softener]||gelatine||inactive_ingredient_of
zinc oxide 10 g in 100 ml topical emulsion [perfecting liquid foundation deep beige spf 15]||medium chain triglyceride||inactive_ingredient_of
norepinephrine bitartrate 1 mg/1 ml intravenous solution [levophed]||metabisulfite sodium||inactive_ingredient_of
aspirin 81 mg oral tablet, film coated||lactose product||inactive_ingredient_of
urtica dioica 3 [hp_x] in 1 ml / iron 3 [hp_x] in 1 ml oral liquid||sodium chloride nasal||inactive_ingredient_of
zinc oxide 3.2 mg in 100 ml / titanium dioxide 2.9 mg in 100 ml topical lotion [yes to carrots daily facial moisturizer spf 15]||octanoic acid, 2,3-dihydroxypropyl ester||inactive_ingredient_of
docusate sodium, sodium 50 mg oral capsule||sorbitol-containing product||inactive_ingredient_of
octinoxate 0.065 g in 1 g / titanium dioxide 0.024 g in 1 g / zinc oxide 0.015 g in 1 g topical paste [lbel effet parfait mineral natural skin effect mousse foundation spf 16 medium 5- beige]||cyclomethicone 5||inactive_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 20 mg in 1 ml / oxybenzone 40 mg in 1 ml topical aerosol, spray [cvs health sport spf 30 clear]||acrylate/isobutyl methacrylate/n-tert-octylacrylamide copolymer (75000 mw)||inactive_ingredient_of
pramoxine hydrochloride 10 mg in 1 g topical cream [first degree maximum strength burn]||cantharis preparation||inactive_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [up and up daytime severe cold]||sentry aq mardel clout||inactive_ingredient_of
capsaicin 0.35 mg/ml / menthol 50 mg/ml / methyl salicylate 200 mg/ml topical cream [medi-derm]||fdc green no. 3||inactive_ingredient_of
menthol 0.25 g in 100 ml topical liquid [celgen advanced hair tonic]||zanthoxylum piperitum fruit pulp||inactive_ingredient_of
titanium dioxide 18.9 mg in 1 ml topical liquid [clarins skin illusion spf 10 natural radiance foundation tint 108]||stearic acid (substance) [ambiguous]||inactive_ingredient_of
alcohol 70 ml in 100 ml topical gel [surya henna hand sanitizer]||water product (product)||inactive_ingredient_of
ambrosia trifida pollen 0.05 g in 1 ml intradermal injection [giant ragweed pollen]||sodium chloride [skin] (product)||inactive_ingredient_of
titanium dioxide 4 mg in 100 ml topical cream [principal secret reclaim oil control hydrator spf-8]||argireline np||inactive_ingredient_of
calcium carbonate 750 mg (ca 300 mg) chewable tablet||medium chain triglycerides (substance)||inactive_ingredient_of
diclofenac sodium 100 mg prolonged-release oral tablet||titanium dioxide||inactive_ingredient_of
dextromethorphan hydrobromide 5 mg in 5 ml / guaifenesin 100 mg in 5 ml / phenylephrine hydrochloride 2.5 mg in 5 ml oral liquid [childrens mucus relief multi symptom cold]||propyl gallate (substance)||inactive_ingredient_of
avobenzone 20.16 mg in 1 ml / octocrylene 30.24 mg in 1 ml / homosalate 50.4 mg in 1 ml / octisalate 45.36 mg in 1 ml topical lotion [coppertone sport spf 15]||arachidyl alcohol||inactive_ingredient_of
diphenhydramine hydrochloride 25 mg oral tablet [allergy]||croscramellose sodium||inactive_ingredient_of
alcohol 75 ml in 100 ml topical cloth [activa]||agua||inactive_ingredient_of
methocarbamol 750 mg oral tablet, film coated||20s, polysorbate||inactive_ingredient_of
lidocaine 4 g in 100 g topical patch||polyvinyl alcohol, unspecified||inactive_ingredient_of
hctz 12.5mg/losartan 100mg tab||talcum powder||inactive_ingredient_of
alcohol 80 ml in 100 ml topical liquid [joeten hand sanitizer]||water product (product)||inactive_ingredient_of
product containing only flurazepam 15 mg/1 each oral capsule||dioxide titanium||inactive_ingredient_of
allantoin 5 mg in 1 g / lidocaine 5 mg in 1 g topical ointment [cbdmedic itch and rash]||zinc oxide product||inactive_ingredient_of
senna/docusate sodium 8.6-50mg oral tablet||cellulose,microcrystalline||inactive_ingredient_of
omnipaque 12mg/ml solution||hydrochloric acid preparations||inactive_ingredient_of
tinidazole 250 mg oral tablet, film coated [tindamax]||glycols, polyethylene||inactive_ingredient_of
omeprazole 20 mg oral tablet, delayed release||magnesium stearate (substance)||inactive_ingredient_of
glycerin 12 g in 200 ml / allantoin 0.6 g in 200 ml topical emulsion||european olive pollen||inactive_ingredient_of
octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel couleur luxe rouge irresistible maximum hydration spf 17 (rose brillance) - red]||product containing ethyl 4-hydroxybenzoate (medicinal product)||inactive_ingredient_of
titanium dioxide 0.3 g in 2 g topical cream [bareminerals spf 20 correcting concealer]||octadecenedioic acid||inactive_ingredient_of
octinoxate 75 mg in 1 g / oxybenzone 50 mg in 1 g topical lipstick [neutrogena revitalizing lip balm spf 20 - sunny berry 30]||mica (substance)||inactive_ingredient_of
quality choice hemorrhoidal ointment||peg-23 lauryl ether||inactive_ingredient_of
ammonium lactate topical 12% topical cream||1,2-propylenglykol||inactive_ingredient_of
alcohol 650 mg in 1 ml topical liquid [care one antibacterial snow kissed pear]||powdered cellulose||inactive_ingredient_of
penicillin v 500mg tablet||titanium oxide||inactive_ingredient_of
doxepin hcl@25 mg@oral@capsule||lac resin||inactive_ingredient_of
lamictal xr 100mg extended-release tablet||hydroxy propyl methyl cellulose||inactive_ingredient_of
triclosan 0.1 g in 100 ml topical soap [essential everyday orange scent]||sulfoacetic acid dodecyl ester s-sodium salt||inactive_ingredient_of
sennosides 8.6 mg oral tablet, film coated [senna-lax]||maldrin||inactive_ingredient_of
titanium dioxide 0.062393 g in 1 g / zinc oxide 0.049 g in 1 g / octinoxate 0.03 g in 1 g topical powder [lbel divine polvos compactos doble uso fps 15 edicion de lujo dorado/double use compact spf 15 gold deluxe edition medium 5]||isostearyl neopentanoate||inactive_ingredient_of
momexin 0.1 % topical cream||aluminum starch octenylsuccinate||inactive_ingredient_of
laevothyroxine sodium 50mcg tablet||magnesium searate||inactive_ingredient_of
alcohol 70 g in 100 ml topical gel [marvelous hand sanitizer]||peg-60 hydrogenated castor oil||inactive_ingredient_of
zinc oxide 200 mg in 1 ml topical lotion [perfecting bb beauty balm natural tint spf 30]||dimethicone-containing product||inactive_ingredient_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (granate seductor) - purple]||(4r)-1-methyl-4-prop-1-en-2-yl-cyclohexene||inactive_ingredient_of
acetic acid 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / iris versicolor root 10 [hp_x] in 59 ml / potassium phosphate, dibasic 10 [hp_x] in 59 ml / lactic acid, dl- 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / sodium phosphate, dibasic, heptahydrate 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / uranyl nitrate hexahydrate 10 [hp_x] in 59 ml oral liquid [sugar metabolizer]||19-o-beta-glucopyranosyl-13-o-(beta-glucopyranosyl(1-2)-beta-glucopyranosyl(1-3))-beta-glucopyranosyl-13-hydroxykaur-16-en-19-oic acid||inactive_ingredient_of
product containing precisely ketorolac trometamol 30 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)||sodium chloride (medication)||inactive_ingredient_of
fluoxetine 10 mg oral tablet||magnesium octadecanoate||inactive_ingredient_of
salicylic acid 15 mg in 1 g topical gel [ambi even and clear exfoliating wash acne treatment]||cocamidopropyl dimethylamine||inactive_ingredient_of
octinoxate 60 mg in 1 ml / titanium dioxide 20 mg in 1 ml topical cream [burberry fresh glow b.b. luminous skin perfecting beauty balm sunscreen broad spectrum spf 20 fair 01]||ethylhexyl stearate||inactive_ingredient_of
octinoxate 1.725 g in 1 ml / titanium dioxide 1.346 g in 1 ml topical cream [flawless finish perfectly satinb 24hr makeup shade soft shell]||iron oxide, red||inactive_ingredient_of
cephalexin 500 mg/1 each oral capsule||ferric oxide black (iron oxide)||inactive_ingredient_of
salicylic acid 20 mg in 1 ml topical cream [dusel psoriasis dead sea salt therapy]||methyl methacrylate/glycol dimethacrylate crosspolymer||inactive_ingredient_of
miconazole nitrate 2% vaginal cream (substance)||apricot kernal oil peg-6 esters||inactive_ingredient_of
salicylic acid 0.02 ml in 1 ml topical soap [st. ives body wash naturally clear skin green tea]||salix alba bark volatile oil||inactive_ingredient_of
hydrocortisone 10 mg in 1 g topical cream [hydrocortisone plus]||stearyl alcohol||inactive_ingredient_of
metadate cd, (30/70 release) 50 mg/24 hr oral capsule, extended release||hydroxypropyl methylcellulose||inactive_ingredient_of
biotene pbf dry mouth toothpaste, oral paste||sodium saccharin||inactive_ingredient_of
corylus americana pollen 0.1 g in 1 ml subcutaneous injection, solution||nacl - sodium chloride||inactive_ingredient_of
potassium chloride sr, 10 meq oral tablet, extended release||castor oil laxative||inactive_ingredient_of
alcohol 80 ml in 100 ml intracisternal liquid [80% alcohol hand sanitizer]||water||inactive_ingredient_of
triclosan 0.003 ml in 1 ml topical liquid [cardinal health antimicrobial soap with triclosan]||1,3-dimethylol-5,5-dimethyl-hydantoin||inactive_ingredient_of
octisalate 50 mg in 1 ml / octocrylene 20 mg in 1 ml / oxybenzone 60 mg in 1 ml / homosalate 100 mg in 1 ml / avobenzone 30 mg in 1 ml topical lotion [paulas choice extra care non-greasy sunscreen spf 50]||water product (substance)||inactive_ingredient_of
dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet||allura red ac||inactive_ingredient_of
aethusa cynapium 200 [hp_c] oral pellet||sucrose-containing product||inactive_ingredient_of
naftifine hcl@1 %@topical@cream (gram)||alcohol cetyl||inactive_ingredient_of
dextromethorphan hydrobromide 30 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml oral solution [equate nite time cough]||sodium citrate (obsolete)||inactive_ingredient_of
avobenzone 3 g in 100 g / homosalate 10 g in 100 g / octisalate 5 g in 100 g / octocrylene 10 g in 100 g topical lotion [excel spf 30]||nitrilotriethanol||inactive_ingredient_of
alcohol 0.69 ml in 1 ml topical gel [mickey and friends moisturising hand cleanser with alcohol aqua]||polyoxyl 40 hydrogenated castor oil||inactive_ingredient_of
menthol 100 mg in 1 ml topical gel [pain relieving roll-on gel]||carbomer homopolymer, unspecified type||inactive_ingredient_of
zinc oxide 86 mg in 1 ml / titanium dioxide 65 mg in 1 ml topical cream [sun shield spf 50]||hydroxide, aluminum||inactive_ingredient_of
24 hr divalproex sodium 250 mg extended release oral tablet||product containing lactose (medicinal product)||inactive_ingredient_of
octinoxate 0.075 g in 1 g / zinc oxide 0.0392 g in 1 g topical lipstick [lbel concentre total labios global perfection spf 20 rouge amore/red]||polyglyceryl - 3 diisostearate||inactive_ingredient_of
buprenorphine hydrochloride 4 mg / naloxone hydrochloride dihydrate 1 mg sublingual film [buprenorphine and naloxone sublingual film]||maltitol (substance)||inactive_ingredient_of
product containing precisely fexofenadine hydrochloride 180 milligram/1 each conventional release oral tablet (clinical drug)||ferric oxide red (iron oxide)||inactive_ingredient_of
avobenzone 0.0003 g in 1 g / octisalate 0.0003 g in 1 g / zinc oxide 0.01 g in 1 g / octinoxate 0.071 g in 1 g / oxybenzone 0.02 g in 1 g topical lipstick [cy better lips balm humectante para labios con color fps 18 (choco therapy) - brown]||alpha tocopheryl acetate (substance)||inactive_ingredient_of
fluoxetine hydrochloride 20 mg oral capsule||quinoline yellow product||inactive_ingredient_of
camphor (natural) 0.6 g in 100 g / menthol, unspecified form 5.2 g in 100 g topical ointment [vital vapor]||castor oil (substance)||inactive_ingredient_of
vardenafil hcl@5 mg@oral@tablet||cellulose, microcrystalline||inactive_ingredient_of
oxybutynin chloride 5 mg oral tablet, extended release [oxybutynin er]||titanium dioxide (substance)||inactive_ingredient_of
titanium dioxide 0.062393 g in 1 g / zinc oxide 0.049 g in 1 g / octinoxate 0.03 g in 1 g topical powder [lbel divine polvos compactos doble uso fps 15 edicion de lujo plateado/double use compact spf 15 silver deluxe edition medium 7]||vitamin e (alpha tocopherol acetate)||inactive_ingredient_of
octinoxate 0.075 g in 1 g topical lipstick [esika pro perfect match volumen spf 20 plus lip liner for maximum fullness - (rosa deseo) - brown]||erioglaucine||inactive_ingredient_of
cyclobenzaprine hydrochloride 10 mg in 30 oral tablet, film coated||lactose monohydrate||inactive_ingredient_of
benzalkonium chloride 0.13 g in 100 ml topical cloth||natrii citras||inactive_ingredient_of
venlafaxine hcl 75mg 24hr tab,sa||hypromellose 2208 (4000 cps)||inactive_ingredient_of
octinoxate 5.5 g in 100 g / titanium dioxide 4.7 g in 100 g topical cream [clinique moisture surge cc compact hydrating colour corrector broad spectrum spf 25]||iron oxide yellow||inactive_ingredient_of
hydrocortisone@2.5 %@topical@cream with perineal applicator||sorbitan monostearate||inactive_ingredient_of
product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)||mannitol product||inactive_ingredient_of
actaea spicata root 10 [hp_x] in 85 g / horse chestnut 10 [hp_x] in 85 g / arnica montana 10 [hp_x] in 85 g / bellis perennis 10 [hp_x] in 85 g / bryonia alba root 10 [hp_x] in 85 g / oyster shell calcium carbonate, crude 10 [hp_x] in 85 g / calcium fluoride 10 [hp_x] in 85 g / causticum 10 [hp_x] in 85 g / black cohosh 10 [hp_x] in 85 g / formic acid 10 [hp_x] in 85 g / hypericum perforatum 10 [hp_x] in 85 g / rhododendron tomentosum leafy twig 10 [hp_x] in 85 g / lithium carbonate 10 [hp_x] in 85 g / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 85 g / phosphorus 10 [hp_x] in 85 g / phytolacca americana root 10 [hp_x] in 85 g / anemone pulsatilla 10 [hp_x] in 85 g / rhododendron aureum leaf 10 [hp_x] in 85 g / toxicodendron pubescens leaf 10 [hp_x] in 85 g / ruta graveolens flowering top 10 [hp_x] in 85 g / salicylic acid 10 [hp_x] in 85 g / sepia officinalis juice 10 [hp_x] in 85 g / zinc 10 [hp_x] in 85 g topical cream [warming arthritic pain and joint relief]||tangerine juice||inactive_ingredient_of
witch hazel 0.05 g in 50 g topical cream [hamsoa atoby medi]||sodium hyaluronate (substance)||inactive_ingredient_of
norgestimate 0.25 mg / ethinyl estradiol 0.035 mg oral tablet [trinessa]||talc (medication)||inactive_ingredient_of
product containing only levothyroxine sodium 250 microgram/1 each oral tablet||tridymite||inactive_ingredient_of
alcohol 70 ml in 100 ml topical liquid [exotic cherry blossom hand sanitizer]||firstflush||inactive_ingredient_of
octinoxate 0.07 g in 1 g / oxybenzone 0.025 g in 1 g topical lipstick [esika perfect match spf 20 red supreme]||sorbitan isostearate||inactive_ingredient_of
ascorbic acid 10 mg / .alpha.-tocopherol acetate, dl- 4.5 mg / calcium carbonate 83 mg / iron 1 mg oral tablet [lydia pinkham herbal supplement]||oxide, ferriferrous||inactive_ingredient_of
product containing precisely hydroxyzine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)||silica (sio2)||inactive_ingredient_of
bupropion hydrochloride 75mg oral tablet [depression/mood disorders]||octadecanoic acid||inactive_ingredient_of
alcohol 700 mg in 1 ml topical liquid [ameriderm foam alcohol hand sanitizer]||glycerin (substance)||inactive_ingredient_of
hydrocortisone 1 g in 100 g topical cream [healerz for itches]||propylene glycol product||inactive_ingredient_of
avobenzone 1000 mg in 50 ml / octinoxate 3750 mg in 50 ml topical cream [laura mercier tinted moisturizer illuminating broad spectrum spf 20 sunscreen 2n1 natural radiance]||óxido de titanio(4)||inactive_ingredient_of
titanium dioxide 1488 mg in 36.3 g topical cream [shiseido sun protection foundation sp20]||stearyl glycyrrhetinate||inactive_ingredient_of
polyvinyl alcohol/povidone 2.7 %-2 % ophthalmic drops||sodium chloride [skin]||inactive_ingredient_of
octinoxate 3712.5 mg in 50 ml / octisalate 1485 mg in 50 ml topical cream [nars velvet matte skin tint malaga]||carbonate, calcium||inactive_ingredient_of
titanium dioxide 31.6 mg in 1 ml topical cream [matissime velvet radiant mat fluid foundation with sunscreen broad spectrum spf 20 mat beige 04]||aluminum hydroxide [nutritional use] (product)||inactive_ingredient_of
rite aid hydrocortisone 1% plus 10 moisturizers topical cream||glycerol||inactive_ingredient_of
product containing precisely pregabalin 200 milligram/1 each conventional release oral capsule||matmate||inactive_ingredient_of
loperamide 2 mg oral capsule||ferriferrous oxide||inactive_ingredient_of
zinc oxide 10 g in 100 g topical stick [nudist lip butter afterglow]||vanilla bean||inactive_ingredient_of
zinc pyrithone 2% shampoo||millet seed||inactive_ingredient_of
octinoxate 1.5 g in 30 g / titanium dioxide 0.5 g in 30 g topical cream [no7 lift and luminate triple action serum foundation sunscreen broad spectrum spf 15 warm beige]||cyclomethicone 6||inactive_ingredient_of
acetaminophen/diphenhydramine hcl 500 mg-25 mg/15 ml oral solution, oral||menthol-containing product||inactive_ingredient_of
clonazepam 1mg tab||starch 1551||inactive_ingredient_of
product containing precisely ketorolac 10 milligram/1 each conventional release oral tablet (clinical drug)||cristobalite||inactive_ingredient_of
topiramate 100 mg oral tablet, film coated||cellulose powders||inactive_ingredient_of
zinc oxide 110 mg in 1 ml topical gel [prep spf 15 lip gloss]||2-methyl-heptadecanoic acid||inactive_ingredient_of
lovastatin 10mg tab ud||starch (corn)||inactive_ingredient_of
holcus lanatus pollen extract 1000 unt/ml injectable solution||sodium chloride [nose]||inactive_ingredient_of
octinoxate 50 mg in 1 ml topical cream [flormar bb matte effect sheer tinted beauty cream sunscreen broad spectrum spf 15 lf51 light]||disteardimonium hectorite||inactive_ingredient_of
calcitriol 1 ug in 1 ml oral solution [rocaltrol]||product containing omega-3-acid ethyl ester||inactive_ingredient_of
avobenzone 2.7 g in 100 ml / octinoxate 6.99 g in 100 ml / octocrylene 2 g in 100 ml topical cream [ultimate miracle worker multi-rejuvenating spf 30]||retinol (vit a)||inactive_ingredient_of
urso, 250 mg oral tablet||peg 8o00||inactive_ingredient_of
cvs eczema relief 1% topical cream||propanediol||inactive_ingredient_of
betamethasone 0.1% cream (substance)||sodium acid phosphate||inactive_ingredient_of
loratadine 10 mg oral tablet [assured allergy relief]||pyrocellulose||inactive_ingredient_of
diclofenac sodium 100mg oral tablet, extended release||lactose monohydrte||inactive_ingredient_of
populus nigra pollen 0.1 g in 1 ml intradermal injection, solution||electrolytes sodium chloride||inactive_ingredient_of
omeprazole 20 mg oral capsule, delayed release [omeprazole dr]||c.i. 77499||inactive_ingredient_of
gabapentin 300mg capsule (substance)||product containing talc (medicinal product)||inactive_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 45 mg in 1 ml / octocrylene 80 mg in 1 ml topical lotion [walgreens broad spectrum sport spf 50 sunscreen]||tocopherol,dl-alpha||inactive_ingredient_of
benzocaine 6 % medicated wipe||agua||inactive_ingredient_of
product containing only progesterone 100 mg/1 each oral capsule (clinical drug)||lecithin, soybean||inactive_ingredient_of
benzalkonium chloride 0.13 g in 100 g topical cloth [5 seconds disinfectant wipes]||h2o - water||inactive_ingredient_of
acetaminophen-codeine 300 mg-30 mg oral tablet||product containing octadecanoic acid (medicinal product)||inactive_ingredient_of
pyrithione zinc 1.0000 ml in 100 ml topical lotion/shampoo [dandruff shampoo daily clean for normal hair]||raw linseed oil||inactive_ingredient_of
product containing precisely eprosartan mesylate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet||crospovidone (15 mpa.s at 5%)||inactive_ingredient_of
avobenzone 3 g in 100 g / homosalate 15 g in 100 g / octisalate 5 g in 100 g / octocrylene 10 g in 100 g / oxybenzone 3 g in 100 g topical stick [ultimate sheer spf 70]||alkyl (c12-15) benzoate||inactive_ingredient_of
embeline 0.05 % topical solution||carbomer-974p||inactive_ingredient_of
ethanol 0.7 ml/ml topical gel||product containing triethanolamine||inactive_ingredient_of
product containing only lamivudine 150 mg and zidovudine 300 mg/1 each oral tablet (clinical drug)||oxides, polyethylene||inactive_ingredient_of
octinoxate 1.95 g in 30 g / titanium dioxide 1.275 g in 30 g / octisalate 1.5 g in 30 g topical cream [no7 perfect and perfect intense advanced all in one foundation spf 50 hazelnut]||dimethicone (medication)||inactive_ingredient_of
capsaicin 0.0006 mg/mg topical gel||sulfate glucosamine||inactive_ingredient_of
menthol 10.4 g in 100 g topical spray [harmony flex 10.4% menthol pain relief spreay 1000mg]||aloe barbadensis leaf extract||inactive_ingredient_of
sodium fluoride 0.15% dental paste [aquafresh advanced freshness]||80s, polysorbate||inactive_ingredient_of
low-dose aspirin, 81 mg oral delayed release tablet||sunset yellow fcf stain||inactive_ingredient_of
structure of right nipple (body structure)||retraction of both nipples||has_finding_site
hands joint||enteropathic arthropathy hand (diagnosis)||has_finding_site
skin arm||skin plaque of upper arm (symptom)||has_finding_site
organ system, gastrointestinal||[d]hyperperistalsis (situation)||has_finding_site
gallbladder structure (body structure)||cholelithiasis with acute cholecystitis (diagnosis)||has_finding_site
chromosome 7||7p21.1 deletion syndrome (disorder)||has_finding_site
structure of organ within abdominopelvic cavity (body structure)||inguinal hernia with gangrene and obstruction (disorder)||has_finding_site
toe fifth||varus rotation of fifth toe of left foot||has_finding_site
interphalangeal joint structure of great toe (body structure)||hypermobile interphalangeal joint of great toe of right foot on active extension (physical finding)||has_finding_site
cerebrum||refractory generalized convulsive epilepsy||has_finding_site
skull bone||x-ray skull sclerotic lesion soft tissue mass||has_finding_site
ut - uterus||late occurrence of first menstrual cycle||has_finding_site
section b endocrine system||pregnancy complications: alopecia||has_finding_site
cerebral structure (body structure)||multi-infarct dementia||has_finding_site
spinal cord tissue structure (body structure)||venous infarct of spinal cord||has_finding_site
bones structure||tuberculous necrosis of bone (disorder)||has_finding_site
upper limb integument||tactile dysesthesia of arm||has_finding_site
bone structure of clavicle and/or sternum (body structure)||cls # dislc sternoclav jt, ant||has_finding_site
brain, nos||delirium caused by dissociative drug||has_finding_site
face (volume)||stretched excess skin of face (finding)||has_finding_site
humeral lesser tuberosity||closed four-part fracture of lesser tuberosity of left humerus (diagnosis)||has_finding_site
structure of musculoskeletal system||hyperextension injuries||has_finding_site
heart, nos||preinfarction; syndrome||has_finding_site
set of digits of hand||mf4||has_finding_site
auris||bite of left ear||has_finding_site
rectal structure||primary malignant neuroendocrine neoplasm of rectum||has_finding_site
first toe||dactylitis of right great toe||has_finding_site
thumb structure||radial polydactyly wassel 4||has_finding_site
vermilion border region||primary malignant neoplasm of vermilion border of lip||has_finding_site
articulatio temporomandibularis||puncture of left temporomandibular joint by needle||has_finding_site
fifth rib, nos||nonunion of fracture of right fifth rib||has_finding_site
spinal cord structure||astroblastoma of spinal cord||has_finding_site
structure of neck of first metacarpal bone of right hand (body structure)||closed fracture of neck of first metacarpal bone of right hand (disorder)||has_finding_site
structure of distal phalanx of second toe (body structure)||wet gangrene of distal phalanx of second toe of left foot||has_finding_site
skin lateral aspect ankle||skin erosion on right lateral ankle||has_finding_site
middle finger structure||ganglion of middle finger of right hand||has_finding_site
multiple topographic sites||superficial injuries involving multiple regions of upper limb(s) with lower limb(s) (disorder)||has_finding_site
skin structure of popliteal fossa (body structure)||carbuncles on left popliteal fossa||has_finding_site
skin of chest||ulcer of midline of chest with subcutaneous necrosis (physical finding)||has_finding_site
brain cerebrospinal fluid pathway (body structure)||too much cerebrospinal fluid in the brain||has_finding_site
maxillary buccal sulcus||blue discoloration of upper buccal vestibule on left||has_finding_site
buccal mucosa, nos||ulcerated mass of buccal mucosa (physical finding)||has_finding_site
human hair||soft||has_finding_site
structure of ampulla of vater||primary malignant neuroendocrine neoplasm of ampulla of vater||has_finding_site
skins||application site disorder infection||has_finding_site
thighs||erythematous wound of right thigh||has_finding_site
d25 hips||open wound of hip with complication||has_finding_site
face skin||incision of face with poorly approximated postsuture edges||has_finding_site
skin structure of lateral portion of neck||full thickness incision of left side of neck (physical finding)||has_finding_site
ostium of coronary artery||dual coronary orifice (disorder)||has_finding_site
heels skin||purpura on heel of right foot||has_finding_site
ventricular conducting pathway (body structure)||wide qrs ventricular tachycardia (disorder)||has_finding_site
skin of antitragus||plaque on both ear antitragi (physical finding)||has_finding_site
foot interphalangeal joint||toes of both feet suddenly 'locked up' (symptom)||has_finding_site
skin of upper eyelid||eschar on upper right eyelid||has_finding_site
proximal epiphysis of second metatarsal bone||x-ray foot erosions 2nd tarsometatarsal joint base||has_finding_site
skin of back of head||incision of back of head with poorly approximated postsuture edges||has_finding_site
varolius, pons||cortical dysgenesis with pontocerebellar hypoplasia due to tubulin beta 3 class iii mutation (disorder)||has_finding_site
anastomosis||gastric anastomotic haemorrh||has_finding_site
pericardial structure||chronic infective pericarditis (disorder)||has_finding_site
temple region structure||neoplasm of soft tissue of temple||has_finding_site
bone structure of t11 (body structure)||spine magnetic resonance imaging thoracic osseous mass associated with bone destruction t11 posterior||has_finding_site
structure of peripheral artery (body structure)||thrombosis; artery, limb||has_finding_site
structure of right half of body (body structure)||hemiplegia of right dominant side (disorder)||has_finding_site
spc||cord multiple sclerosis||has_finding_site
respiratory tract||respiratory status is consistent with or improved from preoperative baseline (finding)||has_finding_site
primary upper left central incisor tooth||chipped enamel of left upper central incisor||has_finding_site
piel||lymphomatoid papulosis-associated mycosis fungoides (diagnosis)||has_finding_site
male genital organ||male infertility of developmental origin (disorder)||has_finding_site
distal interphalangeal joint of fourth toe||amputation of fourth toe of right foot at distal interphalangeal joint||has_finding_site
skin of scalp||papule on the scalp on the left side||has_finding_site
pelvic integument||eschar of diaper area with smooth and red appearance||has_finding_site
right vesicoureteric junction (body structure)||primary right vesico-ureteric reflux grade 5 measured by voiding cystourethrography||has_finding_site
drainage angle||moderate open angle (finding)||has_finding_site
eye, cornea||corneal ulcer due to vitamin a deficiency||has_finding_site
large intestine: general terms||traumatic perforation of large intestine||has_finding_site
skin, nos||multiple basal cell papillomata (disorder)||has_finding_site
joint structure (body structure)||chondrocalcinosis due to dicalcium phosphate crystals, of the pelvic region and thigh||has_finding_site
structure of rotator cuff including muscles and tendons||sprain of shoulder rotator cuff||has_finding_site
lambdoid suture of skull||kleeblattschadel deformity||has_finding_site
joint of hand||felty's syndrome of hand||has_finding_site
skin structure of medial surface of thumb||skin wound of medial aspect of right thumb||has_finding_site
uterine structure (body structure)||obstetric inversion of uterus with postnatal problem (disorder)||has_finding_site
lymph node structures||lymphadenitis; acute||has_finding_site
tendon, nos||failure of tendon graft (disorder)||has_finding_site
skin structure of right upper limb||primary basal cell carcinoma of right upper limb (disorder)||has_finding_site
eye structure||type 2 diabetes mellitus with ophthalmic complications||has_finding_site
entire digit||hand-foot syndrome in sickle cell anemia (disorder)||has_finding_site
female reproductive tract||genital tract infection following ectopic pregnancy||has_finding_site
shoulder joint||open inferior dislocation of humerus||has_finding_site
spinal cord, nos||spinal cord tumor malignant intramedullary||has_finding_site
entire gravid uterus||retr.incar.grav.ut.+p/n comp.||has_finding_site
corpus ciliares||noninfectious secondary iridocyclitis||has_finding_site
structure of right vertebral artery (body structure)||cerebral angiography absent right vertebral artery||has_finding_site
structure of right lower leg||amputation right lower leg stump assessment||has_finding_site
myelons||familial spastic paraplegia autosomal recessive type 54||has_finding_site
limb structure||paresis left sided||has_finding_site
bicipital line||tender on palpation bicipital groove lippman's test right||has_finding_site
bloods capillary||majocchi capillaritis||has_finding_site
bone structure of tibia and/or fibula||x-ray of lower leg: lytic lesion with geographic pattern||has_finding_site
structure of left femoral canal (body structure)||gangrene co-occurrent and due to bilateral femoral hernia||has_finding_site
retina right eye (physical finding)||night blindness of right eye||has_finding_site
structure of right upper lid margin||blepharitis of right upper eyelid||has_finding_site
joints sacro iliac||open complete rupture of sacroiliac joint (disorder)||has_finding_site
skin of plantar surface, fourth toe||macule on plantar surface of right fourth toe (physical finding)||has_finding_site
organ body||sepsis caused by anaerobic bacteria||has_finding_site
alimentary tract, nos||complete fecal incontinence (finding)||has_finding_site
tracheas||unanticipated difficult airway||has_finding_site
peripheral nerve structure of upper limb (body structure)||upper limb nerve lesion (disorder)||has_finding_site
bone structure of left radius (body structure)||congenital absence of bilateral radiuses||has_finding_site
aorta.root||enlarged aortic root (finding)||has_finding_site
bone structure of t4 (body structure)||spine magnetic resonance imaging t2-weighted thoracic osseous mass hypointense signal t4 anterior||has_finding_site
structure of permanent maxillary left third molar tooth||distal caries of left upper third molar||has_finding_site
upper extremity>thumb||superficial bite of thumb||has_finding_site
lower back structure (body structure)||weeping wound of left lower back (physical finding)||has_finding_site
bone, skeletal||adult fucosidosis (disorder)||has_finding_site
pulmo dexter||vascular ring with malrotation and dextroversion of heart and hypoplasia of right lung and left arterial duct||has_finding_site
heart||bradycardic cardiac arrest (disorder)||has_finding_site
endocrine pluriglandular||carney-stratakis dyad||has_finding_site
foot structure||congenital absence of lower leg and foot||has_finding_site
tooth 29||hemorrhage of gingiva on lingual surface of right mandibular second bicuspid||has_finding_site
bone structure of rib, sternum and clavicle (body structure)||benign neoplasm of ribs, sternum and/or clavicle||has_finding_site
structure of shaft of fourth metacarpal bone of right hand||open fracture of shaft of fourth metacarpal bone of right hand (disorder)||has_finding_site
fourth distal phalanx of foot||wet gangrene of distal phalanx of fourth toe of left foot (physical finding)||has_finding_site
skin system||reticulohistiocytome du dos de l'adulte||has_finding_site
haematopoietic system||aleukemic mast cell leukemia (disorder)||has_finding_site
skin of back of head||curvilinear incision of back of head (physical finding)||has_finding_site
mental region||neoplasm of soft tissue of chin||has_finding_site
kidney parts||obstructive nephropathy due to prostate cancer||has_finding_site
skin structure of interdigital space of foot (body structure)||skin pimple between toes (symptom)||has_finding_site
splenic structure (body structure)||mycosis fungoides of spleen (diagnosis)||has_finding_site
ureter, nos||neoplasms, ureteral||has_finding_site
40 blood vessels: general terms||leakage of vascular graft||has_finding_site
smooth muscle (organ) structure (body structure)||diffuse dysfunction of smooth muscle of gastrointestinal tract, nos||has_finding_site
mucous membrane of lower lip||squamous cell carcinoma of mucous membrane of lower lip (diagnosis)||has_finding_site
wrist skin||open incision of left wrist||has_finding_site
masticator compartment||cellulitis of masticator space of mouth||has_finding_site
ear and related structures||localisation of voice normal||has_finding_site
proximal interphalangeal joint of second digit of foot||active flexion of pip joint of second toe of right foot hypermobile||has_finding_site
retinas||very severe npdr (nonproliferative diabetic retinopathy)||has_finding_site
anatomical or acquired body structure (body structure)||central post stroke pain||has_finding_site
bone, maxilla||sequestrum of the maxilla||has_finding_site
integumental system||generalized peeling skin syndrome||has_finding_site
skin structure of foot||unclean incision of right foot (physical finding)||has_finding_site
left mammary region||tenderness of lower outer quadrant of left breast||has_finding_site
skin of hindlimb, nos||tingling of both arms and both legs||has_finding_site
skin of part of middle finger||skin texture of distal aspect of middle finger of left hand||has_finding_site
anterior surface of upper arm||cellulitis extremities upper arm left volar aspect||has_finding_site
face skins||skin spot of face||has_finding_site
faces||crane heise syndrome (disorder)||has_finding_site
skin of middle finger, nos||furuncle of distal end of middle finger of left hand (physical finding)||has_finding_site
bone structure of left zygomatic arch||open fracture of left zygomatic arch||has_finding_site
prepuce of penis||form of the prepuce||has_finding_site
skin medial surface elbow||skin scab of medial aspect of left elbow||has_finding_site
skin structure of scalp (body structure)||ulcer of right side of scalp||has_finding_site
first web space||pain between the right great and second toes||has_finding_site
structure of lateral condyle of femur (body structure)||stress fracture of lateral condyle of femur||has_finding_site
upper trunk||purpura of left lateral superior trunk||has_finding_site
structure of tendon of toe (body structure)||septic tenosynovitis of fifth toe of left foot||has_finding_site
structure of nuchal region of neck||wound of posterior neck with poorly approximated postsuture edges (physical finding)||has_finding_site
skin of medial aspect of ankle||skin crack of medial aspect of right ankle||has_finding_site
skin of axilla||skin lump within left armpit||has_finding_site
muscles structure||syndrome, aicardi||has_finding_site
musculoskeletal structure of finger||strain of finger||has_finding_site
structure of back of thoracic region||contusion of left back wall of thorax||has_finding_site
structure of epitrochlear lymph node (body structure)||ulceration of epitrochlear lymph node (disorder)||has_finding_site
structure of middle phalanx of little toe||burns of dorsal aspect of middle phalanx of little toe of left foot||has_finding_site
skin of fourth toe, nos||skin erosion on left fourth toe||has_finding_site
choroid, right eye||rupture of choroid of right eye||has_finding_site
skin and/or subcutaneous tissue structure of hand (body structure)||soft tissue swelling of hand (symptom)||has_finding_site
urinary bladder structure (body structure)||spontaneous abortion with tear of bladder||has_finding_site
pharyngo-||iatrogenic pharyngeal perforation||has_finding_site
brain tissue structure||low amplitude eeg tracing (finding)||has_finding_site
bones, cuneiform||open fracture of cuneiform bone of right foot (diagnosis)||has_finding_site
tendon long head of biceps||calcific tendonitis in the right biceps tendon||has_finding_site
muscle, heart||cardiomyopathy in myotonic dystrophy||has_finding_site
genital systems set||pathogen-negative nsgi||has_finding_site
right cornea (physical finding)||keratoconjunctivitis of right eye due to herpes zoster (diagnosis)||has_finding_site
mitral valve, nos||rheumatic mitral valve failure (diagnosis)||has_finding_site
buttocks set||serosanguineous drainage from wound of left buttock (physical finding)||has_finding_site
structure of skin of right hip (body structure)||skin abscess of right hip (diagnosis)||has_finding_site
structure of male genital system subdivision (body structure)||spermatemphraxis||has_finding_site
anterior uveal tract structure (body structure)||cidofovir-induced anterior uveitis (disorder)||has_finding_site
femoral nerve||nerve diseases, femoral||has_finding_site
generative organs, female||female gonococcal pelvic inflammatory disease (disorder)||has_finding_site
structure of gum of mandible||perio-endo defect of gingiva of right lower second bicuspid||has_finding_site
skin of front of forearm||skin plaque of anterior aspect of right forearm (symptom)||has_finding_site
hair follicle structure (body structure)||androgenic alopecias||has_finding_site
skin structure of lateral part of heel||papule on lateral heel of right foot||has_finding_site
tendon of extensor pollicis longus||mallet thumb with open tendon injury (disorder)||has_finding_site
proximal epiphysis of humerus||partial epiphyseal arrest of left proximal humerus (disorder)||has_finding_site
skin structure of lateral surface of index finger (body structure)||skin cyst of lateral aspect of index finger of right hand (symptom)||has_finding_site
skin of forearm, nos||circumferential warmth of right mid forearm (physical finding)||has_finding_site
respiratory tract, nos||respiratory adenocarcinoma with cartilaginous or osseous metaplasia||has_finding_site
bone tissue of ulna||closed fracture of the radius and ulna||has_finding_site
structure of visual system||alternating exotropia with x and/or y pattern (disorder)||has_finding_site
bone organ||dysbaric osteonecrosis||has_finding_site
thigh part||swelling of right distal thigh (physical finding)||has_finding_site
area thoracic||splinter of left chest||has_finding_site
skin of lateral surface of elbow||patch on outside of right elbow||has_finding_site
urethras||urethra malignant carcinoma squamous cell with horn formation||has_finding_site
gluteal sulcus structure (body structure)||skin blister of intragluteal cleft||has_finding_site
structure of heart, unspecified||sca||has_finding_site
joint of wrist||closed fract sublx radcarp jt||has_finding_site
structure of skin between second and third toes (body structure)||desquamation between second and third toes on right foot||has_finding_site
bone tissue of radius||neoplasm of uncertain behavior of radius||has_finding_site
muscle of trunk||neoplasm of uncertain behavior of muscle of trunk, nos||has_finding_site
integumental system||site-specific disorder of skin (disorder)||has_finding_site
skin of neck, nos||skin texture velvety on neck (physical finding)||has_finding_site
bone structure of cranium||skull injuries, crushing||has_finding_site
bone structure of talus||secondary malignant neoplasm of talus||has_finding_site
cervical vertebra axis||spondylolisthesis of occipito-atlanto-axial region||has_finding_site
bone structure of radius and/or ulna (body structure)||solitary bone cyst, ulna and radius||has_finding_site
subcutaneous tissue structure of forearm (body structure)||crepitus of forearm||has_finding_site
vertebral arteries||stroke of vertebral artery (diagnosis)||has_finding_site
structure of posterior lateral branch of right coronary artery||coronary angiography: right coronary right posterolateral segment aneurysm (procedure)||has_finding_site
metatarsal bone structure||metatarsal spur of right foot||has_finding_site
skin structure of right eyelid||sebaceous cyst of bilateral eyelids||has_finding_site
mucosa of buccal surface of mandibular gingiva||lump right lower gum outside back||has_finding_site
tendon and tendon sheath of hip, nos||tendinitis of right hip (disorder)||has_finding_site
enamel dent||chipped enamel of right upper second molar (physical finding)||has_finding_site
microscopic skin vascular structure (body structure)||venous star||has_finding_site
jaw region structure (body structure)||desmoplastic small round cell tumor of jaw||has_finding_site
t7 vertebra||mri thoracic osseous mass s/i ratio isointense t7 mid||has_finding_site
skin of frontal region||incision of forehead with ragged edges (physical finding)||has_finding_site
structure of right ovary (body structure)||endometriosis of bilateral ovaries (disorder)||has_finding_site
structure of buccal mucosa (body structure)||color of lesion of buccal mucosa||has_finding_site
embryonic trigeminal artery (body structure)||persistent embryonic trigeminal artery (disorder)||has_finding_site
proximal interphalangeal joint of fifth finger||wet gangrene of proximal interphalangeal joint of little finger of right hand (physical finding)||has_finding_site
structure of trunk of pulmonary artery (body structure)||systemic to pulmonary collateral artery connecting with central pulmonary arteries||has_finding_site
external auditory meatus right (physical finding)||otitis externa of bilateral external auditory canals caused by candida species (disorder)||has_finding_site
coronal suture||cloverleaf skull with multiple congenital anomalies syndrome||has_finding_site
structure of peripheral cornea of right eye (body structure)||marginal keratitis of right eye caused by staphylococcus toxin (disorder)||has_finding_site
structure of deciduous maxillary left central incisor tooth||x-ray of teeth: cavity of left maxillary central incisor||has_finding_site
structure of joint of left great toe||gouty arthritis of left great toe (disorder)||has_finding_site
donor site||hypertrophic scarring of skin donor site||has_finding_site
ulnar nerve at elbow||tenderness on palpation over ulnar nerve (physical finding)||has_finding_site
gastrointestinal tract, liver||reactivation of hepatitis b virus (diagnosis)||has_finding_site
structure of toe of right foot (body structure)||bilateral acquired deformity of toe of feet||has_finding_site
respiratory system, lung||bronchitis and pneumonitis caused by chemical fumes||has_finding_site
right b1||bronchoscopy thin secretions of right apical segmental bronchus||has_finding_site
articul cartilage humeral head||right shoulder mri non-acute chondral injury of inferior humeral head||has_finding_site
cubital region||ecchymosis of right elbow||has_finding_site
cerebral structure (body structure)||lewy body dementia with behavioral disturbance (disorder)||has_finding_site
gastrointestinal organ system||peritonitis; meconium||has_finding_site
fetal structures||autositic twin of asymmetrical conjoined twins||has_finding_site
bone structure of t3 (body structure)||t-spine mri t2-weighted osseous mass isointense signal t3 cephalad||has_finding_site
toe, nos||splinter of toe without major open wound (diagnosis)||has_finding_site
skin structure of left lower limb (body structure)||pigmented hairy epidermal nevus of left lower limb (disorder)||has_finding_site
dorsal region of hand||tenderness of dorsal aspect of right hand (physical finding)||has_finding_site
peripheral nerve structure||neuropathy in renal failure (disorder)||has_finding_site
throats||patch of pharynx||has_finding_site
skin structure of perianal area||neoplasm of skin of perianal region (diagnosis)||has_finding_site
female genital system||langerhans cell sarcoma of female genitalia||has_finding_site
integument||trichrome vitiligo (disorder)||has_finding_site
skin of body||famil pigment purpuric erupt||has_finding_site
joint of cervical vertebra||multiple-level cervical spondylosis without myelopathy||has_finding_site
sternocleidomastoid||weakness of sternomastoid (finding)||has_finding_site
skin structure of upper lip (body structure)||crusts were seen on the right upper lip||has_finding_site
adrenal cortex structure (body structure)||glucocorticoid-responsive primary hyperaldosteronism||has_finding_site
skin||skin scar contracture||has_finding_site
structure of internal part of mouth||inflammatory red coloured lesion of internal part of mouth caused by drug||has_finding_site
human nail structure||photo onycholysis||has_finding_site
comm av (non-mit/tricus) leaf||fenestration of atrioventricular valve leaflet in atrioventricular septal defect (disorder)||has_finding_site
acromium||neoplasm of acromion||has_finding_site
vena basilica antebrachii||central line type basilic central venous line in place||has_finding_site
humerus, nos||upper arm bone pain worse with lifting (symptom)||has_finding_site
junction neuromuscular||neonatal myasthenia gravis||has_finding_site
salivary glands: type and structure||scirrhous adenocarcinoma of salivary gland (diagnosis)||has_finding_site
structure of umbilical blood vessel||congenital arteriovenous fistula of umbilical blood vessels||has_finding_site
palmar aponeurosis structure (body structure)||dupuytren contracture of right palm (disorder)||has_finding_site
cutaneous tissue||eczematized psoriasis (disorder)||has_finding_site
bone structure of distal ulna (body structure)||dislocation of distal end of left ulna||has_finding_site
skin of upper arm (body structure)||skin lesion on upper arms||has_finding_site
skin of perineal||blister of perineum (& traumatic)||has_finding_site
back upper||erythematous wound of left upper back||has_finding_site
skin structure of lower lip||vesicle on the face lip lower left||has_finding_site
skin of temple (body structure)||fluctuant tissue surrounding incision of temple (physical finding)||has_finding_site
bodies vertebral||disorder of vertebra (disorder)||has_finding_site
lumbosacral spinal cord nerve root, nos||lumbosacral radiculoplexus neuropathy due to type 1 diabetes mellitus||has_finding_site
optic nerve, nos||primary malignant neoplasm of optic nerve (disorder)||has_finding_site
structure of basal anterior segment of left cardiac ventricle (body structure)||stress radionuclide ventriculography: image #1 left ventricle wall motion hypokinetic anterobasal (procedure)||has_finding_site
20 to 29 percent of body surface (body structure)||burn: 30-39% of body surface, 20-29% bs full thickness||has_finding_site
bones||osteonecrosis due to trauma (disorder)||has_finding_site
femoropatellar articulations||subluxation knee joint open traumatic patellofemoral||has_finding_site
tracheobronchial structure||foreign body in tracheobronchial tree||has_finding_site
vasa sanguinea retinae||occult neovascularization of macula||has_finding_site
mucosa oral||minimal keratinized residual ridge mucosa (finding)||has_finding_site
structure of lungs, unspecified||allergic bronchopulmonary aspergillosis (abpa)||has_finding_site
neurologic system||tetanic opisthotonus (disorder)||has_finding_site
structure of pelvic region of trunk of female (body structure)||obstetric trauma causing pelvic hematoma nos (disorder)||has_finding_site
structure of internal part of mouth||abnormal taste in mouth (finding)||has_finding_site
muscle of thigh, nos||paralytic muscular calcification and ossification of thigh (diagnosis)||has_finding_site
fetal structures||pygodidymus||has_finding_site
mucosa of buccal surface of maxillary gingiva||vesicle of buccal maxillary gingiva on right||has_finding_site
enamel structure (body structure)||interproximal enamel caries (disorder)||has_finding_site
prostate, nos||calculus prostatic||has_finding_site
structure of joint of right ankle (body structure)||arthritis of right ankle caused by bacteria||has_finding_site
010-012 skin||macular cutaneous amyloidosis||has_finding_site
main biliary duct||neoplasm of uncertain behavior of common bile duct (disorder)||has_finding_site
skin of medial border of foot||skin lesion of medial aspect of right foot||has_finding_site
structure of right eyelid||cicatricial ectropion of bilateral eyelids (disorder)||has_finding_site
structure of right eyelid||congenital retraction of both eyelids||has_finding_site
buttock (surface region)||indurated tissue surrounding wound of left buttock||has_finding_site
skin of body||melanotic freckle||has_finding_site
distal interphalangeal joint of middle finger||x-ray of finger: subchondral cyst of distal interphalangeal joint of middle finger of left hand (procedure)||has_finding_site
glomerulus kidney||childhood nephrotic syndrome (disorder)||has_finding_site
breast anatomy (body structure)||persistent mastalgia||has_finding_site
dental enamels||enamel pearl||has_finding_site
extremities (anatomy)||congenital malrotation of limb (disorder)||has_finding_site
28 lungs||pneumonia due to human metapneumovirus (disorder)||has_finding_site
clavicular||multiple fractures of clavicle||has_finding_site
skin of upper back||incision of right upper back with venous bleeding (physical finding)||has_finding_site
structure of right temporomandibular joint (body structure)||arthritis of right temporomandibular joint (disorder)||has_finding_site
soft tissue nos (body structure)||soft tissue lesion||has_finding_site
sinus paranasal||angiomyosarcoma of accessory sinus||has_finding_site
heart structure||angina pectoris following myocardial infarction||has_finding_site
skin of lateral half of thoracic segment of trunk (body structure)||purulent incision of right lateral chest||has_finding_site
upper urinary system||focal pyelonephritis (disorder)||has_finding_site
skin of border of foot||border of burns of feet||has_finding_site
penis structure||penile lymphedema||has_finding_site
structure of peripheral retina of right eye (body structure)||vitreoretinal tuft of right eye||has_finding_site
womb structure||retroverted gravid uterus (disorder)||has_finding_site
trunk of left renal arterial tree||atheroembolism of both renal arteries||has_finding_site
elbow (anatomy)||pain;elbow||has_finding_site
biliary duct||proliferation of bile canaliculi||has_finding_site
left lungs||lung malignant adenocarcinoma secondary left||has_finding_site
long arm of chromosome (body structure)||monosomy 7q31||has_finding_site
skin of top of head||incision of top of head with uniform healing ridge||has_finding_site
skin and subcutaneous tissue structure of hand||ct scan right hand soft tissue swelling (procedure)||has_finding_site
skeletal system||mixed sclerosing bone dystrophy with extra-skeletal manifestation (disorder)||has_finding_site
entire skin of abdomen (body structure)||skin cyst of entire abdomen (symptom)||has_finding_site
lungs parenchyma||idiopath dif pulm ossification||has_finding_site
lacrimal structure||obs of measures of lacrimation||has_finding_site
atrial||bradycardia sinus||has_finding_site
face (anatomy)||overgrowth, macrocephaly, facial dysmorphism syndrome||has_finding_site
mucous membrane structure||ulcerative mucositis due to non-antineoplastic therapy (disorder)||has_finding_site
metatarsophalang jt big toe||pain of metatarsophalangeal joint of great toe of left foot elicited by active abduction (physical finding)||has_finding_site
facial skin fold (body structure)||skin texture of both paranasal folds (physical finding)||has_finding_site
hindlimb||drop attacks in middle-aged woman (finding)||has_finding_site
structure of auditory system (body structure)||combined visual and hearing impairment||has_finding_site
tracheal structure (body structure)||oral endotracheal tube in situ||has_finding_site
structure of nerve root and/or plexus||disorders of spinal neurones manifest by hyperactivity (disorder)||has_finding_site
nail region structure||onychomycosis due to opportunistic infection (disorder)||has_finding_site
04 breasts||breast implants rupture||has_finding_site
structure of interphalangeal joint of right thumb||diffuse tenderness on palpation of interphalangeal joint of right thumb||has_finding_site
bone marrow (body structure)||biopsy bone marrow malignant neoplasm immunoproliferative disease (procedure)||has_finding_site
diaphragm structure||lian-siguer-welti syndrome (disorder)||has_finding_site
left middle ear structure||chronic serosanguineous otitis media of both middle ears||has_finding_site
internal rectal venous plexus (body structure)||bleeding grade iv internal hemorrhoid||has_finding_site
glans penis structure (body structure)||y-shaped laceration on the glans penis||has_finding_site
cavity, peritoneal||ascites tense||has_finding_site
skin of forearm||contact dermatitis of left forearm (diagnosis)||has_finding_site
thymus, nos||thymus disease nos (disorder)||has_finding_site
tissue, connective||sclerodermatomyositis (disorder)||has_finding_site
hip joint structure||hip catches during movement||has_finding_site
ulna, nos||pathological fracture of ulna due to tumour||has_finding_site
skin of index finger||papule of index finger of right hand (physical finding)||has_finding_site
placentomes (body structure)||placental polyp - delivered with postnatal complication (disorder)||has_finding_site
mammary region||erythematous tissue surrounding wound of left breast||has_finding_site
corneal structure||congenital corneal opacity not interfering with vision (diagnosis)||has_finding_site
skin of jawline (body structure)||skin tag along anterior jaw line (physical finding)||has_finding_site
structure of urinary system||recurrent microscopic haematuria||has_finding_site
articular cartilages||osteochondrosis; juvenile, limb, upper||has_finding_site
structure of distal phalanx of index finger (body structure)||diffuse burn of distal phalanx of index finger of right hand||has_finding_site
intervertebral joint, nos||recurrent dislocation of multiple vertebral sites||has_finding_site
structure of muscle acting on ankle joint||progressive myositis ossificans of right ankle||has_finding_site
structure of hand, unspecified||contusion,hand,exc finger||has_finding_site
scalp (anatomy)||animal bite of scalp||has_finding_site
middle finger skin||skin papule of proximal middle finger of right hand||has_finding_site
brain cerebrospinal fluid path||lumbosacral spina bifida aperta with hydrocephalus (disorder)||has_finding_site
skin eyebrow||bullae on both eyebrows (physical finding)||has_finding_site
appendix, nos||acute focal appendicitis (disorder)||has_finding_site
skin of side of chin (body structure)||skin tag on left side of chin (physical finding)||has_finding_site
peripheral cornea||arcus of cornea (disorder)||has_finding_site
structure of cervical spine joint region||decreased passive range of cervical spine flexion||has_finding_site
structure of left sacroiliac joint (body structure)||osteoarthritis of bilateral sacroiliac joints||has_finding_site
retinal||retinal hyaline dystrophy (diagnosis)||has_finding_site
chest region||percutaneous chest drain in place with serous drainage||has_finding_site
cerebellopontine angle||head computed tomography contrast enhancing lesion cerebellopontine angle||has_finding_site
laryngeal structure (body structure)||burns of larynx, trachea, and lung (diagnosis)||has_finding_site
structure of left knee joint||modified ashworth scale - extension left knee (physical finding)||has_finding_site
ligament of joint, unspecified (body structure)||desmitis of collateral ligament of coffin joint||has_finding_site
skeletal muscle structure of upper arm||traumatic myositis ossificans of upper arm (diagnosis)||has_finding_site
bone structure of right tibia (body structure)||closed fractuere of spine of right tibia (disorder)||has_finding_site
body system (body structure)||may-hegglin anomaly (diagnosis)||has_finding_site
upper back structure||purulent laceration of right upper back (physical finding)||has_finding_site
skin ventral surface thigh||ulcer of anterior surface of left thigh (physical finding)||has_finding_site
structure of musculoskeletal system of thoracic spine||thor spine crepitus palpable||has_finding_site
skin structure of palmar surface of ring finger||skin texture of palmar aspect of ring finger of left hand (physical finding)||has_finding_site
pulmonary||lung disease with diseases ec||has_finding_site
bone structure of second rib (body structure)||closed fracture of left second rib (diagnosis)||has_finding_site
hand skin||tactile hyperesthesia of right hand||has_finding_site
set of accessory nerves||palsies, traumatic eleventh-nerve||has_finding_site
liver, nos||acute fulminating viral hepatitis (disorder)||has_finding_site
blood vessels: general terms||decreased capillary fragility||has_finding_site
ulnar nerve, nos||ulnar nerve observation||has_finding_site
bone structure of t8 (body structure)||magnetic resonance imaging of thoracic spine: mass of mid t8 vertebra associated with bone destruction (procedure)||has_finding_site
nerve xs||vagus nerve sensory dis||has_finding_site
skin structure of medial surface of thumb||skin lesion on medial aspect of right thumb||has_finding_site
lig. collaterale ulnare||open division elbow, medial collateral ligament (disorder)||has_finding_site
crural region||gas gangrene-leg||has_finding_site
gastrointestinal tract, small intestine||female rectocoele co-occurrent with enterocele||has_finding_site
lower lip structure (body structure)||bite of right lower lip (physical finding)||has_finding_site
valve, heart||prosthetic heart valve malfunction regurgitation||has_finding_site
skin of dorsum of foot||skin nodule of dorsal aspect of right foot||has_finding_site
back lower||warm tissue surrounding wound of right lower back (physical finding)||has_finding_site
skin of anal part of perineum||resid haemorrhoidal skin tag||has_finding_site
wrist joint (body structure)||chronic gout of wrist without tophus due to renal impairment||has_finding_site
retinal structure (body structure)||tapetoretinal degeneration||has_finding_site
female gonad||clear cell adenocarcinoma of ovary (disorder)||has_finding_site
skin structure of neck (body structure)||macule on neck||has_finding_site
talocalcaneonavicular joint||x-ray of foot: joint space narrowing of intertarsal joint of calcaneus||has_finding_site
structures of the central nervous system||neuroinvasive venezuelan equine encephalitis||has_finding_site
tibial and fibular structures||x-ray of lower leg: lytic lesion with soft tissue mass inferiorly (procedure)||has_finding_site
left ear structure (body structure)||otolaryngologic surgical result of left ear: pain worsened||has_finding_site
bone structure of ankle joint region (body structure)||pathologic fracture of ankle at site of neoplasm (disorder)||has_finding_site
nose bridge||full thickness ulcer of dorsum of nose (physical finding)||has_finding_site
structure of right femoral canal||femoral hernia bilateral with gangrene and obstruction||has_finding_site
talonavicular joint||mri ankle joint effusion left talonavicular||has_finding_site
central nervous system space||secondary intracranial hypotension||has_finding_site
nerve, optic||amblyopia toxic||has_finding_site
head||microcephalic primordial dwarfism of toriello type||has_finding_site
capsule of intertarsal joint (body structure)||capsulitis of tarsus (disorder)||has_finding_site
structure of left ring finger||crushing injury of left ring finger||has_finding_site
blood vessel structure of skin||toxic urticated erythema caused by drug||has_finding_site
skin structure (body structure)||dyskeratosis congenita syndrome||has_finding_site
maxillary left first premolar||cervical filling in left upper first bicuspid (physical finding)||has_finding_site
conjunctiva||conjunctival intraepithelial neoplasia (disorder)||has_finding_site
skin of body||bacterial yaws (treponema pertenue) butter yaws||has_finding_site
skin of sacral region||abrasion of sacral region (disorder)||has_finding_site
structure of lymph node of thorax||letterer-siwe disease of intrathoracic lymph nodes (disorder)||has_finding_site
lateral segmental bronchus of right middle lobe||bronchoscopy foreign body of right middle lobe lateral segmental bronchus||has_finding_site
genital system, female, uterus||cervix prolapsed into vagina (finding)||has_finding_site
skin nos||sunlight-induced angio-oedema-urticaria||has_finding_site
midtarsal joint||decreased posterior movement of midtarsal joints on anteroposterior glide maneuver of both feet (physical finding)||has_finding_site
arch of vertebra, nos||rachischisis with hydrocephalus (diagnosis)||has_finding_site
first dorsal vertebra||magnetic resonance imaging of thoracic spine: perispinal mass of t1 vertebra enhanced with gadolinium||has_finding_site
maxillary bone||osteoradionecrosis of the maxilla||has_finding_site
bone structure of tenth rib||delayed union of fracture of right tenth rib posteriorly (diagnosis)||has_finding_site
right ear, nos||conductive hearing loss of right ear (diagnosis)||has_finding_site
lungs||pulmonary immaturity of fetus or newborn||has_finding_site
structure of body of second thoracic vertebra||mri thoracic osseous destructive lesion vertebral body t2||has_finding_site
skin structure of palmar surface of little finger (body structure)||fissure of skin of palmar aspect of little finger of right hand||has_finding_site
structure of hand||indurated wound of left hand (physical finding)||has_finding_site
bone mastoid||mastoid fracture||has_finding_site
structure of lower leg||primary malignant neoplasm of blood vessel of lower leg (diagnosis)||has_finding_site
bursa of elbow||injury of bursa of elbow (disorder)||has_finding_site
oviduct||fallopian tube injury with open wound into abdominal cavity||has_finding_site
vertebrate brain||hypoxic-ischaemic encephalopathy||has_finding_site
structure of middle phalanx of little finger||dry gangrene of middle phalanx of little finger of left hand (physical finding)||has_finding_site
macula||degeneration of macula due to cyst or hole||has_finding_site
pubic ligament (body structure)||symphysis pubis sprain||has_finding_site
articular cartilage of femoral condyle (body structure)||magnetic resonance imaging of knee: chondral fissure of medial aspect of trochlea||has_finding_site
second metatarsal bone||x-ray foot fracture left second metatarsal||has_finding_site
skin structure of upper chest wall||skin fissure on left upper chest (physical finding)||has_finding_site
lower inner quadrant of left breast||ultrasound of breast: mass of inferior medial quadrant of left breast (procedure)||has_finding_site
extremitas sternalis claviculae||open fracture of proximal third (group iii) of clavicle||has_finding_site
cor||heart-hand syndrome type 2||has_finding_site
precerebral artery (body structure)||precerebral artery occlusion nos (disorder)||has_finding_site
valves, mitral||mitral incompetence, non-rheumatic||has_finding_site
musculoskeletal structure of spine||thoracogenic scoliosis (diagnosis)||has_finding_site
glomerulus structure||hereditary diffuse membranous glomerulonephritis||has_finding_site
cheek, nos||avulsion of cheek (disorder)||has_finding_site
middle periphery of retina (body structure)||phakoma of midperiphery of right eye||has_finding_site
skin of foot, nos||skin rash of left foot with moccasin distribution||has_finding_site
ovary left||left ovarian primary sarcoma||has_finding_site
proximal interphalangeal joint structure of third toe||degree of improvement of passive range of motion of proximal interphalangeal joint of third toe of right foot on flexion (physical finding)||has_finding_site
structure of anterior communicating artery||spontaneous hemorrhage of subarachnoid space from anterior communicating artery (disorder)||has_finding_site
obturator lymph node group||secondary and unspecified malignant neoplasm of obturator lymph nodes||has_finding_site
urinary bladder structure||noncompliant bladder||has_finding_site
hp||anomaly of pituitary gland nos||has_finding_site
upper limb structure||laceration arm||has_finding_site
cerebellopontile angles||magnetic resonance imaging of brain: t2-weighted se decreased signal cerebellopontine angle||has_finding_site
extensor of knee joint (body structure)||knee muscle weakness of extension left only||has_finding_site
third dorsal vertebra||magnetic resonance imaging of thoracic spine: perispinal mass of t3 vertebra with isointense signal intensity (s/i) ratio||has_finding_site
facial skin fold (body structure)||cysts on paranasal fold (physical finding)||has_finding_site
mesentery structure||neoplasm of mesentery (diagnosis)||has_finding_site
mucosa, nasal||rhinitis (disorder)||has_finding_site
tissues, connective||hyperelastosis cutis||has_finding_site
nervous system structure||quadriplegia with associated quadriparesis (disorder)||has_finding_site
body of organ||septicemic plague (disorder)||has_finding_site
parametrium, nos||pelvic cellulitis||has_finding_site
digits||postaxial polydactyly and intellectual disability syndrome (disorder)||has_finding_site
body system, hepatic||glissonian cirrhosis (disorder)||has_finding_site
entire right achilles tendon||congenital bilateral short achilles tendons (disorder)||has_finding_site
cranial nerve structure (body structure)||avulsion of cranial nerve||has_finding_site
skin of the forearm||examination of tissue surrounding incision of left forearm (physical finding)||has_finding_site
ossa manus||tuberculosis of bone of hand||has_finding_site
skins||linear lichen planus||has_finding_site
metacarpophalangeal jt thumb||burns of metacarpophalangeal joint of thumb of right hand||has_finding_site
structure of sclera of right eye||congenital anomaly of bilateral sclerae||has_finding_site
upper pole artery (body structure)||aneurysm of right superior renal artery||has_finding_site
structure of intestine||enteritis radiation||has_finding_site
skin thumbs||cut of thumb||has_finding_site
tubes, neural||thoracic spina bifida with hydrocephalus - open||has_finding_site
comb bundle||sporadic infantile bilateral striatal necrosis (disorder)||has_finding_site
spinal segment of epidural space||epidural haematoma||has_finding_site
[so]nipple||ulcer of nipple tissue base (physical finding)||has_finding_site
skin of part of shoulder (body structure)||pustules on back of shoulder (physical finding)||has_finding_site
pleural membrane structure||carcinoma in situ of pleura (diagnosis)||has_finding_site
urinary system, kidney||pigment nephropathy||has_finding_site
obstetrical canal||obstructed labor caused by bony pelvis with antenatal problem||has_finding_site
brain tissue structure||echinococcosis encephalitis||has_finding_site
arch of thoracic vertebra, nos||spina bifida of thoracolumbar region with hydrocephalus||has_finding_site
thumb||frostbite of left thumb (diagnosis)||has_finding_site
hand-right||open extra-articular fracture of base of fourth metacarpal bone of right hand (diagnosis)||has_finding_site
structure of skin and/or mucous membrane||lyell syndrome caused by drug||has_finding_site
skin structure of shoulder (body structure)||width of ulcer of anterior surface of right shoulder||has_finding_site
bowel, nos||dietetic enteritis (disorder)||has_finding_site
thigh structure||inferior lateral to superior medial wound of right thigh (physical finding)||has_finding_site
duodenal||acute duodenal ulcer without hemorrhage and without perforation but with obstruction (disorder)||has_finding_site
choroidal and retinal structures (body structure)||subretinal lipid deposit (finding)||has_finding_site
lens (eye)||spherophakia brachymorphia syndrome||has_finding_site
skin nos (body structure)||malignant pyoderma (disorder)||has_finding_site
010-012 skin||acrosyringeal adenomatosis||has_finding_site
eighth dorsal vertebra||t-spine mri osseous mass associated with hypervascularity t8 mid||has_finding_site
bones, nos||osteonecrosis, unspecified||has_finding_site
cardiac muscle (tissue)||dilated cardiomyopathy due to viral myocarditis||has_finding_site
cervix uteri including exocervix and endocervix||stenosis of cervix complicating postpartum care - delivered during previous episode of care||has_finding_site
metatarsophalang jt great toe||mtp joint of right great toe feels loose||has_finding_site
c3 vertebra||magnetic resonance imaging of cervical spine: cystic caudal mass of c3 vertebra (procedure)||has_finding_site
vagino-||stenosis of vagina in pregnancy, childbirth and the puerperium||has_finding_site
cervix uteri structure (body structure)||observation of measures of cervix||has_finding_site
lumbar spinal cord structure||open compression fracture of l1 vertebral body with spinal cord injury||has_finding_site
right hip joint structure||hip effusion right||has_finding_site
oral mucosa||melanin pigmentation of oral mucosa associated with systemic condition (disorder)||has_finding_site
apparatus respiratorius||cardiorespiratory failure during and/or resulting from a procedure||has_finding_site
skin of perioral region of face||ulcer around left side of mouth surrounded by callus (physical finding)||has_finding_site
footpad||vesicle of footpad (finding)||has_finding_site
parotid duct orifice||erythema of right parotid orifice (physical finding)||has_finding_site
minor salivary glands set||extravasation cyst of minor salivary gland||has_finding_site
entire tooth (body structure)||hypodontia and nail dysgenesis (disorder)||has_finding_site
renal calyces||acquired calyceal diverticulum||has_finding_site
os||disappearing bone disease (disorder)||has_finding_site
aortic structure||mechanical complication of intra-aortic balloon||has_finding_site
stomach, nos||gastric neuropacemaker device in situ||has_finding_site
tracheas||papillary carcinoma of trachea (diagnosis)||has_finding_site
structure of proximal phalanx of ring finger||x-ray of finger: lytic lesion of proximal phalanx of ring finger of left hand||has_finding_site
systems, peripheral nervous||juvenile onset huntington dis||has_finding_site
valva atrioventricularis dextra||severe tricuspid valve stenosis||has_finding_site
vascular structure of right upper limb (body structure)||ischaemia of right upper limb||has_finding_site
toe||macrodact toes-fatty nrve tumr||has_finding_site
epistropheus||mri cervical osseous mass cystic c2 perineural||has_finding_site
skin of auricle of ear||plaque on left auricle||has_finding_site
renal tubule||fanconi-de toni-debre syndrome (disorder)||has_finding_site
skin of index finger||plaque on the fingers left index finger distal||has_finding_site
structure of tendon and tendon sheath of knee||disorder synovium and tendon knee||has_finding_site
periungual skin of finger||lichenification of periungual region of index finger of right hand||has_finding_site
chromosome pair 11 (cell structure)||11p15 deletion syndrome (disorder)||has_finding_site
system, respiratory||increased bronchial sounds||has_finding_site
head (anatomy)||face mask squeeze (disorder)||has_finding_site
structure of nuchal region of neck (body structure)||neck posterior tissue injury laceration extending to fascia||has_finding_site
stapes structure (body structure)||stapes normal||has_finding_site
structure tooth||impacted mesiodens (disorder)||has_finding_site
bone structure of right tibia||bone cyst of right tibia||has_finding_site
common (non-mitr, non-tricusp) atriovent valve structure||atrioventricular septal defect, atrial and ventricular components with common atrioventricular valve with unbalanced commitment of valve to left ventricle||has_finding_site
macula||indocyanine green angiography showed hot spot(s) in the macula temporally||has_finding_site
vagina, nos||precursor b-cell lymphoblastic lymphoma of vagina (diagnosis)||has_finding_site
pharynx||glass in pharynx (disorder)||has_finding_site
nail unit of toe||reported friction burn of toenail by cloth (history)||has_finding_site
cervical spines||fracture of facet of cervical spine (disorder)||has_finding_site
sacrum||foetal sacral teratoma||has_finding_site
craniopharyngeal duct||benign neoplasm of craniopharyngeal duct (diagnosis)||has_finding_site
skin of little finger, nos||pustules on the fingers left little finger proximal||has_finding_site
female perineal structure (body structure)||scalling of female perineum (finding)||has_finding_site
metatarsophala joint third toe||hypermobile metatarsophalangeal joint of third toe of right foot on active flexion||has_finding_site
legs||frostbite with tissue necrosis of knee and lower leg (disorder)||has_finding_site
skin of the back||traumatic blister of back (disorder)||has_finding_site
b3 adrenal glands||adrenal haemorrhage due to birth injury||has_finding_site
cerebral structure (body structure)||non-amnestic alzheimer disease||has_finding_site
buccal gingival crevice (body structure)||relative probing depth at the buccal left lower second molar||has_finding_site
abdomens||pain during inflow of dialysate||has_finding_site
structure of myocardium of left ventricle (body structure)||left ventricular myocardial noncompaction cardiomyopathy (disorder)||has_finding_site
neck skin||multiple skin tags on neck (disorder)||has_finding_site
medullari, conus||syndrome; conus medullaris||has_finding_site
bones toes||benign neoplasm of phalanx of foot (disorder)||has_finding_site
basal ganglia structure||parkinsonism caused by carbon disulfide||has_finding_site
lymphoid system||cutaneous b-cell pseudolymphoma caused by borrelia (diagnosis)||has_finding_site
pancreatic duct, nos||intraduct papilloma of pancreas||has_finding_site
ren||high ren thresh for glucose||has_finding_site
bone foot||open fracture dislocation of metatarsophalangeal joint, single (diagnosis)||has_finding_site
circulatory system||pulse, carotid arterial, abnormal||has_finding_site
artery, cerebral||cerebral arterial aneurysm||has_finding_site
nervous systems||injury;neurological||has_finding_site
lobular bronchiole||drug-induced bronchiolit oblit||has_finding_site
stifle joint, nos||finding of lachman's test (finding)||has_finding_site
phalanges||closed fracture dislocation multiple digits||has_finding_site
armpit skin||papule within both armpits||has_finding_site
hands skin||bullae on left hand||has_finding_site
endocrine/metabolic organ system||hereditary disorder of endocrine system (disorder)||has_finding_site
skin structure of shoulder||skin tag on back of right shoulder||has_finding_site
soft tissues, nos||tta||has_finding_site
rectums||stricture of rectum||has_finding_site
structure of nail unit of great toe||reddish-blue discoloration of great toenail of left foot (symptom)||has_finding_site
trunk of left common carotid tree||echocardiography: atherosclerosis of left carotid artery||has_finding_site
ophthalmic||optic nerve coloboma with renal disease||has_finding_site
structure of joint of left elbow||gouty arthritis of left elbow||has_finding_site
anulus tympanicus||lack of ossification of tympanic anulus||has_finding_site
right cornea||central pterygium of eye, bilateral||has_finding_site
skin of gluteal region||carbuncle of left buttock (diagnosis)||has_finding_site
orbital region structure||ocular implant extrusion (disorder)||has_finding_site
marrow, bone||b-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); e2a-pbx1 (tcf3-pbx1)||has_finding_site
atrio-ventricular nodes||second-degree heart block||has_finding_site
structure of visual system (body structure)||blindness;temporary||has_finding_site
mesial gingival crevice (body structure)||relative probing depth at mesial right upper third molar||has_finding_site
aortic arch structure||rt aort arch & lt descend aort||has_finding_site
oculomotor nerve tree||marcus-gunn syndrome (diagnosis)||has_finding_site
costovertebral joint structure (body structure)||disloc costovert joint||has_finding_site
skin of dorsum of foot||cysts on top of right foot (physical finding)||has_finding_site
buccal mucosa (body structure)||adherent white plaques on buccal mucosa||has_finding_site
brain tissue||stroke syndrome anterior circulation uncertain pathology||has_finding_site
bones of cranium and face||internasal dysostosis||has_finding_site
thoracic spinal cord structure||concussion and oedema of thoracic spinal cord||has_finding_site
choroidal structure (body structure)||mcp - multifocal choroiditis and panuveitis syndrome||has_finding_site
retinal||x-linked mental handicap-retinitis pigmentosa syndrome||has_finding_site
toe structure||sausage toe (finding)||has_finding_site
systemic vascular structure (body structure)||polyarteritis nodosa with multi-organ involvement (disorder)||has_finding_site
lower outer quadrant of left breast (body structure)||mammogram increased size of mass #1 of inferior lateral quadrant of left breast||has_finding_site
structure of centrum of lumbar vertebra (body structure)||hemicentric lumbar centrum||has_finding_site
structure of left tympanic membrane (body structure)||chronic left myringitis||has_finding_site
structure of auditory system||hearing loss in left ear||has_finding_site
synovial structure of knee||cyst, popliteal||has_finding_site
middle periphery of retina||midperipheral choroidal rupture of inferior aspect of right eye (physical finding)||has_finding_site
yellow fat (body structure)||widespread lipoatrophy||has_finding_site
structure of joint of right hand||arthropathy of joint of right hand (disorder)||has_finding_site
parencephalons||spinocerebellar atrophy i||has_finding_site
distal interphalangeal joint of little finger||x-ray of finger: mallet deformity of left little finger with dislocation (procedure)||has_finding_site
parietal cortex||mass of right parietal lobe of brain||has_finding_site
t12 vertebra||spine magnetic resonance imaging thoracic osseous mass size t12 anterior (___ mm)||has_finding_site
tracheal||chondrosarcoma of trachea (diagnosis)||has_finding_site
skin of ext auditory meatus||vesicles in ear canal (finding)||has_finding_site
temporomandibular joint (tmj)||pink and red appearance of wound bed of left temporomandibular joint (physical finding)||has_finding_site
blood vessel of stomach||angiodysplasia of stomach and duodenum without hemorrhage||has_finding_site
left first cranial nerve||arteritic anterior ischemic optic neuropathy of left eye (disorder)||has_finding_site
pupil structure||abnormal pupil reaction||has_finding_site
bone structure of mandible||malignant ameloblastoma of mandible (disorder)||has_finding_site
skin structure of external genitalia (body structure)||shape of incision of genitalia||has_finding_site
doudenal lumen||volvulus of duodenum (disorder)||has_finding_site
structure of periprostatic tissue||periprostatic; adhesion||has_finding_site
nephr(o)-||chronic milk alkali syndrome (disorder)||has_finding_site
skin of medial surface, thumb||skin patch of medial aspect of left thumb||has_finding_site
fourth thoracic vertebral body||malunion of fracture of fourth thoracic vertebral body||has_finding_site
right bronchus||bronchoscopy right lung main stem bronchus mass (___ mm) friable||has_finding_site
bone structure of t2||spine magnetic resonance imaging thoracic osseous mass size t2 mid (___ mm)||has_finding_site
structure of left anterior uveal tract (body structure)||chronic anterior uveitis of left eye||has_finding_site
attached surface of gingiva||focal palmoplantar and gingival keratoderma (disorder)||has_finding_site
structure, fetal||craniopagus occipitalis||has_finding_site
pelvis||traumatic amputation of part of pelvis||has_finding_site
pulmonary venous structure (body structure)||infracardiac location of anomalous pulmonary venous connection||has_finding_site
bladder||bladder malignant neoplasm primary||has_finding_site
brain tissue structure (body structure)||encephalitis caused by hendra virus (disorder)||has_finding_site
entire skin of upper lip (body structure)||chancre on entire upper lip (physical finding)||has_finding_site
skin of external nose||viral wart on nose (disorder)||has_finding_site
skin structure of right lower limb (body structure)||erysipelas of bilateral lower limbs (disorder)||has_finding_site
structure of right auricular appendage||abnormality of right atrial appendage||has_finding_site
structure of body of tenth thoracic vertebra||fracture of t9-t10 vertebral body wedge compression||has_finding_site
head>temporomandibular joint||bony swelling of the temporomandibular joint (finding)||has_finding_site
fungiform papillae set||tender fungiform papillae of tongue||has_finding_site
distal phalanx of third digit of hand||open mallet fracture of distal phalanx of middle finger||has_finding_site
joint of second toe (body structure)||contracture of second toe of right foot (physical finding)||has_finding_site
left thorax||open fracture of proximal third of left clavicle with minimal displacement (type i)||has_finding_site
suprasegmental levels of nervous system||delirium caused by substance or medication||has_finding_site
structure of distal phalanx of little toe (body structure)||closed epiphyseal fracture of distal phalanx of fifth toe of left foot||has_finding_site
spinal nerve root, nos||diphtheria radiculomyelitis (disorder)||has_finding_site
tissues (body)||reported tissue injury||has_finding_site
structure of muscle of forearm (body structure)||diastasis of muscle forearm||has_finding_site
fingers of skin||eschars were seen on multiple fingers of both hands||has_finding_site
eye right||absolute glaucoma right eye||has_finding_site
structure of peroneus longus muscle tendon (body structure)||pain of right peroneus longus tendon above malleolus elicited by motion||has_finding_site
structure of product of conception (body structure)||old meconium staining liquor||has_finding_site
cardiovascular organ system||congenital anomaly of circulatory system corrected||has_finding_site
nervus cranialis||tumour of cranial nerve||has_finding_site
structure of urinary tract proper||obstruction; urinary||has_finding_site
integument||pityriasis rotunda||has_finding_site
colons||colitis (diagnosis)||has_finding_site
gastrointestinal tracts||lactobezoar (disorder)||has_finding_site
right b2||bronchoscopy telangiectasia of lateral aspect of right upper lobe posterior segmental bronchus (procedure)||has_finding_site
lower extremities||autosomal recessive amelia||has_finding_site
intrahepatic biliary tract structure (body structure)||precursor t-cell lymphoblastic lymphoma of intrahepatic bile duct (diagnosis)||has_finding_site
areola skin||ulcer of areola with full thickness skin loss (physical finding)||has_finding_site
bone, mandibular||goldenhar-gorlin syndromes||has_finding_site
reticulums||traumatic reticulopericarditis||has_finding_site
mcpjbt - metatarsophalangeal joint of big toe||active motion right great toe mtp hypermobile||has_finding_site
skin structure of upper arm (body structure)||secondary malignant skin neoplasm of upper arm (diagnosis)||has_finding_site
arteries, renal||occlusion; renal artery||has_finding_site
f18 umbilical cord||false knot of umbilical cord (disorder)||has_finding_site
anorectal junction||inflammatory cloacogenic polyp (diagnosis)||has_finding_site
arches dent||open bite (disorder)||has_finding_site
arch, dental||non-work interfer funct occl||has_finding_site
proximal interphalangeal joint structure of third finger||active extension of left middle finger proximal interphalangeal joint (___ degrees)||has_finding_site
intestinal||heterophyiasis (diagnosis)||has_finding_site
tarsal region||contracture of ankle joint (disorder)||has_finding_site
vascular structure of pancreas (body structure)||arteriography of celiac axis: vessel displacement in pancreas||has_finding_site
skin of shoulder, nos||width of ulcer of posterior surface of left shoulder||has_finding_site
fifth thoracic vertebra||mri thoracic osseous mass t2 hypointense signal t5 mid||has_finding_site
sagittal sutures||sagittal suture in transverse diameter (finding)||has_finding_site
upper extremity.right>upper arm||chemical burn of right upper arm (disorder)||has_finding_site
retinal structure (body structure)||chorioretinal scar postinflammatory||has_finding_site
splen||spleen palpable on inspiration||has_finding_site
structure of posterior surface of lower leg (body structure)||swelling of proximal posterior aspect of right lower leg||has_finding_site
skin ankle||incision of left ankle with sutures in place (physical finding)||has_finding_site
structure of lateral chest wall (body structure)||foul-smelling weeping wound of right lateral chest (physical finding)||has_finding_site
cochlea, nos||cochlear dysplasia of right ear (diagnosis)||has_finding_site
right abdominal lumbar region||rebound tendern r lumbar||has_finding_site
left retina||proliferative diabetic retinopathy of left eye (diagnosis)||has_finding_site
hand structure (body structure)||asymmetrical hands (finding)||has_finding_site
structure of second left posterolateral branch of circumflex branch of left coronary artery||coronary angiography: left coronary second left posterolateral branch aneurysm discrete||has_finding_site
structure of hemorrhoidal plexus||gangrenous pile||has_finding_site
rbcs||g-6-pd class ii variant anemia||has_finding_site
structure of back of lower thoracic region||tissue surrounding wound of right mid back (physical finding)||has_finding_site
of skin breast||ulcer on both breasts||has_finding_site
cornea, right eye||filamentary keratopathy of bilateral eyes||has_finding_site
sixth dorsal vertebra||magnetic resonance imaging of thoracic spine: peritendinous mass of t6 vertebra with hypointense signal intensity (s/i) ratio||has_finding_site
left occipital lobe structure (body structure)||brain biopsy glioblastoma multiforme of left occipital lobe||has_finding_site
humeral trochlea||open fracture of trochlea of right humerus with displacement (diagnosis)||has_finding_site
left maxillary central incisor tooth||purulent discharge of gums on left maxillary central incisor (physical finding)||has_finding_site
heart structure||tic-tac rhythm||has_finding_site
microscopic skin vascular structure||cholesterol atheroembolism of skin||has_finding_site
umbilical cord||umbilical cord three times around neck (disorder)||has_finding_site
skin structure of lower chest wall||lichenification chest left lower (inferior)||has_finding_site
010-012 skin||hemolytic anemia with emphysema and cutis laxa||has_finding_site
structure of right mastoid bone||disorder of right mastoid||has_finding_site
colon (anatomy)||dolichocolon congenital||has_finding_site
structure of raphe of soft palate||mass of midline of soft palate||has_finding_site
skin of inside of elbow||skin lesion on medial aspect of both elbows||has_finding_site
structure of female genital system subdivision (body structure)||uterine dysfunction||has_finding_site
legs lower skin||varicose veins of left lower extremity with ulcer of other part of lower leg (diagnosis)||has_finding_site
pulmones||restrictive lung disease due to amyotrophic lateral sclerosis||has_finding_site
distal interphalangeal joint structure of fifth toe||hypermobile distal interphalangeal joint of fifth toe of left foot on passive motion (physical finding)||has_finding_site
lateral cutaneous branch of t12||lateral cutaneous branch t12 injury (disorder)||has_finding_site
oculus||constant comitant hypertropia||has_finding_site
rectum structure||finding of appearance of rectum (finding)||has_finding_site
distal gingival crevice||relative probing depth at distal right upper second molar (physical finding)||has_finding_site
mesial marginal gingivae||purulent discharge of gums on mesial surface of right maxillary cuspid||has_finding_site
trachea||puncture wound of trachea (diagnosis)||has_finding_site
intervertebral disk, t5-t6||neoplasm of t5-t6 intervertebral disc (diagnosis)||has_finding_site
peritoneum||benign fibrohistiocytic neoplasm of peritoneum||has_finding_site
left breast structure (body structure)||ecchymotic tissue surrounding wound of left breast (physical finding)||has_finding_site
distal interphalangeal joint of third digit of foot||burns of medial aspect of distal interphalangeal joint of middle toe of left foot (physical finding)||has_finding_site
lingua||local recurrence of malignant neoplasm of tongue (diagnosis)||has_finding_site
skin of scalp||edges of incision of scalp||has_finding_site
structure of musculoskeletal system (body structure)||adson's sign (finding)||has_finding_site
structure of left visual system (body structure)||bilateral blindnesses||has_finding_site
right lower primary tooth b||x-ray teeth bone loss right lower lateral incisor incisal||has_finding_site
structure of capillary blood vessel (organ) (body structure)||aureus lichens||has_finding_site
lung tissues||large cell carcinoma of lung with rhabdoid phenotype||has_finding_site
auditory structure (body structure)||seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance||has_finding_site
bone structure of seventh rib||malunion of fracture of right seventh rib in middle||has_finding_site
skin of breast||deep incision of left breast (physical finding)||has_finding_site
bone, nos||fracture, closed||has_finding_site
circulatory system||haemodynamically stable||has_finding_site
anterior chamber of the eye||finding of anterior chamber intraocular lens||has_finding_site
structure of right forearm (body structure)||puncture wound of right forearm||has_finding_site
subcutaneous tissue structure of toe (body structure)||lump under skin of toe of left foot (symptom)||has_finding_site
skin structure of right eyelid (body structure)||wound of right eyelid due to nonvenomous insect bite (disorder)||has_finding_site
structure of right eyelid||congenital coloboma of right eyelid (disorder)||has_finding_site
upper parasternal region||murmur lusb continuous transmitted along left sternal border||has_finding_site
lung structure||absence of lung||has_finding_site
structure of nail unit of third toe||ingrowing nail of lateral border of third toe of left foot||has_finding_site
breast||irregular lump of breast (finding)||has_finding_site
skin of part of breast||skin papule of right lower inner breast||has_finding_site
skin, trunk, local||scales of trunk||has_finding_site
tongue structure (body structure)||tongue abscess (diagnosis)||has_finding_site
skin eyebrow||petechial hemorrhage of left inner eyebrow||has_finding_site
tendon of rectus femoris (body structure)||magnetic resonance imaging of knee: complete tear of rectus femoris tendon at patellar insertion (procedure)||has_finding_site
structure of shoulder region, unspecified||dec pass range shoulder adduct||has_finding_site
structure of innominate bone and/or sacrum and/or coccyx||pathologic fracture of pelvis at site of neoplasm||has_finding_site
female genital organ structure||villous adenocarcinoma of female genitalia (diagnosis)||has_finding_site
structure of nasal-orbit bony complex (body structure)||sequestrum of nasal-orbit complex||has_finding_site
skin structure of dorsum of foot||skin pimple of top of right foot||has_finding_site
temple region structure||indurated tissue surrounding wound of temple||has_finding_site
hepatic organ system||steroid hepatopathy||has_finding_site
nervous system structure (body structure)||ataxia due to mitochondrial mutations (disorder)||has_finding_site
pudendum (female)||primary adenocarcinoma of vulva||has_finding_site
skin of scalp, nos||hypotrichosis 2||has_finding_site
radial and ulna structures||fracture of radius or ulna of right arm (diagnosis)||has_finding_site
flexor tendon of wrist (body structure)||partial division flexor tendon wrist||has_finding_site
structure of foot joint region||no foot movement||has_finding_site
skin elbow||superficial incision of left elbow||has_finding_site
intestines||toxic dilatation of intestine||has_finding_site
skin of eyelid||junctional nevus of eyelid||has_finding_site
p1/p2 joint of digit 4||pip joint of left fourth toe feels unstable||has_finding_site
32||probing depth at the lingual right lower third molar||has_finding_site
haderup designation -2||purulent discharge of gums on mesial surface of left mandibular lateral incisor (physical finding)||has_finding_site
skin of sole of foot||keratoderma with woolly hair type iv||has_finding_site
structure of tendon of fibularis longus||magnetic resonance imaging of ankle: degeneration of left peroneus longus tendon (procedure)||has_finding_site
urogenital structure||chemical burns genitourinary organs||has_finding_site
pon||pontocerebellar hypoplasia||has_finding_site
skin structure of dorsal area of wrist (body structure)||excoriation of dorsal aspect of left wrist||has_finding_site
bone structure of t4 (body structure)||magnetic resonance imaging of thoracic spine: mass of mid t4 vertebra with hyperintense signal intensity (s/i) ratio (procedure)||has_finding_site
bone, skeletal||atrophic non-union of fracture||has_finding_site
human hair||alopecia medicamentosa||has_finding_site
retroperitoneal compartment||retroperitoneal masses||has_finding_site
thighs||multiple injuries of thigh||has_finding_site
mammary||suppressed lactation, antepartum condition or complication||has_finding_site
scapula||size of scapula finding||has_finding_site
intertarsal joint structure||x-ray of foot: soft tissue swelling of intertarsal joint (procedure)||has_finding_site
vag||dysplasia of vagina, unspecified||has_finding_site
eyelid skin upper||malignant melanoma of right upper eyelid, including canthus (diagnosis)||has_finding_site
structure of intercarpal joint (body structure)||x-ray of hand: erosions of intercarpal joints of right hand||has_finding_site
shoulder-left||open wound of left shoulder due to dog bite (disorder)||has_finding_site
trachea||tracheal cicatrix (diagnosis)||has_finding_site
skin system||ulcer of skin caused by polycyclic aromatic hydrocarbons (disorder)||has_finding_site
structure of left eyelid (body structure)||congenital retraction of bilateral eyelids (disorder)||has_finding_site
lung structure (body structure)||pulmonary lipid storage disease||has_finding_site
skinned||generalised psoriasis||has_finding_site
spinal cord, nos||diver's palsy||has_finding_site
proximal interphalangeal joint of little finger||pain of proximal interphalangeal joint of little finger of right hand elicited by flexion (physical finding)||has_finding_site
skin nos (body structure)||secondary localised cutaneous amyloidosis||has_finding_site
right ventricular structure (body structure)||right ventricular myocardial size - finding||has_finding_site
structure of left bulbar conjunctiva||congenital symblepharon of bilateral conjunctivae (disorder)||has_finding_site
skin structure of dorsum of foot||skin graft on the left foot dorsal aspect||has_finding_site
rectum structure (body structure)||rectal malignant neoplasm by direct extension from vagina||has_finding_site
gingiva of upper jaw||gingival hemorrhage at upper central incisor on right||has_finding_site
digitus quartus [iv] manus||abduction of ring finger (physical finding)||has_finding_site
capsule, tenon's||orbital tenonitis||has_finding_site
radial head of humerus||open capitellar fracture of humerus||has_finding_site
calcaneal region structure||bursitis of left heel (diagnosis)||has_finding_site
skin structure (body structure)||severe systemic illness-induced cutaneous atrophy||has_finding_site
structure of myocardium of right atrium (body structure)||mri of heart for morphology: right atrium myocardium infiltrated||has_finding_site
entire skin of sole of foot||palmoplantar keratoderma, 46,xx sex reversal, predisposition to squamous cell carcinoma syndrome||has_finding_site
right upper eyelid||hypotrichosis of right upper eyelid (disorder)||has_finding_site
terminal ileum||barium enema multiple ulcerations of terminal ileum (procedure)||has_finding_site
ovarium||mature solid teratoma of ovary (disorder)||has_finding_site
legs||splinter of lower leg, without major open wound, infected (disorder)||has_finding_site
iris||melanoma; iris||has_finding_site
breathing passages||occupational asthma||has_finding_site
thyroid structure||hodgkin's lymphoma of thyroid gland with nodular sclerosis, cellular phase (diagnosis)||has_finding_site
xxx>joint||kaschin-beck dis.-multipl.site||has_finding_site
structure of transverse process of axis||magnetic resonance imaging of cervical spine: destructive lesion of transverse process of c2 vertebra (procedure)||has_finding_site
tracheal structure||adenoviral laryngotracheobronchitis (diagnosis)||has_finding_site
arterial grafts||infected iliopopliteal graft (disorder)||has_finding_site
vagus nerve, nos||tenth cranial nerve palsy||has_finding_site
structure of substantia propria of cornea of right eye (body structure)||groenouw corneal dystrophy type i of right eye (diagnosis)||has_finding_site
brain tissue structure||refractory abdominal migraine (disorder)||has_finding_site
right lower second permanent premolar tooth||furcation involvement of gingiva of right lower second bicuspid class f2||has_finding_site
eye, iris||miotic cyst of the iris||has_finding_site
skin of circumoral region of face||plaque around both sides of mouth (physical finding)||has_finding_site
crural region||chronic non-pressure ulcer of lower leg with muscle involvement without evidence of necrosis (diagnosis)||has_finding_site
ectodermal||trichothiodystrophy type g||has_finding_site
esophagus||malignant mesenchymal neoplasm of esophagus||has_finding_site
head soft tissue||secondary malignant soft tissue neoplasm of head (diagnosis)||has_finding_site
elbow skin||irregularly shaped incision of left elbow||has_finding_site
bone structure of lower leg (body structure)||x-ray of lower leg: lytic lesion with amorphous periosteal reaction (procedure)||has_finding_site
head of middle phalanx of finger||fracture of finger middle phalanx head open||has_finding_site
urethral (qualifier value)||urethra neoplasm malignant secondary by separate metastasis from prostate||has_finding_site
skins||neurocutaneous melanosis sequence||has_finding_site
temporomandibular joint, nos||pain in right temporomandibular joint||has_finding_site
a. superior cerebelli||stroke of left superior cerebellar artery with cerebral infarction (diagnosis)||has_finding_site
skin of dorsal surface of fourth toe||excoriation was seen on the right fourth toe dorsal aspect||has_finding_site
hand-right||tophus of bilateral hands co-occurrent and due to gout (disorder)||has_finding_site
skin structure of fourth toe||skin erosion on distal end of left fourth toe||has_finding_site
ankle subdivision||dehiscence of laceration of left ankle (physical finding)||has_finding_site
distal phalanx of little finger||soft tissue pain of extensor surface of distal phalanx of little finger of right hand (symptom)||has_finding_site
wall of conjunctival sac||conjunctivitis rosacea||has_finding_site
lc - left colon||benign carcinoid tumor of descending colon (disorder)||has_finding_site
upper rt quadrt of dental arch||supernumerary deciduous maxillary right central incisor tooth (morphologic abnormality)||has_finding_site
diaphragmatic||intradiaphragmatic abscess||has_finding_site
nail unit structure||nails pterygium||has_finding_site
blood vessel structure of skin||periarteritis nodosa, benign, cutaneous||has_finding_site
bladder walls||hemorrhage into bladder wall||has_finding_site
myoneural junctions||familial infantile myasthenia (disorder)||has_finding_site
corneal||recurrent pterygium (diagnosis)||has_finding_site
right lower quadrant of abdomen||rebound tenderness of right lower quadrant||has_finding_site
third metatarsophalangeal joint||charcot's arthropathy of mtp joint of third toe of right foot||has_finding_site
left foot||chronic ulcer of left foot due to diabetes mellitus||has_finding_site
uteri||finding of fluid thrill of uterus (finding)||has_finding_site
knees skin||skin blister of right knee||has_finding_site
structure of left lunate bone (body structure)||aseptic necrosis of left lunate (disorder)||has_finding_site
seventh dorsal vertebra||magnetic resonance imaging of thoracic spine: perispinal mass of t7 vertebra with hyperintense t2 signal (procedure)||has_finding_site
axis vertebra||magnetic resonance imaging of cervical spine: cystic caudal mass of c2 vertebra (procedure)||has_finding_site
brains||acute cerebrovascular accident due to ischemia (disorder)||has_finding_site
windpipe||parainfluenza virus laryngotracheitis (disorder)||has_finding_site
structure of sclera of left eye (body structure)||scleritis left eye||has_finding_site
glandula pinealis||brain ct contrast enhancing lesion pineal||has_finding_site
exocrine and endocrine pancreas, nos||pancreatic malignant neoplasm, local recurrence||has_finding_site
a78 lumbosacral spinal cord||traumatic spondylopathy of lumbosacral region||has_finding_site
91 penis||undifferentiated carcinoma of penis (diagnosis)||has_finding_site
skin structure of forehead (body structure)||ulcer of forehead with subcutaneous necrosis (physical finding)||has_finding_site
bone structure of left radius||congenital absence of bilateral radiuses (disorder)||has_finding_site
articulation||arthropathy associated with non-infectious gastrointestinal condition (diagnosis)||has_finding_site
structure of tendon of peroneus longus||tenderness on palpation of peroneus longus and brevis tendons of right ankle below malleolus||has_finding_site
skin structure of inguinal region (body structure)||width of ulcer of left inguinal region||has_finding_site
long arm of chromosome (cell structure)||medial deletion of long arm of chromosome 9||has_finding_site
products of conception and embryonic structures||placental site nodule (disorder)||has_finding_site
musculoskeletal||finding of walking distance||has_finding_site
structure of umbilical cord stump||umbilical cord stump base inflamed||has_finding_site
skin structure of upper back (body structure)||patch back upper left||has_finding_site
ventriculus||nud (nonulcer dyspepsia)||has_finding_site
bone structure of head||sequelae of fracture of skull and facial bones||has_finding_site
elbow (anatomy)||crushing injury of elbow (disorder)||has_finding_site
leg||haematoma of lower leg||has_finding_site
paravertebral region||laceration of left upper paraspinal region with staples in place (physical finding)||has_finding_site
orbital region structure||childhood-onset autosomal recessive myopathy with external ophthalmoplegia||has_finding_site
skin of toe, nos||skin lesion of toe of right foot (symptom)||has_finding_site
lower third of ureter (body structure)||ureterolithiasis of lower third of ureter||has_finding_site
humeral capitulum||closed capitellar fracture of left humerus involving trochlea (diagnosis)||has_finding_site
temple region structure (body structure)||direction of wound of temple (physical finding)||has_finding_site
structure of internal part of mouth (body structure)||primary kaposi's sarcoma of oral cavity (disorder)||has_finding_site
digits hand||deep third degree burns of fingers of left hand||has_finding_site
knee region structure||knee somatic dysfunction||has_finding_site
human blood vessel||grange occlusive arterial syndrome||has_finding_site
visual system structure (body structure)||lateral conjugate gaze||has_finding_site
bone structure of left acetabulum||congenital dysplasia of left hip (disorder)||has_finding_site
iris of right eye||iritis of right eye caused by herpes simplex virus||has_finding_site
head of top||curvilinear wound of top of head (physical finding)||has_finding_site
chest wall, nos||chest wall abscess||has_finding_site
os||haemorrhage of mouth||has_finding_site
chromosome pair 10||chromosome 10p trisomy||has_finding_site
tracheo-||acquired tracheal fistula||has_finding_site
scapula, nos||lack of ossification of scapula (disorder)||has_finding_site
lower left first bicuspid||lingual caries of left lower first bicuspid||has_finding_site
of lower back skin||curvilinear incision of right lower back (physical finding)||has_finding_site
renal tubules||renal tubular defect (diagnosis)||has_finding_site
structure of left buttock||open wound of left buttock (physical finding)||has_finding_site
gravid uterus structure (body structure)||gravid uterus at 20-24 weeks size (finding)||has_finding_site
lens of eye (body structure)||congenital pigmentation of lens||has_finding_site
structure of right wrist (body structure)||laceration of right wrist (disorder)||has_finding_site
skin structure of calf of leg||wheal on both superior calves||has_finding_site
skin structure of right lower eyelid (body structure)||xanthelasma of right lower eyelid (physical finding)||has_finding_site
lower bowel structures (body structure)||extrasphincteric fistula (disorder)||has_finding_site
back structure||benign neoplasm of back nos||has_finding_site
skin structure of breast||skin texture of right breast (physical finding)||has_finding_site
inner layer of right eyeball||benign neoplasm of right retina||has_finding_site
metacarpophalangeal joint of middle finger||active flexion of mcp joint of middle finger of left hand||has_finding_site
vulvas||lichenification of vulva (finding)||has_finding_site
duodenal structure||helicobacter pylori associated and drug-induced duodenal ulcer||has_finding_site
cheeks skin||skin fissure on both cheeks||has_finding_site
tooth structure||abutment tooth condition moderately compromised, 1 or 2 sextants (finding)||has_finding_site
head+neck>vertebral artery.right||echocardiography: atherosclerosis of right vertebral artery||has_finding_site
paravertebral region (body structure)||indurated wound of right lower paraspinal region||has_finding_site
skin structure of plantar surface of fourth toe (body structure)||petechial hemorrhage of plantar aspect of fourth toe of left foot||has_finding_site
skin and/or subcutaneous tissue of lower lip||deep third degree burn of upper and lower lip (disorder)||has_finding_site
musculoskeletal struct spine||idiopathic kyphoscoliosis||has_finding_site
structure of stomach||metaplastic gastritis||has_finding_site
structure of lumbar vertebral column region (body structure)||lumbar spine inflamed (finding)||has_finding_site
mammary region||finding of lactation||has_finding_site
pituitary glands||malignant pituitary blastoma (disorder)||has_finding_site
skin structure of lower eyelid||chancre on right lower eyelid (physical finding)||has_finding_site
skin structure (body structure)||constitutive skin pigmentation||has_finding_site
urethral orifice||urethral meatal stenosis||has_finding_site
genitalia, male||congenital male infertility (disorder)||has_finding_site
set of veins||tuberculosis of a vein||has_finding_site
cerebrovascular system, nos||cerebrovascular accident due to right carotid artery stenosis (disorder)||has_finding_site
vestibulocochlear system||prelingual non-syndromic genetic deafness (disorder)||has_finding_site
skin structure of ankle (body structure)||erythematous tissue surrounding incision of left ankle||has_finding_site
structure of trunk of pulmonary artery||systemic to pulmonary collateral artery from right carotid artery||has_finding_site
organ system, pulmonary||borg breathlessness score: 5 severe (finding)||has_finding_site
structure of shaft of first metacarpal bone of right hand (body structure)||closed fracture of shaft of first metacarpal bone of right hand (diagnosis)||has_finding_site
tunica conjunctiva bulbi||drainage bleb, flat||has_finding_site
common av valve structure||atrioventricular septal defect & common atriovent junction||has_finding_site
skin of natal cleft (body structure)||pilonidal abscess of natal cleft (disorder)||has_finding_site
sacral vertebra||osteoporotic fracture of sacral vertebra||has_finding_site
lower right eyelid||abrasion of right lower eyelid (diagnosis)||has_finding_site
structure of perilunate joint (body structure)||closed fracture dislocation perilunate (dorsal)||has_finding_site
skin structure of lateral region of trunk (body structure)||desquamation of left lateral inferior trunk (physical finding)||has_finding_site
genital systems||swollen tissue surrounding wound of genitalia||has_finding_site
jugular lymph node||jugular lymphadenopathy||has_finding_site
microscopic skin vascular structure||telangiectasia following surgery (disorder)||has_finding_site
intestinal tract, nos||viral enteritis nos||has_finding_site
cns-brain||wilhelmsen-lynch disease||has_finding_site
bones of thigh||acquired external femoral torsion (disorder)||has_finding_site
fat, subcutaneous||necrobiosis lipoidica diabeticorum (disorder)||has_finding_site
left external auditory canal||recurrent otitis externa of left external auditory canal caused by human herpes simplex virus (disorder)||has_finding_site
ankle left||left ankle tissue injury puncture swelling||has_finding_site
middle third of shaft of rib||malunion of fracture of right second rib in middle||has_finding_site
skin structure of buttock (body structure)||skin rash of both buttocks (symptom)||has_finding_site
structure of cerebrum||status epilepticus due to generalized idiopathic epilepsy (disorder)||has_finding_site
skeletal muscle structure of left upper arm||injury of muscle of left upper arm (disorder)||has_finding_site
body system, dermatologic||epidermal dysplasia||has_finding_site
skin structure of hip (body structure)||pressure-induced deep tissue damage of unspecified hip (diagnosis)||has_finding_site
nail unit structure (body structure)||odonto-onychial dysplas + alop||has_finding_site
structure of abdominopelvic cavity and/or content of abdominopelvic cavity and/or anterior abdominal wall||direct inguinal hernia on the right side||has_finding_site
peripheral artery||thrombosis of subclavian artery (diagnosis)||has_finding_site
skin of carpal region||carbuncle of wrist||has_finding_site
structure of coronal suture of skull (body structure)||fibroblast growth factor receptor 3 (fgfr3) related craniosynostosis||has_finding_site
upper arm left||serosanguineous drainage from wound on left upper arm||has_finding_site
renal collecting system structure||hydronephrosis congenital||has_finding_site
skin of elbow (body structure)||straight incision of right elbow (physical finding)||has_finding_site
blood vessel structure of skin (body structure)||rothmann-makai syndrome||has_finding_site
skin structure of upper chest wall||skin wound of right upper chest||has_finding_site
corneal structure (body structure)||contact lens related sterile keratitis||has_finding_site
lower respiratory tract structure||chest auscultation obs||has_finding_site
areola skin||desquamation on both areolae (physical finding)||has_finding_site
visual pathway structure (body structure)||malignant optic glioma of adulthood (diagnosis)||has_finding_site
structure of left upper eyelid (body structure)||blepharochalasis left upper eyelid||has_finding_site
forefoot (region of foot)||postural calcaneovalgus (disorder)||has_finding_site
xxx>bone marrow||salmonella osteomyelitis||has_finding_site
gynecologic body system||dietary amenorrhea (finding)||has_finding_site
intestino-||ascaris peritoneal granuloma (disorder)||has_finding_site
lower inner quadrant of right breast||mammogram previous mass #1 of inferior medial quadrant of right breast with microcalcifications||has_finding_site
genital system, female, vagina||circumferential urethrovaginal fistula with severe scarring||has_finding_site
vascular structure of upper limb (body structure)||bruit over hemodialysis access fistula of left arm||has_finding_site
ear-related structure||grommet blocked||has_finding_site
dentitions||completely dentate teeth condition minimally compromised with 3 or less in one sextant (finding)||has_finding_site
pair of lungs||consolidation lungs||has_finding_site
musculus quadriceps femoris||congenital absence of quadriceps muscle (disorder)||has_finding_site
structure of interphalangeal joint of hand||sensation of something floating in l index finger joint||has_finding_site
right b6||bronchoscopy ulceration of posterior aspect of right lower lobe superior segmental bronchus||has_finding_site
ovarian germ cell endodermal sinus tumor stage i c||ovarian germ cell endodermal sinus tumour stage i||classifies
residual stage of angle-closure glaucoma||glaucomas, narrow-angle||classifies
age-related osteoporosis with current pathological fracture, right humerus, initial encounter for fracture||osteoporosis, unspecified||classifies
tuberculoses, pulmonary||pulmonary tuberculosis nos (disorder)||classifies
angiotensin ii abnormal||angiotensin ii abnormal||classifies
carbohydrate antigen 15-3 increased||carbohydrate antigen 15-3 increased||classifies
obsv-adult antisoc behav||personal history of mental disorder; mental and behavioral problems; observation and screening for mental condition||classifies
disp fx of olecran pro w intartic extn right ulna, init||fracture of the upper limb, initial encounter||classifies
gen noncv ep w/o intr ep||generalised onset non-motor seizure||classifies
interleukin-5 therapy||interleukin therapy||classifies
syndrome, loeffler||simple pulmonary eosinophilias||classifies
congenital discoid meniscus (diagnosis)||discoid meniscus||classifies
crushing injury (disorder)||injuries, crush||classifies
urine volume 24 hour increased||increased urine output||classifies
simple type schizophrenia, chronic state with acute exacerbation||[x]schizophrenia, unspecified (disorder)||classifies
drainage of intracerebral hematoma||evacuation of intracerebral hematoma (procedure)||classifies
hemarthrosis of the elbow||haemarthrosis of unspecified site||classifies
neuronal neuropathy||neuronal neuropathy||classifies
gas embolisms||embolus, air||classifies
gastroenteritis adenovirus||adenovirus food poisoning (disorder)||classifies
neoplasm, stomach||stomach--tumors||classifies
contaminations, food||contamination foods||classifies
sprain of metacarpophalangeal joint of unspecified thumb, initial encounter||sprains and strains, initial encounter||classifies
t amplitude decreased||electrocardiogram t wave amplitude decreased||classifies
stereotactic gamma beam radiosurgery of pelvic region||radiosurg stereotactic||classifies
amphetamines nos increased||amphetamines positive||classifies
[d]other urination abnormality nos||other and unspecified genitourinary symptoms||classifies
closed fracture of base of skull with cerebral laceration and contusion, with brief [less than one hour] loss of consciousness||skull; fracture, base||classifies
intellectual development disorders||intellectual developmental disorder||classifies
anesth compl-antepartum||anesthetic complication nos||classifies
toxicity renal||toxic; nephropathy||classifies
bilirubin level test||blood bilirubin (lab test)||classifies
fx unsp part of unsp clavicle, subs for fx w malunion||fracture of the upper limb, subsequent encounter||classifies
ostomy obstruction||stoma obstruction||classifies
sars-cov-1 infection||severe acute respiratory syndrome nos||classifies
cervical sloughing||uterine cervical exfoliation||classifies
arteriovenous malformation of vessel of lower limb||cardiac and circulatory congenital anomalies||classifies
myeloperoxidase deficiency||mpo - myeloperoxidase def||classifies
application site joint erythema||application site joint redness||classifies
precursor b-lymphoblastic lymphoma/leukaemia stage i||stage i precursor b-lymphoblastic lymphoma||classifies
lip and/or oral cavity cancer stage unspecified||lip and/or oral cavity cancer||classifies
anom anter seg nec-eye||congenital anomalies of anterior chamber of eye (diagnosis)||classifies
atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (asc-h)||abnormal findings without diagnosis||classifies
red blood cell enzymes abnormal (finding)||rbc enzymes abnormal||classifies
drug dose omission||product dose omission issue||classifies
mediastinal shift (finding)||mediastinal shift (finding)||classifies
unspecified alveolar and parietoalveolar pneumopathy||pulmonary disease||classifies
pasngr in 3-whl mv injured in clsn w ped/anml nontraf, init||external cause codes: intent of injury, accidental/unintentional||classifies
bypass jejunum to jejunum with autologous tissue substitute, percutaneous endoscopic approach||upper gi therapeutic procedures, nec (open and laparoscopic)||classifies
cognitive dysfunction||cognitive deficit||classifies
catheter site excoriation||catheter site erosion||classifies
ocular stent placement||glaucoma drainage device placement||classifies
anthrax septicaemia||anthrax sepsis||classifies
clostridium difficile infection recurrence||gastroenteritis due to clostridium difficile||classifies
lipotropic medication toxicity||toxicity to various agents||classifies
elderly primigravida with baby delivered||elderly primigravida||classifies
ultrasound anterior segment of eye||us scan of eye||classifies
decollete lifting||neck lift||classifies
aspergillus test negative||aspergillus test negative||classifies
testicular granulosa cell neoplasm||granulosa cell neoplasm of the testis||classifies
bypass l ext iliac art to b int ilia w synth sub, perc endo||arterial peripheral bypass||classifies
aspiration and puncture||paracenteses||classifies
aspiration bursa||aspiration;bursa||classifies
citrate transporter deficiency||citrate transporter deficiency||classifies
culture mouth positive||nonsp.positive culture find||classifies
skin infection||cellulitis (diagnosis)||classifies
allergies feathers||allergy to animal||classifies
cesarean delivery||caesarian section delivery||classifies
porphyria, nos||disorder of porphyrin metabolism||classifies
infection (disorder)||infection||classifies
ami nos, initial||mi - acute myocardial infarction||classifies
lead urine high||lead urine high||classifies
malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect stage i||stage i hypopharynx carcinoma||classifies
metastatic tumor to the pleura||metastatic malignant neoplasm to pleura||classifies
(tinnitus) or (hearing noises)||tinnitus (finding)||classifies
lymphocytic gastritis||cg - chronic gastritis||classifies
swelling of retina||edema retinal||classifies
diarrhoea due to campylobacter jejuni||gastroenteritis campylobacter||classifies
intrusive thoughts||intrusive thought||classifies
anastomosis of urinary bladder (procedure)||anastomosis of urinary bladder (procedure)||classifies
bone callus excessive||bone callus excessive||classifies
cerebrospinal fluid red blood cell count||cerebrospinal fluid red blood cell count||classifies
wegener granulomatosis, formerly||klinger's disease||classifies
fall from non-in-line roller-skates, sequela||external cause codes: sequela||classifies
[v]other specified general medical examination (context-dependent category)||medical examination/evaluation||classifies
venereal lymphogranuloma proctitis||frei disease||classifies
antibiotic resistant escherichia coli test negative||escherichia test negative||classifies
other physeal fracture of lower end of ulna, unspecified arm, subsequent encounter for fracture with delayed healing||fracture of the upper limb, subsequent encounter||classifies
dist oth spec amino ac met nos||inborn amino acidopathies||classifies
tumors, glomus tympanicum||paraganglion neoplasm||classifies
venipuncture site bruise||vessel puncture site bruise||classifies
hepaplastin value decreased||hepaplastin low||classifies
histiocytosis haematophagic||lymphohistiocytosis; hemophagocytic||classifies
intraoperative blood loss||procedural bleeding||classifies
postprocedural fever||high body temperature||classifies
culture wound||wound culture||classifies
medical and surgical @ gastrointestinal system @ bypass @ small intestine @ open @ nonautologous tissue substitute @ cecum||upper gi therapeutic procedures, nec (open and laparoscopic)||classifies
nephropathy due to ischaemia||ischaemic nephropathy||classifies
hypocalcaemic seizure||seizures due to hypocalcemia||classifies
manufacturing stability testing preservative issue||manufacturing stability testing issue||classifies
hyposthenuria||impairment of urinary concentration||classifies
toxic effect of unspecified substance, undetermined, subsequent encounter||toxic effects, subsequent encounter||classifies
peripheral corneal degeneration, bilateral||cornea and external disease||classifies
acetonemia (diagnosis)||acetonaemia||classifies
kidney tumours stage iv||renal cell cancer, stage iv||classifies
biopsy thyroid gland abnormal||thyroid gland biopsy abnormal||classifies
stroke volume normal||normal cardiac stroke volume (finding)||classifies
leukemia myelogenous||unspecified myeloid leukemia||classifies
enteric duplication (disorder)||enteric duplication (disorder)||classifies
unspecified occupant of ambulance or fire engine injured in traffic accident, subsequent encounter||external cause codes: subsequent encounter||classifies
atrial septal heart defects||septal defects, atrial||classifies
respiratory disease due to chemical fumes and vapours (disorder)||respiratory fume inhalation disorder||classifies
glucose-6-phosphate deficiency anemia, nos||hemolytic anemias||classifies
implant site effusion||implant site extravasation||classifies
medical and surgical @ upper bones @ supplement @ metacarpal, right @ percutaneous @ autologous tissue substitute @ no qualifier||musculoskeletal device procedures, nec||classifies
necrosis of flap||flap necrosis||classifies
poor peripheral circulation (disorder)||poor peripheral circ||classifies
chronic rhinosinusitis without nasal polyps||chronic rhinosinusitis without nasal polyps||classifies
introduction of antineoplastic, monoclonal antibody, into nose, via natural or artificial opening||chemotherapies||classifies
acquired color vision deficiencies||color blindness, acquired||classifies
war operations involving unsp dest arcrft, civilian, init||external cause codes: transport; not mvt; initial encounter||classifies
diverticuloma||diverticuloma||classifies
central nervous system--infections||central infections nervous system||classifies
pathological fracture in neoplastic disease, left femur, subsequent encounter for fracture with nonunion||pathological fracture, subsequent encounter||classifies
peripheral gangrene (disorder)||[d]gangrene (context-dependent category)||classifies
frostbite nec/nos||frostbite (disorder)||classifies
retroperitoneal biopsy (procedure)||retroperitoneal biopsy (procedure)||classifies
unspecified catatonic schizophrenia (disorder)||praecox; dementia||classifies
medical and surgical @ anatomical regions, lower extremities @ supplement @ femoral region, bilateral @ percutaneous endoscopic @ autologous tissue substitute @ no qualifier||inguinal/femoral hernia repair||classifies
clinically-driven target vessel revascularisation||arterial revascularisation||classifies
pain localized||pains||classifies
[x]unspecfd viral encephalitis||encephalomyelitis, infectious, viral||classifies
hiv infection centers for disease control category c1||hiv infection centers for disease control category c||classifies
papule red lichenoid||lichen rubra planus||classifies
sticky feeling in eyes||abnormal;sensation;eye||classifies
fail mech induct-antepar||failed induction of labor (diagnosis)||classifies
primary insomnia (disorder)||insomnia [d]||classifies
continuous cpap (procedure)||cont pos airways pres therapy||classifies
disorder of ear, nos||a-90 diseases of the ear: general terms||classifies
eczema; hot place||erythema ab igne [dermatitis ab igne]||classifies
vulval cancer recurrent||vulval cancer recurrent||classifies
drain of l knee bursa/lig with drain dev, perc endo approach||incision and drainage of musculoskeletal tissue and joints||classifies
exocrine pancreatic insufficiency (diagnosis)||insufficiency pancreatic||classifies
transfusion dependent thrombocytopenia||thrombopenias||classifies
x-ray of salivary gland normal||x-ray nos face and mouth normal||classifies
product substitution issue generic to brand||product substitution issue||classifies
renal function disorder||insufficiency renal||classifies
dependence on respirator [ventilator]||other respiratory insufficiency||classifies
evoked potentials visual normal||evoked potentials visual normal||classifies
therapeutic ovarian suppression||therapeutic ovarian suppression||classifies
destruction of hepatic artery, percutaneous endoscopic approach||saphenous vein harvest and other therapeutic vessel removal||classifies
traumatic deafness, nos||traumatic deafness (finding)||classifies
radiotherapy to lung||radiotherapy to lung||classifies
celiac art compress syn||celiac trunk compression syndrome||classifies
incision of tissue connecting tongue and floor of mouth||lingual frenotomy||classifies
traumatic pneumohaemothorax without open wound into thorax||hemothorax due to trauma||classifies
lymphoid leukemia nos (disorder)||lymphoid leukaemia, no icd-o subtype||classifies
varicose veins (diagnosis)||venous ectasia (morphologic abnormality)||classifies
intramyelinic edema||intramyelinic edema||classifies
acute upper respiratory infection (diagnosis)||urti (upper respiratory tract infection)||classifies
cauterization of little's area||nasal cautery (procedure)||classifies
recurrent extraosseous ewing's sarcoma||recurrent extraosseous ewing sarcoma||classifies
apolipoprotein b abnormal||apolipoprotein b abnormal||classifies
mucosal pigmentation||mucosal pigmentation||classifies
two chambered right ventricle||right ventricular false tendon||classifies
hepatologist consultation||request consultation by specialist (treatment)||classifies
increased catecholamines||blood catecholamines increased||classifies
large cleaved follicular center cell lymphoma (lukes-collins classification) stage iii||follicle center lymphoma, follicular grade i, ii, iii stage iii||classifies
reposition right toe phalangeal joint, percutaneous approach||joint fusion (excluding spine)||classifies
[d]musculoskeletal pain||pain;musculoskeletal||classifies
malignant neoplasm of clitoris stage iii||stage iii carcinoma of the vulva||classifies
hypersplenism, nos||hypersplenism (disorder)||classifies
metastatic esophageal adenocarcinoma||oesophageal adenocarcinoma site unspecified stage iv||classifies
lipodermoid tumour||lipodermoid tumor||classifies
hemorrhage of jejunum||small intestinal hemorrhage||classifies
bacterial pericarditis (diagnosis)||bacterial; pericarditis||classifies
aphasias, primary progressive||mesulam's syndrome||classifies
effects of; hunger||[x]starvation||classifies
anti-cyclic citrullinated peptide antibody positive (finding)||anti-ccp (anti-cyclic citrullinated peptide) antibody positive||classifies
twiddler's syndrome||twiddler's syndrome||classifies
revision of drainage device in periph nrv, open approach||peripheral nerve procedures, nec||classifies
afp decreased||alphafoetoprotein low||classifies
chronic nephritis||chronic; glomerulonephritis||classifies
unspecified duodenal ulcer nos (disorder)||duodenal ulcers||classifies
dermal mycosis||dermatomycosis||classifies
bypass bi ureter to l ureter with autol sub, open approach||urinary diversion with anastomosis or ostomy||classifies
rectal carcinoma stage unspecified||carcinoma of the rectum||classifies
vagina; discharge||vaginal discharges||classifies
cotton wool patches||retina exudates||classifies
meningiomatosis, nos||lymphoplasmacyte-rich meningioma||classifies
cyst spleen||spleen; cyst||classifies
peptic perforation ulcer||peptic perforation ulcer||classifies
small lymphocytic lymphoma, consistent with cll (working formulation)||malignant lymphoma, lymphocytic, well differentiated, diffuse||classifies
spermatogenesis reversible inhibition of||azoospermia (finding)||classifies
thrombin time increased||tt increased||classifies
tubal excisions||tubal excisions||classifies
carotid-subclavian bypass||carotid artery bypass||classifies
glial scar||glial scars||classifies
generalised convulsion||fits||classifies
bronchogenic; cyst, congenital||bronchogenic cyst||classifies
syndrome foetal distress||distress - fetal||classifies
antibody result abnormal||antibody test abnormal||classifies
anemia;vitamin b12 deficiency||vit b12 defic anemia, unsp||classifies
pseudoneoplasm abdominal||abdomen lumps||classifies
water deprivation test (procedure)||water deprivation test (procedure)||classifies
porphobilinogen increased||porphobilinogen urine increased||classifies
ehlers-danlos syndrome, nos||ehlers danlos syndromes||classifies
simple chronic serous otitis media||chronic otitis media (diagnosis)||classifies
of face numbness||reduced sensation||classifies
vulva; hemorrhage||vulval haemorrhage||classifies
painful red eye||pain in eye||classifies
burn of unsp degree of forehead and cheek, init encntr||burn and corrosion, initial encounter||classifies
unconsciousness||lost consciousness||classifies
ggtp decreased||gamma-glutamyltransferase decreased||classifies
palmar edema||oedema peripheral||classifies
crystalluria sulfonamide||urinary crystal||classifies
umbilical cord; short||short cord unspecified (disorder)||classifies
isoimmunization from other and unspec blood-group incompatibility, unspec as to eoc in pregnancy||isoimmune haemolytic disease||classifies
ischaemic bowel disease, nos||unspecified vascular insufficiency of intestine||classifies
revision of nonaut sub in l up extrem, open approach||musculoskeletal device procedures, nec||classifies
slipped capilal femoral epiphysis||slipped; epiphysis||classifies
qtc||qt interval (observable entity)||classifies
asthma chronic obstructive pulmonary disease overlap syndrome||asthma-chronic obstructive pulmonary disease overlap syndrome||classifies
acquired immune deficiency||acquired immune deficiency syndrome (aids) (disorder)||classifies
opn trmtc dslctn hip jt, post||injury;dislocation;musculoske||classifies
abdominal hernia nos, obstructive||abdominal hernia obstructive||classifies
red vision||erythropsia (disorder)||classifies
imaging @ respiratory system @ computerized tomography (ct scan) @ tracheobronchial tree, right @ other contrast @ unenhanced and enhanced @ none||computerized tomography (ct) with contrast||classifies
placenta percreta (physical finding)||accreta; placenta||classifies
gonococcal infection of joint (disorder)||gonococcal: [joint infection nos] or [rheumatism] (disorder)||classifies
scirrhous carcinoma of the rectum stage unspecified||carcinoma rectum||classifies
mucinous ductal breast carcinoma stage iv||infiltrating colloid breast carcinoma||classifies
lesion of tibial nerve (disorder)||peripheral nerve lesion||classifies
vitreous opacities||vitreous opacities (finding)||classifies
unspecified vitamin deficiency||hypovitaminosis nos||classifies
malignant neoplasm of bladder, part unspecified stage i, without cancer in situ||malignant neoplasm of bladder stage i, without cancer in situ||classifies
manufacturing active pharmaceutical ingredient contamination||manufacturing materials contamination||classifies
major lacerat great saph at hip and thi lev, left leg, init||injury to blood vessels, initial encounter||classifies
medical and surgical @ anatomical regions, lower extremities @ reattachment @ hindquarter, right @ open @ no device @ no qualifier||musculoskeletal procedures, nec||classifies
infections, haemophilus||haemophilus infect||classifies
pustules on lip||oral pustule||classifies
apa positive||antiphospholipid antibodies positive||classifies
inflammation;tympanic membra||tympanic membrane inflammation||classifies
stage iii t-cell non-hodgkin lymphoma||ann arbor stage iii t-cell non-hodgkin lymphoma||classifies
blepharectomy (procedure)||excision, eyelid||classifies
viral hepatitis (diagnosis)||virus hepatitis||classifies
hla-b gene status assay||hla-b gene status assay||classifies
mild hyperem grav-deliv||excessive pregnancy vomiting||classifies
medical and surgical @ upper veins @ drainage @ brachial vein, left @ open @ no device @ no qualifier||artery, vein, and great vessel procedures, nec||classifies
mri of head||mri of head||classifies
lymphocytic gastritis||cg - chronic gastritis||classifies
intentional self-harm by jumping or lying in front of motor vehicle, initial encounter||external cause codes: motor vehicle traffic (mvt); initial encounter||classifies
adhesns/ankylosis - tmj||tooth ankylosis||classifies
product process control issue||product process control issue||classifies
drainage of left seminal vesicle with drainage device, open approach||prostate and seminal vesicle procedures (excluding prostatectomy)||classifies
disorders of vitreous body||disorder of vitreous cavity||classifies
[x]spinal osteochondrosis, unspecified (disorder)||osteochondrosis not specified as adult or juvenile, of unspecified site||classifies
human t-cell lymphotropic virus infection||human t-cell lymphotropic virus infection nos||classifies
section 8-4 orthodontic procedures||orthodontic procedure (procedure)||classifies
complete lesion of l1 level of lumbar spinal cord, initial encounter||spinal cord injury (sci), initial encounter||classifies
unsp physeal fracture of upper end of unsp femur, init||fracture of the lower limb (except hip), initial encounter||classifies
neop of uncertain behaviour pleura, thymus and mediastinum||tumor of mediastinum||classifies
pythium insidiosum infection||pythioses||classifies
ankle injury||injury; joint||classifies
dislocation of mtp joint of unsp great toe, subs||dislocations, subsequent encounter||classifies
product contamination fungal||product contamination microbial||classifies
airway secretion excessive||increased bronchial secretion||classifies
interleukin-9 therapy||therapy, interleukin||classifies
change intermittent pressure device on left toe||packing and dressing procedures||classifies
intracav aspergillus fung ball||aspergilloma (disorder)||classifies
byssinosis||byssinosis (diagnosis)||classifies
scapulothoracic dissociation||scapulothoracic dissociation||classifies
legal intervention involving injury by tear gas, unspecified person injured, initial encounter||external cause codes: poisoning by non-drug||classifies
benign congenital hypotonia (disorder) [ambiguous]||hypotonia benign congenital||classifies
medical and surgical @ anatomical regions, upper extremities @ repair @ lower arm, left @ percutaneous endoscopic @ no device @ no qualifier||musculoskeletal procedures, nec||classifies
mucosal discolouration||mucosal discolouration||classifies
tooth inflammation||endodontic inflammation||classifies
partial prothrombin time||ptt||classifies
hemiblock||left bundle branch block nos||classifies
abnormal growth hormone||blood growth hormone abnormal||classifies
polyglandul dysfunc nec||polyglandular; disorder||classifies
pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (disorder)||pandas (diagnosis)||classifies
heart graft dysfunction||complication of transplanted heart||classifies
subacute combined cord degeneration||subacute combined cord degeneration||classifies
extirpation of matter from stomach, pylorus, via natural or artificial opening||upper gi therapeutic procedures, nec (endoscopic)||classifies
drainage of left wrist region, open approach, diagnostic||subcutaneous tissue, fascia, and muscle biopsy||classifies
revision of nonautologous tissue substitute in lower muscle, external approach||musculoskeletal device procedures, nec||classifies
chronic enteropathy||irritable bowel disease||classifies
tuberculosis (a15-a19)||tuberculous infections||classifies
multiple myeloma in remission||plasma cell myeloma in remission||classifies
drainage of right knee joint with drain dev, perc approach||aspiration of joint||classifies
weir mitchell syndrome||erythromelalgia (disorder)||classifies
malignant neoplasm of bronchus and lung stage iv||stage iv lung cancer||classifies
salter-harris type ii physeal fracture of lower end of humerus, left arm, subsequent encounter for fracture with routine healing||fracture of the upper limb, subsequent encounter||classifies
myelomalacia (disorder)||myelomalacia (disorder)||classifies
fundoplication procedure||esophagogastric fundoplasty fundoplication||classifies
lymphocytic enteritis (disorder)||microscopic enteritis||classifies
drowning and submersion due to falling or jumping from unspecified burning watercraft, initial encounter||external cause codes: drowning/submersion; initial encounter||classifies
disorder tubular kidney||kidney tubule disorder||classifies
plasmacytic leukemia (in remission)||plsm cell leuk w rmson||classifies
transnasal humified rapid-insufflation ventilator exchange||mechanical ventilation||classifies
primary erythrocytosis||vera, polycythemia ruba||classifies
cutaneous extramedullary haemopoiesis||cutaneous extramedullary hemopoiesis||classifies
tracheal aspiration procedure||tracheal aspiration procedure||classifies
hypomenorrhea (diagnosis)||light periods||classifies
progression of psoriatic arthritis||arthritis psoriatics||classifies
malignant neoplasm of middle lobe, bronchus or lung, cell type unspecified stage iv||stage iv lung cancer ajcc v7||classifies
removal of retained deciduous teeth||teeth--extraction||classifies
fracture of condyle of tibia (disorder)||fracture of tibia, nos||classifies
precerebral arteriosclerosis||precerebral arteriosclerosis||classifies
encounter for screening for malignant neoplasm, site unspecified||neoplasm-related encounters||classifies
standing instability||difficulty in standing||classifies
tuberculosis of other specified bone (disorder)||tuberculosis of bone||classifies
plantarflexed metatarsal||deformity; foot||classifies
esophageal adenocarcinoma thoracic in situ||adenocarcinoma in situ of esophagus (diagnosis)||classifies
migraine with acute onset aura||migraine auras||classifies
tb of thyroid-exam unkn||thyroid gland tuberculosis||classifies
gastric hypothermia||other non-or upper gi therapeutic procedures||classifies
malignant hypertension||hypertension with complications and secondary hypertension||classifies
chr ethmoidal sinusitis||chronic infection of sinus, nos||classifies
post-surgical hypothyroidism||hypothyroidism; postprocedural||classifies
unconscious (finding)||[d]unconsciousness (situation)||classifies
ventilation-perfusion scintigraphy||ventilation-perfusion scintigraphies||classifies
gender identity disorders||gender dysphoria||classifies
dual energy x ray absorptiometry scan||bone densitometry||classifies
fibrous tumor, solitary||mesothelioma||classifies
difficulty thinking||mental handicap||classifies
breath hydrogen test||h2bt - hydrogen breath test||classifies
discolored urine (finding)||chromaturia||classifies
mobilization of peripheral blood progenitor cells||hematopoietic stem cell mobilization (procedure)||classifies
triglycerides abnormal nos||blood triglycerides abnormal||classifies
ischiogluteal bursitis||bursitis nos (disorder)||classifies
microangiopathy, nos||microangiopathy (disorder)||classifies
non-prs chr ulc unsp prt unsp lw leg w bne invl w/o evd necr||non-pressure ulcer of skin||classifies
ear protector attentuat assess w occupational hear equip||diagnostic audiology||classifies
echinococc granul nec||echinococcus||classifies
accidental dural puncture||dural tap||classifies
hemorrhagic condition||haemorrhag condition, unsp||classifies
paranasal sinus infection||inflammation; nasal sinus||classifies
disorder developmental regression||developmental regression (disorder)||classifies
lipoprotein (a) normal||lipoprotein (a) normal||classifies
disp fx of greater trochanter of r femr, 7thr||fracture of the neck of the femur (hip), subsequent encounter||classifies
tendinitis achilles||teninitis||classifies
aspiration spermatocele abnormal||aspiration spermatocele abnormal||classifies
articulation problem||dysarthria||classifies
esophageal squamous cell carcinoma abdominal stage ii||esophageal squamous cell carcinoma stage ii||classifies
medical and surgical @ subcutaneous tissue and fascia @ revision @ subcutaneous tissue and fascia, head and neck @ open @ infusion device @ no qualifier||subcutaneous tissue and fascia procedures, nec||classifies
urine cotinine test positive||nicotine test positive||classifies
quincke's edema||urticaria; giant||classifies
vasculitis necrotizing||systemic necrotising vasculitis||classifies
parasite tissue specimen test positive||parasite tissue specimen test positive||classifies
subluxation of joint (diagnosis)||joint dislocation||classifies
drug effect deminished||therapeutic product effect decreased||classifies
complement factor nos high||complement factor nos increased||classifies
potomania||primary polydipsias||classifies
fracture of ankle||fracture of ankle nos||classifies
medical and surgical @ lower arteries @ insertion @ foot artery, left @ open @ intraluminal device @ no qualifier||cardiovascular device procedures, nec||classifies
impotence, male sexual||male erectile disorder (disorder)||classifies
injury to other intrathoracic organs without mention of open wound into cavity||[x]injuries to the thorax||classifies
larynx cancer recurrent||laryngeal cancer recurrent||classifies
medical and surgical @ anatomical regions, upper extremities @ repair @ upper arm, left @ percutaneous endoscopic @ no device @ no qualifier||musculoskeletal procedures, nec||classifies
adenocarcinoma of nasal cavity||carcinoma of nasal cavity (diagnosis)||classifies
heterotopic ossification, posterior lumbar spine||peri-spinal heterotopic ossification||classifies
infantile central apnoea||infantile apnoea||classifies
inner ear vascular insufficiency||vestibular ischemia||classifies
supplement left humeral head with autologous tissue substitute, percutaneous approach||musculoskeletal device procedures, nec||classifies
brow; presentation||brow presentation of fetus (disorder)||classifies
injury abdo/pelvic vessel nos||vascular injury nos||classifies
decreased pituitary luteinizing hormone level (biological function)||blood luteinizing hormone decreased||classifies
incision of pericardium nos (procedure)||1-391 pericardium: incisions||classifies
strain of muscle, fascia and tendon of long head of biceps, right arm, initial encounter||sprains and strains, initial encounter||classifies
erosion, limited to enamel||disorders of teeth and jaw||classifies
pulmonary eosinophilic granuloma||letterer siwe dis||classifies
urinary frequency||urination frequency||classifies
excessive dynamic airway collapse||excessive dynamic airway collapse||classifies
hiv infection who clinical stage ii||hiv infection who clinical stage ii||classifies
infusion site plaque||infusion site plaque||classifies
decreased tolerance||decreased drug tolerance||classifies
neonatal tachycardia (diagnosis)||neonatal tachycardia (diagnosis)||classifies
vaginitis staphylococcal||vulvovaginitis staphylococcal||classifies
deep venous thrombosis femoral||venous thrombosis deep||classifies
increased qrs voltage||electrocardiogram: qrs complex abnormal||classifies
joints tender||pain in joints||classifies
modified vaginal hysterectomy||hysterectomy procedures||classifies
mouth tenderness||pain;mouth||classifies
[x]secondary parkinsm,unspecif||syndrome parkinsonism||classifies
medical and surgical @ male reproductive system @ drainage @ penis @ percutaneous @ drainage device @ no qualifier||penis procedures (excluding circumcision)||classifies
aftertaste||impaired sense of taste||classifies
attem abort w hemorrhage||abortion, failed attempt||classifies
drug-induced cough||coughing||classifies
other secondary osteonecrosis, right finger(s)||aseptic necrosis and osteonecrosis||classifies
deep brain stimulation (procedure)||brain deep stimulation||classifies
paraphrenic schizophrenia||[x]schizophrenia, unspecified (disorder)||classifies
other specified disorders of prostate||of prostate disease||classifies
superfic inj head nec||injury to skin||classifies
congenital or acquired abnormality of vulva, unspecified as to episode of care in pregnancy||vulval disorder, nos||classifies
diseases, liver||hepatic disease nos||classifies
voice lowered||[d]dysphonia||classifies
reversal of curarisation||reversal of neuromuscular blockade||classifies
lip discomfort||discomfort in mouth (finding)||classifies
non-drinker, nos||abstains from alcohol||classifies
bitterness||things taste abnormal||classifies
antioxidant therapy||antioxidant therapy||classifies
cold dysaesthesia||cold dysaesthesia||classifies
premature ventricular contraction (pvc)||ventricular premature depolarization (diagnosis)||classifies
cronobacter infections||cronobacter infections||classifies
cystatin c measurement||cystatin c||classifies
biopsy chorionic villous abnormal||biopsy chronic villous abnormal||classifies
metastatic salivary gland cancer||metastatic salivary gland cancer||classifies
arterit ischaem opt neuropathy||ischemic optic neuropathies||classifies
bcg immunisation||administration of vaccine product containing only live attenuated mycobacterium bovis antigen||classifies
person boarding or alighting a heavy transport vehicle injured in collision with fixed or stationary object, sequela||external cause codes: sequela||classifies
sweat sodium test elevated||sweat test abnormal||classifies
physical rehabilitation and diagnostic audiology @ rehabilitation @ motor treatment @ respiratory system - lower back / lower extremity @ therapeutic exercise @ mechanical @ none||physical, occupational, and respiratory therapy treatment||classifies
gamma nail fixation||fractures osteosynthesis||classifies
precancerous lesion of digestive tract||precancerous lesion of digestive tract||classifies
rndx gastrointestinal alteration||dyspepsia||classifies
other and unspec abnormality of organs and soft tissues of pelvis, antepart cond or comp||reproductive system disease||classifies
cerebrospinal fluid protein decreased||decreased csf protein||classifies
open #neck of femur nos||femur neck fractures||classifies
medical and surgical @ lower joints @ revision @ hip joint, right @ external @ external fixation device @ no qualifier||joint fusion (excluding spine)||classifies
stage iii urinary bladder transitional cell carcinoma||stage iii transitional cell carcinoma of urinary bladder||classifies
fibroadenosis breast||fibroadenoma of breast (disorder)||classifies
androgens||androgens||classifies
medical device site hypoesthesia||medical device site hypoaesthesia||classifies
marginal blepharitis||eyelid; inflammation||classifies
labor and delivery complicated by vasa praevia||abnormal insertion of umbilical cord||classifies
aspirin-like platelet defect||congenital thrombocyte disorder||classifies
abort nos w pel inf-comp||induced abortion||classifies
closed dislocation of hip, nos||dislocated joint||classifies
normal ventricular ejection fraction||ejection fraction normal||classifies
streptococcus viridans group infection||alpha hemolytic streptococcal infection||classifies
vasculitis aggravated||inflammation of blood vessel||classifies
disorders, speech sound||phonological disorder||classifies
cardiac enzymes normal (finding)||myocardial necrosis marker normal||classifies
bacterial ear infection, nos||ear infection bacterial||classifies
svo2||venous oxygen saturation||classifies
partial traumatic amputation of right great toe, sequela||sequela of injury||classifies
monocular exotropia with other noncommitancies||crossed eye||classifies
eyelid entropion/trichias.nos||entropion (disorder)||classifies
tb periph lymph-no exam||tuberculosis peripheral lymph nodes||classifies
open fracture of bones, unspecified (disorder)||fracture, open||classifies
dystrophic nails||dystrophia unguium||classifies
sleep nasendoscopy||sleep nasendoscopy||classifies
carotid vascular resistance increased||carotid vascular resistance increased||classifies
cardiac ventriculogram left||ventriculogram left||classifies
stent-graft perforation by another device||device breakage||classifies
other spirochaetal infection nos||spirochetes disease||classifies
tentorial tear||dural tear (diagnosis)||classifies
vitello-intestinal duct remnant||vitello-intestinal duct remnant||classifies
nkh-non-ketotic hyperglycinaem||hyperglycinemia (disorder)||classifies
fungaemia||fungaemia (disorder)||classifies
waaler-rose test negative||negative rheumatoid factor||classifies
tuberculous abscess of spinal cord, bacteriological or histological examination not done||unspecified tuberculosis of central nervous system||classifies
epidermoid cyst of pituitary gland (disorder)||central nervous system dermoid tumour||classifies
eee - eastern equine encephalitis||east equine encephalitis||classifies
c-telopeptide increased||c-telopeptide increased||classifies
fluoroscopic angiography of cerebral artery||fluoroscopic angiography of cerebral artery with contrast (procedure)||classifies
unspecified benign neoplasm of heart (diagnosis)||unspecified benign neoplasm of heart||classifies
haemolytic disease of fetus and newborn due to isoimmunisation||fetalis, erythroblastosis||classifies
hepatic cirrhosis (diagnosis)||scar tissue replaces healthy tissue in the liver||classifies
vagotomies, proximal gastric||division of vagus nerve nos||classifies
bowel carcinoma large||colon nos cancer||classifies
prostatectomy (treatment)||prostate resection||classifies
rectal formulation administered by other route||incorrect route of product administration||classifies
inferiority (emotional)||inferiority complex||classifies
membrane; cyclitic||cyclitic; membrane||classifies
replacement of left hip joint with ceramic on polyethylene synthetic substitute, cemented, open approach||arthroplasties hip||classifies
x-ray renal intravenous pyelogram (ivp)||urography||classifies
hepatitis c virus genotype 6 positive||hepatitis c virus test positive||classifies
increased alkaline phosphatase||blood alkaline phosphatase high||classifies
injection site scabbing||injection site scabbing||classifies
respiratory obstruction unspecified||disease lung obstruction||classifies
liver disorders in pregnancy, with delivery||hepatic disorder nos||classifies
incessant ventricular tachycardia||ventricular tachycardia (diagnosis)||classifies
complete traumatic metacarpophalangeal amputation of right middle finger, subsequent encounter||amputation of a limb, subsequent encounter||classifies
muscular dystrophies and other myopathies, unspecified||progressive muscular dystrophy (diagnosis)||classifies
dysuria, spastic||pain during urination (symptom)||classifies
columbia suicide severity rating scale abnormal||columbia suicide severity rating scale abnormal||classifies
lipodermatosclerosis||syndrome, postthrombotic||classifies
closed fracture of base of skull with other and unspecified intracranial hemorrhage, with concussion, unspecified||base fractures skull||classifies
gallbladder, carcinoma||gallbladder cancer nos||classifies
immunodef fol heredit defctv response to epstein-barr virus||immune disorder (nos)||classifies
vomit compl preg-antepar||morning sickness||classifies
abscesses perinephric||perinephric abscess||classifies
pneumonia atypical||atypical pneumonia (disorder)||classifies
surgical fixation of arytenoid cartilage||laryngeal repair||classifies
latent tetany||latent tetany||classifies
other scleral disorders nos (disorder)||disorder of sclera, nos||classifies
malignant tumor of retained testis||malignant neoplasm of testis, unspecified whether descended or undescended||classifies
open orbital blow-out fracture||skull and face fractures||classifies
syndromes, exfoliative||syndrome, exfoliative||classifies
congenital monorchidism||congenital monorchidism||classifies
endometrium pseudodecidual||endometrium, hyperplasia||classifies
necrotising mediastinitis||mediastinitis||classifies
release mitral valve, percutaneous endoscopic approach||heart valve replacement and other valve procedures (non-endovascular)||classifies
cancer of the cervix, stage iii||uterine cervical cancer, stage iii||classifies
puncture wound without foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter||open wounds of trunk, subsequent encounter||classifies
implant site nerve injury||implant site nerve injury||classifies
immunosuppressed nos||immunologic deficiency syndromes||classifies
occlusion of cystic duct with intraluminal device, open approach||hepatobiliary and pancreatic procedures, nec||classifies
shy micturation||bashful kidney||classifies
atrioventricular node dispersion||atrioventricular node dispersion||classifies
condylar process of mandible, closed fracture||fracture; jaw||classifies
removal of breast tissue with preservation of skin and nipple||mastectomy (procedure)||classifies
delta aminolevulinate urine high||delta aminolevulinate urine high||classifies
inlet contraction of pelvis in pregnancy, labor, and delivery||cephalopelvic disproportion [ambiguous]||classifies
defic dis phenylalanine hydroxylase severe||phenylketonuria (diagnosis)||classifies
keratosis spinulosus||keratosis spinulosa||classifies
autoimmune gastritis||chronic gastritis||classifies
toxic megacolon (disorder)||megacolons||classifies
renal disease end stage||end-stage renal failure||classifies
gamma-glutamyl transferase concentration increased above normal||gamma-gt increased||classifies
gastrin measurement (procedure)||blood gastrin||classifies
renal cancer stage iii||renal cell carcinoma, stage iii||classifies
lingual fibroma||fibroma oral||classifies
medical and surgical @ lower bones @ drainage @ fibula, left @ open @ no device @ no qualifier||incision and drainage of musculoskeletal tissue and joints||classifies
device cracked||device breakage||classifies
cd8 lymphocytes high||cd8 lymphocytes increased||classifies
friedländer's bacil; pneumonia||klebsiella pneumonia||classifies
perineal induration||perineal induration||classifies
cardiac examination||cardiovascular examination||classifies
closed fracture of one or more phalanges of hand||fracture of hand bone, nos||classifies
cfc1||cfc||classifies
subacute hepatic necrosis||necrosis liver||classifies
polytoxicomania||chemical addiction||classifies
sweat test nos (procedure)||sweat test nos (procedure)||classifies
breathlessness lying flat||breathless - lying flat||classifies
toxic epidermal necrolysis (disorder)||syndrome, lyell's||classifies
t-cell acute lymphoblastic leukaemia||t-cell acute lymphoblastic leukemia (disorder)||classifies
chronic leukemia unclassifiable||chronic leukemia, disease||classifies
flat anterior chamber hypotony of left eye||other specified eye disorders||classifies
ob pyemic embol-postpart||complication of the puerperium, nos||classifies
malignant neoplasm of cecum stage i||dukes a colon cancer||classifies
resection of right seminal vesicle, percutaneous endoscopic approach||prostate and seminal vesicle procedures (excluding prostatectomy)||classifies
end-tidal co2 increased||end-tidal co2 increased||classifies
qrs prolonged||qrs widened||classifies
vascular-biliary fistula (disorder)||vascular-biliary fistula (disorder)||classifies
hydroxyproline abnormal||hydroxyproline urine abnormal||classifies
generalized epileptic seizure||seizure disorder (diagnosis)||classifies
platelet disorders, blood||platelet abnormality||classifies
brown-sequard syndrome||syndrome, brown-sequard's||classifies
biopsy site unspecified abnormal||abnormal biopsy||classifies
tcc of renal pelvis and ureter||transitional cell cancer of the renal pelvis and ureter nos||classifies
foetal cystic hygroma||fetal cystic hygroma||classifies
tracheostomy||tracheostomy (treatment)||classifies
hyperostosis, cortical congenital||caffey||classifies
type 2 diabetes mellitus - poor control||diabetes mellitus loss of control||classifies
spcfd anom jaw cranl bse||jaw dis||classifies
removal of traction apparatus on neck||immobilization by splint or other external device||classifies
olfactory acuity test normal||olfactory test normal||classifies
function studies; cardiovascular abnormal||nonspecific abnormal results of function study, cardiovascular||classifies
revision of spacer in right temporomandibular joint, percutaneous approach||arthroplasty of other joint (excluding knee and hip)||classifies
lcc - liver cell carcinoma||carcinoma of liver cells||classifies
gastrooesophageal hernia||esophageal hiatal hernia||classifies
crush injury,arm,mlti sites||limb crushing injury||classifies
meningitis due to anaerobic bacteria||meningitis, bacterial||classifies
paranoid disorder, nos||psychosis, atypical||classifies
biopsies lungs||biopsy of lung (procedure)||classifies
skin oozing||skin weeping||classifies
viremia||viraemia||classifies
vitamin excess specified||vitamin excess unspecified||classifies
pulse, corrigan's||pulse abnormal||classifies
tongue aphtha formation||ulceration tongue||classifies
bypass peritoneal cavity to right pleural cavity with synthetic substitute, percutaneous approach||other peritoneal cavity procedures||classifies
intraocular lens discolouration||device colour issue||classifies
refraction disorder nec||disorder accommodation||classifies
sinonasal-type haemangiopericytoma||glomangiopericytoma||classifies
enterovirus serology test||enterovirus test||classifies
amniotic cavity and membrane problem nos, unspecified (disorder)||amniotic cavity disorder nos||classifies
lymphocyte blast cell transformation assay, nos||lymphocyte transformation test||classifies
situational anxiety||anxious; sensation||classifies
conjunctivochalasis of left eye||cornea and external disease||classifies
removal of synthetic substitute from right sternoclavicular joint, percutaneous approach||arthroplasty of other joint (excluding knee and hip)||classifies
opn skul/oth fx-brf coma||multiple fractures, unspec||classifies
biopsy bladder abnormal||biopsy bladder abnormal||classifies
confluent and reticulated; papillomatosis||confluent and reticulated papillomatosis of gougerot and carteaud||classifies
lymphocyte percentage increased||lymphocyte percentage increased||classifies
brucella serology positive||brucella test positive||classifies
liver hematoma and contusion without open wound into cavity||liver hematoma (disorder)||classifies
tubal excisions||fallopian tube excision||classifies
dilation of left common iliac artery, percutaneous approach||angioplasty and related vessel procedures (endovascular; excluding carotid)||classifies
encephalopathy neonatal acute||neonatal encephalopathy (disorder)||classifies
antibiogram||antimicrobial susceptibility test||classifies
pulmonary collapse in the perinatal period||congenital incomplete expansion of lung||classifies
glutamic-pyruvate transaminase increased||alt increased||classifies
endovascular aortic aneurysm repair||repair of aortic aneurysm||classifies
replacement of right tarsal joint with autologous tissue substitute, open approach||arthroplasty of other joint (excluding knee and hip)||classifies
other fetal and placental problems affecting management of mother||fetal disorder nos||classifies
supplement left iris with nonautologous tissue substitute, open approach||procedure on eye (procedure)||classifies
acute cellular rejection||graft rejection||classifies
subcapsular plaque||lens opacities||classifies
respiratory complications associated with device||respiratory complications associated with device||classifies
bejel||njovera||classifies
binaural hearing aid device fitting using hear aid equipment||ent procedures, nec||classifies
basketball game||external cause codes: activity codes||classifies
diseases of the jaws||disease jaw||classifies
prothrombin time ratio low||prothrombin time ratio low||classifies
sars-cov-2 antibody test positive||severe acute respiratory syndrome coronavirus 2 antibody test positive||classifies
stricture or atresia of the vagina||atresia; vagina||classifies
therapy, estrogen||oestrogen therapy||classifies
gynecological examination normal (finding)||gynaecological examination normal||classifies
male dyspareunia due to a general medical condition||coitus painful||classifies
tilt table test normal||tilt table test normal||classifies
paraparesis, spastic||paraparesis (lower extremities)||classifies
malignant lymphoma unclassifiable low grade||malignant lymphoma unclassifiable low grade||classifies
testicular hypogonadism, nos||hypogonadotropic; eunuchoidism||classifies
postprocedural cardiac arrest following cardiac surgery||postprocedural or postoperative circulatory system complication||classifies
urethral irritation||urethritis noninfective||classifies
uraemic anaemia||anemia of renal disease (disorder)||classifies
[x]filariasis, unspecified (disorder)||filariasis||classifies
excision of neoplasm of kidney||excision of neoplasm of kidney (procedure)||classifies
atherosclerosis of arteries of extremities with ulceration||peripheral artery occlusive disease||classifies
posterior synechiae (disorder)||iris adhesions||classifies
adhesion; nasal||nasal adhesions||classifies
fungus urine test negative||fungal test negative||classifies
abnormal psp test||abnormal phenolsulfonphthalein test result||classifies
product label counterfeit||product label counterfeit||classifies
constipation prophylaxis||constipation prophylaxis||classifies
incorrect dosage administered||incorrect dosage administered||classifies
afterbirth pain||afterbirth pains||classifies
retinal neovascularization (disorder)||retinal disorders nec||classifies
total excision of pineal gland||other therapeutic endocrine procedures||classifies
tumor pseudoprogression||tumour pseudoprogression||classifies
hemimelias||congenital reduction deformity of a limb||classifies
mobilization of peripheral blood progenitor cells||stem cell mobilization therapy||classifies
prostate electron beam therapy||electron radiation therapy to prostate||classifies
red man syndrome||red mans syndrome||classifies
crush betw fish boat and oth wtrcrft/obj due to clsn, sqla||external cause codes: sequela||classifies
diffuse large cell lymphoma (diffuse large b-cell lymphoma) (working formulation) stage ii||stage ii diffuse large b-cell lymphoma||classifies
radiation pericarditis||radiation pericarditis||classifies
straddling tricuspid valve (diagnosis)||straddling tricuspid valve (diagnosis)||classifies
monaural hearing aid assessment||diagnostic audiology (procedure)||classifies
carbuncle and furuncle of other specified sites||carbuncles||classifies
nerve paralyses, oculomotor||third cranial nerve palsy (diagnosis)||classifies
injection of knee joint (procedure)||injections joint||classifies
bk polyomavirus test||bk polyomavirus test||classifies
thrombosed piles internal||thrombosed hemorrhoids nos (disorder)||classifies
north american cutaneous blastomycosis||north american cutaneous blastomycosis||classifies
endometrial hypertrophy||endometrium; hypertrophy||classifies
itching of breast||itching;skin||classifies
cryoglobulinemic; vasculitis||cryoglobulinaemia||classifies
actinomycotic infection, cutaneous||actinomycosis; cutaneous||classifies
serotonin deficiency||serotonin deficiency||classifies
pneumonia due to pseudomonas (diagnosis)||pseudomonas pneumonia||classifies
gu tb nos-unspec||tuberculosis genitourinary nos||classifies
neoplasm of bronchus||bronchial neoplasms||classifies
supplement right breast with autologous tissue substitute, via natural or artificial opening endoscopic||reconstruction of breast (treatment)||classifies
elevated serum acid phosphatase||blood acid phosphatase increased||classifies
essential hypertension nos (disorder)||hypertension, arterial, idiopathic||classifies
hemorrhage; rectum||prb - rectal bleeding||classifies
refractory b-cell small lymphocytic lymphoma||refractory b-cell small lymphocytic lymphoma||classifies
medical and surgical @ eye @ occlusion @ lacrimal duct, right @ percutaneous @ extraluminal device @ no qualifier||procedures on the eyelids||classifies
pleuritic chest pain||pain, pleuritic||classifies
hypotensives||decreased blood pressure||classifies
adenoma, hepatocellular, benign||adenoma of liver||classifies
salpingo-oophoritis unspecif.||inflammation of fallopian tube||classifies
increased pituitary luteinising hormone level||blood luteinizing hormone increased||classifies
medical and surgical @ upper veins @ supplement @ cephalic vein, right @ percutaneous @ nonautologous tissue substitute @ no qualifier||vessel repair and replacement||classifies
ultralight, microlight or powered-glider collision injuring occupant, sequela||external cause codes: sequela||classifies
ringing in ears||tinnitus, unspecified ear||classifies
retinal hemorrhage spotted||retinal hemorrhage (finding)||classifies
motor ataxia (finding)||[d]ataxia nos (context-dependent category)||classifies
lips swelling non-specific||swelling of the lips||classifies
benign fibroadenoma (morphologic abnormality)||breast mouse||classifies
poisoning by anti-infective agent (disorder)||toxicity to various agents||classifies
epigastric hernioplasty||abdominal herniorrhaphy||classifies
glasgow coma scale score 13-15, unspecified time||nervous system signs and symptoms||classifies
cellulitis of eyelid||cellulitis (diagnosis)||classifies
cardiac fibrillation||fibrillation; heart||classifies
urticaria recurrent||hives nos||classifies
multiplex congenita, arthrogryposis||guérin stern syndrome||classifies
reticulosarcoma axilla||stage ii diffuse large b-cell lymphoma||classifies
administration site oedema||administration site edema||classifies
ms-like syndrome||insular sclerosis||classifies
transfer right lower extremity bursa and ligament, percutaneous endoscopic approach||musculoskeletal procedures, nec||classifies
increased proteins urine||protein urine present||classifies
legal abortion (disorder)||abortions induced||classifies
thoracic spond.+ myelopathy||spondylosis with myelopathy, nos||classifies
iron deficiency anaemia due to chronic blood loss (disorder)||other deficiency anaemias||classifies
encephalitis meningococcal||meningococcus; infection, encephalitis (manifestation)||classifies
edema-like||edema (diagnosis)||classifies
rsd - reflex sympath dystroph||algodystrophy||classifies
fructose semen increased||fructose semen increased||classifies
reaction to flavouring||reaction to food additive||classifies
[x]intestinal helminthiasis, unspecified (disorder)||worms||classifies
coagulase positive staphylococcal infection||staphylococcal infectious disease||classifies
forehead edema||edema face||classifies
stenosis pyloric||pyloric stenosis||classifies
empyema w/o fistula||pleural empyema||classifies
magic - mouth and genital ulcers with inflamed cartilage syn||magic - mouth-gen ulc+inf cart||classifies
thrombosing arteritis||inflammatory arterial reaction||classifies
calcium; ionized||ca ionized ea.tst||classifies
medical and surgical @ lymphatic and hemic systems @ extirpation @ lymphatic, right axillary @ percutaneous @ no device @ no qualifier||lymphatic procedures, nec||classifies
acute pericarditis - unspecified (disorder)||pericardium; inflammation||classifies
bartonella quintana test positive||bartonella test positive||classifies
vesicular; mole||hydatidiform mole benign||classifies
squamous cell carcinoma of the vagina stage i||epidermoid carcinoma of vagina||classifies
hypos||low blood sugar level||classifies
anterior cord synd/t1-t6||beck syndrome||classifies
[d]death less than 24 hours from onset of illness nos||death, sudden||classifies
staphylococcal osteomyelitis||staphylococcal osteomyelitis (diagnosis)||classifies
ventricl shunt-thorax||insertion; replacement; or removal of extracranial ventricular shunt||classifies
abscess;peritonsillar||peritonsillar abscess (physical finding)||classifies
sore nipple (finding)||nipples painful||classifies
acute synovitis||synovitis, nos||classifies
bowenoid papulosis (disorder)||bowenoid papulosis||classifies
esophageal laceration||rupture esophagus||classifies
knee replacement, partial||knee replacement arthroplasty||classifies
pulmonary alveolar bleeding||pulmonary alveolar haemorrhage||classifies
laryngoscopy abnormal||laryngoscopy abnormal||classifies
small cell cerebriform (mycosis fungoides sezary syndrome) (kiel classification) stage iii||stage iii cutaneous (skin) t-cell non-hodgkin lymphoma||classifies
igg4 related disease||immunoglobulin g4 related disease||classifies
neurosensory disorder||sensory system disorders||classifies
peripheral arterial occlusive disease fontaine stage i||paod - periph arter occlus dis||classifies
instability of internal left knee prosthesis, initial encounter||complication of internal orthopedic device or implant, initial encounter||classifies
anti-hbc antibody positive||hepatitis b virus core antibody positive||classifies
ctt scan normal||cat normal||classifies
haptoglobin normal||haptoglobin normal||classifies
nondependent cannabis abuse||medication abuse||classifies
palindromic rheumatism, left shoulder||other specified joint disorders, site unspecified||classifies
retinitis (disorder)||retina inflamed||classifies
[x]other chest pain||pain;chest||classifies
edema of penis (diagnosis)||penile edema (physical finding)||classifies
poisoning by local anesthetics, assault, sequela||poisoning/toxic effect/adverse effects/underdosing, sequela||classifies
keratitis herpetic||herpes simplex keratitis (disorder)||classifies
culture cervix negative||culture cervix negative||classifies
legally induced abortion, unspecified, without mention of complication||abortions induced||classifies
venous thrombosis neonatal||venous thrombosis neonatal||classifies
trichomoniasis; intestinal||intestinal trichomoniasis (diagnosis)||classifies
osteopedion||lithopedian||classifies
headache, psychogenic||tension type headache, unspecified||classifies
resection of right wrist joint, open approach||joint tissue excision (excluding discectomy)||classifies
amoebic nondysenteric colitis||amoebic colitides||classifies
cavernous; lung||phthisis, pulmonary||classifies
perforation rectum||rectum; perforation||classifies
intrapulmonary hemorrhage||hemorrhage; lung||classifies
oth spcf deformity head||head deformity||classifies
lower extremities deep decreased reflex test||decreased reflex||classifies
scrn malig neo-intes nos||other screening for suspected conditions (not mental disorders or infectious disease)||classifies
obstruc/fet malpos-antep||obstructed labor||classifies
apolipoprotein b-100, familial ligand-defective||hyperlipidemia, familial combined||classifies
pancreas neoplasm malignant non-resectable||exocrine cancer||classifies
spirometry||spirometry test||classifies
hemodynamic test||hemodynamic test||classifies
congenital pneumonia of newborn (diagnosis)||congenital; pneumonia||classifies
perirenal; abscess||perinephric abscess (disorder)||classifies
urinary bladder explosion||urinary bladder explosion||classifies
other closed skull fracture with subarachnoid, subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level||skull fracture (diagnosis)||classifies
carcinomas, hepatocellular||liver cancers||classifies
spondylopathy in diseases classd elswhr, thoracic region||spondylopathies/spondyloarthropathy (including infective)||classifies
schistosoma hematobium infection (disorder)||cystitis with bilharziasis||classifies
porencephaly [ambiguous]||porencephalus||classifies
creatine kinase mm result||blood creatine phosphokinase mm||classifies
oedema limbs-trunk of||[d]edema, generalized||classifies
ann arbor stage ii follicular lymphoma||follicular lymphoma stage ii||classifies
biliary tract infection bacterial||biliary tract infection bacterial||classifies
prophylaxis against dehydration||prophylaxis against dehydration||classifies
medical and surgical @ gastrointestinal system @ dilation @ anus @ percutaneous @ intraluminal device @ no qualifier||lower gi therapeutic procedures, nec (excluding open and laparoscopic)||classifies
biopsy peripheral nerve||peripheral nerve biopsy||classifies
hypocortisolaemia||glucocorticoid deficient||classifies
aderm||dermatoglyphic abnormality||classifies
antibody nos normal||antibody test normal||classifies
acyanotic congenital heart disease, nos||congenital cardiac disorders||classifies
embolism due to genitourinary prosthetic devices, implants and grafts, initial encounter||complication of genitourinary device, implant or graft, initial encounter||classifies
retrovirus ex vivo gene therapy||ex vivo gene therapy||classifies
transtympanic administration||injections, intratympanic||classifies
infection; urinary tract||infection urinary tract||classifies
diffuse large cell lymphoma (peripheral t-cell lymphoma unspecified) (working formulation) stage iii||peripheral t-cell lymphoma unspecified stage iii||classifies
cancer, metastatic to liver||2-malig neop liver||classifies
other forms of epilepsy nos||epileptic seizures||classifies
hypertens nos-antepartum||raised blood pressure (disorder)||classifies
opn skl base fx-coma nos||base fractures skull||classifies
nondisplaced spiral fracture of shaft of ulna, unspecified arm, subsequent encounter for closed fracture with routine healing||fracture of the upper limb, subsequent encounter||classifies
mouth; candidiasis||candidiasis; mouth||classifies
central retinal arterial occlusion||artery; retina, occlusion artery||classifies
solid pseudopapillary tumour of the pancreas||frantz tumor||classifies
upper limb motor deficit||deficits neurologic||classifies
small intestine atresia and stenosis||congenital small intestinal atresia||classifies
barium double contrast nos abnormal||barium double contrast abnormal||classifies
gastrointestinal fistula repair||gastrointestinal fistula repair||classifies
epididymal infection||inflammation; epididymis||classifies
corneal foreign body (disorder)||intraocular foreign body||classifies
excision of left thyroid artery, percutaneous endoscopic approach, diagnostic||artery, vein, and great vessel procedures, nec||classifies
palatectomy||palatectomy||classifies
antral polyp||sinus; polyp||classifies
localised pruritus||pruritus;skin||classifies
extraction of vagus nerve, percutaneous approach||cns excision procedures||classifies
laryngeal and ocular granulation in indian children||shabbir syndrome||classifies
nontraumatic rupture of extensor tendons of hand and wrist||traumatic rupture of tendon (disorder)||classifies
virus body fluid no organisms observed||viral test negative||classifies
metastatic breast adenocarcinoma||breast cancer, stage iv||classifies
portal hypertens gastropathy||hypertensive portal gastropathy (diagnosis)||classifies
hypercellular marrow||bone hyperplasia marrow||classifies
bleeding chronic gastrointestinal||chronic gi haemorrhage||classifies
dysplasia of vagina (disorder)||dysplasia of vagina, unspecified||classifies
medical and surgical @ subcutaneous tissue and fascia @ insertion @ subcutaneous tissue and fascia, trunk @ percutaneous @ infusion device @ no qualifier||subcutaneous tissue and fascia procedures, nec||classifies
betaglobulin||betaglobulin||classifies
removal of nonautologous tissue substitute from left elbow joint, open approach||musculoskeletal device procedures, nec||classifies
acute respiratory insufficiency||acute respiratry failure||classifies
infestation; tapeworm, fish||fish tapeworm; infestation||classifies
ethanol high||blood ethanol increased||classifies
weissella infection||weissella infection||classifies
disease of eye||eye diseases||classifies
stage iii esophageal adenocarcinoma||oesophageal adenocarcinoma stage iii||classifies
urti - viral upper respiratory tract infection||viral upper respiratory tract infection (disorder)||classifies
hyperesthesia teeth||hyperesthesia teeth||classifies
sphingomonas paucimobilis infection||sphingomonas paucimobilis infection||classifies
medical and surgical @ lower joints @ drainage @ toe phalangeal joint, left @ percutaneous @ no device @ diagnostic||puncture of joint, nos||classifies
vitello-intestinal duct remnant||vitello-intestinal duct remnant||classifies
full-thickness skin loss due to third degree burn, nos, of multiple sites of lower limb||111 burn injuries||classifies
bleeding, vaginal||pv - vaginal blood loss||classifies
medical and surgical @ muscles @ excision @ hand muscle, right @ open @ no device @ diagnostic||subcutaneous tissue, fascia, and muscle biopsy||classifies
familial spinal arachnoiditis||arachnoiditis (disorder)||classifies
mixed incontinence, urge and stress||urinary bladder incontinence||classifies
type 2 diabetes w prolif diabetic rtnop w/o macular edema||diabetes-related complication||classifies
quadriplegia and quadriparesis of c5-c7, incomplete||bilateral diplegia||classifies
catatonic type schizophrenia, subchronic state||schizophrenia disorders (diagnosis)||classifies
nk cell count increased||nk cell count increased||classifies
hypertriglyceridemia (diagnosis)||increased triglycerides||classifies
colonic stenosis||large intestinal stricture nos||classifies
hemorrhage aggravated||bleeding problems||classifies
broncho alveolar lavage||lavages, bronchoalveolar||classifies
lethal midline granuloma stage i||stage i angiocentric lymphoma||classifies
antibiotic level therapeutic||antibiotic level therapeutic||classifies
removal of drainage device from right ear, via natural or artificial opening endoscopic||ent drainage (excluding myringotomy)||classifies
viral acanthoma||viral acanthoma||classifies
otitis media post measles||otitis media post measles||classifies
medial tibial stress syndrome (mtss)||shin splint||classifies
primary focal hyperhidrosis of face (diagnosis)||other specified and unspecified skin disorders||classifies
cmv colitis recurrent||colitis cmv||classifies
avalanche, landslide, or mudslide, initial encounter||external cause codes: intent of injury, accidental/unintentional||classifies
supplement tricuspid valve created from right atrioventricular valve with nonautologous tissue substitute, percutaneous approach||heart valve replacement and other valve procedures (endovascular)||classifies
removal of medical device occlusion||removal of medical device occlusion||classifies
enzymes testing||enzymes testing||classifies
angioma of lip||hemangioma cutaneous||classifies
blood sugar decreased||sugar blood decreased||classifies
needle stick/puncture||injury associated with device||classifies
eye ache||pain in eye||classifies
elevate mood||euphorias||classifies
traumatic amputation of limb (disorder)||limb traumatic amputation||classifies
blood glucagon increased||blood glucagon increased||classifies
plasma lactic acid normal||blood lactic acid normal||classifies
ovarian fibroma||fibroma of ovary (disorder)||classifies
congenital intestinal malformation nos||congenital intestinal malformation||classifies
heigmab||hepatitis e antibody (laboratory procedure)||classifies
oesophageal candidiasis recurrent||candidiasis of the esophagus (disorder)||classifies
deformity of nose||deformity of nose||classifies
gastric retention (disorder)||impaired gastric emptying||classifies
peripheral haemopoietic stem cell transplant||transplantations, stem cell||classifies
benign laryngeal tumor||larynx||classifies
aphthous ulcerations||oral aphthae nos||classifies
phenylalanine screening test, blood||blood phenylalanine measurement by guthrie microbiologic assay (lab test)||classifies
skin reaction localised||skin reaction (observable entity)||classifies
fluid in fallopian tube||hydrosalpinx (diagnosis)||classifies
cerebral; hyperemia||cerebral congestion||classifies
brachial pulse normal||brachial pulse normal||classifies
fetal presentation transverse oblique||transverse lie of foetus||classifies
obstetrics @ pregnancy @ extraction @ products of conception, ectopic @ via natural or artificial opening @ no device @ no qualifier||removal of ectopic pregnancy||classifies
carcinoma of ovary||cancer ovaries||classifies
red blood cells uirne negative||red blood cells urine negative||classifies
pustulosis, exanthematous, acute generalized||acute generalized exanthematous pustulosis (disorder)||classifies
drug dependence in mother complicating pregnancy, childbirth, and puerperium||pregnancy and drug dependence (disorder)||classifies
function liver decreased||dysfunctions, liver||classifies
cardiac perforation||cardiac perforation||classifies
orbital osteoperiostitis||periostitis||classifies
acute pyelitis (disorder)||pyelitis (diagnosis)||classifies
osteoarthrosis, localized, not specified whether primary or secondary, shoulder region||djd||classifies
adrenal gland biopsy abnormal||adrenal gland biopsy abnormal||classifies
venous oxygen partial pressure decreased||venous oxygen partial pressure decreased||classifies
unsp fracture of lower end of right humerus, init for opn fx||fracture of the upper limb, initial encounter||classifies
other fetal and placental problems affecting management of mother||disorder of fetus||classifies
alteration of left lower extremity with nonautologous tissue substitute, open approach||cosmetic procedure (qualifier value)||classifies
infected induced abortion||induced abortion infection||classifies
culture negative||culture negative||classifies
leukoplakia of vulva||vulva - kraurosis||classifies
maculopapular cutaneous mastocytosis||urticaria pigmentosa, nos||classifies
other complications of obstetrical surgical wounds, unspecified as to episode of care||postoperative wound complication||classifies
vasa previa complicating labor and delivery||vasa praevia unspecified||classifies
open fracture of external condyle of humerus||fractured humerus||classifies
amniocentesis normal||amniocentesis normal||classifies
fimbrioplasty (procedure)||fimbrioplasty||classifies
ca larynx - nos (disorder)||laryngeal cancer (diagnosis)||classifies
edema of eyelid (disorder)||edema eyelid||classifies
activated partial thromboplastin time shortened||activated partial thromboplastin time shortened||classifies
joint disorder, temporomandibular||myofascial pain dysfunction syndrome, temporomandibular joint||classifies
streptococcal abscess||streptococcal abscess||classifies
electrocardiogram signs of ventricular hypertrophy||ecg signs of ventricular hypertrophy||classifies
surgery testis incision||other male genital procedures||classifies
articular crepitation||joints noise||classifies
ther cognitive||behavior conditioning therapy||classifies
systemic blastomycosis||systemic blastomycosis||classifies
blood clots||thrombotic disorder||classifies
ca endometrium stage 0||stage 0 cancer of the endometrium||classifies
bypass abdominal aorta to abd aorta, perc endo approach||vascular bypass of peripheral artery||classifies
abdominal wall phlegmon||cellulitis (diagnosis)||classifies
feelings of inferiority||inferiority complex||classifies
application site cold feeling||application site cold feeling||classifies
abdominal wall operation nos||abdominal wall operations nos||classifies
nasal discharge discoloration||nasal discharge discoloration||classifies
upper respiratory tract infection viral nos||upper respiratory tract infection (& viral) nos (disorder)||classifies
quadriplegia and quadriparesis of c5-c7, complete||quadriplegia (disorder)||classifies
reticulosis, malignant||angiocentric lymphomas||classifies
coronary angiogram normal||normal coronary arteriogram||classifies
fistulas ureteral||ureteric fistula||classifies
non-lymphocytic leukemia chronic||chronic myelosis||classifies
superficial bruising of hip||contusion nos||classifies
dislocation of mcp joint of left little finger, sequela||sequela of injury||classifies
blood urine||red blood cell- red blood cells in urine||classifies
monplga upr lmb dmnt sde||monoplegias||classifies
medical and surgical @ skin and breast @ replacement @ skin, right upper arm @ external @ nonautologous tissue substitute @ full thickness||transplantations, skin||classifies
abrasion forearm||removal of superficial layer of skin by dermabrasion||classifies
alpha hemolytic streptococcus test positive||streptococcus identification test positive||classifies
ovarian germ cell polyembryoma stage i c||ovarian germ cell polyembryoma stage i||classifies
alteration of nasal mucosa and soft tissue, perc approach||cosmetic procedure (qualifier value)||classifies
lymphoepithelioid lymphoma (kiel classification) stage i||peripheral t-cell lymphoma unspecified stage i||classifies
edema of tongue||lingual edema||classifies
bone marrow disease||bone marrow disorder nos||classifies
tumor of parathyroid gland||parathyroid gland tumor||classifies
retinal vein thrombosis||thrombosis of retinal vein (disorder)||classifies
infection in marrow transplant recipients||infection in an immunocompromised host||classifies
local excision of lesion of vulva (procedure)||operative procedures on the vulva||classifies
recurrent burkitt lymphoma||burkitt's tumour or lymphoma recurrent||classifies
anal inflammation (disorder)||inflammation of anus||classifies
glaucoma secondary to oth eye disord, left eye, severe stage||glaucoma nos (disorder)||classifies
x-ray thoracic spine abnormal||x-ray nos spine abnormal||classifies
intraocular lens haptic breakage||device breakage||classifies
ligament sprain||ligaments sprain||classifies
jejunocolonic fistula||enterocolic fistula (disorder)||classifies
acquired hemophilia (disorder)||coagulation and hemorrhagic disorders||classifies
expiratory reserve volume high||expiratory reserve volume high||classifies
allergic reaction to food||food allergy (finding)||classifies
5-47 malabsorption syndromes||malabsorption syndromes||classifies
closure delayed fontanelles||delayed closure of the fontanelles||classifies
meningococcal myocarditis (diagnosis)||meningococcal myocarditis (diagnosis)||classifies
extraction of middle esophagus, perc endo approach, diagn||gi system biopsy (non-endoscopic)||classifies
erythema due to first degree burn of breast||epidermal burn of skin (disorder)||classifies
device failure to power up||device electrical finding||classifies
herpes simplex nos||hsv infection||classifies
x-ray of orbit normal||x-ray nos face and mouth normal||classifies
marburg haemorrhagic fever||vervet monkey disease||classifies
interstitial heart fibrosis||myocardium; fibrosis||classifies
displaced transverse fracture of right patella, initial encounter for open fracture type iiia, iiib, or iiic||fracture of the lower limb (except hip), initial encounter||classifies
gamma-glutamyl transferase concentration increased above normal||gamma-glutamyl transferase concentration increased above normal||classifies
respiratory lesion||diseases and syndromes of respiratory system||classifies
edema-like||oedema - symptom||classifies
respiratory complications, nec in mdr24_0||post procedural complication||classifies
other specified disorders of bone, lower leg||other specified bone disease and musculoskeletal deformities||classifies
operation on seminal vesicle||operation seminal vesicle nos||classifies
corneal sloughing||corneal exfoliation||classifies
hepatobiliary pain||liver pain (finding)||classifies
coagulation factor viii activity||factor viii coagulation activity||classifies
fracture neck of||cervical vertebral fracture||classifies
laparoscopic antireflux surgery||esophagogastric fundoplasty [dup] (procedure)||classifies
neoplasm;respiratory||respiratory system neoplasm||classifies
epidermal appendage tumor||neoplasm skin||classifies
elevated serum aldosterone||blood aldosterone increased||classifies
venous ulcer recurrent||skin ulcers||classifies
testicular yolk sac tumour stage i||testicular yolk sac tumour stage i||classifies
lesion corneal||corneal lesion (disorder)||classifies
infectious encephalomyelitis||inflammation of brain and spine||classifies
parotid enlargement||parotid gland enlargement of||classifies
major depressive disorder with melancholic features||major depression, nos||classifies
disease, caisson||decompression; disease||classifies
stage i hypopharyngeal squamous cell carcinoma ajcc v7||squamous cell carcinoma of hypopharynx||classifies
hbeag measurement||hepatitis be antigen measurement (procedure)||classifies
carpal bone(s); fracture||fracture of distal end of radius and ulna (diagnosis)||classifies
spermatic cord granuloma||sperm granuloma (disorder)||classifies
malignant tumour of head and neck||head and neck cancer||classifies
parotid region pain||salivary gland pain||classifies
continuing pregnancy after spontaneous abortion of one fetus or more, first trimester, fetus 5||multiple gestation, unspecified||classifies
repeated open application test||repeated open application test||classifies
precancerous lesion of colon||precancerous lesion of digestive tract||classifies
plasmapheresis||therapeu plasmapheresis||classifies
enlargement, heart||cardiomegaly||classifies
septic anthrax (diagnosis)||anthrax septicaemia||classifies
unspecified senile and presenile organic psychotic conditions||psychotic disorder due to a general medical condition||classifies
hemangioma other sites||hemangioma of unspecified site||classifies
memory loss or impairment||amnesia, nos||classifies
genital hemorrhage nos||bleeding genitals||classifies
malig tumour ant floor mouth||lip and/or oral cavity cancer||classifies
medical and surgical @ respiratory system @ revision @ tracheobronchial tree @ external @ synthetic substitute @ no qualifier||respiratory system procedures, nec||classifies
tuberculous pleurisy, tubercle bacilli found by microscopy||tuberculosis pleurisy||classifies
arrhythmia absoluta||atrial fibrillation (af)||classifies
tumor of ampulla of vater||neoplasm of ampulla of vater||classifies
occlusion of left external carotid artery, percutaneous approach||ligation and embolization of vessels||classifies
female infertility nec||female infertility||classifies
bladder; neurogenic, cauda equina syndrome||lumbosacral syndrome||classifies
maximal breathing capacity||maximum breathing capacity||classifies
pancreatic pseudoaneurysm||pancreatic pseudoaneurysm||classifies
necrotizing sialometaplasia (disorder)||sialometaplasia||classifies
luckenschadel||craniolacunia||classifies
arteritic anterior ischaemic optic neuropathy||aion - acute ischaemic optic neuropathy||classifies
cervical discharge||discharge uterine cervix||classifies
plasma exchange||plasmaphoresis||classifies
intra-peritoneal abscess drainage||drainage of abscess (procedure)||classifies
medical and surgical @ lower bones @ removal @ upper femur, left @ percutaneous endoscopic @ nonautologous tissue substitute @ no qualifier||musculoskeletal device procedures, nec||classifies
[x]oth unspecif symbolic dysf||[d]symbolic dysfunction nos||classifies
streptococcal infectious disease, nos||streptococcus bacteria infection||classifies
cardiac toxicities||cardiac toxicities||classifies
fentanyl 100 mcg per 2 ml prefilled syringe||fentanila||active_moiety_of
silver nitrate 12 [hp_x] in 1 ml / ferula sumbul root 6 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / chamomile 6 [hp_x] in 1 ml / cinchona officinalis bark 6 [hp_x] in 1 ml / citrullus colocynthis fruit 6 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / nutmeg 6 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml oral liquid [baby gas drops]||activate charcoal||active_moiety_of
benzalkonium chloride 0.13 topical cloth [america1 hand wipes]||product containing benzalkonium||active_moiety_of
gabapentin 600 mg oral tablet [gabapentin]||product containing gabapentin (medicinal product)||active_moiety_of
asafetida 8 [hp_x] in 100 ml / strychnos ignatii seed 8 [hp_x] in 100 ml / valeriana officinalis whole 8 [hp_x] in 100 ml / oat bran 8 [hp_x] in 100 ml / silver nitrate 8 [hp_x] in 100 ml / hyoscyamus niger 8 [hp_x] in 100 ml / paeonia officinalis root 8 [hp_x] in 100 ml / datura stramonium 8 [hp_x] in 100 ml / anamirta cocculus whole 8 [hp_x] in 100 ml oral liquid [kids relief]||bran oats||active_moiety_of
picea mariana resin 20 [hp_x] in 1 ml / horse chestnut 20 [hp_x] in 1 ml / aloe 20 [hp_x] in 1 ml / aluminum oxide 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / activated charcoal 20 [hp_x] in 1 ml / chelidonium majus 20 [hp_x] in 1 ml / collinsonia canadensis root 20 [hp_x] in 1 ml / graphite 20 [hp_x] in 1 ml / goldenseal 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / magnesium chloride 20 [hp_x] in 1 ml / daphne mezereum bark 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / podophyllum 20 [hp_x] in 1 ml / frangula purshiana bark 20 [hp_x] in 1 ml / sanicula europaea whole 20 [hp_x] in 1 ml / selenium 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / silicon dioxide 20 [hp_x] in 1 ml / tobacco leaf 20 [hp_x] in 1 ml / veratrum album root 20 [hp_x] in 1 ml / zinc 20 [hp_x] in 1 ml / echinacea, unspecified 8 [hp_x] in 1 ml / iris versicolor root 8 [hp_x] in 1 ml / phytolacca americana root 8 [hp_x] in 1 ml / taraxacum officinale 8 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / iris versicolor root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml oral liquid [constipation]||american tobacco leaf||active_moiety_of
quetiapine fumarate 400 mg oral tablet, extended release||quétiapine||active_moiety_of
hydrocortisone .284 g in 28.4 g topical cream [duane reade]||hydrocortisonum||active_moiety_of
garlic 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / cysteine 6 [hp_x] in 1 ml / methionine 8 [hp_x] in 1 ml / phytolacca americana root 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / chromium 8 [hp_x] in 1 ml / cobalt 8 [hp_x] in 1 ml / copper 8 [hp_x] in 1 ml / iron 8 [hp_x] in 1 ml / iodine 8 [hp_x] in 1 ml / iridium 8 [hp_x] in 1 ml / potassium carbonate 8 [hp_x] in 1 ml / lithium carbonate 8 [hp_x] in 1 ml / magnesium 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / molybdenum 8 [hp_x] in 1 ml / sodium chloride 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / strontium carbonate 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / vanadium 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / phenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [metox]||dysprosium||active_moiety_of
solanum dulcamara top 2 [hp_x] in 1 ml / arnica montana 3 [hp_x] in 1 ml / toxicodendron pubescens leaf 3 [hp_x] in 1 ml / sanguinaria canadensis root 3 [hp_x] in 1 ml / sus scrofa cartilage 6 [hp_x] in 1 ml / sus scrofa umbilical cord 6 [hp_x] in 1 ml / nadide 6 [hp_x] in 1 ml / sodium diethyl oxalacetate 6 [hp_x] in 1 ml / pantothenic acid 6 [hp_x] in 1 ml / sus scrofa placenta 6 [hp_x] in 1 ml / sulfur 6 [hp_x] in 1 ml / chondroitin sulfate sodium (bovine) 6 [hp_x] in 1 ml / dimethyl sulfone 6 [hp_x] in 1 ml / apiole (parsley) 6 [hp_x] in 1 ml / cinnamic acid 6 [hp_x] in 1 ml / menadione 6 [hp_x] in 1 ml / piperine 6 [hp_x] in 1 ml / .alpha.-lipoic acid 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / comfrey root 8 [hp_x] in 1 ml / somatropin 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / enterococcus faecalis 30 [hp_c] in 1 ml oral liquid [chronagesic]||menaphthone preparation||active_moiety_of
hydrochlorothiazide 12.5 mg / quinapril 10 mg oral tablet [quinaretic]||(3s)-2-((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid||active_moiety_of
alcohol 14 ml in 20 ml topical liquid [ohhy secure]||methylcarbinol||active_moiety_of
cinnamon 3 [hp_x] in 1 ml / gentiana lutea root 3 [hp_x] in 1 ml / syzygium cumini seed 3 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / colchicum autumnale bulb 6 [hp_x] in 1 ml / bos taurus colostrum 6 [hp_x] in 1 ml / copper gluconate 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / magnesium gluconate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / sus scrofa pancreas 6 [hp_x] in 1 ml / potassium gluconate 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / gold 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / malus pumila flower 8 [hp_x] in 1 ml / nitric acid 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / water 8 [hp_x] in 1 ml / scrophularia nodosa whole 8 [hp_x] in 1 ml / fagus sylvatica flowering top 12 [hp_x] in 1 ml oral liquid [gi drainage]||malus pumila flower||active_moiety_of
amlodipine (as amlodipine besilate) 5 mg / hctz 12.5 mg / valsartan 160 mg oral tablet||amlodipino||active_moiety_of
cotton 0.05 g in 1 ml intradermal injection, solution||cotton||active_moiety_of
solidago virgaurea flowering top 3 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / clerodendranthus spicatus leaf 6 [hp_x] in 1 ml / chondrodendron tomentosum root 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / turpentine oil 6 [hp_x] in 1 ml / apis mellifera venom 8 [hp_x] in 1 ml / agathosma betulina leaf 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / sus scrofa renal pelvis 8 [hp_x] in 1 ml / sus scrofa ureter 8 [hp_x] in 1 ml / sus scrofa urethra 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml / glyoxal trimer dihydrate 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / sodium pyruvate 10 [hp_x] in 1 ml / quercetin 10 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [d2 organ support]||agathosma betulina leaf||active_moiety_of
ambrosia trifida pollen 0.00013 g in 1 ml / ambrosia artemisiifolia pollen 0.00013 g in 1 ml / ambrosia psilostachya pollen 0.00013 g in 1 ml / carya illinoinensis pollen 0.0000267 g in 1 ml / carya alba pollen 0.0000267 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.00008 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.0004 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml intradermal injection, solution||betula nigra pollen extract||active_moiety_of
dioscorea villosa tuber 6 [hp_x] in 1 ml / egg phospholipids 6 [hp_x] in 1 ml / sepia officinalis juice 6 [hp_x] in 1 ml / viola odorata whole 6 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / lithium carbonate 8 [hp_x] in 1 ml / thyroid, bovine 8 [hp_x] in 1 ml / sus scrofa placenta 8 [hp_x] in 1 ml / guaiacum officinale resin 10 [hp_x] in 1 ml / solanum tuberosum whole 10 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / gold monosulfide 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / quinine sulfate 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / lilium lancifolium whole flowering 12 [hp_x] in 1 ml / toxicodendron vernix leafy twig 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / aluminum oxide 12 [hp_x] in 1 ml oral liquid [motivation]||egg phospholipid (substance)||active_moiety_of
lidex ointment 0.05%||fluocinonide fapg||active_moiety_of
zinc oxide 14 g in 100 g topical lotion [diaper cream]||zinc óxido||active_moiety_of
allium porrum allergenic extract 100 mg/ml injectable solution||leek allergenic extract||active_moiety_of
salicylic acid 0.691 g in 133 ml topical liquid [clarity clear skin essentials foaming cleanser]||salicylic acid product (product)||active_moiety_of
bengay ultra strength pain relieving topical cream||synthetic camphor||active_moiety_of
artemisia californica pollen 0.0036 g in 1 ml / xanthium strumarium pollen 0.0036 g in 1 ml / artemisia vulgaris pollen 0.0036 g in 1 ml / artemisia tridentata pollen 0.0036 g in 1 ml / artemisia dracunculus pollen 0.0036 g in 1 ml / kochia scoparia pollen 0.0036 g in 1 ml / chenopodium album pollen 0.0036 g in 1 ml / iva axillaris pollen 0.0036 g in 1 ml / artemisia frigida pollen 0.0036 g in 1 ml / amaranthus retroflexus pollen 0.0036 g in 1 ml / salsola kali pollen 0.0036 g in 1 ml / rumex acetosella pollen 0.0036 g in 1 ml / amaranthus tuberculatus pollen 0.0036 g in 1 ml / rumex crispus pollen 0.0036 g in 1 ml intradermal injection, solution||artemisia frigida pollen||active_moiety_of
zolpidem tartrate 5 mg oral tablet, film coated [ambien]||zpd||active_moiety_of
titanium dioxide 415 mg in 10 g topical stick [bareminerals complexion rescue hydrating foundation broad spectrum spf 25 buttercream 2w]||titanium white||active_moiety_of
clematis vitalba whole 5 [hp_x] in 0.095 ml / helianthemum nummularium whole 5 [hp_x] in 0.095 ml / impatiens glandulifera whole 5 [hp_x] in 0.095 ml / olea europaea flower 5 [hp_x] in 0.095 ml / ornithogalum umbellatum whole 5 [hp_x] in 0.095 ml / prunus cerasifera whole 5 [hp_x] in 0.095 ml oral solution [rescue energy]||ornithogalum umbellatum extract||active_moiety_of
benzalkonium chloride 0.13 g in 100 ml topical liquid [antibac hand wash spring water]||benzalkonium product||active_moiety_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg / guaifenesin 200 mg oral capsule, liquid filled [severe cold and flu daytime non-drowsy]||phenylephrine||active_moiety_of
astragalus propinquus root 3 [hp_x] in 1 ml / baptisia tinctoria 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / araneus diadematus 30 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / atropa belladonna whole 30 [hp_c] in 1 ml / eupatorium perfoliatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / silicon dioxide 30 [hp_c] in 1 ml / thuja occidentalis leafy twig 30 [hp_c] in 1 ml / bilberry 30 [hp_c] in 1 ml oral liquid [4 detox-virus]||lachesis muta venom||active_moiety_of
apple cider vinegar 500 mg / pomegranate juice 40 ug / beet juice 40 ug oral chewable gel||apple cider vinegar||active_moiety_of
chelidonium majus 3 [hp_x] in 1 ml / echinacea 3 [hp_x] in 1 ml / bos taurus adrenal gland 24 [hp_x] in 1 ml / bos taurus spleen 24 [hp_x] in 1 ml / silybum marianum seed 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml oral liquid [adrenal tincture]||carduus marianus seed||active_moiety_of
felis catus hair 10000 [bau] in 1 ml intradermal injection, solution||cat hair (felis domesticus)||active_moiety_of
benzalkonium chloride 0.2 g in 100 g topical cloth [julep antibacterial sanitizing wipes]||benzalkonium (product)||active_moiety_of
arnica montana root 8 [hp_x] in 100 g / rhododendron tomentosum leafy twig 3 [hp_x] in 100 g / toxicodendron pubescens shoot 8 [hp_x] in 100 g / sulfur 15 [hp_x] in 100 g / horse chestnut 4 [hp_x] in 100 g / betula pendula leaf 8 [hp_x] in 100 g / hedera helix flowering twig 6 [hp_x] in 100 g / melilotus officinalis top 4 [hp_x] in 100 g cutaneous ointment [zellulisan]||arnica montana radix||active_moiety_of
covaryx 1.25mg-2.5mg tablet||estrogen conjugate||active_moiety_of
apis mellifera 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bromine 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / ferrosoferric phosphate 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / hippomane mancinella fruiting leafy twig 15 [hp_x] in 1 ml / calomel 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / plantago major 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / viola tricolor 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml oral liquid [ear care]||daphne mezereum bark||active_moiety_of
ethinyl estradiol + norgestimate 0.035mg/0.25mg tablet||ethinyloestradiol||active_moiety_of
lidocaine hydrochloride, injectable, 5%-0.8% injectable solution||2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide||active_moiety_of
pyrithione zinc 2.1 g in 100 ml topical liquid [lancell huitomo hair loss prevention hair grower clean formula]||zinc, bis(2-pyridylthio)-, n,n'-dioxide||active_moiety_of
dimethicone 1 g in 100 g / zinc oxide 12 g in 100 g topical cream [abc arbonne baby care diaper rash]||oxyde de zinc||active_moiety_of
silver nitrate 6 [hp_x] in 1 ml / baptisia tinctoria 6 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / echinacea purpurea 3 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / phosphorus 6 [hp_x] in 1 ml / pulsatilla vulgaris 6 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / thuja occidentalis leaf 6 [hp_x] in 1 ml / thymus serpyllum 6 [hp_x] in 1 ml oral liquid [stay well]||echinacea||active_moiety_of
silicon dioxide 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / sulfuric acid 15 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / sanicula europaea leaf 16 [hp_x] in 1 ml / tellurium 16 [hp_x] in 1 ml / saccharomyces cerevisiae 16 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / barium carbonate 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / activated charcoal 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / nitric acid 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml oral liquid [fungal]||silicas||active_moiety_of
dimercaptocuccinic acid 1 milligram in 1 vial intravenous injection, powder, lyophilized, for solution [dmsa]||dmsa (2,3 dimercaptosuccinic acid)||active_moiety_of
zinc oxide 40 % topical ointment||sunscreen with zinc oxide (medication)||active_moiety_of
semecarpus anacardium juice 30 [hp_c] in 30 ml / arnica montana 1.5 [hp_c] in 30 ml / calcium fluoride 30 [hp_c] in 30 ml / silybum marianum seed oil 1.5 [hp_c] in 30 ml / cinchona officinalis bark 3 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / ginkgo 3 [hp_c] in 30 ml / egg phospholipids 6 [hp_c] in 30 ml / achillea millefolium 1.5 [hp_c] in 30 ml / phosphoric acid 30 [hp_c] in 30 ml / saccharomyces cerevisiae rna 6 [hp_c] in 30 ml / silicon dioxide 6 [hp_c] in 30 ml / zinc sulfate heptahydrate 6 [hp_c] in 30 ml oral spray [brain power]||egg yolk phospholipids||active_moiety_of
carbidopa 25/levodopa 100mg tab||carbidopa anhydrous (substance)||active_moiety_of
centella asiatica 1 [hp_x] in 1 g / arctium lappa root 1 [hp_x] in 1 g / arsenic acid 12 [hp_x] in 1 g / arsenic trioxide 12 [hp_x] in 1 g / sodium borate 12 [hp_x] in 1 g / graphite 12 [hp_x] in 1 g / daphne mezereum bark 12 [hp_x] in 1 g / sodium chloride 12 [hp_x] in 1 g / petrolatum 12 [hp_x] in 1 g / phytolacca americana root 12 [hp_x] in 1 g / sepia officinalis juice 12 [hp_x] in 1 g / potassium arsenite anhydrous 16 [hp_x] in 1 g topical gel [psoriasis]||coastal water-hyssop whole||active_moiety_of
zocor 10 mg oral tablet||product containing simvastatin (medicinal product)||active_moiety_of
phenol 32.5 mg/ml / scarlet red 1.9 mg/ml topical spray||sudan red||active_moiety_of
geranium robertianum whole 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1 ml / apis mellifera 4 [hp_x] in 1 ml / equisetum hyemale whole 4 [hp_x] in 1 ml / fumaria officinalis flowering top 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / pinus sylvestris leafy twig 4 [hp_x] in 1 ml / veronica officinalis flowering top 4 [hp_x] in 1 ml / gentiana lutea root 5 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / mercuric cyanide 8 [hp_x] in 1 ml / scrophularia nodosa whole 8 [hp_x] in 1 ml / aloe 8 [hp_x] in 1 ml / ferrous iodide 8 [hp_x] in 1 ml / myosotis arvensis whole 10 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / juglans regia leaf 12 [hp_x] in 1 ml / bos taurus parathyroid gland 12 [hp_x] in 1 ml / sus scrofa thymus 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml oral liquid [lymphdrainex]||pinus sylvestris top||active_moiety_of
ringer-lactate infusion solution bag||cl||active_moiety_of
carya illinoinensis pollen 0.1 g in 1 ml / acer saccharum pollen 0.033 g in 1 ml / acer negundo pollen 0.033 g in 1 ml / acer rubrum pollen 0.033 g in 1 ml / quercus rubra pollen 0.033 g in 1 ml / quercus virginiana pollen 0.033 g in 1 ml / quercus alba pollen 0.033 g in 1 ml / platanus occidentalis pollen 0.1 g in 1 ml / salix nigra pollen 0.1 g in 1 ml percutaneous injection, solution [pollens - trees, tree mix 5]||sugar maple pollen||active_moiety_of
amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula populifolia pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.005 g in 1 ml / populus alba pollen 0.005 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.0004 g in 1 ml / morus rubra pollen 0.002 g in 1 ml intradermal injection, solution||redroot pigweed pollen extract||active_moiety_of
sucralfate@1 gram@oral@tablet||aluminum, hexadeca-mu-hydroxytetracosahydroxy(mu8-(1,3,4,6-tetra-o-sulfo-beta-d-fructofuranosyl alpha-d-glucopyranoside tetrakis(hydrogen sulfato)(8-)))hexadeca-||active_moiety_of
benzalkonium chloride 1.3 mg in 1 ml topical liquid [hygiene clean balsam fir hand sanitizer alcohol free]||benzalkonium-containing product||active_moiety_of
felis catus hair 16 [bau] in 1 ml / alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.0008 g in 1 ml / aspergillus fumigatus 0.00008 g in 1 ml / cochliobolus sativus 0.0004 g in 1 ml / cladosporium cladosporioides 0.0004 g in 1 ml / phoma destructiva 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.00008 g in 1 ml / rhizopus stolonifer 0.00008 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml subcutaneous injection, solution||phoma destructiva||active_moiety_of
menthol 22 mg/ml topical cream||menthol, unspecified form||active_moiety_of
dimethicone 12 mg in 1 g topical lotion [aveeno daily moisturizing]||product containing dimeticone (medicinal product)||active_moiety_of
harpagophytum procumbens root 1 [hp_x] in 1 ml / salix alba bark 1 [hp_x] in 1 ml / colchicum autumnale bulb 3 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / aconitum napellus whole 12 [hp_x] in 1 ml / arnica montana whole 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / iris versicolor root 12 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 12 [hp_x] in 1 ml / lespedeza capitata flowering top 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / claviceps purpurea sclerotium 12 [hp_x] in 1 ml / spigelia anthelmia whole 12 [hp_x] in 1 ml / filipendula ulmaria root 12 [hp_x] in 1 ml / tartaric acid 12 [hp_x] in 1 ml oral liquid [joint tonic r ii]||filipendula ulmaria root||active_moiety_of
alcohol 2649.787 ml in 3785.41 ml cutaneous gel [workforce personal care hand sanitizer unscented]||ethanol (substance)||active_moiety_of
hydromorphone hcl 2 mg per 1 ml injection||hydromorphone (product)||active_moiety_of
alcohol 0.62 ml in 1 ml topical gel [jack n jill koala hand sanitizer]||ethyl alcohol (substance)||active_moiety_of
pramipexole dihydrochloride 1mg tablet||2 amino 6 propylaminotetrahydrobenzothiazole||active_moiety_of
potassium bromide 4 [hp_x] in 30 ml / caffeine 6 [hp_x] in 30 ml / avena sativa flowering top 2 [hp_x] in 30 ml / matricaria chamomilla whole 2 [hp_x] in 30 ml / strychnos ignatii seed 4 [hp_x] in 30 ml / passiflora incarnata flowering top 2 [hp_x] in 30 ml / silver nitrate 30 [hp_x] in 30 ml / zinc valerate dihydrate 4 [hp_x] in 30 ml oral solution/ drops [guna sleep support]||bromide ions||active_moiety_of
australian pine pollen extract 20000 unt/ml injectable solution||tree pollen-australian pine||active_moiety_of
alcohol 80 ml in 100 ml intra-arterial liquid [80% alcohol hand sanitizer]||alkohol||active_moiety_of
arsenic trioxide 30 [hp_c] in 30 [hp_c] / oyster shell calcium carbonate, crude 30 [hp_c] in 30 [hp_c] / matricaria recutita 30 [hp_c] in 30 [hp_c] / hyoscyamus niger 30 [hp_c] in 30 [hp_c] / strychnos ignatii seed 30 [hp_c] in 30 [hp_c] / lachesis muta venom 30 [hp_c] in 30 [hp_c] / pulsatilla vulgaris 30 [hp_c] in 30 [hp_c] / sepia officinalis juice 30 [hp_c] in 30 [hp_c] / strychnos nux-vomica seed 30 [hp_c] in 30 [hp_c] / sodium chloride 30 [hp_c] in 30 [hp_c] oral spray [sibling jealousy]||sepia officinalis juice||active_moiety_of
benzalkonium chloride 0.55 % medicated liquid soap||benzalkonium (substance)||active_moiety_of
juniperus virginiana pollen 0.00008 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya tomentosa pollen 0.001 g in 1 ml / ulmus americana pollen 0.00008 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / iva annua pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / bassia scoparia pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / phoma destructiva 0.002 g in 1 ml / candida albicans 0.00008 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.0004 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml intradermal injection, solution||cat hair standardized allergenic extract||active_moiety_of
ulmus minor whole 5 [hp_x] in 0.095 ml oral solution [bach original flower remedies]||ulmus procera whole extract||active_moiety_of
lamictal xr 300 mg 24 hr extended release oral tablet||lamotrigina||active_moiety_of
dimethicone 1 g in 100 g / octinoxate 7.5 g in 100 g / oxybenzone 2.5 g in 100 g topical stick [fruit smoothies strawberry banana]||dimethyl polysiloxane||active_moiety_of
ciclopirox and nail lacquer remover, non-acetone@8 %@topical@kit||ciclopirox (medication)||active_moiety_of
leader pain reliever extra strength caplet||4-acetamidophenol||active_moiety_of
avobenzone 3 g in 100 g / homosalate 15 g in 100 g / octisalate 5 g in 100 g / octocrylene 2.7 g in 100 g topical gel [hydrating lip balm sunscreen]||octyl salicylate||active_moiety_of
aluminum oxide 10 [hp_x] in 59 ml / chrysopogon zizanioides root 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / butyric acid 10 [hp_x] in 59 ml / centella asiatica 10 [hp_x] in 59 ml / daphne mezereum bark 10 [hp_x] in 59 ml / kerosene 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [athletes foot fighter]||sepia officinalis juice||active_moiety_of
menthol 130 mg in 1 g topical cream [the skateboarding pain relieving liniment]||menthol, unspecified form||active_moiety_of
gibberella fujikuroi 20000 [pnu] in 1 ml percutaneous solution||gibberella fujikuroi||active_moiety_of
naproxen 500 mg oral tablet, enteric coated [naproxen er]||(s)-(+)-naproxen||active_moiety_of
camphor 0.006 mg/mg / menthol 0.052 mg/mg topical ointment||camphor (natural)||active_moiety_of
alcohol 75 ml in 100 ml topical liquid [alpha handrub]||bd persist||active_moiety_of
cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya alba pollen 0.001 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml / ambrosia trifida pollen 0.000027 g in 1 ml / ambrosia artemisiifolia pollen 0.000027 g in 1 ml / ambrosia psilostachya pollen 0.000027 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml intradermal injection, solution||english plantain pollen extract||active_moiety_of
aconitum napellus 10 [hp_x] in 59 ml / epinephrine 10 [hp_x] in 59 ml / ammonium carbonate 10 [hp_x] in 59 ml / antimony potassium tartrate 10 [hp_x] in 59 ml / aralia racemosa root 10 [hp_x] in 59 ml / bromine 10 ml in 59 ml / chlorine 10 [hp_x] in 59 ml / eriodictyon californicum leaf 10 [hp_x] in 59 ml / eucalyptus globulus leaf 10 [hp_x] in 59 ml / grindelia hirsutula flowering top 10 [hp_x] in 59 ml / lobelia inflata 10 [hp_x] in 59 ml / sodium sulfate 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / quebracho bark 10 [hp_x] in 59 ml / trifolium pratense flower 10 [hp_x] in 59 ml oral liquid [asthmacare]||grindelia hirsutula flowering top extract||active_moiety_of
leucine 0.0002 g in 5.0 ml / isoleucine 0.0001 g in 5.0 ml topical liquid [vial 2 ampoule]||leucine (medication)||active_moiety_of
fluorouracil topical 5% topical cream||product containing fluorouracil||active_moiety_of
camphor (natural) 11 g in 100 g / eucalyptus oil 10 g in 100 g / menthol 10 g in 100 g / methyl salicylate 10 g in 100 g topical cream [sports balm]||oil of eucalyptus||active_moiety_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [nighttime severe cold and flu relief]||antinauseants doxylamine||active_moiety_of
phenergan 12.5 mg oral tablet||promethazine product||active_moiety_of
alcohol 310 ml in 500 ml topical gel [hug lets clean sanitizer gel(ethanol)]||alcohol (ethyl)||active_moiety_of
octinoxate 7 g in 100 g / oxybenzone 3 g in 100 g topical lipstick [mint sunscreen lip moisturizer]||omc cinnamate||active_moiety_of
acetaminophen/dextromethorphan hbr 160 mg-5 mg/5 ml oral suspension, oral (final dose form)||acetaminophen product||active_moiety_of
neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen 10 ug in 0.5 ml intramuscular injection, powder, lyophilized, for solution [mena]||neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen||active_moiety_of
homosalate 100 g in 2 ml / octisalate 50 g in 2 ml / oxybenzone 40 g in 2 ml / avobenzone 20 g in 2 ml / octocrylene 13 g in 2 ml topical liquid [all day moisture with ahas spf 15 broad spectrum sunscreen]||benzoic acid, 2-hydroxy-, 2-ethylhexyl ester||active_moiety_of
zinc oxide 20 g in 100 g topical ointment [sunscreen]||sunscreen with zinc oxide (medication)||active_moiety_of
sorghum halepense pollen 1000 [pnu] in 1 ml subcutaneous solution [johnson grass]||allergenic extract, grass, johnson||active_moiety_of
echinacea purpurea 3 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / baptisia tinctoria root 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / anemone pulsatilla 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / phosphorus 6 [hp_x] in 1 ml / thymus serpyllum 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml oral liquid [stay well]||thymus serpyllum (substance)||active_moiety_of
tuna allergenic extract 100 mg/ml injectable solution||tuna||active_moiety_of
lamotrigine 50mg dispersible tablet||lamotriginum||active_moiety_of
isopropyl alcohol 700 mg in 1 ml topical gel [guard hand sanitizer]||2 propanol||active_moiety_of
avobenzone 0.031 g in 1 ml / octisalate 0.047 g in 1 ml / octocrylene 0.052 g in 1 ml topical cream [revitalizing supreme plus global anti-aging cell power creme broad spectrum spf 15]||octocrilene-containing product||active_moiety_of
barium carbonate 30 [hp_c] in 30 [hp_c] / phenol 30 [hp_c] in 30 [hp_c] / oyster shell calcium carbonate, crude 30 [hp_c] in 30 [hp_c] / tribasic calcium phosphate 30 [hp_c] in 30 [hp_c] / chelidonium majus 30 [hp_c] in 30 [hp_c] / carbon disulfide 30 [hp_c] in 30 [hp_c] / goldenseal 30 [hp_c] in 30 [hp_c] / hyoscyamus niger 30 [hp_c] in 30 [hp_c] / canis lupus familiaris milk 30 [hp_c] in 30 [hp_c] / nutmeg 30 [hp_c] in 30 [hp_c] / sulfur 30 [hp_c] in 30 [hp_c] oral spray [memory boost]||golden seal root||active_moiety_of
omeprazole 20 mg oral capsule, delayed release [omeprazole]||omep||active_moiety_of
spironolactone 5 g in 100 g / tretinoin 0.05 g in 100 g / niacinamide 2 g in 100 g topical gel||niacinamide preparation||active_moiety_of
amanita muscaria fruiting body 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / gold 20 [hp_x] in 1 ml / berberis aquifolium root bark 20 [hp_x] in 1 ml / dieffenbachia seguine 20 [hp_x] in 1 ml / candida albicans 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / conium maculatum flowering top 20 [hp_x] in 1 ml / graphite 20 [hp_x] in 1 ml / chamaelirium luteum root 20 [hp_x] in 1 ml / goldenseal 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / wood creosote 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / mercury 20 [hp_x] in 1 ml / hexaplex trunculus hypobranchial gland juice 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / sodium chloride 20 [hp_x] in 1 ml / nitric acid 20 [hp_x] in 1 ml / anemone pulsatilla 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / sulfur 20 [hp_x] in 1 ml / lycosa tarantula 20 [hp_x] in 1 ml / thuja occidentalis leafy twig 20 [hp_x] in 1 ml / zinc 20 [hp_x] in 1 ml / apis mellifera 11 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 11 [hp_x] in 1 ml oral liquid [v-fem care]||anemone pulsatilla whole||active_moiety_of
apap 500 mg / asa 500 mg / caffeine 65 mg oral powder||ácido acetilsalicílico||active_moiety_of
eucalyptol 0.92 mg in 1 ml / menthol 0.42 mg in 1 ml / methyl salicylate 0.60 mg in 1 ml / thymol 0.64 mg in 1 ml oral mouthwash [antiseptic]||cineole||active_moiety_of
aquilegia vulgaris 1 [hp_x] in 41 ml / avena sativa flowering top 1 [hp_x] in 41 ml / matricaria recutita 1 [hp_x] in 41 ml / arabica coffee bean 200 [hp_c] in 41 ml / cypripedium parvifolum root 3 [hp_x] in 41 ml / hops 3 [hp_x] in 41 ml / potassium phosphate, dibasic 12 [hp_x] in 41 ml / passiflora incarnata flowering top 1 [hp_x] in 41 ml / valerian 1 [hp_x] in 41 ml / zinc 12 [hp_x] in 41 ml oral liquid [sprayology sleepease]||product containing phosphate||active_moiety_of
ligustrum vulgare pollen 1 g in 20 ml subcutaneous injection, solution [privet pollen]||ligustrum pollen||active_moiety_of
docusate sodium, sodium 100 mg oral capsule||product containing docusate||active_moiety_of
aconitum napellus 6 [hp_c] in 33.3 mg / atropa belladonna 30 [hp_c] in 33.3 mg / calcium sulfide 30 [hp_c] in 33.3 mg / silicon dioxide 6 [hp_x] in 33.3 mg / mercurius solubilis 6 [hp_c] in 33.3 mg / sulfur 6 [hp_c] in 33.3 mg oral granule [equine respiratory relief]||ca+2||active_moiety_of
oryctolagus cuniculus hair extract 50 mg/ml injectable solution||oryctolagus cuniculus hair||active_moiety_of
pulsatilla vulgaris 2 [hp_x] in 1 ml / euphorbia resinifera resin 6 [hp_x] in 1 ml / luffa operculata fruit 6 [hp_x] in 1 ml / mercuric iodide 8 [hp_x] in 1 ml / silver nitrate 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (propiolactone inactivated) 11 [hp_x] in 1 ml / influenza a virus a/hong kong/4801/2014 x-263b (h3n2) hemagglutinin antigen (propiolactone inactivated) 11 [hp_x] in 1 ml / influenza b virus b/brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) 11 [hp_x] in 1 ml / sinusitisinum 17 [hp_x] in 1 ml / aspergillus niger var. niger 10 [hp_c] in 1 ml / candida albicans 10 [hp_c] in 1 ml / gallic acid monohydrate 10 [hp_c] in 1 ml / mucor racemosus 10 [hp_c] in 1 ml / escherichia coli 30 [hp_c] in 1 ml oral liquid [ent support]||silver cation||active_moiety_of
aspergillus nidulans allergenic extract 0.05 gm/ml injectable solution||aspergillus nidulans||active_moiety_of
estrogens, conjugated (usp) 0.9 mg oral tablet [premarin]||equine estrogen, conjugated||active_moiety_of
calendula officinalis flowering top 1 [hp_x] in 1 g / arnica montana 1 [hp_x] in 1 g / hypericum perforatum 1 [hp_x] in 1 g / comfrey root 3 [hp_x] in 1 g / bellis perennis 12 [hp_x] in 1 g / ledum palustre twig 12 [hp_x] in 1 g / sulfuric acid 12 [hp_x] in 1 g / calcium fluoride 30 [hp_x] in 1 g / ferrosoferric phosphate 30 [hp_x] in 1 g / toxicodendron pubescens leaf 30 [hp_x] in 1 g / ruta graveolens flowering top 30 [hp_x] in 1 g / sodium sulfate 30 [hp_c] in 1 g topical gel [trauma plus gel]||rhododendron tomentosum leafy twig||active_moiety_of
anti-interleukin-1.alpha. immunoglobulin g rabbit 9 [hp_x] in 1 ml / anti-interleukin-1.alpha. immunoglobulin g rabbit 30 {kp_c} in 1 ml / apomorphine 8 [hp_x] in 1 ml / apomorphine 30 {kp_c} in 1 ml / arnica montana 3 [hp_x] in 1 ml / metenkefalin 9 [hp_x] in 1 ml / metenkefalin 30 {kp_c} in 1 ml / bryonia alba root 4 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / bos taurus hypothalamus 5 [hp_x] in 1 ml / sus scrofa hypothalamus 5 [hp_x] in 1 ml / bos taurus limbic system 6 [hp_x] in 1 ml / bos taurus limbic system 200 {kp_c} in 1 ml / sus scrofa limbic system 6 [hp_x] in 1 ml / sus scrofa limbic system 200 {kp_c} in 1 ml / bos taurus nerve 6 [hp_x] in 1 ml / bos taurus nerve 30 {kp_c} in 1 ml / sus scrofa nerve 6 [hp_x] in 1 ml / sus scrofa nerve 30 {kp_c} in 1 ml / bos taurus pituitary gland 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml oral spray [ouch]||sus scrofa limbic system||active_moiety_of
aconitum napellus 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / activated charcoal 15 [hp_x] in 1 g / matricaria recutita 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / collinsonia canadensis root 15 [hp_x] in 1 g / citrullus colocynthis fruit pulp 15 [hp_x] in 1 g / ecballium elaterium fruit 15 [hp_x] in 1 g / gelsemium sempervirens root 15 [hp_x] in 1 g / ipecac 15 [hp_x] in 1 g / iris versicolor root 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / magnesium carbonate 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / podophyllum 15 [hp_x] in 1 g / rheum officinale whole 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / tobacco leaf 15 [hp_x] in 1 g / bilberry 15 [hp_x] in 1 g / horse chestnut 3 [hp_x] in 1 g / juglans regia whole 3 [hp_x] in 1 g / valerian 3 [hp_x] in 1 g oral pellet [diarrhea]||lycopodium clavatum spore||active_moiety_of
bicisate dihydrochloride 0.9 mg intravenous injection [neurolite vial a]||bicisate (substance)||active_moiety_of
apis mellifera 3 [hp_x] in 1 ml / betula pubescens bark 3 [hp_x] in 1 ml / betula pubescens leaf 3 [hp_x] in 1 ml / formica rufa 7 [hp_x] in 1 ml / silver 8 [hp_x] in 1 ml / arnica montana 17 [hp_x] in 1 ml oral liquid||silver drug||active_moiety_of
menthol 2.5 mg oral lozenge [halls honey chamomile]||menthol (product)||active_moiety_of
norgestimate 0.25 mg / ethinyl estradiol 0.035 mg oral tablet, film coated [femynor]||norgestimate (substance)||active_moiety_of
ascorbic acid/cyanocobalamin/ferrous asparto glycinate/folic acid/iron polysaccharide/stomach, desiccated/succinic acid/zinc 60 mg-25 mcg-50 mg-1 mg-100 mg-100 mg-50 mg-15 mg oral tablet [niferex]||butanedionic acid||active_moiety_of
dimethicone 50 ug in 1 mg topical cream [dimethicone]||dimeticone-containing product||active_moiety_of
camphor 55 mg/ml / menthol 55 mg/ml topical spray||synthetic camphor||active_moiety_of
benzalkonium chloride 0.2 g in 221 g topical soap [xtracare foam antibacterial hand wash vanilla passion flower]||product containing benzalkonium (medicinal product)||active_moiety_of
leader headache relief extra strength tablet||n-acetyl-p-aminophenol||active_moiety_of
arnica montana 3 [hp_x] in 1 ml / dieffenbachia seguine 6 [hp_x] in 1 ml / milk thistle 3 [hp_x] in 1 ml / turnera diffusa leafy twig 1 [hp_x] in 1 ml / galium aparine 3 [hp_x] in 1 ml / sus scrofa adrenal gland 12 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / asian ginseng 1 [hp_x] in 1 ml / lactuca virosa 3 [hp_x] in 1 ml / nuphar luteum root 2 [hp_x] in 1 ml / sus scrofa testicle 6 [hp_x] in 1 ml / phosphoric acid 200 [hp_c] in 1 ml / sus scrofa pituitary gland 12 [hp_x] in 1 ml / populus tremuloides bark 1 [hp_x] in 1 ml / populus tremuloides leaf 1 [hp_x] in 1 ml / testosterone 30 [hp_x] in 1 ml / thuja occidentalis leafy twig 200 [hp_c] in 1 ml / sus scrofa thymus 6 [hp_x] in 1 ml / thyroid, porcine 12 [hp_x] in 1 ml oral liquid [vital male sexual energy]||nuphar luteum root||active_moiety_of
dryopteris filix-mas root 1 [hp_x] in 1 ml / artemisia vulgaris root 2 [hp_x] in 1 ml / artemisia cina pre-flowering top 3 [hp_x] in 1 ml / melilotus officinalis top 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / spigelia anthelmia 3 [hp_x] in 1 ml / teucrium marum 3 [hp_x] in 1 ml / thymus serpyllum 3 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / schoenocaulon officinale seed 12 [hp_x] in 1 ml / ascaris lumbricoides 15 [hp_x] in 1 ml / trichinella spiralis 15 [hp_x] in 1 ml / enterobius vermicularis 33 [hp_x] in 1 ml / taenia solium 12 [hp_c] in 1 ml / trichomonas vaginalis 13 [hp_c] in 1 ml / giardia lamblia 18 [hp_c] in 1 ml / cryptosporidium parvum 20 [hp_c] in 1 ml / taenia saginata 20 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [ver]||quassia amara wood extract||active_moiety_of
octinoxate 0.372 g in 0.375 g / titanium dioxide 0.372 g in 0.375 g topical lotion [sun defense cream]||titanium(iv) oxide||active_moiety_of
solanum dulcamara top 4 [hp_x] in 1 ml / echinacea angustifolia 4 [hp_x] in 1 ml / horse chestnut 6 [hp_x] in 1 ml / antimony potassium tartrate 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / protortonia cacti 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / gentiana lutea root 6 [hp_x] in 1 ml / geranium robertianum 6 [hp_x] in 1 ml / anemone pulsatilla 6 [hp_x] in 1 ml / conium maculatum flowering top 6 [hp_x] in 1 ml / lactic acid, l- 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / phenylalanine 8 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / ferrosoferric phosphate 10 [hp_x] in 1 ml / pork liver 10 [hp_x] in 1 ml / sus scrofa hypothalamus 10 [hp_x] in 1 ml / sus scrofa spleen 10 [hp_x] in 1 ml / cortisone acetate 13 [hp_x] in 1 ml / mercurius solubilis 13 [hp_x] in 1 ml / barium carbonate 28 [hp_x] in 1 ml / glyphosate 1000 [hp_x] in 1 ml / sus scrofa umbilical cord 6 [hp_c] in 1 ml / sus scrofa tonsil 6 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 9 [hp_c] in 1 ml / liothyronine 10 [hp_c] in 1 ml / sus scrofa bone marrow 12 [hp_c] in 1 ml / bisphenol a 12 [hp_c] in 1 ml / bromine 12 [hp_c] in 1 ml / chlorine 12 [hp_c] in 1 ml / hydrofluoric acid 12 [hp_c] in 1 ml / iodine 12 [hp_c] in 1 ml / escherichia coli 30 [hp_c] in 1 ml oral liquid [d3 organ support]||asorbicap||active_moiety_of
arnica montana 4 [hp_x] in 113 g / cupric arsenite 10 [hp_x] in 113 g / copper 11 [hp_x] in 113 g / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 113 g / toxicodendron pubescens leaf 4 [hp_x] in 113 g topical cream [charley horse]||magnesium ion||active_moiety_of
arnica montana 3 [hp_x] in 1 ml / pork brain 6 [hp_x] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / cinchona officinalis bark 6 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / egg phospholipids 12 [hp_x] in 1 ml / achillea millefolium 3 [hp_x] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml oral spray [brain energy]||cinchona officinalis bark extract||active_moiety_of
vfend 200mg powder for injection (premier prorx)||voriconazole product||active_moiety_of
cochlearia officinalis flowering top 30 [hp_c] oral pellet [cochlearia officinalis]||cochlearia officinalis flowering top extract||active_moiety_of
palmitic acid 7.25 g in 30 ml / stearic acid 7.25 g in 30 ml / oleic acid 14.5 g in 30 ml / bismuth subcarbonate 1.89 g in 30 ml / boric acid 0.95 g in 30 ml topical ointment [sha-lem]||fatty acid 18:0||active_moiety_of
olea europaea pollen 0.05 g in 1 ml subcutaneous injection, solution [pollens - trees, olive olea europaea]||tree pollen-olive||active_moiety_of
menthol 10 mg / lidocaine 40 mg transdermal patch [zims max freeze]||lidocaína||active_moiety_of
zinc acetate anhydrous 2 [hp_x] / zinc gluconate 2 [hp_x] oral bar, chewable [zicam cold remedy medicated fruit drops]||zinc cation||active_moiety_of
aconitum napellus whole 200 [hp_c] in 1 ml / arnica montana whole 3 [hp_x] in 1 ml / bellis perennis whole 3 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / sus scrofa cartilage 6 [hp_x] in 1 ml / causticum 200 [hp_c] in 1 ml / matricaria chamomilla whole 3 [hp_x] in 1 ml / arabica coffee bean 200 [hp_c] in 1 ml / euphorbia resinifera resin 6 [hp_x] in 1 ml / pseudognaphalium obtusifolium whole 3 [hp_x] in 1 ml / hypericum perforatum whole 200 [hp_c] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / passiflora incarnata flowering top 1 [hp_x] in 1 ml / rancid beef 200 [hp_c] in 1 ml / ranunculus bulbosus whole 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml oral spray [pain]||pseudognaphalium obtusifolium||active_moiety_of
ibuprofen 400mg tablet||ibuprofen (substance)||active_moiety_of
garlic 10 [hp_x] in 59 ml / semecarpus anacardium juice 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / gamboge 10 [hp_x] in 59 ml / mercurius solubilis 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / nitric acid 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [allergy food andchemical relief]||phosphorus, nos||active_moiety_of
sunmark stool softener plus stimulant laxative 50mg-8.6mg tablet||senna (medication)||active_moiety_of
docusate sodium/benzocaine 283 mg-20 mg/5 ml rectal enema (ml)||benzocaine (medication)||active_moiety_of
zinc oxide 10 g in 100 ml topical emulsion [perfecting liquid foundation rosy beige spf 15]||zinc óxido||active_moiety_of
gabapentin 400 mg oral capsule [neurontin]||product containing gabapentin||active_moiety_of
arnica montana 18 [hp_x] in 4 g / bryonia alba root 8 [hp_x] in 4 g / matricaria recutita 8 [hp_x] in 4 g / hypericum perforatum 8 [hp_x] in 4 g / kalmia latifolia leaf 8 [hp_x] in 4 g / toxicodendron pubescens leaf 8 [hp_x] in 4 g sublingual pellet [arthritis relief]||bryonia alba root||active_moiety_of
zinc oxide 60 mg in 1 ml / titanium dioxide 23 mg in 1 ml topical cream [isa sunguard spf 30]||product containing titanium dioxide||active_moiety_of
aloe vera leaf 30 [hp_c] in 1 ml / aluminum oxide 30 [kp_c] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / barium carbonate 30 [hp_c] in 1 ml / bryonia alba root 30 [hp_c] in 1 ml / activated charcoal 30 [hp_c] in 1 ml / matricaria recutita 30 [hp_c] in 1 ml / potassium dichromate 30 [hp_c] in 1 ml / phosphorus 30 in 1 ml / lead 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / sulfur 30 [hp_c] in 1 ml oral liquid [lung large intestine meridian opener]||matricaria recutita||active_moiety_of
ammonium chloride 5 [hp_c] in 1 ml / juniper berry 7 [hp_c] in 1 ml / baptisia tinctoria root 4 [hp_c] in 1 ml / toxicodendron pubescens leaf 7 [hp_c] in 1 ml / adenosine triphosphate 5 [hp_x] in 1 ml / podophyllum resin 5 [hp_c] in 1 ml / colchicum autumnale bulb 7 [hp_c] in 1 ml / levothyroxine 4 [hp_c] in 1 ml sublingual solution/ drops [r08 lymphatics]||product containing podophyllum resin (medicinal product)||active_moiety_of
titanium dioxide 5.76 g in 100 g / zinc oxide 2.94 g in 100 g topical cream [super cc plus cream spf 30]||zn(ii)||active_moiety_of
oxygen 210 ml in 1 l / nitrogen 790 ml in 1 l respiratory (inhalation) gas [medical air compressed]||o element||active_moiety_of
garlic 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / cysteine 6 [hp_x] in 1 ml / methionine 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / chromium 8 [hp_x] in 1 ml / cobalt 8 [hp_x] in 1 ml / copper 8 [hp_x] in 1 ml / iron 8 [hp_x] in 1 ml / iodine 8 [hp_x] in 1 ml / iridium 8 [hp_x] in 1 ml / potassium carbonate 8 [hp_x] in 1 ml / lithium carbonate 8 [hp_x] in 1 ml / magnesium 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / molybdenum 8 [hp_x] in 1 ml / sodium chloride 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / strontium carbonate 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / vanadium 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / phenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / arsenic acid 1000 [hp_x] in 1 ml / mercurius solubilis 1000 [hp_x] in 1 ml / lead 1000 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [metdetox]||lead||active_moiety_of
methotrexate sodium 25 mg in 1 ml intra-arterial injection, solution||l-glutamic acid, n-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-||active_moiety_of
allantoin .5 g in 100 g / dimethicone 2 g in 100 g / menthol .45 g in 100 g topical cream [smart choice barrier]||menthol (medication)||active_moiety_of
gnp terbinafine hydrochloride 1% jock itch topical cream||terbinafina||active_moiety_of
nda020983 60 actuat albuterol 0.09 mg/actuat metered dose inhaler||bronchodilators albuterol||active_moiety_of
triticum aestivum whole 1 [hp_x] in 1 ml / alfalfa 3 [hp_x] in 1 ml / arnica montana 3 [hp_x] in 1 ml / asclepias tuberosa root 3 [hp_x] in 1 ml / matricaria recutita 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / eucalyptus globulus leaf 3 [hp_x] in 1 ml / fucus vesiculosus 3 [hp_x] in 1 ml / hordeum vulgare top 3 [hp_x] in 1 ml / iodine 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / plantago major 3 [hp_x] in 1 ml / raphanus sativus 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / trigonella foenum-graecum whole 3 [hp_x] in 1 ml / symphytum officinale whole 6 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / oryza sativa whole 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / acetone 9 [hp_x] in 1 ml / sodium tripolyphosphate 9 [hp_x] in 1 ml / propylene glycol 9 [hp_x] in 1 ml / benzene 9 [hp_x] in 1 ml / ammonium chloride 9 [hp_x] in 1 ml / sodium lauryl sulfate 9 [hp_x] in 1 ml / turpentine oil 9 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / oenanthe aquatica fruit 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml oral liquid [pneumotox]||arnica montana/leopard's ban||active_moiety_of
naphazoline hydrochloride/pheniramine maleate 0.027%-0.315% ophthalmic solution [opcon-a allergy]||prophenpyridamine||active_moiety_of
octinoxate 0.065 g in 1 g / zinc oxide 0.036 g in 1 g topical lotion [esika pro instant perfection 3 en 1 face refining foundation spf 25 medio 4 - beige]||zinc (as oxide)||active_moiety_of
allantoin 0.5 % / benzethonium chloride 0.1 % topical ointment||benzenemethanaminium, n,n-dimethyl-n-(2-(2-(4-(1,1,3,3-tetramethylbutyl)phenoxy)ethoxy)ethyl)-, chloride||active_moiety_of
influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / human herpesvirus 1 15 [hp_x] in 1 ml / human herpesvirus 2 15 [hp_x] in 1 ml / human herpesvirus 6 15 [hp_x] in 1 ml / human herpesvirus 5 18 [hp_x] in 1 ml / hepatitis b virus 33 [hp_x] in 1 ml / human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_c] in 1 ml / human adenovirus b serotype 7 strain 55142 antigen 12 [hp_c] in 1 ml / human herpesvirus 4 16 [hp_c] in 1 ml oral liquid [virus combination]||lymphocryptovirus||active_moiety_of
abilify 10 mg oral tablet||aripiprazole (medication)||active_moiety_of
ivermectin .136 mg / pyrantel pamoate .114 mg oral tablet, chewable [vetrishield plus flavored chewables (medium) 26 to 50 lbs]||imectro||active_moiety_of
topiramate 100mg tablet (substance)||tpm||active_moiety_of
product containing only cinacalcet 90 mg/1 each oral tablet (clinical drug)||sensipar||active_moiety_of
walgreens mucus relief dm 12 hour extended-release tablet||dextromethorphan product||active_moiety_of
cinchona officinalis bark 3 [hp_x] / bryonia alba root 4 [hp_x] / matricaria chamomilla whole 3 [hp_x] / citrullus colocynthis fruit pulp 4 [hp_x] / ipecac 4 [hp_x] / atropa belladonna whole 3 [hp_x] / potentilla anserina whole 1 [hp_x] oral pellet [diarrhea relief]||citrullus colocynthis fruit without seed||active_moiety_of
amyl nitrite 6 [hp_c] in 28 g / lachesis muta venom 6 [hp_c] in 28 g / sanguinaria canadensis root 6 [hp_c] in 28 g oral pellet [whp be gone hot flashes tm]||n-amyl nitrite||active_moiety_of
lidocaine/kinesiology tape@5 %@topical@combination package (ea)||lidocaine (substance)||active_moiety_of
benzocaine 20% oromucosal gel/jelly [good sense oral pain relief]||benzocaine (medication)||active_moiety_of
lactic acid, l- 3 [hp_x] / viscum album fruiting top 3 [hp_x] / iodine 3 [hp_x] / fucus vesiculosus 6 [hp_x] / galium aparine 6 [hp_x] / sus scrofa thyroid 6 [hp_x] / prasterone 6 [hp_x] / phenyl isothiocyanate 6 [hp_x] / tyramine 6 [hp_x] / adenosine triphosphate disodium 7 [hp_x] / oxogluric acid 7 [hp_x] / fumaric acid 7 [hp_x] / malic acid 7 [hp_x] / colchicum autumnale bulb 8 [hp_x] / conium maculatum flowering top 8 [hp_x] / sodium diethyl oxalacetate 8 [hp_x] / sus scrofa umbilical cord 8 [hp_x] / pork liver 8 [hp_x] / sus scrofa bone marrow 8 [hp_x] / sus scrofa pineal gland 8 [hp_x] / sus scrofa spleen 8 [hp_x] / sus scrofa thymus 8 [hp_x] / calcium fluoride 12 [hp_x] / anemone pulsatilla 12 [hp_x] / spongia officinalis skeleton, roasted 12 [hp_x] / cortisone acetate 30 [hp_x] / mercuric chloride 60 [hp_x] / liothyronine 15 [hp_c] / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] / escherichia coli 30 [hp_c] oral tablet [energize]||5-androsten-3-beta-hydroxy-17-one||active_moiety_of
homosalate 100 mg in 1 g / avobenzone 30 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 20 mg in 1 g topical spray [signature care sport spf 30 sunscreen]||homosalato||active_moiety_of
celecoxib 200 mg oral capsule||celebrex||active_moiety_of
baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / ambrosia artemisiifolia 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / euphrasia stricta 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml oral liquid [allerstat ii]||sulfur preparations (medication)||active_moiety_of
avobenzone 28 mg in 1 g / homosalate 95 mg in 1 g / octinoxate 75 mg in 1 g / octocrylene 25.6 mg in 1 g / oxybenzone 47.5 mg in 1 g topical lotion [anew clinical skinvincible multi-shield]||homosalatum||active_moiety_of
sanguinaria canadensis root 30 [hp_c] in 30 [hp_c] oral pellet [sanguinaria canadensis]||sanguinaria canadensis root||active_moiety_of
atropine sulfate + diphenoxylate hydrochloride 0.025mg/2.5mg tablet (product)||atropine (medication)||active_moiety_of
certolizumab pegol 400 mg (200 mg x 2) subcut kit||cimzia||active_moiety_of
aconitum napellus 200 [hp_c] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / arabica coffee bean 200 [hp_c] in 1 ml / dioscorea villosa root 3 [hp_x] in 1 ml / gelsemium sempervirens root 3 [hp_x] in 1 ml / pseudognaphalium obtusifolium 3 [hp_x] in 1 ml / iris versicolor root 3 [hp_x] in 1 ml / stellaria media 3 [hp_x] in 1 ml / verbascum thapsus 3 [hp_x] in 1 ml / passiflora incarnata top 2 [hp_x] in 1 ml oral spray [tension headache]||iris versicolor root extract||active_moiety_of
pramipexole dihydrochloride 0.5mg tablet (product)||2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole||active_moiety_of
clematis vitalba flower 30 [hp_c] in 59 ml / helianthemum nummularium flower 30 [hp_c] in 59 ml / impatiens glandulifera flower 30 [hp_c] in 59 ml / ornithogalum umbellatum 30 [hp_c] in 59 ml / prunus cerasifera flower 30 [hp_c] in 59 ml oral liquid [calm five]||helianthemum nummularium flower extract||active_moiety_of
chlorhexidine gluconate 1.2 [iu] in 1 ml buccal liquid [chlorhexidine gluconate 0.12% oral rinse]||chlorhexidine (substance)||active_moiety_of
zinc oxide 6.8 g in 100 ml / octinoxate 3 g in 100 ml topical cream [always foundation makeup broad spectrum spf 15 buff]||octylmethoxycinnamate||active_moiety_of
memantine hcl@21 mg@oral@capsule sprinkle, extended release 24 hr||tricyclo(3.3.1.13,7)decan-1-amine, 3,5-dimethyl-||active_moiety_of
megrix, 0.0375%-5% topical device||8 methyl n vanillyl 6 nonenamide||active_moiety_of
tylenol arthritis pain 650mg extended-relief caplet||product containing acetaminophen||active_moiety_of
mineral oil/petrolatum, white 42.5%-57.3% ophthalmic ointment [refresh pm]||paraffin-white soft [eye]||active_moiety_of
gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml / periplaneta americana 0.002 g in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / canis lupus familiaris hair 0.0004 g in 1 ml / felis catus hair 80 [bau] in 1 ml / ulmus americana pollen 0.0004 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / fraxinus americana pollen 0.0004 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / candida albicans 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml subcutaneous injection, solution||bermuda grass smut extract||active_moiety_of
capsaicin 0.34 mg in 1 ml / methyl salicylate 100 mg in 1 ml topical cream [perform atomic heat]||capsaicin||active_moiety_of
benzoyl peroxide 28.3 g in 100 g topical cream [ab skincare acne spot treatment]||benzyl peroxide||active_moiety_of
cetylpyridinium topical 0.07% mucous membrane liquid||cetyl pyridinium||active_moiety_of
titanium dioxide 1.2726 g in 14 g / octinoxate 0.98 g in 14 g / octocrylene 0.56 g in 14 g topical cream [age20s signature essence cover pact moisture 21 light beige]||titanium dioxide (product)||active_moiety_of
octinoxate 82.5 mg in 1 ml / octisalate 22 mg in 1 ml / titanium dioxide 58.3 mg in 1 ml topical cream [la mer the radiant skintint broad spectrum spf 30]||titanium dioxide (substance)||active_moiety_of
nicotine 21mg/24hours patch||(s)-(-)-nicotine||active_moiety_of
dextromethorphan-guaifenesin 20 mg-200 mg/20 ml oral liquid||dm||active_moiety_of
benzalkonium chloride 1 mg in 1 ml topical liquid [hand wash]||product containing benzalkonium||active_moiety_of
alcohol 80 ml in 100 ml topical solution [egx chemical]||alcohol, denatured||active_moiety_of
celecoxib 200mg cap ud||benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl]-||active_moiety_of
simethicone@80 mg@oral@tablet||dimethyl polysiloxane||active_moiety_of
bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 g / influenza a virus 30 [hp_x] in 1 g / rancid beef 30 [hp_x] in 1 g / bufo bufo cutaneous gland 15 [hp_x] in 1 g / aconitum napellus 10 [hp_x] in 1 g / amanita muscaria var. muscaria fruiting body 10 [hp_x] in 1 g / american ginseng 10 [hp_x] in 1 g / baptisia tinctoria 10 [hp_x] in 1 g / bryonia alba root 10 [hp_x] in 1 g / chelidonium majus 10 [hp_x] in 1 g / eupatorium perfoliatum flowering top 10 [hp_x] in 1 g / calcium sulfide 10 [hp_x] in 1 g / lachesis muta venom 10 [hp_x] in 1 g / lycopodium clavatum spore 10 [hp_x] in 1 g / strychnos nux-vomica seed 10 [hp_x] in 1 g / toxicodendron pubescens leaf 10 [hp_x] in 1 g / sanguinaria canadensis root 10 [hp_x] in 1 g / sulfur 10 [hp_x] in 1 g / thuja occidentalis leafy twig 10 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g / influenza b virus 30 [hp_x] in 1 g oral pellet [sick stopper]||thylox||active_moiety_of
salsola kali pollen extract 100 mg/ml injectable solution||russian thistle pollen extract||active_moiety_of
titanium dioxide 0.0624 g in 1 g / zinc oxide 0.049 g in 1 g / octinoxate 0.03 g in 1 g topical powder [lbel divine polvos compactos doble uso fps 15 edicion de lujo dorado/double use compact spf 15 gold deluxe edition medium 6]||paste, lassar's||active_moiety_of
almond 12 [hp_x] in 1 ml / cashew 12 [hp_x] in 1 ml / black walnut 12 [hp_x] in 1 ml / pecan 12 [hp_x] in 1 ml / coconut 12 [hp_x] in 1 ml / olive oil 12 [hp_x] in 1 ml / chinese chestnut 12 [hp_x] in 1 ml / trapa bicornis seed 12 [hp_x] in 1 ml / pine nut 12 [hp_x] in 1 ml / macadamia nut 12 [hp_x] in 1 ml / pistachio 12 [hp_x] in 1 ml / peanut 15 [hp_x] in 1 ml / english walnut 15 [hp_x] in 1 ml / brazil nut 15 [hp_x] in 1 ml / american hazelnut 15 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / anemone pulsatilla 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / mockernut 12 [hp_c] in 1 ml oral liquid [nut antigens]||black walnut||active_moiety_of
gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / felis catus hair 400 [bau] in 1 ml / dermatophagoides farinae 400 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / candida albicans 0.00008 g in 1 ml / aspergillus fumigatus 0.00008 g in 1 ml / fusarium oxysporum 0.00008 g in 1 ml / phoma destructiva 0.002 g in 1 ml / rhizopus stolonifer 0.00008 g in 1 ml subcutaneous injection, solution||aureobasidium pullulans var. pullutans allergenic extract||active_moiety_of
zestril 40 mg oral tablet, once-daily||l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-||active_moiety_of
brimonidine tartrate 0.2% e/d||brimonidine||active_moiety_of
matricaria chamomilla 6 [hp_x] in 1 g / sodium carbonate 15 [hp_x] in 1 g / iris versicolor root 6 [hp_x] in 1 g / ruta graveolens flowering top 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / aloe 15 [hp_x] in 1 g / angelica sinensis root 15 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / bismuth 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / goldenseal 15 [hp_x] in 1 g / ipecac 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / myrrh 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / ginger 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g oral pellet [indigestion-gas]||p element||active_moiety_of
alcohol 70 ml in 100 ml topical gel [st. tropica tropical touch beauty sanitizer]||ethyl alcohol-containing product||active_moiety_of
lamotrigine 100mg dispersible tablet (product)||1,2,4-triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-||active_moiety_of
alcohol 75 ml in 100 ml topical swab [wet wipe 12 pack]||äthylalkohol||active_moiety_of
health mart pain reliever pm extra strength caplet||p-acetylaminophenol||active_moiety_of
ulmus crassifolia pollen 20000 [pnu] in 1 ml intradermal solution [cedar elm pollen]||ulmus crassifolia pollen||active_moiety_of
calendula officinalis flowering top 2 [hp_x] in 1 g / echinacea, unspecified 2 [hp_x] in 1 g / origanum majorana whole 2 [hp_x] in 1 g / lilium lancifolium whole flowering 3 [hp_x] in 1 g / thuja occidentalis whole 3 [hp_x] in 1 g / wood creosote 6 [hp_x] in 1 g / pulsatilla vulgaris 6 [hp_x] in 1 g / silver 7 [hp_x] in 1 g / candida albicans 33 [hp_x] in 1 g topical gel||silver||active_moiety_of
oxygen 210 ml in 1 l nasal gas||oxygen 16||active_moiety_of
clobazam 2.5 mg/1 ml oral suspension [onfi]||clobazam (medication)||active_moiety_of
onion 1 [hp_x] oral granule [allium cepa]||onion allergenic extract||active_moiety_of
acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 30 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml oral liquid [night time cold/flu relief cherry]||p-hydroxyacetanilide||active_moiety_of
avobenzone 30 mg in 1 ml / homosalate 50 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [lancome paris renergie lift multiaction ultra firming and dark spot correcting moisturizer broad spectrum spf 30 sunscreen]||2-ethylhexyl-2-cyano-3,3-diphenylacrylate (substance)||active_moiety_of
oxygen .99 l in 1 l respiratory (inhalation) gas||oxygen||active_moiety_of
alcohol 75 ml in 100 ml topical gel [brookstone advanced hand sanitizer lemon zest]||1-hydroxyethane||active_moiety_of
sugar beet allergenic extract 0.05 gm/ml injectable solution||beta vulgaris allergenic extract||active_moiety_of
lipitor (as atorvastatin calcium) 20 mg oral tablet||atorvastatin - chemical (substance)||active_moiety_of
sodium chloride 9mg/ml injection (product)||chloride (substance)||active_moiety_of
guaifenesin 400 mg in 20 ml / dextromethorphan hydrobromide 20 mg in 20 ml / phenylephrine hydrochloride 10 mg in 20 ml oral liquid [mucus relief severe congestion and cough maximum strength]||dextromethorphan product||active_moiety_of
acyclovir sodium 500mg powder for solution for injection||aciclovir [skin] (substance)||active_moiety_of
alcohol 0.50 ml in 1 ml / lidocaine hydrochloride 20 mg in 1 ml topical cloth [sting relief]||éthanol||active_moiety_of
melilotus officinalis top 1 [hp_x] in 1 ml oral tincture [melilotus officinalis (n)]||melilotus officinalis||active_moiety_of
nitrous oxide 99 l in 100 l respiratory (inhalation) gas||nitrous oxide (substance)||active_moiety_of
gluconolactone 0.029 mg in 1.4 mg / epigallocatechin gallatyl glucoside 0.0007 mg in 1.4 mg / madecassoside 0.00001 mg in 1.4 mg topical patch [dr.plinus zero trouble]||epigallocatechin gallatyl glucoside||active_moiety_of
diphenhydramine hydrochloride 50 mg in 30 ml oral solution [up and up nighttime sleep aid]||rigidyl||active_moiety_of
aesculus carnea flower 10 [hp_x] in 59 ml / aloe 10 [hp_x] in 59 ml / euphorbia resinifera resin 10 [hp_x] in 59 ml / fagus sylvatica flowering top 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / juglans regia flowering top 10 [hp_x] in 59 ml / potassium chloride 10 [hp_x] in 59 ml / magnesium chloride 10 [hp_x] in 59 ml / achillea millefolium 10 [hp_x] in 59 ml / hydrochloric acid 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / spongia officinalis skeleton, roasted 10 [hp_x] in 59 ml / tin 10 [hp_x] in 59 ml / theridion curassavicum 10 [hp_x] in 59 ml oral liquid [reserved]||fagus sylvatica flowering top||active_moiety_of
homosalate 3 g in 100 g / avobenzone 2 g in 100 g / octisalate 4.5 g in 100 g / octocrylene 3 g in 100 g topical lotion [banana boat ultra sport sunscreen broad spectrum spf 15]||bmdbm cpd||active_moiety_of
product containing precisely atomoxetine (as atomoxetine hydrochloride) 25 milligram/1 each conventional release oral capsule (clinical drug)||(-)-tomoxetine||active_moiety_of
paracetamol 500 mg oral tablet||acetaminofén||active_moiety_of
goodsense esomeprazole magnesium 20mg delayed-release capsule||esomeprazole-containing product||active_moiety_of
podophyllum 5 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / niacinamide 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / colchicum autumnale bulb 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / bilberry 8 [hp_x] in 1 ml / norepinephrine 8 [hp_x] in 1 ml / aspirin 10 [hp_x] in 1 ml / adenosine triphosphate disodium 10 [hp_x] in 1 ml / anthraquinone 10 [hp_x] in 1 ml / histamine dihydrochloride 10 [hp_x] in 1 ml / magnesium gluconate 10 [hp_x] in 1 ml / nadide 10 [hp_x] in 1 ml / naphthoquine 10 [hp_x] in 1 ml / ubidecarenone 10 [hp_x] in 1 ml / pantothenic acid 10 [hp_x] in 1 ml / manganese phosphate, dibasic 15 [hp_x] in 1 ml / hydroquinone 3 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [bio cytotox phase]||mg+2||active_moiety_of
juglans regia leaf 6 [hp_x] in 1 ml / spigelia anthelmia 15 [hp_x] in 1 ml / thymol 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / artemisia cina pre-flowering top 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / dryopteris filix-mas root 15 [hp_x] in 1 ml / punica granatum root bark 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / artemisia abrotanum flowering top 15 [hp_x] in 1 ml / naphthalene 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / krameria lappacea root 15 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / schoenocaulon officinale seed 15 [hp_x] in 1 ml / santonin 15 [hp_x] in 1 ml / horse chestnut 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / turpentine oil 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / teucrium marum 15 [hp_x] in 1 ml / artemisia vulgaris root 15 [hp_x] in 1 ml oral liquid [parasites]||na+||active_moiety_of
prednisolone sodium phosphat + sulfacetamide sodium 2.5mg/100mg solution (product)||pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-||active_moiety_of
solidago canadensis pollen 20000 [pnu] in 1 ml intradermal solution [goldenrod]||canada goldenrod pollen extract||active_moiety_of
phytolacca americana root 1 [hp_x] in 1 g / comfrey leaf 3 [hp_x] in 1 g / bellis perennis 6 [hp_x] in 1 g / ledum palustre twig 6 [hp_x] in 1 g / ruta graveolens flowering top 6 [hp_x] in 1 g / magnesium phosphate, dibasic trihydrate 9 [hp_x] in 1 g / silicon dioxide 9 [hp_x] in 1 g topical gel [muscle ice]||comfrey root extract||active_moiety_of
apocynum cannabinum root 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / selenicereus grandiflorus stem 10 [hp_x] in 59 ml / convallaria majalis 10 [hp_x] in 59 ml / cypripedium parvifolum root 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / nitroglycerin 10 [hp_x] in 59 ml / naja naja venom 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / spigelia anthelmia 10 [hp_x] in 59 ml / spongia officinalis skeleton, roasted 10 [hp_x] in 59 ml oral liquid [heart regularity]||spigelia anthelmia whole preparation||active_moiety_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / milk thistle 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / taraxacum officinale flowering top 3 [hp_x] in 1 ml / trifolium pratense leaf 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / benzene 9 [hp_x] in 1 ml / acetone 9 [hp_x] in 1 ml / ammonium chloride 9 [hp_x] in 1 ml / propylene glycol 9 [hp_x] in 1 ml / sodium benzenesulfonate 9 [hp_x] in 1 ml / sodium lauryl sulfate 9 [hp_x] in 1 ml / sodium tripolyphosphate 9 [hp_x] in 1 ml / turpentine oil 9 [hp_x] in 1 ml / methyl alcohol 9 [hp_x] in 1 ml / chlorine 10 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml oral liquid [enviroclenz]||cl - chlorine||active_moiety_of
beta vulgaris 3 [hp_x] in 1 ml / peumus boldus leaf 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / petroselinum crispum 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bisphenol a 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / glyphosate 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / bacillus thuringiensis 12 [hp_x] in 1 ml / aspartame 30 [hp_x] in 1 ml / benzalkonium chloride 30 [hp_x] in 1 ml / formaldehyde 30 [hp_x] in 1 ml / methylene chloride 30 [hp_x] in 1 ml / methylparaben 30 [hp_x] in 1 ml / propylparaben 30 [hp_x] in 1 ml / sodium benzoate 30 [hp_x] in 1 ml / sodium citrate 30 [hp_x] in 1 ml / titanium dioxide 30 [hp_x] in 1 ml / zinc oxide 30 [hp_x] in 1 ml oral liquid [addiclenz]||zinc, nos||active_moiety_of
product containing precisely modafinil 200 milligram/1 each conventional release oral tablet||(-)-modafinil||active_moiety_of
matricaria chamomilla 6 [hp_x] in 1 g / sodium carbonate 15 [hp_x] in 1 g / iris versicolor root 6 [hp_x] in 1 g / ruta graveolens flowering top 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / aloe 15 [hp_x] in 1 g / angelica sinensis root 15 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / bismuth 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / goldenseal 15 [hp_x] in 1 g / ipecac 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / myrrh 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / ginger 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g oral pellet [indigestion-gas]||aloe (substance)||active_moiety_of
chelidonium majus 3 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_x] in 1 ml / iodine 4 [hp_x] in 1 ml / lycopus virginicus 4 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / cysteine 9 [hp_x] in 1 ml / manganese gluconate 10 [hp_x] in 1 ml / oxogluric acid 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / fumaric acid 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / anemone pulsatilla 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / eugenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lidocaine 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / titanium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / rubella virus 12 [hp_x] in 1 ml / mumps virus 30 [hp_x] in 1 ml / human coxsackievirus a2 33 [hp_c] in 1 ml / human coxsackievirus a7 33 [hp_c] in 1 ml / human coxsackievirus b1 33 [hp_c] in 1 ml / human coxsackievirus b3 33 [hp_c] in 1 ml / human coxsackievirus b4 33 [hp_c] in 1 ml oral liquid [oligo bio iodine]||rubulavirus mumps||active_moiety_of
aconitum napellus 10 [hp_x] in 120 ml / apis mellifera 10 [hp_x] in 120 ml / arnica montana 10 [hp_x] in 120 ml / arsenic trioxide 10 [hp_x] in 120 ml / atropa belladonna 10 [hp_x] in 120 ml / bellis perennis 10 [hp_x] in 120 ml / bryonia alba root 10 [hp_x] in 120 ml / calendula officinalis flowering top 10 [hp_x] in 120 ml / matricaria recutita 10 [hp_x] in 120 ml / clematis recta flowering top 10 [hp_x] in 120 ml / clematis vitalba flower 10 [hp_x] in 120 ml / ferrosoferric phosphate 10 [hp_x] in 120 ml / histamine dihydrochloride 10 [hp_x] in 120 ml / hypericum perforatum 10 [hp_x] in 120 ml / strychnos ignatii seed 10 [hp_x] in 120 ml / impatiens glandulifera flower 10 [hp_x] in 120 ml / ornithogalum umbellatum flowering top 10 [hp_x] in 120 ml / passiflora incarnata flowering top 10 [hp_x] in 120 ml / phosphorus 10 [hp_x] in 120 ml / prunus cerasifera flower 10 [hp_x] in 120 ml / toxicodendron pubescens leaf 10 [hp_x] in 120 ml / sulfur 10 [hp_x] in 120 ml / comfrey root 10 [hp_x] in 120 ml / veratrum album root 10 [hp_x] in 120 ml oral liquid [multi-stress control]||thylox||active_moiety_of
epinephrine 10 [hp_x] in 59 ml / chaste tree 10 [hp_x] in 59 ml / ailanthus altissima flowering twig 10 [hp_x] in 59 ml / aletris farinosa root 10 [hp_x] in 59 ml / dill 10 [hp_x] in 59 ml / bromus ramosus flower 10 [hp_x] in 59 ml / dieffenbachia seguine 10 [hp_x] in 59 ml / carpinus betulus flowering top 10 [hp_x] in 59 ml / clematis vitalba flower 10 [hp_x] in 59 ml / conium maculatum flowering top 10 [hp_x] in 59 ml / helleborus niger root 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / egg phospholipids 10 [hp_x] in 59 ml / mentha piperita 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / olea europaea flower 10 [hp_x] in 59 ml / nerium oleander leaf 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / tropaeolum majus 10 [hp_x] in 59 ml / xerophyllum asphodeloides 10 [hp_x] in 59 ml / zinc 10 [hp_x] in 59 ml oral liquid [sluggish mind]||dieffenbachia seguine whole||active_moiety_of
avobenzone 25.1 mg in 1 ml / homosalate 62.7 mg in 1 ml / octisalate 41.8 mg in 1 ml / octocrylene 23 mg in 1 ml / oxybenzone 16.7 mg in 1 ml topical spray [australian gold broad spectrum spf 30]||octocrilene||active_moiety_of
isopropyl alcohol 75 ml in 100 ml topical liquid [opi topical solution hand sanitizer non-sterile solution isopropyl alcohol antiseptic 75%]||propanol 02||active_moiety_of
rabeprazole sodium@20 mg@oral@tablet, delayed release (enteric coated)||rabeprazole-containing product||active_moiety_of
oxybenzone 4.50 g in 100 g / octinoxate 2.0 g in 100 g topical stick [beeswax lip balm spf 15]||oxibenzona||active_moiety_of
amaranthus retroflexus pollen 0.00033 g in 1 ml / ambrosia trifida pollen 0.0000044 g in 1 ml / ambrosia artemisiifolia pollen 0.0000044 g in 1 ml / ambrosia psilostachya pollen 0.0000044 g in 1 ml / quercus alba pollen 0.00033 g in 1 ml / cladosporium cladosporioides 0.00017 g in 1 ml / poa pratensis pollen 133.33 [bau] in 1 ml / cynodon dactylon pollen 66.67 [bau] in 1 ml / candida albicans 0.00017 g in 1 ml / aspergillus fumigatus 0.00017 g in 1 ml / sorghum halepense pollen 0.00033 g in 1 ml / ustilago cynodontis 0.000415 g in 1 ml / sporisorium cruentum 0.000415 g in 1 ml / pleospora herbarum 0.00083 g in 1 ml / aureobasidium pullulans var. pullutans 0.00083 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00083 g in 1 ml / periplaneta americana 0.00083 g in 1 ml / ustilago nuda hordei 0.00021 g in 1 ml / ustilago maydis 0.00021 g in 1 ml / ustilago avenae 0.00021 g in 1 ml / ustilago tritici 0.00021 g in 1 ml / rhizopus stolonifer 0.00083 g in 1 ml / phoma destructiva 0.00083 g in 1 ml / dermatophagoides pteronyssinus 166.67 [au] in 1 ml / canis lupus familiaris hair 0.00083 g in 1 ml / alternaria alternata 0.00083 g in 1 ml / dermatophagoides farinae 166.67 [au] in 1 ml / felis catus hair 33.33 [bau] in 1 ml / gallus gallus feather 0.00028 g in 1 ml / anas platyrhynchos feather 0.00028 g in 1 ml / anser anser feather 0.00028 g in 1 ml intradermal injection, solution||duck feathers extract (product)||active_moiety_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [cold and flu night]||delta-methorphan||active_moiety_of
apis mellifera 30 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / barium carbonate 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / cicuta virosa root 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / iron 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / mercurius solubilis 30 [hp_c] in 1 ml / sodium sulfate 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / pulsatilla vulgaris 30 [hp_c] in 1 ml / sepia officinalis juice 30 [hp_c] in 1 ml / lycosa tarantula 30 [hp_c] in 1 ml / thuja occidentalis leafy twig 30 [hp_c] in 1 ml oral liquid [governing vessel conception vessel meridian opener]||pulsatilla vulgaris whole||active_moiety_of
beta carotene 600 [iu] / vitamin a acetate 1100 [iu] / ascorbic acid 60 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, dl- 30 [iu] / thiamine mononitrate 1.6 mg / riboflavin 1.8 mg / niacinamide 15 mg / pyridoxine hydrochloride 2.5 mg / folic acid 0.4 mg / levomefolate calcium 0.6 mg / cobalamin 5 ug / iron 29 mg / magnesium oxide 25 mg / zinc oxide 15 mg oral tablet, coated [select-ob]||vitamin b6||active_moiety_of
octinoxate 0.075 g in 1 ml / octisalate 0.04 g in 1 ml / oxybenzone 0.04 g in 1 ml topical lotion [lbel hydra calme spf 15]||octyl salicylate (substance)||active_moiety_of
lisinopril@40 mg@oral@tablet||l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-||active_moiety_of
ambrosia trifida pollen 0.00013 g in 1 ml / ambrosia artemisiifolia pollen 0.00013 g in 1 ml / ambrosia psilostachya pollen 0.00013 g in 1 ml / periplaneta americana 0.0004 g in 1 ml / gallus gallus feather 0.00013 g in 1 ml / anas platyrhynchos feather 0.00013 g in 1 ml / anser anser feather 0.00013 g in 1 ml / dermatophagoides farinae 3.2 [au] in 1 ml / dermatophagoides pteronyssinus 3.2 [au] in 1 ml / canis lupus familiaris hair 0.0004 g in 1 ml / felis catus hair 80 [bau] in 1 ml / ulmus americana pollen 0.0004 g in 1 ml / plantago lanceolata pollen 0.0004 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / poa pratensis pollen 32 [bau] in 1 ml / alternaria alternata 0.0004 g in 1 ml / cladosporium cladosporioides 0.0004 g in 1 ml / betula nigra pollen 0.0004 g in 1 ml / populus deltoides pollen 0.0004 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / aureobasidium pullulans var. pullutans 0.0004 g in 1 ml / kochia scoparia pollen 0.0004 g in 1 ml / candida albicans 0.0004 g in 1 ml subcutaneous injection, solution||weed pollen-giant (tall) ragweed||active_moiety_of
alcohol 0.659 ml in 1 ml topical cloth [pdi sani-hands for kids antimicrobial alcohol gel hand wipes]||ethanol||active_moiety_of
colax, 5 mg oral delayed release tablet||desacetylbisacodyl||active_moiety_of
sargramostim 500 ug in 1 ml subcutaneous injection, solution [leukine]||gm-csf||active_moiety_of
avobenzone 20 mg in 1 g / octinoxate 60 mg in 1 g / octocrylene 27 mg in 1 g / oxybenzone 20 mg in 1 g topical cream [revive fermitif neck renewal broad spectrum spf 15 sunscreen]||omc cinnamate||active_moiety_of
ranitidine hydrochloride 150 mg oral tablet [equaline]||product containing ranitidine||active_moiety_of
ginkgo 6 [hp_x] in 1 ml / oxogluric acid 8 [hp_x] in 1 ml / anhydrous citric acid 8 [hp_x] in 1 ml / fumaric acid 8 [hp_x] in 1 ml / malic acid 8 [hp_x] in 1 ml / pyruvic acid 8 [hp_x] in 1 ml / succinic acid 8 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / mercury 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pork kidney 12 [hp_x] in 1 ml / sus scrofa lymph 12 [hp_x] in 1 ml / 1,2-naphthoquinone 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / sus scrofa urinary bladder 12 [hp_x] in 1 ml / aconitic acid, (z)- 30 [hp_x] in 1 ml oral liquid [kidnex iv]||citric acid, anhydrous||active_moiety_of
calendula officinalis flowering top 3 [hp_x] / atropa belladonna 17 [hp_x] / beef tongue 17 [hp_x] / bos taurus bone 17 [hp_x] / sus scrofa tooth 17 [hp_x] / silver 20 [hp_x] / silicon dioxide 30 [hp_x] oral pellet||porcine tooth preparation||active_moiety_of
cichorium intybus flower 12 [hp_c] in 1 ml / aesculus hippocastanum flower 12 [hp_c] in 1 ml / palladium 15 [hp_c] in 1 ml / pulsatilla vulgaris 15 [hp_c] in 1 ml / ornithogalum umbellatum flowering top 12 [hp_c] in 1 ml / juglans regia flowering top 12 [hp_c] in 1 ml / strychnos ignatii seed 20 [hp_c] in 1 ml / lachesis muta venom 20 [hp_c] in 1 ml / gelsemium sempervirens root 12 [hp_c] in 1 ml / agrimonia eupatoria flower 12 [hp_c] in 1 ml / eucalyptus globulus leaf 12 [hp_c] in 1 ml / mimulus guttatus flowering top 12 [hp_c] in 1 ml / petunia axillaris whole 12 [hp_c] in 1 ml / trillium chloropetalum whole 12 [hp_c] in 1 ml / zinnia elegans whole 12 [hp_c] in 1 ml / arsenic trioxide 7 [hp_c] in 1 ml / sodium chloride 20 [hp_c] in 1 ml / arnica montana 15 [hp_c] in 1 ml / arnica montana flower 12 [hp_c] in 1 ml / dicentra formosa whole 12 [hp_c] in 1 ml / populus tremula flowering top 12 [hp_c] in 1 ml / fuchsia magellanica whole 12 [hp_c] in 1 ml / cytisus scoparius flower 12 [hp_c] in 1 ml / artemisia tridentata whole 12 [hp_c] in 1 ml / matricaria chamomilla flowering top 15 [hp_c] in 1 ml / ehrendorferia chrysantha whole 12 [hp_c] in 1 ml / larix decidua flowering top 12 [hp_c] in 1 ml / cornus nuttallii whole 12 [hp_c] in 1 ml / lonicera caprifolium flower 12 [hp_c] in 1 ml / aesculus carnea flower 12 [hp_c] in 1 ml / eriodictyon californicum flowering top 12 [hp_c] in 1 ml sublingual solution/ drops [f27 mvon]||zinnia elegans whole extract||active_moiety_of
sodium tetrachloroaurate 10 [hp_m] oral pellet||tetrachloroaurate ion||active_moiety_of
valacyclovir hydrochloride 1 gm oral tablet||aciclovir - chemical (substance)||active_moiety_of
fagopyrum esculentum 3 [hp_x] in 1 ml / magnesium chloride 3 [hp_x] in 1 ml / citrus bioflavonoids 8 [hp_x] in 1 ml / pork heart 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / arsenic triiodide 12 [hp_x] in 1 ml / gold trichloride 12 [hp_x] in 1 ml / barium chloride dihydrate 12 [hp_x] in 1 ml / calcium iodide 12 [hp_x] in 1 ml / cholesterol 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / arnica montana 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml oral liquid [circulatone]||iodide ion||active_moiety_of
ambrosia artemisiifolia pollen extract 20000 pnu/ml / ambrosia trifida pollen extract 20000 pnu/ml injectable solution||ambrosia trifida pollen||active_moiety_of
oxygen 0.99 kg in 1 kg respiratory (inhalation) gas [oxygen refrigerated liquid]||o>2<||active_moiety_of
ibuprofen 200 mg oral tablet, coated||(±)-ibuprofen||active_moiety_of
acetaminophen 325 mg and tramadol 37.5 mg oral tablet||product containing tramadol||active_moiety_of
acetaminophen 325 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, coated [pressure pain mucus]||analgesics acetaminophen||active_moiety_of
cepacol sore throat plus cough (benzocaine 7.5 mg / dextromethorphan hydrobromide 5 mg) oral lozenge||benzocaine (otic) (medication)||active_moiety_of
octocrylene 5 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml / homosalate 2 g in 100 ml / avobenzone 3 g in 100 ml topical cream [spa pharma olive oil moisturizing cream]||octocrilene product||active_moiety_of
bombyx mori fiber allergenic extract 100 mg/ml injectable solution||silk allergenic extract||active_moiety_of
dimethicone 1.2% topical application lotion [aveeno skin relief moisturizing]||dimeticone (substance)||active_moiety_of
acetaminophen/dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride 325 mg-10 mg-200 mg-5 mg oral tablet [leader severe congestion pain relief cold]||guaifenesin (medication)||active_moiety_of
camphor (synthetic) 4.7 g in 100 g / menthol 1.25 g in 100 g / eucalyptus oil 1.2 g in 100 g topical ointment [personal care vaporizing chestrub]||menthol (medication)||active_moiety_of
epinephrine 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / mahonia aquifolium root bark 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / crotalus horridus horridus venom 15 [hp_x] in 1 ml / digitalis 15 [hp_x] in 1 ml / iron 15 [hp_x] in 1 ml / nitroglycerin 15 [hp_x] in 1 ml / glycyrrhiza glabra 15 [hp_x] in 1 ml / centella asiatica 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml oral liquid [energy complex]||chelidonium majus whole extract||active_moiety_of
menthol 7.6 mg oral lozenge [medique medikoff drops]||menthol||active_moiety_of
daptomycin 350 mg intravenous powder for solution||daptomycin (product)||active_moiety_of
sulfamethoxazole 800 mg in 28 / trimethoprim 160 mg in 28 oral tablet||sulfamethoxazole product||active_moiety_of
titanium dioxide 60 mg in 1 ml / zinc oxide 60 mg in 1 ml topical cream [koa protect our ocean life oxybenzone free broad spectrum spf 30 uva uvb protection sunscreen]||zn2+||active_moiety_of
formaldehyde 0.40 kg in 1 kg topical solution [formaldehyde 37% inhibited 7-12% methanol]||product containing formaldehyde (medicinal product)||active_moiety_of
cyanocobalamin 1mg/1ml injection||product containing vitamin b12 (product)||active_moiety_of
benzalkonium chloride 0.0013 g in 1 ml topical swab||product containing benzalkonium||active_moiety_of
aluminum zirconium octachlorohydrex gly 14.4 g in 75 g topical stick [sport anti-perpirant sportstick molton brown london]||aluminum zirconium octachlorohydrex gly||active_moiety_of
lidocaine/menthol 4%-4% topical application patch, extended release [lidocaine-menthol]||lidocaine||active_moiety_of
geranium robertianum 4 [hp_x] in 1.1 ml / rorippa nasturtium-aquaticum 4 [hp_x] in 1.1 ml / ferrous iodide 12 [hp_x] in 1.1 ml / juglans regia flowering top 3 [hp_x] in 1.1 ml / myosotis arvensis 3 [hp_x] in 1.1 ml / scrophularia nodosa 3 [hp_x] in 1.1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1.1 ml / veronica officinalis flowering top 3 [hp_x] in 1.1 ml / equisetum hyemale 4 [hp_x] in 1.1 ml / fumaria officinalis flowering top 4 [hp_x] in 1.1 ml / sodium sulfate 4 [hp_x] in 1.1 ml / pinus sylvestris top 4 [hp_x] in 1.1 ml / gentiana lutea root 5 [hp_x] in 1.1 ml / araneus diadematus 6 [hp_x] in 1.1 ml / sarsaparilla 6 [hp_x] in 1.1 ml / tribasic calcium phosphate 12 [hp_x] in 1.1 ml / levothyroxine 12 [hp_x] in 1.1 ml intradermal injection [lymphomyosot]||sodium ion||active_moiety_of
tilletia caries 40000 [pnu] in 1 ml intradermal injection, solution||wheat smut allergenic extract||active_moiety_of
cyclophosphamide 2g/100ml infusion (substance)||cyclophosphamide anhydrous||active_moiety_of
benazepril hydrochloride 10 mg oral tablet, film coated [benazepril hydrochloride]||benazeprilat||active_moiety_of
arnica montana 1.5 [hp_c] in 30 ml / arsenic trioxide 200 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / echinacea, unspecified 1.5 [hp_c] in 30 ml / hamamelis virginiana leaf 1.5 [hp_c] in 30 ml / chamaelirium luteum root 1.5 [hp_c] in 30 ml / pork liver 3 [hp_c] in 30 ml / iris versicolor root 3 [hp_c] in 30 ml / sus scrofa pancreas 3 [hp_c] in 30 ml / phosphoric acid 200 [hp_c] in 30 ml / rosmarinus officinalis flowering top 1.5 [hp_c] in 30 ml / claviceps purpurea sclerotium 30 [hp_c] in 30 ml / syzygium cumini seed 1.5 [hp_c] in 30 ml / uranyl nitrate hexahydrate 30 [hp_c] in 30 ml oral spray [diabetigen]||chamaelirium luteum root||active_moiety_of
acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 30 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml oral solution [cold and flu]||doxylamine (medication)||active_moiety_of
betula pendula bark 1 [hp_x] in 1 ml / caltha palustris 3 [hp_x] in 1 ml / galium aparine 3 [hp_x] in 1 ml / thuja occidentalis leafy twig 3 [hp_x] in 1 ml / urtica urens 3 [hp_x] in 1 ml / clematis recta flowering top 4 [hp_x] in 1 ml / hedera helix flowering twig 4 [hp_x] in 1 ml / juniper berry 4 [hp_x] in 1 ml / sempervivum tectorum leaf 4 [hp_x] in 1 ml / echinacea angustifolia 5 [hp_x] in 1 ml / garlic 6 [hp_x] in 1 ml / silver 8 [hp_x] in 1 ml / calcium fluoride 8 [hp_x] in 1 ml / nitric acid 8 [hp_x] in 1 ml / sedum acre 8 [hp_x] in 1 ml / phosphorus 9 [hp_x] in 1 ml / apis mellifera 12 [hp_x] in 1 ml / rancid beef 12 [hp_x] in 1 ml / ononis spinosa whole 5 [hp_c] in 1 ml oral liquid [healing support]||echinacea angustifolia whole extract||active_moiety_of
spinach 1 g in 20 ml percutaneous injection, solution [spinach]||spinach allergenic extract||active_moiety_of
midazolam hydrochloride 2mg/1ml oral syrup||4h-imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-||active_moiety_of
plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula populifolia pollen 0.002 g in 1 ml / acer negundo pollen 0.0004 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml subcutaneous injection, solution||populus deltoides ssp. deltoides pollen extract||active_moiety_of
hydrocortisone 1 g in 100 ml topical lotion [vetergen hydrocortisone]||hydrocortisone preparation||active_moiety_of
acer negundo pollen 0.0000133 g in 1 ml / carya alba pollen 0.0000066 g in 1 ml / carya illinoinensis pollen 0.0000066 g in 1 ml / sorghum halepense pollen 0.0000133 g in 1 ml / cynodon dactylon pollen 2.67 [bau] in 1 ml / poa pratensis pollen 26.67 [bau] in 1 ml / populus deltoides pollen 0.0000133 g in 1 ml / rumex acetosella pollen 0.0000133 g in 1 ml / ambrosia trifida pollen 0.0000066 g in 1 ml / ambrosia artemisiifolia pollen 0.0000066 g in 1 ml / salsola kali pollen 0.0000133 g in 1 ml / plantago lanceolata pollen 0.0000133 g in 1 ml / iva annua var. annua pollen 0.00033 g in 1 ml / kochia scoparia pollen 0.0000133 g in 1 ml / amaranthus retroflexus pollen 0.0000133 g in 1 ml / chenopodium album pollen 0.0000133 g in 1 ml / ulmus americana pollen 0.0000133 g in 1 ml / quercus alba pollen 0.0000133 g in 1 ml / betula nigra pollen 0.0000133 g in 1 ml / fraxinus americana pollen 0.0000133 g in 1 ml / juniperus virginiana pollen 0.0000133 g in 1 ml intradermal injection, solution||russian thistle pollen extract||active_moiety_of
horse chestnut 4 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / echinacea angustifolia 2 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 4 [hp_x] in 1 ml / hydrofluoric acid 8 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / claviceps purpurea sclerotium 6 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml oral liquid [varicose vein complex]||claviceps purpurea sclerotium||active_moiety_of
baccharis sarothroides whole 10000 [pnu] in 1 ml / baccharis halimifolia pollen 10000 [pnu] in 1 ml intradermal solution [baccharis]||baccharis sarothroides whole allergenic extract||active_moiety_of
aminocaproic acid 250 mg/ml injectable solution||aminocaproic acid-containing product||active_moiety_of
acetaminophen 325 mg / dextromethorphan hbr 10 mg / guaifenesin 200 mg / phenylephrine hcl 5 mg per 15 ml oral solution||benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (r)-||active_moiety_of
product containing only acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg/1 each oral capsule||p-acetamidophenol||active_moiety_of
corticotropin 30 [hp_x] in 1 ml / .gamma.-aminobutyric acid 3 [hp_c] in 1 ml / glutamic acid 3 [hp_c] in 1 ml / norepinephrine 30 [hp_c] in 1 ml / acetylcholine chloride 1 [hp_m] in 1 ml / epinephrine 1 [hp_m] in 1 ml / serotonin 1 [hp_m] in 1 ml / thyroid 12 [hp_c] in 1 ml / barium carbonate 200 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 200 [hp_c] in 1 ml / datura stramonium 1 [hp_m] in 1 ml / semecarpus anacardium juice 200 [hp_c] in 1 ml / levodopa 1 [hp_m] in 1 ml oral spray [neuro balance pro]||(r)-(-)-epinephrine||active_moiety_of
alcohol 75 ml in 100 ml topical cloth [rightcare alcohol hand sanitizing wipes]||ethyl alcohol product||active_moiety_of
arsenic trioxide 12 [hp_x] in 59 ml / bryonia alba root 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / goldenseal 12 [hp_x] in 59 ml / lycopodium clavatum spore 12 [hp_x] in 59 ml / sodium chloride 12 [hp_x] in 59 ml / pulsatilla vulgaris 12 [hp_x] in 59 ml / schoenocaulon officinale seed 12 [hp_x] in 59 ml / claviceps purpurea sclerotium 12 [hp_x] in 59 ml / sulfur 12 [hp_x] in 59 ml oral spray [allergyease grain and gluten]||arsenic cation (3)||active_moiety_of
amyl nitrite 6 [hp_c] in 28 g / lachesis muta venom 6 [hp_c] in 28 g / sanguinaria canadensis root 6 [hp_c] in 28 g oral pellet [whp be gone hot flashes tm]||red puccoon root||active_moiety_of
diphenhydramine hydrochloride 2 g in 100 g / zinc acetate 0.1 g in 100 g topical cream [anti itch and skin protectant]||zinc-containing product||active_moiety_of
quercus alba pollen 40000 [pnu] in 1 ml subcutaneous injection, solution [quercus alba pollen]||white oak pollen extract||active_moiety_of
ee/norethin fe(eqv-loestrin fe 1/20),28||norethisterone (substance)||active_moiety_of
lovastatin 40mg tab||6alpha-methylcompactin||active_moiety_of
atropine sulfate 6 [hp_x] / aconitum napellus 4 [hp_x] / bryonia alba root 4 [hp_x] / citrullus colocynthis fruit pulp 4 [hp_x] / cupric sulfate 6 [hp_x] oral tablet [bhi spasm pain]||citrullus colocynthis fruit pulp||active_moiety_of
octinoxate 0.066 g in 1 g / oxybenzone 0.015 g in 1 g topical lipstick [esika extreme moisturizing spf 16 (rosa esplendor) - pink]||octyl methoxycinnamate (substance)||active_moiety_of
agrimonia eupatoria flower 10 [hp_x] in 10 ml / semecarpus anacardium juice 10 [hp_x] in 10 ml / gold 10 [hp_x] in 10 ml / avena sativa flowering top 10 [hp_x] in 10 ml / borage 10 [hp_x] in 10 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 10 ml / capsicum 10 [hp_x] in 10 ml / carpinus betulus flowering top 10 [hp_x] in 10 ml / black cohosh 10 [hp_x] in 10 ml / cinchona officinalis bark 10 [hp_x] in 10 ml / hypericum perforatum 10 [hp_x] in 10 ml / strychnos ignatii seed 10 [hp_x] in 10 ml / potassium bromide 10 [hp_x] in 10 ml / larix decidua flowering top 10 [hp_x] in 10 ml / sodium carbonate 10 [hp_x] in 10 ml / sodium sulfate 10 [hp_x] in 10 ml / phosphoric acid 10 [hp_x] in 10 ml / phosphorus 10 [hp_x] in 10 ml / pulsatilla vulgaris 10 [hp_x] in 10 ml / sepia officinalis juice 10 [hp_x] in 10 ml / sinapis arvensis flowering/fruiting top 10 [hp_x] in 10 ml / tobacco leaf 10 [hp_x] in 10 ml oral liquid [good mood enhancer]||agrimonia eupatoria flower extract||active_moiety_of
dm/acetaminophen/doxylamine 15 mg-325 mg-6.25 mg oral capsule||doxilamina||active_moiety_of
apap 325 mg / oxycodone hydrochloride 7.5 mg oral tablet [endocet]||4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one||active_moiety_of
isopropyl alcohol 0.75 ml in 1 ml topical gel [verasteril advanced hand sanitizer]||alcohol,isopropyl||active_moiety_of
cvs nicotine polacrilex 4mg chewing gum (fruit)||(s)-3-(n-methylpyrrolidin-2-yl)pyridine||active_moiety_of
epinephrine 6 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_x] in 1 ml / bos taurus pituitary gland 6 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / cortisone acetate 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / zanthoxylum americanum bark 30 [hp_c] in 1 ml oral liquid [stress / fatigue]||arsenic cation (3)||active_moiety_of
aggrenox 25/200 12hr extended release oral capsule||dipyramidole||active_moiety_of
alcohol 68 ml in 100 ml topical gel [anti-bacterial hand sunshine and lemons]||product containing ethanol (medicinal product)||active_moiety_of
magnesium sulfate 100% powder for solution [leader epsom salt]||mg+2||active_moiety_of
benzalkonium chloride 1 mg in 1 g topical cloth [gsd good hygiene defense wet wipes]||alocane max strength||active_moiety_of
cinnamon allergenic extract 0.05 gm/ml injectable solution||cinnamomum spp. extract||active_moiety_of
agrostis gigantea pollen 20000 [bau] in 1 ml / poa pratensis pollen 20000 [bau] in 1 ml / anthoxanthum odoratum pollen 20000 [bau] in 1 ml / dactylis glomerata pollen 20000 [bau] in 1 ml / phleum pratense pollen 20000 [bau] in 1 ml percutaneous solution [k-o-r-t and sweet vernal standardized grass pollen mix]||oralair 100||active_moiety_of
uad otic, 1%-0.35%-10000 units/ml otic suspension||neomycin||active_moiety_of
niacinamide 2 g in 100 g topical liquid [limulus bio cellulose mask whitening]||niacinamide product||active_moiety_of
echinacea, unspecified 6 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / passiflora incarnata flowering top 6 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / epinephrine 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / matricaria chamomilla 15 [hp_x] in 1 ml / arabica coffee bean 15 [hp_x] in 1 ml / cypripedium parviflorum var. pubescens root 15 [hp_x] in 1 ml / digitalis 15 [hp_x] in 1 ml / hyoscyamus niger 15 [hp_x] in 1 ml / strychnos ignatii seed 15 [hp_x] in 1 ml / impatiens glandulifera flower 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / scutellaria lateriflora whole 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / datura stramonium 15 [hp_x] in 1 ml / citharacanthus spinicrus 15 [hp_x] in 1 ml / theridion curassavicum 15 [hp_x] in 1 ml / veratrum viride root 15 [hp_x] in 1 ml / hops 15 [hp_x] in 1 ml / hypericum perforatum 6 [hp_x] in 1 ml oral liquid [hypercalm-mental focus]||humulus lupulus extract (substance)||active_moiety_of
amoxicillin-clavulanate 875 mg-125 mg oral tablet||amoxicillin anhydrous||active_moiety_of
atropa belladonna 200 [hp_c] in 1 ml / lytta vesicatoria 200 [hp_c] in 1 ml / causticum 200 [hp_c] in 1 ml / artemisia cina pre-flowering top 6 [hp_x] in 1 ml / equisetum hyemale 3 [hp_x] in 1 ml / strychnos ignatii seed 200 [hp_c] in 1 ml / physalis alkekengi fruit 3 [hp_x] in 1 ml / sepia officinalis juice 200 [hp_c] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / verbascum thapsus 3 [hp_x] in 1 ml oral liquid [bedwetting]||cantharis||active_moiety_of
morphine sulfate 60mg m/r capsule (substance)||product containing morphine (medicinal product)||active_moiety_of
dimethicone 1 g in 100 g / octinoxate 7.5 g in 100 g / oxybenzone 2.5 g in 100 g topical stick [fruit smoothies berry explosion]||product containing dimeticone (medicinal product)||active_moiety_of
product containing only mirtazapine 7.5 mg/1 each oral tablet||mirtazapine product||active_moiety_of
arsenic trioxide 15 [hp_x] in 1 ml / calcium iodide 15 [hp_x] in 1 ml / carbo animalis 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / wood creosote 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / juniperus sabina leafy twig 15 [hp_x] in 1 ml / claviceps purpurea sclerotium 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / capsella bursa-pastoris 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / trillium erectum root 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml oral liquid [female fibroids]||claviceps purpurea sclerotium||active_moiety_of
focalin (dexmethylphenidate hydrochloride 2.5 mg) oral tablet||dexmethylphenidate (product)||active_moiety_of
alcohol 70 ml in 100 ml topical gel [liquidproof gel hand sanitizer]||alcohol,ethyl||active_moiety_of
glipizide 10mg ud tab||glydiazinamide||active_moiety_of
cetirizine hydrochloride 5 mg / pseudoephedrine hydrochloride 120 mg oral tablet, extended release [signature care allergy relief d]||product containing cetirizine||active_moiety_of
paricalcitol 1 ug oral capsule, liquid filled [zemplar]||paricalcitol||active_moiety_of
dextromethorphan hydrobromide 15 mg oral capsule, liquid filled [tussin cough non-drowsy]||dextrométhorphane||active_moiety_of
poloxamer 407 0.1 ml in 1 ml ophthalmic liquid [natural care]||407s, poloxamer||active_moiety_of
baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / lobelia inflata 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / sus scrofa lung 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / potassium carbonate 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml oral liquid [infectistat]||product containing sulfur (medicinal product)||active_moiety_of
alcohol 0.75 ml in 1 ml topical gel [omni fresh by facela hand sanitizer]||alkohol||active_moiety_of
cinnamic acid 6 [hp_x] in 1 ml / phlorizin 6 [hp_x] in 1 ml / aspartame 6 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / malvin 15 [hp_x] in 1 ml / adenosine triphosphate disodium 6 [hp_c] in 1 ml / silver nitrate 6 [hp_c] in 1 ml / fructose 6 [hp_c] in 1 ml / dextrose 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / lactose 6 [hp_c] in 1 ml / sucrose 6 [hp_c] in 1 ml / corticotropin 8 [hp_c] in 1 ml / high fructose corn syrup 9 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml / acer saccharum sap 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [sugar and food additive allergen mix]||porcine jejunum preparation||active_moiety_of
acetaminophen 80 mg / chlorpheniramine maleate 0.5 mg / phenylephrine hcl 1.25 mg chewable tablet||alahist d||active_moiety_of
zinc 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g / collinsonia canadensis root 15 [hp_x] in 1 g / phytolacca americana root 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / picea mariana resin 15 [hp_x] in 1 g / horse chestnut 15 [hp_x] in 1 g / aloe 15 [hp_x] in 1 g / aluminum oxide 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / activated charcoal 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / goldenseal 15 [hp_x] in 1 g / potassium carbonate 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / magnesium chloride 15 [hp_x] in 1 g / daphne mezereum bark 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / podophyllum 15 [hp_x] in 1 g / krameria lappacea root 15 [hp_x] in 1 g / sanicula europaea leaf 15 [hp_x] in 1 g / selenium 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g / silicon dioxide 15 [hp_x] in 1 g / tobacco leaf 15 [hp_x] in 1 g / veratrum album root 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / iris versicolor root 6 [hp_x] in 1 g oral pellet [constipation]||veratrum album root extract||active_moiety_of
atorvastatin (as atorvastatin calcium trihydrate) 10 mg oral tablet||atorvastatine||active_moiety_of
isopropyl alcohol 50 ml in 100 ml topical liquid [rubbing alcohol]||alcohol rub||active_moiety_of
pyrithione zinc 10 mg in 1 ml topical lotion [mizani scalp care conditioner antidandruff conditioner]||zinc pyrithione shampoo (medication)||active_moiety_of
sodium monofluorophosphate 7.6 mg in 1 g dental paste, dentifrice [united airlines business class kit]||f- element||active_moiety_of
octinoxate 0.07 g in 1 g / oxybenzone 0.02 g in 1 g / titanium dioxide 0.02 g in 1 g topical cream [esika 3-in-1 pro make up foundation spf 20 base de maquillaje para rostro 3-en-1 pro fps 20 (beige 3) - beige]||titanium(iv) oxide||active_moiety_of
ceanothus americanus leaf 1 [hp_x] in 1 ml / marsdenia condurango bark 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / ligusticum porteri root 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / astragalus propinquus root 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / sodium borate 6 [hp_x] in 1 ml / bos taurus spleen 8 [hp_x] in 1 ml / bos taurus thymus 8 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml oral liquid [fngsode]||bos taurus thymus preparation||active_moiety_of
myosotis arvensis 3 [hp_x] in 1 ml / scrophularia nodosa 3 [hp_x] in 1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1 ml / veronica officinalis flowering top 3 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / fumaria officinalis flowering top 4 [hp_x] in 1 ml / geranium robertianum 4 [hp_x] in 1 ml / nasturtium officinale 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / pinus sylvestris leafy twig 4 [hp_x] in 1 ml / gentiana lutea root 5 [hp_x] in 1 ml / juglans regia leaf 5 [hp_x] in 1 ml / juglans regia fruit rind, immature 5 [hp_x] in 1 ml / araneus diadematus 6 [hp_x] in 1 ml / smilax regelii root 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [bio lymph phase]||quercetin (substance)||active_moiety_of
fluticasone propionate/salmeterol 500/50 mcg/inhal dry powder inhaler, 60 blisters||wixela||active_moiety_of
cetirizine hydrochloride 10 mg oral tablet, film coated [signature care allergy relief]||acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-||active_moiety_of
chlamydia trachomatis 12 [hp_x] in 1 ml oral liquid [chla homo]||c. trachomatis||active_moiety_of
aluminum zirconium trichlorohydrex gly 18 g in 100 g topical stick [secret invisible tropical orchid]||aluminum zirconium glycine trichloro hydrate complex||active_moiety_of
halobetasol propionate 0.50 mg in 1 g topical ointment [ultravate]||21-chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione||active_moiety_of
apis mellifera 10 [hp_x] in 59 ml / calcium picrate 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / calcium sulfide 10 [hp_x] in 59 ml / juglans regia fruit rind, immature 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / delphinium staphisagria seed 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / thuja occidentalis leafy twig 10 [hp_x] in 59 ml oral liquid [stye relief]||kieselsäureanhydrid||active_moiety_of
artemisia ludoviciana pollen 0.1 g in 1 ml subcutaneous solution [prairie mugwort darkleaved sagebrush]||dark leaved mugwort pollen extract||active_moiety_of
aconitum napellus 15 [hp_x] in 1 mg / silver nitrate 15 [hp_x] in 1 mg / gold 15 [hp_x] in 1 mg / baptisia tinctoria root 15 [hp_x] in 1 mg / bryonia alba root 15 [hp_x] in 1 mg / chelidonium majus 15 [hp_x] in 1 mg / black cohosh 15 [hp_x] in 1 mg / conium maculatum flowering top 15 [hp_x] in 1 mg / gelsemium sempervirens root 15 [hp_x] in 1 mg / strychnos ignatii seed 15 [hp_x] in 1 mg / potassium carbonate 15 [hp_x] in 1 mg / lachesis muta venom 15 [hp_x] in 1 mg / lilium lancifolium bulb 15 [hp_x] in 1 mg / lycopodium clavatum spore 15 [hp_x] in 1 mg / sodium carbonate 15 [hp_x] in 1 mg / sodium chloride 15 [hp_x] in 1 mg / phosphoric acid 15 [hp_x] in 1 mg / phosphorus 15 [hp_x] in 1 mg / trinitrophenol 15 [hp_x] in 1 mg / lead 15 [hp_x] in 1 mg / sepia officinalis juice 15 [hp_x] in 1 mg / delphinium staphisagria seed 15 [hp_x] in 1 mg / datura stramonium 15 [hp_x] in 1 mg / thuja occidentalis leafy twig 15 [hp_x] in 1 mg / zinc 15 [hp_x] in 1 mg / matricaria recutita 3 [hp_x] in 1 mg / hypericum perforatum 3 [hp_x] in 1 mg / valerian 3 [hp_x] in 1 mg oral pellet [calm remedy water]||lycopodium clavatum spore extract||active_moiety_of
dextromethorphan hb/doxylamine 15 mg-6.25 mg/15 ml oral solution, oral||zzzquil ultra||active_moiety_of
octinoxate 68 mg in 1 ml / titanium dioxide 40 mg in 1 ml / zinc oxide 152 mg in 1 ml topical cream [cc super active complete correction sunscreen broad spectrum spf 50 70 beige]||zinc óxido||active_moiety_of
amiloride 4 [hp_x] in 30 ml / apis mellifera 2 [hp_x] in 30 ml / berberis vulgaris fruit 0.3 g in 30 ml / hydrochlorothiazide 4 [hp_x] in 30 ml / sus scrofa pituitary gland 12 [hp_x] in 30 ml / hieracium pilosella flowering top 0.3 g in 30 ml / solidago virgaurea flowering top 0.3 g in 30 ml / spironolactone 4 [hp_x] in 30 ml oral solution/ drops [guna-diur]||solidago virgaurea flowering top||active_moiety_of
echinacea angustifolia 8 [hp_x] in 1 ml / goldenseal 8 [hp_x] in 1 ml / lomatium dissectum whole 8 [hp_x] in 1 ml / phytolacca americana root 8 [hp_x] in 1 ml / aconitum napellus 30 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / atropa belladonna 30 [hp_c] in 1 ml / human breast tumor cell 30 [hp_c] in 1 ml / human coxsackievirus a 30 [hp_c] in 1 ml / eupatorium perfoliatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / human herpesvirus 3 30 [hp_c] in 1 ml / influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) whole 30 [hp_c] in 1 ml / influenza a virus a/north carolina/04/2016 (h3n2) whole 30 [hp_c] in 1 ml / influenza b virus b/iowa/06/2017 whole 30 [hp_c] in 1 ml / influenza b virus b/singapore/inftt-16-0610/2016 whole 30 [hp_c] in 1 ml / measles virus 30 [hp_c] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml oral liquid [virosode]||human sputum, bordetella pertussis infected||active_moiety_of
ginger 3 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / lactic acid, dl- 6 [hp_x] in 1 ml / cyclamen purpurascens tuber 8 [hp_q] in 1 ml / kerosene 8 [hp_x] in 1 ml / tobacco leaf 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / cadmium sulfide 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / colchicum autumnale bulb 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / theridion curassavicum 12 [hp_x] in 1 ml / euphorbia corollata root 24 [hp_x] in 1 ml oral liquid [nausia]||conium maculatum flowering top extract||active_moiety_of
serotonin hydrochloride 4 [hp_x] in 1 ml / oxitriptan 6 [hp_x] in 1 ml / acetaldehyde 6 [hp_x] in 1 ml / acetylcholine chloride 6 [hp_x] in 1 ml / apiole (parsley) 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / aspartame 6 [hp_x] in 1 ml / butylated hydroxytoluene 6 [hp_x] in 1 ml / caffeic acid 6 [hp_x] in 1 ml / cinnamic acid 6 [hp_x] in 1 ml / coniferyl alcohol 6 [hp_x] in 1 ml / coumarin 6 [hp_x] in 1 ml / dopamine hydrochloride 6 [hp_x] in 1 ml / estradiol 6 [hp_x] in 1 ml / .gamma.-aminobutyric acid 6 [hp_x] in 1 ml / gallic acid monohydrate 6 [hp_x] in 1 ml / histamine dihydrochloride 6 [hp_x] in 1 ml / hydrocortisone 6 [hp_x] in 1 ml / indole 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / phenylalanine 6 [hp_x] in 1 ml / malvin 6 [hp_x] in 1 ml / yeast mannan 6 [hp_x] in 1 ml / melatonin 6 [hp_x] in 1 ml / menadione 6 [hp_x] in 1 ml / norepinephrine bitartrate 6 [hp_x] in 1 ml / octopamine hydrochloride 6 [hp_x] in 1 ml / phenyl isothiocyanate 6 [hp_x] in 1 ml / phlorizin 6 [hp_x] in 1 ml / piperine 6 [hp_x] in 1 ml / progesterone 6 [hp_x] in 1 ml / pyrrole 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / salsolinol hydrochloride 6 [hp_x] in 1 ml / taurine 6 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml / chlorogenic acid 12 [hp_x] in 1 ml oral liquid [multi-phenolic]||4-[(1r)-2-amino-1-hydroxyethyl]-1,2-benzenediol||active_moiety_of
bleomycin 15units powder for injection solution vial||blm||active_moiety_of
gold monosulfide 30 [hp_c] in 1 ml oral liquid [aurum sulphuratum]||gold cation (3+)||active_moiety_of
fagus grandifolia pollen 0.0021 g in 1 ml / platanus occidentalis pollen 0.0021 g in 1 ml / juglans nigra pollen 0.0021 g in 1 ml / salix nigra pollen 0.0021 g in 1 ml / carpinus caroliniana pollen 0.0021 g in 1 ml / picea pungens pollen 0.0021 g in 1 ml / acer negundo pollen 0.0021 g in 1 ml / pinus strobus pollen 0.0021 g in 1 ml / celtis occidentalis pollen 0.0021 g in 1 ml / acer saccharum pollen 0.0021 g in 1 ml / juniperus ashei pollen 0.0021 g in 1 ml / betula papyrifera pollen 0.0021 g in 1 ml / juniperus virginiana pollen 0.0021 g in 1 ml / acer rubrum pollen 0.0021 g in 1 ml / morus rubra pollen 0.0021 g in 1 ml / juniperus pinchotii pollen 0.0021 g in 1 ml / carya ovata pollen 0.0021 g in 1 ml / acer saccharinum pollen 0.0021 g in 1 ml / liquidambar styraciflua pollen 0.0021 g in 1 ml / ailanthus altissima pollen 0.0021 g in 1 ml / fraxinus americana pollen 0.0021 g in 1 ml / carya alba pollen 0.0021 g in 1 ml / morus alba pollen 0.0021 g in 1 ml / populus alba pollen 0.0021 g in 1 ml intradermal injection, solution||morus rubra pollen||active_moiety_of
aciclovir 400mg disp tab||aciclovir [eyes] (product)||active_moiety_of
potassium sulfate 15 [hp_c] in 15 [hp_c] oral pellet [kali sulphuricum]||element k||active_moiety_of
droperidol 2.5 milligram in 1 milliliter intramuscular injection [inapsine]||droperidol [anesthesia]||active_moiety_of
titanium dioxide 2.5 mg in 100 mg / zinc oxide 7.2 mg in 100 mg topical cream [arbonne intelligence pollution defense spf30 cc cream - dark shade]||zinc (as zinc oxide)||active_moiety_of
oxygen 396 l in 396 l respiratory (inhalation) gas [oxygen size d]||oxygen product||active_moiety_of
titanium dioxide 4.2 g in 100 g topical paste [flawless skin total protection concealer spf 25]||titanium oxide||active_moiety_of
ropivacaine hydrochloride 5 mg in 1 ml epidural injection, solution||1 propyl 2',6' pipecoloxylidide||active_moiety_of
oxygen 99 in 100 l respiratory (inhalation) liquid||o>2<||active_moiety_of
ibuprofen 200 mg oral tablet [pain relief]||(±)-p-isobutylhydratropic acid||active_moiety_of
potassium chloride 10 meq oral tablet||k+||active_moiety_of
solidago virgaurea flowering top 3 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / clerodendranthus spicatus leaf 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / agathosma betulina leaf 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / chondrodendron tomentosum root 8 [hp_x] in 1 ml / sus scrofa renal pelvis 8 [hp_x] in 1 ml / turpentine oil 8 [hp_x] in 1 ml / sus scrofa ureter 8 [hp_x] in 1 ml / sus scrofa urethra 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml / acetaldehyde 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / sodium pyruvate 10 [hp_x] in 1 ml / quercetin 10 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / apis mellifera venom 18 [hp_x] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [d2 organ support]||cupric||active_moiety_of
hydroquinone 0.04 mg in 1 ml topical emulsion [zo skin health pigment control plus brightening creme hydroquinone plus vitamin c]||p-dihydroxybenzene||active_moiety_of
dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.0004 g in 1 ml / gallus gallus feather 0.000027 g in 1 ml / anas platyrhynchos feather 0.000027 g in 1 ml / anser anser feather 0.000027 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / candida albicans 0.0004 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / phoma destructiva 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / ustilago nuda hordei 0.0005 g in 1 ml / ustilago maydis 0.0005 g in 1 ml / ustilago avenae 0.0005 g in 1 ml / ustilago tritici 0.0005 g in 1 ml / ustilago cynodontis 0.00004 g in 1 ml / sporisorium cruentum 0.00004 g in 1 ml intradermal injection, solution||allergenic extract, helminthosporium sativum||active_moiety_of
octinoxate 3.6 g in 1 g / octisalate 2.5 g in 1 g / oxybenzone 1.5 g in 1 g topical lipstick [lip balm chocolate peppermint flavored]||octinoxate||active_moiety_of
apis mellifera 8 [hp_x] in 1 ml / echinacea, unspecified 8 [hp_x] in 1 ml / goldenseal 8 [hp_x] in 1 ml / thuja occidentalis leafy twig 8 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / amanita muscaria fruiting body 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / azadirachta indica bark 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / calendula officinalis flowering top 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / milk thistle 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / sage 15 [hp_x] in 1 ml / selenium 15 [hp_x] in 1 ml / taraxacum officinale 15 [hp_x] in 1 ml / lycosa tarantula 15 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / bacillus anthracis 20 [hp_x] in 1 ml / influenza a virus 35 [hp_x] in 1 ml / influenza b virus 35 [hp_x] in 1 ml oral liquid [immune waker]||zn||active_moiety_of
xylocaine viscous, 2% mucous membrane solution||acetamide, 2-(diethylamino)-n-(2,6-dimethylphenyl)-||active_moiety_of
antipyrine 50 mg in 1 ml / benzocaine 50 mg in 1 ml / phenylephrine hydrochloride 1.25 mg in 1 ml auricular (otic) liquid [ortizol otic solution]||benzocaine (otic)||active_moiety_of
prednisolone sodium phosphate 15 mg/5 ml (5 ml) oral solution, oral||metacortandralone||active_moiety_of
ethinyloestradiol+desogestrel 30mcg/150mcg tablet||combined o/c-ethinylestradiol||active_moiety_of
echinacea purpurea 3 [hp_x] in 30 ml / gelsemium sempervirens root 12 [hp_x] in 30 ml / goldenseal 3 [hp_x] in 30 ml / st. john's wort 3 [hp_x] in 30 ml / lycopodium clavatum spore 12 [hp_x] in 30 ml / sodium chloride 12 [hp_x] in 30 ml / nitric acid 12 [hp_x] in 30 ml / ranunculus bulbosus 12 [hp_x] in 30 ml / toxicodendron pubescens leaf 12 [hp_x] in 30 ml / thuja occidentalis leafy twig 12 [hp_x] in 30 ml oral liquid [hpz]||bigonia sempervirens root||active_moiety_of
alcohol 380 ml in 100 / benzalkonium chloride 0.65 g in 100 / methylisothiazolinone 0.65 g in 100 / propylene glycol 0.65 g in 100 / phenoxyethanol 0.65 g in 100 extracorporeal cloth||methylisothiazolinone||active_moiety_of
acetaminophen 650 mg / dextromethorphan hydrobromide 20 mg / phenylephrine hydrochloride 10 mg oral powder, for solution [severe cold and cough daytime]||paracetamol||active_moiety_of
echinacea angustifolia 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / picea mariana resin 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / skatole 15 [hp_x] in 1 ml / candida albicans 30 [hp_x] in 1 ml oral liquid [fungustat i]||anemone pulsatilla whole||active_moiety_of
bupropion hydrochloride 200 mg oral tablet, extended release [bupropion hydrochloride (sr)]||bupropion||active_moiety_of
acetaminophen/chlorpheniramine maleate/dextromethorphan hydrobromide/phenylephrine hydrochloride 325 mg-2 mg-10 mg-5 mg oral tablet [good neighbor pharmacy cold head congestion]||r(-)-phenylephrine||active_moiety_of
apis mellifera 12 [hp_x] in 1 ml / arsenic triiodide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / kerosene 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / delphinium staphisagria seed 12 [hp_x] in 1 ml / urtica urens 12 [hp_x] in 1 ml / histamine dihydrochloride 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / thuja occidentalis leaf 12 [hp_x] in 1 ml / graphite 30 [hp_x] in 1 ml oral liquid [skin and itch]||kerosene||active_moiety_of
avobenzone 3 g in 100 g / homosalate 10 g in 100 g / octisalate 5 g in 100 g / octocrylene 4 g in 100 g / oxybenzone 5 g in 100 g topical spray [kids spf 50]||homosalate||active_moiety_of
product containing only ibuprofen 600 mg/1 each oral tablet (clinical drug)||ibuprofen (medication)||active_moiety_of
benzalkonium chloride 1:750 (0.13 %) miscell solution, non-oral||benzalkonium (substance)||active_moiety_of
sulfadimethoxine 113.5 g in 0.45 kg / ormetoprim 68.1 g in 0.45 kg oral powder [rofenaid 40]||ormetoprim||active_moiety_of
benzocaine 6mg/menthol 10mg lozenge||product containing menthol||active_moiety_of
sodium fluoride 0.02 mg in 1 ml oral rinse||f- element||active_moiety_of
ferula assa-foetida resin 12 [hp_x] in 1 ml / arabica coffee bean 30 [hp_x] in 1 ml / nitroglycerin 12 [hp_x] in 1 ml / strychnos ignatii seed 30 [hp_x] in 1 ml / lachesis muta venom 30 [hp_x] in 1 ml / moschus moschiferus musk sac resin 12 [hp_x] in 1 ml / anemone pratensis 30 [hp_x] in 1 ml sublingual solution [d-47]||glycerin trinitrate||active_moiety_of
human immunoglobulin g 100 mg in 1 ml intravenous solution [panzyga]_#3||immune globulin human||active_moiety_of
atriplex wrightii pollen extract 1 mg/ml injectable solution||saltbush pollen extract||active_moiety_of
octinoxate 7.5 g in 100 g / soybean oil 3.0 g in 100 g / octisalate 2.0 g in 100 g / oxybenzone 4.0 g in 100 g / titanium dioxide 2.5 g in 100 g topical spray [spf 30 sunscreen]||soybean oil emulsion (treatment)||active_moiety_of
alcohol 165.6116 ml in 236.588 ml cutaneous gel [workforce personal care hand sanitizer unscented]||ethanol-containing product||active_moiety_of
echinacea, unspecified 3 [hp_x] in 1 ml / bos taurus ovary 6 [hp_x] in 1 ml / beef 6 [hp_x] in 1 ml / sus scrofa fallopian tube 6 [hp_x] in 1 ml / antimony trisulfide 8 [hp_x] in 1 ml oral liquid||beef allergenic extract||active_moiety_of
salicylic acid 20 mg in 1 g topical lotion [dr. sheffield psoriasis medicated moisturizer]||salicylic acid product||active_moiety_of
candida albicans 30 [hp_c] in 473 ml oral liquid [aquaflora phase i]||candida albicans diagnostic allergen extract (product)||active_moiety_of
adenosine triphosphate disodium 4 [hp_x] in 1 ml / benzoic acid 6 [hp_x] in 1 ml / choline hydroxide 6 [hp_x] in 1 ml / cinnamic acid 6 [hp_x] in 1 ml / eugenol 6 [hp_x] in 1 ml / folic acid 6 [hp_x] in 1 ml / formaldehyde 6 [hp_x] in 1 ml / histamine dihydrochloride 6 [hp_x] in 1 ml / asparagine monohydrate 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / cow milk 6 [hp_x] in 1 ml / menadione 6 [hp_x] in 1 ml / sus scrofa ovary 6 [hp_x] in 1 ml / petroselinum crispum 6 [hp_x] in 1 ml / phenyl isothiocyanate 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / lactose, unspecified form 6 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / coumarin 8 [hp_x] in 1 ml / estrone 8 [hp_x] in 1 ml / .gamma.-aminobutyric acid 8 [hp_x] in 1 ml / lactic acid, l- 8 [hp_x] in 1 ml / canis lupus familiaris milk 30 [hp_x] in 1 ml / felis catus milk 30 [hp_x] in 1 ml / human milk 30 [hp_x] in 1 ml / piperine 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 6 [hp_c] in 1 ml / calcium fluoride 6 [hp_c] in 1 ml / tribasic calcium phosphate 6 [hp_c] in 1 ml / activated charcoal 6 [hp_c] in 1 ml / matricaria recutita 6 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 6 [hp_c] in 1 ml / toxicodendron pubescens leaf 6 [hp_c] in 1 ml / calcium citrate 6 [hp_c] in 1 ml / calcium gluconate 6 [hp_c] in 1 ml oral liquid [dairy allergen mix]||matricaria recutita whole extract||active_moiety_of
hydralazine hydrochloride, 50 mg oral tablet||hydralazinum||active_moiety_of
laccocephalum mylittae whole 100 mg / areca catechu fruit rind 100 mg / english walnut 50 mg / wormwood 50 mg / alisma plantago-aquatica subsp. orientale root 50 mg / clove 50 mg / pumpkin seed 60 mg oral tablet [mecare pet natural dewormer cats]||artemisia absinthium l.||active_moiety_of
3 hand sanitizers kit||äthanol||active_moiety_of
titanium dioxide 0.2328 g in 6 ml / octinoxate 0.3 g in 6 ml topical cream [age20s jericho rose tone essential uv primer green mint]||octyl methoxycinnamate||active_moiety_of
hydrochlorothiazide 12.5 mg / valsartan 160 mg oral tablet, film coated||6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide||active_moiety_of
allium cepa whole 6 [hp_x] / arsenic trioxide 9 [hp_x] / strychnos nux-vomica seed 6 [hp_x] / schoenocaulon officinale seed 6 [hp_x] / lobaria pulmonaria 6 [hp_x] / copper 9 [hp_x] / aralia racemosa root 6 [hp_x] oral pellet [allergy relief]||arsenic cation (3+)||active_moiety_of
activated charcoal 3 [hp_x] in 1 g oral powder||charcoal medicinal vegetable||active_moiety_of
alcohol 75 ml in 100 ml topical gel [surely hand sanitizer]||alcohol, ethyl||active_moiety_of
octinoxate 5 mg in 100 mg / zinc oxide 5 mg in 100 mg topical cream [cream]||sun screens zinc oxide||active_moiety_of
ampicillin / sulbactam 1.5 gm injection||ampicillins||active_moiety_of
baptisia tinctoria root 3 [hp_x] / goldenseal 3 [hp_x] / myrrh 3 [hp_x] / nasturtium officinale 3 [hp_x] / phytolacca americana root 3 [hp_x] / fenugreek leaf 3 [hp_x] / echinacea, unspecified 3 [hp_x] / acacia pollen 30 [hp_x] / alnus rubra pollen 30 [hp_x] / alnus incana subsp. rugosa pollen 30 [hp_x] / fraxinus velutina pollen 30 [hp_x] / fraxinus pennsylvanica pollen 30 [hp_x] / fraxinus americana pollen 30 [hp_x] / populus tremuloides pollen 30 [hp_x] / morella cerifera pollen 30 [hp_x] / fagus grandifolia pollen 30 [hp_x] / betula papyrifera pollen 30 [hp_x] / betula nigra pollen 30 [hp_x] / betula lenta pollen 30 [hp_x] / robinia pseudoacacia pollen 30 [hp_x] / acer negundo pollen 30 [hp_x] / juniperus ashei pollen 30 [hp_x] / juniperus pinchotii pollen 30 [hp_x] / juniperus virginiana pollen 30 [hp_x] / populus deltoides subsp. deltoides pollen 30 [hp_x] / populus deltoides subsp. monilifera pollen 30 [hp_x] / cupressus arizonica pollen 30 [hp_x] / taxodium distichum pollen 30 [hp_x] / phoenix dactylifera pollen 30 [hp_x] / ulmus americana pollen 30 [hp_x] / ulmus crassifolia pollen 30 [hp_x] / ulmus pumila pollen 30 [hp_x] / ulmus rubra pollen 30 [hp_x] / eucalyptus globulus pollen 30 [hp_x] / pseudotsuga menziesii pollen 30 [hp_x] / celtis occidentalis pollen 30 [hp_x] / carya glabra pollen 30 [hp_x] / carya ovata pollen 30 [hp_x] / carya laciniosa pollen 30 [hp_x] / carya alba pollen 30 [hp_x] / ligustrum vulgare pollen 30 [hp_x] / acer saccharum pollen 30 [hp_x] / acer rubrum pollen 30 [hp_x] / morus rubra pollen 30 [hp_x] / quercus virginiana pollen 30 [hp_x] / quercus rubra pollen 30 [hp_x] / quercus alba pollen 30 [hp_x] / carya illinoinensis pollen 30 [hp_x] / pinus strobus pollen 30 [hp_x] / populus alba pollen 30 [hp_x] / liquidambar styraciflua pollen 30 [hp_x] / platanus occidentalis pollen 30 [hp_x] / juglans nigra pollen 30 [hp_x] / salix nigra pollen 30 [hp_x] / baccharis halimifolia pollen 30 [hp_x] / amaranthus palmeri pollen 30 [hp_x] / xanthium strumarium pollen 30 [hp_x] / rumex crispus pollen 30 [hp_x] / chenopodium album pollen 30 [hp_x] / iva annua pollen 30 [hp_x] / artemisia vulgaris pollen 30 [hp_x] / urtica dioica pollen 30 [hp_x] / amaranthus retroflexus pollen 30 [hp_x] / plantago lanceolata pollen 30 [hp_x] / ambrosia trifida pollen 30 [hp_x] / ambrosia artemisiifolia pollen 30 [hp_x] / paspalum notatum pollen 30 [hp_x] / cynodon dactylon pollen 30 [hp_x] / poa pratensis pollen 30 [hp_x] / festuca pratensis pollen 30 [hp_x] / sorghum halepense pollen 30 [hp_x] / lolium perenne pollen 30 [hp_x] / dactylis glomerata pollen 30 [hp_x] / agrostis gigantea pollen 30 [hp_x] oral tablet, orally disintegrating [allergena seasonal allergy tabs]||tree pollen-eucalyptus||active_moiety_of
cinnamon 3 [hp_x] in 1 ml / gentiana lutea root 3 [hp_x] in 1 ml / syzygium cumini seed 3 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / colchicum autumnale bulb 6 [hp_x] in 1 ml / bos taurus colostrum 6 [hp_x] in 1 ml / copper gluconate 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / magnesium gluconate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / nitric acid 6 [hp_x] in 1 ml / sus scrofa pancreas 6 [hp_x] in 1 ml / potassium gluconate 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / scrophularia nodosa 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / gold 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / malus pumila flower 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / fagus sylvatica flowering top 12 [hp_x] in 1 ml oral liquid [gi drainage]||manganese ion (mn2+)||active_moiety_of
prinivil 20 mg oral tablet||prinivil||active_moiety_of
oxygen 99 l in 100 l respiratory (inhalation) gas||product containing oxygen (medicinal product)||active_moiety_of
silicon dioxide 6 [hp_x] in 1 ml / atropa belladonna 6 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 6 [hp_x] in 1 ml / black cohosh 6 [hp_x] in 1 ml / anemone pulsatilla 6 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml / palladium 10 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml / bos taurus ovary 200 [hp_x] in 1 ml sublingual solution [n-8]||pd element||active_moiety_of
alternaria alternata 0.1 g in 1 ml / aspergillus fumigatus 0.025 g in 1 ml / aspergillus nidulans 0.025 g in 1 ml / aspergillus niger var. niger 0.025 g in 1 ml / aspergillus terreus 0.025 g in 1 ml / cladosporium cladosporioides 0.1 g in 1 ml / penicillium digitatum 0.025 g in 1 ml / penicillium expansum 0.05 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.025 g in 1 ml / clonostachys rosea f. rosea 0.025 g in 1 ml percutaneous injection, solution||aspergillus fumigatus allergenic extract (medication)||active_moiety_of
cynanchum vincetoxicum root 6 [hp_x] in 59 ml / echinacea, unspecified 6 [hp_x] in 59 ml / bos taurus hypothalamus 6 [hp_x] in 59 ml / sus scrofa cerebrum 8 [hp_x] in 59 ml / pork liver 8 [hp_x] in 59 ml / pork kidney 8 [hp_x] in 59 ml / methylcobalamin 8 [hp_x] in 59 ml / sus scrofa pancreas 8 [hp_x] in 59 ml / sus scrofa stomach 8 [hp_x] in 59 ml / apc-356433 8 [hp_x] in 59 ml / apc-356434 8 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 59 ml / gamboge 12 [hp_x] in 59 ml / gelsemium sempervirens root 12 [hp_x] in 59 ml / graphite 12 [hp_x] in 59 ml / sodium chloride 12 [hp_x] in 59 ml / strychnos nux-vomica seed 12 [hp_x] in 59 ml / phytolacca americana root 12 [hp_x] in 59 ml / 7-keto-dehydroepiandrosterone 30 [hp_x] in 59 ml / adenosine triphosphate disodium 30 [hp_x] in 59 ml / glucagon 30 [hp_x] in 59 ml / insulin pork 30 [hp_x] in 59 ml / lactic acid, l- 30 [hp_x] in 59 ml / proteus vulgaris 30 [hp_c] in 59 ml oral liquid [weight management]||phytolacca americana root (substance)||active_moiety_of
homosalate 80 mg in 1 ml / octisalate 40 mg in 1 ml / avobenzone 30 mg in 1 ml / octocrylene 20 mg in 1 ml topical lotion [nu skin ageloc me day s3 broad spectrum spf 25]||benzoic acid, 2-hydroxy-, 2-ethylhexyl ester||active_moiety_of
uniferron 100 mg per 1 ml injectable solution||iron preparations (medication)||active_moiety_of
octinoxate 6.5 g in 30 g / titanium dioxide 4.25 g in 30 g / octisalate 5 g in 30 g topical cream [no7 perfect and perfect advanced all in one foundation spf 50 wheat]||product containing titanium dioxide||active_moiety_of
alcohol 80 ml in 100 ml topical solution||alcohol,ethyl||active_moiety_of
bisacodyl 5 mg in 161 mg / docusate sodium 16.75 mg in 161 mg oral tablet [dyrax-q tab]||docusate (substance)||active_moiety_of
aloe 200 [hp_c] oral pellet||aloe (substance)||active_moiety_of
avobenzone 1.5 g in 50 ml / octisalate 2.5 g in 50 ml / homosalate 2.5 g in 50 ml / octocrylene 1.35 g in 50 ml topical cream [ahava active deadsea minerals age control even tone moisturizer broad spectrum spf20]||benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||active_moiety_of
arsenic trioxide 12 [hp_x] in 59 ml / baptisia tinctoria root 12 [hp_x] in 59 ml / chloramphenicol 12 [hp_x] in 59 ml / echinacea, unspecified 12 [hp_x] in 59 ml / elaeis guineensis fruit 12 [hp_x] in 59 ml / goldenseal 12 [hp_x] in 59 ml / mercurius solubilis 12 [hp_x] in 59 ml / myrrh 12 [hp_x] in 59 ml / nasturtium officinale 12 [hp_x] in 59 ml / strychnos nux-vomica seed 12 [hp_x] in 59 ml / phosphorus 12 [hp_x] in 59 ml / phytolacca americana root 12 [hp_x] in 59 ml / pulsatilla vulgaris 12 [hp_x] in 59 ml / ricinus communis seed 12 [hp_x] in 59 ml / sepia officinalis juice 12 [hp_x] in 59 ml / zanthoxylum americanum bark 12 [hp_x] in 59 ml oral spray [allergyease mold]||strychnos nux-vomica seed extract||active_moiety_of
black cohosh 3 [hp_x] in 30 ml / lachesis muta venom 8 [hp_x] in 30 ml / platinum 8 [hp_x] in 30 ml / sanguinaria canadensis root 3 [hp_x] in 30 ml / sepia officinalis juice 3 [hp_x] in 30 ml / melissa officinalis 2 [hp_x] in 30 ml / sulfuric acid 6 [hp_x] in 30 ml / valerian 6 [hp_x] in 30 ml / aconitum napellus 6 [hp_x] in 30 ml oral liquid [sepia plex]||sanguinaria canadensis||active_moiety_of
advil pm 200mg-25mg liqui-gels||diphenhydramine-containing product||active_moiety_of
sodium fluoride 1.5498 g in 126 g topical aerosol, foam [ionite apf foam]||f- element||active_moiety_of
diphenhydramine hydrochloride 25mg tablet (product)||diphenhydramine (product)||active_moiety_of
acetazolamide 500mg oral capsule, extended release||acetazolamide - chemical||active_moiety_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [equate nighttime vapor ice cold anf flu]||dextromethorphan-containing product||active_moiety_of
pulsatilla vulgaris 3 [hp_x] / euphorbia resinifera resin 6 [hp_x] / calcium sulfate 3 [hp_x] / oyster shell calcium carbonate, crude 3 [hp_x] oral capsule [clear sinus and ear]||anemone pulsatilla extract||active_moiety_of
trichothecium roseum 0.1 g in 1 ml intradermal solution||allergenic extract, cephalothecium roseum||active_moiety_of
antimony potassium tartrate 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / camphor (natural) 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / sodium sulfate 15 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml / drosera anglica 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / influenza a virus 30 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / sanguinaria canadensis root 15 [hp_x] in 1 ml / tussilago farfara 15 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / potassium iodide 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / myrrh 15 [hp_x] in 1 ml / tin 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / eucalyptus gum 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml oral liquid [broncare]||pulsatilla vulgaris whole||active_moiety_of
acer negundo pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / dactylis glomerata pollen 4000 [bau] in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / betula populifolia pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / anthoxanthum odoratum pollen 4000 [bau] in 1 ml / lolium perenne pollen 4000 [bau] in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / alnus rhombifolia pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml intradermal injection, solution||white alder pollen extract||active_moiety_of
niacin 750 mg oral tablet, extended release 24 hr||vitamins nicotinic acid||active_moiety_of
alcohol 0.7 ml in 1 ml topical gel [fortaderm antiseptic hand sanitizer]||ethyl alcohol-containing product||active_moiety_of
fucus vesiculosus 3 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_x] in 1 ml / thyroid 6 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml oral liquid [thyropar]||spongia officinalis skeleton extract||active_moiety_of
insulin glargine, recombinant/lixisenatide 100 u/1 ml-33 mcg/1 ml subcutaneous solution [soliqua 100/33]||product containing lixisenatide||active_moiety_of
1 ml denosumab 60 mg/ml prefilled syringe [prolia]||denosumab-containing product||active_moiety_of
cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.00008 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / kochia scoparia pollen 0.0004 g in 1 ml / chenopodium album pollen 0.0004 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / salsola kali pollen 0.0004 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml intradermal injection, solution||box elder pollen||active_moiety_of
uric acid 15 [hp_x] in 1 ml / benzoic acid 10 [hp_x] in 1 ml / berberis vulgaris root bark 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / lytta vesicatoria 10 [hp_x] in 1 ml / centaurea benedicta 10 [hp_x] in 1 ml / ceanothus americanus leaf 10 [hp_x] in 1 ml / chelidonium majus 10 [hp_x] in 1 ml / chionanthus virginicus bark 10 [hp_x] in 1 ml / cinchona officinalis bark 10 [hp_x] in 1 ml / dioscorea villosa tuber 10 [hp_x] in 1 ml / mucuna pruriens fruit trichome 10 [hp_x] in 1 ml / iris versicolor root 10 [hp_x] in 1 ml / juniper berry 10 [hp_x] in 1 ml / strychnos nux-vomica seed 10 [hp_x] in 1 ml / ptelea trifoliata bark 10 [hp_x] in 1 ml / taraxacum officinale 10 [hp_x] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / cynara scolymus leaf 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml oral liquid [detoxifier]||mexican yam||active_moiety_of
fraxinus americana pollen 20000 [pnu] in 1 ml / betula nigra pollen 20000 [pnu] in 1 ml / juglans nigra pollen 20000 [pnu] in 1 ml / populus deltoides pollen 20000 [pnu] in 1 ml / ulmus americana pollen 20000 [pnu] in 1 ml / carya ovata pollen 20000 [pnu] in 1 ml / acer saccharum pollen 20000 [pnu] in 1 ml / quercus rubra pollen 20000 [pnu] in 1 ml / platanus occidentalis pollen 20000 [pnu] in 1 ml / salix nigra pollen 20000 [pnu] in 1 ml subcutaneous injection, solution [pollens - trees, tree mix 11]||platanus occidentalis pollen||active_moiety_of
octinoxate 7.5 g in 100 g / octocrylene 5 g in 100 g / titanium dioxide 8.5 g in 100 g / zinc oxide 2.94 g in 100 g topical lotion [healthy wear tinted moisturizer spf 50]||titanium white||active_moiety_of
sodium citrate 4 gram/100 ml (4 %) miscell solution, non-oral||citric acid anhydrous||active_moiety_of
antimony potassium tartrate 200 [hp_c] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / sus scrofa lung 6 [hp_x] in 1 ml / mercuric chloride 200 [hp_c] in 1 ml / aspidosperma quebracho-blanco bark 3 [hp_x] in 1 ml / lobaria pulmonaria 200 [hp_c] in 1 ml / teucrium marum 3 [hp_x] in 1 ml oral spray [snore defense]||mercuric cation||active_moiety_of
product containing only glycopyrronium bromide 2 mg/1 each oral tablet (clinical drug)||glycopyrronium-containing product||active_moiety_of
octinoxate 74.9 mg in 1 ml / titanium dioxide 22.8 mg in 1 ml topical cream [bright future skin tint spf 25 25 beige beige]||octinoxate||active_moiety_of
divalproex sodium 125 mg oral tablet, delayed release [depakote]||ácido valproico||active_moiety_of
vancomycin hcl 10 gram intraven vial (ea)||vancomicina||active_moiety_of
acetaminophen/dextromethorphan hydrobromide/doxylamine succinate 325 mg-15 mg-6.25 mg oral capsule, liquid filled [nite time cold/flu formula]||dextromethorfan||active_moiety_of
coumarin 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / bambusa vulgaris leaf 9 [hp_x] in 1 ml / barley 9 [hp_x] in 1 ml / poppy seed 9 [hp_x] in 1 ml / corn 9 [hp_x] in 1 ml / flax seed 9 [hp_x] in 1 ml / levant cotton seed 9 [hp_x] in 1 ml / millet 9 [hp_x] in 1 ml / sorghum bicolor whole 9 [hp_x] in 1 ml / oat 9 [hp_x] in 1 ml / brown rice 9 [hp_x] in 1 ml / rye 9 [hp_x] in 1 ml / safflower 9 [hp_x] in 1 ml / sesame seed 9 [hp_x] in 1 ml / sorghum 9 [hp_x] in 1 ml / soybean 9 [hp_x] in 1 ml / sugarcane 9 [hp_x] in 1 ml / sunflower seed 9 [hp_x] in 1 ml / wheat 9 [hp_x] in 1 ml / amaranth 6 [hp_c] in 1 ml / avena sativa flowering top 6 [hp_c] in 1 ml / sodium sulfate 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / elymus repens root 6 [hp_c] in 1 ml / corticotropin 8 [hp_c] in 1 ml / enterococcus faecalis 30 [hp_c] in 1 ml oral liquid [grain mix system formula]||xiao mai||active_moiety_of
camphor (synthetic) 3 g in 100 ml / menthol 10 g in 100 ml / methyl salicylate 10 g in 100 ml topical liquid [zihuadick pain relieving]||salicylic acid [callosity] (substance)||active_moiety_of
sodium monofluorophosphate 1.4 g in 200 g / silicon dioxide 14 g in 200 g / glycerin 5 g in 200 g oral paste [nano silver toothpaste]||f- element||active_moiety_of
avobenzone 0.03 g in 1 g / octisalate 0.05 g in 1 g / octocrylene 0.03 g in 1 g / oxybenzone 0.05 g in 1 g topical cream [lbel lederm 55plus jour spf 15 facial treatment against advanced signs of aging day - all skin types]||oxybenzonum||active_moiety_of
pyrithione zinc 10 mg in 1 ml topical liquid [topcare gentle dandruff green apple]||zpt||active_moiety_of
aesculus hippocastanum flower 10 [hp_x] in 59 ml / aloe 10 [hp_x] in 59 ml / arnica montana 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / borage 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / carpinus betulus flowering top 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / potassium sulfate 10 [hp_x] in 59 ml / mentha piperita 10 [hp_x] in 59 ml / nitric acid 10 [hp_x] in 59 ml / olea europaea flower 10 [hp_x] in 59 ml / onosmodium virginianum whole 10 [hp_x] in 59 ml / palladium 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / tropaeolum majus 10 [hp_x] in 59 ml / ulmus procera flowering twig 10 [hp_x] in 59 ml / viola tricolor 10 [hp_x] in 59 ml oral liquid [self pity]||onosmodium virginianum whole extract||active_moiety_of
fexmid 7.5mg tablet||cyclobenzaprine (substance)||active_moiety_of
adenosine triphosphate disodium 6 [hp_x] in 1 ml / nadide 6 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / ipecac 6 [hp_x] in 1 ml / robinia pseudoacacia bark 6 [hp_x] in 1 ml / sulfur 6 [hp_x] in 1 ml / oregano 6 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_q] in 1 ml / sus scrofa umbilical cord 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / strychnos nux-vomica seed 8 [hp_x] in 1 ml / coumarin 8 [hp_x] in 1 ml / centaurium erythraea 10 [hp_x] in 1 ml / pancrelipase 12 [hp_x] in 1 ml / hydrochloric acid 6 [hp_c] in 1 ml / anhydrous citric acid 6 [hp_c] in 1 ml / formic acid 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / coenzyme a 8 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [refl hs]||oregano allergenic extract||active_moiety_of
avobenzone 25.8 mg in 1 ml / homosalate 64.5 mg in 1 ml / octisalate 43 mg in 1 ml / octocrylene 23.7 mg in 1 ml / oxybenzone 17.2 mg in 1 ml topical aerosol, spray [australian gold broad spectrum spf 30 with invisidry technology]||octocrilene (product)||active_moiety_of
alternaria alternata 30 [hp_x] in 1 ml / aspergillus niger var. niger 30 [hp_x] in 1 ml / candida albicans 30 [hp_x] in 1 ml / candida parapsilosis 30 [hp_x] in 1 ml / saccharomyces cerevisiae 30 [hp_x] in 1 ml / mucor racemosus 30 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla pratensis whole 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / rhizopus stolonifer 30 [hp_c] in 1 ml oral liquid [mold antigens]||phosphorus 31||active_moiety_of
avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 7 g in 100 ml / oxybenzone 5 g in 100 ml topical liquid [tender moments baby sunscreen broad spectrum spf 50 jafra]||3,3,5-trimethylcyclohexyl salicylate||active_moiety_of
caulophyllum thalictroides root 3 [hp_x] oral pellet||caulophyllum thalictroides root||active_moiety_of
aspirin 6 mg / menthol 5 mg oral lozenge [biovanta trip action tart cherry and honey]||acetylsalicylic acid - chemical||active_moiety_of
sodium fluoride 0.1 g in 100 ml / allantoin 0.05 g in 100 ml dental paste, dentifrice [dio pororo kids foaming]||5-ureido-2,4-imidazolidindione||active_moiety_of
titanium dioxide 4.47 g in 45 g / octinoxate 3.15 g in 45 g / zinc oxide 1.32 g in 45 g topical cream [luminous goddess aura bb]||octylmethoxycinnamate||active_moiety_of
potassium chloride 10meq extended release capsule (product)||k+ element||active_moiety_of
oyster shell calcium carbonate, crude 30 [hp_c] / iron 30 [hp_c] / graphite 30 [hp_c] / potassium carbonate 30 [hp_c] / sodium chloride 30 [hp_c] oral tablet, chewable [weight loss relief]||iron agent (substance)||active_moiety_of
hydrocortisone 0.01 mg/mg / phenol 0.005 mg/mg topical gel||hydrocortisone preparation||active_moiety_of
avobenzone 1 g in 100 ml / oxybenzone 3 g in 100 ml / homosalate 5 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml topical lotion [spf 30 sunscreen tottle]||salicylic acid 2-ethylhexyl ester||active_moiety_of
dexamethasone 500micrograms/5ml oral solution (product)||dxevo||active_moiety_of
dexbrompheniramine maleate/pseudoephedrine sulfate 6 mg-120 mg oral tablet, extended release [valu-hist]||product containing pseudoephedrine||active_moiety_of
avena sativa flowering top 1 [hp_c] in 1 ml / beta vulgaris whole 1 [hp_c] in 1 ml / medicago sativa whole 2 [hp_c] in 1 ml / chelidonium majus whole 2 [hp_c] in 1 ml / larrea tridentata leaf 2 [hp_c] in 1 ml / phytolacca americana root 2 [hp_c] in 1 ml / urtica dioica whole 2 [hp_c] in 1 ml / verbascum thapsus whole 2 [hp_c] in 1 ml / viscum album fruiting top 2 [hp_c] in 1 ml / oxalis acetosella leaf 5 [hp_c] in 1 ml / silver 6 [hp_c] in 1 ml / calcium fluoride 6 [hp_c] in 1 ml / thuja occidentalis leafy twig 6 [hp_c] in 1 ml / thymol 7 [hp_c] in 1 ml / bacillus anthracis immunoserum rabbit 12 [hp_c] in 1 ml / baptisia tinctoria root 12 [hp_c] in 1 ml / alternanthera sessilis whole 12 [hp_c] in 1 ml / alcohol, x-ray exposed (1000 rad) 12 [hp_c] in 1 ml oral liquid [apizastat]||baptisia tinctoria root||active_moiety_of
alcohol 80 ml in 100 ml topical solution [magic water drinks, llc]||etoh - alcohol||active_moiety_of
baccharis halimifolia pollen extract 0.025 gm/ml / desertbroom whole extract 0.025 gm/ml injectable solution||groundsel pollen extract||active_moiety_of
baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / borrelia burgdorferi 12 [hp_x] in 1 ml / babesia microti 20 [hp_x] in 1 ml / ehrlichia canis 20 [hp_x] in 1 ml / neisseria meningitidis 30 [hp_x] in 1 ml / hepatitis b virus 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / bryonia alba root 30 [hp_c] in 1 ml / chelidonium majus 30 [hp_c] in 1 ml / colchicum autumnale bulb 30 [hp_c] in 1 ml / kalmia latifolia leaf 30 [hp_c] in 1 ml / ledum palustre twig 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / toxicodendron pubescens leaf 30 [hp_c] in 1 ml oral liquid [jointox bb]||rhus acutiloba leaf||active_moiety_of
influenza a virus 30 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / aluminum oxide 15 [hp_x] in 1 ml / antimony potassium tartrate 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / crotalus horridus horridus venom 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / ledum palustre twig 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / bilberry 15 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / hypericum perforatum 6 [hp_x] in 1 ml oral liquid [post - vaccination]||evening trumpetflower root||active_moiety_of
titanium dioxide 74.7 mg in 1 ml / zinc oxide 47.5 mg in 1 ml topical liquid [foundcealer multi-tasking foundation broad spectrum spf 20 sunscreen 50s deep sand]||zn2+||active_moiety_of
camphor 3%/menthol 3% top gel||menthol product||active_moiety_of
melissa officinalis 3 [hp_x] in 1 ml / sepia officinalis juice 6 [hp_x] in 1 ml / aconitum napellus 10 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / kalanchoe daigremontiana leaf 3 [hp_x] in 1 ml / matricaria recutita 3 [hp_x] in 1 ml oral liquid||kalanchoe daigremontiana leaf extract||active_moiety_of
product containing precisely isosorbide mononitrate 10 milligram/1 each conventional release oral tablet (clinical drug)||monocinque||active_moiety_of
chaste tree 2 [hp_x] in 1 ml / avena sativa flowering top 1 [hp_x] in 1 ml / carpinus betulus flower 15 [hp_x] in 1 ml / castanea sativa flower 15 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_x] in 1 ml / turnera diffusa leafy twig 1 [hp_x] in 1 ml / populus tremula flowering top 30 [hp_x] in 1 ml / ulex europaeus flower 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / passiflora incarnata flowering top 1 [hp_x] in 1 ml / sepia officinalis juice 30 [hp_x] in 1 ml / epinephrine 6 [hp_x] in 1 ml / gold 30 [hp_x] in 1 ml / prunus cerasifera flower 15 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / potassium phosphate, dibasic 30 [hp_x] in 1 ml / mandragora officinarum root 30 [hp_x] in 1 ml / lycopodium clavatum spore 60 [hp_x] in 1 ml / rosa canina flower 15 [hp_x] in 1 ml / sinapis arvensis flowering/fruiting top 15 [hp_x] in 1 ml / aethusa cynapium 30 [hp_x] in 1 ml / alfalfa 1 [hp_x] in 1 ml / silver nitrate 30 [hp_x] in 1 ml / ceratostigma willmottianum flower 30 [hp_x] in 1 ml sublingual solution/ drops [b07 dprsn antitox]||turnera diffusa leafy twig||active_moiety_of
althaea officinalis root 30 [hp_c] in 1 ml oral liquid [althaea officinalis]||althaea officinalis root extract||active_moiety_of
calcium fluoride 10 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / calcium sulfate anhydrous 10 [hp_x] in 1 ml / ferrosoferric phosphate 10 [hp_x] in 1 ml / potassium chloride 10 [hp_x] in 1 ml / potassium phosphate, dibasic 10 [hp_x] in 1 ml / potassium sulfate 10 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 1 ml / sodium chloride 10 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 10 [hp_x] in 1 ml / sodium sulfate 10 [hp_x] in 1 ml / silicon dioxide 10 [hp_x] in 1 ml oral liquid [cell salts]||calcium 2+||active_moiety_of
valproic acid (as valproate semisodium) 250 mg gastro-resistant oral tablet||dpa - dipropylacetic acid||active_moiety_of
arsenic trioxide 10 [hp_x] in 59 ml / arsenic triiodide 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / carbo animalis 10 [hp_x] in 59 ml / wood creosote 10 [hp_x] in 59 ml / lachesis muta venom 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml oral liquid [cs-brain]||carbo animalis||active_moiety_of
hydromorphone hcl in 0.9% nacl 10 mg/25 ml (0.4 mg/ml) injection patient controlled analgesia syringe||dihydromorfinon||active_moiety_of
ambrosia trifida pollen 40000 [pnu] in 1 ml subcutaneous solution [giant ragweed]||ambrosia trifida pollen||active_moiety_of
xerophyllum asphodeloides 30 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / semecarpus anacardium juice 15 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / croton tiglium seed 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / grindelia hirsutula flowering top 15 [hp_x] in 1 g / daphne mezereum bark 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / ranunculus bulbosus 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / smilax ornata root 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g / rumex crispus root 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / urtica urens 6 [hp_x] in 1 g oral pellet [poison ivy]||strychnos nux-vomica seed||active_moiety_of
lactic acid, l- 3 [hp_x] / viscum album fruiting top 3 [hp_x] / iodine 3 [hp_x] / fucus vesiculosus 6 [hp_x] / galium aparine 6 [hp_x] / sus scrofa thyroid 6 [hp_x] / prasterone 6 [hp_x] / phenyl isothiocyanate 6 [hp_x] / tyramine 6 [hp_x] / adenosine triphosphate disodium 7 [hp_x] / oxogluric acid 7 [hp_x] / fumaric acid 7 [hp_x] / malic acid 7 [hp_x] / colchicum autumnale bulb 8 [hp_x] / conium maculatum flowering top 8 [hp_x] / sodium diethyl oxalacetate 8 [hp_x] / sus scrofa umbilical cord 8 [hp_x] / pork liver 8 [hp_x] / sus scrofa bone marrow 8 [hp_x] / sus scrofa pineal gland 8 [hp_x] / sus scrofa spleen 8 [hp_x] / sus scrofa thymus 8 [hp_x] / calcium fluoride 12 [hp_x] / anemone pulsatilla 12 [hp_x] / spongia officinalis skeleton, roasted 12 [hp_x] / cortisone acetate 30 [hp_x] / mercuric chloride 60 [hp_x] / liothyronine 15 [hp_c] / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] / escherichia coli 30 [hp_c] oral tablet [energize]||i element||active_moiety_of
benzalkonium chloride 1.3 mg in 1 ml topical cloth [disney mickey and friends antibacterial hand wipes]||benzalkonium-containing product||active_moiety_of
aluminum oxide 10 [hp_x] in 59 ml / semecarpus anacardium juice 10 [hp_x] in 59 ml / avena sativa flowering top 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / tribasic calcium phosphate 10 [hp_x] in 59 ml / potassium phosphate, dibasic 10 [hp_x] in 59 ml / picric acid 10 [hp_x] in 59 ml / zinc 10 [hp_x] in 59 ml oral liquid [mental alertness]||calcium ion||active_moiety_of
melatonin 6 [hp_x] in 1 ml / nadide 6 [hp_x] in 1 ml / niacin 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / zinc sulfate heptahydrate 6 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa hypothalamus 8 [hp_x] in 1 ml / lithium carbonate 8 [hp_x] in 1 ml / magnesium carbonate 8 [hp_x] in 1 ml / sus scrofa pineal gland 8 [hp_x] in 1 ml oral spray [melatonin forte]||pyridoxine preparation (substance)||active_moiety_of
atenolol 25 milligram in 1 tablet oral tablet [atenolol]||1-p-carbamoylmethylphenoxy-3-isopropylamino-2-propanol||active_moiety_of
cynodon dactylon pollen 1000 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.005 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 80 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / alternaria alternata 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / cochliobolus sativus 0.00008 g in 1 ml / ulmus americana pollen 0.005 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / morus rubra pollen 0.005 g in 1 ml / equus caballus hair 0.002 g in 1 ml subcutaneous injection, solution||felis catus hair||active_moiety_of
dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@15 mg@oral@capsule, ext release 24 hr||amphetamine-containing product||active_moiety_of
aconitum napellus 12 [hp_x] in 50 ml / semecarpus anacardium fruit 6 [hp_x] in 50 ml / bryonia dioica root 3 [hp_x] in 50 ml / gelsemium sempervirens root 4 [hp_x] in 50 ml / menyanthes trifoliata 3 [hp_x] in 50 ml / macropiper methysticum root 8 [hp_x] in 50 ml / schoenocaulon officinale seed 3 [hp_x] in 50 ml / spigelia anthelmia 3 [hp_x] in 50 ml oral solution/ drops [apo-dolor]||aconitum napellus whole extract||active_moiety_of
wormwood 2 [hp_x] in 1 ml / arsenic trioxide 6 [hp_x] in 1 ml / garlic 6 [hp_x] in 1 ml / amoeba proteus 12 [hp_x] in 1 ml / ammonium phosphate, dibasic 6 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / cinchona officinalis bark 4 [hp_x] in 1 ml / veratrum album root 6 [hp_x] in 1 ml sublingual solution [d-101]||cinchona officinalis bark extract||active_moiety_of
gibberella fujikuroi 0.00625 g in 1 ml / mucor plumbeus 0.00625 g in 1 ml / alternaria alternata 0.00625 g in 1 ml / acremonium strictum 0.00625 g in 1 ml / botrytis cinerea 0.00625 g in 1 ml / cladosporium sphaerospermum 0.00625 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00625 g in 1 ml / pleospora betae 0.00625 g in 1 ml / cochliobolus sativus 0.00625 g in 1 ml / candida albicans 0.00625 g in 1 ml / chaetomium globosum 0.00625 g in 1 ml / rhizopus stolonifer 0.00625 g in 1 ml / trichophyton mentagrophytes 0.00625 g in 1 ml / aspergillus niger var. niger 0.00625 g in 1 ml / aureobasidium pullulans var. pullutans 0.00625 g in 1 ml / epicoccum nigrum 0.00625 g in 1 ml percutaneous solution [new stock fungi mix]||epicoccum nigrum allergenic extract||active_moiety_of
carbon dioxide 990 ml in 1 l respiratory (inhalation) gas [carbon dioxide refrigerated]||carbogen||active_moiety_of
bos taurus adrenal gland 5 [hp_x] in 60 ml / arsenic 6 [hp_x] in 60 ml / adenosine triphosphate 5 [hp_x] in 60 ml / sodium borate 12 [hp_x] in 60 ml / echinacea angustifolia 12 [hp_x] in 60 ml / gliotoxin 12 [hp_x] in 60 ml / hydrastis canadensis whole 3 [hp_x] in 60 ml / beef liver 3 [hp_x] in 60 ml / lomatium dissectum whole 3 [hp_x] in 60 ml / bos taurus lymph 3 [hp_x] in 60 ml / bos taurus mesenchyme 6 [hp_x] in 60 ml / phytolacca americana whole 12 [hp_x] in 60 ml / bos taurus spleen 3 [hp_x] in 60 ml / stachybotrys chartarum 12 [hp_x] in 60 ml / tabebuia impetiginosa whole 3 [hp_x] in 60 ml / bos taurus thymus 3 [hp_x] in 60 ml / elymus repens whole 3 [hp_x] in 60 ml oral solution/ drops||elymus repens whole||active_moiety_of
potassium gluconate 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / serinus canaria feather 9 [hp_x] in 1 ml / felis catus hair 9 [hp_x] in 1 ml / bos taurus skin 9 [hp_x] in 1 ml / gallus gallus feather 9 [hp_x] in 1 ml / canis lupus familiaris skin 9 [hp_x] in 1 ml / anas platyrhynchos feather 9 [hp_x] in 1 ml / meriones unguiculatus skin 9 [hp_x] in 1 ml / capra hircus skin 9 [hp_x] in 1 ml / anser anser feather 9 [hp_x] in 1 ml / cavia porcellus skin 9 [hp_x] in 1 ml / mesocricetus auratus skin 9 [hp_x] in 1 ml / sus scrofa skin 9 [hp_x] in 1 ml / equus caballus skin 9 [hp_x] in 1 ml / mus musculus skin 9 [hp_x] in 1 ml / melopsittacus undulatus feather 9 [hp_x] in 1 ml / oryctolagus cuniculus skin 9 [hp_x] in 1 ml / rattus norvegicus skin 9 [hp_x] in 1 ml / house dust 9 [hp_x] in 1 ml / barley 9 [hp_x] in 1 ml / corn grain 9 [hp_x] in 1 ml / oat 9 [hp_x] in 1 ml / wheat 9 [hp_x] in 1 ml / brown rice 9 [hp_x] in 1 ml / millet 9 [hp_x] in 1 ml / sorghum bicolor whole 9 [hp_x] in 1 ml / dermatophagoides farinae 9 [hp_x] in 1 ml / alfalfa 9 [hp_x] in 1 ml / solidago virgaurea flowering top 9 [hp_x] in 1 ml / trifolium pratense flower 9 [hp_x] in 1 ml / fagus grandifolia pollen 9 [hp_x] in 1 ml / ulmus americana pollen 9 [hp_x] in 1 ml / juglans nigra pollen 9 [hp_x] in 1 ml / salix nigra pollen 9 [hp_x] in 1 ml / acer negundo pollen 9 [hp_x] in 1 ml / populus deltoides subsp. deltoides pollen 9 [hp_x] in 1 ml / carya ovata pollen 9 [hp_x] in 1 ml / betula occidentalis pollen 9 [hp_x] in 1 ml / quercus rubra pollen 9 [hp_x] in 1 ml / platanus occidentalis pollen 9 [hp_x] in 1 ml / fraxinus americana pollen 9 [hp_x] in 1 ml / poa pratensis top 9 [hp_x] in 1 ml / dactylis glomerata top 9 [hp_x] in 1 ml / agrostis gigantea pollen 9 [hp_x] in 1 ml / phleum pratense top 9 [hp_x] in 1 ml / ambrosia acanthicarpa pollen 9 [hp_x] in 1 ml / ambrosia trifida pollen 9 [hp_x] in 1 ml / ambrosia artemisiifolia 9 [hp_x] in 1 ml / ambrosia psilostachya pollen 9 [hp_x] in 1 ml / rumex acetosella pollen 9 [hp_x] in 1 ml / rumex crispus top 9 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / histamine dihydrochloride 30 [hp_x] in 1 ml / hyaluronidase 30 [hp_x] in 1 ml / interferon .gamma. porcine recombinant 30 [hp_x] in 1 ml / serotonin hydrochloride 30 [hp_x] in 1 ml oral liquid [enviro ii]||chicken feathers diagnostic allergen extract (product)||active_moiety_of
liquidambar styraciflua pollen 0.1 g in 1 ml intradermal injection, solution||liquidambar styraciflua pollen||active_moiety_of
arsenic trioxide 6 [hp_x] in 1 ml / passiflora incarnata flowering top 6 [hp_x] in 1 ml / rhododendron aureum leaf 6 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / matricaria recutita 12 [hp_x] in 1 ml / arabica coffee bean 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / strychnos ignatii seed 12 [hp_x] in 1 ml / potassium phosphate, dibasic 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / delphinium staphisagria seed 12 [hp_x] in 1 ml / valerian 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / veratrum album root 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml oral liquid [stress and anxiety]||coffea corymbulosa seed||active_moiety_of
loperamide hydrochloride 2 mg oral tablet [welmate anti diarrheal loperamide hcl]||vaprino||active_moiety_of
octocrylene 30 mg in 1 ml / octinoxate 30 mg in 1 ml / avobenzone 10 mg in 1 ml topical oil [natural tanning and body oil spf6]||2-ethylhexyl-p-methoxycinnamate (substance)||active_moiety_of
aloe vera leaf 3 [hp_x] in 3 ml / arnica montana 1 [hp_x] in 3 ml / calendula officinalis flower 3 [hp_x] in 3 ml / bellis perennis 4 [hp_x] in 3 ml topical gel [zims max arnica homeopathic]||arnica montana radix||active_moiety_of
acetic acid 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / iris versicolor root 10 [hp_x] in 59 ml / potassium phosphate, dibasic 10 [hp_x] in 59 ml / lactic acid, dl- 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / sodium phosphate, dibasic, heptahydrate 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / uranyl nitrate hexahydrate 10 [hp_x] in 59 ml oral liquid [sugar metabolizer]||acid phosphoric||active_moiety_of
salicylic acid .02 ml topical swab [medicated acne pads]||sa - salicylic acid||active_moiety_of
antimony potassium tartrate 30 [hp_c] in 30 [hp_c] / arsenic trioxide 30 [hp_c] in 30 [hp_c] / atropa belladonna 30 [hp_c] in 30 [hp_c] / escherichia coli 200 [hp_c] in 30 [hp_c] / oyster shell calcium carbonate, crude 30 [hp_c] in 30 [hp_c] / selenicereus grandiflorus stem 30 [hp_c] in 30 [hp_c] / causticum 30 [hp_c] in 30 [hp_c] / copper 30 [hp_c] in 30 [hp_c] / solanum dulcamara top 30 [hp_c] in 30 [hp_c] / ipecac 30 [hp_c] in 30 [hp_c] / calcium sulfide 30 [hp_c] in 30 [hp_c] / potassium sulfate 30 [hp_c] in 30 [hp_c] / lycopodium clavatum spore 30 [hp_c] in 30 [hp_c] / sodium carbonate 30 [hp_c] in 30 [hp_c] / strychnos nux-vomica seed 30 [hp_c] in 30 [hp_c] / phosphorus 30 [hp_c] in 30 [hp_c] / pulsatilla vulgaris 30 [hp_c] in 30 [hp_c] / sepia officinalis juice 30 [hp_c] in 30 [hp_c] / polygala senega root 30 [hp_c] in 30 [hp_c] oral spray [difficult expectoration]||strychnos nux-vomica seed||active_moiety_of
cladosporium sphaerospermum 0.025 g in 1 ml / aspergillus niger var. niger 0.025 g in 1 ml / alternaria alternata 0.025 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.025 g in 1 ml percutaneous solution [mold mix 3]||allergenic extract, penicillium notatum||active_moiety_of
avobenzone 25.8 mg in 1 ml / homosalate 86 mg in 1 ml / octisalate 43 mg in 1 ml / octocrylene 23.65 mg in 1 ml / oxybenzone 34.4 mg in 1 ml topical aerosol, spray [solscents flower blast broad spectrum spf 50]||2-ethylhexyl 2-cyano-3,3-diphenylacrylate||active_moiety_of
(spl review) alcohol 80 ml in 100 ml topical gel [hand sanitizer]||äthylalkohol||active_moiety_of
robafen cf, 10 mg-100 mg-5 mg/5 ml oral syrup||dxm||active_moiety_of
bupropion hydrochloride 150 mg oral tablet, film coated, extended release [bupropion hydrochloride]||bupropion (medication)||active_moiety_of
milk thistle 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / artemisia cina pre-flowering top 3 [hp_x] in 1 ml / schoenocaulon officinale seed 3 [hp_x] in 1 ml / teucrium marum 3 [hp_x] in 1 ml / turpentine oil 5 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml / spigelia anthelmia 6 [hp_x] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / barium carbonate 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / ferric chloride hexahydrate 30 [hp_c] in 1 ml / sodium chloride 30 [hp_c] in 1 ml / silicon dioxide 30 [hp_c] in 1 ml / sulfur 30 [hp_c] in 1 ml oral liquid [10 parasite detox]||sulfur product (substance)||active_moiety_of
dermatophagoides pteronyssinus 400 [au] in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / iva annua pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / candida albicans 0.00008 g in 1 ml / phoma destructiva 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / cladosporium cladosporioides 0.00008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / gallus gallus feather 0.0000266 g in 1 ml / anas platyrhynchos feather 0.0000266 g in 1 ml / anser anser feather 0.0000266 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya tomentosa pollen 0.00004 g in 1 ml / ustilago nuda hordei 0.0005 g in 1 ml / ustilago maydis 0.0005 g in 1 ml / ustilago avenae 0.0005 g in 1 ml / ustilago tritici 0.0005 g in 1 ml subcutaneous injection, solution||oat smut allergenic extract||active_moiety_of
dextrose monohydrate 2.23 g in 70 ml / trisodium citrate dihydrate 1.84 g in 70 ml / anhydrous citric acid 209 mg in 70 ml / sodium phosphate, monobasic, monohydrate 155 mg in 70 ml / adenine 19.3 mg in 70 ml intravenous solution [cpda-1]||phosphate product||active_moiety_of
xanthium strumarium pollen 0.05 g in 1 ml / chenopodium album pollen 0.05 g in 1 ml / amaranthus retroflexus pollen 0.05 g in 1 ml / rumex crispus pollen 0.025 g in 1 ml / rumex acetosella pollen 0.025 g in 1 ml subcutaneous injection, solution [pollens - weeds, weed mix 2630]||weed pollen-cocklebur||active_moiety_of
nitrous oxide 99 kg in 100 kg respiratory (inhalation) gas||laughing gas||active_moiety_of
avobenzone 30 mg in 1 g / oxybenzone 40 mg in 1 g / homosalate 130 mg in 1 g / octocrylene 20 mg in 1 g / octisalate 50 mg in 1 g topical aerosol, spray [cvs health baby spf 50]||benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||active_moiety_of
anacardium occidentale fruit 1 [hp_q] oral pellet||anacardium occidentale||active_moiety_of
arsenic triiodide 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / helianthemum canadense 15 [hp_x] in 1 g / calcium sulfide 15 [hp_x] in 1 g / histamine dihydrochloride 15 [hp_x] in 1 g / goldenseal 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / potassium dichromate 15 [hp_x] in 1 g / potassium iodide 15 [hp_x] in 1 g / mercuric iodide 15 [hp_x] in 1 g / mercury 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / schoenocaulon officinale seed 15 [hp_x] in 1 g / lobaria pulmonaria 15 [hp_x] in 1 g / verbascum thapsus 15 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g oral pellet [sinusitis]||verbascum thapsus whole||active_moiety_of
hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet||2-butyl-4-chloro-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-methanol||active_moiety_of
alcohol 0.8 ml in 1 ml topical gel [hand sanitizer rinse free]||ethyl alcohol||active_moiety_of
sulfamethoxazole/trimethoprim 800 mg-160 mg oral tablet [sulfameth/trimeth]||sulfametoxazol||active_moiety_of
juglans regia leaf 6 [hp_x] in 1 ml / spigelia anthelmia 15 [hp_x] in 1 ml / thymol 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / artemisia cina pre-flowering top 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / dryopteris filix-mas root 15 [hp_x] in 1 ml / punica granatum root bark 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / artemisia abrotanum flowering top 15 [hp_x] in 1 ml / naphthalene 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / krameria lappacea root 15 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / schoenocaulon officinale seed 15 [hp_x] in 1 ml / santonin 15 [hp_x] in 1 ml / horse chestnut 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / turpentine oil 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / teucrium marum 15 [hp_x] in 1 ml / artemisia vulgaris root 15 [hp_x] in 1 ml oral liquid [parasites]||peruvian krameria root||active_moiety_of
product containing precisely amitriptyline hydrochloride 100 milligram/1 each conventional release oral tablet||product containing amitriptyline||active_moiety_of
levothyroxine sodium 200mcg oral tablet||lt4||active_moiety_of
dorzolamide hydrochloride 2%, timolol maleate 0.5% ophthalmic drops, solution_#1||cosopt||active_moiety_of
nystatin-triamcinolone topical 100000 units/g-0.1% topical cream||nystatin vaginal||active_moiety_of
chaste tree 15 [hp_x] in 1 ml / american ginseng 15 [hp_x] in 1 ml / barium carbonate 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / dieffenbachia seguine 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / onosmodium virginianum whole 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / saw palmetto 15 [hp_x] in 1 ml / selenium 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / thuja occidentalis leafy twig 3 [hp_x] in 1 ml oral liquid [libido]||conium maculatum flowering top||active_moiety_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 spf 25 (granate seductor femme) - purple]||4-methoxy-2-hydroxybenzophenone||active_moiety_of
alcohol 62 g in 100 g topical liquid||alcohol anhydrous||active_moiety_of
american ginseng 1 [hp_c] in 30 ml / arnica montana 1.5 [hp_c] in 30 ml / gold 30 [hp_c] in 30 ml / barium carbonate 30 [hp_c] in 30 ml / atropa belladonna 3 [hp_c] in 30 ml / calcium fluoride 6 [hp_c] in 30 ml / cholesterol 15 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / ginkgo 3 [hp_c] in 30 ml / saccharomyces cerevisiae rna 3 [hp_c] in 30 ml / viscum album fruiting top 1.5 [hp_c] in 30 ml / ginger 30 [hp_c] in 30 ml oral spray [heartery]||ginkgo||active_moiety_of
copper 380 square mm intrauteri intrauterine device||coppers||active_moiety_of
eucalyptol 0.092 g in 100 ml / menthol 0.042 g in 100 ml / methyl salicylate 0.060 g in 100 ml / thymol 0.064 g in 100 ml oral mouthwash [buenos dias de personna original]||product containing menthol (medicinal product)||active_moiety_of
plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / carya tomentosa pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml intradermal injection, solution||carya pecan pollen||active_moiety_of
acetaminophen/dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride 650 mg/20 ml-20 mg/20 ml-400 mg/20 ml-10 mg/20 ml oral solution [leader tussin cf]||phenylephrine-containing product||active_moiety_of
echinacea angustifolia whole 3 [hp_x] in 1 ml / collinsonia canadensis root 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / potassium iodide 6 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / pine tar 6 [hp_x] in 1 ml / ferrosoferric phosphate 8 [hp_x] in 1 ml / horse chestnut 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / berberis vulgaris root bark 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / wood creosote 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / stellaria media 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / turpentine oil 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml / bufo bufo cutaneous gland 14 [hp_x] in 1 ml oral liquid [lymph ii]||aqua fortis / nitric acid||active_moiety_of
benzalkonium chloride 0.1 g in 100 ml topical gel [trolls grape scented hand sanitizer 01]||benzalkonium (product)||active_moiety_of
phenylephrine hydrochloride 5 mg / acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg oral tablet [conrx daytime]||acetamidophenol||active_moiety_of
potassium sulfate 6 [hp_x] / salicylic acid 6 [hp_x] / silicon dioxide 6 [hp_x] / calcium sulfate anhydrous 6 [hp_x] / quinine sulfate 12 [hp_x] / allylthiourea 6 [hp_x] / citrus bioflavonoids 300 mg / ginkgo 30 mg / thiamine 0.5 mg / riboflavin 0.5 mg / niacinamide 10 mg / pantothenic acid 2.5 mg / pyridoxine 0.5 mg / cyanocobalamin 200 ug / biotin 100 ug / folic acid 200 ug / inositol 37.5 mg / zinc picolinate 7.5 mg / ascorbic acid 150 mg oral tablet, multilayer [ring relief]||2-pyridinecarboxylic acid, zinc complex||active_moiety_of
acetaminophen 325 mg / dextromethorphan hbr 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg per 10 ml oral solution||benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (r)-||active_moiety_of
iodine 3 [hp_c] in 1 ml / phytolacca americana root 3 [hp_c] in 1 ml / epinephrine 5 [hp_c] in 1 ml / sus scrofa thyroid 5 [hp_c] in 1 ml / corticotropin 14 [hp_c] in 1 ml / atropa belladonna 34 [hp_c] in 1 ml / phosphorus 55 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 89 [hp_c] in 1 ml / sodium chloride 89 [hp_c] in 1 ml / nutmeg 89 [hp_c] in 1 ml / datura stramonium 89 [hp_c] in 1 ml / silver nitrate 233 [hp_c] in 1 ml oral liquid [mbm 11 thyroid adrenal]||silver cation||active_moiety_of
witch hazel 50 g in 100 g topical swab [shopko medicated cooling]||a.e.r. witch hazel (obsolete)||active_moiety_of
alcohol 62 ml in 100 ml topical gel [monopoly hand sanitizer mnply 100]||methylcarbinol||active_moiety_of
serinus canaria feather 10000 [pnu] in 1 ml intradermal solution [canary feathers]||serinus canaria feather extract||active_moiety_of
octisalate 0.21 g in 4.25 g / avobenzone 0.09 g in 4.25 g / octocrylene 0.06 g in 4.25 g / octinoxate 0.28 g in 4.25 g topical stick||octyl-methoxycinnamate||active_moiety_of
calcipotriene 0.005%, betamethasone dipropionate 0.064% topical suspension||1,24(oh)2-22-ene-24-cyclopropyl d3||active_moiety_of
titanium dioxide 0.042 g in 1 g / zinc oxide 0.07 g in 1 g / octinoxate 0.075 g in 1 g topical cream [missha m perfect cover bb spf42 no23]||omc cinnamate||active_moiety_of
amaranthus palmeri pollen 0.05 g in 1 ml / amaranthus retroflexus pollen 0.05 g in 1 ml subcutaneous injection, solution [pollens - weeds, careless/pigweed mix]||redroot pigweed pollen extract||active_moiety_of
dimethicone 1 g in 100 g / octinoxate 7.5 g in 100 g / oxybenzone 2.5 g in 100 g topical stick [fruit smoothies orange cream]||omc cinnamate||active_moiety_of
chlorhexidine diacetate 0.5 mg/ml topical spray||chlorhexidine (substance)||active_moiety_of
alternaria alternata 0.002 g in 1 ml / ambrosia trifida pollen 0.0006666 g in 1 ml / ambrosia artemisiifolia pollen 0.0006666 g in 1 ml / ambrosia psilostachya pollen 0.0006666 g in 1 ml / anser anser feather 0.000667 g in 1 ml / gallus gallus feather 0.000667 g in 1 ml / anas platyrhynchos feather 0.000667 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / phoma destructiva 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / kochia scoparia pollen 0.00008 g in 1 ml / chenopodium album pollen 0.00008 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / salsola kali pollen 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.0002 g in 1 ml / ustilago avenae 0.0002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml intradermal injection, solution||allergenic extract, pullularia pullulans||active_moiety_of
dimethicone 0.9 g in 45 ml topical liquid [queens rose recovery serum]||dimeticone||active_moiety_of
fraxinus americana pollen 0.05 g in 1 ml cutaneous injection [white ash pollen]||fraxinus americana pollen extract||active_moiety_of
gabapentin 100mg capsule (product)||gabapentin||active_moiety_of
eucalyptol 0.92 mg in 1 ml / menthol 0.42 mg in 1 ml / methyl salicylate 0.60 mg in 1 ml / thymol 0.64 mg in 1 ml oral rinse [antiseptic]||thymol||active_moiety_of
alcohol 70 ml in 100 ml topical gel [sani gel]||äthanol||active_moiety_of
ropivacaine hcl 0.5% inj,vil,20ml||(s)-ropivacaine||active_moiety_of
octinoxate 4.08 mg in 60 ml / octisalate 2.70 mg in 60 ml / zinc oxide 8.06 mg in 60 ml / titanium dioxide 2.92 mg in 60 ml topical cream [atomy sunscreen white broad spectrum spf50 plus]||zinc 2+||active_moiety_of
octinoxate 5 g in 100 g topical cream [flormar reborn bb sunscreen broad spectrum spf 30 cp21 soft beige]||octyl-methoxycinnamate||active_moiety_of
titanium dioxide 2.32 ml in 30 ml / octinoxate 0.9 ml in 30 ml cutaneous cream [peach sake pore bb spf20 pa plus number2 natural beige]||titanium metallicum / titanium||active_moiety_of
montelukast 5 mg (as montelukast sodium 5.2 mg) chewable tablet||montelukastum||active_moiety_of
ginkgo 6 [hp_x] in 1 ml / sus scrofa colon 6 [hp_x] in 1 ml / sus scrofa lung 6 [hp_x] in 1 ml / sus scrofa pancreas 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / copper 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / tin 8 [hp_x] in 1 ml / oxogluric acid 8 [hp_x] in 1 ml / citric acid monohydrate 8 [hp_x] in 1 ml / fumaric acid 8 [hp_x] in 1 ml / malic acid 8 [hp_x] in 1 ml / pyruvic acid 8 [hp_x] in 1 ml / succinic acid 8 [hp_x] in 1 ml / 1,2-naphthoquinone 9 [hp_x] in 1 ml / arsenic 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / aconitic acid 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml oral liquid [lungex ii]||arsenic||active_moiety_of
e-z scrub with ultradex 30 mg/ml medicated pad||chloroxylenol (product)||active_moiety_of
titanium dioxide 15 g in 100 g / zinc oxide 5 g in 100 g topical powder [bareminerals matte foundation broad spectrum spf 15 fair]||zinc white||active_moiety_of
influenza a virus 30 [hp_x] in 1 ml / tellurium 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / ferrosoferric phosphate 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / potassium sulfate 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / plantago major 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [ear care]||lycopodium clavatum spore||active_moiety_of
dr scholl's corn removers, 40% topical pad||salicylic acid [psoriasis] (substance)||active_moiety_of
atropa belladonna 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / matricaria recutita 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / pulsatilla vulgaris 30 [hp_c] in 1 ml / sulfur 30 [hp_c] in 1 ml auricular (otic) liquid [earache drops]||lycopodium clavatum spore extract||active_moiety_of
octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [effet parfait hydratess long-lasting intense moisturizing spf 20 (mandarine) - orange]||2-hydroxy-4-methoxybenzone||active_moiety_of
aconitum napellus 20 [hp_x] in 1 g / apis mellifera 20 [hp_x] in 1 g / arnica montana 20 [hp_x] in 1 g / arsenic trioxide 20 [hp_x] in 1 g / atropa belladonna 20 [hp_x] in 1 g / bellis perennis 20 [hp_x] in 1 g / bryonia alba root 20 [hp_x] in 1 g / calendula officinalis flowering top 20 [hp_x] in 1 g / matricaria recutita 20 [hp_x] in 1 g / helianthemum canadense 20 [hp_x] in 1 g / ferrosoferric phosphate 20 [hp_x] in 1 g / histamine dihydrochloride 20 [hp_x] in 1 g / hypericum perforatum 20 [hp_x] in 1 g / strychnos ignatii seed 20 [hp_x] in 1 g / daphne mezereum bark 20 [hp_x] in 1 g / ornithogalum umbellatum 20 [hp_x] in 1 g / passiflora incarnata flowering top 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / prunus spinosa flower bud 20 [hp_x] in 1 g / toxicodendron pubescens leaf 20 [hp_x] in 1 g / lactic acid, l- 20 [hp_x] in 1 g / sulfur 20 [hp_x] in 1 g / veratrum album root 20 [hp_x] in 1 g / valerian 8 [hp_x] in 1 g oral pellet [panic ease]||purple passionflower||active_moiety_of
gallus gallus feather 0.0333 g in 1 ml / anas platyrhynchos feather 0.0333 g in 1 ml / anser anser feather 0.0333 g in 1 ml subcutaneous injection, solution||chicken feather extract||active_moiety_of
menthol 150 mg in 1 g topical gel [sana sana menthol external analgesic]||cyclohexanol, 5-methyl-2-(1-methylethyl)-||active_moiety_of
ceanothus americanus leaf 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / marsdenia condurango bark 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / momordica balsamina immature fruit 6 [hp_x] in 1 ml / anemone pratensis 6 [hp_x] in 1 ml / sus scrofa bile duct 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / ipecac 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / potassium dichromate 8 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / sus scrofa nasal mucosa 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sus scrofa oral mucosa 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / sus scrofa rectal mucosa 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / mannose, d- 8 [hp_x] in 1 ml / semecarpus anacardium juice 9 [hp_x] in 1 ml / wood creosote 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / mandragora officinarum root 10 [hp_x] in 1 ml / oxalis acetosella leaf 10 [hp_x] in 1 ml / sus scrofa urinary bladder 6 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [intercellular detox]||sus scrofa bile duct preparation||active_moiety_of
aspirin 250 mg and acetaminophen 250 mg and caffeine 65 mg oral tablet||3,7-dihydro-1,3,7-trimethyl-1h-purine-2,6-dione||active_moiety_of
ethanol 0.62 ml/ml / isopropyl alcohol 0.05 ml/ml topical foam||etanol||active_moiety_of
isopropyl alcohol 75 ml in 100 ml topical liquid [purifie]||alcohol rubbing||active_moiety_of
ondansetron hydrochloride 4mg tablet||product containing ondansetron (medicinal product)||active_moiety_of
alcohol 70 ml in 100 ml topical spray [on guard sanitizing mist]||1-hydroxyethane||active_moiety_of
alcohol 80 ml in 100 ml topical liquid [hemphills bliss hand sanitizer]||éthanol||active_moiety_of
beta carotene 2840 [iu] / ascorbic acid 120 mg / cholecalciferol 840 [iu] / .alpha.-tocopherol acetate, d- 2 mg / thiamine 1.5 mg / riboflavin 4 mg / niacinamide 20 mg / pyridoxine hydrochloride 50 mg / folic acid 1 mg / cyanocobalamin .012 mg / calcium carbonate 215 mg / iron 26 mg / magnesium 25 mg / zinc oxide 25 mg / cupric cation 2 mg / iodine .223 mg oral tablet [moms choice rx]||vitamin b12 compound||active_moiety_of
benzoyl peroxide topical 5% topical gel||peroxide, dibenzoyl||active_moiety_of
fraxinus americana pollen 0.002 g in 1 ml / betula nigra pollen 0.005 g in 1 ml / acer negundo pollen 0.005 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.005 g in 1 ml / quercus alba pollen 0.005 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.005 g in 1 ml / populus nigra pollen 0.0025 g in 1 ml / populus alba pollen 0.0025 g in 1 ml / salix nigra pollen 0.005 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml subcutaneous injection, solution||populus deltoides ssp. deltoides pollen extract||active_moiety_of
bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 ml / influenza a virus 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / antimony potassium tartrate 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / matricaria recutita 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 15 [hp_x] in 1 ml / iron 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / salix nigra bark 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / apis mellifera 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [fever infection]||rhus toxicodendron leaf||active_moiety_of
omega-3-acid ethyl esters 1g oral capsule, liquid filled||omega 3||active_moiety_of
rancid beef 30 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria root 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / activated charcoal 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / colchicum autumnale bulb 15 [hp_x] in 1 g / daphne odora bark 15 [hp_x] in 1 g / ipecac 15 [hp_x] in 1 g / iris versicolor root 15 [hp_x] in 1 g / potassium carbonate 15 [hp_x] in 1 g / wood creosote 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / magnesium carbonate 15 [hp_x] in 1 g / mercury 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / spigelia anthelmia 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / matricaria recutita 3 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g / ruta graveolens flowering top 3 [hp_x] in 1 g / taraxacum officinale 3 [hp_x] in 1 g oral pellet [gas - indigestion]||blue flag root||active_moiety_of
hctz 25 mg / triamterene 37.5 mg oral capsule [dyazide]||product containing hydrochlorothiazide||active_moiety_of
ampicillin+sulbactam 10g/5g injection (product)||sulbactam (product)||active_moiety_of
bupivacaine hydrochloride 5 mg/ml / epinephrine 0.005 mg/ml injection [sensorcaine with epinephrine]||1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamide||active_moiety_of
entecavir@0.5 mg@oral@tablet||entecavir anhydrous||active_moiety_of
atropa belladonna 30 [hp_x] in 1 ml / echinacea angustifolia 30 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 30 [hp_x] in 1 ml / gelsemium sempervirens root 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / phosphoric acid 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_x] in 1 ml oral liquid [viral hp]||rhus toxicarium leaf||active_moiety_of
diphtheria,pertus(acell),tetanus/hepb/polio/hib conj-meng/pf@15 unit-(20-20mcg)-5 unit-10 mcg-(29-7-26d unit)-3mcg/0.5ml@intramusc@syringe (ml)||inactivated poliovirus type ii||active_moiety_of
hydrogen peroxide 3.57 ml in 119 ml topical spray, metered [your label here hydrogen peroxide first aid]||preop||active_moiety_of
alternaria alternata 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / dermatophagoides farinae 400 [au] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / poa pratensis pollen 32 [bau] in 1 ml / sporisorium cruentum 0.0004 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / carya tomentosa pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / morus alba pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml subcutaneous injection, solution||american house dust mite allergenic extract||active_moiety_of
carbidopa 25/levodopa 100mg tab ud||carbidopa anhydrous||active_moiety_of
ensulizole 0.03 mg in 1 ml topical liquid [covergirl outlast stay fabulous 3in1 foundation broad spectrum spf 20 - 875 soft sable]||2-phenylbenzimidazole-5-sulphonic acid||active_moiety_of
bismuth 15 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / matricaria chamomilla 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / iris versicolor root 15 [hp_x] in 1 g / potassium dichromate 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / magnesium carbonate 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_m] in 1 g / phosphorus 15 [hp_x] in 1 g / podophyllum 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / radish 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / tobacco leaf 15 [hp_x] in 1 g / verbascum thapsus 15 [hp_x] in 1 g / ginger 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g / juglans regia leaf 6 [hp_x] in 1 g oral pellet [digestive care]||arsenic cation (3)||active_moiety_of
boron gluconate 6 [hp_x] in 1 ml / calcium gluconate 6 [hp_x] in 1 ml / chromium gluconate 6 [hp_x] in 1 ml / cobaltous gluconate 6 [hp_x] in 1 ml / copper gluconate 6 [hp_x] in 1 ml / ferrous gluconate 6 [hp_x] in 1 ml / magnesium gluconate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / potassium gluconate 6 [hp_x] in 1 ml / selenium dioxide 6 [hp_x] in 1 ml / sodium gluconate 6 [hp_x] in 1 ml / zinc gluconate 6 [hp_x] in 1 ml / potassium phosphate, dibasic 8 [hp_x] in 1 ml / nickel 8 [hp_x] in 1 ml / vanadium 8 [hp_x] in 1 ml / tribasic calcium phosphate 9 [hp_x] in 1 ml oral liquid [electrolyte plus]||oxide, selenium||active_moiety_of
xanthium strumarium pollen 0.05 g in 1 ml / plantago lanceolata pollen 0.05 g in 1 ml / chenopodium album pollen 0.05 g in 1 ml / amaranthus retroflexus pollen 0.05 g in 1 ml percutaneous injection, solution [4 weed mix]||amaranthus retroflexus pollen||active_moiety_of
aralia racemosa root 12 [hp_x] in 59 ml / arsenic trioxide 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / strychnos nux-vomica seed 12 [hp_x] in 59 ml / cervus elaphus horn oil 12 [hp_x] in 59 ml / phosphorus 12 [hp_x] in 59 ml / silicon dioxide 12 [hp_x] in 59 ml / sulfur 12 [hp_x] in 59 ml oral liquid [allergies animal hair and dander]||silica, colloidal||active_moiety_of
benzalkonium chloride 0.5 g in 100 ml topical soap [antiseptic liquid]||product containing benzalkonium||active_moiety_of
cinchona officinalis bark 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / nutmeg 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / gelsemium sempervirens root 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / lachesis muta venom 8 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / human herpesvirus 4 30 [hp_x] in 1 ml / human herpesvirus 3 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / poliovirus 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / hepatitis b virus 33 [hp_x] in 1 ml / human coxsackievirus b1 15 [hp_c] in 1 ml / human coxsackievirus b4 15 [hp_c] in 1 ml oral liquid [virosode]||atropa belladonna whole extract||active_moiety_of
octinoxate 75 mg in 1 ml / octisalate 20 mg in 1 ml / octocrylene 40 mg in 1 ml topical lotion [nu skin nu colour advanced finish broad spectrum spf 15 - neutral beige]||2-ethylhexyl-p-methoxycinnamate (substance)||active_moiety_of
mammal liver 6 [hp_x] / magnesium hydroxide 6 [hp_x] / pulsatilla vulgaris 12 [hp_x] / potentilla erecta root 30 [hp_x] oral pellet||mammal liver preparation||active_moiety_of
glycerin 12 g in 150 ml topical spray [hyalucollagen moisture skin]||glycerol product (product)||active_moiety_of
sour cherry 0.05 g in 1 ml intradermal injection, solution||sour cherry||active_moiety_of
arsenic trioxide 6 [hp_x] in 1 ml / atropa belladonna 30 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / activated charcoal 30 [hp_x] in 1 ml / bos taurus pituitary gland, posterior 30 [hp_x] in 1 ml / sodium sulfate 30 [hp_x] in 1 ml / veratrum album root 30 [hp_x] in 1 ml / eriodictyon californicum leaf 12 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / dibasic potassium phosphate 30 [hp_x] in 1 ml sublingual solution [d-43]||veratrum album root extract||active_moiety_of
sklice 5 mg/ml topical lotion||ivermectin (product)||active_moiety_of
product containing precisely raloxifene hydrochloride 60 milligram/1 each conventional release oral tablet||raloxifene (substance)||active_moiety_of
phentermine hydrochloride 37.5 mg (equivalent to phentermine 30 mg) oral tablet||product containing phentermine (medicinal product)||active_moiety_of
potassium chloride 20 meq oral tablet, extended release [klor-con m20]||k+||active_moiety_of
apap extra strength, 500 mg oral tablet||acetaminophen||active_moiety_of
amrix 15mg extended-release capsule||cyclobenzaprine (substance)||active_moiety_of
ascorbic acid/cyanocobalamin/folic acid/niacin/pyridoxine/riboflavin/sodium fluoride/thiamine/vitamin a/vitamin d/vitamin e 60 mg-0.0045 mg-0.3 mg-13.5 mg-1.05 mg-1.2 mg-0.25 mg-1.05 mg-2500 iu-400 iu-15 iu oral tablet, chewable||n-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-l-glutamic acid||active_moiety_of
gnp pain relief extra strength 500mg easy tab tablet||acetaminophen (medication)||active_moiety_of
nitroglycerin 0.4 mg sublingual tablet, orally disintegrating [nitroglycerin]||product containing glyceryl trinitrate||active_moiety_of
calcium chloride 15 [hp_x] in 1 ml / calcium bicarbonate 15 [hp_x] in 1 ml / potassium sulfate 15 [hp_x] in 1 ml / sodium bicarbonate 15 [hp_x] in 1 ml / artemisia abrotanum flowering top 10 [hp_x] in 1 ml / silver nitrate 10 [hp_x] in 1 ml / arsenic trioxide 10 [hp_x] in 1 ml / barium carbonate 10 [hp_x] in 1 ml / sodium borate 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / selenicereus grandiflorus stem 10 [hp_x] in 1 ml / calcium fluoride 10 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / calcium sulfate anhydrous 10 [hp_x] in 1 ml / chelidonium majus 10 [hp_x] in 1 ml / cholesterol 10 [hp_x] in 1 ml / arabica coffee bean 10 [hp_x] in 1 ml / conium maculatum flowering top 10 [hp_x] in 1 ml / solanum dulcamara top 10 [hp_x] in 1 ml / ferrosoferric phosphate 10 [hp_x] in 1 ml / hydrofluoric acid 10 [hp_x] in 1 ml / fumaria officinalis flowering top 10 [hp_x] in 1 ml / gratiola officinalis 10 [hp_x] in 1 ml / helleborus niger root 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / goldenseal 10 [hp_x] in 1 ml / iodine 10 [hp_x] in 1 ml / potassium carbonate 10 [hp_x] in 1 ml / potassium chloride 10 [hp_x] in 1 ml / potassium phosphate, dibasic 10 [hp_x] in 1 ml / lilium lancifolium whole flowering 10 [hp_x] in 1 ml / lycopodium clavatum spore 10 [hp_x] in 1 ml / magnesium chloride 10 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 1 ml / sodium chloride 10 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 10 [hp_x] in 1 ml / sodium sulfate 10 [hp_x] in 1 ml / phosphorus 10 [hp_x] in 1 ml / podophyllum 10 [hp_x] in 1 ml / pulsatilla vulgaris 10 [hp_x] in 1 ml / smilax regelii root 10 [hp_x] in 1 ml / claviceps purpurea sclerotium 10 [hp_x] in 1 ml / selenium 10 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml / silicon dioxide 10 [hp_x] in 1 ml / spigelia anthelmia 10 [hp_x] in 1 ml / sulfur 10 [hp_x] in 1 ml oral liquid [renew]||molecular iodine||active_moiety_of
plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / alternaria alternata 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml / equus caballus hair 0.002 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / oryctolagus cuniculus hair 0.002 g in 1 ml / odocoileus virginianus hair 0.002 g in 1 ml / bos taurus hair 0.002 g in 1 ml subcutaneous injection, solution||domestic dog hair||active_moiety_of
capsicum 3 [hp_x] in 1 ml / fennel seed 3 [hp_x] in 1 ml / comfrey root 3 [hp_x] in 1 ml / silver nitrate 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml oral liquid [gastrotone]||fennel seeds||active_moiety_of
slash pine pollen extract 20000 unt/ml injectable solution||slash pine pollen extract||active_moiety_of
chamomile/coffea arabica/common hop/common oat/nux vomica/passiflora incarnata/sulfur/zincum valerianicum 2 x-12 x-2 x-2 x-12 x-2 x-12 x-6 x oral tablet, disintegrating [homeopathic calm]||coffea moka seed||active_moiety_of
ibuprofen/glycerin@600 mg@oral@kit||ibuprofen product (substance)||active_moiety_of
solidago virgaurea flowering top 3 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / clerodendranthus spicatus leaf 6 [hp_x] in 1 ml / chondrodendron tomentosum root 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / agathosma betulina leaf 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / sus scrofa renal pelvis 8 [hp_x] in 1 ml / turpentine oil 8 [hp_x] in 1 ml / sus scrofa ureter 8 [hp_x] in 1 ml / sus scrofa urethra 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml / acetaldehyde 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / sodium pyruvate 10 [hp_x] in 1 ml / quercetin 10 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / apis mellifera venom 18 [hp_x] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [d2 organ support]||calcium sulphide||active_moiety_of
avobenzone 2 g in 100 g / homosalate 10 g in 100 g / octisalate 5 g in 100 g / oxybenzone 3 g in 100 g topical lotion [no-ad face spf 30 6oz]||oxibenzona||active_moiety_of
horse chestnut 1 [hp_x] / witch hazel 1 [hp_x] / paeonia officinalis root 3 [hp_x] / collinsonia canadensis root 3 [hp_x] / teucrium marum 3 [hp_x] / verbascum thapsus 3 [hp_x] / peumus boldus leaf 1 [hp_x] / sulfur 4 [hp_x] / sodium nitrate 3 [hp_x] / krameria lappacea root 3 [hp_x] / nitric acid 8 [hp_x] / sodium chloride 8 [hp_x] / podophyllum peltatum root 4 [hp_x] / ruta graveolens flowering top 8 [hp_x] / apis mellifera 4 [hp_x] oral pellet [hemorrhoids relief]||paeonia officinalis root||active_moiety_of
benzalkonium chloride 1.33 mg in 1 ml topical swab [bzk]||benzalkonium-containing product||active_moiety_of
drospirenone 3mg/ee 0.03mg tab,28||combined oral contraceptive - ethinyloestradiol||active_moiety_of
camphor 0.04 mg/mg / menthol 0.1 mg/mg / methyl salicylate 0.3 mg/mg topical ointment||menthol (medication)||active_moiety_of
maxzide (hctz 25 mg / triamterene 37.5 mg) oral tablet||hydrochlorothiazidum||active_moiety_of
epinephrine 10 [hp_x] in 59 ml / alfalfa 10 [hp_x] in 59 ml / ambergris 10 [hp_x] in 59 ml / semecarpus anacardium juice 10 [hp_x] in 59 ml / silver nitrate 10 [hp_x] in 59 ml / avena sativa flowering top 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / anhydrous citric acid 10 [hp_x] in 59 ml / carbon monoxide 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / bos taurus hypothalamus 10 [hp_x] in 59 ml / potassium phosphate, dibasic 10 [hp_x] in 59 ml / egg phospholipids 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / sus scrofa pituitary gland 10 [hp_x] in 59 ml / selenium 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / thyroid, unspecified 10 [hp_x] in 59 ml / aesculus hippocastanum flower 10 [hp_x] in 59 ml / carpinus betulus flowering top 10 [hp_x] in 59 ml / olea europaea flower 10 [hp_x] in 59 ml oral liquid [9-1-1 burnout]||perfect choice one minute||active_moiety_of
product containing sertraline 50 mg/1 each oral tablet (clinical drug)||sertralina||active_moiety_of
interferon beta-1a/albumin human@30 mcg (1 ml)@intramusc@kit||interferon beta-1a (hamster)||active_moiety_of
apis mellifera 3 [hp_x] in 1 ml / aloe 4 [hp_x] in 1 ml / sus scrofa cerebrum 6 [hp_x] in 1 ml / sus scrofa pineal gland 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa hypothalamus 8 [hp_x] in 1 ml / apiole (parsley) 12 [hp_x] in 1 ml oral liquid [limbex]||porcine pituitary gland preparation||active_moiety_of
gelsemium sempervirens root 10 [hp_x] in 59 ml / nitroglycerin 10 [hp_x] in 59 ml / iris versicolor root 10 [hp_x] in 59 ml / potassium carbonate 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / nickel 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / sanguinaria canadensis root 10 [hp_x] in 59 ml / claviceps purpurea sclerotium 10 [hp_x] in 59 ml / spigelia anthelmia 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [migraine relief]||ion potassium||active_moiety_of
arnica montana 12 [hp_x] in 1 ml / atropa belladonna 6 [hp_x] in 1 ml / cortisone acetate 24 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / comfrey root 12 [hp_x] in 1 ml oral liquid [relief-tone]||st johnswort||active_moiety_of
cinnamon 3 [hp_x] in 1 ml / gentiana lutea root 3 [hp_x] in 1 ml / syzygium cumini seed 3 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / colchicum autumnale bulb 6 [hp_x] in 1 ml / bos taurus colostrum 6 [hp_x] in 1 ml / copper gluconate 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / magnesium gluconate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / potassium gluconate 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / scrophularia nodosa 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / gold 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / malus pumila flower 8 [hp_x] in 1 ml / nitric acid 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / water 8 [hp_x] in 1 ml / fagus sylvatica flowering top 12 [hp_x] in 1 ml oral liquid [gi drainage]||silver cation||active_moiety_of
lisinopril 20mg tablet||l-proline, 1-(n2-(1-carboxy-3-phenylpropyl)-l-lysyl)-, dihydrate, (s)-||active_moiety_of
claravis 40mg capsule||isotretinoino||active_moiety_of
avobenzone 30 mg in 1 g / homosalate 150 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 100 mg in 1 g / oxybenzone 30 mg in 1 g topical stick [neutrogena wet skin kids beach and pool sunscreen broad spectrum spf70 plus]||homosalato||active_moiety_of
hi-cor, 1% topical cream||hc||active_moiety_of
dimethyl fumarate 120 mg oral capsule||bafiertam||active_moiety_of
benzalkonium chloride 1.2 mg in 1 ml topical cloth [biopure antibacterial hand wipes benzalkonium chloride 0.12% - 250 wipes]||benzalkonium-containing product||active_moiety_of
product containing precisely carvedilol 12.5 milligram/1 each conventional release oral tablet (clinical drug)||carvédilol||active_moiety_of
avobenzone 2 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g / oxybenzone 4 g in 100 g topical lotion [ultrasol nature baby sunscreen]||salicylic acid 2-ethylhexyl ester||active_moiety_of
sus scrofa adrenal gland 6 [hp_x] in 1 g / thyroid, bovine 8 [hp_x] in 1 g / somatropin 12 [hp_x] in 1 g topical cream [viiva bioderma actives hgh cream]||somatropin-containing product||active_moiety_of
cinnamon 12 [hp_x] in 1 ml / echinacea angustifolia 12 [hp_x] in 1 ml / goldenseal 12 [hp_x] in 1 ml / arctium lappa root 12 [hp_x] in 1 ml / trifolium pratense flower 12 [hp_x] in 1 ml oral liquid [regen hp]||cinnamon allergen diagnostic allergen extract||active_moiety_of
cow milk 60 [hp_x] in 1 ml / skim milk 60 [hp_x] in 1 ml / cow milk fat 60 [hp_x] in 1 ml / casein, lactococcus lactis cultured, aged 60 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium roqueforti cultured, aged 60 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium camemberti cultured, aged 60 [hp_x] in 1 ml / barley 60 [hp_x] in 1 ml / corn 60 [hp_x] in 1 ml / wheat gluten 60 [hp_x] in 1 ml / oat 60 [hp_x] in 1 ml / white rice 60 [hp_x] in 1 ml / rye 60 [hp_x] in 1 ml / wheat 60 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / hyoscyamus niger 15 [hp_x] in 1 ml / solanum nigrum whole 15 [hp_x] in 1 ml / datura stramonium 15 [hp_x] in 1 ml / tobacco leaf 15 [hp_x] in 1 ml / solanum lycopersicum 15 [hp_x] in 1 ml / lactose 15 [hp_x] in 1 ml / solanum tuberosum 15 [hp_x] in 1 ml / saccharomyces cerevisiae 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / antimony trisulfide 10 [hp_x] in 1 ml / silver nitrate 10 [hp_x] in 1 ml / arsenic trioxide 10 [hp_x] in 1 ml / baptisia tinctoria root 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / centaurea benedicta 10 [hp_x] in 1 ml / cinchona officinalis bark 10 [hp_x] in 1 ml / gelsemium sempervirens root 10 [hp_x] in 1 ml / ipecac 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / sodium chloride 10 [hp_x] in 1 ml / phosphorus 10 [hp_x] in 1 ml / podophyllum 10 [hp_x] in 1 ml / pulsatilla vulgaris 10 [hp_x] in 1 ml / toxicodendron pubescens leaf 10 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml / elymus repens root 10 [hp_x] in 1 ml / verbascum thapsus 10 [hp_x] in 1 ml / iris versicolor root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / lycopodium clavatum spore 10 [hp_x] in 1 ml oral liquid [dairy - grain - nightshades]||cow's milk||active_moiety_of
homosalate 10 g in 100 ml / octisalate 2.6 g in 100 ml / octocrylene 2.4 g in 100 ml / oxybenzone 5 g in 100 ml / avobenzone 3 g in 100 ml topical cream [sun protection emulsion face broad spectrum spf 30 la prairie group]||bmdbm cpd||active_moiety_of
hydrochlorothiazide 50 mg oral tablet [hydrokraft]||hydrochlorothiazide-containing product||active_moiety_of
hamamelis virginiana bark 4 [hp_x] in 20 ml / mercurialis perennis 4 [hp_x] in 20 ml / crataegus fruit 4 [hp_x] in 20 ml / copper 12 [hp_x] in 20 ml / achillea millefolium 4 [hp_x] in 20 ml / equisetum arvense branch 4 [hp_x] in 20 ml / capsella bursa-pastoris 4 [hp_x] in 20 ml / selenicereus grandiflorus stem 4 [hp_x] in 20 ml oral liquid [unda 8]||mercurialis perennis extract||active_moiety_of
alcohol 325 ml in 500 ml / propyl alcohol 45 g in 500 ml extracorporeal gel||propan-1-ol||active_moiety_of
phenylalanine 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / ascorbic acid 4 [hp_c] in 1 ml / iron 6 [hp_c] in 1 ml / ferric chloride hexahydrate 6 [hp_c] in 1 ml / ferrosoferric phosphate 6 [hp_c] in 1 ml / ferrous sulfate 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / corticotropin 8 [hp_c] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml / enterococcus faecalis 30 [hp_c] in 1 ml oral liquid [iron mix system formula]||rutoside||active_moiety_of
zinc oxide 60 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 50 mg in 1 ml topical lotion [jacket spf-50 broad spectrum sunscreen]||octyl salicylate (substance)||active_moiety_of
gabapentin 600 mg oral tablet, film coated [gabapentin]||1-(aminomethyl)cyclohexaneacetic acid||active_moiety_of
avena sativa flowering top 3 [hp_x] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / scrophularia nodosa 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / artemisia cina pre-flowering top 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / mercury 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / selenium 30 [hp_c] in 1 ml oral liquid [progena lyme disease]||artemisia cina pre-flowering top||active_moiety_of
alcohol 62 g in 100 ml topical liquid [justice mixed berry anti bac hand sanitizer]||alcohol, denatured||active_moiety_of
solanum dulcamara top 4 [hp_x] in 1 ml / echinacea angustifolia 4 [hp_x] in 1 ml / horse chestnut 6 [hp_x] in 1 ml / antimony potassium tartrate 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / protortonia cacti 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / gentiana lutea root 6 [hp_x] in 1 ml / geranium robertianum 6 [hp_x] in 1 ml / anemone pratensis 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / acetylcholine chloride 6 [hp_x] in 1 ml / mannose, d- 6 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / sus scrofa umbilical cord 10 [hp_x] in 1 ml / pork liver 10 [hp_x] in 1 ml / sus scrofa hypothalamus 10 [hp_x] in 1 ml / sus scrofa bone marrow 10 [hp_x] in 1 ml / sus scrofa spleen 10 [hp_x] in 1 ml / cortisone acetate 13 [hp_x] in 1 ml / sus scrofa adrenal gland 13 [hp_x] in 1 ml / mercurius solubilis 13 [hp_x] in 1 ml / sus scrofa thyroid 13 [hp_x] in 1 ml / barium carbonate 28 [hp_x] in 1 ml / sus scrofa tonsil 28 [hp_x] in 1 ml oral liquid [bio tonsilla phase]||calcium 2+||active_moiety_of
amanita muscaria fruiting body 800 [hp_c] in 1 ml / copper 18 [hp_x] in 1 ml / iodine 21 [hp_x] in 1 ml / bufo bufo cutaneous gland 21 [hp_x] in 1 ml / thyroid, porcine 21 [hp_x] in 1 ml oral liquid [emvita 18]||thyroid, pork||active_moiety_of
ambrosia psilostachya pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia trifida pollen 0.0000267 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya alba pollen 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / ustilago nuda hordei 0.0001 g in 1 ml / ustilago maydis 0.0001 g in 1 ml / ustilago avenae 0.0001 g in 1 ml / ustilago tritici 0.0001 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / alternaria alternata 0.002 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / candida albicans 0.00008 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml intradermal injection, solution||betula nigra pollen extract||active_moiety_of
populus alba pollen extract 50 mg/ml injectable solution||white poplar pollen extract||active_moiety_of
health mart ibuprofen pm 200mg-38mg caplet||ethanamine, 2-(diphenylmethoxy)-n,n-dimethyl-||active_moiety_of
nulytely 4 liter jug powder for solution||potassium ion||active_moiety_of
homosalate 99 mg in 1 ml / oxybenzone 29.7 mg in 1 ml / avobenzone 29.7 mg in 1 ml / octisalate 49.5 mg in 1 ml / octocrylene 27.23 mg in 1 ml topical lotion [solmate broad spectrum spf 50 sport sunscreen]||benzophenone-3||active_moiety_of
pentobarbital sodium 50 mg/ml injectable solution [nembutal]||2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-||active_moiety_of
ondansetron hydrochloride 8mg oral tablet||ondansetron-containing product||active_moiety_of
amlodipine besylate 5 mg and atorvastatin 80 mg oral tablet||atorvastatin||active_moiety_of
protortonia cacti 3 [hp_c] in 1 ml / sus scrofa lung 3 [hp_c] in 1 ml / strychnos ignatii seed 34 [hp_c] in 1 ml / causticum 233 [hp_c] in 1 ml / sodium chloride 233 [hp_c] in 1 ml oral liquid [mbm 7 lung]||causticum||active_moiety_of
niacinamide 2 g in 100 g / adenosine 0.04 g in 100 g topical cream [queen purecell whitening repair finalizing]||β-pyridinecarboxamide||active_moiety_of
isopropyl alcohol 2142.88 g in 3380.08 g topical gel [antibac-7000]||isopropyl alcohol-containing product||active_moiety_of
glycyrrhiza glabra 3 [hp_x] in 1 ml / aloe 4 [hp_x] in 1 ml / astacus astacus 6 [hp_x] in 1 ml / berberis aquifolium root bark 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / sodium carbonate 6 [hp_x] in 1 ml / sucrose 6 [hp_x] in 1 ml / bos taurus bile 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / pancrelipase 8 [hp_x] in 1 ml / fragaria vesca fruit 9 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / euphorbia resinifera resin 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / magnesium carbonate 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / proteus inconstans 15 [hp_x] in 1 ml oral liquid [leaky gut formula]||ox bile extract (medication)||active_moiety_of
amanita muscaria fruiting body 12 [hp_x] in 1 ml / protortonia cacti 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / gelsemium sempervirens root 30 [hp_x] in 1 ml / influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / latrodectus mactans 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / citharacanthus spinicrus 30 [hp_x] in 1 ml / clostridium botulinum 30 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml / pseudomonas aeruginosa 30 [hp_x] in 1 ml / proteus morganii 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / clostridium perfringens 15 [hp_c] in 1 ml / human herpesvirus 4 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / poliovirus 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [neurotox]||lycopodium clavatum spore extract||active_moiety_of
alcohol 70 ml in 100 ml topical liquid [nano mini raspberry hand sanitizer]||dehydrated ethanol||active_moiety_of
alcohol 62 g in 100 g topical aerosol, foam [alcare or foamed antiseptic handrub]||etoh - alcohol||active_moiety_of
activated charcoal 200 [kp_c] in 200 [kp_c] oral pellet [carbo vegetabilis]||activate charcoal||active_moiety_of
product containing prednisone 5 mg/1 each oral tablet||product containing prednisone||active_moiety_of
avobenzone 18 mg in 1 g / octisalate 30 mg in 1 g / octocrylene 48 mg in 1 g / homosalate 60 mg in 1 g topical aerosol, spray [bondi sands fragrance free spf 30 sunscreen]||octocrilene-containing product||active_moiety_of
zinc 15 [hp_x] in 1 ml / matricaria chamomilla 6 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / gold 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / black cohosh 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / strychnos ignatii seed 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lilium lancifolium whole flowering 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / sodium carbonate 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / phosphoric acid 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / picric acid 15 [hp_x] in 1 ml / lead 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / datura stramonium 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / hypericum perforatum 6 [hp_x] in 1 ml / valerian 6 [hp_x] in 1 ml oral liquid [stress-tension]||carbonate||active_moiety_of
metoprolol succinate 50 mg oral tablet, extended release [metoprolol succinate avpak]||metoprolol (substance)||active_moiety_of
allantoin 0.05 g in 100 g topical liquid [kenaf wet wipe kids]||allantoin||active_moiety_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / formaldehyde 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / adenosine triphosphate disodium 12 [hp_x] in 1 ml / alternaria alternata 12 [hp_x] in 1 ml / aspergillus niger var. niger 12 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml / candida parapsilosis 12 [hp_x] in 1 ml / mucor racemosus 12 [hp_x] in 1 ml / aureobasidium pullulans var. pullutans 12 [hp_x] in 1 ml / rhizopus stolonifer 12 [hp_x] in 1 ml / saccharomyces cerevisiae 12 [hp_x] in 1 ml / methylcobalamin 12 [hp_x] in 1 ml / lactic acid, l- 12 [hp_x] in 1 ml / stachybotrys chartarum 12 [hp_x] in 1 ml / escherichia coli 30 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [fng]||myrrh (commiphora myrrha)||active_moiety_of
cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.0004 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / carya alba pollen 0.0002 g in 1 ml / carya illinoinensis pollen 0.0002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml intradermal injection, solution||allergenic extract,grass,bermuda||active_moiety_of
camphor (synthetic) 48 mg in 1 g / eucalyptus oil 12 mg in 1 g / menthol, unspecified form 26 mg in 1 g topical ointment [cvs health medicated chest rub]||synthetic camphor||active_moiety_of
avobenzone 30 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [garnier skin renew dark spot hand treatment broad spectrum spf 30]||avobenzone (product)||active_moiety_of
plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / avena sativa pollen 0.00008 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.00008 g in 1 ml / felis catus hair 80 [bau] in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / juglans nigra pollen 0.0004 g in 1 ml / broussonetia papyrifera pollen 0.00067 g in 1 ml / morus rubra pollen 0.00067 g in 1 ml / morus alba pollen 0.00067 g in 1 ml subcutaneous injection, solution||populus alba pollen||active_moiety_of
lisinopril 30 mg oral tablet, film coated||lisinopril anhydrous||active_moiety_of
atropa belladonna 10 [hp_x] in 59 ml / bellis perennis 10 [hp_x] in 59 ml / benzoic acid 10 [hp_x] in 59 ml / causticum 10 [hp_x] in 59 ml / equisetum hyemale 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / plantago major 10 [hp_x] in 59 ml / rhus aromatica root bark 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml oral liquid [bed wetting prevention]||lycopodium clavatum spore extract||active_moiety_of
dextrose monohydrate 50 g in 1000 ml / sodium chloride 2.25 g in 1000 ml / potassium chloride 1.49 g in 1000 ml intravenous injection, solution [potassium chloride in dextrose and sodium chloride]||potassium cation||active_moiety_of
arnica montana 12 [hp_x] in 30 ml / gold 12 [hp_x] in 30 ml / ubidecarenone 3 [hp_x] in 30 ml / sus scrofa diencephalon 6 [hp_x] in 30 ml / fumaric acid 3 [hp_x] in 30 ml / sus scrofa adrenal gland 200 [hp_x] in 30 ml / pork kidney 6 [hp_x] in 30 ml / melatonin 4 [hp_c] in 30 ml / melilotus 6 [hp_x] in 30 ml / sodium pyruvate 3 [hp_x] in 30 ml / olea europaea flower 3 [hp_x] in 30 ml / lead 12 [hp_x] in 30 ml / rauwolfia serpentina 6 [hp_x] in 30 ml / spigelia 6 [hp_x] in 30 ml / viscum album fruit 3 [hp_x] in 30 ml oral solution/ drops [guna-hypertension]||sus scrofa adrenal gland||active_moiety_of
methylphenidate 18 mg/24 hr oral tablet, extended release||methylphenidan||active_moiety_of
semecarpus anacardium juice 12 [hp_x] in 1 ml / apis mellifera 200 [hp_c] in 1 ml / activated charcoal 200 [hp_c] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / anamirta cocculus seed 30 [hp_c] in 1 ml / potassium phosphate, dibasic 12 [hp_x] in 1 ml / strychnos nux-vomica seed 30 [hp_c] in 1 ml / passiflora incarnata top 1 [hp_x] in 1 ml / phosphoric acid 200 [hp_c] in 1 ml / tobacco leaf 6 [hp_x] in 1 ml oral spray [jet lag]||potassium ions||active_moiety_of
sodium chloride 600 mg in 100 ml / potassium chloride 30 mg in 100 ml / calcium chloride 20 mg in 100 ml / sodium lactate 310 mg in 100 ml subcutaneous solution [gms electrolyte solution compound sodium lactate hartmanns]||sodium cation||active_moiety_of
biotene pbf dry mouth toothpaste, oral paste||fluoride ion (substance)||active_moiety_of
cladribine 10mg tab dosepak,4||cladribine (medication)||active_moiety_of
donepezil hydrochloride 10 mg oral tablet||donepezil (product)||active_moiety_of
sulfamethoxazole/trimethoprim 800 mg-160 mg oral tablet [sulfamethoxazole/trimethoprim ds]||sulfamethoxazole - chemical (substance)||active_moiety_of
sodium monofluorophosphate 0.76 g in 100 g dental paste, dentifrice [white glo coffee tea drinkers formula]||fluoride ion||active_moiety_of
fluoroestradiol f 18 intravenous solution [cerianna]||16-alpha-(18-fluoro)-17betaestradiol||active_moiety_of
paracetamol 325mg/hydrocodone 7.5mg tablet||hydrocodone-containing product||active_moiety_of
octinoxate 60 mg in 1500 mg / titanium dioxide 18.9 mg in 1500 mg topical lotion [flawless finish perfectly nude makeup broad spectrum sunscreen spf 15 shade amber]||titanium dioxide product||active_moiety_of
guaifenesin 1200 mg / dextromethorphan hydrobromide 60 mg oral tablet, extended release [rugby mucus relief dm]||(+)-dextromethorphan||active_moiety_of
agrostis gigantea pollen 25000 [bau] in 1 ml / poa pratensis pollen 25000 [bau] in 1 ml / dactylis glomerata pollen 25000 [bau] in 1 ml / phleum pratense pollen 25000 [bau] in 1 ml subcutaneous solution [k-o-r-t standardized grass pollen mix]||oralair 100||active_moiety_of
aconitum napellus 20 [hp_x] in 1 ml / epinephrine 20 [hp_x] in 1 ml / american ginseng 20 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / baptisia tinctoria 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / chelidonium majus 20 [hp_x] in 1 ml / cinchona officinalis bark 20 [hp_x] in 1 ml / iodine 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / potassium iodide 20 [hp_x] in 1 ml / lachesis muta venom 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / lycopus virginicus 20 [hp_x] in 1 ml / sodium chloride 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / anemone pulsatilla 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / saw palmetto 20 [hp_x] in 1 ml / thyroid, unspecified 20 [hp_x] in 1 ml / echinacea, unspecified 11 [hp_x] in 1 ml / ginkgo 11 [hp_x] in 1 ml / phytolacca americana root 11 [hp_x] in 1 ml oral liquid [exhaustion]||pulsatilla vulgaris||active_moiety_of
product containing only ibuprofen 600 mg/1 each oral tablet (clinical drug)||ibuprofen (otc)||active_moiety_of
entex lq, 100 mg-10 mg/5 ml oral liquid||guaifenesin||active_moiety_of
benzalkonium chloride 0.13 g in 100 g topical swab [bzk antiseptic towelette]||benzalkonium product||active_moiety_of
dryopteris filix-mas root 1 [hp_x] in 1 ml / artemisia vulgaris root 2 [hp_x] in 1 ml / artemisia cina pre-flowering top 3 [hp_x] in 1 ml / melilotus officinalis top 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / teucrium marum 3 [hp_x] in 1 ml / thymus serpyllum 3 [hp_x] in 1 ml / spigelia anthelmia 6 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / schoenocaulon officinale seed 12 [hp_x] in 1 ml / ascaris lumbricoides 15 [hp_x] in 1 ml / trichinella spiralis 15 [hp_x] in 1 ml / enterobius vermicularis 33 [hp_x] in 1 ml / taenia solium 12 [hp_c] in 1 ml / trichomonas vaginalis 13 [hp_c] in 1 ml / giardia lamblia 18 [hp_c] in 1 ml / cryptosporidium parvum 20 [hp_c] in 1 ml / taenia saginata 20 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [ver]||graphites||active_moiety_of
acyclovir, 800 mg oral tablet||product containing aciclovir (medicinal product)||active_moiety_of
amlodipine 5 mg / valsartan 320 mg oral tablet||diovan [brand name]||active_moiety_of
alcohol 60 ml in 100 ml topical gel [germ nix antibacterial hand sanitizer]||ethanols||active_moiety_of
octinoxate 74 mg in 1 ml / titanium dioxide 61 mg in 1 ml topical liquid [buxom show some skin weightless foundation broad spectrum spf 30 sweet as honey]||dióxido de titanio||active_moiety_of
felis catus hair 16 [bau] in 1 ml / dermatophagoides farinae 400 [au] in 1 ml / alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / ustilago cynodontis 0.00004 g in 1 ml / sporisorium cruentum 0.00004 g in 1 ml intradermal injection, solution||cat hair (felis domesticus) standardized||active_moiety_of
barium carbonate 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / fucus vesiculosus 30 [hp_x] in 1 ml / iodine 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 30 [hp_x] in 1 ml / sus scrofa thyroid 30 [hp_x] in 1 ml oral liquid [thyroid hp]||oyster shell calcium carbonate preparation||active_moiety_of
plantago lanceolata pollen 0.00008 g in 1 ml / chenopodium album pollen 0.0004 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / ambrosia artemisiifolia pollen 160 [au] in 1 ml / rumex acetosella pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / betula populifolia pollen 0.002 g in 1 ml / acer negundo pollen 0.0004 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / populus deltoides pollen 0.0004 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.00008 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.0004 g in 1 ml / morus rubra pollen 0.00008 g in 1 ml subcutaneous injection, solution||big-bud hickory pollen||active_moiety_of
octisalate 50 mg in 1 ml / homosalate 100 mg in 1 ml / octocrylene 50 mg in 1 ml / avobenzone 23 mg in 1 ml topical lotion [shiseido ultimate sun protector]||product containing avobenzone||active_moiety_of
juniperus virginiana twig 30 [hp_c] in 30 [hp_c] oral pellet [juniperus virginiana]||juniperus virginiana twig extract||active_moiety_of
wormwood 15 [hp_x] in 1 ml / semecarpus anacardium juice 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / atropa belladonna 20 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / camphor (natural) 15 [hp_x] in 1 ml / matricaria chamomilla 15 [hp_x] in 1 ml / black cohosh 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / arabica coffee bean 15 [hp_x] in 1 ml / cypripedium parviflorum var. pubescens root 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / hops 15 [hp_x] in 1 ml / hyoscyamus niger 15 [hp_x] in 1 ml / strychnos ignatii seed 15 [hp_x] in 1 ml / potassium bromide 15 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / passiflora incarnata flowering top 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / scutellaria lateriflora whole 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / valerian 11 [hp_x] in 1 ml oral liquid [insomnia]||thuja occidentalis leafy twig||active_moiety_of
aconitum napellus 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / arnica montana 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / atropa belladonna 10 [hp_x] in 59 ml / bellis perennis 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / calendula officinalis flowering top 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / clematis recta flowering top 10 [hp_x] in 59 ml / clematis vitalba flower 10 [hp_x] in 59 ml / ferrosoferric phosphate 10 [hp_x] in 59 ml / histamine dihydrochloride 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / impatiens glandulifera flower 10 [hp_x] in 59 ml / ornithogalum umbellatum flowering top 10 [hp_x] in 59 ml / passiflora incarnata flowering top 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / prunus cerasifera flower 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / comfrey root 10 [hp_x] in 59 ml / veratrum album root 10 [hp_x] in 59 ml oral liquid [serenity remedy no. 12]||symphytum officinale rhizome/root extract||active_moiety_of
arginine hydrochloride 120 mg / lycopene 0.1 mg / niacin 25 mg / pyridoxine hydrochloride 5 mg / .alpha.-tocopherol acetate, dl- 10 mg / zinc oxide 20 mg / panax ginseng leaf 400 mg / hydrolysed lepidium meyenii root (enzymatic) 400 mg / ginkgo biloba root 1000 mg / tribulus terrestris root 500 mg / guarana 100 mg oral capsule||tribulus terrestris root extract||active_moiety_of
chelidonium majus 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / gentiana lutea root 3 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml oral liquid [allerstat i]||activated charcoal - chemical||active_moiety_of
zinc gluconate 1 [hp_x] / eupatorium perfoliatum flowering top 1 [hp_x] / sambucus nigra flower 1 [hp_x] / valerian 1 [hp_x] / chamomile 2 [hp_x] / mentha piperita 2 [hp_x] / myrrh 2 [hp_x] / glycyrrhiza glabra leaf 3 [hp_x] oral tablet, orally disintegrating [cold-eeze plus nighttime multi-symptom relief]||glycyrrhiza glabra leaf extract||active_moiety_of
echinacea angustifolia 1 [hp_x] in 1 ml / cow milk 30 [hp_x] in 1 ml / lobelia inflata 3 [hp_x] in 1 ml / passiflora incarnata flowering top 1 [hp_x] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_x] in 1 ml / thymus serpyllum 1 [hp_x] in 1 ml / valerian 1 [hp_x] in 1 ml / atropa belladonna 4 [hp_x] in 1 ml / sambucus nigra flowering top 1 [hp_x] in 1 ml / protortonia cacti 4 [hp_x] in 1 ml / hedera helix flowering twig 3 [hp_x] in 1 ml / ipecac 30 [hp_x] in 1 ml / potassium nitrate 8 [hp_x] in 1 ml / corallium rubrum exoskeleton 10 [hp_x] in 1 ml / copper 10 [hp_x] in 1 ml / drosera rotundifolia 2 [hp_x] in 1 ml / goldenseal 2 [hp_x] in 1 ml / blatta orientalis 3 [hp_x] in 1 ml sublingual solution/ drops [b14 bronchotox]||golden seal extract||active_moiety_of
product containing precisely quetiapine (as quetiapine fumarate) 100 milligram/1 each conventional release oral tablet (clinical drug)||product containing quetiapine||active_moiety_of
uloric, 80 mg oral tablet||febuxostatum||active_moiety_of
premier value lubricant eye drops 0.4%-0.3% ophthalmic solution||peg 400||active_moiety_of
avobenzone 30 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 27.5 mg in 1 ml topical lotion [everyday nourishing broad spectrum spf30 sunscreen uva-uvb suncreen]||2-ethylhexyl 2-hydroxybenzoate||active_moiety_of
product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug)||17-ethinyl-3,17-estradiol||active_moiety_of
benzalkonium chloride 0.05 g in 100 ml topical liquid [dr.toc perfect clean hand wash]||product containing benzalkonium (medicinal product)||active_moiety_of
titanium dioxide 72 g in 1000 g / zinc oxide 90 g in 1000 g topical lotion [eltamd uv luminous]||titanium oxide||active_moiety_of
octisalate 4.9 g in 100 ml / homosalate 9.8 g in 100 ml / octocrylene 9.5 g in 100 ml / avobenzone 2.8 g in 100 ml topical spray [play antioxidant body mist spf 50 with vitamin c]||benzoic acid, 2-hydroxy-, 2-ethylhexyl ester||active_moiety_of
nickel sulfate hexahydrate 36 ug in 48 h / lanolin alcohols 810 ug in 48 h / neomycin sulfate 486 ug in 48 h / potassium dichromate 15.7 ug in 48 h / benzocaine 378 ug in 48 h / tetracaine hydrochloride 66 ug in 48 h / dibucaine hydrochloride 66 ug in 48 h / geraniol 81 ug in 48 h / cinnamaldehyde 41 ug in 48 h / cinnamyl alcohol 63 ug in 48 h / hydroxycitronellal 63 ug in 48 h / eugenol 41 ug in 48 h / isoeugenol 17 ug in 48 h / .alpha.-amylcinnamaldehyde 17 ug in 48 h / evernia prunastri 81 ug in 48 h / rosin 972 ug in 48 h / propylparaben 162 ug in 48 h / methylparaben 162 ug in 48 h / ethylparaben 162 ug in 48 h / butylparaben 162 ug in 48 h / benzylparaben 162 ug in 48 h / balsam peru 648 ug in 48 h / ethylenediamine 18 ug in 48 h / cobaltous chloride hexahydrate 4 ug in 48 h cutaneous patch [t.r.u.e. test panel 1.3]||propyl parahydroxybenzoate||active_moiety_of
sorghum halepense pollen 0.0029 g in 1 ml / lolium perenne pollen 5882 [bau] in 1 ml / fraxinus americana pollen 0.0029 g in 1 ml / populus deltoides pollen 0.0029 g in 1 ml / ulmus americana pollen 0.0029 g in 1 ml / platanus occidentalis pollen 0.0029 g in 1 ml / juglans nigra pollen 0.0029 g in 1 ml / plantago lanceolata pollen 0.0029 g in 1 ml / bassia scoparia pollen 0.0029 g in 1 ml / chenopodium album pollen 0.0029 g in 1 ml / amaranthus retroflexus pollen 0.0029 g in 1 ml / salsola kali pollen 0.0029 g in 1 ml / ambrosia trifida pollen 0.00145 g in 1 ml / ambrosia artemisiifolia pollen 0.00145 g in 1 ml / cyclachaena xanthifolia pollen 0.00145 g in 1 ml / iva annua pollen 0.00145 g in 1 ml / quercus virginiana pollen 0.00097 g in 1 ml / quercus rubra pollen 0.00097 g in 1 ml / quercus alba pollen 0.00097 g in 1 ml / acer saccharum pollen 0.00097 g in 1 ml / acer rubrum pollen 0.00097 g in 1 ml / acer saccharinum pollen 0.00097 g in 1 ml / betula lenta pollen 0.00048 g in 1 ml / betula papyrifera pollen 0.00048 g in 1 ml / betula nigra pollen 0.00048 g in 1 ml / betula occidentalis pollen 0.00048 g in 1 ml / betula populifolia pollen 0.00048 g in 1 ml / betula alleghaniensis pollen 0.00048 g in 1 ml intradermal injection, solution||acer saccharinum pollen||active_moiety_of
ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / candida albicans 0.00008 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml subcutaneous injection, solution||bermuda grass smut allergenic extract||active_moiety_of
titanium dioxide 20 mg in 1 g topical stick [flormar delicious lip stylo sunscreen broad spectrum spf 15 ds09 delicious abstract melon]||titanium dioxide product||active_moiety_of
homosalate 15 ml in 100 ml / octisalate 5 ml in 100 ml / octocrylene 7 ml in 100 ml / avobenzone 3 ml in 100 ml topical lotion [ocean potion cool dry touch sport 30 sunscreen]||salicylic acid 2-ethylhexyl ester||active_moiety_of
amphetamine-dextroamphetamine 7.5 mg oral tablet||amphetamine (d-)||active_moiety_of
triticum aestivum whole 1 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / rhamnus cathartica fruit 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / glycyrrhiza glabra 6 [hp_x] in 1 ml / stillingia sylvatica root 6 [hp_x] in 1 ml / trifolium pratense flower 6 [hp_x] in 1 ml / zanthoxylum americanum bark 6 [hp_x] in 1 ml / acetone 9 [hp_x] in 1 ml / sodium tripolyphosphate 12 [hp_x] in 1 ml / propylene glycol 12 [hp_x] in 1 ml / sodium benzenesulfonate 12 [hp_x] in 1 ml / ammonium chloride 12 [hp_x] in 1 ml / sodium lauryl sulfate 12 [hp_x] in 1 ml / turpentine oil 12 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml oral liquid [envirotox]||acid, nitric||active_moiety_of
avena sativa whole 1 [hp_x] in 1 ml / valeriana officinalis whole 1 [hp_x] in 1 ml / humulus lupulus whole 2 [hp_x] in 1 ml / arabica coffee bean 4 [hp_x] in 1 ml / strychnos ignatii whole 6 [hp_x] in 1 ml / zinc valerate dihydrate 9 [hp_x] in 1 ml / ammonium bromide 3 [hp_x] in 1 ml / chamomile 4 [hp_x] in 1 ml / eschscholzia californica 2 [hp_x] in 1 ml / passiflora incarnata whole 2 [hp_x] in 1 ml sublingual solution [d14]||bromide ions||active_moiety_of
ringer-lactate solution||potassium(i) cation||active_moiety_of
citharacanthus spinicrus 6 [hp_c] in 6 [hp_c] oral pellet [tarentula cubensis]||citharacanthus spinicrus preparation||active_moiety_of
cinacalcet 90mg tablet (product)||product containing cinacalcet (medicinal product)||active_moiety_of
menthol 3 g in 100 ml transdermal liniment [yun xiang jing]||mentol||active_moiety_of
onion 1 [hp_x] in 1 ml / echinacea angustifolia whole 1 [hp_x] in 1 ml / sucrose 200 [hp_x] in 1 ml / scrophularia nodosa 30 [hp_x] in 1 ml / candida albicans 200 [hp_x] in 1 ml / calcium iodide 30 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / chelidonium majus 30 [hp_x] in 1 ml / artemisia cina pre-flowering top 3 [hp_x] in 1 ml / colchicum autumnale bulb 30 [hp_x] in 1 ml / echinacea purpurea 1 [hp_x] in 1 ml / achillea millefolium 1 [hp_x] in 1 ml / cow milk 200 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / uric acid 15 [hp_x] in 1 ml / cinchona officinalis bark 3 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / solidago virgaurea flowering top 1 [hp_x] in 1 ml / garlic 1 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / arsenic triiodide 15 [hp_x] in 1 ml / asterias rubens 8 [hp_x] in 1 ml / indole 30 [hp_x] in 1 ml / lactic acid, dl- 200 [hp_x] in 1 ml / lactic acid, l- 200 [hp_x] in 1 ml / skatole 30 [hp_x] in 1 ml sublingual solution/ drops [a04 deep antitox]||milk, cow||active_moiety_of
citalopram hydrobromide 10mg tab||citalopram (product)||active_moiety_of
alternaria alternata 0.00017 g in 1 ml / felis catus hair 1.33 [bau] in 1 ml / dermatophagoides pteronyssinus 833.33 [au] in 1 ml / platanus occidentalis pollen 0.0083 g in 1 ml / morus rubra pollen 0.0083 g in 1 ml / juniperus virginiana pollen 0.0083 g in 1 ml / ambrosia artemisiifolia pollen 16666 [au] in 1 ml subcutaneous injection, solution||european house dust mite||active_moiety_of
avodart 0.5 mg oral capsule||17beta-n-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one||active_moiety_of
gabapentin 600 mg oral tablet||gralise||active_moiety_of
amoxicillin 500 milligram in 1 tablet oral tablet, film coated [amoxicillin]||(2s,5r,6r)-6-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid||active_moiety_of
product containing only bicalutamide 50 mg/1 each oral tablet (clinical drug)||4'-cyano-alpha,alpha,alpha-trifuloro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide||active_moiety_of
bivalirudin 250 mg intraven vial with threaded port (ea)||bivalirudin||active_moiety_of
avobenzone 2 g in 100 ml / homosalate 4 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 3 g in 100 ml topical lotion [aloe up sport spf-15]||octocrylene-containing product||active_moiety_of
antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / azadirachta indica bark 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / lycoperdon utriforme fruiting body 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / croton tiglium seed 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / kerosene 15 [hp_x] in 1 ml / pulex irritans 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / rumex crispus root 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / urtica urens 3 [hp_x] in 1 ml oral liquid [skin - hair care]||anemone pulsatilla extract||active_moiety_of
fraxinus americana pollen 0.05 g in 1 ml / fagus grandifolia pollen 0.05 g in 1 ml / betula nigra pollen 0.05 g in 1 ml / juglans nigra pollen 0.05 g in 1 ml / populus deltoides pollen 0.05 g in 1 ml / ulmus americana pollen 0.05 g in 1 ml / carya ovata pollen 0.05 g in 1 ml / acer saccharum pollen 0.05 g in 1 ml / quercus rubra pollen 0.05 g in 1 ml / platanus occidentalis pollen 0.05 g in 1 ml / salix nigra pollen 0.05 g in 1 ml percutaneous injection, solution [pollens - trees, tree mix 11]||tree pollen-shagbark hickory||active_moiety_of
gelsemium sempervirens root 3 [hp_x] oral pellet||gelsemium sempervirens root||active_moiety_of
alcohol 68 ml in 100 ml topical gel [anti-bacterial hand island margarita]||alcohol, denatured||active_moiety_of
cynanchum vincetoxicum root 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / methylcobalamin 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / apc-356433 8 [hp_x] in 1 ml / apc-356434 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / gamboge 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / 7-keto-dehydroepiandrosterone 30 [hp_x] in 1 ml / adenosine triphosphate disodium 30 [hp_x] in 1 ml / glucagon 30 [hp_x] in 1 ml / insulin pork 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [lean love]||angustifolia echinacea||active_moiety_of
magnesium sulfate/sodium chloride 4 gm/100 ml-0.9% intravenous solution||mg+2||active_moiety_of
alcohol 0.8 l in 1 l topical gel [hand sanitizer]||ethyl alcohol||active_moiety_of
magnesium hydroxide 1200 mg in 15 ml oral suspension [topcare milk of magnesia]||hydroxide||active_moiety_of
ranitidine hydrochloride 75 mg oral tablet [good sense acid reducer]||1,1-ethenediamine, n-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-||active_moiety_of
baptisia tinctoria root 3 [hp_x] in 1 ml / marsdenia condurango bark 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / ligusticum porteri root 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / astragalus nuttallii leaf 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / ipecac 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / hydrochloric acid 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / human herpesvirus 4 30 [hp_x] in 1 ml oral liquid [ebv/cfs plus]||nitric acid (substance)||active_moiety_of
alfalfa 10 [hp_x] in 59 ml / ambergris 10 [hp_x] in 59 ml / semecarpus anacardium juice 10 [hp_x] in 59 ml / silver nitrate 10 [hp_x] in 59 ml / gold 10 [hp_x] in 59 ml / avena sativa flowering top 10 [hp_x] in 59 ml / dieffenbachia seguine 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / anamirta cocculus seed 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / potassium phosphate, dibasic 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / selenium 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [recharge remedy no. 18]||ambergris||active_moiety_of
arnica montana 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / matricaria recutita 12 [hp_x] in 1 ml / wood creosote 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral liquid [teething]||quso f-22||active_moiety_of
niacinamide 1.00 g in 50 ml / adenosine 0.02 g in 50 ml topical cream [botanic heal boh probioderm repair lifting]||adenosine preparation (product)||active_moiety_of
arsenic trioxide 10 [hp_x] in 59 ml / dieffenbachia seguine 10 [hp_x] in 59 ml / phenol 10 [hp_x] in 59 ml / daphne odora bark 10 [hp_x] in 59 ml / syzygium jambos seed 10 [hp_x] in 59 ml / potassium phosphate, dibasic 10 [hp_x] in 59 ml / lobelia inflata 10 [hp_x] in 59 ml / nicotine 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / plantago major 10 [hp_x] in 59 ml / sucrose 10 [hp_x] in 59 ml / delphinium staphisagria seed 10 [hp_x] in 59 ml / tobacco leaf 10 [hp_x] in 59 ml / thuja occidentalis leafy twig 10 [hp_x] in 59 ml oral liquid [smoke control]||alpha-d-glucopyranoside, beta-d-fructofuranosyl||active_moiety_of
product containing precisely gabapentin 600 milligram/1 each conventional release oral tablet (clinical drug)||gabapentin||active_moiety_of
spiroctan 50 mg oral tablet||verospirone||active_moiety_of
cetylpyridinium chloride 0.15505 g in 80 / propylene glycol 2.8352 g in 80 topical cloth||propan-1,2-diol||active_moiety_of
alcohol 620 mg in 1 ml topical gel [justice rabbit strawberry scent anti-bacterial hand sanitizer]||éthanol||active_moiety_of
titanium dioxide 7 g in 100 g / zinc oxide 9 g in 100 g topical cream [alba botanica baby mineral sunscreen spf45]||dioxide titanium||active_moiety_of
methenamine mandelate 500mg tablet (product)||hexaminum||active_moiety_of
product containing only progesterone 200 mg/1 each oral capsule||progesterone preparation (product)||active_moiety_of
vitamins b1,b2,b3,b5,and b6 100 mg-2 mg-100 mg-2 mg-2 mg/ml injection vial (ml)||vitamin pp||active_moiety_of
ammonium carbonate 6 [hp_c] in 1 ml / levothyroxine 3 [hp_q] in 1 ml / crotalus durissus terrificus venom 1 [hp_q] in 1 ml / fucus vesiculosus 4 [hp_c] in 1 ml / camphor (natural) 1 [hp_q] in 1 ml / liothyronine 3 [hp_q] in 1 ml / adenosine triphosphate 5 [hp_x] in 1 ml / iodine 1 [hp_q] in 1 ml / dibasic potassium phosphate 3 [hp_x] in 1 ml sublingual solution/ drops [r06 thyroid]||adenosine triphosphate||active_moiety_of
glycerin 1.0 g in 100 ml topical cream [benton fermentation essence]||glycerol - chemical (substance)||active_moiety_of
acetaminophen/chlorpheniramine maleate/dextromethorphan hydrobromide/phenylephrine hydrochloride 325 mg-2 mg-10 mg-5 mg oral tablet [multi-symptom cold nighttime]||paracetamol - chemical||active_moiety_of
octinoxate 2.25 g in 30 ml / titanium dioxide 2.13 g in 30 ml topical emulsion [alabaster perfecting makeup spf 25 merle norman]||product containing titanium dioxide (medicinal product)||active_moiety_of
isopropyl alcohol 80 ml in 100 ml topical liquid [garb2art cosmetics strawberry fizz hand sanitizer]||alcohol rubbing||active_moiety_of
chlorpheniramine maleate 2 mg/5 ml oral syrup [chlor-tripolon]||chlorpheniramine (product)||active_moiety_of
garlic 3 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium oxide 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium oxide 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium oxide 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml oral liquid [metalstat]||co - cobalt||active_moiety_of
homosalate 80 mg in 1 ml / octinoxate 50 mg in 1 ml / oxybenzone 40 mg in 1 ml / avobenzone 28.5 mg in 1 ml topical lotion [anew vitale day]||hmbp cpd||active_moiety_of
homosalate 15 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 10 g in 100 ml / avobenzone 3 g in 100 ml topical lotion [rocky mountain spf 50]||product containing avobenzone (medicinal product)||active_moiety_of
octinoxate 75 mg in 1 ml / meradimate 50 mg in 1 ml / oxybenzone 50 mg in 1 ml / octisalate 50 mg in 1 ml cutaneous lotion [pro-tect sunscreen for professionals]||anthranilic acid, p-menth-3-yl ester||active_moiety_of
carbon dioxide 990 g in 1 kg respiratory (inhalation) gas||carbon dioxide (co2)||active_moiety_of
trifolium pratense flower 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 ml / sus scrofa pituitary gland 30 [hp_x] in 1 ml / anguilla rostrata blood serum 30 [hp_x] in 1 ml / tartaric acid 30 [hp_x] in 1 ml / theridion curassavicum 30 [hp_x] in 1 ml / sus scrofa thyroid 30 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / corticotropin 30 [hp_c] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / carbo animalis 30 [hp_c] in 1 ml / activated charcoal 30 [hp_c] in 1 ml / human breast tumor cell 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / strychnos wallichiana bark 30 [hp_c] in 1 ml / potassium dichromate 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / sodium phosphate, dibasic, heptahydrate 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / claviceps purpurea sclerotium 30 [hp_c] in 1 ml / sulfuric acid 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / allylthiourea 30 [hp_c] in 1 ml / thuja occidentalis leafy twig 30 [hp_c] in 1 ml / veratrum album root 30 [hp_c] in 1 ml / alcohol, x-ray exposed (1000 rad) 30 [hp_c] in 1 ml oral liquid [1 detoxification]||alcohol, x-ray exposed (1000 rad)||active_moiety_of
onion 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / eucalyptus globulus leaf 3 [hp_x] in 1 ml / sage 3 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / euphrasia stricta 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / schoenocaulon officinale seed 6 [hp_x] in 1 ml / viscum album fruiting top 6 [hp_x] in 1 ml / sus scrofa nasal mucosa 6 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / ammonium carbonate 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / potassium dichromate 12 [hp_x] in 1 ml / mercury 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml oral liquid [upper respiratory support]||goldenseal root||active_moiety_of
rancid beef 30 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / activated charcoal 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / colchicum autumnale bulb 15 [hp_x] in 1 ml / daphne odora bark 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / wood creosote 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / magnesium carbonate 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / spigelia anthelmia 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / matricaria recutita 6 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / ruta graveolens flowering top 6 [hp_x] in 1 ml / taraxacum officinale 6 [hp_x] in 1 ml oral liquid [doggy breath]||ipecac preparations||active_moiety_of
valsartan 320 mg / hydrochlorothiazide 12.5 mg oral tablet, film coated [valsartan and hydrochlorothiazide]||l-valine, n-(1-oxopentyl)-n-((2'-(1h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-||active_moiety_of
aluminum zirconium trichlorohydrex gly 18 g in 100 g topical stick [secret invisible powder fresh]||aluminum zirconium trichlorohydrex glycine||active_moiety_of
antacid ds with simethicone, 200 mg-200 mg-20 mg/5 ml oral suspension||dimethicone-containing product||active_moiety_of
phenylephrine hydrochloride/promethazine hydrochloride 5 mg/5 ml-6.25 mg/5 ml oral syrup [phenameth vc]||promethazinum||active_moiety_of
causticum 30 [hp_c] / chamomile 30 [hp_c] / arnica montana 30 [hp_c] / ledum palustre twig 30 [hp_c] / kalmia latifolia whole 30 [hp_c] / toxicodendron pubescens leaf 30 [hp_c] / bryonia alba root 30 [hp_c] / rhododendron aureum leaf 30 [hp_c] / solanum dulcamara flower 6 [hp_c] oral capsule, gelatin coated [arthritis-ease]||bryonia alba root||active_moiety_of
sus scrofa pancreas 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / syzygium cumini seed 12 [hp_x] in 1 ml oral liquid [gastropanpar]||strychnos nux-vomica seed||active_moiety_of
cynodon dactylon pollen 80 [bau] in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.0004 g in 1 ml / alternaria alternata 0.002 g in 1 ml / fusarium oxysporum 0.01 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / juniperus virginiana pollen 0.01 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya alba pollen 0.001 g in 1 ml subcutaneous injection, solution||pascopyrum smithii pollen extract||active_moiety_of
acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 30 mg in 30 ml / doxylamine succinate 12.5 mg in 30 ml oral solution [nighttime cold and flu relief]||product containing doxylamine||active_moiety_of
camphor (synthetic) 48 g in 1 g / eucalyptus oil 12 mg in 1 g / menthol 26 mg in 1 g topical jelly [chest rub]||product containing menthol (medicinal product)||active_moiety_of
sorafenib 200 mg oral tablet [nexavar]||sorafenib-containing product||active_moiety_of
alcohol 70 ml in 100 ml topical gel [aerium hand sanitizer 70% 500ml]||ethyl alcohol product||active_moiety_of
horse chestnut 10 [hp_x] in 1 ml / anacardium occidentale fruit 14 [hp_x] in 1 ml / aralia racemosa root 10 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / arsenic triiodide 15 [hp_x] in 1 ml / bellis perennis 7 [hp_x] in 1 ml / calcium fluoride 20 [hp_x] in 1 ml / milk thistle 15 [hp_x] in 1 ml / simaba cedron seed 9 [hp_x] in 1 ml / chamaelirium luteum root 10 [hp_x] in 1 ml / ledum palustre twig 20 [hp_x] in 1 ml / manganese acetate tetrahydrate 20 [hp_x] in 1 ml / myrtus communis top 6 [hp_x] in 1 ml / physalis alkekengi fruit 7 [hp_x] in 1 ml / ruta graveolens flowering top 10 [hp_x] in 1 ml / selenium 30 [hp_x] in 1 ml / ferula sumbul root 14 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_c] in 1 ml / veratrum viride root 6 [hp_x] in 1 ml oral liquid [lv-fx]||fluoride ion (substance)||active_moiety_of
product containing precisely trimethoprim 100 milligram/1 each conventional release oral tablet (clinical drug)||trimethoprim||active_moiety_of
sarsaparilla 4 [hp_x] in 20 ml / primula veris 4 [hp_x] in 20 ml / strychnos nux-vomica seed 4 [hp_x] in 20 ml / comfrey root 6 [hp_x] in 20 ml / lead 12 [hp_x] in 20 ml / rheum tanguticum whole 4 [hp_x] in 20 ml / english walnut 4 [hp_x] in 20 ml oral liquid [unda 41]||strychnos nux-vomica seed extract||active_moiety_of
goldenseal 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / atropa belladonna whole 6 [hp_x] in 1 ml / bos taurus thymus 8 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / bos taurus spleen 8 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / lomatium dissectum root 12 [hp_x] in 1 ml / botulinum toxin type a 18 [hp_x] in 1 ml / chlamydia trachomatis 18 [hp_x] in 1 ml / clostridium tetani 18 [hp_x] in 1 ml / escherichia coli 18 [hp_x] in 1 ml / neisseria meningitidis 18 [hp_x] in 1 ml / pasteurella multocida 18 [hp_x] in 1 ml / streptococcus pneumoniae 18 [hp_x] in 1 ml / proteus vulgaris 18 [hp_x] in 1 ml / pseudomonas aeruginosa 18 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 18 [hp_x] in 1 ml / staphylococcus aureus 18 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml oral liquid [bacsode]||proteus vulgaris (organism)||active_moiety_of
salicylic acid 0.5 % mask||ortho-hydroxybenzoic acid||active_moiety_of
octocrylene 5 g in 100 g / oxybenzone 2 g in 100 g / zinc oxide 3.9 g in 100 g topical lotion [peter island sunscreen spf 50]||2-benzoyl-5-methoxyphenol||active_moiety_of
quercus lobata pollen 0.05 g in 1 ml intradermal injection, solution||california white oak pollen extract||active_moiety_of
benzocaine 200 mg in 1 g topical gel [oral analgesic maximum strength]||benzocaine||active_moiety_of
arginine hydrochloride 120 mg / lycopene 0.1 mg / niacin 25 mg / pyridoxine hydrochloride 5 mg / .alpha.-tocopherol acetate, dl- 10 mg / zinc oxide 20 mg / panax ginseng leaf 400 mg / hydrolysed lepidium meyenii root (enzymatic) 400 mg / ginkgo biloba root 1000 mg / tribulus terrestris root 500 mg / guarana 100 mg oral capsule||amino-5-guanidino-pentanoic acid||active_moiety_of
amlodipine besylate 10 mg / olmesartan medoxomil 20 mg oral tablet||calcium channel blockers amlodipine||active_moiety_of
cynanchum vincetoxicum root 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / methylcobalamin 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / apc-356433 8 [hp_x] in 1 ml / apc-356434 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / gamboge 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / 7-oxodehydroepiandrosterone 3-acetate 30 [hp_x] in 1 ml / adenosine triphosphate disodium 30 [hp_x] in 1 ml / glucagon 30 [hp_x] in 1 ml / insulin pork 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [ha2cg evolution]||gelsemium sempervirens root extract||active_moiety_of
butenafine hydrochloride 1% cream||butenafina||active_moiety_of
vigabatrin 500 mg oral powder in packet (ea)||product containing vigabatrin (medicinal product)||active_moiety_of
ceanothus americanus leaf 4 [hp_x] in 1 ml / semecarpus anacardium juice 6 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / marsdenia condurango bark 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / momordica balsamina immature fruit 6 [hp_x] in 1 ml / oxalis acetosella leaf 6 [hp_x] in 1 ml / pulsatilla vulgaris 6 [hp_x] in 1 ml / sus scrofa bile duct 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / ipecac 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / potassium dichromate 8 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / sus scrofa nasal mucosa 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sus scrofa oral mucosa 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / sus scrofa rectal mucosa 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / yeast mannan 8 [hp_x] in 1 ml / wood creosote 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / mandragora officinarum root 10 [hp_x] in 1 ml / sus scrofa urinary bladder 6 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [matrix support]||sus scrofa jejunum||active_moiety_of
antimony trisulfide 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercuric sulfide 15 [hp_x] in 1 ml / sodium carbonate 15 [hp_x] in 1 ml / nitric acid 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / juniperus sabina leafy twig 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml oral liquid [warts - moles - skin tags]||sepia officinalis juice||active_moiety_of
al oh 400mg/mg oh 400mg/simethicone 40mg/5ml liquid||aluminium hydroxide - chemical||active_moiety_of
famotidine/pf@20 mg/2 ml@intraven@vial (ml)||3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)-n(sup 2)-sulfamoylpropionamidine||active_moiety_of
ethanol 61.5 % medicated pad||product containing ethanol (medicinal product)||active_moiety_of
plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.0004 g in 1 ml / urtica dioica pollen 0.0004 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / ambrosia artemisiifolia pollen 160 [au] in 1 ml / rumex acetosella pollen 0.005 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / betula populifolia pollen 0.005 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.005 g in 1 ml / populus deltoides pollen 0.0004 g in 1 ml / ulmus americana pollen 0.0004 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.0004 g in 1 ml / juglans nigra pollen 0.00008 g in 1 ml / morus rubra pollen 0.0004 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml intradermal injection, solution||populus alba pollen||active_moiety_of
testosterone 4mg/24hrs patch||testosterones (medication)||active_moiety_of
avobenzone 20 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [anti-aging eye sunscreen broad spectrum spf 15]||bmdbm cpd||active_moiety_of
beta vulgaris 3 [hp_x] in 1 ml / peumus boldus leaf 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / sarsaparilla 6 [hp_x] in 1 ml / gelsemium sempervirens root 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml oral liquid [metabolic detox]||bigonia sempervirens root||active_moiety_of
benzethonium chloride topical application liquid [lacrosse all body cleanser]||product containing benzethonium (medicinal product)||active_moiety_of
gabapentin 300 mg oral capsule [gabapentin]||gabapentino||active_moiety_of
subutex 2mg sublingual tablet||2-(n-cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol||active_moiety_of
benzalkonium chloride 0.13 g in 1 ml / lidocaine hydrochloride 25 mg in 1 ml topical spray [pain relieving]||product containing benzalkonium (medicinal product)||active_moiety_of
alka-seltzer plus cold formula, 325 mg-2 mg-7.8 mg oral tablet, effervescent||acetylsalicylic acid - chemical||active_moiety_of
sodium fluoride 1.1% toothpaste||fluoride ion||active_moiety_of
american ginseng 4 [hp_x] in 1 ml / chaste tree 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / dieffenbachia seguine 6 [hp_x] in 1 ml / potassium bromide 6 [hp_x] in 1 ml / lytta vesicatoria 8 [hp_x] in 1 ml / turnera diffusa leafy twig 8 [hp_x] in 1 ml / sus scrofa umbilical cord 8 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa testicle 8 [hp_x] in 1 ml / sus scrofa prostate 8 [hp_x] in 1 ml / strychnine phosphate dihydrate 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sus scrofa diencephalon 8 [hp_x] in 1 ml / pork heart 8 [hp_x] in 1 ml / ferrosoferric phosphate 10 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 1 ml / selenium 10 [hp_x] in 1 ml / zinc 10 [hp_x] in 1 ml / sus scrofa pineal gland 12 [hp_x] in 1 ml / cortisone acetate 13 [hp_x] in 1 ml / manganese phosphate, dibasic 20 [hp_x] in 1 ml / lycopodium clavatum spore 28 [hp_x] in 1 ml / testosterone 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [male stimulant]||sus scrofa pineal gland||active_moiety_of
glycopyrrolate 0.2mg/ml inj_#2||product containing glycopyrronium (medicinal product)||active_moiety_of
capsaicin/menthol 0.0375%-5% topical application patch, extended release [pallerix]||8-methyl-n-vanillyl-6-nonenamide||active_moiety_of
solidago virgaurea flowering top 3 [hp_x] in 1 ml / capsella bursa-pastoris 3 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 3 [hp_x] in 1 ml / mercury 8 [hp_x] in 1 ml / copaifera officinalis resin 9 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / equisetum hyemale 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / aconitum napellus 6 [hp_c] in 1 ml / benzoic acid 6 [hp_c] in 1 ml / tribasic calcium phosphate 6 [hp_c] in 1 ml / lytta vesicatoria 6 [hp_c] in 1 ml / strychnos ignatii seed 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / strychnos nux-vomica seed 6 [hp_c] in 1 ml / smilax ornata root 6 [hp_c] in 1 ml / delphinium staphisagria seed 6 [hp_c] in 1 ml / thuja occidentalis leafy twig 6 [hp_c] in 1 ml oral liquid [urinary tract]||jesuit's balsam resin||active_moiety_of
berberis vulgaris root bark 30 [hp_x] in 1 ml / lytta vesicatoria 30 [hp_x] in 1 ml / clematis recta flowering top 30 [hp_x] in 1 ml / equisetum hyemale 30 [hp_x] in 1 ml / canis lupus familiaris milk 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / anemone pratensis 30 [hp_x] in 1 ml / smilax ornata root 30 [hp_x] in 1 ml / sepia officinalis juice 30 [hp_x] in 1 ml / delphinium staphisagria seed 30 [hp_x] in 1 ml oral liquid [cystoges hp]||canis lupus familiaris milk preparation||active_moiety_of
hand sanitizer 2pk each 29.6ml mandarin scent kit||alcohol etílico||active_moiety_of
sodium fluoride 0.07 g in 28.35 g dental gel, dentifrice [pure snow whitening]||fluoride ion (substance)||active_moiety_of
american ginseng 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / mahonia aquifolium root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / glycyrrhiza glabra 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / urtica urens 3 [hp_x] in 1 ml oral liquid [energy vitality assist]||chelidonium majus whole||active_moiety_of
cefadroxil 1 g in 1 g not applicable powder||oracefal||active_moiety_of
camphor (synthetic) 1.6 g in 100 g / menthol 2 g in 100 g topical patch [magictop pain relief patch]||synthetic camphor||active_moiety_of
octinoxate 6.5 g in 100 ml / octisalate 2.5 g in 100 ml / zinc oxide 8.5 g in 100 ml topical emulsion [neova dna damage control - everyday broad spectrum spf 44]||octyl salicylate||active_moiety_of
dexamethasone sodium phosphate 10mg/1ml solution for injection_#1||16alpha-methyl-9alpha-fluoroprednisolone||active_moiety_of
methocarb 500-ezs kit||1,2-propanediol, 3-(2-methoxyphenoxy)-, 1-carbamate||active_moiety_of
zinc oxide 7.5 ml in 100 ml topical lotion [puristics totally ageless spf 15 daily anti-aging]||zinc white||active_moiety_of
alcohol 0.75 u in 1 u topical cloth [safetymax alcohol wipes]||1-hydroxyethane||active_moiety_of
echinacea 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml oral liquid [virostat]||aconitum napellus whole||active_moiety_of
bacitracin 500 unt / neomycin 3.5 mg / polymyxin b 10,000 unt per gm topical ointment||otic preparations neomycin preparations||active_moiety_of
onion 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / alfalfa 12 [hp_x] in 1 ml / amaranthus palmeri pollen 12 [hp_x] in 1 ml / bambusa vulgaris leaf 12 [hp_x] in 1 ml / xanthium strumarium pollen 12 [hp_x] in 1 ml / taraxacum officinale whole 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / poa pratensis pollen 12 [hp_x] in 1 ml / chenopodium album pollen 12 [hp_x] in 1 ml / iva angustifolia pollen 12 [hp_x] in 1 ml / festuca pratensis pollen 12 [hp_x] in 1 ml / artemisia vulgaris pollen 12 [hp_x] in 1 ml / dactylis glomerata pollen 12 [hp_x] in 1 ml / lolium perenne pollen 12 [hp_x] in 1 ml / red clover 12 [hp_x] in 1 ml / agrostis stolonifera pollen 12 [hp_x] in 1 ml / amaranthus retroflexus pollen 12 [hp_x] in 1 ml / artemisia tridentata pollen 12 [hp_x] in 1 ml / anthoxanthum odoratum pollen 12 [hp_x] in 1 ml / phleum pratense pollen 12 [hp_x] in 1 ml / ambrosia psilostachya pollen 12 [hp_x] in 1 ml / trifolium repens flower 12 [hp_x] in 1 ml / rumex crispus pollen 12 [hp_x] in 1 ml / rumex acetosella pollen 12 [hp_x] in 1 ml / amaranthus spinosus pollen 12 [hp_x] in 1 ml / iva annua pollen 12 [hp_x] in 1 ml oral liquid [weed grass antigens]||common sagebrush pollen extract||active_moiety_of
paroxetine hydrochloride hemihydrate 30 mg oral tablet [paroxetine]||paroxetine||active_moiety_of
toprol xl 100 mg 24 hr extended release oral tablet||product containing metoprolol (medicinal product)||active_moiety_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [maximum strength non drowsy daytime sinus and cold]||phenylephrine (substance)||active_moiety_of
dicyclomine hydrochloride 20mg tablet (product)||dicicloverina||active_moiety_of
dextromethorphan/phenylephrine/acetaminophen/chlorpheniramin@5 mg-2.5 mg-160 mg-1 mg/5 ml@oral@suspension, oral (final dose form)||fenilefrina||active_moiety_of
zenpep (lipase 10,000 unt / amylase 42,000 unt / protease 32,000 unt) delayed release oral capsule||pancreatic lipase||active_moiety_of
hydromorphone hydrochloride 500 mg/50 ml intravenous solution||hydromorfona||active_moiety_of
cranberry 0.05 g in 1 ml subcutaneous injection, solution||cranberry allergenic extract||active_moiety_of
horse chestnut 12 [hp_x] in 59 ml / arnica montana 12 [hp_x] in 59 ml / bellis perennis 12 [hp_x] in 59 ml / bryonia alba root 12 [hp_x] in 59 ml / hypericum perforatum 12 [hp_x] in 59 ml / ledum palustre twig 12 [hp_x] in 59 ml / lithium carbonate 12 [hp_x] in 59 ml / phytolacca americana root 12 [hp_x] in 59 ml / toxicodendron pubescens leaf 12 [hp_x] in 59 ml oral spray [comfypet pain relief]||toxicodendron pubescens leaf||active_moiety_of
atropa belladonna 6 [hp_x] in 0.45 ml / euphrasia stricta 6 [hp_x] in 0.45 ml / calcium sulfide 12 [hp_x] in 0.45 ml ophthalmic solution/ drops [irritated eye relief]||butibel||active_moiety_of
product containing precisely warfarin sodium 6 milligram/1 each conventional release oral tablet||4-hydroxy-3-(3-oxo-1-phenylbutyl)coumarin||active_moiety_of
avobenzone 0.1175 g in 4.25 g / octinoxate 0.282 g in 4.25 g / oxybenzone 0.141 g in 4.25 g topical stick [sun shades lip balm key lime pie]||omc cinnamate||active_moiety_of
picric acid 12 [hp_x] in 1 ml / arsenic trioxide 30 [hp_x] in 1 ml / gold 30 [hp_x] in 1 ml / strychnos ignatii seed 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / nitric acid 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / sepia officinalis juice 30 [hp_x] in 1 ml oral liquid [depressoforce]||arsenic cation (3+)||active_moiety_of
sincalide 0.005 mg injection [kinevac]||sincalide preparation||active_moiety_of
memantine hydrochloride 28 mg oral capsule, extended release||memantine-containing product||active_moiety_of
acetaminophen/hydrocodone bitartrate 300 mg-7.5 mg oral tablet [vicodin es]||zyfrel||active_moiety_of
matricaria recutita 10 [hp_x] in 59 ml / clematis vitalba flower 10 [hp_x] in 59 ml / croton tiglium seed 10 [hp_x] in 59 ml / tubocurarine chloride 10 [hp_x] in 59 ml / solanum dulcamara top 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / iodine 10 [hp_x] in 59 ml / lathyrus sativas seed 10 [hp_x] in 59 ml / lonicera caprifolium flowering top 10 [hp_x] in 59 ml / achillea millefolium 10 [hp_x] in 59 ml / hydrochloric acid 10 [hp_x] in 59 ml / rosa damascena flowering top 10 [hp_x] in 59 ml / sucrose 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / corn silk 10 [hp_x] in 59 ml oral liquid [indecision]||german chamomilla extract||active_moiety_of
nephron fa tablet||nicotinic acid amide||active_moiety_of
adenosine phosphate disodium 6 [hp_x] in 1 ml / malic acid 6 [hp_x] in 1 ml / sodium diethyl oxalacetate 6 [hp_x] in 1 ml / orotic acid 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / apiole (parsley) 6 [hp_x] in 1 ml / cinnamic acid 6 [hp_x] in 1 ml / streptococcus viridans group 12 [hp_x] in 1 ml / streptococcus pneumoniae 15 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / echinacea angustifolia 15 [hp_x] in 1 ml / helicobacter pylori 15 [hp_x] in 1 ml / mycoplasma pneumoniae 15 [hp_x] in 1 ml / proteus mirabilis 15 [hp_x] in 1 ml / proteus vulgaris 15 [hp_x] in 1 ml / pseudomonas aeruginosa 15 [hp_x] in 1 ml / yersinia enterocolitica 17 [hp_x] in 1 ml / streptococcus agalactiae 9 [hp_c] in 1 ml / legionella pneumophila 11 [hp_c] in 1 ml / enterococcus faecalis 13 [hp_c] in 1 ml / streptococcus mutans 13 [hp_c] in 1 ml / listeria monocytogenes 14 [hp_c] in 1 ml / shigella dysenteriae 15 [hp_c] in 1 ml / shigella sonnei 15 [hp_c] in 1 ml / streptococcus dysgalactiae 15 [hp_c] in 1 ml / streptococcus uberis 15 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml / streptococcus equinus 32 [hp_c] in 1 ml oral liquid [bacteria combination]||riboflavin-containing product||active_moiety_of
famotidine 10 mg / calcium carbonate 800 mg / magnesium hydroxide 165 mg oral tablet, chewable [duo fusion]||famotidina||active_moiety_of
acetaminophen 500 mg / phenylephrine hydrochloride 5 mg oral tablet [swift sinus pain]||phenylephrine-containing product||active_moiety_of
carya illinoinensis pollen 0.1 g in 1 ml subcutaneous solution [pecan pollen]||juglans rubra pollen||active_moiety_of
silicon dioxide 2 g in 100 g / sodium monofluorophosphate 0.35 g in 100 g dental paste, dentifrice [k-mom kids tooth]||fluoride ion (substance)||active_moiety_of
oxycodone hydrochloride 10 mg oral tablet, extended release||4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one||active_moiety_of
octocrylene 7 g in 100 ml / octisalate 2 g in 100 ml / octinoxate 7.5 g in 100 ml topical cream [silk line silk day cream spf 15]||2-ethylhexyl-4-methoxycinnamate||active_moiety_of
punica granatum root bark 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / juglans regia leaf 5 [hp_x] in 1 ml / dryopteris filix-mas root 6 [hp_x] in 1 ml / wormwood 15 [hp_x] in 1 ml / horse chestnut 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / artemisia cina pre-flowering top 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / krameria lappacea root 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / schoenocaulon officinale seed 15 [hp_x] in 1 ml / santonin 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / spigelia anthelmia 15 [hp_x] in 1 ml / teucrium marum 15 [hp_x] in 1 ml oral liquid [parasite detox]||schoenocaulon officinale seed||active_moiety_of
titanium dioxide 74 mg in 1 g / zinc oxide 114 mg in 1 g topical lotion [cerave developed with dermatologists baby sunscreen broad spectrum spf 45]||titanium dioxide-containing product||active_moiety_of
octinoxate 3.3 g in 44 g / homosalate 4.4 g in 44 g / titanium dioxide 4.4 g in 44 g topical cream [pur cc cream spf 40 light]||2-ethylhexyl-4-methoxycinnamate||active_moiety_of
octinoxate 40 mg in 1 g / titanium dioxide 23.6 mg in 1 g topical stick [benefit hello happy air foundation shade 8]||titanium dioxide-containing product||active_moiety_of
menthol, unspecified form 0.42 mg in 1 ml / thymol 0.64 mg in 1 ml / eucalyptol 0.92 mg in 1 ml / methyl salicylate 0.6 mg in 1 ml oral mouthwash [family wellness ultra mouthwash]||phenol, 5-methyl-2-(1-methylethyl)-||active_moiety_of
oxaprozin potassium 600mg tablet (product)||oxaprozin product||active_moiety_of
matricaria recutita 30 [hp_c] in 59 ml / iodine 30 [hp_c] in 59 ml / lycopus virginicus 6 h in 59 ml / strychnos nux-vomica seed 30 h in 59 ml / ginger 3 [hp_x] in 59 ml oral spray [thyroid soothe]||lycopus virginicus||active_moiety_of
aconitum napellus/cinchona officinalis/european mistletoe/gnaphalium polycephalum/magnesia phosphoricum/marsh tea/rhus toxicodendron 6 x-3 x-3 x-3 x-6 x-6 x-6 x oral tablet [hyland's leg cramps]||pseudognaphalium obtusifolium whole extract||active_moiety_of
ketorolac tromethamine 30 mg in 1 ml intramuscular injection, solution [acunivive 60]||anti-inflammatory nonsteroidal ketorolac||active_moiety_of
atropa belladonna 30 [hp_x] in 1 ml / conium maculatum flowering top 30 [hp_x] in 1 ml / solanum dulcamara top 30 [hp_x] in 1 ml / calcium sulfide 30 [hp_x] in 1 ml / potassium dichromate 30 [hp_x] in 1 ml / mercurius solubilis 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / matricaria recutita 30 [hp_c] in 1 ml oral liquid [ear inflammation plus]||ca++||active_moiety_of
dermatophagoides farinae 400 [au] in 1 ml / felis catus hair 80 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / mucor racemosus 0.002 g in 1 ml / alternaria alternata 0.00008 g in 1 ml / pleospora herbarum 0.004 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.004 g in 1 ml / acer rubrum pollen 0.004 g in 1 ml / carya alba pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.004 g in 1 ml / rumex acetosella pollen 0.004 g in 1 ml / candida albicans 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / epicoccum nigrum 0.002 g in 1 ml intradermal injection, solution||mucor extract||active_moiety_of
gentianella amarella flower 5 [hp_x] in 30 ml / ulex europaeus flower 5 [hp_x] in 30 ml / ilex aquifolium flowering top 5 [hp_x] in 30 ml / lonicera caprifolium flowering top 5 [hp_x] in 30 ml / sinapis arvensis flowering/fruiting top 5 [hp_x] in 30 ml / ornithogalum umbellatum flowering top 5 [hp_x] in 30 ml / castanea sativa flower 5 [hp_x] in 30 ml / salix alba flowering top 5 [hp_x] in 30 ml / strychnos ignatii seed 200 [hp_c] in 30 ml / sodium chloride 200 [hp_c] in 30 ml oral liquid [the flower remedy happy heart]||strychnos ignatii seed extract||active_moiety_of
aluminum oxide 15 [hp_x] in 1 g / american ginseng 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / conium maculatum flowering top 15 [hp_m] in 1 g / gelsemium sempervirens root 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / potassium carbonate 15 [hp_x] in 1 g / potassium iodide 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / lycopus virginicus 15 [hp_x] in 1 g / sodium chloride 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / phytolacca americana root 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / saw palmetto 15 [hp_x] in 1 g / thyroid, unspecified 15 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g oral pellet [jet lag]||strychnos nux-vomica seed extract||active_moiety_of
aconitum napellus 10 [hp_x] in 59 ml / aethusa cynapium 10 [hp_x] in 59 ml / silver nitrate 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / borage 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / castanea sativa flower 10 [hp_x] in 59 ml / cytisus scoparius flowering top 10 [hp_x] in 59 ml / digitalis 10 [hp_x] in 59 ml / eriodictyon californicum leaf 10 [hp_x] in 59 ml / jatropha curcas seed 10 [hp_x] in 59 ml / prunus laurocerasus leaf 10 [hp_x] in 59 ml / lolium temulentum top 10 [hp_x] in 59 ml / hippomane mancinella fruiting leafy twig 10 [hp_x] in 59 ml / hexaplex trunculus hypobranchial gland juice 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / sinapis arvensis flowering/fruiting top 10 [hp_x] in 59 ml / spongia officinalis skeleton, roasted 10 [hp_x] in 59 ml oral liquid [intense anxiety]||jatropha curcas seed extract||active_moiety_of
alcohol 0.62 g in 1 g / triclosan 0.03 g in 1 g topical gel [quik gel]||etoh - alcohol||active_moiety_of
methylphenidate hcl (aptensio xr) 20mg cap,sa||methylphenidan||active_moiety_of
aluminum oxide 30 [hp_x] in 1 ml / antimony potassium tartrate 30 [hp_x] in 1 ml / cadmium sulfate 30 [hp_x] in 1 ml / anamirta cocculus seed 30 [hp_x] in 1 ml / ipecac 30 [hp_x] in 1 ml / strychnos nux-vomica seed 30 [hp_x] in 1 ml / tobacco leaf 30 [hp_x] in 1 ml oral liquid [lax-eze plus]||product containing ipecacuanha||active_moiety_of
furosemide 10 mg in 1 ml intravenous injection, solution [furosemide]_#1||benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-||active_moiety_of
albuterol 90mcg (cfc-f) 200d oral inhl||salbutamol-containing product||active_moiety_of
imipenem+cilastatin 250mg/250mg injection (product)||anhydrous, imipenem||active_moiety_of
heparin sodium 5000 [usp'u] in 1 ml subcutaneous injection||product containing porcine heparin (medicinal product)||active_moiety_of
fagus grandifolia pollen 0.0166666 g in 1 ml / populus deltoides pollen 0.0166666 g in 1 ml / quercus rubra pollen 0.0166666 g in 1 ml / carya ovata pollen 0.0166666 g in 1 ml / fraxinus americana pollen 0.0166666 g in 1 ml / betula nigra pollen 0.0166666 g in 1 ml subcutaneous solution [eastern 6 tree pollen mix]||tree pollen-eastern cottonwood||active_moiety_of
avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 10 g in 100 ml topical lotion [sport sunscreen spf 30]||2-ethylhexyl salicylate||active_moiety_of
rolaids extra strength chewable tablet (cool strawberry)||mg(ii)||active_moiety_of
salicylic acid 2 g in 100 ml topical cream [rapid action daily face wash daylogic]||salicylic acid [callosity]||active_moiety_of
alcohol 75 ml in 1000 ml topical liquid [hello bello]||1-hydroxyethane||active_moiety_of
product containing only oxycodone hydrochloride 30 mg/1 each oral tablet (clinical drug)||oxycodonum||active_moiety_of
guaifenesin/pseudoephedrine hydrochloride 600 mg-60 mg oral tablet, extended release [leader mucus relief d]||psi-ephedrine||active_moiety_of
acetaminophen 650 mg / diphenhydramine hydrochloride 25 mg / phenylephrine hydrochloride 10 mg oral powder, for solution [equate flu and severe cold and cough]||(-)-m-hydroxy-α-(methylaminomethyl)benzyl alcohol||active_moiety_of
tetrahydrozoline hydrochloride 0.5 mg in 1 ml ophthalmic solution [assured original relief eye]||tetryzolin||active_moiety_of
equisetum arvense top 3 [hp_x] in 1 g / salix alba bark 3 [hp_x] in 1 g / stellaria media 3 [hp_x] in 1 g / urtica urens 3 [hp_x] in 1 g / horse chestnut 3 [hp_x] in 1 g / comfrey root 3 [hp_x] in 1 g / daphne mezereum bark 3 [hp_x] in 1 g / althaea officinalis root 3 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 g / calendula officinalis flowering top 3 [hp_x] in 1 g topical cream [wellheal]||calendula officinalis flowering top||active_moiety_of
famotidine/ibuprofen 26.6 mg-800 mg oral tablet [duexis]||p-isobutylhydratropic acid||active_moiety_of
product containing precisely carvedilol 25 milligram/1 each conventional release oral tablet||carvedilol (product)||active_moiety_of
simaba cedron seed 30 [hp_c] oral pellet [cedron]||simaba cedron seed extract||active_moiety_of
24 hr nifediac cc 30 mg extended release oral tablet||nifedipine||active_moiety_of
dextromethorphan hydrobromide 5 mg in 5 ml / guaifenesin 100 mg in 5 ml oral liquid [pediacare childrens cough and congestion]||guaiphenesin||active_moiety_of
horse chestnut 3 [hp_x] in 1 g / equisetum arvense top 3 [hp_x] in 1 g / aconitum napellus 5 [hp_x] in 1 g / atropa belladonna 5 [hp_x] in 1 g / berberis vulgaris root bark 5 [hp_x] in 1 g / sloe 5 [hp_x] in 1 g / toxicodendron pubescens leaf 5 [hp_x] in 1 g / urtica dioica leaf 5 [hp_x] in 1 g / gold 10 [hp_x] in 1 g topical gel||blackthorn berry||active_moiety_of
alcohol 71 ml in 100 ml topical gel [hand sanitizer]||etoh||active_moiety_of
tobramycin 28 mg inhalation capsule [tobi podhaler]||tobramycin [respiratory use] (substance)||active_moiety_of
sarsaparilla 15 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / berberis vulgaris root bark 15 [hp_x] in 1 g / giant puffball 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / croton tiglium seed 15 [hp_x] in 1 g / solanum dulcamara top 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / calcium sulfide 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / daphne mezereum bark 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / kerosene 15 [hp_x] in 1 g / pulex irritans 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g / sulfur iodide 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g / rumex crispus root 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / urtica urens 6 [hp_x] in 1 g oral pellet [eczema - skin care]||lycopodium clavatum spore extract||active_moiety_of
gallus gallus feather 0.00013 g in 1 ml / anas platyrhynchos feather 0.00013 g in 1 ml / anser anser feather 0.00013 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / ustilago nuda hordei 0.0001 g in 1 ml / ustilago maydis 0.0001 g in 1 ml / ustilago avenae 0.0001 g in 1 ml / ustilago tritici 0.0001 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / salsola kali pollen 0.0004 g in 1 ml subcutaneous injection, solution||redroot pigweed pollen extract||active_moiety_of
acetaminophen/hydrocodone bitartrate 325 mg-10 mg oral tablet [hydrocodone bitartrate-acetaminophen]||hydrocodone (substance)||active_moiety_of
octinoxate 0.07 g in 1 ml / zinc oxide 0.072 g in 1 ml topical liquid [lbel concentre total base serum ultra-fluid foundation spf 25 claire 1 - beige]||2-ethylhexyl-p-methoxycinnamat||active_moiety_of
aspirin 325 mg / chlorpheniramine maleate 2 mg / phenylephrine bitartrate 7.8 mg oral tablet, effervescent [equaline effervescent cold relief]||chlorpheniramine (medication)||active_moiety_of
alcohol 70 ml in 100 ml topical spray [sanitizing hand]||dehydrated ethanol||active_moiety_of
product containing metformin hydrochloride 1000 milligram/1 each oral tablet (clinical drug)||imidodicarbonimidic diamide, n,n-dimethyl-||active_moiety_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / milk thistle 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / taraxacum officinale flowering top 3 [hp_x] in 1 ml / trifolium pratense leaf 3 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / phytolacca americana root 8 [hp_x] in 1 ml / acetone 9 [hp_x] in 1 ml / ammonium chloride 9 [hp_x] in 1 ml / benzene 9 [hp_x] in 1 ml / propylene glycol 9 [hp_x] in 1 ml / sodium lauryl sulfate 9 [hp_x] in 1 ml / sodium tripolyphosphate 9 [hp_x] in 1 ml / turpentine oil 9 [hp_x] in 1 ml / methyl alcohol 9 [hp_x] in 1 ml / chlorine 10 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml oral liquid [enviroclenz]||acid, nitric||active_moiety_of
rumex acetosella pollen 0.025 g in 1 ml / plantago lanceolata pollen 0.025 g in 1 ml subcutaneous solution [plantain sorrel mix]||weed pollen-english plantain||active_moiety_of
acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [rexall nighttime cold flu]||4-hydroxyacetanilide||active_moiety_of
apis mellifera 3 [hp_x] in 1 ml / aloe 4 [hp_x] in 1 ml / sus scrofa cerebrum 6 [hp_x] in 1 ml / sus scrofa pineal gland 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa hypothalamus 8 [hp_x] in 1 ml / apiole (parsley) 12 [hp_x] in 1 ml oral liquid [limbex]||sus scrofa hypothalamus preparation||active_moiety_of
benzethonium chloride 2 mg/ml / benzocaine 200 mg/ml topical cream||norisc||active_moiety_of
titanium dioxide 8 ml in 100 ml / octinoxate 2.5 ml in 100 ml topical lotion [cafe mocha always color stay-on makeup spf 10]||matmate||active_moiety_of
silver nitrate 6 [hp_x] / arnica montana root 8 [hp_x] / arisaema triphyllum root 4 [hp_x] / oyster shell calcium carbonate, crude 30 [hp_x] / activated charcoal 10 [hp_x] / causticum 6 [hp_x] / hyoscyamus niger 6 [hp_x] / paris quadrifolia 5 [hp_x] / phosphorus 10 [hp_x] / verbascum thapsus 8 [hp_x] oral tablet [bhi throat]||verbascum thapsus whole extract||active_moiety_of
hydroquinone .02 g in 1 g topical cream [clear-n-smooth super-ultimate]||product containing hydroquinone (medicinal product)||active_moiety_of
titanium dioxide 3.44 g in 100 ml / zinc oxide 4.0 g in 100 ml topical lotion [radiant defense perfecting liquid broad spectrum spf 30 - beige]||boo-boo magic||active_moiety_of
epinephrine 15 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / saccharomyces cerevisiae 15 [hp_x] in 1 ml / elymus repens root 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / antimony trisulfide 10 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 10 [hp_x] in 1 ml / mahonia aquifolium root bark 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / cinchona officinalis bark 10 [hp_x] in 1 ml / chamaelirium luteum root 10 [hp_x] in 1 ml / goldenseal 10 [hp_x] in 1 ml / iodine 10 [hp_x] in 1 ml / iris versicolor root 10 [hp_x] in 1 ml / potassium carbonate 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / lycopodium clavatum spore 10 [hp_x] in 1 ml / mercury 10 [hp_x] in 1 ml / sodium carbonate 10 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 10 [hp_x] in 1 ml / nitric acid 10 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml / phosphorus 10 [hp_x] in 1 ml / podophyllum 10 [hp_x] in 1 ml / pulsatilla vulgaris 10 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / english walnut 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml oral liquid [candida - yeast]||iodine, nos||active_moiety_of
triticum aestivum whole 1 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / zanthoxylum americanum bark 3 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / salicylic acid 30 [hp_x] in 1 ml / corticotropin 30 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / eugenol 30 [hp_x] in 1 ml / stearyl alcohol 30 [hp_x] in 1 ml / xylitol 30 [hp_x] in 1 ml / estrone 30 [hp_x] in 1 ml / benzoic acid 30 [hp_x] in 1 ml / chlorine 30 [hp_x] in 1 ml / potassium sorbate 30 [hp_x] in 1 ml / sorbitol 30 [hp_x] in 1 ml / resorcinol 30 [hp_x] in 1 ml / benzyl alcohol 30 [hp_x] in 1 ml / lactic acid, dl- 30 [hp_x] in 1 ml / isopropyl palmitate 30 [hp_x] in 1 ml / boric acid 30 [hp_x] in 1 ml / acetic acid 30 [hp_x] in 1 ml / phenylbutazone 30 [hp_x] in 1 ml / petrolatum 30 [hp_x] in 1 ml / lead 30 [hp_x] in 1 ml oral liquid [chemtox]||cl||active_moiety_of
semecarpus anacardium juice 10 [hp_x] in 59 ml / agrimonia eupatoria flower 10 [hp_x] in 59 ml / gold 10 [hp_x] in 59 ml / avena sativa flowering top 10 [hp_x] in 59 ml / borage 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / capsicum 10 [hp_x] in 59 ml / carpinus betulus flowering top 10 [hp_x] in 59 ml / black cohosh 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / potassium bromide 10 [hp_x] in 59 ml / larix decidua flowering top 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / sodium sulfate 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / sinapis arvensis flowering/fruiting top 10 [hp_x] in 59 ml / tobacco leaf 10 [hp_x] in 59 ml oral liquid [good mood enhancer]||st john's wort||active_moiety_of
agrimonia eupatoria 10 [hp_x] in 29 ml / semecarpus anacardium juice 10 [hp_x] in 29 ml / gold 10 [hp_x] in 29 ml / avena sativa flowering top 10 [hp_x] in 29 ml / borage 10 [hp_x] in 29 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 29 ml / capsicum 10 [hp_x] in 29 ml / carpinus betulus flowering top 10 [hp_x] in 29 ml / black cohosh 10 [hp_x] in 29 ml / cinchona officinalis bark 10 [hp_x] in 29 ml / hypericum perforatum 10 [hp_x] in 29 ml / strychnos ignatii seed 10 [hp_x] in 29 ml / potassium bromide 10 [hp_x] in 29 ml / larix decidua flowering top 10 [hp_x] in 29 ml / sodium carbonate 10 [hp_x] in 29 ml / sodium sulfate 10 [hp_x] in 29 ml / phosphoric acid 10 [hp_x] in 29 ml / phosphorus 10 [hp_x] in 29 ml / pulsatilla vulgaris 10 [hp_x] in 29 ml / sepia officinalis juice 10 [hp_x] in 29 ml / sinapis arvensis flowering/fruiting top 10 [hp_x] in 29 ml / tobacco leaf 10 [hp_x] in 29 ml oral liquid [cheerfulness]||o-phosphoric acid||active_moiety_of
camphor (natural) 6 [hp_x] in 1 ml / black cohosh 6 [hp_x] in 1 ml / saffron 6 [hp_x] in 1 ml / potassium bromide 6 [hp_x] in 1 ml / lithium carbonate 8 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / dopamine hydrochloride 8 [hp_x] in 1 ml / sus scrofa hypothalamus 8 [hp_x] in 1 ml / serotonin hydrochloride 8 [hp_x] in 1 ml / thyroid, porcine 8 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / hyoscyamus niger 12 [hp_x] in 1 ml / strychnos ignatii seed 12 [hp_x] in 1 ml / oenanthe crocata root 12 [hp_x] in 1 ml / pulsatilla pratensis whole 12 [hp_x] in 1 ml / datura stramonium 12 [hp_x] in 1 ml / lycosa tarantula 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / platinum 18 [hp_x] in 1 ml oral liquid [mood swings]||aconitum napellus whole extract||active_moiety_of
ginger 3 [hp_x] in 1 ml / cyclamen purpurascens tuber 6 [hp_x] in 1 ml / ipecac 6 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / lactic acid, dl- 6 [hp_x] in 1 ml / tobacco leaf 6 [hp_x] in 1 ml / kerosene 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / cadmium sulfide 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / colchicum autumnale bulb 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / theridion curassavicum 12 [hp_x] in 1 ml / euphorbia corollata root 24 [hp_x] in 1 ml oral liquid [nausia]||anamirta cocculus seed||active_moiety_of
camphor (synthetic) 30 mg in 1 g / menthol, unspecified form 10 mg in 1 g / phenol 15 mg in 1 g / petrolatum 892 mg in 1 g topical cream [abridge cold sore treatment]||product containing white paraffin (medicinal product)||active_moiety_of
cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.0004 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / carya alba pollen 0.0002 g in 1 ml / carya illinoinensis pollen 0.0002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml intradermal injection, solution||hicoria pecan pollen||active_moiety_of
amphetamine/dextroamphet 15mg sa cap||dexamfetamine||active_moiety_of
avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 2.75 g in 100 ml / oxybenzone 4 g in 100 ml topical spray [aloe up pro 50 continuous sunscreen]||octisalate||active_moiety_of
guaifenesin 400 mg oral tablet [pharbinex]||guaifenesin product||active_moiety_of
biotin 0.01 ml in 100 ml topical liquid [spai-sons procapell]||-(+)-biotin||active_moiety_of
nalbuphine hydrochloride 20 mg in 1 ml intramuscular injection, solution [nalbuphine hydrochloride]||nalbuphine-containing product||active_moiety_of
trout 1 g in 20 ml percutaneous injection, solution [lake trout]||trout||active_moiety_of
triaminic fever & pain, 160 mg/5 ml oral liquid||paracetamol - chemical||active_moiety_of
product containing captopril 50 mg/1 each oral tablet||cp||active_moiety_of
avobenzone 1.9 g in 100 ml / octinoxate 7.3 g in 100 ml / octisalate 3.9 g in 100 ml / octocrylene 6.9 g in 100 ml topical aerosol, spray [tan towel spf 30 clear broad spectrum]||octocrilenum||active_moiety_of
epoetin alfa-epbx 20,000 unt per 2 ml injectable solution||epoetin alfa (medication)||active_moiety_of
avobenzone 3 g in 100 g / homosalate 13 g in 100 g / octisalate 5 g in 100 g / octocrylene 5 g in 100 g / oxybenzone 6 g in 100 g topical lotion [academy sport spf 50]||1-(4-(1,1-dimethylethyl)phenyl)-3-(4-methoxyphenyl)-1,3-propanedione||active_moiety_of
bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 ml / influenza a virus 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / antimony potassium tartrate 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / matricaria recutita 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 15 [hp_x] in 1 ml / iron 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / salix nigra bark 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [fever - infection]||phosphorous||active_moiety_of
arnica montana 4 [hp_x] in 1 g / strychnos ignatii seed 4 [hp_x] in 1 g / ruta graveolens flowering top 4 [hp_x] in 1 g / scutellaria lateriflora whole 4 [hp_x] in 1 g / taraxacum officinale 4 [hp_x] in 1 g / valerian 4 [hp_x] in 1 g / veratrum album root 4 [hp_x] in 1 g / atropa belladonna 4 [hp_x] in 1 g / causticum 4 [hp_x] in 1 g / artemisia cina flower 4 [hp_x] in 1 g / potassium bromide 4 [hp_x] in 1 g / potassium carbonate 4 [hp_x] in 1 g / frangula californica bark 4 [hp_x] in 1 g / hypericum perforatum 4 [hp_x] in 1 g / lycopodium clavatum spore 4 [hp_x] in 1 g / black cohosh 4 [hp_x] in 1 g / pseudognaphalium obtusifolium 4 [hp_x] in 1 g / jatropha curcas seed 4 [hp_x] in 1 g topical cream [veive cbd muscle relaxer]||mountain arnica whole||active_moiety_of
zinc oxide 112 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 60 mg in 1 ml topical spray [babyganics spf 50 plus sunscreen]||sunscreen with zinc oxide (medication)||active_moiety_of
(spl review) benzalkonium chloride 0.13 g in 100 g / benzocaine 20 g in 100 g / zinc chloride 0.15 g in 100 g / menthol, unspecified form 0.25 g in 100 g oral cream [4x medicated toothache and gum cream]||benzocaine for hemorrhoids (medication)||active_moiety_of
sodium chloride 0.9 % in 250 ml injection||sodium ion||active_moiety_of
octinoxate 75 mg in 1 ml / octisalate 30 mg in 1 ml / oxybenzone 30 mg in 1 ml topical cream [daily moisturizing spf 15]||octyl salicylate||active_moiety_of
aluminum zirconium pentachlorohydrex gly 16.3 ml in 96.1 ml topical liquid [dry idea ad antiperspirant roll-on powder fresh]||aluminum zirconium pentachlorohydrex gly||active_moiety_of
chaste tree 3 [hp_x] in 1 ml / angelica sinensis root 3 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml / arnica montana 6 [hp_x] in 1 ml / black cohosh 3 [hp_x] in 1 ml / estradiol 9 [hp_c] in 1 ml / estriol 9 [hp_c] in 1 ml / estrone 9 [hp_c] in 1 ml / galium aparine 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / asian ginseng 3 [hp_x] in 1 ml / progesterone 6 [hp_x] in 1 ml / sepia officinalis juice 30 [hp_c] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / viscum album fruiting top 3 [hp_x] in 1 ml / bos taurus ovary 30 [hp_c] in 1 ml oral spray [problen estrogen and progesterone]||ginseng, asian||active_moiety_of
avobenzone 3 g in 100 g / homosalate 10 g in 100 g / octocrylene 10 g in 100 g topical stick [kiss therapy spf 30 cucumber melon lip balm]||octocrilene product||active_moiety_of
pelargonium sidoides root 1 [hp_x] oral tablet, chewable [umcka coldcare mint chewable]||pelargonium sidoides root||active_moiety_of
calcium phosphate, dibasic, anhydrous 0.1 g in 100 g / calcium carbonate 30 g in 100 g / alcloxa 0.1 g in 100 g / aminocaproic acid 0.1 g in 100 g dental paste, dentifrice [dr.el gum care tooth]||ca2+||active_moiety_of
berberis vulgaris root bark 4 [hp_x] in 1 ml / black cohosh 4 [hp_x] in 1 ml / cinchona officinalis bark 4 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / ranunculus bulbosus 4 [hp_x] in 1 ml / horse chestnut 6 [hp_x] in 1 ml / cupric acetate 6 [hp_x] in 1 ml / nadide 6 [hp_x] in 1 ml / sodium diethyl oxalacetate 6 [hp_x] in 1 ml / niacinamide 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / ammonium chloride 8 [hp_x] in 1 ml / sus scrofa cartilage 8 [hp_x] in 1 ml / sus scrofa intervertebral disc 8 [hp_x] in 1 ml / picric acid 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / silver 10 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / sus scrofa umbilical cord 10 [hp_x] in 1 ml / sus scrofa adrenal gland 10 [hp_x] in 1 ml / pseudognaphalium obtusifolium 10 [hp_x] in 1 ml / sus scrofa bone marrow 10 [hp_x] in 1 ml / mercuric oxide 10 [hp_x] in 1 ml / pantothenic acid 10 [hp_x] in 1 ml / sulfur 28 [hp_x] in 1 ml / enterobacter cloacae 30 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [spinalmax]||brimstone||active_moiety_of
octisalate 0.21 g in 4.25 g / avobenzone 0.09 g in 4.25 g / octocrylene 0.06 g in 4.25 g / octinoxate 0.28 g in 4.25 g topical stick||2-ethylhexyl-p-methoxycinnamate||active_moiety_of
potassium dichromate 6 [hp_x] in 1 ml / schoenocaulon officinale seed 6 [hp_x] in 1 ml / luffa operculata fruit 6 [hp_x] in 1 ml / galphimia glauca flowering top 6 [hp_x] in 1 ml / histamine dihydrochloride 6 [hp_x] in 1 ml nasal liquid [allergy bee gone for kids]||schoenocaulon officinale seed||active_moiety_of
selrx 2.3 % medicated shampoo||product containing selenium sulfide (medicinal product)||active_moiety_of
alanine 10 [hp_x] in 1 ml / arginine 10 [hp_x] in 1 ml / levocarnitine 10 [hp_x] in 1 ml / cysteine 10 [hp_x] in 1 ml / glutamine 10 [hp_x] in 1 ml / histidine 10 [hp_x] in 1 ml / isoleucine 10 [hp_x] in 1 ml / leucine 10 [hp_x] in 1 ml / lysine 10 [hp_x] in 1 ml / methionine 10 [hp_x] in 1 ml / ornithine 10 [hp_x] in 1 ml / proline 10 [hp_x] in 1 ml / serine 10 [hp_x] in 1 ml / tryptophan 10 [hp_x] in 1 ml / tyrosine 10 [hp_x] in 1 ml / valine 10 [hp_x] in 1 ml / apis mellifera 200 [hp_c] in 1 ml / biotin 10 [hp_x] in 1 ml / sus scrofa skin 9 [hp_c] in 1 ml / galium aparine whole 5 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / somatropin 60 [hp_x] in 1 ml / sus scrofa pituitary gland 30 [hp_c] in 1 ml / sodium chloride 200 [hp_c] in 1 ml / pantothenic acid 6 [hp_x] in 1 ml / phosphoric acid 3 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 200 [hp_c] in 1 ml oral spray [vital skin hair nails]||galium aparine whole extract||active_moiety_of
product containing precisely diclofenac sodium 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug)||diclofenac product (product)||active_moiety_of
urtica dioica pollen 20000 [pnu] in 1 ml intradermal injection, solution||urtica dioica pollen extract||active_moiety_of
lidocaine@3.5 %@topical@adhesive patch, medicated||lidocaine (product)||active_moiety_of
octinoxate 50 g in 1000 ml / octisalate 20 g in 1000 ml / oxybenzone 30 g in 1000 ml / titanium dioxide 65.22 g in 1000 ml topical lotion [nu skin nu colour moisturshade finish spf 15 natural beige]||octyl methoxycinnamate (substance)||active_moiety_of
iodine/isopropyl alcohol 1 %-70 % topical solution, non-oral||isopropyl rubbing alcohol||active_moiety_of
lycopodium clavatum spore 3 [hp_c] in 1 ml / sodium chloride 3 [hp_c] in 1 ml / sepia officinalis juice 3 [hp_c] in 1 ml / atropa belladonna 4 [hp_c] in 1 ml / causticum 4 [hp_c] in 1 ml / phosphorus 4 [hp_c] in 1 ml / sulfur 4 [hp_c] in 1 ml / oxitriptan 6 [hp_c] in 1 ml / aluminum oxide 8 [hp_c] in 1 ml / silicon dioxide 8 [hp_c] in 1 ml / acetylcholine chloride 8 [hp_c] in 1 ml / dopamine hydrochloride 8 [hp_c] in 1 ml / norepinephrine 8 [hp_c] in 1 ml / phenethylamine hydrochloride 8 [hp_c] in 1 ml / serotonin hydrochloride 8 [hp_c] in 1 ml / adenosine cyclic phosphate 10 [hp_c] in 1 ml / sus scrofa cerebrum 10 [hp_c] in 1 ml / sus scrofa diencephalon 10 [hp_c] in 1 ml / sus scrofa umbilical cord 10 [hp_c] in 1 ml / pantothenic acid 10 [hp_c] in 1 ml / sus scrofa pineal gland 10 [hp_c] in 1 ml / lactic acid, l- 10 [hp_c] in 1 ml / alcaligenes faecalis 30 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [elevate]||causticum||active_moiety_of
preplus, prenatal multivitamins with folic acid 1 mg oral tablet||ácido fólico||active_moiety_of
product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)||n-(p-(o-1h-tetrazol-5-ylphenyl)benzyl)-n-valeryl-l-valine||active_moiety_of
lufenuron 1 g in 1 g not applicable powder||n-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylaminocarbonyl)-2,6-difluorobenzamide||active_moiety_of
barium carbonate 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / fucus vesiculosus 30 [hp_x] in 1 ml / iodine 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 30 [hp_x] in 1 ml / thyroid, unspecified 30 [hp_x] in 1 ml oral liquid [iodium hp]||fucus vesiculosus extract||active_moiety_of
alcohol 70 g in 100 ml topical liquid [sense fresh ethyl alcohol 70%]||methylcarbinol||active_moiety_of
avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 80 mg in 1 ml topical liquid [life extension shade factor spf30]||octyl salicylate (substance)||active_moiety_of
octinoxate 6 g in 100 ml / zinc oxide 12 g in 100 ml topical lotion [spf 50 moisturizing sunscreen broad spectrum]||lassar's paste||active_moiety_of
octisalate 50 mg in 1 ml / octocrylene 50 mg in 1 ml / avobenzone 25 mg in 1 ml topical lotion [1000 roses daily shade facial spf 18]||octyl salicylate||active_moiety_of
makena 275 mg per 1.1 ml auto-injector||17 ohp - 17-hydroxyprogesterone||active_moiety_of
acetaminophen 325 mg / phenylephrine hydrochloride 5 mg / dextromethorphan hydrobromide 10 mg oral capsule, liquid filled [d - time]||dextrométhorphane||active_moiety_of
acer rubrum pollen extract 10,000 unt/ml injectable solution||acer rubrum pollen||active_moiety_of
sus scrofa spleen 6 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / ceanothus americanus leaf 12 [hp_x] in 1 ml / quinine sulfate 12 [hp_x] in 1 ml / strychnos ignatii seed 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml oral liquid [spleenpar]||hydrogen nitrate||active_moiety_of
alcohol 75 ml in 100 ml topical liquid [surface sanitizer]||product containing ethanol||active_moiety_of
1 ml octreotide 0.5 mg/ml injection [sandostatin]||l-cysteinamide, d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (r-(r*,r*))-||active_moiety_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (granate seductor femme) - purple]||2-hydroxy-4-methoxy-benzophenone||active_moiety_of
arnica montana 6 [hp_x] in 1 ml / calendula officinalis flowering top 1 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / ledum palustre twig 3 [hp_x] in 1 ml topical spray [cut and wound remedy]||rhododendron tomentosum leafy twig extract||active_moiety_of
benzalkonium chloride 0.1 % / ethanol 75 % medicated pad||alcohol, ethyl||active_moiety_of
d||during the last 7 days, on how many days did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10 minutes at a time [ipaq]||has_component
i have missed work without bothering to call in||i have missed work without bothering to call in:find:pt:^patient:ord:phenx||has_component
(3β,14β,17α)-cholest-5-en-3-ol||cholesterol.in ldl pattern bi:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:electrophoresis||has_component
blackberry (rubus fruticosus)||blackberry igg-mcnc||has_component
follicle-stimulating horm prod (product)||follitropin [units/volume] in serum or plasma --10 minutes post xxx challenge||has_component
coronavirus, nos||hcov 229e rna low resp ql naa+non-probe||has_component
corneal dystrophy suspected||corneal dystrophy suspected:type:to identify measures at a point in time:cornea:nominal||has_component
infection (disorder)||infections present &or treated during this pregnancy for live birth:presence or identity:to identify measures at a point in time:^patient:nominal:ultrasound standard certificate of live birth||has_component
dsdna||deoxyribonucleic acid double strand antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:body fluid, unsp:ordinal:immunoassay||has_component
general activity||endotracheal tube activity:find:pt:^patient:ord||has_component
vanamide||urea [moles/time] in 24 hour urine||has_component
cyclosporin-a||cyclosporin index||has_component
dna double strand igg||dna double strand ab.igg:titr:pt:ser:qn||has_component
guidance for thrombectomy||rfa guidance for thrombectomy of vein-- w contrast iv||has_component
ar element||left eye argon laser coagulation treatment comment [interpretation]||has_component
views+ap||xr pelvis ap and oblique||has_component
100 leukocytes||polymorphonuclear cells/100 leukocytes:number fraction:to identify measures at a point in time:peritoneal dialysis fluid:quantitative||has_component
multisection ventilation+perfusion^w radionuclide ih+w radionuclide iv||spect lung vp w rnc ih+iv||has_component
notes||obstetrics midwife consult note||has_component
how many||considering your shortness of breath over the past 7d, rate the amount of difficulty you had when walking up 5 stairs without stopping:find:7d:^patient:ord:promis||has_component
cells.cd14/100 cells||cd14 cells/100 cells (specimen)||has_component
product containing stanozolol (medicinal product)||stanozolol ur-mcnc||has_component
4h-imidazol-4-one, 2-amino-1,5-dihydro-1-methyl-||citrulline/creatinine:ratio:24 hours:urine:quantitative||has_component
8-hydroxyloxapine (substance)||8-hydroxyloxapine:presence or threshold:to identify measures at a point in time:urine:ordinal:screen||has_component
cytarabine (substance)||cytarabine/pegaspargase/thioguanine/vincristine||has_component
spatial guidance for medical procedure||guidance for biopsy.needle:finding:to identify measures at a point in time:abdomen>liver:document:radiofluoroscopy||has_component
cardiac output, nos||rv cardiac index mr||has_component
can pronounce accrementitial||pronounce accrementitial nih||has_component
phenx measure - environmental exposures - day care - pre-school attendance||phenx measure - environmental exposures - day care - pre-school attendance:-:point in time:^patient:-:phenx||has_component
exhl gas||respiratory rate --resting||has_component
leu 12||cd19+cd43+ cells nfr tiss||has_component
durations||deprecated alcohol-substance abuse rehabilitation treatment plan, visit duration time||has_component
herpes simplex virus 1 & 2||hsv1+2 ab pattern ser-imp||has_component
barium product||xr abdomen and rf gastrointestinal tract upper w air contrast po and w barium contrast po||has_component
panitumumab antibody, human||cbdca/moab abx-egf/tax||has_component
e coli||escherichia coli enterotoxigenic sta gene:presence or threshold:to identify measures at a point in time:isolate:ordinal:probe.amp.tar||has_component
platelet [dup] (body structure)||sulfisoxazole induced platelet igm fc ql||has_component
iodide peroxidase (substance)||thyroperoxidase ab [units/volume] in body fluid by immunoassay||has_component
deoxyribonucleic acid of human papillomavirus (substance)||naa with probe detection for human papilloma virus genotype (lab test)||has_component
evaluation and management||surgical oncology preoperative evaluation and management note||has_component
d||oasis d - adl and iadls - discharge from agency:-:pt:^patient:-:cms assessment||has_component
somatotropin^29th specimen||somatotropin^29th specimen:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
androstanediol (substance)||3-alpha-androstanediol glucuronide:substance concentration:to identify measures at a point in time:serum:quantitative||has_component
thyrotropic hormone preparation (product)||measurement of plasma thyroid stimulating hormone concentration 60 minutes after challenge (procedure)||has_component
manufactured form||promis pediatric short form - emotional distress - anxiety 8b - version 1.1:-:1w:^patient:-:promis.peds||has_component
tapeworms, pork||taenia solium larva antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
dicarboxytetradecenoylcarnitine (c14:1-dc)||dicarboxytetradecenoylcarnitine (c14:1-dc):substance concentration:to identify measures at a point in time:dried blood spot:quantitative||has_component
jk^a ag inferred phenotype||jk sup(a) ag inferred phenotype molgen ql (bld/tiss donor)||has_component
scientific study||study observation:finding:to identify measures at a point in time:heart.great vessels^fetus:nominal:ultrasound||has_component
human hepatitis b virus hbv||hepatitis b virus codon m204i [presence] by genotype method||has_component
after values||prolactin [mass/volume] in serum or plasma --20 minutes post xxx challenge||has_component
infection (disorder)||healthcare-associated infection flag:finding:point in time:^patient:ordinal||has_component
note (document)||covid-19+intubation+cardiopulmonary resuscitation note:find:pt:{setting}:doc:{role}||has_component
cell positive for cd13 antigen||cd13+cd33+hla-dr+ cells/100 cells (csf)||has_component
benzamide, n-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9ci)||ctx/pcb/pred/vcr||has_component
dopamine preparation||dopamine [mass/volume] in serum or plasma||has_component
vanilla (vanilla planifolia) ab||vanilla igg ab [units/volume] in serum||has_component
using verbal communication (qualifier value)||speaking:finding:to identify measures at a point in time:^patient:ordinal:rfc assessment||has_component
gram negative bacillus||wound gram stain for (-) bacilli||has_component
593-594 colon||circulating tumor cells.colon [#/volume] in blood||has_component
creatinina||methylmalonate/creat 24h ur||has_component
wuchereria bancrofti+brugia malayi antibody.igg1||wuchereria bancrofti+brugia malayi ab.igg1:prthr:pt:ser:ord:ia||has_component
blood group antigen rh3||e ag p hsct rbc ql||has_component
viruses||fluav whole genome sequence nom (isol)||has_component
loracepam||lorazepam:prthr:pt:tissco:ord:screen||has_component
unspecified substance||post-heparin lipolytic activity measurement||has_component
grade, nos||timi grade^post procedure:score:to identify measures at a point in time:coronary arteries.segment:ordinal:angiogram||has_component
(multisection||multisection transrectal:finding:to identify measures at a point in time:pelvis>prostate:document:ultrasound||has_component
multisection||multisection:find:pt:lower extremity>tibioperoneal vessels:doc:mr.angio||has_component
bacteria identified||bacteria identified:presence or identity:to identify measures at a point in time:drain:nominal:aerobic culture||has_component
pregnancy, function||pregnancy function.knowledge:find:pt:^patient:ord:observed.omaha||has_component
borrelia burgdorferi 23kd||b. burgdorferi 23kd igm ib ql (csf)||has_component
p a 145 c kit||cd117 ag:prthr:pt:tiss:ord:immune stain||has_component
blood group antigen rh2||hbb c.251g>a bld ql||has_component
a ag||i avoid places that strongly remind me of a bad experience in the last 2w or more:finding:to identify measures at a point in time:^patient:ordinal:m3||has_component
thiodiglycolate/creatinine||thiodiglycolate/creatinine (u) [mass ratio]||has_component
blood group antigen a, nos||neisseria meningitidis serogroup a ag [presence] in isolate by agglutination||has_component
after values (qualifier value)||glucose 4h p 75 g glc po serpl-scnc||has_component
sulfoglycosphingolipid||sulfatide antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal:immune blot||has_component
igg||parrot feather igg ab [presence] in serum||has_component
cinnamon (cinnamomum spp) ab||cinnamon igg ab [mass/volume] in serum||has_component
within blood vessels||bp dias 24h mean||has_component
antibody to porcine influenza virus a||porcine influenza virus a ab:acnc:pt:ser:qn||has_component
htlv i p32 antibody||human t cell lymphotropic virus (htlv) type 1 p32 antibody assay (procedure)||has_component
fibrinopeptide b beta (15-42) antigen||fibrinopeptide b beta (15-42) ag:acnc:pt:ppp:qn:ia||has_component
babesia sp antibody||babesia ab titr ser||has_component
hepatitis c virus rna||hcv rna mar naa+probe-log#||has_component
virus coxsackie||coxsackievirus b3 antibody:dilution factor (titer):to identify measures at a point in time:body fluid, unsp:quantitative:complement fixation||has_component
challenge||cortisol [moles/volume] in serum or plasma --1 hour post xxx challenge||has_component
mareks disease virus ab||mareks disease virus ab [presence] in serum by neutralization test||has_component
ehrlichia chaffeensis antibody||ehrlichia chaffeensis antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal||has_component
osmolality (function)||osmolality sweat||has_component
study observation||us spine fetus study||has_component
scores (qualifier value)||emotion score:score:4w:^event:qn:skindex-29||has_component
polysomnography panel||polysomnography panel||has_component
sex of individual||forced sex nrate dys||has_component
lcds v5.00 - special treatments, procedures, and programs - discharge||lcds v5.00 - special treatments, procedures, and programs - discharge:-:pt:^patient:-:cms assessment||has_component
behavioral symptoms trigger||behavioral symptoms trigger:find:pt:^patient:nar:mds||has_component
epstein barr virus early diffuse ab||ebv ea-d ab ser ql if||has_component
extractable nuclear||pcna extractable nuclear ab line blot ql (csf)||has_component
resident assessment protocol 14--dehydration &or fluid maint - triggered||resident assessment protocol 14--dehydration/fluid maint - triggered [minimum data set]||has_component
flow velocities, blood||tv reg vmax sys dop||has_component
promis pediatric short form - physical function - upper extremity 8a - version 1.0 raw score||promis pediatric short form - physical function - upper extremity 8a - version 1.0 raw score:score:pt:^patient:qn:promis.peds||has_component
sulfatoglycosphingolipids||sulfatide antibody.immunoglobulin m:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immunoassay||has_component
clostridioides difficile antibody||measurement of clostridium difficile antibody (procedure)||has_component
multisection^wo contrast||multisection^wo contrast:finding:to identify measures at a point in time:head>orbit+face:document:computed tomography||has_component
aldosterone^20m post xxx challenge||aldosterone [mass/volume] in serum or plasma --20 minutes post xxx challenge||has_component
pain effect on function||pain effect on function during last 2d:-:2 days:^patient:-||has_component
pamidronate disodium (medication)||apd/ifn-a||has_component
nuclear (nucleus)||sjogrens syndrome-a extractable nuclear 52kd ab qn (s)||has_component
glucose^1h post 75 g glucose po||glucose^1h post 75 g glucose po:mcnc:pt:ser:qn||has_component
time (e.g. seconds)||current set of nebulization cycles time.remaining nebulizer||has_component
coxsackieviruses||coxsackievirus b2 ab spec 1 (s) [titer]||has_component
positioning attribute||are you able to stand up from a push-up position five times quickly:find:pt:^patient:ord:promis||has_component
lead analyte (substance)||lead [moles/volume] in blood||has_component
oxazimedrine||phenmetrazine cutoff screen (u) [mass/vol]||has_component
organizationstaff||unfilled nursing staff job positions/mean number of nursing staff:nfr:rptperiod:{nursing unit}.{job position}:qn:nmmds||has_component
multisection^wo & w contrast||mr knee-l wo+w contr iv||has_component
maltose binding protein ab.ige||maltose binding protein antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
urea^2h specimen||urea^2 hours specimen:substance concentration:to identify measures at a point in time:dialysis fluid:quantitative||has_component
d - answer to question||chlamydia trachomatis d+e+f+g+h+i+j+k iga ab [titer] in serum by immunofluorescence||has_component
vitamin b<sub>4</sub> (substance)||flavin adenine dinucleotide:mcnc:pt:ser:qn||has_component
chlamydia twar||c. pneumoniae igg ia ql (s)||has_component
immunoglobulin e (ige)||food allerg mix8 ige ql||has_component
insulin^8th specimen post xxx challenge||insulin 8th specimen post unsp challenge [moles/vol]||has_component
version||functional assessment of cancer therapy - lung symptom index questionnaire - 6 items - version 4 (fact - flsi 6) [facit]||has_component
i||i felt tense in past 7 days [promis]||has_component
prazepam product||prazepam cutoff confirm (u) [mass/vol]||has_component
age (qualifier value)||age when first fed something other than breast milk or formula:time:point in time:^patient:quantitative||has_component
o-desmethyltramadol||o-nortramadol [presence] in urine||has_component
bacillus pseudomallei||right tonsil burkholderia pseudomallei detection on methylene blue stain (lab test)||has_component
after values||glucose^2nd specimen post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
trypsin^4th specimen post dose sincalide||trypsin [enzymatic activity/volume] in body fluid --4th specimen post sincalide||has_component
bartonella henselae ab.igm||bartonella henselae antibody.immunoglobulin m:arbitrary concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||has_component
influenza virus a ribonucleic acid||fluav rna naa+probe ql (pericard fld)||has_component
multisection^w contrast||deprecated chest+abdomen+pelvis+lower extremity.bilateral>aorta.thoracic+aorta.abdominal+vessels ct angiogram w contrast iv||has_component
penicillin g ab||penicillin g antibody.immunoglobulin g:mass concentration:to identify measures at a point in time:serum:quantitative||has_component
s antigen||color me healthy - children's symptom assessment app||has_component
genes||atp5a1 gene mutation analysis limited to known familial mutations:find:pt:bld/tiss:doc:molgen||has_component
notes||note:finding:to identify measures at a point in time:patient's home:document:respiratory therapy||has_component
assessment||formal pain assessment using standardized tool:finding:to identify measures at a point in time:^patient:ordinal:cms assessment||has_component
estrogens/estrone||estrone/creat ur-srto||has_component
tsh recept||thyrotropin receptor antibody:arbitrary concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||has_component
dmpk gene allele 2||dmpk gene allele 2.ctg repeats:entnum:pt:bld/tiss:qn:molgen||has_component
neutrophils.band form||neuts band/leuk nfr fld manual||has_component
qualitative mobility||lcds v3.00 - mobility - admission performance during 3d assessment period:-:3 days:^patient:-:cms assessment||has_component
coagulation tissue factor induced.factor substitution||coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma:time:to identify measures at a point in time:platelet poor plasma^control:quantitative:tilt tube||has_component
class||canary droppings antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
dna (deoxyribonucleic acid)||hadv dna nph ql naa+non-probe||has_component
gene||dmd gene mutations tested for molgen nom (bld/tiss)||has_component
burnetii coxiella||coxiella burnetii ab:imp:pt:ser:nom||has_component
virus||prrsv ab [presence] in serum by immunoassay||has_component
immunoglobulin, light chain (substance)||immunoglobulin light chains.kappa.free/immunoglobulin light chains.lambda.free:mass ratio:to identify measures at a point in time:cerebral spinal fluid:quantitative||has_component
blood flows||blood flow velocity.systolic.max:velocity:to identify measures at a point in time:ductus arteriosus:quantitative:ultrasound.doppler||has_component
dna (deoxyribonucleic acid)||b19v dna ur ql naa+probe||has_component
encephalitozoon intestinalis (a. cali, d.p. kotler & j.m. orenstein) r.a. hartskeerl, t. van gool, a.r.j. schuitema, e.s. didier & w.j. terpstra, 1995||gallbladder culture encephalitozoon intestinalis||has_component
deoxyribonucleic acid||pcv type 2 dna naa+probe ql (specimen)||has_component
being sad made it hard for me to do things with my friends in past 7d||being sad made it hard for me to do things with my friends in past 7d:find:7d:^patient:ord:promis||has_component
guidance for percutaneous aspiration of cyst||guidance for percutaneous aspiration of cyst:finding:to identify measures at a point in time:abdomen>ileum.left:document:computed tomography||has_component
6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy||6p25 & 6q23 & 11q & 8q24 & 9p21 chromosome partial aneuploidy:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:fish||has_component
others||my child knew he or she could trust others in our family in past 4 weeks [promis.parentproxy]||has_component
body temperature||horowitz index^^adjusted to patient's actual temperature:ratio:to identify measures at a point in time:blood venous+inhaled gas:quantitative||has_component
squash antigen||squash ige qn||has_component
human immunodefic virus 1||hiv 1 rna naa+probe ql (bld)||has_component
cells set||sickle cells lm ql (bld)||has_component
tissue transglutaminase iga ab||ttg iga ia qn (s)||has_component
matuzumab||emd 72000/ly231514||has_component
guidance for drainage and placement of drainage catheter||guidance for drainage+placement of drainage catheter:find:pt:abdomen>retroperitoneum:doc:us||has_component
anti-candida albicans igg||c. albicans igg (s) [mass/vol]||has_component
product||drug type used in your lifetime||has_component
yersinia pestis (lehmann and neumann 1896) van loghem 1944 (approved lists 1980), nom. cons.||pacing wires culture yersinia pestis||has_component
6-mp||mp/mtx/vcr||has_component
trichlorophenoxyacetate||trichlorophenoxyacetate:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
n tau-methylhistidine||3-methylhistidine [units/volume] in serum or plasma||has_component
mentha piperita ab.ige||mentha piperita antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
thrombus||maximum clot strength amplitude.kaolin induced^after addition of heparinase:len:pt:bld:qn||has_component
complement factor (substance)||c1 s complement assay (procedure)||has_component
fluids output||fluid output.insensible:volume rate:8 hours:^patient:quantitative:estimated||has_component
mds v3.0 - rai v1.17.2 - health conditions - np, nq, sp||mds v3.0 - rai v1.17.2 - health conditions - np, nq, sp:-:to identify measures at a point in time:^patient:-:cms assessment||has_component
vincristine sulfate (product)||bleomycin/adriamycin/cyclophosphamide/oncovin/dexamethasone||has_component
spermatozoa.normal head||spermatozoa.normal head/100 spermatozoa:number fraction:to identify measures at a point in time:semen:quantitative||has_component
note (document)||discharge summary note:finding:to identify measures at a point in time:{setting}:document:neuropsychology||has_component
general activity||coagulation factor viii activity actual/normal in platelet poor plasma by chromogenic method||has_component
external rotation passive range of motion||shoulder external rotation passive range of motion quantitative||has_component
dengue virus, type 1||dengue virus 1 rna:prthr:pt:ser:ord:probe.amp.tar||has_component
herpes virus 8 antibody||herpes virus 8 ab.igm:titr:pt:ser:qn:if||has_component
escherichia coli shiga-like toxin 1||escherichia coli shiga-like toxin 1+2 [presence] in stool by immunoassay||has_component
haemophilus influenzae b antigen||haemophilus influenzae b ag [presence] in specimen by latex agglutination||has_component
gestation||things during pregnancy ever phenx||has_component
doxorubicin.hcl||bcg/cyclophosphamide/doxorubicin/tegafur||has_component
home dialysis patients who received transplant||home dialysis patients who received transplant:number:reporting period:^population:quantitative||has_component
cd - cadmium||measurement of cadmium in 24 hour urine specimen (procedure)||has_component
sphere||sphere far:invlen:pt:eye.right:qn:phoropter||has_component
immunoglobulin a||phosphatidylethanolamine ab.iga.b2gp1 dependent:mom:pt:ser:qn||has_component
blood group antigen i||i get a real gnawing hunger for a cigarette when l haven't smoked in a while [promis]||has_component
vascular flow, function (observable entity)||penile cavernosal artery end diastolic blood flow--baseline by us.doppler||has_component
superkingdom bacteria (organism)||bacteria identified:prid:pt:crn:nom:culture||has_component
mitochondrion||mitochondria m2 antibody.immunoglobulin g:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||has_component
goal context (qualifier value)||goals, preferences, and priorities upon death [reported]||has_component
after values (qualifier value)||busulfan [mass/volume] in plasma --4 hours post busulfan infusion completion||has_component
6h-purine-6-thione, 2-amino-1,7-dihydro- (9ci)||thioguanine:mcnc:pt:ser/plas:qn||has_component
fy1 (isbt symbol)||fy^a^ blood group typing||has_component
calcium leucovorin product||cf/uft/vp-16||has_component
fetal chromosome x & y aneuploidy||chr x and y aneuploidy dosage of chromosome-specific cfdna nom (cfdna)||has_component
cell positive for cd3 antigen||cd3-cd56+ cells/100 cells in tissue||has_component
gd(iii) texaphyrin||pci-0120/txt||has_component
secale cereale antibody.immunoglobulin e||secale cereale antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
ketones^1h post xxx challenge||ketones^1h post xxx challenge:mcnc:pt:urine:qn:test strip||has_component
erect body position||norepinephrine [moles/volume] in plasma --10 minutes post standing||has_component
endogenous thrombin potential||endogenous thrombin potential^after addition of factor viii ab:tmscnc:pt:ppp:qn:chromo||has_component
epstein-barr virus early antibody (substance)||epstein barr virus early ab.igg:titr:pt:csf:qn:if||has_component
problem;eye||when was your child first diagnosed as having an eye problem:time stamp-date and time:to identify measures at a point in time:^patient:quantitative:phenx||has_component
forms||promis short form - alcohol - positive consequences 7a - version 1.0 raw score:score:pt:^patient:qn:promis||has_component
blood group antigen i (substance)||i felt that my family understood me in past 4 weeks [promis.peds]||has_component
unesterified fatty acid (substance)||fatty acids.nonesterified^9th specimen post cfst:scnc:pt:ser/plas:qn||has_component
toxin, ricinus||ricin toxin igm ab [presence] in serum by immunofluorescence||has_component
mallein||b mallei rx 2d p .1ml mallein||has_component
salmonella enterica subspecies enterica serovar typhi h antibody||s typhi h ab ser ql||has_component
chicken feather||chicken feather+duck feather+goose feather+turkey feather ige multidisk qn (s)||has_component
neisseria gonorrhoeae antigen||neisseria gonorrhoeae ag [presence] in specimen by immunofluorescence||has_component
views pa + lateral||views pa + lateral + oblique:finding:to identify measures at a point in time:upper extremity.right>wrist:document:xr||has_component
product containing dactinomycin (medicinal product)||vincristine/actinomycin-d/cyclophosphamide/adriamycin/dacarbazine||has_component
map2k2 gene targeted mutation analysis||map2k2 gene targeted mutation analysis:find:pt:bld/tiss:doc:molgen||has_component
pyruvate (substance)||pyruvate^post exercise:mass concentration:to identify measures at a point in time:whole blood:quantitative||has_component
cell structure||cd19+cd43+ cells/100 cells (csf)||has_component
assessment||r macula comp func erg||has_component
d||how much difficulty do you currently have planning an activity several days in advance, like a meal, trip, or visit to friends [neuroqol]||has_component
vascular endothelial growth factor a||vegfa gene.c.-1498c>g & c.-1498c>t:geno:pt:bld/tiss:nom:molgen||has_component
blood group antigen i||i think that i will be contaminated with a serious disease:find:pt:^patient:ord:scared-r||has_component
d15-d16 i blood group antigens||i have trouble keeping track of what i am doing if i get interrupted in past 4w:finding:4 weeks:^patient:ordinal:promis.peds||has_component
isophenphos||isofenphos (specimen) [mass/mass]||has_component
alpha-fucosidase||alpha fucosidase qn (wbc)||has_component
polymorphonuclear cells/leukocytes||polys nfr.df prt manual||has_component
multisection^wo & w contrast||multisection^wo & w contrast intravenous:finding:to identify measures at a point in time:chest>brachial plexus:document:magnetic resonance||has_component
diagnosis||diagnosis.addressed by plan:impression/interpretation of study:to identify measures at a point in time:speech therapy treatment plan:set||has_component
asparaginase macrogol||mtx/peg-asp||has_component
width||accommodation width.measured 3:length:to identify measures at a point in time:eye:quantitative:minus glass||has_component
operation (surgery)||us liver during surgery||has_component
duck enteritis virus||duck enteritis virus antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
views perfusion||nm hrt pf w dpy+rnc iv||has_component
cobalamin||cobalamin [mass/volume] in serum||has_component
influenza virus b victoria lineage ribonucleic acid||flubv vic rna ct resp qn naa+probe||has_component
scored||promis parent proxy - global health 7 - version 1.0 raw score:score:pt:^patient:qn:promis.parentproxy||has_component
alternaria alternata+american house dust mite||(alternaria alternata+dermatophagoides farinae) ab.igg:mcnc:pt:ser:qn:multidisk||has_component
haa - hepatitis a antibody||hepatitis a antibody test (procedure)||has_component
7-alpha,12-alpha dihydroxycholest-4-en-3-one||7a12adiohchol4en3one bld-scnc||has_component
cells.cd20+cd25+||cd20+cd25- cells/100 cells in blood||has_component
class||class:type:pt:urine tube:nom||has_component
counseling note||counseling note:finding:to identify measures at a point in time:{setting}:document:palliative care||has_component
blood lymphocyte||percentage lymphocytes||has_component
for transplanted kidney||multisection for transplanted kidney vessels:finding:to identify measures at a point in time:pelvis:document:ultrasound.doppler||has_component
reports studies||study report:find:pt:^patient:doc:pulmonary function||has_component
gastrin^7th specimen||gastrin^7th specimen post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
6 mp||ara-c/mp/mtx/peg-asp/vcr||has_component
views||rfa gastroduodenal a views w contr ia||has_component
human anti-mouse antibody||human antimouse antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
n nos ag||alpha-n-acetylgalactosaminidase:ccnt:pt:wbc:qn||has_component
cv2 antibody||cv2 ab titr serpl if||has_component
leptospira interrogans serovar canicola antibody (substance)||l inter canic ab titr ser||has_component
hiv 2 p34||hiv 2 p34 ab [presence] in serum by immunoblot||has_component
d||oasis d - patient history and diagnoses - start of care or resumption of care:-:pt:^patient:-:cms assessment||has_component
medicago sativa antibody.immunoglobulin g||alfalfa igg rast class (s)||has_component
telephone number (property)||primary contact phone number:tele:pt:facility:nom||has_component
tg - triglyceride||serum random triglyceride measurement (procedure)||has_component
status post||lactate 3 hr post unsp challenge [mass/vol]||has_component
coxsackievirus b ab||coxsackievirus b antibody.immunoglobulin g^2nd specimen:dilution factor (titer):to identify measures at a point in time:cerebral spinal fluid:quantitative||has_component
irf-pai - impairment group - discharge||irf-pai - impairment group - discharge:-:to identify measures at a point in time:^patient:-:cms assessment||has_component
precis||oncology discharge sum||has_component
duck feather ab||duck feather ab.ige:prthr:pt:ser:ord||has_component
superficial biopsy||us guided bone super bx||has_component
discharge notification note||emergency department discharge notification||has_component
parrot feather ab||budgerigar feather+canary feather+finch feather+parakeet feather+parrot feather ige multidisk qn (s)||has_component
influenzavirus a antibody||fluav igm ia ql (s)||has_component
product containing cocaine||cocaine+benzoylecgonine:presence or threshold:to identify measures at a point in time:urine:ordinal:confirm||has_component
hiv 1 gp41+gp43 ab||hiv1 gp41+gp43 ab ser ql ib||has_component
sjogrens syndrome-b extractable nuclear||sjogrens syndrome-b extractable nuclear antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune diffusion||has_component
maximal||mitral valve medial annulus tissue velocity.a-wave.max by us.tissue doppler||has_component
status, functional||functional status of graft:finding:point in time:{graft}:nominal||has_component
am||i am satisfied with my ability to work in the past 7 days [neuroqol]||has_component
amylase product||24 hour urine amylase output||has_component
post||glucose 1 hr post dose lactose po [moles/vol]||has_component
dosages (qualifier value)||androsterone^pre dose dexamethasone:mass rate:24 hours:urine:quantitative||has_component
clostridium tetani (organism)||c tetani ab sp2 ser-acnc||has_component
fiber.soluble intake||soluble fiber intake 24 hour measured||has_component
ct - chlamydia trachomatis||chlamydia trachomatis dna:prthr:pt:vag:ord:probe.amp.tar||has_component
gabhs - group a beta-hemolytic streptococcus||oropharynx culture group a beta-hemolytic streptococcus||has_component
guidance for repair of central venous catheter without port or pump||rfa guidance for repair of cv catheter without port or pump of vein||has_component
urinalysis procedure||urinalysis studies:complex:-:^patient:set||has_component
prescription||do you have someone to pick up a prescription if you need it:find:pt:^patient:ord:promis||has_component
virus||west nile virus igg avidity ia ql (s)||has_component
surface||stroke volume/body surface area:arvol:pt:heart.ventricle.left:qn:us.doppler||has_component
peak inspiratory flow^at 2.5 liter per second on ventilator||deprecated peak inspiratory flow respiratory system airway opening by airway pressure monitor --at 2.5 liter per second on ventilator||has_component
marrow neutrophil||polymorphonuclear cells/100 leukocytes in body fluid||has_component
how much did pain interfere with your close personal relationships in past 7d||how much did pain interfere with your close personal relationships in past 7d:find:7d:^patient:ord:promis||has_component
notes||note:find:pt:{setting}:doc:pediatric pulmonology||has_component
red ant (pogonomyrmex barbatus) ige||pogonomyrmex barbatus ab.ige.rast class:prthr:pt:ser:ord||has_component
during the past 30 days, how many days out of 30 were you totally unable to work or carry out your normal activities because of these feelings||during the past 30 days, how many days out of 30 were you totally unable to work or carry out your normal activities because of these feelings [kessler 6 distress]||has_component
white blood cell (wbc)||lymphocytes/100 leukocytes in body fluid by manual count||has_component
scores (qualifier value)||ceramide risk score:score:pt:plas:qn:calculated||has_component
note||palltv care team note||has_component
influenza type b||influenza virus b antigen:presence or threshold:to identify measures at a point in time:respiratory.upper:ordinal:immunoassay.rapid||has_component
am||i am able to read like i used to in the past 7 days [facit]||has_component
somatotropin^12th specimen||somatotropin 12th specimen post unsp challenge [moles/vol]||has_component
phosphoglycerate kinase||phosphoglycerate kinase:ccnt:pt:rbc:qn||has_component
hedis 2017 value set - chlamydia tests||hedis 2017, 2018 value set - chlamydia tests:-:to identify measures at a point in time:^patient:-||has_component
other||other cells/100 leukocytes:nfr:pt:body fld:qn||has_component
deoxyribonucleic acid of candida lusitaniae||naa with probe detection for candida lusitaniae dna in vaginal fluid (lab test)||has_component
hedis 2017 value set - serum potassium||hedis 2017 value set - serum potassium:-:pt:^patient:-||has_component
cis-diammine(1,1-cyclobutanedicarboxylato)platinum||cbdca/dox/iff||has_component
p wave axis horizontal plane||p wave axis.horizontal plane:angle:to identify measures at a point in time:reference beat:quantitative:ekg||has_component
blastomyces sp.||blastomyces sp dna [presence] in tissue by naa with probe detection||has_component
volumes||volume.expired:volume rate:to identify measures at a point in time:respiratory system:quantitative||has_component
attribute type||regular multiple vit phenx||has_component
ach||fgfr3 gene targeted mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||has_component
cells.cd62||cells.cd62/100 cells:nfr:pt:xxx:qn||has_component
region orifice area||pulmonic valve region orifice area by us.doppler vti + diameter calculated||has_component
histology||histology international classification of diseases-o-3:presence or identity:to identify measures at a point in time:cancer.not specified:nominal||has_component
3-(.alpha.-acetonylbenzyl)-4-hydroxycoumarin||warfarin:scnc:pt:urine:qn||has_component
eggs, unfertilized||egg white igg ab [presence] in serum||has_component
100 cells||cells.cd10+cd19+/100 cells:nfr:pt:tiss:qn||has_component
(views||views 2:find:pt:chest>clavicle.left:doc:xr||has_component
rubella virus ab||mev + muv + rubv igg pnl serpl-acnc||has_component
antibody to streptococcus pneumoniae danish serotype 1||s. pneumoniae 1 ab spec 2 (s) [mass/vol]||has_component
health conditions||lcds v5.00 - health conditions - admission [cms assessment]||has_component
set of cells||cells.cd45:number concentration (count/vol):to identify measures at a point in time:respiratory.lower:quantitative:flow cytometry||has_component
view||nm skeletal system.peripheral views for bone density||has_component
guidance||mg guided brst-r clip place||has_component
rhizopus nigricans||rhizopus nigricans ab.igg:mcnc:pt:ser:qn||has_component
hematinics (medication)||red cell vitamin b2 level||has_component
interventional||acute heart failure within 24 hours prior to procedure||has_component
6-alpha hydroxytetrahydro-11-dehydrocorticosterone^pre high dose dexamethasone||6-alpha hydroxytetrahydro-11-dehydrocorticosterone^pre high dose dexamethasone:mcnc:24h:urine:qn||has_component
cell, epithelial||epithelial cells.non-squamous:ncnc:pt:urine:qn:automated count||has_component
yersinia||yersinia species culture||has_component
cd3+cd4+cd45ro+cd45ra+ cells||cd3+cd4+cd45ro+cd45ra- cells/100 cells in blood||has_component
fluav||fluav h3 rna naa+probe ql (nph)||has_component
t8 antigens, t-cell||cells.cd4-cd8-/100 cells.cd3+tcr alpha beta+:number fraction:to identify measures at a point in time:whole blood:quantitative||has_component
preparation, pharmaceutical||current level of confidence i can follow directions when my doctor changes my medications:finding:to identify measures at a point in time:^patient:ordinal:promis||has_component
murray valley enceph virus||murray valley encephalitis virus ab.igg:prthr:pt:xxx:ord:ia||has_component
immunoglobulin m||chlamydia sp ab.igm:acnc:pt:csf:qn:if||has_component
epstein barr virus capsid||epstein barr virus capsid ab.igg avidity:prthr:pt:ser:ord:ia||has_component
cancer, unspecified site||verbatim description of primary colorectal cancer diagnosis narrative [phenx]||has_component
named||i had trouble remembering the name of a familiar person in the past 7d:finding:7 days:^patient:ordinal:neuroqol||has_component
multisection^wo contrast||multisection^wo contrast:find:pt:chest>lung parenchyma:doc:ct||has_component
epstein barr virus early ab||ebv ea igg titr ser if||has_component
adriblastin||bleo/ctx/dox/moab idec-c2b8/mtx/pred/vcr||has_component
views pa and lateral||xr wrist-l pa+lat+obl||has_component
carnitine acyl||acylcarnitine/carnitine.free (c0) (u) [molar ratio]||has_component
micrococcus meningitidis cerebrospinalis||n. meningitidis c igg (s) [mass/vol]||has_component
epstein barr virus nuclear||ebv na ab csf ql||has_component
high blood glucose||high blood glucose:history:to identify measures at a point in time:^patient:ordinal||has_component
lactalbumin alpha leukotriene release||lactalbumin alpha leukotriene release:mcnc:pt:wbc:qn||has_component
human influenza a virus||influenza virus a ab^1st specimen:prthr:pt:ser:ord||has_component
medication administered||medication.administered:finding:to identify measures at a point in time:^patient:narrative||has_component
eicosapentaenoate intake||eicosapentaenoate intake:mass rate:24 hours:^patient:quantitative:estimated||has_component
note (document)||referral note:find:pt:{setting}:doc:oral and maxillofacial surgery||has_component
surgical operation note||surgical operation note:find:pt:outpatient:doc:nurse||has_component
virus venez equine enceph||venezuelan equine encephalitis virus ag [presence] in specimen by neutralization test||has_component
scrk protein||fructokinase measurement (procedure)||has_component
silver birch (betula verrucosa)||silver birch recombinant (rbet v) 1 ige ab/ige total in serum||has_component
public communication document name||public communication document name||has_component
pharmacological substance||bacterial gyra gene drug resistance mutation:prid:pt:isolate/specimen:nom:molgen||has_component
glucose (dextrose) (medication)||glucose^1h post dose insulin iv:mcnc:pt:ser/plas:qn||has_component
xxx challenge||thyrotropin^5th specimen post xxx challenge:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
radioisotope||views for blood flow^w radionuclide intravenous:finding:to identify measures at a point in time:not specified>vessel:document:nm||has_component
mycoplasma pneumoniae ab^2nd specimen||mycoplasma pneumoniae ab [titer] in serum --2nd specimen||has_component
modes of transfer||modes of transfer:-:pt:^patient:set||has_component
la crosse virus ab.igm||la crosse virus igm antibody titer in serum||has_component
rehabilitation.alcohol &or substance abuse service attachment||rehabilitation.alcohol &or substance abuse service attachment:finding:to identify measures at a point in time:{setting}:document:{role}||has_component
xxx challenge||prolactin sp4 p chal serpl-mcnc||has_component
hexaporphyrin||hexacarboxylporphyrin/creatinine (u) [molar ratio]||has_component
hiv 2 ab||hiv2 antibody level (procedure)||has_component
patient discharge||oasis d - elimination status - discharge from agency:-:to identify measures at a point in time:^patient:-:cms assessment||has_component
acth||cortisol free [mass/volume] in 24 hour urine --48 hours post dose corticotropin||has_component
self-care interventions (procedure)||self-care abilities:find:pt:^patient:nom||has_component
guidance||guidance for embolization for tumor^w embolic agent ia:find:pt:abdomen>hepatic artery:doc:{imaging modality}||has_component
metamyelocytes/100 leukocytes||metamyelocytes/100 leukocytes in cerebral spinal fluid by manual count||has_component
anaplasma marginale ab||anaplasma marginale ab [presence] in serum by card agglutination||has_component
organic acid (substance)||organic acid 1 quantitative||has_component
status post||bicarbonate post secretin stimulation panel:-:pt:body fld:qn||has_component
bacteria gram-positive||probe amplification test panels blood culture id gram-positive organisms||has_component
bordetella avium ab||bordetella avium antibody assay (procedure)||has_component
extractable nuclear||sjogrens syndrome-a extractable nuclear antibody+sjogrens syndrome-b extractable nuclear antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
brucella canis antibody||brucella canis ab.igg:titr:pt:csf:qn||has_component
csa||cyclosporine.polyclonal (bld) [mass/vol]||has_component
aspergillus niger||aspergillus niger b ab:prthr:pt:ser:ord:immune diffusion||has_component
vers||promis short form - physical function 6b - version 1.2 raw score||has_component
consumptions, oxygen||oxygen consumption (vo2)/body surface area [volume rate/area]||has_component
enterobacteriaceae (organism)||non-enterobacteriaceae identified org specific cx nom (isol)||has_component
amiodarone product||amiodarone+desethylamiodarone:mcnc:pt:ser:qn||has_component
protein (obsolete)||protein:mass concentration:to identify measures at a point in time:plasma:quantitative||has_component
plasma cells/100 leukocytes||plasma cells/100 leukocytes:number fraction:to identify measures at a point in time:cerebral spinal fluid:quantitative:microscopy||has_component
carbamazepine free and total trough and 10,11-epoxide panel||carbamazepine free & total trough & 10,11-epoxide panel:-:to identify measures at a point in time:serum/plasma:quantitative||has_component
noradrenaline||norepinephrine [mass/volume] in urine --5th specimen post xxx challenge||has_component
flow velocity, blood||pulmonary vein - right upper maximum blood flow velocity during systole by us.doppler||has_component
n-acetylaspartate/creatinine||n-acetylaspartate/creatinine (u) [mass ratio]||has_component
glucose^30m post 75 g glucose po||glucose^30m post 75 g glucose po:mcnc:pt:ser/plas:qn||has_component
aspergillus flavus ab||aspergillus flavus antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
my arm on this side feels numb in the past 7 days||my arm on this side feels numb in the past 7 days [facit]||has_component
note (document)||audiology diagnostic study note||has_component
bacteria identified||bacteria identified # 3 aer cx nom (bronch spec)||has_component
mesotheliocyte||mesothelial cells/100 leukocytes:number fraction:to identify measures at a point in time:vitreous fluid:quantitative:manual count||has_component
human papillomavirus, nos||human papilloma virus 18 deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:not specified:ordinal:probe.amp.tar||has_component
petroselinum crispum ab||parsley igg (s) [mass/vol]||has_component
dna/desoxyribonucleic acid||human bocavirus deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:probe.amp.tar||has_component
electronic health record (ehr) implementation stage||electronic health record implementation stage:finding:to identify measures at a point in time:{nursing unit}:ordinal:nmmds||has_component
substances||microalbumin excretion rate||has_component
immunoglobulins, e||(gadus morhua+mytilus edulis+pandalus borealis+salmo salar+thunnus albacares) antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative:multidisk||has_component
free fractionated catecholamine (substance)||catecholamines free fractionated 2 hr post 300 ug clonidine po (p) [mass/vol]||has_component
albumen||albumin/protein.total:mass decimal fraction:to identify measures at a point in time:urine:quantitative:electrophoresis||has_component
bovine herpesvirus 1 ab||bovine herpesvirus 1 ab cf ql (s)||has_component
idua gene targeted mutation analysis||idua gene targeted mutation analysis:prid:pt:bld/tiss:nom:molgen||has_component
bathed||prior - bathing:finding:to identify measures at a point in time:^patient:ordinal:oasis||has_component
immunoglobulins e||cashew+pecan or hickory nut+walnut+pistachio ige rast class multidisk (s)||has_component
factor intrinsic||intrinsic factor ab:prthr:pt:ser:ord:ria||has_component
igm antibody||rickettsia prowazekii igm ab [titer] in body fluid||has_component
aspergillus fumigatus ag||aspergillus fumigatus antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:immune fluorescence||has_component
multisection^wo contrast||multisection^wo contrast:find:pt:head>face & neck:doc:ct||has_component
orthodontic procedure (procedure)||periodontal procedure is related to orthodontic treatment plan||has_component
escherichia coli k99 (organism)||escherichia coli k99 [presence] in isolate by agglutination||has_component
borrelia burgdorferi johnson et al. 1984 emend. baranton et al. 1992||borrelia burgdorferi antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:synovial fluid (joint fluid):ordinal||has_component
methemoglobin/hemoglobin.total||methemoglobin (bldcv) [mass fraction]||has_component
multisection for pulmonary embolus||cta pa-bl + le vv-bl for pe+dvt w cont iv||has_component
9α-fluoro-16α-methylprednisolone||cc-5013/dexamethasone||has_component
sh2d1a gene targeted mutation analysis||sh2d1a gene targeted mutation analysis in blood or tissue by molecular genetics method||has_component
antibody to centromere protein b||centromere b ab ser ql ib||has_component
hiv genotype||hiv gentyp islt||has_component
note (document)||procedure note:find:pt:{setting}:doc:plastic surgery||has_component
vaccine administration tier||vaccine administration tier:type:to identify measures at a point in time:^event:nominal||has_component
heinz bodies/100 erythrocytes||heinz bodies/100 erythrocytes:number fraction:to identify measures at a point in time:whole blood:quantitative||has_component
xxx challenge||creatinine [moles/volume] in urine --1 hour pre xxx challenge||has_component
albumin||albumin/creatinine:ratio:to identify measures at a point in time:urine:quantitative:detection limit <= 1.0 mg/l||has_component
fc receptor iii||cells.cd3-cd16+cd56+/100 cells:nfr:pt:bone mar:qn||has_component
toxoplasma gondii dna (substance)||toxoplasma gondii dna [presence] in placenta by naa with probe detection||has_component
hearing loss newborn screening comment-discussion||hearing loss newborn screening comment-discussion nar (ear)||has_component
legionella pneumophila 10 ab||l. pneumophila 10 igm (s) [titer]||has_component
h nos||salmonella paratyphi b h ab [titer] in serum||has_component
immunoglobulin m (igm)||escherichia coli ab.igm:acnc:pt:ser:qn||has_component
ristocetin induced platelet aggregation, function||pa rist 1200 ug/ml prp||has_component
compliance||dynamic lung compliance||has_component
vitamin e (tocopherol)||when you took vitamin e, how much did you usually take:find:pt:^patient:ord:phenx||has_component
cellula||cells.cd10+cd19+/100 cells:number fraction:to identify measures at a point in time:tissue, unspecified:quantitative||has_component
streptococcus pneumoniae 4 antibody.immunoglobulin g||streptococcus pneumoniae danish serotype 4 ab.igg^2nd specimen:acnc:pt:ser:qn||has_component
xxx challenge||glucose [mass/volume] in serum or plasma --11th specimen post xxx challenge||has_component
tmstp||date and time of scheduled task:tmstp:pt:^event:qn||has_component
gene (substance)||btd gene full mutation analysis in blood or tissue by sequencing||has_component
views ski jump||views ski jump:find:pt:lower extremity>hindfoot+midfoot:doc:xr||has_component
didehydrodeoxythymidine||stavudine in serum or plasma (lab test)||has_component
mitochondrial structure (body structure)||mitochondria dna complex iii targeted mutation analysis in blood or tissue by molecular genetics method||has_component
cardiopulmonary resuscitation technique||cpr technique||has_component
chemotherapy effectiveness panel||chemotherapy effectiveness panel:presence or identity:-:whole blood/tissue, unspecified:document||has_component
leishmania donovani antibody||leishmania donovani ab.igm:titr:pt:ser:qn:if||has_component
anti-psychotic agent (product)||antipsychotics not otherwise specified 7/more||has_component
drug, tricyclic antidepressant||tricyclic antidepressants:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:screen||has_component
time (e.g. seconds)||test time end clock time||has_component
clarithromycin (medication)||clarithromycin:dilution factor (titer):to identify measures at a point in time:isolate+serum:quantitative:serum bacterial titer||has_component
biopsy, nos||us guidance for biopsy of spleen||has_component
views^w contrast intra multiple ducts||mg brst duct views w contr intra dcts||has_component
(multisection||multisection^w contrast intravenous:finding:to identify measures at a point in time:lower extremity.bilateral>thigh:document:computed tomography||has_component
fifth disease virus||parvovirus b19 igg 1st specimen/2nd specimen (s) [ratio]||has_component
swallowed||mds v3.0 - rai v1.14.1, v1.15.1, v1.16.1 - swallowing &or nutritional status:-:to identify measures at a point in time:^patient:-:cms assessment||has_component
prednisone preparation||amoplace||has_component
blood group antigen rh5||hbv e ag ria ql (s)||has_component
eosinophils/100 cells||eosinophils/100 cells:number fraction:to identify measures at a point in time:marrow (bone):quantitative:manual count||has_component
coding system.original.seer||coding system.original.seer [identifier] cancer registry||has_component
met||methionine/total aa (dbs) [molar fraction]||has_component
care self||prior functioning.self care:find:pt:^patient:ord:cms assessment||has_component
ap view||views ap + lateral:find:pt:upper extremity>elbow:doc:xr||has_component
a-ase||asparaginase/cyclophosphamide/daunorubicin/methotrexate/prednisone/vincristine||has_component
xylose^baseline||xylose bs serpl-mcnc||has_component
von willebrand factor product||vwf cleaving protease actual/normal ia (ppp) [rel catalytic activity/vol]||has_component
blood flow, nos||blood flow velocity.mean:vel:pt:cerebral artery anterior^fetus:qn:us.doppler||has_component
protein preparations||measurement of nuclear matrix protein 22 in urine specimen||has_component
field of vision||field of vision:find:pt:^patient:ord:rfc assessment||has_component
brain 14-3-3 protein||14-3-3 antigen:arbitrary concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||has_component
aquaporin 4 water channel antibody.immunoglobulin g||aquaporin 4 water channel ab.igg:prthr:pt:ser/plas:ord||has_component
antibody to rickettsia akari||rickettsia akari antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
status post||somatotropin 1 hr post dose arginine+insulin [mass/vol]||has_component
class||yellow dock ige rast class (s)||has_component
fy^a ab||f little y super little a ab:prthr:pt:ser/plas^donor:ord||has_component
secale cereale antigen||grass allergen mix 7 (bermuda grass+meadow fescue+rye grass+timothy grass+cultivated rye) ige ab [units/volume] in serum by multidisk||has_component
active c1r/c1s (substance)||complement c1r2+c1s2 measurement (procedure)||has_component
i felt that i was not needed in past 7d||i felt that i was not needed in past 7d:finding:7 days:^patient:ordinal:promis||has_component
cell types||cells.cd19+lambda+/100 cells:nfr:pt:bld:qn||has_component
haddock (melanogrammus aeglefinus) ab||melanogrammus aeglefinus antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
multisection||ct foot-bl||has_component
cannabinoid (product)||cannabinoids ur ql scn>20 ng/ml||has_component
creatinine (substance)||2,3-dinor 11b-pg f2a/creat ur||has_component
antigens cd 004||cd4+cd45ro+ cells [#/volume] in tissue||has_component
etoposido||bms-182751/etoposide||has_component
streptococcus pneumoniae danish serotype 9n ab||streptococcus pneumoniae danish serotype 9n antibody^1st specimen:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immunoassay||has_component
identifier (property) (qualifier value)||referring person identifier:id:pt:skilled nursing treatment plan:nom||has_component
human t cell lymphotropic virus type iii||human immunodeficiency virus reverse transcriptase+protease gene mutations tested for:presence or identity:to identify measures at a point in time:isolate:nominal||has_component
wbc||leukocytes [#/volume] in cerebral spinal fluid --1st tube||has_component
insulin product||insulin 3h p 75 g glc po serpl-scnc||has_component
mycoplasma mycoides ss mycoides small colony||mycoplasma mycoides subspecies mycoides small colony ab:prthr:pt:ser:ord:comp fix||has_component
sjogrens syndrome-a extractable nuclear 60kd ab||sjogrens syndrome-a extractable nuclear 60kd antibody:dilution factor (titer):to identify measures at a point in time:body fluid, unsp:quantitative:immunoassay||has_component
multisection^wo & w contrast iv && multisection||multisection^wo & w contrast intravenous && multisection^w contrast iv:finding:to identify measures at a point in time:head && head>temporal bone:document:computed tomography||has_component
influenzavirus||deprecated influenza virus a ab [units/volume] in serum||has_component
loperamide induced platelet ab||loperamide induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry||has_component
coagulation surface induced||coagulation surface induced:time:to identify measures at a point in time:whole blood^control:quantitative:coagulation assay.saline 1:1||has_component
5-methyltetrahydrofolate||5-methyltetrahydrofolate/folate [molar fraction]||has_component
notes||discharge summary note:find:pt:{setting}:doc:psychiatry||has_component
pains||promis parent proxy short form - pain interference 8a - version 2.0 raw score:score:pt:^patient:qn:promis.parentproxy||has_component
dialyses||dialysis stations:num:pt:facility:qn||has_component
study observation||fetal limbs narrative study observation us||has_component
thiophosphoramide||carboplatin/etoposide/mitoxantrone/thiotepa||has_component
ed medication data||ed medication data deeds||has_component
licensed nursing staff||licensed nursing staff.primary nursing license type:number:to identify measures at a point in time:{nursing unit}:quantitative:nmmds||has_component
measles virus, german||rubella virus ab ql (csf)||has_component
wheel long ramp during 2d assessment period||wheel long ramp during 2d assessment period:find:2d:^patient:ord:care||has_component
antigen of human orthopneumovirus (substance)||rsv ag lower resp ql if||has_component
d15-d16 i blood group antigens||i am confident i can help prevent or reduce problems associated with my health [pam]||has_component
max||radial strain rate.systole.max:arat:pt:heart.ventricle.left:qn:us.2d||has_component
sterilization consent||sterilization consent||has_component
leukocyte 7||cells.cd56+cd57+/100 cells:nfr:pt:bone mar:qn||has_component
hepatitis b virus e antigen||hepatitis b virus e antigen:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
phexxi||lactate dehydrogenase:ccnc:pt:plr fld:qn||has_component
little f||little f ab serpl bpu ql||has_component
oat pollen (avena sativa cultivated) ige||oat pollen ige qn (s)||has_component
plan of treatment||overall plan of care/advance care directives - subheading||has_component
parrot feather ab||parrot feather ige rast ql||has_component
finding of mycoplasma species||mycoplas+ureoplas pnl spec cult||has_component
beneflur||cytarabine/fludarabine||has_component
staff assessment of daily and activity preferences||staff assessment of daily and activity preferences||has_component
7s gamma globulin||sulfatide igg and igm panel - serum||has_component
discharged||discharge potential and overall status section:-:point in time:^patient:-||has_component
apsa - phosphatidylserine ab||phosphatidylserine igg ab [units/volume] in serum||has_component
saturation oxygen||oxygen saturation:mass decimal fraction:to identify measures at a point in time:blood - cord:quantitative||has_component
streptococcus pneumoniae danish serotype 9v ab.igg^2nd specimen||streptococcus pneumoniae danish serotype 9v igg ab [ratio] in serum --2nd specimen/1st specimen||has_component
transcobalamin ii (substance)||apo-transcobalamin ii:substance concentration:to identify measures at a point in time:serum:quantitative||has_component
staphylococcus pyogenes citreus||s. aureus identification and resistance panel molgen (islt/spec)||has_component
i blood group antigens||current level of confidence i can communicate well with my doctors and nurses:finding:to identify measures at a point in time:^patient:ordinal:promis||has_component
blood group antibody s (substance)||s blood group antibody identification||has_component
promis pediatric item bank - fatigue - version 2.0||promis pediatric item bank - fatigue - version 2.0:-:to identify measures at a point in time:^patient:-:promis.peds||has_component
albumen||microalbumin||has_component
note||group counseling note:find:pt:{setting}:doc:social worker||has_component
hydrochloride, daunorubicin||v-tad||has_component
start date for episode of care||start date for episode of care||has_component
lymphocyte antigen cd100 (substance)||cd100:arbitrary concentration:to identify measures at a point in time:leukocytes:quantitative||has_component
lately, i tended to blame myself for my problems||lately, i tended to blame myself for my problems:find:pt:^patient:ord:neuroqol||has_component
dolichovespula arenaria antibody.immunoglobulin g||yellow hornet igg ab [units/volume] in serum||has_component
rickettsia conorii antibody (substance)||r conorii igg titr fld if||has_component
blood group antigen s (substance)||protein s actual/normal:reltime:pt:ppp:qn:coag||has_component
21-hydroxysteroid hydroxylase||21-hydroxylase ab [presence] in serum||has_component
starasid||prednisone-cytarabine-thioguanine-cyclophosphamide-vincristine||has_component
antigen, cd34||deprecated cd34 cells/100 cells in blood||has_component
have you ever felt as if you were reliving some traumatic event that you experienced or witnessed||have you ever felt as if you were reliving some traumatic event that you experienced or witnessed:find:pt:^patient:ord:phenx||has_component
bizzozero corpuscle||fentanyl ind plt igg serpl ql fc||has_component
section 3 viruses||vzv igg sp2 ser-acnc||has_component
ribonucleic acid polymerase iii rp11 antibody||ribonucleic acid polymerase iii rp11 antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative:line blot||has_component
conditions &or diseases make resident's cognitive, activities of daily living, mood or behavior patterns unstable||conditions &or diseases make resident's cognitive, adl, mood or behavior patterns unstable:find:pt:^patient:ord:mds||has_component
juniperus sabinoides specific immunoglobulin e (substance)||mountain juniper rast||has_component
gbu4-5 ab||gbu4-5 ab:acnc:pt:ser/plas:qn:ia||has_component
ab.iga||phospholipid antibody.immunoglobulin a & immunoglobulin g & immunoglobulin m panel:-:to identify measures at a point in time:serum:quantitative||has_component
immunological substance||cardiolipin antigen preparation||has_component
promis item bank - dyspnea functional limitations - version 1.0||promis item bank - dyspnea functional limitations - version 1.0:-:pt:^patient:-:promis||has_component
gene (substance)||hiv 1 rna rt sequence nom (s/p/bld)||has_component
unspecified substance||calculus exam. general (procedure)||has_component
certified||cms certification number:identifier:to identify measures at a point in time:agency:nominal:oasis||has_component
emotional health||emotional well-being - fams [facit]||has_component
views pa and r-lateral||xr skull pa and right lateral and left lateral||has_component
i got all the help i needed from my family in past 4 weeks||i got all the help i needed from my family in past 4w:find:4w:^patient:ord:promis.peds||has_component
cells.cd56||deprecated cd56 cells fr xxx||has_component
bacteroides fragilis (organism)||b fragilis igm ser-acnc||has_component
blood clot (morphologic abnormality)||clot lysis estimate:prctl:pt:bld:qn:thromboelastography||has_component
i-antigen||lately, because of my illness, i felt emotionally distant from other people:find:pt:^patient:ord:neuroqol||has_component
100 leukocytes||monocytes/leuk nfr bronch manual||has_component
surgical operation note date||operative note date||has_component
multisection||multisection for pyloric stenosis:find:pt:abdomen>pylorus:doc:us||has_component
hemolysin, nos||hemolysin detection, cold, quantitative (procedure)||has_component
viridae||hhv6 dna # tiss naa+probe||has_component
i have difficulty swallowing soft or mashed foods in the past 7d||i have difficulty swallowing soft or mashed foods in the past 7 days [facit]||has_component
(multisection||multisection^wo & w contrast intrathecal:finding:to identify measures at a point in time:chest>spine.thoracic:document:computed tomography||has_component
phenytoin induced platelet ab||phenytoin induced platelet igg fc ql||has_component
flowing||blood flow velocity.mean:velocity:to identify measures at a point in time:pulmonary artery.main:quantitative:ultrasound.doppler||has_component
sehydrin||cddp/hdz/vbl||has_component
infection tbc||mycobacterium tuberculosis pnca gene pyrazinamide resistance mutation [identifier] by molecular method||has_component
multisection^w contrast||multisection^w contrast intravenous:finding:to identify measures at a point in time:head>brain & head+neck>larynx:document:magnetic resonance||has_component
microscopic (qualifier value)||microscopic observation smear nom (specimen)||has_component
toxoplasma gondii antibody (substance)||toxoplasma gondii ab:acnc:pt:csf:qn||has_component
11-dehydrotetrahydrocorticosterone/creatinine||11-dehydrotetrahydrocorticosterone/creatinine [molar ratio] in urine||has_component
4-amino-4-deoxy-10-methylpteroyl-l-glutamic acid||com protocol||has_component
dose per administration||somatotropin pre dose triple bolus [mass/vol]||has_component
(±)-1-(2,6-dimethylphenoxy)propan-2-amine||mexiletine:scnc:pt:urine:qn||has_component
salmonella paratyphi b, h antibody||s. paratyphi b h ab qn (s)||has_component
numeric||sequence number.hospital cancer||has_component
product containing methotrexate||cytarabine/etoposide/ifosfamide/leucovorin calcium/methotrexate/prednisolone||has_component
product containing eculizumab||eculizumab:mass concentration:to identify measures at a point in time:serum:quantitative||has_component
dihydrocodeine free+hydrocodol free||dihydrocodeine.free+hydrocodol.free:prthr:pt:ser/plas:ord:screen||has_component
fcn||promis item bank - cognitive function - abilities subset - version 2.0:-:7d:^patient:-:promis||has_component
ehrlichia canis antibody (substance)||ehrlichia canis ab:prthr:pt:ser:ord:ia||has_component
product containing calcium folinate (medicinal product)||doxorubicin/fluorouracil/leucovorin calcium/vinorelbine||has_component
human papillomaviruses||human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 e6+e7 mrna:prthr:pt:cvx:ord:probe.amp.tar||has_component
twar - taiwan acute respiratory chlamydia antibody||chlamydia pneumoniae iga level (procedure)||has_component
carob (ceratonia siliqua)||carob ige rast class (s)||has_component
power||power level^peak during exercise:engrat:pt:^patient:qn||has_component
streptococcus pneumoniae 3 antibody||streptococcus pneumoniae danish serotype 3 antibody^1st specimen:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immunoassay||has_component
home dialysis patients at beginning of reporting period||home dialysis patients at beginning of reporting period:number:to identify measures at a point in time:^population:quantitative||has_component
rubeola virus antibody||mev igg and igm panel (csf)||has_component
adult self-report long form total score||adult self-report long form total score [mfq]||has_component
cyclosporine product||cyclosporine trough bld-mcnc||has_component
htlv wi||htlv i p19 ab qn (s)||has_component
gv - gardnerella vaginalis||g vaginalis genital ql cult||has_component
dextromethamphetamine||dextromethamphetamine:mcnc:pt:urine:qn||has_component
compared to 10y ago, has there been any change in remembering he or she has already told someone something||compared to 10y ago, has there been any change in remembering he or she has already told someone something:find:pt:^patient:ord:ecog.partner||has_component
scientific study||study observation:find:pt:visual pathway.left:ord:vep||has_component
single view||views^wo & w weight:find:pt:upper extremity.right>acromioclavicular joint:doc:xr||has_component
activity||i have to limit my sexual activity because of diarrhea in the past 7d:finding:7 days:^patient:ordinal:facit||has_component
cms - cardiovascular exam panel||cms - cardiovascular exam panel:-:point in time:^patient:narrative||has_component
(views) + (view ap||xr t-spine ap+lat||has_component
i blood group antigens||when i get really happy about something, i tend to do things that can lead to trouble:find:pt:^patient:ord:upps-r-c||has_component
single view||xr shoulder - left transthoracic||has_component
bile acid||trihydroxy bile acid measurement||has_component
lacrosse virus||la crosse virus antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:body fluid, unsp:ordinal:immunoassay||has_component
salmonella enterica subspecies enterica serovar paratyphi b antibody (substance)||s. paratyphi b ab ql (s)||has_component
multisection^wo & w contrast||multisection^wo & w contrast intravenous:finding:to identify measures at a point in time:lower extremity.right>lower extremity joint:document:magnetic resonance||has_component
t cell crossmatch||b+t cell xm ser+bld fc-imp||has_component
somatotropin||somatotropin:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
human leukocyte antigen hla-dr antigen||cd13+hla-dr+ cells nfr mar||has_component
sindbis virus antibody||sindbis virus antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||has_component
d||cortis f pre 50 ug acth im 24h ur-mcnc||has_component
campylobacter jejuni||campylobacter jejuni ab [units/volume] in serum||has_component
challenge||dhea 30m p chal serpl-mcnc||has_component
human herpesvirus 4 group||epstein barr virus nuclear igg ab [titer] in cerebral spinal fluid||has_component
can pronounce brobdingnagian||can pronounce brobdingnagian [nih toolbox]||has_component
immunoglobulin ige, nos||allergen panel in serum respiratory allergy profile with total ige area 17||has_component
problem (finding)||date the psychological, psychiatric, emotional, or behavioral problem started [phenx]||has_component
reading (activity)||activity preferences - reading or writing [minimum data set]||has_component
ige total||brome ige/ige total %||has_component
genes||otc gene mutations tested for molgen nom (bld/tiss)||has_component
views ap||views ap + lateral:finding:to identify measures at a point in time:chest>spine.thoracic:document:xr.portable||has_component
myoglobins||serum myoglobin measurement (lab test)||has_component
anti-la crosse virus igg||lacv igg spec ql if||has_component
section 3 viruses||hepatitis c virus genotype & drug resistance panel:-:to identify measures at a point in time:isolate+serum:-||has_component
streptococcus pneumoniae 19 a igg||streptococcus pneumoniae danish serotype 19a antibody.immunoglobulin g^1st specimen:mass concentration:to identify measures at a point in time:serum:quantitative:immunoassay||has_component
dna / desoxyribonucleic acid||plasma cell dna content and proliferation panel fc (bm)||has_component
cd16 antigen||cd16+ cd56+ cells per 100 cells in body fluid (lab test)||has_component
how many||eaten large amt food edds||has_component
enteropeptidase (substance)||enteropeptidase (p) [catalytic activity/vol]||has_component
thyroglobulin^post thyroglobulin antibody neutralization||thyroglobulin^post thyroglobulin antibody neutralization:mcnc:pt:ser/plas:qn:ia||has_component
blood group antigen a, nos||adenovirus a+b+c+d+e dna:prthr:pt:respiratory:ord:probe.amp.tar||has_component
creatinine^6th specimen||adenosine monophosphate.cyclic/creatinine [ratio] in urine --6th specimen post xxx challenge||has_component
organization||deprecated phenx measure - family control and organization||has_component
phenytoin free & total panel||phenytoin free and total panel - serum or plasma||has_component
kind||provider type:type:pt:provider:nom:mdsv3||has_component
after||multisection post mortem:find:pt:xxx:doc:ct||has_component
creatinine (substance)||11-ketoetiocholanolone/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||has_component
i ag||i have discomfort or pain in my pelvic area in the past 7d:finding:7 days:^patient:ordinal:facit||has_component
100 cells||terminal deoxyribonucleotidyl transferase cells/100 cells in bone marrow||has_component
epirubicin hydrochloride (medication)||cape/cddp/emd 72000/epi||has_component
prism base||right eye prism base direction near by phoropter||has_component
sheep wool ab.ige||sheep wool ab.ige:acnc:pt:ser:qn||has_component
asparaginase (substance)||asparaginase/cisplatin/cytarabine/dexamethasone/etoposide||has_component
microscopic (qualifier value)||microscopic observation:prid:pt:xxx:nom:wright stain||has_component
lymphocyte, nos||lymphocytes/100 wbc auto (bld)||has_component
does your spouse or parent ever complain about your involvement with drugs||does your spouse or parent ever complain about your involvement with drugs:finding:to identify measures at a point in time:^patient:ordinal:samhsa||has_component
prednisone preparation (substance)||chlorambucil/etoposide/prednisone/vincristine||has_component
substance (attribute)||dichlorophenoxyacetate measurement (procedure)||has_component
d15-d16 i blood group antigens||i am limited in doing my work (include work at home) [promis]||has_component
respiratory allergen panel||respiratory allergen panel, us - greater ohio valley b - serum||has_component
immunoglobulin a antibody to endomysium||endomysium antibody.immunoglobulin a:presence or threshold:to identify measures at a point in time:serum:ordinal:immune fluorescence||has_component
platelet antibody.immunoglobulin m||hydrocortisone induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry||has_component
caring for my ostomy appliance is difficult in the past 7d||caring for my ostomy appliance is difficult in the past 7d:finding:7 days:^patient:ordinal:facit||has_component
igg antibody||c immitis igg csf-acnc||has_component
dsdna||cytp insitu hybrid urne spec 3-5 probes cptr ea||has_component
phenx - visual acuity protocol 111101||phenx - visual acuity protocol:-:point in time:^patient:-:phenx||has_component
blood group antigen a||was anyone murdered who was a parent, a brother, a sister, a very close friend, a boyfriend or girlfriend, or someone who lived with you:find:pt:^patient:ord:ltvh||has_component
paper wasp (polistes spp)||paper wasp recombinant (rpol d) 5 ige ab [units/volume] in serum||has_component
heinz bodies||heinz bodies lm ql (bld)||has_component
multisection||mra spinal veins wo and w contrast iv||has_component
trailing||blood pressure systolic and diastolic--post phlebotomy||has_component
natulanar||nm/pcb/vcr||has_component
l-arginin||arginine [moles/volume] in body fluid||has_component
challenge||norepineph p chal plas-mcnc||has_component
aspartate (asp)||nmdar igg if ql||has_component
xxx challenge||insulin 2.6h p chal serpl-acnc||has_component
creatinina||aluminum/creatinine [mass ratio] in urine||has_component
lead analyte (substance)||r wave duration.lead ii:time:to identify measures at a point in time:heart:quantitative:ekg||has_component
proinsulin||measurement of proinsulin||has_component
position, sitting||sit to lying - functional goal during 3 day assessment period [cms assessment]||has_component
maxima||food allergen mix 5 (peanut+cow milk+egg white+cod+soybean+wheat) ige ab [units/volume] in serum by multidisk||has_component
motion - physical agent||flexion.active range of motion:angle:pt:shoulder:qn||has_component
protein||protein s ag/coagulation factor x ag:mrto:pt:ppp:qn:coag||has_component
trtdos||methane/expired gas [volume fraction] in exhaled gas --pre dose carbohydrate||has_component
complement c1 esterase inhibitor free ab||complement c1 esterase inhibitor free igg ab [mass/volume] in serum or plasma||has_component
methicillin resistant staph aureus||staphylococcus aureus.methicillin resistant isolate:prthr:pt:nose:ord:organism specific culture||has_component
score (attribute)||mean score:score:pt:^patient:qn:ecog||has_component
virus||highlands j virus antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:not specified:ordinal:immunoassay||has_component
pepper white ab.igg.rast class||pepper white antibody.immunoglobulin g.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
human leukocyte antigen-cw10(w3)||hla-cw10(w3) ql (bld/tiss donor)||has_component
micro||microscopic observation:presence or identity:to identify measures at a point in time:peritoneal fluid /ascites:nominal:gram stain||has_component
immunologic factors||immunology profile (procedure)||has_component
has there been renovation in your home during the past 12mo||has there been renovation in your home during the past 12mo:find:12mo:^patient:ord:feas||has_component
growth hormone preparation||urine growth hormone level||has_component
time duration (property) (qualifier value)||date and time of surgery:time stamp-date and time:to identify measures at a point in time:^patient:quantitative||has_component
events (event)||anxiety aversive event scared-r||has_component
non-protein nitrogen (substance)||nitrogen.nonprotein [presence] in blood||has_component
maximum clot firmness.extrinsic coagulation system activated||mcf.fibrinolysis supp bld rotem||has_component
cocaine panel||cocaine panel - urine||has_component
transverse plane (body structure)||transverse section shape {dent arch}||has_component
report (document)||noninv arteriosclerosis study rpt||has_component
thermoactinomyces candidus (organism)||thermoactinomyces vulgaris antibody:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal||has_component
plasma proteins||protein measurement by electrophoretic fractionation and quantitation (procedure)||has_component
lactose^2h post 50 g lactose po||lactose [mass/volume] in serum or plasma --2 hours post 50 g lactose po||has_component
do you get invitations to go out and do things with other people||do you get invitations to go out and do things with other people [promis]||has_component
voriconazole induced platelet ab||voriconazole induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc)||has_component
additional concerns - fact-b||additional concerns - fact-b [facit]||has_component
consultation note||consultation note:finding:to identify measures at a point in time:{setting}:document:dialysis+therapeutic apheresis||has_component
intravascular diastolic||bp dias 8h mean||has_component
has the child received a transfusion of blood or blood products or been given a medicine called immune gamma globulin in the past y||has the child received a transfusion of blood or blood products or been given a medicine called immune gamma globulin in the past y:find:1y:^patient:ord:phenx||has_component
dibromodulcitol||thioguanine-procarbazine-mitolactol-lomustine-vincristine||has_component
versioned||functional assessment of cancer therapy for patients undergoing bone marrow transplantation questionnaire - version 4:-:pt:^patient:-:facit||has_component
nutritional||mds v3.0 - rai v1.17.2 - swallowing &or nutritional status - osa:-:pt:^patient:-:cms assessment||has_component
after||cortisol^12th specimen post xxx challenge:scnc:pt:ser/plas:qn||has_component
view (attribute)||views spot:find:pt:breast:doc:mg||has_component
creatinine renal clearance/1.73 sq m.predicted||creatinine renal clearance/1.73 sq m.predicted cockcroft-gault formula, bsa formula [vol rate/area]||has_component
staphylococcus aureus methicillin resistance sccmec||staphylococcus aureus methicillin resistance sccmec & meca+mecc genes panel:-:pt:nose:-||has_component
body surface||cardiac output/body surface area.2 chamber:volume rate/area:to identify measures at a point in time:heart.ventricle.left:quantitative:ultrasound.mod.single-plane.calculated||has_component
event||cd45 positive events:num:pt:xxx:qn||has_component
antigen of human papilloma virus 6||antigen detection for hpv type 6 + 11 + 42 + 43 + 44||has_component
bartonella sp antibody||bartonella sp ab.igg:acnc:pt:ser:qn:ia||has_component
gelatin porcine antibody.immunoglobulin e||gelatin porcine ab.ige:acnc:pt:ser:qn||has_component
r wave duration.lead v1||r' wave dur l-v1||has_component
genus salmonella (organism)||stool culture for salmonella and/or shigella (lab test)||has_component
labor and delivery records||labor and delivery records||has_component
versions||promis parent proxy short form - cognitive function 7a - version 1.0 raw score:score:pt:^patient:qn:promis.parentproxy||has_component
when your child talks on the phone, he or she is not sure when its their turn to speak||when your child talks on the phone, he or she is not sure when its their turn to speak:finding:to identify measures at a point in time:^patient:ordinal:aq adolescent||has_component
it is hard for me to find the right words to say what i mean||it is hard for me to find the right words to say what i mean:finding:to identify measures at a point in time:^patient:ordinal:neuroqol.peds||has_component
streptococcus pneumoniae nana gene||s pneum nana swab ql naa+probe||has_component
thyroid stimulating hormone (substance)||tsh sp5 p chal serpl-acnc||has_component
normetadrenaline||normetanephrine [mass/vol]||has_component
7s gamma globulin||rubv igg csf ql ia||has_component
antibody nuclear||sjogrens syndrome-a extractable nuclear ab ib qn (s)||has_component
cytomegalovirus (living organism) (organism)||cmv org specific cx ql (bld)||has_component
hla antigen (substance)||hla-a3 [presence] in donor||has_component
spherocytes.micro||spherocytes.micro [presence] in blood by light microscopy||has_component
glycine max antibody.immunoglobulin e||soybean ige rast ql||has_component
chestnut (pollen) specific immunoglobulin e||rt206 specific ige antibody measurement||has_component
difficulty jumping||jumping - difficulty [optimal]||has_component
views^w contrast||views^w contrast intravenous:finding:point in time:kidney.bilateral+collecting system:narrative:xr||has_component
note||respiratory therapy treatment plan progress note and attainment of goals set||has_component
immunoglobulin igm, nos||lymphocytic choriomeningitis virus antibody.immunoglobulin g & immunoglobulin m panel:-:to identify measures at a point in time:cerebral spinal fluid:quantitative||has_component
views||views for infarct^w tc-99m pyp iv:find:pt:chest>heart:doc:nm||has_component
product containing dehydroepiandrosterone (medicinal product)||dhea-s serpl-scnc||has_component
other people avoid hanging out with me because of my illness history in the past 4w||other people avoid hanging out with me because of my illness history in the past 4 weeks [facit]||has_component
microscopic (qualifier value)||fat spt ql sudan iii stn||has_component
platelet concentrate units||platelet concentrate units given:num:pt:^bpu:qn||has_component
5-fluorocytosine^trough||5-fluorocytosine [mass/volume] in serum or plasma --trough||has_component
oxygen saturation^during anesthesia||oxygen saturation in arterial blood by pulse oximetry --during anesthesia||has_component
streptococcus pneumoniae danish serotype 18c ab.igg^2nd specimen||streptococcus pneumoniae danish serotype 18c ab.igg^2nd specimen/1st specimen:ratio:pt:ser:qn||has_component
antibacterial antibody||chlamydia trachomatis igg level (procedure)||has_component
pancreatic elastase i||elastase panc2 ser-ccnc||has_component
administrative information||lcds v4.00 - administrative information - admission:-:pt:^patient:-:cms assessment||has_component
perimeter (qualifier value)||perimeter:len:pt:head^fetus:qn:us.estimated from jeanty 1982||has_component
treatment plan note||treatment plan note:finding:to identify measures at a point in time:{setting}:document:allergy and immunology||has_component
after values (qualifier value)||ketones 3h p chal ur ql||has_component
cd34+cd117+ blasts||cd34+cd117+ blasts/100 blasts (specimen)||has_component
m not otherwise specified antigen||creatinine renal clearance/1.73 sq m.predicted.male:volume rate/area:to identify measures at a point in time:serum/plasma:quantitative:cockcroft-gault formula, bsa formula||has_component
nuclear (nucleus)||jo-1 extractable nuclear ab:acnc:pt:ser:qn:ia||has_component
mycoplasma sp and ureaplasma sp||mycoplasma sp+ureaplasma sp:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:organism specific culture||has_component
mononuclear cells/100 leukocytes||mononuc cells/leuk nfr bronch||has_component
1,3-bis(2-chloroethyl)-1-nitrosourea||carmustine/cytarabine/etoposide/melphalan||has_component
neisseria meningitidis serogroup a igg||neisseria meningitidis serogroup a antibody.immunoglobulin g:mass concentration:to identify measures at a point in time:serum:quantitative:immunoassay||has_component
asthma, unspecified||it was hard for my child to take a deep breath because of asthma in past 7d:find:7d:^patient:ord:promis.parentproxy||has_component
extractable nuclear antibody||ena jo1 ab ser-acnc||has_component
discharge, patient||discharge summary note:find:pt:hospital:doc:physician||has_component
vaginalis trichomonas||t. vaginalis ag if ql (genital specimen)||has_component
blood group antigen, nos||antigens present bld||has_component
clot formation.glass bead induced panel||clot formation.glass bead induced panel:-:pt:bld:-:microviscometry||has_component
pank2 gene targeted mutation analysis||pank2 gene mut anl bld/t||has_component
pregnanetriolone||pregnanetriolone/tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [molar ratio] in 24 hour urine||has_component
cell large unstained||large unstained cells/100 leukocytes:nfr:pt:bld:qn:automated count||has_component
arthropod borne virus||arbovirus ab [interpretation] in serum by immunofluorescence||has_component
race (classification)||race:type:pt:^patient:nom:ussg-fht||has_component
phenx measure - pain||phenx measure - pain, abdominal - type and intensity:-:to identify measures at a point in time:^patient:-:phenx||has_component
transformation gene: oncogene hamsv||hras gene targeted mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||has_component
note||discharge summary note:find:pt:{setting}:doc:radiation oncology||has_component
intravascular (qualifier value)||intravascular systolic:pres:pt:celiac trunk artery:qn||has_component
mobility aids - none of the above were normally used in last 7 days||mobility aids - none of the above were normally used in last 7d:finding:7 days:^patient:ordinal:mdsv3||has_component
view (attribute)||views^w contrast intravenous:finding:to identify measures at a point in time:abdomen>vena cava.inferior:document:radiofluoroscopy.angio||has_component
special treatments, procedures and programs||lcds v3.00 - special treatments, procedures, and programs - admission [cms assessment]||has_component
diallylmal||allobarbital [presence] in stool||has_component
fluav||influenza virus a h2 ab [titer] in serum by hemagglutination inhibition||has_component
feels||over the past w, are you able to deal with feelings of depression or feeling blue:find:1w:^patient:ord:haq||has_component
thiazides tested for||thiazides tested screen nom (u)||has_component
cell count & differential panel with glucose & protein||cell cnt & diff pnl with glu & prot fld||has_component
pathology procedures||speech-language pathology services - concurrent minutes--week 2 [cms assessment]||has_component
factor, immune||toxoplasma serology||has_component
firvanq||vancomycin ige ab [units/volume] in serum||has_component
anti antibodies cardiolipins||iga anticardiolipin level||has_component
dengue virus 1 and 2 and 3 and 4 rna||dengue virus 1+2+3+4 ribonucleic acid:presence or threshold:to identify measures at a point in time:amniotic fluid:ordinal:probe.amp.tar||has_component
gd1a ganglioside antibody||deprecated ganglioside gd1a ab [presence] in serum||has_component
headache (finding)||which best describes how you are usually affected by severe headaches:find:pt:^patient:ord:phenx||has_component
ribonucleic acid of severe acute respiratory syndrome coronavirus 2||detection of ribonucleic acid of sars-cov-2 using polymerase chain reaction||has_component
carnitine esters||carnitine esters (u) [mass/vol]||has_component
are you able to do vigorous activities, such as playing sports||are you able to do vigorous activities, such as playing sports:find:pt:^patient:ord:promis||has_component
pseudoephedrine induced platelet ab||pseudoephedrine induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry||has_component
parmesan cheese||cheese parmesan ab.ige:acnc:pt:ser:qn||has_component
dehydrogenase, glutamate||glutaminate dh - serum||has_component
paraldehyde (product)||acetaldehyde and paraldehyde panel in serum or plasma (lab test)||has_component
(multisection||multisection^wo contrast:find:pt:chest>clavicle.right:doc:ct||has_component
streptococcus pneumoniae danish||s pneum da 1 igg ser-acnc||has_component
mobility||promis pediatric short form - mobility 8a - version 2.0:-:7d:^patient:-:promis.peds||has_component
thorium||thorium:mcnt:pt:hair:qn||has_component
abo1 (isbt symbol)||are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby:finding:to identify measures at a point in time:^patient:ordinal:nupdq||has_component
blood group antibody system, nos||blood group antibodies identified in blood product unit||has_component
liver fibrosis score||liver fibrosis score panel - serum or plasma calculated by hepascore||has_component
meperidine+normeperidine||meperidine + normeperidine pnl serpl||has_component
filobasidiella neoformans||deprecated cryptococcus neoformans ag [titer] in serum by latex agglutination||has_component
i used a walker, cane or crutches to get around in past 7d||i used a walker, cane or crutches to get around in past 7d:finding:7 days:^patient:ordinal:promis||has_component
loinc class types||latex recombinant (rhev b) 5 ab.ige.rast class:prthr:pt:ser:ord||has_component
ademetionine (substance)||s-adenosylmethionine/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||has_component
4-sulfatase, n-acetylgalactosamine||n-acetylgalactosamine-4-sulfatase:ccnc:pt:amnio fld:qn||has_component
problem, nos||my voice problem causes me to lose income [phenx]||has_component
pefloxacine||pefloxacin [mass] of dose||has_component
cholesterol in ldl 5||cholesterol.in ldl 5:scnc:pt:ser/plas:qn||has_component
mucor sp antibody||measurement of mucor species antibody (procedure)||has_component
thicknss||l ret rnfl nasal inf thickness oct||has_component
antibodies, gliadin||antibody; gliadin||has_component
guidance for localization of tumor^w 18f-fdg iv+wo contrast||pet+ct guidance for localization of tumor of skull vertex to mid-thigh-- w 18f-fdg iv and wo contrast||has_component
gluten ab.ige||gluten ige ab rast class [presence] in serum||has_component
how many ds was actigraph worn||how many ds was actigraph worn:number:to identify measures at a point in time:^patient:quantitative:phenx||has_component
target oxygen||oxygen target^at end expiration:vfr/ppres:pt:airway adaptor:qn||has_component
pharmacologic substance||indexing - drug interactions:-:-:^fda product label:narrative||has_component
immunologic reaction, function (observable entity)||coccidioides skin test||has_component
4'-hydroxyacetanilide||apap dose||has_component
plasmocytes||plasma cells/100 leukocytes:number fraction:to identify measures at a point in time:cerebral spinal fluid:quantitative:manual count||has_component
a,b||niemann pick disease a+b newborn screening panel:-:to identify measures at a point in time:dried blood spot:-||has_component
protein-containing product||calcium [moles/volume] corrected for total protein in blood||has_component
hedis 2019-2020 value set - psa tests||hedis 2019-2020 value set - psa tests||has_component
complement system proteins||deprecated c1 plas qn||has_component
urea (product)||urea nitrogen [mass ratio] in serum or plasma--post dialysis/pre dialysis||has_component
ige - immunoglobulin e||black pepper ige ab rast class [presence] in serum||has_component
turnips||turnip ige qn||has_component
protein s+acarboxy antigen||protein s+acarboxy ag ia qn (ppp)||has_component
microfilaria antibody||microfilaria antibody test (lab test)||has_component
genes||pseudorabies virus g1 gene del ab ia ql (s)||has_component
antigen, viral||bovine herpesvirus 1 antigen assay (procedure)||has_component
viruses, general||influenza virus a h16 ab:titr:pt:ser:qn:hai||has_component
platinum metallicum||cisplatin/cyclophosphamide/filgrastim||has_component
allergen specific antibody interpretation, semi-quantitative||deprecated elderberry ige ab rast class in serum||has_component
viruses||equine arteritis virus ab [titer] in serum||has_component
need for and availability of continuous positive airway pressure device||need for and availability of continuous positive airway pressure device:finding:to identify measures at a point in time:^patient:ordinal:cms assessment||has_component
vancomycin resistant enterococci||enterococcus vancomycin resistant culture (procedure)||has_component
what was your new daytime activity or job||what was your new daytime activity or job:finding:to identify measures at a point in time:^patient:nominal:phenx||has_component
domain bacteria (organism)||bacteria throat cult||has_component
person-centered primary care measure||person-centered primary care measure:-:to identify measures at a point in time:^patient:-:pcpcm||has_component
3β-hydroxyandrost-5-en-17-one||dehydroepiandrosterone^2 hours post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
18-hydroxycorticosterone||18-hydroxycorticosterone^30 minutes post dose corticotropin:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
multisection^wo & w contrast iv||ct liver wo and w contrast iv||has_component
expiratory reserve||expiratory reserve:volume:to identify measures at a point in time:respiratory system:quantitative:helium single breath||has_component
multisection||mr lumbar spine wo and w contrast it||has_component
red blood cells||rbc auto (u) [#/vol]||has_component
human leucocyte antigen (hla) antigen||hla-b56(22) ql||has_component
pregnanediol (substance)||pregnanediol [mass/volume] in 24 hour urine --pre dose dexamethasone||has_component
compounds, polychlorobiphenyl||polychlorinated biphenyl (pcb) [mass/volume] in body fluid||has_component
ampicillin ab||ampicillin ige ab [units/volume] in serum||has_component
confidence in cause of death||confidence in cause of death||has_component
cystoisospora belli||small intestine mucosal tissue culture for cystoisospora belli (lab test)||has_component
allergen specific antibody interpretation, semi-quantitative||gadus chalcogrammus roe antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
gangliosides||ganglioside gq1b antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||has_component
micro||microscopic observation:presence or identity:to identify measures at a point in time:superficial tissue.fine needle aspiration:nominal:cytology stain||has_component
dose||hydrogen/expired gas 2 hr post dose glucose (exhl gas) [volume fraction]||has_component
glycogen heart disease||pompe disease:imp:pt:bld.dot:nom||has_component
ganglioside antibody||ganglioside antibody level||has_component
gentamicin^trough||gentamicin^trough:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
progress||pediatric rheumatology progress note||has_component
bacteria sp.||bacteria identified # 7 anaer cx nom (specimen)||has_component
n-alpha acetyllysine/creatinine||n-alpha acetyllysine/creatinine [molar ratio] in urine||has_component
dactylis glomerata ab||dactylis glomerata antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
i am disappointed in my ability to socialize with my family in the past 7 days||i am disappointed in my ability to socialize with my family in the past 7d:find:7d:^patient:ord:neuroqol||has_component
dna - deoxyribonucleic acid||ureaplasma parvum dna:prthr:pt:genital:ord:probe.amp.tar||has_component
porcine enterovirus ab||pev ab ser ql ia||has_component
aldosterone-containing product||aldosterone + ra + arr pnl plas||has_component
allergen specific antibody interpretation, semi-quantitative||artemisia dracunculus antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_component
heptanoic acid, 4,6-dioxo-||succinylacetone:prthr:pt:urine:ord||has_component
fungus identified||fungus stl cult||has_component
hepatitis e virus ab.igm||hepatitis e virus igg and igm panel in serum||has_component
assess||eating during 2d assessment period:finding:2 days:^patient:ordinal:care||has_component
deoxyribonucleic acid of neisseria gonorrhoeae (substance)||n gonorrhoea dna snv ql naa+non-probe||has_component
trtdos||tsh 45m p trh iv serpl-mcnc||has_component
thyroid structure||thyroid transcription factor 1 ag:prthr:pt:tiss:ord:immune stain||has_component
b antibody||coxsackievirus b igg spec 2 (s) [titer]||has_component
immunol sensitization||indication for immunization||has_component
patency||views for patency of biliary structures^w tc-99m intravenous:finding:to identify measures at a point in time:abdomen>biliary ducts+gallbladder:document:nm||has_component
human parechoviruses||parechovirus a rna:prthr:pt:csf:ord:non-probe.amp.tar||has_component
xxx challenge||glucose 14th specimen post unsp challenge [mass/vol]||has_component
divalproex||drug assay valproic dipropylacetic acid total||has_component
loinc class types||lolium perenne ab.ige.rast class:prthr:pt:ser:ord||has_component
cytochrome p450, family 2, subfamily c, polypeptide 19||cyp2c19 c.681g>a(*2) bld/t ql||has_component
m ag||hemoglobin m-boston:presence or threshold:to identify measures at a point in time:whole blood:ordinal||has_component
after values||c peptide^14th specimen post xxx challenge:scnc:pt:ser/plas:qn||has_component
nuclear||scl-70 extractable nuclear ab [presence] in serum by immunoblot||has_component
300 virus||influenza virus a h5 antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||has_component
fentanyl (substance)||fentanyl:mass concentration:to identify measures at a point in time:urine:quantitative:confirm||has_component
condition (attribute)||reportable condition response description.brief:finding:to identify measures at a point in time:^patient:narrative||has_component
haema||fetal cerebral artery middle minimal flow velocity us.doppler||has_component
haptoglobins||haptoglobin (body fld) [mass/vol]||has_component
pork bladder worm||taenia solium larva igm ab [units/volume] in cerebral spinal fluid||has_component
hla - human leucocyte antigen b54(22)||hla-b54(22) in blood or tissue of donor (lab test)||has_component
multisection^wo & w contrast iv||ct hip - left wo and w contrast iv||has_component
symptom||current level of confidence i understand the difference between my symptoms and medication side effects [promis]||has_component
id||deprecated occupational therapy treatment plan, referring person identifier||has_component
staff assessment of daily and activity preferences||staff assessment of daily and activity preferences:find:pt:^patient:nom:cms assessment||has_component
porcine reproductive and respiratory syndrome virus north american strain antibody.immunoglobulin g||porcine reproductive and respiratory syndrome virus north american strain antibody.immunoglobulin g:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||has_component
ferrous chloride (substance)||urine ferrous chloride level||has_component
giardia lamblia dna||g. lamblia dna naa+non-probe ql (stl)||has_component
vedolizumab (medication)||drug assay vedolizumab||has_component
s||u.s. adult food security survey score [u.s. fss]||has_component
number (qualifier value)||serial # peritoneal drain||has_component
fluids intake (treatment)||fluid intake.enteral tube:volume rate:8 hours:upper gi tract:quantitative||has_component
bacteria ag||paeniclostridium sordellii antigen assay (procedure)||has_component
t(10;11)(p12;q23)(mllt10,mll)||t(10;11)(mllt10,mll) bld/t ql||has_component
virus||avian infectious laryngotracheitis virus antigen:presence or threshold:to identify measures at a point in time:not specified:ordinal||has_component
serpulina pilosicoli||brachyspira pilosicoli dna:prthr:pt:xxx:ord:probe.amp.tar||has_component
ige.total||cockatiel feather ige/total ige (s) [%]||has_component
streptococcus pneumoniae 19||deprecated streptococcus pneumoniae 19 ab [units/volume] in serum||has_component
pyrus communis ab.ige||pyrus communis antibody.immunoglobulin e/immunoglobulin e.total:arbitrary fraction:to identify measures at a point in time:serum:quantitative||has_component
post||11dc 2.5h p chal serpl-mcnc||has_component
after||11dc sp4 p chal serpl-mcnc||has_component
lysyl hydroxlase 3||plod3 gene full mutation analysis sequencing doc (bld/tiss)||has_component
blood lymphocyte||lymphocyte proliferation stimulated by tuberculin [units/volume] in blood||has_component
bartonella sp ab||bartonella sp igg ab [titer] in cerebral spinal fluid||has_component
fc gamma receptor iii||cd3-cd16+ cells # fld||has_component
flumequine (substance)||flumequine islt kb||has_component
ca element||calcium oxalate dihydrate/total in stone by infrared spectroscopy||has_component
ceftizoxime (product)||ceftizoxime induced platelet antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:flow cytometry||has_component
lime (citrus aurantifolia) igg||citrus aurantifolia antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
docosapentaenate w3||docosapentaenate (c22:5w3)/fatty acids.c14-c22 in blood||has_component
viruses, general||parainfluenza virus 4 rna naa+probe ql (lower resp)||has_component
cells.cd3-cd16+cd56+/100 cells||cells.cd3-cd16+cd56+/100 cells:nfr:pt:bone mar:qn||has_component
genus: human herpesvirus 1 group||herpes simplex virus identified in vaginal fluid by organism specific culture||has_component
immunoglobulin igg (substance)||measles virus antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal||has_component
chlamydia sp||chlamydia sp antibody.immunoglobulin a:presence or threshold:to identify measures at a point in time:serum:ordinal:immunoassay||has_component
blood flow velocity.systole.max||blood flow velocity.systole.max/blood flow velocity.diastole.max:velocity ratio:to identify measures at a point in time:pulmonary vein.left lower:quantitative:ultrasound.doppler||has_component
alpha amanitine||alpha-amanitin ur-mcnc||has_component
abo1 (isbt symbol)||could you get a friend or family member to help fix something at home if you need it:find:pt:^patient:ord:promis||has_component
lymphocytes.abnormal/100 leukocytes||lymphocytes.abnormal/100 leukocytes:number fraction:to identify measures at a point in time:vitreous fluid:quantitative:manual count||has_component
reactiv||history of adverse drug reaction:finding:point in time:^patient:narrative||has_component
mycobacterium tuberculosis deoxyribonucleic acid||mycobacterium tuberculosis dna:prthr:pt:semen:ord:probe.amp.tar||has_component
chlamydia sp||chlamydia sp ab [titer] in cerebral spinal fluid||has_component
additional concerns - fact-br-parent||additional concerns - fact-br-parent:-:pt:^patient:-:facit||has_component
occupational therapies||occupational therapy - concurrent minutes--week 1 [cms assessment]||has_component
transfuse platelet concentrate||num units trans platelet conc||has_component
challenges||gastrin 5 min post unsp challenge [mass/vol]||has_component
virus||measles virus igm ab [presence] in serum||has_component
virus, nos||la crosse virus ab:acnc:pt:ser:ordqn:if||has_component
h2a-h2b dna ab.igg||h2a-h2b deoxyribonucleic acid antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_component
hydromorphonum||hydromorphone [presence] in urine by confirmatory method||has_component
coccidioides immitis exoantigen||coccidioides immitis exoantigen identification (procedure)||has_component
bodies weight||body weight:mass:pt:^fetus:qn:us+estimated from ac.warsof 1977||has_component
d-glucose||glucose [moles/volume] in dialysis fluid||has_component
fetal age||gestational age:time:pt:^fetus:qn:us+estimated from ofd.hansmann 1986||has_component
prx||prx gene targeted mutation analysis molgen nom (bld/tiss)||has_component
prostvac||fowlpox-psa-tricom vaccine/vaccinia-prostate-specific antigen-tricom vaccine||has_component
polistes spp||polistes spp ab.ige:mcnc:pt:ser:qn||has_component
borrelia burgdorferi antibody.immunoglobulin m||b burgdor igm csf-acnc||has_component
levorphanol (substance)||levorphanol:prthr:pt:urine:ord||has_component
which cigarette would, or did, you hate most to give up||smoke first give up ftnd||has_component
therapies||special treatments &or programs - none of above:finding:to identify measures at a point in time:^patient:ordinal:mds||has_component
specimen age||specimen age (specimen)||has_component
neuro-musculo-skeletal function:status||neuro-musculo-skeletal function.status:find:pt:^patient:ord:observed.omaha||has_component
(acarus siro+lepidoglyphus destructor+tyrophagus putrescentiae+glycyphagus domesticus)||(acarus siro+lepidoglyphus destructor+tyrophagus putrescentiae+glycyphagus domesticus) leukotriene release:mcnc:pt:wbc:qn||has_component
bacillus abortus||brucella abortus ab [units/volume] in serum by agglutination||has_component
i had trouble doing schoolwork when i had pain in past 7d||i had trouble doing schoolwork when i had pain in past 7d:find:7d:^patient:ord:promis||has_component
pepper green||green pepper igg ab [units/volume] in serum||has_component
proalbumin||prealbumin elph (u) [mass fraction]||has_component
antitrypsin||serpina1 gene targeted mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||has_component
dibekacin (medication)||dibekacin [susceptibility] by minimum inhibitory concentration (mic)||has_component
albumin (substance)||albumin:scnc:pt:ser/plas:qn:bcg||has_component
fluphenazine (product)||fluphenazine:scnc:pt:ser/plas:qn||has_component
creatinine (substance)||carnitine/creat ur||has_component
self-care - discharge goal||mds v3.0 - rai v1.14.1, v1.15.1 - self-care - discharge goal:-:3d:^patient:-:cms assessment||has_component
output.ileostomy||output.ileostomy 1h mrate||has_component
antibody to rhodococcus equi||rhodococcus equi ab:prthr:pt:ser:ord:immune diffusion||has_component
vira||virus amn cult||has_component
coproporphyrin (substance)||coproporphyrin:mrat:xxx:stool:qn||has_component
balance test||standing balance test - scale score^^adjusted for age:score:pt:^patient:qn:nih toolbox||has_component
platelet-derived growth factor b+bb||platelet-derived growth factor b+bb [mass/volume] in serum or plasma||has_component
stages||extraocular retinoblastoma classification^at final disease stage:class:to identify measures at a point in time:eye.right:ordinal:reese-ellsworth system||has_component
platelet antibody.immunoglobulin m||candesartan induced platelet igm fc ql||has_component
plenamine||glutamate decarboxylase antibody:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal:immune fluorescence||has_component
sjogrens syndrome-b extractable nuclear||sjogrens syndrome-b extractable nuclear ab [presence] in cerebral spinal fluid by immunoassay||has_component
xxx challenge||calcium^pre xxx challenge:scnc:pt:ser/plas:qn||has_component
views^w radionuclide iv||nm ureter and urinary bladder views||has_component
measurement - action (qualifier value)||deprecated phenx measure - angina||has_component
dextromethorphan (product)||d-methorphan serpl-scnc||has_component
hemolytic complements, total||complement total hemolytic ch50:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||has_component
status post||somatotropin [units/volume] in serum or plasma --2 hours post dose arginine+insulin||has_component
reserves of emergency supplies||reserves of emergency supplies:-:to identify measures at a point in time:^event:-:u.s. centers for disease control and prevention.eoc||has_component
vascular flow (function)||fetal mitral valve peak systolic flow velocity us.doppler||has_component
antithyroglobulin||thyroglobulin ab if (s) [titer]||has_component
physical pressure||pressure gradient 2:difference:to identify measures at a point in time:region of interest.not specified:quantitative:ultrasound.doppler||has_component
platelet antibody||niacin+lovastatin induced platelet igg fc ql||has_component
mammalian gestation||during the last 3 months of your pregnancy, how many times did you drink 4 alcoholic drinks or more in one sitting [phenx]||has_component
sargramostatin||filgrastim/flt3 ligand/milodistim/sargramostim||has_component
expiratory pressure.max||max exp press p bd respiratory||has_component
viridae||cache valley virus ab:prthr:pt:ser:ord:neut||has_component
human papillomavirus 011||human papilloma virus 11 dna:ncnc:pt:xxx:qn:probe.amp.tar||has_component
helminthosporium sp ab.ige||helminthosporium sp ige rast class (s)||has_component
conium maculatum flowering top extract||oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / dysphania ambrosioides 30 [hp_x] in 1 ml / anamirta cocculus seed 30 [hp_x] in 1 ml / conium maculatum flowering top 30 [hp_x] in 1 ml / strychnos nux-vomica seed 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / pulsatilla pratensis 30 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / tobacco leaf 30 [hp_x] in 1 ml oral liquid [dizziness hp]||has_active_ingredient
ativan [brand name]||lorazepam@2 mg@oral@tablet||has_active_ingredient
grass pollen-sweet vernal, standardized||anthoxanthum odoratum grass pollen extract 1000 bau/ml injectable solution||has_active_ingredient
bacillus calmette-guerin antigen||bacillus calmette-guerin antigen only product||has_active_ingredient
perphenazine (substance)||product containing precisely perphenazine 4 milligram/1 each conventional release oral tablet (clinical drug)||has_active_ingredient
magnesium hydroxide product||calcium carbonate/famotidine/magnesium hydroxide||has_active_ingredient
carmustina||product containing only carmustine (medicinal product)||has_active_ingredient
alcohol anhydrous||alcohol 70 ml in 100 ml topical gel [(ethanol70%) dr keeps one gel (ethanol)]||has_active_ingredient
bd persist||alcohol 70 ml in 100 ml topical gel [primest hand sanitizer non-sterile alcohol antiseptic topical solution 70]||has_active_ingredient
benzenepropanaminium, gamma-(aminocarbonyl)-n-methyl-n,n-bis(1-methylethyl)-gamma-phenyl-, iodide||phenylpropanolamine + chlorpheniramine + dextromethorphan + isopropamide iodide (medication)||has_active_ingredient
eupatorium perfoliatum flowering top||aconitum napellus whole 30 [hp_c] in 1 g / arsenic triiodide 30 [hp_c] in 1 g / bryonia alba root 30 [hp_c] in 1 g / eupatorium perfoliatum flowering top 30 [hp_c] in 1 g / gelsemium sempervirens root 30 [hp_c] in 1 g / escargot shell, cooked 30 [hp_c] in 1 g / hydrogen 30 [hp_c] in 1 g / influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) 30 [hp_c] in 1 g / influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) 30 [hp_c] in 1 g / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 30 [hp_c] in 1 g / wood creosote 30 [hp_c] in 1 g / phosphorus 30 [hp_c] in 1 g / teucrium scorodonia flowering top 30 [hp_c] in 1 g / thuja occidentalis leafy twig 30 [hp_c] in 1 g / veratrum viride root 30 [hp_c] in 1 g / cairina moschata heart/liver autolysate 200 [hp_c] in 1 g oral pellet [all flu]||has_active_ingredient
somatropin (recombinant mouse cells)||somatropin(rmc) only product in parenteral dose form||has_active_ingredient
laevothyroxine sodium||levothyroxine sodium 0.15mg tablet (product)||has_active_ingredient
fenofibric acid||product containing fenofibric acid (medicinal product)||has_active_ingredient
product containing avobenzone||avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 7 g in 100 ml topical jelly [brightening daily protector broad spectrum spf 30]||has_active_ingredient
prednisona||deltasone, 20 mg oral tablet||has_active_ingredient
belladonna extract, usp||sage 15 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / azadirachta indica bark 16 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 16 [hp_x] in 1 ml / selenium 15 [hp_x] in 1 ml / taraxacum officinale 15 [hp_x] in 1 ml / lycosa tarantula 15 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / influenza a virus 30 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / amanita muscaria fruiting body 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / calendula officinalis flowering top 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / milk thistle 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml oral liquid [i-waker]||has_active_ingredient
sodium chloride [nose] (substance)||aconitum napellus 20 [hp_x] in 1 g / semecarpus anacardium juice 20 [hp_x] in 1 g / silver nitrate 20 [hp_x] in 1 g / arsenic trioxide 20 [hp_x] in 1 g / cypripedium parvifolum root 20 [hp_x] in 1 g / gelsemium sempervirens root 20 [hp_x] in 1 g / strychnos ignatii seed 20 [hp_x] in 1 g / potassium carbonate 20 [hp_x] in 1 g / lycopodium clavatum spore 20 [hp_x] in 1 g / sodium chloride 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / sambucus nigra flowering top 20 [hp_x] in 1 g / sepia officinalis juice 20 [hp_x] in 1 g / delphinium staphisagria seed 20 [hp_x] in 1 g / datura stramonium 20 [hp_x] in 1 g / lycosa tarantula 20 [hp_x] in 1 g / theridion curassavicum 20 [hp_x] in 1 g / passiflora incarnata flowering top 8 [hp_x] in 1 g / valerian 8 [hp_x] in 1 g oral pellet [fear phobia]||has_active_ingredient
benzalkonium chloride - chemical (substance)||benzalkonium chloride .13 g in 100 ml topical solution [agrobac pure foam]||has_active_ingredient
niacinamide||tricare prenatal tablet||has_active_ingredient
antigen of measles morbillivirus||measles and mumps and rubella and varicella virus vaccine||has_active_ingredient
zinci oxydum||octinoxate 61.2 mg in 1 ml / zinc oxide 30.6 mg in 1 ml topical lotion [all day moisture]||has_active_ingredient
dimethicone||dimethicone 180 mg oral capsule, liquid filled||has_active_ingredient
2'deoxy-2',2'-difluorocytidine, hydrochloride||gemcitabine hydrochloride 1 gm intravenous powder for solution [gemcitabine novaplus]||has_active_ingredient
hydrochloride, labetalol||labetalol hydrochloride, 300 mg oral tablet||has_active_ingredient
product containing ethyl alcohol||alcohol 80 ml in 100 ml topical liquid [quantum liquid hand sanitizer]||has_active_ingredient
a.e.r. witch hazel||witch hazel 0.07 g in 70 g topical cream [hamsoa yuyu diaper]||has_active_ingredient
lignocaine hydrochloride [antiarrhythmic] (product)||lidocaine hydrochloride 5 % / phenylephrine hydrochloride 0.25 % topical spray||has_active_ingredient
sunscreen with zinc oxide (medication)||zinc oxide 85 mg in 1 g / titanium dioxide 75 mg in 1 g topical cream [i conceal flawless foundation broad spectrum spf 30 sunscreen mocha]||has_active_ingredient
sepia officinalis juice||causticum 12 mg / sodium chloride 12 mg / strychnos nux-vomica seed 12 mg / pulsatilla vulgaris 12 mg / sepia officinalis juice 12 mg / delphinium staphisagria seed 12 mg / thuja occidentalis leafy twig 12 mg oral tablet [urinary incontinence relief]||has_active_ingredient
dioctyl sodium sulfosuccinate||docusate sodium 100 mg oral capsule, liquid filled [health mart stool softener]||has_active_ingredient
claviceps purpurea sclerotium||placenta compositum solution for injection||has_active_ingredient
homosalato||avobenzone 2 g in 100 g / homosalate 10 g in 100 g / octisalate 5 g in 100 g / octocrylene 5 g in 100 g topical lotion [meijer spf 15]||has_active_ingredient
p-acetaminophenol||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [cold and flu relief daytime non drowsy]||has_active_ingredient
l-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid||carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg oral tablet||has_active_ingredient
5-fluoracil||product containing fluorouracil in oral dosage form (medicinal product form)||has_active_ingredient
blue flag root||uric acid 15 [hp_x] in 1 mg / benzoic acid 10 [hp_x] in 1 mg / berberis vulgaris root bark 10 [hp_x] in 1 mg / bryonia alba root 10 [hp_x] in 1 mg / lytta vesicatoria 10 [hp_x] in 1 mg / cnicus benedictus 10 [hp_x] in 1 mg / ceanothus americanus leaf 10 [hp_x] in 1 mg / chelidonium majus 10 [hp_x] in 1 mg / chionanthus virginicus bark 10 [hp_x] in 1 mg / cinchona officinalis bark 10 [hp_x] in 1 mg / dioscorea villosa root 10 [hp_x] in 1 mg / mucuna pruriens fruit trichome 10 [hp_x] in 1 mg / iris versicolor root 10 [hp_x] in 1 mg / strychnos nux-vomica seed 10 [hp_x] in 1 mg / ptelea trifoliata bark 10 [hp_x] in 1 mg / taraxacum officinale 10 [hp_x] in 1 mg / silybum marianum seed 3 [hp_x] in 1 mg / cynara scolymus leaf 3 [hp_x] in 1 mg / solidago virgaurea flowering top 3 [hp_x] in 1 mg / taraxacum officinale 3 [hp_x] in 1 mg / juniperus communis whole 10 [hp_x] in 1 mg oral pellet [cleanse remedy water]||has_active_ingredient
sorghum halepense pollen||felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / alternaria alternata 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml subcutaneous injection, solution||has_active_ingredient
product containing menthol||capsaicin/menthol 0.05 %-5 % topical adhesive patch, medicated||has_active_ingredient
flexiban||cyclobenzaprine hydrochlorid 10mg tablet||has_active_ingredient
alcohol,ethyl||alcohol 69 ml in 100 ml topical gel [adore bubble gum hand sanitizer]||has_active_ingredient
berberis vulgaris root bark extract||wormwood 1 [hp_x] / urtica urens 1 [hp_x] / lemon 2 [hp_x] / quince 2 [hp_x] / berberis vulgaris root bark 3 [hp_x] / larix decidua resin 3 [hp_x] / silicon dioxide 20 [hp_x] oral pellet||has_active_ingredient
sodium mycophenolate||myfortic 180mg delayed-release tablet||has_active_ingredient
lignocaine hcl [anaesthesia]||lidocaine hydrochloride 40 mg in 1000 mg topical spray [extra strength wound care]||has_active_ingredient
omc cinnamate||octinoxate 1.07 g in 21 ml / titanium dioxide 0.3 g in 21 ml topical emulsion [cle de peau beaute radiant foundation n b90]||has_active_ingredient
alkyl dimethylbenzyl ammonium chloride||benzalkonium chloride 0.13 g in 100 ml topical liquid [non alcohol hand sanitizer]||has_active_ingredient
pot marigold flowering top||calendula officinalis flowering top 1 [hp_x] in 1 g / arnica montana 1 [hp_x] in 1 g / hypericum perforatum 1 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g / bellis perennis 12 [hp_x] in 1 g / ledum palustre twig 12 [hp_x] in 1 g / sulfuric acid 12 [hp_x] in 1 g / calcium fluoride 30 [hp_x] in 1 g / ferrosoferric phosphate 30 [hp_x] in 1 g / toxicodendron pubescens leaf 30 [hp_x] in 1 g / ruta graveolens flowering top 30 [hp_x] in 1 g / sodium sulfate 30 [hp_c] in 1 g topical gel [trauma plus gel]||has_active_ingredient
salicylic acid [psoriasis]||salicylic acid 20 mg in 1 ml topical gel [zo medical aknebright acne spot and pigmentation treatment]||has_active_ingredient
o-chlorooxazepam||almazine 1 mg oral tablet||has_active_ingredient
menthol (medication)||eucalyptol 0.92 mg in 1 ml / menthol 0.42 mg in 1 ml / methyl salicylate 0.6 mg in 1 ml / thymol 0.64 mg in 1 ml oral liquid [amber mouth rinse]||has_active_ingredient
butyl methoxydibenzoylmethane||avobenzone 30 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 20 mg in 1 ml topical lotion [daily moisturizer]||has_active_ingredient
clot||clotrimazole 1 g in 100 g topical cream [dynarex antifungal]||has_active_ingredient
product containing ipilimumab (medicinal product)||ipilimumab 5mg/ml inj,soln,40ml||has_active_ingredient
rumex acetosella pollen||rumex crispus pollen 20000 [pnu] in 1 ml / rumex acetosella pollen 20000 [pnu] in 1 ml subcutaneous injection, solution||has_active_ingredient
calcium sulfide (substance)||activated charcoal 30 [hp_x] in 1 ml / copper 30 [hp_x] in 1 ml / drosera rotundifolia 30 [hp_x] in 1 ml / calcium sulfide 30 [hp_x] in 1 ml / ipecac 30 [hp_x] in 1 ml / lachesis muta venom 30 [hp_x] in 1 ml / lobelia inflata whole 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / pulsatilla pratensis whole 30 [hp_x] in 1 ml / rumex crispus root 30 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 30 [hp_x] in 1 ml oral liquid [bronchi hp]||has_active_ingredient
levothyroxine sodium (substance)||levothyroxine sodium 88 mcg oral tablet||has_active_ingredient
topiramate (topamax)||beta-d-fructopyranose, 2,3:4,5-bis-o-(1-methylethylidene)-, sulfamate||has_active_ingredient
warfarin sodium||warfarin na 2.5mg tab||has_active_ingredient
zolpidem hemitartrate||zolpidem hemitartrate 10mg tablet (substance)||has_active_ingredient
2-ethylhexyl salicylate||zinc oxide 5.6695 g in 100 g / octisalate 4.5 g in 100 g / octocrylene 4.5 g in 100 g / homosalate 6 g in 100 g topical lotion [hawaiian tropic matte effect mineral enriched sunscreen spf 30]||has_active_ingredient
l-proline, 1-(n2-(1-carboxy-3-phenylpropyl)-l-lysyl)-, dihydrate, (s)-||lisinopril@2.5 mg@oral@tablet||has_active_ingredient
octylmethoxycinnamate||octinoxate 75 mg in 1 g / zinc oxide 48 mg in 1 g topical cream [dynamic sunscreen broad spectrum spf 55]||has_active_ingredient
cyproheptadine hydrochloride (medication)||cyproheptadine hcl 4 mg oral tablet||has_active_ingredient
aureobasidium pullulans var. pullutans allergenic extract||dermatophagoides farinae 400 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / phoma destructiva 0.00008 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / candida albicans 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.0008 g in 1 ml / cochliobolus sativus 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml / gallus gallus feather 0.00003 g in 1 ml / anas platyrhynchos feather 0.00003 g in 1 ml / anser anser feather 0.00003 g in 1 ml intradermal injection, solution||has_active_ingredient
2-ethylhexyl-p-methoxycinnamate||octinoxate 0.065 g in 1 g / titanium dioxide 0.024 g in 1 g / zinc oxide 0.015 g in 1 g topical paste [lbel effet parfait mineral natural skin effect mousse foundation spf 16 (claire 2) - beige]||has_active_ingredient
antimony sulfide||antimony trisulfide 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / giant puffball 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / croton tiglium seed 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / kerosene 15 [hp_x] in 1 ml / pulex irritans 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / smilax regelii root 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / rumex crispus root 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / urtica urens 3 [hp_x] in 1 ml oral liquid [urticaria - rashes]||has_active_ingredient
sulphur colloid||product containing colloid sulfur and resorcinol in cutaneous dose form (medicinal product form)||has_active_ingredient
glipizidum||glipizide@5 mg@oral@tablet||has_active_ingredient
l-ofloxacin||levaquin 750 mg oral tablet||has_active_ingredient
cantharis||echinacea, unspecified 6 [hp_x] in 1 ml / american ginseng 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / potassium iodide 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / lycopus virginicus 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / saw palmetto 15 [hp_x] in 1 ml / aluminum oxide 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml oral liquid [jet lag]||has_active_ingredient
festuca pratensis pollen||ambrosia trifida pollen 0.00125 g in 1 ml / ambrosia bidentata pollen 0.00125 g in 1 ml / ambrosia artemisiifolia pollen 0.00125 g in 1 ml / ambrosia psilostachya pollen 0.00125 g in 1 ml / amaranthus palmeri pollen 0.00125 g in 1 ml / amaranthus retroflexus pollen 0.00125 g in 1 ml / amaranthus spinosus pollen 0.00125 g in 1 ml / amaranthus tuberculatus pollen 0.00125 g in 1 ml / kochia scoparia pollen 0.005 g in 1 ml / fagus grandifolia pollen 0.00021 g in 1 ml / platanus occidentalis pollen 0.00021 g in 1 ml / juglans nigra pollen 0.00021 g in 1 ml / salix nigra pollen 0.00021 g in 1 ml / carpinus caroliniana pollen 0.00021 g in 1 ml / picea pungens pollen 0.00021 g in 1 ml / acer negundo pollen 0.00021 g in 1 ml / pinus strobus pollen 0.00021 g in 1 ml / celtis occidentalis pollen 0.00021 g in 1 ml / acer saccharum pollen 0.00021 g in 1 ml / juniperus ashei pollen 0.00021 g in 1 ml / betula papyrifera pollen 0.00021 g in 1 ml / juniperus virginiana pollen 0.00021 g in 1 ml / acer rubrum pollen 0.00021 g in 1 ml / morus rubra pollen 0.00021 g in 1 ml / juniperus pinchotii pollen 0.00021 g in 1 ml / carya ovata pollen 0.00021 g in 1 ml / acer saccharinum pollen 0.00021 g in 1 ml / liquidambar styraciflua pollen 0.00021 g in 1 ml / ailanthus altissima pollen 0.00021 g in 1 ml / fraxinus americana pollen 0.00021 g in 1 ml / carya alba pollen 0.00021 g in 1 ml / morus alba pollen 0.00021 g in 1 ml / populus alba pollen 0.00021 g in 1 ml / cynodon dactylon pollen 1045.5 [bau] in 1 ml / poa pratensis pollen 454.5 [bau] in 1 ml / festuca pratensis pollen 454.5 [bau] in 1 ml / dactylis glomerata pollen 454.5 [bau] in 1 ml / lolium perenne pollen 454.5 [bau] in 1 ml / agrostis gigantea pollen 454.5 [bau] in 1 ml / anthoxanthum odoratum pollen 454.5 [bau] in 1 ml / phleum pratense pollen 454.5 [bau] in 1 ml / poa compressa pollen 0.000227 g in 1 ml / typha latifolia pollen 0.000227 g in 1 ml / bromus secalinus pollen 0.000227 g in 1 ml / zea mays pollen 0.000227 g in 1 ml / secale cereale pollen 0.000227 g in 1 ml / triticum aestivum pollen 0.000227 g in 1 ml / sorghum halepense pollen 0.000227 g in 1 ml / elymus repens pollen 0.000227 g in 1 ml / phalaris arundinacea pollen 0.000227 g in 1 ml / bromus inermis pollen 0.000227 g in 1 ml / sorghum bicolor ssp. drummondii pollen 0.000227 g in 1 ml / arrhenatherum elatius pollen 0.000227 g in 1 ml / holcus lanatus pollen 0.000227 g in 1 ml / pascopyrum smithii pollen 0.000227 g in 1 ml / artemisia vulgaris pollen 0.00125 g in 1 ml / artemisia absinthium pollen 0.00125 g in 1 ml / artemisia tridentata pollen 0.00125 g in 1 ml / artemisia ludoviciana pollen 0.00125 g in 1 ml / iva xanthifolia pollen 0.0025 g in 1 ml / iva annua var. annua pollen 0.0025 g in 1 ml / rumex crispus pollen 0.0025 g in 1 ml / rumex acetosella pollen 0.0025 g in 1 ml intradermal injection, solution||has_active_ingredient
european house dust mite extract (medication)||european house dust mite extract 5000 au/ml injectable solution||has_active_ingredient
zyvox||linezolid 1 kg in 1 kg not applicable powder||has_active_ingredient
tree pollen-american beech||liquidambar styraciflua pollen 0.01 g in 1 ml / ulmus americana pollen 0.01 g in 1 ml / platanus occidentalis pollen 0.01 g in 1 ml / fagus grandifolia pollen 0.01 g in 1 ml / populus deltoides pollen 0.01 g in 1 ml / acer saccharum pollen 0.01 g in 1 ml / quercus rubra pollen 0.01 g in 1 ml / carya ovata pollen 0.01 g in 1 ml / fraxinus americana pollen 0.01 g in 1 ml / betula nigra pollen 0.01 g in 1 ml percutaneous solution [eastern 10 tree pollen mix]||has_active_ingredient
c.i. pigment white 4||zinc oxide 20 kg in 100 kg topical ointment||has_active_ingredient
mephitis mephitis anal gland fluid||drosera rotundifolia 3 [hp_x] in 1 ml / atropa belladonna 4 [hp_x] in 1 ml / quillaja saponaria bark 4 [hp_x] in 1 ml / protortonia cacti 4 [hp_x] in 1 ml / helleborus foetidus root 4 [hp_x] in 1 ml / ipecac 4 [hp_x] in 1 ml / mephitis mephitis anal gland fluid 4 [hp_x] in 1 ml / veratrum album root 4 [hp_x] in 1 ml oral liquid||has_active_ingredient
diphenylglyoxal superoxide||benzoyl peroxide 2.5 g in 100 g topical cream [oil-free acne cleanser]||has_active_ingredient
lactuca crispa whole||lactuca sativa whole extract 25 mg/ml injectable solution||has_active_ingredient
salicylic acid 2-ethylhexyl ester||avobenzone 30 mg in 1 ml / homosalate 75 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 27.5 mg in 1 ml / oxybenzone 20 mg in 1 ml topical lotion [raydiant by australian gold vitamin d broad spectrum spf 30]||has_active_ingredient
etanol||alcohol 40 ml in 50 ml topical liquid [lovluv instant hand sanitizer]||has_active_ingredient
ceplene||influenza a virus 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / american ginseng 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / euphrasia stricta 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / sage 15 [hp_x] in 1 ml / lobaria pulmonaria 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [sniffles]||has_active_ingredient
6β,7β;15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone||drospirenone 3mg + ethinyl estradiol 20microgram + levomefolate calcium 451microgram tablet||has_active_ingredient
product containing perfluorochemical (product)||product containing perfluorochemical||has_active_ingredient
petroselinum crispum||chaste tree 3 [hp_x] in 1 ml / american ginseng 3 [hp_x] in 1 ml / juniperus virginiana twig 3 [hp_x] in 1 ml / lycopodium clavatum spore 3 [hp_x] in 1 ml / petroselinum crispum 3 [hp_x] in 1 ml / pulsatilla vulgaris 3 [hp_x] in 1 ml / saw palmetto 3 [hp_x] in 1 ml / urtica dioica 3 [hp_x] in 1 ml / zanthoxylum americanum bark 3 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / sus scrofa testicle 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa prostate 6 [hp_x] in 1 ml / clematis recta flowering top 12 [hp_x] in 1 ml oral liquid [endoplex m]||has_active_ingredient
hypochlorous acid||hypochlorous acid 0.003 g in 100 ml topical liquid [dr.devirus]||has_active_ingredient
dimethicone (medication)||dimethicone 0.95 mg in 1 ml / glycerin 6.125 mg in 1 ml topical liquid [cleanser sensitive skin]||has_active_ingredient
dimethicone-containing product||octinoxate 6.8 g in 100 g / oxybenzone 3 g in 100 g / dimethicone 2 g in 100 g topical stick [blistex ultra rich hydration]||has_active_ingredient
iron, reduced||ascorbic acid 120 mg / vitamin d 400 [iu] / iron 27 mg / .alpha.-tocopherol acetate 30 [iu] / thiamine 3 mg / riboflavin 3.4 mg / niacinamide 20 mg / pyridoxine hydrochloride 20 mg / folic acid 1 mg / potassium iodide 150 mg / zinc oxide 25 mg / cupric oxide 2 mg / docusate sodium 50 mg / calcium citrate 124 mg oral tablet [prenatal vitamin]||has_active_ingredient
interferon alfa-2b,recombinant||interferon alfa-2b-containing product in parenteral dose form||has_active_ingredient
sarsaparilla (ornata)||ceanothus americanus leaf 1 [hp_x] in 1 ml / euphrasia stricta 1 [hp_x] in 1 ml / geranium robertianum 1 [hp_x] in 1 ml / juglans regia leaf 1 [hp_x] in 1 ml / juglans regia fruit rind, immature 1 [hp_x] in 1 ml / myosotis arvensis 1 [hp_x] in 1 ml / sarsaparilla 1 [hp_x] in 1 ml / scrophularia nodosa 1 [hp_x] in 1 ml / teucrium scorodonia flowering top 1 [hp_x] in 1 ml / althaea officinalis root 1 [hp_x] in 1 ml / peumus boldus leaf 1 [hp_x] in 1 ml / calendula officinalis flowering top 1 [hp_x] in 1 ml / thuja occidentalis leaf 1 [hp_x] in 1 ml / fumaria officinalis flowering top 1 [hp_x] in 1 ml / pinus sylvestris leafy twig 1 [hp_x] in 1 ml / gentiana lutea root 1 [hp_x] in 1 ml / potassium iodide 1 [hp_x] in 1 ml / echinacea, unspecified 1 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / viscum album fruiting top 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / veronica officinalis flowering top 4 [hp_x] in 1 ml / apis mellifera 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / ferrous iodide 8 [hp_x] in 1 ml / mercuric cyanide 8 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / bos taurus parathyroid gland 12 [hp_x] in 1 ml / bos taurus thymus 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml oral liquid [lymph care]||has_active_ingredient
oxyde de zinc||zinc oxide 250 mg in 1 g topical lotion [raw elements baby kids broad spectrum spf30]||has_active_ingredient
liquid paraffin||mineral oil 200 mg in 1 g / petrolatum 800 mg in 1 g ophthalmic ointment [soothe night time]||has_active_ingredient
nci co28l3||piperonyl butoxide 4 ml in 100 ml / pyrethrum extract 0.33 ml in 100 ml topical oil [licel]||has_active_ingredient
oyster shell calcium carbonate preparation||silver nitrate 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / calcium silicate 10 [hp_x] in 59 ml / calcium sulfate anhydrous 10 [hp_x] in 59 ml / activated charcoal 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / sodium phosphate, dibasic, heptahydrate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / robinia pseudoacacia bark 10 [hp_x] in 59 ml / sulfuric acid 10 [hp_x] in 59 ml oral liquid [acid detox]||has_active_ingredient
cobalt (57-co) chloride (substance)||cobalt cl co-57 + cyanocobalamin + cyanocobalamin co-57 + intrinsic factor||has_active_ingredient
product containing phenelzine (medicinal product)||product containing only phenelzine in oral dose form (medicinal product form)||has_active_ingredient
eastern poison oak leaf extract||influenza a virus 30 [hp_x] in 1 ml / american ginseng 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_c] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / euphrasia stricta 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / schoenocaulon officinale seed 15 [hp_x] in 1 ml / sage 15 [hp_x] in 1 ml / lobaria pulmonaria 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [cold - sinus]||has_active_ingredient
camellia japonica seed oil||camellia japonica seed oil 2 g in 100 ml topical liquid [sandawha camellia repair hair oil]||has_active_ingredient
onion||aconitum napellus 6 [hp_x] in 1 g / gelsemium sempervirens root 6 [hp_x] in 1 g / onion 6 [hp_x] in 1 g / zinc gluconate 2 [hp_x] in 1 g oral tablet [cold]||has_active_ingredient
azo||phenazopyridine-containing product in oral dose form||has_active_ingredient
3-isobutyl gaba||lyrica 150 mg oral capsule||has_active_ingredient
product containing ethanol (medicinal product)||alcohol 70 ml in 100 ml topical gel [aerium hand sanitizer 70% 100ml]||has_active_ingredient
2-oxopentanedioic acid||artemisia abrotanum flowering top 10 [hp_x] in 59 ml / epinephrine 10 [hp_x] in 59 ml / corticotropin 10 [hp_x] in 59 ml / .alpha.-ketoglutaric acid 10 [hp_x] in 59 ml / .alpha.-lipoic acid 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / calcium fluoride 10 [hp_x] in 59 ml / anhydrous citric acid 10 [hp_x] in 59 ml / coenzyme a 10 [hp_x] in 59 ml / herring sperm dna 10 [hp_x] in 59 ml / iron 10 [hp_x] in 59 ml / sus scrofa adrenal gland 10 [hp_x] in 59 ml / hekla lava 10 [hp_x] in 59 ml / helleborus niger root 10 [hp_x] in 59 ml / bos taurus hypothalamus 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / sus scrofa ovary 10 [hp_x] in 59 ml / saccharomyces cerevisiae rna 10 [hp_x] in 59 ml / claviceps purpurea sclerotium 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / thiamine hydrochloride 10 [hp_x] in 59 ml oral liquid [anti-aging and wrinkles for women]||has_active_ingredient
sodium chloride [eye] (substance)||pulsatilla vulgaris 1 [hp_x] in 1 ml / plantago major 3 [hp_x] in 1 ml / luffa operculata fruit 3 [hp_x] in 1 ml / mercuric iodide 6 [hp_x] in 1 ml / sus scrofa nasal mucosa 8 [hp_x] in 1 ml / euphorbia resinifera resin 8 [hp_x] in 1 ml / silver nitrate 9 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / sinusitisinum 20 [hp_x] in 1 ml oral liquid [sinusitis]||has_active_ingredient
echinacea||aconitum napellus 15 [hp_x] in 1 ml / arnica montana root 15 [hp_x] in 1 ml / bellis perennis 15 [hp_x] in 1 ml / calendula officinalis flowering top 15 [hp_x] in 1 ml / echinacea, unspecified 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 15 [hp_x] in 1 ml / hypericum perforatum 15 [hp_x] in 1 ml / ledum palustre twig 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / comfrey root 15 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml oral liquid [bangs scrapes]||has_active_ingredient
clindamycin hydrochloride||clindamycin 150 mg oral tablet||has_active_ingredient
bordetella pertussis bacterium||baptisia tinctoria 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / calendula officinalis flowering top 4 [hp_x] in 1 ml / chelidonium majus 4 [hp_x] in 1 ml / veronicastrum virginicum root 4 [hp_x] in 1 ml / ligusticum porteri root 4 [hp_x] in 1 ml / lomatium dissectum root 4 [hp_x] in 1 ml / myrrh 4 [hp_x] in 1 ml / nasturtium officinale 4 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / taraxacum officinale 4 [hp_x] in 1 ml / fenugreek seed 4 [hp_x] in 1 ml / urtica dioica 4 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / astragalus propinquus root 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / chamomile 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / thuja occidentalis leafy twig 30 [hp_x] in 1 ml / antimony trisulfide 30 [hp_x] in 1 ml / bordetella pertussis 30 [hp_c] in 1 ml / tetanus toxin 30 [hp_c] in 1 ml / thimerosal 30 [hp_c] in 1 ml oral liquid [vax]||has_active_ingredient
4-hydroxypyrazolyl(3,4-d)pyrimidine||product containing allopurinol 300 mg/1 each oral tablet (clinical drug)||has_active_ingredient
pleospora herbarum allergenic extract||alternaria alternata 0.002 g in 1 ml / ambrosia trifida pollen 0.0006666 g in 1 ml / ambrosia artemisiifolia pollen 0.0006666 g in 1 ml / ambrosia psilostachya pollen 0.0006666 g in 1 ml / anser anser feather 0.000667 g in 1 ml / gallus gallus feather 0.000667 g in 1 ml / anas platyrhynchos feather 0.000667 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / phoma destructiva 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / kochia scoparia pollen 0.00008 g in 1 ml / chenopodium album pollen 0.00008 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / salsola kali pollen 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.0002 g in 1 ml / ustilago avenae 0.0002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml subcutaneous injection, solution||has_active_ingredient
sus scrofa umbilical cord preparation||chaste tree 6 [hp_x] in 1 ml / ambergris 6 [hp_x] in 1 ml / apiole (parsley) 6 [hp_x] in 1 ml / estradiol 6 [hp_x] in 1 ml / estriol 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / melatonin 6 [hp_x] in 1 ml / testosterone 6 [hp_x] in 1 ml / adenosine triphosphate disodium 8 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / nadide 8 [hp_x] in 1 ml / pantothenic acid 8 [hp_x] in 1 ml / lactic acid, l- 8 [hp_x] in 1 ml / ubidecarenone 8 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / estrone 8 [hp_x] in 1 ml / sus scrofa umbilical cord 30 [hp_x] in 1 ml / sus scrofa adrenal gland 30 [hp_x] in 1 ml / pork liver 30 [hp_x] in 1 ml / sus scrofa lymph 30 [hp_x] in 1 ml / sus scrofa bone marrow 30 [hp_x] in 1 ml / sus scrofa ovary 30 [hp_x] in 1 ml / sus scrofa testicle 30 [hp_x] in 1 ml / sus scrofa pancreas 30 [hp_x] in 1 ml / sus scrofa spleen 30 [hp_x] in 1 ml / somatropin 30 [hp_x] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [hgh young again]||has_active_ingredient
etoh - alcohol||alcohol 70 ml in 100 ml topical gel [bye bye germs hand sanitizer advanced formula aloe and vitamin e]||has_active_ingredient
strychnos nux-vomica seed||potassium phosphate, dibasic 3 [hp_x] in 1 ml / sodium sulfate 3 [hp_x] in 1 ml / chaste tree 6 [hp_x] in 1 ml / chelidonium majus 6 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / milk thistle 6 [hp_x] in 1 ml / cysteine 6 [hp_x] in 1 ml / gamboge 6 [hp_x] in 1 ml / centella asiatica 6 [hp_x] in 1 ml / potassium carbonate 6 [hp_x] in 1 ml / strychnos nux-vomica seed 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / rosa canina flower 6 [hp_x] in 1 ml / salix alba bark 6 [hp_x] in 1 ml / green tea leaf 6 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / graphite 8 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 12 [hp_x] in 1 ml / sus scrofa adrenal gland 12 [hp_x] in 1 ml / pork liver 12 [hp_x] in 1 ml / sus scrofa pancreas 12 [hp_x] in 1 ml / bos taurus pituitary gland 12 [hp_x] in 1 ml / sus scrofa placenta 12 [hp_x] in 1 ml / thyroid, bovine 12 [hp_x] in 1 ml / water 6 [hp_c] in 1 ml / gymnema sylvestre leaf 6 [hp_c] in 1 ml oral liquid [natural fit]||has_active_ingredient
phenylephrine hydrochloride (medication)||acetaminophen 250 mg in 10 ml / dextromethorphan hydrobromide 13.33 mg in 10 ml / guaifenesin 200 mg in 10 ml / phenylephrine hydrochloride 5 mg in 10 ml oral liquid [broncomar]||has_active_ingredient
polymyxin b sulf [eye]||bacitracin zinc 400 [iu] in 1 g / neomycin sulfate 5 mg in 1 g / polymyxin b sulfate 5000 [iu] in 1 g topical ointment [triple antibiotic]||has_active_ingredient
povidone-iodine [gynecological use]||povidone-iodine 0.1 mg/mg topical ointment [dermawound]||has_active_ingredient
sorghum bicolor subsp. drummondii pollen||sorghum bicolor ssp. drummondii pollen 0.05 g in 1 ml subcutaneous injection, solution||has_active_ingredient
bumetanidum||amiloride / bumetanide oral product||has_active_ingredient
giardia intestinalis (lambl, 1859) kofoid & christiansen, 1915||artemisia vulgaris root 2 [hp_x] in 1 ml / artemisia cina pre-flowering top 3 [hp_x] in 1 ml / melilotus officinalis top 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / teucrium marum 3 [hp_x] in 1 ml / thymus serpyllum 3 [hp_x] in 1 ml / dryopteris filix-mas root 4 [hp_x] in 1 ml / spigelia anthelmia 6 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / schoenocaulon officinale seed 12 [hp_x] in 1 ml / ascaris lumbricoides 15 [hp_x] in 1 ml / trichinella spiralis 15 [hp_x] in 1 ml / enterobius vermicularis 33 [hp_x] in 1 ml / taenia solium 12 [hp_c] in 1 ml / trichomonas vaginalis 13 [hp_c] in 1 ml / giardia lamblia 18 [hp_c] in 1 ml / cryptosporidium parvum 20 [hp_c] in 1 ml / taenia saginata 20 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [ver]||has_active_ingredient
vaginal preparations clindamycin phosphate||clindamycin phosphate 150 mg/1 ml injection solution_#3||has_active_ingredient
1-(aminomethyl)cyclohexaneacetic acid||gabapentin 300mg capsule (product)||has_active_ingredient
adenosine 5'-(trihydrogen diphosphate), 5'-5'-ester with 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, hydroxide, inner salt||ascorbic acid 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / acetaldehyde 6 [hp_x] in 1 ml / prasterone 6 [hp_x] in 1 ml / phlorizin 6 [hp_x] in 1 ml / adenosine triphosphate disodium 8 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / citric acid monohydrate 8 [hp_x] in 1 ml / fumaric acid 8 [hp_x] in 1 ml / glyoxal trimer dihydrate 8 [hp_x] in 1 ml / nadide 8 [hp_x] in 1 ml / pantothenic acid 8 [hp_x] in 1 ml / insulin pork 8 [hp_x] in 1 ml / pork liver 10 [hp_x] in 1 ml / sus scrofa pancreas 10 [hp_x] in 1 ml / glucagon 12 [hp_x] in 1 ml / barium oxalate 6 [hp_c] in 1 ml / alloxan 6 [hp_c] in 1 ml / berberis vulgaris root bark 6 [hp_c] in 1 ml / human breast tumor cell 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / momordica balsamina immature fruit 6 [hp_c] in 1 ml / phosphoric acid 6 [hp_c] in 1 ml / phosphorus 6 [hp_c] in 1 ml / syzygium cumini seed 6 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / gymnema sylvestre leaf 30 [hp_c] in 1 ml / trigonella foenum-graecum whole 30 [hp_c] in 1 ml oral liquid [glucoreg]||has_active_ingredient
camphor (synthetic)||camphor (synthetic) 48 mg in 1 g / eucalyptus oil 12 mg in 1 g / menthol, unspecified form 26 mg in 1 g topical ointment [equate vaporizing]||has_active_ingredient
phytolacca americana root||bellis perennis 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / arnica montana 12 [hp_x] in 1 ml / cairina moschata heart/liver autolysate 12 [hp_x] in 1 ml / calcium iodide 12 [hp_x] in 1 ml / potassium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / sulfur iodide 12 [hp_x] in 1 ml oral liquid [elimitone]||has_active_ingredient
product containing titanium dioxide||octinoxate 0.065 g in 1 g / titanium dioxide 0.024 g in 1 g / zinc oxide 0.015 g in 1 g topical paste [lbel effet parfait mineral natural skin effect mousse foundation spf 16 (medium 6) - brown]||has_active_ingredient
mucinex||ephedrine hydrochloride + guaifenesin 25mg/200mg tablet (product)||has_active_ingredient
ir||echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / sus scrofa thymus 6 [hp_x] in 1 ml / bos taurus thymus 6 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / armoracia rusticana whole 3 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / handroanthus impetiginosus whole 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / propolis wax 3 [hp_x] in 1 ml / anemone pulsatilla 12 [hp_x] in 1 ml topical spray [viatrexx-f gus]||has_active_ingredient
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole||product containing precisely metronidazole 500 milligram/1 each conventional release oral tablet (clinical drug)||has_active_ingredient
anuvex||avobenzone 30 mg in 1 ml / homosalate 120 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 50 mg in 1 ml / oxybenzone 30 mg in 1 ml topical cream [neutrogena clinical lifting wrinkle treatment system]||has_active_ingredient
bellis perennis||phytolacca americana root 4 [hp_x] in 1 g / bellis perennis 6 [hp_x] in 1 g / ledum palustre twig 6 [hp_x] in 1 g / ruta graveolens flowering top 6 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g / magnesium phosphate, dibasic trihydrate 9 [hp_x] in 1 g / silicon dioxide 9 [hp_x] in 1 g topical gel [muscle ice]||has_active_ingredient
fluconazole (medication)||fluconazole 150mg oral tablet||has_active_ingredient
titanium dioxide||titanium dioxide 1.7 g in 12 g topical powder [advanced hydro-liquid compact (refill)b60]||has_active_ingredient
product containing ferrous fumarate (medicinal product)||ferrous fumarate + folic acid + pyridoxine hcl (medication)||has_active_ingredient
dextromethmorphan hydrobromide||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [multi-symptom relief cold and flu multi-symptom relief]||has_active_ingredient
cynara scolymus leaf||aluminum oxide 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / calcium iodide 10 [hp_x] in 59 ml / lytta vesicatoria 10 [hp_x] in 59 ml / centaurea benedicta 10 [hp_x] in 59 ml / silybum marianum seed 10 [hp_x] in 59 ml / chelidonium majus 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / cynara scolymus leaf 10 [hp_x] in 59 ml / dioscorea villosa tuber 10 [hp_x] in 59 ml / calcium sulfide 10 [hp_x] in 59 ml / iris versicolor root 10 [hp_x] in 59 ml / juniper berry 10 [hp_x] in 59 ml / potassium iodide 10 [hp_x] in 59 ml / mercury 10 [hp_x] in 59 ml / mercuric chloride 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / ptelea trifoliata bark 10 [hp_x] in 59 ml / ricinus communis seed 10 [hp_x] in 59 ml / robinia pseudoacacia bark 10 [hp_x] in 59 ml / anguilla rostrata blood serum 10 [hp_x] in 59 ml / solidago virgaurea flowering top 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / sulfuric acid 10 [hp_x] in 59 ml / taraxacum officinale 10 [hp_x] in 59 ml oral liquid [total body detox]||has_active_ingredient
fradiomycin sulfate||dexamethasone 0.1%/n-mycin 3.5mg/polymyx 10000unt/gm oint,oph||has_active_ingredient
dihydrocodeine-containing product||dihydrocodeine||has_active_ingredient
sus scrofa eye||euphrasia stricta 3 [hp_x] in 1 ml / ginkgo 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / glutathione 6 [hp_x] in 1 ml / ubidecarenone 6 [hp_x] in 1 ml / zinc gluconate 6 [hp_x] in 1 ml / citrus bioflavonoids 8 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / ammonium chloride 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / cyanocobalamin 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / magnesium carbonate 12 [hp_x] in 1 ml / selenium dioxide 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / beta carotene 9 [hp_c] in 1 ml oral liquid [occuloplex i]||has_active_ingredient
protortonia cacti||bryonia alba root 3 [hp_c] in 1 ml / protortonia cacti 3 [hp_c] in 1 ml / drosera rotundifolia flowering top 3 [hp_c] in 1 ml / ipecac 3 [hp_c] in 1 ml / pulsatilla vulgaris 6 [hp_c] in 1 ml / rumex crispus root 6 [hp_c] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_c] in 1 ml / lobaria pulmonaria 3 [hp_c] in 1 ml / antimony potassium tartrate 6 [hp_c] in 1 ml oral syrup [chestal]||has_active_ingredient
alprazolam||alprazolam 2 mg orodispersible tablet||has_active_ingredient
product containing zinc and zinc compound||141 zinc and zinc compounds||has_active_ingredient
docusate sodium (obsolete)||equaline stool softener capsule||has_active_ingredient
edible burdock root||thyroid, unspecified 15 [hp_x] in 1 ml / barium carbonate 10 [hp_x] in 1 ml / berberis vulgaris root bark 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 1 ml / cinchona officinalis bark 10 [hp_x] in 1 ml / conium maculatum flowering top 10 [hp_x] in 1 ml / digitalis 10 [hp_x] in 1 ml / ferric picrate 10 [hp_x] in 1 ml / goldenseal 10 [hp_x] in 1 ml / iodine 10 [hp_x] in 1 ml / lycopodium clavatum spore 10 [hp_x] in 1 ml / strychnos nux-vomica seed 10 [hp_x] in 1 ml / chondrodendron tomentosum root 10 [hp_x] in 1 ml / pulsatilla vulgaris 10 [hp_x] in 1 ml / saw palmetto 10 [hp_x] in 1 ml / selenium 10 [hp_x] in 1 ml / delphinium staphisagria seed 10 [hp_x] in 1 ml / thuja occidentalis leafy twig 10 [hp_x] in 1 ml / trifolium pratense flower 10 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml oral liquid [prostate]||has_active_ingredient
inflammation otc deep pain care hot||capsicum 1 [hp_m] in 1 [hp_m] oral pellet [capsicum annuum]||has_active_ingredient
product containing hydrogen peroxide (medicinal product)||hydrogen peroxide 30 mg in 1 ml topical liquid [psp hydrogen peroxide]||has_active_ingredient
2-hydroxy-4-methoxybenzophenon||avobenzone 22.4 mg in 1 ml / drometrizole trisiloxane 5 mg in 1 ml / homosalate 80 mg in 1 ml / octisalate 24 mg in 1 ml / octocrylene 44.8 mg in 1 ml / oxybenzone 28.8 mg in 1 ml topical lotion [garnier ombrelle spf 30 sport endurance water resistant]||has_active_ingredient
toxicodendron pubescens leaf extract||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / lobelia inflata 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / comfrey root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / sus scrofa lung 6 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 1 ml / ferrum phosphoricum 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / potassium carbonate 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml oral liquid [infectistat]||has_active_ingredient
8beta-[(methylthio)methyl]-6-propylergoline monomethanesulfonate||pergolide mesylate bulk powder||has_active_ingredient
1-(4-(1,1-dimethylethyl)phenyl)-3-(4-methoxyphenyl)-1,3-propanedione||avobenzone 3 g in 100 ml / homosalate 4 g in 100 ml / octisalate 4.5 g in 100 ml / octocrylene 2.6 g in 100 ml topical lotion [olay total effects feather weight moisturizer with sunscreen broadspectrum spf 15 fragrance free]||has_active_ingredient
butyl methoxydibenzoylmethane||oxybenzone 3 g in 100 g / octocrylene 5 g in 100 g / avobenzone 2 g in 100 g topical lotion [hawaiian tropic]||has_active_ingredient
aspart||insulin aspart 100units/ml injection solution 10ml vial||has_active_ingredient
quercus kelloggii pollen||quercus kelloggii pollen 0.001 g in 1 ml intradermal solution [california black oak pollen]||has_active_ingredient
sk-diphenhydramine||publix allergy 25mg tablet||has_active_ingredient
prednisolona||prednisolone-containing product in otic dose form||has_active_ingredient
pinus sylvestris leafy twig||geranium robertianum 4 [hp_x] in 1.1 ml / rorippa nasturtium-aquaticum 4 [hp_x] in 1.1 ml / ferrous iodide 12 [hp_x] in 1.1 ml / juglans regia flowering top 3 [hp_x] in 1.1 ml / myosotis arvensis 3 [hp_x] in 1.1 ml / scrophularia nodosa 3 [hp_x] in 1.1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1.1 ml / veronica officinalis flowering top 3 [hp_x] in 1.1 ml / equisetum hyemale 4 [hp_x] in 1.1 ml / fumaria officinalis flowering top 4 [hp_x] in 1.1 ml / sodium sulfate 4 [hp_x] in 1.1 ml / pinus sylvestris top 4 [hp_x] in 1.1 ml / gentiana lutea root 5 [hp_x] in 1.1 ml / araneus diadematus 6 [hp_x] in 1.1 ml / sarsaparilla 6 [hp_x] in 1.1 ml / tribasic calcium phosphate 12 [hp_x] in 1.1 ml / levothyroxine 12 [hp_x] in 1.1 ml intramuscular injection [lymphomyosot]||has_active_ingredient
perindopril erbumine||perindopril erbumine@8 mg@oral@tablet||has_active_ingredient
benzalkonium chloride (medication)||benzalkonium chloride 0.13 g in 100 ml topical solution [beauty concepts antibacterial hand wipes peppermint]||has_active_ingredient
tranhexamic acid||tranexamic acid 100mg/ml inj amp 10ml||has_active_ingredient
ibuprofene||ibuprofen 200 mg oral tablet, coated [ibuprofen]||has_active_ingredient
pulsatilla pratensis whole||anemone pratensis 4 [hp_x] in 1 ml / euphorbia resinifera resin 6 [hp_x] in 1 ml / luffa operculata fruit 6 [hp_x] in 1 ml / mercuric iodide 8 [hp_x] in 1 ml / silver nitrate 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / sinusitisinum 17 [hp_x] in 1 ml / aspergillus niger var. niger 10 [hp_x] in 1 ml / candida albicans 10 [hp_c] in 1 ml / gallic acid monohydrate 10 [hp_c] in 1 ml / mucor racemosus 10 [hp_c] in 1 ml / escherichia coli 30 [hp_c] in 1 ml oral liquid [ent support]||has_active_ingredient
terazocin hydrochloride (substance)||terazosin hcl 5mg cap,ud||has_active_ingredient
ethene, tetrafluoro-, homopolymer||product containing perfluoroalkylpolyether and polytetrafluoroethylene (medicinal product)||has_active_ingredient
benzophenone 3||octisalate 5 g in 100 g / oxybenzone 6 g in 100 g / octocrylene 10 g in 100 g / avobenzone 3 g in 100 g / homosalate 10 g in 100 g topical aerosol [banana boat]||has_active_ingredient
muscle relaxants skeletal chlorzoxazone||chlorzoxozone 500 mg oral tablet||has_active_ingredient
anguilla rostrata blood serum||trifolium pratense flower 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 ml / sus scrofa pituitary gland 30 [hp_x] in 1 ml / anguilla rostrata blood serum 30 [hp_x] in 1 ml / tartaric acid 30 [hp_x] in 1 ml / theridion curassavicum 30 [hp_x] in 1 ml / sus scrofa thyroid 30 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / corticotropin 30 [hp_c] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / carbo animalis 30 [hp_c] in 1 ml / activated charcoal 30 [hp_c] in 1 ml / human breast tumor cell 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / strychnos wallichiana bark 30 [hp_c] in 1 ml / potassium dichromate 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / sodium phosphate, dibasic, heptahydrate 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / claviceps purpurea sclerotium 30 [hp_c] in 1 ml / sulfuric acid 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / allylthiourea 30 [hp_c] in 1 ml / thuja occidentalis leafy twig 30 [hp_c] in 1 ml / veratrum album root 30 [hp_c] in 1 ml / alcohol, x-ray exposed (1000 rad) 30 [hp_c] in 1 ml oral liquid [1 detoxification]||has_active_ingredient
spirillum cholerae||echinacea angustifolia whole 3 [hp_x] in 1 ml / aloe 7 [hp_x] in 1 ml / colchicum autumnale bulb 8 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / strychnos nux-vomica seed 8 [hp_x] in 1 ml / arsenic trioxide 8 [hp_x] in 1 ml / acetic acid 12 [hp_x] in 1 ml / quinine sulfate 12 [hp_x] in 1 ml / vibrio cholerae 12 [hp_x] in 1 ml / proteus vulgaris 16 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / helicobacter pylori 30 [hp_x] in 1 ml / botulinum toxin type a 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / salmonella enterica enterica serovar enteritidis 30 [hp_c] in 1 ml / clostridium difficile 30 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [dysbio plus]||has_active_ingredient
lassar paste||zinc oxide 80 mg in 1 ml / pramoxine hydrochloride 10 mg in 1 ml topical lotion [ddm calaclear]||has_active_ingredient
phosphorofluoridic acid, disodium salt||sodium monofluorophosphate 0.00243 g in 1 g dental paste, dentifrice [wicked cool fluoride tween mild mint lmft]||has_active_ingredient
acid, nitric||apis mellifera 3 [hp_x] in 1 ml / arsenic trioxide 200 [hp_c] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / sodium borate 200 [hp_c] in 1 ml / capsicum 6 [hp_x] in 1 ml / solanum dulcamara top 30 [hp_c] in 1 ml / echinacea angustifolia whole 3 [hp_x] in 1 ml / mercuric chloride 200 [hp_c] in 1 ml / nitric acid 200 [hp_c] in 1 ml / rancid beef 200 [hp_c] in 1 ml / toxicodendron pubescens leaf 200 [hp_c] in 1 ml / sulfur iodide 200 [hp_c] in 1 ml / thuja occidentalis leafy twig 200 [hp_c] in 1 ml oral spray [canker plus cold sore relief]||has_active_ingredient
ae-mite, dermatophagoides pteronyssinus||dermatophagoides farinae extract 15,000 au/ml / dermatophagoides pteronyssinus extract 15,000 au/ml injectable solution||has_active_ingredient
sodium fluoride product||sodium fluoride 2.72 % oral foam||has_active_ingredient
hyoscyamus niger extract||sus scrofa stomach 5 [hp_c] in 1 ml / strychnos nux-vomica seed 89 [hp_c] in 1 ml / gold 144 [hp_c] in 1 ml / antimony trisulfide 233 [hp_c] in 1 ml / hyoscyamus niger 233 [hp_c] in 1 ml / sulfur 233 [hp_c] in 1 ml / marsdenia condurango bark 3 [hp_c] in 1 ml oral liquid [mbm 10 stomach]||has_active_ingredient
rhododendron aureum leaf||apis mellifera 30 [hp_x] in 1 ml / bryonia alba root 30 [hp_x] in 1 ml / causticum 30 [hp_x] in 1 ml / colchicum autumnale bulb 30 [hp_x] in 1 ml / potassium carbonate 30 [hp_x] in 1 ml / kalmia latifolia leaf 30 [hp_x] in 1 ml / ledum palustre twig 30 [hp_x] in 1 ml / anemone pratensis 30 [hp_x] in 1 ml / rhododendron aureum leaf 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml oral liquid [arthritis hp]||has_active_ingredient
titanium dioxide (product)||titanium dioxide 19 mg in 1 ml topical cream [everlasting foundation broad spectrum spf15 wheat 109]||has_active_ingredient
pinus echinata pollen||pinus echinata pollen 0.0166666 g in 1 ml / pinus taeda pollen 0.0166666 g in 1 ml / pinus strobus pollen 0.0166666 g in 1 ml percutaneous solution [pine pollen mix]||has_active_ingredient
galium odoratum extract||alchemilla xanthochlora flowering top 1 [hp_x] in 100 ml / galium odoratum 1 [hp_x] in 100 ml / matricaria recutita 1 [hp_x] in 100 ml / viola odorata 1 [hp_x] in 100 ml / cinchona officinalis bark 2 [hp_x] in 100 ml / mentha piperita 1 [hp_x] in 100 ml / rosmarinus officinalis flowering top 1 [hp_x] in 100 ml / valerian 1 [hp_x] in 100 ml / chamaelirium luteum root 2 [hp_x] in 100 ml / chaste tree 3 [hp_x] in 100 ml / black cohosh 3 [hp_x] in 100 ml / convallaria majalis 3 [hp_x] in 100 ml / saffron 3 [hp_x] in 100 ml / cyclamen purpurascens tuber 3 [hp_x] in 100 ml / turnera diffusa leafy twig 3 [hp_x] in 100 ml / goldenseal 3 [hp_x] in 100 ml / caulophyllum thalictroides root 4 [hp_x] in 100 ml / lilium lancifolium flowering top 4 [hp_x] in 100 ml / packera aurea 4 [hp_x] in 100 ml / delphinium staphisagria seed 4 [hp_x] in 100 ml / naja naja venom 8 [hp_x] in 100 ml oral liquid [female tonic]||has_active_ingredient
cianocobalamina||vitamin a 3500 [iu] / ascorbic acid 60 mg / vitamin d 700 [iu] / .alpha.-tocopherol, d- 22.5 [iu] / phytonadione .020 mg / thiamine 1.35 mg / riboflavin 1.7 mg / niacinamide 18 mg / folic acid .4 mg / cyanocobalamin .018 mg / biotin .075 mg / pantothenic acid .016 mg / calcium 210 mg / magnesium oxide 140 mg / zinc oxide 15 mg / selenium .11 mg / copper 2 mg / magnesium 140 mg / chromium nicotinate .12 mg / lycopene .3 mg oral capsule||has_active_ingredient
2-heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, (r-(r*,s*-(z)))-||product containing only cilastatin and imipenem and relebactam (medicinal product)||has_active_ingredient
semecarpus anacardium juice||epinephrine 10 [hp_x] in 59 ml / corticotropin 10 [hp_x] in 59 ml / agrimonia eupatoria flower 10 [hp_x] in 59 ml / semecarpus anacardium juice 10 [hp_x] in 59 ml / antimony trisulfide 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / castanea sativa flower 10 [hp_x] in 59 ml / cortisone acetate 10 [hp_x] in 59 ml / fucus vesiculosus 10 [hp_x] in 59 ml / bos taurus hypothalamus 10 [hp_x] in 59 ml / potassium dichromate 10 [hp_x] in 59 ml / nerium oleander leaf 10 [hp_x] in 59 ml / sus scrofa pituitary gland 10 [hp_x] in 59 ml / schoenocaulon officinale seed 10 [hp_x] in 59 ml / delphinium staphisagria seed 10 [hp_x] in 59 ml / thyroid, unspecified 10 [hp_x] in 59 ml oral liquid [slim remedy no. 15]||has_active_ingredient
alcohol,ethyl||benzocaine 0.6 mg in 100 ml / alcohol 60 ml in 100 ml topical swab [insect sting relief pad]||has_active_ingredient
migranal (obsolete)||dihydroergotamine mesylate 1 mg in 1 ml intramuscular injection, solution [d.h.e. 45]||has_active_ingredient
methyl 2-hydroxybenzoate||camphor 3.1 % / menthol 2.6 % / methyl salicylate 10.1 % medicated patch||has_active_ingredient
human coxsackievirus a7||chelidonium majus 3 [hp_x] in 1 ml / iodine 4 [hp_x] in 1 ml / lycopus virginicus 4 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 7 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / cysteine 9 [hp_x] in 1 ml / manganese gluconate 10 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / fumaric acid 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / eugenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lidocaine 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / titanium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / rubella virus 16 [hp_x] in 1 ml / mumps virus 30 [hp_x] in 1 ml / human coxsackievirus a2 16 [hp_c] in 1 ml / human coxsackievirus a7 16 [hp_c] in 1 ml / human coxsackievirus b1 16 [hp_c] in 1 ml / human coxsackievirus b3 16 [hp_c] in 1 ml / human coxsackievirus b4 16 [hp_c] in 1 ml oral liquid [oligo bio iodine]||has_active_ingredient
arnica montana extract||arnica montana 3 [hp_x] in 113 g topical gel [arnica pain relief]||has_active_ingredient
iris versicolor root extract||gelsemium sempervirens root 10 [hp_x] in 59 ml / iris versicolor root 10 [hp_x] in 59 ml / potassium carbonate 10 [hp_x] in 59 ml / nickel 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / sanguinaria canadensis root 10 [hp_x] in 59 ml / spigelia anthelmia 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [migraine relief]||has_active_ingredient
shade uvaguard||avobenzone 30 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 70 mg in 1 g topical cream [lancome paris renergie lift multi action broad spectrum spf 15 sunscreen lifting and firming for dry skin]||has_active_ingredient
2-hydroxy-4-methoxybenzone||avobenzone 30.9 mg in 1 g / homosalate 133.9 mg in 1 g / octisalate 51.5 mg in 1 g / octocrylene 72.1 mg in 1 g / oxybenzone 41.2 mg in 1 g topical spray [sunscreen]||has_active_ingredient
dextromethorphan hydrobromide||dextromethorphan 30 mg in 5 ml oral syrup [delsym]||has_active_ingredient
titanium(iv) oxide||titanium dioxide 20 mg in 1 ml / zinc oxide 10 mg in 1 ml topical cream [personalized day moisturizer with spf]||has_active_ingredient
timothy grass pollen extract||anthoxanthum odoratum pollen 33333.333 [bau] in 1 ml / dactylis glomerata pollen 33333.333 [bau] in 1 ml / phleum pratense pollen 33333.333 [bau] in 1 ml subcutaneous solution [t-o-s standardized grass pollen mix]||has_active_ingredient
phosphorus-containing product||actaea spicata root 30 [hp_x] in 118 ml / bellis perennis 30 [hp_x] in 118 ml / bryonia alba root 30 [hp_x] in 118 ml / calcium sulfide 30 [hp_x] in 118 ml / lithium carbonate 30 [hp_x] in 118 ml / phytolacca americana root 30 [hp_x] in 118 ml / salicylic acid 30 [hp_x] in 118 ml / horse chestnut 30 [hp_x] in 118 ml / arnica montana 30 [hp_x] in 118 ml / causticum 30 [hp_x] in 118 ml / black cohosh 30 [hp_x] in 118 ml / silicon dioxide 30 [hp_x] in 118 ml / toxicodendron pubescens leaf 30 [hp_x] in 118 ml / sulfur 30 [hp_x] in 118 ml / calcium fluoride 30 [hp_x] in 118 ml / formic acid 30 [hp_x] in 118 ml / hypericum perforatum 30 [hp_x] in 118 ml / pulsatilla vulgaris 30 [hp_x] in 118 ml / ruta graveolens flowering top 30 [hp_x] in 118 ml / magnesium phosphate, dibasic trihydrate 30 [hp_x] in 118 ml / phosphorus 30 [hp_x] in 118 ml / zinc 30 [hp_x] in 118 ml / sepia officinalis juice 30 [hp_x] in 118 ml oral liquid [arthro-ionx]||has_active_ingredient
product containing dextromethorphan hydrobromide (medicinal product)||acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 20 mg in 30 ml / guaifenesin 400 mg in 30 ml / phenylephrine hydrochloride 10 mg in 30 ml oral liquid [daytime cold and flu relief]||has_active_ingredient
pyrantel pamoate||moxidectin 0.06 mg / pyrantel pamoate 12.5 mg / sarolaner 3 mg chewable tablet [simparica trio]||has_active_ingredient
ranitidine hydrochloride (substance)||ranitidine hydrochloride 150 mg oral tablet [equaline]||has_active_ingredient
zinc d-gluconate (1:2)||zinc gluconate 50 mg oral capsule [pegasus male sexual enhancer]||has_active_ingredient
ado||adenosine 3mg/ml inj,syringe 2ml||has_active_ingredient
alcohol, grain||alcohol 44.25 ml in 150 ml topical spray [tongyi cleanguard multipurpose bactericidal cleaner]||has_active_ingredient
3,3,5-trimethylcyclohexyl 2-hydroxybenzoate||avobenzone 0.21 g in 7 g / homosalate 0.56 g in 7 g / octocrylene 0.35 g in 7 g topical stick [eos active protection lemon twist sunscreen lip balm broad spectrum spf 15]||has_active_ingredient
oxide zinc||titanium dioxide 43 mg in 1 ml / zinc oxide 30 mg in 1 ml topical lotion [aveeno ultra-calming daily moisturizer sunscreen broad spectrum spf 30]||has_active_ingredient
product containing glycerol (medicinal product)||glycerin 1.22 g in 200 ml topical lotion [plu body scrub hazelnut]||has_active_ingredient
product containing zinc oxide||zinc oxide 532 mg in 1 g topical paste [diaper rash]||has_active_ingredient
dextrose preparation (product)||glucose / potassium chloride / sodium chloride||has_active_ingredient
atorvastatin calcium||product containing atorvastatin 40 mg/1 each oral tablet||has_active_ingredient
2-ethylhexyl-2-cyano-3,3-diphenylacrylate||avobenzone 9.35 mg in 1 ml / octocrylene 18.7 mg in 1 ml / octisalate 28.05 mg in 1 ml topical spray [australian gold instant bronzer spf 8 sunscreen]||has_active_ingredient
solenopsis invicta extract (product)||solenopsis invicta allergenic extract 0.05 gm/ml injectable solution||has_active_ingredient
carpinus caroliniana pollen||fagus grandifolia pollen 0.0008 g in 1 ml / platanus occidentalis pollen 0.0008 g in 1 ml / juglans nigra pollen 0.0008 g in 1 ml / salix nigra pollen 0.0008 g in 1 ml / carpinus caroliniana pollen 0.0008 g in 1 ml / picea pungens pollen 0.0008 g in 1 ml / acer negundo pollen 0.0008 g in 1 ml / pinus strobus pollen 0.0008 g in 1 ml / celtis occidentalis pollen 0.0008 g in 1 ml / acer saccharum pollen 0.0008 g in 1 ml / juniperus ashei pollen 0.0008 g in 1 ml / betula papyrifera pollen 0.0008 g in 1 ml / juniperus virginiana pollen 0.0008 g in 1 ml / acer rubrum pollen 0.0008 g in 1 ml / morus rubra pollen 0.0008 g in 1 ml / juniperus pinchotii pollen 0.0008 g in 1 ml / carya ovata pollen 0.0008 g in 1 ml / acer saccharinum pollen 0.0008 g in 1 ml / liquidambar styraciflua pollen 0.0008 g in 1 ml / ailanthus altissima pollen 0.0008 g in 1 ml / fraxinus americana pollen 0.0008 g in 1 ml / carya alba pollen 0.0008 g in 1 ml / morus alba pollen 0.0008 g in 1 ml / populus alba pollen 0.0008 g in 1 ml intradermal injection, solution||has_active_ingredient
dulcolax soft chews||aluminum hydroxide 400 mg in 10 ml / magnesium hydroxide 400 mg in 10 ml / dimethicone 40 mg in 10 ml oral liquid [antacid]||has_active_ingredient
h-17-b||hydrocortisone butyrate 0.1 % topical ointment (gram)||has_active_ingredient
chloride benzalkonium||benzalkonium chloride 0.10 g in 100 ml topical cloth [sweet skin etc hand sanitizer wipes]||has_active_ingredient
juglans alba pollen||cynodon dactylon pollen 16 [bau] in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / poa pratensis pollen 400 [bau] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / betula nigra pollen 0.0004 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / carya tomentosa pollen 0.00004 g in 1 ml / quercus alba pollen 0.0004 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia trifida pollen 0.00008 g in 1 ml / ambrosia artemisiifolia pollen 0.00008 g in 1 ml / ambrosia psilostachya pollen 0.00008 g in 1 ml subcutaneous injection, solution||has_active_ingredient
product containing titanium dioxide (medicinal product)||octinoxate 7 g in 100 g / titanium dioxide 5.3 g in 100 g / avobenzone 2.97 g in 100 g / octocrylene 7.5 g in 100 g / octisalate 5 g in 100 g / homosalate 7.5 g in 100 g topical cream [carecella daily sun cream]||has_active_ingredient
product containing iodine and/or iodine compound||corticotropin 6 [hp_x] in 1 ml / chaste tree 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml / canis lupus familiaris milk 16 [hp_x] in 1 ml oral liquid [anpituapar]||has_active_ingredient
(3r,5s,6e)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid||product containing only rosuvastatin (medicinal product)||has_active_ingredient
product containing merbromin||merbromin-containing product in cutaneous dose form||has_active_ingredient
ethinylestradiol [endocrine]||ethinyl estradiol+norgestimate 0.035mg/0.25mg tablet||has_active_ingredient
hepatitis virus a||triticum aestivum whole 1 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / arsenic trioxide 6 [hp_x] in 1 ml / glutathione 6 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / sus scrofa lymph 6 [hp_x] in 1 ml / phosphoric acid 6 [hp_x] in 1 ml / sus scrofa spleen 6 [hp_x] in 1 ml / chelone glabra 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / hepatitis a virus 18 [hp_x] in 1 ml / hepatitis c virus 18 [hp_x] in 1 ml / hepatitis b virus 33 [hp_x] in 1 ml oral liquid [hepatitis-sode]||has_active_ingredient
cattle epithelium allergenic extract||bos taurus epithelia extract 0.05 gm/ml injectable solution||has_active_ingredient
mercurius solubilis preparation||antimony potassium tartrate 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / mercurius solubilis 10 [hp_x] in 59 ml / pilocarpus jaborandi leaf 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / sambucus nigra flowering top 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / sulfuric acid 10 [hp_x] in 59 ml oral liquid [no sweat anti perspirant]||has_active_ingredient
calcarea carbonica||calcium carbonate and cholecalciferol in oral dosage form||has_active_ingredient
ipecac (drug)||echinacea angustifolia 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / ipecac 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) 10 [hp_c] in 1 ml / influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) 10 [hp_c] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 10 [hp_c] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 10 [hp_c] in 1 ml oral liquid [influaforce]||has_active_ingredient
titanium white||titanium oxide||has_active_ingredient
trialodine||desyrel 50 mg oral tablet||has_active_ingredient
octyl salicylate (substance)||avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [la roche posay laboratoire dermatologique sport anthelios activewear broad spectrum spf 60 sunscreen]||has_active_ingredient
jacaranda caroba flower||jacaranda caroba flower 30 [hp_c] oral pellet [jacaranda caroba]||has_active_ingredient
valacyclovir hcl||valacyclovir hydrochloride 500 mg oral tablet [valacyclovir hcl avpak]||has_active_ingredient
octyl methoxycinnamate||homosalate 10 g in 1 ml / octinoxate 7.5 g in 1 ml / octisalate 5 g in 1 ml / octocrylene 5 g in 1 ml / avobenzone 3 g in 1 ml topical lotion [general protection]||has_active_ingredient
pigment white 6||titanium dioxide 2.1 g in 100 ml / octinoxate 4 g in 100 ml topical cream [h-e-b skin corrective innovative skin perfector bb broad spectrum spf15 sunscreen medium/deep]||has_active_ingredient
hydrochloride, duloxetine||duloxetine hydrochloride 60 mg oral capsule, delayed release||has_active_ingredient
box elder pollen||urtica dioica pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula populifolia pollen 0.00008 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.0004 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml / equus caballus hair 0.002 g in 1 ml subcutaneous injection, solution||has_active_ingredient
neutra-phos-k||aconitum napellus 6 [hp_c] in 29.6 ml / silver nitrate 9 [hp_c] in 29.6 ml / centaurium erythraea flower 5 [hp_x] in 29.6 ml / ilex aquifolium flowering top 5 [hp_x] in 29.6 ml / juglans regia flowering top 5 [hp_x] in 29.6 ml / potassium carbonate 6 [hp_c] in 29.6 ml / sodium chloride 6 [hp_x] in 29.6 ml / phosphorus 6 [hp_c] in 29.6 ml topical spray [temperament and boundaries]||has_active_ingredient
zincum oxydatum||octisalate 2.523 g in 50 ml / octocrylene 3.532 g in 50 ml / zinc oxide 7.723 g in 50 ml topical cream [shiseido future solution lx universal defense e]||has_active_ingredient
atropa belladonna||arnica montana 12 [hp_x] / atropa belladonna 12 [hp_x] / bryonia alba root 12 [hp_x] / gelsemium sempervirens root 12 [hp_x] / toxicodendron pubescens leaf 12 [hp_x] oral tablet [homeopathic nerve pain]||has_active_ingredient
octyl salicylate (substance)||avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [skinceuticals sport uv defense sunscreen broad spectrum spf 50]||has_active_ingredient
butriptyline (product)||butriptylene||has_active_ingredient
product containing zinc oxide||octinoxate 0.075 g in 1 g / zinc oxide 0.0392 g in 1 g topical lipstick [esika pro hidracolor 3 in 1 moisturizing, color and perfecting effect spf 25 (nude moccha) - orange]||has_active_ingredient
copanlisib (medication)||product containing only copanlisib in parenteral dose form (medicinal product form)||has_active_ingredient
benzalkonium chloride - chemical (substance)||benzalkonium chloride 0.13 mg in 100 ml topical liquid [wipe-out antibacterial wipes fresh scent]||has_active_ingredient
glycerin||glycerin 200 [hp_c] oral pellet [hahnemann sneezing]||has_active_ingredient
caffeine-containing product||chlorpheniramine + phenylpropanolamine + caffeine||has_active_ingredient
hekla lava||arnica montana 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / boron gluconate 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / hekla lava 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral liquid [calcium composition]||has_active_ingredient
lassars paste||product containing only miconazole and zinc oxide in cutaneous dose form (medicinal product form)||has_active_ingredient
broccoli allergenic extract||broccoli 0.1 g in 1 ml intradermal injection, solution||has_active_ingredient
meloxicam-containing product||meloxicam 7.5mg tablet (product)||has_active_ingredient
methylphenidate hydrochloride (substance)||methylphenidate hydrochloride 27 mg oral tablet||has_active_ingredient
manganese acetate tetrahydrate||potassium alum 10 [hp_x] in 59 ml / benzoic acid 10 [hp_x] in 59 ml / cadmium sulfate 10 [hp_x] in 59 ml / chelidonium majus 10 [hp_x] in 59 ml / colchicum autumnale bulb 10 [hp_x] in 59 ml / solanum dulcamara top 10 [hp_x] in 59 ml / bos taurus hypothalamus 10 [hp_x] in 59 ml / manganese acetate tetrahydrate 10 [hp_x] in 59 ml / mercurius solubilis 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / nitric acid 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / ranunculus bulbosus 10 [hp_x] in 59 ml / rhododendron aureum leaf 10 [hp_x] in 59 ml / thyroid, unspecified 10 [hp_x] in 59 ml oral liquid [environmental adaptation weather changes]||has_active_ingredient
boo-boo magic||dimethicone 5 mg in 354 mg topical lotion [xtracare skin relief oatmeal daily moisturizing]||has_active_ingredient
product containing arsenic trioxide (medicinal product)||arsenic trioxide only product in parenteral dose form||has_active_ingredient
solidago virgaurea flowering top||aluminum oxide 15 [hp_x] in 59.1 ml / avena sativa flowering top 4 [hp_x] in 59.1 ml / sodium borate 8 [hp_x] in 59.1 ml / candida albicans 16 [hp_x] in 59.1 ml / phenol 8 [hp_x] in 59.1 ml / ceanothus americanus leaf 4 [hp_x] in 59.1 ml / echinacea angustifolia 4 [hp_x] in 59.1 ml / gaultheria procumbens top 6 [hp_x] in 59.1 ml / sus scrofa adrenal gland 9 [hp_x] in 59.1 ml / goldenseal 5 [hp_x] in 59.1 ml / flax seed 6 [hp_x] in 59.1 ml / lithium carbonate 12 [hp_x] in 59.1 ml / sus scrofa bone marrow 9 [hp_x] in 59.1 ml / sodium chloride 12 [hp_x] in 59.1 ml / phosphoric acid 12 [hp_x] in 59.1 ml / phytolacca americana root 12 [hp_x] in 59.1 ml / lactic acid, l- 12 [hp_x] in 59.1 ml / sepia officinalis juice 15 [hp_x] in 59.1 ml / silicon dioxide 12 [hp_x] in 59.1 ml / solidago virgaurea flowering top 4 [hp_x] in 59.1 ml / tellurium 15 [hp_x] in 59.1 ml / teucrium marum 6 [hp_x] in 59.1 ml / zinc 15 [hp_x] in 59.1 ml oral liquid [mycocan-chord]||has_active_ingredient
vitamin b complex||sodium ascorbate 120 mg / cholecalciferol 450 [iu] / tocophersolan 30 [iu] / thiamine mononitrate 3 mg / riboflavin 3 mg / niacinamide 20 mg / pyridoxine hydrochloride 50 mg / folic acid 1 mg / cyanocobalamin 10 ug / calcium formate 155 mg / calcium carbonate 45 mg / ferrous bisglycinate 32 mg / potassium iodide 100 ug / zinc oxide 10 mg / choline bitartrate 55 mg oral tablet [pre-tabs dha multi-vitamin/mineral supplement]||has_active_ingredient
wheat loose smut extract||ustilago tritici 0.1 g in 1 ml subcutaneous injection, solution||has_active_ingredient
petrolatum, white||zinc oxide 6 g in 100 g / octinoxate 6 g in 100 g / petrolatum 30 g in 100 g / mineral oil 30 g in 100 g / avobenzone 1 g in 100 g topical stick [biorlx lip balm hemp]||has_active_ingredient
diabetas||glyburide 5mg tab,ud||has_active_ingredient
eupatorium capillifolium pollen||dogfennel pollen extract 10,000 unt/ml injectable solution||has_active_ingredient
naphazoline||hamamelis and naphazoline product||has_active_ingredient
folic acid product||remedient capsule||has_active_ingredient
parvum cryptosporidium||baptisia tinctoria root 3 [hp_x] in 1 ml / cajuput oil 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / alpine strawberry 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / senna leaf 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / ipecac 6 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa spleen 8 [hp_x] in 1 ml / cinchona officinalis bark 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / blastocystis hominis 12 [hp_c] in 1 ml / cryptosporidium parvum 12 [hp_c] in 1 ml / giardia lamblia 12 [hp_c] in 1 ml / entamoeba histolytica 18 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [amoeba]||has_active_ingredient
mineral supplements selenium||silver nitrate 6 [hp_x] in 30 ml / arnica montana root 6 [hp_x] in 30 ml / avena sativa flowering top 3 [hp_x] in 30 ml / potassium phosphate, dibasic 6 [hp_x] in 30 ml / selenium 6 [hp_x] in 30 ml / semecarpus anacardium juice 6 [hp_x] in 30 ml / gelsemium sempervirens root 6 [hp_x] in 30 ml / phosphoric acid 6 [hp_x] in 30 ml sublingual liquid [acidum phosphoricum plex]||has_active_ingredient
oxygen (substance)||oxygen .99 l in 1 l respiratory (inhalation) gas||has_active_ingredient
apomorfina||apomorphine only product||has_active_ingredient
bryonia alba root||bryonia alba root 30 [hp_x] oral tablet [bryonia alba]||has_active_ingredient
amlodipine free base||amlodipino||has_active_ingredient
dolutegravir sodium (substance)||dolutegravir 25mg tab||has_active_ingredient
etoh - alcohol||alcohol 75 ml in 100 ml topical solution [livegreen sugar mint antibacterial hand sanitizer]||has_active_ingredient
citric acid preparation||citric acid and nalidixic acid only product||has_active_ingredient
doxycycline (as hyclate)||doxycycline hyclate 100mg tab||has_active_ingredient
colistin sulfate (substance)||neomycin sulf/colistin sul/hydrocortisone ac/thonzonium brom@3.3 mg-3 mg-10 mg-0.5 mg/ml@otic (ear)@suspension, drops(final dosage form)(ml)||has_active_ingredient
pyrilamine product||chlorpheniramine and phenylephrine and pyrilamine only product||has_active_ingredient
silver preparation||silver 23 mg in 1000 ml topical gel [sovereign silver eerste hulp gel]||has_active_ingredient
natural camphor||apis mellifera 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / matricaria chamomilla 6 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / amanita muscaria fruiting body 12 [hp_x] in 1 ml / atropine 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / cicuta virosa root 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / hyoscyamus niger 12 [hp_x] in 1 ml / canis lupus familiaris milk 12 [hp_x] in 1 ml / moschus moschiferus musk sac resin 12 [hp_x] in 1 ml / datura stramonium 12 [hp_x] in 1 ml / lycosa tarantula 12 [hp_x] in 1 ml / veratrum album root 12 [hp_x] in 1 ml / homarus americanus digestive fluid 17 [hp_x] in 1 ml / camphor (natural) 30 [hp_x] in 1 ml oral liquid [rage]||has_active_ingredient
rosuvastatin calcium||crestor, 40 mg oral tablet||has_active_ingredient
4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-l-phenylalanine||t4 preparation||has_active_ingredient
glyclazide||gliclazide only product in oral dose form||has_active_ingredient
tibolone (substance)||tibolonum||has_active_ingredient
lycoperdon utriforme fruiting body||chelidonium majus whole 3 [hp_x] in 1 ml / lobelia inflata whole 3 [hp_x] in 1 ml / rumex crispus root 3 [hp_x] in 1 ml / sambucus nigra flowering top 3 [hp_x] in 1 ml / polygala senega root 3 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / virola sebifera resin 6 [hp_x] in 1 ml / lobaria pulmonaria 6 [hp_x] in 1 ml / sulfur 6 [hp_x] in 1 ml / ustilago maydis 6 [hp_x] in 1 ml / laricifomes officinalis fruiting body 8 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml / milk thistle 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / scrophularia nodosa whole 12 [hp_x] in 1 ml / amanita muscaria fruiting body 10 [hp_c] in 1 ml / lycoperdon utriforme fruiting body 10 [hp_c] in 1 ml / claviceps purpurea sclerotium 10 [hp_c] in 1 ml / cairina moschata heart/liver autolysate 30 [hp_c] in 1 ml / bacillus anthracis immunoserum rabbit 30 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / baptisia tinctoria root 30 [hp_c] in 1 ml / berberis vulgaris root bark 30 [hp_c] in 1 ml / clostridium botulinum 30 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) 30 [hp_c] in 1 ml / influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) 30 [hp_c] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 30 [hp_c] in 1 ml / vaccinia virus 30 [hp_c] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_c] in 1 ml / streptococcus pneumoniae 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / vaccinia virus strain new york city board of health live antigen 30 [hp_c] in 1 ml oral liquid [bio-immune]||has_active_ingredient
cinchona officinalis bark extract||tsuga canadensis bark 10 [hp_x] / ammonium bromide 10 [hp_x] / ammonium chloride 10 [hp_x] / semecarpus anacardium juice 10 [hp_x] / antimony trisulfide 10 [hp_x] / silver 10 [hp_x] / oyster shell calcium carbonate, crude 10 [hp_x] / capsicum 10 [hp_x] / cinchona officinalis bark 10 [hp_x] / iron 10 [hp_x] / fucus vesiculosus 10 [hp_x] / strychnos ignatii seed 10 [hp_x] / potassium dichromate 10 [hp_x] / sodium sulfate 10 [hp_x] / nerium oleander leaf 10 [hp_x] / phosphorus 10 [hp_x] / phytolacca americana root 10 [hp_x] / schoenocaulon officinale seed 10 [hp_x] / delphinium staphisagria seed 10 [hp_x] / sulfur 10 [hp_x] / thyroid, unspecified 10 [hp_x] / veratrum album root 10 [hp_x] topical patch [sp6 complete]||has_active_ingredient
keflex||product containing cephalexin 250 mg/1 each oral capsule||has_active_ingredient
b-12||cyanocobalamin 1mg/1ml inj||has_active_ingredient
oxyde de zinc||zinc oxide 22.5 g in 100 g topical stick [badger spf 35 all season face]||has_active_ingredient
salix alba flower extract||dryopteris filix-mas root 3 [hp_x] / pteridium aquilinum whole 3 [hp_x] / salix purpurea bark 3 [hp_x] / willow bark 3 [hp_x] / salix alba flower 3 [hp_x] / asplenium scolopendrium top 3 [hp_x] oral pellet||has_active_ingredient
benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2ar-(2aalpha,4beta,4abeta,6beta,9alpha(alphar*,betas*),11alpha,1-2alpha,12aalpha,12balpha))-||paclitaxel 6mg/ml infusion concentrate 50ml vial||has_active_ingredient
horse chestnut preparation||horse chestnut 10 [hp_x] in 59 ml / arnica montana 10 [hp_x] in 59 ml / calcium fluoride 10 [hp_x] in 59 ml / activated charcoal 10 [hp_x] in 59 ml / silybum marianum seed 10 [hp_x] in 59 ml / collinsonia canadensis root 10 [hp_x] in 59 ml / echinacea purpurea 10 [hp_x] in 59 ml / hamamelis virginiana root bark/stem bark 10 [hp_x] in 59 ml / lachesis muta venom 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / claviceps purpurea sclerotium 10 [hp_x] in 59 ml oral liquid [varicose veins]||has_active_ingredient
pantenyl||dexpanthenol 250 mg/ml injection vial (ml)||has_active_ingredient
h2 - hydrogen||aconitum napellus 30 [hp_c] in 1 g / arsenic triiodide 30 [hp_c] in 1 g / bryonia alba root 30 [hp_c] in 1 g / eupatorium perfoliatum flowering top 30 [hp_c] in 1 g / gelsemium sempervirens root 30 [hp_c] in 1 g / escargot shell, cooked 30 [hp_c] in 1 g / hydrogen 30 [hp_c] in 1 g / influenza a virus a/brisbane/10/2010 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) 30 [hp_c] in 1 g / influenza a virus a/brisbane/10/2010 (h1n1) neuraminidase antigen (mdck cell derived, propiolactone inactivated) 30 in 1 g / influenza a virus a/south australia/55/2014 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) 30 [hp_c] in 1 g / influenza a virus a/south australia/55/2014 (h3n2) neuraminidase antigen (mdck cell derived, propiolactone inactivated) 30 in 1 g / influenza b virus b/utah/9/2014 hemagglutinin antigen (mdck cell derived, propiolactone inactivated) 30 [hp_c] in 1 g / influenza b virus b/utah/9/2014 neuraminidase antigen (mdck cell derived, propiolactone inactivated) 30 in 1 g / wood creosote 30 [kp_c] in 1 g / phosphorus 30 [hp_c] in 1 g / teucrium scorodonia flowering top 30 [hp_c] in 1 g / thuja occidentalis leafy twig 30 [hp_c] in 1 g / veratrum viride root 30 [hp_c] in 1 g / cairina moschata heart/liver autolysate 200 [hp_c] in 1 g oral pellet [flu guard]||has_active_ingredient
sodium chloride [nose] (substance)||sodium chloride 900 mg in 100 ml intravenous injection, solution [alfa veterinary 0.9% sodium chloride]||has_active_ingredient
methyl salicylate (product)||menthol 14.5 g in 100 ml / methyl salicylate 30 g in 100 ml topical oil [eagle medicated]||has_active_ingredient
mustard greens allergenic extract||mustard greens allergenic extract 50 mg/ml injectable solution||has_active_ingredient
natural camphor||berberis vulgaris root bark 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / ammonium carbonate 6 [hp_x] in 1 ml / camphor (natural) 6 [hp_x] in 1 ml / cysteine 6 [hp_x] in 1 ml / strychnos nux-vomica seed 6 [hp_x] in 1 ml / sulfuric acid 6 [hp_x] in 1 ml / acetaldehyde 12 [hp_x] in 1 ml / benzene 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / phenol 12 [hp_x] in 1 ml / wood creosote 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / naphthalene 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / formaldehyde solution 12 [hp_x] in 1 ml / carbon tetrachloride 16 [hp_x] in 1 ml / chloroform 16 [hp_x] in 1 ml / ether 16 [hp_x] in 1 ml / paraffin 16 [hp_x] in 1 ml / kerosene 16 [hp_x] in 1 ml oral liquid [chemtox]||has_active_ingredient
octocrileno||octisalate 6.65 g in 95 g / octocrylene 7.6 g in 95 g / avobenzone 2.85 g in 95 g / homosalate 14.25 g in 95 g topical lotion [sea and ski spf 50 sport]||has_active_ingredient
titanium dioxide (substance)||octinoxate 7.5 g in 100 g / octisalate 5.0 g in 100 g / titanium dioxide 1.0 g in 100 g topical lipstick [lip conditioner spf 15]||has_active_ingredient
esterified estrogens (medication)||product containing conjugated estrogen and esterified estrogen and medroxyprogesterone (medicinal product)||has_active_ingredient
p element||influenza a virus 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / american ginseng 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / euphrasia stricta 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / sage 15 [hp_x] in 1 ml / lobaria pulmonaria 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [sniffles]||has_active_ingredient
pantoprazole sodium||pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant oral tablet||has_active_ingredient
populus deltoides subsp. monilifera pollen||populus deltoides subsp. monilifera pollen 0.1 g in 1 ml percutaneous solution [western cottonwood pollen]||has_active_ingredient
aspirin chemicals||aspirin 300 mg chewable tablet||has_active_ingredient
triclosanum||triclosan 4.6 mg in 1 ml topical liquid [rite aid renewal white tea]||has_active_ingredient
l-(-)-histidine||oxitriptan 200 [kp_c] in 1 ml / choline chloride 200 [kp_c] in 1 ml / dopamine 200 [kp_c] in 1 ml / glutamic acid 200 [kp_c] in 1 ml / glycine 200 [kp_c] in 1 ml / histidine 200 [kp_c] in 1 ml / levodopa 200 [kp_c] in 1 ml / melanin synthetic (tyrosine, peroxide) 200 [kp_c] in 1 ml / melatonin 200 [kp_c] in 1 ml / norepinephrine 200 [kp_c] in 1 ml / octopamine 200 [kp_c] in 1 ml / 5-methoxytryptamine 200 [kp_c] in 1 ml / phenylalanine 200 [kp_c] in 1 ml / serotonin 200 [kp_c] in 1 ml / taurine 200 [kp_c] in 1 ml / tryptophan 200 [kp_c] in 1 ml / tyrosine 200 [kp_c] in 1 ml oral spray [neuro 3]||has_active_ingredient
product containing zinc oxide (medicinal product)||octinoxate 3.75 g in 100 g / octisalate 2.5 g in 100 g / titanium dioxide 7.8 g in 100 g / zinc oxide 4.8 g in 100 g topical powder [too cool for school dinoplatz loose and silly no. 2 illusion]||has_active_ingredient
box elder pollen||ambrosia trifida pollen 0.000027 g in 1 ml / ambrosia artemisiifolia pollen 0.000027 g in 1 ml / ambrosia psilostachya pollen 0.000027 g in 1 ml / carya illinoinensis pollen 0.0002 g in 1 ml / carya alba pollen 0.0002 g in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.00008 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / acer negundo pollen 0.0004 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / rumex acetosella pollen 0.0004 g in 1 ml intradermal injection, solution||has_active_ingredient
phosphorus||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea 3 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / euphrasia stricta 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / ambrosia artemisiifolia 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml oral liquid [allerstat ii]||has_active_ingredient
premenstrual therapeutics pamabrom||pamabrom 50 mg oral tablet, film coated [diurex max]||has_active_ingredient
zinc óxido||octinoxate 7.5 g in 100 g / zinc oxide 4.9 g in 100 g topical stick [ultra balm moisturizing protective lips spf 20 nude caramel]||has_active_ingredient
trichophyton mentagrophytes allergenic extract||trichophyton mentagrophytes 0.01 g in 1 ml / trichophyton rubrum 0.01 g in 1 ml intradermal injection, solution||has_active_ingredient
ulmus americana pollen||poa pratensis pollen 160 [bau] in 1 ml / ulmus americana pollen 0.00008 g in 1 ml / ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / kochia scoparia pollen 0.00008 g in 1 ml / chenopodium album pollen 0.00008 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / salsola kali pollen 0.00008 g in 1 ml / rumex acetosella pollen 0.00008 g in 1 ml subcutaneous injection, solution||has_active_ingredient
absolute ethanol||alcohol 3600 ml in 4800 ml topical gel [instant hand sanitizer]||has_active_ingredient
zyprexa||olanzapine 10 mg oral tablet||has_active_ingredient
rtca||ribavirin 6 g respiratory (inhalation) powder, for solution [virazole]||has_active_ingredient
lycopodium clavatum spore||antimony potassium tartrate 30 [hp_c] in 30 [hp_c] / escherichia coli 200 [hp_c] in 30 [hp_c] / bryonia alba root 30 [hp_c] in 30 [hp_c] / camphor (natural) 30 [hp_c] in 30 [hp_c] / chelidonium majus 30 [hp_c] in 30 [hp_c] / grindelia hirsutula flowering top 30 [hp_c] in 30 [hp_c] / wood creosote 30 [hp_c] in 30 [hp_c] / lycopodium clavatum spore 30 [hp_c] in 30 [hp_c] / sodium sulfate 30 [hp_c] in 30 [hp_c] / phosphorus 30 [hp_c] in 30 [hp_c] oral spray [chest cold]||has_active_ingredient
olanzapinum||olanzapine 5mg dispersible tablet (product)||has_active_ingredient
podophyllum peltatum rhizome/root extract||berberis vulgaris root bark 6 [hp_x] in 1 ml / milk thistle 3 [hp_x] in 1 ml / chelidonium majus 6 [hp_c] in 1 ml / podophyllum 6 [hp_x] in 1 ml / anguilla rostrata blood serum 30 [hp_c] in 1 ml / symphoricarpos albus fruit 200 [hp_x] in 1 ml / ginger 6 [hp_x] in 1 ml oral liquid [pregnancy balance]||has_active_ingredient
spigelia anthelmia whole||spigelia anthelmia 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / corallium rubrum whole 10 [hp_x] in 1 ml sublingual solution [am-9]||has_active_ingredient
pinus banksiana pollen||pinus banksiana pollen extract 50 mg/ml injectable solution||has_active_ingredient
2-ethylhexyl-2-cyano-3,3-diphenylacrylate||avobenzone 3 g in 100 kg / octinoxate 7.5 g in 100 kg / octisalate 5 g in 100 kg / octocrylene 2.5 g in 100 kg topical cream [anti-aging day broad spectrum spf 30 la prairie group ag]||has_active_ingredient
óxido de cinc||titanium dioxide 45.5 mg in 1 ml / zinc oxide 35 mg in 1 ml topical liquid [sugar rush skin treat poreless tinted moisturizer broad spectrum spf 20 sunscreen deep]||has_active_ingredient
vildagliptina||product containing vildagliptin in oral dosage form||has_active_ingredient
atriplex polycarpa pollen||atriplex polycarpa pollen 0.1 g in 1 ml subcutaneous solution [allscale]||has_active_ingredient
botulinum antitoxin||heptavalent (abcdefg) equine antitoxin||has_active_ingredient
chloride, potassium||thermotabs, 30 mg-450 mg oral tablet||has_active_ingredient
co2 - carbon dioxide||carbon dioxide + oxygen gas (product)||has_active_ingredient
benzoic acid, 2-hydroxy-, 2-ethylhexyl ester||avobenzone 5.1 g in 170 g / homosalate 25.5 g in 170 g / octisalate 8.5 g in 170 g / octocrylene 13.6 g in 170 g topical aerosol, spray [solrx kids spf 60 c-spray]||has_active_ingredient
benzophenone 3||octinoxate 75 mg in 1 g / oxybenzone 20 mg in 1 g topical gel [neutrogena moistureshine lip soother sunscreen spf20 - glisten 20]||has_active_ingredient
product containing metformin hydrochloride (medicinal product)||metformin hcl 500 mg oral tablet, extended release 24 hr||has_active_ingredient
dessicated thyroid extract||horse chestnut 10 [hp_x] in 1 ml / anacardium occidentale fruit 14 [hp_x] in 1 ml / aralia racemosa root 10 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / arsenic triiodide 15 [hp_x] in 1 ml / bellis perennis 7 [hp_x] in 1 ml / calcium fluoride 20 [hp_x] in 1 ml / milk thistle 15 [hp_x] in 1 ml / simaba cedron seed 9 [hp_x] in 1 ml / chamaelirium luteum root 10 [hp_x] in 1 ml / ledum palustre twig 20 [hp_x] in 1 ml / manganese acetate tetrahydrate 20 [hp_x] in 1 ml / myrtus communis top 6 [hp_x] in 1 ml / physalis alkekengi fruit 7 [hp_x] in 1 ml / ruta graveolens flowering top 10 [hp_x] in 1 ml / selenium 30 [hp_x] in 1 ml / ferula sumbul root 14 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_c] in 1 ml / veratrum viride root 6 [hp_x] in 1 ml oral liquid [lv-fx]||has_active_ingredient
ceftriaxone, disodium salt||ceftriaxone sodium 250 mg injection powder for solution||has_active_ingredient
product containing dimethicone||simethicone 125 mg oral capsule, liquid filled [alka-seltzer anti-gas]||has_active_ingredient
isopropyl alcohol (substance) [ambiguous]||isopropyl alcohol 75 ml in 100 ml topical gel [hand sanitizer gel]||has_active_ingredient
honey bee||apis mellifera 12 [hp_x] in 1 ml / araneus diadematus 9 [hp_x] in 1 ml / berberis vulgaris root bark 12 [hp_x] in 1 ml / equisetum hyemale 7 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / juglans regia whole 6 [hp_x] in 1 ml / manganese phosphate, dibasic 9 [hp_x] in 1 ml / niacinamide 9 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / smilax regelii root 9 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / urtica urens 6 [hp_x] in 1 ml oral liquid [ohm drainage lymphatic terrain]||has_active_ingredient
silicon dioxide||bambusa vulgaris whole 6 [hp_x] in 1 ml / stachys officinalis 6 [hp_x] in 1 ml / bos taurus intervertebral disc 6 [hp_x] in 1 ml / rosmarinus officinalis flowering top 6 [hp_x] in 1 ml / formica rufa 7 [hp_x] in 1 ml / antimony 8 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml oral liquid||has_active_ingredient
aluminum zirconium glycine tetrachloro hydrate complex||aluminum zirconium tetrachlorohydrex gly 19 g in 100 g topical stick [secret outlast invisible sport fresh]||has_active_ingredient
ethanol (substance)||alcohol 75 g in 100 g topical gel [vida]||has_active_ingredient
testosterone preparation||axiron 30mg/actuation topical solution||has_active_ingredient
potassium chloride (medication)||calcium fluoride 12 [hp_c] / tribasic calcium phosphate 12 [hp_c] / calcium sulfate anhydrous 12 [hp_c] / ferrosoferric phosphate 12 [hp_c] / potassium chloride 12 [hp_c] / dibasic potassium phosphate 12 [hp_c] / potassium sulfate 12 [hp_c] / magnesium phosphate, dibasic trihydrate 12 [hp_c] / sodium chloride 12 [hp_c] / sodium phosphate, dibasic, heptahydrate 12 [hp_c] / sodium sulfate 12 [hp_c] / silicon dioxide 12 [hp_c] oral tablet [stamina]||has_active_ingredient
copper 63||american ginseng 3 [hp_x] in 1 ml / potassium gluconate 3 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / magnesium gluconate 6 [hp_x] in 1 ml / sus scrofa pancreas 6 [hp_x] in 1 ml / sus scrofa spleen 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / copper 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / oxogluric acid 8 [hp_x] in 1 ml / anhydrous citric acid 8 [hp_x] in 1 ml / fumaric acid 8 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 8 [hp_x] in 1 ml / malic acid 8 [hp_x] in 1 ml / pyruvic acid 8 [hp_x] in 1 ml / succinic acid 8 [hp_x] in 1 ml / naphthoquine 9 [hp_x] in 1 ml / aconitic acid, (z)- 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml oral liquid [spleenex v]||has_active_ingredient
product containing glycerol||glycerin 26 g in 200 ml topical liquid [dead skin perfect cleanser]||has_active_ingredient
benzalkonium chloride||benzalkonium chloride 0.115 mg in 100 mg topical patch [bloom wellness]||has_active_ingredient
prednisolone preparation (substance)||(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione||has_active_ingredient
dioxide titanium||titanium dioxide 31.6 mg in 1 ml / octinoxate 29.97 mg in 1 ml topical liquid [givenchy photo perfexion fluid foundation spf 20 perfect petal tint 2]||has_active_ingredient
pure oxygen||oxygen 240 l in 240 l respiratory (inhalation) gas [oxygen size c]||has_active_ingredient
phenylephrine hcl [cvs sympath||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [daytime cold and flu relief]||has_active_ingredient
hydrocodone (substance)||product containing only chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product)||has_active_ingredient
triclosan [dup] (substance)||triclosan 0.46 ml in 100 ml topical soap [cvs antibacterial foaming kitchen]||has_active_ingredient
oxycodone hydrochloride||oxycodone hydrochloride 10 mg / acetaminophen 325 mg oral tablet [endocet]||has_active_ingredient
porcine heparin sodium (substance)||heparin sodium,porcine/d5w 12,500 unit/250 ml intraven intravenous solution||has_active_ingredient
arumacil||lanolin 136.4 mg in 1 g / petrolatum 469.9 mg in 1 g topical ointment [diaper rash skin protectant]||has_active_ingredient
influenza a virus a/guangdong-maonan/swl1536/2019 (h1n1) antigen||galphimia glauca flowering top 4 [hp_x] in 1 ml / causticum 6 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 6 [hp_x] in 1 ml / ipecac 6 [hp_x] in 1 ml / aconitum napellus whole 9 [hp_x] in 1 ml / potassium dichromate 9 [hp_x] in 1 ml / avena sativa flowering top 12 [hp_x] in 1 ml / influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / pratia purpurascens 16 [hp_x] in 1 ml / cairina moschata heart/liver autolysate 16 [hp_x] in 1 ml / echinacea angustifolia whole 3 [hp_c] in 1 ml / zeltnera venusta whole flowering 30 [hp_c] in 1 ml oral liquid [influenseg]||has_active_ingredient
arnica montana extract||angelica sinensis root 6 [hp_x] / arnica montana 6 [hp_c] / magnesium phosphate, dibasic trihydrate 8 [hp_x] / passiflora incarnata flowering top 3 [hp_x] / silicon dioxide 8 [hp_x] oral tablet [birth-heal]||has_active_ingredient
quassia amara wood||amanita muscaria fruiting body 6 [hp_x] in 118 ml / lycoperdon utriforme fruiting body 6 [hp_x] in 118 ml / hydrochloric acid 6 [hp_x] in 118 ml / quassia amara wood 6 [hp_x] in 118 ml / pine tar 6 [hp_x] in 118 ml / delphinium staphisagria seed 6 [hp_x] in 118 ml / sulfur 6 [hp_x] in 118 ml / semecarpus anacardium juice 6 [hp_x] in 118 ml / apis mellifera 6 [hp_x] in 118 ml / causticum 6 [hp_x] in 118 ml / graphite 8 [hp_x] in 118 ml / nerium oleander leaf 6 [hp_x] in 118 ml / toxicodendron pubescens leaf 6 [hp_x] in 118 ml topical shampoo [licenex]||has_active_ingredient
arnica tincture||tribasic calcium phosphate 10 [hp_x] in 15 ml / graphite 10 [hp_x] in 15 ml / silicon dioxide 10 [hp_x] in 15 ml / allylthiourea 10 [hp_x] in 15 ml / hydrofluoric acid 10 [hp_x] in 15 ml / arnica montana 10 [hp_x] in 15 ml / calcium fluoride 10 [hp_x] in 15 ml / calendula officinalis flowering top 10 [hp_x] in 15 ml / phytolacca americana root 10 [hp_x] in 15 ml / juniperus sabina leafy twig 10 [hp_x] in 15 ml / thuja occidentalis leafy twig 10 [hp_x] in 15 ml topical liquid [healthful naturals scar remover]||has_active_ingredient
ornithogalum umbellatum flowering top||ilex aquifolium flowering top 3 [hp_c] in 236.5 ml / impatiens glandulifera flower 3 [hp_c] in 236.5 ml / helianthemum nummularium flower 3 [hp_c] in 236.5 ml / ornithogalum umbellatum flowering top 3 [hp_c] in 236.5 ml oral liquid [calm down dog/cat - good dog/cat]||has_active_ingredient
product containing glimepiride (medicinal product)||amaryl 4mg tablet||has_active_ingredient
activated charcoal - chemical||passiflora incarnata flowering top 3 [hp_x] in 1 ml / matricaria chamomilla 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / fucus vesiculosus 4 [hp_x] in 1 ml / chaste tree fruit 6 [hp_x] in 1 ml / dibasic potassium phosphate 6 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / strychnos nux-vomica seed 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / chelidonium majus 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / bos taurus pituitary gland, posterior 10 [hp_x] in 1 ml / corticotropin 10 [hp_x] in 1 ml / thyroid, bovine 10 [hp_x] in 1 ml / thyroid, ovine 1 [hp_q] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 12 [hp_x] in 1 ml / ubidecarenone 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / sus scrofa pituitary gland 12 [hp_x] in 1 ml / bos taurus hypothalamus 12 [hp_x] in 1 ml / sus scrofa placenta 12 [hp_x] in 1 ml / silver nitrate 20 [hp_x] in 1 ml / berberis vulgaris root bark 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / digitalis 20 [hp_x] in 1 ml / iris versicolor root 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / sodium carbonate 20 [hp_x] in 1 ml / sodium sulfate 20 [hp_x] in 1 ml / anemone pulsatilla 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / scutellaria lateriflora 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / datura stramonium 20 [hp_x] in 1 ml / semecarpus anacardium juice 200 [hp_x] in 1 ml / agrimonia eupatoria flower 6 [hp_c] in 1 ml / castanea sativa leaf 6 [hp_c] in 1 ml / ceratostigma willmottianum flower 6 [hp_c] in 1 ml / aesculus hippocastanum flower 9 [hp_c] in 1 ml / centaurium erythraea flower 9 [hp_c] in 1 ml oral liquid [metalock]||has_active_ingredient
oxygen, nos||helium 200 ml in 1 l / oxygen 500 ml in 1 l / nitrogen 300 ml in 1 l respiratory (inhalation) gas||has_active_ingredient
2-ethylhexyl 2-cyano-3,3-diphenylacrylate||avobenzone 30 mg in 1 g / homosalate 150 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 100 mg in 1 g topical spray [neutrogena beach defense water plus sun protection sunscreen stick broad spectrum spf 50 plus]||has_active_ingredient
product containing white soft paraffin (medicinal product)||camphor/menthol/petrolatum/phenol topical application ointment [blistex lip medex]||has_active_ingredient
matricaria recutita extract||atropa belladonna 18 [hp_x] in 0.05 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 0.05 ml / capsicum 6 [hp_x] in 0.05 ml / matricaria recutita 15 [hp_x] in 0.05 ml / potassium dichromate 12 [hp_x] in 0.05 ml / plantago major 4 [hp_x] in 0.05 ml / verbascum thapsus 4 [hp_x] in 0.05 ml auricular (otic) liquid [auro homeopathic ear relief drops]||has_active_ingredient
otic preparations isopropyl alcohol||isopropyl alcohol 2.839 l in 3.785 l topical solution [polysan]||has_active_ingredient
dextroamphetamine saccharate (substance)||amphetamine-dextroamphetamine er, 5 mg oral capsule, extended release||has_active_ingredient
dimethyl polysiloxane||dimethicone 13 mg in 1 ml topical lotion [members select daily moisturizing]||has_active_ingredient
aspirins||pain reliever plus, 250 mg-250 mg-65 mg oral tablet||has_active_ingredient
sodium allopurinol||1,5-dihydro-4h-pyrazolo[3,4-d]pryimidin-4-one monosodium salt||has_active_ingredient
2-ethylhexyl-4-methoxycinnamate||octinoxate 261 mg in 9 g / titanium dioxide 648 mg in 9 g topical stick [shiseido uv protective foundation fair ivory]||has_active_ingredient
salicylic acid [callosity] (product)||salicylic acid 5 mg in 1 ml topical liquid [neutrogena skinclearing oil free makeup - natural ivory 20]||has_active_ingredient
dexamphetamine sulphate||dextroamphetamine saccharate 3.75 mg / amphetamine aspartate monohydrate 3.75 mg / dextroamphetamine sulfate 3.75 mg / amphetamine sulfate 3.75 mg oral tablet [adderall]||has_active_ingredient
caco3||calcium carbonate 750 mg oral tablet, chewable [equaline extra strength antacid]||has_active_ingredient
arnica montana/leopard's ban||apis mellifera 8 [hp_x] in 1 g / echinacea, unspecified 8 [hp_x] in 1 g / goldenseal 8 [hp_x] in 1 g / thuja occidentalis leafy twig 8 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / amanita muscaria fruiting body 15 [hp_x] in 1 g / garlic 15 [hp_x] in 1 g / aloe 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / azadirachta indica bark 15 [hp_x] in 1 g / baptisia tinctoria root 15 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / calendula officinalis flowering top 15 [hp_x] in 1 g / capsicum 15 [hp_x] in 1 g / milk thistle 15 [hp_x] in 1 g / calcium sulfide 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / mercury 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / sage 15 [hp_x] in 1 g / selenium 15 [hp_x] in 1 g / taraxacum officinale 15 [hp_x] in 1 g / lycosa tarantula 15 [hp_x] in 1 g / zinc 15 [hp_x] in 1 g / ginger 15 [hp_x] in 1 g / bacillus anthracis 20 [hp_x] in 1 g / influenza a virus 35 [hp_x] in 1 g / influenza b virus 35 [hp_x] in 1 g oral pellet [immune waker]||has_active_ingredient
european house dust mite extract (medication)||dermatophagoides farinae 400 [au] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / bos taurus hair 0.002 g in 1 ml / sus scrofa hair 0.002 g in 1 ml / capra hircus hair 0.002 g in 1 ml / mucor racemosus 0.002 g in 1 ml subcutaneous injection, solution||has_active_ingredient
zinc oxide (substance)||zinc gluconate 1 [hp_x] / zinc oxide 1 [hp_x] / sambucus nigra flower 1 [hp_x] oral tablet, orally disintegrating [nbb cherry]||has_active_ingredient
black walnut pollen extract||acer negundo pollen 0.0083 g in 1 ml / juniperus ashei pollen 0.0017 g in 1 ml / juglans nigra pollen 0.0017 g in 1 ml / fraxinus americana pollen 0.0083 g in 1 ml / quercus alba pollen 0.0083 g in 1 ml / ulmus americana pollen 0.0017 g in 1 ml / carya alba pollen 0.00083 g in 1 ml / carya illinoinensis pollen 0.00083 g in 1 ml / phleum pratense pollen 16666.67 [bau] in 1 ml / ambrosia artemisiifolia pollen 133.33 [au] in 1 ml / iva annua var. annua pollen 0.0017 g in 1 ml subcutaneous injection, solution||has_active_ingredient
(+/-)-alpha-tocopherol acetate||alpha-tocopherol acetate 30 unt / vit-c 100 mg / beta carotene 1000 unt / calcium carbonate 200 mg / calcium pantothenate 7 mg / cholecalciferol 400 unt / doss sodium 25 mg / ferrous fumarate 29 mg / folate 1 mg / niacinamide 15 mg / vitamin b6 hydrochloride 20 mg / riboflavin 3 mg / vitamin b1 3 mg / vitamin b12 0.012 mg / zno 20 mg oral tablet||has_active_ingredient
3,3,5-trimethylcyclohexyl salicylate||avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 10 g in 100 ml topical spray [sunscreen mist broad spectrum spf 50 supergoop]||has_active_ingredient
4,5 diphenyl 2 oxazolepropionic acid||oxaprozin 600mg oral tablet||has_active_ingredient
product containing dextromethorphan hydrobromide||phenylephrine hydrochloride 5 mg / acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg oral capsule, liquid filled [alka-seltzer plus maximum strength day cold and flu powermax gel]||has_active_ingredient
benzylpenicilloyl polylysine-containing product||bpo-oligolysine||has_active_ingredient
guaifenesin (substance)||chlorpheniramine and guaifenesin and hydrocodone and pseudoephedrine only product in oral dose form||has_active_ingredient
anhydrous sulfate of lime||potassium chloride 6 [hp_x] in 1 ml / calcium sulfate anhydrous 10 [hp_x] in 1 ml / sulfur 6 [hp_c] in 1 ml / mucor racemosus 6 [hp_c] in 1 ml / goldenseal 7 [hp_c] in 1 ml / potassium dichromate 7 [hp_c] in 1 ml / lachesis muta venom 7 [hp_c] in 1 ml / mercuric sulfide 7 [hp_c] in 1 ml / calcium sulfide 7 [hp_c] in 1 ml / silver nitrate 10 [hp_c] in 1 ml / cobalt 10 [hp_c] in 1 ml / copper 10 [hp_c] in 1 ml / manganese 10 [hp_c] in 1 ml / silicon dioxide 10 [hp_c] in 1 ml / aspergillus fumigatus 10 [hp_c] in 1 ml / aspergillus niger var. niger 10 [hp_c] in 1 ml / candida albicans 10 [hp_c] in 1 ml / thuja occidentalis leafy twig 12 [hp_c] in 1 ml / sinusitisinum 15 [hp_c] in 1 ml oral liquid [sinusitis plus with ent support]||has_active_ingredient
air -retired-||air- and carbon dioxide-containing product||has_active_ingredient
mercuric oxide||berberis vulgaris root bark 4 [hp_x] in 1 ml / black cohosh 4 [hp_x] in 1 ml / cinchona officinalis bark 4 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / ranunculus bulbosus 4 [hp_x] in 1 ml / horse chestnut 6 [hp_x] in 1 ml / cupric acetate 6 [hp_x] in 1 ml / nadide 6 [hp_x] in 1 ml / sodium diethyl oxalacetate 6 [hp_x] in 1 ml / niacinamide 6 [hp_x] in 1 ml / picric acid 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / ammonium chloride 8 [hp_x] in 1 ml / sus scrofa cartilage 8 [hp_x] in 1 ml / sus scrofa intervertebral disc 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / silver 10 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / sus scrofa umbilical cord 10 [hp_x] in 1 ml / sus scrofa adrenal gland 10 [hp_x] in 1 ml / pseudognaphalium obtusifolium 10 [hp_x] in 1 ml / sus scrofa bone marrow 10 [hp_x] in 1 ml / mercuric oxide 10 [hp_x] in 1 ml / pantothenic acid 10 [hp_x] in 1 ml / sulfur 28 [hp_x] in 1 ml / enterobacter cloacae 30 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [spinalmax]||has_active_ingredient
hydrogen oxide||water 985.77 g in 1000 ml irrigation solution [fad first aid direct buffered eye and skin]||has_active_ingredient
ruta graveolens flowering top extract||antimony potassium tartrate 10 [hp_x] in 1 ml / bellis perennis 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 1 ml / capsicum 10 [hp_x] in 1 ml / chelidonium majus 10 [hp_x] in 1 ml / copper 10 [hp_x] in 1 ml / digitalis 10 [hp_x] in 1 ml / drosera anglica 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / lactic acid, dl- 10 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 10 [hp_x] in 1 ml / magnesium carbonate 10 [hp_x] in 1 ml / manganese acetate tetrahydrate 10 [hp_x] in 1 ml / strychnos nux-vomica seed 10 [hp_x] in 1 ml / phytolacca americana root 10 [hp_x] in 1 ml / toxicodendron pubescens leaf 10 [hp_x] in 1 ml / ruta graveolens flowering top 10 [hp_x] in 1 ml / lactic acid, l- 10 [hp_x] in 1 ml / sulfuric acid 10 [hp_x] in 1 ml / verbascum thapsus 10 [hp_x] in 1 ml / vipera berus venom 10 [hp_x] in 1 ml / arnica montana 10 [hp_x] in 1 ml oral liquid [swimmers friend]||has_active_ingredient
titanium dioxide product||zinc oxide 1.16 g in 40 ml / titanium dioxide 2.04 g in 40 ml topical cream [air cotton makeup base 02 spf30]||has_active_ingredient
daphne mezereum bark||thuja occidentalis leafy twig 6 [hp_c] in 1 ml / daphne mezereum bark 8 [hp_c] in 1 ml / silicon dioxide 8 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / measles virus 30 [hp_c] in 1 ml / mumps virus 30 [hp_c] in 1 ml / bordetella pertussis 30 [hp_c] in 1 ml / poliovirus 30 [hp_c] in 1 ml / rubella virus 30 [hp_c] in 1 ml / clostridium tetani 30 [hp_c] in 1 ml / human breast tumor cell 15 [hp_c] in 1 ml / antimony trisulfide 30 [hp_c] in 1 ml / ledum palustre twig 30 [hp_c] in 1 ml / thimerosal 30 [hp_c] in 1 ml oral liquid [vax reaction]||has_active_ingredient
ketorolac trometamol||ketorolac tromethamine 30 mg in 1 ml intravenous injection, solution [ketorolac tromethamine]||has_active_ingredient
taraxacum officinale extract (substance)||arnica montana 1.5 [hp_c] in 30 ml / bryonia alba root 200 [hp_c] in 30 ml / silybum marianum seed oil 0.5 [hp_c] in 30 ml / chelidonium majus 200 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / pork liver 3 [hp_c] in 30 ml / cervus elaphus horn oil 4 [hp_c] in 30 ml / sus scrofa pancreas 4 [hp_c] in 30 ml / taraxacum officinale 1 [hp_c] in 30 ml oral spray [livergen]||has_active_ingredient
helleborus niger root||gold 10 [hp_x] in 59 ml / mahonia aquifolium root bark 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / capsicum 10 [hp_x] in 59 ml / carbo animalis 10 [hp_x] in 59 ml / eutrochium purpureum root 10 [hp_x] in 59 ml / geranium maculatum root 10 [hp_x] in 59 ml / helleborus niger root 10 [hp_x] in 59 ml / juglans regia flowering top 10 [hp_x] in 59 ml / lobelia cardinalis 10 [hp_x] in 59 ml / lonicera caprifolium flowering top 10 [hp_x] in 59 ml / hippomane mancinella fruiting leafy twig 10 [hp_x] in 59 ml / melilotus officinalis top 10 [hp_x] in 59 ml / mercury 10 [hp_x] in 59 ml / achillea millefolium 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / corn silk 10 [hp_x] in 59 ml / viola odorata 10 [hp_x] in 59 ml oral liquid [nostalgia]||has_active_ingredient
ato||avena sativa flowering top 10 [hp_x] in 59 ml / camphor (natural) 10 [hp_x] in 59 ml / arabica coffee bean 10 [hp_x] in 59 ml / cypripedium parvifolum root 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / passiflora incarnata flowering top 10 [hp_x] in 59 ml / valerian 10 [hp_x] in 59 ml / aconitum napellus 10 [hp_x] in 59 ml / horse chestnut 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / hyoscyamus niger 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml oral liquid [sleep now remedy]||has_active_ingredient
clobetasol propionate (substance)||clobetasol propionate 0.5 mg in 1 g topical cream||has_active_ingredient
potassium exchange resin||714 potassium-removing resins||has_active_ingredient
alcohol (ethyl)||benzalkonium cl 0.125 % / ethanol 5 % medicated pad||has_active_ingredient
ethanol-containing product||alcohol 70 ml in 100 ml topical gel [defendr hand sanitizer]||has_active_ingredient
iva axillaris pollen extract||iva axillaris pollen extract 100 mg/ml injectable solution||has_active_ingredient
p-chloro-m-xylenol||chloroxylenol 3 mg in 1 ml topical soap [gold and sudsy]||has_active_ingredient
diäthylaminoäthanol ester der p-butylaminobenzösäure||lidocaine and tetracaine only product||has_active_ingredient
aconitum napellus whole extract||aconitum napellus 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / gold 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / black cohosh 15 [hp_x] in 1 g / conium maculatum flowering top 15 [hp_x] in 1 g / gelsemium sempervirens root 15 [hp_x] in 1 g / strychnos ignatii seed 15 [hp_x] in 1 g / potassium carbonate 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lilium lancifolium whole flowering 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / sodium carbonate 15 [hp_x] in 1 g / sodium chloride 15 [hp_x] in 1 g / phosphoric acid 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / trinitrophenol 15 [hp_x] in 1 g / lead 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g / delphinium staphisagria seed 15 [hp_x] in 1 g / datura stramonium 15 [hp_x] in 1 g / thuja occidentalis leafy twig 15 [hp_x] in 1 g / zinc 15 [hp_x] in 1 g / matricaria recutita 3 [hp_x] in 1 g / hypericum perforatum 3 [hp_x] in 1 g / valerian 3 [hp_x] in 1 g oral pellet [stress - tension]||has_active_ingredient
1-propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride||benzethonium chloride 0.2 mg in 9 ml / dyclonine hydrochloride 0.75 mg in 9 ml topical liquid [benzethonium chloride plus dyclonine hydrochloride]||has_active_ingredient
3-phenyl-l-alanine||parenteral amino acid 15% combination no.1@15 %@intraven@intravenous solution||has_active_ingredient
sodium polyacrylate (8000 mw)||alfalfa 3 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / fucus vesiculosus 4 [hp_x] in 1 ml / hordeum vulgare top 4 [hp_x] in 1 ml / nasturtium aquaticum 4 [hp_x] in 1 ml / raphanus sativus 4 [hp_x] in 1 ml / triticum aestivum whole 4 [hp_x] in 1 ml / iodine 6 [hp_x] in 1 ml / ubidecarenone 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / manganese gluconate 8 [hp_x] in 1 ml / brown rice 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / paraffin 30 [hp_x] in 1 ml / ethylene glycol 30 [hp_x] in 1 ml / propyl alcohol 30 [hp_x] in 1 ml / palmitic acid 30 [hp_x] in 1 ml / dimethicone 30 [hp_x] in 1 ml / sodium polyacrylate (8000 mw) 30 [hp_x] in 1 ml / glutaral 30 [hp_x] in 1 ml / methyl acrylate 30 [hp_x] in 1 ml / anhydrous citric acid 30 [hp_x] in 1 ml / tartaric acid 30 [hp_x] in 1 ml / anthraquinone 30 [hp_x] in 1 ml / hydrogen peroxide 30 [hp_x] in 1 ml / glycolic acid 30 [hp_x] in 1 ml / ammonium thioglycolate 30 [hp_x] in 1 ml / sodium carbonate 30 [hp_x] in 1 ml / ethanolamine 30 [hp_x] in 1 ml / 2,5-diaminotoluene sulfate 30 [hp_x] in 1 ml / p-aminophenol 30 [hp_x] in 1 ml oral liquid [universaltox]||has_active_ingredient
ethanol-containing product||alcohol 350 g in 500 ml topical gel [coso health hand sanitizer green tea]||has_active_ingredient
1-hydroxyethane||alcohol 68 ml in 100 ml topical gel [anti-bacterial hand fresh cut lilacs]||has_active_ingredient
product containing colecalciferol (medicinal product)||active fe tablet||has_active_ingredient
carolina jessamine root||aconitum napellus 30 [hp_c] / aluminum oxide 30 [hp_c] / antimony trisulfide 30 [hp_c] / antimony potassium tartrate 30 [hp_c] / apis mellifera 30 [hp_c] / silver nitrate 30 [hp_c] / arnica montana 30 [hp_c] / arsenic trioxide 30 [hp_c] / atropa belladonna 30 [hp_c] / bryonia alba root 30 [hp_c] / calendula officinalis flowering top 30 [hp_c] / lytta vesicatoria 30 [hp_c] / activated charcoal 30 [hp_c] / matricaria recutita 30 [hp_c] / cinchona officinalis bark 30 [hp_c] / anamirta cocculus seed 30 [hp_c] / arabica coffee bean 30 [hp_c] / citrullus colocynthis fruit pulp 30 [hp_c] / drosera rotundifolia 30 [hp_c] / euphrasia stricta 30 [hp_c] / ferrosoferric phosphate 30 [hp_c] / gelsemium sempervirens root 30 [hp_c] / calcium sulfide 30 [hp_c] / histamine dihydrochloride 30 [hp_c] / hypericum perforatum whole 30 [hp_c] / strychnos ignatii seed 30 [hp_c] / ipecac 30 [hp_c] / potassium dichromate 30 [hp_c] / rhododendron tomentosum leafy twig 30 [hp_c] / lycopodium clavatum spore 30 [hp_c] / magnesium phosphate, dibasic trihydrate 30 [hp_c] / mercuric chloride 30 [hp_c] / sodium chloride 30 [hp_c] / strychnos nux-vomica seed 30 [hp_c] / phosphorus 30 [hp_c] / pulsatilla pratensis whole 30 [hp_c] / rancid beef 30 [hp_c] / toxicodendron pubescens leaf 30 [hp_c] / ruta graveolens flowering top 30 [hp_c] / silicon dioxide 30 [hp_c] / spongia officinalis skeleton, roasted 30 [hp_c] / delphinium staphisagria seed 30 [hp_c] / sulfur 30 [hp_c] / comfrey root 30 [hp_c] / tobacco leaf 30 [hp_c] / veratrum album root 30 [hp_c] oral pellet [family i kit]||has_active_ingredient
temozolomida||temozolomide-containing product in oral dose form||has_active_ingredient
benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||octocrylene 7 g in 100 ml / avobenzone 3 g in 100 ml / octisalate 5 g in 100 ml / homosalate 10 g in 100 ml topical cream [tinted moisturizer spf 30 broad spectrum]||has_active_ingredient
phenyl butyrate||berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / salicylic acid 30 [hp_x] in 1 ml / corticotropin 30 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / eugenol 30 [hp_x] in 1 ml / stearyl alcohol 30 [hp_x] in 1 ml / xylitol 30 [hp_x] in 1 ml / estrone 30 [hp_x] in 1 ml / benzoic acid 30 [hp_x] in 1 ml / chlorine 30 [hp_x] in 1 ml / potassium sorbate 30 [hp_x] in 1 ml / sorbitol 30 [hp_x] in 1 ml / resorcinol 30 [hp_x] in 1 ml / benzyl alcohol 30 [hp_x] in 1 ml / lactic acid, dl- 30 [hp_x] in 1 ml / isopropyl palmitate 30 [hp_x] in 1 ml / boric acid 30 [hp_x] in 1 ml / acetic acid 30 [hp_x] in 1 ml / phenyl butyrate 30 [hp_x] in 1 ml / petrolatum 30 [hp_x] in 1 ml / lead 30 [hp_x] in 1 ml oral liquid [chemdetox]||has_active_ingredient
oxybenzone [dup] (substance)||avobenzone 0.0003 g in 1 g / octisalate 0.0003 g in 1 g / zinc oxide 0.01 g in 1 g / octinoxate 0.071 g in 1 g / oxybenzone 0.02 g in 1 g topical lipstick [cy better lips balm humectante para labios con color fps 18 (pink star) - pink]||has_active_ingredient
fingolimod hydrochloride||fingolimod 0.25mg cap||has_active_ingredient
1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1h-indol-2-carboxylic acid||product containing only trandolapril 4 mg/1 each oral tablet||has_active_ingredient
product containing digitalis||arnica montana 3 [hp_x] in 1 ml / selenicereus grandiflorus stem 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / spigelia anthelmia 3 [hp_x] in 1 ml / digitalis 6 [hp_x] in 1 ml / potassium phosphate, dibasic 6 [hp_x] in 1 ml / prunus laurocerasus leaf 6 [hp_x] in 1 ml / tobacco leaf 6 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / amanita muscaria fruiting body 12 [hp_x] in 1 ml / gold trichloride 12 [hp_x] in 1 ml / nitroglycerin 12 [hp_x] in 1 ml / strychnos ignatii seed 12 [hp_x] in 1 ml / kalmia latifolia leaf 12 [hp_x] in 1 ml / latrodectus mactans 12 [hp_x] in 1 ml / valerian 12 [hp_x] in 1 ml oral liquid [cardioforce i]||has_active_ingredient
alcohol anhydrous||alcohol 177.35 ml in 40 topical cloth||has_active_ingredient
clonidine (as clonidine hydrochloride)||clonidine hcl 0.3 mg oral tablet||has_active_ingredient
trimethobenzamide (medication)||n-[[4-(2-dimethylaminoethoxy)phenyl]methyl]-3,4,5-trimethoxybenzamide||has_active_ingredient
cyclohexanol, 5-methyl-2-(1-methylethyl)-||(spl review) benzalkonium chloride 1.3 mg in 1 g / benzocaine 200 mg in 1 g / menthol 2.6 mg in 1 g / zinc cation 1.5 mg in 1 g topical cream [orajel 4x medicated for toothache and gum, cream]||has_active_ingredient
cochliobolus spicifer allergenic extract||cochliobolus spicifer allergenic extract 1000 unt/ml injectable solution||has_active_ingredient
midazolam (as hydrochloride)||midazolam hcl 1 mg/ml injection vial (ml)||has_active_ingredient
product containing ibuprofen (medicinal product)||ibuprofen 400mg tablet (product)||has_active_ingredient
ethyl alcohol product||alcohol 77 ml in 100 ml topical gel [be clean antiseptic hand gel]||has_active_ingredient
dimethyl carbinol||isopropyl alcohol 91 ml in 100 ml topical liquid [isopropyl alcohol 91 percent readyincase]||has_active_ingredient
6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione||clioquinol and fluocinolone only product||has_active_ingredient
phenylephrine (as hydrochloride)||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 100 mg / phenylephrine hydrochloride 5 mg oral tablet||has_active_ingredient
arsénico trióxido||wormwood 15 [hp_x] in 1 ml / anacardium occidentale fruit 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / camphor (natural) 15 [hp_x] in 1 ml / matricaria recutita 15 [hp_x] in 1 ml / black cohosh 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / arabica coffee bean 15 [hp_x] in 1 ml / cypripedium parvifolum root 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / hops 15 [hp_x] in 1 ml / hyoscyamus niger 15 [hp_x] in 1 ml / strychnos ignatii seed 15 [hp_x] in 1 ml / potassium bromide 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / passiflora incarnata flowering top 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / scutellaria lateriflora 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / passiflora incarnata flowering top 8 [hp_x] in 1 ml / valerian 8 [hp_x] in 1 ml / passiflora incarnata flowering top 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml oral liquid [insomnia]||has_active_ingredient
racemic lactic acid||panax quinquefolius whole 15 [hp_c] in 1 ml / epifagus virginiana 15 [hp_c] in 1 ml / jacaranda caroba flower 15 [hp_c] in 1 ml / lactic acid, dl- 15 [hp_c] in 1 ml / centella asiatica 100 [hp_c] in 1 ml / hydrogen cyanide 100 [hp_c] in 1 ml oral liquid [musco mxt]||has_active_ingredient
allergenic extracts dust mite american house||ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / candida albicans 0.00008 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_ingredient
neurospora intermedia||neurospora intermedia 0.1 g in 1 ml intradermal solution||has_active_ingredient
tribasic calcium phosphate (substance)||aconitum napellus 10 [hp_x] in 118 ml / alfalfa 10 [hp_x] in 118 ml / silver nitrate 10 [hp_x] in 118 ml / arsenic trioxide 10 [hp_x] in 118 ml / gold 10 [hp_x] in 118 ml / avena sativa flowering top 10 [hp_x] in 118 ml / barium carbonate 10 [hp_x] in 118 ml / tribasic calcium phosphate 10 [hp_x] in 118 ml / chamomile 10 [hp_x] in 118 ml / gelsemium sempervirens root 10 [hp_x] in 118 ml / nitroglycerin 10 [hp_x] in 118 ml / strychnos ignatii seed 10 [hp_x] in 118 ml / potassium arsenite anhydrous 10 [hp_x] in 118 ml / potassium phosphate, dibasic 10 [hp_x] in 118 ml / hops 10 [hp_x] in 118 ml / hydrochloric acid 10 [hp_x] in 118 ml / sodium phosphate, dibasic, heptahydrate 10 [hp_x] in 118 ml / passiflora incarnata flower 10 [hp_x] in 118 ml / phosphorus 10 [hp_x] in 118 ml / delphinium staphisagria seed 10 [hp_x] in 118 ml / datura stramonium 10 [hp_x] in 118 ml oral liquid [anxietrex anxiety relief formula]||has_active_ingredient
california black oak pollen extract||quercus agrifolia pollen 6666.6666 [pnu] in 1 ml / quercus kelloggii pollen 6666.6666 [pnu] in 1 ml / quercus garryana pollen 6666.6666 [pnu] in 1 ml intradermal solution [western oak pollen mix]||has_active_ingredient
amitiza||lubiprostone 24mcg oral cap||has_active_ingredient
sweet gum pollen extract||liquidambar styraciflua pollen 0.05 g in 1 ml intradermal injection, solution||has_active_ingredient
myfembree||estradiol 1mg oral tablet||has_active_ingredient
lycopodium clavatum spore||beta vulgaris 3 [hp_x] in 1 ml / peumus boldus leaf 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / petroselinum crispum 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / aspartame 30 [hp_x] in 1 ml / benzalkonium chloride 30 [hp_x] in 1 ml / formaldehyde 30 [hp_x] in 1 ml / methylene chloride 30 [hp_x] in 1 ml / methylparaben 30 [hp_x] in 1 ml / propylparaben 30 [hp_x] in 1 ml / sodium benzoate 30 [hp_x] in 1 ml / sodium citrate 30 [hp_x] in 1 ml / titanium dioxide 30 [hp_x] in 1 ml / zinc oxide 30 [hp_x] in 1 ml oral liquid [addiclenz]||has_active_ingredient
wool grease||zinc oxide 0.125 g in 1 g / lanolin 0.5 g in 1 g topical paste [baby bum]||has_active_ingredient
methyl o-hydroxybenzoate||menthol 10 g in 100 g / menthyl salicylate, (+/-)- 30 g in 100 g / camphor (natural) 4 g in 100 g topical cream [pain relief rub]||has_active_ingredient
mesylate, 2-bromoergocryptine||bromocriptine (as bromocriptine mesilate) 2.5 mg oral tablet||has_active_ingredient
peridex||ketoconazole 2 mg in 1 ml / chlorhexidine gluconate 2 mg in 1 ml / salicyloyl phytosphingosine 0.2 mg in 1 ml topical solution [phyto chx ket flush]||has_active_ingredient
acetamide, n-(4-hydroxyphenyl)-||acetaminophen/dextromethorphan hydrobromide/doxylamine succinate 650 mg/30 ml-30 mg/30 ml-12.5 mg/30 ml oral solution [good sense nighttime cold & flu]||has_active_ingredient
guaifenesin - chemical||gnp sinus relief pressure & pain maximum strength caplet||has_active_ingredient
hieracium pilosella whole||hieracium pilosella whole 4 [hp_x] in 20 ml / equisetum arvense top 4 [hp_x] in 20 ml / arctostaphylos uva-ursi leaf 4 [hp_x] in 20 ml / juniperus communis whole 4 [hp_x] in 20 ml / cytisus scoparius flowering top 4 [hp_x] in 20 ml / silver 12 [hp_x] in 20 ml oral liquid [unda 7]||has_active_ingredient
tree pollen-red cedar||juniperus virginiana pollen 1 g in 20 ml percutaneous injection, solution [red cedar pollen]||has_active_ingredient
dichlothiazide||hydrochlorothiazide-triamterene, 50 mg-75 mg oral tablet||has_active_ingredient
allergenic extract, grass, kentucky blue||phleum pratense pollen 5000 [pnu] in 1 ml / dactylis glomerata pollen 5000 [pnu] in 1 ml / poa pratensis pollen 5000 [pnu] in 1 ml / agrostis gigantea pollen 5000 [pnu] in 1 ml / anthoxanthum odoratum pollen 5000 [pnu] in 1 ml subcutaneous injection, solution [5 grass mix]||has_active_ingredient
menthol||phytolacca americana root 1 [hp_x] in 1 g / comfrey root 3 [hp_x] in 1 g / bellis perennis 6 [hp_x] in 1 g / ledum palustre twig 6 [hp_x] in 1 g / ruta graveolens flowering top 6 [hp_x] in 1 g / magnesium phosphate, dibasic trihydrate 9 [hp_x] in 1 g / silicon dioxide 9 [hp_x] in 1 g / menthol 700 g in 1 g topical gel [muscle ice]||has_active_ingredient
homosalate (substance)||avobenzone 2.0 ml in 100 ml / homosalate 6.5 ml in 100 ml / octinoxate 7.0 ml in 100 ml / octisalate 5.0 ml in 100 ml / oxybenzone 3.0 ml in 100 ml topical lotion [tahitian noni sunscreen spf 30]||has_active_ingredient
antibacterial oritavancin||oritavancin (product)||has_active_ingredient
hydroxyzine hcl [anxiolytic]||product containing only hydroxyzine hydrochloride 50 mg/1 each oral tablet||has_active_ingredient
carisoprodol (product)||carisoprodol 350mg oral tablet||has_active_ingredient
wool grease (substance)||lanolin 30 % topical ointment||has_active_ingredient
aluminum zirconium tetrachlorohydrex gly||aluminum zirconium tetrachlorohydrex gly 19.2 g in 100 g topical stick [degree cool rush antiperspirant and deodorant]||has_active_ingredient
matmate||ensulizole 39 mg in 1 g / titanium dioxide 49 mg in 1 g / zinc oxide 49 mg in 1 g / octocrylene 30 mg in 1 g / octinoxate 74 mg in 1 g topical cream [bling day everyday sunscreen broad spectrum spf 50]||has_active_ingredient
vitamin d||vitamin a 1500 [iu] in 1 ml / ascorbic acid 35 mg in 1 ml / vitamin d 400 [iu] in 1 ml / sodium fluoride 0.25 mg in 1 ml oral solution/ drops [tri-vitamin with fluoride]||has_active_ingredient
alkyl dimethylbenzyl ammonium chloride||benzalkonium chloride 0.65 g in 500 ml topical liquid [skin aid medics antibacterial citrus rush moisturizing]||has_active_ingredient
adrenocorticotrophin||.gamma.-aminobutyric acid 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / norepinephrine 6 [hp_x] in 1 ml / serotonin hydrochloride 6 [hp_x] in 1 ml / corticotropin 8 [hp_x] in 1 ml / anacardium occidentale fruit 30 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / barium carbonate 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / tribasic calcium phosphate 30 [hp_c] in 1 ml / hyoscyamus niger 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / datura stramonium 30 [hp_c] in 1 ml oral liquid [neuro-pro t007]||has_active_ingredient
adakveo||crizanlizumab-containing product in parenteral dose form||has_active_ingredient
strychnos ignatii seed||bladderwrack/calcarea carbonica/cayenne/ferrum metallicum/graphite/ignatia amara/running clubmoss 12 x-12 x-12 x-12 x-12 x-12 x-12 x oral tablet, disintegrating [appetite control]||has_active_ingredient
clonazepam-containing product||product containing only clonazepam 0.5 milligram/1 each oral tablet||has_active_ingredient
allylisopropyl malonylurea||product containing only aprobarbital (medicinal product)||has_active_ingredient
box elder pollen||poa pratensis pollen 160 [bau] in 1 ml / ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.00008 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_ingredient
dipotassium hydrogen monophosphate||sodium sulfate 12 [hp_x] in 1 ml / arnica montana flower 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / calcium phosphate 12 [hp_x] in 1 ml / calcium sulfate 12 [hp_x] in 1 ml / ferrum phosphoricum 12 [hp_x] in 1 ml / potassium chloride 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / potassium phosphate, dibasic 12 [hp_x] in 1 ml / potassium sulfate 12 [hp_x] in 1 ml / sodium phosphate 12 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml oral liquid||has_active_ingredient
arnica montana whole extract||calcium sulfide 12 [hp_x] in 1 g / silicon dioxide 12 [hp_x] in 1 g / sulfur 12 [hp_x] in 1 g / echinacea angustifolia root 3 [hp_x] in 1 g / ichthammol 2 [hp_x] in 1 g / arnica montana 3 [hp_x] in 1 g / calendula officinalis flowering top 3 [hp_x] in 1 g topical salve [prid salve]||has_active_ingredient
natural camphor||camphor (natural) 1 [hp_q] in 1 ml / graphite 1 [hp_q] in 1 ml / strychnos ignatii seed 7 [hp_c] in 1 ml / datura stramonium 2 [hp_q] in 1 ml / ruta graveolens flowering top 7 [hp_c] in 1 ml / adenosine triphosphate 7 [hp_x] in 1 ml / gold 1 [hp_q] in 1 ml sublingual solution/ drops [g14 parasymp-met]||has_active_ingredient
oxibenzona||avobenzone 0.0003 g in 1 g / octisalate 0.0003 g in 1 g / zinc oxide 0.01 g in 1 g / octinoxate 0.071 g in 1 g / oxybenzone 0.02 g in 1 g topical lipstick [cy better lips balm humectante para labios con color fps 18 (pure oxygen) - beige]||has_active_ingredient
äthanol||alcohol 80 ml in 100 ml topical liquid [econo-gel ea hand sanitizer]||has_active_ingredient
product containing hydrocortisone (medicinal product)||hydrocortisone@1 %@topical@ointment (gram)||has_active_ingredient
adrenaline (substance)||epinephrine 0.1 mg in 1 ml endotracheal injection, solution [epinephrine]||has_active_ingredient
1,2-propanediol, 3-(2-methoxyphenoxy)-||dextromethorphan hbr 3 mg/ml / guaifenesin 20 mg/ml oral suspension||has_active_ingredient
ferrous fumarate (product)||product containing ethinylestradiol and ferrous fumarate and norgestrel (medicinal product)||has_active_ingredient
2-ethylhexyl-4-methoxycinnamate||octinoxate 0.375 g in 5 g / octisalate 0.2 g in 5 g / oxybenzone 0.2 g in 5 g topical cream [lbel paris regression jour]||has_active_ingredient
homosalate||avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 100 mg in 1 ml topical cream [sun bum face 50 sunscreen]||has_active_ingredient
ornithogalum umbellatum extract||prunus cerasifera flower 30 [hp_c] in 1 ml / clematis vitalba flower 30 [hp_c] in 1 ml / impatiens glandulifera flower 30 [hp_c] in 1 ml / helianthemum nummularium flower 30 [hp_c] in 1 ml / ornithogalum umbellatum 30 [hp_c] in 1 ml oral liquid [rescue 5]||has_active_ingredient
hydrogen peroxide (h2o2)||pur-oxy teat dip 1.7 % / 0.5 % topical solution||has_active_ingredient
alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2h-1-benzopyran-2-methanol||nebivolol (as hydrochloride)||has_active_ingredient
copper product||bos taurus parathyroid gland 6 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral liquid [parathyroplex]||has_active_ingredient
sodium 2-mercaptoethanesulphonate||mesna 200mg injection solution 2ml ampoule||has_active_ingredient
frangulae cortex||garlic 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / methionine 6 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml / selenium dioxide 8 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml oral liquid [metalogin]||has_active_ingredient
cyclohexanol, 5-methyl-2-(1-methylethyl)-||dexpanthenol 0.002 in 500 g / menthol 0.003 in 500 g / salicylic acid 0.0025 in 500 g topical shampoo [hasol anti hair loss]||has_active_ingredient
diclofenac sodium [eye] (product)||diclofenac sodium 100 mg oral tablet, film coated, extended release||has_active_ingredient
octyl salicylate (substance)||homosalate 2.4 mg in 40 ml / octinoxate 2.72 mg in 40 ml / octisalate 1 mg in 40 ml / octocrylene 0.49 mg in 40 ml topical cream [sun project light sun essence]||has_active_ingredient
octocrilene (product)||octinoxate 2277 mg in 75 ml / octocrylene 3926 mg in 75 ml / oxybenzone 1570 mg in 75 ml / zinc oxide 7537 mg in 75 ml topical emulsion [cle de peau beaute uv protective for body]||has_active_ingredient
goldenseal root||aralia racemosa root 12 [hp_x] in 59 ml / periplaneta americana 12 [hp_x] in 59 ml / blatta orientalis 12 [hp_x] in 59 ml / chelidonium majus 12 [hp_x] in 59 ml / goldenseal 12 [hp_x] in 59 ml / flax seed 12 [hp_x] in 59 ml / phosphorus 12 [hp_x] in 59 ml / sulfur 12 [hp_x] in 59 ml / trifolium pratense flower 12 [hp_x] in 59 ml oral liquid [dust mite and roach allergy relief]||has_active_ingredient
octyl methoxycinnamate (substance)||octinoxate 0.068 g in 1 g topical lipstick [esika pro hd longwear long-lasting high-definition color spf 20 rosa viva - pink]||has_active_ingredient
hydrocodone bitartrate (product)||vicodin es, 300 mg-7.5 mg oral tablet||has_active_ingredient
vitamin b3||nephron-fa, vitamin b complex with c, folic acid, iron and docusate oral tablet||has_active_ingredient
sulphur||milk thistle 3 [hp_x] in 1 ml / chelidonium majus 4 [hp_x] in 1 ml / lycopodium clavatum spore 4 [hp_x] in 1 ml / taraxacum officinale 4 [hp_x] in 1 ml / avena sativa flowering top 6 [hp_x] in 1 ml / cynara scolymus leaf 6 [hp_x] in 1 ml / methylcobalamin 6 [hp_x] in 1 ml / menadione 6 [hp_x] in 1 ml / .alpha.-lipoic acid 8 [hp_x] in 1 ml / cinchona officinalis bark 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / acetaldehyde 10 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 10 [hp_x] in 1 ml / cholesterol 10 [hp_x] in 1 ml / formic acid 10 [hp_x] in 1 ml / histamine dihydrochloride 10 [hp_x] in 1 ml / malic acid 10 [hp_x] in 1 ml / sodium diethyl oxalacetate 10 [hp_x] in 1 ml / sulfur 13 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 28 [hp_x] in 1 ml / orotic acid monohydrate 7 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [detox i]||has_active_ingredient
chloride, benzethonium||benzethonium chloride 0.2 g in 100 ml topical liquid [hand kleen foaming instant hand sanitizer]||has_active_ingredient
oyster shell calcium carbonate, crude||capsicum 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium oxide 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium oxide 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lanthanum oxide 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / niobium 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium 12 [hp_x] in 1 ml / samarium oxide 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / tantalum 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / corticotropin 30 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 ml / sus scrofa pituitary gland 30 [hp_x] in 1 ml / anguilla rostrata blood serum 30 [hp_x] in 1 ml / tartaric acid 30 [hp_x] in 1 ml / theridion curassavicum 30 [hp_x] in 1 ml / sus scrofa thyroid 30 [hp_x] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / bromine 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / carbo animalis 30 [hp_c] in 1 ml / activated charcoal 30 [hp_c] in 1 ml / human breast tumor cell 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / potassium dichromate 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / sodium phosphate, dibasic, heptahydrate 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / claviceps purpurea sclerotium 30 [hp_c] in 1 ml / strychnos wallichiana bark 30 [hp_c] in 1 ml / sulfuric acid 30 [hp_c] in 1 ml / allylthiourea 30 [hp_c] in 1 ml / thuja occidentalis leafy twig 30 [hp_c] in 1 ml / veratrum album root 30 [hp_c] in 1 ml / alcohol, x-ray exposed (1000 rad) 30 [hp_c] in 1 ml oral liquid [1 detoxification]||has_active_ingredient
product containing sodium fluoride||potassium nitrate 50 mg in 1 g / sodium fluoride 1.1 mg in 1 g dental paste, dentifrice [colgate sensitive smartfoam with whitening]||has_active_ingredient
sodium fluoride (substance)||sodium fluoride 27.2 mg in 1 mg topical gel [pcxx one minte gel grape explosion]||has_active_ingredient
amylobarbitone||5-ethyl-5-(3-methylbutyl)barbituric acid||has_active_ingredient
paroxetine hydrochloride, hemihydrate||paroxetine hcl@40 mg@oral@tablet||has_active_ingredient
ax||amoxycillin trihydrate 400mg tablet disperdose for oral suspension||has_active_ingredient
analgesics tramadol hydrochloride||acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet||has_active_ingredient
phosphorus-containing product||adenosine cyclic phosphate 6 [hp_x] in 30 ml / turnera diffusa leafy twig 6 [hp_x] in 30 ml / sus scrofa adrenal gland 30 [hp_x] in 30 ml / sus scrofa pituitary gland 30 [hp_x] in 30 ml / sus scrofa hypothalamus 30 [hp_x] in 30 ml / melatonin 30 [hp_x] in 30 ml / sus scrofa testicle 30 [hp_x] in 30 ml / sus scrofa pancreas 30 [hp_x] in 30 ml / phosphorus 6 [hp_x] in 30 ml / sus scrofa pineal gland 30 [hp_x] in 30 ml / sus scrofa thymus 30 [hp_x] in 30 ml / thyroid 30 [hp_x] in 30 ml oral solution/ drops [guna-male]||has_active_ingredient
2-2etn-2mephacn||lidocaine 3400 mg in 85 g / benzethonium chloride 170 mg in 85 g topical aerosol, spray [green guard super stat blood clotting first aid]||has_active_ingredient
baptisia tinctoria root extract||measles virus 30 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / influenza a virus 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / antimony potassium tartrate 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / matricaria chamomilla 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / trifolium pratense flower 15 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [viral]||has_active_ingredient
aconitum napellus||aconitum napellus 12 [hp_x] in 1 g oral pellet [aconitum napellus]||has_active_ingredient
métronidazole||metronidazole 500 mg oral tablet||has_active_ingredient
meclizine dihydrochloride monohydrate||rite aid motion sickness relief 25mg chewable tablet||has_active_ingredient
neomycin sulfate [ear] (product)||bacitracin zinc 400 [iu] in 1 g / neomycin sulfate 3.5 mg in 1 g / polymyxin b sulfate 5000 [iu] in 1 g topical ointment [antibiotic]||has_active_ingredient
4'-hydroxyacetanilide||acetaminophen 500 mg / diphenhydramine 12.5 mg oral capsule, coated [percogesic extra strength]||has_active_ingredient
oxybenzene||phenol 6 [hp_x] oral pellet||has_active_ingredient
avobenzone (substance)||avobenzone 1.5 g in 50 g / octisalate 1.5 g in 50 g / octocrylene 2.5 g in 50 g topical cream [botanics shine away mattifying day cream sunscreen broad spectrum spf 15]||has_active_ingredient
sus scrofa pituitary gland preparation||alpha 8 [hp_x] in 30 ml / cervus elaphus velvet 6 [hp_x] in 30 ml / pork liver 6 [hp_x] in 30 ml / somatropin 12 [hp_x] in 30 ml / dalotuzumab 12 [hp_x] in 30 ml / insulin-like growth factor-2 12 [hp_x] in 30 ml / sus scrofa pituitary gland, posterior 5 [hp_c] in 30 ml oral spray [hgh plus]||has_active_ingredient
primaquin||primaquine only product in oral dose form||has_active_ingredient
salicylic acid [acne] (product)||salicylic acid 0.17 g in 9 ml topical liquid||has_active_ingredient
acacia pollen allergen (substance)||echinacea, unspecified 3 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / fenugreek leaf 3 [hp_x] in 1 ml / acacia pollen 30 [hp_x] in 1 ml / fraxinus pennsylvanica pollen 30 [hp_x] in 1 ml / betula occidentalis pollen 30 [hp_x] in 1 ml / acer negundo pollen 30 [hp_x] in 1 ml / juniperus virginiana pollen 30 [hp_x] in 1 ml / populus deltoides pollen 30 [hp_x] in 1 ml / taxodium distichum pollen 30 [hp_x] in 1 ml / ulmus americana pollen 30 [hp_x] in 1 ml / celtis occidentalis pollen 30 [hp_x] in 1 ml / carya ovata pollen 30 [hp_x] in 1 ml / ligustrum vulgare pollen 30 [hp_x] in 1 ml / acer saccharum pollen 30 [hp_x] in 1 ml / acer rubrum pollen 30 [hp_x] in 1 ml / morus rubra pollen 30 [hp_x] in 1 ml / quercus virginiana pollen 30 [hp_x] in 1 ml / quercus rubra pollen 30 [hp_x] in 1 ml / quercus alba pollen 30 [hp_x] in 1 ml / carya illinoinensis pollen 30 [hp_x] in 1 ml / pinus strobus pollen 30 [hp_x] in 1 ml / populus alba pollen 30 [hp_x] in 1 ml / liquidambar styraciflua pollen 30 [hp_x] in 1 ml / platanus occidentalis pollen 30 [hp_x] in 1 ml / juglans nigra pollen 30 [hp_x] in 1 ml / salix nigra pollen 30 [hp_x] in 1 ml / baccharis halimifolia pollen 30 [hp_x] in 1 ml / amaranthus palmeri pollen 30 [hp_x] in 1 ml / xanthium strumarium pollen 30 [hp_x] in 1 ml / rumex crispus pollen 30 [hp_x] in 1 ml / chenopodium album pollen 30 [hp_x] in 1 ml / iva annua pollen 30 [hp_x] in 1 ml / artemisia vulgaris pollen 30 [hp_x] in 1 ml / urtica dioica pollen 30 [hp_x] in 1 ml / amaranthus retroflexus pollen 30 [hp_x] in 1 ml / plantago lanceolata pollen 30 [hp_x] in 1 ml / ambrosia trifida pollen 30 [hp_x] in 1 ml / ambrosia artemisiifolia pollen 30 [hp_x] in 1 ml / paspalum notatum pollen 30 [hp_x] in 1 ml / cynodon dactylon pollen 30 [hp_x] in 1 ml / poa pratensis pollen 30 [hp_x] in 1 ml / festuca pratensis pollen 30 [hp_x] in 1 ml / sorghum halepense pollen 30 [hp_x] in 1 ml / lolium perenne pollen 30 [hp_x] in 1 ml / dactylis glomerata pollen 30 [hp_x] in 1 ml / agrostis gigantea pollen 30 [hp_x] in 1 ml oral liquid [allergena zone 2 kids]||has_active_ingredient
light anhydrous silicic acid||arnica montana 3 [hp_x] in 1 ml / echinacea 3 [hp_x] in 1 ml / comfrey root 30 [hp_x] in 1 ml / hekla lava 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / calcium fluoride 30 [hp_x] in 1 ml / tribasic calcium phosphate 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / silicon dioxide 200 [hp_x] in 1 ml / boron gluconate 12 [hp_x] in 1 ml oral liquid [calcium composition]||has_active_ingredient
l-isoleucine (substance)||trophamine 6% solution for injection||has_active_ingredient
lassar's paste||titanium dioxide 79 mg in 1 ml / zinc oxide 67 mg in 1 ml topical liquid [total eye 3-in-1 renewal therapy spf 35]||has_active_ingredient
lidocaine hcl||bupivacaine hydrochloride 0.09 g in 30 ml / ketorolac tromethamine 0.09 g in 30 ml / chitosan low molecular weight (20-200 mpa.s) 0.03 g in 30 ml / lidocaine hydrochloride 50 g in 30 ml topical spray, metered [chi-myst resolve topical]||has_active_ingredient
siltuximab (product)||siltuximab 400 mg injection [sylvant]||has_active_ingredient
testosterones||testosterone 20.25 mg in 1.25 g topical gel, metered||has_active_ingredient
pure oxygen||oxygen 99 l in 99 l respiratory (inhalation) gas||has_active_ingredient
metronidazole product||metronidazole 500mg tab,ud||has_active_ingredient
19-norethisterone||ethinyl estradiol and norethindrone product||has_active_ingredient
strychnos nux-vomica seed extract||arnica montana 30 [hp_x] in 1 ml / gold 30 [hp_x] in 1 ml / selenicereus grandiflorus stem 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / strychnos nux-vomica seed 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / solidago virgaurea flowering top 30 [hp_x] in 1 ml oral liquid [hypert hp]||has_active_ingredient
aqua fortis/nitric acid||antimony trisulfide 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / causticum 15 [hp_x] in 1 g / solanum dulcamara top 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / mercuric sulfide 15 [hp_x] in 1 g / sodium carbonate 15 [hp_x] in 1 g / nitric acid 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / juniperus sabina leafy twig 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g / silicon dioxide 15 [hp_x] in 1 g / delphinium staphisagria seed 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / thuja occidentalis leafy twig 15 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g oral pellet [warts - moles - skin tags]||has_active_ingredient
ethanol-containing product||alcohol 75 in 100 topical cloth [disinfectant wipes]||has_active_ingredient
pteroyl-l-glutamate||ascorbic acid/biotin/cyanocobalamin/folic acid/niacinamide/pantothenic acid/pyridoxine/riboflavin/thiamine 60 mg-300 mcg-6 mcg-1 mg-20 mg-10 mg-10 mg-1.7 mg-1.5 mg oral tablet [vp-vite rx]||has_active_ingredient
trimethoprim sulfate||polymyxin b 10000 unt/ml / tmp 1 mg/ml ophthalmic solution [polytrim]||has_active_ingredient
octinoxate||octinoxate 0.05 g in 1 ml / oxybenzone 0.02 g in 1 ml topical emulsion [esika pro hydro-nutritive foundation spf 15 (rosa 3) - pink]||has_active_ingredient
acetamide, n-(2-(5-methoxy-1h-indol-3-yl)ethyl)-||melatonin 6 [hp_x] in 1 ml oral liquid||has_active_ingredient
nitrous acid, sodium salt||sodium nitrite (substance)||has_active_ingredient
product containing ezetimibe (medicinal product)||ezetimiba||has_active_ingredient
bouteloua gracilis pollen extract||bouteloua gracilis pollen extract 20,000 unt/ml injectable solution||has_active_ingredient
oxide, zinc||titanium dioxide 1.92 g in 40 g / zinc oxide 0.768 g in 40 g / arbutin 0.8 g in 40 g / adenosine 0.016 g in 40 g / octinoxate 1.2 g in 40 g / octisalate 0.8 g in 40 g topical cream [superplus beblesh balm triple functions spf25 pa 2plus]||has_active_ingredient
product containing degarelix||firmagon kit||has_active_ingredient
sus scrofa adrenal gland preparation||bos taurus adrenal gland 30 [kp_c] in 1 ml / sus scrofa adrenal gland 30 [kp_c] in 1 ml / .alpha.-ketoglutaric acid 30 [kp_c] in 1 ml / .alpha.-lipoic acid 30 [kp_c] in 1 ml / ascorbic acid 30 [kp_c] in 1 ml / berberis vulgaris root 200 [kp_c] in 1 ml / activated charcoal 30 [kp_c] in 1 ml / centaurea benedicta 30 [kp_c] in 1 ml / milk thistle 30 [kp_c] in 1 ml / colchicum autumnale bulb 6 [hp_c] in 1 ml / galium aparine 30 [kp_c] in 1 ml / binetrakin 200 [kp_c] in 1 ml / beef kidney 200 [kp_c] in 1 ml / pork kidney 200 [kp_c] in 1 ml / beef liver 200 [kp_c] in 1 ml / pork liver 200 [kp_c] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / bos taurus lymph 200 [kp_c] in 1 ml / sus scrofa lymph 200 [kp_c] in 1 ml / bos taurus mesenchyme 200 [kp_c] in 1 ml / sus scrofa mesenchyme 200 [kp_c] in 1 ml / strychnos nux-vomica seed 200 [kp_c] in 1 ml / taraxacum officinale 200 [kp_c] in 1 ml / bos taurus thymus 200 [kp_c] in 1 ml / sus scrofa thymus 200 [kp_c] in 1 ml / bos taurus tonsil 200 [kp_c] in 1 ml / sus scrofa tonsil 200 [kp_c] in 1 ml / thyroid, bovine 200 [kp_c] in 1 ml / thyroid, porcine 200 [kp_c] in 1 ml oral spray [systemic detox]||has_active_ingredient
hydroquinone (medication)||hydroquinone 4 g in 100 g topical emulsion||has_active_ingredient
betamethasone sodium phosphate (substance)||betamethasone acetate 3mg/1ml, betamethasone sodium phosphate 3mg/1ml suspension for injection||has_active_ingredient
bos taurus pituitary gland||arnica montana 6 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / turnera diffusa leafy twig 3 [hp_x] in 1 ml / asian ginseng 3 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / herring sperm dna 9 [hp_x] in 1 ml / saccharomyces cerevisiae rna 9 [hp_x] in 1 ml / tribulus terrestris root 3 [hp_x] in 1 ml / cervus elaphus horn oil 6 [hp_x] in 1 ml / bos taurus pituitary gland 5 [hp_c] in 1 ml oral spray [problen dna rna rejuvenation]||has_active_ingredient
glipizide (medication)||glipizide 10mg oral tablet||has_active_ingredient
aluminum zirconium tetrachlorohydrex gly||aluminum zirconium tetrachlorohydrex gly 15.2 g in 100 g topical stick [dove men plus care elements mineral and sage antiperspirant]||has_active_ingredient
menthol, unspecified form||menthol and methyl salicylate only product in cutaneous dose form||has_active_ingredient
alcohol||alcohol 68 ml in 68 ml topical gel [hand sanitizer ocean breeze]||has_active_ingredient
achillea mellefolium extract||micrurus corallinus venom 35 [hp_x] in 1 ml / horse chestnut 20 [hp_x] in 1 ml / aloe 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / calcium fluoride 20 [hp_x] in 1 ml / capsicum 20 [hp_x] in 1 ml / collinsonia canadensis root 20 [hp_x] in 1 ml / crotalus horridus horridus venom 20 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 20 [hp_x] in 1 ml / hydrofluoric acid 20 [hp_x] in 1 ml / hypericum perforatum 20 [hp_x] in 1 ml / lachesis muta venom 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / achillea millefolium 20 [hp_x] in 1 ml / naja naja venom 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / paeonia officinalis root 20 [hp_x] in 1 ml / plantago major 20 [hp_x] in 1 ml / quercus robur nut 20 [hp_x] in 1 ml / krameria lappacea root 20 [hp_x] in 1 ml / vipera berus venom 21 [hp_x] in 1 ml / echinacea, unspecified 11 [hp_x] in 1 ml / solidago virgaurea flowering top 11 [hp_x] in 1 ml / urtica urens 11 [hp_x] in 1 ml oral liquid [hemorrhoids]||has_active_ingredient
titanium oxide||titanium dioxide 70 mg in 1 ml / zinc oxide 60 mg in 1 ml topical lotion [neostrata sheer physical protection sunscreen broad spectrum spf 50]||has_active_ingredient
golden seal||goldenseal 5 [hp_x] in 1 ml / berberis vulgaris root bark 6 [hp_x] in 1 ml / sodium borate 6 [hp_x] in 1 ml / sucrose 6 [hp_x] in 1 ml / caffeine 6 [hp_x] in 1 ml / gallic acid monohydrate 6 [hp_x] in 1 ml / indole 6 [hp_x] in 1 ml / garlic 8 [hp_x] in 1 ml / echinacea angustifolia 8 [hp_x] in 1 ml / ferula assa-foetida resin 8 [hp_x] in 1 ml / acetaldehyde 8 [hp_x] in 1 ml / estrone 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / ustilago maydis 12 [hp_x] in 1 ml / saccharomyces cerevisiae 60 [hp_x] in 1 ml oral liquid [candida plus]||has_active_ingredient
1-[[[(1 r)-1-[3-[(1e)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid||montelukast only product||has_active_ingredient
diphenhydramine hydrochloride [antihistamine] (product)||walgreens nighttime allergy relief 25mg caplet||has_active_ingredient
allergenic extract, fungi, aspergillus fumigatus||dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / felis catus hair 400 [bau] in 1 ml / cladosporium cladosporioides 0.01 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / aspergillus fumigatus 0.01 g in 1 ml subcutaneous injection, solution||has_active_ingredient
tsuga canadensis flower bud||tsuga canadensis bark 9 [hp_c] in 9 [hp_c] / tsuga canadensis flower bud 9 [hp_c] in 9 [hp_c] oral pellet [abies canadensis]||has_active_ingredient
quercus velutina pollen extract||quercus velutina pollen 1 g in 20 ml subcutaneous injection, solution [black oak pollen]||has_active_ingredient
antimony trisulfide||aconitum napellus whole 30 [hp_c] in 1 ml / semecarpus anacardium juice 30 [hp_c] in 1 ml / antimony trisulfide 30 [hp_c] in 1 ml / barium carbonate 12 [hp_c] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / calcium silicate 12 [hp_x] in 1 ml / cicuta virosa root 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml oral spray [overwhelmed]||has_active_ingredient
acidum nicotinicum||vitafol caplet||has_active_ingredient
product containing sodium bicarbonate||k+ bitartrate 900 mg / nahco3 600 mg rectal suppository||has_active_ingredient
rhodotorula mucilaginosa allergenic extract||rhodotorula mucilaginosa allergenic extract 10000 unt/ml injectable solution||has_active_ingredient
lycopodium clavatum spore||activated charcoal 12 [hp_x] / lycopodium clavatum spore 30 [hp_x] / strychnos nux-vomica seed 30 [hp_x] / matricaria chamomilla 6 [hp_x] / cinchona officinalis bark 6 [hp_x] / anamirta cocculus seed 12 [hp_x] / ipecac 6 [hp_x] / delphinium staphisagria seed 12 [hp_x] oral tablet [quitters relief digestion]||has_active_ingredient
sheep sorrel pollen extract||echinacea purpurea 1 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 1 [hp_x] in 1 ml / verbascum thapsus 3 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / alfalfa 9 [hp_x] in 1 ml / ulmus americana pollen 9 [hp_x] in 1 ml / acer pseudoplatanus pollen 9 [hp_x] in 1 ml / fraxinus americana pollen 9 [hp_x] in 1 ml / fagus sylvatica flowering top 9 [hp_x] in 1 ml / juglans nigra pollen 9 [hp_x] in 1 ml / salix nigra pollen 9 [hp_x] in 1 ml / acer negundo pollen 9 [hp_x] in 1 ml / populus deltoides subsp. deltoides pollen 9 [hp_x] in 1 ml / ambrosia acanthicarpa pollen 9 [hp_x] in 1 ml / ambrosia trifida pollen 9 [hp_x] in 1 ml / solidago virgaurea pollen 9 [hp_x] in 1 ml / poa pratensis pollen 9 [hp_x] in 1 ml / dactylis glomerata pollen 9 [hp_x] in 1 ml / betula occidentalis pollen 9 [hp_x] in 1 ml / trifolium pratense pollen 9 [hp_x] in 1 ml / quercus rubra pollen 9 [hp_x] in 1 ml / agrostis gigantea pollen 9 [hp_x] in 1 ml / carya ovata pollen 9 [hp_x] in 1 ml / rumex acetosella pollen 9 [hp_x] in 1 ml / ambrosia artemisiifolia pollen 9 [hp_x] in 1 ml / phleum pratense pollen 9 [hp_x] in 1 ml / ambrosia psilostachya pollen 9 [hp_x] in 1 ml / rumex crispus pollen 9 [hp_x] in 1 ml / ailanthus altissima pollen 12 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / gold trichloride 12 [hp_x] in 1 ml / camphor (natural) 12 [hp_x] in 1 ml / ipecac 12 [hp_x] in 1 ml / potassium dichromate 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml oral liquid [hayfever tonic]||has_active_ingredient
betula pendula leaf extract||horse chestnut 4 [hp_x] in 35 g / arnica montana 8 [hp_x] in 35 g / betula pendula leaf 8 [hp_x] in 35 g / hedera helix flowering twig 6 [hp_x] in 35 g / rhododendron tomentosum leafy twig 3 [hp_x] in 35 g / melilotus officinalis top 4 [hp_x] in 35 g / toxicodendron pubescens leaf 8 [hp_x] in 35 g / sulfur 15 [hp_x] in 35 g topical ointment [zellulisan]||has_active_ingredient
epinephryl borate (product)||product containing only epinephryl borate (medicinal product)||has_active_ingredient
glucose preparations||dextrose/fructose/phosphoric acid 1.87 gm/5 ml-1.87 gm/5 ml-21.5 mg/5 ml oral solution||has_active_ingredient
omc cinnamate||octinoxate 7.5 g in 100 g / oxybenzone 2 g in 100 g topical emulsion [lbel efet parfait spots reducing effect foundation spf 18 - claire 4]||has_active_ingredient
ethanol-containing product||alcohol 0.8 ml in 1 ml topical solution [hand sanitizer]||has_active_ingredient
quercus alba pollen allergen||quercus virginiana pollen 0.0167 g in 1 ml / quercus rubra pollen 0.0167 g in 1 ml / quercus alba pollen 0.0167 g in 1 ml subcutaneous injection, solution||has_active_ingredient
silicas||silicon dioxide 6 [hp_x] in 1 ml / arnica montana 6 [hp_x] in 1 ml / ostrea edulis shell 6 [hp_x] in 1 ml / levisticum officinale root 6 [hp_x] in 1 ml / sodium carbonate 6 [hp_x] in 1 ml / orchis mascula tuber 6 [hp_x] in 1 ml / fluorapatite 7 [hp_x] in 1 ml / ferrous arsenate 7 [hp_x] in 1 ml / bos taurus cerebellum 8 [hp_x] in 1 ml oral liquid||has_active_ingredient
metronidazole-containing product||metronidazole 500 mg oral tablet [protostat]||has_active_ingredient
ferric carboxymaltose||ferric carboxymaltose only product in parenteral dose form||has_active_ingredient
hydrogen peroxide [skin]||hydrogen peroxide 15 mg in 1 ml oral liquid||has_active_ingredient
oxazepam (substance)||product containing only oxazepam (medicinal product)||has_active_ingredient
p-hydroxy-acetanilid||gnp children's pain relief 160mg/5ml suspension (bubble gum)||has_active_ingredient
lycopodium clavatum spore extract||wheat 1 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / jateorhiza calumba root 3 [hp_x] in 1 ml / fragaria vesca fruit 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / senna leaf 3 [hp_x] in 1 ml / wormwood 6 [hp_x] in 1 ml / cinchona officinalis bark 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / beef liver 24 [hp_x] in 1 ml / bos taurus adrenal gland 30 [hp_x] in 1 ml / cajuput oil 1 [hp_x] in 1 ml / sus scrofa spleen 24 [hp_x] in 1 ml / amoeba proteus 30 [hp_c] in 1 ml / giardia lamblia 30 [hp_c] in 1 ml oral liquid [amoebasode]||has_active_ingredient
phenylephrine hydrochloride (medication)||phenylephrine hcl/dextromethorphan hbr/acetaminophen/guaifen 10 mg-20 mg-650 mg-400 mg oral powder in packet (ea)||has_active_ingredient
conyza canadensis||horse chestnut 6 [hp_x] in 50 ml / antimony trisulfide 6 [hp_x] in 50 ml / silver nitrate 10 [hp_x] in 50 ml / arnica montana 6 [hp_x] in 50 ml / berberis vulgaris root bark 6 [hp_x] in 50 ml / activated charcoal 9 [hp_x] in 50 ml / ceanothus americanus leaf 6 [hp_x] in 50 ml / cholesterol 10 [hp_x] in 50 ml / cinchona officinalis bark 8 [hp_x] in 50 ml / artichoke 6 [hp_x] in 50 ml / equisetum arvense top 6 [hp_x] in 50 ml / conyza canadensis 6 [hp_x] in 50 ml / fucus vesiculosus 6 [hp_x] in 50 ml / ginkgo 10 [hp_x] in 50 ml / hamamelis virginiana root bark/stem bark 6 [hp_x] in 50 ml / chamaelirium luteum root 6 [hp_x] in 50 ml / goldenseal 6 [hp_x] in 50 ml / arctium lappa root 6 [hp_x] in 50 ml / lespedeza capitata flowering top 6 [hp_x] in 50 ml / ranunculus bulbosus 4 [hp_x] in 50 ml / daikon 6 [hp_x] in 50 ml / robinia pseudoacacia bark 10 [hp_x] in 50 ml / taraxacum officinale 6 [hp_x] in 50 ml / viburnum prunifolium bark 6 [hp_x] in 50 ml / wine grape 6 [hp_x] in 50 ml oral solution/ drops [lab1796 detox escort]||has_active_ingredient
hydrodiuril||olmesartan medoxomil 40 mg / amlodipine 5 mg / hydrochlorothiazide 25 mg oral tablet [olmesartan medoxomil, amlodipine and hydrochlorothiazide 40/5/25 mg]||has_active_ingredient
dinoprostonum||prostaglandin e>2< preparation||has_active_ingredient
spiritus vini||alcohol 75 ml in 100 ml topical solution [purelogic hand sanitizer lemon zest]||has_active_ingredient
tramadol||acetaminophen and tramadol only product in oral dose form||has_active_ingredient
selective 5-ht receptor agonists sumatriptan succinate||sumatriptan succinate 6 mg in 0.5 ml subcutaneous injection [sumatriptan]||has_active_ingredient
octocrilene product||avobenzone 1.25 g in 50 ml / octinoxate 3.745 g in 50 ml / oxybenzone 0.5 g in 50 ml / octocrylene 1 g in 50 ml topical cream [laura mercier tinted moisturizer broad spectrum spf 30 sunscreen - 5n1 walnut]||has_active_ingredient
copper (cu)||onion 8 [hp_x] in 30 ml / apis mellifera 12 [hp_x] in 30 ml / aralia racemosa root 1 [hp_x] in 30 ml / silver nitrate 10 [hp_x] in 30 ml / ascorbic acid 2 [hp_x] in 30 ml / black currant 1 [hp_x] in 30 ml / helianthemum canadense 4 [hp_x] in 30 ml / copper 4 [hp_x] in 30 ml / euphorbia resinifera resin 4 [hp_x] in 30 ml / histamine dihydrochloride 200 [hp_x] in 30 ml / interferon gamma-1b 4 [hp_c] in 30 ml / interleukin-10 4 [hp_c] in 30 ml / human interleukin 12 4 [hp_c] in 30 ml / manganese gluconate 4 [hp_x] in 30 ml / melilotus 3 [hp_x] in 30 ml / plantago major 2 [hp_x] in 30 ml / rosa canina fruit 1 [hp_x] in 30 ml / european elderberry 2 [hp_x] in 30 ml oral spray [guna-rhino nose]||has_active_ingredient
iva axillaris pollen extract||cyclachaena xanthifolia pollen extract 50 mg/ml / iva axillaris pollen extract 50 mg/ml / iva annua pollen extract 50 mg/ml injectable solution||has_active_ingredient
product containing misoprostol (medicinal product)||misoprostol 100 mcg oral tablet [misoprost]||has_active_ingredient
evening trumpetflower root||arsenic triiodide 6 [hp_c] in 28 g / eupatorium perfoliatum flowering top 6 [hp_c] in 28 g / gelsemium sempervirens root 6 [hp_c] in 28 g oral pellet [flu-like symptoms]||has_active_ingredient
atriplex polycarpa pollen extract||atriplex polycarpa pollen 0.0003333 g in 1 ml / atriplex lentiformis pollen 0.0003333 g in 1 ml / atriplex canescens pollen 0.0003333 g in 1 ml subcutaneous solution [scale atriplex mix]||has_active_ingredient
dl-methionine||methionine (medication)||has_active_ingredient
tylenol||acetaminophen 650 mg oral tablet, extended release [8 hour arthritis pain]||has_active_ingredient
benzenesulfonamide, n-(1,1-dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)-||inrebic||has_active_ingredient
product containing alprostadil (medicinal product)||edex cartridge 10mcg powder for injection||has_active_ingredient
zinc(ii) acetate||zinc acetate topical product||has_active_ingredient
fosinopril sodium (medication)||product containing only fosinopril sodium 40 mg/1 each oral tablet (clinical drug)||has_active_ingredient
nexium [brand name]||esomeprazole magnesium 20 mg oral tablet, delayed release (enteric coated)||has_active_ingredient
ornithogalum umbellatum extract||arsenic trioxide 10 [hp_x] in 1 ml / arsenic triiodide 10 [hp_x] in 1 ml / artemisia vulgaris root 9 [hp_x] in 1 ml / gold 10 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / chionanthus virginicus bark 7 [hp_x] in 1 ml / corallium rubrum exoskeleton 15 [hp_x] in 1 ml / egg phospholipids 15 [hp_x] in 1 ml / morella cerifera root bark 7 [hp_x] in 1 ml / ornithogalum umbellatum 10 [hp_x] in 1 ml / petroselinum crispum 10 [hp_x] in 1 ml / sanguinaria canadensis root 10 [hp_x] in 1 ml oral liquid [category iii]||has_active_ingredient
range oil||echinacea, unspecified 6 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / arsenic tribromide 15 [hp_x] in 1 g / carbo animalis 15 [hp_x] in 1 g / causticum 15 [hp_x] in 1 g / centella asiatica 15 [hp_x] in 1 g / potassium bromide 15 [hp_x] in 1 g / potassium iodide 15 [hp_x] in 1 g / wood creosote 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / kerosene 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g oral pellet [rosacea]||has_active_ingredient
arsenic trioxide (product)||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia whole 3 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / hyoscyamus niger 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / rancid beef 12 [hp_x] in 1 ml / citharacanthus spinicrus 12 [hp_x] in 1 ml oral liquid [pyostat]||has_active_ingredient
óxido de titanio(4)||octinoxate 2.45 g in 35 g / titanium dioxide 4.03 g in 35 g / zinc oxide 1.72 g in 35 g / octisalate 1.58 g in 35 g topical cream [15hr cover lasting m201 medium beige spf50]||has_active_ingredient
octocrilene product||octocrylene 2.75 g in 100 ml / avobenzone 3 g in 100 ml / oxybenzone 6 g in 100 ml / octisalate 5 g in 100 ml / homosalate 10 g in 100 ml topical lotion [dermisa sunscreen spf 55 broad spectrum]||has_active_ingredient
product containing methimazole||product containing only thiamazole 5 mg/1 each oral tablet||has_active_ingredient
1,1'-(1,10-decanediyl)bis(4-amino-2-methylquinolinium)||benzocaine / dequalinium||has_active_ingredient
minoxidil [androgen alopecia] (product)||loniten 2.5 mg oral tablet||has_active_ingredient
benicar||amlodipine (as amlodipine besylate) 10 mg and olmesartan medoxomil 20 mg oral tablet||has_active_ingredient
alcohol (ethyl)||alcohol 2461 ml in 3785 ml topical gel [american beauty advanced hand sanitizer]||has_active_ingredient
2-ethylhexyl-p-methoxycinnamate (substance)||octinoxate 1 mg in 5 ml / octocrylene 1 mg in 5 ml / oxybenzone 1 mg in 5 ml / titanium dioxide 1 mg in 5 ml / avobenzone 1 mg in 5 ml topical spray [sun spr spf 50]||has_active_ingredient
product containing white soft paraffin (medicinal product)||petrolatum 0.340 g in 1 g topical ointment||has_active_ingredient
pleospora herbarum allergenic extract||fusarium oxysporum 0.000833 g in 1 ml / cladosporium cladosporioides 0.000833 g in 1 ml / cochliobolus sativus 0.000833 g in 1 ml / candida albicans 0.000833 g in 1 ml / aspergillus fumigatus 0.000833 g in 1 ml / ustilago cynodontis 0.0004167 g in 1 ml / sporisorium cruentum 0.0004167 g in 1 ml / pleospora herbarum 0.000833 g in 1 ml / aureobasidium pullulans var. pullutans 0.000833 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.000833 g in 1 ml / periplaneta americana 0.000833 g in 1 ml / ustilago nuda hordei 0.0002083 g in 1 ml / ustilago maydis 0.0002083 g in 1 ml / ustilago avenae 0.0002083 g in 1 ml / ustilago tritici 0.0002083 g in 1 ml / rhizopus stolonifer 0.000833 g in 1 ml / phoma destructiva 0.000833 g in 1 ml / dermatophagoides pteronyssinus 166.67 [au] in 1 ml / canis lupus familiaris hair 0.000833 g in 1 ml / alternaria alternata 0.000833 g in 1 ml / dermatophagoides farinae 166.67 [au] in 1 ml / felis catus hair 166.67 [bau] in 1 ml / gallus gallus feather 0.0002783 g in 1 ml / anas platyrhynchos feather 0.0002783 g in 1 ml / anser anser feather 0.002783 g in 1 ml subcutaneous injection, solution||has_active_ingredient
human coxsackievirus b1 (organism)||chelidonium majus whole 3 [hp_x] in 1 ml / iodine 4 [hp_x] in 1 ml / lycopus virginicus whole 4 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 7 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / cysteine 9 [hp_x] in 1 ml / manganese gluconate 10 [hp_x] in 1 ml / oxogluric acid 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / fumaric acid 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / pulsatilla vulgaris whole 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / eugenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lidocaine 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / titanium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / rubella virus 16 [hp_x] in 1 ml / mumps virus 30 [hp_x] in 1 ml / human coxsackievirus a2 16 [hp_c] in 1 ml / human coxsackievirus a7 16 [hp_c] in 1 ml / human coxsackievirus b1 16 [hp_c] in 1 ml / human coxsackievirus b3 16 [hp_c] in 1 ml / human coxsackievirus b4 16 [hp_c] in 1 ml oral liquid [oligo bio iodine]||has_active_ingredient
cns stimulants pitolisant||1-(3-(3-(4-chlorophenyl)propoxy)propyl)piperidine||has_active_ingredient
cortril||fusidic acid- and hydrocortisone-containing product in cutaneous dose form||has_active_ingredient
3,4-pyridinedimethanol, 5-hydroxy-6-methyl-||ascorbic acid/cyanocobalamin/folic acid/niacin/pyridoxine/riboflavin/sodium fluoride/thiamine/vitamin a/vitamin d/vitamin e 60 mg-0.0045 mg-0.3 mg-13.5 mg-1.05 mg-1.2 mg-1 mg-1.05 mg-2500 iu-400 iu-15 iu oral tablet, chewable [multivitamin with fluoride]||has_active_ingredient
calcium(2+) chloride||lactated ringer's inj||has_active_ingredient
capsaicina||capsaicin 0.15 % / menthol 13.5 % / methyl salicylate 30 % topical ointment||has_active_ingredient
product containing dexamethasone sodium phosphate (medicinal product)||medidex, 4 mg/ml injectable solution||has_active_ingredient
product containing phosphorus (medicinal product)||potassium gluconate 6 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / beef liver 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / peanut 12 [hp_x] in 1 ml / black walnut 12 [hp_x] in 1 ml / english walnut 12 [hp_x] in 1 ml / almond 12 [hp_x] in 1 ml / cashew 12 [hp_x] in 1 ml / coconut 12 [hp_x] in 1 ml / pecan 12 [hp_x] in 1 ml / brazil nut 12 [hp_x] in 1 ml / tomato 12 [hp_x] in 1 ml / potato 12 [hp_x] in 1 ml / black pepper 12 [hp_x] in 1 ml / eggplant 12 [hp_x] in 1 ml / canola oil 12 [hp_x] in 1 ml / flax seed 12 [hp_x] in 1 ml / sesame seed 12 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium roqueforti cultured, aged 12 [hp_x] in 1 ml / cow milk 12 [hp_x] in 1 ml / beef 12 [hp_x] in 1 ml / lamb 12 [hp_x] in 1 ml / pork 12 [hp_x] in 1 ml / chicken 12 [hp_x] in 1 ml / egg 12 [hp_x] in 1 ml / kidney bean 12 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / apple 12 [hp_x] in 1 ml / wheat 12 [hp_x] in 1 ml / banana 12 [hp_x] in 1 ml / strawberry 12 [hp_x] in 1 ml / orange 12 [hp_x] in 1 ml / atlantic cod 12 [hp_x] in 1 ml / northern bluefin tuna 12 [hp_x] in 1 ml / atlantic salmon 12 [hp_x] in 1 ml / edible rock crab 12 [hp_x] in 1 ml / pacific oyster 12 [hp_x] in 1 ml / common shrimp 12 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / histamine dihydrochloride 30 [hp_x] in 1 ml / hyaluronidase 30 [hp_x] in 1 ml / interferon .gamma. porcine recombinant 30 [hp_x] in 1 ml / serotonin hydrochloride 30 [hp_x] in 1 ml oral liquid [allergen i]||has_active_ingredient
allergenic extract, kochia||sorghum halepense pollen 0.003 g in 1 ml / ambrosia trifida pollen 0.0015 g in 1 ml / ambrosia artemisiifolia pollen 0.0015 g in 1 ml / ulmus americana pollen 0.003 g in 1 ml / plantago lanceolata pollen 0.003 g in 1 ml / fraxinus americana pollen 0.003 g in 1 ml / amaranthus retroflexus pollen 0.003 g in 1 ml / salsola kali pollen 0.003 g in 1 ml / kochia scoparia pollen 0.003 g in 1 ml / chenopodium album pollen 0.003 g in 1 ml / lolium perenne pollen 6666.67 [bau] in 1 ml / platanus occidentalis pollen 0.003 g in 1 ml / artemisia vulgaris pollen 0.003 g in 1 ml / iva axillaris pollen 0.003 g in 1 ml / populus nigra pollen 0.0015 g in 1 ml / populus alba pollen 0.0015 g in 1 ml / quercus virginiana pollen 0.001 g in 1 ml / quercus rubra pollen 0.001 g in 1 ml / quercus alba pollen 0.001 g in 1 ml intradermal injection, solution||has_active_ingredient
oatmeal,colloidal||colloidal oatmeal 5 % topical lotion||has_active_ingredient
sodium acetate||clinimix e 8/10 sulfite-free, amino acids 8% with 10% dextrose and electrolytes (clinimix e sulfite-free) intravenous solution||has_active_ingredient
live attenuated rotavirus antigen||live attenuated rotavirus antigen only vaccine product||has_active_ingredient
methocarbamol (substance)||methocarbamol 500mg tab||has_active_ingredient
primidone (substance)||primidone 50 mg oral tablet||has_active_ingredient
product containing phosphorus (product)||ceanothus americanus leaf 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / marsdenia condurango bark 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / momordica balsamina immature fruit 6 [hp_x] in 1 ml / pulsatilla pratensis whole 6 [hp_x] in 1 ml / sus scrofa bile duct 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / ipecac 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / potassium dichromate 8 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / sus scrofa nasal mucosa 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sus scrofa oral mucosa 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / sus scrofa rectal mucosa 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / mannose, d- 8 [hp_x] in 1 ml / semecarpus anacardium juice 9 [hp_x] in 1 ml / wood creosote 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / oxalis acetosella leaf 10 [hp_x] in 1 ml / mandragora officinarum root 16 [hp_x] in 1 ml / sus scrofa urinary bladder 6 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [matrix support]||has_active_ingredient
belladonna (substance)||atropa belladonna 10 [hp_x] / gold 10 [hp_x] / lead 30 [hp_x] / honey 30 [hp_x] oral pellet||has_active_ingredient
amox||amoxicillin 875mg tablet||has_active_ingredient
(3r,3as,6ar)-tetrahydro-2h-furo[2,3-b]furan-3-yl (2s,3r)-4-(4-amino-n-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate||product containing only darunavir in oral dose form (medicinal product form)||has_active_ingredient
scrophularia nodosa whole||echinacea angustifolia 1 [hp_x] in 100 ml / scrophularia nodosa 1 [hp_x] in 100 ml / artemisia abrotanum flowering top 3 [hp_x] in 100 ml / kerosene 3 [hp_x] in 100 ml / aloe 1 [hp_x] in 100 ml / mercurius solubilis 12 [hp_x] in 100 ml / crotalus horridus horridus venom 10 [hp_x] in 100 ml / thuja occidentalis leafy twig 10 [hp_x] in 100 ml / lachesis muta venom 8 [hp_x] in 100 ml / aristolochia clematitis root 6 [hp_x] in 100 ml oral liquid [lymphonest]||has_active_ingredient
octyl methoxycinnamate||octocrylene 10 g in 250 ml / octinoxate 10 g in 250 ml topical cream [beautipharm body moisturizer spf 10]||has_active_ingredient
3-quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-, hydrate (1:1)||bosutinib 400 mg oral tablet||has_active_ingredient
benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||homosalate 4.25 g in 100 ml / octisalate 4.75 g in 100 ml / zinc oxide 7 g in 100 ml topical cream [always foundation makeup broad spectrum spf 15 cocoa]||has_active_ingredient
fostamatinib (medication)||fostamatinib||has_active_ingredient
2,3:4,5-di-o-isopropylidene-β-d-fructopyranose sulfamate||phentermine hydrochloride/topiramate 15 mg-92 mg oral capsule, extended release||has_active_ingredient
thuja occidentalis twig||iodine 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / barium carbonate 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / digitalis 15 [hp_x] in 1 ml / ferric picrate 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / chondrodendron tomentosum root 15 [hp_x] in 1 ml / saw palmetto 15 [hp_x] in 1 ml / selenium 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / trifolium pratense flower 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / solidago virgaurea flowering top 6 [hp_x] in 1 ml oral liquid [prostate]||has_active_ingredient
dalteparin,porcine||product containing only dalteparin in parenteral dose form (medicinal product form)||has_active_ingredient
titanium dioxide (product)||titanium dioxide 51 mg in 1 ml / zinc oxide 28 mg in 1 ml topical cream [cover-expert sunscreen broad spectrum spf 15 no.5 peach beige]||has_active_ingredient
2 thiolpropionamidoacetic acid||product containing only tiopronin (medicinal product)||has_active_ingredient
oyster shell calcium carbonate, crude||causticum 10 [hp_x] in 59 ml / euphrasia stricta 10 [hp_x] in 59 ml / naphthalene 10 [hp_x] in 59 ml / quassia amara wood 10 [hp_x] in 59 ml / jacobaea maritima 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / calcium fluoride 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml oral liquid [eyeclear pro]||has_active_ingredient
zirtek||cetirizine hydrochloride 10 mg oral capsule [cetirizine hydrochloride (hives relief)]||has_active_ingredient
bazedoxifeno||bazedoxifene / estrogens, conjugated (usp) oral product||has_active_ingredient
flax||coumarin 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / bambusa vulgaris leaf 9 [hp_x] in 1 ml / barley 9 [hp_x] in 1 ml / corn 9 [hp_x] in 1 ml / levant cotton seed 9 [hp_x] in 1 ml / flax seed 9 [hp_x] in 1 ml / millet 9 [hp_x] in 1 ml / sorghum bicolor whole 9 [hp_x] in 1 ml / oat 9 [hp_x] in 1 ml / eschscholzia californica 9 [hp_x] in 1 ml / brown rice 9 [hp_x] in 1 ml / rye 9 [hp_x] in 1 ml / safflower 9 [hp_x] in 1 ml / sesame seed 9 [hp_x] in 1 ml / sorghum 9 [hp_x] in 1 ml / soybean 9 [hp_x] in 1 ml / sugarcane 9 [hp_x] in 1 ml / sunflower seed 9 [hp_x] in 1 ml / wheat 9 [hp_x] in 1 ml / amaranth 6 [hp_c] in 1 ml / avena sativa flowering top 6 [hp_c] in 1 ml / sodium sulfate 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / elymus repens root 6 [hp_c] in 1 ml / corticotropin 8 [hp_c] in 1 ml / enterococcus faecalis 30 [hp_c] in 1 ml oral liquid [chip cravings]||has_active_ingredient
lachesis muta venom||lachesis muta venom 15 [hp_c] sublingual pellet [lachesis mutus]||has_active_ingredient
naltrexone-containing product||morphine / naltrexone||has_active_ingredient
salix nigra pollen||plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / periplaneta americana 0.002 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / salix nigra pollen 0.002 g in 1 ml intradermal injection, solution||has_active_ingredient
product containing gabapentin||gabapentin 600mg tab||has_active_ingredient
nasal sodium chloride||parenteral saline||has_active_ingredient
european arnica whole||chaste tree 3 [hp_x] in 41 ml / american ginseng 2 [hp_x] in 41 ml / silver nitrate 30 [hp_c] in 41 ml / arnica montana 3 [hp_x] in 41 ml / dieffenbachia seguine 6 [hp_x] in 41 ml / turnera diffusa leafy twig 2 [hp_x] in 41 ml / lactuca virosa 3 [hp_x] in 41 ml / nuphar luteum root 2 [hp_x] in 41 ml / sus scrofa testicle 6 [hp_x] in 41 ml / phosphoric acid 200 [hp_c] in 41 ml oral liquid [sprayology man power]||has_active_ingredient
(+-)-verapamil hydrochloride||verapamil hydrochloride 2.5 mg in 1 ml intravenous injection, solution [verapamil hydrochloride]_#2||has_active_ingredient
pepto-bismol||gnp pink bismuth 262mg chewable tablet||has_active_ingredient
sulfuric acid-containing product||silver nitrate 6 [hp_x] in 100 ml / sulfuric acid 6 [hp_x] in 100 ml / bellis perennis 1 [hp_x] in 100 ml / lytta vesicatoria 4 [hp_x] in 100 ml / gratiola officinalis 4 [hp_x] in 100 ml / goldenseal 5 [hp_x] in 100 ml / lachesis muta venom 8 [hp_x] in 100 ml / glechoma hederacea flowering top 1602 mg in 100 ml oral solution/ drops [opsonat]||has_active_ingredient
zinc acetate||pramoxine hydrochloride/zinc acetate 1%-0.1% topical application lotion [caldyphen clear]||has_active_ingredient
cyclopropaneacetic acid, 1-((((1r)-1-(3-((1e)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, monosodium salt||montelukast sodium 5 mg oral tablet, chewable [singulair]||has_active_ingredient
monohydrochloride, ondansetron||ondansetron hydrochloride 2 mg in 1 ml intramuscular injection_#1||has_active_ingredient
pork liver, cooked||chaste tree 6 [hp_x] in 1 ml / ambergris 6 [hp_x] in 1 ml / petroselinum crispum 6 [hp_x] in 1 ml / estradiol 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / melatonin 6 [hp_x] in 1 ml / testosterone 6 [hp_x] in 1 ml / adenosine triphosphate disodium 8 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / nadide 8 [hp_x] in 1 ml / pantothenic acid 8 [hp_x] in 1 ml / lactic acid, l- 8 [hp_x] in 1 ml / ubidecarenone 8 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / estrone 8 [hp_x] in 1 ml / sus scrofa umbilical cord 30 [hp_x] in 1 ml / sus scrofa adrenal gland 30 [hp_x] in 1 ml / pork liver 30 [hp_x] in 1 ml / sus scrofa lymph 30 [hp_x] in 1 ml / sus scrofa bone marrow 30 [hp_x] in 1 ml / sus scrofa ovary 30 [hp_x] in 1 ml / sus scrofa testicle 30 [hp_x] in 1 ml / sus scrofa pancreas 30 [hp_x] in 1 ml / sus scrofa spleen 30 [hp_x] in 1 ml / somatropin 30 [hp_x] in 1 ml / apiole (parsley) 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [hgh young again]||has_active_ingredient
florphenicol||florfenicol 23 mg in 1 ml oral solution, concentrate [florcon]||has_active_ingredient
red imported fire ant allergenic extract||solenopsis invicta allergenic extract 0.01 gm/ml injectable solution||has_active_ingredient
absolute ethanol||alcohol 70 ml in 100 ml topical gel [coconut and lime scented hand sanitizer]||has_active_ingredient
benzoic acid, 2-hydroxy-, 2-ethylhexyl ester||zinc oxide 7.8 ml in 100 ml / octisalate 4 ml in 100 ml / octinoxate 7.5 ml in 100 ml topical cream [sun total protector color 30 light tint]||has_active_ingredient
magnesium phosphate, dibasic trihydrate||bryonia alba root 6 [hp_c] in 59 ml / echinacea purpurea 3 [hp_x] in 59 ml / ferrosoferric phosphate 6 [hp_c] in 59 ml / potassium sulfate 6 [hp_c] in 59 ml / magnesium phosphate, dibasic trihydrate 6 [hp_c] in 59 ml / plantago major 3 [hp_x] in 59 ml oral spray [kc-defense]||has_active_ingredient
alkylbenzyldimethylammonium chloride||benzalkonium chloride 1.2 mg/ml medicated liquid soap [safeguard antibacterial foaming]||has_active_ingredient
sulfur preparations||lactic acid, l- 3 [hp_x] in 2.2 ml / colchicum autumnale bulb 4 [hp_x] in 2.2 ml / conium maculatum flowering top 4 [hp_x] in 2.2 ml / galium aparine 4 [hp_x] in 2.2 ml / fucus vesiculosus 6 [hp_x] in 2.2 ml / sedum acre 6 [hp_x] in 2.2 ml / sempervivum tectorum leaf 6 [hp_x] in 2.2 ml / adenosine triphosphate 8 [hp_x] in 2.2 ml / fumaric acid 8 [hp_x] in 2.2 ml / .alpha.-ketoglutaric acid 8 [hp_x] in 2.2 ml / malic acid 8 [hp_x] in 2.2 ml / sodium diethyl oxalacetate 8 [hp_x] in 2.2 ml / pulsatilla vulgaris 8 [hp_x] in 2.2 ml / spongia officinalis skeleton, roasted 8 [hp_x] in 2.2 ml / sus scrofa thyroid 8 [hp_x] in 2.2 ml / calcium fluoride 10 [hp_x] in 2.2 ml / sus scrofa umbilical cord 10 [hp_x] in 2.2 ml / pork liver 10 [hp_x] in 2.2 ml / sus scrofa bone marrow 10 [hp_x] in 2.2 ml / sus scrofa spleen 10 [hp_x] in 2.2 ml / sulfur 10 [hp_x] in 2.2 ml / sus scrofa thymus 10 [hp_x] in 2.2 ml / viscum album fruit 3 [hp_x] in 2.2 ml / cortisone acetate 28 [hp_x] in 2.2 ml subcutaneous injection [thyreoidea compositum]||has_active_ingredient
2-hydroxy-4-methoxy-benzophenone||blue lizard aust snscrn spf 30+ regu obsolete||has_active_ingredient
1-piperazineacetamide, n-(2,6-dimethylphenyl)-4-(2-hydroxy- 3-(2-methoxyphenoxy)propyl)-||ranexa 1000 mg 12hr extended release oral tablet||has_active_ingredient
quetiapine (as fumarate)||quetiapine 50mg tablet (product)||has_active_ingredient
stanozolol [anemia]||stanozolol only product in oral dose form||has_active_ingredient
chlorhexidine -retired-||chlorhexidine- and chlorobutanol-containing product in oromucosal dose form||has_active_ingredient
antidepressants bupropion hbr||aplenzin 348 mg 24hr extended release oral tablet||has_active_ingredient
bendroflumethiazidum||product containing atenolol and bendroflumethiazide in oral dosage form||has_active_ingredient
guaifenesin - chemical (substance)||dextromethorphan hydrobromide/guaifenesin 10 mg/5 ml-100 mg/5 ml oral solution [good sense tussin dm]||has_active_ingredient
clematis recta flowering top||garlic 2 [hp_x] in 1 ml / calendula officinalis flowering top 2 [hp_x] in 1 ml / sambucus nigra flowering top 3 [hp_x] in 1 ml / clematis recta flowering top 6 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / graphite 8 [hp_x] in 1 ml / kerosene 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / croton tiglium seed 12 [hp_x] in 1 ml / mercuric sulfide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml oral liquid [herpes simplex plus]||has_active_ingredient
salicylic acid [acne]||salicylic acid 1 g in 100 g topical lotion [al0078101 alba botanica good and clean acne wash]||has_active_ingredient
paste, lassar's||titanium dioxide 65 mg in 1 g / zinc oxide 60 mg in 1 g topical cream [kiinsun sunscreen broad spectrum spf50]||has_active_ingredient
green bell pepper||activated charcoal 30 [kp_c] in 1 ml / ageratina aromatica root 30 [kp_c] in 1 ml / ferrous iodide 30 [kp_c] in 1 ml / gelsemium sempervirens root 30 [kp_c] in 1 ml / calcium sulfide 30 [kp_c] in 1 ml / histamine 30 [kp_c] in 1 ml / interleukin-12 human 200 [kp_c] in 1 ml / interferon gamma-1a 200 [kp_c] in 1 ml / iodine 30 [kp_c] in 1 ml / potassium gluconate 30 [kp_c] in 1 ml / lycopodium clavatum spore 30 [kp_c] in 1 ml / cajuput oil 30 [kp_c] in 1 ml / black currant 1 [hp_x] in 1 ml / rosa canina fruit 1 [hp_x] in 1 ml / serotonin 30 [kp_c] in 1 ml / xanthine 30 [kp_c] in 1 ml / almond 30 [kp_c] in 1 ml / apple 30 [kp_c] in 1 ml / banana 30 [kp_c] in 1 ml / barley 30 [kp_c] in 1 ml / bean 30 [kp_c] in 1 ml / beef 30 [kp_c] in 1 ml / cashew 30 [kp_c] in 1 ml / casein, emmental cultured 30 [kp_c] in 1 ml / casein, lactococcus lactis cultured 30 [kp_c] in 1 ml / casein, lactococcus lactis cultured, aged 30 [kp_c] in 1 ml / casein, lactococcus lactis cultured, penicillium camemberti cultured, aged 30 [kp_c] in 1 ml / chicken 30 [kp_c] in 1 ml / cocoa 30 [kp_c] in 1 ml / coconut 30 [kp_c] in 1 ml / cod, unspecified 30 [kp_c] in 1 ml / coffee bean 30 [kp_c] in 1 ml / cotton fiber 30 [kp_c] in 1 ml / cotton seed 30 [kp_c] in 1 ml / arched swimming crab, cooked 30 [kp_c] in 1 ml / blue crab 30 [kp_c] in 1 ml / dungeness crab, cooked 30 [kp_c] in 1 ml / serrated swimming crab, cooked 30 [kp_c] in 1 ml / snow crab, unspecified 30 [kp_c] in 1 ml / egg 30 [kp_c] in 1 ml / eggplant 30 [kp_c] in 1 ml / flax seed 30 [kp_c] in 1 ml / wheat gluten 30 [kp_c] in 1 ml / green bell pepper 30 [kp_c] in 1 ml / hazelnut, unspecified 30 [kp_c] in 1 ml / lamb 30 [kp_c] in 1 ml / cow milk 30 [kp_c] in 1 ml / onion 30 [kp_c] in 1 ml / orange 30 [kp_c] in 1 ml / oyster, unspecified 30 [kp_c] in 1 ml / peanut 30 [kp_c] in 1 ml / pecan 30 [kp_c] in 1 ml / pork 30 [kp_c] in 1 ml / potato 30 [kp_c] in 1 ml / brown rice 30 [kp_c] in 1 ml / starch, rice 30 [kp_c] in 1 ml / white rice 30 [kp_c] in 1 ml / salmon, unspecified 30 [kp_c] in 1 ml / shrimp, unspecified 30 [kp_c] in 1 ml / strawberry 30 [kp_c] in 1 ml / soybean 30 [kp_c] in 1 ml / tea leaf 30 [kp_c] in 1 ml / tomato 30 [kp_c] in 1 ml / tuna, unspecified 30 [kp_c] in 1 ml / english walnut 30 [kp_c] in 1 ml / wheat 30 [kp_c] in 1 ml oral spray [foods]||has_active_ingredient
zinc oxide product||zinc oxide 20 g in 100 g topical ointment [curetech]||has_active_ingredient
zinci oxydum||cod liver oil and zinc oxide only product||has_active_ingredient
menthol product||menthol 50 mg topical patch [winco cold and hot medicated patch large]||has_active_ingredient
claviceps purpurea sclerotium||goldenseal 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / calcium iodide 15 [hp_x] in 1 ml / carbo animalis 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / wood creosote 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / juniperus sabina leafy twig 15 [hp_x] in 1 ml / claviceps purpurea sclerotium 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / capsella bursa-pastoris 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / trillium erectum root 15 [hp_x] in 1 ml oral liquid [female femroids]||has_active_ingredient
smilax ornata root extract||horse chestnut 4 [hp_x] in 100 g / apis mellifera 4 [hp_x] in 100 g / araneus diadematus 14 [hp_x] in 100 g / barium carbonate 14 [hp_x] in 100 g / equisetum hyemale 3 [hp_x] in 100 g / fucus vesiculosus 3 [hp_x] in 100 g / fumaria officinalis flowering top 2 [hp_x] in 100 g / juglans cinerea branch bark/root bark 2 [hp_x] in 100 g / potassium iodide 2 [hp_x] in 100 g / potassium chloride 2 [hp_x] in 100 g / myosotis arvensis 2 [hp_x] in 100 g / nasturtium officinale 2 [hp_x] in 100 g / sodium sulfate 2 [hp_x] in 100 g / phytolacca americana root 2 [hp_x] in 100 g / smilax ornata root 2 [hp_x] in 100 g / scrophularia nodosa 3 [hp_x] in 100 g / claviceps purpurea sclerotium 6 [hp_x] in 100 g / teucrium scorodonia flowering top 2 [hp_x] in 100 g / thyroid, unspecified 10 [hp_x] in 100 g / vipera berus venom 6 [hp_x] in 100 g topical gel [ohm drainage lymphatic]||has_active_ingredient
dostarlimab (substance)||dostarlimab only product in parenteral dose form||has_active_ingredient
epidermophyton floccosum allergenic extract||epidermophyton floccosum extract 0.001 gm/ml injectable solution||has_active_ingredient
d,l-malic acid||bos taurus adrenal gland 200 [kp_c] in 1 ml / sus scrofa adrenal gland 200 [kp_c] in 1 ml / ascorbic acid 30 [kp_c] in 1 ml / brain-derived neurotrophic factor human 30 [kp_c] in 1 ml / prasterone 30 [kp_c] in 1 ml / malic acid 30 [kp_c] in 1 ml / basic fibroblast growth factor (human) 30 [kp_c] in 1 ml / fucus vesiculosus 30 [kp_c] in 1 ml / histidine 30 [kp_c] in 1 ml / hyaluronidase 30 [kp_c] in 1 ml / human interleukin-6 (nonglycosylated) 30 [kp_c] in 1 ml / lactic acid 30 [kp_c] in 1 ml / sus scrofa lymph vessel 30 [kp_c] in 1 ml / bos taurus lymph vessel 30 [kp_c] in 1 ml / sus scrofa mesenchyme 30 [kp_c] in 1 ml / nadide 30 [kp_c] in 1 ml / sodium diethyl oxalacetate 30 [kp_c] in 1 ml / sodium pyruvate 30 [kp_c] in 1 ml / sodium sulfate 200 [kp_c] in 1 ml / phenylalanine 30 [kp_c] in 1 ml / prolactin 30 [kp_c] in 1 ml / rancid beef 30 [kp_c] in 1 ml / thuja occidentalis leaf 200 [kp_c] in 1 ml / dodecahydroxycyclohexane dihydrate 30 [kp_c] in 1 ml / tyrosine 30 [kp_c] in 1 ml oral spray [viatrexx-mesenchyme]||has_active_ingredient
graphites||onion 2 [hp_x] in 1 g / echinacea angustifolia 2 [hp_x] in 1 g / hirudin 4 [hp_x] in 1 g / polygonatum cyrtonema root 4 [hp_x] in 1 g / vespa crabro 6 [hp_x] in 1 g / gold 8 [hp_x] in 1 g / bos taurus cartilage 10 [hp_x] in 1 g / copper 8 [hp_x] in 1 g / sus scrofa skin 8 [hp_x] in 1 g / bos taurus placenta 8 [hp_x] in 1 g / silicon dioxide 8 [hp_x] in 1 g / thuja occidentalis whole 8 [hp_x] in 1 g / silver 12 [hp_x] in 1 g / barium citrate 12 [hp_x] in 1 g / graphite 17 [hp_x] in 1 g topical gel||has_active_ingredient
(s)-1-(n(2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-l-proline||lisinopril 20mg oral tablet||has_active_ingredient
omc cinnamate||octinoxate 30 mg in 1 ml / titanium dioxide 62.8 mg in 1 ml / zinc oxide 19.2 mg in 1 ml topical cream [erborian - bb creme au ginseng clair spf 20]||has_active_ingredient
bleomycin sulfas||bleomycin (as bleomycin sulfate) 30 unt injection||has_active_ingredient
(+-)-phenisopropylamine sulfate||amphetamine aspartate/amphetamine sulfate/dextroamphetamine saccharate/dextroamphetamine sulfate 30 mg oral tablet [dextroamphetamin sacc/sulf-amphetamine aspart/sulf]||has_active_ingredient
tragacanth gum||tragacanth allergenic extract 1 mg/ml injectable solution||has_active_ingredient
avobenzone product||avobenzone 90 g in 1 g / homosalate 2250 g in 1 g / octisalate 250 g in 1 g / octocrylene 8 g in 1 g topical spray [sunscreen]||has_active_ingredient
olaparib (substance)||olaparib (medication)||has_active_ingredient
eastern poison oak leaf extract||aconitum napellus 20 [hp_x] in 1 g / arnica montana 20 [hp_x] in 1 g / arsenic trioxide 20 [hp_x] in 1 g / baptisia tinctoria root 20 [hp_x] in 1 g / atropa belladonna 20 [hp_x] in 1 g / bryonia alba root 20 [hp_x] in 1 g / calendula officinalis flowering top 20 [hp_x] in 1 g / matricaria recutita 20 [hp_x] in 1 g / chelidonium majus 20 [hp_x] in 1 g / crotalus horridus horridus venom 20 [hp_x] in 1 g / gelsemium sempervirens root 20 [hp_x] in 1 g / calcium sulfide 20 [hp_x] in 1 g / wood creosote 20 [hp_x] in 1 g / mercury 20 [hp_x] in 1 g / myrrh 20 [hp_x] in 1 g / strychnos nux-vomica seed 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / plantago major 20 [hp_x] in 1 g / toxicodendron pubescens leaf 20 [hp_x] in 1 g / silicon dioxide 20 [hp_x] in 1 g / delphinium staphisagria seed 20 [hp_x] in 1 g / echinacea, unspecified 8 [hp_x] in 1 g oral pellet [oral care - gingivitis]||has_active_ingredient
silver||arnica montana 3 [hp_x] in 1 ml / astragalus propinquus root 3 [hp_x] in 1 ml / formica rufa 6 [hp_x] in 1 ml / silver 30 [hp_x] in 1 ml oral liquid||has_active_ingredient
strychnos nux-vomica seed||thyroid, unspecified 15 [hp_x] in 1 ml / barium carbonate 10 [hp_x] in 1 ml / berberis vulgaris root bark 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 1 ml / cinchona officinalis bark 10 [hp_x] in 1 ml / conium maculatum flowering top 10 [hp_x] in 1 ml / digitalis 10 [hp_x] in 1 ml / ferric picrate 10 [hp_x] in 1 ml / goldenseal 10 [hp_x] in 1 ml / iodine 10 [hp_x] in 1 ml / lycopodium clavatum spore 10 [hp_x] in 1 ml / strychnos nux-vomica seed 10 [hp_x] in 1 ml / chondrodendron tomentosum root 10 [hp_x] in 1 ml / pulsatilla vulgaris 10 [hp_x] in 1 ml / saw palmetto 10 [hp_x] in 1 ml / selenium 10 [hp_x] in 1 ml / delphinium staphisagria seed 10 [hp_x] in 1 ml / thuja occidentalis leafy twig 10 [hp_x] in 1 ml / trifolium pratense flower 10 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml oral liquid [prostate]||has_active_ingredient
meclozine hydrochloride (substance)||meclizine hydrochloride 25 mg oral tablet [motion sickness less drowsy formula]||has_active_ingredient
paste, lassar's||menthol 1 mg in 1 g / zinc oxide 200 mg in 1 g topical ointment [chamosyn]||has_active_ingredient
titanium white||octinoxate 1.28 g in 32 g / titanium dioxide .96 g in 32 g topical cream [ceramide lift and firm makeup broad spectrum sunscreen spf 15 bisque]||has_active_ingredient
dioxide titanium||octinoxate 0.07 g in 1 g / oxybenzone 0.02 g in 1 g / titanium dioxide 0.02 g in 1 g topical powder [esika 3-in-1 pro makeup foundation spf 20]||has_active_ingredient
3β-hydroxyandrost-5-en-17-one||turnera diffusa leafy twig 12 [hp_x] in 30 ml / egg phospholipids 12 [hp_x] in 30 ml / phosphoric acid 12 [hp_x] in 30 ml / saw palmetto 12 [hp_x] in 30 ml / cholesterol 12 [hp_x] in 30 ml / herring sperm dna 12 [hp_x] in 30 ml / bos taurus hypothalamus 12 [hp_x] in 30 ml / sus scrofa adrenal gland 12 [hp_x] in 30 ml / prasterone 12 [hp_x] in 30 ml / pregnenolone 12 [hp_x] in 30 ml / progesterone 12 [hp_x] in 30 ml / testosterone 12 [hp_x] in 30 ml oral liquid [total andro-bal]||has_active_ingredient
tpm||topiramate 50 mg oral capsule, extended release [topiramate]||has_active_ingredient
carolina jessamine root||gelsemium sempervirens root 4 [hp_x] in 1 ml / pseudognaphalium luteoalbum leaf 4 [hp_x] in 1 ml / aconitum napellus 6 [hp_x] in 1 ml / atropa belladonna 6 [hp_x] in 1 ml / mandragora officinarum root 6 [hp_x] in 1 ml / toxicodendron pubescens leaf 6 [hp_x] in 1 ml / penoxsulam 10 [hp_x] in 1 ml oral liquid||has_active_ingredient
salicylic acid [antifungal]||salicylic acid 10 mg/ml medicated liquid soap [biore]||has_active_ingredient
sulphur product||aconitum napellus 10 [hp_x] in 59 ml / bromine 10 [hp_x] in 59 ml / protortonia cacti 10 [hp_x] in 59 ml / corallium rubrum exoskeleton 10 [hp_x] in 59 ml / copper 10 [hp_x] in 59 ml / drosera rotundifolia 10 [hp_x] in 59 ml / ferrosoferric phosphate 10 [hp_x] in 59 ml / calcium sulfide 10 [hp_x] in 59 ml / iodine 10 [hp_x] in 59 ml / potassium dichromate 10 [hp_x] in 59 ml / mephitis mephitis anal gland fluid 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / rumex crispus root 10 [hp_x] in 59 ml / sanguinaria canadensis root 10 [hp_x] in 59 ml / spongia officinalis skeleton, roasted 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [cough control]||has_active_ingredient
diovan||aliskiren / valsartan||has_active_ingredient
3-(o-methoxyphenoxy)-1,2-propanediol||dextromethorphan hydrobromide/guaifenesin 20 mg/10 ml-400 mg/10 ml oral suspension [up & up adult cough formula dm max]||has_active_ingredient
pot marigold flowering top||aconitum napellus 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bellis perennis 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / calendula officinalis flowering top 15 [hp_x] in 1 ml / matricaria chamomilla 15 [hp_x] in 1 ml / helianthemum canadense 15 [hp_x] in 1 ml / ferrosoferric phosphate 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / hypericum perforatum 15 [hp_x] in 1 ml / strychnos ignatii seed 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / ornithogalum umbellatum 15 [hp_x] in 1 ml / passiflora incarnata flowering top 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / prunus spinosa flower bud 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / lactic acid, l- 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / veratrum album root 15 [hp_x] in 1 ml / valerian 6 [hp_x] in 1 ml oral liquid [panic button]||has_active_ingredient
enterobius vermicularis||artemisia vulgaris root 2 [hp_x] in 1 ml / melilotus officinalis top 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / teucrium marum 3 [hp_x] in 1 ml / thymus serpyllum 3 [hp_x] in 1 ml / dryopteris filix-mas root 4 [hp_x] in 1 ml / artemisia cina pre-flowering top 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / spigelia anthelmia 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / schoenocaulon officinale seed 12 [hp_x] in 1 ml / ascaris lumbricoides 15 [hp_x] in 1 ml / trichinella spiralis 15 [hp_x] in 1 ml / enterobius vermicularis 33 [hp_x] in 1 ml / taenia solium 12 [hp_c] in 1 ml / trichomonas vaginalis 13 [hp_c] in 1 ml / giardia lamblia 18 [hp_c] in 1 ml / cryptosporidium parvum 20 [hp_c] in 1 ml / taenia saginata 20 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [ver]||has_active_ingredient
aconitum napellus||aconitum napellus 15 [hp_x] in 1 ml / ammonium benzoate 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / benzoic acid 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / colchicum autumnale bulb 15 [hp_x] in 1 ml / pseudognaphalium obtusifolium 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / potassium iodide 15 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 15 [hp_x] in 1 ml / lithium carbonate 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / sambucus nigra flowering top 15 [hp_x] in 1 ml / strychnine 15 [hp_x] in 1 ml / hypericum perforatum 6 [hp_x] in 1 ml / urtica urens 6 [hp_x] in 1 ml oral liquid [sciatica-nerve care]||has_active_ingredient
sorbitol (medication)||dextrose monohydrate 12.50 g in 500 ml / sorbitol 12.50 g in 500 ml / sodium lactate 3.95 g in 500 ml / sodium chloride 2.40 g in 500 ml / potassium chloride 0.37 g in 500 ml / magnesium chloride 0.21 g in 500 ml / calcium chloride 0.19 g in 500 ml intraperitoneal injection, solution||has_active_ingredient
miconazole [genital] (product)||miconazole injection (medication)||has_active_ingredient
redroot pigweed pollen extract||rumex acetosella pollen 0.0000666 g in 1 ml / urtica dioica pollen 0.0003333 g in 1 ml / felis catus hair 33.33 g in 1 ml / canis lupus familiaris hair 0.0008333 g in 1 ml / acer negundo pollen 0.0000666 g in 1 ml / juniperus ashei pollen 0.0000666 g in 1 ml / juglans nigra pollen 0.0000666 g in 1 ml / platanus occidentalis pollen 0.0000666 g in 1 ml / populus deltoides pollen 0.0000666 g in 1 ml / fraxinus americana pollen 0.0000133 g in 1 ml / quercus alba pollen 0.0000666 g in 1 ml / ulmus americana pollen 0.0000666 g in 1 ml / morus alba pollen 0.00833 g in 1 ml / cynodon dactylon pollen 13.3333 g in 1 ml / phleum pratense pollen 666.67 g in 1 ml / ambrosia artemisiifolia pollen 5.33 g in 1 ml / amaranthus retroflexus pollen 0.00033 g in 1 ml / salsola kali pollen 0.0000666 g in 1 ml / iva annua var. annua pollen 0.0000666 g in 1 ml / carya alba pollen 0.0000333 g in 1 ml / carya illinoinensis pollen 0.0000333 g in 1 ml subcutaneous injection, solution||has_active_ingredient
psychostimulants dextroamphetamine sulfate||amphetamine aspartate/amphetamine sulfate/dextroamphetamine saccharate/dextroamphetamine sulfate 25 mg oral capsule, extended release [adderall xr]||has_active_ingredient
menthol||allantoin 0.005 mg/mg / menthol 0.001 mg/mg topical ointment||has_active_ingredient
pseudoephedrine hydrochloride (substance)||brompheniramine maleate/pseudoephedrine hydrochloride 1 mg/5 ml-15 mg/5 ml oral solution||has_active_ingredient
potassium bromide (substance)||antimony potassium tartrate 10 [hp_x] in 59 ml / asterias rubens 10 [hp_x] in 59 ml / iron 10 [hp_x] in 59 ml / calcium sulfide 10 [hp_x] in 59 ml / potassium bromide 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / sanguinaria canadensis root 10 [hp_x] in 59 ml / selenium 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / thuja occidentalis leafy twig 10 [hp_x] in 59 ml oral liquid [acne clear]||has_active_ingredient
product containing treprostinil (medicinal product)||treprostinil sodium 1mg/ml injection solution 20ml vial||has_active_ingredient
alirocumab (medication)||alirocumab 75 mg per 1 ml auto-injector||has_active_ingredient
pramoxine hydrochloride (product)||pramoxine hydrochloride 10 mg/ml topical foam||has_active_ingredient
4-tertiary-butyl-4'-methoxy-dibenzoylmethane (substance)||avobenzone 3 g in 1 ml / homosalate 10 g in 1 ml / octinoxate 7.5 g in 1 ml / octisalate 5 g in 1 ml / octocrylene 5 g in 1 ml topical lotion [general protection]||has_active_ingredient
pramoxine hcl||cvs triple antibiotic & pain relief maximum strength topical ointment||has_active_ingredient
fluticasone (product)||fluticasone only product in nasal dose form||has_active_ingredient
obiltoxaximab-containing product||product containing only obiltoxaximab in parenteral dose form (medicinal product form)||has_active_ingredient
product containing naproxen sodium||naproxen sodium 220 mg oral tablet, film coated [rugby all day relief]||has_active_ingredient
germanium (medication)||horseradish 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / brucella abortus 12 [hp_x] in 1 ml / escherichia coli 12 [hp_x] in 1 ml / germanium 15 [hp_x] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 60 [hp_x] in 1 ml / clostridium tetani 60 [hp_x] in 1 ml / rancid beef 60 [hp_x] in 1 ml / francisella tularensis 60 [hp_x] in 1 ml / yersinia enterocolitica 60 [hp_x] in 1 ml / brucella melitensis 9 [hp_c] in 1 ml / serratia marcescens 12 [hp_c] in 1 ml / citrobacter koseri 12 [hp_c] in 1 ml / enterobacter aerogenes 15 [hp_c] in 1 ml / yersinia pestis 15 [hp_c] in 1 ml / bacillus cereus 18 [hp_c] in 1 ml / pseudomonas aeruginosa 30 [hp_c] in 1 ml / coxiella burnetii 30 [hp_c] in 1 ml / proteus mirabilis 30 [hp_c] in 1 ml oral liquid [biotox bac i]||has_active_ingredient
octocrilene-containing product||octocrylene 60 mg in 1 ml / octinoxate 49 mg in 1 ml / avobenzone 30 mg in 1 ml / oxybenzone 30 mg in 1 ml topical cream [moisturising sunscreen spf15]||has_active_ingredient
ethanol (substance)||alcohol 70 ml in 100 ml topical gel [insta clean antiseptic hand sanitizer gel fresh air]||has_active_ingredient
deferasirox||deferasirox 180 mg oral granules||has_active_ingredient
aminocaproic acid - chemical (product)||aminocaproic acid only product in parenteral dose form||has_active_ingredient
camphor (synthetic)||camphor (synthetic) 10 / menthol 10.28 / methyl salicylate 15.43 topical patch [shanghai shang shi zhi tong gao pain relieving]||has_active_ingredient
alternaria alternata diagnostic allergen extract (product)||alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / rhizopus stolonifer 0.00008 g in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / candida albicans 0.002 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.00008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00008 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml intradermal injection, solution||has_active_ingredient
european arnica whole||bos taurus eye 10 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml / equisetum arvense top 20 [hp_x] in 1 ml oral liquid||has_active_ingredient
porcine thymus preparation||fennel seed 2 [hp_x] in 1 ml / fucus vesiculosus 3 [hp_x] in 1 ml / lecithin, soybean 3 [hp_x] in 1 ml / ammonium carbonate 6 [hp_x] in 1 ml / caulophyllum thalictroides root 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / phosphorus 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / rubus idaeus leaf 6 [hp_x] in 1 ml / artemisia abrotanum flowering top 30 [hp_x] in 1 ml / semecarpus anacardium juice 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_x] in 1 ml / barium chloride dihydrate 30 [hp_x] in 1 ml / helleborus niger root 30 [hp_x] in 1 ml / strychnos ignatii seed 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / niacinamide 30 [hp_x] in 1 ml / claviceps purpurea sclerotium 30 [hp_x] in 1 ml / sus scrofa thymus 30 [hp_x] in 1 ml / sus scrofa thyroid 30 [hp_x] in 1 ml / ammonium bromide 8 [hp_x] in 1 ml / antimony trisulfide 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / tribasic calcium phosphate 30 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / human chorionic gonadotropin 60 [hp_x] in 1 ml / calcium arsenate 8 [hp_x] in 1 ml oral spray [hcg formula]||has_active_ingredient
pulsatilla vulgaris extract||atropa belladonna 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / matricaria chamomilla 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / anemone pulsatilla 30 [hp_c] in 1 ml / sulfur 30 [hp_c] in 1 ml auricular (otic) liquid [ear care earache drops]||has_active_ingredient
product containing topiramate||topiramate, 200 mg oral tablet||has_active_ingredient
titanium white||octinoxate 2.516 g in 34 g / titanium dioxide 0.748 g in 34 g / zinc oxide 5.542 g in 34 g topical cream [shiseido suncare ultimate]||has_active_ingredient
honey bee||apis mellifera 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_x] in 1 ml / atropa belladonna 30 [hp_x] in 1 ml / chamomile 30 [hp_x] in 1 ml / echinacea 30 [hp_x] in 1 ml / lachesis muta venom 30 [hp_x] in 1 ml / mercurius solubilis 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml oral liquid [bac hp]||has_active_ingredient
claviceps purpurea sclerotium||american ginseng 1 [hp_x] in 1 ml / ginkgo 1 [hp_x] in 1 ml / centella asiatica 1 [hp_x] in 1 ml / fallopia multiflora root 1 [hp_x] in 1 ml / aronia melanocarpa fruit 3 [hp_x] in 1 ml / bilberry 3 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium chloride dihydrate 12 [hp_x] in 1 ml / potassium phosphate, dibasic 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / claviceps purpurea sclerotium 12 [hp_x] in 1 ml / tobacco leaf 12 [hp_x] in 1 ml / viscum album fruiting top 12 [hp_x] in 1 ml / ubidecarenone 30 [hp_x] in 1 ml / adenosine triphosphate 30 [hp_x] in 1 ml oral liquid [ginkgo tonic]||has_active_ingredient
äthanol||alcohol 10.353 ml in 14.79 ml topical gel [antimicrobial hand sanitizer]||has_active_ingredient
echinacea angustifolia extract||echinacea angustifolia 9 [hp_c] in 9 [hp_c] oral pellet [echinacea angustifolia]||has_active_ingredient
ferrlecit||sodium ferric gluconate complex 62.5 mg/5 ml intravenous solution [ferrlecit]||has_active_ingredient
dexmethylphenidate hydrochloride (substance)||dexmethylphenidate hydrochloride 5 mg oral capsule, extended release [focalin xr]||has_active_ingredient
2-butyl-4-chloro-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-methanol, monopotassium salt||hyzaar 50mg-12.5mg tablet||has_active_ingredient
t4 thyroxine sodium preparation||levothyroxine sodium 88mcg tablet (product)||has_active_ingredient
naphazoline hydrochloride(obsolete)||naphazoline hydrochloride .12 mg in 1 ml / polysorbate 80 2 mg in 1 ml ophthalmic liquid [rohto cool]||has_active_ingredient
äthylalkohol||alcohol 3.059 ml in 4.37 ml topical cloth [juicey alcohol hand wipes]||has_active_ingredient
guaianesin||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg / guaifenesin 200 mg oral capsule, liquid filled [daytime severe cold and flu daytime non-drowsy]||has_active_ingredient
2-(acetyloxy)benzoic acid||aspirin 81 mg oral tablet, dispersible||has_active_ingredient
bryonia alba root||aconitum napellus 3 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / toxicodendron pubescens leaf 4 [hp_x] in 1 ml / echinacea angustifolia 5 [hp_x] in 1 ml / sanguinaria canadensis root 5 [hp_x] in 1 ml / bryonia alba root 6 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 6 [hp_x] in 1 ml / euphorbia resinifera resin 6 [hp_x] in 1 ml / gelsemium sempervirens root 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / cortisone acetate 6 [hp_x] in 1 ml / dopamine hydrochloride 6 [hp_x] in 1 ml / silver nitrate 8 [hp_x] in 1 ml / arsenic trioxide 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / pulsatilla vulgaris 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / thuja occidentalis leafy twig 8 [hp_x] in 1 ml / glyoxal trimer dihydrate 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / pyruvaldehyde 10 [hp_x] in 1 ml / zinc 10 [hp_x] in 1 ml oral liquid [bio glyoxal phase]||has_active_ingredient
lachesis muta venom||hypericum perforatum 30 [hp_x] in 1 ml / lachesis muta venom 30 [hp_x] in 1 ml / lytta vesicatoria 30 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / plantago major 6 [hp_x] in 1 ml sublingual solution [d-78]||has_active_ingredient
octyl-methoxycinnamate||octinoxate 0.065 g in 1 g / titanium dioxide 0.024 g in 1 g / zinc oxide 0.015 g in 1 g topical paste [lbel mousse matiffiant matte finish mousse foundation spf 16 base textura mousse acabado mate fps 16 claire 2- beige]||has_active_ingredient
product containing dextromethorphan hydrobromide||gnp adult tussin cf max multi-symptom cold solution||has_active_ingredient
octyl salicylate (substance)||avobenzone 27 mg in 1 ml / homosalate 40 mg in 1 ml / octisalate 45 mg in 1 ml / octocrylene 60 mg in 1 ml / oxybenzone 45 mg in 1 ml topical lotion [neutrogena clear face breakout free oil free broad spectrum spf 55]||has_active_ingredient
antinauseants doxylamine succinate||dextromethorphan hydrobromide 30 mg in 20 ml / doxylamine succinate 12.5 mg in 20 ml oral solution [topcare tussin dm max]||has_active_ingredient
nicotine (substance)||gnp nicotine polacrilex 2mg chewing gum (cool mint)||has_active_ingredient
midazolam hydrochloride (product)||midazolam hydrochloride 1 mg in 1 ml intramuscular injection [midazolam]||has_active_ingredient
ethanols||alcohol 80 ml in 100 ml topical solution [mani spa guard antiseptic hand sanitizer]||has_active_ingredient
lignocaine hydrochloride [eye] (substance)||lidocaine hydrochloride 4 g in 1 ml topical cream [xolido]||has_active_ingredient
alkohol||alcohol 80 ml in 100 ml topical gel [iqt hand sanitizer gel]||has_active_ingredient
dextroamphetamine saccharate (product)||amphetamine/dextroamphetamine 7.5mg tab||has_active_ingredient
aluminum zirconium glycine tetrachloro hydrate complex||aluminum zirconium tetrachlorohydrex gly 80 mg in 1 ml topical cream [nosudamas for normal to dry skin]||has_active_ingredient
octylsalicylate||avobenzone 3 g in 100 g / homosalate 13 g in 100 g / octisalate 5 g in 100 g / octocrylene 2 g in 100 g / oxybenzone 4 g in 100 g topical spray [kroger kroger kids sunscreen spf 50]||has_active_ingredient
colloidal oatmeal (medication)||ecoderm 1 mg/ml topical lotion||has_active_ingredient
ondansetron monohydrochloride dihydrate||ondansetron hcl@2 mg/ml@intraven@vial (ml)||has_active_ingredient
2-hydroxy-1,2,3-propanetricarboxyic acid||2-hydroxypropanetricarboxylic acid||has_active_ingredient
product containing macrogol 3350||golytely 4 liter jug powder for solution (pineapple)||has_active_ingredient
allergenic extracts dust mite american house||felis catus hair 400 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.0004 g in 1 ml / gallus gallus feather 0.00003 g in 1 ml / anas platyrhynchos feather 0.00003 g in 1 ml / anser anser feather 0.00003 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / candida albicans 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml intradermal injection, solution||has_active_ingredient
pork liver, cooked||cynanchum vincetoxicum root 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / methylcobalamin 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / apc-356433 8 [hp_x] in 1 ml / apc-356434 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / gamboge 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / 7-oxodehydroepiandrosterone 3-acetate 30 [hp_x] in 1 ml / adenosine triphosphate disodium 30 [hp_x] in 1 ml / glucagon 30 [hp_x] in 1 ml / insulin pork 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [weight management]||has_active_ingredient
nci co28l3||piperonyl butoxide and pyrethrin only product||has_active_ingredient
field horsetail top extract||achillea millefolium 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / equisetum arvense top 3 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / apis mellifera 8 [hp_x] in 1 ml / ferrous disulfide 8 [hp_x] in 1 ml / larix decidua resin 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml oral liquid||has_active_ingredient
d3 - cholecalciferol||.beta.-carotene 600 [iu] / vitamin a acetate 1100 [iu] / ascorbic acid 60 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, dl- 30 [iu] / thiamine mononitrate 1.6 mg / riboflavin 1.8 mg / niacinamide 15 mg / pyridoxine hydrochloride 2.5 mg / folic acid 0.4 mg / levomefolate calcium 0.6 mg / cobalamin 5 ug / iron 29 mg / magnesium oxide 25 mg / zinc oxide 15 mg oral tablet, chewable [select ob]||has_active_ingredient
padimate o||oxybenzone 3 mg in 1 g / petrolatum 30.2 mg in 1 g / padimate o 8 mg in 1 g topical lipstick [eight hour lip spf 15]||has_active_ingredient
product containing chlorzoxozone (medicinal product)||chlorzoxazone only product in oral dose form||has_active_ingredient
urtica dioica pollen extract||plantago lanceolata pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / avena sativa pollen 0.00008 g in 1 ml / phleum pratense pollen 800 [bau] in 1 ml / pascopyrum smithii pollen 0.0004 g in 1 ml / felis catus hair 400 [bau] in 1 ml / periplaneta americana 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / morus rubra pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_ingredient
n2-[(1s)-1-carboxy-3-phenylpropyl]-l-lysyl-l-proline, dihydrate||product containing only lisinopril 20 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug)||has_active_ingredient
menthol (medication)||camphor 60 mg/ml / menthol 120 mg/ml topical cream [muellergesic]||has_active_ingredient
avobenzone-containing product||avobenzone 0.09 g in 4.25 g / octinoxate 0.28 g in 4.25 g / octisalate 0.21 g in 4.25 g / octocrylene 0.06 g in 4.25 g topical stick [beeswax spf 15 lip]||has_active_ingredient
diperodon||diperodon||has_active_ingredient
ranitidine-containing product||ranitidine 300 mg oral tablet [rantec]||has_active_ingredient
theophylline (medication)||ephedrine and theophylline only product in oral dose form||has_active_ingredient
benzalkonium chloride||benzalkonium chloride 0.8 g in 100 ml topical aerosol, foam [hand sanitizer]||has_active_ingredient
dioctyl sulfosuccinate, sodium||rite aid col-rite stool softener 100mg softgel||has_active_ingredient
cinacalcet hydrochloride (medication)||sensipar, 90 mg oral tablet||has_active_ingredient
acetamide, 2-(diethylamino)-n-(2,6-dimethylphenyl)-||lidocaine 560 mg transdermal patch [up and up lidocaine pain relief]||has_active_ingredient
hydrobromide, dextromethorphan||phenylephrine hydrochloride 5 mg / acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [vicks nyquil severe cold and flu]||has_active_ingredient
populus deltoides pollen||plantago lanceolata pollen 0.0004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.0004 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / morus rubra pollen 0.00008 g in 1 ml / urtica dioica pollen 0.0004 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / fraxinus americana pollen 0.0004 g in 1 ml / betula populifolia pollen 0.00008 g in 1 ml / acer negundo pollen 0.0004 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / ulmus americana pollen 0.0004 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.00008 g in 1 ml intradermal injection, solution||has_active_ingredient
carolina jessamine root||micrurus corallinus venom 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / gold 15 [hp_x] in 1 ml / barium carbonate 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / crotalus horridus horridus venom 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / picric acid 15 [hp_x] in 1 ml / lead 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / datura stramonium 15 [hp_x] in 1 ml / theridion curassavicum 15 [hp_x] in 1 ml / euphrasia stricta 3 [hp_x] in 1 ml oral liquid [macular degeneration]||has_active_ingredient
aspartate, magnesium||product containing only magnesium aspartate (medicinal product)||has_active_ingredient
acetaminophen||acetaminophen/chlorpheniramine maleate/phenylephrine hydrochloride 325 mg-2 mg-5 mg oral tablet [uni dri]||has_active_ingredient
4-hydroxyphenyl-beta-d-glucopyranoside||arbutin 2 g in 100 ml / adenosine 0.05 g in 100 ml topical cream [cellbn damage anti-aging eye reviver]||has_active_ingredient
hydroxyethane||alcohol 70 ml in 100 ml topical spray [citizen sanitizer 70% etoh]||has_active_ingredient
6 methylcompactin||lovastatin 40 mg oral tablet||has_active_ingredient
product containing benazepril hydrochloride||amlodipine besylate + benazepril hydrochloride 2.5mg/10mg capsule (product)||has_active_ingredient
octyl methoxycinnamate||avobenzone 2.7 g in 100 ml / homosalate 2 g in 100 ml / octinoxate 5 g in 100 ml / octocrylene 2.16 g in 100 ml topical cream [ultimate miracle worker eye spf 15]||has_active_ingredient
impatiens glandulifera flower||matricaria recutita 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / achillea millefolium 3 [hp_x] in 1 ml / bryonia alba root 4 [hp_x] in 1 ml / calendula officinalis flowering top 4 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / bellis perennis 6 [hp_x] in 1 ml / toxicodendron pubescens leaf 6 [hp_x] in 1 ml / clematis vitalba flower 8 [hp_x] in 1 ml / helianthemum nummularium flower 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / impatiens glandulifera flower 8 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml oral liquid [post-dental visit]||has_active_ingredient
b1 vitamins||ascorbic acid/cyanocobalamin/folic acid/niacin/pyridoxine/riboflavin/sodium fluoride/thiamine/vitamin a/vitamin d/vitamin e 60 mg-0.0045 mg-0.3 mg-13.5 mg-1.05 mg-1.2 mg-0.25 mg-1.05 mg-2500 iu-400 iu-15 iu oral tablet, chewable [multivitamin with fluoride]||has_active_ingredient
dl-erythro-alpha-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride||mefloquine hcl 250mg tab||has_active_ingredient
lysine acetate||alanine 21.7 mg/ml / arginine 14.7 mg/ml / aspartate 4.34 mg/ml / glutamate 7.49 mg/ml / glycine 10.4 mg/ml / histidine 8.94 mg/ml / isoleucine 7.49 mg/ml / leucine 10.4 mg/ml / lysine 11.8 mg/ml / methionine 7.49 mg/ml / phenylalanine 10.4 mg/ml / proline 8.94 mg/ml / serine 5.92 mg/ml / threonine 7.49 mg/ml / tryptophan 2.5 mg/ml / tyrosine 0.39 mg/ml / valine 9.6 mg/ml injectable solution [plenamine]||has_active_ingredient
narcotics morphine||product containing only morphine and naltrexone in oral dose form (medicinal product form)||has_active_ingredient
lassar paste||zinc oxide 11.6 mg in 100 ml topical cream [shineblock]||has_active_ingredient
sunscreen with zinc oxide (medication)||homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / zinc oxide 165 mg in 1 g topical lotion [obagi-c rx system sun shield broad spectrum spf 50 matte sunscreen]||has_active_ingredient
phenylephrine hydrochloride [cvs sympathomimetic] (product)||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [day cold and flu plus]||has_active_ingredient
benzalkonium chloride (substance)||benzalkonium chloride 4.66 g in 3782.95 g topical solution [insta-clear foaming hand sanitizer]||has_active_ingredient
5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,beta-trimethyl-,(z)-2-butenedioate(1:1)||product containing precisely trimipramine maleate 100 milligram/1 each conventional release oral capsule||has_active_ingredient
product containing nicotine||rite aid nicotine polacrilex 2mg chewing gum (cool mint)||has_active_ingredient
norethisterone [malignancy]||ethinyl estradiol+norethindrone 0.035mg/0.4mg tablet||has_active_ingredient
lactobacillus casei subsp. casei||bacillus subtilis/bifidobacterium breve/bifidobacterium lactis/bifidobacterium longum/lactobacillus acidophilus/lactobacillus casei/lactobacillus plantarum/lactobacillus rhamnosus/lactobacillus salivarius/lactobacillus sporogenes/probiotic cultures 30 billion org oral capsule [provad]||has_active_ingredient
benzalkonium chloride (substance)||benzalkonium chloride 0.13 mg in 1 ml topical swab [nice n clean wipes sani-hands antibacterial hand wipes]||has_active_ingredient
doryx||product containing precisely doxycycline hyclate 100 milligram/1 each conventional release oral capsule||has_active_ingredient
cynodon dactylon||poa pratensis pollen 160 [bau] in 1 ml / ulmus americana pollen 0.0004 g in 1 ml / ambrosia trifida pollen 0.000027 g in 1 ml / ambrosia artemisiifolia pollen 0.000027 g in 1 ml / ambrosia psilostachya pollen 0.000027 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.00008 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / populus deltoides pollen 0.0004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml intradermal injection, solution||has_active_ingredient
alpha-glyceryl guaiacol ether||acetaminophen/dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride 325 mg-15 mg-200 mg-5 mg oral tablet [leader pain relief cold pe]||has_active_ingredient
pork kidney preparation||cynanchum vincetoxicum root 6 [hp_x] / echinacea angustifolia 6 [hp_x] / sus scrofa hypothalamus 6 [hp_x] / pork liver 8 [hp_x] / pork kidney 8 [hp_x] / methylcobalamin 8 [hp_x] / gamboge 12 [hp_x] / graphite 12 [hp_x] / strychnos nux-vomica seed 12 [hp_x] / phytolacca americana root 12 [hp_x] / 7-keto-dehydroepiandrosterone 30 [hp_x] / adenosine triphosphate disodium 30 [hp_x] / glucagon 30 [hp_x] / insulin pork 30 [hp_x] / lactic acid, l- 30 [hp_x] / proteus vulgaris 30 [hp_c] oral tablet [professional weight support]||has_active_ingredient
paracetamol-containing product||acetaminophen/oxycodone hydrochloride 325 mg-5 mg oral tablet [percocet]||has_active_ingredient
benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||homosalate 8.5 g in 85 g / octinoxate 6.375 g in 85 g / titanium dioxide 2.737 g in 85 g / zinc oxide 4.25 g in 85 g topical lotion [obagi sun shield tint warm sunscreen broad spectrum spf 50]||has_active_ingredient
arsenous oxide||picric acid 15 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / onion 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / calendula officinalis flowering top 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / jacobaea maritima 15 [hp_x] in 1 g / euphrasia stricta 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / mercuric chloride 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / phytolacca americana root 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g oral pellet [eye care]||has_active_ingredient
strychnos nux-vomica seed extract||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / ambrosia artemisiifolia 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / euphrasia stricta 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml oral liquid [histastat pollen]||has_active_ingredient
1,4-benzenediol||hydroquinone 2% topical application gel/jelly||has_active_ingredient
aluminium hydroxide (in vac)||sunmark antacid, 200 mg-200 mg-20 mg/5 ml oral suspension||has_active_ingredient
aluminum (substance)||garlic 4 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium oxide 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / atropa belladonna 30 [hp_c] in 1 ml / berberis vulgaris root bark 30 [hp_c] in 1 ml / causticum 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / calcium sulfide 30 [hp_c] in 1 ml / hypericum perforatum 30 [hp_c] in 1 ml / ipecac 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / veratrum album root 30 [hp_c] in 1 ml oral liquid [7 heavy metal detox]||has_active_ingredient
zolpidem tartrate (substance)||zolpidem tartrate 6.25 mg oral tablet, film coated, extended release [zolpidem tartrate extended-release]||has_active_ingredient
product containing nelarabine (medicinal product)||nelarabine||has_active_ingredient
lime pyrolignite||calcium acetate 667 mg (calcium 169 mg) oral capsule||has_active_ingredient
pamoate, hydroxyzine||product containing hydroxyzine pamoate 25 mg/1 each oral capsule||has_active_ingredient
product containing lisinopril (medicinal product)||product containing only lisinopril 5 mg/1 each oral tablet||has_active_ingredient
ensulizole||titanium dioxide 0.819 g in 15 g / ensulizole 0.405 g in 15 g topical powder [thefaceshop cushion cc oil-free spf 50 natural beige]||has_active_ingredient
dihydroergotoxine mesylate||dihydroergotamine mesilate||has_active_ingredient
lactose, unspecified form||egg shell, cooked 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 15 [hp_x] in 1 ml / ascorbic acid 16 [hp_x] in 1 ml / black mustard seed 16 [hp_x] in 1 ml / solanum nigrum whole 16 [hp_x] in 1 ml / anacardium occidentale fruit 16 [hp_x] in 1 ml / solanum lycopersicum 16 [hp_x] in 1 ml / sodium nitrite 16 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / allylthiourea 15 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / amanita muscaria fruiting body 15 [hp_x] in 1 ml / onion 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / saccharin 15 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / lycoperdon utriforme fruiting body 15 [hp_x] in 1 ml / caffeine 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / cinnamon 15 [hp_x] in 1 ml / protortonia cacti 15 [hp_x] in 1 ml / cynara scolymus leaf 15 [hp_x] in 1 ml / alpine strawberry 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / solidago virgaurea flowering top 6 [hp_x] in 1 ml / urtica urens 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / sucrose 16 [hp_x] in 1 ml / mentha piperita 15 [hp_x] in 1 ml / abrus precatorius seed 15 [hp_x] in 1 ml / juglans regia leaf 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / nutmeg 15 [hp_x] in 1 ml / podophyllum 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / astacus astacus 16 [hp_x] in 1 ml / glycyrrhiza glabra 16 [hp_x] in 1 ml / solanum tuberosum 16 [hp_x] in 1 ml / saccharomyces cerevisiae 16 [hp_x] in 1 ml / lactose, unspecified form 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml oral liquid [food additives]||has_active_ingredient
butyl-methoxydibenzoylmethane||avobenzone 30 mg in 1 g / homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 50 mg in 1 g topical spray [fruit of the earth cabana beach club with manuka honey and essential oils spf 50]||has_active_ingredient
california black oak pollen extract||quercus agrifolia pollen 0.0166666 g in 1 ml / quercus kelloggii pollen 0.0166666 g in 1 ml / quercus garryana pollen 0.0166666 g in 1 ml subcutaneous solution [western oak pollen mix]||has_active_ingredient
phosphorus-31||ammonium carbonate 10 [hp_x] in 10 ml / asafetida 10 [hp_x] in 10 ml / baptisia tinctoria root 10 [hp_x] in 10 ml / activated charcoal 10 [hp_x] in 10 ml / phenol 10 [hp_x] in 10 ml / graphite 10 [hp_x] in 10 ml / wood creosote 10 [hp_x] in 10 ml / mercuric chloride 10 [hp_x] in 10 ml / nerium oleander leaf 10 [hp_x] in 10 ml / phosphorus 10 [hp_x] in 10 ml / toxicodendron pubescens leaf 10 [hp_x] in 10 ml / zinc 10 [hp_x] in 10 ml oral liquid [foul bowel]||has_active_ingredient
histamine dihydrochloride||histamine dihydrochloride 30 [hp_c] sublingual pellet [histaminum hydrochloricum]||has_active_ingredient
gallus species diagnostic allergen extract||chicken 0.05 g in 1 ml intradermal solution [chicken meat]||has_active_ingredient
artemisia ludoviciana pollen extract||artemisia ludoviciana pollen 0.1 g in 1 ml intradermal injection, solution||has_active_ingredient
triprolidine monohydrochloride||triprolidine hcl/dextromethorphan hbr/acetaminophen 2.5 mg-20 mg-650 mg/20 ml oral liquid (ml)||has_active_ingredient
enrofloxacin product||enrofloxacin 5 mg/ml / silver sulfadiazine 10 mg/ml otic solution||has_active_ingredient
sulphur product||xerophyllum asphodeloides 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / semecarpus anacardium juice 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / croton tiglium seed 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / grindelia hirsutula flowering top 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / ranunculus bulbosus 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / smilax ornata root 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / taraxacum officinale 6 [hp_x] in 1 ml / urtica urens 6 [hp_x] in 1 ml oral liquid [poison ivy]||has_active_ingredient
tree pollen-shagbark hickory||fraxinus americana pollen 40000 [pnu] in 1 ml / fagus grandifolia pollen 40000 [pnu] in 1 ml / betula nigra pollen 40000 [pnu] in 1 ml / juglans nigra pollen 40000 [pnu] in 1 ml / populus deltoides pollen 40000 [pnu] in 1 ml / ulmus americana pollen 40000 [pnu] in 1 ml / carya ovata pollen 40000 [pnu] in 1 ml / acer saccharum pollen 40000 [pnu] in 1 ml / quercus rubra pollen 40000 [pnu] in 1 ml / platanus occidentalis pollen 40000 [pnu] in 1 ml / salix nigra pollen 40000 [pnu] in 1 ml percutaneous injection, solution [pollens - trees, tree mix 11]||has_active_ingredient
1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol||24 hr venlafaxine 75 mg extended release oral tablet||has_active_ingredient
selenicereus grandiflorus stem||hamamelis virginiana bark 4 [hp_x] in 20 ml / mercurialis perennis 4 [hp_x] in 20 ml / crataegus fruit 4 [hp_x] in 20 ml / copper 12 [hp_x] in 20 ml / achillea millefolium 4 [hp_x] in 20 ml / equisetum arvense branch 4 [hp_x] in 20 ml / capsella bursa-pastoris 4 [hp_x] in 20 ml / selenicereus grandiflorus stem 4 [hp_x] in 20 ml oral liquid [unda 8]||has_active_ingredient
métronidazole||product containing metronidazole 500 mg/1 each oral tablet||has_active_ingredient
eucalyptus pollen (substance)||eucalyptus tree diagnostic allergen diagnostic allergen extract||has_active_ingredient
spongia officinalis skeleton extract||lycopus virginicus 1 [hp_x] in 100 ml / spongia officinalis skeleton, roasted 1 [hp_x] in 100 ml / lophophytum leandrii 6 [hp_x] in 100 ml / quinine arsenite 6 [hp_x] in 100 ml / tribasic calcium phosphate 8 [hp_x] in 100 ml / magnesium phosphate, dibasic trihydrate 8 [hp_x] in 100 ml oral liquid [lycopus]||has_active_ingredient
griseofulvin product||gris-peg, ultramicrocrystalline 125 mg oral tablet||has_active_ingredient
norcholestenol iodomethyl (131-i)||product containing norcholestenol iodomethyl (131-i) (medicinal product)||has_active_ingredient
menthol (product)||menthol 750 mg topical patch [cvs extra strength cold and hot medicated patch]||has_active_ingredient
16α,17α-isopropylidenedioxyprednisolone||desonide 0.05% lotion||has_active_ingredient
malus pumila flower||aconitum napellus 10 [hp_x] in 59 ml / angelica archangelica root 10 [hp_x] in 59 ml / silver nitrate 10 [hp_x] in 59 ml / calendula officinalis flowering top 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / black cohosh 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / lobelia cardinalis 10 [hp_x] in 59 ml / malus domestica flower 10 [hp_x] in 59 ml / achillea millefolium 10 [hp_x] in 59 ml / nitric acid 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sage 10 [hp_x] in 59 ml oral liquid [claustrophobia]||has_active_ingredient
proparacine product (product)||product containing proxymetacaine in ocular dose form (medicinal product form)||has_active_ingredient
clenbuterolum||clenbuterol-containing product||has_active_ingredient
ethyl alcohol (product)||alcohol 91 ml in 130 ml topical gel [aquabain instant hand sanitizer]||has_active_ingredient
paracetamol - chemical (substance)||gnp sinus pressure/pain maximum strength 325mg-5mg caplet||has_active_ingredient
sodium benzoate-containing product||sodium benzoate 0.5 g in 100 ml topical liquid [seo jeong ho hwang chill deodorant]||has_active_ingredient
antigen of haemophilus influenzae type b||vaccine product containing only acellular bordetella pertussis and clostridium tetani and corynebacterium diphtheriae and haemophilus influenzae type b and inactivated whole human poliovirus antigens (medicinal product)||has_active_ingredient
bd persist||ethanol 600 ml in 1000 ml topical gel [american continental techlabs, llc instant hand sanitizer]||has_active_ingredient
elymus repens pollen extract||elymus repens pollen 0.05 g in 1 ml intradermal injection [quackgrass pollen]||has_active_ingredient
tree pollen-white oak||amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya alba pollen 0.001 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml intradermal injection, solution||has_active_ingredient
menthol (substance)||menthol 3.0 g in 100 g / methyl salicylate 10.0 g in 100 g topical aerosol, spray [salonpas pain relieving jet]||has_active_ingredient
lime sulfur||calcium polysulfide 0.25 g in 100 g topical cream [classic lime sulfur]||has_active_ingredient
ciprofloxacin hydrochloride||product containing only ciprofloxacin hydrochloride 250 mg/1 each oral tablet||has_active_ingredient
fluorine-18 16 alpha-fluoroestradiol||f-18 16 alpha-fluoroestradiol||has_active_ingredient
cargosil||acyclovir 50 mg buccal tablet [sitavig]||has_active_ingredient
octocrilene-containing product||avobenzone 0.03 g in 1 ml / ensulizole 0.03 g in 1 ml / octisalate 0.05 g in 1 ml / octocrylene 0.05 g in 1 ml / oxybenzone 0.06 g in 1 ml topical lotion [lbel dermo clarite clarifying and moisturizing with spf 30]||has_active_ingredient
immunoglobulin (substance)||vaccinia immune globulin human im||has_active_ingredient
avobenzone||avobenzone 1286 mg in 51.45 g / octinoxate 3807 mg in 51.45 g / octocrylene 1029 mg in 51.45 g topical cream [shiseido benefiance nutriperfect day]||has_active_ingredient
benzocaine - chemical (substance)||zinc chloride 0.15 g in 100 g / menthol 0.25 g in 100 g / benzocaine 20 g in 100 g topical cream [cvs severe toothache and gum relief triple medicated]||has_active_ingredient
isopropyl alcohol product||isopropyl alcohol 70 ml in 100 ml topical swab||has_active_ingredient
carya ovata pollen||acer saccharum pollen 0.005 g in 1 ml / quercus rubra pollen 0.005 g in 1 ml / carya ovata pollen 0.005 g in 1 ml / fraxinus americana pollen 0.005 g in 1 ml / betula nigra pollen 0.005 g in 1 ml / liquidambar styraciflua pollen 0.005 g in 1 ml / ulmus americana pollen 0.005 g in 1 ml / platanus occidentalis pollen 0.005 g in 1 ml / fagus grandifolia pollen 0.005 g in 1 ml / populus deltoides pollen 0.005 g in 1 ml subcutaneous solution [eastern 10 tree pollen mix]||has_active_ingredient
octylmethoxycinnamate||avobenzone 30 mg in 1 ml / ensulizole 20 mg in 1 ml / octinoxate 20 mg in 1 ml / octocrylene 50 mg in 1 ml topical cream [black rice platinum absolute youth spf 15]||has_active_ingredient
valaciclovir hydrochloride||valacyclovir hydrochloride 500 mg oral tablet [valacyclovir]||has_active_ingredient
liquid paraffin [laxative] (substance)||mineral oil 20%/petrolatum 80% oph oint||has_active_ingredient
etoh||alcohol 68 l in 100 l topical gel [pfp polyclean hand sanitizer - gel 68]||has_active_ingredient
sus scrofa jejunum||adenosine triphosphate disodium 4 [hp_x] in 1 ml / apiole (parsley) 6 [hp_x] in 1 ml / benzoic acid 6 [hp_x] in 1 ml / choline hydroxide 6 [hp_x] in 1 ml / cinnamic acid 6 [hp_x] in 1 ml / eugenol 6 [hp_x] in 1 ml / folic acid 6 [hp_x] in 1 ml / formaldehyde 6 [hp_x] in 1 ml / histamine dihydrochloride 6 [hp_x] in 1 ml / asparagine monohydrate 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / cow milk 6 [hp_x] in 1 ml / menadione 6 [hp_x] in 1 ml / sus scrofa ovary 6 [hp_x] in 1 ml / phenyl isothiocyanate 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / lactose, unspecified form 6 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / coumarin 8 [hp_x] in 1 ml / estrone 8 [hp_x] in 1 ml / .gamma.-aminobutyric acid 8 [hp_x] in 1 ml / lactic acid, l- 8 [hp_x] in 1 ml / canis lupus familiaris milk 30 [hp_x] in 1 ml / felis catus milk 30 [hp_x] in 1 ml / human milk 30 [hp_c] in 1 ml / piperine 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 6 [hp_c] in 1 ml / calcium fluoride 6 [hp_c] in 1 ml / tribasic calcium phosphate 6 [hp_c] in 1 ml / activated charcoal 6 [hp_c] in 1 ml / matricaria recutita 6 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 6 [hp_c] in 1 ml / toxicodendron pubescens leaf 6 [hp_c] in 1 ml / calcium citrate 6 [hp_c] in 1 ml / calcium gluconate 6 [hp_c] in 1 ml oral liquid [dairy allergen mix]||has_active_ingredient
shade uvaguard||avobenzone 3.0 g in 100 ml / ensulizole 1.0 g in 100 ml / octisalate 5.0 g in 100 ml topical lotion [ponds luminous moisture day spf 15]||has_active_ingredient
prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13e)-||misoprostol oral product||has_active_ingredient
zanthoxylum americanum bark||selenicereus grandiflorus stem 10 [hp_x] in 59 ml / caulophyllum thalictroides root 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / black cohosh 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / viburnum opulus bark 10 [hp_x] in 59 ml / zanthoxylum americanum bark 10 [hp_x] in 59 ml oral liquid [menstrual cramps and irregularities]||has_active_ingredient
phenylephrine hcl [eye] (substance)||phenylephrine hydrochloride 10mg/1ml solution for injection_#1||has_active_ingredient
octyl-methoxycinnamate||octocrylene 70 mg in 1 ml / oxybenzone 60 mg in 1 ml / octisalate 50 mg in 1 ml / octinoxate 75 mg in 1 ml / titanium dioxide 57 mg in 1 ml topical lotion [cetaphil daily facial moisturizer with suncreen spf 50]||has_active_ingredient
dimeticona||dimethicone 3 g in 227 g topical lotion [xtracare with cooling action oatmeal skin relief calmin]||has_active_ingredient
product containing lactic acid||lactic acid 26.4 mg in 1 ml topical solution [uddercare plus part a]||has_active_ingredient
aripiprazole||aripiprazole 2 mg oral tablet with sensor and strip||has_active_ingredient
ciprofloxacin hydrochloride (medication)||ciprofloxacin hydrochloride 1 g in 1 g not applicable powder||has_active_ingredient
paroxetine hydrochloride hemihydrate (substance)||paroxetine hydrochloride, 30 mg oral tablet||has_active_ingredient
sulfamethoxazole (substance)||trimethoprim 160mg/sulfamethoxazole 800mg tablet||has_active_ingredient
methotrexate sodium (substance)||product containing only methotrexate 5 mg/1 each oral tablet||has_active_ingredient
dextromethmorphan hydrobromide||acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [nighttime]||has_active_ingredient
product containing epinephrine (medicinal product)||aconitum ferox root 10 [hp_x] in 59 ml / epinephrine 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / silver nitrate 10 [hp_x] in 59 ml / avena sativa flowering top 10 [hp_x] in 59 ml / baptisia tinctoria root 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / scutellaria lateriflora 10 [hp_x] in 59 ml / ferula sumbul root 10 [hp_x] in 59 ml / thyroid, unspecified 10 [hp_x] in 59 ml / viola odorata 10 [hp_x] in 59 ml / aesculus hippocastanum flower 10 [hp_x] in 59 ml / scleranthus annuus flowering top 10 [hp_x] in 59 ml oral liquid [mental calm]||has_active_ingredient
2-(1-h-imidazol-4-yl) ethylamine dihydrochloride||histamine dihydrochloride 30 [hp_x] in 23 g oral globule||has_active_ingredient
toradol||tropicamide 10 mg in 1 ml / ketorolac tromethamine 5 mg in 1 ml / proparacaine hydrochloride 5 mg in 1 ml / phenylephrine hydrochloride 25 mg in 1 ml ophthalmic solution/ drops [mydriatic-4]||has_active_ingredient
sodium tetrachloroaurate||sodium tetrachloroaurate 30 [hp_c] oral pellet [aurum muriaticum natronatum]||has_active_ingredient
metacortandracin||prednisone 10 mg oral tablet [predone]||has_active_ingredient
anemone pratensis extract||ginger 3 [hp_x] in 1 ml / ipecac 6 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / lactic acid, dl- 6 [hp_x] in 1 ml / cyclamen purpurascens tuber 8 [hp_x] in 1 ml / kerosene 8 [hp_x] in 1 ml / tobacco leaf 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / cadmium sulfide 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / colchicum autumnale bulb 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pulsatilla pratensis whole 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / theridion curassavicum 12 [hp_x] in 1 ml / euphorbia corollata root 24 [hp_x] in 1 ml oral liquid [nausia]||has_active_ingredient
sulphur product||sulfur 35 mg in 1 g topical cream [acne clearing sulfur mask]||has_active_ingredient
omc cinnamate||oxybenzone 5 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 4 g in 100 ml / octocrylene 4 g in 100 ml topical aerosol, spray [derma soleil dry sports 30 spf]||has_active_ingredient
titanium dioxide (product)||titanium dioxide 5 ml in 100 ml / zinc oxide 3 ml in 100 ml topical lotion [renewal daily moisturizer sensitive skin]||has_active_ingredient
oxide, zinc||titanium dioxide 7.75 g in 100 ml / zinc oxide 10 g in 100 ml topical cream [stay ageless tinted mineral sunscreen broad spectrum spf 30]||has_active_ingredient
rumex acetosella pollen||rumex acetosella pollen 0.05 g in 1 ml / rumex crispus pollen 0.05 g in 1 ml percutaneous injection, solution [sorrel/dock mix]||has_active_ingredient
pigment white 6||zinc oxide 6.4 mg in 100 ml / titanium dioxide 5.1 mg in 100 ml topical lotion [josie maran argan daily moisturizer spf47]||has_active_ingredient
strychnos nux-vomica seed extract||solidago virgaurea flowering top 3 [hp_x] in 1 ml / capsella bursa-pastoris 3 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 3 [hp_x] in 1 ml / mercury 8 [hp_x] in 1 ml / copaifera officinalis resin 9 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / equisetum hyemale 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / aconitum napellus 6 [hp_c] in 1 ml / benzoic acid 6 [hp_c] in 1 ml / tribasic calcium phosphate 6 [hp_c] in 1 ml / lytta vesicatoria 6 [hp_c] in 1 ml / strychnos ignatii seed 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / strychnos nux-vomica seed 6 [hp_c] in 1 ml / smilax regelii root 6 [hp_c] in 1 ml / delphinium staphisagria seed 6 [hp_c] in 1 ml / thuja occidentalis leafy twig 6 [hp_c] in 1 ml oral liquid [urinary tract]||has_active_ingredient
lisinopril||lisinopril, 40 mg oral tablet||has_active_ingredient
acetaminophen-containing product||acetaminophen 325 mg oral tablet [typhen]||has_active_ingredient
nystatin [systemic] (product)||nystatin/triamcinolone acetonide 100,000 unit/gram-0.1 % topical ointment (gram)||has_active_ingredient
melilotus officinalis||artemisia vulgaris root 2 [hp_x] in 1 ml / artemisia cina pre-flowering top 3 [hp_x] in 1 ml / melilotus officinalis top 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / teucrium marum 3 [hp_x] in 1 ml / thymus serpyllum 3 [hp_x] in 1 ml / dryopteris filix-mas root 4 [hp_x] in 1 ml / spigelia anthelmia 6 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / schoenocaulon officinale seed 12 [hp_x] in 1 ml / ascaris lumbricoides 15 [hp_x] in 1 ml / trichinella spiralis 15 [hp_x] in 1 ml / enterobius vermicularis 33 [hp_x] in 1 ml / taenia solium 12 [hp_c] in 1 ml / trichomonas vaginalis 13 [hp_c] in 1 ml / giardia lamblia 18 [hp_c] in 1 ml / cryptosporidium parvum 20 [hp_c] in 1 ml / taenia saginata 20 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [ver]||has_active_ingredient
venlafaxine hydrochloride (product)||effexor xr 75 mg 24hr extended release oral capsule||has_active_ingredient
doxycycline hyclate||doxycycline hyclate 100 mg oral capsule [morgidox]||has_active_ingredient
ethyl alcohol (product)||alcohol 620 mg in 1 g topical cloth [recens hand sanitizer wipes]||has_active_ingredient
5h-dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-||clozapine (accord) 100mg tab||has_active_ingredient
neomycin sulfate (substance)||repara triple antibiotic (bacitracin 400 unt / neomycin 3.5 mg / polymyxin b 5000 unt) per gm topical ointment||has_active_ingredient
gentianae radix||apis mellifera 6 [hp_x] in 50 ml / tribasic calcium phosphate 12 [hp_x] in 50 ml / solanum dulcamara top 6 [hp_x] in 50 ml / equisetum hyemale 4 [hp_x] in 50 ml / ferrous iodide 12 [hp_x] in 50 ml / fumaria officinalis flowering top 4 [hp_x] in 50 ml / gentiana lutea root 5 [hp_x] in 50 ml / geranium robertianum 4 [hp_x] in 50 ml / potassium iodide 8 [hp_x] in 50 ml / sodium sulfate 3 [hp_x] in 50 ml / pinus sylvestris leafy twig 4 [hp_x] in 50 ml / smilax ornata root 6 [hp_x] in 50 ml / scrophularia nodosa 3 [hp_x] in 50 ml / lobaria pulmonaria 5 [hp_x] in 50 ml / teucrium scorodonia flowering top 3 [hp_x] in 50 ml / veronica officinalis flowering top 3 [hp_x] in 50 ml oral liquid [bodyanew lymph lungs]||has_active_ingredient
p-acetamidophenol||acetaminophen 250 mg / aspirin 250 mg / caffeine 65 mg oral tablet, film coated [leader migraine relief]||has_active_ingredient
ledum palustre twig||goldenseal 11 [hp_x] in 1 ml / aconitum napellus 20 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml / bellis perennis 20 [hp_x] in 1 ml / calendula officinalis flowering top 20 [hp_x] in 1 ml / echinacea, unspecified 20 [hp_x] in 1 ml / gelsemium sempervirens root 20 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 20 [hp_x] in 1 ml / hypericum perforatum 20 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / ruta graveolens flowering top 20 [hp_x] in 1 ml / delphinium staphisagria seed 20 [hp_x] in 1 ml / comfrey root 20 [hp_x] in 1 ml oral liquid [injury-rescue]||has_active_ingredient
etanol||alcohol 0.70 topical cloth [moisturizing sanitizer towelettes green tea]||has_active_ingredient
paracetamol||acetaminophen/chlorpheniramine/pse||has_active_ingredient
ipecac||mercurius solubilis 5 [hp_c] / veratrum album root 5 [hp_c] / podophyllum 5 [hp_c] / chamomile 5 [hp_c] / ipecac 5 [hp_c] / pulsatilla vulgaris 5 [hp_c] oral liquid [bebelyn diarreah]||has_active_ingredient
dimeticone product||sunmark antacid, 400 mg-400 mg-40 mg/5 ml oral suspension||has_active_ingredient
ranitidine hydrochloride (medication)||ranitidine (as ranitidine hydrochloride) 25 mg/ml solution for injection||has_active_ingredient
apc-356434||cynanchum vincetoxicum root 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / methylcobalamin 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / apc-356433 8 [hp_x] in 1 ml / apc-356434 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / gamboge 14 [hp_x] in 1 ml / 7-oxodehydroepiandrosterone 3-acetate 30 [hp_x] in 1 ml / adenosine triphosphate disodium 30 [hp_x] in 1 ml / insulin pork 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [weight management]||has_active_ingredient
corynebacterium diphtheriae antigen||low dose diphtheria vaccine||has_active_ingredient
anser anser feather extract||goose feather extract 10000 unt/ml injectable solution||has_active_ingredient
hmds||17β-hydroxy-2-hydroxymethylidene-17α-methyl-3-androstanone||has_active_ingredient
cardio-vascular agents ivabradine||product containing ivabradine in oral dose form (medicinal product form)||has_active_ingredient
octyl methoxycinnamate (substance)||titanium dioxide 0.3 g in 30 ml / octinoxate 2.248 g in 30 ml / octocrylene 1.8 g in 30 ml topical cream [face guard advanced]||has_active_ingredient
naproxen (substance)||naproxen 500 mg oral tablet, delayed release||has_active_ingredient
octyl-methoxycinnamate||octinoxate 1.5 g in 30 g / titanium dioxide 0.48 g in 30 g topical emulsion [no7 beautifully matte foundation sunscreen broad spectrum spf 15 cool vanilla]||has_active_ingredient
serenoa||chimaphila umbellata 3 [hp_x] in 1 ml / sus scrofa pituitary gland 3 [hp_c] in 1 ml / saw palmetto 6 [hp_c] in 1 ml / arctostaphylos uva-ursi leaf 6 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / sarsaparilla 30 [hp_c] in 1 ml / potassium phosphate, dibasic 1 [hp_m] in 1 ml / phosphoric acid 1 [hp_m] in 1 ml / zinc 1 [hp_m] in 1 ml oral liquid [12 male reproductive]||has_active_ingredient
arnica montana whole extract||symphytum officinale whole 30 [hp_c] in 1 ml / zinnia elegans whole 30 [hp_c] in 1 ml / peppermint 30 [hp_c] in 1 ml / semecarpus anacardium juice 12 [hp_x] in 1 ml / musa x paradisiaca flower 30 [hp_c] in 1 ml / arnica montana 120 [hp_c] in 1 ml / strychnos ignatii seed 60 [hp_c] in 1 ml / calochortus gunnisonii whole 30 [hp_c] in 1 ml / citrus paradisi whole 30 [hp_c] in 1 ml / mimulus ringens whole 30 [hp_c] in 1 ml / ranunculus bulbosus whole 30 [hp_c] in 1 ml / ehrendorferia chrysantha whole 30 [hp_c] in 1 ml / chaste tree 6 [hp_x] in 1 ml / arnica montana flower 30 [hp_c] in 1 ml / rudbeckia hirta whole 30 [hp_c] in 1 ml / potassium bromide 10 [hp_x] in 1 ml / achillea millefolium flower 30 [hp_c] in 1 ml / cornus nuttallii whole 30 [hp_c] in 1 ml / toxicodendron diversilobum whole 30 [hp_c] in 1 ml / phosphoric acid 10 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 30 [hp_c] in 1 ml / phosphorus 12 [hp_x] in 1 ml / myosotis sylvatica flowering top 30 [hp_c] in 1 ml / melilotus officinalis top 30 [hp_c] in 1 ml / canis lupus familiaris milk 10 [hp_x] in 1 ml / carnegiea gigantea flower 30 [hp_c] in 1 ml / eriodictyon californicum flowering top 30 [hp_c] in 1 ml / pinus sylvestris flowering top 30 [hp_c] in 1 ml sublingual solution/ drops [f15 mnd-mmry]||has_active_ingredient
stannum||aluminum oxide 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / arsenic triiodide 10 [hp_x] in 59 ml / berberis vulgaris root bark 10 [hp_x] in 59 ml / cadmium sulfide 10 [hp_x] in 59 ml / chelidonium majus 10 [hp_x] in 59 ml / chromic oxide 10 [hp_x] in 59 ml / copper 10 [hp_x] in 59 ml / cysteine 10 [hp_x] in 59 ml / glycerin 10 [hp_x] in 59 ml / glycyrrhiza glabra 10 [hp_x] in 59 ml / potassium chloride 10 [hp_x] in 59 ml / magnesium sulfate heptahydrate 10 [hp_x] in 59 ml / mercuric chloride 10 [hp_x] in 59 ml / mercuric cyanide 10 [hp_x] in 59 ml / calomel 10 [hp_x] in 59 ml / daphne mezereum bark 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / nickel 10 [hp_x] in 59 ml / cod liver oil 10 [hp_x] in 59 ml / phytolacca americana root 10 [hp_x] in 59 ml / lead iodide 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / selenium 10 [hp_x] in 59 ml / solidago virgaurea flowering top 10 [hp_x] in 59 ml / tin 10 [hp_x] in 59 ml oral liquid [heavy metal detox]||has_active_ingredient
privet tree pollen||privet pollen extract 50 mg/ml injectable solution||has_active_ingredient
mountain arnica||arnica montana 3 [hp_x] in 1 ml / matricaria recutita 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / boron gluconate 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / hekla lava 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml oral liquid [calciforce]||has_active_ingredient
sus scrofa lymph||milk thistle 3 [hp_x] in 1 ml / chelidonium majus 4 [hp_x] in 1 ml / cinchona officinalis bark 4 [hp_x] in 1 ml / lycopodium clavatum spore 4 [hp_x] in 1 ml / taraxacum officinale 4 [hp_x] in 1 ml / veratrum album root 4 [hp_x] in 1 ml / avena sativa flowering top 6 [hp_x] in 1 ml / cynara scolymus leaf 6 [hp_x] in 1 ml / methylcobalamin 6 [hp_x] in 1 ml / menadione 6 [hp_x] in 1 ml / .alpha.-lipoic acid 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 10 [hp_x] in 1 ml / cholesterol 10 [hp_x] in 1 ml / formic acid 10 [hp_x] in 1 ml / glyoxal trimer dihydrate 10 [hp_x] in 1 ml / histamine dihydrochloride 10 [hp_x] in 1 ml / malic acid 10 [hp_x] in 1 ml / sodium diethyl oxalacetate 10 [hp_x] in 1 ml / sulfur 13 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 28 [hp_x] in 1 ml / orotic acid monohydrate 7 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [detox i]||has_active_ingredient
phenylephrine hcl [eye] (product)||acetaminophen/dextromethorphan hydrobromide/doxylamine succinate/phenylephrine hydrochloride 325 mg/15 ml-10 mg/15 ml-6.25 mg/15 ml-5 mg/15 ml oral solution [good neighbor pharmacy cold multi-symptom]||has_active_ingredient
etanol||alcohol 62 ml in 100 ml topical solution [scott moisturizing instant hand sanitizer]||has_active_ingredient
niacinamide (substance)||niacinamide 2 g in 100 ml / adenosine 0.04 g in 100 ml topical cream [abalone aqua flood water]||has_active_ingredient
levothyroxine sodium preparation (product)||levothyroxine sodium 25mcg tablet||has_active_ingredient
euphorbia resinifera resin||onion 8 [hp_x] in 30 ml / apis mellifera 12 [hp_x] in 30 ml / aralia racemosa root 1 [hp_x] in 30 ml / silver nitrate 10 [hp_x] in 30 ml / ascorbic acid 2 [hp_x] in 30 ml / black currant 1 [hp_x] in 30 ml / helianthemum canadense 4 [hp_x] in 30 ml / copper 4 [hp_x] in 30 ml / euphorbia resinifera resin 4 [hp_x] in 30 ml / histamine dihydrochloride 200 [hp_x] in 30 ml / interferon gamma-1b 4 [hp_c] in 30 ml / interleukin-10 4 [hp_c] in 30 ml / human interleukin 12 4 [hp_c] in 30 ml / manganese gluconate 4 [hp_x] in 30 ml / melilotus 3 [hp_x] in 30 ml / plantago major 2 [hp_x] in 30 ml / rosa canina fruit 1 [hp_x] in 30 ml / european elderberry 2 [hp_x] in 30 ml oral spray [guna-rhino nose]||has_active_ingredient
glucose monohydrate (substance)||dextrose 30 % in water 30 % intraven intravenous solution||has_active_ingredient
ethanol-containing product||ethanol 60.7 % / isopropyl alcohol 8.7 % topical spray||has_active_ingredient
may apple root||antimony trisulfide 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / bismuth 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / matricaria recutita 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / magnesium carbonate 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / podophyllum 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / daikon 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / tobacco leaf 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / juglans regia fruit rind, immature 3 [hp_x] in 1 ml oral liquid [digestive care]||has_active_ingredient
product containing zinc and/or zinc compound||arsenic trioxide 12 [hp_x] / lycopodium clavatum spore 6 [hp_x] / pulsatilla vulgaris 6 [hp_x] / toxicodendron pubescens leaf 6 [hp_x] / sulfur 6 [hp_x] / zinc 12 [hp_x] oral tablet, soluble [restful legs]||has_active_ingredient
echinacea angustifolia whole||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / fucus vesiculosus 3 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / cadmium sulfide 13 [hp_x] in 1 ml oral liquid [free radistat]||has_active_ingredient
succinylcholine chloride (substance)||succinylcholine chloride 20 mg/ml injection vial (ml)||has_active_ingredient
teicoplanin (substance)||product containing only teicoplanin in parenteral dose form (medicinal product form)||has_active_ingredient
phenazopyridine hydrochloride||phenazopyridine hydrochloride 95 mg oral tablet [urinary pain relief]||has_active_ingredient
monosodium dihydrogen monophosphate||cvs disposable rectal enema (triple pack)||has_active_ingredient
product containing strontium (product)||activated charcoal 4 [hp_x] in 1 ml / iron 4 [hp_x] in 1 ml / sulfur 4 [hp_x] in 1 ml / magnesium 4 [hp_x] in 1 ml / aluminum 4 [hp_x] in 1 ml / calcium 4 [hp_x] in 1 ml / silicon 4 [hp_x] in 1 ml / phosphorus 4 [hp_x] in 1 ml / chloride ion 4 [hp_x] in 1 ml / manganese 4 [hp_x] in 1 ml / zinc 4 [hp_x] in 1 ml / potassium 4 [hp_x] in 1 ml / lanthanum 4 [hp_x] in 1 ml / nickel 4 [hp_x] in 1 ml / selenium 4 [hp_x] in 1 ml / beryllium 4 [hp_x] in 1 ml / vanadium 4 [hp_x] in 1 ml / boron 4 [hp_x] in 1 ml / yttrium 4 [hp_x] in 1 ml / strontium 4 [hp_x] in 1 ml / gadolinium 4 [hp_x] in 1 ml / cobalt 4 [hp_x] in 1 ml / fluoride ion 4 [hp_x] in 1 ml / neodymium 4 [hp_x] in 1 ml / chromium 4 [hp_x] in 1 ml / tellurium 4 [hp_x] in 1 ml / bromine 4 [hp_x] in 1 ml / copper 4 [hp_x] in 1 ml / lithium 4 [hp_x] in 1 ml / antimony 4 [hp_x] in 1 ml / titanium 4 [hp_x] in 1 ml / zirconium 4 [hp_x] in 1 ml / rubidium 4 [hp_x] in 1 ml / sodium 4 [hp_x] in 1 ml / thulium 4 [hp_x] in 1 ml / molybdenum 4 [hp_x] in 1 ml / samarium 4 [hp_x] in 1 ml / ytterbium 4 [hp_x] in 1 ml / iodine 4 [hp_x] in 1 ml / cerium 4 [hp_x] in 1 ml / dysprosium 4 [hp_x] in 1 ml / praseodymium 4 [hp_x] in 1 ml / scandium 4 [hp_x] in 1 ml / erbium 4 [hp_x] in 1 ml / lutetium 4 [hp_x] in 1 ml / gallium 4 [hp_x] in 1 ml / thorium 4 [hp_x] in 1 ml / tungsten 4 [hp_x] in 1 ml / barium 4 [hp_x] in 1 ml / tin 4 [hp_x] in 1 ml / bismuth 4 [hp_x] in 1 ml / holmium 4 [hp_x] in 1 ml / tantalum 4 [hp_x] in 1 ml / terbium 4 [hp_x] in 1 ml / germanium 4 [hp_x] in 1 ml / indium 4 [hp_x] in 1 ml / thallium 4 [hp_x] in 1 ml / cesium 4 [hp_x] in 1 ml / ruthenium 4 [hp_x] in 1 ml / silver 4 [hp_x] in 1 ml / europium 4 [hp_x] in 1 ml / niobium 4 [hp_x] in 1 ml / hafnium 4 [hp_x] in 1 ml / rhenium 4 [hp_x] in 1 ml / gold 4 [hp_x] in 1 ml / iridium 4 [hp_x] in 1 ml / osmium 4 [hp_x] in 1 ml / palladium 4 [hp_x] in 1 ml / platinum 4 [hp_x] in 1 ml / rhodium 4 [hp_x] in 1 ml oral liquid [trace mineral cord]||has_active_ingredient
toxicodendron pubescens leaf||silver nitrate 200 [hp_c] / toxicodendron pubescens leaf 200 [hp_c] oral pellet [sloth 40 (number 104)]||has_active_ingredient
octocrylene||octinoxate 1557 mg in 31.77 g / octocrylene 953 mg in 31.77 g / zinc oxide 3971 mg in 31.77 g topical lotion [shiseido urban environment oil-free uv protector]||has_active_ingredient
spigelia anthelmia whole preparation||barium carbonate 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / artemisia cina flower 30 [hp_x] in 1 ml / iron 30 [hp_x] in 1 ml / mercuric sulfate 30 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 30 [hp_x] in 1 ml / schoenocaulon officinale seed 30 [hp_x] in 1 ml / spigelia anthelmia 30 [hp_x] in 1 ml / teucrium marum 30 [hp_x] in 1 ml oral liquid [verma hp]||has_active_ingredient
trichophyton rubrum allergenic extract||trichophyton rubrum 0.05 g in 1 ml intradermal solution||has_active_ingredient
omc cinnamate||octinoxate 0.065 g in 1 ml / titanium dioxide 0.016 g in 1 ml topical liquid [lbel natural finish moisturizing foundation spf 25 (medium 6) - brown]||has_active_ingredient
(s)-1-(3-mercapto-2-methyl-1-oxopropyl)-l-proline||captopril 25mg oral tablet||has_active_ingredient
aureobasidium pullulans var. pullutans||aureobasidium pullulans var. pullutans extract 0.1 gm/ml injectable solution||has_active_ingredient
tenofovir df||truvada, 200 mg-300 mg oral tablet||has_active_ingredient
galphimia glauca flowering top||adenosine cyclic phosphate 12 [hp_x] in 59 ml / epinephrine 12 [hp_x] in 59 ml / corticotropin 12 [hp_x] in 59 ml / hyacinthoides non-scripta 12 [hp_x] in 59 ml / onion 12 [hp_x] in 59 ml / collinsonia canadensis root 12 [hp_x] in 59 ml / cortisone acetate 12 [hp_x] in 59 ml / euphrasia stricta 12 [hp_x] in 59 ml / galphimia glauca flowering top 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / potassium chloride 12 [hp_x] in 59 ml / sus scrofa nasal mucosa 12 [hp_x] in 59 ml / sodium chloride 12 [hp_x] in 59 ml / saccharomyces cerevisiae rna 12 [hp_x] in 59 ml / rumex crispus root 12 [hp_x] in 59 ml / schoenocaulon officinale seed 12 [hp_x] in 59 ml / sage 12 [hp_x] in 59 ml / tanacetum vulgare top 12 [hp_x] in 59 ml / trifolium pratense flower 12 [hp_x] in 59 ml / vinca minor 12 [hp_x] in 59 ml oral liquid [allergies northeast u.s.]||has_active_ingredient
teucrium marum extract||juglans regia leaf 6 [hp_x] in 1 ml / spigelia anthelmia 15 [hp_x] in 1 ml / thymol 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / artemisia cina pre-flowering top 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / dryopteris filix-mas root 15 [hp_x] in 1 ml / punica granatum root bark 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / artemisia abrotanum flowering top 15 [hp_x] in 1 ml / naphthalene 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / krameria lappacea root 15 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / schoenocaulon officinale seed 15 [hp_x] in 1 ml / santonin 15 [hp_x] in 1 ml / horse chestnut 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / turpentine oil 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / teucrium marum 15 [hp_x] in 1 ml / artemisia vulgaris root 15 [hp_x] in 1 ml oral liquid [parasites]||has_active_ingredient
p-hydroxyphenol||hydroquinone 1 g in 50 g / octinoxate .25 g in 50 g topical cream [top white]||has_active_ingredient
thuja occidentalis leaf||astragalus propinquus root 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / gentiana lutea root 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / mercurius solubilis 30 [hp_c] in 1 ml / pulsatilla vulgaris 30 [hp_c] in 1 ml / sepia officinalis juice 30 [hp_c] in 1 ml / thuja occidentalis leaf 30 [hp_c] in 1 ml oral liquid [8 fungal yeast infection]||has_active_ingredient
nabumeton||nabumetone 500 mg oral tablet, film coated [nabumetone 500 mg]||has_active_ingredient
estradiol-containing product||estradiol 0.06% gel (product)||has_active_ingredient
johnson grass pollen extract||anthoxanthum odoratum pollen 4000 [bau] in 1 ml / cynodon dactylon pollen 2000 [bau] in 1 ml / lolium perenne pollen 4000 [bau] in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.01 g in 1 ml / dermatophagoides pteronyssinus 2000 [au] in 1 ml / dactylis glomerata pollen 4000 [bau] in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml intradermal injection, solution||has_active_ingredient
frovatriptan-containing product||oral form frovatriptan||has_active_ingredient
ethanol-containing product||alcohol 2838 ml in 3785 ml topical gel [hand sanitizer]||has_active_ingredient
product containing dimeticone||dimethicone 125 mg oral capsule, liquid filled [extra strength gas relief]||has_active_ingredient
ethanol-containing product||alcohol 75 ml in 100 ml topical gel [germs be gone hand sanitizer]||has_active_ingredient
human papillomavirus type 45 l1 capsid protein antigen||gardasil 9, 9-valent intramuscular suspension_#1||has_active_ingredient
pholcodine (product)||folcodina||has_active_ingredient
diphenoxylate (substance)||product containing only atropine and diphenoxylate (medicinal product)||has_active_ingredient
octyl salicylate (substance)||avobenzone 30 mg in 1 g / homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 40 mg in 1 g / oxybenzone 50 mg in 1 g topical aerosol, spray [h.e.b solutions sunscreen]||has_active_ingredient
capsaicin-containing product||capsaicin, 0.025% topical film||has_active_ingredient
2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide||gen7t 3.5% topical patch||has_active_ingredient
ailanthus altissima pollen||ambrosia trifida pollen 0.00125 g in 1 ml / ambrosia bidentata pollen 0.00125 g in 1 ml / ambrosia artemisiifolia pollen 0.00125 g in 1 ml / ambrosia psilostachya pollen 0.00125 g in 1 ml / amaranthus palmeri pollen 0.00125 g in 1 ml / amaranthus retroflexus pollen 0.00125 g in 1 ml / amaranthus spinosus pollen 0.00125 g in 1 ml / amaranthus tuberculatus pollen 0.00125 g in 1 ml / kochia scoparia pollen 0.005 g in 1 ml / fagus grandifolia pollen 0.00021 g in 1 ml / platanus occidentalis pollen 0.00021 g in 1 ml / juglans nigra pollen 0.00021 g in 1 ml / salix nigra pollen 0.00021 g in 1 ml / carpinus caroliniana pollen 0.00021 g in 1 ml / picea pungens pollen 0.00021 g in 1 ml / acer negundo pollen 0.00021 g in 1 ml / pinus strobus pollen 0.00021 g in 1 ml / celtis occidentalis pollen 0.00021 g in 1 ml / acer saccharum pollen 0.00021 g in 1 ml / juniperus ashei pollen 0.00021 g in 1 ml / betula papyrifera pollen 0.00021 g in 1 ml / juniperus virginiana pollen 0.00021 g in 1 ml / acer rubrum pollen 0.00021 g in 1 ml / morus rubra pollen 0.00021 g in 1 ml / juniperus pinchotii pollen 0.00021 g in 1 ml / carya ovata pollen 0.00021 g in 1 ml / acer saccharinum pollen 0.00021 g in 1 ml / liquidambar styraciflua pollen 0.00021 g in 1 ml / ailanthus altissima pollen 0.00021 g in 1 ml / fraxinus americana pollen 0.00021 g in 1 ml / carya alba pollen 0.00021 g in 1 ml / morus alba pollen 0.00021 g in 1 ml / populus alba pollen 0.00021 g in 1 ml / cynodon dactylon pollen 1045.5 [bau] in 1 ml / poa pratensis pollen 454.5 [bau] in 1 ml / festuca pratensis pollen 454.5 [bau] in 1 ml / dactylis glomerata pollen 454.5 [bau] in 1 ml / lolium perenne pollen 454.5 [bau] in 1 ml / agrostis gigantea pollen 454.5 [bau] in 1 ml / anthoxanthum odoratum pollen 454.5 [bau] in 1 ml / phleum pratense pollen 454.5 [bau] in 1 ml / poa compressa pollen 0.000227 g in 1 ml / typha latifolia pollen 0.000227 g in 1 ml / bromus secalinus pollen 0.000227 g in 1 ml / zea mays pollen 0.000227 g in 1 ml / secale cereale pollen 0.000227 g in 1 ml / triticum aestivum pollen 0.000227 g in 1 ml / sorghum halepense pollen 0.000227 g in 1 ml / elymus repens pollen 0.000227 g in 1 ml / phalaris arundinacea pollen 0.000227 g in 1 ml / bromus inermis pollen 0.000227 g in 1 ml / sorghum bicolor ssp. drummondii pollen 0.000227 g in 1 ml / arrhenatherum elatius pollen 0.000227 g in 1 ml / holcus lanatus pollen 0.000227 g in 1 ml / pascopyrum smithii pollen 0.000227 g in 1 ml / artemisia vulgaris pollen 0.00125 g in 1 ml / artemisia absinthium pollen 0.00125 g in 1 ml / artemisia tridentata pollen 0.00125 g in 1 ml / artemisia ludoviciana pollen 0.00125 g in 1 ml / iva xanthifolia pollen 0.0025 g in 1 ml / iva annua var. annua pollen 0.0025 g in 1 ml / rumex crispus pollen 0.0025 g in 1 ml / rumex acetosella pollen 0.0025 g in 1 ml intradermal injection, solution||has_active_ingredient
atenolol (product)||(spl review) atenolol 25 mg oral tablet||has_active_ingredient
anemone pulsatilla whole||silver nitrate 6 [hp_x] / asafetida 6 [hp_x] / activated charcoal 12 [hp_x] / matricaria recutita 6 [hp_x] / cinchona officinalis bark 6 [hp_x] / citrullus colocynthis fruit pulp 6 [hp_x] / lycopodium clavatum spore 30 [hp_x] / nutmeg 6 [hp_x] / pulsatilla vulgaris 6 [hp_x] oral tablet [tummy ache 4kids]||has_active_ingredient
aesculus hippocastanum flower||helianthemum nummularium flower 5 [hp_x] in 0.095 ml / clematis vitalba flower 5 [hp_x] in 0.095 ml / impatiens glandulifera flower 5 [hp_x] in 0.095 ml / prunus cerasifera flower 5 [hp_x] in 0.095 ml / ornithogalum umbellatum whole 5 [hp_x] in 0.095 ml / aesculus hippocastanum flower 5 [hp_x] in 0.095 ml oral solution [rescue sleep]||has_active_ingredient
oxypertine-containing product||oxypertine||has_active_ingredient
chlorine gas||berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / salicylic acid 30 [hp_x] in 1 ml / corticotropin 30 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / eugenol 30 [hp_x] in 1 ml / stearyl alcohol 30 [hp_x] in 1 ml / xylitol 30 [hp_x] in 1 ml / estrone 30 [hp_x] in 1 ml / benzoic acid 30 [hp_x] in 1 ml / chlorine 30 [hp_x] in 1 ml / potassium sorbate 30 [hp_x] in 1 ml / sorbitol 30 [hp_x] in 1 ml / resorcinol 30 [hp_x] in 1 ml / benzyl alcohol 30 [hp_x] in 1 ml / lactic acid 30 [hp_x] in 1 ml / isopropyl palmitate 30 [hp_x] in 1 ml / boric acid 30 [hp_x] in 1 ml / acetic acid 30 [hp_x] in 1 ml / phenylbutazone 30 [hp_x] in 1 ml / petrolatum 30 [hp_x] in 1 ml / lead 30 [hp_x] in 1 ml oral liquid [chemtox]||has_active_ingredient
alkylbenzyldimethylammonium chloride||benzalkonium chloride 0.23 mg in 180 mg topical gel [dr lift antibacterial body scrub]||has_active_ingredient
alcohol, grain||alcohol 70 ml in 100 ml topical gel [zen hand sanitizer]||has_active_ingredient
disodium phosphorofluoridate||sodium monofluorophosphate 0.15% dental paste [aquafresh]||has_active_ingredient
egg extract||potassium gluconate 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / coffea arabica seed, roasted 10 [hp_x] in 1 ml / green tea leaf 10 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / peanut 12 [hp_x] in 1 ml / black walnut 12 [hp_x] in 1 ml / english walnut 12 [hp_x] in 1 ml / almond 12 [hp_x] in 1 ml / cashew 12 [hp_x] in 1 ml / coconut 12 [hp_x] in 1 ml / pecan 12 [hp_x] in 1 ml / brazil nut 12 [hp_x] in 1 ml / tomato 12 [hp_x] in 1 ml / potato 12 [hp_x] in 1 ml / black pepper 12 [hp_x] in 1 ml / eggplant 12 [hp_x] in 1 ml / canola oil 12 [hp_x] in 1 ml / flax seed 12 [hp_x] in 1 ml / sesame seed 12 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium roqueforti cultured, aged 12 [hp_x] in 1 ml / cow milk 12 [hp_x] in 1 ml / beef 12 [hp_x] in 1 ml / lamb 12 [hp_x] in 1 ml / pork 12 [hp_x] in 1 ml / chicken 12 [hp_x] in 1 ml / egg 12 [hp_x] in 1 ml / kidney bean 12 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / apple 12 [hp_x] in 1 ml / wheat 12 [hp_x] in 1 ml / banana 12 [hp_x] in 1 ml / strawberry 12 [hp_x] in 1 ml / orange 12 [hp_x] in 1 ml / atlantic cod 12 [hp_x] in 1 ml / northern bluefin tuna 12 [hp_x] in 1 ml / atlantic salmon 12 [hp_x] in 1 ml / edible rock crab 12 [hp_x] in 1 ml / pacific oyster 12 [hp_x] in 1 ml / common shrimp 12 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / histamine dihydrochloride 30 [hp_x] in 1 ml / hyaluronidase 30 [hp_x] in 1 ml / interferon .gamma. porcine recombinant 30 [hp_x] in 1 ml / serotonin hydrochloride 30 [hp_x] in 1 ml / cocoa 10 [hp_c] in 1 ml oral liquid [enviro i]||has_active_ingredient
methylcarbinol||alcohol 0.8 ml in 1 ml topical cloth [latalia sanitizing wipes]||has_active_ingredient
calendula officinalis flowering top||strychnos ignatii seed 30 [hp_x] in 1 ml / delphinium staphisagria seed 8 [hp_x] in 1 ml / echinacea purpurea 3 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / calendula officinalis flowering top 3 [hp_x] in 1 ml / ledum palustre twig 6 [hp_x] in 1 ml / arnica montana 18 [hp_x] in 1 ml / ruta graveolens flowering top 12 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / hypericum perforatum 10 [hp_x] in 1 ml / matricaria recutita 5 [hp_x] in 1 ml topical gel [stellalife vega oral care gel]||has_active_ingredient
trichoderma viride extract||cladosporium cladosporioides 0.005 g in 1 ml / acremonium strictum 0.005 g in 1 ml / trichothecium roseum 0.00036 g in 1 ml / passalora fulva 0.00036 g in 1 ml / cochliobolus spicifer 0.00036 g in 1 ml / myrothecium verrucaria 0.00036 g in 1 ml / hypomyces perniciosus 0.00036 g in 1 ml / neurospora crassa 0.00036 g in 1 ml / khuskia oryzae 0.00036 g in 1 ml / paecilomyces variotii 0.00036 g in 1 ml / microascus brevicaulis 0.00036 g in 1 ml / colletotrichum coccodes 0.00036 g in 1 ml / pleospora herbarum 0.00036 g in 1 ml / streptomyces griseus 0.00036 g in 1 ml / trichoderma viride 0.00036 g in 1 ml / trichophyton schoenleinii 0.00036 g in 1 ml / mycocladus corymbiferus 0.00042 g in 1 ml / acrothecium robustum 0.00042 g in 1 ml / humicola grisea 0.00042 g in 1 ml / microsporum audouinii 0.00042 g in 1 ml / microsporum canis 0.00042 g in 1 ml / apiospora montagnei 0.00042 g in 1 ml / phycomyces blakesleeanus 0.00042 g in 1 ml / sporotrichum pruinosum 0.00042 g in 1 ml / stachybotrys chartarum 0.00042 g in 1 ml / syncephalastrum racemosum 0.00042 g in 1 ml / tetracoccosporium paxianum 0.00042 g in 1 ml / verticillium albo-atrum 0.00042 g in 1 ml / ustilago cynodontis 0.0025 g in 1 ml / sporisorium cruentum 0.0025 g in 1 ml / canis lupus familiaris hair 0.005 g in 1 ml / felis catus hair 500 [bau] in 1 ml intradermal injection, solution||has_active_ingredient
clavulanate potassium (product)||amoxicillin/clavulanate potassium 500 mg-125 mg oral tablet||has_active_ingredient
product containing hydromorphone hydrochloride||dilaudid-5, 1 mg/ml oral liquid||has_active_ingredient
vitamin b a 02||product containing only riboflavin in oral dose form (medicinal product form)||has_active_ingredient
thylox||juniperus communis stem 9 [hp_x] in 1 ml / sodium hypochlorite 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_x] in 1 ml / phenol 30 [hp_x] in 1 ml / chelidonium majus 9 [hp_x] in 1 ml / histamine dihydrochloride 30 [hp_x] in 1 ml / ichthammol 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / mercurius solubilis 30 [hp_x] in 1 ml / sodium bicarbonate 30 [hp_x] in 1 ml / solidago virgaurea flowering top 9 [hp_x] in 1 ml / anhydrous citric acid 30 [hp_x] in 1 ml / benzoic acid 30 [hp_x] in 1 ml / berberis vulgaris root bark 12 [hp_x] in 1 ml / betula pendula leaf 9 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / chlorine 30 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml sublingual solution/ drops [n03 exchem]||has_active_ingredient
magnesium sulfate heptahydrate (substance)||magnesium sulphate 5%(4gm/100ml) intravenous||has_active_ingredient
candida albicans extract||fusarium oxysporum 0.0008 g in 1 ml / cladosporium cladosporioides 0.0008 g in 1 ml / poa pratensis pollen 3333.33 [bau] in 1 ml / cynodon dactylon pollen 333.33 [bau] in 1 ml / cochliobolus sativus 0.0008 g in 1 ml / candida albicans 0.0008 g in 1 ml / aspergillus fumigatus 0.0008 g in 1 ml / sorghum halepense pollen 0.0017 g in 1 ml / periplaneta americana 0.0008 g in 1 ml / rhizopus stolonifer 0.0008 g in 1 ml / phoma destructiva 0.0008 g in 1 ml / dermatophagoides pteronyssinus 333.33 [au] in 1 ml / canis lupus familiaris hair 0.0008 g in 1 ml / alternaria alternata 0.00017 g in 1 ml / dermatophagoides farinae 333.33 [au] in 1 ml / felis catus hair 33.33 [bau] in 1 ml / ustilago cynodontis 0.00042 g in 1 ml / sporisorium cruentum 0.00042 g in 1 ml / ustilago nuda hordei 0.00021 g in 1 ml / ustilago maydis 0.00021 g in 1 ml / ustilago avenae 0.00021 g in 1 ml / ustilago tritici 0.00021 g in 1 ml / pleospora herbarum 0.0008 g in 1 ml / aureobasidium pullulans var. pullutans 0.0008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.0008 g in 1 ml / gallus gallus feather 0.00028 g in 1 ml / anas platyrhynchos feather 0.00028 g in 1 ml / anser anser feather 0.00028 g in 1 ml subcutaneous injection, solution||has_active_ingredient
lachesis muta venom||echinacea angustifolia 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / sus scrofa lymph 6 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / potassium chloride 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral liquid [homeoplex f]||has_active_ingredient
atropine sulfate, 3(s)-endo-isomer||product containing only hyoscyamine sulfate 0.125 milligram/1 each oral tablet||has_active_ingredient
compound f||hydrocortisone 1 g in 100 g topical cream [meijer intense healing]||has_active_ingredient
potassium dichromate (product)||arsenic trioxide 12 [hp_x] in 30 ml / potassium dichromate 12 [hp_x] in 30 ml / mercurius solubilis 12 [hp_x] in 30 ml / pulsatilla vulgaris 12 [hp_x] in 30 ml / sepia officinalis juice 12 [hp_x] in 30 ml / echinacea, unspecified 3 [hp_x] in 30 ml / goldenseal 3 [hp_x] in 30 ml / phytolacca americana root 3 [hp_x] in 30 ml / baptisia tinctoria 3 [hp_x] in 30 ml / toxicodendron pubescens leaf 12 [hp_x] in 30 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 30 ml oral liquid [chron sino]||has_active_ingredient
probenecid-containing product||probenecide||has_active_ingredient
natriumkarbonat||antimony trisulfide 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 20 [hp_x] in 1 ml / causticum 20 [hp_x] in 1 ml / solanum dulcamara top 20 [hp_x] in 1 ml / graphite 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / mercuric sulfide 20 [hp_x] in 1 ml / sodium carbonate 20 [hp_x] in 1 ml / nitric acid 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / juniperus sabina leafy twig 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / silicon dioxide 20 [hp_x] in 1 ml / delphinium staphisagria seed 20 [hp_x] in 1 ml / sulfur 20 [hp_x] in 1 ml / thuja occidentalis leafy twig 20 [hp_x] in 1 ml / taraxacum officinale 8 [hp_x] in 1 ml oral liquid [warts - moles - skin tags]||has_active_ingredient
3,5-diamino-6-(2,3-dichlorophenyl)-as-triazine||lamotrigine 200 mg oral tablet, disintegrating||has_active_ingredient
2-ethylhexyl-2-cyano-3,3- diphenylacrylate (substance)||avobenzone 20 mg in 1 ml / homosalate 70 mg in 1 ml / octocrylene 50 mg in 1 ml topical aerosol, spray [cvs health sport spf 30 clear]||has_active_ingredient
bmdbm cpd||avobenzone 25 mg in 1 ml / homosalate 80 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 80 mg in 1 ml topical lotion [neutrogena clear body breakout free oil free sunscreen broad spectrum spf 30]||has_active_ingredient
sodium fluorophosphate||sodium monofluorophosphate 0.1 g in 100 g dental paste, dentifrice [ancalima-good morning]||has_active_ingredient
ethyl p-aminobenzoate||cepacol instamax, 15 mg-20 mg mucous membrane lozenge||has_active_ingredient
botrytis cinerea extract (product)||gibberella fujikuroi 0.00625 g in 1 ml / mucor plumbeus 0.00625 g in 1 ml / alternaria alternata 0.00625 g in 1 ml / acremonium strictum 0.00625 g in 1 ml / botrytis cinerea 0.00625 g in 1 ml / cladosporium sphaerospermum 0.00625 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00625 g in 1 ml / pleospora betae 0.00625 g in 1 ml / cochliobolus sativus 0.00625 g in 1 ml / candida albicans 0.00625 g in 1 ml / chaetomium globosum 0.00625 g in 1 ml / rhizopus stolonifer 0.00625 g in 1 ml / trichophyton mentagrophytes 0.00625 g in 1 ml / aspergillus niger var. niger 0.00625 g in 1 ml / aureobasidium pullulans var. pullutans 0.00625 g in 1 ml / epicoccum nigrum 0.00625 g in 1 ml intradermal solution [new stock fungi mix]||has_active_ingredient
impatiens glandulifera flower extract||epinephrine 20 [hp_x] in 1 g / citharacanthus spinicrus 20 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / matricaria recutita 15 [hp_x] in 1 g / cypripedium parvifolum root 15 [hp_x] in 1 g / digitalis 15 [hp_x] in 1 g / gelsemium sempervirens root 15 [hp_x] in 1 g / hops 15 [hp_x] in 1 g / strychnos ignatii seed 15 [hp_x] in 1 g / impatiens glandulifera flower 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / sodium chloride 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / scutellaria lateriflora 15 [hp_x] in 1 g / delphinium staphisagria seed 15 [hp_x] in 1 g / datura stramonium 15 [hp_x] in 1 g / theridion curassavicum 15 [hp_x] in 1 g / echinacea, unspecified 8 [hp_x] in 1 g / ginkgo 8 [hp_x] in 1 g / hypericum perforatum 8 [hp_x] in 1 g / passiflora incarnata flowering top 8 [hp_x] in 1 g oral pellet [hyperactivity - mental focus]||has_active_ingredient
cefuroximo||cefuroxime-containing product in ocular dose form||has_active_ingredient
salicylic acid 2-ethylhexyl ester||avobenzone 3 mg in 100 ml / homosalate 4 mg in 100 ml / octisalate 4.5 mg in 100 ml / octocrylene 2.6 mg in 100 ml topical lotion [olay regenerist regenerating moisturizer broad spectrum spf 15]||has_active_ingredient
phenylephrine hydrochloride (medication)||phenylephrine hcl/dextromethorphan hbr/acetaminophen/guaifen 5 mg-10 mg-325 mg-200 mg oral capsule||has_active_ingredient
antiviral valacyclovir hcl||valtrex, 500 mg oral tablet||has_active_ingredient
etoh||alcohol 75 ml in 100 ml topical spray [hand sanitizer]||has_active_ingredient
alcohol, ethyl||alcohol 62 ml in 100 ml topical gel [meijer hand sanitizer 59ml 01]||has_active_ingredient
cat hair (felis domesticus)||canis lupus familiaris hair extract 0.01 gm/ml / felis catus hair extract 400 bau/ml injectable solution||has_active_ingredient
aluminum oxide - chemical||aluminum oxide 7 [hp_x] in 118 ml / calcium fluoride 6 [hp_x] in 118 ml / calcium silicate 5 [hp_x] in 118 ml / magnesium sulfate heptahydrate 7 [hp_x] in 118 ml / silicon dioxide 4 [hp_x] in 118 ml / sulfur 4 [hp_x] in 118 ml / titanium 7 [hp_x] in 118 ml / zinc 8 [hp_x] in 118 ml topical spray [puriton skin protectant homeopathic]||has_active_ingredient
product containing moroctocog alfa (medicinal product)||moroctocog alfa only product in parenteral dose form||has_active_ingredient
meningococcus||anaplasma phagocytophilum 15 [hp_x] in 1 ml / babesia microti 15 [hp_x] in 1 ml / bartonella henselae 15 [hp_x] in 1 ml / borrelia burgdorferi 15 [hp_x] in 1 ml / ehrlichia canis 15 [hp_x] in 1 ml / mycoplasma pneumoniae 15 [hp_x] in 1 ml / measles virus 16 [hp_x] in 1 ml / neisseria meningitidis 27 [hp_x] in 1 ml / hepatitis b virus 15 [hp_c] in 1 ml oral liquid [co-infxn]||has_active_ingredient
veronica officinalis flowering top||scrophularia nodosa 3 [hp_x] in 1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1 ml / veronica officinalis flowering top 3 [hp_x] in 1 ml / equisetum arvense top 4 [hp_x] in 1 ml / fumaria officinalis flowering top 4 [hp_x] in 1 ml / geranium robertianum 4 [hp_x] in 1 ml / nasturtium officinale 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / pinus sylvestris leafy twig 4 [hp_x] in 1 ml / gentiana lutea root 5 [hp_x] in 1 ml / juglans regia fruit rind, immature 5 [hp_x] in 1 ml / juglans regia leaf 5 [hp_x] in 1 ml / sarsaparilla 6 [hp_x] in 1 ml / clematis vitalba flower 8 [hp_x] in 1 ml / helianthemum nummularium flower 8 [hp_x] in 1 ml / impatiens glandulifera flower 8 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / myosotis arvensis 9 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / sus scrofa lymph 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml oral liquid [pre-dental visit]||has_active_ingredient
isocitrate dehydrogenase-2 inhibitor||isocitrate dehydrogenase-2 inhibitor||has_active_ingredient
orchard grass pollen extract||poa pratensis pollen 11111 [bau] in 1 ml / dactylis glomerata pollen 11111 [bau] in 1 ml / lolium perenne pollen 11111 [bau] in 1 ml / agrostis gigantea pollen 11111 [bau] in 1 ml / anthoxanthum odoratum pollen 11111 [bau] in 1 ml / phleum pratense pollen 11111 [bau] in 1 ml / poa compressa pollen 0.0056 g in 1 ml / arrhenatherum elatius pollen 0.0056 g in 1 ml / holcus lanatus pollen 0.0056 g in 1 ml intradermal injection, solution||has_active_ingredient
avena sativa top||phosphoric acid 3 [hp_x] in 50 ml / amanita muscaria fruiting body 6 [hp_x] in 50 ml / semecarpus anacardium fruit 10 [hp_x] in 50 ml / avena sativa flowering top 1 [hp_x] in 50 ml / cinchona officinalis bark 3 [hp_x] in 50 ml / strychnos ignatii seed 4 [hp_x] in 50 ml / schoenocaulon officinale seed 4 [hp_x] in 50 ml / macropiper methysticum root 8 [hp_x] in 50 ml oral solution/ drops [psy-stabil]||has_active_ingredient
citrate tamoxifen||tamoxifen 20 mg oral tablet||has_active_ingredient
product containing sennoside (medicinal product)||docusate sodium/sennosides 50 mg-8.6 mg oral tablet||has_active_ingredient
claviceps purpurea sclerotium||claviceps purpurea sclerotium 3 [hp_x] oral pellet||has_active_ingredient
3,3,5-trimethylcyclohexyl salicylate||avobenzone 2.7 g in 100 kg / homosalate 9.0 g in 100 kg / octisalate 4.5 g in 100 kg / octocrylene 9.0 g in 100 kg topical cream [line interception power duo day cream suncreen broad spectrum spf 30]||has_active_ingredient
bos taurus cartilage preparation||onion 3 [hp_x] in 1 g / betula pubescens leaf 3 [hp_x] in 1 g / aconitum napellus 6 [hp_x] in 1 g / arnica montana 6 [hp_x] in 1 g / bos taurus cartilage 6 [hp_x] in 1 g / formica rufa 7 [hp_x] in 1 g / tin 8 [hp_x] in 1 g / gold 10 [hp_x] in 1 g topical cream||has_active_ingredient
berberis vulgaris root bark extract||berberis vulgaris root bark 1 [hp_x] oral tablet||has_active_ingredient
pyridoxine hcl||pyridoxine hydrochloride 100 mg in 1 ml intravenous injection, solution||has_active_ingredient
2-hydroxy-4-methoxybenzophenone,[2-hydroxy-4-methoxyphenyl]phenylmethanone||avobenzone 0.2472 g in 12 ml / octinoxate 0.60564 g in 12 ml / octocrylene 0.618 g in 12 ml / oxybenzone 0.2472 g in 12 ml topical emulsion [cle de peau beaute protective fortifying n]||has_active_ingredient
lytta vesicatoria 30 [hp_x] in 1 ml / berberis vulgaris root bark 30 [hp_x] in 1 ml / canis lupus familiaris milk 30 [hp_x] in 1 ml / clematis recta flowering top 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / delphinium staphisagria seed 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / sepia officinalis juice 30 [hp_x] in 1 ml / smilax regelii root 30 [hp_x] in 1 ml oral liquid [cystoges hp]||canis lupus familiaris milk||active_ingredient_of
adenosine triphosphate disodium 4 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / sodium carbonate 6 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / wheat gluten 30 [hp_x] in 1 ml / amaranth 6 [hp_c] in 1 ml / avena sativa flowering top 6 [hp_c] in 1 ml / sodium sulfate 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / elymus repens root 6 [hp_c] in 1 ml / cortisone acetate 8 [hp_c] in 1 ml / glyphosate 12 [hp_c] in 1 ml / enterococcus faecalis 30 [hp_c] in 1 ml oral liquid [grain and soy allergen mix]||oat flowering top||active_ingredient_of
avobenzone 2.5 g in 100 g / homosalate 5 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g / octocrylene 9 g in 100 g / oxybenzone 5 g in 100 g topical aerosol, spray [ultrasol sport sunscreen]||2-benzoyl-5-methoxyphenol||active_ingredient_of
octinoxate 65 mg in 1 ml / homosalate 50 mg in 1 ml / octisalate 45 mg in 1 ml / titanium dioxide 34 mg in 1 ml / octocrylene 30 mg in 1 ml topical cream [jungsaemmool skin setting tone correcting base]||octylsalicylate||active_ingredient_of
ginger 3 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / lactic acid, dl- 6 [hp_x] in 1 ml / cyclamen purpurascens tuber 8 [hp_q] in 1 ml / kerosene 8 [hp_x] in 1 ml / tobacco leaf 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / cadmium sulfide 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / colchicum autumnale bulb 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / theridion curassavicum 12 [hp_x] in 1 ml / euphorbia corollata root 24 [hp_x] in 1 ml oral liquid [nausia]||kerosene||active_ingredient_of
meclizine hydrochloride 12.5mg tablet (product)||meclizine hydrochloride (substance)||active_ingredient_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / milk thistle 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / taraxacum officinale flowering top 3 [hp_x] in 1 ml / trifolium pratense leaf 3 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / phytolacca americana root 8 [hp_x] in 1 ml / acetone 9 [hp_x] in 1 ml / ammonium chloride 9 [hp_x] in 1 ml / benzene 9 [hp_x] in 1 ml / propylene glycol 9 [hp_x] in 1 ml / sodium lauryl sulfate 9 [hp_x] in 1 ml / sodium tripolyphosphate 9 [hp_x] in 1 ml / turpentine oil 9 [hp_x] in 1 ml / methyl alcohol 9 [hp_x] in 1 ml / chlorine 10 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml oral liquid [enviroclenz]||chelidonium majus extract||active_ingredient_of
sodium phosphate, dibasic 7 g in 118 ml / sodium phosphate, monobasic 19 g in 118 ml rectal enema [sunmark]||sodium phosphate, dibasic||active_ingredient_of
radish 8 [hp_x] in 8 [hp_x] oral pellet [raphanus sativus]||radish||active_ingredient_of
folivane-ob capsule||acidum ascorbicum||active_ingredient_of
ergocalciferol 1.25 mg oral capsule, liquid filled [vitamin d]||(5z,7e,22e)-(3s)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol||active_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 107.2 mg in 1 ml / octisalate 32.1 mg in 1 ml / octocrylene 60 mg in 1 ml / oxybenzone 38.6 mg in 1 ml topical lotion [la roche posay laboratoire dermatologique anthelios 60 face and body cooling water broad spectrum spf 60 sunscreen water resistant 80 minutes]||3,3,5-trimethylcyclohexyl salicylate||active_ingredient_of
acetaminophen 162.5 mg / chlorpheniramine maleate 2 mg / dextromethorphan hbr 10 mg / phenylephrine hcl 5 mg oral capsule||p-hydroxy-acetanilid||active_ingredient_of
lycopodium clavatum spore 2 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / tsuga canadensis bark 3 [hp_x] in 1 ml / ammonium bromide 3 [hp_x] in 1 ml / ammonium chloride 3 [hp_x] in 1 ml / pulsatilla vulgaris 3 [hp_x] in 1 ml / potassium dichromate 3 [hp_x] in 1 ml / ammonium carbonate 6 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / calcium arsenate 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / potassium carbonate 30 [hp_x] in 1 ml / semecarpus anacardium juice 4 [hp_c] in 1 ml / iodine 4 [hp_c] in 1 ml / thyroid, porcine 5 [hp_c] in 1 ml / leptin human 9 [hp_c] in 1 ml oral liquid [slim]||iodine (medication)||active_ingredient_of
garlic 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / methionine 6 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml / selenium dioxide 8 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [metalogin]||selenium oxide||active_ingredient_of
apocynum cannabinum root 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / selenicereus grandiflorus stem 10 [hp_x] in 59 ml / convallaria majalis 10 [hp_x] in 59 ml / cypripedium parvifolum root 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / nitroglycerin 10 [hp_x] in 59 ml / naja naja venom 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / spigelia anthelmia 10 [hp_x] in 59 ml / spongia officinalis skeleton, roasted 10 [hp_x] in 59 ml oral liquid [heart regularity]||spongia officinalis skeleton, roasted||active_ingredient_of
avobenzone 3 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g / octocrylene 2.7 g in 100 g / oxybenzone 4 g in 100 g topical cream [advanced anti-wrinkle therapy cicatricure]||2-ethylhexyl-p-methoxycinnamate||active_ingredient_of
ondansetron hydrochloride 2 mg in 1 ml intravenous injection||ondansetron hydrochloride (substance)||active_ingredient_of
zolpidem tartrate 10 mg oral tablet, film coated [zolpidem tartrate]||n,n,6-trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate||active_ingredient_of
ambrosia artemisiifolia pollen extract 20000 pnu/ml / ambrosia trifida pollen extract 20000 pnu/ml injectable solution||weed pollen-giant (tall) ragweed||active_ingredient_of
menthol 5 mg in 1 g topical lipstick [maybelline new york baby lips dr rescue medicated balm]||diaperene adult||active_ingredient_of
octinoxate 126 mg in 1.7 g / titanium dioxide 54 mg in 1.7 g topical stick [nars pure sheer spf lip treatment bianca]||titanium dioxide (substance)||active_ingredient_of
passiflora incarnata flowering top 3 [hp_x] in 30 ml / ipomoea purga root 8 [hp_x] in 30 ml / arabica coffee bean 10 [hp_x] in 30 ml / magnesium 10 [hp_x] in 30 ml / palladium 10 [hp_x] in 30 ml / tellurium 10 [hp_x] in 30 ml / phosphoric acid 14 [hp_x] in 30 ml / strychnos ignatii seed 8 [hp_x] in 30 ml sublingual liquid [passiflora plex]||tellurium (substance)||active_ingredient_of
alfalfa 3 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / fucus vesiculosus 4 [hp_x] in 1 ml / hordeum vulgare top 4 [hp_x] in 1 ml / nasturtium aquaticum 4 [hp_x] in 1 ml / raphanus sativus 4 [hp_x] in 1 ml / triticum aestivum whole 4 [hp_x] in 1 ml / iodine 6 [hp_x] in 1 ml / ubidecarenone 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / manganese gluconate 8 [hp_x] in 1 ml / brown rice 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / paraffin 30 [hp_x] in 1 ml / ethylene glycol 30 [hp_x] in 1 ml / propyl alcohol 30 [hp_x] in 1 ml / palmitic acid 30 [hp_x] in 1 ml / dimethicone 30 [hp_x] in 1 ml / sodium polyacrylate (8000 mw) 30 [hp_x] in 1 ml / glutaral 30 [hp_x] in 1 ml / methyl acrylate 30 [hp_x] in 1 ml / anhydrous citric acid 30 [hp_x] in 1 ml / tartaric acid 30 [hp_x] in 1 ml / anthraquinone 30 [hp_x] in 1 ml / hydrogen peroxide 30 [hp_x] in 1 ml / glycolic acid 30 [hp_x] in 1 ml / ammonium thioglycolate 30 [hp_x] in 1 ml / sodium carbonate 30 [hp_x] in 1 ml / ethanolamine 30 [hp_x] in 1 ml / 2,5-diaminotoluene sulfate 30 [hp_x] in 1 ml / p-aminophenol 30 [hp_x] in 1 ml oral liquid [universaltox]||alfalfa (medication)||active_ingredient_of
witch hazel 0.001 g in 120 g topical cream [mefactory super deep cleansing foa m]||hamamelis water||active_ingredient_of
health mart loratadine 10mg tablet||4-(8-chloro-5,6-dihydro-11h-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester||active_ingredient_of
gnp fast maximum night time cold & flu liquid||phenylephrine hydrochloride [cvs sympathomimetic] (product)||active_ingredient_of
titanium dioxide 13.38 g in 100 g / octinoxate 4 g in 100 g topical powder [isa knox ageless moist serum two way cake 21 (refill)]||product containing titanium dioxide||active_ingredient_of
octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel hydratess long-lasting intense moisturizing spf 20 - vin]||oxybenzone [dup] (substance)||active_ingredient_of
oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / calcium fluoride 30 [hp_x] in 1 ml / tribasic calcium phosphate 30 [hp_x] in 1 ml / hekla lava 30 [hp_x] in 1 ml / hydrofluoric acid 30 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / ruta graveolens flowering top 30 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / comfrey root 30 [hp_x] in 1 ml oral liquid [bone repair hp]||rhus toxicarium leaf||active_ingredient_of
solidago virgaurea flowering top 3 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / clerodendranthus spicatus leaf 6 [hp_x] in 1 ml / chondrodendron tomentosum root 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / agathosma betulina leaf 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / sus scrofa renal pelvis 8 [hp_x] in 1 ml / turpentine oil 8 [hp_x] in 1 ml / sus scrofa ureter 8 [hp_x] in 1 ml / sus scrofa urethra 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml / acetaldehyde 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / sodium pyruvate 10 [hp_x] in 1 ml / quercetin 10 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / apis mellifera venom 18 [hp_x] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [d2 organ support]||mercury(ii) chloride||active_ingredient_of
houttuynia cordata whole 0.7875 g / pyroligneous acid 1.75 g / schorl tourmaline 0.2625 g / phyllostachys edulis vinegar 2.625 g topical patch [detox foot patchs]||phyllostachys edulis vinegar||active_ingredient_of
abies alba leafy twig 8 [hp_x] in 1 ml / calcium acetate 12 [hp_x] in 1 ml / calcium hypophosphite 12 [hp_x] in 1 ml / calcium chloride 12 [hp_x] in 1 ml / calcium oxalate monohydrate 12 [hp_x] in 1 ml / tribasic calcium phosphate 15 [hp_x] in 1 ml / calcium picrate 12 [hp_x] in 1 ml / calendula officinalis flowering top 6 [hp_x] in 1 ml / calcium hexafluorosilicate 12 [hp_x] in 1 ml / sulfur iodide 12 [hp_x] in 1 ml / calcium sulfate anhydrous 12 [hp_x] in 1 ml / bos taurus gallstone 15 [hp_x] in 1 ml / urtica urens 12 [hp_x] in 1 ml / vitamin d 12 [hp_x] in 1 ml / cholesterol 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / calcium arsenate 8 [hp_x] in 1 ml / calcium iodide 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 6 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / calcium fluoride 15 [hp_x] in 1 ml / sus scrofa parathyroid gland 9 [hp_c] in 1 ml / comfrey root 6 [hp_x] in 1 ml sublingual solution/ drops [c08 calcium metabolism]||sus scrofa parathyroid gland preparation||active_ingredient_of
alcohol 70 ml in 100 ml topical gel [bluzen hand sanitizer unscented]||alcool éthylique||active_ingredient_of
isopropyl alcohol 70 ml in 100 g topical cloth [penorra sanitary wipes]||otic preparations isopropyl alcohol||active_ingredient_of
amaranthus retroflexus pollen 0.01 g in 1 ml / salsola kali pollen 0.01 g in 1 ml / plantago lanceolata pollen 0.01 g in 1 ml / xanthium strumarium pollen 0.01 g in 1 ml / chenopodium album pollen 0.01 g in 1 ml intradermal solution [common weed mix]||chenopodium album pollen||active_ingredient_of
alcohol 70 ml in 100 ml topical gel [dr.s clean hand]||alcohol (grain)||active_ingredient_of
vitamin a 3000 [iu] / calcium pantothenate 7.5 mg / ascorbic acid 300 mg / cholecalciferol 1000 [iu] / .alpha.-tocopherol succinate, d- 100 [iu] / thiamine 20 mg / riboflavin 5 mg / niacinamide 25 mg / pyridoxine hydrochloride 25 mg / folic acid 1 mg / biotin 100 ug / cyanocobalamin 50 ug / selenium 100 ug / magnesium oxide 50 mg / zinc oxide 25 mg / cupric sulfate 1.5 mg / manganese 1.5 mg / chromium 50 ug / thioctic acid 15 mg / lutein 5 mg oral tablet [strovite one caplets]||copper monosulphate||active_ingredient_of
parenteral form pentazocine (product)||pentazocin||active_ingredient_of
activated charcoal 1 [hp_x] in 1 ml / chamomile 3 [hp_x] in 1 ml / lycopodium clavatum spore 3 [hp_x] in 1 ml / nutmeg 3 [hp_x] in 1 ml / passiflora incarnata flowering top 3 [hp_x] in 1 ml / radish 3 [hp_x] in 1 ml / smilax ornata root 3 [hp_x] in 1 ml / ginger 3 [hp_x] in 1 ml / aloe 4 [hp_x] in 1 ml oral liquid [tummy calm]||smilax ornata root||active_ingredient_of
felis catus hair 400 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.0004 g in 1 ml / gallus gallus feather 0.00003 g in 1 ml / anas platyrhynchos feather 0.00003 g in 1 ml / anser anser feather 0.00003 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / candida albicans 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml subcutaneous injection, solution||chicken feathers extract||active_ingredient_of
doxycycline only product in oral dose form||doxiciclina||active_ingredient_of
polyethylene glycol 400 4.0 mg in 1 ml / propylene glycol 3.0 mg in 1 ml ophthalmic solution/ drops [equate support advanced lubricant drops multidose]||propanediol 01 02||active_ingredient_of
alcohol 0.75 ml in 1 ml topical liquid [hand sanitizer]||ethanol||active_ingredient_of
alcohol 0.7 ml in 1 ml topical liquid [dr. shield laboratories antiseptic hand sanitizer]||ethyl alcohol product||active_ingredient_of
carya illinoinensis pollen 0.05 g in 1 ml / acer saccharum pollen 0.017 g in 1 ml / acer negundo pollen 0.017 g in 1 ml / acer rubrum pollen 0.017 g in 1 ml / quercus rubra pollen 0.017 g in 1 ml / quercus virginiana pollen 0.017 g in 1 ml / quercus alba pollen 0.017 g in 1 ml / platanus occidentalis pollen 0.05 g in 1 ml / salix nigra pollen 0.05 g in 1 ml percutaneous injection, solution [pollens - trees, tree mix 5]||quercus rubra pollen (substance)||active_ingredient_of
polymyxin b sulfate 10000 [usp'u] in 1 g / neomycin sulfate 3.5 mg in 1 g / bacitracin zinc 500 [usp'u] in 1 g / pramoxine hydrochloride 10 mg in 1 g topical ointment [avon hexashield triple antibiotic with pain relief]||4-(3-(p-butoxyphenoxy)propyl)morpholine hydrochloride||active_ingredient_of
alcohol 70 ml in 100 ml topical gel [hand sanitizer circle k]||ethanol-containing product||active_ingredient_of
yervoy 50 mg in 10 ml injection||product containing ipilimumab (medicinal product)||active_ingredient_of
alchemilla xanthochlora flowering top 1 [hp_x] in 100 ml / galium odoratum 1 [hp_x] in 100 ml / matricaria recutita 1 [hp_x] in 100 ml / viola odorata 1 [hp_x] in 100 ml / cinchona officinalis bark 2 [hp_x] in 100 ml / mentha piperita 1 [hp_x] in 100 ml / rosmarinus officinalis flowering top 1 [hp_x] in 100 ml / valerian 1 [hp_x] in 100 ml / chamaelirium luteum root 2 [hp_x] in 100 ml / chaste tree 3 [hp_x] in 100 ml / black cohosh 3 [hp_x] in 100 ml / convallaria majalis 3 [hp_x] in 100 ml / saffron 3 [hp_x] in 100 ml / cyclamen purpurascens tuber 3 [hp_x] in 100 ml / turnera diffusa leafy twig 3 [hp_x] in 100 ml / goldenseal 3 [hp_x] in 100 ml / caulophyllum thalictroides root 4 [hp_x] in 100 ml / lilium lancifolium flowering top 4 [hp_x] in 100 ml / packera aurea 4 [hp_x] in 100 ml / delphinium staphisagria seed 4 [hp_x] in 100 ml / naja naja venom 8 [hp_x] in 100 ml oral liquid [female tonic]||delphinium staphisagria seed||active_ingredient_of
aethusa cynapium 10 [hp_x] in 59 ml / althaea officinalis root 10 [hp_x] in 59 ml / aluminum oxide 10 [hp_x] in 59 ml / antimony trisulfide 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / baptisia tinctoria root 10 [hp_x] in 59 ml / bismuth subnitrate 10 [hp_x] in 59 ml / activated charcoal 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / collinsonia canadensis root 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 ml in 59 ml / gamboge 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / gratiola officinalis 10 [hp_x] in 59 ml / juglans cinerea branch bark/root bark 10 [hp_x] in 59 ml / skim milk 10 [hp_x] in 59 ml / cow milk 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / podophyllum 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml oral liquid [lower gi relief]||silicon dioxide (amorphous)||active_ingredient_of
aconitum napellus 20 [hp_x] in 1 ml / epinephrine 20 [hp_x] in 1 ml / american ginseng 20 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / baptisia tinctoria 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / chelidonium majus 20 [hp_x] in 1 ml / cinchona officinalis bark 20 [hp_x] in 1 ml / iodine 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / potassium iodide 20 [hp_x] in 1 ml / lachesis muta venom 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / lycopus virginicus 20 [hp_x] in 1 ml / sodium chloride 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / anemone pulsatilla 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / saw palmetto 20 [hp_x] in 1 ml / thyroid, unspecified 20 [hp_x] in 1 ml / echinacea, unspecified 11 [hp_x] in 1 ml / ginkgo 11 [hp_x] in 1 ml / phytolacca americana root 11 [hp_x] in 1 ml oral liquid [exhaustion]||i element||active_ingredient_of
epinephrine only product in pulmonary dose form||primatene reformulated jan 2019||active_ingredient_of
benzethonium chloride 2 mg/ml / dimethicone 20 mg/ml topical lotion||benzethonium chloride (substance)||active_ingredient_of
flurandrenolide 0.05% cream,top||fludroxycortide||active_ingredient_of
viscum album fruiting top 3 [hp_x] in 1 ml / cobaltous gluconate 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / ferrous fumarate 6 [hp_x] in 1 ml / magnesium aspartate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / phosphorus 6 [hp_x] in 1 ml / potassium aspartate 6 [hp_x] in 1 ml / sodium molybdate 6 [hp_x] in 1 ml / adenosine cyclic phosphate 8 [hp_x] in 1 ml / cerous oxalate nonahydrate 8 [hp_x] in 1 ml / nickel acetate 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / chromium 8 [hp_x] in 1 ml / cobalt 8 [hp_x] in 1 ml / copper 8 [hp_x] in 1 ml / iron 8 [hp_x] in 1 ml / iodine 8 [hp_x] in 1 ml / iridium 8 [hp_x] in 1 ml / potassium carbonate 8 [hp_x] in 1 ml / lithium 8 [hp_x] in 1 ml / magnesium 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / molybdenum 8 [hp_x] in 1 ml / sodium chloride 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / strontium 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / vanadium 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / cholecalciferol 8 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / aluminum oxide 30 [hp_x] in 1 ml / mercuric chloride 30 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [energy catalyst]||product containing gold||active_ingredient_of
aconitum napellus 12 [hp_x] in 118 ml / apis mellifera 12 [hp_x] in 118 ml / arnica montana 12 [hp_x] in 118 ml / arsenic trioxide 12 [hp_x] in 118 ml / atropa belladonna 12 [hp_x] in 118 ml / bellis perennis 12 [hp_x] in 118 ml / bryonia alba root 12 [hp_x] in 118 ml / calendula officinalis flowering top 12 [hp_x] in 118 ml / matricaria recutita 12 [hp_x] in 118 ml / helianthemum canadense 12 [hp_x] in 118 ml / clematis recta flowering top 12 [hp_x] in 118 ml / ferrosoferric phosphate 12 [hp_x] in 118 ml / histamine dihydrochloride 12 [hp_x] in 118 ml / hypericum perforatum 12 [hp_x] in 118 ml / strychnos ignatii seed 12 [hp_x] in 118 ml / impatiens glandulifera flower 12 [hp_x] in 118 ml / ornithogalum umbellatum 12 [hp_x] in 118 ml / passiflora incarnata flowering top 12 [hp_x] in 118 ml / phosphorus 12 [hp_x] in 118 ml / prunus cerasifera flower 12 [hp_x] in 118 ml / toxicodendron pubescens leaf 12 [hp_x] in 118 ml / sulfur 12 [hp_x] in 118 ml / comfrey root 12 [hp_x] in 118 ml / veratrum album root 12 [hp_x] in 118 ml oral liquid [anxiety and stress]||strychnos ignatii seed||active_ingredient_of
lovastatin 40mg tab||lovastatin product||active_ingredient_of
chloramphenicol sodium succinate injection||chloramphenicol sodium succinate (medication)||active_ingredient_of
(spl review) alcohol 70 g in 100 ml topical liquid [kundal pure and safe pocket perfume hand sanitizer mist white musk]||product containing ethanol||active_ingredient_of
acetaminophen/oxycodone hydrochloride 325 mg-7.5 mg oral tablet||oxycodone hydrochloride (substance)||active_ingredient_of
alcohol 72 ml in 100 ml topical gel [mountain ice advanced hand sanitizer]||1-hydroxyethane||active_ingredient_of
dapsone 25mg tablet||4,4'-sulfonyldianiline||active_ingredient_of
product containing only sotalol hydrochloride 160 mg/1 each oral tablet||sotalol hydrochloride (medication)||active_ingredient_of
ibren 600mg tablet||non-prescription ibuprofen (medication)||active_ingredient_of
olmesartan/hydrochlorothiazide 40 mg-25 mg oral tablet||product containing hydrochlorothiazide||active_ingredient_of
arnica montana whole 3 [hp_x] in 1 ml / echinacea angustifolia whole 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / glycyrrhiza glabra 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / kalmia latifolia leaf 6 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 6 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / arbutus andrachne leafy shoot 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / canis lupus familiaris milk 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / tellurium 16 [hp_x] in 1 ml oral liquid [borr plus]||neutra-phos-k||active_ingredient_of
acetaminophen/dextromethorphan hydrobromide/phenylephrine hydrochloride 325 mg-10 mg-5 mg oral capsule, liquid filled [good neighbor pharmacy day time cold & flu]||analgesics acetaminophen||active_ingredient_of
adenosine triphosphate 30 [hp_x] in 30 ml / lard 30 [hp_c] in 30 ml / sus scrofa cerebrum 30 [hp_c] in 30 ml / coenzyme a 30 [hp_x] in 30 ml / sus scrofa colon 30 [hp_x] in 30 ml / sus scrofa duodenum 30 [hp_x] in 30 ml / bos taurus bile 30 [hp_c] in 30 ml / fumaric acid 60 [hp_x] in 30 ml / thyroid, porcine 30 [hp_c] in 30 ml / pork liver 30 [hp_c] in 30 ml / bos taurus hypothalamus 30 [hp_c] in 30 ml / pyruvaldehyde 60 [hp_x] in 30 ml / glyoxal 60 [hp_x] in 30 ml / sus scrofa pancreas 30 [hp_x] in 30 ml oral liquid [formula 1]||ox bile extract (substance)||active_ingredient_of
dimethicone 13 mg in 1 ml topical lotion [harmon daily moisturzier]||product containing dimethicone||active_ingredient_of
adenosine cyclic phosphate 8 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 12 [hp_x] in 1 ml / adenosine triphosphate disodium 12 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / anhydrous citric acid 8 [hp_x] in 1 ml / coenzyme a 12 [hp_x] in 1 ml / herring sperm dna 30 [hp_x] in 1 ml / fumaric acid 12 [hp_x] in 1 ml / glycyrrhiza glabra 4 [hp_x] in 1 ml / calcium sulfide 30 [hp_x] in 1 ml / arctium lappa root 4 [hp_x] in 1 ml / magnesium phosphate, dibasic 12 [hp_x] in 1 ml / manganese acetate tetrahydrate 10 [hp_x] in 1 ml / nadide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / sodium pyruvate 12 [hp_x] in 1 ml / niacinamide 6 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / frangula purshiana bark 4 [hp_x] in 1 ml / riboflavin 10 [hp_x] in 1 ml / saccharomyces cerevisiae rna 30 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / succinic acid 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / thyroid, bovine 9 [hp_x] in 1 ml / trifolium pratense flower 4 [hp_x] in 1 ml / zanthoxylum americanum bark 4 [hp_x] in 1 ml / zinc gluconate 10 [hp_x] in 1 ml oral liquid [metabopath]||3 pyridinecarboxamide||active_ingredient_of
atropa belladonna 6 [hp_x] in 10 ml / euphrasia stricta 6 [hp_x] in 10 ml / calcium sulfide 12 [hp_x] in 10 ml ophthalmic gel [pink eye nighttime]||euphrasia stricta||active_ingredient_of
somatropin 6 [hp_x] in 30 ml / dalotuzumab 6 [hp_x] in 30 ml / saccharomyces cerevisiae rna 6 [hp_x] in 30 ml / herring sperm dna 6 [hp_x] in 30 ml / sus scrofa adrenal gland 6 [hp_x] in 30 ml / pork liver 6 [hp_x] in 30 ml / sus scrofa pituitary gland 6 [hp_x] in 30 ml / sus scrofa thymus 6 [hp_x] in 30 ml / thyroid, unspecified 6 [hp_x] in 30 ml / sus scrofa placenta 6 [hp_x] in 30 ml / sus scrofa ovary 6 [hp_x] in 30 ml / artemisia abrotanum flowering top 10 [hp_x] in 30 ml / semecarpus anacardium juice 10 [hp_x] in 30 ml / arsenic trioxide 10 [hp_x] in 30 ml / barium carbonate 10 [hp_x] in 30 ml / barium chloride dihydrate 10 [hp_x] in 30 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 30 ml / tribasic calcium phosphate 10 [hp_x] in 30 ml / iron 10 [hp_x] in 30 ml / fucus vesiculosus 10 [hp_x] in 30 ml / hekla lava 10 [hp_x] in 30 ml / helleborus niger root 10 [hp_x] in 30 ml / strychnos ignatii seed 10 [hp_x] in 30 ml / lycopodium clavatum spore 10 [hp_x] in 30 ml / niacinamide 10 [hp_x] in 30 ml / claviceps purpurea sclerotium 10 [hp_x] in 30 ml / silicon dioxide 10 [hp_x] in 30 ml / cobalt 12 [hp_x] in 30 ml / lithium carbonate 12 [hp_x] in 30 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 30 ml / manganese acetate tetrahydrate 12 [hp_x] in 30 ml / potassium phosphate, dibasic 12 [hp_x] in 30 ml / selenium 12 [hp_x] in 30 ml / zinc 12 [hp_x] in 30 ml oral spray [rejuvenate 2000 athletic formula for women]||porcine adrenal gland preparation||active_ingredient_of
digoxin 0.125mg tablet (product)||digoxin (product)||active_ingredient_of
aminophylline 500 mg/20 ml intraven ampul (ml)||aminophylline dihydrate||active_ingredient_of
citharacanthus spinicrus 15 [hp_x] in 1 ml / lycosa tarantula 15 [hp_x] in 1 ml / theridion curassavicum 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / vespa crabro 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 6 [hp_x] in 1 ml / solidago virgaurea flowering top 6 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / araneus diadematus 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / azadirachta indica bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / dieffenbachia seguine 15 [hp_x] in 1 ml / calendula officinalis flowering top 15 [hp_x] in 1 ml / formica rufa 15 [hp_x] in 1 ml / grindelia hirsutula flowering top 15 [hp_x] in 1 ml / hypericum perforatum 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / latrodectus mactans 15 [hp_x] in 1 ml / ledum palustre twig 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / pulex irritans 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml oral liquid [bug bites - itch stopper]||rancid beef preparation||active_ingredient_of
tinidazol||tinidazole (product)||active_ingredient_of
onion 6 [hp_x] in 1 ml / arabica coffee bean 6 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / anemone pulsatilla 6 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / matricaria chamomilla 6 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml oral liquid [childrens nighttime cold and cough]||matricaria chamomilla whole||active_ingredient_of
procrit 4000 unt in 1 ml injection||epoetin alfa (product)||active_ingredient_of
entrectinib@100 mg@oral@capsule||n-(5-(3,5-difluorobenzyl)-1h-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2h-pyran-4-ylamino)benzamide||active_ingredient_of
product containing only pafuramidine in oral dose form (medicinal product form)||pafuramidine-containing product||active_ingredient_of
clonidine only product in oral dose form||clonidine product||active_ingredient_of
petrolatum 0.929 mg/mg topical ointment||white soft paraffin||active_ingredient_of
accupril 5mg tablet||quinapril hydrochloride||active_ingredient_of
avobenzone 15 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 30 mg in 1 g / oxybenzone 40 mg in 1 g topical cream [neutrogena men age fighter face broad spectrum spf15]||2-hydroxy-4-methoxybenzophenone||active_ingredient_of
oral form senna||product containing sennoside (medicinal product)||active_ingredient_of
terbinafine hydrochloride 250mg tablet||hydrochloride terbinafine||active_ingredient_of
gleptoferron 200 mg in 1 ml intramuscular injection [gleptoforte]||gleptoferron||active_ingredient_of
quflora, multiple vitamins with fluoride 0.25 mg oral tablet, chewable||vitamin a as acetate||active_ingredient_of
water 985.77 g in 1000 ml topical solution [fad first aid direct eyewash]||hydrogen oxide||active_ingredient_of
corn silk 1 [hp_x] oral pellet||corn silk preparation||active_ingredient_of
pyrithione zinc 10 mg in 1 ml topical shampoo [matrix biolage scalpsync antidandruff]||zinc pyrithione-containing product||active_ingredient_of
pectin 12 mg oral lozenge [walgreen cl pectin throat pops]||methoxy pectin||active_ingredient_of
meclizine hcl 25 mg oral tablet||meclizine hydrochloride (medication)||active_ingredient_of
comfrey root 3 [hp_x] in 1 g / capsicum 6 [hp_x] in 1 g / ledum palustre twig 6 [hp_x] in 1 g / colchicum autumnale bulb 12 [hp_x] in 1 g / rhododendron aureum leaf 12 [hp_x] in 1 g / ruta graveolens flowering top 12 [hp_x] in 1 g topical gel [arthronew am]||ledum palustre twig extract||active_ingredient_of
alcohol 75 ml in 100 ml topical solution [body prescriptions hydrating aloe vera hand sanitizer]||ethyl alcohol (substance)||active_ingredient_of
baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / arsenic triiodide 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / potassium chloride 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml oral liquid [scrophularitone]||echinacea angustifolia extract||active_ingredient_of
product containing only ibuprofen 800 mg/1 each oral tablet (clinical drug)||(±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid||active_ingredient_of
doxycycline hyclate 100 mg oral tablet [pelodis]||doxycycline hyclate||active_ingredient_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / thuja occidentalis leafy twig 30 [hp_c] in 1 ml / apis mellifera 200 [hp_c] in 1 ml / pulsatilla vulgaris 200 [hp_c] in 1 ml / delphinium staphisagria seed 200 [hp_c] in 1 ml / barium carbonate 1 [hp_m] in 1 ml / bryonia alba root 1 [hp_m] in 1 ml / calcium sulfide 1 [hp_m] in 1 ml oral liquid [1 bladder]||barium carbonate||active_ingredient_of
sennosides 25 mg in 15 ml oral liquid [cvs senna laxative]||sennoside-containing product||active_ingredient_of
dextromethorphan hydrobromide/guaifenesin 10 mg/5 ml-100 mg/5 ml oral liquid [tussi-organidin dm nr]||dextromethorphan hydrobromide (medication)||active_ingredient_of
silybum marianum seed 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / chenopodium ambrosioides 6 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml oral liquid [hepapar]||dandelion extract||active_ingredient_of
fluralaner 500 mg topical solution [bravecto]||bravecto||active_ingredient_of
product containing only prolintane (medicinal product)||product containing prolintane||active_ingredient_of
paclitaxel@6 mg/ml@intraven@vial (ml)||product containing paclitaxel||active_ingredient_of
pinus strobus specific diagnostic allergen extract||white pine pollen||active_ingredient_of
product containing precisely silodosin 4 milligram/1 each conventional release oral capsule (clinical drug)||silodosin product||active_ingredient_of
petrolatum 779.9 mg in 1 g / zinc oxide 76 mg in 1 g topical ointment [mayinglong hemorrhoidal]||mineral supplements zinc oxide||active_ingredient_of
prazosin hydrochloride 1mg (product)||hcl, prazosin||active_ingredient_of
echinacea angustifolia 6 [hp_x] in 1 g sublingual tablet [echinacea angustifolia]||echinacea angustifolia||active_ingredient_of
carya illinoinensis pollen 0.05 g in 1 ml / acer saccharum pollen 0.017 g in 1 ml / acer negundo pollen 0.017 g in 1 ml / acer rubrum pollen 0.017 g in 1 ml / quercus rubra pollen 0.017 g in 1 ml / quercus virginiana pollen 0.017 g in 1 ml / quercus alba pollen 0.017 g in 1 ml / platanus occidentalis pollen 0.05 g in 1 ml / salix nigra pollen 0.05 g in 1 ml percutaneous injection, solution [pollens - trees, tree mix 5]||box elder maple pollen extract||active_ingredient_of
octinoxate 562 mg in 1 g / octisalate 250 mg in 1 g / zinc oxide 1000 mg in 1 g / octocrylene 1000 mg in 1 g topical cream [sunscreen]||2-ethylhexyl-p-methoxycinnamat||active_ingredient_of
duragesic-75, 75 mcg/hr transdermal film, extended release||fentanyl (substance)||active_ingredient_of
acetaminophen 325 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, coated [mucus relief cold and sinus]||3-(o-methoxyphenoxy)-1,2-propanediol||active_ingredient_of
alcohol 0.072 mg in 1 ml topical soap [foaming sanitizing hand]||alcohol||active_ingredient_of
spinach allergenic extract 0.05 gm/ml injectable solution||spinach||active_ingredient_of
glycerin 3 g in 100 ml topical liquid [ing ampoule]||glycerol analyte||active_ingredient_of
sorghum halepense pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / poa pratensis pollen 571.43 [bau] in 1 ml / festuca pratensis pollen 571.43 [bau] in 1 ml / dactylis glomerata pollen 571.43 [bau] in 1 ml / lolium perenne pollen 571.43 [bau] in 1 ml / agrostis gigantea pollen 571.43 [bau] in 1 ml / phleum pratense pollen 571.43 [bau] in 1 ml / anthoxanthum odoratum pollen 571.43 [bau] in 1 ml / alnus rhombifolia pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / morus alba pollen 0.002 g in 1 ml / bos taurus hair 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml intradermal injection, solution||allergenic extract,grass,redtop||active_ingredient_of
acetaminophen/hydrocodone bitartrate 325 mg-2.5 mg oral tablet [verdrocet]||product containing hydrocodone bitartrate||active_ingredient_of
apis mellifera 6 [hp_x] in 1 ml / clematis recta whole 4 [hp_x] in 1 ml / anemone pulsatilla 5 [hp_x] in 1 ml / chimaphila umbellata 4 [hp_x] in 1 ml / sus scrofa testicle 200 [hp_x] in 1 ml / chaste tree 4 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml sublingual solution [n-7]||sus scrofa testicle preparation||active_ingredient_of
betamethasone acetate 3 mg in 1 ml / betamethasone sodium phosphate 3 mg in 1 ml soft tissue injection, suspension [celestone soluspan]||betamethasone acetate (substance)||active_ingredient_of
eurotium amstelodami 0.05 g in 1 ml subcutaneous solution||ae-aspergillus amsterdami||active_ingredient_of
amphetamine-dextroamphetamine 20 mg oral capsule, extended release||dexamfetamine sulphate||active_ingredient_of
barium carbonate 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / fucus vesiculosus 30 [hp_x] in 1 ml / iodine 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 30 [hp_x] in 1 ml / sus scrofa thyroid 30 [hp_x] in 1 ml oral liquid [thyroid hp]||iodine||active_ingredient_of
diazepam 10 mg oral tablet [diazepam]||diazepam-containing product||active_ingredient_of
glycerin 10.82 g in 100 ml topical liquid [bio dna serum]||1,2,3-trihydroxypropane||active_ingredient_of
niacinamide 1.80 g in 45 ml / adenosine 0.018 g in 45 ml topical liquid [bring green carrot vita dark spot serum]||adenosine (substance)||active_ingredient_of
sulfur 12 [hp_x] / atropa belladonna 12 [hp_x] / caulophyllum thalictroides root 12 [hp_x] / black cohosh 12 [hp_x] / nitroglycerin 12 [hp_x] / strychnos ignatii seed 12 [hp_x] / lachesis muta venom 30 [hp_x] / anemone pulsatilla 12 [hp_x] / sepia officinalis juice 12 [hp_x] sublingual tablet [menopause plus sleep]||belladonna preparation (substance)||active_ingredient_of
alternaria alternata 0.002 g in 1 ml / ambrosia trifida pollen 0.0006666 g in 1 ml / ambrosia artemisiifolia pollen 0.0006666 g in 1 ml / ambrosia psilostachya pollen 0.0006666 g in 1 ml / anser anser feather 0.000667 g in 1 ml / gallus gallus feather 0.000667 g in 1 ml / anas platyrhynchos feather 0.000667 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / phoma destructiva 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / kochia scoparia pollen 0.00008 g in 1 ml / chenopodium album pollen 0.00008 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / salsola kali pollen 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.0002 g in 1 ml / ustilago avenae 0.0002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml intradermal injection, solution||amaranthus retroflexus pollen||active_ingredient_of
econazole and hydrocortisone only product||econazol||active_ingredient_of
ritonavir-containing product||ritonavir-containing product||active_ingredient_of
benzalkonium chloride 0.13 in 100 topical cloth [wet wipe]||benzalkonium chloride (substance)||active_ingredient_of
product containing indomethacin 25 mg/1 each oral capsule||product containing indometacin||active_ingredient_of
cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.005 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / dermatophagoides pteronyssinus 1000 [au] in 1 ml / alternaria alternata 0.005 g in 1 ml / aspergillus fumigatus 0.005 g in 1 ml subcutaneous injection, solution||cultivated oat pollen extract||active_ingredient_of
losartan potassium 100 mg oral tablet, film coated [losartan potassium]||losartan monopotassium salt||active_ingredient_of
folic acid 140 ug in 1 ml / biotin 20 ug in 1 ml / cyanocobalamin 1 ug in 1 ml intravenous injection, solution [pediatric infuvite multiple vitamins]||folicin||active_ingredient_of
boron 30 [hp_c] in 1 [hp_c] sublingual pellet||boron||active_ingredient_of
titanium dioxide 2.7 g in 35 g / zinc oxide 1.3 g in 35 g topical cream [mineral beauty balm broad spectrum spf 50 sunscreen uva-uvb suncreen light/medium]||dióxido de titanio||active_ingredient_of
lidocaine 40 mg/ml / menthol 10 mg/ml topical cream||lidocaine (product)||active_ingredient_of
dimethicone 0.55 g in 55 g cutaneous cream [esopinio animating water]||dimeticona||active_ingredient_of
berberis vulgaris root bark 4 [hp_x] in 1 ml / black cohosh 4 [hp_x] in 1 ml / cinchona officinalis bark 4 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 4 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 4 [hp_x] in 1 ml / ranunculus bulbosus 4 [hp_x] in 1 ml / horse chestnut 6 [hp_x] in 1 ml / cupric acetate 6 [hp_x] in 1 ml / nadide 6 [hp_x] in 1 ml / sodium diethyl oxalacetate 6 [hp_x] in 1 ml / niacinamide 6 [hp_x] in 1 ml / picric acid 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / ammonium chloride 8 [hp_x] in 1 ml / sus scrofa cartilage 8 [hp_x] in 1 ml / sus scrofa intervertebral disc 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / silver 10 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / sus scrofa umbilical cord 10 [hp_x] in 1 ml / sus scrofa adrenal gland 10 [hp_x] in 1 ml / pseudognaphalium obtusifolium 10 [hp_x] in 1 ml / sus scrofa bone marrow 10 [hp_x] in 1 ml / mercuric oxide 10 [hp_x] in 1 ml / pantothenic acid 10 [hp_x] in 1 ml / sulfur 28 [hp_x] in 1 ml / enterobacter cloacae 30 [hp_c] in 1 ml / salmonella enterica enterica serovar enteritidis 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [clean sweep formula 2]||salmonella enterica subsp. enterica ser. enteritidis||active_ingredient_of
ledum palustre twig 6 [hp_x] in 1 ml / calendula officinalis flowering top 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / hypericum perforatum 10 [hp_x] in 1 ml / strychnos ignatii seed 30 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / ruta graveolens flowering top 12 [hp_x] in 1 ml / arnica montana 18 [hp_x] in 1 ml / matricaria recutita 5 [hp_x] in 1 ml / echinacea purpurea 3 [hp_x] in 1 ml / delphinium staphisagria seed 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml topical gel [stellalife vega oral care gel]||matricaria recutita||active_ingredient_of
solanum dulcamara top 6 [hp_c] in 28 g / activated charcoal 6 [hp_c] in 28 g / chelone glabra 6 [hp_c] in 28 g / goldenseal 6 [hp_c] in 28 g oral pellet [stomach disorders]||solanum dulcamara top extract||active_ingredient_of
garlic 3 [hp_x] in 1 ml / echinacea angustifolia whole 3 [hp_x] in 1 ml / ginkgo 3 [hp_x] in 1 ml / viscum album fruiting top 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 6 [hp_x] in 1 ml / aconitum napellus whole 12 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / baptisia tinctoria root 12 [hp_x] in 1 ml / chelidonium majus whole 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / mercury 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / influenza a virus a/brisbane/02/2018 ivr-190 (h1n1) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza a virus a/kansas/14/2017 x-327 (h3n2) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / measles virus 12 [hp_x] in 1 ml oral liquid [virimmune]||angustifolia echinacea||active_ingredient_of
benzalkonium chloride 1 mg in 1 ml topical soap [gentle hand antibacterial vanilla almond]||benzalkonium chloride||active_ingredient_of
phosphorus 6 [hp_c] oral pellet [phosphorus 6c]||mineral supplements phosphorus preparations||active_ingredient_of
product containing ramipril 10 mg/1 each oral capsule (clinical drug)||ramipril||active_ingredient_of
bos taurus cerebellum 8 [hp_x] in 1 ml / bos taurus brain 8 [hp_x] in 1 ml / bos taurus pineal gland 8 [hp_x] in 1 ml / bos taurus nerve 8 [hp_x] in 1 ml / bifenthrin 8 [hp_x] in 1 ml / sus scrofa thalamus 8 [hp_x] in 1 ml / sus scrofa ear 17 [hp_x] in 1 ml oral liquid||bovine pineal gland preparation||active_ingredient_of
product containing chlortalidone 25 mg/1 each oral tablet (clinical drug)||product containing chlorthalidone||active_ingredient_of
diltiazem (watson-xr) 240mg sa cap||diltiazem hydrochloride 2||active_ingredient_of
eucalyptol 0.92 mg in 1 ml / menthol 0.42 mg in 1 ml / methyl salicylate 0.60 mg in 1 ml / thymol 0.64 mg in 1 ml oral mouthwash [giant eagle spring fresh antiseptic]||cineole||active_ingredient_of
arnica montana 12 [hp_x] in 30 ml / gold 12 [hp_x] in 30 ml / ubidecarenone 3 [hp_x] in 30 ml / sus scrofa diencephalon 6 [hp_x] in 30 ml / fumaric acid 3 [hp_x] in 30 ml / sus scrofa adrenal gland 200 [hp_x] in 30 ml / pork kidney 6 [hp_x] in 30 ml / melatonin 4 [hp_c] in 30 ml / melilotus 6 [hp_x] in 30 ml / sodium pyruvate 3 [hp_x] in 30 ml / olea europaea flower 3 [hp_x] in 30 ml / lead 12 [hp_x] in 30 ml / rauwolfia serpentina 6 [hp_x] in 30 ml / spigelia 6 [hp_x] in 30 ml / viscum album fruit 3 [hp_x] in 30 ml oral solution/ drops [guna-hypertension]||mountain arnica extract||active_ingredient_of
ceftazidime in is-osm dextrose 2 gram/50 ml intraven iv solution, piggyback premix frozen(ml)||ceftazidime||active_ingredient_of
amitriptyline hydrochloride 10mg oral tablet||amitriptyline hcl [enuresis]||active_ingredient_of
artemisia abrotanum flowering top 6 [hp_c] / aconitum napellus 1 [hp_m] / aethusa cynapium 200 [hp_c] / chaste tree 200 [hp_c] / ailanthus altissima flowering twig 30 [hp_c] / ambergris 30 [hp_c] / ambrosia artemisiifolia pollen 30 [hp_c] / ammonium carbonate 30 [hp_c] / antimony trisulfide 6 [hp_c] / apis mellifera 1 [hp_m] / arnica montana 3 [hp_c] / arsenic trioxide 3 [hp_c] / gold 200 [hp_c] / baptisia tinctoria root 200 [hp_c] / barium carbonate 30 [hp_c] / atropa belladonna 3 [hp_c] / borrelia burgdorferi 200 [hp_c] / bothrops atrox venom 30 [hp_c] / lycoperdon utriforme fruiting body 30 [hp_c] / bromine 30 [hp_c] / cadmium sulfate 30 [hp_c] / dieffenbachia seguine 30 [hp_c] / oyster shell calcium carbonate, crude 1 [hp_m] / camphor (natural) 200 [hp_c] / phenol 6 [hp_c] / milk thistle 30 [hp_c] / ceanothus americanus leaf 30 [hp_c] / chelidonium majus 6 [hp_c] / quinine sulfate 3 [hp_x] / artemisia cina pre-flowering top 3 [hp_x] / cinchona officinalis bark 3 [hp_c] / cicuta virosa root 30 [hp_c] / cobalt 30 [hp_c] / colchicum autumnale bulb 30 [hp_c] / conium maculatum flowering top 3 [hp_c] / crotalus horridus horridus venom 6 [hp_c] / croton tiglium seed 30 [hp_c] / copper 6 [hp_c] / solanum dulcamara top 30 [hp_c] / micrurus corallinus venom 30 [hp_c] / eupatorium perfoliatum flowering top 200 [hp_c] / hydrofluoric acid 30 [hp_c] / galphimia glauca flowering top 30 [hp_c] / graphite 200 [hp_c] / hamamelis virginiana root bark/stem bark 200 [hp_c] / hekla lava 30 [hp_c] / helleborus niger root 30 [hp_c] / calcium sulfide 6 [hp_c] / hydrogen cyanide 30 [hp_c] / hyoscyamus niger 6 [hp_c] / hypericum perforatum 1 [hp_m] / potassium bromide 30 [hp_c] / potassium carbonate 200 [hp_c] / potassium iodide 6 [hp_c] / lathyrus sativas seed 30 [hp_c] / prunus laurocerasus leaf 30 [hp_c] / ledum palustre twig 1 [hp_m] / lobelia inflata 30 [hp_c] / mercuric cyanide 200 [hp_c] / mercurius solubilis 6 [hp_c] / daphne mezereum bark 200 [hp_c] / moschus moschiferus whole 30 [hp_c] / hydrochloric acid 30 [hp_c] / naja naja venom 30 [hp_c] / sodium carbonate 30 [hp_c] / nitric acid 30 [hp_c] / nutmeg 30 [hp_c] / rancid beef 200 [hp_c] / phosphoric acid 6 [hp_c] / picric acid 200 [hp_c] / lead 30 [hp_c] / toxicodendron pubescens leaf 1 [hp_m] / ruta graveolens flowering top 6 [hp_c] / sambucus nigra flowering top 30 [hp_c] / sanguinaria canadensis root 200 [hp_c] / sarracenia purpurea 30 [hp_c] / claviceps purpurea sclerotium 6 [hp_c] / sepia officinalis juice 6 [hp_c] / datura stramonium 30 [hp_c] / sulfuric acid 30 [hp_c] / tobacco leaf 30 [hp_c] / lycosa tarantula 30 [hp_c] / turpentine oil 6 [hp_c] / teucrium marum 200 [hp_c] / veratrum album root 200 [hp_c] / veratrum viride root 30 [hp_c] / vipera berus venom 30 [hp_c] oral pellet [joette calabrese survivalist kit]||sambucus nigra flowering top||active_ingredient_of
meperidine hydrochloride, 100 mg oral tablet||pethidine hydrochloride [anaesthesia]||active_ingredient_of
product containing precisely oxycodone hydrochloride 30 milligram/1 each conventional release oral tablet||oxecta||active_ingredient_of
calcium carbonate 500 mg oral tablet, chewable [topcare antacid calcium]||calcium (as carbonate)||active_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 60 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [vichy laboratoires aqualia thermal sunscreen]||2-ethylhexyl salicylate||active_ingredient_of
product containing only mirtazapine 45 mg/1 each oral tablet||mirtazapine-containing product||active_ingredient_of
bexarotene 1% gel,top||bexaroten||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [basic care nighttime severe cold and flu]||p-acetylaminophenol||active_ingredient_of
benzocaine 3825 mg in 85 g / benzethonium chloride 76.5 mg in 85 g topical aerosol, spray [aeroaid antiseptic first aid]||inactisol||active_ingredient_of
zinc oxide 14 % topical cream||c.i. pigment white 4||active_ingredient_of
polyvinyl alcohol, unspecified 5 mg in 1 ml / povidone, unspecified 6 mg in 1 ml ophthalmic solution/ drops [artificial tears]||polividone||active_ingredient_of
aripiprazole@20 mg@oral@tablet,disintegrating||abilify||active_ingredient_of
product containing only benserazide and levodopa (medicinal product)||dl-serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide||active_ingredient_of
allium cepa whole 6 [hp_x] / arsenic trioxide 9 [hp_x] / strychnos nux-vomica seed 6 [hp_x] / schoenocaulon officinale seed 6 [hp_x] / lobaria pulmonaria 6 [hp_x] / copper 9 [hp_x] / aralia racemosa root 6 [hp_x] oral pellet [allergy relief]||strychnos nux-vomica seed||active_ingredient_of
caffeine 6 [hp_x] in 1 ml / naja naja venom 4 [hp_x] in 1 ml / agkistrodon piscivorus venom 6 [hp_x] in 1 ml oral spray [pain relief caffeine and snake venom]||agkistrodon piscivorus venom||active_ingredient_of
atropa belladonna 6 [hp_x] / bryonia alba root 6 [hp_x] / pulsatilla vulgaris 6 [hp_x] / apis mellifera 8 [hp_x] / bos taurus ovary 20 [hp_x] / sus scrofa fallopian tube 20 [hp_x] oral pellet||apis melifica / honey bee||active_ingredient_of
dermatophagoides farinae 400 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / cladosporium herbarum 0.002 g in 1 ml / mucor racemosus 0.002 g in 1 ml / alternaria alternata 0.0004 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 160 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / poa pratensis pollen 800 [bau] in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / pleospora herbarum 0.0004 g in 1 ml / carya tomentosa pollen 0.0004 g in 1 ml / morus alba pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml subcutaneous injection, solution||boxelder pollen||active_ingredient_of
avobenzone 3 g in 100 g / octisalate 5 g in 100 g / octocrylene 3 g in 100 g / homosalate 10 g in 100 g / oxybenzone 4 g in 100 g topical spray [hawaiian tropic]||benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||active_ingredient_of
aconitum napellus 200 [hp_c] in 1 ml / arnica montana 3 [hp_x] in 1 ml / arsenic trioxide 200 [hp_c] in 1 ml / bellis perennis 3 [hp_x] in 1 ml / sus scrofa cartilage 6 [hp_x] in 1 ml / causticum 200 [hp_c] in 1 ml / matricaria chamomilla 3 [hp_x] in 1 ml / arabica coffee bean 200 [hp_c] in 1 ml / euphorbia resinifera resin 6 [hp_x] in 1 ml / pseudognaphalium obtusifolium 3 [hp_x] in 1 ml / hypericum perforatum 200 [hp_c] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / passiflora incarnata top 1 [hp_x] in 1 ml / rancid beef 200 [hp_c] in 1 ml / ranunculus bulbosus 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml oral liquid [pain]||hyperici herba||active_ingredient_of
zinc oxide 85.0 mg in 1 ml / titanium dioxide 65.0 mg in 1 ml topical cream [cover recover spf 30 beige]||zinc óxido||active_ingredient_of
acetaminophen 500 mg oral tablet [acetaminophen tablets, 500 mg extra strength]||n-(4-hydroxyphenyl)acetanilide||active_ingredient_of
product containing only chlorhexidine and chlorobutanol (medicinal product)||2-propanol, 1,1,1-trichloro-2-methyl-||active_ingredient_of
dexmethylphenidate only product in oral dose form||dexmethylphenidate (substance)||active_ingredient_of
tsuga canadensis bark 1 [hp_x] oral pellet||tsuga canadensis bark extract||active_ingredient_of
octinoxate 6 ml in 30 ml topical cream [long last make up 02 (neo heliopan)]||octyl-methoxycinnamate||active_ingredient_of
matricaria recutita 3 [hp_x] in 1 ml / passiflora incarnata flowering top 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / semecarpus anacardium juice 20 [hp_x] in 1 ml / antimony trisulfide 20 [hp_x] in 1 ml / silver nitrate 20 [hp_x] in 1 ml / berberis vulgaris root bark 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / chelidonium majus 20 [hp_x] in 1 ml / digitalis 20 [hp_x] in 1 ml / graphite 20 [hp_x] in 1 ml / hops 20 [hp_x] in 1 ml / iris versicolor root 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / sodium carbonate 20 [hp_x] in 1 ml / sodium sulfate 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / anemone pratensis 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / scutellaria lateriflora 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / datura stramonium 20 [hp_x] in 1 ml oral liquid [appetite control]||carbonic acid, dipotassium salt||active_ingredient_of
passiflora incarnata flowering top 3 [hp_x] in 1 ml / matricaria chamomilla 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / fucus vesiculosus 4 [hp_x] in 1 ml / chaste tree fruit 6 [hp_x] in 1 ml / dibasic potassium phosphate 6 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / strychnos nux-vomica seed 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / chelidonium majus 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / bos taurus pituitary gland, posterior 10 [hp_x] in 1 ml / corticotropin 10 [hp_x] in 1 ml / thyroid, bovine 10 [hp_x] in 1 ml / thyroid, ovine 1 [hp_q] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 12 [hp_x] in 1 ml / ubidecarenone 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / sus scrofa pituitary gland 12 [hp_x] in 1 ml / bos taurus hypothalamus 12 [hp_x] in 1 ml / sus scrofa placenta 12 [hp_x] in 1 ml / silver nitrate 20 [hp_x] in 1 ml / berberis vulgaris root bark 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / digitalis 20 [hp_x] in 1 ml / iris versicolor root 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / sodium carbonate 20 [hp_x] in 1 ml / sodium sulfate 20 [hp_x] in 1 ml / anemone pulsatilla 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / scutellaria lateriflora 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / datura stramonium 20 [hp_x] in 1 ml / semecarpus anacardium juice 200 [hp_x] in 1 ml / agrimonia eupatoria flower 6 [hp_c] in 1 ml / castanea sativa leaf 6 [hp_c] in 1 ml / ceratostigma willmottianum flower 6 [hp_c] in 1 ml / aesculus hippocastanum flower 9 [hp_c] in 1 ml / centaurium erythraea flower 9 [hp_c] in 1 ml oral liquid [metalock]||phytolacca americana root extract||active_ingredient_of
alcohol 62 ml in 100 ml topical gel [santizall hand sanitizer]||spiritus vini||active_ingredient_of
acetyl coenzyme a 6 [hp_x] in 1 ml / adenosine triphosphate disodium 6 [hp_x] in 1 ml / sus scrofa adrenal cortex 6 [hp_x] in 1 ml / bacopa monnieri whole 6 [hp_x] in 1 ml / equol, (+/-)- 6 [hp_x] in 1 ml / oxytocin acetate 6 [hp_x] in 1 ml / sedum roseum root 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / quinine sulfate 6 [hp_x] in 1 ml / iodine 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / phosphorus 6 [hp_x] in 1 ml / dopamine hydrochloride 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / artemisia cina pre-flowering top 8 [hp_x] in 1 ml / serotonin hydrochloride 8 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [appetite control]||phosphorus, nos||active_ingredient_of
felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.01 g in 1 ml / periplaneta americana 0.01 g in 1 ml / alternaria alternata 0.0004 g in 1 ml / cochliobolus sativus 0.01 g in 1 ml subcutaneous injection, solution||allergenic extract, helminthosporium sativum||active_ingredient_of
titanium dioxide 0.358 g in 8.33 g topical powder [pure finish mineral powder foundation spf 20 pure finish 7]||dióxido de titanio||active_ingredient_of
ambrosia psilostachya pollen 30 [hp_x] in 1 ml / salsola tragus pollen 30 [hp_x] in 1 ml / cynodon dactylon pollen 30 [hp_x] in 1 ml / bromus inermis pollen 30 [hp_x] in 1 ml / bromus secalinus pollen 30 [hp_x] in 1 ml / sorghum halepense pollen 30 [hp_x] in 1 ml / poa pratensis pollen 30 [hp_x] in 1 ml / festuca pratensis pollen 30 [hp_x] in 1 ml / dactylis glomerata pollen 30 [hp_x] in 1 ml / lolium perenne pollen 30 [hp_x] in 1 ml / agrostis gigantea pollen 30 [hp_x] in 1 ml / phleum pratense pollen 30 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / fenugreek leaf 3 [hp_x] in 1 ml / acacia pollen 30 [hp_x] in 1 ml / alnus incana subsp. rugosa pollen 30 [hp_x] in 1 ml / fraxinus velutina pollen 30 [hp_x] in 1 ml / populus deltoides subsp. monilifera pollen 30 [hp_x] in 1 ml / ulmus crassifolia pollen 30 [hp_x] in 1 ml / ulmus pumila pollen 30 [hp_x] in 1 ml / eucalyptus globulus pollen 30 [hp_x] in 1 ml / juniperus scopulorum pollen 30 [hp_x] in 1 ml / ligustrum vulgare pollen 30 [hp_x] in 1 ml / prosopis juliflora pollen 30 [hp_x] in 1 ml / morus alba pollen 30 [hp_x] in 1 ml / quercus agrifolia pollen 30 [hp_x] in 1 ml / olea europaea pollen 30 [hp_x] in 1 ml / phoenix dactylifera pollen 30 [hp_x] in 1 ml / pinus strobus pollen 30 [hp_x] in 1 ml / liquidambar styraciflua pollen 30 [hp_x] in 1 ml / platanus occidentalis pollen 30 [hp_x] in 1 ml / ailanthus altissima pollen 30 [hp_x] in 1 ml / juglans nigra pollen 30 [hp_x] in 1 ml / salix nigra pollen 30 [hp_x] in 1 ml / atriplex canescens pollen 30 [hp_x] in 1 ml / amaranthus palmeri pollen 30 [hp_x] in 1 ml / rumex crispus pollen 30 [hp_x] in 1 ml / chenopodium album pollen 30 [hp_x] in 1 ml / amaranthus retroflexus pollen 30 [hp_x] in 1 ml / plantago lanceolata pollen 30 [hp_x] in 1 ml / ambrosia acanthicarpa pollen 30 [hp_x] in 1 ml oral liquid [allergena zone 9]||plantago lanceolata pollen||active_ingredient_of
acetaminophen 500/dexbromphenir 1mg tab||hydroxyacetanilide||active_ingredient_of
matricaria recutita 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / achillea millefolium 3 [hp_x] in 1 ml / bryonia alba root 4 [hp_x] in 1 ml / calendula officinalis flowering top 4 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / bellis perennis 6 [hp_x] in 1 ml / toxicodendron pubescens leaf 6 [hp_x] in 1 ml / clematis vitalba flower 8 [hp_x] in 1 ml / helianthemum nummularium flower 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / impatiens glandulifera flower 8 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml oral liquid [post-dental visit]||matricaria recutita whole extract||active_ingredient_of
xeljanz, 10 mg oral tablet||tofacitinib citrate||active_ingredient_of
aquilegia vulgaris 2 [hp_x] in 1 ml / avena sativa flowering top 2 [hp_x] in 1 ml / matricaria recutita 2 [hp_x] in 1 ml / arabica coffee bean 6 [hp_x] in 1 ml / cypripedium parviflorum var. pubescens root 3 [hp_x] in 1 ml / hops 3 [hp_x] in 1 ml / hypericum perforatum 6 [hp_x] in 1 ml / potassium phosphate, dibasic 12 [hp_x] in 1 ml / melatonin 6 [hp_x] in 1 ml / melissa officinalis 3 [hp_x] in 1 ml / sodium chloride 30 [hp_c] in 1 ml / passiflora incarnata flowering top 2 [hp_x] in 1 ml / valerian 2 [hp_x] in 1 ml oral liquid [insomnia]||aquilegia vulgaris extract||active_ingredient_of
50 ml ruxience 10 mg/ml injection||product containing rituximab (medicinal product)||active_ingredient_of
60 actuat fluticasone propionate 0.23 mg/actuat / salmeterol 0.021 mg/actuat metered dose inhaler [advair]||serevent diskus||active_ingredient_of
calcium carbonate 420 mg oral tablet, chewable [physicianscare antacid]||mylicon children's||active_ingredient_of
influenza a virus 35 [hp_x] in 1 ml / american ginseng 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / euphrasia stricta 20 [hp_x] in 1 ml / gaultheria procumbens top 20 [hp_x] in 1 ml / gelsemium sempervirens root 20 [hp_x] in 1 ml / calcium sulfide 20 [hp_x] in 1 ml / histamine dihydrochloride 20 [hp_x] in 1 ml / goldenseal 20 [hp_x] in 1 ml / potassium dichromate 20 [hp_x] in 1 ml / mercury 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / pulsatilla vulgaris 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / schoenocaulon officinale seed 20 [hp_x] in 1 ml / sage 20 [hp_x] in 1 ml / lobaria pulmonaria 20 [hp_x] in 1 ml / verbascum thapsus 20 [hp_x] in 1 ml / echinacea, unspecified 8 [hp_x] in 1 ml / goldenseal 8 [hp_x] in 1 ml / influenza b virus 35 [hp_x] in 1 ml oral liquid [cold cough]||fluav||active_ingredient_of
aloh/mgoh/simethicone regular strength liquid||aluminium hydroxide [nutr]||active_ingredient_of
product containing only aprepitant (medicinal product)||3h-1,2,4-triazol-3-one, 5-(((2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-||active_ingredient_of
product containing precisely fluconazole 150 milligram/1 each conventional release oral tablet||fluconazole (substance)||active_ingredient_of
tizanidine 2 mg oral tablet||5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole hydrochloride||active_ingredient_of
glycopyrrolate 0.2 mg/1 ml injection solution_#4||glycopyrrolate product||active_ingredient_of
sulfatrim (sulfamethoxazole 800 mg / trimethoprim 160 mg) oral tablet||sulfamethoxazole (medication)||active_ingredient_of
alcohol 70 ml in 100 ml topical gel [hanna hand sanitizer gel]||etoh - alcohol||active_ingredient_of
ascorbic acid 35 mg / cholecalciferol 400 unt / niacin 8 mg / riboflavin 0.6 mg / sodium fluoride 0.55 mg (fluoride 0.25 mg) / thiamine 0.5 mg / vitamin a 1500 unt / vitamin b 12 2 mcg / vitamin b6 0.4 mg / vitamin e 5 unt per ml oral solution||riboflavin preparation (substance)||active_ingredient_of
alcohol 0.7 ml in 1 ml topical gel [just be happy hand sanitizer]||methylcarbinol||active_ingredient_of
ginger 3 [hp_x] in 1 ml / cyclamen purpurascens tuber 6 [hp_x] in 1 ml / ipecac 6 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / skim milk 6 [hp_x] in 1 ml / lactic acid, dl- 6 [hp_x] in 1 ml / tobacco leaf 6 [hp_x] in 1 ml / kerosene 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / cadmium sulfide 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / colchicum autumnale bulb 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / theridion curassavicum 12 [hp_x] in 1 ml / euphorbia corollata root 24 [hp_x] in 1 ml oral liquid [nausia]||cadmium sulfide||active_ingredient_of
bismuth subsalicylate 262 mg oral tablet, chewable [rite aid stomach relief]||bismuth subsalicylate||active_ingredient_of
dimethicone 2 mg in 200 ml topical cream [moist moisture skin toner]||dimethicone||active_ingredient_of
krameria lappacea root 15 [hp_x] in 1 ml / picea mariana resin 15 [hp_x] in 1 ml / horse chestnut 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / aluminum oxide 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / activated charcoal 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / collinsonia canadensis root 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / magnesium chloride 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / podophyllum 15 [hp_x] in 1 ml / sanicula europaea leaf 15 [hp_x] in 1 ml / selenium 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / tobacco leaf 15 [hp_x] in 1 ml / veratrum album root 15 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / taraxacum officinale 6 [hp_x] in 1 ml oral liquid [constipation]||sanicula europaea leaf||active_ingredient_of
azacitidine 100 mg subcutaneous powder for injection||azacytidine, 5-||active_ingredient_of
pimecrolimus 10 mg/ml topical cream||pimecrolimus (medication)||active_ingredient_of
alcohol 0.7 ml in 1 ml topical gel [new horizon hand sanitizer]||product containing ethyl alcohol||active_ingredient_of
levomepromazine only product in oral dose form||product containing levomeprazine (medicinal product)||active_ingredient_of
everolimus@3 mg@oral@tablet for suspension||40-o-(2-hydroxyethyl)-rapamycin||active_ingredient_of
product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release oral tablet (clinical drug)||ondansetron monohydrochloride||active_ingredient_of
oxaliplatin 5 mg in 1 ml intravenous injection, solution, concentrate [oxaliplatin]||oxaliplatin||active_ingredient_of
phenylephrine hcl/acetaminophn 5 mg-325 mg oral capsule||paracetamol (substance)||active_ingredient_of
camphor 60 mg/ml / menthol 150 mg/ml / methyl salicylate 400 mg/ml topical oil||synthetic camphor||active_ingredient_of
product containing only levothyroxine sodium 150 microgram/1 each oral tablet||levothyroxine sodium preparation (substance)||active_ingredient_of
menthol 130 mg in 1 g topical cream [the skateboarding pain relieving liniment]||menthol-containing product||active_ingredient_of
respiratory syncytial virus immune globulin for intravenous use (medication)||respiratory syncytial virus antibody||active_ingredient_of
nifedipine 60 mg oral tablet, extended release||4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester||active_ingredient_of
avobenzone 0.01 ml in 1 ml / octocrylene 0.03 ml in 1 ml / oxybenzone 0.03 ml in 1 ml topical oil [banana boat deep tanning dry spf 8]||1-(4-(1,1-dimethylethyl)phenyl)-3-(4-methoxyphenyl)-1,3-propanedione||active_ingredient_of
potassium chloride 1 [hp_x] oral tablet||chloride potassium||active_ingredient_of
product containing only hydralazine and isosorbide in oral dose form (medicinal product form)||isosorbide||active_ingredient_of
benzalkonium chloride 1.5 mg in 1 ml topical gel [antibacterial hand wash for kids pineapple and coconut scented]||benzalkonium chloride - chemical (substance)||active_ingredient_of
product containing paritaprevir||paritaprevir (product)||active_ingredient_of
germanium (substance)||germanium, nos||active_ingredient_of
aconitum napellus 3 [hp_x] in 57 g / arnica montana 3 [hp_x] in 57 g / arsenic triiodide 8 [hp_x] in 57 g / belladonna leaf 3 [hp_x] in 57 g / bellis perennis 3 [hp_x] in 57 g / bryonia alba root 3 [hp_x] in 57 g / calendula officinalis flowering top 3 [hp_x] in 57 g / matricaria recutita 3 [hp_x] in 57 g / echinacea angustifolia 3 [hp_x] in 57 g / echinacea purpurea 3 [hp_x] in 57 g / graphite 8 [hp_x] in 57 g / hamamelis virginiana root bark/stem bark 3 [hp_x] in 57 g / calcium sulfide 4 [hp_x] in 57 g / hypericum perforatum 3 [hp_x] in 57 g / lachesis muta venom 8 [hp_x] in 57 g / ledum palustre twig 3 [hp_x] in 57 g / achillea millefolium 3 [hp_x] in 57 g / mercurius solubilis 9 [hp_x] in 57 g / phytolacca americana root 6 [hp_c] in 57 g / ruta graveolens flowering top 3 [hp_x] in 57 g / toxicodendron pubescens leaf 3 [hp_x] in 57 g / silicon dioxide 4 [hp_x] in 57 g / stellaria media 3 [hp_x] in 57 g / sulfur 5 [hp_x] in 57 g / comfrey root 3 [hp_x] in 57 g / thuja occidentalis leafy twig 3 [hp_x] in 57 g topical ointment [nans healing]||matricaria recutita extract||active_ingredient_of
smilax ornata root 15 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / lycoperdon utriforme fruiting body 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / croton tiglium seed 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / kerosene 15 [hp_x] in 1 ml / pulex irritans 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / urtica urens 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / taraxacum officinale 6 [hp_x] in 1 ml oral liquid [rashes-hives]||bryonia alba root extract||active_ingredient_of
staphylococcal enterotoxin c specific diagnostic allergen extract||staphylococcus aureus enterotoxin c||active_ingredient_of
arnica montana flower 2 mg in 1 g / chamomile 2 mg in 1 g topical cream [flexitol first aid]||chamomile extract product||active_ingredient_of
product containing precisely levofloxacin 500 milligram/1 each conventional release oral tablet||(s)-ofloxacin||active_ingredient_of
erysipelothrix rhusiopathiae vaccine - leptospira canicola - grippotyphosa - hardjo - icterohemorrhagiae - pomona bacterin||antigen of leptospira canicola (substance)||active_ingredient_of
benzalkonium chloride .0013 kg in 1 kg topical soap [theorie moroccan fig nourishing hand wash]||chloride, benzalkonium||active_ingredient_of
oxygen 99.5 % gas for inhalation [oxymed]||pure oxygen||active_ingredient_of
shagbark hickory pollen extract 10000 unt/ml injectable solution||carya ovata pollen||active_ingredient_of
white pepper allergenic extract 0.1 gm/ml injectable solution||white pepper||active_ingredient_of
somatropin 6 [hp_x] in 30 ml / dalotuzumab 6 [hp_x] in 30 ml / saccharomyces cerevisiae rna 6 [hp_x] in 30 ml / herring sperm dna 6 [hp_x] in 30 ml / sus scrofa adrenal gland 6 [hp_x] in 30 ml / pork liver 6 [hp_x] in 30 ml / sus scrofa pituitary gland 6 [hp_x] in 30 ml / sus scrofa thymus 6 [hp_x] in 30 ml / thyroid, unspecified 6 [hp_x] in 30 ml / sus scrofa placenta 6 [hp_x] in 30 ml / sus scrofa testicle 6 [hp_x] in 30 ml / artemisia abrotanum flowering top 10 [hp_x] in 30 ml / semecarpus anacardium juice 10 [hp_x] in 30 ml / arsenic trioxide 10 [hp_x] in 30 ml / barium carbonate 10 [hp_x] in 30 ml / barium chloride dihydrate 10 [hp_x] in 30 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 30 ml / tribasic calcium phosphate 10 [hp_x] in 30 ml / iron 10 [hp_x] in 30 ml / fucus vesiculosus 10 [hp_x] in 30 ml / hekla lava 10 [hp_x] in 30 ml / helleborus niger root 10 [hp_x] in 30 ml / strychnos ignatii seed 10 [hp_x] in 30 ml / lycopodium clavatum spore 10 [hp_x] in 30 ml / niacinamide 10 [hp_x] in 30 ml / claviceps purpurea sclerotium 10 [hp_x] in 30 ml / silicon dioxide 10 [hp_x] in 30 ml / cobalt 12 [hp_x] in 30 ml / lithium carbonate 12 [hp_x] in 30 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 30 ml / manganese acetate tetrahydrate 12 [hp_x] in 30 ml / potassium phosphate, dibasic 12 [hp_x] in 30 ml / selenium 12 [hp_x] in 30 ml / zinc 12 [hp_x] in 30 ml oral spray [rejuvenate 2000 pm formula for men]||porcine adrenal gland preparation||active_ingredient_of
aconitum napellus 20 [hp_x] in 1 ml / antimony potassium tartrate 20 [hp_x] in 1 ml / silver nitrate 20 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / matricaria recutita 20 [hp_x] in 1 ml / chelidonium majus 20 [hp_x] in 1 ml / black cohosh 20 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 20 [hp_x] in 1 ml / hypericum perforatum 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / ruta graveolens flowering top 20 [hp_x] in 1 ml / lactic acid, l- 20 [hp_x] in 1 ml / datura stramonium 20 [hp_x] in 1 ml / strychnine 20 [hp_x] in 1 ml / phytolacca americana root 8 [hp_x] in 1 ml / comfrey root 8 [hp_x] in 1 ml oral liquid [muscle - tendon]||bryonia alba root||active_ingredient_of
sodium bicarbonate 0.9 meq/ml intraven vial (ml)||sodium hydrogencarbonate||active_ingredient_of
vosevi oral product||vosevi||active_ingredient_of
alcohol 0.7 ml in 1 ml topical gel [miggy foundation 70% hand sanitizer]||drinking alcohol||active_ingredient_of
product containing only calcium carbonate and colecalciferol in oral dose form (medicinal product form)||calcium carbonate (substance)||active_ingredient_of
product containing precisely hydrochlorothiazide 12.5 milligram/1 each conventional release oral capsule (clinical drug)||hydrochlorothiazide||active_ingredient_of
product containing only kanamycin (medicinal product)||product containing kanamycin (medicinal product)||active_ingredient_of
glycerin 10 g in 100 ml topical liquid [medi hydro dp stem c ampoule]||glycerol product||active_ingredient_of
titanium dioxide 0.80 g in 13.32 g / zinc oxide 0.63 g in 13.32 g topical stick [cerave developed with dermatologists sunscreen broad spectrum spf 50]||zno||active_ingredient_of
sodium borate 3 [hp_x] in 1 ml / thuja occidentalis leafy twig 3 [hp_x] in 1 ml / arsenic trioxide 6 [hp_x] in 1 ml / wood creosote 6 [hp_x] in 1 ml / sulfur 6 [hp_x] in 1 ml / candida parapsilosis 12 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / aspergillus niger var. niger 12 [hp_c] in 1 ml / mucor racemosus 12 [hp_c] in 1 ml / rhizopus stolonifer 12 [hp_c] in 1 ml / issatchenkia orientalis whole 14 [hp_c] in 1 ml / candida tropicalis 34 [hp_c] in 1 ml oral liquid [candida ease]||sodium tetraborate (substance)||active_ingredient_of
product containing only carisoprodol 350 mg/1 each oral tablet (clinical drug)||2-methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate||active_ingredient_of
vaccines viral measles, live, attenuated||rubeola virus antigen||active_ingredient_of
octinoxate 4.5 g in 100 ml / oxybenzone 1.5 g in 100 ml topical lotion [land shark spf 8]||omc cinnamate||active_ingredient_of
product containing technetium (99m-tc) human immunoglobulin g in parenteral dose form (medicinal product form)||product containing technetium (99m-tc) human immunoglobulin g (medicinal product)||active_ingredient_of
cupric acetate 30 [hp_c] in 1 ml oral liquid [cuprum aceticum]||copper(i) acetate||active_ingredient_of
dermatophagoides pteronyssinus 400 [au] in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / iva annua pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / candida albicans 0.00008 g in 1 ml / phoma destructiva 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / cladosporium cladosporioides 0.00008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / gallus gallus feather 0.0000266 g in 1 ml / anas platyrhynchos feather 0.0000266 g in 1 ml / anser anser feather 0.0000266 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya tomentosa pollen 0.00004 g in 1 ml / ustilago nuda hordei 0.0005 g in 1 ml / ustilago maydis 0.0005 g in 1 ml / ustilago avenae 0.0005 g in 1 ml / ustilago tritici 0.0005 g in 1 ml subcutaneous injection, solution||fraxinus americana pollen extract||active_ingredient_of
hydrocortisone, rectal, 30 mg rectal suppository||hydrocortisone acetate [musculoskeletal use] (product)||active_ingredient_of
medpura hand sanitizer, 70% topical gel||alcohol isopropílico||active_ingredient_of
niacinamide 2 g in 100 ml / adenosine 0.04 g in 100 ml / glycerin 2.8 g in 100 ml topical liquid [banobagi vita cocktail foil mask age]||adenosine-containing product||active_ingredient_of
20 ml chloroprocaine hydrochloride 20 mg/ml injection||chloroprocaine hydrochloride||active_ingredient_of
aethusa cynapium 10 [hp_x] in 59 ml / garlic 10 [hp_x] in 59 ml / baptisia tinctoria root 10 [hp_x] in 59 ml / capsicum 10 [hp_x] in 59 ml / activated charcoal 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / collinsonia canadensis root 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 [hp_x] in 59 ml / marsdenia condurango bark 10 [hp_x] in 59 ml / gamboge 10 [hp_x] in 59 ml / gratiola officinalis 10 [hp_x] in 59 ml / cow milk 10 [hp_x] in 59 ml / lactic acid, dl- 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / podophyllum 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml oral liquid [probiotic restoration]||silicon dioxide||active_ingredient_of
thiothixene only product in oral dose form||tiotixenum||active_ingredient_of
octinoxate 60 mg in 1 ml / titanium dioxide 56 mg in 1 ml topical emulsion [vitalumiere aqua ultra-light skin perfecting sunscreen makeup broad spectrum spf 15, 21 beige]||product containing titanium dioxide||active_ingredient_of
hypericum perforatum 3 [hp_x] in 1 g / phytolacca americana root 3 [hp_x] in 1 g / guaiac 6 [hp_x] in 1 g / ledum palustre twig 6 [hp_x] in 1 g / conium maculatum flowering top 30 [hp_x] in 1 g topical gel [back and neck rescue]||poison hemlock flowering top extract||active_ingredient_of
chionanthus virginicus bark 30 [hp_c] in 1 ml / arsenic trioxide 1 [hp_m] in 1 ml / strychnos nux-vomica seed 1 [hp_m] in 1 ml / platinum 1 [hp_m] in 1 ml / bos taurus bile 3 [hp_x] in 1 ml oral liquid [2 gallbladder]||platinum||active_ingredient_of
benzalkonium chloride 0.13 g in 100 ml topical liquid [home formation antibacteria -berry]||alkylbenzyldimethylammonium chloride||active_ingredient_of
onion 6 [hp_x] in 1 ml / garlic 6 [hp_x] in 1 ml / .alpha.-lipoic acid 12 [hp_x] in 1 ml / aluminum oxide 15 [hp_x] in 1 ml / arsenic 15 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / cadmium 15 [hp_x] in 1 ml / milk thistle 4 [hp_x] in 1 ml / cetraria islandica subsp. islandica 12 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / cysteine 12 [hp_x] in 1 ml / glycyrrhiza glabra 4 [hp_x] in 1 ml / pork liver 9 [hp_x] in 1 ml / arctium lappa root 4 [hp_x] in 1 ml / lycopodium clavatum spore 4 [hp_x] in 1 ml / mercurius solubilis 15 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / plantago major 4 [hp_x] in 1 ml / lead 15 [hp_x] in 1 ml / pyridoxine hydrochloride 12 [hp_x] in 1 ml / selenium 15 [hp_x] in 1 ml / stillingia sylvatica root 4 [hp_x] in 1 ml / thyroid, bovine 9 [hp_x] in 1 ml / trifolium pratense flower 4 [hp_x] in 1 ml / ginger 6 [hp_x] in 1 ml oral liquid [metal-chord]||onion allergenic extract||active_ingredient_of
hydroxychloroquine sulfate, 200 mg oral tablet||hydroxychloroquine sulfate||active_ingredient_of
alcohol 80 ml in 100 ml topical liquid [cleanest co hand sanitizer]||alcohol denatured||active_ingredient_of
atropine sulfate 0.1mg/1ml solution for injection with 21 gauge, 1.5 inch needle||atropine sulfate - chemical (substance)||active_ingredient_of
prosol, amino acids 20% (prosol sulfite-free) intravenous solution||acidum asparticum||active_ingredient_of
zolpidem tartrate 10mg tab,ud||zolpidem tartrate (substance)||active_ingredient_of
arsenic trioxide 100 [hp_x] in 1 ml / baptisia tinctoria root 100 [hp_x] in 1 ml / bryonia alba root 100 [hp_x] in 1 ml / solanum dulcamara top 100 [hp_x] in 1 ml / echinacea angustifolia 100 [hp_x] in 1 ml / echinacea purpurea 100 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 100 [hp_x] in 1 ml / ferrosoferric phosphate 100 [hp_x] in 1 ml / gelsemium sempervirens root 100 [hp_x] in 1 ml / potassium chloride 100 [hp_x] in 1 ml / phosphorus 100 [hp_x] in 1 ml / anemone pulsatilla 100 [hp_x] in 1 ml / sulfur 100 [hp_x] in 1 ml / zinc acetate anhydrous 100 [hp_x] in 1 ml / zinc carbonate 100 [hp_x] in 1 ml / zinc 100 [hp_x] in 1 ml / zinc chloride 100 [hp_x] in 1 ml / zinc oxide 100 [hp_x] in 1 ml / zinc picrate nonahydrate 100 [hp_x] in 1 ml / zinc valerate dihydrate 100 [hp_x] in 1 ml / cairina moschata heart/liver autolysate 200 [hp_c] in 1 ml / influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) whole 200 [hp_c] in 1 ml oral liquid [cold/flu hp]||solanum dulcamara top||active_ingredient_of
product containing precisely fenofibrate micronized 200 milligram/1 each conventional release oral capsule||propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-, 1-methylethyl ester||active_ingredient_of
mucor racemosus 6 [hp_x] in 1 ml oral liquid [pleo muc]||mucor extract||active_ingredient_of
cefazolin sodium 330 mg in 1 ml intramuscular injection, powder, for solution [cefazolin]||cephazolin sodium||active_ingredient_of
ibuprofen 200 mg oral tablet, film coated [dye free ibuprofen]||ibuprofen [cns analgesic] [see j28..]||active_ingredient_of
product containing only posaconazole in oral dose form (medicinal product form)||posaconazole||active_ingredient_of
rough marshelder pollen extract 20000 unt/ml injectable solution||allergenic extract, iva ciliata, i. xanthifolia pollen||active_ingredient_of
levothyroxine sodium@125 mcg@oral@tablet||laevothyroxine sodium preparation||active_ingredient_of
belladonna alkaloid and ergotamine and phenobarbital only product||belladonna alkaloids - chemical||active_ingredient_of
ivermectin 0.136 mg / pyrantel 114 mg chewable tablet||pyrantel base (as pyrantel pamoate)||active_ingredient_of
lidocaine hydrochloride+epinephrine 1%/1:200,000 injection||lidocaine hydrochloride anhydrous||active_ingredient_of
product containing only levonorgestrel 1.5 mg/1 each oral tablet||13-beta-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one||active_ingredient_of
corvite 150, vitamin b complex with c, folic acid, iron and zinc oral tablet||(3as,4s,6ar)-hexahydro-2-oxo-1h-thieno[3,4-d]imidazole-4-valeric acid||active_ingredient_of
dimethicone 0.6 g in 100 ml topical shampoo [gyeol]||dimethyl polysiloxane||active_ingredient_of
amaranthus retroflexus pollen 0.02 g in 1 ml / salsola kali pollen 0.02 g in 1 ml / plantago lanceolata pollen 0.02 g in 1 ml / xanthium strumarium pollen 0.02 g in 1 ml / chenopodium album pollen 0.02 g in 1 ml intradermal solution [common weed mix]||xanthium strumarium pollen extract||active_ingredient_of
heptanoic acid 0.4 % / iodine 1 % topical solution||heptanoic acid (substance)||active_ingredient_of
allium cepa whole 30 [hp_c] in 60 ml / ambrosia artemisiifolia 30 [hp_c] in 60 ml / arsenic trioxide 30 [hp_c] in 60 ml / euphrasia stricta 30 [hp_c] in 60 ml / galphimia glauca flowering top 30 [hp_c] in 60 ml / histamine dihydrochloride 30 [hp_c] in 60 ml / lemna minor 30 [hp_c] in 60 ml / flax seed 30 [hp_c] in 60 ml / luffa operculata fruit 30 [hp_c] in 60 ml / sodium chloride 30 [hp_c] in 60 ml / fomitopsis pinicola fruiting body 30 [hp_c] in 60 ml / schoenocaulon officinale seed 30 [hp_c] in 60 ml oral liquid [triple allergy defense]||luffa operculata fruit||active_ingredient_of
sulfur 50 mg in 1 g / salicylic acid 30 mg in 1 g topical ointment [glovers anti-dandruff]||nizoral psoriasis||active_ingredient_of
avobenzone 3 g in 100 ml / octinoxate 7.5 g in 100 ml / octocrylene 7.5 g in 100 ml topical cream [carecella day cream]||octinoxate||active_ingredient_of
bicillin c-r 1,200,000units/2ml suspension for injection||procaine benzylpenicillin (substance)||active_ingredient_of
calendula officinalis flowering top 12 [hp_x] in 1 ml / croton tiglium seed 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / plantago major 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / smilax regelii root 30 [hp_x] in 1 ml topical spray [muscle/tendon pain and stress relief]||plantago major whole||active_ingredient_of
betula pubescens leaf 2 [hp_c] / black cohosh 2 [hp_c] / crataegus laevigata fruit 2 [hp_c] / equisetum hyemale 2 [hp_c] / frangula alnus bark 2 [hp_c] / solidago virgaurea flowering top 2 [hp_c] / adonis vernalis 3 [hp_c] / apocynum androsaemifolium root 3 [hp_c] / chelidonium majus 3 [hp_c] / lycopodium clavatum spore 3 [hp_c] / drimia maritima bulb 3 [hp_c] oral tablet [homeopathic weight loss formula]||cimicifugae racemosae rhizoma||active_ingredient_of
triticum aestivum whole 1 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / zanthoxylum americanum bark 3 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / salicylic acid 30 [hp_x] in 1 ml / corticotropin 30 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / eugenol 30 [hp_x] in 1 ml / stearyl alcohol 30 [hp_x] in 1 ml / xylitol 30 [hp_x] in 1 ml / estrone 30 [hp_x] in 1 ml / benzoic acid 30 [hp_x] in 1 ml / chlorine 30 [hp_x] in 1 ml / potassium sorbate 30 [hp_x] in 1 ml / sorbitol 30 [hp_x] in 1 ml / resorcinol 30 [hp_x] in 1 ml / benzyl alcohol 30 [hp_x] in 1 ml / lactic acid, dl- 30 [hp_x] in 1 ml / isopropyl palmitate 30 [hp_x] in 1 ml / boric acid 30 [hp_x] in 1 ml / acetic acid 30 [hp_x] in 1 ml / phenylbutazone 30 [hp_x] in 1 ml / petrolatum 30 [hp_x] in 1 ml / lead 30 [hp_x] in 1 ml oral liquid [chemtox]||burdock root extract||active_ingredient_of
adenosine cyclic phosphate 12 [hp_x] in 59 ml / epinephrine 12 [hp_x] in 59 ml / corticotropin 12 [hp_x] in 59 ml / hyacinthoides non-scripta 12 [hp_x] in 59 ml / onion 12 [hp_x] in 59 ml / collinsonia canadensis root 12 [hp_x] in 59 ml / cortisone acetate 12 [hp_x] in 59 ml / euphrasia stricta 12 [hp_x] in 59 ml / galphimia glauca flowering top 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / potassium chloride 12 [hp_x] in 59 ml / sus scrofa nasal mucosa 12 [hp_x] in 59 ml / sodium chloride 12 [hp_x] in 59 ml / saccharomyces cerevisiae rna 12 [hp_x] in 59 ml / rumex crispus root 12 [hp_x] in 59 ml / schoenocaulon officinale seed 12 [hp_x] in 59 ml / sage 12 [hp_x] in 59 ml / tanacetum vulgare top 12 [hp_x] in 59 ml / trifolium pratense flower 12 [hp_x] in 59 ml / vinca minor 12 [hp_x] in 59 ml oral liquid [allergies northeast u.s.]||histamine dihydrochloride||active_ingredient_of
blink tears 0.25 % ophthalmic solution||ocusan dry eyes||active_ingredient_of
petrolatum, white 100% topical application gel/jelly [tugaboos petroleum jelly]||petrolatum, white||active_ingredient_of
chondrus crispus 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / smilax regelii root 3 [hp_x] in 1 ml / ginger 3 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / aralia racemosa root 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / lytta vesicatoria 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / sodium carbonate 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml oral liquid [allerforce]||oyster shell calcium carbonate preparation||active_ingredient_of
combination, aspirin-dipyridamole drug||aspirin product||active_ingredient_of
broussonetia papyrifera pollen 0.1 g in 1 ml subcutaneous solution [paper mulberry pollen]||paper mulberry pollen allergen||active_ingredient_of
minocycline hydrochloride 135 mg oral tablet, film coated, extended release [solodyn]||monohydrochloride, minocycline||active_ingredient_of
menthol 105 / methyl salicylate 31.5 / eucalyptus oil 105 topical patch [theraderm pain relieving patch]||product containing menthol (medicinal product)||active_ingredient_of
sodium hydroxide 10% top soln||soda, caustic||active_ingredient_of
sodium chloride 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / calcium fluoride 10 [hp_x] in 59 ml / guaiac 10 [hp_x] in 59 ml / hekla lava 10 [hp_x] in 59 ml / egg phospholipids 10 [hp_x] in 59 ml / parathyroid hormone 10 [hp_x] in 59 ml / pyridoxine hydrochloride 10 [hp_x] in 59 ml oral liquid [m3 metabolic mineral modulator]||guaiacum (resin)||active_ingredient_of
octinoxate 55 mg in 1 ml / titanium dioxide 27 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [just enough spf 15 tinted moisturizer tan is beautiful]||salicylic acid 2-ethylhexyl ester||active_ingredient_of
barley 0.1 g in 1 ml subcutaneous injection, solution||barley allergenic extract||active_ingredient_of
product containing diltiazem hydrochloride 90 mg/1 each oral tablet (clinical drug)||diltiazem hydrochloride (substance)||active_ingredient_of
enrofloxacin 22.7 mg oral tablet [fluroxin flavored]||enrofloxacin-containing product||active_ingredient_of
octinoxate 7 g in 100 ml / octisalate 3 g in 100 ml / oxybenzone 2 g in 100 ml topical lotion [reef safe spf 15]||anuvex||active_ingredient_of
fentanyl 100 ug in 1 h transdermal patch, extended release [fentanyl transdermal]||fentanil||active_ingredient_of
esomeprazole 20 mg delayed release oral tablet||nexium||active_ingredient_of
venlafaxine hcl 150mg 24hr cap,sa||effexor||active_ingredient_of
methyl salicylate 20 g in 100 g / menthol, unspecified form 5 g in 100 g / capsaicin .035 g in 100 g / lidocaine 0.5 g in 100 g topical patch [medi-sulting topical pain relief]||(e)-n-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide||active_ingredient_of
carya illinoinensis pollen 0.1 g in 1 ml / acer saccharum pollen 0.033 g in 1 ml / acer negundo pollen 0.033 g in 1 ml / acer rubrum pollen 0.033 g in 1 ml / quercus rubra pollen 0.033 g in 1 ml / quercus virginiana pollen 0.033 g in 1 ml / quercus alba pollen 0.033 g in 1 ml / platanus occidentalis pollen 0.1 g in 1 ml / salix nigra pollen 0.1 g in 1 ml percutaneous injection, solution [pollens - trees, tree mix 5]||quercus virginiana pollen allergen (substance)||active_ingredient_of
lignocaine 2% injection 2ml||lidocaine hydrochloride||active_ingredient_of
chaste tree 20 [hp_x] in 1 g / american ginseng 20 [hp_x] in 1 g / barium carbonate 20 [hp_x] in 1 g / berberis vulgaris root bark 20 [hp_x] in 1 g / bryonia alba root 20 [hp_x] in 1 g / dieffenbachia seguine 20 [hp_x] in 1 g / lytta vesicatoria 20 [hp_x] in 1 g / causticum 20 [hp_x] in 1 g / chelidonium majus 20 [hp_x] in 1 g / cinchona officinalis bark 20 [hp_x] in 1 g / conium maculatum flowering top 20 [hp_x] in 1 g / gaultheria procumbens top 20 [hp_x] in 1 g / graphite 20 [hp_x] in 1 g / potassium carbonate 20 [hp_x] in 1 g / lycopodium clavatum spore 20 [hp_x] in 1 g / strychnos nux-vomica seed 20 [hp_x] in 1 g / onosmodium virginianum root 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / saw palmetto 20 [hp_x] in 1 g / selenium 20 [hp_x] in 1 g / sepia officinalis juice 20 [hp_x] in 1 g / silicon dioxide 20 [hp_x] in 1 g / delphinium staphisagria seed 20 [hp_x] in 1 g / goldenseal 8 [hp_x] in 1 g / thuja occidentalis leafy twig 8 [hp_x] in 1 g oral pellet [libido]||lycopodium clavatum spore extract||active_ingredient_of
amanita muscaria fruiting body 12 [hp_x] in 1 ml / protortonia cacti 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / gelsemium sempervirens root 30 [hp_x] in 1 ml / influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / latrodectus mactans 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / citharacanthus spinicrus 30 [hp_x] in 1 ml / botulinum toxin type a 30 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_x] in 1 ml / pseudomonas aeruginosa 30 [hp_x] in 1 ml / proteus morganii 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / clostridium perfringens 15 [hp_c] in 1 ml / human herpesvirus 4 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / poliovirus 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [neurotox]||tantalum (substance)||active_ingredient_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (rosa romantica femme) - pink]||benzophenone 3||active_ingredient_of
echinacea, unspecified 3 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / fenugreek leaf 3 [hp_x] in 1 ml / acacia pollen 30 [hp_x] in 1 ml / alnus rubra pollen 30 [hp_x] in 1 ml / alnus incana subsp. rugosa pollen 30 [hp_x] in 1 ml / fraxinus velutina pollen 30 [hp_x] in 1 ml / fraxinus pennsylvanica pollen 30 [hp_x] in 1 ml / fraxinus americana pollen 30 [hp_x] in 1 ml / morella cerifera pollen 30 [hp_x] in 1 ml / eucalyptus globulus pollen 30 [hp_x] in 1 ml / prosopis juliflora pollen 30 [hp_x] in 1 ml / broussonetia papyrifera pollen 30 [hp_x] in 1 ml / morus rubra pollen 30 [hp_x] in 1 ml / morus alba pollen 30 [hp_x] in 1 ml / quercus alba pollen 30 [hp_x] in 1 ml / phoenix dactylifera pollen 30 [hp_x] in 1 ml / pinus strobus pollen 30 [hp_x] in 1 ml / ligustrum vulgare pollen 30 [hp_x] in 1 ml / juglans nigra pollen 30 [hp_x] in 1 ml / xanthium strumarium pollen 30 [hp_x] in 1 ml / rumex acetosella pollen 30 [hp_x] in 1 ml / rumex crispus pollen 30 [hp_x] in 1 ml / chenopodium album pollen 30 [hp_x] in 1 ml / artemisia vulgaris pollen 30 [hp_x] in 1 ml / urtica dioica pollen 30 [hp_x] in 1 ml / amaranthus retroflexus pollen 30 [hp_x] in 1 ml / amaranthus spinosus pollen 30 [hp_x] in 1 ml / plantago lanceolata pollen 30 [hp_x] in 1 ml / ambrosia artemisiifolia pollen 30 [hp_x] in 1 ml / paspalum notatum pollen 30 [hp_x] in 1 ml / cynodon dactylon pollen 30 [hp_x] in 1 ml / poa pratensis pollen 30 [hp_x] in 1 ml / sorghum halepense pollen 30 [hp_x] in 1 ml / dactylis glomerata pollen 30 [hp_x] in 1 ml / lolium perenne pollen 30 [hp_x] in 1 ml / anthoxanthum odoratum pollen 30 [hp_x] in 1 ml oral liquid [allergena hawaii, puerto rico and the virgin islands]||weed pollen-english plantain||active_ingredient_of
today's health stool softner plus tablet||docusate sodium (obsolete)||active_ingredient_of
alcohol 80 ml in 100 ml topical liquid [alcohol]||alcohol denatured||active_ingredient_of
oxytetracycline and phenazopyridine and sulfamethizole only product||5-hydroxytetracycline||active_ingredient_of
product containing precisely hydralazine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)||hydralazine hydrochloride (substance)||active_ingredient_of
0.6 ml lovenox 100 mg/ml prefilled syringe||enoxaparin sodium (medication)||active_ingredient_of
ensulizole 0.405 g in 15 g / titanium dioxide 0.819 g in 15 g topical powder [ohui ultimate cover cc cushion compact 01 light beige]||titanium dioxide (substance)||active_ingredient_of
olea europaea pollen 0.05 g in 1 ml subcutaneous injection [european olive pollen]||tree pollen-olive||active_ingredient_of
chelidonium majus 3 [hp_x] in 1 ml / iodine 4 [hp_x] in 1 ml / lycopus virginicus 4 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 7 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / cysteine 9 [hp_x] in 1 ml / manganese gluconate 10 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / fumaric acid 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / eugenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lidocaine 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / titanium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / rubella virus 16 [hp_x] in 1 ml / mumps virus 30 [hp_x] in 1 ml / human coxsackievirus a2 16 [hp_c] in 1 ml / human coxsackievirus a7 16 [hp_c] in 1 ml / human coxsackievirus b1 16 [hp_c] in 1 ml / human coxsackievirus b3 16 [hp_c] in 1 ml / human coxsackievirus b4 16 [hp_c] in 1 ml oral liquid [oligo bio iodine]||mercury nitrate ammoniate (1:2:2)||active_ingredient_of
xerophyllum asphodeloides 30 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / semecarpus anacardium juice 15 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / croton tiglium seed 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / grindelia hirsutula flowering top 15 [hp_x] in 1 g / daphne mezereum bark 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / ranunculus bulbosus 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / smilax ornata root 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g / rumex crispus root 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / urtica urens 6 [hp_x] in 1 g oral pellet [poison ivy]||urtica urens||active_ingredient_of
etynodiol product||etynodol||active_ingredient_of
chlorpheniramine maleate 0.4 mg/ml / dextromethorphan hydrobromide 2 mg/ml / phenylephrine hydrochloride 1 mg/ml oral solution||phenylephrine hcl [nose]||active_ingredient_of
benzalkonium chloride 0.00585 g topical solution [fastray intl antibacterial wet wipes]||benzalkonium chloride [dup] (substance)||active_ingredient_of
solanum dulcamara top 4 [hp_x] in 1 ml / echinacea angustifolia 4 [hp_x] in 1 ml / horse chestnut 6 [hp_x] in 1 ml / antimony potassium tartrate 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / protortonia cacti 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / gentiana lutea root 6 [hp_x] in 1 ml / geranium robertianum 6 [hp_x] in 1 ml / pulsatilla vulgaris 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / phenylalanine 8 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / ferrum phosphoricum 10 [hp_x] in 1 ml / pork liver 10 [hp_x] in 1 ml / sus scrofa hypothalamus 10 [hp_x] in 1 ml / sus scrofa spleen 10 [hp_x] in 1 ml / cortisone acetate 13 [hp_x] in 1 ml / mercurius solubilis 13 [hp_x] in 1 ml / barium carbonate 28 [hp_x] in 1 ml / glyphosate 1000 [hp_x] in 1 ml / sus scrofa umbilical cord 6 [hp_c] in 1 ml / sus scrofa tonsil 6 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 9 [hp_c] in 1 ml / liothyronine 10 [hp_c] in 1 ml / sus scrofa bone marrow 12 [hp_c] in 1 ml / bisphenol a 12 [hp_c] in 1 ml / bromine 12 [hp_c] in 1 ml / chlorine 12 [hp_c] in 1 ml / hydrofluoric acid 12 [hp_c] in 1 ml / iodine 12 [hp_c] in 1 ml / escherichia coli 30 [hp_c] in 1 ml oral liquid [detox iii]||echinacea angustifolia||active_ingredient_of
acetaminophen 325 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, coated [severe congestion and pain]||phenylephrine hcl [eye] (product)||active_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 100 mg in 1 ml topical lotion [sun bum spf 70 premium moisturizing sunscreen]||bmdbm cpd||active_ingredient_of
alcohol 62 ml in 100 ml topical spray [grove blood orange]||product containing ethyl alcohol (medicinal product)||active_ingredient_of
honeydew melon allergenic extract 50 mg/ml injectable solution||honeydew melon||active_ingredient_of
pulsatilla vulgaris 2 [hp_x] in 1 ml / euphorbia resinifera resin 6 [hp_x] in 1 ml / luffa operculata fruit 6 [hp_x] in 1 ml / mercuric iodide 8 [hp_x] in 1 ml / silver nitrate 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (propiolactone inactivated) 11 [hp_x] in 1 ml / influenza a virus a/hong kong/4801/2014 x-263b (h3n2) hemagglutinin antigen (propiolactone inactivated) 11 [hp_x] in 1 ml / influenza b virus b/brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) 11 [hp_x] in 1 ml / sinusitisinum 17 [hp_x] in 1 ml / aspergillus niger var. niger 10 [hp_c] in 1 ml / candida albicans 10 [hp_c] in 1 ml / gallic acid monohydrate 10 [hp_c] in 1 ml / mucor racemosus 10 [hp_c] in 1 ml / escherichia coli 30 [hp_c] in 1 ml oral liquid [ent support]||sinusitisinum||active_ingredient_of
morphine sulfate 50 mg prolonged-release oral capsule||avinza||active_ingredient_of
bos taurus bone 200 [kp_c] in 1 ml / sus scrofa bone 200 [kp_c] in 1 ml / calcitonin 200 [kp_c] in 1 ml / bos taurus cartilage 200 [kp_c] in 1 ml / sus scrofa cartilage 200 [kp_c] in 1 ml / bos taurus red blood cell 200 [kp_c] in 1 ml / sus scrofa red blood cell 200 [kp_c] in 1 ml / interleukin-3 200 [kp_c] in 1 ml / bos taurus parathyroid gland 200 [kp_c] in 1 ml / sus scrofa parathyroid gland 200 [kp_c] in 1 ml / vitamin d 30 [kp_c] in 1 ml oral spray [osteosis]||bos taurus cartilage||active_ingredient_of
ambrosia artemisiifolia pollen 4000 [au] in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / anthoxanthum odoratum pollen 4000 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / lolium perenne pollen 4000 [bau] in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / mucor racemosus 0.002 g in 1 ml / morus alba pollen 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml subcutaneous injection, solution||tree pollen-black walnut||active_ingredient_of
lyrica, 200 mg oral capsule||product containing pregabalin||active_ingredient_of
atropa belladonna 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / matricaria chamomilla 30 [hp_c] in 1 ml / anemone pulsatilla 30 [hp_c] in 1 ml / sulfur 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml auricular (otic) liquid [4 kids earache relief]||matricaria recutita||active_ingredient_of
alcohol 66.5 ml in 350 ml / carbomer homopolymer, unspecified type 0.665 mg in 350 ml / silver cation 1.75 mg in 350 ml / trolamine 1.05 mg in 350 ml / propylene glycol 17.5 mg in 350 ml extracorporeal liquid [runyi miaojie hand sanitizer]||triethanolamine||active_ingredient_of
garlic 12 [hp_x] in 1 ml / aloe 6 [hp_x] in 1 ml / mycobacterium tuberculosis 30 [hp_x] in 1 ml / eucalyptus globulus leaf 12 [hp_x] in 1 ml / canis lupus familiaris milk 30 [hp_x] in 1 ml / cow milk 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / delphinium staphisagria seed 12 [hp_x] in 1 ml / staphylococcus epidermidis 30 [hp_x] in 1 ml / staphylococcus haemolyticus 30 [hp_x] in 1 ml / staphylococcus simulans 30 [hp_x] in 1 ml / streptococcus pyogenes 30 [hp_x] in 1 ml / sulfur 30 [hp_x] in 1 ml sublingual solution [d-102]||aloes - chemical (substance)||active_ingredient_of
onion 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pulsatilla 12 [hp_x] in 1 ml / alfalfa 12 [hp_x] in 1 ml / amaranthus hybridus pollen 12 [hp_x] in 1 ml / bambusa vulgaris leaf 12 [hp_x] in 1 ml / xanthium strumarium pollen 12 [hp_x] in 1 ml / taraxacum officinale 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / poa pratensis top 12 [hp_x] in 1 ml / chenopodium album pollen 12 [hp_x] in 1 ml / iva angustifolia pollen 12 [hp_x] in 1 ml / iva annua pollen 12 [hp_x] in 1 ml / festuca pratensis pollen 12 [hp_x] in 1 ml / artemisia vulgaris pollen 12 [hp_x] in 1 ml / dactylis glomerata pollen 12 [hp_x] in 1 ml / lolium perenne pollen 12 [hp_x] in 1 ml / trifolium pratense pollen 12 [hp_x] in 1 ml / agrostis stolonifera pollen 12 [hp_x] in 1 ml / amaranthus retroflexus pollen 12 [hp_x] in 1 ml / artemisia tridentata pollen 12 [hp_x] in 1 ml / amaranthus spinosus pollen 12 [hp_x] in 1 ml / anthoxanthum odoratum pollen 12 [hp_x] in 1 ml / phleum pratense pollen 12 [hp_x] in 1 ml / ambrosia psilostachya pollen 12 [hp_x] in 1 ml / trifolium repens pollen 12 [hp_x] in 1 ml / rumex crispus top 12 [hp_x] in 1 ml / rumex acetosa whole 12 [hp_x] in 1 ml oral liquid [weed grass antigens]||pulsatilla vulgaris whole||active_ingredient_of
formic acid 608 g in 1 l topical solution, concentrate [provita hoofsure endurance xl]||acide formique||active_ingredient_of
efavirenz + emtricitabine + tenofovir disoproxil fumarate (medication)||tenofovir disoproxil (substance)||active_ingredient_of
avena sativa flowering top 3 [hp_x] in 1 ml / asparagus adscendens root 3 [hp_x] in 1 ml / nuphar luteum root 6 [hp_x] in 1 ml / pomegranate 6 [hp_x] in 1 ml / spermidine 6 [hp_x] in 1 ml / spermine 6 [hp_x] in 1 ml / turnera diffusa leafy twig 9 [hp_x] in 1 ml / selenium 9 [hp_x] in 1 ml / delphinium staphisagria seed 9 [hp_x] in 1 ml / thuja occidentalis leaf 12 [hp_x] in 1 ml oral liquid [body balance]||avena sativa top||active_ingredient_of
angelica sinensis root 3 [hp_x] in 4 g / sus scrofa blood 7 [hp_c] in 4 g / lenograstim 4 [hp_c] in 4 g / interleukin-11 5 [hp_c] in 4 g / interleukin-3 5 [hp_c] in 4 g / binetrakin 4 [hp_c] in 4 g / shiitake mushroom 8 [hp_x] in 4 g / reishi 8 [hp_x] in 4 g / sus scrofa small intestine mucosa lymph follicle 4 [hp_c] in 4 g / melatonin 4 [hp_c] in 4 g / sus scrofa spleen 4 [hp_c] in 4 g oral pellet [guna-tonsils]||product containing interleukin-11 (medicinal product)||active_ingredient_of
salicylic acid 2% topical solution||acid, ortho-hydroxybenzoic||active_ingredient_of
flu vac qs 21-22 (2yr up) cell 60 mcg (15 mcg x 4)/0.5 ml intramusc vial (ml)||influenza a virus a/washington/19/2020 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated)||active_ingredient_of
product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug)||ranitidine hydrochloride||active_ingredient_of
dextromethorphan hydrobromide/promethazine hydrochloride 15 mg/5 ml-6.25 mg/5 ml oral syrup [dextromethorphan/promethazine]||hydrobromide, dextromethorphan||active_ingredient_of
hyacinthoides non-scripta 6 [hp_c] oral pellet||hyacinthoides non-scripta whole||active_ingredient_of
propofol 200mg/20ml injection||2,6 diisopropylphenol||active_ingredient_of
water 1 ml in 1 ml intravenous injection, solution [sterile diluent for remodulin]||watering||active_ingredient_of
arsenic trioxide 30 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml / strychnos ignatii seed 30 [hp_x] in 1 ml / potassium carbonate 30 [hp_x] in 1 ml / lachesis muta venom 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / anemone pratensis 30 [hp_x] in 1 ml / delphinium staphisagria seed 30 [hp_x] in 1 ml oral liquid [anxiety hp]||phosphorous||active_ingredient_of
erythromycin ophthalmic 0.5% ophthalmic ointment||product containing erythromycin (medicinal product)||active_ingredient_of
moxidectin 1 g in 1 g powder||anthelmintics moxidectin||active_ingredient_of
product containing precisely ibuprofen 200 milligram/1 each conventional release oral tablet (clinical drug)||p-isobutylhydratropic acid||active_ingredient_of
acetaminophen/dextromethorphan hbr@160 mg-5 mg/5 ml@oral@liquid (ml)||dextromethmorphan hydrobromide||active_ingredient_of
premier value hydrocortisone maximum strength 1% topical cream||cortisols||active_ingredient_of
product containing only cuprous oxide (medicinal product)||copper oxide||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [circle k nighttime cold and flu]||p-acetylaminophenol||active_ingredient_of
adenosine cyclic phosphate 10 [hp_x] in 29.6 ml / epinephrine 10 [hp_x] in 29.6 ml / corticotropin 10 [hp_x] in 29.6 ml / onion 10 [hp_x] in 29.6 ml / alnus serrulata bark 10 [hp_x] in 29.6 ml / centaurea benedicta 10 [hp_x] in 29.6 ml / chicory root 10 [hp_x] in 29.6 ml / cortisone acetate 10 [hp_x] in 29.6 ml / mucuna pruriens fruit trichome 10 [hp_x] in 29.6 ml / euphrasia stricta 10 [hp_x] in 29.6 ml / galphimia glauca flowering top 10 [hp_x] in 29.6 ml / histamine dihydrochloride 10 [hp_x] in 29.6 ml / juglans cinerea branch bark/root bark 10 [hp_x] in 29.6 ml / potassium chloride 10 [hp_x] in 29.6 ml / sus scrofa nasal mucosa 10 [hp_x] in 29.6 ml / nasturtium officinale 10 [hp_x] in 29.6 ml / sodium chloride 10 [hp_x] in 29.6 ml / saccharomyces cerevisiae rna 10 [hp_x] in 29.6 ml / toxicodendron pubescens leaf 10 [hp_x] in 29.6 ml / schoenocaulon officinale seed 10 [hp_x] in 29.6 ml / sassafras albidum root bark 10 [hp_x] in 29.6 ml oral liquid [southeast regional allergies]||juglans cinerea branch bark/root bark||active_ingredient_of
aluminum sulfate 54 mg subgingival solution||aluminum sulfate-containing product||active_ingredient_of
ascorbic acid/cyanocobalamin/folic acid/niacin/pyridoxine/riboflavin/sodium fluoride/thiamine/vitamin a/vitamin d/vitamin e 60 mg-0.0045 mg-0.3 mg-13.5 mg-1.05 mg-1.2 mg-0.25 mg-1.05 mg-2500 iu-400 iu-15 iu oral tablet, chewable [mvc-fluoride]||product containing vitamin b6 (medicinal product)||active_ingredient_of
acer negundo pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / dactylis glomerata pollen 4000 [bau] in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / betula populifolia pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / anthoxanthum odoratum pollen 4000 [bau] in 1 ml / lolium perenne pollen 4000 [bau] in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / alnus rhombifolia pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml subcutaneous injection, solution||short ragweed pollen extracts||active_ingredient_of
plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / periplaneta americana 0.002 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / salix nigra pollen 0.002 g in 1 ml intradermal injection, solution||white oak pollen||active_ingredient_of
alfalfa pollen extract 1 mg/ml injectable solution||alfalfa pollen extract||active_ingredient_of
apis mellifera 6 [hp_x] in 41 ml / peumus boldus leaf 4 [hp_x] in 41 ml / fucus vesiculosus 4 [hp_x] in 41 ml / galium aparine 4 [hp_x] in 41 ml / gamboge 4 [hp_x] in 41 ml / hamamelis virginiana root bark/stem bark 4 [hp_x] in 41 ml / pork liver 12 [hp_x] in 41 ml / histamine dihydrochloride 200 [hp_c] in 41 ml / sus scrofa pancreas 12 [hp_x] in 41 ml / thuja occidentalis leafy twig 6 [hp_x] in 41 ml oral liquid [diet power]||bladderwrack extract||active_ingredient_of
glimepiride (product)||glimepiride||active_ingredient_of
titanium dioxide 21.25 g in 100 g / zinc oxide 17 g in 100 g topical powder [elf spf 45 sunscreen uva/uvb protection]||dióxido de titanio||active_ingredient_of
palmitic acid 7.25 g in 30 ml / stearic acid 7.25 g in 30 ml / oleic acid 14.5 g in 30 ml / bismuth subcarbonate 1.89 g in 30 ml / boric acid 0.95 g in 30 ml topical ointment [sha-lem]||bismuth subcarbonate (substance)||active_ingredient_of
betula pubescens leaf 5 [hp_x] / aconitum napellus 6 [hp_x] / arnica montana 6 [hp_x] / bos taurus cartilage 8 [hp_x] / tin 8 [hp_x] / gold 10 [hp_x] / onion 17 [hp_x] / formica rufa 17 [hp_x] oral pellet||onion||active_ingredient_of
rumex acetosella pollen 0.0005 g in 1 ml / rumex crispus pollen 0.0005 g in 1 ml intradermal solution [dock-sorrel mix]||weed pollen-sheep sorrel||active_ingredient_of
octisalate 5 g in 100 g / octocrylene 10 g in 100 g / avobenzone 3 g in 100 g / homosalate 10 g in 100 g topical gel [play spf 30 lip shield coconut]||avobenzone||active_ingredient_of
zaleplon 10 mg oral capsule [sonata]||zaleplon||active_ingredient_of
product containing only diltiazem (medicinal product)||tiadylt||active_ingredient_of
n,n-dimethyl-p-toluidine only product||n,n-dimethyl-p-toluidine product||active_ingredient_of
n-hydroxy-n'-phenyloctanediamide||n1 hydroxy n8 phenyloctanediamide||active_ingredient_of
calcium fluoride 3 [hp_x] / calcium sulfate anhydrous 3 [hp_x] / potassium sulfate 3 [hp_x] / sodium chloride 3 [hp_x] / sodium sulfate 6 [hp_x] oral tablet [bio-combination 20]||potassium sulfate (medication)||active_ingredient_of
garlic 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / cysteine 6 [hp_x] in 1 ml / methionine 8 [hp_x] in 1 ml / phytolacca americana root 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / chromium 8 [hp_x] in 1 ml / cobalt 8 [hp_x] in 1 ml / copper 8 [hp_x] in 1 ml / iron 8 [hp_x] in 1 ml / iodine 8 [hp_x] in 1 ml / iridium 8 [hp_x] in 1 ml / potassium carbonate 8 [hp_x] in 1 ml / lithium carbonate 8 [hp_x] in 1 ml / magnesium 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / molybdenum 8 [hp_x] in 1 ml / sodium chloride 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / strontium carbonate 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / vanadium 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / phenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [metox]||magnesio||active_ingredient_of
atropa belladonna 4 [hp_x] in 1 g / calendula officinalis flowering top 1 [hp_x] in 1 g / lytta vesicatoria 5 [hp_x] in 1 g / causticum 6 [hp_x] in 1 g / hypericum perforatum 1 [hp_x] in 1 g / delphinium staphisagria seed 5 [hp_x] in 1 g topical cream||causticum||active_ingredient_of
strychnos nux-vomica seed 12 [hp_x] in 30 ml / arsenic trioxide 12 [hp_x] in 30 ml / cinchona officinalis bark 12 [hp_x] in 30 ml / capsicum 3 [hp_x] in 30 ml / nitric acid 12 [hp_x] in 30 ml / mercuric chloride 12 [hp_x] in 30 ml / atropa belladonna 12 [hp_x] in 30 ml / cajuput oil 4 [hp_x] in 30 ml / lycopodium clavatum spore 12 [hp_x] in 30 ml / phosphorus 12 [hp_x] in 30 ml / phytolacca americana root 6 [hp_x] in 30 ml / frangula purshiana bark 3 [hp_x] in 30 ml / alpine strawberry 12 [hp_x] in 30 ml oral liquid [vermafuge -ag lycopodium]||product containing belladonna||active_ingredient_of
acetylcholine chloride 144 [hp_x] in 59 ml / acetaldehyde 144 [hp_x] in 59 ml / apiole (parsley) 144 [hp_x] in 59 ml / ascorbic acid 144 [hp_x] in 59 ml / butylated hydroxytoluene 144 [hp_x] in 59 ml / caffeic acid 144 [hp_x] in 59 ml / candida albicans 144 [hp_x] in 59 ml / quinic acid 144 [hp_x] in 59 ml / cinnamic acid 144 [hp_x] in 59 ml / coniferyl alcohol 144 [hp_x] in 59 ml / coumarin 144 [hp_x] in 59 ml / dopamine 144 [hp_x] in 59 ml / estrone 144 [hp_x] in 59 ml / .gamma.-aminobutyric acid 144 [hp_x] in 59 ml / gallic acid 144 [hp_x] in 59 ml / histamine 144 [hp_x] in 59 ml / indole 144 [hp_x] in 59 ml / levodopa 144 [hp_x] in 59 ml / malvin 144 [hp_x] in 59 ml / yeast mannan 144 [hp_x] in 59 ml / melatonin 144 [hp_x] in 59 ml / menadione 144 [hp_x] in 59 ml / norepinephrine 144 [hp_x] in 59 ml / octopamine 144 [hp_x] in 59 ml / phenylalanine 144 [hp_x] in 59 ml / phenyl isothiocyanate 144 [hp_x] in 59 ml / phlorizin 144 [hp_x] in 59 ml / piperine 144 [hp_x] in 59 ml / progesterone 144 [hp_x] in 59 ml / pyrrole 144 [hp_x] in 59 ml / quercetin 144 [hp_x] in 59 ml / rutin 144 [hp_x] in 59 ml / salsolinol 144 [hp_x] in 59 ml / serotonin 144 [hp_x] in 59 ml / taurine 144 [hp_x] in 59 ml / testosterone 144 [hp_x] in 59 ml / tryptophan 144 [hp_x] in 59 ml oral spray [biophenolics]||apiole||active_ingredient_of
dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / candida albicans 0.00008 g in 1 ml / aspergillus fumigatus 10.00008 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / cochliobolus sativus 0.00008 g in 1 ml / cladosporium cladosporioides 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml intradermal injection, solution||duck feathers extract||active_ingredient_of
acetaminophen 325 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, coated [acetaminophen, guaifenesin, phenylephrine hydrochloride]||hydroxyacetanilide||active_ingredient_of
product containing only diazepam 2 mg/1 each oral tablet||diazepam (substance)||active_ingredient_of
achillea millefolium 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / equisetum arvense top 3 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / apis mellifera 8 [hp_x] in 1 ml / ferrous disulfide 8 [hp_x] in 1 ml / larix decidua resin 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml oral liquid||berberis vulgaris root bark extract||active_ingredient_of
rosuvastatin calcium 5 mg oral tablet, coated||rosuvastatin calcium (crestor)||active_ingredient_of
hydrogen cation 10 mg in 1 ml topical spray [hy iq open wound for dogs]||hydrogen cation||active_ingredient_of
fluoxetine (as fluoxetine hydrochloride) 20 mg oral capsule||fluoxetine hydrochloride||active_ingredient_of
cynodon dactylon whole 10000 [pnu] in 1 ml / sorghum halepense pollen 10000 [pnu] in 1 ml / phleum pratense 10000 [pnu] in 1 ml / dactylis glomerata 10000 [pnu] in 1 ml / poa pratensis 10000 [pnu] in 1 ml / agrostis gigantea pollen 10000 [pnu] in 1 ml / festuca pratensis 10000 [pnu] in 1 ml / lolium perenne 10000 [pnu] in 1 ml / anthoxanthum odoratum 10000 [pnu] in 1 ml subcutaneous injection, solution [9 southern grass mix]||phleum pratense allergenic extract||active_ingredient_of
isopropyl alcohol 75 ml in 100 ml extracorporeal liquid [ssential hand sanitizer]||alcohol rub||active_ingredient_of
quercus robur flower 30 [hp_c] in 1 ml oral liquid [oak]||quercus robur flower extract||active_ingredient_of
product containing chlorhexidine and phenol (medicinal product)||chlorhexidine (substance)||active_ingredient_of
camphor (natural) 2 [hp_x] in 1 g / berberis vulgaris root bark 7 [hp_x] in 1 g / calendula officinalis flowering top 7 [hp_x] in 1 g / st. john's wort 7 [hp_x] in 1 g / gold 10 [hp_x] in 1 g topical ointment||guanyejinsitao||active_ingredient_of
glycerin 0.0025 mg in 1 ml / naphazoline hydrochloride 0.00012 mg in 1 ml ophthalmic solution/ drops [dg health maximum redness relief]||glycérol||active_ingredient_of
potassium carbonate 10 [hp_m] in 10 [hp_m] oral pellet [kali carbonicum]||dipotassium carbonate||active_ingredient_of
oxygen 99 l in 1 l respiratory (inhalation) gas||elemental oxygen||active_ingredient_of
bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / crotalus horridus horridus venom 15 [hp_x] in 1 ml / ferrosoferric phosphate 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / veratrum viride root 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml oral liquid [inflammation]||strychnos nux-vomica seed||active_ingredient_of
alcohol 600 ml in 750 ml topical liquid [hand sanitizer]||alcohol denatured||active_ingredient_of
artemisia tridentata pollen 0.05 g in 1 ml subcutaneous injection [common sage pollen]||artemisia tridentata pollen||active_ingredient_of
acetaminophen/dextromethorphan/doxylamine 325 mg-15 mg-6.25 mg oral capsule||product containing dextromethorphan hydrobromide||active_ingredient_of
potassium hydroxide 5% solution||ätzkali||active_ingredient_of
lactic acid, l- 6 [hp_x] in 2 ml oral liquid||l-(+)-lactic acid||active_ingredient_of
aluminum chloride 250 mg/ml mucous membrane topical solution [hemoban]||anhydrous aluminum chloride||active_ingredient_of
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (fucsia cautivante exotic) - pink]||octyl methoxycinnamate (substance)||active_ingredient_of
staphylococcus aureus 15 [hp_x] / klebsiella pneumoniae 15 [hp_x] / enterococcus faecalis 12 [hp_c] / streptococcus pneumoniae 12 [hp_c] / streptococcus agalactiae 12 [hp_c] / streptococcus mutans 12 [hp_c] / haemophilus influenzae type b 12 [hp_c] / streptococcus viridans group 36 [hp_c] oral tablet [upper respiratory staph/strep combination]||streptococcus faecalis andrewes and horder 1906 (approved lists 1980)||active_ingredient_of
product containing only vinorelbine (medicinal product)||vinorelbine||active_ingredient_of
homosalate 9 g in 100 g / octisalate 4.5 g in 100 g / octocrylene 6 g in 100 g / avobenzone 2.7 g in 100 g topical spray [banana boat]||octisalate||active_ingredient_of
hydrocortisone acetate 1 g in 100 g topical cream [hydrocortisone]||hydrocortisone acetate [eye] (substance)||active_ingredient_of
octinoxate 0.07 g in 1 ml / zinc oxide 0.072 g in 1 ml topical liquid [lbel concentre total base serum ultra-fluid foundation spf 25 claire 2 - beige]||sunscreen with zinc oxide (medication)||active_ingredient_of
calcium sulfate anhydrous 1 [hp_x] oral tablet||anhydrous sulfate of lime||active_ingredient_of
aluminum chlorohydrate 20.2 g in 100 g topical aerosol, spray [degree]||pentahydroxydialuminum chloride||active_ingredient_of
tadalafil only product||pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6r,12ar)-||active_ingredient_of
product containing tetrabenazine in oral dosage form||2-oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine||active_ingredient_of
titanium dioxide 35 mg in 1 ml / zinc oxide 100 mg in 1 ml topical lotion [sunbetter broad spectrum spf 75 sunscreen tone smart]||titanium dioxide-containing product||active_ingredient_of
proteus vulgaris 7 [hp_x] in 1 ml oral liquid [pleo san prot]||proteus vulgaris hauser 1885 (approved lists 1980) emend. judicial commission 1999||active_ingredient_of
trazodone hcl@50 mg@oral@tablet||trazodone hcl||active_ingredient_of
walgreens fluticasone propionate allergy reliever 24 hour 50mcg/actuation nasal spray||fluticasone propionate [respiratory use] (product)||active_ingredient_of
hydrochlorothiazide/irbesartan 12.5 mg-150 mg oral tablet||irbesartan-containing product||active_ingredient_of
arsenic trioxide 10 [hp_x] in 59 ml / baptisia tinctoria root 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / solanum dulcamara top 10 [hp_x] in 59 ml / echinacea, unspecified 10 [hp_x] in 59 ml / echinacea purpurea 10 [hp_x] in 59 ml / ferrosoferric phosphate 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / potassium chloride 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / zinc acetate anhydrous 10 [hp_x] in 59 ml / zinc carbonate 10 [hp_x] in 59 ml / zinc 10 [hp_x] in 59 ml / zinc chloride 10 [hp_x] in 59 ml / zinc oxide 10 [hp_x] in 59 ml / zinc picrate nonahydrate 10 [hp_x] in 59 ml / zinc valerate dihydrate 10 [hp_x] in 59 ml oral liquid [colds and flu/multi symptom reliever]||bryonia alba root extract||active_ingredient_of
prinivil 2.5mg tablet||l-proline, 1-(n2-(1-carboxy-3-phenylpropyl)-l-lysyl)-, dihydrate, (s)-||active_ingredient_of
antimony trisulfide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / hekla lava 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / hydrofluoric acid 30 [hp_x] in 1 ml oral liquid [dentaforce]||mercurius solubilis preparation||active_ingredient_of
avobenzone 3 g in 100 ml / homosalate 15 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 2.8 g in 100 ml / oxybenzone 6 g in 100 ml topical lotion [ultimate sheer sunscreen spf 70 exchange select]||oxybenzone||active_ingredient_of
avidoxy 100mg tablet||doxycycline product||active_ingredient_of
sodium fluoride 7.9 mg in 1 g / hydrofluoric acid 4.4 mg in 1 g dental gel [perfect choice]||sodium fluoride product||active_ingredient_of
glyceryl laurate 0.0448 g in 56 g / levulinic acid 0.028 g in 56 g / caprylhydroxamic acid 0.0112 g in 56 g / alcohol 0.0112 ml in 56 g topical cloth [purus antibacterial wipes]||product containing ethyl alcohol (medicinal product)||active_ingredient_of
alcohol 2 g in 100 ml topical solution [hygiene wipes (alcohol)]||alcohol etílico||active_ingredient_of
octinoxate 7.5 g in 100 ml / octisalate 3 g in 100 ml / zinc oxide 3 g in 100 ml topical lotion [kiss my face - face factor spf 30]||zinc (as zinc oxide)||active_ingredient_of
mycobacterium microti immunoserum rabbit 9 [hp_x] in 10 ml / mycobacterium bovis immunoserum rabbit 9 [hp_x] in 10 ml / streptococcus pyogenes immunoserum rabbit 9 [hp_x] in 10 ml topical liquid [pleo poly t]||mycobacterium microti immunoserum rabbit||active_ingredient_of
acetaminophen 325 mg in 15 ml / phenylephrine hydrochloride 5 mg in 15 ml / dextromethorphan hydrobromide 10 mg in 15 ml / guaifenesin 200 mg in 15 ml oral liquid [vicks severe cold and flu]||guaiacol glyceryl ether||active_ingredient_of
ferrum phosphoricum 30 [hp_c] in 1 ml oral liquid [ferrum phos]||ferrum phosphoricum||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [nighttime cold and flu]||butanedioic acid, compound with n,n-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine(1:1)||active_ingredient_of
wormwood 30 [hp_c] in 1 ml oral pellet [nervousness excitement]||artemisia (wormwood)||active_ingredient_of
iva xanthifolia pollen 0.0045 g in 1 ml / artemisia vulgaris pollen 0.0045 g in 1 ml / artemisia tridentata pollen 0.0045 g in 1 ml / ambrosia acanthicarpa pollen 0.0045 g in 1 ml / ambrosia trifida pollen 0.0045 g in 1 ml / chenopodium album pollen 0.0045 g in 1 ml / amaranthus retroflexus pollen 0.0045 g in 1 ml / salsola kali pollen 0.0045 g in 1 ml / ambrosia artemisiifolia pollen 0.0045 g in 1 ml / ambrosia psilostachya pollen 0.0045 g in 1 ml / atriplex canescens pollen 0.0045 g in 1 ml subcutaneous injection, solution||weed pollen-russian thistle||active_ingredient_of
apis mellifera 30 [hp_c] in 30 [hp_c] / berberis vulgaris root bark 30 [hp_c] in 30 [hp_c] / bryonia alba root 30 [hp_c] in 30 [hp_c] / lytta vesicatoria 30 [hp_c] in 30 [hp_c] / sarsaparilla 30 [hp_c] in 30 [hp_c] / delphinium staphisagria seed 30 [hp_c] in 30 [hp_c] / urtica urens 30 [hp_c] in 30 [hp_c] oral spray [uti and kidney stones]||delphinium staphisagria seed||active_ingredient_of
hypericum perforatum 3 [hp_x] in 40 mg / chamomile 3 [hp_x] in 40 mg / strychnos ignatii seed 30 [hp_c] in 40 mg / aji pepper 30 [hp_c] in 40 mg / potassium phosphate 6 [hp_c] in 40 mg oral granule [grief and pining formula]||potassium (as phosphate)||active_ingredient_of
product containing primaquine phosphate 26.3 mg/1 each oral tablet||primaquine phosphate (substance)||active_ingredient_of
calendula officinalis flowering top 1 [hp_x] in 1 g / arnica montana 1 [hp_x] in 1 g / hypericum perforatum 1 [hp_x] in 1 g / comfrey root 3 [hp_x] in 1 g / bellis perennis 12 [hp_x] in 1 g / ledum palustre twig 12 [hp_x] in 1 g / sulfuric acid 12 [hp_x] in 1 g / calcium fluoride 30 [hp_x] in 1 g / ferrosoferric phosphate 30 [hp_x] in 1 g / toxicodendron pubescens leaf 30 [hp_x] in 1 g / ruta graveolens flowering top 30 [hp_x] in 1 g / sodium sulfate 30 [hp_c] in 1 g topical gel [trauma plus]||calcium fluoride||active_ingredient_of
homosalate 153.15 mg in 1 ml / octisalate 51.05 mg in 1 ml / octocrylene 102.1 mg in 1 ml / oxybenzone 61.26 mg in 1 ml / avobenzone 30.63 mg in 1 ml topical lotion [coppertone ultra guard spf 70 sunscreen]||2-ethylhexyl 2-cyano-3,3-diphenyl-2-propenoate||active_ingredient_of
aciclovir 200 mg oral capsule||9-[(2-hydroxyethoxy)methyl]guanine||active_ingredient_of
felis catus hair 400 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.00008 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / ambrosia trifida pollen 0.00067 g in 1 ml / ambrosia artemisiifolia pollen 0.00067 g in 1 ml / ambrosia psilostachya pollen 0.00067 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / phoma destructiva 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml intradermal injection, solution||cladosporium cladosporioides||active_ingredient_of
amphetamine/dextroamphetamine 20mg tab||dextroamphetamine saccharate||active_ingredient_of
bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - haemophilus somnus bacterin (substance)||antigen of bovine herpesvirus 1||active_ingredient_of
flunisolide only product||flunisolide preparation (product)||active_ingredient_of
acetaminophen 325 mg / phenylephrine hydrochloride 5 mg oral tablet [sinus congestion and pain daytime, non-drowsy]||phenylephrine hcl [eye] (substance)||active_ingredient_of
calendula officinalis flower 1 [hp_x] in 1 ml / apis mellifera 12 [hp_x] in 1 ml / azadirachta indica bark 1 [hp_x] in 1 ml / thuja occidentalis leafy twig 3 [hp_x] in 1 ml / echinacea purpurea 1 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / plantago major 1 [hp_x] in 1 ml / datura stramonium 30 [hp_x] in 1 ml / okoubaka aubrevillei bark 6 [hp_x] in 1 ml dental rinse [stellalife vega oral care coconut]||phosphorus-containing product||active_ingredient_of
.gamma.-aminobutyric acid 100 mg oral capsule [theramine]||piperidic acid||active_ingredient_of
publix tussin cf 10mg-100mg-5mg/5ml liquid||dextromethorphan hydrobromide||active_ingredient_of
potassium bromide 8 [hp_x] / cinchona officinalis bark 8 [hp_x] / sulfur 8 [hp_x] / solanum dulcamara top 8 [hp_x] / goldenseal 8 [hp_x] / arnica montana 8 [hp_x] / bryonia alba root 8 [hp_x] / causticum 8 [hp_x] oral tablet, chewable [tinnitus real relief]||sulfur product (substance)||active_ingredient_of
silver nitrate 30 [hp_c] / gold 30 [hp_c] oral pellet [hardmet car 40 (number 90)]||silver mononitrate||active_ingredient_of
alcohol 0.62 ml in 1 ml topical gel [izod saltwater hand sanitizer]||ethyl alcohol||active_ingredient_of
melissa officinalis 4 [hp_x] in 20 ml / achillea millefolium 4 [hp_x] in 20 ml / lactuca virosa 4 [hp_x] in 20 ml / thyme 4 [hp_x] in 20 ml / passiflora incarnata flowering top 4 [hp_x] in 20 ml / verbena officinalis 4 [hp_x] in 20 ml / valerian 4 [hp_x] in 20 ml oral liquid [unda 228]||verbena officinalis whole||active_ingredient_of
lidocaine hydrochloride 2% oromucosal solution [xylocaine]||lidocaine hydrochloride anhydrous||active_ingredient_of
rite aid ibuprofen pain relief 200mg caplet||propionic acid-ibuprofen||active_ingredient_of
simvastatin 20mg tab||simvastatina||active_ingredient_of
niravi 4 % medicated patch||product containing lidocaine (medicinal product)||active_ingredient_of
solidago virgaurea flowering top 3 [hp_x] in 1 ml / baptisia tinctoria 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / clerodendranthus spicatus leaf 6 [hp_x] in 1 ml / chondrodendron tomentosum root 6 [hp_x] in 1 ml / smilax regelii root 6 [hp_x] in 1 ml / turpentine 6 [hp_x] in 1 ml / apis mellifera venom 8 [hp_x] in 1 ml / agathosma betulina leaf 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / sus scrofa renal pelvis 8 [hp_x] in 1 ml / sus scrofa ureter 8 [hp_x] in 1 ml / sus scrofa urethra 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml / glyoxal trimer dihydrate 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / sodium pyruvate 10 [hp_x] in 1 ml / quercetin 10 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [detox ii]||smilax regelii root extract||active_ingredient_of
alcohol 400 ml in 500 ml topical gel [medpanol]||äthanol||active_ingredient_of
titanium dioxide 60 mg in 1 g / zinc oxide 47 mg in 1 g topical stick [cetaphil sheer mineral sunscreen stick spf 50]||sunscreen with zinc oxide (medication)||active_ingredient_of
urtica dioica 3 [hp_x] in 1 ml / betula pubescens leaf 4 [hp_x] in 1 ml / silver sulfide 6 [hp_x] in 1 ml / magnesium phosphate, tribasic, pentahydrate 6 [hp_x] in 1 ml / ferrosoferric phosphate 6 [hp_x] in 1 ml / bos taurus bone marrow 8 [hp_x] in 1 ml oral liquid||bos taurus bone marrow preparation||active_ingredient_of
lidocaine hydrochloride 10 mg in 1 ml / epinephrine bitartrate 0.01 mg in 1 ml infiltration injection, solution [xylocaine]||lignocaine hydrochloride||active_ingredient_of
calcitriol 250nanograms capsule (product)||d3, 1 alpha,25-dihydroxyvitamin||active_ingredient_of
acer negundo pollen 0.0083 g in 1 ml / juniperus ashei pollen 0.0017 g in 1 ml / juglans nigra pollen 0.0017 g in 1 ml / fraxinus americana pollen 0.0083 g in 1 ml / quercus alba pollen 0.0083 g in 1 ml / ulmus americana pollen 0.0017 g in 1 ml / carya alba pollen 0.00083 g in 1 ml / carya illinoinensis pollen 0.00083 g in 1 ml / phleum pratense pollen 16666.67 [bau] in 1 ml / ambrosia artemisiifolia pollen 133.33 [au] in 1 ml / iva annua var. annua pollen 0.0017 g in 1 ml intradermal injection, solution||carya tomentosa pollen||active_ingredient_of
lidocaine hcl/benzalkonium chl 0.5 %-0.13 % topical cream in packet (ea)||xylocitin||active_ingredient_of
octinoxate 1.5 g in 30 g / titanium dioxide 0.5 g in 30 g topical cream [no7 lift and luminate triple action serum foundation sunscreen broad spectrum spf 15 warm ivory]||titanium white||active_ingredient_of
solidago virgaurea flowering top 3 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / orthosiphon aristatus whole 6 [hp_x] in 1 ml / chondrodendron tomentosum root 6 [hp_x] in 1 ml / smilax regelii root 6 [hp_x] in 1 ml / apis mellifera venom 6 [hp_x] in 1 ml / agathosma betulina leaf 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / sus scrofa renal pelvis 8 [hp_x] in 1 ml / turpentine oil 8 [hp_x] in 1 ml / sus scrofa ureter 8 [hp_x] in 1 ml / sus scrofa urethra 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml / glyoxal trimer dihydrate 8 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / sodium pyruvate 10 [hp_x] in 1 ml / quercetin 10 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [detox ii]||sus scrofa urethra preparation||active_ingredient_of
avobenzone 90 g in 1 g / homosalate 2250 g in 1 g / octisalate 250 g in 1 g / octocrylene 8 in 1 g topical spray [sunscreen]||homosalato||active_ingredient_of
androsterone 30 [kp_c] in 1 ml / artichoke 30 [kp_c] in 1 ml / adenosine triphosphate 30 [kp_c] in 1 ml / basic fibroblast growth factor (human) 200 [kp_c] in 1 ml / ersofermin 200 [kp_c] in 1 ml / adenosine cyclic phosphate 30 [kp_c] in 1 ml / levocarnitine 30 [kp_c] in 1 ml / centella asiatica 30 [kp_c] in 1 ml / citric acid monohydrate 30 [kp_c] in 1 ml / cobalt 30 [kp_c] in 1 ml / estrogens, esterified 200 [kp_c] in 1 ml / ferrous fumarate 30 [kp_c] in 1 ml / fumaric acid 30 [kp_c] in 1 ml / heptaminol 30 [kp_c] in 1 ml / hamamelis virginiana bark 30 [kp_c] in 1 ml / hyaluronidase 30 [kp_c] in 1 ml / interleukin-3 200 [kp_c] in 1 ml / potassium aspartate 30 [kp_c] in 1 ml / lactic acid 30 [kp_c] in 1 ml / bos taurus lymph vessel 200 [kp_c] in 1 ml / sus scrofa lymph vessel 200 [kp_c] in 1 ml / melilotus officinalis whole 30 [kp_c] in 1 ml / manganese 30 [kp_c] in 1 ml / sodium diethyl oxalacetate 30 [kp_c] in 1 ml / sodium pyruvate 30 [kp_c] in 1 ml / quinhydrone 30 [kp_c] in 1 ml / succinic acid 30 [kp_c] in 1 ml / bos taurus vein 200 [kp_c] in 1 ml / sus scrofa vein 200 [kp_c] in 1 ml / vitamin a 30 [kp_c] in 1 ml / zinc 30 [kp_c] in 1 ml topical spray [viatrexx-cellulite]||product containing ferrous fumarate||active_ingredient_of
dextromethorphan and promethazine only product||dex||active_ingredient_of
infliximab-abda||infliximab product||active_ingredient_of
benzoic acid 15 [hp_x] in 1 g / berberis vulgaris root bark 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / centaurea benedicta 15 [hp_x] in 1 g / ceanothus americanus leaf 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / chionanthus virginicus bark 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / dioscorea villosa tuber 15 [hp_x] in 1 g / mucuna pruriens fruit trichome 15 [hp_x] in 1 g / iris versicolor root 15 [hp_x] in 1 g / juniper berry 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / ptelea trifoliata bark 15 [hp_x] in 1 g / taraxacum officinale 15 [hp_x] in 1 g / uric acid 15 [hp_x] in 1 g / silybum marianum seed 3 [hp_x] in 1 g / cynara scolymus leaf 3 [hp_x] in 1 g / solidago virgaurea flowering top 3 [hp_x] in 1 g oral pellet [drainer]||ptelea trifoliata bark||active_ingredient_of
sodium monofluorophosphate 0.0072 mg/mg toothpaste||sodium monofluorophosphate (medication)||active_ingredient_of
homosalate 9 g in 100 g / octocrylene 7 g in 100 g / octisalate 4.5 g in 100 g / avobenzone 2.7 g in 100 g topical spray [banana boat sport coolzone clear sunscreen broad spectrum spf 50 plus]||butyl-methoxydibenzoylmethane||active_ingredient_of
ondansetron hydrochloride 2 mg in 1 ml intravenous injection, solution [ondansetron]||dihydrate, ondansetron monohydrochloride||active_ingredient_of
quality choice nighttime cold & flu 650mg-30mg-12.5mg/30ml liquid (cherry)||dextromethorphan hydrobromide (substance)||active_ingredient_of
clonazepam@2 mg@oral@tablet||clonazepam [status epilepsy]||active_ingredient_of
glycerin 0.01 in 100 / phenoxyethanol 0.2 in 100 / cetylpyridinium chloride 0.03 in 100 / benzalkonium chloride 0.4 in 100 / didecyldimonium chloride 0.2 in 100 / anhydrous citric acid 0.01 in 100 / tocopherol 0.0025 in 100 / aloe vera leaf 0.0025 in 100 / dimethicone 0.05 in 100 topical cloth [disinfect wipes]||anhydrous citric acid||active_ingredient_of
antimony trisulfide 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercuric sulfide 15 [hp_x] in 1 ml / sodium carbonate 15 [hp_x] in 1 ml / nitric acid 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / juniperus sabina leafy twig 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml oral liquid [warts - moles - skin tags]||oyster shell calcium carbonate preparation||active_ingredient_of
oxybutynin hydrochloride 5 mg prolonged-release oral tablet||oxybutynin chloride||active_ingredient_of
aspergillus niger var. niger 0.02 g in 1 ml / aspergillus fumigatus 0.02 g in 1 ml / eurotium amstelodami 0.02 g in 1 ml / aspergillus flavus 0.02 g in 1 ml / aspergillus nidulans 0.02 g in 1 ml subcutaneous solution [aspergillus mix]||aspergillus fumigatus allergenic extract||active_ingredient_of
product containing aurothioglucose (medicinal product)||gold, (1-thio-d-glucopyranosato-o2,s1)-||active_ingredient_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / gelsemium sempervirens root 3 [hp_x] in 1 ml / apis mellifera 4 [hp_x] in 1 ml / pseudognaphalium luteoalbum leaf 4 [hp_x] in 1 ml / colchicum autumnale flower 5 [hp_x] in 1 ml / formica rufa 5 [hp_x] in 1 ml / arnica montana root 10 [hp_x] in 1 ml oral liquid||colchicum autumnale flower extract||active_ingredient_of
fraxinus latifolia pollen 0.1 g in 1 ml subcutaneous injection, solution||oregon ash pollen extract||active_ingredient_of
alprazolam (product)||alprazolan||active_ingredient_of
zinc oxide 101 mg in 1 g topical stick [chapstick total hydration moisture tint very berry]||zinc oxide||active_ingredient_of
dextromethorphan hydrobromide 0.667 mg/ml / guaifenesin 6.67 mg/ml oral solution||dextromethorphan hydrobromide product||active_ingredient_of
menthol 20 mg oral lozenge [vicks vapocool severe honey lemon chill drops]||mentol||active_ingredient_of
adenosine triphosphate 5 [hp_x] in 1 ml / saffron 2 [hp_q] in 1 ml / toxicodendron pubescens leaf 1 [hp_q] in 1 ml / sepia officinalis juice 2 [hp_q] in 1 ml / ammonium carbonate 6 [hp_c] in 1 ml / hypericum perforatum 7 [hp_c] in 1 ml / saw palmetto 1 [hp_q] in 1 ml sublingual solution/ drops [g10 cerebral-met]||sepia officinalis juice||active_ingredient_of
allergenic extract, helminthosporium sativum 10000pnu/ml inj||cochliobolus sativus allergenic extract||active_ingredient_of
alcohol 68 ml in 100 ml topical gel [blueberry cream anti-bacterial hand sanitizer]||hydroxyethane||active_ingredient_of
diperodon preparations||campho-phenique maximum strength||active_ingredient_of
arnica montana 3 [hp_x] in 1 ml / calendula officinalis flowering top 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / fenugreek seed 3 [hp_x] in 1 ml / urtica dioica 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / potassium nitrate 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / babesia microti 15 [hp_x] in 1 ml / borrelia burgdorferi 15 [hp_x] in 1 ml / ehrlichia canis 15 [hp_x] in 1 ml / japanese encephalitis virus 15 [hp_x] in 1 ml / ledum palustre twig 30 [hp_x] in 1 ml / neisseria meningitidis 30 [hp_x] in 1 ml / hepatitis b virus 33 [hp_x] in 1 ml oral liquid [lyme plus]||toxicodendron pubescens leaf||active_ingredient_of
24 hr guanfacine 3 mg extended release oral tablet [intuniv]||n-(aminoiminomethyl)-2,6-dichlorobenzeneacetamide hydrochloride||active_ingredient_of
bile salts (medication)||bile salts (medication)||active_ingredient_of
product containing only eszopiclone 1 mg/1 each oral tablet (clinical drug)||1-piperazinecarobxylic acid,4-methyl-,(5s)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5h-pyrrolo[3,4-b]pyrazin-5-yl ester||active_ingredient_of
silver 20 [hp_x] in 1 ml / lead 30 [hp_x] in 1 ml / chelidonium majus 4 [hp_x] in 1 ml / formica rufa 6 [hp_x] in 1 ml / bos taurus spleen 8 [hp_x] in 1 ml / helleborus niger root 12 [hp_x] in 1 ml / antimony 12 [hp_x] in 1 ml oral liquid||bos taurus spleen||active_ingredient_of
product containing only pioglitazone 30 mg/1 each oral tablet (clinical drug)||pioglitazone hydrochloride (product)||active_ingredient_of
homosalate 100 mg in 1 ml / octocrylene 40 mg in 1 ml / octisalate 50 mg in 1 ml / titanium dioxide 40 mg in 1 ml topical cream [laura geller better than bare tinted moisturizer broad spectrum sunscreen spf 50 plus fair 130]||octocrileno||active_ingredient_of
plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / rumex acetosella pollen 4000 [au] in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / avena sativa pollen 0.00008 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / betula populifolia pollen 0.00008 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / carya alba pollen 0.0002 g in 1 ml / carya illinoinensis pollen 0.0002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.004 g in 1 ml / populus alba pollen 0.004 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml intradermal injection, solution||carya oliviformis pollen||active_ingredient_of
caffeine 200 mg oral tablet, film coated [stay awake]||1,3,7-trimethylpurine-2,6-dione||active_ingredient_of
alcohol 350 g in 500 ml topical gel [moisturizing hand sanitizer green tea]||ethyl alcohol (product)||active_ingredient_of
poa pratensis pollen 160 [bau] in 1 ml / ulmus americana pollen 0.00008 g in 1 ml / ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / kochia scoparia pollen 0.00008 g in 1 ml / chenopodium album pollen 0.00008 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / salsola kali pollen 0.00008 g in 1 ml / rumex acetosella pollen 0.00008 g in 1 ml intradermal injection, solution||american elm pollen extract||active_ingredient_of
bendroflumethiazide in oral dosage form||bendroflumethiazide (product)||active_ingredient_of
top care children's pain relief plus multi-symptom cold suspension (grape)||dextromethorphan hydrobromide (product)||active_ingredient_of
acetaminophen/aspirin/caffeine 250 mg-250 mg-65 mg oral tablet [headache formula added strength]||aspirin [antiplatelet]||active_ingredient_of
hypericum perforatum 6 [hp_x] / ruta graveolens flowering top 6 [hp_x] / ledum palustre twig 6 [hp_x] / bellis perennis 6 [hp_x] / calcium fluoride 6 [hp_x] / tribasic calcium phosphate 3 [hp_x] / calcium sulfate anhydrous 3 [hp_x] / ferrum phosphoricum 3 [hp_x] / potassium chloride 3 [hp_x] / potassium phosphate, dibasic 3 [hp_x] / potassium sulfate 3 [hp_x] / magnesium phosphate, dibasic trihydrate 3 [hp_x] / sodium chloride 6 [hp_x] / sodium phosphate, dibasic, heptahydrate 3 [hp_x] / sodium sulfate 3 [hp_x] / silicon dioxide 6 [hp_x] / arnica montana 30 [hp_x] oral tablet, soluble [arnisport]||phosphoric acid, calcium salt (2:3)||active_ingredient_of
cynodon dactylon pollen 1250 [bau] in 1 ml / poa pratensis pollen 12500 [bau] in 1 ml / dactylis glomerata pollen 12500 [bau] in 1 ml / agrostis gigantea pollen 12500 [bau] in 1 ml / phleum pratense pollen 12500 [bau] in 1 ml / festuca pratensis pollen 12500 [bau] in 1 ml / lolium perenne pollen 12500 [bau] in 1 ml / anthoxanthum odoratum pollen 12500 [bau] in 1 ml subcutaneous injection, solution||allergenic extract,timothy grass pollen||active_ingredient_of
octinoxate 50 mg in 1 g / octisalate 25 mg in 1 g / titanium dioxide 11 mg in 1 g topical lipstick [neutrogena moistureshine spf20 nude blush 240]||2-ethylhexyl-p-methoxycinnamat||active_ingredient_of
prazosin hydrochloride 2 mg oral capsule [minipress]||hcl, prazosin||active_ingredient_of
enoxaparin sodium 150mg/ml injection solution 1ml prefilled syringe (product)||lovenox [brand name]||active_ingredient_of
calcium hypophosphite 36.5 g in 1000 ml / dextrose monohydrate 275 g in 1000 ml / potassium chloride 15 g in 1000 ml / potassium phosphate, monobasic 0.5 g in 1000 ml / sodium chloride 2.0 g in 1000 ml oral solution [amcalcilyte forte]||glucose monohydrate (substance)||active_ingredient_of
lorazepam 2mg/ml injection solution 10ml vial (product)||ativan||active_ingredient_of
glycerin 11 mg in 1 ml topical cream [hydra lifting firming moisturizing cream]||product containing glycerol||active_ingredient_of
epinephrine 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / lycopus virginicus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml oral liquid [thyroid-adrenal]||lycopodium clavatum spore||active_ingredient_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / lytta vesicatoria 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / protortonia cacti 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / packera aurea 12 [hp_x] in 1 ml oral liquid [renatone]||protortonia cacti||active_ingredient_of
alcohol 1324.89 ml in 1892.7 ml topical gel||product containing ethanol (medicinal product)||active_ingredient_of
klebsiella pneumoniae 15 [hp_x] in 1 ml / enterococcus faecalis 12 [hp_c] in 1 ml / streptococcus pneumoniae 12 [hp_c] in 1 ml / streptococcus agalactiae 12 [hp_c] in 1 ml / streptococcus mutans 12 [hp_c] in 1 ml / haemophilus influenzae type b 12 [hp_c] in 1 ml / staphylococcus aureus 15 [hp_c] in 1 ml / streptococcus viridans group 36 [hp_c] in 1 ml oral liquid [staph/strep combination]||enterococcus faecalis||active_ingredient_of
methadone hcl 5 mg oral tablet||althose||active_ingredient_of
benzalkonium chloride 0.1 g in 100 ml topical liquid [quatro shield hand sanitizer]||benzalkonium chloride||active_ingredient_of
alcohol 60 ml in 100 ml topical gel [centecassol s.o.s sanitizer]||product containing ethanol (medicinal product)||active_ingredient_of
product containing ombitasvir and paritaprevir and ritonavir (medicinal product)||paritaprevir||active_ingredient_of
titanium dioxide 4.47 g in 45 g / octinoxate 3.15 g in 45 g / zinc oxide 1.32 g in 45 g topical cream [luminous goddess aura bb]||titanium dioxide product||active_ingredient_of
rancid beef 30 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / araneus diadematus 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / azadirachta indica bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / dieffenbachia seguine 15 [hp_x] in 1 ml / calendula officinalis flowering top 15 [hp_x] in 1 ml / formica rufa 15 [hp_x] in 1 ml / grindelia hirsutula flowering top 15 [hp_x] in 1 ml / hypericum perforatum 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / latrodectus mactans 15 [hp_x] in 1 ml / ledum palustre twig 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / pulex irritans 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / citharacanthus spinicrus 15 [hp_x] in 1 ml / lycosa tarantula 15 [hp_x] in 1 ml / theridion curassavicum 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / vespa crabro 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml oral liquid [bites - stings]||pulex irritans||active_ingredient_of
octisalate 40.365 mg in 1 ml / avobenzone 26.91 mg in 1 ml / homosalate 80.73 mg in 1 ml / octocrylene 80.73 mg in 1 ml topical lotion [coppertone kids clear spf 50]||octocrilene product||active_ingredient_of
titanium dioxide 62.2 mg in 1 ml / zinc oxide 38.3 mg in 1 ml topical liquid [rainforest of the sea water foundation broad spectrum spf 15 sunscreen 39g medium-tan golden]||zno||active_ingredient_of
homosalate 0.0878 ml in 1 ml / octinoxate 0.05 ml in 1 ml / octisalate 0.05 ml in 1 ml / octocrylene 0.025 ml in 1 ml / oxybenzone 0.05 ml in 1 ml / avobenzone 0.03 ml in 1 ml topical lotion [banana boat sport body and scalp spf 30]||2-hydroxy-4-methoxybenzophenone||active_ingredient_of
amanita muscaria var. muscaria fruiting body 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / gold 20 [hp_x] in 1 ml / mahonia aquifolium root bark 20 [hp_x] in 1 ml / dieffenbachia seguine 20 [hp_x] in 1 ml / candida albicans 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / conium maculatum flowering top 20 [hp_x] in 1 ml / graphite 20 [hp_x] in 1 ml / chamaelirium luteum root 20 [hp_x] in 1 ml / goldenseal 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / wood creosote 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / mercury 20 [hp_x] in 1 ml / sodium chloride 20 [hp_x] in 1 ml / nitric acid 20 [hp_x] in 1 ml / pulsatilla vulgaris 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / sulfur 20 [hp_x] in 1 ml / lycosa tarantula 20 [hp_x] in 1 ml / thuja occidentalis leafy twig 20 [hp_x] in 1 ml / zinc 20 [hp_x] in 1 ml / apis mellifera 8 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 8 [hp_x] in 1 ml / hexaplex trunculus hypobranchial gland juice 20 [hp_x] in 1 ml oral liquid [vaginitis - feminine care]||potassium carbonate (medication)||active_ingredient_of
gabapentin 400 mg oral capsule [gabapentin]||product containing gabapentin (medicinal product)||active_ingredient_of
amlodipine 10 mg and olmesartan 40 mg oral tablet||besylate amlodipine||active_ingredient_of
beta vulgaris 3 [hp_x] in 1 ml / peumus boldus leaf 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / smilax ornata whole 6 [hp_x] in 1 ml / gelsemium sempervirens root 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / iodine 12 in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pulsatilla pratensis whole 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml oral liquid [systemic detox]||beta vulgaris||active_ingredient_of
meloxicam 15 mg oral tablet||méloxicam||active_ingredient_of
echinacea angustifolia 3 [hp_x] in 1 ml / aloe 6 [hp_x] in 1 ml / colchicum autumnale bulb 8 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / strychnos nux-vomica seed 8 [hp_x] in 1 ml / arsenic trioxide 8 [hp_q] in 1 ml / acetic acid 12 [hp_x] in 1 ml / quinine sulfate 12 [hp_x] in 1 ml / vibrio cholerae 12 [hp_x] in 1 ml / proteus vulgaris 16 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / helicobacter pylori 30 [hp_x] in 1 ml / botulinum toxin type a 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / salmonella enterica enterica serovar enteritidis 30 [hp_c] in 1 ml / clostridium difficile 30 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [dysbio plus]||aloe||active_ingredient_of
aluminum oxide 12 [hp_x] in 50 ml / bryonia dioica root 4 [hp_x] in 50 ml / citrullus colocynthis fruit pulp 4 [hp_x] in 50 ml / lachesis muta venom 30 [hp_x] in 50 ml / lycopodium clavatum spore 4 [hp_x] in 50 ml / mercuric chloride 8 [hp_x] in 50 ml / strychnos nux-vomica seed 6 [hp_x] in 50 ml / lead acetate 12 [hp_x] in 50 ml / sulfur 12 [hp_x] in 50 ml oral liquid [dr. reckeweg r37 colinteston combination product]||sulfur (medication)||active_ingredient_of
octinoxate 0.07 g in 1 ml / titanium dioxide 0.0244 g in 1 ml topical lotion [lbel effet parfait signs of age appearance minimizer foundation spf 20 fm claire 3 - beige]||dióxido de titanio||active_ingredient_of
uramit mb capsule||salol||active_ingredient_of
aconitum napellus 10 [hp_x] in 59 ml / epinephrine 10 [hp_x] in 59 ml / ammonium carbonate 10 [hp_x] in 59 ml / antimony potassium tartrate 10 [hp_x] in 59 ml / aralia racemosa root 10 [hp_x] in 59 ml / bromine 10 [hp_x] in 59 ml / chlorine 10 [hp_x] in 59 ml / eriodictyon californicum leaf 10 [hp_x] in 59 ml / eucalyptus globulus leaf 10 [hp_x] in 59 ml / grindelia hirsutula flowering top 10 [hp_x] in 59 ml / lobelia inflata 10 [hp_x] in 59 ml / sodium sulfate 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / aspidosperma quebracho-blanco bark 10 [hp_x] in 59 ml / trifolium pratense flower 10 [hp_x] in 59 ml oral liquid [bronchialcare soins des bronches]||product containing phosphorus||active_ingredient_of
barium carbonate 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / magnesium carbonate 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / thuja occidentalis leafy twig 10 [hp_x] in 59 ml oral liquid [attention and learning enhancement]||thuja occidentalis leafy twig||active_ingredient_of
pipemidic acid only product||piperamic acid||active_ingredient_of
iodine 2.5 mg/ml topical solution [io-shield]||i- element||active_ingredient_of
glycerin 49.84 g in 100 ml / dimethicone 1 g in 100 ml topical lotion [plu moisture honey sugar facial scrub]||dimeticona||active_ingredient_of
dextromethorphan hydrobromide 60 mg / guaifenesin 1200 mg oral tablet [mucus relief dm extended release caplets]||dextromethorphan hydrobromide (product)||active_ingredient_of
thyroid (porcine) 30mg oral tablet||pig thyroid||active_ingredient_of
ivermectin 0.0155 mg/mg / praziquantel 0.0775 mg/mg oral paste [zimecterin gold]||prasiquantel||active_ingredient_of
leflunomide 20 mg oral tablet, film coated||leflunomida||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral tablet, coated [nyquil severe]||antinauseants doxylamine succinate (medication)||active_ingredient_of
alcohol 0.69 ml in 1 ml topical gel [looney tunes moisturizing hand cleanser with alcohol pearl]||ethyl alcohol||active_ingredient_of
onion 6 [hp_x] in 1 ml / echinacea angustifolia whole 6 [hp_x] in 1 ml / sodium sulfate 6 [hp_x] in 1 ml / potassium carbonate 8 [hp_x] in 1 ml / mephitis mephitis anal gland fluid 8 [hp_x] in 1 ml / sanguinaria canadensis root 8 [hp_x] in 1 ml / blatta orientalis 8 [hp_x] in 1 ml / amanita muscaria fruiting body 12 [hp_x] in 1 ml / antimony potassium tartrate 12 [hp_x] in 1 ml / arsenic triiodide 12 [hp_x] in 1 ml / phenol 12 [hp_x] in 1 ml / cinchona officinalis bark 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / claviceps purpurea sclerotium 12 [hp_x] in 1 ml / sulfuric acid 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml / ammonium carbonate 12 [hp_x] in 1 ml / aspergillus niger var. niger 15 [hp_x] in 1 ml oral liquid [myccombination]||claviceps purpurea sclerotium||active_ingredient_of
quality choice all day allergy 10mg tablet||cetirizine hydrochloride [dup] (substance)||active_ingredient_of
chlorthalidone 25 mg oral tablet||edarbyclor||active_ingredient_of
avobenzone 3 ml in 100 ml / homosalate 8 ml in 100 ml / octisalate 5 ml in 100 ml / octocrylene 8 ml in 100 ml / octinoxate 7.5 ml in 100 ml topical cream [sol leon sunscreen spf 30]||octylsalicylate||active_ingredient_of
lidocaine 240 mg / menthol 60 mg topical patch [icy hot with lidocaine]||.omega.-diethylamino-2,6-dimethylacetanilide||active_ingredient_of
lidocaine 0.035 mg/mg / menthol 0.07 mg/mg medicated patch||product containing lidocaine (medicinal product)||active_ingredient_of
product containing temozolomide 140 mg/1 each oral capsule||8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3h)-one||active_ingredient_of
apis mellifera 6 [hp_x] in 1 ml / clematis recta whole 4 [hp_x] in 1 ml / anemone pulsatilla 5 [hp_x] in 1 ml / chimaphila umbellata 4 [hp_x] in 1 ml / sus scrofa testicle 200 [hp_x] in 1 ml / chaste tree 4 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml sublingual solution [n-7]||sepia officinalis juice||active_ingredient_of
ceanothus americanus leaf 4 [hp_x] in 1 ml / veratrum album root 4 [hp_x] in 1 ml / semecarpus anacardium juice 6 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / marsdenia condurango bark 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / momordica balsamina immature fruit 6 [hp_x] in 1 ml / oxalis acetosella leaf 6 [hp_x] in 1 ml / pulsatilla vulgaris 6 [hp_x] in 1 ml / sus scrofa bile duct 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / sus scrofa large intestine 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / ipecac 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / potassium dichromate 8 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / sus scrofa nasal mucosa 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sus scrofa oral mucosa 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / sus scrofa rectal mucosa 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / yeast mannan 8 [hp_x] in 1 ml / atropa belladonna 10 [hp_x] in 1 ml / wood creosote 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / mandragora officinarum root 10 [hp_x] in 1 ml / sus scrofa urinary bladder 6 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [mucous membrane core formula]||sus scrofa pancreas||active_ingredient_of
normosol-r/dextrose 5% inj||anhydrous sodium acetate||active_ingredient_of
meperidine hcl 100 mg oral tablet||meperidine hydrochloride (medication)||active_ingredient_of
liquidambar styraciflua pollen 0.0001 g in 1 ml / ulmus americana pollen 0.0001 g in 1 ml / platanus occidentalis pollen 0.0001 g in 1 ml / fagus grandifolia pollen 0.0001 g in 1 ml / populus deltoides pollen 0.0001 g in 1 ml / acer saccharum pollen 0.0001 g in 1 ml / quercus rubra pollen 0.0001 g in 1 ml / carya ovata pollen 0.0001 g in 1 ml / fraxinus americana pollen 0.0001 g in 1 ml / betula nigra pollen 0.0001 g in 1 ml percutaneous solution [eastern 10 tree pollen mix]||betula nigra pollen extract||active_ingredient_of
50 ml dilaudid 10 mg/ml injection||hydromorphone hydrochloride||active_ingredient_of
thysanotus tuberosus flower 200 [hp_c] in 1 ml / grevillea buxifolia flower 200 [hp_c] in 1 ml / drosera rotundifolia flowering top 200 [hp_c] in 1 ml / telopea speciosissima flower 200 [hp_c] in 1 ml oral liquid [crisis comfort]||grevillea buxifolia flower extract||active_ingredient_of
vicks dayquil cold & flu 325mg-10mg-5mg liquicap||phenylephrine (as hydrochloride)||active_ingredient_of
humorsol ophthalmic product||demecarium-containing product||active_ingredient_of
delsym dm children's cough + chest congestion solution||guaiacol glyceryl ether||active_ingredient_of
aspirin + papaveretum||aspirin (medication)||active_ingredient_of
salix nigra bark 1 [hp_x] oral pellet||salix flavovirens bark||active_ingredient_of
antithrombin||inhibitor, direct thrombin||active_ingredient_of
gnp day time severe cold & flu liquid||phenylephrine hydrochloride||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [maximum strength nighttime sinus and cold]||hcl phenylephrine||active_ingredient_of
echinacea angustifolia 1 [hp_x] / hamamelis virginiana root bark/stem bark 2 [hp_x] / tribasic calcium phosphate 3 [hp_x] / goldenseal 4 [hp_x] / polygala senega root 4 [hp_x] / silicon dioxide 4 [hp_x] / conium maculatum flowering top 4 [hp_x] / sodium tetrachloroaurate 5 [hp_x] / oyster shell calcium carbonate, crude 5 [hp_x] / fucus vesiculosus 5 [hp_x] / lachesis muta venom 8 [hp_x] oral tablet, orally disintegrating [echinacea]||bladder wrack extract||active_ingredient_of
alcohol 0.72 ml in 1 ml topical liquid [pasion hand sanitizer]||ethanol (substance)||active_ingredient_of
acetaminophen 80 mg/0.8 ml oral solution [pain & fever]||acenol||active_ingredient_of
promacot 25 mg oral tablet||promethazine hcl [anesthesia] (substance)||active_ingredient_of
sennosides 50 kg in 50 kg powder [calcium sennosides 60%]||laxatives senna||active_ingredient_of
sodium phosphate, dibasic, heptahydrate 3.5 g in 661 ml / sodium phosphate, monobasic 9.5 g in 661 ml rectal enema [fleet for children]||dibasic sodium phosphate heptahydrate (substance)||active_ingredient_of
gallus gallus feather 0.1 g in 1 ml / anas platyrhynchos feather 0.1 g in 1 ml / anser anser feather 0.1 g in 1 ml percutaneous injection, solution [animal allergens, feather mix]||goose feathers diagnostic allergen extract||active_ingredient_of
perfluorobutane (substance)||perfluorobutane product||active_ingredient_of
aluminum oxide 10 [hp_x] in 59 ml / antimony trisulfide 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / asarum europaeum 10 [hp_x] in 59 ml / baptisia tinctoria root 10 [hp_x] in 59 ml / phenol 10 [hp_x] in 59 ml / quinine arsenate 10 [hp_x] in 59 ml / anamirta cocculus seed 10 [hp_x] in 59 ml / egg phospholipids 10 [hp_x] in 59 ml / picric acid 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [appetite enhancer]||phospholipids, egg||active_ingredient_of
product containing iohexol in parenteral dosage form||iohexol (procedure)||active_ingredient_of
wormwood 1 [hp_x] / gentiana lutea root 1 [hp_x] / taraxacum palustre root 2 [hp_x] / strychnos nux-vomica seed 5 [hp_x] oral pellet||taraxacum palustre root||active_ingredient_of
bivalirudin 250 mg intravenous injection, powder, lyophilized, for solution||bivalirudin (substance)||active_ingredient_of
nyquil cold & flu nighttime, 650 mg-30 mg-12.5 mg/30 ml oral liquid||doxylamine succinate (substance)||active_ingredient_of
berberis vulgaris root bark 3 [hp_x] in 1 ml / horseradish 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / tabebuia impetiginosa bark 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / formaldehyde 8 [hp_x] in 1 ml / phenol 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / adenosine triphosphate disodium 12 [hp_x] in 1 ml / methylcobalamin 12 [hp_x] in 1 ml / lactic acid, l- 12 [hp_x] in 1 ml / mucor racemosus 16 [hp_x] in 1 ml / alternaria alternata 16 [hp_x] in 1 ml / aspergillus niger var. niger 16 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml / candida parapsilosis 12 [hp_x] in 1 ml / saccharomyces cerevisiae 12 [hp_x] in 1 ml / rhizopus stolonifer 14 [hp_c] in 1 ml / escherichia coli 30 [hp_c] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [fng]||e. coli||active_ingredient_of
ibuprofen 200 mg oral capsule, liquid filled [migraine relief]||ibuprofen [musculoskeletal use]||active_ingredient_of
mahonia aquifolium root bark 2 [hp_x] in 21 g / calendula officinalis flowering top 2 [hp_x] in 21 g / goldenseal 2 [hp_x] in 21 g / boric acid 1 [hp_x] in 21 g / zinc oxide 1 [hp_x] in 21 g / sodium borate 1 [hp_x] in 21 g / calcium sulfate 1 [hp_x] in 21 g / antimony trisulfide 1 [hp_x] in 21 g topical cream [berberis antiseptic]||berberis aquifolium root bark||active_ingredient_of
dextromethorphan + doxylamine + phenylephrine (medication)||dextromethorphan (substance)||active_ingredient_of
hyaluronic acid 2.5 g intraepidermal injection||acid, hyaluronic||active_ingredient_of
cortisone acetate 6 [hp_x] in 1 ml / epinephrine 6 [hp_x] in 1 ml / quinine arsenate 10 [hp_x] in 1 ml / chamaelirium luteum root 10 [hp_x] in 1 ml / hypericum perforatum 10 [hp_x] in 1 ml / dibasic potassium phosphate 10 [hp_x] in 1 ml / strychnos nux-vomica seed 10 [hp_x] in 1 ml / selenium 10 [hp_x] in 1 ml / gold 10 [hp_x] in 1 ml / enterobacter cloacae 30 [hp_c] in 1 ml oral liquid [bio mood phase]||adrenaline||active_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 27.5 mg in 1 ml / oxybenzone 30 mg in 1 ml topical lotion [suntone broad spectrum spf 50 sunscreen]||octylsalicylate||active_ingredient_of
picric acid 6 [hp_x] oral pellet||picric acid (substance)||active_ingredient_of
cvs anti-diarrheal 262mg/15ml suspension (vanilla)||product containing bismuth subsalicylate||active_ingredient_of
aconitum napellus 200 [hp_c] / onion 200 [hp_c] / antimony potassium tartrate 200 [hp_c] / apis mellifera 200 [hp_c] / silver nitrate 200 [hp_c] / arnica montana 200 [hp_c] / arsenic trioxide 200 [hp_c] / atropa belladonna 200 [hp_c] / bryonia alba root 200 [hp_c] / oyster shell calcium carbonate, crude 200 [hp_c] / tribasic calcium phosphate 200 [hp_c] / calendula officinalis flowering top 200 [hp_c] / lytta vesicatoria 200 [hp_c] / activated charcoal 200 [hp_c] / caulophyllum thalictroides root 200 [hp_c] / causticum 200 [hp_c] / matricaria recutita 200 [hp_c] / cinchona officinalis bark 200 [hp_c] / anamirta cocculus seed 200 [hp_c] / arabica coffee bean 200 [hp_c] / citrullus colocynthis fruit pulp 200 [hp_c] / euphrasia stricta 200 [hp_c] / ferrum phosphoricum 200 [hp_c] / gelsemium sempervirens root 200 [hp_c] / nitroglycerin 200 [hp_c] / calcium sulfide 200 [hp_c] / hypericum perforatum 200 [hp_c] / strychnos ignatii seed 200 [hp_c] / ipecac 200 [hp_c] / potassium dichromate 200 [hp_c] / lachesis muta venom 200 [hp_c] / ledum palustre twig 200 [hp_c] / lycopodium clavatum spore 200 [hp_c] / magnesium phosphate, dibasic trihydrate 200 [hp_c] / mercury 200 [hp_c] / sodium chloride 200 [hp_c] / strychnos nux-vomica seed 200 [hp_c] / phosphorus 200 [hp_c] / phytolacca americana root 200 [hp_c] / pulsatilla vulgaris 200 [hp_c] / rancid beef 200 [hp_c] / toxicodendron radicans leaf 200 [hp_c] / ruta graveolens flowering top 200 [hp_c] / sepia officinalis juice 200 [hp_c] / silicon dioxide 200 [hp_c] / spongia officinalis skeleton, roasted 200 [hp_c] / delphinium staphisagria seed 200 [hp_c] / sulfur 200 [hp_c] / comfrey root 200 [hp_c] / thuja occidentalis leafy twig 200 [hp_c] oral pellet [homeopathic remedy kit 200c]||rancid beef preparation||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [nighttime cold and flu]||n-(4-hydroxyphenyl)acetamide||active_ingredient_of
bos taurus cerebellum 17 [hp_x] / bos taurus brain 17 [hp_x] / bos taurus pineal gland 17 [hp_x] / pseudognaphalium luteoalbum leaf 17 [hp_x] / sus scrofa ear 17 [hp_x] / bos taurus nerve 17 [hp_x] / bifenthrin 20 [hp_x] / tin 20 [hp_x] oral pellet||sn||active_ingredient_of
avobenzone 3 ml in 100 ml / homosalate 8 ml in 100 ml / octisalate 5 ml in 100 ml / octocrylene 8 ml in 100 ml / octinoxate 7.5 ml in 100 ml topical cream [sol leon sunscreen spf 30]||octylmethoxycinnamate||active_ingredient_of
chlorpheniramine maleate 2 mg / phenylephrine bitartrate 7.8 mg / aspirin 325 mg oral tablet, effervescent [good sense effervescent cold relief]||phenylephrine bitartrate (substance)||active_ingredient_of
butalbital and caffeine and paracetamol only product in oral dose form||iso-butylallylbarbituric acid||active_ingredient_of
ampicillin sodium 2 gm injection powder for solution||d-(-)-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, sodium salt||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [vicks dayquil cold and flu multi-symptom relief]||dextromethorphan hydrobromide (product)||active_ingredient_of
titanium dioxide 60 mg in 1 ml / zinc oxide 60 mg in 1 ml topical cream [coral safe spf-30 broad spectrum sunscreen]||dioxide titanium||active_ingredient_of
co-phenotrope 2.5mg/25mcg tab||atropine sulphate - chemical (substance)||active_ingredient_of
tylenol children's cold plus flu suspension (grape)||phenylephrine hydrochloride [nose] (substance)||active_ingredient_of
vitrexate multivitamin caplet||magnesium oxide-containing product||active_ingredient_of
sulfacetamide sodium/sulfur 10 %-4 % topical pads, medicated (ea)||sulfur (medication)||active_ingredient_of
plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / avena sativa pollen 0.00008 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.00008 g in 1 ml / felis catus hair 80 [bau] in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / juglans nigra pollen 0.0004 g in 1 ml / broussonetia papyrifera pollen 0.00067 g in 1 ml / morus rubra pollen 0.00067 g in 1 ml / morus alba pollen 0.00067 g in 1 ml intradermal injection, solution||white oak pollen||active_ingredient_of
alcohol 0.54 topical cloth [quash multi sanitizing tissue]||ethyl alcohol product||active_ingredient_of
oxybenzone 5 g in 100 g / homosalate 6 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g topical cream||octyl-methoxycinnamate||active_ingredient_of
ziprasidone hcl@80 mg@oral@capsule||ziprasidone hcl||active_ingredient_of
dextromethorphan hydrobromide 20 mg in 20 ml / guaifenesin 400 mg in 20 ml oral solution [signature care tussin]||glyceryl ether, guaiacol||active_ingredient_of
dexamethasone 6 mg oral tablet [decadron]||methylfluorprednisolone||active_ingredient_of
zinc oxide 24.7 g in 100 g topical powder [(re) setting 100% mineral powder translucent broad spectrum sunscreen spf 35]||lassars paste||active_ingredient_of
plerixafor only product in parenteral dose form||mezobil||active_ingredient_of
product containing only sodium bicarbonate and sodium chloride (medicinal product)||product containing sodium chloride||active_ingredient_of
zinc oxide 1.59 g in 30 g / titanium dioxide 1.86 g in 30 g topical lotion [candy doll bright pure base]||sunscreen with zinc oxide (medication)||active_ingredient_of
ferrous fumarate 53.5 mg / iron 38 mg / ascorbic acid 25 mg / folic acid 1 mg / thiamine mononitrate 2 mg / riboflavin 3 mg / niacin 1.8 mg / calcium pantothenate 5 mg / pyridoxine hydrochloride 25 mg / biotin 300 ug / cyanocobalamin 12.5 ug / cupric sulfate 2 mg / magnesium sulfate, unspecified form 5 mg / zinc sulfate, unspecified form 10 mg / omega-3 fatty acids 200 mg / doconexent 156 mg / icosapent 39 mg oral capsule, liquid filled [dothelle dha]||magnesium sulfate, unspecified form||active_ingredient_of
acer saccharinum pollen 0.05 g in 1 ml intradermal injection [silver maple pollen]||silver maple pollen extract||active_ingredient_of
avobenzone 19.8 mg in 1 ml / homosalate 74.3 mg in 1 ml / octisalate 49.6 mg in 1 ml / octocrylene 27.3 mg in 1 ml / oxybenzone 19.8 mg in 1 ml topical lotion [panama jack broad spectrum spf 30]||2-ethylhexyl salicylate||active_ingredient_of
aconitum napellus 7 [hp_x] in 30 ml / araneus diadematus 9 [hp_x] in 30 ml / arnica montana 6 [hp_x] in 30 ml / cynanchum vincetoxicum root 12 [hp_x] in 30 ml / baptisia tinctoria 8 [hp_x] in 30 ml / bryonia alba root 10 [hp_x] in 30 ml / echinacea angustifolia 6 [hp_x] in 30 ml / equisetum hyemale 7 [hp_x] in 30 ml / eupatorium perfoliatum flowering top 10 [hp_x] in 30 ml / gelsemium sempervirens root 8 [hp_x] in 30 ml / calcium sulfide 12 [hp_x] in 30 ml / juglans regia leaf 6 [hp_x] in 30 ml / phytolacca americana root 10 [hp_x] in 30 ml / sanguinaria canadensis root 8 [hp_x] in 30 ml / sarsaparilla 9 [hp_x] in 30 ml / sulfur 10 [hp_x] in 30 ml / zinc 12 [hp_x] in 30 ml oral spray [ohm-inma]||aconitum napellus||active_ingredient_of
codeine phosphate 30 mg / acetaminophen 300 mg oral tablet [acetaminophen with codeine]||codeine phosphate||active_ingredient_of
titanium dioxide 31.6 mg in 1 ml / octinoxate 29.97 mg in 1 ml topical liquid [givenchy photo perfexion fluid foundation spf 20 perfect gold tint 7]||titanium oxide||active_ingredient_of
mirtazapine 30 mg oral tablet, film coated [remeron]||6-azamianserin||active_ingredient_of
helianthemum nummularium flower 5 [hp_x] / clematis vitalba flower 5 [hp_x] / impatiens glandulifera flower 5 [hp_x] / prunus cerasifera flower 5 [hp_x] / ornithogalum umbellatum whole 5 [hp_x] / aesculus hippocastanum flower 5 [hp_x] oral capsule, liquid filled [rescue sleep]||prunus cerasifera flower extract||active_ingredient_of
simparica trio 0.12 mg / 25 mg / 6 mg chewable tablet||simparica trio||active_ingredient_of
nortriptyline (as nortriptyline hcl) 25 mg oral capsule||nortriptyline hydrochloride [enuresis - no agents here]||active_ingredient_of
sodium phosphate, dibasic, heptahydrate 2.7 g in 45 ml / sodium phosphate, monobasic 7.2 g in 45 ml oral liquid [fleet]||monosodium dihydrogen orthophosphate||active_ingredient_of
titanium dioxide 1.56 g in 25 g / zinc oxide 0.96 g in 25 g / arbutin 0.5 g in 25 g / adenosine 0.01 g in 25 g topical cream [superplus beblesh balm spf25 pa 2plus]||titanium dioxide-containing product||active_ingredient_of
nitric acid 30 [hp_c] in 1 ml oral pellet [warts]||acid, nitric||active_ingredient_of
apap 325 mg / oxycodone hydrochloride 5 mg oral tablet [percocet]||oxycodone hydrochloride (product)||active_ingredient_of
epinephrine 1 mg/ml injection syringe (ml)||adrenaline [resp]||active_ingredient_of
novobiocin product (product)||novobiocin product||active_ingredient_of
benzoic acid 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / centaurea benedicta 15 [hp_x] in 1 ml / ceanothus americanus leaf 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / chionanthus virginicus bark 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / dioscorea villosa tuber 15 [hp_x] in 1 ml / mucuna pruriens fruit trichome 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / juniper berry 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / ptelea trifoliata bark 15 [hp_x] in 1 ml / taraxacum officinale 15 [hp_x] in 1 ml / uric acid 15 [hp_x] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / cynara scolymus leaf 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml oral liquid [detox complex]||juniperus communis fruit extract||active_ingredient_of
estradiol valerate 40 mg/1 ml intramuscular oil||oestradiol valerate preparation||active_ingredient_of
heb antacid regular strength liquid (mint)||dimeticone||active_ingredient_of
methylphenidate hcl@10 mg@oral@tablet||quillivant||active_ingredient_of
eucalyptol 0.092 g in 100 ml / menthol 0.042 g in 100 ml / methyl salicylate 0.060 g in 100 ml / thymol 0.064 g in 100 ml oral mouthwash [buenos dias de personna cool mint]||zineol||active_ingredient_of
metronidazole 500mg tab||metronidazole||active_ingredient_of
ammonium phosphate, dibasic 10 [hp_x] in 59 ml / atropa belladonna 10 [hp_x] in 59 ml / colchicum autumnale bulb 10 [hp_x] in 59 ml / formic acid 10 [hp_x] in 59 ml / fraxinus excelsior bark 10 [hp_x] in 59 ml / fraxinus excelsior leaf 10 [hp_x] in 59 ml / ledum palustre twig 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / urtica urens 10 [hp_x] in 59 ml oral liquid [gout symptom reliever]||deadly nightshade||active_ingredient_of
romifidine hydrochloride 1 g in 1 g not applicable powder||romifidine hydrochloride||active_ingredient_of
zonegran, 100 mg oral capsule||3-sulfamoylmethyl-1,2-benzisoxazole||active_ingredient_of
octinoxate 0.66 g in 11 g / titanium dioxide 1.28 g in 11 g / zinc oxide 0.32 g in 11 g topical powder [slim fit moist spf 50]||matmate||active_ingredient_of
alcohol 75 ml in 100 g topical liquid [clean care hand sanitizer tissue]||product containing ethyl alcohol (medicinal product)||active_ingredient_of
zinc gluconate 1 [hp_x] / sambucus nigra flower 1 [hp_x] / eupatorium perfoliatum flowering top 1 [hp_x] / mentha piperita 2 [hp_x] / myrrh 2 [hp_x] / glycyrrhiza glabra leaf 3 [hp_x] oral tablet, orally disintegrating [cold-eeze natural multi-symptom relief]||eupatorium perfoliatum flowering top||active_ingredient_of
bismuth subsalicylate 1050 mg in 30 ml oral suspension [stomach relief maximum strength]||product containing bismuth subsalicylate (medicinal product)||active_ingredient_of
adalimumab 40 mg per 0.8 ml auto-injector||adalimumab-containing product||active_ingredient_of
sumatriptan 25mg tablet||sumatriptan (as succinate)||active_ingredient_of
capsaicin 0.025% topical application cream [born again super pain relieving]||(e)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide||active_ingredient_of
diltiazem hydrochloride 180 mg oral capsule, extended release [diltiazem hydrochloride]||diltiazem hcl product||active_ingredient_of
product containing fremanezumab in parenteral dose form (medicinal product form)||ajovy||active_ingredient_of
artemisia cina pre-flowering top 200 [hp_c] oral pellet [cina 200c]||artemisia cina pre-flowering top||active_ingredient_of
avobenzone 30 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 20 mg in 1 ml topical lotion [aveeno positively radiant daily moisturizer sunscreen broad spectrum spf 15]||2-ethylhexyl-4-methoxycinnamate||active_ingredient_of
sodium phosphate, dibasic, heptahydrate 6 [hp_c] in 59 ml / equisetum arvense top 3 [hp_x] in 59 ml / pulsatilla vulgaris 3 [hp_x] in 59 ml / sodium sulfate 6 [hp_c] in 59 ml / calcium fluoride 6 [hp_c] in 59 ml oral spray [bladder control]||dibasic sodium phosphate heptahydrate (substance)||active_ingredient_of
artemether- and lumefantrine-containing product in oral dose form||artemether||active_ingredient_of
madopar oral product||3,4-dihydroxy-l-phenylalanine||active_ingredient_of
clomipramine hydrochloride 75 mg/1 each oral capsule||clomipramine hydrochloride||active_ingredient_of
sodium chloride 0.9 g in 100 ml intravenous injection, solution [saline]_#2||salt, nos||active_ingredient_of
benzonatate 100mg capsule (product)||benzonatate (product)||active_ingredient_of
benzalkonium 0.1 g in 100 g cutaneous soap [biosilk]||chloride, benzalkonium||active_ingredient_of
carya alba pollen 0.0004 g in 1 ml / carya illinoinensis pollen 0.0004 g in 1 ml / ambrosia trifida pollen 0.0000266 g in 1 ml / ambrosia artemisiifolia pollen 0.0000266 g in 1 ml / ambrosia psilostachya pollen 0.0000266 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.0004 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / chenopodium album pollen 0.01 g in 1 ml / iva annua var. annua pollen 0.01 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml intradermal injection, solution||allergenic extract,grass,johnson||active_ingredient_of
octinoxate 4.70 g in 235 g / avobenzone 1.76 g in 235 g topical lotion [sunzone sunscreen family spf 30 broad spectrum]||4-tert-but-4'-meth-dibenzlmete||active_ingredient_of
metoprolol succinate 50mg prolonged-release oral tablet||toprol-xl||active_ingredient_of
verapamil hcl@240 mg@oral@tablet, extended release||ipoveratril hydrochloride||active_ingredient_of
cupric acetate 6 [hp_x] / lobelia spicata leaf 6 [hp_x] / pork kidney 6 [hp_x] / tobacco leaf 10 [hp_x] / arsenic trioxide 12 [hp_x] oral pellet||tabacum leaf||active_ingredient_of
amanita muscaria var. muscaria fruiting body 20 [hp_x] in 1 g / arsenic trioxide 20 [hp_x] in 1 g / gold 20 [hp_x] in 1 g / mahonia aquifolium root bark 20 [hp_x] in 1 g / dieffenbachia seguine 20 [hp_x] in 1 g / candida albicans 20 [hp_x] in 1 g / lytta vesicatoria 20 [hp_x] in 1 g / conium maculatum flowering top 20 [hp_x] in 1 g / graphite 20 [hp_x] in 1 g / chamaelirium luteum root 20 [hp_x] in 1 g / goldenseal 20 [hp_x] in 1 g / potassium carbonate 20 [hp_x] in 1 g / wood creosote 20 [hp_x] in 1 g / lycopodium clavatum spore 20 [hp_x] in 1 g / mercury 20 [hp_x] in 1 g / sodium chloride 20 [hp_x] in 1 g / nitric acid 20 [hp_x] in 1 g / pulsatilla vulgaris 20 [hp_x] in 1 g / toxicodendron pubescens leaf 20 [hp_x] in 1 g / sepia officinalis juice 20 [hp_x] in 1 g / sulfur 20 [hp_x] in 1 g / lycosa tarantula 20 [hp_x] in 1 g / thuja occidentalis leafy twig 20 [hp_x] in 1 g / zinc 20 [hp_x] in 1 g / apis mellifera 8 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 8 [hp_x] in 1 g / hexaplex trunculus hypobranchial gland juice 20 [hp_x] in 1 g oral pellet [vaginitis - feminine care]||lytta vesicatoria||active_ingredient_of
neomycin sulfate 3.5 mg in 1 g / pramoxine hydrochloride 10 mg in 1 g / bacitracin zinc 500 [iu] in 1 g / polymyxin b sulfate 10000 [iu] in 1 g topical ointment [antibiotic plus pain relief]||bacitracin zinc complex||active_ingredient_of
netarsudil mesylate 0.20 mg in 1 ml / latanoprost 0.05 mg in 1 ml ophthalmic solution/ drops [rocklatan]||netarsudil (as dimesylate)||active_ingredient_of
parenteral nutrition solution amino acids 8% (hepatamine) intravenous solution||glycine product (product)||active_ingredient_of
menthol, unspecified form 4534 mg in 226.7 g topical lotion [flexible pain relief]||cyclohexanol, 5-methyl-2-(1-methylethyl)-||active_ingredient_of
pramipexole dihydrochloride 375microgram extended release tablet (product)||pramipexole dihydrochloride (substance)||active_ingredient_of
hamster skin extract 0.1 gm/ml injectable solution||mesocricetus auratus skin extract||active_ingredient_of
bupropion hcl 100mg 12hr sa tab||product containing bupropion hydrochloride (medicinal product)||active_ingredient_of
ranitidine hcl 150mg tab ud||n-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine, hydrochloride||active_ingredient_of
dextrose 5%, sodium chloride 0.3% solution for injection_#2||chloride sodium||active_ingredient_of
sodium fluoride 0.25 mg in 1 ml / eucalyptol 0.92 mg in 1 ml / thymol 0.64 mg in 1 ml / menthol 0.42 mg in 1 ml oral mouthwash [mastic dent]||menthol (medication)||active_ingredient_of
product containing only trazodone hydrochloride 50 mg/1 each oral tablet (clinical drug)||trazodone hydrochloride [dup] (substance)||active_ingredient_of
pneumococcal 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19a, 19f, 20, 22f, 23f, and 33f conjugate vaccine||streptococcus pneumoniae capsular polysaccharide antigen 26 (substance)||active_ingredient_of
garlic 2 [hp_x] in 1 ml / calendula officinalis flowering top 2 [hp_x] in 1 ml / sambucus nigra flowering top 3 [hp_x] in 1 ml / clematis recta flowering top 6 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / kerosene 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / graphite 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / croton tiglium seed 12 [hp_x] in 1 ml / mercuric sulfide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml oral liquid [herpes simplex plus]||cinnabar||active_ingredient_of
methenamine 81 mg / phenyl salicylate 32.4 mg / sodium phosphate, monobasic, anhydrous 40.8 mg / methylene blue anhydrous 10.8 mg / hyoscyamine sulfate 0.12 mg oral tablet [vilevev mb]||hyoscyamine sulfate||active_ingredient_of
avobenzone 20 mg in 1 ml / homosalate 75.1 mg in 1 ml / octisalate 50.1 mg in 1 ml / octocrylene 27.5 mg in 1 ml / oxybenzone 20 mg in 1 ml topical lotion [australian gold broad spectrum spf 30]||homosalato||active_ingredient_of
chlorphenamine and paracetamol product||chlorphenamine-containing product||active_ingredient_of
galium aparine 3 [hp_x] in 30 ml / sus scrofa adrenal gland 12 [hp_x] in 30 ml / pork liver 6 [hp_x] in 30 ml / sus scrofa pituitary gland 12 [hp_x] in 30 ml / asian ginseng 1 [hp_x] in 30 ml / nuphar lutea root 2 [hp_x] in 30 ml / sus scrofa testicle 6 [hp_x] in 30 ml / phosphoric acid 200 [hp_c] in 30 ml / populus tremuloides whole 3 [hp_x] in 30 ml / testosterone 30 [hp_x] in 30 ml / turnera diffusa leafy twig 3 [hp_x] in 30 ml oral liquid [libido]||populus tremuloides whole||active_ingredient_of
benzonatate 100mg oral capsule, liquid filled||benzonatate (product)||active_ingredient_of
phosphoric acid 12 [kp_c] in 1 ml / atropa belladonna 12 [kp_c] in 1 ml / echinacea angustifolia 3 [kp_c] in 1 ml / eupatorium perfoliatum whole 12 [kp_c] in 1 ml / gelsemium sempervirens root 12 [kp_c] in 1 ml / goldenseal 3 [kp_c] in 1 ml / iodine 12 [kp_c] in 1 ml / lachesis muta venom 12 [kp_c] in 1 ml / lycopodium clavatum spore 12 [kp_c] in 1 ml / tropaeolum majus 3 [kp_c] in 1 ml / strychnos nux-vomica seed 12 [kp_c] in 1 ml / phosphorus 12 [kp_c] in 1 ml / rancid beef 30 [kp_c] in 1 ml / selenium 12 [kp_c] in 1 ml / sus scrofa spleen 6 [kp_c] in 1 ml / bos taurus spleen 6 [kp_c] in 1 ml / sus scrofa thymus 6 [kp_c] in 1 ml / bos taurus thymus 6 [kp_c] in 1 ml / zinc 12 [kp_c] in 1 ml oral spray [viatrexx-virus]||bovine thymus preparation||active_ingredient_of
eucalyptol 0.92 mg in 1 ml / menthol 0.42 mg in 1 ml / methyl salicylate 0.6 mg in 1 ml / thymol 0.64 mg in 1 ml oral liquid [smart sense spring mint]||menthol (substance)||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule [daytime cold and flu multi-symptom relief]||hcl phenylephrine||active_ingredient_of
pyrithione zinc 2.1 g in 100 ml topical shampoo [revagain hair and scalp revitalizing]||bis(n-oxopyridine-2-thionato)zinc (ii)||active_ingredient_of
octinoxate 7.40 g in 100 g / homosalate 6.20 g in 100 g / octisalate 5.00 g in 100 g / oxybenzone 3.10 g in 100 g / avobenzone 1.50 g in 100 g topical cream [venofye orchard bee brilliance spf 30]||2-hydroxy-4-methoxybenzone||active_ingredient_of
afamelanotide only product in subcutaneous dose form||scenesse||active_ingredient_of
product containing cyclizine and morphine||morphine (medication)||active_ingredient_of
cladosporium sphaerospermum 13333.333 [pnu] in 1 ml / cochliobolus sativus 13333.333 [pnu] in 1 ml / alternaria alternata 13333.333 [pnu] in 1 ml intradermal solution [ahh mold mix]||allergenic extract,alternaria alternata||active_ingredient_of
product containing only ciclesonide in nasal dose form (medicinal product form)||product containing ciclesonide||active_ingredient_of
k+ bicarbonate 10 meq effervescent oral tablet||fast heartburn relief otc||active_ingredient_of
avena sativa flowering top 3 [hp_x] in 1 ml / hops 3 [hp_x] in 1 ml / passiflora incarnata flowering top 3 [hp_x] in 1 ml / dibasic potassium phosphate 6 [hp_x] in 1 ml / phosphoric acid 6 [hp_x] in 1 ml / semecarpus anacardium juice 6 [hp_c] in 1 ml / silver nitrate 6 [hp_c] in 1 ml / strychnos ignatii seed 6 [hp_c] in 1 ml oral spray [peacefuli]||humulus lupulus extract||active_ingredient_of
octinoxate 75 mg in 1 ml / zinc oxide 90 mg in 1 ml topical lotion [phace bioactive soothing day plus primer broad-spectrum spf 46]||zno||active_ingredient_of
white glo bio-enzyme kit||sodium monofluorophosphate (substance)||active_ingredient_of
product containing bacampicillin in oral dosage form||1'-ethoxycarbonyloxyethyl-(6-d-alpha-aminophenylacetamido)penicillanate||active_ingredient_of
coal tar and lecithin only product||liquor picis carbonis||active_ingredient_of
echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / ambrosia artemisiifolia 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / potassium dichromate 12 [hp_x] in 1 ml / nutmeg 12 [hp_x] in 1 ml oral liquid [sinutone]||echinacea angustifolia whole||active_ingredient_of
anthim||product containing obiltoxaximab||active_ingredient_of
titanium dioxide 2.44 g in 100 ml / octinoxate 7 g in 100 ml topical emulsion [lbel effet parfait signs of age appearance minimizer foundation spf 20 fm medium 6]||titanium dioxide (substance)||active_ingredient_of
acetaminophen/dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride 325 mg-15 mg-200 mg-5 mg oral tablet [medi-first non-pseudo cold relief]||guaifenesin (substance)||active_ingredient_of
chlorpheniramine maleate 4 mg oral tablet [chlortab-4]||chlorpheniramine maleate (substance)||active_ingredient_of
camphor oil 8 % / peppermint oil 8 % topical gel||camphor, (synthetic)||active_ingredient_of
sepia officinalis juice 6 [hp_c] in 40 ml / larrea tridentata top 6 [hp_c] in 40 ml / potassium phosphate, dibasic 6 [hp_x] in 40 ml / pulsatilla patens 6 [hp_c] in 40 ml / nitric acid 6 [hp_c] in 40 ml oral tincture [vagi-clear]||nitric acid (substance)||active_ingredient_of
doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg / dextromethorphan hydrobromide 10 mg / acetaminophen 325 mg oral capsule, liquid filled [alka-seltzer plus maximum strength cough, mucus and congestion night powermax]||acetominophen||active_ingredient_of
topotecan 4mg powder for infusion solution vial (product)||topotecan hcl||active_ingredient_of
isosorbide mononitrate 20mg oral tab||product containing isosorbide mononitrate||active_ingredient_of
ziprasidone only product in oral dose form||ziprasidona||active_ingredient_of
product containing acyclovir 400 mg/1 each oral tablet||2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6h-purin-6-one||active_ingredient_of
isoproterenol + cyclopentamine||n,alpha-dimethylcyclopentaneethylamine||active_ingredient_of
octinoxate 7.5 ml in 100 ml / octisalate 5 ml in 100 ml / oxybenzone 3 ml in 100 ml / titanium dioxide 2 ml in 100 ml topical lotion [safe sea for kids sunscreen with jellyfish sting protective spf 30 plus]||titanium white||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, coated||product containing dextromethorphan hydrobromide||active_ingredient_of
mondoxyne nl 50mg capsule||okebo||active_ingredient_of
ibuprofen 100 mg in 5 ml oral suspension [childrens ibuprofen oral suspension]||non-prescription ibuprofen||active_ingredient_of
product containing only esomeprazole in parenteral dose form (medicinal product form)||esomeprazole (substance)||active_ingredient_of
acetaminophen 325 mg in 15 ml / dextromethorphan hydrobromide 10 mg in 15 ml / phenylephrine hydrochloride 5 mg in 15 ml oral liquid [day time cold and flu relief non drowsy]||dextromethmorphan hydrobromide||active_ingredient_of
artemisia vulgaris pollen 0.0125 g in 1 ml / artemisia absinthium pollen 0.0125 g in 1 ml / artemisia tridentata pollen 0.0125 g in 1 ml / artemisia ludoviciana pollen 0.0125 g in 1 ml intradermal injection, solution||common sagebrush pollen extract||active_ingredient_of
pelargonium sidoides root 1 [hp_x] / aconitum napellus 4 [hp_x] / bryonia alba root 4 [hp_x] / eucalyptus globulus leaf 2 [hp_x] / eupatorium perfoliatum flowering top 6 [hp_x] / gelsemium sempervirens root 4 [hp_x] / ipecac 3 [hp_x] / phosphorus 6 [hp_x] oral tablet, chewable [umcka cold flu berry chewable]||phosphorus-containing product||active_ingredient_of
cladosporium cladosporioides 0.005 g in 1 ml / acremonium strictum 0.005 g in 1 ml / trichothecium roseum 0.00036 g in 1 ml / passalora fulva 0.00036 g in 1 ml / cochliobolus spicifer 0.00036 g in 1 ml / myrothecium verrucaria 0.00036 g in 1 ml / hypomyces perniciosus 0.00036 g in 1 ml / neurospora crassa 0.00036 g in 1 ml / khuskia oryzae 0.00036 g in 1 ml / paecilomyces variotii 0.00036 g in 1 ml / microascus brevicaulis 0.00036 g in 1 ml / colletotrichum coccodes 0.00036 g in 1 ml / pleospora herbarum 0.00036 g in 1 ml / streptomyces griseus 0.00036 g in 1 ml / trichoderma viride 0.00036 g in 1 ml / trichophyton schoenleinii 0.00036 g in 1 ml / mycocladus corymbiferus 0.00042 g in 1 ml / acrothecium robustum 0.00042 g in 1 ml / humicola grisea 0.00042 g in 1 ml / microsporum audouinii 0.00042 g in 1 ml / microsporum canis 0.00042 g in 1 ml / apiospora montagnei 0.00042 g in 1 ml / phycomyces blakesleeanus 0.00042 g in 1 ml / sporotrichum pruinosum 0.00042 g in 1 ml / stachybotrys chartarum 0.00042 g in 1 ml / syncephalastrum racemosum 0.00042 g in 1 ml / tetracoccosporium paxianum 0.00042 g in 1 ml / verticillium albo-atrum 0.00042 g in 1 ml / ustilago cynodontis 0.0025 g in 1 ml / sporisorium cruentum 0.0025 g in 1 ml / canis lupus familiaris hair 0.005 g in 1 ml / felis catus hair 500 [bau] in 1 ml subcutaneous injection, solution||pleospora herbarum||active_ingredient_of
ferrous sulfate, 325 mg oral tablet||product containing ferrous sulfate (medicinal product)||active_ingredient_of
metoprolol-hydrochlorothiazide||hidroclorotiazida||active_ingredient_of
roweepra 500 mg oral tablet||spritam||active_ingredient_of
menthol 5.8 oral lozenge [cherry cough drops]||menthol||active_ingredient_of
dasiglucagon 0.6 mg/0.6 ml subcutaneous solution [zegalogue]_#1||antidiabetics dasiglucagon||active_ingredient_of
dexamethasone sodium phosphate 10mg injection solution vial (product)||dexamethasone sodium phosphate [musculoskeletal use]||active_ingredient_of
benzocaine 20 % oral gel||benzocainum||active_ingredient_of
acetaminophen 325 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [sinus congestion and pain]||4-hydroxyacetanilide||active_ingredient_of
aluminum oxide 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / calcium iodide 10 [hp_x] in 59 ml / lytta vesicatoria 10 [hp_x] in 59 ml / centaurea benedicta 10 [hp_x] in 59 ml / silybum marianum seed 10 [hp_x] in 59 ml / chelidonium majus 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / cynara scolymus leaf 10 [hp_x] in 59 ml / dioscorea villosa tuber 10 [hp_x] in 59 ml / calcium sulfide 10 [hp_x] in 59 ml / iris versicolor root 10 [hp_x] in 59 ml / juniper berry 10 [hp_x] in 59 ml / potassium iodide 10 [hp_x] in 59 ml / mercury 10 [hp_x] in 59 ml / mercuric chloride 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / ptelea trifoliata bark 10 [hp_x] in 59 ml / ricinus communis seed 10 [hp_x] in 59 ml / robinia pseudoacacia bark 10 [hp_x] in 59 ml / anguilla rostrata blood serum 10 [hp_x] in 59 ml / solidago virgaurea flowering top 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / sulfuric acid 10 [hp_x] in 59 ml / taraxacum officinale 10 [hp_x] in 59 ml oral liquid [total body detox]||potassium iodide||active_ingredient_of
(spl review) alcohol 75 ml in 100 ml topical gel [mosaic hand sanitizer]||alcohol (grain)||active_ingredient_of
avobenzone 16.2 mg in 1 ml / octisalate 40.5 mg in 1 ml / octocrylene 22.3 mg in 1 ml topical spray [australian gold broad spectrum spf 15]||octocrylene product||active_ingredient_of
titanium dioxide 0.732 mg in 3 g / zinc oxide 0.702 mg in 3 g topical powder [zo skin health sunscreen plus broad-spectrum spf 40 deep]||zincum oxydatum||active_ingredient_of
isopropyl alcohol 0.7 ml in 1 ml topical cloth [alcohol prep pad 70 isopropyl alcohol]||isopropyl alcohol||active_ingredient_of
potassium chloride 30meq/1l, dextrose 5%, sodium chloride 0.45% solution for injection||of potassium chloride||active_ingredient_of
chaste tree 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / gold 10 [hp_x] in 59 ml / sodium borate 10 [hp_x] in 59 ml / conium maculatum flowering top 10 [hp_x] in 59 ml / iron 10 [hp_x] in 59 ml / iodine 10 [hp_x] in 59 ml / lilium lancifolium whole flowering 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / palladium 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml oral liquid [ferticare]||lycopodium clavatum spore||active_ingredient_of
dextrose monohydrate 2.42 g in 110 ml / sodium chloride 990 mg in 110 ml / mannitol 825 mg in 110 ml / adenine 30 mg in 110 ml intravenous solution [adsol red cell preservation solution system]||monohydrate, glucose||active_ingredient_of
product containing precisely rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug)||rosuvastatin calcium||active_ingredient_of
quinine sulphate 324mg capsule||chininum sulphuricum||active_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / oxybenzone 60 mg in 1 ml / octocrylene 100 mg in 1 ml / octisalate 50 mg in 1 ml topical lotion [walmart equate beauty ultra light sunscreen spf 100]||3,3,5-trimethylcyclohexyl 2-hydroxybenzoate||active_ingredient_of
aconitum napellus 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / arnica montana 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / atropa belladonna 10 [hp_x] in 59 ml / bellis perennis 10 [hp_x] in 59 ml / bryonia alba root 10 [hp_x] in 59 ml / calendula officinalis flowering top 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / clematis recta flowering top 10 [hp_x] in 59 ml / clematis vitalba flower 10 [hp_x] in 59 ml / ferrosoferric phosphate 10 [hp_x] in 59 ml / histamine dihydrochloride 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / impatiens glandulifera flower 10 [hp_x] in 59 ml / ornithogalum umbellatum flowering top 10 [hp_x] in 59 ml / passiflora incarnata flowering top 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / prunus cerasifera flower 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / comfrey root 10 [hp_x] in 59 ml / veratrum album root 10 [hp_x] in 59 ml oral liquid [serenity remedy no. 12]||bellis perennis whole||active_ingredient_of
heparin sodium 5000 units in 1 milliliter subcutaneous injection, solution||heparin sodium||active_ingredient_of
health mart children's ibuprofen 100mg/5ml suspension (grape)||benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-||active_ingredient_of
product containing only droperidol (medicinal product)||2h-benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-||active_ingredient_of
aconitum napellus 200 [hp_c] in 15 ml / onion 30 [hp_c] in 15 ml / silver nitrate 6 [hp_c] in 15 ml / arnica montana 6 [hp_c] in 15 ml / arsenic trioxide 1 [hp_m] in 15 ml / ferula assa-foetida resin 30 [hp_c] in 15 ml / asclepias tuberosa root 4 [hp_x] in 15 ml / gold 30 [hp_c] in 15 ml / berberis vulgaris root bark 4 [hp_x] in 15 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 15 ml / calcium fluoride 12 [hp_x] in 15 ml / tribasic calcium phosphate 30 [hp_c] in 15 ml / calcium sulfate anhydrous 30 [hp_c] in 15 ml / matricaria chamomilla 30 [hp_c] in 15 ml / quinine arsenite 6 [hp_c] in 15 ml / echinacea angustifolia 4 [hp_x] in 15 ml / euphrasia stricta 4 [hp_x] in 15 ml / ferrosoferric phosphate 12 [hp_x] in 15 ml / gelsemium sempervirens root 6 [hp_c] in 15 ml / hekla lava 12 [hp_x] in 15 ml / calcium sulfide 6 [hp_c] in 15 ml / goldenseal 5 [hp_x] in 15 ml / potassium dichromate 6 [hp_c] in 15 ml / potassium chloride 4 [hp_x] in 15 ml / potassium sulfate 4 [hp_x] in 15 ml / lachesis muta venom 200 [hp_c] in 15 ml / lycopodium clavatum spore 30 [hp_c] in 15 ml / mercurius solubilis 6 [hp_c] in 15 ml / mercuric sulfide 12 [hp_x] in 15 ml / sodium chloride 4 [hp_x] in 15 ml / sodium sulfate 6 [hp_c] in 15 ml / nitric acid 12 [hp_x] in 15 ml / phosphorus 30 [hp_c] in 15 ml / anemone pratensis 6 [hp_c] in 15 ml / rancid beef 1 [hp_m] in 15 ml / toxicodendron pubescens leaf 30 [hp_c] in 15 ml / schoenocaulon officinale seed 30 [hp_c] in 15 ml / sambucus nigra flowering top 4 [hp_x] in 15 ml / silicon dioxide 6 [hp_c] in 15 ml / sinusitisinum 30 [hp_c] in 15 ml / spigelia anthelmia 6 [hp_c] in 15 ml / sulfur 6 [hp_c] in 15 ml / comfrey root 6 [hp_x] in 15 ml / teucrium marum 6 [hp_c] in 15 ml / thuja occidentalis leafy twig 30 [hp_c] in 15 ml oral liquid [nose relief]||gelsemium sempervirens root||active_ingredient_of
methenamine/methylene blue/salicylate/sodium phos/hyoscyamin@81.6 mg-10.8 mg-36.2 mg-40.8 mg-0.12 mg@oral@tablet||levsin||active_ingredient_of
cinchona officinalis bark 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / nutmeg 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / gelsemium sempervirens root 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / lachesis muta venom 8 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / human herpesvirus 4 30 [hp_x] in 1 ml / human herpesvirus 3 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / poliovirus 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / hepatitis b virus 33 [hp_x] in 1 ml / human coxsackievirus b1 15 [hp_c] in 1 ml / human coxsackievirus b4 15 [hp_c] in 1 ml oral liquid [virosode]||golden seal root||active_ingredient_of
bambusa vulgaris whole 6 [hp_x] in 1 ml / viscum album fruiting top 6 [hp_x] in 1 ml / formica rufa 7 [hp_x] in 1 ml / tin 10 [hp_x] in 1 ml / equisetum arvense top 15 [hp_x] in 1 ml / bos taurus eye 8 [hp_x] in 1 ml oral liquid||stannum||active_ingredient_of
clematis vitalba flower 3 [hp_x] in 1 ml / helianthemum nummularium flower 3 [hp_x] in 1 ml / impatiens glandulifera flower 3 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 3 [hp_x] in 1 ml / passiflora incarnata flowering top 3 [hp_x] in 1 ml / angelica sinensis root 6 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / cocoa 6 [hp_x] in 1 ml / lithium carbonate 6 [hp_x] in 1 ml / prunus cerasifera flower 6 [hp_x] in 1 ml / valerian 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / semecarpus anacardium juice 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / strychnos ignatii seed 12 [hp_x] in 1 ml / macropiper methysticum root 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml oral liquid [anxious]||valerian root||active_ingredient_of
potassium gluconate 6 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / beef liver 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / peanut 12 [hp_x] in 1 ml / black walnut 12 [hp_x] in 1 ml / english walnut 12 [hp_x] in 1 ml / almond 12 [hp_x] in 1 ml / cashew 12 [hp_x] in 1 ml / coconut 12 [hp_x] in 1 ml / pecan 12 [hp_x] in 1 ml / brazil nut 12 [hp_x] in 1 ml / solanum lycopersicum 12 [hp_x] in 1 ml / potato 12 [hp_x] in 1 ml / black pepper 12 [hp_x] in 1 ml / eggplant 12 [hp_x] in 1 ml / levant cotton seed 12 [hp_x] in 1 ml / flax seed 12 [hp_x] in 1 ml / sesame seed 12 [hp_x] in 1 ml / casein, lactococcus lactis cultured 12 [hp_x] in 1 ml / cow milk 12 [hp_x] in 1 ml / beef 12 [hp_x] in 1 ml / lamb 12 [hp_x] in 1 ml / pork 12 [hp_x] in 1 ml / chicken 12 [hp_x] in 1 ml / egg 12 [hp_x] in 1 ml / kidney bean 12 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / malus pumila flower 12 [hp_x] in 1 ml / wheat 12 [hp_x] in 1 ml / banana 12 [hp_x] in 1 ml / alpine strawberry 12 [hp_x] in 1 ml / orange 12 [hp_x] in 1 ml / cod, unspecified 12 [hp_x] in 1 ml / tuna, unspecified 12 [hp_x] in 1 ml / salmon, unspecified 12 [hp_x] in 1 ml / limulus polyphemus 12 [hp_x] in 1 ml / oyster, unspecified 12 [hp_x] in 1 ml / shrimp, unspecified 12 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / histamine dihydrochloride 30 [hp_x] in 1 ml / hyaluronidase 30 [hp_x] in 1 ml / interferon .gamma. porcine recombinant 30 [hp_x] in 1 ml / serotonin hydrochloride 30 [hp_x] in 1 ml oral liquid [allergen i]||casein, lactococcus lactis cultured||active_ingredient_of
titanium dioxide 63 mg in 1 ml / zinc oxide 63 mg in 1 ml topical liquid [pur air perfection cc cushion foundation broad spectrum spf 50 plus (light)]||mineral supplements zinc oxide||active_ingredient_of
alcohol 62 ml in 100 ml topical gel [anti-bac hand sanitizer strawberry scented]||grain alcohol||active_ingredient_of
loteprednol etabonate 0.5% ophthalmic suspension||chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate||active_ingredient_of
calamine and dibrompropamidine only product||calamine||active_ingredient_of
alcohol 0.7 ml in 1 ml topical gel [germ shark lemon scented hand sanitizer gel]||spiritus vini||active_ingredient_of
allium cepa whole 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / alfalfa 12 [hp_x] in 1 ml / amaranthus palmeri pollen 12 [hp_x] in 1 ml / bambusa vulgaris leaf 12 [hp_x] in 1 ml / agrimonia eupatoria flowering top 12 [hp_x] in 1 ml / taraxacum officinale 12 [hp_x] in 1 ml / solidago canadensis flowering top 12 [hp_x] in 1 ml / poa pratensis pollen 12 [hp_x] in 1 ml / chenopodium album pollen 12 [hp_x] in 1 ml / iva annua pollen 12 [hp_x] in 1 ml / festuca pratensis pollen 12 [hp_x] in 1 ml / artemisia vulgaris pollen 12 [hp_x] in 1 ml / dactylis glomerata pollen 12 [hp_x] in 1 ml / lolium perenne pollen 12 [hp_x] in 1 ml / red clover 12 [hp_x] in 1 ml / agrostis gigantea pollen 12 [hp_x] in 1 ml / amaranthus retroflexus pollen 12 [hp_x] in 1 ml / artemisia tridentata pollen 12 [hp_x] in 1 ml / amaranthus spinosus pollen 12 [hp_x] in 1 ml / anthoxanthum odoratum pollen 12 [hp_x] in 1 ml / phleum pratense pollen 12 [hp_x] in 1 ml / ambrosia psilostachya pollen 12 [hp_x] in 1 ml / trifolium repens flower 12 [hp_x] in 1 ml / rumex crispus pollen 12 [hp_x] in 1 ml / iva angustifolia pollen 12 [hp_x] in 1 ml / oxalis montana leaf 12 [hp_x] in 1 ml oral liquid [weed grass antigens]||allergenic extract, pigweed, spiny||active_ingredient_of
dexamethasone 0.1 % / tobramycin 0.3 % ophthalmic suspension||product containing tobramycin (medicinal product)||active_ingredient_of
product containing only praziquantel (medicinal product)||product containing praziquantel||active_ingredient_of
laverdia 10 mg oral tablet||laverdia||active_ingredient_of
diclofenac potassium 50 mg oral tablet, film coated||diclofenac potassium [dup] (substance)||active_ingredient_of
protonix, 40 mg oral delayed release tablet||pantoprazole sodium||active_ingredient_of
product containing only metamfetamine hydrochloride 5 mg/1 each oral tablet||methamphetamine hydrochloride (medication)||active_ingredient_of
hydroquinone microspheres 4 % topical cream, er multiphase in pump (gram)||hydroquinone||active_ingredient_of
dieffenbachia seguine 6 [hp_x] / daphne odora bark 12 [hp_x] / graphite 12 [hp_x] / valerian 6 [hp_x] sublingual tablet [smoke free]||natural graphite (substance)||active_ingredient_of
zinc oxide 126 mg in 1 ml topical lotion [sunnydays broad spectrum spf 30 tinted sunscreen 40 runyon]||zinc óxido||active_ingredient_of
sodium chloride 600 mg in 100 ml / potassium chloride 30 mg in 100 ml / calcium chloride 20 mg in 100 ml / sodium lactate 310 mg in 100 ml intravenous solution [gms electrolyte solution compound sodium lactate hartmanns]||product containing potassium chloride||active_ingredient_of
clotrimazole 10 mg in 1 g topical cream [sunmark clotrimazole]||clotrimazole (substance)||active_ingredient_of
homosalate 6 mg in 1 g / octinoxate 7.5 mg in 1 g / octisalate 5 mg in 1 g / oxybenzone 5 mg in 1 g topical lotion [sunscreen]||oxybenzonum||active_ingredient_of
uni-buff, buffered 325 mg oral tablet||aspirina||active_ingredient_of
nifedipine (mylan-xl) 90mg sa tab||nifedipine product||active_ingredient_of
eszopiclone@2 mg@oral@tablet||eszopiclone (medication)||active_ingredient_of
camphor (synthetic) 40 mg in 1 g / menthol, unspecified form 100 mg in 1 g / methyl salicylate 300 mg in 1 g topical cream [walgreens muscle rub ulra strength]||natural camphor||active_ingredient_of
clobetasone only product||cloburate||active_ingredient_of
naproxen sodium 220 mg oral tablet [flanax pain and fever reliever]||naproxen sodium (substance)||active_ingredient_of
benzalkonium chloride 0.1 u in 100 u topical cloth [hops antibacterial wet wipes]||chloride, benzalkonium||active_ingredient_of
diclofenac na 75mg tab,ec,ud||diclofenac sodium 2 (substance)||active_ingredient_of
product containing only gabapentin 400 mg/1 each oral capsule (clinical drug)||gabapentin (product)||active_ingredient_of
doxepin 25 mg oral capsule||sinquan||active_ingredient_of
arsenic trioxide 12 [hp_x] in 30 ml / echinacea, unspecified 3 [hp_x] in 30 ml / gelsemium sempervirens root 12 [hp_x] in 30 ml / strychnos nux-vomica seed 12 [hp_x] in 30 ml / lycopodium clavatum spore 12 [hp_x] in 30 ml / atropa belladonna 12 [hp_x] in 30 ml / rancid beef 30 [hp_x] in 30 ml / toxicodendron pubescens leaf 30 [hp_x] in 30 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 30 ml / baptisia tinctoria 3 [hp_x] in 30 ml / phosphorus 12 [hp_x] in 30 ml / foscolic acid 12 [hp_x] in 30 ml oral liquid [virex]||foscolic acid||active_ingredient_of
aralia racemosa root 30 [hp_c] oral pellet [aralia racemosa]||aralia racemosa root extract||active_ingredient_of
benzoic acid 3 [hp_x] in 1 ml / pulsatilla vulgaris 3 [hp_x] in 1 ml / rhododendron aureum leaf 3 [hp_x] in 1 ml / filipendula ulmaria root 3 [hp_x] in 1 ml / aconitum napellus 4 [hp_x] in 1 ml / solanum dulcamara top 4 [hp_x] in 1 ml / euphorbia resinifera resin 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / asclepias tuberosa root 6 [hp_x] in 1 ml / lithium benzoate 8 [hp_x] in 1 ml oral liquid [rheumatism]||benzoic||active_ingredient_of
aconitum napellus 20 [hp_x] in 1 ml / ammonium benzoate 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / benzoic acid 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / causticum 20 [hp_x] in 1 ml / cinchona officinalis bark 20 [hp_x] in 1 ml / colchicum autumnale bulb 20 [hp_x] in 1 ml / pseudognaphalium obtusifolium 20 [hp_x] in 1 ml / iris versicolor root 20 [hp_x] in 1 ml / potassium iodide 20 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 20 [hp_x] in 1 ml / lithium carbonate 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / phytolacca americana root 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / ruta graveolens flowering top 20 [hp_x] in 1 ml / sambucus nigra flowering top 20 [hp_x] in 1 ml / strychnine 20 [hp_x] in 1 ml / hypericum perforatum 11 [hp_x] in 1 ml / urtica urens 11 [hp_x] in 1 ml oral liquid [sciatica-back care]||ruta graveolens flowering top||active_ingredient_of
pyridoxine hydrochloride 20 mg / selenium 55 ug / folic acid 1000 ug / magnesium oxide 200 mg / molybdenum 45 ug / thiamine mononitrate 3 mg / cyanocobalamin 8 ug / chromium nicotinate 35 ug / cholecalciferol 20 ug / riboflavin 3.4 mg / niacinamide 20 mg / zinc oxide 25 mg / calcium carbonate 200 mg / ascorbic acid 120 mg / manganese sulfate 2.3 mg / .alpha.-tocopherol acetate, dl- 30 mg / vitamin a acetate 1500 ug oral tablet [vitranol]||dl-.alpha.-tocopheryl acetate||active_ingredient_of
omeprazole 20mg sa cap||product containing omeprazole (medicinal product)||active_ingredient_of
xylometazoline-containing product in nasal dose form||xylometazoline (substance)||active_ingredient_of
niacinamide 0.60 g in 30 g / adenosine 0.01 g in 30 g topical cream [prestige shiny gold]||nicotinamide (substance)||active_ingredient_of
alcohol 70 g in 100 ml topical gel [beautaime hand doctor a]||alcohol||active_ingredient_of
arsenic trioxide 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / alternaria alternata 12 [hp_x] in 1 ml / aspergillus niger var. niger 12 [hp_x] in 1 ml / rhizopus stolonifer 12 [hp_x] in 1 ml / mucor racemosus 12 [hp_x] in 1 ml / aureobasidium pullulans var. pullutans 12 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml / candida parapsilosis 12 [hp_x] in 1 ml / saccharomyces cerevisiae 12 [hp_x] in 1 ml oral liquid [mold antigens]||alternaria alternata||active_ingredient_of
arsenic trioxide 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / sepia officinalis juice 30 [hp_x] in 1 ml / alternaria alternata 200 [hp_x] in 1 ml / aspergillus niger var. niger 200 [hp_x] in 1 ml / rhizopus stolonifer 200 [hp_x] in 1 ml / mucor racemosus 200 [hp_x] in 1 ml / aureobasidium pullulans var. pullutans 200 [hp_x] in 1 ml / candida albicans 200 [hp_x] in 1 ml / candida parapsilosis 200 [hp_x] in 1 ml / saccharomyces cerevisiae rna 200 [hp_x] in 1 ml oral liquid [mold antigens]||mycocandida parapsilosis||active_ingredient_of
matricaria chamomilla 6 [hp_x] in 1 g / sodium carbonate 15 [hp_x] in 1 g / iris versicolor root 6 [hp_x] in 1 g / ruta graveolens flowering top 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / aloe 15 [hp_x] in 1 g / angelica sinensis root 15 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / baptisia tinctoria 15 [hp_x] in 1 g / bismuth 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / goldenseal 15 [hp_x] in 1 g / ipecac 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / myrrh 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / ginger 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g oral pellet [tummy upset]||myrrh||active_ingredient_of
alcohol 62 ml in 100 ml topical gel [careone instant hand sanitizer with aloe and vitamin e]||ethyl alcohol product||active_ingredient_of
calcium fluoride 15 [hp_x] in 1 ml / tribasic calcium phosphate 15 [hp_x] in 1 ml / calcium sulfate anhydrous 15 [hp_x] in 1 ml / ferrosoferric phosphate 15 [hp_x] in 1 ml / potassium chloride 15 [hp_x] in 1 ml / dibasic potassium phosphate 15 [hp_x] in 1 ml / potassium sulfate 15 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 15 [hp_x] in 1 ml / sodium sulfate 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml oral liquid [cell salts]||muriate of potash||active_ingredient_of
dexamethasone sodium phospha 4mg/ml injection (product)||dexamethasone sod phos [mskel]||active_ingredient_of
lidocaine/prilocaine 2.5%-2.5% topical application cream [relador pak plus]||alpha-diethylamino-2,6-dimethylacetanilide||active_ingredient_of
product containing only gentamicin and hydrocortisone (medicinal product)||gentamicins (medication)||active_ingredient_of
pregabalin 100mg cap,ud||3-(aminomethyl)-5-methyl-hexanoic acid||active_ingredient_of
arnica montana root 2 [hp_x] in 2.2 ml / atropa belladonna 2 [hp_x] in 2.2 ml / calendula officinalis flowering top 2 [hp_x] in 2.2 ml / matricaria recutita 3 [hp_x] in 2.2 ml / achillea millefolium 3 [hp_x] in 2.2 ml / calcium sulfide 6 [hp_x] in 2.2 ml / comfrey root 6 [hp_x] in 2.2 ml / aconitum napellus 2 [hp_x] in 2.2 ml / bellis perennis 2 [hp_x] in 2.2 ml / mercurius solubilis 6 [hp_x] in 2.2 ml / hypericum perforatum 2 [hp_x] in 2.2 ml / echinacea, unspecified 2 [hp_x] in 2.2 ml / echinacea purpurea 2 [hp_x] in 2.2 ml / hamamelis virginiana root bark/stem bark 1 [hp_x] in 2.2 ml intra-articular injection [traumeel]||bellis perennis whole||active_ingredient_of
paramethadione only product||parametadiona||active_ingredient_of
octinoxate 0.3 g in 6 ml / titanium dioxide 0.2328 g in 6 ml topical cream [age20s jericho rose tone essential uv primer pale lavender]||matmate||active_ingredient_of
garlic 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / fucus vesiculosus 3 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml oral liquid [dentastat]||phytolacca americana root extract||active_ingredient_of
product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)||product containing paracetamol (medicinal product)||active_ingredient_of
spearmint 0.05 g in 1 ml intradermal injection, solution||mentha viridis allergenic extract||active_ingredient_of
cotton seed 0.05 g in 1 ml intradermal injection, solution||cotton seed allergenic extract||active_ingredient_of
aconitum napellus 20 [hp_x] in 1 ml / apis mellifera 20 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / atropa belladonna 20 [hp_x] in 1 ml / bellis perennis 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / calendula officinalis flowering top 20 [hp_x] in 1 ml / matricaria recutita 20 [hp_x] in 1 ml / helianthemum canadense 20 [hp_x] in 1 ml / ferrosoferric phosphate 20 [hp_x] in 1 ml / histamine dihydrochloride 20 [hp_x] in 1 ml / hypericum perforatum 20 [hp_x] in 1 ml / strychnos ignatii seed 20 [hp_x] in 1 ml / daphne mezereum bark 20 [hp_x] in 1 ml / ornithogalum umbellatum 20 [hp_x] in 1 ml / passiflora incarnata flowering top 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / prunus spinosa flower bud 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / lactic acid, l- 20 [hp_x] in 1 ml / sulfur 20 [hp_x] in 1 ml / veratrum album root 20 [hp_x] in 1 ml / valerian 8 [hp_x] in 1 ml oral liquid [panic ease]||belladonna preparation (substance)||active_ingredient_of
hydrocodone bitartrate 20 mg oral capsule, extended release [zohydro er]||hydrocodone bitartrate (product)||active_ingredient_of
avobenzone 25.6 mg in 1 ml / homosalate 63.9 mg in 1 ml / octisalate 42.7 mg in 1 ml / octocrylene 23.5 mg in 1 ml / oxybenzone 17.1 mg in 1 ml topical spray [solmate broad spectrum spf 30]||2-hydroxy-4-methoxybenzophenone,[2-hydroxy-4-methoxyphenyl]phenylmethanone||active_ingredient_of
isopropyl alcohol 70 ml in 100 ml topical cloth||2-propanol||active_ingredient_of
amanita muscaria fruiting body 12 [hp_x] in 1 ml / protortonia cacti 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / gelsemium sempervirens root 30 [hp_x] in 1 ml / influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / latrodectus mactans 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / citharacanthus spinicrus 30 [hp_x] in 1 ml / botulinum toxin type a 30 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_x] in 1 ml / pseudomonas aeruginosa 30 [hp_x] in 1 ml / proteus morganii 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / clostridium perfringens 15 [hp_c] in 1 ml / human herpesvirus 4 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / poliovirus 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [neurotox]||citharacanthus spinicrus preparation||active_ingredient_of
isopropyl alcohol 75 l in 100 l topical solution [chemsanitize 700]||rubbing alcohol (substance)||active_ingredient_of
namzaric 10mg/14mg 24hr sprinkle cap sa||aricept||active_ingredient_of
product containing precisely dicycloverine hydrochloride 10 milligram/1 each conventional release oral capsule||hydrochloride, dicyclomine||active_ingredient_of
cyclobenzaprine hcl 7.5 mg oral tablet||cyclobenzaprine hcl||active_ingredient_of
avobenzone 3 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 5 g in 100 ml topical emulsion [fevanzon polypeptide revitalizing essence emulsion]||benzoic acid, 2-hydroxy-, 2-ethylhexyl ester||active_ingredient_of
avobenzone 20 mg in 1 g / octinoxate 50 mg in 1 g / octisalate 30 mg in 1 g topical cream [sisleya global anti-age hand care spf 15]||butyl-methoxydibenzoylmethane||active_ingredient_of
garlic 2 [hp_x] in 1 ml / calendula officinalis flowering top 2 [hp_x] in 1 ml / sambucus nigra flowering top 3 [hp_x] in 1 ml / clematis recta flowering top 6 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / graphite 8 [hp_x] in 1 ml / kerosene 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / croton tiglium seed 12 [hp_x] in 1 ml / mercuric sulfide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml oral liquid [herpes simplex plus]||kerosine||active_ingredient_of
product containing benzfetamine 50 mg/1 each oral tablet (clinical drug)||benzfetamine hydrochloride||active_ingredient_of
baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / borrelia burgdorferi 12 [hp_x] in 1 ml / japanese encephalitis virus 12 [hp_x] in 1 ml / neisseria meningitidis 15 [hp_x] in 1 ml / hepatitis b virus 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / bryonia alba root 30 [hp_c] in 1 ml / chelidonium majus 30 [hp_c] in 1 ml / colchicum autumnale bulb 30 [hp_c] in 1 ml / kalmia latifolia leaf 30 [hp_c] in 1 ml / ledum palustre twig 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / toxicodendron pubescens leaf 30 [hp_c] in 1 ml oral liquid [lyme hp]||echinacea angustifolia||active_ingredient_of
apis mellifera 6 [hp_x] in 50 ml / tribasic calcium phosphate 12 [hp_x] in 50 ml / solanum dulcamara top 6 [hp_x] in 50 ml / equisetum hyemale 4 [hp_x] in 50 ml / ferrous iodide 12 [hp_x] in 50 ml / fumaria officinalis flowering top 4 [hp_x] in 50 ml / gentiana lutea root 5 [hp_x] in 50 ml / geranium robertianum 4 [hp_x] in 50 ml / potassium iodide 8 [hp_x] in 50 ml / sodium sulfate 3 [hp_x] in 50 ml / pinus sylvestris leafy twig 4 [hp_x] in 50 ml / smilax ornata root 6 [hp_x] in 50 ml / scrophularia nodosa 3 [hp_x] in 50 ml / lobaria pulmonaria 5 [hp_x] in 50 ml / teucrium scorodonia flowering top 3 [hp_x] in 50 ml / veronica officinalis flowering top 3 [hp_x] in 50 ml oral liquid [bodyanew lymph lungs]||teucrium scorodonia flowering top||active_ingredient_of
homosalate 15 ml in 100 ml / octisalate 5 ml in 100 ml / octocrylene 7 ml in 100 ml / avobenzone 3 ml in 100 ml topical spray [ocean potion instant dry 50 mist kids sunscreen]||2-ethylhexyl 2-cyano-3,3-diphenyl-2-propenoate||active_ingredient_of
norethindrone acetate 1 mg / ethinyl estradiol 0.02 mg oral tablet [microgestin 24 fe]||product containing norethisterone acetate||active_ingredient_of
health mart calcium antacid extra strength 750mg chewable tablet (assorted berry)||calcium carbonate (1:1)||active_ingredient_of
sulfurous acid 30 [hp_c] in 1 ml oral liquid [sulphurosum acidum]||sulfurous acid||active_ingredient_of
chondrodendron tomentosum root 8 [hp_x] in 1 ml / petroselinum crispum whole 3 [hp_x] in 1 ml / smilax ornata root 3 [hp_x] in 1 ml / pork kidney 6 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / rubia tinctorum root 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / elymus repens root 12 [hp_x] in 1 ml oral liquid [renapar]||smilax ornata root extract||active_ingredient_of
methoxsalen injectable product||8-methoxy-4',5':6,7-furocoumarin||active_ingredient_of
triticum aestivum whole 1 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / frangula alnus bark 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / stillingia sylvatica root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / zanthoxylum americanum bark 3 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / salicylic acid 30 [hp_x] in 1 ml / corticotropin 30 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / eugenol 30 [hp_x] in 1 ml / stearyl alcohol 30 [hp_x] in 1 ml / xylitol 30 [hp_x] in 1 ml / estrone 30 [hp_x] in 1 ml / benzoic acid 30 [hp_x] in 1 ml / chlorine 30 [hp_x] in 1 ml / potassium sorbate 30 [hp_x] in 1 ml / sorbitol 30 [hp_x] in 1 ml / resorcinol 30 [hp_x] in 1 ml / benzyl alcohol 30 [hp_x] in 1 ml / lactic acid, dl- 30 [hp_x] in 1 ml / isopropyl palmitate 30 [hp_x] in 1 ml / boric acid 30 [hp_x] in 1 ml / acetic acid 30 [hp_x] in 1 ml / phenylbutazone 30 [hp_x] in 1 ml / petrolatum 30 [hp_x] in 1 ml / lead 30 [hp_x] in 1 ml oral liquid [chemtox]||hexadecanoic acid 1-methylethyl ester||active_ingredient_of
alfalfa 10 [hp_x] in 59 ml / avena sativa flowering top 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / barium iodide 10 [hp_x] in 59 ml / barium chloride dihydrate 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / calcium fluoride 10 [hp_x] in 59 ml / tribasic calcium phosphate 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / thuja occidentalis leafy twig 10 [hp_x] in 59 ml oral liquid [childrens growth and development]||thuja occidentalis twig||active_ingredient_of
alpha-tocopherol acetate 1.4 mg/ml / vit-c 16 mg/ml / biotin 0.004 mg/ml / dexpanthenol 1 mg/ml / vit-d 0.002 mg/ml / folate 0.028 mg/ml / niacinamide 3.4 mg/ml / vit-b6 hydrochloride 0.2 mg/ml / riboflavin 0.28 mg/ml / vit-b1 hydrochloride 0.24 mg/ml / vitamin a 0.14 mg/ml / vitamin b12 0.0002 mg/ml / vitamin k1 0.04 mg/ml injectable solution||ascorbic acid [urine ph - no drugs here] (product)||active_ingredient_of
atractylodes lancea root 2 g in 100 g / citrus aurantium fruit 1 g in 100 g / prunus persica leaf 2 g in 100 g / chenopodium album whole 52 g in 100 g / salix alba bark 2 g in 100 g / morus alba stem 2 g in 100 g / frankincense 1 g in 100 g / inula helenium root 2 g in 100 g / forsythia suspensa fruit 2 g in 100 g / myrrh 1 g in 100 g / prunus persica seed 1 g in 100 g / sulfur 1 g in 100 g / lonicera dasystyla flower bud 2 g in 100 g / purslane 3 g in 100 g / lead tetroxide 33 g in 100 g topical ointment [band leemyungnae goyak]||lonicera dasystyla flower bud||active_ingredient_of
oxytocin 2 [usp'u] in 100 ml intravenous injection, solution||oxytocin preparation (substance)||active_ingredient_of
urea formaldehyde resin only product||urea formaldehyde resin-containing product||active_ingredient_of
felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / alternaria alternata 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml intradermal injection, solution||canis lupus familiaris hair extract||active_ingredient_of
alcohol 80 ml in 100 ml topical liquid [dr. wrights antiseptic hand sanitizer]||1-hydroxyethane||active_ingredient_of
cod liver oil only product||oil, cod liver||active_ingredient_of
octinoxate 4.08 mg in 60 ml / octisalate 2.70 mg in 60 ml / zinc oxide 8.06 mg in 60 ml / titanium dioxide 2.92 mg in 60 ml topical cream [atomy sunscreen white broad spectrum spf50 plus]||salicylic acid 2-ethylhexyl ester||active_ingredient_of
vitamin a acetate 2000 [iu] / beta carotene 2000 [iu] / ascorbic acid 120 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, dl- 9.9 mg / thiamine mononitrate 1.84 mg / riboflavin 3 mg / niacinamide 20 mg / pyridoxine hydrochloride 10 mg / folic acid 1 mg / cyanocobalamin 12 ug / calcium carbonate 200 mg / ferrous fumarate 27 mg / zinc oxide 25 mg / cupric oxide 2 mg oral tablet [westab plus]||product containing thiamine mononitrate||active_ingredient_of
epinephrine 6 [hp_x] in 1 ml / dibasic potassium phosphate 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphoric acid 30 [hp_x] in 1 ml / turnera diffusa leafy twig 1 [hp_x] in 1 ml / balsam peru 9 [hp_x] in 1 ml / quinine arsenite 12 [hp_x] in 1 ml / clematis vitalba flower 8 [hp_c] in 1 ml / carpinus betulus flower 8 [hp_c] in 1 ml / glycyrrhiza glabra 1 [hp_x] in 1 ml / impatiens glandulifera flower 8 [hp_c] in 1 ml / helianthemum nummularium flower 8 [hp_c] in 1 ml / selenium 15 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 8 [hp_c] in 1 ml / thyroid, unspecified 6 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / bos taurus pituitary gland, posterior 15 [hp_x] in 1 ml / olea europaea flower 8 [hp_c] in 1 ml / prunus cerasifera flower 8 [hp_c] in 1 ml / cinchona officinalis bark 12 [hp_x] in 1 ml / acetic acid 30 [hp_x] in 1 ml / american ginseng 2 [hp_x] in 1 ml / arnica montana 12 [hp_x] in 1 ml sublingual solution/ drops [b02 adrenal pep]||bos taurus pituitary gland preparation||active_ingredient_of
alcohol 70 ml in 100 ml topical gel [eqo gel]||etoh||active_ingredient_of
matricaria recutita 3 [hp_x] in 1 ml / black cohosh 3 [hp_x] in 1 ml / cinchona officinalis bark 3 [hp_x] in 1 ml / saffron 3 [hp_x] in 1 ml / chamaelirium luteum root 3 [hp_x] in 1 ml / mentha piperita 3 [hp_x] in 1 ml / senna leaf 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / viola odorata 3 [hp_x] in 1 ml / chaste tree 4 [hp_x] in 1 ml / convallaria majalis 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / lilium lancifolium whole flowering 4 [hp_x] in 1 ml / delphinium staphisagria seed 4 [hp_x] in 1 ml / cyclamen purpurascens tuber 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / cinnamon 12 [hp_x] in 1 ml / hexaplex trunculus hypobranchial gland juice 12 [hp_x] in 1 ml / naja naja venom 15 [hp_x] in 1 ml oral liquid [female support]||extract valerian||active_ingredient_of
podophyllum 5 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / niacinamide 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / colchicum autumnale bulb 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / bilberry 8 [hp_x] in 1 ml / norepinephrine 8 [hp_x] in 1 ml / aspirin 10 [hp_x] in 1 ml / adenosine triphosphate disodium 10 [hp_x] in 1 ml / anthraquinone 10 [hp_x] in 1 ml / histamine dihydrochloride 10 [hp_x] in 1 ml / magnesium gluconate 10 [hp_x] in 1 ml / nadide 10 [hp_x] in 1 ml / naphthoquine 10 [hp_x] in 1 ml / ubidecarenone 10 [hp_x] in 1 ml / pantothenic acid 10 [hp_x] in 1 ml / manganese phosphate, dibasic 15 [hp_x] in 1 ml / hydroquinone 3 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [bio cytotox phase]||vitamin b1 hydrochloride||active_ingredient_of
hypam 25 mg oral capsule||pamoate, hydroxyzine||active_ingredient_of
alcohol 700 mg in 1 ml topical liquid [sierra soft alcohol hand sanitizer]||äthanol||active_ingredient_of
triticum aestivum whole 1 [hp_x] in 1 ml / cajuput oil 1 [hp_x] in 1 ml / baptisia tinctoria 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / frasera caroliniensis root 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / senna leaf 3 [hp_x] in 1 ml / wormwood 6 [hp_x] in 1 ml / beef liver 8 [hp_x] in 1 ml / bos taurus spleen 8 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / cinchona officinalis bark 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / amoeba proteus 8 [hp_c] in 1 ml / giardia lamblia 9 [hp_c] in 1 ml oral liquid [amoebasode]||baptisia tinctoria||active_ingredient_of
dexamethasone 0.001 mg/mg / neomycin 0.0035 mg/mg / polymyxin b 10 unt/mg ophthalmic ointment [ocu-trol]||polymyxin b sulf [eye] (product)||active_ingredient_of
product containing only clonazepam 1 mg/1 each oral tablet (clinical drug)||clonazepam [status epilepsy] (product)||active_ingredient_of
aloe 15 [hp_x] in 1 g / silver nitrate 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / benzoic acid 15 [hp_c] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / causticum 15 [hp_x] in 1 g / equisetum hyemale 15 [hp_x] in 1 g / iron 15 [hp_x] in 1 g / gelsemium sempervirens root 15 [hp_x] in 1 g / strychnos ignatii seed 15 [hp_x] in 1 g / potassium phosphate, dibasic 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / sodium chloride 15 [hp_x] in 1 g / nitric acid 15 [hp_x] in 1 g / plantago major 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / rhus aromatica root bark 15 [hp_x] in 1 g / saw palmetto 15 [hp_x] in 1 g / claviceps purpurea sclerotium 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g / delphinium staphisagria seed 15 [hp_x] in 1 g / datura stramonium 15 [hp_x] in 1 g / thyroid, unspecified 15 [hp_x] in 1 g / verbascum thapsus 15 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g / goldenseal 3 [hp_x] in 1 g oral pellet [incontinence]||potassium phosphate,dibasic||active_ingredient_of
oyster shell calcium carbonate, crude 12 [hp_x] in 59 ml / causticum 12 [hp_x] in 59 ml / chloramphenicol 12 [hp_x] in 59 ml / colchicum autumnale bulb 12 [hp_x] in 59 ml / gamboge 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / goldenseal 12 [hp_x] in 59 ml / ichthammol 12 [hp_x] in 59 ml / egg phospholipids 12 [hp_x] in 59 ml / egg shell, cooked 12 [hp_x] in 59 ml / egg shell membrane 12 [hp_x] in 59 ml / pulsatilla vulgaris 12 [hp_x] in 59 ml / rancid beef 12 [hp_x] in 59 ml oral liquid [eggs and meats intolerances]||colchicum autumnale bulb extract||active_ingredient_of
daclizumab injectable product||product containing daclizumab||active_ingredient_of
chondrus crispus 3 [hp_x] in 1 ml / glycyrrhiza glabra 3 [hp_x] in 1 ml / smilax regelii root 3 [hp_x] in 1 ml / ginger 3 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / aralia racemosa root 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / lytta vesicatoria 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / sodium carbonate 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml oral liquid [allerforce]||onion allergenic extract||active_ingredient_of
alcohol 480 ml in 160 extracorporeal cloth||ethanol-containing product||active_ingredient_of
product containing aspirin and methocarbamol in oral dose form (medicinal product form)||methocarbamol (product)||active_ingredient_of
product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)||6α-fluorotriamcinolone acetonide||active_ingredient_of
ropinirole hydrochloride 0.25 mg oral tablet [ropinirole hydrochloride]||ropinirole hydrochloride [dup] (substance)||active_ingredient_of
hydroxyzine pamoate 25mg cap||ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compound with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid)(1:1)||active_ingredient_of
flupentixol + melitracen||melitracen (substance)||active_ingredient_of
dronabinol 10 mg oral capsule||tetrahydrocannabinol (substance)||active_ingredient_of
product containing ethinylestradiol 0.03 milligram and levonorgestrel 0.15 milligram/1 each oral tablet (clinical drug)||ethynylestradiol||active_ingredient_of
furazolidone 1 g in 1 g not applicable powder||furazolidone (product)||active_ingredient_of
product containing ascorbic acid and ferrous gluconate and folic acid in oral dose form (medicinal product form)||folsäure||active_ingredient_of
oxygen 99 l in 99 l respiratory (inhalation) gas||o 2||active_ingredient_of
kaolin 0.145 mg/mg / zinc oxide 0.25 mg/mg topical ointment||zinc óxido||active_ingredient_of
pancreatic alpha-amylase 30 [kp_c] in 1 ml / cellulase (trichoderma longibrachiatum) 30 [kp_c] in 1 ml / lactase 30 [kp_c] in 1 ml / pancreatic triacylglycerol lipase 30 [kp_c] in 1 ml / lysosomal alpha-glucosidase 30 [kp_c] in 1 ml / pancrelipase protease 30 [kp_c] in 1 ml / sacrosidase 30 [kp_c] in 1 ml topical spray [viatrexx-enzyme plus]||cellulase (trichoderma longibrachiatum)||active_ingredient_of
product containing precisely propranolol hydrochloride 10 milligram/1 each conventional release oral tablet||hydrochloride, propranolol||active_ingredient_of
calcium carbonate 1000 mg oral tablet, chewable [qc antacid calcium assorted berry]||calcium carbonate (medication)||active_ingredient_of
alcohol 65 ml in 100 ml topical gel [laura ashley antibacterial hand sanitizer cotton blossom scented with vitamin e and aloe vera]||bd persist||active_ingredient_of
avobenzone 3 g in 1 ml / octisalate 5 g in 1 ml / homosalate 10 g in 1 ml / octocrylene 5 g in 1 ml / octinoxate 7.5 g in 1 ml topical lotion [general protection]||4-tertiary-butyl-4'-methoxy-dibenzoylmethane (substance)||active_ingredient_of
box elder maple pollen extract 50 mg/ml / hard maple pollen extract 50 mg/ml / red maple pollen extract 50 mg/ml injectable solution||box elder pollen||active_ingredient_of
product containing only quinidine in oral dose form (medicinal product form)||α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol||active_ingredient_of
cow milk 60 [hp_x] in 1 g / skim milk 60 [hp_x] in 1 g / cow milk fat 60 [hp_x] in 1 g / casein, lactococcus lactis cultured, aged 60 [hp_x] in 1 g / casein, lactococcus lactis cultured, penicillium roqueforti cultured, aged 60 [hp_x] in 1 g / casein, lactococcus lactis cultured, penicillium camemberti cultured, aged 60 [hp_x] in 1 g / barley 60 [hp_x] in 1 g / corn 60 [hp_x] in 1 g / wheat gluten 60 [hp_x] in 1 g / oat 60 [hp_x] in 1 g / white rice 60 [hp_x] in 1 g / rye 60 [hp_x] in 1 g / wheat 60 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / capsicum 15 [hp_x] in 1 g / solanum dulcamara top 15 [hp_x] in 1 g / hyoscyamus niger 15 [hp_x] in 1 g / solanum nigrum whole 15 [hp_x] in 1 g / datura stramonium 15 [hp_x] in 1 g / tobacco leaf 15 [hp_x] in 1 g / solanum lycopersicum 15 [hp_x] in 1 g / lactose 15 [hp_x] in 1 g / solanum tuberosum 15 [hp_x] in 1 g / saccharomyces cerevisiae 15 [hp_x] in 1 g / ustilago maydis 15 [hp_x] in 1 g / antimony trisulfide 10 [hp_x] in 1 g / silver nitrate 10 [hp_x] in 1 g / arsenic trioxide 10 [hp_x] in 1 g / baptisia tinctoria root 10 [hp_x] in 1 g / bryonia alba root 10 [hp_x] in 1 g / centaurea benedicta 10 [hp_x] in 1 g / cinchona officinalis bark 10 [hp_x] in 1 g / gelsemium sempervirens root 10 [hp_x] in 1 g / ipecac 10 [hp_x] in 1 g / lachesis muta venom 10 [hp_x] in 1 g / sodium chloride 10 [hp_x] in 1 g / phosphorus 10 [hp_x] in 1 g / podophyllum 10 [hp_x] in 1 g / pulsatilla vulgaris 10 [hp_x] in 1 g / toxicodendron pubescens leaf 10 [hp_x] in 1 g / sepia officinalis juice 10 [hp_x] in 1 g / elymus repens root 10 [hp_x] in 1 g / verbascum thapsus 10 [hp_x] in 1 g / iris versicolor root 3 [hp_x] in 1 g / solidago virgaurea flowering top 3 [hp_x] in 1 g / lycopodium clavatum spore 10 [hp_x] in 1 g oral pellet [dairy - grain - nightshades]||wheat gluten extract||active_ingredient_of
bacitracin 400 unt / lidocaine 40 mg / neomycin 3.5 mg / polymyxin b 5000 unt per gm topical ointment||lidocaína||active_ingredient_of
arsenic trioxide 12 [hp_x] in 30 ml / echinacea, unspecified 3 [hp_x] in 30 ml / gelsemium sempervirens root 12 [hp_x] in 30 ml / strychnos nux-vomica seed 12 [hp_x] in 30 ml / lycopodium clavatum spore 12 [hp_x] in 30 ml / atropa belladonna 12 [hp_x] in 30 ml / rancid beef 30 [hp_x] in 30 ml / toxicodendron pubescens leaf 30 [hp_x] in 30 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 30 ml / baptisia tinctoria 3 [hp_x] in 30 ml / phosphorus 12 [hp_x] in 30 ml / foscolic acid 12 [hp_x] in 30 ml oral liquid [virex]||bigonia sempervirens root||active_ingredient_of
povidone-iodine 100 mg in 1 ml topical liquid [cvs povidone-iodine]||povidone iodine product||active_ingredient_of
product containing only amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form)||amlodipine||active_ingredient_of
200 ml milrinone lactate 0.2 mg/ml injection||milrinone lactate (medication)||active_ingredient_of
1 ml glatiramer acetate 40 mg/ml prefilled syringe [glatopa]||l-glutamic acid peptide with l-alanine, l-lysine and l-tyrosine, acetate (salt)||active_ingredient_of
vfend, 40 mg/ml oral powder for reconstitution||voriconazole-containing product||active_ingredient_of
calcium sulfide 6 [hp_c] in 59 ml / potassium chloride 6 [hp_c] in 59 ml / potassium carbonate 30 [hp_c] in 59 ml / potassium dichromate 6 [hp_c] in 59 ml / strychnos nux-vomica seed 6 [hp_c] in 59 ml oral liquid [mucus-clear nighttime]||calcium sulphide||active_ingredient_of
avobenzone 3 ml in 100 ml / homosalate 13 ml in 100 ml / octisalate 3 ml in 100 ml / octocrylene 2 ml in 100 ml / oxybenzone 6 ml in 100 ml topical lotion [bilboa capri sunscreen spf 30]||2-ethylhexyl-2-cyano-3,3- diphenylacrylate||active_ingredient_of
benzethonium chloride 0.001 kg in 1 kg / thymol 0.001 kg in 1 kg topical emulsion [forticept udder forte sanitizing teat dip]||benzethonium chloride (substance)||active_ingredient_of
mupirocin calcium 20 mg in 1 g topical cream [mupirocin]||mupirocin calcium||active_ingredient_of
apis mellifera 8 [hp_x] in 1 g / echinacea, unspecified 8 [hp_x] in 1 g / goldenseal 8 [hp_x] in 1 g / thuja occidentalis leafy twig 8 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / amanita muscaria fruiting body 15 [hp_x] in 1 g / garlic 15 [hp_x] in 1 g / aloe 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / azadirachta indica bark 15 [hp_x] in 1 g / baptisia tinctoria root 15 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / calendula officinalis flowering top 15 [hp_x] in 1 g / capsicum 15 [hp_x] in 1 g / milk thistle 15 [hp_x] in 1 g / calcium sulfide 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / mercury 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / sage 15 [hp_x] in 1 g / selenium 15 [hp_x] in 1 g / taraxacum officinale 15 [hp_x] in 1 g / lycosa tarantula 15 [hp_x] in 1 g / zinc 15 [hp_x] in 1 g / ginger 15 [hp_x] in 1 g / bacillus anthracis 20 [hp_x] in 1 g / influenza a virus 35 [hp_x] in 1 g / influenza b virus 35 [hp_x] in 1 g oral pellet [immune waker]||thuja occidentalis leafy twig||active_ingredient_of
calcium silicate 5 [hp_x] in 59 ml / silicon dioxide 4 [hp_x] in 59 ml / sulfur 4 [hp_x] in 59 ml / sodium chloride 4 [hp_x] in 59 ml / iron 7 [hp_x] in 59 ml / ferrosoferric phosphate 7 [hp_x] in 59 ml / phosphorus 6 [hp_x] in 59 ml / ferric chloride hexahydrate 7 [hp_x] in 59 ml / titanium 7 [hp_x] in 59 ml nasal spray [mineffect nasal mist]||sulfur (medication)||active_ingredient_of
homosalate 150 mg in 1 ml / avobenzone 30 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml topical lotion [equate spf 50 ultra sunscreen]||4-tert-but-4'-meth-dibenzlmete||active_ingredient_of
diazolidinyl urea 446 ug in 48 h / clioquinol 77 ug in 48 h / chlorquinaldol 77 ug in 48 h / tixocortol pivalate 2 ug in 48 h / gold sodium thiosulfate 23 ug in 48 h / imidurea 486 ug in 48 h / budesonide 0.8 ug in 48 h / hydrocortisone butyrate 16 ug in 48 h / 2-mercaptobenzothiazole 61 ug in 48 h / bacitracin 486 ug in 48 h / parthenolide 2 ug in 48 h / disperse blue 106 41 ug in 48 h / bronopol 203 ug in 48 h cutaneous patch [t.r.u.e. test panel 3.3]||hydrocortisone-17-butyrate||active_ingredient_of
hydroxyzine hcl 25mg tab,ud||hydroxyzine hcl||active_ingredient_of
silicon dioxide 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / sulfuric acid 15 [hp_x] in 1 g / zinc 15 [hp_x] in 1 g / apis mellifera 6 [hp_x] in 1 g / thuja occidentalis leafy twig 6 [hp_x] in 1 g / candida albicans 15 [hp_x] in 1 g / sanicula europaea leaf 16 [hp_x] in 1 g / tellurium 16 [hp_x] in 1 g / saccharomyces cerevisiae 16 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / barium carbonate 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / activated charcoal 15 [hp_x] in 1 g / copper 15 [hp_x] in 1 g / solanum dulcamara top 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / potassium carbonate 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / daphne mezereum bark 15 [hp_x] in 1 g / nitric acid 15 [hp_x] in 1 g / phosphorus 15 [hp_x] in 1 g / phytolacca americana root 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g oral pellet [fungus fighter]||copper (substance)||active_ingredient_of
octinoxate 75 mg in 1 g / meradimate 50 mg in 1 g / oxybenzone 50 mg in 1 g / octisalate 50 mg in 1 g cutaneous lotion [pro-tect sunscreen for professionals]||2-ethylhexyl 2-hydroxybenzoate||active_ingredient_of
product containing only abietic acid (medicinal product)||product containing abietic acid||active_ingredient_of
sus scrofa skin extract 10,000 unt/ml injectable solution||hog skin extract||active_ingredient_of
frangula purshiana bark 1 [hp_x] in 100 ml / silybum marianum seed 1 [hp_x] in 100 ml / taraxacum officinale 1 [hp_x] in 100 ml / chelidonium majus 1 [hp_x] in 100 ml / veronicastrum virginicum root 2 [hp_x] in 100 ml / morella cerifera root bark 2 [hp_x] in 100 ml / berberis vulgaris root bark 2 [hp_x] in 100 ml / sodium sulfate 6 [hp_x] in 100 ml / magnesium phosphate, dibasic trihydrate 8 [hp_x] in 100 ml / copper 8 [hp_x] in 100 ml oral liquid [cholenest]||copper (product)||active_ingredient_of
sulfamethoxazole/trimethoprim 800 mg-160 mg oral tablet [sulfatrim-ds]||triméthoprime||active_ingredient_of
cow milk 60 [hp_x] in 1 g / skim milk 60 [hp_x] in 1 g / cow milk fat 60 [hp_x] in 1 g / casein, lactococcus lactis cultured, aged 60 [hp_x] in 1 g / casein, lactococcus lactis cultured, penicillium roqueforti cultured, aged 60 [hp_x] in 1 g / casein, lactococcus lactis cultured, penicillium camemberti cultured, aged 60 [hp_x] in 1 g / barley 60 [hp_x] in 1 g / corn 60 [hp_x] in 1 g / wheat gluten 60 [hp_x] in 1 g / oat 60 [hp_x] in 1 g / white rice 60 [hp_x] in 1 g / rye 60 [hp_x] in 1 g / wheat 60 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / capsicum 15 [hp_x] in 1 g / solanum dulcamara top 15 [hp_x] in 1 g / hyoscyamus niger 15 [hp_x] in 1 g / solanum nigrum whole 15 [hp_x] in 1 g / datura stramonium 15 [hp_x] in 1 g / tobacco leaf 15 [hp_x] in 1 g / solanum lycopersicum 15 [hp_x] in 1 g / lactose 15 [hp_x] in 1 g / solanum tuberosum 15 [hp_x] in 1 g / saccharomyces cerevisiae 15 [hp_x] in 1 g / ustilago maydis 15 [hp_x] in 1 g / antimony trisulfide 10 [hp_x] in 1 g / silver nitrate 10 [hp_x] in 1 g / arsenic trioxide 10 [hp_x] in 1 g / baptisia tinctoria root 10 [hp_x] in 1 g / bryonia alba root 10 [hp_x] in 1 g / centaurea benedicta 10 [hp_x] in 1 g / cinchona officinalis bark 10 [hp_x] in 1 g / gelsemium sempervirens root 10 [hp_x] in 1 g / ipecac 10 [hp_x] in 1 g / lachesis muta venom 10 [hp_x] in 1 g / sodium chloride 10 [hp_x] in 1 g / phosphorus 10 [hp_x] in 1 g / podophyllum 10 [hp_x] in 1 g / pulsatilla vulgaris 10 [hp_x] in 1 g / toxicodendron pubescens leaf 10 [hp_x] in 1 g / sepia officinalis juice 10 [hp_x] in 1 g / elymus repens root 10 [hp_x] in 1 g / verbascum thapsus 10 [hp_x] in 1 g / iris versicolor root 3 [hp_x] in 1 g / solidago virgaurea flowering top 3 [hp_x] in 1 g / lycopodium clavatum spore 10 [hp_x] in 1 g oral pellet [dairy - grain - nightshades]||podophyllum||active_ingredient_of
(spl review) alcohol 75 ml in 100 ml extracorporeal gel [instant hand sanitizer]||methylcarbinol||active_ingredient_of
riboflavin ophthalmic 0.146% ophthalmic solution||riboflavin 5 + phosphate sodium||active_ingredient_of
nicotine oral (product)||nicotine product (substance)||active_ingredient_of
prosopis juliflora specific extract (product)||mesquite pollen||active_ingredient_of
bos taurus pituitary gland 6 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml oral liquid||sus scrofa adrenal gland preparation||active_ingredient_of
lisinopril 20mg tab||product containing lisinopril (medicinal product)||active_ingredient_of
apis mellifera 6 [hp_x] in 20 ml / atropa belladonna 5 [hp_x] in 20 ml / calendula officinalis flowering top 4 [hp_x] in 20 ml / echinacea purpurea 4 [hp_x] in 20 ml / goldenseal 5 [hp_x] in 20 ml / phytolacca americana root 4 [hp_x] in 20 ml / plantago major 3 [hp_x] in 20 ml / sage 3 [hp_x] in 20 ml / zinc gluconate 1 [hp_x] in 20 ml / baptisia tinctoria root 1 [hp_x] in 20 ml / ulmus rubra bark 1 [hp_x] in 20 ml / sulfur 4 [hp_x] in 20 ml / zinc acetate anhydrous 4 [hp_x] in 20 ml / vincetoxicum hirundinaria root 6 [hp_x] in 20 ml / cairina moschata heart/liver autolysate 20 [hp_x] in 20 ml oral spray [reboost]||cairina moschata heart/liver autolysate||active_ingredient_of
lidocaine hydrochloride 40 mg in 1000 mg topical gel [extra strength pretat]||lignocaine hcl [antiarrhythm]||active_ingredient_of
clindamycin hcl 300mg cap||clindamycin hcl||active_ingredient_of
arum maculatum root 5 [hp_x] in 1 ml / pteridium aquilinum whole 5 [hp_x] in 1 ml oral liquid||arum maculatum root extract||active_ingredient_of
bufo bufo cutaneous gland 30 [hp_x] in 1 ml / cicuta virosa root 30 [hp_x] in 1 ml / strychnine 30 [hp_x] in 1 ml oral liquid [nuroplex]||strychnine (substance)||active_ingredient_of
omeprazole 20mg gastro-resistant oral capsule||product containing omeprazole||active_ingredient_of
product containing only bupropion hydrochloride 75 mg/1 each oral tablet||antidepressants bupropion hydrochloride||active_ingredient_of
esperoct 3000iu powder for injection||product containing recombinant antihemophilic factor agent (product)||active_ingredient_of
ocular beta-adrenergic blocking agents timolol maleate + travoprost||travoprostum||active_ingredient_of
viscum album fruiting top 3 [hp_x] in 1 ml / cobaltous gluconate 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / ferrous fumarate 6 [hp_x] in 1 ml / magnesium aspartate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / phosphorus 6 [hp_x] in 1 ml / potassium aspartate 6 [hp_x] in 1 ml / sodium molybdate 6 [hp_x] in 1 ml / adenosine cyclic phosphate 8 [hp_x] in 1 ml / cerous oxalate nonahydrate 8 [hp_x] in 1 ml / nickel acetate 8 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / cholecalciferol 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / chromium 8 [hp_x] in 1 ml / cobalt 8 [hp_x] in 1 ml / copper 8 [hp_x] in 1 ml / iron 8 [hp_x] in 1 ml / iodine 8 [hp_x] in 1 ml / iridium 8 [hp_x] in 1 ml / potassium carbonate 8 [hp_x] in 1 ml / lithium 8 [hp_x] in 1 ml / magnesium 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / molybdenum 8 [hp_x] in 1 ml / sodium chloride 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / strontium 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / vanadium 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / aluminum oxide 30 [hp_x] in 1 ml / mercuric chloride 30 [hp_x] in 1 ml / arsenic trioxide 1000 [hp_x] in 1 ml / mercurius solubilis 1000 [hp_x] in 1 ml / lead 1000 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [energy catalyst]||sr - strontium||active_ingredient_of
octinoxate 75 mg in 1 g / meradimate 50 mg in 1 g / oxybenzone 50 mg in 1 g / octisalate 50 mg in 1 g cutaneous lotion [pro-tect sunscreen for professionals]||octyl-methoxycinnamate||active_ingredient_of
sarcobatus vermiculatus pollen extract 0.05 gm/ml injectable solution||sarcobatus vermiculatus pollen||active_ingredient_of
zofran 4 mg oral tablet||antinauseants ondansetron hcl||active_ingredient_of
octinoxate 7.5 g in 100 g / zinc oxide 7 g in 100 g / oxybenzone 5 g in 100 g / octisalate 5 g in 100 g / octocrylene 2 g in 100 g topical cream [op spf45 face clear zinc potion]||oxybenzone [dup] (substance)||active_ingredient_of
butalbital 50mg, acetaminophen 300mg oral capsule||acetamidophenol||active_ingredient_of
isopropyl alcohol 187.5 ml in 250 ml extracorporeal liquid||isopropyl alcohol (substance)||active_ingredient_of
alcohol 75 ml in 100 ml topical liquid [clean simple hand sanitizer]||grain alcohol||active_ingredient_of
bryonia alba root 30 [hp_x] in 1 ml / colchicum autumnale bulb 30 [hp_x] in 1 ml / formica rufa 30 [hp_x] in 1 ml / kalmia latifolia leaf 30 [hp_x] in 1 ml / ledum palustre twig 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / rhododendron aureum leaf 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml oral liquid [jointox ai]||kalmia latifolia leaf||active_ingredient_of
hydrocortisone/neomycin sulfate/polymyxin b sulfate 1%-0.35%-10000 u/1 ml otic solution [otocidin]||therapeutic hydrocortisone||active_ingredient_of
aralia racemosa root 10 [hp_x] in 29.6 ml / arsenic trioxide 10 [hp_x] in 29.6 ml / histamine dihydrochloride 10 [hp_x] in 29.6 ml / strychnos nux-vomica seed 10 [hp_x] in 29.6 ml / cervus elaphus horn oil 10 [hp_x] in 29.6 ml / phosphorus 10 [hp_x] in 29.6 ml / silicon dioxide 10 [hp_x] in 29.6 ml / sulfur 10 [hp_x] in 29.6 ml oral liquid [pet hair and dander allergies]||arsenic trioxide (substance)||active_ingredient_of
rizatriptan benzoate 5mg tab||rizatriptan (as benzoate)||active_ingredient_of
fusarium oxysporum 0.00083 g in 1 ml / cladosporium cladosporioides 0.00083 g in 1 ml / cochliobolus sativus 0.00083 g in 1 ml / candida albicans 0.00083 g in 1 ml / aspergillus fumigatus 0.00017 g in 1 ml / ustilago cynodontis 0.00042 g in 1 ml / sporisorium cruentum 0.00042 g in 1 ml / pleospora herbarum 0.00083 g in 1 ml / aureobasidium pullulans var. pullutans 0.00083 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00083 g in 1 ml / periplaneta americana 0.00083 g in 1 ml / rhizopus stolonifer 0.00083 g in 1 ml / phoma destructiva 0.00083 g in 1 ml / dermatophagoides pteronyssinus 166.67 [au] in 1 ml / canis lupus familiaris hair 0.00083 g in 1 ml / alternaria alternata 0.00083 g in 1 ml / dermatophagoides farinae 166.67 [au] in 1 ml / felis catus hair 166.67 [bau] in 1 ml / ustilago nuda hordei 0.00021 g in 1 ml / ustilago maydis 0.00021 g in 1 ml / ustilago avenae 0.00021 g in 1 ml / ustilago tritici 0.00021 g in 1 ml / gallus gallus feather 0.00028 g in 1 ml / anas platyrhynchos feather 0.00028 g in 1 ml / anser anser feather 0.00028 g in 1 ml subcutaneous injection, solution||domestic cat hair||active_ingredient_of
sambucus nigra flowering top 12 [hp_c] in 12 [hp_c] oral pellet [sambucus nigra]||sambucus nigra flowering top||active_ingredient_of
lidocaine hcl/epinephrine 10 mg/ml (1 %)-1:100,000 injection syringe (ml)||bronitin mist||active_ingredient_of
calcium chloride 330 mg in 1000 ml / dextrose monohydrate 300 g in 1000 ml / magnesium chloride 260 mg in 1000 ml / potassium acetate 1 g in 1000 ml / sodium acetate anhydrous 3 g in 1000 ml / sodium chloride 5.4 g in 1000 ml oral solution [glucaminolyte forte]||aminosyn 3.5 % m, sulfite free||active_ingredient_of
today's health aspirin 81mg chewable tablet||aspirin [musculoskeletal use] (substance)||active_ingredient_of
sodium fluoride 0.25 mg / vitamin a palmitate 2500 [iu] / ascorbic acid 60 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate 15 [iu] / thiamine mononitrate 1.05 mg / riboflavin 1.2 mg / niacinamide 13.5 mg / pyridoxine hydrochloride 1.05 mg / folic acid 0.3 mg / cyanocobalamin 4.5 ug oral tablet, chewable [mvc]||cholecalciferol preparation (substance)||active_ingredient_of
alcohol 63 ml in 100 ml topical liquid [rue21 posh antibacterial hand sanitizer]||dehydrated ethanol||active_ingredient_of
camphor 3 % / menthol 2 % topical solution||menthol (substance)||active_ingredient_of
distichlis spicata pollen 0.05 g in 1 ml subcutaneous injection [salt grass pollen]||allergenic extract, salt grass pollen||active_ingredient_of
sunflower seed specific extract (product)||seeds sunflower||active_ingredient_of
aethusa cynapium 12 [hp_x] in 118 ml / aluminum oxide 12 [hp_x] in 118 ml / ammonium carbonate 12 [hp_x] in 118 ml / asafetida 12 [hp_x] in 118 ml / baptisia tinctoria root 12 [hp_x] in 118 ml / atropa belladonna 12 [hp_x] in 118 ml / sodium borate 12 [hp_x] in 118 ml / activated charcoal 12 [hp_x] in 118 ml / phenol 12 [hp_x] in 118 ml / matricaria recutita 12 [hp_x] in 118 ml / citrullus colocynthis fruit pulp 12 [hp_x] in 118 ml / dioscorea villosa tuber 12 [hp_x] in 118 ml / graphite 12 [hp_x] in 118 ml / ipecac 12 [hp_x] in 118 ml / wood creosote 12 [hp_x] in 118 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 118 ml / mercuric chloride 12 [hp_x] in 118 ml / sodium phosphate, dibasic, heptahydrate 12 [hp_x] in 118 ml / strychnos nux-vomica seed 12 [hp_x] in 118 ml / nerium oleander leaf 12 [hp_x] in 118 ml / phosphorus 12 [hp_x] in 118 ml / lead 12 [hp_x] in 118 ml / pulsatilla vulgaris 12 [hp_x] in 118 ml / toxicodendron pubescens leaf 12 [hp_x] in 118 ml / senna leaf 12 [hp_x] in 118 ml / silicon dioxide 12 [hp_x] in 118 ml / sulfur 12 [hp_x] in 118 ml / valerian 12 [hp_x] in 118 ml / zinc 12 [hp_x] in 118 ml oral liquid [digestive upsets]||thylox||active_ingredient_of
chaste tree 6 [hp_x] / ambergris 6 [hp_x] / apiole (parsley) 6 [hp_x] / estradiol 6 [hp_x] / estriol 6 [hp_x] / levodopa 6 [hp_x] / melatonin 6 [hp_x] / testosterone 6 [hp_x] / adenosine triphosphate disodium 8 [hp_x] / .alpha.-lipoic acid 8 [hp_x] / nadide 8 [hp_x] / pantothenic acid 8 [hp_x] / lactic acid, l- 8 [hp_x] / ubidecarenone 8 [hp_x] / barium carbonate 8 [hp_x] / conium maculatum flowering top 8 [hp_x] / selenium 8 [hp_x] / estrone 8 [hp_x] / sus scrofa umbilical cord 30 [hp_x] / sus scrofa adrenal gland 30 [hp_x] / pork liver 30 [hp_x] / sus scrofa hypothalamus 30 [hp_x] / sus scrofa lymph 30 [hp_x] / sus scrofa bone marrow 30 [hp_x] / sus scrofa ovary 30 [hp_x] / sus scrofa testicle 30 [hp_x] / sus scrofa pancreas 30 [hp_x] / sus scrofa spleen 30 [hp_x] / somatropin 30 [hp_x] / proteus morganii 30 [hp_c] oral tablet [hgh vitality]||porcine spleen preparation||active_ingredient_of
silver cyanide 21 [hp_x] in 1 ml / strychnos nux-vomica seed 50 [hp_c] in 1 ml / lycopodium clavatum spore 200 [hp_c] in 1 ml / chelidonium majus 21 [hp_x] in 1 ml / ginger 21 [hp_x] in 1 ml / matricaria recutita 21 [hp_x] in 1 ml / sus scrofa pancreas 21 [hp_x] in 1 ml oral liquid [chavita 3]||porcine pancreas preparation||active_ingredient_of
potassium carbonate 15 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / phosphoric acid 8 [hp_x] in 1 ml / lactic acid, l- 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / glycerin 12 [hp_x] in 1 ml / glycyrrhiza glabra 1 [hp_x] in 1 ml / lactose, unspecified form 15 [hp_x] in 1 ml / sucrose 30 [hp_x] in 1 ml / selenium 30 [hp_x] in 1 ml / magnesium sulfate heptahydrate 12 [hp_x] in 1 ml / pancrelipase 30 [hp_x] in 1 ml / syzygium cumini seed 3 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / lactic acid, dl- 15 [hp_x] in 1 ml / saccharin 15 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_x] in 1 ml / epinephrine 12 [hp_x] in 1 ml / bos taurus pituitary gland, posterior 30 [hp_x] in 1 ml sublingual solution/ drops [b05 gluco balance]||glycerin||active_ingredient_of
amaranthus retroflexus pollen 0.0004 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya alba pollen 0.001 g in 1 ml / poa pratensis pollen 800 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / candida albicans 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml intradermal injection, solution||allergenic extract, candida albicans||active_ingredient_of
ceanothus americanus leaf 1 [hp_x] in 1 ml / euphrasia stricta 1 [hp_x] in 1 ml / geranium robertianum 1 [hp_x] in 1 ml / juglans regia leaf 1 [hp_x] in 1 ml / juglans regia fruit rind, immature 1 [hp_x] in 1 ml / myosotis arvensis 1 [hp_x] in 1 ml / sarsaparilla 1 [hp_x] in 1 ml / scrophularia nodosa 1 [hp_x] in 1 ml / teucrium scorodonia flowering top 1 [hp_x] in 1 ml / althaea officinalis root 1 [hp_x] in 1 ml / peumus boldus leaf 1 [hp_x] in 1 ml / calendula officinalis flowering top 1 [hp_x] in 1 ml / thuja occidentalis leaf 1 [hp_x] in 1 ml / fumaria officinalis flowering top 1 [hp_x] in 1 ml / pinus sylvestris leafy twig 1 [hp_x] in 1 ml / gentiana lutea root 1 [hp_x] in 1 ml / potassium iodide 1 [hp_x] in 1 ml / echinacea, unspecified 1 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / viscum album fruiting top 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / veronica officinalis flowering top 4 [hp_x] in 1 ml / apis mellifera 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / ferrous iodide 8 [hp_x] in 1 ml / mercuric cyanide 8 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / bos taurus parathyroid gland 12 [hp_x] in 1 ml / bos taurus thymus 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml oral liquid [lymph care]||thuja occidentalis leaf extract||active_ingredient_of
product containing only colistin and hydrocortisone and neomycin (medicinal product)||neomycin preparations (otic) (medication)||active_ingredient_of
neurospora intermedia 40000 [pnu] in 1 ml intradermal injection, solution||neurospora intermedia||active_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 150 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 100 mg in 1 ml / oxybenzone 60 mg in 1 ml topical aerosol, spray [cvs health sport spf 70 clear]||benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||active_ingredient_of
product containing human alpha1 proteinase inhibitor in parenteral dose form (medicinal product form)||prolastin-c||active_ingredient_of
hydromorphone hydrochloride 4 mg in 1 ml intramuscular injection, solution||novolauden||active_ingredient_of
myosotis arvensis 3 [hp_x] in 1 ml / scrophularia nodosa 3 [hp_x] in 1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1 ml / veronica officinalis flowering top 3 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / fumaria officinalis flowering top 4 [hp_x] in 1 ml / geranium robertianum 4 [hp_x] in 1 ml / nasturtium aquaticum 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / pinus sylvestris leafy twig 4 [hp_x] in 1 ml / gentiana lutea root 5 [hp_x] in 1 ml / juglans regia flowering top 5 [hp_x] in 1 ml / araneus diadematus 6 [hp_x] in 1 ml / smilax regelii root 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [bio lymphomyosot]||forget-me-not extract||active_ingredient_of
risedronate sodium 75mg tablet (product)||risedronate sodium monohydrate||active_ingredient_of
avapro 300mg tablet||product containing irbesartan||active_ingredient_of
titanium dioxide 0.0624 g in 1 g / zinc oxide 0.049 g in 1 g / octinoxate 0.03 g in 1 g topical powder [lbel divine polvos compactos doble uso fps 15 edicion de lujo dorado/double use compact spf 15 gold deluxe edition medium 7]||boo-boo magic||active_ingredient_of
glycerin 14.4 g in 100 g / phenylephrine hydrochloride 0.25 g in 100 g / pramoxine hydrochloride 1 g in 100 g / petrolatum 15 g in 100 g topical cream [up and up hemorrhoidal]||phenylephrine hydrochloride (medication)||active_ingredient_of
zinc oxide 6.4 mg in 100 ml / titanium dioxide 5.1 mg in 100 ml topical lotion [josie maran argan daily moisturizer spf47]||lassars paste||active_ingredient_of
octinoxate 7.5 g in 100 g / zinc oxide 7.84 g in 100 g topical cream [clarite makeup for a cleaner appearance spf 30 340-f]||octyl methoxycinnamate||active_ingredient_of
calcium carbonate 750 mg oral tablet, chewable [antacid]||kohlensaurer kalk||active_ingredient_of
octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel hydratess long-lasting intense moisturizing spf 20 - rose clasique]||hmbp cpd||active_ingredient_of
avobenzone 30 mg in 1 ml / homosalate 25 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 27 mg in 1 ml topical cream, augmented [bb medium]||octocrilene-containing product||active_ingredient_of
acetaminophen 325 mg / dextromethorphan hydrobromide 15 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [major night time multi symptom cold and flu relief]||dextromethorphan hydrobromide (medication)||active_ingredient_of
aconitum napellus 30 [hp_x] in 59 ml / arsenic trioxide 30 [hp_x] in 59 ml / barium carbonate 30 [hp_x] in 59 ml / bryonia alba root 30 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 30 [hp_x] in 59 ml / lytta vesicatoria 30 [hp_x] in 59 ml / gelsemium sempervirens root 30 [hp_x] in 59 ml / graphite 30 [hp_x] in 59 ml / goldenseal 30 [hp_x] in 59 ml / potassium iodide 30 [hp_x] in 59 ml / lachesis muta venom 30 [hp_x] in 59 ml / lycopodium clavatum spore 30 [hp_x] in 59 ml / mercury 30 [hp_x] in 59 ml / sodium chloride 30 [hp_x] in 59 ml / strychnos nux-vomica seed 30 [hp_x] in 59 ml / phytolacca americana root 30 [hp_x] in 59 ml / pulsatilla vulgaris 30 [hp_x] in 59 ml / toxicodendron pubescens leaf 30 [hp_x] in 59 ml / sepia officinalis juice 30 [hp_x] in 59 ml / silicon dioxide 30 [hp_x] in 59 ml / sulfur 30 [hp_x] in 59 ml / phosphorus 30 [hp_x] in 59 ml oral liquid [constitutional enhancer]||oyster shell calcium carbonate, crude||active_ingredient_of
potassium gluconate 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / bambusa vulgaris leaf 9 [hp_x] in 1 ml / barley 9 [hp_x] in 1 ml / poppy seed 9 [hp_x] in 1 ml / corn 9 [hp_x] in 1 ml / flax seed 9 [hp_x] in 1 ml / cotton seed 9 [hp_x] in 1 ml / millet 9 [hp_x] in 1 ml / sorghum 9 [hp_x] in 1 ml / avena sativa flowering top 9 [hp_x] in 1 ml / oryza sativa whole 9 [hp_x] in 1 ml / rye 9 [hp_x] in 1 ml / safflower 9 [hp_x] in 1 ml / sesame seed 9 [hp_x] in 1 ml / soybean 9 [hp_x] in 1 ml / sugarcane 9 [hp_x] in 1 ml / helianthus annuus flowering top 9 [hp_x] in 1 ml / wheat 9 [hp_x] in 1 ml / coffea arabica seed, roasted 10 [hp_x] in 1 ml / green tea leaf 10 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / anemone pulsatilla 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / almond 12 [hp_x] in 1 ml / cashew 12 [hp_x] in 1 ml / peanut 12 [hp_x] in 1 ml / beef 12 [hp_x] in 1 ml / brazil nut 12 [hp_x] in 1 ml / pecan 12 [hp_x] in 1 ml / casein, streptococcus thermophilus cultured, propionibacterium freudenreichii subsp. shermanii cultured, aged 12 [hp_x] in 1 ml / chicken breast 12 [hp_x] in 1 ml / orange 12 [hp_x] in 1 ml / coconut 12 [hp_x] in 1 ml / pacific cod 12 [hp_x] in 1 ml / egg 12 [hp_x] in 1 ml / fragaria vesca fruit 12 [hp_x] in 1 ml / black walnut 12 [hp_x] in 1 ml / english walnut 12 [hp_x] in 1 ml / cow milk 12 [hp_x] in 1 ml / lamb 12 [hp_x] in 1 ml / limulus polyphemus 12 [hp_x] in 1 ml / tomato 12 [hp_x] in 1 ml / apple 12 [hp_x] in 1 ml / banana 12 [hp_x] in 1 ml / oyster, unspecified 12 [hp_x] in 1 ml / kidney bean 12 [hp_x] in 1 ml / black pepper 12 [hp_x] in 1 ml / pork 12 [hp_x] in 1 ml / salmon, unspecified 12 [hp_x] in 1 ml / shrimp, unspecified 12 [hp_x] in 1 ml / eggplant 12 [hp_x] in 1 ml / potato 12 [hp_x] in 1 ml / tuna, unspecified 12 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / histamine dihydrochloride 30 [hp_x] in 1 ml / hyaluronidase 30 [hp_x] in 1 ml / interferon .gamma. porcine recombinant 30 [hp_x] in 1 ml / serotonin hydrochloride 30 [hp_x] in 1 ml / cocoa 10 [hp_c] in 1 ml oral liquid [enviro i]||poppy seed allergenic extract||active_ingredient_of
(spl review) alcohol 0.75 ml in 1 g topical cloth [sanitizing wipes]||alkohol||active_ingredient_of
eucalyptol 0.92 mg in 1 ml / menthol, unspecified form 0.42 mg in 1 ml / methyl salicylate 0.6 mg in 1 ml / thymol 0.64 mg in 1 ml oral mouthwash [listerine ultraclean antiseptic cool mint]||listerine ultraclean||active_ingredient_of
avobenzone 30 mg in 1 g / homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 40 mg in 1 g / oxybenzone 50 mg in 1 g topical spray [fruit of the earth spacology sport spf 50]||benzophenone-3||active_ingredient_of
avobenzone 1.2 g in 59 ml / octinoxate 4.24 g in 59 ml / oxybenzone 2.84 g in 59 ml topical lotion [mario badescu collagen spf 15]||2-ethylhexyl-p-methoxycinnamate||active_ingredient_of
aconitum napellus 4 [hp_x] in 1 ml / bryonia alba root 4 [hp_x] in 1 ml / hyoscyamus niger 4 [hp_x] in 1 ml / ipecac 4 [hp_x] in 1 ml / lobaria pulmonaria 4 [hp_x] in 1 ml / tobacco leaf 4 [hp_x] in 1 ml / phosphorus 5 [hp_x] in 1 ml / antimony potassium tartrate 6 [hp_x] in 1 ml / wood creosote 6 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_x] in 1 ml / clostridium tetani 30 [hp_x] in 1 ml oral liquid [pertussis]||creosote (substance)||active_ingredient_of
amantadine hydrochloride 100mg capsule (product)||amantadine hcl [anti viral]||active_ingredient_of
amanita muscaria fruiting body 15 [hp_x] in 1 ml / avicularia avicularia 16 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / hyoscyamus niger 15 [hp_x] in 1 ml / hypericum perforatum 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / magnesium carbonate 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / lead 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / claviceps purpurea sclerotium 15 [hp_x] in 1 ml / strychnine 15 [hp_x] in 1 ml / lycosa tarantula 15 [hp_x] in 1 ml / valerian 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / matricaria chamomilla 6 [hp_x] in 1 ml / passiflora incarnata flowering top 6 [hp_x] in 1 ml oral liquid [restless leg]||cinchona officinalis bark||active_ingredient_of
amphetamine aspartate/amphetamine sulfate/dextroamphetamine saccharate/dextroamphetamine sulfate 30 mg oral capsule, extended release [mixed amphetamine salts]||desoxynorephedrine sulfate||active_ingredient_of
allantoin 0.5 % / lidocaine 0.5 % topical cream||lidocaine substances||active_ingredient_of
homosalate 10 g in 100 g / octisalate 5 g in 100 g / oxybenzone 5 g in 100 g / octocrylene 2 g in 100 g / avobenzone 2 g in 100 g topical spray [no-ad spf45 continuous mist sunscreen]||octocrylene-containing product||active_ingredient_of
morus alba pollen 0.05 g in 1 ml subcutaneous injection, solution||white mulberry pollen allergen||active_ingredient_of
altace oral product||altace [brand name]||active_ingredient_of
diethylstilbestrol-containing product in parenteral dose form||trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol||active_ingredient_of
carisoprodol 350 mg oral tablet [vanadom]||carisoprodate||active_ingredient_of
avobenzone 2 g in 100 g / octocrylene 5 g in 100 g / oxybenzone 3 g in 100 g topical lotion [meijer oil free faces spf 30]||oxybenzone||active_ingredient_of
niacinamide 0.46 g in 23 g / adenosine 0.0092 g in 23 g topical patch [celderma crystal skin mask]||β-pyridinecarboxamide||active_ingredient_of
sensor 3 ml lyumjev 100 unt/ml pen injector||lispro||active_ingredient_of
avobenzone 3 g in 100 g / octocrylene 5 g in 100 g / homosalate 10 g in 100 g topical cream [regeneration wrinkle control cream spf 15]||avobenzone (substance)||active_ingredient_of
cvs antacid & pain reliever effervescent tablet||citric acid monohydrate||active_ingredient_of
centaurium erythraea flower 5 [hp_x] in 29.6 ml / ceratostigma willmottianum flower 5 [hp_x] in 29.6 ml / potassium phosphate, dibasic 6 [hp_x] in 29.6 ml / larix decidua flowering top 5 [hp_x] in 29.6 ml / lycopodium clavatum spore 6 [hp_c] in 29.6 ml / sodium chloride 6 [hp_x] in 29.6 ml / sodium phosphate, dibasic, heptahydrate 6 [hp_x] in 29.6 ml / silicon dioxide 12 [hp_x] in 29.6 ml oral spray [male balance]||ceratostigma willmottianum flower||active_ingredient_of
lithium citrate only product||citric acid, trilithium salt||active_ingredient_of
baptisia tinctoria root 3 [hp_x] / goldenseal 3 [hp_x] / myrrh 3 [hp_x] / nasturtium officinale 3 [hp_x] / phytolacca americana root 3 [hp_x] / fenugreek leaf 3 [hp_x] / echinacea, unspecified 3 [hp_x] / acacia pollen 30 [hp_x] / alnus rubra pollen 30 [hp_x] / alnus incana subsp. rugosa pollen 30 [hp_x] / fraxinus velutina pollen 30 [hp_x] / fraxinus pennsylvanica pollen 30 [hp_x] / fraxinus americana pollen 30 [hp_x] / populus tremuloides pollen 30 [hp_x] / morella cerifera pollen 30 [hp_x] / fagus grandifolia pollen 30 [hp_x] / betula papyrifera pollen 30 [hp_x] / betula nigra pollen 30 [hp_x] / betula lenta pollen 30 [hp_x] / robinia pseudoacacia pollen 30 [hp_x] / acer negundo pollen 30 [hp_x] / juniperus ashei pollen 30 [hp_x] / juniperus pinchotii pollen 30 [hp_x] / juniperus virginiana pollen 30 [hp_x] / populus deltoides subsp. deltoides pollen 30 [hp_x] / populus deltoides subsp. monilifera pollen 30 [hp_x] / cupressus arizonica pollen 30 [hp_x] / taxodium distichum pollen 30 [hp_x] / phoenix dactylifera pollen 30 [hp_x] / ulmus americana pollen 30 [hp_x] / ulmus crassifolia pollen 30 [hp_x] / ulmus pumila pollen 30 [hp_x] / ulmus rubra pollen 30 [hp_x] / eucalyptus globulus pollen 30 [hp_x] / pseudotsuga menziesii pollen 30 [hp_x] / celtis occidentalis pollen 30 [hp_x] / carya glabra pollen 30 [hp_x] / carya ovata pollen 30 [hp_x] / carya laciniosa pollen 30 [hp_x] / carya alba pollen 30 [hp_x] / ligustrum vulgare pollen 30 [hp_x] / acer saccharum pollen 30 [hp_x] / acer rubrum pollen 30 [hp_x] / morus rubra pollen 30 [hp_x] / quercus virginiana pollen 30 [hp_x] / quercus rubra pollen 30 [hp_x] / quercus alba pollen 30 [hp_x] / carya illinoinensis pollen 30 [hp_x] / pinus strobus pollen 30 [hp_x] / populus alba pollen 30 [hp_x] / liquidambar styraciflua pollen 30 [hp_x] / platanus occidentalis pollen 30 [hp_x] / juglans nigra pollen 30 [hp_x] / salix nigra pollen 30 [hp_x] / baccharis halimifolia pollen 30 [hp_x] / amaranthus palmeri pollen 30 [hp_x] / xanthium strumarium pollen 30 [hp_x] / rumex crispus pollen 30 [hp_x] / chenopodium album pollen 30 [hp_x] / iva annua pollen 30 [hp_x] / artemisia vulgaris pollen 30 [hp_x] / urtica dioica pollen 30 [hp_x] / amaranthus retroflexus pollen 30 [hp_x] / plantago lanceolata pollen 30 [hp_x] / ambrosia trifida pollen 30 [hp_x] / ambrosia artemisiifolia pollen 30 [hp_x] / paspalum notatum pollen 30 [hp_x] / cynodon dactylon pollen 30 [hp_x] / poa pratensis pollen 30 [hp_x] / festuca pratensis pollen 30 [hp_x] / sorghum halepense pollen 30 [hp_x] / lolium perenne pollen 30 [hp_x] / dactylis glomerata pollen 30 [hp_x] / agrostis gigantea pollen 30 [hp_x] oral tablet, orally disintegrating [allergena seasonal allergy tabs]||morella cerifera pollen||active_ingredient_of
acetaminophen 650 mg / pheniramine maleate 20 mg / phenylephrine hydrochloride 10 mg granules for oral solution||phenylephrine hydrochloride [cvs sympathomimetic]||active_ingredient_of
gelsemium sempervirens root 30 [hp_c] sublingual pellet [gelsemium sempervirens 30c]||gelsemium sempervirens root||active_ingredient_of
plasma expanders dextran hm||dextran-70||active_ingredient_of
adenosine cyclic phosphate 12 [hp_x] in 118 ml / corticotropin 30 [hp_x] in 118 ml / onion 12 [hp_x] in 118 ml / ambrosia artemisiifolia 12 [hp_x] in 118 ml / arsenic trioxide 12 [hp_x] in 118 ml / arisaema triphyllum root 12 [hp_x] in 118 ml / arundo pliniana root 12 [hp_x] in 118 ml / cortisone acetate 12 [hp_x] in 118 ml / euphrasia stricta 12 [hp_x] in 118 ml / galphimia glauca flowering top 12 [hp_x] in 118 ml / histamine dihydrochloride 12 [hp_x] in 118 ml / potassium chloride 12 [hp_x] in 118 ml / sus scrofa nasal mucosa 12 [hp_x] in 118 ml / naphthalene 12 [hp_x] in 118 ml / sodium chloride 12 [hp_x] in 118 ml / saccharomyces cerevisiae rna 12 [hp_x] in 118 ml / schoenocaulon officinale seed 12 [hp_x] in 118 ml / sulfur 12 [hp_x] in 118 ml / wyethia helenioides root 12 [hp_x] in 118 ml oral liquid [allergies]||galphimia glauca flowering top||active_ingredient_of
titanium dioxide 4 g in 100 g / octinoxate 7 g in 100 g / octisalate 4 g in 100 g / oxybenzone 3 g in 100 g topical lotion [sun screen]||octyl methoxycinnamate||active_ingredient_of
diphenhydramine citrate 38 mg / ibuprofen 200 mg oral tablet, film coated [basic care ibuprofen pm]||citrate, diphenhydramine||active_ingredient_of
butalbital and caffeine and codeine and paracetamol product||7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol||active_ingredient_of
octinoxate 0.065 g in 1 g / titanium dioxide 0.0244 g in 1 g / zinc oxide 0.0157 g in 1 g topical paste [lbel mousse matiffiant matte finish mousse foundation spf 15 clare 1/ beige]||product containing zinc oxide||active_ingredient_of
dinitolmide 1 kg in 1 kg not applicable powder [zoalene]||dinitrotoluamide||active_ingredient_of
niacin only product in oral dose form||ácido nicotínico||active_ingredient_of
benzalkonium chloride 0.1 g in 100 ml topical gel [nickelodeon raspberry scented hand sanitizer 01]||benzalkonium chloride (medication)||active_ingredient_of
eribulin only product in parenteral dose form||halichondrin b analog||active_ingredient_of
acetaminophen 250 mg / aspirin 250 mg / caffeine 65 oral tablet, coated||cafeína||active_ingredient_of
zinc oxide 10.3 g in 100 g / ferric oxide red 0.05 g in 100 g / petrolatum 79.25 g in 100 g / phenylephrine hydrochloride 0.25 g in 100 g topical ointment [fargelin hemorrhoidal]||zinc oxide (medication)||active_ingredient_of
alcohol 0.7 ml in 1 ml topical gel [dr.germ hand sanitizer gel]||äthylalkohol||active_ingredient_of
product containing prednisone 50 mg/1 each oral tablet (clinical drug)||perrigo prednisone||active_ingredient_of
alcohol 62 ml in 100 ml topical liquid [guardrx red thyme]||product containing ethyl alcohol||active_ingredient_of
acetaminophen 325 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg / dextromethorphan hydrobromide 15 mg oral tablet [aramark multi-symptom cold relief]||product containing acetaminophen||active_ingredient_of
senna leaf 500 mg in 4 g / aloe 200 mg in 4 g / magnolia officinalis bark 200 mg in 4 g / paeonia lactiflora root 200 mg in 4 g / rhubarb 200 mg in 4 g / plantago indica seed coat 2000 mg in 4 g oral granule [byun rak]||paeonia lactiflora root||active_ingredient_of
guaifenesin 1200 mg oral tablet, extended release [mucus relief]||guaiphenezine||active_ingredient_of
venlafaxine hcl 75mg 24hr tab,sa||venlafaxine hcl||active_ingredient_of
adderall, 15 mg oral tablet||amphetamine aspartate||active_ingredient_of
petrolatum, white 100% topical application ointment||paraffin white soft bp (product)||active_ingredient_of
product containing only vardenafil 5 mg/1 each oral tablet (clinical drug)||hydrochloride, vardenafil||active_ingredient_of
elexacaftor- ivacaftor- tezacaftor drug combination||ivacaftor||active_ingredient_of
artemisia abrotanum flowering top 10 [hp_x] in 59 ml / epinephrine 10 [hp_x] in 59 ml / corticotropin 10 [hp_x] in 59 ml / .alpha.-ketoglutaric acid 10 [hp_x] in 59 ml / .alpha.-lipoic acid 10 [hp_x] in 59 ml / barium carbonate 10 [hp_x] in 59 ml / calcium fluoride 10 [hp_x] in 59 ml / anhydrous citric acid 10 [hp_x] in 59 ml / coenzyme a 10 [hp_x] in 59 ml / herring sperm dna 10 [hp_x] in 59 ml / iron 10 [hp_x] in 59 ml / sus scrofa adrenal gland 10 [hp_x] in 59 ml / hekla lava 10 [hp_x] in 59 ml / helleborus niger root 10 [hp_x] in 59 ml / bos taurus hypothalamus 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / sus scrofa ovary 10 [hp_x] in 59 ml / saccharomyces cerevisiae rna 10 [hp_x] in 59 ml / claviceps purpurea sclerotium 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / thiamine hydrochloride 10 [hp_x] in 59 ml oral liquid [anti-aging and wrinkles for women]||barium carbonate||active_ingredient_of
influenza a virus 30 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / antimony potassium tartrate 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / matricaria recutita 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / trifolium pratense flower 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml oral liquid [viral infection]||lachesis muta venom||active_ingredient_of
zinci oxydum||zinc oxide 40 g in 100 g topical cream [diaperene maximum]||has_active_moiety
aconitum napellus whole||betula pubescens leaf 3 [hp_x] in 1 g / mandragora officinarum root 3 [hp_x] in 1 g / antimony trisulfide 5 [hp_x] in 1 g / aconitum napellus 6 [hp_x] in 1 g / arnica montana 6 [hp_x] in 1 g / bos taurus cartilage 6 [hp_x] in 1 g / silver 8 [hp_x] in 1 g topical cream||has_active_moiety
etoh - ethanol||alcohol 65.2 ml in 100 ml topical liquid [clean xpress alcohol gel instant skin sanitizer]||has_active_moiety
tetramethylene bis(methanesulfonate)||busulfan 60 mg per 10 ml injection||has_active_moiety
paraffin oil||cvs lubricant eye ointment||has_active_moiety
2-ethylhexyl salicylate||avobenzone 1.5 g in 50 g / octocrylene 2 g in 50 g / octisalate 1 g in 50 g topical cream [no7 protect and perfect intense day cream spf 15]||has_active_moiety
minossidile||minoxidil 5 gm per 100 ml topical solution||has_active_moiety
antidepressants amitriptyline||product containing precisely amitriptyline hydrochloride 100 milligram/1 each conventional release oral tablet||has_active_moiety
weed pollen-sheep sorrel||felis catus hair 400 [bau] in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / ulmus americana pollen 0.0004 g in 1 ml / acer negundo pollen 0.0004 g in 1 ml / carya tomentosa pollen 0.0004 g in 1 ml / platanus occidentalis pollen 0.0004 g in 1 ml / morus alba pollen 0.0004 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 160 [au] in 1 ml / plantago lanceolata pollen 0.0004 g in 1 ml / salsola kali pollen 0.0004 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml intradermal injection, solution||has_active_moiety
salicylic acid acetate||aspirin 81 mg oral tablet, enteric coated [family pharmacy aspirin]||has_active_moiety
titanium dioxide||titanium dioxide 94 mg in 1 g / zinc oxide 39 mg in 1 g topical lotion [oi lin deep moisture sunscreen spf 25]||has_active_moiety
veal allergenic extract||veal 0.05 g in 1 ml intradermal injection, solution||has_active_moiety
acetamide, 2-(diethylamino)-n-(2,6-dimethylphenyl)-||lidocaine hydrochloride 40 mg in 1000 mg topical cream [naturally hl extra strength burn numbing]||has_active_moiety
homosalate||octocrylene 51.05 mg in 1 ml / avobenzone 30.63 mg in 1 ml / octisalate 51.05 mg in 1 ml / homosalate 76.575 mg in 1 ml topical lotion [australian gold instant bronzer 30 sunscreen]||has_active_moiety
delta-cortisone||prednisone 20 mg in 20 oral tablet||has_active_moiety
paracétamol||acetaminophen 325mg/dm 10mg/phenylephrine 5mg cap,oral||has_active_moiety
n-acetyl-p-aminophenol||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [topcare day time cold and flu]||has_active_moiety
strychnos nux-vomica seed||american ginseng 3 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / smilax ornata root 3 [hp_x] in 1 ml / chaste tree 6 [hp_x] in 1 ml / turnera diffusa leafy twig 6 [hp_x] in 1 ml / saw palmetto 6 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml oral liquid [endurotone]||has_active_moiety
cultivated tobacco leaf||artery porcine/baryta carbonica/black nightshade/claviceps purpurea/cuprum sulphuricum/embryo porcine/funiculus umbilicalis/horse chestnut/natrum pyruvicum/placenta porcine/plumbum iodatum/sarcolacticum acidum/strophanthus hispidus/tobacco/vein porcine/vipera berus venom/yellow sweetclover 10 x/22 mcl-13 x/22 mcl-6 x/22 mcl-4 x/22 mcl-6 x/22 mcl-8 x/22 mcl-10 x/22 mcl-4 x/22 mcl-8 x/22 mcl-6 x/22 mcl-18 x/22 mcl-4 x/22 mcl-6 x/22 mcl-10 x/22 mcl-8 x/22 mcl-10 x/22 mcl-6 x/22 mcl injection solution [placenta compositum]||has_active_moiety
2-ethylhexyl-p-methoxycinnamate||octinoxate 34.9 mg in 1 ml / octisalate 40 mg in 1 ml topical cream [burberry cashmere long-lasting flawless soft-matte foundation sunscreen spf20 camel]||has_active_moiety
tree pollen-mesquite||echinacea, unspecified 3 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / fenugreek leaf 3 [hp_x] in 1 ml / acacia pollen 30 [hp_x] in 1 ml / alnus incana subsp. rugosa pollen 30 [hp_x] in 1 ml / fraxinus velutina pollen 30 [hp_x] in 1 ml / populus deltoides subsp. monilifera pollen 30 [hp_x] in 1 ml / ulmus crassifolia pollen 30 [hp_x] in 1 ml / ulmus pumila pollen 30 [hp_x] in 1 ml / eucalyptus globulus pollen 30 [hp_x] in 1 ml / juniperus scopulorum pollen 30 [hp_x] in 1 ml / ligustrum vulgare pollen 30 [hp_x] in 1 ml / prosopis juliflora pollen 30 [hp_x] in 1 ml / morus alba pollen 30 [hp_x] in 1 ml / quercus agrifolia pollen 30 [hp_x] in 1 ml / olea europaea pollen 30 [hp_x] in 1 ml / phoenix dactylifera pollen 30 [hp_x] in 1 ml / pinus strobus pollen 30 [hp_x] in 1 ml / liquidambar styraciflua pollen 30 [hp_x] in 1 ml / platanus occidentalis pollen 30 [hp_x] in 1 ml / ailanthus altissima pollen 30 [hp_x] in 1 ml / juglans nigra pollen 30 [hp_x] in 1 ml / salix nigra pollen 30 [hp_x] in 1 ml / atriplex canescens pollen 30 [hp_x] in 1 ml / amaranthus palmeri pollen 30 [hp_x] in 1 ml / rumex crispus pollen 30 [hp_x] in 1 ml / chenopodium album pollen 30 [hp_x] in 1 ml / amaranthus retroflexus pollen 30 [hp_x] in 1 ml / plantago lanceolata pollen 30 [hp_x] in 1 ml / ambrosia acanthicarpa pollen 30 [hp_x] in 1 ml / ambrosia psilostachya pollen 30 [hp_x] in 1 ml / salsola tragus pollen 30 [hp_x] in 1 ml / cynodon dactylon pollen 30 [hp_x] in 1 ml / bromus inermis pollen 30 [hp_x] in 1 ml / bromus secalinus pollen 30 [hp_x] in 1 ml / sorghum halepense pollen 30 [hp_x] in 1 ml / poa pratensis pollen 30 [hp_x] in 1 ml / festuca pratensis pollen 30 [hp_x] in 1 ml / dactylis glomerata pollen 30 [hp_x] in 1 ml / lolium perenne pollen 30 [hp_x] in 1 ml / agrostis gigantea pollen 30 [hp_x] in 1 ml / phleum pratense pollen 30 [hp_x] in 1 ml oral liquid [allergena zone 9]||has_active_moiety
oryctolagus cuniculus hair||arsenic trioxide 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / serinus canaria feather 15 [hp_c] in 1 ml / felis catus hair 15 [hp_c] in 1 ml / gallus gallus feather 15 [hp_c] in 1 ml / bos taurus hair 15 [hp_c] in 1 ml / canis lupus familiaris hair 15 [hp_c] in 1 ml / cavia porcellus hair 15 [hp_c] in 1 ml / mesocricetus auratus skin 15 [hp_c] in 1 ml / equus caballus dander 15 [hp_c] in 1 ml / mus musculus hair 15 [hp_c] in 1 ml / sus scrofa hair 15 [hp_c] in 1 ml / rattus norvegicus hair 15 [hp_c] in 1 ml / anas platyrhynchos feather 18 [hp_c] in 1 ml / anser anser feather 18 [hp_c] in 1 ml / oryctolagus cuniculus hair 39 [hp_c] in 1 ml oral liquid [animal antigens]||has_active_moiety
product containing menthol||camphor (synthetic) 0.047 g in 1 g / eucalyptus oil 0.012 g in 1 g / menthol 0.0125 g in 1 g topical ointment [priyal pride chest rub]||has_active_moiety
benzalkonium||benzalkonium chloride 0.0013 g in 1 g topical gel [gfs bioprotect aloe vera hand sanitizer]||has_active_moiety
veratrum album root extract||causticum 12 [hp_x] / citrullus colocynthis fruit pulp 12 [hp_x] / copper 12 [hp_x] / magnesium phosphate, dibasic trihydrate 12 [hp_x] / phytolacca americana root 12 [hp_x] / toxicodendron pubescens leaf 12 [hp_x] / tin 12 [hp_x] / veratrum album root 12 [hp_x] oral tablet [leg cramp relief]||has_active_moiety
plasma expanders dextran-70||dextran 70 1 mg/ml / polyethylene glycol 400 10 mg/ml / povidone 10 mg/ml / tetrahydrozoline hydrochloride 0.5 mg/ml ophthalmic solution||has_active_moiety
2-ethylhexyl 2-hydroxybenzoate||avobenzone 3 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml / oxybenzone 5 g in 100 ml topical cream [meaningful beauty cindy crawford antioxidant spf 20 uva/uvb]||has_active_moiety
aspirin - chemical (substance)||caffeine 65 mg / acetaminophen 250 mg / aspirin 250 mg oral tablet, coated [pain stoppers extra]||has_active_moiety
pseudognaphalium obtusifolium whole extract||pseudognaphalium obtusifolium 3 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / black cohosh 4 [hp_x] in 1 ml / cinchona officinalis bark 4 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / ranunculus bulbosus 4 [hp_x] in 1 ml / horse chestnut 6 [hp_x] in 1 ml / sodium borate 6 [hp_x] in 1 ml / cupric acetate 6 [hp_x] in 1 ml / potassium carbonate 6 [hp_x] in 1 ml / pulsatilla vulgaris 6 [hp_x] in 1 ml / claviceps purpurea sclerotium 6 [hp_x] in 1 ml / ammonium chloride 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / silver 10 [hp_x] in 1 ml / tribasic calcium phosphate 10 [hp_x] in 1 ml / sus scrofa adrenal gland 10 [hp_x] in 1 ml / mercuric oxide, yellow 10 [hp_x] in 1 ml / sepia officinalis juice 10 [hp_x] in 1 ml / zinc 10 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / trinitrophenol 12 [hp_x] in 1 ml / sulfur 30 [hp_x] in 1 ml / sus scrofa cartilage 12 [hp_c] in 1 ml / sus scrofa intervertebral disc 12 [hp_c] in 1 ml / sus scrofa bone marrow 12 [hp_c] in 1 ml oral liquid [arthritis joints]||has_active_moiety
product containing morphine||morphine sulfate 80mg prolonged-release oral capsule||has_active_moiety
octocrilene-containing product||avobenzone 2 g in 100 g / homosalate 10 g in 100 g / octisalate 5 g in 100 g / octocrylene 4 g in 100 g / oxybenzone 5 g in 100 g topical lotion [exsel sport spf 30]||has_active_moiety
aqua fortis / nitric acid||garlic 2 [hp_x] in 1 ml / calendula officinalis flowering top 2 [hp_x] in 1 ml / sambucus nigra flowering top 3 [hp_x] in 1 ml / clematis recta flowering top 6 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / graphite 8 [hp_x] in 1 ml / kerosene 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / croton tiglium seed 12 [hp_x] in 1 ml / mercuric sulfide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml oral liquid [herpes simplex plus]||has_active_moiety
product containing aspirin||phenylephrine bitartrate 7.8 mg / aspirin 325 mg / chlorpheniramine maleate 2 mg oral tablet, effervescent [top value effervescent cold relief - orange]||has_active_moiety
selenicereus grandiflorus stem extract||selenicereus grandiflorus stem 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / sus scrofa artery 6 [hp_x] in 1 ml / pork heart 6 [hp_x] in 1 ml / arnica montana 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium chloride dihydrate 12 [hp_x] in 1 ml / cholesterol 12 [hp_x] in 1 ml / lecithin, soybean 12 [hp_x] in 1 ml / magnesium chloride 12 [hp_x] in 1 ml / oxalic acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml oral liquid [vascu-pro t009]||has_active_moiety
alcohol ethyl||benzalkonium chloride 0.05 % / ethanol 70 % topical spray||has_active_moiety
oyster shell calcium carbonate preparation||fucus vesiculosus 3 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml oral liquid [thyropar]||has_active_moiety
juglans oliviformis pollen||ambrosia trifida pollen 0.00067 g in 1 ml / ambrosia artemisiifolia pollen 0.00067 g in 1 ml / ambrosia psilostachya pollen 0.00067 g in 1 ml / carya illinoinensis pollen 0.0002 g in 1 ml / carya alba pollen 0.0002 g in 1 ml / ustilago nuda hordei 0.0001 g in 1 ml / ustilago maydis 0.0001 g in 1 ml / ustilago avenae 0.0001 g in 1 ml / ustilago tritici 0.0001 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / ustilago cynodontis 0.0002 g in 1 ml / sporisorium cruentum 0.0002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / poa pratensis pollen 800 [bau] in 1 ml / alternaria alternata 0.0004 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.0004 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / kochia scoparia pollen 0.0004 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / salsola kali pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
atriplex wrightii pollen||atriplex wrightii pollen 20000 [pnu] in 1 ml subcutaneous solution [annual saltbush]||has_active_moiety
arsenic 3+||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / borrelia burgdorferi 12 [hp_x] in 1 ml / babesia microti 20 [hp_x] in 1 ml / ehrlichia canis 20 [hp_x] in 1 ml / japanese encephalitis virus 30 [hp_x] in 1 ml / neisseria meningitidis 30 [hp_x] in 1 ml / hepatitis b virus 38 [hp_x] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / bryonia alba root 30 [hp_c] in 1 ml / chelidonium majus 30 [hp_c] in 1 ml / colchicum autumnale bulb 30 [hp_c] in 1 ml / kalmia latifolia leaf 30 [hp_c] in 1 ml / ledum palustre twig 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / toxicodendron pubescens leaf 30 [hp_c] in 1 ml oral liquid [lyme hp]||has_active_moiety
mesocricetus auratus hair extract||felis catus skin 60 [hp_x] in 1 ml / canis lupus familiaris skin 60 [hp_x] in 1 ml / oryctolagus cuniculus skin 60 [hp_x] in 1 ml / equus caballus skin 60 [hp_x] in 1 ml / serinus canaria feather 60 [hp_x] in 1 ml / gallus gallus feather 60 [hp_x] in 1 ml / anas platyrhynchos feather 60 [hp_x] in 1 ml / anser anser feather 60 [hp_x] in 1 ml / melopsittacus undulatus feather 60 [hp_x] in 1 ml / phasianus colchicus feather 60 [hp_x] in 1 ml / meleagris gallopavo feather 60 [hp_x] in 1 ml / felis catus hair 60 [hp_x] in 1 ml / human dander 60 [hp_x] in 1 ml / canis lupus familiaris hair 60 [hp_x] in 1 ml / equus caballus hair 60 [hp_x] in 1 ml / oryctolagus cuniculus hair 60 [hp_x] in 1 ml / human hair 60 [hp_x] in 1 ml / human skin 60 [hp_x] in 1 ml / sheep wool 60 [hp_x] in 1 ml / bos taurus hair 60 [hp_x] in 1 ml / capra hircus hair 60 [hp_x] in 1 ml / cavia porcellus hair 60 [hp_x] in 1 ml / mesocricetus auratus hair 60 [hp_x] in 1 ml / wheat gluten 15 [hp_x] in 1 ml / aspergillus niger var. niger 15 [hp_x] in 1 ml / cladosporium herbarum 15 [hp_x] in 1 ml / house dust 15 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / saccharomyces cerevisiae 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / antimony trisulfide 10 [hp_x] in 1 ml / apis mellifera 10 [hp_x] in 1 ml / arsenic trioxide 10 [hp_x] in 1 ml / baptisia tinctoria root 10 [hp_x] in 1 ml / blatta orientalis 10 [hp_x] in 1 ml / bromine 10 [hp_x] in 1 ml / bryonia alba root 10 [hp_x] in 1 ml / centaurea benedicta 10 [hp_x] in 1 ml / chelidonium majus 10 [hp_x] in 1 ml / cinchona officinalis bark 10 [hp_x] in 1 ml / ipecac 10 [hp_x] in 1 ml / lycopodium clavatum spore 10 [hp_x] in 1 ml / strychnos nux-vomica seed 10 [hp_x] in 1 ml / podophyllum 10 [hp_x] in 1 ml / toxicodendron pubescens leaf 10 [hp_x] in 1 ml / silicon dioxide 10 [hp_x] in 1 ml / iris versicolor root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml oral liquid [dust - mold - dander]||has_active_moiety
loperamide (substance)||anti-diarrheal, 2 mg oral capsule||has_active_moiety
1,3-benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-||albuterol 0.083% solution||has_active_moiety
2-ethylhexyl-p-methoxycinnamate (substance)||octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 highly moisturizing and coloring spf 25 (coral intense) - red]||has_active_moiety
taxol konzentrat||paclitaxel 100 mg per 16.7 ml injectable solution||has_active_moiety
onion allergenic extract||onion 6 [hp_x] in 1 ml / bryonia alba root 6 [hp_x] in 1 ml / matricaria chamomilla 3 [hp_x] in 1 ml / euphrasia stricta 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / arabica coffee bean 3 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / anemone pulsatilla 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral liquid [4 kids cold and mucus nighttime]||has_active_moiety
sus scrofa adrenal gland preparation||azadirachta indica bark 8 [hp_x] in 1 ml / atropa belladonna 8 [hp_x] in 1 ml / berberis vulgaris root bark 9 [hp_x] in 1 ml / peumus boldus leaf 4 [hp_x] in 1 ml / candida albicans 30 [hp_x] in 1 ml / ceanothus americanus leaf 4 [hp_x] in 1 ml / cetraria islandica subsp. islandica 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / echinacea angustifolia 4 [hp_x] in 1 ml / sus scrofa adrenal gland 9 [hp_x] in 1 ml / glycyrrhiza glabra 4 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 6 [hp_x] in 1 ml / pork liver 9 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / centella asiatica 6 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / arctium lappa root 4 [hp_x] in 1 ml / ledum palustre twig 9 [hp_x] in 1 ml / achillea millefolium 12 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / myrrh 4 [hp_x] in 1 ml / sus scrofa pancreas 9 [hp_x] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / plantago major 4 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / solidago virgaurea flowering top 4 [hp_x] in 1 ml / ginger 6 [hp_x] in 1 ml oral liquid [bacteria chord]||has_active_moiety
chicken meat extract||chicken allergenic extract 0.05 gm/ml injectable solution||has_active_moiety
furosemide (substance)||frusemide 20 mg oral tablet||has_active_moiety
octyl salicylate||octocrylene 35 mg in 1 ml / octisalate 50 mg in 1 ml / homosalate 80 mg in 1 ml / avobenzone 27 mg in 1 ml / oxybenzone 40 mg in 1 ml topical lotion [cvs pharmacy spf 30 beach guard sun]||has_active_moiety
sodium sulfate anhydrous||arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / mahonia aquifolium root bark 15 [hp_x] in 1 ml / calcium fluoride 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / magnesium carbonate 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / sodium carbonate 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / sodium sulfate 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / claviceps purpurea sclerotium 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / thymus serpyllum 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / cinchona bark 15 [hp_x] in 1 ml oral liquid [connective tissue]||has_active_moiety
amantadina||symmetrel 50mg/5ml syrup||has_active_moiety
octylmethoxycinnamate||titanium dioxide 0.035 g in 1 g / oxybenzone 0.03 g in 1 g / octinoxate 0.03 g in 1 g topical powder [lbel effet parfait loose extra-fine portable]||has_active_moiety
cl- element||normal saline 10 ml injection||has_active_moiety
twyneo||benzoyl peroxide 10 g in 100 ml topical gel [intensive face and body acne treatment]||has_active_moiety
4-tertiary-butyl-4'-methoxy-dibenzoylmethane (substance)||avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 50 mg in 1 ml / oxybenzone 60 mg in 1 ml topical lotion [la roche posay laboratoire dermatologique anthelios 45 ultra light sunscreen fluid water resistant 40]||has_active_moiety
calcium sulfide (substance)||calendula officinalis flowering top 3 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / ledum palustre twig 6 [hp_x] in 1 ml / matricaria recutita 5 [hp_x] in 1 ml / strychnos ignatii seed 30 [hp_x] in 1 ml / arnica montana 18 [hp_x] in 1 ml / ruta graveolens flowering top 12 [hp_x] in 1 ml / delphinium staphisagria seed 8 [hp_x] in 1 ml / hypericum perforatum 10 [hp_x] in 1 ml / echinacea purpurea 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml dental spray [stellalife vega oral care]||has_active_moiety
lytta vesicatoria preparation||ledum palustre twig 30 [hp_c] in 30 ml / lytta vesicatoria 30 [hp_c] in 30 ml / lachesis muta venom 30 [hp_c] in 30 ml / arnica montana 30 [hp_c] in 30 ml / apis mellifera 30 [hp_c] in 30 ml / st. john's wort 30 [hp_c] in 30 ml oral liquid [nenningers naturals]||has_active_moiety
terfenadine carboxylate||fexofenadine hydrochloride 180 mg oral tablet, film coated [equate allergy relief]||has_active_moiety
oat flowering top||avena sativa flowering top 1 [hp_x] in 1 ml / ammonium bromide 3 [hp_x] in 1 ml / matricaria chamomilla 6 [hp_x] in 1 ml / arabica coffee bean 6 [hp_x] in 1 ml / gelsemium sempervirens root 6 [hp_x] in 1 ml / tryptophan 6 [hp_x] in 1 ml / phosphoric acid 6 [hp_x] in 1 ml / valerian 30 [hp_x] in 1 ml oral liquid [quiet calm]||has_active_moiety
yeast||calendula officinalis flowering top 2 [hp_x] in 1 g / echinacea, unspecified 2 [hp_x] in 1 g / sweet marjoram 2 [hp_x] in 1 g / lilium lancifolium whole flowering 3 [hp_x] in 1 g / thuja occidentalis whole 3 [hp_x] in 1 g / wood creosote 6 [hp_x] in 1 g / pulsatilla vulgaris 6 [hp_x] in 1 g / silver 7 [hp_x] in 1 g / candida albicans 33 [hp_x] in 1 g vaginal suppository||has_active_moiety
carbonate||calcium carbonate 750 mg oral tablet, chewable [topcare antacid extra strength assorted berry]||has_active_moiety
bryonia alba root extract||aconitum napellus 20 [hp_x] in 1 ml / epinephrine 20 [hp_x] in 1 ml / american ginseng 20 [hp_x] in 1 ml / arnica montana 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / baptisia tinctoria 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / chelidonium majus 20 [hp_x] in 1 ml / cinchona officinalis bark 20 [hp_x] in 1 ml / iodine 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / potassium iodide 20 [hp_x] in 1 ml / lachesis muta venom 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / lycopus virginicus 20 [hp_x] in 1 ml / sodium chloride 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / anemone pulsatilla 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / saw palmetto 20 [hp_x] in 1 ml / thyroid, unspecified 20 [hp_x] in 1 ml / echinacea, unspecified 11 [hp_x] in 1 ml / ginkgo 11 [hp_x] in 1 ml / phytolacca americana root 11 [hp_x] in 1 ml oral liquid [exhaustion]||has_active_moiety
ranitidine (medication)||product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)||has_active_moiety
fluoride ion||ascorbic acid/cyanocobalamin/niacin/pyridoxine/riboflavin/sodium fluoride/thiamine/vitamin a/vitamin d/vitamin e 35 mg/1 ml-0.002 mg/1 ml-8 mg/1 ml-0.4 mg/1 ml-0.6 mg/1 ml-0.25 mg/1 ml-0.5 mg/1 ml-1500 iu/1 ml-400 iu/1 ml-5 iu/1 ml oral liquid [poly-vi-flor]||has_active_moiety
juglans regia leaf extract||bacillus anthracis immunoserum rabbit 200 [hp_c] in 1 ml / antimony trisulfide 30 [hp_c] in 1 ml / centella asiatica 30 [hp_c] in 1 ml / juglans regia fruit rind, immature 6 [hp_x] in 1 ml / juglans regia leaf 6 [hp_x] in 1 ml / potassium bromide 30 [hp_c] in 1 ml / ledum palustre twig 6 [hp_x] in 1 ml / sodium sulfide nonahydrate 200 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / radium bromide 200 [hp_c] in 1 ml / sanguinaria canadensis root 3 [hp_x] in 1 ml / sulfur iodide 200 [hp_c] in 1 ml / thuja occidentalis leafy twig 200 [hp_c] in 1 ml / urtica urens 3 [hp_x] in 1 ml oral spray [acne]||has_active_moiety
sus scrofa lung||antimony potassium tartrate 200 [hp_c] in 1 ml / arisaema triphyllum root 30 [hp_c] in 1 ml / spongilla lacustris 12 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / bryonia alba root 200 [hp_c] in 1 ml / drosera rotundifolia 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 200 [hp_c] in 1 ml / potassium bromide 6 [hp_x] in 1 ml / sus scrofa lung 6 [hp_x] in 1 ml / phosphorus 30 [hp_c] in 1 ml / anemone pratensis 30 [hp_c] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 12 [hp_x] in 1 ml / lobaria pulmonaria 200 [hp_c] in 1 ml / sulfur iodide 200 [hp_c] in 1 ml / urtica urens 200 [hp_c] in 1 ml oral spray [cough plus bronchial]||has_active_moiety
(s)-4-pregnene-3,20-dione||progesterone 1 mg in 1 mg transdermal cream [p75 lav progesterone cream]||has_active_moiety
β-dimethylaminoethanol diphenylmethyl ether||diphenhydramine citrate/ibuprofen 38 mg-200 mg oral tablet||has_active_moiety
phycomyces blakesleeanus||mycocladus corymbiferus 0.0083 g in 1 ml / acrothecium robustum 0.0083 g in 1 ml / humicola grisea 0.0083 g in 1 ml / microsporum audouinii 0.0083 g in 1 ml / microsporum canis 0.0083 g in 1 ml / apiospora montagnei 0.0083 g in 1 ml / phycomyces blakesleeanus 0.0083 g in 1 ml / sporotrichum pruinosum 0.0083 g in 1 ml / stachybotrys chartarum 0.0083 g in 1 ml / syncephalastrum racemosum 0.0083 g in 1 ml / tetracoccosporium paxianum 0.0083 g in 1 ml / verticillium albo-atrum 0.0083 g in 1 ml intradermal injection, solution||has_active_moiety
pascopyrum smithii pollen extract||cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / phleum pratense pollen 800 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula populifolia pollen 0.002 g in 1 ml / acer negundo pollen 0.0004 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / quercus alba pollen 0.0004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / broussonetia papyrifera pollen 0.00013 g in 1 ml / morus rubra pollen 0.00013 g in 1 ml / morus alba pollen 0.00013 g in 1 ml subcutaneous injection, solution||has_active_moiety
toxicodendron vernix leafy twig||toxicodendron vernix leafy twig 9 [hp_c] in 9 [hp_c] oral pellet [rhus venenata]||has_active_moiety
cordianine||allantoin topical 0.5% topical gel||has_active_moiety
paraffinum album||phenylephrine hydrochloride 2.5 mg in 1 g / mineral oil 140 mg in 1 g / petrolatum 749 mg in 1 g topical ointment [signature care hemorrhoidal]||has_active_moiety
(+-)-n-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine||product containing fluoxetine 10 mg/1 each oral capsule||has_active_moiety
corgard||nadolol, 80 mg oral tablet||has_active_moiety
glycopyrronium-containing product||glycopyrrolate 0.2 mg/ml injectable solution||has_active_moiety
tree pollen-black willow||urtica dioica pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula populifolia pollen 0.00008 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.0004 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus nigra pollen 0.001 g in 1 ml / populus alba pollen 0.001 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml / equus caballus hair 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
2-benzoyl-5-methoxyphenol||octinoxate 0.071 g in 1 g / oxybenzone 0.016 g in 1 g topical lipstick [lbel couleur luxe rouge irresistible maximum hydration spf 17 (vin) - purple]||has_active_moiety
omeprazolum||product containing only omeprazole 40 mg and sodium bicarbonate 1100 mg/1 each oral capsule||has_active_moiety
phosphoric acid (substance)||echinacea angustifolia 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / marsdenia condurango bark 4 [hp_x] in 1 ml / ginkgo 4 [hp_x] in 1 ml / ligusticum porteri root 4 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / astragalus propinquus root 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / bos taurus thymus 8 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / alternaria alternata 12 [hp_x] in 1 ml / aspergillus niger var. niger 12 [hp_x] in 1 ml / candida albicans 12 [hp_x] in 1 ml / candida parapsilosis 12 [hp_x] in 1 ml / mucor racemosus 12 [hp_x] in 1 ml / aureobasidium pullulans var. pullutans 12 [hp_x] in 1 ml / rhizopus stolonifer 12 [hp_x] in 1 ml / saccharomyces cerevisiae 12 [hp_x] in 1 ml oral liquid [fng i]||has_active_moiety
ethanol (substance)||alcohol 350 ml in 500 ml topical gel [advanced 2 in 1 hand sanitizer]||has_active_moiety
product containing benzalkonium||benzalkonium chloride 0.1 %-3" x 4" topical adhesive patch, medicated||has_active_moiety
giant scallop preparation||giant scallop 300 [hp_c] oral pellet [pecten]||has_active_moiety
oat flowering top||alfalfa 3 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / fucus vesiculosus 3 [hp_x] in 1 ml / american ginseng 6 [hp_x] in 1 ml / sodium carbonate 6 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml / sus scrofa pineal gland 8 [hp_x] in 1 ml / rhododendron aureum leaf 10 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / silver nitrate 12 [hp_x] in 1 ml / cadmium iodide 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / holmium 16 [hp_x] in 1 ml / radium bromide 16 [hp_x] in 1 ml / citharacanthus spinicrus 30 [hp_x] in 1 ml / uranyl nitrate hexahydrate 30 [hp_x] in 1 ml / alcohol, x-ray exposed (1000 rad) 30 [hp_x] in 1 ml oral liquid [terrestristat]||has_active_moiety
chamaelirium luteum root extract||arnica montana 1.5 [hp_c] in 30 ml / arsenic trioxide 200 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / echinacea, unspecified 1.5 [hp_c] in 30 ml / hamamelis virginiana leaf 1.5 [hp_c] in 30 ml / chamaelirium luteum root 1.5 [hp_c] in 30 ml / pork liver 3 [hp_c] in 30 ml / iris versicolor root 3 [hp_c] in 30 ml / sus scrofa pancreas 3 [hp_c] in 30 ml / phosphoric acid 200 [hp_c] in 30 ml / rosmarinus officinalis flowering top 1.5 [hp_c] in 30 ml / claviceps purpurea sclerotium 30 [hp_c] in 30 ml / syzygium cumini seed 1.5 [hp_c] in 30 ml / uranyl nitrate hexahydrate 30 [hp_c] in 30 ml oral spray [diabetigen]||has_active_moiety
cysplatyna||cisplatin 50mg/50ml injection solution (product)||has_active_moiety
cl- element||nulytely orange, oral powder for reconstitution||has_active_moiety
pulsatilla vulgaris whole||onion 6 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / anemone pulsatilla 6 [hp_x] in 1 ml / matricaria chamomilla 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / arabica coffee bean 6 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml oral liquid [4 kids cold and cough nighttime]||has_active_moiety
product containing octocrilene (medicinal product)||octocrylene 80 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 50 mg in 1 ml / oxybenzone 30 mg in 1 ml / avobenzone 25 mg in 1 ml topical lotion [cocooil spf30]||has_active_moiety
clobetasol (product)||clobetasol (eqv-temovate e), 0.05% topical cream||has_active_moiety
motrin ib||midol cramps and body aches formula 200mg tablet||has_active_moiety
ethyl alcohol product||alcohol 75 ml in 100 ml topical gel [baby beluga instant hand sanitizer]||has_active_moiety
oxycodeinon||oxycodone hydrochloride 5 mg oral tablet||has_active_moiety
(s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid||levofloxacin (as levofloxacin hemihydrate) 250 mg oral tablet||has_active_moiety
black cohosh||black cohosh 4 [hp_x] in 2 ml / anamirta cocculus seed 4 [hp_x] in 2 ml / cypripedium parviflorum var. pubescens root 4 [hp_x] in 2 ml / strychnos ignatii seed 6 [hp_x] in 2 ml / passiflora incarnata flowering top 4 [hp_x] in 2 ml / platinum 10 [hp_x] in 2 ml / valerian 4 [hp_x] in 2 ml / zinc valerate dihydrate 8 [hp_x] in 2 ml intravenous injection [hevert calmvalera comp.]||has_active_moiety
spices, saffron||potassium acetate 6 [hp_x] in 1 ml / antimony trisulfide 30 [hp_x] in 1 ml / saffron 6 [hp_x] in 1 ml / umbilicus rupestris 30 [hp_x] in 1 ml / corallium rubrum exoskeleton 10 [hp_x] in 1 ml / bos taurus pancreas 15 [hp_x] in 1 ml / quercus alba wood 30 [hp_x] in 1 ml sublingual solution [d-93]||has_active_moiety
pot marigold flower||apis mellifera 8 [hp_x] in 30 ml / calendula officinalis flower 1 [hp_x] in 30 ml / malic acid 6 [hp_x] in 30 ml / equisetum hyemale 3 [hp_x] in 30 ml / fumaric acid 6 [hp_x] in 30 ml / graphite 12 [hp_x] in 30 ml / juglans regia fruit rind, immature 5 [hp_x] in 30 ml / levothyroxine 12 [hp_x] in 30 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 30 ml / myosotis arvensis 4 [hp_x] in 30 ml / sodium diethyl oxalacetate 6 [hp_x] in 30 ml / sodium pyruvate 6 [hp_x] in 30 ml / phytolacca americana root 4 [hp_x] in 30 ml / sarsaparilla 3 [hp_x] in 30 ml / taraxacum officinale 1 [hp_x] in 30 ml / dodecahydroxycyclohexane dihydrate 6 [hp_x] in 30 ml / sus scrofa placenta 6 [hp_x] in 30 ml / horse chestnut 2 [hp_x] in 30 ml / goldenseal 5 [hp_x] in 30 ml / centella asiatica whole 2 [hp_x] in 30 ml oral solution/ drops [guna lympho detox]||has_active_moiety
product containing guaifenesin (medicinal product)||cold & head congestion severe, 325 mg-200 mg-5 mg oral tablet||has_active_moiety
propanamide, n-phenyl-n-(1-(2-phenylethyl)-4-piperidinyl)-||fentanyl citrate 800 ug buccal tablet [fentanyl buccal]||has_active_moiety
cadmium cation||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / fucus vesiculosus 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 3 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / cadmium sulfide 13 [hp_x] in 1 ml oral liquid [free radistat]||has_active_moiety
penicillium notatum allergenic extract||dermatophagoides farinae 400 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / cladosporium herbarum 0.002 g in 1 ml / mucor racemosus 0.002 g in 1 ml / alternaria alternata 0.0004 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 160 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml / poa pratensis pollen 800 [bau] in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / pleospora herbarum 0.0004 g in 1 ml / carya tomentosa pollen 0.0004 g in 1 ml / morus alba pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
metolazonum||metolazone 2.5 mg oral tablet [metolazone]||has_active_moiety
sepia officinalis juice||aesculus hippocastanum flower 10 [hp_x] in 59 ml / aloe 10 [hp_x] in 59 ml / arnica montana 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / borage 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / carpinus betulus flowering top 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / potassium sulfate 10 [hp_x] in 59 ml / mentha piperita 10 [hp_x] in 59 ml / nitric acid 10 [hp_x] in 59 ml / olea europaea flower 10 [hp_x] in 59 ml / nerium oleander leaf 10 [hp_x] in 59 ml / onosmodium virginianum whole 10 [hp_x] in 59 ml / palladium 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / tropaeolum majus 10 [hp_x] in 59 ml / ulmus procera flowering twig 10 [hp_x] in 59 ml / viola tricolor 10 [hp_x] in 59 ml oral liquid [self pity]||has_active_moiety
pulsatilla vulgaris extract||apis mellifera 8 [hp_x] in 1 ml / echinacea, unspecified 8 [hp_x] in 1 ml / goldenseal 8 [hp_x] in 1 ml / thuja occidentalis leafy twig 8 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / amanita muscaria fruiting body 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / azadirachta indica bark 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / calendula officinalis flowering top 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / milk thistle 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / sage 15 [hp_x] in 1 ml / selenium 15 [hp_x] in 1 ml / taraxacum officinale 15 [hp_x] in 1 ml / lycosa tarantula 15 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / bacillus anthracis 20 [hp_x] in 1 ml / influenza a virus 35 [hp_x] in 1 ml / influenza b virus 35 [hp_x] in 1 ml oral liquid [immune waker]||has_active_moiety
rumex crispus root||bryonia alba root 3 [hp_c] in 1 ml / protortonia cacti 3 [hp_c] in 1 ml / drosera rotundifolia 3 [hp_c] in 1 ml / ipecac 3 [hp_c] in 1 ml / pulsatilla vulgaris 6 [hp_c] in 1 ml / rumex crispus root 6 [hp_c] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_c] in 1 ml / lobaria pulmonaria 3 [hp_c] in 1 ml / antimony potassium tartrate 6 [hp_c] in 1 ml oral syrup [365 everyday value be well cough ease]||has_active_moiety
chloride ion||sodium chloride 0.99 g in 100 ml topical liquid [bye bye (toc toc)]||has_active_moiety
shade uvaguard||octocrylene 10 g in 100 g / oxybenzone 6 g in 100 g / avobenzone 2 g in 100 g topical stick [banana boat]||has_active_moiety
product containing deutetrabenazine (medicinal product)||deutetrabenazine 6 mg oral tablet||has_active_moiety
1,3,7-trimethylpurine-2,6-dione||product containing acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg/1 each oral tablet||has_active_moiety
aluminum chloride hydroxide||aluminum sesquichlorohydrate 16 g in 100 g topical aerosol, spray||has_active_moiety
zinc, bis(1-hydroxy-2(1h)-pyridinethionato)-||zinc pyrithione 0.5 % medicated shampoo||has_active_moiety
cinchona officinalis bark extract||antimony trisulfide 10 [hp_x] in 29.6 ml / silver nitrate 10 [hp_x] in 29.6 ml / activated charcoal 10 [hp_x] in 29.6 ml / chelidonium majus 10 [hp_x] in 29.6 ml / cinchona officinalis bark 10 [hp_x] in 29.6 ml / graphite 10 [hp_x] in 29.6 ml / goldenseal 10 [hp_x] in 29.6 ml / ipecac 10 [hp_x] in 29.6 ml / potassium carbonate 10 [hp_x] in 29.6 ml / lycopodium clavatum spore 10 [hp_x] in 29.6 ml / strychnos nux-vomica seed 10 [hp_x] in 29.6 ml / pulsatilla vulgaris 10 [hp_x] in 29.6 ml oral liquid [indigestion symptom formula]||has_active_moiety
egg yolk lecithins||semecarpus anacardium juice 30 [hp_c] in 30 ml / arnica montana 1.5 [hp_c] in 30 ml / calcium fluoride 30 [hp_c] in 30 ml / silybum marianum seed oil 1.5 [hp_c] in 30 ml / cinchona officinalis bark 3 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / ginkgo 3 [hp_c] in 30 ml / egg phospholipids 6 [hp_c] in 30 ml / achillea millefolium 1.5 [hp_c] in 30 ml / phosphoric acid 30 [hp_c] in 30 ml / saccharomyces cerevisiae rna 6 [hp_c] in 30 ml / silicon dioxide 6 [hp_c] in 30 ml / zinc sulfate heptahydrate 6 [hp_c] in 30 ml oral spray [brain power]||has_active_moiety
abilify||abilify maintena kit||has_active_moiety
lidocaine||lidocaine hydrochloride 1% epidural solution [shocaine 1%]||has_active_moiety
absolute ethanol||alcohol 70 ml in 100 ml topical liquid [lagrace aqua perfect hand sanitizerspray]||has_active_moiety
dimethicone as antiflatulent (medication)||dimethicone 7.06 g in 50 ml topical cream [oxy stem m]||has_active_moiety
7-chloro-7-deoxylincomycin||clindamycin phosphate 10 mg in 1 g topical gel||has_active_moiety
antimony cation (3+)||matricaria recutita 3 [hp_x] in 1 g / myrrh 3 [hp_x] in 1 g / rosmarinus officinalis flowering top 3 [hp_x] in 1 g / ruta graveolens flowering top 5 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g / antimony potassium tartrate 6 [hp_c] in 1 g topical gel [soothing respiratory rub]||has_active_moiety
ethyl alcohol||alcohol 70 ml in 100 ml topical gel [canpaco hand sanitizer]||has_active_moiety
sepia officinalis juice||oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / skim milk 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / whey 12 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium roqueforti cultured, aged 12 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium camemberti cultured, aged 12 [hp_x] in 1 ml / casein, lactococcus lactis cultured, aged 12 [hp_x] in 1 ml / casein, lactococcus lactis cultured 12 [hp_x] in 1 ml / goat milk 12 [hp_x] in 1 ml / cow milk 12 [hp_x] in 1 ml / casein, emmental cultured 12 [hp_x] in 1 ml oral liquid [dairy antigens]||has_active_moiety
datura stramonium extract||asafetida 8 [hp_x] in 100 ml / strychnos ignatii seed 8 [hp_x] in 100 ml / valerian 8 [hp_x] in 100 ml / avena sativa flowering top 8 [hp_x] in 100 ml / silver nitrate 8 [hp_x] in 100 ml / lycosa tarantula 8 [hp_x] in 100 ml / hyoscyamus niger 8 [hp_x] in 100 ml / paeonia officinalis root 8 [hp_x] in 100 ml / datura stramonium 8 [hp_x] in 100 ml / anamirta cocculus seed 8 [hp_x] in 100 ml oral syrup [calm kids relief]||has_active_moiety
octinoxate (substance)||octinoxate 0.07 g in 1 g topical lipstick [esika pro advance lasting long-lasting and comfort spf 20 (marron havana) - brown]||has_active_moiety
lachesis muta venom||micrurus corallinus venom 30 [hp_x] in 1 g / chaste tree 10 [hp_x] in 1 g / angelica sinensis root 10 [hp_x] in 1 g / arsenic trioxide 10 [hp_x] in 1 g / bryonia alba root 10 [hp_x] in 1 g / lytta vesicatoria 10 [hp_x] in 1 g / caulophyllum thalictroides root 10 [hp_x] in 1 g / black cohosh 10 [hp_x] in 1 g / cinchona officinalis bark 10 [hp_x] in 1 g / crotalus horridus horridus venom 10 [hp_x] in 1 g / turnera diffusa leafy twig 10 [hp_x] in 1 g / nitroglycerin 10 [hp_x] in 1 g / chamaelirium luteum root 10 [hp_x] in 1 g / strychnos ignatii seed 10 [hp_x] in 1 g / potassium carbonate 10 [hp_x] in 1 g / lachesis muta venom 10 [hp_x] in 1 g / naja naja venom 10 [hp_x] in 1 g / strychnos nux-vomica seed 10 [hp_x] in 1 g / phosphorus 10 [hp_x] in 1 g / pulsatilla vulgaris 10 [hp_x] in 1 g / salix nigra bark 10 [hp_x] in 1 g / sanguinaria canadensis root 10 [hp_x] in 1 g / sepia officinalis juice 10 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g / valerian 3 [hp_x] in 1 g oral pellet [menopause]||has_active_moiety
product containing ethyl alcohol||benzalkonium chloride 0.1 mg in 100 ml / alcohol 80 ml in 100 ml topical cloth [lifetogo alcohol wipes 10 pack]||has_active_moiety
drosera rotundifolia extract||aconitum napellus 10 [hp_x] in 29.6 ml / bromine 10 [hp_x] in 29.6 ml / protortonia cacti 10 [hp_x] in 29.6 ml / corallium rubrum exoskeleton 10 [hp_x] in 29.6 ml / copper 10 [hp_x] in 29.6 ml / drosera rotundifolia 10 [hp_x] in 29.6 ml / calcium sulfide 10 [hp_x] in 29.6 ml / iodine 10 [hp_x] in 29.6 ml / mephitis mephitis anal gland fluid 10 [hp_x] in 29.6 ml / spongia officinalis skeleton, roasted 10 [hp_x] in 29.6 ml oral liquid [childrens cough symptom formula]||has_active_moiety
immunoglobulin g (human)||immunoglobulin g, human 20 % per 20 ml injection||has_active_moiety
zinnia elegans whole||prunus persica flower 12 [hp_c] in 1 ml / nelumbo nucifera flower 12 [hp_c] in 1 ml / anagallis arvensis extract 12 [hp_c] in 1 ml / tropaeolum majus flower 12 [hp_c] in 1 ml / phosphoric acid 12 [hp_c] in 1 ml / acer nigrum whole 12 [hp_c] in 1 ml / verbena officinalis flowering top 12 [hp_c] in 1 ml / american ginseng 4 [hp_x] in 1 ml / aesculus hippocastanum flower 12 [hp_c] in 1 ml / borago officinalis flower 12 [hp_c] in 1 ml / capsicum 12 [hp_c] in 1 ml / carpinus betulus flower 12 [hp_c] in 1 ml / prunella vulgaris flower 12 [hp_c] in 1 ml / umbellularia californica whole 12 [hp_c] in 1 ml / iris missouriensis whole 12 [hp_c] in 1 ml / ulmus procera flowering twig 12 [hp_c] in 1 ml / olea europaea flower 12 [hp_c] in 1 ml / fuchsia magellanica whole 12 [hp_c] in 1 ml / quinine arsenite 9 [hp_c] in 1 ml / cornus nuttallii whole 12 [hp_c] in 1 ml / rudbeckia hirta whole 12 [hp_c] in 1 ml / syringa vulgaris flower 12 [hp_c] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / aloe vera flower 12 [hp_c] in 1 ml / arnica montana flower 12 [hp_c] in 1 ml / chaste tree 4 [hp_x] in 1 ml / alfalfa 4 [hp_x] in 1 ml / zinnia elegans whole 12 [hp_c] in 1 ml sublingual solution/ drops [f20 vtlty]||has_active_moiety
buprenorfina||buprenorphine hydrochloride 8 mg sublingual tablet [buprenorphine hydrochloride sublingual]||has_active_moiety
lassars paste||vitamin a 4000 [iu] / ascorbic acid 120 mg / cholecalciferol 400 [iu] / .alpha.-tocopherol acetate, dl- 22 [iu] / thiamine mononitrate 1.84 mg / riboflavin 3 mg / niacinamide 20 mg / pyridoxine hydrochloride 10 mg / folic acid 1 mg / cyanocobalamin 12 ug / calcium carbonate 200 mg / iron 29 mg / zinc oxide 25 mg / cupric oxide 2 mg oral tablet [prenatal plus]||has_active_moiety
thuja occidentalis whole extract||equisetum arvense top 2 [hp_x] in 1 g / levisticum officinale root 2 [hp_x] in 1 g / sloe 2 [hp_x] in 1 g / urtica dioica 2 [hp_x] in 1 g / dryopteris filix-mas root 3 [hp_x] in 1 g / formica rufa 3 [hp_x] in 1 g / pteridium aquilinum whole 3 [hp_x] in 1 g / asplenium scolopendrium top 3 [hp_x] in 1 g / bos taurus thymus 4 [hp_x] in 1 g / mammal liver 4 [hp_x] in 1 g / ostrea edulis shell 5 [hp_x] in 1 g / silver 6 [hp_x] in 1 g / pork kidney 6 [hp_x] in 1 g / thuja occidentalis whole 6 [hp_x] in 1 g / amanita muscaria fruiting body 7 [hp_x] in 1 g / silicon dioxide 12 [hp_x] in 1 g / mercury 14 [hp_x] in 1 g oral pellet||has_active_moiety
arabian coffee bean||atropa belladonna 30 [hp_c] in 30 [hp_c] / oyster shell calcium carbonate, crude 30 [hp_c] in 30 [hp_c] / lytta vesicatoria 30 [hp_c] in 30 [hp_c] / matricaria recutita 30 [hp_c] in 30 [hp_c] / arabica coffee bean 30 [hp_c] in 30 [hp_c] / copper 30 [hp_c] in 30 [hp_c] / lachesis muta venom 30 [hp_c] in 30 [hp_c] / hyoscyamus niger 30 [hp_c] in 30 [hp_c] / phytolacca americana root 30 [hp_c] in 30 [hp_c] / datura stramonium 30 [hp_c] in 30 [hp_c] / veratrum album root 30 [hp_c] in 30 [hp_c] oral spray [pinching and biting]||has_active_moiety
gamma interferon-sch||interferon-.gamma. 12 [hp_c] oral tablet [cold-fix (for children)]||has_active_moiety
ir element||echinacea angustifolia 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / ipecac 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / hydrochloric acid 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / human herpesvirus 5 30 [hp_x] in 1 ml oral liquid [cmv stat]||has_active_moiety
ginseng preparation||chaste tree 20 [hp_x] in 1 ml / american ginseng 20 [hp_x] in 1 ml / barium carbonate 20 [hp_x] in 1 ml / berberis vulgaris root bark 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / dieffenbachia seguine 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / causticum 20 [hp_x] in 1 ml / chelidonium majus 20 [hp_x] in 1 ml / cinchona officinalis bark 20 [hp_x] in 1 ml / conium maculatum flowering top 20 [hp_x] in 1 ml / gaultheria procumbens top 20 [hp_x] in 1 ml / graphite 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / onosmodium virginianum root 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / saw palmetto 20 [hp_x] in 1 ml / selenium 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / silicon dioxide 20 [hp_x] in 1 ml / delphinium staphisagria seed 20 [hp_x] in 1 ml / goldenseal 8 [hp_x] in 1 ml / thuja occidentalis leafy twig 8 [hp_x] in 1 ml oral liquid [libido]||has_active_moiety
coal tar product||coal tar 5 mg in 1 ml topical cream [psodex psoriasis cream standard therapy]||has_active_moiety
amanita muscaria var. muscaria||amanita muscaria var. muscaria fruiting body 10 [hp_x] in 59 ml / aluminum oxide 10 [hp_x] in 59 ml / anagallis arvensis 10 [hp_x] in 59 ml / antimony potassium tartrate 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / arsenic triiodide 10 [hp_x] in 59 ml / giant puffball 10 [hp_x] in 59 ml / causticum 10 [hp_x] in 59 ml / mucuna pruriens fruit trichome 10 [hp_x] in 59 ml / fagopyrum esculentum 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / potassium chloride 10 [hp_x] in 59 ml / hydrochloric acid 10 [hp_x] in 59 ml / nerium oleander leaf 10 [hp_x] in 59 ml / kerosene 10 [hp_x] in 59 ml / pine tar 10 [hp_x] in 59 ml / radium bromide 12 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / selenium 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / urtica urens 10 [hp_x] in 59 ml oral liquid [skin irritations and itch relief]||has_active_moiety
avena sativa flowering top||pancrelipase 10 [hp_x] in 1 ml / pepsin 4 [hp_x] in 1 ml / frangula purshiana bark 1 [hp_x] in 1 ml / glycyrrhiza glabra 2 [hp_x] in 1 ml / star anise 1 [hp_x] in 1 ml / potassium carbonate 10 [hp_x] in 1 ml / activated charcoal 20 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / cajuput oil 3 [hp_x] in 1 ml / carbo animalis 15 [hp_x] in 1 ml / bos taurus bile 4 [hp_x] in 1 ml / lycopodium clavatum spore 9 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 8 [hp_x] in 1 ml / strychnos nux-vomica seed 30 [hp_x] in 1 ml / gentiana lutea root 1 [hp_x] in 1 ml / indole 12 [hp_x] in 1 ml / skatole 12 [hp_x] in 1 ml / avena sativa flowering top 1 [hp_x] in 1 ml / chelidonium majus 1 [hp_x] in 1 ml / radish 8 [hp_x] in 1 ml / alfalfa 1 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml sublingual solution/ drops [b04 digestion]||has_active_moiety
histamines||adenosine cyclic phosphate 12 [hp_x] in 59 ml / epinephrine 12 [hp_x] in 59 ml / corticotropin 12 [hp_x] in 59 ml / onion 12 [hp_x] in 59 ml / ambrosia artemisiifolia 12 [hp_x] in 59 ml / chelidonium majus 12 [hp_x] in 59 ml / chenopodium vulvaria 12 [hp_x] in 59 ml / chicory root 12 [hp_x] in 59 ml / cortisone acetate 12 [hp_x] in 59 ml / euphrasia stricta 12 [hp_x] in 59 ml / galphimia glauca flowering top 12 [hp_x] in 59 ml / hedera helix flowering twig 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / juglans cinerea branch bark/root bark 12 [hp_x] in 59 ml / potassium chloride 12 [hp_x] in 59 ml / sus scrofa nasal mucosa 12 [hp_x] in 59 ml / sodium chloride 12 [hp_x] in 59 ml / anemone patens 12 [hp_x] in 59 ml / saccharomyces cerevisiae rna 12 [hp_x] in 59 ml / schoenocaulon officinale seed 12 [hp_x] in 59 ml / teucrium scorodonia flowering top 12 [hp_x] in 59 ml oral liquid [allergies great lakes u.s.]||has_active_moiety
human breast tumor cell||epinephrine 3 [hp_x] / gold 8 [hp_x] / human breast tumor cell 24 [hp_x] / echinacea, unspecified 3 [hp_x] / gelsemium sempervirens root 6 [hp_x] / ginkgo 3 [hp_x] / influenza b virus 12 [hp_x] / phosphoric acid 6 [hp_x] / scutellaria lateriflora top 6 [hp_x] oral tablet, orally disintegrating [chronic fatigue therapy]||has_active_moiety
matmate||titanium dioxide 5 g in 100 g / zinc oxide 5 g in 100 g topical cream [purminerals 4-in-1 mineral tinted moisturizer broad spectrum spf 20 (light)]||has_active_moiety
decitabine product||decitabine 50mg powder for injection solution vial||has_active_moiety
rancid beef preparation||apis mellifera 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_x] in 1 ml / atropa belladonna 30 [hp_x] in 1 ml / matricaria recutita 30 [hp_x] in 1 ml / echinacea angustifolia 30 [hp_x] in 1 ml / lachesis muta venom 30 [hp_x] in 1 ml / mercurius solubilis 30 [hp_x] in 1 ml / pulsatilla vulgaris 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml oral liquid [bacto plus hp]||has_active_moiety
citharacanthus spinicrus preparation||juniperus virginiana twig 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / syzygium cumini seed 3 [hp_x] in 1 ml / chelidonium majus 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / myrtus communis top 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / citharacanthus spinicrus 12 [hp_x] in 1 ml oral liquid [pancreaforce]||has_active_moiety
(all-z)-4,7,10,13,16,19-docosahexaenoic acid||ob complete one with dha, prenatal multivitamins with folic acid 1 mg oral capsule||has_active_moiety
pigment white 6||titanium dioxide 110 mg in 1 ml topical liquid [bareminerals bareskin pure brightening serum foundation broad spectrum spf 20 bare nude]||has_active_moiety
n2 element||nitrogen 99 ml in 100 ml respiratory (inhalation) gas||has_active_moiety
wild gentian root||lycopodium clavatum spore 30 [hp_x] in 30 ml / strychnos nux-vomica seed 12 [hp_x] in 30 ml / echinacea, unspecified 3 [hp_x] in 30 ml / baptisia tinctoria 3 [hp_x] in 30 ml / pulsatilla vulgaris 30 [hp_x] in 30 ml / sepia officinalis juice 30 [hp_x] in 30 ml / phosphoric acid 12 [hp_x] in 30 ml / wood creosote 12 [hp_x] in 30 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 30 ml / sodium borate 12 [hp_x] in 30 ml / gentiana lutea root 3 [hp_x] in 30 ml / nutmeg 12 [hp_x] in 30 ml / asafetida 12 [hp_x] in 30 ml oral liquid [cand-ex]||has_active_moiety
tellurium metallicum / tellurium||silicon dioxide 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / sulfuric acid 15 [hp_x] in 1 ml / zinc 15 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / sanicula europaea leaf 16 [hp_x] in 1 ml / tellurium 16 [hp_x] in 1 ml / saccharomyces cerevisiae 16 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / barium carbonate 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / activated charcoal 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / solanum dulcamara top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / daphne mezereum bark 15 [hp_x] in 1 ml / nitric acid 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml oral liquid [fungal]||has_active_moiety
ji xue cao whole||centella asiatica 10 mg in 10 g / neomycin sulfate 3.5 mg in 10 g / hydrocortisone acetate 10 mg in 10 g topical ointment [no-scar oint.]||has_active_moiety
bryonia alba root extract||bryonia alba root 200 [hp_c] / conium maculatum flowering top 30 [hp_c] oral pellet [tinnam 40 number 77]||has_active_moiety
amlodipine (substance)||amlodipine (as amlodipine besilate) 10 mg oral tablet||has_active_moiety
alcohol, ethyl||alcohol 62 ml in 100 ml topical solution [vanilla sugar anti-bacterial scented hand sanitizer]||has_active_moiety
diltiazem-containing product||cardizem tablets-30 mg||has_active_moiety
doxepin product||doxepin hydrochloride 100 mg/1 each oral capsule||has_active_moiety
f- element||sodium fluoride 0.24 g in 100 g / potassium nitrate 5 g in 100 g dental paste, dentifrice [family wellness maximum strength]||has_active_moiety
perphenazine (substance)||perphenazine 4 mg oral tablet [trilafon]||has_active_moiety
german chamomile extract||althaea officinalis root 1 [hp_x] in 148 ml / antimony pentasulfide 12 [hp_x] in 148 ml / antimony potassium tartrate 6 [hp_x] in 148 ml / bryonia alba root 6 [hp_x] in 148 ml / cetraria islandica subsp. islandica 1 [hp_x] in 148 ml / matricaria recutita 1 [hp_x] in 148 ml / drosera rotundifolia 6 [hp_x] in 148 ml / echinacea angustifolia 1 [hp_x] in 148 ml / ipecac 6 [hp_x] in 148 ml / potassium chloride 6 [hp_x] in 148 ml / plantago lanceolata pollen 1 [hp_x] in 148 ml / rumex crispus root 6 [hp_x] in 148 ml / polygala senega root 6 [hp_x] in 148 ml / spongia officinalis skeleton, roasted 6 [hp_x] in 148 ml / sus scrofa thymus 1 [hp_x] in 148 ml / trifolium pratense flower 1 [hp_x] in 148 ml / urtica dioica 1 [hp_x] in 148 ml / verbascum thapsus 1 [hp_x] in 148 ml oral liquid [cough relief syrup]||has_active_moiety
furosemidum||frusemide 50mg/5ml s/f oral solution (substance)||has_active_moiety
etoh - alcohol||alcohol 70 ml in 100 ml topical gel [dermonano]||has_active_moiety
brewer's yeast allergenic extract||alternaria alternata 30 [hp_x] in 1 ml / aspergillus niger var. niger 30 [hp_x] in 1 ml / candida albicans 30 [hp_x] in 1 ml / candida parapsilosis 30 [hp_x] in 1 ml / saccharomyces cerevisiae 30 [hp_x] in 1 ml / mucor racemosus 30 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla pratensis whole 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / rhizopus stolonifer 30 [hp_c] in 1 ml oral liquid [mold antigens]||has_active_moiety
3,3,5-trimethylcyclohexyl 2-hydroxybenzoate||avobenzone 30 mg in 1 ml / homosalate 90 mg in 1 ml / octocrylene 27 mg in 1 ml topical cream [hydra-essential spf 15 broad spectrum - spf 15 - sunscreen]||has_active_moiety
meadow fescue grass pollen extract||cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.005 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / dermatophagoides pteronyssinus 1000 [au] in 1 ml / alternaria alternata 0.005 g in 1 ml / aspergillus fumigatus 0.005 g in 1 ml intradermal injection, solution||has_active_moiety
glycerol||glycerin 0.3 g in 100 ml topical liquid [jena cell vl gravity essence for body only.]||has_active_moiety
titanium dioxide (product)||titanium dioxide 8.8 g in 124 g / zinc oxide 4.34 g in 124 g topical lotion [safe harbor natural suncare broad spectrum]||has_active_moiety
zn2+||zinc oxide 15 g in 100 g topical spray [trader joes zinc oxide mineral sunscreen spf 30]||has_active_moiety
bees honey||aconitum napellus 20 [hp_x] in 1 g / apis mellifera 20 [hp_x] in 1 g / arnica montana 20 [hp_x] in 1 g / arsenic trioxide 20 [hp_x] in 1 g / atropa belladonna 20 [hp_x] in 1 g / bellis perennis 20 [hp_x] in 1 g / bryonia alba root 20 [hp_x] in 1 g / calendula officinalis flowering top 20 [hp_x] in 1 g / matricaria recutita 20 [hp_x] in 1 g / helianthemum canadense 20 [hp_x] in 1 g / ferrosoferric phosphate 20 [hp_x] in 1 g / histamine dihydrochloride 20 [hp_x] in 1 g / hypericum perforatum 20 [hp_x] in 1 g / strychnos ignatii seed 20 [hp_x] in 1 g / daphne mezereum bark 20 [hp_x] in 1 g / ornithogalum umbellatum 20 [hp_x] in 1 g / passiflora incarnata flowering top 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / prunus spinosa flower bud 20 [hp_x] in 1 g / toxicodendron pubescens leaf 20 [hp_x] in 1 g / lactic acid, l- 20 [hp_x] in 1 g / sulfur 20 [hp_x] in 1 g / veratrum album root 20 [hp_x] in 1 g / valerian 8 [hp_x] in 1 g oral pellet [panic ease]||has_active_moiety
avena sativa top||arnica montana 6 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / turnera diffusa leafy twig 3 [hp_x] in 1 ml / asian ginseng 3 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / herring sperm dna 9 [hp_x] in 1 ml / saccharomyces cerevisiae rna 9 [hp_x] in 1 ml / tribulus terrestris root 3 [hp_x] in 1 ml / cervus elaphus horn oil 6 [hp_x] in 1 ml / bos taurus pituitary gland 5 [hp_c] in 1 ml oral spray [problen dna rna rejuvenation]||has_active_moiety
4-tert-but-4'-meth-dibenzlmete||avobenzone 0.03 g in 1 g / octisalate 0.05 g in 1 g / octocrylene 0.03 g in 1 g / oxybenzone 0.05 g in 1 g topical cream [lbel lederm 45plus jour spf 15 facial treatment against noticeable signs of aging day - normal to dry skin]||has_active_moiety
product containing ethanol||alcohol 80 ml in 100 ml topical spray [miss life panthenol hand sanitizer]||has_active_moiety
rye||rye 1 g in 20 ml subcutaneous injection, solution [rye food]||has_active_moiety
alcohol denatured||alcohol 72 ml in 100 ml topical gel [gilway antiseptic hand saniizer 8 fl.oz]||has_active_moiety
amoxicillin anhydrous (substance)||dispermox 40 mg/ml oral suspension||has_active_moiety
sulfur product (product)||goldenseal 6 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / onion 6 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / anemone pulsatilla 6 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml oral liquid [childrens cold and cough grape flavor]||has_active_moiety
benzocaine - chemical||benzocaine 200 mg dental gel||has_active_moiety
stone red||calamine/zinc oxide 8%-8% topical application suspension [good neighbor pharmacy calamine]||has_active_moiety
octyl salicylate||octisalate 3 g in 100 ml / zinc oxide 6.82 g in 100 ml topical cream [earth long wear makeup broad spectrum spf 20]||has_active_moiety
ethanols||alcohol 195 g in 314 g topical gel [vita vie hand sanitizer lemon]||has_active_moiety
hyoscyamus niger extract||chaste tree 6 [hp_x] in 1 ml / avena sativa flowering top 1 [hp_x] in 1 ml / cinchona officinalis bark 6 [hp_x] in 1 ml / hops 2 [hp_x] in 1 ml / hyoscyamus niger 200 [hp_c] in 1 ml / strychnos ignatii seed 200 [hp_c] in 1 ml / passiflora incarnata flowering top 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml oral spray [anxiety]||has_active_moiety
hydroxyacetanilide||caffeine 65 mg / acetaminophen 250 mg / aspirin 250 mg oral tablet [gencare headache relief]||has_active_moiety
doxylamine (product)||sunmark nite time cold & flu solution (cherry)||has_active_moiety
fluconazol||product containing only fluconazole 200 mg/1 each oral tablet||has_active_moiety
risperidone (product)||product containing only risperidone 2 mg/1 each oral tablet||has_active_moiety
product containing senna||sunmark stool softener plus stimulant laxative 50mg-8.6mg tablet||has_active_moiety
lemon||quince 1 [hp_x] in 1 ml / lemon 1 [hp_x] in 1 ml oral liquid||has_active_moiety
cyclohexanol, 5-methyl-2-(1-methylethyl)-||camphor 0.048 mg/mg / eucalyptus oil 0.026 mg/mg / menthol 0.012 mg/mg topical ointment||has_active_moiety
titanium metallicum||titanium dioxide 3.86 g in 50 g / octinoxate 1.5 g in 50 g cutaneous cream [aloe sun bb spf20 pa plus number1 natural skin]||has_active_moiety
product containing oxygen||carbon dioxide 300 ml in 1 l / oxygen 700 ml in 1 l respiratory (inhalation) gas||has_active_moiety
alkohol||alcohol 80 ml in 100 ml topical gel [ihs 2000]||has_active_moiety
delta(1)hydrocortisone||miconazole nitrate 23 mg/ml / polymyxin b sulfate 0.5293 mg/ml / prednisolone acetate 5 mg/ml otic suspension [surolan]||has_active_moiety
baptisia tinctoria root extract||cairina moschata heart/liver autolysate 50 [hp_c] in 59.2 ml / arsenic trioxide 10 [hp_x] in 59.2 ml / baptisia tinctoria root 10 [hp_x] in 59.2 ml / bryonia alba root 10 [hp_x] in 59.2 ml / solanum dulcamara top 10 [hp_x] in 59.2 ml / echinacea, unspecified 10 [hp_x] in 59.2 ml / echinacea purpurea 10 [hp_x] in 59.2 ml / eupatorium perfoliatum flowering top 10 [hp_x] in 59.2 ml / ferrosoferric phosphate 10 [hp_x] in 59.2 ml / gelsemium sempervirens root 10 [hp_x] in 59.2 ml / potassium chloride 10 [hp_x] in 59.2 ml / skim milk 10 [hp_x] in 59.2 ml / phosphorus 10 in 59.2 ml / pulsatilla vulgaris 10 [hp_x] in 59.2 ml / sulfur 10 [hp_x] in 59.2 ml / zinc acetate anhydrous 10 [hp_x] in 59.2 ml / zinc carbonate 10 [hp_x] in 59.2 ml / zinc 10 [hp_x] in 59.2 ml / zinc chloride 10 [hp_x] in 59.2 ml / zinc oxide 10 [hp_x] in 59.2 ml / zinc picrate nonahydrate 10 [hp_x] in 59.2 ml / zinc valerate dihydrate 10 [hp_x] in 59.2 ml oral liquid [colds and flu response]||has_active_moiety
gliocladium viride extract||gliocladium viride allergenic extract 1 mg/ml injectable solution||has_active_moiety
gastric intrinsic factor||biopar delta-forte softgel capsule||has_active_moiety
3,4,5-trihydroxybenzoic acid (substance)||chrysopogon zizanioides root 10 [hp_x] in 1 ml / barium iodide 18 [hp_x] in 1 ml / calcium acetate 10 [hp_x] in 1 ml / calendula officinalis flowering top 3 [hp_x] in 1 ml / gallic acid monohydrate 12 [hp_x] in 1 ml / gamboge 5 [hp_x] in 1 ml / hyoscyamus niger 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / aqua regia 15 [hp_x] in 1 ml / physostigma venenosum seed 10 [hp_x] in 1 ml / schoenocaulon officinale seed 10 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_c] in 1 ml / urtica urens 5 [hp_x] in 1 ml / zinc oxide 30 [hp_x] in 1 ml oral liquid [thy-plex]||has_active_moiety
benzonatato||product containing only benzonatate 100 mg/1 each oral capsule (clinical drug)||has_active_moiety
camphor, (synthetic)||camphor (synthetic) 40 mg in 1 g / menthol, unspecified form 100 mg in 1 g / methyl salicylate 300 mg in 1 g topical cream [walgreens pain relieving cream]||has_active_moiety
tree pollen-elm, cedar||cedar elm pollen extract 0.1 gm/ml injectable solution||has_active_moiety
as3+||uric acid 15 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / benzoic acid 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / matricaria chamomilla 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / colchicum autumnale bulb 15 [hp_x] in 1 g / eupatorium perfoliatum flowering top 15 [hp_x] in 1 g / gaultheria procumbens top 15 [hp_x] in 1 g / guaiacum officinale resin 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / potassium dichromate 15 [hp_x] in 1 g / kalmia latifolia leaf 15 [hp_x] in 1 g / rhododendron tomentosum leafy twig 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / ruta graveolens flowering top 15 [hp_x] in 1 g / juniperus sabina leafy twig 15 [hp_x] in 1 g / strychnine 15 [hp_x] in 1 g / arctium lappa root 6 [hp_x] in 1 g / phytolacca americana root 6 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g oral pellet [rheumatic-joint care]||has_active_moiety
ch3-b12||cynanchum vincetoxicum root 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / methylcobalamin 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / apc-356433 8 [hp_x] in 1 ml / apc-356434 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / gamboge 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / 7-keto-dehydroepiandrosterone 30 [hp_x] in 1 ml / adenosine triphosphate disodium 30 [hp_x] in 1 ml / glucagon 30 [hp_x] in 1 ml / insulin pork 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [weight management support]||has_active_moiety
zinc (as zinc oxide)||formula 21 25 % topical cream||has_active_moiety
ranitidina||ranitidine hcl 150mg cap||has_active_moiety
benhydramin||diphenhydramine hcl 50mg/ml inj syr 1ml||has_active_moiety
prunus cerasifera flower extract||plantago major 1 [hp_x] in 1 ml / arnica montana 30 [hp_x] in 1 ml / atropa belladonna 30 [hp_x] in 1 ml / calendula officinalis flowering top 9 [hp_x] in 1 ml / matricaria chamomilla 8 [hp_x] in 1 ml / clematis vitalba flower 30 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 8 [hp_x] in 1 ml / solanum dulcamara whole 8 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / histamine dihydrochloride 12 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / helianthemum nummularium flower 30 [hp_x] in 1 ml / sulfur 9 [hp_c] in 1 ml / verbascum thapsus 1 [hp_x] in 1 ml / aconitum napellus whole 30 [hp_x] in 1 ml / prunus cerasifera flower 30 [hp_x] in 1 ml / achillea millefolium 3 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / hypericum perforatum 6 [hp_x] in 1 ml / impatiens glandulifera flower 30 [hp_x] in 1 ml / mentha piperita 1 [hp_x] in 1 ml / apis mellifera 12 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 8 [hp_x] in 1 ml / echinacea purpurea 6 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 1 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / veratrum album root 30 [hp_x] in 1 ml / ferrosoferric phosphate 15 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / bellis perennis 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml topical cream [b20 acute rescue]||has_active_moiety
2-ethylhexyl salicylate||avobenzone 30 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 50 mg in 1 ml topical lotion [garnier skinactive clearly brighter brightening and smoothing daily moisturizer broad spectrum spf 15 sunscreen]||has_active_moiety
polygala senega root||polygala senega root 30 [hp_c] in 1 ml oral liquid [senega officinalis]||has_active_moiety
magnesium ion||magnesium oxide 400 mg oral tablet [leader magnesium oxide]||has_active_moiety
zolpidem product||zolpidem tartrate er, 6.25 mg oral tablet, extended release||has_active_moiety
acidum alendronicum||alendronate sodium 70mg tablet||has_active_moiety
enalaprilat anhydrous||vaseretic (enalapril maleate 10 mg / hctz 25 mg) oral tablet||has_active_moiety
asplenium scolopendrium top||dryopteris filix-mas root 5 [hp_x] in 1 ml / pteridium aquilinum whole 5 [hp_x] in 1 ml / chelidonium majus 5 [hp_x] in 1 ml / taraxacum palustre root 5 [hp_x] in 1 ml / salix alba flower 5 [hp_x] in 1 ml / solidago virgaurea flowering top 5 [hp_x] in 1 ml / salix purpurea bark 5 [hp_x] in 1 ml / willow bark 5 [hp_x] in 1 ml / asplenium scolopendrium top 5 [hp_x] in 1 ml oral liquid||has_active_moiety
sepia officinalis juice||aloe 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / benzoic acid 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / equisetum hyemale 15 [hp_x] in 1 ml / iron 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / strychnos ignatii seed 15 [hp_x] in 1 ml / potassium phosphate, dibasic 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / nitric acid 15 [hp_x] in 1 ml / plantago major 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / rhus aromatica root bark 15 [hp_x] in 1 ml / saw palmetto 15 [hp_x] in 1 ml / claviceps purpurea sclerotium 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / delphinium staphisagria seed 15 [hp_x] in 1 ml / datura stramonium 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml oral liquid [incontinence]||has_active_moiety
imidodicarbonimidic diamide, n,n-dimethyl-||metformin hydrochloride 1000 mg oral tablet, extended release||has_active_moiety
may apple root||podophyllum 30 [hp_c] in 1 ml oral liquid [podophyllum peltatum]||has_active_moiety
product containing dimethicone||sunmark gas relief 180mg ultra strength softgel||has_active_moiety
d-methorphan||gnp night time cold & flu relief solution (original)||has_active_moiety
arsenic trioxide (substance)||echinacea 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / onion 12 [hp_x] in 1 ml / ambrosia artemisiifolia 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / potassium dichromate 12 [hp_x] in 1 ml / nutmeg 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml oral liquid [sinus rescue 2]||has_active_moiety
loratadine (substance)||product containing precisely loratadine 10 milligram/1 each conventional release oral tablet (clinical drug)||has_active_moiety
product containing ethinylestradiol (medicinal product)||nortrel 1/35, 35 mcg-1 mg oral tablet_#1||has_active_moiety
bethanechol||bethanechol chloride 25 mg oral tablet||has_active_moiety
crotalus horridus horridus venom||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / hyoscyamus niger 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / rancid beef 12 [hp_x] in 1 ml / citharacanthus spinicrus 12 in 1 ml oral liquid [septastat]||has_active_moiety
product containing tamsulosin||dutasteride 500microgram + tamsulosin hydrochloride 400microgram capsule (product)||has_active_moiety
piperacillin anhydrous||piperacillin-tazobactam 4 g-0.5 g intravenous powder for injection||has_active_moiety
arsenic cation (3)||bos taurus bile 3 [hp_x] in 1 ml / chionanthus virginicus bark 34 [hp_c] in 1 ml / arsenic trioxide 1 [hp_x] in 1 ml / strychnos nux-vomica seed 1 [hp_m] in 1 ml / platinum 1 [hp_m] in 1 ml oral liquid [2 gallbladder]||has_active_moiety
atropine [chemical substance]||atropine sulfate 2 mg (atropine base 1.67 mg) per 0.7 ml auto-injector||has_active_moiety
commiphora myrrha gum resin||echinacea, unspecified 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium aquaticum 3 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / tabebuia impetiginosa bark 6 [hp_x] in 1 ml / bos taurus adrenal gland 8 [hp_x] in 1 ml / sus scrofa lymph 8 [hp_x] in 1 ml / bos taurus spleen 8 [hp_x] in 1 ml / bos taurus thymus 8 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / botulinum toxin type a 30 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_x] in 1 ml / pseudomonas aeruginosa 30 [hp_x] in 1 ml / yersinia enterocolitica 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / clostridium perfringens 15 [hp_c] in 1 ml / amoeba proteus 30 [hp_c] in 1 ml oral liquid [bac gd]||has_active_moiety
pseudoephedrine||guaifenesin/pseudoephedrine hydrochloride 600 mg-60 mg oral tablet, extended release [guaifenesin pse sr]||has_active_moiety
red maple pollen extract||red maple pollen extract 50 mg/ml injectable solution||has_active_moiety
octocrylene||octisalate 0.05 g in 1 ml / avobenzone 0.03 g in 1 ml / octinoxate 0.029 g in 1 ml / octocrylene 0.022 g in 1 ml topical lotion [for men maca root energetic face protector spf 15]||has_active_moiety
selenicereus grandiflorus stem||selenicereus grandiflorus stem 10 [hp_x] in 59 ml / caulophyllum thalictroides root 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / black cohosh 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / viburnum opulus bark 10 [hp_x] in 59 ml / zanthoxylum americanum bark 10 [hp_x] in 59 ml oral liquid [menstrual cramps and irregularities]||has_active_moiety
fraxinus americana pollen extract||white ash pollen extract 1 mg/ml injectable solution||has_active_moiety
paracetamol - chemical (substance)||phenylephrine hydrochloride 5 mg / acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg oral capsule, liquid filled [alka-seltzer plus maximum strength night cold and flu powermax gels]||has_active_moiety
riboflavine preparation (substance)||m-natal plus tablet||has_active_moiety
urtica urens extract||egg shell, cooked 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 15 [hp_x] in 1 ml / ascorbic acid 16 [hp_x] in 1 ml / black mustard seed 16 [hp_x] in 1 ml / solanum nigrum whole 16 [hp_x] in 1 ml / anacardium occidentale fruit 16 [hp_x] in 1 ml / solanum lycopersicum 16 [hp_x] in 1 ml / sodium nitrite 16 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / allylthiourea 15 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / amanita muscaria fruiting body 15 [hp_x] in 1 ml / onion 15 [hp_x] in 1 ml / garlic 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / saccharin 15 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / lycoperdon utriforme fruiting body 15 [hp_x] in 1 ml / caffeine 15 [hp_x] in 1 ml / capsicum 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / cinnamon 15 [hp_x] in 1 ml / protortonia cacti 15 [hp_x] in 1 ml / cynara scolymus leaf 15 [hp_x] in 1 ml / alpine strawberry 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / solidago virgaurea flowering top 6 [hp_x] in 1 ml / urtica urens 15 [hp_x] in 1 ml / ginger 15 [hp_x] in 1 ml / sucrose 16 [hp_x] in 1 ml / mentha piperita 15 [hp_x] in 1 ml / abrus precatorius seed 15 [hp_x] in 1 ml / juglans regia leaf 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / nutmeg 15 [hp_x] in 1 ml / podophyllum 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / astacus astacus 16 [hp_x] in 1 ml / glycyrrhiza glabra 16 [hp_x] in 1 ml / solanum tuberosum 16 [hp_x] in 1 ml / saccharomyces cerevisiae 16 [hp_x] in 1 ml / lactose, unspecified form 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml oral liquid [food additives]||has_active_moiety
pigment white 6||titanium dioxide 4.9 g in 100 g / octinoxate 2 g in 100 g topical powder [isaknox ageless serum compact 23]||has_active_moiety
guaiacol glyceryl ether||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg / guaifenesin 200 mg oral capsule [daytime mucus relief severe cold maximum strength]||has_active_moiety
solidago virgaurea flowering top extract||aluminum oxide 15 [hp_x] in 59.1 ml / avena sativa flowering top 4 [hp_x] in 59.1 ml / sodium borate 8 [hp_x] in 59.1 ml / candida albicans 16 [hp_x] in 59.1 ml / phenol 8 [hp_x] in 59.1 ml / ceanothus americanus leaf 4 [hp_x] in 59.1 ml / echinacea angustifolia 4 [hp_x] in 59.1 ml / gaultheria procumbens top 6 [hp_x] in 59.1 ml / sus scrofa adrenal gland 9 [hp_x] in 59.1 ml / goldenseal 5 [hp_x] in 59.1 ml / flax seed 6 [hp_x] in 59.1 ml / lithium carbonate 12 [hp_x] in 59.1 ml / sus scrofa bone marrow 9 [hp_x] in 59.1 ml / sodium chloride 12 [hp_x] in 59.1 ml / phosphoric acid 12 [hp_x] in 59.1 ml / phytolacca americana root 12 [hp_x] in 59.1 ml / lactic acid, l- 12 [hp_x] in 59.1 ml / sepia officinalis juice 15 [hp_x] in 59.1 ml / silicon dioxide 12 [hp_x] in 59.1 ml / solidago virgaurea flowering top 4 [hp_x] in 59.1 ml / tellurium 15 [hp_x] in 59.1 ml / teucrium marum 6 [hp_x] in 59.1 ml / zinc 15 [hp_x] in 59.1 ml oral liquid [mycocan-chord]||has_active_moiety
fluoxetine product||product containing fluoxetine 20 mg/1 each oral capsule||has_active_moiety
n-acetyl-p-aminophenol||apap 32.5 mg/ml / dextromethorphan hydrobromide 1 mg/ml / guaifenesin 20 mg/ml / phenylephrine hydrochloride 0.5 mg/ml oral suspension||has_active_moiety
vincetoxicum hirundinaria leaf extract||formic acid 8 [hp_x] in 50 ml / nitric acid 6 [hp_x] in 50 ml / baptisia tinctoria root 5 [hp_x] in 50 ml / graphite 8 [hp_x] in 50 ml / calcium sulfide 8 [hp_x] in 50 ml / thuja occidentalis leafy twig 10 [hp_x] in 50 ml / vincetoxicum hirundinaria leaf 8 [hp_x] in 50 ml / glechoma hederacea flowering top 4 [hp_x] in 50 ml oral solution/ drops [habifac]||has_active_moiety
fluoride ion||euphrasia stricta 6 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / magnesium carbonate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / osmium 15 [hp_x] in 1 ml / physostigma venenosum seed 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 16 [hp_x] in 1 ml oral liquid [visiopar]||has_active_moiety
alahist d||acetaminophen 80 mg / phenylephrine hcl 2.5 mg chewable tablet||has_active_moiety
3-(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-ylidene)-n,n-dimethylpropan-1-amine||product containing amitriptyline hydrochloride 100 mg/1 each oral tablet||has_active_moiety
pravachol||pravastatin na 40mg tab,ud||has_active_moiety
product containing pregabalin||pregabalin, 200 mg oral capsule||has_active_moiety
aluminum chlorohydrate (substance)||aluminum chlorohydrate 23.3 g in 100 g topical aerosol, spray [axe]||has_active_moiety
dextromethorphan-containing product||dextromethorphan hydrobromide 5 mg / benzocaine 7.5 mg oral lozenge [mixed berry sore throat and cough lozenge]||has_active_moiety
allantoin||adenosine 0.04 g in 10 ml / allantoin 0.03 g in 10 ml topical liquid [botanic twenty hypercare plumping formula]||has_active_moiety
sodium sulphate, anhydrous||bacillus anthracis immunoserum rabbit 200 [hp_c] in 1 ml / antimony trisulfide 30 [hp_c] in 1 ml / centella asiatica 30 [hp_c] in 1 ml / juglans regia fruit rind, immature 6 [hp_x] in 1 ml / juglans regia leaf 6 [hp_x] in 1 ml / potassium bromide 30 [hp_c] in 1 ml / ledum palustre twig 6 [hp_x] in 1 ml / sodium sulfate 200 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / radium bromide 200 [hp_c] in 1 ml / sanguinaria canadensis root 3 [hp_x] in 1 ml / sulfur iodide 200 [hp_c] in 1 ml / thuja occidentalis leafy twig 200 [hp_c] in 1 ml / urtica urens 3 [hp_x] in 1 ml oral spray [acne]||has_active_moiety
octinoxate||octinoxate 74.9 mg in 1 ml / titanium dioxide 26 mg in 1 ml / oxybenzone 20 mg in 1 ml topical lotion [mark got the goods multi-benefit foundation]||has_active_moiety
herring sperm dna||adenosine cyclic phosphate 12 [hp_x] in 59.1 ml / arnica montana 12 [hp_x] in 59.1 ml / peumus boldus leaf 3 [hp_x] in 59.1 ml / calcium iodide 12 [hp_x] in 59.1 ml / calendula officinalis flowering top 30 [hp_x] in 59.1 ml / sus scrofa cartilage 6 [hp_x] in 59.1 ml / ceanothus americanus leaf 9 [hp_x] in 59.1 ml / coenzyme a 12 [hp_x] in 59.1 ml / herring sperm dna 12 [hp_x] in 59.1 ml / echinacea angustifolia 4 [hp_x] in 59.1 ml / hamamelis virginiana root bark/stem bark 12 [hp_x] in 59.1 ml / calcium sulfide 12 [hp_x] in 59.1 ml / bos taurus hypothalamus 12 [hp_x] in 59.1 ml / nadide 12 [hp_x] in 59.1 ml / naja naja venom 15 [hp_x] in 59.1 ml / sodium sulfate 30 [hp_x] in 59.1 ml / kidney bean 4 [hp_x] in 59.1 ml / phosphorus 15 [hp_x] in 59.1 ml / phytolacca americana root 4 [hp_x] in 59.1 ml / pinus sylvestris leafy twig 9 [hp_x] in 59.1 ml / sus scrofa pituitary gland 12 [hp_x] in 59.1 ml / rancid beef 12 [hp_x] in 59.1 ml / silicon dioxide 12 [hp_x] in 59.1 ml / sulfur 15 [hp_x] in 59.1 ml / thuja occidentalis leafy twig 15 [hp_x] in 59.1 ml / thyroid, unspecified 9 [hp_x] in 59.1 ml / viscum album fruiting top 12 [hp_x] in 59.1 ml oral liquid [lymph-tone iii]||has_active_moiety
onion||onion 12 [hp_x] in 59.1 ml / echinacea, unspecified 4 [hp_x] in 59.1 ml / goldenseal 5 [hp_x] in 59.1 ml / potassium dichromate 12 [hp_x] in 59.1 ml / mercurius solubilis 30 [hp_x] in 59.1 ml / mercuric sulfide 12 [hp_x] in 59.1 ml / sus scrofa nasal mucosa 9 [hp_x] in 59.1 ml / sodium sulfate 12 [hp_x] in 59.1 ml / nutmeg 6 [hp_x] in 59.1 ml / pulsatilla vulgaris 12 [hp_x] in 59.1 ml oral liquid [sinus-tone]||has_active_moiety
miconazole [oropharyngeal]||miconazole nitrate 2% topical application cream [triple care antifungal]||has_active_moiety
gaultheria procumbens top extract||uric acid 15 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / benzoic acid 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / matricaria chamomilla 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / colchicum autumnale bulb 15 [hp_x] in 1 g / eupatorium perfoliatum flowering top 15 [hp_x] in 1 g / gaultheria procumbens top 15 [hp_x] in 1 g / guaiacum officinale resin 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / potassium dichromate 15 [hp_x] in 1 g / kalmia latifolia leaf 15 [hp_x] in 1 g / rhododendron tomentosum leafy twig 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / ruta graveolens flowering top 15 [hp_x] in 1 g / juniperus sabina leafy twig 15 [hp_x] in 1 g / strychnine 15 [hp_x] in 1 g / arctium lappa root 6 [hp_x] in 1 g / phytolacca americana root 6 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g oral pellet [rheumatic-joint care]||has_active_moiety
lidocaine (product)||lidocaine hydrochloride anhydrous 10 mg in 1 ml / epinephrine bitartrate 0.005 mg in 1 ml epidural injection, solution||has_active_moiety
octyl-methoxycinnamate||octinoxate 1.5 ml in 30 ml topical cream [intervene makeup spf 15 soft shell]||has_active_moiety
4'-fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone||haloperidol decanoate 100 mg in 1 ml intramuscular injection [haldol decanoate]||has_active_moiety
clindamicina||clindamycin phosphate 150 mg in 1 ml intravenous injection, solution, concentrate [clindamycin]||has_active_moiety
erythroxylum catuaba bark extract||gambir 2 mg in 1 g / mucuna pruriens seed .025 mg in 1 g / erythroxylum catuaba bark .025 mg in 1 g / epimedium grandiflorum top .012 mg in 1 g / turnera diffusa leaf .124 mg in 1 g / ginkgo .124 mg in 1 g / eleuthero .124 mg in 1 g / panax notoginseng root .018 mg in 1 g / tribulus terrestris fruit .124 mg in 1 g topical gel [edge]||has_active_moiety
2-(diethylamino)-2',6'-acetoxylidide||benzocaine 120 mg/ml / lidocaine hydrochloride 50 mg/ml / tetracaine hydrochloride 10 mg/ml topical spray||has_active_moiety
selenium sulphide||head & shoulders clinical solutions 10 mg/ml medicated shampoo||has_active_moiety
(s)-2-(6-methoxy-2-naphthyl)propanoic acid||naproxen sodium 220 mg oral capsule, liquid filled [aleve]||has_active_moiety
tylenol||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral tablet [only for cold and flu cough suppressant]||has_active_moiety
benzol||sulfuric acid 15 [hp_x] in 1 ml / acetone 15 [hp_x] in 1 ml / picric acid 15 [hp_x] in 1 ml / pine tar 12 [hp_x] in 1 ml / sulfonmethane 15 [hp_x] in 1 ml / vanadium 15 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / aniline 30 [hp_x] in 1 ml / benzene 15 [hp_x] in 1 ml / phenol 30 [hp_x] in 1 ml / methyl alcohol 12 [hp_x] in 1 ml / kerosene 30 [hp_x] in 1 ml / phenolphthalein 15 [hp_x] in 1 ml / turpentine oil 12 [hp_x] in 1 ml / benzo(a)pyrene 30 [hp_x] in 1 ml / carbon tetrachloride 15 [hp_x] in 1 ml / trichloroethylene 30 [hp_x] in 1 ml / ether 12 [hp_x] in 1 ml / magnesium sulfate heptahydrate 15 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / lead chloride 15 [hp_x] in 1 ml / lead 15 [hp_x] in 1 ml sublingual solution/ drops [n02 petrochem]||has_active_moiety
bur oak pollen extract||quercus velutina pollen 0.0025 g in 1 ml / quercus macrocarpa pollen 0.0025 g in 1 ml / quercus muehlenbergii pollen 0.0025 g in 1 ml / quercus virginiana pollen 0.0025 g in 1 ml / quercus rubra pollen 0.0025 g in 1 ml / quercus palustris pollen 0.0025 g in 1 ml / quercus stellata pollen 0.0025 g in 1 ml / quercus alba pollen 0.0025 g in 1 ml intradermal injection, solution||has_active_moiety
aspidosperma quebracho-blanco bark||avena sativa flowering top 9 [hp_x] / epinephrine 18 [hp_x] / milk thistle 6 [hp_x] / st. john's wort 18 [hp_x] / wood creosote 18 [hp_x] / lobelia inflata 12 [hp_x] / strychnos nux-vomica seed 18 [hp_x] / aspidosperma quebracho-blanco bark 18 [hp_x] / valerian 18 [hp_x] oral lozenge [smokers nicotine relief]||has_active_moiety
guaifenesin - chemical||mucinex freefrom cold & flu daytime, 20 mg-400 mg-10 mg/20 ml oral liquid||has_active_moiety
3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine||product containing precisely lamotrigine 100 milligram/1 each conventional release oral tablet (clinical drug)||has_active_moiety
product containing gold (medicinal product)||trifolium pratense flower 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium oxide 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / corticotropin 30 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 30 [hp_x] in 1 ml / sus scrofa pituitary gland 30 [hp_x] in 1 ml / anguilla rostrata blood serum 30 [hp_x] in 1 ml / tartaric acid 30 [hp_x] in 1 ml / theridion curassavicum 30 [hp_x] in 1 ml / sus scrofa thyroid 30 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / bromine 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / carbo animalis 30 [hp_c] in 1 ml / activated charcoal 30 [hp_c] in 1 ml / human breast tumor cell 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / strychnos wallichiana bark 30 [hp_c] in 1 ml / potassium dichromate 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / sodium phosphate, dibasic, heptahydrate 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / rancid beef 30 [hp_c] in 1 ml / claviceps purpurea sclerotium 30 [hp_c] in 1 ml / sulfuric acid 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / allylthiourea 30 [hp_c] in 1 ml / thuja occidentalis leafy twig 30 [hp_c] in 1 ml / veratrum album root 30 [hp_c] in 1 ml / alcohol, x-ray exposed (1000 rad) 30 [hp_c] in 1 ml oral liquid [1 detoxification]||has_active_moiety
hydrocortisone-containing product||hydrocortisone 1% topical application cream [dr. sheffield's hydrocortisone]||has_active_moiety
dodecahydroxycyclohexane||bos taurus adrenal gland 200 [kp_c] in 1 ml / sus scrofa adrenal gland 200 [kp_c] in 1 ml / ascorbic acid 30 [kp_c] in 1 ml / brain-derived neurotrophic factor human 30 [kp_c] in 1 ml / prasterone 30 [kp_c] in 1 ml / malic acid 30 [kp_c] in 1 ml / basic fibroblast growth factor (human) 30 [kp_c] in 1 ml / fucus vesiculosus 30 [kp_c] in 1 ml / histidine 30 [kp_c] in 1 ml / hyaluronidase 30 [kp_c] in 1 ml / human interleukin-6 (nonglycosylated) 30 [kp_c] in 1 ml / lactic acid 30 [kp_c] in 1 ml / sus scrofa lymph vessel 30 [kp_c] in 1 ml / bos taurus lymph vessel 30 [kp_c] in 1 ml / sus scrofa mesenchyme 30 [kp_c] in 1 ml / nadide 30 [kp_c] in 1 ml / sodium diethyl oxalacetate 30 [kp_c] in 1 ml / sodium pyruvate 30 [kp_c] in 1 ml / sodium sulfate 200 [kp_c] in 1 ml / phenylalanine 30 [kp_c] in 1 ml / prolactin 30 [kp_c] in 1 ml / rancid beef 30 [kp_c] in 1 ml / thuja occidentalis leaf 200 [kp_c] in 1 ml / dodecahydroxycyclohexane dihydrate 30 [kp_c] in 1 ml / tyrosine 30 [kp_c] in 1 ml topical spray [viatrexx-mesenchyme]||has_active_moiety
paracetamol - chemical (substance)||product containing only acetaminophen 650 mg and hydrocodone bitartrate 10 mg/1 each oral tablet||has_active_moiety
iva annua var. annua pollen||onion 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pulsatilla 12 [hp_x] in 1 ml / alfalfa 12 [hp_x] in 1 ml / amaranthus hybridus pollen 12 [hp_x] in 1 ml / bambusa vulgaris leaf 12 [hp_x] in 1 ml / xanthium strumarium pollen 12 [hp_x] in 1 ml / taraxacum officinale 12 [hp_x] in 1 ml / solidago virgaurea flowering top 12 [hp_x] in 1 ml / poa pratensis top 12 [hp_x] in 1 ml / chenopodium album pollen 12 [hp_x] in 1 ml / iva angustifolia pollen 12 [hp_x] in 1 ml / iva annua pollen 12 [hp_x] in 1 ml / festuca pratensis pollen 12 [hp_x] in 1 ml / artemisia vulgaris pollen 12 [hp_x] in 1 ml / dactylis glomerata pollen 12 [hp_x] in 1 ml / lolium perenne pollen 12 [hp_x] in 1 ml / trifolium pratense pollen 12 [hp_x] in 1 ml / agrostis stolonifera pollen 12 [hp_x] in 1 ml / amaranthus retroflexus pollen 12 [hp_x] in 1 ml / artemisia tridentata pollen 12 [hp_x] in 1 ml / amaranthus spinosus pollen 12 [hp_x] in 1 ml / anthoxanthum odoratum pollen 12 [hp_x] in 1 ml / phleum pratense pollen 12 [hp_x] in 1 ml / ambrosia psilostachya pollen 12 [hp_x] in 1 ml / trifolium repens pollen 12 [hp_x] in 1 ml / rumex crispus top 12 [hp_x] in 1 ml / rumex acetosa whole 12 [hp_x] in 1 ml oral liquid [weed grass antigens]||has_active_moiety
tree pollen-american elm||acer negundo pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [bau] in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / populus deltoides pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / carya tomentosa pollen 0.001 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / alternaria alternata 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml subcutaneous injection, solution||has_active_moiety
product containing acetaminophen||top care cold head congestion nighttime cool ice caplet||has_active_moiety
oxide, zinc||titanium dioxide 220.8 mg in 1 g / zinc oxide 100 mg in 1 g topical powder [arbonne got you covered mineral foundation broad spectrum spf 15 sunscreen rose]||has_active_moiety
nicotiana tabacum leaf||calendula officinalis flowering top 3 [hp_x] / matricaria recutita 3 [hp_x] / sepia officinalis juice 3 [hp_c] / tobacco leaf 6 [hp_c] / anamirta cocculus seed 15 [hp_c] / strychnos nux-vomica seed 15 [hp_c] topical patch [gopatch tummyrelief]||has_active_moiety
causticum preparation||causticum 8 [hp_x] in 113 g / pseudognaphalium obtusifolium 6 [hp_x] in 113 g topical cream [relaxing leg cream homeopathic pm]||has_active_moiety
lycopodium clavatum spore extract||aconitum napellus whole 30 [hp_x] in 1 ml / amanita muscaria fruiting body 30 [hp_x] in 1 ml / onion 30 [hp_x] in 1 ml / arnica montana whole 30 [hp_x] in 1 ml / arabica coffee bean 30 [hp_x] in 1 ml / hypericum perforatum whole 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / mercurius solubilis 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / lead 30 [hp_x] in 1 ml oral liquid [neuralgia hp]||has_active_moiety
cinchona officinalis bark extract||uric acid 15 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / benzoic acid 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / matricaria chamomilla 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / colchicum autumnale bulb 15 [hp_x] in 1 g / eupatorium perfoliatum flowering top 15 [hp_x] in 1 g / gaultheria procumbens top 15 [hp_x] in 1 g / guaiacum officinale resin 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / potassium dichromate 15 [hp_x] in 1 g / kalmia latifolia leaf 15 [hp_x] in 1 g / rhododendron tomentosum leafy twig 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / ruta graveolens flowering top 15 [hp_x] in 1 g / juniperus sabina leafy twig 15 [hp_x] in 1 g / strychnine 15 [hp_x] in 1 g / arctium lappa root 6 [hp_x] in 1 g / phytolacca americana root 6 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g oral pellet [rheumatic-joint care]||has_active_moiety
ribavirin-containing product||ribavirin 600mg tablet||has_active_moiety
pilocarpine||pilocarpine 2% soln,oph||has_active_moiety
bromotheophylline||acetaminophen/pamabrom/pyrilamine maleate 500 mg-25 mg-15 mg oral tablet [premenstrual symptom relief]||has_active_moiety
stellaria media extract||achillea millefolium flower 1 [hp_x] in 51.7 g / st. john's wort 1 [hp_x] in 51.7 g / stellaria media 1 [hp_x] in 51.7 g / calendula officinalis flower 1 [hp_x] in 51.7 g / plantago major 1 [hp_x] in 51.7 g / commiphora myrrha whole 1 [hp_x] in 51.7 g / salvia officinalis whole 1 [hp_x] in 51.7 g / comfrey leaf 1 [hp_x] in 51.7 g topical salve [poison ivy care]||has_active_moiety
aciclovir [systemic] (substance)||aciclovir 800mg tablet||has_active_moiety
lansoprazolum||lansoprazole 15 mg gastro-resistant oral capsule||has_active_moiety
ativan [brand name]||lorazepam 1mg oral tablet||has_active_moiety
homosalatum||avobenzone 3 g in 100 ml / homosalate 15 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 8 g in 100 ml topical spray [sunscreen spf 30 wegmans]||has_active_moiety
pyridoxine (vit b<n>6</n>)||ascorbic acid/biotin/calcium/cholecalciferol/cyanocobalamin/docosahexaenoic acid/folic acid/iodine/iron/magnesium/pyridoxine/vitamin e 85 mg-500 mcg-155 mg-1000 iu-12 mcg-400 mg-1 mg-150 mcg-28 mg-50 mg-25 mg-10 iu oral capsule, liquid filled [prenate enhance]||has_active_moiety
helianthemum canadense extract||arsenic triiodide 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / helianthemum canadense 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / potassium iodide 15 [hp_x] in 1 ml / mercuric iodide 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / schoenocaulon officinale seed 15 [hp_x] in 1 ml / lobaria pulmonaria 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml oral liquid [sinusitis]||has_active_moiety
zinc oxide product||octinoxate 4 g in 100 g / zinc oxide 2.4 g in 100 g topical cream [studio look base de alta cobertura para el rostro con fps 20 toffee 240-c]||has_active_moiety
1-(1h-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol||pindolol 10mg tablet (product)||has_active_moiety
dióxido de titanio||titanium dioxide 2.6736 g in 100 ml / octinoxate 7.2 g in 100 ml topical cream [brucke a.c.c. calming cool suncream]||has_active_moiety
box elder pollen||plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / carya tomentosa pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
eastern white pine pollen extract||pinus strobus pollen extract 0.001 gm/ml injectable solution||has_active_moiety
sambucus nigra flowering top||micrurus corallinus venom 35 [hp_x] in 1 ml / apis mellifera 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / lytta vesicatoria 20 [hp_x] in 1 ml / cinchona officinalis bark 20 [hp_x] in 1 ml / colchicum autumnale bulb 20 [hp_x] in 1 ml / convallaria majalis 20 [hp_x] in 1 ml / crotalus horridus horridus venom 20 [hp_x] in 1 ml / naja naja venom 20 [hp_x] in 1 ml / digitalis 20 [hp_x] in 1 ml / lachesis muta venom 20 [hp_x] in 1 ml / mercury 20 [hp_x] in 1 ml / sodium carbonate 20 [hp_x] in 1 ml / sodium sulfate 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / sambucus nigra flowering top 20 [hp_x] in 1 ml / strophanthus hispidus seed 20 [hp_x] in 1 ml / thuja occidentalis leafy twig 20 [hp_x] in 1 ml / vipera berus venom 20 [hp_x] in 1 ml / echinacea, unspecified 11 [hp_x] in 1 ml / arctium lappa root 11 [hp_x] in 1 ml / solidago virgaurea flowering top 11 [hp_x] in 1 ml / taraxacum officinale 11 [hp_x] in 1 ml / urtica urens 11 [hp_x] in 1 ml / juniper berry 20 [hp_x] in 1 ml oral liquid [edema]||has_active_moiety
titanium dioxide||titanium dioxide 0.0624 g in 1 g / zinc oxide 0.049 g in 1 g / octinoxate 0.03 g in 1 g topical powder [lbel divine polvos compactos doble uso fps 15 edicion de lujo dorado/double use compact spf 15 gold deluxe edition medium 6]||has_active_moiety
heparin porcine||heparin sodium, porcine 5000 unt/ml includes injectable solution, injection & cartridge||has_active_moiety
diphenhydramine (medication)||valu-dryl, 25 mg oral tablet||has_active_moiety
minocycline (medication)||minocycline hydrochloride 50mg capsule (product)||has_active_moiety
rhodotorula rubra||echinacea, unspecified 3 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / fenugreek leaf 3 [hp_x] in 1 ml / acremonium strictum 30 [hp_x] in 1 ml / alternaria alternata 30 [hp_x] in 1 ml / aspergillus niger var. niger 30 [hp_x] in 1 ml / aureobasidium pullulans var. pullutans 30 [hp_x] in 1 ml / botrytis cinerea 30 [hp_x] in 1 ml / chaetomium globosum 30 [hp_x] in 1 ml / cladosporium cladosporioides 30 [hp_x] in 1 ml / cochliobolus spicifer 30 [hp_x] in 1 ml / epicoccum nigrum 30 [hp_x] in 1 ml / haematonectria haematococca 30 [hp_x] in 1 ml / mucor plumbeus 30 [hp_x] in 1 ml / neurospora sitophila 30 [hp_x] in 1 ml / khuskia oryzae 30 [hp_x] in 1 ml / penicillium chrysogenum var. chrysogenum 30 [hp_x] in 1 ml / phoma exigua var. exigua 30 [hp_x] in 1 ml / rhizopus stolonifer 30 [hp_x] in 1 ml / rhodotorula rubra 30 [hp_x] in 1 ml / stemphylium sarciniforme 30 [hp_x] in 1 ml / trichoderma viride 30 [hp_x] in 1 ml / trichophyton mentagrophytes 30 [hp_x] in 1 ml oral liquid [allergena mold mix]||has_active_moiety
medicago sativa whole extract||alfalfa 6 [hp_x] in 1 ml / ascorbyl palmitate 6 [hp_x] in 1 ml / cysteine 6 [hp_x] in 1 ml / barley 6 [hp_x] in 1 ml / laminaria digitata 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / methionine 6 [hp_x] in 1 ml / nasturtium officinale 6 [hp_x] in 1 ml / n,n-dimethylglycine 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / raphanus sativus 6 [hp_x] in 1 ml / sodium selenite 6 [hp_x] in 1 ml / wheat 6 [hp_x] in 1 ml / ubidecarenone 6 [hp_x] in 1 ml / .alpha.-lipoic acid 8 [hp_x] in 1 ml / .gamma.-aminobutyric acid 8 [hp_x] in 1 ml / oryza sativa whole 8 [hp_x] in 1 ml / tocopherol 8 [hp_x] in 1 ml / zinc picolinate 8 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / glutathione 12 [hp_x] in 1 ml / magnesium fluoride 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 30 [hp_x] in 1 ml / glyoxal trimer dihydrate 30 [hp_x] in 1 ml oral liquid [free radical]||has_active_moiety
penciclovir (product)||famciclovir 495 g in 500 g not applicable powder [x]||has_active_moiety
escitalopram (substance)||escitalopram oxalate 20 mg oral tablet [escitalopram]||has_active_moiety
delphinium staphisagria seed||semecarpus anacardium juice 12 [hp_c] in 1 ml / berberis vulgaris root bark 12 [hp_c] in 1 ml / sodium chloride 12 [hp_c] in 1 ml / nitric acid 12 [hp_c] in 1 ml / strychnos nux-vomica seed 12 [hp_c] in 1 ml / delphinium staphisagria seed 12 [hp_c] in 1 ml / sulfur 12 [hp_c] in 1 ml / thuja occidentalis leafy twig 12 [hp_c] in 1 ml oral liquid [stress complex]||has_active_moiety
o-(4-hydroxy-3,5-diidophenyl)-3,5-diiodo-l-tyrosine||levothyroxine sodium 50micrograms tablet (product)||has_active_moiety
salicylic acid [psoriasis] (substance)||menthol 110 mg/ml / methyl salicylate 310 mg/ml topical cream||has_active_moiety
cyclobenzaprine (product)||24 hr cyclobenzaprine hydrochloride 15 mg extended release oral capsule||has_active_moiety
li+||chondrus crispus 3 [hp_x] in 1 ml / black cohosh 3 [hp_x] in 1 ml / filipendula ulmaria root 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / urtica urens 3 [hp_x] in 1 ml / zanthoxylum americanum bark 3 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / colchicum autumnale bulb 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / formica rufa 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / rhododendron aureum leaf 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml oral liquid [rheumaforce]||has_active_moiety
hydrargyrum||aloe 15 [hp_x] in 1 ml / causticum 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cholesterol 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / colchicum autumnale bulb 15 [hp_x] in 1 ml / cyclamen purpurascens tuber 15 [hp_x] in 1 ml / euphrasia stricta 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / physostigma venenosum seed 15 [hp_x] in 1 ml / prunus spinosa flower bud 15 [hp_x] in 1 ml / polygala senega root 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / tobacco leaf 15 [hp_x] in 1 ml / activated charcoal 15 [hp_x] in 1 ml oral liquid [eye floaters]||has_active_moiety
sodium+||walgreens ready to use enema||has_active_moiety
flounder allergenic extract||flounder allergenic extract 50 mg/ml injectable solution||has_active_moiety
norgestimato||ethinyl estradiol 0.025 mg / norgestimate 0.18 mg oral tablet||has_active_moiety
avena sativa top||american ginseng 4 [hp_x] in 41 ml / arnica montana 4 [hp_x] in 41 ml / avena sativa flowering top 4 [hp_x] in 41 ml / milk thistle 4 [hp_x] in 41 ml / elaeis guineensis fruit 15 [hp_x] in 41 ml / sus scrofa adrenal gland 12 [hp_x] in 41 ml / sodium chloride 30 [hp_c] in 41 ml / phosphoric acid 200 [hp_c] in 41 ml / thuja occidentalis leafy twig 200 [hp_c] in 41 ml oral liquid [body balance]||has_active_moiety
vaxneuvance||pneumococcal 20-valent vaccine, diphtheria conjugate intramuscular suspension [prevnar 20]||has_active_moiety
aspergillus fumigatus extract (product)||dermatophagoides pteronyssinus 80 [au] in 1 ml / dermatophagoides farinae 80 [au] in 1 ml / felis catus hair 16 [bau] in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / periplaneta americana 0.0004 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / mucor racemosus 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / carya alba pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / morus alba pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / urtica dioica pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
chloroxylenol (substance)||chloroxylenol 0.003 mg in 1 ml topical liquid [brighton professional antibacterial hand so ap]||has_active_moiety
absolute ethanol||alcohol 291.18 ml in 80 extracorporeal cloth||has_active_moiety
siberian elm pollen extract||ulmus pumila pollen 0.05 g in 1 ml percutaneous injection, solution [ulmus pumila pollen]||has_active_moiety
sulfur jodatum||sulfur iodide 6 [hp_x] in 1 ml / mahonia aquifolium root bark 1 [hp_x] in 1 ml / berberis vulgaris root bark 1 [hp_x] in 1 ml / antimony trisulfide 30 [hp_x] in 1 ml / carbo animalis 1 [hp_x] in 1 ml / calcium sulfide 6 [hp_x] in 1 ml / arsenic triiodide 6 [hp_x] in 1 ml / bromine 6 [hp_x] in 1 ml oral solution/ drops [combination remedy 35 - acne pimples]||has_active_moiety
octinoxate||octinoxate 1.11 g in 15 ml / octisalate 0.74 g in 15 ml / avobenzone 0.44 g in 15 ml topical cream [mint fusion lip balm spf 30 supergoop]||has_active_moiety
bolus alba||attapulgite 3270 mg / kaolin 130 mg / carob 440 mg / pectin, citrus 290 mg / magnesium trisilicate 150 mg oral tablet [endosorb bolus]||has_active_moiety
alcohol isopropílico||isopropyl alcohol 75 ml in 100 ml topical liquid [ripclear antiseptic hand sanitizer]||has_active_moiety
florfenicol product||florfenicol 1 g in 1 g not applicable powder||has_active_moiety
enalaprilat anhydrous||product containing only enalapril maleate 10 mg/1 each oral tablet (clinical drug)||has_active_moiety
2-ethylhexyl-p-methoxycinnamat||octinoxate 382 mg in 9.8 g / titanium dioxide 588 mg in 9.8 g topical powder [shiseido sheer matifying compact (refill) i40]||has_active_moiety
äthylalkohol||alcohol 66 in 100 topical cloth [first safety hand sanitizing tissue]||has_active_moiety
red clover pollen extract||trifolium pratense pollen extract 20000 unt/ml injectable solution||has_active_moiety
iodide ion||arnica montana 30 [hp_c] in 1 ml / bryonia alba root 30 [hp_c] in 1 ml / matricaria recutita 30 [hp_c] in 1 ml / potassium iodide 30 [hp_c] in 1 ml / pulsatilla vulgaris 30 [hp_c] in 1 ml / toxicodendron pubescens leaf 30 [hp_c] in 1 ml / lactic acid, l- 30 [hp_c] in 1 ml / zinc oxide 30 [hp_c] in 1 ml oral liquid [sore muscle and joint relief]||has_active_moiety
azithromycin anhydrous||azithromycin@250 mg@oral@tablet||has_active_moiety
anhydrous glucose (substance)||dextrose monohydrate 2.42 g in 110 ml / sodium chloride 990 mg in 110 ml / mannitol 825 mg in 110 ml / adenine 30 mg in 110 ml intravenous solution [adsol red cell preservation]||has_active_moiety
dimethicone (medication)||simethicone 180 mg oral capsule, liquid filled [anti-gas ultra strength]||has_active_moiety
hyoscyamus niger leaf extract||hyoscyamus niger leaf 2 [hp_x] oral pellet||has_active_moiety
aciphex||rabeprazole na 20mg tab,ec||has_active_moiety
sulfur preparations (medication)||adenosine triphosphate disodium 6 [hp_x] in 1 ml / nadide 6 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / robinia pseudoacacia bark 6 [hp_x] in 1 ml / sulfur 6 [hp_x] in 1 ml / oregano 6 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_x] in 1 ml / sus scrofa umbilical cord 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / strychnos nux-vomica seed 8 [hp_x] in 1 ml / coumarin 8 [hp_x] in 1 ml / pancrelipase 12 [hp_x] in 1 ml / hydrochloric acid 6 [hp_c] in 1 ml / anhydrous citric acid 6 [hp_c] in 1 ml / formic acid 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / coenzyme a 8 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [reflux]||has_active_moiety
acv||valaciclovir 1000 mg oral tablet||has_active_moiety
benzophenone 3||avobenzone 3 g in 100 g / homosalate 15 g in 100 g / octisalate 5 g in 100 g / octocrylene 2.75 g in 100 g / oxybenzone 6 g in 100 g topical spray [ultimate sheer spf 55 body]||has_active_moiety
thuja occidentalis twig||citrullus colocynthis fruit pulp 4 [hp_x] in 30 ml / sus scrofa embryo 6 [hp_x] in 30 ml / sus scrofa adrenal gland 6 [hp_x] in 30 ml / sus scrofa placenta 6 [hp_x] in 30 ml / selenium 6 [hp_x] in 30 ml / thuja occidentalis leafy twig 8 [hp_x] in 30 ml / conium maculatum flowering top 4 [hp_x] in 30 ml / aconitum napellus 4 [hp_x] in 30 ml / aloe 4 [hp_x] in 30 ml / barium oxalosuccinate 6 [hp_x] in 30 ml / sus scrofa cerebrum 6 [hp_x] in 30 ml / arnica montana 3 [hp_x] in 30 ml / sus scrofa hypothalamus 6 [hp_x] in 30 ml / ubidecarenone 5 [hp_x] in 30 ml oral solution/ drops [guna healthy brain]||has_active_moiety
homosalatum||avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octocrylene 10 g in 100 ml / octisalate 5 g in 100 ml topical lotion [ct spf 20]||has_active_moiety
zolpidem product||zolpidem tartrate 10 mg oral tablet, film coated [ambien]||has_active_moiety
atlantic poison oak leaf||calendula officinalis flowering top 12 [hp_x] in 1 ml / croton tiglium seed 30 [hp_x] in 1 ml / sodium chloride 30 [hp_x] in 1 ml / plantago major 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / smilax regelii root 30 [hp_x] in 1 ml topical spray [muscle/tendon pain stress relief]||has_active_moiety
chlorine||whey 9 [hp_x] in 1 ml / calcium phosphate, unspecified form 9 [hp_x] in 1 ml / sodium citrate, unspecified form 9 [hp_x] in 1 ml / sodium chloride 9 [hp_x] in 1 ml / sodium phosphate 9 [hp_x] in 1 ml / sorbic acid 9 [hp_x] in 1 ml / citric acid monohydrate 9 [hp_x] in 1 ml / apocarotenal 9 [hp_x] in 1 ml / .beta.-carotene 9 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium roqueforti cultured, aged 9 [hp_x] in 1 ml / casein, lactococcus lactis cultured, penicillium camemberti cultured, aged 9 [hp_x] in 1 ml / casein, lactococcus lactis cultured, aged 9 [hp_x] in 1 ml / casein, lactococcus lactis cultured 9 [hp_x] in 1 ml / casein, streptococcus thermophilus cultured, propionibacterium freudenreichii subsp. shermanii cultured, aged 9 [hp_x] in 1 ml / casein, emmental cultured 9 [hp_x] in 1 ml / cow milk 9 [hp_x] in 1 ml / goat milk 9 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / skim milk 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml oral liquid [dairy antigens]||has_active_moiety
product containing aluminum hydroxide||al hydroxide/mg hydroxide/simethicone 200 mg-200 mg-20 mg/5 ml oral suspension||has_active_moiety
shavetail grass top||betula pendula leaf 3 [hp_x] / mandragora officinarum root 3 [hp_x] / sus scrofa meniscus 6 [hp_x] / formica rufa 10 [hp_x] / arnica montana 15 [hp_x] / equisetum arvense top 15 [hp_x] oral pellet||has_active_moiety
o>2<||oxygen .99 l in 1 l respiratory (inhalation) gas||has_active_moiety
aspergillus niger||aspergillus niger var. niger 20000 [pnu] in 1 ml subcutaneous injection, solution [aspergillus niger var niger]||has_active_moiety
octyl methoxycinnamate (substance)||octinoxate 30 mg in 1 ml / titanium dioxide 17.5 mg in 1 ml topical cream [teint couture everwear 24h wear satin finish full coverage and comfort broad spectrum spf 20 p115]||has_active_moiety
nad+||ascorbic acid 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / acetaldehyde 6 [hp_x] in 1 ml / prasterone 6 [hp_x] in 1 ml / phlorizin 6 [hp_x] in 1 ml / adenosine triphosphate disodium 8 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / citric acid monohydrate 8 [hp_x] in 1 ml / fumaric acid 8 [hp_x] in 1 ml / glyoxal trimer dihydrate 8 [hp_x] in 1 ml / nadide 8 [hp_x] in 1 ml / pantothenic acid 8 [hp_x] in 1 ml / insulin pork 8 [hp_x] in 1 ml / pork liver 10 [hp_x] in 1 ml / sus scrofa pancreas 10 [hp_x] in 1 ml / glucagon 12 [hp_x] in 1 ml / barium oxalate 6 [hp_c] in 1 ml / alloxan 6 [hp_c] in 1 ml / berberis vulgaris root bark 6 [hp_c] in 1 ml / human breast tumor cell 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / momordica balsamina immature fruit 6 [hp_c] in 1 ml / phosphoric acid 6 [hp_c] in 1 ml / phosphorus 6 [hp_c] in 1 ml / syzygium cumini seed 6 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / gymnema sylvestre leaf 30 [hp_c] in 1 ml / trigonella foenum-graecum whole 30 [hp_c] in 1 ml oral liquid [glucoreg]||has_active_moiety
poison hemlock flowering top extract||epinephrine 10 [hp_x] in 59 ml / chaste tree 10 [hp_x] in 59 ml / ailanthus altissima flowering twig 10 [hp_x] in 59 ml / aletris farinosa root 10 [hp_x] in 59 ml / dill 10 [hp_x] in 59 ml / bromus ramosus flower 10 [hp_x] in 59 ml / dieffenbachia seguine 10 [hp_x] in 59 ml / carpinus betulus flowering top 10 [hp_x] in 59 ml / clematis vitalba flower 10 [hp_x] in 59 ml / conium maculatum flowering top 10 [hp_x] in 59 ml / helleborus niger root 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / egg phospholipids 10 [hp_x] in 59 ml / mentha piperita 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / olea europaea flower 10 [hp_x] in 59 ml / nerium oleander leaf 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / tropaeolum majus 10 [hp_x] in 59 ml / xerophyllum asphodeloides 10 [hp_x] in 59 ml / zinc 10 [hp_x] in 59 ml oral liquid [sluggish mind]||has_active_moiety
methylcarbinol||alcohol 1 ml topical solution [beclean sanitizing wipe 75 percent alcohol]||has_active_moiety
equisetum hyemale||equisetum hyemale 30 [hp_c] oral pellet [equisetum hyemale]||has_active_moiety
salicylic acid [acne] (product)||salicylic acid 1.8 % topical cream||has_active_moiety
aldehydo-d-glucose||dextrose monohydrate 2 g in 63 ml / trisodium citrate dihydrate 1.66 g in 63 ml / anhydrous citric acid 188 mg in 63 ml / sodium phosphate, monobasic, monohydrate 140 mg in 63 ml / adenine 17.3 mg in 63 ml intravenous solution [cpda-1]||has_active_moiety
spongia officinalis skeleton, roasted||chelidonium majus 3 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_x] in 1 ml / skim milk 4 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / thyroid, porcine 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml oral liquid [thyro tonic]||has_active_moiety
strychnos nux-vomica seed||aralia racemosa root 12 [hp_x] in 59 ml / arsenic trioxide 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / strychnos nux-vomica seed 12 [hp_x] in 59 ml / cervus elaphus horn oil 12 [hp_x] in 59 ml / phosphorus 12 [hp_x] in 59 ml / silicon dioxide 12 [hp_x] in 59 ml / sulfur 12 [hp_x] in 59 ml oral liquid [allergies animal hair and dander]||has_active_moiety
absolute ethanol||alcohol 21 ml in 30 ml topical gel [the cure power sanitizer hand clean gel(ethanol)]||has_active_moiety
2-ethylhexyl-p-methoxycinnamate (substance)||octinoxate 74.25 mg in 1 ml / octocrylene 59.4 mg in 1 ml / octisalate 49.5 mg in 1 ml / zinc oxide 29.106 mg in 1 ml topical lotion [bellagio sunscreen for face spf 30]||has_active_moiety
aconitum napellus||echinacea angustifolia 1 [hp_x] in 1 g / calendula officinalis flowering top 1 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 1 [hp_x] in 1 g / echinacea purpurea 2 [hp_x] in 1 g / bellis perennis 2 [hp_x] in 1 g / matricaria recutita 3 [hp_x] in 1 g / hypericum perforatum 3 [hp_x] in 1 g / achillea millefolium 3 [hp_x] in 1 g / rhododendron tomentosum leafy twig 4 [hp_x] in 1 g / arnica montana 4 [hp_x] in 1 g / bryonia alba root 8 [hp_x] in 1 g / calcium sulfide 8 [hp_x] in 1 g / nadide 8 [hp_x] in 1 g / pantothenic acid 8 [hp_x] in 1 g / lactic acid, l- 8 [hp_x] in 1 g / comfrey root 8 [hp_x] in 1 g / toxicodendron pubescens leaf 8 [hp_x] in 1 g / aconitum napellus 12 [hp_x] in 1 g / sus scrofa umbilical cord 12 [hp_x] in 1 g / sus scrofa adrenal gland 12 [hp_x] in 1 g topical gel [celeragesic]||has_active_moiety
petrolatum||petrolatum 1 g in 1 g topical ointment [being well body]||has_active_moiety
egg (chicken) allergenic extract||egg (chicken) allergenic extract 100 mg/ml injectable solution||has_active_moiety
golden seal root extract||bismuth subnitrate 200 [hp_c] in 1 ml / calcium sulfate anhydrous 200 [hp_c] in 1 ml / carbo animalis 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / cinchona officinalis bark 200 [hp_c] in 1 ml / goldenseal 12 [hp_x] in 1 ml / strychnos nux-vomica seed 200 [hp_c] in 1 ml / ornithogalum umbellatum 12 [hp_x] in 1 ml / rancid beef 200 [hp_c] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral spray [stomach distress]||has_active_moiety
barium ion||american ginseng 3 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / sus scrofa pancreas 6 [hp_x] in 1 ml / sus scrofa spleen 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / cobalt 8 [hp_x] in 1 ml / nickel 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / oxogluric acid 8 [hp_x] in 1 ml / anhydrous citric acid 8 [hp_x] in 1 ml / fumaric acid 8 [hp_x] in 1 ml / malic acid 8 [hp_x] in 1 ml / pyruvic acid 8 [hp_x] in 1 ml / succinic acid 8 [hp_x] in 1 ml / naphthoquine 9 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / aconitic acid, (z)- 12 [hp_x] in 1 ml / magnesium gluconate 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml oral liquid [spleenex vh]||has_active_moiety
as3+||almond 12 [hp_x] in 1 ml / cashew 12 [hp_x] in 1 ml / black walnut 12 [hp_x] in 1 ml / pecan 12 [hp_x] in 1 ml / coconut 12 [hp_x] in 1 ml / olive oil 12 [hp_x] in 1 ml / chinese chestnut 12 [hp_x] in 1 ml / trapa bicornis seed 12 [hp_x] in 1 ml / pine nut 12 [hp_x] in 1 ml / macadamia nut 12 [hp_x] in 1 ml / pistachio 12 [hp_x] in 1 ml / peanut 15 [hp_x] in 1 ml / english walnut 15 [hp_x] in 1 ml / brazil nut 15 [hp_x] in 1 ml / american hazelnut 15 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / anemone pulsatilla 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / mockernut 12 [hp_c] in 1 ml oral liquid [nut antigens]||has_active_moiety
doxycycline (anhydrous)||product containing doxycycline 50 mg/1 each oral capsule||has_active_moiety
p-(5-p-tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide||celecoxib 100 mg/1 each oral capsule||has_active_moiety
product containing clonazepam (medicinal product)||product containing precisely clonazepam 1 milligram/1 each conventional release oral tablet||has_active_moiety
clay 347||kaolin 4.0 g in 100 g topical cream [dr pore tightening pink clay facial mask]||has_active_moiety
n,n,alpha-trimethyl-10h-phenothiazine-10-ethanamine||promethazine 25 mg oral tablet||has_active_moiety
methionine||clinimix e 4.25/5 injectable solution||has_active_moiety
cl- element||dextrose monohydrate 1.1 g in 100 ml / sodium citrate, unspecified form 0.588 g in 100 ml / sodium chloride 0.41 g in 100 ml / sodium phosphate, monobasic, monohydrate 0.276 g in 100 ml / citric acid monohydrate 0.042 g in 100 ml / adenine 0.03 g in 100 ml intravenous injection, solution [as 3]||has_active_moiety
1,2-propanediol, 3-(2-methoxyphenoxy)-||guaifenesin 100 mg in 5 ml oral liquid [guaap]||has_active_moiety
oyster shell calcium carbonate, crude||atropa belladonna 6 [hp_c] in 1 ml / berberis vulgaris root bark 6 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 6 [hp_c] in 1 ml / lytta vesicatoria 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml oral tincture [kidney stone clear]||has_active_moiety
rumex acetosella pollen||urtica dioica pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / avena sativa pollen 0.00008 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.00008 g in 1 ml / felis catus hair 400 [bau] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / populus deltoides pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
apis melifica/h1y bee||geranium robertianum 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / scrophularia nodosa 3 [hp_x] in 1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1 ml / apis mellifera 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / fumaria officinalis flowering top 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / pinus sylvestris leafy twig 4 [hp_x] in 1 ml / veronica officinalis flowering top 4 [hp_x] in 1 ml / aloe 4 [hp_x] in 1 ml / gentiana lutea root 5 [hp_x] in 1 ml / smilax ornata whole 6 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / mercuric cyanide 8 [hp_x] in 1 ml / ferrous iodide 8 [hp_x] in 1 ml / myosotis arvensis 10 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / juglans regia leaf 12 [hp_x] in 1 ml / bos taurus parathyroid gland 12 [hp_x] in 1 ml / sus scrofa thymus 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml oral liquid [lymphdrainex]||has_active_moiety
mercaptamine-containing product||cysteamine 0.44 % ophthalmic solution||has_active_moiety
atomoxetina||atomoxetine hcl 25 mg oral capsule||has_active_moiety
n(1)-acetyl-4-aminophenylsulfonamide||plexion (sulfacetamide sodium 9.8 % / sulfur 4.8 % ) topical lotion||has_active_moiety
ethyl alcohol||alcohol 310.0 g in 500 ml topical gel [poltone hand sanitizer]||has_active_moiety
triclosan (medication)||triclosan 10 mg in 500 mg topical gel [liquid hand cleanse]||has_active_moiety
antidiabetics dapagliflozin||dapagliflozin propanediol 2.5 mg / metformin hydrochloride 1000 mg oral tablet, film coated, extended release [xigduo xr]||has_active_moiety
artemisia absinthium extract||wormwood 96.6 g in 100 ml topical liquid [caso skin vita]||has_active_moiety
2-ethylhexyl salicylate||avobenzone 3 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g / octocrylene 2.7 g in 100 g / oxybenzone 4 g in 100 g topical cream [advanced anti-wrinkle therapy cicatricure]||has_active_moiety
4-hydroxyacetanilide||health mart severe cold & cough & flu nighttime powder for solution||has_active_moiety
quercus garryana pollen||quercus kelloggii pollen 0.0333333 g in 1 ml / quercus garryana pollen 0.0333333 g in 1 ml / quercus agrifolia pollen 0.0333333 g in 1 ml intradermal solution [western oak pollen mix]||has_active_moiety
poa compressa pollen extract||poa compressa pollen 0.0036 g in 1 ml / typha latifolia pollen 0.0036 g in 1 ml / bromus secalinus pollen 0.0036 g in 1 ml / zea mays pollen 0.0036 g in 1 ml / secale cereale pollen 0.0036 g in 1 ml / triticum aestivum pollen 0.0036 g in 1 ml / sorghum halepense pollen 0.0036 g in 1 ml / elymus repens pollen 0.0036 g in 1 ml / phalaris arundinacea pollen 0.0036 g in 1 ml / bromus inermis pollen 0.0036 g in 1 ml / sorghum bicolor ssp. drummondii pollen 0.0036 g in 1 ml / arrhenatherum elatius pollen 0.0036 g in 1 ml / holcus lanatus pollen 0.0036 g in 1 ml / pascopyrum smithii pollen 0.0036 g in 1 ml intradermal injection, solution||has_active_moiety
yellow puccoon root||epinephrine 12 [hp_x] in 59 ml / atropa belladonna 12 [hp_x] in 59 ml / bromine 12 [hp_x] in 59 ml / carbo animalis 12 [hp_x] in 59 ml / colchicum autumnale bulb 12 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 12 [hp_x] in 59 ml / histamine dihydrochloride 12 [hp_x] in 59 ml / goldenseal 12 [hp_x] in 59 ml / potassium carbonate 12 [hp_x] in 59 ml / lycopodium clavatum spore 12 [hp_x] in 59 ml / mercurius solubilis 12 [hp_x] in 59 ml / pulsatilla vulgaris 12 [hp_x] in 59 ml / urtica urens 12 [hp_x] in 59 ml oral spray [allergyease shellfish and seafood]||has_active_moiety
dimethicone as antiflatulent||simethicone 66.7 mg/ml oral suspension||has_active_moiety
gaultheria procumbens top||phosphorus 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / silver 15 [hp_x] in 1 ml / saw palmetto 15 [hp_x] in 1 ml / gold 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / lycoperdon utriforme fruiting body 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / syzygium cumini seed 15 [hp_x] in 1 ml / chionanthus virginicus bark 15 [hp_x] in 1 ml / chamaelirium luteum root 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / cynara scolymus leaf 6 [hp_x] in 1 ml / urtica urens 6 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml oral liquid [diabase]||has_active_moiety
bryonia alba root extract||bryonia alba root 30 [hp_x] in 30 [hp_x] oral pellet [bryonia]||has_active_moiety
2 hydroxybenzoic acid||dragon 4 % / 10 % / 30 % topical cream||has_active_moiety
naphthoquine||podophyllum 5 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / niacinamide 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / colchicum autumnale bulb 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / bilberry 8 [hp_x] in 1 ml / norepinephrine 8 [hp_x] in 1 ml / aspirin 10 [hp_x] in 1 ml / adenosine triphosphate disodium 10 [hp_x] in 1 ml / anthraquinone 10 [hp_x] in 1 ml / histamine dihydrochloride 10 [hp_x] in 1 ml / magnesium gluconate 10 [hp_x] in 1 ml / nadide 10 [hp_x] in 1 ml / naphthoquine 10 [hp_x] in 1 ml / ubidecarenone 10 [hp_x] in 1 ml / pantothenic acid 10 [hp_x] in 1 ml / manganese phosphate, dibasic 15 [hp_x] in 1 ml / hydroquinone 3 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [bio cytotox phase]||has_active_moiety
phosphorus preparations||rancid beef 30 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / activated charcoal 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / colchicum autumnale bulb 15 [hp_x] in 1 ml / daphne odora bark 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / wood creosote 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / magnesium carbonate 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / spigelia anthelmia 15 [hp_x] in 1 ml / sulfur 15 [hp_x] in 1 ml / matricaria recutita 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / ruta graveolens flowering top 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml oral liquid [doggy breath]||has_active_moiety
zn2+||zinc oxide 0.75 g in 5 ml topical lotion [scarscreen]||has_active_moiety
???lead||datura stramonium 800 [hp_c] in 1 ml / moschus moschiferus musk sac resin 16 [hp_m] in 1 ml / sulfur 18 [hp_m] in 1 ml / hyoscyamus niger 21 [hp_x] in 1 ml / lead 21 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 21 [hp_x] in 1 ml / sus scrofa thymus 21 [hp_x] in 1 ml oral liquid [emvita 14]||has_active_moiety
fenofibric acid (medication)||fenofibrate 145 mg in 30 oral tablet||has_active_moiety
yeast, unspecified||house dust 15 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / blatta orientalis 15 [hp_x] in 1 ml / bromine 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / centaurea benedicta 15 [hp_x] in 1 ml / felis catus hair 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / canis lupus familiaris hair 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / podophyllum 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / claviceps purpurea sclerotium 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / saccharomyces cerevisiae 16 [hp_x] in 1 ml / solidago virgaurea flowering top 6 [hp_x] in 1 ml oral liquid [dust-mold-dander]||has_active_moiety
citrullus colocynthis fruit without seed||wormwood 10 [hp_x] in 59 ml / aloe 10 [hp_x] in 59 ml / arnica montana 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 [hp_x] in 59 ml / fagus sylvatica flowering top 10 [hp_x] in 59 ml / calcium sulfide 10 [hp_x] in 59 ml / ilex aquifolium flowering top 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / malus domestica flower 10 [hp_x] in 59 ml / nitric acid 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / pinus sylvestris flowering top 10 [hp_x] in 59 ml / platinum 10 [hp_x] in 59 ml / salix alba flowering top 10 [hp_x] in 59 ml / strychnine 10 [hp_x] in 59 ml / green tea leaf 10 [hp_x] in 59 ml / verbascum thapsus 10 [hp_x] in 59 ml oral liquid [vindictive]||has_active_moiety
product containing benzalkonium (medicinal product)||(spl review) benzalkonium chloride 0.001 topical cloth [germ-away]||has_active_moiety
bee honey||matricaria chamomilla 15 [hp_x] in 1 ml / uric acid 15 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / benzoic acid 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / guaiacum officinale resin 15 [hp_x] in 1 ml / colchicum autumnale bulb 15 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / kalmia latifolia leaf 15 [hp_x] in 1 ml / rhododendron tomentosum leafy twig 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / juniperus sabina leafy twig 15 [hp_x] in 1 ml / strychnine 15 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml oral liquid [joint care]||has_active_moiety
oxybenzonum||homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 40 mg in 1 g / oxybenzone 50 mg in 1 g / avobenzone 30 mg in 1 g topical aerosol, spray [kroger kids spf 50 sunscreen]||has_active_moiety
carvedilol (substance)||carvedilol 25 mg oral tablet [coreg]||has_active_moiety
agrimonia eupatoria flower extract||aesculus carnea flower 30 [hp_c] in 118.2 ml / aesculus hippocastanum flower 30 [hp_c] in 118.2 ml / horse chestnut 30 [hp_c] in 118.2 ml / agrimonia eupatoria flower 30 [hp_c] in 118.2 ml / bromus ramosus flower 30 [hp_c] in 118.2 ml / calluna vulgaris flowering top 30 [hp_c] in 118.2 ml / carpinus betulus flowering top 30 [hp_c] in 118.2 ml / castanea sativa flower 30 [hp_c] in 118.2 ml / centaurium erythraea flower 30 [hp_c] in 118.2 ml / ceratostigma willmottianum flower 30 [hp_c] in 118.2 ml / cichorium intybus flower 30 [hp_c] in 118.2 ml / fagus sylvatica flowering top 30 [hp_c] in 118.2 ml / gentianella amarella flower 30 [hp_c] in 118.2 ml / helianthemum nummularium flower 30 [hp_c] in 118.2 ml / hottonia palustris flower 30 [hp_c] in 118.2 ml / ilex aquifolium flowering top 30 [hp_c] in 118.2 ml / impatiens glandulifera flower 30 [hp_c] in 118.2 ml / juglans regia flowering top 30 [hp_c] in 118.2 ml / larix decidua flowering top 30 [hp_c] in 118.2 ml / lonicera caprifolium flowering top 30 [hp_c] in 118.2 ml / malus domestica flower 30 [hp_c] in 118.2 ml / mimulus guttatus flowering top 30 [hp_c] in 118.2 ml / olea europaea flower 30 [hp_c] in 118.2 ml / ornithogalum umbellatum flowering top 30 [hp_c] in 118.2 ml / pinus sylvestris flowering top 30 [hp_c] in 118.2 ml / prunus cerasifera flower 30 [hp_c] in 118.2 ml / quercus robur flower 30 [hp_c] in 118.2 ml / rosa canina flower 30 [hp_c] in 118.2 ml / salix alba flowering top 30 [hp_c] in 118.2 ml / scleranthus annuus flowering top 30 [hp_c] in 118.2 ml / sinapis arvensis flowering/fruiting top 30 [hp_c] in 118.2 ml / ulex europaeus flower 30 [hp_c] in 118.2 ml / verbena officinalis flowering top 30 [hp_c] in 118.2 ml / vitis vinifera flowering top 30 [hp_c] in 118.2 ml oral liquid [fields of flowers]||has_active_moiety
naja naja venom||naja naja venom 350 ug in 1 ml oral spray, metered [nyloxin stage 3 pain relief]||has_active_moiety
clindamicina||clindamycin phosphate 150 mg in 1 ml intramuscular injection, solution [clindamycin]_#2||has_active_moiety
spiritus vini||alcohol 350 g in 500 ml topical gel [natura s hand sanitizer]||has_active_moiety
common st. john's wort herb||hypericum perforatum 30 [hp_x] in 1 g sublingual tablet [hypericum perforatum]||has_active_moiety
2-ethylhexyl-2-cyano-3,3-diphenylacrylate||avobenzone 25.8 mg in 1 ml / homosalate 85.8 mg in 1 ml / octisalate 42.9 mg in 1 ml / octocrylene 23.6 mg in 1 ml / oxybenzone 34.3 mg in 1 ml topical spray [aloe up broad spectrum spf 50]||has_active_moiety
(2s)-2-amino-5-(carbamimidamido)pentanoic acid||arginine 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa pineal gland 6 [hp_x] in 1 ml / progesterone 6 [hp_x] in 1 ml / atropa belladonna 6 [hp_c] in 1 ml / chelidonium majus 6 [hp_c] in 1 ml / dioscorea villosa tuber 6 [hp_c] in 1 ml / estrone 6 [hp_c] in 1 ml / sus scrofa adrenal gland 6 [hp_c] in 1 ml / sus scrofa hypothalamus 6 [hp_c] in 1 ml / sus scrofa ovary 6 [hp_c] in 1 ml / lilium lancifolium whole flowering 12 [hp_c] in 1 ml / anemone pulsatilla 12 [hp_c] in 1 ml / sepia officinalis juice 12 [hp_c] in 1 ml / sulfur 12 [hp_c] in 1 ml oral liquid [endopure pro]||has_active_moiety
dl-pantothenol||panthenol 0.005 in 250 ml / niacinamide 0.0001 in 250 ml topical shampoo [phytopecia hair boosting]||has_active_moiety
artemisia californica pollen extract||artemisia californica pollen 0.0036 g in 1 ml / xanthium strumarium pollen 0.0036 g in 1 ml / artemisia vulgaris pollen 0.0036 g in 1 ml / artemisia tridentata pollen 0.0036 g in 1 ml / artemisia dracunculus pollen 0.0036 g in 1 ml / kochia scoparia pollen 0.0036 g in 1 ml / chenopodium album pollen 0.0036 g in 1 ml / iva axillaris pollen 0.0036 g in 1 ml / artemisia frigida pollen 0.0036 g in 1 ml / amaranthus retroflexus pollen 0.0036 g in 1 ml / salsola kali pollen 0.0036 g in 1 ml / rumex acetosella pollen 0.0036 g in 1 ml / amaranthus tuberculatus pollen 0.0036 g in 1 ml / rumex crispus pollen 0.0036 g in 1 ml subcutaneous injection, solution||has_active_moiety
titanium white||octinoxate 68 mg in 1 ml / titanium dioxide 40 mg in 1 ml / zinc oxide 152 mg in 1 ml topical cream [cc super active complete correction sunscreen broad spectrum spf 50 50 beige]||has_active_moiety
timothy pollen||cynodon dactylon pollen 16 [bau] in 1 ml / festuca pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 160 [bau] in 1 ml / pascopyrum smithii pollen 0.0004 g in 1 ml / felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml subcutaneous injection, solution||has_active_moiety
sodium cation||sodium chloride 12 [hp_c] in 1 ml / delphinium staphisagria seed 12 [hp_c] in 1 ml / strychnos ignatii seed 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml oral liquid||has_active_moiety
alocane max strength||benzalkonium chloride 0.13 g in 100 ml topical liquid [antibacterial handwash berry medley]||has_active_moiety
sunflower||helianthus annuus pollen 1 g in 20 ml percutaneous injection, solution [sunflower pollen]||has_active_moiety
lassars paste||zinc oxide 10% top oint||has_active_moiety
oxygen usp||oxygen 210 ml in 1 l respiratory (inhalation) gas [oxygen]||has_active_moiety
dioxide titanium||octinoxate 1.95 g in 30 g / titanium dioxide 1.275 g in 30 g / octisalate 1.5 g in 30 g topical cream [no7 perfect and perfect intense advanced all in one foundation spf 50 bamboo]||has_active_moiety
wild turnip pollen||brassica rapa pollen extract 100 mg/ml injectable solution||has_active_moiety
cattle epithelium allergenic extract||bos taurus skin 10000 [pnu] in 1 ml percutaneous solution [cattle epithelia]||has_active_moiety
oyster shell calcium carbonate preparation||cyanocobalamin 6 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / potassium carbonate 6 [hp_x] in 1 ml / levocarnitine 6 [hp_x] in 1 ml / glutamine 6 [hp_x] in 1 ml / ornithine 6 [hp_x] in 1 ml / tryptophan 6 [hp_x] in 1 ml / tyrosine 6 [hp_x] in 1 ml / sus scrofa ovary 6 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / human chorionic gonadotropin 60 [hp_x] in 1 ml oral liquid [platinum for women]||has_active_moiety
benzalkonium product||benzalkonium chloride 0.13 g in 100 g topical cloth [alta antibacterial hand wipes]||has_active_moiety
populus nigra pollen||amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / fraxinus americana pollen 0.005 g in 1 ml / betula populifolia pollen 0.005 g in 1 ml / ulmus americana pollen 0.005 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya alba pollen 0.001 g in 1 ml / populus nigra pollen 0.0025 g in 1 ml / populus alba pollen 0.0025 g in 1 ml / morus rubra pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
phenylephrine (medication)||phenylephrine hydrochloride 10 mg in 17000 mg / acetaminophen 650 mg in 17000 mg / chlorpheniramine maleate 4 mg in 17000 mg oral powder, for solution [antiflu powder]||has_active_moiety
oxibenzona||octinoxate 75 mg in 1 g / oxybenzone 20 mg in 1 g topical gel [neutrogena moistureshine lip soother sunscreen spf20 - shimmer 10]||has_active_moiety
product containing menthol (medicinal product)||chlorpheniramine maleate 13.4 mg / methyl salicylate 26.9 mg / scopolia carniolica whole 2.7 mg / menthol 26.9 mg / peppermint oil 26.9 mg / camphor (synthetic) 13.4 mg / phellodendron amurense whole 13.4 mg topical patch [pain]||has_active_moiety
para-dihydroxybenzene||hydroquinone 6 g in 100 g / hydrocortisone 0.5 g in 100 g / tretinoin 0.05 g in 100 g topical emulsion||has_active_moiety
cyclamen purpurascens tuber extract||cyclamen purpurascens tuber 30 [hp_c] in 30 [hp_c] oral pellet [cyclamen europaeum]||has_active_moiety
product containing octocrilene (medicinal product)||octinoxate 5.994 mg in 100 ml / octisalate 3.000 mg in 100 ml / octocrylene 2.400 mg in 100 ml / avobenzone 3.000 mg in 100 ml topical cream [youth cell day cream broad spectrum spf-15 sunscreen (50 ml)]||has_active_moiety
hydrastis canadensis root powder||ceanothus americanus leaf 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / marsdenia condurango bark 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / momordica balsamina immature fruit 6 [hp_x] in 1 ml / anemone pratensis 6 [hp_x] in 1 ml / sus scrofa bile duct 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / ipecac 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / potassium dichromate 8 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / sus scrofa nasal mucosa 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sus scrofa oral mucosa 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / sus scrofa rectal mucosa 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / mannose, d- 8 [hp_x] in 1 ml / semecarpus anacardium juice 9 [hp_x] in 1 ml / wood creosote 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / mandragora officinarum root 10 [hp_x] in 1 ml / oxalis acetosella leaf 10 [hp_x] in 1 ml / sus scrofa urinary bladder 6 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [intercellular detox]||has_active_moiety
fluoride ion (substance)||sodium fluoride 0.02% oromucosal solution [listerine nightly reset]||has_active_moiety
haematonectria haematococca allergenic extract||haematonectria haematococca extract 0.001 gm/ml injectable solution||has_active_moiety
product containing pyrimethamine (medicinal product)||pyrimethamine 50 mg / leucovorin calcium 10 mg oral capsule||has_active_moiety
fluoride ion (substance)||horse chestnut 3 [hp_x] in 1 ml / collinsonia canadensis root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / pulsatilla vulgaris 4 [hp_x] in 1 ml / arnica montana 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / hydrofluoric acid 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / paeonia officinalis root 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml oral liquid [vascular hp]||has_active_moiety
sus scrofa thymus||sus scrofa thymus 8 [hp_x] in 1 ml oral liquid [thymus]||has_active_moiety
ustilago maydis allergenic extract||ustilago maydis 30 [hp_c] in 30 [hp_c] oral pellet [ustilago maidis]||has_active_moiety
repagermanium||tabebuia impetiginosa bark 3 [hp_x] in 1 ml / cat's claw 3 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa pituitary gland 200 [hp_x] in 1 ml / sus scrofa adrenal gland 60 [hp_x] in 1 ml / nadide 12 [hp_x] in 1 ml / lactic acid, dl- 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / coenzyme a 30 [hp_x] in 1 ml / adenosine triphosphate 30 [hp_x] in 1 ml / bis(carboxyethyl)germanium sesquioxide 8 [hp_x] in 1 ml / ubidecarenone 200 [hp_x] in 1 ml oral liquid [krebs stimulator plus]||has_active_moiety
homosalato||homosalate 80 mg in 1 ml / octocrylene 50 mg in 1 ml / zinc oxide 80 mg in 1 ml / octisalate 50 mg in 1 ml topical cream [ultra replenishing sunscreen spf 40]||has_active_moiety
cortisone preparation (product)||arnica montana 4 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / echinacea angustifolia 5 [hp_x] in 1 ml / sanguinaria canadensis root 5 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 6 [hp_x] in 1 ml / euphorbia resinifera resin 6 [hp_x] in 1 ml / dopamine hydrochloride 6 [hp_x] in 1 ml / phytolacca americana root 7 [hp_x] in 1 ml / aconitum napellus 8 [hp_x] in 1 ml / silver nitrate 8 [hp_x] in 1 ml / arsenic trioxide 8 [hp_x] in 1 ml / bryonia alba root 8 [hp_x] in 1 ml / gelsemium sempervirens root 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / anemone pratensis 8 [hp_x] in 1 ml / toxicodendron pubescens leaf 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / thuja occidentalis leafy twig 8 [hp_x] in 1 ml / cortisone acetate 8 [hp_x] in 1 ml / acetaldehyde 10 [hp_x] in 1 ml / formaldehyde 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / zinc 10 [hp_x] in 1 ml oral liquid [bio glyoxal phase]||has_active_moiety
4-acetamidophenol||acetaminophen 650 mg in 30 ml / dextromethorphan hydrobromide 20 mg in 30 ml / phenylephrine hydrochloride 10 mg in 30 ml oral syrup [daytime severe cold and cough]||has_active_moiety
rahf||antihemophilic pegylated 3000unt/vil inj||has_active_moiety
benzalkonium-containing product||benzalkonium chloride 0.113 g in 113 g topical soap [dial antibacterial bar]||has_active_moiety
tree pollen-american elm||fraxinus americana pollen 0.1 g in 1 ml / betula papyrifera pollen 0.033 g in 1 ml / betula nigra pollen 0.033 g in 1 ml / betula pendula pollen 0.033 g in 1 ml / juglans nigra pollen 0.1 g in 1 ml / populus deltoides pollen 0.1 g in 1 ml / ulmus americana pollen 0.1 g in 1 ml subcutaneous injection, solution [pollens - trees, tree mix 6]||has_active_moiety
zinc 2+||titanium dioxide 51 mg in 1 ml / zinc oxide 28 mg in 1 ml topical cream [cover-expert sunscreen broad spectrum spf 15 no.9 honey beige]||has_active_moiety
thr||calcitonin human 6 [hp_x] in 30 ml / isoleucine 3 [hp_x] in 30 ml / leucine 3 [hp_x] in 30 ml / lysine 3 [hp_x] in 30 ml / methionine 3 [hp_x] in 30 ml / phenylalanine 3 [hp_x] in 30 ml / threonine 3 [hp_x] in 30 ml / tryptophan 3 [hp_x] in 30 ml / valine 3 [hp_x] in 30 ml / calcium carbonate 30 [hp_x] in 30 ml / calcium fluoride 30 [hp_x] in 30 ml / calcium phosphate 30 [hp_x] in 30 ml / sus scrofa bone 30 [hp_x] in 30 ml / sus scrofa parathyroid gland 30 [hp_x] in 30 ml oral solution/ drops [osteobios]||has_active_moiety
dried thyroid||bos taurus thymus 12 [hp_x] in 1 ml / thyroid, unspecified 12 [hp_x] in 1 ml / bos taurus pituitary gland, posterior 12 [hp_x] in 1 ml / bos taurus pancreas 12 [hp_x] in 1 ml / bos taurus adrenal gland 12 [hp_x] in 1 ml / bos taurus testicle 12 [hp_x] in 1 ml sublingual solution/ drops [d-19]||has_active_moiety
α-diethylamino-2,6-dimethylacetanilide||lidocaine hydrochloride 0.5 g in 100 g / benzalkonium chloride 0.13 g in 100 g topical cream [first aid only first aid/ burn]||has_active_moiety
rhus toxicarium leaf||arsenic acid 30 [hp_c] in 30 [hp_c] / atropa belladonna 30 [hp_c] in 30 [hp_c] / bryonia alba root 30 [hp_c] in 30 [hp_c] / carbo animalis 30 [hp_c] in 30 [hp_c] / cinchona officinalis bark 30 [hp_c] in 30 [hp_c] / artemisia cina pre-flowering top 30 [hp_c] in 30 [hp_c] / citrullus colocynthis fruit pulp 30 [hp_c] in 30 [hp_c] / graphite 30 [hp_c] in 30 [hp_c] / strychnos ignatii seed 30 [hp_c] in 30 [hp_c] / lycopodium clavatum spore 30 [hp_c] in 30 [hp_c] / sodium chloride 30 [hp_c] in 30 [hp_c] / nitric acid 30 [hp_c] in 30 [hp_c] / toxicodendron pubescens leaf 30 [hp_c] in 30 [hp_c] oral spray [severe back pain]||has_active_moiety
2-carboxyphenol||bismuth subsalicylate 262 mg oral tablet, chewable [health care america pink bismuth]||has_active_moiety
br- element||bromine 10 [hp_c] in 118 ml / activated charcoal 10 [hp_c] in 118 ml / lobelia inflata 10 [hp_c] in 118 ml / phosphorus 10 [hp_c] in 118 ml / silicon dioxide 10 [hp_c] in 118 ml / ammonium carbonate 10 [hp_c] in 118 ml / antimony arsenate 10 [hp_c] in 118 ml / antimony potassium tartrate 10 [hp_c] in 118 ml oral liquid [lung remedy]||has_active_moiety
triclosan product||triclosan 1.5 mg in 1 ml topical gel [pacific anti-bacterial hand cleanse kiwi essence]||has_active_moiety
tree pollen-white ash||fraxinus americana pollen 0.05 g in 1 ml / betula papyrifera pollen 0.017 g in 1 ml / betula nigra pollen 0.017 g in 1 ml / betula pendula pollen 0.017 g in 1 ml / juglans nigra pollen 0.05 g in 1 ml / populus deltoides pollen 0.05 g in 1 ml / ulmus americana pollen 0.05 g in 1 ml percutaneous injection, solution [pollens - trees, tree mix 6]||has_active_moiety
canada goldenrod pollen extract||canada goldenrod pollen extract 20000 unt/ml injectable solution||has_active_moiety
zanthoxylum americanum bark extract||selenicereus grandiflorus stem 10 [hp_x] in 59 ml / caulophyllum thalictroides root 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / black cohosh 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / viburnum opulus bark 10 [hp_x] in 59 ml / zanthoxylum americanum bark 10 [hp_x] in 59 ml oral liquid [menstrual cramps and irregularities]||has_active_moiety
omc cinnamate||octinoxate 75 mg in 1 ml / octisalate 20 mg in 1 ml / octocrylene 40 mg in 1 ml topical lotion [nu skin nu colour advanced finish broad spectrum spf 15 - soft beige]||has_active_moiety
4-hydroxyacetanilide||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [severe sinus congestion allergy and cough formula]||has_active_moiety
ethanols||alcohol 65 ml in 100 ml topical gel [lemon, verbena and cedar hand sanitizer]||has_active_moiety
b polymyxin||neopolydex ophthalmic ointment||has_active_moiety
product containing calcium (product)||calcium 0.99 oral tablet [hantai 8030 ca-d3 premium]||has_active_moiety
l-glutamic acid γ-amide||alanine 6 [hp_x] in 1 ml / arginine 6 [hp_x] in 1 ml / asparagine 6 [hp_x] in 1 ml / cysteine 6 [hp_x] in 1 ml / monosodium glutamate anhydrous 6 [hp_x] in 1 ml / glutamine 6 [hp_x] in 1 ml / glycine 6 [hp_x] in 1 ml / histidine 6 [hp_x] in 1 ml / isoleucine 6 [hp_x] in 1 ml / leucine 6 [hp_x] in 1 ml / lysine 6 [hp_x] in 1 ml / methionine 6 [hp_x] in 1 ml / phenylalanine 6 [hp_x] in 1 ml / proline 6 [hp_x] in 1 ml / serine 6 [hp_x] in 1 ml / threonine 6 [hp_x] in 1 ml / tyrosine 6 [hp_x] in 1 ml / tryptophan 6 [hp_x] in 1 ml / valine 6 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / calcium fluoride 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / calcium sulfate anhydrous 8 [hp_x] in 1 ml / ferrum phosphoricum 8 [hp_x] in 1 ml / potassium chloride 8 [hp_x] in 1 ml / potassium phosphate, dibasic 8 [hp_x] in 1 ml / potassium sulfate 8 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 8 [hp_x] in 1 ml / sodium chloride 8 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 8 [hp_x] in 1 ml / sodium sulfate 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / chlorella vulgaris 6 [hp_x] in 1 ml / turnera diffusa leafy twig 3 [hp_x] in 1 ml / herring sperm dna 6 [hp_c] in 1 ml / somatropin 24 [hp_x] in 1 ml / asian ginseng 3 [hp_x] in 1 ml / nuphar luteum root 3 [hp_x] in 1 ml / toxicodendron pubescens leaf 200 [hp_c] in 1 ml / saccharomyces cerevisiae rna 6 [hp_c] in 1 ml / selenium 8 [hp_x] in 1 ml / zinc 8 [hp_x] in 1 ml / aspartic acid 6 [hp_x] in 1 ml / spirulina platensis 6 [hp_x] in 1 ml oral spray [dna rna spectrum]||has_active_moiety
2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide||lidocaine hydrochloride 10 mg in 1 ml topical liquid [natures craft lidocaine male genital desensitizer]||has_active_moiety
alcohol ethyl||(spl review) alcohol 71 g in 100 g topical liquid [mellow hand sanitizer with aloe and vitamin e 59ml 01]||has_active_moiety
(+)-(s)-naproxen||naproxen 500 milligram in 1 tablet oral tablet||has_active_moiety
solanum dulcamara stem extract||solanum dulcamara stem 4 [hp_x] in 20 ml / hypericum perforatum 4 [hp_x] in 20 ml / gold 12 [hp_x] in 20 ml / petroselinum crispum 4 [hp_x] in 20 ml / calendula officinalis flowering top 4 [hp_x] in 20 ml / silver 12 [hp_x] in 20 ml / lycopodium clavatum spore 4 [hp_x] in 20 ml oral liquid [unda 37]||has_active_moiety
nystatin [mouth] (product)||triamcin+nyst 0.1%/100ku/g crm||has_active_moiety
o||oxygen 99 l in 100 l nasal gas||has_active_moiety
phenylethylbarbiturate||atropine sulfate/hyoscyamine sulfate/phenobarbital/scopolamine hydrobromide 0.0194 mg/5 ml-0.1037 mg/5 ml-16.2 mg/5 ml-0.0065 mg/5 ml oral elixir [se-donna pb hyos]||has_active_moiety
product containing succinylcholine||succinylcholine chloride 20 mg in 1 ml intramuscular injection, solution [anectine]||has_active_moiety
ethyl alcohol product||isopropyl alcohol 5 ml in 100 ml / alcohol 65 ml in 100 ml topical liquid [b-good hand and skin disinfecting agent]||has_active_moiety
benzalkonium (substance)||benzalkonium chloride 0.13 g in 100 g topical cloth [premier value antibacterial hand sanitizingenriched with alo enriched with aloe vera]||has_active_moiety
product containing digoxin||digoxin@125 mcg (0.125 mg)@oral@tablet||has_active_moiety
ethanol-containing product||alcohol 65.0 ml in 100 ml topical liquid [fresh decor coconut cream]||has_active_moiety
johnson grass pollen extract||juniperus virginiana pollen 0.00008 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya tomentosa pollen 0.001 g in 1 ml / ulmus americana pollen 0.00008 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / iva annua pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / bassia scoparia pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / felis catus hair 16 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / phoma destructiva 0.002 g in 1 ml / candida albicans 0.00008 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.0004 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml intradermal injection, solution||has_active_moiety
thyroid, porcine||echinacea angustifolia whole 1 [hp_x] in 1 ml / peumus boldus leaf 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / arnica montana whole 12 [hp_x] in 1 ml / calcium iodide 12 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 12 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / adenosine triphosphate disodium 12 [hp_x] in 1 ml / ubidecarenone 12 [hp_x] in 1 ml / naja naja venom 15 [hp_x] in 1 ml / tribasic calcium phosphate 30 [hp_x] in 1 ml / influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza a virus a/hong kong/2671/2019 ivr-208 (h3n2) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / sodium sulfate 30 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / sulfur 30 [hp_x] in 1 ml / human breast tumor cell 200 [hp_x] in 1 ml oral liquid [lymph iii]||has_active_moiety
zinc oxide (medication)||zinc oxide 20 g in 100 g topical stick [sunscreen]||has_active_moiety
octocrilene (substance)||avobenzone 3 g in 100 g / homosalate 13 g in 100 g / octisalate 5 g in 100 g / octocrylene 7 g in 100 g / oxybenzone 4 g in 100 g topical lotion [goodsense sunscreen spf 50]||has_active_moiety
ofloxacino||product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug)||has_active_moiety
ferrosoferric phosphate||silicon dioxide 12 [hp_x] in 1 ml / onion 30 [hp_x] in 1 ml / calendula officinalis flowering top 1 [hp_x] in 1 ml / echinacea angustifolia 1 [hp_x] in 1 ml / calcium sulfide 200 [hp_x] in 1 ml / lachesis muta venom 90 [hp_x] in 1 ml / ferrosoferric phosphate 60 [hp_x] in 1 ml / goldenseal 1 [hp_x] in 1 ml / aconitum napellus 200 [hp_x] in 1 ml / garlic 30 [hp_x] in 1 ml / atropa belladonna 200 [hp_x] in 1 ml / virola sebifera resin 2 [hp_x] in 1 ml / thuja occidentalis leafy twig 90 [hp_x] in 1 ml / calcium sulfate anhydrous 60 [hp_x] in 1 ml sublingual solution/ drops [n09 bacterotox]||has_active_moiety
naproxen product||anaprox 275mg tablet||has_active_moiety
propranolol product||product containing only propranolol hydrochloride 20 mg/1 each oral tablet (clinical drug)||has_active_moiety
diphenhydramine [dup] (substance)||diphenhydramine hcl 2 % topical gel (gram)||has_active_moiety
lidocainum||lidocaine hydrochloride 40 mg/ml medicated pad [alocane]||has_active_moiety
citric acid (anhydrous)||dextrose monohydrate 2.23 g in 70 ml / trisodium citrate dihydrate 1.84 g in 70 ml / anhydrous citric acid 209 mg in 70 ml / sodium phosphate, monobasic, monohydrate 155 mg in 70 ml / adenine 19.3 mg in 70 ml intravenous solution [cpda-1]||has_active_moiety
product containing rifampicin||rifampicin 300 mg oral capsule||has_active_moiety
borate ion||sodium borate 1 [hp_x] oral pellet||has_active_moiety
cortone||cortisone acetate 30 [hp_c] in 1 ml oral liquid [cortisone aceticum]||has_active_moiety
riboflavin mononucleotide||dexpanthenol 10 mg/ml / niacinamide 100 mg/ml / vitamin b6 hydrochloride 10 mg/ml / riboflavin 5 mg/ml / vit-b1 hydrochloride 100 mg/ml / vitamin b12 0.1 mg/ml injectable solution||has_active_moiety
morphine product||morphine sulfate er, 15 mg/12 hr oral tablet, extended release||has_active_moiety
guaiphenesin carbamate||methocarbamol 500mg oral tablet||has_active_moiety
triamterene product||triamterene 37.5mg, hydrochlorothiazide 25mg oral capsule||has_active_moiety
sisal fiber allergenic extract||agave sisalana fiber extract 50 mg/ml injectable solution||has_active_moiety
acetominophen||acetaminophen/dextromethorphan hydrobromide/phenylephrine hydrochloride 325 mg-10 mg-5 mg oral capsule, liquid filled [leader daytime cold & flu relief]||has_active_moiety
anser anser feather extract||felis catus hair 400 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.0004 g in 1 ml / gallus gallus feather 0.00003 g in 1 ml / anas platyrhynchos feather 0.00003 g in 1 ml / anser anser feather 0.00003 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / candida albicans 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml intradermal injection, solution||has_active_moiety
titanium dioxide||octinoxate 3.5 g in 100 g / titanium dioxide 14.00 g in 100 g topical powder [sooryehan dabityoon jiyoon two way cake 23]||has_active_moiety
d-glucose, anhydrous||dextrose monohydrate 1.79 g in 70 ml / trisodium citrate dihydrate 1.84 g in 70 ml / anhydrous citric acid 209 mg in 70 ml / sodium phosphate, monobasic, unspecified form 156 mg in 70 ml intravenous solution [imuflex wb-sp blood bag system with integral whole blood leukocyte reduction filter (saving platelets) with diversion blood sampling arm]||has_active_moiety
ceanothus americanus leaf extract||silybum marianum seed 1 [hp_x] in 1 ml / chelidonium majus 1 [hp_x] in 1 ml / taraxacum officinale 1 [hp_x] in 1 ml / chionanthus virginicus bark 3 [hp_x] in 1 ml / quassia amara wood 3 [hp_x] in 1 ml / ceanothus americanus leaf 12 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / teucrium marum 12 [hp_x] in 1 ml / beef liver 200 [hp_x] in 1 ml / culver's root 12 [hp_x] in 1 ml oral liquid [liver tonic i]||has_active_moiety
cyclobenzaprinum||flexeril, 5 mg oral tablet||has_active_moiety
vitamin d>2< (substance)||ergocalciferol 1.25 mg oral capsule||has_active_moiety
dehydrated ethanol||alcohol 4 ml in 5 ml topical liquid [hand sanitizer]||has_active_moiety
product containing codeine (medicinal product)||acetaminophen 300 mg and codeine phosphate 30 mg oral tablet||has_active_moiety
adenylpyrophosphate||cynanchum vincetoxicum root 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / methylcobalamin 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / apc-356433 8 [hp_x] in 1 ml / apc-356434 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / gamboge 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / 7-oxodehydroepiandrosterone 3-acetate 30 [hp_x] in 1 ml / adenosine triphosphate disodium 30 [hp_x] in 1 ml / glucagon 30 [hp_x] in 1 ml / insulin pork 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [weight management]||has_active_moiety
immunoglobulin g4, anti-(human cd4 (antigen)) (human-mouse monoclonal 5a8 gamma-4-chain), disulfide with human-mouse monoclonal 5a8 kappa-chain, dimer||trogarzo 200 mg per 1.33 ml injection||has_active_moiety
doxylaminum||gnp severe night time cold & flu solution||has_active_moiety
rhizopus stolonifer allergenic extract||periplaneta americana 0.002 g in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / canis lupus familiaris hair 0.0004 g in 1 ml / felis catus hair 80 [bau] in 1 ml / ulmus americana pollen 0.0004 g in 1 ml / ambrosia trifida pollen 0.000027 g in 1 ml / ambrosia artemisiifolia pollen 0.000027 g in 1 ml / ambrosia psilostachya pollen 0.000027 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / fraxinus americana pollen 0.0004 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / candida albicans 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml subcutaneous injection, solution||has_active_moiety
homosalate (substance)||avobenzone 3 g in 100 g / homosalate 5 g in 100 g / octisalate 5 g in 100 g / octocrylene 7 g in 100 g topical cream [cc creme concealer broad spectrum spf 20 jafra]||has_active_moiety
diacetyl benzoyl lathyrol||diacetyl benzoyl lathyrol 0.1 ml in 100 ml topical cream [gongjinhyang seol whitening jinaek program]||has_active_moiety
allergenic extract, short ragweed||echinacea, unspecified 3 [hp_x] in 1 ml / baptisia tinctoria root 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / myrrh 3 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / fenugreek leaf 3 [hp_x] in 1 ml / acacia pollen 30 [hp_x] in 1 ml / fraxinus pennsylvanica pollen 30 [hp_x] in 1 ml / betula occidentalis pollen 30 [hp_x] in 1 ml / acer negundo pollen 30 [hp_x] in 1 ml / juniperus virginiana pollen 30 [hp_x] in 1 ml / populus deltoides pollen 30 [hp_x] in 1 ml / taxodium distichum pollen 30 [hp_x] in 1 ml / ulmus americana pollen 30 [hp_x] in 1 ml / celtis occidentalis pollen 30 [hp_x] in 1 ml / carya ovata pollen 30 [hp_x] in 1 ml / ligustrum vulgare pollen 30 [hp_x] in 1 ml / acer saccharum pollen 30 [hp_x] in 1 ml / acer rubrum pollen 30 [hp_x] in 1 ml / morus rubra pollen 30 [hp_x] in 1 ml / quercus virginiana pollen 30 [hp_x] in 1 ml / quercus rubra pollen 30 [hp_x] in 1 ml / quercus alba pollen 30 [hp_x] in 1 ml / carya illinoinensis pollen 30 [hp_x] in 1 ml / pinus strobus pollen 30 [hp_x] in 1 ml / populus alba pollen 30 [hp_x] in 1 ml / liquidambar styraciflua pollen 30 [hp_x] in 1 ml / platanus occidentalis pollen 30 [hp_x] in 1 ml / juglans nigra pollen 30 [hp_x] in 1 ml / salix nigra pollen 30 [hp_x] in 1 ml / baccharis halimifolia pollen 30 [hp_x] in 1 ml / amaranthus palmeri pollen 30 [hp_x] in 1 ml / xanthium strumarium pollen 30 [hp_x] in 1 ml / rumex crispus pollen 30 [hp_x] in 1 ml / chenopodium album pollen 30 [hp_x] in 1 ml / iva annua pollen 30 [hp_x] in 1 ml / artemisia vulgaris pollen 30 [hp_x] in 1 ml / urtica dioica pollen 30 [hp_x] in 1 ml / amaranthus retroflexus pollen 30 [hp_x] in 1 ml / plantago lanceolata pollen 30 [hp_x] in 1 ml / ambrosia trifida pollen 30 [hp_x] in 1 ml / ambrosia artemisiifolia pollen 30 [hp_x] in 1 ml / paspalum notatum pollen 30 [hp_x] in 1 ml / cynodon dactylon pollen 30 [hp_x] in 1 ml / poa pratensis pollen 30 [hp_x] in 1 ml / festuca pratensis pollen 30 [hp_x] in 1 ml / sorghum halepense pollen 30 [hp_x] in 1 ml / lolium perenne pollen 30 [hp_x] in 1 ml / dactylis glomerata pollen 30 [hp_x] in 1 ml / agrostis gigantea pollen 30 [hp_x] in 1 ml oral liquid [allergena zone 2]||has_active_moiety
pulsatilla vulgaris||antimony trisulfide 10 [hp_x] in 59 ml / silver nitrate 10 [hp_x] in 59 ml / activated charcoal 10 [hp_x] in 59 ml / chelidonium majus 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / goldenseal 10 [hp_x] in 59 ml / ipecac 10 [hp_x] in 59 ml / potassium carbonate 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml oral liquid [indigestion relief]||has_active_moiety
cochliobolus spicifer||trichothecium roseum 0.0071 g in 1 ml / passalora fulva 0.0071 g in 1 ml / cochliobolus spicifer 0.0071 g in 1 ml / myrothecium verrucaria 0.0071 g in 1 ml / hypomyces perniciosus 0.0071 g in 1 ml / neurospora crassa 0.0071 g in 1 ml / khuskia oryzae 0.0071 g in 1 ml / paecilomyces variotii 0.0071 g in 1 ml / microascus brevicaulis 0.0071 g in 1 ml / colletotrichum coccodes 0.0071 g in 1 ml / pleospora herbarum 0.0071 g in 1 ml / streptomyces griseus 0.0071 g in 1 ml / trichoderma viride 0.0071 g in 1 ml / trichophyton schoenleinii 0.0071 g in 1 ml intradermal injection, solution||has_active_moiety
2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b][1,5]benzodiazepine||olanzapine 15 mg oral tablet [zyprexa]||has_active_moiety
2-ethylhexyl-p-methoxycinnamate (substance)||octinoxate 50 mg in 1 ml topical cream [pretty by flormar mattifying foundation 005 soft beige]||has_active_moiety
sepia officinalis juice||solidago virgaurea flowering top 3 [hp_x] in 1 ml / capsella bursa-pastoris 3 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 3 [hp_x] in 1 ml / mercury 8 [hp_x] in 1 ml / copaifera officinalis resin 9 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / equisetum hyemale 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / aconitum napellus 6 [hp_c] in 1 ml / benzoic acid 6 [hp_c] in 1 ml / tribasic calcium phosphate 6 [hp_c] in 1 ml / lytta vesicatoria 6 [hp_c] in 1 ml / strychnos ignatii seed 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / strychnos nux-vomica seed 6 [hp_c] in 1 ml / smilax regelii root 6 [hp_c] in 1 ml / delphinium staphisagria seed 6 [hp_c] in 1 ml / thuja occidentalis leafy twig 6 [hp_c] in 1 ml oral liquid [urinary tract]||has_active_moiety
2-ethylhexyl-2-cyano-3,3-diphenylacrylate||octinoxate 75 mg in 1 ml / octocrylene 27.9 mg in 1 ml topical stick [nu skin sunright lip balm broad spectrum spf 15]||has_active_moiety
1-pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphas)-||roweepra 750mg tablet||has_active_moiety
nicotinamide product||spironolactone 5 g in 100 g / dapsone 8.5 g in 100 g / niacinamide 2 g in 100 g topical gel||has_active_moiety
metoprolol-containing product||product containing only metoprolol tartrate 50 mg/1 each oral tablet (clinical drug)||has_active_moiety
porcine heparin product||heparin sodium 1000 unit/ml solution for injection ampule||has_active_moiety
aspirin product||sunmark aspirin low dose 81mg chewable tablet (cherry)||has_active_moiety
acetaminophen (substance)||acetaminophen 325 mg in 15 ml / dextromethorphan hydrobromide 10 mg in 15 ml / guaifenesin 200 mg in 15 ml / phenylephrine hydrochloride 5 mg in 15 ml oral solution [topcare day time cold and flu]||has_active_moiety
product containing phenylephrine (medicinal product)||dextromethorphan hydrobromide 4 mg/ml / guaifenesin 50 mg/ml / phenylephrine hydrochloride 2.5 mg/ml oral solution||has_active_moiety
solanum dulcamara top extract||onion 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / eucalyptus globulus leaf 3 [hp_x] in 1 ml / sage 3 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / euphrasia stricta 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / schoenocaulon officinale seed 6 [hp_x] in 1 ml / viscum album fruiting top 6 [hp_x] in 1 ml / sus scrofa nasal mucosa 6 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / ammonium carbonate 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / potassium dichromate 12 [hp_x] in 1 ml / mercury 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml oral liquid [upper respiratory support]||has_active_moiety
dexmedetomidina||dexmedetomidine hydrochloride 4 ug in 1 ml intravenous injection [dexmedetomidine hydrochloride]_#1||has_active_moiety
topical form isotretinoin||zenatane 40mg capsule||has_active_moiety
antimony trisulfide||aloe 10 [hp_x] in 118 ml / activated charcoal 10 [hp_x] in 118 ml / strychnos nux-vomica seed 10 [hp_x] in 118 ml / antimony trisulfide 10 [hp_x] in 118 ml / selenium 10 [hp_x] in 118 ml / apis mellifera 10 [hp_x] in 118 ml / nutmeg 10 [hp_x] in 118 ml / baptisia tinctoria root 10 [hp_x] in 118 ml / matricaria recutita 10 [hp_x] in 118 ml / ipecac 10 [hp_x] in 118 ml / strophanthus hispidus seed 10 [hp_x] in 118 ml / anemone pratensis 10 [hp_x] in 118 ml oral liquid [digestrex digestive relief formula]||has_active_moiety
trihexyphenidyl product||bentex 5 mg oral tablet||has_active_moiety
product containing ipecacuanha (medicinal product)||house dust 15 [hp_x] in 1 ml / iris versicolor root 6 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / apis mellifera 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / blatta orientalis 15 [hp_x] in 1 ml / bromine 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / centaurea benedicta 15 [hp_x] in 1 ml / felis catus hair 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / canis lupus familiaris hair 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / podophyllum 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / claviceps purpurea sclerotium 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / saccharomyces cerevisiae 16 [hp_x] in 1 ml / solidago virgaurea flowering top 6 [hp_x] in 1 ml oral liquid [dust-mold-dander]||has_active_moiety
octylsalicylate||octisalate 0.21 g in 4.25 g / avobenzone 0.09 g in 4.25 g / octocrylene 0.06 g in 4.25 g / octinoxate 0.28 g in 4.25 g topical stick||has_active_moiety
dessicated thyroid extract||calcium iodide 4 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / potassium iodide 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa spleen 6 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 6 [hp_x] in 1 ml / sus scrofa thymus 6 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / ferrous iodide 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / calcium hexafluorosilicate 8 [hp_x] in 1 ml oral liquid [progena thyro plus]||has_active_moiety
methyl 2-hydroxybenzoate||capsaicin/methyl salicylate/menthol@0.025 %-12 %-1 %@topical@cream (gram)||has_active_moiety
lead (pb)||arsenic trioxide 800 [hp_c] in 1 ml / lycopodium clavatum spore 16 [hp_m] in 1 ml / lead 18 [hp_m] in 1 ml / achillea millefolium 21 [hp_x] in 1 ml / sus scrofa cerebellum 21 [hp_x] in 1 ml oral liquid [emvita 26]||has_active_moiety
aqua fortis / nitric acid||calendula officinalis flowering top 2 [hp_x] in 1 ml / sambucus nigra flowering top 3 [hp_x] in 1 ml / garlic 6 [hp_x] in 1 ml / clematis recta flowering top 6 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / graphite 8 [hp_x] in 1 ml / kerosene 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / croton tiglium seed 12 [hp_x] in 1 ml / mercuric sulfide 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml oral liquid [hers plus]||has_active_moiety
sodium+||sodium bicarbonate 40mg/ml inj||has_active_moiety
propan-2-ol (substance)||isopropyl alcohol 0.7 u in 1 u topical cloth [sani-ultra wipes]||has_active_moiety
sulfur, nos||salicylic acid/sulfur@2 %-2 %@topical@shampoo (gram)||has_active_moiety
white-heart hickory pollen||chenopodium album pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / carya alba pollen 0.001 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
bryonia alba root extract||bryonia alba root 3 [hp_c] in 1 ml / protortonia cacti 3 [hp_c] in 1 ml / drosera rotundifolia flowering top 3 [hp_c] in 1 ml / ipecac 3 [hp_c] in 1 ml / pulsatilla vulgaris 6 [hp_c] in 1 ml / rumex crispus root 6 [hp_c] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_c] in 1 ml / lobaria pulmonaria 3 [hp_c] in 1 ml / antimony potassium tartrate 6 [hp_c] in 1 ml oral syrup [chestal]||has_active_moiety
vaporized peracetic acid sterilization||peracetic acid 0.15 g in 60 ml topical spray [pu us lemon]||has_active_moiety
pinus sylvestris flowering top||symphytum officinale whole 30 [hp_c] in 1 ml / zinnia elegans whole 30 [hp_c] in 1 ml / peppermint 30 [hp_c] in 1 ml / semecarpus anacardium juice 12 [hp_x] in 1 ml / musa x paradisiaca flower 30 [hp_c] in 1 ml / arnica montana 120 [hp_c] in 1 ml / strychnos ignatii seed 60 [hp_c] in 1 ml / calochortus gunnisonii whole 30 [hp_c] in 1 ml / citrus paradisi whole 30 [hp_c] in 1 ml / mimulus ringens whole 30 [hp_c] in 1 ml / ranunculus bulbosus whole 30 [hp_c] in 1 ml / ehrendorferia chrysantha whole 30 [hp_c] in 1 ml / chaste tree 6 [hp_x] in 1 ml / arnica montana flower 30 [hp_c] in 1 ml / rudbeckia hirta whole 30 [hp_c] in 1 ml / potassium bromide 10 [hp_x] in 1 ml / achillea millefolium flower 30 [hp_c] in 1 ml / cornus nuttallii whole 30 [hp_c] in 1 ml / toxicodendron diversilobum whole 30 [hp_c] in 1 ml / phosphoric acid 10 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 30 [hp_c] in 1 ml / phosphorus 12 [hp_x] in 1 ml / myosotis sylvatica flowering top 30 [hp_c] in 1 ml / melilotus officinalis top 30 [hp_c] in 1 ml / canis lupus familiaris milk 10 [hp_x] in 1 ml / carnegiea gigantea flower 30 [hp_c] in 1 ml / eriodictyon californicum flowering top 30 [hp_c] in 1 ml / pinus sylvestris flowering top 30 [hp_c] in 1 ml sublingual solution/ drops [f15 mnd-mmry]||has_active_moiety
johnson grass smut extract||sporisorium cruentum 0.05 g in 1 ml cutaneous injection [smut, johnson grass]||has_active_moiety
retinoids adapalene||adapalene 0.001 mg/mg topical gel [differin]||has_active_moiety
antimony cation (3+)||influenza a virus 30 [hp_x] in 1 ml / antimony potassium tartrate 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / drosera anglica 15 [hp_x] in 1 ml / eucalyptus gum 15 [hp_x] in 1 ml / histamine dihydrochloride 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / potassium dichromate 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / potassium iodide 15 [hp_x] in 1 ml / myrrh 15 [hp_x] in 1 ml / sodium sulfate 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / rumex crispus root 15 [hp_x] in 1 ml / sambucus nigra flowering top 15 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 15 [hp_x] in 1 ml / tussilago farfara 15 [hp_x] in 1 ml / verbascum thapsus 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [cold - cough]||has_active_moiety
ácido clavulánico||amoxicillin/clavulanate potassium 875 mg-125 mg oral tablet||has_active_moiety
risedronic acid product||risedronate sodium hemi-pentahydrate 35 mg oral tablet, film coated_#2||has_active_moiety
mimulus guttatus flowering top||solidago virgaurea flowering top 1 [hp_x] in 1 ml / asparagus 2 [hp_x] in 1 ml / juniperus communis whole 2 [hp_x] in 1 ml / saw palmetto 2 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 2 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / equisetum arvense top 3 [hp_x] in 1 ml / rhus aromatica root bark 3 [hp_x] in 1 ml / urtica dioica 3 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / rubia tinctorum root 6 [hp_x] in 1 ml / delphinium staphisagria seed 6 [hp_x] in 1 ml / cobalt 8 [hp_x] in 1 ml / fagus sylvatica flowering top 8 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / larix decidua flowering top 8 [hp_x] in 1 ml / manganese 8 [hp_x] in 1 ml / mimulus guttatus flowering top 8 [hp_x] in 1 ml / nitric acid 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / ulex europaeus flower 8 [hp_x] in 1 ml / benzoic acid 12 [hp_x] in 1 ml oral liquid [kidney drainage]||has_active_moiety
sus scrofa bone marrow preparation||chaste tree fruit 6 [hp_x] / ambergris 6 [hp_x] / estradiol 6 [hp_x] / levodopa 6 [hp_x] / melatonin 6 [hp_x] / petroselinum crispum whole 6 [hp_x] / adenosine triphosphate disodium 8 [hp_x] / alpha lipoic acid 8 [hp_x] / nadide 8 [hp_x] / pantothenic acid 8 [hp_x] / lactic acid, l- 8 [hp_x] / ubidecarenone 8 [hp_x] / barium carbonate 8 [hp_x] / conium maculatum flowering top 8 [hp_x] / selenium 8 [hp_x] / estrone 8 [hp_x] / testosterone 8 [hp_x] / sus scrofa umbilical cord 30 [hp_x] / sus scrofa adrenal gland 30 [hp_x] / pork liver 30 [hp_x] / sus scrofa hypothalamus 30 [hp_x] / sus scrofa lymph 30 [hp_x] / sus scrofa bone marrow 30 [hp_x] / sus scrofa ovary 30 [hp_x] / sus scrofa testicle 30 [hp_x] / sus scrofa pancreas 30 [hp_x] / sus scrofa spleen 30 [hp_x] / somatropin 30 [hp_x] / proteus morganii 30 [hp_c] oral tablet [high vitality tab]||has_active_moiety
rehmannia glutinosa root||scrophularia buergeriana root 1.8 g in 100 g / scutellaria baicalensis root 7.5 g in 100 g / ampelopsis japonica tuber 3.75 g in 100 g / angelica gigas root oil 1.88 g in 100 g / rhubarb 7.5 g in 100 g / astragalus propinquus root 1.88 g in 100 g / bletilla striata tuber 1.88 g in 100 g / rehmannia glutinosa root 1.88 g in 100 g / cinnamon bark oil 1.88 g in 100 g / frankincense 1.88 g in 100 g / momordica cochinchinensis seed 1.88 g in 100 g / paeonia lactiflora root 1.88 g in 100 g / phellodendron chinensis bark 1.88 g in 100 g / myrrh 1.88 g in 100 g / lead tetroxide 25 g in 100 g / sulfur 0.1 g in 100 g / apricot kernel oil 1.88 g in 100 g / angelica dahurica root 1.88 g in 100 g / yellow wax 3.75 g in 100 g / citrus aurantium fruit rind 0.1 g in 100 g topical ointment [goryeodyo goyak]||has_active_moiety
calcium hexafluorosilicate||calcium hexafluorosilicate 30 [hp_c] in 1 ml oral liquid [lapis albus]||has_active_moiety
eucalyptus globulus leaf essential oil||camphor 5 % / eucalyptus oil 1.2 % / menthol 2.6 % topical ointment||has_active_moiety
rubidio||american ginseng 3 [hp_x] in 1 ml / ginkgo 3 [hp_x] in 1 ml / arsenic triiodide 12 [hp_x] in 1 ml / avena sativa flowering top 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / thyroid, porcine 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony 12 [hp_x] in 1 ml / barium 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / calcium 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium 12 [hp_x] in 1 ml / chloride ion 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / fluoride ion 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / gallium 12 [hp_x] in 1 ml / germanium 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / hafnium 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / lanthanum 12 [hp_x] in 1 ml / lithium 12 [hp_x] in 1 ml / lutetium 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / niobium 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / potassium 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhenium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium 12 [hp_x] in 1 ml / ruthenium 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / scandium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / silicon 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / sodium 12 [hp_x] in 1 ml / strontium 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / tantalum 12 [hp_x] in 1 ml / tellurium 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / thorium 12 [hp_x] in 1 ml / thulium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / titanium 12 [hp_x] in 1 ml / tungsten 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium 12 [hp_x] in 1 ml / yttrium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / zirconium 12 [hp_x] in 1 ml oral liquid [pituistat]||has_active_moiety
silver drug||robinia pseudoacacia bark 4 [hp_x] / silver 6 [hp_x] / sus scrofa adrenal gland 6 [hp_x] / tobacco leaf 6 [hp_x] / strychnos nux-vomica seed 6 [hp_x] / copper 8 [hp_x] / sodium phosphate 10 [hp_x] oral pellet||has_active_moiety
product containing cetirizine||allergy relief 24 hour relief 10mg tablet||has_active_moiety
docusate-containing product||tricare dha one, prenatal multivitamins with folic acid 1 mg and docusate oral capsule||has_active_moiety
benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester||oxybenzone 38.8 mg in 1 ml / avobenzone 29.1 mg in 1 ml / homosalate 121.25 mg in 1 ml / octisalate 48.5 mg in 1 ml / octocrylene 26.68 mg in 1 ml topical spray [panama jack spf 85 sport dry touch sunscreen]||has_active_moiety
lactoflavin preparation||ascorbic acid 60 mg / cholecalciferol 2000 [iu] / tocopherol 35 [iu] / thiamine 1.5 mg / riboflavin 1.7 mg / niacinamide 20 mg / pyridoxine hydrochloride 10 mg / folic acid 1 mg / cobalamin 6 ug / biotin 300 ug / pantothenic acid 10 mg / zinc oxide 12.5 mg / selenomethionine 70 ug oral tablet, coated [vital-d rx]||has_active_moiety
allergenic extract, short ragweed||poa pratensis pollen 160 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / ulmus americana pollen 0.002 g in 1 ml / ambrosia trifida pollen 0.0000267 g in 1 ml / ambrosia artemisiifolia pollen 0.0000267 g in 1 ml / ambrosia psilostachya pollen 0.0000267 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / plantago lanceolata pollen 0.00008 g in 1 ml / candida albicans 0.002 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / acer negundo pollen 0.000078 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / iva annua var. annua pollen 0.00008 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
darbepoetin alfa (medication)||aranesp albumin free, 200 mcg/ml injectable solution||has_active_moiety
loperamide||loperamide hydrochloride 2mg capsule||has_active_moiety
dextromethorfan||apap 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule||has_active_moiety
2-ethylhexyl salicylate||avobenzone 2 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g / oxybenzone 4 g in 100 g topical lotion [ultrasol sunscreen lotion spf 45]||has_active_moiety
fusarium oxysporum allergenic extract||gallus gallus feather 0.0000267 g in 1 ml / anas platyrhynchos feather 0.0000267 g in 1 ml / anser anser feather 0.0000267 g in 1 ml / ustilago nuda hordei 0.0005 g in 1 ml / ustilago maydis 0.0005 g in 1 ml / ustilago avenae 0.0005 g in 1 ml / ustilago tritici 0.0005 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml / cochliobolus sativus 0.00008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.00008 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / candida albicans 0.002 g in 1 ml / fusarium oxysporum 0.00008 g in 1 ml / cladosporium cladosporioides 0.00008 g in 1 ml / phoma destructiva 0.00008 g in 1 ml / rhizopus stolonifer 0.00008 g in 1 ml intradermal injection, solution||has_active_moiety
sus scrofa umbilical cord preparation||lactic acid, l- 3 [hp_x] in 1 ml / viscum album fruiting top 3 [hp_x] in 1 ml / iodine 3 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml / galium aparine whole 6 [hp_x] in 1 ml / sodium diethyl oxalacetate 6 [hp_x] in 1 ml / thyroid, porcine 6 [hp_x] in 1 ml / prasterone 6 [hp_x] in 1 ml / phenyl isothiocyanate 6 [hp_x] in 1 ml / tyramine 6 [hp_x] in 1 ml / adenosine triphosphate disodium 7 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 7 [hp_x] in 1 ml / fumaric acid 7 [hp_x] in 1 ml / malic acid 7 [hp_x] in 1 ml / colchicum autumnale bulb 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sus scrofa umbilical cord 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / sus scrofa bone marrow 8 [hp_x] in 1 ml / sus scrofa pineal gland 8 [hp_x] in 1 ml / sus scrofa spleen 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / pulsatilla pratensis whole 12 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 12 [hp_x] in 1 ml / cortisone acetate 30 [hp_x] in 1 ml / mercuric chloride 60 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / escherichia coli 30 [hp_c] in 1 ml / liothyronine 30 [hp_c] in 1 ml oral liquid [thyro support]||has_active_moiety
buspirone-containing product||buspar, 10 mg oral tablet||has_active_moiety
aralia racemosa root extract||aralia racemosa root 30 [hp_c] in 1 ml oral liquid [aralia racemosa]||has_active_moiety
knitbone root||arnica montana flower 1 [hp_x] in 1 g / calendula officinalis flowering top 2 [hp_x] in 1 g / comfrey root 2 [hp_x] in 1 g / thuja occidentalis whole 2 [hp_x] in 1 g / urtica urens 1 [hp_x] in 1 g / larix decidua resin 2 [hp_x] in 1 g / lytta vesicatoria 7 [hp_x] in 1 g / silver 8 [hp_x] in 1 g topical gel||has_active_moiety
arnica (arnica montana)||arnica montana 3 [hp_x] in 1 ml / pork brain 6 [hp_x] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / cinchona officinalis bark 6 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / somatropin 30 [hp_x] in 1 ml / lecithin, soybean 12 [hp_x] in 1 ml / achillea millefolium 3 [hp_x] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / zinc sulfate heptahydrate 12 [hp_x] in 1 ml / saccharomyces cerevisiae rna 6 [hp_c] in 1 ml oral spray [brain power]||has_active_moiety
eptifibatide||eptifibatide 20 mg in 10 ml intravenous injection||has_active_moiety
miconazole (substance)||miconazole nitrate@2 %@topical@ointment(ml)||has_active_moiety
2-hydroxypropanoic acid||adenosine triphosphate disodium 4 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / coumarin 8 [hp_x] in 1 ml / bambusa vulgaris leaf 9 [hp_x] in 1 ml / barley 9 [hp_x] in 1 ml / poppy seed 9 [hp_x] in 1 ml / corn 9 [hp_x] in 1 ml / flax seed 9 [hp_x] in 1 ml / levant cotton seed 9 [hp_x] in 1 ml / millet 9 [hp_x] in 1 ml / sorghum bicolor whole 9 [hp_x] in 1 ml / oat 9 [hp_x] in 1 ml / brown rice 9 [hp_x] in 1 ml / rye 9 [hp_x] in 1 ml / safflower 9 [hp_x] in 1 ml / sesame seed 9 [hp_x] in 1 ml / sorghum 9 [hp_x] in 1 ml / soybean 9 [hp_x] in 1 ml / sugarcane 9 [hp_x] in 1 ml / sunflower seed 9 [hp_x] in 1 ml / wheat 9 [hp_x] in 1 ml / bacillus thuringiensis 10 [hp_x] in 1 ml / wheat gluten 30 [hp_x] in 1 ml / amaranth 6 [hp_c] in 1 ml / avena sativa flowering top 6 [hp_c] in 1 ml / sodium sulfate 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / elymus repens root 6 [hp_c] in 1 ml / corticotropin 8 [hp_c] in 1 ml / glyphosate 12 [hp_c] in 1 ml / enterococcus faecalis 30 [hp_c] in 1 ml oral liquid [grain and soy allergen mix]||has_active_moiety
octylsalicylate||avobenzone 25.83 mg in 1 ml / homosalate 129.15 mg in 1 ml / octisalate 43.05 mg in 1 ml / octocrylene 23.68 mg in 1 ml topical spray [australian gold botanical sunscreen broad spectrum spf 50 natural]||has_active_moiety
aimovig||{2 (1 ml erenumab-aooe 70 mg/ml auto-injector [aimovig]) } pack [aimovig autoinjector (140 mg dose)]||has_active_moiety
phoma destructiva allergenic extract||fusarium oxysporum 0.00083 g in 1 ml / cladosporium cladosporioides 0.00083 g in 1 ml / cochliobolus sativus 0.00083 g in 1 ml / candida albicans 0.00083 g in 1 ml / aspergillus fumigatus 0.00017 g in 1 ml / ustilago cynodontis 0.00042 g in 1 ml / sporisorium cruentum 0.00042 g in 1 ml / pleospora herbarum 0.00083 g in 1 ml / aureobasidium pullulans var. pullutans 0.00083 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00083 g in 1 ml / periplaneta americana 0.00083 g in 1 ml / rhizopus stolonifer 0.00083 g in 1 ml / phoma destructiva 0.00083 g in 1 ml / dermatophagoides pteronyssinus 166.67 [au] in 1 ml / canis lupus familiaris hair 0.00083 g in 1 ml / alternaria alternata 0.00083 g in 1 ml / dermatophagoides farinae 166.67 [au] in 1 ml / felis catus hair 166.67 [bau] in 1 ml / ustilago nuda hordei 0.00021 g in 1 ml / ustilago maydis 0.00021 g in 1 ml / ustilago avenae 0.00021 g in 1 ml / ustilago tritici 0.00021 g in 1 ml / gallus gallus feather 0.00028 g in 1 ml / anas platyrhynchos feather 0.00028 g in 1 ml / anser anser feather 0.00028 g in 1 ml subcutaneous injection, solution||has_active_moiety
1-hydroxyethane||alcohol 80 ml in 100 ml subcutaneous liquid [80% alcohol hand sanitizer]||has_active_moiety
tree pollen-red cedar||poa pratensis pollen 160 [bau] in 1 ml / ulmus americana pollen 0.00008 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / plantago lanceolata pollen 0.0004 g in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / acer negundo pollen 0.00008 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.0004 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / rumex acetosella pollen 0.0004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / carya tomentosa pollen 0.00004 g in 1 ml / ambrosia artemisiifolia pollen 0.00013 g in 1 ml / ambrosia trifida pollen 0.00013 g in 1 ml / ambrosia psilostachya pollen 0.00013 g in 1 ml subcutaneous injection, solution||has_active_moiety
cetirizine (product)||cetirizine hydrochloride 10 mg oral tablet, film coated [berkley and jensen allergy relief]||has_active_moiety
product containing nitrogen (medicinal product)||nitrogen 990 ml in 1 l respiratory (inhalation) liquid||has_active_moiety
docetaxel anhydrous||docetaxel 10mg/ml injection solution 80mg vial (product)||has_active_moiety
acer saccharum sap extract||cinnamic acid 6 [hp_x] in 1 ml / phlorizin 6 [hp_x] in 1 ml / silver nitrate 6 [hp_c] in 1 ml / adenosine triphosphate disodium 6 [hp_c] in 1 ml / sucrose 6 [hp_c] in 1 ml / dextrose 6 [hp_c] in 1 ml / ribose, d- 6 [hp_c] in 1 ml / fructose 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / acer saccharum sap 6 [hp_c] in 1 ml / lactose 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / corticotropin 8 [hp_c] in 1 ml / malvin 15 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [sugar cravings]||has_active_moiety
mercuric cation||echinacea angustifolia 3 [hp_x] in 1 ml / aloe 6 [hp_x] in 1 ml / colchicum autumnale bulb 8 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / strychnos nux-vomica seed 8 [hp_x] in 1 ml / arsenic trioxide 8 [hp_x] in 1 ml / clostridium difficile 8 [hp_x] in 1 ml / acetic acid 12 [hp_x] in 1 ml / quinine sulfate 12 [hp_x] in 1 ml / vibrio cholerae 12 [hp_x] in 1 ml / proteus vulgaris 16 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / helicobacter pylori 30 [hp_x] in 1 ml / yersinia enterocolitica 30 [hp_x] in 1 ml / botulinum toxin type a 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / brugia malayi 39 [hp_c] in 1 ml oral liquid [dysbio plus]||has_active_moiety
pancrelipase protease||zenpep 15,000 unt / 63,000 unt / 47,000 unt delayed release oral capsule||has_active_moiety
boxelder maple pollen||carya illinoinensis pollen 0.0125 g in 1 ml / quercus virginiana pollen 0.0125 g in 1 ml / ulmus americana pollen 0.0125 g in 1 ml / acer negundo pollen 0.0125 g in 1 ml intradermal solution [central eastern 4 tree pollen mix]||has_active_moiety
l-(3-hydroxyphenyl)-n-methylethanolamine||acetaminophen 500 mg / dextromethorphan hydrobromide 20 mg / phenylephrine hydrochloride 10 mg oral powder, for solution [leader multi symptom flu and severe cold]||has_active_moiety
dermatophagoides farinae allergenic extract||felis catus hair 400 [bau] in 1 ml / dermatophagoides farinae 400 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / candida albicans 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / betula nigra pollen 0.002 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / kochia scoparia pollen 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml intradermal injection, solution||has_active_moiety
mg+2||adenosine cyclic phosphate 10 [hp_x] in 59.1 ml / arnica montana 30 [hp_x] in 59.1 ml / gold trichloride 12 [hp_x] in 59.1 ml / barium chloride dihydrate 12 [hp_x] in 59.1 ml / borage 6 [hp_x] in 59.1 ml / cholesterol 12 [hp_x] in 59.1 ml / lemon juice 4 [hp_x] in 59.1 ml / coenzyme a 10 [hp_x] in 59.1 ml / conium maculatum flowering top 12 [hp_x] in 59.1 ml / digitalis 6 [hp_x] in 59.1 ml / ginkgo 4 [hp_x] in 59.1 ml / bos taurus hypothalamus 12 [hp_x] in 59.1 ml / potassium iodide 12 [hp_x] in 59.1 ml / prunus laurocerasus leaf 10 [hp_x] in 59.1 ml / magnesium chloride 8 [hp_x] in 59.1 ml / nadide 9 [hp_x] in 59.1 ml / kidney bean 5 [hp_x] in 59.1 ml / phosphorus 30 [hp_x] in 59.1 ml / thyroid, bovine 12 [hp_x] in 59.1 ml oral liquid [circulopath]||has_active_moiety
octylmethoxycinnamate||octinoxate 3.5 g in 50 ml / octocrylene 2.5 g in 50 ml / octisalate 2.25 g in 50 ml topical cream [multi protection uv bouncer]||has_active_moiety
tetryzoline (substance)||dextran 70/peg-400/povidone/tetrahydrozoline hydrochloride 0.1%-1%-1%-0.05% ophthalmic solution [leader eye drops]||has_active_moiety
acidum lacticum||glyceryl laurate .0025 kg in 1 kg / lactic acid .03 kg in 1 kg topical solution||has_active_moiety
nizoral psoriasis||eucalyptol 0.092 g in 100 ml / menthol 0.042 g in 100 ml / methyl salicylate 0.060 g in 100 ml / thymol 0.064 g in 100 ml oral mouthwash [buenos dias de personna mint]||has_active_moiety
diltiazem (medication)||diltiazem hydrochloride 30 mg oral tablet, film coated [diltiazem hydrochloride]||has_active_moiety
creosote (substance)||horse chestnut 12 [hp_x] in 59.1 ml / azadirachta indica bark 8 [hp_x] in 59.1 ml / barium carbonate 12 [hp_x] in 59.1 ml / berberis vulgaris root bark 12 [hp_x] in 59.1 ml / peumus boldus leaf 4 [hp_x] in 59.1 ml / bufo bufo cutaneous gland 12 [hp_x] in 59.1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 59.1 ml / tribasic calcium phosphate 12 [hp_x] in 59.1 ml / coenzyme a 12 [hp_x] in 59.1 ml / collinsonia canadensis root 10 [hp_x] in 59.1 ml / echinacea angustifolia 6 [hp_x] in 59.1 ml / ferrum phosphoricum 12 [hp_x] in 59.1 ml / sus scrofa adrenal gland 9 [hp_x] in 59.1 ml / bos taurus hypothalamus 12 [hp_x] in 59.1 ml / wood creosote 15 [hp_x] in 59.1 ml / nadide 12 [hp_x] in 59.1 ml / sodium chloride 12 [hp_x] in 59.1 ml / phosphorus 30 [hp_x] in 59.1 ml / phytolacca americana root 4 [hp_x] in 59.1 ml / pinus sylvestris leafy twig 9 [hp_x] in 59.1 ml / sus scrofa pituitary gland 6 [hp_x] in 59.1 ml / pine tar 6 [hp_x] in 59.1 ml / pulsatilla vulgaris 12 [hp_x] in 59.1 ml / silicon dioxide 12 [hp_x] in 59.1 ml / stillingia sylvatica root 4 [hp_x] in 59.1 ml / thuja occidentalis leafy twig 12 [hp_x] in 59.1 ml oral liquid [lymph-tone ii]||has_active_moiety
2-hydroxy-4-methoxybenzophenone||octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 spf 25 (nude prisma) - beige]||has_active_moiety
ceftriaxone||ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial||has_active_moiety
oxybenzone (substance)||octinoxate 7.5 g in 100 ml / oxybenzone 5 g in 100 ml / octisalate 5 g in 100 ml / avobenzone 2 g in 100 ml / octocrylene 4 g in 100 ml topical cream [daily protect sunscreen moisturizer broad spectrum spf 30]||has_active_moiety
noradrenalin||.gamma.-aminobutyric acid 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / norepinephrine bitartrate 6 [hp_x] in 1 ml / serotonin hydrochloride 6 [hp_x] in 1 ml / corticotropin 15 [hp_c] in 1 ml / semecarpus anacardium juice 30 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / barium carbonate 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / tribasic calcium phosphate 30 [hp_c] in 1 ml / hyoscyamus niger 30 [hp_c] in 1 ml / lycopodium clavatum spore 30 [hp_c] in 1 ml / datura stramonium 30 [hp_c] in 1 ml oral liquid [add hp]||has_active_moiety
product containing ethanol||alcohol 70 g in 100 g topical liquid [aram hand sanitizing wipe]||has_active_moiety
r(-)-phenylephrine||brompheniramine maleate/dextromethorphan hydrobromide/phenylephrine hydrochloride 4 mg/5 ml-20 mg/5 ml-10 mg/5 ml oral solution [lohist-peb-dm]||has_active_moiety
alcohol (grain)||alcohol 70 l in 100 l topical gel [premium gel alcohol hand sanitizer]||has_active_moiety
ubrogepantum||ubrelvy 50mg tablet||has_active_moiety
aconitum napellus whole||spongia officinalis skeleton, roasted 4 [hp_x] in 1 ml / causticum 6 [hp_x] in 1 ml / lachesis muta venom 8 [hp_x] in 1 ml / calcium sulfide 5 [hp_x] in 1 ml / thymus serpyllum 3 [hp_x] in 1 ml / antimony potassium tartrate 6 [hp_x] in 1 ml / aconitum napellus 6 [hp_x] in 1 ml / drosera rotundifolia 4 [hp_x] in 1 ml sublingual solution [d-8]||has_active_moiety
4-chloro-m-xylenol||chloroxylenol 15 g in 1 l topical soap [chemstation e2]||has_active_moiety
goose feathers allergenic extract||gallus gallus feather 200 [pnu] in 1 ml / anser anser feather 200 [pnu] in 1 ml / anas platyrhynchos feather 200 [pnu] in 1 ml intradermal injection, solution [animal allergens, feather mix]||has_active_moiety
copper-63||punica granatum root bark 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / juglans regia leaf 5 [hp_x] in 1 ml / dryopteris filix-mas root 6 [hp_x] in 1 ml / wormwood 15 [hp_x] in 1 ml / horse chestnut 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / artemisia cina pre-flowering top 15 [hp_x] in 1 ml / copper 15 [hp_x] in 1 ml / ipecac 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / krameria lappacea root 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / schoenocaulon officinale seed 15 [hp_x] in 1 ml / santonin 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / spigelia anthelmia 15 [hp_x] in 1 ml / teucrium marum 15 [hp_x] in 1 ml oral liquid [parasite detox]||has_active_moiety
pulsatilla vulgaris||picea mariana resin 12 [hp_x] in 59 ml / antimony trisulfide 12 [hp_x] in 59 ml / asafetida 12 [hp_x] in 59 ml / baptisia tinctoria 12 [hp_x] in 59 ml / sodium borate 12 [hp_x] in 59 ml / candida albicans 12 [hp_x] in 59 ml / lachesis muta venom 12 [hp_x] in 59 ml / phosphoric acid 12 [hp_x] in 59 ml / phytolacca americana root 12 [hp_x] in 59 ml / pulsatilla vulgaris 12 [hp_x] in 59 ml / lobaria pulmonaria 12 [hp_x] in 59 ml / sulfur 12 [hp_x] in 59 ml / thuja occidentalis leafy twig 12 [hp_x] in 59 ml topical liquid [candidol candida overgrowth sympton relief]||has_active_moiety
azithromycin anhydrous||azithromycin 100 mg/5 ml oral powder for suspension||has_active_moiety
product containing pantoprazole||protonix 40 mg (pantoprazole sodium sesquihydrate 45.1 mg) delayed release oral tablet||has_active_moiety
berberis aquifolium root bark||gold 10 [hp_x] in 59 ml / mahonia aquifolium root bark 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / capsicum 10 [hp_x] in 59 ml / carbo animalis 10 [hp_x] in 59 ml / eutrochium purpureum root 10 [hp_x] in 59 ml / geranium maculatum root 10 [hp_x] in 59 ml / helleborus niger root 10 [hp_x] in 59 ml / juglans regia flowering top 10 [hp_x] in 59 ml / lobelia cardinalis 10 [hp_x] in 59 ml / lonicera caprifolium flowering top 10 [hp_x] in 59 ml / hippomane mancinella fruiting leafy twig 10 [hp_x] in 59 ml / melilotus officinalis top 10 [hp_x] in 59 ml / mercury 10 [hp_x] in 59 ml / achillea millefolium 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / corn silk 10 [hp_x] in 59 ml / viola odorata 10 [hp_x] in 59 ml oral liquid [nostalgia]||has_active_moiety
decongestants phenylephrine||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [cold and flu severe nighttime]||has_active_moiety
pork liver||somatropin 6 [hp_x] in 30 ml / dalotuzumab 6 [hp_x] in 30 ml / saccharomyces cerevisiae rna 6 [hp_x] in 30 ml / herring sperm dna 6 [hp_x] in 30 ml / sus scrofa adrenal gland 6 [hp_x] in 30 ml / pork liver 6 [hp_x] in 30 ml / sus scrofa pituitary gland 6 [hp_x] in 30 ml / sus scrofa thymus 6 [hp_x] in 30 ml / thyroid, unspecified 6 [hp_x] in 30 ml / sus scrofa placenta 6 [hp_x] in 30 ml / sus scrofa ovary 6 [hp_x] in 30 ml / artemisia abrotanum flowering top 10 [hp_x] in 30 ml / semecarpus anacardium juice 10 [hp_x] in 30 ml / arsenic trioxide 10 [hp_x] in 30 ml / barium carbonate 10 [hp_x] in 30 ml / barium chloride dihydrate 10 [hp_x] in 30 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 30 ml / tribasic calcium phosphate 10 [hp_x] in 30 ml / iron 10 [hp_x] in 30 ml / fucus vesiculosus 10 [hp_x] in 30 ml / hekla lava 10 [hp_x] in 30 ml / helleborus niger root 10 [hp_x] in 30 ml / strychnos ignatii seed 10 [hp_x] in 30 ml / lycopodium clavatum spore 10 [hp_x] in 30 ml / niacinamide 10 [hp_x] in 30 ml / claviceps purpurea sclerotium 10 [hp_x] in 30 ml / silicon dioxide 10 [hp_x] in 30 ml / cobalt 12 [hp_x] in 30 ml / lithium carbonate 12 [hp_x] in 30 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 30 ml / manganese acetate tetrahydrate 12 [hp_x] in 30 ml / potassium phosphate, dibasic 12 [hp_x] in 30 ml / selenium 12 [hp_x] in 30 ml / zinc 12 [hp_x] in 30 ml oral spray [rejuvenate 2000 pm formula for women]||has_active_moiety
2(1h)-pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-,(2r-cis)-||emtricitabine 200 mg / tenofovir disoproxil fumarate 300 mg oral tablet [truvada]||has_active_moiety
salicylic acid [callosity] (product)||methyl salicylate 10 g in 100 g topical cream [teds topical pain cream]||has_active_moiety
etoh - ethanol||alcohol 0.7 ml in 1 ml topical gel [nautica non scented hand sanitizer 70 ethyl alcohol]||has_active_moiety
product containing isopropyl alcohol||isopropyl alcohol 91% topical application solution [quality choice isopropyl rubbing alcohol]||has_active_moiety
aluminum chlorhydrate||aluminum chlorohydrate 20 g in 100 g topical stick [tussy antiperspirant and deodorant invisible original fresh spice]||has_active_moiety
(-)-trans-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine||paroxetine hydrochloride, 20 mg oral tablet||has_active_moiety
(±)-6-chloro-α-methylcarbazole-2-acetic acid||carprofen 25 mg oral tablet [carprofen]||has_active_moiety
leflunomidum||leflunomide 10 mg oral tablet, film coated||has_active_moiety
tylenol||acetaminophen-hydrocodone bitartrate, 217 mg-5 mg/10 ml oral liquid||has_active_moiety
octyl-methoxycinnamate||octinoxate 0.07 g in 1 g / octocrylene 0.05 g in 1 g / zinc oxide 0.1666 g in 1 g topical cream [lbel defense total compact suncreen spf 50 for face - matte finish]||has_active_moiety
product containing ethanol (medicinal product)||alcohol 616 ml in 1 ml topical gel [advanced hand sanitizer]||has_active_moiety
aloes - chemical (substance)||arnica montana 6 [hp_x] / aloe 6 [hp_x] / picea mariana resin 6 [hp_x] / lycopodium clavatum spore 6 [hp_x] / selenicereus grandiflorus stem 6 [hp_x] / oyster shell calcium carbonate, crude 8 [hp_x] / zinc carbobenzoxy-.beta.-alanyltaurinate 4 [hp_x] sublingual pellet [taurox immune support]||has_active_moiety
lonicera caprifolia flower||alfalfa top 30 [hp_c] in 1 ml / amaranthus palmeri pollen 30 [hp_c] in 1 ml / ambrosia artemisiifolia pollen 30 [hp_c] in 1 ml / barley 30 [hp_c] in 1 ml / betula pubescens flower bud 30 [hp_c] in 1 ml / histamine dihydrochloride 30 [hp_c] in 1 ml / rye 30 [hp_c] in 1 ml / sheep wool 30 [hp_c] in 1 ml / iva annua pollen 30 [hp_c] in 1 ml / lolium perenne top 30 [hp_c] in 1 ml / lonicera caprifolium flower 30 [hp_c] in 1 ml / lolium perenne pollen 30 [hp_c] in 1 ml / taraxacum officinale 30 [hp_c] in 1 ml / dermatophagoides pteronyssinus 30 [hp_c] in 1 ml / festuca pratensis pollen 30 [hp_c] in 1 ml / leucanthemum vulgare pollen 30 [hp_c] in 1 ml / betula lenta pollen 30 [hp_c] in 1 ml / capra hircus hair 30 [hp_c] in 1 ml / wheat 30 [hp_c] in 1 ml / amaranthus retroflexus pollen 30 [hp_c] in 1 ml / dermatophagoides farinae 30 [hp_c] in 1 ml / phleum pratense pollen 30 [hp_c] in 1 ml / schoenocaulon officinale seed 30 [hp_c] in 1 ml / anthoxanthum odoratum pollen 30 [hp_c] in 1 ml / bos taurus skin 30 [hp_c] in 1 ml / canis lupus familiaris skin 30 [hp_c] in 1 ml / capra hircus skin 30 [hp_c] in 1 ml / garlic 30 [hp_c] in 1 ml / xanthium strumarium pollen 30 [hp_c] in 1 ml / felis catus hair 30 [hp_c] in 1 ml / oat 30 [hp_c] in 1 ml / phleum pratense top 30 [hp_c] in 1 ml / brown rice 30 [hp_c] in 1 ml / turpentine oil 30 [hp_c] in 1 ml / chenopodium album pollen 30 [hp_c] in 1 ml / anser anser feather 30 [hp_c] in 1 ml / arsenic triiodide 30 [hp_c] in 1 ml / artemisia vulgaris pollen 30 [hp_c] in 1 ml / betula occidentalis pollen 30 [hp_c] in 1 ml / dactylis glomerata pollen 30 [hp_c] in 1 ml / gallus gallus feather 30 [hp_c] in 1 ml / poa pratensis pollen 30 [hp_c] in 1 ml / corn grain 30 [hp_c] in 1 ml / anas platyrhynchos feather 30 [hp_c] in 1 ml / dysphania ambrosioides pollen 30 [hp_c] in 1 ml / equus caballus skin 30 [hp_c] in 1 ml / euphrasia stricta 30 [hp_c] in 1 ml / silicon dioxide 30 [hp_c] in 1 ml / solidago virgaurea flowering top 30 [hp_c] in 1 ml / taraxacum officinale pollen 30 [hp_c] in 1 ml / agrostis gigantea pollen 30 [hp_c] in 1 ml / ambrosia trifida pollen 30 [hp_c] in 1 ml sublingual solution/ drops [s12 airborne]||has_active_moiety
h2o - water||water for injection,sterile injection ampul (ml)||has_active_moiety
cochliobolus sativus||felis catus hair 400 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.00008 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / ambrosia trifida pollen 0.00067 g in 1 ml / ambrosia artemisiifolia pollen 0.00067 g in 1 ml / ambrosia psilostachya pollen 0.00067 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / phoma destructiva 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / sorghum halepense pollen 0.00008 g in 1 ml / ustilago cynodontis 0.001 g in 1 ml / sporisorium cruentum 0.001 g in 1 ml subcutaneous injection, solution||has_active_moiety
goose feathers allergenic extract||anser anser feather 0.001 g in 1 ml subcutaneous solution [goose feathers]||has_active_moiety
asarum europaeum||asarum europaeum 12 [hp_c] oral pellet||has_active_moiety
fer||epinephrine 15 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / mahonia aquifolium root bark 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / crotalus horridus horridus venom 15 [hp_x] in 1 ml / digitalis 15 [hp_x] in 1 ml / iron 15 [hp_x] in 1 ml / nitroglycerin 15 [hp_x] in 1 ml / glycyrrhiza glabra 15 [hp_x] in 1 ml / centella asiatica 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / ruta graveolens flowering top 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml oral liquid [vitality]||has_active_moiety
lycopodium clavatum spore extract||arsenic trioxide 12 [hp_x] in 30 ml / echinacea, unspecified 3 [hp_x] in 30 ml / gelsemium sempervirens root 12 [hp_x] in 30 ml / strychnos nux-vomica seed 12 [hp_x] in 30 ml / lycopodium clavatum spore 12 [hp_x] in 30 ml / atropa belladonna 12 [hp_x] in 30 ml / rancid beef 30 [hp_x] in 30 ml / toxicodendron pubescens leaf 30 [hp_x] in 30 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 30 ml / baptisia tinctoria 3 [hp_x] in 30 ml / phosphorus 12 [hp_x] in 30 ml / foscolic acid 12 [hp_x] in 30 ml oral liquid [virex]||has_active_moiety
alcohol ethyl||alcohol 68 ml in 100 ml topical gel [anti-bacterial hand fiji white sands]||has_active_moiety
titanium dioxide-containing product||titanium dioxide 65.05 mg in 1 ml / octinoxate 39.972 mg in 1 ml topical cream [hyaluronic hydra-foundation spf30 300c cool medium fair]||has_active_moiety
mineral supplements selenium||medicago sativa whole 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / frangula purshiana bark 3 [hp_x] in 1 ml / rheum palmatum root 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / beef liver 8 [hp_x] in 1 ml / sus scrofa intestinal mucosa 8 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / carbo animalis 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / artemisia cina pre-flowering top 12 [hp_x] in 1 ml / mandragora officinarum root 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / spigelia anthelmia whole 12 [hp_x] in 1 ml / veratrum album root 12 [hp_x] in 1 ml / bilirubin 15 [hp_x] in 1 ml / creatine 15 [hp_x] in 1 ml / creatinine 15 [hp_x] in 1 ml / indole 15 [hp_x] in 1 ml / skatole 15 [hp_x] in 1 ml / proteus mirabilis 20 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 12 [hp_c] in 1 ml oral liquid [colotox]||has_active_moiety
nicotiana tabacum (tobacco) leaf extract||horse chestnut 4 [hp_x] in 2.2 ml / lactic acid, l- 4 [hp_x] in 2.2 ml / claviceps purpurea sclerotium 4 [hp_x] in 2.2 ml / cupric sulfate 6 [hp_x] in 2.2 ml / melilotus officinalis top 6 [hp_x] in 2.2 ml / sus scrofa placenta 6 [hp_x] in 2.2 ml / solanum nigrum whole 6 [hp_x] in 2.2 ml / strophanthus hispidus seed 6 [hp_x] in 2.2 ml / sus scrofa embryo 8 [hp_x] in 2.2 ml / sodium pyruvate 8 [hp_x] in 2.2 ml / sus scrofa vein 8 [hp_x] in 2.2 ml / sus scrofa artery 10 [hp_x] in 2.2 ml / sus scrofa umbilical cord 10 [hp_x] in 2.2 ml / tobacco leaf 10 [hp_x] in 2.2 ml / vipera berus venom 10 [hp_x] in 2.2 ml / barium carbonate 13 [hp_x] in 2.2 ml / lead iodide 18 [hp_x] in 2.2 ml intravenous injection [placenta compositum]||has_active_moiety
fentanyl||fentanyl 12.5 ug transdermal patch [fentanyl system]||has_active_moiety
cefepim||cefepime hydrochloride 1 g in 50 ml intravenous injection, solution [cefepime]||has_active_moiety
allergenic extract, corn smut||fusarium oxysporum 0.0008 g in 1 ml / cladosporium cladosporioides 0.0008 g in 1 ml / poa pratensis pollen 3333.33 [bau] in 1 ml / cynodon dactylon pollen 333.33 [bau] in 1 ml / cochliobolus sativus 0.0008 g in 1 ml / candida albicans 0.0008 g in 1 ml / aspergillus fumigatus 0.0008 g in 1 ml / sorghum halepense pollen 0.0017 g in 1 ml / periplaneta americana 0.0008 g in 1 ml / rhizopus stolonifer 0.0008 g in 1 ml / phoma destructiva 0.0008 g in 1 ml / dermatophagoides pteronyssinus 333.33 [au] in 1 ml / canis lupus familiaris hair 0.0008 g in 1 ml / alternaria alternata 0.00017 g in 1 ml / dermatophagoides farinae 333.33 [au] in 1 ml / felis catus hair 33.33 [bau] in 1 ml / ustilago cynodontis 0.00042 g in 1 ml / sporisorium cruentum 0.00042 g in 1 ml / ustilago nuda hordei 0.00021 g in 1 ml / ustilago maydis 0.00021 g in 1 ml / ustilago avenae 0.00021 g in 1 ml / ustilago tritici 0.00021 g in 1 ml / pleospora herbarum 0.0008 g in 1 ml / aureobasidium pullulans var. pullutans 0.0008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.0008 g in 1 ml / gallus gallus feather 0.00028 g in 1 ml / anas platyrhynchos feather 0.00028 g in 1 ml / anser anser feather 0.00028 g in 1 ml subcutaneous injection, solution||has_active_moiety
benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (r)-||triaminic day time cold & cough, 5 mg-2.5 mg/5 ml oral liquid||has_active_moiety
milk thistle (silybum marianum) seed extract||aluminum oxide 15 [hp_x] in 59.1 ml / arsenic trioxide 12 [hp_x] in 59.1 ml / baptisia tinctoria root 4 [hp_x] in 59.1 ml / atropa belladonna 12 [hp_x] in 59.1 ml / peumus boldus leaf 4 [hp_x] in 59.1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 59.1 ml / milk thistle 4 [hp_x] in 59.1 ml / matricaria recutita 12 [hp_x] in 59.1 ml / chelidonium majus 4 [hp_x] in 59.1 ml / echinacea angustifolia 4 [hp_x] in 59.1 ml / goldenseal 4 [hp_x] in 59.1 ml / egg phospholipids 12 [hp_x] in 59.1 ml / ledum palustre twig 16 [hp_x] in 59.1 ml / lycopodium clavatum spore 12 [hp_x] in 59.1 ml / mercurius solubilis 15 [hp_x] in 59.1 ml / measles virus 30 [hp_x] in 59.1 ml / human sputum, bordetella pertussis infected 30 [hp_x] in 59.1 ml / phytolacca americana root 4 [hp_x] in 59.1 ml / rancid beef 30 [hp_x] in 59.1 ml / toxicodendron pubescens leaf 12 [hp_x] in 59.1 ml / silicon dioxide 12 [hp_x] in 59.1 ml / sulfur 15 [hp_x] in 59.1 ml / taraxacum officinale 4 [hp_x] in 59.1 ml / thuja occidentalis leafy twig 6 [hp_x] in 59.1 ml / thyroid, unspecified 9 [hp_x] in 59.1 ml oral liquid [vac-chord]||has_active_moiety
mentha piperita extract||matricaria recutita 3 [hp_x] in 1 ml / black cohosh 3 [hp_x] in 1 ml / mentha piperita 3 [hp_x] in 1 ml / senna leaf 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / viola odorata 3 [hp_x] in 1 ml / chaste tree fruit 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / lilium lancifolium whole flowering 4 [hp_x] in 1 ml / delphinium staphisagria seed 4 [hp_x] in 1 ml / saffron 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / cinchona officinalis bark 8 [hp_x] in 1 ml / convallaria majalis 8 [hp_x] in 1 ml / cyclamen purpurascens tuber 8 [hp_x] in 1 ml / cinnamon 12 [hp_x] in 1 ml / hexaplex trunculus hypobranchial gland juice 12 [hp_x] in 1 ml / naja naja venom 15 [hp_x] in 1 ml oral liquid [female support]||has_active_moiety
copper 2+||c-nate dha, prenatal multivitamins with folic acid 1 mg oral capsule||has_active_moiety
arabian coffee roasted bean allergenic extract||arnica montana 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / dysphania ambrosioides 10 [hp_x] in 59 ml / quinine salicylate 10 [hp_x] in 59 ml / black cohosh 10 [hp_x] in 59 ml / coffea arabica seed, roasted 10 [hp_x] in 59 ml / potassium iodide 10 [hp_x] in 59 ml / kalmia latifolia leaf 10 [hp_x] in 59 ml / magnesium carbonate 10 [hp_x] in 59 ml / manganese acetate tetrahydrate 10 [hp_x] in 59 ml / manganese carbonate 10 [hp_x] in 59 ml / mercury 10 [hp_x] in 59 ml / sodium salicylate 10 [hp_x] in 59 ml / salicylic acid 10 [hp_x] in 59 ml / allylthiourea 10 [hp_x] in 59 ml / thyroid, unspecified 10 [hp_x] in 59 ml oral liquid [tinnitus relief]||has_active_moiety
na+ element||sinucleanse micro-filtered nasal wash system kit||has_active_moiety
mineral oil oil||mineral oil 14 g in 100 g / petrolatum 74.9 g in 100 g / phenylephrine hydrochloride 0.25 g in 100 g topical ointment [hemorrhoidal]||has_active_moiety
apap (obsolete)||wal-phed pe severe cold 325mg-12.5mg-5mg caplet||has_active_moiety
european olive pollen extract||olea europaea pollen 1000 [pnu] in 1 ml subcutaneous injection, suspension [center-al - olea europaea pollen]||has_active_moiety
weed pollen-sheep sorrel||onion 3 [hp_x] in 1 ml / ambrosia artemisiifolia 6 [hp_x] in 1 ml / euphrasia stricta 3 [hp_x] in 1 ml / schoenocaulon officinale seed 6 [hp_x] in 1 ml / rumex acetosella pollen 6 [hp_x] in 1 ml / rumex crispus top 6 [hp_x] in 1 ml / poa pratensis top 6 [hp_x] in 1 ml / dactylis glomerata top 6 [hp_x] in 1 ml / agrostis gigantea pollen 6 [hp_x] in 1 ml / phleum pratense top 6 [hp_x] in 1 ml / solidago virgaurea flowering top 6 [hp_x] in 1 ml / trifolium pratense flower 6 [hp_x] in 1 ml / alfalfa 6 [hp_x] in 1 ml / ambrosia trifida pollen 6 [hp_x] in 1 ml / ambrosia acanthicarpa pollen 6 [hp_x] in 1 ml / ambrosia psilostachya pollen 6 [hp_x] in 1 ml / ulmus americana pollen 6 [hp_x] in 1 ml / platanus occidentalis pollen 6 [hp_x] in 1 ml / fraxinus americana pollen 6 [hp_x] in 1 ml / fagus grandifolia pollen 6 [hp_x] in 1 ml / juglans nigra pollen 6 [hp_x] in 1 ml / salix nigra pollen 6 [hp_x] in 1 ml / acer negundo pollen 6 [hp_x] in 1 ml / populus deltoides subsp. deltoides pollen 6 [hp_x] in 1 ml / betula occidentalis pollen 6 [hp_x] in 1 ml / quercus rubra pollen 6 [hp_x] in 1 ml / carya ovata pollen 6 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / histamine dihydrochloride 6 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml oral liquid [allersode ii]||has_active_moiety
lettuce diagnostic allergen extract||lettuce 1 g in 20 ml subcutaneous injection, solution [lettuce]||has_active_moiety
artemisia ludoviciana pollen extract||artemisia ludoviciana pollen extract 0.1 gm/ml injectable solution||has_active_moiety
solanum nigrum whole||artery porcine/baryta carbonica/black nightshade/claviceps purpurea/cuprum sulphuricum/embryo porcine/funiculus umbilicalis/horse chestnut/natrum pyruvicum/placenta porcine/plumbum iodatum/sarcolacticum acidum/strophanthus hispidus/tobacco/vein porcine/vipera berus venom/yellow sweetclover 10 x/22 mcl-13 x/22 mcl-6 x/22 mcl-4 x/22 mcl-6 x/22 mcl-8 x/22 mcl-10 x/22 mcl-4 x/22 mcl-8 x/22 mcl-6 x/22 mcl-18 x/22 mcl-4 x/22 mcl-6 x/22 mcl-10 x/22 mcl-8 x/22 mcl-10 x/22 mcl-6 x/22 mcl injection solution [placenta compositum]||has_active_moiety
turnera diffusa leaf extract||dioscorea villosa root 30 mg / epimedium grandiflorum top 175 mg / arginine hydrochloride 40 mg / tyrosine 60 mg / avena sativa leaf 5 mg / angelica sinensis root 2.5 mg / histidine 100 mg / turnera diffusa leaf 50 mg / american ginseng 40 mg / tribulus terrestris root 25 mg / panax ginseng fruit 40 mg / ginkgo 40 mg / cordyceps gunnii fruiting body 10 mg / cnidium monnieri fruit 15 mg / momordica charantia fruit 50 mg / mucuna pruriens whole 40 mg / black pepper 25 mg oral capsule||has_active_moiety
alcohol anhydrous||alcohol 62 ml in 100 ml topical gel [apple harvest scented hand sanitizer]||has_active_moiety
fenilefrina||asa 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine bitartrate 7.8 mg effervescent oral tablet||has_active_moiety
losartan||losartan 50mg tab ud||has_active_moiety
2-(diphenylmethoxy)-n,n-dimethylethylamine||sleep aid (diphenhydramine), 50 mg oral capsule||has_active_moiety
tolterodinum||tolterodine tartrate 4 mg oral capsule, extended release||has_active_moiety
compro||prochlorperazine edisylate 5 mg in 1 ml intramuscular injection [prochlorperazine edisylate]||has_active_moiety
product containing vitamin b12 (medicinal product)||fucus vesiculosus 2 [hp_x] in 1 ml / cyanocobalamin 6 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / levocarnitine 30 [hp_x] in 1 ml / ornithine 30 [hp_x] in 1 ml / antimony trisulfide 8 [hp_x] in 1 ml / human chorionic gonadotropin 60 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / sodium sulfate 10 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / pancrelipase 12 [hp_x] in 1 ml / sus scrofa hypothalamus 18 [hp_x] in 1 ml oral liquid [hcg with slimming herbs]||has_active_moiety
topiramatum||topiramate 50mg oral tablet||has_active_moiety
bisacodilo||bisacodyl 5 mg oral tablet, delayed release [stimulant laxative]||has_active_moiety
diethyl oxalacetate||ceanothus americanus leaf 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / marsdenia condurango bark 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / momordica balsamina immature fruit 6 [hp_x] in 1 ml / anemone pratensis 6 [hp_x] in 1 ml / sus scrofa bile duct 8 [hp_x] in 1 ml / sus scrofa colon 8 [hp_x] in 1 ml / sus scrofa duodenum 8 [hp_x] in 1 ml / sus scrofa esophagus 8 [hp_x] in 1 ml / sus scrofa eye 8 [hp_x] in 1 ml / sus scrofa gallbladder 8 [hp_x] in 1 ml / sus scrofa ileum 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / ipecac 8 [hp_x] in 1 ml / sus scrofa jejunum 8 [hp_x] in 1 ml / potassium dichromate 8 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / sus scrofa nasal mucosa 8 [hp_x] in 1 ml / sodium diethyl oxalacetate 8 [hp_x] in 1 ml / sus scrofa oral mucosa 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / phosphorus 8 [hp_x] in 1 ml / sus scrofa rectal mucosa 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / sulfur 8 [hp_x] in 1 ml / veratrum album root 8 [hp_x] in 1 ml / mannose, d- 8 [hp_x] in 1 ml / semecarpus anacardium juice 9 [hp_x] in 1 ml / wood creosote 10 [hp_x] in 1 ml / lachesis muta venom 10 [hp_x] in 1 ml / oxalis acetosella leaf 10 [hp_x] in 1 ml / mandragora officinarum root 16 [hp_x] in 1 ml / sus scrofa urinary bladder 6 [hp_c] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [intercellular detox]||has_active_moiety
product containing zolpidem||zolpidem hemitartrate 10mg tablet (substance)||has_active_moiety
clavulanic acid (product)||amoxicillin 250/clav k 62.5mg/5ml susp||has_active_moiety
(3s)-2-((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid||quinapril hydrochloride 20 mg oral tablet [accupril]||has_active_moiety
alcohol anhydrous||alcohol 62 ml in 100 ml topical gel [acore peppermint hand sanitizer girls]||has_active_moiety
malus domestica flower extract||cinnamon 3 [hp_x] in 1 ml / gentiana lutea root 3 [hp_x] in 1 ml / syzygium cumini seed 3 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / colchicum autumnale bulb 6 [hp_x] in 1 ml / bos taurus colostrum 6 [hp_x] in 1 ml / copper gluconate 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / magnesium gluconate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / sus scrofa pancreas 6 [hp_x] in 1 ml / potassium gluconate 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / scrophularia nodosa 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / gold 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / malus pumila flower 8 [hp_x] in 1 ml / nitric acid 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / water 8 [hp_x] in 1 ml / fagus sylvatica flowering top 12 [hp_x] in 1 ml oral liquid [gi drainage]||has_active_moiety
product containing morphine||morphine sulfate 4 mg/ml intraven vial (ml)||has_active_moiety
k+ element||potassium chloride 10meq prolonged-release oral tablet||has_active_moiety
benzalkonium (substance)||benzalkonium chloride 0.13 g in 100 ml topical spray [wipe out-lemon scent]||has_active_moiety
product containing desoximetasone||topicort 0.25% topical spray||has_active_moiety
sus scrofa lymph vessel||androsterone 30 [kp_c] in 1 ml / artichoke 30 [kp_c] in 1 ml / adenosine triphosphate 30 [kp_c] in 1 ml / basic fibroblast growth factor (human) 200 [kp_c] in 1 ml / ersofermin 200 [kp_c] in 1 ml / adenosine cyclic phosphate 30 [kp_c] in 1 ml / levocarnitine 30 [kp_c] in 1 ml / centella asiatica 30 [kp_c] in 1 ml / citric acid monohydrate 30 [kp_c] in 1 ml / cobalt 30 [kp_c] in 1 ml / estrogens, esterified 200 [kp_c] in 1 ml / ferrous fumarate 30 [kp_c] in 1 ml / fumaric acid 30 [kp_c] in 1 ml / heptaminol 30 [kp_c] in 1 ml / hamamelis virginiana bark 30 [kp_c] in 1 ml / hyaluronidase 30 [kp_c] in 1 ml / interleukin-3 200 [kp_c] in 1 ml / potassium aspartate 30 [kp_c] in 1 ml / lactic acid 30 [kp_c] in 1 ml / bos taurus lymph vessel 200 [kp_c] in 1 ml / sus scrofa lymph vessel 200 [kp_c] in 1 ml / melilotus officinalis whole 30 [kp_c] in 1 ml / manganese 30 [kp_c] in 1 ml / sodium diethyl oxalacetate 30 [kp_c] in 1 ml / sodium pyruvate 30 [kp_c] in 1 ml / quinhydrone 30 [kp_c] in 1 ml / succinic acid 30 [kp_c] in 1 ml / bos taurus vein 200 [kp_c] in 1 ml / sus scrofa vein 200 [kp_c] in 1 ml / vitamin a 30 [kp_c] in 1 ml / zinc 30 [kp_c] in 1 ml topical spray [viatrexx-cellulite]||has_active_moiety
sulfuric acid disodium salt, anhydrous||arnica montana 30 [hp_c] in 5 ml / arsenic trioxide 30 [hp_c] in 5 ml / bellis perennis 30 [hp_c] in 5 ml / passiflora incarnata flowering top 30 [hp_c] in 5 ml / valerian 30 [hp_c] in 5 ml / apis mellifera 30 [hp_c] in 5 ml / human breast tumor cell 30 [hp_c] in 5 ml / helianthemum canadense 30 [hp_c] in 5 ml / clematis recta flowering top 30 [hp_c] in 5 ml / arabica coffee bean 30 [hp_c] in 5 ml / strychnos ignatii seed 30 [hp_c] in 5 ml / lachesis muta venom 30 [hp_c] in 5 ml / magnesium phosphate, dibasic trihydrate 30 [hp_c] in 5 ml / sodium chloride 30 [hp_c] in 5 ml / sodium sulfate 30 [hp_c] in 5 ml / ornithogalum umbellatum 30 [hp_c] in 5 ml / phosphoric acid 30 [hp_c] in 5 ml / salix nigra bark 30 [hp_c] in 5 ml / delphinium staphisagria seed 30 [hp_c] in 5 ml oral liquid [century 21 acute stress]||has_active_moiety
equisetum arvense vegetative top||calendula officinalis flowering top 1 [hp_x] in 100 ml / matricaria recutita 1 [hp_x] in 100 ml / saffron 3 [hp_x] in 100 ml / equisetum arvense top 1 [hp_x] in 100 ml / hamamelis virginiana root bark/stem bark 1 [hp_x] in 100 ml / lamium album 1 [hp_x] in 100 ml / achillea millefolium 1 [hp_x] in 100 ml / plantago major 1 [hp_x] in 100 ml / quercus robur flower 1 [hp_x] in 100 ml / capsella bursa-pastoris 1 [hp_x] in 100 ml / trillium erectum whole 2 [hp_x] in 100 ml / urtica dioica 1 [hp_x] in 100 ml / viscum album whole 3 [hp_x] in 100 ml oral liquid [trillium]||has_active_moiety
product containing phosphate||apis mellifera 6 [hp_c] in 28 g / black cohosh 6 [hp_c] in 28 g / calcium fluoride 6 [hp_c] in 28 g / sodium phosphate, dibasic, heptahydrate 6 [hp_c] in 28 g / toxicodendron pubescens leaf 6 [hp_c] in 28 g oral pellet [minor arthritic pain]||has_active_moiety
anhydrous glucose||dextrose monohydrate 50 mg in 1 ml intravenous injection, solution [dextrose]_#2||has_active_moiety
1-(4-(1,1-dimethylethyl)phenyl)-3-(4-methoxyphenyl)-1,3-propanedione||avobenzone 9.35 mg in 1 ml / octocrylene 18.7 mg in 1 ml / octisalate 28.05 mg in 1 ml topical spray [australian gold instant bronzer spf 8 sunscreen]||has_active_moiety
ragwitek||plantago lanceolata pollen 0.002 g in 1 ml / carya illinoinensis pollen 0.0002 g in 1 ml / carya alba pollen 0.0002 g in 1 ml / chenopodium album pollen 0.0004 g in 1 ml / urtica dioica pollen 0.0004 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / rumex acetosella pollen 0.0004 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.00008 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / pascopyrum smithii pollen 0.0004 g in 1 ml / felis catus hair 400 [bau] in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / betula populifolia pollen 0.0004 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / populus deltoides pollen 0.0004 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / platanus occidentalis pollen 0.00008 g in 1 ml / salix nigra pollen 0.002 g in 1 ml / juglans nigra pollen 0.0004 g in 1 ml / morus rubra pollen 0.0004 g in 1 ml intradermal injection, solution||has_active_moiety
alprazolam-containing product||alprazolam@2 mg@oral@tablet||has_active_moiety
chlorpheniramine (substance)||tylenol children's cold plus flu suspension (bubblegum)||has_active_moiety
latanoprost-containing product||dorzolamide hydrochloride 20 mg in 1 ml / brimonidine tartrate 1.5 mg in 1 ml / latanoprost 0.05 mg in 1 ml / timolol maleate 5 mg in 1 ml ophthalmic solution/ drops [tim-brim-dor-lat]||has_active_moiety
sulfur preparations||matricaria chamomilla 10 [hp_x] in 1 ml / mercurius solubilis 15 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml auricular (otic) solution/ drops [rexallear relief ear drops]||has_active_moiety
calcium cation||bos taurus parathyroid gland 6 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral liquid [parathyroplex]||has_active_moiety
2-ethylhexyl 2-hydroxybenzoate||homosalate 9 g in 100 g / octocrylene 7 g in 100 g / octisalate 4.5 g in 100 g / avobenzone 2.7 g in 100 g topical spray [hawaiian tropic island sport sunscreen uvauvb broad spectrum spf 50]||has_active_moiety
alternaria alternata diagnostic allergen extract||cladosporium sphaerospermum 0.00025 g in 1 ml / aspergillus niger var. niger 0.00025 g in 1 ml / alternaria alternata 0.00025 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00025 g in 1 ml intradermal solution [mold mix 3]||has_active_moiety
chloroxylenol (substance)||chloroxylenol 2.5 mg in 1 ml topical soap [hand antibacterial]||has_active_moiety
iodide ion||chelidonium majus 3 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 3 [hp_x] in 1 ml / iodine 4 [hp_x] in 1 ml / lycopus virginicus 6 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / pinus sylvestris leafy twig 6 [hp_x] in 1 ml / fucus vesiculosus 8 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa thyroid 9 [hp_x] in 1 ml / cysteine 10 [hp_x] in 1 ml / manganese gluconate 12 [hp_x] in 1 ml / .alpha.-ketoglutaric acid 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / fumaric acid 12 [hp_x] in 1 ml / potassium iodide 12 [hp_x] in 1 ml / sodium diethyl oxalacetate 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / eugenol 12 [hp_x] in 1 ml / formaldehyde 12 [hp_x] in 1 ml / lidocaine 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / titanium 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / mumps virus 30 [hp_x] in 1 ml / human coxsackievirus a2 16 [hp_c] in 1 ml / human coxsackievirus a7 16 [hp_c] in 1 ml / human coxsackievirus b1 16 [hp_c] in 1 ml / human coxsackievirus b3 16 [hp_c] in 1 ml / human coxsackievirus b4 16 [hp_c] in 1 ml oral liquid [oligo bio iodine]||has_active_moiety
sodium cation||fucus vesiculosus 2 [hp_x] in 1 ml / cyanocobalamin 6 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / levocarnitine 30 [hp_x] in 1 ml / ornithine 30 [hp_x] in 1 ml / antimony trisulfide 8 [hp_x] in 1 ml / human chorionic gonadotropin 60 [hp_x] in 1 ml / sus scrofa thyroid 8 [hp_x] in 1 ml / sodium sulfate 10 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / pancrelipase 12 [hp_x] in 1 ml / sus scrofa hypothalamus 18 [hp_x] in 1 ml oral liquid [optimal hcg]||has_active_moiety
guaianesin||dextromethorphan hydrobromide/guaifenesin 10 mg/5 ml-100 mg/5 ml oral syrup [silexin]||has_active_moiety
apap||mucus relief cold, flu & sore throat, 325 mg-10 mg-200 mg-5 mg oral tablet||has_active_moiety
oralair 100||lolium perenne pollen 20000 [pnu] in 1 ml subcutaneous injection, suspension [center-al - lolium perenne pollen]||has_active_moiety
dehydrated ethanol||alcohol 75 ml in 100 ml topical gel [boogoo hand sanitizer]||has_active_moiety
octylsalicylate||avobenzone 30 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 30 mg in 1 g topical cream [lancome paris high resolution refill 3x triple action renewal anti wrinkle broad spectrum spf 15 sunscreen]||has_active_moiety
carya ovata pollen||carya glabra pollen 0.00025 g in 1 ml / carya alba pollen 0.00025 g in 1 ml / carya ovata pollen 0.00025 g in 1 ml / carya laciniosa pollen 0.00025 g in 1 ml intradermal solution [hickory pollen mix]||has_active_moiety
bovine mesenchyme preparation||bos taurus adrenal gland 200 [kp_c] in 1 ml / sus scrofa adrenal gland 200 [kp_c] in 1 ml / ascorbic acid 30 [kp_c] in 1 ml / brain-derived neurotrophic factor human 30 [kp_c] in 1 ml / prasterone 30 [kp_c] in 1 ml / malic acid 30 [kp_c] in 1 ml / basic fibroblast growth factor (human) 30 [kp_c] in 1 ml / fucus vesiculosus 30 [kp_c] in 1 ml / histidine 30 [kp_c] in 1 ml / hyaluronidase 30 [kp_c] in 1 ml / human interleukin-6 (nonglycosylated) 30 [kp_c] in 1 ml / lactic acid 30 [kp_c] in 1 ml / sus scrofa lymph vessel 30 [kp_c] in 1 ml / bos taurus lymph vessel 30 [kp_c] in 1 ml / sus scrofa mesenchyme 30 [kp_c] in 1 ml / nadide 30 [kp_c] in 1 ml / sodium diethyl oxalacetate 30 [kp_c] in 1 ml / sodium pyruvate 30 [kp_c] in 1 ml / sodium sulfate 200 [kp_c] in 1 ml / phenylalanine 30 [kp_c] in 1 ml / prolactin 30 [kp_c] in 1 ml / rancid beef 30 [kp_c] in 1 ml / thuja occidentalis leaf 200 [kp_c] in 1 ml / dodecahydroxycyclohexane dihydrate 30 [kp_c] in 1 ml / tyrosine 30 [kp_c] in 1 ml oral spray [viatrexx-mesenchyme]||has_active_moiety
oyster shell calcium carbonate preparation||alfalfa 1 [hp_x] in 41 ml / arnica montana 3 [hp_x] in 41 ml / oyster shell calcium carbonate, crude 200 [hp_c] in 41 ml / calcium fluoride 30 [hp_c] in 41 ml / tribasic calcium phosphate 30 [hp_c] in 41 ml / sus scrofa cartilage 6 [hp_x] in 41 ml / hydrofluoric acid 30 [hp_c] in 41 ml / comfrey root 30 [hp_c] in 41 ml oral liquid [sprayology bone builder]||has_active_moiety
zinc óxido||titanium dioxide 0.957 g in 30 ml / zinc oxide 0.282 g in 30 ml topical suspension [magic foundation flawless long-lasting coverage sunscreen broad spectrum spf 15]||has_active_moiety
alcohol (ethyl)||alcohol 0.8 ml in 1 ml topical liquid [ma magic armour hand and skin sanitizer]||has_active_moiety
phenylephrine (product)||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / doxylamine succinate 6.25 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [equate vapor ice cold and flu]||has_active_moiety
17-α-ethynyl-19-norandrost-4-en-17-β-ol-3-one||ethinyl estradiol-norethindrone 35 mcg-0.5 mg oral tablet||has_active_moiety
myristica fragrans allergenic extract||onion 12 [hp_x] in 59.1 ml / mercuric sulfide 12 [hp_x] in 59.1 ml / echinacea angustifolia 4 [hp_x] in 59.1 ml / goldenseal 4 [hp_x] in 59.1 ml / potassium dichromate 12 [hp_x] in 59.1 ml / mercurius solubilis 30 [hp_x] in 59.1 ml / nutmeg 6 [hp_x] in 59.1 ml / pulsatilla vulgaris 12 [hp_x] in 59.1 ml / sodium sulfate 12 [hp_x] in 59.1 ml / sus scrofa nasal mucosa 9 [hp_x] in 59.1 ml oral liquid [sinus-tone]||has_active_moiety
chloride, hydrogen||milk thistle 6 [hp_x] in 1 ml / helianthemum canadense 6 [hp_x] in 1 ml / solanum dulcamara top 6 [hp_x] in 1 ml / galium aparine 6 [hp_x] in 1 ml / magnesium chloride 6 [hp_x] in 1 ml / sodium sulfate 6 [hp_x] in 1 ml / viscum album fruiting top 6 [hp_x] in 1 ml / hydrochloric acid 6 [hp_x] in 1 ml / estrone 8 [hp_x] in 1 ml / sodium chloride 10 [hp_x] in 1 ml / ailanthus altissima flowering twig 12 [hp_x] in 1 ml / barium chloride dihydrate 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / ceanothus americanus leaf 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml / cinchona officinalis bark 12 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / crotalus durissus terrificus venom 16 [hp_x] in 1 ml oral liquid [ebv/cfs plus]||has_active_moiety
ethinyl estradiol (medication)||norgestimate 0.18 mg / ethinyl estradiol 0.025 mg oral tablet, coated||has_active_moiety
venlafaxine (medication)||venlafaxine hcl 150 mg 24hr extended release oral capsule||has_active_moiety
étodolac||product containing precisely etodolac 400 milligram/1 each conventional release oral tablet (clinical drug)||has_active_moiety
polymyxin b||polymyxin b sulfate 500000 [usp'u] intramuscular injection, powder, for solution [polymyxin b]||has_active_moiety
montelukast-containing product||singulair 10mg tablet||has_active_moiety
quercus rubra pollen||quercus rubra pollen 20000 [pnu] in 1 ml percutaneous solution [red oak pollen]||has_active_moiety
benzocaine - chemical (substance)||benzocaine/benzoin compound 20%-0.5% oromucosal film||has_active_moiety
octisalate||octisalate 0.21 g in 4.25 g / avobenzone 0.09 g in 4.25 g / octocrylene 0.06 g in 4.25 g / octinoxate 0.28 g in 4.25 g topical stick||has_active_moiety
potassium(i) cation||lactated ringers solution for injection||has_active_moiety
triazolam||halcion 250micrograms tablet||has_active_moiety
tazobactam||piperacillin sodium/tazobactam sodium 3 gm-0.375 gm intravenous powder for solution [amerinet choice zosyn]||has_active_moiety
titanium dioxide (product)||zinc oxide 4.9 g in 100 g / titanium dioxide 13.7 g in 100 g topical cream [haute protection high protection tinted compact broad spectrum spf 50 honey]||has_active_moiety
human recombinant keratinocyte growth factor-containing product||palifermin 6.25mg/vil inj||has_active_moiety
cultivated oat pollen extract||avena sativa pollen 0.05 g in 1 ml subcutaneous injection, solution [pollens - grasses, oats, common, cultivated avena sativa]||has_active_moiety
l-lactic acid (substance)||chaste tree 6 [hp_x] in 1 ml / ambergris 6 [hp_x] in 1 ml / apiole (parsley) 6 [hp_x] in 1 ml / estradiol 6 [hp_x] in 1 ml / estriol 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / melatonin 6 [hp_x] in 1 ml / testosterone 6 [hp_x] in 1 ml / adenosine triphosphate disodium 8 [hp_x] in 1 ml / .alpha.-lipoic acid 8 [hp_x] in 1 ml / nadide 8 [hp_x] in 1 ml / pantothenic acid 8 [hp_x] in 1 ml / lactic acid, l- 8 [hp_x] in 1 ml / ubidecarenone 8 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / estrone 8 [hp_x] in 1 ml / sus scrofa umbilical cord 30 [hp_x] in 1 ml / sus scrofa adrenal gland 30 [hp_x] in 1 ml / pork liver 30 [hp_x] in 1 ml / sus scrofa hypothalamus 30 [hp_x] in 1 ml / sus scrofa lymph 30 [hp_x] in 1 ml / sus scrofa bone marrow 30 [hp_x] in 1 ml / sus scrofa ovary 30 [hp_x] in 1 ml / sus scrofa testicle 30 [hp_x] in 1 ml / sus scrofa pancreas 30 [hp_x] in 1 ml / sus scrofa spleen 30 [hp_x] in 1 ml / somatropin 30 [hp_x] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [hgh vitality]||has_active_moiety
rhus toxicarium leaf||calendula officinalis flowering top 1 [hp_x] in 1 g / arnica montana 1 [hp_x] in 1 g / hypericum perforatum 3 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g / bellis perennis 12 [hp_x] in 1 g / activated charcoal 12 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 12 [hp_x] in 1 g / achillea millefolium 12 [hp_x] in 1 g / toxicodendron pubescens leaf 12 [hp_x] in 1 g / ruta graveolens flowering top 12 [hp_x] in 1 g / veratrum album root 12 [hp_x] in 1 g topical gel [injury topical]||has_active_moiety
amlodipine - chemical (substance)||amlodipine besylate/benazepril 10 mg-40 mg oral capsule||has_active_moiety
seroquel||quetiapine fumarate 25mg ud tab||has_active_moiety
2-mercaptopyridine 1-oxide zinc salt||dial dandruff control hair and body 0.95 % medicated shampoo||has_active_moiety
isradipinum||isradipine 5 mg/1 each oral capsule||has_active_moiety
octyl-methoxycinnamate||octinoxate 30 mg in 1 ml / titanium dioxide 29.2 mg in 1 ml topical emulsion [dior prestige le nectar de teint exceptional revitalizing foundation satin radiance with sunscreen broad spectrum spf20 tints 010]||has_active_moiety
adrenaline (product)||bupivacaine hydrochloride 0.5%/epinephrine 50micrograms 10ml (1:200000) injection solution||has_active_moiety
tretinoin [cytostatic]||tretinoin topical 0.05% topical gel||has_active_moiety
lidocaína||epinephrine 0.005 mg/ml / lidocaine hydrochloride 5 mg/ml injectable solution||has_active_moiety
hypochlorous acid||hypochlorous acid 0.025 g in 500 ml topical spray [ssacsu hand sanitizer]||has_active_moiety
d-psi-2-methylamino-1-phenyl-1-propanol||fexofenadine hcl-pseudoephedrine hcl, 60 mg-120 mg oral tablet, extended release||has_active_moiety
guaifenesin - chemical (substance)||acetaminophen 650 mg in 20 ml / dextromethorphan hydrobromide 20 mg in 20 ml / guaifenesin 400 mg in 20 ml / phenylephrine hydrochloride 10 mg in 20 ml oral solution [fast acting cold, flu and sore throat relief]||has_active_moiety
avobenzone (product)||avobenzone 2.5 g in 100 g / octisalate 5 g in 100 g / homosalate 10 g in 100 g / octocrylene 5 g in 100 g / oxybenzone 6 g in 100 g topical lotion [noad sport spf 50]||has_active_moiety
butyl-methoxydibenzoylmethane||avobenzone 2 g in 100 ml / homosalate 6.5 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml / oxybenzone 4 g in 100 ml topical cream [murad - age reform - perfecting day spf 30]||has_active_moiety
cyclamen purpurascens tuber||ambergris 3 [hp_x] in 1 ml / sodium salicylate 3 [hp_x] in 1 ml / bryonia alba root 6 [hp_x] in 1 ml / kerosene 6 [hp_x] in 1 ml / tobacco leaf 6 [hp_x] in 1 ml / sus scrofa cerebellum 6 [hp_x] in 1 ml / cyclamen purpurascens tuber 9 [hp_x] in 1 ml / silver nitrate 12 [hp_x] in 1 ml / asarum canadense root 12 [hp_x] in 1 ml / calcium sulfate anhydrous 12 [hp_x] in 1 ml / carbon disulfide 12 [hp_x] in 1 ml / quinine sulfate 12 [hp_x] in 1 ml / anamirta cocculus seed 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / digitalis 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / macropiper methysticum root 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / theridion curassavicum 12 [hp_x] in 1 ml oral liquid [vertigone]||has_active_moiety
octyl-methoxycinnamate||octinoxate 75 mg in 1 g / zinc oxide 105 mg in 1 g topical cream [cerave developed with dermatologists skin renewing broad spectrum spf 30 day]||has_active_moiety
cotton seed allergenic extract||cotton seed 0.001 g in 1 ml percutaneous solution [cottonseed]||has_active_moiety
dichromate||uric acid 15 [hp_x] in 1 g / aconitum napellus 15 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / arnica montana 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / atropa belladonna 15 [hp_x] in 1 g / benzoic acid 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / oyster shell calcium carbonate, crude 15 [hp_x] in 1 g / matricaria chamomilla 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / colchicum autumnale bulb 15 [hp_x] in 1 g / eupatorium perfoliatum flowering top 15 [hp_x] in 1 g / gaultheria procumbens top 15 [hp_x] in 1 g / guaiacum officinale resin 15 [hp_x] in 1 g / iodine 15 [hp_x] in 1 g / potassium dichromate 15 [hp_x] in 1 g / kalmia latifolia leaf 15 [hp_x] in 1 g / rhododendron tomentosum leafy twig 15 [hp_x] in 1 g / anemone pulsatilla 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / ruta graveolens flowering top 15 [hp_x] in 1 g / juniperus sabina leafy twig 15 [hp_x] in 1 g / strychnine 15 [hp_x] in 1 g / arctium lappa root 6 [hp_x] in 1 g / phytolacca americana root 6 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g oral pellet [rheumatic-joint care]||has_active_moiety
avobenzone (obsolete)||octocrylene 50 mg in 1 ml / drometrizole trisiloxane 40 mg in 1 ml / titanium dioxide 33 mg in 1 ml / avobenzone 30 mg in 1 ml / ecamsule 15 mg in 1 ml topical cream [garnier ombrelle spf 45 face ultra light]||has_active_moiety
bladderwrack extract||passiflora incarnata flowering top 3 [hp_x] in 1 ml / matricaria chamomilla 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / fucus vesiculosus 4 [hp_x] in 1 ml / chaste tree fruit 6 [hp_x] in 1 ml / dibasic potassium phosphate 6 [hp_x] in 1 ml / sodium chloride 6 [hp_x] in 1 ml / strychnos nux-vomica seed 6 [hp_x] in 1 ml / phytolacca americana root 6 [hp_x] in 1 ml / chelidonium majus 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / bos taurus pituitary gland, posterior 10 [hp_x] in 1 ml / thyroid, bovine 10 [hp_x] in 1 ml / thyroid, ovine 1 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 12 [hp_x] in 1 ml / ubidecarenone 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / sus scrofa pituitary gland 12 [hp_x] in 1 ml / bos taurus hypothalamus 12 [hp_x] in 1 ml / sus scrofa placenta 12 [hp_x] in 1 ml / silver nitrate 20 [hp_x] in 1 ml / berberis vulgaris root bark 20 [hp_x] in 1 ml / bryonia alba root 20 [hp_x] in 1 ml / digitalis 20 [hp_x] in 1 ml / iris versicolor root 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / sodium sulfate 20 [hp_x] in 1 ml / anemone pulsatilla 20 [hp_x] in 1 ml / toxicodendron pubescens leaf 20 [hp_x] in 1 ml / scutellaria lateriflora whole 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / datura stramonium 20 [hp_x] in 1 ml / semecarpus anacardium juice 200 [hp_x] in 1 ml / agrimonia eupatoria flower 6 [hp_c] in 1 ml / castanea sativa leaf 6 [hp_c] in 1 ml / ceratostigma willmottianum flower 6 [hp_c] in 1 ml / aesculus hippocastanum flower 9 [hp_c] in 1 ml / centaurium erythraea flower 9 [hp_c] in 1 ml / corticotropin 15 [hp_c] in 1 ml oral liquid [metalock]||has_active_moiety
human papillomavirus (hpv)||human papillomavirus 15 [hp_x] in 1 ml oral liquid [human papilloma virus homochord]||has_active_moiety
carbamic acid, (5-(phenylthio)-1h-benzimidazol-2-yl)-, methyl ester||fenbendazole 100 mg/ml oral suspension [panacur]||has_active_moiety
lozartan||losartan potassium 50 mg oral tablet, film coated [losartan]||has_active_moiety
synthetic camphor||camphor (synthetic) 17.05 mg / peppermint oil 22.73 mg / levomenthol 45.45 mg / methyl salicylate 45.45 mg / zinc oxide 215.91 mg cutaneous patch [arex sinsin pas]||has_active_moiety
phenylephrine (medication)||acetaminophen 650 mg in 20 ml / guaifenesin 400 mg in 20 ml / phenylephrine hydrochloride 10 mg in 20 ml oral solution [mucinex sinus-max severe congestion relief clear and cool]||has_active_moiety
benzethonium-containing product||(spl review) benzethonium chloride 0.095 g in 100 ml topical gel [hand sanitizer]||has_active_moiety
trazodona||trazodone hydrochloride 50 mg oral tablet, film coated||has_active_moiety
etoh - alcohol||alcohol 225 ml in 300 ml topical gel [hand sanitizer]||has_active_moiety
homosalate||homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 30 mg in 1 g / zinc oxide 28.5 mg in 1 g topical stick [sun bum tinted lip balm raisin hell]||has_active_moiety
ethyl p-aminobenzoate||cvs oral anesthetic 20% maximum strength topical gel||has_active_moiety
apap||flu relief therapy nighttime, 325 mg-12.5 mg-5 mg/15 ml oral syrup||has_active_moiety
ofloxacin-containing product||ofloxacin@0.3 %@otic (ear)@drops||has_active_moiety
ranunculus bulbosus||apis mellifera 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / sodium borate 10 [hp_x] in 59 ml / capsicum 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / peppermint 10 [hp_x] in 59 ml / daphne mezereum bark 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / paraffin 10 [hp_x] in 59 ml / ranunculus bulbosus 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml oral liquid [viratrol herpes symptom relief]||has_active_moiety
product containing digitalis||potassium chloride 3 [hp_x] in 1 ml / potassium phosphate, dibasic 3 [hp_x] in 1 ml / plantago major 3 [hp_x] in 1 ml / selenicereus grandiflorus stem 5 [hp_x] in 1 ml / digitalis 6 [hp_x] in 1 ml / beef heart 6 [hp_x] in 1 ml / levocarnitine 6 [hp_x] in 1 ml / valine 6 [hp_x] in 1 ml / sus scrofa thyroid 6 [hp_x] in 1 ml / artemisia abrotanum flowering top 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / egg phospholipids 12 [hp_x] in 1 ml / spigelia anthelmia 12 [hp_x] in 1 ml oral liquid [cardio tonic]||has_active_moiety
2-hydroxy-4-methoxybenzophenon||octinoxate 7.5 g in 100 g / oxybenzone 6 g in 100 g / padimate o 8 g in 100 g topical lipstick [lightning mcqueen sun smacker spf 24 revved up raspberry]||has_active_moiety
3,3,5-trimethylcyclohexyl salicylate||homosalate 100 mg in 1 ml / octocrylene 65 mg in 1 ml / octisalate 50 mg in 1 ml / avobenzone 35 mg in 1 ml / drometrizole trisiloxane 25 mg in 1 ml / ecamsule 5 mg in 1 ml topical lotion [garnier ombrelle spf 45 complete lightweight]||has_active_moiety
oxaliplatin (product)||oxaliplatin 5mg/ml (pf) soln inj||has_active_moiety
guaifenesin - chemical||acetaminophen/dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride 250 mg-10 mg-200 mg-5 mg oral capsule, liquid filled [alka-seltzer plus severe cough, mucus & congestion]||has_active_moiety
4-acetamidophenol||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [non drowsy daytime sinus congestion and cough relief]||has_active_moiety
p-hydroxy-acetanilid||gnp children's multi-symptom cold plus suspension||has_active_moiety
recticare advanced wipes||glycerin 2.5 mg in 1 ml / naphazoline hydrochloride 1.12 mg in 1 ml ophthalmic solution/ drops [lidl redness relief]||has_active_moiety
diiodine||povidone-iodine 0.75 g in 100 ml topical solution||has_active_moiety
product containing phenylephrine||acetaminophen 325 mg in 15 ml / dextromethorphan hydrobromide 10 mg in 15 ml / guaifenesin 200 mg in 15 ml / phenylephrine hydrochloride 5 mg in 15 ml oral solution [equate daytime severe]||has_active_moiety
borage extract||borage 6 [hp_x] in 1 ml / cupric acetate 6 [hp_x] in 1 ml / bos taurus conjunctiva 8 [hp_x] in 1 ml / bos taurus lymph vessel 8 [hp_x] in 1 ml / sus scrofa umbilical cord 8 [hp_x] in 1 ml / bos taurus cartilage 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / viscum album fruiting top 15 [hp_x] in 1 ml oral liquid||has_active_moiety
odevixibat||odevixibat (as odevixibat sesquihydrate) 400 mcg oral capsule||has_active_moiety
spiritus vini||alcohol 0.7 ml in 1 ml topical gel [solgreat instant hand sanitizer]||has_active_moiety
sus scrofa adrenal gland preparation||echinacea angustifolia 3 [hp_x] in 1 ml / centella asiatica 3 [hp_x] in 1 ml / saw palmetto 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / thuja occidentalis leafy twig 3 [hp_x] in 1 ml / astragalus propinquus root 6 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / sus scrofa lymph 6 [hp_x] in 1 ml / zinc gluconate 6 [hp_x] in 1 ml / juniperus virginiana twig 8 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / sus scrofa testicle 12 [hp_x] in 1 ml / sus scrofa prostate 12 [hp_x] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / rhododendron aureum leaf 12 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 12 [hp_x] in 1 ml / calcium sulfate anhydrous 30 [hp_x] in 1 ml / lycopodium clavatum spore 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / botulinum toxin type a 30 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_x] in 1 ml / pseudomonas aeruginosa 30 [hp_x] in 1 ml / proteus morganii 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml oral liquid [androtox]||has_active_moiety
somatotropin||sus scrofa adrenal gland 6 [hp_x] in 1 g / thyroid, bovine 8 [hp_x] in 1 g / somatropin 12 [hp_x] in 1 g topical cream [viiva bioderma actives hgh cream]||has_active_moiety
bos taurus brain||betula pubescens leaf 3 [hp_x] / betula pubescens bark 4 [hp_x] / bos taurus cerebellum 17 [hp_x] / bos taurus brain 17 [hp_x] / bos taurus pituitary gland 17 [hp_x] / bos taurus eye 17 [hp_x] / bos taurus nerve 17 [hp_x] / sus scrofa thalamus 17 [hp_x] / arnica montana 30 [hp_x] / silicon dioxide 30 [hp_x] / lead 30 [hp_x] oral pellet||has_active_moiety
oxichlorochine||hydroxychloroquine sulphate 200mg tablet (product)||has_active_moiety
octyl salicylate (substance)||avobenzone 30 mg in 1 ml / homosalate 100 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 100 mg in 1 ml topical lotion [sun bum spf 50 premium moisturizing sunscreen]||has_active_moiety
thymol product||eucalyptol 0.092 g in 100 ml / menthol 0.042 g in 100 ml / methyl salicylate 0.06 g in 100 ml / thymol 0.064 g in 100 ml oral mouthwash [family wellness blue mint]||has_active_moiety
berberis vulgaris root bark||melatonin 6 [hp_x] in 1 ml / arginine 6 [hp_x] in 1 ml / citrulline 6 [hp_x] in 1 ml / ubidecarenone 6 [hp_x] in 1 ml / lanosterol 8 [hp_x] in 1 ml / mevalonolactone 8 [hp_x] in 1 ml / squalene 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / cholesterol 8 [hp_x] in 1 ml / coumarin 8 [hp_x] in 1 ml / formaldehyde 8 [hp_x] in 1 ml / gelsemium sempervirens root 8 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / lead 8 [hp_x] in 1 ml / pantothenic acid 10 [hp_x] in 1 ml / nitroglycerin 6 [hp_c] in 1 ml / lycopodium clavatum spore 6 [hp_c] in 1 ml / phosphorus 6 [hp_c] in 1 ml / berberis vulgaris root bark 8 [hp_c] in 1 ml / red yeast 8 [hp_c] in 1 ml / nitric oxide 12 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml / toxicodendron pubescens leaf 30 [hp_c] in 1 ml oral liquid [vascuflow]||has_active_moiety
fluoride ion (substance)||sodium monofluorophosphate 1.4 mg in 1 g dental paste, dentifrice [toms whole care cinnamon clove fights cavities whitening fresh breath helps fight tartar]||has_active_moiety
pravastatin (medication)||product containing pravastatin sodium 20 mg/1 each oral tablet (clinical drug)||has_active_moiety
oxybenzone [dup] (substance)||octinoxate 4.1 mg in 1 g / oxybenzone 1.4 mg in 1 g topical cream [prevage anti-aging eye cream spf 15]||has_active_moiety
allergenic extract, beech||fraxinus americana pollen 500 [pnu] in 1 ml / fagus grandifolia pollen 500 [pnu] in 1 ml / betula papyrifera pollen 500 [pnu] in 1 ml / betula nigra pollen 500 [pnu] in 1 ml / betula pendula pollen 500 [pnu] in 1 ml / juglans nigra pollen 500 [pnu] in 1 ml / populus deltoides pollen 500 [pnu] in 1 ml / ulmus americana pollen 500 [pnu] in 1 ml intradermal injection, solution [pollens - trees, tree mix 6]||has_active_moiety
2-hydroxy-4-methoxybenzophenone,[2-hydroxy-4-methoxyphenyl]phenylmethanone||avobenzone 0.01 ml in 1 ml / octocrylene 0.077 ml in 1 ml / oxybenzone 0.03 ml in 1 ml topical spray [hawaiian tropic kids spf 30]||has_active_moiety
allergenic extract,grass,bermuda||cynodon dactylon pollen 80 [bau] in 1 ml / ambrosia artemisiifolia pollen 160 [au] in 1 ml / ulmus americana pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / poa pratensis pollen 800 [bau] in 1 ml / chenopodium album pollen 0.0004 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / festuca pratensis pollen 800 [bau] in 1 ml / lolium perenne pollen 800 [bau] in 1 ml / phleum pratense pollen 800 [bau] in 1 ml / salsola kali pollen 0.0004 g in 1 ml intradermal injection, solution||has_active_moiety
arsenate||calcium arsenate 30 [hp_c] in 1 ml oral pellet [headache]||has_active_moiety
octocrilene product||octocrylene 7.5 g in 100 ml / avobenzone 3 g in 100 ml / octisalate 5 g in 100 ml / homosalate 10 g in 100 ml topical cream [play everyday spf 50 with sunflower extract]||has_active_moiety
cow milk allergenic extract||abelmoschus moschatus seed 12 [hp_x] in 59.1 ml / araneus diadematus 12 [hp_x] in 59.1 ml / asafetida 12 [hp_x] in 59.1 ml / baptisia tinctoria root 30 [hp_x] in 59.1 ml / berberis vulgaris root bark 4 [hp_x] in 59.1 ml / candida albicans 18 [hp_x] in 59.1 ml / activated charcoal 15 [hp_x] in 59.1 ml / escherichia coli 24 [hp_c] in 59.1 ml / bos taurus colostrum 8 [hp_x] in 59.1 ml / marsdenia condurango bark 12 [hp_x] in 59.1 ml / bos taurus bile 8 [hp_x] in 59.1 ml / pork liver 9 [hp_x] in 59.1 ml / cow milk 12 [hp_x] in 59.1 ml / lycopodium clavatum spore 12 [hp_x] in 59.1 ml / mandragora officinarum root 12 [hp_x] in 59.1 ml / mercurius solubilis 12 [hp_x] in 59.1 ml / sus scrofa nasal mucosa 9 [hp_x] in 59.1 ml / frangula purshiana bark 4 [hp_x] in 59.1 ml / rheum officinale root 4 [hp_x] in 59.1 ml / selenium 15 [hp_x] in 59.1 ml / veratrum album root 12 [hp_x] in 59.1 ml oral liquid [colo-chord]||has_active_moiety
claritin||loratadine 10 mg disintegrating oral tablet||has_active_moiety
aciclovir-containing product||acyclovir 800 mg oral tablet||has_active_moiety
carbonate||echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / hypericum perforatum 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / potassium carbonate 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla pratensis 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml oral liquid [pneumostat]||has_active_moiety
product containing fenofibric acid (medicinal product)||product containing fenofibrate 145 mg/1 each oral tablet||has_active_moiety
porcine umbilical cord preparation||horse chestnut 4 [hp_x] in 1 ml / lactic acid, l- 4 [hp_x] in 1 ml / claviceps purpurea sclerotium 4 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / melilotus officinalis top 6 [hp_x] in 1 ml / sus scrofa placenta 6 [hp_x] in 1 ml / solanum nigrum whole 6 [hp_x] in 1 ml / strophanthus hispidus seed 6 [hp_x] in 1 ml / prasterone 6 [hp_x] in 1 ml / quercetin 6 [hp_x] in 1 ml / rutin 6 [hp_x] in 1 ml / sodium pyruvate 8 [hp_x] in 1 ml / sus scrofa vein 8 [hp_x] in 1 ml / sus scrofa artery 10 [hp_x] in 1 ml / sus scrofa umbilical cord 10 [hp_x] in 1 ml / tobacco leaf 10 [hp_x] in 1 ml / vipera berus venom 10 [hp_x] in 1 ml / barium carbonate 13 [hp_x] in 1 ml / lead iodide 18 [hp_x] in 1 ml / astragalus exscapus whole flowering/fruiting 6 [hp_c] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [bio placenta phase]||has_active_moiety
titanium white||titanium dioxide 146.3 mg in 1 g / octinoxate 67 mg in 1 g / octisalate 40 mg in 1 g topical cream [jungsaemmool masterclass radiant cushion n1 ivory]||has_active_moiety
octylsalicylate||octocrylene 9 g in 100 ml / titanium dioxide 7 g in 100 ml / octisalate 5 g in 100 ml topical lotion [5281 sunscreen]||has_active_moiety
oyster shell calcium carbonate, crude||thuja occidentalis leafy twig 6 [hp_c] in 1 ml / daphne mezereum bark 8 [hp_c] in 1 ml / silicon dioxide 8 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / measles virus 30 [hp_c] in 1 ml / mumps virus 30 [hp_c] in 1 ml / bordetella pertussis 30 [hp_c] in 1 ml / poliovirus 30 [hp_c] in 1 ml / rubella virus 30 [hp_c] in 1 ml / clostridium tetani 30 [hp_c] in 1 ml / human breast tumor cell 15 [hp_c] in 1 ml / antimony trisulfide 30 [hp_c] in 1 ml / ledum palustre twig 30 [hp_c] in 1 ml / thimerosal 30 [hp_c] in 1 ml oral liquid [vax reaction]||has_active_moiety
chelidonium majus||asterias rubens 15 [hp_x] in 1 ml / gold 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / benzoic acid 15 [hp_x] in 1 ml / berberis vulgaris root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / ceanothus americanus leaf 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / chionanthus virginicus bark 15 [hp_x] in 1 ml / dioscorea villosa tuber 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / sodium carbonate 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / ptelea trifoliata bark 15 [hp_x] in 1 ml / silybum marianum seed 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml oral liquid [lymphatic drainer]||has_active_moiety
ranitidine product||ranitidine 150 mg (as ranitidine hcl 168 mg) oral tablet||has_active_moiety
ambrosia artemisiifolia whole||onion 30 [hp_x] in 1 ml / ambrosia artemisiifolia 30 [hp_x] in 1 ml / apis mellifera 30 [hp_x] in 1 ml / arsenic trioxide 30 [hp_x] in 1 ml / euphrasia stricta 30 [hp_x] in 1 ml / strychnos nux-vomica seed 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / pulsatilla vulgaris whole 30 [hp_x] in 1 ml / solidago virgaurea flowering top 30 [hp_x] in 1 ml / sulfur 30 [hp_x] in 1 ml oral liquid [histapoll hp]||has_active_moiety
silver cation||alcohol 66.5 ml in 350 ml / carbomer homopolymer, unspecified type 0.665 mg in 350 ml / silver cation 1.75 mg in 350 ml / trolamine 1.05 mg in 350 ml / propylene glycol 17.5 mg in 350 ml extracorporeal liquid [runyi miaojie hand sanitizer]||has_active_moiety
curvularia inaequalis allergenic extract||curvularia inaequalis 20000 [pnu] in 1 ml subcutaneous injection, solution [curvularia]||has_active_moiety
haematonectria haematococca||gibberella fujikuroi extract 0.025 gm/ml / haematonectria haematococca extract 0.025 gm/ml injectable solution||has_active_moiety
ferrous cation||ferrous cation 1 [hp_x] / sulfur 1 [hp_x] oral tablet||has_active_moiety
octyl methoxycinnamate||zinc oxide 4.9 g in 100 g / titanium dioxide 6.24 g in 100 g / octinoxate 3 g in 100 g topical powder [double use compact spf 15 gold deluxe edition claire 4]||has_active_moiety
chloride ions||anhydrous glucose 25 g/500 ml and potassium chloride 750 mg/500 ml and sodium chloride 2.25 g/500 ml solution for infusion bag||has_active_moiety
grain alcohol||alcohol 0.7 ml in 1 ml topical spray [mius]||has_active_moiety
äthylalkohol||alcohol 62 ml in 100 ml topical liquid [symmetry foaming hand sanitizer]||has_active_moiety
subsalicylate bismuth||bismuth subsalicylate 262 mg oral tablet, chewable [basic care stomach relief]||has_active_moiety
octylmethoxycinnamate||octinoxate 0.047 g in 1 g / oxybenzone 0.009 g in 1 g topical lipstick [lbel couleur luxe amplifier xp amplifying spf 15 - malbec]||has_active_moiety
esomeprazolum||esomeprazole 20 mg oral capsule, delayed release [health mart esomeprazole magnesium]||has_active_moiety
adenosine agent (product)||niacinamide 1 mg in 50 ml / adenosine 0.02 mg in 50 ml topical cream [prestige caviar super aqua serum]||has_active_moiety
dihydrochlorothiazide||hydrochlorothiazide@12.5 mg@oral@capsule||has_active_moiety
lithium ion||amanita muscaria fruiting body 12 [hp_x] in 1 ml / protortonia cacti 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / indium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / gelsemium sempervirens root 30 [hp_x] in 1 ml / influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 30 [hp_x] in 1 ml / latrodectus mactans 30 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / toxicodendron pubescens leaf 30 [hp_x] in 1 ml / citharacanthus spinicrus 30 [hp_x] in 1 ml / clostridium botulinum 30 [hp_x] in 1 ml / escherichia coli 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml / pseudomonas aeruginosa 30 [hp_x] in 1 ml / proteus morganii 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar typhi 33 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / clostridium perfringens 15 [hp_c] in 1 ml / human herpesvirus 4 30 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / poliovirus 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml oral liquid [neurotox]||has_active_moiety
albumin, aggregated||albumin aggregated 2 mg in 15 ml intravenous injection, powder, lyophilized, for suspension [pulmotech maa]||has_active_moiety
product containing ethyl alcohol||alcohol 0.7 ml in 1 ml topical gel [roots hand sanitizer gel, fragranced]||has_active_moiety
influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (formaldehyde inactivated)||influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza a virus a/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza b virus b/maryland/15/2016 antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 12 [hp_x] in 1 ml / human adenovirus e serotype 4 strain cl-68578 antigen 15 [hp_x] in 1 ml / human adenovirus b serotype 7 strain 55142 antigen 15 [hp_x] in 1 ml / human herpesvirus 1 15 [hp_x] in 1 ml / human herpesvirus 2 15 [hp_x] in 1 ml / human herpesvirus 5 18 [hp_x] in 1 ml / human herpesvirus 4 18 [hp_x] in 1 ml / hepatitis b virus 33 [hp_x] in 1 ml / norwalk virus 30 [hp_c] in 1 ml oral liquid [virus plus]||has_active_moiety
bmdbm cpd||octinoxate 75 mg in 1 ml / octocrylene 50 mg in 1 ml / avobenzone 30 mg in 1 ml topical lotion [cocooil spf15]||has_active_moiety
(4s,4as,5as,6s,12as,z)-2-[amino(hydroxy)methylene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydrotetracene-1,3,12(2h,4h,12ah)-trione||chlortetracycline hydrochloride 50 g in 0.45 kg oral granule [aureomycin]||has_active_moiety
1-(n(sup 2)-((s)-1-carboxy-3-phenylpropyl)-l-lysyl)-l-proline||prinivil, 2.5 mg oral tablet||has_active_moiety
oxibenzona||octinoxate 7.5 g in 100 g / oxybenzone 6 g in 100 g / avobenzone 3 g in 100 g topical stick [lip balm]||has_active_moiety
mg+2||ailanthus altissima flowering twig 12 [hp_c] in 40 ml / strychnos nux-vomica seed 12 [hp_c] in 40 ml / chamomile 12 [hp_c] in 40 ml / potassium phosphate, dibasic 6 [hp_x] in 40 ml / magnesium phosphate, dibasic trihydrate 6 [hp_x] in 40 ml oral tincture [headache soothe]||has_active_moiety
caffeine||aspirin 500 mg / caffeine 60 mg oral tablet, effervescent [blowfish]||has_active_moiety
pd element||garlic 3 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / berberis vulgaris root bark 3 [hp_x] in 1 ml / arctium lappa root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / lanthanum 14 [hp_c] in 1 ml / niobium 30 [hp_c] in 1 ml / tantalum 30 [hp_c] in 1 ml / aluminum 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / silver 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / barium carbonate 12 [hp_x] in 1 ml / beryllium 12 [hp_x] in 1 ml / bismuth 12 [hp_x] in 1 ml / boron 12 [hp_x] in 1 ml / bromine 12 [hp_x] in 1 ml / cadmium 12 [hp_x] in 1 ml / cerium 12 [hp_x] in 1 ml / cesium chloride 12 [hp_x] in 1 ml / chromium 12 [hp_x] in 1 ml / cobalt 12 [hp_x] in 1 ml / copper 12 [hp_x] in 1 ml / dysprosium 12 [hp_x] in 1 ml / erbium 12 [hp_x] in 1 ml / europium oxide 12 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / gadolinium oxide 12 [hp_x] in 1 ml / germanium sesquioxide 12 [hp_x] in 1 ml / holmium 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lithium carbonate 12 [hp_x] in 1 ml / magnesium 12 [hp_x] in 1 ml / manganese 12 [hp_x] in 1 ml / mercurius solubilis 12 [hp_x] in 1 ml / molybdenum 12 [hp_x] in 1 ml / neodymium oxide 12 [hp_x] in 1 ml / nickel 12 [hp_x] in 1 ml / osmium 12 [hp_x] in 1 ml / palladium 12 [hp_x] in 1 ml / platinum 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / praseodymium 12 [hp_x] in 1 ml / rhodium 12 [hp_x] in 1 ml / rubidium nitrite 12 [hp_x] in 1 ml / samarium oxide 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / tin 12 [hp_x] in 1 ml / strontium carbonate 12 [hp_x] in 1 ml / terbium 12 [hp_x] in 1 ml / thallium 12 [hp_x] in 1 ml / uranyl nitrate hexahydrate 12 [hp_x] in 1 ml / vanadium 12 [hp_x] in 1 ml / ytterbium oxide 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml oral liquid [metalstat]||has_active_moiety
product containing ethyl alcohol (medicinal product)||alcohol 75 g in 100 topical cloth||has_active_moiety
n-acetyl-p-aminophenol||sunmark 8 hour pain relief 650mg extended-release caplet||has_active_moiety
glucose (anhydrous)||heparin sodium,porcine in 0.9 % sodium chloride 50 unit/ml intraven intravenous solution||has_active_moiety
econazole (substance)||econazole nitrate 1% cream (substance)||has_active_moiety
mercuric cation||lactic acid, l- 3 [hp_x] / viscum album fruiting top 3 [hp_x] / iodine 3 [hp_x] / fucus vesiculosus 6 [hp_x] / galium aparine 6 [hp_x] / sus scrofa thyroid 6 [hp_x] / prasterone 6 [hp_x] / phenyl isothiocyanate 6 [hp_x] / tyramine 6 [hp_x] / adenosine triphosphate disodium 7 [hp_x] / oxogluric acid 7 [hp_x] / fumaric acid 7 [hp_x] / malic acid 7 [hp_x] / colchicum autumnale bulb 8 [hp_x] / conium maculatum flowering top 8 [hp_x] / sodium diethyl oxalacetate 8 [hp_x] / sus scrofa umbilical cord 8 [hp_x] / pork liver 8 [hp_x] / sus scrofa bone marrow 8 [hp_x] / sus scrofa pineal gland 8 [hp_x] / sus scrofa spleen 8 [hp_x] / sus scrofa thymus 8 [hp_x] / calcium fluoride 12 [hp_x] / anemone pulsatilla 12 [hp_x] / spongia officinalis skeleton, roasted 12 [hp_x] / cortisone acetate 30 [hp_x] / mercuric chloride 60 [hp_x] / liothyronine 15 [hp_c] / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] / escherichia coli 30 [hp_c] oral tablet [energize]||has_active_moiety
naproxen (substance)||prosaid 500mg tablet||has_active_moiety
kerosine||sarsaparilla 15 [hp_x] in 1 g / antimony trisulfide 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / berberis vulgaris root bark 15 [hp_x] in 1 g / giant puffball 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / croton tiglium seed 15 [hp_x] in 1 g / solanum dulcamara top 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / calcium sulfide 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / daphne mezereum bark 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / kerosene 15 [hp_x] in 1 g / pulex irritans 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / sepia officinalis juice 15 [hp_x] in 1 g / sulfur iodide 15 [hp_x] in 1 g / echinacea, unspecified 6 [hp_x] in 1 g / rumex crispus root 6 [hp_x] in 1 g / taraxacum officinale 6 [hp_x] in 1 g / urtica urens 6 [hp_x] in 1 g oral pellet [eczema - skin care]||has_active_moiety
etoh - ethanol||alcohol 80 ml in 100 ml topical liquid [gold eagle motor force hand sanitizer]||has_active_moiety
bacitracin product (product)||bacitracin zinc/polymyxin b sulfate 500 u/1 gm-10000 u/1 gm ophthalmic ointment [polycidin]||has_active_moiety
urtica urens whole extract||berberis vulgaris root bark 2 [hp_x] in 1 ml / populus tremula whole 3 [hp_x] in 1 ml / saw palmetto 3 [hp_x] in 1 ml / urtica urens 3 [hp_x] in 1 ml / larix decidua resin 8 [hp_x] in 1 ml / black pepper 17 [hp_x] in 1 ml oral liquid||has_active_moiety
zinc cation||titanium dioxide 40 mg in 1 ml / zinc oxide 50 mg in 1 ml topical cream [body conditioner]||has_active_moiety
cat hair extract||felis catus hair 2000 [bau] in 1 ml / ambrosia artemisiifolia pollen 20000 [au] in 1 ml / aspergillus fumigatus 0.01 g in 1 ml / alternaria alternata 0.01 g in 1 ml intradermal injection, solution||has_active_moiety
cephalexin anhydrous (medication)||zartan, 500 mg oral capsule||has_active_moiety
tsukubaenolide||tacrolimus 0.5mg capsule||has_active_moiety
vitamin b 12||thrivite rx tablet||has_active_moiety
chelidonium majus whole||baptisia tinctoria 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / calendula officinalis flowering top 4 [hp_x] in 1 ml / chelidonium majus 4 [hp_x] in 1 ml / veronicastrum virginicum root 4 [hp_x] in 1 ml / ligusticum porteri root 4 [hp_x] in 1 ml / lomatium dissectum root 4 [hp_x] in 1 ml / myrrh 4 [hp_x] in 1 ml / nasturtium aquaticum 4 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / taraxacum officinale 4 [hp_x] in 1 ml / fenugreek seed 4 [hp_x] in 1 ml / urtica dioica 4 [hp_x] in 1 ml / astragalus propinquus root 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / chamomile 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / thuja occidentalis leafy twig 30 [hp_x] in 1 ml / antimony trisulfide 30 [hp_x] in 1 ml / bordetella pertussis 30 [hp_c] in 1 ml / tetanus toxin 30 [hp_c] in 1 ml / thimerosal 30 [hp_c] in 1 ml oral liquid [vax]||has_active_moiety
product containing salsalate (medicinal product)||product containing salsalate 500 mg/1 each oral tablet (clinical drug)||has_active_moiety
2,3-4,5-bis-o-(1-methylethylidene)-beta-d-fructopyranose sulfamate||topiramate 15mg conventional release oral capsule||has_active_moiety
nitric acid||horse chestnut 2 [hp_x] in 1 g / milk thistle 2 [hp_x] in 1 g / echinacea, unspecified 2 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 2 [hp_x] in 1 g / krameria lappacea whole 2 [hp_x] in 1 g / nitric acid 7 [hp_x] in 1 g / arnica montana 7 [hp_x] in 1 g / calcium fluoride 9 [hp_x] in 1 g / sepia officinalis juice 9 [hp_x] in 1 g / activated charcoal 11 [hp_x] in 1 g topical cream||has_active_moiety
borate ion||sodium borate 30 [hp_c] oral pellet [borax 30c]||has_active_moiety
3,3,5-trimethylcyclohexyl 2-hydroxybenzoate||avobenzone 30 mg in 1 g / homosalate 150 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 100 mg in 1 g / oxybenzone 60 mg in 1 g topical aerosol, spray [h.e.b solutions sunscreen]||has_active_moiety
myosotis arvensis||myosotis arvensis 3 [hp_x] in 1 ml / scrophularia nodosa 3 [hp_x] in 1 ml / teucrium scorodonia flowering top 3 [hp_x] in 1 ml / veronica officinalis flowering top 3 [hp_x] in 1 ml / equisetum arvense top 4 [hp_x] in 1 ml / fumaria officinalis flowering top 4 [hp_x] in 1 ml / geranium robertianum 4 [hp_x] in 1 ml / nasturtium officinale 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / pinus sylvestris leafy twig 4 [hp_x] in 1 ml / gentiana lutea root 5 [hp_x] in 1 ml / juglans regia fruit rind, immature 5 [hp_x] in 1 ml / juglans regia leaf 5 [hp_x] in 1 ml / sarsaparilla 6 [hp_x] in 1 ml / clematis vitalba flower 8 [hp_x] in 1 ml / helianthemum nummularium flower 8 [hp_x] in 1 ml / impatiens glandulifera flower 8 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / tribasic calcium phosphate 12 [hp_x] in 1 ml / ferrous iodide 12 [hp_x] in 1 ml / sus scrofa lymph 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml oral liquid [pre-dental visit]||has_active_moiety
white oak pollen||dermatophagoides farinae 400 [au] in 1 ml / felis catus hair 80 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / poa pratensis pollen 160 [bau] in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / mucor racemosus 0.002 g in 1 ml / alternaria alternata 0.00008 g in 1 ml / pleospora herbarum 0.004 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.004 g in 1 ml / acer rubrum pollen 0.004 g in 1 ml / carya alba pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.004 g in 1 ml / rumex acetosella pollen 0.004 g in 1 ml / candida albicans 0.002 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / epicoccum nigrum 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
avobenzone (product)||avobenzone 2 g in 100 ml / octinoxate 7.5 g in 100 ml / octisalate 5 g in 100 ml / oxybenzone 6 g in 100 ml topical lotion [age defying moisturizer spf 18]||has_active_moiety
ethinyl oestradiol preparation||norethindrone 0.4 mg / ethinyl estradiol 0.035 mg oral tablet, chewable [wymzya fe]||has_active_moiety
mercurius solubilis||apis mellifera 12 [hp_x] in 59.1 ml / baptisia tinctoria root 4 [hp_x] in 59.1 ml / atropa belladonna root 12 [hp_x] in 59.1 ml / calendula officinalis flowering top 4 [hp_x] in 59.1 ml / clove 1 [hp_x] in 59.1 ml / calcium sulfide 15 [hp_x] in 59.1 ml / goldenseal 2 [hp_x] in 59.1 ml / lachesis muta venom 12 [hp_x] in 59.1 ml / mentha piperita 1 [hp_x] in 59.1 ml / mercurius solubilis 12 [hp_x] in 59.1 ml / myrrh 2 [hp_x] in 59.1 ml / phytolacca americana root 4 [hp_x] in 59.1 ml / sage 1 [hp_x] in 59.1 ml / acmella oleracea flowering top 2 [hp_x] in 59.1 ml / thymus serpyllum 2 [hp_x] in 59.1 ml oral liquid [throat-spray tone]||has_active_moiety
n-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide||buspirone hydrochloride 15mg oral tablet||has_active_moiety
phenylephrine-containing product||acetaminophen 325 mg / phenylephrine hydrochloride 5 mg oral tablet, film coated [sinus congestion and pain daytime non-drowsy]||has_active_moiety
n2 - nitrogen||nitrogen 99 l in 100 l respiratory (inhalation) gas||has_active_moiety
weed pollen-short ragweed||acer negundo pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [bau] in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / populus deltoides pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / carya tomentosa pollen 0.001 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / alternaria alternata 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml subcutaneous injection, solution||has_active_moiety
benzocaine (medication)||benzocaine 20% dental gel||has_active_moiety
cafeína||caffeine citrate 6 [hp_x] in 1 ml / cannabis sativa subsp. sativa flowering top 2 [hp_x] in 1 ml oral spray [sciatica formula]||has_active_moiety
aminoethylsulfonic acid||glycyrrhiza glabra 3 [hp_x] in 1 ml / ginger 3 [hp_x] in 1 ml / histamine dihydrochloride 4 [hp_x] in 1 ml / taurine 6 [hp_x] in 1 ml / schoenocaulon officinale seed 6 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / sodium carbonate 12 [hp_x] in 1 ml / ambrosia artemisiifolia 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / chondrus 3 [hp_x] in 1 ml oral liquid [allergy composition]||has_active_moiety
bromus inermis pollen||bromus inermis pollen 0.05 g in 1 ml subcutaneous injection, solution||has_active_moiety
hydromorphon||hydromorphone 8 mg oral tablet||has_active_moiety
gold cation (3+)||gold trichloride 7 [hp_x] in 1 ml / magnesium hydroxide 5 [hp_x] in 1 ml / strychnos ignatii seed 5 [hp_x] in 1 ml / royal jelly 6 [hp_x] in 1 ml / avena sativa flowering top 3 [hp_x] in 1 ml / phosphoric acid 5 [hp_x] in 1 ml / silicon dioxide 7 [hp_x] in 1 ml / st. john's wort 3 [hp_x] in 1 ml / mammal liver 5 [hp_x] in 1 ml oral liquid||has_active_moiety
2-2etn-2mephacn||licodaine 20 mg/ml injectable solution||has_active_moiety
k+ element||potassium chloride 20meq tab,sa,ud (dispersible)||has_active_moiety
3-[2-(dimethylamino)ethyl]-n-methylindole-5-methanesulfonamide||sumatriptan 25mg tablet||has_active_moiety
goats weed||hypericum perforatum 50 [hp_m] in 1 g / ledum palustre twig 50 [hp_m] in 1 g / arnica montana 50 [hp_m] in 1 g / toxicodendron pubescens leaf 50 [hp_m] in 1 g / ruta graveolens flowering top 50 [hp_m] in 1 g topical patch [activmend pro]||has_active_moiety
after-bug||oatmeal, gum fraction topical application powder for suspension [oatmeal bath]||has_active_moiety
salicylic acid 2-ethylhexyl ester||avobenzone 0.75 g in 1 g / octocrylene 2.00 g in 1 g / octisalate 1.25 g in 1 g topical cream [no7 restore and renew face and neck multi action day cream sunscreen broad spectrum spf 30]||has_active_moiety
coal tar preparation (product)||coal tar 1 % medicated shampoo||has_active_moiety
äthylalkohol||alcohol 1 ml topical cloth [alcohol sanitizer wipes]||has_active_moiety
onfi||onfi 2.5mg/ml suspension||has_active_moiety
borreliella burgdorferi||aconitum napellus 30 [hp_x] in 1 ml / epinephrine 8 [hp_x] in 1 ml / arnica montana 30 [hp_x] in 1 ml / borrelia burgdorferi 12 [hp_x] in 1 ml / calendula officinalis flowering top 3 [hp_x] in 1 ml / ledum palustre twig 12 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml oral liquid [ticked]||has_active_moiety
cephuroxime||product containing only cefuroxime 250 mg/1 each oral tablet (clinical drug)||has_active_moiety
epinefrina||epinephrine 20 [hp_x] in 1 ml / thyroid, unspecified 20 [hp_x] in 1 ml / aloe 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / graphite 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / lycopus virginicus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / silicon dioxide 15 [hp_x] in 1 ml / spongia officinalis skeleton, roasted 15 [hp_x] in 1 ml / echinacea, unspecified 11 [hp_x] in 1 ml oral liquid [thyroid care]||has_active_moiety
gold cation (3+)||gold trichloride 12 [hp_c] oral pellet||has_active_moiety
gibberella fujikuroi extract||fusarium moniliforme antigen 25 mg/ml / haematonectria haematococca allergenic extract 25 mg/ml injectable solution||has_active_moiety
octocrileno||octocrylene 41.8 mg in 1 ml / zinc oxide 104.5 mg in 1 ml topical lotion [blue lizard sport sunscreen]||has_active_moiety
benzocaine (substance)||benzocaine 20% oromucosal gel/jelly [leader oral analgesic gel]||has_active_moiety
adenogesic||adenosine 0.04 g in 10 ml / allantoin 0.03 g in 10 ml topical liquid [botanic twenty hypercare plumping formula]||has_active_moiety
(1s,3s,5s)-2-((2s)-amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile||dapagliflozin/saxagliptin 5 mg-5 mg oral tablet [qtern]||has_active_moiety
chlorhexidine (product)||chlorohexidine gluconate 1.2 % topical solution||has_active_moiety
dicycloverine product||dicyclomine hcl 20 mg oral tablet||has_active_moiety
impatiens glandulifera flower||helianthemum nummularium flower 5 [hp_x] in 0.095 ml / clematis vitalba flower 5 [hp_x] in 0.095 ml / impatiens glandulifera flower 5 [hp_x] in 0.095 ml / prunus cerasifera flower 5 [hp_x] in 0.095 ml / ornithogalum umbellatum whole 5 [hp_x] in 0.095 ml / aesculus hippocastanum flower 5 [hp_x] in 0.095 ml oral solution [rescue sleep kids dropper]||has_active_moiety
formaldehyde product (product)||aluminum chloride 0.408 g in 1.675 ml / glycerin 0.211 g in 1.675 ml / formaldehyde 0.068 g in 1.675 ml / alcohol 0.065 g in 1.675 ml / methyl alcohol 0.003 g in 1.675 ml topical liquid [keratex khh]||has_active_moiety
white oak pollen||plantago lanceolata pollen 0.005 g in 1 ml / urtica dioica pollen 0.005 g in 1 ml / ambrosia artemisiifolia pollen 10000 [au] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / alternaria alternata 0.002 g in 1 ml / betula nigra pollen 0.005 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml subcutaneous injection, solution||has_active_moiety
1,1-dimethyl-2-phenylethylamine||phentermine hcl 30mg tab||has_active_moiety
ruta graveolens flowering top extract||calendula officinalis flowering top 1 [hp_x] in 1 g / arnica montana whole 1 [hp_x] in 1 g / hypericum perforatum whole 3 [hp_x] in 1 g / comfrey root 6 [hp_x] in 1 g / bellis perennis whole 12 [hp_x] in 1 g / activated charcoal 12 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 12 [hp_x] in 1 g / achillea millefolium whole 12 [hp_x] in 1 g / toxicodendron pubescens leaf 12 [hp_x] in 1 g / ruta graveolens flowering top 12 [hp_x] in 1 g / veratrum album root 12 [hp_x] in 1 g topical lotion [injury topical]||has_active_moiety
anamirta cocculus seed extract||aluminum oxide 10 [hp_x] in 59 ml / antimony trisulfide 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / asarum europaeum 10 [hp_x] in 59 ml / baptisia tinctoria root 10 [hp_x] in 59 ml / phenol 10 [hp_x] in 59 ml / quinine arsenate 10 [hp_x] in 59 ml / anamirta cocculus seed 10 [hp_x] in 59 ml / egg phospholipids 10 [hp_x] in 59 ml / picric acid 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [appetite enhancer]||has_active_moiety
adenosin||niacinamide 0.3 g in 100 ml / adenosine 0.04 g in 100 ml topical emulsion [taeyangsoo plavitalemulsion]||has_active_moiety
gelsemium sempervirens root extract||aconitum napellus 20 [hp_x] in 1 ml / semecarpus anacardium juice 20 [hp_x] in 1 ml / silver nitrate 20 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / cypripedium parvifolum root 20 [hp_x] in 1 ml / gelsemium sempervirens root 20 [hp_x] in 1 ml / strychnos ignatii seed 20 [hp_x] in 1 ml / potassium carbonate 20 [hp_x] in 1 ml / lycopodium clavatum spore 20 [hp_x] in 1 ml / sodium chloride 20 [hp_x] in 1 ml / phosphorus 20 [hp_x] in 1 ml / sambucus nigra flowering top 20 [hp_x] in 1 ml / sepia officinalis juice 20 [hp_x] in 1 ml / delphinium staphisagria seed 20 [hp_x] in 1 ml / datura stramonium 20 [hp_x] in 1 ml / lycosa tarantula 20 [hp_x] in 1 ml / theridion curassavicum 20 [hp_x] in 1 ml / passiflora incarnata flowering top 8 [hp_x] in 1 ml / valerian 8 [hp_x] in 1 ml oral liquid [fear phobia]||has_active_moiety
verapamil (substance)||trandolapril-verapamil hydrochloride, 4 mg-240 mg oral tablet, extended release||has_active_moiety
p-acetylaminophenol||trezix 320.5mg-30mg-16mg capsule||has_active_moiety
zinc cation||titanium dioxide 34 mg in 1 g / zinc oxide 160 mg in 1 g topical liquid [sun bum mineral sunscreen broad spectrum spf 50]||has_active_moiety
(-)-naloxone||buprenorphine/naloxone 4.2 mg-0.7 mg buccal mucosa film||has_active_moiety
aralia racemosa root extract||aralia racemosa root 3 [hp_x] in 1 ml / saw palmetto 3 [hp_x] in 1 ml / sus scrofa adrenal gland 6 [hp_x] in 1 ml / sus scrofa testicle 6 [hp_x] in 1 ml / sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa prostate 6 [hp_x] in 1 ml / chaste tree 12 [hp_x] in 1 ml / clematis recta flowering top 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / thuja occidentalis leaf 12 [hp_x] in 1 ml oral liquid [endopar m]||has_active_moiety
fentanyl (product)||fentanyl 25 ug in 1 h transdermal patch, extended release [fentanyl]||has_active_moiety
nicotinamide||cyanocobalamin 0.1 mg in 1 ml / thiamine hydrochloride 100 mg in 1 ml / pyridoxine hydrochloride 10 mg in 1 ml / niacinamide 100 mg in 1 ml / dexpanthenol 10 mg in 1 ml / riboflavin 5'-phosphate sodium 5 mg in 1 ml intravenous injection [vitamin b complex hp]||has_active_moiety
2,2 difluorodexoycytidine||gemcitabine 200 mg injection||has_active_moiety
wyethia helenioides root extract||wood tar hydrocarbon distillate 15 [hp_x] in 1 ml / aletris farinosa root 7 [hp_x] in 1 ml / fennel seed 15 [hp_x] in 1 ml / salix nigra bark 15 [hp_x] in 1 ml / wyethia helenioides root 20 [hp_x] in 1 ml oral liquid [adr-bal]||has_active_moiety
allergenic extract, cottonwood fremont||populus fremontii pollen extract 50 mg/ml injectable solution||has_active_moiety
anticoagulants heparin sodium porcine||heparin sodium, 10000 units/ml injectable solution_#1||has_active_moiety
benzalkonium (product)||benzalkonium chloride 1.3 mg in 1 ml topical liquid [safesure hand sanitizer]||has_active_moiety
pregabalin-containing product||pregabalin 150mg oral cap||has_active_moiety
antimony sulfide||antimony trisulfide 9 [hp_c] in 9 [hp_c] oral pellet [antimonium crudum]||has_active_moiety
product containing salicylic acid||walgreens salicylic acid callus removers||has_active_moiety
strychnos nux-vomica seed||daphne odora bark 4 [hp_c] / syzygium jambos seed 3 [hp_c] / dieffenbachia seguine 4 [hp_c] / delphinium staphisagria seed 4 [hp_c] / semecarpus anacardium juice 4 [hp_c] / strychnos nux-vomica seed 4 [hp_c] / tobacco leaf 3 [hp_c] oral tablet [homeopathic stop smoking formula]||has_active_moiety
chemical oxygen||oxygen 99 l in 99 l respiratory (inhalation) gas||has_active_moiety
titanium dioxide (substance)||titanium dioxide 62.2 mg in 1 ml / zinc oxide 38.3 mg in 1 ml topical liquid [rainforest of the sea water foundation broad spectrum spf 15 sunscreen 27s light-medium sand]||has_active_moiety
product containing alendronic acid||fosamax 35 mg (as alendronate sodium 45.7 mg) oral tablet||has_active_moiety
zn2+||octinoxate 20 mg in 1 ml / oxybenzone 40 mg in 1 ml / zinc oxide 38 mg in 1 ml topical lotion [wolf daily moisturizier spf 15]||has_active_moiety
avobenzone product||octocrylene 3 g in 100 g / avobenzone 1.5 g in 100 g / homosalate 3 g in 100 g / octisalate 4.5 g in 100 g topical lotion [hawaiian tropic]||has_active_moiety
magnesium 2+||citrullus colocynthis fruit pulp 6 [hp_x] in 25 ml / magnesium phosphate, dibasic trihydrate 6 [hp_x] in 25 ml / matricaria recutita 6 [hp_x] in 25 ml / dioscorea villosa root 6 [hp_x] in 25 ml oral liquid [gas and colic kids relief baby]||has_active_moiety
clematis recta flowering top||sus scrofa pituitary gland 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / aconitum napellus whole 12 [hp_x] in 1 ml / aloe 12 [hp_x] in 1 ml / aluminum oxide 12 [hp_x] in 1 ml / antimony trisulfide 12 [hp_x] in 1 ml / apis mellifera 12 [hp_x] in 1 ml / silver nitrate 12 [hp_x] in 1 ml / arnica montana whole 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / bellis perennis whole 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / calendula officinalis flowering top 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / matricaria chamomilla whole 12 [hp_x] in 1 ml / chelidonium majus whole 12 [hp_x] in 1 ml / helianthemum canadense 12 [hp_x] in 1 ml / clematis recta flowering top 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / gamboge 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / histamine dihydrochloride 12 [hp_x] in 1 ml / goldenseal 12 [hp_x] in 1 ml / hydrofluoric acid 12 [hp_x] in 1 ml / hypericum perforatum whole 12 [hp_x] in 1 ml / strychnos ignatii seed 12 [hp_x] in 1 ml / impatiens glandulifera flower 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / sodium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / ornithogalum umbellatum whole 12 [hp_x] in 1 ml / passiflora incarnata flowering top 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / lead 12 [hp_x] in 1 ml / prunus cerasifera flower 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / sepia officinalis juice 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / comfrey root 12 [hp_x] in 1 ml / allylthiourea 12 [hp_x] in 1 ml / veratrum album root 12 [hp_x] in 1 ml oral liquid [recalibr8]||has_active_moiety
methylhomatropine||homatropine-hydrocodone 1.5 mg-5 mg/5 ml oral syrup||has_active_moiety
amlodipine - chemical (substance)||amlodipine besylate 5mg/olmesartan medoxomil 20mg tab,ud||has_active_moiety
sepia officinalis juice||norepinephrine 6 [hp_x] in 1 ml / octopamine 6 [hp_x] in 1 ml / insulin pork 15 [hp_x] in 1 ml / hydrocortisone 6 [hp_c] in 1 ml / ascorbic acid 6 [hp_c] in 1 ml / sus scrofa adrenal gland 6 [hp_c] in 1 ml / pork heart 6 [hp_c] in 1 ml / sus scrofa pituitary gland 6 [hp_c] in 1 ml / lactic acid, l- 6 [hp_c] in 1 ml / sus scrofa thyroid 6 [hp_c] in 1 ml / corticotropin 8 [hp_c] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 8 [hp_c] in 1 ml / ubidecarenone 8 [hp_c] in 1 ml / arsenic trioxide 30 [hp_c] in 1 ml / gold 30 [hp_c] in 1 ml / barium carbonate 30 [hp_c] in 1 ml / oyster shell calcium carbonate, crude 30 [hp_c] in 1 ml / nitroglycerin 30 [hp_c] in 1 ml / iodine 30 [hp_c] in 1 ml / potassium iodide 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / lithium carbonate 30 [hp_c] in 1 ml / lobelia inflata 30 [hp_c] in 1 ml / mercurius solubilis 30 [hp_c] in 1 ml / naja naja venom 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / sepia officinalis juice 30 [hp_c] in 1 ml / spongia officinalis skeleton, roasted 30 [hp_c] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [pericardium/triple warmer meridian formula]||has_active_moiety
polymyxin b (substance)||trimethoprim sulfate 1 mg in 1 ml / polymyxin b sulfate 10000 [usp'u] in 1 ml ophthalmic solution [polymyxin b sulfate and trimethoprim]||has_active_moiety
ractopamine hydrochloride||ractopamine hydrochloride 1 g in 1 g not applicable powder||has_active_moiety
product containing paracetamol (medicinal product)||acetaminophen 160 mg in 5 ml oral suspension [childrens pain and fever]||has_active_moiety
narcotics tapentadol||nucynta er 100mg extended-release tablet||has_active_moiety
guaianesin||acetaminophen 325 mg / dextromethorphan hydrobromide 10 mg / guaifenesin 200 mg / phenylephrine hydrochloride 5 mg oral capsule, liquid filled [vicks dayquil severe cold and flu]||has_active_moiety
ropivacaine (substance)||ropivacaine hydrochloride 5 mg in 1 ml infiltration injection, solution [naropin]_#4||has_active_moiety
product containing menthol||menthol 8 g in 100 ml / methyl salicylate 26 g in 100 ml topical oil [medicated oil]||has_active_moiety
quinina||baptisia tinctoria 3 [hp_x] in 1 ml / echinacea, unspecified 3 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / quinine sulfate 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / loxosceles reclusa 12 [hp_x] in 1 ml / claviceps purpurea sclerotium 12 [hp_x] in 1 ml / citharacanthus spinicrus 12 [hp_x] in 1 ml / latrodectus mactans 12 [hp_x] in 1 ml / bacillus anthracis immunoserum rabbit 33 [hp_x] in 1 ml oral liquid [septaforce]||has_active_moiety
echinacea, unspecified||antimony trisulfide 15 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / berberis vulgaris root bark 15 [hp_x] in 1 g / giant puffball 15 [hp_x] in 1 g / bryonia alba root 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / chelidonium majus 15 [hp_x] in 1 g / croton tiglium seed 15 [hp_x] in 1 g / solanum dulcamara top 15 [hp_x] in 1 g / graphite 15 [hp_x] in 1 g / histamine dihydrochloride 15 [hp_x] in 1 g / lycopodium clavatum spore 15 [hp_x] in 1 g / daphne mezereum bark 15 [hp_x] in 1 g / strychnos nux-vomica seed 15 [hp_x] in 1 g / kerosene 15 [hp_x] in 1 g / pulex irritans 15 [hp_x] in 1 g / pulsatilla vulgaris 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / smilax regelii root 15 [hp_x] in 1 g / sulfur 15 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g / rumex crispus root 3 [hp_x] in 1 g / taraxacum officinale 3 [hp_x] in 1 g / urtica urens 3 [hp_x] in 1 g oral pellet [urticaria - rashes]||has_active_moiety
matricaria chamomilla||matricaria recutita 3 [hp_x] in 20 g / passiflora incarnata flowering top 3 [hp_x] in 20 g / magnesium phosphate 6 [hp_c] in 20 g / calcium phosphate 6 [hp_c] in 20 g / matricaria recutita 30 [hp_c] in 20 g oral granule [pupteeth]||has_active_moiety
2-phenylbenzimidazol-5-sulphonic acid||ensulizole 30 mg in 1 ml / homosalate 100 mg in 1 ml / octinoxate 75 mg in 1 ml / octocrylene 70 mg in 1 ml / zinc oxide 80 mg in 1 ml topical cream [sun defense uvscreen spf 48]||has_active_moiety
sus scrofa pituitary gland||somatropin 30 [hp_x] in 1 ml / pork liver 6 [hp_x] in 1 ml / sus scrofa pituitary gland 30 [hp_x] in 1 ml oral spray [hgh-pro]||has_active_moiety
calcium 2+||publix antacid extra strength 750mg chewable tablet (tropical fruit)||has_active_moiety
mexiletine-containing product||mexiletine hydrochloride 250 mg oral capsule [mexitil]||has_active_moiety
salicylic acid [psoriasis] (substance)||salicylic acid 0.5 mg in 100 ml / chloroxylenol 1 mg in 100 ml topical shampoo [medicated]||has_active_moiety
sus scrofa pancreas||arnica montana 1.5 [hp_c] in 30 ml / bryonia alba root 200 [hp_c] in 30 ml / silybum marianum seed oil 0.5 [hp_c] in 30 ml / chelidonium majus 200 [hp_c] in 30 ml / herring sperm dna 3 [hp_c] in 30 ml / pork liver 3 [hp_c] in 30 ml / cervus elaphus horn oil 4 [hp_c] in 30 ml / sus scrofa pancreas 4 [hp_c] in 30 ml / taraxacum officinale 1 [hp_c] in 30 ml oral spray [livergen]||has_active_moiety
eastern sycamore pollen extract||plantago lanceolata pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 800 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / felis catus hair 400 [bau] in 1 ml / periplaneta americana 0.002 g in 1 ml / dermatophagoides pteronyssinus 400 [au] in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / salix nigra pollen 0.002 g in 1 ml subcutaneous injection, solution||has_active_moiety
product containing menthol (medicinal product)||menthol 5.52 mg oral lozenge [sugar free honey-lemon fishermans friend menthol cough suppressant]||has_active_moiety
santalum spicatum whole extract||clove 40 mg in 100 ml / santalum spicatum whole 0.2 mg in 100 ml topical ointment [mollenol sensitive]||has_active_moiety
levonorgestrel [combined oral contraceptive] (product)||levonorgestrel 0.1 mg / ethinyl estradiol 0.02 mg oral tablet [lutera]||has_active_moiety
celtis occidentalis pollen extract||celtis occidentalis pollen 0.05 g in 1 ml subcutaneous injection, solution [celtis occidentalis pollen]||has_active_moiety
tolnaphthate||tolnaftate 1.3 g in 130 g topical spray [tolnaftate]||has_active_moiety
ustilago avenae||felis catus hair 16 [bau] in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.0004 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / aspergillus fumigatus 0.00008 g in 1 ml / fusarium oxysporum 0.0004 g in 1 ml / cochliobolus sativus 0.0004 g in 1 ml / cladosporium cladosporioides 0.0004 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.0004 g in 1 ml / phoma destructiva 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.0004 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.0004 g in 1 ml / ustilago nuda hordei 0.0001 g in 1 ml / ustilago maydis 0.0001 g in 1 ml / ustilago avenae 0.0001 g in 1 ml / ustilago tritici 0.0001 g in 1 ml / ustilago cynodontis 0.0002 g in 1 ml / sporisorium cruentum 0.0002 g in 1 ml intradermal injection, solution||has_active_moiety
dióxido de titanio||octinoxate 1072 mg in 21 ml / titanium dioxide 292 mg in 21 ml topical cream [cle de peau beaute radiant foundation o50]||has_active_moiety
trazodona||trazodone hydrochloride 100mg tablet (product)||has_active_moiety
ca 2+||calcium carbonate 500 mg oral tablet, chewable [premier value extra strength chewable antacid assorted berry]||has_active_moiety
ethanol (substance)||alcohol 70.4 ml in 100 ml topical liquid [wish/ wish ultra slim hand sanitizer]||has_active_moiety
1-hydroxyethane||alcohol 0.659 ml in 1 ml topical cloth [hand sanitizing wipes]||has_active_moiety
dipropylacetic acid (dpa)||product containing precisely valproate sodium 500 milligram/1 each gastro-resistant oral tablet (clinical drug)||has_active_moiety
avobenzone (obsolete)||octocrylene 60 mg in 1 ml / octinoxate 49 mg in 1 ml / avobenzone 30 mg in 1 ml / oxybenzone 30 mg in 1 ml topical cream [natural bb cream spf15]||has_active_moiety
octocrileno||avobenzone 30 mg in 1 ml / homosalate 135 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 100 mg in 1 ml topical lotion [neutrogena invisible daily defense sunscreen broad spectrum spf 60 plus]||has_active_moiety
aluminum 3+||aluminum zirconium tetrachlorohydrex gly 15.2 g in 100 g topical stick [dove advanced care restore antiperspirant deodorant]||has_active_moiety
1-hydroxyethane||alcohol 75 ml in 100 ml topical solution [safe warrior instant hand sanitizer with moisturizers and aloe vera]||has_active_moiety
etoh - alcohol||alcohol 0.7 ml in 1 ml topical cloth [germ shark px7 hand jumbo hand sanitizing wipes]||has_active_moiety
alcohol, denatured||(spl review) alcohol 62 g in 112 ml topical gel [hand sanitizer]||has_active_moiety
pinus taeda pollen||pinus taeda pollen 20000 [pnu] in 1 ml intradermal solution [loblolly pine pollen]||has_active_moiety
aconitum napellus extract||aconitum napellus 0.0123 g in 65 g / apis mellifera 8 [hp_x] in 65 g / arnica montana flower 0.0123 g in 65 g / bryonia alba root 4 [hp_x] in 65 g / calendula officinalis flowering top 1 [hp_x] in 65 g / camphor (natural) 3 [hp_x] in 65 g / hamamelis virginiana root bark/stem bark 0.0123 g in 65 g / phytolacca americana root 6 [hp_x] in 65 g / toxicodendron pubescens leaf 6 [hp_x] in 65 g / comfrey root 6 [hp_x] in 65 g topical cream [outpain]||has_active_moiety
alcohol (ethyl)||alcohol 80 ml in 100 ml topical solution [octoclenz]||has_active_moiety
populus nigra pollen||plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.0004 g in 1 ml / urtica dioica pollen 0.0004 g in 1 ml / amaranthus retroflexus pollen 0.00008 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / rumex acetosella pollen 0.0004 g in 1 ml / cynodon dactylon pollen 16 [bau] in 1 ml / festuca pratensis pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / avena sativa pollen 0.002 g in 1 ml / phleum pratense pollen 800 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / fraxinus americana pollen 0.00008 g in 1 ml / betula nigra pollen 0.0004 g in 1 ml / acer negundo pollen 0.0004 g in 1 ml / juniperus virginiana pollen 0.00008 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / ulmus americana pollen 0.00008 g in 1 ml / quercus alba pollen 0.0004 g in 1 ml / carya alba pollen 0.00004 g in 1 ml / carya illinoinensis pollen 0.00004 g in 1 ml / platanus occidentalis pollen 0.0004 g in 1 ml / populus nigra pollen 0.0002 g in 1 ml / populus alba pollen 0.0002 g in 1 ml / salix nigra pollen 0.0004 g in 1 ml / juglans nigra pollen 0.0004 g in 1 ml intradermal injection, solution||has_active_moiety
sus scrofa pancreas preparation||silybum marianum seed 2 [hp_x] in 4 g / ceanothus americanus leaf 6 [hp_x] in 4 g / chelidonium majus 2 [hp_x] in 4 g / chionanthus virginicus bark 6 [hp_x] in 4 g / choline hydroxide 4 [hp_x] in 4 g / cobalamin 4 [hp_x] in 4 g / fumaric acid 4 [hp_x] in 4 g / sus scrofa gallbladder 8 [hp_x] in 4 g / pork liver 6 [hp_x] in 4 g / inositol 4 [hp_x] in 4 g / sus scrofa jejunum 8 [hp_x] in 4 g / potassium sulfate 12 [hp_x] in 4 g / culver's root 6 [hp_x] in 4 g / lycopodium clavatum spore 6 [hp_x] in 4 g / sodium diethyl oxalacetate 4 [hp_x] in 4 g / sodium pyruvate 4 [hp_x] in 4 g / sodium sulfate 8 [hp_x] in 4 g / niacin 6 [hp_x] in 4 g / sus scrofa pancreas 8 [hp_x] in 4 g / pyridoxine hydrochloride 6 [hp_x] in 4 g / riboflavin 6 [hp_x] in 4 g / sus scrofa spleen 8 [hp_x] in 4 g / taraxacum officinale 2 [hp_x] in 4 g / thiamine hydrochloride 6 [hp_x] in 4 g oral pellet [guna-liver]||has_active_moiety
siliceous earth, purified||beta vulgaris 1 [hp_x] in 1 ml / peumus boldus leaf 1 [hp_x] in 1 ml / centaurea benedicta 1 [hp_x] in 1 ml / chelidonium majus 1 [hp_x] in 1 ml / coffea arabica seed, roasted 1 [hp_x] in 1 ml / equisetum arvense top 1 [hp_x] in 1 ml / petroselinum crispum 1 [hp_x] in 1 ml / taraxacum officinale 1 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / ginkgo 6 [hp_x] in 1 ml / potassium chloride 6 [hp_x] in 1 ml / potassium phosphate, dibasic 6 [hp_x] in 1 ml / potassium sulfate 6 [hp_x] in 1 ml / germanium sesquioxide 8 [hp_x] in 1 ml / silicon dioxide 8 [hp_x] in 1 ml / calcium fluoride 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml oral liquid [hydration complex]||has_active_moiety
artemisia vulgaris root||xanthium strumarium pollen 0.05 g in 1 ml / plantago lanceolata pollen 0.05 g in 1 ml / chenopodium album pollen 0.05 g in 1 ml / artemisia vulgaris root 0.05 g in 1 ml / amaranthus retroflexus pollen 0.05 g in 1 ml / rumex acetosella pollen 0.05 g in 1 ml / rumex crispus pollen 0.05 g in 1 ml subcutaneous injection, solution [weed mix number 7b]||has_active_moiety
product containing dexamethasone (medicinal product)||dexamethasone 1 milligram in 1 milliliter oral solution, concentrate||has_active_moiety
gamboge||gamboge 30 [hp_c] in 1 ml oral pellet [diarrhea colic]||has_active_moiety
loratadine (substance)||loratadine 5mg chewable tablet||has_active_moiety
ca 2+||tribasic calcium phosphate 6 [hp_x] / ferrosoferric phosphate 6 [hp_x] / potassium phosphate, dibasic 6 [hp_x] / magnesium phosphate, dibasic trihydrate 6 [hp_x] / sodium phosphate, dibasic, heptahydrate 6 [hp_x] oral tablet [five phos]||has_active_moiety
product containing benzalkonium (medicinal product)||skin-aid-medics antibacterial wipes kit watermelon, cucumber, coconut, lemon kit||has_active_moiety
etoh - ethanol||alcohol 0.7 ml in 1 ml topical gel [instant hand sanitizing gel]||has_active_moiety
octylmethoxycinnamate||titanium dioxide 6.4 ml in 80 ml / octinoxate 2 ml in 80 ml topical liquid [jafra always color stay-on makeup spf 10]||has_active_moiety
teucrium marum||artemisia vulgaris root 3 [hp_x] in 1 ml / artemisia cina pre-flowering top 3 [hp_x] in 1 ml / teucrium marum 3 [hp_x] in 1 ml / dryopteris filix-mas root 4 [hp_x] in 1 ml / spigelia anthelmia 6 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / mercuric chloride 12 [hp_x] in 1 ml / schoenocaulon officinale seed 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / tanacetum vulgare top 12 [hp_x] in 1 ml / ascaris lumbricoides 30 [hp_x] in 1 ml / taenia solium 30 [hp_x] in 1 ml oral liquid [vermex]||has_active_moiety
prednisone product||product containing only prednisone 20 mg/1 each oral tablet||has_active_moiety
vitamin d>2< preparation||ergocalciferol 50000 unit oral capsule||has_active_moiety
dog epithelia||allergenic extrt, dog epithelia 1:10 inj||has_active_moiety
3-fluorothiamphenicol||florfenicol 300 mg in 1 ml subcutaneous injection, solution [loncor 300]||has_active_moiety
methyltestosterone-containing product||methyltestosterone 1.25 mg / estrogens, esterified 0.625 mg oral tablet, coated [eemt hs]||has_active_moiety
guaifenesina||dextromethorphan hydrobromide/guaifenesin 60 mg-1200 mg oral tablet, extended release [equaline mucus-dm]||has_active_moiety
benzoyl peroxide [acne] (product)||benzoyl peroxide 10% topical application gel/jelly [student's choice acne medication]||has_active_moiety
atriplex canescens pollen||atriplex canescens pollen 0.1 g in 1 ml intradermal injection, solution||has_active_moiety
sulphur||sulfur 6 [hp_x] topical liquid [naturasil ringworm]||has_active_moiety
4-(6-methoxy-2-naphthalenyl)-2-butanone||nabumetone 1000 mg oral tablet [relafen]||has_active_moiety
niacin (as niacinamide)||niacinamide 0.84 g in 42 g / adenosine 0.01 g in 42 g topical patch [arocell super power mask]||has_active_moiety
product containing eptacog alfa activated||novoseven, 1200 mcg (1.2 mg) intravenous powder for injection||has_active_moiety
impatiens glandulifera flower||epinephrine 15 [hp_x] in 1 g / citharacanthus spinicrus 15 [hp_x] in 1 g / aconitum napellus 10 [hp_x] in 1 g / silver nitrate 10 [hp_x] in 1 g / arsenic trioxide 10 [hp_x] in 1 g / baptisia tinctoria 10 [hp_x] in 1 g / matricaria recutita 10 [hp_x] in 1 g / cypripedium parvifolum root 10 [hp_x] in 1 g / digitalis 10 [hp_x] in 1 g / gelsemium sempervirens root 10 [hp_x] in 1 g / hops 10 [hp_x] in 1 g / strychnos ignatii seed 10 [hp_x] in 1 g / impatiens glandulifera flower 10 [hp_x] in 1 g / iodine 10 [hp_x] in 1 g / lachesis muta venom 10 [hp_x] in 1 g / lycopodium clavatum spore 10 [hp_x] in 1 g / sodium chloride 10 [hp_x] in 1 g / strychnos nux-vomica seed 10 [hp_x] in 1 g / scutellaria lateriflora 10 [hp_x] in 1 g / delphinium staphisagria seed 10 [hp_x] in 1 g / datura stramonium 10 [hp_x] in 1 g / theridion curassavicum 10 [hp_x] in 1 g / echinacea, unspecified 3 [hp_x] in 1 g / ginkgo 3 [hp_x] in 1 g / hypericum perforatum 3 [hp_x] in 1 g / passiflora incarnata flowering top 3 [hp_x] in 1 g oral pellet [hyperactivity - mental focus]||has_active_moiety
trillium erectum root extract||trillium erectum root 30 [hp_c] oral pellet [trillium pendulum]||has_active_moiety
natural graphite (substance)||graphite 10 [hp_x] in 1 g / ranunculus bulbosus 10 [hp_x] in 1 g / sodium chloride 6 [hp_x] in 1 g / thuja occidentalis leafy twig 6 [hp_x] in 1 g topical ointment [terragen hg treatment]||has_active_moiety
bellis perennis||aconitum napellus 20 [hp_x] in 1 g / arnica montana 20 [hp_x] in 1 g / bellis perennis 20 [hp_x] in 1 g / calendula officinalis flowering top 20 [hp_x] in 1 g / echinacea, unspecified 20 [hp_x] in 1 g / gelsemium sempervirens root 20 [hp_x] in 1 g / hamamelis virginiana root bark/stem bark 20 [hp_x] in 1 g / hypericum perforatum 20 [hp_x] in 1 g / ledum palustre twig 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / toxicodendron pubescens leaf 20 [hp_x] in 1 g / ruta graveolens flowering top 20 [hp_x] in 1 g / delphinium staphisagria seed 20 [hp_x] in 1 g / comfrey root 20 [hp_x] in 1 g / goldenseal 8 [hp_x] in 1 g oral pellet [injury - rescue]||has_active_moiety
oxybenzonum||octocrylene 9 g in 100 ml / octinoxate 7.5 g in 100 ml / oxybenzone 3 g in 100 ml / titanium dioxide 1.5 g in 100 ml topical cream [briteprep fx]||has_active_moiety
silicon dioxide, fumed||somatropin 6 [hp_x] in 30 ml / dalotuzumab 6 [hp_x] in 30 ml / saccharomyces cerevisiae rna 6 [hp_x] in 30 ml / herring sperm dna 6 [hp_x] in 30 ml / sus scrofa adrenal gland 6 [hp_x] in 30 ml / pork liver 6 [hp_x] in 30 ml / sus scrofa pituitary gland 6 [hp_x] in 30 ml / sus scrofa thymus 6 [hp_x] in 30 ml / thyroid, unspecified 6 [hp_x] in 30 ml / sus scrofa placenta 6 [hp_x] in 30 ml / sus scrofa ovary 6 [hp_x] in 30 ml / artemisia abrotanum flowering top 10 [hp_x] in 30 ml / semecarpus anacardium juice 10 [hp_x] in 30 ml / arsenic trioxide 10 [hp_x] in 30 ml / barium carbonate 10 [hp_x] in 30 ml / barium chloride dihydrate 10 [hp_x] in 30 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 30 ml / tribasic calcium phosphate 10 [hp_x] in 30 ml / iron 10 [hp_x] in 30 ml / fucus vesiculosus 10 [hp_x] in 30 ml / hekla lava 10 [hp_x] in 30 ml / helleborus niger root 10 [hp_x] in 30 ml / strychnos ignatii seed 10 [hp_x] in 30 ml / lycopodium clavatum spore 10 [hp_x] in 30 ml / niacinamide 10 [hp_x] in 30 ml / claviceps purpurea sclerotium 10 [hp_x] in 30 ml / silicon dioxide 10 [hp_x] in 30 ml / cobalt 12 [hp_x] in 30 ml / lithium carbonate 12 [hp_x] in 30 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 30 ml / manganese acetate tetrahydrate 12 [hp_x] in 30 ml / potassium phosphate, dibasic 12 [hp_x] in 30 ml / selenium 12 [hp_x] in 30 ml / zinc 12 [hp_x] in 30 ml oral spray [rejuvenate 2000 pm formula for women]||has_active_moiety
bd persist||alcohol 62 ml in 100 ml topical gel [ultra defense sani smart watermelon delight]||has_active_moiety
antimony trisulfide||antimony trisulfide 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / iron 10 [hp_x] in 59 ml / hyoscyamus niger 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / delphinium staphisagria seed 10 [hp_x] in 59 ml / thuja occidentalis leafy twig 10 [hp_x] in 59 ml / veratrum album root 10 [hp_x] in 59 ml oral liquid [eating disorders]||has_active_moiety
dextromethmorphan||dm/pe/acetaminophen/doxylamine 10 mg-5 mg-325 mg-6.25 mg/15 ml oral liquid (ml)||has_active_moiety
alcohol anhydrous||alcohol 70 ml in 100 ml topical gel [leafree hand sanitizer 10.14oz]||has_active_moiety
lisinopril anhydrous||prinivil 2.5mg tablet||has_active_moiety
product containing pramocaine (medicinal product)||glycerin 144 mg in 1 g / phenylephrine hydrochloride 2.5 mg in 1 g / pramoxine hydrochloride 10 mg in 1 g / petrolatum 150 mg in 1 g topical cream [preparation h maximum strength]||has_active_moiety
thuja occidentalis leafy twig||beta vulgaris 3 [hp_x] in 1 ml / peumus boldus leaf 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / smilax regelii root 6 [hp_x] in 1 ml / gelsemium sempervirens root 7 [hp_x] in 1 ml / veratrum album root 7 [hp_x] in 1 ml / iron 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / selenium 12 [hp_x] in 1 ml / thuja occidentalis leafy twig 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml oral liquid [detox]||has_active_moiety
octisalate||avobenzone 29.4 mg in 1 ml / homosalate 73.4 mg in 1 ml / octisalate 48.9 mg in 1 ml / octocrylene 26.9 mg in 1 ml / oxybenzone 19.6 mg in 1 ml topical lotion [panama jack boad spectrum spf 30]||has_active_moiety
fluoride ion||sodium fluoride 0.2 mg in 1 ml topical mouthwash [act total care anticavity fluoride icy clean mint]||has_active_moiety
carya ovata pollen||ulmus americana pollen 0.0001428 g in 1 ml / fagus grandifolia pollen 0.0001428 g in 1 ml / populus deltoides pollen 0.0001428 g in 1 ml / quercus rubra pollen 0.0001428 g in 1 ml / carya ovata pollen 0.0001428 g in 1 ml / fraxinus americana pollen 0.0001428 g in 1 ml / betula nigra pollen 0.0001428 g in 1 ml subcutaneous solution [eastern 7 tree pollen mix]||has_active_moiety
free calcium||lycopus virginicus 1 [hp_x] in 100 ml / spongia officinalis skeleton, roasted 1 [hp_x] in 100 ml / lophophytum leandrii 6 [hp_x] in 100 ml / quinine arsenite 6 [hp_x] in 100 ml / tribasic calcium phosphate 8 [hp_x] in 100 ml / magnesium phosphate, dibasic trihydrate 8 [hp_x] in 100 ml oral liquid [lycopus]||has_active_moiety
fluoride ion||sodium fluoride 0.2 mg in 1 ml oral rinse [kids flouride rinse]||has_active_moiety
butyl-methoxydibenzoylmethane||avobenzone 3 g in 100 g / homosalate 15 g in 100 g / octisalate 5 g in 100 g / octocrylene 7 g in 100 g topical lotion [face potion]||has_active_moiety
allergenic extract, chaetomium globosum||cochliobolus sativus 20000 [pnu] in 1 ml / chaetomium globosum 20000 [pnu] in 1 ml / gibberella zeae 20000 [pnu] in 1 ml / mucor plumbeus 20000 [pnu] in 1 ml / phoma exigua var. exigua 20000 [pnu] in 1 ml / rhizopus arrhizus 20000 [pnu] in 1 ml subcutaneous injection, solution [midwest molds]||has_active_moiety
apap||acetaminophen/dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride 325 mg-10 mg-200 mg-5 mg oral tablet [multi-symptom cold daytime]||has_active_moiety
thiosinamine||quinine sulfate 6 [hp_c] / salicylic acid 5 [hp_c] / allylthiourea 3 [hp_c] / petroselinum crispum 3 [hp_c] / potassium phosphate, dibasic 3 [hp_c] oral tablet [homeopathic ringing ear formula]||has_active_moiety
adefovir-containing product||product containing precisely adefovir dipivoxil 10 milligram/1 each conventional release oral tablet||has_active_moiety
pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6r,12ar)-||tadalafil 5mg tablet (product)||has_active_moiety
weed pollen-kochia (firebush)||chenopodium album pollen 0.016666 g in 1 ml / bassia scoparia pollen 0.016666 g in 1 ml / salsola kali pollen 0.016666 g in 1 ml percutaneous solution [central western weed mix]||has_active_moiety
mentol||lidocaine hydrochloride 7 mg in 1 ml / menthol 2 mg in 1 ml topical gel [aloe vera gel]||has_active_moiety
piperidinic acid||.gamma.-aminobutyric acid 6 [hp_x] in 1 ml oral liquid||has_active_moiety
hypochlorous acid (substance)||titanium dioxide 0.005 g in 50 ml / hypochlorous acid 0.004 g in 50 ml topical liquid [clen germ killer-spray]||has_active_moiety
noréthistérone||product containing only ethinylestradiol 0.035 milligram and norethisterone 0.5 milligram/1 each oral tablet||has_active_moiety
4-hydroxyacetanilide||acetaminophen 650 mg oral tablet, film coated, extended release [care one pain relief 8 hour]||has_active_moiety
iodine product (substance)||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / fucus vesiculosus 3 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / iodine 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / zinc 12 [hp_x] in 1 ml / cadmium sulfide 13 [hp_x] in 1 ml oral liquid [free radistat]||has_active_moiety
menthol-containing product||camphor 50 mg/ml / menthol 80 mg/ml / methyl salicylate 100 mg/ml topical oil||has_active_moiety
ibuprofen [cns analgesic] [see j28..] (substance)||ibuprofen 600 milligram in 1 tablet oral tablet, film coated||has_active_moiety
6-o-methylerythromycin||clarithromycin 250 mg oral tablet||has_active_moiety
salicylic acid 2-ethylhexyl ester||homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / zinc oxide 165 mg in 1 g topical lotion [obagi-c rx system sun shield broad spectrum spf 50 matte sunscreen]||has_active_moiety
o-phosphoric acid||aluminum oxide 30 [hp_c] in 1 ml / silver nitrate 30 [hp_c] in 1 ml / berberis vulgaris fruit 30 [hp_c] in 1 ml / conium maculatum flowering top 30 [hp_c] in 1 ml / iron 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / guaiacum officinale resin 30 [hp_c] in 1 ml / hydrogen 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / phosphoric acid 30 [hp_c] in 1 ml / toxicodendron pubescens leaf 30 [hp_c] in 1 ml oral liquid [fibromyalgia hp]||has_active_moiety
juglans regia flowering top||aconitum napellus 6 [hp_c] in 29.6 ml / silver nitrate 9 [hp_c] in 29.6 ml / centaurium erythraea flower 5 [hp_x] in 29.6 ml / ilex aquifolium flowering top 5 [hp_x] in 29.6 ml / juglans regia flowering top 5 [hp_x] in 29.6 ml / potassium carbonate 6 [hp_c] in 29.6 ml / sodium chloride 6 [hp_x] in 29.6 ml / phosphorus 6 [hp_c] in 29.6 ml topical spray [temperament and boundaries]||has_active_moiety
alkohol||alcohol 94.4 ml in 118 ml topical spray [smith golden rule hand sanitizer]||has_active_moiety
metronidazole (substance)||protostat, 250 mg oral tablet||has_active_moiety
2-ethylhexyl-p-methoxycinnamate||octinoxate 4.87 g in 65 ml / titanium dioxide 2.76 g in 65 ml / octocrylene 1.95 g in 65 ml / avobenzone 1.62 g in 65 ml topical cream [belucie luxury uv sun]||has_active_moiety
questionnaire or interview||i had to work really hard to pay attention or i would make a mistake in the past 7d:find:7d:^patient:ord:neuroqol||has_class
laboratory services||s mansoni ab ser ql||has_class
microbiology and antimicrobial susceptibility||bordetella holmesii deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:respiratory.upper:ordinal:probe.amp.tar||has_class
hematology nos||deprecated heparin ab ser qn pl agg||has_class
hepatology (field)||mitochondria ab:acnc:pt:ser:qn||has_class
infectiousdisease||influenza virus a ag [presence] in lower respiratory specimen by immunofluorescence||has_class
laboratory||influenza virus a antibody.immunoglobulin a:mass concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||has_class
laboratory services||feline infectious peritonitis virus ab:prthr:pt:ser:ord:ia||has_class
chemistry and chemistry challenge||preg bs serpl-mcnc||has_class
microbiology and antimicrobial susceptibility||streptococcus pneumoniae 56 antibody.immunoglobulin g:mass concentration:point in time:serum:quantitative||has_class
lab||morphology:imp:pt:bone mar:nar||has_class
lab||isobutyrylcarnitine (c4) [moles/vol]||has_class
infectiousdisease||capripox virus ab [presence] in serum by neutralization test||has_class
microbiology and antimicrobial susceptibility||clostridioides difficile bi-nap1-027 strain dna [presence] in stool by naa with probe detection||has_class
clin||health department:identifier:to identify measures at a point in time:organization:nominal||has_class
clinical||view pa 45 degree flexion:finding:to identify measures at a point in time:lower extremity>knee:document:xr||has_class
quality of life outcomes in neurological disorders (neuroqol) survey||i could walk on rough, uneven surfaces such as lawns, gravel driveway in the past 7 days [neuroqol.peds]||has_class
clinical nec (not elsewhere classified in lnc)||guidance for biopsy.needle:finding:to identify measures at a point in time:neck>thyroid gland:document:ultrasound||has_class
lab||promyelocytes/leuk nfr fld manual||has_class
laboratory||hypoxanthine phosphoribosyltransferase [enzymatic activity/volume] in red blood cells||has_class
allergy/allergic reaction nos||penicillium sp antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_class
microbiology order set||hcv ab mu set patient||has_class
quality of life outcomes in neurological disorders (neuroqol) survey||lately i felt embarrassed about my illness:finding:to identify measures at a point in time:^patient:ordinal:neuroqol.peds||has_class
science of genetics||dna marker analysis test coverage panel molgen (bld/tiss)||has_class
cell markers||cells.cd10+cd19+:number concentration (count/vol):to identify measures at a point in time:whole blood:quantitative||has_class
clinical nec (not elsewhere classified in lnc)||iv #||has_class
chemistry procedures||urea spec-scnc||has_class
hypersensitive||a fumigatus (rasp f) 6 ige rast ql||has_class
chemistry procedures||glucosylceramidase tiss ql||has_class
infectiousdisease||enterotoxin:mcnc:pt:ser:qn||has_class
clin||ability to plan:finding:to identify measures at a point in time:^patient:ordinal:hl7.ccdar2||has_class
laboratories||apolipoprotein e:mcnc:pt:csf:qn||has_class
minimum data set (mds) for nursing home resident assessment and care screening panels||staff assessment for pain:-:point in time:^patient:-||has_class
chemistry technique||creatinine [mass/volume] in peritoneal dialysis fluid --24 hour specimen||has_class
challenge tests||prolactin 3rd specimen post unsp challenge [mass/vol]||has_class
general health survey||as a result of any emotional problems, have you accomplished less than you would like in the past 4w:finding:4 weeks:^patient:ordinal:vr||has_class
infectiousdisease||brucella sp identified:presence or identity:to identify measures at a point in time:milk:nominal:organism specific culture||has_class
hemodyn||cardiac output/body surface area:arvrat:pt:heart.ventricle.left:qn:angiography.single plane||has_class
laboratories||top2a gene 17q21-22 deletion+duplication:prthr:pt:tiss:ord:fish||has_class
lab||a-oh alpraz fld cfm-mcnc||has_class
laboratory||b quintana igm titr ser if||has_class
centers for medicare & medicaid services (cms) survey||agency patient number:id:pt:^patient:nom:cms assessment||has_class
microbiology and antimicrobial susceptibility||bovine diarrhea virus ag:prthr:pt:nose:ord||has_class
infectiousdisease||y. enterocolitica igm ia qn (s)||has_class
drug toxicology||metaxalone:mass concentration:to identify measures at a point in time:whole blood:quantitative||has_class
radiology procedures||views greater than or equal to 3 && view pa:finding:to identify measures at a point in time:chest>ribs.left && chest:document:xr||has_class
hx||military service:finding:point in time:^patient:narrative||has_class
card.us.dicom||time to max tissue velocity.systole:time:to identify measures at a point in time:heart.ventricle.left.mid inferior:quantitative:ultrasound.tissue doppler||has_class
laboratory (environment)||jwh-200 4-hydroxyindole:presence or threshold:to identify measures at a point in time:whole blood:ordinal||has_class
clinical nec (not elsewhere classified in lnc)||date of onset of chest discomfort:time stamp -- date and time:point in time:^patient:quantitative||has_class
lab||rickettsia spotted fever group dna [presence] in specimen by naa with probe detection||has_class
laboratory (environment)||num hla ab positive cells||has_class
doc.ontology||readiness for military duty assessment note:finding:to identify measures at a point in time:{setting}:document:{role}||has_class
test;microbiology||chlamydophila psittaci ab [titer] in serum||has_class
clinical nec||classroom rules are applied equally:find:pt:^patient:ord:phenx||has_class
lab||smooth muscle igg ql (s)||has_class
clinical||views ap + lateral:find:pt:upper extremity>thumb:doc:xr||has_class
cell markers||cd7 abnormal blood cells/abnormal blood cells.total in blood||has_class
facility||archive facility identification number npi cancer||has_class
h&p.px||murmur radiating to body location [anatomy] by auscultation||has_class
laboratories||pemoline [mass/time] in 24 hour urine||has_class
spec||clot:presence or threshold:to identify measures at a point in time:body fluid, unsp:ordinal||has_class
quality audit marker survey||physical performance [qam]||has_class
orthopedics surgery||xr should-r 3v+ax||has_class
laboratory (environment)||mvev ab ser ql||has_class
hypersensitivity symptoms||carp ige qn||has_class
clinical nec (not elsewhere classified in lnc)||skin assessment panel||has_class
doc.ontology||md op note||has_class
clinical||multisection^w tc-99m mertiatide intravenous:finding:to identify measures at a point in time:abdomen>kidney.bilateral:document:nm.spect||has_class
microbiology and antimicrobial susceptibility||bacitracin mic [susc]||has_class
attach.rehab.ot||assessment information:cmplx:pt:occupational therapy treatment plan:set||has_class
survey||thinking about my life, i expect to achieve what i want in life [promis.peds]||has_class
laboratory services||s. typhi h d ab aggl (s) [titer]||has_class
laboratories||s. pneumoniae 20 igg spec 1 (s) [mass/vol]||has_class
chemistry and chemistry - challenge||calcium^4 hours post xxx challenge:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
lab||gd3 gangl igg+igm ser ql line blot||has_class
chemistry and chemistry - challenge||nonalcoholic steatohepatitis and fibrosis panel||has_class
laboratories||constitutive heterochromatin analysis in blood or tissue by banding||has_class
survey||are you able to reach into a low cupboard:find:pt:^patient:ord:promis||has_class
endocrine/metabolic organ system||glucose tolerance:imp:pt:ser/plas:nar||has_class
questionnaire or interview||ambulatory aid:find:pt:^patient:ord:morse fall scale||has_class
general health survey||my arms or legs feel weak in the past 7d:finding:7 days:^patient:ordinal:facit||has_class
test chemical||beta aminoisobutyrate [mass/volume] in amniotic fluid||has_class
laboratory (environment)||methaqualone:mcnc:pt:urine:qn||has_class
microbiology nos||blastomyces dermatitidis ab.igg:prthr:pt:csf:ord||has_class
chemical testing||c16 ceramide/c24 ceramide plas-srto||has_class
microbiology tests||cytomegalovirus dna:ncnc:pt:bld:qn:probe.amp.tar||has_class
laboratory||hazelnut recombinant (rcor a) 1 ige ab rast class [presence] in serum||has_class
microbiology and antimicrobial susceptibility||chlamydia trachomatis b ab.igm:titr:pt:ser:qn||has_class
input/output timed molecular||output.ileostomy:mass rate:10 hours:lower gi tract:quantitative||has_class
patient reported outcomes measurement system (promis) survey||i was loud when i drank in past 30d [promis]||has_class
lab||doxycycline [susceptibility]||has_class
laboratories||num 1/2 units trans platpheresis||has_class
laboratory (environment)||protein fractions immunofixation [interp]||has_class
molecular pathology tests||fgfr3 gene mut anl amn/cvs||has_class
laboratories||megaloblasts:ncnc:pt:bld:qn:manual count||has_class
infectiousdisease||streptococcus pneumoniae danish serotype 9n ab^2nd specimen:acnc:pt:ser:qn:ia||has_class
clinical nec (not elsewhere classified in lnc)||view lateral crosstable:finding:to identify measures at a point in time:not specified>spine:document:xr||has_class
infectiousdisease||hev ab ql (body fld)||has_class
clin||additional cause of injury [ntds]||has_class
laboratories||spermatozoa.thick midpiece/100 spermatozoa:number fraction:to identify measures at a point in time:semen:quantitative||has_class
chemicals testing||phenylalanine+tyrosine:presence or threshold:to identify measures at a point in time:urine:ordinal||has_class
clinical nec (not elsewhere classified in lnc)||guidance for transjugular biopsy of liver||has_class
pneumology||admission evaluation note:finding:to identify measures at a point in time:hospital:document:pulmonary disease||has_class
neurology (field)||herpes simplex virus antibody:dilution factor (titer):to identify measures at a point in time:cerebral spinal fluid:quantitative:complement fixation||has_class
microbiology procedure, nos||t brucei dna bld ql naa+probe||has_class
ultrasound;cardiac||myocardial mass:mass:pt:heart.ventricle.left:qn:us.2d+calculated by area-length method||has_class
tests ultrasound||fetal head study observation us||has_class
infectiousdisease||ehrlichia chaffeensis igg ab [presence] in cerebral spinal fluid||has_class
infectiousdisease||fluv ab titr ser||has_class
laboratory services||alpha-1-fetoprotein [mass/volume] in amniotic fluid||has_class
microbiology and antimicrobial susceptibility||dengue virus 2 antibody.neut:presence or threshold:to identify measures at a point in time:not specified:ordinal:virus neutralization||has_class
laboratory services||cocaine [presence] in unknown substance by screen method||has_class
chemical tests||glycine [moles/volume] in dbs||has_class
scan-ultrasound, obst.||births.total:number:to identify measures at a point in time:^patient:quantitative:reported||has_class
clinical nec (not elsewhere classified in lnc)||us guided pancreas drain+cath place||has_class
infectiousdisease||leishmania infantum+donovani ab.igm:titr:pt:ser/plas:qn:if||has_class
clinical nec||vacuum dust contaminant phenx||has_class
laboratories||endocrine newborn screening panel:-:pt:bld.dot:-||has_class
panel.survey.sdoh||money and resources [prapare]||has_class
healthy weight summary||is the patient breastfed||has_class
drug toxicology||cyclosporine peak bld-mcnc||has_class
minimum data set (mds) for nursing home resident assessment and care screening survey||resident assessment protocol 9--behavioral symptoms - triggered:finding:to identify measures at a point in time:^patient:nominal:mds||has_class
neuro||west nile virus igm ab [units/volume] in cerebral spinal fluid by immunoassay||has_class
drug/tox||arsenic.inorganic (24h u) [mass/vol]||has_class
infectiousdisease||kanamycin 6.0 ug/ml:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:method for slow-growing mycobacteria||has_class
nih - motor||hold 50s trial 2 eyes open+foam nih||has_class
lab||rinderpest virus ab neut test (s) [titer]||has_class
microbiology (procedure)||bwamba virus igg ab [presence] in specimen by immunoassay||has_class
chemicals testing||idl small ser-scnc||has_class
cardio-pericardial||us ta + aa||has_class
chemistry and chemistry challenge||17-hydroxycorticosteroids [moles/volume] in 24 hour urine||has_class
drug/tox||4-hydroxymidazolam [mass/volume] in urine||has_class
laboratory||hadv lower resp ql cult||has_class
infectiousdisease||influenza virus a & b ribonucleic acid panel:-:to identify measures at a point in time:tissue, unspecified:-:probe.amp.tar||has_class
laboratory||biotin:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
laboratory (environment)||hsv 2 ag ql (eye)||has_class
chemistry and chemistry challenge||thyrotropin^4th specimen post xxx challenge:acnc:pt:ser/plas:qn||has_class
molpath||krit1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal||has_class
infectiousdisease||thermoactinomyces sacchari antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||has_class
challenge testing||aldosterone pre unsp challenge [moles/vol]||has_class
chemical measurement||beta glucuronidase [enzymatic activity/volume] in cerebral spinal fluid||has_class
laboratory||bacampicillin disk diffusion (kb) [susc]||has_class
phenx (procedure)||i have the coordination i need to be physically active during my free time on most days [phenx]||has_class
microbiology and antimicrobial susceptibility||s. pneumoniae 8 igg spec 2 (s) [mass/vol]||has_class
lab||hydroxyzine:mass concentration:to identify measures at a point in time:urine:quantitative||has_class
rad||cta lower extremity vessels - left||has_class
cardiology||deprecated aortic valve regurgitant jet regurgitation degree by us||has_class
drug levels & toxicology||ropivacaine serpl-mcnc||has_class
laboratories||sulfatide ab ser ql||has_class
infectiousdisease||virginiamycin susc islt||has_class
obstetrics and gynaecology (qualifier value)||blood flow.systolic.max:vel:pt:heart.ventricle.right.outflow tract:qn:us.doppler||has_class
infectiousdisease||fungal ab panel immune diff (specimen)||has_class
microbiology and antimicrobial susceptibility||gentamicin.high potency:susc:pt:isolate:ordqn:mic||has_class
clinical||admission history and physical note:finding:point in time:{setting}:document:{provider}||has_class
home health care classification (hhcc) survey||confusion:find:pt:^patient:ord:observed.ccc||has_class
clin||multisection:find:pt:carotid vessel:doc:mr.angio||has_class
microbiology and antimicrobial susceptibility||leptospira interrogans serovar hardjo ab:prthr:pt:ser:ord:ia||has_class
micro||equine influenza virus a2 antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||has_class
drug/tox||phentermine [presence] in urine by screen method||has_class
drug/tox||hydrocodone ql (gast fld)||has_class
microbiology (procedure)||m. capricolum ss capripneumonia ab qn (s)||has_class
clinical||note:find:pt:custodial care facility:doc:mental health||has_class
laboratory (environment)||sp gr ur refract.auto||has_class
loinc document ontology||ot eval note||has_class
clin||views le 3:finding:to identify measures at a point in time:head>skull:document:xr||has_class
survey.gnhlth||i am confident that i can tell when this person needs to get medical care and when i can handle the problem myself:finding:to identify measures at a point in time:^caregiver:ordinal:pam||has_class
laboratory||imipenem mic [susc]||has_class
laboratory services||macroamylase [presence] in serum or plasma||has_class
haematology nos||note:finding:to identify measures at a point in time:telehealth:document:hematology+medical oncology||has_class
lab||cd198 cells/100 cells (bld)||has_class
drug/tox||1,2,3-trichlorobenzene:mcnc:pt:ser/plas:qn||has_class
survey||during the last mo did you not eat for a whole day because your family didn't have enough money for food:find:1mo:^patient:ord:u.s. food security survey.child||has_class
drug levels and toxicology||ce bld-mcnc||has_class
diagnostic service sources microbiology||sars coronavirus 2 orf1ab region:threshold number:to identify measures at a point in time:oropharyngeal wash:quantitative:probe.amp.tar||has_class
obstetrics and gynaecology||diameter.max:len:pt:ovary.largest follicle:qn:us.measured||has_class
cancer, oncology||2nd course treatment.biological reponse modifier therapy:presence or identity:to identify measures at a point in time:subsequent cancer rx:nominal||has_class
respiratory therapy attachment||deprecated||has_class
chemistry and chemistry - challenge||somatotropin^7th specimen post xxx challenge:scnc:pt:ser/plas:qn||has_class
survey.neuro||nih stroke scale interval:find:pt:^patient:nom:nihss||has_class
microbiology and antimicrobial susceptibility||ilheus virus ab.igg:prthr:pt:xxx:ord:ia||has_class
laboratory services||parainfluenza virus identified:prid:pt:nose:nom:organism specific culture||has_class
covid-19 related survey questions||paralyzed or frozen when i thought about or was exposed to information about the coronavirus in past 2w:finding:2 weeks:^patient:ordinal||has_class
laboratories||papaverine induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry||has_class
microbiology and antimicrobial susceptibility||human coronavirus oc43 rna:prthr:pt:respiratory.upper:ord:probe.amp.tar||has_class
lab||kappa lc free ser neph-mcnc||has_class
rad||nm thyroid gland views w i-131 iv||has_class
allergic state (disorder)||ginger igg qn||has_class
chemistry measurement||glucose diafp-mcnc||has_class
laboratory (environment)||hydralazine [mass/volume] in serum or plasma||has_class
surveys||are you able to put on a pullover sweater [promis]||has_class
cardiology field||diameter 2:length:to identify measures at a point in time:mitral valve:quantitative:ultrasound||has_class
laboratory services||deprecated microscopic observation [identifier] in stool by ova and parasite preparation||has_class
chemistry and chemistry challenge||atrial natriuretic factor:mass concentration:to identify measures at a point in time:blood arterial:quantitative||has_class
laboratory||alpha aminobutyrate:substance concentration:to identify measures at a point in time:dried blood spot:quantitative||has_class
lab||m myc my sc ab ser ql ia||has_class
med pulm||helium vfr/ppres away adap||has_class
clinical nec (not elsewhere classified in lnc)||did he or she ever have an operation to straighten his or her eyes [phenx]||has_class
clinical nec (not elsewhere classified in lnc)||ems physician qualification:type:to identify measures at a point in time:provider:nominal||has_class
chemical tests||human epididymis protein 4 eia [moles/vol]||has_class
laboratories||eeev igg ser ql||has_class
lab||deprecated s pneum4 igg sp2 ser ia-mcnc||has_class
laboratories||creatine [mass/volume] in 24 hour urine||has_class
laboratory services||local assigning authority:identifier:to identify measures at a point in time:isolate:nominal||has_class
pathology procedure||deprecated tbo stn tiss||has_class
laboratory||xylose 2h p 25 g xyl po serpl-scnc||has_class
laboratory (environment)||alpha aminobutyrate:prthr:pt:ser/plas:ord||has_class
ultrasound;cardiac||left ventricular myocardial mass by us.m-mode||has_class
drug levels & toxicology||sulfate.total/creatinine [molar ratio] in urine||has_class
survey instrument||was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject:find:rptperiod:^patient:ord:cam.cms||has_class
drug levels and toxicology||phorate ur-mcnc||has_class
lab||monocytes.immature:presence or threshold:to identify measures at a point in time:whole blood:ordinal||has_class
laboratories||thyroxine.free:mcnc:pt:ser/plas:qn:ia||has_class
laboratories||trimethoprim islt grad strip||has_class
mutations||htc2 gene mutations tested for:prid:pt:bld/tiss:nom:molgen||has_class
drug/tox||tetrahydrocannabinol [presence] in blood by confirmatory method||has_class
clin||psychotic symptoms respond to antipsychotic medications:find:pt:^patient:ord:di-pad cgp v 1.4||has_class
microbiology and antimicrobial susceptibility||c. immitis ab cf ql (s)||has_class
lab||t(15;17) bcr1/control mar||has_class
molpath||fetal chromosome 13+18+21 trisomy:presence or threshold:to identify measures at a point in time:plasma.cfdna:ordinal:dosage of chromosome specific cf dna||has_class
nephrology- a specialty area of medicine||views^during surgery w contrast retrograde:finding:to identify measures at a point in time:abdomen>kidney & abdomen+pelvis>ureter & pelvis>urinary bladder:document:radiofluoroscopy||has_class
allergic reaction caused by substance||tree allerg mix 9 ige qn||has_class
vital sign (observable entity)||hemodynamic resistance/body surface area:resistance/area:to identify measures at a point in time:pulmonary vasculature:quantitative||has_class
section 3-5 microbiology procedures||cytomegalovirus antigen:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal:immune fluorescence||has_class
chal||prolactin pre ins iv serpl-mcnc||has_class
drug levels & toxicology||cadmium (tiss) [mass/mass]||has_class
microbiology (procedure)||brucella suis ab [presence] in serum||has_class
infectiousdisease||atovaquone:susc:pt:isolate:ordqn:mic||has_class
questionnaire or interview||promis parent proxy short form - pain interference 8a - version 2.0 raw score||has_class
cancer, oncology||cancer chemotherapy received in the past 4w or will be received in the next 4w:finding:to identify measures at a point in time:^patient:ordinal||has_class
chemistry and chemistry - challenge||glucose^4h specimen:mcnc:pt:ser/plas:qn||has_class
microbiology and antimicrobial susceptibility||rifabutin 1 ug/ml islt slowmyco||has_class
laboratories||chocolate antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_class
doc.ontology||ltc fac referral note||has_class
infectiousdisease||chlamydia trachomatis and neisseria gonorrhoeae rrna panel - vaginal fluid by naa with probe detection||has_class
infectiousdisease||borrelia burgdorferi antigen:presence or threshold:to identify measures at a point in time:not specified:ordinal||has_class
laboratory services||xanthine 24h ur-srate||has_class
lab||thiosulfate renal clearance in 24 hour urine and serum or plasma||has_class
genetics (field)||apoe gene alleles e2 & e3 & e4:prid:pt:bld/tiss:nom:molgen||has_class
clinical||occupational exposure:history:to identify measures at a point in time:^patient:nominal||has_class
radiology||xr shoulder 5 views||has_class
laboratory||posaconazole:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal||has_class
chemistry and chemistry challenge||retinal:mcnc:pt:ser/plas:qn||has_class
omaha||mental health.status:finding:to identify measures at a point in time:^community:ordinal:observed.omaha||has_class
inoculation, nos||rubella vaccine was received by children under the age of 18 in the household during the pregnancy:find:pt:^mother:ord||has_class
clinical nec (not elsewhere classified in lnc)||can pronounce as:find:pt:^patient:ord:nih toolbox||has_class
microbiology nos||sars coronavirus 2 ab.igm:prthr:pt:ser/plas:ord:ia||has_class
minimum data set for nursing home resident assessment and care screening||wound infection (other than foot) in last 7d:find:7d:^patient:ord:mdsv3||has_class
microbiology (as purpose of biopsy)||schistosoma sp ab [presence] in serum by immunoassay||has_class
chemical testing||pgk ser-ccnc||has_class
lab||carnitine biosynthesis intermediates pattern:imp:pt:bld.dot:nar||has_class
rearrangements, gene||rara gene rearrangements:prthr:pt:bld/tiss:ord:fish||has_class
infectiousdisease||rickettsia spotted fever group antibody.immunoglobulin m^1st specimen:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||has_class
hematology (coagulation) and differential count||cell count & differential panel:-:pt:periton fld:qn||has_class
chemistry panel||mitochondrial respiratory chain enzyme analysis panel - fibroblast||has_class
laboratory (environment)||11-deoxycortisol^2 hours post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
laboratory (environment)||rabv rna spec ql naa+probe||has_class
infectiousdisease||a. phagocytophilum igm ql (csf)||has_class
microbiology and antimicrobial susceptibility||bacillus anthracis antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:immune fluorescence||has_class
microbiology (lab test)||listeria sp:presence or threshold:to identify measures at a point in time:cheese:ordinal:organism specific culture||has_class
laboratory services||slev igg titr ser||has_class
clinical nec||discharge summary note:find:pt:{setting}:doc:neurology||has_class
cell markers||platelet cd41 actual/normal fc (bld) [relative ratio]||has_class
chemistry and chemistry - challenge||fsh serpl-acnc||has_class
phenx||problem after cutting down or going without drinking:find:pt:^patient:nom:ssaga ii||has_class
laboratory services||powv igg titr spec||has_class
drug levels & toxicology||cobalt (syn fld) [mass/vol]||has_class
panel.micro||ocular pathogens pnl corn/cnjt naa+probe||has_class
survey.neuroq||i worry about getting a good job because of my medical condition in the past 7 days [neuroqol.peds]||has_class
laboratories||leukocytes other/100 leukocytes:number fraction:to identify measures at a point in time:cerebral spinal fluid:quantitative||has_class
radiology procedures||xr hand-bl brewerton||has_class
microbiology procedure, nos||enterovirus igm ab [presence] in cerebral spinal fluid by immunoassay||has_class
radiology procedures||xr joint views lat w man stress||has_class
microbiology and antimicrobial susceptibility||borrelia burgdorferi ab.igm:prthr:pt:synv fld:ord||has_class
clinical nec (not elsewhere classified in lnc)||institution referred to npi cancer registry||has_class
lab||betula verrucosa recombinant (rbet v) 1 ab.ige.rast class:prthr:pt:ser:ord||has_class
laboratory||toxaphene:mass concentration:to identify measures at a point in time:water:quantitative||has_class
chemistry and chemistry challenge||beta globulin/protein.total in 24 hour urine||has_class
molpath||cells.s phase/100 cells:number fraction:to identify measures at a point in time:whole blood:quantitative||has_class
lab||arachidonate (c20:4w6)+linoleate (c18:2w6)/fatty acids.c14-c22 (bld) [mass fraction]||has_class
drug levels & toxicology||fluoxetine [mass/volume] in serum or plasma||has_class
serology (antibodies and most antigens except blood bank and infectious agents)||ampar2 igg serpl ql cba ifa||has_class
document ontology||postoperative evaluation and management note:finding:to identify measures at a point in time:{setting}:document:obstetrics||has_class
clinical nec||voiding pattern gu||has_class
radiology test||guidance for needle localization:find:pt:breast.right:doc:us||has_class
laboratory (environment)||denv 2+4 rna ser ql naa+probe||has_class
admin||person assigned to task:pn:pt:personnel:nom||has_class
clin||note:find:pt:outpatient:doc:radiology||has_class
survey||date of first syphilis treatment during pregnancy:date:pt:^mother:qn||has_class
clinical||gestational age:time:pt:^fetus:qn:us+estimated from tc.nimrod 1986||has_class
general behavioral health / psychiatry||deprecated||has_class
microbiology and antimicrobial susceptibility||pneumocystis jiroveci:prthr:pt:xxx:ord:calcofluor white preparation||has_class
clin||ct foot wo contrast||has_class
microbiology and antimicrobial susceptibility||rinderpest virus antigen:presence or threshold:to identify measures at a point in time:not specified:ordinal:immune fluorescence||has_class
microbiology procedure (procedure)||hhv 8 dna naa+probe (bm) [#/vol]||has_class
microbiology test (procedure)||virus identified:prid:pt:xxx:nom:microscopy.electron||has_class
infertility studies||deprecated number of entities [#] in spermatozoa||has_class
chemistry and chemistry - challenge||amylase (duod fld) [catalytic activity/vol]||has_class
laboratory||nordiazepam [mass/volume] in serum or plasma by confirmatory method||has_class
infectiousdisease||nitrofurazone [susc]||has_class
infectiousdisease||eeev igm ser ql ia||has_class
laboratory (environment)||mold identified:prid:pt:isolate:nom:probe.amp.tar||has_class
microbiology procedure (procedure)||avian paramyxovirus 1 rna:acnc:pt:xxx:qn:probe.amp.tar||has_class
chemistry and chemistry challenge||fructosamine/protein:ratio:pt:ser/plas:qn||has_class
clinical||views lateral + pa^w inspiration + w expiration:find:pt:chest:doc:xr||has_class
urologic (qualifier value)||letter:finding:to identify measures at a point in time:hospital:document:pediatric urology||has_class
lab||hepatitis b virus deoxyribonucleic acid:arbitrary concentration:to identify measures at a point in time:not specified:quantitative:probe.amp.tar||has_class
chemistry and chemistry challenge||crp high sensitivity method [mass/vol]||has_class
laboratory services||vancomycin resistant enterococcus [presence] in specimen by organism specific culture||has_class
infectiousdisease||l inter igg titr ser||has_class
ophthalmology optical coherence tomography (otc)||macular grid.center point thickness:length:to identify measures at a point in time:eye:quantitative:oct||has_class
clinical nec||o2 end exp vfr/ppres away adap||has_class
psychiatric rehabilitation attachment||deprecated psychiatric rehabilitation treatment plan, justification (narrative)||has_class
gynaecology obstetrics||study observation:finding:point in time:aortic arch^fetus:narrative:ultrasound||has_class
lab||proinsulin [moles/volume] in serum or plasma --1 hour post xxx challenge||has_class
cardiovascular body system||cholesterol.non-esterified/cholesterol.total:sfr:pt:ser/plas:qn:gc||has_class
microbiology and antimicrobial susceptibility||candida sp deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:vagina:ordinal:probe.amp.sig||has_class
laboratory (environment)||hedis 2014-2016 value set - serum potassium||has_class
microbiology procedure, nos||rotavirus ab [titer] in serum by immunoassay||has_class
laboratories||basophils manual cnt (pleur fld) [#/vol]||has_class
laboratory (environment)||ph:log substance concentration:to identify measures at a point in time:prostatic fld:quantitative||has_class
nephrology (field)||multisection^w contrast iv:find:pt:kidney.bilateral+collecting system:nar:ct||has_class
infectiousdisease||mev rna naa+probe ql (specimen)||has_class
clinical nec (not elsewhere classified in lnc)||initial evaluation note:finding:to identify measures at a point in time:{setting}:document:pediatrics||has_class
clinical||oxygen/gas total 24 hour maximum inhaled gas||has_class
questionnaire or interview||meaning and purpose survey - cat item bank - age 18+ [nih toolbox]||has_class
doc.ontology||cardio attend icu note||has_class
diagnostic service sources microbiology (procedure)||rubella virus ab [presence] in serum by latex agglutination||has_class
microbiology nos (procedure)||cmv igm serpl ql||has_class
radiology studies||rf parotid gland - left views w contrast intra salivary duct||has_class
laboratory (environment)||cd57 antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:immune stain||has_class
radiology||multisection^w contrast intravenous:finding:to identify measures at a point in time:chest>coronary arteries+pulmonary arteries:document:computed tomography.angio||has_class
laboratory||dna analysis discrete sequence variation basic associated observations panel - blood or tissue by molecular genetics method||has_class
clin||ed h&p note||has_class
microbiology and antimicrobial susceptibility||fungus identified:prid:pt:tiss:nom:culture||has_class
cardiovascular structure (body structure)||r' wave amplitude.lead v4:electrical potential (voltage):to identify measures at a point in time:heart:quantitative:ekg||has_class
chemistry and chemistry - challenge||tiglylgly ur ql||has_class
laboratory (environment)||apramycin:susc:pt:isolate:ordqn:mic||has_class
laboratory (environment)||treponema pallidum ab:acnc:pt:ser:qn:immobilization||has_class
vital signs||pulse wave form carot a-r dop||has_class
laboratory services||herpes simplex virus 2 deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:genital:ordinal:probe.amp.tar||has_class
laboratory||di(2-ethylhexyl) phthalate:mass concentration:to identify measures at a point in time:water:quantitative||has_class
infectiousdisease||herpes virus 6 igg ab [titer] in cerebral spinal fluid||has_class
laboratory||hydroxyproline:substance concentration:to identify measures at a point in time:body fluid, unsp:quantitative||has_class
chemistry and chemistry challenge||bilirubin.glucuronidated/bilirubin.total:mfr:pt:ser/plas:qn||has_class
laboratory services||hla-a66(10):prthr:pt:bld/tiss^donor:ord||has_class
chemistry and chemistry - challenge||igm.intrathecally synthesized/igm.total:mfr:pt:csf:qn||has_class
laboratories||creatinine [mass/volume] in serum or plasma --2.5 hours post xxx challenge||has_class
clin||nyha functional class||has_class
4||patient reported outcome quality of life tool||has_class
laboratories||genechip manufacturer id bld/t||has_class
electrocardiogram measures||p-r interval l-v6||has_class
clinical nec (not elsewhere classified in lnc)||my voice gives out on me in the middle of speaking [phenx]||has_class
centers for medicaid and medicare (cms) pnl||mds v3.0 - rai v1.17.2 - bladder and bowel - ipa:-:rptperiod:^patient:-:cms assessment||has_class
microbiology and antimicrobial susceptibility||coxiella burnetii phase 2 iga ab [units/volume] in serum||has_class
obstetrics/gynecology||obgyn post-op e/m note||has_class
blood pressure finding (finding)||intravascular systolic:pres:pt:great toe arteries.right:qn||has_class
general health survey panels||pain panel [koos]||has_class
oasis||pressure injury:find:pt:^patient:ord:oasis||has_class
infectiousdisease||sulfisoxaz titr sbt||has_class
laboratory (environment)||human leukocyte antigen-dw20:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal||has_class
laboratories||coliform bacteria [#/mass] in egg by viability count||has_class
chemical procedure (procedure)||methgb mfr bldmv||has_class
laboratory services||insulin 4h p chal serpl-acnc||has_class
orthopedics (profession)||xr should-l ap ir+ap er+ax+y||has_class
drug toxicology||pcp cto sal cfm-mcnc||has_class
survey instruments||i am able to communicate with others in the past 7d:finding:7 days:^patient:ordinal:facit||has_class
chemicals testing||calcium:mcnc:pt:dial fld prt:qn||has_class
chemistry and chemistry - challenge||nbs test results pnl dbs||has_class
infectiousdisease||influenza virus a polymerase rna:prid:pt:isolate:nom:sequencing||has_class
infectiousdisease||porcine respiratory coronavirus antibody/negative control:relative ratio:to identify measures at a point in time:serum:quantitative:immunoassay||has_class
laboratory (environment)||unident cells # snv manual||has_class
hematology (coagulation) and differential count||complement decay accelerating factor:prthr:pt:rbc:ord||has_class
antimicrobial susceptibility||cefonicid:titr:pt:isolate+ser:qn:sbt||has_class
clinical nec||phenx - family history of speech and language impairment protocol:-:point in time:^patient:-:phenx||has_class
laboratory||vanadium/creat 24h ur-srto||has_class
infectiousdisease||escherichia coli k99 dna [cycle threshold #] in specimen by naa with probe detection||has_class
centers for medicare & medicaid services set||mds v3.0 - rai v1.16.1 - nursing home quarterly (nq) item set:-:pt:^patient:-:cms assessment||has_class
neurology speciality||extractable nuclear ab:acnc:pt:csf:qn:ia||has_class
clinical nec||multisection^w contrast iv:find:pt:abdomen+pelvis:doc:ct||has_class
drug levels & toxicology||cadmium [moles/mass] in hair||has_class
genet||ttr allele2 bld/t||has_class
card.us||contractility:finding:to identify measures at a point in time:heart.ventricle.right:ordinal:ultrasound+estimated||has_class
survey.cms||resident believes he or she is capable of increased independence in at least some adls:find:pt:^patient:ord:cms assessment||has_class
chal||insulin^5 hours post meal:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
microbiology procedure (procedure)||t. gondii igm ia ql (csf)||has_class
hl a antigens||hla-bw:type:pt:bld/tiss^donor:nom||has_class
infectiousdisease||cytomegalovirus [presence] in urine by shell vial culture||has_class
infectiousdisease||deprecated gram positive blood culture panel by nucleic acid capture and probe detection in positive blood culture||has_class
lab||selenium wat-mcnc||has_class
laboratory||osmotic fragility 0.55% sodium chloride (rbc)||has_class
clinical||voluntary ventilation.max^post bronchodilator/voluntary ventilation.max predicted:relative volume rate:to identify measures at a point in time:respiratory system:quantitative||has_class
clinical nec (not elsewhere classified in lnc)||rfa extremity veins - right views w contrast iv||has_class
clin||name suffix:pn:pt:^patient:nom||has_class
clinical||xr ankle ge 3v||has_class
cardiology field||cor stent expan press||has_class
lab||glucose 2h p glc bld-mcnc||has_class
chemistry and chemistry - challenge||transferrin.carbohydrate deficient.disialo/transferrin.total^^standardized per ifcc-rmp for cdt:mass fraction:to identify measures at a point in time:serum/plasma:quantitative||has_class
microbiology and antimicrobial susceptibility||hbv core ag tiss ql imstn||has_class
lab||bilirubin.indirect [moles/volume] in peritoneal fluid||has_class
laboratory services||efavirenz^peak:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
survey instrument||radiation in last 14d - while a resident:finding:14 days:^patient:ordinal:mdsv3||has_class
survey.gnhlth||i am bothered by side effects of treatment in the past 7 days [facit]||has_class
laboratory||hna 3 genotype in blood||has_class
microbiology and antimicrobial susceptibility||ebv ea ab ser ia-acnc||has_class
laboratory (environment)||ormetoprim+sulfadimethoxine [susceptibility]||has_class
laboratories||acth pre glc plas-scnc||has_class
microbiology and antimicrobial susceptibility||deprecated s pneum3 ab sp2 ser-acnc||has_class
clinical nec (not elsewhere classified in lnc)||patient id data deeds||has_class
lab||paraldehyde dose||has_class
microbiology tests||hepatitis a virus antibody.immunoglobulin g+immunoglobulin m:presence or threshold:to identify measures at a point in time:serum:ordinal||has_class
microbiology nos||schistosoma igg csf ia-acnc||has_class
molecular pathology||spast gene targeted mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||has_class
lab||calcium.ionized [moles/volume] in serum or plasma --3rd specimen post xxx challenge||has_class
loinc document ontology||evaluation note:finding:to identify measures at a point in time:{setting}:document:immunology||has_class
clinical nec||response entropy score ctx eeg||has_class
microbiology and antimicrobial susceptibility||t. pallidum ab qn||has_class
laboratory services||1,1-dimethoxyhexadecane/palmitate:mass ratio:to identify measures at a point in time:fibroblasts:quantitative||has_class
cell markers||cd3+cd25+ cells nfr tiss||has_class
laboratory||somatotropin [mass/volume] in serum or plasma --1.5 hours post dose glucagon||has_class
phenx||about how often did you eat mayonnaise, regular-fat, in past 12 months [phenx]||has_class
infectiousdisease||streptococcus pneumoniae danish serotype 7f ab^2nd specimen:mcnc:pt:ser:qn||has_class
microbiology and antimicrobial susceptibility||rick typhus igg titr ser||has_class
infectiousdisease||national (usa) pfge pattern [identifier] in isolate||has_class
echography (procedure)||gestational age:time:to identify measures at a point in time:^fetus:quantitative:ultrasound+estimated from bd||has_class
lab||methadone ql (specimen)||has_class
clinical nec (not elsewhere classified in lnc)||pediatric dermatology preoperative evaluation and management note||has_class
laboratory (environment)||c fetus ab titr ser||has_class
medicine, pulmonary||pressure.positive end expiratory.total:pressure:to identify measures at a point in time:respiratory system:quantitative||has_class
laboratories||vw ab ql||has_class
general health survey||compared to 10 years ago, has there been any change in cooking or working and talking at the same time [ecog]||has_class
clin||sao2 pre bd % blda pulseox||has_class
laboratories||c. trachomatis d+e+f+g+h+i+j+k iga (s) [titer]||has_class
lab||bacteria identified cx nom (water)||has_class
radiology test||multisection:finding:to identify measures at a point in time:lower extremity.left>thigh:document:computed tomography||has_class
laboratory||b. divergens ab ql (s)||has_class
chemistry and chemistry challenge||glucose [mass/volume] in serum or plasma --36 hours post xxx challenge||has_class
radiology test||rfa ao arch+carot+vert a-bl vs w contr ia||has_class
laboratory (environment)||streptococcus sp deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:whole blood:ordinal:probe.amp.tar||has_class
laboratory (environment)||blood group antibody screen:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:peg||has_class
microbiology and antimicrobial susceptibility||bacteria bone anaerobe+aerobe cult||has_class
abxbact||bacterial carbapenem resistance blavim gene:presence or threshold:to identify measures at a point in time:whole blood.pos growth:ordinal:probe.mag capture||has_class
doc.ontology||occupational therapy long term care facility consult note||has_class
cell markers||cd11b cells (bld) [#/vol]||has_class
pathology||microscopic observation esterase stain.non-specific nom (tiss)||has_class
substance abuse and mental health services administration (samhsa) survey||are you always able to stop using drugs when you want to:finding:to identify measures at a point in time:^patient:ordinal:samhsa||has_class
challenge tests||corticotropin^10 am specimen:mcnc:pt:plas:qn||has_class
obstetrics and gynaecology (qualifier value)||preparation techniques [type] in cervical or vaginal smear or scraping by cyto stain||has_class
psychiatric rehabilitation attachments||deprecated psychiatric rehabilitation treatment plan, medication name + identifier identifier||has_class
ophthalmology / optometry||a-wave implicit time^light-adapted:time:to identify measures at a point in time:retina.left:quantitative:electroretinogram||has_class
clinical||blda+bldmv fshunt vol temp adj vfr||has_class
gynecology obstetrics||diameter.transverse:length:to identify measures at a point in time:thorax^fetus:quantitative:ultrasound.measured||has_class
microbiology and antimicrobial susceptibility||parvovirus b19 dna:ncnc:pt:ser/plas:qn:probe.amp.tar||has_class
science of genetics||17-hydroxyprogesterone^1 day post dose dexamethasone:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
clinical||multisection^wo & w contrast iv:find:pt:upper extremity.left>shoulder vessels:doc:mr.angio||has_class
radiology procedures||deprecated dexa||has_class
clinical nec (not elsewhere classified in lnc)||fluid output pericardial drain 24h||has_class
drug levels and toxicology||alprazolam [mass/volume] in serum or plasma||has_class
drug toxicology||cannabinoids tested for:presence or identity:to identify measures at a point in time:urine:narrative:screen||has_class
chemistry and chemistry - challenge||protein ssa method ql (u)||has_class
sero||adalimumab ab [mass/vol]||has_class
clinical nec||phenx measure - difficulty in conceiving:-:to identify measures at a point in time:^patient:-:phenx||has_class
microbiology and antimicrobial susceptibility||p micra dna snv ql naa+non-probe||has_class
laboratories||tetradecenoylcarnitine (c14:1)/tetradecanoylcarnitine (c14):srto:pt:bld.dot:qn||has_class
infectiousdisease||microscopic observation other stain nom (duod fld)||has_class
diagnostic service sources microbiology||htlv i p36 antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||has_class
challenge testing||dehydroepiandrosterone sulfate^1st specimen post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
general health survey||i have been able to concentrate in the past 7d:find:7d:^patient:ord:facit||has_class
clinical nec||multisection:finding:to identify measures at a point in time:extremity.left:document:computed tomography||has_class
drug/tox||indium (bld) [mass/vol]||has_class
cvs - cardiovascular system||diameter:length:to identify measures at a point in time:pulmonic valve:quantitative:ultrasound.measured||has_class
pulm||type of bag-mask ventilation used||has_class
ultrasounds||ejection time:time:pt:heart.ventricle.right:qn:us.doppler||has_class
clin||mv med ann a-prime vmax tdi||has_class
laboratory||candida albicans antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||has_class
neurology (field)||c immitis igg + igm pnl csf||has_class
microbiology and antimicrobial susceptibility||coxsackievirus b6 ab [titer] in serum --1st specimen||has_class
microbiology and antimicrobial susceptibility||coxsackievirus a3 antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||has_class
chemistry and chemistry challenge||somatotropin^pre dose arginine:acnc:pt:ser/plas:qn||has_class
infectiousdisease||hbv core ab ia.rapid ql (s/p/bld)||has_class
laboratories||nuclear igg ser ql ia||has_class
imaging, ultrasonographic||orifice area.minor axis.min:area:to identify measures at a point in time:mitral valve:quantitative:ultrasound.2d||has_class
infectiousdisease||cmv igg 1st specimen/2nd specimen ia [ratio]||has_class
clin||fda label otc - preg/breast feed||has_class
clinical nec||ejection fraction:volume fraction:to identify measures at a point in time:heart.ventricle.left:quantitative:ultrasound.2d+calculated by modified simpson method||has_class
vascular, heart||surgical operation note:finding:to identify measures at a point in time:{setting}:document:interventional cardiology||has_class
clinical nec||nitrous oxide^at end expiration:volume fraction/pressure (partial):to identify measures at a point in time:airway adaptor:quantitative||has_class
clin||coding system.original.coc:identifier:to identify measures at a point in time:cancer registry:nominal||has_class
questionnaire or interview||irf-pai v4.0 - special treatments, procedures, and programs - discharge [cms assessment]||has_class
doc.ontology||wound care management evaluation note||has_class
challenge testing||creat 1h pre chal ur-mcnc||has_class
laboratories||specimen wt 72h stl-mrate||has_class
radiology studies||guidance for placement of tube:find:pt:abdomen+pelvis>gastrointestinal tract:doc:rf||has_class
challenge testing||c peptide^5h post dose glucose:mcnc:pt:ser/plas:qn||has_class
laboratories||glucose^2nd specimen post xxx challenge:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
chemistry and chemistry challenge||vitronectin:mass concentration:to identify measures at a point in time:plasma:quantitative||has_class
mental health survey||i have been sleeping too much since i took my last screen [m3]||has_class
diagnosis, ultrasound||study observation:finding:point in time:face^fetus:narrative:ultrasound||has_class
chemical test, nos||lipoprotein midband b serpl-mcnc||has_class
radiology studies||multisection:finding:to identify measures at a point in time:lower extremity.bilateral>thigh:document:magnetic resonance||has_class
section 3-5 microbiology procedures||hiv 1 & 2 rna serpl naa+probe||has_class
microbiology and antimicrobial susceptibility||denv ab ql (specimen)||has_class
drug/tox||4-hydroxy-tamoxifen:mcnc:pt:ser/plas:qn||has_class
infectiousdisease||dengue virus 1+3 ribonucleic acid:presence or threshold:to identify measures at a point in time:serum:ordinal:probe.amp.tar||has_class
microbiology tests||echovirus 7 ab qn (csf)||has_class
4||promis short form - satisfaction with social roles and activities 4a - version 2.0||has_class
survey instrument||i worry that my health might get worse in the past 7d:finding:7 days:^patient:ordinal:neuroqol.peds||has_class
laboratory (environment)||rickettsia rickettsii ab:prthr:pt:ser:ord:if||has_class
clin||group counseling note:find:pt:outpatient:doc:diabetology||has_class
genet||hla-dr18(3) ql||has_class
sensitivities||ticarcillin+clavulanate mic [susc]||has_class
cellmark||cd55+cd59 deficient rbc+granulocytes nar (bld) [interp]||has_class
lab||stachybotrys chartarum ab.igg.rast class:prthr:pt:ser:ord||has_class
chemistry and chemistry challenge||hydrogen/expired gas post 50 g lactose po (exhl gas) [volume fraction]||has_class
chemistry procedure||proline serpl-scnc||has_class
cardiovascular organ system||pv regurg vmin dias end us||has_class
chemistry and chemistry challenge||oxyhemoglobin/hemoglobin.total:mfr:pt:bldcov:qn||has_class
survey instrument||i had difficulty calming down in past 7d:find:7d:^patient:ord:promis||has_class
survey||promis parent proxy physical function - upper extremity - version 1.0 t-score||has_class
infectiousdisease||c burnet ph1 igg ser ql||has_class
molecular pathology||aptx gene targeted mutation analysis:prid:pt:bld/tiss:nom:molgen||has_class
laboratories||chlamydia trachomatis d+k antibody.immunoglobulin m:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_class
laboratory (environment)||e. coli labile toxin ql (specimen)||has_class
microbiology (lab test)||epstein barr virus ab panel:-:pt:ser^donor:-||has_class
laboratories||chlorobenzilate:mcnc:pt:air:qn||has_class
chemistry and chemistry challenge||vasopressin^1h post xxx challenge:mcnc:pt:plas:qn||has_class
microbiology||ebv dna bld ql naa+probe||has_class
laboratory (environment)||tpmt gene targeted mutation analysis molgen nom (bld/tiss)||has_class
laboratory||dog recombinant (rcan f) 4 ige ab rast class [presence] in serum||has_class
laboratory (environment)||ethanol serpl ql||has_class
chemistry and chemistry - challenge||dimethylacetal panel:-:pt:rbc:-||has_class
microbiology and antimicrobial susceptibility||taenia solium larva dna [presence] in tissue by naa with probe detection||has_class
infectiousdisease||deprecated s pneum2 igg sp1 ser-mcnc||has_class
lab||cd15 cells/100 cells (bm)||has_class
microbiology and antimicrobial susceptibility||bacterial vancomycin resistance vanc1 gene:presence or threshold:to identify measures at a point in time:isolate/specimen:ordinal:molecular genetics||has_class
4||final score [duke-ad]||has_class
endocrine structure||glucose [moles/volume] in serum or plasma --6th specimen post xxx challenge||has_class
respiratory measures and ventilator management||co2 end exp vfr/ppres away adap||has_class
infectiousdisease||chlamydia sp ab.igg:prthr:pt:ser:ord:ia||has_class
laboratory||le^a antigen:presence or threshold:to identify measures at a point in time:erythrocytes^donor:ordinal||has_class
allergy disorders||cucurbita pepo antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_class
cardiol||regurgitation degree:arbitrary:to identify measures at a point in time:mitral valve:ordinal:ultrasound.doppler||has_class
laboratory||organic acids pattern csf-imp||has_class
allergic reaction caused by substance||cefuroxime triggered leukotriene release (wbc) [mass/vol]||has_class
coagulations studies||heparin cofactor ii actual/normal chromogenic method (ppp) [rel catalytic activity/vol]||has_class
optic||l eye argon lc localization||has_class
laboratories||b. miyamotoi igm ia qn||has_class
consensus measures for phenotypes and exposures (phenx)||percentage area affected by eczema:nrat:pt:head+neck:qn:phenx||has_class
cardiology (qualifier value)||slope 2:vel:pt:circulatory system.xxx:qn:us.m-mode||has_class
urine examination - general||sulfonamide crystals:number aeric (number per area):to identify measures at a point in time:urine sediment:quantitative:microscopy.light.hpf||has_class
sero||scl-70 extractable nuclear antibody:arbitrary concentration:to identify measures at a point in time:body fluid, unsp:quantitative:immunoassay||has_class
urine examination - general (procedure)||nitrite ur strip-mcnc||has_class
chemistry and chemistry challenge||citrate:mass concentration:to identify measures at a point in time:semen:quantitative||has_class
clinical nec (not elsewhere classified in lnc)||mg guided brst-l pc bx cn||has_class
unlisted microbiology procedure||chlamydia trachomatis c iga ab [titer] in serum by immunofluorescence||has_class
drug toxicology||norchlordiazepoxide:mass concentration:to identify measures at a point in time:whole blood:quantitative:confirm||has_class
serology||ribosomal antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immune blot||has_class
lab||ustilago maydis antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_class
infectiousdisease||rsv ag if ql (bal)||has_class
infectiousdisease||brucella melitensis ab [presence] in serum||has_class
patient reported outcomes measurement system (promis) survey||i have trouble keeping track of what i am doing if i get interrupted in past 4w:finding:4 weeks:^patient:ordinal:promis.peds||has_class
microbiology and antimicrobial susceptibility||caspofungin:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:minimum inhibitory concentration||has_class
clinical||cardiac output/body surface area:volume rate/area:to identify measures at a point in time:heart.ventricle.right:quantitative:nuclear.blood pool||has_class
antibiotic susceptibility||ofloxacin:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:minimum inhibitory concentration||has_class
infectiousdisease||ebv capsid p18 igg ia.rapid ql (s)||has_class
micro||respiratory pathogens dna and rna panel naa+probe (lower resp)||has_class
laboratory (environment)||candida albicans deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:serum:ordinal:probe.amp.tar||has_class
pneumology (field)||volume.expired per minute/body weight^on ventilator:vratcnt:pt:respiratory system:qn||has_class
obstetrics/gynecology||estriol:scnc:24h:urine:qn||has_class
hypersensitivity; reaction||reindeer epithelium antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_class
laboratory services||hbv surface ag fld ql||has_class
section 3-5 microbiology procedures||mycobacterium tuberculosis deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:urine:ordinal:probe.amp.tar||has_class
document ontology||primary care education note||has_class
chemical measurement||isovalerylgly/creat ur||has_class
survey||adl and iadls - follow-up [oasis-c]||has_class
infectiousdisease||l acidophilus cc # mlk cult||has_class
genet||aspa gene p.ala305glu [presence] in blood or tissue by molecular genetics method||has_class
survey||i have had fevers - episodes of high body temperature - in the past 7d:finding:7 days:^patient:ordinal:facit||has_class
survey.mlhfq||did your heart failure prevent you from living as you wanted during the past mo (4w) by causing swelling in your ankles or legs:finding:1 month:^patient:ordinal:mlhfq||has_class
infectiousdisease||acanthamoeba sp dna naa+probe ql (tiss)||has_class
laboratory services||cytoplasmic ig cells/100 cells (bld)||has_class
lab||cottage cheese ige ab [units/volume] in serum||has_class
laboratory (environment)||a-oh-triazolam ser-mcnc||has_class
chemistry and chemistry challenge||beta 2 globulin:mass concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative:electrophoresis||has_class
chemistry and chemistry - challenge||sodium corrected for glucose [moles/vol]||has_class
laboratories||pemoline:mass concentration:to identify measures at a point in time:urine:quantitative:screen||has_class
laboratory||olea europaea pollen antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_class
general health survey||pediatric blood pressure screening results:impression/interpretation of study:to identify measures at a point in time:^patient:ordinal||has_class
infectiousdisease||borrelia burgdorferi ab:prthr:pt:body fld:ord:ia||has_class
oncology field||descriptor.other:finding:to identify measures at a point in time:cancer.not specified:narrative||has_class
genetics||trbv29 gene segments/trbv gene segments.total:number fraction:to identify measures at a point in time:whole blood:quantitative||has_class
questionnaire or interview||i can keep up with my social commitments in the past 7d:find:7d:^patient:ord:neuroqol||has_class
diagnostic service sources microbiology (procedure)||schistosoma sp ab.igg:acnc:pt:ser:qn:ia||has_class
hypersensitivity symptoms||food allerg mix20 ige rast ql||has_class
chemistry and chemistry challenge||testosterone [mass/volume] in serum or plasma --2nd specimen post xxx challenge||has_class
residual functional capacity assessment||other alleged impairments:imp:pt:^patient:nar:rfc assessment||has_class
infectiousdisease||cefoperazone [susceptibility] by gradient strip||has_class
challenge testing||cortisol^1 hour post dose corticotropin:impression/interpretation of study:to identify measures at a point in time:serum/plasma:nominal||has_class
microbiology (procedure)||influenza virus a non-structural protein rna [presence] in isolate by sequencing||has_class
microbiology and antimicrobial susceptibility||bordetella pertussis.pertussis toxin ab.igg:prthr:pt:ser:ord:ia||has_class
4||additional concerns - physical:-:to identify measures at a point in time:^patient:-:facit||has_class
hypersensitivity symptoms||red cedar ige rast ql||has_class
unified parkinson's disease rating scale||facial expression [updrs]||has_class
laboratories||pendimethalin:mcnc:pt:bld:qn||has_class
laboratories||trans cells #/area ur comp assist||has_class
clinical nec (not elsewhere classified in lnc)||deprecated views ap & axillary & y:finding:point in time:shoulder.left:narrative:xr||has_class
microbiology||lacv ab ser ql hai||has_class
hypersensitivity symptoms||west water hemp igg4-mcnc||has_class
clinical||people with confirmed positive lab results:num:pt:^population:qn||has_class
clinical||color^5 minutes post birth:function:to identify measures at a point in time:^patient:ordinal:apgar||has_class
survey instruments||everything seemed senseless to me in last w:find:1w:^patient:ord:bsl-23||has_class
4||quality of life score change:scorediff:pt:^patient:qn:hoos||has_class
cardiology field||stenosis degree:length fraction:to identify measures at a point in time:posterior descending from right coronary artery:quantitative:angiogram||has_class
infectiousdisease||deprecated streptococcus pneumoniae 7f antibody.immunoglobulin g:mass concentration:point in time:serum:quantitative||has_class
laboratory||spermatozoa:number concentration (count/vol):to identify measures at a point in time:semen:quantitative||has_class
administrative document||speech generating device attachment||has_class
laboratory (environment)||coxsackievirus b6 ab:titr:pt:ser:qn:comp fix||has_class
laboratories||monensin spec-mcnt||has_class
microbiology procedure||e cloac com dna l resp naa+non-prb-ncncrng||has_class
laboratory||le sup(x) ab ql (s/p bpu)||has_class
laboratory (environment)||cystine:scnc:pt:vitr fld:qn||has_class
infectiousdisease||netilmicin disk diffusion (kb) [susc]||has_class
microbiology and antimicrobial susceptibility||other antibiotic trough mlc (isol+s) [susc]||has_class
doc.ontology||consultation note:finding:to identify measures at a point in time:{setting}:document:clinical cardiac electrophysiology||has_class
clin||pressure.continuous positive airway.95%:pressure:24 hours^maximum value over interval:respiratory system:quantitative||has_class
unlisted microbiology||hbv surface ag serpl cfm-%||has_class
document ontology||va compensation and pension (c and p) examination large/small intestines||has_class
chemistry and chemistry challenge||albumin unsp time dl <= 20 mg/l (u) [mass/time]||has_class
laboratory services||treponema pallidum antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immunoassay||has_class
chemistry technique||cortisol spec 2 ql (sal)||has_class
neurology (field)||acanthamoeba sp identified org specific cx nom (csf)||has_class
microbiology (lab test)||francisella tularensis antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immunoassay||has_class
lab||a. felis igg if (s) [titer]||has_class
drugdose||p-methylhippurate dose||has_class
lab||wr sup(b) ab [presence] in serum or plasma||has_class
loinc document ontology||psychiatric educ note||has_class
microbiology procedure, nos||borrelia burgdorferi 49736 antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_class
microbiology and antimicrobial susceptibility||herpes simplex virus 1:prthr:pt:isolate:ord:if||has_class
allergic reaction (nos)||dog recombinant (rcan f) 5 ab.ige.rast class:prthr:pt:ser:ord||has_class
immune hypersensitivity disorder||kiwifruit triggered histamine release [units/volume] in blood||has_class
card.us||regurgitation degree:arb:pt:tricuspid valve:ord:us.doppler||has_class
laboratories||doravirine:susc:pt:isolate:ord:genotyping||has_class
clin||your child likes to collect information about categories of things, types of car, types of bird, types of train, types of plant, etc:find:pt:^patient:ord:aq adolescent||has_class
questionnaire or interview||lying flat - confidence - score change:scorediff:pt:^patient:qn:optimal||has_class
respiratory measures and ventilator management||expiratory gas flow.max^on ventilator:volume rate:to identify measures at a point in time:respiratory system.airway:quantitative||has_class
diagnostic ultrasonography, nos||fet thorax area diam prod der us||has_class
micro||deprecated streptococcus pneumoniae 19 igg ab [mass/volume] in serum||has_class
laboratory||imipramine:presence or threshold:to identify measures at a point in time:gastric fluid/contents:ordinal||has_class
infectiousdisease||tick mouth intact [identifier]||has_class
document ontology||va compensation and pension (c and p) examination genitourinary||has_class
science of genetics||f8 gene intron 1 inversion targeted mutation analysis in amniotic fluid or chorionic villus sample by molecular genetics method||has_class
lab||calcitonin:mass concentration:to identify measures at a point in time:body fluid, unsp:quantitative||has_class
microbiology (lab test)||hiv 2 ab ib ql (s)||has_class
body system, cardiovascular||lv sv us.2d+calc||has_class
survey||mother's most recent treponemal test type [cdc.cs]||has_class
survey.promis||my child was too tired to eat in past 7d:find:7d:^patient:ord:promis.parentproxy||has_class
infectiousdisease||streptococcus pneumoniae danish serotype 19b igg ab [mass/volume] in serum||has_class
consensus measures for phenotypes and exposures||tap right foot - 10 times [phenx]||has_class
chemistry and chemistry challenge||glucose 1.5h p 50 g lac po serpl-mcnc||has_class
urology (qualifier value)||carnitine free smn-scnc||has_class
clinical nec (not elsewhere classified in lnc)||ao.sinotub junc es diameter 2d us||has_class
circulatory system||note:finding:to identify measures at a point in time:{setting}:document:thoracic and cardiac surgery.attending||has_class
dental||second bone reference:anat:pt:{dental arch}:nom||has_class
infectiousdisease||varicella zoster virus dna [presence] in cornea or conjunctiva by naa with probe detection||has_class
rad||rf guidance for placement of catheter in fallopian tube||has_class
chemistry and chemistry challenge||metanephrine and normetanephrine [interp]||has_class
chemistry and chemistry - challenge||chloride:mass concentration:to identify measures at a point in time:body fluid, unsp:quantitative||has_class
centers for medicare & medicaid services set||mds v3.0 - rai v1.16.1 - nursing home omra-discharge (nod) & swing bed omra-discharge (sod) item set:-:to identify measures at a point in time:^patient:-:cms assessment||has_class
lab||hemoglobin n - baltimore elph ph 6.3 ql (bld)||has_class
chemistry test||proline [presence] in serum or plasma||has_class
microbiology (lab test)||streptococcus agalactiae ag:prthr:pt:xxx:ord:la||has_class
ergotherapy||responsible attending physicican information:cmplx:pt:occupational therapy treatment plan:set||has_class
phenx||did some of these thoughts seem to you to be unreasonable [cidi-sf]||has_class
laboratory services||carcinoembryonic ag qn||has_class
clin||length of laps:len:pt:^patient:qn:phenx||has_class
neurology (field)||herpes simplex virus 1+2 ab.igm:acnc:pt:csf:qn||has_class
laboratory services||psilocybin/psilocin [mass ratio]||has_class
microbiology nos||neisseria meningitidis serogroup w135 syng gene:threshnum:pt:xxx:qn:probe.amp.tar||has_class
ge - gastroenterology||giardia lamblia ag & cryptosporidium parvum ag & entamoeba histolytica or dispar ag:prid:pt:stool:nom||has_class
infectiousdisease||bartonella henselae antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal||has_class
hem/bc||neutrophils:ncnc:pt:bld^control:qn:flow cytometry||has_class
healthcare effectiveness data information set order set||hedis 2014-19 ser creat||has_class
loinc document ontology||admission evaluation note:find:pt:{setting}:doc:social worker||has_class
disorder due to allergic reaction||cockspur ige ab rast class [presence] in serum||has_class
diagnostic service sources microbiology||eastern equine encephalitis virus ab.igm:prthr:pt:csf:ord:ia||has_class
chemistry test||albumin 24h ur elph-mrate||has_class
laboratories||epstein barr virus nuclear igg ab [titer] in cerebral spinal fluid||has_class
microbiology and antimicrobial susceptibility||sars-cov urbani rna naa+probe ql (stl)||has_class
cell markers||cd4+cd7-cd49d- cells/100 cells in body fluid||has_class
laboratory services||cefpodoxime [susceptibility] by minimum lethal concentration (mlc)||has_class
laboratory (environment)||little k ab ql (s/p bpu)||has_class
orthopedic surgery||multisection^wo & w contrast intravenous:finding:to identify measures at a point in time:lower extremity>foot:document:computed tomography||has_class
clinical nec||heel-shin - r||has_class
laboratories||tube # pcar||has_class
section 3-1 blood coagulation procedures||heparin ab:prthr:pt:ppp:ord:platelet aggr||has_class
cellmark||cd2+cd26+ cells # bld||has_class
chemistry and chemistry - challenge||bilirubin.direct [presence] in serum or plasma||has_class
laboratory||glycine/total aa (dbs) [molar fraction]||has_class
hem/bc||prolymphocytes:prthr:pt:bld:ord||has_class
microbiology and antimicrobial susceptibility||hsv1 igg fld-acnc||has_class
panel.survey.wellrx||wellrx questionnaire - revised:-:pt:^patient:-:wellrx||has_class
clinical nec||resp contra to elev head of bed >30 deg||has_class
bldbk||plasma units available:number:to identify measures at a point in time:^bpu:quantitative||has_class
drug/tox||methcathinone [presence] in urine by screen method||has_class
general health survey||difficult times have strengthened my faith or spiritual beliefs in the past 7d:finding:7 days:^patient:ordinal:facit||has_class
panel.hedis||hedis 2015-2020 value set - hba1c tests||has_class
microbiology and antimicrobial susceptibility||streptococcus pneumoniae danish serotype 9n antibody.immunoglobulin g^1st specimen:mass concentration:to identify measures at a point in time:serum:quantitative||has_class
body measure||chest circumference at nipple line||has_class
hepatology (field)||hepatitis c virus 5-1-1 ab [presence] in serum||has_class
radiology studies||rf guided tendon inj||has_class
laboratory||ehrlichia canis+ewingii groel gene:prthr:pt:bld:ord:non-probe.amp.tar||has_class
orthopedics (profession)||multisection:find:pt:upper extremity>hand:doc:xr.tomography||has_class
clinical nec (not elsewhere classified in lnc)||hematology discharge sum||has_class
infectiousdisease||theileria equi antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immune fluorescence||has_class
laboratory (environment)||leu+ile dbs-mcnc||has_class
rheumatology||fodrin.alpha subunit ab.iga:acnc:pt:ser/plas:qn:ia||has_class
neuro||torch panel (csf)||has_class
clinical||contrib fact staff-related mersth||has_class
laboratory services||muscle sarcolemma antibody:dilution factor (titer):to identify measures at a point in time:pleural fluid (thoracentesis fld):quantitative:immune fluorescence||has_class
laboratory||b. burgdorferi igm ia qn (s)||has_class
lab||interferon.beta ab:titr:pt:ser/plas:qn||has_class
hematology (coagulation) and differential count||other cells/100 leukocytes in pericardial fluid by manual count||has_class
clinical nec||pulmonary hypertension [class]||has_class
drug levels & toxicology||promethazine [mass/volume] in urine||has_class
drug toxicology||thiazides cutoff screen (u) [mass/vol]||has_class
questionnaire or interview||mds v3.0 - rai v1.14.1, v1.15.1, v1.16.1 - special treatments, procedures, and programs - no, so:-:to identify measures at a point in time:^patient:-:cms assessment||has_class
patient reported outcomes information system (promis)||it takes me longer than other people to get my school work done in past 4w - severity:finding:4 weeks:^patient:ordinal:promis.peds||has_class
lab||reticulocyte mean volume [entitic volume] in reticulocytes||has_class
laboratories||netilmicin islt kb||has_class
hepatology (qualifier value)||hepatitis b virus surface ab panel:-:pt:ser/plas:-||has_class
microbiology (procedure)||echinococcus sp ab.igg4:acnc:pt:ser:qn||has_class
hypersensitivity reaction (nos)||carageenan ab.ige.rast class:prthr:pt:ser:ord||has_class
microbiology tests||leptospira sp igg ia qn (s)||has_class
general health survey||i feel uncertain about my future health in the past 7 days [facit]||has_class
ultrasound diagnostic procedure||pulmonic valve maximum blood flow velocity by us.doppler||has_class
rheumatology (qualifier value)||nuclear ab [titer] in synovial fluid||has_class
orthopedic||views ap internal rotation + ap external rotation + axillary:find:pt:upper extremity.left>shoulder:doc:xr||has_class
laboratory services||halazepam:mcnc:pt:ser/plas:qn||has_class
clinical nec (not elsewhere classified in lnc)||views for fistula:finding:to identify measures at a point in time:abdomen+pelvis>gastrointestinal tract:document:radiofluoroscopy||has_class
cardiology (qualifier value)||pulmonic valve vena contracta diameter by us.doppler||has_class
chemical procedure, nos||beta galactosidase [enzymatic activity/volume] in dbs||has_class
general behavioral health / psychiatry||substances that have caused you to fail to do what was normally expected of you during the past 3 months [nida]||has_class
clinical nec (not elsewhere classified in lnc)||fluid output.gastric tube:vrat:1h:upper gi tract:qn||has_class
laboratory||c trach ab sp2 ser-acnc||has_class
microbiology (lab test)||fluav h7 rna spec ql naa+probe||has_class
vital signs (function)||oxygen saturation:mfr:pt:heart.ventricle.right:qn||has_class
infectiousdisease||lumpy skin disease virus deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:not specified:ordinal:restriction fragment length polymorphism||has_class
laboratory services||vendor software version:identifier:to identify measures at a point in time:weighing device:nominal||has_class
vital signs (function)||splenic artery mean blood pressure||has_class
body system, endocrine/metabolic||thyroxine.free:substance concentration:to identify measures at a point in time:serum/plasma:quantitative:dialysis||has_class
laboratory services||homocitrulline:scnc:pt:amnio fld:qn||has_class
radiology||nm knee - bilateral views||has_class
laboratories||herpes simplex virus 1 & 2 & varicella zoster virus deoxyribonucleic acid panel:-:to identify measures at a point in time:cerebral spinal fluid:-:probe.amp.tar||has_class
eye.refraction||horizontal prism.in far:invlen:pt:eye.right:qn:phoropter||has_class
laboratories||european tick borne encephalitis virus igg ab [presence] in cerebral spinal fluid by immunoassay||has_class
consensus measures for phenotypes and exposures||in the past year, have you been treated with antibiotics for a chest illness [phenx]||has_class
laboratories||zinc phosphide gicnt-mcnt||has_class
lab||lamotrigine [mass/volume] in urine by confirmatory method||has_class
microbiology (as purpose of biopsy)||fungus spec cult org #5||has_class
clinical nec (not elsewhere classified in lnc)||deprecated fractional oxyhemoglobin by pulse oximetry --post treatment||has_class
survey instrument||current level of confidence i can get in and out of bed without falling:find:pt:^patient:ord:promis||has_class
clinical nec||stroke volume:vol:pt:heart.ventricle.right:qn:us.2d.tricuspid valve.calculated||has_class
fetal us scan||fet bpd from ga.rempen91||has_class
microbiology and antimicrobial susceptibility||chikv ab neut test (specimen) [titer]||has_class
general microbiology procedures||t. annulata ab qn (s)||has_class
microbiology procedures||pneumocystis jiroveci ag:prthr:pt:thrt:ord:if||has_class
infectiousdisease||streptomycin 4.0 ug/ml:susc:pt:isolate:ordqn:method for slow-growing mycobacteria||has_class
radiology test||multisection^w radionuclide intravenous:finding:to identify measures at a point in time:chest>lung:document:pt||has_class
test;microbiology||salmonella sp ab [units/volume] in serum||has_class
mutation gene||flna gene targeted mutation analysis molgen doc (bld/tiss)||has_class
body system, cardiovascular||intravascular diastolic:pres:pt:inferior mesenteric artery:qn||has_class
clinical nec (not elsewhere classified in lnc)||can pronounce viscous [nih toolbox]||has_class
cell markers||cells.cd3-cd57+/100 cells:number fraction:to identify measures at a point in time:body fluid, unsp:quantitative||has_class
drug levels & toxicology||vedolizumab ia [mass/vol]||has_class
genetics||chr 13+18+21+x+y aneup amn/cvs fish||has_class
4||putting on and taking off footwear - most dependent performance during the past mo:find:1mo:^patient:ord:cms assessment||has_class
hematology and cell counts||hemoglobin f [units/volume] in blood by electrophoresis||has_class
laboratory (environment)||venlafaxine [mass/volume] in body fluid||has_class
radiology test||xr knee-r ap||has_class
infectiousdisease||chlamydia sp antigen:presence or threshold:to identify measures at a point in time:urine:ordinal:immunoassay||has_class
blood bank tests||d nos ab ql||has_class
microbiology and antimicrobial susceptibility||bordetella pertussis igm ab [presence] in serum||has_class
skin challenge tests||tuberculosis reaction wheal^3d post 5 tu id:diam:pt:skin:qn||has_class
chemistry and chemistry - challenge||glutaric acidemia 2/ethylmalonic encephalopathy (dbs) [interp]||has_class
laboratories||tha 24h ur-scnc||has_class
cv panels||framingham risk assess||has_class
allergic reaction nos (disorder)||plum ige ab/ige total in serum||has_class
laboratory||tpmt activity in rbc by production of 6-mmp riboside||has_class
microbiology and antimicrobial susceptibility||histoplasma capsulatum m ab [presence] in serum by immune diffusion (id)||has_class
infectiousdisease||parainfluenza virus 2 ab [titer] in serum||has_class
bldbk.genotyping||jk^b antigen inferred phenotype:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||has_class
microbiology procedure, nos||influenza virus a neuraminidase rna [type] in specimen by sequencing||has_class
laboratory (environment)||aspergillus sp dna naa+probe ql (tiss)||has_class
infectiousdisease||y entero o:5 ab ser ql||has_class
chemistry and chemistry - challenge||aldosterone:sub:xxx:urine:qn||has_class
biomedical device (physical object)||alert priority:type:pt:infusion pump:nom||has_class
section 3-5 microbiology procedures||toxoplasma sp antibody.immunoglobulin m:dilution factor (titer):to identify measures at a point in time:serum:quantitative||has_class
infectiousdisease||toxocara canis ab.igg:prthr:pt:ser:ord:ia||has_class
chemistry and chemistry - challenge||d- & l-2-hydroxyglutarate pattern:impression/interpretation of study:to identify measures at a point in time:cerebral spinal fluid:narrative||has_class
infectiousdisease||deprecated s typhi d ab ser ql||has_class
infectiousdisease||rinderpest virus antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immunoassay||has_class
orthopaedics||mr ankle and foot||has_class
med pulm||frc pre bd||has_class
chemistry and chemistry - challenge||trypsin^1st specimen post dose sincalide:catalytic concentration:to identify measures at a point in time:body fluid, unsp:quantitative||has_class
laboratory||listeria sp antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||has_class
end stage renal disease (esrd) survey||dialysis facility npi:identifier:point in time:facility:nominal||has_class
pulmonary ventilator management||no2 during insp vfr/ppres gas ds.il||has_class
lab||purkinje cells antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immune blot||has_class
drug/tox||lysergate diethylamide ql||has_class
microbiology and antimicrobial susceptibility||cryptoc ab ser ql if||has_class
microbiology and antimicrobial susceptibility||hcv ab signal/cutoff (body fld) [rel units/vol]||has_class
neuro||cd4+cd7-cd26- cells/100 cells in cerebral spinal fluid||has_class
neurology||h. influenzae c ag if ql (csf)||has_class
document ontology||cmplx med cond action plan||has_class
infectiousdisease||francisella tularensis antibody.immunoglobulin a:dilution factor (titer):to identify measures at a point in time:serum:quantitative||has_class
chemical procedure (procedure)||disaccharidases panel (small intestine tissue)||has_class
lab||rai1 17p11.2 del+dup bld/t fish||has_class
questionnaire or interview||walking 10 feet on uneven surfaces - functional ability:find:pt:^patient:ord:cms assessment||has_class
laboratory||glucose^7th specimen post xxx challenge:scnc:pt:ser/plas:qn||has_class
cardiology (qualifier value)||stroke volume:vol:pt:heart.ventricle.left:qn:us.2d+calculated by bullet method||has_class
physical assessment findings||area of identified wound bed appearance/area of wound bed of wound base||has_class
clin||date of end of pregnancy:date:to identify measures at a point in time:^patient:quantitative:phenx||has_class
phenx (procedure)||how many years in total did you take premarin - exclude those periods when you temporarily stopped [ca teachers]||has_class
lab||nickel [mass/time] in 24 hour stool||has_class
4||promis short form - upper extremity 7a - version 2.0||has_class
refraction of eye, function (observable entity)||sphere:invlen:pt:eye.right:qn:autorefractor.auto||has_class
lab||porcine reproductive and respiratory syndrome virus orf5 gene sequence homology to lelystad:nfr:pt:isolate:qn:sequencing||has_class
laboratory services||mars2 gene full mutation analysis sequencing nom (bld/tiss)||has_class
survey instruments||drug abuse screening test-10:-:12 months:^patient:-:dast-10||has_class
microbiology and antimicrobial susceptibility||hhv 6b dna serpl ql naa+probe||has_class
panel.survey.gnhlth||pediatric - functional assessment of anorexia cachexia - child questionnaire - version 1:-:to identify measures at a point in time:^patient:-:facit||has_class
surveys||nutritional approaches during last 7d - while a resident:find:7d:^patient:nom:cms assessment||has_class
chal||glucagon [mass/volume] in serum or plasma --1.5 hours post meal||has_class
deprecated streptococcus pneumoniae u.s. serotypes||streptococcus pneumoniae 8 ab.igg^2nd specimen/1st specimen:ratio:pt:ser:qn||has_class
hl7 cytogenetics panels||chromosome analysis.metaphase panel:-:pt:amnio fld:-:fish||has_class
drug levels & toxicology||palladium hair-mcnt||has_class
patient reported outcomes measurement system (promis) survey||are you able to turn a key to unlock a door:find:pt:^patient:ord:promis||has_class
chemistry and chemistry challenge||glucose 3h p glc serpl-mcnc||has_class
pneumol||xr chest r-obl||has_class
document ontology||transfer summary note:finding:to identify measures at a point in time:{setting}:document:pediatrics||has_class
clinical nec||po2 aveolus calc||has_class
chemistry measurement||t-cell receptor excision circle:z score:to identify measures at a point in time:dried blood spot:quantitative||has_class
microbiology (lab test)||htlv ii ab ql (csf)||has_class
laboratory services||middle east respiratory syndrome coronavirus ribonucleic acid:presence or threshold:to identify measures at a point in time:respiratory.lower:ordinal:probe.amp.tar||has_class
pathology studies||extent of inferior margin carcinoma involvement lm ql (breast cancer specimen)||has_class
laboratories||cyanocobalamin.po (dose) [mass]||has_class
clinical nec (not elsewhere classified in lnc)||base curve 2:length:to identify measures at a point in time:cornea.left:quantitative:keratometry||has_class
lab||proinsulin:mcnc:pt:ser/plas:qn||has_class
molecular pathology tests||mlycd gene deletion+duplication & full mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||has_class
microbiology and antimicrobial susceptibility||vancomycin:susc:pt:isolate:ord:genotyping||has_class
lab||tree allerg mix3 ige ql||has_class
chemistry and chemistry - challenge||glutamine+histidine csf-scnc||has_class
ultrasound procedure, nos||fet abd circum from ga.hadlock 1984||has_class
gene alteration||npm1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal||has_class
chemistry and chemistry - challenge||metanephrine & normetanephrine:impression/interpretation of study:point in time:serum/plasma:narrative||has_class
laboratory (environment)||hgb blda oximetry-mcnc||has_class
organ system, cardiovascular||rfa guided vein cvc rem--w contr iv||has_class
laboratory (environment)||sulfate [mass/volume] in urine||has_class
laboratory (environment)||helminth+arthropod identified:presence or identity:to identify measures at a point in time:not specified:nominal||has_class
loinc document ontology||orthopaedic surgery outpatient note||has_class
survey.gnhlth||i have trouble getting myself dressed in the past 7d:find:7d:^patient:ord:facit||has_class
molecular pathology tests||bche gene targeted mutation analysis:presence or identity:to identify measures at a point in time:whole blood/tissue, unspecified:nominal:molecular genetics||has_class
infectiousdisease||human immunodeficiency virus 1 p32 antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immune blot||has_class
4||adl & ials:-:point in time:^patient:-||has_class
oncology||left pelvic lymph nodes positive [#] in specimen||has_class
clin||spinal cord injury medicine outpatient annual evaluation note||has_class
microbiology and antimicrobial susceptibility||equine infectious anemia virus ag if ql (specimen)||has_class
antimicrobial susceptibility||talampicillin mlc [susc]||has_class
lab||c0 (u) [moles/vol]||has_class
phenx (procedure)||anxiety going to school scared-r||has_class
laboratory||sdhd gene targeted mutation analysis:prid:pt:bld/tiss:nom:molgen||has_class
laboratory||nevirapine:susceptibility:to identify measures at a point in time:isolate:ordinal:genotyping||has_class
drug levels & toxicology||hydromorphone/creatinine (u) [mass ratio]||has_class
chemistry and chemistry challenge||catechols plas-mcnc||has_class
survey instrument||catchment area panel [nmmds] population||has_class
drug levels & toxicology||zaleplon/creatinine confirm (u) [mass ratio]||has_class
survey.oasis||regimen change in past 14d - icd code ^^^4:prid:14d:^patient:nom:oasis||has_class
infectiousdisease||borrelia burgdorferi ab.igg:acnc:pt:body fld:qn||has_class
laboratory services||jwh-073 butanoate bld ql||has_class
infectiousdisease||s. pneumoniae ag la ql (isol)||has_class
laboratory (environment)||ena ss-a 60kd ab fld ql||has_class
microbiology and antimicrobial susceptibility||trichomonas sp identified:prid:pt:xxx:nom:organism specific culture||has_class
chemistry and chemistry - challenge||pyridinoline/creatinine (u) [molar ratio]||has_class
infectiousdisease||ascaris sp igg ia ql (s)||has_class
chemistry and chemistry challenge||3-hydroxydodecanoate.free:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
cvs - cardiovascular system||view ap lateral-decubitus:find:pt:chest:doc:xr||has_class
clinical chemistry test||xanthopterin [moles/volume] in serum or plasma||has_class
emergency (deeds)||name:person name:to identify measures at a point in time:^emergency contact:nominal||has_class
section 3-5 microbiology procedures||chikungunya virus ab.igm and igg panel - serum or plasma||has_class
drug levels and toxicology||o-nortramadol ql (u)||has_class
laboratory (environment)||c. fetus ag if ql (genital fluid)||has_class
admin||transferred from facility||has_class
laboratory services||clorazepate:mass:point in time:dose med or substance:quantitative||has_class
obstetrics and gynecology (qualifier value)||pregnancy status:find:pt:^patient:nom:reported||has_class
infectiousdisease||n men sg a+y ag spec ql||has_class
radiology test||multisection gated+ejection fraction^at rest+w stress+w radionuclide iv:find:pt:chest>heart:doc:nm.spect||has_class
immune hypersensitivity disorder (disorder)||egg yolk ige ab [units/volume] in serum||has_class
microbiology procedure||brucella sp ab spec 1 ql (s)||has_class
hl7 genetics panels||dna region of interest panel||has_class
blood coagulation test||beta 2 glycoprotein 1 igg and igm panel (s)||has_class
clinical||have you been very upset about having these symptoms [phenx]||has_class
laboratory||salicylazosulfapyridine (s) [mass/vol]||has_class
laboratories||prion protein.abnormal:prthr:pt:tiss:ord:ib||has_class
chemistry and chemistry - challenge||protoporphyrin [mass/time] in 24 hour stool||has_class
cardiology (qualifier value)||st wave displacement.end.lead avl:electrical potential (voltage):to identify measures at a point in time:heart:quantitative:ekg||has_class
hematology and cell counts||polymorphonuclear cells/leukocytes:nfr.df:pt:periton fld:qn:manual count||has_class
section 3-5 microbiology procedures||measles virus ag [presence] in throat||has_class
sensitivities||virginiamycin [susceptibility]||has_class
genetics (field)||gba gene targeted mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||has_class
nephrology (qualifier value)||hippurate crystals:naric:pt:urine sed:qn:microscopy.light.hpf||has_class
chemistry and chemistry - challenge||calcium:substance rate:1 hour:urine:quantitative||has_class
laboratory services||cortisol [moles/volume] in saliva (oral fluid) --15 minutes post 1 ug/kg crh iv||has_class
microbiology and antimicrobial susceptibility||muv ab qn (csf)||has_class
laboratory (environment)||alpha2 glob mfr dial fld elph||has_class
reference document||fda insert pharmacogenomics||has_class
rad||xr chest r-obl+l-obl upr||has_class
lab||fibroblast growth factor 23.intact^6th specimen post xxx challenge:mass concentration:to identify measures at a point in time:plasma:quantitative:immunoassay||has_class
hematology and cell counts||platelets:number concentration (count/vol):to identify measures at a point in time:plasma:quantitative||has_class
laboratory services||propylthiouracil:mass concentration:to identify measures at a point in time:urine:quantitative||has_class
serology||hubf ab ser ql if||has_class
unlisted microbiology procedure||trichinella spiralis dna [presence] in tissue by naa with probe detection||has_class
clinical nec||vaccine doses distributed||has_class
clinical||surgery phone note||has_class
minimum data set (mds) for nursing home resident assessment and care screening||can recall current season:find:pt:^patient:ord:mds||has_class
drug levels & toxicology||sulfadiazine bld-mcnc||has_class
lab||tricyclic antidepressants:prthr:pt:urine:ord||has_class
microbiology procedure, nos||chlamydia trachomatis rrna [presence] in throat by naa with probe detection||has_class
laboratory (environment)||glucose 30m p 50 g lac po ur ql strip||has_class
laboratories||epithelial cells.renal [#/volume] in urine by computer assisted method||has_class
antimicrobial susceptibility - finding||amphotericin b:titr:pt:isolate+ser:qn:sbt||has_class
chemistry and chemistry challenge||cytokeratin 19 (pericard fld) [mass/vol]||has_class
microbiology and antimicrobial susceptibility||hsv1 dna spec ql naa+probe||has_class
survey instrument||walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4w:finding:4 weeks:^patient:ordinal:saq||has_class
lab||growth phase [type] in skin melanoma by light microscopy||has_class
clin||psychiatry procedure note||has_class
molpath||karyotyp tiss fetus||has_class
chemical test, nos||sodium:scnc:pt:vitr fld:qn||has_class
lab||aesculus hippocastanum ab.ige:prthr:pt:ser:ord||has_class
laboratory (environment)||beta-n-acetylhexosaminidase.a:prthr:pt:tiss:ord||has_class
microbiology and antimicrobial susceptibility||zika virus antibody.neut:presence or threshold:to identify measures at a point in time:not specified:ordinal:virus neutralization||has_class
clinical nec (not elsewhere classified in lnc)||first degree burn area/body surface area:ararea:pt:^patient:qn:estimated||has_class
laboratory (environment)||beryllium (bld) [mass/vol]||has_class
clin||guidance additional for aspiration of cyst:find:pt:breast.left:doc:mg||has_class
microbiology and antimicrobial susceptibility||bacteria csf cult||has_class
nephrology- a specialty area of medicine||gran casts #/area urns lpf||has_class
nephrol||erythrocyte clumps:presence or threshold:to identify measures at a point in time:urine sediment:ordinal:microscopy.light||has_class
allergy/allergic reaction nos||deprecated mint ige ab [units/volume] in serum||has_class
laboratories||hna 1b/1b ab ser ql ia||has_class
deprecated streptococcus pneumoniae u.s. serotypes||streptococcus pneumoniae 4 antibody^1st specimen:mass concentration:to identify measures at a point in time:serum:quantitative||has_class
laboratory||chek2 gene c.470c>t and 1100delc molgen nom (bld/tiss)||has_class
microbiology and antimicrobial susceptibility||herpes simplex virus 1 igg ab [units/volume] in serum||has_class
microbiology and antimicrobial susceptibility||entamoeba histolytica ag [units/volume] in serum||has_class
consensus measures for phenotypes and exposures (phenx)||has your child ever woken up screaming during the night:finding:to identify measures at a point in time:^patient:ordinal:phenx||has_class
oncologic||age and site and morphology override flag cancer case||has_class
radiology studies||views ge 3:find:pt:upper extremity.right>thumb:doc:xr||has_class
microbiology test (procedure)||parainfluenza virus ab:acnc:pt:ser:qn||has_class
microbiology procedure||jamestown canyon virus rna [units/volume] (viral load) in specimen by naa with probe detection||has_class
chemistry and chemistry - challenge||urate [mass/volume] in 2 hour urine||has_class
deprecated streptococcus pneumoniae u.s. serotypes||streptococcus pneumoniae 4 antibody.immunoglobulin g^1st specimen:mass concentration:to identify measures at a point in time:serum:quantitative||has_class
chemistry and chemistry - challenge||ph^^adjusted to patient's actual temperature:log substance concentration:to identify measures at a point in time:bldcov:quantitative||has_class
us||gestational age:time:to identify measures at a point in time:^fetus:quantitative:ultrasound+estimated from gsl.hansmann 1979||has_class
gynaecology obstetric||body weight:mass:pt:^fetus:qn:us+estimated from ac&fl&hc.ott 1986||has_class
clinical||tidal volume inspired spontaneous+mechanical measured --on ventilator||has_class
infectiousdisease||metronidazole titr sbt||has_class
microbiology nos||pseudorabies virus g1 gene del ab ql (s)||has_class
allergic reaction, nos||european house dust mite ige ab rast class [presence] in serum||has_class
laboratories||food allerg mix20 ige rast ql||has_class
chemical procedure (procedure)||galactokinase deficiency ql (dbs) [interp]||has_class
microbiology and antimicrobial susceptibility||foot and mouth disease virus antigen:presence or threshold:to identify measures at a point in time:throat:ordinal:immunoassay||has_class
drug toxicology||doxepin+nordoxepin:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||has_class
infectiousdisease||strongyloides sp ab:acnc:pt:ser:qn||has_class
structure of cardiovascular system, unspecified||bp mean--sup||has_class
laboratory||glucose 1h p glc serpl-imp||has_class
infectiousdisease||pcv1 dna ct spec qn naa+probe||has_class
survey||current level of confidence i can actively participate in decisions about my treatment:find:pt:^patient:ord:promis||has_class
infectiousdisease||{human immunodeficiency virus art medication} doses missed 2d ago:number:to identify measures at a point in time:^patient:quantitative:reported.actg||has_class
drug levels and toxicology||triazolam:mcnc:pt:body fld:qn:confirm||has_class
sections 3-4 cardiovascular system||multisection:finding:to identify measures at a point in time:upper extremity.left>upper extremity artery:document:ultrasound.doppler||has_class
clinical||xr cervical spine oblique and (lateral w flexion and w extension)||has_class
chal||somatotropin^10 pm specimen:acnc:pt:ser/plas:qn||has_class
laboratories||dog dander ab.ige.rast class:prthr:pt:ser:ord||has_class
laboratory||deprecated ganglioside gm1 igg ab [presence] in serum by immunoblot||has_class
chemical measurement, nos||sialate ql (u)||has_class
laboratory services||brucella sp antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified^fetus:ordinal:immune stain||has_class
laboratories||2,4-dichlorophenoxyacetate:mcnc:pt:urine:qn||has_class
drug levels & toxicology||imipenem:mcnc:pt:xxx:qn||has_class
infectiousdisease||eastern equine encephalitis virus rna [presence] in cerebral spinal fluid by probe||has_class
obstetrics gynaecology||body weight:mass:pt:^fetus:qn:estimated by palpation||has_class
drug levels & toxicology||chlordiazep cto ur cfm-mcnc||has_class
cellmark||cells.cd17/100 cells:number fraction:to identify measures at a point in time:whole blood:quantitative||has_class
microbiology and antimicrobial susceptibility||vibrio cholerae toxin ctxa gene [presence] in stool by naa with probe detection||has_class
laboratory (environment)||ph vag strip||has_class
radiology studies||rfa brachial artery views w contrast ia||has_class
chemistry test||amylase sal-ccnc||has_class
laboratory||red beet ige ab [units/volume] in serum||has_class
lab||bordetella parapertussis is1001 dna:prthr:pt:respiratory.lower:ord:non-probe.amp.tar||has_class
laboratory services||alprazolam:prthr:pt:gast fld:ord||has_class
infectiousdisease||virginiamycin [susceptibility] by gradient strip||has_class
infectiousdisease||pivampicillin [susceptibility] by disk diffusion (kb)||has_class
hypersensitivity symptom||acarus siro antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||has_class
medical and surgical @ central nervous system and cranial nerves @ repair @ optic nerve @ percutaneous @ no device @ no qualifier||repair optic nerve, percutaneous approach||has_expanded_form
drainage of splenic vein with drainage device, open approach||drainage of splenic vein with drainage device, open approach||has_expanded_form
ptbp2 gene||polypyrimidine tract binding protein 2||has_expanded_form
poisoning by aminoglycosides, undetermined, subsequent encounter||poisoning by aminoglycosides, undetermined, subsequent encounter||has_expanded_form
dilation of celiac artery with 3 drug-elut, open approach||dilation of celiac artery with 3 drug-elut, open approach||has_expanded_form
dilation of carina, percutaneous approach||dilation of carina, percutaneous approach||has_expanded_form
medical and surgical @ subcutaneous tissue and fascia @ destruction @ subcutaneous tissue and fascia, left foot @ open @ no device @ no qualifier||destruction of left foot subcutaneous tissue and fascia, open approach||has_expanded_form
potassium channel tetramerization domain containing 11||c17orf36||has_expanded_form
bypass transverse colon to rectum with nonautologous tissue substitute, open approach||bypass transverse colon to rectum with nonautologous tissue substitute, open approach||has_expanded_form
nondisp fx of prox phalanx of r less toe(s), 7thd||nondisplaced fracture of proximal phalanx of right lesser toe(s), subsequent encounter for fracture with routine healing||has_expanded_form
imaging @ endocrine system @ magnetic resonance imaging (mri) @ thyroid gland @ other contrast @ none @ none||mri of thyroid gland using oth contrast||has_expanded_form
medical and surgical @ gastrointestinal system @ bypass @ esophagus, middle @ open @ no device @ jejunum||bypass middle esophagus to jejunum, open approach||has_expanded_form
displaced comminuted fracture of shaft of left femur, subsequent encounter for open fracture type iiia, iiib, or iiic with malunion||displaced comminuted fracture of shaft of left femur, subsequent encounter for open fracture type iiia, iiib, or iiic with malunion||has_expanded_form
[d]epigastric pain (context-dependent category)||[d]epigastric pain (context-dependent category)||has_expanded_form
views^w contrast intra-arterial:finding:to identify measures at a point in time:pelvis>pelvis arteries:document:radiofluoroscopy.angio||views^w contrast ia:find:pt:pelvis>pelvis arteries:doc:rf.angio||has_expanded_form
nrv cndj test 7-8 studies||nerve transmission studies, 7-8 studies||has_expanded_form
medical and surgical @ endocrine system @ destruction @ adrenal gland, left @ open @ no device @ no qualifier||medical and surgical @ endocrine system @ destruction @ adrenal gland, left @ open @ no device @ no qualifier||has_expanded_form
malignant neoplasm of scapula and long bones of unspecified upper limb||malig neoplasm of scapula and long bones of unsp upper limb||has_expanded_form
ultrasonography of lumbar spine (procedure)||ultrasonography of lumbar spine||has_expanded_form
drainage of lower tooth, open approach, multiple||medical and surgical @ mouth and throat @ drainage @ lower tooth @ open @ no device @ multiple||has_expanded_form
lyssa||lyssa||has_expanded_form
drainage of left renal artery with drain dev, perc approach||medical and surgical @ lower arteries @ drainage @ renal artery, left @ percutaneous @ drainage device @ no qualifier||has_expanded_form
replace buttock skin w nonaut sub, part thick, extern||replacement of buttock skin with nonautologous tissue substitute, partial thickness, external approach||has_expanded_form
acute epiglottitis and supraglottitis (disorder)||acute epiglottitis nos||has_expanded_form
t cell receptor beta variable 12-5||trbv12-5||has_expanded_form
acquired atrophy of left ovary and fallopian tube||acquired atrophy of left ovary and fallopian tube||has_expanded_form
medical and surgical @ head and facial bones @ release @ ethmoid bone, right @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ head and facial bones @ release @ ethmoid bone, right @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
drainage of tibial nerve, open approach||drainage of tibial nerve, open approach||has_expanded_form
antisperm antibodies test||antisperm antibodies test (immunobead)||has_expanded_form
bypass right external iliac artery to left external iliac artery with autologous venous tissue, percutaneous endoscopic approach||medical and surgical @ lower arteries @ bypass @ external iliac artery, right @ percutaneous endoscopic @ autologous venous tissue @ external iliac artery, left||has_expanded_form
lead-induced chronic gout, unspecified wrist, with tophus||lead-induced chronic gout, unspecified wrist, with tophus (tophi)||has_expanded_form
chorionic gonadotropin beta subunit 8||chorionic gonadotropin subunit beta 8||has_expanded_form
d ag:prthr:pt:rbc^donor:ord||d ag rbc donr ql||has_expanded_form
drug screen quantitative everolimus||everolimus||has_expanded_form
medical and surgical @ muscles @ excision @ abdomen muscle, right @ percutaneous @ no device @ no qualifier||medical and surgical @ muscles @ excision @ abdomen muscle, right @ percutaneous @ no device @ no qualifier||has_expanded_form
division of right upper arm muscle, perc endo approach||division of right upper arm muscle, perc endo approach||has_expanded_form
puncture wound without foreign body of pharynx and cervical esophagus, sequela||puncture wound without foreign body of pharynx and cervical esophagus, sequela||has_expanded_form
medical and surgical @ lower joints @ fusion @ tarsal joint, left @ percutaneous @ nonautologous tissue substitute @ no qualifier||fusion of left tarsal joint with nonautologous tissue substitute, percutaneous approach||has_expanded_form
release urethra, via natural or artificial opening||release urethra, via natural or artificial opening||has_expanded_form
restriction of head lymph with extralum dev, open approach||restriction of head lymphatic with extraluminal device, open approach||has_expanded_form
inpatient consultation||inpatient consultation||has_expanded_form
salter-harris type ii physeal fracture of phalanx of right toe, sequela||salter-harris type ii physeal fracture of phalanx of right toe, sequela||has_expanded_form
rickettsia typhus group and rickettsia spotted fever group acute and convalescent igg and igm panel - serum by immunofluorescence||rickettsia tg+sfg igg+igm pnl ser if||has_expanded_form
roundabout; nausea||motion sickness (finding)||has_expanded_form
excision of thoracic aorta, descending, open approach||excision of thoracic aorta, descending, open approach||has_expanded_form
group counseling note:find:pt:{setting}:doc:social worker||sw group counseling note||has_expanded_form
apta registry organization data panel:-:to identify measures at a point in time:organization:-:apta||apta registry organization data panel:-:to identify measures at a point in time:organization:-:apta||has_expanded_form
unspecified dislocation of right toe(s), initial encounter||unspecified dislocation of right toe(s), initial encounter||has_expanded_form
acetylcholinesterase:catalytic concentration:to identify measures at a point in time:not specified:quantitative||acetylcholinesterase (specimen) [catalytic activity/vol]||has_expanded_form
other specified diabetes mellitus with diabetic nephropathy||other specified diabetes mellitus with diabetic nephropathy||has_expanded_form
unspecified injury of thigh||unspecified injury of thigh||has_expanded_form
revision of intraluminal device in heart, open approach||medical and surgical @ heart and great vessels @ revision @ heart @ open @ intraluminal device @ no qualifier||has_expanded_form
rhytidectomy of neck with platysmal tightening (treatment)||rhytidectomy; neck with platysmal tightening (platysmal flap, p-flap)||has_expanded_form
bypass coronary artery, one artery from left internal mammary with autologous arterial tissue, open approach||bypass coronary artery, one artery from left internal mammary with autologous arterial tissue, open approach||has_expanded_form
gardnerella vaginalis rrna [presence] in genital specimen by probe||gardnerella vaginalis rrna [presence] in genital specimen by probe||has_expanded_form
no filt remov w/in 3mos plcm||no filt remov w/in 3mos plcm||has_expanded_form
octenoylcarnitine (c8:1) [moles/volume] in serum or plasma||octenoylcarnitine (c8:1) [moles/volume] in serum or plasma||has_expanded_form
revision of internal fixation device in right clavicle, percutaneous approach||revision of internal fixation device in right clavicle, percutaneous approach||has_expanded_form
syphilis complicating childbirth||syphilis complicating childbirth (diagnosis)||has_expanded_form
ba244n20.11||lcn1p2 gene||has_expanded_form
insertion of intramed fix into r tibia, perc endo approach||insertion of intramed fix into r tibia, perc endo approach||has_expanded_form
medical and surgical @ anatomical regions, upper extremities @ revision @ upper extremity, left @ percutaneous endoscopic @ autologous tissue substitute @ no qualifier||revision of autologous tissue substitute in left upper extremity, percutaneous endoscopic approach||has_expanded_form
intentional self-harm by hot tap water, initial encounter||intentional self-harm by hot tap water, initial encounter||has_expanded_form
tcl1-neighboring gene 1||tng1||has_expanded_form
replacement of left lower leg subcutaneous tissue and fascia with autologous tissue substitute, percutaneous approach||replacement of left lower leg subcutaneous tissue and fascia with autologous tissue substitute, percutaneous approach||has_expanded_form
removal of autologous tissue substitute from lumbar vertebral disc, open approach||medical and surgical @ lower joints @ removal @ lumbar vertebral disc @ open @ autologous tissue substitute @ no qualifier||has_expanded_form
medical and surgical @ lower joints @ revision @ sacroiliac joint, left @ open @ autologous tissue substitute @ no qualifier||medical and surgical @ lower joints @ revision @ sacroiliac joint, left @ open @ autologous tissue substitute @ no qualifier||has_expanded_form
faw||fasciolar white matter||has_expanded_form
tranylcypromine [mass/volume] in serum or plasma||tranylcypromine:mcnc:pt:ser/plas:qn||has_expanded_form
general transcription factor iiia pseudogene 3||general transcription factor iiia pseudogene 3||has_expanded_form
undef.xstng nfcltyw icd dx||undef.xstng nfcltyw icd dx||has_expanded_form
oxygen saturation:mfr:pt:coronary sinus:qn||sao2 % cs||has_expanded_form
medical and surgical @ head and facial bones @ supplement @ hyoid bone @ open @ synthetic substitute @ no qualifier||supplement hyoid bone with synthetic substitute, open approach||has_expanded_form
mra ivc||multisection:find:pt:abdomen>vena cava.inferior:doc:mr.angio||has_expanded_form
spermatogenesis associated 41 (non-protein coding)||spermatogenesis associated 41 (non-protein coding)||has_expanded_form
complete traumatic metacarpophalangeal amputation of right ring finger, subsequent encounter||complete traumatic mcp amputation of right ring finger, subs||has_expanded_form
drainage of left abdomen bursa and ligament, open approach, diagnostic||medical and surgical @ bursae and ligaments @ drainage @ abdomen bursa and ligament, left @ open @ no device @ diagnostic||has_expanded_form
unsp enterovirus as the cause of diseases classd elswhr||unspecified enterovirus as the cause of diseases classified elsewhere||has_expanded_form
nondisplaced comminuted fracture of shaft of left femur, subsequent encounter for open fracture type i or ii with routine healing||nondisp commnt fx shaft of l femr, 7the||has_expanded_form
cape/r115777/txt||capecitabine/docetaxel/tipifarnib||has_expanded_form
myosin, skeletal muscle, heavy chain||myhc-iib||has_expanded_form
vegetable fibers:presence or threshold:to identify measures at a point in time:stool:ordinal:microscopy.light||vegetable fibers stl ql micro||has_expanded_form
astn1 gene||astrotactin||has_expanded_form
rabies virus igg ab [presence] in specimen by immunofluorescence||rabies virus igg if ql (specimen)||has_expanded_form
computed tomographic (ct) colonography, diagnostic, including image postprocessing; without contrast material||ct colonography dx||has_expanded_form
medical and surgical @ upper arteries @ destruction @ external carotid artery, right @ percutaneous @ no device @ no qualifier||medical and surgical @ upper arteries @ destruction @ external carotid artery, right @ percutaneous @ no device @ no qualifier||has_expanded_form
deprecated neutrophil cytoplasmic antibody:arbitrary concentration:point in time:serum:quantitative||deprecated neutrophil cytoplasmic antibody:arbitrary concentration:point in time:serum:quantitative||has_expanded_form
injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela||injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela||has_expanded_form
alcoholic (laennec's) cirrhosis with ascites (diagnosis)||alcoholic (laennec's) cirrhosis with ascites (diagnosis)||has_expanded_form
medical and surgical @ gastrointestinal system @ restriction @ large intestine, right @ percutaneous @ no device @ no qualifier||medical and surgical @ gastrointestinal system @ restriction @ large intestine, right @ percutaneous @ no device @ no qualifier||has_expanded_form
cad measures grp||cad measures grp||has_expanded_form
replacement of right kidney pelvis with autologous tissue substitute, via natural or artificial opening||replacement of r kidney pelvis with autol sub, via opening||has_expanded_form
insert radioact elem in small intest, perc endo||insert radioact elem in small intest, perc endo||has_expanded_form
negative elongation factor polypeptide a||negative elongation factor complex member a gene||has_expanded_form
excision of r low leg tendon, perc endo approach, diagn||excision of right lower leg tendon, percutaneous endoscopic approach, diagnostic||has_expanded_form
chronic giant papillary conjunctivitis, unspecified eye||chronic giant papillary conjunctivitis, unspecified eye||has_expanded_form
occlusion bi vas deferens w intralum dev, open||occlusion bi vas deferens w intralum dev, open||has_expanded_form
urine ost pouch w bltinconv||ostomy pouch, urinary, with barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each||has_expanded_form
mt-nd5 pseudogene 23||mtnd5p23 gene||has_expanded_form
contusion of heart without hemopericardium, sequela||contusion of heart without hemopericardium, sequela||has_expanded_form
reattachment of left lung, open approach||reattachment of left lung, open approach||has_expanded_form
administration @ physiological systems and anatomical regions @ introduction @ pleural cavity @ percutaneous @ antineoplastic @ other antineoplastic||introduction of other antineoplastic into pleural cavity, percutaneous approach||has_expanded_form
laceration without foreign body of unspecified lesser toe(s) with damage to nail||laceration w/o fb of unsp lesser toe(s) w damage to nail||has_expanded_form
reposition left fibula with ring external fixation device, percutaneous endoscopic approach||reposition left fibula with ring external fixation device, percutaneous endoscopic approach||has_expanded_form
travel medical exam||exam;travel||has_expanded_form
endodontic overfill (diagnosis)||endodontic overfill||has_expanded_form
other injuries of lung, bilateral, subsequent encounter||other injuries of lung, bilateral, subsequent encounter||has_expanded_form
release vestibular gland, external approach||release vestibular gland, external approach||has_expanded_form
corrosion of first degree of left wrist, sequela||corrosion of first degree of left wrist, sequela||has_expanded_form
creutzfeldt-jakob disease, sporadic||scjd||has_expanded_form
pedal cycle driver injured in noncollision transport accident in traffic accident, initial encounter||pedal cycle driver injured in noncollision transport accident in traffic accident, initial encounter||has_expanded_form
ultrasonography of head and neck (procedure)||ultrasonography of head and neck (procedure)||has_expanded_form
statin not presc disch||statin not presc disch||has_expanded_form
calcium.ionized [moles/volume] in serum or plasma --6th specimen post xxx challenge||ca-i sp6 p chal serpl-scnc||has_expanded_form
retired procedure (procedure) [20535002]||venipuncture, cutdown; younger than age 1 year||has_expanded_form
lt-for-dates 2500+g||light-for-dates without mention of fetal malnutrition, 2.500+ grams||has_expanded_form
medical and surgical @ heart and great vessels @ bypass @ pulmonary artery, right @ open @ synthetic substitute @ innominate artery||bypass right pulmonary artery from innominate artery with synthetic substitute, open approach||has_expanded_form
war op w dest arcrft due to onboard fire, civilian, subs||war op w dest arcrft due to onboard fire, civilian, subs||has_expanded_form
release left carpometacarpal joint, open approach||medical and surgical @ upper joints @ release @ carpometacarpal joint, left @ open @ no device @ no qualifier||has_expanded_form
pentane:mcnc:pt:body fld:qn||pentane [mass/volume] in body fluid||has_expanded_form
fragmentation of right axillary vein, percutaneous approach||medical and surgical @ upper veins @ fragmentation @ axillary vein, right @ percutaneous @ no device @ no qualifier||has_expanded_form
laceration of lung, unilateral, subsequent encounter||laceration of lung, unilateral, subsequent encounter||has_expanded_form
removal of nonautologous tissue substitute from left patella, percutaneous endoscopic approach||medical and surgical @ lower bones @ removal @ patella, left @ percutaneous endoscopic @ nonautologous tissue substitute @ no qualifier||has_expanded_form
posterior subluxation of left ulnohumeral joint, sequela||posterior subluxation of left ulnohumeral joint, sequela||has_expanded_form
graellsia||graellsia grote, 1896||has_expanded_form
mycn protooncogene, bhlh transcription factor||mycn proto-oncogene, bhlh transcription factor gene||has_expanded_form
nondisplaced spiral fracture of shaft of left fibula, subsequent encounter for closed fracture with routine healing||nondisplaced spiral fracture of shaft of left fibula, subsequent encounter for closed fracture with routine healing||has_expanded_form
ultrasonography of bilateral kidneys||ultrasound scan of bilateral kidneys||has_expanded_form
fem1ap4 gene||fem-1 homolog a (c. elegans) pseudogene 4||has_expanded_form
revision of other device in head, external approach||revision of other device in head, external approach||has_expanded_form
r ret rnfl 4 o'clock thickness oct||retinal nerve fiber layer.clock hour 4 thickness:len:pt:retina.right:qn:oct||has_expanded_form
dehydrogenase/reductase 9||3-alpha hydroxysteroid dehydrogenase||has_expanded_form
unspecified injury of left renal artery, sequela||unspecified injury of left renal artery, sequela||has_expanded_form
cd117 ag immune stain ql (bld)||cd117 antigen:presence or threshold:to identify measures at a point in time:whole blood:ordinal:immune stain||has_expanded_form
mh clubhouse svc, per diem||mental health clubhouse services, per diem||has_expanded_form
salter-harris type iii physeal fracture of lower end of ulna, unspecified arm||sltr-haris type iii physeal fx lower end of ulna, unsp arm||has_expanded_form
supplement left nipple with nonautologous tissue substitute, via natural or artificial opening||supplement left nipple with nonautologous tissue substitute, via natural or artificial opening||has_expanded_form
hmpv a+b l+n genes nph ql naa+probe||human metapneumovirus a+b l+n genes:presence or threshold:to identify measures at a point in time:naspopharynx:ordinal:probe.amp.tar||has_expanded_form
nav2-as1 gene||nav2-as1||has_expanded_form
bypass right popliteal artery to lower extremity vein with autologous venous tissue, percutaneous endoscopic approach||bypass r popl art to low ex vein w autol vn, perc endo||has_expanded_form
medical and surgical @ lower joints @ supplement @ sacroiliac joint, left @ open @ autologous tissue substitute @ no qualifier||supplement left sacroiliac joint with autologous tissue substitute, open approach||has_expanded_form
abi family, member 3||abi3 gene||has_expanded_form
familial multiple coagulation factor deficiency iv||multiple coagulation factor deficiency iv||has_expanded_form
closed dislocation of interphalangeal joint of hand||disl interphaln hand-cl||has_expanded_form
stress incontinence (& symptom)||incontinence stress||has_expanded_form
ct scan of thoracic aorta using intravasc optic cohere||imaging @ upper arteries @ computerized tomography (ct scan) @ thoracic aorta @ none @ intravascular optical coherence @ none||has_expanded_form
other physeal fracture of upper end of radius, left arm, initial encounter for closed fracture||oth physeal fracture of upper end of radius, left arm, init||has_expanded_form
toxic effect of carbon dioxide, undetermined, sequela||toxic effect of carbon dioxide, undetermined, sequela||has_expanded_form
deprecated social work team note||deprecated social work team note||has_expanded_form
bypass l int iliac art to low ex art w autol vn, perc endo||bypass l int iliac art to low ex art w autol vn, perc endo||has_expanded_form
leukemia, acute lymphoblastic, susceptibility to, 2||leukemia, acute lymphoblastic, susceptibility to, 2||has_expanded_form
rxfpr1||leucine-rich repeat-containing g protein-coupled receptor 7||has_expanded_form
revision of int fix in r tibia, perc endo approach||revision of int fix in r tibia, perc endo approach||has_expanded_form
extirpation of matter from left elbow joint, percutaneous endoscopic approach||medical and surgical @ upper joints @ extirpation @ elbow joint, left @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
imaging @ veins @ fluoroscopy @ superior vena cava @ low osmolar @ none @ none||imaging @ veins @ fluoroscopy @ superior vena cava @ low osmolar @ none @ none||has_expanded_form
hepatic regenerative stimulation substance||erv1, s. cerevisiae, homolog of||has_expanded_form
laceration without foreign body of back wall of thorax with penetration into thoracic cavity||laceration without foreign body of back wall of thorax with penetration into thoracic cavity||has_expanded_form
release hard palate, open approach||release hard palate, open approach||has_expanded_form
echinacea ige ab [units/volume] in serum||echinacea antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||has_expanded_form
medical and surgical @ tendons @ replacement @ upper leg tendon, right @ percutaneous endoscopic @ synthetic substitute @ no qualifier||replacement of right upper leg tendon with synthetic substitute, percutaneous endoscopic approach||has_expanded_form
hura brasiliensis/assacu||hura brasiliensis/assacu||has_expanded_form
c1orf61||mir9-1hg gene||has_expanded_form
hyperpth||hyperparathyroidism (diagnosis)||has_expanded_form
displaced fracture of medial condyle of right femur, subsequent encounter for closed fracture with malunion||displaced fracture of medial condyle of right femur, subsequent encounter for closed fracture with malunion||has_expanded_form
injection, cefotaxime sodium, per gm||injection, cefotaxime sodium, per gm||has_expanded_form
nondisplaced comminuted fracture of left patella, subsequent encounter for open fracture type iiia, iiib, or iiic with routine healing||nondisp commnt fx l patella, 7thf||has_expanded_form
plvc exam w/o pap smear ea.e||pelvic exam without pap smear each exam||has_expanded_form
removal of infusion dev from gallbladder, perc endo approach||removal of infusion dev from gallbladder, perc endo approach||has_expanded_form
drainage of left hand with drainage device, percutaneous approach||drainage of left hand with drainage device, perc approach||has_expanded_form
keratin 8 pseudogene 31||keratin 8 pseudogene 31||has_expanded_form
enfuvirtide islt phenotyp||enfuvirtide islt phenotyp||has_expanded_form
culcita||culcita||has_expanded_form
medical and surgical @ lymphatic and hemic systems @ supplement @ lymphatic, right axillary @ open @ synthetic substitute @ no qualifier||supplement r axilla lymph with synth sub, open approach||has_expanded_form
protein feed time:time stamp -- date and time:point in time:^patient:quantitative||protein feed time:tmstp:pt:^patient:qn||has_expanded_form
antipsychotics nos 7/more||antipsychotics not otherwise specified 7/more||has_expanded_form
isocitrate dehydrogenase 2||idh2 gene||has_expanded_form
mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (eg, hematoxylin and eosin, toluidine blue), head, neck, hands, feet, genitalia, or any location with surgery directly involving muscle, cartilage, bone, tendon, major nerves, or vessels; each additional stage after the first stage, up to 5 tissue blocks (list separately in addition to code for primary procedure)||mohs addl stage||has_expanded_form
chelidonium majus, homeopathic preparation||chelidonium majus / greater celandine / swallow wort||has_expanded_form
supplement radial nerve with synthetic substitute, percutaneous approach||supplement radial nerve with synthetic substitute, percutaneous approach||has_expanded_form
power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each||power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each||has_expanded_form
bypass r atrium to l pulm art with zooplastic, open approach||medical and surgical @ heart and great vessels @ bypass @ atrium, right @ open @ zooplastic tissue @ pulmonary artery, left||has_expanded_form
extirpation of matter from lumbar vertebra, percutaneous approach||extirpation of matter from lumbar vertebra, perc approach||has_expanded_form
displaced fracture of proximal phalanx of right middle finger, subsequent encounter for fracture with delayed healing||displaced fracture of proximal phalanx of right middle finger, subsequent encounter for fracture with delayed healing||has_expanded_form
imaging @ non-axial upper bones @ plain radiography @ elbow, left @ low osmolar @ none @ none||plain radiography of left elbow using low osmolar contrast||has_expanded_form
medical and surgical @ female reproductive system @ reposition @ fallopian tube, left @ open @ no device @ no qualifier||reposition left fallopian tube, open approach||has_expanded_form
release right inguinal lymphatic, perc endo approach||release right inguinal lymphatic, perc endo approach||has_expanded_form
taurine [presence] in urine||taurine [presence] in urine||has_expanded_form
closure multiple vsd w/removal artery band||cl mult vsd w/rem pul band||has_expanded_form
nitrofurantoin [susceptibility] by minimum inhibitory concentration (mic)||nitrofurantoin:susc:pt:isolate:ordqn:mic||has_expanded_form
diabetes due to undrl condition w diabetic mononeuropathy||diabetes mellitus due to underlying condition with diabetic mononeuropathy||has_expanded_form
nedd6||nedd6||has_expanded_form
displaced fracture of hook process of hamate [unciform] bone, unspecified wrist, initial encounter for closed fracture||disp fx of hook process of hamate bone, unsp wrist, init||has_expanded_form
medical and surgical @ hepatobiliary system and pancreas @ drainage @ common bile duct @ open @ no device @ diagnostic||drainage of common bile duct, open approach, diagnostic||has_expanded_form
occlusion of right internal carotid artery, percutaneous endoscopic approach||occlusion of right internal carotid artery, percutaneous endoscopic approach||has_expanded_form
medical and surgical @ ear, nose, sinus @ excision @ nasal septum @ via natural or artificial opening endoscopic @ no device @ no qualifier||excision of nasal septum, endo||has_expanded_form
revision of nonautologous tissue substitute in left clavicle, percutaneous endoscopic approach||revision of nonaut sub in l clavicle, perc endo approach||has_expanded_form
bilirubin (bldc) [moles/vol]||bilirubin:scnc:pt:bldc:qn||has_expanded_form
flg gene||filaggrin||has_expanded_form
sleep electroencephalogram (procedure)||electroencephalogram, sleep||has_expanded_form
sebacylcarnitine (c10-dc)/creatinine:srto:pt:urine:qn||sebacylcarn/creat ur-srto||has_expanded_form
unspecified disorder of patella, right knee||unspecified disorder of patella, right knee||has_expanded_form
nondisplaced segmental fracture of shaft of right tibia, initial encounter for open fracture type iiia, iiib, or iiic||nondisplaced segmental fracture of shaft of right tibia, initial encounter for open fracture type iiia, iiib, or iiic||has_expanded_form
zinc finger protein 284||znf284 gene||has_expanded_form
diarrhea 11, malabsorptive, congenital||idis||has_expanded_form
forkhead box d3 gene||foxd3 gene||has_expanded_form
destruction of thorax lymphatic, perc endo approach||medical and surgical @ lymphatic and hemic systems @ destruction @ lymphatic, thorax @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
remove infusion dev from l metatarsophal jt, perc endo||remove infusion dev from l metatarsophal jt, perc endo||has_expanded_form
body surface:area:to identify measures at a point in time:^patient:quantitative:measured||bsa measured||has_expanded_form
deprecated||date range:daterange:to identify measures at a point in time:hospitalization leading to pulmonary therapy treatment:quantitative||has_expanded_form
polymerase (rna) i polypeptide c, 30kda||polr1c gene||has_expanded_form
hoxb7||hoxb7||has_expanded_form
medical and surgical @ head and facial bones @ revision @ nasal bone @ percutaneous endoscopic @ internal fixation device @ no qualifier||revision of internal fixation device in nasal bone, percutaneous endoscopic approach||has_expanded_form
inga <moths>||inga <moths>||has_expanded_form
destruction of right upper extremity lymphatic, open approach||destruction of right upper extremity lymphatic, open approach||has_expanded_form
puncture wound without foreign body of left hand||puncture wound without foreign body of left hand||has_expanded_form
medical and surgical @ upper arteries @ restriction @ temporal artery, right @ percutaneous @ intraluminal device @ no qualifier||medical and surgical @ upper arteries @ restriction @ temporal artery, right @ percutaneous @ intraluminal device @ no qualifier||has_expanded_form
division of chordae tendineae, open approach||division of chordae tendineae, open approach||has_expanded_form
hclp-1||klhdc2 gene||has_expanded_form
other cells/100 leukocytes:number fraction:to identify measures at a point in time:dialysis fluid:quantitative:manual count||other cells/100 leukocytes:number fraction:to identify measures at a point in time:dialysis fluid:quantitative:manual count||has_expanded_form
dilation of right ulnar artery with three drug-eluting intraluminal devices, percutaneous approach||dilation of right ulnar artery with three drug-eluting intraluminal devices, percutaneous approach||has_expanded_form
medical and surgical @ respiratory system @ occlusion @ carina @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ respiratory system @ occlusion @ carina @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
medical and surgical @ muscles @ drainage @ hip muscle, right @ percutaneous endoscopic @ no device @ diagnostic||medical and surgical @ muscles @ drainage @ hip muscle, right @ percutaneous endoscopic @ no device @ diagnostic||has_expanded_form
joint derangement (disorder)||derangements joint||has_expanded_form
xstng hm visit 15min||xstng hmvst 15min||has_expanded_form
war operations involving explosion of torpedo, military personnel||war operations involving explosion of torpedo, military personnel||has_expanded_form
unspecified sprain of unspecified shoulder joint, initial encounter||unspecified sprain of unspecified shoulder joint, initial encounter||has_expanded_form
displaced unspecified condyle fracture of lower end of left femur, subsequent encounter for closed fracture with routine healing||displaced unspecified condyle fracture of lower end of left femur, subsequent encounter for closed fracture with routine healing||has_expanded_form
trav13-2 gene||trav13-2||has_expanded_form
beam radiation of maxilla using photons <1 mev||radiation therapy @ musculoskeletal system @ beam radiation @ maxilla @ photons <1 mev @ none @ none||has_expanded_form
fusion of thoracic vertebral joint with autologous tissue substitute, anterior approach, anterior column, open approach||fusion thor jt w autol sub, ant appr a col, open||has_expanded_form
insertion of internal fixation device into left upper femur, percutaneous endoscopic approach||medical and surgical @ lower bones @ insertion @ upper femur, left @ percutaneous endoscopic @ internal fixation device @ no qualifier||has_expanded_form
gamma-glutamyltransferase light chain 5 pseudogene||ggtlc5p gene||has_expanded_form
spotted fever, mediterranean||boutonneuse fever||has_expanded_form
zygorhizidium||zygorhizidium <lobulomycetales incertae sedis>||has_expanded_form
anes intracranial craniotomy/craniectomy hmtma||anes intracranial craniotomy/craniectomy hmtma||has_expanded_form
event mersth||event mersth||has_expanded_form
displaced fracture of epiphysis (separation) (upper) of right femur, subsequent encounter for closed fracture with malunion||displaced fracture of epiphysis (separation) (upper) of right femur, subsequent encounter for closed fracture with malunion||has_expanded_form
removal of brace on left finger||placement @ anatomical regions @ removal @ finger, left @ external @ brace @ no qualifier||has_expanded_form
foot amputation status||status amput foot||has_expanded_form
medical and surgical @ ear, nose, sinus @ excision @ external ear, left @ external @ no device @ diagnostic||excision of left external ear, external approach, diagnostic||has_expanded_form
medical and surgical @ upper joints @ revision @ elbow joint, right @ percutaneous @ external fixation device @ no qualifier||revision of external fixation device in right elbow joint, percutaneous approach||has_expanded_form
solenopsis invicta antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||solenopsis invicta ab.ige:acnc:pt:ser:qn||has_expanded_form
corneal deposits argentous right eye||argentous corneal deposits of right eye||has_expanded_form
plain radiography of bilateral kidneys||imaging @ urinary system @ plain radiography @ kidneys, bilateral @ none @ none @ none||has_expanded_form
echovirus nos ab:titr:pt:ser:qn||echovirus nos ab:titr:pt:ser:qn||has_expanded_form
child medical problem phenx||if you are currently at a clinic with your child to see a physician, what is the problem that brought you [phenx]||has_expanded_form
rnu6-1169p gene||rna, u6 small nuclear 1169, pseudogene||has_expanded_form
thymus biopsy||biopsy of thymus||has_expanded_form
removal of colon/ileostomy||total abdominal colectomy without proctectomy with continent ileostomy||has_expanded_form
displ maisonneuve's fx l leg, 7thq||displaced maisonneuve's fracture of left leg, subsequent encounter for open fracture type i or ii with malunion||has_expanded_form
rna, 7sl, cytoplasmic 242, pseudogene||rna, 7sl, cytoplasmic 242, pseudogene||has_expanded_form
insertion of ext fix into l tarsal jt, perc endo approach||medical and surgical @ lower joints @ insertion @ tarsal joint, left @ percutaneous endoscopic @ external fixation device @ no qualifier||has_expanded_form
supplement left upper femur with synthetic substitute, percutaneous approach||supplement left upper femur with synth sub, perc approach||has_expanded_form
drainage of left knee tendon with drainage device, open approach||drainage of left knee tendon with drainage device, open approach||has_expanded_form
ddb1 and cul4 associated factor 1 gene||dcaf1 gene||has_expanded_form
disp fx of l ulna styloid process, init for opn fx type i/2||displaced fracture of left ulna styloid process, initial encounter for open fracture type i or ii||has_expanded_form
decompress spinal cord thrc||decompress spinal cord thrc||has_expanded_form
medical and surgical @ upper joints @ revision @ thoracolumbar vertebral disc @ open @ drainage device @ no qualifier||revision of drainage device in thoracolumbar vertebral disc, open approach||has_expanded_form
periprosthetic osteolysis of internal prosthetic left knee joint||periprosthetic osteolysis of internal prosthetic left knee joint||has_expanded_form
torus fx upper end of r humerus, subs for fx w delay heal||torus fracture of upper end of right humerus, subsequent encounter for fracture with delayed healing||has_expanded_form
loc123688||hydroxylysine kinase||has_expanded_form
medical and surgical @ hepatobiliary system and pancreas @ revision @ pancreas @ external @ infusion device @ no qualifier||revision of infusion device in pancreas, external approach||has_expanded_form
fet chromo abn-antepart||chromosomal abnormality in fetus, affecting management of mother, antepartum||has_expanded_form
olfactory receptor family 10 subfamily c member 1||olfactory receptor family 10 subfamily c member 1||has_expanded_form
multisection^w tc-99m hmpao iv:find:pt:head>brain:doc:nm.spect||multisection^w tc-99m hmpao iv:find:pt:head>brain:doc:nm.spect||has_expanded_form
contusion of unsp little finger w damage to nail, init||contusion of unspecified little finger with damage to nail, initial encounter||has_expanded_form
injury of visual cortex, right side, sequela||injury of visual cortex, right side, sequela||has_expanded_form
subluxation of t3/t4 thoracic vertebra, sequela||subluxation of t3/t4 thoracic vertebra, sequela||has_expanded_form
medical and surgical @ central nervous system and cranial nerves @ extirpation @ cerebral meninges @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ central nervous system and cranial nerves @ extirpation @ cerebral meninges @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
fcf1p2||fcf1p2||has_expanded_form
displaced midcervical fracture of left femur, subsequent encounter for closed fracture with nonunion||displaced midcervical fracture of left femur, subsequent encounter for closed fracture with nonunion||has_expanded_form
burn of 3rd deg mu sites of right wrist and hand||burn of third degree of multiple sites of right wrist and hand||has_expanded_form
ct149||tekt5||has_expanded_form
bypass l subclav vein to up vein w autol sub, open||bypass l subclav vein to up vein w autol sub, open||has_expanded_form
implant or abutment supported fixed denture for completely edentulous arch (treatment)||implnt/abut suprtd fixd dent||has_expanded_form
bleedings intracranial||intracranial haemorrhage, unspecified||has_expanded_form
phenx - assessment of functional gastrointestinal disorders - child protocol 190103:-:to identify measures at a point in time:^patient:-:phenx||phenx - assessment of functional gastrointestinal disorders - child protocol 190103:-:pt:^patient:-:phenx||has_expanded_form
electrocardiogram, routine ecg with at least 12 leads, interpretation and report only||electrocardiogram report||has_expanded_form
bypass abdominal aorta to bilateral internal iliac arteries with nonautologous tissue substitute, percutaneous endoscopic approach||bypass abdominal aorta to bilateral internal iliac arteries with nonautologous tissue substitute, percutaneous endoscopic approach||has_expanded_form
medical and surgical @ muscles @ insertion @ lower muscle @ open @ other device @ no qualifier||insertion of other device into lower muscle, open approach||has_expanded_form
excision of r low extrem bursa/lig, perc approach, diagn||excision of right lower extremity bursa and ligament, percutaneous approach, diagnostic||has_expanded_form
nondisp fx of dist phalanx of l thm, subs for fx w nonunion||nondisp fx of dist phalanx of l thm, subs for fx w nonunion||has_expanded_form
alcohol abuse with withdrawal uncomplicated||alcohol abuse with withdrawal uncomplicated||has_expanded_form
medical and surgical @ female reproductive system @ extirpation @ cul-de-sac @ percutaneous @ no device @ no qualifier||extirpation of matter from cul-de-sac, percutaneous approach||has_expanded_form
bypass ascending colon to descending colon, open approach||bypass ascending colon to descending colon, open approach||has_expanded_form
discission of vitreous strands without removal by pars plana approach||retired procedure [10182003]||has_expanded_form
encounter due to allergy to peanuts||allergy peanuts||has_expanded_form
strain of extensor muscle, fascia and tendon of left middle finger at wrist and hand level, sequela||strain of extensor muscle, fascia and tendon of left middle finger at wrist and hand level, sequela||has_expanded_form
supplement left temporal artery with autologous tissue substitute, percutaneous approach||supplement l temporal art with autol sub, perc approach||has_expanded_form
blood flow velocity.diastole.max:vel:pt:mitral valve:qn:us.doppler||blood flow velocity.diastole.max:vel:pt:mitral valve:qn:us.doppler||has_expanded_form
displaced spiral fracture of shaft of radius, left arm, subsequent encounter for open fracture type i or ii with malunion||displ spiral fx shaft of rad, l arm, 7thq||has_expanded_form
unspecified disorders of menstruation and other abnormal bleeding from female genital tract||unspecified disorders of menstruation and other abnormal bleeding from female genital tract||has_expanded_form
icans||immune effector cell-associated neurotoxicity syndrome (diagnosis)||has_expanded_form
trns typ||transplant type [anatomy]||has_expanded_form
sphyrna tudes (valenciennes, 1822)||great hammerhead <sphyrna tudes>||has_expanded_form
revision of extraluminal device in kidney, via opening||revision of extraluminal device in kidney, via natural or artificial opening||has_expanded_form
supplement left knee joint with nonaut sub, open approach||supplement left knee joint with nonautologous tissue substitute, open approach||has_expanded_form
laparoscopic ablation of renal lesion or tissue||lap abltn renal les/tiss||has_expanded_form
medical and surgical @ female reproductive system @ resection @ vestibular gland @ external @ no device @ no qualifier||resection of vestibular gland, external approach||has_expanded_form
zscan31||znf310p||has_expanded_form
carcinoid tumor of the thymus||thymic carcinoid||has_expanded_form
extraction of right lower arm skin, external approach||extraction of right lower arm skin, external approach||has_expanded_form
peanut (rara h) 3 igg4-mcnc||peanut (rara h) 3 igg4-mcnc||has_expanded_form
driver of three-wheeled motor vehicle injured in collision with railway train or railway vehicle in nontraffic accident, initial encounter||driver of 3-whl mv inj in clsn w rail trn/veh nontraf, init||has_expanded_form
toxic effect of contact with other venomous animals, intentional self-harm, sequela||toxic effect of contact with other venomous animals, intentional self-harm, sequela||has_expanded_form
medical and surgical @ upper veins @ supplement @ cephalic vein, left @ open @ autologous tissue substitute @ no qualifier||supplement left cephalic vein with autologous tissue substitute, open approach||has_expanded_form
reposition sacrum with internal fixation device, percutaneous endoscopic approach||reposition sacrum with int fix, perc endo approach||has_expanded_form
gdh||gdh/6pgl endoplasmic bifunctional protein||has_expanded_form
neuronal nuclear type 2 ab:prthr:pt:csf:ord:ia||neuronal nuclear type 2 ab ia ql (csf)||has_expanded_form
terrorism involving destruction of aircraft, public safety official injured, sequela||terrorism w dest arcrft, publ sfty offcl injured, sequela||has_expanded_form
removal of synthetic substitute from face, external approach||medical and surgical @ anatomical regions, general @ removal @ face @ external @ synthetic substitute @ no qualifier||has_expanded_form
excision of upper lip, percutaneous approach||medical and surgical @ mouth and throat @ excision @ upper lip @ percutaneous @ no device @ no qualifier||has_expanded_form
medical aid in dying consult note||medical aid in dying consult note||has_expanded_form
physical rehabilitation and diagnostic audiology @ rehabilitation @ motor treatment @ integumentary system - lower back / lower extremity @ range of motion and joint mobility @ none @ none||range of motion and joint mobility treatment of integumentary system - lower back / lower extremity||has_expanded_form
excision of left epididymis, open approach, diagnostic||excision of left epididymis, open approach, diagnostic||has_expanded_form
removal of radioactive element from esophagus, via natural or artificial opening||removal of radioactive element from esophagus, via natural or artificial opening||has_expanded_form
phf4||phd finger protein 21b||has_expanded_form
avsd3||atrioventricular septal defect 3||has_expanded_form
pathological fracture, right shoulder, sequela||pathological fracture, right shoulder, sequela||has_expanded_form
cysto laser tx ureteral calc||cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)||has_expanded_form
placement @ anatomical regions @ removal @ toe, right @ external @ splint @ no qualifier||removal of splint on right toe||has_expanded_form
hoxb gene family||homeo box b cluster||has_expanded_form
planned chemo regimen docd prior start new tx||planned chemotherapy regimen, including at a minimum: drug(s) prescribed, dose, and duration, documented prior to initiation of a new treatment regimen (onc)||has_expanded_form
spherical power [inverse length] left eye||spherical power invlen l eye||has_expanded_form
unlisted procedure lungs & pleura||unlisted procedure, lungs and pleura||has_expanded_form
galactorrhea-del w p/p||galactorrhea associated with childbirth, delivered, with mention of postpartum complication||has_expanded_form
obstetrics @ pregnancy @ drainage @ products of conception @ percutaneous @ no device @ fetal blood||drainage of fetal blood from products of conception, percutaneous approach||has_expanded_form
repair right upper leg, external approach||repair right upper leg, external approach||has_expanded_form
infections, leishmania||leishmania infections||has_expanded_form
excision of right axillary vein, open approach, diagnostic||medical and surgical @ upper veins @ excision @ axillary vein, right @ open @ no device @ diagnostic||has_expanded_form
dilation of ileum with intraluminal device, via natural or artificial opening endoscopic||medical and surgical @ gastrointestinal system @ dilation @ ileum @ via natural or artificial opening endoscopic @ intraluminal device @ no qualifier||has_expanded_form
alp bone z-score serpl||alkaline phosphatase.bone:z score:to identify measures at a point in time:serum/plasma:quantitative||has_expanded_form
glutamine/creatinine:ratio:pt:urine:qn||glutamine/creatinine:ratio:pt:urine:qn||has_expanded_form
medical and surgical @ heart and great vessels @ excision @ pulmonary vein, left @ percutaneous endoscopic @ no device @ diagnostic||medical and surgical @ heart and great vessels @ excision @ pulmonary vein, left @ percutaneous endoscopic @ no device @ diagnostic||has_expanded_form
medical and surgical @ upper arteries @ dilation @ thyroid artery, right @ percutaneous endoscopic @ intraluminal device, two @ no qualifier||dilation of right thyroid artery with two intraluminal devices, percutaneous endoscopic approach||has_expanded_form
poisoning by, adverse effect of and underdosing of digestants||digestants||has_expanded_form
fluid output.urine nephrostomy:volume:to identify measures at a point in time:urinary tract:quantitative:measured||fluid output.urine nephrostomy:volume:to identify measures at a point in time:urinary tract:quantitative:measured||has_expanded_form
medical and surgical @ upper joints @ resection @ metacarpophalangeal joint, left @ open @ no device @ no qualifier||resection of left metacarpophalangeal joint, open approach||has_expanded_form
medical and surgical @ bursae and ligaments @ release @ sternum bursa and ligament @ percutaneous @ no device @ no qualifier||medical and surgical @ bursae and ligaments @ release @ sternum bursa and ligament @ percutaneous @ no device @ no qualifier||has_expanded_form
dilation of left lacrimal duct with intraluminal device, open approach||dilation of l lacrml duct with intralum dev, open approach||has_expanded_form
sltr-haris type i physl fx low end l tibia, 7thd||sltr-haris type i physl fx low end l tibia, 7thd||has_expanded_form
wd repeat containing, antisense to tp53||wrap53 gene||has_expanded_form
excision of right lower arm, percutaneous approach, diagnostic||excision of right lower arm, percutaneous approach, diagn||has_expanded_form
repair left vocal cord, endo||medical and surgical @ mouth and throat @ repair @ vocal cord, left @ via natural or artificial opening endoscopic @ no device @ no qualifier||has_expanded_form
dichlorodiphenyldichloroethylene:mass content:to identify measures at a point in time:not specified:quantitative||dde spec-mcnt||has_expanded_form
hedis 2014-16 ser k||hedis 2014-2016 value set - serum potassium||has_expanded_form
alveolar echinococcosis, hepatic||echinococcosis of liver, nos||has_expanded_form
boron/creatinine:substance ratio:24 hours:urine:quantitative||boron/creatinine:substance ratio:24 hours:urine:quantitative||has_expanded_form
recreational therapy nos (procedure)||recreation therapies||has_expanded_form
removal of other device from left pleural cavity, percutaneous approach||removal of other device from left pleural cavity, percutaneous approach||has_expanded_form
ct scan of l calcaneus using h osm contrast||imaging @ non-axial lower bones @ computerized tomography (ct scan) @ calcaneus, left @ high osmolar @ none @ none||has_expanded_form
fluoroscopy of right upper extremity arteries||imaging @ upper arteries @ fluoroscopy @ upper extremity arteries, right @ none @ none @ none||has_expanded_form
division of right foot skin, external approach||division of right foot skin, external approach||has_expanded_form
kirsten ras1||kras gene||has_expanded_form
revise infusion dev in r carpometacarp jt, extern||medical and surgical @ upper joints @ revision @ carpometacarpal joint, right @ external @ infusion device @ no qualifier||has_expanded_form
change other device on right finger||change other device on right finger||has_expanded_form
nfct agt genotype nucleic acid cytomegalovirus||nfct agt genotype nucleic acid cytomegalovirus||has_expanded_form
occlusion of bilateral spermatic cords with extraluminal device, open approach||occlusion of bilateral spermatic cords with extraluminal device, open approach||has_expanded_form
drainage of left ankle tendon with drainage device, open approach||drainage of left ankle tendon with drainage device, open approach||has_expanded_form
cancer identification section:-:to identify measures at a point in time:^patient:set:naaccr v.11||cancer id section naaccr v.11||has_expanded_form
pars neodentata||neodentate part of the dentate nucleus||has_expanded_form
insertion of intraluminal device into left ventricle, percutaneous endoscopic approach||insert of intralum dev into l ventricle, perc endo approach||has_expanded_form
nondisplaced fracture of medial condyle of right tibia, subsequent encounter for open fracture type i or ii with malunion||nondisp fx of med condyle of r tibia, 7thq||has_expanded_form
pathological fracture in oth disease, right humerus, init||pathological fracture in oth disease, right humerus, init||has_expanded_form
removal of drainage device from spinal cord, open approach||medical and surgical @ central nervous system and cranial nerves @ removal @ spinal cord @ open @ drainage device @ no qualifier||has_expanded_form
medical and surgical @ mouth and throat @ supplement @ upper lip @ percutaneous @ synthetic substitute @ no qualifier||supplement upper lip with synth sub, perc approach||has_expanded_form
unspecified maternal hypertension, unspecified trimester||unspecified maternal hypertension||has_expanded_form
amaurosis congenita of leber, type 1||crb||has_expanded_form
pressure ulcer of left hip||pressure ulcer of left hip||has_expanded_form
hhv6 igg titr csf if||hhv6 igg titr csf if||has_expanded_form
transfer left trunk muscle, superficial inferior epigastric artery flap, percutaneous endoscopic approach||transfer left trunk muscle, siea flap, perc endo approach||has_expanded_form
cd4+cd45+ cells nfr tiss||cells.cd4+cd45+/100 cells:number fraction:to identify measures at a point in time:tissue, unspecified:quantitative||has_expanded_form
poisn by mixed bact vaccines w/o a pertuss, assault, sequela||poisoning by mixed bacterial vaccines without a pertussis component, assault, sequela||has_expanded_form
other specified injury of femoral artery, left leg||other specified injury of femoral artery, left leg||has_expanded_form
linc01867 gene||linc01867||has_expanded_form
labor and delivery comp by vascular lesion of cord, fetus 2||labor and delivery complicated by vascular lesion of cord, fetus 2||has_expanded_form
patient referral for psychotherapy documented (mdd, mdd adol)||pt referral psych docd||has_expanded_form
other secondary osteonecrosis, right hand||other secondary osteonecrosis, right hand||has_expanded_form
inj musc/tend anterior grp at low leg level, unsp leg, subs||inj musc/tend anterior grp at low leg level, unsp leg, subs||has_expanded_form
hhip-as1||hhip-as1||has_expanded_form
medical and surgical @ lower veins @ insertion @ saphenous vein, right @ percutaneous endoscopic @ intraluminal device @ no qualifier||medical and surgical @ lower veins @ insertion @ saphenous vein, right @ percutaneous endoscopic @ intraluminal device @ no qualifier||has_expanded_form
medication dispensed.extended doc||medication dispensed.extended:finding:to identify measures at a point in time:^patient:document||has_expanded_form
nondisp avulsion fx left ilium, subs for fx w nonunion||nondisplaced avulsion fracture of left ilium, subsequent encounter for fracture with nonunion||has_expanded_form
revision of nonaut sub in male perineum, extern approach||revision of nonaut sub in male perineum, extern approach||has_expanded_form
first bone reference:anat:pt:{dental arch}:nom||first bone reference:anat:pt:{dental arch}:nom||has_expanded_form
protocadherin gamma subfamily a, 4||protocadherin gamma subfamily a, 4||has_expanded_form
trmt1p1 gene||trmt1p1 gene||has_expanded_form
repair arterial blockage||radiological supervision and interpretation of balloon dilation of narrowed renal or abdominal organ artery||has_expanded_form
medical and surgical @ upper arteries @ occlusion @ thyroid artery, left @ percutaneous endoscopic @ intraluminal device @ no qualifier||medical and surgical @ upper arteries @ occlusion @ thyroid artery, left @ percutaneous endoscopic @ intraluminal device @ no qualifier||has_expanded_form
znf222||znf222||has_expanded_form
primary hyperoxaluria type 2||glyoxylate and hydroxypyruvate reductase gene||has_expanded_form
flj12787||utp15||has_expanded_form
mrpl42p6||mrpl42p6||has_expanded_form
pathological resorption of dental structure (diagnosis)||pathological resorption of dental structure||has_expanded_form
remove infusion dev from l carpometacarp jt, open||remove infusion dev from l carpometacarp jt, open||has_expanded_form
antitussives||poisoning by, adverse effect of and underdosing of antitussives||has_expanded_form
maternal care for (suspected) cnsl malform in fetus, fetus 4||maternal care for (suspected) cnsl malform in fetus, fetus 4||has_expanded_form
heat exposure on board watercraft||heat exposure on board watercraft||has_expanded_form
drainage of aortic lymphatic, perc endo approach||medical and surgical @ lymphatic and hemic systems @ drainage @ lymphatic, aortic @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
blister (nonthermal), unspecified foot||blister (nonthermal), unspecified foot||has_expanded_form
deprecated 14-3-3 protein [presence] in cerebral spinal fluid by immunoblot||14-3-3 protein:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal:immune blot||has_expanded_form
abnormal csf findings||abnormal; fluid, cerebrospinal||has_expanded_form
virus spec cult||virus identified cx nom (specimen)||has_expanded_form
hspb2-c11orf52||hspb2-c11orf52 gene||has_expanded_form
destruction of sciatic nerve, perc endo approach||destruction of sciatic nerve, percutaneous endoscopic approach||has_expanded_form
low dose rate (ldr) brachytherapy of left breast using cesium 137 (cs-137)||ldr brachytherapy of l breast using cesium 137||has_expanded_form
gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty||v-band gastroplasty||has_expanded_form
repair gastrointestinal system in products of conception, open approach||repair gastrointestinal system in products of conception, open approach||has_expanded_form
long intergenic non-protein coding rna 2133||linc02133 gene||has_expanded_form
poisoning by tetracyclic antidepressants, accidental (unintentional), subsequent encounter||poisoning by tetracyclic antidepressants, accidental (unintentional), subsequent encounter||has_expanded_form
fos-induced growth factor||fos-induced growth factor||has_expanded_form
sry-box transcription factor 8||sox8 gene||has_expanded_form
florfenicol mic [susc]||florfenicol [susceptibility] by minimum inhibitory concentration (mic)||has_expanded_form
exam;partial;cardiovascular||exam;partial;cardiovascular||has_expanded_form
revision of monitoring device in azygos vein, open approach||revision of monitoring device in azygos vein, open approach||has_expanded_form
nondisplaced fracture of head of unspecified radius||nondisplaced fracture of head of unspecified radius||has_expanded_form
repair blood vessel, direct; lower extremity||repair blood vessel lesion||has_expanded_form
rnu6-1270p||rna, u6 small nuclear 1270, pseudogene||has_expanded_form
excision of left upper extremity, percutaneous endoscopic approach||medical and surgical @ anatomical regions, upper extremities @ excision @ upper extremity, left @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
revision of drainage device in upper vein, percutaneous approach||revision of drainage device in upper vein, perc approach||has_expanded_form
type 2, 3-methylglutaconicaciduria||mga type iis||has_expanded_form
burn due to loc fire on board oth powered wtrcrft, subs||burn due to localized fire on board other powered watercraft, subsequent encounter||has_expanded_form
drain of r int mamm art with drain dev, perc endo approach||medical and surgical @ upper arteries @ drainage @ internal mammary artery, right @ percutaneous endoscopic @ drainage device @ no qualifier||has_expanded_form
nondisplaced fracture of medial condyle of right femur, subsequent encounter for open fracture type i or ii with malunion||nondisplaced fracture of medial condyle of right femur, subsequent encounter for open fracture type i or ii with malunion||has_expanded_form
chromosome 17 open reading frame 54||c17orf54||has_expanded_form
suprvsn of preg rslt from assisted reprodctv tech, third tri||supervision of pregnancy resulting from assisted reproductive technology, third trimester||has_expanded_form
displaced comminuted fracture of shaft of ulna, left arm, initial encounter for open fracture type iiia, iiib, or iiic||displ commnt fx shaft of ulna, l arm, 7thc||has_expanded_form
tmem243 gene||mmtrag||has_expanded_form
dop ft ves||us.doppler foot vessels||has_expanded_form
medical and surgical @ upper arteries @ dilation @ hand artery, left @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ upper arteries @ dilation @ hand artery, left @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
medical and surgical @ urinary system @ restriction @ ureter, right @ percutaneous endoscopic @ intraluminal device @ no qualifier||restrict of r ureter with intralum dev, perc endo approach||has_expanded_form
other specified injury of unspecified blood vessel at lower leg level, unspecified leg, sequela||other specified injury of unspecified blood vessel at lower leg level, unspecified leg, sequela||has_expanded_form
rassf8||ras association domain family, member 8||has_expanded_form
medical and surgical @ gastrointestinal system @ occlusion @ jejunum @ percutaneous endoscopic @ extraluminal device @ no qualifier||medical and surgical @ gastrointestinal system @ occlusion @ jejunum @ percutaneous endoscopic @ extraluminal device @ no qualifier||has_expanded_form
infectious bronchitis virus mass-41 antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:hemagglutination inhibition||infectious bronchitis virus mass-41 antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:hemagglutination inhibition||has_expanded_form
rothmund thomson syndrome type 1 (disorder)||rothmund thomson syndrome type 1 (disorder)||has_expanded_form
pharmacology pt's home note||note:finding:to identify measures at a point in time:patient's home:document:pharmacology||has_expanded_form
revision of synthetic substitute in left knee joint, femoral surface, external approach||medical and surgical @ lower joints @ revision @ knee joint, femoral surface, left @ external @ synthetic substitute @ no qualifier||has_expanded_form
supplement l knee tendon with nonaut sub, perc endo approach||supplement l knee tendon with nonaut sub, perc endo approach||has_expanded_form
poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional)||poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional)||has_expanded_form
g protein-coupled receptor 92||lpar5 gene||has_expanded_form
cnn3||calponin, acidic||has_expanded_form
injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less||injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less||has_expanded_form
bacteria [#/area] in urine sediment by automated count||bacteria:number aeric (number per area):to identify measures at a point in time:urine sediment:quantitative:automated count||has_expanded_form
inj oth blood vessels at wrs/hnd lv of left arm, subs||inj oth blood vessels at wrs/hnd lv of left arm, subs||has_expanded_form
lens type far:type:to identify measures at a point in time:glasses prescription.lens.right:nominal||lens type far:type:pt:glasses prescription.lens.right:nom||has_expanded_form
imaging @ hepatobiliary system and pancreas @ other imaging @ hepatobiliary system, all @ fluorescing agent @ none @ none||imaging @ hepatobiliary system and pancreas @ other imaging @ hepatobiliary system, all @ fluorescing agent @ none @ none||has_expanded_form
sequelae cerebrovascul disease||late effect cv dis nos||has_expanded_form
hladm||major histocompatibility complex, class ii, dm alpha||has_expanded_form
placement @ anatomical regions @ change @ upper arm, right @ external @ pressure dressing @ no qualifier||change pressure dressing on right upper arm||has_expanded_form
accidental puncture and laceration of left eye and adnexa during other procedure||accidental puncture and laceration of left eye and adnexa during other procedure||has_expanded_form
bypass left innominate vein to upper vein with autologous venous tissue, percutaneous endoscopic approach||bypass left innominate vein to upper vein with autologous venous tissue, percutaneous endoscopic approach||has_expanded_form
division of right ear skin, external approach||medical and surgical @ skin and breast @ division @ skin, right ear @ external @ no device @ no qualifier||has_expanded_form
mech comp respirator||mechanical complication of respirator [ventilator]||has_expanded_form
oxygen content:substance concentration:to identify measures at a point in time:blood venous:quantitative||oxygen content:substance concentration:to identify measures at a point in time:blood venous:quantitative||has_expanded_form
unspecified subluxation of unspecified wrist and hand, sequela||unspecified subluxation of unspecified wrist and hand, sequela||has_expanded_form
poisoning by ophthalmological drugs and preparations, accidental (unintentional), sequela||poisoning by ophthalmological drugs and preparations, accidental (unintentional), sequela||has_expanded_form
please list the size, mg, or amount per dose of medication your child currently takes:finding:to identify measures at a point in time:^patient:nominal:phenx||please list the size, mg, or amount per dose of medication your child currently takes [phenx]||has_expanded_form
ibuprofen screen [mass/vol]||ibuprofen:mcnc:pt:ser/plas:qn:screen||has_expanded_form
care management note||care management note:find:pt:{setting}:doc:{role}||has_expanded_form
remove of monitor dev from pancreat duct, perc endo approach||remove of monitor dev from pancreat duct, perc endo approach||has_expanded_form
medical and surgical @ muscles @ destruction @ head muscle @ percutaneous @ no device @ no qualifier||medical and surgical @ muscles @ destruction @ head muscle @ percutaneous @ no device @ no qualifier||has_expanded_form
medical and surgical @ mouth and throat @ excision @ buccal mucosa @ open @ no device @ diagnostic||excision of buccal mucosa, open approach, diagnostic||has_expanded_form
ush1b||nsrd2||has_expanded_form
a3galnt||forssman synthetase||has_expanded_form
revision of synthetic substitute in right finger phalangeal joint, percutaneous approach||revision of synthetic substitute in right finger phalangeal joint, percutaneous approach||has_expanded_form
part1||prostate androgen-regulated transcript 1||has_expanded_form
displ transverse fx shaft of humer, r arm, 7thd||displaced transverse fracture of shaft of humerus, right arm, subsequent encounter for fracture with routine healing||has_expanded_form
corrosion of third degree of left knee, subsequent encounter||corrosion of third degree of left knee, subsequent encounter||has_expanded_form
area kam of pandya-1973||area kam of pandya-1973||has_expanded_form
coccidia identified:presence or identity:to identify measures at a point in time:tissue small intestine:nominal:giemsa stain||coccidia identified in small intestine tissue by giemsa stain||has_expanded_form
ampar2 igg cell binding immunofluorescent assay ql (csf)||ampar2 igg csf ql cba ifa||has_expanded_form
temocillin:dilution factor (titer):to identify measures at a point in time:isolate+serum:quantitative:serum bacterial titer||temocillin titr sbt||has_expanded_form
medical and surgical @ lower bones @ drainage @ toe phalanx, left @ open @ no device @ no qualifier||drainage of left toe phalanx, open approach||has_expanded_form
tongue; scrotal||fissure; tongue||has_expanded_form
blisters with epidermal loss due to second degree burn of multiple sites of upper limb, except wrist and hand||blisters, epidermal loss [second degree] of multiple sites of upper limb, except wrist and hand||has_expanded_form
measure observations:finding:point in time:^patient:narrative||measure observations narrative||has_expanded_form
transfer phrenic nerve to phrenic nerve, open approach||medical and surgical @ peripheral nervous system @ transfer @ phrenic nerve @ open @ no device @ phrenic nerve||has_expanded_form
broad casts:naric:pt:urine:qn:computer assisted||broad casts:number aeric (number per area):to identify measures at a point in time:urine:quantitative:computer assisted||has_expanded_form
dilation of left hand artery with 2 drug-elut, perc approach||dilation of left hand artery with 2 drug-elut, perc approach||has_expanded_form
medical and surgical @ upper arteries @ dilation @ temporal artery, left @ percutaneous endoscopic @ intraluminal device, drug-eluting, three @ no qualifier||dilate l temporal art w 3 drug-elut, perc endo||has_expanded_form
release left posterior tibial artery, percutaneous approach||medical and surgical @ lower arteries @ release @ posterior tibial artery, left @ percutaneous @ no device @ no qualifier||has_expanded_form
inspection of right upper leg, percutaneous endoscopic approach||medical and surgical @ anatomical regions, lower extremities @ inspection @ upper leg, right @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
dilation of esophagus with intralum dev, perc endo approach||dilation of esophagus with intraluminal device, percutaneous endoscopic approach||has_expanded_form
vendor serial number:identifier:to identify measures at a point in time:wound drain device:nominal||vendor serial number:identifier:to identify measures at a point in time:wound drain device:nominal||has_expanded_form
mir6750||mir6750||has_expanded_form
hgb pre therapeutic phlebotomy bld-mcnc||hemoglobin^pre therapeutic phlebotomy:mass concentration:to identify measures at a point in time:whole blood:quantitative||has_expanded_form
formate (u) [mass/vol]||formate:mass concentration:to identify measures at a point in time:urine:quantitative||has_expanded_form
injury branches celiac and mesenteric artery||injury of branches of celiac and mesenteric artery (diagnosis)||has_expanded_form
s1pr1 gene||d1s3362||has_expanded_form
medical and surgical @ lymphatic and hemic systems @ excision @ lymphatic, internal mammary, right @ percutaneous @ no device @ diagnostic||excision of int mamm, r lymph, perc approach, diagn||has_expanded_form
duck enteritis virus ab:prthr:pt:ser:ord:neut||dve ab ser ql nt||has_expanded_form
medical and surgical @ anatomical regions, general @ revision @ neck @ percutaneous @ other device @ no qualifier||medical and surgical @ anatomical regions, general @ revision @ neck @ percutaneous @ other device @ no qualifier||has_expanded_form
or1k1 gene||olfactory receptor family 1 subfamily k member 1||has_expanded_form
nvasv hmodynmc line rmvl ea.||nvasv hmodynmc line rmvl ea.||has_expanded_form
phencyclidine (milk) [mass/vol]||phencyclidine:mass concentration:to identify measures at a point in time:milk:quantitative||has_expanded_form
hrd1||synoviolin 1||has_expanded_form
myeloperoxidase antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immunoassay||myeloperoxidase ab:acnc:pt:ser:qn:ia||has_expanded_form
other mechanical complication of infusion catheter||other mechanical complication of infusion catheter||has_expanded_form
bypass left subclavian artery to l pulm art, open approach||bypass left subclavian artery to left pulmonary artery, open approach||has_expanded_form
restriction of upper vein with extralum dev, perc approach||restriction of upper vein with extralum dev, perc approach||has_expanded_form
medical and surgical @ heart and great vessels @ bypass @ pulmonary artery, right @ percutaneous endoscopic @ autologous venous tissue @ subclavian||bypass r pulm art from subclav w autol vn, perc endo||has_expanded_form
extirpation of matter from left innominate vein, percutaneous endoscopic approach||medical and surgical @ upper veins @ extirpation @ innominate vein, left @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
transmissible gastroenteritis virus ab:prthr:pt:ser:ord:neut||transmissible gastroenteritis virus ab:prthr:pt:ser:ord:neut||has_expanded_form
medical and surgical @ upper joints @ insertion @ sternoclavicular joint, left @ open @ internal fixation device @ no qualifier||medical and surgical @ upper joints @ insertion @ sternoclavicular joint, left @ open @ internal fixation device @ no qualifier||has_expanded_form
histoplasma capsulatum mycelial phase ab:prthr:pt:ser:ord:comp fix||histoplasma capsulatum mycelial phase ab [presence] in serum by complement fixation||has_expanded_form
adenine:mass concentration:to identify measures at a point in time:serum:quantitative||adenine [mass/volume] in serum||has_expanded_form
supplement hard palate with synthetic substitute, percutaneous approach||supplement hard palate with synthetic substitute, percutaneous approach||has_expanded_form
cytosolic iron-sulfur assembly component 2b||family with sequence similarity 96 member b||has_expanded_form
medical and surgical @ peripheral nervous system @ division @ ulnar nerve @ open @ no device @ no qualifier||division of ulnar nerve, open approach||has_expanded_form
legal intervention involving other firearm discharge, unspecified person injured, subsequent encounter||legal intervnt w firearm disch, unsp person injured, subs||has_expanded_form
norclomipramine ur ql||norclomipramine [presence] in urine||has_expanded_form
lot # bpu||lot number nom (bpu) [id]||has_expanded_form
chloroquine:mass:pt:dose:qn||chloroquine [mass] of dose||has_expanded_form
chlamydia females||chlamydia females||has_expanded_form
division of pudendal nerve, percutaneous endoscopic approach||medical and surgical @ peripheral nervous system @ division @ pudendal nerve @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
insertion of infusion device into left atrium, perc approach||insertion of infusion device into left atrium, perc approach||has_expanded_form
incision procedures on the mediastinum||incision of the mediastinum||has_expanded_form
medical and surgical @ female reproductive system @ extirpation @ fallopian tube, right @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ female reproductive system @ extirpation @ fallopian tube, right @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
echo virus infect nos||echo virus infection in conditions classified elsewhere and of unspecified site||has_expanded_form
type of substance abused by family member||type of substance abused by fam mem||has_expanded_form
medical and surgical @ urinary system @ excision @ kidney, left @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ urinary system @ excision @ kidney, left @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
medical and surgical @ central nervous system and cranial nerves @ fragmentation||medical and surgical @ central nervous system and cranial nerves @ fragmentation||has_expanded_form
unspecified fracture of left talus||unspecified fracture of left talus||has_expanded_form
loose body in unspecified toe joints||loose body in unspecified toe joints||has_expanded_form
replacement of left elbow bursa and ligament with autologous tissue substitute, open approach||replacement of left elbow bursa and ligament with autologous tissue substitute, open approach||has_expanded_form
ped on rolr-skt inj pk-up truck, pk-up/van nontraf, sequela||ped on rolr-skt inj pk-up truck, pk-up/van nontraf, sequela||has_expanded_form
microrna 542||mir542||has_expanded_form
borrelia garinii+afzelii oppa1 gene:prthr:pt:bld:ord:non-probe.amp.tar||borrelia garinii+afzelii oppa1 gene [presence] in blood by naa with non-probe detection||has_expanded_form
verticillium||verticillium <order phyllachorales>||has_expanded_form
destruction of left lower arm skin, external approach||destruction of left lower arm skin, external approach||has_expanded_form
oth neonatal hypoglycaemia||oth neonatal hypoglycemia||has_expanded_form
drain head neck symp nrv w drain dev, perc endo||medical and surgical @ peripheral nervous system @ drainage @ head and neck sympathetic nerve @ percutaneous endoscopic @ drainage device @ no qualifier||has_expanded_form
caregiver train in grooming/hygiene using assist equipment||caregiver train in grooming/hygiene using assist equipment||has_expanded_form
pathologists/dermatopathologists is the same clinician who performed the biopsy||pathologists/dermatopathologists is the same clinician who performed the biopsy||has_expanded_form
undefined, narrative required - christian science||undefined christian science care narrative required||has_expanded_form
masters' stress test, two-step||master step test||has_expanded_form
anxious||rndx anxiety (diagnosis)||has_expanded_form
medical and surgical @ anatomical regions, general @ removal @ perineum, male @ external @ synthetic substitute @ no qualifier||medical and surgical @ anatomical regions, general @ removal @ perineum, male @ external @ synthetic substitute @ no qualifier||has_expanded_form
alteration of l knee with nonaut sub, perc approach||alteration of left knee region with nonautologous tissue substitute, percutaneous approach||has_expanded_form
electrophoresis, hemoglobin||hemoglobin electrophoresis test||has_expanded_form
dilation of r axilla art with 4 drug-elut, perc approach||dilation of right axillary artery with four or more drug-eluting intraluminal devices, percutaneous approach||has_expanded_form
hsv 2 ag if ql (genital specimen)||hsv 2 ag if ql (genital specimen)||has_expanded_form
removal of nonautologous tissue substitute from vas deferens, via natural or artificial opening endoscopic||removal of nonaut sub from vas deferens, endo||has_expanded_form
posterior part of superior frontal gyrus||psfg||has_expanded_form
uroporphyrin 3 isomer (stl) [moles/mass]||uroporphyrin 3 isomer [moles/mass] in stool||has_expanded_form
hsv islt if||herpes simplex virus identified in isolate by immunofluorescence||has_expanded_form
excision of left hand vein, percutaneous approach, diagn||medical and surgical @ upper veins @ excision @ hand vein, left @ percutaneous @ no device @ diagnostic||has_expanded_form
during the daytime, do you experience an overwhelming desire to go to sleep - so overwhelming that you cannot resist:finding:to identify measures at a point in time:^patient:ordinal:phenx||daytime desire to sleep phenx||has_expanded_form
myocrd img pet prfuj single study rest/stress||myocrd img pet 1std rst/strs||has_expanded_form
intravascular diastolic:pressure:to identify measures at a point in time:inferior mesenteric artery:quantitative||im a bp dias||has_expanded_form
removal of drainage device from l hip jt, extern approach||medical and surgical @ lower joints @ removal @ hip joint, left @ external @ drainage device @ no qualifier||has_expanded_form
insertion of defib lead into r ventricle, perc endo approach||insertion of defib lead into r ventricle, perc endo approach||has_expanded_form
repair cervicothoracic vertebral joint, external approach||medical and surgical @ upper joints @ repair @ cervicothoracic vertebral joint @ external @ no device @ no qualifier||has_expanded_form
medical and surgical @ lower arteries @ bypass @ common iliac artery, left @ percutaneous endoscopic @ autologous venous tissue @ common iliac arteries, bilateral||bypass l com iliac art to b com ilia w autol vn, perc endo||has_expanded_form
sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d||semaphorin 3d||has_expanded_form
calcific tendinitis, unspecified upper arm||calcific tendinitis, unspecified upper arm||has_expanded_form
reattachment of left hand tendon, open approach||medical and surgical @ tendons @ reattachment @ hand tendon, left @ open @ no device @ no qualifier||has_expanded_form
microscopic observation cyto stain nom (soft tissue fine needle aspirate)||microscopic observation [identifier] in soft tissue fine needle aspirate by cyto stain||has_expanded_form
poisoning by oth nonsteroid anti-inflam drugs, undet, init||poisoning by oth nonsteroid anti-inflam drugs, undet, init||has_expanded_form
other specified disorder of metabolism (disorder)||metabolism disorder nec||has_expanded_form
rny4p29||rny4p29 gene||has_expanded_form
supplement upper gingiva with nonaut sub, open approach||supplement upper gingiva with nonaut sub, open approach||has_expanded_form
fluoroscopy r renal art w l osm contrast, laser intraop||fluoroscopy r renal art w l osm contrast, laser intraop||has_expanded_form
gestational trophoblastic tumor protein 1||stard7||has_expanded_form
hepatobiliary diseases||liver and biliary disorder||has_expanded_form
adefovir islt phenotyp||adefovir:susc:pt:isolate:ordqn:phenotyping||has_expanded_form
celecoxib/fluorouracil/irinotecan/leucovorin calcium||cf/cpt-11/5-fu/sc-58635||has_expanded_form
burkitt lymphoma receptor 1||burkitt lymphoma receptor 1, gtp binding protein (chemokine (c-x-c motif) receptor 5)||has_expanded_form
meconium aspiration with respiratory symptoms||aspiration of meconium with respiratory symptoms||has_expanded_form
medical and surgical @ tendons @ reposition @ hip tendon, right @ open @ no device @ no qualifier||reposition right hip tendon, open approach||has_expanded_form
revision of drainage device in left lung, open approach||revision of drainage device in left lung, open approach||has_expanded_form
r typhi igg ser ql ia||rickettsia typhi igg ab [presence] in serum by immunoassay||has_expanded_form
medical and surgical @ lower joints @ revision @ hip joint, left @ percutaneous endoscopic @ synthetic substitute @ no qualifier||medical and surgical @ lower joints @ revision @ hip joint, left @ percutaneous endoscopic @ synthetic substitute @ no qualifier||has_expanded_form
sars1||sars1||has_expanded_form
fanconi anemia, complementation group q||fanconi anemia, complementation group q||has_expanded_form
calcium transporter 2||epithelial calcium channel 1||has_expanded_form
williams-beuren syndrome chromosome region 28||williams-beuren syndrome chromosome region 28||has_expanded_form
bypass descending colon to cutaneous with synthetic substitute, percutaneous approach||bypass descend colon to cutan with synth sub, perc approach||has_expanded_form
infection caused by blastomyces dermatitidis (disorder)||blastomycotic infection nos||has_expanded_form
bypass abd aorta to r int ilia w nonaut sub, open||bypass abdominal aorta to right internal iliac artery with nonautologous tissue substitute, open approach||has_expanded_form
comprehensive prolonged new out-of-office 180 minutes homeopathic intake||comprehensive prolonged new out-of-office 180 minutes homeopathic intake||has_expanded_form
replacement of right eye with autol sub, open approach||medical and surgical @ eye @ replacement @ eye, right @ open @ autologous tissue substitute @ no qualifier||has_expanded_form
drainage of coccygeal glomus with drain dev, open approach||drainage of coccygeal glomus with drain dev, open approach||has_expanded_form
medical and surgical @ gastrointestinal system @ drainage @ peritoneum @ percutaneous @ no device @ diagnostic||drainage of peritoneum, percutaneous approach, diagnostic||has_expanded_form
g-esoph reflx tst w/electrod||gastroesophageal reflux test of esophagus with mucosal attached telemetry ph electrode placement, recording, analysis, and interpretation||has_expanded_form
removal of tracheostomy device from trachea, perc approach||removal of tracheostomy device from trachea, percutaneous approach||has_expanded_form
medical and surgical @ lower joints @ inspection @ lumbosacral joint @ percutaneous endoscopic @ no device @ no qualifier||medical and surgical @ lower joints @ inspection @ lumbosacral joint @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
occupant (driver) (passenger) of three-wheeled motor vehicle injured in other specified transport accidents, sequela||occupant (driver) (passenger) of three-wheeled motor vehicle injured in other specified transport accidents, sequela||has_expanded_form
dilation of ascending colon with intralum dev, perc approach||dilation of ascending colon with intraluminal device, percutaneous approach||has_expanded_form
superficial foreign body of right middle finger, subsequent encounter||superficial foreign body of right middle finger, subsequent encounter||has_expanded_form
analysis for antibody to mycoplasma (bacteria)||analysis for antibody to mycoplasma (bacteria)||has_expanded_form
introduce electrol/water bal in mouth/phar, perc||administration @ physiological systems and anatomical regions @ introduction @ mouth and pharynx @ percutaneous @ electrolytic and water balance substance @ no qualifier||has_expanded_form
poisoning by barbiturates, undetermined, sequela||poisoning by barbiturates, undetermined, sequela||has_expanded_form
gaj||meiotic nuclear divisions 1, s. cerevisiae, homolog of||has_expanded_form
vascular surgery note||note:find:pt:{setting}:doc:vascular surgery||has_expanded_form
removal of packing material on face||removal of packing material on face||has_expanded_form
linc00412 gene||linc00412||has_expanded_form
medical and surgical @ anatomical regions, upper extremities @ supplement @ hand, right @ open @ nonautologous tissue substitute @ no qualifier||supplement right hand with nonautologous tissue substitute, open approach||has_expanded_form
xr skull lat xtable||view lateral crosstable:finding:to identify measures at a point in time:head>skull:document:xr||has_expanded_form
cotinine analysis each test||cotinine analysis each test||has_expanded_form
drainage of prostate, perc endo approach, diagn||drainage of prostate, percutaneous endoscopic approach, diagnostic||has_expanded_form
aptt.factor substitution in platelet poor plasma --1 hour post incubation||coagulation surface induced.factor substitution^1 hour post incubation:time:to identify measures at a point in time:platelet poor plasma:quantitative||has_expanded_form
acyp||acyp2||has_expanded_form
restrict r com iliac vein w intralum dev, open||restriction of right common iliac vein with intraluminal device, open approach||has_expanded_form
carcinoma in situ of skin of unsp eyelid, including canthus||carcinoma in situ of skin of unspecified eyelid, including canthus||has_expanded_form
recurrent pterygium of unspecified eye||recurrent pterygium of eye||has_expanded_form
c psittaci igm titr ser if||c psittaci igm titr ser if||has_expanded_form
o tsut gill ab titr ser if||orientia tsutsugamushi gilliam antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||has_expanded_form
lcacd||vlcad||has_expanded_form
parasimulium||parasimulium||has_expanded_form
insertion of other device into resp tract, via opening||insertion of other device into resp tract, via opening||has_expanded_form
crus primum lobuli ansiformis cerebelli [h vii a]||crus i of the ansiform lobule||has_expanded_form
medical and surgical @ upper joints @ revision @ carpometacarpal joint, left @ external @ synthetic substitute @ no qualifier||medical and surgical @ upper joints @ revision @ carpometacarpal joint, left @ external @ synthetic substitute @ no qualifier||has_expanded_form
bacteria identified # 4 iv line culture nom (line specimen)||bacteria identified # 4 iv line culture nom (line specimen)||has_expanded_form
polio virus 2 antibody^2nd specimen:dilution factor (titer):to identify measures at a point in time:serum:quantitative||polio virus 2 ab [titer] in serum --2nd specimen||has_expanded_form
long intergenic non-protein coding rna 2654||linc02654||has_expanded_form
mcdr2||dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type iii||has_expanded_form
fracture of unspecified shoulder girdle, part unspecified, sequela||fracture of unsp shoulder girdle, part unspecified, sequela||has_expanded_form
luma||mgc3222||has_expanded_form
coxsackievirus b6 ab^1st specimen:titr:pt:ser:qn||coxsackievirus b6 ab spec 1 (s) [titer]||has_expanded_form
diltiazem:mcnc:pt:ser/plas:qn||diltiazem:mcnc:pt:ser/plas:qn||has_expanded_form
latex igg4 ab [mass/volume] in serum||latex ab.igg4:mcnc:pt:ser:qn||has_expanded_form
bonzo||tymstr||has_expanded_form
platelets, pathogen reduced||platelets pheresis path redu||has_expanded_form
medical and surgical @ lower arteries @ bypass @ hepatic artery @ open @ no device @ renal artery, bilateral||bypass hepatic artery to bilateral renal artery, open approach||has_expanded_form
dkfzp434l1435||valyl-trna synthetase 2, mitochondrial||has_expanded_form
bypass l int carotid to r extracran art w autol art, open||bypass left internal carotid artery to right extracranial artery with autologous arterial tissue, open approach||has_expanded_form
reposition left zygomatic bone, perc endo approach||medical and surgical @ head and facial bones @ reposition @ zygomatic bone, left @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
multiple fractures of pelvis with unstable disruption of pelvic ring, subsequent encounter for fracture with delayed healing||multiple fractures of pelvis with unstable disruption of pelvic ring, subsequent encounter for fracture with delayed healing||has_expanded_form
embolism & thrombosis of unspecified artery||embolism and thrombosis of unspecified artery||has_expanded_form
corrosion of third degree of lip(s)||corrosion of third degree of lip(s)||has_expanded_form
fused toes, right foot||fused toes, right foot||has_expanded_form
reticuloendotheliosis virus ab:prthr:pt:ser:ord:ia||reticuloendotheliosis virus ab ia ql (s)||has_expanded_form
ankl1||germ cell-specific protein containing ank, sam, and basic leucine zipper domains||has_expanded_form
eif3a gene||kiaa0139||has_expanded_form
degeneration of iris (pigmentary), bilateral||degeneration of iris (pigmentary), bilateral||has_expanded_form
hepta-cp stl-scnt||heptacarboxylporphyrin:scnt:pt:stool:qn||has_expanded_form
fusion of right tarsal joint with nonautologous tissue substitute, percutaneous approach||fusion of right tarsal joint with nonautologous tissue substitute, percutaneous approach||has_expanded_form
remove bile duct stone||removal of bile duct stone, accessed through the skin||has_expanded_form
revision of infusion device in left carpal joint, external approach||medical and surgical @ upper joints @ revision @ carpal joint, left @ external @ infusion device @ no qualifier||has_expanded_form
physical rehabilitation and diagnostic audiology @ rehabilitation @ speech assessment @ none @ voice @ aerodynamic function @ none||voice assessment using aerodynamic function equipment||has_expanded_form
salter-harris type i physeal fracture of lower end of unspecified femur, subsequent encounter for fracture with nonunion||salter-harris type i physeal fracture of lower end of unspecified femur, subsequent encounter for fracture with nonunion||has_expanded_form
malonate:mcnc:pt:urine:qn||malonate:mcnc:pt:urine:qn||has_expanded_form
primary care urgent care center note||note:find:pt:urgent care center:doc:primary care||has_expanded_form
replacement of upper spine bursa and ligament with synthetic substitute, percutaneous endoscopic approach||replace up spine bursa/lig w synth sub, perc endo||has_expanded_form
chronic atticoantral suppurative otitis media, left ear||chronic atticoantral suppurative otitis media, left ear||has_expanded_form
lamina 7||rexed's lamina vii||has_expanded_form
occlusion of colic vein with extraluminal device, percutaneous endoscopic approach||occlusion of colic vein with extraluminal device, percutaneous endoscopic approach||has_expanded_form
contusion of fallopian tube, bilateral, subsequent encounter||contusion of fallopian tube, bilateral, subsequent encounter||has_expanded_form
burn of first degree of unspecified single finger (nail) except thumb, initial encounter||burn first degree of unsp single finger except thumb, init||has_expanded_form
drainage of right seminal vesicle, perc endo approach||medical and surgical @ male reproductive system @ drainage @ seminal vesicle, right @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
oth non-follic lymphoma, lymph nodes of head, face, and neck||other non-follicular lymphoma, lymph nodes of head, face, and neck (diagnosis)||has_expanded_form
other hand tendon transposition||other hand tendon transposition||has_expanded_form
bypass left fallopian tube to uterus with nonautologous tissue substitute, percutaneous endoscopic approach||medical and surgical @ female reproductive system @ bypass @ fallopian tube, left @ percutaneous endoscopic @ nonautologous tissue substitute @ uterus||has_expanded_form
t cell receptor beta variable 10-2||t cell receptor beta variable 10-2||has_expanded_form
neoplastic syndrome||malignant, benign, and unspecified neoplasms, cysts, polyps (diagnosis)||has_expanded_form
supplement access pancr duct with autol sub, perc approach||supplement accessory pancreatic duct with autologous tissue substitute, percutaneous approach||has_expanded_form
partial foot, shoe insert with longitudinal arch, toe filler||partial foot, shoe insert with longitudinal arch, toe filler||has_expanded_form
medical and surgical @ upper bones @ insertion @ scapula, left @ percutaneous endoscopic @ internal fixation device @ no qualifier||insertion of int fix into l scapula, perc endo approach||has_expanded_form
chiropractic manipulation of head, direct visceral||chiropractic manipulation of head, direct visceral||has_expanded_form
prolyl endopeptidase-like||prepl||has_expanded_form
reposition left carpometacarpal joint with external fixation device, open approach||reposition left carpometacarpal joint with external fixation device, open approach||has_expanded_form
drainage of glomus jugulare with drain dev, open approach||drainage of glomus jugulare with drainage device, open approach||has_expanded_form
morphine (unknown substance) [mass/vol]||morphine:mass concentration:to identify measures at a point in time:unknown substance:quantitative||has_expanded_form
phenx - body composition by dual-energy x-ray absorptiometry protocol:-:point in time:^patient:-:phenx||phenx - body composition by dual-energy x-ray absorptiometry protocol 020301:-:to identify measures at a point in time:^patient:-:phenx||has_expanded_form
underdosing of other antiprotozoal drugs, sequela||underdosing of other antiprotozoal drugs, sequela||has_expanded_form
adult osteochondrosis of spine, occipt-atlan-ax region||adult osteochondrosis of occipito-atlanto-axial region (diagnosis)||has_expanded_form
treat hip wall fracture||treat hip wall fracture||has_expanded_form
igkv1or2108||igkv1or2108||has_expanded_form
unspecified superficial injury of right wrist, initial encounter||unspecified superficial injury of right wrist, init encntr||has_expanded_form
cystine:presence or threshold:to identify measures at a point in time:urine:ordinal||cystine:prthr:pt:urine:ord||has_expanded_form
disopyramide (gast fld) [mass/vol]||disopyramide:mass concentration:to identify measures at a point in time:gastric fluid/contents:quantitative||has_expanded_form
elbow - right flexion passive range of motion quantitative||flexion.passive range of motion:angle:pt:elbow.right:qn||has_expanded_form
mirna4271||microrna 4271||has_expanded_form
clecsf2||clec2b gene||has_expanded_form
excision of l low arm & wrist tendon, perc endo approach||excision of l low arm & wrist tendon, perc endo approach||has_expanded_form
third degree burn of abdominal wall (disorder)||full-thickness skin loss due to burn (third degree nos) of abdominal wall||has_expanded_form
other parachutist accident, subsequent encounter||other parachutist accident, subsequent encounter||has_expanded_form
collapsed vertebra, nec, occipt-atlan-ax region, sqla||collapsed vertebra, nec, occipt-atlan-ax region, sqla||has_expanded_form
restrict of sup mesent art with extralum dev, perc approach||restrict of sup mesent art with extralum dev, perc approach||has_expanded_form
cough ys phenx||for how many years have you had this cough [phenx]||has_expanded_form
ax ab:prthr:pt:ser/plas^donor:ord||ax antibody:presence or threshold:to identify measures at a point in time:serum/plasma^donor:ordinal||has_expanded_form
krt86 gene||k86||has_expanded_form
ct scapula-l wo+w contr iv||multisection^wo & w contrast iv:find:pt:chest>scapula.left:doc:ct||has_expanded_form
excision of medulla oblongata, percutaneous approach, diagnostic||medical and surgical @ central nervous system and cranial nerves @ excision @ medulla oblongata @ percutaneous @ no device @ diagnostic||has_expanded_form
primary stage of yaws||primary frambesia||has_expanded_form
pre-eclampsia or eclampsia superimposed on pre-existing hypertension, with delivery||pre-eclampsia or eclampsia superimposed on pre-existing hypertension, delivered, with or without mention of antepartum condition||has_expanded_form
pax5 ag [presence] in tissue by immune stain||pax5 ag immune stain ql (tiss)||has_expanded_form
toxic effect of other specified inorganic substances, intentional self-harm, initial encounter||toxic effect of inorganic substances, self-harm, init||has_expanded_form
lncrna tcons_00024492||long intergenic non-protein coding rna 1082||has_expanded_form
incis spine 3 column adl seg||osteotomy spine posterior 3 column ea addl sgm||has_expanded_form
medical and surgical @ upper bones @ revision @ radius, right @ open @ nonautologous tissue substitute @ no qualifier||medical and surgical @ upper bones @ revision @ radius, right @ open @ nonautologous tissue substitute @ no qualifier||has_expanded_form
occlusion of jejunum with intraluminal device, via opening||occlusion of jejunum with intraluminal device, via opening||has_expanded_form
long intergenic noncoding rna haglr||hoxd cluster antisense rna 1 (non-protein coding)||has_expanded_form
views ap + lateral^w standing:find:pt:lower extremity.right>ankle:doc:xr||xr ankle - right ap and lateral w standing||has_expanded_form
respir pthgn mult rev trans&amp prb tech 20 trgt||respir pathogen 20 targets||has_expanded_form
replacement of right abdomen muscle with nonautologous tissue substitute, percutaneous endoscopic approach||replace of r abd muscle with nonaut sub, perc endo approach||has_expanded_form
npipb12||nuclear pore complex interacting protein family member b12||has_expanded_form
carboxypeptidase a1 (pancreatic) gene||cpa1||has_expanded_form
drainage of left main bronchus with drainage device, percutaneous approach||medical and surgical @ respiratory system @ drainage @ main bronchus, left @ percutaneous @ drainage device @ no qualifier||has_expanded_form
fluid intake:vrat:24h:^patient:qn:estimated||fluid intake 24 hour estimated||has_expanded_form
liver kidney microsomal 1 antibody:presence or threshold:to identify measures at a point in time:body fluid, unsp:ordinal:immune fluorescence||liver kidney microsomal 1 ab:prthr:pt:body fld:ord:if||has_expanded_form
medical and surgical @ female reproductive system @ release @ fallopian tube, left @ percutaneous endoscopic @ no device @ no qualifier||release left fallopian tube, perc endo approach||has_expanded_form
medical and surgical @ heart and great vessels @ bypass @ pulmonary artery, left @ open @ autologous arterial tissue @ carotid||bypass left pulmonary artery from carotid with autologous arterial tissue, open approach||has_expanded_form
measurement and monitoring @ physiological systems @ measurement @ olfactory @ external @ acuity @ no qualifier||measurement of olfactory acuity, external approach||has_expanded_form
medical and surgical @ urinary system @ insertion @ bladder @ percutaneous @ other device @ no qualifier||medical and surgical @ urinary system @ insertion @ bladder @ percutaneous @ other device @ no qualifier||has_expanded_form
administration @ physiological systems and anatomical regions @ introduction @ coronary artery @ percutaneous @ thrombolytic @ other thrombolytic||introduction of other thrombolytic into coronary artery, percutaneous approach||has_expanded_form
drainage of left hip muscle, perc endo approach||medical and surgical @ muscles @ drainage @ hip muscle, left @ percutaneous endoscopic @ no device @ no qualifier||has_expanded_form
consult with dentist||consult with dentist||has_expanded_form
medical and surgical @ head and facial bones @ release @ mandible, right @ open @ no device @ no qualifier||medical and surgical @ head and facial bones @ release @ mandible, right @ open @ no device @ no qualifier||has_expanded_form
insert tissue expander in chest subcu/fascia, perc||insertion of tissue expander into chest subcutaneous tissue and fascia, percutaneous approach||has_expanded_form
evaluation and management of anticoagulation note:find:pt:{setting}:doc:{role}||evaluation and management of anticoagulation note:find:pt:{setting}:doc:{role}||has_expanded_form
drvvt.hexagonal phase phospholipid actual/normal:reltime:pt:ppp:qn:coag||drvvt.hexagonal phase phospholipid actual/normal:reltime:pt:ppp:qn:coag||has_expanded_form
medical and surgical @ lower joints @ excision @ ankle joint, right @ open @ no device @ diagnostic||medical and surgical @ lower joints @ excision @ ankle joint, right @ open @ no device @ diagnostic||has_expanded_form
g protein-coupled receptor kinase 5 gene||g protein-coupled receptor kinase 5||has_expanded_form
liveborn infants according to place of birth and type of delivery||liveborn infants according to place of birth and type of del||has_expanded_form
medical and surgical @ ear, nose, sinus @ drainage @ auditory ossicle, left @ open @ drainage device @ no qualifier||drainage of left auditory ossicle with drainage device, open approach||has_expanded_form
person injured in collision betw oth mtr veh (traffic), subs||person injured in collision between other specified motor vehicles (traffic), subsequent encounter||has_expanded_form
closure of rectovaginal fistula by abdominal approach with concomitant colostomy||closure of rectovaginal fistula; abdominal approach, with concomitant colostomy||has_expanded_form
alpha glucosidase||alpha-glucosidase, acid||has_expanded_form
consult with specialist for social problems||consult;specialist;social||has_expanded_form
thrb gene.p.ala317thr:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||thrb gene.p.ala317thr:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||has_expanded_form
measurement of lymphatic pressure, open approach||measurement of lymphatic pressure, open approach||has_expanded_form
edema of right upper eyelid||edema of right upper eyelid||has_expanded_form
vanilloylglycine [moles/vol]||vanilloylglycine serpl-scnc||has_expanded_form
burn due to fishing boat on fire, subsequent encounter||burn due to fishing boat on fire, subsequent encounter||has_expanded_form
fluoxetine/creatinine:mrto:pt:urine:qn||fluoxetine/creatinine [mass ratio] in urine||has_expanded_form
magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s), followed by contrast material(s) and further sequences||retired procedure [33571007]||has_expanded_form
shank-associated rh domain interactor||shank associated rh domain interactor||has_expanded_form
ct guidance for drainage and placement of drainage catheter of pelvis-- wo contrast||guidance for drainage+placement of drainage catheter^wo contrast:find:pt:pelvis:doc:ct||has_expanded_form
extirpation of matter from left inferior parathyroid gland, percutaneous endoscopic approach||extirpate matter from l inf parathyroid, perc endo||has_expanded_form
epilepsy, progressive myoclonic, 6||epm6||has_expanded_form
medical and surgical @ gastrointestinal system @ repair @ stomach @ percutaneous endoscopic @ no device @ no qualifier||repair stomach, percutaneous endoscopic approach||has_expanded_form
revision of intralum dev in up art, perc endo approach||revision of intralum dev in up art, perc endo approach||has_expanded_form
stenosis of rectum and anus nos (disorder)||stenosis of anus and rectum||has_expanded_form
ice msg ea.20min||ice msg ea.20min||has_expanded_form
aerospace med note||note:find:pt:{setting}:doc:aerospace medicine||has_expanded_form
medical and surgical @ lower joints @ replacement @ hip joint, left @ open @ synthetic substitute, ceramic on polyethylene @ no qualifier||medical and surgical @ lower joints @ replacement @ hip joint, left @ open @ synthetic substitute, ceramic on polyethylene @ no qualifier||has_expanded_form
revision of drain dev in r carpometacarp jt, open approach||medical and surgical @ upper joints @ revision @ carpometacarpal joint, right @ open @ drainage device @ no qualifier||has_expanded_form
fatty acid oxidation defects newborn screening comment-discussion:txt:pt:bld.dot:nar||fod nbs comment||has_expanded_form
insertion of radioactive element into right breast, open approach||insertion of radioact elem into r breast, open approach||has_expanded_form
oviductal surgery salpingostomy||salpingostomy (treatment)||has_expanded_form
effects of heat and/or light||heat effect nos||has_expanded_form
excision of right upper lobe bronchus, percutaneous endoscopic approach, diagnostic||medical and surgical @ respiratory system @ excision @ upper lobe bronchus, right @ percutaneous endoscopic @ no device @ diagnostic||has_expanded_form
supplement left upper lobe bronchus with synth sub, endo||supplement left upper lobe bronchus with synthetic substitute, via natural or artificial opening endoscopic||has_expanded_form
medical and surgical @ tendons @ supplement @ thorax tendon, left @ percutaneous endoscopic @ synthetic substitute @ no qualifier||medical and surgical @ tendons @ supplement @ thorax tendon, left @ percutaneous endoscopic @ synthetic substitute @ no qualifier||has_expanded_form
medical and surgical @ urinary system @ drainage @ urethra @ via natural or artificial opening endoscopic @ no device @ no qualifier||medical and surgical @ urinary system @ drainage @ urethra @ via natural or artificial opening endoscopic @ no device @ no qualifier||has_expanded_form
3-methoxytyramine.free [moles/volume] in serum or plasma||3-methoxytyramine.free [moles/vol]||has_expanded_form
other chondrocalcinosis, multiple sites||other chondrocalcinosis, multiple sites||has_expanded_form
cyp2d6 gene trgt seq alys 3' gene dupl/mlt||cyp2d6 3' gene dup/mlt||has_expanded_form
ara-c/dnr/gm-csf||cytarabine/daunorubicin/sargramostim||has_expanded_form
carbohydrate-deficient glycoprotein syndrome type ia||carbohydrate deficient glycoprotein (cdg) syndrome (cdgs) 1||has_expanded_form
e3 (u) [moles/vol]||e3 (u) [moles/vol]||has_expanded_form
parachutist injured on landing, subsequent encounter||parachutist injured on landing, subsequent encounter||has_expanded_form
displ seg fx shaft of l femr, 7thh||displ seg fx shaft of l femr, 7thh||has_expanded_form
canarypox virus ag [presence] in serum||canarypox virus ag:prthr:pt:ser:ord||has_expanded_form
resection of right seminal vesicle, open approach||resection of right seminal vesicle, open approach||has_expanded_form
oxsr1 gene||oxidative stress responsive kinase 1||has_expanded_form
imaging @ non-axial lower bones @ fluoroscopy @ calcaneus, right @ none @ none @ none||imaging @ non-axial lower bones @ fluoroscopy @ calcaneus, right @ none @ none @ none||has_expanded_form
avg sta day/night o2 < 1 lpm||prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is less than 1 liter per minute (lpm)||has_expanded_form
other specified injury of other specified blood vessels at shoulder and upper arm level, right arm, subsequent encounter||inj oth blood vessels at shldr/up arm, right arm, subs||has_expanded_form
poisoning by iron and its compounds, assault, subsequent encounter||poisoning by iron and its compounds, assault, subsequent encounter||has_expanded_form
microrna 138-2||mirn138-2||has_expanded_form
prkrirp8||prkrirp8||has_expanded_form
excision of left common iliac artery, percutaneous approach||excision of left common iliac artery, percutaneous approach||has_expanded_form
pdzk11||pdzd11 gene||has_expanded_form
infectious disease, bacterial vaginosis and vaginitis, quantitative real-time amplification of dna markers for gardnerella vaginalis, atopobium vaginae, megasphaera type 1, bacterial vaginosis associated bacteria-2 (bvab-2), and lactobacillus species (l. crispatus and l. jensenii), utilizing vaginal-fluid specimens, algorithm reported as a positive or negative for high likelihood of bacterial vaginosis, includes separate detection of trichomonas vaginalis and/or candida species (c. albicans, c. tropicalis, c. parapsilosis, c. dubliniensis), candida glabrata, candida krusei, when reported||nfct ds bv&vaginitis dna alg||has_expanded_form
medical and surgical @ lower veins @ drainage @ inferior vena cava @ percutaneous endoscopic @ no device @ diagnostic||medical and surgical @ lower veins @ drainage @ inferior vena cava @ percutaneous endoscopic @ no device @ diagnostic||has_expanded_form
toxic effect of venom of caterpillars, assault, sequela||toxic effect of venom of caterpillars, assault, sequela||has_expanded_form
fluoroscopy of right subclavian vein using h osm contrast||imaging @ veins @ fluoroscopy @ subclavian vein, right @ high osmolar @ none @ none||has_expanded_form
drainage of right hand vein with drain dev, perc approach||medical and surgical @ upper veins @ drainage @ hand vein, right @ percutaneous @ drainage device @ no qualifier||has_expanded_form
chromosome 8 trisomy [percentile] by cytogenetics||chromosome 8 trisomy:percentile:to identify measures at a point in time:whole blood/tissue, unspecified:quantitative:cytogenetics||has_expanded_form
application of interdental fixation device for conditions other than fracture or dislocation, includes removal||application of interdental fixation device for conditions other than fracture or dislocation, includes removal||has_expanded_form
us guided absc drain+cath place||guidance for drainage of abscess+placement of drainage catheter:finding:to identify measures at a point in time:not specified:document:ultrasound||has_expanded_form
snow veh acc-motorcycl||nontraffic accident involving motor-driven snow vehicle injuring motorcyclist||has_expanded_form
supplement right basilic vein with synth sub, open approach||medical and surgical @ upper veins @ supplement @ basilic vein, right @ open @ synthetic substitute @ no qualifier||has_expanded_form
mipepp2||mipepp2||has_expanded_form
usp32p1 gene||ubiquitin specific peptidase 32 pseudogene 1||has_expanded_form
torus fracture of upper end of right fibula, sequela||torus fracture of upper end of right fibula, sequela||has_expanded_form
vitamin a deficiency with other ocular manifestations -retired-||vitamin a deficiency with other ocular manifestations -retired-||has_expanded_form
nondisp fx of fourth metatarsal bone, left foot, sequela||nondisp fx of fourth metatarsal bone, left foot, sequela||has_expanded_form
trp-tgg3-1||trp3||has_expanded_form
revision of synthetic substitute in right toe phalanx, percutaneous endoscopic approach||revision of synthetic substitute in right toe phalanx, percutaneous endoscopic approach||has_expanded_form
introduce of low dose il-2 into central art, open approach||administration @ physiological systems and anatomical regions @ introduction @ central artery @ open @ antineoplastic @ low-dose interleukin-2||has_expanded_form
rps2p20 gene||ribosomal protein s2 pseudogene 20||has_expanded_form
bypass sup mesent vein to low vein w autol vn, open||bypass sup mesent vein to low vein w autol vn, open||has_expanded_form
medical and surgical @ heart and great vessels @ supplement @ ventricle, right @ percutaneous endoscopic @ synthetic substitute @ no qualifier||supplement r ventricle with synth sub, perc endo approach||has_expanded_form
injury of r int carotid, intcr w loc of 31-59 min, sequela||injury of r int carotid, intcr w loc of 31-59 min, sequela||has_expanded_form
bmiq19||bmiq19||has_expanded_form
respiratory syncytial virus antibody.immunoglobulin g:dilution factor (titer):to identify measures at a point in time:serum:quantitative||rsv igg (s) [titer]||has_expanded_form
zinc finger protein 441||flj38637||has_expanded_form
mir606||hsa-mir-606||has_expanded_form
excision of right glenoid cavity, percutaneous approach, diagnostic||excision of right glenoid cavity, perc approach, diagn||has_expanded_form
presence of artificial hip joint, bilateral||presence of artificial hip joint, bilateral||has_expanded_form
salter-harris type ii physeal fracture of lower end of ulna, left arm, sequela||salter-harris type ii physeal fracture of lower end of ulna, left arm, sequela||has_expanded_form
other heelies accident, sequela||other heelies accident, sequela||has_expanded_form
anserine/creatinine [ratio] in 24 hour urine||anserine/creat 24h ur-rto||has_expanded_form
maternal care for (suspected) damage to fetus from viral disease in mother, fetus 4||maternal care for (suspected) damage to fetus from viral disease in mother, fetus 4||has_expanded_form
removal of nonaut sub from l low femur, perc approach||removal of nonaut sub from l low femur, perc approach||has_expanded_form
bypass azygos vein to upper vein with autologous arterial tissue, open approach||bypass azygos vein to upper vein with autologous arterial tissue, open approach||has_expanded_form
smim15 gene||dkfzp686e2158||has_expanded_form
vestigial like family member 2||vestigial like family member 2 gene||has_expanded_form
repair respiratory system in poc with oth dev, perc approach||repair respiratory system in poc with oth dev, perc approach||has_expanded_form
poisoning by cocaine, accidental (unintentional), initial encounter||poisoning by cocaine, accidental (unintentional), initial encounter||has_expanded_form
cutaneous t-cell lymphoma, unsp, intra-abdominal lymph nodes||cutaneous t-cell lymphoma, unsp, intra-abdominal lymph nodes||has_expanded_form
reposition right femoral vein, percutaneous approach||reposition right femoral vein, percutaneous approach||has_expanded_form
amco||codox-m||has_expanded_form
explosion and rupture of pressurized-gas tank, subsequent encounter||explosion and rupture of pressurized-gas tank, subs encntr||has_expanded_form
sprain of interphalangeal joint of unsp great toe, subs||sprain of interphalangeal joint of unsp great toe, subs||has_expanded_form
pcdhb9 gene||pcdhb9||has_expanded_form
drain of r hypogast vein with drain dev, perc endo approach||medical and surgical @ lower veins @ drainage @ hypogastric vein, right @ percutaneous endoscopic @ drainage device @ no qualifier||has_expanded_form
contrast radiography of bladder||cystography||has_expanded_form
extirpation of matter from femoral nerve, perc endo approach||extirpation of matter from femoral nerve, percutaneous endoscopic approach||has_expanded_form
medical and surgical @ urinary system @ revision @ bladder @ percutaneous endoscopic @ monitoring device @ no qualifier||medical and surgical @ urinary system @ revision @ bladder @ percutaneous endoscopic @ monitoring device @ no qualifier||has_expanded_form
opiates:mcnc:pt:saliva:qn:screen||opiates:mass concentration:to identify measures at a point in time:saliva:quantitative:screen||has_expanded_form
cmfvp(t)||cyclophosphamide/fluorouracil/methotrexate/prednisone/tamoxifen/vincristine||has_expanded_form
vpmpr||nucleus ventralis posteromedialis, pars principalis||has_expanded_form
vocation activ/commun assessment using prosthesis||physical rehabilitation and diagnostic audiology @ rehabilitation @ activities of daily living assessment @ none @ vocational activities and functional community or work reintegration skills @ prosthesis @ none||has_expanded_form
ecrg4||esophageal cancer-related gene 4||has_expanded_form
bovine diarrhea virus ribonucleic acid:presence or threshold:to identify measures at a point in time:not specified:ordinal:probe.amp.tar||bvdv rna spec ql naa+probe||has_expanded_form
labor and delivery comp by oth cord entangle, w/o comprsn||labor and delivery comp by oth cord entangle, w/o comprsn||has_expanded_form
pulmonary hypertension, primary||ppht - primary pulmonary hypertension||has_expanded_form
drainage of l epididymis with drain dev, perc endo approach||drainage of left epididymis with drainage device, percutaneous endoscopic approach||has_expanded_form
removal of int fix from l patella, open approach||removal of internal fixation device from left patella, open approach||has_expanded_form
slc2a1-as1 gene||slc2a1 antisense rna 1||has_expanded_form
restriction of upper esophagus with intraluminal device, via natural or artificial opening endoscopic||medical and surgical @ gastrointestinal system @ restriction @ esophagus, upper @ via natural or artificial opening endoscopic @ intraluminal device @ no qualifier||has_expanded_form
extirpation of matter from right tympanic membrane, endo||extirpation of matter from right tympanic membrane, endo||has_expanded_form
3-hydroxyglutarate/creatinine:substance ratio:24 hours:urine:quantitative||3-hydroxyglutarate/creatinine (24h u) [molar ratio]||has_expanded_form
fragmentation in right lower lobe bronchus, via natural or artificial opening||medical and surgical @ respiratory system @ fragmentation @ lower lobe bronchus, right @ via natural or artificial opening @ no device @ no qualifier||has_expanded_form
heat-shock 27-kd protein 2||hs.78846||has_expanded_form
nondisp fx of lateral condyle of unsp tibia, 7thj||nondisp fx of lateral condyle of unsp tibia, 7thj||has_expanded_form
medical and surgical @ hepatobiliary system and pancreas @ bypass @ gallbladder @ percutaneous endoscopic @ no device @ stomach||medical and surgical @ hepatobiliary system and pancreas @ bypass @ gallbladder @ percutaneous endoscopic @ no device @ stomach||has_expanded_form
medical and surgical @ upper arteries @ occlusion @ radial artery, left @ percutaneous @ no device @ no qualifier||medical and surgical @ upper arteries @ occlusion @ radial artery, left @ percutaneous @ no device @ no qualifier||has_expanded_form
repair left lower lung lobe, open approach||repair left lower lung lobe, open approach||has_expanded_form
vascular abnormalities of conjunctiva, right eye||vascular abnormalities of conjunctiva, right eye||has_expanded_form
medical and surgical @ lower veins @ extirpation @ portal vein @ open @ no device @ no qualifier||medical and surgical @ lower veins @ extirpation @ portal vein @ open @ no device @ no qualifier||has_expanded_form
drd3 gene||dopamine receptor d3||has_expanded_form
contact radiation of cervix||contact radiation of cervix||has_expanded_form
transposition ovary(s)||transposition of ovary||has_expanded_form
glucose^2 hours specimen:substance concentration:to identify measures at a point in time:dialysis fluid:quantitative||glucose 2 hour specimen (dial fld) [moles/vol]||has_expanded_form
medical and surgical @ lower bones @ drainage @ tarsal, right @ open @ no device @ no qualifier||drainage of right tarsal, open approach||has_expanded_form
administration of coronavirus vaccine 1, booster||fee covid-19 vac 1 booster||has_expanded_form
cutaneous vesicostomy (treatment)||cutaneous vesicostomy||has_expanded_form
inspection of products of conception, perc endo approach||inspection of products of conception, percutaneous endoscopic approach||has_expanded_form
sltr-haris type ii physl fx low end unsp fibula, 7thd||salter-harris type ii physeal fracture of lower end of unspecified fibula, subsequent encounter for fracture with routine healing||has_expanded_form
underdosing of antirheumatics, nec, subs||underdosing of antirheumatics, not elsewhere classified, subsequent encounter||has_expanded_form
contusion, breast (disorder)||breast; contusion||has_expanded_form
mpi gene targeted mutation analysis:find:pt:bld/tiss:doc:molgen||mpi gene targeted mutation analysis molgen doc (bld/tiss)||has_expanded_form
linc02119||linc02119 gene||has_expanded_form
spls||structure of subparietal sulcus||has_expanded_form
partial traumatic amputation of one right lesser toe, subs||partial traumatic amputation of one right lesser toe, subsequent encounter||has_expanded_form
surgical arthroscopy of wrist with release of transverse carpal ligament||endoscopy, wrist, surgical, with release of transverse carpal ligament||has_expanded_form
medical and surgical @ upper bones @ revision @ finger phalanx, left @ percutaneous endoscopic @ autologous tissue substitute @ no qualifier||revise of autol sub in l finger phalanx, perc endo approach||has_expanded_form
body mass index [bmi] 30-39, adult||body mass index [bmi] 30-39, adult||has_expanded_form
therapeutic drug monitor||encounter for therapeutic drug monitoring||has_expanded_form
steroid responders borderline glaucoma||steroid glaucoma borderline||has_expanded_form
other contact with turkey, sequela||other contact with turkey, sequela||has_expanded_form
histoplasmosis duboisii||histoplasmosis; histoplasma duboisii||has_expanded_form
electronic analysis antitachy pacemaker system||electronic analysis antitachy pacemaker system||has_expanded_form
oth spcf urinary incontince||other specified urinary incontinence||has_expanded_form
magnetic resonance imaging (mri) of bilateral lower extremity arteries||imaging @ lower arteries @ magnetic resonance imaging (mri) @ lower extremity arteries, bilateral @ none @ none @ none||has_expanded_form
function compared to previous assessment:finding:to identify measures at a point in time:optic disc+retinal nerve fiber layer.left:ordinal:electroretinogram||l optic disc+rnfl comp func erg||has_expanded_form
grip and coiled-coil domain-containing protein 2||gcc2||has_expanded_form
dcaf13p3||dcaf13p3||has_expanded_form
time by us||time:time:pt:circulatory system.xxx:qn:us||has_expanded_form
removal of monitoring device from left lung, percutaneous endoscopic approach||removal of monitoring device from l lung, perc endo approach||has_expanded_form
phosphatidylethanolamine antibody.immunoglobulin a:arbitrary concentration:to identify measures at a point in time:serum:quantitative||phosphatidylethanolamine iga qn (s)||has_expanded_form
sult1c4||sulfotransferase family, cytosolic, 1c, member 2||has_expanded_form
guidance for angioplasty^w contrast intra-arterial:finding:to identify measures at a point in time:neck>carotid artery.extracranial:document:radiofluoroscopy.angio||guidance for angioplasty^w contrast ia:find:pt:neck>carotid artery.extracranial:doc:rf.angio||has_expanded_form
auts7||auts7||has_expanded_form
drainage of lower vein, percutaneous approach, diagnostic||drainage of lower vein, percutaneous approach, diagnostic||has_expanded_form
alteration of left ankle region with synthetic substitute, percutaneous endoscopic approach||alteration of left ankle region with synthetic substitute, percutaneous endoscopic approach||has_expanded_form
newborn hearing screen method:type:point in time:ear:nominal||nb hearing scn meth||has_expanded_form
mental retardation, autosomal dominant 55, with seizures||mrd55||has_expanded_form
unspecified occupant of military vehicle injured in traffic accident, sequela||occup of military vehicle injured in traf, sequela||has_expanded_form
medical and surgical @ muscles @ extirpation @ hand muscle, left @ percutaneous @ no device @ no qualifier||medical and surgical @ muscles @ extirpation @ hand muscle, left @ percutaneous @ no device @ no qualifier||has_expanded_form
[x]dependence on other enabling machines and devices||dependence on other enabling machines and devices||has_expanded_form
bypass coronary artery, one artery from abdominal artery with autologous arterial tissue, percutaneous endoscopic approach||bypass 1 cor art from abd art w autol art, perc endo||has_expanded_form
effect prosthetic device||effect(s);prosthetic device||has_expanded_form
reg3g||unq429||has_expanded_form
resection of nasal septum, open approach||medical and surgical @ ear, nose, sinus @ resection @ nasal septum @ open @ no device @ no qualifier||has_expanded_form
acebutolol fld-mcnc||acebutolol:mass concentration:to identify measures at a point in time:body fluid, unsp:quantitative||has_expanded_form
medical and surgical @ bursae and ligaments @ reposition @ shoulder bursa and ligament, left @ open @ no device @ no qualifier||reposition left shoulder bursa and ligament, open approach||has_expanded_form
medical and surgical @ heart and great vessels @ dilation @ coronary artery, three arteries @ open @ intraluminal device, four or more @ bifurcation||dilation of coronary artery, three arteries, bifurcation, with four or more intraluminal devices, open approach||has_expanded_form
toxic effect of aflatoxin, accidental (unintentional)||toxic effect of aflatoxin, accidental (unintentional)||has_expanded_form
displaced transverse fracture of shaft of unspecified ulna, subsequent encounter for open fracture type i or ii with malunion||displ transverse fx shaft of unsp ulna, 7thq||has_expanded_form
reposition left lacrimal gland, open approach||medical and surgical @ eye @ reposition @ lacrimal gland, left @ open @ no device @ no qualifier||has_expanded_form
middletonia||middletonia||has_expanded_form
acute tonsillitis||acute tonsillitis nos (disorder)||has_expanded_form
mir301b gene||mirn301b||has_expanded_form
s roseus ige qn||sporobolomyces roseus ab.ige:acnc:pt:ser:qn||has_expanded_form
medical and surgical @ mouth and throat @ alteration @ lower lip @ external @ nonautologous tissue substitute @ no qualifier||alteration of lower lip with nonaut sub, extern approach||has_expanded_form
destruction of lumbar sympathetic nerve, percutaneous approach||destruction of lumbar sympathetic nerve, perc approach||has_expanded_form
mr pit+sella turc wo contr||mr pit+sella turc wo contr||has_expanded_form
kcnh7||potassium voltage-gated channel, subfamily h (eag-related), member 7||has_expanded_form
too many things at once phenx||too many things at once phenx||has_expanded_form
parthenium integrifolia/part||parthenium integrifolia / parthenium root||has_expanded_form
immunoglobulin gene rearrangements:finding:to identify measures at a point in time:whole blood/tissue, unspecified:narrative:molecular genetics||immunoglobulin gene rearrangements:finding:to identify measures at a point in time:whole blood/tissue, unspecified:narrative:molecular genetics||has_expanded_form
medical and surgical @ lower bones @ insertion||lower bones, insertion||has_expanded_form
hemoglobin calc (bldcv) [mass/vol]||hemoglobin [mass/volume] in central venous blood by calculation||has_expanded_form
origin recognition complex, subunit 5, s. cerevisiae, homolog of||ppp1r117||has_expanded_form
spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens||spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens||has_expanded_form
social problem with insurance||problem;social;insurance||has_expanded_form
delay flap/sectioning flap scalp arms/legs||delay of flap or sectioning of flap (division and inset); at scalp, arms, or legs||has_expanded_form
medical and surgical @ upper bones @ drainage @ ulna, right @ open @ no device @ no qualifier||drainage of right ulna, open approach||has_expanded_form
medical and surgical @ anatomical regions, general @ inspection @ head @ percutaneous @ no device @ no qualifier||medical and surgical @ anatomical regions, general @ inspection @ head @ percutaneous @ no device @ no qualifier||has_expanded_form
medical and surgical @ central nervous system and cranial nerves @ removal @ cerebral ventricle @ percutaneous @ infusion device @ no qualifier||medical and surgical @ central nervous system and cranial nerves @ removal @ cerebral ventricle @ percutaneous @ infusion device @ no qualifier||has_expanded_form
diuretics nom (u)||diuretics:presence or identity:to identify measures at a point in time:urine:nominal||has_expanded_form
drainage of left nipple with drainage device, perc approach||drainage of left nipple with drainage device, perc approach||has_expanded_form
traum hemor r cereb w loc w dth d/t brain inj bf consc, init||traumatic hemorrhage of right cerebrum with loss of consciousness of any duration with death due to brain injury prior to regaining consciousness, initial encounter||has_expanded_form
muscle performance assessment of musculoskeletal system - upper back / upper extremity||muscle performance assessment of musculoskeletal system - upper back / upper extremity||has_expanded_form
lettuce ige ab rast class [presence] in serum||lactuca sativa ab.ige.rast class:prthr:pt:ser:ord||has_expanded_form
posterior tibial artery diastolic blood pressure||post tibl a bp dias||has_expanded_form
doxycycline [susceptibility] by minimum inhibitory concentration (mic)||doxycycline islt mic||has_expanded_form
mir6834 gene||microrna 6834||has_expanded_form
medical and surgical @ upper arteries @ release @ hand artery, left @ open @ no device @ no qualifier||release left hand artery, open approach||has_expanded_form
open frac of bos with oth and unspec intcran hem, with prolonged loc and return to pecl||open fracture of base of skull with other and unspecified intracranial hemorrhage, with prolonged [more than 24 hours] loss of consciousness and return to pre-existing conscious level||has_expanded_form
nondisplaced comminuted fracture of shaft of left tibia, subsequent encounter for open fracture type iiia, iiib, or iiic with delayed healing||nondisplaced comminuted fracture of shaft of left tibia, subsequent encounter for open fracture type iiia, iiib, or iiic with delayed healing||has_expanded_form
nedd4-2||ubiquitin protein ligase nedd4-like||has_expanded_form
acute embolism and thombos unsp calf muscular vein||acute embolism and thrombosis of calf muscular vein||has_expanded_form
other superficial bite of breast, left breast||other superficial bite of breast, left breast||has_expanded_form
ampicillin^peak:mcnc:pt:ser/plas:qn||ampicillin^peak:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||has_expanded_form
piwi-interacting rna cluster 11||pirc11||has_expanded_form
disp fx of head of left radius, subs for clos fx w malunion||disp fx of head of left radius, subs for clos fx w malunion||has_expanded_form
ldr brachytherapy of kidney using iridium 192||ldr brachytherapy of kidney using iridium 192||has_expanded_form
s. rectivirgula ab ql (s)||saccharopolyspora rectivirgula antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||has_expanded_form
upper joints, change||upper joints, change||has_expanded_form
peroneal tendinitis, right leg||peroneal tendinitis, right leg||has_expanded_form
change anorectal packing material||placement @ anatomical orifices @ change @ anorectal @ external @ packing material @ no qualifier||has_expanded_form
excision of right upper extremity, percutaneous approach, diagnostic||excision of right upper extremity, percutaneous approach, diagnostic||has_expanded_form
m7mls2||m7mls2||has_expanded_form
insertion of internal fixation device into cervical vertebral joint, percutaneous endoscopic approach||medical and surgical @ upper joints @ insertion @ cervical vertebral joint @ percutaneous endoscopic @ internal fixation device @ no qualifier||has_expanded_form
unspecified injury of ureter, initial encounter||unspecified injury of ureter, initial encounter||has_expanded_form
transferrin receptor.soluble:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||transferrin receptor.soluble [mass/vol]||has_expanded_form
removal of nonautologous tissue substitute from kidney, percutaneous approach||removal of nonaut sub from kidney, perc approach||has_expanded_form
batesia <butterflies>||batesia||has_expanded_form
mir6769a||mir6769a||has_expanded_form
personnel nine-digit postal code||nine-digit postal code:location:to identify measures at a point in time:personnel:nominal||has_expanded_form
bypass hepatic vein to lower vein with autologous arterial tissue, open approach||medical and surgical @ lower veins @ bypass @ hepatic vein @ open @ autologous arterial tissue @ lower vein||has_expanded_form
military operations involving other explosions and fragments||military operations involving other explosions and fragments||has_expanded_form
drain of r int iliac art with drain dev, perc endo approach||drainage of right internal iliac artery with drainage device, percutaneous endoscopic approach||has_expanded_form
inspection of left elbow joint, percutaneous endoscopic approach||inspection of left elbow joint, perc endo approach||has_expanded_form
actin binding transcription modulator||actin binding transcription modulator||has_expanded_form
excision of appendix, open approach, diagnostic||excision of appendix, open approach, diagnostic||has_expanded_form
mastotomy w/exploration/drainage abscess deep||mastotomy with exploration or drainage of abscess, deep||has_expanded_form
facial tic||facial tic disorder||has_expanded_form
contusion of unspecified upper arm||contusion of unspecified upper arm||has_expanded_form
fut10 gene||fut10 gene||has_expanded_form
ananas comosus ab.igg:mcnc:pt:ser:qn||pineapple igg-mcnc||has_expanded_form
bypass right posterior tibial artery to lower extremity artery with synthetic substitute, percutaneous approach||bypass right posterior tibial artery to lower extremity artery with synthetic substitute, percutaneous approach||has_expanded_form
galnac transferase 11||galnact11||has_expanded_form
excise max/zygoma b9 tumor||excise max/zygoma b9 tumor||has_expanded_form
dyspnea^resting:find:pt:respiratory system:ord||dyspnea respiratory system --resting||has_expanded_form
11-deoxycorticosterone [mass/volume] in urine||11doc ur-mcnc||has_expanded_form
unstable burst fx t7-t8 vertebra, subs for fx w delay heal||unstable burst fx t7-t8 vertebra, subs for fx w delay heal||has_expanded_form
nk1 transcription factor related, locus 1 (drosophila)||nk1 homeobox 1||has_expanded_form
actin binding lim protein family, member 2||ablim2||has_expanded_form
nm views for abscess w ga-67 iv||nm unspecified body region views for abscess w ga-67 iv||has_expanded_form
acrosome formation associated factor||c9orf11||has_expanded_form
release right tarsal joint, percutaneous endoscopic approach||release right tarsal joint, percutaneous endoscopic approach||has_expanded_form
medical and surgical @ lower veins @ bypass @ splenic vein @ percutaneous endoscopic @ nonautologous tissue substitute @ lower vein||bypass splenic vein to low vein w nonaut sub, perc endo||has_expanded_form
excision of left ulna, percutaneous endoscopic approach||excision of left ulna, percutaneous endoscopic approach||has_expanded_form
underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela||underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela||has_expanded_form
medical and surgical @ anatomical regions, general @ revision @ gastrointestinal tract @ open @ infusion device @ no qualifier||revision of infusion device in gi tract, open approach||has_expanded_form
insertion of intralum dev into inf mesent art, perc approach||medical and surgical @ lower arteries @ insertion @ inferior mesenteric artery @ percutaneous @ intraluminal device @ no qualifier||has_expanded_form
duloxetine:prthr:pt:ser/plas:ord:screen||duloxetine screen ql||has_expanded_form
hepatitis b virus codon 214 [identifier] by genotype method||hbv 214 islt genotyp||has_expanded_form
medical and surgical @ male reproductive system @ removal @ vas deferens @ external @ intraluminal device @ no qualifier||removal of intralum dev from vas deferens, extern approach||has_expanded_form
drainage of left main bronchus, open approach, diagnostic||medical and surgical @ respiratory system @ drainage @ main bronchus, left @ open @ no device @ diagnostic||has_expanded_form
removal of spacer from right finger phalangeal joint, percutaneous endoscopic approach||medical and surgical @ upper joints @ removal @ finger phalangeal joint, right @ percutaneous endoscopic @ spacer @ no qualifier||has_expanded_form
unspecified injury at t1 level of thoracic spinal cord||unspecified injury at t1 level of thoracic spinal cord||has_expanded_form
linc01052||linc01052 gene||has_expanded_form
ras homolog gene family, member n||rho family gtpase 2||has_expanded_form
dilate of l face vein with intralum dev, perc endo approach||dilate of l face vein with intralum dev, perc endo approach||has_expanded_form
removal of extraluminal device from vas deferens, open approach||removal of extraluminal device from vas deferens, open approach||has_expanded_form
transfer left foot bursa and ligament, perc endo approach||transfer left foot bursa and ligament, percutaneous endoscopic approach||has_expanded_form
can pronounce stochastic:find:pt:^patient:ord:nih toolbox||can pronounce stochastic:find:pt:^patient:ord:nih toolbox||has_expanded_form
defb14||defb114 gene||has_expanded_form
medical and surgical @ heart and great vessels @ release @ conduction mechanism @ percutaneous endoscopic @ no device @ no qualifier||release conduction mechanism, perc endo approach||has_expanded_form
supplement hepatic artery with synth sub, perc approach||supplement hepatic artery with synthetic substitute, percutaneous approach||has_expanded_form
unspecified injury of radial artery at forearm level||unspecified injury of radial artery at forearm level||has_expanded_form
fusion of left toe phalangeal joint with nonautologous tissue substitute, percutaneous approach||fusion of left toe phalangeal joint with nonautologous tissue substitute, percutaneous approach||has_expanded_form
pnctr w foreign body of abd wall, l upr q w penet perit cav||puncture wound with foreign body of abdominal wall, left upper quadrant with penetration into peritoneal cavity||has_expanded_form
ptms gene||parat||has_expanded_form
myc gene rearrangements:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:fish||myc gene rearrangements:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:fish||has_expanded_form
gonorrhea complicating childbirth (diagnosis)||gonorrhea complicating childbirth||has_expanded_form
medical and surgical @ lower joints @ fusion @ hip joint, left @ percutaneous endoscopic @ nonautologous tissue substitute @ no qualifier||fusion of left hip joint with nonaut sub, perc endo approach||has_expanded_form
prsn brd/alit pedl cyc injured in clsn w rail trn/veh, init||prsn brd/alit pedl cyc injured in clsn w rail trn/veh, init||has_expanded_form
trgv11 gene||t cell receptor gamma variable 11 (non-functional)||has_expanded_form
release right trunk tendon, percutaneous endoscopic approach||release right trunk tendon, percutaneous endoscopic approach||has_expanded_form
medical and surgical @ bursae and ligaments @ transfer @ elbow bursa and ligament, right @ open @ no device @ no qualifier||transfer right elbow bursa and ligament, open approach||has_expanded_form
left-right determination, factor a||lefta||has_expanded_form
zinc finger dhhc-type palmitoyltransferase 15||zdhhc15||has_expanded_form
other fracture of sacrum, init encntr for open fracture||other fracture of sacrum, initial encounter for open fracture||has_expanded_form
revision of synthetic substitute in pancreatic duct, open approach||revision of synthetic substitute in pancreatic duct, open approach||has_expanded_form
microalbumin/creat 12h ur||microalbumin/creatinine [mass ratio] in 12 hour urine||has_expanded_form
resection of left maxillary sinus, percutaneous endoscopic approach||resection of left maxillary sinus, perc endo approach||has_expanded_form
clcp1||clcp1||has_expanded_form
removal of nonaut sub from abd wall, perc approach||removal of nonautologous tissue substitute from abdominal wall, percutaneous approach||has_expanded_form
nags gene targeted mutation analysis:prid:pt:bld/tiss:nom:molgen||molecular pathology tests||class_of
glucose [mass/volume] in serum or plasma --3.5 hours post dose glucose||laboratory services||class_of
reference values source:find:pt:^patient:nom:phenx||clinical nec (not elsewhere classified in lnc)||class_of
vancomycin:titr:pt:isolate+ser:qn:sbt||infectiousdisease||class_of
17-hydroxyprogesterone:scnc:pt:saliva:qn||laboratory||class_of
mito enzy fib 1-14c-leuc substr-ccnt||laboratory||class_of
fatty acid oxidation panel:-:pt:fibroblasts:-||chemistry procedures||class_of
manganese intake 24h measured||clinical nec (not elsewhere classified in lnc)||class_of
morus alba antibody.immunoglobulin e/immunoglobulin e.total:arbitrary fraction:to identify measures at a point in time:serum:quantitative||allergy disorders||class_of
toxocara sp ab qn (s)||laboratory||class_of
intravascular mean:pressure:to identify measures at a point in time:arterial system:quantitative:cnap||bp (blood pressure)||class_of
a1at fld-mcnc||chemistry and chemistry challenge||class_of
yellow fever virus rna naa+probe ql (bld)||microbiology nos (procedure)||class_of
blood flow velocity.systolic.max:vel:pt:pulmonic valve^fetus:qn:us.doppler||fetal us scan||class_of
cd3+cd57+ cells nfr mar||cellmark||class_of
gestational age:time:pt:^fetus:qn:us+estimated from crl.hadlock 1992||echotomography||class_of
peak inspiratory flow respiratory system airway||respiratory measures and ventilator management||class_of
gamma globulin/protein.total in urine by electrophoresis||chemistry and chemistry challenge||class_of
rickettsia typhus group igg ab [titer] in cerebral spinal fluid||neurol||class_of
tear secretion comment:impression/interpretation of study:to identify measures at a point in time:eye.right:narrative:schirmer test||ophthalmology / optometry||class_of
rf wrist - bilateral arthrogram||clinical nec (not elsewhere classified in lnc)||class_of
benzoylecgonine:prthr:pt:meconium:ord:screen||laboratory (environment)||class_of
hiv 1 gp120 ab ib ql (s)||infectiousdisease||class_of
toxoplasma gondii ab.igm:titr:pt:csf:qn||microbiology tests||class_of
pediatrics hospital procedure note||document ontology||class_of
heavy metals [presence] in 24 hour urine||drug toxicology||class_of
intrinsic factor antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||sero||class_of
cortis 1h p 1 ug/kg crh iv serpl-mcnc||chemistry and chemistry - challenge||class_of
collagen ntx/creat ur-srto||chemistry test||class_of
view l-lateral upright:finding:to identify measures at a point in time:chest:document:xr||radiology||class_of
solid org transplant eval note||document ontology||class_of
phenx measure - hormonal therapy:-:point in time:^patient:-:phenx||consensus measures for phenotypes and exposures (phenx) panels||class_of
c peptide^45m post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||challenge tests||class_of
chief complaint:find:pt:^patient:nom:reported||clin||class_of
hsv identified org specific cx nom (body fld)||microbiology and antimicrobial susceptibility||class_of
fsh sp2 p chal serpl-acnc||lab||class_of
ldlr gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method||gene mutation||class_of
schistosoma sp ab.ige.rast class:prthr:pt:ser:ord||laboratories||class_of
asparagine [moles/volume] in urine||laboratory||class_of
yeast.pseudohyphae:presence or threshold:to identify measures at a point in time:urine sediment:ordinal:microscopy.light||urine examination (procedure)||class_of
echovirus 7 ab cf (s) [titer]||infectiousdisease||class_of
microscopic observation:prid:pt:xxx:nom:acid fast stain.kinyoun||laboratories||class_of
mononuclear+mesothelial cells/100 leukocytes:number fraction:to identify measures at a point in time:body fluid, unsp:quantitative:manual count||hematology (coagulation) and differential count||class_of
xr chest ap+lat+r-obl+l-obl||clin||class_of
aureobasidium pullulans ab [presence] in serum||microbiology and antimicrobial susceptibility||class_of
pumpkin seed ige qn (s)||laboratory services||class_of
volume in urine collected for unspecified duration||laboratories||class_of
ascorbate^post dose oral:mass rate:24 hours:urine:quantitative||challenge test||class_of
c cladosporioides ige qn||hypersensitivity (finding)||class_of
renin^30 minutes post xxx challenge:catalytic concentration:to identify measures at a point in time:plasma:quantitative||cardiovascular structure||class_of
view ap^w standing:find:pt:lower extremity.bilateral>knee:doc:xr||radiology||class_of
insulin^30 minutes post dose glucagon:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||laboratories||class_of
thinking about the past 4 weeks, my child was happy with life in his/her neighborhood [promis.parentproxy]||survey.promis||class_of
geri med h&p note||doc.ontology||class_of
mr brain.temporal wo contr||clinical nec (not elsewhere classified in lnc)||class_of
beta aminoisobutyrate [moles/volume] in amniotic fluid||chemistry and chemistry challenge||class_of
oxyphenisatin cutoff [mass/mass] in stool||lab||class_of
prostaglandin e1:mass concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||chemical procedure, nos||class_of
kit gene c.2447a>t molgen ql (bld/tiss)||molecular pathology tests||class_of
date received form||clin||class_of
lactate csf-mcnc||chemistry technique||class_of
serotonin release.heparin.low molecular weight (s) [interp]||laboratory (environment)||class_of
rh antigens & k ag panel:-:pt:bld:-||lab||class_of
diameter:length:to identify measures at a point in time:aorta.root:quantitative:ultrasound.2d||circulatory||class_of
intravascular mean:pressure:to identify measures at a point in time:splenic artery:quantitative||blood pressure central molecular||class_of
can recall that he or she is in a nursing home in last 7d:finding:7 days:^patient:ordinal:mdsv3||survey.mds||class_of
fasciola hepatica ab [presence] in serum by immunoassay||microbiology and antimicrobial susceptibility||class_of
m cap caprip ab ser-acnc||laboratory (environment)||class_of
streptococcus pneumoniae antigen:presence or threshold:to identify measures at a point in time:isolate:ordinal:latex agglutination||microbiology and antimicrobial susceptibility||class_of
cd11c cells # bld||lab||class_of
consultation note:finding:to identify measures at a point in time:{setting}:document:reproductive endocrinology and infertility||clin||class_of
ige ab serpl ql||clinical chemistry test||class_of
ribosomal ab ser ql if||serology - non-micro||class_of
i react slower than most people my age when i play games in past 4 weeks - frequency [promis.peds]||patient reported outcomes measurement system (promis) survey||class_of
estrone:mass rate:24 hours:urine:quantitative||chemistry||class_of
influenza virus a h3 rna:prthr:pt:respiratory.upper:ord:probe.amp.tar||microbiology and antimicrobial susceptibility||class_of
start time:tmstp:pt:study:qn||timp proteins||class_of
other biologicals - injected [phenx]||phenx (procedure)||class_of
hexadecadienoate:scnc:pt:ser/plas:qn||chemistry and chemistry challenge||class_of
gram negative bacteria identified nucleic acid capture and probe detection (pos bld culture) [interp]||laboratory (environment)||class_of
g-oh-butyr ur ql scn||laboratory (environment)||class_of
deprecated ribosomal p protein ab ser||laboratory||class_of
hhv6 igm ser-acnc||infectiousdisease||class_of
views for blood flow^w tc-99m glucoheptonate intravenous:finding:to identify measures at a point in time:abdomen>renal vessels:document:nm||radiology test||class_of
7-aminoflunitrazepam [presence] in urine||lab||class_of
2-ethyl-3-hydroxypropionate/creatinine:srto:pt:urine:qn||chemistry and chemistry challenge||class_of
atenolol:mass:to identify measures at a point in time:dose:quantitative||laboratory services||class_of
2-hydroxycaproate/creatinine (u) [molar ratio]||chemistry and chemistry - challenge||class_of
phosphoethanolamine (amn fld) [mass/vol]||chemical test||class_of
ct ankle-r wo contr||radiology studies||class_of
yeast brewer's ab.ige.rast class:prthr:pt:ser:ord||laboratory (environment)||class_of
oxygen (bldc) [partial pressure]||chemistry and chemistry challenge||class_of
cells.cd10+cd19+/100 cells:nfr:pt:tiss:qn||cellmark||class_of
multisection:find:pt:upper extremity.right>shoulder:doc:us||radiology studies||class_of
renin upright (p) [mass/vol]||chem||class_of
rubv ag spt ql||microbiology procedure||class_of
b burgdor igg+igm csf-imp||microbiology and antimicrobial susceptibility||class_of
angiotensin ii^upright:scnc:pt:plas:qn||chemistry procedures||class_of
t cruzi igg ser ql||laboratory services||class_of
mg.stereo guided brst-r pc bx cn||radiology||class_of
contraception risk:find:pt:^patient:ord:observed.ccc||survey||class_of
cancer antigen 19-9:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||chemistry and chemistry challenge||class_of
lactate (bldc) [moles/vol]||chemistry and chemistry challenge||class_of
lh serpl-acnc||structure of endocrine system||class_of
phenx measure - body image:-:to identify measures at a point in time:^patient:-:phenx||clinical nec (not elsewhere classified in lnc)||class_of
pseudorabies virus ag neut test ql (specimen)||laboratories||class_of
codeine mec cfm-mcnt||laboratory (environment)||class_of
mezlocillin:susc:pt:isolate:ordqn:agar diffusion||infectiousdisease||class_of
oat pollen ige qn (s)||lab||class_of
do^a antibody:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal||bldbk||class_of
anserine:prthr:pt:ser/plas:ord||chemistry and chemistry - challenge||class_of
lymphocytes.kappa/lymphocytes.lambda:nrto:pt:bld:qn||lab||class_of
vital capacity:volume:to identify measures at a point in time:respiratory system:quantitative:helium single breath||pneumol||class_of
leptospira ag ur ql if||microbiology and antimicrobial susceptibility||class_of
estriol ur-mcnc||laboratory (environment)||class_of
coxsackievirus b4 ab qn (s)||lab||class_of
situation in which you were afraid you might die or get really badly hurt, or when you were very scared or felt like there was nothing you could do to stop what was happening:finding:to identify measures at a point in time:^patient:nominal:ltvh||consensus measures for phenotypes and exposures||class_of
ph of semen||chemistry and chemistry challenge||class_of
indolamine:mass concentration:to identify measures at a point in time:serum:quantitative||chemistry and chemistry - challenge||class_of
nausea:prthr:pt:^patient:ord||clin||class_of
intravascular systolic^supine:pressure:to identify measures at a point in time:arterial system:quantitative||blood pressure positional molecular||class_of
hepatitis c virus rna [log units/volume] (viral load) in serum or plasma by naa with probe detection||infectiousdisease||class_of
influenza virus a h5a rna:prthr:pt:xxx:ord:probe.amp.tar||microbiology and antimicrobial susceptibility||class_of
phosphatidylserine-prothrombin complex igm ab [units/volume] in serum or plasma by immunoassay||blood coagulation panel||class_of
body temperature:temperature:to identify measures at a point in time:mouth:quantitative||specific body temperature||class_of
doxazosin induced platelet antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:flow cytometry||sero||class_of
h. capsulatum ag ia (csf) [mass/vol]||microbiology and antimicrobial susceptibility||class_of
calcit sp9 p chal serpl-mcnc||chemistry and chemistry - challenge||class_of
frequency of verbally abusive behavioral symptoms:nrat:pt:^patient:qn:mds||survey.mds||class_of
3-hydroxy,3-methylglutarate/creatinine (u) [mass ratio]||laboratory (environment)||class_of
r. equi ab immune diff ql (s)||diagnostic service sources microbiology (procedure)||class_of
multisection:find:pt:lower extremity>hip:doc:mr||orthopedic||class_of
nuclear ab pattern:imp:pt:ser:nar:if||serology - non-micro||class_of
while sleeping, does your child have trouble breathing, or struggle to breathe:finding:to identify measures at a point in time:^patient:ordinal:phenx||clinical||class_of
spect for abscess w ga-67 iv||radiology studies||class_of
cefamandole:susc:pt:isolate:ordqn:gradient strip||laboratory services||class_of
chymotrypsin^3rd specimen post dose sincalide:catalytic concentration:to identify measures at a point in time:body fluid, unsp:quantitative||chemistry and chemistry - challenge||class_of
aminosalicylate [mass/vol]||drug levels and toxicology||class_of
cells.cd4+cd7-cd26-/100 cells:nfr:pt:bld:qn||laboratory services||class_of
col+rec surg educ note||clinical||class_of
reflex irritability^10m post birth:fcn:pt:^patient:ord:apgar||clin||class_of
erythrocytes.nucleated/100 leukocytes:ratio:to identify measures at a point in time:whole blood:quantitative||hematology and cell counts||class_of
quinine ind plt igm serpl ql fc||serology - non-micro||class_of
cytology nipple dis doc cyto||laboratory||class_of
erysipelothrix tonsillarum deoxyribonucleic acid:threshold number:to identify measures at a point in time:not specified:quantitative:probe.amp.tar||infectiousdisease||class_of
netilmicin^peak:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||laboratories||class_of
sporothrix schenckii ab:titr:pt:csf:qn||microbiology and antimicrobial susceptibility||class_of
fibrinopeptide b beta (1-14) antigen:arbitrary concentration:to identify measures at a point in time:platelet poor plasma:quantitative:immunoassay||blood coagulation tests||class_of
spermatozoa.isolated tail/100 spermatozoa:number fraction:to identify measures at a point in time:semen:quantitative||infertility studies||class_of
us guided uterus amn fld asp||rad||class_of
liver steatosis grade serpl ql||chemistry and chemistry challenge||class_of
progress note:finding:to identify measures at a point in time:{setting}:document:clinical genetics||clinical nec (not elsewhere classified in lnc)||class_of
nk cytotox.6.25:1 e:t/pos cntrl bld mc||laboratories||class_of
xylose^1h post 25 g xylose po:mcnc:pt:urine:qn||lab||class_of
i had trouble relaxing in past 7d:find:7d:^patient:ord:promis||patient reported outcomes measurement system (promis) survey||class_of
prothrombin antibody.immunoglobulin m:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||blood coagulation screen, nos||class_of
hcov hku1 rna naa+probe ql (asp)||infectiousdisease||class_of
hla-dpw5 ql||laboratory||class_of
i felt thankful in past 7 days [promis.peds]||survey.promis||class_of
number of days hospitalized due to vaccination adverse event||immunization||class_of
psoriasis treatment effectiveness:finding:to identify measures at a point in time:^patient:ordinal:phenx||consensus measures for phenotypes and exposures||class_of
lv sv us.2d.mod-bp-el||ultrasound;cardiac||class_of
corticotropin^15 minutes pre dose insulin intravenous:substance concentration:to identify measures at a point in time:plasma:quantitative||chemistry and chemistry challenge||class_of
total score:score:to identify measures at a point in time:^patient:quantitative:audit||general health survey||class_of
mozzarella cheese igg ab [units/volume] in serum||laboratory services||class_of
deprecated htlv i+ii rgp46-ii ab ser ql||microbiology (lab test)||class_of
l eye ant chamber angle||clin||class_of
gardnerella vaginalis+prevotella sp morphotypes [presence] in vaginal fluid by light microscopy||laboratory services||class_of
herpes simplex virus 1 dna:lncnc:pt:amnio fld:qn:probe.amp.tar||laboratory (environment)||class_of
my child is afraid to eat because it may make her-him sick in the past 7 days [facit]||4||class_of
endocrine disorders:impression/interpretation of study:to identify measures at a point in time:dried blood spot:ordinal||chemistry and chemistry challenge||class_of
creatinine 4 hr specimen [mass/vol]||chemistry procedure||class_of
3-hydroxydodecanoate.free (3-oh-c12:0) [moles/volume] in serum or plasma||laboratories||class_of
us.doppler head limited||testing ultrasound||class_of
rabbit urine proteins ige ab rast class [presence] in serum||laboratory (environment)||class_of
furoate/creatinine [mass ratio] in urine||laboratory||class_of
actinomyces sp antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||laboratory services||class_of
gla gene full mutation analysis:finding:point in time:whole blood/tissue, unspecified:document:sequencing||molecular pathology||class_of
tetracycline (dose) [mass]||lab||class_of
gestational age:time:point in time:^fetus:quantitative:ultrasound.estimated from gsd.rempen.91||ultra-sound scan-obst.||class_of
vertical diameter:length:to identify measures at a point in time:cornea.left:quantitative||eye.px.nei||class_of
rubella diagnosis^pre pregnancy:find:pt:^patient:ord||history of (contextual qualifier) (qualifier value)||class_of
glucagon post fast [mass/vol]||endocrine system in general||class_of
human papilloma virus 45 dna [presence] in specimen by naa with probe detection||laboratory (environment)||class_of
clinical observation of the presence of blood, bleeding on probing, bop:find:pt:tooth:nom:phenx||clinical||class_of
hiv 2 proviral dna:prthr:pt:bld:ord:probe.amp.tar||microbiology and antimicrobial susceptibility||class_of
l1cam gene targeted mutation analysis:prid:pt:bld/tiss:nom:molgen||lab||class_of
duck hepatitis virus 1 antigen:presence or threshold:to identify measures at a point in time:not specified:ordinal:virus neutralization||microbiology and antimicrobial susceptibility||class_of
how much did pain interfere with the things you usually do for fun in past 7d:find:7d:^patient:ord:promis||survey||class_of
nutr+diet plan of care note||clin||class_of
y. enterocolitica o:8 ab ql (csf)||microbiology and antimicrobial susceptibility||class_of
tsh 3h p chal serpl-acnc||laboratory (environment)||class_of
asparagine:mass concentration:to identify measures at a point in time:amniotic fluid:quantitative||laboratory||class_of
non-agency caregiver ability and willingness to assist with medical procedures/treatments [cms assessment]||survey||class_of
epstein barr virus band pattern:impression/interpretation of study:to identify measures at a point in time:not specified:narrative:immune blot||infectiousdisease||class_of
pyridoxal phosphate:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||chemicals testing||class_of
acidity.titratable:substance concentration:to identify measures at a point in time:gastric fluid/contents:quantitative||chemistry and chemistry - challenge||class_of
toxoplasma gondii antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:ordinal||microbiology and antimicrobial susceptibility||class_of
go up and down 4 steps - usual functional ability during assessment period [cms assessment]||centers for medicare & medicaid services (cms) survey||class_of
deprecated morphine gast ql||laboratory services||class_of
mumps virus sh gene:threshnum:pt:xxx:qn:probe.amp.tar||microbiology and antimicrobial susceptibility||class_of
lp serpl-mcnc||section 3-7 chemistry procedures||class_of
saint louis encephalitis virus antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||infectiousdisease||class_of
a little u super little b ab:prthr:pt:ser/plas:ord||bldbk||class_of
anxiety thoughts bad events scared-r||clinical||class_of
herpes simplex virus 2 ab [units/volume] in body fluid||microbiology and antimicrobial susceptibility||class_of
hepatitis b virus deoxyribonucleic acid panel:-:to identify measures at a point in time:serum/plasma:-||microbiology panel||class_of
pklr gene deletion+duplication & full mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||molecular pathology tests||class_of
herpes virus 8 dna [#/volume] (viral load) in urine by naa with probe detection||laboratory||class_of
herpes simplex virus 2 antigen:presence or threshold:to identify measures at a point in time:skin:ordinal||infectiousdisease||class_of
borrelia burgdorferi 39kd ab.igm:acnc:pt:ser:ord:eia||microbiology and antimicrobial susceptibility||class_of
when my child was in pain he or she became quiet in past 7d:find:7d:^patient:ord:promis.parentproxy||patient reported outcomes measurement system (promis) survey||class_of
intravascular end diastolic^post procedure:pressure:to identify measures at a point in time:heart.ventricle.left:quantitative||heart procedures||class_of
irf-pai v3.0 - staff assessment for mental status:-:reporting period:^patient:-:cms assessment||centers for medicaid and medicare (cms) pnl||class_of
crisis intervention note:find:pt:{setting}:doc:nurse||clinical nec (not elsewhere classified in lnc)||class_of
acetaminophen ab.ige:acnc:pt:ser:qn||allergic reaction to substance (disorder)||class_of
plasminogen activator inhibitor 1 ag:acnc:pt:ppp:qn:eia||hematology (discipline)||class_of
herpes simplex virus 1+2 igm ab [presence] in body fluid||microbiology and antimicrobial susceptibility||class_of
hdlc dial fld-scnc||chemistry measurement||class_of
coxsackievirus b2 ab [titer] in serum by complement fixation --2nd specimen||microbiology and antimicrobial susceptibility||class_of
coxsackievirus b5 ab [units/volume] in serum||infectiousdisease||class_of
zikv igm if (s) [titer]||infectiousdisease||class_of
s little c 2 antigen inferred phenotype:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||bldbk||class_of
spermatozoa:morphology:to identify measures at a point in time:semen:nominal||laboratory||class_of
clinical notes and chart sections:complex:-:^patient:set||clinical report attachments||class_of
beta-n-acetylhexosaminidase.a (fibroblast) [catalytic activity/mass]||lab||class_of
heptacarboxylate [moles/mass] in stool||chemistry and chemistry - challenge||class_of
rf guidance for aspiration of cyst of ovary||obstetrics and gynaecology (qualifier value)||class_of
silver 24h ur-srate||laboratory||class_of
wnv igg titr fld||micro||class_of
b. burgdorferi igm ql (syn fld)||laboratory||class_of
coconut ige ab rast class [presence] in serum||lab||class_of
deprecated s pneum4 igg ser-acnc||lab||class_of
deprecated streptococcus pneumoniae 14 igg ab [mass/volume] in serum||microbiology and antimicrobial susceptibility||class_of
calcium:mcnc:pt:water:qn||laboratories||class_of
creatinine [mass/time] in 18 hour urine||laboratories||class_of
parasite mar micro||lab||class_of
taurodeoxycholate [moles/vol]||chemistry and chemistry challenge||class_of
cardiothor surg ms hosp progress note||clin||class_of
oxygen [partial pressure] in cord blood||lab||class_of
streptococcus pneumoniae danish serotype 6b ab.igg^2nd specimen:acnc:pt:ser:qn||lab||class_of
fatty acids:mass rate:24 hours:stool:quantitative||chemicals testing||class_of
carnitine esters [moles/volume] in serum or plasma||chemistry and chemistry - challenge||class_of
barium:prthr:pt:ser/plas:ord||drug/tox||class_of
multisection^wo contrast:find:pt:head>temporomandibular joint:doc:mr||clinical||class_of
capacity.inspiratory:vol:pt:respiratory system:qn:spirometry||pulmonology||class_of
amiodarone [mass/volume] in serum or plasma||laboratory (environment)||class_of
cholesterol/total:mfr:pt:calculus:qn||nephrology (qualifier value)||class_of
hcv gentype + resist pnl||hepatology (field)||class_of
clot initiation.kaolin+tissue factor induced:time:pt:bld:qn||hematol||class_of
d-serine/creatinine (u) [molar ratio]||chemistry and chemistry - challenge||class_of
sebacylcarnitine (c10-dc) [moles/volume] in amniotic fluid||laboratories||class_of
hhv7 igg titr ser||infectiousdisease||class_of
mds v3.0 - rai v1.17.2 - type of assessment on existing record to be modified or inactivated:-:pt:^patient:-:cms assessment||surveys||class_of
deprecated streptococcus pneumoniae 14 igg ab [mass/volume] in serum by immunoassay --2nd specimen||infectiousdisease||class_of
metabolism measurement device vendor software version||laboratory||class_of
expiratory gas flow.max.personal best:volume rate:to identify measures at a point in time:respiratory system.airway:quantitative||clinical nec||class_of
human leukocyte antigen-dw8:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal||hla factors||class_of
cryptococcus neoformans ab [titer] in serum||microbiology (lab test)||class_of
have you ever been treated for a serious infection with an antibiotic, other than penicillin, which was administered by injection or drip for a w or more:history:to identify measures at a point in time:^patient:ordinal:phenx||consensus measures for phenotypes and exposures||class_of
saint louis encephalitis virus igm ab [titer] in cerebral spinal fluid||neurology (qualifier value)||class_of
hippurate [presence] in urine||drug levels and toxicology||class_of
febrile agglutinin ab panel:titr:pt:ser:qn||microbiology (procedure)||class_of
b-hcg serpl-acnc||chemical testing||class_of
fda insert nonclinical tox||clin||class_of
oasis c2 - current number of unhealed pressure injuries at each stage - start of care or resumption of care:-:pt:^patient:-:cms assessment||centers for medicaid and medicare (cms) pnl||class_of
3-hydroxyvalerate [presence] in urine||laboratory||class_of
aripiprazole/creatinine [mass ratio] in urine by confirmatory method||laboratories||class_of
history of allergies:finding:point in time:^patient:nominal:reported||clinical||class_of
flt3 gene targeted mutation analysis in blood or tissue by molecular genetics method||gene mutation type||class_of
deprecated melon ige ab [units/volume] in serum||immune hypersensitivity reaction (disorder)||class_of
phospholipid:mass concentration:point in time:serum/plasma:quantitative||chemical testing||class_of
mr prostate w contr iv||clinical||class_of
i am able to drive a vehicle - my car, truck, etc - in the past 7d:finding:7 days:^patient:ordinal:facit||general health survey||class_of
lomefloxacin:susc:pt:isolate:ordqn:agar diffusion||microbiology and antimicrobial susceptibility||class_of
b. dermatitidis exoantigen nom (isol)||microbiology and antimicrobial susceptibility||class_of
i have trouble walking in the past 7d:find:7d:^patient:ord:facit||general health survey||class_of
myristate entsub rbc||chemicals testing||class_of
phenyltoloxamine:mcnc:pt:urine:qn||laboratory||class_of
tt bld-imp||laboratory services||class_of
mononuclear cells/100 wbc auto (pericard fld)||laboratory (environment)||class_of
s. paratyphi b h ab (s) [titer]||microbiology and antimicrobial susceptibility||class_of
can pronounce chorus [nih toolbox]||general behavioral health / psychiatry||class_of
weight [mass/time] of 48 hour stool||laboratory services||class_of
fluid output.cerebral ventricle drain:vrat:24h:cerebral ventricles:qn||input/output timed molecular||class_of
observational assessment of cognitive status at 2d assessment period:-:2d:^patient:-||survey.care||class_of
oxalate serpl-mcnc||chemistry measurement||class_of
legionella longbeachae 1 ab [presence] in serum||laboratory||class_of
active suicidal ideation with specific plan and intent:find:1mo:^patient:ord||4||class_of
cftr gene targeted mutation analysis ms.maldi-tof nom (bld/tiss)||molecular pathology tests||class_of
medical research council breathlessness scale grade:finding:to identify measures at a point in time:^patient:ordinal:medical research council||clinical nec (not elsewhere classified in lnc)||class_of
multisection:finding:to identify measures at a point in time:lower extremity:document:magnetic resonance||clinical nec (not elsewhere classified in lnc)||class_of
c antigen:presence or threshold:to identify measures at a point in time:red blood cells cord:ordinal||lab||class_of
gynecology history and physical note||obstetrics/gynecology||class_of
how much have any of these fears ever interfered with your life or activities [cidi-sf]||consensus measures for phenotypes and exposures (phenx)||class_of
staphylococcus aureus enterotoxin b seb gene:prthr:pt:xxx:ord:probe.amp.tar||lab||class_of
nordiazepam cutoff confirm (sal) [mass/vol]||drug toxicology||class_of
deprecated rvot vmean dop.meas||obstetrics ultrasound||class_of
lemon igg ab [units/volume] in serum||laboratories||class_of
methyl amyl ketone:mcnc:pt:urine:qn||drug toxicology||class_of
horseradish igg4 ab [mass/volume] in serum||disorder due to allergic reaction (disorder)||class_of
hbv surface ab ser ql||infectiousdisease||class_of
weev ab spec 2 if (s) [titer]||microbiology and antimicrobial susceptibility||class_of
coxiella burnetii ab.igg^1st specimen:titr:pt:ser:qn:if||test;microbiology||class_of
pullularia sp ab ql (s)||infectiousdisease||class_of
fluid management note:find:pt:{setting}:doc:{role}||loinc document ontology||class_of
creatinine:mass rate:4 hours:urine:quantitative||laboratories||class_of
insulin ab [titer] in serum||sero||class_of
disabled family coping family [ccc]||home health care classification (hhcc)||class_of
i need to sleep during the day in the past 7d:finding:7 days:^patient:ordinal:facit||general health survey||class_of
e. aerog+amn+gergo dna bld pos ql naa+pr||microbiology and antimicrobial susceptibility||class_of
sphere far:invlen:pt:glasses prescription.lens.left:qn||ophthalmology / optometry||class_of
dop extr v-r||circulatory systems||class_of
views for bone density:armass:pt:lower extremity.right>hip:qn:dxa||clinical||class_of
myocardial performance index:trto:pt:heart.ventricle.right:qn:us.doppler||diagnostic ultrasonography, nos||class_of
weev ab titr ser||micro||class_of
24 hour predicted protein calc (u) [mass/time]||laboratory (environment)||class_of
date and time of incident management system activation||clin||class_of
oxygen saturation:mfr:pt:heart.atrium.right.high:qn||hemodyn||class_of
prolactin [mass/volume] in serum or plasma --pre dose insulin iv||chemistry - challenge||class_of
bupivacaine antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||sensitivity||class_of
alkaline phosphatase.liver 2:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal||chemistry and chemistry challenge||class_of
fatigue --post exercise||clinical nec (not elsewhere classified in lnc)||class_of
fxn gene.gaa repeats:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||molecular pathology tests||class_of
views 2:find:pt:pelvis:doc:xr||radiology studies||class_of
urea/creatinine (u) [molar ratio]||chemicals testing||class_of
gamma tocopherol entsub rbc||chemical measurement, nos||class_of
acepromazine (bld) [mass/vol]||laboratory (environment)||class_of
ceftazidime 1 ug/ml islt slowmyco||infectiousdisease||class_of
fet lv.post wall thick sys us.meas.rt 2d||structure of cardiovascular system (body structure)||class_of
streptomycin 1.0 ug/ml:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:method for slow-growing mycobacteria||microbiology and antimicrobial susceptibility||class_of
cd11a blasts bld-acnc||cellmark||class_of
porphyrins 24h ur-mcnc||hematology (field)||class_of
propranolol 24h ur-srate||drug levels and toxicology||class_of
surgery sequence:find:pt:^patient:nom:phenx||consensus measures for phenotypes and exposures (phenx)||class_of
diameter:len:pt:pulmonary artery.right:qn:us||ultrasound scan nos||class_of
fluoride (24h u) [moles/time]||laboratory services||class_of
naaccr facility identification system coding system:prid:pt:cancer.xxx:nom||tumrrgt||class_of
j pnt st amp+80ms l-iii||clin||class_of
glucose 3m p chal serpl-scnc||chemistry and chemistry - challenge||class_of
s. pullorum ab immune diff ql (s)||infectiousdisease||class_of
how often does your child use cigarettes, smokeless tobacco, snuff, or other tobacco products:number=count/time:to identify measures at a point in time:^patient:quantitative:phenx||phenx||class_of
number of days of passive range of motion [minimum data set]||minimum data set (mds) for nursing home resident assessment and care screening||class_of
a. fumigatus ab ql (s)||microbiology nos||class_of
alpha aminobutyrate:presence or threshold:24 hours:urine:ordinal||chemistry and chemistry - challenge||class_of
hedis 2017 value sets:-:pt:^patient:-||healthcare effectiveness data and information set panel||class_of
cev igm (s) [titer]||infectiousdisease||class_of
during the past 3mo, how often have you failed to do what was normally expected of you because of your use of street opioids:find:3mo:^patient:ord:nida||survey instrument||class_of
mercury [mass/mass] in tissue||drug levels & toxicology||class_of
fluav ab titr ser hai||infectiousdisease||class_of
nickel:substance concentration:24 hours:urine:quantitative||lab||class_of
minocycline strip [susc]||microbiology and antimicrobial susceptibility||class_of
eastern equine encephalitis virus ab:prthr:pt:csf:ord:comp fix||infectiousdisease||class_of
creatine kinase.aberrant band/creatine kinase.total:cfr.df:pt:ser/plas:qn:electrophoresis||chemistry and chemistry challenge||class_of
carbamazepine free serpl-mcnc||drug toxicology||class_of
galactosemia newborn screening panel (si units):-:pt:bld.dot:-||chemistry||class_of
ptpn11 gene mutation analysis:prid:pt:bld/tiss:nom:molgen||science of genetics||class_of
clomipramine+norclomipramine^trough:mcnc:pt:ser/plas:qn||lab||class_of
my child felt tired in past 7d:finding:7 days:^patient:ordinal:promis.parentproxy||patient reported outcomes measurement system (promis) survey||class_of
lh 30m p chal serpl-acnc||chemistry - challenge||class_of
function compared to previous assessment:find:pt:optic disc+retinal nerve fiber layer.left:ord:electroretinogram||ophthalmology+optometry||class_of
diastolic blood pressure 12 hour maximum||cardiology||class_of
trichomonas vaginalis:presence or threshold:to identify measures at a point in time:genital:ordinal:organism specific culture||microbiology||class_of
amniotic fluid index:length:to identify measures at a point in time:am fld space.quadrant two^fetus:quantitative:ultrasound.derived||ultrasound techniques||class_of
neurology op note||neurol||class_of
s. paratyphi c h ab (s) [titer]||microbiology and antimicrobial susceptibility||class_of
multisection^wo & w contrast iv:find:pt:lower extremity.right>foot:doc:ct||radiology test||class_of
comorbidities and complications 1:presence or identity:point in time:^patient:nominal||tumor registry (naaccr)||class_of
ovine progressive pneumonia virus ab:prthr:pt:ser:ord:immune diffusion||microbiology and antimicrobial susceptibility||class_of
xr chest 1v w insp||pulmonol||class_of
echovirus 9 ab:acnc:pt:ser:qn:comp fix||laboratory (environment)||class_of
parkinsonian proto||clinical nec||class_of
multisection for pregnancy:finding:to identify measures at a point in time:pelvis+^fetus:document:ultrasound.doppler||clinical nec (not elsewhere classified in lnc)||class_of
oxycodone+oxymorphone:presence or threshold:to identify measures at a point in time:saliva:ordinal:screen||drug/tox||class_of
icteric interf index serpl-acnc||laboratories||class_of
staphylococcus aureus dna [ncncrange] in lower respiratory specimen qualitative by naa with non-probe detection||infectiousdisease||class_of
rubv rna spec ql naa+probe||infectiousdisease||class_of
stenosis degree:length fraction:to identify measures at a point in time:proximal left anterior descending artery:quantitative:angiogram||heart procedure||class_of
classical swine fever virus ag:prthr:pt:tiss:ord:if||microbiology nos||class_of
glucose^overnight dwell:substance concentration:to identify measures at a point in time:peritoneal dialysis fluid:quantitative||chemistry and chemistry - challenge||class_of
yersinia pseudotuberculosis 1 ab:titr:pt:ser:qn||microbiology and antimicrobial susceptibility||class_of
note:find:pt:{setting}:doc:plastic surgery||document ontology||class_of
rumex crispus antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||lab||class_of
adenovirus b+c+e dna naa+probe ql (resp)||microbiology and antimicrobial susceptibility||class_of
galc gene targeted mutation analysis molgen doc (bld/tiss)||laboratory services||class_of
mra circle of willis wo+w contr iv||cardio-pericardial||class_of
c. parapsilosis dna naa+probe ql (s)||microbiology (procedure)||class_of
views screening:finding:to identify measures at a point in time:breast.right:document:mg.ffd||clinical nec||class_of
fluav phill ab ser-acnc||microbiology and antimicrobial susceptibility||class_of
serotonin release.heparin.unfractionated interpretation:impression/interpretation of study:to identify measures at a point in time:serum:narrative||laboratory||class_of
t. vaginalis rrna naa+probe ql (cvx)||diagnostic service sources microbiology (procedure)||class_of
malignant cells nfr pcar||lab||class_of
during the past 3 months, how often have you failed to do what was normally expected of you because of your use of methamphetamine [nida]||general behavioral health / psychiatry||class_of
did you have one or more severe blistering sunburns as a child or teenager [phenx]||consensus measures for phenotypes and exposures||class_of
glucose^2.5 hours post 50 g lactose oral:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||challenge tests||class_of
lupin seed ige qn||disorder due to allergic reaction||class_of
human immunodeficiency virus genotype panel:-:point in time:isolate:-:genotyping||laboratory services||class_of
aflatoxin m1 (specimen) [mass/mass]||laboratory||class_of
3-methylhistidine:substance concentration:to identify measures at a point in time:dried blood spot:quantitative||chemistry and chemistry - challenge||class_of
glucose 14m p chal serpl-scnc||laboratory||class_of
sarcomatous pattern in carcinosarcoma nom (tumor)||oncology field||class_of
gluten antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||laboratory (environment)||class_of
blatella germanica ab.ige/ige.total:afr:pt:ser:qn||hypersensitivity reactions||class_of
coxsackievirus a9 antibody.immunoglobulin g:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||microbiology and antimicrobial susceptibility||class_of
wnv rna tiss ql naa+probe||infectiousdisease||class_of
did you have hot flashes or chills:finding:point in time:^patient:ordinal||reported.phq||class_of
calcium^4h post xxx challenge:scnc:pt:ser/plas:qn||chemistry - challenge||class_of
metoprolol ur-mcnc||drug levels & toxicology||class_of
ampicillin mlc [susc]||infectiousdisease||class_of
triazolam [moles/vol]||drug levels & toxicology||class_of
natamycin susc islt||microbiology and antimicrobial susceptibility||class_of
plan of care note:finding:to identify measures at a point in time:{setting}:document:dialysis.interdisciplinary||document ontology||class_of
have you been a very nervous person during the past 4 weeks [veterans rand]||survey.gnhlth||class_of
body weight^post dialysis:mass:pt:^patient:qn:measured||weighted||class_of
r glasses rx lens type n||clinical nec (not elsewhere classified in lnc)||class_of
clostridium chauvoei antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:immune fluorescence||microbiology and antimicrobial susceptibility||class_of
spasm stress test panel:-:pt:^patient:-||cardiology (field)||class_of
lpt 2.0 ug pha bld-nrate||lab||class_of
tahyna virus antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:not specified:ordinal:immunoassay||microbiology test (procedure)||class_of
clozapine+norclozapine:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||drug/tox||class_of
insulin human ab ser-acnc||laboratory (environment)||class_of
sisomicin:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal||lab||class_of
trypanosoma brucei gambiense ab:prthr:pt:ser:ord:aggl||diagnostic service sources microbiology||class_of
sapovirus rna:prthr:pt:xxx:ord:probe.amp.tar||lab||class_of
deprecated cd32 wbc-acnc||cellmark||class_of
borrelia burgdorferi antibody:impression/interpretation of study:to identify measures at a point in time:serum:nominal||infectiousdisease||class_of
rubv ser cult||infectiousdisease||class_of
fetal kidney - right volume derived by us||nephrology- a specialty area of medicine||class_of
friendship survey - age 18+ - t-score:tscore:pt:^patient:qn:nih toolbox||nih toolbox emotion domain||class_of
ap dimension.left atrium/ap dimension.aorta root:lenrto:pt:heart.atrium.left:qn:us||ultrasound;cardiac||class_of
virginiamycin [susceptibility] by minimum inhibitory concentration (mic)||laboratory||class_of
heteroph ab titr ser||infectiousdisease||class_of
temazepam:mcnc:pt:urine:qn:confirm||drug toxicology||class_of
oval fat bodies (globules):prthr:pt:urine:ord:computer assisted||laboratory services||class_of
vasopressin:mcnc:pt:ser/plas:qn||measurement, chemical||class_of
microorganism identification and resistance pattern determination panel by molecular genetics method||microbiology and antimicrobial susceptibility||class_of
hemoglobin m - hyde park [presence] in blood||lab||class_of
iduronate-2-sulfatase [enzymatic activity/mass] in leukocytes||laboratory services||class_of
leukemia markers nar (bld) [interp]||cell markers||class_of
have you had a strong desire or urge to use medications for anxiety or sleep at least once a week or more often in past 3mo:finding:3 months:^patient:ordinal:tobacco, alcohol, prescription medications, and other substance use assessment||survey.mtlhlth||class_of
psych eval note||document ontology||class_of
terbufos spec-mcnt||drug levels and toxicology||class_of
cancer ag 19-9:acnc:pt:body fld:qn||laboratory||class_of
sulfamethoxazole^trough:mcnc:pt:ser/plas:qn||drug levels and toxicology||class_of
intravascular systolic:pres:pt:iliac artery.right:qn||blood pressure measurements||class_of
note:finding:to identify measures at a point in time:{setting}:document:psychiatry.team||doc.ontology||class_of
e ab [presence] in serum or plasma||laboratory||class_of
nm liver and biliary ducts and gallbladder views for patency||clin||class_of
mcoln1 gene mut anl bld/t||molecular pathology||class_of
phosphate (24h u) [mass/time]||chemistry and chemistry - challenge||class_of
voice gives out phenx||clinical nec||class_of
treponema pallidum ab [units/volume] in specimen||microbiology and antimicrobial susceptibility||class_of
has anyone ever intentionally damaged or destroyed property owned by you or by someone in your household:finding:to identify measures at a point in time:^patient:ordinal:ltvh||clinical nec (not elsewhere classified in lnc)||class_of
swine vesicular disease virus ag [presence] in skin||lab||class_of
trazodone [presence] in gastric fluid||lab||class_of
hedis 2015-2020 value set - ldl-c tests||hedis panels||class_of
1,5-anhydroglucitol serpl-mcnc||chemical measurement||class_of
colistin spec-mcnc||drug/tox||class_of
type of left coronary artery catheter||cardiology (qualifier value)||class_of
herpes simplex virus 1+2 deoxyribonucleic acid:number concentration (count/vol):to identify measures at a point in time:tissue, unspecified:quantitative:probe.amp.tar||laboratory services||class_of
myxoma virus antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||infectiousdisease||class_of
wound tunneling panel:-:to identify measures at a point in time:wound:-||clinical nec||class_of
histoplasma capsulatum antigen:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immunoassay||lab||class_of
study observation:finding:point in time:head.lateral cerebral ventricles^fetus:narrative:ultrasound||obgyn||class_of
teratozoospermia index smn-acnc||laboratory||class_of
ovine herpesvirus 2 ab:prthr:pt:ser:ord||laboratories||class_of
b parapert spec ql cult||infectiousdisease||class_of
irritable bowel disease prognostic panel ia||laboratories||class_of
purkinje cells ab [presence] in cerebral spinal fluid by immunoblot||laboratory services||class_of
gastrin^pre xxx challenge:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||laboratory services||class_of
streptococcus pneumoniae 4 antibody.immunoglobulin g^2nd specimen:arbitrary concentration:to identify measures at a point in time:serum:quantitative||infectiousdisease||class_of
ft4i serpl calc-mcnc||chemistry nos||class_of
service comment 49:imp:pt:xxx:nom||lab report general comments||class_of
health care supervision.behavior:find:pt:^community:ord:observed.omaha||survey||class_of
does your child tend to take things literally:find:pt:^patient:ord:cast||phenx (procedure)||class_of
insulin 10h p chal serpl-mcnc||chemistry and chemistry challenge||class_of
age and mode of onset notes:text:to identify measures at a point in time:^patient:nominal:di-pad cgp v 1.4||clinical nec||class_of
aldosterone-18-glucuronide:scnc:pt:urine:qn||laboratory services||class_of
physical findings of right conjunctiva narrative||ophthalmology / optometry||class_of
nortramadol [mass/volume] in serum or plasma by confirmatory method||laboratory services||class_of
mycoplasma sp and ureaplasma sp [identifier] in vaginal fluid by organism specific culture||infectiousdisease||class_of
hla-dw18(w6) [presence] in donor||genetics||class_of
cells.cd20+fmc7+:number concentration (count/vol):to identify measures at a point in time:tissue, unspecified:quantitative||lab||class_of
pca-2 igg ab [titer] in serum by immunofluorescence||neurol||class_of
hpiv4 rna lower resp ql naa+probe||laboratory services||class_of
creatinine/calcium (u) [mass ratio]||chemical tests||class_of
amylase s2 cfr serpl||chemicals testing||class_of
risk adjustment factor:score:to identify measures at a point in time:^patient:quantitative||clin.risk||class_of
triglyceride (24h stl) [mass/time]||chemistry and chemistry - challenge||class_of
osmotic fragility 0.30% sodium chloride 24 hr 37 degree c incubation (rbc)||hem/bc||class_of
other organic condition related to mental retardation and developmental disabilities:finding:to identify measures at a point in time:^patient:ordinal:mds||4||class_of
xr sacroiliac joint - left views||radiology test||class_of
organization zip code||administrative - clinical class||class_of
s little c 2 antigen inferred phenotype:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified^donor:ordinal:molecular genetics||blood bank||class_of
xr finger fifth - right views||radiology procedures||class_of
catheterization & angiography procedures performed panel:-:pt:^patient:-||cardiac panels||class_of
i am frustrated by the infection in the past 7d:find:7d:^patient:ord:facit||survey instrument||class_of
human leukocyte antigen-dw20:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified^donor:ordinal||laboratory (environment)||class_of
hiv 1 p26 ab ib ql (s)||infectiousdisease||class_of
j pnt depr l-iii||ecg measurement||class_of
tbev igg spec ql ia||microbiology and antimicrobial susceptibility||class_of
views^w contrast ia:find:pt:head+neck>carotid artery & head>cerebral artery.left:doc:rf.angio||vascular, heart||class_of
ct head ltd wo contr||radiology studies||class_of
lactate [moles/volume] in pleural fluid||lab||class_of
beta 1 globulin/protein.total in urine by electrophoresis||chemistry and chemistry challenge||class_of
n,n-dimethylarginine serpl-mcnc||laboratory (environment)||class_of
hla-a+b+c sbt high res-imp||genet||class_of
vascular surg tech note||clinical||class_of
how often does he or she let you down when you are counting on him or her:finding:to identify measures at a point in time:^patient:ordinal:midus ii||clinical nec||class_of
in what language do you think:finding:to identify measures at a point in time:^patient:nominal:nlaas||clin||class_of
metamyelocytes/100 leukocytes:number fraction:to identify measures at a point in time:cerebral spinal fluid:quantitative:manual count||hematology and cell counts||class_of
bartonella quintana igg ab [units/volume] in serum||lab||class_of
pathology report reviewed [identifier] in specimen||pathology studies||class_of
enterovirus rna naa+probe ql (s)||lab||class_of
lv max strain rate dias 3d us||clin||class_of
hla-dqb1 unresolved alleles [type] in donor by high resolution||hl a antigens||class_of
mold allerg mix4 ige rast ql||laboratory services||class_of
n men sg y ag csf ql||laboratories||class_of
insulin [moles/volume] in serum or plasma --1 minute post dose glucose iv||chal||class_of
orifice area.minor axis.min:area:pt:mitral valve:qn:us.2d||cardiol||class_of
american house dust mite ige ab rast class [presence] in serum||allergic disorder||class_of
mycoplasma pneumoniae ab [titer] in serum by complement fixation||lab||class_of
ofloxacin 4.0 ug/ml:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:method for slow-growing mycobacteria||laboratories||class_of
adenovirus dna:ncnc:pt:urine:qn:probe.amp.tar||lab||class_of
views^w contrast intra salivary duct:finding:to identify measures at a point in time:head>submandibular gland:document:radiofluoroscopy||rad||class_of
lesion located at vessel bifurcation:prthr:pt:coronary arteries:ord||cardiology (qualifier value)||class_of
glucagon^1h post meal:mcnc:pt:ser/plas:qn||systems, endocrine||class_of
moxalactam:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal||finding of antimicrobial susceptibility (finding)||class_of
prosthesis complaint {dental prosthesis} - reported||clin||class_of
apmv2 ab ser-acnc||unlisted microbiology||class_of
date of entry||centers for medicare & medicaid services (cms) survey||class_of
vesicular stomatitis virus antigen:presence or threshold:to identify measures at a point in time:skin:ordinal:complement fixation||infectiousdisease||class_of
microscopic observation [identifier] in duodenal fluid by other stain||microbiology and antimicrobial susceptibility||class_of
naso-labial angle:angle:pt:skull:qn:xr.measured||clin||class_of
coronary lesion located at vessel bifurcation||cardiac procedure||class_of
bwamba virus igm ab [presence] in specimen by immunoassay||test;microbiology||class_of
date and time task assigned:tmstp:pt:^event:qn||clinical nec||class_of
cd16 blasts/100 blasts (bm)||laboratory services||class_of
care tool - acute care:-:point in time:^patient:-||surveys||class_of
prostaglandin d2 serpl-mcnc||chemical procedure, nos||class_of
wish to discuss contraception||obstetrics and gynecology (qualifier value)||class_of
total score [audit-c]||survey.gnhlth||class_of
toxocara ab ser-acnc||infectiousdisease||class_of
molybdenum (bld) [mass/vol]||drug levels and toxicology||class_of
chymopapain igg4 (s) [mass/vol]||allergic reaction to substance (disorder)||class_of
i have weakness in my arms or legs in the past 7 days [facit]||survey.gnhlth||class_of
11-oxo-androsterone/creatinine:mass ratio:24 hours:urine:quantitative||laboratory services||class_of
intravascular systolic:pres:pt:arterial system:qn:palpation||vital sign||class_of
nucleated erythrocytes/100 leukocytes [ratio] in body fluid by automated count||lab||class_of
virus identified in lung tissue by culture||medicine, respiratory||class_of
xr foot ap||orthopedic||class_of
coxsackievirus a3 ab:titr:pt:ser:qn||infectiousdisease||class_of
taenia solium igg ab [titer] in serum by immunofluorescence||infectiousdisease||class_of
rhinovirus+enterovirus rna naa+probe ql (upper resp)||microbiology and antimicrobial susceptibility||class_of
instrumental activities of daily living priorities for the next 6mo:finding:to identify measures at a point in time:^patient:narrative:cms assessment||survey||class_of
vital capacity:vol:pt:respiratory system:qn:predicted||clinical||class_of
molybdenum:mass concentration:to identify measures at a point in time:body fluid, unsp:quantitative||lab||class_of
cardiovascular alteration:finding:to identify measures at a point in time:cardiovascular system:ordinal:observed.ccc||home health care classification survey||class_of
stroke volume:volume:to identify measures at a point in time:heart.ventricle.left:quantitative:ultrasound.2d+calculated by cube method||clinical nec||class_of
amino acids:presence or identity:to identify measures at a point in time:whole blood:nominal||chemical test, nos||class_of
fda package insert intended use of the device||reference document||class_of
cefuroxime parenter islt mlc||finding of antimicrobial susceptibility (finding)||class_of
consent:find:pt:{setting}:doc:radiology||doc.ontology||class_of
protein.monoclonal band 1 [mass/volume] in urine by electrophoresis||chemistry and chemistry - challenge||class_of
hx of childhood diseases||clinical||class_of
estrone (e1).bioavailable/estrone (e1).total in serum or plasma||obgyn||class_of
clotrimazole:susceptibility:to identify measures at a point in time:isolate:quantitative:minimum lethal concentration||infectiousdisease||class_of
cat epithelium ige (s) [ratio]||reaction; allergic||class_of
date therapy regimen resumed:date:pt:^patient:qn:cms assessment||4||class_of
ophthalmoscopy method:type:pt:eye:nom:*||eye structure (body structure)||class_of
episode of care diagnosis.primary:imp:pt:^patient:nom||clinical||class_of
natural killer cell cytotoxicity.il-2 stimulated 30:1 effector to target cell ratio/positive control:relative arbitrary concentration:to identify measures at a point in time:whole blood mc:quantitative||hematology (coagulation) and differential count||class_of
major crossmatch [interpretation] by prewarmed||lab||class_of
phosphatidylethanolamine ab.iga:acnc:pt:ser:qn||hematology||class_of
lymphocytes/leukocytes:nfr.df:pt:pericard fld:qn:manual count||hematology and cell counts||class_of
primary nursing license type provider [nmmds]||nursing management minimum data set||class_of
views:find:pt:upper extremity>hand:doc:xr.portable||orthopedics (profession)||class_of
b. burgdorferi 30kd igg ib ql (s)||microbiology test (procedure)||class_of
views ap + axillary:find:pt:upper extremity.bilateral>shoulder:doc:xr||clinical nec (not elsewhere classified in lnc)||class_of
tree allergen mix 2 (boxelder+white oak+white elm+cottonwood+pecan/hickory) ige ab [presence] in serum by multidisk||hypersensitivity (qualifier value)||class_of
i get emotional support from my partner - spouse in the past 7 days [facit]||general health survey||class_of
galns fib-ccnt||laboratory||class_of
physical therapy - co-treatment minutes^week 1:time:rptperiod:^patient:qn:cms assessment||centers for medicare & medicaid services (cms) survey||class_of
lactate dehydrogenase [enzymatic activity/volume] in pleural fluid||chemical test, nos||class_of
haemophilus influenzae bex gene:threshnum:pt:xxx:qn:probe.amp.tar||microbiology and antimicrobial susceptibility||class_of
liver cytosol ab [presence] in serum by immunoassay||laboratory||class_of
leptospira interrogans serovar mitis ab:prthr:pt:ser:ord:aggl||microbiology and antimicrobial susceptibility||class_of
nitrite:mass concentration:to identify measures at a point in time:urine:quantitative:test strip||urinalyses||class_of
homocystine [moles/volume] in urine||laboratory||class_of
potassium (bldmv) [moles/vol]||test chemical||class_of
a-cortolone 2d p high dex 24h ur-mcnc||chemistry - challenge||class_of
mycoplasma pneumoniae antibody^1st specimen:dilution factor (titer):to identify measures at a point in time:serum:quantitative||microbiology and antimicrobial susceptibility||class_of
urtica dioica ab.igg:acnc:pt:ser:qn||laboratory services||class_of
nitrogen.nonprotein:mcnc:pt:bld:qn||chemistry and chemistry - challenge||class_of
mycobacterium leprae folp1 gene dapsone resistance mutation:presence or threshold:to identify measures at a point in time:isolate/specimen:ordinal:molecular genetics||infectiousdisease||class_of
intravenous lipid emulsion [mass/volume] in serum by nephelometry||test chemical||class_of
hla ab positive cells (s) [#]||laboratory services||class_of
neighbors scold children phenx||phenx||class_of
prolactin [mass/vol]||chemistry and chemistry challenge||class_of
pressure.positive end expiratory^on ventilator:pressure:to identify measures at a point in time:respiratory system:quantitative||clinical||class_of
hemoglobin a/hemoglobin.total [pure mass fraction] in blood by hplc||hematology (coagulation) and differential count||class_of
human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:cervix:ordinal:probe.amp.tar||infectiousdisease||class_of
staphylococcus aureus.methicillin resistant isolate:presence or threshold:to identify measures at a point in time:nose:ordinal:organism specific culture||lab||class_of
how much did pain interfere with your ability to remember things in past 7d:find:7d:^patient:ord:promis||survey||class_of
physical abuse investigation was initiated||clinical nec||class_of
busulfan^trough:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||laboratory services||class_of
nras gene:variant call file:to identify measures at a point in time:cancer specimen:document:sequencing||dna sequence alteration||class_of
bartonella vinsonii berkhoffii ab.igg:titr:pt:ser:qn||infectiousdisease||class_of
neutrophil cytoplasmic antibody.perinuclear:arbitrary concentration:to identify measures at a point in time:serum:quantitative||serology - non-micro||class_of
calcium intake:substance amount:to identify measures at a point in time:^patient:quantitative:estimated||input/output electrolytes and calories||class_of
other-confidential section:-:to identify measures at a point in time:^patient:set:naaccr v.12||cancer, oncology||class_of
liver fibrosis score calculated by hepascore [score]||chemical tests||class_of
ao root es diameter (2d us)/bsa||procedure ultrasound||class_of
mycoplasma hominis dna [presence] in cornea or conjunctiva by naa with probe detection||laboratory (environment)||class_of
checklist:find:pt:emergency department:doc:{role}||doc.ontology||class_of
multisection limited:find:pt:lower extremity>lower extremity joint:doc:mr||clinical nec||class_of
food allerg mix13 ige ql||allergic reaction (disorder)||class_of
size ear-l est||dental||class_of
glucose 2 hr post dose lactose po (u) [mass/vol]||laboratory services||class_of
blood flow velocity.mean.max:velocity:to identify measures at a point in time:{circulatory system}:quantitative:ultrasound.doppler||sections 3-4 cardiovascular system||class_of
xr ribs - left anterior and lateral||clinical nec||class_of
herpes simplex virus 1+2 ab.igm:prthr:pt:ser:ord:if||infectiousdisease||class_of
major axis.systole.min:length:to identify measures at a point in time:heart.ventricle.right:quantitative:ultrasound.2d||clinical||class_of
fluid output total 10h||clinical nec||class_of
color ur||laboratory services||class_of
my child hurt a lot in past 7d:find:7d:^patient:ord:promis.parentproxy||4||class_of
imi+rel islt grad strip||sensitivity||class_of
multisection^wo & w reduced contrast volume iv:find:pt:head>maxillofacial region:doc:ct||radiology test||class_of
onset of painful contractions||emergency (deeds)||class_of
views ventilation+perfusion quantitative^w radionuclide intravenous:finding:to identify measures at a point in time:chest>lung:document:nm||radiology studies||class_of
e ag^during infancy:prthr:pt:rbc:ord||laboratory||class_of
chlamydophila psittaci iga ab [titer] in serum by immunofluorescence||laboratory||class_of
blaoxa-23-like islt/spm ql||finding of antimicrobial susceptibility (finding)||class_of
2-dce-if 1d p iff 24h ur-mrate||lab||class_of
arthropod identified:prid:pt:xxx:nom:perm mount||infectiousdisease||class_of
insulin^45m post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||challenge tests||class_of
transmission arterial blood pulse oximetry||pneumology (field)||class_of
bordetella avium ab [titer] in serum by agglutination||laboratory||class_of
hydrocodone [presence] in urine by screen method||drug levels & toxicology||class_of
hpiv3 rna islt ql naa+probe||infectiousdisease||class_of
tetrahydrocorticosterone/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||chemistry and chemistry challenge||class_of
dialysis at time of death||end stage renal disease (esrd) survey||class_of
serpine1 gene mutation analysis:presence or identity:point in time:whole blood/tissue, unspecified:narrative:molecular genetics||genes mutation||class_of
neighborhood &or workplace safety.behavior:finding:to identify measures at a point in time:^patient:ordinal:observed.omaha||survey instruments||class_of
phentermine serpl-mcnc||drug toxicology||class_of
levofloxacin 2.0 ug/ml:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:method for slow-growing mycobacteria||microbiology and antimicrobial susceptibility||class_of
thiazides tested screen nar (u)||drug levels and toxicology||class_of
hsv2 dna tiss ql naa+probe||microbiology and antimicrobial susceptibility||class_of
gestational age estimated from femur length on us by osaka 1989 method||obstetrics and gynaecology (qualifier value)||class_of
peanut ige ab/ige total in serum||laboratories||class_of
dhea-s baseline [mass/vol]||laboratory (environment)||class_of
24 hour predicted protein [mass/time range] based on random urine by calculation||chemistry and chemistry - challenge||class_of
escherichia coli o157:h7 igg ab [units/volume] in serum||infectiousdisease||class_of
cytochrome c oxidase:catalytic content:to identify measures at a point in time:tissue, unspecified:quantitative||chemical test, nos||class_of
s. pneumoniae danish type 9v igg spec 1 (s) [mass/vol]||microbiology and antimicrobial susceptibility||class_of
17-ketogenic steroids [moles/volume] in 24 hour urine||chemistry||class_of
left ventricular basal anterior segmental wall motion by cardiac angiogram||circulatory systems||class_of
thiocyanate:mass concentration:to identify measures at a point in time:urine:quantitative||drug levels & toxicology||class_of
2,5-furandicarboxylate/creatinine [molar ratio] in urine||unlisted chemistry procedure||class_of
right pulmonary artery systolic blood pressure||blood pressure result||class_of
tapentadol:prthr:pt:urine:ord:screen||laboratories||class_of
mrsa dna spec ql naa+probe||abxbact||class_of
carumonam:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal||finding of antimicrobial susceptibility||class_of
phencyclidine:mcnc:pt:unk sub:qn||laboratories||class_of
epstein barr virus nuclear ab:titr:pt:csf:qn||neurology||class_of
bouteloua gracilis ab.ige.rast class:prthr:pt:ser:ord||hypersensitivity reaction (disorder)||class_of
t. evansi ag aggl ql (bld)||laboratories||class_of
are you able to turn pages in a book:finding:to identify measures at a point in time:^patient:ordinal:promis||survey instruments||class_of
multisection^w contrast intravenous:finding:to identify measures at a point in time:upper extremity>wrist:document:magnetic resonance||clinical||class_of
i jump into things without thinking:finding:to identify measures at a point in time:^patient:ordinal:phenx||consensus measures for phenotypes and exposures (phenx)||class_of
rickettsia spotted fever group ab.igm:acnc:pt:ser:qn||microbiology (as purpose of biopsy)||class_of
netilmicin:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||drug/tox||class_of
risk assessment and screening note:find:pt:{setting}:doc:pastoral care||clinical nec (not elsewhere classified in lnc)||class_of
neisseria meningitidis antigen:arbitrary concentration:to identify measures at a point in time:cerebral spinal fluid:quantitative||microbiology and antimicrobial susceptibility||class_of
linezolid:susc:pt:isolate:ord:genotyping||microbiology and antimicrobial susceptibility||class_of
date and time of first balloon inflation heart cardiac catheterization||clinical||class_of
f tular rrna tiss ql probe||diagnostic service sources microbiology||class_of
multisection^w contrast intravenous:finding:to identify measures at a point in time:chest>heart:document:computed tomography||clinical nec||class_of
clostridioides difficile ab:acnc:pt:ser:qn||microbiology and antimicrobial susceptibility||class_of
la crosse virus antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative or ordinal:eia||laboratories||class_of
xr bones survey ltd||rad||class_of
does your health now limit you in taking care of your personal needs (dress, comb hair, toilet, eat, bathe) [promis]||survey instruments||class_of
ceftizoxime:susc:pt:isolate:ordqn:gradient strip||sensitivities||class_of
sars coronavirus 2 ribonucleic acid:presence or threshold:to identify measures at a point in time:oropharyngeal wash:ordinal:probe.amp.tar||laboratory||class_of
public communication document type:type:pt:document:nom||doc.publichealth||class_of
beta globulin.abnormal band [mass/volume] in serum or plasma by electrophoresis||laboratory||class_of
cortisol^9 am specimen:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||chemistry and chemistry - challenge||class_of
deprecated mthfr gene p.ala677val [presence] in blood or tissue by molecular genetics method||laboratory||class_of
bacillus anthracis ag [presence] in specimen||infectiousdisease||class_of
cardiac output:vrat:pt:heart.ventricle.left:qn:mr||hemodynamics molecular||class_of
end-diastolic volume:volume:to identify measures at a point in time:heart.ventricle.left:quantitative:ultrasound.2d.a4c+calc by single plane method of disks||cardiovascular structure (body structure)||class_of
insulin post 12 hr fast qn||laboratory (environment)||class_of
perioperative injury risk [ccc]||surveys||class_of
have you ever used this drug to keep from having any of these problems or make them go away:find:pt:^patient:ord:ssaga ii||clinical nec (not elsewhere classified in lnc)||class_of
beta-2-microglobulin [mass/vol]||chemistry test||class_of
personnel job title||clinical nec (not elsewhere classified in lnc)||class_of
retinal nerve fiber layer.clock hour 11 thickness:length:to identify measures at a point in time:retina.right:quantitative:oct||clinical||class_of
hhv7 dna # tiss naa+probe||microbiology and antimicrobial susceptibility||class_of
ampicillin (dose) [mass]||lab||class_of
glucose tolerance 2h gestational panel:-:-:serum/plasma:-||panel.chem||class_of
antimony:prthr:24h:urine:ord||drug toxicology||class_of
human immunodeficiency virus 1 & 2 antibody panel:-:to identify measures at a point in time:serum/plasma:-:immunoassay||microbiology tests||class_of
service comment 45||miscellaneous tests||class_of
scedosporium apiospermum dna [presence] in specimen by naa with probe detection||general microbiology procedures||class_of
wbc other auto nom (bld)||hematology/cell counts||class_of
imipramine trough serpl-mcnc||laboratory||class_of
tetrahydrofuran:mass concentration:to identify measures at a point in time:urine:quantitative||laboratory services||class_of
us nuchal fold fetus study||obstetrics, gynecology||class_of
suberylcarnitine (c8-dc):catalytic content:to identify measures at a point in time:fibroblasts:quantitative||chemistry and chemistry challenge||class_of
individual education plan information:cmplx:pt:occupational therapy treatment plan:set||occupational therapy||class_of
ct shoulder - bilateral wo contrast||rad||class_of
pulmonic valve maximum regurgitant blood flow velocity.e wave by us.doppler||ultrasound studies||class_of
how intense was your pain at its worse in the past 7d:finding:7 days:^patient:ordinal:promis||survey.promis||class_of
c. trachomatis dna naa+probe ql (anal)||microbiology and antimicrobial susceptibility||class_of
guidance for injection:find:pt:abdomen>spine.lumbar epidural space & pelvis>sacrum epidural space:doc:ct||clin||class_of
pt org registry id||american physical therapy association (apta)||class_of
mucin-like carcinoma associated ag:acnc:pt:plr fld:qn||chemistry and chemistry challenge||class_of
herbicide nom (ingesta)||laboratories||class_of
chemotherapy or other medication for this condition:hx:pt:^patient:nom:phenx||phenx||class_of
xp22.33 +or yp11.32 del+dup bld/t fish||laboratory||class_of
amylase plr-ccnc||lab||class_of
kynurenin:scnc:pt:ser/plas:qn||chemistry and chemistry challenge||class_of
how much can you open up to him or her if you need to talk about your worries [midus ii]||clinical nec (not elsewhere classified in lnc)||class_of
pancreatic polypeptide [mass/volume] in serum or plasma --25m post sham feeding||lab||class_of
platelet aggregation ristocetin induced in platelet rich plasma --1500 ug/ml||laboratory||class_of
segmented neutrophils [#/volume] in body fluid by manual count||hem/bc||class_of
chikungunya virus rna [presence] in urine by naa with probe detection||laboratory (environment)||class_of
lithium [moles/volume] in urine||laboratory||class_of
during the past 1w, how often have you been bothered by symptoms of your skin problem:find:1w:^patient:ord:skindex mini||survey instruments||class_of
cd20 antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:immune stain||cell markers||class_of
ct guidance for fine needle aspiration of lymph node||clinical nec||class_of
norcitalopram:scnc:pt:ser/plas:qn||lab||class_of
toxoplasma gondii [presence] in amniotic fluid by organism specific culture||general microbiology procedures||class_of
monochloroacetate ur-mcnc||drug levels & toxicology||class_of
gatifloxacin disk diffusion (kb) [susc]||lab||class_of
o2 ct ra.high-scnc||lab||class_of
i am able to put my thoughts together in the past 7 days [facit]||general health survey||class_of
caretaking &or parenting.knowledge:finding:to identify measures at a point in time:^family:ordinal:observed.omaha||survey instruments||class_of
chlamydia trachomatis antigen:presence or threshold:to identify measures at a point in time:urethra:ordinal||micro||class_of
microorganism preliminary growth org specific cx ql (body fld)||microbiology nos (procedure)||class_of
gestational age estimated from femur length on us by hohler 1982 method||obstetrics gynecology||class_of
sars-cov-2 rna opa wash ql naa+probe||microbiology and antimicrobial susceptibility||class_of
aspergillus terreus ab:acnc:pt:ser:qn||allergies||class_of
view spot^w radionuclide intravenous:finding:to identify measures at a point in time:neck>thyroid gland:document:nm||radiology procedures||class_of
food allerg mix17 ige qn||laboratory (environment)||class_of
subtelomere analysis [identifier] in blood or tissue by fish nominal||laboratories||class_of
aldosterone [moles/volume] in serum or plasma --pre xxx challenge||chemistry and chemistry - challenge||class_of
i am disappointed in my ability to meet the needs of my friends in the past 7 days [neuroqol]||survey.neuroq||class_of
physical findings of throat narrative||clin||class_of
herpes simplex virus antibody:dilution factor (titer):to identify measures at a point in time:cerebral spinal fluid:quantitative||laboratory (environment)||class_of
influenza virus a ab:titr:pt:csf:qn||lab||class_of
deprecated cd94 cells/100 cells in blood||laboratories||class_of
prism near:inverse length:to identify measures at a point in time:eye.left:quantitative:phoropter||eyeball||class_of
gamma hydroxybutyrate:mass concentration:point in time:urine:quantitative||chemistry procedure||class_of
cowdria ruminantium ab [presence] in serum by immunoblot||section 3-5 microbiology procedures||class_of
urea nit sp2 diafp-mcnc||laboratory services||class_of
ophthalmic oct panel||ophthalmology+optometry||class_of
deprecated respiratory therapy treatment plan, medication name identifier||pulmonary medicine (qualifier value)||class_of
broad casts:number concentration (count/vol):to identify measures at a point in time:urine:quantitative:computer assisted||nephrol||class_of
malus sylvestris tree ab.ige.rast class:prthr:pt:ser:ord||laboratory||class_of
ast (periton fld) [catalytic activity/vol]||hepatology (field)||class_of
hpv35+39+68 dna cvx ql naa+probe||infectiousdisease||class_of
b. burgdorferi 23kd igm ql (s)||laboratory (environment)||class_of
cd8+cd3- cells/100 cells (specimen)||lab||class_of
when i was in pain it showed on my face in past 7d:find:7d:^patient:ord:promis||survey instrument||class_of
somatotropin^1.5h post dose glucagon:acnc:pt:ser/plas:qn||challenge tests||class_of
volume kidney-l by aut||clinical nec||class_of
lysozyme (body fld) [mass/vol]||chemistry and chemistry challenge||class_of
igg ser elph-mcnc||chemistry and chemistry challenge||class_of
list sorting working memory test - raw score:score:pt:^patient:qn:nih toolbox||general behavioral health / psychiatry||class_of
2,8-dihydroxyadenine:scnc:pt:ser/plas:qn||laboratories||class_of
aluminum:mass concentration:24 hours:urine:quantitative||lab||class_of
hepatitis c virus igg ab [units/volume] in serum||infectiousdisease||class_of
vzv dna naa+probe ql (corn/cnjt)||microbiology and antimicrobial susceptibility||class_of
thyroperoxidase ab csf ia-acnc||neurology (qualifier value)||class_of
are you able to dry your back with a towel:find:pt:^patient:ord:promis||4||class_of
derived american joint committee on cancer-7 t descriptor:presence or identity:to identify measures at a point in time:cancer.not specified:nominal||oncology (field)||class_of
histoplasma capsulatum h & m ab panel:-:pt:csf:-||microbiology and antimicrobial susceptibility||class_of
ganglioside gd1b igg ab [units/volume] in cerebral spinal fluid by immunoassay||laboratory services||class_of
glutamate/amino acids.total in hair||laboratory||class_of
talampicillin islt mic||infectiousdisease||class_of
chemotherapy effectiveness panel [identifier] - blood or tissue||laboratories||class_of
rabies virus ab:acnc:pt:tiss:qn||microbiology and antimicrobial susceptibility||class_of
fetal abdomen circumference per estimated gestational age||clin||class_of
death registration date:date:pt:^patient:qn||questionnaire or interview||class_of
hla-dr+ cells/100 cells in bone marrow||laboratories||class_of
reviewing cytologist:identifier:point in time:cervix/vagina:nominal:cytology stain||lab||class_of
rems communication plan:-:-:^fda package insert:narrative||clinical nec||class_of
sulfate-3-glucuronyl paragloboside igm ab [units/volume] in cerebral spinal fluid||serology - non-micro||class_of
platelet aggregation.ristocetin+control prp induced:relative arbitrary concentration:to identify measures at a point in time:platelet poor plasma:quantitative||coag||class_of
adenovirus dna:prid:pt:xxx:nom:rflp||infectiousdisease||class_of
sars coronavirus urbani antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||infectiousdisease||class_of
coxiella burnetii phase 1 ab.igg:titr:pt:ser:qn||microbiology nos (procedure)||class_of
mlh1 gene targeted mutation analysis molgen nom (bld/tiss)||laboratories||class_of
guided vein throm inf d1 w throm in cath||radiology||class_of
nitrofurantoin (dose) [mass]||drug doses||class_of
c peptide^5 minutes post 1 mg glucagon intravenous:substance concentration:to identify measures at a point in time:serum/plasma:quantitative||chemistry and chemistry challenge||class_of
amphetamines screen (u) [mass/vol]||drug levels & toxicology||class_of
tgfb3 gene targeted mutation analysis molgen doc (bld/tiss)||genetics||class_of
va c&p exam general medical||clinical nec (not elsewhere classified in lnc)||class_of
st slope l-ii||cardiol||class_of
ck bb cfr.df serpl elph||laboratories||class_of
helminth identified:presence or identity:to identify measures at a point in time:not specified:nominal:macro/micro id||general microbiology procedures||class_of
fluid intake total 12h||clin||class_of
physical security assessment system details:finding:to identify measures at a point in time:^event:narrative||survey instrument||class_of
vma + creat pnl 24h ur||chemistry procedure||class_of
fetal colon study observation us||obgyn||class_of
biopterin/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||laboratories||class_of
somatotropin [mass/volume] in serum or plasma --2 hours post dose clonidine||laboratory services||class_of
pv1 ab sp2 titr ser nt||laboratory||class_of
multisection^w radionuclide iv:find:pt:whole body:doc:nm.spect+ct||clinical nec||class_of
when my child was in pain he or she asked to see a doctor in past 7d:finding:7 days:^patient:ordinal:promis.parentproxy||survey instruments||class_of
chest affects description phenx||clinical nec (not elsewhere classified in lnc)||class_of
2,4-dichlorophenoxyacetate [mass/vol]||drug levels & toxicology||class_of
penicillin:susc:pt:isolate:ordqn||infectiousdisease||class_of
m/schadd dbs-imp||laboratory (environment)||class_of
hepatitis c virus core antigen:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:immunoassay||hepatol||class_of
2,3-diphosphoglycerate:mass concentration:to identify measures at a point in time:serum:quantitative||chemistry and chemistry challenge||class_of
cd19+smig lambda+ qn (wbc)||cell markers||class_of
serotonin release.heparin.unfractionated panel - serum||laboratory||class_of
chronic bronch dr comfirmed phenx||clin||class_of
rubella virus ab.igg^1st specimen/2nd specimen:ratio:pt:ser:qn||laboratory testing, microbiology||class_of
h. pylori igg qn (s)||laboratories||class_of
dermatophilus congolensis antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:immunoassay||lab||class_of
gestational age estimated from femur length on us by chitty 1997 method||ultrasounds, diagnostic||class_of
t. equigenitalis dna naa+probe ql (genital specimen)||microbiology (as purpose of biopsy)||class_of
medication:find:pt:^patient:nom:phenx||clin||class_of
pristanate (c15:0(ch3)4) [moles/vol]||chemistry procedure||class_of
borrelia burgdorferi g39/40 igg bands [identifier] in specimen by immunoblot||laboratory (environment)||class_of
streptococcus pneumoniae 7f ab.igg:mcnc:pt:ser:qn||laboratory||class_of
t(9;22)(q34.1;q11)(abl1,bcr) b3a2 fusion transcript/control transcript [# ratio] in blood or tissue by molecular genetics method||genet||class_of
isavuconazole mic [susc]||abxbact||class_of
igm 24h ur ql ife||chemistry and chemistry challenge||class_of
fetal trisomy 21 prior risk [likelihood] based on maternal age||laboratory (environment)||class_of
i believe that receiving treatment for bone disease will be inconvenient:finding:to identify measures at a point in time:^patient:ordinal:facit||survey instrument||class_of
arterial-venous oxygen saturation difference:volume content:point in time:whole blood:quantitative||clinical nec||class_of
acebutolol 24h ur-mrate||drug/tox||class_of
18oh-cortis 24h ur-srate||laboratory services||class_of
asfv ab ser ql||infectiousdisease||class_of
rh ig expire bpu||laboratory||class_of
color (nasal fluid)||laboratory||class_of
cannabinoids [presence] in unknown substance by screen method||drug levels and toxicology||class_of
esrd dialysis adequacy panel:-:point in time:^patient:-:esrd||surveys||class_of
pravastatin ind plt igm serpl ql fc||lab||class_of
bacteria identified in pleural fluid by culture||microbiology and antimicrobial susceptibility||class_of
lv output us.m-mode+calc||card.us||class_of
race:type:to identify measures at a point in time:^patient:nominal:ussg-fht||united states surgeon general family health tool (ussgfht) survey||class_of
albumin/globulin:mrto:pt:urine:qn:electrophoresis||chemistry and chemistry - challenge||class_of
glucose 25 min post unsp challenge [mass/vol]||challenge testing||class_of
promis pediatric positive affect - version 1.0 t-score:tscore:pt:^patient:qn:promis.peds||patient reported outcomes measurement system (promis) survey||class_of
spermatozoa antibody.immunoglobulin a:presence or threshold:to identify measures at a point in time:serum:ordinal||test infertility||class_of
periodont special gingiva psr||dental||class_of
malonylcarn/c10 dbs-srto||chemical procedure, nos||class_of
dimethylsulfoxide:prthr:pt:ser/plas:ord||laboratory (environment)||class_of
plesiomonas shigelloides:prthr:pt:stool:ord:culture||laboratory||class_of
proinsulin [moles/volume] in serum or plasma --baseline||laboratories||class_of
glucose [mass/volume] in urine --4 hours post dose glucose||endocrine system||class_of
evaluation and management consent:finding:to identify measures at a point in time:{setting}:document:patient||clinical nec (not elsewhere classified in lnc)||class_of
chikungunya virus antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:immune fluorescence||infectiousdisease||class_of
disease stage score for risk calculation:score:point in time:^patient:ordinal||clin.risk||class_of
principal result interpreter study||survey instruments||class_of
cobalamins renal clearance:volume rate:24 hours:urine+serum/plasma:quantitative||section 3-7 chemistry procedures||class_of
black west walnut ige qn||allergic; reaction||class_of
lymphoma - acute screen markers [interpretation] in specimen narrative||laboratory||class_of
how often did your fatigue make you feel less alert in past 7d:find:7d:^patient:ord:promis||survey instrument||class_of
soybean igg-mcnc||laboratories||class_of
myxoma virus ag:prthr:pt:xxx:ord||microbiology and antimicrobial susceptibility||class_of
retinol binding protein (24h u) [mass/vol]||chemical tests||class_of
diagnosis||physical||class_of
gfr/1.73 sq m isotopic (u+s/p) [vol rate/area]||chemical testing||class_of
mycoplasma genitalium dna:prthr:pt:xxx:ord:probe.amp.tar||infectiousdisease||class_of
clostridium botulinum toxin:prid:pt:xxx:nom:ia||microbiology and antimicrobial susceptibility||class_of
ethanol cutoff [mass/volume] in urine for confirmatory method||laboratories||class_of
carboxyhemoglobin/hemoglobin.total:mfr:pt:bld:qn||laboratory||class_of
hav rna and parvovirus b19 dna panel naa+probe (p donor)||laboratories||class_of
headaches:find:pt:^patient:ord:ndi||survey.gnhlth||class_of
shortness of breath [minimum data set]||minimum data set for nursing home resident assessment and care screen||class_of
dehydration &or fluid maintenance trigger:finding:to identify measures at a point in time:^patient:narrative:mds||survey||class_of
plan of care note:finding:to identify measures at a point in time:{setting}:document:pediatric surgery||document ontology||class_of
neisseria sp identified:prid:pt:anal:nom:organism specific culture||laboratory testing, microbiology||class_of
cyp2c19 gene allele [genotype] in blood or tissue by molecular genetics method nominal||pgx||class_of
gas flow at 50% of forced expiration/gas flow at 50% of forced inspiration^pre bronchodilation:relative volume rate:to identify measures at a point in time:respiratory system:quantitative||respiratory measures and ventilator management||class_of
saint louis encephalitis virus rna:prthr:pt:xxx:ord:probe.amp.tar||infectiousdisease||class_of
extent of harm to the patient [ahrq]||survey instruments||class_of
mt-atp6 gene targeted mutation analysis:find:pt:bld/tiss:doc:molgen||genetics||class_of
candida albicans ab [presence] in serum by immune diffusion (id)||laboratories||class_of
cftr gene c.3120+1g>a [presence] in blood or tissue by molecular genetics method||science of genetics||class_of
u2 small nuclear ribonucleoprotein igg ql (s)||laboratory (environment)||class_of
bicarbonate [moles/volume] in cord blood||measurement, chemical||class_of
methyprylon:mass:to identify measures at a point in time:dose:quantitative||drugdose||class_of
new situations make me anxious:finding:to identify measures at a point in time:^patient:ordinal:aq||phenx (procedure)||class_of
cmv dna naa+probe ql (specimen)||microbiology nos (procedure)||class_of
[prctl] bdy weight.10th ga corr||clin||class_of
beta 2 globulin:mass rate:24 hours:urine:quantitative:electrophoresis||chemistry and chemistry challenge||class_of
erythrocytes [#/area] in vaginal fluid by wet preparation||hematology and cell counts||class_of
views + lateral crosstable:finding:to identify measures at a point in time:lower extremity.right>hip:document:xr||clinical nec (not elsewhere classified in lnc)||class_of
eastern equine encephalitis virus igm ab [presence] in body fluid by immunoassay||laboratory (environment)||class_of
how often do you feel so sleepy during the day that it interrupts your normal activities [phenx]||consensus measures for phenotypes and exposures (phenx)||class_of
2-oxo,3-methylvalerate [moles/vol]||laboratory services||class_of
imipramine+desipr serpl ql||laboratory services||class_of
glucose^1 hour post 50 g lactose oral:presence or threshold:to identify measures at a point in time:urine:ordinal:test strip||lab||class_of
hla-b49(21) donr ql||hla ag||class_of
aspa gene targeted mutation analysis molgen nom (bld/tiss)||molecular pathology||class_of
gas flow.secondary gas setting:volume rate:to identify measures at a point in time:ventilator:quantitative||clin||class_of
dementia other than alzheimer's disease [minimum data set]||minimum data set (mds) for nursing home resident assessment and care screening||class_of
mh nurse cust care fac note||clinical||class_of
allo-thf 24h ur-srate||chemistry procedures||class_of
other error requiring modification.other specified:type:to identify measures at a point in time:^patient:nominal:mdsv3||survey||class_of
specimen drawn:time stamp-date and time:to identify measures at a point in time:serum/plasma:quantitative||specimen information||class_of
anthoxanthum odoratum ab.ige/ige.total:afr:pt:ser:qn||laboratories||class_of
marital status:type:to identify measures at a point in time:^contact:nominal||clinical nec||class_of
resistivity index:velrto:pt:umbilical artery.at placenta^fetus:qn:us.doppler||obstetrics/gynecology||class_of
i felt mad in past 7 days [promis]||patient reported outcomes measurement system (promis) survey||class_of
corticotropin 4th specimen post unsp challenge (p) [mass/vol]||laboratories||class_of
easter lily ige qn (s)||laboratory (environment)||class_of
globotriaosylsphingosine:scnc:pt:bld:qn||chemistry and chemistry challenge||class_of
listeria sp ab [titer] in serum by complement fixation||infectiousdisease||class_of
taurine (dbs) [moles/vol]||chemistry and chemistry challenge||class_of
my child knew that our family would be there if he or she needed them in past 4w:find:4w:^patient:ord:promis.parentproxy||patient reported outcomes information system (promis)||class_of
ampv b ab titr ser||microbiology and antimicrobial susceptibility||class_of
microorganism resistance mutation amino acid change type:type:pt:isolate/specimen:nom:molgen||laboratories||class_of
axis far:angle:pt:eye.left:qn:phoropter||eye refraction||class_of
calcium hydrogen phosphate dihydrate [mass/time] in 24 hour urine||chemistry and chemistry challenge||class_of
npdc gene targeted mutation analysis:finding:to identify measures at a point in time:whole blood/tissue, unspecified:document:molecular genetics||molecular pathology||class_of
optimal confidence - baseline||outpatient physical therapy improvement in movement assessment log (optimal) panel||class_of
proteus sp dna spt naa+non-prb-ncncrng||microbiology and antimicrobial susceptibility||class_of
clindamycin.high potency [susceptibility] by minimum inhibitory concentration (mic)||finding of antimicrobial susceptibility||class_of
active suicidal ideation with some intent to act, without specific plan lifetime||surveys||class_of
length.max:len:pt:ear.left^fetus:qn:us.measured||obstetrics and gynaecology (qualifier value)||class_of
cocaine spec ql||laboratory||class_of
oxygen saturation in cord blood||chemical testing||class_of
hepatitis b virus deoxyribonucleic acid:log arbitrary concentration:to identify measures at a point in time:tissue, unspecified:quantitative:probe.amp.tar||hepatol||class_of
rickettsia typhi antibody.immunoglobulin a:arbitrary concentration:to identify measures at a point in time:serum:quantitative:immune fluorescence||microbiology procedure (procedure)||class_of
cannabinoids synthetic ql (bld)||drug/tox||class_of
illegal drug use in the past 1y:finding:1 year:^patient:ordinal||clinical nec||class_of
education note:finding:to identify measures at a point in time:{setting}:document:dialysis||clinical||class_of
age when first prescribed [phenx]||clin||class_of
neutrophils nfr.df bld manual||laboratory||class_of
bicarbonate [moles/volume] in urine||chemical test, nos||class_of
lactate dehydrogenase [presence] in urine||chemical testing||class_of
guidance for ablation of tissue:finding:to identify measures at a point in time:abdomen>liver:document:computed tomography||clinical||class_of
clozapine spec ql||laboratory||class_of
have you ever worn contact lenses [phenx]||clinical nec||class_of
stairs - functional ability:find:pt:^patient:ord||clinical||class_of
xr pisiform+triquetrum-bl views||clin||class_of
mitral valve regurgitant fraction by us.doppler+calculated by continuity vti||circulatory||class_of
money and resources [prapare]||surveys||class_of
melanin:prthr:pt:urine:ord||laboratory (environment)||class_of
cells.cd235a/100 cells:nfr:pt:xxx:qn||laboratories||class_of
pressure injuries - unstageable due to coverage of wound bed by slough &or eschar:-:pt:^patient:-||survey instrument||class_of
discharge summary note:find:pt:{setting}:doc:internal medicine||clinical nec||class_of
bacteria nph aerobe cult||unlisted microbiology||class_of
views^w contrast intra-arterial:finding:to identify measures at a point in time:abdomen+pelvis>iliac artery.left:document:radiofluoroscopy.angio||radiology||class_of
other people have told me i seemed confused in the past 7d:finding:7 days:^patient:ordinal:facit||survey instruments||class_of
acetylcholine receptor binding ab qn (s)||neurology speciality||class_of
general health:finding:to identify measures at a point in time:^patient:ordinal||clinical||class_of
glucose 16 min post unsp challenge [mass/vol]||endocrine structure (body structure)||class_of
isoleucine/amino acids.total in dbs||lab||class_of
encephalopathy autoimmune ab panel:-:pt:csf:-||neurology (qualifier value)||class_of
nursing certification panel:-:pt:{nursing unit}:-:nmmds||nursing management minimum data set (nmmds) panels||class_of
choose the number of the activity you would most like to be able to do without any difficulty [optimal]||4||class_of
integumentary status:-:pt:^patient:-||outcome and assessment information set (oasis) set||class_of
hydromorphone cutoff [mass/volume] in urine for confirmatory method||drug toxicology||class_of
t(11;19)(q23;p13.1)(mll,ell) fusion transcript [presence] in blood or tissue by molecular genetics method||molpath||class_of
fungi.filamentous lm.hpf (urine sed) [#/area]||laboratory||class_of
norpropoxyphene:mass content:to identify measures at a point in time:stool:quantitative||laboratory (environment)||class_of
cells.cd4+cd29+/100 cells:nfr:pt:bld:qn||cellmark||class_of
trypanosoma brucei rhodesiense antibody:presence or threshold:to identify measures at a point in time:serum:ordinal||microbiology (procedure)||class_of
nm abd views for therapy w tc99msc iv||radiology test||class_of
internal rotation.passive range of motion:angle:pt:shoulder.right:qn||orthopedics (profession)||class_of
palmitoylcarn amn-scnc||chemistry and chemistry challenge||class_of
my thinking has been foggy in past 7d:find:7d:^patient:ord:promis||questionnaire or interview||class_of
reducing substances:presence or threshold:to identify measures at a point in time:stool:ordinal:post hydrolysis||chemistry and chemistry - challenge||class_of
physical findings of pupil||clinical||class_of
compared to 10 years ago, has there been any change in remembering the current date or day of the week [ecog]||general health survey||class_of
basophils/100 leukocytes in amniotic fluid by manual count||hematology/cell counts||class_of
epineph sp6 p chal plas-scnc||chemistry and chemistry - challenge||class_of
have you ever taken prescription medication for headache on a daily basis, whether or not you have a headache, to help prevent a severe headache from happening in the first place [phenx]||consensus measures for phenotypes and exposures||class_of
valine:mass concentration:to identify measures at a point in time:urine:quantitative||chemistry and chemistry challenge||class_of
hyoscyamine (u) [mass/vol]||drug toxicology||class_of
cefotetan:susc:pt:isolate:qn:mlc||microbiology and antimicrobial susceptibility||class_of
dermatology operative note||clinical||class_of
diffusion capacity/alveolar volume:inverse inspired volume:to identify measures at a point in time:respiratory system:quantitative||clin||class_of
carrot igg4 ab [mass/volume] in serum||laboratory services||class_of
pyridinoline/creatinine (2h u) [mass ratio]||clinical chemistry test||class_of
alpha 2 globulin:mcnc:pt:urine:qn:electrophoresis||lab||class_of
cobalamin (vitamin b12) [moles/volume] in body fluid||laboratories||class_of
microscopic observation giemsa stain nom (amn fld)||infectiousdisease||class_of
htt gene.cag repeats:presence or threshold:to identify measures at a point in time:amniotic fluid/cvs:ordinal:molecular genetics||molpath||class_of
education note:finding:to identify measures at a point in time:{setting}:document:palliative care||clinical nec||class_of
7-dehydrocholesterol and 8-dehydrocholesterol panel - serum or plasma||chemistry and chemistry - challenge||class_of
fluav h7 ab titr ser||microbiology procedure (procedure)||class_of
lepidoglyphus destructor ab.ige:acnc:pt:ser:qn||allergic reaction nos||class_of
brucella melitensis ab [units/volume] in serum by latex agglutination||lab||class_of
radiology administrative note||doc.ontology||class_of
rabbit hemorrhagic disease virus ag ia ql (tiss)||infectiousdisease||class_of
phase.mean^resting:angle:to identify measures at a point in time:heart.ventricle.left:quantitative:nm.spect||cardiology field||class_of
cholesterol in hdl 2a/cholesterol in total hdl in serum or plasma by electrophoresis||circulatory systems||class_of
coronary segment addl details pnl||cardiac panel||class_of
prior level of function:finding:to identify measures at a point in time:physical therapy treatment plan:narrative||attach.rehab.pt||class_of
gigartinales sp. bold:aal3140||open wound of right shoulder||random
pork liver 8 [hp_x] in 1 ml / somatropin 30 [hp_x] in 1 ml / sus scrofa pituitary gland 30 [hp_x] in 1 ml oral spray [original formula]||atropa belladonna 200 [hp_c] in 1 ml / lytta vesicatoria 200 [hp_c] in 1 ml / causticum 200 [hp_c] in 1 ml / artemisia cina pre-flowering top 6 [hp_x] in 1 ml / equisetum hyemale 3 [hp_x] in 1 ml / strychnos ignatii seed 200 [hp_c] in 1 ml / physalis alkekengi fruit 6 [hp_x] in 1 ml / sepia officinalis juice 200 [hp_c] in 1 ml / anemone pratensis 12 [hp_x] in 1 ml / verbascum thapsus 6 [hp_x] in 1 ml oral spray [incontinence]||random
ft- hai testcd||lymaenon sp. bioug22831-a05||random
zinc gluconate 1 [hp_x] / eupatorium perfoliatum flowering top 1 [hp_x] / sambucus nigra flower 1 [hp_x] / valerian 1 [hp_x] / chamomile 2 [hp_x] / mentha piperita 2 [hp_x] / myrrh 2 [hp_x] / glycyrrhiza glabra leaf 3 [hp_x] oral tablet, orally disintegrating [cold-eeze plus nighttime multi-symptom relief]||mesoridazine serpl-scnc||random
burns of left ear (diagnosis)||my child knew he or she could rely on our family in past 4w:finding:4 weeks:^patient:ordinal:promis.parentproxy||random
anesthesia for procedure on veins of lower leg||division of urinary tract (body structure)||random
x-ray nos skull normal||generalized skin lesions||random
operculariidae||3 ml insulin lispro-aabc 100 unt/ml cartridge||random
swelling of left distal forearm (physical finding)||arcuate part of fibrous tendon sheath of left index finger||random
immune reconstitution inflammatory syndrome associated tuberculosis||melanocytoma of eyeball||random
fetal biophysical profile; with non-stress testing||tot prosth repl knee + cement||random
lymph node||cryptodiscus tabularum||random
human metapneumovirus b||oxidoreductases, n demethylating||random
adv eff systemic agt nos||knife, myringotomy||random
small intestine mucosa culture mycobacterium tuberculosis (lab test)||infections, astroviridae||random
congenital cortical and zonular cataract||pullulan||random
anomaly of chromosome pair 11||chromosome 9 trisomy syndrome||random
anti-cd137 monoclonal antibody||rhabdovirus of blue crab (organism)||random
stephensoniella <segmented worms>||rathayibacter sp. f120||random
desbruyeresia||cnto3157||random
hydrocyrius colombiae||unclassified philoplitis||random
blindness or low vision nos (disorder)||fumaria <plant>||random
medical and surgical @ female reproductive system @ extirpation @ fallopian tubes, bilateral @ via natural or artificial opening @ no device @ no qualifier||adrenaline 10 microgram/ml and mepivacaine hydrochloride 20 mg/ml solution for injection||random
disulfoton poisoning (disorder)||de ritis ratio abnormal||random
skeleton (ex vivo)||cesarean delivery only w/postpartum care||random
telenomus sp. bioug19893-e11||allergenic extract, house dust||random
cardiotomy||amoxicillin 875 mg oral tablet, film coated||random
periventricular haemorrhage neonatal||tonsils tumors||random
unclassified grapholitini||sexual functioning status||random
epiphysis greater trochanter||toxicology testing for insecticide, nos||random
topiramate@50 mg@oral@tablet||hydrellia notata||random
mn025||nurse specialist||random
product containing only teicoplanin in parenteral dose form (medicinal product form)||left shoulder pain elicited by active cross-chest adduction (___ degrees)||random
domatinostat||stenosis of brachiocephalic artery||random
referral by hospital-based speech and language therapist (procedure)||septoglomus||random
admission to psychiatry department||copper (64-cu) diacetyl-bis n-(4)-methylthiosemicarbazone product||random
cd79a cells/100 cells (bm)||c5 innervation||random
en139544||ear canal stenosis postoperative||random
product containing galactose microparticles||mannitol permease activity||random
iatrogenic complication of vascular surgery (disorder)||stain method||random
interspinalis thoracis (body structure)||bony part of right pedicle of second thoracic vertebra||random
kayser-fleisher ring||c3 plr-mcnc||random
unclassified lichenostigma||hard cider||random
combined right retrograde left heart catheterization for congenital anomalies||atfbt||random
reconstruct cranial bone||alburnoides sp. j256 ke-2019||random
abnormal enzyme/coenzyme activity||anterior synechia of iris of left eye||random
13 weeks gestation of pregnancy||seed germination||random
xr wrist-r lat w ext||inocephalus glycosmus||random
life assurance examination nos (procedure)||sezary syndrome stage i||random
mirn390 microrna, arabidopsis||progesterone reductase||random
adenocarcinoma in situ of cervix (diagnosis)||exsa protein, bacteria||random
medical and surgical @ upper arteries @ replacement @ external carotid artery, right||(alternaria alternata+aspergillus fumigatus+cladosporium herbarum+penicillium notatum) ab.ige:acnc:pt:ser:qn:multidisk||random
salpingoneostomy||division of soft tissue, nos||random
siltuximab (medication)||points triggering||random
murine encephalomyelitis (disorder)||phenazopyridine hydrochloride 200 mg oral tablet, coated [phenazopyridine hydrochloride]||random
shock during or following labor and delivery, unspecified as to episode of care or not applicable||medical and surgical @ ear, nose, sinus @ repair @ external ear, right @ percutaneous endoscopic @ no device||random
dnimi cpd||helicopter, device||random
calcium ascorbate 50 mg / ferrous asparto glycinate 50 mg / polysaccharide iron complex 100 mg / succinic acid 50 mg [niferex-150]||system; sclerosis||random
risk control: drug abuse||prid||random
aedes sp. bioug26185-a03||acanthosis||random
trichoptera sp. bold:aad2781||cecidomyiidae sp. bioug24496-f07||random
palex bclfp44 840579 44mm/precut petite mini colostomy bag+resin seal+microporous adhesive+filter||genital varices in pregnancy vulvar||random
pituitary tumour recurrent||endovascular repair of visceral aorta by fenestrated endograft||random
relationship_type||stempellinella sp. bioug20465-h01||random
unclassified chelon||passive range of toe abduction (observable entity)||random
ttg igg ser ql||bismuth subsalicylate 262 mg oral tablet, chewable [heb stomach relief]||random
gymnostomum hymenostylioides (broth. & dixon) r.h.zander||unable to communicate intentions (finding)||random
distal tendon of left gastrocnemius||allergy to first generation cephalosporin (finding)||random
presence; lung transplant||lumen of trunk of superior lingular artery||random
hepatitis c relapse||csf g||random
medical and surgical @ upper bones @ revision @ scapula, right @ percutaneous @ internal fixation device||unclassified calyptostomatidae||random
boana||sweat gland carcinoma||random
pz01||construction of intermarginal adhesions (procedure)||random
carcinoma colon dukes b1||(spl review) alcohol 0.7 ml in 1 ml topical gel [hand sanitizer]||random
level of spine intervention:find:pt:^patient:nom||splenic precursor lymphoblastic lymphoma||random
insertion of distraction device into posterior lumbar spinous process||inc act range midtarsal prona||random
alenatea||recombinant human antithrombin iii product||random
methanofuran||dinophasma||random
medical and surgical @ central nervous system and cranial nerves @ transfer @ accessory nerve @ open @ no device @ hypoglossal nerve||flecainide peak serpl-mcnc||random
ancistrus sp. 9 gscs-2015||accidental cut, puncture, perforation or hemorrhage during administration of enema (finding)||random
american ginseng 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / mahonia aquifolium root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / chelidonium majus 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / conium maculatum flowering top 15 [hp_x] in 1 ml / glycyrrhiza glabra 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / sodium chloride 15 [hp_x] in 1 ml / strychnos nux-vomica seed 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / phytolacca americana root 15 [hp_x] in 1 ml / pulsatilla vulgaris 15 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / taraxacum officinale 3 [hp_x] in 1 ml / urtica urens 3 [hp_x] in 1 ml oral liquid [energy vitality assist]||hemorrhoid internal||random
sis-gamma||oleic acid 200 mg / polidocanol 20 mg rectal suppository||random
family history of craniosynostosis||vlnt - vascularized lymph node transfer||random
chlorophyllin copper complex 5 mg/ml / papain 77.1 mg/ml / urea 100 mg/ml topical spray [panafil]||pregnancy; abruptio or ablatio placentae||random
radionuclide rhenium 186 hydroxyethylidene diphosphonate therapy (procedure)||5-dcpmh||random
leukemic cell||entire baby tooth||random
staphylococcus phage lorac||toxic; purpura||random
negative regulation of metanephric mesenchymal cell migration||concentrate for suspension for injection||random
xylenes||echocardiography using pharmacologic stress agent (procedure)||random
positive regulation of interleukin-34 production||open dislocation, multiple and ill-defined sites||random
formicarius||plasma alanine aminotransferase test||random
decreased passive forward flexion of left shoulder (physical finding)||dose failure in insulin-shock||random
umbaspis||halobacillus sp. hpb31||random
x-ray toes dislocation right second toe joint pip||bermuda grass pollen extract injectable product||random
mir-361, human||halomonas sp. agd 1||random
cryptinae sp. bioug25051-d02||sleep disorder caused by psychoactive substance (disorder)||random
carb metab inborn err||rna binding motif protein 25||random
st amplitude||chemical categsd structurally||random
minocycline hcl@75 mg@oral@capsule||circumflex coronary artery||random
unspecified benign neoplasm of heart (diagnosis)||coccomyxa sp. uah-lu||random
penicillin g benzathine 600,000unit/ml injection||dermovate-nn||random
lacazia loboi infection||hyperproteinorrhachia||random
arms burning upper||methyl 3-(4-(4,5-bis(4-(isopropyl(methyl)amino)phenyl)-1h-imidazol-2-yl)phenyl)acrylate||random
megaselia sp. bioug27172-d12||shavcr1 measurment||random
child attention deficit disorder (diagnosis)||coronary angiography: right coronary first right posterolateral branch stenosis multiple discrete (procedure)||random
repair procedures on tongue||exalgo 8 mg 24hr extended release oral tablet||random
naarda||right maxillary artery||random
streptokinase titr ser||hosp equipment supplies||random
thyroid biopsy recurrence after ablation (procedure)||methoxydimethyltryptamine||random
cryptophthalmos syndrome||intracranial space-occupying lesion (disorder)||random
neonatal jaundice due to abo incompatibility (disorder)||unclassified microcerotermes||random
ivd test reagent/kits, molecular assay, gene anomaly, deletion/duplication, ftsj1||logistic regressions||random
carboxymeth 0.5/glyc 0.9% oph soln 0.4ml||positive regulation of flagellated sperm motility||random
chlorfenvinphos||suture insertion||random
sfrs2-interacting protein||otolaryngologic surgical result: right external auditory canal incision||random
polymeric stents||recurrent rectal adenocarcinoma||random
cong.subglottic web of larynx||htlv 1 nucleic acid detection||random
anterior pituitary hyperfunction (diagnosis)||bronchoscopy with destruction of tumor by laser surgery||random
other fracture of lower end of unspecified tibia, subsequent encounter for open fracture type i or ii with delayed healing||unclassified/other cancer||random
ob ultrasound pregnancy not present||adhd, predominantly inattentive type (diagnosis)||random
thymelaeaceae||notonomus||random
unclassified haloferax||progesterone 1.5 hr post unsp challenge [mass/vol]||random
thyroid (porcine) 300mg oral tablet||group ii chaperonins||random
cacicus solitarius||parotid duct probing||random
unclassified adisura||recurrent appendix mucinous adenocarcinoma||random
greeneria||alpha proteobacterium eu6||random
loose body in joint of hand (disorder)||hemorrhagic bullae||random
tooth avulsion||belladonna-phenobarbital, 0.0194 mg-0.1037 mg-16.2 mg-0.0065 mg/5 ml oral elixir||random
syphilitic oral snail track ulcer (disorder)||sudden bursts of laughter||random
embryonal neuroepithelial neoplasm of central nervous system||pain of right shoulder elicited by passive motion||random
pharmaceutical excipient (substance)||cortisol free hplc (24h u) [mass or moles/vol]||random
organoaxial gastric volvulus||17-hydroxyprogesterone decreased||random
gallbladder calculus without cholecystitis or cholangitis||trophic disorders||random
inferior lateral to superior medial laceration of right lateral chest wall (physical finding)||hospital&#x7c;anytypeofservice&#x7c;anykindofdocument&#x7c;anyrole&#x7c;anysubjectmatterdomain||random
prednisone 1 mg [rayos]||hdac11 gene||random
sedum rupestre l.||exposure to allergen||random
development||treponema sp. uba3649||random
aspirin (substance)||thick-knees||random
[x]contact with powered lawnmower, occurrence at school, other institution and public administrative area (event)||esophageal sphincter, upper||random
burns of dorsal aspect of proximal phalanx of thumb of left hand||clidinium bromid||random
nasal pruritus||trunk of first posterior intercostal artery||random
alanine 8.8 mg/ml / arginine 4.4 mg/ml / dibasic potassium phosphate 2.61 mg/ml / glucose 250 mg/ml / glycine 8.8 mg/ml / histidine 1.86 mg/ml / isoleucine 2.03 mg/ml / leucine 2.63 mg/ml / lysine 2.46 mg/ml / magnesium chloride 0.01 meq/ml / methionine 2.46 mg/ml / phenylalanine 2.63 mg/ml / proline 1.78 mg/ml / sodium acetate 0.036 meq/ml / sodium chloride 0.013 meq/ml / threonine 1.78 mg/ml / tryptophan 0.76 mg/ml / tyrosine 0.17 mg/ml / valine 1.95 mg/ml [travasol 4.25/25]||clindamycinum||random
supernumerary permanent teeth (disorder)||diagnosis.primary:complex:to identify measures at a point in time:physical therapy treatment:set||random
ivd test reagent/kits, serology, virus, retrovirus, hiv-1||environment hospital-based outpatient physical medicine clinic||random
auxin response factor 8, arabidopsis||congenital misalignment of arch of sacral vertebra||random
s/pt thick burn-scapular regn.||cystoscopic indwelling catheterization of ureter (procedure)||random
viscum album fruiting top 4 [hp_x] in 1 g / stachys officinalis 8 [hp_x] in 1 g / rosmarinus officinalis flowering top 8 [hp_x] in 1 g / formica rufa 9 [hp_x] in 1 g / bos taurus intervertebral disc 10 [hp_x] in 1 g / silicon dioxide 19 [hp_x] in 1 g / silver 22 [hp_x] in 1 g / arnica montana 22 [hp_x] in 1 g / bambusa vulgaris whole 8 [hp_x] in 1 g rectal suppository||1,4-dihydropyridine||random
feature of lower limb||ceratoppia sp. bioug21082-d02||random
medical and surgical @ lower arteries @ destruction @ colic artery, left @ percutaneous @ no device @ no qualifier||unclassified vibrio||random
mech compl of internal fixation device of vertebrae, sequela||pesticide measurement||random
orphenadrine citrate 100 mg||2,3-dihydroxybenzoate 3,4-dioxygenase||random
mixed culture bacterium am_gf1dd01_03||tolmetinum||random
neonatal conjunctivitis of bilateral eyes||abnormal urinalysis (finding)||random
neoschrammeniella||.beta.-carotene||random
diameter product:area:pt:thorax^fetus:qn:us.derived||pseudoalteromonas sp. sr44-2||random
adverse reaction to androgen or anabolic steroid nos||bradyrhizobium sp. 13los57_5||random
medical and surgical @ upper joints @ drainage @ elbow joint, right @ percutaneous endoscopic||product containing binimetinib (medicinal product)||random
white pine pollen (substance)||sprain of fifth toe of right foot (diagnosis)||random
syo1||ropivacaine hydrochloride 7.5 mg in 1 ml epidural injection, solution [naropin]||random
liver fibrosis score (lab test)||mitochondrial trna 5'-end processing||random
flexivirga anzai et al. 2012 emend. hyeon et al. 2017||acetylthiocholine||random
quinidine bisulfate (substance)||oxygen compounds, unspecified||random
gramicidin d:titr:pt:isolate+ser:qn:sbt||it takes me longer than other people to get my school work done in past 4w - frequency:finding:4 weeks:^patient:ordinal:promis.peds||random
avobenzone 30 mg in 1 ml / homosalate 120 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 17 mg in 1 ml / oxybenzone 30 mg in 1 ml topical lotion [roc multi correxion lift anti gravity day moisturizer sunscreen broad spectrum spf30]||colon; abscess||random
aspirin and papaveretum product||medical and surgical @ lower joints @ removal @ sacrococcygeal joint @ external @ infusion device||random
iris inflammation||accidental ingestion of scombroid fish (event)||random
obstruction co-occurrent and due to right inguinal hernia||physical rehabilitation and diagnostic audiology @ rehabilitation @ activities of daily living assessment @ none @ anthropometric characteristics @ none||random
lycoperdon cf. dermoxanthum stb0624||acetaminophen-phenyltoloxamine 600 mg-66 mg oral tablet, extended release||random
father smokes (situation)||complete traumatic amputation at level between elbow and wrist, left arm||random
histocompatibility antigen hla-b13 in blood or tissue of donor||deprecated||random
pericardial empyema||unclassified cochylis||random
macrophages.alveolar||minocycline 90 mg (as minocycline hydrochloride) 24 hr extended release oral tablet||random
prurigo gestationis of besnier||granulocyte macrophage colony stimulating factor||random
v-set domain containing t cell activation inhibitor 1 wt allele||tissue specimen from conjunctiva (specimen)||random
candidatus peribacter sp. uba1555||entire gastric pyloric gland||random
solriamfetol tablets||acetaminophen@100 mg/ml@oral@drops||random
scleromalacia perforans of bilateral eyes (disorder)||col1a2 pathogenic variant (lab test)||random
aluminum sesquichlorohydrate 16 g in 100 g topical aerosol, spray||psychoorganic syndrome||random
angina associated with type 2 diabetes mellitus||superf.vagina inj.nos+infect.||random
acid, sulfonic||synthase, glutamate||random
product containing sitagliptin 100 mg/1 each oral tablet||how often did you eat cold cereal in the past 30d||random
rfa peritoneum views w contrast percutaneous intraperitoneal||aeromonas caviae infection||random
chlorpheniramine maleate 0.4 mg/ml / hydrocodone bitartrate 0.334 mg/ml / phenylephrine hydrochloride 1 mg/ml [efasin-hd]||wahlenbergia||random
il-tif||product containing pyrrolidine||random
magnetic resonance imaging of thoracic spine: solid mass of mid t4 vertebra||interferon omega [mass/vol]||random
optipranolol||mefenamate [moles/volume] in serum or plasma||random
borrelia burgdorferi iga ab [presence] in serum by immunoassay||iridocyclitis due to tuberculosis||random
unclassified sicarius||glucose/insulin:mass ratio:to identify measures at a point in time:serum/plasma:quantitative||random
chlamydophila psittaci iga ab [units/volume] in cerebral spinal fluid||phaselicystis||random
service coordination total:score:to identify measures at a point in time:^patient:quantitative:epcam||arthrogryposis, distal, type 4 (disorder)||random
(spl review) chloroxylenol 0.015 g in 100 ml topical liquid [dc berry scented hand sanitizer 01]||cefotiam (product)||random
menthol 40 mg/ml||contracture of right shoulder on adduction (physical finding)||random
electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with simple spinal cord or peripheral nerve (eg, sacral nerve) neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional||temperatures, melting point||random
biliary catheter insertion||abscess of pituitary||random
apis mellifera 4 [hp_x] in 1 ml / atropine sulfate 6 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / caulophyllum thalictroides root 4 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 4 [hp_x] in 1 ml / cupric acetate 4 [hp_x] in 1 ml / gelsemium sempervirens root 4 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / chamaelirium luteum root 4 [hp_x] in 1 ml / strychnos ignatii seed 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / tin 8 [hp_x] in 1 ml / viburnum opulus bark 3 [hp_x] in 1 ml oral liquid [pms complex]||s-488210/s-488211||random
mesarteritis; syphilitic, brain (etiology)||extended oligoarthritis||random
synovial membrane of left subcutaneous trochanteric bursa||dietary advice||random
chlorpromazine hcl 200mg tab||superior parathyroid gland capsule||random
what was your new daytime activity or job||carbamazepine dbs-mcnc||random
nondisp fx of ant process of l calcaneus, init for opn fx||kounis syndrome type ii||random
lumbricidae sp. lu_216||2 ml aripiprazole 200 mg/ml prefilled syringe||random
allantoin shampoo product||1w||random
ampv c ab ser ql||habromys chinanteco (organism)||random
drainage of r low extrem with drain dev, perc endo approach||explain the cost of service to patient and/or family before rendering care||random
removal of encircling suture from around perianal sphincter||open treatment of supracondylar humeral fracture||random
covid-19 consultation note||haplotaxis||random
menthol, unspecified form 10.5 g in 10.5 ml topical spray [prof]||insulin lispro pen injector [lyumjev]||random
pressure, peer||miconazole-containing product in cutaneous dose form||random
ropivacaine hydrochloride 2 mg in 1 ml perineural injection, solution [ropivacaine hydrochloride]||stage iv primary peritoneal cancer ajcc v7||random
internal oblique division of ascending part of left deep circumflex iliac artery||mouse stomach||random
dihydrodihydroxybenzoate dehydrogenase activity||astrovirus, chicken||random
product containing albiglutide (medicinal product)||mt-cyb pseudogene 26||random
factor viii injection||urine mercury (lab test)||random
sodium:substance rate:18 hours:urine:quantitative||cholesterol.in ldl/cholesterol.in hdl:mcrto:to identify measures at a point in time:serum/plasma:quantitative||random
medical and surgical @ lymphatic and hemic systems @ destruction @ lymphatic, mesenteric @ open||tricuspid leaflet abnormality (diagnosis)||random
stenosis degree:lenfr:pt:left main coronary artery:qn:angiogram||paracentesis of bladder||random
ascococcus mesenteroides||intra arterial line||random
pentazocine rectal product||arsenic/creat ur-srto||random
phendimetrazine tartrate 17.5mg tab||kidney disease, chronic||random
lepidoptera sp. bold:aac7737||episcleritis of left eye (diagnosis)||random
revascularization, endovascular, open or percutaneous, tibial/peroneal artery, unilateral, each additional vessel; with atherectomy, includes angioplasty within the same vessel, when performed (list separately in addition to code for primary procedure)||venlafaxine induced neutrophil antibody.immunoglobulin g||random
remifentanil hydrochloride (medication)||cardiac resynchronisation therapy / pacemaker insertion||random
monitor individual's adherence to exercise program/activity||okoubaka aubrevillei bark extract||random
gigartinales sp. bold:aao5074||crushing injury of right hip, sequela||random
drug resistance, bacterial||entire right colic lymph node (body structure)||random
alleculinae||medical and surgical @ upper arteries @ reposition @ hand artery, left @ percutaneous endoscopic @ no device||random
extrapleural lung lobectomy||ithome tamarugensis||random
emotional problems nervousness||gestational age and weight conditions||random
air synthetic protein||excess sick leave||random
goserelin acetate regimen||inferior division of posterior branch of right anterior segmental artery||random
dscada cpd||biopsy hypopharynx neoplasm (procedure)||random
benzalkonium chloride 0.1 g in 100 g / alcohol 15 ml in 100 g topical cloth [surface wipes]||food red 105||random
arginine 350 mg extended release oral tablet||cortisol 30 min post dose corticotropin [moles/vol]||random
fees med||multisection:finding:to identify measures at a point in time:pelvis>sacrum:document:xr.tomography||random
metubine iodide 2 mg/ml injectable solution||diagnostic testing action||random
xanthium strumarium pollen 0.001 g in 1 ml intradermal solution [cocklebur]||mesenteric artery occlusion||random
hygophum proximum becker, 1965||upregulation of nad(p)h oxidase activity||random
acetaminophen increased||morphine sulfate 2 mg/1 ml injection solution_#2||random
ichneumonidae sp. bold:aaq0483||panel.cv||random
leucophenga sp. 3 hwc-2015||administration of vaccine product containing only streptococcus pneumoniae antigen||random
long evans rats||stribild, 150 mg-150 mg-200 mg-300 mg oral tablet||random
abnormality of circulating fibrinogen||passiflora lancetillensis||random
unsocial unaggress-mod||x-ray of toe: lytic lesion||random
unclassified cixiidae||skin scab of ring finger of left hand||random
removal of monitoring device from trachea, perc approach||fallopian tube lymphoma||random
oxidase||localized superficial swelling, mass, or lump||random
truffles||hippocampus sp. tcmqs1706||random
theophylline:mass or substance concentration:to identify measures at a point in time:serum/plasma:quantitative||liagora donaldiana||random
gallbladder & biliary tract: excision||composite hodgkin's and non-hodgkin's lymphoma of jaw||random
open inferior dislocation of right humerus||sediments urinary||random
isosource vhn liquid 250ml||g/cubic meter||random
1-octadecyl-3-pyrrolidinemethanol||articular cartilage of inferior surface of body of fifth sacral segment||random
heart rate &#x7c; xxx &#x7c; specific heart rate||homogentisic acid (substance)||random
mucor plumbeus allergenic extract injectable product||hb sn baltimore||random
calcific chronic pancreatitis||product containing nitrofurantoin monohydrate 75 mg and nitrofurantoin 25 mg/1 each oral capsule (clinical drug)||random
galium tinctorium||increased vitamin a (biological function)||random
congenital intestinal obstruction||vit k intake 24h est||random
testicular yolk sac tumor, glandular-alveolar pattern||dasiglucagon||random
seventh costochondral joint||lower back pain radiating to right ankle||random
aspartate (substance)||bone disorders, general and nec||random
imatinib (as imatinib mesylate) 100 mg oral tablet||aeromonas sp. aer21-vdl-porcine||random
aluminum:substance concentration:to identify measures at a point in time:water:quantitative||fetal scalp electrode monitoring||random
infection;toe(s)||sarilumab auto-injector [kevzara]||random
recurrent childhood anaplastic large cell lymphoma||malunion of fracture of proximal end of left ulna||random
molecular analysis table||pain score change:scorediff:pt:^patient:qn:hoos||random
benzoyl peroxide medicated liquid soap||deprecated streptococcus pneumoniae 2 igg ab [mass/volume] in serum --1st specimen||random
other restorative dental service||3-adca||random
destruction of lesion or structure by heat application, nos||lidocaine substances||random
second degree burn of male genitalia||1,5-pentanediol, sodium salt||random
renal arteritis||i am sleeping well in the past 7d:find:7d:^patient:ord:facit||random
dki||tactile sensation decreased hemisensory (physical finding)||random
micrococcus sedentarius (organism)||tumor; odontogenic, calcifying epithelial||random
2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate||ups2 protein, s cerevisiae||random
computerized tomography (ct scan) of pelvic arteries using high osmolar contrast||arterial embolectomy||random
4-fluorohexbutinol||safyral 28 day pack||random
embryology (field)||drainage of cyst of pancreas (procedure)||random
preauricular region structure||stearic acid, 2-(2-hydroxyethoxy)ethyl ester||random
human metapneumovirus pneumonia (diagnosis)||peripheral t-cell lymphoma unspecified stage iv||random
sexual assault with digital penetration of vagina (event)||estradiol 0.025mg/day (lyllana) patch||random
sprain of ligament of ankle joint (disorder)||unclassified haploptychius||random
bacillus sp. e(2018)||oceanobacillus sp. 3r-ma05||random
levothyroxine sodium 0.15 mg / liothyronine sodium 0.0375 mg oral tablet [thyrolar]||46,xx androgen-induced disorder of sex development due to maternal adrenal hyperplasia||random
product containing only dipyridamole in parenteral dose form (medicinal product form)||coffin joint (body structure)||random
acanthephyra media||trunk of muscular branch of ulnar artery||random
weight maintenance regimen or diet||percutaneous core needle biopsy of mediastinum||random
closed fracture of epiphyseal plate of metatarsal bone (disorder)||malignant neo mandible||random
99mtc-human serum albumin||female condom use||random
4-amino-2-hydroxybutylyldibekacin||epstein-barr virus-positive diffuse large b-cell lymphoma, not otherwise specified||random
estradiol^7th specimen post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative:high sensitivity||cows - sweating||random
sleep disturbances nec||on examination - right kidney palpable (finding)||random
polymyxin b adverse reaction||lactic acidosis secondary to grain overload||random
hla-dr10 antigen (substance)||xr finger.4th-l ap+lat||random
other infantile cerebral palsy nos (disorder)||other injuries||random
plane of inter-regional intervertebral discs||chemical substitution||random
bypass abd aorta to r int ilia w nonaut sub, open||russell's viper venom time||random
repair of ruptured tendon, nos||gherlin||random
octocrylene 2.5 mg in 100 ml / octinoxate 2.5 mg in 100 ml / avobenzone 1 mg in 100 ml topical oil [peach tanning oil spf 15]||gastroesophageal intussusception (diagnosis)||random
congenital anomaly of bilateral corneas||respite care in last 14 days - while not a resident [mdsv3]||random
abrasion of gum||quinapril hcl 20 mg oral tablet||random
nystatin [mouth] (substance)||positive regulation of ergot alkaloid formation||random
biotin 0.3 mg / dicalcium phosphate 27 mg oral tablet||sinuvent pe 600mg-15mg extended-release tablet||random
fremanezumab||children malnutrition||random
esophageal squamous epithelium||phthiodiolone ketoreductase||random
forehead; deformity||product containing precisely nitisinone 20 milligram/1 each conventional release oral capsule (clinical drug)||random
my child felt cheerful in past 7d:find:7d:^patient:ord:promis.parentproxy||food in the stomach||random
knee somatic dysfunction||stage iv large cell lung carcinoma||random
sympathetic trunk, nos||pois/exp ?intent antiepileptic indust/construct area||random
perform cool & soothing pain relieving, 3.5% topical gel||nitrogen mustard derivative adverse reaction||random
placement @ anatomical regions @ removal @ neck @ external @ traction apparatus @ no qualifier||fractures greenstick||random
hemoglobin g-coushatta/hemoglobin.total||spectacles||random
fishermen, hunters and related workers||intelligence and ability||random
encephalitis due to congenital syphilis||serpula columbiana||random
law occupations (occupation)||diovan hct, 12.5 mg-80 mg oral tablet||random
serous detachment of the macula||zinc oxide 12.6616 g in 50 ml / octinoxate 6.8 g in 50 ml / octisalate 4.5 g in 50 ml / titanium dioxide 4.0006 g in 50 ml topical lotion [intense uv protection cream]||random
contact lens product ophthalmic solution [visine for contacts]||entire medial talocalcaneal ligament (body structure)||random
galactosides||chaste tree 6 [hp_x] in 1 ml / ambergris 6 [hp_x] in 1 ml / apiole (parsley) 6 [hp_x] in 1 ml / estradiol 6 [hp_x] in 1 ml / estriol 6 [hp_x] in 1 ml / levodopa 6 [hp_x] in 1 ml / melatonin 6 [hp_x] in 1 ml / testosterone 6 [hp_x] in 1 ml / adenosine triphosphate disodium 8 [hp_x] in 1 ml / thioctic acid 8 [hp_x] in 1 ml / nadide 8 [hp_x] in 1 ml / pantothenic acid 8 [hp_x] in 1 ml / lactic acid, l- 8 [hp_x] in 1 ml / ubidecarenone 8 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / selenium 8 [hp_x] in 1 ml / estrone 8 [hp_x] in 1 ml / sus scrofa umbilical cord 30 [hp_x] in 1 ml / sus scrofa adrenal gland 30 [hp_x] in 1 ml / pork liver 30 [hp_x] in 1 ml / sus scrofa lymph 30 [hp_x] in 1 ml / sus scrofa bone marrow 30 [hp_x] in 1 ml / sus scrofa ovary 30 [hp_x] in 1 ml / sus scrofa testicle 30 [hp_x] in 1 ml / sus scrofa pancreas 30 [hp_x] in 1 ml / sus scrofa spleen 30 [hp_x] in 1 ml / somatropin 30 [hp_x] in 1 ml / proteus morganii 30 [hp_c] in 1 ml oral liquid [hgh young again]||random
atovaquone 250mg, proguanil hydrochloride 100mg oral tablet||medical and surgical @ urinary system @ reposition @ bladder neck @ open @ no device||random
invertebrates||bent bone of r ulna, subs for opn fx type 3a/b/c w malunion||random
anisocoria - unequal pupil diameter (disorder)||paraprenanthes||random
carboplatin/cisplatin/paclitaxel||zofran, 8 mg oral tablet||random
t vaginalis genital ql cult||multiple carboxylase deficiency, early onset||random
hmw1 adhesin, bacteria||[x]other specified arthritis (disorder)||random
sordaria sp. jk39||breast abnormal secretion opalescent fluid both||random
benztropine mesylate 2mg tab||osteonecrosis of femur due to trauma||random
health mart artificial tears sterile lubricant eye drops||achromobacter sp. s169-ii-3||random
apoidea sp. 0428c201||ether lipid metabolism||random
sp1 wt allele||matricaria recutita 3 [hp_x] in 1 ml / black cohosh 3 [hp_x] in 1 ml / cinchona officinalis bark 3 [hp_x] in 1 ml / saffron 3 [hp_x] in 1 ml / chamaelirium luteum root 3 [hp_x] in 1 ml / mentha piperita 3 [hp_x] in 1 ml / senna leaf 3 [hp_x] in 1 ml / valerian 3 [hp_x] in 1 ml / viola odorata 3 [hp_x] in 1 ml / chaste tree 4 [hp_x] in 1 ml / convallaria majalis 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / lilium lancifolium whole flowering 4 [hp_x] in 1 ml / delphinium staphisagria seed 4 [hp_x] in 1 ml / cyclamen purpurascens tuber 6 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / cinnamon 12 [hp_x] in 1 ml / hexaplex trunculus hypobranchial gland juice 12 [hp_x] in 1 ml / naja naja venom 15 [hp_x] in 1 ml oral liquid [female support]||random
primary adenocarcinoma of lung (diagnosis)||calcium/phosphate serpl||random
drosophila micromyia||peritoneal catheter dysfunction||random
aromatic amino acid family biosynthetic process via prephenate||relebactam (substance)||random
chimeric proteins||operation on neck, nos||random
plc148||pimple||random
anterior nerve rootlet complex of right first cervical nerve||cast care education (regime/therapy)||random
pms1 mutation||medical care--utilization review||random
family phyllachoraceae||steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)||random
unclassified pyrinia||bact attachment sites||random
dnm1l gene||thoracic subsegment of dorsal gray column of spinal cord||random
fact-bl version 4 - losing hope against illness||primary intracranial melanoma||random
drotuss-cp 5mg-5mg-2mg/5ml liquid||orthocladiinae sp. bioug25091-f07||random
unclassified hygrochroma||lepidoptera sp. bold:aau0589||random
auxin response factor 8, arabidopsis||alcohol-induced psychotic disorder with delusions (diagnosis)||random
amylase + crcl pnl ur+serpl||diagnostic radiologic examination of pharynx with fluoroscopy||random
ruegeria sp. jz11is21||bronchoscopy (diagnostic) main carina ulcerations medial (___ mm)||random
adrenal gland histopathology procedures||sodium sulfite||random
herpes lips||vasculotropin||random
non-ampullary adenocarcinoma||ventricular escape rhythm||random
imaging @ urinary system @ plain radiography @ kidneys, ureters and bladder||le not otherwise specified antibody:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal||random
cardiac catheterization pulmonary artery wedge pressure (procedure)||when i am mad, i sometimes say things that i later regret:finding:to identify measures at a point in time:^patient:ordinal:upps-r-c||random
chronic duodenal ulcer unspecified (disorder)||otolaryngologic surgical result: hematoma of right external auditory canal incision||random
platelet aggregation nos abnormal||rheumatoid arthritis of right ankle and foot with involvement of other organs and systems||random
{30 (lenvatinib 10 mg oral capsule) } pack [lenvima 10]||adrenogenital disorder||random
pig-y protein, human||person categorized by religious affiliation (person)||random
n0 regional lymph nodes finding||catabolic state||random
acipimox allergy (disorder)||gingival culture periodontal pocket second sample tooth (#___) (lab test)||random
malignant epithelial neoplasm of oropharynx||complement factors||random
female reproductive tract carcinoma in situ nos||chlorinated hydrocarbon toxicity (disorder)||random
structure of capillary blood vessel (organ) (body structure)||paranasal sinus and nasal cavity squamous cell carcinoma||random
transplantation of ureter||unclassified cimbex||random
nonfamilial asexual dwarfism||catheter,foley dover 12fr 30ml kendall #403712||random
zuclomifene||fifth phacomatosis||random
malaria; congenital, falciparum||volume.expired per minute/body weight^on ventilator:vratcnt:pt:respiratory system:qn||random
genus emberiza||mmac1 coding region mutation present||random
lutein + kale, 15 mg oral capsule||abnormal menstruation (finding)||random
arterial intramural hematoma||17500 (qualifier value)||random
antibodies mycoplasma||baptisia tinctoria 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / tabebuia impetiginosa bark 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / calendula officinalis flowering top 4 [hp_x] in 1 ml / chelidonium majus 4 [hp_x] in 1 ml / veronicastrum virginicum root 4 [hp_x] in 1 ml / ligusticum porteri root 4 [hp_x] in 1 ml / lomatium dissectum root 4 [hp_x] in 1 ml / myrrh 4 [hp_x] in 1 ml / nasturtium officinale 4 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / taraxacum officinale 4 [hp_x] in 1 ml / fenugreek seed 4 [hp_x] in 1 ml / urtica dioica 4 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / astragalus propinquus root 6 [hp_x] in 1 ml / propolis wax 6 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa thymus 8 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna 12 [hp_x] in 1 ml / chamomile 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / thuja occidentalis leafy twig 30 [hp_x] in 1 ml / antimony trisulfide 30 [hp_x] in 1 ml / bordetella pertussis 30 [hp_c] in 1 ml / tetanus toxin 30 [hp_c] in 1 ml / thimerosal 30 [hp_c] in 1 ml oral liquid [vax]||random
akirin 1||cortinarius subrubrovelatus||random
cardiac septostomy catheter, balloon||michigan||random
molecularly targeted therapy||supplement right tympanic membrane with autol sub, endo||random
pilocarpine pill||porencephaly (disorder)||random
cecidomyiidae sp. cnfdf196-14||other specified diseases of liver||random
fasanella tarsomullerectomy||parvoraphidia||random
priority of disease contact||hyperglycinemia [dup] (disorder)||random
cleft soft palate with bilateral cleft lip and alveolus (disorder)||fluoroscopic angiography guidance for substance removal of central venous catheter lumen obstruction||random
accidentally pushed by a crowd by collective fear or panic (finding)||trithuria austinensis d.d.sokoloff, remizowa, t.d.macfarl. & rudall||random
sympetes sp. col1301||cuculus lepidus (organism)||random
sphingosine||dorsal tributary of first posterior intercostal vein||random
l3 acute lymphoblastic leukemia||rectimarginalis||random
amorphophallus angustispathus||transudates exudates||random
literature||i have someone who will listen to me when i need to talk||random
osteogenic protein 1, human||pelvis &#x7c; radio fluoroscopy &#x7c; radiology||random
rhizopus stolonifer allergenic extract||rings (physical object)||random
anterior chamber flare||dihydropyridines||random
salter-harris type i physeal fracture of lower end of ulna, left arm, initial encounter for closed fracture||paccal 1 mg/ml injectable solution||random
transforaminal injection of steroid into single epidural space of thoracic spine using computed tomography (ct) guidance||28th interval st segment||random
membrane associated ring-ch-type finger 9 gene||neoplasm of soft tissue of abdominal wall||random
surgery.general||fetal angelman syndrome risk:likelihood:pt:wbc.dna+plas.cfdna:qn:dosage of chromosome specific cf dna||random
astrocytoma of retina (disorder)||flavone apiosyltransferase activity||random
i isolate myself from others because of my condition in the past 7d:find:7d:^patient:ord:facit||calcium [mass/volume] in urine||random
chlorpheniramine maleate 4 mg / guaifenesin 300 mg / phenylephrine hydrochloride 20 mg extended release oral tablet||calcium carbonate||random
benign neoplasm of cervix uteri||primary dysfunctional labor (history)||random
auricularis superior tendon||discoidin domain receptor||random
n-(17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)phthalimide||afghanistan (geographic location)||random
primary adenosquamous cell carcinoma of larynx||porcine circovirus type 2 ab &#x7c; serum &#x7c; microbiology||random
factor viii procoagulant activity||subcutaneous panniculitic t-cell lymphoma (provisional subtype) refractory||random
skin neoplasm back malignant||amphetamine/dextroamphetamine 10mg tab,ud||random
trisamine||sus scrofa pancreas 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / lycopodium clavatum spore 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / syzygium cumini seed 12 [hp_x] in 1 ml oral liquid [gastropanpar]||random
other spinal muscular atrophy||left ventricular myocardial noncompaction cardiomyopathy (disorder)||random
description of skin lesions (symptom)||narcotic and drug control||random
additional concerns - fait-f [facit]||chronic duodenal ulcer without hemorrhage or perforation and without obstruction||random
trichothecium roseum allergenic extract injectable product||ob operative note||random
calculated (qualifier value)||aortofemoral artery bypass graft using vein||random
microvirga sp. cl7.50||measurement and monitoring @ physiological systems @ measurement @ central nervous @ percutaneous @ pressure @ intracranial||random
food shields||aluminum zirconium trichlorohydrex gly 18 g in 100 g topical stick [old spice pacific paradise refillable]||random
afatinib oral tablet||displaced fracture of shaft of first metacarpal bone, right hand||random
streptomyces sp. mbrc-60||cerebral degeneration associated with another disorder (disorder)||random
right vertebral artery||chlorhexidine ab.ige.rast class:prthr:pt:ser:ord||random
amount of hip pain experienced while walking of a hard surface (asphalt, concrete, etc.) in the last week||laparoscopy sling operation stress incont||random
brassia r.br., 1813||morphine so4 10mg/ml (pf) inj_#2||random
non-anesthetic gases||bacillaceae bacterium guds1213||random
marasmius elaeocephalus singer, 1964||exoglossum maxillingua (lesueur, 1817)||random
smith extractable nuclear ab+ribonucleoprotein extractable nuclear ab ia ql (s)||intraoperative gastrointestinal injury, ctcae||random
mga3||hiatus hernia strangulated||random
stammering/stuttering/tic||neoleptophlebia||random
unclassified naarda||stage ivc epidermoid carcinoma of hypopharynx||random
gemcitabine (as hydrochloride)||[x]other and unspecified hormone antagonists causing adverse effects in therapeutic use (finding)||random
toilet upstairs (finding)||negative regulation of template switch recombination involved in replication fork processing||random
product containing only donepezil hydrochloride 5 mg/1 each oral tablet (clinical drug)||oyst cal, 1 g oral tablet||random
scarring (qualifier value)||arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); with ultrasound guidance, with permanent recording and reporting||random
gallbladder and duodenum, cs||ppcm||random
phenyl-tertiary-butylamine||laryngeal||random
package empty units||single allergens||random
traumatic vasospastic syndrome, initial encounter||medical and surgical @ subcutaneous tissue and fascia @ alteration @ subcutaneous tissue and fascia, right upper arm||random
diffuse follicle center lymphoma, lymph nodes mult site||salicylic acid 0.5% topical application soap||random
fad diets||hiatal; hernia, congenital||random
listeria sp:presence or threshold:to identify measures at a point in time:cheese:ordinal:organism specific culture||osteoporosis postsurgical malabsorption other site (diagnosis)||random
nuclei raphe magnus||intervertebral tributary of left seventh posterior intercostal vein||random
finding related to ability to use consonant vowel consonant combination||open wound of toe, complicated||random
rhodocyclaceae bacterium mori9||upstream transcription factor||random
protease inhibitor 3, skin-derived (skalp)||gene abnormality||random
intrathoracic aortic aneurysm repair, nos||acute graft versus host disease in skin||random
left external auditory canal structure||stone pine ige &#x7c; serum &#x7c; allergy||random
anteromedial surface of shaft of right fibula||product containing only coagulation factor xiii (medicinal product)||random
simethicone 4 mg/ml||unclassified spiroplasma||random
allergy to phenylbutazone (finding)||isoproterenol pill||random
disseminated peripheral chorioretinitis with choroiditis||immobilization by bandaging (procedure)||random
urine oxalate measurement (procedure)||gonadal dysgenesis||random
maxillaria sect. nitidobulbon||anastomosis of stomach (procedure)||random
niaprazine 3 mg/ml oral solution||dermatophagoides farinae 16 [au] in 1 ml / alternaria alternata 0.002 g in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / candida albicans 0.002 g in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / fusarium oxysporum 0.002 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.002 g in 1 ml / phoma destructiva 0.002 g in 1 ml / aureobasidium pullulans var. pullutans 0.002 g in 1 ml / rhizopus stolonifer 0.002 g in 1 ml / pleospora herbarum 0.002 g in 1 ml subcutaneous injection, solution||random
cynara scolymus leaf extract||deer fly (chrysops flavidus (whole body)) igg4||random
(spina bifida without mention of hydrocephalus, unspecified) or (split notochord syndrome)||saliva antibodies hiv-1 gp120 by immunoblot||random
ganoderma sp. bab-5194||relapsing polychondrits,larynx||random
revsc opn/prq tib/pero w/athrc/angiop uni ea vsl||cefepime+clav islt kb||random
product containing precisely methazolamide 25 milligram/1 each conventional release oral tablet||stemona sp. shut-0001||random
arum maculatum root 5 [hp_x] in 1 ml / pteridium aquilinum whole 5 [hp_x] in 1 ml oral liquid||tuberculosis; adenopathy||random
rash allergic||gallbladder anastom nec||random
pontinus||maintenance of percutaneous endoscopic gastrostomy tube||random
tracheal web||etazolate||random
fetal or neonatal non-traumatic intraventricular hemorrhage (disorder)||note:find:pt:telehealth:doc:social worker||random
deprecated phenx measure - personal history of type 1- type 2 diabetes||direct gonioscopy||random
molluscum contagiosum subgroup virus||2-hexoxybenzamide||random
psctk3||perciformes sp. bold:aaa6429||random
burns of toes||rac 109, monohydrochloride, (+-)-isomer||random
lyperosomum||octinoxate 3 mg in 40 mg / meradimate 1.4 mg in 40 mg topical cream [laura mercier tinted moisturizer spf-20 walnut spf-20 walnut]||random
periosteum of right lamina of sixth cervical vertebra||camki||random
text-miscellaneous section:-:pt:^patient:set:naaccr v.11||testosterone [mass/volume] in dbs||random
proteoglycan (substance)||opn tx nasomax fx multple||random
piperazine 133 mg/ml oral solution||lamivudinum||random
are you able to dress yourself, including tying shoelaces and doing buttons [promis]||stichopathes cf. maldivensis pn61_b||random
pleosporales sp. mf560||amino acids, peptides, and proteins||random
capsule open||polydatin 0.22 in 100 ml topical cream [sooryehan pure-whitening essence]||random
stiff limbs||penthea||random
hypertrophy of pylorus (finding)||dasypodaini||random
lysyl oxidase-like protein 2||nifl protein, bacteria||random
slc31 proteins||edible plants||random
rhodiola l., 1753||malignant pituitary blastoma (disorder)||random
thinking about my life, my life is filled with meaning [promis.peds]||homosalate 4.25 g in 100 ml / octisalate 4.75 g in 100 ml / zinc oxide 7 g in 100 ml topical cream [always foundation makeup broad spectrum spf 15 honey]||random
eulophidae sp. bioug24094-c06||radical mastoidectomy with obliteration of mastoid cavity and eustachian tube and closure of external auditory canal||random
neutral distilled alcoholic spirit||mcfd4||random
liver fibrosis interpretation||tbc1d2b, leu793ter||random
kat3b protein, human||aspiration of upper limb using cone beam computed tomography guidance (procedure)||random
weed pollen-english plantain||minaria magisteriana (rapini) konno & rapini||random
diphtheritic peritonitis (disorder)||cilastatin||random
zavedos 5mg inj pdr||ulcer on volar surface of right forearm||random
kininogen, nos||bussuquara virus||random
contracture of third toe of right foot||unclassified nannocoris||random
calcium:mass concentration:to identify measures at a point in time:peritoneal dialysis fluid:quantitative||urea@30 %@topical@foam (gram)||random
allantoin 0.5 % / benzethonium chloride 0.1 % topical solution||aluminum zirconium tetrachlorohydrex gly 11.4 g in 100 g topical stick [axe signature island antiperspirant]||random
evp-0015962||peripheral corneal degeneration, bilateral||random
general medicine (qualifier value)||hypertensive heart&renal dis wth (congestive) heart failure||random
i feel tired in the past 7 days [facit]||acquired hallux limitus of bilateral great toes (disorder)||random
careers||insulin signaling pathway||random
osteoporosis without pathological fracture||albumin human 0.25 g in 1 ml intravenous solution [albuminex]_#2||random
aluminum zirconium octachlorohydrex gly 13.94 in 85 g topical gel [right guard sport fresh]||pink and red appearance of wound bed of left temporomandibular joint (physical finding)||random
bolitoglossa||menses frequent||random
presence; bone marrow transplant||pentolinium tartrate (medication)||random
disposable soft left contact lenses replaced weekly||neurospora sitophila antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||random
platelet igm||unclassified galerucinae||random
benign neoplasm of skin of buttock (disorder)||complications procedure||random
coleoptera sp. bold:acm1266||fcv||random
carb-o-philic 40, 40% topical gel||ascorbate and aldarate metabolism pathway||random
blood erythropoietin abnormal||urate encephalopathy||random
remove infusion dev from sacrococcygeal jt, extern||supplement right foot artery with synthetic substitute, percutaneous endoscopic approach||random
thyroid microsome antibody||chrysogorgiidae||random
ustilago nuda protein antigen||synechococcus sp. ag-686-a05||random
reinsertion of cardiac pacemaker battery (procedure) [ambiguous]||calcium carbonate 350 mg / magnesium hydroxide 150 mg chewable tablet||random
ivd test reagent/kits, molecular assay, infection, parasite, trypanosoma species||growth arrest and dna-damage-inducible, alpha-like||random
cdl3 complex location||alanine aminotransferase.macromolecular:ccnc:pt:ser/plas:qn||random
streptomyces sp. o27||4-aminobenzoate||random
tidal wave due to landslide, subsequent encounter||chlorobenzenes||random
blister of hip (& traumatic) (disorder)||eukaryotic peptide initiation factor-5||random
gastrointestinal adenocarcinoma||trifluperidol (substance)||random
reposition right carpal joint, external approach||hydrocortisone 1%, acetic acid, glacial 2% otic drops, solution||random
pollen wall assembly||blisters with epidermal loss due to burn (second degree) of upper limb, except wrist and hand||random
involve the individual in formulating goals that are specific, measurable, realistic, and time-lined||study observation:find:pt:heart.ventricle.right.outflow tract^fetus:nom:us||random
atrophic gastric mucosa||snail, nos||random
protatlanta souleyeti (smith, 1888)||rectopexy using sutures||random
bone of radius||leptoneta||random
neoplasm of soft tissue of temple (diagnosis)||iohexol product||random
ku80||genus catostomus||random
culex pipiens ab.igg4:mcnc:pt:ser:qn||methyl 3-(4-(4,5-bis(4-(isopropyl(methyl)amino)phenyl)-1h-imidazol-2-yl)phenyl)acrylate||random
other specified retinal disorder||immunoglobulin kappa variable 2-26||random
unclassified pingasa||mitobronitol 125 mg||random
oral form theophylline||4-(4-(3,4-difluorophenyl)pyrimidin-2-yl)-n-(pyridazin-3-yl)piperazine-1-carboxamide||random
escherichia sp. uiwrf0844||colitis ulcerative aggravated||random
celeriac||skin crust on palmar surface of ring finger of right hand||random
deprecated||aerosil 380||random
thyatirinae||intra-operative skin closure count of sponges incorrect (treatment)||random
emerin protein, rat||malignant neoplasm of pyloric antrum stage iv nos||random
malignant tumor of the minor salivary gland||keratic precipitates (finding)||random
nuclearia sp. a1||fetlock region of equine limb (body structure)||random
pluteus roseipes hohn., 1902||euryalida sp. bold:aal3350||random
amy101||cpd iii||random
clot initiation.kaolin induced/clot initiation.kaolin induced post heparin neutralization calc (bld) [time ratio]||sixth cranial nerve palsy||random
cytomegalovirus ab:prthr:pt:ser/plas:ord||diffuse cholesteatosis, left ear||random
calcitonin^4th specimen||iron, carbonyl||random
thymidylate synthase inhibitor-containing product||unclassified eustrongylides||random
latent subchronic schizophrenia||pseudomyrmex||random
diffuse dry gangrene of third toe of right foot (physical finding)||chrysolarentia argodesma||random
carbidopa 61.25 mg / levodopa 245 mg extended release oral capsule||deep necro of under tiss due to burn (dtd) of wrist, w/o ment of loss of wrist||random
1,2-dihydroxy-4-(nitroethenyl)benzene||hla-a32(19) donr ql||random
locally advanced unresectable esophageal adenocarcinoma||lead high||random
aortic valve regurgitant volume||diterpenoids, kaurane||random
magnetoreception by sensory perception of electrical stimulus||p2ry11 gene||random
treatment for abnormal pap test:type:pt:^patient:nom||clobetasone 1 mg/ml||random
labiosimplex longispicularis||malignant neoplasm of peritoneum and retroperitoneum (diagnosis)||random
phenx measure - physical activity - readiness:-:to identify measures at a point in time:^patient:-:phenx||apis mellifera 10 [hp_x] in 59 ml / calcium picrate 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / calcium sulfide 10 [hp_x] in 59 ml / juglans regia fruit rind, immature 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml / delphinium staphisagria seed 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml / thuja occidentalis leafy twig 10 [hp_x] in 59 ml oral liquid [stye relief]||random
skin and subcutaneous tissue disorders nec||pterodrilus annulatus||random
final inset of skin flap||lack of bone formation||random
progression of prostate cancer||wheal on right superior calf (physical finding)||random
other+unspecified disorders of circulatory system classif||opn destruction pleural lesion||random
androsterone &#x7c; urine &#x7c; chemistry - non-challenge||product containing only quetiapine 50 mg/1 each oral tablet||random
trial attempt phenx||dikraneura sp. bioug20479-b09||random
salmonella mundonobo (organism)||adhesive strips clear||random
activated charcoal 30 [hp_c] in 30 [hp_c] / copper 30 [hp_c] in 30 [hp_c] / mercurius solubilis 30 [hp_c] in 30 [hp_c] / phosphorus 30 [hp_c] in 30 [hp_c] / pulsatilla vulgaris 30 [hp_c] in 30 [hp_c] / tin 30 [hp_c] in 30 [hp_c] / veratrum album root 30 [hp_c] in 30 [hp_c] oral spray [nagging cough]||stroke volume:vol:pt:heart.ventricle.left:qn:us.2d.aortic root.calculated||random
primary refluxing megaureter||catarase||random
mannosidase defic dis||emc virus group, nos||random
avobenzone 26.8 mg in 1 ml / homosalate 96 mg in 1 ml / octisalate 28.8 mg in 1 ml / octocrylene 53.8 mg in 1 ml / oxybenzone 34.6 mg in 1 ml topical lotion [la roche posay laboratoire dermatologique anthelios aox daily antioxidant serum broad spectrum spf 50 sunscreen]||acquired metabolic and toxic encephalopathies (disorder)||random
neoplasm of uncertain or unknown behavior of brain, supratentorial (disorder)||muscle induration||random
5-(6-hydroxy-7-(3-methylbut-2-en-1-yl)-1-benzofuran-2-yl)-4-(3-methylbut-2-en-1-yl)benzene-1,3-diol||replacement of left humeral shaft with nonautologous tissue substitute, percutaneous endoscopic approach||random
unclassified schilbeidae||congenital pes planus (diagnosis)||random
nocardiosis associated with aids (disorder)||antithyroid agent (substance)||random
mouth burn||maxillary diseases||random
oribatulidae sp. bioug18532-d08||hydrocortisone sodium phosphate 50 mg/ml||random
butanol dehydrogenase||down-regulation of granulocyte macrophage colony-stimulating factor production||random
royal navy officer||saksenaea vasiformis (organism)||random
endometrial cystic hyperplasia||dental disorders hard tissues of teeth deposits (diagnosis)||random
abiraterone acetate 500 mg oral tablet [zytiga]||posterior surface of notch region of scapula||random
plagiosphaera immersa (trail) petr., 1960||megalophaedusa||random
trunk of thoracodorsal nerve||benign neoplasm of abdomen||random
pm-1 ab [titer] in serum by immunofluorescence||recall, mental||random
rai1 gene 17p11.2 deletion+duplication:presence or identity:to identify measures at a point in time:whole blood/tissue, unspecified:nominal:fish||succinylcholine chloride 20mg/ml inj||random
linagliptin 5 mg oral tablet||human immunodeficiency virus (hiv) centers for disease control and prevention (cdc) category c1 (aids) (finding)||random
arnium arizonense||medetomidine hydrochloride 1 mg/ml injectable solution||random
fluoride, phenylmethanesulfonyl||emtricitabine / tenofovir alafenamide oral tablet||random
leiomyosarcoma of superior vena cava||self-inflicted overdose of desoxycorticosterones (diagnosis)||random
biopsy of skull (procedure)||turkic language (qualifier value)||random
4-hydroxy-4-methyl-2-ketoglutarate aldolase||revefenacin 175 mcg in 3 ml inhalation solution||random
primary chronic gout without tophus of wrist (disorder)||apolipoprotein a-ii abnormal||random
tissue block identifier:id:pt:specimen:nom||patient notified (situation)||random
3-methylhistidine/creatinine:ratio:pt:urine:qn||immunological pregnancy tests||random
purpura of proximal end of index finger of left hand (physical finding)||chromosome band involved start||random
alpha proteobacterium scgc aaa028-n14||nuclear medicine @ musculoskeletal system @ planar nuclear medicine imaging @ spine @ technetium 99m (tc-99m) @ none @ none||random
ethanaminium, 2-((diethoxyphosphinyl)thio)-n,n,n-trimethyl-, iodide||fmdv - foot and mouth disease virus||random
pentoxifylline extended release oral capsule||percentage food eaten score 10||random
secondary malignant neoplasm of eustachian tube (disorder)||prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5z,11alpha,13e,15r)-||random
sexual functioning status (observable entity)||chionoecetes tanneri rathbun, 1893||random
sclerosing cholangitides, primary||upregulation of protein serine/threonine phosphatase activity||random
aspiration; syndrome||banks, blood||random
alphavirus test||octocrylene 0.10 ml in 1 ml / oxybenzone 0.05 ml in 1 ml / avobenzone 0.03 ml in 1 ml topical spray [banana boat ultra defense spf 60 canada]||random
tipulidae sp. bold:aac9088||methylene chloride [moles/volume] in blood||random
genus lawsonia||exhalation rib dysfunction||random
vpmpr||vinburnine 40 mg oral tablet||random
ct of left lower extremity||division of middle trunk of brachial plexus||random
rubella (excl pregnancy)||metrotop 0.8% gel 30g||random
atp8b1, asp554asn||during the last month did you not eat for a whole day because your family didn't have enough money for food [u.s. fss - child]||random
protohyale cf. jarrettae bcamp0183||lotilaner||random
fluoride sodium||iron:mcnc:pt:csf:qn||random
polarization, fluorescence||hydrochlorothiazide / methyldopa||random
brucella antibody||tranosema forster, 1869||random
elks/rab6-interacting/cast family member 1||aprepitant 125mg pwdr,renst-oral pkt||random
medical and surgical @ anatomical regions, general @ extirpation @ upper jaw||traumatic perforation of large intestine||random
deficiency vitamin||muscle body of right infraspinatus||random
spinal fractures and dislocations||poisoning caused by biological substance||random
vestibular fossa||entire mediastinal vein (body structure)||random
do you feel handicapped by a hearing problem||gnas1 gene mutation||random
unclassified musoniella||type i diabetes mellitus with ophthalmic complications (disorder)||random
unspecified human immunodeficiency virus [hiv] disease||repair of congenital tibial pseudarthrosis (treatment)||random
bromodiphenhydramine [mass/volume] in serum or plasma||phenolphthalein 65 mg||random
electric vacuum aspiration||complement enzyme, active (substance)||random
dihydroxyacetone topical lotion||phenylephrine tannate/chlorpheniramine tannate@5 mg-4.5 mg@oral@tablet,chewable||random
hypersensitivity myocarditis||rho(d) immune globulin 2500 iu intravenous solution [winrho sdf]||random
removal of intralum dev from low intest tract, via opening||cone dystrophy||random
operation on cerebral ventricle drainage with drainage device||mental disorder during pregnancy/childbirth/puerperium nos||random
trimethylamine||cyclizine / dipipanone oral tablet||random
juglans californica pollen 0.025 g in 1 ml / juglans regia pollen 0.025 g in 1 ml subcutaneous solution [western walnut pollen mix]||accidents occurring in industrial places and premises||random
scelioninae sp. bioug24095-a05||melanoma; auricle, ear||random
pseudoalteromonas sp. b-dpys1||unclassified nocardiaceae||random
ssrna negative-strand viruses||blasts.cd15:arbitrary concentration:to identify measures at a point in time:marrow (bone):quantitative||random
porphyrins, urine||viral disease carrier||random
panamius||teleopsis||random
redundant; stomach||1p31.2-p31.1||random
medical and surgical @ lower arteries @ extirpation @ foot artery, right @ percutaneous endoscopic @ no device||current level of confidence i can ask for help when i don't understand something:find:pt:^patient:ord:promis||random
chlorphentermine ql (u)||conjugates estrogen||random
cecidomyiidae sp. bioug27726-e06||t wave amp l-v3||random
haematological radiotherapies||sclerococcum||random
transposition of scrotal tissue, nos||unidentified cells/100 leukocytes:number fraction:to identify measures at a point in time:whole blood:quantitative:manual count||random
pericardial cavity of inferior vena cava||venous plexus||random
lower extremity application of casts||camphor (natural) 3.1 g in 100 g / menthol 3.0 g in 100 g topical cream [arneu]||random
unclassified philoenia||sensory-and-motor-derived factor||random
increased renal ca++ excretion [pe]||thiopental ige ab [units/volume] in serum||random
chronic disease of tonsils and adenoids, unspecified||sars-cov-2 (covid-19) orf1ab region naa+probe (oropharyngeal wash) [threshnum]||random
ricker disease||legal abortion with septic embolism (disorder)||random
lophiostoma ces. & de not., 1863||calcium sulfide 6 [hp_c] in 59 ml / potassium chloride 6 [hp_c] in 59 ml / potassium carbonate 30 [hp_c] in 59 ml / potassium dichromate 6 [hp_c] in 59 ml / strychnos nux-vomica seed 6 [hp_c] in 59 ml oral liquid [mucus-clear nighttime]||random
tanytarsus sp. bold:acc1609||dna, cruciform||random
removal of foreign body from knee||external abdominal hernia||random
allergy to progestational hormone (finding)||cytomegalovirus urinary tract infection||random
elaphoglossum longistipitatum a.rojas||product containing hydromorphone in oral dose form (medicinal product form)||random
anesthesia complications during pregnancy||yersinia||random
co-codamol 8mg/500mg effervescent tablet (substance)||substanceadminsubstitutionnotallowedreason||random
vitamin d3 activation||ketorolac tromethamine 4.5 mg in 1 ml ophthalmic solution/ drops [acuvail]||random
injury undetermined whether accidentally or purposely inflicted, by crashing of aircraft||hematoma of vulva (disorder)||random
localized adult-onset periodontitis||klk2 wt allele||random
thiabendazole 500 mg||pathology biopsy report:finding:to identify measures at a point in time:ovary:narrative||random
octagam 2.5g/50ml i-v inf||ip30||random
dobesilic acid||other forms of secondary syphilis (disorder)||random
fimbristylis sp. ceh-2010||articular capsule of joint of left twelfth costal head||random
attend covid-19 intub+consult||hsa-mir-4271||random
saussurea schanginiana (wydler) fisch.||noncompliance of therapeutic regimen||random
octanoylcarn serpl-scnc||glycolithocholate [moles/vol]||random
renagel, 400 mg oral tablet||trogulocratus||random
crushing injury of left ring finger||ptca left blalock lesion classification||random
islet cell neoplasms and apudoma nec||2-hydroxyestrone & 16-alpha hydroxyestrone panel:-:pt:ser/plas:-||random
aids-related kaposi sarcoma i (immune system) status||menthol 2.5 mg oral lozenge||random
fungal sp. e14835f||bone tissue of middle phalanx of middle finger||random
implantation of electromagnetic hearing aid||thyatirinae||random
agrobacterium sp. ea_r_62||hydrocodone bitartrate 0.6 mg/ml||random
congenital factor viii deficiency||artificial kidney clotting during dialysis||random
formica sp. bioug24438-h09||disassembly of microtubules||random
ct chest limited wo contrast||octinoxate 3 ml in 60 ml / octocrylene 0.6 ml in 60 ml topical cream [medi uv block suncream spf50 pa]||random
(dactylis glomerata+festuca elatior+holcus lanatus+lolium perenne+phleum pratense+poa pratensis) leukotriene release:mass concentration:to identify measures at a point in time:leukocytes:quantitative||spinocalanus longicornis||random
nostoc minutum desmazieres ex bornet and flahault 1886||yellow fever vaccine (product)||random
other specified disorders of bone density and structure, thigh||max hc oral product||random
hiv-2 test negative||doxazosin 4mg m/r tablet (substance)||random
ischemic; colitis||valve stenoses, mitral||random
salinicoccus sp. hob5||hair bearing graft of skin to other site||random
msql1tn||chlorpheniramine/phenylephrine/dextromethorphan/guaifenesin@2.5 mg-8.5 mg-22.5 mg-125 mg/5 ml@oral@syrup||random
unspecified open wound of right shoulder, sequela||alkylamides, polyunsaturated||random
rna, u6a small nuclear, formerly||ct of limb regions||random
aluminium oxide ore||cerebrospinal fluid glucose abnormal||random
unclassified tropheus||start date of respiratory therapy [mdsv3]||random
congenital hand deformity transverse deficiency||medical and surgical @ ear, nose, sinus @ dilation @ eustachian tube, right @ via natural or artificial opening||random
frankia sp. acocri.1||pseudophloeospora jollyi||random
abduction of ring finger||incomplete precocious puberty||random
diphenhydramine oral solution||malunion of fracture of left fourth rib anteriorly||random
multiple open wounds of shoulder and upper arm (disorder)||alcohol 585 g in 1 ml topical liquid [crisp apple hand sani]||random
glucose^3.5h post 75 g glucose po:mcnc:pt:ser/plas:qn||spinosuncus||random
foot joint synovial fluid||euphorbia brachiata||random
doxazosin induced platelet ab.igm:prthr:pt:ser/plas:ord:flow cytometry||unclassified scolecobasidium||random
x-ray of hip: radiodense loose bodies superiorly||chironomus sp. bioug21226-c04||random
subintima layer of synovial membrane of acromioclavicular joint||human immunodeficiency virus-1 (hiv) indirect immunofluorescence assay (procedure)||random
efavirenz^peak:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||mean cell haemoglobin concentration low||random
kidney cancer pt0 tnm finding v8||shigella sp. bard11||random
mean blood pressure decreased||atherectomy of artery||random
obstetrical pyemic and septic embolism, postpartum condition or complication||open wound of elbow left due to bite||random
abortion complete||loans, student||random
t-b cell activating molecule||flucelvax 2012-2013 formula||random
hsp90-targeted sn-38 conjugate pen-866||generalised urticarial rash||random
legal intervention involving unspecified gas, law enforcement official injured, initial encounter||nervous system disorders, ctcae||random
chiropractic adjustment of lower extremity (treatment)||[d]epigastric pain (situation)||random
niastella sp. sttd671||soluble liver ab [presence] in serum by immunoassay||random
extension exercises for neck to increase movement||6||random
disorder of bone and articular cartilage (disorder)||dopaminergic drugs (substance)||random
clomocycline adverse reaction||cervix disorders||random
pain of lateral aspect of right proximal forearm elicited by active supination (physical finding)||note:find:pt:patient's home:doc:{role}||random
biliary anomalies (disorder)||glucagon 1 hr post meal [mass/vol]||random
subcorneal pustular dermatosis||anthomyiidae sp. bioug02375-h11||random
housing ownership and tenure (observable entity)||infarctions||random
grade 2 nodular sclerosing hodgkin's lymphoma of salivary gland||decreased glycogenolysis||random
puncture wound of toe (diagnosis)||n1a: only micrometastasis, none > 0.2 cm in greatest dimension||random
small intestine computerised tomography||coxsackie myopericarditis||random
legionella antibody assay||complete traumatic amputation at right shoulder joint, sequela||random
type b gastritis||salmonella oersterbro||random
telmisartan ind plt igm serpl ql fc||electricity; effects||random
chest wall discomfort||mtus1 protein, xenopus||random
lcs - lambeth communication scale||tracheostomy speech valves||random
zinc oxide 66.6 mg in 1 ml / titanium dioxide 99.9 mg in 1 ml topical lotion [blue lizard sheer spf 50 sunscreen]||bnp increased||random
lymphocyte antigen cd105 (substance)||benign neoplasm of blood vessel of hand (disorder)||random
vestibular evoked myogenic potential (vemp) testing, with interpretation and report; cervical (cvemp) and ocular (ovemp)||trigonopterus sp. arc2344||random
non-toxic goiter||operations by other sites or systems (procedure)||random
sokolow-lyon index positive||mole of skin||random
sinularia||sodium laureth-5 sulfate||random
vertebral column reconstruction||saturnia sp. jr-1997||random
superficial venous reflux disease||avobenzone 25.8 mg in 1 ml / homosalate 85.8 mg in 1 ml / octisalate 42.9 mg in 1 ml / octocrylene 23.6 mg in 1 ml / oxybenzone 34.3 mg in 1 ml topical spray [aloe up broad spectrum spf 50]||random
corrosions of right ear drum||nuclear protein in testis (nut) midline carcinoma||random
bp dias 24h mean||h-glo-cys-gly-oh||random
x-box binding protein 1, human||entire pituitary gland (body structure)||random
infant eating problem||marine sediment bacterium isa-1159||random
[d]encopresis (situation)||complications specified during childbirth||random
old pulmonary tuberculosis||insulin-like growth factor decreased||random
permabond 910||homosalate 4.25 g in 100 ml / octisalate 4.75 g in 100 ml / zinc oxide 7 g in 100 ml topical cream [always foundation makeup broad spectrum spf 15 cocoa]||random
sodium-nucleoside cotransporter||pangio cf. kuhlii vs-2007||random
middle phalanx of fourth digit of left hand||left fourth plantar tarsometatarsal ligament||random
hydrocodone bitartrate 5 mg||pancreatic intraepithelial neoplasia-1b||random
genes plant||arthritis of bilateral elbows||random
koenig rutzen reinforced ileostomy drainable bag||hsv 1 org specific cx ql (specimen)||random
methylmalonate measurement||unclassified botryochytrium||random
glucose^2h specimen:scnc:pt:dial fld:qn||maclura pomifera pollen 1 g in 20 ml percutaneous injection, solution [osage orange var bois darc pollen]||random
human serum albumin product||inj occpnt,rail veh-collsn-veh||random
pkd2 gene mut anl bld/t||moderate acute malnutrition in infancy childhood and adolescence||random
diosmin 500 mg oral tablet||accelerator, particle||random
heaviness of smoking index||refractory acute lymphoblastic leukemia||random
sapeli (entandrophragma cylindricum) ige &#x7c; serum &#x7c; allergy||dibrompropamidine only product in ocular dose form||random
philharmostes sp. cnccolvg00007069||cenobamate 12.5mgx14/25mgx14 pack 28||random
enceph viruses western equine||personality: [inadequate personality disorder] or [asthenic] or [dependent] or [labile]||random
biopsy tongue malignant neoplasm lymphoma anaplastic large cell t-cell type (procedure)||caspase 2 subunit p18||random
intracranial venous sinus thrombosis||unclassified methylorosula||random
strumigenys sp. dbb237_sphera_nr10||grade of polychromatic cataract of left eye (physical finding)||random
drospirenone 3 mg / ethinyl estradiol 0.03 mg / levomefolate calcium 0.451 mg oral tablet, film coated [safyral]||brr2 protein, human||random
lansoprazole + naproxen (product)||sheep diseases||random
pelargonium graveolens flower oil||reposition splenic vein, open approach||random
procarbazine hydrochloride 50mg capsule (product)||alveolus||random
congenital anomalies of retina||encapsulated mass||random
prolonged thrombocytopenia||colostomy washer miscell each||random
radius+ulna.right||alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / rhizopus stolonifer 0.00008 g in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / candida albicans 0.002 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / cochliobolus sativus 0.002 g in 1 ml / cladosporium cladosporioides 0.00008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00008 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml / gallus gallus feather 0.00067 g in 1 ml / anas platyrhynchos feather 0.00067 g in 1 ml / anser anser feather 0.00067 g in 1 ml intradermal injection, solution||random
puncture wound without foreign body, left lower leg, initial encounter||thrombosis of right atrial appendage (diagnosis)||random
equine arteritis virus antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:virus neutralization||ascidae sp. bioug21405-b06||random
hydrocodone and potassium guaiacolsulfonate product||sodium chloride nasal spray [saline]||random
mannitol 40 mg inhalation capsule||functional assessment of chronic illness therapy-dyspnea||random
mozzarella cheese igg qn (s)||zuclopenthixol 20 mg/ml oral solution||random
nerve agent detectors||plant glycoside, nos||random
bipol i cur depress-mild||unspecified fracture of left patella, initial encounter for closed fracture||random
diastolic blood pressure 8 hour mean||interpretation iep (csf) [interp]||random
1-b6c abdomen: destructive procedures||retinopexy||random
marcicide ii (substance)||pain of right ankle elicited by active plantar flexion and inversion against resistance (physical finding)||random
head control - supported sitting:find:pt:^patient:ord:timp||medical and surgical @ endocrine system @ excision @ coccygeal glomus||random
smds||cystitomes||random
salicylic acid [psoriasis] (product)||right to counsel||random
ppar pathway||cromolyn + xylometazoline||random
stygobromus sp. 1 agc-2019||alpha,alpha-trehalose glucohydrolase activity||random
acute megakaryoblastic leukemia with cbfa2t3-glis2||525-527 family eimeriidae||random
egophony at left apex (physical finding)||palinurus||random
toxodon||facial infiltrating lipomatosis||random
unclassified anagrus||grand son||random
fungal sp. ariz l138||indolent t-cell lymphoproliferative disorder of gastrointestinal tract||random
toxoneuron||ct guidance for biopsy of abdomen-- wo contrast||random
insertion of le veen shunt (procedure)||education about adaptation techniques for sensory deficit||random
prolapsed arm presentation||other fracture of shaft of unspecified humerus, subsequent encounter for fracture with malunion||random
calcium gluconate monohydrate||aldred syndrome||random
positive regulation of g-csf production||tegafur 100 mg and uracil 224 mg oral capsule||random
simulium ochraceum s. l. bold:abu7853||pomaglumetad methionil||random
epi(eqv-adrenaclick)0.3mg/0.3ml injctr||anystidae sp. bioug19351-g07||random
medical and surgical @ heart and great vessels @ dilation @ coronary artery, one artery @ percutaneous @ intraluminal device||unspecified injury of left forearm, initial encounter||random
foreign body under foreskin (disorder)||product prescribing issue||random
diastolic heart failure (disorder)||human leukocyte antigen-dw20:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified^donor:ordinal||random
wenzhou tombus-like virus 4||prosthetic heart valve malfunction regurgitation||random
hydrocortisone medicated shampoo [sentry hc dermasphere]||fisculla dumach, mausbach & bonkowski 2017||random
amlodipine besylate 5mg||recurrent cholangiocarcinoma||random
female tuberc pelv inflamm dis||diseases inflammatory||random
hospital dental staffs||popa||random
nhpacb||sandalwood oil 6 [hp_x] in 1 ml / petroselinum crispum 3 [hp_x] in 1 ml / chimaphila umbellata 2 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / spongilla lacustris 8 [hp_x] in 1 ml / ferrosoferric phosphate 10 [hp_x] in 1 ml / turpentine oil 8 [hp_x] in 1 ml / smilax ornata root 6 [hp_x] in 1 ml / lytta vesicatoria 12 [hp_x] in 1 ml / causticum 8 [hp_x] in 1 ml / citrullus colocynthis fruit pulp 8 [hp_x] in 1 ml / watermelon seed 3 [hp_x] in 1 ml / cucurbita pepo flower 3 [hp_x] in 1 ml / populus tremuloides bark 2 [hp_x] in 1 ml / arctostaphylos uva-ursi leaf 1 [hp_x] in 1 ml / atropa belladonna 10 [hp_x] in 1 ml / piper cubeba fruit 3 [hp_x] in 1 ml / echinacea angustifolia 1 [hp_x] in 1 ml / equisetum hyemale 6 [hp_x] in 1 ml / mitchella repens 1 [hp_x] in 1 ml / eryngium yuccifolium root 2 [hp_x] in 1 ml / macropiper methysticum root 2 [hp_x] in 1 ml / apis mellifera 6 [hp_x] in 1 ml sublingual solution/ drops [d06 bldr-drn]||random
congenital cyst of oviduct||[d]electromyogram (emg) abnormal (context-dependent category)||random
examination penis||infection by schistosomatium (disorder)||random
pseudomonas sp. wxgsd1||medical and surgical @ upper bones @ replacement @ cervical vertebra @ open @ autologous tissue substitute @ no qualifier||random
hydroxyethyl starch 130-0.4 injectable product||musculoskeletal - other sites: reconstruction||random
decreased sperm viability||product quality, supply, distribution, manufacturing and quality system issues||random
unclassified siphonogramen||cyclopentolate hydrochloride||random
polyerga neu||anomopoda sp. bold:aac9302||random
diplotaxis belfragei||mixes past with present (finding)||random
gland disease, salivary||chemotherapies||random
titanium dioxide 60 mg in 1 ml / zinc oxide 60 mg in 1 ml topical cream [pure haven body spf 30]||midazolam hcl 2 mg/2 ml (1 mg/ml) injection vial (ml)_#1||random
wellferon 10megaunits/1ml inj||ca - bone cancer||random
brevibacterium sp. tsa8b||downregulation of sensory perception of sweet taste||random
total lung capacity decreased||peripheral nerve neurostimulator electrode procedures (procedure)||random
dilation of right hand vein, perc endo approach||medical and surgical @ lymphatic and hemic systems @ restriction @ lymphatic, left axillary||random
somatotropin^1h post dose insulin iv:acnc:pt:ser/plas:qn||hydrocortisone 10 mg [cortef]||random
skull and brain therapeutic procedures||downregulation of protein processing in phagocytic vesicle||random
carolis disease||steironema raf., 1821||random
eastern equine encephalitis virus igm ab [presence] in serum by immunoassay||benzthiazide measurement (procedure)||random
isopropylphthalimide||inhalant abuse with inhalant-induced dementia (diagnosis)||random
optokinetic nystagmus test, bidirectional, with recording (procedure)||open biopsy of endometrium (procedure)||random
nsaa1-stand||semitendinosus muscle and/or tendon structure||random
dopamine hydrochloride 200mg/5ml infusion concentrate (substance)||nk cells may be decreased||random
hexyldecyl laurate||bronchoscopy circumferential ulceration of left main bronchus (procedure)||random
haemopoiesis impaired||green pepper ige ab rast class [presence] in serum||random
molindone hcl@25 mg@oral@tablet||water, o-15||random
n-desalkylflurazepam &#x7c; hair &#x7c; drug toxicology||stool softener dc 240mg softgel||random
venotripsy, nos||bilateral paronychia of thumbs||random
sarcoptiformes sp. bioug13499-e05||recommendation:imp:pt:^patient:doc||random
pramoxine hydrochloride 10 mg/ml||other specified rheumatoid arthritis, multiple sites||random
reticulate hyperpigmentation (periocular, perioral, chest, neck, abdomen)||cardiomyopathy due to hypertension (disorder)||random
ldh increased serum||hematoma of scrotum (disorder)||random
rts2||motor responses||random
necrosis of flap||mood persistence:find:pt:^patient:ord:mds||random
maleylacetone||diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae b vaccine||random
neoplasm of autonomic nerves of popliteal space (diagnosis)||l-mefol/a-cyst/meb12/algal oil 6 mg-600 mg-2 mg-90.314 mg oral tablet||random
unclassified sanguibacter||penicillium sp. gca-683-22||random
glucosidase (substance)||iatrogenic hypotension (disorder)||random
2-methoxy-3-methyl-1,4-benzoquinone||disseminated intravascular coagulation||random
can exact number of adenomas be determined:find:pt:^patient:ord:phenx||biopsy of cervix showed mesodermal mixed tumor||random
chronic gingivitis co-occurrent and due to dental plaque||neuro-qol pediatric item bank - anger - version 1.0:-:pt:^patient:-:neuroqol.peds||random
tenesmus present (context-dependent category)||agaricus loricatus fr. 1838||random
electrolyte management||gnathoxylocopa||random
aluminum sesquichlorohydrate 180 mg/ml [arrid extra dry]||iddabs||random
phenx - word decoding protocol:-:point in time:^patient:-:phenx||primary hybrid total replacement of joint (procedure)||random
insulin^1.5 hours post dose glucose:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||receptor, fmet-leu-phe||random
strain of tendon of upper limb (disorder)||revision orbital floor implant||random
isosorbide dinitrate 1.25 mg/actuat oral spray||lower extremity arteries||random
12 hr bupropion hydrochloride 100 mg extended release oral tablet [budeprion]||coconut oil 6 g in 100 ml / chamomile 1 g in 100 ml / calendula officinalis flower 1 g in 100 ml / sunflower oil 2 g in 100 ml / dexpanthenol 0.1 g in 100 ml / urtica dioica leaf 0.02 g in 100 ml / plantago major leaf 0.02 g in 100 ml / cotinus coggygria leaf 0.02 g in 100 ml topical cream [vivalacara dermalere advanced skin cream]||random
vit-b1 25 mg/ml injectable solution||quaternium 52||random
entire tunica submucosa||generic drug products begining with the letter h||random
acebutolol and hydrochlorothiazide product||go up and down 4 steps - usual functional ability:find:rptperiod:^patient:ord:cms assessment||random
weeping wound of right mid paraspinal region||catheterization, swan ganz||random
guidance for thrombectomy^w contrast intravenous:finding:to identify measures at a point in time:not specified>vein:document:radiofluoroscopy.angio||gatifloxacin oral suspension [tequin]||random
supplement left middle finger with synth sub, open approach||aneurysm of pulmonary artery (disorder)||random
nerve to left eleventh external intercostal muscle||flagecidin||random
excretion, intestinal||nursemaid's elbow, unspecified elbow, sequela||random
hla-dw14 [presence]||copaifera officinalis resin||random
lateral branch of posterior ramus of eleventh thoracic nerve to longissimus thoracis||dog house disease||random
cynanchum vincetoxicum root 6 [hp_x] in 1 ml / echinacea angustifolia 6 [hp_x] in 1 ml / sus scrofa hypothalamus 6 [hp_x] in 1 ml / sus scrofa cerebrum 8 [hp_x] in 1 ml / pork liver 8 [hp_x] in 1 ml / pork kidney 8 [hp_x] in 1 ml / methylcobalamin 8 [hp_x] in 1 ml / sus scrofa pancreas 8 [hp_x] in 1 ml / sus scrofa stomach 8 [hp_x] in 1 ml / apc-356433 8 [hp_x] in 1 ml / apc-356434 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 12 [hp_x] in 1 ml / gamboge 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / strychnos nux-vomica seed 12 [hp_x] in 1 ml / phytolacca americana root 12 [hp_x] in 1 ml / 7-oxodehydroepiandrosterone 3-acetate 30 [hp_x] in 1 ml / adenosine triphosphate disodium 30 [hp_x] in 1 ml / glucagon 30 [hp_x] in 1 ml / insulin pork 30 [hp_x] in 1 ml / lactic acid, l- 30 [hp_x] in 1 ml / proteus vulgaris 30 [hp_c] in 1 ml oral liquid [weight management]||fusion of left hip joint with nonautologous tissue substitute, percutaneous endoscopic approach||random
zalcitabine-containing product||estrone 6 [hp_x] in 1 ml / sus scrofa ovary 6 [hp_x] in 1 ml oral liquid [estrogen]||random
hypoparathyroidism, autosomal recessive||medical and surgical @ respiratory system @ destruction @ lung, left||random
prilocaina||complement factor abnormal||random
phoridae sp. bold:ace4146||garlic 10 [hp_x] in 59 ml / semecarpus anacardium juice 10 [hp_x] in 59 ml / apis mellifera 10 [hp_x] in 59 ml / gamboge 10 [hp_x] in 59 ml / mercurius solubilis 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / nitric acid 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sulfur 10 [hp_x] in 59 ml oral liquid [allergy food andchemical relief]||random
negative regulation of microvillus assembly||irf-pai v4.0 - hearing, speech, and vision - discharge||random
5,6-dihydroxy-7,8,3',4'-tetramethoxyflavone||op skl vlt fx-concus nos||random
product containing guaifenesin and pseudoephedrine in oral dose form (medicinal product form)||tex19 protein, mouse||random
pseudomonas sp. 2-47(2010)||disorder of cornea associated with contact lens (disorder)||random
minchamia||c19orf56||random
core calosphace||structure of extensor carpi radialis muscle||random
chinese imperial ch'in dog||prostaglandin f2 alpha &#x7c; serum or plasma &#x7c; chemistry - non-challenge||random
secondary osteoarthritis, unspecified ankle and foot||human normal immunoglobulin 3g intravenous infusion||random
semecarpus anacardium juice 10 [hp_x] in 59 ml / agrimonia eupatoria flower 10 [hp_x] in 59 ml / gold 10 [hp_x] in 59 ml / avena sativa flowering top 10 [hp_x] in 59 ml / borage 10 [hp_x] in 59 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml / capsicum 10 [hp_x] in 59 ml / carpinus betulus flowering top 10 [hp_x] in 59 ml / black cohosh 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / strychnos ignatii seed 10 [hp_x] in 59 ml / potassium bromide 10 [hp_x] in 59 ml / larix decidua flowering top 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / sodium sulfate 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / phosphorus 10 [hp_x] in 59 ml / pulsatilla vulgaris 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / sinapis arvensis flowering/fruiting top 10 [hp_x] in 59 ml / tobacco leaf 10 [hp_x] in 59 ml oral liquid [good mood enhancer]||tomographies||random
nursing care: surgical drain #2 connection to bulb suction (treatment)||saccoglossus||random
reticulocyte percent count||pathologic fracture of forearm (diagnosis)||random
medical and surgical @ urinary system @ dilation @ bladder @ percutaneous||medical and surgical @ hepatobiliary system and pancreas @ fragmentation @ pancreatic duct @ external @ no device||random
her-2 antagonists||egyptian; anemia or chlorosis||random
unclassified hysterium||unclassified anthepiscopus||random
smad, common||neoplasm of arachnoid of spinal meninges (diagnosis)||random
frostbite with tissue necrosis of unspecified arm, subsequent encounter||cutis laxa, autosomal dominant 1||random
zinc oxide 51.4 mg in 1 ml / titanium dioxide 73.6 mg in 1 ml topical cream [mineral sunscreen broad spectrum spf 45]||postsurgical state acquired absence of hip joint||random
tongue red swollen pain||methyl benzene||random
thrombopoietin, recombinant human||genioplasty (procedure)||random
berberis vulgaris root bark 3 [hp_x] in 1 ml / milk thistle 3 [hp_x] in 1 ml / chelidonium majus 3 [hp_x] in 1 ml / collinsonia canadensis root 3 [hp_x] in 1 ml / solidago virgaurea flowering top 3 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / bos taurus bile 6 [hp_q] in 1 ml / apis mellifera 30 [hp_c] in 1 ml / barium chloride dihydrate 30 [hp_c] in 1 ml / ceanothus americanus leaf 30 [hp_c] in 1 ml / quinine sulfate 30 [hp_c] in 1 ml / iodine 30 [hp_c] in 1 ml / lachesis muta venom 30 [hp_c] in 1 ml / mercurius solubilis 30 [hp_c] in 1 ml / strychnos nux-vomica seed 30 [hp_c] in 1 ml / phosphorus 30 [hp_c] in 1 ml / silicon dioxide 30 [hp_c] in 1 ml oral liquid [2 lymphatic drainage]||entire frontal gyrus (body structure)||random
photobioreactors||proteins, growth suppressor||random
structure of sheathed arteries of spleen (body structure)||substance abuse prevention alcohol||random
eversion strength of right ankle extensor digitorum longus||hearing aid remote control||random
propylthiouracil 200 mg||wound of left lateral chest with poorly approximated postsuture edges (physical finding)||random
tender heel pad (finding)||centromeric heterochromatin biosynthesis||random
cotabflu pill||o/e - dead nos (finding)||random
phenylephrine + acetaminophen (medication)||acute prerenal failure||random
chlophedianol-chlorcyclizine||other malignant neoplasm of colon recurrent||random
apomorphine hydrochloride 10 mg/ml solution for injection||asphyxia; mucus, newborn||random
coughing syrups||branded drug names b to bl||random
belt device||microbiology test of skin lesion of distal ring finger of left hand (lab test)||random
derangement of meniscus of right knee joint||anti-egfrviii immunotoxin mr1-1||random
family apogonidae - cardinalfishes||beta lactamase organism identified &#x7c; isolate &#x7c; microbiology||random
edetate calcium disodium (anhydrous)||saltator orenocensis (organism)||random
product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug)||interferon alpha level decreased||random
functional disorder of gastrointestinal tract (disorder)||bryonies||random
body mass index [bmi] 30-39, adult||burn of first degree of lip(s), subsequent encounter||random
cognitive technique||painful legs moving toes||random
tritrichomonas suis||supervision of young primigravida, third trimester||random
unclassified tylenchidae||lymphocytes:number aeric (number per area):to identify measures at a point in time:semen:quantitative:microscopy.light.hpf||random
open wound of scrotum without complication (disorder)||astrocytoma of diencephalon||random
multisection^w contrast intravenous:finding:to identify measures at a point in time:chest>chest vessels & abdomen>abdominal vessels & pelvis>pelvis vessels:document:computed tomography.angio||apogonidae sp. 3 jd-2016||random
fluoroscopic venography of right extremity||incision and drainage of abscess of back (procedure)||random
imaging @ female reproductive system @ plain radiography @ fallopian tube, left||calonectris||random
dextrose 15gm/37.5gm squeeze tube||carcinoma-associated mucin||random
orthotylus sp. bioug26594-c07||one eye-severe/oth-nos||random
transverse branch of meningeal branch of left eleventh thoracic nerve||thoracoscopy w/bx med space||random
hypervariability||n-(6-ethoxybenzo(d)thiazol-2-yl)cyclohexanecarbothiamide||random
tilletia caries 40000 [pnu] in 1 ml intradermal injection, solution||hodgkin's disease, lymphocytic-histiocytic predominance inv head/neck lymph ns||random
pepaxto 20mg powder for injection||nesampelos lucens (poir.) b.nord.||random
cecidomyiidae sp. bold:acs2860||ibuprofen 0.05 mg/mg topical gel [cuprofen]||random
bioluminescence||cerebellar calcifications||random
injury to other nerve nos||pinus ponderosa ab.ige:acnc:pt:ser:qn||random
destruction of pancreatic duct, via natural or artificial opening endoscopic||pompholyx/dis sweat glands||random
aponeurosis of ischiocavernosus||eyelid seborrhoeic keratosis||random
response to cadmium||trichopria sp. bioug32226-a07||random
entire lamina of cervical vertebra (body structure)||yes, and i have been a little concerned||random
finding related to ability to use consonant vowel combination||nairobi sheep disease virus ab (s) [titer]||random
agrobacterium sp. ccbau 31169||ganglioside gt1b antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal:immune blot||random
chorda kikonaiensis||specified salivary appar nec||random
apoptotic protease mch-6 gene||posterior branch of lateral cutaneous branch of ventral branch of first lumbar artery||random
interleukin-8 secretion||citharacanthus spinicrus preparation||random
diagnostic aspiration of left fifth toe pip joint (lab test)||size of anterior lateral cystic neck mass deep to sternocleidomastoid||random
tuberculosis of lung with cavitation (disorder)||hydroxyalprazolam [presence] in urine by screen method||random
operation on bone of skull||alternaria||random
inflammation of testis||proteus sp. krd11||random
ranunculus silerifolius||gustatory alteration:find:pt:mouth:ord:observed.ccc||random
zinc oxide 14 g in 100 g / benzyl alcohol 10.5 g in 100 g / diphenhydramine hydrochloride 2 g in 100 g topical cream [ivarest]||htlv 1||random
detection of high humidity stimulus involved in sensory perception||streptococcus pneumoniae serotype 32a||random
unclassified chlorogloeopsis||burinex pill||random
vx-710||pacemaker right ventricular leads implanted unipolar||random
skin structure under microscope (body structure)||fluoroscopic angiography of uterine artery with contrast||random
shoulder joint||tetrapyrrole breakdown||random
fusarium sp. ncim 1100||nicking-closing enzyme||random
opticokinetic nystagmus tests||upucerthia validirostris validirostris||random
fibrinogen and split products, peroxidase, antigen, antiserum, control||redness of upper eyelid binocular||random
wasp venom (substance)||stoma site vasculitis||random
guaifed-pse, 600 mg-120 mg oral tablet, extended release||tingis sp. unsw ent 00050630||random
1-603-604 endocrine system: excisions||squamous epithelium, nos||random
consumer research||displaced supracondylar fracture with intracondylar extension of lower end of right femur, subsequent encounter for closed fracture with routine healing||random
up regulation of b cell antigen processing and presentation||antidiuretic hormone related conditions||random
halococcus sp. kei-06||entire shaft of rib||random
cossoninae||allantonectria earle, 1901||random
p2ry12||mood disorder; persistent||random
skin of distal zone of arm||deep cold plus||random
3-(2-(4-(p-fluorobenzoyl)-1-piperidinyl)ethyl)-2,4(1h,3h)-quinazolinedione l-tartrate||mass no move with respiration||random
localized pruritus||washington state||random
rad||poisoning by pertussis vaccine, incl combinations with a pertussis component||random
chronic kidney disease due to hypertension||blood osmolarity abnormal||random
mitochondrial dynamics protein, 49-kd||shot size, device (qualifier value)||random
acadvl, 3-bp del, nt388||renal and liver transplant||random
extrahepatic biliary tree injury||gluteal muscle||random
lypd1 protein, human||advance directive - do not resuscitate [minimum data set]||random
arteries, renal||olive pollen (olea europaea) native (nole e) 1 ige &#x7c; serum &#x7c; allergy||random
mattole||tanytarsus sp. bioug20384-h08||random
sulfisoxazole [susceptibility] by serum bactericidal titer||output.ileostomy [mass/time] 1 hour||random
fasciclin||unable rem name reign monarch||random
urticaria acute||tf gene full mutation analysis:find:pt:bld/tiss:doc:sequencing||random
mycobacterium tuberculosis deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:semen:ordinal:probe.amp.tar||partial thickness (second degree) burn left hand (diagnosis)||random
miconazole nitrate 2 g in 100 g topical powder [remedy antifungal]||gapdhl15||random
econazole nitrate 10 mg/ml||discharge by trauma surgeon||random
urodynamic study using catheter (procedure)||gu tb nos-no exam||random
lung biopsy malignant neoplasm carcinoid goblet cell||oleanders, nerium||random
localized anterior staphyloma (disorder)||biotin:mcnc:pt:ser/plas:qn||random
rhodopseudomonas||cd72 &#x7c; white blood cells &#x7c; cell markers||random
oxazepam 15mg tab||optic nerve biopsy glioblastoma multiforme of right optic nerve (procedure)||random
views^w flexion + w extension:finding:to identify measures at a point in time:abdomen>spine.lumbar:document:xr||znf216 protein, human||random
small intestinal serosa||multisection^wo contrast:finding:to identify measures at a point in time:head>face & neck:document:computed tomography||random
bleo/cddp/vbl/vp-16||obese protein||random
manipulation of abdominal tissue, nos||caspase recruitment domain family member 8||random
sheep sorrel pollen extract 10000 unt/ml||therapy, interleukin||random
chlorpheniramine maleate 0.75 mg / codeine phosphate 5 mg / phenylephrine hcl 2.5 mg / potassium iodide 75 mg per 5 ml syrup||irf5, 5-bp ins, promoter region||random
puncture wound w/o foreign body of toe w/o damage to nail||apg7, s. cerevisiae, homolog of, apg7||random
trentepohliales sp. 38||ophthalmodynamometry normal||random
lactic acid, l- 6 [hp_x] in 2 ml oral liquid||ovulation tests, by visual color comparison methods for human luteinizing hormone||random
enlarging||chlorpromazine hydrochloride 25 mg oral tablet [chlorpromazine]||random
s-phase checkpoint||naegleria fowleri (organism)||random
exosc2 protein, human||peroxisome biogenesis disorder 11a (zellweger)||random
burns of proximal phalanx of second toe of right foot (physical finding)||ll1 - permanent lower left 1 tooth||random
contusion of finger of left hand||wall of trunk of first septal branch of left posterior interventricular artery||random
epithelioid sarcoma (diagnosis)||home dialysis patients who received transplant population #||random
igm 24h ur ql ife||order isopoda||random
cicadinae||mental retardation, autosomal dominant 56||random
cell adhesion involved in prostatic bud elongation||patient-device incompatibility||random
cefamandole (as cefamandole nafate) 285 mg/ml injectable solution||demicryptochironomus||random
trissolcus||right ranine vein||random
circular dichroism||frequently||random
congenital musculoskeletal anomaly||mixed type liposarcoma of penis (diagnosis)||random
cadherin||other procedures on ureter||random
my arms or legs feel weak in the past 7d:finding:7 days:^patient:ordinal:facit||ceftriaxone sodium 250mg injection (product)||random
palmitate-1-14c||syphilis late with keratitis||random
fracture of lateral condyle of tibia (diagnosis)||white ramus communicans of right tenth intercostal nerve||random
blood group antigen m, nos||patch of ring finger of right hand (physical finding)||random
involuntary role reversal (finding)||fascia of third palmar interosseous of hand||random
hypersensitivity: [angiitis] or [arteritis]||xr tomography humerus||random
temporal wasting||equine arteritis virus ag:prthr:pt:tiss:ord:immune stain||random
defective tear drainage||magnesium [moles/volume] in leukocytes||random
mamoreocelis xerophila n.m.machado-de-lima & branco, 2020||abnormality, forces of labor||random
abc||corrosion of first degree of left shoulder, sequela||random
zuclopenthixol 10mg tablet||mech hip extension assist||random
assessment of family status related to human sexuality||magnesium ascorbyl phosphate||random
amyl ether bld-mcnc||roralpha2 protein, human||random
other skateboard accident, sequela||ileectomy anast stomach/ileum||random
emo1-anger responded as disgust||tuberous sclerosis 2 (disorder)||random
carbon monoxide fumes from conflagration in travel trailer (event)||hyposplenism||random
unclassified opiinae||empididae sp. bioug02367-g06||random
acid, flufenamic||brimonidine and timolol product||random
ulcerative proctocolitis nos||product containing steroid (product)||random
unclassified diptera||medical and surgical @ upper joints @ destruction @ shoulder joint, right||random
socket||suberate [moles/volume] in serum or plasma||random
vestibular paralysis||amisulpride 2.5 mg in 1 ml intravenous injection, solution [barhemsys]_#2||random
disposition of patient discharged||myxosarcoma, malignant||random
sepia officinalis juice 200 [kp_c] in 200 [kp_c] oral pellet [sepia]||alcohol 75 ml in 100 topical cloth [75% alcohol wipes]||random
h capsul yst ab titr ser cf||pglu-glu dkm||random
diethylaminoethyl cellulose chromatography||nobrium||random
bowel; contracture||sarcoma of ovary (disorder)||random
removal of embedded foreign body in dentoalveolar bone||biopsy of vestibule of mouth||random
confirmed e-cigarette or vaping product use associated lung injury||alkaline phosphatase.intestinal 2/alkaline phosphatase.total:cfr:pt:ser/plas:qn||random
procedure on brain||vaginal birth after cesarean delivery||random
dairying||brassica oleracea var capitata ab.igg||random
gentamicin sulfate (usp)||ropinirole 250micrograms tablet||random
gene expression profile||malignant syndrome nos||random
potassium chloride 1.5g/pack granule (product)||home patients restarting dialysis||random
alcedoecus||phenytoin.total/phenytoin.free:mrto:pt:ser/plas:qn||random
dehiscence of incision of left buttock||thioridazine oral suspension [mellaril-s]||random
pachynematus clibrichellus||lampetra sp. cr_lau96||random
how well can you tell a funny event to a group of children:finding:to identify measures at a point in time:^patient:nominal:seq-c||n-benzyloxycarbonyltyrosine-4-nitrophenyl ester||random
arginine/total aa (specimen) [molar fraction]||chl - conductive hearing loss||random
acetaminophen - pholcodine - pseudoephedrine||multiple incisions of forehead (physical finding)||random
during the past 24h, how has pain interfered with your mood:score:24h:^patient:ord:bpi.short||tubulo-papillary adenoma||random
tuberculosis of esophagus, confirmed by animal inoculation||congenital end-plate acetylcholine receptor deficiency (disorder)||random
cold foot||interstitial pulmonary disease||random
gouty tophi of heart (disorder)||secondary dysmenorrhea (disorder)||random
gastritis caused by fungus||tendon dislocation||random
cryptococcus neoformans antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||phantom shocks||random
triazine||pantoea eucrina brady et al. 2010||random
ro-183981||mastoid abscess||random
costochondral separation||nudibranchia sp. bold:aaa4061||random
chronic dacryoadenitis||gryllotalpicola sp. r2||random
cecidomyiidae sp. bold:acn4893||epithelioid granulomas||random
myopathy, distal, tateyama type||employee compensation||random
fungus:prid:pt:prostatic fld:nom:fungus stain||human papilloma virus 16 dna:prthr:pt:anorectal:ord:probe.amp.tar||random
aluminum sesquichlorohydrate 13.6 g in 100 ml topical emulsion [esika winner sport antiperspirant roll-on deodorant]||chemokine receptor gene||random
radial nerve decompression||bony part of third lumbar vertebra||random
drainage of lower esophagus with drainage device, percutaneous approach||procedure on anterior segment of eye||random
pre-operative evaluation and management note||mycophenolate&#x7c;mcnc&#x7c;pt&#x7c;anybldserpl||random
refractory breast implant-associated anaplastic large cell lymphoma||cancer of nasal cavity||random
'locked in' syndrome||acc,ignition,cloth-press lamp||random
1-azcp-3-pu||clozapine 25 mg oral tablet, orally disintegrating||random
intrauterine pregnancy||thoracic vertebral segment of anterior longitudinal ligament||random
diltiazem hydrochloride 360 mg extended release oral capsule||badusa a.gray, 1859||random
conjugated bilirubin level increased||cecidomyiidae sp. sswlf2886-13||random
examination and observation following transport accident||cerebrovascular accident due to thrombosis of left posterior cerebral artery (disorder)||random
viral wart on nose (disorder)||ulcer of calf due to atherosclerosis of artery of lower limb (disorder)||random
blood antidiuretic hormone increased||microbiology test of skin lesion of cheeks (lab test)||random
adjst mandiblr resctn prosthss||entire intervertebral foramen of thoracic vertebra (body structure)||random
dopamine receptor d1a||dermal filler overcorrection||random
medical and surgical @ male reproductive system @ release @ epididymis, bilateral @ percutaneous @ no device||vibrio sp. 09bszb-3||random
d-152 sprains and strains of the lower extremities||bronchoscopes, rigid||random
89c family procaviidae||fracture dislocation of wrist joint carpometacarpal open||random
titanium dioxide 31.6 mg in 1 ml topical cream [matissime velvet radiant mat fluid foundation with sunscreen broad spectrum spf 20 mat vanilla 3.5]||genes, chloroplast||random
diptera sp. bold:aag7445||syringobulbia (disorder)||random
fusarium poae||ywhae||random
dislocation of costovertebral joint (disorder)||t-cell large granular lymphocyte leukemia expressing the t-cell receptor gamma-delta||random
diptera sp. bold:aav5942||coronary myocardial bridging||random
doppler ultrasonography of vein of limb||diethylamines||random
vestibular neuronitis of left ear||ankrd26-related thrombocytopenia and leukemia predisposition||random
carbomer homopolymer (allyl sucrose crosslinked)||hair observation||random
disruption of vessel repair (disorder)||complication of transplanted organs or tissue, initial encounter||random
aphonopelma sp. aph_1218||pellet wound of hand (disorder)||random
epiphyseal arrest leg left proximal tibia partial||collagen fibers.microscopic observation:prid:pt:tiss:nom:van gieson stain||random
can pronounce accrementitial||lurasidone (substance)||random
2-hydroxyflutamide depot||salicylic acid 2 mg in 100 ml topical spray [proactiv acne clearing body]||random
acute hospital admission considered appropriate:find:pt:^patient:nom:care||entire substantia propria of cornea (body structure)||random
toxic; nephropathy, drugs||body cavity endoscope (physical object)||random
spirobolida||dihydroxyacetonephosphate acyltransferase||random
bony part of nasal septum||medical and surgical @ upper arteries @ dilation @ internal carotid artery, right @ percutaneous endoscopic||random
military rank/grade||licorice ige qn (s)||random
antineoplastic and immunomodulating agents||lymphoma, non-hodgkin's, lymphoblastic metastatic childhood||random
skin crust of entire upper back (symptom)||human papillomavirus type 1 (organism)||random
blue thera-band exercises for both elbows to increase strength (treatment)||scaly skin rash over the perineum||random
insertion of monitoring device into azygos vein, percutaneous endoscopic approach||corynebacterium mycetoides (ex castellani 1942) collins 1983 emend. nouioui et al. 2018||random
ketotifen fumarate 0.025% ophthalmic solution [good sense itchy eye drops]||medical and surgical @ lower arteries @ extirpation @ colic artery, left @ open @ no device @ no qualifier||random
erythematous tissue surrounding incision of back of head (physical finding)||u-4748||random
cerebrovascular; disorder, arteriosclerotic||diabetes or abnormal glucose tolerance complicating pregnancy; childbirth; or the puerperium||random
ligament of lower limb||atpase, chloroplast||random
anterior cutaneous branch of ventral ramus of right sixth thoracic spinal nerve||ankylosed teeth||random
interferon-gamma-inducible protein 30||product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral capsule (clinical drug)||random
lsh w/t/o ut 250 g or less||aphonopelma sp. aph_0966||random
decreased tissue and serum alkaline phosphatase||views^w manual stress:find:pt:lower extremity.left>foot:doc:xr||random
dendroica graciae yaegeri (organism)||microscopic observation silver impregnation stain.dieterle nom (tiss)||random
opioid-containing antitussives/expectorants||medial subluxation of proximal end of tibia, right knee||random
rupture of membranous urethra||unclassified cypridinodes||random
triprolidine (medication)||absent/underdeveloped outermost bone of 4th toe||random
guidance for removal of venous filter from superior vena cava||phenylephrine / pyrilamine nasal spray||random
creation of a-v graft fistula for dialysis (treatment)||synovial cavity of right t8-t9 vertebral arch joint||random
mediastinum repair (procedure)||octinoxate 7.5 g in 100 g / titanium dioxide 4.19 g in 100 g topical liquid [sheer defense tinted moisturizer broad spectrum spf 15 m50 merle norman]||random
endarterectomy of inferior mesenteric artery (procedure)||salicylic acid 28 % topical film-forming solution er with applicator||random
pelvic organ inj nec-opn||trigonostemon balgooyi r.y.yu & welzen, 2018||random
preventive medicine services||year of birth of second granddaughter by child #8||random
transluminal use||genus cittura (organism)||random
octinoxate 7.25 g in 100 g / titanium dioxide 5.742 g in 100 g / zinc oxide 4.75 g in 100 g topical cream [boscia daily defense sunscreen broad spectrum spf 50 pa]||tissue injury middle left paraspinal incision bleeding||random
anesthesia for abdominal wound dehiscence, nos||amylase / bacillus coagulans / lipase / protease||random
eml4-alk fusion protein variant 5a||duplicaria bernardi (deshayes, 1857)||random
bursera altijuga rzed., calderon & medina||stereophaedusa hiraseana||random
skin tag on back of right shoulder (physical finding)||partial excision of gallbladder||random
medical and surgical @ female reproductive system @ drainage @ uterus||radiotherapy to abdomen||random
codium sp. dml65827||displaced pilon fracture of unspecified tibia, subsequent encounter for open fracture type iiia, iiib, or iiic with nonunion||random
workforce||alpha-hydro-omega-hydroxypoly(oxyethylene)a-poly(oxopropylene)b-poly(oxyethylene)a block copolymer||random
boliscus||burn-caustic organic chemical||random
orchitis/epididymitis||pineal germinoma||random
malignant neoplasm of rectum stage ii||c18:1-dc (dbs) [moles/vol]||random
ulcer of left buttock stage ii||raphe nuclei (classical)||random
coding system.original.seer:id:pt:cancer registry:nom||bosentan (substance)||random
natamycin 20 mg/ml [pimafucin]||isoproterenol hydrochloride 1% inhalation solution||random
nuclear expression of stat6 protein||ziziphus jujuba var. spinosa seed||random
diplophyllum andrewsii||tra-1-60 protein, human||random
oraov2||multiple closed fractures of skull or face with cerebral laceration or contusion||random
atrophy, multisystem||other human immunodeficiency virus infection||random
macrophage cell differentiation||652 family apoidea - bees||random
laryngotomy with removal of tumour||alcoholic cirrhosis of liver with ascites||random
cottus aenaeus||rocio virus disease||random
ainhum (disorder)||insulin ab (s) [titer]||random
qtc prolongation||exam. for institution nos||random
thailand; fever||screw (physical object)||random
hedis 2020 value sets:-:pt:^patient:-||prodorylaiminae||random
candidatus campbellbacteria bacterium lh_s37||9-(3-(cytos-1-yl)propyl)-2-dimethylaminopurin-6-one||random
closed treatment of non-blowout orbital fracture with manipulation (treatment)||chlorpheniramine maleate/phenylephrine hcl/dextromethorphan 8 mg-20 mg-30 mg oral tablet, extended release 12 hr||random
fasciculus retroflexus of the midbrain||vatairea lundellii (standl.) killip ex record||random
malignant_cells||phyllachora chloridis dayarathne, shivas. & k.d. hyde, 2017||random
pyorrhea||secondary megacolon - acquired (disorder)||random
thoracic cage structure (body structure)||alcohol 68 ml in 68 ml topical gel [hand sanitizer ocean breeze]||random
mds v3.0 - rai v1.16.1 - nursing home and swing bed omra (no and so) item set [cms assessment]||outcomes rehabilitation||random
cong anomalies of mother||phocomelia of a limb (diagnosis)||random
biopsy bile duct normal||anthodon decussatum||random
histone cluster 1, h3j gene||physician providing a service in an unlisted health professional shortage area (hpsa)||random
human papilloma virus 11 dna:ncnc:pt:xxx:qn:probe.amp.tar||trabecular bone of proximal epiphysis of phalanx of finger||random
fisp12 protein||remove anal fist complex||random
docosahexaenoate (c22:6w3)||downregulation of octadecene anabolism||random
antimony trisulfide 6 [hp_x] in 1 ml / corallium rubrum exoskeleton 6 [hp_x] in 1 ml / saffron 6 [hp_x] in 1 ml / potassium acetate 6 [hp_x] in 1 ml oral liquid||uranium:mass concentration:24 hours:urine:quantitative||random
chlorhexidine 200 mg/ml||requip xl, 8 mg oral tablet, extended release||random
longidorella||opn # sesamoid bone hand||random
cutaneous; coccidioidomycosis (manifestation)||gnrh signaling pathway||random
polyp of sphenoidal sinus (disorder)||stage i thyroid papillary carcinoma||random
entire pars interarticularis of thoracic vertebra (body structure)||bacillus sp. kb129||random
enfuvirtide (medication)||12 am specimen||random
mesna 100 mg/1 ml intravenous solution||lyme elisa positive||random
left secondary third lower molar tooth||bacterium c0877||random
bacterium hn3-5-34||phomopsis sp. m31||random
medical and surgical @ urinary system @ bypass @ ureters, bilateral @ percutaneous endoscopic @ synthetic substitute @ ureter, left||total abdominal colectomy with ileostomy||random
anesthesia for procedure on male external genitalia, nos||excision procedures on the larynx||random
surgery epididymis aspiration of spermatocele||polyprenol metabolism||random
reduction of intussusception of small intestine||medical and surgical @ lower joints @ extirpation @ lumbar vertebral joint @ percutaneous @ no device||random
hus1b protein, human||avobenzone 0.03015 g in 1 ml / octinoxate 0.0744 g in 1 ml / octisalate 0.0503 g in 1 ml / oxybenzone 0.0201 g in 1 ml topical lotion [clinique for men broad spectrum spf 21 moisturizer]||random
immolina||albidiferax sp. se3pw_3422||random
synovial structure of ankle and foot (body structure)||module 1: other correspondence||random
sciatia||periodontitis as manifestation of systemic disease (disorder)||random
tamarindus (plant)||leukemia burkitt cell||random
structure of under border of second rib (body structure)||syndactyly, 2-3, 3-4 toe||random
cecidomyiinae sp. bioug20389-h07||optic disc depression||random
plasma cells/100 leukocytes:number fraction:to identify measures at a point in time:bronchial:quantitative||displaced transverse fracture of shaft of right tibia, subsequent encounter for open fracture type i or ii with routine healing||random
cutaneous sporotrichosis (diagnosis)||unsp physeal fracture of lower end of unspecified femur||random
trospium chloride er, 60 mg oral capsule, extended release||[v]cnsl relt/pt sx behav+orien||random
total clearance predicted normalized by body mass index||ventral ramus of seventh cervical spinal nerve||random
acute inferolateral myocardial infarction with subsequent care||epipristis nelearia||random
transvascular approach (qualifier value)||triphalangeal thumb with polysyndactyly||random
cog1 gene||homosalate 0.35 g in 3.5 g / octinoxate 0.14 g in 3.5 g / avobenzone 0.105 g in 3.5 g / octocrylene 0.07 g in 3.5 g topical lipstick [lipstick queen endless summer broad spectrum spf 15 sunscreen]||random
ncs left ulnar nerve motor above-below elbow conduction velocity (___ m/sec)||esterified estrogen and methyltestosterone only product in oral dose form||random
decidual metaplasia||extrinsic muscles of eyeball||random
multimorphic rash (disorder)||pyelectasia (diagnosis)||random
feline papillomavirus type 3||flexion deformity of left wrist||random
bone thumb||chronic or unspecified gastric ulcer with hemorrhage||random
hormone-dependent neoplasms||coarse respiratory crackles (finding)||random
blood smear test normal||product containing dexmethylphenidate hydrochloride (medicinal product)||random
agrimonia eupatoria flower 10 [hp_x] in 10 ml / semecarpus anacardium juice 10 [hp_x] in 10 ml / gold 10 [hp_x] in 10 ml / avena sativa flowering top 10 [hp_x] in 10 ml / borage 10 [hp_x] in 10 ml / oyster shell calcium carbonate, crude 10 [hp_x] in 10 ml / capsicum 10 [hp_x] in 10 ml / carpinus betulus flowering top 10 [hp_x] in 10 ml / black cohosh 10 [hp_x] in 10 ml / cinchona officinalis bark 10 [hp_x] in 10 ml / hypericum perforatum 10 [hp_x] in 10 ml / strychnos ignatii seed 10 [hp_x] in 10 ml / potassium bromide 10 [hp_x] in 10 ml / larix decidua flowering top 10 [hp_x] in 10 ml / sodium carbonate 10 [hp_x] in 10 ml / sodium sulfate 10 [hp_x] in 10 ml / phosphoric acid 10 [hp_x] in 10 ml / phosphorus 10 [hp_x] in 10 ml / pulsatilla vulgaris 10 [hp_x] in 10 ml / sepia officinalis juice 10 [hp_x] in 10 ml / sinapis arvensis flowering/fruiting top 10 [hp_x] in 10 ml / tobacco leaf 10 [hp_x] in 10 ml oral liquid [good mood enhancer]||wrist effusion||random
cervix prolapsed into vagina (finding)||potassium chloride 1.33 meq/ml [klorvess]||random
felis catus hair 400 [bau] in 1 ml / canis lupus familiaris hair 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / alternaria alternata 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / poa pratensis pollen 4000 [bau] in 1 ml subcutaneous injection, solution||field of vision:finding:to identify measures at a point in time:^patient:ordinal:rfc assessment||random
periaqueductal grays, central||b burgdor ab titr ser if||random
application site phlebitis||pronotalia sp. cntnk202-14||random
lateral patellofemoral disloc||paramyxovirus bat/gh48/2008||random
trabecular bone of left lamina of fifth thoracic vertebra||trunk of right arteria radialis indicis||random
mdl-20,646||isopropyl alcohol 75 ml in 100 ml topical spray [defense ag disinfectant]||random
did the treatment staff discuss how your health and treatment may affect your personal relationships||muscular branch of left eleventh posterior intercostal artery||random
ribosomal protein l9 pseudogene 27||phalaris, nos||random
pogonomyrmex, nos||tooth movement techniques||random
snrnp200, ser1087leu||physconia elegantula||random
forelimb structure||anthrax immunoglobulin||random
thresholds||a26-a29 types of pain||random
pyrrolase, tryptophan||diphenylbutylpiperidine||random
daphniphyllaceae||surgical removal of non-impacted tooth (procedure)||random
right vastus intermedius||strychnos nux-vomica seed||random
respiratory treatments administered at home:finding:to identify measures at a point in time:^patient:nominal:cms assessment||drainage of vagina with drainage device, endo||random
unclassified planomicrobium||cd11a, cd11b, and cd18 phenotyping panel - blood qualitative||random
removal of foreign body from bone of left ankle (treatment)||alpha-1,4-glucosidase deficiency||random
fosopamine||collonia||random
aluminum chlorohydrate 23.5 g in 100 g topical aerosol, spray [secret outlast protecting dry]||ciprofloxacin product||random
bilirubin:substance concentration:to identify measures at a point in time:serum/plasma/whole blood:quantitative||yeast bakers ab.ige.rast class:acnc:pt:ser:ord||random
pelvic prolapse conditions||contusion of colon (diagnosis)||random
medial branch of posterior ramus of right eighth cervical nerve||mild laceration of heart with hemopericardium, subs encntr||random
salicylic acid / triclosan topical product||von willebrand's factor activity normal||random
ochronosis||unclassified narnaviridae||random
3-dehydroquinate dehydratase (substance)||excision of neurolemmoma of cutaneous nerve||random
microscopic examination of bacterial smear of cerebrospinal fluid specimen (procedure)||[x]other specified effects of reduced temperature||random
ann arbor stage iii lymphoplasmacytic lymphoma||tall tented t wave||random
how often did your fatigue make it difficult to start anything new in past 7d:finding:7 days:^patient:ordinal:promis||macrophages:number concentration (count/vol):to identify measures at a point in time:pericardial fluid:quantitative||random
lamyctinus||chemotherapy agents, cancer||random
androcymbium||1,2-benzopyrone||random
kcct decreased||antaeotricha sp. janzen370||random
nuclear protein localization 4 protein, mouse||sinus of valsalva aneurysm||random
etidronate pill||mlc2b||random
c165906||fitting procedure (procedure)||random
trunk of coccygeal part of inferior gluteal artery||inherited metabolic disorder of nervous system (disorder)||random
oth parlyt synd fol unsp cerebvasc disease aff left dom side||(s)-2-amino-3-(1h-indol-3-yl)-propanoic acid||random
irrigation sleeve,sur-fit c#0242-54||inflammation; hepatic duct||random
closed fracture acetabulum, anterior lip alone||the aortic valve cusps are deformed, tricuspid||random
salacia l., 1771||arthritis in other bacterial diseases classified elsewhere||random
views ap + y:finding:to identify measures at a point in time:upper extremity>shoulder:document:xr||chronic conjunctivitis||random
dysregulated host response (qualifier value)||fractures, sprain||random
lancet,at-last||urine protein/creatinine ratio||random
vap - ventilator associated pneumonia||hepatic venous pressure gradient increased||random
xylariales sp. cm69||plasma acid phosphatase||random
thiamin-responsive maple syrup urine disease (disorder)||bone weight decreased||random
dislocation toe||finding reported by subject or history provider (finding)||random
puncture wound with foreign body of abdominal wall, unspecified quadrant with penetration into peritoneal cavity, initial encounter||withdrawal hepatitis||random
advanced unresectable gastric adenocarcinoma||prostatic utricle orifice||random
tenderness on palpation of lateral one-third of clavicle (physical finding)||balneomonas||random
remove nonaut sub from l toe phalanx jt, perc endo||demerol 25 mg in 1 ml cartridge||random
external cause codes: pedestrian; not mvt; initial encounter||unclassified schizochytrium||random
honeys||apache ii score increased||random
pneumocystis carinii||oxazine dye||random
emission spectrometry||closure of lacrimal punctum of left lower eyelid (treatment)||random
lestidium||trabecular bone of distal end of phalanx of ring finger||random
overdose of opiate analgesic of undetermined intent (disorder)||vesicle of buccal maxillary gingiva on right (physical finding)||random
hepatic portal vein||green monkey disease||random
pisolithus sp. tns-f2158||auricular aneurysmectomy (procedure)||random
commersonia j.r.forst. & g.forst.||s. pneumoniae 20 igg 2nd specimen/1st specimen (s) [ratio]||random
epimysium of temporalis||quadrantectomies, breast||random
unclassified duganella||tumor enlargement||random
bone of right fifth metacarpal bone||vitreous opacities (disorder)||random
double outlet of left ventricle||ala-lys-leu-phe-leu-phe-leu-ala-leu-leu-leu-ala-tyr-val-ala||random
acharia hubner, 1819||10 - fatigue as bad as you can imagine||random
ext pollicis brev tend sheath||4-acryloylmorpholine||random
aluminum||6-(3-dimethylamino-1-propylidene) benzofuro(2,3-e)-12h-benzo(b)oxepine fumarate||random
lateral head of flexor digitorum accessorius||calcium carbonate/ergocalciferol (vitamin d2) 600 mg calcium-200 unit oral capsule||random
unclassified molgolaimus||chlamydophila psittaci antibody.immunoglobulin g:dilution factor (titer):to identify measures at a point in time:serum:quantitative:immune fluorescence||random
complication of drug delivery system removal||nitrous oxide^at end expiration:vfr/ppres:pt:airway adaptor:qn||random
atticoantrostomy of ear (procedure)||dipyrone / homatropine oral solution||random
other closed skull fracture without mention of intracranial injury, with no loss of consciousness||ectopic spleen (disorder)||random
2-ethyl-5-(3-indolyl)oxazole||sodium urate crystals:prthr:pt:urine sed:ord:microscopy.light||random
unclassified musoniella||chilostoma fuchsiana||random
floxuridinum||albumin given &#x7c; patient &#x7c; blood bank||random
palindromic rheum.-shoulder||meconium specimen||random
muscle reattached||hungarosoma bokori||random
ym-881||medical and surgical @ head and facial bones @ excision @ zygomatic bone, left @ open @ no device @ no qualifier||random
nystan pill||accidental laceration during a procedure (finding)||random
20-deoxy-5-cevanine-3-ol-6-one||myelopoiesis assessment:find:pt:bone mar:nar||random
adverse reaction to vitamins nec||microbacterium sp. ik1_86||random
co sup(a) ag [presence] on red blood cells||vital capacity:vol:pt:respiratory system:qn:predicted||random
pralidoxime||other upper respiratory tract disease nos||random
fine needle aspiration biopsy of intra-abdominal mass (procedure)||rheum (organism)||random
megaselia sp. bold:aam9355||willing to be donor of lung||random
lansky||rieux's hernia||random
fascia of leg posterior compartment (body structure)||retired procedure [42285008]||random
base fractures skull||scrotal discomfort||random
blood/lymphatic cancer||fluticasone furoate 0.1 mg/actuat / umeclidinium 0.0625 mg/actuat / vilanterol 0.025 mg/actuat [trelegy]||random
11-ketoetiocholanolone [mass/volume] in 24 hour urine --2 days post high dose dexamethasone||escallonia alpina poepp. ex dc.||random
parainfluenza virus 3 igg ql (s)||vascular access site hematoma||random
antral carcinoma||alternating exotropia with x and/or y pattern||random
[x]cellulitis of other parts limb (disorder)||ramus cutaneus medialis (ramus dorsalis) (arteria intercostalis posterior)||random
unlisted special service or report||bariatric surgery discharge summary||random
closed anterior dislocation of humerus (disorder)||fusidate 0.02 mg/mg / hydrocortisone 0.01 mg/mg topical gel||random
encounter for fitting and adjustment of partial artificial right leg||olanzapine 15 mg disintegrating oral tablet||random
alpha proteobacterium scgc aaa027-n08||skin of side of nose||random
atriplex confertifolia pollen 0.05 g in 1 ml intradermal injection [shad scale pollen]||death instantaneous, no symptoms||random
3 hydroxyanthranilic acid oxygenase||neonatal (disseminated) listeriosis||random
complera oral product||salmonella amounderness (organism)||random
acetaminophen / chlorpheniramine / guaifenesin oral product||fetal narrative [interpretation] study observation.general 2nd trimester, multiple fetuses us||random
cartilage development involved in endochondral bone morphogenesis||phenprocoumon:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||random
velvet grass pollen extract||fibrillary astrocyte (cell)||random
operation on aneurysm of brachial artery||thinking about the past 4 weeks, my life was the best [promis]||random
oga||trunk of descending branch of left colic artery||random
dop extr v-l||sulfate sodium||random
scalenus minimus branch of fifth cervical nerve||rehabilitation hospital (environment)||random
h2n2 influenza||dengue virus 1+2+3+4 ab.iga+igg+igm:imp:pt:xxx:ord:ia||random
ct temporal bone - right wo contrast||molecular dynamics (md) simulation||random
program 6 month injectable for cats 100 mg/ml prefilled syringe, 0.8 ml||long-term: improve transfer capability to and from chair dependently||random
product containing only pramipexole 0.088 milligram/1 each oral tablet||catheter,foley 24fr 30cc bard#0166si-24||random
acetaminophen 227 mg / caffeine 32.4 mg / salicylamide 97.2 mg oral tablet||camphor (synthetic) 100 mg in 1 g / menthol 100 mg in 1 g topical cream [cbdmedic arthritis pain relief]||random
ischnosiphon obliquus (rudge) koern.||limnophyes sp. bioug22909-a07||random
nps0102||inhibition of microtubule-dependent nucleus positioning||random
hydrocortisone 10 mg/ml / neomycin 3.5 mg/ml / polymyxin b 10000 unt/ml [casporyn hc]||difficulty sleep||random
increased bronchial sounds (finding)||incomplete ossification of centrum of lumbar vertebra (disorder)||random
aconitum napellus extract||bacterial abscess of mitral valve (disorder)||random
skin crack of dorsal aspect of index finger of left hand||aluminum sesquichlorohydrate 0.136 g in 1 ml topical liquid [pulso antiperspirant roll-on deodorant]||random
scapulothoracic dissociation||plug||random
striae on buttocks (physical finding)||closed renal biopsy fine needle aspiration (procedure)||random
pararhagadochir trinitatis (saussure, 1896)||perinephric fat||random
mycotic infection screening||csf leukocyte/erythrocyte ratio||random
upd23a||htlv 1 nucleic acid detection (procedure)||random
heinz bodies||6,11-dihydro-11-oxodibenz(b,e)oxepin-2-acetic acid||random
perineal incision||e coli sxt spec ia-acnc||random
avobenzone 30 mg in 1 g / homosalate 100 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 50 mg in 1 g topical spray [fruit of the earth cabana beach club with manuka honey and essential oils spf 50]||methylcellulose (4000 mpa.s)||random
percutaneous insertion of catheter into hepatic vein using fluoroscopic guidance with contrast (procedure)||cystostomy, cystotomy with drainage||random
active range of shoulder adduction (observable entity)||win 52035-2||random
division of musculoskeletal system||ethmocephalus||random
nuclear membrane pores nuclear ab pattern if (s) [titer]||recreational therapy evaluation note||random
lymphomas unclassifiable malignant||qs-podci pediatric parent-reported version test||random
superficial injury of face, neck, and scalp except eye||clcd - cleidocranial dysplasia||random
ferrous sulfate 325 mg extended release oral tablet||tretinoin 0.025% cream||random
root canal infection||nda020983 60 actuat ventolin 0.09 mg/actuat metered dose inhaler||random
autologous cultured chondrocyte only product in parenteral dose form||gynaecologic examination||random
nata 29 ob, prenatal multivitamins with folic acid 1 mg oral tablet||sars-cov-1 test negative||random
coleogyne torr.||genus acidovorax (organism)||random
nostoc sp. cena239||other specified congenit malformation skull & face bones||random
fetal-maternal hemorrhage - delivered (disorder)||saint louis encephalitis virus ab.igg:acnc:pt:csf:qn||random
garlic igg qn||magnetic resonance imaging of shoulder: full thickness defect of articular cartilage of posterior aspect of right glenoid (procedure)||random
toileting assistive device||acetaminophen+hydrocodone bitartrate 500mg/7.5mg elixir||random
medical and surgical @ upper veins @ restriction @ face vein, right @ percutaneous @ no device @ no qualifier||antithrombin, direct||random
[m]mesothelial neoplasm nos (morphologic abnormality)||hepatitis c virus genotype 1a positive||random
skin structure of hypogastric region (body structure)||decreased ovarian estrogen secretion [pe]||random
c4 vertebral pedicle||unclassified wahnesia||random
obstetric ultrasound: narrative observation of umbilical cord||epithelioid sarcoma of urethra (diagnosis)||random
diagnostic cystoscopy with ureteral catheterization with brush biopsy (procedure)||borrelia burgdorferi ab:prthr:pt:body fld:ord:ia||random
x-ray of foot: mixed lytic and sclerotic lesion with intact cortex (procedure)||monomethylol dicyandiamide||random
[q] buckle (qualifier value)||reagents, microbiology, control, fungi/yeast test||random
cecidomyiidae sp. bioug20884-d10||avobenzone 28.5 mg in 1 ml / homosalate 50 mg in 1 ml / octinoxate 70 mg in 1 ml / octisalate 30 mg in 1 ml / octocrylene 90 mg in 1 ml topical cream [pur confort spf 15]||random
physical medicine massage, initial 30 minutes||urinalysis nec||random
fatty acids:mass rate:24 hours:stool:quantitative||functional assessment of cancer therapy for patients with prostate cancer questionnaire - version 4 (fact-p) [facit]||random
epithelioid intraocular melanoma||psbg 1||random
salicylic acid topical 40% topical stick||transmission electron microscopy (tem)||random
pql1219||lupus anticoagulant neutralization platelet||random
feline herpesvirus antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||femoco biosynthetic process||random
complex burn of upper limb (disorder)||cervical wet mount smear||random
closed traumatic subluxation knee joint, unspecified (disorder)||medial branch of dorsal branch of first posterior intercostal artery||random
allergenic extract, tag alder||structure of blood vessel within small intestine||random
product containing indometacin 50 mg/1 each oral capsule (clinical drug)||psychogenic tremor (disorder)||random
3beta,7beta,11-trihydroxy-5alpha,6alpha-epoxy-9,11-secogorgostan-9-one||exploratory operation||random
camphor 3 % / menthol 2.52 % medicated patch||tris-(2pmg)ea||random
thyrotropin^pre xxx challenge:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||t-cell receptor gene rearrangement test||random
[x]infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts||staphylococcal; meningitis||random
genital labial abscess||primary somatosensory area||random
malignant tumour of buccal aspect of lip||muscular branch of anterior ramus of right eleventh thoracic nerve||random
packager/labeler (occupation)||branches of left coronary artery||random
shunt; central, with prosthetic graft||macular dystrophy congenital||random
pollen wall formation||cortical sep latency||random
entire right achilles tendon||malignant neoplasm of trachea||random
malignant tumour small int||catheter,intermittent 12fr cure #m12||random
board and care home||androgen receptor antagonist||random
gpti transamidase||unclassified taupapillomavirus||random
rhinosporidial papilloma (disorder)||mechanical ventilation management: invasive||random
subacute non-puerperal mastitis||aneurysms, berry||random
episodic ataxia type 5 (disorder)||other specified injury of femoral artery, left leg||random
drug withdrawal therapies||multiple mitral papillary muscles with hammock valve (disorder)||random
neisseriaceae prevot 1933 (approved lists 1980) emend. adeolu and gupta 2013||fluctuance||random
delusion of being loved||cls trm dslctn knee jt, medial||random
inhalation sedation (procedure)||panniculitis due to immunological disorder||random
yellow dock pollen extract 10000 unt/ml||malignant melanoma of skin of canthus of right eyelid||random
other fracture of unspecified lower leg||implantable cardioverter defibrillator||random
patient maintained yard or garden dependently (physical finding)||adeh||random
suppressed lactation, unspecified as to episode of care||octinoxate 75 mg in 1 g / oxybenzone 40 mg in 1 g topical salve [carmex daily care moisturizing lip balm merry berry spf 15]||random
transport problems (finding)||manufactured material||random
linagliptin in oral dosage form||moles per unit time (qualifier value)||random
neck mass||clinical copd questionnaire 1 week version questionnaire test code||random
carthamus tinctorius ab.ige.rast class &#x7c; serum &#x7c; allergy||ngarawa sp. 922.5||random
hazardia detonsa||neurodevelopmental disorder nos||random
squamous cell carcinoma in situ, no international classification of diseases for oncology subtype||foot ulcer||random
stage iiib cervical cancer ajcc v8||angiocentric glioma (who grade i)||random
resect forarm/wrist tum 3cm>||alpha particle||random
vermilionectomy lip shv w/mucosal advmnt||pharyngeal anastomotic leak||random
osteoarthritis primary||trachea (rings); deformity, acquired||random
intentional collision of motor vehicle with other motor vehicle, initial encounter||annuli extracellular matrix||random
imaging guidance procedure||s2 part of posterior external vertebral venous plexus||random
training for power wheelchair mobility on level surface dependently||fumigant||random
covid-19-associated stroke||cartilage of inferior surface of posterolateral part of body of lumbar vertebra||random
hypromellose 2910 (15000 mpa.s)||x-ray femur fracture pediatric salter type ii||random
disseminated paracoccidioidomycosis||i>int< phenotype (finding)||random
unclassified allorhogas||finding of electrocardiogram qrs axis (finding)||random
salicylic acid / sulfur medicated shampoo||does not run up steps (finding)||random
m4s1||blood pressure taking education (regime/therapy)||random
proml1||aeromonas salmonicida (lehmann and neumann 1896) griffin et al. 1953||random
alphaproteobacteria bacterium smt01s||sugar absorption test panel &#x7c; urine &#x7c; chemistry panels||random
chlamydia sp iga ia ql (s)||left acromion||random
skeleton diagnostic radiopharmaceuticals||congenital microtias||random
copper 2 mg oral tablet||eumorphobotys||random
vesicle on the elbows left outside||retained (old) fb following penetrating wound of left orbit||random
ru24756||htx2||random
m ag inferred phenotype||voluven injectable product||random
delivery by caesarean section for breech presentation||zema-pak 1.5 mg oral tablet 35 count 10 day pack||random
partial traumatic amputation of right hand at wrist level||oth ob surg compl-unspec||random
palmar fasciitis||unit of dose calculation||random
peptide, delta-sleep||colonoscopy.thru stoma||random
imd12||bone immobilization||random
bony part of lamina of first thoracic vertebra||unclassified peyssonnelia||random
plexus lumbosacralis; compression||lepidoptera sp. bold:aal9909||random
local anesthetic axillary compartment block (procedure)||congenital heart valve dysplasia||random
biscogniauxia sp. ti070912||chondroitin sulfates / hyaluronate prefilled syringe [discovisc]||random
cylindrotominae||climacteric arthritis, hand||random
vacuolar hydrogen-transporting atpase||age at last menstrual period:time:to identify measures at a point in time:^patient:quantitative||random
synthesizers, speech||agglutinations, sperm||random
alcohol 62 g in 100 g topical liquid [instant hand sanitizer with aloe and vitamin e 01]||diplogephyra sp. anic2||random
antipyrine / meprobamate / papaverine oral tablet||metastatic lung non-small cell carcinoma||random
dxa bone armass bmd||unclassified beijerinckia||random
deprecated sagittal sinus vein - left fluoroscopic angiogram w contrast iv||gtp1 protein, s cerevisiae||random
protriptyline hydrochloride 5 mg oral tablet [vivactil]||hypertension control absent||random
mass of right parietal lobe of brain||butyrivibrio sp.||random
abdominal aortography||poruchy sluchu nec in mdrcze24_0||random
insulin 2.6h p chal serpl-acnc||zinc oxide 3.3 mg in 1 ml / titanium dioxide 4.3 mg in 1 ml topical liquid [almay age smart shade cc luminous primer spf 15]||random
erythema of interphalangeal joint of finger of left hand (physical finding)||rast class||random
epithelium proper of esophagus||clarke's sign of right knee (physical finding)||random
bacterial antibody assay (procedure)||sciaridae sp. bioug21449-g12||random
sigalionidae sp. ma13-pol492||echography normal||random
magnetic resonance imaging of thoracic spine: mass of thoracic vertebra enhanced with gadolinium (procedure)||elapsoidea semiannulata bocage, 1882||random
hysterectomy (ovaries conserved)||win 65936||random
sensorcaine||axelopran||random
quetiapine 150 mg [seroquel]||product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)||random
medical and surgical @ central nervous system and cranial nerves @ division @ acoustic nerve @ percutaneous endoscopic @ no device @ no qualifier||chronic rapidly progressive glomerulonephritis (disorder)||random
prevymis, 480 mg/24 ml intravenous solution||campylobacter jejuni antibody:arbitrary concentration:to identify measures at a point in time:serum:quantitative||random
iron polysaccharide complex + folic acid||retired procedure (procedure) [69977004]||random
left nasal bone||varicella virus test positive||random
insertion of infusion device into r buttock, open approach||vulnerability (disorders)||random
n-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine||rrb1||random
hodgkin's lymp.dep.-intrapelv.||specimen weight:mrat:48h:stool:qn||random
petrochromis||medical and surgical @ lower joints @ revision @ hip joint, acetabular surface, left @ open @ synthetic substitute||random
surface region of thorax||sodium channel inhibitor activity||random
human adenovirus 3||unclassified diplodia||random
contusion, scrotum or testis (disorder)||anagnostidinema||random
cd64 cells nfr mar||bassia||random
asperitas badjavensis rensch, 1930||fh: aortic aneurysm||random
beta-ketoadipyl coenzyme a thiolase activity||silicone sheet/foam dressings||random
notoseris||vaccine, salmonella||random
cordilox mr pill||organism specific culture technique (qualifier value)||random
tailor's bunions||rasbora cf. naggsi hs-2020||random
difficulty driving a car||urinalysis dipstick w reflex microscopic panel:-:pt:urine:-||random
deficiencies, storage pool||zasmidium dalbergiae||random
closed fracture of epiphyseal plate of metatarsal bone||spine magnetic resonance imaging thoracic osseous cystic mass t9 caudal||random
aconitum napellus 3 [hp_x] in 59 ml / bryonia alba root 3 [hp_x] in 59 ml / hypericum perforatum 3 [hp_x] in 59 ml topical oil [frankincense and myrrh neck shoulder and knee]||breast neurofibroma||random
oxalis montana leaf extract||fosphenytoin sodium 75 mg/ml [sesquient]||random
carbon monoxide oxygenase (cytochrome b-561) (substance)||albumin csf elph-mcnc||random
clear cell variant thyroid gland follicular carcinoma||tendon of medial thigh muscle||random
(views ap + lateral + merchants) + (views^w standing):find:pt:lower extremity.bilateral>knee:doc:xr||views^w tc-99m pertechnetate intravenous:finding:to identify measures at a point in time:neck>parotid gland:document:nm||random
unclassified amycolatopsis||excision of lesion of vein of lower limb||random
aleyrodidae sp. bioug02533-h10||difficulty performing dressing activity||random
juvenile osteochondrosis of primary patellar centre||dorsal nail matrix of thumb||random
blood flow velocity.diastole.max:velocity:to identify measures at a point in time:mitral valve:quantitative:ultrasound.doppler||x-ray of teeth: cavity of incisal surface of right maxillary central incisor||random
phoma dactylidis||medical and surgical @ female reproductive system @ change @ vagina and cul-de-sac||random
cefixime 400mg cap ud||beta-glucoside transport||random
hemolytic anemia drug induced||punica granatum seed oil||random
reconstruction with local flap (procedure)||hem/bc||random
ncs musculocutaneous right side motor recording site||membrane (organ)||random
intracranial injury unspecified nature with open intracranial wound||dimethicone/vinyl dimethicone crosspolymer||random
touch (regime/therapy)||fra11d||random
subdivision of proximal surface of body of talus||peak level||random
bypass left external iliac artery to left internal iliac artery, open approach||lesions on neck (physical finding)||random
skin wound of posterior aspect of right ankle (symptom)||cefuroxime ophthalmic product||random
ch'i kung||bradyrhizobiaceae bacterium ellin7199||random
bupropion hcl@150 mg@oral@tablet, extended release 12 hr||keratosis lichenoides chronica||random
forebrain bundle, medial||fasciolidae||random
medical and surgical @ urinary system @ occlusion @ ureter, left @ percutaneous endoscopic @ intraluminal device||bilirubin, albumin bound measurement (procedure)||random
quenocol||allergy testing||random
vestibular evaluation with recording of oscillating tracking||benign neoplasm of connective tissue||random
choroidal atrophy and alopecia syndrome (diagnosis)||structure of sacral myotome (body structure)||random
gyrelmis||multisection:finding:to identify measures at a point in time:lower extremity.left>lower leg vessels:document:magnetic resonance.angio||random
does not apply||sarcophaga sp. bioug24352-c06||random
acinetobacter spec cult||left elbow skin||random
tendon of temporalis muscle||full thickness reconstruction of eyelid up to two-thirds of eyelid, one stage||random
contiguous mantle cell lymphoma stage ii||titanium dioxide 4.9 g in 100 g / octinoxate 2 g in 100 g topical powder [oh age recovery tri shield pact 10]||random
group counseling note||revision of total arthroplasty of knee||random
pseudoephedrine hydrochloride/triprolidine hydrochloride 60 mg-2.5 mg oral tablet||diphosphoglycerate phosphatase||random
meloxicam 10 mg oral capsule [vivlodex]||triprolidine (medication)||random
percutaneous angioplasty of pulmonary vein||major laceration of left external jugular vein, sequela||random
toxoplasmosis; meningoencephalitis, congenital (etiology)||exspor||random
thrb gene.p.ala317thr:presence or threshold:to identify measures at a point in time:whole blood/tissue, unspecified:ordinal:molecular genetics||genotype drug resistance test||random
syntaxin-7||other iris or ciliary body disorder nos||random
demyelinating diseases of the central nervous system||mammary duct ectasia of left breast||random
mt1||pregnancy; hypertension, with albuminuria, severe||random
tubaria keralensis||infective aortitis (disorder)||random
titanium dioxide 66.46 mg in 1 ml / zinc oxide 42.2 mg in 1 ml topical lotion [perfectionist pro multi-defense uv fluid broad sprectrum spf 45]||medical and surgical @ upper bones @ repair @ ulna, right @ external @ no device||random
respiration_pattern||dextromethorphan / promethazine oral solution||random
dance, tap||readers, cervical cytology slide, automated||random
product containing only phenelzine in oral dose form (medicinal product form)||cobalt &#x7c; cerebral spinal fluid &#x7c; drug toxicology||random
primary malignant neoplasm of gallbladder||wernicke-korsakoff syndromes||random
unclassified xymmer||endodermal sinus tumor (morphologic abnormality)||random
[x]additional respiratory disease classification terms (disorder)||hymenoptera sp. bold:aac8392||random
laminaria japonica||tunica intima of arch of aorta||random
hyphoderma wallr., 1833||lorlatinib@100 mg@oral@tablet||random
sexuality.behavior:find:pt:^patient:ord:observed.omaha||se 780||random
unsp car occupant injured in clsn w ped/anml nontraf, subs||fracture of fourth metatarsal bone displaced right foot||random
contusion of unspecified part of small intestine, initial encounter||rimapam oral product||random
articular injections, intra||lanolin 500 mg in 1 g topical ointment [soothe and cool free medseptic skin protectant]||random
t1 root of right medial pectoral nerve||olfactory acuity test normal||random
leptogenys kraepelini group sp. zb43776||watara dworakowska, 1977||random
angioplasty of renal artery||neosalanx sp. f03||random
ighv1-69d gene||skin of lateral part of elbow||random
pou3f3 protein, human||methylcellulose (15 cps)||random
hemorrhagiparous thrombocytic dystrophy gene anomaly detection reagents||egophony at left apex||random
neural epidermal growth factor-like 1||tenderness of left thigh localized distal (physical finding)||random
siphonodictyon||handleyomys||random
ceratopogonidae sp. bioug14676-g05||t5 branch to iliocostalis thoracis||random
microscopic examination of bacterial smear of seminal fluid specimen||phenolphthalein (product)||random
operation on seminal vesicle nos (procedure)||peruvian; wart||random
eyelid; impetigo (manifestation)||victim of other person's behav||random
lateral spinothalamic tract||biopsy esophageal benign neoplasm (procedure)||random
bone and/or joint yaws lesions||outlook||random
structure of hair follicle of abdomen||organ component of metatarsal bone||random
mobility||smartrx 0.1 mg/mg medicated pad||random
scaling, subgingival||finding of drug-related rituals (finding)||random
gastric emptying, function||meta-dihydroxybenzenes||random
training for manual wheelchair mobility on ramps with contact guard (treatment)||rosemary oil 2.49 mg in 1 ml topical shampoo [zippity doos for children]||random
prostanoid biosynthesis||biopsy palate normal||random
blood group antigen pr<sub>3d</sub>||psychogenic amnesia (disorder)||random
ena scl70 ab ser ql ib||source documents||random
cardiac measurement device vendor model number||other diseases of nasal cavity and sinuses||random
intellectual disability and developmental disability with no organic condition [mdsv3]||hyaline cartilage of fourth metacarpal bone||random
anal biopsy abnormal||methylphenobarbitone 200mg tablet||random
renal glomerular amyloid deposition||fat embolism; puerperal||random
open wound of ocular adnexa (diagnosis)||orthocentrus sp. bbhyk385-10||random
entire interosseous metatarsal spaces||smittia sp. sseib10732-13||random
unclassified patania||ldlr gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method||random
cd-go skull xr||11-deoxycortisol^pre dose metyrapone&#x7c;pt&#x7c;ser/plas||random
plantago lanceolata pollen||coital bleeding||random
subluxation of unsp parts of right shoulder girdle, subs||covid-19 intub+cpr||random
amg628||atrial natriuretic factor &#x7c; plasma &#x7c; chemistry - non-challenge||random
allergic keratoconjunctivitis||cancer-associated region long noncoding rna 5||random
vita-e gels 75iu capsule||borohydrides||random
right tmj crepitus on closing||t-spine mri osseous structures associated with anemia t12||random
corlanor 5 mg (as ivabradine hcl 5.39 mg) oral tablet||product containing only afamelanotide in subcutaneous dose form (medicinal product form)||random
cisplatin/etoposide/mitoxantrone/tamoxifen||b.eye-mvi, l.eye-ntvi||random
west indian lemongrass oil||medical and surgical @ head and facial bones @ release @ sphenoid bone||random
cullin complex location||cryotherapy applied to both knees||random
stannous fluoride oral gel product||shvg skn lesion 1 trunk/arm/leg diam 1.1-2.0 cm||random
multisection^wo contrast:finding:to identify measures at a point in time:lower extremity.right:document:magnetic resonance||sinusitides, ethmoidal||random
clobazam 2.5 mg/ml oral suspension [onfi]||arteriovenous fistula clotted||random
retract nipple-del w p/p||injury of unspecified blood vessel at ankle and foot level (disorder)||random
incision and curettage of lacrimal canaliculus||peptidyl-prolyl cis/trans isomerase, mitochondrial||random
operation on umbilicus, nos||shiga's bacillus||random
spine magnetic resonance imaging thoracic osseous mass size t6 (___ mm)||prostaglandin-e2 9-reductase||random
unclassified trichinella||change other device in vulva, external approach||random
abdominal wall biopsy||fosamprenavir only product in oral dose form||random
removal of drainage device from pelvic cavity, open approach||implantation of tissue mandril for vascular graft (procedure)||random
thrombosis mesenteric artery||laparoscopic treatment of ectopic pregnancy with oophorectomy (procedure)||random
dislocation and sprain of joints and ligaments of shoulder girdle||clonidine hcl 0.1 mg oral tablet||random
crypturaphis grassii silvestri, 1935||mesial filling in right upper third molar (physical finding)||random
aluminum chlorohydrate 20 g in 100 g topical stick [dove bloom 24h invisible solid antiperspirant deodorant]||congenital hernia of bladder||random
optic disc infarction||dialysis patients who have pending enrollment in medicare at end of reporting period population #||random
thyroxine binding globulin:mcnc:pt:bld:qn||alverine 120 mg||random
tributary of inferior left pulmonary vein (body structure)||carbon tet bld-mcnc||random
staphylococcus schleiferi (organism)||release head and neck bursa and ligament, open approach||random
ammonia sp. 2306_4||retinol||random
leucine-rich and ankyrin repeats 1||catheter site edema||random
(spl review) alcohol 75 ml in 100 ml extracorporeal gel [instant hand sanitizer]||dimethicone 1.25 g in 50 g topical cream [queens rose elysee essence eye]||random
neurod1 gene||inwardly rectifying potassium channels||random
cyanidiales||aftertaste||random
retained plastic fragments||burns marshall maneuvre||random
view ap:finding:to identify measures at a point in time:upper extremity.right>finger.fifth:document:xr||family history of aneurysm of thoracic aorta||random
posterior wall of right external acoustic tube||proinsulin [mass/volume] in serum or plasma||random
macrophysis||shrimps, brine||random
p56(lck)||phytosphingosine hydrochloride 0.5 mg/ml medicated shampoo||random
platypalpus sp. bioug32189-d11||genus petaurista (organism)||random
visual disorders nec||unclassified anabaena||random
flep protocol||self reported weight proto||random
loss of chromosome 18||nondisplaced transverse fracture of left acetabulum, subsequent encounter for fracture with delayed healing||random
bovine herpesvirus 1 ab||aids pharm||random
greulich and pyle bone age assessment||congenital pulmonary alveolar capillary dysplasia||random
body lewis||robotic surgical cutting stapler||random
fac06130||glucose challenge panel:-:pt:exhl gas:qn||random
bioymifi||cryptomicrotia brachydactyly syndrome excess fingertip arch||random
neonatal hypoxic conditions||circulating-water hot/cold therapy pack||random
mass of shoulder region||lamotrigine &#x7c; xxx &#x7c; drug toxicology||random
overthecounterproductindicator||us ob fetus est gest age from ulna length (___ weeks)||random
eye muscle sheath ophthalmic implants||allopathic & osteopathic physicians; orthopaedic surgery, hand surgery||random
presence of pressure ulcers||release right kidney pelvis, via natural or artificial opening||random
posterior dislocation of right ulnohumeral joint, init||positive regulation of transcription from rna polymerase ii promoter of calcium-mediated signalling||random
tunica adventitia (vesicula seminalis)||balclutha sp. bioug25685-c02||random
0.9% saline||arthrocentesis aspir&/inj interm jt/burs w/us||random
osimertinib oral tablet||cyclin b1||random
sdmt - total score||aspartate/creatinine:mass ratio:24 hours:urine:quantitative||random
pmax airway||sodium blood increased||random
skin papule of right lower inner breast (symptom)||punctoribatidae sp. bioug22655-f04||random
closure of a postauricular mastoid fistula||staphylococcus sp. gr 5-07||random
annexin vii||choroid spindle cell type b melanoma||random
watersipora||potamorrhaphis||random
azithromycin dihydrate - chemical (substance)||cancer of pancreas (excl head)||random
magnetic resonance imaging of head for planning of stereotactic radiotherapy (procedure)||gp38 antigen, schistosoma mansoni||random
iniencephaly nos (disorder)||septal-1 artery last inflation balloon size (mm)||random
mitochondrial complex i deficiency, nuclear type 19||transvaginal ultrasound: mass of right fallopian tube (procedure)||random
complete traumatic amputation at level between elbow and wrist, left arm, subsequent encounter||rupture of internal jugular vein (diagnosis)||random
coccomyxa fottii barcyte & nedbalova, 2016||vaccination site haemorrhage||random
2-(4-(aminomethyl)benzylidene)-3-oxo-2h-thiophene-7-carboxylic acid||dentin layer of left upper canine tooth||random
repair right carpal joint, percutaneous endoscopic approach||structure of eleventh costal cartilage||random
ascorhynchus castellioides stock, 1957||visceral steatoses||random
nasal-orbital complex||indocid r oral product||random
neoplastic ependymal cell||structure of male genital system subdivision (body structure)||random
anaemia due to chronic blood loss||nondisplaced fracture of head of unspecified radius||random
metformin extended release oral tablet||feelings of omnipotence||random
creatine blood||sarcoidoses||random
urinary tract infection enterococcal||nervus zygomaticus||random
essian pill||localized adhesions and/or strands of conjunctiva (disorder)||random
bos taurus skin extract 1000 unt/ml injectable solution||fatal; syncope||random
adrenal cortex ab&#x7c;acnc&#x7c;pt&#x7c;anybldserpl||purinoceptor agonists, p2||random
doesn commun with diff people||cisplatin-pembrolizumab-pemetrexed||random
phenobarbitone sodium 60mg tablets (substance)||supplements, visco||random
cytochrome p-450 cyp1a2 inducers||sulindac 200 mg oral tablet [sulindac]||random
posterior recurrent tibial artery||metacognition, function (observable entity)||random
sensorimotor demyelinating neuropathy||staphylococcus aureus toxic shock syndrome toxin 1||random
segmental pulmonary artery||adolescent unwed mother||random
catheter site necrosis||cefotetan||random
cancer of the tonsil||obstetric surgery antepartum fetal surgery||random
transluminal operation on aorta nos||malig melanoma arm||random
superficial tissue massage of calf||urethra cancer recurrent||random
prelaminar branch of right eighth posterior intercostal artery||multilocular cystic nephroma||random
liagora donaldiana||synencephalus||random
factor viii assay, one stage||hednota||random
follicle centre lymphoma, follicular grade i, ii, iii||5oh-methyluracil serpl-scnc||random
influenza virus a ab^1st specimen:prthr:pt:ser:ord||medical and surgical @ gastrointestinal system @ revision @ mesentery @ percutaneous endoscopic @ synthetic substitute||random
sulfacetamide sodium/sulfur@10 %-5 % (w/w)@topical@cream (gram)||cag1 protein, candida albicans||random
unclassified adeloneivaia||engaged in sledding (qualifier value)||random
other aminoglycosides in atc||anidulafungin:susc:pt:isolate:ordqn:gradient strip||random
jasminum officinale flower extract||fluid intake total &#x7c; patient &#x7c; general intake||random
light microscopy, nos||downregulation of oxidoreductase activity||random
transcription, genetic||to what degree did your fatigue interfere with your physical functioning in past 7 days [promis]||random
iodogorgoic acid||leucocytozoon sp. cyte01||random
aromatoleum toluclasticum||niva-fol pill||random
degeneration of thoracolumbar intervertebral disc (diagnosis)||doxorubicin/monoclonal antibody c225||random
second thoracic spinal nerve||unclassified aminobacter||random
diltiazem pill||bupivacaine monohydrochloride, monohydrate||random
somatotropin^45m post dose macimorelin:mcnc:pt:ser:qn:ia||anti-alpha5-beta1 integrin||random
resection of base of medial distal phalanx of fourth toe of left foot (treatment)||open #skull vlt no intracranial injury, unspec state consc||random
anas hep duct/tr jej ins tube||chironomidae sp. bioug30364-b03||random
dispensers||octinoxate 7.5 g in 100 ml / octisalate 4.0 g in 100 ml / oxybenzone 3.0 g in 100 ml topical emulsion [veil fluid makeup ivory spf 15]||random
strain of musc/fasc/tend at shldr/up arm, left arm, subs||late effect of injury to peripheral nerve of shoulder girdle and upper limb||random
cath insert site right radial artery||butalbitalum||random
non-avian gizzard||cecal hemorrhage||random
right glenohumeral joint branch of right anterior circumflex humeral artery||hamamelis virginiana root bark/stem bark||random
dimethicone 0.75 mg in 1 ml / glycerin 12 mg in 1 ml topical cream [purifying oxygenating serum]||rose oil miscell oil (ml)||random
oat cell carcinoma of the esophagus||1-48e breast: manipulations||random
survey.gnhlth||congenital shortening of both achilles tendons||random
tsuga canadensis bark 10 [hp_x] / ammonium bromide 10 [hp_x] / ammonium chloride 10 [hp_x] / semecarpus anacardium juice 10 [hp_x] / antimony trisulfide 10 [hp_x] / silver 10 [hp_x] / oyster shell calcium carbonate, crude 10 [hp_x] / capsicum 10 [hp_x] / cinchona officinalis bark 10 [hp_x] / iron 10 [hp_x] / fucus vesiculosus 10 [hp_x] / strychnos ignatii seed 10 [hp_x] / potassium dichromate 10 [hp_x] / sodium sulfate 10 [hp_x] / nerium oleander leaf 10 [hp_x] / phosphorus 10 [hp_x] / phytolacca americana root 10 [hp_x] / schoenocaulon officinale seed 10 [hp_x] / delphinium staphisagria seed 10 [hp_x] / sulfur 10 [hp_x] / thyroid, unspecified 10 [hp_x] / veratrum album root 10 [hp_x] topical patch [sp6 complete]||ethanolamine oleate 50 mg/ml||random
fentanyl citrate (substance)||medical and surgical @ lower joints @ revision @ sacrococcygeal joint @ percutaneous endoscopic @ internal fixation device||random
silicon dioxide pill||aortograph translumbar normal||random
camptoprosopella sp. bioug32141-e12||skin lesion of dorsal aspect of left thumb||random
distal tendon of right helicis major||aminoglycoside 2'-n-acetyltransferase||random
advanced urethral urothelial carcinoma||stamina decreased||random
stage ib cutaneous melanoma ajcc v7||chronic osteomyelitis of middle finger of left hand (diagnosis)||random
first lumbar spinal nerve||diptera sp. lhsmi376-09||random
hyoscyamin||chlorhexidine / sodium fluoride oral liquid product||random
colorectal tumor suppressor||occupational exposure to covid-19||random
us guide intraop||blood viscosity decreased||random
dolichopodidae sp. bioug20912-f12||ventricular; empyema||random
methadone hydrochloride 40 mg||contraindicated drug combination administered||random
acyloxyacyl hydrolase||rough cocklebur pollen extract 50 mg/ml injectable solution||random
refused by parents of subject (qualifier value)||playing cards or table games||random
hip joint implant||coldtuss-dr, 2 mg-15 mg-6 mg/5 ml oral liquid||random
physical security assessment system details:find:pt:^event:nar||underdosing of unsp hormones and synthetic substitutes, init||random
ovarian hormone||epidermoid cyst of vocal cord (disorder)||random
bladder squamous cell carcinoma stage iv||wbc manual cnt (syn fld) [#/vol]||random
unclassified helicops||activated protein c resistance congenital||random
eupodidae sp. bioug25925-b11||buccal gingival crevice (body structure)||random
other specified rheumatoid arthritis, unspecified wrist||aircraft machine injury - parachutist injured||random
ct scan of pelvis by reconstruction with iv contrast||cntf receptor-related disorders||random
guaifenesin/dextromethorphan hbr@50 mg-5 mg/5 ml@oral@syrup||zanthoxylum bungeanum fruit||random
transplanted heart-lung present (finding)||views ap and lateral||random
ovarian endocrine activity alteration [pe]||allergy to grains||random
flurbiprofen 100mg tab||decreased sense of smell||random
hama questionnaire question||glycogen synthase d phosphatase||random
injury of the thoracic spinal cord (diagnosis)||flexion.active range of motion:angle:to identify measures at a point in time:shoulder.right:quantitative||random
amphetamines [presence] in specimen||hematology discharge summary||random
pseudoephedrine hydrochloride/triprolidine hydrochloride 60 mg-2.5 mg oral tablet [tri-pseudafed]||medical and surgical @ upper arteries @ bypass @ innominate artery @ open @ autologous arterial tissue @ upper arm artery, right||random
exosc2 protein, human||plastic repair procedure (procedure)||random
stricture or kinking of ureter||recurrent dislocation, ankle, foot and toes||random
c peptide 45 min post unsp challenge [mass/vol]||eupatorium capillifolium pollen 0.025 g in 1 ml intradermal solution [dog fennel]||random
camphor (synthetic) 3.10 g in 100 g / menthol 2.60 g in 100 g transdermal patch [tong feng ding pain relief]||carboxyhemoglobin/hemoglobin.total:mfr:pt:bld:qn||random
avobenzone 30 mg in 1 ml / homosalate 20 mg in 1 ml / octinoxate 75 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 50 mg in 1 ml topical cream [kiss my face spf-50 face factor]||calculus||random
janus kinase 2||phoronis sp. 1 as-2015||random
potassium chloride 6 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / sus scrofa lung 8 [hp_x] in 1 ml / mycoplasma pneumoniae 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / haemophilus influenzae type b 16 [hp_x] in 1 ml / streptococcus pneumoniae 16 [hp_x] in 1 ml / oxygen 16 [hp_x] in 1 ml / antimony arsenate 30 [hp_x] in 1 ml / camphor (natural) 30 [hp_x] in 1 ml / chelidonium majus whole 30 [hp_x] in 1 ml / quinine hydrochloride 30 [hp_x] in 1 ml / copper 30 [hp_x] in 1 ml / ipecac 30 [hp_x] in 1 ml / pratia purpurascens 30 [hp_x] in 1 ml / phosphorus 30 [hp_x] in 1 ml / polygala senega root 30 [hp_x] in 1 ml / tin 30 [hp_x] in 1 ml / veratrum viride root 30 [hp_x] in 1 ml oral liquid [lung drainage]||lsd (drug)||random
imaging @ central nervous system @ computerized tomography (ct scan) @ brain @ high osmolar @ unenhanced and enhanced||bradyrhizobium sp. 05los21r6_43||random
patient recall status (finding)||devices weighing||random
sulfamethoxazole and/or trimethoprim poisoning (disorder)||human herpesvirus 8 (organism)||random
downregulation of lipid localisation||captopril product||random
guatteria||history of sustained ventricular fibrillation (situation)||random
grade 3 duodenum obstruction||treat slipped epiphysis||random
venous ectasia||allergenic extracts 10000 pnu/1 ml intradermal injectable [allpyral special mix bulk molds]||random
structure of coronoid process of right mandible (body structure)||resorcinol / sulfur topical product||random
delinquents||x-ray of ankle: osteopenia of tibiotalar joint (procedure)||random
aminoxaphen||occupational therapy vestibular exercises standing with head immobile eyes up and down (treatment)||random
visken pill||neomycin sulfate 3.5 mg in 1 ml / polymyxin b sulfate 10000 [iu] in 1 ml / hydrocortisone 10 mg in 1 ml auricular (otic) solution [neomycin and polymyxin b sulfates and hydrocortisone]||random
dsrad||aspirates||random
probing depth at lingual right lower third molar||estradiol in topical dosage form||random
uteropexy (procedure)||unclassified acrothrix||random
lugano classification stage ii adult lymphoma ajcc v8||powellomyces||random
sporisorium cruentum||cratyna sp. bioug20764-h04||random
laser destruction of vaginal lesion||poisoning by antihyperlipidaemic and antiarteriosclerotic drugs||random
gelidium elegans||mammogram mass #1 of superior medial quadrant of left breast with microcalcifications (procedure)||random
substance abuse and mental health services administration (samhsa) survey||small intestinal ulcer perforation||random
17-ketogenic steroids 48 hr post 500 ug dexamethasone po 2.5 day low dose q6h (24h u) [mass/time]||tolnaftate 10 mg/ml / triclosan 2 mg/ml topical spray [nail md spray]||random
microgastrinae sp. bold:aaa9386||x-ray of foot: extra-articular fracture of medial process of right calcaneus (procedure)||random
injury; birth, spinal cord||toxoplasma infections||random
romanogobio sp. zfmk_ich_52042||ammonium phosphate, dibasic 10 [hp_x] in 59 ml / atropa belladonna 10 [hp_x] in 59 ml / colchicum autumnale bulb 10 [hp_x] in 59 ml / formic acid 10 [hp_x] in 59 ml / fraxinus excelsior bark 10 [hp_x] in 59 ml / fraxinus excelsior leaf 10 [hp_x] in 59 ml / ledum palustre twig 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / urtica urens 10 [hp_x] in 59 ml oral liquid [gout symptom reliever]||random
[x]o sp n-inf diso/lym v+lym n||velphoro, 2500 mg (500 mg elemental iron) oral tablet, chewable||random
synalpheus aff. herricki kmh-2016||liver neopl||random
nicotine - chemical||calcinosis universalis (disorder)||random
muscle biopsy normal||[x]injury of other & unspecif musc & tendons at thigh level||random
fmtestcd||dual coronary orifice (disorder)||random
regular or repetitive complaints of hunger:finding:to identify measures at a point in time:^patient:ordinal:mds||other neonatal hypocalcaemia||random
geriatric depression scale original long form||octinoxate 5424 mg in 110.7 g / octocrylene 3321 mg in 110.7 g / zinc oxide 13.84 g in 110.7 g topical lotion [shiseido extra smooth sun protection n]||random
erythromycin - zinc acetate||cerebral infarction foetal||random
superficial atypical lipomatous tumor||monoplegia; embolic||random
mucosa of surface of tongue (body structure)||fucus ceranoides||random
cytospora abietis||hydatoscia||random
malignant melanoma of leg/hip||alternariaster||random
family history of aneurysm of blood vessel of brain (situation)||premature rupture of membranes affecting fetus or newborn||random
difficulty driving a car||r3601tn||random
alcohol 700 ml in 1000 ml topical gel [dr.s clean advanced hand sanitizer]||licuala parviflora dammer ex becc.||random
pank2, ivs4as, g-t, -1||stylopallene||random
clinical or research facility||surface of right superior articular process proper of second thoracic vertebra||random
chest wall procedures, nec||moderate physical activity.work domain [ipaq]||random
laceration of long flexor muscle, fascia and tendon of thumb at wrist and hand level||toluenediamine (substance)||random
salicylic acid topical lotion||microrna 773a, arabidopsis||random
body function icf code:find:pt:^patient:nom||ophthalmol op procedure note||random
syndactyly, preaxial polydactyly, and sternal deformity||fundic gland||random
ulcers of male genital organs||inherited complement deficiency diseases||random
introduction of anti-inflammatory into respiratory tract, via natural or artificial opening endoscopic||epichloes||random
mathematical sign (attribute)||length of wound of right middle back (physical finding)||random
quinazoline-containing product||endocrinologist||random
benserazide 50 mg and levodopa 200 mg oral capsule||neopl histol type||random
international physical activity questionnaire (ipaq)||tricalcium phosphate 3.3g/sachet powder (equiv to 1.2g/sachet calcium)||random
technique, ablation||toxic pulmonary arterial hypertension||random
ureteric hemorrhage||black sea bass 0.05 g in 1 ml percutaneous solution [black bass]||random
closed manual reduction of articular fracture of interphalangeal joint (procedure)||breast carcinoma metastatic in the bone||random
microrna 1302-3||calcium carbonate pill||random
scheloribatidae sp. bold:ace1665||corallina sp. 2015-sob||random
indurated incision of abdominal wall||chlamyd trachom serotype d ab||random
vilazodone:prthr:pt:ser/plas:ord:screen||chromosomal alterations of group a (disorder)||random
knee patella||medical and surgical @ female reproductive system @ removal @ uterus and cervix @ via natural or artificial opening @ nonautologous tissue substitute||random
breast cancer type 1 susceptibility protein||hmtt-benzamide||random
naftin-mp 1% topical cream||sotalol hydrochloride 40mg tablet||random
erythema of lateral aspect of fourth toe of right foot (physical finding)||set of pelvic splanchnic nerves||random
specify, in general, what you have you ever experienced, witnessed, or otherwise been involved in any events that could have brought serious harm or even death to you or someone else:find:pt:^patient:nom:phenx||melanoma metastatic in the central nervous system||random
camphor/menthol/petrolatum/phenol topical application ointment [blistex lip medex]||decreased range wrist movement||random
mepivacaine hydrochloride 30 mg in 1 ml subcutaneous injection, solution [isocaine]||melanoma; eye||random
colinus cristatus sonnini||nuck canal||random
ataxiagraphs||cystoscopy and lithotripsy of calculus of bladder using laser (procedure)||random
weight loss advised (context-dependent category)||holosystolic heart murmur||random
diphenoxylate hydrochloride 2.5mg, atropine sulfate 0.025mg oral tablet||perceptual disturbance||random
type 2 diabetes mellitus with proliferative diabetic retinopathy||interfering rnas small||random
medical and surgical @ lower arteries @ supplement @ peroneal artery, right @ percutaneous endoscopic @ nonautologous tissue substitute||myocardial imaging infarct avid planar qual/quan||random
displacement therapy of nose, proetz type||extirpation of matter from right tympanic membrane, via natural or artificial opening endoscopic||random
compound, quaternary ammonium||ketorolac tromethamine 5 mg/ml ophthalmic solution [acular]||random
hernia; muscle||full-thickness skin loss due to burn (third degree nos) of face, head, and neck||random
haloniscus sp. 2 sjbc-2008||sjogrens syndrome-a extractable nuclear 60kd ab [titer] in body fluid by immunoassay||random
gdc treatment type terminology||trna aminoacylation for protein translation||random
clot stiffness reduction percent due to fibrinolysis in blood by calculation||malignant blood vessel neoplasm, metastatic||random
fefol||vitamin e hemisuccinate||random
chronic left-sided ulcerative colitis (diagnosis)||methylcellulose oral powder in packet (ea)||random
leptosciarella sp. 9 br-2018||nasal actinobacillosis of sheep (disorder)||random
bacteria identified:presence or identity:to identify measures at a point in time:ulcer:nominal:aerobic culture||occlusion and stenosis of cerebellar arteries||random
medical and surgical @ upper arteries @ replacement @ hand artery, right @ percutaneous endoscopic @ nonautologous tissue substitute @ no qualifier||blood alkalinisation therapy||random
enalapril maleate+diuretic (substance)||hypoplastic metacarpals||random
trichoderma sp. ppri 13819||entire left lobe of liver (body structure)||random
tumor fistulization||2-l-proline-6-l-alaninephysalemin||random
cancer pagurus antigen||sticta||random
cecidomyiidae sp. bioug19703-h10||scenedesmus sp. pj-2012||random
sciences, cognitive||periosteum of proximal epiphysis of middle phalanx of ring finger||random
medical and surgical @ urinary system @ bypass @ ureters, bilateral @ open @ nonautologous tissue substitute||molecular sieving||random
methylobacterium sp. ma1.12||medical and surgical @ tendons @ release @ foot tendon, left @ open @ no device||random
polyarteritis nodosa and allied conditions||probing depth at mesial left upper central incisor||random
pulmonary vascular disorder||burns involving 50-59% of body surface (diagnosis)||random
excision of nodule of larynx||serine-type exopeptidase activity||random
niacinamide 20 mg||tis primary tumor stage finding||random
multisection perfusion^at rest+w adenosine+w tl-201 intravenous:finding:to identify measures at a point in time:chest>heart:document:nm.spect||physics, nuclear||random
peripheral arterial occlusive disease fontaine stage iia||malignant neoplasm of lesser curvature of stomach (diagnosis)||random
covert conditioning||active flexion of cervical spine (physical finding)||random
pathologic joint dislocation||mesenteric abscess||random
hydrogenophaga sp. pg-10||benign epididymal epithelial mesothelioma||random
breast stimulation (procedure)||monofluorophosphate / silicon dioxide oral paste product||random
octinoxate 55 mg in 1 ml / titanium dioxide 27 mg in 1 ml / octisalate 30 mg in 1 ml topical cream [just enough spf 15 tinted moisturizer fair is beautiful]||physician payment rev commission||random
infection of skin of eyelid and periocular region (disorder)||certhiaxis cinnamomeus cearensis (organism)||random
subepidermal nodular fibrosis||diphenhydramine hydrochloride 50 mg/20 ml oral solution [good neighbor pharmacy allergy]||random
monotypic pc dna index mar fc-rto||hypertrophic cardiomyopathy gene mutation panel reagents||random
hexose catabolism||hepatitis c virus genotype panel:-:pt:isolate+ser:-||random
external constriction of unspecified wrist, initial encounter||loss of both lateral eyebrows (physical finding)||random
nitrogen assimilation control protein, e coli||dressing, odor absorbent, hydropolymer@6" x 6"@miscell@bandage||random
patient-initiated spirometric phys/qhp r&i only||leukocyte product issued (procedure)||random
streptococcus sp. tatac-06||guidance for transcatheter placement of stent:find:pt:xxx:doc:{imaging modality}||random
infection neutropenic||fetus or newborn affected by noxious substance transmitted via placenta or breast milk||random
sacro-iliac spondylosis||specific immunoglobulins (product)||random
creatinine^pre dialysis&#x7c;pt&#x7c;ser/plas||tumor necrosis factor receptor fragment (159-178)||random
glasgow coma scale score 9-12, unspecified time||skin of posterior surface of ankle||random
physical rehabilitation and diagnostic audiology @ rehabilitation @ motor treatment @ neurological system - upper back / upper extremity @ motor function||inv-covid-19 vacc (moderna) (pf) inj 7ml||random
plant, edible||ventral ramus of left second thoracic spinal nerve||random
menthol 100 mg/ml / methyl salicylate 150 mg/ml topical cream||output.stool:vrat:1h:lower gi tract:qn||random
upper gastrointestinal series abnormal||inflammatory disorder of breast (disorder)||random
miconazole nitrate 0.0025 mg/mg / zinc oxide 0.15 mg/mg topical ointment||diltzac 360 mg extended release oral capsule||random
genus pichia||polyploidy syndrome, nos||random
systemic arterial trunk||calcium disorder||random
stage ib pancreatic cancer ajcc v6 and v7||nkp80||random
antimicrobial stewardship||childhood nasal cavity carcinoma||random
affinity labeling reagents||moderate midline deviation of maxillary tooth position to left (diagnosis)||random
cyclizine oral tablet [marezine]||mass conditions nec||random
allergenic extract- cockroach, german blatella germanica 20000 [pnu] in 1 ml intradermal injection, solution||deep incision of left breast||random
bupivacaine hcl 0.5 % / epinephrine (as bitartrate) 1:200,000 per 10 ml injection||epitrochlear lymph nodes||random
colletes escalerai noskiewicz||equilenin||random
peloid therapy||eudorylas sp. bioug21845-h05||random
pkd1p1 gene||hearts||random
unclassified spongiibacter||communicating branch of sensory root of left facial nerve with left vagus nerve||random
tropolone||medical and surgical @ lower veins @ occlusion @ foot vein, left||random
furuncles on left lower cheek||product containing precisely isosorbide mononitrate 20 milligram/1 each conventional release oral tablet (clinical drug)||random
malignant renal hypertension||activation of haematopoietic stem cell differentiation||random
drug toxicity prophylaxis||rhus toxicarium leaf||random
exubera inhalant product||isopropanol [mass/mass] in tissue||random
nifurtimox only product||excision, tumor, soft tissue of shoulder area, subfascial (eg, intramuscular); 5 cm or greater||random
rhizoctonia sp. 2-4||osmoglyn oral product||random
encounter for examination of eyes and vision nos||e+m consent||random
product containing only cyclizine and morphine in parenteral dose form (medicinal product form)||closed fracture of phalanx of finger, nos||random
osteotomy of humerus with internal fixation||malignant neoplasm of meckel's diverticulum resectable||random
hla class ii histocompatibility antigen, dq alpha chains||excision of right femoral shaft, perc endo approach||random
octinoxate 40 mg in 1 ml / titanium dioxide 50 mg in 1 ml / zinc oxide 91 mg in 1 ml topical cream [equate ziinc sunscreen ultra broad spectrum]||protoplasmic astrocytoma of brain (disorder)||random
flip test||clematis recta flowering top extract||random
felodipine 2.5 mg oral tablet, extended release [plendil]||anterior branch of lateral cutaneous branch of right subcostal artery||random
acute hemolytic transfs react, unsp incompatibility, subs||vestigial remnant of ovary||random
nat2 polymorphism||promis item bank - smoking - negative health expectancies for all smokers - version 1.0||random
myelofibrosis with myelometaplasia||motor evoked potential||random
home visit est patient||coronary angiography: coronary artery bypass graft insertion site left posterior descending artery (procedure)||random
serosanguineous drainage from wound of left buttock (physical finding)||nerve to first internal intercostal muscle||random
anaesthesia and allied procedures||ostopore del 7410/64 ileobag||random
left sublingual artery||epidermal growth factor receptor gene activation||random
pinanga blume||cystic; kidney||random
bony part of distal metaphysis of first metacarpal bone||aeromonas sp. 603696||random
hyperemesis gravidarum with electrolyte imbalance (diagnosis)||pseudanthias elongatus (franz, 1910)||random
breast cancer male||stenosis of subvalvular region of neoaortic valve||random
hsd17b4, arg106pro||isoforms, rna||random
ultrasonic guidance for endomyocardial biopsy||unclassified toxodon||random
mri knee bone contusion medial femoral condyle lateral||hycleus phaleratus||random
sodium channel, voltage-gated, type ii, alpha 2 protein, human||negative regulation of cytolysis of cells in other organism involved in symbiotic interaction||random
bristow operation for dislocation of shoulder||unclassified euxoa||random
fenofibrate 120mg tab||bionole||random
displaced comminuted fracture of right tibial shaft (diagnosis)||control||random
painful; ejaculation||how many times have you been treated with steroid pills or injections, such as prednisone or solumedrol, for a chest illness [phenx]||random
victim of abusive sexual relationship with partner (finding)||mra shoulder vessels - right wo and w contrast iv||random
procedure on extremity (procedure)||autopsy planned||random
chlorhexidine and chlorobutanol only product||bilateral humero-ulnar synostosis||random
occlusion of left basilic vein with intraluminal device, open approach||mag-200 200 mg oral tablet||random
cryptococcus bhutanensis||fracture femur supracondylar displaced without intracondylar extension||random
north american indian and inuit||osteonecrosis due to previous trauma of unspecified ulna||random
unclassified eocyzicus||fetal or neonatal effect of narcotic transmitted via breast milk (disorder)||random
carbamazepine||pik3ca gene mutation||random
cathepsin g (substance)||ureter endoscopy & treatment||random
tenderness of foot joint||heterotrimeric ikk complex||random
isopto atropine 0.5 % ophthalmic solution||diaphorase; deficiency||random
congenital non bullous ichthyosiform erythroderma||ln resp neoadj therapy ca spec cap prot||random
coastal sedge||nondisp fx of base of 4th mc bone, l hand, 7thd||random
homocysteine methyltransferase (substance)||coleoptera sp. indobiosys-ccdb25606-c10||random
dietary and nutritional issues||axinaea ruiz & pav.||random
drainage of perirenal abscess (procedure)||parvovirus||random
proximal tendon of levator scapulae||prolonged services||random
multisection^wo contrast:finding:to identify measures at a point in time:lower extremity.right>ankle:document:magnetic resonance||microvillus inclusion disease||random
other disorders of skin and subcutaneous tissue, not elsewhere classified||gm2 gangliosidose||random
pineocytomas||medical and surgical @ female reproductive system @ extirpation @ uterus @ open||random
f. tularensis igg qn||ultrafoam sponge collar 100 cm||random
miscarriage of right tubal ectopic pregnancy (disorder)||pericarditis due to histoplasma capsulatum (diagnosis)||random
revision of other device in esophagus, via opening||aortic; peripheral; and visceral artery aneurysms||random
mrna 3'-utr adenylate/uridylate-rich element binding||malignant neoplasm of cervix uteri stage i||random
col||linc02682 gene||random
dimethicone 50 ug in 1 mg topical cream [dimethicone]||visual inattention (extinction)||random
inhibitors, caspase||cocamide||random
pigweed spiny||nyvepria 10 mg/ml prefilled syringe||random
sulfate, sodium dodecyl||anesthetic complication cardiac nos||random
ambrisentan 5 mg oral tablet, film coated [ambrisentan]||atrophy; brain||random
stempellinella sp. bioug20847-e02||refractory anaplastic large cell lymphoma||random
aluminum zirconium tetrachlorohydrex gly 20 g in 100 g topical stick [secret clinical strength shower fresh invisible]||product sterile packaging disrupted||random
atopsyche peravia||plicamycinum||random
allergy to h+/k+-exchanging atpase inhibitor (finding)||esophageal squamous cell carcinoma middle third in situ||random
monocytes+macrophages/100 leukocytes in tissue||decreased cardiac index||random
privacy||transferase inhibitor product||random
calyptrochaeta leptoloma (broth.) h.rob.||phenobarbital 20mg/5ml elixir||random
acidum ascorbicum||tournefortia luzonica||random
paroxetine 30 mg oral tablet||metopirone test normal||random
seamless pipe and tube drawer (occupation)||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / lobelia inflata 3 [hp_x] in 1 ml / lomatium dissectum root 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / sus scrofa lung 6 [hp_x] in 1 ml / comfrey root 6 [hp_x] in 1 ml / aconitum napellus 12 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / bryonia alba root 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / eupatorium perfoliatum flowering top 12 [hp_x] in 1 ml / ferrosoferric phosphate 12 [hp_x] in 1 ml / gelsemium sempervirens root 12 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / potassium carbonate 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml / sodium sulfate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / toxicodendron pubescens leaf 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / sulfur 12 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml oral liquid [infectistat]||random
unclassified halobacteriales||100 spermatozoa||random
atrophy of thigh muscles||clinical pharmacy service||random
abstinent from drug misuse in normal environment||procamide||random
phenazopyridine oral product||hotspot point relief 0.06 % topical gel||random
economic models||alcohol 65.76 ml in 100 ml topical gel [rhino pure]||random
drug addict renotif-hs2a to ho||lateral cutaneous tributary of sixth posterior intercostal vein||random
levothyroxine na 0.15mg tab (synthroid)||parsley||random
austrocoenagrion lyelli (tillyard, 1913)||lepidoptera sp. bold:aaa4693||random
h2a.b variant histone 1||mackerel 0.05 g in 1 ml subcutaneous injection, solution||random
fungal sp. yx-47||fetal and neonatal alloimmune thrombocytopenia||random
body solution||periodontium atrophies||random
methylnaltrexone oral tablet||clear cell adenocarcinoma of ureter||random
normal abg||euzora||random
no active dorsal r rotation||entire ankle joint||random
yin deficiency||eczemin, 1% topical cream||random
wolbachia endosymbiont of fannia serena||sodium benzoate 100 mg/ml / sodium phenylacetate 100 mg/ml injection [ammonul]||random
malignant enterochromaffin cell carcinoid tumor of stomach||chondrocalcinosis due to pyrophosphate crystals, of other specified site (disorder)||random
nci ctep simple disease classification skin neoplasm category terminology||hand tool, device||random
family caprimulgidae (organism)||emergency management plan approver name:identifier:to identify measures at a point in time:^event:nominal||random
breast cancer visceral crisis||mitotic nuclear pore complex disassembly||random
glucarate catabolism||hamilton depression rating scale - 17 item clinical classification test code||random
structural unit, protein||lepidoptera sp. bold:aag5816||random
paramoeba karteshi||paraburkholderia sp. gv072||random
ig variable region||retired procedure (procedure) [6283005]||random
aleiodes sp. bold:aah8757||bacterium ebad36||random
over the past w, are you able to get in and out of bed:find:1w:^patient:ord:haq||membrane proteins, thylakoid||random
intervertebral syndesmosis||clavator eximius||random
imipramine cutoff:mass concentration:to identify measures at a point in time:urine:quantitative:confirm||blastocladiella||random
coronary stent stenosis||release pip joint contracture||random
tuberculosis of vein||suit, gravity||random
kir2dl3 wt allele||reduced heart rate variability||random
cell crystal||troxyl||random
total population of age 30-34 years population||atd5||random
buspirone induced platelet antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:flow cytometry||phosphatase regulator activity||random
trintellix (vortioxetine) 15 mg oral tablet||unclassified niastella||random
negative regulation of myosin ii polymerization||spontaneous abortion with pulmonary embolism||random
lepidoptera sp. bold:aaa0584||magnetic resonance imaging of knee: diffuse chondral thinning of mid region of medial facet of patella||random
fallopian tube prosthesis, natural||delmadinone acetate||random
agri-mectin oral product||unclassified radopholus||random
silver nitrate 6 [hp_c] in 180 / veratrum album root 30 [hp_c] in 180 / arsenic triiodide 30 [hp_c] in 180 / hyoscyamus niger leaf 30 [hp_c] in 180 oral tablet [brightspark]||phenx||random
multisection for abscess^w ga-67 iv:find:pt:xxx:doc:nm.spect||gentianella amarella flower 5 [hp_x] in 30 ml / ulex europaeus flower 5 [hp_x] in 30 ml / larix decidua flowering top 5 [hp_x] in 30 ml / quercus robur flower 5 [hp_x] in 30 ml / olea europaea flower 5 [hp_x] in 30 ml / castanea sativa flower 5 [hp_x] in 30 ml / bromus ramosus flower 5 [hp_x] in 30 ml / activated charcoal 200 [hp_c] in 30 ml oral liquid [the flower remedy get up and go]||random
acid amino acid ligases||ultraviolet light b (uvb) treatment of dorsal aspect of right wrist||random
product containing ethambutol and isoniazid in oral dose form (medicinal product form)||mg(ii) acetate||random
tetrose (substance)||muscarinic acetylcholine receptor signaling pathway involved in negative regulation of heart rate||random
fragrance series (product)||spinal segmental dysfunction||random
cheerleading (history)||flavobacterium sp. t77.09.p.rbt.el.h.kidney.m||random
family caulimoviridae||cyclin i||random
progesterone||penicillium sp. 2nvqb37-3||random
candida albicans dna [presence] by naa with probe detection in positive blood culture||hyperpyrexia; malignant||random
region imaged: breast||puncture of shaft of penis||random
abdominal lymphatic chain||myelitis acute flaccid||random
serum rheumatoid antibody level (procedure)||mucosa-associated lymphoid tissue (malt) lymphoma of breast||random
grk5||ct guidance for aspiration of kidney - right||random
keratodermia blennorrhagica||peg-8 distearate||random
(actinidia deliciosa+carica papaya+mangifera indica+musa spp+persea americana) antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative:multidisk||encounter for antenatal screening for streptococcus b||random
flexible endoscope||dihydroxycholecalciferols||random
camponotus sp. bold:aaa9461||corrosion of third degree of multiple right fingers (nail), including thumb||random
nucleus of origin of right seventh thoracic spinal nerve||cystourethroscopy; with treatment of ureteropelvic junction stricture (eg, balloon dilation, laser, electrocautery, and incision)||random
lymphomatoid papulosis-associated mycosis fungoides (diagnosis)||octopodidae||random
audiometric test normal||acroceuthes||random
blood group antibodies identified in serum or plasma||cribriform carcinoma of nasal cavity||random
alpha-d-galactosidase enzyme oral product||lens, contact, for reading discomfort||random
localized fibrous tumor||cryoglobulin &#x7c; blood &#x7c; chemistry - non-challenge||random
device environmental compatibility issue||my child felt respected in past 7d:find:7d:^patient:ord:promis.parentproxy||random
occlusion; basilar artery||physical examination maneuver related to upper extremity||random
product containing alkylating agent (product)||chest auscultation finding (finding)||random
patient clothing||medical and surgical @ lower joints @ insertion @ sacroiliac joint, left @ percutaneous @ infusion device||random
measles virus 30 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml / influenza a virus 30 [hp_x] in 1 ml / aconitum napellus 15 [hp_x] in 1 ml / antimony potassium tartrate 15 [hp_x] in 1 ml / arnica montana 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria root 15 [hp_x] in 1 ml / atropa belladonna 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / lytta vesicatoria 15 [hp_x] in 1 ml / matricaria chamomilla 15 [hp_x] in 1 ml / gaultheria procumbens top 15 [hp_x] in 1 ml / calcium sulfide 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / toxicodendron pubescens leaf 15 [hp_x] in 1 ml / trifolium pratense flower 15 [hp_x] in 1 ml / goldenseal 6 [hp_x] in 1 ml / influenza b virus 30 [hp_x] in 1 ml oral liquid [viral]||trabecular bone of base of phalanx of little finger||random
tests, limulus||hematological and lymphoid tissue therapeutic procedures||random
julida sp. bold:aam4847||thymopentin||random
medical and surgical @ peripheral nervous system @ supplement @ tibial nerve||monitoring of smoking cessation therapy||random
heavy metal screen on blood||postpartum stress disorder||random
murine experimental organism diagnosis||excision of head of pancreas||random
10-undecynoic acid||ocular surface stem cell transplant rejection||random
finding of protrusion of tongue (finding)||robo3, gln773ter||random
medical and surgical @ eye @ drainage @ lower eyelid, left @ open||accident from diving or jumping into water [swimming pool]||random
concurrent procedures during flexible bronchoscopy of right lung (procedure)||left contact lens base curve 1||random
nasal mucosal hyperemia||ureteric: [colic (& c/o)] or [pain]||random
ethylhexyl stearate||medical and surgical @ lower joints @ revision @ sacrococcygeal joint @ percutaneous endoscopic @ internal fixation device||random
trentepohliaceae sp. kukwa 19443||protein structural element||random
product containing precisely morphine sulfate 20 milligram/1 each prolonged-release oral capsule||ribonucleotide reductase m2 b (tp53 inducible) wt allele||random
subject, healthy||protein initiator methionine removal involved in protein maturation||random
centella asiatica 10 mg in 10 g / neomycin sulfate 3.5 mg in 10 g / hydrocortisone acetate 10 mg in 10 g topical ointment [no-scar oint.]||lower esophageal electrical stimulation system pulse generator||random
body weight:mass:duration of an encounter^first value observed during an interval:^patient:quantitative:measured||chronic pyelitis nos||random
mds v3.0 - rai v1.17.2 - health conditions - np, nq, sp||kiaa0664l1||random
rape fantasy||medical and surgical @ subcutaneous tissue and fascia @ transfer @ subcutaneous tissue and fascia, right foot @ open||random
role relationship component||defibrillators, external, manual||random
chart evaluation by non-healthcare professional (procedure)||refid||random
corticomedullary ratio, decreased||details of prior grafts-operation #4 (treatment)||random
injury of collateral ligament of tarsus||inflammation scan||random
hypericum perforatum 30 [hp_x] in 1 g sublingual tablet [hypericum perforatum]||physicians specializing||random
tamarix parviflora dc.||examination for other specified condition||random
salmonella iiib 47:z52:z35 (organism)||positron emission tomography using methionine c-11 (procedure)||random
pseudallescheria infections||von willebrand disease type 2b (disorder)||random
parribacus||arteriovenous graft haemorrhage||random
skin syndactyly between second and third toes||alcohol, bile||random
closed fracture of phalanx of finger, nos||medical and surgical @ lower veins @ occlusion @ common iliac vein, right @ percutaneous @ intraluminal device||random
myh7 gene familial mut analysis molgen doc (bld/tiss)||psb-12062||random
medicinal enzyme overdose||views for bone density:t score:to identify measures at a point in time:lower extremity.left>femur:quantitative:dxa||random
antigen dependent b cell activation||paraboea xiangguiensis w.b.xu & b.pan, 2017||random
b-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma stage i||advice about tepid sponging||random
bms-707035||dexchlorpheniramine maleate 2 mg/5 ml oral syrup||random
clarke's sign of knee (physical finding)||csf mononuclear cell count increased||random
borrelia burgdorferi immunoglobulin g||anthoxanthum odoratum pollen 10000 [bau] in 1 ml percutaneous solution||random
megakaryocytes normal||middletonia||random
unable to grip||decreased numbers of memory b cells||random
deep tibial lymphatic tree of left leg||norovirus genogroup i ag:prthr:pt:stool:ord||random
avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octisalate 4.5 g in 100 ml / octocrylene 5.5 g in 100 ml / oxybenzone 5 g in 100 ml topical lotion [mary kay suncare sunscreen broad spectrum spf 50]||glycymeris||random
myeloid neoplasms with germline runx1 mutation||sodium bicarbonate 650mg oral tablet||random
selenium radioisotope (substance)||medical and surgical @ muscles @ excision @ perineum muscle @ percutaneous @ no device @ no qualifier||random
deficiency; anemia, 6-pgd||wheel 10 ft (3 m) during 2d assessment period:finding:2 days:^patient:ordinal:care||random
proteinaceous extracellular matrix||hypocoagulable state||random
ascorbic acid/cholecalciferol/copper/cyanocobalamin/folic acid/iron/magnesium/niacin/pyridoxine/riboflavin/thiamine/vitamin a/vitamin e/zinc 160 mg-400 iu-1 mg-30 mcg-1250 mcg-75 mg-30 mg-20 mg-20 mg-4 mg-4 mg-2100 iu-40 iu-20 mg oral tablet [active fe]||congenital failure of cleavage, nos||random
klebsiella oxytoca deoxyribonucleic acid:presence or threshold:to identify measures at a point in time:whole blood.pos growth:ordinal:probe.amp.tar||cribriform fascia of saphenous opening||random
contraceptives, oral||desipramine ur-scnc||random
organ component of soleus||stem cells, pluripotent||random
cultivated mushroom 0.05 g in 1 ml intradermal injection, solution||talipes planovalgus||random
avobenzone 0.03 g in 1 ml / homosalate 0.1 g in 1 ml / octocrylene 0.08 g in 1 ml topical lotion [lbel defense total broad spectrum spf 50 plus sunscreen for face and body]||ferrous fumarate-containing product||random
percutaneous transluminal removal of foreign body from heart||gemcitabine hydrochloride 1 g intravenous injection, powder, lyophilized, for solution [gemcitabine]||random
failure heart signs symptoms||psychiatric somatotherapy||random
careless weed pollen extract injectable product||revisional fusion of joint (procedure)||random
unclassified spirulina||child examination.: hearing (procedure)||random
renal tubular necrosis||sporotrichum roseum||random
yuckysy4 cpd||early intrauterine fetal death||random
unclassified acidiphilium||secondary syphilitic periostitis (disorder)||random
dhb2i cpd||firvanq 25mg/ml powder for solution kit||random
dilutional coagulopathy||product containing only cinacalcet (medicinal product)||random
complications of labor and delivery nos, unspecified||other joint derangement, nec, involving unspecified site in mdr24_0||random
head injury nos (disorder)||salipaludibacillus||random
methoxsalen (product)||epilepsy; convulsions||random
poc5 centriolar protein||delivery; delayed||random
pituitary abscess (diagnosis)||bronchoalveolar lavage abnormal||random
renal failure aggravated||california encephalitis virus antibody:dilution factor (titer):to identify measures at a point in time:serum:quantitative||random
gonocephalus (organism)||pulse oximetry monitoring (regime/therapy)||random
pyrolaceae||late effects of intracerebral hemorrhage||random
edema of sclera (finding)||solidago virgaurea flowering top 3 [hp_x] in 1 ml / baptisia tinctoria root 4 [hp_x] in 1 ml / berberis vulgaris root bark 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / lytta vesicatoria 6 [hp_x] in 1 ml / capsicum 6 [hp_x] in 1 ml / cupric sulfate 6 [hp_x] in 1 ml / chondrodendron tomentosum root 6 [hp_x] in 1 ml / smilax regelii root 6 [hp_x] in 1 ml / turpentine oil 6 [hp_x] in 1 ml / apis mellifera venom 8 [hp_x] in 1 ml / agathosma betulina leaf 8 [hp_x] in 1 ml / mercuric chloride 8 [hp_x] in 1 ml / sus scrofa renal pelvis 8 [hp_x] in 1 ml / sus scrofa ureter 8 [hp_x] in 1 ml / sus scrofa urethra 8 [hp_x] in 1 ml / sus scrofa urinary bladder 8 [hp_x] in 1 ml / glyoxal trimer dihydrate 10 [hp_x] in 1 ml / calcium sulfide 10 [hp_x] in 1 ml / sodium pyruvate 10 [hp_x] in 1 ml / quercetin 10 [hp_x] in 1 ml / escherichia coli 15 [hp_x] in 1 ml / shigella dysenteriae 30 [hp_c] in 1 ml oral liquid [detox ii]||random
craniodiaphyseal dysplasia, autosomal dominant (disorder)||spontaneous haemorrhage, nos||random
other helicopter accident injuring occupant, subs encntr||other specified symptoms involving abdomen and pelvis||random
ultrasound guided biopsy of peritoneum||diphenhydramine hydrochloride 25 mg oral tablet, chewable [sleep aid]||random
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) wt allele||congenital meatal stenosis of penis||random
flaxseed whole||fluid balance therapy||random
sars-cov-2 (covid-19) rna naa+probe ql (oropharyngeal wash)||stained specimen||random
anterior colporrhaphy, repair of cystocele with or without repair of urethrocele||measure of abdomen (observable entity)||random
efavirenz in oral dosage form||cardiac muscle biopsy showed iron deposits (procedure)||random
afp interp amn-imp||intracranial procedure||random
gen cnv epil w intr epil||antibiotic x 5108||random
benign neoplasm of apex of urinary bladder (disorder)||zinc oxide 15 g in 100 g topical spray [trader joes zinc oxide mineral sunscreen spf 30]||random
le-like drug eruption||stage i precursor t-lymphoblastic lymphoma/leukemia||random
kitasatospora sp. isom306_otu1433||other postpartum phlebitis and thrombosis||random
non-amnestic alzheimer disease (disorder)||metathelazia multipapillata (organism)||random
clovers||exostectomy of toe fourth left distal phalanx||random
maternal care for (suspected) central nervous system malformation in fetus, fetus 4||managing dietary regime||random
benefit||gbe1, trp548ter||random
necrotizing otitis externa (diagnosis)||pathologic fracture of thumb of left hand||random
neck of proximal phalanx of little finger (body structure)||acaphyllisa sp. 18sr18||random
neuritis; herniation, nucleus pulposus, lumbosacral (etiology)||unclassified diamesa||random
octinoxate 60 mg in 1 ml / titanium dioxide 20 mg in 1 ml topical cream [burberry fresh glow b.b. luminous skin perfecting beauty balm sunscreen broad spectrum spf 20 dark 03]||chlorpheniramine maleate 4 mg||random
norovirus genogroup i+ii orf1-orf2 junction region naa+probe ql (stl)||medical and surgical @ heart and great vessels @ repair @ atrial septum @ open @ no device @ no qualifier||random
contraction (finding)||reference id||random
aluminum magnesium silicate / magnesium hydroxide / simethicone pill||catheter dislodgment||random
action status unknown||ph:log substance concentration:to identify measures at a point in time:synovial fluid (joint fluid):quantitative||random
finding related to general body function (finding)||afferent pathways||random
red light eye reflex decreased||multiple osteochondromas||random
down-regulation of dna metabolic process||calculus analysis nos (procedure)||random
gordialycus||blood methanol measurement||random
suture of wound, primary||sterile potassium chloride concentrate 15% njection solution 10ml ampoule||random
purine deoxyribonucleoside monophosphate catabolism||aph (& [abruptio placentae] and [placenta praevia]) (disorder)||random
carbon oxygen lyase||dissolve (transformation)||random
neuritis; infectious||viral uveitis||random
aeromonas infections||familial chordoma||random
tadocizumab||fracture, delayed healing||random
ferraplus pill||vertigo paroxysmal benign||random
7q deletion||articular cartilage of scaphoid facet of trapezoid||random
tesamorelin acetate@1 mg@subcut@vial (ea)||quadruplet gestation placenta status (diagnosis)||random
lumbar puncture abnormal||ofloxacin 200 mg oral tablet, coated [ofloxacin]||random
lip and oral cavity cancer pathologic distant metastasis tnm finding v6||malignant neoplasm of hilus (of lung)||random
anaphylaxis caused by shellfish||alcohol 670 mg in 1 ml topical liquid [touchland power mist moisturizing hand sanitizer neutral scented]||random
melanocortin receptor 3||[x]other placental disorders||random
calcium polycarbophil 625mg tab,chewable||medical and surgical @ gastrointestinal system @ drainage @ ileum @ percutaneous @ drainage device @ no qualifier||random
other diseases of lung (disorder)||calcium sodium phosphate||random
oestradiol normal||kidney injury, acute||random
lentiviruses, equine||css09-most lethal attempt damage||random
familial chondrocalcinosis, left shoulder||5-bromo-2-ethoxybenzamide||random
wood sawyer||staphylococcal infection, unspecified site||random
croton pallidulus baill.||scrupus||random
surface of middle phalanx of second toe||unable to walk on narrow line||random
malignant spindle-shaped smooth muscle cell||unclassified trilacuna||random
snhg20 gene||cushingoid, ctcae||random
hypomyces perniciosus allergenic extract injectable solution||transient arthropathy involving multiple sites||random
final route and method of delivery [us standard certificate of live birth]||aortic arch anomalies nos||random
pseudoephedrine / triprolidine oral tablet [actifed]||magnetic resonance imaging of upper limb (procedure)||random
thyrotropin^45m post dose trh iv:mcnc:pt:ser/plas:qn||periungual skin of finger (body structure)||random
fracture head radial||lepidostoma doligung||random
polychaeta sp. ksa_1593||cocamidopropylbetaine (in water)||random
nerve palsy obturator||open fracture subluxation of the wrist||random
malignant neoplasm of cervix uteri stage i||cirrhosis; alcoholic||random
exposure to electric transmission lines||spectacle fit & dispense||random
product containing elosulfase alfa||phenoperidine hydrochloride 2mg/2ml injection||random
k(2)so(4)||weight of dust collected [mass] [phenx]||random
lateral cutaneous branch of ventral branch of right fourth lumbar artery||levetiracetam induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc)||random
surgeries, metabolic||melanocytic naevus of face||random
i have numbness in my legs in the past 7d:finding:7 days:^patient:ordinal:facit||topiramate-containing product in oral dose form||random
charcot's joint hand right||[x]fail/rej oth trnspl org/tis||random
foraminiferida||acute renal failure after childbirth||random
pul01||pigweed antibody.immunoglobulin g||random
acquired colloid milium (disorder)||influenza a virus (h1n1) antigen / influenza a virus (h3n2) antigen / influenza b virus antigen prefilled syringe [afluria quadrivalent 2020-2021]||random
[x]other forms of paracoccidioidomycosis||cd16+ cd56+ cells per 100 cells in body fluid (lab test)||random
paraneoplastic encephalomyelitis (disorder)||benproperine oral product||random
hydrochloride, naphazoline||delay flap/sectioning flap scalp arms/legs||random
coryphoideae||pharomachrus pavoninus||random
isoproterenol hydrochloride 1:5000mg injection||unclassified galerucinae||random
unclassified paralobesia||tooth; rotation||random
cementogenesis, function (observable entity)||right radial blood vessel rupture||random
cecidomyiidae sp. bioug14678-a09||seminal vesiculitis (disorder)||random
subcostal recession (finding)||lepidoptera sp. bold:aae5794||random
bartonella henselae dna:prthr:pt:xxx:ord:probe.amp.tar||fgfr3, lys650gln||random
dregeoside e||ambidexter||random
denosumab therapy (procedure)||encephalitis seen on mri||random
tritirachiomycetes||aspergillus niger ab.igg:prthr:pt:ser:ord||random
slow fetal growth or malnutrition (diagnosis)||infection, fusarium||random
reducing-body myopathy||chironomidae sp. bioug25004-c07||random
medically prescribed prolongation of labelled treatment duration||hiv 1 ab:prthr:pt:ser^donor:ord||random
otoacoustic emissions test abnormal||product containing only celiprolol hydrochloride 200 mg/1 each oral tablet (clinical drug)||random
tenderness on palpation of lateral one-third of both clavicles (physical finding)||vph1||random
vpb||lygus sp. bioug22657-h01||random
atrioventricular valve annulus||screening and diagnostic method for aod use||random
unclassified tectocepheidae||mucociliary clearance defect||random
other open skull fracture without mention of intracranial injury, with moderate [1-24 hours] loss of consciousness||oxtriphylline tablets||random
corrosion of second degree of left palm||product containing inebilizumab (medicinal product)||random
oth degeneratve disor/globe||carboxypeptidase b2, plasma, mouse||random
medical and surgical @ skin and breast @ replacement @ skin, left foot @ external @ synthetic substitute||infectious agent antigen detection by immunofluorescent technique; adenovirus||random
small hcc||mifepristone oral product||random
agif||benzenesulfonamide, 4-amino-n-((butylamino)carbonyl)-||random
angina due to type 2 diabetes mellitus||regulation of lateral plate mesodermal cell fate determination||random
2-hydroxycaproate/creat ur-srto||adenylyltransferase, nicotinamide-nucleotide||random
sympt/complaint;muscle(s)||subd.h'ge+open i/c+no loc||random
(s)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7] indolizino[1,2-b] quinoline-3,14-(4h,12h)-dione monohydrochloride||sterol regulatory element binding protein 002||random
zinc finger and scan domain containing 31||areopaguristes cf. jousseaumei mb-a066415||random
sweat discoloration||cecidomyiidae sp. bold:acb2383||random
clear cell adenocarcinoma of ovary||malignant neoplasm of bladder, part unspecified stage iii||random
normiflo injectable product||measured quantity of intake of bioactive substance (observable entity)||random
proximal ureteral laceration on the left||bacteria identified:prid:pt:amnio fld:nom:anaerobic culture||random
alcohol 11.08 ml in 1 ml / lactic acid, unspecified form 17.6 mg in 1 ml / benzoic acid 1.5 mg in 1 ml / salicylic acid 1 mg in 1 ml auricular (otic) liquid [ear cleansing]||bellis perennis 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / trifolium pratense flower 3 [hp_x] in 1 ml / phytolacca americana root 4 [hp_x] in 1 ml / arnica montana 12 [hp_x] in 1 ml / cairina moschata heart/liver autolysate 12 [hp_x] in 1 ml / calcium iodide 12 [hp_x] in 1 ml / potassium chloride 12 [hp_x] in 1 ml / nitric acid 12 [hp_x] in 1 ml / phosphoric acid 12 [hp_x] in 1 ml / sulfur iodide 12 [hp_x] in 1 ml oral liquid [elimitone]||random
gastrointestinal cancers - liver||trexall, 10 mg oral tablet||random
entomobryidae sp. bioug16745-d10||5'-o-(l-valyl)-5-fluorouridine hydrochloride||random
alpha proteobacterium d0-pb-f01||superficial injury of thigh||random
accident occurred at home (history)||medical and surgical @ subcutaneous tissue and fascia @ revision @ subcutaneous tissue and fascia, lower extremity @ open @ other device||random
pleurisy with effusion, with mention of a bacterial cause other than tuberculosis||repair of epispadias using onlay patch (procedure)||random
thyroid binding globulin increased||cyp21p||random
auricular branch of left posterior auricular artery||cpsq5, formerly||random
chest pain on exertion (finding)||dorsal nail plate of finger||random
prutect top emulsion||ae-acacia, dealbata, pollen||random
guidance for removal of foreign body:finding:to identify measures at a point in time:not specified>vessel:document:radiofluoroscopy.angio||unclassified diadema||random
entire extensor compartment of thigh||medical and surgical @ skin and breast @ replacement @ skin, face @ external @ nonautologous tissue substitute @ partial thickness||random
other pregnancy complication unspecified (disorder)||lower leg right||random
subdural abscess of brain, any part||neoplasm of uncertain behavior of tonsil (disorder)||random
book prices||medical and surgical @ subcutaneous tissue and fascia @ alteration @ subcutaneous tissue and fascia, right neck @ open||random
down regulation of hematopoietic progenitor cell differentiation||prominent and arched upper lip||random
neanuridae sp. bioug19505-c10||trimipramine-containing product in oral dose form||random
amylase plr-ccnc||seq inj,not spec by bod reg||random
bone disorders nec||medical and surgical @ respiratory system @ excision @ lingula bronchus @ open @ no device||random
base curve 1:length:to identify measures at a point in time:contact lens.left:quantitative||acute leukemia not otherwise specified||random
lactifluus dinghuensis||lifted mechanically:find:pt:^patient:ord:mds||random
speaking:finding:to identify measures at a point in time:^patient:ordinal:rfc assessment||hla-drb345 unreslvd donr high res||random
gjb1 gene mutation analysis limited to known familial mutations &#x7c; blood or tissue &#x7c; mutations||nucleated rbc/100 wbc (bld) [ratio]||random
isoprostane||infection by metagonimus yokogawai||random
deep intracranial venous system||displaced transverse fracture of shaft of unspecified radius, subsequent encounter for closed fracture with malunion||random
acetaminophen / promethazine||puncture of posterior neck (physical finding)||random
fungal endophyte sp. ap691||excision of lesion of trachea||random
proline [moles/vol]||secondary syphilis of tonsils (diagnosis)||random
endometritis complicating the pregnancy||reported trauma to head||random
ent services ears||central nervous system depression||random
glucan 1,3-beta-glucosidase (substance)||sciaridae sp. bioug20883-h06||random
suture of ligament of upper extremity||l-argininamide, n-benzoyl-l-isoleucyl-l-alpha-glutamylglycyl-n-(4-nitrophenyl)-, monohydrochloride||random
polyurethane foam (substance)||ptca saphenous vein graft #3 gradient postprocedural (treatment)||random
disease of digestive system abscess||linezolid 1 kg in 1 kg not applicable powder||random
achromobacter cycloclastes (organism)||aluminum sesquichlorohydrate 24 g in 100 g topical aerosol, spray [antiperspirant above teen boy]||random
ivd test reagent/kits, molecular assay, gene anomaly, mutation, raf1||penile paget disease||random
abdominal wall muscle||3,3,3-trifluoro-2-methyl-dl-alanine||random
vwf cp act/nor ppp ia||lidocaine 50 mg/ml / menthol 30 mg/ml [lexifen]||random
coxiella burnetii; endocarditis (etiology)||3-benzyl-1-(dimethylaminomethyl)-3,4,5,9-tetranaphtho(2-1b)(2-1h)-furanone||random
diazepam measurement (procedure)||antiparkinsonians||random
fungus on microscopy (finding)||lentil allergenic extract 0.05 gm/ml injectable solution||random
ulnar nerve lesion [ambiguous]||skin neoplasm nose of uncertain behavior||random
entire left hip joint||view ap for scoliosis^w standing + w r-bending:find:pt:chest>spine.thoracic & abdomen>spine.lumbar:doc:xr||random
therapeutic hyperthermia||endocrinologist review||random
erythromycin stearate (substance)||inhibition of cellular catabolic process||random
apgar score component||chlamydia trachomatis c antibody.immunoglobulin a:presence or threshold:to identify measures at a point in time:serum:ordinal||random
picochlorum sp. rcc748||chaetonotus aff. daphnes 2 mk-2019||random
eye movement data analysis||glucose [interpretation] in serum or plasma--1 hour post dose glucose||random
erosion cervix||analysis of emergency department visits||random
structural barrier.other specified||cytochromes c2||random
solvent recycling units||product manufactured as ocular dosage form (product)||random
implant site thrombosis||fibreop destr les bel trachea||random
stemphylium sp. fa-8j||ficinia schrad., 1832||random
todiramphus veneratus (organism)||zinc oxide 200 mg in 1 g topical cream [chae organics safe4u sunscreen broad spectrum spf 30 natural mineral sunscreen]||random
circaea mollis siebold & zucc.||vagina tendinum musculorum abductoris longi et extensoris pollicis brevis||random
amiloride||glyptelasma||random
triethylhexanoin||able to engage in a hobby||random
white carrot||detection of bacteria procedure||random
general qualifier||hypoplectrus sp. 209284||random
aneurysm of conjunctiva (disorder)||r parkeri igm titr fld if||random
chlamydomona||manipulation of wrist joint under anaesthetic||random
basidiomycota incertae sedis||streptomyces aurantiacus (rossi doria 1891) waksman 1953 (approved lists 1980) emend. lanoot et al. 2002||random
insulin pump||encephalitis toxic acute||random
virus dna infections||klebsiella species||random
neopl rad ind||abcb4 gene targeted mutation analysis||random
agenesis; brain, part of||medical and surgical @ heart and great vessels @ bypass @ coronary artery, two arteries @ open @ autologous venous tissue||random
tumor of skin with apocrine differentiation||venipuncture site bruise||random
leopard fundus||closure of ileal fistula||random
drri1-o: go to family when need advice||repair of ascending aorta||random
congenital abnormal fusion of ischium||anti-rejection therapy||random
multisection^wo & w contrast intravenous:finding:to identify measures at a point in time:abdomen>retroperitoneum:document:computed tomography||bone pain in foot||random
maternal care for known or suspected disproportion||human papilloma virus 16 deoxyribonucleic acid||random
total lumbar corpectomy with decompression of spinal cord, nerve roots and cauda equina by transperitoneal approach||skin moisture barrier dressing kit||random
incomitant hypophoria||toileting ability||random
aleyrodidae sp. bioug31092-a02||unclassified leptoceridae||random
mouse salivary gland neoplasms||20 ml ms 25 mg/ml injection||random
chlorhexidine diacetate 0.5 mg/ml topical spray [septi-soothe]||bullous corneal epithelial oedema||random
gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq. in., without adhesive border, each dressing||disciform macular degeneration||random
bacterium hjq-4||acochlidia||random
crassula hemisphaerica||abrasions or bruises||random
low expression||resorcinol 20 % / sulfur 30 % topical paste||random
helium 20%/oxygen 80% gas||ovarian germ cell polyembryoma stage iii||random
pontocyprididae sp. 26-3 amge-2015||commicarpus parviflorus thulin, 1990||random
natal multimammate mouse||meprobamate (medication)||random
simethicone 125 mg oral tablet||insect venom caus toxic effect||random
fold, ig||product containing calcium carbonate and kaolin (medicinal product)||random
lettuce whole allergenic extract injectable product||ace inhibitor prophylaxis||random
aluminum chloride topical solution [hemox a]||tachyarrhythmia (disorder)||random
[d]bony lytic lesions on x-ray||upper dentures currently being worn (history)||random
toenail scraping (lab test)||norlaudanosoline||random
salicylic acid 2 ml in 100 ml topical liquid [acne solutions cleansing foam]||lower limb arterial thrombosis||random
patient has need for adapted eating utensils (physical finding)||part stomach||random
florfenicol-containing product||salicylic acid topical application lotion||random
referral for psychiatric aftercare in halfway house||lichen condition||random
old laceration of muscles of pelvic floor||pulse volume - full||random
respiratory failure; insufficiency; arrest||labrenzia sp. hden17||random
thelymitra||nocardia sp. ec52||random
cellular response to ionomycin||beilschmiedia||random
recurrent plasma cell neoplasm||wound infiltration of local anaesthetic||random
allergy to dipivefrin||unclassified leptodontidium||random
8-hydroxy amoxapine||does not repair conversation||random
igm.intrathecally synthesized/igm.total in cerebral spinal fluid||ribosomal||random
11-hydroxy-15-oxokaur-16-en-19-olic acid||antipathes subpinnata ellis & solander, 1786||random
venom, spider||vl 2397||random
prothrombin antibody.immunoglobulin m:arbitrary concentration:to identify measures at a point in time:serum/plasma:quantitative||entire ureter (body structure)||random
septicaemia due to serratia||complement factor nos decreased||random
leucanthemella tzvelev, 1961||bilat ing hernia w gang||random
wheeze absent (finding)||pseudobombax||random
skeleton diagnostic radiopharmaceuticals||artonitidin b||random
arunta interclusa||lateral branch of dorsal branch of left seventh posterior intercostal artery||random
bony part of arch of eighth thoracic vertebra||cerebrospinal fluid tests (excluding microbiology)||random
frostbite of foot (diagnosis)||hydrogen peroxide 200 mg/ml topical cream||random
lidocaine hcl/epinephrine bit 20 mg/ml (2 %)-1:50,000 injection cartridge (ml)||cytokine production||random
sebaceous cell carcinoma of the rat skin||iodine 123 (i123) uptake study of thyroid||random
pyrginae||antibody-dependent cellular cytotoxicity, function||random
employer alcohol or other drugs policy||serum immunofluorescence epstein barr virus capsid antibody||random
1st deg burn arm nos||meat white||random
macaque stool associated virus 12||lacrimal apparatus structure||random
petrolatum 490 mg/ml / zinc oxide 150 mg/ml topical cream||lec-5 standard version - assault with a weapon: witnessed||random
unsp fx low end r femr, 7the||culprit lesion of coronary artery||random
bacteria identified:prid:pt:nph:nom:aerobic culture||increased range of cervical spine movement (finding)||random
delayed union of greenstick fracture (morphologic abnormality)||hemangioendothelioma, benign||random
division of musculoskeletal system (procedure)||naloxone hydrochloride dihydrate||random
product containing precisely amiodarone hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug)||cells, mechanoreceptor||random
flj20716||twin sibling (person)||random
structure of sinus venosus of sclera||phaeococcomyces aff. nigricans p40d010||random
product containing only amlodipine 10 mg and atorvastatin 40 mg/1 each oral tablet||cecidomyiidae sp. bioug15340-a12||random
alcohol production process||intubation (note)||random
coma scale abnormal||family paenibacillaceae||random
blood osmolarity increased||ailanthus altissima flowering twig 12 [hp_c] in 40 ml / strychnos nux-vomica seed 12 [hp_c] in 40 ml / chamomile 12 [hp_c] in 40 ml / potassium phosphate, dibasic 6 [hp_x] in 40 ml / magnesium phosphate, dibasic trihydrate 6 [hp_x] in 40 ml oral tincture [headache soothe]||random
canis lupus familiaris hair 0.00008 g in 1 ml / dermatophagoides farinae 16 [au] in 1 ml / aspergillus fumigatus 0.002 g in 1 ml / dermatophagoides pteronyssinus 16 [au] in 1 ml / fusarium oxysporum 0.002 g in 1 ml / phoma destructiva 0.002 g in 1 ml / periplaneta americana 0.00008 g in 1 ml / cochliobolus sativus 0.00008 g in 1 ml / cladosporium cladosporioides 0.00008 g in 1 ml / penicillium chrysogenum var. chrysogenum 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.01 g in 1 ml / ustilago nuda hordei 0.0005 g in 1 ml / ustilago maydis 0.0005 g in 1 ml / ustilago avenae 0.0005 g in 1 ml / ustilago tritici 0.0005 g in 1 ml / gallus gallus feather 0.0000266 g in 1 ml / anas platyrhynchos feather 0.0000266 g in 1 ml / anser anser feather 0.00000266 g in 1 ml subcutaneous injection, solution||unclassified siculodinae||random
sufentanil pill||pediococcus pentosaceus (organism)||random
methanesulfonothioic acid s,s'-1,5-pentanediyl ester||unclassified cladorrhinum||random
parodontoses||multisection^wo & w contrast intrathecal:finding:to identify measures at a point in time:chest>spine.thoracic:document:computed tomography||random
unclassified weissella||blood lactate dehydrogenase||random
homosalate 7 g in 100 g / octinoxate 2.5 g in 100 g / oxybenzone 2.0 g in 100 g / titanium dioxide 4.1 g in 100 g topical cream [cc cream broad spectrum spf 30 merle norman]||event activation or deactivation||random
inon ace solution oral product||female genitalia observations||random
flammulina velutipes isometric virus||ulcer of axilla with skin loss (physical finding)||random
carnitine acyltransferases||path report.gross spec||random
clostridia bacterium 62_21||chaetomium umbonatum||random
panacagrimonas sp.||injection of steroid into posterior segment of eye (procedure)||random
cmv colitis recurrent||disease (or disorder); low back||random
sertraline hydrochloride (substance)||bacillus sp. em13||random
thrombolysis of cerebral artery by intravenous infusion (procedure)||remove spine lamina >2 crvcl||random
benign neoplasm of autonomic nerve of right orbit||subcutaneous tissue of plantar surface of fifth toe||random
abrasions||deutoleon navas, 1927||random
cdkn2a+cdk4 gene targeted mutation analysis &#x7c; blood or tissue &#x7c; mutations||wheezing inspiratory on right medially posteriorly||random
viral strain||parastizocera||random
halorubrum sp. 6||unclassified mesochorus||random
tafenoquine oral product||anemias hemolytic mechanical factor||random
microscopic observation:prid:pt:stool:nom:ova and parasite preparation||(views 2) + (view tunnel^w standing):find:pt:lower extremity.left>knee:doc:xr||random
cetirizine hydrochloride 10 mg oral capsule, liquid filled [good sense all day allergy]||embolism; puerperal, fat||random
limnophyes sp. bioug22314-a01||strongly disagree||random
thorius minutissimus||albumen||random
hydroxyprogesterone caproate (usp) 250 mg/ml injection [makena]||vaginal hysterectomy with enterocele repair||random
captopril tablets||views perfusion^at rest+w adenosine+w radionuclide iv:find:pt:chest>heart:doc:nm||random
sleep-cycle issues set||salvax 60 mg/ml topical foam||random
niphargus gabrovceci||zinnimidine||random
a.retinae; thrombosis||octinoxate 75 mg in 1 ml / octocrylene 15 mg in 1 ml / octisalate 50 mg in 1 ml / homosalate 90 mg in 1 ml / avobenzone 20 mg in 1 ml / oxybenzone 50 mg in 1 ml topical lotion [fruit of the earth block up sport spf 50 sunscreen]||random
computed tomography of abdomen, pelvis and left lower limb with contrast||lorbrena 25 mg oral tablet||random
duramorph 10 mg per 10 ml injection||n-2-cyanoethylamphetamine||random
clinodactyly||nondisp suprcndl fx w intrcndl extn low end unsp femr, 7thp||random
1-nitroso-3-pyrrolidinol||rectosigmoidectomy altemeier operation, perineal rectal pull-through||random
ass1 gene targeted mutation analysis||titanium dioxide 57.6 mg in 1 ml / zinc oxide 29.4 mg in 1 ml topical cream [super bb beauty balm cream spf 30]||random
muscle fasciculus of sartorius||hospital course narrative||random
lymphocytes (body fld) [#/vol]||unspecified injury of left thigh, initial encounter||random
removal of brace||plotosus lineatus complex sp. type02||random
product containing only amitriptyline and chlordiazepoxide (medicinal product)||medical and surgical @ respiratory system @ destruction @ upper lung lobe, right||random
bacillus sp. c-d-tsa11||acquired immunodeficiency syndrome (aids) carrier (finding)||random
dermoid cyst of brain (disorder)||miconazole nitrate 200 mg vaginal suppository [vagistat 3]||random
increased levels sodium||human coronavirus oc43 ag [presence] in specimen by immunofluorescence||random
afterbrain||near-total pancreatectomy with preservation of duodenum||random
internalid||acantholichen sorediatus||random
lamm syndrome||bicuspid; aortic valve||random
nonketotic hyperglycemic-hyperosmolar coma||chancre on right second toe||random
marsupialisation of pilonidal sinus||hyalella||random
cadmium (specimen) [mass/vol]||albinism, partial||random
perineum skin lesion condyloma||macrodantin 100mg capsule||random
oedema of right lower limb||emtricitabine 200 mg||random
cottopsis gulosus||guaifenesin / phenylephrine / phenylpropanolamine||random
does comprehend language (finding)||interlobular stroma of liver||random
xyleninae||amlodipine-telmisartan 10 mg-80 mg oral tablet||random
repair of nasolabial flaps||ivd test reagent/kits, molecular assay, gene anomaly, mutation, ush2a||random
thoracic basivertebral vein||erythroplakia of tongue||random
apis mellifera 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / sodium borate 10 [hp_x] in 59 ml / capsicum 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / peppermint 10 [hp_x] in 59 ml / daphne mezereum bark 10 [hp_x] in 59 ml / sodium chloride 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / paraffin 10 [hp_x] in 59 ml / ranunculus bulbosus 10 [hp_x] in 59 ml / toxicodendron pubescens leaf 10 [hp_x] in 59 ml oral liquid [viratrol herpes symptom relief]||ostomy belt, device (physical object)||random
drospirenone-estetrol 3 mg-14.2 mg oral tablet||glycolate 0.7 mg/mg [fluoro/gly]||random
chloramphenicol 250mg oral capsule||neophylax acutus||random
ulcers, wounds and skin problems:find:pt:^patient:nom:cms assessment||monotypic plasma cell dna index fc (bm) [ratio]||random
c peptide^45m post dose glucose:mcnc:pt:ser/plas:qn||hematological analyses nec||random
lung graft inflation problem||x-ray;facial bone(s)||random
allograft for temporary wound closure of genitalia (treatment)||syndrome; vasovagal||random
pharm schools||antral carcinoma||random
medical and surgical @ heart and great vessels @ extirpation @ coronary artery, three arteries @ percutaneous endoscopic @ no device||aglantha||random
fibrodontia||brucella abortus antibody:presence or threshold:to identify measures at a point in time:whey:ordinal:agglutination.ring test||random
delphinus||excision lesion of middle ear||random
dislocation of tooth, initial encounter||interpersonal relationship knowledge family [omaha]||random
tobramycin:mcnc:pt:csf:qn||valine [mass/volume] in urine||random
725 metal moulders and coremakers||2',3'-dideoxycytidine monophosphate||random
nep negative||stathmopodidae||random
hypsipetes moheliensis (benson, 1960)||group teaching||random
myocardial mass||when my child was in pain he or she avoided using the part of his or her body that hurt in past 7 days [promis.parentproxy]||random
herpesvirus 2 gamma ateline||multiple nerve injury (diagnosis)||random
ivd test reagent/kits, molecular assay, infection, bacteria, staphylococcus aureus, dna||office manager nos (occupation)||random
nm whole body views for tumor w ga-67 iv||medical and surgical @ lymphatic and hemic systems @ extraction @ bone marrow, vertebral @ percutaneous @ no device||random
unclassified pseudobutyrivibrio||bacillus sp. b-23286||random
puncture wound of hip (disorder)||calcium oxalate urolithiasis (finding)||random
eudiagogini||stellaria media, homeopathic preparation||random
acari sp. bold:aab1050||pronounce tough nih||random
epilepsy due to infectious encephalitis (disorder)||schizopterinae sp. ucr ent 00094167||random
hexanes||genital pain male||random
ejaculation; precocious||rnase h, hiv||random
olive pollen ige ab rast class [presence] in serum||appias olferna swinhoe, 1890||random
systolic blood pressure--standing||campopleginae sp. bioug23655-e04||random
2-dcecp||fucobiose||random
medical and surgical @ lower arteries @ destruction @ posterior tibial artery, right @ percutaneous||chryseobacterium carnipullorum charimba et al. 2013||random
receptors, histamine||smc6 protein, xenopus||random
rifargiriinae||ivd test reagent/kits, molecular assay, gene anomaly, mutation, col1a1||random
rv opn red #+int fxn+k-wire||mopath procedure level 6||random
idiopathic corneal edema (disorder)||sta-r12||random
salicylic acid 2 g in 100 ml topical lotion [oil-free acne wash]||transcultural nurs||random
lidocaine only product in oromucosal dose form||pseudomonas sp. gm9||random
machilis sp. ar01||menses finding:finding:point in time:^patient:nominal:reported||random
intrapulmonary part of superior pulmonary vein||deafness, small bowel diverticulosis, neuropathy syndrome (disorder)||random
trastuzumab 150 mg in 7.4 ml intravenous injection, powder, lyophilized, for solution [herceptin]||postprocedural intestinal steatorrhea (diagnosis)||random
carbenoxalone||percutaneous cholecystotomy||random
replacement of right hip joint, acetabular surface with metal synthetic substitute, open approach||diptera sp. bold:aal4574||random
cysts on the right little toe proximal||roleclasspassive||random
drainage of right ovary, open approach||human immunodeficiency virus 1 ribonucleic acid:number concentration (count/vol):to identify measures at a point in time:plasma:quantitative:probe.amp.sig||random
absent radial pulse (physical finding)||lipase binding protein, rat||random
primary dysautonomia||pre-existing condition improved||random
penicillin g benzathine 450000 unt/ml / penicillin g procaine 150000 unt/ml [bicillin]||spironolactone 50 mg oral tablet [spironolactone]||random
methylprednisolone 500mg powder and solvent for injection solution vial||repair defect of artery||random
unclassified ramphogordius||cryptosporidium sp. 1196||random
citrex s-5||right anterior short insular gyrus||random
nepeta racemosa lam., 1785||ligament of joint, unspecified (body structure)||random
[x]other laxatives causing adverse effects in therapeutic use (disorder)||accidental intraoperative puncture of skin and subcutaneous tissue during a dermatological procedure (diagnosis)||random
ear antitragus mass (___ mm)||fourth costal head joint||random
trictenotoma sp. upolzl0208||fibroblast growth factor receptor 1 c.1966a>g||random
ondansetron 0.8 mg/ml||grade 3 gallbladder fistula, ctcae||random
d4t 5 mg oral capsule||carpet weed||random
service request relationship||vasotomy vasograms uni/bi||random
ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; radiofrequency||urtica dioica pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / ambrosia artemisiifolia pollen 4000 [au] in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / festuca pratensis pollen 4000 g in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / avena sativa pollen 0.0004 g in 1 ml / phleum pratense pollen 800 [bau] in 1 ml / pascopyrum smithii pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus virginiana pollen 0.0004 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / carya alba pollen 0.0002 g in 1 ml / carya illinoinensis pollen 0.0002 g in 1 ml / platanus occidentalis pollen 0.0004 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / morus rubra pollen 0.002 g in 1 ml intradermal injection, solution||random
unclassified phalacridae||mustela||random
genus syntrophobacter (organism)||rbap48 protein||random
frame shifting, ribosomal||american ginseng 4 [hp_x] in 1 ml / chaste tree 6 [hp_x] in 1 ml / ascorbic acid 6 [hp_x] in 1 ml / dieffenbachia seguine 6 [hp_x] in 1 ml / potassium bromide 6 [hp_x] in 1 ml / lytta vesicatoria 8 [hp_x] in 1 ml / turnera diffusa leafy twig 8 [hp_x] in 1 ml / sus scrofa umbilical cord 8 [hp_x] in 1 ml / sus scrofa adrenal gland 8 [hp_x] in 1 ml / sus scrofa pituitary gland 8 [hp_x] in 1 ml / sus scrofa testicle 8 [hp_x] in 1 ml / sus scrofa prostate 8 [hp_x] in 1 ml / strychnine phosphate dihydrate 8 [hp_x] in 1 ml / conium maculatum flowering top 8 [hp_x] in 1 ml / sus scrofa diencephalon 8 [hp_x] in 1 ml / pork heart 8 [hp_x] in 1 ml / ferrosoferric phosphate 10 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 10 [hp_x] in 1 ml / selenium 10 [hp_x] in 1 ml / zinc 10 [hp_x] in 1 ml / sus scrofa pineal gland 12 [hp_x] in 1 ml / cortisone acetate 13 [hp_x] in 1 ml / manganese phosphate, dibasic 20 [hp_x] in 1 ml / lycopodium clavatum spore 28 [hp_x] in 1 ml / testosterone 30 [hp_x] in 1 ml / salmonella enterica subsp. enterica serovar enteritidis 30 [hp_c] in 1 ml oral liquid [male stimulant]||random
uterine corpus carcinoma pathologic primary tumor tnm finding v7||vertebral foramen of fourth thoracic vertebra||random
plasma cholesterol increased||product containing precisely glimepiride 3 milligram/1 each conventional release oral tablet (clinical drug)||random
asenapine pill||sewage derived gemycircularvirus 4||random
coronary artery structure||acute osteomyelitis, hand||random
eurotium herbariorum allergenic extract 10000 unt/ml injectable solution||[x]assault by sharp object, occurrence at other specified place (finding)||random
neuromyopathies||pramoxine hydrochloride/zinc acetate 1%-0.1% topical application lotion [caldyphen clear]||random
cladophialophora humicola||vestibular evoked myogenic potentials||random
closed fracture of patella (disorder)||colostomy infection (disorder)||random
ulcer peptic reactivated||swelling of great toe right lateral||random
defective molecular assembly (finding)||intensive care psychiatric disorder (diagnosis)||random
medical and surgical @ lower arteries @ dilation @ popliteal artery, right @ open @ no device||finding of benefit status (finding)||random
tendon of fibularis brevis||beta-2 transferrin:presence or threshold:to identify measures at a point in time:cerebral spinal fluid:ordinal||random
glucosamine hcl 500 mg oral capsule||coagulation factor ix chapel hill variant (substance)||random
appendicolysis||low anorectal malformation||random
bos taurus pineal gland||diazepam ql||random
passive physical exercise (observable entity)||protein total increased||random
obsolete acute-phase response protein activity||british isles||random
igg cells/100 cells in specimen||operating room shoes||random
prednisolone 0.005 mg/mg paste||pronto with metal comb, 3%-0.3% topical shampoo||random
genetic markers||aib1||random
correction of metatarsus varus (procedure)||root of left lower subscapular nerve||random
duroziez's murmur (finding)||pars medialis nuclei parabrachialis medialis||random
carbidopa (product)||periploca forrestii||random
breasts skin||circatrigintan biorhythm (function)||random
removal pilonidal cyst||codeine sulfate 30mg tablet (product)||random
acting oddly in public||electrocardiogram t wave amplitude increased||random
olfactory acuity test normal||c1s, 3-bp del, nt945||random
superf inj foot/toe nec||reason for non-completion||random
phosphomethylpyrimidine kinase||caenolestes||random
philol classical||number of days of training and skill practice in eating or swallowing [minimum data set]||random
cataloging||personality, as if||random
musculoskeletal system of left leg||sulfamethizole &#x7c; serum or plasma &#x7c; drug toxicology||random
sycobia sp. 1 yw-2020||capillary electrochromatographies||random
bilateral fluorescein and indocyanine-green angiography with multiframe imaging, interpretation, and report||medical and surgical @ lower veins @ supplement @ hypogastric vein, right @ percutaneous endoscopic||random
pionosomus||2-hydroxy-1,2,3-propanetricarboxylic acid, anhydrous||random
ct scan right foot fracture (procedure)||segesterone acetate/ethinyl estradiol@0.15 mg-0.013 mg/24 hr@vaginal@ring, vaginal||random
tremor neonatal||rfa aortic arch and carotid artery - bilateral and vertebral artery - bilateral views w contrast ia||random
can pronounce sergeant [nih toolbox]||web 2086||random
lingual cusp of left mandibular second premolar tooth||arsenate ion||random
salicylic acid [acne] (substance)||znf56||random
closure of ventricular septal defect with pulmonary valvotomy and patch||tumor destruction||random
partial mastectomy of left breast||phosphate&#x7c;pt&#x7c;ser/plas&#x7c;94.97 g/mole||random
ultra frozen||nuclear medicine study of heart wall motion at rest or stress with evaluation of blood ejection from heart, single study, first pass technique||random
extrinsic cartilagenous obstruction of eustachian tube (disorder)||foreign body of sclera of left eye (physical finding)||random
cblif, gln5arg||asphyxia due to foreign body in larynx||random
aliphatic carboxylate c14-c26 esters measurement||vehicle safety promotion||random
ophthalmicmyd 0.5% ophthalmic solution||joint of head of fourth rib||random
valvata||dexamethasone / tramazoline||random
artist||serping1 gene targeted mutation analysis &#x7c; blood or tissue &#x7c; mutations||random
chaste tree 20 [hp_x] in 1 g / american ginseng 20 [hp_x] in 1 g / barium carbonate 20 [hp_x] in 1 g / berberis vulgaris root bark 20 [hp_x] in 1 g / bryonia alba root 20 [hp_x] in 1 g / dieffenbachia seguine 20 [hp_x] in 1 g / lytta vesicatoria 20 [hp_x] in 1 g / causticum 20 [hp_x] in 1 g / chelidonium majus 20 [hp_x] in 1 g / cinchona officinalis bark 20 [hp_x] in 1 g / conium maculatum flowering top 20 [hp_x] in 1 g / gaultheria procumbens top 20 [hp_x] in 1 g / graphite 20 [hp_x] in 1 g / potassium carbonate 20 [hp_x] in 1 g / lycopodium clavatum spore 20 [hp_x] in 1 g / strychnos nux-vomica seed 20 [hp_x] in 1 g / onosmodium virginianum root 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / saw palmetto 20 [hp_x] in 1 g / selenium 20 [hp_x] in 1 g / sepia officinalis juice 20 [hp_x] in 1 g / silicon dioxide 20 [hp_x] in 1 g / delphinium staphisagria seed 20 [hp_x] in 1 g / goldenseal 8 [hp_x] in 1 g / thuja occidentalis leafy twig 8 [hp_x] in 1 g oral pellet [libido]||unclassified omaliinae||random
intercalated duct of pancreas||hamartomatous diseases||random
automated med record system||platelet function test (procedure)||random
balaenoptera physalus||animal bite of chest||random
fluoroscopic corpora cavernosography||iop reduced <15% pre-intervention level||random
1,2-dihydroxypropane catabolism||open division hip ligament nos||random
3-hexylsalicylic acid||coal tar 50 mg/ml / salicylic acid 20 mg/ml medicated shampoo||random
premedication||brigatinib (medication)||random
risperidone induced platelet igg fc ql||oils, croton||random
famotidine 20 mg oral tablet, chewable [pepcid ac]||pagavirus s05c849||random
elongin c||unresectable malignant liver neoplasm||random
lifting - confidence:finding:to identify measures at a point in time:^patient:ordinal:optimal||genus sericopelma (organism)||random
disorder of salivary structure (disorder)||pilocarpine hydrochloride 15 mg/ml||random
acetone increased||preop dental product||random
disorder of nipple (disorder)||cefuroxime sodium 1.5 gm injection powder for solution [kefurox]||random
charcoal 250 mg oral delayed release tablet||us scan of upper limb vessels (procedure)||random
hepatopancreas||disseminated choroiditis and chorioretinitis, posterior pole||random
3-azabicyclo(3.1.0)hexane-2-carboxamide, n-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-((2s)-2-((((1,1- dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6- dimethyl-, (1r,2s,5s)-||unclassified actinobacteridae||random
b. abortus ab aggl qn (s)||mtnd4p29||random
pontocaine||gongylonema verrucosum (organism)||random
bimanual phacoemulsification of lens with intraocular lens implantation||proctotrupes||random
prior functioning.transfer:find:pt:^patient:ord:cms assessment||ethanol 0.91 ml/ml topical spray||random
bryonia alba root 1 [hp_x] in 1 g / arsenic triiodide 6 [hp_x] in 1 g / barium carbonate 8 [hp_x] in 1 g / aluminum oxide 12 [hp_x] in 1 g / calendula officinalis flowering top 12 [hp_x] in 1 g / sulfuric acid 12 [hp_x] in 1 g / comfrey root 12 [hp_x] in 1 g topical lotion [chafe rescue]||hla-a33(19):prthr:pt:bld/tiss:ord||random
c.pregnancy; viral hepatitis||slc4a11, ivs15as, -6, del/ins||random
cd3+cd8+cd27+cd45ro+cd62l+ cells [#/volume] in blood||ethinyl estradiol / levonorgestrel oral product||random
furuncle of medial aspect of ring finger of right hand (physical finding)||foreign body granuloma of skin and subcutaneous tissue||random
biopsy of pancreas showed sarcoma||fluav + flubv pnl tiss naa+probe||random
blood immunoglobulin a normal||malignant pyoderma||random
did your heart failure prevent you from living as you wanted during the past mo (4w) by making you sit or lie down to rest during the day:find:1mo:^patient:ord:mlhfq||syphilis complicating childbirth||random
metatarsophalangeal joint of fifth toe||maxillary alveolar hypoplasia (diagnosis)||random
ipratropium nasal spray||chesapeake bay retriever||random
del(18q)||acetaminophen/caffeine/salicylamide 226.8 mg-32.4 mg-97.2 mg oral tablet||random
syntherata||education about use of covering device||random
fistulariidae||cyclophosphamide 500mg injection (pdr for recon) (substance)||random
part of body of mandible closed fracture of other and unspecified part||growth hormone receptor absent (disorder)||random
glucose^2 hours post meal:substance concentration:to identify measures at a point in time:serum/plasma/whole blood:quantitative||solute carrier family 25, member 5||random
structure of posterior auricularis muscle (body structure)||unclassified shimazuella||random
h2a-ubiquitin hydrolase||ultrasound;cardiac||random
homeobox 1e||hopf disease||random
post-surg cardiovasc struct||polar localization during asymmetric division and redistribution protein, arabidopsis||random
dexchlorpheniramine maleate/pseudoephedrine hydrochloride 1 mg/5 ml-30 mg/5 ml oral solution [deltuss dp]||anti-neutrophil cytoplasmic antibody screen||random
salicylic acid 0.03 mg/mg / sulfur 0.05 mg/mg topical ointment||etanercept therapy||random
sodium silicofluoride||intervertebral foramen of thoracic vertebrae||random
behavior identification assessment, administered by a physician or other qualified health care professional, each 15 minutes of the physician's or other qualified health care professional's time face-to-face with patient and/or guardian(s)/caregiver(s) administering assessments and discussing findings and recommendations, and non-face-to-face analyzing past data, scoring/interpreting the assessment, and preparing the report/treatment plan||qbeta replicase||random
bifidobacterium orla-jensen 1924||nephrostomy obstructed (physical finding)||random
t(3;5)(q25.1;q35.1)(mlf1,npm1)||rna, met transfer||random
co2 adjusted to patient's actual temperature (bldmv) [partial pressure]||aequidens||random
congenital malposition of inferior vena cava (diagnosis)||post radiation injury of nervous system||random
pantoporia consimilis||deprecated||random
vascular system disorders obstruction superior vena cava||bipol i currnt manic-mod||random
cells, fetal stem||medical and surgical @ central nervous system and cranial nerves @ insertion @ cranial nerve @ percutaneous @ monitoring device @ no qualifier||random
metal abrasion of upper arms||selonsertib||random
cd3+4+45ro+45ra- cells nfr bld||gur language (qualifier value)||random
diisopropylphosphorylthiocholine iodide||gordonia virus kvothe||random
solanum dulcamara top 10 [hp_x] in 1 g / nitric acid 10 [hp_x] in 1 g / thuja occidentalis leafy twig 10 [hp_x] in 1 g / antimony trisulfide 12 [hp_x] in 1 g / oyster shell calcium carbonate, crude 12 [hp_x] in 1 g / silicon dioxide 12 [hp_x] in 1 g topical paste [haloderm advanced]||adductor magnus branch of tibial nerve||random
chironominae sp. bioug21901-c12||eeg finding, nos||random
calcium phosphate, dibasic, anhydrous 0.1 g in 100 g / calcium carbonate 30 g in 100 g / alcloxa 0.1 g in 100 g / aminocaproic acid 0.1 g in 100 g dental paste, dentifrice [dr.el gum care tooth]||glomerida sp. bold:aal3715||random
osteochondral lesion of right talus (diagnosis)||swimming (history)||random
fluticasone propionate 100 mcg / salmeterol 50 mcg (salmeterol xinafoate 72.5 mcg) per actuat dry powder inhaler, 28 actuat||genus lebetimonas (organism)||random
intention od calc-chan block||refractory pancreatic ductal adenocarcinoma||random
violent traumatic event having been in tidal wave due to storm||[v]twin, unspecified, not hospitalised||random
epididymal enlargement||bone structure of left clavicle (body structure)||random
u ab serpl bpu ql||rpsa, arg180trp||random
udpglucose-hexose-1-phosphate uridylyltransferase (substance)||resectable pleural malignant mesothelioma||random
tuberculanostoma cilium fluke, 1943||accident due to contact with hot or corrosive substance||random
aseptic necrosis of left lunate||intrachamber systolic &#x7c; heart.ventricle right &#x7c; specific central blood pressure||random
history and physical note:finding:to identify measures at a point in time:{setting}:document:gynecology||aspergillus flavus 30 [hp_x] in 1 ml / aspergillus fumigatus 30 [hp_x] in 1 ml / eurotium herbariorum 30 [hp_x] in 1 ml / aspergillus nidulans 30 [hp_x] in 1 ml / aspergillus niger var. niger 30 [hp_x] in 1 ml / penicillium camemberti 30 [hp_x] in 1 ml / penicillium chrysogenum var. chrysogenum 30 [hp_x] in 1 ml / penicillium digitatum 30 [hp_x] in 1 ml / penicillium roqueforti 30 [hp_x] in 1 ml sublingual solution [a-22]||random
nail embedded in skin||timm13b||random
tucks hemorrhoidal rectal suppository||disease (or disorder); glomerular, in septicemia, streptococcal (etiology)||random
incision of right mid paraspinal region extending to bone||intestinal angioedema caused by angiotensin-converting enzyme inhibitor (disorder)||random
poractant alfa product||lower respiratory tract infection viral||random
levothyroxine sodium 13 mcg oral capsule||voiding cystourethrogram appearance of urethra||random
oscimin 0.375 mg extended release oral tablet||finding related to ability to use decision making strategies||random
congenital refluxing megaureter (disorder)||hemolytic anemia due to glutathione metabolism disorder nos (disorder)||random
repair, complex, scalp, arms, and/or legs||rho(d) immune globulin/maltose@2,500 unit (500 mcg)/2.2 ml@injection@vial (ml)||random
other specified disorders of joint, site unspecified||angina pectoris recurrent||random
lv max twist rate 2d us||polygonibacillus||random
unclassified andrographis||heart tissue||random
lower alveolar ridge squamous cell carcinoma||salmonella group g1 and g2 phase 1 a-e||random
fiberoptic ileoscopy through stoma with biopsy (procedure)||solenopsis invicta allergenic extract 10,000 unt/ml injectable solution||random
leuprolide acetate (lupron) 11.25mg (3 month) inj,susp,la||3-hydroxybenzoate||random
light signal transduction||erection and ejaculation conditions and disorders||random
epichloe sp. rnj3202||niacinamide@750 mg@oral@tablet, extended release||random
gemella massiliensis||c.pregnancy; transverse and oblique lie||random
acute blistering eruption of skin (disorder)||alpha-flupenthixol||random
can pronounce scion:finding:to identify measures at a point in time:^patient:ordinal:amnart||pineus coloradensis (gillette, 1907)||random
alternaria sp. popeuph49||piroxicam pois undetermine int||random
benign granular cell neoplasm of the soft palate||prolactin inhibiting factor alteration [pe]||random
morphology [interpretation] in bone marrow narrative||sarcops calvus||random
infections - congenital||surgical drainage of extraperitoneal lymphocele to peritoneal cavity||random
peracetic acid 0.15 g in 60 ml topical spray [pu us lemon]||nonylacridine orange||random
osteopathic treatment of upper extremities using lymphatic pump||cichlidogyrus amieti birgi & euzet, 1983||random
iris color brown both eyes||blood pressure monitor device||random
radiation therapy @ endocrine system @ brachytherapy @ thyroid @ high dose rate (hdr) @ iridium 192 (ir-192)||tourniquet observation||random
haemolytic anaemia caused by malaria||instillation site discharge||random
infusion site mobility decreased||[x]occupant of heavy transport vehicle injured in collision with other nonmotor vehicle, person injured while boarding or alighting (event)||random
schistosoma sp ab qn (s)||lidocaine hcl/pf 10 mg/ml (1 %) injection ampul (ml)||random
feline panleukopenia virus ab||bmp receptor||random
fluid intake management||assigned surgeon||random
lipoprotein (a) increased||cytospora aff. variostromatica cbs 118565||random
ascending aortic rupture||second-generation antidepressive agents||random
labor and delivery complicated by vascular lesion of cord, fetus 2||cerebral cyst (disorder)||random
problems related to unwanted pregnancy||streptomyces sp. lc548||random
skin lacks elastic recoil||glutamate ionotropic receptor delta type subunit 2||random
phenylisopropyladenosine||product containing only tranylcypromine 10 mg/1 each oral tablet||random
views pa + lateral + waters + towne:find:pt:head>skull:doc:xr||ritters disease||random
lepidoptera sp. bold:aam9469||camylofine / dipyrone pill||random
branch of common interosseous artery||insect bite (nonvenomous) of right thumb||random
ability to wash your back||ircon pill||random
transection of fallopian tube by abdominal approach||left glenohumeral joint||random
right thigh tissue injury laceration multiple||aphyosemion exigoideum radda & huber, 1977||random
c burnet ag tiss ql ia||referral to community podiatrist||random
i forget things easily [neuroqol.peds]||arthropathy, unspecified, other specified sites||random
pressure ulcer of right upper back (diagnosis)||rhodococcus sp. ws6||random
fibrous body (morphologic abnormality)||unclassified anoecia||random
x-ray of hip: erosion of medial aspect of femoral head (procedure)||cartilage, nos||random
irish potato||trabecular bone of right pedicle of twelfth thoracic vertebra||random
routine immunisation||solution, isotonic||random
removal of foreign body from chest by incision lower right||con-4619||random
tada2a||urticarial||random
hydrochlorothiazide and valsartan only product||medical and surgical @ eye @ removal @ eye, left @ via natural or artificial opening @ infusion device @ no qualifier||random
left-to-right cardiac shunt||zinc spec-mcnt||random
maurus||roseomonas eburnea wang et al. 2016||random
cholecalciferol 25 mcg oral tablet [vitamin d3]||termination of pregnancy complicated by shock||random
rho gtpase activating protein 6||open ant end ant semicir canal||random
moroxydine (product)||accessory parathyroid gland (body structure)||random
chlorpromazine hydrochloride 200 mg oral tablet, coated||viral fusion protein||random
narrowing||indicator variegatus lesson, 1830||random
arth excision natural ligament||bothriocotyle||random
medical and surgical @ male reproductive system @ excision @ testis, right @ open @ no device @ diagnostic||pulm||random
l breast inferior medial quad previous mass 1 size increase||levothyroxine oral solution [tirosint]||random
radiation therapy @ gastrointestinal system @ brachytherapy @ duodenum @ low dose rate (ldr)||biopsy ct guidance kidney||random
gastrointestinal amyloidosis||aif||random
unclassified dichopygina||malignant neoplasm of trigone of urinary bladder stage 0, without cancer in situ||random
distractibility di-pad||h*ngeq/ml||random
recurrent dislocation of patella, left knee||scid due to ada deficiency, early-onset||random
trunk of right pre-optic artery||myopathy, distal 3||random
has pain that has been most uncomfortable in this area the past 12 months [phenx]||cephalin floculation, blood||random
pvc group||ppg-26-buteth-26||random
lithobiidae sp. 08bbmyr-007||squamous cell carcinoma ag:mcnc:pt:body fld:qn||random
serologically defined locus-1 (sd-1)||excision of adenoid||random
cupriavidus sp. b52||evaluation; mental health, requested by authority||random
onetouch ultra2 system||rhodotorula mucilaginosa||random
guaifenesin/phenylephrine hydrochloride/phenylpropanolamine hydrochloride 100 mg/5 ml-5 mg/5 ml-20 mg/5 ml oral liquid [guaifenesin/ppa/pe]||aorto-oesophageal fistula||random
monochaetia karstenii||esa36 protein, streptomyces thermoviolaceus||random
views greater than or equal to 3 && view pa:finding:to identify measures at a point in time:chest>ribs.left && chest:document:xr||absent or severely reduced levels of serum immunoglobulins||random
nadh-nitrate reductase||bone of cuboid||random
knowledge: anticoagulation therapy management||complaint(s);hair||random
subdivision of compartment of palm of hand||c peptide^30m post meal:mcnc:pt:ser/plas:qn||random
cyclophilin71 protein, arabidopsis||abn ftl hrt rate/rhy-uns||random
esophageal scarring||cardiac catheterization left atrium mass||random
gelatin sponge,absorb/porcine 4 topical sponge||poisoning by chloramphenicol group, accidental, init||random
ear auricle dysmorphic bony abnormality right (physical finding)||peoplecare 845219 male urin x1||random
nasal decongestion therapy||veillonella ratti (rogosa 1965) mays et al. 1982 emend. kraatz and taras 2008||random
carcinoma in situ of skin of forearm||vytorin, 10 mg-20 mg oral tablet||random
egf-like-domain, multiple 3||dnpns||random
disposable syringe||wrong vaccine administered||random
passenger in heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident, sequela||dysaesthesia pharynx||random
unclassified herpetogramma||other specified functional endoscopic sinus surgery - diagnostic endoscopy of nose or sinus||random
current level of confidence i can follow directions when my doctor changes my medications:finding:to identify measures at a point in time:^patient:ordinal:promis||ovarian germ cell polyembryoma stage iii||random
cells.cd4+cd8+/100 cells:nfr:pt:bld:qn||unclassified polyplectropus||random
tenderness on palpation of lateral border of scapula (physical finding)||traulia||random
litoribacter ruber tian et al. 2010||prp i/hern init reduc >5 yr||random
scrotal hypoaesthesia||itln1 wt allele||random
ehlers-danlos syndrome, spondylodysplastic type, 3||sinuses||random
nps01tn||unclassified paenibacillus||random
matricaria recutita 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 3 [hp_x] in 1 ml / hypericum perforatum 3 [hp_x] in 1 ml / achillea millefolium 3 [hp_x] in 1 ml / bryonia alba root 4 [hp_x] in 1 ml / calendula officinalis flowering top 4 [hp_x] in 1 ml / arnica montana 4 [hp_x] in 1 ml / bellis perennis 6 [hp_x] in 1 ml / toxicodendron pubescens leaf 6 [hp_x] in 1 ml / clematis vitalba flower 8 [hp_x] in 1 ml / helianthemum nummularium flower 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / impatiens glandulifera flower 8 [hp_x] in 1 ml / ornithogalum umbellatum flowering top 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / activated charcoal 12 [hp_x] in 1 ml oral liquid [trauma remedy]||hemiodoecellus||random
hypotrichosis of right upper eyelid||paraplegia in last 7d||random
joint crepitance||duodenal ulcer with perforation (diagnosis)||random
myxococcus sp. hbum 92087||epididymis-specific protein e4, human||random
hydrofluoric acid 30 [hp_c] oral pellet [hydrofluoricum acidum]||congestive heart failure; nonhypertensive||random
during the past 30d, how many ds out of 30 were you totally unable to work or carry out your normal activities because of these feelings||inflammation throat||random
guarea ecuadoriensis||barbiturate, nos||random
fungus identified:presence or identity:to identify measures at a point in time:whole blood:nominal:routine fungal culture||bnzlcgn||random
corticotropin^30m pre xxx challenge:scnc:pt:plas:qn||chironomus sp. bioug01408-h05||random
neuron component||toxosiphon lindenii||random
pre-pregnancy counselling (procedure)||tall stature, scoliosis, macrodactyly of hallux syndrome||random
dextrose monohydrate 1.1 g in 100 ml / sodium citrate, unspecified form 0.588 g in 100 ml / sodium chloride 0.41 g in 100 ml / sodium phosphate, monobasic, monohydrate 0.276 g in 100 ml / citric acid monohydrate 0.042 g in 100 ml / adenine 0.03 g in 100 ml intravenous injection, solution [as 3]||ureteral dilatation||random
i feel numbness at my surgical site in the past 7d:find:7d:^patient:ord:facit||android pelvis; with disproportion, causing obstructed labor||random
superfetations||pisolithus sp. tns-f2158||random
perhydrol||outside reference range||random
multiple basal cell papillomata (disorder)||direct repair of artery of lower extremity||random
21-hydroxylase ab||living cost||random
cephalexin monohydrate (substance)||foreign body skin head+neck||random
candida albicans test||avobenzone 8.1 mg in 1 ml / octisalate 24.3 mg in 1 ml / octocrylene 6.885 mg in 1 ml / oxybenzone 8.1 mg in 1 ml topical aerosol, spray [solmate broad spectrum spf 8]||random
oxazoles||colon carcinoma dukes b1||random
cavity of patella||impaired social functioning||random
sars-cov-1 test negative||hepatitis d immunization||random
medical and surgical @ upper joints @ revision @ metacarpophalangeal joint, right @ open||deprecated desmethylmethsuximide:mass concentration:point in time:serum:quantitative||random
admin forms - scotland||mirn1192 microrna, mouse||random
dimethicone 1 g in 100 g / octinoxate 7.5 g in 100 g / oxybenzone 2.5 g in 100 g topical stick [fruit smoothies orange cream]||extension exercises for neck to increase movement (treatment)||random
hypohidrosis with neurolabyrinthitis||gdc sample type id terminology||random
triclosan 0.1 g in 100 ml topical soap [up (and) up green apple scent]||person on outside of three-wheeled motor vehicle injured in collision with two- or three-wheeled motor vehicle in traffic accident, subsequent encounter||random
egf family of proteins||history of immune thrombocytopenia||random
budesonide||multisection^wo contrast:find:pt:pelvis>pelvis bones:doc:ct||random
poisoning by phosphorus due to a self-inflicted overdose||dangerous behaviors||random
delphinieae||endoplasmic reticulum||random
my child felt cheerful in past 7 days [promis.parentproxy]||jo-1 extractable nuclear ab ia qn (s)||random
ap4b1, 1-bp del, 869c||salter-harris type ii physeal fracture of lower end of unspecified fibula, subsequent encounter for fracture with routine healing||random
citric acid / sodium bicarbonate effervescent oral tablet||sulmazol||random
diphenhydramine hydrochloride 50 mg in 30 ml oral solution [health mart z sleep]||glossina||random
thoracic segment of left anterior corticospinal tract||respiratory arrest of newborn (diagnosis)||random
modes of transfer||pancarditis (disorder)||random
restriction of right innominate vein with intraluminal device, open approach||ezetimibe-rosuvastatin 10 mg-40 mg oral tablet||random
allopathic & osteopathic physicians; internal medicine||otitis media with effusion - serous (disorder)||random
cecidomyiidae sp. bioug24124-c11||floret-like pattern||random
data processors, electronic recording, electrocardiography||radiation tx delivery superficial&/ortho volta||random
parapsychological phenomena||phg1 protein, dictyostelium discoideum||random
genus acinonyx||contracture of rectus femoris (disorder)||random
pythium sp. py294||myelogram of posterior fossa (procedure)||random
betapace af 100mg tablet||allo-tetrahydrocortisol:substance rate:24 hours:urine:quantitative||random
x-ray hands lytic lesion||di-2-ethylhexyl phthalate product||random
trypsin 24 mg||ca - cancer of gum||random
ganglioside storage disease, nos||bancrofti filaria||random
normal external genitalia||polyneuritis; cranialis||random
cecidomyiidae sp. bioug21500-d08||adaptability diminished||random
olsalazine adverse reaction (disorder)||acetaminophen 300 mg / oxycodone hydrochloride 7.5 mg [prolate]||random
sjogrens syndrome-a extractable nuclear ab+sjogrens syndrome-b extractable nuclear ab [units/volume] in serum||aspirin extended release oral tablet [zero-order release]||random
musculi pectinati of right atrium (body structure)||polistes spp recombinant (rpol d) 5 ab.ige.rast class:prthr:pt:ser:ord||random
administration @ physiological systems and anatomical regions @ introduction @ peripheral vein @ percutaneous @ pancreatic islet cells||active range shoulder flexion||random
region imaged: head||complex extracapsular cataract extraction with insertion of prosthesis (treatment)||random
tight junction (body structure)||wadi monkey||random
luteal cell tumour||sodium hypochlorite 1.25 mg/ml topical spray||random
brompheniramine maleate 2 mg in 10 ml / phenylephrine hydrochloride 5 mg in 10 ml oral liquid [dibromm cold and allergy relief childrens]||oral and maxillofacial surgery admission history and physical note||random
chlamydia sp igg ab [units/volume] in serum --1st specimen||fractures phalanges||random
rfa carotid artery and cerebral artery - left views w contrast ia||mesochorus sp. nl1953||random
cpm (continuous passive mobilization device) monitoring||substance with serpin protease inhibitor mechanism of action||random
pseudomonas sp. ync-9||removal of implant from tarsal and metatarsal bones||random
aub stuf with lent and veg||adductor tendon||random
unclassified methanobacterium||blind left eye (disorder)||random
central nervous system cyst fluid sample (specimen)||chlamydia sp antigen||random
spine fusion extra segment||injury; internal, multiple||random
cerebrospinal fluid cell content nos (procedure)||surface of ampulla of uterine tube||random
strip, craniosynostosis, preformed||unable to restrain urination at night while asleep (symptom)||random
childhood chronic myelogenous leukemia||neurofibrosarcoma||random
allergenic extract, tricotheciumroseum mold||hypogonadotropic hypogonadism, severe microcephaly, sensorineural hearing loss, dysmorphism syndrome (disorder)||random
sonchus luxurians (r.e.fr.) c.jeffrey||region of embryonic palatal epithelium||random
erythroplakia of tongue||drug usage testing methods||random
complex tear of lateral meniscus, current injury, left knee||lending - action||random
transsexualism, nos||lactate^1h post xxx challenge:mcnc:pt:bld:qn||random
rlf protein involved in activation of lmyc||myoclonic seizure (physical finding)||random
gallbladder culture encephalitozoon intestinalis||primary vesicoureteric reflux||random
birth, nos||reticulosarcoma involving intra-abdominal lymph nodes||random
pseudoparmelia condyloides||medical and surgical @ lower joints @ removal @ lumbosacral joint @ percutaneous endoscopic @ drainage device||random
nondisplaced oblique fracture of shaft of left fibula, subsequent encounter for closed fracture with routine healing||iodine contrast media allergy||random
dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@10 mg@oral@tablet||hexadecadrol||random
im b1 mrw cel ther xcl hrvst||undaria pinnatifida||random
gentamicin and hydrocortisone only product||open fracture of leg, nos||random
level of fontanelle - finding||medical and surgical @ endocrine system @ extirpation @ carotid body, left||random
neoplasm of jaw (disorder)||entire distal tendon of semitendinosus||random
procedure drg type||stretched abdominal wall skin (finding)||random
boc cell adhesion associated, oncogene regulated protein, human||titanium dioxide 0.54 g in 12 g topical powder [shiseido advanced hydro-liquid compact (refill) i100]||random
fistula of hand joint||papillomatoses||random
insert pack into abdominal cav||died/expired||random
failure to lose weight (finding)||cantellius secundus (broch, 1931)||random
myxoma of the left atrium||spinal cord tissue operation||random
fluoxetine 20 mg||bleeding umbilical cord||random
trospium||bypass of duodenum nos (procedure)||random
anastomotic ulcer perforation, obstructive||coma scale, best verbal response, incomprehensible words||random
urine specimen obtained via indwelling urinary catheter||phlaeothripidae sp. bold:aci3029||random
323/a3||chromous chloride 0.002 mg/ml / copper sulfate 0.2 mg/ml / manganese chloride 0.16 mg/ml / zinc chloride 0.8 mg/ml injectable solution||random
staphylococcus aureus methicillin resistance sccmec [presence] in nose by naa with probe detection||ovarian squamous cell tumor||random
insulin-like growth factor-ii.high molecular weight [mass/vol]||generalised exfoliative dermatitis caused by drug||random
medical and surgical @ central nervous system and cranial nerves @ drainage @ epidural space, intracranial @ open @ drainage device||burns of knee||random
11-deoxycortisol^2.5h post xxx challenge:mcnc:pt:ser/plas:qn||fungal sp. e12916a||random
stromal tumor, endometrial||spathicarpeae||random
silver nitrate 6 [hp_x] / asafetida 6 [hp_x] / activated charcoal 12 [hp_x] / matricaria recutita 6 [hp_x] / cinchona officinalis bark 6 [hp_x] / citrullus colocynthis fruit pulp 6 [hp_x] / lycopodium clavatum spore 30 [hp_x] / nutmeg 6 [hp_x] / pulsatilla vulgaris 6 [hp_x] oral tablet [tummy ache 4kids]||physical findings:find:pt:ankle:nar:observed||random
neoplasm of soft tissue of trunk||streptomyces sp. a495 ydz-ah||random
labile emotional control||transvesical (qualifier value)||random
rupture iliac artery||incr act range cer spine ext||random
xylose 4 hr post 25 g xylose po (bld) [mass/vol]||stage iii esophageal adenocarcinoma||random
inflammation of specific body systems (disorder)||clitocybe alkaliviolascens||random
leucopenic enteritis||product containing only moxifloxacin in oral dose form (medicinal product form)||random
sphincterotomy anal division sphincter spx||ascorbic acid 35 mg/ml / cholecalciferol 0.01 mg/ml / niacin 8 mg/ml / riboflavin 0.6 mg/ml / thiamine 0.5 mg/ml / vitamin a 0.45 mg/ml / vitamin b12 0.002 mg/ml / vitamin b6 0.4 mg/ml / vitamin e 2.25 mg/ml [poly-vi-sol]||random
procamide||therapeutic injection of left hip using fluoroscopic guidance||random
mr&#x7c;upper extremity&#x7c;multisection^wo contrast&#x7c;laterality:any||cranberry||random
6-23-24 acid-base balance disorders||product containing chlorpropamide 250 mg/1 each oral tablet (clinical drug)||random
l. interrogans sv panama ab aggl ql (s)||menthol 0.1 mg/mg topical gel||random
adenylate cyclase activating polypeptide 1 (pituitary)||metoprolol tartrate 100mg tablet||random
pipenzolate+dimethicone||estimated glomerular filtration rate increased||random
electromagnetic, microwave||malignant neoplasm of sternum||random
therapeutic substance unit characteristic (observable entity)||3-hydroxypalmitoylcarnitine (c16-oh) [moles/volume] in dbs||random
benzydamine hydrochloride 3 mg / cetylpyridinium chloride 1.33 mg oral lozenge||loratadine 10 mg oral tablet, film coated [handy solutions 24 hour allergy]||random
nephropathy caused by heavy metals (disorder)||artificially sweetened beverages||random
interleukin-15-receptor complex||centrocytic (mantle cell) lymphoma (kiel classification) stage ii||random
heparin neutralization assay, nos||appenzeller sennenhunde||random
contracture of third toe of right foot (physical finding)||wormwood 15 [hp_x] in 1 ml / semecarpus anacardium juice 15 [hp_x] in 1 ml / silver nitrate 15 [hp_x] in 1 ml / arsenic trioxide 20 [hp_x] in 1 ml / atropa belladonna 20 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 15 [hp_x] in 1 ml / camphor (natural) 15 [hp_x] in 1 ml / matricaria chamomilla 15 [hp_x] in 1 ml / black cohosh 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / arabica coffee bean 15 [hp_x] in 1 ml / cypripedium parviflorum var. pubescens root 15 [hp_x] in 1 ml / gelsemium sempervirens root 15 [hp_x] in 1 ml / hops 15 [hp_x] in 1 ml / hyoscyamus niger 15 [hp_x] in 1 ml / strychnos ignatii seed 15 [hp_x] in 1 ml / potassium bromide 15 [hp_x] in 1 ml / strychnos nux-vomica seed 20 [hp_x] in 1 ml / passiflora incarnata flowering top 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / scutellaria lateriflora whole 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 15 [hp_x] in 1 ml / valerian 11 [hp_x] in 1 ml oral liquid [insomnia]||random
herpes simplex virus ab:titr:pt:csf:qn||megaselia sp. bioug27491-b06||random
product containing steroid||life expectancy shortened||random
albumin abnormal||croton polyandrus spreng.||random
prophylaxis against dehydration||dogs tapeworms||random
truseltiq pill||escape of urine from transplanted ureter||random
person on outside of pick-up truck or van injured in noncollision transport accident in traffic accident, initial encounter||agrodiaetus arasbarani||random
prilocaine poisoning (disorder)||oceanobacillus sp. 3r-ma05||random
crisis oculogyric||childhood lung non-small cell carcinoma||random
body of right sixth costal cartilage||medical and surgical @ upper joints @ removal @ elbow joint, right @ percutaneous @ drainage device @ no qualifier||random
amt rec infinity obs||finding of digoxin level (finding)||random
cardiohepatic syndrome||removal of foreign body from soft tissue, nos||random
chlorpheniramine 1mg/phenylephrine 2.5mg/5ml syrup||cornea of right eye clear after surgery (treatment)||random
product contamination and sterility issues||spermatozoa.head motile w igm/100 spermatozoa in semen by immunobead||random
dalteparin sodium 7500 unt in 0.3 ml prefilled syringe||epinephrine hydrochloride||random
crossmatch incompatible||sphingorhabdus sp. alg239-r122||random
bony vestibule structure (body structure)||neoplasm of uncertain behavior of lateral wall of oropharynx (diagnosis)||random
icdc breeds terminology||deprecated cd56 cells/100 cells in unspecified specimen||random
skin structure of philtrum||bacterial blepharitis||random
xr and rf chest ge 4 views and views||receptors, il-10||random
feeding tube user||readiness for military duty assessment note:finding:to identify measures at a point in time:{setting}:document:{role}||random
glycine n-choloyltransferase (substance)||mycobacterium phage whouxphf||random
keratosis lichenoides chronica (disorder)||destruction procedures on benign or premalignant lesions of the integumentary system||random
atypical pna path pnl resp naa+probe||meta cresyl acetate 25% otic solution [cresylate]||random
medical and surgical @ heart and great vessels @ supplement @ ventricle, left @ percutaneous endoscopic @ autologous tissue substitute @ no qualifier||periungual skin of finger (body structure)||random
abcb4 gene targeted mutation analysis in blood or tissue by molecular genetics method||hilpertia r.h.zander, 1989||random
other zoonotic bacterial diseases, not elsewhere classified||unclassified chelomatolichus||random
ii(3)(neuaca2-8neuac)gg4cer||injury of nerve roots and/or spinal plexus of multiple sites||random
mammogram size of previous mass #3 of superior lateral quadrant of left breast (procedure)||platelets &#x7c; plasma &#x7c; hematology and cell counts||random
psychotic; state||mycobacterium phage lilizi||random
rsss0117||american physical therapy association (apta) panels||random
protein phosphatase, pten||qs-qscat||random
gastro-jejunal bypass (including bariatric)||regulation of cxcl1 production||random
haderup designation 5-||avobenzone 30 mg in 1 g / homosalate 150 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 100 mg in 1 g topical spray [neutrogena beach defense water plus sun protection sunscreen stick broad spectrum spf 50 plus]||random
other artery/arteriole dis.||revision of internal fixation device in nasal bone, percutaneous endoscopic approach||random
glycerin 5 g in 100 ml topical cream [aewajin derma hydrocell]||corrosion of third degree of left hand, unspecified site, sequela||random
haber's syndrome (disorder)||community grief response||random
your child has to work really hard to pay attention or he or she makes mistakes in past 4w - severity:finding:4 weeks:^patient:ordinal:promis.parentproxy||monograph||random
crossed hemiplegias||stage ivb colon cancer||random
surgery not indicated||traumatic arthropathy of sternoclavicular joint||random
erbeta||4-tert-butylbenzoic acid-containing product||random
pancreatic pp cell||rapid eye movement sleep (function)||random
hyphomicrobium stutzer and hartleb 1899 (sic)||ptca left blalock lesion classification (treatment)||random
aphonopelma sp. aph_0299||c trach+gc pnl urth naa+probe||random
pseudomonas sp. sg-1-03||mir4737 gene||random
lymphatic duct injury||somnium||random
patient breast aware||stamaril injectable product||random
money changer (occupation)||nt157 compound||random
(c11)gb 67||trandolapril 4 mg / verapamil hydrochloride 240 mg extended release oral tablet||random
pituitary deficiency due to empty sella turcica syndrome (disorder)||thinking about the past 4w, my life was the best:find:4w:^patient:ord:promis||random
coding system||sicyos||random
dapagliflozin 5 mg / metformin hydrochloride 500 mg extended release oral tablet||fam70a||random
throat||pulvinar, nos||random
superficial pain on intercourse||corrosion of first degree of hip and lower limb,except ankle and foot||random
stimulant drug therapy for attention deficit hyperactivity disorder||ostomy obstruction||random
yunnanilus sp. kx-2017||isoleucine [mass/volume] in serum or plasma||random
titanium dioxide 2.5 ml in 1 ml / zinc oxide 2.5 ml in 1 ml topical lotion [cargo tinted moisturizer spf 20]||glycerin topical cream||random
thysanoptera sp. bold:acc4263||acontiinae||random
product containing precisely glibenclamide micronized 4.5 milligram/1 each conventional release oral tablet||virginiamycin:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:gradient strip||random
fxn gene allele 2.gaa repeats &#x7c; blood or tissue &#x7c; nucleotide repeats||nifedipine 90 mg extended release oral tablet [nifediac]||random
rupture, aortic||psathyrella epimyces||random
measurements, speech production||gentamycin complex||random
compartment of thigh (body structure)||dec active range knee exten||random
melaleuca thymoides labill.||pueraria montana var. chinensis root extract||random
hydrogen peroxide 2.94 ml in 2.94 ml oral solution [oroxid forte oral hygiene]||what kind of work were you doing the longest||random
bromhexine / fominoben oral tablet||device embolization||random
yellow fever virus antibody||muscle fasciculus of left abductor pollicis longus||random
nadph delta(4)-3-ketosteroid 5 alpha-oxidoreductase||spontaneous recovery of conditioned reflex||random
puncture of ventricular shunt tubing||total number of tissue cores (observable entity)||random
chronic lymphocytic leukemia stage 3||eubothrium||random
mucous plugging, recurrent||cdisc sdtm nutrition findings about test name terminology||random
other tranquilizer poisoning (disorder)||rabbit material (substance)||random
corneal laceration repair||fiber||random
sulfisoxazole (dose) [mass]||skin plaque of left thumb (symptom)||random
longidorella||respiratory allergen panel, us - subtropical florida||random
creatinina||views ap + lateral crosstable:finding:to identify measures at a point in time:lower extremity.right>hip:document:xr||random
n-hydroxy-chhob||product containing cariprazine in oral dose form (medicinal product form)||random
enlarged aortic root (finding)||micrurus corallinus venom 35 [hp_x] in 1 g / apis mellifera 15 [hp_x] in 1 g / arsenic trioxide 15 [hp_x] in 1 g / lytta vesicatoria 15 [hp_x] in 1 g / cinchona officinalis bark 15 [hp_x] in 1 g / colchicum autumnale bulb 15 [hp_x] in 1 g / convallaria majalis 15 [hp_x] in 1 g / crotalus horridus horridus venom 15 [hp_x] in 1 g / digitalis 15 [hp_x] in 1 g / juniperus communis fruit 15 [hp_x] in 1 g / lachesis muta venom 15 [hp_x] in 1 g / mercury 15 [hp_x] in 1 g / naja naja venom 15 [hp_x] in 1 g / sodium carbonate 15 [hp_x] in 1 g / sodium sulfate 15 [hp_x] in 1 g / toxicodendron pubescens leaf 15 [hp_x] in 1 g / sambucus nigra flowering top 15 [hp_x] in 1 g / strophanthus hispidus seed 15 [hp_x] in 1 g / thuja occidentalis leafy twig 15 [hp_x] in 1 g / vipera berus venom 15 [hp_x] in 1 g / echinacea, unspecified 8 [hp_x] in 1 g / arctium lappa root 8 [hp_x] in 1 g / solidago virgaurea flowering top 8 [hp_x] in 1 g / taraxacum officinale 8 [hp_x] in 1 g / urtica urens 8 [hp_x] in 1 g oral pellet [edema]||random
injury to gastrointestinal tract pancreatic duct||acetaminophen 120 mg [feverall]||random
benign retina tumor||neoplasm of skeletal and soft tissue||random
occlusion nos||structure of vestibule of larynx (body structure)||random
chironomus sp. bioug22928-b12||macule on left buttock||random
potassium alum 3 [hp_x] oral granule [alumen]||nodus lymphoideus ligamenti arteriosi||random
polyneuropathy caused by borrelia species (diagnosis)||ampelisca eschrichtii kroyer, 1842||random
erythrocyte sedimentation rate result||digital therapeutics metabolic syndrome||random
serum growth hormone abnormal||abnormally small parotid gland||random
thorax spine fusion||mental retardation, autosomal recessive 44||random
potassium-dependent sodium/calcium exchanger||cholesterol.non-esterified/cholesterol.total:sfr:pt:ser/plas:qn:gc||random
cistr||mammography - screening||random
malignant skin neoplasm of back||infertile partner||random
immunoglobulin g4, anti-(human granulocyte-macrophage colony-stimulating-factor receptor alpha-chain) (human monoclonal cam-3001 heavy chain), disulfide with human monoclonal cam-3001 lambda-chain, dimer||laceration of duodenum, sequela||random
osteoporosis without pathological fracture||detergent asthma (disorder)||random
reduced size of pulp chamber of tooth||biliverdin (substance)||random
acetaminophen and tramadol only product in oral dose form||unclassified pileolaria (in: annelida)||random
cosmopteriginae sp. bioug04912-e12||isosorbide dinitrate 40mg capsule (product)||random
psychosexual dysfunction with premature ejaculation||teicoplanin trough serpl-mcnc||random
cd13 cells/100 cells in bone marrow||product containing iloperidone (medicinal product)||random
hypodermatidosis||coxsackievirus a9 igg if (s) [titer]||random
hemocyanin (substance)||allograft dressings||random
(2alpha,3beta,19alpha)-2,3,19,24-tetrahydroxyolean-12-en-28-oic acid||adhesive capsulitis of the shoulder||random
leucocoprinus sp. tsp3_8||aspidiella||random
xr tomo sacrum||phloroglucinol 80 mg / trimethylphloroglucinol 80 mg oral capsule||random
observation of heart||endal hd 12.5mg-2mg-7.5mg/5ml syrup||random
geminin||nucleic acid synthesis inhibitor||random
orientia tsutsugamushi litchfield ab [units/volume] in serum||entire outer surface of rib (body structure)||random
estrogen receptor status 3+||guaifenesin (product)||random
unclassified lebertia||crescendo seizures||random
unclassified hahellaceae||prism intermediate||random
mucosal cyst of postmastoidectomy cavity||n-phso2-mbi||random
sphenoiditis||lymphoblastic lymphoma (precursor b-lymphoblastic lymphoma/leukemia)||random
lidocaine hydrochloride/menthol 4%-1% topical application patch, extended release [hot & cold lidocaine pain relieving patches]||albraunia speta, 1982||random
modalities uvb treatment of wrist bilateral ulnar||crushing injury; trunk, with limb(s)||random
gcs eye 1st enctr||calcium:mass concentration:to identify measures at a point in time:water:quantitative||random
urinary crystal, amorphous phosphate (finding)||tritrichomonas suis||random
petrolatum 41 mg in 1 g topical stick [shopko medicated lip balm]||bacillus sp. tgr36||random
solar radiation-related skin squamous cell carcinoma||2,6-epoxy-2h-naphthaceno(1,2-b)oxocin-14-carboxylic acid, 11-((6-deoxy-3-c-methyl-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2r-(2alpha,3beta,4alpha,5beta,6alpha,11beta,13alpha,14alpha))-||random
how often did you have difficulty with lack of interest in sex||co2 total abnormal nos||random
potassium chloride only product in parenteral dose form||ventral surface of tongue||random
x-ray of teeth: cavity of incisal surface of right maxillary central incisor||beta-1,4-mannosyl-glycoprotein beta-1,4-n-acetylglucosaminyltransferase activity||random
patient will remain free of or recover fully from serious side effects or untoward reaction to medications.||biopsy stomach malignant neoplasm carcinoma (procedure)||random
general medical exam nec||ifi - idiopath fecal incontin||random
refractory primary central nervous system neoplasm||pars nasalis pharyngis||random
structure of middle cervical ganglion (body structure)||nasal surface of horizontal plate of left palatine bone||random
glycerol kinase deficiency||not limited at all||random
left temporal crest of mandible||pain in right toe (diagnosis)||random
during infancies, hyperbilirubinemia||view laurin:finding:to identify measures at a point in time:lower extremity>knee:document:xr||random
palatitis (disorder)||neutrophil-rich hepatocellular carcinoma||random
ultrasound scan of upper limb vessels (procedure)||streptococcus pneumoniae danish serotype 18c igg ab [mass/volume] in serum||random
agaricaceae chevall., 1826||bypass right peroneal artery to lower extremity vein with nonautologous tissue substitute, open approach||random
heparan sulfate lyase activity||mononeuropathy simplex, diabetic||random
vesicle of lower central palpebral conjunctiva of left eye||sputum smear specimen||random
hair keratins||medical and surgical @ head and facial bones @ replacement @ occipital bone @ percutaneous||random
halobetasol- and tazarotene-containing product||other chronic osteomyelitis||random
fluids output (treatment)||ivd panels, human genetics, bone disorder, skeletal dysplasia||random
bigfin eelpout||other open skull fracture with intracranial injury of other and unspecified nature, with prolonged [more than 24 hours] loss of consciousness, without return to pre-existing conscious level||random
hrd positive advanced ovarian cancer||formyl peptide recept||random
uhdr1-finances||tramadol mabo||random
dibutyl phthalate-containing product||allyl sulfide oral tablet||random
bubblegum-related protein||ambulances, air||random
unclassified pulveroboletus||acetaminophen 100 mg/ml [infantaire]||random
keratoconjunctivitis of right eye due to herpes zoster (diagnosis)||thb/creat ur-srto||random
c. jejuni ab qn (s)||benzocaine + hexylresorcinol + sulfathiazole + tyrothricin (medication)||random
stable burst fracture of first cervical vertebra, init||cortisol [interpretation] in serum or plasma--1 hour post dose corticotropin||random
del(4)||h/o: cardiovascular disease (& [heart (& [myocardial])]) (situation)||random
blood in pulmonary arterial tree||repair of carotid body (procedure)||random
chlamydophila pneumoniae ab.igg:prthr:pt:ser:ord:ia||irf-pai v4.0 - quality indicators - admission [cms assessment]||random
biopsy esophageal malignant lymphoma marginal zone b-cell (procedure)||coconut water||random
avobenzone 3 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 5 g in 100 ml topical cream [fevanzon revitalizing cream]||y chromosome deletion [identifier] in blood or tissue nominal||random
part of endoplasmic reticulum cistern||leptodactylon pungens||random
guidance for percutaneous biopsy:finding:to identify measures at a point in time:chest>mediastinum:document:computed tomography||disorder of tendon of right hand (disorder)||random
post procedural complication||neurohypophyseal peptides||random
cholagogues, choleretics||magnetic resonance imaging of thoracic spine: perispinal mass of t12 vertebra with hypointense t2 signal (procedure)||random
medical and surgical @ urinary system @ revision @ ureter @ open||familial; erythrocytosis||random
encounter for fitting and adjustment of partial artificial right arm||x-hist dm 3mg-2mg-2mg/ml pediatric drops||random
fracture of other tarsal bones||osmolality (body fld) [osmolality]||random
cytosine deoxyribonucleoside||sliding plasty of tricuspid papillary muscle||random
retinal ischaemia||bdi0104||random
antigen test for detection of clostridium difficile toxin in stool||pyridoxine 25 mg||random
ruscogenin topical product||hb (hemoglobin) determination reagents||random
m-toluidine||serum total t4 measurement (procedure)||random
laryngoscopic vocal cord polypectomy (procedure)||left fourth lumbar nerve||random
cells.cd22+cd19+/100 cells:number fraction:to identify measures at a point in time:body fluid, unsp:quantitative||unclassified pegomya||random
[x]glomerular disorders in diabetes mellitus||medical and surgical @ head and facial bones @ reposition @ palatine bone, right @ external @ no device||random
aminobacter sp. mdw-2||dorsal part of pons||random
prostaglandin i2 (prostacyclin) synthase||lower lid ectropion with retraction (disorder)||random
choroidal and/or retinal structures||sprain of anterior cruciate ligament of left knee, init||random
hydroxytriazolam (substance)||born in jamaica (finding)||random
fet ts 21 risk wbc.dna+cfdna qn||cubitermes sp. t37||random
ferrous succinate / succinic acid pill||chest>heart||random
fusarium sp. zg-3-1-3||control of gene expression by vitamin d receptor||random
unclassified cnemoplites||th||random
numbers (numerals)||minimal or lack of speech||random
helminth+arthropod identified:presence or identity:to identify measures at a point in time:not specified:nominal:rearing/culture||esophageal diseases||random
splenic t lymphoblastic lymphoma||carya alba pollen 0.0004 g in 1 ml / carya illinoinensis pollen 0.0004 g in 1 ml / ambrosia trifida pollen 0.0000266 g in 1 ml / ambrosia artemisiifolia pollen 0.0000266 g in 1 ml / ambrosia psilostachya pollen 0.0000266 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / cynodon dactylon pollen 80 [bau] in 1 ml / juniperus virginiana pollen 0.002 g in 1 ml / populus deltoides pollen 0.00008 g in 1 ml / betula nigra pollen 0.00008 g in 1 ml / fraxinus americana pollen 0.0004 g in 1 ml / quercus alba pollen 0.00008 g in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / chenopodium album pollen 0.01 g in 1 ml / iva annua var. annua pollen 0.01 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml intradermal injection, solution||random
raspberry tongue||product containing only enalapril maleate 2.5 mg/1 each oral tablet (clinical drug)||random
anterior wedging of the 12th thoracic vertebra||algoriphagus yeomjeoni||random
enzymes||does not cough up sputum||random
right auricular appendage||unclassified curtobacterium||random
blood alkaline phosphatase intestine||anular pancreas||random
down-regulation of jak-stat cascade||tenderness on palpation of both elbows at biceps insertion (physical finding)||random
other lacrimal gland dis. nos||congenital deformity of both upper limbs||random
extracavitary primary effusion lymphoma||radiant heater||random
radiotherapy to lesion of canthus||hereditary hemoglobinopathy due to globin chain mutation (disorder)||random
chironomidae sp. bioug02205-d12||desbruyeresia||random
crass-like phages||penetrating abdominal aortic ulcer||random
ankylosis-upper/arm||marine virus afvg_25m451||random
viburnum opulus bark 3 [hp_x] in 1 ml / magnesium phosphate, dibasic trihydrate 8 [hp_x] in 1 ml / estrone 12 [hp_x] in 1 ml / pulsatilla vulgaris 12 [hp_x] in 1 ml / sodium borate 30 [hp_x] in 1 ml / mercurius solubilis 30 [hp_x] in 1 ml / nitric acid 30 [hp_x] in 1 ml / silicon dioxide 30 [hp_x] in 1 ml / thuja occidentalis leafy twig 30 [hp_x] in 1 ml oral liquid [gyno complex]||rage vc1 protein||random
midazolam/creatinine [mass ratio] in urine by confirmatory method||conjugated bile acids (substance)||random
superficial fascia of female breast proper||acid, gallic||random
docosahexaenoic acid 500 mg / eicosapentaenoic acid 760 mg / omega-3 acid ethyl esters (usp) 190 mg oral capsule||cecidomyiidae sp. bold:acd3343||random
hormone-refractory breast cancer||longitudinal deficiency, ulnar, complete or partial (with or without distal deficiencies, incomplete)||random
unclassified bryopsidales||bitten by duck||random
wedge compression fracture of first thoracic vertebra, subsequent encounter for fracture with routine healing||late effect of complication of pregnancy, childbirth, and the puerperium||random
atropine / diphenoxylate||mucous membrane of floor of mouth||random
zoton oral product||neoplasm of autonomic nerves of flank (diagnosis)||random
herpes simplex dermatitis of eyelid (diagnosis)||ferate 256 mg (iron 28 mg) oral tablet||random
pantoprazole 2 mg/ml oral solution||right anterior deep temporal artery||random
sudden onset of cold leg (symptom)||phenytoin oral capsule [epanutin]||random
myochrous denticollis||unspecified superficial injury of left thigh, sequela||random
unclassified maullinia||benzalkonium chloride 1.3 mg/ml / benzocaine 75 mg/ml [viroxyn]||random
agelasine g||night sweats:finding:24 hours:immune system:ordinal:reported.hiv-ssc||random
[m]other monocytic leukaemia nos||urostrophus||random
protein, rxr||large b-cell lymphoma [type] in tissue||random
salivix pastille||cortisol^1.5h post xxx challenge:scnc:pt:ser/plas:qn||random
xylaria sp. pb3f3||anatomical planes set||random
hyaline cartilage of second metatarsal bone||chrysanthemum leucanthemum antibody.immunoglobulin e:arbitrary concentration:to identify measures at a point in time:serum:quantitative||random
x-ray of lumbosacral spine: osteophytes projecting anteriorly from vertebral bodies inferior endplate of l3 vertebra (procedure)||triplex dna binding||random
cortex (cerebral)||malignant tumor involving vulva by separate metastasis from endometrium||random
pain of volar aspect of both forearms elicited by active supination (physical finding)||white matter disorder due to vascular abnormality (disorder)||random
salicylic acid 20 mg in 1 ml topical gel [clear skin days clarifying serum]||adargileukin alfa||random
implant site pustules||medical and surgical @ peripheral nervous system @ destruction @ sacral sympathetic nerve @ percutaneous endoscopic||random
right thyroepiglotticus||alcohol 36.58 ml in 59 ml topical gel [prevail hand sanitizer lemongrass]||random
isopropyl alcohol 70 ml in 70 ml topical gel [blue gallonhand sanitizer]||penicillin-resistant streptococcus pneumoniae infection||random
personal history of diseases of the musculoskeletal system and connective tissue||computed tomography arteriography of pulmonary artery with contrast||random
uroporphyrin/porphyrins.total:sfr.df:24h:urine:qn||biological reservoir||random
aethusa cynapium 10 [hp_x] in 59 ml / althaea officinalis root 10 [hp_x] in 59 ml / aluminum oxide 10 [hp_x] in 59 ml / antimony trisulfide 10 [hp_x] in 59 ml / arsenic trioxide 10 [hp_x] in 59 ml / baptisia tinctoria root 10 [hp_x] in 59 ml / bismuth subnitrate 10 [hp_x] in 59 ml / activated charcoal 10 [hp_x] in 59 ml / matricaria recutita 10 [hp_x] in 59 ml / cinchona officinalis bark 10 [hp_x] in 59 ml / collinsonia canadensis root 10 [hp_x] in 59 ml / citrullus colocynthis fruit pulp 10 ml in 59 ml / gamboge 10 [hp_x] in 59 ml / graphite 10 [hp_x] in 59 ml / gratiola officinalis 10 [hp_x] in 59 ml / juglans cinerea branch bark/root bark 10 [hp_x] in 59 ml / skim milk 10 [hp_x] in 59 ml / cow milk 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / strychnos nux-vomica seed 10 [hp_x] in 59 ml / podophyllum 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / silicon dioxide 10 [hp_x] in 59 ml oral liquid [lower gi relief]||podarcis sp. db19585||random
fractured scaphoid||celleporaria||random
medical and surgical @ hepatobiliary system and pancreas @ reposition @ hepatic duct, right @ percutaneous endoscopic||methandriol (substance)||random
medical and surgical @ urinary system @ dilation @ bladder neck @ percutaneous||benign neuroendocrine neoplasm of sigmoid colon||random
rnax diet actions||deep fascia of leg||random
plazomicin sulfate@500 mg/10 ml (50 mg/ml)@intraven@vial (ml)||coproica sp. ttmdi809-10||random
glucose^2 hours post 75 g glucose oral:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||octinoxate 0.068 g in 1 g topical lipstick [esika pro hd color matte high definition color spf 20 rosa viva mate - pink]||random
fpr-rs6 protein, mouse||insect-related poisoning||random
c ab [titer] in serum or plasma||hystrix brachyura (organism)||random
acantholichen sorediatus||bacterial urinary tract infection||random
spine magnetic resonance imaging thoracic osseous mass enhanced with gadolinium t10 anterior||fetus+chorioamnionitis||random
sorilux 0.005% topical foam||astler-coller c1 colon carcinoma||random
patient summary:finding:to identify measures at a point in time:^patient:document||knee reoperations||random
tyrozets||proto-oncogene protein, erbb-1||random
malignant neoplasm of other sites of rectum, rectosigmoid junction, and anus||campylobacter sp identified:prid:pt:body fld:nom:organism specific culture||random
leadwort family||ptosis of eyebrow (physical finding)||random
urocoptoidea||chronic tension-type headache (diagnosis)||random
assura drainable ileostomy bag||other contact with nonvenomous snake, subsequent encounter||random
anterior segmental instrumentation of 4-7 vertebral segments||solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 protein, human||random
stoma site haemorrhage||neoplasm by histology||random
quinupristin+dalfopristin (substance)||drainage of left vitreous, percutaneous approach, diagnostic||random
defects in the complement system (diagnosis)||unclassified megalopinus||random
incenter patients who transferred to other dialysis unit population #||orientocoluber||random
black and blue||recurrent intravascular b-cell lymphoma||random
division of perineum tendon, perc endo approach||cognitive techniques of affect and behavior change||random
structure of collecting tubule (body structure)||lack of bone formation||random
closed fracture of ramus of left mandible (disorder)||abhydrolase domain-containing protein 16a, phospholipase||random
cell interactions||enteropathy associated t-cell lymphoma||random
magnetic resonance imaging of ankle: appearance of right posterior tibial tendon (procedure)||malignant tumor of duodenum (disorder)||random
fevers, japanese spotted||foot laceration||random
ivd test reagent/kits, molecular assay, gene anomaly, deletion/duplication, slc9a6||unspecified perichondritis of pinna (disorder)||random
displ suprcndl fx w/o intrcndl extn low end unsp femr, 7thc||drown due to falling or jumping from burning canoe or kayak||random
acute interstitial pneumonitis||allium schoenoprasum||random
[d]chronic retention of urine (context-dependent category)||ceratobasidium cornigerum||random
diffuse small cleaved cell lymphoma (intestinal t-cell lymphoma) (working formulation)||salicylic acid 5 mg in 1 ml topical gel [clearcalm non-drying acne treatment]||random
chronic oedema of legs||c bot tox spec ia||random
herpes simplex virus igm &#x7c; serum &#x7c; microbiology||vaccine-induced seroconversion||random
drisapersen sodium||inbred shr rat||random
referral to surgical fitter (procedure)||metastatic primary peritoneal carcinoma||random
perinatal pulmonary collapse nos||open wound lower extremity foot heel||random
operative procedure on bone of lower extremity (procedure)||candidatus liberibacter sp. 432-2||random
systemic periarteritis nodosa||potassium-removing resin||random
ixodes||product containing precisely lamivudine 300 milligram/1 each conventional release oral tablet||random
congenital hypoplastic anemia||blood 1,25-dihydroxycholecalciferol decreased||random
fluid output.pericardial drain:volume rate:1 hour:pericardial space:quantitative||raillietina species||random
benhydramin||alpha-1 anti-trypsin low||random
familial renal cancer||pn1: metastasis with a lymph node mass 2 cm or less in greatest dimension and less than or equal to 5 nodes positive, none more than 2 cm in greatest dimension (testis) (finding)||random
mononuclear cells/100 leukocytes in pericardial fluid by automated count||emollient bath additives (product)||random
proteasome localization to nuclear periphery||streptococcus pneumoniae 20 ab.igg^2nd specimen/1st specimen:ratio:pt:ser:qn||random
foreign body granuloma of colon||head turn for treatment of swallowing dysfunction||random
4-amino-3-chlorophenyl hydrogen sulfate||drainage of abdominal wall abscess||random
removal of blood clot from ureter by incision||flexion strength of ring finger (physical finding)||random
hemorrhagic mucosa of duodenum (disorder)||gtp diphosphate-lyase (cyclizing; 3',5'-cyclic-gmp-forming) activity||random
secondary parkinsonism||i was too tired to do things outside in past 7d:find:7d:^patient:ord:promis||random
sf303 cpd||medical and surgical @ gastrointestinal system @ fragmentation @ transverse colon||random
veillonella sp. sp4-iso-1_h08x2||drb5*0101 (substance)||random
horse dander specific immunoglobulin e (substance)||microgametophyte development||random
tacca j.r.forst. & g.forst., 1775||unclassified apalacris||random
demifacet of manubrium for second costal cartilage||alpelisib 50 mg oral tablet [piqray]||random
unclassified gibellula||lepidoptera sp. bold:aac0983||random
tear disorder||endoplasmic reticulum protein-containing complex||random
parkinson disease 14||superior labial branch of maxillary nerve (body structure)||random
skin tag of volar aspect of left upper arm||vegetable crumble (substance)||random
sciaridae sp. bold:aci3053||thyroid hormone organification defect||random
acquired varus deformity of limb (disorder)||erythema; elevatum diutinum||random
meperidine hydrochloride 100mg tablet (product)||fradizine||random
proconvertin||distal tendon of left gastrocnemius||random
paraprotein measurement (procedure)||left cochlear nerve||random
capsaicin 0.25 mg/ml / histamine dihydrochloride 0.75 mg/ml topical cream||grade 2 bloating||random
other peritonitis||age at death of female cousin #2 by father's brother #4 (history)||random
pathologic stage iib esophageal adenocarcinoma ajcc v8||venule of dermis||random
diethyl ether:mass concentration:to identify measures at a point in time:urine:quantitative||eupselia sp. anicmk47||random
fimbrial; cyst||rip3||random
lecidea ach., 1803||metastatic extraosseous myxoid chondrosarcoma||random
momes syndrome||ghi protein, salmo salar||random
t12 segment of dorsal gray column of spinal cord||pyrenochaeta sp. 04090205a||random
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial||cranioleuca||random
supination contracture of wrist (disorder)||malignant small cell neoplasm of retina (diagnosis)||random
cecidomyiidae sp. bioug09022-g03||alanine 8.8 mg/ml / arginine 4.89 mg/ml / calcium chloride 0.004 meq/ml / dibasic potassium phosphate 2.61 mg/ml / glucose 100 mg/ml / glycine 4.38 mg/ml / histidine 2.04 mg/ml / isoleucine 2.55 mg/ml / leucine 3.11 mg/ml / lysine 2.47 mg/ml / magnesium chloride 0.01 meq/ml / methionine 1.7 mg/ml / phenylalanine 2.38 mg/ml / proline 2.89 mg/ml / serine 2.13 mg/ml / sodium acetate trihydrate 2.97 mg/ml / sodium chloride 0.013 meq/ml / threonine 1.79 mg/ml / tryptophan 0.77 mg/ml / tyrosine 0.17 mg/ml / valine 2.47 mg/ml [clinimix e 4.25/10]||random
x-ray of pelvis and hips, ap and lateral views||tap binding protein (tapasin) gene||random
excision of ganglion of foot||health public service||random
fee for service||infant development inventory:-:to identify measures at a point in time:^patient:-:idi||random
methylmalonic aciduria/homocystinuria gene panel reagents||sprains and strains of sacroiliac region||random
acridines||genus chaetasbolisia||random
neonatal mastitis||carbidopa 50 mg / l-dopa 200 mg extended release oral tablet||random
furuncles on both supraclavicular regions of chest (physical finding)||synovial fluid crystal present||random
keratoconjunctivitis sicca, in sjögren's syndrome||linospadix longicruris (becc.) burret||random
accidental fluorouracil poison||structure of lymphatics of heart and pericardial sac||random
madhucas||trypanosomiasis meningit||random
myotube differentiation||eap2||random
sodium stannate||unclassified pherocera||random
prelaminar branch of spinal branch of right third lumbar artery||unsp microorganism dna naa+probe ql||random
treat knee fracture(s)||t1-t6 fx-cl/cen cord syn||random
anystidae sp. bioug22414-b04||linoleic acid 300 mg oral capsule||random
sandrow syndrome||burkholderia sp. c24||random
zinc oxide 86 mg in 1 ml / titanium dioxide 65 mg in 1 ml topical cream [sun shield spf 50]||cholangiocarcinoma, intrahepatic, malignant||random
estradiol enanthate (substance)||adamts19 antisense rna 1||random
assisted circulation||aicardi's syndrome||random
aeromicrobium panaciterrae||bromperidol, 82br-labeled||random
avobenzone 2.7 g in 100 kg / homosalate 9.0 g in 100 kg / octisalate 4.5 g in 100 kg / octocrylene 9.0 g in 100 kg topical cream [line interception power duo day cream suncreen broad spectrum spf 30]||x-ray of hip, von rossen view||random
excision of lesion of lip||adenoid cystic carcinoma of submandibular gland (diagnosis)||random
hh18||secretin porcine||random
fibrous layer of articular capsule of right t11-t12 vertebral arch joint||alpha-2c adrenoreceptor||random
codeine phosphate 60 mg||anti-epileptic agent [epc]||random
tipranavir 100mg/ml oral solution||abdomen>liver||random
hospital admission emergency neurosurgical||cerebral cavernous malformations 1 protein||random
gastric ec-cell serotonin-producing neuroendocrine tumor||gatifloxacin product||random
ether product||thistles, common||random
cylicodiscus harms, 1897||structure of corneal endothelium||random
gyalecta caudiospora||acetone measurement (procedure)||random
bone head of femur||serv cardiol hosp||random
spleen ischemia||reduction of open fracture without manipulation (procedure)||random
acid synthases, fatty||repeat prescription monitoring status (finding)||random
open fractures involving skull or face with other bones, with cerebral laceration and contusion, with brief [less than one hour] loss of consciousness||pantothenic acid preparation (substance)||random
history of - meningitis||congenital abnormality of urinary system||random
haematoma of right orbit||pmf - progressive massive fibr||random
factors, gdp exchange||narcissisms||random
debridement of open fracture of hand, nos||staphylococcus aureus enterotoxin c||random
central segment of ulnar nerve||entire anterior recurrent tibial artery||random
x-ray skull fracture paranasal sinuses maxillary left||leptospira interrogans serovar panama antibody:presence or threshold:to identify measures at a point in time:serum:ordinal:agglutination||random
partly unossified atlas at birth||tarasa rhombifolia krapov.||random
allopurinol / lesinurad oral tablet [duzallo]||streptococcus equi||random
infection caused by spirocerca lupi (disorder)||agitated depression||random
oxygen saturation||aluminum zirconium tetrachlorohydrex gly 15.2 g in 100 g topical stick [axe signature forest antiperspirant deodorant]||random
oth ob surg compl-postpa||unclassified netelia||random
animi-3 pill||polypedilum sp. bioug27391-g12||random
lyell||kounis syndrome type ii||random
plasma cell myeloma by iss stage||unclassified carininidae||random
sexual harrassments||cryptococcus antibody test||random
pseudomonas sp. wxbsy1||endosulfan i:mass content:to identify measures at a point in time:not specified:quantitative||random
diabetes; cataract (manifestation)||6,6'-dithiobis-2-naphthalenol||random
guidance for venous sampling of adrenal vein||about how often did you eat fruit (not juices) in past 12 months [phenx]||random
mycoplasma capricolum subspecies capripneumonia antigen:presence or threshold:to identify measures at a point in time:not specified:ordinal||callicebus pallescens||random
removal of foreign body from rectum (procedure)||healthcare econ organ||random
amaranthus retroflexus pollen extract 0.1 gm/ml injectable solution||gamma-ketovaleric acid (substance)||random
x-ray of humerus: mixed lytic and sclerotic lesion of right proximal humerus (procedure)||dressing,low adherence and wound contact materials||random
congenital smallness||hydrocodone bitartrate 50 mg oral capsule, extended release [zohydro er]||random
aluminum magnesium silicate / magnesium hydroxide / simethicone pill||clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8||random
stiff gait||renal tubule adenoma||random
hydrocortisone 1 mg [alkindi]||removal of internal fixation device from left acetabulum, external approach||random
qudexy xr 25 mg 24 hr extended release oral capsule||lepidoptera sp. bold:aac7737||random
rivastigmine 1.5 mg [exelon]||coffee bean allergenic extract 100 mg/ml injectable solution||random
magnetic resonance imaging of heart for morphology: left ventricle (procedure)||polydextrose (substance)||random
forearm &#x7c; computed tomography &#x7c; radiology||4-amino-6-methylthio-1-(2',2'-diethoxyethyl)-1h-pyrazolo(3,4-d)pyrimidine||random
congenital hypoplasia of odontoid process of axis (disorder)||upregulation of telomeric d-loop disassembly||random
injection site thrombosis||muscle layer of right uterine tube||random
fluoroscopy and embolisation of mesenteric artery||triprolidine/pseudoephedrin/dm 0.938 mg-10 mg-4 mg/ml oral liquid (ml)||random
special screening examination for other protozoal diseases and helminthiases||injury of pancreatic duct (diagnosis)||random
uterine corpus endometrial stromal sarcoma by ajcc v8 stage||carbamide peroxide 6.5 mg in 100 ml auricular (otic) liquid [ear wax removal aid]||random
abdominal wall bleeding||pichia sp. nrrl y-11513||random
posterior surface of duct of seminal vesicle||burns of dorsal aspect of metacarpophalangeal joint of thumb of left hand||random
seminoma; unspecified site||microgastrinae sp. extraction586||random
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)||clostridium sp. culture jar-56||random
complex burn of lower limb||laceration of right forearm with aligned margins||random
peptide fragments||ethylene (substance)||random
parandra sp. ddm0029||common hepatic ductal adventitia||random
dobesilic acid oral product||tuberculosis of lung with cavitation, bacteriological or histological examination not done||random
di(2-ethylhexyl) phthalate [mass/volume] in water||glyoxylate reductase and hydroxypyruvate reductase||random
cervical segment of left dorsal gray column of spinal cord||poisoning by profenamine||random
nodes groin||garcinia||random
compact bone of superior articular process of thoracic vertebra||ligularia cass., 1816||random
recessus retroesophagealis||insecticide resistance||random
mers-cov rna bld ql naa+probe||esophageal neuroendocrine tumor g2||random
6-acetamido-6,8-dideoxy-erythro-galacto-octopyranosyl-1-oxyacetic acid||muscle fasciculus of levator labii superioris alaeque nasi||random
manipulation procedure by body site||carp protein, card-containing||random
administration @ physiological systems and anatomical regions @ introduction @ coronary artery @ open @ thrombolytic @ other thrombolytic||levothyroxine na 0.050mg/ml soln,oral,ud||random
anti-thyroid antibody negative||other seborrheic keratosis||random
3,5-dioxo-1,2-diphenyl-4-n-butylpyrazolidine||vendor model number:identifier:to identify measures at a point in time:refractive error device:nominal||random
quantitative measurement of mass rate of excretion of glucose in 24 hour urine specimen||spag5 protein, human||random
prkm8||firmiana platanifolia||random
normal serum ferritin||echinococcus granulosus ige ab rast class [presence] in serum||random
sds01-days unproductive||oral mucosal exfoliation||random
apibacter sp. b3546||stichopus||random
bony socket for right second lower premolar tooth||first aid instructional blanket||random
uperolein||computing, mathematic||random
bronchial polyp||sodium fluoride oral product||random
fractures, cartilage||ct kidney wo contr||random
t. vaginalis dna naa+probe ql (cvx)||seen in rheumatology clinic (finding)||random
polycentropus sp. gmycc32||carybdeida||random
fusaricidin a||cmt demyelinating gene targeted mutation analysis molgen doc (bld/tiss)||random
recept calcium||malignant angioendotheliomatosis||random
radionuclide ventriculography at cardiac rest||nannizziopsis crocodili||random
sugars multiple quant||azygos lobe fissure, lung||random
intrapulmonary part of pulmonary venous tree organ||binaural hearing aid, contralateral routing system, ite/ite||random
burning-watercr.nos-sub occup.||beryllium poisoning||random
influenza virus||nondisplaced fracture of distal phalanx of right middle finger, subsequent encounter for fracture with nonunion||random
fetal intrauterine intestinal perforation co-occurrent and due to congenital atresia of intestinal tract (disorder)||nutrition counseling||random
relapsed mpnst||ct scan arthrogram of joint lower extremity||random
napomyza||dappled diaphyseal dysplasia (disorder)||random
leg lengths||rutidosis leptorhynchoides||random
muscle flap operation||sexual trauma||random
boletina sp. bbdee922-10||vesciseta subgroup||random
cholinesterase reactivator (substance)||opiate-induced constipation||random
immunity, humoral||ercp: pancreas findings||random
influenza vaccine tv split 2013-14(18 yr,up) cell derived/pf 45 mcg (15 mcg x 3)/0.5 ml intramusc syringe (ml)||hymenoptera sp. bold:aau8455||random
adalimumab 40 mg/0.4 ml subcutaneous kit||unclassified arcticiflavibacter||random
maldescent of testis, unilateral (disorder)||vasculature of fifth thoracic vertebra||random
plaque on the fingers left index finger distal||creation of vascular bypass, nos||random
hematoporphyrin / procaine oral capsule||unclassified pratylenchus||random
marginal corneal ulcer of left eye (disorder)||barc type 0 bleeding||random
anthrax, unspecified||3-dimensional (3d) magnetic resonance imaging (mri) rendering with interpretation and reporting, and image postprocessing under concurrent supervision||random
unable to balance when sitting||ring chromosome 5 syndrome||random
tarache||cerebrospinal fluid wbc decreased||random
left multifidus cervicis epimysium||borrelia burgdorferi antibody.immunoglobulin g:arbitrary concentration:to identify measures at a point in time:body fluid, unsp:quantitative||random
activities involving walking and running||cmbl||random
blood corticosterone increased||ighmbp2, ala528thr||random
elderly primigravida, antepartum||s-liposomal doxorubicin||random
neurodevelopmental disorder with or without anomalies of the brain, eye, or heart||ultrasound therapy systems, tissue ablation||random
injection of heart||alanine / arginine / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine injectable product||random
closed torus fracture of radius (disorder)||[x]contact knife/sword os plce||random
rd114 sensitivity||homeopathic therapy (regime/therapy)||random
peptide bond formation||panperitonitis||random
corymbia citriodora leaf oil||camphor 1.5 % / menthol 1.5 % / methyl salicylate 5 % topical solution||random
xr knee - left pa w standing||arthrotomy of knee||random
chronic aggressive hepatitis (disorder)||malignant neoplasm of vulva staging regional lymph nodes n2/iva (diagnosis)||random
jewelry/precious metal worker||acetabular dysplasia||random
blood group antibody p<sub>2</sub> (substance)||discolouration of skin||random
epg222 protease, penicillium chrysogenum||plasmid||random
cd3+cd8+ (t8 suppressor cells) cells/100 cells (bronch spec)||repair of ulna||random
avobenzone 2 g in 100 kg / octinoxate 7.5 g in 100 kg / octisalate 3 g in 100 kg topical cream [anti-aging eye broad spectrum spf 15 la prairie switzerland]||tramadol hydrochloride 200 mg oral tablet, extended release_#2||random
prostaglandin-e>2< 9-ketoreductase (substance)||ranolazine 1000mg tab,sa||random
callionymus olidus gunther, 1873||precursor cell lymphoblastic lymphoma of lung (diagnosis)||random
microscopic observation:presence or identity:to identify measures at a point in time:lymph node.fine needle aspiration:nominal:cytology stain||disorders, nasal||random
embryonic cyst of adnexa||position prone||random
legal physical restraint performed (context-dependent category)||oth physeal fracture of upper end of radius, left arm, init||random
calcification; adrenal||neoplasm of anal canal (diagnosis)||random
supramarginal area 40||frequent snacking||random
discoveries drug||guaiacolsulfonate / hydrocodone oral product||random
planning, development||lateral surface of tendon of long head of triceps brachii||random
supplement cervical vertebral disc with autologous tissue substitute, percutaneous endoscopic approach||stomach cancer, metastatic||random
diazepam tiss cfm-mcnt||type iii hypersensitivity reaction||random
park7 gene targeted mutation analysis molgen nom (bld/tiss)||ocular hemangiopericytoma||random
admission evaluation note:finding:to identify measures at a point in time:hospital:document:nurse||dilated superficial veins of superior medial quadrant of left breast||random
reported puncture wound of toe by single bullet||implant site dermatitis||random
application to mental health review tribunal by the patient under section 66 of the mental health act 1983 (england and wales)||phentermine oral tablet||random
heartgard plus||puncture wound of forearm (diagnosis)||random
gpr39 wt allele||(congenital limb deformity nos) or (pes cavus) or (claw toe) or (dysmorphic toes) or (larsen's syndrome)||random
percutaneous fine needle aspiration biopsy of breast using imaging guidance||bupivacaine hydrochloride, 0.5% preservative-free injectable solution||random
bovista polymorpha||endoscopic occlusion of right fallopian tube using fallopian tube occlusion insert||random
impatiophila pulla fu & gao, 2016||cytoplasmic||random
l-glutamic acid, polymer with l-alanine, l-lysine and l-tyrosine||epiphysis||random
centriacinar emphysemas||nyssomyia sp. ipg sgb124||random
compl rpr t-fallot w/pulm atresia||can exact number of adenomas be determined:find:pt:^patient:ord:phenx||random
anterior subluxation of left sternoclavicular joint, init||genital neoplasm, male||random
lachesis venom||unclassified ansonia||random
spondylolisthesis; degenerative||campylaimus gerlachi||random
myocardial infarction acute after cabg||ih antibody||random
vegebanger (substance)||sdhaf1, gly57arg||random
acetylphenol||vesicularia reticulata (dozy & molk.) broth.||random
cytosolic chaperonin||isomerases, ketose-aldose||random
western equine encephalitis virus ab:prthr:pt:csf:ord:comp fix||bacitracin zinc 0.5 unt/mg||random
micropsectra sp. bioug21287-b10||magnetic resonance imaging urography||random
effects of heat and light, unspecified||otitis externa due to pseudomonas aeruginosa||random
arthrogryposis multiplex congenita, neurogenic, with agenesis of the corpus callosum||cellulomonas (organism)||random
shaft of penis||chloroflexi bacterium 13_1_40cm_2_67_6||random
benzalkonium chloride 0.188 g in 50 / didecyldimonium chloride 0.188 g in 50 / alcohol 40 ml in 50 extracorporeal cloth [alcohol wipes]||vascular device infection||random
fusion of left hip joint with nonautologous tissue substitute, open approach||fusion of thumb||random
equipment observation||structure of bone of left femur (body structure)||random
kanamycin a sulfate (medication)||lateral part of right leg||random
amyl nitrite 0.18 ml nasal inhalant||infection by parafilaria||random
multisynostotic osteodysgenesis||streptomyces sp. lbum 1478||random
autoimmune chronic hepatitides||ear finding||random
bacterium symbiont of siboglinum cf. poseidoni||econazole:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:gradient strip||random
ny-ren-41||skin crust circular in shape [as symptom]||random
dislocation of unsp interphalangeal joint of l mid finger||prosimulium mixtum||random
open division of tendon of upper arm||tissue transglutaminase antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal||random
chronic non-pressure ulcer of the left ankle (diagnosis)||mitochondrial dis||random
chaunocephalus||visual brightness||random
unclassified dasyatis||subdivision of splenic artery||random
1,3-propanediol, 2-methyl-2-propyl-, dicarbamate||phenylbutyrate oral product||random
insertion of stent into vein||unclassified metaceronema||random
orajel baby 7.5 % topical swab||cisplatin/cytarabine/methylprednisolone/pixantrone||random
under care of int care splst||childhood cns germinoma||random
alternaria lolii||structure of ligament of sacroiliac joint and pubic symphysis (body structure)||random
gentamicin 0.3% pres free e/d||st2.soluble ia (s) [mass/vol]||random
phosphoglyceride metabolic process||[x]intentional self harm by hanging, strangulation and suffocation, occurrence at unspecified place (finding)||random
new technology @ cardiovascular system @ dilation||chryseobacterium sp. na405||random
cl skull fx nec-coma nos||unclassified paramphistomoidea||random
medical and surgical @ lower veins @ extraction @ foot vein, right @ open @ no device @ no qualifier||sordariomycetes sp. p10572em1cc945||random
carcinoma neuroendocrine||florajen bifidoblend||random
lesions toes||urine organic acids (& level)||random
montecrinane b||n-(1-((2,4-diamino-6-pteridinyl)methyl)-3,4-dihydro -2h-1,4-benzothiazine-7-carbonyl)-l-2-aminoadipic acid||random
common iliac artery penetrating ulcer||unclassified draconematidae||random
pathology report reviewed:id:pt:specimen:nom||ovarian monodermal and highly specialized teratoma||random
yohimbine 5.4 mg||total score:score:to identify measures at a point in time:^patient:quantitative:bomc||random
folliculitis of lids (disorder)||right ventricular pressure||random
avobenzone 3 g in 100 ml / homosalate 10 g in 100 ml / octisalate 4.5 g in 100 ml / octocrylene 5.5 g in 100 ml / oxybenzone 5 g in 100 ml topical lotion [mary kay suncare sunscreen broad spectrum spf 50]||ct lungs diagnost pneumothorax||random
delusional disorder, persecutory type||arteriovenous malformation, intracranial||random
muscles supraspinatus||family size||random
informed of reason for referral (situation)||[m]ductal/lobular/medull.neop.||random
trithuria austinensis||strain extn musc/fasc/tend r rng fngr at forarm lv, sequela||random
structure of half of thorax lateral to midsagittal plane (body structure)||extirpation of matter from right ankle joint, open approach||random
zinc oxide 17 g in 100 g topical lotion [baby mineral spf 50]||orange oil oil||random
cecidomyiidae sp. bioug32050-h02||washing machines||random
cocaine hydrochloride 40 mg in 1 ml nasal solution [numbrino]||burns of radial aspect of interphalangeal joint of thumb of right hand||random
apnea test abnormal||aneurysmectomy (procedure)||random
risperidone 3 mg oral tablet, disintegrating [risperdal m-tab]||pseudomonas sp. saj4||random
aspartate/creatinine&#x7c;mrto&#x7c;urine||betula lenta pollen 0.0166666 g in 1 ml / betula nigra pollen 0.0166666 g in 1 ml / betula populifolia pollen 0.0166666 g in 1 ml percutaneous solution [birch pollen mix]||random
subcutaneous tissue structure of ankle (body structure)||articular facet of second metatarsal||random
tendon therapeutic procedures||japanese encephalitis virus inactivated antigen||random
beta globulin||fluoroscopic angiography of left adrenal vein with iv contrast||random
medical and surgical @ upper arteries @ reposition @ hand artery, left @ percutaneous endoscopic @ no device @ no qualifier||avobenzone 90 g in 1 g / homosalate 2250 g in 1 g / octisalate 250 g in 1 g / octocrylene 8 in 1 g topical spray [sunscreen]||random
i am satisfied with my ability to work (include work at home):finding:to identify measures at a point in time:^patient:ordinal:promis||skin cyst of cheek||random
new relationship (finding)||n. caninum ab ia qn (s)||random
6-phosphogluconate dehydrogenase measurement, erythrocytes||pinguiophyceae||random
specimen from pancreas (specimen)||dixioria||random
paraphaeosphaeria sp. 113a||nvp018||random
docosahexaenoate chewable tablet||ilheus virus ribonucleic acid:presence or threshold:to identify measures at a point in time:not specified:ordinal:probe.amp.tar||random
methanosphaera sp. iso3-f5||right v6b||random
clouded consciousness (finding)||chiropractic @ anatomical regions @ manipulation @ sacrum @ external||random
normal menopause||food in esophagus causing other injury||random
miconazolum||methylcellulose (with sugar) 2 gram/19 gram oral powder (gram)||random
chromosomes, human, pair 17||serinus canicollis sassii||random
psychotic symptoms respond to antipsychotic medications:find:pt:^patient:ord:di-pad cgp v 1.4||nqrf protein, vibrio alginolyticus||random
stereotactic||clsr rectovag fstl tprnl prnl bdy rcnstj||random
zileuton@600 mg@oral@tablet,extended release multiphase 12 hr||intervention regime||random
adenovirus ag:prthr:pt:stool:ord:if||unclassified plutellus||random
inhibition of sprouting angiogenesis||cymbopogon schoenanthus leaf||random
desmethoxyyangonin||cardiac therapeutic procedures||random
bbs18||imaging @ respiratory system @ computerized tomography (ct scan) @ tracheobronchial tree, right @ other contrast @ unenhanced and enhanced @ none||random
deformity, nos||formation of syndactyly of toe||random
sporadic diffuse gastric adenocarcinoma||pronounce brobdingnagian nih||random
intentional vincristine poisoning||propionicin sm1||random
stage i ureter cancer ajcc v8||basal cell carcinoma of left upper extremity (diagnosis)||random
morphine sulfate@90 mg@oral@capsule,extended release multiphase 24hr||contracture of toe joint||random
northern pike||bacterial infections oral||random
insulin porcine ab:acnc:pt:ser:qn||lethe diana (butler, 1866)||random
benzalkonium chloride 1 mg in 1 ml topical soap [new wave cleaning solutions foaming hand sanitizer]||ulcer of perineum tissue base granulation (physical finding)||random
medical and surgical @ mouth and throat @ supplement @ larynx||anatomic location directly invaded by primary malignant neoplasm||random
aminodeoxychorismate lyase||douglas fir pollen extract 50 mg/ml injectable solution||random
dehydroepiandrosterone sulfate^6th specimen post xxx challenge:mcnc:pt:ser/plas:qn||outcome of delivery||random
medical and surgical @ upper veins @ dilation @ brachial vein, left @ percutaneous endoscopic @ no device||thoracic spine crepitus palpable (finding)||random
chamerion angustifolium ab.ige.rast class:prthr:pt:ser:ord||campylobacter sp identified||random
phenazopyridine hydrochloride 50 mg||magnetic resonance imaging of heart for morphology: left ventricle inflow decreased (procedure)||random
phenax germar, 1833||transverse and oblique lie; maternal care||random
estrogens, esterified (usp) 1.25 mg / methyltestosterone 2.5 mg [covaryx]||cl skull vlt fx/hem nec||random
anorectal squamous cell metaplasia||bathroom (environment)||random
left anterior bronchopulmonary segmental parenchyma||po2 eating room air max bldc tco2||random
i am bothered by being shorter than other people in the past 4w:find:4w:^patient:ord:facit||acute monocytic leukemia, morphology||random
organic acid analysis abnormal||primnoidae||random
medical and surgical @ upper bones @ release @ humeral shaft, left @ percutaneous endoscopic @ no device||phospho-jet||random
subluxation of unspecified interphalangeal joint of specified finger with unspecified laterality||application of skin substitute graft of foot, total wound surface area 100.0 sq cm or more, each additional 100.0 sq cm or less||random
blepharophimosis right upper eyelid||lens esculenta antibody.immunoglobulin e.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||random
pandanus welwitschii rendle||pythium sp. p19448||random
mitral valve regurgitant blood flow volume during systole by us.doppler+calculated by continuity vti||metastases to salivary gland||random
diffuse endocapillary proliferative glomerulonephritis (disorder)||xxx>spinal artery||random
pulm function rv change after bronchodilator as % of predicted value||lymph node malignant lymphoma follicular grade 3a (diagnosis)||random
yaws of bone (disorder)||basophils nfr.df bronch manual||random
allergy to buprenorphine||anterior superior segmental portal vein||random
lispro insulin in parenteral dosage form||hydrocortisone/iodoquinol 1 %-1 % topical cream (gram)||random
subgingival scaling (procedure)||apo-transcobalamin ii [moles/volume] in serum||random
monuron||prq trluml coronary angio/atherect one art/brnch||random
inferior longitudinal muscle of tongue||puncture of right side of neck with surrounding erythema||random
change of dressing (other than burns) under anesthesia (other than local)||coronary angiography: coronary artery bypass graft insertion site right posterolateral segment obstruction calcific||random
penicillin v potassium 250 mg per 5 ml oral solution||embryonic muscle cell||random
microbacterium sp. ecp9||mild pulmonary hypertension (disorder)||random
serum albumin, radio iodinated||rabies vaccine poisoning||random
mechanical complication of cardiac electrode (diagnosis)||gynostemma (plant)||random
alm-acral lentig melanoma skin||adenocarcinoma of intrahepatic bile duct (diagnosis)||random
pinus virginiana pollen extract 0.05 gm/ml injectable solution||kadsulignan p||random
embryonic lip||ophidium aculeatum||random
stiolto||carcinoma in situ of male genital organ (disorder)||random
epstein barr virus dna:lncnc:pt:xxx:qn:probe.amp.tar||hip and knee flexion [timp]||random
poisoning by oth antidysrhythmic drugs, self-harm||oncology admission history and physical note||random
pressure ulcer of right buttock, stage 1||condyline||random
wood sawyer||papule between fourth and fifth toes on right foot (physical finding)||random
closed truncal valvotomy (procedure)||jankowskia sp. lep4521||random
risk assessment and screening note:find:pt:custodial care facility:doc:{role}||d.choledochus; cyst||random
impaired bed mobility||intravascular mean &#x7c; great toe arteries left &#x7c; specific blood pressure||random
gymnometriocnemus sp. bioug21460-b12||left basal pneumonia||random
sprues||mouse ganglioneuroblastoma||random
omeprazole only product||cyanobacteria bacterium uba7694||random
fibroma of the ovary||torsion of spermatic cord||random
obliquus capitis inferior (body structure)||cecidomyiidae sp. bold:acd3343||random
endosymbiont of unclassified escarpiid||x-5108||random
vas deferens disorders||unionicola <genus>||random
calcium carbonate 328 mg / magnesium carbonate 172 mg oral tablet||tnf receptors||random
cmh4||bombus sp. bioug27888-c07||random
measurement of legionella species antibody (procedure)||drainage of left upper arm subcutaneous tissue and fascia, open approach, diagnostic||random
calf muscle||overexertion from lifting||random
alkaline phosphatase increased||fentanyl citrate, 1000 mcg/250 ml-nacl 0.9% injectable solution||random
chronic; pericarditis||unclassified saccharomonospora||random
exploratory thoracotomy||antisera, all fluorescent, leptospira spp.||random
p38 mitogen-activated protein kinase inhibitor ly3007113||emtricitabine / rilpivirine / tenofovir alafenamide oral tablet||random
sympetes sp. col1301||eiee5||random
product containing only hydrocodone and ibuprofen in oral dose form (medicinal product form)||prednisolone tertiary butylacetate (substance)||random
clostridium perfringens infections||meperidine hcl/pf 75 mg/ml injection ampul (ml)||random
cortex, cerebellar||neomusotima conspurcatalis||random
tb thoracic nodes-unspec||lower extremity cellulitis recurrent||random
eeev igm titr csf if||potassium azide||random
impatiens sect. tuberosae s.x.yu & wei wang, 2015||cheilanthes alabamensis (buckley) kunze||random
irish traveller (ethnic group)||lymphatic cyst||random
magnetic resonance imaging of thoracic spine: mass of right side of t2 vertebra with hyperintense t2 signal||subjective visual disturbance||random
goose feather ige ab [units/volume] in serum||magnetic resonance imaging of ankle: chronic complete tear of left anterior talofibular ligament (procedure)||random
edema thigh||stage ii vulvar cancer||random
bensylpenicillin||marinobacter sp. mh5||random
triclosan 0.35 % medicated liquid soap||bacillus sp. 43bk8y10||random
caustic alkalis causing toxic effect||chronic arthralgia of temporomandibular joint (disorder)||random
sulfur 50 mg/ml||polyisobutylene (1100000 mw)||random
rv contractility us+est||dexetimide hydrochloride||random
zinc oxide 200 mg in 1 ml topical lotion [argan stem cell bb benefit balm un-tinted sfp 30]||negative regulation of antibody-dependent cell death||random
small intestinal b-cell non-hodgkin lymphoma||antigens, cd158b||random
daclizumab (medication)||biologic phenomena||random
mesobatrachia sp. g8.3||short-term physical therapy goals increase range of motion of right ankle by (treatment)||random
intentional poisoning by topical/infiltration anesthetics||flulaval quadrivalent 2020-2021||random
patient condition determination||arteriosclerosis/ atherosclerosis||random
bentonite||entire ligament of distal interphalangeal joint of finger||random
5-methyltetrahydrofolate/folate:substance fraction:to identify measures at a point in time:serum/plasma:quantitative||platygastridae sp. bioug14903-a08||random
no carer||chlophedianol hydrochloride 12.5 mg in 30 ml / pyrilamine maleate 25 mg in 30 ml oral liquid [texaclear kids allergy]||random
metastatic malignant digestive system neoplasm||culturally sensitive prevention approach||random
product containing gilteritinib (medicinal product)||adult mesenchymal chondrosarcoma||random
tenotomy, flexor, palm, open, each tendon||d-152 sprains and strains of the lower extremities||random
herpes simplex virus 1+2 igm &#x7c; cerebral spinal fluid &#x7c; microbiology||speech/lang deficits following unsp cerebrovascular disease||random
arthrodesis nail, sterile||other specified functional disorder of intestine||random
nerve to thyroarytenoid||yeast bakers antibody.immunoglobulin e.rast class:arbitrary concentration:to identify measures at a point in time:serum:ordinal||random
carbamazepine 100 mg oral capsule, extended release||unspecified systemic agent causing adverse effects in therapeutic use||random
anomaly of external ear congenital||aluminum hydroxide 400 mg in 5 ml / magnesium hydroxide 400 mg in 5 ml / dimethicone 40 mg in 5 ml oral suspension [maximum strength antacid cherry]||random
hemoglobin baden||liotrix (liothyronine sodium 25 mcg / levothyroxine sodium 100 mcg) oral tablet||random
pholidoteuthis||gist, benign||random
transectn & oversewing pt||administration site joint effusion||random
vitamin b12 1 mg/ml prefilled syringe||polyepiphyseal dysplasia type 1||random
dee96||tester, nos||random
progression, disease||inflammation of skin||random
cyprostat pill||request for consultation, nos||random
deoxypyridinoline/pyridinoline:srto:pt:urine:qn||phorate serpl-mcnc||random
downregulation of dibenzo-p-diazine biosynthesis||deprecated||random
body fluid alpha-1-globulin measurement||cervical spine joint structure||random
varicella immunisation||bacterium nlae-zl-g378||random
ear canal mass||organic acidemia conditions suspected:presence or identity:to identify measures at a point in time:dried blood spot:nominal||random
glycerin 12 g in 200 ml / allantoin 0.6 g in 200 ml topical emulsion||antarctobacter sp. lts-7||random
12 hr dextromethorphan hydrobromide 28 mg / guaifenesin 835 mg extended release oral tablet||nondisplaced comminuted fracture of shaft of right femur, initial encounter for open fracture type i or ii||random
blepharitis/stye/chalazion||active range of shoulder flexion (observable entity)||random
ctx/dox/tmx/zdx||staurochilus sp. lior 012||random
pegintron 150 mcg injection||pn2a category||random
retina left eye||speech babble||random
peroneal tendinitis, right leg||octakis(2,3-dimethyl-6-o-sulfo)-gamma-cyclodextrin||random
salt light white ileostomy bag||encounter due to absence of family member||random
during the past 30d, on how many d did you drink one or more drinks of an alcoholic beverage:nrat:30d:^patient:qn:phenx||pharmacogenet||random
perforation of vagina following induced termination of pregnancy (diagnosis)||unclassified prismatomeris||random
bacitracin 0.5 unt/mg / lidocaine hydrochloride 0.04 mg/mg topical ointment||3-apfqa||random
abnormal thyroxine -retired-||unclassified hysterium||random
downregulation of lysosome organization and biogenesis||conjunctival laceration||random
ehv-4||structure of sweat gland of left upper eyelid||random
camellia, nos||i became easily upset in the past 7d||random
acyloxyacyl hydrolase activity||burning caused by caustic and corrosive substance (finding)||random
diffuse lesion||wash upper body - usual functional ability:finding:reporting period:^patient:ordinal:cms assessment||random
peroxo-titanate||rub, pleural||random
nizatidine 150mg capsule||edqm-hc administration device terminology||random
respiratory signs and symptoms nec||tc-99m-bicisate||random
av fistula maturation failure||infected rash||random
unit of erythrocyte analysis||maltreatment/abuse||random
open fracture of seven ribs||acute phlebitis; thrombophlebitis and thromboembolism||random
intrinsic factor blocking igg ab [units/volume] in serum by radioimmunoassay (ria)||3-o-(n-(p-fluorobenzenesulfonyl)carbamoyl)oleanolic acid||random
computed tomography of head: appearance of infratemporal fossa||pronator muscle||random
gastric granular cell tumor||partial ostectomy of facial bone (procedure)||random
dentatorubral-pallidoluysian atrophy (drpla)||ability to control behaviour||random
ft-ump||ser transfer rna||random
cell organisation||ivd test reagent/kits, molecular assay, gene anomaly, deletion/duplication, tbx5||random
drug catalogs as topic||deprecated speech pathology note||random
pregnant - on abdominal palpation (diagnosis)||xr hip-r ap+lat xtable||random
unclassified anthomyiidae||dhea pre 250 ug corticotropin [mass/vol]||random
articular facet of metatarsal bone||torulopsis infection||random
home aide care||diptera sp. bold:aam6646||random
sodium fluoride 0.559 mg in 1 ml oral mouthwash [xerostom]||benzalkonium chloride 1.5 mg in 1 ml topical gel [antibacterial refreshing hand wash aloe vera scented with softening aloe vera and vitamin e]||random
cynodon dactylon pollen 80 [bau] in 1 ml / ambrosia artemisiifolia pollen 160 [au] in 1 ml / ulmus americana pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / sorghum halepense pollen 0.0004 g in 1 ml / poa pratensis pollen 800 [bau] in 1 ml / chenopodium album pollen 0.0004 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / festuca pratensis pollen 800 [bau] in 1 ml / lolium perenne pollen 800 [bau] in 1 ml / phleum pratense pollen 800 [bau] in 1 ml / salsola kali pollen 0.0004 g in 1 ml intradermal injection, solution||unclassified nyssomyia||random
active range of thumb flexion||sighs/resp event setting vent||random
zuclopenthixol decanoate 100mg/2ml injection||xipamid ql (u)||random
chlorhexidine / phenylephrine topical cream||hand muscle tranplantation||random
bundle of hoche||breast hematoma (disorder)||random
intraaortic balloon pump||musculoskeletal and soft tissue imaging procedures||random
nondisp fx of glenoid cav of scapula, r shldr, 7thg||4-cyano-1-(2-iodophenyl)-5-(4-methoxyphenyl)-n-(piperidin-1-yl)-1h-pyrazole-3-carboxamide||random
passive extension of distal interphalangeal joint of index finger of left hand (physical finding)||spinal nerve root l4||random
coronary angioplasty catheter (physical object)||5-dimethylaminonaphthalene-1-sulfonyl-calmodulin||random
sores on left side of tongue (symptom)||555-561 order strongylida||random
sarcosine:acceptor oxidoreductase (demethylating)||lipid & glucose panel||random
injections, intra ocular||recurrent indolent adult non-hodgkin lymphoma||random
culicinae sp. bioug24639-c02||teaching about diversional therapy||random
pentastomidas||opacity of right corneal limbus (physical finding)||random
migration, transepithelial||promote liquid vanilla 1000ml||random
stage i nasal type nk/t-cell lymphoma||folic acid / teferrol / vitamin b12 oral liquid product||random
skin sensitivity, function||homologous recombination repair gene mutation||random
verrucous carcinoma of anal margin (diagnosis)||kiwi (ract d) 8 ige rast ql||random
structure of bone marrow of left hand (body structure)||laryngeal prosthes,blom-singer in2025-sl||random
spin labels||kermia aureotincta||random
phasiinae||dilation of 1 cor art with intralum dev, perc approach||random
regulation of ribonucleotide diphosphate reductase activity||x-ray teeth bone loss left upper first bicuspid||random
plaque abdomen entire lower (inferior)||unclassified elateridae||random
dinotrema sp. bioug06189-g11||nose/mouth/pharynx operatn nos||random
flowsheet:find:pt:{setting}:doc:endocrinology||family size, expected||random
eudyptes sp. clade x||camphor (synthetic) 4.7 g in 100 g / menthol 1.25 g in 100 g / eucalyptus oil 1.2 g in 100 g topical ointment [personal care vaporizing chestrub]||random
lemaireodirphia||family size||random
laxative habit||alcohol 3 ml topical cloth [sanitizing wipes]||random
repair stomach, percutaneous endoscopic approach||abnormality of the line of schwalbe||random
strength from family [living with hiv]||unclassified cicindela||random
s' wave dur l-v1||adnexa uteri cyst||random
perm lower lt central incisor||alanine 21.7 mg/ml / arginine 14.7 mg/ml / aspartate 4.34 mg/ml / glutamate 7.49 mg/ml / glycine 10.4 mg/ml / histidine 8.94 mg/ml / isoleucine 7.49 mg/ml / leucine 10.4 mg/ml / lysine 11.8 mg/ml / methionine 7.49 mg/ml / phenylalanine 10.4 mg/ml / proline 8.94 mg/ml / serine 5.92 mg/ml / threonine 7.49 mg/ml / tryptophan 2.5 mg/ml / tyrosine 0.39 mg/ml / valine 9.6 mg/ml [plenamine]||random
puncture wound of penis with foreign body (diagnosis)||galactostasis||random
blood immunoglobulin a normal||bed rails used for bed mobility or transfer:find:pt:^patient:ord:mds||random
magnetic resonance imaging of thoracic spine: perispinal mass of t9 vertebra with isointense t1 signal||ovarian germ cell endodermal sinus tumor stage iii c||random
computerized dynamic posturography sensory organization test (cdp-sot), 6 conditions (ie, eyes open, eyes closed, visual sway, platform sway, eyes closed platform sway, platform and visual sway), including interpretation and report; with motor control test (mct) and adaptation test (adt)||igh gene rearrang dir probe||random
bilateral femoral hernia, with gangrene||[x]drown+submer whil in natural water occ sport/athlet area||random
ticarcillin [susceptibility] by gradient strip||nitrofurantoin 100 mg prolonged-release oral capsule||random
bladder adenocarcinoma stage iv||anticoagulation not indicated||random
colon anterior resection||crystal identification by light microscopy urine sediment (lab test)||random
type 2 papillary renal cell cancer||inocybe sp. th9980||random
osteosarcoma, recurrent||device component missing||random
methylhistamine||21-(acetyloxy)-11,17-dihydroxypregn-4- ene-3,20-dione||random
corneal graft failure||crambidae sp. 1299||random
interferometry, microscopic||resisted stepping exercises requiring assistance||random
nodule of ala nasi (physical finding)||sugar, urine screen||random
calcium hydrogen phosphate anhydrous||pancreatic degenerative atrophy||random
hymenoptera sp. bold:aan0586||avipendekin pegol||random
tilapia ige rast class (s)||bone of proximal epiphysis||random
alysiinae sp. bioug21700-a12||gastrin^5th specimen post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||random
spontaneous hemorrhage of gingiva on distal surface of left maxillary lateral incisor||sacituzumab (substance)||random
coccidioides immitis antibody||transitional dentitions||random
left ventricular hypertrophy change:finding:to identify measures at a point in time:^patient:ordinal:esrd||blood pressure orthostatic decreased||random
somatosensory evoked potentials abnormal||hb alpha2 gamma2||random
rinderpest virus antigen:presence or threshold:to identify measures at a point in time:exudate:ordinal||timidity||random
articular cartilage of right superior articular process of twelfth thoracic vertebra||bradybaena||random
b-cell lymphoma-leukemia 10 protein||bartonella sp. cdc_skunk||random
glucotrol 2.5 mg extended release oral tablet||extranodal marginal zone b-cell lymphoma (malt type) nos||random
revision total knee arthroplasty||fatty casts ur ql comp assist||random
intraoperative hypotension||atpase||random
ivd test reagent/kits, molecular assay, gene anomaly, mutation, hadha||psychosis and psychotic disorders (smq)||random
incobotulinumtoxina 50 unt [xeomin]||ethanol metabolic process||random
shallow vestibular depth after teeth loss (disorder)||swezeyia sp. sc_08059||random
sodium phosphate, tribasic, anhydrous||squamous cell neoplasm (morphologic abnormality)||random
craniotus||i am able to do all of the work that people expect me to do in the past 7d:finding:7 days:^patient:ordinal:neuroqol||random
schizosaccharomyces pombe (organism)||nondisplaced simple supracondylar fracture without intercondylar fracture of left humerus, sequela||random
(7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pergen-5(10)-en-20-yn-3-one steroid||ocular stem cell transplant||random
clobazam 10mg tablet (product)||acetaminophen / dextromethorphan / diphenhydramine / guaifenesin / phenylephrine oral capsule||random
excision of lesion of leg||transfusion reaction due to immunoglobulin a||random
campylobacter fetus antibody||myh4 gene||random
robinson||hand &#x7c; x-ray &#x7c; radiology||random
chest pain, retrosternal||small intest inj nec-cl||random
compared to 10y ago, has there been any change in keeping financial records organized:find:pt:^patient:ord:ecog||nottingham glandular differentiation score of primary malignant neoplasm of breast||random
blood uric acid abnormal nos||nail root of toe||random
entoloma sericeum var. cinereo-opacum||lateral articular facet of patella||random
veterinary terminology services laboratory maintained reference set||filoviridae infect||random
hard maple pollen extract 1 mg/ml injectable solution||pmt4p-pmt4p complex||random
medical and surgical @ hepatobiliary system and pancreas @ excision @ cystic duct @ percutaneous endoscopic||exocrine pancreas iga+igg ab [presence] in serum or plasma by immunofluorescence||random
medical and surgical @ hepatobiliary system and pancreas @ occlusion @ hepatic duct, left @ via natural or artificial opening||n-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine||random
ephedrine sulfate 5 mg/ml intravenous solution||stage ivb colon cancer ajcc v7||random
octinoxate 75 mg in 1 g / zinc oxide 48 mg in 1 g topical cream [mr daily defense broad spectrum sunscreen spf 55]||n-benzoyltyrosyl-4-hydroxyphenylalaninol acetate||random
plasma cholesterol normal||beta 2 glycoprotein 1 antibody.immunoglobulin a:arbitrary concentration:to identify measures at a point in time:serum:quantitative||random
bone structure of proximal left fibula||water oak pollen extract 40000 unt/ml injectable solution||random
assessment of patient status related to hypothermia||outlet muscular septum||random
4-hydroxyvalerate/creatinine &#x7c; urine &#x7c; chemistry - non-challenge||megaselia sp. bioug22343-f07||random
internal organ injury, initial encounter||unclassified flavobacterium||random
structure of pigmented layer of left iris||x-ray wrist single scaphoid view||random
eating / feeding / drinking finding||wnv igg avidity ser ql ia||random
respiratory function analyzers||beclomethasone dipropionate 0.04 mg/actuation inhalation aerosol liquid [qvar redihaler]||random
thricops sp. bioug22515-b06||malignant brain neoplasm||random
influenza virus vaccine, adjuvanted 45 mcg/0.5 ml intramuscular suspension [fluad 2016-2017 formula]||mass of right superior external auditory canal wall (physical finding)||random
promethazine hydrochloride 25mg/suppository||unclassified mortierella||random
enable||stigmatopteris c.chr., 1909||random
kloeckera apis||legal intervnt w unsp explosv, law enforc offl inj, sequela||random
plant mucilages||up-regulation of trail-activated extrinsic apoptotic signaling pathway||random
unclassified dicranocephalus||halorubrum sp. tbz112||random
urinary bag 3/4" miscell package||sandostatin lar 5 mg/ml injectable solution||random
chlorisondamine (substance)||microwave therapy to hand (procedure)||random
aluminum hydroxide overdose||idarubicin hydrochloride 5mg injection (pdr for recon) (substance)||random
relationship to patient's mother||ivd panels, human genetics, metabolic disorder, peroxisomal disorder, zellweger spectrum, zellweger syndrome||random
arachidate (c20:0) [entitic substance] in red blood cells||partial traumatic amp of right hand at wrist level, sequela||random
leptogium sp. jr10038b||gallium&#x7c;mcnc&#x7c;pt&#x7c;anybldserpl||random
limnephilus||curvilinear wound of top of head (physical finding)||random
number of previous doses:num:pt:^patient:qn||cpv2||random
when your child talks on the phone, he or she is not sure when its their turn to speak:finding:to identify measures at a point in time:^patient:ordinal:aq adolescent||cvs athlete's foot 2% topical liquid spray||random
octinoxate 50 mg in 1 ml / titanium dioxide 31 mg in 1 ml topical liquid [ultra le teint velvet blurring smooth-effect foundation velvet matte finish broad spectrum spf 15 sunscreen b20]||fty720-mitoxy||random
octisalate 5 g in 100 g / octocrylene 10 g in 100 g / avobenzone 3 g in 100 g topical lotion [alba botanica even advanced moisturizer spf15]||carboplatin/doxorubicin/sargramostim||random
left ventricular concentric remodeling||study observation:find:pt:heart.chambers:nom:us||random
n(g)-methylarginine||cdisc questionnaire rand 36-item health survey 1.0 test name terminology||random
naan bread (substance)||refractory langerhans cell histiocytosis||random
cmx||blood corticotrophin abnormal||random
iris, pupillary margin||diopatra||random
glutamate signalling pathway||socialization alteration||random
retrovirus||unclassified sordariomycetidae||random
3,3-dimethyl-1-(3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl)piperidine||cinnamon 3 [hp_x] in 1 ml / gentiana lutea root 3 [hp_x] in 1 ml / syzygium cumini seed 3 [hp_x] in 1 ml / silver nitrate 6 [hp_x] in 1 ml / colchicum autumnale bulb 6 [hp_x] in 1 ml / bos taurus colostrum 6 [hp_x] in 1 ml / copper gluconate 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / magnesium gluconate 6 [hp_x] in 1 ml / manganese gluconate 6 [hp_x] in 1 ml / sus scrofa pancreas 6 [hp_x] in 1 ml / potassium gluconate 6 [hp_x] in 1 ml / rumex crispus root 6 [hp_x] in 1 ml / scrophularia nodosa 6 [hp_x] in 1 ml / sus scrofa stomach 6 [hp_x] in 1 ml / gold 8 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 8 [hp_x] in 1 ml / activated charcoal 8 [hp_x] in 1 ml / pork intestine 8 [hp_x] in 1 ml / malus pumila flower 8 [hp_x] in 1 ml / nitric acid 8 [hp_x] in 1 ml / prunus cerasifera flower 8 [hp_x] in 1 ml / water 8 [hp_x] in 1 ml / fagus sylvatica flowering top 12 [hp_x] in 1 ml oral liquid [gi drainage]||random
pseudomonas sp. rm12el_20b||egotism||random
virginiamycin [susceptibility] by gradient strip||mucosal discolouration gi||random
views limited diagnostic:finding:to identify measures at a point in time:breast.left:document:mg||pneumonia; neonatal||random
trogon personatus submontanus||gauze bandage@12"x360"@topical@tape, non-medicated||random
joint therapeutic procedures||peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial||random
product containing only cimetidine in parenteral dose form (medicinal product form)||intraoperative hemorrhage and hematoma of a nervous system organ or structure complicating other procedure||random
up regulation of lipid biosynthetic process||collinsella intestinalis kageyama and benno 2000 emend. nouioui et al. 2018||random
congenital tricuspid atresia and stenosis||construction of cutaneous stoma of urinary bladder (procedure)||random
molluginaceae||medical and surgical @ lower arteries @ insertion @ superior mesenteric artery @ percutaneous @ intraluminal device @ no qualifier||random
osteoclastogenesis inhibitory factor||herpes simplex virus 1 dna:prthr:pt:genital:ord:probe.amp.tar||random
eph recept tyrosine kinase||boron intake:mrat:24h:^patient:qn:estimated||random
apap 400 mg / hydrocodone bitartrate 7.5 mg oral tablet [zydone]||primary mucinous adenocarcinoma of ovary (disorder)||random
lobe of thymus||tendon dislocation||random
unclassified haemoproteus||viral corneal ulcer||random
benzoic acid product||sbil-2 transduced autologous tumor-infiltrating lymphocyte||random
rnax instruct to avoid bladder irritants (treatment)||echocardiography: anterolateral dilation of left ventricle (procedure)||random
[x]exposure to ignition of highly flammable material, occurrence at sports and athletics area (event)||spondylodiscitis||random
repair of tendo achilles||induration of both shoulders||random
activity intolerance||long-term physical therapy goals increase tone in muscles of left elbow (treatment)||random
difficulty coping with grief responses||reagents, immunoassay, autoimmune, rheumatism||random
left anterior cervical lymphatic chain||urine ferrous chloride level (procedure)||random
camphor (synthetic) 17.05 mg / peppermint oil 22.73 mg / levomenthol 45.45 mg / methyl salicylate 45.45 mg / zinc oxide 215.91 mg topical patch [arex sinsin pas]||medical and surgical @ eye @ alteration @ upper eyelid, right @ open @ no device||random
quercus robur flower extract||fpsa-tri/vpsa-tri||random
hymenoptera sp. bold:aaj1797||capsaicin 0.25 mg in 1 ml topical solution [revlex arthritis pain relief]||random
computed tomography of head: foreign body||took more than twice the recommended dose of laxatives often in last 3 months in order to avoid gaining weight [reported.phq]||random
tuberculosis of intrathoracic lymph nodes, bact or hist exam unknown||bk polyomavirus test||random
pneumonia due to mycoplasma pneumoniae (disorder)||primary kaposi's sarcoma of oral cavity (diagnosis)||random
deprecated tib-l xr port||corrosion of second degree of left ankle, subs encntr||random
delayed union of fracture of right ninth rib (diagnosis)||verrucomicrobia bacterium imcc15090||random
unclassified monoposthiidae||pseudoephedrine hydrochloride/terfenadine 120 mg-60 mg oral tablet, extended release||random
stabilex - dental precision attachment (physical object)||rash ecchymotic||random
medical and surgical @ gastrointestinal system @ bypass @ esophagus, middle @ open @ no device @ duodenum||specimen from conjunctiva obtained by scraping (specimen)||random
electrocardiogram electrically inactive area||green-backed robin||random
dihydropyridine derivative calcium channel blocker (substance)||mianserin 60 mg oral tablet||random
stoma training (regime/therapy)||coma scale, best verbal response, incomprehensible words||random
medical and surgical @ lower joints @ replacement @ sacroiliac joint, right @ open @ synthetic substitute @ no qualifier||sports hernia||random
ivd test reagent/kits, immunoassay, rapid test||elmidae sp. comdb003-13||random
regulation of 2'(3')-polynucleotidase activity||arterial pulses||random
obstruction of urethral urinary catheter||folic acid / pyridoxine / vitamin b12 oral product||random
dactylis glomerata ab||stomach chief cell||random
polyoxyethylene ether||traumatic injury of sacrum||random
duzallo pill||programs, managed care||random
deppea||venae articulares||random
unspecified laceration of liver without mention of open wound into cavity||other specified inflammatory polyarthropathy||random
peptide abc transporter||trovan||random
stuporous catatonia||nk cell lectin-like receptor subfamily d||random
uridyl transferase activity||sodium fluoride 0.2 mg in 1 ml oral mouthwash [smileguard spider sense spider-man bubblegum]||random
leucine synthesis||meperidine:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||random
withdrawal reaction of childhood or adolescence||opt abnormal||random
titanium dioxide 9.4 g in 124 g / zinc oxide 4.96 g in 124 g topical lotion [safe harbor natural suncare natural sheer mineral]||medical and surgical @ upper veins @ replacement @ azygos vein @ open||random
delayed union of fracture of shaft of left hand (diagnosis)||sacle - subacute cutaneous lupus erythematosus||random
motile sperm||mycobacterium phage ihop||random
phosphate increased||pigment cell (cell)||random
tuberculosis exposure screen follow-up status:type:to identify measures at a point in time:^patient:nominal:cphs||unclassified corylophidae||random
rheb protein, drosophila||ribosomal p ab.igg:acnc:pt:ser:qn||random
chlorpromazine measurement||actinomycetales bacterium hpa160||random
barium sulfate embolism (disorder)||sciaridae sp. bold:acg3397||random
benzoic acid 3 [hp_x] in 1 ml / pulsatilla vulgaris 3 [hp_x] in 1 ml / rhododendron aureum leaf 3 [hp_x] in 1 ml / filipendula ulmaria root 3 [hp_x] in 1 ml / aconitum napellus 4 [hp_x] in 1 ml / solanum dulcamara top 4 [hp_x] in 1 ml / euphorbia resinifera resin 4 [hp_x] in 1 ml / ledum palustre twig 4 [hp_x] in 1 ml / asclepias tuberosa root 6 [hp_x] in 1 ml / lithium benzoate 8 [hp_x] in 1 ml oral liquid [rheumatism]||eulophidae sp. bioug03191-g05||random
lensometry contacts right lens secondary curve (___ mm)||stage ii colorectal cancer||random
scales on both lateral ankles (physical finding)||g-csf level normal||random
clostridium difficle||chromosome banding abnormal||random
phentermine hcl 30mg tab||sprain of other specified site of elbow and forearm -retired-||random
menthol 12% topical application spray||jaw; osteonecrosis||random
amination||product containing precisely filgrastim (as pegfilgrastim) 10 milligram/1 milliliter conventional release solution for injection (clinical drug)||random
phenx measure - child head circumference:-:pt:^patient:-:phenx||entire cervical spinal cord posterior horn (body structure)||random
osteopathy, chondropathy, acquired deformity||mr chest w contrast iv||random
mechanical failure of left knee prosthetic joint (disorder)||scaridae||random
anaphes sp. bioug16094-f03||irrigation of colon||random
esophageal adenocarcinoma metastatic||fac071tn||random
sars-cov-2 stimulated gamma interferon release by t-cells [units/volume] in blood||titanium dioxide 0.2328 g in 6 ml / octinoxate 0.3 g in 6 ml topical cream [age20s jericho rose tone essential uv primer green mint]||random
cervical basivertebral foramen||panorpa leucoptera panorpa leucoptera||random
unclassified plocamium||dilatation; bladder, congenital||random
picobirnavirus predict_pbv-46||entire upper genitourinary tract (body structure)||random
production, crop||acnidazil cream 15g||random
articular facet of head of sixth rib||third degree burns of second toe of right foot (physical finding)||random
implant and catheter site reactions||ndp, cys69ser||random
diptera sp. bold:aam6646||proteostasis deficiency||random
motif protein, tripartite||neuro-qol item bank - satisfaction with social roles - version 1.0:-:to identify measures at a point in time:^patient:-:neuroqol||random
sloughing; scrotum||toxic effect of other specified substances nos||random
ranitidine 150 mg oral granule, effervescent||first degree burns of labia minora (diagnosis)||random
disorder of pancreatic islets||myroides odoratimimus or myroides odoratus (finding)||random
polyglactin||unstable hemoglobin detection||random
fungal sp. agrd107||[x]injury of unspecified nerve at hip and thigh level (disorder)||random
rogerpetersonia aime & mctaggart, 2020||pseudospondylolisthesis||random
triticum aestivum pollen antibody.igg4:mass concentration:to identify measures at a point in time:serum:quantitative||astler-coller c1 colon carcinoma||random
liothyronine pill||antidipsotropic agents||random
uranium:substance concentration:to identify measures at a point in time:urine:quantitative||deprecated cardiac rehabilitation treatment plan, medication route identifier||random
medical and surgical @ urinary system @ replacement @ bladder @ via natural or artificial opening endoscopic @ autologous tissue substitute @ no qualifier||nondisp fx of fourth metatarsal bone, left foot, sequela||random
patch on left upper back (physical finding)||vesicle on left lateral eyebrow (physical finding)||random
crest of neck of rib||iron isotope studies||random
organisation/methods officer (occupation)||blood vessel repair carotid artery||random
cysts duct gartner's||cavus deformity of foot, acquired||random
actinium isotope||malignant neoplasm of gingiva staging||random
bryonia marmorata e.petit||uterine body sarcoma||random
[x]motorbike rider injury||coulometric method, carbon-dioxide||random
ciclopirox topical 0.77% topical suspension||apply (administration method)||random
pulmonary antihypertensives||dyclonine hydrochloride 2 mg / menthol 5 mg / pectin 6 oral lozenge [sucrets]||random
medical and surgical @ upper joints @ inspection @ finger phalangeal joint, right||morphine 100 mg/12 hours oral tablet, extended release||random
abnormality of the outermost bone of the thumb||xr toe 2nd-l ap+lat+obl||random
increased urine volume||myochrous denticollis||random
lyomyces sp. jc-2020a||negative regulation of red blood cell clearance||random
liver elastography||cadaveric renal transplant||random
infect enoplida||clean wound of right elbow||random
product containing bethanechol chloride 25 mg/1 each oral tablet||granulocyte-colony-stimulating factor, n-met-ala(1)-thr(3)-tyr(4)-arg(5)-ser(17)-||random
cladosporium sp. f1||buccal branch of right facial nerve||random
myocilin||rabeprazole induced platelet igg &#x7c; serum or plasma &#x7c; serology - non-micro||random
orientocoluber||vasculature of bony part of proximal phalanx of left big toe||random
positive regulation of cell cycle transition||beta-phenylacrolein||random
optic atrophy secondary to papilloedema||bundle, median forebrain||random
adipocyte of epicardial fat of left ventricle||connective and other soft tissue of thorax axilla||random
exodeconus miersii (hook.f.) d'arcy||secretases||random
malignant neoplasm of specified parts of peritoneum nos (disorder)||endophytic bacterium 11(2011)||random
excision of lesion of mastoid bone||hyperstrotia nana||random
subretinal hemorrhage of right eye (diagnosis)||ulnohumeral (joint) sprain of unspecified elbow, sequela||random
low serum iron||wolbachia endosymbiont of horridipamera nietneri||random
deleterious msh6 gene mutation||ponesimod 8 mg oral tablet [ponvory]||random
intestinal helminthiasis (diagnosis)||during unspecified surgical and medical care||random
walker reinforcement education (regime/therapy)||brucella test positive||random
adverse reaction caused by coagulation factor||oatmeal 50 mg in 1 g topical cream [flexitol eczema and dermatitis]||random
finding related to ability to grip||petrejoides||random
laceration of anterior tibial artery, left leg, init encntr||compl labour/delivery stillbirth||random
lacrimal duct bilateral &#x7c; radio fluoroscopy &#x7c; radiology||yolk sac tumor of the sellar region||random
cotyloid cavities||tp53-induced glycolysis and apoptosis regulator, mouse||random
xenogeneic transplantation||insertion of abdominal cavity catheter extension, beneath the skin||random
neoliodidae sp. bold:adi0525||rhodomicrobium sp. bf13||random
laothoe amurensis||prickly-pears||random
white ramus communicans of ninth intercostal nerve||dermal autograft of scalp||random
petrolatum 340 mg in 100 g topical ointment [advanced healing]||poorly defined (qualifier value)||random
gpr101 protein, human||phosphoarginine catabolism||random
cyclophosphamide, 25 mg oral capsule||skeletal muscle tissue of buccinator||random
does your health now limit you in doing heavy work around the house like scrubbing floors, or lifting or moving heavy furniture:finding:to identify measures at a point in time:^patient:ordinal:promis||sorbus zahlbruckneri c.k.schneid.||random
excoriation on upper left eyelid (physical finding)||peripheral neuroepithelioma of bone nos||random
sarcosinaemia||sensory perception of electrical stimulus||random
enrich liquid 250ml||unconscious partial||random
rotavirus antibody positive||modalities uvb treatment of forearm bilateral||random
scatopsidae sp. bioug32136-f10||mammogram previous mass #3 of superior lateral quadrant of left breast with unchanged microcalcifications||random
lepidoptera sp. bold:aaa3122||salmonella enterica subsp. enterica ser. oersterbro||random
caprimulgus cayennensis leopetes (organism)||buchnera aphidicola munson et al. 1991||random
b. suis ab ql (s)||london deauville criteria point scale||random
periosteum of upper end of right metacarpal bone||brn 3 transcription factor||random
centroblastic lymphoma post-transplant lymphoproliferative disorder||open wound of mouth, unspecified site, complicated||random
purulent discharge of gums on mesial surface of left mandibular lateral incisor||physical rehabilitation and diagnostic audiology @ diagnostic audiology @ hearing assessment @ none @ electrocochleography @ none @ none||random
i was able to use a spoon to bring food up to my mouth in the past 7d:find:7d:^patient:ord:neuroqol.peds||hydrochloride, chlordiazepoxide||random
refer to physiotherapist||poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations nos||random
3-(5-chloro-2-furoyl)-3,7-diazabicyclo(3.3.0)octane||zinc oxide 4.2 g in 1 g / titanium dioxide 6 g in 1 g topical powder [the healthy powder spf16]||random
right spinoglenoid notch||araneae sp. bold:aaj3631||random
stage i t lymphoblastic leukemia/lymphoma||amiodarone oral product||random
nicotiana longiflora||bromine compound, nos||random
n-methylnicotinium, (s)-isomer||dorsal surface of base of tongue||random
product dropper tip missing||megaselia sp. bioug14907-c11||random
sigmoidoscopy and fecal microbiota transplantation||g(s)alpha||random
cholecystitis, ctcae_5||seen by social services (finding)||random
excision of benign tumor or cyst of mandible||arrange the oxygenation and artificial ventilation equipment and material (e.g., laryngoscopes, tubes, aspirator, masks, magill forceps, stiffening wires, phonendoscope)||random
finding of receipt of benefit status (finding)||preauricular cyst (diagnosis)||random
infectious mononucleosis test positive (& paul bunnell (& monospot)) (finding)||product containing tacrolimus 0.5 milligram/1 each oral capsule||random
mtnd4p29 gene||disease, kosaka-shibayama||random
9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride||lymphoid tissue therapeutic procedures||random
hd2||unclassified hydrophilidae||random
azathioprine 10 mg||ivd test reagent/kits, molecular assay, gene anomaly, deletion/duplication, pomt2||random
b7 h2 antigen||able to finger feed (finding)||random
anti-epithelial antibody||defibrillator/pacemakers, external||random
nuclear medicine @ central nervous system @ positron emission tomographic (pet) imaging @ brain @ carbon 11 (c-11) @ none||2-(7-butyl-2-(4-(2-(((18)f)fluoroethoxy)phenyl)-5-methylpyrazolo(1,5-a)pyrimidin-3-yl)-n,n-diethylacetamide||random
open fracture of left zygomatic arch (disorder)||medical and surgical @ subcutaneous tissue and fascia @ replacement @ subcutaneous tissue and fascia, left lower leg @ percutaneous @ autologous tissue substitute @ no qualifier||random
multisection limited^wo contrast:finding:to identify measures at a point in time:neck>spine.cervical:document:computed tomography||cyclic amp dependent protein kinase catalytic subunit||random
austrogoniodes||[v]drug use (situation)||random
medical and surgical @ lower bones @ replacement @ upper femur, right @ percutaneous @ autologous tissue substitute @ no qualifier||diclofenac sodium 12.5 mg rectal suppository||random
medical and surgical @ muscles @ resection @ facial muscle @ percutaneous endoscopic @ no device||giant cell sarcoma of anus (diagnosis)||random
marine bacterium b39||release of median arcuate ligament (procedure)||random
extracellular signal regulated kinases||thyroxine free abnormal||random
[v]twin, unspecified, born outside hospital and not hospitalized||procedure on organ (procedure)||random
adenylpyrophosphatase||dextrose monohydrate 50 mg in 1 ml intravenous injection, solution [dextrose]_#3||random
aesculus carnea flower 10 [hp_x] in 59 ml / aloe 10 [hp_x] in 59 ml / euphorbia resinifera resin 10 [hp_x] in 59 ml / fagus sylvatica flowering top 10 [hp_x] in 59 ml / gelsemium sempervirens root 10 [hp_x] in 59 ml / hypericum perforatum 10 [hp_x] in 59 ml / juglans regia flowering top 10 [hp_x] in 59 ml / potassium chloride 10 [hp_x] in 59 ml / magnesium chloride 10 [hp_x] in 59 ml / achillea millefolium 10 [hp_x] in 59 ml / hydrochloric acid 10 [hp_x] in 59 ml / sodium carbonate 10 [hp_x] in 59 ml / phosphoric acid 10 [hp_x] in 59 ml / lead 10 [hp_x] in 59 ml / sepia officinalis juice 10 [hp_x] in 59 ml / spongia officinalis skeleton, roasted 10 [hp_x] in 59 ml / tin 10 [hp_x] in 59 ml / theridion curassavicum 10 [hp_x] in 59 ml oral liquid [reserved]||calcium concentration in urine above normal (finding)||random
tooth, molar||isocitrate dehydrogenase [nadp], mitochondrial arg140gly||random
i felt loved by my parents or guardians in the past 7d:finding:7 days:^patient:ordinal:neuroqol.peds||product containing precisely alpelisib 50 milligram/1 each conventional release oral tablet (clinical drug)||random
phlebolymphoedema||ovarian biphasic or triphasic teratoma||random
acetaminophen 300 mg / oxycodone hydrochloride 7.5 mg [prolate]||polyethylene glycol 400 4 mg/ml / propylene glycol 3 mg/ml [ocusan dry eyes]||random
glycoside compound||n-cyclopropylcarbonyl-2-(7-methoxy-1-naphthyl)ethylamine||random
heterophile antibody||sodium fluoride 6 mg in 1 g dental gel, dentifrice [orajel]||random
uterine cervical exfoliation||pinus virginiana pollen||random
adverse effect of oxytocic drugs, sequela||innohep||random
consultant progress note||biopsy nasopharynx abnormal||random
man||revision of arm nerve(s)||random
gd2-directed antibody||proteinase gene||random
fluoride, acidulated phosphate||salicylic acid 0.02 mg/mg medicated bar soap||random
tremor, metallic||guaifenesin 20 mg/ml / hydrocodone bitartrate 1 mg/ml / phenylephrine hydrochloride 1.5 mg/ml [entex hc discontinued]||random
total salpingectomy||anal smear (lab test)||random
vestibular evaluation with recording||hamartoses nos||random
polycystic kidney disease 1, severe||i am bothered by being shorter than other people in the past 4w:finding:4 weeks:^patient:ordinal:facit||random
x-ray sternoclavicular joint erosion left||nasal disorders nec||random
burkholderia sp. bfe18u||unclassified heveochlorella||random
table, examination||idiopathic progressive polyneuropathy (diagnosis)||random
echography of scrotum and contents (procedure)||vincristine sulfate 1mg/1ml injection||random
other specified infections of the breast and nipple associated with childbirth, unspecified as to episode of care or not applicable||poractant alfa 80 mg/ml||random
pupillary abnormality, right eye||scribble protein, rat||random
retinal arterial occlusive vasculitis||quinidine sulfate 300mg tablet||random
thyroid atrophy nos||exc face-mm b9+marg 0.6-1 cm||random
lymphatic vessels||superficial foreign body of chest wall without major open wound but with infection||random
tumour of soft tissue of back||stress, emotional||random
female lactation||bone, condyle||random
product containing cetyl alcohol||nerve to left inferior oblique||random
patch||obstructed labor due to shoulder presentation, fetus 1||random
arnica montana flower 1 [hp_x] in 1 g / calendula officinalis flowering top 2 [hp_x] in 1 g / comfrey root 2 [hp_x] in 1 g / thuja occidentalis whole 2 [hp_x] in 1 g / urtica urens 1 [hp_x] in 1 g / larix decidua resin 2 [hp_x] in 1 g / lytta vesicatoria 7 [hp_x] in 1 g / silver 8 [hp_x] in 1 g topical gel||up regulation of iron ion transport||random
developmental and epileptic encephalopathy 73||fomitiporia murrill, 1907||random
product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule||hemorrhagic proctitis||random
revision of decompression of carpal tunnel (procedure)||immunoglobulin g antibody to human coronavirus nl63 (substance)||random
bupivacaine hydrochloride 2.5 mg in 1 ml intracaudal injection, solution||lolium perenne ab.ige.rast class:acnc:pt:ser:ord||random
product containing only miglustat in oral dose form (medicinal product form)||protein, adamtsl||random
foeniculum vulgare whole||female genital system contrast procedure (procedure)||random
red blood cell separation reagent||field of public health medicine||random
herxheimer jarisch reaction||infantile renal fibrosarcoma||random
ability to clean toilet (observable entity)||2-haloacid dehalogenase activity||random
unclassified thermosphaera||francolinus clappertoni koenigseggi (organism)||random
s-phase cells/100 cells in blood||articular branch of ulnar nerve to wrist joint||random
skeletal system (mmhcc)||zero point zero three||random
insertion of int fix into l orbit, open approach||other musculo-skeletal operat.||random
raynaud-like disorder||neurogenic tumor||random
oth congenital malformation syndromes, nec||pseudoramichloridium cheew. & crous, 2009||random
cocaine induced cerebrovascular accident||cholesterol.in vldl||random
poisoning by mercury (diagnosis)||serum calcium normal||random
gamma globin||bladder incontinence was demonstrated with valsalva||random
third degree burn of maxillary attached gingiva||trilostane 10 mg [vetoryl]||random
small intestinal mucositis||doxycycline monohydrate 100 mg [okebo]||random
ramaria gracilis||fetlock region of equine limb (body structure)||random
cellulitis of right second toe||locally advanced digestive system carcinoma||random
trithorax homologue 2||alpha-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile||random
cleft palate with cleft lip bilateral||unclassified cyrtopogon||random
4-n,n'-dimethylamino-benzoic acid, 2-ethylhexyl ester||androgen-binding protein||random
occupant of special vehicle used mainly in agriculture injured in transport accident||pupillary deformity||random
glucose, serum, measurement||abusive emotional relationship with wife (finding)||random
meligethes angustatus kuster, 1848||sarcoptiformes sp. bioug13499-e05||random
spinocerebellar ataxia 34||correction of transposition of great vessels (procedure)||random
regulation of corticosteroid hormone secretion||mazosia aff. melanophthalma ups frisch 11/ug140c||random
cogc-2 protein, c elegans||rickettsia prowazekii ab:titr:pt:ser:qn:if||random
allopathic & osteopathic physicians; psychiatry & neurology, psychiatry||(r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol||random
deprecated occupational therapy treatment plan, author id identifier||benzenemethanaminium, n,n-dimethyl-n-(2-(2-(4-(1,1,3,3-tetramethylbutyl)phenoxy)ethoxy)ethyl)-, chloride||random
guaifenesin / phenylephrine oral suspension||encounter for breast reconstruction following mastectomy (treatment)||random
spirosphaera carici-graminis voglmayr, 1997||muscle layer of diverticulum of seminal vesicle||random
unclassified philhygra||3-hydroxy-4-methoxybenzenesulfonate||random
imaging @ urinary system @ plain radiography @ urethra @ none||leucine specific trna||random
iverhart max 68 ug / 57 mg / 57 mg chewable tablet||nucleic acid sequence with relative specificity for microorganism (substance)||random
psychiatry care plan (record artifact)||immunosuppressed patients||random
glucose transporter type1 (glut-1) deficiency||posterior medial tributary of superficial venous system of lower extremity||random
bone tissue of vomer||neuromuscular blockade observable||random
wall of superior part of anal canal||3,4-dihydroxyphenethylamine, ascorbate:oxygen oxidoreductase (beta-hydroxylating)||random
hepatic contusion||strovite one caplet||random
[x]assault by pesticide (finding)||oesophageal adenocarcinoma cervical stage ii||random
platycephalus arenarius||estrogen serpl-mcnc||random
relicina filsonii||multisection^w contrast intravenous:finding:to identify measures at a point in time:chest>scapula.right:document:magnetic resonance||random
reduced number of t cells||bovista minor||random
pregntrlone/the+thf+5a-thf 24h ur-srto||pneumonia; toxoplasmosis (manifestation)||random
cytochrome p450 family 21 subfamily a member 2||bradyrhizobium sp. lmical48||random
fluoroscopy diaphragm||prenatal vit/iron fum/folic ac 45-1mg oral tablet||random
longidorella penetrans (thorne & swanger, 1936)||unhealthy alcohol drinking behavior||random
wound edges approximated (finding)||injection, intraventricular||random
infection caused by acinetobacter||quercus robur flower extract||random
calcium calculus (morphologic abnormality)||incomitant heterotropia||random
magnetic resonance imaging of thoracic spine: mass of posterior aspect of t2 vertebra with isointense t1 signal (procedure)||air pollution, indoor||random
other organic condition related to mental retardation and developmental disabilities:find:pt:^patient:ord:mds||cefotaxime (as cefotaxime sodium) 20 mg/ml injection||random
visible peristalsis (finding)||atropine sulfate 0.03 mg / benzoic acid 4.5 mg / hyoscyamine sulfate 0.03 mg / methenamine 40.8 mg / methylene blue 5.4 mg / phenyl salicylate 18.1 mg oral tablet [uri-sep]||random
bucalcide mucosal product||disease caused by ciliate protozoa||random
alysiinae sp. asgle924-10||gladiogobius||random
mucoid drainage of indwelling catheter site (physical finding)||open fracture of skull vault with cerebral laceration and contusion without loss of consciousness (diagnosis)||random
rarely (once a month or less)||chlamydia trachomatis b antibody.immunoglobulin m:presence or threshold:to identify measures at a point in time:serum:ordinal||random
c1q serpl-mcnc||improvement in level of depressed mood (finding)||random
bifid epiglottis||papule on left lateral superior trunk||random
growth-differentiation factor 8||cgp-20712a||random
trilobar skull shape||structure of nail of finger (body structure)||random
astrocytoma grades i & ii of brain||synapsins||random
rotatores muscle group||labile hypertension||random
phenylephrine hcl/hydrocodone bitartrate/chlorpheniramine 5 mg-1.67 mg-2 mg/5 ml oral liquid (ml)||guidance for localization of tumor^w 18f-fdg intravenous+wo contrast:finding:to identify measures at a point in time:whole body>skull vertex to mid-thigh:document:pt+computed tomography||random
interstitial laser destruction of lesion of breast (procedure)||transplant of hepatobil & pancr into poc, perc endo approach||random
uterine and fallopian tube neoplasms, malignant and unspecified (smq)||zinc oxide 5.5 mg in 100 ml / titanium dioxide 5.5 mg in 100 ml topical cream [cc cream tan200]||random
cecitis||exophytic polypoid lesion||random
triiodothyronine.free:mcnc:pt:ser/plas:qn:ia||cecidomyiidae sp. bioug27379-f10||random
bennett's fracture, left hand, subsequent encounter for fracture with routine healing||intraarticular fractures||random
measurement of products of conception, cardiac sound, via natural or artificial opening||idf-11774||random
giardia lamblia antibody||family pseudomonadaceae||random
structure of left hemidiaphragm (body structure)||pivot shift test - instability||random
b. burgdorferi 37kd igm ib ql (csf)||glutamate dehydrogenase level normal||random
corneal deposits (diagnosis)||fraxinus velutina ab.ige.rast class &#x7c; serum &#x7c; allergy||random
meclozine-containing product||deformity; ruptured||random
biopsy of cervix showed mesodermal mixed tumor (procedure)||prostaglandin 9-ketoreductase||random
childhood dermatomyositis||rg sup(a) ag ql (rbc)||random
cerebellar ataxia and mental retardation with quadrupedal locomotion 1||calcium sulfide 6 [hp_c] in 59 ml / potassium chloride 6 [hp_c] in 59 ml / potassium carbonate 30 [hp_c] in 59 ml / potassium dichromate 6 [hp_c] in 59 ml / strychnos nux-vomica seed 6 [hp_c] in 59 ml oral liquid [mucus-clear nighttime]||random
bacterium isolated but not further identified (finding)||chemical explosion burn of upper arm (history)||random
external ocular photography for medical evaluation and documentation||benign hepatobiliary neoplasm||random
da2-da6 high incidence blood group antigens||benzocaine 50 mg/ml topical lotion||random
3-chlorolactate||opn replacemnt tracheal stent||random
burn of unspecified body region, unspecified thickness||traumatic perforation of large intestine without open wound into cavity||random
poor quality image display on device||culture typing gas/high pres liq chromatography||random
ligamentum teres hepati||pseudovibrio sp. au274||random
karnofsky performance status 10||capra hircus skin 30 [hp_x] in 1 ml / felis catus skin 30 [hp_x] in 1 ml / bos taurus skin 30 [hp_x] in 1 ml / canis lupus familiaris skin 30 [hp_x] in 1 ml / equus caballus skin 30 [hp_x] in 1 ml / capra hircus hair 30 [hp_x] in 1 ml / sheep wool 30 [hp_x] in 1 ml sublingual solution [a-1]||random
meprobamate 400 mg oral tablet||measles virus n mrna||random
diapriidae sp. cnkjp197-14||element, enhancer||random
znf663||microrasbora||random
(3s)-1-(5-tert-butyl-3-((1-cyclopropyltetrazol-5-yl)methyl)triazolo(4,5-d)pyrimidin-7-yl)pyrrolidin-3-ol||b-large cell anaplastic lymphoma (kiel classification) stage iii||random
encapsulated||skin tag on medial surface of left knee (physical finding)||random
unclassified pagurus||organohalogen compounds||random
ileocecal valve||dentine of lower central secondary incisor tooth||random
bl34 (body structure)||house fumigated (finding)||random
obsessive compulsive disorder (ocd)||abnormal red-cell morphology nos||random
special anesthesia service||incision site pain||random
phlyctenular keratoconjunctivitis caused by staphylococcus toxin (disorder)||exploration of muscle of hand (procedure)||random
pipothiazine overdose (disorder)||sf36305b||random
roleclassmutualrelationship||multiple liveborn in hospital by vaginal delivery (situation)||random
ricinocarpos tuberculatus||dorsal tubercle of right radius||random
loxophyllum||pelvic insufficiency fracture||random
biophysical agent used:presence or identity:point in time:^patient:nominal||crystal id light microscopy alys tiss/any fluid||random
variant sinoatrial nodal artery||stool chymotrypsin abnormal||random
rupture; ureter, nontraumatic||instability, microsatellite||random
subclinical hyperthyroidism (diagnosis)||stress image 2 lv wall motion dyskinetic anterolateral||random
dislocation; radioulnar proximal||oxytetracyclinum||random
clonostachys lucifer schroers & samuels, 2001||stage ia hepatocellular cancer||random
oth and unspec cereb lacer and contu, w/o ment of open intcran wound, prol loc and rtrn to pecl||vibrio sp. falf213||random
subcutaneous reservoir (physical object)||medical and surgical @ heart and great vessels @ insertion @ pericardium @ percutaneous @ cardiac lead, defibrillator @ no qualifier||random
calyptrochaeta leptoloma||x-ray of left knee, lateral view, standing (procedure)||random
bacteria bal anaerobe cult||pramoxine 1%/zinc acetate 0.1% lotion||random
urine temazepam level||primary cerebral lymphoma in immunocompetent host||random
skin of medial surface, second finger||difficulty shaving (finding)||random
sciences, library||bristowia heterospinosa reimoser, 1934||random
trachea; deviation||pleurota aprilella||random
pterygoplichthys cf. disjunctivus/pardalis dz3681||25-hydroxy vitamin d3 1-alpha-hydroxylase activity||random
glycerin 0.4 g in 100 g topical soap [sella natural hair]||mr upper extremity.joint||random
unspecified disorder of synovium and tendon, lower leg||oxyphencyclimine and psycholeptics||random
segmental infantile haemangioma||eumonostilifera||random
noninfectious, vesicular and/or bullous disease (navigational concept)||quercus lobata pollen 0.05 g in 1 ml intradermal injection, solution||random
australoheros||cicadellidae sp. bioug23199-h04||random
cold contaminant-free iodine i 131 metaiodobenzylguanidine||duplodnaviria||random
trandolapril and verapamil hydrochloride extended-release tablets||pre-occipital cortex||random
pharyngeal candida albicans infection||cynanchinae||random
ins new/rplc prm pacemaker w/transv eltrd ventr||limnophyton sp. 1 lyc-2011||random
can pronounce valetudinarian [nih toolbox]||pancreatic infiltrating duct carcinoma, nos||random
unclassified verrucosispora||vitamin/nutritional deficiency||random
peritonitis and intra-abdominal abscess||topiramate 50mg extended-release capsule||random
klaforan||open clipping of left fallopian tube (procedure)||random
specimen from major salivary gland||thyroid procedure platysma closed with absorbable sutures (treatment)||random
claw toe operation by implant (treatment)||juvenile idiopathic generalized osteoporosis (disorder)||random
unsp car occ inj in clsn with statnry object in traf, init||esr||random
vascular sign or symptom, nos||cannabis abuse nondependent||random
psyllium seed 3.4 gram/5.8 gram oral powder (gram)||helotiaceae sp. pd x nig 3||random
pathologic fracture of vertebra (diagnosis)||telepathol||random
cefsulodin &#x7c; serum or plasma &#x7c; drug toxicology||neurological exam||random
serum proteins borderline low (finding)||allergy to oxymetazoline||random
arthrobacter sp. mdt2-a||substance use daily dose||random
skin swelling of||open fracture of proximal phalanx of first toe of right foot (diagnosis)||random
velocity-time integral:velocity:point in time:circulatory system.to be specified in another part of the message:quantitative:ultrasound.doppler||phenx - cardiorespiratory fitness - treadmill protocol:-:point in time:^patient:-:phenx||random
upper jugular lymph nodes||wardill repair cleft palate||random
us guidance for drainage of abscess and placement of drainage catheter of unspecified body region||methyl linoleate 13-hydroperoxide, (9z,11e)-||random
drosophila madikerii||[v]routine postpartum follow-up (situation)||random
metabolic bone disease (disorder)||incision of left wrist (physical finding)||random
period of life beginning after birth and ending before death (qualifier value)||beta+ thalassaemia||random
dolutegravir sodium 10 mg oral tablet [tivicay]||us prostate transrectal for volume measurement||random
unclassified halobacteriales||family ranidae (organism)||random
pyraustinae||sudal 60/500||random
bretylium 2mg/ml d5w inj bag 250ml||kidney excision (procedure)||random
chironomidae sp. bioug25004-c07||medical and surgical @ upper joints @ removal @ cervical vertebral joint @ percutaneous||random
medical and surgical @ upper bones @ insertion @ ulna, left @ percutaneous @ external fixation device, limb lengthening @ no qualifier||diagnostic radiography during operative procedure||random
amputation of finger through middle phalanx (procedure)||avobenzone 30 mg in 1 g / octisalate 50 mg in 1 g / octocrylene 70 mg in 1 g topical cream [lancome paris renergie lift multi action all]||random
bypass left basilic vein to upper vein, perc endo approach||division of joint capsule of elbow||random
influenza a virus a/tasmania/503/2020 (h3n2) antigen 0.03 mg/ml / influenza a virus a/washington/19/2020 (h1n1) antigen 0.03 mg/ml / influenza b virus b/darwin/7/2019 antigen 0.03 mg/ml / influenza b virus b/singapore/inftt-16-0610/2016 antigen 0.03 mg/ml prefilled syringe [flucelvax quadrivalent 2021-2022]||corrosion of third degree of unspecified foot||random
urine drug screen dextromethorphan and levorphanol (lab test)||metacarpal i||random
pain of right acromioclavicular joint elicited on overhead motion||vasculature of periosteum of lunate||random
adverse effect of calcium-channel blockers, sequela||calan sr 120mg sustained-release caplet||random
helotiales sp. sgsf151||chondroma sarcomatosum localized||random
disease caused by opisthorchiidae||history of sustained ventricular fibrillation||random
lithotripter, device||cholates||random
anemia; aplastic, constitutional||myocardium of anterior region of mid zone of right ventricle||random
vectocardiogram||peg-hemoglobin||random
masochism, sexual||arthrobacter sp. mmrf573||random
ivd test reagent/kits, serology, virus, retrovirus, hiv-1||healthy subject||random
flucelvax quadrivalent 2021-2022 vaccine 0.5 ml prefilled syringe||neonatal demise twins||random
factor viii, human 33.3 unt/ml / von willebrand factor, human 66.7 unt/ml injectable solution||collagen type iii||random
trichomes||war operations involving destruction of aircraft due to enemy fire or explosives||random
lactic acid 26.4 mg in 1 ml topical solution [uddercare plus part a]||17-hydroxyprogesterone^1 day post dose dexamethasone:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||random
trichinella sp igg ab [units/volume] in serum||k-y silk-e vaginal moisturizer||random
riluzole 50 mg oral film [exservan]||on examination - breast lump fixed to skin||random
rh2(cap)4||thyroid gland ablat - irradiat||random
2-amino-6-(2-formyl-5-hydroxymethylpyrrol-1-yl)hexanoic acid||geminivirus subgroup iii||random
ease of action||1-aza-2,4-cyclopentadiene||random
oxtriphylline 600mg tab,sa||dictya sp. bbded286-10||random
delia||nptia||random
lazr2f11||elsinoe proteae||random
outcome, rehabilitation||chief cell adenoma of the parathyroid||random
admission to intensive care unit (procedure)||reticulosarcoma involving lymph nodes of head, face, and neck||random
blood clot excretion||clindamycin 600 mg per 4 ml injection||random
c3 convertase activator||diathermy of fingers||random
beta, ph-30||infiltrating ductal carcinoma of breast, stage 3||random
alcohol 0.26 g in 26 g topical gel [brompton and langley ginger lily and lime moisturizing hand sanitizer ginger lily and lime]||lymphocyte proliferation.beryllium stimulation panel||random
pustules on both upper cheeks||hexyldecyl laurate||random
carrington skin balm top gel||primary idiopathic aplastic anemia||random
histidine [mass/volume] in blood||soft tissue haemorrhage||random
bupivacaine hydrochloride 2.5 mg in 1 ml infiltration injection, solution [bupivacaine hydrochloride]||insulin novolin 70/30 inj innolet 3ml||random
occup safety||retinopexy using diathermy||random
bone infect nec-pelvis||naphazoline 0.3 mg/ml / polysorbate 20 2.4 mg/ml ophthalmic solution [floril redness relief]||random
ekc||ultrasonography of bilateral adrenal glands (procedure)||random
molecular pathology procedure, level 1 - fukutin (fktn) gene analysis for detection of retrotransposon insertion variant||bismuth chelate overdose||random
ovarian germ cell yolk sac tumour stage iv||coccidioides immitis igm &#x7c; cerebral spinal fluid &#x7c; microbiology||random
total reconstruction of external ear using cartilage graft, fascia flap and skin graft (procedure)||wuchereria bancrofti+brugia malayi ab.igg1||random
calbindin||radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater||random
afranthidium (nigranthidium) sp. jrl-2016||tar oil (product)||random
sg-dhmo||nonseminomatous germinoma of digestive tract (diagnosis)||random
knee mri articular cartilage fissure trochlea medial||clozapine (clozaril)||random
unclassified ramaria||arthrd ant interdy cervcl belw c2 ea addl ntrspc||random
cardiac asthma (diagnosis)||reticuloendothelioses, familial||random
hackberry pollen allergen||age at death of female cousin #1 by father's sister #1||random
replacement of left hip joint with metal synthetic substitute, uncemented, open approach||displ commnt fx shaft of r femr, 7thq||random
infusion of substance to disrupt blood brain barrier||psychology, military||random
balln angiopl hepatic artery||sialate:prthr:pt:urine:ord||random
injury of optic nerve, left eye||ribonucleic acid of influenza a virus h5||random
painless mass||imidazolyl ethanamide pentandioic acid||random
gemcitabine only product in parenteral dose form||diffuse large cell lymphoma (peripheral t-cell lymphoma unspecified) (working formulation) stage iii||random
sfz-5-sfx||regulation of hindgut contraction||random
lobular carcinoma in situ of bilateral breasts||primary malignant neoplasm of round ligament of uterus||random
3,4-dihydroxyphenyllactate/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||nucleus of hypothalamus||random
num prev surg at/near level||bronchoscopy foreign body of right middle lobe lateral segmental bronchus||random
orthodontic appliance, device (physical object)||infusion site hypertrophy||random
homatropine / hydrocodone oral solution [hycodan]||acetone in body fluid (lab test)||random
thoracic spine pseudarthrosis||aethusa cynapium 12 [hp_x] in 118 ml / aluminum oxide 12 [hp_x] in 118 ml / ammonium carbonate 12 [hp_x] in 118 ml / asafetida 12 [hp_x] in 118 ml / baptisia tinctoria root 12 [hp_x] in 118 ml / atropa belladonna 12 [hp_x] in 118 ml / sodium borate 12 [hp_x] in 118 ml / activated charcoal 12 [hp_x] in 118 ml / phenol 12 [hp_x] in 118 ml / matricaria recutita 12 [hp_x] in 118 ml / citrullus colocynthis fruit pulp 12 [hp_x] in 118 ml / dioscorea villosa tuber 12 [hp_x] in 118 ml / graphite 12 [hp_x] in 118 ml / ipecac 12 [hp_x] in 118 ml / wood creosote 12 [hp_x] in 118 ml / magnesium phosphate, dibasic trihydrate 12 [hp_x] in 118 ml / mercuric chloride 12 [hp_x] in 118 ml / sodium phosphate, dibasic, heptahydrate 12 [hp_x] in 118 ml / strychnos nux-vomica seed 12 [hp_x] in 118 ml / nerium oleander leaf 12 [hp_x] in 118 ml / phosphorus 12 [hp_x] in 118 ml / lead 12 [hp_x] in 118 ml / pulsatilla vulgaris 12 [hp_x] in 118 ml / toxicodendron pubescens leaf 12 [hp_x] in 118 ml / senna leaf 12 [hp_x] in 118 ml / silicon dioxide 12 [hp_x] in 118 ml / sulfur 12 [hp_x] in 118 ml / valerian 12 [hp_x] in 118 ml / zinc 12 [hp_x] in 118 ml oral liquid [digestive upsets]||random
aesculus carnea flower 30 [hp_c] in 59.1 ml / aesculus hippocastanum flower 30 [hp_c] in 59.1 ml / horse chestnut 30 [hp_c] in 59.1 ml / agrimonia eupatoria flower 30 [hp_c] in 59.1 ml / bromus ramosus flower 30 [hp_c] in 59.1 ml / calluna vulgaris flowering top 30 [hp_c] in 59.1 ml / carpinus betulus flowering top 30 [hp_c] in 59.1 ml / castanea sativa flower 30 [hp_c] in 59.1 ml / centaurium erythraea flower 30 [hp_c] in 59.1 ml / ceratostigma willmottianum flower 30 [hp_c] in 59.1 ml / cichorium intybus flower 30 [hp_c] in 59.1 ml / clematis vitalba flower 30 [hp_c] in 59.1 ml / fagus sylvatica flowering top 30 [hp_c] in 59.1 ml / gentianella amarella flower 30 [hp_c] in 59.1 ml / helianthemum nummularium flower 30 [hp_c] in 59.1 ml / hottonia palustris flower 30 [hp_c] in 59.1 ml / ilex aquifolium flowering top 30 [hp_c] in 59.1 ml / impatiens glandulifera flower 30 [hp_c] in 59.1 ml / juglans regia flowering top 30 [hp_c] in 59.1 ml / larix decidua flowering top 30 [hp_c] in 59.1 ml / lonicera caprifolium flowering top 30 [hp_c] in 59.1 ml / malus domestica flower 30 [hp_c] in 59.1 ml / mimulus guttatus flowering top 30 [hp_c] in 59.1 ml / olea europaea flower 30 [hp_c] in 59.1 ml / ornithogalum umbellatum flowering top 30 [hp_c] in 59.1 ml / pinus sylvestris flowering top 30 [hp_c] in 59.1 ml / populus tremula flowering top 30 [hp_c] in 59.1 ml / prunus cerasifera flower 30 [hp_c] in 59.1 ml / quercus robur flower 30 [hp_c] in 59.1 ml / rosa canina flower 30 [hp_c] in 59.1 ml / salix alba flowering top 30 [hp_c] in 59.1 ml / scleranthus annuus flowering top 30 [hp_c] in 59.1 ml / sinapis arvensis flowering/fruiting top 30 [hp_c] in 59.1 ml / ulex europaeus flower 30 [hp_c] in 59.1 ml / ulmus procera flowering twig 30 [hp_c] in 59.1 ml / verbena officinalis flowering top 30 [hp_c] in 59.1 ml / vitis vinifera flowering top 30 [hp_c] in 59.1 ml oral liquid [fields of flowers]||cupiennin 1a||random
kerita||unclassified opecoelidae||random
rupture of tendon of knee reg||belimumab only product in parenteral dose form||random
process utilizing autophagic mechanism||plethora (physical finding)||random
sebaceous gland neopl||broxil pill||random
leukocyte casts:number concentration (count/vol):to identify measures at a point in time:urine:quantitative:computer assisted||varicella-like rash||random
medical and surgical @ gastrointestinal system @ drainage @ appendix @ open @ no device||terminalia, nos||random
medical and surgical @ lower arteries @ drainage @ internal iliac artery, left||respiratory syncytial virus as the cause of diseases classified to other chapters||random
biopsy of upper limb using computed tomography guidance||allium ferganicum vved., 1924||random
colon descendens||canagliflozin (anhydrous)||random
bursa subdeltoidea||silicone sheet tissue reconstructive material, sterile (physical object)||random
chemokine (c-c motif) ligand 4 gene||unclassified chaetasbolisia||random
coagulation assessment blood test, plasma or whole blood||powder for cutaneous solution||random
ozimops sp. alphacoronavirus||chironomidae sp. bioug24548-c12||random
lesinurad/allopurinol 200 mg-200 mg oral tablet||fk-506 pharmacogenetic test reagents||random
serum fetuin-a||galactosemias newborn screening comment/discussion||random
calcium hydrogen phosphate dihydrate (24h u) [mass/time]||burning sensation of lower limb||random
vibrio sp. hdep29||crown proper of maxillary second molar tooth||random
seroquel 100 mg oral tablet||aphantochilidae||random
permethylsorbitol||paraclytus||random
magnetic resonance imaging of lumbar spine: extrusion from l1-l2 intervertebral disc space on left||papuadytes sp. mb487||random
cervical spine disease||octinoxate 75 mg in 1 g / zinc oxide 48 mg in 1 g topical cream [dynamic sunscreen broad spectrum spf 55 sun protection]||random
methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate||conventional release soft vaginal capsule (dose form)||random
de novo nad biosynthetic process from tryptophan||vitacea scepsiformis||random
palindromic rheumatism of other specified site||product containing precisely levetiracetam 100 milligram/1 milliliter conventional release solution for injection (clinical drug)||random
fsrg1||blackfly genomovirus 10||random
dislocation of lens (diagnosis)||laser destruction of lesion of vagina||random
colchicine 0.6 mg oral capsule||ct guidance for injection of ankle - left||random
insect bite to cornea - nonvenomous||trachelectomies||random
orthotylus nyctalis||intentional self harm by steam, hot vapours and hot objects, occurrence at other specified place||random
cells.cd38+lambda+/100 cells &#x7c; blood &#x7c; cell markers||haemochromatosis type 4||random
men1, lys135ile||foetal period||random
phenothiazine/related antipsychotics||enhancer of zeste 2 gene mutation||random
adapalene and benzoyl peroxide gel||[m]glioblastoma nos (morphologic abnormality)||random
product containing pertuzumab||assault by discharge of revolver||random
axiocerses||unclassified limnesiidae||random
cytokine inducible sh2-containing protein||african dormouse||random
ct ankle - right wo contrast||diabetes mellitus due to underlying condition with other specified complication||random
unclassified paenibacillaceae||labeling reagents, affinity||random
chronic osteomyelitis of distal phalanx of second toe of left foot||herpes zoster radiculopathy||random
eudorylaimus sp. konza viiaa-74 d||a19 choroid plexus||random
sclera disease||[x]car occupant injured in collision with two- or three-wheeled motor vehicle, person on outside of vehicle injured in nontraffic accident (event)||random
v-y advancement collumellar lengthening||feet talipes right||random
lolium perenne pollen||intracerebral haematoma evacuation||random
removal of subcutaneous intravenous access reservoir||withdrawn (finding)||random
dracoamoeba||pseudoceros laingensis newman & cannon, 1998||random
non-medical public and private facilities||leukocytes other:number concentration (count/vol):to identify measures at a point in time:synovial fluid (joint fluid):quantitative:manual count||random
hearing status [omaha]||3,5,3'5' tetraiodothyronine||random
antiribosomal p protein antibody (substance)||medical and surgical @ lower veins @ reposition @ renal vein, right @ percutaneous||random
root pulp of left maxillary third molar tooth||fungal sp. ariz l138||random
sarolaner 40 mg chewable tablet||congenital anomaly of esophagus (diagnosis)||random
substance abuse control||thyroid gland inflammation||random
pseudoxycheila||chlamydia trachomatis pneumonia||random
fusarium sp. 4 ae-2013||osteonecrosis due to drugs, multiple sites||random
rahnella sp. m72troncod||lam facetectomy & foramotomy 1 segment lumbar||random
t4 2nd specimen post unsp challenge [mass/vol]||myelopoiesis assessment nar (bm)||random
specified breast anomalies nos||benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1), mixt. with 2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide||random
staplers, surgical, circular, powered||strabismus following ocular surgery||random
transgastric drainage of pancreatic lesion (procedure)||amyotrophic lateral sclerosis pathway||random
extracellular (qualifier value)||monuron (substance)||random
cis sp. bold:aau8196||hemorrhagic breast cyst||random
percutaneous transluminal revascularization of acute subtotal occlusion of a single coronary artery with atherectomy, angioplasty, and insertion of stent||mal-a-ket wipes 2 % / 1 % medicated pad||random
plmt nephroureteral cath prq new access rs&i||adalimumab 50 mg/ml prefilled syringe [humira]||random
pistachio ige ab [units/volume] in serum||breast squamous cell carcinoma||random
zinc oxide 48 mg in 1 g / octinoxate 75 mg in 1 g topical cream [dynamic sunscreen broad spectrum spf 55]||musculus peroneus longus||random
parreysia corrugata (muller, 1774)||genotyping for medication susceptibility||random
dextromethorphan-guaifenesin 10 mg-187 mg/5 ml oral liquid||cerebral hem at birth||random
primary malignant neuroendocrine neoplasm of body of stomach (disorder)||fat emboli||random
rectum||family formicidae||random
vericiguat (substance)||regulation of peptidyl-serine phosphorylation of stat protein||random
base,dist phalanx ring finger||sequence determination, amino acid||random
structure of facial nerve motor branch||x-ray of hand, views (procedure)||random
2-oxoisocaproate/creatinine &#x7c; urine &#x7c; chemistry - non-challenge||deprecated respiratory therapy treatment plan, current level of function (narrative)||random
signal, protein sorting||reinsertion||random
tetrazygia rich. ex dc.||laceration of lower palpebral conjunctiva of left eye (physical finding)||random
medical and surgical @ gastrointestinal system @ resection @ sigmoid colon @ percutaneous endoscopic||t-large cell anaplastic (ki-1+) lymphoma (kiel classification) stage ii||random
paroxetine hcl 12.5 mg oral tablet, extended release 24 hr||cancer ag 50 &#x7c; serum or plasma &#x7c; chemistry - non-challenge||random
entamoeba histolytica ab:acnc:pt:ser:qn:ha||section 5-5 radiologic procedures on the gastrointestinal tract||random
doxylamine succinate 20 mg / vit-b6 hydrochloride 20 mg extended release oral tablet||excoriation on proximal end of right third toe||random
chronic lacrimal canaliculitis of left lacrimal passage||neurenteric cyst and associated malformation||random
yes||ondansetron oral film [zuplenz]||random
rfa pa-bl views w contr ia||x-ray of toe: lytic lesion||random
agents, antiprotozoal||urostomy complication||random
.alpha.,.alpha.-dibromo-d-camphor||vionex 5.2 mg/ml medicated liquid soap||random
nitidulinae||post technics||random
plants, asparagus||avobenzone 3 g in 100 g / octinoxate 7.5 g in 100 g / octisalate 5 g in 100 g / octocrylene 2.7 g in 100 g / oxybenzone 4 g in 100 g topical cream [advanced anti-wrinkle therapy cicatricure]||random
lysinoalanine||glaucidium brasilianum||random
stomach carcinoma stage iv without metastases||unclassified modestobacter||random
microrna 509-1||during the past 24h, how has pain interfered with your mood:score:24h:^patient:ord:bpi.short||random
abdmnal pain unspcf site||ligase gene||random
fam hx of congen malform, deformations and chromsoml abnlt||heinz body determination, induced (procedure)||random
tyrant flycatcher (organism)||unclassified leptoceridae||random
otolaryngologic surgical result of left ear: hearing||clotrimazole 10% vaginal cream pack (substance)||random
history alcohol use behavior problem drinker||daucus virgatus||random
rf chest views w contrast po||unclassified mysmenidae||random
hemorrhage during pregnancy before 23rd gestational week as antepartum condition (diagnosis)||henriettella naudin||random
panacagrimonas sp.||casirivimab- and imdevimab-containing product in parenteral dose form||random
ephialtes||radical resection of tumor (eg, sarcoma), soft tissue of pelvis and hip area; 5 cm or greater||random
absent ribs||teletherapy dose rate (qualifier value)||random
fracture of thumb, part unspecified||medical and surgical @ lower bones @ reposition @ toe phalanx, left @ open @ external fixation device||random
puncture wound of hip (diagnosis)||other spec.pulm.circulat.dis.||random
plerixafor injection [mozobil]||cmv ag spec ql if||random
aids related cervical cancer||optic disc pallor excessive||random
herpes simplex virus 1+2 antibody pattern:impression/interpretation of study:to identify measures at a point in time:serum:nominal||neuroectodermal differentiation||random
dextrose 1.2 gram/3 ml (40 %) oral gel in syringe (ml)||infections, corynebacterium||random
systemic to pulmonary collateral artery from right renal artery||anthranilate breakdown||random
sacroperineal approach||immune-associated nucleotide-binding protein 2||random
corneal granular dystrophies||zbed1||random
taste receptor activity||[so]specified nose nec||random
gamma-tubulin small complex location||cardiophobia||random
mucosa of ventrum of tongue||supracervical hysterectomy with left salpingo-oophorectomy (procedure)||random
structure of genitourinary tract||platelet disorders nec||random
miconazole topical powder||vitreous humor||random
xanthonemataceae||mental foramen (body structure)||random
actinomycosis; cutaneous||cows - sweating||random
scopolamine hydrobromide 400micrograms tablet (product)||other systemic antibiotics causing adverse effects in therapeutic use||random
phleum pratense recombinant (rphl p) 7+12 antibody.immunoglobulin e.rast class||ivd test reagent/kits, molecular assay, gene anomaly, mutation, fgfr3||random
subdivision of thoracic content||unresectable esophageal adenocarcinoma||random
location of mass of right external auditory canal wall (physical finding)||bacillus sp. 5b6||random
flexor tendon of wrist||acellular pertussis vaccine, inactivated 0.116 mg/ml / diphtheria toxoid vaccine, inactivated 50 unt/ml / hepatitis b surface antigen vaccine 0.02 mg/ml / poliovirus vaccine inactivated, type 1 (mahoney) 80 unt/ml / poliovirus vaccine inactivated, type 2 (mef-1) 16 unt/ml / poliovirus vaccine inactivated, type 3 (saukett) 64 unt/ml / tetanus toxoid vaccine, inactivated 20 unt/ml prefilled syringe||random
triamcinolone acetonide 0.25 mg/ml [flutex]||methylphenidate hydrochloride 27 mg [concerta]||random
platyphora decorata||chlorpheniramine maleate 4 mg / phenylpropanolamine hcl 50 mg / pseudoephedrine hcl 10 mg / pyrilamine maleate 25 mg oral tablet||random
malignant hypertension||transfusion reactions, hypotensive||random
luride, 0.5 mg oral tablet, chewable||x-ray of lower leg: mixed lytic and sclerotic lesion with periosteal reaction||random
upper arm burn caused by gunpowder explosion||crushing injury of left ring finger, subsequent encounter||random
minocycline 135 mg extended release oral tablet||accessory tissue on left atrioventricular valve leaflet (disorder)||random
scopolamine (substance)||deoxyglidobactin c||random
multiple ulcers of left upper arm (#___)||superficial foreign body of penis without major open wound but with infection||random
spore germination||benzodiazepine related hypnotics and sedatives||random
benzethonium chloride 1.3 mg/ml||infrared treatment of lateral aspect of left foot||random
equipment error/failure (finding)||skin fissure on anterior heel of right foot (physical finding)||random
ulceration of gingivae||duocarmycins||random
inj||crofelemer 125 mg oral delayed release tablet||random
difficulty with anesthesia||chironomidae sp. bioug24931-g08||random
lpgp1||purulent; pericarditis||random
human isophane insulin 85 unit/ml and recombinant human regular insulin 15 unit/ml suspension for injection||tsp-2 protein, schistosoma mansoni||random
posteriorly-angulated ears||aluminum zirconium octachlorohydrex gly 0.2 g in 1 ml topical liquid [revlon mitchum clinical gel]||random
blood catecholamine measurement||dichelobacter nodosus||random
haemorrhagic cyst of ovary||squamous cell carcinoma of head and neck metastatic||random
g-protein coupled nucleotide receptor binding||scores, organ dysfunction||random
paraesthesia of fingers||cyanobium sp. jj25vir||random
crowds||fungal screen positive||random
mitogen-activated protein kinase kinase kinase 1 gene||allergy testing aureobasidium pullulans (lab test)||random
leave, sick||nephrotic syndrome+dis.ec nos||random
esophageal lumen||neural network of right parietal bone||random
ataxia-telangiectasia mutated gene||tritirachiales aime & schell 2011||random
transport; not mvt||food allergy||random
partial nephrectomy nos||cyclin g2||random
methyldopa/ hydrochlorothiazide||tetrapyrrole degradation||random
mammography reference location (finding)||paraesthesia||random
muscle body of auricularis posterior||paranasal therapeutic procedures||random
tropidia sp. chase o-241||malignant neoplasm of dome of urinary bladder recurrent||random
carduus marianus seed||timolol only product in ocular dose form||random
cordia||chemokine (c-c motif) receptor 3, rat||random
late effect of radiation (disorder)||hemolymphoid system subdivision||random
hydrochloride anhydrous, ciprofloxacin||lymph node malignant lymphoma follicular grade 3a intrapelvic (diagnosis)||random
pedobacter sp. bca45||[x]foreign body in other and combined sites of genitourinary tract (disorder)||random
multiple tumor suppressor 1||eucalyptus globulus leaf 2 [hp_c] in 1 ml / ipecac 3 [hp_c] in 1 ml / aconitum napellus 3 [hp_c] in 1 ml / influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (propiolactone inactivated) 8 [hp_c] in 1 ml / influenza a virus a/hong kong/4801/2014 x-263b (h3n2) hemagglutinin antigen (propiolactone inactivated) 8 [hp_c] in 1 ml / influenza b virus b/brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) 8 [hp_c] in 1 ml / respiratory syncytial virus immune globulin intravenous (human) 8 [hp_c] in 1 ml / atropa belladonna 30 [hp_c] in 1 ml / bryonia alba root 30 [hp_c] in 1 ml / eupatorium perfoliatum flowering top 30 [hp_c] in 1 ml / gelsemium sempervirens root 30 [hp_c] in 1 ml / wood creosote 30 [hp_c] in 1 ml / veratrum viride root 30 [hp_c] in 1 ml oral liquid [influenza plus]||random
rickettsia monacensis simser et al. 2019||nitrosospira sp. nsp1||random
antral carcinoma stage iv nos||octinoxate 61.2 mg in 1 ml / zinc oxide 30.6 mg in 1 ml topical lotion [beauty hydrating]||random
up-regulation of epiboly||anicteric leptospirosis (disorder)||random
underdosing of local antifung/infect/inflamm drugs, subs||product containing eszopiclone in oral dosage form (medicinal product form)||random
vascular surgery procedure on abdominal region||candida albicans antigen||random
benzalkonium chloride 13 mg/ml||receptor aggregation||random
psoas muscle||unilateral naevoid telangiectasia||random
date of diagnosis of multiple tumors:time stamp-date and time:to identify measures at a point in time:cancer.not specified:quantitative||cd246 antigen protein variant||random
ureter resection with end-to-end anastomosis (procedure)||digoxin levels||random
follitropin beta 300 unt/ml||fetal supraventricular tachycardia||random
allantoin 5 mg in 1 g / lidocaine 5 mg in 1 g topical ointment [cbdmedic itch and rash]||diethylmalonylbenzylidene oxypropene dimethicone||random
tyzine nasal product||wet shelter||random
riehl||eating disorder diabetes mellitus type 1||random
locally advanced rectal adenocarcinoma||medical and surgical @ upper arteries @ insertion @ hand artery, left @ open @ infusion device @ no qualifier||random
neisseria gonorrhoeae deoxyribonucleic acid (substance)||zinc finger protein snai1||random
unclassified chionodes||mazzaella g.de toni f., 1936||random
cassava latent virus||pericardectomies||random
lactobacillus fermentum||i am motivated to do my usual activities in the past 7 days [facit]||random
post procedural pruritus||serum random triglyceride level||random
phleboplasty||diag techniques neurol||random
epithelial cells:ncnc:pt:urine:qn:automated||5p tetrasomy||random
acinetobacter sp. i15||cta lower extremity vessels - left||random
obs thought throw things away||dilation of l com carotid with 3 drug-elut, perc approach||random
anti s||johnson grass pollen extract 500 unt/ml||random
vol dist steady state obs norm by bmi||destruction of left seminal vesicle, percutaneous approach||random
near miss, healthcare||hyla||random
salmonella abortus equi||severe insufficient nutrition||random
product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)||labiosimplex longispicularis (wood, 1929)||random
glucose^1st specimen||mood disorder with depressive symptoms caused by synthetic cathinone (disorder)||random
avobenzone 2 g in 100 ml / homosalate 10 g in 100 ml / octisalate 5 g in 100 ml / octocrylene 4 g in 100 ml / oxybenzone 5 g in 100 ml topical lotion [sport sunscreen spf 30 exchange select]||plant, cotton||random
rhodobacteraceae bacterium d3010||arnica montana 30 [hp_c] in 5 ml / arsenic trioxide 30 [hp_c] in 5 ml / bellis perennis 30 [hp_c] in 5 ml / passiflora incarnata flowering top 30 [hp_c] in 5 ml / valerian 30 [hp_c] in 5 ml / apis mellifera 30 [hp_c] in 5 ml / human breast tumor cell 30 [hp_c] in 5 ml / helianthemum canadense 30 [hp_c] in 5 ml / clematis recta flowering top 30 [hp_c] in 5 ml / arabica coffee bean 30 [hp_c] in 5 ml / strychnos ignatii seed 30 [hp_c] in 5 ml / lachesis muta venom 30 [hp_c] in 5 ml / magnesium phosphate, dibasic trihydrate 30 [hp_c] in 5 ml / sodium chloride 30 [hp_c] in 5 ml / sodium sulfate 30 [hp_c] in 5 ml / ornithogalum umbellatum 30 [hp_c] in 5 ml / phosphoric acid 30 [hp_c] in 5 ml / salix nigra bark 30 [hp_c] in 5 ml / delphinium staphisagria seed 30 [hp_c] in 5 ml oral liquid [century 21 acute stress]||random
diabetes mellitus, maturity-onset||keratosis obturans of external ear (canal)||random
mitral stenosis with insuffic.||solder flux (substance)||random
trna-glu-ctc-8-1||other displaced fracture of first cervical vertebra||random
seminal vesicle part of left middle rectal artery||influenza with respiratory manifestation other than pneumonia (disorder)||random
hypoglossal nerve disorder||influenza virus a h1 2009 pandemic rna panel - specimen by naa with probe detection||random
decreased eicosapentaenoic acid diet (regime/therapy)||superficial spreading melanoma stage iii||random
pkd2 gene targeted mutation analysis molgen doc (bld/tiss)||craterostigma||random
benign neoplasm ovarian lig.||virgibacillus sp. hb50||random
injury; multiple sites, intrathoracic organs||intermittent pulse oximetry||random
supracervical hysterectomy with left salpingo-oophorectomy (procedure)||melanoma inhibitor of apoptosis protein, human||random
bulging of intervertebral disc at l3-l4 central (diagnosis)||drug ineffective||random
speech-language pathology&#x7c;anytypeofservice&#x7c;anykindofnote&#x7c;anysetting||simpla 380303 extension tube x10||random
parenteral administration route abdomen left||la crosse virus ab:prthr:pt:ser:ord:hai||random
inocybe sp. pbm3528||trisomy; 13, meiotic nondisjunction||random
regulation of heart induction by regulation of canonical wnt receptor signaling pathway||ssrna virus, (-) strand||random
zidovudine 100 mg/1 each oral capsule||superficial injury of leg (& [ankle] or [hip] or [thigh])||random
bypass right atrium to right pulmonary artery with autologous venous tissue, open approach||carapoia||random
product containing dexbrompheniramine and pseudoephedrine||triclosan 0.6 ml in 100 ml topical liquid [foaming antibacterial cucumber melon]||random
amobarbital:mcnt:pt:meconium:qn||spar||random
serosanguineous drainage of stump of right arm amputation (physical finding)||ultrasound.doppler.calculated||random
transversalis fascia of lower abdominal quadrant||breast asymmetrical||random
mumps virus ab [units/volume] in serum||unspecified disorder of synovium and tendon, left lower leg||random
octinoxate 0.0664 g in 1 g / oxybenzone 0.0151 g in 1 g topical lipstick [esika hydracolor 2 in 1 spf 25 (granate seductor) - purple]||alcohol and/or drug services||random
penicillium sp. e/pt/6/4||flavin-containing monooxygenase 2||random
ritual female circumcision||ultrasound treatment to hip (regime/therapy)||random
aids with encephalopathy (disorder)||x-ray of femur: location of sclerotic lesion (procedure)||random
polymorphus hemangioendothelioma||[x]other disorders of branched chain amino acid metabolism||random
caspase recruitment domain family, member 8 gene||subfragments, myosin||random
closed reduction of monteggia type fracture dislocation of elbow with manipulation||pilosa, bidens||random
scanning systems, laser/light, orthopedic impression, spinal orthosis/prosthesis/seat cushion||collection method:type:to identify measures at a point in time:dried blood spot:nominal||random
laceration of cervix, postpartum||cyphellophora||random
guaifenesin/dextromethorphan 200 mg-15 mg/5 ml oral syrup||tracheobronchial stents||random
removal of infusion device from chest wall, open approach||septal wall hypokinesia||random
combined pulmonary fibrosis and emphysema syndrome||coronary angiography: coronary artery bypass graft insertion site proximal left anterior descending obstruction (procedure)||random
acute female pelvic cellulitis (disorder)||dimethicone/vinyl dimethicone crosspolymer (hard particle)||random
cardiodactylus manus||encephalocele nasofrontal||random
fluocinolone acetonide 0.0625 mg/ml [synalar 1:4]||unclassified chrysopeleiinae||random
cytoskeleton ab [titer] in serum by immunofluorescence||deoxyribonucleic acid of angiostrongylus cantonensis (substance)||random
virus; hepatitis, carrier (b surface antigen (hbsag)||infantile lymphoedema (praecox)||random
nondisplaced comminuted fracture of shaft of right tibia, subsequent encounter for open fracture type i or ii with malunion||chorioretinal scar of midperipheral retina of left eye||random
planococcus sp. tibet-ix21||c7 segment of posterior gray column of spinal cord||random
amino acid measured intake from parenteral nutrition in 24 hours||vegf, hypoxia, and angiogenesis||random
aspen pollen extract 100 mg/ml injectable solution||carnitor 1g/10ml solution||random
szepligetella sp. derv055||cortisone acetate@25 mg@oral@tablet||random
sulphamethoxazole-trimethoprim||biopsy of soft tissue of upper arm||random
product containing only citric acid and nalidixic acid (medicinal product)||troglitazone 400 mg oral tablet [rezulin]||random
alfalfa 10 [hp_x] in 59 ml / ammonium carbonate 10 [hp_x] in 59 ml / dill 10 [hp_x] in 59 ml / antimony trisulfide 10 [hp_x] in 59 ml / gold 10 [hp_x] in 59 ml / benzoic acid 10 [hp_x] in 59 ml / mahonia aquifolium root bark 10 [hp_x] in 59 ml / fagus sylvatica flowering top 10 [hp_x] in 59 ml / ilex aquifolium flowering top 10 [hp_x] in 59 ml / lycopodium clavatum spore 10 [hp_x] in 59 ml / achillea millefolium 10 [hp_x] in 59 ml / hydrochloric acid 10 [hp_x] in 59 ml / scabies lesion lysate (human) 10 [hp_x] in 59 ml / salix alba flowering top 10 [hp_x] in 59 ml oral liquid [melancholic]||nud (nonulcer dyspepsia)||random
protocalliphora sp. bioug18471-h08||kiaa2018||random
secondary malignant neoplasm of other specified site, not elsewhere classified||infusion associated shivering||random
legally induced abortion, unspecified, complicated by embolism||(1alpha(r*),2beta)-(+-) of n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid||random
hiya nigrescens||fetal ear - left maximum length us||random
osteoporotic fracture of femur||avobenzone 20 mg in 1 ml / homosalate 70 mg in 1 ml / octocrylene 50 mg in 1 ml topical aerosol, spray [cvs health sport spf 30 clear]||random
ferrous gluconate (product)||metaxalone 400mg tablet (product)||random
osa||18-hydroxy-corticosteroids||random
revision of intraluminal device in low intest tract, endo||drug dependence of mother, delivered, with or without mention of antepartum condition||random
brussel sprouts (brassica oleracea var gemmifera)||glucose 6h p 100 g glc po serpl-mcnc||random
maxillofacial prosthesis user||fam14b||random
morphine oral liquid product||levothyroxine na 137mcg cap||random
cholecalciferol 10000 unt / menatetrenone 0.1 mg oral capsule||pacing/defibrillation lead electrical adaptor (physical object)||random
ellychnia sp. bioug20571-b01||aconitum napellus 12 [hp_x] in 1 g oral pellet [aconitum napellus]||random
alpha tnf increased||finding of posterior choanae||random
cephradine 250 mg/5 ml oral powder for reconstitution||hypercoagulable state||random
stefin b||tributary of inferior left pulmonary vein (body structure)||random
ring device||plasma creatine phosphokinase mb normal||random
polymyositis haemorrhagica||behcet syndrome, incomplete type||random
pulmonary mycotoxicosis||fasciitis, nec, site unspecified in icd10am_2000||random
dihydropyrimidinase (substance)||centromeric protein a||random
triprolidine hydrochloride 2.5 mg||child examination at 7 months with explicit context (situation)||random
sea-blue histiocyte syndrome (disorder)||adrenaline||random
tauropyrone||structure of superior bulb of internal jugular vein||random
nhp2 ribonucleoprotein homolog protein, human||plain x-ray imaging - action (qualifier value)||random
skin neoplasm bleeding||during the past 30 days, how many days out of 30 were you totally unable to work or carry out your normal activities because of these feelings||random
hypohepatia||aeromicrobium panaciterrae cui et al. 2007||random
rpr tendon sheath extensor f/arm&/wrist w/graft||distal trisomy 1p (disorder)||random
ivd test reagent/kits, molecular assay, gene anomaly, mutation, cox15||techniques, stereotactic||random
joint dislocation nec||unclassified sympetes||random
genus pyrenophora||unclassified enhygromyxa||random
hereditary, developmental and congenital associations||caridina||random
finding of hip joint - range of movement||rp-response||random
obstructed labor due to incomplete rotation of fetal head||immunology studies (lab test)||random
unclassified flagellimonas||neoplasm, tracheal||random
calcification of tricuspid valve||reported friction burn of fingernail by fiberglass||random
sudan blue stain||streptomyces sp. zg0416||random
unclassified pungitius||diffuse warmth of right foot (physical finding)||random
bimatoprost 0.01% ophthalmic solution [lumigan]||ability to perform road safety drill||random
lamotrigine (eqv-lamictal xr) 100mg tab,sa||transplant donor sites||random
arterial bruit absent (situation)||folacin preparation||random
sputum cytology abnormal||arnica montana 1.73 g in 29.7 g / hamamelis virginiana leaf 0.0178 g in 29.7 g topical cream [arnica montana nartex]||random
ethynodiol diacetate preparation (product)||myoglobin urine||random
tryptophan 2-c-methyltransferase (substance)||mouse malignant ovarian granulosa cell tumor||random
theoclear-80 oral liquid product||anticoagulation drug level normal||random
displaced other fracture of tuberosity of left calcaneus, sequela||amino acid agonists, excitatory||random
oral administration of radioactive material therapy agent||avobenzone 27 mg in 1 ml / homosalate 40 mg in 1 ml / octisalate 45 mg in 1 ml / octocrylene 60 mg in 1 ml / oxybenzone 45 mg in 1 ml topical lotion [harmon face values break-out free spf 55 sunscreen]||random
i am satisfied with my ability to take care of personal and household responsibilities in the past 7 days [neuroqol]||agrimonia microcarpa||random
document section (record artifact)||unilateral percutaneous endovascular revascularization of popliteal artery with transluminal stent placement, atherectomy, and angioplasty within the same vessel||random
apmv1 rna spec naa+probe-acnc||ketones 3.5 hr post unsp challenge ql (u)||random
galactoschesis||manufacturing facility pressure differential issue||random
chrysofolia crous & m.j. wingf., 2015||other general signs and symptoms||random
21-hydroxylase ab:prthr:pt:ser:ord||carbamazepine (nostrum) 100mg sa cap||random
twin monster, nos||octinoxate 0.075 g in 1 ml / oxybenzone 0.03 g in 1 ml topical lipstick [lbel divine lip gloss lip gloss spf 15 fm brillo labial fps 15 fm sweet framboise - pink]||random
histidine / isoleucine / leucine / lysine / methionine / phenylalanine / threonine / tryptophan / valine injectable product||cinchocaine and hydrocortisone only product||random
squamous cell bladder carcinoma stage iii||rubella diagnosis --pre pregnancy||random
adult osteochondritis of spine (disorder)||testicular and epididymal infections and inflammations||random
aphakic glaucoma (disorder)||willing to be donor of heart||random
nigella sativa seed||superior anal nerves set||random
healthcare associated parainfluenza virus disease||bretylium 2mg/ml d5w inj bag 250ml||random
nettenchelys||structure of shaft of second metatarsal bone||random
ceftaroline:susceptibility:to identify measures at a point in time:isolate:quantitative or ordinal:gradient strip||alkali (substance)||random
contraception care (regime/therapy)||congenital anomaly of anterior chamber of eye nos||random
scorpion beta-toxin tz1, tityus zulianus||repair left lower arm, percutaneous endoscopic approach||random
orthocladiinae sp. bioug24730-b11||gapdhp50 gene||random
palatal side of maxillary gingiva||other injury of prostate, subsequent encounter||random
3-(1-(4-chlorophenyl)-3-oxobutyl)-4-hydroxy-2h-1-benzopyran-2-one||repair right anterior tibial artery, percutaneous endoscopic approach||random
poecilimon||osteochondritis dissecans of left ankle||random
marsupn lesion of bone of face||x-ray lumbosacral spine bone density increased||random
chronic (qualifier value)||deficiency of aryl sulphotransferase||random
superficial injury of back nos, infected (disorder)||atony of colon (disorder)||random
pediatric outcomes data collection instrument, adolescent self-reported version questionnaire test name||ece1 gene (lab test)||random
inhibitors, growth||chronic lymphocytic inflammation, nos||random
hepatocellular carcinoma-associated antigen 587||respiratory effort increased||random
sudafed 120 mg extended release oral tablet||prelaminar branch of spinal branch of third lumbar artery||random
product containing precisely lorazepam 2 milligram/1 each conventional release oral tablet||deoxyribose||random
i understand the nature and causes of this person's health:find:pt:^caregiver:ord:pam||evaluation method||random
gas||adp-ribosylation factor 2 protein, rat||random
allopurinol oral capsule||rupture of bladder||random
plaque radiation of mandible||diadenosine 5',5'''-(p(1),p(4)-dithio-p(2),p(3)-chloromethylene)tetraphosphate||random
surgical procedure, cytoreductive||regions, lumbosacral||random
beta carotene oral product||otomar-hc 0.1%-1%-1% otic solution||random
estrogen receptor status (lab test)||ecchymosis of both ankles (physical finding)||random
tff peptides||uterine tumor-delivered||random
dilation of left anterior tibial artery, open approach||cervicovaginal secretion||random
clonidine hydrochloride 0.5 mg/ml [duraclon]||idiopathic familial dystonia||random
jacaranda caroba flower 30 [hp_c] oral pellet [jacaranda caroba]||5 ml protamine sulfate (usp) 10 mg/ml injection||random
rejection; transplant, lung(s)||dumping (jejunal) syndrome||random
aphidiinae sp. bioug02443-e11||hepatocyte nuclear factor 6-beta||random
absent tendon reflex||delivery by cesarean hysterectomy observed||random
specific granule||lordosis post surgical||random
coxsackievirus a||aspiration; syndrome of newborn||random
reagents, streptococcus group||ocular nerve and muscle disorders||random
salicylic acid topical lotion [acneclir]||surgical pathology with gross and microscopic examination of soft tissue lipoma||random
eudorylaimus sp. konza viiaa-74 d||plasma cells per 100 leukocytes (lab test)||random
delayed union of fracture of left scapula||protein localisation in golgi membrane||random
bordetella pertussis ag:prthr:pt:sputum:ord:if||frac proximal end of humerus||random
macrocentrum hook.f., 1867||otc, leu45pro||random
soybean (glycine max) ige||product containing recombinant parathyroid hormone (medicinal product)||random
dispatchers, emergency medical||cerebral infarction due to thrombosis of precerebral arteries||random
dicarboxylate||dst plus pak||random
macrosiphon||382||random
hypoesthesia teeth||cecidomyiidae sp. bioug21363-d12||random
imaging @ non-axial lower bones @ magnetic resonance imaging (mri) @ knee, right @ other contrast||occup of pk-up/van injured in collision w 2/3-whl mv in traf||random
repair gi sys in poc with oth dev, perc approach||menthol, unspecified form 5 g topical patch [medirelief ultra]||random
positive regulation of (z)-nonadeca-1,14-diene synthesis||bivalirudin||random
hand &#x7c; x-ray &#x7c; radiology||obstruction of left eustachian tube||random
median nerve component of anterior root of right sixth cervical nerve||perinatal infection nos||random
hedis 2009-2013 codes to identify anticonvulsant serum concentration monitoring tests - valproate (mpm-e)||malignant head catarrh||random
eupodidae sp. bioug26325-f10||sea lice bites||random
ophthalmic fluid drainage||unclassified mucor||random
hymenoptera sp. bold:aab0762||lymphosarcoma of lymph nodes of axilla and/or upper limb (disorder)||random
x-ray of shoulder: narrowing of joint space (procedure)||suprasternal recession||random
camellia japonica leaf extract||activity alteration [ccc]||random
brovex ct 12mg chewable tablet||intra-operative finding of corneal clarity: edema _____grade (1-4) (treatment)||random
hormone receptor positive breast cancer||ketoacidosis (diabetic)||random
proline:scnc:pt:ser/plas:qn||creat 10h p chal serpl-scnc||random
apl differentiation syndrome||osteoarthritis of right ankle due to trauma||random
3-hydroxyvalerate:presence or threshold:to identify measures at a point in time:urine:ordinal||enterobacteriaceae bacterium uba2575||random
scatopsciara sp. bioug27147-c10||diisopropyl dilinoleate||random
dental precision attachment - ball (physical object)||left brachial fascia||random
anacardiaceae sp. cp293||solanum, nos||random
isobutyrates||thermoanaerobacterium sp. j04c009an||random
influenza a virus vaccine, a-texas-50-2012 x-223a (h3n2), inactivated 0.03 mg/ml / influenza a-california-7-2009-(h1n1)v-like virus vaccine 0.03 mg/ml / influenza b virus vaccine, b-massachusetts-2-2012-like virus 0.03 mg/ml [flulaval 2014-2015 formula]||repair of tendon of hand by graft or implant||random
neisseria meningitidis serogroup y capsular polysaccharide tetanus toxoid protein conjugate vaccine||displ longitud fx r patella, 7thr||random
hearing change (finding)||congenital pneumonia of newborn chlamydia||random
glucosuccine||sodium vitf-scnc||random
dermatologic examination abnormal||alcoholic neurologic psychosis||random
cyclomethicone 6||revision of internal fixation||random
oropharyngeal pain||central nervous system depression [pe]||random
conditions associated with central nervous system haemorrhages and cerebrovascular accidents (smq)||troglophilus sp. 2-1 sk-2013||random
pooling test||schistosoma spindale (& [infection])||random
durd||skinner boxes||random
ductal adenocarcinoma||bruising easy||random
maxipro hbv super soluble pdr||boil of axilla||random
hepatitis c virus core antigen:presence or threshold:to identify measures at a point in time:serum/plasma:ordinal:immunoassay||california mugwort pollen extract||random
ochrosia juss., 1789||alanine 4.22 mg/ml / arginine 4.32 mg/ml / aspartate 2.98 mg/ml / glucose 100 mg/ml / glutamate 3.14 mg/ml / glycine 2.12 mg/ml / histidine 1.28 mg/ml / isoleucine 2.8 mg/ml / leucine 4.25 mg/ml / lysine 4.46 mg/ml / magnesium chloride 0.00148 meq/ml / methionine 0.73 mg/ml / phenylalanine 1.26 mg/ml / potassium chloride 0.013 meq/ml / proline 3.07 mg/ml / serine 2.25 mg/ml / sodium chloride 0.0205 meq/ml / sodium phosphate 0.00347 meq/ml / threonine 1.7 mg/ml / tryptophan 0.85 mg/ml / tyrosine 1.15 mg/ml / valine 2.12 mg/ml [aminosyn ii 4.5 % m in 10 % dextrose]||random
transfer summary note:find:pt:custodial care facility:doc:{role}||infection by histoplasma capsulatum, with mention of other manifestation||random
trolandapril||thoracic intrathecal neurolysis||random
grass pollen specific allergen extract||helina sp. bioug25807-d05||random
mitochondrial complex iv deficiency, nuclear type 17||cilastatin na 250mg/imipenem 250mg/vil inj iv||random
translocated promoter region (to activated met oncogene) protein, human||pediasia||random
other bursitis, not elsewhere classified, elbow||cnesia nr. dissimilis thsim007-09||random
driver of hv veh injured in clsn w unsp mv nontraf, subs||tafluprost 15 microgram/ml eye drops||random
diazepam tablets||bordetella pertussis antigen-containing vaccine product||random
vesicle on left thigh||evulsion, nos||random
oxybenzone 48.8 mg in 1 ml / avobenzone 19.52 mg in 1 ml / homosalate 97.6 mg in 1 ml / octisalate 48.8 mg in 1 ml / octocrylene 19.52 mg in 1 ml topical lotion [no-ad sun care broad spectrum spf 50 baby sunscreen]||microfilaria malayi||random
operator of medical device icsr terminology||catheterization coronary artery bypass graft origin forth saphenous vein graft obstruction||random
calophyllum obliquinervium merr.||strictures urethra||random
blue discoloration of upper buccal vestibule on both sides (physical finding)||leishmania leishmania infantum||random
ureterocele, unilateral||unsp injury of muscle, fascia and tendon of abdomen, init||random
indomethacin 50mg capsule (product)||hsa-let-7 microrna||random
genus atopostipes (organism)||eastern equine encephalitis virus ab:prthr:pt:csf:ord:comp fix||random
composite quantity frequency index||dorsal aspect of wrist||random
radial collateral ligament of wrist joint||knowledge level: pregnancy (observable entity)||random
choledochoduodenal fistula (diagnosis)||foot stretching||random
opll||contrave||random
obstruction by abnormal pelvic soft tissues during labor, antepartum||2 ml iobenguane i-131 15 mci/ml injection [azedra]||random
yucca schidigera||etofylline / theophylline oral liquid product||random
ceftaroline fosamil 400 mg injection||miyoshi myopathy 3 gene anomaly detection reagents||random
dna, d(p-thio)((2'-o-(2-methoxyethyl))rg-(2'-o-(2-methoxyethyl))rg-(2'-o-(2-methoxyethyl))rg-(2'-o-(2-methoxyethyl))ra-m5c-g-m5c-g-g-m5c-g-m5c-t-m5c-g-g-(2'-o-(2-methoxyethyl))m5ru-(2'-o-(2-methoxyethyl))m5rc-(2'-o-(2-methoxyethyl))ra-(2'-o-(2-methoxyethyl))m5ru)||other drug psychoses||random
curvilinear incision of left forearm||unclassified characiformes||random
sulfur adverse reaction||verrucous carcinoma of the supraglottis||random
cyclocitropside c||fracture of greater tuberosity of humerus||random
leptodontidium sp. bc_besc_246c||benign congenital hypotonia (disorder) [ambiguous]||random
cydia||white ramus communicans of left seventh intercostal nerve||random
skin structure of right upper limb||bronchoscopy (diagnostic) left lung main stem bronchial mass (___ mm)||random
spontaneous abortion in first trimester (diagnosis)||zinc finger rna binding protein, zebrafish||random
operational research||iron proteins, nonheme||random
calcinosis cutis, metastatic||anal fistula infection||random
caeruloplasmin measurement||uropathy obstructive||random
wound tunneling panel:-:to identify measures at a point in time:wound:-||neoplasm of uncertain or unknown behavior of testis||random
ipratropium bromide 0.03% spray||unclassified glomales||random
allergy testing avocado igg antibody in serum||night blindness nos (disorder)||random
sk&f 95448||general amino acid control response||random
cousinia pinarocephala boiss.||relaxin family peptide receptor 1||random
trabeculated knee tibia/insert prosthesis (physical object)||absent nerve fiber layer of optic disc of left eye along inferior temporal arcad||random
paenibacillus sp. r-45550||phenylhydrazines||random
entomobryidae sp. bioug20914-f07||right apical branch of variant right bronchial artery||random
fibrillary glomerulonephritis||tingling of lip (symptom)||random
salivary cortisol decreased||gripping and opening containers with minimum assistance (physical finding)||random
nris and ssris||incision and curettage of lacrimal canaliculus (procedure)||random
microscopic observation:prid:pt:xxx:nom:india ink preparation||greatest measured dimension||random
history of clinical finding (situation)||consent type||random
structure of thoracic paraspinous muscle group (body structure)||structure of shaft of eleventh rib (body structure)||random
nonparalyt polio-type 3||pai-1 4g/5g polymorphism||random
ultrasound.estimated from cerebellar diameter||calcification and ossification of muscle of upper arm due to burn||random
amlodipine besylate 10 mg / valsartan 160 mg / hydrochlorothiazide 25 mg oral tablet, film coated||compact bone of diaphysis proper of phalanx of middle finger||random
camphor (synthetic) 0.4 mg / levomenthol 1.8 mg / methyl salicylate 2 mg topical patch [pain relief]||dioxolanes||random
cytomegalovirus igm ab [titer] in serum or plasma by immunofluorescence||interleukin 12 p70||random
tissue cult allogen derm subst trunk wound surface area 100 sq cm or greater||avobenzone 3 g in 100 g / homosalate 8 g in 100 g / octisalate 4 g in 100 g / octocrylene 5 g in 100 g topical cream [olay luminous whip active moisturizer broad spectrum spf 25]||random
medical and surgical @ skin and breast @ destruction @ skin, left lower arm @ external @ no device @ no qualifier||patch of periungual region of index finger of left hand (physical finding)||random
contusion of neck (physical finding)||3,5,3',5'-tetraiodotyrosyltyrosine||random
agenesis of punctum lacrimale||histiocytic proliferation - category||random
agamous 1 protein||medical and surgical @ upper veins @ extirpation @ internal jugular vein, left @ open @ no device @ no qualifier||random
cinnamic acid, nickel (+2) salt||chromosomes d||random
tuberculosis of mother, complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition||wd repeat domain 37 protein, human||random
product containing only rotigotine in transdermal dose form (medicinal product form)||helicopsin, helicops angulatus||random
child and adolescent psychiatry progress note||immobilization, tonic||random
formaldehyde .2 ml in 59 ml topical liquid [forma-ray]||decreased rod erg||random
medical and surgical @ ear, nose, sinus @ revision @ nasal mucosa and soft tissue @ external @ drainage device||pelargonium sidoides root 1 [hp_x] oral tablet, chewable [umcka coldcare mint chewable]||random
malabsorption from administration site||medical and surgical @ gastrointestinal system @ extraction @ esophagogastric junction @ via natural or artificial opening endoscopic||random
bacterial susceptibility panel:-:pt:isolate:ordqn:agar diffusion||cecidomyiidae sp. bold:ace1178||random
wall of trunk of left ovarian artery||entire obturator internus muscle ischial bursa||random
vr-12 vitality (vt) score - oblique method t-score||train collision with rock, passenger injured (event)||random
mucous threads #/area urns auto||bacteria identified:prid:pt:asp:nom:culture||random
previsceral ganglion||rac1, val51met||random
heterotopic ossification, posterior lumbar spine||interferon alpha level decreased||random
treprostinil 2.5 mg in 1 ml subcutaneous injection, solution||closed rhinoplasty||random
hydroxyzine [mass] of dose||dnas, chloroplast||random
corrective lens.right||2-hexyl-2,3,5,5-tetramethyl-4-(3-iodo-2-oxopropylidene)imidazolidine-1-oxyl||random
familial infantile cortical hyperostosis||epipleminae sp. indobiosys-ccdb26703-g11||random
views:find:pt:head>orbit.right:doc:xr||unclassified pseudomallada||random
reproductive function.knowledge:find:pt:^patient:ord:observed.omaha||x-ray of finger: non-septated mixed lytic and sclerotic lesion||random
oligia fasciuncula||candidatus gottesmanbacteria bacterium||random
pistacia lentiscus resin||fractional flow reserve using intracoronary bolus (observable entity)||random
mycteroperca||lip||random
unclassified ceratopus||antagonist, folic acid||random
tendon flexor compart leg||integumentary status||random
maprotiline + normap pnl serpl||cellulitis of the abdominal wall||random
yeast-form cell wall||genital anaesthesia||random
benign neoplasm of skin of lip (diagnosis)||ab nos w embolism-inc||random
imaging||local anesthetic regional block||random
brucella iga antibody in serum (lab test)||pharyngeal biopsy sample||random
other specified disorders of cornea||acute myeloid leukaemia with bcr-abl1||random
ropivacaine hydrochloride 5 mg/ml [naropin]||sunmark miconazole 3 vaginal cream combination pack (prefilled)||random
osteoporosis in other disorders classified elsewhere||medical and surgical @ female reproductive system @ change @ vulva @ external @ other device @ no qualifier||random
vinburnine oral product||product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 10 milligram/1 each conventional release oral tablet (clinical drug)||random
congenital abnormalities of gu system||pain of right shoulder elicited during external rotation against resistance at 90 degrees abduction (physical finding)||random
paecilomyces persicinus||entire articular facet of second metatarsal (body structure)||random
disorder of sympathetic nervous system||zinc tetrabenzylpyridoporphyrin||random
cells.cd3+cd8+cd45ro+cd45ra-/100 cells||strike or hit against bottom when jumping or diving into water||random
cromolyn pill||oth abdominal hernia without obstruction or gangrene||random
gain of chromosome 8||crystal urine||random
region of surface of clavicle||sorbitan olivate||random
entire subfascial prepatellar bursa||transfer rna alanine 29 (anticodon cgc)||random
prilocaine hcl||capsicum mirabile mart.||random
diterpene cyclase activity||viral carditis (disorder)||random
protocols: self-care||internasal dysostosis (disorder)||random
diphenhydramine hydrochloride 1.25 mg/ml oral solution [benadryl]||cord entanglement without compression||random
chromosome xq28 trisomy syndrome||product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)||random
sedatives/hypnotics,other||wrists||random
x-ray face orbits erosion||ligularia dictyoneura (franch.) hand.-mazz.||random
membrane-limited cytoplasmic organelle||thoracic artery injection||random
vitamin b<sub>12</sub> binding protein||mercaptomerin - chemical||random
neuroglial network of gray matter of lumbar subsegment of spinal cord||bk polyomavirus test||random
skin tag of distal end of right thigh||acids, oleic||random
ippv - intermittent positive pressure ventilation||trade and service environment (environment)||random
cmp th cd inj-no bny inj,t7-12||hyperkinetic ventricular wall (finding)||random
peritoneum closure (treatment)||leukocytosis||random
acetaminophen / phenylpropanolamine oral tablet||pseudopithyella minuscula||random
hand rash||paralysis; pharynx||random
amphetamines bld ql scn||laceration of right hip||random
small intestinal necrosis||dabrafenib 75 mg oral capsule [tafinlar]||random
panic self-control||aradus compar kiritshenko, 1913||random
change other device on right finger||cardiac catheterization: upper collateral peak systolic pressure||random
jamestown canyon virus rna naa+probe qn (specimen)||insulin isophane / insulin, regular, human injectable suspension [human mixtard]||random
carcinosarcoma of intrahepatic bile duct (diagnosis)||dehydroepiandrosterone sulfate^1st specimen post xxx challenge:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||random
tc-6683||pyrococcus||random
haematopoietic leukopenia (smq)||umbaspis||random
surgery intra-operative surgical positioning||scleroproteins||random
alcohol 16.2 ml in 30 ml topical gel [plu clean hand sanitizer gel peach]||x-ray of humerus: mixed lytic and sclerotic lesion with lamellated periosteal reaction||random
tic regimen||malignant neoplasm of body of stomach recurrent||random
boredom||radionuclide ectopic gastric mucosa study||random
oxygen saturation^during anesthesia||gth ii-alpha||random
partial/complete duplication of the proximal phalanx of the 3rd toe||product containing only trimipramine maleate 25 mg/1 each oral capsule||random
unab grip use supinat wrist||bacteria identified in ocular fluid by aerobe culture||random
alpha-1b adrenoreceptor||chicken smacovirus mg4_885||random
camphor 3.1 % / menthol 15.6 % / methyl salicylate 20.7 % topical ointment||hospital admission, emergency, indirect (procedure)||random
upper second molar socket||protozoal corneal ulcer||random
acoustic shock||capsule open||random
proteobacteria gamma subdivision||positive regulation of calcium in er||random
x-ray face sinus||hla-b*5701 assay negative||random
latrotoxin receptor activity||trichrome stain technique (qualifier value)||random
tunica adventitia||watch repairer (occupation)||random
octyldodecyl neopentanoate||2-(-glucopyranosyloxy)-benzyl 3-(-glucopyranosyloxy)-benzoate||random
ulipristal acetate 5 mg oral tablet||crataegus castlegarensis||random
tiazac 420mg extended-release capsule||infarction; myocardial, subsequent, anterior wall||random
goserelin acetate regimen||ulcer peptic reactivated||random
hematocrit auto (bld) [pure volume fraction]||pdgf recept||random
ginkgo 6 [hp_x] in 1 ml / english walnut 6 [hp_x] in 1 ml / arctium lappa root 6 [hp_x] in 1 ml / thuja occidentalis leafy twig 6 [hp_x] in 1 ml / epinephrine 15 [hp_x] in 1 ml / candida albicans 15 [hp_x] in 1 ml / thyroid, unspecified 15 [hp_x] in 1 ml / saccharomyces cerevisiae 16 [hp_x] in 1 ml / elymus repens root 15 [hp_x] in 1 ml / ustilago maydis 15 [hp_x] in 1 ml / antimony trisulfide 15 [hp_x] in 1 ml / arsenic trioxide 15 [hp_x] in 1 ml / baptisia tinctoria 15 [hp_x] in 1 ml / mahonia aquifolium root bark 15 [hp_x] in 1 ml / bryonia alba root 15 [hp_x] in 1 ml / tribasic calcium phosphate 15 [hp_x] in 1 ml / cinchona officinalis bark 15 [hp_x] in 1 ml / chamaelirium luteum root 15 [hp_x] in 1 ml / goldenseal 15 [hp_x] in 1 ml / iodine 15 [hp_x] in 1 ml / iris versicolor root 15 [hp_x] in 1 ml / potassium carbonate 15 [hp_x] in 1 ml / lachesis muta venom 15 [hp_x] in 1 ml / lycopodium clavatum spore 15 [hp_x] in 1 ml / mercury 15 [hp_x] in 1 ml / sodium carbonate 15 [hp_x] in 1 ml / sodium phosphate, dibasic, heptahydrate 15 [hp_x] in 1 ml / nitric acid 15 [hp_x] in 1 ml / sepia officinalis juice 15 [hp_x] in 1 ml / phosphorus 15 [hp_x] in 1 ml / podophyllum 15 [hp_x] in 1 ml / anemone pulsatilla 15 [hp_x] in 1 ml / echinacea, unspecified 6 [hp_x] in 1 ml oral liquid [candid- y]||hl2||random
urea:substance rate:12 hours:urine:quantitative||nitrogen 77 %||random
ceftazidime induced neutrophil ab.igm||isopropyl alcohol 750 ml in 1000 ml topical liquid [hand sanitizer]||random
carcinoma ex spiradenocylindroma||cuscuta subgen. grammica (lour.) peter, 1891||random
vocal cord paralysis unilateral left||right periphrenic fascia||random
trunk stretching||eupatorium capillifolium pollen 10000 [pnu] in 1 ml subcutaneous solution [dog fennel]||random
bacteria identified aer cx nom (nph)||pseudoxanthoma elasticum (disorder)||random
indomethacin rectal product||gestational age &#x7c; fetus &#x7c; ob ultrasound||random
cat serum albumin ige qn (s)||esophagus, crico-pharyngeus||random
menthol 62.5 mg/ml topical cream||taurine&#x7c;scnc&#x7c;urine||random
lanosulin catabolic process||abscess; lung||random
downregulation of gut granule assembly||salmonella group o:9 (organism)||random
local anesthesia not in conjunction with surgery of nose and sinuses (medication)||uterus; anomaly, in pregnancy or childbirth||random
skin of circumoral region of face||medical and surgical @ eye @ release @ anterior chamber, left||random
medical food oral solution [hcu lophlex lq]||abscess of bursa of knee||random
superficial foreign body of left thumb, sequela||dyclonine hydrochloride 2 mg / menthol 5 mg / pectin 6 mg oral lozenge||random
pardosa jambaruensis tanaka, 1990||prism intermediate||random
dorsal thalamus (anthoney)||pituitary macroadenoma (disorder)||random
unclassified paraphlepsius||mitrofanoff procedure||random
chlormethiazole oral capsule [heminevrin]||(neoplasms) or (cancers) (disorder)||random
[x]exposure to ignition or melting of nightwear (finding)||ceftriaxone 1g injection (pdr for recon) (product)||random
nt5c2||unclassified calyptostomatidae||random
azadirachta indica bark 8 [hp_x] in 1 ml / atropa belladonna 8 [hp_x] in 1 ml / berberis vulgaris root bark 9 [hp_x] in 1 ml / peumus boldus leaf 4 [hp_x] in 1 ml / candida albicans 30 [hp_x] in 1 ml / ceanothus americanus leaf 4 [hp_x] in 1 ml / cetraria islandica subsp. islandica 12 [hp_x] in 1 ml / crotalus horridus horridus venom 12 [hp_x] in 1 ml / echinacea angustifolia 4 [hp_x] in 1 ml / sus scrofa adrenal gland 9 [hp_x] in 1 ml / glycyrrhiza glabra 4 [hp_x] in 1 ml / hamamelis virginiana root bark/stem bark 6 [hp_x] in 1 ml / pork liver 9 [hp_x] in 1 ml / goldenseal 5 [hp_x] in 1 ml / centella asiatica 6 [hp_x] in 1 ml / hypericum perforatum 12 [hp_x] in 1 ml / arctium lappa root 4 [hp_x] in 1 ml / ledum palustre twig 9 [hp_x] in 1 ml / achillea millefolium 12 [hp_x] in 1 ml / measles virus 30 [hp_x] in 1 ml / myrrh 4 [hp_x] in 1 ml / sus scrofa pancreas 9 [hp_x] in 1 ml / human sputum, bordetella pertussis infected 30 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / plantago major 4 [hp_x] in 1 ml / rancid beef 30 [hp_x] in 1 ml / solidago virgaurea flowering top 4 [hp_x] in 1 ml / ginger 6 [hp_x] in 1 ml oral liquid [bacteria chord]||new technology @ anatomical regions @ introduction @ peripheral vein @ percutaneous @ iobenguane i-131 antineoplastic @ new technology group 5||random
metastatic neoplasm to the adrenals||primary approximation of peripheral nerve||random
oriental american||cervical vertebral canal||random
elastin microfibril interfacer 1||panitumumab injection [vectibix]||random
cftr gene c.2789+5g>a [presence] in blood or tissue by molecular genetics method||insulin nph||random
chlorophytum leptoneurum||drainage of left internal jugular vein, percutaneous endoscopic approach||random
blood 1,25-dihydroxycholecalciferol increased||diabetes mellitus in pregnancy (diagnosis)||random
organ subdivision||baptisia tinctoria root 3 [hp_x] in 1 ml / echinacea angustifolia 3 [hp_x] in 1 ml / goldenseal 3 [hp_x] in 1 ml / sus scrofa thymus 6 [hp_x] in 1 ml / arsenic trioxide 12 [hp_x] in 1 ml / atropa belladonna whole 12 [hp_x] in 1 ml / calcium sulfide 12 [hp_x] in 1 ml / iridium 12 [hp_x] in 1 ml / lachesis muta venom 12 [hp_x] in 1 ml oral liquid [thymupar]||random
entire tendon of adductor pollicis||intermediate cuneiform facet of medial cuneiform bone||random
vibrio sp. pid31_10||excision of perivesical tissue||random
transfer summary note:find:pt:{setting}:doc:physician||unclassified physocyclus||random
contusion of lower back||cd45rb antigen:presence or threshold:to identify measures at a point in time:tissue, unspecified:ordinal:immune stain||random
lithodes sp. decnz250-09||cepacol sore throat & cough, 7.5 mg-5 mg oral lozenge||random
disorder of amnion (disorder)||creosol [presence] in specimen||random
unilateral recurrent inguinal hernia with gangrene (situation)||etioporphyrin (substance)||random
mesomelic dwarfism of hypoplastic tibia and radius type||zona reticularis of adrenal gland (body structure)||random
amoxicillin / nystatin pill||aleiodes sp. bioug26749-a07||random
skin structure of lower abdomen (body structure)||unclassified spilomelinae||random
laurence-moon syndrome||medical and surgical @ central nervous system and cranial nerves @ excision @ cerebral ventricle @ open @ no device @ no qualifier||random
methylophilales bacterium 16-45-7||nanogram/microliter||random
dihydrodiol dehydrogenase 3||injury undetermined whether accidentally or purposely inflicted, poisoning by liquefied petrol gas distributed in mobile containers||random
abscess of urethral gland (disorder)||eiav ag spec ql if||random
structure of vein of thorax||diameter.biparietal.mean:length:to identify measures at a point in time:head^fetus:quantitative:ultrasound.estimated from cerebellar diameter||random
cream, multi ingredient topical application cream [harber pharmaceuticals]||panzem ncd||random
percut embolisn hepatic artery||aphelinidae sp. bioug04898-e07||random
[x]foreign body in other and combined sites of genitourinary tract||drug resistance (disorder)||random
continuous electrocardiogram complete heart block (procedure)||aduhelm injectable product||random
growth, phototrophic||chlorpheniramine / phenylephrine extended release suspension||random
antigen, cdw50||barley ige rast class (s)||random
hpv 58 dna naa+probe ql (specimen)||receptor protein kinase interactions||random
oatp1b3 inhibitors||delusional conclusion (finding)||random
needle biopsy or removal of lymph nodes||privet pollen extract||random
balanced rearrangements and structural markers, not elsewhere classified||trunk of lateral dorsal digital nerve of second toe||random
cosmos cav.||trunk of branch of upper deep buccal branch of left facial nerve to left levator labii superioris||random
keratoacanthoma||conjunctival limbal autograft||random
ampv b ab titr ser||cyanotic||random
clot strength.adenosine diphosphate induced:lenfr:pt:bld:qn:calculated||abdominal hernia nos gangrenous||random
buprenorphine 2mg/naloxone 0.5mg film,sublingual||toxosiphon lindenii||random
e421 - mannitol||leptolyngbya gelatinosa||random
homosalate 60 mg in 1 ml / octisalate 50 mg in 1 ml / octocrylene 70 mg in 1 ml / titanium dioxide 31 in 1 ml topical cream [loreal paris sublime bronze summer express wash off face bronzer broad spectrum spf 20 sunscreen]||removal of tubal pregnancy without salpingectomy (treatment)||random
gramicidin/neomycin/polymyxin b||sebacylcarnitine (c10-dc)/creatinine:substance ratio:to identify measures at a point in time:urine:quantitative||random
spinal nerve, communicating branches||diaulinopsis sp. 4 zls-2005||random
structure of left cortex of lens (body structure)||indurated incision of abdominal wall (physical finding)||random
pleural malignant mesothelioma by ajcc v8 stage||unclassified leucocoprinus||random
operation on hydrocele nos||transport services including ambulance||random
diagnostic procedure on extraocular muscle and tendon with temporary detachment from globe||mitogen activated protein kinase kinase 7||random
octinoxate 75 mg in 1 g / oxybenzone 20 mg in 1 g topical gel [neutrogena moistureshine lip soother sunscreen spf20 - glow 70]||azorella sect. schizeilema (hook.f.) benth. & hook.f., 1867||random
fowl pox viruses||estrogen binding protein measurement||random
instruction imperative||s-isomer etiracetam||random
eq-5d-5l||dcr2 gene||random
technique, clinical laboratory||human adenovirus species b (organism)||random
tablet in vomitus||alpha-2-glycoprotein 1, zinc||random
spina bif.+hydroc.-open-thorac||yugoslavia (geographic location)||random
phyllanthusmin c||polyvinyl-alcohol dehydrogenase (acceptor) (substance)||random
right bronchial tree||snake gourd extract||random
status of lymphovascular invasion by primary malignant neoplasm of major salivary gland||radiographic imaging of cisterna magna||random
callosity on toe (disorder)||lesions toes left fourth toe distal||random
nonverbal learning||exposure to electric current from transformer||random
lymphocyte-rich hodgkin's lymphoma of lymph node||tortricidae sp. bold:aaf9376||random
genitals itching||colonoscopy using guidance (treatment)||random
primula knuthiana pax, 1905||euphrasia stricta 6 [hp_x] in 1 ml / gold 12 [hp_x] in 1 ml / calcium fluoride 12 [hp_x] in 1 ml / causticum 12 [hp_x] in 1 ml / conium maculatum flowering top 12 [hp_x] in 1 ml / magnesium carbonate 12 [hp_x] in 1 ml / phosphorus 12 [hp_x] in 1 ml / silicon dioxide 12 [hp_x] in 1 ml / osmium 15 [hp_x] in 1 ml / physostigma venenosum seed 15 [hp_x] in 1 ml / thuja occidentalis leafy twig 16 [hp_x] in 1 ml oral liquid [occulopar]||random
unclassified thanasimus||medical and surgical @ upper bones @ reposition @ metacarpal, left @ percutaneous||random
negative regulation of nodal signalling pathway involved in determination of left/right asymmetry||care protocol||random
superficial partial thickness burn of head (disorder)||iodine isotope uptake decreased||random
butenafine product||cellcept 500mg powder for injection||random
mustard ab.igg:acnc:pt:ser:qn||magnetic resonance imaging of thoracic spine: mass of right side of t3 vertebra with hyperintense signal intensity (s/i) ratio (procedure)||random
cheek papular rash||cysteine 3.5 mg/ml / inositol 8.3 mg/ml / methionine 8.3 mg/ml / sodium propionate 5 mg/ml / urea 83.4 mg/ml [amino-cerv]||random
prothrombin antigen actual/normal:relative mass concentration:to identify measures at a point in time:platelet poor plasma:quantitative:immunoassay||oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified||random
dog (rcan f) 4 ige rast ql||ketorolac tromethamine 0.5 % ophthalmic drops||random
angular||clubiona subdidentata||random
mica*009 ab.igg:prthr:pt:ser:ord||polysyndactyly-craniofacial anomalies syndrome||random
muscular branch of medial branch of fourth thoracic posterior ramus||hydrocortisone 1% topical application cream [monistat soothing care itch relief]||random
gemcitabine hydrochloride 38 mg/1 ml intravenous solution_#1||penicillium sp. ds-6pc-2-7-1||random
disease, reimann periodic||fetal anemia (diagnosis)||random
chronic osteomyelitis involving upper arm||lithotabs, 300 mg oral tablet||random
interferon regulatory factor 2-binding protein 2||frostbite with tissue necrosis of other & unspecif sites||random
set of paratracheal lymphatic vessels||inhibition of androst-4-ene-3,17-dione anabolism||random
tirbanibulin||yeast &#x7c; sputum &#x7c; microbiology||random
arthrp acetblr/prox fem prostc agrft/algrft||fiacitabinum||random
porphyria, hepatocutaneous type||tagrisso||random
xylaria sp. mt06||tricalysia a.rich. ex dc.||random
chlorthalidone-clonidine 15 mg-0.2 mg oral tablet||injection site hyperesthesia||random
glycol salicylate / nonivamide / salicylic acid topical product||tripelennamine:mass:to identify measures at a point in time:dose:quantitative||random
cortisol^11th specimen post xxx challenge&#x7c;pt&#x7c;saliva||hypertrophic osteoarthropathy other site (diagnosis)||random
4-chloro-3,5- xylenol (product)||thrombosis of intracranial veins||random
octisalate 5 g in 100 g / oxybenzone 6 g in 100 g / octocrylene 10 g in 100 g / avobenzone 3 g in 100 g / homosalate 10 g in 100 g topical aerosol [banana boat]||plasma radioiron clearance||random
bradyrhizobium sp. 289s2||diptera sp. bold:aai4225||random
skeletal system of left upper free limb||polyplectropus sp. i2||random
delayed hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter||allergy testing dust mite specific ige (___ iu/ml)||random
dosing instruction imperative (qualifier value)||genestein||random
salicylic acid 275 mg/ml||retinal rod photorecept cells||random
gpr39 protein, human||insect bite of trunk, non-venomous, infected||random
ceutorhynchini||family history: low vision (situation)||random
tissue injury upper right paraspinal wound weeping||imaging procedures nec||random
intellectual disability, cataract, calcified pinna, myopathy syndrome||myeloperoxidase deficiency syndrome (disorder)||random
cervical, vaginal and external female genital anomalies, unspecified (disorder)||unclassified kitasatospora||random
phenylephrine / pyrilamine oral product||malg protein, thermococcus litoralis||random
hd-mtx/hd-arac/thiotepa/rituximab||coccus sp. spq.143||random
ptca ascending aorta severity of stenosis preprocedure||surgical excision of ectopic pregnancy unspecified location||random
c3 branch to levator scapulae||magnetic resonance imaging of knee: softening of articular cartilage of anterior aspect of lateral tibial plateau||random
synchronization, eeg phase||12 hr acetazolamide 500 mg extended release oral capsule||random
technetium phytate||peripheral t-cell lymphomas nec||random
clobetasol 17-propanoate||bromelains 50000 u oral tablet||random
medical and surgical @ lower joints @ repair @ tarsometatarsal joint, left @ external @ no device @ no qualifier||misleading laboratory test result||random
promyelocytic leukemia gene||infections, animal salmonella||random
cecidomyiidae sp. bioug21363-d12||aorto-bronchial fistula||random
growth hormone & glucose post clonidine stimulation panel:-:pt:ser/plas:qn||alternaria sp. 30425||random
expiratory gas flow.max^post bronchodilation:vrat:pt:respiratory system.airway:qn||flavonolignans||random
piperonyl butoxide / pyrethrins shampoo product||eosinophilic; cystitis||random
felis catus hair 16 [bau] in 1 ml / alternaria alternata 0.00008 g in 1 ml / canis lupus familiaris hair 0.00008 g in 1 ml / periplaneta americana 0.0008 g in 1 ml / aspergillus fumigatus 0.00008 g in 1 ml / cochliobolus sativus 0.0004 g in 1 ml / cladosporium cladosporioides 0.0004 g in 1 ml / phoma destructiva 0.00008 g in 1 ml / aureobasidium pullulans var. pullutans 0.00008 g in 1 ml / rhizopus stolonifer 0.00008 g in 1 ml / pleospora herbarum 0.00008 g in 1 ml / ustilago nuda hordei 0.00002 g in 1 ml / ustilago maydis 0.00002 g in 1 ml / ustilago avenae 0.00002 g in 1 ml / ustilago tritici 0.00002 g in 1 ml intradermal injection, solution||mylabris||random
immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia||aspiration subcutaneous reservoir connecting to brain lesion||random
chest retractions||somatosensory nervous system||random
x-ray cavity r upper first bicuspid involving pulpal tissue||adenocarcinoma with neuroendocrine differentiation||random
multiple cardiac abnormalities congenital||infraauricular region||random
plaque perianal||device regulations, medical||random
escherichia coli o45||protroctopsocus enigmaticus||random
lepechinia||furosemide [mass/volume] in serum or plasma||random
stevia rebaudiana whole||pseudorabies virus g1 gene deletion ab [presence] in serum by immunoassay||random
bacillus sp. 43bk8y10||jk3 ab [presence] in serum or plasma||random
prot-att study monitoring||high grade malignant peripheral nerve sheath tumor||random
magnetic resonance imaging of abdomen without contrast||optical-guidance prostate biopsy system handpiece and needle||random
neural precursor cell expressed developmentally down regulated protein 8||xr calcaneus - bilateral lateral||random
thromboxane b2 (substance)||shaft of rib, nos||random
perforation of rectum (disorder)||diptera sp. bold:aap8082||random
thinodytes||creat 1h pre chal ur-scnc||random
enteritis, mink viral||duraxin (acetaminophen 300 mg / phenyltoloxamine citrate 20 mg / salicylamide 200 mg) oral capsule||random
temporomandibular; dislocation||oral discharge||random
salmonella korovi (organism)||radioactive water pollutants||random
hematopoietic neoplasm of uncertain behavior (morphologic abnormality)||alpha-amino-gamma-(phenyltelluro)butyric acid||random
virus identified:prid:pt:stool:nom:culture||endometrial scratching||random
degree of difficulty experienced due to your knee while doing light domestic duties (cooking, dusting, etc) in the last w:finding:1 week:^patient:ordinal:koos||phenylpropanol||random
rayos 2mg delayed-release tablet||plain x-ray clavicle normal (finding)||random
sulfur--isotopes||glycerol:substance concentration:to identify measures at a point in time:urine:quantitative||random
male erectile disorder (disorder)||car passenger injured in collision with railway train or railway vehicle in nontraffic accident, subsequent encounter||random
parachloramine||ulcer of forehead with partial thickness skin loss (physical finding)||random
regurgitant blood flow velocity.e wave.max:velocity:to identify measures at a point in time:pulmonic valve:quantitative:ultrasound.doppler||considering your shortness of breath over the past 7d, rate the amount of difficulty you had when making a bed:find:7d:^patient:ord:promis||random
unspecified occupant of three-wheeled motor vehicle injured in collision with fixed or stationary object in nontraffic accident, sequela||erichsonius brachycephalus||random
hip-r ext arom qn||endocarditis pseudomonal||random
hydrophorus||unknown outcome||random
s-carboxymethylcysteine synthase (substance)||congenital superior sulcus anomaly of orbit (disorder)||random
arthritis of left temporomandibular joint (disorder)||current tobacco smoker or currently exposed to secondhand smoke (asthma)||random
self-induced vomiting to lose weight||carcinoma of oropharynx||random
surgery alveoloplasty||choroidal atrophy and alopecia syndrome (diagnosis)||random
milestone: stacks 5 or more blocks (physical finding)||swallowing status: pharyngeal phase||random
cortisol^5m pre 1 ug/kg crh iv||thyroid calcification||random
wakefulness||kcnh1, ile467val||random
salmonella 54;e,h;1,5||prednisolone phosphate||random
empagliflozin pill||bendamustine hydrochloride 90 mg/ml injection||random
syndrome; trisomy, 18||chancre on left alar groove||random
young adult-onset distal hereditary motor neuropathy||angraecum corrugatum||random
child without parent||structure of superior iliac crest region of trunk||random
phenylephrine hcl/ppa/acetaminophen/pyrilamine/chlorphenir@@oral@tablet||industrialization||random
ultrasound of pelvis: catheterized post-void residual volume of bladder||acarospora||random
eustroma||pea stem necrosis virus||random
2-deoxyintegristerone a||arachidonic acid lipoxygenase||random
oesophageal ph increased||filgrastim (substance)||random
sarna||pseudosarcomatous carcinoma of appendix (diagnosis)||random
stimulation spinal cord||plazomicin 50 mg/ml||random
skin fissure on right labia||accidental chlorpheniramine overdose||random
sclera||nitrate:mcnt:pt:xxx:qn||random
plasma protein||verrucomicrobia bacterium imcc15200||random
pelvic pain (symptom)||medical and surgical @ male reproductive system @ repair @ scrotum @ percutaneous endoscopic @ no device||random
carbon dioxide gas for inhalation||nephropathy, hypercalcemic||random
adhesions and disruptions of iris and ciliary body nos (disorder)||thermotoga neapolitana (organism)||random
thoracoabdominal aortic aneurysm enlargement||anacidity, gastric||random
theobroma l., 1753||products, household||random
nasal septum finding (finding)||vascular access site haemorrhage||random
poroma||benzydamine / cetylpyridinium oral lozenge||random
ecchymotic tissue surrounding wound of left breast||report id||random
tree allergen mix 9 (grey alder+silver birch+hazelnut+white oak+willow) ige ab [units/volume] in serum by multidisk||flj11240||random
ankle; joint pain||melaena gastric ulcer||random
inflammatory oedema reaction||nail disease||random
removal of autol sub from chest wall, perc endo approach||gluconate 2-dehydrogenase||random
palpomyia sp. bioug24417-e09||cholecystogram (procedure)||random
amount of haemolysis||comamonas margaretae||random
psilocybin cutoff:mass concentration:to identify measures at a point in time:urine:quantitative:screen||acetaminophen and phenylephrine product||random
legionella pneumophila 1||fluoroscopic venography of transjugular intrahepatic portosystemic shunt stent using contrast||random
posterior border of vomer||mithracidae||random
anhydrous glucose 50 mg/ml and potassium chloride 1.5 mg/ml and sodium chloride 4.5 mg/ml solution for infusion||laryngeal nerve dysfunction||random
bacillus sp. bab-4147||other soft tissue disorders, not elsewhere classified||random
acute htr nos||disorder convulsive||random
virus vaccine, covid-19||chlorpromazine hydrochloride 10 mg oral tablet, coated||random
thrombin topical spray [thrombin-jmi]||cyp2d6 3' gene dup/mlt||random
titanium dioxide 6.45 g in 100 g topical cream [boscia all in one b.b. eye brightener broad spectrum spf 20]||light chain analysis abnormal||random
unclassified bacillus (in: bacteria)||aspidodera sp. mex003a||random
[m]syringoma nos||paspalum commersonii||random
abltj soft tis inferior turbinates uni/bi supfc||bacterium tsby-89||random
malignant salivary gland cancer stage iii||computed tomography and drainage of thyroid||random
skin test for neurospora sitophila||pentadecane biosynthetic process||random
infect rna virus||patient registered - gp13||random
stavudine in serum or plasma (lab test)||initial orthotic management and training with assessment and fitting of lower extremities and trunk, each 15 minutes||random
riboflavin synthase||nomo1 protein, mouse||random
microbiology test of skin lesion of lateral aspect of little toe of right foot||rhodocista centenaria kawasaki et al. 1994||random
newspaper||irvan syndrome||random
pulmonary fat embolism||hoaap protocol||random
polysorbate 80 10 mg/ml [avitears]||relationship with neighbors - finding||random
post adrenalectomy syndrome||alfaro||random
exercises for right forearm to increase strength (treatment)||cloves||random
drainage of deep periurethral abscess (procedure)||cyanosis of left arm (symptom)||random
mapkk7 protein kinase||bird-headed dwarfism with features of premature senility||random
phenyl mercury compounds||cysts on posterior scalp (physical finding)||random
negative chemotaxis involved in interneuron migration from the subpallium to the cortex||24 hr fesoterodine fumarate 8 mg extended release oral tablet [toviaz]||random
hemicentric lumbar centrum (disorder)||central part of body of eleventh thoracic vertebra||random
caprylic(capric mono)diglcyerides||differentiating agents||random
dextromethorphan / guaifenesin / pseudoephedrine pill||infusion of intra-arterial thrombolytic agent with percutaneous transluminal coronary angioplasty||random
armboard, wheelchair||night blue stain||random
product containing imiquimod||closed fracture of l1 vertebral body with spinal cord injury||random
streptomyces sp. st-931||postoophorectomy osteoporosis with pathological fracture of lower leg||random
post-surgical urinary structure||thirst (finding)||random
infective myositis, unspecified leg||presence or threshold||random
social alienations||metabolic acidosis, nag, bicarbonate losses||random
medial eminences||personality trait related to social interaction||random
malignant neoplasm of external lip, not specified as upper or lower||idn-5109||random
palsies, cranial nerve||pers hx type 1-2 diabetes proto||random
dichlorobenzidine [mass/volume] in urine||dioxin compound||random
lycenchelys||submission domain||random
endocrine disrupting chemicals||benz(a)anthracene-7,12-dione, 1,2,3,4-tetrahydro-1,11-dihydroxy-8-methoxy-3-methyl-, (1s-cis)-||random
cleora||salmonella group f||random
platytettix sudra||benzocaine 200 mg in 1 g / benzalkonium chloride 1.3 mg in 1 g / zinc chloride 1.5 mg in 1 g / menthol 2.6 mg in 1 g topical cream [orajel 4x medicated pm for toothache and gum]||random
porcine circovirus type 2 dna [#/volume] (viral load) in specimen by naa with probe detection||pain of both shoulders elicited by active abduction||random
fracture of ramus of left mandible, 7thg||rhonchus||random
head and neck merkel cell carcinoma of unknown primary||acute; pneumothorax||random
sinus tarsi syndrome (diagnosis)||accidents occurring in industrial places and premises||random
zonography||congenital pontocerebellar hypoplasia (disorder)||random
rabies immunoglobulins||stereotactic radiosurgery of brain tissue (procedure)||random
product containing precisely tramadol hydrochloride 400 milligram/1 each prolonged-release oral tablet||id||random
ppg/creat ur||amalaraeus||random
impaired role performance||gnat1, gly38asp||random
norchlordiazep bld cfm-mcnc||up regulation of cyanophore differentiation||random
antiparkinson therapeutic role||banara aubl., 1775||random
nondisplaced comminuted fracture of shaft of unspecified tibia||teaching about nephrostomy care||random
islet cell 512 ab [units/volume] in serum by immunoassay||picris hispanica||random
aspergillus species reagents, identification||left eye||random
aeromonas sp. a07||common sagebrush pollen extract||random
calcium oxalate dihydrate/total in stone by infrared spectroscopy||perforation of uterus||random
unclassified cypria||resp obst-inhaled foreign body||random
total cholesterol/hdl ratio increased||calogaya arup, froden & schting, 2013||random
neofusicoccum luteum fusarivirus 1||acetaminophen / codeine oral liquid product||random
vfend oral liquid product||efavirenz [susceptibility] by phenotype method||random
sexual functioning status (observable entity)||salmonella sp serotype [identifier] in isolate by agglutination||random
s. pneumoniae 34 igg spec 1 (s) [mass/vol]||absolute probing depth at mesial left upper central incisor (physical finding)||random
tpmp||rotavirus neutralising antibody positive||random
pharmacy services, online||radical resection of tumor right 1st toe proximal phalanx||random
menopausal effects on the genitourinary tract||excision of appendix, open approach, diagnostic||random
primary signet ring stromal tumor of the testis||connection; digestive tract - uterus||random
complement c2:prthr:pt:ser/plas:ord||destruction of right maxillary sinus, endo||random
dexamethasone sodium phosphate@4 mg/ml@injection@syringe (ml)||entire neck of proximal phalanx of little finger||random
knotless polypropylene sutures||microbiology test of skin lesion between second and third toes of left foot (lab test)||random
tendon reflex exaggerated||metastatic small cell carcinoma (morphologic abnormality)||random
triiodothyronine.free&#x7c;mcnc&#x7c;pt&#x7c;anybldserpl||ambrosia artemisiifolia pollen 4000 [au] in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / anthoxanthum odoratum pollen 4000 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / lolium perenne pollen 4000 [bau] in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / mucor racemosus 0.002 g in 1 ml / morus alba pollen 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml intradermal injection, solution||random
platygastridae sp. bioug03166-a01||lymphocyte proliferation. 2.0 ug phytohemagglutinin stimulation:nrat:pt:bld:qn||random
aconitum napellus 20 [hp_x] in 1 g / arnica montana 20 [hp_x] in 1 g / arsenic trioxide 20 [hp_x] in 1 g / baptisia tinctoria root 20 [hp_x] in 1 g / atropa belladonna 20 [hp_x] in 1 g / bryonia alba root 20 [hp_x] in 1 g / calendula officinalis flowering top 20 [hp_x] in 1 g / matricaria recutita 20 [hp_x] in 1 g / chelidonium majus 20 [hp_x] in 1 g / crotalus horridus horridus venom 20 [hp_x] in 1 g / gelsemium sempervirens root 20 [hp_x] in 1 g / calcium sulfide 20 [hp_x] in 1 g / wood creosote 20 [hp_x] in 1 g / mercury 20 [hp_x] in 1 g / myrrh 20 [hp_x] in 1 g / strychnos nux-vomica seed 20 [hp_x] in 1 g / phosphorus 20 [hp_x] in 1 g / plantago major 20 [hp_x] in 1 g / toxicodendron pubescens leaf 20 [hp_x] in 1 g / silicon dioxide 20 [hp_x] in 1 g / delphinium staphisagria seed 20 [hp_x] in 1 g / echinacea, unspecified 8 [hp_x] in 1 g oral pellet [oral care - gingivitis]||imaging @ hepatobiliary system and pancreas @ computerized tomography (ct scan) @ liver and spleen @ low osmolar @ unenhanced and enhanced||random
escin / nylidrin topical product||polypedilum sp. bioug21039-h08||random
keroplatidae sp. bioug06334-h05||unclassified proaphelinoides||random
surgery nurse surgical operation note||woodsorrel||random
breast and ovarian cancer||i know what each of this person's prescribed medications do caregiver [pam]||random
geodia phlegraei||repair of rotator cuff||random
cdisc cdash units for planned exposure terminology||dental branch of right anterior superior alveolar artery||random
css04-most severe idea, control-p_m||peripheral t-cell lymphoma refractory||random
post-operative grade of haze of corneal transplant of left eye||biopsy of salivary gland||random
arch of t7 vertebra||malignant neoplasm of small intestine, incl duodenum recurrent||random
pregnancy-specific beta-1 globulin||renal anastomosis||random
other fractures of lower end of right radius||alanine 3.48 mg/ml / arginine 3.56 mg/ml / aspartate 2.45 mg/ml / glucose 50 mg/ml / glutamate 2.58 mg/ml / glycine 1.75 mg/ml / histidine 1.05 mg/ml / isoleucine 2.31 mg/ml / leucine 3.5 mg/ml / lysine 3.68 mg/ml / magnesium chloride 0.00148 meq/ml / methionine 0.6 mg/ml / phenylalanine 1.04 mg/ml / potassium chloride 0.013 meq/ml / proline 2.52 mg/ml / serine 1.86 mg/ml / sodium chloride 0.0205 meq/ml / sodium phosphate 0.00347 meq/ml / threonine 1.4 mg/ml / tryptophan 0.7 mg/ml / tyrosine 0.94 mg/ml / valine 1.75 mg/ml [aminosyn ii 3.5 % m in 5 % dextrose]||random
cellulases||female gonadal function disorders||random
skin papule of proximal middle finger of right hand||region of wall of eyeball||random
leukoencephalitis acuta hemorrhagica||benzoyl peroxide 5% (alcohol based) gel||random
incenter patients who transferred to other dialysis unit:num:rptperiod:^population:qn||beta-endorphin, 2-nitro-4-azidophenylsulfenyl-||random
behavior observation||blood flow, renal, effective||random
streptomyces sp. wmmb 690||lichenification fingers left middle finger dorsal||random
genus arborimus||fam131b wt allele||random
open reduction of fracture of wall of acetabulum with internal fixation (procedure)||plegridy 63 mcg per 0.5 ml auto-injector||random
mo053||ascorbic acid/biotin/calcium pantothenate/copper/cyanocobalamin/ferrous fumarate/folic acid/iron polysaccharide/magnesium/manganese/niacin/pyridoxine hydrochloride/riboflavin/thiamine mononitrate/zinc 210 mg-300 mcg-7 mg-800 mcg-10 mcg-130 mg-1 mg-92.4 mg-6.9 mg-1.3 mg-20 mg-25 mg-5 mg-5 mg-18.2 mg oral capsule [folivane-ob]||random
mannose biosynthetic process||membrana stapedialis||random
rp-54275||arrest; epiphyseal||random
cell count & differential panel:-:pt:synv fld:qn||dengue tetravalent vaccine, live, vero cell/pf@10exp4.5-10exp6 ccid50/0.5 ml@subcut@vial (ea)||random
chemical cauterization of granulation tissue (ie, proud flesh)||pseudomonas sp. umab-16||random
epinephrine / prilocaine cartridge [citanest forte]||stage 0 large cell lung cancer||random
child weight = 75th centile||boniva, 3 mg/3 ml intravenous solution||random
melanoma of the conjunctiva cn0b (no biopsy) tnm finding v7||college of american pathologists cancer checklist; appendix: resection (record artifact)||random
desquamation on right temple (physical finding)||cesarean section for; stenosis or stricture, cervix||random
ovarian neoplasms, malignant and unspecified (smq)||perivascular disease||random
unclassified erioptera||brassica oleracea var capitata ab.igg||random
localized swelling of dorsal aspect of hand||deacetylcephapirin||random
complications of skin graft (allograft) (autograft)||professional sportsman||random
embryologic remnant||recurrent metastatic merkel cell carcinoma||random
poisoning by histamine h2-receptor blockers, self-harm, init||silodosin pill||random
phosphoribosylpyrophosphate synthetase superactivity (disorder)||enkephalin, nos||random
baker's yeast igg ia ql (s)||saint louis encephalitis virus rna [presence] in serum by naa with probe detection||random
mycosphaerella sp. agrar182||tissue expansion procedure||random
sympathetic ganglion block (procedure)||atypical glandular cells of uncertain significance||random
respiratory sinus arrhythmia magnitude||modulation by symbiont of host apoptotic process||random
echocardiography: appearance of aortic valve (procedure)||meningococcal pharyngitis (disorder)||random
surgical removal of tooth fragment involving bone||brainstem death||random
avobenzone 2 g in 100 g / homosalate 10 g in 100 g / octisalate 5 g in 100 g / octocrylene 4 g in 100 g / oxybenzone 5 g in 100 g topical lotion [exsel sport spf 30]||multisection^wo contrast:find:pt:head+neck>larynx:doc:ct||random
hemoglobin bourmedes phenotype||muscular dystrophy, limb-girdle, type 2y||random
pork antibody.immunoglobulin g.rast class:presence or threshold:to identify measures at a point in time:serum:ordinal||allograft-associated haemorrhagic sarcoma||random
gentamicin and hydrocortisone only product||frmpd2 gene||random
fissure dent||developmental disorder (diagnosis)||random
glyceryl stearate citrate||vaccine product containing coxiella burnetii antigen (medicinal product)||random
optx slp fem epiphysis ostpl fem nck heyman px||tonsillar inflammation||random
biopsy of hypopharynx showed lymphoma (procedure)||paratesticular region||random
mgc88288||cherimolacyclopeptide c||random
cold & flu nighttime relief softgel||nausea post radiotherapy||random
segesterone ac/ethin estradiol 0.15 mg-0.013 mg/24 hr vaginal ring, vaginal||vfq2-rate your overall health||random
sulfamic acid||axial mesoderm structural organization||random
rna polymerase iii general transcription initiation factor activity||cloxacillin oral capsule||random
parasite blood test||application of support for penis||random
benzalkonium chloride 0.059 g in 59 ml topical gel [hulk grape hand sanitizer]||2,5-anhydromannitol||random
paraplegia-paraparesis rehabilitation (regime/therapy)||skin ulcer swab||random
classical; hemophilia||navicular bone of forefoot||random
testicular yolk sac tumor, hepatoid pattern||neofabraea sp. cks1058||random
application of pugh traction||glucose standard deviation:mcnc:rptperiod:interstitial fluid:qn:calculated||random
skin wound of anterior aspect of both wrists||arthropathy following intestinal bypass, hand||random
suture of intestine||medical and surgical supplies - dressings||random
carbamic acid, (1-(((1-ethyl-3-((3-(4-morpholinyl)propyl)amino)-2,3-dioxopropyl)amino)carbonyl)-3-methylbutyl)-, phenylmethyl ester, stereoisomer||ompc ab.iga:prthr:pt:ser:ord:ia||random
protein complex subunit||adverse effect of pertussis vaccine, inc combin w pertuss||random
candidatus marinimicrobia bacterium uba5683||stomach body||random
breast cesium therapy||unclassified taiwanoserica||random
abnormality of palatopharyngeus muscle||psoralen and long-wave ultraviolet radiation therapy-associated skin malignancy (disorder)||random
x-ray of left wrist, single scaphoid view||product containing ezetimibe 10 mg/1 each oral tablet (clinical drug)||random
venous complication as postpartum condition or complication (diagnosis)||episcleral layer of left eyeball||random
vasculitis, systemic||questionnaires beck youth inventory anxiety (bai-y)||random
product containing precisely amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug)||excision of cecum, via natural or artificial opening endoscopic||random
o+p bld/t wright stn||lamb 0.1 mg in 1 ml percutaneous injection, solution||random
consultation note:find:pt:outpatient hospital:doc:{role}||monitoring of arterial flow, coronary, open approach||random
product containing indomethacin||repair pul venous stenosis||random
skin neoplasm malignant adnexa primary||ziprasidone hydrochloride 80mg oral capsule||random
failure of sterile precautions during lumbar puncture (treatment)||malacetic 1 % / 0.15 % medicated shampoo||random
wall of superior lacrimal canaliculus||lyperosomum||random
pegomya sp. bioug23268-h06||vitreous; floater||random
gtbpb||enteritis infect of mink||random
malignant neoplasm lymphoma b-cell high grade||fragment, ig||random
lymphatic tree of left wrist||open bite of thumb without damage to nail||random
desquamation was seen on the left wrist||budesonide adverse reaction (disorder)||random
streptomyces sp. bab-1839||hdmx gene amplification||random
repair of defect of fascia of lower limb (procedure)||laryngeal biopsy normal||random
axillary disease||smoking deterrent filter miscell each||random
tractus hypothalamotegmentalis||n(delta)-carbamylornithine||random
clinical trials reporting program terminology||venous stasis ulcer co-occurrent with oedema of lower leg||random
response to paraquat||localized periodontitis (disorder)||random
heterotypic antibodies||4-hydroxy-3-methoxyphenylglycol||random
myosin light chain 6, alkali, smooth muscle and nonmuscle||minor cognitive motor disorder||random
structure of bursa of lower leg (body structure)||family nitrosomonadaceae (organism)||random
methyl ester, aspartylphenylalanine||serol||random
product containing pravastatin sodium 10 mg/1 each oral tablet||urobilinogen, increased level||random
1,2,8-indolizinetriol, octahydro-, (1s-(1alpha,2alpha,8beta,8abeta))-||international system of units-derived unit of volume||random
stratiomys||gstb||random
metanephric distal convoluted tubule development||acute; reticulosis||random
subluxation of posterior left shoulder||pneumonitis due to inhalation of oil or essence nos (disorder)||random
bony part of thoracic vertebra||pulmonary edema aggravated||random
muscidae sp. bold:aal2821||trichostetha fascicularis (linnaeus, 1767)||random
lamyctinus||primary malignant neoplasm of intra-abdominal organs (diagnosis)||random
benzyl isoquinoline||drainage of carina with drainage device, endo||random
downregulation of voltage gated sodium channel activity||transcription factor, hnf6||random
throat||neoplasm of acromion (disorder)||random
1-hexadecyltrimethylammonium chloride||mucosal haemorrhage||random
fibronectin decreased||amnesias, global||random
3,8-dimethoxyfuro(3,2-g)coumarin||paradoxosomatidae||random
unclassified brachistinae||lentinus cf. fasciatus||random
small cleaved cell (diffuse)||patch on the fingers right little finger proximal||random
la nt hpl imm 1:2 plat lysate ppp||arthritis in other viral diseases classified elsewhere, pelvic region and thigh||random
unspecified fracture of shaft of right femur, subsequent encounter for open fracture type i or ii with delayed healing||product containing only trazodone hydrochloride 150 mg/1 each oral tablet||random
aids-related plasmablastic lymphoma||tetradecan-1-ol||random
other tear of unspecified meniscus, current injury, left knee, subsequent encounter||transports (animal life circumstance)||random
porphyria, erythrohepatic||neoplastic small b-lymphocyte||random
promis short form - cognitive function - abilities subset 8a - version 2.0 raw score:score:pt:^patient:qn:promis||unclassified psychodinae||random
ascending aorta perforation||medical and surgical @ upper arteries @ revision @ upper artery @ open||random
stage iiia malignant mesothelioma||diabetes mellitus, due to underlying condition, drug or chemical induced, or other specified type||random
mesonyssus melloi||pina protein, enterobacteria phage t4||random
sf36 v1.0 standard - social functioning 0-100 score||brodmann area 9 of left middle frontal gyrus||random
noctuidae sp. bold:aag6144||testoderm 0.167 mg/hr transdermal system||random
unclassified castilleja||ceanothus americanus leaf 1 [hp_x] in 1 ml / euphrasia stricta 1 [hp_x] in 1 ml / geranium robertianum 1 [hp_x] in 1 ml / juglans regia leaf 1 [hp_x] in 1 ml / juglans regia fruit rind, immature 1 [hp_x] in 1 ml / myosotis arvensis 1 [hp_x] in 1 ml / sarsaparilla 1 [hp_x] in 1 ml / scrophularia nodosa 1 [hp_x] in 1 ml / teucrium scorodonia flowering top 1 [hp_x] in 1 ml / althaea officinalis root 1 [hp_x] in 1 ml / peumus boldus leaf 1 [hp_x] in 1 ml / calendula officinalis flowering top 1 [hp_x] in 1 ml / thuja occidentalis leaf 1 [hp_x] in 1 ml / fumaria officinalis flowering top 1 [hp_x] in 1 ml / pinus sylvestris leafy twig 1 [hp_x] in 1 ml / gentiana lutea root 1 [hp_x] in 1 ml / potassium iodide 1 [hp_x] in 1 ml / echinacea, unspecified 1 [hp_x] in 1 ml / nasturtium officinale 3 [hp_x] in 1 ml / viscum album fruiting top 3 [hp_x] in 1 ml / phytolacca americana root 3 [hp_x] in 1 ml / capsicum 3 [hp_x] in 1 ml / veronica officinalis flowering top 4 [hp_x] in 1 ml / apis mellifera 4 [hp_x] in 1 ml / equisetum hyemale 4 [hp_x] in 1 ml / sodium sulfate 4 [hp_x] in 1 ml / barium carbonate 8 [hp_x] in 1 ml / tribasic calcium phosphate 8 [hp_x] in 1 ml / calcium sulfide 8 [hp_x] in 1 ml / ferrous iodide 8 [hp_x] in 1 ml / mercuric cyanide 8 [hp_x] in 1 ml / araneus diadematus 12 [hp_x] in 1 ml / bos taurus parathyroid gland 12 [hp_x] in 1 ml / bos taurus thymus 12 [hp_x] in 1 ml / sus scrofa thyroid 12 [hp_x] in 1 ml oral liquid [lymph care]||random
computerized tomography (ct) with contrast||bilirub amn ql||random
vena basalis communis lobi inferioris pulmonis sinistri||radium cation||random
escitalopram oxalate 20 mg oral tablet, film coated [escitalopram]||oxicodona||random
knee microhaemorrhage||fac07126||random
product containing only hydromorphone hydrochloride 2.6 mg/1 each oral capsule (clinical drug)||st elevation myocardial infarction by ecg finding||random
serum glomerular basement membrane antibody level||place of occurrence of accident or poisoning, office||random
animal motivation||some patients have no structural brain abnormalities||random
xr ribs views + chest pa||aseptic necrosis of bone of left hip (disorder)||random
liner,rubber pants||rash follicular||random
nerve stimulation test normal||anesthesia for open or surgical arthroscopic/endoscopic procedures on distal radius, distal ulna, wrist, or hand joints; not otherwise specified||random
spontaneous hematoma of spinal cord||mouse bladder lymphoma||random
clitoromegaly||product containing etodolac in oral dosage form||random
bacillaceae bacterium cl3.96||rh isoimmunization affecting care of mother (diagnosis)||random
sars coronavirus 2 rna panel:-:pt:saliva:-:probe.amp.tar||mag hydrox/aluminum hyd/simeth 200 mg-200 mg-20 mg/5 ml oral suspension, oral (final dose form)||random
modulation of peptidase activity in other organism involved in symbiotic interaction||abnormal spermatogenesis (finding)||random
chlorpheniramine maleate/hydrocodone bitartrate/phenylephrine hydrochloride 2.5 mg/5 ml-3.5 mg/5 ml-10 mg/5 ml oral solution [relacon-hc]||acrolejeunea emergens||random
etaa1 activator of atr kinase||angiography fluoroscopic lower extremity vessel with contrast||random
diceratocephalidae||unclassified apristurus||random
traction detachment of far peripheral retina of left eye (physical finding)||tricyclic antidepressants:prthr:pt:urine:ord||random
phenobarbital, 60 mg oral tablet||radionuclide heart study abnormal||random
i am satisfied with my ability to do regular personal responsibilities:finding:to identify measures at a point in time:^patient:ordinal:promis||fact-hep version 4 - i am satisfied with my sex life||random
cecidomyiidae sp. bioug27379-f10||norepinephrine:mcnc:24h:urine:qn||random
local recurrence of malignant tumor of rectum (disorder)||atorvastatin (substance)||random
lateral sinus||diaptomus serbicus||random
breast prosthesis operation (procedure)||infection; campylobacter||random
pigmented villonodular synovitis of multiple sites (diagnosis)||dispas disintegrating oral product||random
deficiency of ketohexokinase||pseudomonas putida group (organism)||random
pectin 2.8 mg oral lozenge [medactive oral relief]||tho complex part of trex complex location||random
bronchoscopy amount of secretions of right upper lobe anterior segmental bronchus||poisoning by oral contraceptives, intentional self-harm, sequela||random
extremity veins - bilateral &#x7c; ultrasound.doppler &#x7c; radiology||mll-af4 fusion protein, human||random
family poaceae - gramineae||stycar graded mounted balls test (procedure)||random
flavobacterium sp. ri1pw_5542||rose oil (substance)||random
orotate/creatinine &#x7c; urine &#x7c; chemistry - non-challenge||citrate--coa ligase (substance)||random
glioma (diagnosis)||ascorbate+dehydroascorbate:mass concentration:to identify measures at a point in time:serum/plasma:quantitative||random
medical and surgical @ gastrointestinal system @ excision @ jejunum @ via natural or artificial opening @ no device @ no qualifier||citrate dehydratase (substance)||random
methotrimeprazine||proximal tendon of left adductor brevis||random
spindle cell transitional cell carcinoma of nasopharynx (diagnosis)||count, microbial colony||random
appearance of wound bed of right thigh (physical finding)||mallet thumb with open tendon injury (disorder)||random
lateral meniscus derangement nos||testolactone-containing product in oral dose form||random
sticta limbata||enterococcal infection||random
on a typical weekday in the summer, about how many h did you generally spend in the mid-day sun:nrat:pt:^patient:qn:nhl||medical and surgical @ upper arteries @ occlusion @ hand artery, left @ open @ extraluminal device||random
ramus dexter (arteria hepatica propria)||prostatic massage (treatment)||random
mvta-inj-trapped by bus door - pedestrian injured||silver stain (substance)||random
program flavor tabs 205 mg oral tablet||unclassified baeosciara||random
raised tg||local anesthesia not in conjunction with surgery of nose and sinuses||random
palmatine ion||defluviitalea jabari et al. 2012||random
triclocarban medicated bar soap||ct guided injection of thoracic spinal nerve root||random
allophanate hydrolase||computed tomography of cervical and lumbar spine with contrast (procedure)||random
structure of left knee joint (body structure)||dr scholl's callous cushion||random
poisoning caused by psilocybin (disorder)||tactile hyperesthesia entire leg left||random
salmonella paratyphi c h ab [titer] in serum||group b1 sox transcription factors||random
hymenoptera sp. bold:aah1107||lumen of trunk of ulnar artery||random
leptomacquartia sp. yymt2013.051||product containing esterified estrogen (medicinal product)||random
benzoyl peroxide 28.3 g in 100 g topical cream [ab skincare acne spot treatment]||periosteum of distal metaphysis of femur||random
babiana horizontalis||drainage of oculomotor nerve, percutaneous approach, diagn||random
chelator sp. vtdes063||plesiodema reuter, 1875||random
cerebroside sulfatase [mass/time] in 24 hour urine||soft tissue swelling of left hand between ring and little finger (symptom)||random
folic acid 2.3 mg||developmental and behavioral screening and testing||random
acetobacter sp. mrl5a||biopsy of lesion of bile duct (procedure)||random
food sweeteners||menu of other findings: systems review||random
abrasion hip/leg-infect||sodium increased||random
corticosteroid injection into t4-t5 epidural space by transforaminal approach||methylobacterium sp. nah_12||random
lesion of bronchus (finding)||pronocephaloidea sp. s5m1a5(m)||random
medical and surgical @ female reproductive system @ revision @ ovary @ external||phorbols||random
medical and surgical @ lower veins @ restriction @ saphenous vein, right @ percutaneous endoscopic @ no device @ no qualifier||1.8 ml bupivacaine hydrochloride 5 mg/ml / epinephrine 0.005 mg/ml cartridge [marcaine with epinephrine]||random
bacterium b11||fungal sp. mkotu2||random
tgfbi, arg124his||crabronidae sp. indobiosys-ccdb26208-e09||random
lipoprotein abnormal||acalonoma pusilla||random
desulfovibrio sp. c4eb.3.4223||gluten-free bread and bread rolls (substance)||random
surgical treatment of ectopic pregnancy; cervical, with evacuation||auditory dysfunction, central||random
roxanol 10 mg rectal suppository||unclassified heveochlorella||random
breads||cw-270033||random
product containing hydrocodone bitartrate 5 mg and ibuprofen 200 mg/1 each oral tablet||leukocyte apheresis - cmv negative (product)||random
intentional hyoscine poisoning (disorder)||right second thoracic nerve||random
vasculature of right cheek||adverse reaction to water, mineral or uric acid metabolism drug nos (disorder)||random
skin alt/wdlps||protojujuboside a||random
mona (multicentric osteolysis nodulosis arthropathy) spectrum||retinal neovascularization, unspecified, unspecified eye||random
ventilator (continually or at night)||helichrysums||random
imaging @ non-axial lower bones @ computerized tomography (ct scan) @ hip, left @ none||stage level 2||random
apoidea sp. ge_be09||pulmonary carcinoma cell type unspecified stage ii||random
naloxone hydrochloride 400mcg/ml injection solution 1ml ampule||bacterium ml2-25||random
gyrus uncinatus||product containing only doxycycline in oral dose form (medicinal product form)||random
anterior bronchopulmonary part of bronchial vein||styracaceae||random
metformin and repaglinide only product in oral dose form||kynurenine formamidase||random
namzaric 21 mg / 10 mg 24hr extended release oral capsule||autopsy, complete gross and microscopic examination, excluding cns||random
skin of temple||post-traumatic wound infection (disorder)||random
unclassified hieracium||tnpo3, arg818pro||random
acquired hallux limitus of bilateral great toes (disorder)||putting on and taking off footwear - functional goal:find:pt:^patient:ord:cms assessment||random
amiodarone hydrochloride 50 mg/ml includes injectable solution and injection||syagrus romanzoffiana pollen 0.1 g in 1 ml intradermal solution [queen palm pollen]||random
interpersonal relationship status family [omaha]||piperlactam s||random
done (qualifier value)||blood alkaline phosphatase intestine||random
impairment of auditory discrimination (finding)||[x]ign/melt nightwear os place||random
tests, skin irritancy||hypocalcemic rickets (disorder)||random
aristolochia sp. lw-2014||arteriovenous fistula site edema||random
aluminum chlorohydrate 20.2 g in 100 g topical aerosol, spray [equate cool mist antiperspirant]||(pll-ha)12||random
severe acute respiratory syndrome nos||num of w postpartum||random
mullerian regression factor||war injury from bullets||random
intentional aflatoxin poisoning||transfer summary note:find:pt:{setting}:doc:rheumatology||random
transient synovitis of hip (disorder)||adhesion of ciliary body||random
octinoxate 50 mg in 1 g / octisalate 30 mg in 1 g / avobenzone 20 mg in 1 g / oxybenzone 20 mg in 1 g / octocrylene 15 mg in 1 g topical lotion [islander spf6]||lateral basal bronchopulmonary part of bronchial artery||random
docimocaria||lenegre disease||random
other specific arthropathies, not elsewhere classified, unspecified site||malignant neoplasm of ill-defined sites within the lip and oral cavity stage i||random
amyloflagellula verrucosa agerer & boidin, 1981||idiopathic chronic gout, unspecified hip||random
parenteral nutrition solution w/electrolytes amino acids 3.5% with electrolytes (travasol) intravenous solution||sister chromatid cohesion||random
col1a2 gene||mrrsdc||random
epstein-barr virus antibody measurement||chronic serosanguineous otitis media of bilateral middle ears||random
anal fistulectomy (treatment)||ivd test reagent/kits, microbiology, bacteria, susceptibility, automated test||random
stage iii appendix neuroendocrine tumor ajcc v8||cervical fracture||random
duodenal ulcer caused by h. pylori (helicobacter pylori)||unclassified isotoma (in: arthropoda)||random
keratomalacia nos (disorder)||tetragnatha||random
laceration of axillary artery, unspecified side, subsequent encounter||parametritis and pelvic cellulitis nos||random
cefadroxil hemihydrate||agenesis; hair||random
endotoxin 1||bedellia||random
bypass l kidney pelvis to colocutan w autol sub, perc endo||medical and surgical @ peripheral nervous system @ release @ sciatic nerve||random
hsv 2 dna naa+probe ql (genital specimen)||sinus cancer metastatic||random
registered with job center (finding)||trimetaphan only product in parenteral dose form||random
nystagmus examination||torulopsis infection||random
aphanius||unknown if any hormone therapy administered; date unknown, o||random
food in esophagus causing other injury||ovarian germ cell polyembryoma stage i||random
intestinal type adenocarcinoma of large intestine (diagnosis)||2-deoxyglucosidase (substance)||random
cancer screening||copolymer 1||random
dicrotendipes sp. bioug27639-g05||vesicular stomatitis new jersey virus ab &#x7c; serum &#x7c; microbiology||random
aerosporin injectable product||neomycin and polymyxin b sulfates and hydrocortisone otic solution||random
open fracture hamate||coronary artery double arterial graft (treatment)||random
fusion plus, vitamin b complex with c, folic acid, iron and probiotics oral capsule||cardioverter-defibrillator final programmed parameters zone 1||random
msrescat||mammary duct; ectasia||random
coxiella burnetii ag||benzalkonium chloride 0.125 g in 100 g / alcohol 5 g in 100 g topical cloth [magic wipes]||random
medical and surgical @ lower bones @ destruction @ pelvic bone, left @ open||stoma site cellulitis||random
jerboa, nos||yellow skin rash (symptom)||random
pedestrian on snowboard injured in collision with other nonmotor vehicle in nontraffic accident||warfarin serpl ql||random
trunk vesicle||mesocolic lymph nodes||random
phacocystectomy||peritoneal catheter dysfunction||random
diagnostic radiologic examination with fluoroscopy, larynx||carbamoyl-phosphate synthetase i deficiency disease||random
retired procedure (procedure) [82370001]||muscle fasciculus of medial rectus||random
incision and drainage of deep hematoma of knee region (procedure)||ambrosia artemisiifolia pollen 4000 [au] in 1 ml / iva annua var. annua pollen 0.002 g in 1 ml / acer negundo pollen 0.002 g in 1 ml / juniperus ashei pollen 0.002 g in 1 ml / juglans nigra pollen 0.002 g in 1 ml / platanus occidentalis pollen 0.002 g in 1 ml / populus deltoides pollen 0.002 g in 1 ml / fraxinus americana pollen 0.002 g in 1 ml / quercus alba pollen 0.002 g in 1 ml / ulmus americana pollen 0.002 g in 1 ml / anthoxanthum odoratum pollen 4000 [bau] in 1 ml / cynodon dactylon pollen 400 [bau] in 1 ml / lolium perenne pollen 4000 [bau] in 1 ml / phleum pratense pollen 4000 [bau] in 1 ml / sorghum halepense pollen 0.002 g in 1 ml / plantago lanceolata pollen 0.002 g in 1 ml / chenopodium album pollen 0.002 g in 1 ml / salsola kali pollen 0.002 g in 1 ml / amaranthus retroflexus pollen 0.002 g in 1 ml / rumex acetosella pollen 0.002 g in 1 ml / carya alba pollen 0.001 g in 1 ml / carya illinoinensis pollen 0.001 g in 1 ml / mucor racemosus 0.002 g in 1 ml / morus alba pollen 0.002 g in 1 ml / periplaneta americana 0.002 g in 1 ml subcutaneous injection, solution||random
cardiac catheterization coronary artery bypass graft body fourth saphenous vein graft flow retrograde (procedure)||neuroglial network of gray matter of l2 segment||random
sulfuric acid 6 [hp_x] in 1 ml / oyster shell calcium carbonate, crude 6 [hp_x] in 1 ml / lycopodium clavatum spore 6 [hp_x] in 1 ml / ammonium bromide 12 [hp_x] in 1 ml / strychnos nux-vomica seed 6 [hp_x] in 1 ml / avena sativa flowering top 6 [hp_x] in 1 ml / graphite 12 [hp_x] in 1 ml / thyroid, unspecified 6 [hp_x] in 1 ml / strychnos ignatii seed 6 [hp_x] in 1 ml / fucus vesiculosus 6 [hp_x] in 1 ml oral liquid [slenderiix]||cardiac catheterization: mean diastolic pressure of common ventricle||random
neisseria meningitidis group y antibody (substance)||disorders of menstruation and other abnormal bleeding from female genital tract||random
active range midtarsal supin||injury of vein of lower limb (disorder)||random
adenosquamous carcinoma of tongue (diagnosis)||509 family trichomonadidae||random
atomoxetine 40 mg oral capsule [strattera]||nordiazepam cutoff:mass concentration:to identify measures at a point in time:saliva:quantitative:confirm||random
adaptinol||plaunotol||random
extirpate of matter from r temporal art, perc endo approach||sprouty homolog 4 (drosophila) protein, xenopus||random
food allergen mix 30a (kiwi+papaya+mango+banana+avocado) ige ab rast class [presence] in serum by multidisk||orbital decompression||random
tubing (physical object)||cervical diseases, uterine||random
deltochilini||nortropanes||random
pelvis endoscopy (procedure)||himalopsyche||random
parapsoriasis varioliformis||lesion of fallopian tube||random
prostatic radiotherapies||thrombophlebitis of left tibial vein (disorder)||random
digital stimulation||therapeutic drug assay - serum or plasma synthetic glucocorticoid||random
exercise-induced asthmas||isopropanol causing tox effect||random
olanzapine pamoate||magnetic resonance imaging thoracic||random
krt1, ile479thr||soap/lanolin@@topical@cleanser (gram)||random
poisoning by local anti-infectives and anti-inflammatory drugs||intentional carmustine poisoning (event)||random
incision and drainage below fascia, with or without tendon sheath involvement, foot; multiple areas||physostigmine sulfate 10 mg/ml eye solution||random
tongue surgery||megaselia sp. bioug22340-f11||random
coffea congensis||g protein coupled receptor 2||random
chemicals - chemical elements - chemical products||excision of tendon for graft (procedure)||random
serum complement c1 esterase inhibitor functional activity||spanish sparrow||random
[x]intentional self harm by explosive material, occurrence at industrial and construction area||wnt signaling pathway inhibitor pri-724||random
nitroglycerin 0.3 mg/hr transdermal system [nitrodisc]||painful os peroneum||random
hormonal therapeutic procedures nec||fas||random
plasma cells/100 leukocytes:nfr:pt:bronchial:qn||study personnel||random
vibratory angio-edema||allergy testing orchard grass erythema||random
redroot sage||aspirin 81 mg oral delayed release tablet||random
hemidesmus||postdysenteric arthropathy, shoulder region||random
maternal and/or fetal condition affecting labor and/or delivery||removal of bile duct prosthesis (procedure)||random
acrylamides||phialocephala w.b. kendr., 1961 <family ophiostomataceae>||random
product containing dichloralphenazone and isometheptene and paracetamol in oral dose form (medicinal product form)||fluorocytosine||random
western ragweed pollen igg||acetaminophen oral tablet [tactinal]||random
aphytis sp. bioug21320-h07||2-hydroxycinnamic acid, (z)-isomer||random
ergotamines||bordetella pertussis+bordetella parapertussis.filamentous hemagglutinin antibody.immunoglobulin a:presence or threshold:to identify measures at a point in time:serum:ordinal:line blot||random
hypocrea sp. crcf16||distal surface of upper first premolar tooth||random
zonular traction peripheral retinal tuft (disorder)||presentation; fetus, in multiple gestation, causing obstructed labor||random
allantoin 0.01 mg/mg / benzocaine 0.2 mg/mg / camphor 0.03 mg/mg / petrolatum 0.649 mg/mg topical ointment||ivd test reagent/kits, serology, bacteria, yersinia species, igg antibody||random
gapdhp50 gene||[x]other bilirubin metabolism disorders (disorder)||random
bradyrhizobium sp. lct2||phensuximide oral tablet||random
joint structure of limb||displaced oblique fracture of shaft of humerus, right arm, subsequent encounter for fracture with nonunion||random
removal of halo device of pelvis||vascellum f. marda, 1958||random
asthma-copd overlap syndrome||tetraclita||random
ivy gourds||macrophage scavenger receptor 1 gene||random
vit-c 250 mg/ml injectable solution||citrullus colocynthis fruit pulp 9 [hp_c] in 9 [hp_c] oral pellet [colocynthis]||random
orchiectomy simple scrotal/inguinal approach||unclassified bacteriophages||random
child health medical examination (procedure)||cryotherapy of benign lesion of skin, single lesion||random
structure of stapedius muscle||stage i adenosquamous cell carcinoma of the lung||random
tissue transglutaminase antibody.immunoglobulin g:presence or threshold:to identify measures at a point in time:serum:ordinal||g immunoglobulins||random
hereditary deafness||medium elast adh no.4 dressing||random
wound infection bacterial||nor passive range thumb abd||random
callaeas wilsoni||unclassified eubacterium||random
contact with centipedes and venomous millipedes (tropical)||von willebrand's factor activity abnormal||random
medical and surgical @ muscles @ supplement @ upper arm muscle, left @ open @ nonautologous tissue substitute||northern ireland (geographic location)||random
product containing levamisole||glutathione increased||random
traumatic injury of celiac artery||primary malignant neoplasm of face (diagnosis)||random
oregano (origanum vulgare) ab||disease of thymus gland, nos||random
iodine 24h ur-mcnc||minor crossmatch [interpretation]||random
incision of left temporomandibular joint extending to fascia (physical finding)||malignant primitive cellular infiltrate||random
drug or chemical induced diabetes mellitus with other diabetic kidney complication||disorder of sex development, 46,xy||random
contraindications, surgery||ipa0308||random
calamine 7.5 % / diphenhydramine hydrochloride 0.93 % topical lotion||austroplebeia sp. symei_n2||random
pulmonary embolism due to and following molar pregnancy||follicular ameloblastoma (morphologic abnormality)||random
plaque of proximal end of middle finger of left hand||stage iv gastric neuroendocrine tumor ajcc v8||random
inhibitors, beta lactamase||capillary of skin||random
aphididae sp. bold:abz7255||egrifta, 1 mg subcutaneous powder for injection||random
aspergillus fumigatus 3||muscskel sympt limb nec||random
heterocyclic cpds||gobiusculus||random
mumps thyroiditis (diagnosis)||olefins, cyclic||random
closed fracture of of navicular bone of wrist (disorder)||2,6-dichloro-n-2-imidazolidinylidenebenzenamine||random
